id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
23504223|NCT00982137|65587774|FG000|Overall Study|Lost to Follow-up|0|||
23504224|NCT00982137|65587775|FG001|Overall Study|Lost to Follow-up|0|||
23504225|NCT00982137|65587776|FG002|Overall Study|Lost to Follow-up|0|||
23504226|NCT00982137|65587777|FG003|Overall Study|Lost to Follow-up|1|||
23706865|NCT04045613|66304268|FG000|Overall Study|Adverse Event|2|||
23504227|NCT00982137|65587774|FG000|Overall Study|Withdrawal by Subject|0|||
23504228|NCT00982137|65587775|FG001|Overall Study|Withdrawal by Subject|1|||
23504229|NCT00982137|65587776|FG002|Overall Study|Withdrawal by Subject|0|||
23504230|NCT00982137|65587777|FG003|Overall Study|Withdrawal by Subject|0|||
23504231|NCT02717611|65587778|FG000|Overall Study|Death|13|||
23504232|NCT02717611|65587778|FG000|Overall Study|Withdrawal by Subject|6|||
23504233|NCT02717611|65587778|FG000|Overall Study|Active, not recruiting|40|||
23504234|NCT02717611|65587778|FG000|Overall Study|Complicating disease|1|||
23504235|NCT03766581|65587779|FG000|Randomization|Other reasons|2|||
23504236|NCT03766581|65587780|FG001|Randomization|Other reasons|1|||
23706866|NCT04045613|66304269|FG001|Overall Study|Adverse Event|2|||
23706867|NCT04045613|66304270|FG002|Overall Study|Adverse Event|1|||
23706868|NCT04045613|66304271|FG003|Overall Study|Adverse Event|1|||
23706869|NCT04045613|66304272|FG004|Overall Study|Adverse Event|0|||
23706870|NCT04045613|66304273|FG005|Overall Study|Adverse Event|0|||
23706871|NCT04045613|66304274|FG006|Overall Study|Adverse Event|1|||
23706872|NCT04045613|66304268|FG000|Overall Study|Withdrawal by Subject|0|||
23706873|NCT04045613|66304269|FG001|Overall Study|Withdrawal by Subject|5|||
23706874|NCT04045613|66304270|FG002|Overall Study|Withdrawal by Subject|0|||
23706875|NCT04045613|66304271|FG003|Overall Study|Withdrawal by Subject|0|||
23706876|NCT04045613|66304272|FG004|Overall Study|Withdrawal by Subject|0|||
23706877|NCT04045613|66304273|FG005|Overall Study|Withdrawal by Subject|1|||
23504237|NCT03766581|65587781|FG002|Randomization|Other reasons|0|||
23504238|NCT03766581|65587782|FG003|Randomization|Other reasons|1|||
23504239|NCT03766581|65587783|FG004|Randomization|Other reasons|0|||
23504240|NCT03766581|65587784|FG005|Randomization|Other reasons|0|||
23504241|NCT03766581|65587785|FG006|Randomization|Other reasons|0|||
23504242|NCT03766581|65587786|FG007|Randomization|Other reasons|0|||
23504243|NCT03766581|65587779|FG000|Randomization|Participant no longer meets study criteria|5|||
23504244|NCT03766581|65587780|FG001|Randomization|Participant no longer meets study criteria|3|||
23504245|NCT03766581|65587781|FG002|Randomization|Participant no longer meets study criteria|4|||
23504246|NCT03766581|65587782|FG003|Randomization|Participant no longer meets study criteria|0|||
23504247|NCT03766581|65587783|FG004|Randomization|Participant no longer meets study criteria|2|||
23504248|NCT03766581|65587784|FG005|Randomization|Participant no longer meets study criteria|3|||
23504249|NCT03766581|65587785|FG006|Randomization|Participant no longer meets study criteria|0|||
23504250|NCT03766581|65587786|FG007|Randomization|Participant no longer meets study criteria|1|||
23504251|NCT03766581|65587779|FG000|Randomization|Participant request to discontinue study treatment|1|||
23504252|NCT03766581|65587780|FG001|Randomization|Participant request to discontinue study treatment|0|||
23504253|NCT03766581|65587781|FG002|Randomization|Participant request to discontinue study treatment|0|||
23504254|NCT03766581|65587782|FG003|Randomization|Participant request to discontinue study treatment|0|||
23504255|NCT03766581|65587783|FG004|Randomization|Participant request to discontinue study treatment|1|||
23504256|NCT03766581|65587784|FG005|Randomization|Participant request to discontinue study treatment|2|||
23504257|NCT03766581|65587785|FG006|Randomization|Participant request to discontinue study treatment|0|||
23504258|NCT03766581|65587786|FG007|Randomization|Participant request to discontinue study treatment|0|||
23504259|NCT03766581|65587779|FG000|Randomization|Participant withdrew consent|1|||
23504260|NCT03766581|65587780|FG001|Randomization|Participant withdrew consent|0|||
23504261|NCT03766581|65587781|FG002|Randomization|Participant withdrew consent|1|||
23504262|NCT03766581|65587782|FG003|Randomization|Participant withdrew consent|2|||
23504263|NCT03766581|65587783|FG004|Randomization|Participant withdrew consent|1|||
23403148|NCT02534883|65223171|FG000|Overall Study|Early Termination|8|||
23504264|NCT03766581|65587784|FG005|Randomization|Participant withdrew consent|1|||
23504265|NCT03766581|65587785|FG006|Randomization|Participant withdrew consent|0|||
23504266|NCT03766581|65587786|FG007|Randomization|Participant withdrew consent|0|||
23504267|NCT03766581|65587779|FG000|Treatment|Adverse Event|82|||
23504268|NCT03766581|65587780|FG001|Treatment|Adverse Event|44|||
23706878|NCT04045613|66304274|FG006|Overall Study|Withdrawal by Subject|0|||
23706879|NCT04045613|66304268|FG000|Overall Study|Physician Decision|2|||
23706880|NCT04045613|66304269|FG001|Overall Study|Physician Decision|0|||
23706881|NCT04045613|66304270|FG002|Overall Study|Physician Decision|0|||
23706882|NCT04045613|66304271|FG003|Overall Study|Physician Decision|0|||
23706883|NCT04045613|66304272|FG004|Overall Study|Physician Decision|1|||
23807645|NCT02516410|66676217|FG000|Overall Study|Adverse Event|0|||
23706884|NCT04045613|66304273|FG005|Overall Study|Physician Decision|0|||
23403149|NCT02534883|65223172|FG001|Overall Study|Early Termination|3|||
23403150|NCT00132301|65223175|FG000|Overall Study|Death|7|||
23807646|NCT02516410|66676218|FG001|Overall Study|Adverse Event|1|||
23807647|NCT02516410|66676217|FG000|Overall Study|Withdrawal by Subject|0|||
23504269|NCT03766581|65587781|FG002|Treatment|Adverse Event|47|||
23504270|NCT03766581|65587782|FG003|Treatment|Adverse Event|46|||
23504271|NCT03766581|65587783|FG004|Treatment|Adverse Event|50|||
23706885|NCT04045613|66304274|FG006|Overall Study|Physician Decision|0|||
23706886|NCT04045613|66304268|FG000|Overall Study|Death|3|||
23706887|NCT04045613|66304269|FG001|Overall Study|Death|0|||
23706888|NCT04045613|66304270|FG002|Overall Study|Death|0|||
23706889|NCT04045613|66304271|FG003|Overall Study|Death|0|||
23706890|NCT04045613|66304272|FG004|Overall Study|Death|0|||
23706891|NCT04045613|66304273|FG005|Overall Study|Death|0|||
23706892|NCT04045613|66304274|FG006|Overall Study|Death|1|||
23706893|NCT04045613|66304268|FG000|Overall Study|Other reasons|0|||
23706894|NCT04045613|66304269|FG001|Overall Study|Other reasons|1|||
23706895|NCT04045613|66304270|FG002|Overall Study|Other reasons|0|||
23706896|NCT04045613|66304271|FG003|Overall Study|Other reasons|0|||
23706897|NCT04045613|66304272|FG004|Overall Study|Other reasons|0|||
23706898|NCT04045613|66304273|FG005|Overall Study|Other reasons|0|||
23706899|NCT04045613|66304274|FG006|Overall Study|Other reasons|1|||
23706900|NCT04045613|66304268|FG000|Overall Study|Progressive disease: Clinical progression|1|||
23706901|NCT04045613|66304269|FG001|Overall Study|Progressive disease: Clinical progression|0|||
23706902|NCT04045613|66304270|FG002|Overall Study|Progressive disease: Clinical progression|3|||
23706903|NCT04045613|66304271|FG003|Overall Study|Progressive disease: Clinical progression|1|||
23706904|NCT04045613|66304272|FG004|Overall Study|Progressive disease: Clinical progression|1|||
23706905|NCT04045613|66304273|FG005|Overall Study|Progressive disease: Clinical progression|3|||
23706906|NCT04045613|66304274|FG006|Overall Study|Progressive disease: Clinical progression|3|||
23706907|NCT04045613|66304268|FG000|Overall Study|Progressive disease: Radiological progression|24|||
23706908|NCT04045613|66304269|FG001|Overall Study|Progressive disease: Radiological progression|6|||
23706909|NCT04045613|66304270|FG002|Overall Study|Progressive disease: Radiological progression|8|||
23706910|NCT04045613|66304271|FG003|Overall Study|Progressive disease: Radiological progression|0|||
23706911|NCT04045613|66304272|FG004|Overall Study|Progressive disease: Radiological progression|6|||
23706912|NCT04045613|66304273|FG005|Overall Study|Progressive disease: Radiological progression|6|||
23706913|NCT04045613|66304274|FG006|Overall Study|Progressive disease: Radiological progression|11|||
23706914|NCT01345123|66304275|FG000|Overall Study|participants no longer with health plan|79|||
23706915|NCT01345123|66304276|FG001|Overall Study|participants no longer with health plan|85|||
23706916|NCT01345123|66304277|FG002|Overall Study|participants no longer with health plan|88|||
23706917|NCT01597622|66304280|FG000|Overall Study|Adverse Event|7|||
23706918|NCT01597622|66304280|FG000|Overall Study|Lack of Efficacy|3|||
23706919|NCT01597622|66304280|FG000|Overall Study|Protocol Violation|1|||
23706920|NCT01597622|66304280|FG000|Overall Study|Lost to Follow-up|1|||
23706921|NCT01597622|66304280|FG000|Overall Study|Investigator Discretion|5|||
23706922|NCT01597622|66304280|FG000|Overall Study|Withdrawal by Subject|20|||
23706923|NCT01597622|66304280|FG000|Overall Study|Death|1|||
23706924|NCT01994226|66304281|FG000|Overall Study|Protocol Violation|13|||
23706925|NCT01994226|66304282|FG001|Overall Study|Protocol Violation|10|||
23706926|NCT01994226|66304281|FG000|Overall Study|Early Cessation of treatment|6|||
23706927|NCT01994226|66304282|FG001|Overall Study|Early Cessation of treatment|11|||
23706928|NCT00986258|66304283|FG000|Observation Period|Not eligible to be dosed|11|||
23706929|NCT00986258|66304283|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
23706930|NCT00986258|66304283|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
23504272|NCT03766581|65587784|FG005|Treatment|Adverse Event|77|||
23504273|NCT03766581|65587785|FG006|Treatment|Adverse Event|5|||
23706931|NCT00986258|66304283|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
23706932|NCT00986258|66304283|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
23706933|NCT00986258|66304283|FG000|Titration and Optimal Dose Period|Other|1|||
23706934|NCT00986258|66304283|FG000|Maintenance Period|Adverse Event|5|||
23706935|NCT00986258|66304283|FG000|Maintenance Period|Lack of Efficacy|2|||
23706936|NCT00986258|66304283|FG000|Maintenance Period|Withdrawal by Subject|2|||
23706937|NCT02773238|66304284|FG000|Overall Study|Lack of Efficacy|4|||
23706938|NCT03699631|66304285|FG000|Overall Study|Adverse Event|3|||
23706939|NCT01746732|66304291|FG000|Lead-In Period|Withdrawal by Subject|1|||
23706940|NCT01746732|66304292|FG001|Lead-In Period|Withdrawal by Subject|0|||
23706941|NCT01746732|66304293|FG002|Lead-In Period|Withdrawal by Subject|0|||
23706942|NCT01746732|66304291|FG000|Period 1|Physician Decision|0|||
23706943|NCT01746732|66304292|FG001|Period 1|Physician Decision|1|||
23706944|NCT01746732|66304293|FG002|Period 1|Physician Decision|0|||
23504274|NCT03766581|65587786|FG007|Treatment|Adverse Event|2|||
23706945|NCT01746732|66304291|FG000|Period 2|Withdrawal by Subject|0|||
23706946|NCT01746732|66304292|FG001|Period 2|Withdrawal by Subject|0|||
23706947|NCT01746732|66304293|FG002|Period 2|Withdrawal by Subject|2|||
23706948|NCT01746732|66304291|FG000|Period 2|Adverse Event|0|||
23706949|NCT01746732|66304292|FG001|Period 2|Adverse Event|0|||
23706950|NCT01746732|66304293|FG002|Period 2|Adverse Event|1|||
23504275|NCT03766581|65587779|FG000|Treatment|Participant request to discontinue treatment|34|||
23504276|NCT03766581|65587780|FG001|Treatment|Participant request to discontinue treatment|6|||
23706951|NCT01746732|66304291|FG000|Period 2|Lost to Follow-up|0|||
23706952|NCT01746732|66304292|FG001|Period 2|Lost to Follow-up|0|||
23706953|NCT01746732|66304293|FG002|Period 2|Lost to Follow-up|1|||
23706954|NCT03504774|66304299|FG000|Overall Study|Adverse Event|2|||
23706955|NCT03504774|66304300|FG001|Overall Study|Adverse Event|0|||
23706956|NCT03504774|66304299|FG000|Overall Study|Lost to Follow-up|0|||
23706957|NCT03504774|66304300|FG001|Overall Study|Lost to Follow-up|1|||
23706958|NCT03504774|66304299|FG000|Overall Study|Protocol Violation|11|||
23504277|NCT03766581|65587781|FG002|Treatment|Participant request to discontinue treatment|10|||
23706959|NCT03504774|66304300|FG001|Overall Study|Protocol Violation|3|||
23706960|NCT03504774|66304299|FG000|Overall Study|failed wk 52 DBPCFC|1|||
23706961|NCT03504774|66304300|FG001|Overall Study|failed wk 52 DBPCFC|0|||
23706962|NCT01515306|66304304|FG000|Overall Study|Adverse Event|3|||
23706963|NCT01515306|66304305|FG001|Overall Study|Adverse Event|2|||
23706964|NCT01515306|66304304|FG000|Overall Study|Progressive Disease|19|||
23706965|NCT01515306|66304305|FG001|Overall Study|Progressive Disease|9|||
23706966|NCT01515306|66304304|FG000|Overall Study|Withdrawal by Subject|1|||
23706967|NCT01515306|66304305|FG001|Overall Study|Withdrawal by Subject|2|||
23706968|NCT01515306|66304304|FG000|Overall Study|Physician Decision|1|||
23706969|NCT01515306|66304305|FG001|Overall Study|Physician Decision|1|||
23706970|NCT02280291|66304306|FG000|Overall Study|Lost to Follow-up|2|||
23706971|NCT02280291|66304307|FG001|Overall Study|Lost to Follow-up|1|||
23706972|NCT02280291|66304308|FG002|Overall Study|Lost to Follow-up|3|||
23504278|NCT03766581|65587782|FG003|Treatment|Participant request to discontinue treatment|10|||
23504279|NCT03766581|65587783|FG004|Treatment|Participant request to discontinue treatment|14|||
23504280|NCT03766581|65587784|FG005|Treatment|Participant request to discontinue treatment|15|||
23504281|NCT03766581|65587785|FG006|Treatment|Participant request to discontinue treatment|0|||
23504282|NCT03766581|65587786|FG007|Treatment|Participant request to discontinue treatment|1|||
23504283|NCT03766581|65587779|FG000|Treatment|Participant withdrew consent|11|||
23504284|NCT03766581|65587780|FG001|Treatment|Participant withdrew consent|4|||
23403151|NCT00132301|65223176|FG001|Overall Study|Death|6|||
23403152|NCT00132301|65223175|FG000|Overall Study|Withdrawal by Subject|5|||
23403153|NCT00132301|65223176|FG001|Overall Study|Withdrawal by Subject|2|||
23403154|NCT00132301|65223175|FG000|Overall Study|Physician Decision|1|||
23403155|NCT00132301|65223176|FG001|Overall Study|Physician Decision|1|||
23403156|NCT00132301|65223175|FG000|Overall Study|Lost to Follow-up|5|||
23403157|NCT00132301|65223176|FG001|Overall Study|Lost to Follow-up|3|||
23403158|NCT00132301|65223175|FG000|Overall Study|Other|1|||
23403159|NCT00132301|65223176|FG001|Overall Study|Other|1|||
23403160|NCT00132301|65223175|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
23403161|NCT00132301|65223176|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
23403162|NCT01402869|65223177|FG000|Overall Study|Required Tooth Extraction|0|||
23403163|NCT01402869|65223178|FG001|Overall Study|Required Tooth Extraction|0|||
23403164|NCT01402869|65223179|FG002|Overall Study|Required Tooth Extraction|1|||
23403165|NCT00553631|65223184|FG000|Overall Study|Withdrawal by Subject|0|||
23403166|NCT00553631|65223185|FG001|Overall Study|Withdrawal by Subject|1|||
23403167|NCT00553631|65223184|FG000|Overall Study|Lost to Follow-up|1|||
23706973|NCT02280291|66304309|FG003|Overall Study|Lost to Follow-up|8|||
23706974|NCT02280291|66304306|FG000|Overall Study|Protocol Violation|1|||
23706975|NCT02280291|66304307|FG001|Overall Study|Protocol Violation|0|||
23706976|NCT02280291|66304308|FG002|Overall Study|Protocol Violation|0|||
23706977|NCT02280291|66304309|FG003|Overall Study|Protocol Violation|0|||
23706978|NCT02280291|66304306|FG000|Overall Study|Other|1|||
23706979|NCT02280291|66304307|FG001|Overall Study|Other|1|||
23706980|NCT02280291|66304308|FG002|Overall Study|Other|0|||
23706981|NCT02280291|66304309|FG003|Overall Study|Other|0|||
23706982|NCT04369430|66304310|FG000|Overall Study|Adverse Event|2|||
23706983|NCT04369430|66304311|FG001|Overall Study|Adverse Event|3|||
23706984|NCT04369430|66304310|FG000|Overall Study|Death|1|||
23706985|NCT04369430|66304311|FG001|Overall Study|Death|0|||
23706986|NCT04369430|66304310|FG000|Overall Study|Withdrawal by Subject|4|||
23706987|NCT04369430|66304311|FG001|Overall Study|Withdrawal by Subject|3|||
23706988|NCT04369430|66304310|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
23706989|NCT04369430|66304311|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
23706990|NCT04369430|66304310|FG000|Overall Study|Lost to Follow-up|0|||
23706991|NCT04369430|66304311|FG001|Overall Study|Lost to Follow-up|1|||
23706992|NCT00488618|66304312|FG000|Overall Study|Adverse Event|13|||
23403168|NCT00553631|65223185|FG001|Overall Study|Lost to Follow-up|0|||
23403169|NCT00950651|65223186|FG000|Overall Study|Adverse Event|17|||
23706993|NCT00488618|66304313|FG001|Overall Study|Adverse Event|17|||
23706994|NCT00488618|66304312|FG000|Overall Study|Insufficient Therapeutic Response|18|||
23706995|NCT00488618|66304313|FG001|Overall Study|Insufficient Therapeutic Response|11|||
23807648|NCT02516410|66676218|FG001|Overall Study|Withdrawal by Subject|1|||
23403170|NCT00950651|65223187|FG001|Overall Study|Adverse Event|20|||
23403171|NCT00950651|65223186|FG000|Overall Study|Death|1|||
23706996|NCT00488618|66304312|FG000|Overall Study|Protocol Violation|0|||
23706997|NCT00488618|66304313|FG001|Overall Study|Protocol Violation|2|||
23706998|NCT00488618|66304312|FG000|Overall Study|Withdrawal of Consent|15|||
23706999|NCT00488618|66304313|FG001|Overall Study|Withdrawal of Consent|13|||
23807649|NCT00468650|66676219|FG000|Overall Study|Lost to Follow-up|4|||
23707000|NCT00488618|66304312|FG000|Overall Study|Lost to Follow-up|1|||
23707001|NCT00488618|66304313|FG001|Overall Study|Lost to Follow-up|0|||
23707002|NCT00516269|66304314|FG000|Overall Study|Adverse Event|2|||
23707003|NCT00516269|66304315|FG001|Overall Study|Adverse Event|1|||
23707004|NCT00516269|66304314|FG000|Overall Study|Lost to Follow-up|0|||
23707005|NCT00516269|66304315|FG001|Overall Study|Lost to Follow-up|1|||
23707006|NCT00516269|66304314|FG000|Overall Study|Protocol Violation|0|||
23707007|NCT00516269|66304315|FG001|Overall Study|Protocol Violation|1|||
23707008|NCT03123354|66304316|FG000|Overall Study|Physician Decision|6|||
23707009|NCT01202227|66304317|FG000|Overall Study|Adverse Event|16|||
23707010|NCT01202227|66304317|FG000|Overall Study|Withdrawal by Subject|2|||
23707011|NCT01202227|66304317|FG000|Overall Study|Lack of Efficacy|1|||
23707012|NCT00414310|66304321|FG000|Overall Study|Not treated|1|||
23707013|NCT00414310|66304322|FG001|Overall Study|Not treated|0|||
23707014|NCT00678587|66304323|FG000|Overall Study|Adverse Event|3|||
23707015|NCT00678587|66304324|FG001|Overall Study|Adverse Event|3|||
23504285|NCT03766581|65587781|FG002|Treatment|Participant withdrew consent|5|||
23504286|NCT03766581|65587782|FG003|Treatment|Participant withdrew consent|5|||
23707016|NCT00678587|66304323|FG000|Overall Study|Lack of Efficacy|1|||
23707017|NCT00678587|66304324|FG001|Overall Study|Lack of Efficacy|0|||
23504287|NCT03766581|65587783|FG004|Treatment|Participant withdrew consent|4|||
23504288|NCT03766581|65587784|FG005|Treatment|Participant withdrew consent|4|||
23707018|NCT00678587|66304323|FG000|Overall Study|Protocol Violation|2|||
23707019|NCT00678587|66304324|FG001|Overall Study|Protocol Violation|1|||
23707020|NCT00678587|66304323|FG000|Overall Study|Study Closed/Terminated|1|||
23707021|NCT00678587|66304324|FG001|Overall Study|Study Closed/Terminated|0|||
23707022|NCT00678587|66304323|FG000|Overall Study|Lost to Follow-up|3|||
23707023|NCT00678587|66304324|FG001|Overall Study|Lost to Follow-up|5|||
23707024|NCT00678587|66304323|FG000|Overall Study|Investigator Discretion|2|||
23707025|NCT00678587|66304324|FG001|Overall Study|Investigator Discretion|6|||
23707026|NCT00678587|66304323|FG000|Overall Study|Withdrew Consent|8|||
23707027|NCT00678587|66304324|FG001|Overall Study|Withdrew Consent|3|||
23707028|NCT02202031|66304327|FG000|Overall Study|Lost to Follow-up|1|||
23707029|NCT02202031|66304328|FG001|Overall Study|Lost to Follow-up|0|||
23707030|NCT02202031|66304327|FG000|Overall Study|Too Busy|1|||
23707031|NCT02202031|66304328|FG001|Overall Study|Too Busy|3|||
23707032|NCT02202031|66304327|FG000|Overall Study|Illness/Medical Reason|0|||
23707033|NCT02202031|66304328|FG001|Overall Study|Illness/Medical Reason|2|||
23707034|NCT02202031|66304327|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
23707035|NCT02202031|66304328|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
23707036|NCT01683071|66304329|FG000|Part 1|Lack of Efficacy|1|||
23707037|NCT01683071|66304330|FG001|Part 1|Lack of Efficacy|0|||
23707038|NCT01683071|66304331|FG002|Part 1|Lack of Efficacy|0|||
23707039|NCT01683071|66304332|FG003|Part 1|Lack of Efficacy|3|||
23707040|NCT01683071|66304333|FG004|Part 1|Lack of Efficacy|0|||
23707041|NCT01683071|66304334|FG005|Part 1|Lack of Efficacy|0|||
23707042|NCT01683071|66304329|FG000|Part 1|Withdrawal by Subject|1|||
23707043|NCT01683071|66304330|FG001|Part 1|Withdrawal by Subject|2|||
23707044|NCT01683071|66304331|FG002|Part 1|Withdrawal by Subject|2|||
23707045|NCT01683071|66304332|FG003|Part 1|Withdrawal by Subject|1|||
23707046|NCT01683071|66304333|FG004|Part 1|Withdrawal by Subject|0|||
23707047|NCT01683071|66304334|FG005|Part 1|Withdrawal by Subject|0|||
23707048|NCT01683071|66304329|FG000|Part 1|Surgery Cancelled|1|||
23707049|NCT01683071|66304330|FG001|Part 1|Surgery Cancelled|0|||
23707050|NCT01683071|66304331|FG002|Part 1|Surgery Cancelled|0|||
23707051|NCT01683071|66304332|FG003|Part 1|Surgery Cancelled|0|||
23707052|NCT01683071|66304333|FG004|Part 1|Surgery Cancelled|0|||
23707053|NCT01683071|66304334|FG005|Part 1|Surgery Cancelled|0|||
23707054|NCT01683071|66304329|FG000|Part 1|Did not receive study drug|1|||
23707055|NCT01683071|66304330|FG001|Part 1|Did not receive study drug|0|||
23707056|NCT01683071|66304331|FG002|Part 1|Did not receive study drug|0|||
23707057|NCT01683071|66304332|FG003|Part 1|Did not receive study drug|1|||
23707058|NCT01683071|66304333|FG004|Part 1|Did not receive study drug|0|||
23707059|NCT01683071|66304334|FG005|Part 1|Did not receive study drug|0|||
23403172|NCT00950651|65223187|FG001|Overall Study|Death|0|||
23403173|NCT00950651|65223186|FG000|Overall Study|Lack of Efficacy|2|||
23403174|NCT00950651|65223187|FG001|Overall Study|Lack of Efficacy|2|||
23403175|NCT00950651|65223186|FG000|Overall Study|Protocol Violation|3|||
23707060|NCT01683071|66304329|FG000|Part 1|Early termination; met exclusion criteria|0|||
23707061|NCT01683071|66304330|FG001|Part 1|Early termination; met exclusion criteria|2|||
23403176|NCT00950651|65223187|FG001|Overall Study|Protocol Violation|4|||
23707062|NCT01683071|66304331|FG002|Part 1|Early termination; met exclusion criteria|1|||
23707063|NCT01683071|66304332|FG003|Part 1|Early termination; met exclusion criteria|0|||
23707064|NCT01683071|66304333|FG004|Part 1|Early termination; met exclusion criteria|0|||
23707065|NCT01683071|66304334|FG005|Part 1|Early termination; met exclusion criteria|0|||
23707066|NCT01683071|66304329|FG000|Part 2|Lack of Efficacy|0|||
23707067|NCT01683071|66304330|FG001|Part 2|Lack of Efficacy|0|||
23707068|NCT01683071|66304331|FG002|Part 2|Lack of Efficacy|0|||
23504289|NCT03766581|65587785|FG006|Treatment|Participant withdrew consent|0|||
23707069|NCT01683071|66304332|FG003|Part 2|Lack of Efficacy|0|||
23707070|NCT01683071|66304333|FG004|Part 2|Lack of Efficacy|3|||
23707071|NCT01683071|66304334|FG005|Part 2|Lack of Efficacy|4|||
23403177|NCT00950651|65223186|FG000|Overall Study|Withdrawal by Subject|8|||
23707072|NCT01683071|66304329|FG000|Part 2|Lost to Follow-up|0|||
23707073|NCT01683071|66304330|FG001|Part 2|Lost to Follow-up|0|||
23707074|NCT01683071|66304331|FG002|Part 2|Lost to Follow-up|0|||
23707075|NCT01683071|66304332|FG003|Part 2|Lost to Follow-up|0|||
23707076|NCT01683071|66304333|FG004|Part 2|Lost to Follow-up|2|||
23707077|NCT01683071|66304334|FG005|Part 2|Lost to Follow-up|0|||
23403178|NCT00950651|65223187|FG001|Overall Study|Withdrawal by Subject|9|||
23403179|NCT04179305|65223190|FG000|Overall Study|Death|1|||
23403180|NCT04179305|65223191|FG001|Overall Study|Death|1|||
23403181|NCT04179305|65223192|FG002|Overall Study|Death|0|||
23403182|NCT04179305|65223193|FG003|Overall Study|Death|0|||
23403183|NCT04179305|65223190|FG000|Overall Study|Lost to Follow-up|1|||
23403184|NCT04179305|65223191|FG001|Overall Study|Lost to Follow-up|1|||
23403185|NCT04179305|65223192|FG002|Overall Study|Lost to Follow-up|0|||
23403186|NCT04179305|65223193|FG003|Overall Study|Lost to Follow-up|0|||
23403187|NCT04179305|65223190|FG000|Overall Study|Withdrawal by Subject|0|||
23403188|NCT04179305|65223191|FG001|Overall Study|Withdrawal by Subject|1|||
23403189|NCT04179305|65223192|FG002|Overall Study|Withdrawal by Subject|0|||
23403190|NCT04179305|65223193|FG003|Overall Study|Withdrawal by Subject|0|||
23403191|NCT04179305|65223190|FG000|Overall Study|Did not have scan|1|||
23403192|NCT04179305|65223191|FG001|Overall Study|Did not have scan|0|||
23403193|NCT04179305|65223192|FG002|Overall Study|Did not have scan|0|||
23403194|NCT04179305|65223193|FG003|Overall Study|Did not have scan|0|||
23403195|NCT04179305|65223190|FG000|Overall Study|In hospice care|3|||
23403196|NCT04179305|65223191|FG001|Overall Study|In hospice care|0|||
23403197|NCT04179305|65223192|FG002|Overall Study|In hospice care|0|||
23707078|NCT01683071|66304329|FG000|Part 2|Withdrawal by Subject|0|||
23707079|NCT01683071|66304330|FG001|Part 2|Withdrawal by Subject|0|||
23707080|NCT01683071|66304331|FG002|Part 2|Withdrawal by Subject|0|||
23707081|NCT01683071|66304332|FG003|Part 2|Withdrawal by Subject|0|||
23707082|NCT01683071|66304333|FG004|Part 2|Withdrawal by Subject|3|||
23707083|NCT01683071|66304334|FG005|Part 2|Withdrawal by Subject|3|||
23707084|NCT01683071|66304329|FG000|Part 2|Surgery cancelled|0|||
23707085|NCT01683071|66304330|FG001|Part 2|Surgery cancelled|0|||
23707086|NCT01683071|66304331|FG002|Part 2|Surgery cancelled|0|||
23707087|NCT01683071|66304332|FG003|Part 2|Surgery cancelled|0|||
23707088|NCT01683071|66304333|FG004|Part 2|Surgery cancelled|4|||
23403198|NCT04179305|65223193|FG003|Overall Study|In hospice care|0|||
23707089|NCT01683071|66304334|FG005|Part 2|Surgery cancelled|2|||
23707090|NCT01683071|66304329|FG000|Part 2|Did not receive study drug|0|||
23707091|NCT01683071|66304330|FG001|Part 2|Did not receive study drug|0|||
23707092|NCT01683071|66304331|FG002|Part 2|Did not receive study drug|0|||
23707093|NCT01683071|66304332|FG003|Part 2|Did not receive study drug|0|||
23707094|NCT01683071|66304333|FG004|Part 2|Did not receive study drug|2|||
23707095|NCT01683071|66304334|FG005|Part 2|Did not receive study drug|1|||
23707096|NCT01683071|66304329|FG000|Part 2|Met exclusion criterion|0|||
23707097|NCT01683071|66304330|FG001|Part 2|Met exclusion criterion|0|||
23707098|NCT01683071|66304331|FG002|Part 2|Met exclusion criterion|0|||
23707099|NCT01683071|66304332|FG003|Part 2|Met exclusion criterion|0|||
23707100|NCT01683071|66304333|FG004|Part 2|Met exclusion criterion|1|||
23707101|NCT01683071|66304334|FG005|Part 2|Met exclusion criterion|1|||
23707102|NCT01683071|66304329|FG000|Part 2|Protocol deviation|0|||
23707103|NCT01683071|66304330|FG001|Part 2|Protocol deviation|0|||
23707104|NCT01683071|66304331|FG002|Part 2|Protocol deviation|0|||
23707105|NCT01683071|66304332|FG003|Part 2|Protocol deviation|0|||
23707106|NCT01683071|66304333|FG004|Part 2|Protocol deviation|1|||
23707107|NCT01683071|66304334|FG005|Part 2|Protocol deviation|2|||
23707108|NCT01683071|66304329|FG000|Part 2|Withdrawal by investigator decision|0|||
23403199|NCT03389308|65223200|FG000|Overall Study|Withdrawal by Subject|5|||
23403200|NCT03389308|65223200|FG000|Overall Study|Lost to Follow-up|3|||
23403201|NCT03389308|65223200|FG000|Overall Study|Adverse Event|2|||
23403202|NCT03389308|65223200|FG000|Overall Study|Sponsor Request|2|||
23707109|NCT01683071|66304330|FG001|Part 2|Withdrawal by investigator decision|0|||
23403203|NCT00038948|65223201|FG000|Overall Study|Adverse Event|131|||
23403204|NCT00038948|65223202|FG001|Overall Study|Adverse Event|43|||
23707110|NCT01683071|66304331|FG002|Part 2|Withdrawal by investigator decision|0|||
23707111|NCT01683071|66304332|FG003|Part 2|Withdrawal by investigator decision|0|||
23707112|NCT01683071|66304333|FG004|Part 2|Withdrawal by investigator decision|1|||
23707113|NCT01683071|66304334|FG005|Part 2|Withdrawal by investigator decision|2|||
23707114|NCT01586156|66304337|FG000|Overall Study|Pregnancy|0|||
23707115|NCT01586156|66304338|FG001|Overall Study|Pregnancy|1|||
23707116|NCT01586156|66304339|FG002|Overall Study|Pregnancy|0|||
23707117|NCT02433288|66304340|FG000|Overall Study|Severe non-compliance to protocol|13|||
23707118|NCT02433288|66304341|FG001|Overall Study|Severe non-compliance to protocol|7|||
23403205|NCT00038948|65223201|FG000|Overall Study|Lost to Follow-up|4|||
23403206|NCT00038948|65223202|FG001|Overall Study|Lost to Follow-up|4|||
23707119|NCT02433288|66304340|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
23707120|NCT02433288|66304341|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
23707121|NCT02433288|66304340|FG000|Overall Study|Withdrawal by Subject|101|||
23707122|NCT02433288|66304341|FG001|Overall Study|Withdrawal by Subject|99|||
23707123|NCT02433288|66304340|FG000|Overall Study|Lost to Follow-up|2|||
23707124|NCT02433288|66304341|FG001|Overall Study|Lost to Follow-up|14|||
23707125|NCT02433288|66304340|FG000|Overall Study|Death|0|||
23707126|NCT02433288|66304341|FG001|Overall Study|Death|3|||
23707127|NCT03215264|66304342|FG000|Dose Level 2|Adverse Event|0|||
23707128|NCT03215264|66304343|FG001|Dose Level 2|Adverse Event|1|||
23707129|NCT03215264|66304344|FG002|Dose Level 2|Adverse Event|0|||
23707130|NCT03215264|66304342|FG000|Dose Level 3|Withdrawal by Subject|0|||
23707131|NCT03215264|66304343|FG001|Dose Level 3|Withdrawal by Subject|0|||
23707132|NCT03215264|66304344|FG002|Dose Level 3|Withdrawal by Subject|1|||
23403207|NCT00038948|65223201|FG000|Overall Study|Nonmedical event|5|||
23403208|NCT00038948|65223202|FG001|Overall Study|Nonmedical event|7|||
23403209|NCT00038948|65223201|FG000|Overall Study|Withdrawal by Subject|23|||
23403210|NCT00038948|65223202|FG001|Overall Study|Withdrawal by Subject|10|||
23403211|NCT00038948|65223201|FG000|Overall Study|Protocol Violation|3|||
23403212|NCT00038948|65223202|FG001|Overall Study|Protocol Violation|7|||
23403213|NCT00038948|65223201|FG000|Overall Study|Lack of Efficacy|3|||
23403214|NCT00038948|65223202|FG001|Overall Study|Lack of Efficacy|6|||
23403215|NCT04774380|65223203|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
23403216|NCT00881894|65223204|FG000|Overall Study|Consent withdrawn|0|||
23403217|NCT00881894|65223205|FG001|Overall Study|Consent withdrawn|1|||
23403218|NCT00881894|65223204|FG000|Overall Study|Other reasons for premature termination|1|||
23403219|NCT00881894|65223205|FG001|Overall Study|Other reasons for premature termination|2|||
23403220|NCT00142792|65223206|FG000|Overall Study|Death|0|||
23403221|NCT00142792|65223207|FG001|Overall Study|Death|0|||
23403222|NCT00142792|65223208|FG002|Overall Study|Death|1|||
23403223|NCT00142792|65223206|FG000|Overall Study|Withdrawal by Subject|3|||
23403224|NCT00142792|65223207|FG001|Overall Study|Withdrawal by Subject|2|||
23403225|NCT00142792|65223208|FG002|Overall Study|Withdrawal by Subject|3|||
23403226|NCT00142792|65223206|FG000|Overall Study|Lost to Follow-up|8|||
23403227|NCT00142792|65223207|FG001|Overall Study|Lost to Follow-up|11|||
23403228|NCT00142792|65223208|FG002|Overall Study|Lost to Follow-up|7|||
23403229|NCT00142792|65223206|FG000|Overall Study|No category|1|||
23403230|NCT00142792|65223207|FG001|Overall Study|No category|2|||
23403231|NCT00142792|65223208|FG002|Overall Study|No category|1|||
23403232|NCT02897115|65223209|FG000|Overall Study|Early termination of study by sponsor|11|||
23403233|NCT02897115|65223210|FG001|Overall Study|Early termination of study by sponsor|8|||
23403234|NCT01544348|65223211|FG000|Overall Study|Lost to Follow-up|1|||
23403235|NCT01544348|65223212|FG001|Overall Study|Lost to Follow-up|0|||
23403236|NCT01544348|65223213|FG002|Overall Study|Lost to Follow-up|0|||
23403237|NCT01544348|65223214|FG003|Overall Study|Lost to Follow-up|0|||
23403238|NCT01544348|65223215|FG004|Overall Study|Lost to Follow-up|0|||
23403239|NCT01544348|65223216|FG005|Overall Study|Lost to Follow-up|0|||
23403240|NCT01544348|65223217|FG006|Overall Study|Lost to Follow-up|1|||
23403241|NCT01544348|65223218|FG007|Overall Study|Lost to Follow-up|0|||
23403242|NCT01544348|65223211|FG000|Overall Study|Withdrawal by Subject|1|||
23403243|NCT01544348|65223212|FG001|Overall Study|Withdrawal by Subject|0|||
23403244|NCT01544348|65223213|FG002|Overall Study|Withdrawal by Subject|0|||
23403245|NCT01544348|65223214|FG003|Overall Study|Withdrawal by Subject|0|||
23403246|NCT01544348|65223215|FG004|Overall Study|Withdrawal by Subject|1|||
23403247|NCT01544348|65223216|FG005|Overall Study|Withdrawal by Subject|2|||
23403248|NCT01544348|65223217|FG006|Overall Study|Withdrawal by Subject|1|||
23403249|NCT01544348|65223218|FG007|Overall Study|Withdrawal by Subject|0|||
23403250|NCT01544348|65223211|FG000|Overall Study|Physician Decision|0|||
23403251|NCT01544348|65223212|FG001|Overall Study|Physician Decision|0|||
23403252|NCT01544348|65223213|FG002|Overall Study|Physician Decision|0|||
23403253|NCT01544348|65223214|FG003|Overall Study|Physician Decision|0|||
23403254|NCT01544348|65223215|FG004|Overall Study|Physician Decision|0|||
23403255|NCT01544348|65223216|FG005|Overall Study|Physician Decision|1|||
23403256|NCT01544348|65223217|FG006|Overall Study|Physician Decision|0|||
23403257|NCT01544348|65223218|FG007|Overall Study|Physician Decision|0|||
23403258|NCT01070979|65223219|FG000|Overall Study|Adverse Event|2|||
23403259|NCT01070979|65223220|FG001|Overall Study|Adverse Event|3|||
23403260|NCT01070979|65223221|FG002|Overall Study|Adverse Event|3|||
23403261|NCT01070979|65223219|FG000|Overall Study|Lost to Follow-up|2|||
23403262|NCT01070979|65223220|FG001|Overall Study|Lost to Follow-up|1|||
23403263|NCT01070979|65223221|FG002|Overall Study|Lost to Follow-up|1|||
23403264|NCT01070979|65223219|FG000|Overall Study|Protocol Violation|0|||
23403265|NCT01070979|65223220|FG001|Overall Study|Protocol Violation|2|||
23707133|NCT00615290|66304345|FG000|Overall Study|Adverse Event|2|||
23707134|NCT00615290|66304345|FG000|Overall Study|Lost to Follow-up|3|||
23403266|NCT01070979|65223221|FG002|Overall Study|Protocol Violation|6|||
23707135|NCT00615290|66304345|FG000|Overall Study|Withdrawal by Subject|1|||
23707136|NCT00615290|66304345|FG000|Overall Study|Other|2|||
23403267|NCT01070979|65223219|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
23403268|NCT01070979|65223220|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
23403269|NCT01070979|65223221|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
23403270|NCT01070979|65223219|FG000|Overall Study|Withdrawal by Subject|3|||
23707137|NCT00316303|66304348|FG000|Overall Study|Lost to Follow-up|11|||
23403271|NCT01070979|65223220|FG001|Overall Study|Withdrawal by Subject|1|||
23403272|NCT01070979|65223221|FG002|Overall Study|Withdrawal by Subject|1|||
23403273|NCT01070979|65223219|FG000|Overall Study|No study drug taken|0|||
23403274|NCT01070979|65223220|FG001|Overall Study|No study drug taken|1|||
23403275|NCT01070979|65223221|FG002|Overall Study|No study drug taken|0|||
23403276|NCT01119287|65223228|FG000|Overall Study|Patient Decision, not related to AE|0|||
23403277|NCT01119287|65223229|FG001|Overall Study|Patient Decision, not related to AE|0|||
23403278|NCT01119287|65223230|FG002|Overall Study|Patient Decision, not related to AE|2|||
23403279|NCT01119287|65223231|FG003|Overall Study|Patient Decision, not related to AE|2|||
23403280|NCT01119287|65223232|FG004|Overall Study|Patient Decision, not related to AE|1|||
23403281|NCT01119287|65223233|FG005|Overall Study|Patient Decision, not related to AE|0|||
23403282|NCT02078752|65223234|FG000|Overall Study|Death|0|||
23707138|NCT00316303|66304349|FG001|Overall Study|Lost to Follow-up|16|||
23707139|NCT01096849|66304350|FG000|Overall Study|Consent Withdrawn|1|||
23707140|NCT01096849|66304351|FG001|Overall Study|Consent Withdrawn|4|||
23707141|NCT01096849|66304352|FG002|Overall Study|Consent Withdrawn|2|||
23403283|NCT02078752|65223235|FG001|Overall Study|Death|3|||
23403284|NCT02078752|65223236|FG002|Overall Study|Death|0|||
23403285|NCT02078752|65223237|FG003|Overall Study|Death|0|||
23403286|NCT02078752|65223238|FG004|Overall Study|Death|0|||
23403287|NCT02078752|65223239|FG005|Overall Study|Death|1|||
23403288|NCT02078752|65223240|FG006|Overall Study|Death|0|||
23403289|NCT02078752|65223241|FG007|Overall Study|Death|1|||
23403290|NCT02078752|65223242|FG008|Overall Study|Death|0|||
23403291|NCT02078752|65223243|FG009|Overall Study|Death|4|||
23403292|NCT02078752|65223234|FG000|Overall Study|Lost to Follow-up|1|||
23403293|NCT02078752|65223235|FG001|Overall Study|Lost to Follow-up|0|||
23403294|NCT02078752|65223236|FG002|Overall Study|Lost to Follow-up|0|||
23504290|NCT03766581|65587786|FG007|Treatment|Participant withdrew consent|0|||
23504291|NCT03766581|65587779|FG000|Treatment|Death|1|||
23504292|NCT03766581|65587780|FG001|Treatment|Death|0|||
23504293|NCT03766581|65587781|FG002|Treatment|Death|0|||
23504294|NCT03766581|65587782|FG003|Treatment|Death|0|||
23504295|NCT03766581|65587783|FG004|Treatment|Death|0|||
23504296|NCT03766581|65587784|FG005|Treatment|Death|0|||
23403295|NCT02078752|65223237|FG003|Overall Study|Lost to Follow-up|1|||
23403296|NCT02078752|65223238|FG004|Overall Study|Lost to Follow-up|0|||
23403297|NCT02078752|65223239|FG005|Overall Study|Lost to Follow-up|0|||
23403298|NCT02078752|65223240|FG006|Overall Study|Lost to Follow-up|0|||
23403299|NCT02078752|65223241|FG007|Overall Study|Lost to Follow-up|0|||
23403300|NCT02078752|65223242|FG008|Overall Study|Lost to Follow-up|0|||
23403301|NCT02078752|65223243|FG009|Overall Study|Lost to Follow-up|0|||
23403302|NCT02078752|65223234|FG000|Overall Study|Withdrawal by Subject|1|||
23403303|NCT02078752|65223235|FG001|Overall Study|Withdrawal by Subject|1|||
23403304|NCT02078752|65223236|FG002|Overall Study|Withdrawal by Subject|1|||
23403305|NCT02078752|65223237|FG003|Overall Study|Withdrawal by Subject|1|||
23403306|NCT02078752|65223238|FG004|Overall Study|Withdrawal by Subject|0|||
23403307|NCT02078752|65223239|FG005|Overall Study|Withdrawal by Subject|3|||
23403308|NCT02078752|65223240|FG006|Overall Study|Withdrawal by Subject|2|||
23403309|NCT02078752|65223241|FG007|Overall Study|Withdrawal by Subject|1|||
23403310|NCT02078752|65223242|FG008|Overall Study|Withdrawal by Subject|0|||
23707142|NCT01096849|66304350|FG000|Overall Study|Lack of Efficacy|0|||
23707143|NCT01096849|66304351|FG001|Overall Study|Lack of Efficacy|2|||
23707144|NCT01096849|66304352|FG002|Overall Study|Lack of Efficacy|0|||
23707145|NCT01096849|66304350|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
23707146|NCT01096849|66304351|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
23707147|NCT01096849|66304352|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
23707148|NCT01096849|66304350|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
23707149|NCT01096849|66304351|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
23707150|NCT01096849|66304352|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
23707151|NCT01096849|66304350|FG000|Overall Study|Administrative Reasons|0|||
23707152|NCT01096849|66304351|FG001|Overall Study|Administrative Reasons|1|||
23707153|NCT01096849|66304352|FG002|Overall Study|Administrative Reasons|2|||
23707154|NCT01096849|66304350|FG000|Overall Study|Lost to Follow-up|1|||
23707155|NCT01096849|66304351|FG001|Overall Study|Lost to Follow-up|3|||
23403311|NCT02078752|65223243|FG009|Overall Study|Withdrawal by Subject|1|||
23403312|NCT02078752|65223234|FG000|Overall Study|Other|0|||
23403313|NCT02078752|65223235|FG001|Overall Study|Other|3|||
23403314|NCT02078752|65223236|FG002|Overall Study|Other|0|||
23403315|NCT02078752|65223237|FG003|Overall Study|Other|0|||
23403316|NCT02078752|65223238|FG004|Overall Study|Other|1|||
23403317|NCT02078752|65223239|FG005|Overall Study|Other|0|||
23403318|NCT02078752|65223240|FG006|Overall Study|Other|0|||
23403319|NCT02078752|65223241|FG007|Overall Study|Other|1|||
23403320|NCT02078752|65223242|FG008|Overall Study|Other|0|||
23403321|NCT02078752|65223243|FG009|Overall Study|Other|0|||
23403322|NCT02078752|65223234|FG000|Overall Study|Study terminated by sponsor|0|||
23504297|NCT03766581|65587785|FG006|Treatment|Death|0|||
23504298|NCT03766581|65587786|FG007|Treatment|Death|0|||
23504299|NCT03766581|65587779|FG000|Treatment|Lost to Follow-up|1|||
23707156|NCT01096849|66304352|FG002|Overall Study|Lost to Follow-up|1|||
23707157|NCT03648476|66304363|FG000|Overall Study|Withdrawal by Subject|2|||
23707158|NCT03648476|66304364|FG001|Overall Study|Withdrawal by Subject|1|||
23707159|NCT01934192|66304366|FG000|Overall Study|Protocol Violation|0|||
23807650|NCT00468650|66676219|FG000|Overall Study|Withdrawal by Subject|2|||
23403323|NCT02078752|65223235|FG001|Overall Study|Study terminated by sponsor|0|||
23403324|NCT02078752|65223236|FG002|Overall Study|Study terminated by sponsor|0|||
23403325|NCT02078752|65223237|FG003|Overall Study|Study terminated by sponsor|0|||
23403326|NCT02078752|65223238|FG004|Overall Study|Study terminated by sponsor|0|||
23403327|NCT02078752|65223239|FG005|Overall Study|Study terminated by sponsor|0|||
23403328|NCT02078752|65223240|FG006|Overall Study|Study terminated by sponsor|0|||
23403329|NCT02078752|65223241|FG007|Overall Study|Study terminated by sponsor|0|||
23403330|NCT02078752|65223242|FG008|Overall Study|Study terminated by sponsor|0|||
23403331|NCT02078752|65223243|FG009|Overall Study|Study terminated by sponsor|5|||
23403332|NCT05525910|65223272|FG000|Period 4|Per sponsor due to study timelines|0|||
23403333|NCT05525910|65223273|FG001|Period 4|Per sponsor due to study timelines|0|||
23403334|NCT05525910|65223274|FG002|Period 4|Per sponsor due to study timelines|1|||
23403335|NCT05525910|65223275|FG003|Period 4|Per sponsor due to study timelines|1|||
23403336|NCT05525910|65223276|FG004|Period 4|Per sponsor due to study timelines|1|||
23403337|NCT03594110|65223277|FG000|Overall Study|Participant concerned about study treatment|23|||
23403338|NCT03594110|65223278|FG001|Overall Study|Participant concerned about study treatment|28|||
23403339|NCT03594110|65223277|FG000|Overall Study|Doctor advice|38|||
23403340|NCT03594110|65223278|FG001|Overall Study|Doctor advice|40|||
23403341|NCT03594110|65223277|FG000|Overall Study|Participants' wish|89|||
23403342|NCT03594110|65223278|FG001|Overall Study|Participants' wish|68|||
23403343|NCT03594110|65223277|FG000|Overall Study|Adverse Event|119|||
23403344|NCT03594110|65223278|FG001|Overall Study|Adverse Event|116|||
23403345|NCT03594110|65223277|FG000|Overall Study|Study drug stopped, reason missing|337|||
23403346|NCT03594110|65223278|FG001|Overall Study|Study drug stopped, reason missing|295|||
23403347|NCT03594110|65223277|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
23403348|NCT03594110|65223278|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
23403349|NCT03594110|65223277|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
23403350|NCT03594110|65223278|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
23403351|NCT03594110|65223277|FG000|Overall Study|Contraindicated drug started|32|||
23403352|NCT03594110|65223278|FG001|Overall Study|Contraindicated drug started|18|||
23403353|NCT03594110|65223277|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
23403354|NCT03594110|65223278|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
23403355|NCT03594110|65223277|FG000|Overall Study|Death|129|||
23403356|NCT03594110|65223278|FG001|Overall Study|Death|120|||
23403357|NCT04240886|65223279|FG000|Treatment Phase|Death|4|||
23403358|NCT04240886|65223279|FG000|Treatment Phase|Discontinuation by Subject|1|||
23403359|NCT04240886|65223279|FG000|Treatment Phase|Adverse Event|5|||
23707160|NCT01934192|66304367|FG001|Overall Study|Protocol Violation|0|||
23707161|NCT01934192|66304368|FG002|Overall Study|Protocol Violation|0|||
23707162|NCT01934192|66304369|FG003|Overall Study|Protocol Violation|1|||
23707163|NCT01934192|66304366|FG000|Overall Study|Other: reached stopping criteria|6|||
23707164|NCT01934192|66304367|FG001|Overall Study|Other: reached stopping criteria|5|||
23707165|NCT01934192|66304368|FG002|Overall Study|Other: reached stopping criteria|1|||
23707166|NCT01934192|66304369|FG003|Overall Study|Other: reached stopping criteria|0|||
23707167|NCT01934192|66304366|FG000|Overall Study|Physician Decision|3|||
23707168|NCT01934192|66304367|FG001|Overall Study|Physician Decision|2|||
23707169|NCT01934192|66304368|FG002|Overall Study|Physician Decision|0|||
23707170|NCT01934192|66304369|FG003|Overall Study|Physician Decision|0|||
23707171|NCT03628508|66304370|FG000|Overall Study|Lost to Follow-up|1|||
23707172|NCT01426425|66304371|FG000|Overall Study|Exited prior to EP study|22|||
23707173|NCT01426425|66304371|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
23707174|NCT01426425|66304371|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
23707175|NCT01189435|66304372|FG000|Overall Study|Withdrawal by Subject|1|||
23707176|NCT01189435|66304372|FG000|Overall Study|Physician Decision|1|||
23707177|NCT03136185|66304373|FG000|Overall Study|Adverse Event|0|||
23707178|NCT03136185|66304374|FG001|Overall Study|Adverse Event|1|||
23707179|NCT03136185|66304375|FG002|Overall Study|Adverse Event|3|||
23707180|NCT03136185|66304376|FG003|Overall Study|Adverse Event|1|||
23707181|NCT03136185|66304377|FG004|Overall Study|Adverse Event|2|||
23707182|NCT03136185|66304378|FG005|Overall Study|Adverse Event|2|||
23707183|NCT03136185|66304379|FG006|Overall Study|Adverse Event|5|||
23707184|NCT03136185|66304380|FG007|Overall Study|Adverse Event|1|||
23707185|NCT03136185|66304381|FG008|Overall Study|Adverse Event|1|||
23707186|NCT03136185|66304373|FG000|Overall Study|Death|0|||
23707187|NCT03136185|66304374|FG001|Overall Study|Death|0|||
23707188|NCT03136185|66304375|FG002|Overall Study|Death|0|||
23707189|NCT03136185|66304376|FG003|Overall Study|Death|1|||
23707190|NCT03136185|66304377|FG004|Overall Study|Death|1|||
23707191|NCT03136185|66304378|FG005|Overall Study|Death|0|||
23707192|NCT03136185|66304379|FG006|Overall Study|Death|1|||
23403360|NCT04240886|65223279|FG000|Follow-up Phase|Withdrawal by Subject|1|||
23403361|NCT04240886|65223279|FG000|Follow-up Phase|Discontinuation by Subject|1|||
23403362|NCT04240886|65223279|FG000|Follow-up Phase|Death|2|||
23403363|NCT01908140|65223284|FG000|Overall Study|Other or Progressive Disease|5|||
23403364|NCT01908140|65223285|FG001|Overall Study|Other or Progressive Disease|12|||
23403365|NCT01908140|65223284|FG000|Overall Study|Lack of Efficacy|7|||
23403366|NCT01908140|65223285|FG001|Overall Study|Lack of Efficacy|5|||
23403367|NCT01908140|65223284|FG000|Overall Study|Withdrawal by Subject|23|||
23403368|NCT01908140|65223285|FG001|Overall Study|Withdrawal by Subject|24|||
23403369|NCT01908140|65223284|FG000|Overall Study|Lost to Follow-up|1|||
23403370|NCT01908140|65223285|FG001|Overall Study|Lost to Follow-up|6|||
23403371|NCT01908140|65223284|FG000|Overall Study|Protocol Violation|8|||
23403372|NCT01908140|65223285|FG001|Overall Study|Protocol Violation|9|||
23403373|NCT01908140|65223284|FG000|Overall Study|Adverse Event|22|||
23403374|NCT01908140|65223285|FG001|Overall Study|Adverse Event|23|||
23403375|NCT04865289|65223288|FG000|Overall Study|Participant ongoing in study|47|||
23707193|NCT03136185|66304380|FG007|Overall Study|Death|0|||
23403376|NCT04865289|65223289|FG001|Overall Study|Participant ongoing in study|35|||
23403377|NCT04865289|65223288|FG000|Overall Study|Death|27|||
23403378|NCT04865289|65223289|FG001|Overall Study|Death|21|||
23403379|NCT00087698|65223291|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
23403380|NCT00087698|65223291|FG000|Overall Study|Death from Other Causes|3|||
23403381|NCT00087698|65223291|FG000|Overall Study|Adverse Event|4|||
23403382|NCT00087698|65223291|FG000|Overall Study|Withdrawal by Subject|4|||
23403383|NCT00087698|65223291|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
23403384|NCT00087698|65223291|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
23403385|NCT00087698|65223291|FG000|Overall Study|Clinical Relapse|1|||
23403386|NCT00087698|65223291|FG000|Overall Study|Death from Study Disease|2|||
23403387|NCT00087698|65223291|FG000|Overall Study|Death from Study Drug Toxicity|2|||
23403388|NCT00087698|65223291|FG000|Overall Study|Protocol Violation|1|||
23403389|NCT00889707|65223293|FG000|Overall Study|Adverse Event|1|||
23403390|NCT00889707|65223294|FG001|Overall Study|Adverse Event|0|||
23403391|NCT00889707|65223293|FG000|Overall Study|Withdrawal by Subject|4|||
23403392|NCT00889707|65223294|FG001|Overall Study|Withdrawal by Subject|3|||
23403393|NCT00889707|65223293|FG000|Overall Study|Lost to Follow-up|0|||
23403394|NCT00889707|65223294|FG001|Overall Study|Lost to Follow-up|2|||
23403395|NCT00889707|65223293|FG000|Overall Study|Lack of Efficacy|2|||
23403396|NCT00889707|65223294|FG001|Overall Study|Lack of Efficacy|5|||
23403397|NCT00784368|65223299|FG000|Overall Study|Physician Decision|0|||
23403398|NCT00784368|65223300|FG001|Overall Study|Physician Decision|0|||
23403399|NCT00784368|65223301|FG002|Overall Study|Physician Decision|6|||
23403400|NCT00784368|65223299|FG000|Overall Study|Lack of Efficacy|2|||
23403401|NCT00784368|65223300|FG001|Overall Study|Lack of Efficacy|0|||
23403402|NCT00784368|65223301|FG002|Overall Study|Lack of Efficacy|1|||
23403403|NCT00784368|65223299|FG000|Overall Study|Adverse Event|6|||
23403404|NCT00784368|65223300|FG001|Overall Study|Adverse Event|9|||
23403405|NCT00784368|65223301|FG002|Overall Study|Adverse Event|2|||
23403406|NCT00784368|65223299|FG000|Overall Study|Diagnosis of fever|0|||
23403407|NCT00784368|65223300|FG001|Overall Study|Diagnosis of fever|0|||
23403408|NCT00784368|65223301|FG002|Overall Study|Diagnosis of fever|1|||
23403409|NCT00784368|65223299|FG000|Overall Study|Worsening of complications|0|||
23403410|NCT00784368|65223300|FG001|Overall Study|Worsening of complications|0|||
23707194|NCT03136185|66304381|FG008|Overall Study|Death|0|||
23707195|NCT03136185|66304373|FG000|Overall Study|Physician Decision|3|||
23707196|NCT03136185|66304374|FG001|Overall Study|Physician Decision|1|||
23707197|NCT03136185|66304375|FG002|Overall Study|Physician Decision|1|||
23707198|NCT03136185|66304376|FG003|Overall Study|Physician Decision|2|||
23707199|NCT03136185|66304377|FG004|Overall Study|Physician Decision|1|||
23707200|NCT03136185|66304378|FG005|Overall Study|Physician Decision|2|||
23707201|NCT03136185|66304379|FG006|Overall Study|Physician Decision|1|||
23707202|NCT03136185|66304380|FG007|Overall Study|Physician Decision|0|||
23707203|NCT03136185|66304381|FG008|Overall Study|Physician Decision|1|||
23403411|NCT00784368|65223301|FG002|Overall Study|Worsening of complications|1|||
23403412|NCT00784368|65223299|FG000|Overall Study|Worsening of symptoms|0|||
23403413|NCT00784368|65223300|FG001|Overall Study|Worsening of symptoms|1|||
23707204|NCT03136185|66304373|FG000|Overall Study|Protocol Defined Disease Progression|0|||
23403414|NCT00784368|65223301|FG002|Overall Study|Worsening of symptoms|0|||
23403415|NCT00784368|65223299|FG000|Overall Study|Withdrawal of informed consent|0|||
23403416|NCT00784368|65223300|FG001|Overall Study|Withdrawal of informed consent|1|||
23403417|NCT00784368|65223301|FG002|Overall Study|Withdrawal of informed consent|0|||
23403418|NCT00811720|65223302|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
23403419|NCT00811720|65223303|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
23403420|NCT00811720|65223302|FG000|All Treated Patients|Adverse Event|20|||
23403421|NCT00811720|65223303|FG001|All Treated Patients|Adverse Event|62|||
23504300|NCT03766581|65587780|FG001|Treatment|Lost to Follow-up|0|||
23504301|NCT03766581|65587781|FG002|Treatment|Lost to Follow-up|0|||
23707205|NCT03136185|66304374|FG001|Overall Study|Protocol Defined Disease Progression|0|||
23707206|NCT03136185|66304375|FG002|Overall Study|Protocol Defined Disease Progression|1|||
23707207|NCT03136185|66304376|FG003|Overall Study|Protocol Defined Disease Progression|0|||
23707208|NCT03136185|66304377|FG004|Overall Study|Protocol Defined Disease Progression|0|||
23707209|NCT03136185|66304378|FG005|Overall Study|Protocol Defined Disease Progression|1|||
23707210|NCT03136185|66304379|FG006|Overall Study|Protocol Defined Disease Progression|0|||
23504302|NCT03766581|65587782|FG003|Treatment|Lost to Follow-up|1|||
23504303|NCT03766581|65587783|FG004|Treatment|Lost to Follow-up|0|||
23504304|NCT03766581|65587784|FG005|Treatment|Lost to Follow-up|0|||
23504305|NCT03766581|65587785|FG006|Treatment|Lost to Follow-up|0|||
23504306|NCT03766581|65587786|FG007|Treatment|Lost to Follow-up|0|||
23504307|NCT03766581|65587779|FG000|Treatment|Poor/Non compliance|2|||
23504308|NCT03766581|65587780|FG001|Treatment|Poor/Non compliance|2|||
23504309|NCT03766581|65587781|FG002|Treatment|Poor/Non compliance|1|||
23504310|NCT03766581|65587782|FG003|Treatment|Poor/Non compliance|1|||
23504311|NCT03766581|65587783|FG004|Treatment|Poor/Non compliance|1|||
23504312|NCT03766581|65587784|FG005|Treatment|Poor/Non compliance|1|||
23504313|NCT03766581|65587785|FG006|Treatment|Poor/Non compliance|0|||
23504314|NCT03766581|65587786|FG007|Treatment|Poor/Non compliance|0|||
23504315|NCT03766581|65587779|FG000|Treatment|Participant no longer meets study criteria|9|||
23504316|NCT03766581|65587780|FG001|Treatment|Participant no longer meets study criteria|1|||
23504317|NCT03766581|65587781|FG002|Treatment|Participant no longer meets study criteria|5|||
23504318|NCT03766581|65587782|FG003|Treatment|Participant no longer meets study criteria|4|||
23504319|NCT03766581|65587783|FG004|Treatment|Participant no longer meets study criteria|4|||
23504320|NCT03766581|65587784|FG005|Treatment|Participant no longer meets study criteria|4|||
23504321|NCT03766581|65587785|FG006|Treatment|Participant no longer meets study criteria|2|||
23504322|NCT03766581|65587786|FG007|Treatment|Participant no longer meets study criteria|0|||
23504323|NCT03766581|65587779|FG000|Treatment|Other reasons|13|||
23504324|NCT03766581|65587780|FG001|Treatment|Other reasons|8|||
23504325|NCT03766581|65587781|FG002|Treatment|Other reasons|3|||
23504326|NCT03766581|65587782|FG003|Treatment|Other reasons|7|||
23504327|NCT03766581|65587783|FG004|Treatment|Other reasons|3|||
23504328|NCT03766581|65587784|FG005|Treatment|Other reasons|3|||
23504329|NCT03766581|65587785|FG006|Treatment|Other reasons|0|||
23504330|NCT03766581|65587786|FG007|Treatment|Other reasons|0|||
23504331|NCT03798483|65587787|FG000|Overall Study|Lost to Follow-up|2|||
23504332|NCT00587054|65587788|FG000|Overall Study|Patient not treated|9|||
23504333|NCT01897454|65587789|FG000|Overall Study|Withdrawal by Subject|1|||
23504334|NCT00381485|65587790|FG000|Open-Label Run-In Period|Adverse Event|9|||
23504335|NCT00381485|65587791|FG001|Open-Label Run-In Period|Adverse Event|0|||
23504336|NCT00381485|65587792|FG002|Open-Label Run-In Period|Adverse Event|0|||
23504337|NCT00381485|65587793|FG003|Open-Label Run-In Period|Adverse Event|0|||
23504338|NCT00381485|65587790|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
23504339|NCT00381485|65587791|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504340|NCT00381485|65587792|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504341|NCT00381485|65587793|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504342|NCT00381485|65587790|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
23504343|NCT00381485|65587791|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504344|NCT00381485|65587792|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504345|NCT00381485|65587793|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504346|NCT00381485|65587790|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
23504347|NCT00381485|65587791|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23707211|NCT03136185|66304380|FG007|Overall Study|Protocol Defined Disease Progression|1|||
23707212|NCT03136185|66304381|FG008|Overall Study|Protocol Defined Disease Progression|1|||
23707213|NCT03136185|66304373|FG000|Overall Study|Withdrawal by Subject|1|||
23707214|NCT03136185|66304374|FG001|Overall Study|Withdrawal by Subject|0|||
23707215|NCT03136185|66304375|FG002|Overall Study|Withdrawal by Subject|1|||
23707216|NCT03136185|66304376|FG003|Overall Study|Withdrawal by Subject|1|||
23707217|NCT03136185|66304377|FG004|Overall Study|Withdrawal by Subject|1|||
23707218|NCT03136185|66304378|FG005|Overall Study|Withdrawal by Subject|1|||
23707219|NCT03136185|66304379|FG006|Overall Study|Withdrawal by Subject|2|||
23707220|NCT03136185|66304380|FG007|Overall Study|Withdrawal by Subject|3|||
23707221|NCT03136185|66304381|FG008|Overall Study|Withdrawal by Subject|3|||
23707222|NCT03136185|66304373|FG000|Overall Study|Not Reported|4|||
23504348|NCT00381485|65587792|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23504349|NCT00381485|65587793|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23504350|NCT00381485|65587790|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
23504351|NCT00381485|65587791|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
23504352|NCT00381485|65587792|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
23504353|NCT00381485|65587793|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
23504354|NCT00381485|65587790|FG000|Open-Label Run-In Period|Treatment failure|1|||
23504355|NCT00381485|65587791|FG001|Open-Label Run-In Period|Treatment failure|0|||
23636600|NCT01498887|66052945|FG001|Overall Study|Lack of Efficacy|3|||
23504356|NCT00381485|65587792|FG002|Open-Label Run-In Period|Treatment failure|0|||
23504357|NCT00381485|65587793|FG003|Open-Label Run-In Period|Treatment failure|0|||
23504358|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23504359|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23504360|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Adverse Event|2|||
23504361|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Adverse Event|5|||
23504362|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23504363|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
23504364|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
23504365|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
23504366|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23504367|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23504368|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
23504369|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23504370|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
23504371|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
23504372|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
23504373|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
23504374|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
23504375|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23504376|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
23504377|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23504378|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
23403422|NCT00811720|65223302|FG000|All Treated Patients|Lack of Efficacy|22|||
23403423|NCT00811720|65223303|FG001|All Treated Patients|Lack of Efficacy|18|||
23403424|NCT00811720|65223302|FG000|All Treated Patients|Non-compliance|0|||
23403425|NCT00811720|65223303|FG001|All Treated Patients|Non-compliance|14|||
23403426|NCT00811720|65223302|FG000|All Treated Patients|Protocol Violation|9|||
23403427|NCT00811720|65223303|FG001|All Treated Patients|Protocol Violation|16|||
23403428|NCT00811720|65223302|FG000|All Treated Patients|Withdrawal by Subject|28|||
23403429|NCT00811720|65223303|FG001|All Treated Patients|Withdrawal by Subject|34|||
23403430|NCT00811720|65223302|FG000|All Treated Patients|Lost to Follow-up|10|||
23403431|NCT00811720|65223303|FG001|All Treated Patients|Lost to Follow-up|16|||
23403432|NCT00811720|65223302|FG000|All Treated Patients|Other Reason|7|||
23403433|NCT00811720|65223303|FG001|All Treated Patients|Other Reason|4|||
23403434|NCT00107276|65223305|FG000|Overall Study|Progression|46|||
23403435|NCT00107276|65223305|FG000|Overall Study|Adverse Event|6|||
23403436|NCT00107276|65223305|FG000|Overall Study|M.D. decision|2|||
23403437|NCT00107276|65223305|FG000|Overall Study|Patient refusal|1|||
23403438|NCT00107276|65223305|FG000|Overall Study|Death|1|||
23403439|NCT00107276|65223305|FG000|Overall Study|Ineligible|16|||
23403440|NCT00488514|65223306|FG000|Overall Study|Adverse Event|41|||
23707223|NCT03136185|66304374|FG001|Overall Study|Not Reported|1|||
23707224|NCT03136185|66304375|FG002|Overall Study|Not Reported|0|||
23707225|NCT03136185|66304376|FG003|Overall Study|Not Reported|1|||
23707226|NCT03136185|66304377|FG004|Overall Study|Not Reported|0|||
23707227|NCT03136185|66304378|FG005|Overall Study|Not Reported|2|||
23707228|NCT03136185|66304379|FG006|Overall Study|Not Reported|1|||
23707229|NCT03136185|66304380|FG007|Overall Study|Not Reported|1|||
23707230|NCT03136185|66304381|FG008|Overall Study|Not Reported|0|||
23707231|NCT01781429|66304382|FG000|Overall Study|Death|0|||
23707232|NCT01781429|66304383|FG001|Overall Study|Death|0|||
23707233|NCT01781429|66304384|FG002|Overall Study|Death|0|||
23707234|NCT01781429|66304385|FG003|Overall Study|Death|0|||
23707235|NCT01781429|66304386|FG004|Overall Study|Death|0|||
23403441|NCT00488514|65223306|FG000|Overall Study|Lost to Follow-up|44|||
23403442|NCT00488514|65223306|FG000|Overall Study|Protocol Violation|32|||
23403443|NCT00488514|65223306|FG000|Overall Study|Withdrawal by Subject|106|||
23707236|NCT01781429|66304387|FG005|Overall Study|Death|0|||
23707237|NCT01781429|66304388|FG006|Overall Study|Death|0|||
23707238|NCT01781429|66304389|FG007|Overall Study|Death|0|||
23403444|NCT00488514|65223306|FG000|Overall Study|Lack of Efficacy|28|||
23403445|NCT00488514|65223306|FG000|Overall Study|Did not meet criteria for treatment|30|||
23403446|NCT00488514|65223306|FG000|Overall Study|Postive drug screen|1|||
23403447|NCT00488514|65223306|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
23403448|NCT00488514|65223306|FG000|Overall Study|Investigator decision|1|||
23403449|NCT00488514|65223306|FG000|Overall Study|Participant had too few migraines|5|||
23403450|NCT00488514|65223306|FG000|Overall Study|Increase in number of migraines|2|||
23403451|NCT00488514|65223306|FG000|Overall Study|Increased use of concomitant medication|1|||
23403452|NCT02949024|65223307|FG000|Overall Study|Withdrawal by Subject|0|||
23403453|NCT02949024|65223308|FG001|Overall Study|Withdrawal by Subject|1|||
23403454|NCT02230189|65223309|FG000|Overall Study|Withdrawal by Subject|3|||
23707239|NCT01781429|66304390|FG008|Overall Study|Death|0|||
23707240|NCT01781429|66304391|FG009|Overall Study|Death|1|||
23707241|NCT01781429|66304392|FG010|Overall Study|Death|0|||
23403455|NCT02230189|65223310|FG001|Overall Study|Withdrawal by Subject|0|||
23403456|NCT02230189|65223311|FG002|Overall Study|Withdrawal by Subject|1|||
23403457|NCT02230189|65223309|FG000|Overall Study|Lost to Follow-up|1|||
23403458|NCT02230189|65223310|FG001|Overall Study|Lost to Follow-up|0|||
23403459|NCT02230189|65223311|FG002|Overall Study|Lost to Follow-up|0|||
23403460|NCT02230189|65223309|FG000|Overall Study|Physician Decision|1|||
23403461|NCT02230189|65223310|FG001|Overall Study|Physician Decision|0|||
23403462|NCT02230189|65223311|FG002|Overall Study|Physician Decision|0|||
23403463|NCT02954458|65223319|FG000|Overall Study|Adverse Event|0|||
23403464|NCT02954458|65223320|FG001|Overall Study|Adverse Event|0|||
23403465|NCT02954458|65223321|FG002|Overall Study|Adverse Event|0|||
23403466|NCT02954458|65223322|FG003|Overall Study|Adverse Event|1|||
23403467|NCT02954458|65223319|FG000|Overall Study|Withdrawal by Subject|0|||
23403468|NCT02954458|65223320|FG001|Overall Study|Withdrawal by Subject|0|||
23403469|NCT02954458|65223321|FG002|Overall Study|Withdrawal by Subject|0|||
23403470|NCT02954458|65223322|FG003|Overall Study|Withdrawal by Subject|1|||
23403471|NCT02954458|65223319|FG000|Overall Study|Physician Decision|0|||
23403472|NCT02954458|65223320|FG001|Overall Study|Physician Decision|0|||
23403473|NCT02954458|65223321|FG002|Overall Study|Physician Decision|1|||
23403474|NCT02954458|65223322|FG003|Overall Study|Physician Decision|1|||
23403475|NCT02954458|65223319|FG000|Overall Study|Lost to Follow-up|1|||
23403476|NCT02954458|65223320|FG001|Overall Study|Lost to Follow-up|0|||
23403477|NCT02954458|65223321|FG002|Overall Study|Lost to Follow-up|0|||
23707242|NCT01781429|66304393|FG011|Overall Study|Death|0|||
23707243|NCT01781429|66304394|FG012|Overall Study|Death|1|||
23403478|NCT02954458|65223322|FG003|Overall Study|Lost to Follow-up|1|||
23403479|NCT02954458|65223319|FG000|Overall Study|Death|0|||
23403480|NCT02954458|65223320|FG001|Overall Study|Death|0|||
23403481|NCT02954458|65223321|FG002|Overall Study|Death|0|||
23403482|NCT02954458|65223322|FG003|Overall Study|Death|1|||
23403483|NCT02954458|65223319|FG000|Overall Study|Other|0|||
23403484|NCT02954458|65223320|FG001|Overall Study|Other|0|||
23403485|NCT02954458|65223321|FG002|Overall Study|Other|0|||
23403486|NCT02954458|65223322|FG003|Overall Study|Other|7|||
23403487|NCT01345929|65223323|FG000|Overall Study|Withdrawal by Subject|9|||
23403488|NCT01345929|65223324|FG001|Overall Study|Withdrawal by Subject|8|||
23403489|NCT01345929|65223323|FG000|Overall Study|Lost to Follow-up|9|||
23403490|NCT01345929|65223324|FG001|Overall Study|Lost to Follow-up|9|||
23403491|NCT01345929|65223323|FG000|Overall Study|Adverse Event|0|||
23403492|NCT01345929|65223324|FG001|Overall Study|Adverse Event|1|||
23403493|NCT01345929|65223323|FG000|Overall Study|Didn't meet eligibility criteria|2|||
23707244|NCT01781429|66304395|FG013|Overall Study|Death|0|||
23403494|NCT01345929|65223324|FG001|Overall Study|Didn't meet eligibility criteria|0|||
23403495|NCT01345929|65223323|FG000|Overall Study|40,000 CFU/ML|1|||
23403496|NCT01345929|65223324|FG001|Overall Study|40,000 CFU/ML|0|||
23403497|NCT01345929|65223323|FG000|Overall Study|Patient withdrawal|0|||
23707245|NCT01781429|66304396|FG014|Overall Study|Death|1|||
23707246|NCT01781429|66304397|FG015|Overall Study|Death|0|||
23707247|NCT01781429|66304382|FG000|Overall Study|Withdrawal by Subject|0|||
23707248|NCT01781429|66304383|FG001|Overall Study|Withdrawal by Subject|0|||
23707249|NCT01781429|66304384|FG002|Overall Study|Withdrawal by Subject|0|||
23707250|NCT01781429|66304385|FG003|Overall Study|Withdrawal by Subject|0|||
23707251|NCT01781429|66304386|FG004|Overall Study|Withdrawal by Subject|0|||
23707252|NCT01781429|66304387|FG005|Overall Study|Withdrawal by Subject|0|||
23707253|NCT01781429|66304388|FG006|Overall Study|Withdrawal by Subject|0|||
23707254|NCT01781429|66304389|FG007|Overall Study|Withdrawal by Subject|0|||
23707255|NCT01781429|66304390|FG008|Overall Study|Withdrawal by Subject|1|||
23403498|NCT01345929|65223324|FG001|Overall Study|Patient withdrawal|1|||
23403499|NCT01603043|65223331|FG000|Overall Study|Study Futility|7|||
23403500|NCT01603043|65223332|FG001|Overall Study|Study Futility|3|||
23403501|NCT03381287|65223333|FG000|Overall Study|Withdrawal by Subject|0|||
23403502|NCT03381287|65223334|FG001|Overall Study|Withdrawal by Subject|1|||
23403503|NCT03381287|65223335|FG002|Overall Study|Withdrawal by Subject|0|||
23403504|NCT03381287|65223336|FG003|Overall Study|Withdrawal by Subject|0|||
23403505|NCT03381287|65223333|FG000|Overall Study|Adverse Event|0|||
23403506|NCT03381287|65223334|FG001|Overall Study|Adverse Event|0|||
23403507|NCT03381287|65223335|FG002|Overall Study|Adverse Event|0|||
23403508|NCT03381287|65223336|FG003|Overall Study|Adverse Event|1|||
23403509|NCT03381287|65223333|FG000|Overall Study|Physician Decision|0|||
23403510|NCT03381287|65223334|FG001|Overall Study|Physician Decision|0|||
23403511|NCT03381287|65223335|FG002|Overall Study|Physician Decision|0|||
23403512|NCT03381287|65223336|FG003|Overall Study|Physician Decision|1|||
23403513|NCT03654274|65223337|FG000|Overall Study|Adverse Event|19|||
23403514|NCT03654274|65223338|FG001|Overall Study|Adverse Event|23|||
23403515|NCT03654274|65223339|FG002|Overall Study|Adverse Event|24|||
23707256|NCT01781429|66304391|FG009|Overall Study|Withdrawal by Subject|3|||
23707257|NCT01781429|66304392|FG010|Overall Study|Withdrawal by Subject|1|||
23707258|NCT01781429|66304393|FG011|Overall Study|Withdrawal by Subject|1|||
23403516|NCT03654274|65223337|FG000|Overall Study|Protocol Deviation|0|||
23403517|NCT03654274|65223338|FG001|Overall Study|Protocol Deviation|2|||
23707259|NCT01781429|66304394|FG012|Overall Study|Withdrawal by Subject|5|||
23707260|NCT01781429|66304395|FG013|Overall Study|Withdrawal by Subject|2|||
23707261|NCT01781429|66304396|FG014|Overall Study|Withdrawal by Subject|3|||
23707262|NCT01781429|66304397|FG015|Overall Study|Withdrawal by Subject|0|||
23707263|NCT01781429|66304382|FG000|Overall Study|Disease Progression|1|||
23707264|NCT01781429|66304383|FG001|Overall Study|Disease Progression|0|||
23707265|NCT01781429|66304384|FG002|Overall Study|Disease Progression|1|||
23707266|NCT01781429|66304385|FG003|Overall Study|Disease Progression|1|||
23707267|NCT01781429|66304386|FG004|Overall Study|Disease Progression|1|||
23707268|NCT01781429|66304387|FG005|Overall Study|Disease Progression|4|||
23707269|NCT01781429|66304388|FG006|Overall Study|Disease Progression|7|||
23707270|NCT01781429|66304389|FG007|Overall Study|Disease Progression|4|||
23707271|NCT01781429|66304390|FG008|Overall Study|Disease Progression|6|||
23707272|NCT01781429|66304391|FG009|Overall Study|Disease Progression|15|||
23707273|NCT01781429|66304392|FG010|Overall Study|Disease Progression|15|||
23707274|NCT01781429|66304393|FG011|Overall Study|Disease Progression|15|||
23707275|NCT01781429|66304394|FG012|Overall Study|Disease Progression|15|||
23707276|NCT01781429|66304395|FG013|Overall Study|Disease Progression|4|||
23707277|NCT01781429|66304396|FG014|Overall Study|Disease Progression|11|||
23707278|NCT01781429|66304397|FG015|Overall Study|Disease Progression|0|||
23707279|NCT01781429|66304382|FG000|Overall Study|Unacceptable Toxicity|0|||
23707280|NCT01781429|66304383|FG001|Overall Study|Unacceptable Toxicity|0|||
23707281|NCT01781429|66304384|FG002|Overall Study|Unacceptable Toxicity|0|||
23403518|NCT03654274|65223339|FG002|Overall Study|Protocol Deviation|0|||
23403519|NCT03654274|65223337|FG000|Overall Study|Lost to Follow-up|8|||
23403520|NCT03654274|65223338|FG001|Overall Study|Lost to Follow-up|6|||
23403521|NCT03654274|65223339|FG002|Overall Study|Lost to Follow-up|5|||
23403522|NCT03654274|65223337|FG000|Overall Study|Withdrawal by Subject|46|||
23403523|NCT03654274|65223338|FG001|Overall Study|Withdrawal by Subject|25|||
23403524|NCT03654274|65223339|FG002|Overall Study|Withdrawal by Subject|33|||
23403525|NCT03654274|65223337|FG000|Overall Study|Lack of Efficacy|4|||
23403526|NCT03654274|65223338|FG001|Overall Study|Lack of Efficacy|5|||
23403527|NCT03654274|65223339|FG002|Overall Study|Lack of Efficacy|7|||
23403528|NCT03654274|65223337|FG000|Overall Study|Pregnancy|2|||
23403529|NCT03654274|65223338|FG001|Overall Study|Pregnancy|2|||
23403530|NCT03654274|65223339|FG002|Overall Study|Pregnancy|1|||
23403531|NCT03654274|65223337|FG000|Overall Study|Other|27|||
23403532|NCT03654274|65223338|FG001|Overall Study|Other|29|||
23403533|NCT03654274|65223339|FG002|Overall Study|Other|32|||
23403534|NCT03654274|65223337|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
23403535|NCT03654274|65223338|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
23403536|NCT03654274|65223339|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
23403537|NCT00972517|65223344|FG000|Overall Study|Adverse Event|0|||
23403538|NCT00972517|65223345|FG001|Overall Study|Adverse Event|0|||
23403539|NCT00972517|65223346|FG002|Overall Study|Adverse Event|0|||
23403540|NCT00972517|65223347|FG003|Overall Study|Adverse Event|1|||
23403541|NCT00972517|65223348|FG004|Overall Study|Adverse Event|0|||
23403542|NCT00972517|65223349|FG005|Overall Study|Adverse Event|0|||
23403543|NCT00972517|65223344|FG000|Overall Study|Withdrawal by Subject|0|||
23403544|NCT00972517|65223345|FG001|Overall Study|Withdrawal by Subject|1|||
23403545|NCT00972517|65223346|FG002|Overall Study|Withdrawal by Subject|0|||
23403546|NCT00972517|65223347|FG003|Overall Study|Withdrawal by Subject|2|||
23707282|NCT01781429|66304385|FG003|Overall Study|Unacceptable Toxicity|0|||
23707283|NCT01781429|66304386|FG004|Overall Study|Unacceptable Toxicity|0|||
23707284|NCT01781429|66304387|FG005|Overall Study|Unacceptable Toxicity|0|||
23707285|NCT01781429|66304388|FG006|Overall Study|Unacceptable Toxicity|0|||
23707286|NCT01781429|66304389|FG007|Overall Study|Unacceptable Toxicity|0|||
23707287|NCT01781429|66304390|FG008|Overall Study|Unacceptable Toxicity|0|||
23707288|NCT01781429|66304391|FG009|Overall Study|Unacceptable Toxicity|0|||
23403547|NCT00972517|65223348|FG004|Overall Study|Withdrawal by Subject|1|||
23403548|NCT00972517|65223349|FG005|Overall Study|Withdrawal by Subject|0|||
23403549|NCT00636181|65223350|FG000|Overall Study|Withdrawal by Subject|8|||
23403550|NCT00636181|65223351|FG001|Overall Study|Withdrawal by Subject|6|||
23403551|NCT00636181|65223352|FG002|Overall Study|Withdrawal by Subject|10|||
23403552|NCT02850978|65223361|FG000|Overall Study|Uncollectable CRF|27|||
23403553|NCT02850978|65223361|FG000|Overall Study|No visit since the first visit|35|||
23707289|NCT01781429|66304392|FG010|Overall Study|Unacceptable Toxicity|0|||
23707290|NCT01781429|66304393|FG011|Overall Study|Unacceptable Toxicity|2|||
23707291|NCT01781429|66304394|FG012|Overall Study|Unacceptable Toxicity|0|||
23707292|NCT01781429|66304395|FG013|Overall Study|Unacceptable Toxicity|0|||
23707293|NCT01781429|66304396|FG014|Overall Study|Unacceptable Toxicity|0|||
23707294|NCT01781429|66304397|FG015|Overall Study|Unacceptable Toxicity|0|||
23707295|NCT01781429|66304382|FG000|Overall Study|Patient Condition Changed|0|||
23707296|NCT01781429|66304383|FG001|Overall Study|Patient Condition Changed|0|||
23707297|NCT01781429|66304384|FG002|Overall Study|Patient Condition Changed|0|||
23707298|NCT01781429|66304385|FG003|Overall Study|Patient Condition Changed|0|||
23403554|NCT02850978|65223361|FG000|Overall Study|Adverse Event|81|||
23707299|NCT01781429|66304386|FG004|Overall Study|Patient Condition Changed|0|||
23707300|NCT01781429|66304387|FG005|Overall Study|Patient Condition Changed|0|||
23707301|NCT01781429|66304388|FG006|Overall Study|Patient Condition Changed|0|||
23707302|NCT01781429|66304389|FG007|Overall Study|Patient Condition Changed|0|||
23707303|NCT01781429|66304390|FG008|Overall Study|Patient Condition Changed|0|||
23707304|NCT01781429|66304391|FG009|Overall Study|Patient Condition Changed|4|||
23707305|NCT01781429|66304392|FG010|Overall Study|Patient Condition Changed|0|||
23707306|NCT01781429|66304393|FG011|Overall Study|Patient Condition Changed|1|||
23707307|NCT01781429|66304394|FG012|Overall Study|Patient Condition Changed|0|||
23707308|NCT01781429|66304395|FG013|Overall Study|Patient Condition Changed|1|||
23707309|NCT01781429|66304396|FG014|Overall Study|Patient Condition Changed|0|||
23707310|NCT01781429|66304397|FG015|Overall Study|Patient Condition Changed|0|||
23707311|NCT01781429|66304382|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
23707312|NCT01781429|66304383|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
23707313|NCT01781429|66304384|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
23707314|NCT01781429|66304385|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
23707315|NCT01781429|66304386|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
23707316|NCT01781429|66304387|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
23707317|NCT01781429|66304388|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
23707318|NCT01781429|66304389|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
23707319|NCT01781429|66304390|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
23707320|NCT01781429|66304391|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
23707321|NCT01781429|66304392|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
23707322|NCT01781429|66304393|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
23707323|NCT01781429|66304394|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
23707324|NCT01781429|66304395|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
23707325|NCT01781429|66304396|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
23707326|NCT01781429|66304397|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
23707327|NCT01781429|66304382|FG000|Overall Study|Enrolled, but not treated|0|||
23707328|NCT01781429|66304383|FG001|Overall Study|Enrolled, but not treated|0|||
23707329|NCT01781429|66304384|FG002|Overall Study|Enrolled, but not treated|0|||
23707330|NCT01781429|66304385|FG003|Overall Study|Enrolled, but not treated|0|||
23707331|NCT01781429|66304386|FG004|Overall Study|Enrolled, but not treated|0|||
23707332|NCT01781429|66304387|FG005|Overall Study|Enrolled, but not treated|0|||
23707333|NCT01781429|66304388|FG006|Overall Study|Enrolled, but not treated|0|||
23707334|NCT01781429|66304389|FG007|Overall Study|Enrolled, but not treated|0|||
23707335|NCT01781429|66304390|FG008|Overall Study|Enrolled, but not treated|0|||
23707336|NCT01781429|66304391|FG009|Overall Study|Enrolled, but not treated|0|||
23707337|NCT01781429|66304392|FG010|Overall Study|Enrolled, but not treated|1|||
23707338|NCT01781429|66304393|FG011|Overall Study|Enrolled, but not treated|0|||
23707339|NCT01781429|66304394|FG012|Overall Study|Enrolled, but not treated|0|||
23707340|NCT01781429|66304395|FG013|Overall Study|Enrolled, but not treated|0|||
23707341|NCT01781429|66304396|FG014|Overall Study|Enrolled, but not treated|0|||
23707342|NCT01781429|66304397|FG015|Overall Study|Enrolled, but not treated|0|||
23707343|NCT00532948|66304402|FG000|Overall Study|Protocol Violation|1|||
23707344|NCT00532948|66304403|FG001|Overall Study|Protocol Violation|0|||
23707345|NCT00532948|66304404|FG002|Overall Study|Protocol Violation|0|||
23707346|NCT00532948|66304402|FG000|Overall Study|Death|3|||
23707347|NCT00532948|66304403|FG001|Overall Study|Death|3|||
23707348|NCT00532948|66304404|FG002|Overall Study|Death|4|||
23707349|NCT00532948|66304402|FG000|Overall Study|Violation of selection criteria at entry|0|||
23707350|NCT00532948|66304403|FG001|Overall Study|Violation of selection criteria at entry|1|||
23707351|NCT00532948|66304404|FG002|Overall Study|Violation of selection criteria at entry|0|||
23707352|NCT00532948|66304402|FG000|Overall Study|Failure to return|0|||
23707353|NCT00532948|66304403|FG001|Overall Study|Failure to return|1|||
23707354|NCT00532948|66304404|FG002|Overall Study|Failure to return|0|||
23707355|NCT01638000|66304406|FG000|Overall Study|Randomized but Never Received Drug|7|||
23707356|NCT01638000|66304407|FG001|Overall Study|Randomized but Never Received Drug|10|||
23707357|NCT01638000|66304406|FG000|Overall Study|Adverse Event|14|||
23707358|NCT01638000|66304407|FG001|Overall Study|Adverse Event|16|||
23707359|NCT01638000|66304406|FG000|Overall Study|Lack of Efficacy|5|||
23707360|NCT01638000|66304407|FG001|Overall Study|Lack of Efficacy|6|||
23707361|NCT01638000|66304406|FG000|Overall Study|Protocol Violation|11|||
23403555|NCT02850978|65223361|FG000|Overall Study|Lack of Efficacy|40|||
23403556|NCT02850978|65223361|FG000|Overall Study|Improvement in condition|34|||
23807651|NCT00468650|66676219|FG000|Overall Study|Protocol Violation|1|||
23707362|NCT01638000|66304407|FG001|Overall Study|Protocol Violation|13|||
23707363|NCT01638000|66304406|FG000|Overall Study|Withdrawal by Subject|21|||
23707364|NCT01638000|66304407|FG001|Overall Study|Withdrawal by Subject|24|||
23707365|NCT01638000|66304406|FG000|Overall Study|Miscellaneous|2|||
23707366|NCT01638000|66304407|FG001|Overall Study|Miscellaneous|2|||
23707367|NCT01740440|66304408|FG000|Overall Study|Lost to Follow-up|3|||
23707368|NCT01675531|66304409|FG000|Overall Study|Adverse Event|9|||
23707369|NCT01675531|66304409|FG000|Overall Study|Withdrawal by Subject|7|||
23707370|NCT01675531|66304409|FG000|Overall Study|Lack of Efficacy|1|||
23707371|NCT01675531|66304409|FG000|Overall Study|Protocol Violation|8|||
23707372|NCT01496430|66304410|FG000|Overall Study|Adverse Event|0|||
23707373|NCT01496430|66304411|FG001|Overall Study|Adverse Event|0|||
23403557|NCT02850978|65223361|FG000|Overall Study|Lost to Follow-up|121|||
23403558|NCT02850978|65223361|FG000|Overall Study|Reason not listed|88|||
23403559|NCT03519997|65223363|FG000|Overall Study|Adverse Event|4|||
23403560|NCT03519997|65223363|FG000|Overall Study|Withdrawal by Subject|2|||
23403561|NCT03519997|65223363|FG000|Overall Study|Protocol Violation|1|||
23403562|NCT00443118|65223364|FG000|Overall Study|unknown primary outcome|3|||
23403563|NCT00443118|65223365|FG001|Overall Study|unknown primary outcome|1|||
23403564|NCT00443118|65223366|FG002|Overall Study|unknown primary outcome|0|||
23403565|NCT00443118|65223364|FG000|Overall Study|Withdrawal by Subject|1|||
23403566|NCT00443118|65223365|FG001|Overall Study|Withdrawal by Subject|0|||
23403567|NCT00443118|65223366|FG002|Overall Study|Withdrawal by Subject|0|||
23403568|NCT02012218|65223367|FG000|Overall Study|Withdrawal by Subject|1|||
23403569|NCT02012218|65223368|FG001|Overall Study|Withdrawal by Subject|0|||
23403570|NCT02012218|65223369|FG002|Overall Study|Withdrawal by Subject|1|||
23403571|NCT02012218|65223370|FG003|Overall Study|Withdrawal by Subject|1|||
23403572|NCT02012218|65223371|FG004|Overall Study|Withdrawal by Subject|1|||
23403573|NCT02012218|65223367|FG000|Overall Study|Adverse Event|1|||
23403574|NCT02012218|65223368|FG001|Overall Study|Adverse Event|0|||
23403575|NCT02012218|65223369|FG002|Overall Study|Adverse Event|0|||
23403576|NCT02012218|65223370|FG003|Overall Study|Adverse Event|1|||
23707374|NCT01496430|66304412|FG002|Overall Study|Adverse Event|1|||
23707375|NCT01496430|66304410|FG000|Overall Study|Major Protocol Deviation|0|||
23403577|NCT02012218|65223371|FG004|Overall Study|Adverse Event|0|||
23403578|NCT02012218|65223367|FG000|Overall Study|Lost to Follow-up|0|||
23403579|NCT02012218|65223368|FG001|Overall Study|Lost to Follow-up|1|||
23403580|NCT02012218|65223369|FG002|Overall Study|Lost to Follow-up|1|||
23403581|NCT02012218|65223370|FG003|Overall Study|Lost to Follow-up|0|||
23403582|NCT02012218|65223371|FG004|Overall Study|Lost to Follow-up|0|||
23403583|NCT02012218|65223367|FG000|Overall Study|Protocol Specified|1|||
23707376|NCT01496430|66304411|FG001|Overall Study|Major Protocol Deviation|0|||
23707377|NCT01496430|66304412|FG002|Overall Study|Major Protocol Deviation|1|||
23707378|NCT01496430|66304410|FG000|Overall Study|Lost to Follow-up|2|||
23707379|NCT01496430|66304411|FG001|Overall Study|Lost to Follow-up|3|||
23707380|NCT01496430|66304412|FG002|Overall Study|Lost to Follow-up|1|||
23707381|NCT01496430|66304410|FG000|Overall Study|Voluntary Withdrawal|2|||
23707382|NCT01496430|66304411|FG001|Overall Study|Voluntary Withdrawal|1|||
23707383|NCT01496430|66304412|FG002|Overall Study|Voluntary Withdrawal|6|||
23707384|NCT01496430|66304410|FG000|Overall Study|Principal Investigator Discretion|0|||
23707385|NCT01496430|66304411|FG001|Overall Study|Principal Investigator Discretion|1|||
23707386|NCT01496430|66304412|FG002|Overall Study|Principal Investigator Discretion|1|||
23707387|NCT01496430|66304410|FG000|Overall Study|Other|2|||
23707388|NCT01496430|66304411|FG001|Overall Study|Other|0|||
23707389|NCT01496430|66304412|FG002|Overall Study|Other|0|||
23707390|NCT00631488|66304413|FG000|Overall Study|Adverse Event|1|||
23707391|NCT00631488|66304414|FG001|Overall Study|Adverse Event|0|||
23707392|NCT00631488|66304415|FG002|Overall Study|Adverse Event|0|||
23707393|NCT00631488|66304413|FG000|Overall Study|Lost to Follow-up|2|||
23707394|NCT00631488|66304414|FG001|Overall Study|Lost to Follow-up|2|||
23707395|NCT00631488|66304415|FG002|Overall Study|Lost to Follow-up|0|||
23707396|NCT00631488|66304413|FG000|Overall Study|Physician Decision|1|||
23707397|NCT00631488|66304414|FG001|Overall Study|Physician Decision|0|||
23707398|NCT00631488|66304415|FG002|Overall Study|Physician Decision|1|||
23707399|NCT00631488|66304413|FG000|Overall Study|Protocol Violation|0|||
23707400|NCT00631488|66304414|FG001|Overall Study|Protocol Violation|0|||
23707401|NCT00631488|66304415|FG002|Overall Study|Protocol Violation|1|||
23707402|NCT02043301|66304416|FG000|Overall Study|Discontinued|0|||
23707403|NCT02043301|66304417|FG001|Overall Study|Discontinued|1|||
23403584|NCT02012218|65223368|FG001|Overall Study|Protocol Specified|0|||
23403585|NCT02012218|65223369|FG002|Overall Study|Protocol Specified|0|||
23807652|NCT02932228|66676220|FG000|Overall Study|Death|8|||
23707404|NCT02043301|66304418|FG002|Overall Study|Discontinued|0|||
23707405|NCT03439748|66304421|FG000|Overall Study|Withdrawal by Subject|11|||
23707406|NCT03439748|66304422|FG001|Overall Study|Withdrawal by Subject|17|||
23707407|NCT01425190|66304424|FG000|Overall Study|Full dose not consumed.|1|||
23707408|NCT01425190|66304425|FG001|Overall Study|Full dose not consumed.|0|||
23707409|NCT01425190|66304426|FG002|Overall Study|Full dose not consumed.|0|||
23403586|NCT02012218|65223370|FG003|Overall Study|Protocol Specified|0|||
23403587|NCT02012218|65223371|FG004|Overall Study|Protocol Specified|0|||
23403588|NCT02012218|65223367|FG000|Overall Study|Protocol Deviation|1|||
23403589|NCT02012218|65223368|FG001|Overall Study|Protocol Deviation|0|||
23403590|NCT02012218|65223369|FG002|Overall Study|Protocol Deviation|0|||
23403591|NCT02012218|65223370|FG003|Overall Study|Protocol Deviation|0|||
23707410|NCT00525148|66304433|FG000|Overall Study|Other Adverse Event|3|||
23707411|NCT00525148|66304434|FG001|Overall Study|Other Adverse Event|5|||
23707412|NCT00525148|66304435|FG002|Overall Study|Other Adverse Event|1|||
23707413|NCT00525148|66304436|FG003|Overall Study|Other Adverse Event|8|||
23707414|NCT00525148|66304433|FG000|Overall Study|Progressive disease|18|||
23707415|NCT00525148|66304434|FG001|Overall Study|Progressive disease|30|||
23707416|NCT00525148|66304435|FG002|Overall Study|Progressive disease|6|||
23707417|NCT00525148|66304436|FG003|Overall Study|Progressive disease|49|||
23707418|NCT00525148|66304433|FG000|Overall Study|Refused continuation of study medication|0|||
23707419|NCT00525148|66304434|FG001|Overall Study|Refused continuation of study medication|2|||
23707420|NCT00525148|66304435|FG002|Overall Study|Refused continuation of study medication|0|||
23707421|NCT00525148|66304436|FG003|Overall Study|Refused continuation of study medication|1|||
23707422|NCT00525148|66304433|FG000|Overall Study|Other than stated|2|||
23707423|NCT00525148|66304434|FG001|Overall Study|Other than stated|1|||
23707424|NCT00525148|66304435|FG002|Overall Study|Other than stated|0|||
23707425|NCT00525148|66304436|FG003|Overall Study|Other than stated|3|||
23707426|NCT00943319|66304437|FG000|Overall Study|Death|1|||
23707427|NCT04737031|66304438|FG000|Overall Study|Patients who did not have a treatment visit|0|||
23707428|NCT04737031|66304439|FG001|Overall Study|Patients who did not have a treatment visit|31|||
23707429|NCT04737031|66304440|FG002|Overall Study|Patients who did not have a treatment visit|93|||
23707430|NCT04737031|66304441|FG003|Overall Study|Patients who did not have a treatment visit|227|||
23707431|NCT02756650|66304442|FG000|Overall Study|Physician Decision|1|||
23707432|NCT02756650|66304442|FG000|Overall Study|Adverse Event|1|||
23707433|NCT01921257|66304445|FG000|Overall Study|Adverse Event|1|||
23707434|NCT01921257|66304445|FG000|Overall Study|Protocol Violation|1|||
23707435|NCT01921257|66304445|FG000|Overall Study|Withdrawal by Subject|1|||
23707436|NCT03799718|66304449|FG000|Overall Study|Adverse Event|2|||
23707437|NCT03442829|66304454|FG000|Overall Study|Scheduling clash|3|||
23707438|NCT03442829|66304455|FG001|Overall Study|Scheduling clash|1|||
23707439|NCT03442829|66304454|FG000|Overall Study|Illness unrelated to study|1|||
23707440|NCT03442829|66304455|FG001|Overall Study|Illness unrelated to study|1|||
23707441|NCT02433379|66304458|FG000|Overall Study|Screen Failures|55|||
23707442|NCT02433379|66304458|FG000|Overall Study|Death|57|||
23403592|NCT02012218|65223371|FG004|Overall Study|Protocol Deviation|0|||
23403593|NCT01490918|65223372|FG000|Overall Study|Lost to Follow-up|2|||
23403594|NCT01490918|65223373|FG001|Overall Study|Lost to Follow-up|1|||
23403595|NCT01490918|65223374|FG002|Overall Study|Lost to Follow-up|0|||
23403596|NCT01490918|65223372|FG000|Overall Study|Withdrawal by Subject|7|||
23403597|NCT01490918|65223373|FG001|Overall Study|Withdrawal by Subject|8|||
23403598|NCT01490918|65223374|FG002|Overall Study|Withdrawal by Subject|3|||
23403599|NCT01490918|65223372|FG000|Overall Study|Adverse Event|0|||
23403600|NCT01490918|65223373|FG001|Overall Study|Adverse Event|0|||
23403601|NCT01490918|65223374|FG002|Overall Study|Adverse Event|1|||
23403602|NCT01490918|65223372|FG000|Overall Study|other cause|4|||
23403603|NCT01490918|65223373|FG001|Overall Study|other cause|5|||
23403604|NCT01490918|65223374|FG002|Overall Study|other cause|8|||
23403605|NCT03073525|65223375|FG000|Overall Study|Withdrawal by Subject|0|||
23403606|NCT03073525|65223376|FG001|Overall Study|Withdrawal by Subject|0|||
23403607|NCT03073525|65223377|FG002|Overall Study|Withdrawal by Subject|3|||
23403608|NCT01465386|65223382|FG000|Overall Study|Lack of Efficacy|3|||
23403609|NCT01465386|65223382|FG000|Overall Study|Adverse Event|1|||
23403610|NCT00429182|65223387|FG000|Overall Study|Not evaluable, Disease Progression|2|||
23403611|NCT00429182|65223387|FG000|Overall Study|Not eligible|5|||
23403612|NCT02347085|65223388|FG000|Overall Study|Adverse Event|2|||
23403613|NCT02347085|65223388|FG000|Overall Study|Lack of Efficacy|1|||
23403614|NCT02347085|65223388|FG000|Overall Study|Withdrawal by Subject|4|||
23403615|NCT02347085|65223388|FG000|Overall Study|Lost to Follow-up|1|||
23403616|NCT02347085|65223388|FG000|Overall Study|Protocol Criteria|2|||
23403617|NCT03533660|65223391|FG000|Overall Study|Withdrawal by Subject|2|||
23403618|NCT03533660|65223392|FG001|Overall Study|Withdrawal by Subject|2|||
23403619|NCT03533660|65223391|FG000|Overall Study|Death|2|||
23403620|NCT03533660|65223392|FG001|Overall Study|Death|4|||
23403621|NCT03533660|65223391|FG000|Overall Study|Adverse Event|0|||
23403622|NCT03533660|65223392|FG001|Overall Study|Adverse Event|2|||
23403623|NCT01206517|65223393|FG000|Overall Study|Withdrawal by Subject|0|||
23707443|NCT02433379|66304458|FG000|Overall Study|Total Withdrawals|209|||
23707444|NCT00115349|66304459|FG000|Overall Study|Study closed due to low enrollment.|11|||
23707445|NCT00115349|66304460|FG001|Overall Study|Study closed due to low enrollment.|9|||
23707446|NCT02108600|66304463|FG000|Overall Study|Withdrawal by Subject|2|||
23707447|NCT02108600|66304464|FG001|Overall Study|Withdrawal by Subject|0|||
23707448|NCT02108600|66304463|FG000|Overall Study|Lost to Follow-up|1|||
23403624|NCT01206517|65223394|FG001|Overall Study|Withdrawal by Subject|0|||
23403625|NCT01206517|65223395|FG002|Overall Study|Withdrawal by Subject|2|||
23403626|NCT01206517|65223396|FG003|Overall Study|Withdrawal by Subject|0|||
23403627|NCT01206517|65223397|FG004|Overall Study|Withdrawal by Subject|1|||
23403628|NCT01206517|65223398|FG005|Overall Study|Withdrawal by Subject|0|||
23403629|NCT00295646|65223399|FG000|Overall Study|Protocol Violation|18|||
23403630|NCT00295646|65223400|FG001|Overall Study|Protocol Violation|20|||
23707449|NCT02108600|66304464|FG001|Overall Study|Lost to Follow-up|1|||
23707450|NCT02115815|66304469|FG000|Overall Study|Withdrawal by Subject|2|||
23807653|NCT02932228|66676221|FG001|Overall Study|Death|23|||
23403631|NCT00295646|65223401|FG002|Overall Study|Protocol Violation|20|||
23707451|NCT02115815|66304470|FG001|Overall Study|Withdrawal by Subject|0|||
23707452|NCT02115815|66304471|FG002|Overall Study|Withdrawal by Subject|0|||
23707453|NCT02115815|66304472|FG003|Overall Study|Withdrawal by Subject|0|||
23707454|NCT02115815|66304473|FG004|Overall Study|Withdrawal by Subject|0|||
23707455|NCT02115815|66304474|FG005|Overall Study|Withdrawal by Subject|0|||
23707456|NCT02115815|66304475|FG006|Overall Study|Withdrawal by Subject|0|||
23707457|NCT02115815|66304469|FG000|Overall Study|Not enough drug to dose participant|0|||
23707458|NCT02115815|66304470|FG001|Overall Study|Not enough drug to dose participant|0|||
23707459|NCT02115815|66304471|FG002|Overall Study|Not enough drug to dose participant|0|||
23707460|NCT02115815|66304472|FG003|Overall Study|Not enough drug to dose participant|0|||
23403632|NCT00295646|65223402|FG003|Overall Study|Protocol Violation|18|||
23403633|NCT00295646|65223399|FG000|Overall Study|Withdrawal by Subject|8|||
23403634|NCT00295646|65223400|FG001|Overall Study|Withdrawal by Subject|9|||
23403635|NCT00295646|65223401|FG002|Overall Study|Withdrawal by Subject|11|||
23707461|NCT02115815|66304473|FG004|Overall Study|Not enough drug to dose participant|0|||
23707462|NCT02115815|66304474|FG005|Overall Study|Not enough drug to dose participant|1|||
23707463|NCT02115815|66304475|FG006|Overall Study|Not enough drug to dose participant|0|||
23707464|NCT02115815|66304469|FG000|Overall Study|Missed appointment, randomized in error|0|||
23707465|NCT02115815|66304470|FG001|Overall Study|Missed appointment, randomized in error|0|||
23403636|NCT00295646|65223402|FG003|Overall Study|Withdrawal by Subject|14|||
23403637|NCT00295646|65223399|FG000|Overall Study|Lost to Follow-up|0|||
23403638|NCT00295646|65223400|FG001|Overall Study|Lost to Follow-up|5|||
23403639|NCT00295646|65223401|FG002|Overall Study|Lost to Follow-up|1|||
23403640|NCT00295646|65223402|FG003|Overall Study|Lost to Follow-up|5|||
23403641|NCT00295646|65223399|FG000|Overall Study|Death|9|||
23403642|NCT00295646|65223400|FG001|Overall Study|Death|7|||
23403643|NCT00295646|65223401|FG002|Overall Study|Death|18|||
23403644|NCT00295646|65223402|FG003|Overall Study|Death|8|||
23403645|NCT02473471|65223405|FG000|Overall Study|poor oral hygiene|2|||
23403646|NCT02473471|65223405|FG000|Overall Study|Lost to Follow-up|1|||
23403647|NCT00783432|65223416|FG000|Overall Study|Adverse Event|22|||
23403648|NCT00783432|65223417|FG001|Overall Study|Adverse Event|17|||
23403649|NCT00783432|65223416|FG000|Overall Study|Lack of Efficacy|20|||
23403650|NCT00783432|65223417|FG001|Overall Study|Lack of Efficacy|21|||
23403651|NCT00783432|65223416|FG000|Overall Study|Lost to Follow-up|11|||
23403652|NCT00783432|65223417|FG001|Overall Study|Lost to Follow-up|6|||
23403653|NCT00783432|65223416|FG000|Overall Study|Withdrawal by Subject|23|||
23403654|NCT00783432|65223417|FG001|Overall Study|Withdrawal by Subject|20|||
23403655|NCT00783432|65223416|FG000|Overall Study|subject moved|3|||
23403656|NCT00783432|65223417|FG001|Overall Study|subject moved|5|||
23403657|NCT00783432|65223416|FG000|Overall Study|Protocol Violation|6|||
23403658|NCT00783432|65223417|FG001|Overall Study|Protocol Violation|9|||
23403659|NCT00972023|65223418|FG000|Overall Study|Withdrawal by Subject|1|||
23403660|NCT03710889|65223422|FG000|Overall Study|Adverse Event|2|||
23403661|NCT03710889|65223422|FG000|Overall Study|Protocol Deviation|1|||
23403662|NCT00442416|65223423|FG000|Overall Study|Adverse Event|4|||
23403663|NCT00442416|65223424|FG001|Overall Study|Adverse Event|1|||
23403664|NCT00442416|65223423|FG000|Overall Study|Death|1|||
23403665|NCT00442416|65223424|FG001|Overall Study|Death|0|||
23403666|NCT00442416|65223423|FG000|Overall Study|Lack of Efficacy|2|||
23403667|NCT00442416|65223424|FG001|Overall Study|Lack of Efficacy|0|||
23403668|NCT00442416|65223423|FG000|Overall Study|Protocol Violation|2|||
23403669|NCT00442416|65223424|FG001|Overall Study|Protocol Violation|3|||
23403670|NCT00442416|65223423|FG000|Overall Study|Withdrew consent|1|||
23403671|NCT00442416|65223424|FG001|Overall Study|Withdrew consent|2|||
23403672|NCT00442416|65223423|FG000|Overall Study|Administrative/Other|27|||
23403673|NCT00442416|65223424|FG001|Overall Study|Administrative/Other|33|||
23403674|NCT03082677|65223427|FG000|Overall Study|Not Treated|2|||
23707466|NCT02115815|66304471|FG002|Overall Study|Missed appointment, randomized in error|0|||
23707467|NCT02115815|66304472|FG003|Overall Study|Missed appointment, randomized in error|0|||
23707468|NCT02115815|66304473|FG004|Overall Study|Missed appointment, randomized in error|0|||
23707469|NCT02115815|66304474|FG005|Overall Study|Missed appointment, randomized in error|1|||
23707470|NCT02115815|66304475|FG006|Overall Study|Missed appointment, randomized in error|0|||
23403675|NCT00305877|65223428|FG000|Overall Study|Lack of Efficacy|6|||
23707471|NCT00771030|66304478|FG000|Overall Study|Adverse Event|0|||
23403676|NCT00305877|65223429|FG001|Overall Study|Lack of Efficacy|9|||
23403677|NCT00305877|65223428|FG000|Overall Study|Adverse Event|9|||
23403678|NCT00305877|65223429|FG001|Overall Study|Adverse Event|14|||
23403679|NCT00305877|65223428|FG000|Overall Study|Death|0|||
23403680|NCT00305877|65223429|FG001|Overall Study|Death|1|||
23403681|NCT00305877|65223428|FG000|Overall Study|Withdrawal by Subject|4|||
23403682|NCT00305877|65223429|FG001|Overall Study|Withdrawal by Subject|2|||
23403683|NCT00305877|65223428|FG000|Overall Study|Physician Decision|1|||
23403684|NCT00305877|65223429|FG001|Overall Study|Physician Decision|1|||
23403685|NCT00305877|65223428|FG000|Overall Study|Never start treatment|2|||
23403686|NCT00305877|65223429|FG001|Overall Study|Never start treatment|5|||
23403687|NCT00305877|65223428|FG000|Overall Study|Ineligible|2|||
23403688|NCT00305877|65223429|FG001|Overall Study|Ineligible|1|||
23403689|NCT00305877|65223428|FG000|Overall Study|Transportation issue with daily RT|0|||
23403690|NCT00305877|65223429|FG001|Overall Study|Transportation issue with daily RT|1|||
23403691|NCT00165789|65223430|FG000|Overall Study|Adverse Event|0|||
23403692|NCT00165789|65223431|FG001|Overall Study|Adverse Event|3|||
23403693|NCT00165789|65223432|FG002|Overall Study|Adverse Event|0|||
23403694|NCT00165789|65223433|FG003|Overall Study|Adverse Event|12|||
23403695|NCT00165789|65223430|FG000|Overall Study|Withdrawal by Subject|0|||
23403696|NCT00165789|65223431|FG001|Overall Study|Withdrawal by Subject|1|||
23403697|NCT00165789|65223432|FG002|Overall Study|Withdrawal by Subject|1|||
23403698|NCT00165789|65223433|FG003|Overall Study|Withdrawal by Subject|2|||
23403699|NCT02271529|65223434|FG000|Overall Study|Withdrawal by Subject|1|||
23403700|NCT00570713|65223435|FG000|Overall Study|Adverse Event|16|||
23403701|NCT00570713|65223436|FG001|Overall Study|Adverse Event|9|||
23403702|NCT00570713|65223435|FG000|Overall Study|Death|7|||
23403703|NCT00570713|65223436|FG001|Overall Study|Death|7|||
23403704|NCT00570713|65223435|FG000|Overall Study|Lack of Efficacy|40|||
23403705|NCT00570713|65223436|FG001|Overall Study|Lack of Efficacy|49|||
23403706|NCT00570713|65223435|FG000|Overall Study|Physician Decision|2|||
23403707|NCT00570713|65223436|FG001|Overall Study|Physician Decision|2|||
23403708|NCT00570713|65223435|FG000|Overall Study|Withdrawal by Subject|3|||
23403709|NCT00570713|65223436|FG001|Overall Study|Withdrawal by Subject|3|||
23403710|NCT00570713|65223435|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
23403711|NCT00570713|65223436|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
23403712|NCT01628913|65223439|FG000|Overall Study|Adverse Event|12|||
23403713|NCT01628913|65223440|FG001|Overall Study|Adverse Event|5|||
23403714|NCT01628913|65223439|FG000|Overall Study|Disease Progression|11|||
23403715|NCT01628913|65223440|FG001|Overall Study|Disease Progression|14|||
23403716|NCT01628913|65223439|FG000|Overall Study|Protocol Violation|1|||
23403717|NCT01628913|65223440|FG001|Overall Study|Protocol Violation|0|||
23403718|NCT01628913|65223439|FG000|Overall Study|Death|1|||
23403719|NCT01628913|65223440|FG001|Overall Study|Death|0|||
23403720|NCT01628913|65223439|FG000|Overall Study|study terminated by Sponsor|4|||
23403721|NCT01628913|65223440|FG001|Overall Study|study terminated by Sponsor|9|||
23403722|NCT01628913|65223439|FG000|Overall Study|Withdrawal by Subject|1|||
23403723|NCT01628913|65223440|FG001|Overall Study|Withdrawal by Subject|0|||
23403724|NCT01628913|65223439|FG000|Overall Study|Physician Decision|1|||
23403725|NCT01628913|65223440|FG001|Overall Study|Physician Decision|3|||
23403726|NCT00524121|65223443|FG000|Overall Study|Disease progression|6|||
23403727|NCT00524121|65223443|FG000|Overall Study|Adverse Event|4|||
23403728|NCT00524121|65223443|FG000|Overall Study|Patient refused|2|||
23403729|NCT00524121|65223443|FG000|Overall Study|Other|1|||
23403730|NCT00524121|65223443|FG000|Overall Study|Death|1|||
23403731|NCT00524121|65223443|FG000|Overall Study|Not treated (became ineligible)|4|||
23403732|NCT00524121|65223443|FG000|Overall Study|Not treated (changed mind)|1|||
23403733|NCT01261975|65223448|FG000|Overall Study|Surgical complication|1|||
23403734|NCT01840943|65223449|FG000|Overall Study|Withdrawal by Subject|5|||
23403735|NCT01840943|65223450|FG001|Overall Study|Withdrawal by Subject|6|||
23403736|NCT01840943|65223449|FG000|Overall Study|Physician Decision|4|||
23403737|NCT01840943|65223450|FG001|Overall Study|Physician Decision|2|||
23403738|NCT01840943|65223449|FG000|Overall Study|Lost to Follow-up|4|||
23403739|NCT01840943|65223450|FG001|Overall Study|Lost to Follow-up|4|||
23403740|NCT00272792|65223451|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
23403741|NCT00272792|65223452|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
23403742|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
23403743|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
23403744|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
23403745|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
23403746|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
23403747|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
23403748|NCT01192126|65223453|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
23403749|NCT01192126|65223454|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
23403750|NCT01192126|65223453|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
23707472|NCT00771030|66304479|FG001|Overall Study|Adverse Event|1|||
23403751|NCT01192126|65223454|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
23403752|NCT00421148|65223464|FG000|Overall Study|Lost to Follow-up|0|||
23707473|NCT00771030|66304480|FG002|Overall Study|Adverse Event|0|||
23403753|NCT00421148|65223465|FG001|Overall Study|Lost to Follow-up|0|||
23403754|NCT00421148|65223466|FG002|Overall Study|Lost to Follow-up|0|||
23403755|NCT00421148|65223467|FG003|Overall Study|Lost to Follow-up|0|||
23403756|NCT00421148|65223468|FG004|Overall Study|Lost to Follow-up|0|||
23403757|NCT00421148|65223469|FG005|Overall Study|Lost to Follow-up|0|||
23403758|NCT00421148|65223470|FG006|Overall Study|Lost to Follow-up|0|||
23403759|NCT00421148|65223471|FG007|Overall Study|Lost to Follow-up|0|||
23403760|NCT00421148|65223472|FG008|Overall Study|Lost to Follow-up|0|||
23403761|NCT00421148|65223473|FG009|Overall Study|Lost to Follow-up|0|||
23403762|NCT00421148|65223474|FG010|Overall Study|Lost to Follow-up|0|||
23403763|NCT00421148|65223475|FG011|Overall Study|Lost to Follow-up|0|||
23403764|NCT00421148|65223476|FG012|Overall Study|Lost to Follow-up|0|||
23403765|NCT00421148|65223477|FG013|Overall Study|Lost to Follow-up|0|||
23403766|NCT00421148|65223478|FG014|Overall Study|Lost to Follow-up|0|||
23403767|NCT00421148|65223479|FG015|Overall Study|Lost to Follow-up|0|||
23403768|NCT00421148|65223480|FG016|Overall Study|Lost to Follow-up|0|||
23403769|NCT00421148|65223481|FG017|Overall Study|Lost to Follow-up|1|||
23403770|NCT00421148|65223482|FG018|Overall Study|Lost to Follow-up|0|||
23403771|NCT00421148|65223483|FG019|Overall Study|Lost to Follow-up|0|||
23403772|NCT00421148|65223464|FG000|Overall Study|Withdrawal by Subject|0|||
23403773|NCT00421148|65223465|FG001|Overall Study|Withdrawal by Subject|0|||
23403774|NCT00421148|65223466|FG002|Overall Study|Withdrawal by Subject|0|||
23403775|NCT00421148|65223467|FG003|Overall Study|Withdrawal by Subject|0|||
23403776|NCT00421148|65223468|FG004|Overall Study|Withdrawal by Subject|0|||
23403777|NCT00421148|65223469|FG005|Overall Study|Withdrawal by Subject|0|||
23403778|NCT00421148|65223470|FG006|Overall Study|Withdrawal by Subject|0|||
23403779|NCT00421148|65223471|FG007|Overall Study|Withdrawal by Subject|0|||
23403780|NCT00421148|65223472|FG008|Overall Study|Withdrawal by Subject|0|||
23707474|NCT00771030|66304481|FG003|Overall Study|Adverse Event|0|||
23707475|NCT00771030|66304482|FG004|Overall Study|Adverse Event|0|||
23707476|NCT00771030|66304483|FG005|Overall Study|Adverse Event|0|||
23707477|NCT00771030|66304484|FG006|Overall Study|Adverse Event|0|||
23707478|NCT01401010|66304485|FG000|Overall Study|Could not interpret assay results|1|||
23707479|NCT01401010|66304486|FG001|Overall Study|Could not interpret assay results|0|||
23707480|NCT03029650|66304489|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
23403781|NCT00421148|65223473|FG009|Overall Study|Withdrawal by Subject|0|||
23403782|NCT00421148|65223474|FG010|Overall Study|Withdrawal by Subject|0|||
23403783|NCT00421148|65223475|FG011|Overall Study|Withdrawal by Subject|0|||
23403784|NCT00421148|65223476|FG012|Overall Study|Withdrawal by Subject|0|||
23403785|NCT00421148|65223477|FG013|Overall Study|Withdrawal by Subject|0|||
23403786|NCT00421148|65223478|FG014|Overall Study|Withdrawal by Subject|0|||
23403787|NCT00421148|65223479|FG015|Overall Study|Withdrawal by Subject|0|||
23403788|NCT00421148|65223480|FG016|Overall Study|Withdrawal by Subject|0|||
23707481|NCT03029650|66304490|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
23707482|NCT03029650|66304489|FG000|Washout (1 Week)|Physician Decision|0|||
23707483|NCT03029650|66304490|FG001|Washout (1 Week)|Physician Decision|1|||
23707484|NCT01871896|66304493|FG000|Overall Study|Lost to Follow-up|1|||
23707485|NCT00069576|66304497|FG000|Original Trial|Lost to Follow-up|25|||
23403789|NCT00421148|65223481|FG017|Overall Study|Withdrawal by Subject|1|||
23403790|NCT00421148|65223482|FG018|Overall Study|Withdrawal by Subject|0|||
23403791|NCT00421148|65223483|FG019|Overall Study|Withdrawal by Subject|0|||
23403792|NCT00421148|65223464|FG000|Overall Study|Protocol Violation|0|||
23403793|NCT00421148|65223465|FG001|Overall Study|Protocol Violation|0|||
23403794|NCT00421148|65223466|FG002|Overall Study|Protocol Violation|0|||
23403795|NCT00421148|65223467|FG003|Overall Study|Protocol Violation|0|||
23403796|NCT00421148|65223468|FG004|Overall Study|Protocol Violation|0|||
23403797|NCT00421148|65223469|FG005|Overall Study|Protocol Violation|1|||
23403798|NCT00421148|65223470|FG006|Overall Study|Protocol Violation|0|||
23403799|NCT00421148|65223471|FG007|Overall Study|Protocol Violation|0|||
23403800|NCT00421148|65223472|FG008|Overall Study|Protocol Violation|0|||
23707486|NCT00069576|66304498|FG001|Original Trial|Lost to Follow-up|33|||
23707487|NCT00069576|66304497|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
23707488|NCT00069576|66304498|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
23707489|NCT04426825|66304499|FG000|Overall Study|Death|17|||
23707490|NCT04426825|66304499|FG000|Overall Study|Lost to Follow-up|1|||
23707491|NCT04426825|66304499|FG000|Overall Study|Study terminated by sponsor|5|||
23707492|NCT02340819|66304505|FG000|Overall Study|Adverse Event|1|||
23707493|NCT02340819|66304505|FG000|Overall Study|Withdrawal by Subject|2|||
23707494|NCT02340819|66304505|FG000|Overall Study|Discontinued with other reason|1|||
23707495|NCT01251276|66304509|FG000|Overall Study|Protocol Violation|1|||
23707496|NCT01251276|66304510|FG001|Overall Study|Protocol Violation|0|||
23707497|NCT01251276|66304509|FG000|Overall Study|Lost to Follow-up|0|||
23707498|NCT01251276|66304510|FG001|Overall Study|Lost to Follow-up|1|||
23707499|NCT01725152|66304514|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
23707500|NCT01725152|66304515|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
23707501|NCT01725152|66304514|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
23403801|NCT00421148|65223473|FG009|Overall Study|Protocol Violation|0|||
23403802|NCT00421148|65223474|FG010|Overall Study|Protocol Violation|0|||
23403803|NCT00421148|65223475|FG011|Overall Study|Protocol Violation|0|||
23403804|NCT00421148|65223476|FG012|Overall Study|Protocol Violation|0|||
23403805|NCT00421148|65223477|FG013|Overall Study|Protocol Violation|0|||
23403806|NCT00421148|65223478|FG014|Overall Study|Protocol Violation|0|||
23403807|NCT00421148|65223479|FG015|Overall Study|Protocol Violation|0|||
23707502|NCT01725152|66304515|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
23707503|NCT01725152|66304514|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
23403808|NCT00421148|65223480|FG016|Overall Study|Protocol Violation|0|||
23707504|NCT01725152|66304515|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
23403809|NCT00421148|65223481|FG017|Overall Study|Protocol Violation|0|||
23403810|NCT00421148|65223482|FG018|Overall Study|Protocol Violation|1|||
23403811|NCT00421148|65223483|FG019|Overall Study|Protocol Violation|0|||
23403812|NCT00181844|65223484|FG000|Signed Consent|Withdrawal by Subject|5|||
23403813|NCT00181844|65223484|FG000|Signed Consent|Did not meet entrance criteria|7|||
23403814|NCT00181844|65223484|FG000|Exposed to Study Medication|Adverse Event|10|||
23403815|NCT00181844|65223484|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
23707505|NCT01725152|66304514|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
23707506|NCT01725152|66304515|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
23707507|NCT00506077|66304516|FG000|Treatment Period 1|Adverse Event|2|||
23707508|NCT00506077|66304517|FG001|Treatment Period 1|Adverse Event|1|||
23707509|NCT00506077|66304516|FG000|Treatment Period 1|Lost to Follow-up|0|||
23707510|NCT00506077|66304517|FG001|Treatment Period 1|Lost to Follow-up|2|||
23707511|NCT00506077|66304516|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23707512|NCT00506077|66304517|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23707513|NCT00506077|66304516|FG000|Treatment Period 2|Adverse Event|0|||
23403816|NCT00181844|65223484|FG000|Exposed to Study Medication|Non-compliance|2|||
23403817|NCT00181844|65223484|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
23403818|NCT00181844|65223484|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
23403819|NCT02580877|65223486|FG000|Overall Study|Withdrawal by Subject|1|||
23403820|NCT02580877|65223487|FG001|Overall Study|Withdrawal by Subject|3|||
23403821|NCT02580877|65223486|FG000|Overall Study|Adverse Event|0|||
23707514|NCT00506077|66304517|FG001|Treatment Period 2|Adverse Event|1|||
23707515|NCT00506077|66304516|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23707516|NCT00506077|66304517|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23707517|NCT03703375|66304518|FG000|Randomization Period|Withdrawal by Subject|0|||
23707518|NCT03703375|66304519|FG001|Randomization Period|Withdrawal by Subject|0|||
23707519|NCT03703375|66304520|FG002|Randomization Period|Withdrawal by Subject|0|||
23707520|NCT03703375|66304521|FG003|Randomization Period|Withdrawal by Subject|1|||
23707521|NCT03703375|66304518|FG000|Randomization Period|Completed safety run-in treatment|7|||
23707522|NCT03703375|66304519|FG001|Randomization Period|Completed safety run-in treatment|0|||
23707523|NCT03703375|66304520|FG002|Randomization Period|Completed safety run-in treatment|0|||
23707524|NCT03703375|66304521|FG003|Randomization Period|Completed safety run-in treatment|0|||
23707525|NCT03703375|66304518|FG000|Treatment Period|Other Reasons|0|||
23707526|NCT03703375|66304519|FG001|Treatment Period|Other Reasons|1|||
23707527|NCT03703375|66304520|FG002|Treatment Period|Other Reasons|0|||
23707528|NCT03703375|66304521|FG003|Treatment Period|Other Reasons|3|||
23707529|NCT03703375|66304518|FG000|Treatment Period|Consent Withdrawal|0|||
23707530|NCT03703375|66304519|FG001|Treatment Period|Consent Withdrawal|0|||
23707531|NCT03703375|66304520|FG002|Treatment Period|Consent Withdrawal|0|||
23707532|NCT03703375|66304521|FG003|Treatment Period|Consent Withdrawal|1|||
23707533|NCT03703375|66304518|FG000|Treatment Period|Death|1|||
23707534|NCT03703375|66304519|FG001|Treatment Period|Death|0|||
23707535|NCT03703375|66304520|FG002|Treatment Period|Death|1|||
23707536|NCT03703375|66304521|FG003|Treatment Period|Death|2|||
23707537|NCT03703375|66304518|FG000|Treatment Period|Toxicity of Study Treatment|2|||
23707538|NCT03703375|66304519|FG001|Treatment Period|Toxicity of Study Treatment|0|||
23707539|NCT03703375|66304520|FG002|Treatment Period|Toxicity of Study Treatment|4|||
23707540|NCT03703375|66304521|FG003|Treatment Period|Toxicity of Study Treatment|1|||
23707541|NCT03703375|66304518|FG000|Treatment Period|Progression|32|||
23707542|NCT03703375|66304519|FG001|Treatment Period|Progression|1|||
23707543|NCT03703375|66304520|FG002|Treatment Period|Progression|7|||
23707544|NCT03703375|66304521|FG003|Treatment Period|Progression|11|||
23707545|NCT03703375|66304518|FG000|Treatment Period|Completed treatment|7|||
23707546|NCT03703375|66304519|FG001|Treatment Period|Completed treatment|2|||
23707547|NCT03703375|66304520|FG002|Treatment Period|Completed treatment|0|||
23707548|NCT03703375|66304521|FG003|Treatment Period|Completed treatment|0|||
23707549|NCT01952834|66304525|FG000|Overall Study|Adverse Event|1|||
23707550|NCT02273050|66304530|FG000|Overall Study|Adverse Event|4|||
23707551|NCT02273050|66304531|FG001|Overall Study|Adverse Event|3|||
23807654|NCT02932228|66676220|FG000|Overall Study|not eligible upon chart review|2|||
23707552|NCT02273050|66304532|FG002|Overall Study|Adverse Event|3|||
23707553|NCT02273050|66304530|FG000|Overall Study|Death|0|||
23707554|NCT02273050|66304531|FG001|Overall Study|Death|0|||
23707555|NCT02273050|66304532|FG002|Overall Study|Death|1|||
23707556|NCT02273050|66304530|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
23403822|NCT02580877|65223487|FG001|Overall Study|Adverse Event|1|||
23504379|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
23707557|NCT02273050|66304531|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
23707558|NCT02273050|66304532|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
23707559|NCT02273050|66304530|FG000|Overall Study|Lack of Efficacy|0|||
23707560|NCT02273050|66304531|FG001|Overall Study|Lack of Efficacy|1|||
23707561|NCT02273050|66304532|FG002|Overall Study|Lack of Efficacy|1|||
23707562|NCT02273050|66304530|FG000|Overall Study|Withdrawal by Subject|17|||
23707563|NCT02273050|66304531|FG001|Overall Study|Withdrawal by Subject|14|||
23403823|NCT01436110|65223488|FG000|Overall Study|Lack of Efficacy|23|||
23403824|NCT01436110|65223489|FG001|Overall Study|Lack of Efficacy|14|||
23403825|NCT01436110|65223490|FG002|Overall Study|Lack of Efficacy|9|||
23403826|NCT01436110|65223488|FG000|Overall Study|Withdrawal by Subject|6|||
23403827|NCT01436110|65223489|FG001|Overall Study|Withdrawal by Subject|8|||
23403828|NCT01436110|65223490|FG002|Overall Study|Withdrawal by Subject|4|||
23403829|NCT01436110|65223488|FG000|Overall Study|Adverse Event|2|||
23403830|NCT01436110|65223489|FG001|Overall Study|Adverse Event|1|||
23403831|NCT01436110|65223490|FG002|Overall Study|Adverse Event|2|||
23403832|NCT01436110|65223488|FG000|Overall Study|Physician Decision|3|||
23403833|NCT01436110|65223489|FG001|Overall Study|Physician Decision|1|||
23403834|NCT01436110|65223490|FG002|Overall Study|Physician Decision|1|||
23403835|NCT01436110|65223488|FG000|Overall Study|Lost to Follow-up|1|||
23403836|NCT01436110|65223489|FG001|Overall Study|Lost to Follow-up|1|||
23403837|NCT01436110|65223490|FG002|Overall Study|Lost to Follow-up|3|||
23403838|NCT01436110|65223488|FG000|Overall Study|Protocol Violation|3|||
23403839|NCT01436110|65223489|FG001|Overall Study|Protocol Violation|1|||
23403840|NCT01436110|65223490|FG002|Overall Study|Protocol Violation|1|||
23403841|NCT01436110|65223488|FG000|Overall Study|Did Not Receive Trial Medication|1|||
23403842|NCT01436110|65223489|FG001|Overall Study|Did Not Receive Trial Medication|0|||
23403843|NCT01436110|65223490|FG002|Overall Study|Did Not Receive Trial Medication|3|||
23403844|NCT00846846|65223497|FG000|Overall Study|Death|56|||
23403845|NCT00846846|65223497|FG000|Overall Study|Withdrawal by Subject|19|||
23707564|NCT02273050|66304532|FG002|Overall Study|Withdrawal by Subject|16|||
23807655|NCT02932228|66676221|FG001|Overall Study|not eligible upon chart review|5|||
23403846|NCT01306643|65223498|FG000|Overall Study|Adverse Event|5|||
23403847|NCT01306643|65223498|FG000|Overall Study|Disease Progression|7|||
23403848|NCT01306643|65223498|FG000|Overall Study|Other: Change in Eligibility Status|1|||
23403849|NCT05219253|65226426|FG000|Overall Study|Withdrawal by Subject|1|||
23403850|NCT05219253|65226427|FG001|Overall Study|Withdrawal by Subject|2|||
23403851|NCT00955474|65226428|FG000|Overall Study|Physician Decision|7|||
23403852|NCT00955474|65226429|FG001|Overall Study|Physician Decision|5|||
23403853|NCT03364231|65226430|FG000|Overall Study|Adverse Event|1|||
23403854|NCT03364231|65226431|FG001|Overall Study|Adverse Event|4|||
23403855|NCT03364231|65226430|FG000|Overall Study|Death|1|||
23403856|NCT03364231|65226431|FG001|Overall Study|Death|0|||
23403857|NCT03364231|65226430|FG000|Overall Study|Investigator Decision|2|||
23403858|NCT03364231|65226431|FG001|Overall Study|Investigator Decision|2|||
23403859|NCT03364231|65226430|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
23403860|NCT03364231|65226431|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
23403861|NCT03364231|65226430|FG000|Overall Study|Withdrawal of Subject Consent|1|||
23403862|NCT03364231|65226431|FG001|Overall Study|Withdrawal of Subject Consent|0|||
23403863|NCT03364231|65226430|FG000|Overall Study|Reason Not Specified|1|||
23403864|NCT03364231|65226431|FG001|Overall Study|Reason Not Specified|0|||
23403865|NCT03364231|65226430|FG000|Overall Study|Disease Progression|0|||
23403866|NCT03364231|65226431|FG001|Overall Study|Disease Progression|6|||
23403867|NCT00003645|65226432|FG000|Overall Study|Death|4|||
23403868|NCT00003645|65226433|FG001|Overall Study|Death|1|||
23403869|NCT00003645|65226432|FG000|Overall Study|Lost to Follow-up|7|||
23403870|NCT00003645|65226433|FG001|Overall Study|Lost to Follow-up|8|||
23403871|NCT00003645|65226432|FG000|Overall Study|Withdrawal by Subject|1|||
23403872|NCT00003645|65226433|FG001|Overall Study|Withdrawal by Subject|3|||
23403873|NCT03306433|65226434|FG000|Overall Study|Lost to Follow-up|3|||
23403874|NCT03306433|65226434|FG000|Overall Study|Patient did not have teeth extracted|1|||
23403875|NCT03306433|65226434|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
23403876|NCT01331681|65226435|FG000|Overall Study|Adverse Event|10|||
23403877|NCT01331681|65226436|FG001|Overall Study|Adverse Event|13|||
23403878|NCT01331681|65226437|FG002|Overall Study|Adverse Event|10|||
23403879|NCT01331681|65226435|FG000|Overall Study|Death|6|||
23403880|NCT01331681|65226436|FG001|Overall Study|Death|6|||
23403881|NCT01331681|65226437|FG002|Overall Study|Death|2|||
23403882|NCT01331681|65226435|FG000|Overall Study|Lack of Efficacy|0|||
23403883|NCT01331681|65226436|FG001|Overall Study|Lack of Efficacy|1|||
23403884|NCT01331681|65226437|FG002|Overall Study|Lack of Efficacy|0|||
23403885|NCT01331681|65226435|FG000|Overall Study|Withdrawal by Subject|12|||
23403886|NCT01331681|65226436|FG001|Overall Study|Withdrawal by Subject|8|||
23403887|NCT01331681|65226437|FG002|Overall Study|Withdrawal by Subject|15|||
23807656|NCT00851643|66676222|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
23403888|NCT01331681|65226435|FG000|Overall Study|Protocol Violation|1|||
23807657|NCT00851643|66676223|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23403889|NCT01331681|65226436|FG001|Overall Study|Protocol Violation|1|||
23403890|NCT01331681|65226437|FG002|Overall Study|Protocol Violation|0|||
23403891|NCT01331681|65226435|FG000|Overall Study|Lost to Follow-up|2|||
23403892|NCT01331681|65226436|FG001|Overall Study|Lost to Follow-up|4|||
23403893|NCT01331681|65226437|FG002|Overall Study|Lost to Follow-up|1|||
23403894|NCT01331681|65226435|FG000|Overall Study|Physician Decision|2|||
23403895|NCT01331681|65226436|FG001|Overall Study|Physician Decision|0|||
23403896|NCT01331681|65226437|FG002|Overall Study|Physician Decision|4|||
23707565|NCT02273050|66304530|FG000|Overall Study|Lost to Follow-up|0|||
23403897|NCT01331681|65226435|FG000|Overall Study|Therapeutic procedure required|1|||
23403898|NCT01331681|65226436|FG001|Overall Study|Therapeutic procedure required|0|||
23403899|NCT01331681|65226437|FG002|Overall Study|Therapeutic procedure required|0|||
23403900|NCT01331681|65226435|FG000|Overall Study|Sponsor decision|1|||
23403901|NCT01331681|65226436|FG001|Overall Study|Sponsor decision|1|||
23403902|NCT01331681|65226437|FG002|Overall Study|Sponsor decision|0|||
23403903|NCT01331681|65226435|FG000|Overall Study|Switching to other therapy|0|||
23403904|NCT01331681|65226436|FG001|Overall Study|Switching to other therapy|0|||
23403905|NCT01331681|65226437|FG002|Overall Study|Switching to other therapy|1|||
23403906|NCT01331681|65226435|FG000|Overall Study|Not Received Study Treatment|0|||
23707566|NCT02273050|66304531|FG001|Overall Study|Lost to Follow-up|2|||
23403907|NCT01331681|65226436|FG001|Overall Study|Not Received Study Treatment|0|||
23403908|NCT01331681|65226437|FG002|Overall Study|Not Received Study Treatment|2|||
23504380|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
23504381|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
23504382|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504383|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504384|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504385|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
23504386|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Administrative|0|||
23504387|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Administrative|1|||
23504388|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Administrative|0|||
23504389|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Administrative|1|||
23504390|NCT00299975|65587796|FG000|Overall Study|Adverse Event|1|||
23504391|NCT00299975|65587797|FG001|Overall Study|Adverse Event|0|||
23504392|NCT00299975|65587798|FG002|Overall Study|Adverse Event|2|||
23504393|NCT00299975|65587796|FG000|Overall Study|Pregnancy|0|||
23504394|NCT00299975|65587797|FG001|Overall Study|Pregnancy|0|||
23504395|NCT00299975|65587798|FG002|Overall Study|Pregnancy|1|||
23504396|NCT00299975|65587796|FG000|Overall Study|Lack of Efficacy|1|||
23504397|NCT00299975|65587797|FG001|Overall Study|Lack of Efficacy|0|||
23504398|NCT00299975|65587798|FG002|Overall Study|Lack of Efficacy|1|||
23707567|NCT02273050|66304532|FG002|Overall Study|Lost to Follow-up|3|||
23707568|NCT02273050|66304530|FG000|Overall Study|Protocol Violation|3|||
23707569|NCT02273050|66304531|FG001|Overall Study|Protocol Violation|1|||
23707570|NCT02273050|66304532|FG002|Overall Study|Protocol Violation|4|||
23707571|NCT00937560|66304533|FG000|Initial Treatment|Death|6|||
23707572|NCT00937560|66304533|FG000|Initial Treatment|Withdraw consent|3|||
23707573|NCT00937560|66304533|FG000|Initial Treatment|Adverse Event|1|||
23707574|NCT00937560|66304533|FG000|Initial Treatment|Lost to Follow-up|1|||
23707575|NCT00937560|66304533|FG000|Initial Treatment|No end of study page|10|||
23707576|NCT00937560|66304533|FG000|Maintenance Treatment|Death|12|||
23707577|NCT00937560|66304533|FG000|Maintenance Treatment|Withdraw consent|5|||
23707578|NCT00937560|66304533|FG000|Maintenance Treatment|According to protocol|1|||
23707579|NCT00905021|66304534|FG000|Overall Study|Adverse Event|2|||
23707580|NCT01346371|66304535|FG000|Overall Study|Lost to Follow-up|2|||
23707581|NCT01346371|66304536|FG001|Overall Study|Lost to Follow-up|0|||
23707582|NCT01005719|66304537|FG000|Period 1|Adverse Event|0|||
23707583|NCT01005719|66304538|FG001|Period 1|Adverse Event|0|||
23707584|NCT01005719|66304539|FG002|Period 1|Adverse Event|0|||
23707585|NCT01005719|66304540|FG003|Period 1|Adverse Event|1|||
23707586|NCT01005719|66304541|FG004|Period 1|Adverse Event|0|||
23707587|NCT01005719|66304542|FG005|Period 1|Adverse Event|0|||
23707588|NCT01005719|66304537|FG000|Period 1|Delay in completing study procedures|0|||
23707589|NCT01005719|66304538|FG001|Period 1|Delay in completing study procedures|0|||
23707590|NCT01005719|66304539|FG002|Period 1|Delay in completing study procedures|0|||
23707591|NCT01005719|66304540|FG003|Period 1|Delay in completing study procedures|0|||
23707592|NCT01005719|66304541|FG004|Period 1|Delay in completing study procedures|0|||
23504399|NCT00299975|65587796|FG000|Overall Study|Lost to Follow-up|1|||
23504400|NCT00299975|65587797|FG001|Overall Study|Lost to Follow-up|0|||
23504401|NCT00299975|65587798|FG002|Overall Study|Lost to Follow-up|0|||
23504402|NCT00299975|65587796|FG000|Overall Study|Withdrawal by Subject|0|||
23504403|NCT00299975|65587797|FG001|Overall Study|Withdrawal by Subject|1|||
23504404|NCT00299975|65587798|FG002|Overall Study|Withdrawal by Subject|3|||
23504405|NCT00299975|65587796|FG000|Overall Study|Physician Decision|0|||
23707593|NCT01005719|66304542|FG005|Period 1|Delay in completing study procedures|1|||
23707594|NCT01005719|66304537|FG000|Period 2|Adverse Event|0|||
23707595|NCT01005719|66304538|FG001|Period 2|Adverse Event|0|||
23707596|NCT01005719|66304539|FG002|Period 2|Adverse Event|0|||
23707597|NCT01005719|66304540|FG003|Period 2|Adverse Event|0|||
23504406|NCT00299975|65587797|FG001|Overall Study|Physician Decision|0|||
23707598|NCT01005719|66304541|FG004|Period 2|Adverse Event|1|||
23707599|NCT01005719|66304542|FG005|Period 2|Adverse Event|1|||
23707600|NCT05460871|66304543|FG000|Overall Study|Withdrawal by Subject|1|||
23707601|NCT05460871|66304544|FG001|Overall Study|Withdrawal by Subject|2|||
23707602|NCT02245568|66304548|FG000|Overall Study|Study terminated by Sponsor|346|||
23707603|NCT02245568|66304548|FG000|Overall Study|Adverse Event|144|||
23504407|NCT00299975|65587798|FG002|Overall Study|Physician Decision|1|||
23504408|NCT02170298|65587799|FG000|Overall Study|Withdrawal by Subject|0|||
23504409|NCT02170298|65587800|FG001|Overall Study|Withdrawal by Subject|1|||
23504410|NCT02170298|65587799|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
23504411|NCT02170298|65587800|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
23504412|NCT05228132|65587801|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
23504413|NCT05228132|65587801|FG000|Overall Study|Adverse Event|3|||
23504414|NCT05228132|65587801|FG000|Overall Study|Lost to Follow-up|1|||
23707604|NCT02245568|66304548|FG000|Overall Study|Lack of Efficacy|98|||
23707605|NCT02245568|66304548|FG000|Overall Study|Withdrawal by Caregiver|85|||
23707606|NCT02245568|66304548|FG000|Overall Study|Withdrawal by Subject|77|||
23707607|NCT02245568|66304548|FG000|Overall Study|Withdrawal by Legal Representative|31|||
23707608|NCT02245568|66304548|FG000|Overall Study|Missing (Site closure)|16|||
23707609|NCT02245568|66304548|FG000|Overall Study|Physician Decision|14|||
23707610|NCT02245568|66304548|FG000|Overall Study|Non-compliance with study drug|11|||
23707611|NCT02245568|66304548|FG000|Overall Study|Death|9|||
23707612|NCT02245568|66304548|FG000|Overall Study|Blue staining|6|||
23707613|NCT02245568|66304548|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
23707614|NCT02245568|66304548|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
23707615|NCT02245568|66304548|FG000|Overall Study|Lost to Follow-up|5|||
23707616|NCT00367640|66304549|FG000|Overall Study|Adverse Event|3|||
23707617|NCT00367640|66304550|FG001|Overall Study|Adverse Event|6|||
23707618|NCT00367640|66304551|FG002|Overall Study|Adverse Event|8|||
23504415|NCT05228132|65587801|FG000|Overall Study|Arteriovenous-fistula mature|1|||
23707619|NCT00367640|66304552|FG003|Overall Study|Adverse Event|0|||
23707620|NCT00367640|66304549|FG000|Overall Study|Withdrawal by Subject|8|||
23707621|NCT00367640|66304550|FG001|Overall Study|Withdrawal by Subject|11|||
23504416|NCT00662012|65587802|FG000|Overall Study|Lost to Follow-up|85|||
23504417|NCT00662012|65587802|FG000|Overall Study|Death|1|||
23707622|NCT00367640|66304551|FG002|Overall Study|Withdrawal by Subject|8|||
23707623|NCT00367640|66304552|FG003|Overall Study|Withdrawal by Subject|6|||
23707624|NCT00367640|66304549|FG000|Overall Study|Any other reason not above-mentioned|7|||
23707625|NCT00367640|66304550|FG001|Overall Study|Any other reason not above-mentioned|5|||
23707626|NCT00367640|66304551|FG002|Overall Study|Any other reason not above-mentioned|3|||
23707627|NCT00367640|66304552|FG003|Overall Study|Any other reason not above-mentioned|4|||
23707628|NCT00487084|66304553|FG000|Overall Study|Did not receive intervention|4|||
23707629|NCT00487084|66304554|FG001|Overall Study|Did not receive intervention|3|||
23707630|NCT00487084|66304555|FG002|Overall Study|Did not receive intervention|5|||
23707631|NCT01263691|66304560|FG000|Overall Study|Lost to Follow-up|1|||
23707632|NCT01263691|66304561|FG001|Overall Study|Lost to Follow-up|0|||
23707633|NCT01263691|66304562|FG002|Overall Study|Lost to Follow-up|1|||
23707634|NCT01263691|66304563|FG003|Overall Study|Lost to Follow-up|1|||
23707635|NCT01263691|66304564|FG004|Overall Study|Lost to Follow-up|0|||
23707636|NCT01263691|66304565|FG005|Overall Study|Lost to Follow-up|0|||
23707637|NCT01263691|66304560|FG000|Overall Study|Withdrawal by Subject|1|||
23707638|NCT01263691|66304561|FG001|Overall Study|Withdrawal by Subject|0|||
23707639|NCT01263691|66304562|FG002|Overall Study|Withdrawal by Subject|0|||
23707640|NCT01263691|66304563|FG003|Overall Study|Withdrawal by Subject|0|||
23707641|NCT01263691|66304564|FG004|Overall Study|Withdrawal by Subject|0|||
23707642|NCT01263691|66304565|FG005|Overall Study|Withdrawal by Subject|0|||
23707643|NCT01263691|66304560|FG000|Overall Study|Adverse Event|1|||
23707644|NCT01263691|66304561|FG001|Overall Study|Adverse Event|0|||
23707645|NCT01263691|66304562|FG002|Overall Study|Adverse Event|0|||
23707646|NCT01263691|66304563|FG003|Overall Study|Adverse Event|0|||
23707647|NCT01263691|66304564|FG004|Overall Study|Adverse Event|0|||
23707648|NCT01263691|66304565|FG005|Overall Study|Adverse Event|0|||
23707649|NCT00777491|66304566|FG000|Overall Study|Protocol Violation|0|||
23707650|NCT00777491|66304567|FG001|Overall Study|Protocol Violation|2|||
23707651|NCT00777491|66304566|FG000|Overall Study|Did not receive any protocol treatment|2|||
23707652|NCT00777491|66304567|FG001|Overall Study|Did not receive any protocol treatment|0|||
23707653|NCT02044159|66304574|FG000|Overall Study|Consent declined (deferred consent)|2|||
23707654|NCT02044159|66304575|FG001|Overall Study|Consent declined (deferred consent)|4|||
23707655|NCT02044159|66304574|FG000|Overall Study|No longer eligible, drug not given|1|||
23707656|NCT02044159|66304575|FG001|Overall Study|No longer eligible, drug not given|0|||
23707657|NCT02044159|66304574|FG000|Overall Study|Nurse declined to give study drug|1|||
23707658|NCT02044159|66304575|FG001|Overall Study|Nurse declined to give study drug|0|||
23707659|NCT02488551|66304578|FG000|Overall Study|Lost to Follow-up|4|||
23707660|NCT02488551|66304579|FG001|Overall Study|Lost to Follow-up|7|||
23707661|NCT02488551|66304580|FG002|Overall Study|Lost to Follow-up|0|||
23707662|NCT02488551|66304581|FG003|Overall Study|Lost to Follow-up|0|||
23707663|NCT02488551|66304578|FG000|Overall Study|Military Deployment|1|||
23707664|NCT02488551|66304579|FG001|Overall Study|Military Deployment|1|||
23707665|NCT02488551|66304580|FG002|Overall Study|Military Deployment|0|||
23707666|NCT02488551|66304581|FG003|Overall Study|Military Deployment|0|||
23707667|NCT02849990|66304583|FG000|Overall Study|Adverse Event|1|||
23707668|NCT02849990|66304583|FG000|Overall Study|Withdrawal by Subject|1|||
23707669|NCT01035255|66304584|FG000|Overall Study|Death|724|||
23707670|NCT01035255|66304585|FG001|Overall Study|Death|844|||
23707671|NCT01035255|66304584|FG000|Overall Study|Lost to Follow-up|2|||
23707672|NCT01035255|66304585|FG001|Overall Study|Lost to Follow-up|5|||
23707673|NCT01035255|66304584|FG000|Overall Study|patient's request|15|||
23707674|NCT01035255|66304585|FG001|Overall Study|patient's request|13|||
23707675|NCT02130427|66304588|FG000|Overall Study|Imaging results not interpretable|30|||
23707676|NCT03670641|66304589|FG000|Overall Study|Lost to Follow-up|3|||
23707677|NCT00339183|66304592|FG000|Overall Study|Adverse Event|5|||
23707678|NCT00339183|66304593|FG001|Overall Study|Adverse Event|3|||
23707679|NCT00339183|66304592|FG000|Overall Study|Withdrawal by Subject|16|||
23707680|NCT00339183|66304593|FG001|Overall Study|Withdrawal by Subject|19|||
23707681|NCT00339183|66304592|FG000|Overall Study|Physician Decision|2|||
23707682|NCT00339183|66304593|FG001|Overall Study|Physician Decision|4|||
23707683|NCT00339183|66304592|FG000|Overall Study|Lost to Follow-up|17|||
23707684|NCT00339183|66304593|FG001|Overall Study|Lost to Follow-up|17|||
23707685|NCT00339183|66304592|FG000|Overall Study|Protocol-specified criteria|12|||
23707686|NCT00339183|66304593|FG001|Overall Study|Protocol-specified criteria|8|||
23707687|NCT00339183|66304592|FG000|Overall Study|Missing reason|3|||
23707688|NCT00339183|66304593|FG001|Overall Study|Missing reason|1|||
23707689|NCT00339183|66304592|FG000|Overall Study|Other|46|||
23707690|NCT00339183|66304593|FG001|Overall Study|Other|40|||
23707691|NCT00339183|66304592|FG000|Overall Study|Ongoing|20|||
23504418|NCT00662012|65587802|FG000|Overall Study|Withdrawal by Subject|1|||
23504419|NCT01558271|65587803|FG000|Overall Study|Adverse Event|6|||
23504420|NCT01558271|65587804|FG001|Overall Study|Adverse Event|3|||
23707692|NCT00339183|66304593|FG001|Overall Study|Ongoing|13|||
23707693|NCT02509598|66308605|FG000|Overall Study|Withdrawal by Subject|1|||
23707694|NCT01822691|66308608|FG000|Overall Study|Withdrawal by Subject|2|||
23707695|NCT02618928|66308617|FG000|Overall Study|Failure to Return|28|||
23707696|NCT02618928|66308617|FG000|Overall Study|Insufficient Virological Response|1|||
23707697|NCT02618928|66308617|FG000|Overall Study|Withdrawal by Subject|2|||
23707698|NCT02618928|66308617|FG000|Overall Study|Death|3|||
23707699|NCT02618928|66308617|FG000|Overall Study|Other|11|||
23707700|NCT02618928|66308617|FG000|Overall Study|Missing|6|||
23707701|NCT02618928|66308617|FG000|Overall Study|Treatment Never Started|7|||
23707702|NCT02006667|66308618|FG000|Overall Study|Adverse Event|3|||
23707703|NCT02006667|66308618|FG000|Overall Study|Death|2|||
23707704|NCT02006667|66308618|FG000|Overall Study|Withdrawal by Subject|1|||
23707705|NCT00586924|66308619|FG000|Overall Study|Adverse event/serious adverse event|0|||
23707706|NCT00586924|66308620|FG001|Overall Study|Adverse event/serious adverse event|0|||
23707707|NCT00586924|66308621|FG002|Overall Study|Adverse event/serious adverse event|0|||
23707708|NCT00586924|66308622|FG003|Overall Study|Adverse event/serious adverse event|1|||
23707709|NCT00586924|66308623|FG004|Overall Study|Adverse event/serious adverse event|0|||
23707710|NCT00586924|66308624|FG005|Overall Study|Adverse event/serious adverse event|2|||
23707711|NCT00586924|66308619|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
23707712|NCT00586924|66308620|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
23504421|NCT01558271|65587805|FG002|Overall Study|Adverse Event|4|||
23504422|NCT01558271|65587803|FG000|Overall Study|Lost to Follow-up|1|||
23504423|NCT01558271|65587804|FG001|Overall Study|Lost to Follow-up|0|||
23504424|NCT01558271|65587805|FG002|Overall Study|Lost to Follow-up|0|||
23504425|NCT01558271|65587803|FG000|Overall Study|Protocol Violation|1|||
23504426|NCT01558271|65587804|FG001|Overall Study|Protocol Violation|0|||
23504427|NCT01558271|65587805|FG002|Overall Study|Protocol Violation|0|||
23504428|NCT01558271|65587803|FG000|Overall Study|Withdrawal by Subject|10|||
23707713|NCT00586924|66308621|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
23504429|NCT01558271|65587804|FG001|Overall Study|Withdrawal by Subject|6|||
23504430|NCT01558271|65587805|FG002|Overall Study|Withdrawal by Subject|12|||
23504431|NCT01558271|65587803|FG000|Overall Study|Physician Decision|0|||
23707714|NCT00586924|66308622|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
23707715|NCT00586924|66308623|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
23504432|NCT01558271|65587804|FG001|Overall Study|Physician Decision|2|||
23707716|NCT00586924|66308624|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
23707717|NCT00586924|66308619|FG000|Overall Study|Disease progression|0|||
23707718|NCT00586924|66308620|FG001|Overall Study|Disease progression|0|||
23707719|NCT00586924|66308621|FG002|Overall Study|Disease progression|0|||
23707720|NCT00586924|66308622|FG003|Overall Study|Disease progression|1|||
23707721|NCT00586924|66308623|FG004|Overall Study|Disease progression|1|||
23707722|NCT00586924|66308624|FG005|Overall Study|Disease progression|0|||
23707723|NCT00586924|66308619|FG000|Overall Study|Development of neutralizing antibodies|2|||
23707724|NCT00586924|66308620|FG001|Overall Study|Development of neutralizing antibodies|2|||
23504433|NCT01558271|65587805|FG002|Overall Study|Physician Decision|1|||
23504434|NCT02615145|65587806|FG000|Overall Study|Did Not Start Treatment|0|||
23504435|NCT02615145|65587807|FG001|Overall Study|Did Not Start Treatment|0|||
23504436|NCT02615145|65587808|FG002|Overall Study|Did Not Start Treatment|1|||
23504437|NCT02615145|65587809|FG003|Overall Study|Did Not Start Treatment|1|||
23504438|NCT02615145|65587806|FG000|Overall Study|Failure to Return|20|||
23504439|NCT02615145|65587807|FG001|Overall Study|Failure to Return|10|||
23504440|NCT02615145|65587808|FG002|Overall Study|Failure to Return|7|||
23504441|NCT02615145|65587809|FG003|Overall Study|Failure to Return|0|||
23504442|NCT02615145|65587806|FG000|Overall Study|Death|2|||
23504443|NCT02615145|65587807|FG001|Overall Study|Death|3|||
23504444|NCT02615145|65587808|FG002|Overall Study|Death|0|||
23504445|NCT02615145|65587809|FG003|Overall Study|Death|0|||
23504446|NCT02615145|65587806|FG000|Overall Study|Other, Not Specified|5|||
23504447|NCT02615145|65587807|FG001|Overall Study|Other, Not Specified|2|||
23504448|NCT02615145|65587808|FG002|Overall Study|Other, Not Specified|0|||
23504449|NCT02615145|65587809|FG003|Overall Study|Other, Not Specified|0|||
23707725|NCT00586924|66308621|FG002|Overall Study|Development of neutralizing antibodies|2|||
23504450|NCT01192516|65587810|FG000|Overall Study|Lost to Follow-up|7|||
23504451|NCT01192516|65587811|FG001|Overall Study|Lost to Follow-up|10|||
23504452|NCT01192516|65587812|FG002|Overall Study|Lost to Follow-up|7|||
23504453|NCT01192516|65587810|FG000|Overall Study|Withdrawal by Subject|4|||
23504454|NCT01192516|65587811|FG001|Overall Study|Withdrawal by Subject|4|||
23707726|NCT00586924|66308622|FG003|Overall Study|Development of neutralizing antibodies|0|||
23707727|NCT00586924|66308623|FG004|Overall Study|Development of neutralizing antibodies|0|||
23707728|NCT00586924|66308624|FG005|Overall Study|Development of neutralizing antibodies|22|||
23707729|NCT00586924|66308619|FG000|Overall Study|Complete response|0|||
23707730|NCT00586924|66308620|FG001|Overall Study|Complete response|1|||
23707731|NCT00586924|66308621|FG002|Overall Study|Complete response|0|||
23707732|NCT00586924|66308622|FG003|Overall Study|Complete response|0|||
23707733|NCT00586924|66308623|FG004|Overall Study|Complete response|2|||
23707734|NCT00586924|66308624|FG005|Overall Study|Complete response|2|||
23707735|NCT00586924|66308619|FG000|Overall Study|Other|1|||
23707736|NCT00586924|66308620|FG001|Overall Study|Other|0|||
23707737|NCT00586924|66308621|FG002|Overall Study|Other|1|||
23707738|NCT00586924|66308622|FG003|Overall Study|Other|1|||
23707739|NCT00586924|66308623|FG004|Overall Study|Other|1|||
23707740|NCT00586924|66308624|FG005|Overall Study|Other|6|||
23707741|NCT04263142|66308625|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23707742|NCT04263142|66308626|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23707743|NCT04263142|66308627|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23707744|NCT04263142|66308628|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23707745|NCT04263142|66308629|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
23707746|NCT04263142|66308625|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23707747|NCT04263142|66308626|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23707748|NCT04263142|66308627|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23707749|NCT04263142|66308628|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23707750|NCT04263142|66308629|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
23707751|NCT02436577|66308630|FG000|Overall Study|Protocol Deviation|0|||
23707752|NCT02436577|66308631|FG001|Overall Study|Protocol Deviation|1|||
23707753|NCT02436577|66308632|FG002|Overall Study|Protocol Deviation|0|||
23707754|NCT02436577|66308633|FG003|Overall Study|Protocol Deviation|0|||
23707755|NCT02436577|66308634|FG004|Overall Study|Protocol Deviation|0|||
23707756|NCT02436577|66308635|FG005|Overall Study|Protocol Deviation|0|||
23707757|NCT01952730|66308637|FG000|Overall Study|FDA shut down core lab used by study|1|||
23707758|NCT00436566|66308638|FG000|Overall Study|Withdrawal by Subject|2|||
23707759|NCT00436566|66308638|FG000|Overall Study|Protocol Violation|1|||
23707760|NCT04439344|66308639|FG000|Overall Study|Never started threapy|3|||
23707761|NCT04439344|66308639|FG000|Overall Study|Ineligible|3|||
23707762|NCT04439344|66308639|FG000|Overall Study|Adverse Event|13|||
23707763|NCT04439344|66308639|FG000|Overall Study|Death|2|||
23707764|NCT04439344|66308639|FG000|Overall Study|Disease progression|29|||
23707765|NCT04439344|66308639|FG000|Overall Study|Withdrawal by Subject|2|||
23707766|NCT04439344|66308639|FG000|Overall Study|Alternative therapy|1|||
23707767|NCT02554253|66308642|FG000|Overall Study|ineligible after enrollment|1|||
23707768|NCT02554253|66308643|FG001|Overall Study|ineligible after enrollment|0|||
23707769|NCT02554253|66308642|FG000|Overall Study|converted to transcatheter procedure|0|||
23504455|NCT01192516|65587812|FG002|Overall Study|Withdrawal by Subject|1|||
23504456|NCT01192516|65587810|FG000|Overall Study|started new treatment|5|||
23504457|NCT01192516|65587811|FG001|Overall Study|started new treatment|1|||
23707770|NCT02554253|66308643|FG001|Overall Study|converted to transcatheter procedure|1|||
23707771|NCT02554253|66308642|FG000|Overall Study|received both drugs|0|||
23707772|NCT02554253|66308643|FG001|Overall Study|received both drugs|1|||
23707773|NCT01830543|66308648|FG000|Overall Study|Subject Decision|19|||
23707774|NCT01830543|66308649|FG001|Overall Study|Subject Decision|21|||
23707775|NCT01830543|66308650|FG002|Overall Study|Subject Decision|57|||
23707776|NCT01830543|66308648|FG000|Overall Study|Adverse Event|91|||
23707777|NCT01830543|66308649|FG001|Overall Study|Adverse Event|77|||
23707778|NCT01830543|66308650|FG002|Overall Study|Adverse Event|76|||
23504458|NCT01192516|65587812|FG002|Overall Study|started new treatment|0|||
23504459|NCT01192516|65587810|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
23707779|NCT01830543|66308648|FG000|Overall Study|Death|20|||
23707780|NCT01830543|66308649|FG001|Overall Study|Death|22|||
23707781|NCT01830543|66308650|FG002|Overall Study|Death|22|||
23707782|NCT01830543|66308648|FG000|Overall Study|Protocol Violation|3|||
23707783|NCT01830543|66308649|FG001|Overall Study|Protocol Violation|7|||
23707784|NCT01830543|66308650|FG002|Overall Study|Protocol Violation|7|||
23707785|NCT01830543|66308648|FG000|Overall Study|Physician Decision|11|||
23707786|NCT01830543|66308649|FG001|Overall Study|Physician Decision|5|||
23707787|NCT01830543|66308650|FG002|Overall Study|Physician Decision|12|||
23707788|NCT01830543|66308648|FG000|Overall Study|Withdrawal by consent|3|||
23707789|NCT01830543|66308649|FG001|Overall Study|Withdrawal by consent|3|||
23707790|NCT01830543|66308650|FG002|Overall Study|Withdrawal by consent|3|||
23707791|NCT01830543|66308648|FG000|Overall Study|Other|12|||
23707792|NCT01830543|66308649|FG001|Overall Study|Other|17|||
23707793|NCT01830543|66308650|FG002|Overall Study|Other|37|||
23707794|NCT01008995|66308651|FG000|Controlled Period|Adverse Event|1|||
23707795|NCT01008995|66308652|FG001|Controlled Period|Adverse Event|2|||
23707796|NCT01008995|66308653|FG002|Controlled Period|Adverse Event|0|||
23707797|NCT01008995|66308654|FG003|Controlled Period|Adverse Event|0|||
23707798|NCT01008995|66308651|FG000|Controlled Period|Other|2|||
23707799|NCT01008995|66308652|FG001|Controlled Period|Other|1|||
23707800|NCT01008995|66308653|FG002|Controlled Period|Other|0|||
23707801|NCT01008995|66308654|FG003|Controlled Period|Other|0|||
23707802|NCT01008995|66308651|FG000|After Controlled Period|Adverse Event|0|||
23707803|NCT01008995|66308652|FG001|After Controlled Period|Adverse Event|0|||
23707804|NCT01008995|66308653|FG002|After Controlled Period|Adverse Event|1|||
23707805|NCT01008995|66308654|FG003|After Controlled Period|Adverse Event|1|||
23707806|NCT01008995|66308651|FG000|After Controlled Period|Other|0|||
23707807|NCT01008995|66308652|FG001|After Controlled Period|Other|0|||
23707808|NCT01008995|66308653|FG002|After Controlled Period|Other|1|||
23707809|NCT01008995|66308654|FG003|After Controlled Period|Other|0|||
23707810|NCT00137436|66308655|FG000|Overall Study|Adverse Event|13|||
23707811|NCT00137436|66308655|FG000|Overall Study|Death|2|||
23707812|NCT00137436|66308655|FG000|Overall Study|Lack of Efficacy|17|||
23707813|NCT00137436|66308655|FG000|Overall Study|Withdrawal by Subject|6|||
23707814|NCT00137436|66308655|FG000|Overall Study|Other|5|||
23707815|NCT02357849|66308656|FG000|Overall Study|Withdrawal by Subject|2|||
23707816|NCT02357849|66308657|FG001|Overall Study|Withdrawal by Subject|3|||
23707817|NCT01468909|66308658|FG000|Overall Study|Never Treated|2|||
23707818|NCT01468909|66308659|FG001|Overall Study|Never Treated|2|||
23707819|NCT03011034|66308660|FG000|Overall Study|Adverse Event|1|||
23707820|NCT03011034|66308661|FG001|Overall Study|Adverse Event|0|||
23707821|NCT02653976|66308667|FG000|Overall Study|Withdrawal by Subject|5|||
23707822|NCT02653976|66308667|FG000|Overall Study|Death|4|||
23707823|NCT04146467|66308670|FG000|Overall Study|Adverse Event|0|||
23707824|NCT04146467|66308671|FG001|Overall Study|Adverse Event|1|||
23707825|NCT04146467|66308670|FG000|Overall Study|Lost to Follow-up|0|||
23707826|NCT04146467|66308671|FG001|Overall Study|Lost to Follow-up|2|||
23707827|NCT04056455|66308672|FG000|Overall Study|Adverse Event|1|||
23707828|NCT04056455|66308673|FG001|Overall Study|Adverse Event|0|||
23707829|NCT04633473|66308674|FG000|Overall Study|Withdrawal by Subject|6|||
23707830|NCT00403559|66308681|FG000|Overall Study|Adverse Event|0|||
23707831|NCT00403559|66308682|FG001|Overall Study|Adverse Event|1|||
23707832|NCT00403559|66308681|FG000|Overall Study|Lost to Follow-up|3|||
23707833|NCT00403559|66308682|FG001|Overall Study|Lost to Follow-up|3|||
23707834|NCT00403559|66308681|FG000|Overall Study|Withdrawal by Subject|1|||
23707835|NCT00403559|66308682|FG001|Overall Study|Withdrawal by Subject|0|||
23707836|NCT00745368|66308710|FG000|Overall Study|Unable to provide sample|3|||
23707837|NCT00905307|66308711|FG000|Overall Study|Switched to Open Label Rescue|7|||
23707838|NCT00905307|66308712|FG001|Overall Study|Switched to Open Label Rescue|17|||
23707839|NCT00905307|66308713|FG002|Overall Study|Switched to Open Label Rescue|11|||
23707840|NCT00905307|66308714|FG003|Overall Study|Switched to Open Label Rescue|11|||
23707841|NCT00905307|66308715|FG004|Overall Study|Switched to Open Label Rescue|4|||
23707842|NCT00905307|66308716|FG005|Overall Study|Switched to Open Label Rescue|15|||
23707843|NCT00905307|66308711|FG000|Overall Study|Lost to Follow-up|0|||
23707844|NCT00905307|66308712|FG001|Overall Study|Lost to Follow-up|0|||
23707845|NCT00905307|66308713|FG002|Overall Study|Lost to Follow-up|0|||
23707846|NCT00905307|66308714|FG003|Overall Study|Lost to Follow-up|0|||
23807658|NCT00851643|66676224|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23707847|NCT00905307|66308715|FG004|Overall Study|Lost to Follow-up|1|||
23707848|NCT00905307|66308716|FG005|Overall Study|Lost to Follow-up|1|||
23707849|NCT00905307|66308711|FG000|Overall Study|Adverse Event|3|||
23707850|NCT00905307|66308712|FG001|Overall Study|Adverse Event|4|||
23707851|NCT00905307|66308713|FG002|Overall Study|Adverse Event|5|||
23707852|NCT00905307|66308714|FG003|Overall Study|Adverse Event|11|||
23707853|NCT00905307|66308715|FG004|Overall Study|Adverse Event|3|||
23707854|NCT00905307|66308716|FG005|Overall Study|Adverse Event|5|||
23403909|NCT00833027|65226438|FG000|Overall Study|Adverse Event|33|||
23707855|NCT00905307|66308711|FG000|Overall Study|Withdrawal by Subject|5|||
23707856|NCT00905307|66308712|FG001|Overall Study|Withdrawal by Subject|13|||
23707857|NCT00905307|66308713|FG002|Overall Study|Withdrawal by Subject|15|||
23707858|NCT00905307|66308714|FG003|Overall Study|Withdrawal by Subject|11|||
23707859|NCT00905307|66308715|FG004|Overall Study|Withdrawal by Subject|4|||
23707860|NCT00905307|66308716|FG005|Overall Study|Withdrawal by Subject|13|||
23707861|NCT00905307|66308711|FG000|Overall Study|Protocol Violation|1|||
23707862|NCT00905307|66308712|FG001|Overall Study|Protocol Violation|0|||
23707863|NCT00905307|66308713|FG002|Overall Study|Protocol Violation|1|||
23707864|NCT00905307|66308714|FG003|Overall Study|Protocol Violation|0|||
23707865|NCT00905307|66308715|FG004|Overall Study|Protocol Violation|0|||
23707866|NCT00905307|66308716|FG005|Overall Study|Protocol Violation|0|||
23707867|NCT00905307|66308711|FG000|Overall Study|Lack of Efficacy|6|||
23707868|NCT00905307|66308712|FG001|Overall Study|Lack of Efficacy|3|||
23707869|NCT00905307|66308713|FG002|Overall Study|Lack of Efficacy|5|||
23707870|NCT00905307|66308714|FG003|Overall Study|Lack of Efficacy|4|||
23504460|NCT01192516|65587811|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
23504461|NCT01192516|65587812|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
23504462|NCT03334903|65587813|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
23504463|NCT03334903|65587814|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
23504464|NCT03334903|65587813|FG000|Overall Study|Protocol Violation|1|||
23504465|NCT03334903|65587814|FG001|Overall Study|Protocol Violation|3|||
23504466|NCT03334903|65587813|FG000|Overall Study|Surgery postponed|1|||
23504467|NCT03334903|65587814|FG001|Overall Study|Surgery postponed|0|||
23504468|NCT03334903|65587813|FG000|Overall Study|Adverse Event|1|||
23504469|NCT03334903|65587814|FG001|Overall Study|Adverse Event|1|||
23504470|NCT03334903|65587813|FG000|Overall Study|Withdrawal by Subject|0|||
23707871|NCT00905307|66308715|FG004|Overall Study|Lack of Efficacy|4|||
23504471|NCT03334903|65587814|FG001|Overall Study|Withdrawal by Subject|1|||
23707872|NCT00905307|66308716|FG005|Overall Study|Lack of Efficacy|8|||
23707873|NCT01395368|66308719|FG000|Overall Study|Physician Decision|14|||
23707874|NCT01395368|66308719|FG000|Overall Study|Withdrawal by Subject|2|||
23707875|NCT02938585|66308721|FG000|Overall Study|Withdrawal by parent or guardian|0|||
23707876|NCT02938585|66308722|FG001|Overall Study|Withdrawal by parent or guardian|1|||
23707877|NCT02938585|66308723|FG002|Overall Study|Withdrawal by parent or guardian|0|||
23707878|NCT02938585|66308724|FG003|Overall Study|Withdrawal by parent or guardian|0|||
23707879|NCT02938585|66308721|FG000|Overall Study|Withdrawal by Subject|0|||
23707880|NCT02938585|66308722|FG001|Overall Study|Withdrawal by Subject|0|||
23707881|NCT02938585|66308723|FG002|Overall Study|Withdrawal by Subject|0|||
23707882|NCT02938585|66308724|FG003|Overall Study|Withdrawal by Subject|5|||
23707883|NCT02935634|66308725|FG000|Randomization|Participant withdrew consent|0|||
23707884|NCT02935634|66308726|FG001|Randomization|Participant withdrew consent|1|||
23707885|NCT02935634|66308727|FG002|Randomization|Participant withdrew consent|0|||
23707886|NCT02935634|66308728|FG003|Randomization|Participant withdrew consent|0|||
23504472|NCT04851314|65587817|FG000|Overall Study|Unable to complete research set-up procedures|0|||
23504473|NCT04851314|65587818|FG001|Overall Study|Unable to complete research set-up procedures|2|||
23504474|NCT04851314|65587817|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
23504475|NCT04851314|65587818|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
23504476|NCT01484197|65587819|FG000|Treatment Period 1|Adverse Event|1|||
23504477|NCT01484197|65587820|FG001|Treatment Period 1|Adverse Event|0|||
23504478|NCT01484197|65587821|FG002|Treatment Period 1|Adverse Event|0|||
23707887|NCT02935634|66308729|FG004|Randomization|Participant withdrew consent|0|||
23707888|NCT02935634|66308730|FG005|Randomization|Participant withdrew consent|0|||
23707889|NCT02935634|66308725|FG000|Randomization|Death|2|||
23707890|NCT02935634|66308726|FG001|Randomization|Death|1|||
23707891|NCT02935634|66308727|FG002|Randomization|Death|1|||
23504479|NCT01484197|65587822|FG003|Treatment Period 1|Adverse Event|0|||
23504480|NCT01484197|65587819|FG000|Treatment Period 2|Subject withdrew consent|0|||
23504481|NCT01484197|65587820|FG001|Treatment Period 2|Subject withdrew consent|0|||
23504482|NCT01484197|65587821|FG002|Treatment Period 2|Subject withdrew consent|0|||
23504483|NCT01484197|65587822|FG003|Treatment Period 2|Subject withdrew consent|1|||
23504484|NCT01500694|65587831|FG000|Overall Study|Adverse Event|4|||
23504485|NCT01500694|65587832|FG001|Overall Study|Adverse Event|3|||
23504486|NCT01500694|65587831|FG000|Overall Study|Protocol Violation|0|||
23504487|NCT01500694|65587832|FG001|Overall Study|Protocol Violation|1|||
23707892|NCT02935634|66308728|FG003|Randomization|Death|0|||
23707893|NCT02935634|66308729|FG004|Randomization|Death|0|||
23504488|NCT01500694|65587831|FG000|Overall Study|Withdrawal by Subject|23|||
23504489|NCT01500694|65587832|FG001|Overall Study|Withdrawal by Subject|14|||
23504490|NCT01500694|65587831|FG000|Overall Study|Lost to Follow-up|2|||
23707894|NCT02935634|66308730|FG005|Randomization|Death|0|||
23707895|NCT02935634|66308725|FG000|Randomization|Other reasons|0|||
23707896|NCT02935634|66308726|FG001|Randomization|Other reasons|2|||
23707897|NCT02935634|66308727|FG002|Randomization|Other reasons|2|||
23707898|NCT02935634|66308728|FG003|Randomization|Other reasons|0|||
23707899|NCT02935634|66308729|FG004|Randomization|Other reasons|0|||
23707900|NCT02935634|66308730|FG005|Randomization|Other reasons|0|||
23707901|NCT02935634|66308725|FG000|Treatment: Track 1|Disease progression|15|||
23707902|NCT02935634|66308726|FG001|Treatment: Track 1|Disease progression|17|||
23707903|NCT02935634|66308727|FG002|Treatment: Track 1|Disease progression|28|||
23707904|NCT02935634|66308728|FG003|Treatment: Track 1|Disease progression|4|||
23707905|NCT02935634|66308729|FG004|Treatment: Track 1|Disease progression|6|||
23707906|NCT02935634|66308730|FG005|Treatment: Track 1|Disease progression|2|||
23504491|NCT01500694|65587832|FG001|Overall Study|Lost to Follow-up|3|||
23504492|NCT01500694|65587831|FG000|Overall Study|Lack of Efficacy|14|||
23504493|NCT01500694|65587832|FG001|Overall Study|Lack of Efficacy|5|||
23504494|NCT01500694|65587831|FG000|Overall Study|Other|9|||
23504495|NCT01500694|65587832|FG001|Overall Study|Other|3|||
23504496|NCT00382252|65587833|FG000|Overall Study|Death|4|||
23504497|NCT00382252|65587833|FG000|Overall Study|Protocol Violation|8|||
23504498|NCT00382252|65587833|FG000|Overall Study|Not treated by RFA|1|||
23504499|NCT02025621|65587840|FG000|Overall Study|Withdrawal by Subject|1|||
23504500|NCT02025621|65587841|FG001|Overall Study|Withdrawal by Subject|0|||
23504501|NCT02025621|65587840|FG000|Overall Study|Death|0|||
23504502|NCT02025621|65587841|FG001|Overall Study|Death|1|||
23504503|NCT02025621|65587840|FG000|Overall Study|No longer eligible|10|||
23707907|NCT02935634|66308725|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
23707908|NCT02935634|66308726|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
23707909|NCT02935634|66308727|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
23707910|NCT02935634|66308728|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
23707911|NCT02935634|66308729|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
23707912|NCT02935634|66308730|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
23707913|NCT02935634|66308725|FG000|Treatment: Track 1|Lost to Follow-up|1|||
23707914|NCT02935634|66308726|FG001|Treatment: Track 1|Lost to Follow-up|0|||
23707915|NCT02935634|66308727|FG002|Treatment: Track 1|Lost to Follow-up|0|||
23707916|NCT02935634|66308728|FG003|Treatment: Track 1|Lost to Follow-up|0|||
23707917|NCT02935634|66308729|FG004|Treatment: Track 1|Lost to Follow-up|0|||
23707918|NCT02935634|66308730|FG005|Treatment: Track 1|Lost to Follow-up|0|||
23707919|NCT02935634|66308725|FG000|Treatment: Track 1|Study drug toxicity|2|||
23707920|NCT02935634|66308726|FG001|Treatment: Track 1|Study drug toxicity|1|||
23707921|NCT02935634|66308727|FG002|Treatment: Track 1|Study drug toxicity|3|||
23707922|NCT02935634|66308728|FG003|Treatment: Track 1|Study drug toxicity|0|||
23707923|NCT02935634|66308729|FG004|Treatment: Track 1|Study drug toxicity|0|||
23707924|NCT02935634|66308730|FG005|Treatment: Track 1|Study drug toxicity|1|||
23707925|NCT02935634|66308725|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
23707926|NCT02935634|66308726|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
23707927|NCT02935634|66308727|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
23707928|NCT02935634|66308728|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
23707929|NCT02935634|66308729|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
23707930|NCT02935634|66308730|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
23707931|NCT02935634|66308725|FG000|Treatment: Track 1|Participant withdrew consent|2|||
23707932|NCT02935634|66308726|FG001|Treatment: Track 1|Participant withdrew consent|0|||
23707933|NCT02935634|66308727|FG002|Treatment: Track 1|Participant withdrew consent|1|||
23707934|NCT02935634|66308728|FG003|Treatment: Track 1|Participant withdrew consent|0|||
23707935|NCT02935634|66308729|FG004|Treatment: Track 1|Participant withdrew consent|1|||
23707936|NCT02935634|66308730|FG005|Treatment: Track 1|Participant withdrew consent|0|||
23707937|NCT02935634|66308725|FG000|Treatment: Track 1|Other reasons|0|||
23707938|NCT02935634|66308726|FG001|Treatment: Track 1|Other reasons|0|||
23707939|NCT02935634|66308727|FG002|Treatment: Track 1|Other reasons|2|||
23707940|NCT02935634|66308728|FG003|Treatment: Track 1|Other reasons|0|||
23707941|NCT02935634|66308729|FG004|Treatment: Track 1|Other reasons|0|||
23707942|NCT02935634|66308730|FG005|Treatment: Track 1|Other reasons|0|||
23707943|NCT02935634|66308725|FG000|Treatment: Track 2|Disease progression|13|||
23504504|NCT02025621|65587841|FG001|Overall Study|No longer eligible|15|||
23504505|NCT02025621|65587840|FG000|Overall Study|Surgery initiated before infusion|3|||
23504506|NCT02025621|65587841|FG001|Overall Study|Surgery initiated before infusion|3|||
23504507|NCT01594762|65587854|FG000|Overall Study|Withdrawal by Subject|1|||
23504508|NCT01594762|65587855|FG001|Overall Study|Withdrawal by Subject|0|||
23504509|NCT01594762|65587854|FG000|Overall Study|Lost to Follow-up|10|||
23707944|NCT02935634|66308726|FG001|Treatment: Track 2|Disease progression|26|||
23707945|NCT02935634|66308727|FG002|Treatment: Track 2|Disease progression|20|||
23707946|NCT02935634|66308728|FG003|Treatment: Track 2|Disease progression|5|||
23707947|NCT02935634|66308729|FG004|Treatment: Track 2|Disease progression|1|||
23504510|NCT01594762|65587855|FG001|Overall Study|Lost to Follow-up|10|||
23504511|NCT03208244|65587860|FG000|Overall Study|Death|1|||
23807659|NCT00851643|66676225|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23504512|NCT03032705|65587861|FG000|Overall Study|Lost to Follow-up|16|||
23504513|NCT03032705|65587862|FG001|Overall Study|Lost to Follow-up|17|||
23504514|NCT03032705|65587861|FG000|Overall Study|did not quality|6|||
23707948|NCT02935634|66308730|FG005|Treatment: Track 2|Disease progression|4|||
23707949|NCT02935634|66308725|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
23707950|NCT02935634|66308726|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
23707951|NCT02935634|66308727|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23707952|NCT02935634|66308728|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23707953|NCT02935634|66308729|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23707954|NCT02935634|66308730|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23707955|NCT02935634|66308725|FG000|Treatment: Track 2|Study drug toxicity|7|||
23707956|NCT02935634|66308726|FG001|Treatment: Track 2|Study drug toxicity|3|||
23707957|NCT02935634|66308727|FG002|Treatment: Track 2|Study drug toxicity|0|||
23707958|NCT02935634|66308728|FG003|Treatment: Track 2|Study drug toxicity|0|||
23707959|NCT02935634|66308729|FG004|Treatment: Track 2|Study drug toxicity|0|||
23707960|NCT02935634|66308730|FG005|Treatment: Track 2|Study drug toxicity|0|||
23707961|NCT02935634|66308725|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
23707962|NCT02935634|66308726|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
23707963|NCT02935634|66308727|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
23707964|NCT02935634|66308728|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
23707965|NCT02935634|66308729|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
23707966|NCT02935634|66308730|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
23707967|NCT02935634|66308725|FG000|Treatment: Track 2|Participant withdrew consent|0|||
23707968|NCT02935634|66308726|FG001|Treatment: Track 2|Participant withdrew consent|1|||
23707969|NCT02935634|66308727|FG002|Treatment: Track 2|Participant withdrew consent|1|||
23707970|NCT02935634|66308728|FG003|Treatment: Track 2|Participant withdrew consent|0|||
23707971|NCT02935634|66308729|FG004|Treatment: Track 2|Participant withdrew consent|1|||
23707972|NCT02935634|66308730|FG005|Treatment: Track 2|Participant withdrew consent|0|||
23707973|NCT02768194|66308731|FG000|Period 1|Adverse Event|0|||
23707974|NCT02768194|66308732|FG001|Period 1|Adverse Event|0|||
23707975|NCT02768194|66308733|FG002|Period 1|Adverse Event|0|||
23707976|NCT02768194|66308734|FG003|Period 1|Adverse Event|1|||
23707977|NCT02768194|66308735|FG004|Period 1|Adverse Event|0|||
23707978|NCT02768194|66308736|FG005|Period 1|Adverse Event|0|||
23707979|NCT02768194|66308731|FG000|Period 2|Other (Reason not specified)|1|||
23707980|NCT02768194|66308732|FG001|Period 2|Other (Reason not specified)|0|||
23707981|NCT02768194|66308733|FG002|Period 2|Other (Reason not specified)|0|||
23707982|NCT02768194|66308734|FG003|Period 2|Other (Reason not specified)|0|||
23707983|NCT02768194|66308735|FG004|Period 2|Other (Reason not specified)|0|||
23707984|NCT02768194|66308736|FG005|Period 2|Other (Reason not specified)|0|||
23707985|NCT02768194|66308731|FG000|Period 3|Other (Reason not specified)|0|||
23707986|NCT02768194|66308732|FG001|Period 3|Other (Reason not specified)|1|||
23707987|NCT02768194|66308733|FG002|Period 3|Other (Reason not specified)|0|||
23707988|NCT02768194|66308734|FG003|Period 3|Other (Reason not specified)|0|||
23707989|NCT02768194|66308735|FG004|Period 3|Other (Reason not specified)|0|||
23707990|NCT02768194|66308736|FG005|Period 3|Other (Reason not specified)|0|||
23707991|NCT01364233|66308737|FG000|Overall Study|Lost to Follow-up|1|||
23707992|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
23707993|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
23707994|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
23707995|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
23707996|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
23707997|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
23707998|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
23707999|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
23708000|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
23708001|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
23708002|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
23708003|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
23708004|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
23708005|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
23708006|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
23708007|NCT03855137|66308740|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
23708008|NCT03855137|66308741|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
23708009|NCT03855137|66308742|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
23708010|NCT03855137|66308740|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
23708011|NCT03855137|66308741|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
23708012|NCT03855137|66308742|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
23708013|NCT03855137|66308740|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
23708014|NCT03855137|66308741|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
23807660|NCT00851643|66676226|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23708015|NCT03855137|66308742|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
23708016|NCT03855137|66308740|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
23708017|NCT03855137|66308741|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
23708018|NCT03855137|66308742|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
23708019|NCT03855137|66308740|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
23708020|NCT03855137|66308741|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
23708021|NCT03855137|66308742|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
23708022|NCT02389816|66308743|FG000|Overall Study|Randomized but Not Treated|1|||
23708023|NCT02389816|66308744|FG001|Overall Study|Randomized but Not Treated|0|||
23708024|NCT02389816|66308745|FG002|Overall Study|Randomized but Not Treated|0|||
23708025|NCT02389816|66308743|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
23708026|NCT02389816|66308744|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
23708027|NCT02389816|66308745|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
23708028|NCT02389816|66308743|FG000|Overall Study|Major Protocol Deviation|1|||
23708029|NCT02389816|66308744|FG001|Overall Study|Major Protocol Deviation|0|||
23708030|NCT02389816|66308745|FG002|Overall Study|Major Protocol Deviation|0|||
23708031|NCT02389816|66308743|FG000|Overall Study|Lost to Follow-up|1|||
23708032|NCT02389816|66308744|FG001|Overall Study|Lost to Follow-up|0|||
23708033|NCT02389816|66308745|FG002|Overall Study|Lost to Follow-up|0|||
23708034|NCT02389816|66308743|FG000|Overall Study|Withdrawal of Consent|6|||
23708035|NCT02389816|66308744|FG001|Overall Study|Withdrawal of Consent|4|||
23708036|NCT02389816|66308745|FG002|Overall Study|Withdrawal of Consent|4|||
23708037|NCT02389816|66308743|FG000|Overall Study|Lack of Efficacy|1|||
23708038|NCT02389816|66308744|FG001|Overall Study|Lack of Efficacy|0|||
23708039|NCT02389816|66308745|FG002|Overall Study|Lack of Efficacy|0|||
23708040|NCT02389816|66308743|FG000|Overall Study|Non Compliance with Study Drug|1|||
23708041|NCT02389816|66308744|FG001|Overall Study|Non Compliance with Study Drug|1|||
23708042|NCT02389816|66308745|FG002|Overall Study|Non Compliance with Study Drug|1|||
23708043|NCT02389816|66308743|FG000|Overall Study|Reason not Specified|0|||
23708044|NCT02389816|66308744|FG001|Overall Study|Reason not Specified|2|||
23708045|NCT02389816|66308745|FG002|Overall Study|Reason not Specified|0|||
23708046|NCT05127421|66308746|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
23708047|NCT05127421|66308747|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
23708048|NCT05127421|66308748|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
23708049|NCT05127421|66308749|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
23708050|NCT05127421|66308746|FG000|4-Week Double-Blind Period|Physician Decision|1|||
23708051|NCT05127421|66308747|FG001|4-Week Double-Blind Period|Physician Decision|0|||
23708052|NCT05127421|66308748|FG002|4-Week Double-Blind Period|Physician Decision|0|||
23708053|NCT05127421|66308749|FG003|4-Week Double-Blind Period|Physician Decision|0|||
23708054|NCT05127421|66308746|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
23708055|NCT05127421|66308747|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
23708056|NCT05127421|66308748|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
23708057|NCT05127421|66308749|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
23708058|NCT05127421|66308746|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23708059|NCT05127421|66308747|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
23708060|NCT05127421|66308748|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23708061|NCT05127421|66308749|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23708062|NCT05127421|66308746|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23708063|NCT05127421|66308747|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
23708064|NCT05127421|66308748|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23708065|NCT05127421|66308749|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23708066|NCT05127421|66308746|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
23708067|NCT05127421|66308747|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
23708068|NCT05127421|66308748|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
23708069|NCT05127421|66308749|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
23708070|NCT05127421|66308746|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
23708071|NCT05127421|66308747|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
23708072|NCT05127421|66308748|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
23708073|NCT05127421|66308749|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
23708074|NCT05127421|66308746|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23708075|NCT05127421|66308747|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23708076|NCT05127421|66308748|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23708077|NCT05127421|66308749|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
23708078|NCT02651194|66308750|FG000|Overall Study|Lost to Follow-up|3|||
23708079|NCT02651194|66308750|FG000|Overall Study|Other|2|||
23708080|NCT00077610|66308751|FG000|Overall Study|Adverse Event|9|||
23708081|NCT00077610|66308752|FG001|Overall Study|Adverse Event|7|||
23708082|NCT00077610|66308753|FG002|Overall Study|Adverse Event|1|||
23708083|NCT00077610|66308751|FG000|Overall Study|Lost to Follow-up|0|||
23708084|NCT00077610|66308752|FG001|Overall Study|Lost to Follow-up|1|||
23708085|NCT00077610|66308753|FG002|Overall Study|Lost to Follow-up|2|||
23708086|NCT00077610|66308751|FG000|Overall Study|Withdrawal by Subject|4|||
23708087|NCT00077610|66308752|FG001|Overall Study|Withdrawal by Subject|10|||
23504515|NCT03032705|65587862|FG001|Overall Study|did not quality|6|||
23708088|NCT00077610|66308753|FG002|Overall Study|Withdrawal by Subject|6|||
23708089|NCT00077610|66308751|FG000|Overall Study|Death|17|||
23708090|NCT00077610|66308752|FG001|Overall Study|Death|13|||
23708091|NCT00077610|66308753|FG002|Overall Study|Death|13|||
23708092|NCT00077610|66308751|FG000|Overall Study|Renal transplant|12|||
23708093|NCT00077610|66308752|FG001|Overall Study|Renal transplant|15|||
23708094|NCT00077610|66308753|FG002|Overall Study|Renal transplant|11|||
23708095|NCT00077610|66308751|FG000|Overall Study|Withdrew from dialysis care|5|||
23708096|NCT00077610|66308752|FG001|Overall Study|Withdrew from dialysis care|0|||
23708097|NCT00077610|66308753|FG002|Overall Study|Withdrew from dialysis care|3|||
23708098|NCT00077610|66308751|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23708099|NCT00077610|66308752|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23708100|NCT00077610|66308753|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23708101|NCT00077610|66308751|FG000|Overall Study|Multiple blood transfusions|0|||
23708102|NCT00077610|66308752|FG001|Overall Study|Multiple blood transfusions|0|||
23708103|NCT00077610|66308753|FG002|Overall Study|Multiple blood transfusions|1|||
23708104|NCT00077610|66308751|FG000|Overall Study|Principal Investigator's decision|1|||
23708105|NCT00077610|66308752|FG001|Overall Study|Principal Investigator's decision|0|||
23708106|NCT00077610|66308753|FG002|Overall Study|Principal Investigator's decision|1|||
23708107|NCT00077610|66308751|FG000|Overall Study|Worsening of health condition|1|||
23708108|NCT00077610|66308752|FG001|Overall Study|Worsening of health condition|1|||
23708109|NCT00077610|66308753|FG002|Overall Study|Worsening of health condition|0|||
23708110|NCT00077610|66308751|FG000|Overall Study|Given Epogen in hospital|1|||
23708111|NCT00077610|66308752|FG001|Overall Study|Given Epogen in hospital|0|||
23708112|NCT00077610|66308753|FG002|Overall Study|Given Epogen in hospital|0|||
23708113|NCT00077610|66308751|FG000|Overall Study|Transferred to other unit|0|||
23708114|NCT00077610|66308752|FG001|Overall Study|Transferred to other unit|0|||
23708115|NCT00077610|66308753|FG002|Overall Study|Transferred to other unit|1|||
23708116|NCT00077610|66308751|FG000|Overall Study|Transferred to nursing home|0|||
23708117|NCT00077610|66308752|FG001|Overall Study|Transferred to nursing home|0|||
23708118|NCT00077610|66308753|FG002|Overall Study|Transferred to nursing home|1|||
23708119|NCT00077610|66308751|FG000|Overall Study|Transfer to satellite unit|1|||
23708120|NCT00077610|66308752|FG001|Overall Study|Transfer to satellite unit|0|||
23708121|NCT00077610|66308753|FG002|Overall Study|Transfer to satellite unit|0|||
23708122|NCT00077610|66308751|FG000|Overall Study|Transfer to other center for surgery|1|||
23708123|NCT00077610|66308752|FG001|Overall Study|Transfer to other center for surgery|0|||
23708124|NCT00077610|66308753|FG002|Overall Study|Transfer to other center for surgery|0|||
23708125|NCT00077610|66308751|FG000|Overall Study|Change in dialysis modality|1|||
23708126|NCT00077610|66308752|FG001|Overall Study|Change in dialysis modality|0|||
23708127|NCT00077610|66308753|FG002|Overall Study|Change in dialysis modality|0|||
23708128|NCT00077610|66308751|FG000|Overall Study|Relocation|0|||
23708129|NCT00077610|66308752|FG001|Overall Study|Relocation|8|||
23708130|NCT00077610|66308753|FG002|Overall Study|Relocation|5|||
23708131|NCT00077610|66308751|FG000|Overall Study|Financial issues|0|||
23708132|NCT00077610|66308752|FG001|Overall Study|Financial issues|1|||
23708133|NCT00077610|66308753|FG002|Overall Study|Financial issues|0|||
23708134|NCT00077610|66308751|FG000|Overall Study|Sponsors decision to withdraw|0|||
23708135|NCT00077610|66308752|FG001|Overall Study|Sponsors decision to withdraw|0|||
23708136|NCT00077610|66308753|FG002|Overall Study|Sponsors decision to withdraw|1|||
23708137|NCT00242580|66308754|FG000|Overall Study|Adverse Event|3|||
23708138|NCT00242580|66308755|FG001|Overall Study|Adverse Event|0|||
23708139|NCT00242580|66308756|FG002|Overall Study|Adverse Event|2|||
23708140|NCT00242580|66308754|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23708141|NCT00242580|66308755|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23708142|NCT00242580|66308756|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23708143|NCT00242580|66308754|FG000|Overall Study|Protocol Violation|0|||
23708144|NCT00242580|66308755|FG001|Overall Study|Protocol Violation|0|||
23708145|NCT00242580|66308756|FG002|Overall Study|Protocol Violation|1|||
23708146|NCT00242580|66308754|FG000|Overall Study|Subject withdrew consent|2|||
23708147|NCT00242580|66308755|FG001|Overall Study|Subject withdrew consent|2|||
23708148|NCT00242580|66308756|FG002|Overall Study|Subject withdrew consent|5|||
23708149|NCT00242580|66308754|FG000|Overall Study|Lost to Follow-up|0|||
23708150|NCT00242580|66308755|FG001|Overall Study|Lost to Follow-up|3|||
23708151|NCT00242580|66308756|FG002|Overall Study|Lost to Follow-up|0|||
23708152|NCT00242580|66308754|FG000|Overall Study|Death|1|||
23708153|NCT00242580|66308755|FG001|Overall Study|Death|2|||
23708154|NCT00242580|66308756|FG002|Overall Study|Death|1|||
23708155|NCT01763905|66308757|FG000|Overall Study|Withdrawal by Subject|1|||
23708156|NCT01763905|66308758|FG001|Overall Study|Withdrawal by Subject|1|||
23708157|NCT01763905|66308759|FG002|Overall Study|Withdrawal by Subject|0|||
23708158|NCT01763905|66308760|FG003|Overall Study|Withdrawal by Subject|1|||
23708159|NCT01763905|66308757|FG000|Overall Study|Decision by sponsor|5|||
23708160|NCT01763905|66308758|FG001|Overall Study|Decision by sponsor|0|||
23708161|NCT01763905|66308759|FG002|Overall Study|Decision by sponsor|8|||
23708162|NCT01763905|66308760|FG003|Overall Study|Decision by sponsor|0|||
23708163|NCT01763905|66308757|FG000|Overall Study|Lost to Follow-up|0|||
23708164|NCT01763905|66308758|FG001|Overall Study|Lost to Follow-up|0|||
23708165|NCT01763905|66308759|FG002|Overall Study|Lost to Follow-up|1|||
23708166|NCT01763905|66308760|FG003|Overall Study|Lost to Follow-up|0|||
23708167|NCT04863014|66308761|FG000|Overall Study|Lost to Follow-up|3|||
23708168|NCT04863014|66308762|FG001|Overall Study|Lost to Follow-up|2|||
23708169|NCT04863014|66308761|FG000|Overall Study|Subject Decision|0|||
23708170|NCT04863014|66308762|FG001|Overall Study|Subject Decision|4|||
23708171|NCT00937768|66308764|FG000|Overall Study|Refused Further Treatment|3|||
23708172|NCT00937768|66308765|FG001|Overall Study|Refused Further Treatment|2|||
23708173|NCT00937768|66308764|FG000|Overall Study|Disease Progression|1|||
23708174|NCT00937768|66308765|FG001|Overall Study|Disease Progression|1|||
23708175|NCT00937768|66308764|FG000|Overall Study|Alternate Treatment|0|||
23708176|NCT00937768|66308765|FG001|Overall Study|Alternate Treatment|1|||
23708177|NCT00937768|66308764|FG000|Overall Study|No Further Funding|4|||
23708178|NCT00937768|66308765|FG001|Overall Study|No Further Funding|4|||
23708179|NCT01687413|66308766|FG000|Overall Study|Withdrawal by Subject|0|||
23708180|NCT01687413|66308767|FG001|Overall Study|Withdrawal by Subject|2|||
23708181|NCT01687413|66308766|FG000|Overall Study|Not eligible|0|||
23708182|NCT01687413|66308767|FG001|Overall Study|Not eligible|2|||
23708183|NCT01687413|66308766|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
23708184|NCT01687413|66308767|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
23708185|NCT02531373|66308768|FG000|Overall Study|Lack of Efficacy|0|||
23708186|NCT02531373|66308769|FG001|Overall Study|Lack of Efficacy|0|||
23708187|NCT02531373|66308770|FG002|Overall Study|Lack of Efficacy|0|||
23708188|NCT02531373|66308771|FG003|Overall Study|Lack of Efficacy|0|||
23708189|NCT02531373|66308772|FG004|Overall Study|Lack of Efficacy|3|||
23708190|NCT02531373|66308773|FG005|Overall Study|Lack of Efficacy|2|||
23708191|NCT02531373|66308774|FG006|Overall Study|Lack of Efficacy|4|||
23708192|NCT02531373|66308775|FG007|Overall Study|Lack of Efficacy|8|||
23708193|NCT02531373|66308776|FG008|Overall Study|Lack of Efficacy|5|||
23708194|NCT02531373|66308768|FG000|Overall Study|Lost to Follow-up|0|||
23708195|NCT02531373|66308769|FG001|Overall Study|Lost to Follow-up|0|||
23708196|NCT02531373|66308770|FG002|Overall Study|Lost to Follow-up|0|||
23708197|NCT02531373|66308771|FG003|Overall Study|Lost to Follow-up|0|||
23708198|NCT02531373|66308772|FG004|Overall Study|Lost to Follow-up|0|||
23708199|NCT02531373|66308773|FG005|Overall Study|Lost to Follow-up|2|||
23708200|NCT02531373|66308774|FG006|Overall Study|Lost to Follow-up|2|||
23708201|NCT02531373|66308775|FG007|Overall Study|Lost to Follow-up|0|||
23708202|NCT02531373|66308776|FG008|Overall Study|Lost to Follow-up|0|||
23708203|NCT02531373|66308768|FG000|Overall Study|Physician Decision|0|||
23708204|NCT02531373|66308769|FG001|Overall Study|Physician Decision|0|||
23708205|NCT02531373|66308770|FG002|Overall Study|Physician Decision|0|||
23708206|NCT02531373|66308771|FG003|Overall Study|Physician Decision|0|||
23708207|NCT02531373|66308772|FG004|Overall Study|Physician Decision|2|||
23708208|NCT02531373|66308773|FG005|Overall Study|Physician Decision|1|||
23708209|NCT02531373|66308774|FG006|Overall Study|Physician Decision|0|||
23708210|NCT02531373|66308775|FG007|Overall Study|Physician Decision|0|||
23708211|NCT02531373|66308776|FG008|Overall Study|Physician Decision|0|||
23708212|NCT02531373|66308768|FG000|Overall Study|Protocol Violation|0|||
23708213|NCT02531373|66308769|FG001|Overall Study|Protocol Violation|0|||
23708214|NCT02531373|66308770|FG002|Overall Study|Protocol Violation|0|||
23708215|NCT02531373|66308771|FG003|Overall Study|Protocol Violation|0|||
23708216|NCT02531373|66308772|FG004|Overall Study|Protocol Violation|0|||
23708217|NCT02531373|66308773|FG005|Overall Study|Protocol Violation|1|||
23708218|NCT02531373|66308774|FG006|Overall Study|Protocol Violation|1|||
23708219|NCT02531373|66308775|FG007|Overall Study|Protocol Violation|0|||
23708220|NCT02531373|66308776|FG008|Overall Study|Protocol Violation|1|||
23708221|NCT02531373|66308768|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23708222|NCT02531373|66308769|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23708223|NCT02531373|66308770|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23708224|NCT02531373|66308771|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23708225|NCT02531373|66308772|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23708226|NCT02531373|66308773|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
23708227|NCT02531373|66308774|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
23708228|NCT02531373|66308775|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
23708229|NCT02531373|66308776|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
23708230|NCT02531373|66308768|FG000|Overall Study|Withdrawal by Subject|0|||
23708231|NCT02531373|66308769|FG001|Overall Study|Withdrawal by Subject|0|||
23708232|NCT02531373|66308770|FG002|Overall Study|Withdrawal by Subject|0|||
23708233|NCT02531373|66308771|FG003|Overall Study|Withdrawal by Subject|0|||
23708234|NCT02531373|66308772|FG004|Overall Study|Withdrawal by Subject|3|||
23708235|NCT02531373|66308773|FG005|Overall Study|Withdrawal by Subject|0|||
23708236|NCT02531373|66308774|FG006|Overall Study|Withdrawal by Subject|0|||
23708237|NCT02531373|66308775|FG007|Overall Study|Withdrawal by Subject|0|||
23708238|NCT02531373|66308776|FG008|Overall Study|Withdrawal by Subject|0|||
23708239|NCT02330549|66308778|FG000|Overall Study|Adverse Event|1|||
23708240|NCT02330549|66308779|FG001|Overall Study|Adverse Event|0|||
23708241|NCT02330549|66308778|FG000|Overall Study|Subject withdrew consent|2|||
23708242|NCT02330549|66308779|FG001|Overall Study|Subject withdrew consent|1|||
23708243|NCT02330549|66308778|FG000|Overall Study|Failure to meet randomization criteria|1|||
23708244|NCT02330549|66308779|FG001|Overall Study|Failure to meet randomization criteria|0|||
23708245|NCT02322892|66308786|FG000|Overall Study|Surgery cancelled|1|||
23708246|NCT02322892|66308787|FG001|Overall Study|Surgery cancelled|2|||
23708247|NCT02322892|66308786|FG000|Overall Study|Met exclusion criteria|0|||
23708248|NCT02322892|66308787|FG001|Overall Study|Met exclusion criteria|1|||
23708249|NCT02322892|66308786|FG000|Overall Study|Protocol Violation|1|||
23708250|NCT02322892|66308787|FG001|Overall Study|Protocol Violation|0|||
23708251|NCT00568958|66308788|FG000|Allocation|Withdrawal by Subject|7|||
23504516|NCT00471328|65587865|FG000|Core Phase|Adverse Event|18|||
23504517|NCT00471328|65587866|FG001|Core Phase|Adverse Event|6|||
23504518|NCT00471328|65587865|FG000|Core Phase|Death|8|||
23708252|NCT00568958|66308789|FG001|Allocation|Withdrawal by Subject|3|||
23708253|NCT00568958|66308788|FG000|Allocation|Physician Decision|2|||
23708254|NCT00568958|66308789|FG001|Allocation|Physician Decision|0|||
23708255|NCT00568958|66308788|FG000|Follow-Up|Withdrawal by Subject|6|||
23708256|NCT00568958|66308789|FG001|Follow-Up|Withdrawal by Subject|6|||
23504519|NCT00471328|65587866|FG001|Core Phase|Death|4|||
23504520|NCT00471328|65587865|FG000|Core Phase|Withdrawal by Subject|2|||
23504521|NCT00471328|65587866|FG001|Core Phase|Withdrawal by Subject|2|||
23504522|NCT00471328|65587865|FG000|Core Phase|Abnormal laboratory value|1|||
23504523|NCT00471328|65587866|FG001|Core Phase|Abnormal laboratory value|0|||
23504524|NCT00471328|65587865|FG000|Core Phase|Disease Progression|78|||
23504525|NCT00471328|65587866|FG001|Core Phase|Disease Progression|53|||
23504526|NCT00471328|65587865|FG000|Core Phase|Administrative Problem|0|||
23504527|NCT00471328|65587866|FG001|Core Phase|Administrative Problem|1|||
23708257|NCT00568958|66308788|FG000|Follow-Up|Physician Decision|1|||
23708258|NCT00568958|66308789|FG001|Follow-Up|Physician Decision|1|||
23708259|NCT00568958|66308788|FG000|Follow-Up|Family Emergency|1|||
23708260|NCT00568958|66308789|FG001|Follow-Up|Family Emergency|0|||
23708261|NCT00568958|66308788|FG000|Follow-Up|Adverse Event|1|||
23708262|NCT00568958|66308789|FG001|Follow-Up|Adverse Event|0|||
23708263|NCT02023164|66308790|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
23708264|NCT02023164|66308791|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
23708265|NCT02940626|66308794|FG000|Overall Study|Death|40|||
23708266|NCT02940626|66308795|FG001|Overall Study|Death|32|||
23708267|NCT02940626|66308794|FG000|Overall Study|Lost to Follow-up|5|||
23708268|NCT02940626|66308795|FG001|Overall Study|Lost to Follow-up|2|||
23708269|NCT02940626|66308794|FG000|Overall Study|Withdrawal by Subject|1|||
23708270|NCT02940626|66308795|FG001|Overall Study|Withdrawal by Subject|0|||
23708271|NCT02940626|66308794|FG000|Overall Study|Transfer to Hospice Care|1|||
23708272|NCT02940626|66308795|FG001|Overall Study|Transfer to Hospice Care|0|||
23708273|NCT02940626|66308794|FG000|Overall Study|Prohibited Concomitant Medication|0|||
23708274|NCT02940626|66308795|FG001|Overall Study|Prohibited Concomitant Medication|1|||
23708275|NCT02273752|66308797|FG000|Overall Study|Trial was terminated early|2|||
23708276|NCT02410902|66308800|FG000|Overall Study|Adverse Event|2|||
23708277|NCT02410902|66308801|FG001|Overall Study|Adverse Event|3|||
23708278|NCT02410902|66308800|FG000|Overall Study|Lost to Follow-up|4|||
23708279|NCT02410902|66308801|FG001|Overall Study|Lost to Follow-up|1|||
23708280|NCT02410902|66308800|FG000|Overall Study|Protocol Violation|1|||
23807661|NCT00851643|66676227|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23807662|NCT00851643|66676222|FG000|Base Study (Up to 12 Months)|Other|0|||
23807663|NCT00851643|66676223|FG001|Base Study (Up to 12 Months)|Other|0|||
23807664|NCT00851643|66676224|FG002|Base Study (Up to 12 Months)|Other|0|||
23807665|NCT00851643|66676225|FG003|Base Study (Up to 12 Months)|Other|0|||
23807666|NCT00851643|66676226|FG004|Base Study (Up to 12 Months)|Other|0|||
23807667|NCT00851643|66676227|FG005|Base Study (Up to 12 Months)|Other|1|||
23807668|NCT00851643|66676222|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
23807669|NCT00851643|66676223|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
23807670|NCT00851643|66676224|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
23807671|NCT00851643|66676225|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
23807672|NCT00851643|66676226|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
23807673|NCT00851643|66676227|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
23807674|NCT00851643|66676222|FG000|Extension Study (Up to 36 Months)|Moved|0|||
23807675|NCT00851643|66676223|FG001|Extension Study (Up to 36 Months)|Moved|2|||
23807676|NCT00851643|66676224|FG002|Extension Study (Up to 36 Months)|Moved|1|||
23807677|NCT00851643|66676225|FG003|Extension Study (Up to 36 Months)|Moved|1|||
23807678|NCT00851643|66676226|FG004|Extension Study (Up to 36 Months)|Moved|0|||
23807679|NCT00851643|66676227|FG005|Extension Study (Up to 36 Months)|Moved|1|||
23807680|NCT01661179|66676228|FG000|Overall Study|Death|1|||
23807681|NCT01661179|66676228|FG000|Overall Study|Withdrawal by Subject|1|||
23807682|NCT01661179|66676228|FG000|Overall Study|Other Eligibility criteria|4|||
23504528|NCT00471328|65587865|FG000|Core Phase|Protocol Deviation|0|||
23504529|NCT00471328|65587866|FG001|Core Phase|Protocol Deviation|1|||
23504530|NCT00471328|65587865|FG000|Extension Phase|Adverse Event|3|||
23807683|NCT00922987|66676238|FG000|Overall Study|Insufficient clinical response|1|||
23807684|NCT00922987|66676238|FG000|Overall Study|Protocol Violation|2|||
23504531|NCT00471328|65587866|FG001|Extension Phase|Adverse Event|12|||
23807685|NCT00922987|66676238|FG000|Overall Study|Adverse Event|1|||
23807686|NCT03796039|66676242|FG000|Overall Study|Death|2|||
23807687|NCT03796039|66676243|FG001|Overall Study|Death|1|||
23807688|NCT03796039|66676242|FG000|Overall Study|Withdrawal by Subject|7|||
23807689|NCT03796039|66676243|FG001|Overall Study|Withdrawal by Subject|4|||
23807690|NCT00423319|66676244|FG000|Overall Study|Death|2|||
23807691|NCT00423319|66676245|FG001|Overall Study|Death|0|||
23807692|NCT00423319|66676244|FG000|Overall Study|Adverse Event|93|||
23807693|NCT00423319|66676245|FG001|Overall Study|Adverse Event|112|||
23807694|NCT00423319|66676244|FG000|Overall Study|Withdrawal by Subject|86|||
23807695|NCT00423319|66676245|FG001|Overall Study|Withdrawal by Subject|99|||
23807696|NCT00423319|66676244|FG000|Overall Study|Lost to Follow-up|4|||
23807697|NCT00423319|66676245|FG001|Overall Study|Lost to Follow-up|3|||
23807698|NCT00423319|66676244|FG000|Overall Study|Poor compliance or noncompliance|1|||
23807699|NCT00423319|66676245|FG001|Overall Study|Poor compliance or noncompliance|1|||
23708281|NCT02410902|66308801|FG001|Overall Study|Protocol Violation|4|||
23708282|NCT02410902|66308800|FG000|Overall Study|Withdrawal by Subject|6|||
23708283|NCT02410902|66308801|FG001|Overall Study|Withdrawal by Subject|8|||
23504532|NCT00471328|65587865|FG000|Extension Phase|Withdrawal by Subject|0|||
23504533|NCT00471328|65587866|FG001|Extension Phase|Withdrawal by Subject|2|||
23504534|NCT00471328|65587865|FG000|Extension Phase|Death|1|||
23504535|NCT00471328|65587866|FG001|Extension Phase|Death|7|||
23504536|NCT00471328|65587865|FG000|Extension Phase|Protocol Deviation|3|||
23504537|NCT00471328|65587866|FG001|Extension Phase|Protocol Deviation|1|||
23504538|NCT00471328|65587865|FG000|Extension Phase|Treatment duration as per protocol|0|||
23504539|NCT00471328|65587866|FG001|Extension Phase|Treatment duration as per protocol|1|||
23504540|NCT00471328|65587865|FG000|Extension Phase|Disease Progression|32|||
23504541|NCT00471328|65587866|FG001|Extension Phase|Disease Progression|44|||
23708284|NCT02410902|66308800|FG000|Overall Study|Non-Compliance|8|||
23708285|NCT02410902|66308801|FG001|Overall Study|Non-Compliance|2|||
23708286|NCT01043185|66308804|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
23807700|NCT00423319|66676244|FG000|Overall Study|No longer meets study criteria|15|||
23807701|NCT00423319|66676245|FG001|Overall Study|No longer meets study criteria|15|||
23708287|NCT01043185|66308805|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
23807702|NCT00423319|66676244|FG000|Overall Study|Other|23|||
23807703|NCT00423319|66676245|FG001|Overall Study|Other|22|||
23807704|NCT02312063|66676246|FG000|Overall Study|Withdrawal by Subject|0|||
23807705|NCT02312063|66676247|FG001|Overall Study|Withdrawal by Subject|1|||
23807706|NCT00931268|66676248|FG000|Overall Study|Lost to Follow-up|6|||
23807707|NCT00750308|66676249|FG000|First Treatment|Adverse Event|0|||
23807708|NCT00750308|66676250|FG001|First Treatment|Adverse Event|1|||
23807709|NCT00750308|66676251|FG002|First Treatment|Adverse Event|0|||
23807710|NCT00750308|66676252|FG003|First Treatment|Adverse Event|0|||
23807711|NCT00750308|66676253|FG004|First Treatment|Adverse Event|0|||
23807712|NCT00750308|66676254|FG005|First Treatment|Adverse Event|0|||
23807713|NCT00750308|66676255|FG006|First Treatment|Adverse Event|0|||
23807714|NCT00750308|66676256|FG007|First Treatment|Adverse Event|0|||
23807715|NCT00750308|66676257|FG008|First Treatment|Adverse Event|0|||
23807716|NCT00750308|66676258|FG009|First Treatment|Adverse Event|0|||
23807717|NCT00750308|66676259|FG010|First Treatment|Adverse Event|1|||
23807718|NCT00750308|66676260|FG011|First Treatment|Adverse Event|1|||
23807719|NCT00750308|66676249|FG000|First Treatment|Withdrawal by Subject|0|||
23807720|NCT00750308|66676250|FG001|First Treatment|Withdrawal by Subject|0|||
23807721|NCT00750308|66676251|FG002|First Treatment|Withdrawal by Subject|0|||
23807722|NCT00750308|66676252|FG003|First Treatment|Withdrawal by Subject|1|||
23807723|NCT00750308|66676253|FG004|First Treatment|Withdrawal by Subject|0|||
23807724|NCT00750308|66676254|FG005|First Treatment|Withdrawal by Subject|0|||
23807725|NCT00750308|66676255|FG006|First Treatment|Withdrawal by Subject|0|||
23807726|NCT00750308|66676256|FG007|First Treatment|Withdrawal by Subject|1|||
23807727|NCT00750308|66676257|FG008|First Treatment|Withdrawal by Subject|0|||
23807728|NCT00750308|66676258|FG009|First Treatment|Withdrawal by Subject|0|||
23807729|NCT00750308|66676259|FG010|First Treatment|Withdrawal by Subject|0|||
23807730|NCT00750308|66676260|FG011|First Treatment|Withdrawal by Subject|0|||
23807731|NCT00750308|66676249|FG000|Second Treatment|Adverse Event|0|||
23807732|NCT00750308|66676250|FG001|Second Treatment|Adverse Event|0|||
23807733|NCT00750308|66676251|FG002|Second Treatment|Adverse Event|0|||
23807734|NCT00750308|66676252|FG003|Second Treatment|Adverse Event|0|||
23807735|NCT00750308|66676253|FG004|Second Treatment|Adverse Event|0|||
23807736|NCT00750308|66676254|FG005|Second Treatment|Adverse Event|1|||
23807737|NCT00750308|66676255|FG006|Second Treatment|Adverse Event|0|||
23807738|NCT00750308|66676256|FG007|Second Treatment|Adverse Event|0|||
23807739|NCT00750308|66676257|FG008|Second Treatment|Adverse Event|1|||
23807740|NCT00750308|66676258|FG009|Second Treatment|Adverse Event|0|||
23807741|NCT00750308|66676259|FG010|Second Treatment|Adverse Event|0|||
23807742|NCT00750308|66676260|FG011|Second Treatment|Adverse Event|0|||
23403910|NCT00833027|65226438|FG000|Overall Study|Death|1|||
23807743|NCT00750308|66676249|FG000|Second Treatment|Withdrawal by Subject|0|||
23807744|NCT00750308|66676250|FG001|Second Treatment|Withdrawal by Subject|0|||
23807745|NCT00750308|66676251|FG002|Second Treatment|Withdrawal by Subject|0|||
23708288|NCT01043185|66308806|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
23708289|NCT01043185|66308807|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
23708290|NCT01043185|66308808|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
23708291|NCT01043185|66308809|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
23708292|NCT01043185|66308810|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
23708293|NCT01043185|66308811|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
23807746|NCT00750308|66676252|FG003|Second Treatment|Withdrawal by Subject|0|||
23807747|NCT00750308|66676253|FG004|Second Treatment|Withdrawal by Subject|1|||
23807748|NCT00750308|66676254|FG005|Second Treatment|Withdrawal by Subject|0|||
23807749|NCT00750308|66676255|FG006|Second Treatment|Withdrawal by Subject|0|||
23807750|NCT00750308|66676256|FG007|Second Treatment|Withdrawal by Subject|0|||
23708294|NCT01043185|66308812|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
23708295|NCT01043185|66308813|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
23708296|NCT01975272|66308814|FG000|Overall Study|Excluded after protocol amendment|1|||
23708297|NCT01975272|66308815|FG001|Overall Study|Excluded after protocol amendment|1|||
23708298|NCT01975272|66308816|FG002|Overall Study|Excluded after protocol amendment|2|||
23708299|NCT00121992|66308817|FG000|Overall Study|Treatment not received|2|||
23708300|NCT00121992|66308818|FG001|Overall Study|Treatment not received|11|||
23708301|NCT03331666|66308822|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
23708302|NCT03331666|66308823|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
23708303|NCT00547378|66308824|FG000|Randomized Cohort|Withdrawal by Subject|7|||
23708304|NCT00547378|66308825|FG001|Randomized Cohort|Withdrawal by Subject|5|||
23708305|NCT00547378|66308826|FG002|Randomized Cohort|Withdrawal by Subject|0|||
23708306|NCT00547378|66308824|FG000|Randomized Cohort|Death|0|||
23708307|NCT00547378|66308825|FG001|Randomized Cohort|Death|1|||
23708308|NCT00547378|66308826|FG002|Randomized Cohort|Death|0|||
23708309|NCT00547378|66308824|FG000|Randomized Cohort|Lost to Follow-up|1|||
23504542|NCT00471328|65587865|FG000|Extension Phase|New cancer Therapy|1|||
23708310|NCT00547378|66308825|FG001|Randomized Cohort|Lost to Follow-up|0|||
23708311|NCT00547378|66308826|FG002|Randomized Cohort|Lost to Follow-up|0|||
23708312|NCT00547378|66308824|FG000|Randomized Cohort|Adverse Event|1|||
23708313|NCT00547378|66308825|FG001|Randomized Cohort|Adverse Event|0|||
23708314|NCT00547378|66308826|FG002|Randomized Cohort|Adverse Event|0|||
23708315|NCT00547378|66308824|FG000|Randomized Cohort|Other reasons|2|||
23708316|NCT00547378|66308825|FG001|Randomized Cohort|Other reasons|0|||
23708317|NCT00547378|66308826|FG002|Randomized Cohort|Other reasons|0|||
23708318|NCT00547378|66308824|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
23708319|NCT00547378|66308825|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
23708320|NCT00547378|66308826|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
23708321|NCT00547378|66308824|FG000|All Implanted Cohort|Adverse Event|4|||
23708322|NCT00547378|66308825|FG001|All Implanted Cohort|Adverse Event|10|||
23708323|NCT00547378|66308826|FG002|All Implanted Cohort|Adverse Event|17|||
23708324|NCT00547378|66308824|FG000|All Implanted Cohort|Lost to Follow-up|0|||
23708325|NCT00547378|66308825|FG001|All Implanted Cohort|Lost to Follow-up|1|||
23708326|NCT00547378|66308826|FG002|All Implanted Cohort|Lost to Follow-up|14|||
23504543|NCT00471328|65587866|FG001|Extension Phase|New cancer Therapy|0|||
23504544|NCT00471328|65587865|FG000|Extension Phase|Administrative Problem|1|||
23504545|NCT00471328|65587866|FG001|Extension Phase|Administrative Problem|0|||
23504546|NCT03052725|65587867|FG000|Overall Study|Adverse Event|2|||
23504547|NCT03052725|65587868|FG001|Overall Study|Adverse Event|0|||
23504548|NCT03052725|65587867|FG000|Overall Study|Withdrawal by Subject|3|||
23504549|NCT03052725|65587868|FG001|Overall Study|Withdrawal by Subject|4|||
23504550|NCT03052725|65587867|FG000|Overall Study|Pregnancy|0|||
23504551|NCT03052725|65587868|FG001|Overall Study|Pregnancy|1|||
23504552|NCT03052725|65587867|FG000|Overall Study|Site closure|0|||
23504553|NCT03052725|65587868|FG001|Overall Study|Site closure|1|||
23504554|NCT03052725|65587867|FG000|Overall Study|Study terminated by sponsor|143|||
23504555|NCT03052725|65587868|FG001|Overall Study|Study terminated by sponsor|144|||
23504556|NCT02927431|65587870|FG000|Overall Study|Withdrawal by Subject|0|||
23708327|NCT00547378|66308824|FG000|All Implanted Cohort|Death|3|||
23504557|NCT02927431|65587871|FG001|Overall Study|Withdrawal by Subject|0|||
23504558|NCT02927431|65587872|FG002|Overall Study|Withdrawal by Subject|1|||
23504559|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
23504560|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
23504561|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
23504562|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
23504563|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
23504564|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
23708328|NCT00547378|66308825|FG001|All Implanted Cohort|Death|1|||
23708329|NCT00547378|66308826|FG002|All Implanted Cohort|Death|4|||
23708330|NCT00547378|66308824|FG000|All Implanted Cohort|Physician Decision|0|||
23708331|NCT00547378|66308825|FG001|All Implanted Cohort|Physician Decision|2|||
23708332|NCT00547378|66308826|FG002|All Implanted Cohort|Physician Decision|6|||
23708333|NCT00547378|66308824|FG000|All Implanted Cohort|Site closure|2|||
23708334|NCT00547378|66308825|FG001|All Implanted Cohort|Site closure|0|||
23504565|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
23504566|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
23504567|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
23504568|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
23504569|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
23708335|NCT00547378|66308826|FG002|All Implanted Cohort|Site closure|1|||
23504570|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
23504571|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
23504572|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
23504573|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
23708336|NCT00547378|66308824|FG000|All Implanted Cohort|Other reasons|1|||
23708337|NCT00547378|66308825|FG001|All Implanted Cohort|Other reasons|0|||
23708338|NCT00547378|66308826|FG002|All Implanted Cohort|Other reasons|1|||
23708339|NCT03245723|66308827|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
23708340|NCT03245723|66308828|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
23708341|NCT03245723|66308827|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
23708342|NCT03245723|66308828|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
23708343|NCT03245723|66308827|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
23708344|NCT03245723|66308828|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
23807751|NCT00750308|66676257|FG008|Second Treatment|Withdrawal by Subject|0|||
23807752|NCT00750308|66676258|FG009|Second Treatment|Withdrawal by Subject|0|||
23807753|NCT00750308|66676259|FG010|Second Treatment|Withdrawal by Subject|0|||
23807754|NCT00750308|66676260|FG011|Second Treatment|Withdrawal by Subject|0|||
23807755|NCT00750308|66676249|FG000|Third Treatment|Withdrawal by Subject|0|||
23807756|NCT00750308|66676250|FG001|Third Treatment|Withdrawal by Subject|1|||
23807757|NCT00750308|66676251|FG002|Third Treatment|Withdrawal by Subject|0|||
23807758|NCT00750308|66676252|FG003|Third Treatment|Withdrawal by Subject|0|||
23807759|NCT00750308|66676253|FG004|Third Treatment|Withdrawal by Subject|0|||
23807760|NCT00750308|66676254|FG005|Third Treatment|Withdrawal by Subject|0|||
23807761|NCT00750308|66676255|FG006|Third Treatment|Withdrawal by Subject|0|||
23807762|NCT00750308|66676256|FG007|Third Treatment|Withdrawal by Subject|0|||
23807763|NCT00750308|66676257|FG008|Third Treatment|Withdrawal by Subject|0|||
23807764|NCT00750308|66676258|FG009|Third Treatment|Withdrawal by Subject|0|||
23807765|NCT00750308|66676259|FG010|Third Treatment|Withdrawal by Subject|0|||
23807766|NCT00750308|66676260|FG011|Third Treatment|Withdrawal by Subject|0|||
23807767|NCT01007942|66676261|FG000|Overall Study|Adverse Event|29|||
23807768|NCT01007942|66676262|FG001|Overall Study|Adverse Event|14|||
23807769|NCT01007942|66676261|FG000|Overall Study|Abnormal test procedure|0|||
23807770|NCT01007942|66676262|FG001|Overall Study|Abnormal test procedure|1|||
23807771|NCT01007942|66676261|FG000|Overall Study|Disease progression|217|||
23807772|NCT01007942|66676262|FG001|Overall Study|Disease progression|242|||
23807773|NCT01007942|66676261|FG000|Overall Study|New cancer therapy|5|||
23807774|NCT01007942|66676262|FG001|Overall Study|New cancer therapy|1|||
23807775|NCT01007942|66676261|FG000|Overall Study|Protocol Violation|1|||
23807776|NCT01007942|66676262|FG001|Overall Study|Protocol Violation|1|||
23807777|NCT01007942|66676261|FG000|Overall Study|Withdrawal by Subject|19|||
23807778|NCT01007942|66676262|FG001|Overall Study|Withdrawal by Subject|14|||
23807779|NCT01007942|66676261|FG000|Overall Study|Lost to Follow-up|1|||
23807780|NCT01007942|66676262|FG001|Overall Study|Lost to Follow-up|0|||
23807781|NCT01007942|66676261|FG000|Overall Study|Administrative problems|2|||
23807782|NCT01007942|66676262|FG001|Overall Study|Administrative problems|0|||
23807783|NCT01007942|66676261|FG000|Overall Study|Death|3|||
23807784|NCT01007942|66676262|FG001|Overall Study|Death|2|||
23807785|NCT01007942|66676261|FG000|Overall Study|Patients untreated|4|||
23807786|NCT01007942|66676262|FG001|Overall Study|Patients untreated|3|||
23807787|NCT05065983|66676270|FG000|Overall Study|Lost to Follow-up|2|||
23807788|NCT00838435|66676273|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
23807789|NCT00838435|66676273|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
23807790|NCT00838435|66676273|FG000|Part 2 (7 Years)|Adverse Event|2|||
23807791|NCT00838435|66676273|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
23807792|NCT00838435|66676273|FG000|Part 2 (7 Years)|Physician Decision|1|||
23807793|NCT00838435|66676273|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
23807794|NCT00838435|66676273|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
23807795|NCT02963311|66676274|FG000|Overall Study|Withdrawal by Subject|1|||
23807796|NCT02963311|66676274|FG000|Overall Study|Screen Failure|4|||
23807797|NCT00673933|66676279|FG000|Overall Study|Withdrawal by Subject|2|||
23807798|NCT00673933|66676279|FG000|Overall Study|Lost to Follow-up|1|||
23807799|NCT03955471|66676289|FG000|Overall Study|Death|22|||
23807800|NCT03955471|66676289|FG000|Overall Study|Lost to Follow-up|1|||
23807801|NCT03955471|66676289|FG000|Overall Study|Withdrawal by Subject|6|||
23504574|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
23807802|NCT03955471|66676289|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
23807803|NCT03733210|66676290|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
23807804|NCT03733210|66676291|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
23807805|NCT00761865|66676296|FG000|Overall Study|Lost to Follow-up|8|||
23807806|NCT00761865|66676297|FG001|Overall Study|Lost to Follow-up|7|||
23807807|NCT01691820|66676298|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
23807808|NCT01691820|66676299|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
23807809|NCT01691820|66676298|FG000|Overall Study|Migrated/moved from study area|7|||
23807810|NCT01691820|66676299|FG001|Overall Study|Migrated/moved from study area|4|||
23807811|NCT01691820|66676298|FG000|Overall Study|Lost to Follow-up|6|||
23807812|NCT01691820|66676299|FG001|Overall Study|Lost to Follow-up|17|||
23807813|NCT01691820|66676298|FG000|Overall Study|Other (unspecified)|4|||
23807814|NCT01691820|66676299|FG001|Overall Study|Other (unspecified)|1|||
23807815|NCT02751359|66676307|FG000|Overall Study|Lost to Follow-up|1|||
23504575|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
23504576|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
23504577|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
23504578|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
23504579|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
23504580|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
23504581|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
23504582|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
23504583|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
23504584|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
23504585|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
23504586|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504587|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504588|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504589|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504590|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504591|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504592|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504593|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504594|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504595|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504596|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504597|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504598|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504599|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504600|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504601|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504602|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23807816|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
23807817|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
23807818|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
23807819|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
23807820|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
23807821|NCT01490866|66676308|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
23807822|NCT01490866|66676308|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
23807823|NCT01490866|66676308|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
23807824|NCT01490866|66676308|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
23807825|NCT01490866|66676308|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
23807826|NCT01490866|66676308|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
23807827|NCT01936623|66676309|FG000|Overall Study|Lost to Follow-up|0|||
23807828|NCT01936623|66676310|FG001|Overall Study|Lost to Follow-up|5|||
23807829|NCT00102687|66676314|FG000|Initial Period|Withdrawal by Subject|6|||
23807830|NCT00102687|66676315|FG001|Initial Period|Withdrawal by Subject|3|||
23807831|NCT00102687|66676316|FG002|Initial Period|Withdrawal by Subject|5|||
23807832|NCT00102687|66676317|FG003|Initial Period|Withdrawal by Subject|0|||
23807833|NCT00102687|66676318|FG004|Initial Period|Withdrawal by Subject|0|||
23807834|NCT00102687|66676314|FG000|Initial Period|Adverse Event|4|||
23807835|NCT00102687|66676315|FG001|Initial Period|Adverse Event|7|||
23807836|NCT00102687|66676316|FG002|Initial Period|Adverse Event|9|||
23807837|NCT00102687|66676317|FG003|Initial Period|Adverse Event|0|||
23807838|NCT00102687|66676318|FG004|Initial Period|Adverse Event|0|||
23807839|NCT00102687|66676314|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
23807840|NCT00102687|66676315|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
23807841|NCT00102687|66676316|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
23807842|NCT00102687|66676317|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
23807843|NCT00102687|66676318|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
23807844|NCT00102687|66676314|FG000|Initial Period|Protocol Violation|0|||
23504603|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23807845|NCT00102687|66676315|FG001|Initial Period|Protocol Violation|0|||
23807846|NCT00102687|66676316|FG002|Initial Period|Protocol Violation|2|||
23807847|NCT00102687|66676317|FG003|Initial Period|Protocol Violation|0|||
23807848|NCT00102687|66676318|FG004|Initial Period|Protocol Violation|0|||
23807849|NCT00102687|66676314|FG000|Initial Period|Physician Decision|2|||
23504604|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504605|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504606|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504607|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504608|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504609|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504610|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504611|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
23504612|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
23504613|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504614|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504615|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504616|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23807850|NCT00102687|66676315|FG001|Initial Period|Physician Decision|9|||
23807851|NCT00102687|66676316|FG002|Initial Period|Physician Decision|6|||
23807852|NCT00102687|66676317|FG003|Initial Period|Physician Decision|0|||
23807853|NCT00102687|66676318|FG004|Initial Period|Physician Decision|0|||
23807854|NCT00102687|66676314|FG000|Initial Period|Sponsor's decision|0|||
23807855|NCT00102687|66676315|FG001|Initial Period|Sponsor's decision|1|||
23504617|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504618|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504619|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504620|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23807856|NCT00102687|66676316|FG002|Initial Period|Sponsor's decision|1|||
23504621|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504622|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23807857|NCT00102687|66676317|FG003|Initial Period|Sponsor's decision|0|||
23807858|NCT00102687|66676318|FG004|Initial Period|Sponsor's decision|0|||
23807859|NCT00102687|66676314|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
23807860|NCT00102687|66676315|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
23807861|NCT00102687|66676316|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
23807862|NCT00102687|66676317|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
23807863|NCT00102687|66676318|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
23807864|NCT00102687|66676314|FG000|Initial Period|Death|1|||
23807865|NCT00102687|66676315|FG001|Initial Period|Death|1|||
23708345|NCT03245723|66308827|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
23708346|NCT03245723|66308828|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
23708347|NCT02370498|66308834|FG000|Overall Study|Adverse Event|10|||
23708348|NCT02370498|66308835|FG001|Overall Study|Adverse Event|8|||
23708349|NCT02370498|66308834|FG000|Overall Study|Death|263|||
23708350|NCT02370498|66308835|FG001|Overall Study|Death|265|||
23708351|NCT02370498|66308834|FG000|Overall Study|Protocol Violation|1|||
23708352|NCT02370498|66308835|FG001|Overall Study|Protocol Violation|2|||
23708353|NCT02370498|66308834|FG000|Overall Study|Withdrawal by Subject|7|||
23708354|NCT02370498|66308835|FG001|Overall Study|Withdrawal by Subject|12|||
23708355|NCT02370498|66308834|FG000|Overall Study|Sponsor's decision|15|||
23708356|NCT02370498|66308835|FG001|Overall Study|Sponsor's decision|9|||
23708357|NCT02104804|66308836|FG000|Overall Study|Did not take study medication|0|||
23708358|NCT02104804|66308837|FG001|Overall Study|Did not take study medication|1|||
23708359|NCT02104804|66308836|FG000|Overall Study|Study specific discontinuation criteria|6|||
23708360|NCT02104804|66308837|FG001|Overall Study|Study specific discontinuation criteria|1|||
23708361|NCT02104804|66308836|FG000|Overall Study|Other listed|2|||
23708362|NCT02104804|66308837|FG001|Overall Study|Other listed|1|||
23708363|NCT02104804|66308836|FG000|Overall Study|Protocol Violation|0|||
23708364|NCT02104804|66308837|FG001|Overall Study|Protocol Violation|1|||
23708365|NCT02104804|66308836|FG000|Overall Study|Adverse Event|4|||
23708366|NCT02104804|66308837|FG001|Overall Study|Adverse Event|3|||
23708367|NCT02104804|66308836|FG000|Overall Study|Withdrawal by Subject|4|||
23708368|NCT02104804|66308837|FG001|Overall Study|Withdrawal by Subject|12|||
23504623|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504624|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504625|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504626|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504627|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504628|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504629|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23708369|NCT00953043|66308838|FG000|Overall Study|Withdrawal by Subject|4|||
23708370|NCT00953043|66308839|FG001|Overall Study|Withdrawal by Subject|0|||
23708371|NCT00953043|66308838|FG000|Overall Study|Physician Decision|0|||
23708372|NCT00953043|66308839|FG001|Overall Study|Physician Decision|2|||
23708373|NCT00696657|66308840|FG000|Overall Study|Protocol Violation|0|||
23708374|NCT00696657|66308841|FG001|Overall Study|Protocol Violation|0|||
23708375|NCT00696657|66308842|FG002|Overall Study|Protocol Violation|0|||
23708376|NCT00696657|66308843|FG003|Overall Study|Protocol Violation|0|||
23504630|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504631|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504632|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504633|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504634|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504635|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504636|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504637|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
23504638|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
23504639|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504640|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504641|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504642|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504643|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504644|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504645|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504646|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504647|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504648|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504649|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504650|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504651|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504652|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504653|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504654|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504655|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504656|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504657|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504658|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504659|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504660|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504661|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504662|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504663|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504664|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
23504665|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504666|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504667|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504668|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504669|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504670|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504671|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504672|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504673|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504674|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504675|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504676|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504677|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504678|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504679|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504680|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504681|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504682|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504683|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504684|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504685|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504686|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504687|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504688|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
23708377|NCT00696657|66308844|FG004|Overall Study|Protocol Violation|0|||
23708378|NCT00696657|66308845|FG005|Overall Study|Protocol Violation|1|||
23504689|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504690|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504691|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
23504692|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
23504693|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23708379|NCT00696657|66308846|FG006|Overall Study|Protocol Violation|0|||
23708380|NCT00696657|66308847|FG007|Overall Study|Protocol Violation|0|||
23708381|NCT00696657|66308848|FG008|Overall Study|Protocol Violation|1|||
23708382|NCT00696657|66308840|FG000|Overall Study|Lack of Efficacy|0|||
23403911|NCT00833027|65226438|FG000|Overall Study|Lack of Efficacy|12|||
23504694|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
23504695|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504696|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23708383|NCT00696657|66308841|FG001|Overall Study|Lack of Efficacy|1|||
23708384|NCT00696657|66308842|FG002|Overall Study|Lack of Efficacy|0|||
23708385|NCT00696657|66308843|FG003|Overall Study|Lack of Efficacy|0|||
23708386|NCT00696657|66308844|FG004|Overall Study|Lack of Efficacy|0|||
23708387|NCT00696657|66308845|FG005|Overall Study|Lack of Efficacy|0|||
23708388|NCT00696657|66308846|FG006|Overall Study|Lack of Efficacy|0|||
23708389|NCT00696657|66308847|FG007|Overall Study|Lack of Efficacy|0|||
23708390|NCT00696657|66308848|FG008|Overall Study|Lack of Efficacy|0|||
23708391|NCT00696657|66308840|FG000|Overall Study|Withdrawal criteria|1|||
23708392|NCT00696657|66308841|FG001|Overall Study|Withdrawal criteria|3|||
23708393|NCT00696657|66308842|FG002|Overall Study|Withdrawal criteria|2|||
23708394|NCT00696657|66308843|FG003|Overall Study|Withdrawal criteria|2|||
23708395|NCT00696657|66308844|FG004|Overall Study|Withdrawal criteria|0|||
23708396|NCT00696657|66308845|FG005|Overall Study|Withdrawal criteria|0|||
23708397|NCT00696657|66308846|FG006|Overall Study|Withdrawal criteria|1|||
23708398|NCT00696657|66308847|FG007|Overall Study|Withdrawal criteria|1|||
23708399|NCT00696657|66308848|FG008|Overall Study|Withdrawal criteria|2|||
23708400|NCT00696657|66308840|FG000|Overall Study|Unclassified|0|||
23708401|NCT00696657|66308841|FG001|Overall Study|Unclassified|1|||
23708402|NCT00696657|66308842|FG002|Overall Study|Unclassified|3|||
23708403|NCT00696657|66308843|FG003|Overall Study|Unclassified|2|||
23708404|NCT00696657|66308844|FG004|Overall Study|Unclassified|4|||
23708405|NCT00696657|66308845|FG005|Overall Study|Unclassified|2|||
23708406|NCT00696657|66308846|FG006|Overall Study|Unclassified|0|||
23708407|NCT00696657|66308847|FG007|Overall Study|Unclassified|0|||
23708408|NCT00696657|66308848|FG008|Overall Study|Unclassified|1|||
23708409|NCT00696657|66308840|FG000|Overall Study|Adverse Event|0|||
23708410|NCT00696657|66308841|FG001|Overall Study|Adverse Event|0|||
23708411|NCT00696657|66308842|FG002|Overall Study|Adverse Event|3|||
23708412|NCT00696657|66308843|FG003|Overall Study|Adverse Event|7|||
23708413|NCT00696657|66308844|FG004|Overall Study|Adverse Event|6|||
23708414|NCT00696657|66308845|FG005|Overall Study|Adverse Event|9|||
23708415|NCT00696657|66308846|FG006|Overall Study|Adverse Event|14|||
23708416|NCT00696657|66308847|FG007|Overall Study|Adverse Event|2|||
23708417|NCT00696657|66308848|FG008|Overall Study|Adverse Event|5|||
23708418|NCT03298412|66308849|FG000|Run-in Period|Other, Not Specified|1|||
23708419|NCT03298412|66308849|FG000|Run-in Period|Disease Progression|1|||
23708420|NCT03298412|66308849|FG000|Run-in Period|Ineligibility Determined|1|||
23708421|NCT03298412|66308849|FG000|Run-in Period|Decision by Sponsor|6|||
23708422|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
23708423|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708424|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708425|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23504697|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23708426|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708427|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708428|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708429|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708430|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23708431|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
23708432|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708433|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708434|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708435|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708436|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23807866|NCT00102687|66676316|FG002|Initial Period|Death|1|||
23807867|NCT00102687|66676317|FG003|Initial Period|Death|0|||
23504698|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504699|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23807868|NCT00102687|66676318|FG004|Initial Period|Death|0|||
23807869|NCT00102687|66676314|FG000|Maintenance Period|Withdrawal by Subject|4|||
23807870|NCT00102687|66676315|FG001|Maintenance Period|Withdrawal by Subject|0|||
23807871|NCT00102687|66676316|FG002|Maintenance Period|Withdrawal by Subject|2|||
23807872|NCT00102687|66676317|FG003|Maintenance Period|Withdrawal by Subject|3|||
23807873|NCT00102687|66676318|FG004|Maintenance Period|Withdrawal by Subject|1|||
23807874|NCT00102687|66676314|FG000|Maintenance Period|Adverse Event|1|||
23807875|NCT00102687|66676315|FG001|Maintenance Period|Adverse Event|0|||
23807876|NCT00102687|66676316|FG002|Maintenance Period|Adverse Event|0|||
23807877|NCT00102687|66676317|FG003|Maintenance Period|Adverse Event|1|||
23807878|NCT00102687|66676318|FG004|Maintenance Period|Adverse Event|3|||
23807879|NCT00102687|66676314|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23807880|NCT00102687|66676315|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
23807881|NCT00102687|66676316|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23807882|NCT00102687|66676317|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
23807883|NCT00102687|66676318|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23807884|NCT00102687|66676314|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23807885|NCT00102687|66676315|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23807886|NCT00102687|66676316|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23807887|NCT00102687|66676317|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
23807888|NCT00102687|66676318|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
23807889|NCT00102687|66676314|FG000|Maintenance Period|Death|0|||
23807890|NCT00102687|66676315|FG001|Maintenance Period|Death|0|||
23807891|NCT00102687|66676316|FG002|Maintenance Period|Death|0|||
23807892|NCT00102687|66676317|FG003|Maintenance Period|Death|1|||
23807893|NCT00102687|66676318|FG004|Maintenance Period|Death|1|||
23807894|NCT00102687|66676314|FG000|Maintenance Period|Physician Decision|1|||
23807895|NCT00102687|66676315|FG001|Maintenance Period|Physician Decision|2|||
23807896|NCT00102687|66676316|FG002|Maintenance Period|Physician Decision|3|||
23807897|NCT00102687|66676317|FG003|Maintenance Period|Physician Decision|0|||
23807898|NCT00102687|66676318|FG004|Maintenance Period|Physician Decision|4|||
23807899|NCT02071849|66676321|FG000|6-month Primary Endpoint|Did not receive device|4|||
23807900|NCT02071849|66676321|FG000|6-month Primary Endpoint|Adverse Event|1|||
23807901|NCT02071849|66676321|FG000|2-year Extended Follow-up|Adverse Event|1|||
23807902|NCT01769339|66676326|FG000|Overall Study|Lost to Follow-up|42|||
23807903|NCT01769339|66676326|FG000|Overall Study|Adverse Event|1|||
23807904|NCT02707861|66676331|FG000|Overall Study|Went onto commercial drug|30|||
23807905|NCT02707861|66676332|FG001|Overall Study|Went onto commercial drug|23|||
23807906|NCT02707861|66676331|FG000|Overall Study|Adverse Event|2|||
23807907|NCT02707861|66676332|FG001|Overall Study|Adverse Event|3|||
23807908|NCT02707861|66676331|FG000|Overall Study|Death|5|||
23807909|NCT02707861|66676332|FG001|Overall Study|Death|2|||
23807910|NCT02707861|66676331|FG000|Overall Study|Lack of Efficacy|0|||
23807911|NCT02707861|66676332|FG001|Overall Study|Lack of Efficacy|2|||
23807912|NCT02707861|66676331|FG000|Overall Study|Physician Decision|1|||
23807913|NCT02707861|66676332|FG001|Overall Study|Physician Decision|4|||
23807914|NCT02707861|66676331|FG000|Overall Study|Withdrawal by Subject|2|||
23807915|NCT02707861|66676332|FG001|Overall Study|Withdrawal by Subject|1|||
23807916|NCT02707861|66676331|FG000|Overall Study|Lost to Follow-up|1|||
23807917|NCT02707861|66676332|FG001|Overall Study|Lost to Follow-up|3|||
23807918|NCT03439852|66676335|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
23807919|NCT03439852|66676336|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
23807920|NCT03439852|66676335|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
23807921|NCT03439852|66676336|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
23807922|NCT03439852|66676335|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
23807923|NCT03439852|66676336|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
23807924|NCT04619992|66676339|FG000|Overall Study|Withdrawal by Subject|1|||
23807925|NCT04619992|66676340|FG001|Overall Study|Withdrawal by Subject|0|||
23807926|NCT02296684|66676341|FG000|Overall Study|Withdrawal by Subject|0|||
23807927|NCT02296684|66676342|FG001|Overall Study|Withdrawal by Subject|1|||
23807928|NCT02296684|66676343|FG002|Overall Study|Withdrawal by Subject|1|||
23807929|NCT02296684|66676341|FG000|Overall Study|Death|2|||
23807930|NCT02296684|66676342|FG001|Overall Study|Death|0|||
23807931|NCT02296684|66676343|FG002|Overall Study|Death|0|||
23807932|NCT01568320|66676344|FG000|Overall Study|Death|20|||
23807933|NCT01568320|66676344|FG000|Overall Study|Lost to Follow-up|9|||
23807934|NCT01568320|66676344|FG000|Overall Study|Withdrawal by Subject|10|||
23807935|NCT01568320|66676344|FG000|Overall Study|Conversion to open repair|1|||
23807936|NCT01568320|66676344|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
23807937|NCT02054130|66676345|FG000|Overall Study|Withdrawal by Subject|4|||
23807938|NCT02054130|66676346|FG001|Overall Study|Withdrawal by Subject|4|||
23807939|NCT02054130|66676347|FG002|Overall Study|Withdrawal by Subject|7|||
23807940|NCT02054130|66676348|FG003|Overall Study|Withdrawal by Subject|10|||
23807941|NCT02054130|66676345|FG000|Overall Study|Death|0|||
23807942|NCT02054130|66676346|FG001|Overall Study|Death|1|||
23807943|NCT02054130|66676347|FG002|Overall Study|Death|0|||
23807944|NCT02054130|66676348|FG003|Overall Study|Death|0|||
23807945|NCT02054130|66676345|FG000|Overall Study|Lost to Follow-up|0|||
23807946|NCT02054130|66676346|FG001|Overall Study|Lost to Follow-up|0|||
23807947|NCT02054130|66676347|FG002|Overall Study|Lost to Follow-up|1|||
23807948|NCT02054130|66676348|FG003|Overall Study|Lost to Follow-up|2|||
23807949|NCT02054130|66676345|FG000|Overall Study|Missed dose|4|||
23807950|NCT02054130|66676346|FG001|Overall Study|Missed dose|6|||
23807951|NCT02054130|66676347|FG002|Overall Study|Missed dose|7|||
23807952|NCT02054130|66676348|FG003|Overall Study|Missed dose|10|||
23807953|NCT03923530|66676349|FG000|Overall Study|Withdrawal by Subject|1|||
23807954|NCT03923530|66676349|FG000|Overall Study|screen failure|3|||
23807955|NCT00759902|66676354|FG000|Overall Study|Adverse Event|0|||
23807956|NCT00759902|66676355|FG001|Overall Study|Adverse Event|1|||
23807957|NCT00809159|66676356|FG000|Part 1|Adverse Event|1|||
23807958|NCT00809159|66676357|FG001|Part 1|Adverse Event|1|||
23807959|NCT00809159|66676358|FG002|Part 1|Adverse Event|0|||
23807960|NCT00809159|66676359|FG003|Part 1|Adverse Event|0|||
23807961|NCT00809159|66676360|FG004|Part 1|Adverse Event|0|||
23807962|NCT00809159|66676361|FG005|Part 1|Adverse Event|0|||
23807963|NCT00809159|66676356|FG000|Part 1|Lost to Follow-up|1|||
23807964|NCT00809159|66676357|FG001|Part 1|Lost to Follow-up|0|||
23807965|NCT00809159|66676358|FG002|Part 1|Lost to Follow-up|0|||
23807966|NCT00809159|66676359|FG003|Part 1|Lost to Follow-up|0|||
23807967|NCT00809159|66676360|FG004|Part 1|Lost to Follow-up|0|||
23807968|NCT00809159|66676361|FG005|Part 1|Lost to Follow-up|0|||
23807969|NCT00809159|66676356|FG000|Part 1|Withdrawal by Subject|3|||
23807970|NCT00809159|66676357|FG001|Part 1|Withdrawal by Subject|1|||
23807971|NCT00809159|66676358|FG002|Part 1|Withdrawal by Subject|0|||
23807972|NCT00809159|66676359|FG003|Part 1|Withdrawal by Subject|0|||
23807973|NCT00809159|66676360|FG004|Part 1|Withdrawal by Subject|0|||
23807974|NCT00809159|66676361|FG005|Part 1|Withdrawal by Subject|0|||
23807975|NCT00809159|66676356|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
23807976|NCT00809159|66676357|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
23807977|NCT00809159|66676358|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
23807978|NCT00809159|66676359|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
23504700|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504701|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504702|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504703|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504704|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504705|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504706|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504707|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504708|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504709|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504710|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504711|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504712|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504713|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504714|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504715|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Death|0|||
23504716|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Death|0|||
23504717|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Death|1|||
23807979|NCT00809159|66676360|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
23807980|NCT00809159|66676361|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
23807981|NCT00809159|66676356|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
23807982|NCT00809159|66676357|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
23807983|NCT00809159|66676358|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
23807984|NCT00809159|66676359|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
23807985|NCT00809159|66676360|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
23807986|NCT00809159|66676361|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
23807987|NCT00809159|66676356|FG000|Part 1 and 2|Administrative problems|0|||
23807988|NCT00809159|66676357|FG001|Part 1 and 2|Administrative problems|0|||
23807989|NCT00809159|66676358|FG002|Part 1 and 2|Administrative problems|0|||
23807990|NCT00809159|66676359|FG003|Part 1 and 2|Administrative problems|1|||
23807991|NCT00809159|66676360|FG004|Part 1 and 2|Administrative problems|0|||
23807992|NCT00809159|66676361|FG005|Part 1 and 2|Administrative problems|0|||
23807993|NCT00809159|66676356|FG000|Part 1 and 2|Adverse Event|0|||
23807994|NCT00809159|66676357|FG001|Part 1 and 2|Adverse Event|0|||
23807995|NCT00809159|66676358|FG002|Part 1 and 2|Adverse Event|1|||
23504718|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Death|0|||
23807996|NCT00809159|66676359|FG003|Part 1 and 2|Adverse Event|0|||
23807997|NCT00809159|66676360|FG004|Part 1 and 2|Adverse Event|1|||
23807998|NCT00809159|66676361|FG005|Part 1 and 2|Adverse Event|1|||
23807999|NCT00809159|66676356|FG000|Part 1 and 2|Lost to Follow-up|0|||
23808000|NCT00809159|66676357|FG001|Part 1 and 2|Lost to Follow-up|0|||
23808001|NCT00809159|66676358|FG002|Part 1 and 2|Lost to Follow-up|1|||
23808002|NCT00809159|66676359|FG003|Part 1 and 2|Lost to Follow-up|1|||
23504719|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Death|0|||
23504720|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Death|0|||
23808003|NCT00809159|66676360|FG004|Part 1 and 2|Lost to Follow-up|0|||
23808004|NCT00809159|66676361|FG005|Part 1 and 2|Lost to Follow-up|0|||
23808005|NCT00809159|66676356|FG000|Part 1 and 2|Withdrawal by Subject|0|||
23808006|NCT00809159|66676357|FG001|Part 1 and 2|Withdrawal by Subject|0|||
23808007|NCT00809159|66676358|FG002|Part 1 and 2|Withdrawal by Subject|4|||
23808008|NCT00809159|66676359|FG003|Part 1 and 2|Withdrawal by Subject|0|||
23808009|NCT00809159|66676360|FG004|Part 1 and 2|Withdrawal by Subject|0|||
23808010|NCT00809159|66676361|FG005|Part 1 and 2|Withdrawal by Subject|1|||
23808011|NCT00741936|66676364|FG000|Overall Study|Lost to Follow-up|1|||
23808012|NCT00741936|66676365|FG001|Overall Study|Lost to Follow-up|1|||
23808013|NCT00741936|66676364|FG000|Overall Study|Adverse Event|3|||
23808014|NCT00741936|66676365|FG001|Overall Study|Adverse Event|4|||
23808015|NCT00741936|66676364|FG000|Overall Study|Pregnancy|0|||
23808016|NCT00741936|66676365|FG001|Overall Study|Pregnancy|1|||
23808017|NCT00741936|66676364|FG000|Overall Study|Protocol Violation|2|||
23808018|NCT00741936|66676365|FG001|Overall Study|Protocol Violation|0|||
23808019|NCT00741936|66676364|FG000|Overall Study|Lack of Efficacy|0|||
23808020|NCT00741936|66676365|FG001|Overall Study|Lack of Efficacy|2|||
23808021|NCT00741936|66676364|FG000|Overall Study|Low compliance|3|||
23808022|NCT00741936|66676365|FG001|Overall Study|Low compliance|0|||
23808023|NCT01408628|66676366|FG000|Consented|Withdrawal by Subject|12|||
23808024|NCT01408628|66676366|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
23808025|NCT01408628|66676366|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
23808026|NCT01408628|66676366|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
23808027|NCT04355663|66676367|FG000|Overall Study|Physician Decision|2|||
23808028|NCT04355663|66676368|FG001|Overall Study|Physician Decision|7|||
23808029|NCT04355663|66676369|FG002|Overall Study|Physician Decision|0|||
23808030|NCT04355663|66676367|FG000|Overall Study|Adverse Event|0|||
23808031|NCT04355663|66676368|FG001|Overall Study|Adverse Event|0|||
23808032|NCT04355663|66676369|FG002|Overall Study|Adverse Event|1|||
23808033|NCT04355663|66676367|FG000|Overall Study|Withdrawal by Subject|0|||
23808034|NCT04355663|66676368|FG001|Overall Study|Withdrawal by Subject|8|||
23808035|NCT04355663|66676369|FG002|Overall Study|Withdrawal by Subject|3|||
23808036|NCT02581163|66676371|FG000|Overall Study|Failure to return|15|||
23808037|NCT02581163|66676371|FG000|Overall Study|Insufficient virological response|3|||
23808038|NCT02581163|66676371|FG000|Overall Study|Withdrew consent|1|||
23808039|NCT02581163|66676371|FG000|Overall Study|Death|1|||
23808040|NCT02581163|66676371|FG000|Overall Study|Other, not specified|9|||
23808041|NCT01744093|66676373|FG000|Overall Study|Withdrawal by Subject|6|||
23808042|NCT01744093|66676374|FG001|Overall Study|Withdrawal by Subject|1|||
23808043|NCT04465630|66676375|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
23808044|NCT04465630|66676375|FG000|Overall Study|Screen failure|8|||
23808045|NCT04465630|66676375|FG000|Overall Study|Baseline failure|16|||
23808046|NCT02639052|66676376|FG000|Overall Study|Lost to Follow-up|1|||
23808047|NCT01359644|66676377|FG000|Treatment Period|Lack of Efficacy|0|||
23808048|NCT01359644|66676378|FG001|Treatment Period|Lack of Efficacy|1|||
23808049|NCT01359644|66676379|FG002|Treatment Period|Lack of Efficacy|0|||
23808050|NCT01359644|66676380|FG003|Treatment Period|Lack of Efficacy|0|||
23808051|NCT01359644|66676381|FG004|Treatment Period|Lack of Efficacy|0|||
23808052|NCT01359644|66676382|FG005|Treatment Period|Lack of Efficacy|0|||
23808053|NCT01359644|66676383|FG006|Treatment Period|Lack of Efficacy|0|||
23808054|NCT01359644|66676384|FG007|Treatment Period|Lack of Efficacy|0|||
23808055|NCT01359644|66676385|FG008|Treatment Period|Lack of Efficacy|0|||
23808056|NCT01359644|66676386|FG009|Treatment Period|Lack of Efficacy|0|||
23808057|NCT01359644|66676377|FG000|Treatment Period|Adverse Event|0|||
23808058|NCT01359644|66676378|FG001|Treatment Period|Adverse Event|0|||
23808059|NCT01359644|66676379|FG002|Treatment Period|Adverse Event|1|||
23808060|NCT01359644|66676380|FG003|Treatment Period|Adverse Event|0|||
23808061|NCT01359644|66676381|FG004|Treatment Period|Adverse Event|0|||
23808062|NCT01359644|66676382|FG005|Treatment Period|Adverse Event|1|||
23808063|NCT01359644|66676383|FG006|Treatment Period|Adverse Event|0|||
23808064|NCT01359644|66676384|FG007|Treatment Period|Adverse Event|0|||
23808065|NCT01359644|66676385|FG008|Treatment Period|Adverse Event|0|||
23808066|NCT01359644|66676386|FG009|Treatment Period|Adverse Event|0|||
23808067|NCT01359644|66676377|FG000|Treatment Period|Lost to Follow-up|0|||
23808068|NCT01359644|66676378|FG001|Treatment Period|Lost to Follow-up|0|||
23808069|NCT01359644|66676379|FG002|Treatment Period|Lost to Follow-up|0|||
23808070|NCT01359644|66676380|FG003|Treatment Period|Lost to Follow-up|0|||
23808071|NCT01359644|66676381|FG004|Treatment Period|Lost to Follow-up|0|||
23808072|NCT01359644|66676382|FG005|Treatment Period|Lost to Follow-up|1|||
23808073|NCT01359644|66676383|FG006|Treatment Period|Lost to Follow-up|0|||
23808074|NCT01359644|66676384|FG007|Treatment Period|Lost to Follow-up|0|||
23808075|NCT01359644|66676385|FG008|Treatment Period|Lost to Follow-up|0|||
23808076|NCT01359644|66676386|FG009|Treatment Period|Lost to Follow-up|0|||
23808077|NCT01359644|66676377|FG000|Follow-up Period|Withdrawal by Subject|0|||
23808078|NCT01359644|66676378|FG001|Follow-up Period|Withdrawal by Subject|0|||
23808079|NCT01359644|66676379|FG002|Follow-up Period|Withdrawal by Subject|0|||
23808080|NCT01359644|66676380|FG003|Follow-up Period|Withdrawal by Subject|0|||
23808081|NCT01359644|66676381|FG004|Follow-up Period|Withdrawal by Subject|0|||
23808082|NCT01359644|66676382|FG005|Follow-up Period|Withdrawal by Subject|1|||
23808083|NCT01359644|66676383|FG006|Follow-up Period|Withdrawal by Subject|0|||
23808084|NCT01359644|66676384|FG007|Follow-up Period|Withdrawal by Subject|0|||
23808085|NCT01359644|66676385|FG008|Follow-up Period|Withdrawal by Subject|0|||
23808086|NCT01359644|66676386|FG009|Follow-up Period|Withdrawal by Subject|0|||
23808087|NCT01359644|66676377|FG000|Follow-up Period|Lost to Follow-up|0|||
23808088|NCT01359644|66676378|FG001|Follow-up Period|Lost to Follow-up|0|||
23808089|NCT01359644|66676379|FG002|Follow-up Period|Lost to Follow-up|0|||
23808090|NCT01359644|66676380|FG003|Follow-up Period|Lost to Follow-up|0|||
23808091|NCT01359644|66676381|FG004|Follow-up Period|Lost to Follow-up|0|||
23808092|NCT01359644|66676382|FG005|Follow-up Period|Lost to Follow-up|0|||
23808093|NCT01359644|66676383|FG006|Follow-up Period|Lost to Follow-up|1|||
23808094|NCT01359644|66676384|FG007|Follow-up Period|Lost to Follow-up|2|||
23808095|NCT01359644|66676385|FG008|Follow-up Period|Lost to Follow-up|0|||
23808096|NCT01359644|66676386|FG009|Follow-up Period|Lost to Follow-up|0|||
23808097|NCT00311311|66676387|FG000|Overall Study|Adverse Event|3|||
23808098|NCT00311311|66676388|FG001|Overall Study|Adverse Event|2|||
23808099|NCT00311311|66676387|FG000|Overall Study|Withdrawal by Subject|1|||
23808100|NCT00311311|66676388|FG001|Overall Study|Withdrawal by Subject|1|||
23808101|NCT00311311|66676387|FG000|Overall Study|Noncompliance|0|||
23808102|NCT00311311|66676388|FG001|Overall Study|Noncompliance|1|||
23808103|NCT00311311|66676387|FG000|Overall Study|Study Termination by Sponsor|3|||
23808104|NCT00311311|66676388|FG001|Overall Study|Study Termination by Sponsor|4|||
23808105|NCT00311311|66676387|FG000|Overall Study|Death|1|||
23808106|NCT00311311|66676388|FG001|Overall Study|Death|0|||
23808107|NCT00311311|66676387|FG000|Overall Study|Lack of ancillary assistance|0|||
23808108|NCT00311311|66676388|FG001|Overall Study|Lack of ancillary assistance|1|||
23808109|NCT01117337|66676389|FG000|Overall Study|Lost to Follow-up|4|||
23808110|NCT01117337|66676390|FG001|Overall Study|Lost to Follow-up|0|||
23808111|NCT01970865|66676391|FG000|Overall Study|Death|3|||
23808112|NCT01970865|66676392|FG001|Overall Study|Death|2|||
23808113|NCT01970865|66676393|FG002|Overall Study|Death|3|||
23808114|NCT01970865|66676394|FG003|Overall Study|Death|6|||
23808115|NCT01970865|66676395|FG004|Overall Study|Death|9|||
23808116|NCT01970865|66676396|FG005|Overall Study|Death|3|||
23808117|NCT01970865|66676397|FG006|Overall Study|Death|2|||
23808118|NCT01970865|66676398|FG007|Overall Study|Death|3|||
23808119|NCT01970865|66676399|FG008|Overall Study|Death|2|||
23808120|NCT01970865|66676400|FG009|Overall Study|Death|2|||
23808121|NCT01970865|66676401|FG010|Overall Study|Death|8|||
23808122|NCT01970865|66676402|FG011|Overall Study|Death|13|||
23808123|NCT01970865|66676403|FG012|Overall Study|Death|25|||
23808124|NCT01970865|66676404|FG013|Overall Study|Death|46|||
23808125|NCT01970865|66676405|FG014|Overall Study|Death|37|||
23808126|NCT01970865|66676406|FG015|Overall Study|Death|22|||
23808127|NCT01970865|66676407|FG016|Overall Study|Death|1|||
23808128|NCT01970865|66676408|FG017|Overall Study|Death|17|||
23808129|NCT01970865|66676391|FG000|Overall Study|Lost to Follow-up|0|||
23808130|NCT01970865|66676392|FG001|Overall Study|Lost to Follow-up|0|||
23808131|NCT01970865|66676393|FG002|Overall Study|Lost to Follow-up|0|||
23808132|NCT01970865|66676394|FG003|Overall Study|Lost to Follow-up|1|||
23808133|NCT01970865|66676395|FG004|Overall Study|Lost to Follow-up|1|||
23808134|NCT01970865|66676396|FG005|Overall Study|Lost to Follow-up|0|||
23808135|NCT01970865|66676397|FG006|Overall Study|Lost to Follow-up|0|||
23808136|NCT01970865|66676398|FG007|Overall Study|Lost to Follow-up|0|||
23808137|NCT01970865|66676399|FG008|Overall Study|Lost to Follow-up|0|||
23808138|NCT01970865|66676400|FG009|Overall Study|Lost to Follow-up|0|||
23808139|NCT01970865|66676401|FG010|Overall Study|Lost to Follow-up|1|||
23808140|NCT01970865|66676402|FG011|Overall Study|Lost to Follow-up|0|||
23808141|NCT01970865|66676403|FG012|Overall Study|Lost to Follow-up|2|||
23808142|NCT01970865|66676404|FG013|Overall Study|Lost to Follow-up|0|||
23808143|NCT01970865|66676405|FG014|Overall Study|Lost to Follow-up|1|||
23808144|NCT01970865|66676406|FG015|Overall Study|Lost to Follow-up|4|||
23808145|NCT01970865|66676407|FG016|Overall Study|Lost to Follow-up|0|||
23808146|NCT01970865|66676408|FG017|Overall Study|Lost to Follow-up|1|||
23808147|NCT01970865|66676391|FG000|Overall Study|Other|0|||
23808148|NCT01970865|66676392|FG001|Overall Study|Other|1|||
23808149|NCT01970865|66676393|FG002|Overall Study|Other|0|||
23808150|NCT01970865|66676394|FG003|Overall Study|Other|1|||
23808151|NCT01970865|66676395|FG004|Overall Study|Other|1|||
23808152|NCT01970865|66676396|FG005|Overall Study|Other|0|||
23808153|NCT01970865|66676397|FG006|Overall Study|Other|1|||
23808154|NCT01970865|66676398|FG007|Overall Study|Other|0|||
23708437|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708438|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23708439|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23808155|NCT01970865|66676399|FG008|Overall Study|Other|0|||
23808156|NCT01970865|66676400|FG009|Overall Study|Other|0|||
23808157|NCT01970865|66676401|FG010|Overall Study|Other|2|||
23808158|NCT01970865|66676402|FG011|Overall Study|Other|3|||
23808159|NCT01970865|66676403|FG012|Overall Study|Other|8|||
23808160|NCT01970865|66676404|FG013|Overall Study|Other|3|||
23808161|NCT01970865|66676405|FG014|Overall Study|Other|2|||
23808162|NCT01970865|66676406|FG015|Overall Study|Other|3|||
23808163|NCT01970865|66676407|FG016|Overall Study|Other|0|||
23808164|NCT01970865|66676408|FG017|Overall Study|Other|2|||
23808165|NCT01970865|66676391|FG000|Overall Study|Participant refused further follow-up|0|||
23808166|NCT01970865|66676392|FG001|Overall Study|Participant refused further follow-up|0|||
23808167|NCT01970865|66676393|FG002|Overall Study|Participant refused further follow-up|0|||
23808168|NCT01970865|66676394|FG003|Overall Study|Participant refused further follow-up|2|||
23808169|NCT01970865|66676395|FG004|Overall Study|Participant refused further follow-up|3|||
23808170|NCT01970865|66676396|FG005|Overall Study|Participant refused further follow-up|0|||
23808171|NCT01970865|66676397|FG006|Overall Study|Participant refused further follow-up|0|||
23808172|NCT01970865|66676398|FG007|Overall Study|Participant refused further follow-up|0|||
23808173|NCT01970865|66676399|FG008|Overall Study|Participant refused further follow-up|0|||
23808174|NCT01970865|66676400|FG009|Overall Study|Participant refused further follow-up|0|||
23808175|NCT01970865|66676401|FG010|Overall Study|Participant refused further follow-up|1|||
23808176|NCT01970865|66676402|FG011|Overall Study|Participant refused further follow-up|4|||
23808177|NCT01970865|66676403|FG012|Overall Study|Participant refused further follow-up|7|||
23808178|NCT01970865|66676404|FG013|Overall Study|Participant refused further follow-up|8|||
23808179|NCT01970865|66676405|FG014|Overall Study|Participant refused further follow-up|3|||
23808180|NCT01970865|66676406|FG015|Overall Study|Participant refused further follow-up|11|||
23808181|NCT01970865|66676407|FG016|Overall Study|Participant refused further follow-up|0|||
23808182|NCT01970865|66676408|FG017|Overall Study|Participant refused further follow-up|6|||
23808183|NCT02939950|66676409|FG000|Overall Study|Lost to Follow-up|13|||
23808184|NCT02939950|66676410|FG001|Overall Study|Lost to Follow-up|16|||
23808185|NCT02939950|66676409|FG000|Overall Study|Positive slit lamp findings|0|||
23808186|NCT02939950|66676410|FG001|Overall Study|Positive slit lamp findings|1|||
23808187|NCT02939950|66676409|FG000|Overall Study|Chalazion upper lid|0|||
23808188|NCT02939950|66676410|FG001|Overall Study|Chalazion upper lid|1|||
23808189|NCT02939950|66676409|FG000|Overall Study|Lack of motivation|0|||
23808190|NCT02939950|66676410|FG001|Overall Study|Lack of motivation|2|||
23808191|NCT02939950|66676409|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
23808192|NCT02939950|66676410|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
23808193|NCT02939950|66676409|FG000|Overall Study|Military orders|1|||
23808194|NCT02939950|66676410|FG001|Overall Study|Military orders|0|||
23808195|NCT02939950|66676409|FG000|Overall Study|Participant Relocated|5|||
23808196|NCT02939950|66676410|FG001|Overall Study|Participant Relocated|3|||
23808197|NCT02939950|66676409|FG000|Overall Study|Study related symptoms|8|||
23808198|NCT02939950|66676410|FG001|Overall Study|Study related symptoms|8|||
23808199|NCT02939950|66676409|FG000|Overall Study|Unacceptable lens movement|2|||
23808200|NCT02939950|66676410|FG001|Overall Study|Unacceptable lens movement|0|||
23808201|NCT02939950|66676409|FG000|Overall Study|Protocol Violation|6|||
23808202|NCT02939950|66676410|FG001|Overall Study|Protocol Violation|3|||
23808203|NCT02939950|66676409|FG000|Overall Study|Physician Decision|2|||
23808204|NCT02939950|66676410|FG001|Overall Study|Physician Decision|0|||
23808205|NCT02939950|66676409|FG000|Overall Study|Pregnancy|6|||
23808206|NCT02939950|66676410|FG001|Overall Study|Pregnancy|7|||
23808207|NCT02939950|66676409|FG000|Overall Study|Withdrawal by Subject|12|||
23808208|NCT02939950|66676410|FG001|Overall Study|Withdrawal by Subject|28|||
23708440|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
23708441|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23708442|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23808209|NCT02939950|66676409|FG000|Overall Study|Adverse Event|7|||
23808210|NCT02939950|66676410|FG001|Overall Study|Adverse Event|3|||
23808211|NCT02939950|66676409|FG000|Overall Study|Randomized, not dispensed|1|||
23808212|NCT02939950|66676410|FG001|Overall Study|Randomized, not dispensed|0|||
23808213|NCT02939950|66676409|FG000|Overall Study|Ineligible at Baseline|2|||
23808214|NCT02939950|66676410|FG001|Overall Study|Ineligible at Baseline|8|||
23808215|NCT01429051|66676413|FG000|Titration Phase|Death|1|||
23808216|NCT01429051|66676413|FG000|Titration Phase|Withdrawal by Subject|7|||
23808217|NCT01429051|66676413|FG000|Titration Phase|Physician Decision|1|||
23808218|NCT01429051|66676413|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
23808219|NCT01429051|66676413|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
23808220|NCT01429051|66676413|FG000|Efficacy Phase|Adverse Event|1|||
23808221|NCT01429051|66676413|FG000|Efficacy Phase|Death|1|||
23808222|NCT01429051|66676413|FG000|Tolerability Phase|Death|5|||
23808223|NCT01429051|66676413|FG000|Tolerability Phase|Adverse Event|2|||
23504721|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Death|0|||
23504722|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Death|0|||
23808224|NCT01429051|66676413|FG000|Tolerability Phase|Withdrawal by Subject|5|||
23808225|NCT01429051|66676413|FG000|Tolerability Phase|Physician Decision|1|||
23808226|NCT01429051|66676413|FG000|Tolerability Phase|Other|2|||
23708443|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23708444|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23504723|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Death|0|||
23504724|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Death|0|||
23708445|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23708446|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23708447|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23708448|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23808227|NCT01597479|66676414|FG000|Overall Study|Protocol Violation|1|||
23808228|NCT01597479|66676415|FG001|Overall Study|Protocol Violation|0|||
23808229|NCT01597479|66676414|FG000|Overall Study|Lost to Follow-up|1|||
23808230|NCT01597479|66676415|FG001|Overall Study|Lost to Follow-up|0|||
23808231|NCT02149121|66676416|FG000|Main Study Period|Lack of Efficacy|2|||
23808232|NCT02149121|66676417|FG001|Main Study Period|Lack of Efficacy|2|||
23808233|NCT02149121|66676418|FG002|Main Study Period|Lack of Efficacy|1|||
23808234|NCT02149121|66676419|FG003|Main Study Period|Lack of Efficacy|0|||
23808235|NCT02149121|66676420|FG004|Main Study Period|Lack of Efficacy|0|||
23808236|NCT02149121|66676421|FG005|Main Study Period|Lack of Efficacy|0|||
23808237|NCT02149121|66676422|FG006|Main Study Period|Lack of Efficacy|0|||
23808238|NCT02149121|66676416|FG000|Main Study Period|Withdrawal by Subject|9|||
23808239|NCT02149121|66676417|FG001|Main Study Period|Withdrawal by Subject|5|||
23808240|NCT02149121|66676418|FG002|Main Study Period|Withdrawal by Subject|1|||
23808241|NCT02149121|66676419|FG003|Main Study Period|Withdrawal by Subject|0|||
23808242|NCT02149121|66676420|FG004|Main Study Period|Withdrawal by Subject|0|||
23808243|NCT02149121|66676421|FG005|Main Study Period|Withdrawal by Subject|0|||
23808244|NCT02149121|66676422|FG006|Main Study Period|Withdrawal by Subject|0|||
23808245|NCT02149121|66676416|FG000|Main Study Period|Adverse Event|2|||
23808246|NCT02149121|66676417|FG001|Main Study Period|Adverse Event|5|||
23808247|NCT02149121|66676418|FG002|Main Study Period|Adverse Event|1|||
23808248|NCT02149121|66676419|FG003|Main Study Period|Adverse Event|0|||
23808249|NCT02149121|66676420|FG004|Main Study Period|Adverse Event|0|||
23808250|NCT02149121|66676421|FG005|Main Study Period|Adverse Event|0|||
23808251|NCT02149121|66676422|FG006|Main Study Period|Adverse Event|0|||
23808252|NCT02149121|66676416|FG000|Main Study Period|Protocol Violation|2|||
23808253|NCT02149121|66676417|FG001|Main Study Period|Protocol Violation|0|||
23808254|NCT02149121|66676418|FG002|Main Study Period|Protocol Violation|0|||
23808255|NCT02149121|66676419|FG003|Main Study Period|Protocol Violation|0|||
23708449|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
23708450|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708451|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708452|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708453|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708454|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708455|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708456|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708457|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
23708458|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
23708459|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708460|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708461|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708462|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708463|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708464|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708465|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708466|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23708467|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
23708468|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708469|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708470|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23808256|NCT02149121|66676420|FG004|Main Study Period|Protocol Violation|0|||
23708471|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708472|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708473|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708474|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708475|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23708476|NCT02175771|66308861|FG000|Run-In Period (Pre-assignment)|Other|8|||
23708477|NCT02175771|66308862|FG001|Run-In Period (Pre-assignment)|Other|0|||
23708478|NCT02175771|66308863|FG002|Run-In Period (Pre-assignment)|Other|0|||
23708479|NCT02175771|66308864|FG003|Run-In Period (Pre-assignment)|Other|0|||
23708480|NCT02175771|66308865|FG004|Run-In Period (Pre-assignment)|Other|0|||
23808257|NCT02149121|66676421|FG005|Main Study Period|Protocol Violation|0|||
23808258|NCT02149121|66676422|FG006|Main Study Period|Protocol Violation|0|||
23808259|NCT02149121|66676416|FG000|Main Study Period|Lost to Follow-up|2|||
23808260|NCT02149121|66676417|FG001|Main Study Period|Lost to Follow-up|1|||
23808261|NCT02149121|66676418|FG002|Main Study Period|Lost to Follow-up|0|||
23504725|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Death|0|||
23504726|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Death|0|||
23808262|NCT02149121|66676419|FG003|Main Study Period|Lost to Follow-up|0|||
23808263|NCT02149121|66676420|FG004|Main Study Period|Lost to Follow-up|0|||
23808264|NCT02149121|66676421|FG005|Main Study Period|Lost to Follow-up|0|||
23808265|NCT02149121|66676422|FG006|Main Study Period|Lost to Follow-up|0|||
23808266|NCT02149121|66676416|FG000|Main Study Period|Death|1|||
23808267|NCT02149121|66676417|FG001|Main Study Period|Death|0|||
23808268|NCT02149121|66676418|FG002|Main Study Period|Death|0|||
23808269|NCT02149121|66676419|FG003|Main Study Period|Death|0|||
23808270|NCT02149121|66676420|FG004|Main Study Period|Death|0|||
23808271|NCT02149121|66676421|FG005|Main Study Period|Death|0|||
23808272|NCT02149121|66676422|FG006|Main Study Period|Death|0|||
23808273|NCT02149121|66676416|FG000|Main Study Period|Physician Decision|1|||
23808274|NCT02149121|66676417|FG001|Main Study Period|Physician Decision|0|||
23808275|NCT02149121|66676418|FG002|Main Study Period|Physician Decision|0|||
23808276|NCT02149121|66676419|FG003|Main Study Period|Physician Decision|0|||
23808277|NCT02149121|66676420|FG004|Main Study Period|Physician Decision|0|||
23808278|NCT02149121|66676421|FG005|Main Study Period|Physician Decision|0|||
23808279|NCT02149121|66676422|FG006|Main Study Period|Physician Decision|0|||
23808280|NCT02149121|66676416|FG000|Main Study Period|Developed any malignancy|0|||
23808281|NCT02149121|66676417|FG001|Main Study Period|Developed any malignancy|1|||
23808282|NCT02149121|66676418|FG002|Main Study Period|Developed any malignancy|1|||
23808283|NCT02149121|66676419|FG003|Main Study Period|Developed any malignancy|0|||
23808284|NCT02149121|66676420|FG004|Main Study Period|Developed any malignancy|0|||
23808285|NCT02149121|66676421|FG005|Main Study Period|Developed any malignancy|0|||
23808286|NCT02149121|66676422|FG006|Main Study Period|Developed any malignancy|0|||
23808287|NCT02149121|66676416|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
23808288|NCT02149121|66676417|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
23808289|NCT02149121|66676418|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
23808290|NCT02149121|66676419|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
23808291|NCT02149121|66676420|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
23808292|NCT02149121|66676421|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
23808293|NCT02149121|66676422|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
23808294|NCT02149121|66676416|FG000|Main Study Period|Disease progression|0|||
23808295|NCT02149121|66676417|FG001|Main Study Period|Disease progression|1|||
23808296|NCT02149121|66676418|FG002|Main Study Period|Disease progression|0|||
23808297|NCT02149121|66676419|FG003|Main Study Period|Disease progression|0|||
23808298|NCT02149121|66676420|FG004|Main Study Period|Disease progression|0|||
23808299|NCT02149121|66676421|FG005|Main Study Period|Disease progression|0|||
23808300|NCT02149121|66676422|FG006|Main Study Period|Disease progression|0|||
23808301|NCT02149121|66676416|FG000|Extension Study Period|Withdrawal by Subject|0|||
23808302|NCT02149121|66676417|FG001|Extension Study Period|Withdrawal by Subject|0|||
23808303|NCT02149121|66676418|FG002|Extension Study Period|Withdrawal by Subject|0|||
23808304|NCT02149121|66676419|FG003|Extension Study Period|Withdrawal by Subject|1|||
23808305|NCT02149121|66676420|FG004|Extension Study Period|Withdrawal by Subject|0|||
23808306|NCT02149121|66676421|FG005|Extension Study Period|Withdrawal by Subject|2|||
23808307|NCT02149121|66676422|FG006|Extension Study Period|Withdrawal by Subject|0|||
23808308|NCT00080938|66676423|FG000|Overall Study|Adverse Event|3|||
23808309|NCT00080938|66676423|FG000|Overall Study|Withdrawal by Subject|6|||
23808310|NCT00080938|66676423|FG000|Overall Study|Death|2|||
23808311|NCT00080938|66676423|FG000|Overall Study|Lack of Efficacy|7|||
23808312|NCT00080938|66676423|FG000|Overall Study|other disease|1|||
23808313|NCT00080938|66676423|FG000|Overall Study|Not started protocol therapy|1|||
23808314|NCT00080938|66676423|FG000|Overall Study|Ineligible|4|||
23808315|NCT00669071|66676424|FG000|Overall Study|Lost to Follow-up|3|||
23808316|NCT00669071|66676424|FG000|Overall Study|Final visit 40 days out of window|1|||
23808317|NCT02989168|66676425|FG000|Overall Study|Withdrawal by Subject|2|||
23808318|NCT02989168|66676426|FG001|Overall Study|Withdrawal by Subject|0|||
23808319|NCT02989168|66676425|FG000|Overall Study|Physician Decision|0|||
23808320|NCT02989168|66676426|FG001|Overall Study|Physician Decision|1|||
23808321|NCT02989168|66676425|FG000|Overall Study|Adverse Event|1|||
23808322|NCT02989168|66676426|FG001|Overall Study|Adverse Event|2|||
23808323|NCT02989168|66676425|FG000|Overall Study|Sponsor stopped study.|1|||
23808324|NCT02989168|66676426|FG001|Overall Study|Sponsor stopped study.|0|||
23808325|NCT00857584|66676434|FG000|Overall Study|Lack of Efficacy|1|||
23808326|NCT00857584|66676435|FG001|Overall Study|Lack of Efficacy|2|||
23808327|NCT00857584|66676434|FG000|Overall Study|Adverse Event|2|||
23808328|NCT00857584|66676435|FG001|Overall Study|Adverse Event|2|||
23808329|NCT00857584|66676434|FG000|Overall Study|Physician Decision|1|||
23808330|NCT00857584|66676435|FG001|Overall Study|Physician Decision|1|||
23808331|NCT03734666|66676436|FG000|Overall Study|Other|7|||
23808332|NCT03734666|66676437|FG001|Overall Study|Other|4|||
23808333|NCT03734666|66676436|FG000|Overall Study|Lost to Follow-up|12|||
23808334|NCT03734666|66676437|FG001|Overall Study|Lost to Follow-up|12|||
23808335|NCT01249365|66676438|FG000|Overall Study|Lost to Follow-up|1|||
23808336|NCT01458106|66676439|FG000|Overall Study|Withdrawal by Subject|2|||
23808337|NCT01458106|66676440|FG001|Overall Study|Withdrawal by Subject|0|||
23808338|NCT01458106|66676439|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
23808339|NCT01458106|66676440|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
23808340|NCT01458106|66676439|FG000|Overall Study|Withdrawn Per Protocol|0|||
23808341|NCT01458106|66676440|FG001|Overall Study|Withdrawn Per Protocol|1|||
23808342|NCT01150890|66676443|FG000|Overall Study|Other|0|||
23808343|NCT01150890|66676444|FG001|Overall Study|Other|1|||
23808344|NCT01150890|66676445|FG002|Overall Study|Other|0|||
23808345|NCT01150890|66676446|FG003|Overall Study|Other|2|||
23808346|NCT01150890|66676443|FG000|Overall Study|Pregnancy|0|||
23808347|NCT01150890|66676444|FG001|Overall Study|Pregnancy|0|||
23808348|NCT01150890|66676445|FG002|Overall Study|Pregnancy|0|||
23808349|NCT01150890|66676446|FG003|Overall Study|Pregnancy|1|||
23808350|NCT01150890|66676443|FG000|Overall Study|Administrative Decision|4|||
23808351|NCT01150890|66676444|FG001|Overall Study|Administrative Decision|4|||
23808352|NCT01150890|66676445|FG002|Overall Study|Administrative Decision|5|||
23808353|NCT01150890|66676446|FG003|Overall Study|Administrative Decision|6|||
23808354|NCT01150890|66676443|FG000|Overall Study|Ineligibility determined|0|||
23808355|NCT01150890|66676444|FG001|Overall Study|Ineligibility determined|1|||
23808356|NCT01150890|66676445|FG002|Overall Study|Ineligibility determined|0|||
23808357|NCT01150890|66676446|FG003|Overall Study|Ineligibility determined|0|||
23808358|NCT01150890|66676443|FG000|Overall Study|Adverse Event|0|||
23808359|NCT01150890|66676444|FG001|Overall Study|Adverse Event|0|||
23808360|NCT01150890|66676445|FG002|Overall Study|Adverse Event|2|||
23808361|NCT01150890|66676446|FG003|Overall Study|Adverse Event|0|||
23808362|NCT01150890|66676443|FG000|Overall Study|Withdrawal by Subject|0|||
23808363|NCT01150890|66676444|FG001|Overall Study|Withdrawal by Subject|0|||
23808364|NCT01150890|66676445|FG002|Overall Study|Withdrawal by Subject|2|||
23808365|NCT01150890|66676446|FG003|Overall Study|Withdrawal by Subject|1|||
23808366|NCT01150890|66676443|FG000|Overall Study|Disease progression|0|||
23808367|NCT01150890|66676444|FG001|Overall Study|Disease progression|7|||
23808368|NCT01150890|66676445|FG002|Overall Study|Disease progression|3|||
23808369|NCT01150890|66676446|FG003|Overall Study|Disease progression|7|||
23808370|NCT00605865|66676447|FG000|Overall Study|Protocol Violation|115|||
23808371|NCT00038649|66676448|FG000|Overall Study|Adverse Event|9|||
23808372|NCT03334721|66676449|FG000|Overall Study|Withdrawal by Subject|1|||
23808373|NCT03334721|66676450|FG001|Overall Study|Withdrawal by Subject|0|||
23808374|NCT03334721|66676449|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
23808375|NCT03334721|66676450|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
23808376|NCT02546362|66676458|FG000|4-week Treatment Period|Lost to Follow-up|1|||
23808377|NCT02546362|66676458|FG000|4-week Treatment Period|Change in medication|2|||
23808378|NCT02546362|66676458|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
23808379|NCT02546362|66676458|FG000|12-week Treatment Period|Lost to Follow-up|2|||
23808380|NCT02546362|66676458|FG000|12-week Treatment Period|Change in medication|1|||
23808381|NCT02667288|66676459|FG000|Overall Study|Protocol Violation|5|||
23808382|NCT02667288|66676459|FG000|Overall Study|Lost to Follow-up|3|||
23808383|NCT02667288|66676459|FG000|Overall Study|Withdrawal by Subject|5|||
23808384|NCT01940497|66676460|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
23808385|NCT01940497|66676461|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
23808386|NCT01940497|66676460|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
23808387|NCT01940497|66676461|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
23808388|NCT01940497|66676460|FG000|Overall Study|Violation of Entry Criteria|1|||
23808389|NCT01940497|66676461|FG001|Overall Study|Violation of Entry Criteria|1|||
23808390|NCT01940497|66676460|FG000|Overall Study|Refused Treatment|1|||
23808391|NCT01940497|66676461|FG001|Overall Study|Refused Treatment|3|||
23808392|NCT01940497|66676460|FG000|Overall Study|Withdrew Consent|6|||
23808393|NCT01940497|66676461|FG001|Overall Study|Withdrew Consent|2|||
23808394|NCT01940497|66676460|FG000|Overall Study|Administrative/Other|1|||
23808395|NCT01940497|66676461|FG001|Overall Study|Administrative/Other|1|||
23808396|NCT00321737|66676462|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
23808397|NCT00321737|66676463|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
23808398|NCT00321737|66676464|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
23808399|NCT00321737|66676462|FG000|Overall Study|Adverse Event|11|||
23808400|NCT00321737|66676463|FG001|Overall Study|Adverse Event|3|||
23808401|NCT00321737|66676464|FG002|Overall Study|Adverse Event|6|||
23808402|NCT00321737|66676462|FG000|Overall Study|Lost to Follow-up|5|||
23808403|NCT00321737|66676463|FG001|Overall Study|Lost to Follow-up|5|||
23808404|NCT00321737|66676464|FG002|Overall Study|Lost to Follow-up|6|||
23808405|NCT00321737|66676462|FG000|Overall Study|Withdrawal by Subject|19|||
23808406|NCT00321737|66676463|FG001|Overall Study|Withdrawal by Subject|12|||
23808407|NCT00321737|66676464|FG002|Overall Study|Withdrawal by Subject|17|||
23808408|NCT00321737|66676462|FG000|Overall Study|Protocol Violation|0|||
23808409|NCT00321737|66676463|FG001|Overall Study|Protocol Violation|0|||
23808410|NCT00321737|66676464|FG002|Overall Study|Protocol Violation|1|||
23808411|NCT00321737|66676462|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
23808412|NCT00321737|66676463|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23808413|NCT00321737|66676464|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23808414|NCT00321737|66676462|FG000|Overall Study|Possible Barrett's Esophagus|2|||
23808415|NCT00321737|66676463|FG001|Overall Study|Possible Barrett's Esophagus|1|||
23808416|NCT00321737|66676464|FG002|Overall Study|Possible Barrett's Esophagus|1|||
23808417|NCT00321737|66676462|FG000|Overall Study|Therapeutic Failure|6|||
23808418|NCT00321737|66676463|FG001|Overall Study|Therapeutic Failure|0|||
23808419|NCT00321737|66676464|FG002|Overall Study|Therapeutic Failure|2|||
23606542|NCT00498797|65950440|FG000|Overall Study|Withdrawal by Subject|4|||
23606543|NCT00498797|65950441|FG001|Overall Study|Withdrawal by Subject|2|||
23606544|NCT00498797|65950440|FG000|Overall Study|Adverse Event|12|||
23606545|NCT00498797|65950441|FG001|Overall Study|Adverse Event|5|||
23606546|NCT00498797|65950440|FG000|Overall Study|Condition under investigation worsened|19|||
23808420|NCT00321737|66676462|FG000|Overall Study|Pregnancy|0|||
23808421|NCT00321737|66676463|FG001|Overall Study|Pregnancy|2|||
23808422|NCT00321737|66676464|FG002|Overall Study|Pregnancy|0|||
23808423|NCT00321737|66676462|FG000|Overall Study|Noncompliance|2|||
23808424|NCT00321737|66676463|FG001|Overall Study|Noncompliance|0|||
23808425|NCT00321737|66676464|FG002|Overall Study|Noncompliance|0|||
23808426|NCT00321737|66676462|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
23808427|NCT00321737|66676463|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
23808428|NCT00321737|66676464|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
23808429|NCT01111019|66676466|FG000|Overall Study|Withdrew Prematurely|2|||
23808430|NCT01111019|66676466|FG000|Overall Study|Other|1|||
23808431|NCT00384176|66676468|FG000|Overall Study|Death|239|||
23808432|NCT00384176|66676469|FG001|Overall Study|Death|247|||
23808433|NCT00384176|66676470|FG002|Overall Study|Death|105|||
23808434|NCT00384176|66676468|FG000|Overall Study|Withdrawal by Subject|52|||
23808435|NCT00384176|66676469|FG001|Overall Study|Withdrawal by Subject|48|||
23808436|NCT00384176|66676470|FG002|Overall Study|Withdrawal by Subject|22|||
23808437|NCT00384176|66676468|FG000|Overall Study|Lost to Follow-up|16|||
23808438|NCT00384176|66676469|FG001|Overall Study|Lost to Follow-up|18|||
23808439|NCT00384176|66676470|FG002|Overall Study|Lost to Follow-up|4|||
23808440|NCT00384176|66676468|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
23808441|NCT00384176|66676469|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
23808442|NCT00384176|66676470|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
23808443|NCT00384176|66676468|FG000|Overall Study|Longer QTC as Visit 1|1|||
23808444|NCT00384176|66676469|FG001|Overall Study|Longer QTC as Visit 1|0|||
23808445|NCT00384176|66676470|FG002|Overall Study|Longer QTC as Visit 1|0|||
23808446|NCT00384176|66676468|FG000|Overall Study|Toxicity of treatment|1|||
23808447|NCT00384176|66676469|FG001|Overall Study|Toxicity of treatment|0|||
23808448|NCT00384176|66676470|FG002|Overall Study|Toxicity of treatment|0|||
23808449|NCT00384176|66676468|FG000|Overall Study|Did not receive study treatment|0|||
23808450|NCT00384176|66676469|FG001|Overall Study|Did not receive study treatment|1|||
23808451|NCT00384176|66676470|FG002|Overall Study|Did not receive study treatment|1|||
23808452|NCT00384176|66676468|FG000|Overall Study|Physician Decision|0|||
23808453|NCT00384176|66676469|FG001|Overall Study|Physician Decision|2|||
23808454|NCT00384176|66676470|FG002|Overall Study|Physician Decision|0|||
23808455|NCT00384176|66676468|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
23808456|NCT00384176|66676469|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
23808457|NCT00384176|66676470|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
23808458|NCT02435836|66676471|FG000|Overall Study|Lost to Follow-up|21|||
23808459|NCT02435836|66676471|FG000|Overall Study|Lack of Efficacy|1|||
23808460|NCT02435836|66676471|FG000|Overall Study|Withdrawal by Subject|236|||
23808461|NCT02435836|66676471|FG000|Overall Study|Insufficient Clinical Response|26|||
23808462|NCT02435836|66676471|FG000|Overall Study|Adverse Event|44|||
23808463|NCT02435836|66676471|FG000|Overall Study|Sponsor discontinued trial|167|||
23808464|NCT02435836|66676471|FG000|Overall Study|Noncompliance|27|||
23808465|NCT02435836|66676471|FG000|Overall Study|Protocol Violation|6|||
23808466|NCT02435836|66676471|FG000|Overall Study|Met Withdrawal Criteria|7|||
23808467|NCT02435836|66676471|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
23808468|NCT01968694|66676472|FG000|Washout (1 Month)|Lost to Follow-up|0|||
23808469|NCT01968694|66676473|FG001|Washout (1 Month)|Lost to Follow-up|1|||
23808470|NCT03118570|66676474|FG000|Overall Study|Adverse Event|2|||
23808471|NCT03118570|66676475|FG001|Overall Study|Adverse Event|0|||
23808472|NCT03118570|66676476|FG002|Overall Study|Adverse Event|0|||
23808473|NCT03118570|66676477|FG003|Overall Study|Adverse Event|0|||
23808474|NCT03118570|66676478|FG004|Overall Study|Adverse Event|3|||
23808475|NCT03118570|66676474|FG000|Overall Study|Withdrawal by Subject|0|||
23808476|NCT03118570|66676475|FG001|Overall Study|Withdrawal by Subject|1|||
23808477|NCT03118570|66676476|FG002|Overall Study|Withdrawal by Subject|4|||
23808478|NCT03118570|66676477|FG003|Overall Study|Withdrawal by Subject|0|||
23808479|NCT03118570|66676478|FG004|Overall Study|Withdrawal by Subject|1|||
23808480|NCT03118570|66676474|FG000|Overall Study|Lost to Follow-up|2|||
23808481|NCT03118570|66676475|FG001|Overall Study|Lost to Follow-up|3|||
23808482|NCT03118570|66676476|FG002|Overall Study|Lost to Follow-up|1|||
23808483|NCT03118570|66676477|FG003|Overall Study|Lost to Follow-up|0|||
23808484|NCT03118570|66676478|FG004|Overall Study|Lost to Follow-up|1|||
23808485|NCT03118570|66676474|FG000|Overall Study|Other, Not Specified|1|||
23808486|NCT03118570|66676475|FG001|Overall Study|Other, Not Specified|3|||
23808487|NCT03118570|66676476|FG002|Overall Study|Other, Not Specified|0|||
23808488|NCT03118570|66676477|FG003|Overall Study|Other, Not Specified|0|||
23808489|NCT03118570|66676478|FG004|Overall Study|Other, Not Specified|0|||
23808490|NCT03096847|66676482|FG000|Overall Study|Other|2|||
23808491|NCT03096847|66676483|FG001|Overall Study|Other|1|||
23808492|NCT03096847|66676484|FG002|Overall Study|Other|2|||
23808493|NCT03096847|66676482|FG000|Overall Study|Lost to Follow-up|1|||
23808494|NCT03096847|66676483|FG001|Overall Study|Lost to Follow-up|0|||
23808495|NCT03096847|66676484|FG002|Overall Study|Lost to Follow-up|1|||
23808496|NCT03096847|66676482|FG000|Overall Study|Death|6|||
23808497|NCT03096847|66676483|FG001|Overall Study|Death|0|||
23808498|NCT03096847|66676484|FG002|Overall Study|Death|2|||
23808499|NCT03096847|66676482|FG000|Overall Study|Protocol Violation|3|||
23808500|NCT03096847|66676483|FG001|Overall Study|Protocol Violation|0|||
23808501|NCT03096847|66676484|FG002|Overall Study|Protocol Violation|6|||
23808502|NCT03096847|66676482|FG000|Overall Study|Physician Decision|12|||
23808503|NCT03096847|66676483|FG001|Overall Study|Physician Decision|2|||
23808504|NCT03096847|66676484|FG002|Overall Study|Physician Decision|8|||
23808505|NCT03096847|66676482|FG000|Overall Study|Withdrawal by Subject|24|||
23808506|NCT03096847|66676483|FG001|Overall Study|Withdrawal by Subject|1|||
23808507|NCT03096847|66676484|FG002|Overall Study|Withdrawal by Subject|12|||
23808508|NCT03096847|66676482|FG000|Overall Study|Adverse Event|72|||
23808509|NCT03096847|66676483|FG001|Overall Study|Adverse Event|6|||
23808510|NCT03096847|66676484|FG002|Overall Study|Adverse Event|28|||
23808511|NCT03096847|66676482|FG000|Overall Study|Progressive disease|97|||
23808512|NCT03096847|66676483|FG001|Overall Study|Progressive disease|10|||
23808513|NCT03096847|66676484|FG002|Overall Study|Progressive disease|78|||
23808514|NCT03096847|66676482|FG000|Overall Study|Non-compliance with study medication|1|||
23808515|NCT03096847|66676483|FG001|Overall Study|Non-compliance with study medication|0|||
23808516|NCT03096847|66676484|FG002|Overall Study|Non-compliance with study medication|0|||
23808517|NCT03096847|66676482|FG000|Overall Study|New therapy for study indication|1|||
23808518|NCT03096847|66676483|FG001|Overall Study|New therapy for study indication|0|||
23808519|NCT03096847|66676484|FG002|Overall Study|New therapy for study indication|1|||
23504727|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Death|0|||
23504728|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Death|0|||
23504729|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Death|0|||
23808520|NCT00468728|66676485|FG000|Treatment|criteria for mITT population|4|||
23808521|NCT00468728|66676486|FG001|Treatment|criteria for mITT population|11|||
23808522|NCT00468728|66676485|FG000|Follow-up|mITT failure|34|||
23808523|NCT00468728|66676486|FG001|Follow-up|mITT failure|31|||
23808524|NCT02823652|66676487|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
23808525|NCT02823652|66676488|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
23808526|NCT02823652|66676489|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
23808527|NCT02823652|66676487|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
23808528|NCT02823652|66676488|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
23808529|NCT02823652|66676489|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
23808530|NCT02823652|66676487|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
23808531|NCT02823652|66676488|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
23808532|NCT02823652|66676489|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
23808533|NCT02823652|66676487|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
23504730|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Death|0|||
23504731|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Death|0|||
23504732|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Death|0|||
23504733|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Death|0|||
23504734|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Death|0|||
23504735|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Death|0|||
23504736|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Death|0|||
23504737|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Death|0|||
23504738|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Death|0|||
23504739|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Death|0|||
23504740|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Death|0|||
23504741|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504742|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504743|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
23504744|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
23504745|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
23504746|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
23504747|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
23504748|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23808534|NCT02823652|66676488|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
23808535|NCT02823652|66676489|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
23808536|NCT00754013|66676490|FG000|Overall Study|Lost to Follow-up|1|||
23808537|NCT00754013|66676491|FG001|Overall Study|Lost to Follow-up|1|||
23808538|NCT00754013|66676490|FG000|Overall Study|didn't return after study termed|3|||
23504749|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23808539|NCT00754013|66676491|FG001|Overall Study|didn't return after study termed|4|||
23808540|NCT01181271|66676492|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
23808541|NCT01181271|66676492|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
23808542|NCT01181271|66676492|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
23808543|NCT01181271|66676492|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
23808544|NCT04032158|66676493|FG000|Overall Study|Study Termination|2|||
23808545|NCT04032158|66676494|FG001|Overall Study|Study Termination|1|||
23808546|NCT04049617|66676495|FG000|Overall Study|Adverse Event|0|||
23808547|NCT04049617|66676496|FG001|Overall Study|Adverse Event|0|||
23808548|NCT04049617|66676497|FG002|Overall Study|Adverse Event|0|||
23808549|NCT04049617|66676498|FG003|Overall Study|Adverse Event|1|||
23808550|NCT04049617|66676499|FG004|Overall Study|Adverse Event|0|||
23808551|NCT04049617|66676500|FG005|Overall Study|Adverse Event|0|||
23504750|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504751|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504752|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504753|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504754|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504755|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504756|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23403912|NCT00833027|65226438|FG000|Overall Study|Lost to Follow-up|24|||
23504757|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504758|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504759|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504760|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23808552|NCT04049617|66676495|FG000|Overall Study|Death|0|||
23808553|NCT04049617|66676496|FG001|Overall Study|Death|0|||
23808554|NCT04049617|66676497|FG002|Overall Study|Death|0|||
23808555|NCT04049617|66676498|FG003|Overall Study|Death|0|||
23808556|NCT04049617|66676499|FG004|Overall Study|Death|0|||
23808557|NCT04049617|66676500|FG005|Overall Study|Death|1|||
23808558|NCT04049617|66676495|FG000|Overall Study|Lost to Follow-up|0|||
23808559|NCT04049617|66676496|FG001|Overall Study|Lost to Follow-up|0|||
23808560|NCT04049617|66676497|FG002|Overall Study|Lost to Follow-up|0|||
23808561|NCT04049617|66676498|FG003|Overall Study|Lost to Follow-up|1|||
23808562|NCT04049617|66676499|FG004|Overall Study|Lost to Follow-up|0|||
23808563|NCT04049617|66676500|FG005|Overall Study|Lost to Follow-up|0|||
23808564|NCT04049617|66676495|FG000|Overall Study|Withdrew consent|0|||
23808565|NCT04049617|66676496|FG001|Overall Study|Withdrew consent|0|||
23808566|NCT04049617|66676497|FG002|Overall Study|Withdrew consent|1|||
23808567|NCT04049617|66676498|FG003|Overall Study|Withdrew consent|0|||
23808568|NCT04049617|66676499|FG004|Overall Study|Withdrew consent|0|||
23808569|NCT04049617|66676500|FG005|Overall Study|Withdrew consent|0|||
23808570|NCT01649271|66676501|FG000|Overall Study|Progressive disease|4|||
23808571|NCT01649271|66676502|FG001|Overall Study|Progressive disease|5|||
23808572|NCT01649271|66676501|FG000|Overall Study|Other Adverse Event|0|||
23808573|NCT01649271|66676502|FG001|Overall Study|Other Adverse Event|2|||
23808574|NCT01649271|66676501|FG000|Overall Study|Withdrawal by Subject|1|||
23808575|NCT01649271|66676502|FG001|Overall Study|Withdrawal by Subject|0|||
23808576|NCT01649271|66676501|FG000|Overall Study|Other than stated above|1|||
23808577|NCT01649271|66676502|FG001|Overall Study|Other than stated above|0|||
23808578|NCT00541970|66676503|FG000|Month 7|Protocol Violation|9|||
23808579|NCT00541970|66676504|FG001|Month 7|Protocol Violation|13|||
23808580|NCT00541970|66676505|FG002|Month 7|Protocol Violation|11|||
23808581|NCT00541970|66676506|FG003|Month 7|Protocol Violation|5|||
23808582|NCT00541970|66676503|FG000|Month 12|Adverse Event|0|||
23808583|NCT00541970|66676504|FG001|Month 12|Adverse Event|1|||
23808584|NCT00541970|66676505|FG002|Month 12|Adverse Event|1|||
23808585|NCT00541970|66676506|FG003|Month 12|Adverse Event|1|||
23808586|NCT00541970|66676503|FG000|Month 12|Protocol Violation|12|||
23808587|NCT00541970|66676504|FG001|Month 12|Protocol Violation|21|||
23808588|NCT00541970|66676505|FG002|Month 12|Protocol Violation|20|||
23808589|NCT00541970|66676506|FG003|Month 12|Protocol Violation|15|||
23808590|NCT00541970|66676503|FG000|Month 18|Adverse Event|0|||
23504761|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504762|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23808591|NCT00541970|66676504|FG001|Month 18|Adverse Event|1|||
23504763|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23808592|NCT00541970|66676505|FG002|Month 18|Adverse Event|1|||
23808593|NCT00541970|66676506|FG003|Month 18|Adverse Event|1|||
23808594|NCT00541970|66676503|FG000|Month 18|Protocol Violation|14|||
23808595|NCT00541970|66676504|FG001|Month 18|Protocol Violation|23|||
23808596|NCT00541970|66676505|FG002|Month 18|Protocol Violation|24|||
23808597|NCT00541970|66676506|FG003|Month 18|Protocol Violation|16|||
23808598|NCT00541970|66676503|FG000|Month 24|Adverse Event|0|||
23808599|NCT00541970|66676504|FG001|Month 24|Adverse Event|1|||
23808600|NCT00541970|66676505|FG002|Month 24|Adverse Event|1|||
23808601|NCT00541970|66676506|FG003|Month 24|Adverse Event|1|||
23808602|NCT00541970|66676503|FG000|Month 24|Protocol Violation|29|||
23808603|NCT00541970|66676504|FG001|Month 24|Protocol Violation|31|||
23808604|NCT00541970|66676505|FG002|Month 24|Protocol Violation|31|||
23808605|NCT00541970|66676506|FG003|Month 24|Protocol Violation|21|||
23808606|NCT00541970|66676503|FG000|Month 36|Protocol Violation|61|||
23808607|NCT00541970|66676504|FG001|Month 36|Protocol Violation|66|||
23808608|NCT00541970|66676505|FG002|Month 36|Protocol Violation|66|||
23808609|NCT00541970|66676506|FG003|Month 36|Protocol Violation|60|||
23808610|NCT00541970|66676503|FG000|Month 48|Withdrawal by Subject|2|||
23808611|NCT00541970|66676504|FG001|Month 48|Withdrawal by Subject|4|||
23808612|NCT00541970|66676505|FG002|Month 48|Withdrawal by Subject|4|||
23808613|NCT00541970|66676506|FG003|Month 48|Withdrawal by Subject|2|||
23808614|NCT00541970|66676503|FG000|Month 48|Other|3|||
23808615|NCT00541970|66676504|FG001|Month 48|Other|1|||
23808616|NCT00541970|66676505|FG002|Month 48|Other|1|||
23808617|NCT00541970|66676506|FG003|Month 48|Other|0|||
23808618|NCT00541970|66676503|FG000|Month 48|Lost to Follow-up|66|||
23808619|NCT00541970|66676504|FG001|Month 48|Lost to Follow-up|68|||
23808620|NCT00541970|66676505|FG002|Month 48|Lost to Follow-up|68|||
23808621|NCT00541970|66676506|FG003|Month 48|Lost to Follow-up|73|||
23808622|NCT00541970|66676503|FG000|Month 60|Protocol Violation|78|||
23808623|NCT00541970|66676504|FG001|Month 60|Protocol Violation|77|||
23808624|NCT00541970|66676505|FG002|Month 60|Protocol Violation|82|||
23808625|NCT00541970|66676506|FG003|Month 60|Protocol Violation|72|||
23808626|NCT02914236|66676509|FG000|Overall Study|Lost to Follow-up|1|||
23808627|NCT04874636|66676512|FG000|Overall Study|Adverse Event|17|||
23808628|NCT04874636|66676513|FG001|Overall Study|Adverse Event|7|||
23808629|NCT04874636|66676512|FG000|Overall Study|Lost to Follow-up|1|||
23808630|NCT04874636|66676513|FG001|Overall Study|Lost to Follow-up|0|||
23808631|NCT04874636|66676512|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23808632|NCT04874636|66676513|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23808633|NCT04874636|66676512|FG000|Overall Study|Physician Decision|1|||
23808634|NCT04874636|66676513|FG001|Overall Study|Physician Decision|0|||
23808635|NCT04874636|66676512|FG000|Overall Study|Withdrawal by Subject|6|||
23808636|NCT04874636|66676513|FG001|Overall Study|Withdrawal by Subject|5|||
23808637|NCT01806506|66676520|FG000|Overall Study|Lost to Follow-up|2|||
23808638|NCT01806506|66676521|FG001|Overall Study|Lost to Follow-up|1|||
23808639|NCT00629265|66676522|FG000|Overall Study|Lost to Follow-up|4|||
23808640|NCT00629265|66676523|FG001|Overall Study|Lost to Follow-up|5|||
23808641|NCT00629265|66676522|FG000|Overall Study|Withdrawal by Subject|11|||
23808642|NCT00629265|66676523|FG001|Overall Study|Withdrawal by Subject|8|||
23808643|NCT00629265|66676522|FG000|Overall Study|Death|1|||
23808644|NCT00629265|66676523|FG001|Overall Study|Death|0|||
23808645|NCT00629265|66676522|FG000|Overall Study|Adverse Event|2|||
23808646|NCT00629265|66676523|FG001|Overall Study|Adverse Event|0|||
23808647|NCT00629265|66676522|FG000|Overall Study|HNC Recurrence|4|||
23808648|NCT00629265|66676523|FG001|Overall Study|HNC Recurrence|0|||
23808649|NCT00629265|66676522|FG000|Overall Study|Other CA Requiring Treatment|1|||
23808650|NCT00629265|66676523|FG001|Overall Study|Other CA Requiring Treatment|3|||
23808651|NCT00629265|66676522|FG000|Overall Study|Needed Esophageal Dilation|4|||
23808652|NCT00629265|66676523|FG001|Overall Study|Needed Esophageal Dilation|1|||
23808653|NCT00629265|66676522|FG000|Overall Study|Unrelated Medical Complications|3|||
23808654|NCT00629265|66676523|FG001|Overall Study|Unrelated Medical Complications|1|||
23808655|NCT00629265|66676522|FG000|Overall Study|Unknown Reason|2|||
23808656|NCT00629265|66676523|FG001|Overall Study|Unknown Reason|2|||
23808657|NCT02444793|66680281|FG000|Overall Study|Lost to Follow-up|2|||
23808658|NCT02444793|66680282|FG001|Overall Study|Lost to Follow-up|2|||
23808659|NCT02444793|66680283|FG002|Overall Study|Lost to Follow-up|0|||
23808660|NCT02444793|66680284|FG003|Overall Study|Lost to Follow-up|0|||
23808661|NCT02444793|66680281|FG000|Overall Study|Death|0|||
23808662|NCT02444793|66680282|FG001|Overall Study|Death|3|||
23808663|NCT02444793|66680283|FG002|Overall Study|Death|0|||
23808664|NCT02444793|66680284|FG003|Overall Study|Death|0|||
23808665|NCT02444793|66680281|FG000|Overall Study|Other|0|||
23808666|NCT02444793|66680282|FG001|Overall Study|Other|0|||
23808667|NCT02444793|66680283|FG002|Overall Study|Other|2|||
23808668|NCT02444793|66680284|FG003|Overall Study|Other|0|||
23808669|NCT02444793|66680281|FG000|Overall Study|Objective progression or relapse|9|||
23808670|NCT02444793|66680282|FG001|Overall Study|Objective progression or relapse|1|||
23808671|NCT02444793|66680283|FG002|Overall Study|Objective progression or relapse|2|||
23808672|NCT02444793|66680284|FG003|Overall Study|Objective progression or relapse|3|||
23808673|NCT04442490|66680285|FG000|Overall Study|Withdrawal by Subject|18|||
23808674|NCT04442490|66680286|FG001|Overall Study|Withdrawal by Subject|10|||
23808675|NCT04442490|66680285|FG000|Overall Study|Lost to Follow-up|7|||
23808676|NCT04442490|66680286|FG001|Overall Study|Lost to Follow-up|7|||
23808677|NCT04442490|66680285|FG000|Overall Study|Adverse Event|2|||
23808678|NCT04442490|66680286|FG001|Overall Study|Adverse Event|6|||
23808679|NCT04442490|66680285|FG000|Overall Study|Noncompliance|3|||
23808680|NCT04442490|66680286|FG001|Overall Study|Noncompliance|1|||
23808681|NCT04442490|66680285|FG000|Overall Study|Physician Decision|2|||
23808682|NCT04442490|66680286|FG001|Overall Study|Physician Decision|1|||
23808683|NCT04442490|66680285|FG000|Overall Study|Reason not Specified|2|||
23808684|NCT04442490|66680286|FG001|Overall Study|Reason not Specified|1|||
23808685|NCT04442490|66680285|FG000|Overall Study|Randomized but not Treated|3|||
23808686|NCT04442490|66680286|FG001|Overall Study|Randomized but not Treated|3|||
23808687|NCT04053465|66680287|FG000|Overall Study|Withdrawal by Subject|4|||
23808688|NCT04053465|66680288|FG001|Overall Study|Withdrawal by Subject|4|||
23808689|NCT00324649|66680289|FG000|Overall Study|Adverse Event|1|||
23808690|NCT00324649|66680290|FG001|Overall Study|Adverse Event|4|||
23808691|NCT00324649|66680289|FG000|Overall Study|Withdrawal by Subject|0|||
23808692|NCT00324649|66680290|FG001|Overall Study|Withdrawal by Subject|1|||
23808693|NCT00324649|66680289|FG000|Overall Study|Noncompliance|1|||
23808694|NCT00324649|66680290|FG001|Overall Study|Noncompliance|0|||
23808695|NCT01995266|66680293|FG000|Overall Study|Death|1|||
23808696|NCT01995266|66680293|FG000|Overall Study|Lack of Efficacy|6|||
23808697|NCT01995266|66680293|FG000|Overall Study|Adverse Event|2|||
23808698|NCT04156620|66680296|FG000|Overall Study|Adverse event - TP 1|5|||
23808699|NCT04156620|66680297|FG001|Overall Study|Adverse event - TP 1|2|||
23808700|NCT04156620|66680296|FG000|Overall Study|Lost to follow-up TP 1|1|||
23808701|NCT04156620|66680297|FG001|Overall Study|Lost to follow-up TP 1|1|||
23808702|NCT04156620|66680296|FG000|Overall Study|Progressive disease - TP 1|0|||
23808703|NCT04156620|66680297|FG001|Overall Study|Progressive disease - TP 1|1|||
23808704|NCT04156620|66680296|FG000|Overall Study|Subject decision - TP 1|3|||
23808705|NCT04156620|66680297|FG001|Overall Study|Subject decision - TP 1|5|||
23808706|NCT04156620|66680296|FG000|Overall Study|Adverse event - TP 2|5|||
23808707|NCT04156620|66680297|FG001|Overall Study|Adverse event - TP 2|6|||
23808708|NCT04156620|66680296|FG000|Overall Study|Death - TP 2|1|||
23808709|NCT04156620|66680297|FG001|Overall Study|Death - TP 2|0|||
23808710|NCT04156620|66680296|FG000|Overall Study|Lost to follow-up - TP 2|5|||
23808711|NCT04156620|66680297|FG001|Overall Study|Lost to follow-up - TP 2|2|||
23808712|NCT04156620|66680296|FG000|Overall Study|Physician decision - TP 2|4|||
23808713|NCT04156620|66680297|FG001|Overall Study|Physician decision - TP 2|2|||
23808714|NCT04156620|66680296|FG000|Overall Study|Pregnancy - TP 2|1|||
23808715|NCT04156620|66680297|FG001|Overall Study|Pregnancy - TP 2|1|||
23808716|NCT04156620|66680296|FG000|Overall Study|Subject decision - TP 2|11|||
23808717|NCT04156620|66680297|FG001|Overall Study|Subject decision - TP 2|9|||
23808718|NCT04156620|66680296|FG000|Overall Study|New therapy for study indication - TP 2|1|||
23808719|NCT04156620|66680297|FG001|Overall Study|New therapy for study indication - TP 2|0|||
23808720|NCT00667810|66680298|FG000|Overall Study|Adverse Event|13|||
23808721|NCT00667810|66680299|FG001|Overall Study|Adverse Event|14|||
23808722|NCT00667810|66680300|FG002|Overall Study|Adverse Event|19|||
23808723|NCT00667810|66680301|FG003|Overall Study|Adverse Event|1|||
23808724|NCT00667810|66680298|FG000|Overall Study|Death|1|||
23808725|NCT00667810|66680299|FG001|Overall Study|Death|1|||
23808726|NCT00667810|66680300|FG002|Overall Study|Death|3|||
23808727|NCT00667810|66680301|FG003|Overall Study|Death|0|||
23808728|NCT00667810|66680298|FG000|Overall Study|Lack of Efficacy|1|||
23808729|NCT00667810|66680299|FG001|Overall Study|Lack of Efficacy|0|||
23808730|NCT00667810|66680300|FG002|Overall Study|Lack of Efficacy|2|||
23808731|NCT00667810|66680301|FG003|Overall Study|Lack of Efficacy|0|||
23808732|NCT00667810|66680298|FG000|Overall Study|Lost to Follow-up|1|||
23808733|NCT00667810|66680299|FG001|Overall Study|Lost to Follow-up|4|||
23808734|NCT00667810|66680300|FG002|Overall Study|Lost to Follow-up|2|||
23808735|NCT00667810|66680301|FG003|Overall Study|Lost to Follow-up|0|||
23808736|NCT00667810|66680298|FG000|Overall Study|Physician Decision|1|||
23808737|NCT00667810|66680299|FG001|Overall Study|Physician Decision|1|||
23808738|NCT00667810|66680300|FG002|Overall Study|Physician Decision|2|||
23504764|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504765|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504766|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504767|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23808739|NCT00667810|66680301|FG003|Overall Study|Physician Decision|0|||
23808740|NCT00667810|66680298|FG000|Overall Study|Protocol Violation|0|||
23808741|NCT00667810|66680299|FG001|Overall Study|Protocol Violation|2|||
23808742|NCT00667810|66680300|FG002|Overall Study|Protocol Violation|0|||
23808743|NCT00667810|66680301|FG003|Overall Study|Protocol Violation|0|||
23808744|NCT00667810|66680298|FG000|Overall Study|Withdrawal by Subject|14|||
23504768|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23808745|NCT00667810|66680299|FG001|Overall Study|Withdrawal by Subject|20|||
23808746|NCT00667810|66680300|FG002|Overall Study|Withdrawal by Subject|29|||
23808747|NCT00667810|66680301|FG003|Overall Study|Withdrawal by Subject|1|||
23808748|NCT00667810|66680298|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
23808749|NCT00667810|66680299|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
23808750|NCT00667810|66680300|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
23808751|NCT00667810|66680301|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23808752|NCT00667810|66680298|FG000|Overall Study|Failed to Return|0|||
23504769|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
23504770|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504771|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504772|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504773|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23808753|NCT00667810|66680299|FG001|Overall Study|Failed to Return|0|||
23808754|NCT00667810|66680300|FG002|Overall Study|Failed to Return|2|||
23808755|NCT00667810|66680301|FG003|Overall Study|Failed to Return|0|||
23808756|NCT00667810|66680298|FG000|Overall Study|Loss of Caregiver|0|||
23808757|NCT00667810|66680299|FG001|Overall Study|Loss of Caregiver|1|||
23808758|NCT00667810|66680300|FG002|Overall Study|Loss of Caregiver|3|||
23808759|NCT00667810|66680301|FG003|Overall Study|Loss of Caregiver|0|||
23808760|NCT00667810|66680298|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
23808761|NCT00667810|66680299|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
23808762|NCT00667810|66680300|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
23808763|NCT00667810|66680301|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
23808764|NCT00667810|66680298|FG000|Overall Study|Other|6|||
23808765|NCT00667810|66680299|FG001|Overall Study|Other|6|||
23808766|NCT00667810|66680300|FG002|Overall Study|Other|5|||
23808767|NCT00667810|66680301|FG003|Overall Study|Other|0|||
23808768|NCT03649412|66680302|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
23808769|NCT03649412|66680303|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
23808770|NCT03649412|66680302|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
23808771|NCT03649412|66680303|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
23808772|NCT03649412|66680302|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23808773|NCT03649412|66680303|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23808774|NCT03649412|66680302|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
23808775|NCT03649412|66680303|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
23808776|NCT03649412|66680302|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
23808777|NCT03649412|66680303|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
23808778|NCT03649412|66680302|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
23808779|NCT03649412|66680303|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
23808780|NCT02981303|66680305|FG000|Overall Study|Progressive Disease|17|||
23808781|NCT02981303|66680306|FG001|Overall Study|Progressive Disease|37|||
23808782|NCT02981303|66680305|FG000|Overall Study|Adverse Event|1|||
23808783|NCT02981303|66680306|FG001|Overall Study|Adverse Event|4|||
23808784|NCT02981303|66680305|FG000|Overall Study|Withdrawal by Subject|0|||
23808785|NCT02981303|66680306|FG001|Overall Study|Withdrawal by Subject|1|||
23808786|NCT01570283|66680307|FG000|Cohort 1: Dose Level 1|Death|0|||
23808787|NCT01570283|66680308|FG001|Cohort 1: Dose Level 1|Death|1|||
23808788|NCT01570283|66680309|FG002|Cohort 1: Dose Level 1|Death|0|||
23808789|NCT01570283|66680310|FG003|Cohort 1: Dose Level 1|Death|0|||
23808790|NCT01570283|66680311|FG004|Cohort 1: Dose Level 1|Death|0|||
23808791|NCT01570283|66680312|FG005|Cohort 1: Dose Level 1|Death|0|||
23808792|NCT01570283|66680307|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23808793|NCT01570283|66680308|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
23808794|NCT01570283|66680309|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23808795|NCT01570283|66680310|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23808796|NCT01570283|66680311|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23808797|NCT01570283|66680312|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23808798|NCT01570283|66680307|FG000|Cohort 2: Dose Level 2|Death|0|||
23808799|NCT01570283|66680308|FG001|Cohort 2: Dose Level 2|Death|0|||
23808800|NCT01570283|66680309|FG002|Cohort 2: Dose Level 2|Death|1|||
23808801|NCT01570283|66680310|FG003|Cohort 2: Dose Level 2|Death|0|||
23808802|NCT01570283|66680311|FG004|Cohort 2: Dose Level 2|Death|0|||
23808803|NCT01570283|66680312|FG005|Cohort 2: Dose Level 2|Death|0|||
23808804|NCT01570283|66680307|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23504774|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504775|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23808805|NCT01570283|66680308|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23808806|NCT01570283|66680309|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23808807|NCT01570283|66680310|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
23808808|NCT01570283|66680311|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23808809|NCT01570283|66680312|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23808810|NCT01570283|66680307|FG000|Cohort 3: Dose Level 3|Death|0|||
23808811|NCT01570283|66680308|FG001|Cohort 3: Dose Level 3|Death|0|||
23808812|NCT01570283|66680309|FG002|Cohort 3: Dose Level 3|Death|0|||
23808813|NCT01570283|66680310|FG003|Cohort 3: Dose Level 3|Death|0|||
23808814|NCT01570283|66680311|FG004|Cohort 3: Dose Level 3|Death|0|||
23808815|NCT01570283|66680312|FG005|Cohort 3: Dose Level 3|Death|1|||
23808816|NCT01570283|66680307|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23808817|NCT01570283|66680308|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23808818|NCT01570283|66680309|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23808819|NCT01570283|66680310|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23808820|NCT01570283|66680311|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23808821|NCT01570283|66680312|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
23808822|NCT03014180|66680313|FG000|Overall Study|Protocol Violation|2|||
23808823|NCT02746471|66680320|FG000|Overall Study|Death|43|||
23808824|NCT02746471|66680320|FG000|Overall Study|Exited before 36 months|1119|||
23808825|NCT00062010|66680321|FG000|Overall Study|Ineligible|3|||
23808826|NCT01765582|66680322|FG000|Overall Study|Other|3|||
23808827|NCT01765582|66680323|FG001|Overall Study|Other|6|||
23808828|NCT01765582|66680324|FG002|Overall Study|Other|9|||
23808829|NCT01765582|66680322|FG000|Overall Study|Lost to Follow-up|2|||
23808830|NCT01765582|66680323|FG001|Overall Study|Lost to Follow-up|2|||
23808831|NCT01765582|66680324|FG002|Overall Study|Lost to Follow-up|1|||
23808832|NCT01765582|66680322|FG000|Overall Study|Death|31|||
23808833|NCT01765582|66680323|FG001|Overall Study|Death|36|||
23808834|NCT01765582|66680324|FG002|Overall Study|Death|33|||
23808835|NCT01765582|66680322|FG000|Overall Study|Sponsor Decision|46|||
23808836|NCT01765582|66680323|FG001|Overall Study|Sponsor Decision|42|||
23808837|NCT01765582|66680324|FG002|Overall Study|Sponsor Decision|42|||
23808838|NCT01765582|66680322|FG000|Overall Study|Withdrawal of Consent|11|||
23808839|NCT01765582|66680323|FG001|Overall Study|Withdrawal of Consent|6|||
23808840|NCT01765582|66680324|FG002|Overall Study|Withdrawal of Consent|10|||
23808841|NCT00354341|66680326|FG000|Overall Study|Adverse Event|1|||
23808842|NCT00354341|66680327|FG001|Overall Study|Adverse Event|0|||
23808843|NCT00354341|66680326|FG000|Overall Study|Death|0|||
23808844|NCT00354341|66680327|FG001|Overall Study|Death|2|||
23808845|NCT00354341|66680326|FG000|Overall Study|Refused treatment|1|||
23808846|NCT00354341|66680327|FG001|Overall Study|Refused treatment|2|||
23808847|NCT00354341|66680326|FG000|Overall Study|Failure to return|0|||
23808848|NCT00354341|66680327|FG001|Overall Study|Failure to return|1|||
23808849|NCT00354341|66680326|FG000|Overall Study|Other|1|||
23808850|NCT00354341|66680327|FG001|Overall Study|Other|2|||
23808851|NCT02791893|66680328|FG000|Blinded Phase|Lost to Follow-up|2|||
23808852|NCT02791893|66680329|FG001|Blinded Phase|Lost to Follow-up|2|||
23808853|NCT02791893|66680328|FG000|Blinded Phase|Withdrawal by Subject|1|||
23808854|NCT02791893|66680329|FG001|Blinded Phase|Withdrawal by Subject|2|||
23808855|NCT02791893|66680328|FG000|Open Label Phase|Lost to Follow-up|3|||
23808856|NCT02791893|66680329|FG001|Open Label Phase|Lost to Follow-up|0|||
23808857|NCT02791893|66680328|FG000|Open Label Phase|Withdrawal by Subject|0|||
23808858|NCT02791893|66680329|FG001|Open Label Phase|Withdrawal by Subject|2|||
23808859|NCT00415194|66680330|FG000|Overall Study|Adverse Event|37|||
23808860|NCT00415194|66680331|FG001|Overall Study|Adverse Event|32|||
23808861|NCT00415194|66680330|FG000|Overall Study|Entry Criteria Not Met|4|||
23808862|NCT00415194|66680331|FG001|Overall Study|Entry Criteria Not Met|8|||
23808863|NCT00415194|66680330|FG000|Overall Study|Lost to Follow-up|1|||
23808864|NCT00415194|66680331|FG001|Overall Study|Lost to Follow-up|0|||
23808865|NCT00415194|66680330|FG000|Overall Study|Physician Decision|10|||
23808866|NCT00415194|66680331|FG001|Overall Study|Physician Decision|16|||
23808867|NCT00415194|66680330|FG000|Overall Study|Progressive Disease|180|||
23808868|NCT00415194|66680331|FG001|Overall Study|Progressive Disease|217|||
23808869|NCT00415194|66680330|FG000|Overall Study|Protocol Violation|4|||
23808870|NCT00415194|66680331|FG001|Overall Study|Protocol Violation|2|||
23808871|NCT00415194|66680330|FG000|Overall Study|Withdrawal by Subject|28|||
23808872|NCT00415194|66680331|FG001|Overall Study|Withdrawal by Subject|21|||
23808873|NCT00415194|66680330|FG000|Overall Study|Death Due to Study Disease|26|||
23808874|NCT00415194|66680331|FG001|Overall Study|Death Due to Study Disease|29|||
23808875|NCT00415194|66680330|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
23808876|NCT00415194|66680331|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
23808877|NCT00415194|66680330|FG000|Overall Study|Death Due to Procedural Related AE|0|||
23808878|NCT00415194|66680331|FG001|Overall Study|Death Due to Procedural Related AE|1|||
23808879|NCT00415194|66680330|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
23808880|NCT00415194|66680331|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
23808881|NCT03340064|66680332|FG000|First Period|Adverse Event, non-fatal|2|||
23808882|NCT03340064|66680333|FG001|First Period|Adverse Event, non-fatal|0|||
23808883|NCT03340064|66680332|FG000|First Period|Lack of Efficacy|3|||
23808884|NCT03340064|66680333|FG001|First Period|Lack of Efficacy|0|||
23808885|NCT03340064|66680332|FG000|Second Period|Adverse Event, non-fatal|1|||
23808886|NCT03340064|66680333|FG001|Second Period|Adverse Event, non-fatal|1|||
23808887|NCT03340064|66680332|FG000|Second Period|Lack of Efficacy|11|||
23808888|NCT03340064|66680333|FG001|Second Period|Lack of Efficacy|0|||
23808889|NCT03340064|66680332|FG000|Second Period|Physician Decision|3|||
23808890|NCT03340064|66680333|FG001|Second Period|Physician Decision|0|||
23808891|NCT03340064|66680332|FG000|Second Period|Withdrawal by Subject|2|||
23808892|NCT03340064|66680333|FG001|Second Period|Withdrawal by Subject|1|||
23808893|NCT03340064|66680332|FG000|Second Period|Approved Drug Available For Indication|1|||
23808894|NCT03340064|66680333|FG001|Second Period|Approved Drug Available For Indication|0|||
23808895|NCT03340064|66680332|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
23808896|NCT03340064|66680333|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
23808897|NCT00477295|66680335|FG000|Overall Study|Adverse Event|31|||
23808898|NCT00477295|66680336|FG001|Overall Study|Adverse Event|35|||
23808899|NCT00477295|66680335|FG000|Overall Study|Withdrawal by Subject|35|||
23808900|NCT00477295|66680336|FG001|Overall Study|Withdrawal by Subject|24|||
23808901|NCT00477295|66680335|FG000|Overall Study|Lack of Efficacy|23|||
23808902|NCT00477295|66680336|FG001|Overall Study|Lack of Efficacy|23|||
23808903|NCT00477295|66680335|FG000|Overall Study|Protocol Violation|3|||
23808904|NCT00477295|66680336|FG001|Overall Study|Protocol Violation|8|||
23808905|NCT00477295|66680335|FG000|Overall Study|Physician Decision|4|||
23808906|NCT00477295|66680336|FG001|Overall Study|Physician Decision|5|||
23808907|NCT00477295|66680335|FG000|Overall Study|Lost to Follow-up|21|||
23808908|NCT00477295|66680336|FG001|Overall Study|Lost to Follow-up|11|||
23808909|NCT00477295|66680335|FG000|Overall Study|Other|4|||
23808910|NCT00477295|66680336|FG001|Overall Study|Other|3|||
23808911|NCT00614926|66680339|FG000|Overall Study|Burden of travel|1|||
23808912|NCT00614926|66680340|FG001|Overall Study|Burden of travel|0|||
23808913|NCT00614926|66680339|FG000|Overall Study|Adverse Event|3|||
23808914|NCT00614926|66680340|FG001|Overall Study|Adverse Event|0|||
23808915|NCT03835221|66680341|FG000|Methafilcon A|Withdrawal by Subject|1|||
23808916|NCT00505375|66680342|FG000|Overall Study|Death|1|||
23808917|NCT00505375|66680343|FG001|Overall Study|Death|0|||
23808918|NCT00505375|66680342|FG000|Overall Study|Withdrawal by Subject|2|||
23808919|NCT00505375|66680343|FG001|Overall Study|Withdrawal by Subject|2|||
23808920|NCT00505375|66680342|FG000|Overall Study|Lost to Follow-up|0|||
23808921|NCT00505375|66680343|FG001|Overall Study|Lost to Follow-up|2|||
23808922|NCT00505375|66680342|FG000|Overall Study|Pregnancy|1|||
23808923|NCT00505375|66680343|FG001|Overall Study|Pregnancy|0|||
23808924|NCT00505375|66680342|FG000|Overall Study|Travel issues|0|||
23808925|NCT00505375|66680343|FG001|Overall Study|Travel issues|1|||
23808926|NCT00103311|66680344|FG000|Overall Study|Lost to Follow-up|1|||
23808927|NCT00103311|66680345|FG001|Overall Study|Lost to Follow-up|0|||
23808928|NCT00103311|66680344|FG000|Overall Study|Withdrawal by Subject|2|||
23808929|NCT00103311|66680345|FG001|Overall Study|Withdrawal by Subject|1|||
23808930|NCT00103311|66680344|FG000|Overall Study|Adverse Event|1|||
23808931|NCT00103311|66680345|FG001|Overall Study|Adverse Event|0|||
23808932|NCT02551666|66680346|FG000|Overall Study|Withdrawal by Subject|1|||
23808933|NCT02551666|66680347|FG001|Overall Study|Withdrawal by Subject|3|||
23808934|NCT03914950|66680350|FG000|Overall Study|Physician Decision|54|||
23808935|NCT02304458|66680351|FG000|Overall Study|Adverse Event|0|||
23808936|NCT02304458|66680352|FG001|Overall Study|Adverse Event|0|||
23808937|NCT02304458|66680353|FG002|Overall Study|Adverse Event|7|||
23808938|NCT02304458|66680354|FG003|Overall Study|Adverse Event|0|||
23808939|NCT02304458|66680355|FG004|Overall Study|Adverse Event|0|||
23808940|NCT02304458|66680356|FG005|Overall Study|Adverse Event|0|||
23808941|NCT02304458|66680357|FG006|Overall Study|Adverse Event|3|||
23808942|NCT02304458|66680358|FG007|Overall Study|Adverse Event|4|||
23808943|NCT02304458|66680351|FG000|Overall Study|Death|0|||
23808944|NCT02304458|66680352|FG001|Overall Study|Death|0|||
23808945|NCT02304458|66680353|FG002|Overall Study|Death|2|||
23808946|NCT02304458|66680354|FG003|Overall Study|Death|0|||
23808947|NCT02304458|66680355|FG004|Overall Study|Death|0|||
23808948|NCT02304458|66680356|FG005|Overall Study|Death|0|||
23808949|NCT02304458|66680357|FG006|Overall Study|Death|1|||
23808950|NCT02304458|66680358|FG007|Overall Study|Death|0|||
23808951|NCT02304458|66680351|FG000|Overall Study|Lack of Efficacy|4|||
23808952|NCT02304458|66680352|FG001|Overall Study|Lack of Efficacy|6|||
23808953|NCT02304458|66680353|FG002|Overall Study|Lack of Efficacy|38|||
23808954|NCT02304458|66680354|FG003|Overall Study|Lack of Efficacy|5|||
23808955|NCT02304458|66680355|FG004|Overall Study|Lack of Efficacy|6|||
23808956|NCT02304458|66680356|FG005|Overall Study|Lack of Efficacy|6|||
23808957|NCT02304458|66680357|FG006|Overall Study|Lack of Efficacy|21|||
23808958|NCT02304458|66680358|FG007|Overall Study|Lack of Efficacy|4|||
23808959|NCT02304458|66680351|FG000|Overall Study|Physician Decision|2|||
23808960|NCT02304458|66680352|FG001|Overall Study|Physician Decision|0|||
23808961|NCT02304458|66680353|FG002|Overall Study|Physician Decision|16|||
23808962|NCT02304458|66680354|FG003|Overall Study|Physician Decision|1|||
23808963|NCT02304458|66680355|FG004|Overall Study|Physician Decision|0|||
23808964|NCT02304458|66680356|FG005|Overall Study|Physician Decision|0|||
23808965|NCT02304458|66680357|FG006|Overall Study|Physician Decision|3|||
23808966|NCT02304458|66680358|FG007|Overall Study|Physician Decision|0|||
23808967|NCT02304458|66680351|FG000|Overall Study|Protocol Violation|0|||
23808968|NCT02304458|66680352|FG001|Overall Study|Protocol Violation|0|||
23808969|NCT02304458|66680353|FG002|Overall Study|Protocol Violation|1|||
23808970|NCT02304458|66680354|FG003|Overall Study|Protocol Violation|0|||
23808971|NCT02304458|66680355|FG004|Overall Study|Protocol Violation|0|||
23808972|NCT02304458|66680356|FG005|Overall Study|Protocol Violation|0|||
23808973|NCT02304458|66680357|FG006|Overall Study|Protocol Violation|0|||
23808974|NCT02304458|66680358|FG007|Overall Study|Protocol Violation|0|||
23808975|NCT02304458|66680351|FG000|Overall Study|Withdrawal by Subject|1|||
23808976|NCT02304458|66680352|FG001|Overall Study|Withdrawal by Subject|0|||
23808977|NCT02304458|66680353|FG002|Overall Study|Withdrawal by Subject|7|||
23808978|NCT02304458|66680354|FG003|Overall Study|Withdrawal by Subject|0|||
23808979|NCT02304458|66680355|FG004|Overall Study|Withdrawal by Subject|0|||
23808980|NCT02304458|66680356|FG005|Overall Study|Withdrawal by Subject|0|||
23808981|NCT02304458|66680357|FG006|Overall Study|Withdrawal by Subject|1|||
23808982|NCT02304458|66680358|FG007|Overall Study|Withdrawal by Subject|0|||
23808983|NCT00848107|66680361|FG000|Overall Study|Lost to Follow-up|2|||
23808984|NCT00848107|66680361|FG000|Overall Study|Withdrawal by Subject|8|||
23808985|NCT00848107|66680361|FG000|Overall Study|Adverse Event|9|||
23808986|NCT00848107|66680361|FG000|Overall Study|Death|1|||
23808987|NCT00848107|66680361|FG000|Overall Study|Pregnancy|1|||
23808988|NCT02229539|66680365|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
23808989|NCT02229539|66680366|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
23808990|NCT02229539|66680367|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
23808991|NCT02229539|66680365|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
23808992|NCT02229539|66680366|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
23808993|NCT02229539|66680367|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
23808994|NCT02229539|66680365|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
23808995|NCT02229539|66680366|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
23808996|NCT02229539|66680367|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
23808997|NCT02229539|66680365|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
23808998|NCT02229539|66680366|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
23808999|NCT02229539|66680367|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
23809000|NCT02229539|66680365|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
23809001|NCT02229539|66680366|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
23809002|NCT02229539|66680367|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
23809003|NCT02229539|66680365|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
23809004|NCT02229539|66680366|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
23809005|NCT02229539|66680367|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
23809006|NCT02229539|66680365|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
23809007|NCT02229539|66680366|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
23809008|NCT02229539|66680367|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
23809009|NCT02229539|66680365|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
23809010|NCT02229539|66680366|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
23809011|NCT02229539|66680367|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
23809012|NCT02229539|66680365|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
23809013|NCT02229539|66680366|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
23809014|NCT02229539|66680367|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
23809015|NCT01929031|66680368|FG000|Overall Study|Adverse Event|3|||
23809016|NCT01929031|66680369|FG001|Overall Study|Adverse Event|1|||
23809017|NCT01929031|66680370|FG002|Overall Study|Adverse Event|1|||
23809018|NCT01929031|66680371|FG003|Overall Study|Adverse Event|0|||
23809019|NCT01929031|66680372|FG004|Overall Study|Adverse Event|0|||
23809020|NCT01929031|66680373|FG005|Overall Study|Adverse Event|0|||
23809021|NCT01929031|66680368|FG000|Overall Study|Protocol Violation|1|||
23809022|NCT01929031|66680369|FG001|Overall Study|Protocol Violation|0|||
23809023|NCT01929031|66680370|FG002|Overall Study|Protocol Violation|0|||
23809024|NCT01929031|66680371|FG003|Overall Study|Protocol Violation|0|||
23809025|NCT01929031|66680372|FG004|Overall Study|Protocol Violation|0|||
23809026|NCT01929031|66680373|FG005|Overall Study|Protocol Violation|1|||
23809027|NCT01929031|66680368|FG000|Overall Study|Reason other than specified above|0|||
23809028|NCT01929031|66680369|FG001|Overall Study|Reason other than specified above|1|||
23809029|NCT01929031|66680370|FG002|Overall Study|Reason other than specified above|0|||
23809030|NCT01929031|66680371|FG003|Overall Study|Reason other than specified above|0|||
23809031|NCT01929031|66680372|FG004|Overall Study|Reason other than specified above|1|||
23809032|NCT01929031|66680373|FG005|Overall Study|Reason other than specified above|0|||
23809033|NCT01777620|66680379|FG000|Overall Study|Subject Withdrawal|1|||
23809034|NCT01777620|66680380|FG001|Overall Study|Subject Withdrawal|0|||
23809035|NCT02749292|66680385|FG000|Overall Study|Physician Decision|1|||
23809036|NCT02749292|66680386|FG001|Overall Study|Physician Decision|0|||
23809037|NCT02749292|66680385|FG000|Overall Study|Withdrawal by Subject|5|||
23809038|NCT02749292|66680386|FG001|Overall Study|Withdrawal by Subject|7|||
23809039|NCT02749292|66680385|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
23809040|NCT02749292|66680386|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
23809041|NCT02749292|66680385|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
23809042|NCT02749292|66680386|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
23809043|NCT02749292|66680385|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
23809044|NCT02749292|66680386|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
23809045|NCT02749292|66680385|FG000|Overall Study|Adverse Event|4|||
23809046|NCT02749292|66680386|FG001|Overall Study|Adverse Event|1|||
23809047|NCT02749292|66680385|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
23809048|NCT02749292|66680386|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
23809049|NCT02749292|66680385|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
23809050|NCT02749292|66680386|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
23809051|NCT02749292|66680385|FG000|Overall Study|Requiring glucocorticoids|0|||
23809052|NCT02749292|66680386|FG001|Overall Study|Requiring glucocorticoids|3|||
23809053|NCT02749292|66680385|FG000|Overall Study|Cancer|1|||
23504776|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504777|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504778|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504779|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504780|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23809054|NCT02749292|66680386|FG001|Overall Study|Cancer|0|||
23809055|NCT01335997|66680387|FG000|Period I and II|Adverse Event|63|||
23809056|NCT01335997|66680388|FG001|Period I and II|Adverse Event|43|||
23809057|NCT01335997|66680387|FG000|Period I and II|Noncompliance with Study Drug|1|||
23809058|NCT01335997|66680388|FG001|Period I and II|Noncompliance with Study Drug|1|||
23809059|NCT01335997|66680387|FG000|Period I and II|Lost to Follow-up|3|||
23809060|NCT01335997|66680388|FG001|Period I and II|Lost to Follow-up|5|||
23809061|NCT01335997|66680387|FG000|Period I and II|Withdrawal by Subject|9|||
23809062|NCT01335997|66680388|FG001|Period I and II|Withdrawal by Subject|4|||
23809063|NCT01335997|66680387|FG000|Period I and II|Study Terminated by Sponsor|406|||
23809064|NCT01335997|66680388|FG001|Period I and II|Study Terminated by Sponsor|415|||
23809065|NCT01335997|66680387|FG000|Period I and II|Protocol Violation|9|||
23809066|NCT01335997|66680388|FG001|Period I and II|Protocol Violation|10|||
23809067|NCT01335997|66680387|FG000|Period I and II|Physician Decision|2|||
23809068|NCT01335997|66680388|FG001|Period I and II|Physician Decision|1|||
23809069|NCT01335997|66680387|FG000|Period III|Adverse Event|0|||
23809070|NCT01335997|66680388|FG001|Period III|Adverse Event|2|||
23809071|NCT01335997|66680387|FG000|Period III|Study Terminated by Sponsor|77|||
23809072|NCT01335997|66680388|FG001|Period III|Study Terminated by Sponsor|76|||
23809073|NCT01335997|66680387|FG000|Period III|Protocol Violation|0|||
23809074|NCT01335997|66680388|FG001|Period III|Protocol Violation|1|||
23809075|NCT01335997|66680387|FG000|Period III|Lost to Follow-up|1|||
23809076|NCT01335997|66680388|FG001|Period III|Lost to Follow-up|0|||
23809077|NCT01470612|66680393|FG000|Overall Study|Adverse Event|20|||
23809078|NCT01470612|66680394|FG001|Overall Study|Adverse Event|80|||
23809079|NCT01470612|66680393|FG000|Overall Study|Death|0|||
23809080|NCT01470612|66680394|FG001|Overall Study|Death|1|||
23809081|NCT01470612|66680393|FG000|Overall Study|Lack of Efficacy|20|||
23809082|NCT01470612|66680394|FG001|Overall Study|Lack of Efficacy|326|||
23809083|NCT01470612|66680393|FG000|Overall Study|Lost to Follow-up|2|||
23809084|NCT01470612|66680394|FG001|Overall Study|Lost to Follow-up|5|||
23809085|NCT01470612|66680393|FG000|Overall Study|Did not meet entrance criteria|0|||
23809086|NCT01470612|66680394|FG001|Overall Study|Did not meet entrance criteria|1|||
23809087|NCT01470612|66680393|FG000|Overall Study|Pregnancy|2|||
23809088|NCT01470612|66680394|FG001|Overall Study|Pregnancy|10|||
23809089|NCT01470612|66680393|FG000|Overall Study|Protocol Violation|2|||
23809090|NCT01470612|66680394|FG001|Overall Study|Protocol Violation|7|||
23809091|NCT01470612|66680393|FG000|Overall Study|Withdrawal by Subject|24|||
23809092|NCT01470612|66680394|FG001|Overall Study|Withdrawal by Subject|79|||
23809093|NCT01470612|66680393|FG000|Overall Study|Other|14|||
23809094|NCT01470612|66680394|FG001|Overall Study|Other|156|||
23809095|NCT03028740|66680396|FG000|Overall Study|Did not Receive Study Drug|4|||
23809096|NCT03028740|66680397|FG001|Overall Study|Did not Receive Study Drug|5|||
23809097|NCT03028740|66680396|FG000|Overall Study|Adverse Event|8|||
23809098|NCT03028740|66680397|FG001|Overall Study|Adverse Event|26|||
23809099|NCT03028740|66680396|FG000|Overall Study|Lack of Efficacy|0|||
23809100|NCT03028740|66680397|FG001|Overall Study|Lack of Efficacy|1|||
23809101|NCT03028740|66680396|FG000|Overall Study|Withdrawal by Subject|48|||
23809102|NCT03028740|66680397|FG001|Overall Study|Withdrawal by Subject|101|||
23809103|NCT03028740|66680396|FG000|Overall Study|Lost to Follow-up|30|||
23809104|NCT03028740|66680397|FG001|Overall Study|Lost to Follow-up|54|||
23809105|NCT03028740|66680396|FG000|Overall Study|Physician Decision|4|||
23809106|NCT03028740|66680397|FG001|Overall Study|Physician Decision|11|||
23809107|NCT03028740|66680396|FG000|Overall Study|Protocol Violation|4|||
23809108|NCT03028740|66680397|FG001|Overall Study|Protocol Violation|8|||
23809109|NCT03028740|66680396|FG000|Overall Study|Non-compliance with Study Drug|0|||
23809110|NCT03028740|66680397|FG001|Overall Study|Non-compliance with Study Drug|2|||
23809111|NCT03028740|66680396|FG000|Overall Study|Study Terminated by Sponsor|467|||
23809112|NCT03028740|66680397|FG001|Overall Study|Study Terminated by Sponsor|917|||
23809113|NCT03028740|66680396|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
23809114|NCT03028740|66680397|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
23809115|NCT03028740|66680396|FG000|Overall Study|Reason not Specified|1|||
23809116|NCT03028740|66680397|FG001|Overall Study|Reason not Specified|5|||
23809117|NCT00643565|66680398|FG000|Overall Study|Death|12|||
23403913|NCT00833027|65226438|FG000|Overall Study|Protocol Violation|115|||
23809118|NCT00643565|66680399|FG001|Overall Study|Death|11|||
23809119|NCT00643565|66680398|FG000|Overall Study|Withdrawal by Subject|4|||
23809120|NCT00643565|66680399|FG001|Overall Study|Withdrawal by Subject|1|||
23809121|NCT00643565|66680398|FG000|Overall Study|Lost to Follow-up|0|||
23809122|NCT00643565|66680399|FG001|Overall Study|Lost to Follow-up|6|||
23809123|NCT00643565|66680398|FG000|Overall Study|Other|7|||
23809124|NCT00643565|66680399|FG001|Overall Study|Other|8|||
23809125|NCT00643565|66680398|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
23809126|NCT00643565|66680399|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
23809127|NCT00643565|66680398|FG000|Overall Study|Recurrence of Disease|2|||
23809128|NCT00643565|66680399|FG001|Overall Study|Recurrence of Disease|1|||
23809129|NCT00643565|66680398|FG000|Overall Study|Progression of Disease|18|||
23809130|NCT00643565|66680399|FG001|Overall Study|Progression of Disease|14|||
23809131|NCT00643565|66680398|FG000|Overall Study|Protocol Violation|3|||
23809132|NCT00643565|66680399|FG001|Overall Study|Protocol Violation|0|||
23809133|NCT00643565|66680398|FG000|Overall Study|Did Not Cooperate|0|||
23809134|NCT00643565|66680399|FG001|Overall Study|Did Not Cooperate|1|||
23809135|NCT00643565|66680398|FG000|Overall Study|Administrative|22|||
23809136|NCT00643565|66680399|FG001|Overall Study|Administrative|16|||
23809137|NCT00643565|66680398|FG000|Overall Study|Adverse Event|5|||
23809138|NCT00643565|66680399|FG001|Overall Study|Adverse Event|8|||
23809139|NCT00319982|66680402|FG000|Overall Study|Withdrawal by Subject|1|||
23809140|NCT00319982|66680403|FG001|Overall Study|Withdrawal by Subject|0|||
23809141|NCT00123955|66680407|FG000|Overall Study|Adverse Event|1|||
23809142|NCT00123955|66680408|FG001|Overall Study|Adverse Event|0|||
23809143|NCT00123955|66680407|FG000|Overall Study|Withdrawal by Subject|4|||
23809144|NCT00123955|66680408|FG001|Overall Study|Withdrawal by Subject|3|||
23809145|NCT00123955|66680407|FG000|Overall Study|Death|0|||
23809146|NCT00123955|66680408|FG001|Overall Study|Death|1|||
23809147|NCT03918109|66680409|FG000|Overall Study|Withdrawal by Subject|0|||
23809148|NCT03918109|66680410|FG001|Overall Study|Withdrawal by Subject|0|||
23809149|NCT03918109|66680411|FG002|Overall Study|Withdrawal by Subject|2|||
23809150|NCT03918109|66680412|FG003|Overall Study|Withdrawal by Subject|1|||
23809151|NCT03918109|66680409|FG000|Overall Study|Lost to Follow-up|0|||
23809152|NCT03918109|66680410|FG001|Overall Study|Lost to Follow-up|0|||
23809153|NCT03918109|66680411|FG002|Overall Study|Lost to Follow-up|0|||
23809154|NCT03918109|66680412|FG003|Overall Study|Lost to Follow-up|1|||
23809155|NCT00418821|66680413|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
23809156|NCT01763684|66680414|FG000|Overall Study|Study terminated early due to low enrollment|126|||
23809157|NCT01763684|66680415|FG001|Overall Study|Study terminated early due to low enrollment|127|||
23809158|NCT01763684|66680414|FG000|Overall Study|Study surgery not performed|7|||
23809159|NCT01763684|66680415|FG001|Overall Study|Study surgery not performed|6|||
23809160|NCT02128217|66680418|FG000|Overall Study|Lost to Follow-up|0|||
23809161|NCT02128217|66680419|FG001|Overall Study|Lost to Follow-up|1|||
23809162|NCT00856830|66680420|FG000|Irinotecan & Bendamustine|Death|0|||
23809163|NCT00856830|66680421|FG001|Irinotecan & Bendamustine|Death|0|||
23809164|NCT00856830|66680422|FG002|Irinotecan & Bendamustine|Death|0|||
23809165|NCT00856830|66680423|FG003|Irinotecan & Bendamustine|Death|2|||
23809166|NCT00856830|66680420|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
23809167|NCT00856830|66680421|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
23809168|NCT00856830|66680422|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
23809169|NCT00856830|66680423|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
23809170|NCT03760250|66680424|FG000|Overall Study|Withdrawal by Subject|1|||
23809171|NCT03760250|66680424|FG000|Overall Study|Physician Decision|1|||
23809172|NCT02802631|66680425|FG000|Overall Study|Withdrawal by Subject|1|||
23809173|NCT02802631|66680426|FG001|Overall Study|Withdrawal by Subject|0|||
23809174|NCT02802631|66680427|FG002|Overall Study|Withdrawal by Subject|0|||
23809175|NCT02802631|66680428|FG003|Overall Study|Withdrawal by Subject|0|||
23809176|NCT02802631|66680429|FG004|Overall Study|Withdrawal by Subject|0|||
23809177|NCT02802631|66680430|FG005|Overall Study|Withdrawal by Subject|0|||
23809178|NCT02802631|66680431|FG006|Overall Study|Withdrawal by Subject|0|||
23809179|NCT02802631|66680432|FG007|Overall Study|Withdrawal by Subject|0|||
23809180|NCT02802631|66680425|FG000|Overall Study|Physician Decision|1|||
23809181|NCT02802631|66680426|FG001|Overall Study|Physician Decision|0|||
23809182|NCT02802631|66680427|FG002|Overall Study|Physician Decision|0|||
23809183|NCT02802631|66680428|FG003|Overall Study|Physician Decision|0|||
23809184|NCT02802631|66680429|FG004|Overall Study|Physician Decision|0|||
23809185|NCT02802631|66680430|FG005|Overall Study|Physician Decision|0|||
23809186|NCT02802631|66680431|FG006|Overall Study|Physician Decision|1|||
23809187|NCT02802631|66680432|FG007|Overall Study|Physician Decision|0|||
23809188|NCT02802631|66680425|FG000|Overall Study|Adverse Event|0|||
23809189|NCT02802631|66680426|FG001|Overall Study|Adverse Event|2|||
23809190|NCT02802631|66680427|FG002|Overall Study|Adverse Event|0|||
23809191|NCT02802631|66680428|FG003|Overall Study|Adverse Event|1|||
23809192|NCT02802631|66680429|FG004|Overall Study|Adverse Event|6|||
23809193|NCT02802631|66680430|FG005|Overall Study|Adverse Event|1|||
23809194|NCT02802631|66680431|FG006|Overall Study|Adverse Event|4|||
23809195|NCT02802631|66680432|FG007|Overall Study|Adverse Event|0|||
23809196|NCT02802631|66680425|FG000|Overall Study|Sponsor Decision|0|||
23809197|NCT02802631|66680426|FG001|Overall Study|Sponsor Decision|0|||
23809198|NCT02802631|66680427|FG002|Overall Study|Sponsor Decision|6|||
23809199|NCT02802631|66680428|FG003|Overall Study|Sponsor Decision|0|||
23809200|NCT02802631|66680429|FG004|Overall Study|Sponsor Decision|2|||
23809201|NCT02802631|66680430|FG005|Overall Study|Sponsor Decision|0|||
23809202|NCT02802631|66680431|FG006|Overall Study|Sponsor Decision|0|||
23809203|NCT02802631|66680432|FG007|Overall Study|Sponsor Decision|4|||
23809204|NCT02858492|66680434|FG000|Overall Study|Withdrawal by Subject|0|||
23809205|NCT02858492|66680435|FG001|Overall Study|Withdrawal by Subject|1|||
23809206|NCT02858492|66680436|FG002|Overall Study|Withdrawal by Subject|0|||
23809207|NCT02858492|66680437|FG003|Overall Study|Withdrawal by Subject|1|||
23809208|NCT02858492|66680434|FG000|Overall Study|Adverse Event|0|||
23809209|NCT02858492|66680435|FG001|Overall Study|Adverse Event|0|||
23809210|NCT02858492|66680436|FG002|Overall Study|Adverse Event|0|||
23809211|NCT02858492|66680437|FG003|Overall Study|Adverse Event|3|||
23809212|NCT02858492|66680434|FG000|Overall Study|Lack of Efficacy|0|||
23809213|NCT02858492|66680435|FG001|Overall Study|Lack of Efficacy|0|||
23809214|NCT02858492|66680436|FG002|Overall Study|Lack of Efficacy|0|||
23809215|NCT02858492|66680437|FG003|Overall Study|Lack of Efficacy|1|||
23809216|NCT02858492|66680434|FG000|Overall Study|Protocol defined stopping criteria|0|||
23809217|NCT02858492|66680435|FG001|Overall Study|Protocol defined stopping criteria|0|||
23809218|NCT02858492|66680436|FG002|Overall Study|Protocol defined stopping criteria|0|||
23809219|NCT02858492|66680437|FG003|Overall Study|Protocol defined stopping criteria|1|||
23809220|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Adverse Event|9|||
23809221|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Adverse Event|4|||
23809222|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Adverse Event|5|||
23809223|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Adverse Event|9|||
23809224|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Adverse Event|8|||
23809225|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Adverse Event|0|||
23809226|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Adverse Event|0|||
23809227|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
23809228|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
23809229|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
23809230|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
23809231|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
23809232|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
23809233|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
23809234|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Death|1|||
23809235|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Death|1|||
23809236|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Death|1|||
23809237|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Death|1|||
23809238|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Death|0|||
23809239|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Death|0|||
23809240|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Death|0|||
23809241|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
23809242|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23809243|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23809244|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23809245|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
23809246|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
23809247|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
23809248|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809249|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809250|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
23809251|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809252|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809253|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809254|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23809255|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
23809256|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
23809257|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
23809258|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
23809259|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
23809260|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
23809261|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
23809262|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Other|2|||
23809263|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Other|9|||
23809264|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Other|9|||
23809265|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Other|3|||
23809266|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Other|2|||
23809267|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Other|0|||
23809268|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Other|0|||
23809269|NCT00361335|66680439|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
23809270|NCT00361335|66680440|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
23809271|NCT00361335|66680441|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
23809272|NCT00361335|66680442|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
23809273|NCT00361335|66680443|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
23809274|NCT00361335|66680444|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
23809275|NCT00361335|66680445|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
23809276|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
23809277|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
23809278|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
23809279|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
23809280|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
23809281|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
23809282|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
23809283|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23809284|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23809285|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23809286|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23809287|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23809288|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23809289|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23809290|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Death|0|||
23809291|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Death|0|||
23809292|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Death|0|||
23809293|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Death|0|||
23809294|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Death|0|||
23809295|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Death|0|||
23809296|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Death|1|||
23809297|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23809298|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23809299|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23809300|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23809301|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23809302|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23809303|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23809304|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Other|1|||
23809305|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Other|0|||
23809306|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Other|0|||
23809307|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Other|1|||
23809308|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Other|0|||
23809309|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Other|1|||
23809310|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Other|2|||
23809311|NCT00361335|66680439|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23809312|NCT00361335|66680440|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23809313|NCT00361335|66680441|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
23809314|NCT00361335|66680442|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23809315|NCT00361335|66680443|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23809316|NCT00361335|66680444|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23809317|NCT00361335|66680445|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
23809318|NCT01780987|66680446|FG000|Overall Study|Adverse Event|0|||
23809319|NCT01780987|66680447|FG001|Overall Study|Adverse Event|4|||
23809320|NCT01780987|66680446|FG000|Overall Study|Withdrawal by Subject|2|||
23809321|NCT01780987|66680447|FG001|Overall Study|Withdrawal by Subject|0|||
23809322|NCT01780987|66680446|FG000|Overall Study|Request of Changing Hospital|0|||
23809323|NCT01780987|66680447|FG001|Overall Study|Request of Changing Hospital|1|||
23809324|NCT01780987|66680446|FG000|Overall Study|Changing Residence|1|||
23809325|NCT01780987|66680447|FG001|Overall Study|Changing Residence|0|||
23809326|NCT01780987|66680446|FG000|Overall Study|Not Receiving any Study Medication|0|||
23809327|NCT01780987|66680447|FG001|Overall Study|Not Receiving any Study Medication|1|||
23809328|NCT02358343|66680462|FG000|Screening Intervention|Death|0|||
23809329|NCT02358343|66680463|FG001|Screening Intervention|Death|2|||
23809330|NCT02358343|66680464|FG002|Screening Intervention|Death|0|||
23809331|NCT02358343|66680465|FG003|Screening Intervention|Death|0|||
23809332|NCT02358343|66680466|FG004|Screening Intervention|Death|0|||
23809333|NCT02358343|66680462|FG000|Screening Intervention|Withdrawal by Subject|1|||
23809334|NCT02358343|66680463|FG001|Screening Intervention|Withdrawal by Subject|0|||
23809335|NCT02358343|66680464|FG002|Screening Intervention|Withdrawal by Subject|0|||
23809336|NCT02358343|66680465|FG003|Screening Intervention|Withdrawal by Subject|0|||
23809337|NCT02358343|66680466|FG004|Screening Intervention|Withdrawal by Subject|0|||
23809338|NCT02358343|66680462|FG000|Screening Intervention|Determined Ineligible|5|||
23809339|NCT02358343|66680463|FG001|Screening Intervention|Determined Ineligible|6|||
23809340|NCT02358343|66680464|FG002|Screening Intervention|Determined Ineligible|0|||
23809341|NCT02358343|66680465|FG003|Screening Intervention|Determined Ineligible|0|||
23809342|NCT02358343|66680466|FG004|Screening Intervention|Determined Ineligible|0|||
23809343|NCT02358343|66680462|FG000|Comparative Efficacy Trial / Observation|Death|0|||
23809344|NCT02358343|66680463|FG001|Comparative Efficacy Trial / Observation|Death|0|||
23809345|NCT02358343|66680464|FG002|Comparative Efficacy Trial / Observation|Death|2|||
23809346|NCT02358343|66680465|FG003|Comparative Efficacy Trial / Observation|Death|0|||
23809347|NCT02358343|66680466|FG004|Comparative Efficacy Trial / Observation|Death|0|||
23809348|NCT02358343|66680462|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
23809349|NCT02358343|66680463|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
23809350|NCT02358343|66680464|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23809351|NCT02358343|66680465|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23809352|NCT02358343|66680466|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23809353|NCT02358343|66680462|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23809354|NCT02358343|66680463|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23809355|NCT02358343|66680464|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
23809356|NCT02358343|66680465|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23809357|NCT02358343|66680466|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23809358|NCT02093221|66680470|FG000|Overall Study|Adverse Event|1|||
23809359|NCT02093221|66680471|FG001|Overall Study|Adverse Event|0|||
23809360|NCT02093221|66680472|FG002|Overall Study|Adverse Event|0|||
23809361|NCT02093221|66680473|FG003|Overall Study|Adverse Event|0|||
23809362|NCT02093221|66680474|FG004|Overall Study|Adverse Event|0|||
23809363|NCT02093221|66680470|FG000|Overall Study|Withdrawal by Subject|1|||
23809364|NCT02093221|66680471|FG001|Overall Study|Withdrawal by Subject|1|||
23809365|NCT02093221|66680472|FG002|Overall Study|Withdrawal by Subject|4|||
23809366|NCT02093221|66680473|FG003|Overall Study|Withdrawal by Subject|1|||
23809367|NCT02093221|66680474|FG004|Overall Study|Withdrawal by Subject|1|||
23809368|NCT02093221|66680470|FG000|Overall Study|Lost to Follow-up|2|||
23809369|NCT02093221|66680471|FG001|Overall Study|Lost to Follow-up|0|||
23809370|NCT02093221|66680472|FG002|Overall Study|Lost to Follow-up|1|||
23809371|NCT02093221|66680473|FG003|Overall Study|Lost to Follow-up|1|||
23809372|NCT02093221|66680474|FG004|Overall Study|Lost to Follow-up|0|||
23809373|NCT02093221|66680470|FG000|Overall Study|Death|0|||
23809374|NCT02093221|66680471|FG001|Overall Study|Death|1|||
23809375|NCT02093221|66680472|FG002|Overall Study|Death|0|||
23809376|NCT02093221|66680473|FG003|Overall Study|Death|0|||
23809377|NCT02093221|66680474|FG004|Overall Study|Death|0|||
23809378|NCT02093221|66680470|FG000|Overall Study|Protocol Violation|0|||
23809379|NCT02093221|66680471|FG001|Overall Study|Protocol Violation|1|||
23809380|NCT02093221|66680472|FG002|Overall Study|Protocol Violation|0|||
23809381|NCT02093221|66680473|FG003|Overall Study|Protocol Violation|0|||
23809382|NCT02093221|66680474|FG004|Overall Study|Protocol Violation|0|||
23809383|NCT02093221|66680470|FG000|Overall Study|Study termination|6|||
23809384|NCT02093221|66680471|FG001|Overall Study|Study termination|5|||
23809385|NCT02093221|66680472|FG002|Overall Study|Study termination|4|||
23809386|NCT02093221|66680473|FG003|Overall Study|Study termination|6|||
23809387|NCT02093221|66680474|FG004|Overall Study|Study termination|7|||
23809388|NCT02400671|66680475|FG000|Overall Study|Death|5|||
23809389|NCT02400671|66680476|FG001|Overall Study|Death|3|||
23809390|NCT02400671|66680477|FG002|Overall Study|Death|4|||
23809391|NCT02400671|66680475|FG000|Overall Study|Lost to Follow-up|20|||
23809392|NCT02400671|66680476|FG001|Overall Study|Lost to Follow-up|27|||
23809393|NCT02400671|66680477|FG002|Overall Study|Lost to Follow-up|24|||
23809394|NCT02400671|66680475|FG000|Overall Study|Withdrawal by Subject|2|||
23809395|NCT02400671|66680476|FG001|Overall Study|Withdrawal by Subject|2|||
23809396|NCT02400671|66680477|FG002|Overall Study|Withdrawal by Subject|0|||
23809397|NCT00986180|66680478|FG000|Overall Study|Adverse Event|21|||
23809398|NCT00986180|66680479|FG001|Overall Study|Adverse Event|23|||
23809399|NCT00986180|66680478|FG000|Overall Study|Lack of Efficacy|4|||
23809400|NCT00986180|66680479|FG001|Overall Study|Lack of Efficacy|3|||
23809401|NCT00986180|66680478|FG000|Overall Study|Lost to Follow-up|5|||
23809402|NCT00986180|66680479|FG001|Overall Study|Lost to Follow-up|7|||
23809403|NCT00986180|66680478|FG000|Overall Study|Physician Decision|1|||
23809404|NCT00986180|66680479|FG001|Overall Study|Physician Decision|3|||
23809405|NCT00986180|66680478|FG000|Overall Study|Protocol Violation|2|||
23809406|NCT00986180|66680479|FG001|Overall Study|Protocol Violation|0|||
23809407|NCT00986180|66680478|FG000|Overall Study|Withdrawal by Subject|1|||
23809408|NCT00986180|66680479|FG001|Overall Study|Withdrawal by Subject|9|||
23809409|NCT00986180|66680478|FG000|Overall Study|Miscellanies|10|||
23809410|NCT00986180|66680479|FG001|Overall Study|Miscellanies|11|||
23809411|NCT01902628|66680480|FG000|Overall Study|Withdrawal of participant's consent|7|||
23809412|NCT01902628|66680480|FG000|Overall Study|Adverse Event|41|||
23809413|NCT01902628|66680480|FG000|Overall Study|Lost to Follow-up|35|||
23809414|NCT02570113|66680481|FG000|Overall Study|Withdrawal by Subject|3|||
23809415|NCT01971970|66680482|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
23809416|NCT01971970|66680483|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
23809417|NCT01971970|66680482|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
23809418|NCT01971970|66680483|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
23809419|NCT01971970|66680482|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
23809420|NCT01971970|66680483|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
23809421|NCT01971970|66680482|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
23809422|NCT01971970|66680483|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
23809423|NCT01971970|66680482|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
23809424|NCT01971970|66680483|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
23809425|NCT01971970|66680482|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
23809426|NCT01971970|66680483|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
23809427|NCT01971970|66680482|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
23809428|NCT01971970|66680483|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
23809429|NCT01700049|66680484|FG000|Overall Study|Withdrawal by Subject|1|||
23809430|NCT02372071|66680487|FG000|Overall Study|Protocol Violation|18|||
23809431|NCT00609466|66680488|FG000|Overall Study|Withdrawal by Subject|0|||
23809432|NCT00609466|66680489|FG001|Overall Study|Withdrawal by Subject|1|||
23809433|NCT00609466|66680490|FG002|Overall Study|Withdrawal by Subject|1|||
23809434|NCT00609466|66680488|FG000|Overall Study|Adverse Event|2|||
23809435|NCT00609466|66680489|FG001|Overall Study|Adverse Event|3|||
23809436|NCT00609466|66680490|FG002|Overall Study|Adverse Event|1|||
23809437|NCT00609466|66680488|FG000|Overall Study|Lack of Efficacy|0|||
23809438|NCT00609466|66680489|FG001|Overall Study|Lack of Efficacy|2|||
23809439|NCT00609466|66680490|FG002|Overall Study|Lack of Efficacy|2|||
23809440|NCT03247517|66680491|FG000|Overall Study|Adverse Event|0|||
23809441|NCT03247517|66680492|FG001|Overall Study|Adverse Event|4|||
23809442|NCT03247517|66680493|FG002|Overall Study|Adverse Event|2|||
23809443|NCT03247517|66680491|FG000|Overall Study|Lost to Follow-up|2|||
23809444|NCT03247517|66680492|FG001|Overall Study|Lost to Follow-up|6|||
23809445|NCT03247517|66680493|FG002|Overall Study|Lost to Follow-up|4|||
23809446|NCT03247517|66680491|FG000|Overall Study|Consent withdrawn by caregiver|1|||
23809447|NCT03247517|66680492|FG001|Overall Study|Consent withdrawn by caregiver|4|||
23809448|NCT03247517|66680493|FG002|Overall Study|Consent withdrawn by caregiver|7|||
23809449|NCT03247517|66680491|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
23809450|NCT03247517|66680492|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
23809451|NCT03247517|66680493|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
23809452|NCT03247517|66680491|FG000|Overall Study|Protocol Violation|0|||
23809453|NCT03247517|66680492|FG001|Overall Study|Protocol Violation|2|||
23809454|NCT03247517|66680493|FG002|Overall Study|Protocol Violation|0|||
23809455|NCT03247517|66680491|FG000|Overall Study|Multiple reasons|3|||
23809456|NCT03247517|66680492|FG001|Overall Study|Multiple reasons|1|||
23809457|NCT03247517|66680493|FG002|Overall Study|Multiple reasons|0|||
23809458|NCT00793780|66680497|FG000|Overall Study|Withdrawal by Subject|2|||
23809459|NCT00793780|66680498|FG001|Overall Study|Withdrawal by Subject|1|||
23809460|NCT02699684|66680499|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
23809461|NCT02699684|66680500|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
23809462|NCT03582826|66680501|FG000|Overall Study|Lost to Follow-up|39|||
23809463|NCT03582826|66680502|FG001|Overall Study|Lost to Follow-up|0|||
23809464|NCT03582826|66680501|FG000|Overall Study|Withdrawal by Subject|2|||
23809465|NCT03582826|66680502|FG001|Overall Study|Withdrawal by Subject|0|||
23809466|NCT04319159|66680503|FG000|Overall Study|Screening failure|13|||
23809467|NCT04319159|66680503|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
23809468|NCT04319159|66680503|FG000|Overall Study|Withdrawal by Subject|1|||
23809469|NCT01951885|66680504|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
23809470|NCT01951885|66680505|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
23809471|NCT01951885|66680504|FG000|Overall Study|Adverse Event|1|||
23809472|NCT01951885|66680505|FG001|Overall Study|Adverse Event|0|||
23809473|NCT01951885|66680504|FG000|Overall Study|Withdrawal by Subject|0|||
23809474|NCT01951885|66680505|FG001|Overall Study|Withdrawal by Subject|1|||
23809475|NCT01951885|66680504|FG000|Overall Study|ineligible due to a change in donor|0|||
23809476|NCT01951885|66680505|FG001|Overall Study|ineligible due to a change in donor|1|||
23809477|NCT01951885|66680504|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
23809478|NCT01951885|66680505|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
23809479|NCT00123474|66680506|FG000|Randomized to Treatment|Randomized, never treated|1|||
23809480|NCT00123474|66680507|FG001|Randomized to Treatment|Randomized, never treated|4|||
23504781|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23809481|NCT00123474|66680508|FG002|Randomized to Treatment|Randomized, never treated|2|||
23809482|NCT00123474|66680509|FG003|Randomized to Treatment|Randomized, never treated|1|||
23809483|NCT00123474|66680506|FG000|As Treated at Study Closure|not reported when site closed|1|||
23809484|NCT00123474|66680507|FG001|As Treated at Study Closure|not reported when site closed|0|||
23809485|NCT00123474|66680508|FG002|As Treated at Study Closure|not reported when site closed|1|||
23809486|NCT00123474|66680509|FG003|As Treated at Study Closure|not reported when site closed|0|||
23809487|NCT00123474|66680506|FG000|As Treated at Study Closure|Adverse Event|10|||
23809488|NCT00123474|66680507|FG001|As Treated at Study Closure|Adverse Event|4|||
23809489|NCT00123474|66680508|FG002|As Treated at Study Closure|Adverse Event|10|||
23809490|NCT00123474|66680509|FG003|As Treated at Study Closure|Adverse Event|8|||
23809491|NCT00123474|66680506|FG000|As Treated at Study Closure|Disease Progression|35|||
23809492|NCT00123474|66680507|FG001|As Treated at Study Closure|Disease Progression|42|||
23809493|NCT00123474|66680508|FG002|As Treated at Study Closure|Disease Progression|29|||
23809494|NCT00123474|66680509|FG003|As Treated at Study Closure|Disease Progression|27|||
23809495|NCT00123474|66680506|FG000|As Treated at Study Closure|Investigator Request|12|||
23809496|NCT00123474|66680507|FG001|As Treated at Study Closure|Investigator Request|6|||
23809497|NCT00123474|66680508|FG002|As Treated at Study Closure|Investigator Request|7|||
23809498|NCT00123474|66680509|FG003|As Treated at Study Closure|Investigator Request|5|||
23809499|NCT00123474|66680506|FG000|As Treated at Study Closure|non-specified|54|||
23809500|NCT00123474|66680507|FG001|As Treated at Study Closure|non-specified|47|||
23809501|NCT00123474|66680508|FG002|As Treated at Study Closure|non-specified|57|||
23809502|NCT00123474|66680509|FG003|As Treated at Study Closure|non-specified|60|||
23809503|NCT00123474|66680506|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
23809504|NCT00123474|66680507|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
23809505|NCT00123474|66680508|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
23809506|NCT00123474|66680509|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
23809507|NCT00123474|66680506|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
23809508|NCT00123474|66680507|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
23809509|NCT00123474|66680508|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
23809510|NCT00123474|66680509|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
23809511|NCT01892657|66680512|FG000|Overall Study|Withdrawal by Subject|6|||
23809512|NCT01892657|66680512|FG000|Overall Study|Protocol Violation|12|||
23809513|NCT00444457|66680513|FG000|Infant Series|Other|0|||
23809514|NCT00444457|66680514|FG001|Infant Series|Other|1|||
23809515|NCT00444457|66680515|FG002|Infant Series|Other|0|||
23809516|NCT00444457|66680516|FG003|Infant Series|Other|0|||
23809517|NCT00444457|66680513|FG000|Infant Series|Parent or legal guardian request|18|||
23809518|NCT00444457|66680514|FG001|Infant Series|Parent or legal guardian request|29|||
23809519|NCT00444457|66680515|FG002|Infant Series|Parent or legal guardian request|34|||
23809520|NCT00444457|66680516|FG003|Infant Series|Parent or legal guardian request|14|||
23504782|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504783|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504784|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504785|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504786|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504787|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504788|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504789|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504790|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504791|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504792|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504793|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504794|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504795|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
23504796|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504797|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504798|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504799|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504800|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504801|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504802|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504803|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504804|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504805|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504806|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504807|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504808|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504809|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504810|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504811|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504812|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23809521|NCT00444457|66680513|FG000|Infant Series|Lost to Follow-up|10|||
23809522|NCT00444457|66680514|FG001|Infant Series|Lost to Follow-up|11|||
23809523|NCT00444457|66680515|FG002|Infant Series|Lost to Follow-up|7|||
23504813|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23809524|NCT00444457|66680516|FG003|Infant Series|Lost to Follow-up|6|||
23809525|NCT00444457|66680513|FG000|Infant Series|Protocol Violation|16|||
23504814|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504815|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504816|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504817|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504818|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504819|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504820|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504821|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
23504822|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504823|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504824|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504825|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504826|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504827|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504828|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504829|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504830|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504831|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504832|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504833|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504834|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504835|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504836|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504837|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504838|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504839|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504840|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504841|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504842|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504843|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504844|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504845|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504846|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504847|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504848|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504849|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
23504850|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
23504851|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
23504852|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504853|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504854|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504855|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504856|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504857|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504858|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504859|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504860|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504861|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504862|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504863|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504864|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504865|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504866|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504867|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504868|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504869|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504870|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504871|NCT03129100|65587876|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23809526|NCT00444457|66680514|FG001|Infant Series|Protocol Violation|8|||
23504872|NCT03129100|65587877|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504873|NCT03129100|65587878|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23809527|NCT00444457|66680515|FG002|Infant Series|Protocol Violation|6|||
23504874|NCT03129100|65587879|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504875|NCT03129100|65587880|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23809528|NCT00444457|66680516|FG003|Infant Series|Protocol Violation|3|||
23809529|NCT00444457|66680513|FG000|Infant Series|Failed to return|5|||
23809530|NCT00444457|66680514|FG001|Infant Series|Failed to return|4|||
23809531|NCT00444457|66680515|FG002|Infant Series|Failed to return|4|||
23809532|NCT00444457|66680516|FG003|Infant Series|Failed to return|2|||
23809533|NCT00444457|66680513|FG000|Infant Series|Investigator request|4|||
23809534|NCT00444457|66680514|FG001|Infant Series|Investigator request|3|||
23809535|NCT00444457|66680515|FG002|Infant Series|Investigator request|3|||
23809536|NCT00444457|66680516|FG003|Infant Series|Investigator request|2|||
23809537|NCT00444457|66680513|FG000|Infant Series|Other|0|||
23809538|NCT00444457|66680514|FG001|Infant Series|Other|2|||
23809539|NCT00444457|66680515|FG002|Infant Series|Other|4|||
23809540|NCT00444457|66680516|FG003|Infant Series|Other|0|||
23809541|NCT00444457|66680513|FG000|Infant Series|Adverse Event|1|||
23809542|NCT00444457|66680514|FG001|Infant Series|Adverse Event|2|||
23809543|NCT00444457|66680515|FG002|Infant Series|Adverse Event|2|||
23809544|NCT00444457|66680516|FG003|Infant Series|Adverse Event|0|||
23809545|NCT00444457|66680513|FG000|Infant Series|Death|0|||
23809546|NCT00444457|66680514|FG001|Infant Series|Death|1|||
23809547|NCT00444457|66680515|FG002|Infant Series|Death|1|||
23809548|NCT00444457|66680516|FG003|Infant Series|Death|1|||
23809549|NCT00444457|66680513|FG000|After Infant Series|Other|0|||
23809550|NCT00444457|66680514|FG001|After Infant Series|Other|1|||
23809551|NCT00444457|66680515|FG002|After Infant Series|Other|1|||
23809552|NCT00444457|66680516|FG003|After Infant Series|Other|1|||
23809553|NCT00444457|66680513|FG000|After Infant Series|Parent or legal guardian request|4|||
23809554|NCT00444457|66680514|FG001|After Infant Series|Parent or legal guardian request|11|||
23809555|NCT00444457|66680515|FG002|After Infant Series|Parent or legal guardian request|6|||
23809556|NCT00444457|66680516|FG003|After Infant Series|Parent or legal guardian request|3|||
23809557|NCT00444457|66680513|FG000|After Infant Series|Failed to return|7|||
23809558|NCT00444457|66680514|FG001|After Infant Series|Failed to return|6|||
23809559|NCT00444457|66680515|FG002|After Infant Series|Failed to return|5|||
23809560|NCT00444457|66680516|FG003|After Infant Series|Failed to return|1|||
23809561|NCT00444457|66680513|FG000|After Infant Series|Lost to Follow-up|5|||
23809562|NCT00444457|66680514|FG001|After Infant Series|Lost to Follow-up|5|||
23809563|NCT00444457|66680515|FG002|After Infant Series|Lost to Follow-up|5|||
23809564|NCT00444457|66680516|FG003|After Infant Series|Lost to Follow-up|2|||
23809565|NCT00444457|66680513|FG000|After Infant Series|Protocol Violation|2|||
23504876|NCT03129100|65587881|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504877|NCT03129100|65587882|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504878|NCT03129100|65587883|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504879|NCT03129100|65587884|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504880|NCT03129100|65587885|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
23504881|NCT03129100|65587886|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504882|NCT03129100|65587887|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504883|NCT03129100|65587888|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504884|NCT03129100|65587889|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504885|NCT03129100|65587890|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504886|NCT03129100|65587891|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504887|NCT03129100|65587892|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504888|NCT03129100|65587893|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504889|NCT03129100|65587894|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504890|NCT03129100|65587895|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504891|NCT03129100|65587896|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504892|NCT03129100|65587897|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504893|NCT03129100|65587898|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23809566|NCT00444457|66680514|FG001|After Infant Series|Protocol Violation|4|||
23809567|NCT00444457|66680515|FG002|After Infant Series|Protocol Violation|2|||
23809568|NCT00444457|66680516|FG003|After Infant Series|Protocol Violation|2|||
23809569|NCT00444457|66680513|FG000|After Infant Series|Adverse Event|2|||
23809570|NCT00444457|66680514|FG001|After Infant Series|Adverse Event|2|||
23809571|NCT00444457|66680515|FG002|After Infant Series|Adverse Event|0|||
23809572|NCT00444457|66680516|FG003|After Infant Series|Adverse Event|0|||
23809573|NCT00444457|66680513|FG000|After Infant Series|Investigator request|0|||
23809574|NCT00444457|66680514|FG001|After Infant Series|Investigator request|0|||
23809575|NCT00444457|66680515|FG002|After Infant Series|Investigator request|0|||
23809576|NCT00444457|66680516|FG003|After Infant Series|Investigator request|1|||
23809577|NCT00444457|66680513|FG000|After Infant Series|Other|0|||
23809578|NCT00444457|66680514|FG001|After Infant Series|Other|1|||
23809579|NCT00444457|66680515|FG002|After Infant Series|Other|0|||
23809580|NCT00444457|66680516|FG003|After Infant Series|Other|0|||
23809581|NCT00444457|66680513|FG000|Toddler Dose|Lost to Follow-up|4|||
23504894|NCT03129100|65587899|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504895|NCT03129100|65587900|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504896|NCT03129100|65587901|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504897|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23809582|NCT00444457|66680514|FG001|Toddler Dose|Lost to Follow-up|1|||
23809583|NCT00444457|66680515|FG002|Toddler Dose|Lost to Follow-up|1|||
23809584|NCT00444457|66680516|FG003|Toddler Dose|Lost to Follow-up|3|||
23809585|NCT00444457|66680513|FG000|Toddler Dose|Failed to return|2|||
23809586|NCT00444457|66680514|FG001|Toddler Dose|Failed to return|2|||
23809587|NCT00444457|66680515|FG002|Toddler Dose|Failed to return|1|||
23504898|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504899|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23809588|NCT00444457|66680516|FG003|Toddler Dose|Failed to return|3|||
23809589|NCT00444457|66680513|FG000|Toddler Dose|Parent or legal guardian request|0|||
23809590|NCT00444457|66680514|FG001|Toddler Dose|Parent or legal guardian request|3|||
23504900|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504901|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504902|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504903|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504904|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504905|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504906|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504907|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504908|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
23809591|NCT00444457|66680515|FG002|Toddler Dose|Parent or legal guardian request|2|||
23809592|NCT00444457|66680516|FG003|Toddler Dose|Parent or legal guardian request|1|||
23809593|NCT00444457|66680513|FG000|Toddler Dose|Protocol Violation|1|||
23809594|NCT00444457|66680514|FG001|Toddler Dose|Protocol Violation|0|||
23809595|NCT00444457|66680515|FG002|Toddler Dose|Protocol Violation|0|||
23809596|NCT00444457|66680516|FG003|Toddler Dose|Protocol Violation|1|||
23809597|NCT00121134|66680517|FG000|Overall Study|Progression of Disease|5|||
23809598|NCT00121134|66680518|FG001|Overall Study|Progression of Disease|3|||
23809599|NCT00121134|66680519|FG002|Overall Study|Progression of Disease|4|||
23809600|NCT00121134|66680520|FG003|Overall Study|Progression of Disease|2|||
23504909|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504910|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504911|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504912|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504913|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504914|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504915|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504916|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504917|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504918|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504919|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504920|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504921|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504922|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504923|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504924|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504925|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504926|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504927|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504928|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504929|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504930|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23809601|NCT00121134|66680517|FG000|Overall Study|Toxicity|4|||
23809602|NCT00121134|66680518|FG001|Overall Study|Toxicity|7|||
23809603|NCT00121134|66680519|FG002|Overall Study|Toxicity|13|||
23809604|NCT00121134|66680520|FG003|Overall Study|Toxicity|5|||
23809605|NCT00121134|66680517|FG000|Overall Study|Physician Decision|6|||
23809606|NCT00121134|66680518|FG001|Overall Study|Physician Decision|4|||
23809607|NCT00121134|66680519|FG002|Overall Study|Physician Decision|4|||
23809608|NCT00121134|66680520|FG003|Overall Study|Physician Decision|1|||
23809609|NCT00121134|66680517|FG000|Overall Study|Treatment Delay|1|||
23809610|NCT00121134|66680518|FG001|Overall Study|Treatment Delay|0|||
23809611|NCT00121134|66680519|FG002|Overall Study|Treatment Delay|0|||
23809612|NCT00121134|66680520|FG003|Overall Study|Treatment Delay|0|||
23504931|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504932|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23809613|NCT00121134|66680517|FG000|Overall Study|Intercurrent Illness|0|||
23809614|NCT00121134|66680518|FG001|Overall Study|Intercurrent Illness|0|||
23809615|NCT00121134|66680519|FG002|Overall Study|Intercurrent Illness|0|||
23809616|NCT00121134|66680520|FG003|Overall Study|Intercurrent Illness|1|||
23809617|NCT00121134|66680517|FG000|Overall Study|Patient Personal Reasons|0|||
23809618|NCT00121134|66680518|FG001|Overall Study|Patient Personal Reasons|1|||
23809619|NCT00121134|66680519|FG002|Overall Study|Patient Personal Reasons|0|||
23809620|NCT00121134|66680520|FG003|Overall Study|Patient Personal Reasons|0|||
23809621|NCT02534844|66680521|FG000|Part B|Withdrawal by Subject|0|||
23809622|NCT02534844|66680522|FG001|Part B|Withdrawal by Subject|0|||
23809623|NCT02534844|66680523|FG002|Part B|Withdrawal by Subject|0|||
23504933|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504934|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
23504935|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
23504936|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
23504937|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
23504938|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504939|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504940|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504941|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504942|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504943|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504944|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504945|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504946|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504947|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23809624|NCT02534844|66680524|FG003|Part B|Withdrawal by Subject|0|||
23809625|NCT02534844|66680525|FG004|Part B|Withdrawal by Subject|2|||
23809626|NCT02534844|66680526|FG005|Part B|Withdrawal by Subject|1|||
23809627|NCT00076804|66680527|FG000|Overall Study|Death|9|||
23504948|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504949|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504950|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504951|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504952|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504953|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23809628|NCT00076804|66680528|FG001|Overall Study|Death|20|||
23809629|NCT00076804|66680527|FG000|Overall Study|Lost to Follow-up|9|||
23809630|NCT00076804|66680528|FG001|Overall Study|Lost to Follow-up|9|||
23809631|NCT00076804|66680527|FG000|Overall Study|Withdrawal by Subject|10|||
23809632|NCT00076804|66680528|FG001|Overall Study|Withdrawal by Subject|8|||
23809633|NCT00076804|66680527|FG000|Overall Study|Early study Closure|32|||
23809634|NCT00076804|66680528|FG001|Overall Study|Early study Closure|32|||
23809635|NCT00197496|66680535|FG000|Baseline to Discharge|not interested|1|||
23809636|NCT00197496|66680536|FG001|Baseline to Discharge|not interested|0|||
23809637|NCT00197496|66680535|FG000|Baseline to Discharge|MRSA|1|||
23809638|NCT00197496|66680536|FG001|Baseline to Discharge|MRSA|0|||
23504954|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504955|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504956|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504957|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23809639|NCT00197496|66680535|FG000|Baseline to Discharge|Physician Decision|0|||
23809640|NCT00197496|66680536|FG001|Baseline to Discharge|Physician Decision|1|||
23809641|NCT00197496|66680535|FG000|Baseline to Discharge|Protocol Violation|0|||
23809642|NCT00197496|66680536|FG001|Baseline to Discharge|Protocol Violation|1|||
23809643|NCT00197496|66680535|FG000|Follow-up|Lost to Follow-up|2|||
23809644|NCT00197496|66680536|FG001|Follow-up|Lost to Follow-up|1|||
23809645|NCT01565850|66680540|FG000|Overall Study|Adverse Event|0|||
23809646|NCT01565850|66680541|FG001|Overall Study|Adverse Event|1|||
23809647|NCT01565850|66680540|FG000|Overall Study|Lost to Follow-up|12|||
23809648|NCT01565850|66680541|FG001|Overall Study|Lost to Follow-up|4|||
23809649|NCT01565850|66680540|FG000|Overall Study|Investigator's Discretion|2|||
23809650|NCT01565850|66680541|FG001|Overall Study|Investigator's Discretion|1|||
23809651|NCT01565850|66680540|FG000|Overall Study|Participant noncompliance|2|||
23809652|NCT01565850|66680541|FG001|Overall Study|Participant noncompliance|0|||
23809653|NCT01565850|66680540|FG000|Overall Study|Withdrew Consent|4|||
23809654|NCT01565850|66680541|FG001|Overall Study|Withdrew Consent|2|||
23809655|NCT00910091|66680545|FG000|Pre-assignment|Withdrawal by Subject|0|||
23809656|NCT00910091|66680546|FG001|Pre-assignment|Withdrawal by Subject|2|||
23809657|NCT00910091|66680545|FG000|Treatment and Survival|Withdrawal by Subject|3|||
23340849|NCT01936181|64992870|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
23504958|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504959|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504960|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504961|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504962|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504963|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504964|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504965|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504966|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504967|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504968|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504969|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504970|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504971|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504972|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504973|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504974|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504975|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504976|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504977|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504978|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504979|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504980|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504981|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504982|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504983|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504984|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23809658|NCT00910091|66680546|FG001|Treatment and Survival|Withdrawal by Subject|4|||
23809659|NCT00910091|66680545|FG000|Treatment and Survival|Adverse Event|1|||
23809660|NCT00910091|66680546|FG001|Treatment and Survival|Adverse Event|0|||
23809661|NCT00289874|66680547|FG000|Overall Study|Adverse Event|1|||
23809662|NCT00289874|66680548|FG001|Overall Study|Adverse Event|5|||
23809663|NCT00289874|66680547|FG000|Overall Study|Lost to Follow-up|1|||
23809664|NCT00289874|66680548|FG001|Overall Study|Lost to Follow-up|1|||
23809665|NCT00289874|66680547|FG000|Overall Study|Protocol Violation|3|||
23809666|NCT00289874|66680548|FG001|Overall Study|Protocol Violation|2|||
23809667|NCT00289874|66680547|FG000|Overall Study|Did not meet eligibility|1|||
23809668|NCT00289874|66680548|FG001|Overall Study|Did not meet eligibility|0|||
23809669|NCT02674061|66680549|FG000|Overall Study|Death|229|||
23809670|NCT02674061|66680550|FG001|Overall Study|Death|77|||
23809671|NCT02674061|66680549|FG000|Overall Study|Lost to Follow-up|3|||
23809672|NCT02674061|66680550|FG001|Overall Study|Lost to Follow-up|3|||
23809673|NCT02674061|66680549|FG000|Overall Study|Withdrawal by Subject|9|||
23809674|NCT02674061|66680550|FG001|Overall Study|Withdrawal by Subject|1|||
23809675|NCT02674061|66680549|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
23809676|NCT02674061|66680550|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
23809677|NCT01059539|66680551|FG000|Overall Study|Adverse Event|66|||
23809678|NCT01059539|66680551|FG000|Overall Study|Insufficient Therapeutic Response|26|||
23809679|NCT01059539|66680551|FG000|Overall Study|Protocol Violation|55|||
23809680|NCT01059539|66680551|FG000|Overall Study|Withdrawal of Consent|80|||
23809681|NCT01059539|66680551|FG000|Overall Study|Lost to Follow-up|42|||
23809682|NCT01059539|66680551|FG000|Overall Study|Reason Not Specified|2|||
23809683|NCT03258853|66680560|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
23809684|NCT03258853|66680561|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
23809685|NCT03484117|66680562|FG000|Overall Study|Lost to Follow-up|1|||
23809686|NCT03484117|66680563|FG001|Overall Study|Lost to Follow-up|3|||
23809687|NCT03484117|66680562|FG000|Overall Study|Declined participation in exit assess|1|||
23809688|NCT03484117|66680563|FG001|Overall Study|Declined participation in exit assess|1|||
23809689|NCT01030341|66680564|FG000|Overall Study|Withdrawal by Subject|1|||
23809690|NCT01030341|66680564|FG000|Overall Study|Lost to Follow-up|2|||
23809691|NCT01347866|66680566|FG000|Overall Study|Death|0|||
23809692|NCT01347866|66680567|FG001|Overall Study|Death|0|||
23809693|NCT01347866|66680568|FG002|Overall Study|Death|0|||
23809694|NCT01347866|66680569|FG003|Overall Study|Death|1|||
23809695|NCT01347866|66680570|FG004|Overall Study|Death|2|||
23809696|NCT01347866|66680571|FG005|Overall Study|Death|2|||
23809697|NCT01347866|66680572|FG006|Overall Study|Death|1|||
23809698|NCT01347866|66680573|FG007|Overall Study|Death|0|||
23504985|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23809699|NCT01347866|66680574|FG008|Overall Study|Death|4|||
23809700|NCT01347866|66680575|FG009|Overall Study|Death|1|||
23809701|NCT01347866|66680576|FG010|Overall Study|Death|3|||
23809702|NCT01347866|66680577|FG011|Overall Study|Death|1|||
23809703|NCT01347866|66680578|FG012|Overall Study|Death|2|||
23809704|NCT01347866|66680579|FG013|Overall Study|Death|0|||
23809705|NCT01347866|66680580|FG014|Overall Study|Death|0|||
23809706|NCT01347866|66680581|FG015|Overall Study|Death|1|||
23809707|NCT01347866|66680582|FG016|Overall Study|Death|0|||
23809708|NCT01347866|66680566|FG000|Overall Study|Lost to Follow-up|0|||
23809709|NCT01347866|66680567|FG001|Overall Study|Lost to Follow-up|0|||
23809710|NCT01347866|66680568|FG002|Overall Study|Lost to Follow-up|0|||
23809711|NCT01347866|66680569|FG003|Overall Study|Lost to Follow-up|0|||
23504986|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504987|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23809712|NCT01347866|66680570|FG004|Overall Study|Lost to Follow-up|0|||
23504988|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504989|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504990|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
23504991|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504992|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504993|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504994|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23809713|NCT01347866|66680571|FG005|Overall Study|Lost to Follow-up|0|||
23809714|NCT01347866|66680572|FG006|Overall Study|Lost to Follow-up|0|||
23809715|NCT01347866|66680573|FG007|Overall Study|Lost to Follow-up|1|||
23809716|NCT01347866|66680574|FG008|Overall Study|Lost to Follow-up|1|||
23809717|NCT01347866|66680575|FG009|Overall Study|Lost to Follow-up|0|||
23809718|NCT01347866|66680576|FG010|Overall Study|Lost to Follow-up|0|||
23809719|NCT01347866|66680577|FG011|Overall Study|Lost to Follow-up|0|||
23809720|NCT01347866|66680578|FG012|Overall Study|Lost to Follow-up|0|||
23809721|NCT01347866|66680579|FG013|Overall Study|Lost to Follow-up|0|||
23809722|NCT01347866|66680580|FG014|Overall Study|Lost to Follow-up|0|||
23809723|NCT01347866|66680581|FG015|Overall Study|Lost to Follow-up|0|||
23809724|NCT01347866|66680582|FG016|Overall Study|Lost to Follow-up|0|||
23809725|NCT01347866|66680566|FG000|Overall Study|Other|3|||
23809726|NCT01347866|66680567|FG001|Overall Study|Other|1|||
23809727|NCT01347866|66680568|FG002|Overall Study|Other|1|||
23809728|NCT01347866|66680569|FG003|Overall Study|Other|4|||
23809729|NCT01347866|66680570|FG004|Overall Study|Other|5|||
23809730|NCT01347866|66680571|FG005|Overall Study|Other|0|||
23809731|NCT01347866|66680572|FG006|Overall Study|Other|5|||
23809732|NCT01347866|66680573|FG007|Overall Study|Other|3|||
23809733|NCT01347866|66680574|FG008|Overall Study|Other|22|||
23809734|NCT01347866|66680575|FG009|Overall Study|Other|5|||
23504995|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504996|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504997|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504998|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504999|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23505000|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23505001|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505002|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505003|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505004|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505005|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505006|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505007|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505008|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809735|NCT01347866|66680576|FG010|Overall Study|Other|0|||
23809736|NCT01347866|66680577|FG011|Overall Study|Other|3|||
23809737|NCT01347866|66680578|FG012|Overall Study|Other|4|||
23809738|NCT01347866|66680579|FG013|Overall Study|Other|4|||
23809739|NCT01347866|66680580|FG014|Overall Study|Other|2|||
23809740|NCT01347866|66680581|FG015|Overall Study|Other|3|||
23809741|NCT01347866|66680582|FG016|Overall Study|Other|0|||
23809742|NCT01347866|66680566|FG000|Overall Study|Subject refused further follow-up|2|||
23809743|NCT01347866|66680567|FG001|Overall Study|Subject refused further follow-up|0|||
23809744|NCT01347866|66680568|FG002|Overall Study|Subject refused further follow-up|0|||
23809745|NCT01347866|66680569|FG003|Overall Study|Subject refused further follow-up|2|||
23809746|NCT01347866|66680570|FG004|Overall Study|Subject refused further follow-up|0|||
23809747|NCT01347866|66680571|FG005|Overall Study|Subject refused further follow-up|1|||
23809748|NCT01347866|66680572|FG006|Overall Study|Subject refused further follow-up|0|||
23809749|NCT01347866|66680573|FG007|Overall Study|Subject refused further follow-up|0|||
23505009|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809750|NCT01347866|66680574|FG008|Overall Study|Subject refused further follow-up|4|||
23809751|NCT01347866|66680575|FG009|Overall Study|Subject refused further follow-up|1|||
23809752|NCT01347866|66680576|FG010|Overall Study|Subject refused further follow-up|0|||
23505010|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809753|NCT01347866|66680577|FG011|Overall Study|Subject refused further follow-up|0|||
23809754|NCT01347866|66680578|FG012|Overall Study|Subject refused further follow-up|1|||
23809755|NCT01347866|66680579|FG013|Overall Study|Subject refused further follow-up|3|||
23809756|NCT01347866|66680580|FG014|Overall Study|Subject refused further follow-up|1|||
23505011|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505012|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505013|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
23809757|NCT01347866|66680581|FG015|Overall Study|Subject refused further follow-up|0|||
23809758|NCT01347866|66680582|FG016|Overall Study|Subject refused further follow-up|2|||
23809759|NCT00380692|66680583|FG000|Study Period II - Double Blind|Adverse Event|1|||
23809760|NCT00380692|66680584|FG001|Study Period II - Double Blind|Adverse Event|0|||
23809761|NCT00380692|66680583|FG000|Study Period II - Double Blind|Protocol Violation|2|||
23809762|NCT00380692|66680584|FG001|Study Period II - Double Blind|Protocol Violation|2|||
23809763|NCT00380692|66680583|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
23809764|NCT00380692|66680584|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
23809765|NCT00380692|66680583|FG000|Study Period II - Double Blind|Physician Decision|0|||
23809766|NCT00380692|66680584|FG001|Study Period II - Double Blind|Physician Decision|1|||
23809767|NCT00380692|66680583|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
23505014|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505015|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
23505016|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
23505017|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505018|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505019|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809768|NCT00380692|66680584|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
23505020|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505021|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809769|NCT00380692|66680583|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
23809770|NCT00380692|66680584|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
23809771|NCT00380692|66680583|FG000|Study Period III - Open Label|Adverse Event|5|||
23809772|NCT00380692|66680584|FG001|Study Period III - Open Label|Adverse Event|3|||
23809773|NCT00380692|66680583|FG000|Study Period III - Open Label|Protocol Violation|0|||
23809774|NCT00380692|66680584|FG001|Study Period III - Open Label|Protocol Violation|0|||
23809775|NCT00380692|66680583|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
23809776|NCT00380692|66680584|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
23809777|NCT00380692|66680583|FG000|Study Period III - Open Label|Physician Decision|0|||
23809778|NCT00380692|66680584|FG001|Study Period III - Open Label|Physician Decision|3|||
23809779|NCT00380692|66680583|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
23809780|NCT00380692|66680584|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
23809781|NCT00380692|66680583|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
23809782|NCT00380692|66680584|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
23809783|NCT02348723|66680585|FG000|Overall Study|No ablation|21|||
23809784|NCT02348723|66680586|FG001|Overall Study|No ablation|20|||
23809785|NCT02348723|66680585|FG000|Overall Study|Non-compliant with Protocol|1|||
23809786|NCT02348723|66680586|FG001|Overall Study|Non-compliant with Protocol|0|||
23809787|NCT02348723|66680585|FG000|Overall Study|Lost to Follow-up|1|||
23809788|NCT02348723|66680586|FG001|Overall Study|Lost to Follow-up|1|||
23809789|NCT02348723|66680585|FG000|Overall Study|Consent withdrawn|1|||
23809790|NCT02348723|66680586|FG001|Overall Study|Consent withdrawn|3|||
23809791|NCT02348723|66680585|FG000|Overall Study|Reason other than specified|1|||
23809792|NCT02348723|66680586|FG001|Overall Study|Reason other than specified|1|||
23809793|NCT02348723|66680585|FG000|Overall Study|Adverse Event|3|||
23809794|NCT02348723|66680586|FG001|Overall Study|Adverse Event|1|||
23505022|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23809795|NCT01946191|66680587|FG000|Allocation|Did not complete orientation|1|||
23809796|NCT01946191|66680588|FG001|Allocation|Did not complete orientation|1|||
23809797|NCT01946191|66680587|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
23809798|NCT01946191|66680588|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
23809799|NCT01946191|66680587|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
23809800|NCT01946191|66680588|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
23809801|NCT01946191|66680587|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
23809802|NCT01946191|66680588|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
23809803|NCT02856880|66680593|FG000|Overall Study|Withdrawal of consent|1|||
23809804|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
23809805|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
23809806|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
23809807|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
23809808|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
23809809|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
23809810|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
23809811|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
23809812|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
23809813|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
23505023|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505024|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505025|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505026|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505027|NCT03129100|65587876|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23809814|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
23809815|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
23809816|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
23809817|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
23809818|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
23809819|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
23809820|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
23809821|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
23809822|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
23809823|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
23809824|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
23809825|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23809826|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23809827|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23809828|NCT03514641|66680596|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23809829|NCT03514641|66680597|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
23809830|NCT03514641|66680598|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23809831|NCT03514641|66680599|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23809832|NCT03514641|66680596|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
23809833|NCT03514641|66680597|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
23809834|NCT03514641|66680598|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
23809835|NCT03514641|66680599|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
23809836|NCT03514641|66680596|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
23809837|NCT03514641|66680597|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
23809838|NCT03514641|66680598|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
23809839|NCT03514641|66680599|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
23809840|NCT03514641|66680596|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
23809841|NCT03514641|66680597|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
23809842|NCT03514641|66680598|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
23809843|NCT03514641|66680599|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
23809844|NCT03514641|66680596|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
23809845|NCT03514641|66680597|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
23809846|NCT03514641|66680598|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
23809847|NCT03514641|66680599|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
23809848|NCT03514641|66680596|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
23809849|NCT03514641|66680597|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
23809850|NCT03514641|66680598|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
23809851|NCT03514641|66680599|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
23809852|NCT00678041|66680606|FG000|Overall Study|Physician Decision|5|||
23809853|NCT00678041|66680607|FG001|Overall Study|Physician Decision|5|||
23809854|NCT02533375|66680608|FG000|Overall Study|Lack of Efficacy|3|||
23809855|NCT02533375|66680608|FG000|Overall Study|Adverse Event|2|||
23809856|NCT00846521|66684196|FG000|Overall Study|Withdrawal by Subject|5|||
23809857|NCT00846521|66684196|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
23809858|NCT00846521|66684196|FG000|Overall Study|Protocol Violation|1|||
23809859|NCT02987959|66684201|FG000|Overall Study|Grantor stopped supply of drugs|6|||
23809860|NCT01345175|66684203|FG000|Overall Study|Physician Decision|0|||
23809861|NCT01345175|66684204|FG001|Overall Study|Physician Decision|1|||
23809862|NCT01345175|66684203|FG000|Overall Study|Withdrawal by Subject|1|||
23809863|NCT01345175|66684204|FG001|Overall Study|Withdrawal by Subject|1|||
23809864|NCT01345175|66684203|FG000|Overall Study|Failed to complete BFI|3|||
23809865|NCT01345175|66684204|FG001|Overall Study|Failed to complete BFI|2|||
23809866|NCT01345175|66684203|FG000|Overall Study|Stopped taking medication|2|||
23809867|NCT01345175|66684204|FG001|Overall Study|Stopped taking medication|2|||
23809868|NCT03573505|66684206|FG000|Overall Study|Adverse Event|1|||
23809869|NCT03573505|66684207|FG001|Overall Study|Adverse Event|1|||
23809870|NCT03573505|66684206|FG000|Overall Study|Consent withdrawn|0|||
23809871|NCT03573505|66684207|FG001|Overall Study|Consent withdrawn|1|||
23505028|NCT03129100|65587877|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505029|NCT03129100|65587878|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23809872|NCT03573505|66684206|FG000|Overall Study|Disease progression|0|||
23809873|NCT03573505|66684207|FG001|Overall Study|Disease progression|1|||
23809874|NCT03573505|66684206|FG000|Overall Study|Site Terminated by Sponsor|1|||
23809875|NCT03573505|66684207|FG001|Overall Study|Site Terminated by Sponsor|1|||
23809876|NCT03573505|66684206|FG000|Overall Study|Study terminated by sponsor|50|||
23809877|NCT03573505|66684207|FG001|Overall Study|Study terminated by sponsor|45|||
23809878|NCT03573505|66684206|FG000|Overall Study|Reason not specified|0|||
23809879|NCT03573505|66684207|FG001|Overall Study|Reason not specified|1|||
23809880|NCT03573505|66684206|FG000|Overall Study|Death|0|||
23809881|NCT03573505|66684207|FG001|Overall Study|Death|4|||
23809882|NCT04430855|66684208|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
23809883|NCT04430855|66684209|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
23809884|NCT04430855|66684208|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
23809885|NCT04430855|66684209|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
23809886|NCT04430855|66684208|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
23809887|NCT04430855|66684209|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
23809888|NCT04430855|66684208|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
23809889|NCT04430855|66684209|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
23809890|NCT04430855|66684208|FG000|Period 1 (Weeks 1-12)|Other|0|||
23809891|NCT04430855|66684209|FG001|Period 1 (Weeks 1-12)|Other|1|||
23809892|NCT04430855|66684208|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
23809893|NCT04430855|66684209|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
23809894|NCT04430855|66684208|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
23809895|NCT04430855|66684209|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
23809896|NCT04430855|66684208|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
23809897|NCT04430855|66684209|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
23809898|NCT02603393|66684210|FG000|Overall Study|Patient/guardian decision|32|||
23809899|NCT02603393|66684211|FG001|Overall Study|Patient/guardian decision|18|||
23809900|NCT02603393|66684210|FG000|Overall Study|Adverse Event|17|||
23809901|NCT02603393|66684211|FG001|Overall Study|Adverse Event|15|||
23809902|NCT02603393|66684210|FG000|Overall Study|Technical problems|4|||
23809903|NCT02603393|66684211|FG001|Overall Study|Technical problems|7|||
23809904|NCT02603393|66684210|FG000|Overall Study|Lack of Efficacy|7|||
23809905|NCT02603393|66684211|FG001|Overall Study|Lack of Efficacy|2|||
23809906|NCT02603393|66684210|FG000|Overall Study|Death|3|||
23809907|NCT02603393|66684211|FG001|Overall Study|Death|4|||
23809908|NCT02603393|66684210|FG000|Overall Study|Physician Decision|3|||
23809909|NCT02603393|66684211|FG001|Overall Study|Physician Decision|3|||
23809910|NCT02603393|66684210|FG000|Overall Study|Protocol deviation|2|||
23809911|NCT02603393|66684211|FG001|Overall Study|Protocol deviation|3|||
23809912|NCT02603393|66684210|FG000|Overall Study|Lost to Follow-up|1|||
23809913|NCT02603393|66684211|FG001|Overall Study|Lost to Follow-up|2|||
23809914|NCT02603393|66684210|FG000|Overall Study|Non-compliance with study treatment|1|||
23809915|NCT02603393|66684211|FG001|Overall Study|Non-compliance with study treatment|0|||
23809916|NCT02603393|66684210|FG000|Overall Study|Sponsor decision|1|||
23809917|NCT02603393|66684211|FG001|Overall Study|Sponsor decision|0|||
23809918|NCT02072148|66684212|FG000|Overall Study|withdrew prior to surgery|23|||
23809919|NCT02072148|66684213|FG001|Overall Study|withdrew prior to surgery|0|||
23809920|NCT02072148|66684214|FG002|Overall Study|withdrew prior to surgery|0|||
23809921|NCT02072148|66684212|FG000|Overall Study|Death|0|||
23809922|NCT02072148|66684213|FG001|Overall Study|Death|0|||
23809923|NCT02072148|66684214|FG002|Overall Study|Death|1|||
23809924|NCT02072148|66684212|FG000|Overall Study|Withdrawal by Subject|0|||
23809925|NCT02072148|66684213|FG001|Overall Study|Withdrawal by Subject|13|||
23809926|NCT02072148|66684214|FG002|Overall Study|Withdrawal by Subject|12|||
23809927|NCT00968799|66684217|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
23809928|NCT00719849|66684218|FG000|Overall Study|Death|0|||
23809929|NCT00719849|66684219|FG001|Overall Study|Death|1|||
23809930|NCT02331368|66684222|FG000|Overall Study|Withdrawal by Subject|3|||
23809931|NCT02593773|66684224|FG000|Overall Study|Voluntary Withdrawal|3|||
23809932|NCT02593773|66684224|FG000|Overall Study|Study Terminated by Sponsor|31|||
23809933|NCT02593773|66684224|FG000|Overall Study|Death|1|||
23809934|NCT00557076|66684228|FG000|Overall Study|Unblinding|0|||
23809935|NCT00557076|66684229|FG001|Overall Study|Unblinding|1|||
23809936|NCT03071094|66684236|FG000|Overall Study|Death|1|||
23809937|NCT03071094|66684237|FG001|Overall Study|Death|1|||
23809938|NCT03071094|66684236|FG000|Overall Study|Adverse Event|1|||
23809939|NCT03071094|66684237|FG001|Overall Study|Adverse Event|0|||
23809940|NCT00450619|66684239|FG000|Overall Study|refused treatment after randomization|2|||
23809941|NCT00450619|66684240|FG001|Overall Study|refused treatment after randomization|0|||
23809942|NCT00450619|66684239|FG000|Overall Study|did not progress; refused further trmt|1|||
23809943|NCT00450619|66684240|FG001|Overall Study|did not progress; refused further trmt|1|||
23809944|NCT00450619|66684239|FG000|Overall Study|Adverse Event|1|||
23809945|NCT00450619|66684240|FG001|Overall Study|Adverse Event|0|||
23809946|NCT00270257|66684243|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
23809947|NCT00270257|66684244|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
23809948|NCT02034058|66684245|FG000|Overall Study|Death|3|||
23809949|NCT02006628|66684246|FG000|Overall Study|Adverse Event|1|||
23809950|NCT02006628|66684247|FG001|Overall Study|Adverse Event|1|||
23809951|NCT02006628|66684246|FG000|Overall Study|Withdrawal by Subject|2|||
23809952|NCT02006628|66684247|FG001|Overall Study|Withdrawal by Subject|1|||
23809953|NCT01167257|66684248|FG000|Overall Study|Lost to Follow-up|2|||
23809954|NCT01167257|66684249|FG001|Overall Study|Lost to Follow-up|2|||
23809955|NCT01167257|66684248|FG000|Overall Study|Withdrew consent|1|||
23809956|NCT01167257|66684249|FG001|Overall Study|Withdrew consent|1|||
23809957|NCT03123861|66684250|FG000|Overall Study|Protocol Violation|1|||
23809958|NCT03123861|66684251|FG001|Overall Study|Protocol Violation|1|||
23809959|NCT03123861|66684250|FG000|Overall Study|Withdrawal by Subject|2|||
23809960|NCT03123861|66684251|FG001|Overall Study|Withdrawal by Subject|2|||
23809961|NCT00988065|66684255|FG000|Overall Study|Adverse Event|4|||
23809962|NCT00988065|66684256|FG001|Overall Study|Adverse Event|10|||
23809963|NCT00988065|66684257|FG002|Overall Study|Adverse Event|2|||
23809964|NCT00988065|66684255|FG000|Overall Study|Lost to Follow-up|1|||
23809965|NCT00988065|66684256|FG001|Overall Study|Lost to Follow-up|2|||
23809966|NCT00988065|66684257|FG002|Overall Study|Lost to Follow-up|2|||
23809967|NCT00988065|66684255|FG000|Overall Study|Subject withdrew consent|3|||
23809968|NCT00988065|66684256|FG001|Overall Study|Subject withdrew consent|5|||
23809969|NCT00988065|66684257|FG002|Overall Study|Subject withdrew consent|2|||
23809970|NCT00988065|66684255|FG000|Overall Study|Noncompliance with protocol|5|||
23809971|NCT00988065|66684256|FG001|Overall Study|Noncompliance with protocol|6|||
23809972|NCT00988065|66684257|FG002|Overall Study|Noncompliance with protocol|9|||
23809973|NCT02387983|66684258|FG000|Overall Study|Adverse Event|4|||
23809974|NCT02387983|66684258|FG000|Overall Study|Protocol Violation|1|||
23809975|NCT02387983|66684258|FG000|Overall Study|Withdrawal by Subject|2|||
23809976|NCT00278889|66684259|FG000|Overall Study|Withdrawal by Subject|0|||
23809977|NCT00278889|66684260|FG001|Overall Study|Withdrawal by Subject|5|||
23809978|NCT00278889|66684261|FG002|Overall Study|Withdrawal by Subject|3|||
23809979|NCT00278889|66684259|FG000|Overall Study|Lost to Follow-up|1|||
23809980|NCT00278889|66684260|FG001|Overall Study|Lost to Follow-up|1|||
23809981|NCT00278889|66684261|FG002|Overall Study|Lost to Follow-up|0|||
23809982|NCT00278889|66684259|FG000|Overall Study|Death|24|||
23809983|NCT00278889|66684260|FG001|Overall Study|Death|21|||
23809984|NCT00278889|66684261|FG002|Overall Study|Death|17|||
23809985|NCT00112866|66684262|FG000|Overall Study|Protocol Violation|1|||
23809986|NCT00112866|66684263|FG001|Overall Study|Protocol Violation|0|||
23809987|NCT00112866|66684262|FG000|Overall Study|did not start treatment post-op|1|||
23809988|NCT00112866|66684263|FG001|Overall Study|did not start treatment post-op|2|||
23809989|NCT03276221|66684264|FG000|Overall Study|Lost to Follow-up|6|||
23809990|NCT03276221|66684265|FG001|Overall Study|Lost to Follow-up|2|||
23809991|NCT03276221|66684266|FG002|Overall Study|Lost to Follow-up|0|||
23809992|NCT03276221|66684264|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
23809993|NCT03276221|66684265|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
23809994|NCT03276221|66684266|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
23809995|NCT01287039|66684267|FG000|Overall Study|Noncompliance with study procedures|0|||
23809996|NCT01287039|66684268|FG001|Overall Study|Noncompliance with study procedures|1|||
23809997|NCT01287039|66684267|FG000|Overall Study|Change of location/residence|0|||
23809998|NCT01287039|66684268|FG001|Overall Study|Change of location/residence|3|||
23809999|NCT01287039|66684267|FG000|Overall Study|Elective surgery|0|||
23810000|NCT01287039|66684268|FG001|Overall Study|Elective surgery|1|||
23810001|NCT01287039|66684267|FG000|Overall Study|Protocol Violation|2|||
23505030|NCT03129100|65587879|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505031|NCT03129100|65587880|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505032|NCT03129100|65587881|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505033|NCT03129100|65587882|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505034|NCT03129100|65587883|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505035|NCT03129100|65587884|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505036|NCT03129100|65587885|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505037|NCT03129100|65587886|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505038|NCT03129100|65587887|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505039|NCT03129100|65587888|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505040|NCT03129100|65587889|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23810002|NCT01287039|66684268|FG001|Overall Study|Protocol Violation|3|||
23505041|NCT03129100|65587890|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505042|NCT03129100|65587891|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505043|NCT03129100|65587892|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23810003|NCT01287039|66684267|FG000|Overall Study|Excluded medication taken|1|||
23810004|NCT01287039|66684268|FG001|Overall Study|Excluded medication taken|0|||
23505044|NCT03129100|65587893|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
23810005|NCT01287039|66684267|FG000|Overall Study|Noncompliance with study medication|0|||
23810006|NCT01287039|66684268|FG001|Overall Study|Noncompliance with study medication|1|||
23810007|NCT01287039|66684267|FG000|Overall Study|Problem with travel|0|||
23505045|NCT03129100|65587894|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505046|NCT03129100|65587895|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
23505047|NCT03129100|65587896|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505048|NCT03129100|65587897|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505049|NCT03129100|65587898|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505050|NCT03129100|65587899|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505051|NCT03129100|65587900|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505052|NCT03129100|65587901|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505053|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505054|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505055|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505056|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505057|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505058|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505059|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505060|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23810008|NCT01287039|66684268|FG001|Overall Study|Problem with travel|1|||
23810009|NCT01287039|66684267|FG000|Overall Study|Death|1|||
23810010|NCT01287039|66684268|FG001|Overall Study|Death|0|||
23810011|NCT01287039|66684267|FG000|Overall Study|Change of residence|1|||
23810012|NCT01287039|66684268|FG001|Overall Study|Change of residence|0|||
23810013|NCT01287039|66684267|FG000|Overall Study|Adverse Event|7|||
23505061|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505062|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505063|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505064|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505065|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505066|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505067|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505068|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505069|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505070|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505071|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505072|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505073|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
23505074|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505075|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505076|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505077|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505078|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505079|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
23505080|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
23505081|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
23505082|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
23505083|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
23505084|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
23505085|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
23505086|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
23505087|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
23505088|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
23505089|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
23505090|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
23505091|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
23505092|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
23505093|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
23505094|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
23505095|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
23505096|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
23505097|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
23505098|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
23505099|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
23810014|NCT01287039|66684268|FG001|Overall Study|Adverse Event|4|||
23810015|NCT01287039|66684267|FG000|Overall Study|Withdrawal by Subject|14|||
23810016|NCT01287039|66684268|FG001|Overall Study|Withdrawal by Subject|11|||
23505100|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
23505101|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
23505102|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
23505103|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
23505104|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
23505105|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505106|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505107|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505108|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23810017|NCT01287039|66684267|FG000|Overall Study|Lost to Follow-up|3|||
23810018|NCT01287039|66684268|FG001|Overall Study|Lost to Follow-up|2|||
23505109|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505110|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505111|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505112|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505113|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505114|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505115|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505116|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505117|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505118|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505119|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505120|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505121|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505122|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505123|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505124|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505125|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
23505126|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505127|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505128|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505129|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505130|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505131|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
23505132|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
23505133|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
23505134|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
23505135|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
23505136|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
23810019|NCT02338193|66684270|FG000|Overall Study|Withdrawal by Subject|0|||
23810020|NCT02338193|66684271|FG001|Overall Study|Withdrawal by Subject|0|||
23810021|NCT02338193|66684272|FG002|Overall Study|Withdrawal by Subject|2|||
23810022|NCT02338193|66684270|FG000|Overall Study|Pregnancy|0|||
23810023|NCT02338193|66684271|FG001|Overall Study|Pregnancy|1|||
23810024|NCT02338193|66684272|FG002|Overall Study|Pregnancy|1|||
23810025|NCT02338193|66684270|FG000|Overall Study|Noncompliant with visits|2|||
23810026|NCT02338193|66684271|FG001|Overall Study|Noncompliant with visits|2|||
23810027|NCT02338193|66684272|FG002|Overall Study|Noncompliant with visits|7|||
23505137|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
23505138|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
23505139|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
23810028|NCT02338193|66684270|FG000|Overall Study|moved out of state|0|||
23810029|NCT02338193|66684271|FG001|Overall Study|moved out of state|1|||
23810030|NCT02338193|66684272|FG002|Overall Study|moved out of state|0|||
23810031|NCT02338193|66684270|FG000|Overall Study|intolerant of side effects|1|||
23810032|NCT02338193|66684271|FG001|Overall Study|intolerant of side effects|0|||
23810033|NCT02338193|66684272|FG002|Overall Study|intolerant of side effects|0|||
23810034|NCT02582866|66684273|FG000|Overall Study|Death|1|||
23505140|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
23505141|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
23810035|NCT02582866|66684273|FG000|Overall Study|Lack of Efficacy|2|||
23810036|NCT02582866|66684273|FG000|Overall Study|Lost to Follow-up|2|||
23810037|NCT02582866|66684273|FG000|Overall Study|Withdrawal by Subject|7|||
23810038|NCT02582866|66684273|FG000|Overall Study|Investigator decision|5|||
23505142|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
23505143|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
23505144|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
23505145|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
23505146|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
23505147|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
23505148|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
23505149|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
23505150|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
23505151|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
23810039|NCT02582866|66684273|FG000|Overall Study|Participant wants to get pregnant|1|||
23810040|NCT02582866|66684273|FG000|Overall Study|Pregnancy|2|||
23505152|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
23505153|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
23505154|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
23810041|NCT02582866|66684273|FG000|Overall Study|Sponsor decision|1|||
23810042|NCT02582866|66684273|FG000|Overall Study|Withdrawal due to personal reasons|1|||
23505155|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
23505156|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
23810043|NCT01173471|66684279|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23810044|NCT01173471|66684280|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23810045|NCT01173471|66684281|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23810046|NCT01173471|66684282|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23810047|NCT01173471|66684279|FG000|Overall Study|Condition under investigation worsened|2|||
23810048|NCT01173471|66684280|FG001|Overall Study|Condition under investigation worsened|0|||
23810049|NCT01173471|66684281|FG002|Overall Study|Condition under investigation worsened|0|||
23810050|NCT01173471|66684282|FG003|Overall Study|Condition under investigation worsened|0|||
23810051|NCT01173471|66684279|FG000|Overall Study|Lost to Follow-up|0|||
23505157|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505158|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505159|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810052|NCT01173471|66684280|FG001|Overall Study|Lost to Follow-up|0|||
23810053|NCT01173471|66684281|FG002|Overall Study|Lost to Follow-up|1|||
23505160|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505161|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505162|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505163|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505164|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810054|NCT01173471|66684282|FG003|Overall Study|Lost to Follow-up|0|||
23810055|NCT01173471|66684279|FG000|Overall Study|Reason given as Other|0|||
23810056|NCT01173471|66684280|FG001|Overall Study|Reason given as Other|0|||
23810057|NCT01173471|66684281|FG002|Overall Study|Reason given as Other|1|||
23810058|NCT01173471|66684282|FG003|Overall Study|Reason given as Other|0|||
23810059|NCT02384941|66684283|FG000|Overall Study|Adverse Event|11|||
23810060|NCT02384941|66684284|FG001|Overall Study|Adverse Event|13|||
23810061|NCT02384941|66684285|FG002|Overall Study|Adverse Event|17|||
23810062|NCT02384941|66684283|FG000|Overall Study|Lost to Follow-up|3|||
23810063|NCT02384941|66684284|FG001|Overall Study|Lost to Follow-up|2|||
23810064|NCT02384941|66684285|FG002|Overall Study|Lost to Follow-up|1|||
23810065|NCT02384941|66684283|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23810066|NCT02384941|66684284|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23810067|NCT02384941|66684285|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23810068|NCT02384941|66684283|FG000|Overall Study|Physician Decision|1|||
23810069|NCT02384941|66684284|FG001|Overall Study|Physician Decision|1|||
23810070|NCT02384941|66684285|FG002|Overall Study|Physician Decision|0|||
23505165|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505166|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505167|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505168|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810071|NCT02384941|66684283|FG000|Overall Study|Protocol Violation|3|||
23810072|NCT02384941|66684284|FG001|Overall Study|Protocol Violation|0|||
23810073|NCT02384941|66684285|FG002|Overall Study|Protocol Violation|0|||
23810074|NCT02384941|66684283|FG000|Overall Study|Withdrawal by Subject|26|||
23810075|NCT02384941|66684284|FG001|Overall Study|Withdrawal by Subject|19|||
23505169|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810076|NCT02384941|66684285|FG002|Overall Study|Withdrawal by Subject|20|||
23810077|NCT02384941|66684283|FG000|Overall Study|Pregnancy|0|||
23810078|NCT02384941|66684284|FG001|Overall Study|Pregnancy|0|||
23810079|NCT02384941|66684285|FG002|Overall Study|Pregnancy|1|||
23810080|NCT02384941|66684283|FG000|Overall Study|Other than specified above|4|||
23810081|NCT02384941|66684284|FG001|Overall Study|Other than specified above|0|||
23810082|NCT02384941|66684285|FG002|Overall Study|Other than specified above|1|||
23810083|NCT00228423|66684286|FG000|Overall Study|Adverse Event|2|||
23810084|NCT00228423|66684287|FG001|Overall Study|Adverse Event|5|||
23810085|NCT00228423|66684286|FG000|Overall Study|Withdrawal by Subject|7|||
23810086|NCT00228423|66684287|FG001|Overall Study|Withdrawal by Subject|3|||
23810087|NCT00228423|66684286|FG000|Overall Study|Protocol Violation|1|||
23810088|NCT00228423|66684287|FG001|Overall Study|Protocol Violation|3|||
23810089|NCT00228423|66684286|FG000|Overall Study|Physician Decision|0|||
23810090|NCT00228423|66684287|FG001|Overall Study|Physician Decision|1|||
23810091|NCT01055132|66684288|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
23810092|NCT01055132|66684289|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
23810093|NCT01055132|66684288|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
23810094|NCT01055132|66684289|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
23810095|NCT03246126|66684294|FG000|Overall Study|Withdrawal by Subject|0|||
23810096|NCT03246126|66684295|FG001|Overall Study|Withdrawal by Subject|1|||
23810097|NCT03469336|66684296|FG000|Overall Study|Adverse Event|1|||
23505170|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505171|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505172|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810098|NCT02493777|66684298|FG000|Overall Study|Lost to Follow-up|0|||
23810099|NCT02493777|66684299|FG001|Overall Study|Lost to Follow-up|1|||
23810100|NCT00430495|66684311|FG000|Overall Study|Adverse Event|2|||
23810101|NCT00430495|66684312|FG001|Overall Study|Adverse Event|3|||
23505173|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505174|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505175|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505176|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505177|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505178|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810102|NCT00430495|66684313|FG002|Overall Study|Adverse Event|2|||
23810103|NCT00430495|66684314|FG003|Overall Study|Adverse Event|0|||
23810104|NCT00430495|66684311|FG000|Overall Study|Death|0|||
23810105|NCT00430495|66684312|FG001|Overall Study|Death|0|||
23810106|NCT00430495|66684313|FG002|Overall Study|Death|1|||
23505179|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505180|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23810107|NCT00430495|66684314|FG003|Overall Study|Death|0|||
23810108|NCT00430495|66684311|FG000|Overall Study|Lost to Follow-up|0|||
23810109|NCT00430495|66684312|FG001|Overall Study|Lost to Follow-up|1|||
23810110|NCT00430495|66684313|FG002|Overall Study|Lost to Follow-up|4|||
23810111|NCT00430495|66684314|FG003|Overall Study|Lost to Follow-up|0|||
23810112|NCT00430495|66684311|FG000|Overall Study|Protocol Violation|1|||
23810113|NCT00430495|66684312|FG001|Overall Study|Protocol Violation|0|||
23505181|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
23505182|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
23505183|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505184|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505185|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505186|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505187|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505188|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505189|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23810114|NCT00430495|66684313|FG002|Overall Study|Protocol Violation|1|||
23810115|NCT00430495|66684314|FG003|Overall Study|Protocol Violation|0|||
23810116|NCT00430495|66684311|FG000|Overall Study|Disease Progression|1|||
23810117|NCT00430495|66684312|FG001|Overall Study|Disease Progression|1|||
23810118|NCT00430495|66684313|FG002|Overall Study|Disease Progression|0|||
23810119|NCT00430495|66684314|FG003|Overall Study|Disease Progression|0|||
23810120|NCT00430495|66684311|FG000|Overall Study|Other|8|||
23810121|NCT00430495|66684312|FG001|Overall Study|Other|2|||
23810122|NCT00430495|66684313|FG002|Overall Study|Other|5|||
23810123|NCT00430495|66684314|FG003|Overall Study|Other|4|||
23810124|NCT00430495|66684311|FG000|Overall Study|Randomized but not Treated|2|||
23810125|NCT00430495|66684312|FG001|Overall Study|Randomized but not Treated|0|||
23810126|NCT00430495|66684313|FG002|Overall Study|Randomized but not Treated|0|||
23810127|NCT00430495|66684314|FG003|Overall Study|Randomized but not Treated|0|||
23810128|NCT00673387|66684315|FG000|Overall Study|Withdrawal by Subject|15|||
23810129|NCT00673387|66684316|FG001|Overall Study|Withdrawal by Subject|16|||
23810130|NCT00673387|66684317|FG002|Overall Study|Withdrawal by Subject|20|||
23810131|NCT00673387|66684318|FG003|Overall Study|Withdrawal by Subject|16|||
23810132|NCT00673387|66684319|FG004|Overall Study|Withdrawal by Subject|18|||
23810133|NCT00673387|66684320|FG005|Overall Study|Withdrawal by Subject|21|||
23810134|NCT00673387|66684321|FG006|Overall Study|Withdrawal by Subject|15|||
23810135|NCT00673387|66684322|FG007|Overall Study|Withdrawal by Subject|21|||
23810136|NCT00673387|66684315|FG000|Overall Study|Adverse Event|3|||
23810137|NCT00673387|66684316|FG001|Overall Study|Adverse Event|1|||
23810138|NCT00673387|66684317|FG002|Overall Study|Adverse Event|5|||
23810139|NCT00673387|66684318|FG003|Overall Study|Adverse Event|2|||
23505190|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505191|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505192|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23810140|NCT00673387|66684319|FG004|Overall Study|Adverse Event|6|||
23505193|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505194|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505195|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505196|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23810141|NCT00673387|66684320|FG005|Overall Study|Adverse Event|2|||
23810142|NCT00673387|66684321|FG006|Overall Study|Adverse Event|5|||
23810143|NCT00673387|66684322|FG007|Overall Study|Adverse Event|5|||
23810144|NCT00673387|66684315|FG000|Overall Study|Physician Decision|0|||
23810145|NCT00673387|66684316|FG001|Overall Study|Physician Decision|0|||
23810146|NCT00673387|66684317|FG002|Overall Study|Physician Decision|0|||
23810147|NCT00673387|66684318|FG003|Overall Study|Physician Decision|0|||
23810148|NCT00673387|66684319|FG004|Overall Study|Physician Decision|0|||
23810149|NCT00673387|66684320|FG005|Overall Study|Physician Decision|5|||
23810150|NCT00673387|66684321|FG006|Overall Study|Physician Decision|1|||
23810151|NCT00673387|66684322|FG007|Overall Study|Physician Decision|1|||
23810152|NCT00673387|66684315|FG000|Overall Study|Protocol Violation|3|||
23505197|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505198|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505199|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505200|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505201|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505202|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505203|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505204|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23810153|NCT00673387|66684316|FG001|Overall Study|Protocol Violation|0|||
23810154|NCT00673387|66684317|FG002|Overall Study|Protocol Violation|1|||
23810155|NCT00673387|66684318|FG003|Overall Study|Protocol Violation|2|||
23810156|NCT00673387|66684319|FG004|Overall Study|Protocol Violation|0|||
23810157|NCT00673387|66684320|FG005|Overall Study|Protocol Violation|1|||
23810158|NCT00673387|66684321|FG006|Overall Study|Protocol Violation|1|||
23810159|NCT00673387|66684322|FG007|Overall Study|Protocol Violation|3|||
23810160|NCT00673387|66684315|FG000|Overall Study|Lost to Follow-up|8|||
23810161|NCT00673387|66684316|FG001|Overall Study|Lost to Follow-up|6|||
23810162|NCT00673387|66684317|FG002|Overall Study|Lost to Follow-up|5|||
23810163|NCT00673387|66684318|FG003|Overall Study|Lost to Follow-up|6|||
23810164|NCT00673387|66684319|FG004|Overall Study|Lost to Follow-up|6|||
23810165|NCT00673387|66684320|FG005|Overall Study|Lost to Follow-up|5|||
23810166|NCT00673387|66684321|FG006|Overall Study|Lost to Follow-up|8|||
23810167|NCT00673387|66684322|FG007|Overall Study|Lost to Follow-up|5|||
23810168|NCT05142566|66684327|FG000|Overall Study|Protocol Violation|1|||
23810169|NCT01403064|66684328|FG000|Overall Study|Death|0|||
23810170|NCT01403064|66684329|FG001|Overall Study|Death|0|||
23810171|NCT01403064|66684330|FG002|Overall Study|Death|1|||
23810172|NCT01403064|66684331|FG003|Overall Study|Death|1|||
23810173|NCT01403064|66684328|FG000|Overall Study|Withdrawal by Subject|0|||
23810174|NCT01403064|66684329|FG001|Overall Study|Withdrawal by Subject|0|||
23810175|NCT01403064|66684330|FG002|Overall Study|Withdrawal by Subject|1|||
23810176|NCT01403064|66684331|FG003|Overall Study|Withdrawal by Subject|1|||
23810177|NCT01403064|66684328|FG000|Overall Study|Other|1|||
23810178|NCT01403064|66684329|FG001|Overall Study|Other|0|||
23810179|NCT01403064|66684330|FG002|Overall Study|Other|2|||
23810180|NCT01403064|66684331|FG003|Overall Study|Other|1|||
23810181|NCT04639713|66684332|FG000|Overall Study|Protocol Noncompliance|2|||
23810182|NCT04639713|66684332|FG000|Overall Study|Withdrawal by Subject|1|||
23810183|NCT01855074|66684334|FG000|Overall Study|Adverse Event|1|||
23810184|NCT01855074|66684334|FG000|Overall Study|Lost to Follow-up|4|||
23810185|NCT01855074|66684334|FG000|Overall Study|Withdrawal by Subject|8|||
23810186|NCT01855074|66684334|FG000|Overall Study|Started but not treated|1|||
23810187|NCT01553279|66684335|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
23810188|NCT01553279|66684336|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
23810189|NCT01553279|66684335|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
23810190|NCT01553279|66684336|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
23810191|NCT01553279|66684335|FG000|Interim Period|Withdrawal by Subject|2|||
23810192|NCT01553279|66684336|FG001|Interim Period|Withdrawal by Subject|2|||
23810193|NCT01553279|66684335|FG000|Interim Period|Lost to Follow-up|1|||
23810194|NCT01553279|66684336|FG001|Interim Period|Lost to Follow-up|0|||
23810195|NCT01553279|66684335|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
23810196|NCT01553279|66684336|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
23810197|NCT01553279|66684335|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
23810198|NCT01553279|66684336|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
23810199|NCT01732874|66684337|FG000|Overall Study|Withdrawal by Subject|5|||
23810200|NCT01732874|66684338|FG001|Overall Study|Withdrawal by Subject|1|||
23810201|NCT01732874|66684337|FG000|Overall Study|Death of Infant|3|||
23810202|NCT01732874|66684338|FG001|Overall Study|Death of Infant|2|||
23810203|NCT01315132|66684339|FG000|Overall Study|not treated due to disease progression|1|||
23810204|NCT02528123|66684342|FG000|Overall Study|Lost to Follow-up|1|||
23810205|NCT00857792|66684343|FG000|Overall Study|inadequate image quality for analysis|12|||
23810206|NCT01732484|66684344|FG000|Overall Study|Death|7|||
23810207|NCT01732484|66684344|FG000|Overall Study|Lost to Follow-up|14|||
23810208|NCT01732484|66684344|FG000|Overall Study|chronical illness|5|||
23810209|NCT04498403|66684350|FG000|Overall Study|Adverse Event|1|||
23810210|NCT04498403|66684351|FG001|Overall Study|Adverse Event|0|||
23810211|NCT04498403|66684350|FG000|Overall Study|Study Terminated By Sponsor|29|||
23810212|NCT04498403|66684351|FG001|Overall Study|Study Terminated By Sponsor|10|||
23810213|NCT01193127|66684355|FG000|Randomized|Surgery Cancelled|0|||
23810214|NCT01193127|66684356|FG001|Randomized|Surgery Cancelled|0|||
23810215|NCT01193127|66684357|FG002|Randomized|Surgery Cancelled|0|||
23810216|NCT01193127|66684358|FG003|Randomized|Surgery Cancelled|1|||
23403914|NCT00833027|65226438|FG000|Overall Study|Withdrawal by Subject|16|||
23403915|NCT00833027|65226438|FG000|Overall Study|Missing|10|||
23403916|NCT02146131|65226439|FG000|Overall Study|Physician Decision|61|||
23403917|NCT02146131|65226440|FG001|Overall Study|Physician Decision|56|||
23403918|NCT01964378|65226441|FG000|Overall Study|Disc. due to death before first dosing|0|||
23403919|NCT01964378|65226442|FG001|Overall Study|Disc. due to death before first dosing|1|||
23403920|NCT01964378|65226441|FG000|Overall Study|Disc. due to AE before first dosing|1|||
23403921|NCT01964378|65226442|FG001|Overall Study|Disc. due to AE before first dosing|0|||
23403922|NCT01964378|65226441|FG000|Overall Study|Death|3|||
23403923|NCT01964378|65226442|FG001|Overall Study|Death|2|||
23403924|NCT01964378|65226441|FG000|Overall Study|Adverse Event|12|||
23403925|NCT01964378|65226442|FG001|Overall Study|Adverse Event|5|||
23403926|NCT01964378|65226441|FG000|Overall Study|Lack of Efficacy|0|||
23403927|NCT01964378|65226442|FG001|Overall Study|Lack of Efficacy|1|||
23403928|NCT01964378|65226441|FG000|Overall Study|Protocol Violation|0|||
23403929|NCT01964378|65226442|FG001|Overall Study|Protocol Violation|1|||
23403930|NCT01964378|65226441|FG000|Overall Study|Lost to Follow-up|0|||
23403931|NCT01964378|65226442|FG001|Overall Study|Lost to Follow-up|1|||
23403932|NCT01964378|65226441|FG000|Overall Study|Withdrawal by Subject|7|||
23403933|NCT01964378|65226442|FG001|Overall Study|Withdrawal by Subject|5|||
23403934|NCT01964378|65226441|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
23403935|NCT01964378|65226442|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
23403936|NCT01964378|65226441|FG000|Overall Study|Other|1|||
23403937|NCT01964378|65226442|FG001|Overall Study|Other|2|||
23403938|NCT02903823|65226450|FG000|Overall Study|Physician Decision|5|||
23403939|NCT02903823|65226450|FG000|Overall Study|Could not advance catheter|1|||
23403940|NCT02903823|65226450|FG000|Overall Study|Catheter dislodgement|1|||
23810217|NCT01193127|66684355|FG000|Treated|Withdrawal by Subject|0|||
23810218|NCT01193127|66684356|FG001|Treated|Withdrawal by Subject|0|||
23403941|NCT01023217|65226451|FG000|Overall Study|Withdrawal by Subject|1|||
23403942|NCT01023217|65226452|FG001|Overall Study|Withdrawal by Subject|0|||
23403943|NCT00503425|65226455|FG000|Overall Study|Participant files lost|6|||
23403944|NCT00503425|65226455|FG000|Overall Study|Adverse Event|5|||
23403945|NCT00503425|65226455|FG000|Overall Study|Lack of Efficacy|25|||
23403946|NCT00503425|65226455|FG000|Overall Study|Withdrawal by Subject|8|||
23403947|NCT00503425|65226455|FG000|Overall Study|Lost to Follow-up|3|||
23403948|NCT00503425|65226455|FG000|Overall Study|Death|3|||
23403949|NCT00503425|65226455|FG000|Overall Study|Missing Data/Unknown|4|||
23403950|NCT02931838|65226464|FG000|Overall Study|Reason not provided by investigator|1|||
23403951|NCT02931838|65226465|FG001|Overall Study|Reason not provided by investigator|0|||
23403952|NCT02931838|65226466|FG002|Overall Study|Reason not provided by investigator|1|||
23403953|NCT02931838|65226467|FG003|Overall Study|Reason not provided by investigator|0|||
23403954|NCT02931838|65226468|FG004|Overall Study|Reason not provided by investigator|0|||
23403955|NCT02931838|65226469|FG005|Overall Study|Reason not provided by investigator|0|||
23505205|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505206|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
23505207|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
23505208|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
23505209|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505210|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23403956|NCT02931838|65226464|FG000|Overall Study|Poor/non-compliance|0|||
23403957|NCT02931838|65226465|FG001|Overall Study|Poor/non-compliance|0|||
23403958|NCT02931838|65226466|FG002|Overall Study|Poor/non-compliance|1|||
23403959|NCT02931838|65226467|FG003|Overall Study|Poor/non-compliance|0|||
23403960|NCT02931838|65226468|FG004|Overall Study|Poor/non-compliance|0|||
23403961|NCT02931838|65226469|FG005|Overall Study|Poor/non-compliance|0|||
23403962|NCT02931838|65226464|FG000|Overall Study|Lack of Efficacy|5|||
23403963|NCT02931838|65226465|FG001|Overall Study|Lack of Efficacy|4|||
23403964|NCT02931838|65226466|FG002|Overall Study|Lack of Efficacy|0|||
23403965|NCT02931838|65226467|FG003|Overall Study|Lack of Efficacy|0|||
23403966|NCT02931838|65226468|FG004|Overall Study|Lack of Efficacy|0|||
23403967|NCT02931838|65226469|FG005|Overall Study|Lack of Efficacy|1|||
23403968|NCT02931838|65226464|FG000|Overall Study|Lost to Follow-up|1|||
23403969|NCT02931838|65226465|FG001|Overall Study|Lost to Follow-up|0|||
23403970|NCT02931838|65226466|FG002|Overall Study|Lost to Follow-up|1|||
23403971|NCT02931838|65226467|FG003|Overall Study|Lost to Follow-up|1|||
23810219|NCT01193127|66684357|FG002|Treated|Withdrawal by Subject|0|||
23810220|NCT01193127|66684358|FG003|Treated|Withdrawal by Subject|1|||
23810221|NCT01172821|66684359|FG000|Overall Study|Adverse Event|5|||
23810222|NCT01172821|66684360|FG001|Overall Study|Adverse Event|2|||
23810223|NCT01172821|66684361|FG002|Overall Study|Adverse Event|2|||
23810224|NCT01172821|66684362|FG003|Overall Study|Adverse Event|7|||
23810225|NCT01172821|66684359|FG000|Overall Study|Protocol Violation|0|||
23810226|NCT01172821|66684360|FG001|Overall Study|Protocol Violation|2|||
23403972|NCT02931838|65226468|FG004|Overall Study|Lost to Follow-up|2|||
23403973|NCT02931838|65226469|FG005|Overall Study|Lost to Follow-up|0|||
23403974|NCT02931838|65226464|FG000|Overall Study|Subject request to discontinue treatment|4|||
23403975|NCT02931838|65226465|FG001|Overall Study|Subject request to discontinue treatment|3|||
23403976|NCT02931838|65226466|FG002|Overall Study|Subject request to discontinue treatment|3|||
23403977|NCT02931838|65226467|FG003|Overall Study|Subject request to discontinue treatment|0|||
23403978|NCT02931838|65226468|FG004|Overall Study|Subject request to discontinue treatment|1|||
23403979|NCT02931838|65226469|FG005|Overall Study|Subject request to discontinue treatment|0|||
23403980|NCT02931838|65226464|FG000|Overall Study|Withdrawal by Subject|1|||
23403981|NCT02931838|65226465|FG001|Overall Study|Withdrawal by Subject|2|||
23403982|NCT02931838|65226466|FG002|Overall Study|Withdrawal by Subject|0|||
23403983|NCT02931838|65226467|FG003|Overall Study|Withdrawal by Subject|1|||
23403984|NCT02931838|65226468|FG004|Overall Study|Withdrawal by Subject|0|||
23403985|NCT02931838|65226469|FG005|Overall Study|Withdrawal by Subject|0|||
23810227|NCT01172821|66684361|FG002|Overall Study|Protocol Violation|1|||
23810228|NCT01172821|66684362|FG003|Overall Study|Protocol Violation|2|||
23810229|NCT01172821|66684359|FG000|Overall Study|Lost to Follow-up|4|||
23810230|NCT01172821|66684360|FG001|Overall Study|Lost to Follow-up|1|||
23403986|NCT02931838|65226464|FG000|Overall Study|Adverse Event|2|||
23403987|NCT02931838|65226465|FG001|Overall Study|Adverse Event|1|||
23403988|NCT02931838|65226466|FG002|Overall Study|Adverse Event|2|||
23403989|NCT02931838|65226467|FG003|Overall Study|Adverse Event|1|||
23403990|NCT02931838|65226468|FG004|Overall Study|Adverse Event|3|||
23403991|NCT02931838|65226469|FG005|Overall Study|Adverse Event|1|||
23403992|NCT02949011|65226472|FG000|Overall Study|Adverse Event|6|||
23403993|NCT02949011|65226473|FG001|Overall Study|Adverse Event|7|||
23403994|NCT02949011|65226474|FG002|Overall Study|Adverse Event|3|||
23403995|NCT02949011|65226472|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23403996|NCT02949011|65226473|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23403997|NCT02949011|65226474|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
23403998|NCT02949011|65226472|FG000|Overall Study|Protocol Deviation|5|||
23403999|NCT02949011|65226473|FG001|Overall Study|Protocol Deviation|3|||
23404000|NCT02949011|65226474|FG002|Overall Study|Protocol Deviation|3|||
23404001|NCT02949011|65226472|FG000|Overall Study|Lack of Efficacy|0|||
23404002|NCT02949011|65226473|FG001|Overall Study|Lack of Efficacy|2|||
23404003|NCT02949011|65226474|FG002|Overall Study|Lack of Efficacy|0|||
23404004|NCT02949011|65226472|FG000|Overall Study|Withdrawal by Subject|13|||
23404005|NCT02949011|65226473|FG001|Overall Study|Withdrawal by Subject|13|||
23404006|NCT02949011|65226474|FG002|Overall Study|Withdrawal by Subject|21|||
23404007|NCT02949011|65226472|FG000|Overall Study|Lost to Follow-up|7|||
23404008|NCT02949011|65226473|FG001|Overall Study|Lost to Follow-up|5|||
23404009|NCT02949011|65226474|FG002|Overall Study|Lost to Follow-up|5|||
23404010|NCT02949011|65226472|FG000|Overall Study|Death|0|||
23404011|NCT02949011|65226473|FG001|Overall Study|Death|0|||
23404012|NCT02949011|65226474|FG002|Overall Study|Death|1|||
23404013|NCT02949011|65226472|FG000|Overall Study|Miscellaneous|2|||
23404014|NCT02949011|65226473|FG001|Overall Study|Miscellaneous|4|||
23404015|NCT02949011|65226474|FG002|Overall Study|Miscellaneous|6|||
23404016|NCT00912782|65226479|FG000|Overall Study|Death|2|||
23404017|NCT00912782|65226480|FG001|Overall Study|Death|1|||
23404018|NCT00912782|65226479|FG000|Overall Study|Lost to Follow-up|0|||
23404019|NCT00912782|65226480|FG001|Overall Study|Lost to Follow-up|1|||
23810231|NCT01172821|66684361|FG002|Overall Study|Lost to Follow-up|2|||
23810232|NCT01172821|66684362|FG003|Overall Study|Lost to Follow-up|2|||
23810233|NCT01172821|66684359|FG000|Overall Study|Withdrawal by Subject|2|||
23810234|NCT01172821|66684360|FG001|Overall Study|Withdrawal by Subject|3|||
23810235|NCT01172821|66684361|FG002|Overall Study|Withdrawal by Subject|3|||
23810236|NCT01172821|66684362|FG003|Overall Study|Withdrawal by Subject|3|||
23810237|NCT01172821|66684359|FG000|Overall Study|Other|3|||
23810238|NCT01172821|66684360|FG001|Overall Study|Other|4|||
23810239|NCT01172821|66684361|FG002|Overall Study|Other|5|||
23810240|NCT01172821|66684362|FG003|Overall Study|Other|3|||
23810241|NCT05256134|66684363|FG000|Overall Study|Study Terminated by Sponsor|11|||
23810242|NCT05256134|66684364|FG001|Overall Study|Study Terminated by Sponsor|10|||
23810243|NCT05256134|66684363|FG000|Overall Study|Withdrawal by Subject|1|||
23810244|NCT05256134|66684364|FG001|Overall Study|Withdrawal by Subject|3|||
23810245|NCT00975286|66684365|FG000|Overall Study|Adverse Event|9|||
23810246|NCT00975286|66684366|FG001|Overall Study|Adverse Event|19|||
23810247|NCT00975286|66684365|FG000|Overall Study|Protocol Violation|1|||
23810248|NCT00975286|66684366|FG001|Overall Study|Protocol Violation|2|||
23810249|NCT00975286|66684365|FG000|Overall Study|Withdrawal by Subject|0|||
23810250|NCT00975286|66684366|FG001|Overall Study|Withdrawal by Subject|2|||
23810251|NCT00975286|66684365|FG000|Overall Study|Familial and Personal Reasons|2|||
23810252|NCT00975286|66684366|FG001|Overall Study|Familial and Personal Reasons|2|||
23810253|NCT00975286|66684365|FG000|Overall Study|Poor Compliance to Protocol|0|||
23810254|NCT00975286|66684366|FG001|Overall Study|Poor Compliance to Protocol|2|||
23810255|NCT00975286|66684365|FG000|Overall Study|Sponsor Decision|0|||
23810256|NCT00975286|66684366|FG001|Overall Study|Sponsor Decision|2|||
23810257|NCT04168190|66684367|FG000|Overall Study|Lost to Follow-up|0|||
23810258|NCT04168190|66684368|FG001|Overall Study|Lost to Follow-up|1|||
23810259|NCT04168190|66684369|FG002|Overall Study|Lost to Follow-up|0|||
23810260|NCT04168190|66684370|FG003|Overall Study|Lost to Follow-up|7|||
23810261|NCT04168190|66684371|FG004|Overall Study|Lost to Follow-up|5|||
23810262|NCT04168190|66684367|FG000|Overall Study|Withdrawal by Subject|1|||
23810263|NCT04168190|66684368|FG001|Overall Study|Withdrawal by Subject|0|||
23404020|NCT00912782|65226479|FG000|Overall Study|Did not receive vascular access type|1|||
23404021|NCT00912782|65226480|FG001|Overall Study|Did not receive vascular access type|2|||
23404022|NCT00912782|65226479|FG000|Overall Study|Relocated before study completion|0|||
23404023|NCT00912782|65226480|FG001|Overall Study|Relocated before study completion|1|||
23404024|NCT02765399|65226481|FG000|Overall Study|Nausea|1|||
23404025|NCT02765399|65226482|FG001|Overall Study|Nausea|0|||
23404026|NCT03257358|65226483|FG000|Overall Study|Adverse Event|25|||
23404027|NCT03257358|65226484|FG001|Overall Study|Adverse Event|12|||
23404028|NCT03257358|65226483|FG000|Overall Study|Lack of Efficacy|1|||
23404029|NCT03257358|65226484|FG001|Overall Study|Lack of Efficacy|1|||
23404030|NCT03257358|65226483|FG000|Overall Study|Lost to Follow-up|12|||
23404031|NCT03257358|65226484|FG001|Overall Study|Lost to Follow-up|4|||
23404032|NCT03257358|65226483|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
23404033|NCT03257358|65226484|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
23404034|NCT03257358|65226483|FG000|Overall Study|Physician Decision|2|||
23404035|NCT03257358|65226484|FG001|Overall Study|Physician Decision|2|||
23404036|NCT03257358|65226483|FG000|Overall Study|Protocol Violation|5|||
23404037|NCT03257358|65226484|FG001|Overall Study|Protocol Violation|3|||
23404038|NCT03257358|65226483|FG000|Overall Study|Technical problems|4|||
23404039|NCT03257358|65226484|FG001|Overall Study|Technical problems|1|||
23810264|NCT04168190|66684369|FG002|Overall Study|Withdrawal by Subject|0|||
23810265|NCT04168190|66684370|FG003|Overall Study|Withdrawal by Subject|2|||
23810266|NCT04168190|66684371|FG004|Overall Study|Withdrawal by Subject|4|||
23404040|NCT03257358|65226483|FG000|Overall Study|Withdrawal by Subject|8|||
23810267|NCT04168190|66684367|FG000|Overall Study|Death|0|||
23404041|NCT03257358|65226484|FG001|Overall Study|Withdrawal by Subject|3|||
23404042|NCT03257358|65226483|FG000|Overall Study|Withdrawal of informed consent|9|||
23404043|NCT03257358|65226484|FG001|Overall Study|Withdrawal of informed consent|5|||
23404044|NCT03257358|65226483|FG000|Overall Study|New therapy for study indication|1|||
23404045|NCT03257358|65226484|FG001|Overall Study|New therapy for study indication|0|||
23404046|NCT03257358|65226483|FG000|Overall Study|No longer requires treatment|0|||
23404047|NCT03257358|65226484|FG001|Overall Study|No longer requires treatment|1|||
23404048|NCT00506779|65226485|FG000|Overall Study|Withdrawal by Subject|1|||
23810268|NCT04168190|66684368|FG001|Overall Study|Death|0|||
23810269|NCT04168190|66684369|FG002|Overall Study|Death|0|||
23810270|NCT04168190|66684370|FG003|Overall Study|Death|1|||
23810271|NCT04168190|66684371|FG004|Overall Study|Death|0|||
23810272|NCT01672970|66684372|FG000|Overall Study|Lack of Efficacy|12|||
23810273|NCT01672970|66684372|FG000|Overall Study|Adverse Event|18|||
23810274|NCT01672970|66684372|FG000|Overall Study|Withdrawal by Subject|2|||
23810275|NCT01672970|66684372|FG000|Overall Study|Lost to Follow-up|5|||
23810276|NCT01672970|66684372|FG000|Overall Study|Other|9|||
23810277|NCT01672970|66684372|FG000|Overall Study|Enrolled but not treated|1|||
23810278|NCT00158600|66684373|FG000|Overall Study|unable to commit time to study|0|||
23810279|NCT00158600|66684374|FG001|Overall Study|unable to commit time to study|1|||
23810280|NCT00158600|66684373|FG000|Overall Study|Adverse Event|2|||
23810281|NCT00158600|66684374|FG001|Overall Study|Adverse Event|1|||
23810282|NCT00158600|66684373|FG000|Overall Study|Death|1|||
23810283|NCT00158600|66684374|FG001|Overall Study|Death|0|||
23810284|NCT00158600|66684373|FG000|Overall Study|Withdrawal by Subject|2|||
23810285|NCT00158600|66684374|FG001|Overall Study|Withdrawal by Subject|2|||
23810286|NCT03551496|66684375|FG000|Overall Study|Death|11|||
23810287|NCT03551496|66684376|FG001|Overall Study|Death|7|||
23810288|NCT03551496|66684375|FG000|Overall Study|Withdrawal by Subject|4|||
23810289|NCT03551496|66684376|FG001|Overall Study|Withdrawal by Subject|3|||
23810290|NCT03551496|66684375|FG000|Overall Study|Other Reasons|1|||
23810291|NCT03551496|66684376|FG001|Overall Study|Other Reasons|0|||
23810292|NCT00390221|66684381|FG000|Overall Study|Lost to Follow-up|0|||
23810293|NCT00390221|66684382|FG001|Overall Study|Lost to Follow-up|3|||
23810294|NCT00390221|66684383|FG002|Overall Study|Lost to Follow-up|0|||
23505211|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505212|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505213|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505214|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505215|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505216|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505217|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505218|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23404049|NCT00506779|65226486|FG001|Overall Study|Withdrawal by Subject|0|||
23404050|NCT00506779|65226487|FG002|Overall Study|Withdrawal by Subject|1|||
23404051|NCT00506779|65226488|FG003|Overall Study|Withdrawal by Subject|0|||
23404052|NCT00506779|65226485|FG000|Overall Study|Adverse Event|0|||
23404053|NCT00506779|65226486|FG001|Overall Study|Adverse Event|1|||
23404054|NCT00506779|65226487|FG002|Overall Study|Adverse Event|1|||
23404055|NCT00506779|65226488|FG003|Overall Study|Adverse Event|1|||
23404056|NCT03465722|65226489|FG000|Overall Study|Withdrawal by Subject|21|||
23404057|NCT03465722|65226490|FG001|Overall Study|Withdrawal by Subject|14|||
23404058|NCT03465722|65226489|FG000|Overall Study|Death|89|||
23404059|NCT03465722|65226490|FG001|Overall Study|Death|87|||
23404060|NCT03465722|65226489|FG000|Overall Study|Lost to Follow-up|5|||
23404061|NCT03465722|65226490|FG001|Overall Study|Lost to Follow-up|3|||
23404062|NCT03465722|65226489|FG000|Overall Study|Administrative/Other|33|||
23404063|NCT03465722|65226490|FG001|Overall Study|Administrative/Other|32|||
23404064|NCT03465722|65226489|FG000|Overall Study|Not treated|1|||
23404065|NCT03465722|65226490|FG001|Overall Study|Not treated|2|||
23404066|NCT03465722|65226489|FG000|Overall Study|Sponsor decision|91|||
23505219|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505220|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23810295|NCT00390221|66684381|FG000|Overall Study|Adverse Event|1|||
23404067|NCT03465722|65226490|FG001|Overall Study|Sponsor decision|98|||
23404068|NCT00539240|65226492|FG000|Overall Study|Withdrawal by Subject|0|||
23404069|NCT00539240|65226493|FG001|Overall Study|Withdrawal by Subject|2|||
23404070|NCT00539240|65226494|FG002|Overall Study|Withdrawal by Subject|0|||
23404071|NCT00539240|65226492|FG000|Overall Study|Protocol Violation|1|||
23404072|NCT00539240|65226493|FG001|Overall Study|Protocol Violation|1|||
23404073|NCT00539240|65226494|FG002|Overall Study|Protocol Violation|4|||
23404074|NCT00539240|65226492|FG000|Overall Study|Lost to Follow-up|2|||
23404075|NCT00539240|65226493|FG001|Overall Study|Lost to Follow-up|3|||
23404076|NCT00539240|65226494|FG002|Overall Study|Lost to Follow-up|1|||
23404077|NCT00539240|65226492|FG000|Overall Study|Adverse Event|3|||
23404078|NCT00539240|65226493|FG001|Overall Study|Adverse Event|1|||
23810296|NCT00390221|66684382|FG001|Overall Study|Adverse Event|4|||
23404079|NCT00539240|65226494|FG002|Overall Study|Adverse Event|10|||
23404080|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Physician Decision|2|||
23404081|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Physician Decision|0|||
23404082|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Physician Decision|0|||
23404083|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Adverse Event|33|||
23404084|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Adverse Event|0|||
23404085|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Adverse Event|0|||
23404086|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
23404087|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23404088|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23404089|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
23404090|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23404091|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23404092|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
23404093|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
23505221|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505222|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505223|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505224|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505225|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505226|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505227|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505228|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505229|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505230|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505231|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505232|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505233|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
23505234|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23404094|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
23404095|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
23404096|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
23404097|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
23505235|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505236|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505237|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505238|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505239|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505240|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505241|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505242|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505243|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23404098|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
23404099|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
23404100|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23404101|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
23404102|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
23505244|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505245|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505246|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505247|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505248|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505249|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505250|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505251|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505252|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505253|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505254|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23404103|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
23404104|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23404105|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23404106|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
23404107|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23404108|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23404109|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
23404110|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
23404111|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
23404112|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
23404113|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
23404114|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
23404115|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
23404116|NCT01466491|65226500|FG000|Overall Study|Protocol Violation|0|||
23404117|NCT01466491|65226501|FG001|Overall Study|Protocol Violation|3|||
23404118|NCT01466491|65226502|FG002|Overall Study|Protocol Violation|2|||
23404119|NCT01466491|65226503|FG003|Overall Study|Protocol Violation|0|||
23404120|NCT01466491|65226500|FG000|Overall Study|Missing Data|0|||
23404121|NCT01466491|65226501|FG001|Overall Study|Missing Data|0|||
23404122|NCT01466491|65226502|FG002|Overall Study|Missing Data|1|||
23404123|NCT01466491|65226503|FG003|Overall Study|Missing Data|0|||
23404124|NCT00803361|65226504|FG000|Overall Study|Adverse Event|13|||
23404125|NCT00803361|65226505|FG001|Overall Study|Adverse Event|3|||
23404126|NCT00803361|65226504|FG000|Overall Study|Lack of Efficacy|4|||
23404127|NCT00803361|65226505|FG001|Overall Study|Lack of Efficacy|13|||
23404128|NCT00803361|65226504|FG000|Overall Study|Lost to Follow-up|1|||
23404129|NCT00803361|65226505|FG001|Overall Study|Lost to Follow-up|2|||
23404130|NCT00803361|65226504|FG000|Overall Study|Physician Decision|1|||
23404131|NCT00803361|65226505|FG001|Overall Study|Physician Decision|0|||
23404132|NCT00803361|65226504|FG000|Overall Study|Protocol Violation|2|||
23404133|NCT00803361|65226505|FG001|Overall Study|Protocol Violation|4|||
23404134|NCT00803361|65226504|FG000|Overall Study|Withdrawal by Subject|5|||
23404135|NCT00803361|65226505|FG001|Overall Study|Withdrawal by Subject|6|||
23404136|NCT02311881|65226506|FG000|Overall Study|Did not meet the study criteria|2|||
23404137|NCT02311881|65226507|FG001|Overall Study|Did not meet the study criteria|2|||
23404138|NCT02311881|65226508|FG002|Overall Study|Did not meet the study criteria|0|||
23404139|NCT02311881|65226506|FG000|Overall Study|Adverse Event|7|||
23404140|NCT02311881|65226507|FG001|Overall Study|Adverse Event|15|||
23404141|NCT02311881|65226508|FG002|Overall Study|Adverse Event|8|||
23404142|NCT02311881|65226506|FG000|Overall Study|Lost to Follow-up|3|||
23404143|NCT02311881|65226507|FG001|Overall Study|Lost to Follow-up|3|||
23505255|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505256|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505257|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505258|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505259|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505260|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
23505261|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
23810297|NCT00390221|66684383|FG002|Overall Study|Adverse Event|3|||
23810298|NCT00390221|66684381|FG000|Overall Study|Investigator Decision|0|||
23810299|NCT00390221|66684382|FG001|Overall Study|Investigator Decision|0|||
23810300|NCT00390221|66684383|FG002|Overall Study|Investigator Decision|1|||
23810301|NCT00390221|66684381|FG000|Overall Study|Withdrawal by Subject|13|||
23810302|NCT00390221|66684382|FG001|Overall Study|Withdrawal by Subject|9|||
23810303|NCT00390221|66684383|FG002|Overall Study|Withdrawal by Subject|7|||
23810304|NCT00390221|66684381|FG000|Overall Study|Subject Non-compliance|1|||
23810305|NCT00390221|66684382|FG001|Overall Study|Subject Non-compliance|0|||
23810306|NCT00390221|66684383|FG002|Overall Study|Subject Non-compliance|2|||
23810307|NCT00390221|66684381|FG000|Overall Study|Other|3|||
23810308|NCT00390221|66684382|FG001|Overall Study|Other|4|||
23810309|NCT00390221|66684383|FG002|Overall Study|Other|2|||
23810310|NCT00712985|66684384|FG000|Overall Study|1 withdrew prior to start of drug|1|||
23810311|NCT00712985|66684384|FG000|Overall Study|1 patient moved out of state|1|||
23810312|NCT00712985|66684384|FG000|Overall Study|Lack of Efficacy|3|||
23810313|NCT02575911|66684386|FG000|Overall Study|Lost to Follow-up|1|||
23810314|NCT02056392|66684389|FG000|Overall Study|Lost to Follow-up|0|||
23810315|NCT02056392|66684390|FG001|Overall Study|Lost to Follow-up|1|||
23810316|NCT02056392|66684391|FG002|Overall Study|Lost to Follow-up|2|||
23810317|NCT02056392|66684392|FG003|Overall Study|Lost to Follow-up|0|||
23810318|NCT02056392|66684393|FG004|Overall Study|Lost to Follow-up|0|||
23810319|NCT02056392|66684394|FG005|Overall Study|Lost to Follow-up|0|||
23810320|NCT02056392|66684389|FG000|Overall Study|Protocol Violation|1|||
23810321|NCT02056392|66684390|FG001|Overall Study|Protocol Violation|0|||
23810322|NCT02056392|66684391|FG002|Overall Study|Protocol Violation|1|||
23810323|NCT02056392|66684392|FG003|Overall Study|Protocol Violation|0|||
23810324|NCT02056392|66684393|FG004|Overall Study|Protocol Violation|0|||
23810325|NCT02056392|66684394|FG005|Overall Study|Protocol Violation|0|||
23810326|NCT02056392|66684389|FG000|Overall Study|Withdrawal by Subject|1|||
23810327|NCT02056392|66684390|FG001|Overall Study|Withdrawal by Subject|0|||
23810328|NCT02056392|66684391|FG002|Overall Study|Withdrawal by Subject|0|||
23810329|NCT02056392|66684392|FG003|Overall Study|Withdrawal by Subject|0|||
23810330|NCT02056392|66684393|FG004|Overall Study|Withdrawal by Subject|1|||
23810331|NCT02056392|66684394|FG005|Overall Study|Withdrawal by Subject|0|||
23810332|NCT00302081|66684395|FG000|Overall Study|Adverse Event|6|||
23810333|NCT00302081|66684396|FG001|Overall Study|Adverse Event|5|||
23810334|NCT00302081|66684397|FG002|Overall Study|Adverse Event|4|||
23810335|NCT00302081|66684395|FG000|Overall Study|Lost to Follow-up|21|||
23810336|NCT00302081|66684396|FG001|Overall Study|Lost to Follow-up|18|||
23810337|NCT00302081|66684397|FG002|Overall Study|Lost to Follow-up|28|||
23810338|NCT00302081|66684395|FG000|Overall Study|Withdrawal by Subject|8|||
23810339|NCT00302081|66684396|FG001|Overall Study|Withdrawal by Subject|12|||
23810340|NCT00302081|66684397|FG002|Overall Study|Withdrawal by Subject|8|||
23810341|NCT00302081|66684395|FG000|Overall Study|Protocol Violation|5|||
23810342|NCT00302081|66684396|FG001|Overall Study|Protocol Violation|1|||
23810343|NCT00302081|66684397|FG002|Overall Study|Protocol Violation|2|||
23810344|NCT00302081|66684395|FG000|Overall Study|Lack of Efficacy|1|||
23810345|NCT00302081|66684396|FG001|Overall Study|Lack of Efficacy|0|||
23810346|NCT00302081|66684397|FG002|Overall Study|Lack of Efficacy|5|||
23810347|NCT00302081|66684395|FG000|Overall Study|Death|2|||
23810348|NCT00302081|66684396|FG001|Overall Study|Death|1|||
23810349|NCT00302081|66684397|FG002|Overall Study|Death|0|||
23810350|NCT00302081|66684395|FG000|Overall Study|Other|13|||
23810351|NCT00302081|66684396|FG001|Overall Study|Other|6|||
23810352|NCT00302081|66684397|FG002|Overall Study|Other|5|||
23810353|NCT01941940|66684398|FG000|Overall Study|Adverse Event|11|||
23810354|NCT01941940|66684398|FG000|Overall Study|Lost to Follow-up|2|||
23810355|NCT01941940|66684398|FG000|Overall Study|Physician Decision|2|||
23810356|NCT01941940|66684398|FG000|Overall Study|Withdrawal by Subject|15|||
23810357|NCT01941940|66684398|FG000|Overall Study|Death|1|||
23810358|NCT01941940|66684398|FG000|Overall Study|Other|1|||
23810359|NCT01941940|66684398|FG000|Overall Study|Other|1|||
23810360|NCT01300052|66684399|FG000|Overall Study|Adverse Event|3|||
23810361|NCT01300052|66684400|FG001|Overall Study|Adverse Event|0|||
23810362|NCT01300052|66684399|FG000|Overall Study|Withdrawal by Subject|2|||
23810363|NCT01300052|66684400|FG001|Overall Study|Withdrawal by Subject|2|||
23810364|NCT01300052|66684399|FG000|Overall Study|Protocol Violation|1|||
23810365|NCT01300052|66684400|FG001|Overall Study|Protocol Violation|1|||
23810366|NCT03188666|66684413|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23810367|NCT03188666|66684414|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
23810368|NCT03188666|66684415|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23810369|NCT03188666|66684416|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23810370|NCT03188666|66684413|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
23810371|NCT03188666|66684414|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
23810372|NCT03188666|66684415|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
23810373|NCT03188666|66684416|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
23810374|NCT03188666|66684413|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23810375|NCT03188666|66684414|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23810376|NCT03188666|66684415|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
23810377|NCT03188666|66684416|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23810378|NCT03188666|66684413|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
23810379|NCT03188666|66684414|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
23810380|NCT03188666|66684415|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
23810381|NCT03188666|66684416|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
23810382|NCT00515541|66684419|FG000|Overall Study|Physician Decision|0|||
23810383|NCT00515541|66684420|FG001|Overall Study|Physician Decision|2|||
23810384|NCT00515541|66684421|FG002|Overall Study|Physician Decision|0|||
23810385|NCT00515541|66684422|FG003|Overall Study|Physician Decision|1|||
23810386|NCT00515541|66684419|FG000|Overall Study|No show for appointments|0|||
23810387|NCT00515541|66684420|FG001|Overall Study|No show for appointments|1|||
23810388|NCT00515541|66684421|FG002|Overall Study|No show for appointments|0|||
23810389|NCT00515541|66684422|FG003|Overall Study|No show for appointments|2|||
23810390|NCT00515541|66684419|FG000|Overall Study|Withdrawal by Subject|0|||
23810391|NCT00515541|66684420|FG001|Overall Study|Withdrawal by Subject|2|||
23810392|NCT00515541|66684421|FG002|Overall Study|Withdrawal by Subject|0|||
23810393|NCT00515541|66684422|FG003|Overall Study|Withdrawal by Subject|2|||
23404144|NCT02311881|65226508|FG002|Overall Study|Lost to Follow-up|2|||
23404145|NCT02311881|65226506|FG000|Overall Study|Protocol Violation|1|||
23404146|NCT02311881|65226507|FG001|Overall Study|Protocol Violation|2|||
23404147|NCT02311881|65226508|FG002|Overall Study|Protocol Violation|3|||
23404148|NCT02311881|65226506|FG000|Overall Study|Withdrawal of consent|14|||
23404149|NCT02311881|65226507|FG001|Overall Study|Withdrawal of consent|16|||
23404150|NCT02311881|65226508|FG002|Overall Study|Withdrawal of consent|17|||
23404151|NCT02311881|65226506|FG000|Overall Study|Other|0|||
23404152|NCT02311881|65226507|FG001|Overall Study|Other|0|||
23404153|NCT02311881|65226508|FG002|Overall Study|Other|1|||
23404154|NCT02311881|65226506|FG000|Overall Study|Lack of Efficacy|1|||
23404155|NCT02311881|65226507|FG001|Overall Study|Lack of Efficacy|2|||
23404156|NCT02311881|65226508|FG002|Overall Study|Lack of Efficacy|0|||
23404157|NCT02311881|65226506|FG000|Overall Study|Subject has border line pregnancy test|1|||
23404158|NCT02311881|65226507|FG001|Overall Study|Subject has border line pregnancy test|0|||
23810394|NCT02685202|66684423|FG000|Overall Study|Lost to Follow-up|9|||
23810395|NCT02139124|66684428|FG000|Overall Study|Adverse Event|2|||
23404159|NCT02311881|65226508|FG002|Overall Study|Subject has border line pregnancy test|0|||
23404160|NCT02311881|65226506|FG000|Overall Study|Withdrawal by Subject|3|||
23404161|NCT02311881|65226507|FG001|Overall Study|Withdrawal by Subject|1|||
23404162|NCT02311881|65226508|FG002|Overall Study|Withdrawal by Subject|4|||
23404163|NCT02311881|65226506|FG000|Overall Study|Sponsor Decision|1|||
23404164|NCT02311881|65226507|FG001|Overall Study|Sponsor Decision|1|||
23404165|NCT02311881|65226508|FG002|Overall Study|Sponsor Decision|1|||
23404166|NCT02311881|65226506|FG000|Overall Study|Protocol Deviation|1|||
23404167|NCT02311881|65226507|FG001|Overall Study|Protocol Deviation|0|||
23404168|NCT02311881|65226508|FG002|Overall Study|Protocol Deviation|0|||
23404169|NCT02311881|65226506|FG000|Overall Study|Non-Compliance|1|||
23404170|NCT02311881|65226507|FG001|Overall Study|Non-Compliance|0|||
23404171|NCT02311881|65226508|FG002|Overall Study|Non-Compliance|2|||
23404172|NCT02311881|65226506|FG000|Overall Study|Physician Decision|0|||
23404173|NCT02311881|65226507|FG001|Overall Study|Physician Decision|0|||
23404174|NCT02311881|65226508|FG002|Overall Study|Physician Decision|1|||
23404175|NCT02311881|65226506|FG000|Overall Study|Medical Monitor Discretion|0|||
23404176|NCT02311881|65226507|FG001|Overall Study|Medical Monitor Discretion|0|||
23404177|NCT02311881|65226508|FG002|Overall Study|Medical Monitor Discretion|1|||
23404178|NCT02311881|65226506|FG000|Overall Study|Participant taking another medication|0|||
23404179|NCT02311881|65226507|FG001|Overall Study|Participant taking another medication|0|||
23404180|NCT02311881|65226508|FG002|Overall Study|Participant taking another medication|1|||
23404181|NCT02311881|65226506|FG000|Overall Study|Serious Adverse Event|0|||
23404182|NCT02311881|65226507|FG001|Overall Study|Serious Adverse Event|1|||
23404183|NCT02311881|65226508|FG002|Overall Study|Serious Adverse Event|0|||
23404184|NCT00339040|65226511|FG000|Stage I|Not able to attend clinic|1|||
23404185|NCT00339040|65226512|FG001|Stage I|Not able to attend clinic|0|||
23404186|NCT00339040|65226511|FG000|Stage I|Protocol Violation|1|||
23404187|NCT00339040|65226512|FG001|Stage I|Protocol Violation|1|||
23404188|NCT00339040|65226511|FG000|Stage II|Lost to Follow-up|3|||
23404189|NCT00339040|65226512|FG001|Stage II|Lost to Follow-up|0|||
23404190|NCT00339040|65226511|FG000|Stage II|Withdrawal by Subject|1|||
23404191|NCT00339040|65226512|FG001|Stage II|Withdrawal by Subject|2|||
23404192|NCT00339040|65226511|FG000|Stage II|Protocol Violation|3|||
23404193|NCT00339040|65226512|FG001|Stage II|Protocol Violation|0|||
23404194|NCT00339040|65226511|FG000|Stage II|Not able to attend clinic|1|||
23404195|NCT00339040|65226512|FG001|Stage II|Not able to attend clinic|0|||
23404196|NCT00339040|65226511|FG000|Stage II|Site closing|2|||
23404197|NCT00339040|65226512|FG001|Stage II|Site closing|0|||
23404198|NCT01119443|65226513|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
23404199|NCT01119443|65226514|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
23404200|NCT00886769|65226515|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23404201|NCT00886769|65226516|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
23404202|NCT01082081|65226522|FG000|Overall Study|Lost to Follow-up|0|||
23404203|NCT01082081|65226523|FG001|Overall Study|Lost to Follow-up|0|||
23404204|NCT01082081|65226524|FG002|Overall Study|Lost to Follow-up|1|||
23404205|NCT01082081|65226522|FG000|Overall Study|Withdrawal by Subject|0|||
23404206|NCT01082081|65226523|FG001|Overall Study|Withdrawal by Subject|0|||
23404207|NCT01082081|65226524|FG002|Overall Study|Withdrawal by Subject|1|||
23404208|NCT01082081|65226522|FG000|Overall Study|Other Reason|0|||
23404209|NCT01082081|65226523|FG001|Overall Study|Other Reason|1|||
23404210|NCT01082081|65226524|FG002|Overall Study|Other Reason|0|||
23404211|NCT00678288|65226525|FG000|Overall Study|Adverse Event|0|||
23404212|NCT00678288|65226526|FG001|Overall Study|Adverse Event|2|||
23404213|NCT00678288|65226525|FG000|Overall Study|Withdrawal by Subject|1|||
23404214|NCT00678288|65226526|FG001|Overall Study|Withdrawal by Subject|1|||
23404215|NCT00678288|65226525|FG000|Overall Study|Study terminated by the sponsor|2|||
23404216|NCT00678288|65226526|FG001|Overall Study|Study terminated by the sponsor|0|||
23404217|NCT00678288|65226525|FG000|Overall Study|Not compliant with study medication|0|||
23404218|NCT00678288|65226526|FG001|Overall Study|Not compliant with study medication|1|||
23404219|NCT00678288|65226525|FG000|Overall Study|Switch to commercial drug|0|||
23404220|NCT00678288|65226526|FG001|Overall Study|Switch to commercial drug|1|||
23404221|NCT00678288|65226525|FG000|Overall Study|Reason not reported|1|||
23404222|NCT00678288|65226526|FG001|Overall Study|Reason not reported|0|||
23404223|NCT00678288|65226525|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
23404224|NCT00678288|65226526|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
23505262|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
23404225|NCT00363142|65226527|FG000|Overall Study|Adverse Event|2|||
23404226|NCT00363142|65226528|FG001|Overall Study|Adverse Event|0|||
23505263|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
23404227|NCT00363142|65226527|FG000|Overall Study|Lack of Efficacy|0|||
23404228|NCT00363142|65226528|FG001|Overall Study|Lack of Efficacy|1|||
23404229|NCT00363142|65226527|FG000|Overall Study|Lost to Follow-up|1|||
23404230|NCT00363142|65226528|FG001|Overall Study|Lost to Follow-up|0|||
23404231|NCT00363142|65226527|FG000|Overall Study|Non-compliance|1|||
23404232|NCT00363142|65226528|FG001|Overall Study|Non-compliance|1|||
23404233|NCT00363142|65226527|FG000|Overall Study|Withdrawal by Subject|3|||
23505264|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
23505265|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
23505266|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
23505267|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
23505268|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
23505269|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
23505270|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
23505271|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
23505272|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
23505273|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
23505274|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
23505275|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
23505276|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
23505277|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
23505278|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
23505279|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
23505280|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
23505281|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
23505282|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
23505283|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
23505284|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
23505285|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
23505286|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
23505287|NCT00291577|65587902|FG000|Overall Study|Adverse Event|1|||
23505288|NCT00291577|65587902|FG000|Overall Study|Other|4|||
23505289|NCT00291577|65587902|FG000|Overall Study|Withdrawal by Subject|2|||
23505290|NCT00291577|65587902|FG000|Overall Study|Lack of Efficacy|14|||
23505291|NCT00601458|65587903|FG000|Overall Study|Dosing Error|1|||
23505292|NCT00601458|65587904|FG001|Overall Study|Dosing Error|0|||
23505293|NCT00601458|65587905|FG002|Overall Study|Dosing Error|0|||
23505294|NCT00601458|65587903|FG000|Overall Study|Incomplete Data|0|||
23505295|NCT00601458|65587904|FG001|Overall Study|Incomplete Data|2|||
23505296|NCT00601458|65587905|FG002|Overall Study|Incomplete Data|0|||
23505297|NCT00601458|65587903|FG000|Overall Study|Protocol Violation|3|||
23505298|NCT00601458|65587904|FG001|Overall Study|Protocol Violation|2|||
23505299|NCT00601458|65587905|FG002|Overall Study|Protocol Violation|1|||
23505300|NCT00601458|65587903|FG000|Overall Study|Early Termination|0|||
23505301|NCT00601458|65587904|FG001|Overall Study|Early Termination|1|||
23505302|NCT00601458|65587905|FG002|Overall Study|Early Termination|1|||
23505303|NCT04706091|65587906|FG000|Treatment 2|Withdrawal by Subject|1|||
23505304|NCT04706091|65587907|FG001|Treatment 2|Withdrawal by Subject|0|||
23505305|NCT03098550|65587908|FG000|Overall Study|Disease Progression|30|||
23505306|NCT03098550|65587909|FG001|Overall Study|Disease Progression|19|||
23505307|NCT03098550|65587910|FG002|Overall Study|Disease Progression|41|||
23505308|NCT03098550|65587908|FG000|Overall Study|Study Drug Toxicity|2|||
23505309|NCT03098550|65587909|FG001|Overall Study|Study Drug Toxicity|1|||
23505310|NCT03098550|65587910|FG002|Overall Study|Study Drug Toxicity|0|||
23505311|NCT03098550|65587908|FG000|Overall Study|Death|1|||
23505312|NCT03098550|65587909|FG001|Overall Study|Death|0|||
23505313|NCT03098550|65587910|FG002|Overall Study|Death|0|||
23505314|NCT03098550|65587908|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
23505315|NCT03098550|65587909|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
23505316|NCT03098550|65587910|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
23505317|NCT03098550|65587908|FG000|Overall Study|Administrative reason by sponsor|0|||
23505318|NCT03098550|65587909|FG001|Overall Study|Administrative reason by sponsor|0|||
23505319|NCT03098550|65587910|FG002|Overall Study|Administrative reason by sponsor|1|||
23505320|NCT03098550|65587908|FG000|Overall Study|Other reasons|2|||
23505321|NCT03098550|65587909|FG001|Overall Study|Other reasons|0|||
23505322|NCT03098550|65587910|FG002|Overall Study|Other reasons|0|||
23505323|NCT00520936|65587913|FG000|Overall Study|Physician Decision|0|||
23505324|NCT00520936|65587914|FG001|Overall Study|Physician Decision|2|||
23505325|NCT00520936|65587915|FG002|Overall Study|Physician Decision|1|||
23505326|NCT00520936|65587916|FG003|Overall Study|Physician Decision|0|||
23505327|NCT00520936|65587917|FG004|Overall Study|Physician Decision|0|||
23505328|NCT00520936|65587918|FG005|Overall Study|Physician Decision|0|||
23505329|NCT00520936|65587919|FG006|Overall Study|Physician Decision|0|||
23505330|NCT00520936|65587920|FG007|Overall Study|Physician Decision|0|||
23505331|NCT00520936|65587913|FG000|Overall Study|Withdrawal by Subject|0|||
23505332|NCT00520936|65587914|FG001|Overall Study|Withdrawal by Subject|0|||
23505333|NCT00520936|65587915|FG002|Overall Study|Withdrawal by Subject|0|||
23505334|NCT00520936|65587916|FG003|Overall Study|Withdrawal by Subject|0|||
23505335|NCT00520936|65587917|FG004|Overall Study|Withdrawal by Subject|0|||
23505336|NCT00520936|65587918|FG005|Overall Study|Withdrawal by Subject|0|||
23505337|NCT00520936|65587919|FG006|Overall Study|Withdrawal by Subject|0|||
23505338|NCT00520936|65587920|FG007|Overall Study|Withdrawal by Subject|1|||
23505339|NCT00520936|65587913|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
23505340|NCT00520936|65587914|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
23505341|NCT00520936|65587915|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
23505342|NCT00520936|65587916|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
23505343|NCT00520936|65587917|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
23505344|NCT00520936|65587918|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
23505345|NCT00520936|65587919|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
23505346|NCT00520936|65587920|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
23505347|NCT00520936|65587913|FG000|Overall Study|Death|0|||
23505348|NCT00520936|65587914|FG001|Overall Study|Death|0|||
23505349|NCT00520936|65587915|FG002|Overall Study|Death|0|||
23505350|NCT00520936|65587916|FG003|Overall Study|Death|0|||
23505351|NCT00520936|65587917|FG004|Overall Study|Death|0|||
23505352|NCT00520936|65587918|FG005|Overall Study|Death|0|||
23505353|NCT00520936|65587919|FG006|Overall Study|Death|1|||
23505354|NCT00520936|65587920|FG007|Overall Study|Death|0|||
23505355|NCT00520936|65587913|FG000|Overall Study|Protocol Violation|0|||
23505356|NCT00520936|65587914|FG001|Overall Study|Protocol Violation|1|||
23505357|NCT00520936|65587915|FG002|Overall Study|Protocol Violation|1|||
23505358|NCT00520936|65587916|FG003|Overall Study|Protocol Violation|0|||
23505359|NCT00520936|65587917|FG004|Overall Study|Protocol Violation|1|||
23505360|NCT00520936|65587918|FG005|Overall Study|Protocol Violation|0|||
23505361|NCT00520936|65587919|FG006|Overall Study|Protocol Violation|1|||
23505362|NCT00520936|65587920|FG007|Overall Study|Protocol Violation|0|||
23505363|NCT00827502|65587921|FG000|Overall Study|randomized but not treated|11|||
23505364|NCT00827502|65587921|FG000|Overall Study|Adverse Event|1|||
23505365|NCT00827502|65587921|FG000|Overall Study|Lost to Follow-up|4|||
23505366|NCT00827502|65587921|FG000|Overall Study|Withdrawal by Subject|5|||
23505367|NCT00621985|65587922|FG000|Dexamethasone Admission|Adverse Event|1|||
23505368|NCT00056316|65587926|FG000|Overall Study|Withdrawal by Subject|2|||
23505369|NCT00056316|65587927|FG001|Overall Study|Withdrawal by Subject|2|||
23505370|NCT00056316|65587926|FG000|Overall Study|Death/NH placement of pt|1|||
23404234|NCT00363142|65226528|FG001|Overall Study|Withdrawal by Subject|1|||
23404235|NCT01558596|65226529|FG000|Overall Study|Withdrawal by Subject|1|||
23810396|NCT02139124|66684429|FG001|Overall Study|Adverse Event|0|||
23810397|NCT02139124|66684430|FG002|Overall Study|Adverse Event|1|||
23404236|NCT01558596|65226530|FG001|Overall Study|Withdrawal by Subject|0|||
23404237|NCT01558596|65226529|FG000|Overall Study|surgery elsewhere or cancelled|1|||
23404238|NCT01558596|65226530|FG001|Overall Study|surgery elsewhere or cancelled|1|||
23404239|NCT01558596|65226529|FG000|Overall Study|Protocol Violation|1|||
23404240|NCT01558596|65226530|FG001|Overall Study|Protocol Violation|0|||
23404241|NCT03273907|65226531|FG000|Overall Study|Death|1|||
23404242|NCT03273907|65226531|FG000|Overall Study|Lost to Follow-up|4|||
23404243|NCT03273907|65226531|FG000|Overall Study|Withdrawal by Subject|2|||
23404244|NCT03273907|65226531|FG000|Overall Study|COVID 19|2|||
23404245|NCT00517699|65226532|FG000|Overall Study|Withdrawal by Subject|1|||
23404246|NCT00517699|65226532|FG000|Overall Study|Lack of Efficacy|1|||
23404247|NCT00517699|65226532|FG000|Overall Study|Administrative error|1|||
23404248|NCT00517699|65226532|FG000|Overall Study|Study terminated by Sponsor|2|||
23404249|NCT00800982|65226536|FG000|Overall Study|Lost to Follow-up|1|||
23404250|NCT00800982|65226537|FG001|Overall Study|Lost to Follow-up|2|||
23404251|NCT00800982|65226536|FG000|Overall Study|Withdrawal by Subject|0|||
23404252|NCT00800982|65226537|FG001|Overall Study|Withdrawal by Subject|1|||
23404253|NCT00800982|65226536|FG000|Overall Study|Patient moved out of state|1|||
23404254|NCT00800982|65226537|FG001|Overall Study|Patient moved out of state|0|||
23404255|NCT04419467|65226545|FG000|Overall Study|Not treated with IP|0|||
23404256|NCT04419467|65226546|FG001|Overall Study|Not treated with IP|0|||
23404257|NCT04419467|65226547|FG002|Overall Study|Not treated with IP|2|||
23404258|NCT04419467|65226545|FG000|Overall Study|Adverse Event|0|||
23404259|NCT04419467|65226546|FG001|Overall Study|Adverse Event|2|||
23404260|NCT04419467|65226547|FG002|Overall Study|Adverse Event|0|||
23404261|NCT04419467|65226545|FG000|Overall Study|Death|1|||
23404262|NCT04419467|65226546|FG001|Overall Study|Death|0|||
23404263|NCT04419467|65226547|FG002|Overall Study|Death|0|||
23404264|NCT04419467|65226545|FG000|Overall Study|Lost to Follow-up|0|||
23404265|NCT04419467|65226546|FG001|Overall Study|Lost to Follow-up|1|||
23404266|NCT04419467|65226547|FG002|Overall Study|Lost to Follow-up|2|||
23404267|NCT04419467|65226545|FG000|Overall Study|Withdrawal by Subject|0|||
23404268|NCT04419467|65226546|FG001|Overall Study|Withdrawal by Subject|0|||
23404269|NCT04419467|65226547|FG002|Overall Study|Withdrawal by Subject|4|||
23404270|NCT04419467|65226545|FG000|Overall Study|Pandemic related|0|||
23404271|NCT04419467|65226546|FG001|Overall Study|Pandemic related|0|||
23404272|NCT04419467|65226547|FG002|Overall Study|Pandemic related|1|||
23404273|NCT04419467|65226545|FG000|Overall Study|Reason not known|1|||
23404274|NCT04419467|65226546|FG001|Overall Study|Reason not known|0|||
23505371|NCT00056316|65587927|FG001|Overall Study|Death/NH placement of pt|1|||
23505372|NCT00838578|65587928|FG000|Overall Study|Protocol Violation|2|||
23505373|NCT01433991|65587929|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
23505374|NCT01433991|65587930|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23810398|NCT02139124|66684431|FG003|Overall Study|Adverse Event|2|||
23404275|NCT04419467|65226547|FG002|Overall Study|Reason not known|0|||
23404276|NCT00952705|65226556|FG000|Overall Study|Lost to Follow-up|24|||
23404277|NCT00952705|65226557|FG001|Overall Study|Lost to Follow-up|8|||
23404278|NCT00952705|65226558|FG002|Overall Study|Lost to Follow-up|9|||
23404279|NCT00952705|65226556|FG000|Overall Study|Withdrawal by Subject|2|||
23404280|NCT00952705|65226557|FG001|Overall Study|Withdrawal by Subject|1|||
23404281|NCT00952705|65226558|FG002|Overall Study|Withdrawal by Subject|1|||
23404282|NCT00952705|65226556|FG000|Overall Study|Death|2|||
23404283|NCT00952705|65226557|FG001|Overall Study|Death|0|||
23404284|NCT00952705|65226558|FG002|Overall Study|Death|0|||
23404285|NCT00952705|65226556|FG000|Overall Study|Incarcerated post dose|5|||
23606547|NCT00498797|65950441|FG001|Overall Study|Condition under investigation worsened|21|||
23404286|NCT00952705|65226557|FG001|Overall Study|Incarcerated post dose|0|||
23404287|NCT00952705|65226558|FG002|Overall Study|Incarcerated post dose|0|||
23404288|NCT00952705|65226556|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
23404289|NCT00952705|65226557|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
23404290|NCT00952705|65226558|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
23404291|NCT00186628|65226559|FG000|Overall Study|Death|2|||
23505375|NCT01433991|65587931|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23505376|NCT01433991|65587932|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23505377|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
23505378|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
23505379|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
23505380|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
23505381|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23505382|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23404292|NCT00186628|65226559|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
23404293|NCT02175277|65226560|FG000|Overall Study|Protocol-specified Criteria|1|||
23404294|NCT01479764|65226562|FG000|Randomized|Adverse Event|1|||
23404295|NCT01479764|65226563|FG001|Randomized|Adverse Event|1|||
23404296|NCT01479764|65226562|FG000|Randomized|Withdrawal by Subject|1|||
23404297|NCT01479764|65226563|FG001|Randomized|Withdrawal by Subject|0|||
23404298|NCT01479764|65226562|FG000|Treated|Lost to Follow-up|0|||
23404299|NCT01479764|65226563|FG001|Treated|Lost to Follow-up|2|||
23404300|NCT01027650|65226566|FG000|Overall Study|Personal Reasons|0|||
23404301|NCT01027650|65226567|FG001|Overall Study|Personal Reasons|0|||
23404302|NCT01027650|65226568|FG002|Overall Study|Personal Reasons|0|||
23404303|NCT01027650|65226569|FG003|Overall Study|Personal Reasons|0|||
23404304|NCT01027650|65226570|FG004|Overall Study|Personal Reasons|2|||
23404305|NCT01027650|65226571|FG005|Overall Study|Personal Reasons|1|||
23404306|NCT01027650|65226572|FG006|Overall Study|Personal Reasons|0|||
23404307|NCT01027650|65226573|FG007|Overall Study|Personal Reasons|0|||
23404308|NCT01027650|65226566|FG000|Overall Study|Lost to Follow-up|0|||
23404309|NCT01027650|65226567|FG001|Overall Study|Lost to Follow-up|0|||
23404310|NCT01027650|65226568|FG002|Overall Study|Lost to Follow-up|0|||
23404311|NCT01027650|65226569|FG003|Overall Study|Lost to Follow-up|0|||
23404312|NCT01027650|65226570|FG004|Overall Study|Lost to Follow-up|0|||
23404313|NCT01027650|65226571|FG005|Overall Study|Lost to Follow-up|0|||
23404314|NCT01027650|65226572|FG006|Overall Study|Lost to Follow-up|1|||
23404315|NCT01027650|65226573|FG007|Overall Study|Lost to Follow-up|0|||
23404316|NCT01027650|65226566|FG000|Overall Study|Lack of Efficacy|0|||
23404317|NCT01027650|65226567|FG001|Overall Study|Lack of Efficacy|0|||
23404318|NCT01027650|65226568|FG002|Overall Study|Lack of Efficacy|0|||
23404319|NCT01027650|65226569|FG003|Overall Study|Lack of Efficacy|0|||
23505383|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23505384|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
23505385|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505386|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505387|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505388|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
23505389|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
23505390|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
23606548|NCT00498797|65950440|FG000|Overall Study|Other|3|||
23606549|NCT00498797|65950441|FG001|Overall Study|Other|1|||
23606550|NCT04693637|65950445|FG000|Overall Study|Death|4|||
23606551|NCT04693637|65950445|FG000|Overall Study|Withdrawal by Subject|3|||
23606552|NCT04693637|65950445|FG000|Overall Study|Physician Decision|2|||
23404320|NCT01027650|65226570|FG004|Overall Study|Lack of Efficacy|0|||
23404321|NCT01027650|65226571|FG005|Overall Study|Lack of Efficacy|1|||
23404322|NCT01027650|65226572|FG006|Overall Study|Lack of Efficacy|0|||
23404323|NCT01027650|65226573|FG007|Overall Study|Lack of Efficacy|0|||
23404324|NCT00200967|65226574|FG000|First Treatment Period|Withdrawal by Subject|5|||
23404325|NCT00200967|65226575|FG001|First Treatment Period|Withdrawal by Subject|1|||
23404326|NCT00200967|65226574|FG000|First Treatment Period|Pregnancy|1|||
23606553|NCT04693637|65950445|FG000|Overall Study|Lost to Follow-up|1|||
23404327|NCT00200967|65226575|FG001|First Treatment Period|Pregnancy|0|||
23606554|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
23606555|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606556|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606557|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606558|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606559|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Adverse Event|0|||
23606560|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Adverse Event|1|||
23606561|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Adverse Event|1|||
23606562|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Adverse Event|0|||
23606563|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Adverse Event|0|||
23606564|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
23606565|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606566|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606567|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606568|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606569|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Physician Decision|1|||
23606570|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Physician Decision|0|||
23606571|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Physician Decision|0|||
23606572|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Physician Decision|0|||
23606573|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Physician Decision|0|||
23606574|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
23606575|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
23606576|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
23606577|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
23606578|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
23606579|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Ongoing|0|||
23606580|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Ongoing|0|||
23606581|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Ongoing|1|||
23606582|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Ongoing|0|||
23606583|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Ongoing|0|||
23606584|NCT00446095|65950446|FG000|Phase I (28 Days)|Adverse Event|0|||
23606585|NCT00446095|65950447|FG001|Phase I (28 Days)|Adverse Event|0|||
23404328|NCT00200967|65226574|FG000|Wash-out Period|Lost to Follow-up|0|||
23404329|NCT00200967|65226575|FG001|Wash-out Period|Lost to Follow-up|1|||
23404330|NCT00200967|65226574|FG000|Second Treatment Period|Withdrawal by Subject|1|||
23404331|NCT00200967|65226575|FG001|Second Treatment Period|Withdrawal by Subject|2|||
23606586|NCT00446095|65950448|FG002|Phase I (28 Days)|Adverse Event|0|||
23606587|NCT00446095|65950449|FG003|Phase I (28 Days)|Adverse Event|1|||
23606588|NCT00446095|65950450|FG004|Phase I (28 Days)|Adverse Event|0|||
23606589|NCT00446095|65950446|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
23404332|NCT00200967|65226574|FG000|Run-out Period|Lost to Follow-up|1|||
23606590|NCT00446095|65950447|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
23606591|NCT00446095|65950448|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
23606592|NCT00446095|65950449|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
23606593|NCT00446095|65950450|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
23606594|NCT02007070|65950451|FG000|Overall Study|Adverse Event|4|||
23606595|NCT02007070|65950451|FG000|Overall Study|Clinical Progression|4|||
23606596|NCT02007070|65950451|FG000|Overall Study|Death|1|||
23606597|NCT02007070|65950451|FG000|Overall Study|Protocol Violation|2|||
23606598|NCT02007070|65950451|FG000|Overall Study|Physician Decision|1|||
23606599|NCT02007070|65950451|FG000|Overall Study|Progressive Disease|21|||
23606600|NCT00048932|65950452|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
23606601|NCT00048932|65950453|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
23606602|NCT00048932|65950454|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
23606603|NCT00048932|65950452|FG000|Double Blind Period (DB)|Adverse Event|51|||
23505391|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
23505392|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
23505393|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
23505394|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505395|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505396|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505397|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23505398|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23606604|NCT00048932|65950453|FG001|Double Blind Period (DB)|Adverse Event|19|||
23606605|NCT00048932|65950454|FG002|Double Blind Period (DB)|Adverse Event|0|||
23606606|NCT00048932|65950452|FG000|Double Blind Period (DB)|Death|5|||
23606607|NCT00048932|65950453|FG001|Double Blind Period (DB)|Death|3|||
23606608|NCT00048932|65950454|FG002|Double Blind Period (DB)|Death|0|||
23606609|NCT00048932|65950452|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
23404333|NCT00200967|65226575|FG001|Run-out Period|Lost to Follow-up|0|||
23606610|NCT00048932|65950453|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
23606611|NCT00048932|65950454|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
23606612|NCT00048932|65950452|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
23606613|NCT00048932|65950453|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
23404334|NCT01824290|65226578|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
23606614|NCT00048932|65950454|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
23606615|NCT00048932|65950452|FG000|Double Blind Period (DB)|Relocation|1|||
23606616|NCT00048932|65950453|FG001|Double Blind Period (DB)|Relocation|0|||
23606617|NCT00048932|65950454|FG002|Double Blind Period (DB)|Relocation|0|||
23606618|NCT00048932|65950452|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
23606619|NCT00048932|65950453|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
23606620|NCT00048932|65950454|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
23606621|NCT00048932|65950452|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
23606622|NCT00048932|65950453|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
23606623|NCT00048932|65950454|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
23606624|NCT00048932|65950452|FG000|Double Blind Period (DB)|Pregnancy|1|||
23606625|NCT00048932|65950453|FG001|Double Blind Period (DB)|Pregnancy|0|||
23606626|NCT00048932|65950454|FG002|Double Blind Period (DB)|Pregnancy|0|||
23606627|NCT00048932|65950452|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
23606628|NCT00048932|65950453|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
23606629|NCT00048932|65950454|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
23606630|NCT00048932|65950452|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
23606631|NCT00048932|65950453|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
23606632|NCT00048932|65950454|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
23606633|NCT00048932|65950452|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
23606634|NCT00048932|65950453|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
23606635|NCT00048932|65950454|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
23606636|NCT00048932|65950452|FG000|Open Label Period (OL)|Death|0|||
23606637|NCT00048932|65950453|FG001|Open Label Period (OL)|Death|0|||
23404335|NCT01824290|65226579|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404336|NCT01824290|65226580|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404337|NCT01824290|65226581|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404338|NCT01824290|65226578|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
23404339|NCT01824290|65226579|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
23404340|NCT01824290|65226580|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
23404341|NCT01824290|65226581|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
23810399|NCT02139124|66684432|FG004|Overall Study|Adverse Event|5|||
23810400|NCT02139124|66684428|FG000|Overall Study|Withdrawal by Subject|2|||
23810401|NCT02139124|66684429|FG001|Overall Study|Withdrawal by Subject|2|||
23810402|NCT02139124|66684430|FG002|Overall Study|Withdrawal by Subject|2|||
23810403|NCT02139124|66684431|FG003|Overall Study|Withdrawal by Subject|2|||
23810404|NCT02139124|66684432|FG004|Overall Study|Withdrawal by Subject|3|||
23810405|NCT02139124|66684428|FG000|Overall Study|Protocol Violation|0|||
23810406|NCT02139124|66684429|FG001|Overall Study|Protocol Violation|0|||
23810407|NCT02139124|66684430|FG002|Overall Study|Protocol Violation|0|||
23606638|NCT00048932|65950454|FG002|Open Label Period (OL)|Death|25|||
23606639|NCT00048932|65950452|FG000|Open Label Period (OL)|Adverse Event|0|||
23606640|NCT00048932|65950453|FG001|Open Label Period (OL)|Adverse Event|0|||
23606641|NCT00048932|65950454|FG002|Open Label Period (OL)|Adverse Event|103|||
23606642|NCT00048932|65950452|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
23606643|NCT00048932|65950453|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
23606644|NCT00048932|65950454|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
23606645|NCT00048932|65950452|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
23606646|NCT00048932|65950453|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
23606647|NCT00048932|65950454|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
23606648|NCT00048932|65950452|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
23606649|NCT00048932|65950453|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
23606650|NCT00048932|65950454|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
23606651|NCT00048932|65950452|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
23606652|NCT00048932|65950453|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
23606653|NCT00048932|65950454|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
23606654|NCT00048932|65950452|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
23606655|NCT00048932|65950453|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
23606656|NCT00048932|65950454|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
23606657|NCT00048932|65950452|FG000|Open Label Period (OL)|Pregnancy|0|||
23810408|NCT02139124|66684431|FG003|Overall Study|Protocol Violation|1|||
23810409|NCT02139124|66684432|FG004|Overall Study|Protocol Violation|1|||
23810410|NCT02139124|66684428|FG000|Overall Study|non-compliant|1|||
23810411|NCT02139124|66684429|FG001|Overall Study|non-compliant|0|||
23810412|NCT02139124|66684430|FG002|Overall Study|non-compliant|0|||
23810413|NCT02139124|66684431|FG003|Overall Study|non-compliant|2|||
23810414|NCT02139124|66684432|FG004|Overall Study|non-compliant|0|||
23810415|NCT02139124|66684428|FG000|Overall Study|incarceration|0|||
23810416|NCT02139124|66684429|FG001|Overall Study|incarceration|0|||
23810417|NCT02139124|66684430|FG002|Overall Study|incarceration|1|||
23810418|NCT02139124|66684431|FG003|Overall Study|incarceration|0|||
23404342|NCT01824290|65226578|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
23810419|NCT02139124|66684432|FG004|Overall Study|incarceration|0|||
23404343|NCT01824290|65226579|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
23404344|NCT01824290|65226580|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
23404345|NCT01824290|65226581|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
23404346|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
23404347|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
23404348|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
23404349|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
23404350|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
23404351|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
23404352|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
23404353|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
23404354|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
23404355|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
23404356|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
23404357|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
23404358|NCT03801928|65226586|FG000|Overall Study|Adverse Event|1|||
23404359|NCT03801928|65226587|FG001|Overall Study|Adverse Event|0|||
23404360|NCT03801928|65226588|FG002|Overall Study|Adverse Event|1|||
23404361|NCT03801928|65226589|FG003|Overall Study|Adverse Event|2|||
23404362|NCT03801928|65226590|FG004|Overall Study|Adverse Event|0|||
23404363|NCT03801928|65226591|FG005|Overall Study|Adverse Event|2|||
23404364|NCT03801928|65226586|FG000|Overall Study|Lack of Efficacy|0|||
23404365|NCT03801928|65226587|FG001|Overall Study|Lack of Efficacy|0|||
23404366|NCT03801928|65226588|FG002|Overall Study|Lack of Efficacy|1|||
23404367|NCT03801928|65226589|FG003|Overall Study|Lack of Efficacy|0|||
23404368|NCT03801928|65226590|FG004|Overall Study|Lack of Efficacy|0|||
23404369|NCT03801928|65226591|FG005|Overall Study|Lack of Efficacy|0|||
23404370|NCT03801928|65226586|FG000|Overall Study|Lost to Follow-up|5|||
23404371|NCT03801928|65226587|FG001|Overall Study|Lost to Follow-up|1|||
23404372|NCT03801928|65226588|FG002|Overall Study|Lost to Follow-up|1|||
23404373|NCT03801928|65226589|FG003|Overall Study|Lost to Follow-up|4|||
23404374|NCT03801928|65226590|FG004|Overall Study|Lost to Follow-up|4|||
23404375|NCT03801928|65226591|FG005|Overall Study|Lost to Follow-up|2|||
23404376|NCT03801928|65226586|FG000|Overall Study|Withdrawal by Subject|0|||
23404377|NCT03801928|65226587|FG001|Overall Study|Withdrawal by Subject|0|||
23404378|NCT03801928|65226588|FG002|Overall Study|Withdrawal by Subject|2|||
23404379|NCT03801928|65226589|FG003|Overall Study|Withdrawal by Subject|1|||
23404380|NCT03801928|65226590|FG004|Overall Study|Withdrawal by Subject|0|||
23404381|NCT03801928|65226591|FG005|Overall Study|Withdrawal by Subject|0|||
23404382|NCT03801928|65226586|FG000|Overall Study|Other|0|||
23404383|NCT03801928|65226587|FG001|Overall Study|Other|2|||
23404384|NCT03801928|65226588|FG002|Overall Study|Other|0|||
23404385|NCT03801928|65226589|FG003|Overall Study|Other|1|||
23404386|NCT03801928|65226590|FG004|Overall Study|Other|0|||
23404387|NCT03801928|65226591|FG005|Overall Study|Other|1|||
23404388|NCT00856635|65226594|FG000|Overall Study|Lost to Follow-up|2|||
23404389|NCT00856635|65226595|FG001|Overall Study|Lost to Follow-up|5|||
23404390|NCT00856635|65226594|FG000|Overall Study|Pregnancy|1|||
23404391|NCT00856635|65226595|FG001|Overall Study|Pregnancy|0|||
23404392|NCT00856635|65226594|FG000|Overall Study|Withdrawal by Subject|3|||
23404393|NCT00856635|65226595|FG001|Overall Study|Withdrawal by Subject|1|||
23404394|NCT00856635|65226594|FG000|Overall Study|Serious Adverse Event|1|||
23404395|NCT00856635|65226595|FG001|Overall Study|Serious Adverse Event|0|||
23404396|NCT00856635|65226594|FG000|Overall Study|Other|1|||
23404397|NCT00856635|65226595|FG001|Overall Study|Other|0|||
23404398|NCT00856635|65226594|FG000|Overall Study|Discontinued at Randomization|2|||
23404399|NCT00856635|65226595|FG001|Overall Study|Discontinued at Randomization|2|||
23404400|NCT02777086|65226598|FG000|Overall Study|Lost to Follow-up|96|||
23404401|NCT02777086|65226599|FG001|Overall Study|Lost to Follow-up|99|||
23404402|NCT00856609|65226600|FG000|Overall Study|Adverse Event|1|||
23404403|NCT00856609|65226601|FG001|Overall Study|Adverse Event|0|||
23404404|NCT00856323|65226602|FG000|Overall Study|Withdrawal by Subject|2|||
23404405|NCT03759600|65226603|FG000|Overall Study|Adverse Event|2|||
23404406|NCT03759600|65226603|FG000|Overall Study|Progressive Disease|15|||
23404407|NCT03759600|65226603|FG000|Overall Study|Site Terminated by Sponsor|3|||
23404408|NCT00540592|65226604|FG000|Overall Study|Adverse Event|0|||
23404409|NCT00540592|65226605|FG001|Overall Study|Adverse Event|1|||
23404410|NCT00540592|65226606|FG002|Overall Study|Adverse Event|0|||
23404411|NCT00540592|65226607|FG003|Overall Study|Adverse Event|0|||
23404412|NCT00540592|65226608|FG004|Overall Study|Adverse Event|1|||
23404413|NCT00540592|65226609|FG005|Overall Study|Adverse Event|0|||
23810420|NCT02139124|66684428|FG000|Overall Study|subject moved|1|||
23404414|NCT00540592|65226610|FG006|Overall Study|Adverse Event|0|||
23404415|NCT00540592|65226611|FG007|Overall Study|Adverse Event|1|||
23404416|NCT00540592|65226612|FG008|Overall Study|Adverse Event|1|||
23404417|NCT00540592|65226613|FG009|Overall Study|Adverse Event|2|||
23404418|NCT00540592|65226604|FG000|Overall Study|Lost to Follow-up|2|||
23404419|NCT00540592|65226605|FG001|Overall Study|Lost to Follow-up|0|||
23404420|NCT00540592|65226606|FG002|Overall Study|Lost to Follow-up|0|||
23404421|NCT00540592|65226607|FG003|Overall Study|Lost to Follow-up|0|||
23404422|NCT00540592|65226608|FG004|Overall Study|Lost to Follow-up|0|||
23404423|NCT00540592|65226609|FG005|Overall Study|Lost to Follow-up|0|||
23404424|NCT00540592|65226610|FG006|Overall Study|Lost to Follow-up|0|||
23404425|NCT00540592|65226611|FG007|Overall Study|Lost to Follow-up|0|||
23404426|NCT00540592|65226612|FG008|Overall Study|Lost to Follow-up|0|||
23404427|NCT00540592|65226613|FG009|Overall Study|Lost to Follow-up|0|||
23404428|NCT00540592|65226604|FG000|Overall Study|Withdrawal by Subject|0|||
23404429|NCT00540592|65226605|FG001|Overall Study|Withdrawal by Subject|0|||
23404430|NCT00540592|65226606|FG002|Overall Study|Withdrawal by Subject|1|||
23404431|NCT00540592|65226607|FG003|Overall Study|Withdrawal by Subject|1|||
23404432|NCT00540592|65226608|FG004|Overall Study|Withdrawal by Subject|0|||
23404433|NCT00540592|65226609|FG005|Overall Study|Withdrawal by Subject|0|||
23404434|NCT00540592|65226610|FG006|Overall Study|Withdrawal by Subject|0|||
23404435|NCT00540592|65226611|FG007|Overall Study|Withdrawal by Subject|0|||
23404436|NCT00540592|65226612|FG008|Overall Study|Withdrawal by Subject|0|||
23404437|NCT00540592|65226613|FG009|Overall Study|Withdrawal by Subject|0|||
23404438|NCT00928187|65226617|FG000|Overall Study|Death|1|||
23404439|NCT00928187|65226618|FG001|Overall Study|Death|2|||
23404440|NCT00928187|65226619|FG002|Overall Study|Death|3|||
23404441|NCT00928187|65226617|FG000|Overall Study|Lost to Follow-up|1|||
23404442|NCT00928187|65226618|FG001|Overall Study|Lost to Follow-up|2|||
23404443|NCT00928187|65226619|FG002|Overall Study|Lost to Follow-up|1|||
23404444|NCT00928187|65226617|FG000|Overall Study|Withdrawal by Subject|0|||
23404445|NCT00928187|65226618|FG001|Overall Study|Withdrawal by Subject|1|||
23404446|NCT00928187|65226619|FG002|Overall Study|Withdrawal by Subject|1|||
23404447|NCT00928187|65226617|FG000|Overall Study|Protocol Violation|0|||
23404448|NCT00928187|65226618|FG001|Overall Study|Protocol Violation|1|||
23404449|NCT00928187|65226619|FG002|Overall Study|Protocol Violation|0|||
23404450|NCT04749745|65226620|FG000|Overall Study|Withdrawal by Subject|1|||
23404451|NCT04749745|65226621|FG001|Overall Study|Withdrawal by Subject|0|||
23404452|NCT01182298|65226622|FG000|Overall Study|Lack of Efficacy|4|||
23404453|NCT01182298|65226622|FG000|Overall Study|Withdrawal by Subject|2|||
23404454|NCT00375674|65226623|FG000|Overall Study|Other|26|||
23404455|NCT00375674|65226624|FG001|Overall Study|Other|18|||
23404456|NCT00375674|65226623|FG000|Overall Study|Death|67|||
23404457|NCT00375674|65226624|FG001|Overall Study|Death|76|||
23404458|NCT00375674|65226623|FG000|Overall Study|Participants refused further follow-up|31|||
23606658|NCT00048932|65950453|FG001|Open Label Period (OL)|Pregnancy|0|||
23606659|NCT00048932|65950454|FG002|Open Label Period (OL)|Pregnancy|6|||
23606660|NCT00048932|65950452|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
23606661|NCT00048932|65950453|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
23606662|NCT00048932|65950454|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
23606663|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Retiring|0|||
23606664|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Retiring|0|||
23606665|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Retiring|2|||
23606666|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
23606667|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
23606668|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
23606669|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Relocated|0|||
23606670|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Relocated|0|||
23606671|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Relocated|6|||
23606672|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
23606673|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
23606674|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
23606675|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Closure|0|||
23606676|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Closure|0|||
23404459|NCT00375674|65226624|FG001|Overall Study|Participants refused further follow-up|30|||
23404460|NCT00375674|65226623|FG000|Overall Study|Lost to Follow-up|17|||
23404461|NCT00375674|65226624|FG001|Overall Study|Lost to Follow-up|15|||
23404462|NCT00375674|65226623|FG000|Overall Study|Enrolled but not treated|3|||
23404463|NCT00375674|65226624|FG001|Overall Study|Enrolled but not treated|2|||
23404464|NCT01484496|65226625|FG000|Period 1|Protocol Violation|3|||
23404465|NCT01484496|65226626|FG001|Period 1|Protocol Violation|4|||
23404466|NCT01484496|65226627|FG002|Period 1|Protocol Violation|0|||
23404467|NCT01484496|65226628|FG003|Period 1|Protocol Violation|0|||
23404468|NCT01484496|65226625|FG000|Period 1|Physician Decision|5|||
23404469|NCT01484496|65226626|FG001|Period 1|Physician Decision|1|||
23404470|NCT01484496|65226627|FG002|Period 1|Physician Decision|0|||
23404471|NCT01484496|65226628|FG003|Period 1|Physician Decision|0|||
23404472|NCT01484496|65226625|FG000|Period 1|Lack of Efficacy|10|||
23404473|NCT01484496|65226626|FG001|Period 1|Lack of Efficacy|15|||
23404474|NCT01484496|65226627|FG002|Period 1|Lack of Efficacy|0|||
23404475|NCT01484496|65226628|FG003|Period 1|Lack of Efficacy|0|||
23606677|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Closure|3|||
23404476|NCT01484496|65226625|FG000|Period 1|Adverse Event|25|||
23404477|NCT01484496|65226626|FG001|Period 1|Adverse Event|40|||
23404478|NCT01484496|65226627|FG002|Period 1|Adverse Event|0|||
23404479|NCT01484496|65226628|FG003|Period 1|Adverse Event|0|||
23404480|NCT01484496|65226625|FG000|Period 1|Withdrawal by Subject|15|||
23404481|NCT01484496|65226626|FG001|Period 1|Withdrawal by Subject|12|||
23404482|NCT01484496|65226627|FG002|Period 1|Withdrawal by Subject|0|||
23404483|NCT01484496|65226628|FG003|Period 1|Withdrawal by Subject|0|||
23404484|NCT01484496|65226625|FG000|Period 1|Lost to Follow-up|2|||
23404485|NCT01484496|65226626|FG001|Period 1|Lost to Follow-up|6|||
23404486|NCT01484496|65226627|FG002|Period 1|Lost to Follow-up|0|||
23404487|NCT01484496|65226628|FG003|Period 1|Lost to Follow-up|0|||
23404488|NCT01484496|65226625|FG000|Period 1|Positive Pregnancy|1|||
23404489|NCT01484496|65226626|FG001|Period 1|Positive Pregnancy|6|||
23404490|NCT01484496|65226627|FG002|Period 1|Positive Pregnancy|0|||
23404491|NCT01484496|65226628|FG003|Period 1|Positive Pregnancy|0|||
23404492|NCT01484496|65226625|FG000|Period 1|Treatment Failure|3|||
23404493|NCT01484496|65226626|FG001|Period 1|Treatment Failure|6|||
23404494|NCT01484496|65226627|FG002|Period 1|Treatment Failure|0|||
23404495|NCT01484496|65226628|FG003|Period 1|Treatment Failure|0|||
23404496|NCT01484496|65226625|FG000|Period 1|Lack of Compliance|2|||
23404497|NCT01484496|65226626|FG001|Period 1|Lack of Compliance|1|||
23404498|NCT01484496|65226627|FG002|Period 1|Lack of Compliance|0|||
23404499|NCT01484496|65226628|FG003|Period 1|Lack of Compliance|0|||
23404500|NCT01484496|65226625|FG000|Period 1|Unable to Visit Site|0|||
23404501|NCT01484496|65226626|FG001|Period 1|Unable to Visit Site|2|||
23404502|NCT01484496|65226627|FG002|Period 1|Unable to Visit Site|0|||
23404503|NCT01484496|65226628|FG003|Period 1|Unable to Visit Site|0|||
23404504|NCT01484496|65226625|FG000|Period 2|Lack of Efficacy|0|||
23404505|NCT01484496|65226626|FG001|Period 2|Lack of Efficacy|0|||
23404506|NCT01484496|65226627|FG002|Period 2|Lack of Efficacy|1|||
23404507|NCT01484496|65226628|FG003|Period 2|Lack of Efficacy|3|||
23404508|NCT01484496|65226625|FG000|Period 2|Adverse Event|0|||
23404509|NCT01484496|65226626|FG001|Period 2|Adverse Event|0|||
23404510|NCT01484496|65226627|FG002|Period 2|Adverse Event|5|||
23404511|NCT01484496|65226628|FG003|Period 2|Adverse Event|13|||
23404512|NCT01484496|65226625|FG000|Period 2|Other|0|||
23404513|NCT01484496|65226626|FG001|Period 2|Other|0|||
23404514|NCT01484496|65226627|FG002|Period 2|Other|9|||
23404515|NCT01484496|65226628|FG003|Period 2|Other|6|||
23404516|NCT00730756|65226629|FG000|Overall Study|Adverse Event|2|||
23404517|NCT00730756|65226630|FG001|Overall Study|Adverse Event|0|||
23404518|NCT00730756|65226629|FG000|Overall Study|Lack of Efficacy|1|||
23404519|NCT00730756|65226630|FG001|Overall Study|Lack of Efficacy|1|||
23404520|NCT00730756|65226629|FG000|Overall Study|Protocol Deviation|1|||
23404521|NCT00730756|65226630|FG001|Overall Study|Protocol Deviation|2|||
23404522|NCT00730756|65226629|FG000|Overall Study|Lost to Follow-up|0|||
23404523|NCT00730756|65226630|FG001|Overall Study|Lost to Follow-up|1|||
23404524|NCT00730756|65226629|FG000|Overall Study|Withdrew Consent|0|||
23404525|NCT00730756|65226630|FG001|Overall Study|Withdrew Consent|1|||
23404526|NCT04828707|65226634|FG000|Overall Study|Lost to Follow-up|3|||
23404527|NCT04828707|65226635|FG001|Overall Study|Lost to Follow-up|2|||
23404528|NCT04828707|65226634|FG000|Overall Study|Withdrawal by Subject|2|||
23404529|NCT04828707|65226635|FG001|Overall Study|Withdrawal by Subject|1|||
23404530|NCT00825994|65226643|FG000|Overall Study|Withdrawal by Subject|2|||
23404531|NCT00825994|65226643|FG000|Overall Study|Lost to Follow-up|1|||
23404532|NCT00825994|65226643|FG000|Overall Study|Protocol Violation|1|||
23404533|NCT00825994|65226643|FG000|Overall Study|Placebo Responder at V2|1|||
23404534|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404535|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404536|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404537|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404538|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404539|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404540|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404541|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404542|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
23404543|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
23404544|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
23404545|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
23404546|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404547|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
23404548|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404549|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404550|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404551|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404552|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404553|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404554|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404555|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
23404556|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
23404557|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404558|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404559|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404560|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404561|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404562|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404563|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404564|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404565|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
23404566|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404567|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
23404568|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
23404569|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
23404570|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
23404571|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404572|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404573|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
23404574|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
23404575|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
23404576|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
23404577|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
23404578|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
23404579|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
23404580|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
23404581|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
23404582|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
23404583|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
23404584|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404585|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404586|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404587|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404588|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404589|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404590|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404591|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
23404592|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404593|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404594|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404595|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404596|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404597|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404598|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
23404599|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
23404600|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
23404601|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
23404602|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
23404603|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
23404604|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
23404605|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
23404606|NCT03328832|65226652|FG000|Overall Study|Lost to Follow-up|0|||
23404607|NCT03328832|65226653|FG001|Overall Study|Lost to Follow-up|1|||
23404608|NCT00980148|65226654|FG000|Overall Study|Discharged from facility|89|||
23404609|NCT00980148|65226655|FG001|Overall Study|Discharged from facility|96|||
23404610|NCT00980148|65226654|FG000|Overall Study|Received other antichlamydia treatment|20|||
23404611|NCT00980148|65226655|FG001|Overall Study|Received other antichlamydia treatment|14|||
23404612|NCT00980148|65226654|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
23404613|NCT00980148|65226655|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
23404614|NCT00980148|65226654|FG000|Overall Study|Various other reasons|8|||
23404615|NCT00980148|65226655|FG001|Overall Study|Various other reasons|9|||
23404616|NCT00374595|65226665|FG000|Overall Study|Death|23|||
23404617|NCT00374595|65226665|FG000|Overall Study|Withdrawal by Subject|39|||
23404618|NCT00374595|65226665|FG000|Overall Study|Lost to Follow-up|3|||
23404619|NCT00374595|65226665|FG000|Overall Study|too much time commitment|1|||
23810421|NCT02139124|66684429|FG001|Overall Study|subject moved|0|||
23404620|NCT00374595|65226665|FG000|Overall Study|transfer care to other clinical site|1|||
23404621|NCT00374595|65226665|FG000|Overall Study|relocation|3|||
23404622|NCT00551031|65226667|FG000|Overall Study|Adverse Event|0|||
23404623|NCT00551031|65226668|FG001|Overall Study|Adverse Event|1|||
23404624|NCT00551031|65226669|FG002|Overall Study|Adverse Event|0|||
23404625|NCT00551031|65226670|FG003|Overall Study|Adverse Event|0|||
23404626|NCT00551031|65226671|FG004|Overall Study|Adverse Event|0|||
23404627|NCT00551031|65226667|FG000|Overall Study|Protocol Violation|1|||
23404628|NCT00551031|65226668|FG001|Overall Study|Protocol Violation|1|||
23404629|NCT00551031|65226669|FG002|Overall Study|Protocol Violation|0|||
23404630|NCT00551031|65226670|FG003|Overall Study|Protocol Violation|0|||
23404631|NCT00551031|65226671|FG004|Overall Study|Protocol Violation|0|||
23404632|NCT00551031|65226667|FG000|Overall Study|Lost to Follow-up|0|||
23404633|NCT00551031|65226668|FG001|Overall Study|Lost to Follow-up|1|||
23404634|NCT00551031|65226669|FG002|Overall Study|Lost to Follow-up|0|||
23404635|NCT00551031|65226670|FG003|Overall Study|Lost to Follow-up|1|||
23404636|NCT00551031|65226671|FG004|Overall Study|Lost to Follow-up|1|||
23404637|NCT00551031|65226667|FG000|Overall Study|Withdrawal by Subject|0|||
23404638|NCT00551031|65226668|FG001|Overall Study|Withdrawal by Subject|4|||
23404639|NCT00551031|65226669|FG002|Overall Study|Withdrawal by Subject|1|||
23404640|NCT00551031|65226670|FG003|Overall Study|Withdrawal by Subject|2|||
23404641|NCT00551031|65226671|FG004|Overall Study|Withdrawal by Subject|0|||
23404642|NCT00551031|65226667|FG000|Overall Study|Serious Adverse Event|0|||
23404643|NCT00551031|65226668|FG001|Overall Study|Serious Adverse Event|2|||
23404644|NCT00551031|65226669|FG002|Overall Study|Serious Adverse Event|1|||
23404645|NCT00551031|65226670|FG003|Overall Study|Serious Adverse Event|0|||
23404646|NCT00551031|65226671|FG004|Overall Study|Serious Adverse Event|0|||
23404647|NCT00551031|65226667|FG000|Overall Study|Did not receive vaccine|1|||
23404648|NCT00551031|65226668|FG001|Overall Study|Did not receive vaccine|2|||
23404649|NCT00551031|65226669|FG002|Overall Study|Did not receive vaccine|0|||
23404650|NCT00551031|65226670|FG003|Overall Study|Did not receive vaccine|0|||
23404651|NCT00551031|65226671|FG004|Overall Study|Did not receive vaccine|0|||
23404652|NCT00600067|65226673|FG000|Overall Study|Adverse Event|0|||
23404653|NCT00600067|65226674|FG001|Overall Study|Adverse Event|1|||
23404654|NCT00600067|65226673|FG000|Overall Study|Lost to Follow-up|2|||
23404655|NCT00600067|65226674|FG001|Overall Study|Lost to Follow-up|3|||
23404656|NCT00600067|65226673|FG000|Overall Study|protocol non-compliance|0|||
23404657|NCT00600067|65226674|FG001|Overall Study|protocol non-compliance|3|||
23404658|NCT00600067|65226673|FG000|Overall Study|Lack of Efficacy|1|||
23404659|NCT00600067|65226674|FG001|Overall Study|Lack of Efficacy|0|||
23404660|NCT01581684|65226675|FG000|Overall Study|Other reason not defined|0|||
23404661|NCT01581684|65226676|FG001|Overall Study|Other reason not defined|0|||
23404662|NCT01581684|65226677|FG002|Overall Study|Other reason not defined|0|||
23404663|NCT01581684|65226678|FG003|Overall Study|Other reason not defined|0|||
23404664|NCT01581684|65226679|FG004|Overall Study|Other reason not defined|0|||
23404665|NCT01581684|65226680|FG005|Overall Study|Other reason not defined|0|||
23404666|NCT01581684|65226681|FG006|Overall Study|Other reason not defined|0|||
23404667|NCT01581684|65226682|FG007|Overall Study|Other reason not defined|0|||
23404668|NCT01581684|65226683|FG008|Overall Study|Other reason not defined|1|||
23404669|NCT01581684|65226684|FG009|Overall Study|Other reason not defined|0|||
23404670|NCT01451749|65226685|FG000|Overall Study|Protocol Violation|14|||
23404671|NCT01451749|65226686|FG001|Overall Study|Protocol Violation|7|||
23404672|NCT01451749|65226685|FG000|Overall Study|Lost to Follow-up|15|||
23404673|NCT01451749|65226686|FG001|Overall Study|Lost to Follow-up|5|||
23404674|NCT01451749|65226685|FG000|Overall Study|Meet the exclusion criteria,and|1|||
23404675|NCT01451749|65226686|FG001|Overall Study|Meet the exclusion criteria,and|1|||
23404676|NCT01451749|65226685|FG000|Overall Study|Adverse Event|2|||
23404677|NCT01451749|65226686|FG001|Overall Study|Adverse Event|0|||
23404678|NCT01451749|65226685|FG000|Overall Study|Withdrawal by Subject|0|||
23404679|NCT01451749|65226686|FG001|Overall Study|Withdrawal by Subject|1|||
23404680|NCT04011735|65226687|FG000|Overall Study|Withdrawal by Subject|1|||
23404681|NCT04011735|65226688|FG001|Overall Study|Withdrawal by Subject|0|||
23404682|NCT04011735|65226689|FG002|Overall Study|Withdrawal by Subject|1|||
23404683|NCT04011735|65226687|FG000|Overall Study|Met exclusion criteria after study entry|0|||
23404684|NCT04011735|65226688|FG001|Overall Study|Met exclusion criteria after study entry|1|||
23404685|NCT04011735|65226689|FG002|Overall Study|Met exclusion criteria after study entry|0|||
23404686|NCT00473889|65226690|FG000|Overall Study|Did not receive study medication|1|||
23404687|NCT00473889|65226691|FG001|Overall Study|Did not receive study medication|4|||
23404688|NCT00473889|65226690|FG000|Overall Study|Adverse Event|30|||
23404689|NCT00473889|65226691|FG001|Overall Study|Adverse Event|17|||
23404690|NCT00473889|65226690|FG000|Overall Study|Protocol Violation|4|||
23404691|NCT00473889|65226691|FG001|Overall Study|Protocol Violation|2|||
23404692|NCT00473889|65226690|FG000|Overall Study|Lack of Efficacy|28|||
23404693|NCT00473889|65226691|FG001|Overall Study|Lack of Efficacy|29|||
23404694|NCT00473889|65226690|FG000|Overall Study|Lost to Follow-up|2|||
23404695|NCT00473889|65226691|FG001|Overall Study|Lost to Follow-up|1|||
23404696|NCT00473889|65226690|FG000|Overall Study|Physician Decision|10|||
23404697|NCT00473889|65226691|FG001|Overall Study|Physician Decision|5|||
23404698|NCT00473889|65226690|FG000|Overall Study|Trial Terminated|3|||
23404699|NCT00473889|65226691|FG001|Overall Study|Trial Terminated|6|||
23404700|NCT00473889|65226690|FG000|Overall Study|Withdrawal by Subject|5|||
23404701|NCT00473889|65226691|FG001|Overall Study|Withdrawal by Subject|0|||
23404702|NCT04263766|65226692|FG000|Overall Study|Withdrawal by Subject|6|||
23404703|NCT04263766|65226693|FG001|Overall Study|Withdrawal by Subject|4|||
23404704|NCT04263766|65226692|FG000|Overall Study|Lack of Efficacy|1|||
23404705|NCT04263766|65226693|FG001|Overall Study|Lack of Efficacy|3|||
23404706|NCT00937495|65226695|FG000|Overall Study|Protocol Violation|2|||
23404707|NCT02852967|65226697|FG000|Overall Study|Adverse Event|3|||
23404708|NCT02852967|65226698|FG001|Overall Study|Adverse Event|1|||
23404709|NCT02852967|65226699|FG002|Overall Study|Adverse Event|0|||
23404710|NCT02852967|65226700|FG003|Overall Study|Adverse Event|1|||
23404711|NCT02852967|65226701|FG004|Overall Study|Adverse Event|0|||
23404712|NCT02852967|65226697|FG000|Overall Study|Death|1|||
23404713|NCT02852967|65226698|FG001|Overall Study|Death|0|||
23606678|NCT00048932|65950452|FG000|Open Label Period (OL)|Trial Terminated|0|||
23606679|NCT00048932|65950453|FG001|Open Label Period (OL)|Trial Terminated|0|||
23606680|NCT00048932|65950454|FG002|Open Label Period (OL)|Trial Terminated|1|||
23606681|NCT00048932|65950452|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
23606682|NCT00048932|65950453|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
23606683|NCT00048932|65950454|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
23606684|NCT00048932|65950452|FG000|Open Label Period (OL)|Patient Decision|0|||
23606685|NCT00048932|65950453|FG001|Open Label Period (OL)|Patient Decision|0|||
23606686|NCT00048932|65950454|FG002|Open Label Period (OL)|Patient Decision|4|||
23606687|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
23606688|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
23606689|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
23606690|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
23606691|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
23606692|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
23606693|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
23606694|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
23606695|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
23606696|NCT00048932|65950452|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
23606697|NCT00048932|65950453|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
23606698|NCT00048932|65950454|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
23606699|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Decision|0|||
23606700|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Decision|0|||
23606701|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Decision|4|||
23606702|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Staff Issues|0|||
23606703|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Staff Issues|0|||
23606704|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Staff Issues|2|||
23606705|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
23606706|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
23606707|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
23606708|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Surgery|0|||
23606709|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Surgery|0|||
23606710|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Surgery|1|||
23606711|NCT02924051|65950455|FG000|Overall Study|Withdrawal by Subject|1|||
23606712|NCT02924051|65950456|FG001|Overall Study|Withdrawal by Subject|9|||
23606713|NCT03560206|65950458|FG000|Overall Study|Lost to Follow-up|19|||
23606714|NCT03560206|65950459|FG001|Overall Study|Lost to Follow-up|11|||
23606715|NCT03560206|65950458|FG000|Overall Study|Withdrawal by Subject|2|||
23606716|NCT03560206|65950459|FG001|Overall Study|Withdrawal by Subject|4|||
23606717|NCT03560206|65950458|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
23606718|NCT03560206|65950459|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
23606719|NCT03560206|65950458|FG000|Overall Study|Busy schedule|14|||
23606720|NCT03560206|65950459|FG001|Overall Study|Busy schedule|2|||
23606721|NCT03560206|65950458|FG000|Overall Study|patients' new health condition such as cancer|10|||
23810422|NCT02139124|66684430|FG002|Overall Study|subject moved|0|||
23404714|NCT02852967|65226699|FG002|Overall Study|Death|0|||
23404715|NCT02852967|65226700|FG003|Overall Study|Death|0|||
23404716|NCT02852967|65226701|FG004|Overall Study|Death|0|||
23404717|NCT02852967|65226697|FG000|Overall Study|Lost to Follow-up|1|||
23404718|NCT02852967|65226698|FG001|Overall Study|Lost to Follow-up|2|||
23404719|NCT02852967|65226699|FG002|Overall Study|Lost to Follow-up|3|||
23404720|NCT02852967|65226700|FG003|Overall Study|Lost to Follow-up|4|||
23404721|NCT02852967|65226701|FG004|Overall Study|Lost to Follow-up|4|||
23404722|NCT02852967|65226697|FG000|Overall Study|Withdrawal by Subject|6|||
23404723|NCT02852967|65226698|FG001|Overall Study|Withdrawal by Subject|12|||
23606722|NCT03560206|65950459|FG001|Overall Study|patients' new health condition such as cancer|1|||
23606723|NCT00237809|65950460|FG000|Overall Study|Lost to Follow-up|11|||
23606724|NCT00237809|65950461|FG001|Overall Study|Lost to Follow-up|10|||
23404724|NCT02852967|65226699|FG002|Overall Study|Withdrawal by Subject|7|||
23404725|NCT02852967|65226700|FG003|Overall Study|Withdrawal by Subject|10|||
23404726|NCT02852967|65226701|FG004|Overall Study|Withdrawal by Subject|10|||
23404727|NCT02852967|65226697|FG000|Overall Study|SAE|0|||
23404728|NCT02852967|65226698|FG001|Overall Study|SAE|0|||
23404729|NCT02852967|65226699|FG002|Overall Study|SAE|0|||
23404730|NCT02852967|65226700|FG003|Overall Study|SAE|3|||
23404731|NCT02852967|65226701|FG004|Overall Study|SAE|0|||
23404732|NCT02852967|65226697|FG000|Overall Study|Elevated Liver Enzymes|2|||
23404733|NCT02852967|65226698|FG001|Overall Study|Elevated Liver Enzymes|0|||
23404734|NCT02852967|65226699|FG002|Overall Study|Elevated Liver Enzymes|0|||
23404735|NCT02852967|65226700|FG003|Overall Study|Elevated Liver Enzymes|2|||
23606725|NCT00237809|65950462|FG002|Overall Study|Lost to Follow-up|9|||
23606726|NCT00237809|65950463|FG003|Overall Study|Lost to Follow-up|9|||
23606727|NCT00458783|65950464|FG000|Overall Study|Protocol Violation|1228|||
23606728|NCT00458783|65950465|FG001|Overall Study|Protocol Violation|1220|||
23404736|NCT02852967|65226701|FG004|Overall Study|Elevated Liver Enzymes|2|||
23404737|NCT02852967|65226697|FG000|Overall Study|Physician Decision|0|||
23404738|NCT02852967|65226698|FG001|Overall Study|Physician Decision|0|||
23404739|NCT02852967|65226699|FG002|Overall Study|Physician Decision|0|||
23404740|NCT02852967|65226700|FG003|Overall Study|Physician Decision|1|||
23404741|NCT02852967|65226701|FG004|Overall Study|Physician Decision|0|||
23404742|NCT02852967|65226697|FG000|Overall Study|Lack of Efficacy|0|||
23606729|NCT04497415|65950468|FG000|Overall Study|Lost to Follow-up|43|||
23606730|NCT04497415|65950469|FG001|Overall Study|Lost to Follow-up|27|||
23606731|NCT00990184|65950474|FG000|Overall Study|Physician Decision|1|||
23606732|NCT02514824|65950480|FG000|Overall Study|Withdrawal by Subject|1|||
23606733|NCT02514824|65950481|FG001|Overall Study|Withdrawal by Subject|0|||
23606734|NCT02514824|65950482|FG002|Overall Study|Withdrawal by Subject|0|||
23606735|NCT02514824|65950483|FG003|Overall Study|Withdrawal by Subject|0|||
23606736|NCT02514824|65950480|FG000|Overall Study|Dose-Limiting Toxicity|0|||
23606737|NCT02514824|65950481|FG001|Overall Study|Dose-Limiting Toxicity|1|||
23606738|NCT02514824|65950482|FG002|Overall Study|Dose-Limiting Toxicity|0|||
23606739|NCT02514824|65950483|FG003|Overall Study|Dose-Limiting Toxicity|0|||
23606740|NCT03611556|65950484|FG000|Overall Study|Death|7|||
23606741|NCT03611556|65950485|FG001|Overall Study|Death|7|||
23606742|NCT03611556|65950486|FG002|Overall Study|Death|3|||
23606743|NCT03611556|65950487|FG003|Overall Study|Death|8|||
23606744|NCT03611556|65950488|FG004|Overall Study|Death|47|||
23606745|NCT03611556|65950489|FG005|Overall Study|Death|32|||
23606746|NCT03611556|65950490|FG006|Overall Study|Death|53|||
23606747|NCT03611556|65950484|FG000|Overall Study|Withdrawal by Subject|0|||
23606748|NCT03611556|65950485|FG001|Overall Study|Withdrawal by Subject|0|||
23606749|NCT03611556|65950486|FG002|Overall Study|Withdrawal by Subject|0|||
23606750|NCT03611556|65950487|FG003|Overall Study|Withdrawal by Subject|0|||
23606751|NCT03611556|65950488|FG004|Overall Study|Withdrawal by Subject|4|||
23606752|NCT03611556|65950489|FG005|Overall Study|Withdrawal by Subject|2|||
23606753|NCT03611556|65950490|FG006|Overall Study|Withdrawal by Subject|4|||
23606754|NCT03611556|65950484|FG000|Overall Study|Sponsor decision|0|||
23606755|NCT03611556|65950485|FG001|Overall Study|Sponsor decision|0|||
23606756|NCT03611556|65950486|FG002|Overall Study|Sponsor decision|0|||
23606757|NCT03611556|65950487|FG003|Overall Study|Sponsor decision|0|||
23606758|NCT03611556|65950488|FG004|Overall Study|Sponsor decision|9|||
23606759|NCT03611556|65950489|FG005|Overall Study|Sponsor decision|4|||
23606760|NCT03611556|65950490|FG006|Overall Study|Sponsor decision|12|||
23606761|NCT03611556|65950484|FG000|Overall Study|Reasons|0|||
23606762|NCT03611556|65950485|FG001|Overall Study|Reasons|0|||
23606763|NCT03611556|65950486|FG002|Overall Study|Reasons|0|||
23606764|NCT03611556|65950487|FG003|Overall Study|Reasons|0|||
23606765|NCT03611556|65950488|FG004|Overall Study|Reasons|2|||
23606766|NCT03611556|65950489|FG005|Overall Study|Reasons|0|||
23606767|NCT03611556|65950490|FG006|Overall Study|Reasons|1|||
23606768|NCT01052714|65950491|FG000|Overall Study|Adverse Event|6|||
23606769|NCT01052714|65950492|FG001|Overall Study|Adverse Event|3|||
23606770|NCT01052714|65950493|FG002|Overall Study|Adverse Event|0|||
23606771|NCT01052714|65950491|FG000|Overall Study|Death|1|||
23606772|NCT01052714|65950492|FG001|Overall Study|Death|2|||
23606773|NCT01052714|65950493|FG002|Overall Study|Death|0|||
23810423|NCT02139124|66684431|FG003|Overall Study|subject moved|0|||
23404743|NCT02852967|65226698|FG001|Overall Study|Lack of Efficacy|1|||
23606774|NCT01052714|65950491|FG000|Overall Study|Lost to Follow-up|2|||
23606775|NCT01052714|65950492|FG001|Overall Study|Lost to Follow-up|3|||
23606776|NCT01052714|65950493|FG002|Overall Study|Lost to Follow-up|0|||
23606777|NCT01052714|65950491|FG000|Overall Study|Physician Decision|9|||
23606778|NCT01052714|65950492|FG001|Overall Study|Physician Decision|9|||
23606779|NCT01052714|65950493|FG002|Overall Study|Physician Decision|1|||
23606780|NCT01052714|65950491|FG000|Overall Study|Withdrawal by Subject|7|||
23606781|NCT01052714|65950492|FG001|Overall Study|Withdrawal by Subject|12|||
23606782|NCT01052714|65950493|FG002|Overall Study|Withdrawal by Subject|1|||
23606783|NCT03142932|65950495|FG000|Overall Study|Lost to Follow-up|2|||
23606784|NCT03142932|65950496|FG001|Overall Study|Lost to Follow-up|11|||
23606785|NCT01480258|65950497|FG000|Infant Series|Protocol Violation|2|||
23606786|NCT01480258|65950498|FG001|Infant Series|Protocol Violation|0|||
23606787|NCT01480258|65950497|FG000|Infant Series|Physician Decision|0|||
23606788|NCT01480258|65950498|FG001|Infant Series|Physician Decision|1|||
23606789|NCT01480258|65950497|FG000|Infant Series|Not Vaccinated|3|||
23606790|NCT01480258|65950498|FG001|Infant Series|Not Vaccinated|0|||
23606791|NCT01480258|65950497|FG000|Infant Series|Adverse Event|1|||
23606792|NCT01480258|65950498|FG001|Infant Series|Adverse Event|1|||
23606793|NCT01480258|65950497|FG000|Infant Series|Withdrawal by Subject|1|||
23606794|NCT01480258|65950498|FG001|Infant Series|Withdrawal by Subject|6|||
23606795|NCT01480258|65950497|FG000|Interim Period|Lost to Follow-up|0|||
23606796|NCT01480258|65950498|FG001|Interim Period|Lost to Follow-up|2|||
23606797|NCT01480258|65950497|FG000|Interim Period|Physician Decision|1|||
23606798|NCT01480258|65950498|FG001|Interim Period|Physician Decision|0|||
23606799|NCT01480258|65950497|FG000|Interim Period|Protocol Violation|0|||
23606800|NCT01480258|65950498|FG001|Interim Period|Protocol Violation|1|||
23606801|NCT01480258|65950497|FG000|Interim Period|Withdrawal by Subject|9|||
23606802|NCT01480258|65950498|FG001|Interim Period|Withdrawal by Subject|6|||
23606803|NCT01829711|65950499|FG000|Overall Study|Lost to Follow-up|2|||
23606804|NCT01829711|65950499|FG000|Overall Study|Withdrawal by Subject|3|||
23606805|NCT01829711|65950499|FG000|Overall Study|Death|4|||
23606806|NCT01829711|65950499|FG000|Overall Study|Started new therapies|17|||
23606807|NCT01829711|65950499|FG000|Overall Study|Adverse Event|3|||
23606808|NCT01829711|65950499|FG000|Overall Study|Due to progression of disease|13|||
23606809|NCT01829711|65950499|FG000|Overall Study|Due to lack of response|1|||
23606810|NCT03979040|65950500|FG000|Overall Study|Withdrawal by Subject|24|||
23606811|NCT03979040|65950501|FG001|Overall Study|Withdrawal by Subject|32|||
23606812|NCT03979040|65950500|FG000|Overall Study|randomized but never started treatment|32|||
23606813|NCT03979040|65950501|FG001|Overall Study|randomized but never started treatment|39|||
23606814|NCT03979040|65950500|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
23606815|NCT03979040|65950501|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
23606816|NCT03002194|65950510|FG000|Overall Study|Lost to Follow-up|6|||
23606817|NCT03002194|65950510|FG000|Overall Study|Adverse Event|1|||
23606818|NCT03002194|65950510|FG000|Overall Study|Lack of Efficacy|1|||
23606819|NCT03002194|65950510|FG000|Overall Study|Withdrawal by Subject|2|||
23606820|NCT03953079|65950511|FG000|Core Study|Withdrawal by Subject|1|||
23606821|NCT03953079|65950512|FG001|Core Study|Withdrawal by Subject|2|||
23606822|NCT03953079|65950513|FG002|Core Study|Withdrawal by Subject|1|||
23606823|NCT03953079|65950511|FG000|Core Study|COVID-19|0|||
23606824|NCT03953079|65950512|FG001|Core Study|COVID-19|1|||
23606825|NCT03953079|65950513|FG002|Core Study|COVID-19|0|||
23606826|NCT03953079|65950511|FG000|Core Study|Difficulties leaving the house|0|||
23606827|NCT03953079|65950512|FG001|Core Study|Difficulties leaving the house|1|||
23606828|NCT03953079|65950513|FG002|Core Study|Difficulties leaving the house|0|||
23606829|NCT03953079|65950511|FG000|Extension Study|Withdrawal by Subject|1|||
23606830|NCT03953079|65950512|FG001|Extension Study|Withdrawal by Subject|0|||
23606831|NCT03953079|65950513|FG002|Extension Study|Withdrawal by Subject|0|||
23606832|NCT03953079|65950511|FG000|Extension Study|Received Rescue Treatment|5|||
23606833|NCT03953079|65950512|FG001|Extension Study|Received Rescue Treatment|6|||
23606834|NCT03953079|65950513|FG002|Extension Study|Received Rescue Treatment|5|||
23606835|NCT03654326|65950514|FG000|Overall Study|Withdrawal by Subject|5|||
23606836|NCT03654326|65950515|FG001|Overall Study|Withdrawal by Subject|3|||
23606837|NCT03654326|65950514|FG000|Overall Study|Physician Decision|0|||
23606838|NCT03654326|65950515|FG001|Overall Study|Physician Decision|1|||
23606839|NCT03654326|65950514|FG000|Overall Study|Unable to adhere to study schedule|0|||
23606840|NCT03654326|65950515|FG001|Overall Study|Unable to adhere to study schedule|1|||
23606841|NCT03654326|65950514|FG000|Overall Study|Lost to Follow-up|1|||
23606842|NCT03654326|65950515|FG001|Overall Study|Lost to Follow-up|1|||
23606843|NCT01419184|65950516|FG000|Overall Study|Site data not available|3|||
23606844|NCT01419184|65950517|FG001|Overall Study|Site data not available|2|||
23606845|NCT01419184|65950516|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
23606846|NCT01419184|65950517|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
23606847|NCT01419184|65950516|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
23606848|NCT01419184|65950517|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
23810424|NCT02139124|66684432|FG004|Overall Study|subject moved|0|||
23404744|NCT02852967|65226699|FG002|Overall Study|Lack of Efficacy|0|||
23606849|NCT01419184|65950516|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
23606850|NCT01419184|65950517|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
23606851|NCT01419184|65950516|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
23606852|NCT01419184|65950517|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
23606853|NCT01419184|65950516|FG000|Overall Study|Participant randomized, not treated|1|||
23606854|NCT01419184|65950517|FG001|Overall Study|Participant randomized, not treated|0|||
23606855|NCT03176407|65950520|FG000|Overall Study|Protocol Violation|1|||
23606856|NCT03176407|65950520|FG000|Overall Study|human failure|1|||
23606857|NCT03176407|65950520|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
23810425|NCT02139124|66684428|FG000|Overall Study|Lost to Follow-up|3|||
23606858|NCT02950961|65950522|FG000|Overall Study|Study had to stop due to COVID.|7|||
23606859|NCT00963924|65950523|FG000|Overall Study|Adverse Event|1|||
23606860|NCT00963924|65950524|FG001|Overall Study|Adverse Event|0|||
23606861|NCT00963924|65950523|FG000|Overall Study|Withdrawal by Subject|0|||
23606862|NCT00963924|65950524|FG001|Overall Study|Withdrawal by Subject|1|||
23606863|NCT00963924|65950523|FG000|Overall Study|Changed antipsychotic|0|||
23606864|NCT00963924|65950524|FG001|Overall Study|Changed antipsychotic|1|||
23606865|NCT00963924|65950523|FG000|Overall Study|Lost to Follow-up|0|||
23606866|NCT00963924|65950524|FG001|Overall Study|Lost to Follow-up|1|||
23606867|NCT00346398|65950525|FG000|Overall Study|Lost to Follow-up|3|||
23606868|NCT00346398|65950526|FG001|Overall Study|Lost to Follow-up|0|||
23404745|NCT02852967|65226700|FG003|Overall Study|Lack of Efficacy|0|||
23404746|NCT02852967|65226701|FG004|Overall Study|Lack of Efficacy|0|||
23404747|NCT02852967|65226697|FG000|Overall Study|Non-compliance|0|||
23404748|NCT02852967|65226698|FG001|Overall Study|Non-compliance|0|||
23404749|NCT02852967|65226699|FG002|Overall Study|Non-compliance|1|||
23404750|NCT02852967|65226700|FG003|Overall Study|Non-compliance|1|||
23404751|NCT02852967|65226701|FG004|Overall Study|Non-compliance|0|||
23404752|NCT02852967|65226697|FG000|Overall Study|Dispensing Drug Violation|0|||
23404753|NCT02852967|65226698|FG001|Overall Study|Dispensing Drug Violation|0|||
23404754|NCT02852967|65226699|FG002|Overall Study|Dispensing Drug Violation|1|||
23404755|NCT02852967|65226700|FG003|Overall Study|Dispensing Drug Violation|0|||
23404756|NCT02852967|65226701|FG004|Overall Study|Dispensing Drug Violation|0|||
23404757|NCT02852967|65226697|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
23404758|NCT02852967|65226698|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
23404759|NCT02852967|65226699|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
23404760|NCT02852967|65226700|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
23404761|NCT02852967|65226701|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
23404762|NCT00310375|65226702|FG000|Primary Reporting Phase|Adverse Event|28|||
23404763|NCT00310375|65226703|FG001|Primary Reporting Phase|Adverse Event|22|||
23404764|NCT00310375|65226704|FG002|Primary Reporting Phase|Adverse Event|0|||
23404765|NCT00310375|65226702|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
23404766|NCT00310375|65226703|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
23404767|NCT00310375|65226704|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
23404768|NCT00310375|65226702|FG000|Primary Reporting Phase|Pregnancy|2|||
23404769|NCT00310375|65226703|FG001|Primary Reporting Phase|Pregnancy|2|||
23404770|NCT00310375|65226704|FG002|Primary Reporting Phase|Pregnancy|0|||
23404771|NCT00310375|65226702|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
23404772|NCT00310375|65226703|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
23404773|NCT00310375|65226704|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
23404774|NCT00310375|65226702|FG000|Primary Reporting Phase|Protocol Violation|8|||
23404775|NCT00310375|65226703|FG001|Primary Reporting Phase|Protocol Violation|5|||
23404776|NCT00310375|65226704|FG002|Primary Reporting Phase|Protocol Violation|0|||
23404777|NCT00310375|65226702|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
23404778|NCT00310375|65226703|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
23404779|NCT00310375|65226704|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
23404780|NCT00310375|65226702|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
23404781|NCT00310375|65226703|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
23404782|NCT00310375|65226704|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
23404783|NCT00310375|65226702|FG000|Primary Reporting Phase|Physician Decision|5|||
23404784|NCT00310375|65226703|FG001|Primary Reporting Phase|Physician Decision|3|||
23404785|NCT00310375|65226704|FG002|Primary Reporting Phase|Physician Decision|0|||
23404786|NCT00310375|65226702|FG000|Primary Reporting Phase|Request of the sponsor|2|||
23404787|NCT00310375|65226703|FG001|Primary Reporting Phase|Request of the sponsor|2|||
23404788|NCT00310375|65226704|FG002|Primary Reporting Phase|Request of the sponsor|0|||
23404789|NCT00310375|65226702|FG000|Primary Reporting Phase|Failed to return|1|||
23404790|NCT00310375|65226703|FG001|Primary Reporting Phase|Failed to return|3|||
23404791|NCT00310375|65226704|FG002|Primary Reporting Phase|Failed to return|0|||
23404792|NCT00310375|65226702|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
23404793|NCT00310375|65226703|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
23404794|NCT00310375|65226704|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
23404795|NCT00310375|65226702|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
23404796|NCT00310375|65226703|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
23404797|NCT00310375|65226704|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
23404798|NCT00310375|65226702|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
23404799|NCT00310375|65226703|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
23404800|NCT00310375|65226704|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
23404801|NCT00310375|65226702|FG000|Primary Reporting Phase|Site closure|3|||
23404802|NCT00310375|65226703|FG001|Primary Reporting Phase|Site closure|0|||
23404803|NCT00310375|65226704|FG002|Primary Reporting Phase|Site closure|0|||
23606869|NCT00346398|65950525|FG000|Overall Study|Withdrawal by Subject|0|||
23606870|NCT00346398|65950526|FG001|Overall Study|Withdrawal by Subject|2|||
23606871|NCT02699099|65950529|FG000|Overall Study|Adverse Event|1|||
23404804|NCT00310375|65226702|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
23404805|NCT00310375|65226703|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
23404806|NCT00310375|65226704|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
23404807|NCT00310375|65226702|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
23404808|NCT00310375|65226703|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
23404809|NCT00310375|65226704|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
23404810|NCT00310375|65226702|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
23404811|NCT00310375|65226703|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
23404812|NCT00310375|65226704|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
23404813|NCT00310375|65226702|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
23404814|NCT00310375|65226703|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
23404815|NCT00310375|65226704|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
23404816|NCT00628446|65226706|FG000|Overall Study|Lost to Follow-up|3|||
23404817|NCT00628446|65226706|FG000|Overall Study|Withdrawal by Subject|1|||
23404818|NCT00628446|65226706|FG000|Overall Study|Protocol Violation|3|||
23404819|NCT01531998|65226710|FG000|Overall Study|Withdrawal by Subject|3|||
23404820|NCT00420381|65226712|FG000|Overall Study|Protocol Violation|1|||
23404821|NCT00645840|65226715|FG000|Overall Study|Protocol Violation|3|||
23404822|NCT02240121|65226716|FG000|Overall Study|Protocol Violation|1|||
23404823|NCT02240121|65226717|FG001|Overall Study|Protocol Violation|2|||
23404824|NCT02240121|65226716|FG000|Overall Study|Physician Decision|0|||
23404825|NCT02240121|65226717|FG001|Overall Study|Physician Decision|1|||
23404826|NCT02240121|65226716|FG000|Overall Study|Change in protocol interpretation|1|||
23404827|NCT02240121|65226717|FG001|Overall Study|Change in protocol interpretation|0|||
23404828|NCT02240121|65226716|FG000|Overall Study|Lack of Efficacy|2|||
23404829|NCT02240121|65226717|FG001|Overall Study|Lack of Efficacy|3|||
23404830|NCT02240121|65226716|FG000|Overall Study|Site closed|1|||
23404831|NCT02240121|65226717|FG001|Overall Study|Site closed|1|||
23404832|NCT02240121|65226716|FG000|Overall Study|Pregnancy|1|||
23404833|NCT02240121|65226717|FG001|Overall Study|Pregnancy|0|||
23404834|NCT02240121|65226716|FG000|Overall Study|Adverse Event|2|||
23404835|NCT02240121|65226717|FG001|Overall Study|Adverse Event|4|||
23404836|NCT02240121|65226716|FG000|Overall Study|Withdrawal by Subject|6|||
23404837|NCT02240121|65226717|FG001|Overall Study|Withdrawal by Subject|2|||
23606872|NCT02699099|65950530|FG001|Overall Study|Adverse Event|0|||
23606873|NCT02699099|65950531|FG002|Overall Study|Adverse Event|2|||
23606874|NCT02699099|65950529|FG000|Overall Study|Lost to Follow-up|0|||
23606875|NCT02699099|65950530|FG001|Overall Study|Lost to Follow-up|1|||
23404838|NCT02240121|65226716|FG000|Overall Study|Lost to Follow-up|3|||
23404839|NCT02240121|65226717|FG001|Overall Study|Lost to Follow-up|4|||
23404840|NCT02240121|65226716|FG000|Overall Study|Other than specified|1|||
23404841|NCT02240121|65226717|FG001|Overall Study|Other than specified|3|||
23404842|NCT03894891|65226718|FG000|Overall Study|Withdrawal by Subject|1|||
23404843|NCT03894891|65226718|FG000|Overall Study|Completed protocol treatment per protocol|5|||
23404844|NCT01055613|65226719|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
23404845|NCT01055613|65226720|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23404846|NCT01055613|65226719|FG000|Overall Study|Unacceptable lens fit|1|||
23404847|NCT01055613|65226720|FG001|Overall Study|Unacceptable lens fit|0|||
23404848|NCT01055613|65226719|FG000|Overall Study|Discomfort|2|||
23404849|NCT01055613|65226720|FG001|Overall Study|Discomfort|1|||
23404850|NCT01055613|65226719|FG000|Overall Study|Lost to Follow-up|1|||
23404851|NCT01055613|65226720|FG001|Overall Study|Lost to Follow-up|1|||
23404852|NCT01055613|65226719|FG000|Overall Study|Protocol Violation|1|||
23404853|NCT01055613|65226720|FG001|Overall Study|Protocol Violation|1|||
23404854|NCT01055613|65226719|FG000|Overall Study|Subject Disinterest|1|||
23404855|NCT01055613|65226720|FG001|Overall Study|Subject Disinterest|1|||
23404856|NCT02131311|65226721|FG000|Overall Study|Adverse Event|2|||
23404857|NCT02131311|65226721|FG000|Overall Study|Protocol Violation|1|||
23404858|NCT02131311|65226721|FG000|Overall Study|Lost to Follow-up|1|||
23404859|NCT00363311|65226726|FG000|Overall Study|Adverse Event|6|||
23404860|NCT00363311|65226727|FG001|Overall Study|Adverse Event|4|||
23404861|NCT00363311|65226726|FG000|Overall Study|Lost to Follow-up|3|||
23404862|NCT00363311|65226727|FG001|Overall Study|Lost to Follow-up|0|||
23404863|NCT00363311|65226726|FG000|Overall Study|Protocol Violation|1|||
23404864|NCT00363311|65226727|FG001|Overall Study|Protocol Violation|2|||
23404865|NCT00363311|65226726|FG000|Overall Study|Withdrawal by Subject|12|||
23404866|NCT00363311|65226727|FG001|Overall Study|Withdrawal by Subject|6|||
23404867|NCT00363311|65226726|FG000|Overall Study|Physician Decision|1|||
23404868|NCT00363311|65226727|FG001|Overall Study|Physician Decision|1|||
23404869|NCT00363311|65226726|FG000|Overall Study|Sponsor Terminated Study|2|||
23404870|NCT00363311|65226727|FG001|Overall Study|Sponsor Terminated Study|2|||
23404871|NCT00363311|65226726|FG000|Overall Study|Disease Progression|46|||
23404872|NCT00363311|65226727|FG001|Overall Study|Disease Progression|26|||
23404873|NCT00363311|65226726|FG000|Overall Study|Non-Compliance|1|||
23404874|NCT00363311|65226727|FG001|Overall Study|Non-Compliance|1|||
23606876|NCT02699099|65950531|FG002|Overall Study|Lost to Follow-up|0|||
23404875|NCT00363311|65226726|FG000|Overall Study|Participant Refused Biopsy|1|||
23404876|NCT00363311|65226727|FG001|Overall Study|Participant Refused Biopsy|0|||
23404877|NCT00363311|65226726|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
23404878|NCT00363311|65226727|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
23404879|NCT00363311|65226726|FG000|Overall Study|Participant Opted for Treatment|1|||
23404880|NCT00363311|65226727|FG001|Overall Study|Participant Opted for Treatment|0|||
23404881|NCT00363311|65226726|FG000|Overall Study|Participant Moved to Another Country|1|||
23404882|NCT00363311|65226727|FG001|Overall Study|Participant Moved to Another Country|0|||
23404883|NCT00363311|65226726|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
23404884|NCT00363311|65226727|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
23404885|NCT00363311|65226726|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
23404886|NCT00363311|65226727|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
23404887|NCT00363311|65226726|FG000|Overall Study|Participant Moved to Louisiana|0|||
23404888|NCT00363311|65226727|FG001|Overall Study|Participant Moved to Louisiana|1|||
23404889|NCT00570323|65229982|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
23404890|NCT00570323|65229983|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
23404891|NCT00570323|65229982|FG000|Started Treatment After Randomization|Protocol Violation|1|||
23404892|NCT00570323|65229983|FG001|Started Treatment After Randomization|Protocol Violation|0|||
23404893|NCT00570323|65229982|FG000|Started Treatment After Randomization|Physician Decision|1|||
23404894|NCT00570323|65229983|FG001|Started Treatment After Randomization|Physician Decision|0|||
23404895|NCT00570323|65229982|FG000|Complete Study After Start|Lost to Follow-up|0|||
23404896|NCT00570323|65229983|FG001|Complete Study After Start|Lost to Follow-up|1|||
23404897|NCT00570323|65229982|FG000|Complete Study After Start|Withdrawal by Subject|2|||
23404898|NCT00570323|65229983|FG001|Complete Study After Start|Withdrawal by Subject|0|||
23404899|NCT00570323|65229982|FG000|Complete Study After Start|Physician Decision|1|||
23404900|NCT00570323|65229983|FG001|Complete Study After Start|Physician Decision|0|||
23404901|NCT03810014|65229984|FG000|Overall Study|Pregnancy|2|||
23404902|NCT03810014|65229985|FG001|Overall Study|Pregnancy|2|||
23404903|NCT03810014|65229986|FG002|Overall Study|Pregnancy|0|||
23404904|NCT03810014|65229987|FG003|Overall Study|Pregnancy|2|||
23404905|NCT00443703|65229989|FG000|Overall Study|Never Treated|3|||
23404906|NCT00443703|65229990|FG001|Overall Study|Never Treated|1|||
23404907|NCT00443703|65229989|FG000|Overall Study|Adverse Event|7|||
23404908|NCT00443703|65229990|FG001|Overall Study|Adverse Event|3|||
23404909|NCT00443703|65229989|FG000|Overall Study|Lack of Efficacy|3|||
23404910|NCT00443703|65229990|FG001|Overall Study|Lack of Efficacy|1|||
23404911|NCT00443703|65229989|FG000|Overall Study|Lost to Follow-up|0|||
23404912|NCT00443703|65229990|FG001|Overall Study|Lost to Follow-up|4|||
23404913|NCT00443703|65229989|FG000|Overall Study|Physician Decision|4|||
23404914|NCT00443703|65229990|FG001|Overall Study|Physician Decision|2|||
23404915|NCT00443703|65229989|FG000|Overall Study|Protocol Violation|1|||
23404916|NCT00443703|65229990|FG001|Overall Study|Protocol Violation|1|||
23404917|NCT00443703|65229989|FG000|Overall Study|Withdrawal by Subject|9|||
23404918|NCT00443703|65229990|FG001|Overall Study|Withdrawal by Subject|6|||
23404919|NCT00443703|65229989|FG000|Overall Study|Progressive Disease|1|||
23404920|NCT00443703|65229990|FG001|Overall Study|Progressive Disease|0|||
23404921|NCT00619918|65229991|FG000|Overall Study|Withdrawal by Subject|4|||
23404922|NCT00619918|65229992|FG001|Overall Study|Withdrawal by Subject|3|||
23404923|NCT00619918|65229991|FG000|Overall Study|Physician Decision|8|||
23404924|NCT00619918|65229992|FG001|Overall Study|Physician Decision|8|||
23404925|NCT00619918|65229991|FG000|Overall Study|Transfer to outside facility|3|||
23404926|NCT00619918|65229992|FG001|Overall Study|Transfer to outside facility|3|||
23404927|NCT00619918|65229991|FG000|Overall Study|Left before receiving first dose|5|||
23404928|NCT00619918|65229992|FG001|Overall Study|Left before receiving first dose|8|||
23404929|NCT00444925|65229993|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
23404930|NCT00444925|65229994|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
23404931|NCT00444925|65229995|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
23404932|NCT00444925|65229993|FG000|Double-blind Treatment Period|Death|2|||
23404933|NCT00444925|65229994|FG001|Double-blind Treatment Period|Death|0|||
23404934|NCT00444925|65229995|FG002|Double-blind Treatment Period|Death|0|||
23404935|NCT00444925|65229993|FG000|Double-blind Treatment Period|Adverse Event|6|||
23404936|NCT00444925|65229994|FG001|Double-blind Treatment Period|Adverse Event|28|||
23404937|NCT00444925|65229995|FG002|Double-blind Treatment Period|Adverse Event|44|||
23404938|NCT00444925|65229993|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
23404939|NCT00444925|65229994|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
23404940|NCT00444925|65229995|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
23404941|NCT00444925|65229993|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
23404942|NCT00444925|65229994|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
23404943|NCT00444925|65229995|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23404944|NCT00444925|65229993|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
23404945|NCT00444925|65229994|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
23404946|NCT00444925|65229995|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
23404947|NCT00444925|65229993|FG000|Double-blind Treatment Period|Other|7|||
23404948|NCT00444925|65229994|FG001|Double-blind Treatment Period|Other|7|||
23404949|NCT00444925|65229995|FG002|Double-blind Treatment Period|Other|12|||
23404950|NCT01963767|65229998|FG000|Overall Study|Withdrawal by Subject|4|||
23404951|NCT01963767|65229999|FG001|Overall Study|Withdrawal by Subject|2|||
23404952|NCT01963767|65229998|FG000|Overall Study|Adverse Event|2|||
23404953|NCT01963767|65229999|FG001|Overall Study|Adverse Event|0|||
23404954|NCT01396187|65230000|FG000|Overall Study|Adverse Event|0|||
23404955|NCT01396187|65230001|FG001|Overall Study|Adverse Event|1|||
23404956|NCT01396187|65230002|FG002|Overall Study|Adverse Event|0|||
23404957|NCT01396187|65230003|FG003|Overall Study|Adverse Event|0|||
23404958|NCT01396187|65230004|FG004|Overall Study|Adverse Event|0|||
23404959|NCT01396187|65230000|FG000|Overall Study|Withdrawal by Subject|0|||
23404960|NCT01396187|65230001|FG001|Overall Study|Withdrawal by Subject|1|||
23404961|NCT01396187|65230002|FG002|Overall Study|Withdrawal by Subject|1|||
23404962|NCT01396187|65230003|FG003|Overall Study|Withdrawal by Subject|0|||
23404963|NCT01396187|65230004|FG004|Overall Study|Withdrawal by Subject|0|||
23404964|NCT01396187|65230000|FG000|Overall Study|Other|1|||
23404965|NCT01396187|65230001|FG001|Overall Study|Other|1|||
23404966|NCT01396187|65230002|FG002|Overall Study|Other|0|||
23404967|NCT01396187|65230003|FG003|Overall Study|Other|0|||
23404968|NCT01396187|65230004|FG004|Overall Study|Other|1|||
23404969|NCT00130039|65230006|FG000|Overall Study|Withdrawal by Subject|15|||
23404970|NCT00130039|65230007|FG001|Overall Study|Withdrawal by Subject|11|||
23404971|NCT00130039|65230006|FG000|Overall Study|Lost to Follow-up|3|||
23404972|NCT00130039|65230007|FG001|Overall Study|Lost to Follow-up|1|||
23404973|NCT00130039|65230006|FG000|Overall Study|Adverse Event|4|||
23404974|NCT00130039|65230007|FG001|Overall Study|Adverse Event|2|||
23404975|NCT00130039|65230006|FG000|Overall Study|Physician Decision|3|||
23404976|NCT00130039|65230007|FG001|Overall Study|Physician Decision|0|||
23404977|NCT00130039|65230006|FG000|Overall Study|clinical events without follow up MRI|5|||
23404978|NCT00130039|65230007|FG001|Overall Study|clinical events without follow up MRI|4|||
23404979|NCT00400517|65230008|FG000|Overall Study|Withdrawal by Subject|1|||
23404980|NCT00400517|65230008|FG000|Overall Study|Physician Decision|1|||
23404981|NCT00837161|65230009|FG000|Overall Study|refused hysterectomy|2|||
23404982|NCT01016067|65230011|FG000|Overall Study|Lost to Follow-up|1|||
23404983|NCT01016067|65230012|FG001|Overall Study|Lost to Follow-up|2|||
23404984|NCT01016067|65230011|FG000|Overall Study|Physician Decision|1|||
23404985|NCT01016067|65230012|FG001|Overall Study|Physician Decision|1|||
23404986|NCT01016067|65230011|FG000|Overall Study|Withdrew due to Relocation|0|||
23404987|NCT01016067|65230012|FG001|Overall Study|Withdrew due to Relocation|1|||
23404988|NCT03547908|65230013|FG000|Overall Study|Still On Study|115|||
23404989|NCT03547908|65230014|FG001|Overall Study|Still On Study|118|||
23404990|NCT03547908|65230013|FG000|Overall Study|Lost to Follow-up|2|||
23404991|NCT03547908|65230014|FG001|Overall Study|Lost to Follow-up|2|||
23404992|NCT03547908|65230013|FG000|Overall Study|Withdrew Consent|2|||
23404993|NCT03547908|65230014|FG001|Overall Study|Withdrew Consent|1|||
23404994|NCT03547908|65230013|FG000|Overall Study|Adverse Event|1|||
23404995|NCT03547908|65230014|FG001|Overall Study|Adverse Event|0|||
23404996|NCT03547908|65230013|FG000|Overall Study|Death|1|||
23404997|NCT03547908|65230014|FG001|Overall Study|Death|0|||
23404998|NCT03547908|65230013|FG000|Overall Study|Investigator's Discretion|0|||
23404999|NCT03547908|65230014|FG001|Overall Study|Investigator's Discretion|1|||
23405000|NCT03547908|65230013|FG000|Overall Study|Randomized But Never Treated|1|||
23405001|NCT03547908|65230014|FG001|Overall Study|Randomized But Never Treated|0|||
23405002|NCT02382991|65230019|FG000|Overall Study|Adverse Event|1|||
23405003|NCT02382991|65230020|FG001|Overall Study|Adverse Event|2|||
23405004|NCT02382991|65230019|FG000|Overall Study|Lost to Follow-up|1|||
23405005|NCT02382991|65230020|FG001|Overall Study|Lost to Follow-up|0|||
23405006|NCT02382991|65230019|FG000|Overall Study|Withdrawal by Subject|0|||
23405007|NCT02382991|65230020|FG001|Overall Study|Withdrawal by Subject|1|||
23405008|NCT00003869|65230021|FG000|Overall Study|Adverse Event|14|||
23405009|NCT00003869|65230022|FG001|Overall Study|Adverse Event|3|||
23405010|NCT00003869|65230021|FG000|Overall Study|Withdrawal by Subject|21|||
23405011|NCT00003869|65230022|FG001|Overall Study|Withdrawal by Subject|3|||
23405012|NCT00003869|65230021|FG000|Overall Study|Death|1|||
23405013|NCT00003869|65230022|FG001|Overall Study|Death|2|||
23405014|NCT00003869|65230021|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
23405015|NCT00003869|65230022|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
23405016|NCT01770743|65230025|FG000|Overall Study|Adverse Event|1|||
23405017|NCT01770743|65230026|FG001|Overall Study|Adverse Event|0|||
23405018|NCT01770743|65230027|FG002|Overall Study|Adverse Event|0|||
23405019|NCT01770743|65230028|FG003|Overall Study|Adverse Event|0|||
23405020|NCT01770743|65230029|FG004|Overall Study|Adverse Event|0|||
23405021|NCT01770743|65230025|FG000|Overall Study|Withdrawal by Subject|0|||
23405022|NCT01770743|65230026|FG001|Overall Study|Withdrawal by Subject|0|||
23405023|NCT01770743|65230027|FG002|Overall Study|Withdrawal by Subject|1|||
23405024|NCT01770743|65230028|FG003|Overall Study|Withdrawal by Subject|1|||
23810426|NCT02139124|66684429|FG001|Overall Study|Lost to Follow-up|2|||
23405025|NCT01770743|65230029|FG004|Overall Study|Withdrawal by Subject|1|||
23405026|NCT01770743|65230025|FG000|Overall Study|Lost to Follow-up|0|||
23405027|NCT01770743|65230026|FG001|Overall Study|Lost to Follow-up|2|||
23405028|NCT01770743|65230027|FG002|Overall Study|Lost to Follow-up|0|||
23405029|NCT01770743|65230028|FG003|Overall Study|Lost to Follow-up|0|||
23405030|NCT01770743|65230029|FG004|Overall Study|Lost to Follow-up|1|||
23405031|NCT01770743|65230025|FG000|Overall Study|Sponsor Terminated Subject|1|||
23405032|NCT01770743|65230026|FG001|Overall Study|Sponsor Terminated Subject|0|||
23405033|NCT01770743|65230027|FG002|Overall Study|Sponsor Terminated Subject|0|||
23405034|NCT01770743|65230028|FG003|Overall Study|Sponsor Terminated Subject|1|||
23405035|NCT01770743|65230029|FG004|Overall Study|Sponsor Terminated Subject|0|||
23405036|NCT01770743|65230025|FG000|Overall Study|Moving Out of State|0|||
23405037|NCT01770743|65230026|FG001|Overall Study|Moving Out of State|1|||
23405038|NCT01770743|65230027|FG002|Overall Study|Moving Out of State|0|||
23405039|NCT01770743|65230028|FG003|Overall Study|Moving Out of State|0|||
23405040|NCT01770743|65230029|FG004|Overall Study|Moving Out of State|0|||
23405041|NCT03542266|65230030|FG000|Treatment Phase|Withdrawal by Subject|1|||
23405042|NCT03542266|65230030|FG000|Treatment Phase|Adverse Event|1|||
23405043|NCT03542266|65230030|FG000|Treatment Phase|PD|1|||
23405044|NCT04389866|65230031|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
23405045|NCT04389866|65230032|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
23405046|NCT01030822|65230034|FG000|Overall Study|Moved/migrated from study area|6|||
23405047|NCT01030822|65230035|FG001|Overall Study|Moved/migrated from study area|7|||
23405048|NCT01030822|65230036|FG002|Overall Study|Moved/migrated from study area|3|||
23405049|NCT01030822|65230034|FG000|Overall Study|Withdrawal by Subject|16|||
23405050|NCT01030822|65230035|FG001|Overall Study|Withdrawal by Subject|13|||
23405051|NCT01030822|65230036|FG002|Overall Study|Withdrawal by Subject|16|||
23405052|NCT01030822|65230034|FG000|Overall Study|Lost to Follow-up|9|||
23405053|NCT01030822|65230035|FG001|Overall Study|Lost to Follow-up|4|||
23405054|NCT01030822|65230036|FG002|Overall Study|Lost to Follow-up|7|||
23405055|NCT01721486|65230041|FG000|Overall Study|Protocol Violation|1|||
23405056|NCT01721486|65230042|FG001|Overall Study|Protocol Violation|0|||
23405057|NCT01721486|65230041|FG000|Overall Study|Physician Decision|0|||
23405058|NCT01721486|65230042|FG001|Overall Study|Physician Decision|1|||
23405059|NCT00355030|65230043|FG000|Study Period 1 Treatment|Adverse Event|1|||
23405060|NCT00355030|65230044|FG001|Study Period 1 Treatment|Adverse Event|1|||
23405061|NCT00355030|65230043|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
23405062|NCT00355030|65230044|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
23405063|NCT00355030|65230043|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
23405064|NCT00355030|65230044|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
23405065|NCT00355030|65230043|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
23405066|NCT00355030|65230044|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
23405067|NCT00355030|65230043|FG000|Study Period 1 Treatment|Physician Decision|0|||
23405068|NCT00355030|65230044|FG001|Study Period 1 Treatment|Physician Decision|1|||
23405069|NCT00355030|65230043|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
23405070|NCT00355030|65230044|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
23405071|NCT00355030|65230043|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
23405072|NCT00355030|65230044|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
23405073|NCT00355030|65230043|FG000|Study Period 1 Treatment|Other|2|||
23405074|NCT00355030|65230044|FG001|Study Period 1 Treatment|Other|6|||
23405075|NCT00355030|65230043|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
23405076|NCT00355030|65230044|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
23405077|NCT00355030|65230043|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
23405078|NCT00355030|65230044|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
23405079|NCT00049322|65230045|FG000|Overall Study|disease burden|0|||
23405080|NCT00049322|65230046|FG001|Overall Study|disease burden|3|||
23405081|NCT00049322|65230045|FG000|Overall Study|Adverse Event|1|||
23405082|NCT00049322|65230046|FG001|Overall Study|Adverse Event|0|||
23405083|NCT00049322|65230045|FG000|Overall Study|refused angio|0|||
23405084|NCT00049322|65230046|FG001|Overall Study|refused angio|3|||
23405085|NCT02375373|65230047|FG000|Overall Study|Withdrawal by Subject|11|||
23405086|NCT02776683|65230049|FG000|Pre-switch Period|Protocol Violation|1|||
23405087|NCT02776683|65230050|FG001|Pre-switch Period|Protocol Violation|0|||
23405088|NCT02776683|65230049|FG000|Pre-switch Period|Adverse Event|21|||
23405089|NCT02776683|65230050|FG001|Pre-switch Period|Adverse Event|0|||
23405090|NCT02776683|65230049|FG000|Pre-switch Period|Withdrawal by Subject|9|||
23405091|NCT02776683|65230050|FG001|Pre-switch Period|Withdrawal by Subject|0|||
23405092|NCT02776683|65230049|FG000|Pre-switch Period|Physician Decision|7|||
23405093|NCT02776683|65230050|FG001|Pre-switch Period|Physician Decision|0|||
23405094|NCT02776683|65230049|FG000|Pre-switch Period|Progressive disease|39|||
23405095|NCT02776683|65230050|FG001|Pre-switch Period|Progressive disease|0|||
23405096|NCT02776683|65230049|FG000|Pre-switch Period|Other than listed|3|||
23405097|NCT02776683|65230050|FG001|Pre-switch Period|Other than listed|0|||
23405098|NCT02776683|65230049|FG000|Post-switch Period|Adverse Event|0|||
23810427|NCT02139124|66684430|FG002|Overall Study|Lost to Follow-up|0|||
23405099|NCT02776683|65230050|FG001|Post-switch Period|Adverse Event|3|||
23405100|NCT02776683|65230049|FG000|Post-switch Period|Withdrawal by Subject|0|||
23405101|NCT02776683|65230050|FG001|Post-switch Period|Withdrawal by Subject|2|||
23405102|NCT02776683|65230049|FG000|Post-switch Period|Physician Decision|0|||
23405103|NCT02776683|65230050|FG001|Post-switch Period|Physician Decision|3|||
23405104|NCT02776683|65230049|FG000|Post-switch Period|Progressive disease|0|||
23405105|NCT02776683|65230050|FG001|Post-switch Period|Progressive disease|20|||
23405106|NCT02776683|65230049|FG000|Post-switch Period|Other than listed|0|||
23405107|NCT02776683|65230050|FG001|Post-switch Period|Other than listed|15|||
23405108|NCT01354223|65230051|FG000|Overall Study|Withdrawal by Subject|3|||
23405109|NCT01354223|65230052|FG001|Overall Study|Withdrawal by Subject|1|||
23405110|NCT01102491|65230053|FG000|Overall Study|Protocol Violation|11|||
23405111|NCT01102491|65230054|FG001|Overall Study|Protocol Violation|12|||
23405112|NCT00700622|65230055|FG000|Overall Study|Adverse Event|4|||
23405113|NCT00700622|65230056|FG001|Overall Study|Adverse Event|0|||
23405114|NCT00700622|65230055|FG000|Overall Study|Lost to Follow-up|0|||
23405115|NCT00700622|65230056|FG001|Overall Study|Lost to Follow-up|1|||
23405116|NCT00700622|65230055|FG000|Overall Study|Physician Decision|2|||
23405117|NCT00700622|65230056|FG001|Overall Study|Physician Decision|1|||
23405118|NCT00700622|65230055|FG000|Overall Study|Protocol Violation|0|||
23606877|NCT02699099|65950529|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
23606878|NCT02699099|65950530|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23606879|NCT02699099|65950531|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
23606880|NCT03875729|65950532|FG000|Overall Study|Adverse Event|0|||
23405119|NCT00700622|65230056|FG001|Overall Study|Protocol Violation|1|||
23405120|NCT00700622|65230055|FG000|Overall Study|Withdrawal by Subject|4|||
23405121|NCT00700622|65230056|FG001|Overall Study|Withdrawal by Subject|1|||
23405122|NCT00700622|65230055|FG000|Overall Study|Other|3|||
23405123|NCT00700622|65230056|FG001|Overall Study|Other|1|||
23405124|NCT00976716|65230057|FG000|Overall Study|Adverse Event|1|||
23405125|NCT04677543|65230058|FG000|Overall Study|Withdrawal by Subject|4|||
23405126|NCT04677543|65230059|FG001|Overall Study|Withdrawal by Subject|1|||
23405127|NCT04677543|65230058|FG000|Overall Study|Physician Decision|0|||
23405128|NCT04677543|65230059|FG001|Overall Study|Physician Decision|1|||
23405129|NCT04677543|65230058|FG000|Overall Study|Adverse Event|0|||
23405130|NCT04677543|65230059|FG001|Overall Study|Adverse Event|1|||
23405131|NCT03432494|65230069|FG000|Overall Study|Death|1|||
23405132|NCT03432494|65230069|FG000|Overall Study|Noncompliance|1|||
23405133|NCT01898286|65230070|FG000|Overall Study|Withdrawal by Subject|1|||
23405134|NCT01898286|65230070|FG000|Overall Study|Protocol Violation|1|||
23405135|NCT01898286|65230070|FG000|Overall Study|Lost to Follow-up|1|||
23405136|NCT04232943|65230073|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
23405137|NCT04232943|65230074|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
23405138|NCT04232943|65230075|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
23405139|NCT04232943|65230073|FG000|Overall Study|Withdrawal by Subject|1|||
23405140|NCT04232943|65230074|FG001|Overall Study|Withdrawal by Subject|1|||
23405141|NCT04232943|65230075|FG002|Overall Study|Withdrawal by Subject|0|||
23405142|NCT01456130|65230082|FG000|Overall Study|Adverse Event|4|||
23405143|NCT01456130|65230082|FG000|Overall Study|Voluntary Withdrawal|1|||
23405144|NCT01456130|65230082|FG000|Overall Study|Lack of Efficacy|4|||
23405145|NCT01456130|65230082|FG000|Overall Study|Other|1|||
23405146|NCT02639247|65230083|FG000|Overall Study|Lost to Follow-up|2|||
23405147|NCT02639247|65230084|FG001|Overall Study|Lost to Follow-up|1|||
23405148|NCT02639247|65230083|FG000|Overall Study|Death|2|||
23606881|NCT03875729|65950533|FG001|Overall Study|Adverse Event|5|||
23606882|NCT03875729|65950532|FG000|Overall Study|Withdrawal by Subject|8|||
23606883|NCT03875729|65950533|FG001|Overall Study|Withdrawal by Subject|11|||
23606884|NCT03875729|65950532|FG000|Overall Study|Pregnancy|0|||
23606885|NCT03875729|65950533|FG001|Overall Study|Pregnancy|1|||
23606886|NCT03875729|65950532|FG000|Overall Study|Lost to Follow-up|0|||
23606887|NCT03875729|65950533|FG001|Overall Study|Lost to Follow-up|5|||
23606888|NCT03875729|65950532|FG000|Overall Study|Personal reasons|2|||
23606889|NCT03875729|65950533|FG001|Overall Study|Personal reasons|0|||
23606890|NCT04749797|65950534|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
23606891|NCT04749797|65950535|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
23606892|NCT04749797|65950536|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
23606893|NCT03820024|65950537|FG000|Overall Study|Physician Decision|1|||
23606894|NCT03820024|65950538|FG001|Overall Study|Physician Decision|2|||
23606895|NCT03042767|65950539|FG000|Overall Study|Lost to Follow-up|1|||
23405149|NCT02639247|65230084|FG001|Overall Study|Death|0|||
23405150|NCT02639247|65230083|FG000|Overall Study|Withdrew Consent|0|||
23405151|NCT02639247|65230084|FG001|Overall Study|Withdrew Consent|1|||
23405152|NCT02639247|65230083|FG000|Overall Study|Protocol Violation|1|||
23606896|NCT03042767|65950540|FG001|Overall Study|Lost to Follow-up|2|||
23606897|NCT00687297|65950542|FG000|Randomization|Withdrawal by Subject|2|||
23606898|NCT00687297|65950543|FG001|Randomization|Withdrawal by Subject|0|||
23606899|NCT00687297|65950542|FG000|Randomization|Withdrew before treatment, ineligible|1|||
23810428|NCT02139124|66684431|FG003|Overall Study|Lost to Follow-up|5|||
23606900|NCT00687297|65950543|FG001|Randomization|Withdrew before treatment, ineligible|1|||
23606901|NCT00687297|65950542|FG000|Induction|Withdrawal by Subject|4|||
23606902|NCT00687297|65950543|FG001|Induction|Withdrawal by Subject|4|||
23606903|NCT00687297|65950542|FG000|Induction|Adverse Event|16|||
23606904|NCT00687297|65950543|FG001|Induction|Adverse Event|15|||
23606905|NCT00687297|65950542|FG000|Induction|Death|7|||
23606906|NCT00687297|65950543|FG001|Induction|Death|11|||
23606907|NCT00687297|65950542|FG000|Induction|Lack of Efficacy|17|||
23606908|NCT00687297|65950543|FG001|Induction|Lack of Efficacy|21|||
23606909|NCT00687297|65950542|FG000|Induction|Ineligible|0|||
23405153|NCT02639247|65230084|FG001|Overall Study|Protocol Violation|0|||
23405154|NCT01147393|65230085|FG000|Dose Level 1|Dose limiting Toxicity|2|||
23405155|NCT01147393|65230085|FG000|Dose Level -1|Dose Limited Toxicity|1|||
23405156|NCT01856322|65230086|FG000|Overall Study|off study due to lack of accrual|0|||
23405157|NCT01856322|65230087|FG001|Overall Study|off study due to lack of accrual|0|||
23405158|NCT01856322|65230088|FG002|Overall Study|off study due to lack of accrual|3|||
23405159|NCT01265992|65230089|FG000|Overall Study|Lost to Follow-up|1|||
23405160|NCT01265992|65230089|FG000|Overall Study|Withdrawal by Subject|1|||
23405161|NCT01265992|65230089|FG000|Overall Study|Adverse Event|1|||
23405162|NCT01265992|65230089|FG000|Overall Study|Administrative reasons|2|||
23405163|NCT01265992|65230089|FG000|Overall Study|Stopped treatment|3|||
23405164|NCT01265992|65230089|FG000|Overall Study|Did not receive treatment|1|||
23405165|NCT02041299|65230091|FG000|Overall Study|Adverse Event|9|||
23405166|NCT02041299|65230092|FG001|Overall Study|Adverse Event|3|||
23405167|NCT02041299|65230091|FG000|Overall Study|Lost to Follow-up|4|||
23405168|NCT02041299|65230092|FG001|Overall Study|Lost to Follow-up|1|||
23405169|NCT02041299|65230091|FG000|Overall Study|Physician Decision|1|||
23405170|NCT02041299|65230092|FG001|Overall Study|Physician Decision|1|||
23405171|NCT02041299|65230091|FG000|Overall Study|Withdrawal by Subject|13|||
23405172|NCT02041299|65230092|FG001|Overall Study|Withdrawal by Subject|7|||
23405173|NCT02041299|65230091|FG000|Overall Study|Protocol Violation|11|||
23405174|NCT02041299|65230092|FG001|Overall Study|Protocol Violation|4|||
23405175|NCT02041299|65230091|FG000|Overall Study|Termination of the study|7|||
23405176|NCT02041299|65230092|FG001|Overall Study|Termination of the study|3|||
23405177|NCT02041299|65230091|FG000|Overall Study|Required bone marrow transplant|0|||
23405178|NCT02041299|65230092|FG001|Overall Study|Required bone marrow transplant|1|||
23405179|NCT02041299|65230091|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
23405180|NCT02041299|65230092|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
23405181|NCT00945659|65230093|FG000|Overall Study|Lost to Follow-up|7|||
23405182|NCT00945659|65230094|FG001|Overall Study|Lost to Follow-up|20|||
23405183|NCT00945659|65230095|FG002|Overall Study|Lost to Follow-up|17|||
23405184|NCT01123148|65230096|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
23405185|NCT01123148|65230096|FG000|Overall Study|Didn't meet milestone criteria|1|||
23405186|NCT03688919|65230099|FG000|Overall Study|Lost to Follow-up|2|||
23405187|NCT03688919|65230100|FG001|Overall Study|Lost to Follow-up|1|||
23405188|NCT03688919|65230099|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
23405189|NCT03688919|65230100|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
23405190|NCT00590122|65230101|FG000|Overall Study|swallowed oral dissolving dose|1|||
23405191|NCT00590122|65230102|FG001|Overall Study|swallowed oral dissolving dose|0|||
23405192|NCT03382912|65230107|FG000|Overall Study|Physician Decision|0|||
23405193|NCT03382912|65230108|FG001|Overall Study|Physician Decision|1|||
23405194|NCT03382912|65230107|FG000|Overall Study|Sponsor Decision|6|||
23405195|NCT03382912|65230108|FG001|Overall Study|Sponsor Decision|6|||
23405196|NCT03382912|65230107|FG000|Overall Study|Withdrawal by Subject|0|||
23405197|NCT03382912|65230108|FG001|Overall Study|Withdrawal by Subject|5|||
23405198|NCT01775553|65230110|FG000|Overall Study|Adverse Event|1|||
23405199|NCT01775553|65230110|FG000|Overall Study|Disease Progression|12|||
23405200|NCT00670930|65230111|FG000|Overall Study|Adminstrative Problem|0|||
23405201|NCT00670930|65230112|FG001|Overall Study|Adminstrative Problem|1|||
23405202|NCT00670930|65230111|FG000|Overall Study|Lost to Follow-up|1|||
23405203|NCT00670930|65230112|FG001|Overall Study|Lost to Follow-up|0|||
23405204|NCT02457247|65230113|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
23405205|NCT02457247|65230114|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
23405206|NCT02457247|65230115|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
23405207|NCT02457247|65230116|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
23405208|NCT02457247|65230113|FG000|Period 1|Significant Protocol Deviation|1|||
23405209|NCT02457247|65230114|FG001|Period 1|Significant Protocol Deviation|1|||
23405210|NCT02457247|65230115|FG002|Period 1|Significant Protocol Deviation|0|||
23405211|NCT02457247|65230116|FG003|Period 1|Significant Protocol Deviation|0|||
23405212|NCT02457247|65230113|FG000|Period 1|Voluntary Withdrawal|1|||
23405213|NCT02457247|65230114|FG001|Period 1|Voluntary Withdrawal|0|||
23405214|NCT02457247|65230115|FG002|Period 1|Voluntary Withdrawal|0|||
23405215|NCT02457247|65230116|FG003|Period 1|Voluntary Withdrawal|0|||
23405216|NCT02457247|65230113|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
23606910|NCT00687297|65950543|FG001|Induction|Ineligible|1|||
23606911|NCT00687297|65950542|FG000|Induction|Patient Noncompliance|1|||
23606912|NCT00687297|65950543|FG001|Induction|Patient Noncompliance|0|||
23405217|NCT02457247|65230114|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
23405218|NCT02457247|65230115|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
23405219|NCT02457247|65230116|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
23405220|NCT02457247|65230113|FG000|Period 2|Significant Protocol Deviation|1|||
23405221|NCT02457247|65230114|FG001|Period 2|Significant Protocol Deviation|0|||
23405222|NCT02457247|65230115|FG002|Period 2|Significant Protocol Deviation|0|||
23405223|NCT02457247|65230116|FG003|Period 2|Significant Protocol Deviation|0|||
23405224|NCT02457247|65230113|FG000|Period 2|Lost to Follow-up|0|||
23405225|NCT02457247|65230114|FG001|Period 2|Lost to Follow-up|1|||
23405226|NCT02457247|65230115|FG002|Period 2|Lost to Follow-up|0|||
23405227|NCT02457247|65230116|FG003|Period 2|Lost to Follow-up|0|||
23405228|NCT02457247|65230113|FG000|Period 2|Voluntary Withdrawal|1|||
23405229|NCT02457247|65230114|FG001|Period 2|Voluntary Withdrawal|1|||
23405230|NCT02457247|65230115|FG002|Period 2|Voluntary Withdrawal|0|||
23405231|NCT02457247|65230116|FG003|Period 2|Voluntary Withdrawal|0|||
23405232|NCT00658541|65230119|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405233|NCT00658541|65230120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405234|NCT00658541|65230119|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23405235|NCT00658541|65230120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405236|NCT01977898|65230121|FG000|Overall Study|Non functioning catheter|1|||
23405237|NCT01977898|65230122|FG001|Overall Study|Non functioning catheter|1|||
23405238|NCT00756275|65230123|FG000|Overall Study|Lost to Follow-up|25|||
23405239|NCT00756275|65230124|FG001|Overall Study|Lost to Follow-up|21|||
23405240|NCT00756275|65230123|FG000|Overall Study|Withdrawal by Subject|4|||
23405241|NCT00756275|65230124|FG001|Overall Study|Withdrawal by Subject|7|||
23405242|NCT00811954|65230125|FG000|Overall Study|Death|10|||
23405243|NCT00811954|65230126|FG001|Overall Study|Death|6|||
23405244|NCT00811954|65230127|FG002|Overall Study|Death|13|||
23405245|NCT00811954|65230125|FG000|Overall Study|Lost to Follow-up|29|||
23405246|NCT00811954|65230126|FG001|Overall Study|Lost to Follow-up|23|||
23606913|NCT00687297|65950542|FG000|Induction|Physician Decision|0|||
23606914|NCT00687297|65950543|FG001|Induction|Physician Decision|2|||
23606915|NCT00687297|65950542|FG000|Induction|Other|0|||
23606916|NCT00687297|65950543|FG001|Induction|Other|1|||
23606917|NCT01029704|65950545|FG000|Overall Study|Adverse Event|0|||
23606918|NCT01029704|65950546|FG001|Overall Study|Adverse Event|0|||
23606919|NCT01029704|65950547|FG002|Overall Study|Adverse Event|0|||
23606920|NCT01029704|65950548|FG003|Overall Study|Adverse Event|0|||
23606921|NCT01029704|65950549|FG004|Overall Study|Adverse Event|0|||
23606922|NCT01029704|65950550|FG005|Overall Study|Adverse Event|0|||
23606923|NCT01029704|65950551|FG006|Overall Study|Adverse Event|1|||
23606924|NCT01029704|65950552|FG007|Overall Study|Adverse Event|1|||
23606925|NCT01029704|65950553|FG008|Overall Study|Adverse Event|0|||
23606926|NCT01029704|65950545|FG000|Overall Study|Withdrawal by Subject|0|||
23606927|NCT01029704|65950546|FG001|Overall Study|Withdrawal by Subject|0|||
23606928|NCT01029704|65950547|FG002|Overall Study|Withdrawal by Subject|0|||
23606929|NCT01029704|65950548|FG003|Overall Study|Withdrawal by Subject|0|||
23606930|NCT01029704|65950549|FG004|Overall Study|Withdrawal by Subject|2|||
23606931|NCT01029704|65950550|FG005|Overall Study|Withdrawal by Subject|1|||
23606932|NCT01029704|65950551|FG006|Overall Study|Withdrawal by Subject|1|||
23606933|NCT01029704|65950552|FG007|Overall Study|Withdrawal by Subject|1|||
23606934|NCT01029704|65950553|FG008|Overall Study|Withdrawal by Subject|0|||
23606935|NCT01029704|65950545|FG000|Overall Study|Lost to Follow-up|0|||
23606936|NCT01029704|65950546|FG001|Overall Study|Lost to Follow-up|0|||
23606937|NCT01029704|65950547|FG002|Overall Study|Lost to Follow-up|0|||
23606938|NCT01029704|65950548|FG003|Overall Study|Lost to Follow-up|0|||
23606939|NCT01029704|65950549|FG004|Overall Study|Lost to Follow-up|0|||
23606940|NCT01029704|65950550|FG005|Overall Study|Lost to Follow-up|0|||
23606941|NCT01029704|65950551|FG006|Overall Study|Lost to Follow-up|1|||
23606942|NCT01029704|65950552|FG007|Overall Study|Lost to Follow-up|1|||
23606943|NCT01029704|65950553|FG008|Overall Study|Lost to Follow-up|1|||
23606944|NCT01029704|65950545|FG000|Overall Study|Lack of Efficacy|0|||
23606945|NCT01029704|65950546|FG001|Overall Study|Lack of Efficacy|0|||
23606946|NCT01029704|65950547|FG002|Overall Study|Lack of Efficacy|0|||
23606947|NCT01029704|65950548|FG003|Overall Study|Lack of Efficacy|0|||
23606948|NCT01029704|65950549|FG004|Overall Study|Lack of Efficacy|2|||
23606949|NCT01029704|65950550|FG005|Overall Study|Lack of Efficacy|3|||
23606950|NCT01029704|65950551|FG006|Overall Study|Lack of Efficacy|1|||
23606951|NCT01029704|65950552|FG007|Overall Study|Lack of Efficacy|2|||
23606952|NCT01029704|65950553|FG008|Overall Study|Lack of Efficacy|0|||
23606953|NCT01029704|65950545|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
23606954|NCT01029704|65950546|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
23606955|NCT01029704|65950547|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
23606956|NCT01029704|65950548|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
23606957|NCT01029704|65950549|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
23606958|NCT01029704|65950550|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
23606959|NCT01029704|65950551|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
23606960|NCT01029704|65950552|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
23606961|NCT01029704|65950553|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
23606962|NCT00321672|65950556|FG000|Overall Study|Withdrawal by Subject|5|||
23606963|NCT00321672|65950557|FG001|Overall Study|Withdrawal by Subject|1|||
23606964|NCT00321672|65950558|FG002|Overall Study|Withdrawal by Subject|2|||
23606965|NCT00321672|65950559|FG003|Overall Study|Withdrawal by Subject|0|||
23606966|NCT00321672|65950556|FG000|Overall Study|Noncompliance|1|||
23606967|NCT00321672|65950557|FG001|Overall Study|Noncompliance|2|||
23606968|NCT00321672|65950558|FG002|Overall Study|Noncompliance|1|||
23606969|NCT00321672|65950559|FG003|Overall Study|Noncompliance|0|||
23606970|NCT00321672|65950556|FG000|Overall Study|Adverse Event|1|||
23606971|NCT00321672|65950557|FG001|Overall Study|Adverse Event|1|||
23606972|NCT00321672|65950558|FG002|Overall Study|Adverse Event|0|||
23606973|NCT00321672|65950559|FG003|Overall Study|Adverse Event|0|||
23606974|NCT00321672|65950556|FG000|Overall Study|Lack of Efficacy|1|||
23606975|NCT00321672|65950557|FG001|Overall Study|Lack of Efficacy|1|||
23606976|NCT00321672|65950558|FG002|Overall Study|Lack of Efficacy|0|||
23606977|NCT00321672|65950559|FG003|Overall Study|Lack of Efficacy|0|||
23606978|NCT00321672|65950556|FG000|Overall Study|Lost to Follow-up|2|||
23606979|NCT00321672|65950557|FG001|Overall Study|Lost to Follow-up|0|||
23606980|NCT00321672|65950558|FG002|Overall Study|Lost to Follow-up|4|||
23606981|NCT00321672|65950559|FG003|Overall Study|Lost to Follow-up|2|||
23606982|NCT00321672|65950556|FG000|Overall Study|Death|1|||
23606983|NCT00321672|65950557|FG001|Overall Study|Death|0|||
23606984|NCT00321672|65950558|FG002|Overall Study|Death|0|||
23810429|NCT02139124|66684432|FG004|Overall Study|Lost to Follow-up|4|||
23810430|NCT02518919|66684433|FG000|Overall Study|Protocol Violation|1|||
23810431|NCT02518919|66684434|FG001|Overall Study|Protocol Violation|1|||
23810432|NCT02518919|66684435|FG002|Overall Study|Protocol Violation|2|||
23810433|NCT01196078|66684438|FG000|Overall Study|Withdrawal by Subject|3|||
23810434|NCT01196078|66684439|FG001|Overall Study|Withdrawal by Subject|5|||
23810435|NCT01196078|66684438|FG000|Overall Study|Adverse Event|4|||
23810436|NCT01196078|66684439|FG001|Overall Study|Adverse Event|4|||
23810437|NCT01196078|66684438|FG000|Overall Study|Protocol Violation|2|||
23810438|NCT01196078|66684439|FG001|Overall Study|Protocol Violation|1|||
23810439|NCT01196078|66684438|FG000|Overall Study|Lack of Efficacy|17|||
23810440|NCT01196078|66684439|FG001|Overall Study|Lack of Efficacy|23|||
23810441|NCT01196078|66684438|FG000|Overall Study|Lost to Follow-up|1|||
23810442|NCT01196078|66684439|FG001|Overall Study|Lost to Follow-up|0|||
23810443|NCT01196078|66684438|FG000|Overall Study|Death|6|||
23810444|NCT01196078|66684439|FG001|Overall Study|Death|4|||
23810445|NCT04078126|66684440|FG000|Washout|Study put on hold due to COVID-19|0|||
23810446|NCT04078126|66684441|FG001|Washout|Study put on hold due to COVID-19|2|||
23810447|NCT04078126|66684440|FG000|Period 2|Study put on hold due to COVID-19|1|||
23810448|NCT04078126|66684441|FG001|Period 2|Study put on hold due to COVID-19|1|||
23810449|NCT02065700|66684443|FG000|Overall Study|Adverse Event|165|||
23810450|NCT02065700|66684444|FG001|Overall Study|Adverse Event|101|||
23810451|NCT02065700|66684443|FG000|Overall Study|Withdrawal by Subject|90|||
23810452|NCT02065700|66684444|FG001|Overall Study|Withdrawal by Subject|29|||
23810453|NCT02065700|66684443|FG000|Overall Study|Lost to Follow-up|12|||
23810454|NCT02065700|66684444|FG001|Overall Study|Lost to Follow-up|9|||
23810455|NCT02065700|66684443|FG000|Overall Study|Physician Decision|2|||
23810456|NCT02065700|66684444|FG001|Overall Study|Physician Decision|0|||
23810457|NCT02065700|66684443|FG000|Overall Study|Sponsor Request|38|||
23405247|NCT00811954|65230127|FG002|Overall Study|Lost to Follow-up|34|||
23405248|NCT00811954|65230125|FG000|Overall Study|Not able to get to clinic|28|||
23405249|NCT00811954|65230126|FG001|Overall Study|Not able to get to clinic|35|||
23405250|NCT00811954|65230127|FG002|Overall Study|Not able to get to clinic|30|||
23405251|NCT00811954|65230125|FG000|Overall Study|Not willing to adhere to requirements|12|||
23405252|NCT00811954|65230126|FG001|Overall Study|Not willing to adhere to requirements|2|||
23405253|NCT00811954|65230127|FG002|Overall Study|Not willing to adhere to requirements|16|||
23405254|NCT00811954|65230125|FG000|Overall Study|Withdraw consent prior study completion|4|||
23405255|NCT00811954|65230126|FG001|Overall Study|Withdraw consent prior study completion|6|||
23405256|NCT00811954|65230127|FG002|Overall Study|Withdraw consent prior study completion|5|||
23405257|NCT00811954|65230125|FG000|Overall Study|Site Closure|4|||
23405258|NCT00811954|65230126|FG001|Overall Study|Site Closure|0|||
23405259|NCT00811954|65230127|FG002|Overall Study|Site Closure|1|||
23606985|NCT00321672|65950559|FG003|Overall Study|Death|0|||
23810458|NCT02065700|66684444|FG001|Overall Study|Sponsor Request|15|||
23810459|NCT02065700|66684443|FG000|Overall Study|Treatment Failure|3|||
23606986|NCT00321672|65950556|FG000|Overall Study|Too far to travel for visits|1|||
23606987|NCT00321672|65950557|FG001|Overall Study|Too far to travel for visits|0|||
23606988|NCT00321672|65950558|FG002|Overall Study|Too far to travel for visits|0|||
23606989|NCT00321672|65950559|FG003|Overall Study|Too far to travel for visits|0|||
23606990|NCT00321672|65950556|FG000|Overall Study|Incarcerated|0|||
23810460|NCT02065700|66684444|FG001|Overall Study|Treatment Failure|2|||
23810461|NCT02065700|66684443|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
23606991|NCT00321672|65950557|FG001|Overall Study|Incarcerated|0|||
23606992|NCT00321672|65950558|FG002|Overall Study|Incarcerated|2|||
23606993|NCT00321672|65950559|FG003|Overall Study|Incarcerated|0|||
23606994|NCT00321672|65950556|FG000|Overall Study|Moved out of state|0|||
23606995|NCT00321672|65950557|FG001|Overall Study|Moved out of state|1|||
23606996|NCT00321672|65950558|FG002|Overall Study|Moved out of state|1|||
23606997|NCT00321672|65950559|FG003|Overall Study|Moved out of state|0|||
23606998|NCT00321672|65950556|FG000|Overall Study|Protocol Violation|0|||
23606999|NCT00321672|65950557|FG001|Overall Study|Protocol Violation|0|||
23607000|NCT00321672|65950558|FG002|Overall Study|Protocol Violation|1|||
23607001|NCT00321672|65950559|FG003|Overall Study|Protocol Violation|0|||
23607002|NCT00321672|65950556|FG000|Overall Study|Diagnosis of testicular cancer|0|||
23607003|NCT00321672|65950557|FG001|Overall Study|Diagnosis of testicular cancer|1|||
23607004|NCT00321672|65950558|FG002|Overall Study|Diagnosis of testicular cancer|0|||
23607005|NCT00321672|65950559|FG003|Overall Study|Diagnosis of testicular cancer|0|||
23607006|NCT00321672|65950556|FG000|Overall Study|Extensive travel required for new job|0|||
23607007|NCT00321672|65950557|FG001|Overall Study|Extensive travel required for new job|1|||
23607008|NCT00321672|65950558|FG002|Overall Study|Extensive travel required for new job|0|||
23607009|NCT00321672|65950559|FG003|Overall Study|Extensive travel required for new job|0|||
23607010|NCT00512902|65950561|FG000|Overall Study|Adverse Event|7|||
23607011|NCT00512902|65950561|FG000|Overall Study|Lost to Follow-up|1|||
23607012|NCT02138838|65950567|FG000|Overall Study|Study Closure|7|||
23607013|NCT02138838|65950568|FG001|Overall Study|Study Closure|6|||
23607014|NCT02138838|65950567|FG000|Overall Study|Withdrawal by Subject|1|||
23607015|NCT02138838|65950568|FG001|Overall Study|Withdrawal by Subject|5|||
23607016|NCT00240994|65950569|FG000|Overall Study|Lost to Follow-up|1|||
23607017|NCT00240994|65950569|FG000|Overall Study|Protocol Violation|1|||
23607018|NCT00240994|65950569|FG000|Overall Study|Graft failure|1|||
23607019|NCT04571944|65950570|FG000|Overall Study|Death|1|||
23607020|NCT04571944|65950571|FG001|Overall Study|Death|0|||
23607021|NCT04571944|65950570|FG000|Overall Study|Withdrawal by Subject|3|||
23607022|NCT04571944|65950571|FG001|Overall Study|Withdrawal by Subject|0|||
23607023|NCT04571944|65950570|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
23607024|NCT04571944|65950571|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
23607025|NCT02325154|65950579|FG000|Overall Study|Physician Decision|1|||
23607026|NCT03678688|65950581|FG000|Overall Study|Reason not Specified|0|||
23607027|NCT03678688|65950582|FG001|Overall Study|Reason not Specified|0|||
23607028|NCT03678688|65950583|FG002|Overall Study|Reason not Specified|3|||
23607029|NCT03678688|65950584|FG003|Overall Study|Reason not Specified|0|||
23607030|NCT03678688|65950585|FG004|Overall Study|Reason not Specified|1|||
23607031|NCT03678688|65950586|FG005|Overall Study|Reason not Specified|0|||
23607032|NCT03678688|65950587|FG006|Overall Study|Reason not Specified|0|||
23607033|NCT03678688|65950588|FG007|Overall Study|Reason not Specified|0|||
23607034|NCT03678688|65950589|FG008|Overall Study|Reason not Specified|0|||
23607035|NCT03678688|65950581|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
23607036|NCT03678688|65950582|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
23607037|NCT03678688|65950583|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
23607038|NCT03678688|65950584|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
23607039|NCT03678688|65950585|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
23607040|NCT03678688|65950586|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
23607041|NCT03678688|65950587|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
23607042|NCT03678688|65950588|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
23607043|NCT03678688|65950589|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
23607044|NCT03678688|65950581|FG000|Overall Study|Covid Related Adverse Event|0|||
23607045|NCT03678688|65950582|FG001|Overall Study|Covid Related Adverse Event|0|||
23607046|NCT03678688|65950583|FG002|Overall Study|Covid Related Adverse Event|0|||
23607047|NCT03678688|65950584|FG003|Overall Study|Covid Related Adverse Event|0|||
23607048|NCT03678688|65950585|FG004|Overall Study|Covid Related Adverse Event|0|||
23607049|NCT03678688|65950586|FG005|Overall Study|Covid Related Adverse Event|3|||
23607050|NCT03678688|65950587|FG006|Overall Study|Covid Related Adverse Event|1|||
23607051|NCT03678688|65950588|FG007|Overall Study|Covid Related Adverse Event|1|||
23607052|NCT03678688|65950589|FG008|Overall Study|Covid Related Adverse Event|0|||
23607053|NCT03678688|65950581|FG000|Overall Study|Physician Decision|0|||
23607054|NCT03678688|65950582|FG001|Overall Study|Physician Decision|0|||
23607055|NCT03678688|65950583|FG002|Overall Study|Physician Decision|0|||
23810462|NCT02065700|66684444|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
23810463|NCT02065700|66684443|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
23810464|NCT02065700|66684444|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
23810465|NCT02065700|66684443|FG000|Overall Study|Non-compliance with Study Procedures|2|||
23810466|NCT02065700|66684444|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23810467|NCT02065700|66684443|FG000|Overall Study|Not Defined|21|||
23810468|NCT02065700|66684444|FG001|Overall Study|Not Defined|3|||
23607056|NCT03678688|65950584|FG003|Overall Study|Physician Decision|0|||
23810469|NCT00127036|66684449|FG000|Overall Study|Insufficient Data for Analysis|6|||
23810470|NCT00127036|66684450|FG001|Overall Study|Insufficient Data for Analysis|11|||
23810471|NCT00127036|66684449|FG000|Overall Study|Screen Failure|2|||
23810472|NCT00127036|66684450|FG001|Overall Study|Screen Failure|0|||
23810473|NCT02227147|66684454|FG000|Controlled Treatment Period|Adverse Event|4|||
23810474|NCT02227147|66684455|FG001|Controlled Treatment Period|Adverse Event|3|||
23810475|NCT02227147|66684454|FG000|Controlled Treatment Period|Other|2|||
23810476|NCT02227147|66684455|FG001|Controlled Treatment Period|Other|0|||
23810477|NCT02227147|66684454|FG000|Follow-up Period|Other|3|||
23810478|NCT02227147|66684455|FG001|Follow-up Period|Other|5|||
23810479|NCT00686075|66684456|FG000|Overall Study|Withdrawal by Subject|4|||
23810480|NCT00686075|66684457|FG001|Overall Study|Withdrawal by Subject|3|||
23810481|NCT00686075|66684458|FG002|Overall Study|Withdrawal by Subject|3|||
23810482|NCT00686075|66684459|FG003|Overall Study|Withdrawal by Subject|7|||
23810483|NCT00686075|66684460|FG004|Overall Study|Withdrawal by Subject|1|||
23810484|NCT00686075|66684461|FG005|Overall Study|Withdrawal by Subject|0|||
23810485|NCT00686075|66684462|FG006|Overall Study|Withdrawal by Subject|0|||
23810486|NCT00686075|66684463|FG007|Overall Study|Withdrawal by Subject|2|||
23810487|NCT00686075|66684464|FG008|Overall Study|Withdrawal by Subject|4|||
23810488|NCT00686075|66684465|FG009|Overall Study|Withdrawal by Subject|6|||
23810489|NCT00686075|66684456|FG000|Overall Study|Lost to Follow-up|3|||
23810490|NCT00686075|66684457|FG001|Overall Study|Lost to Follow-up|6|||
23810491|NCT00686075|66684458|FG002|Overall Study|Lost to Follow-up|3|||
23810492|NCT00686075|66684459|FG003|Overall Study|Lost to Follow-up|2|||
23810493|NCT00686075|66684460|FG004|Overall Study|Lost to Follow-up|3|||
23810494|NCT00686075|66684461|FG005|Overall Study|Lost to Follow-up|3|||
23810495|NCT00686075|66684462|FG006|Overall Study|Lost to Follow-up|0|||
23810496|NCT00686075|66684463|FG007|Overall Study|Lost to Follow-up|0|||
23810497|NCT00686075|66684464|FG008|Overall Study|Lost to Follow-up|2|||
23810498|NCT00686075|66684465|FG009|Overall Study|Lost to Follow-up|3|||
23810499|NCT00686075|66684456|FG000|Overall Study|Other|1|||
23810500|NCT00686075|66684457|FG001|Overall Study|Other|1|||
23810501|NCT00686075|66684458|FG002|Overall Study|Other|0|||
23810502|NCT00686075|66684459|FG003|Overall Study|Other|0|||
23810503|NCT00686075|66684460|FG004|Overall Study|Other|0|||
23810504|NCT00686075|66684461|FG005|Overall Study|Other|0|||
23810505|NCT00686075|66684462|FG006|Overall Study|Other|0|||
23810506|NCT00686075|66684463|FG007|Overall Study|Other|0|||
23810507|NCT00686075|66684464|FG008|Overall Study|Other|0|||
23810508|NCT00686075|66684465|FG009|Overall Study|Other|1|||
23810509|NCT02923674|66684466|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
23810510|NCT02923674|66684467|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
23810511|NCT02923674|66684468|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
23810512|NCT02923674|66684466|FG000|Overall Study|Lost to Follow-up|7|||
23810513|NCT02923674|66684467|FG001|Overall Study|Lost to Follow-up|12|||
23810514|NCT02923674|66684468|FG002|Overall Study|Lost to Follow-up|7|||
23810515|NCT02923674|66684466|FG000|Overall Study|Problem with intervention|2|||
23810516|NCT02923674|66684467|FG001|Overall Study|Problem with intervention|2|||
23810517|NCT02923674|66684468|FG002|Overall Study|Problem with intervention|1|||
23810518|NCT02923674|66684466|FG000|Overall Study|Adverse Event|3|||
23810519|NCT02923674|66684467|FG001|Overall Study|Adverse Event|1|||
23810520|NCT02923674|66684468|FG002|Overall Study|Adverse Event|1|||
23810521|NCT02923674|66684466|FG000|Overall Study|Withdrawal by Subject|2|||
23810522|NCT02923674|66684467|FG001|Overall Study|Withdrawal by Subject|2|||
23810523|NCT02923674|66684468|FG002|Overall Study|Withdrawal by Subject|2|||
23810524|NCT03052322|66684473|FG000|Overall Study|Other un-specified|1|||
23810525|NCT03052322|66684474|FG001|Overall Study|Other un-specified|2|||
23810526|NCT03052322|66684473|FG000|Overall Study|Withdrawal by Subject|10|||
23810527|NCT03052322|66684474|FG001|Overall Study|Withdrawal by Subject|9|||
23810528|NCT03052322|66684473|FG000|Overall Study|Death|0|||
23810529|NCT03052322|66684474|FG001|Overall Study|Death|2|||
23810530|NCT03052322|66684473|FG000|Overall Study|Lack of Efficacy|1|||
23810531|NCT03052322|66684474|FG001|Overall Study|Lack of Efficacy|2|||
23810532|NCT03052322|66684473|FG000|Overall Study|Protocol Violation|1|||
23810533|NCT03052322|66684474|FG001|Overall Study|Protocol Violation|0|||
23810534|NCT03052322|66684473|FG000|Overall Study|Lost to Follow-up|2|||
23810535|NCT03052322|66684474|FG001|Overall Study|Lost to Follow-up|4|||
23810536|NCT03052322|66684473|FG000|Overall Study|Adverse Event|6|||
23810537|NCT03052322|66684474|FG001|Overall Study|Adverse Event|13|||
23810538|NCT04614246|66684475|FG000|Overall Study|Adverse Event|0|||
23810539|NCT04614246|66684476|FG001|Overall Study|Adverse Event|1|||
23810540|NCT04614246|66684477|FG002|Overall Study|Adverse Event|1|||
23810541|NCT04614246|66684478|FG003|Overall Study|Adverse Event|2|||
23810542|NCT04614246|66684479|FG004|Overall Study|Adverse Event|1|||
23810543|NCT04614246|66684475|FG000|Overall Study|Lost to Follow-up|0|||
23810544|NCT04614246|66684476|FG001|Overall Study|Lost to Follow-up|1|||
23810545|NCT04614246|66684477|FG002|Overall Study|Lost to Follow-up|0|||
23810546|NCT04614246|66684478|FG003|Overall Study|Lost to Follow-up|1|||
23810547|NCT04614246|66684479|FG004|Overall Study|Lost to Follow-up|3|||
23810548|NCT04614246|66684475|FG000|Overall Study|Other reason|0|||
23810549|NCT04614246|66684476|FG001|Overall Study|Other reason|1|||
23810550|NCT04614246|66684477|FG002|Overall Study|Other reason|2|||
23810551|NCT04614246|66684478|FG003|Overall Study|Other reason|0|||
23810552|NCT04614246|66684479|FG004|Overall Study|Other reason|0|||
23810553|NCT04614246|66684475|FG000|Overall Study|Withdrawal by Subject|4|||
23810554|NCT04614246|66684476|FG001|Overall Study|Withdrawal by Subject|2|||
23810555|NCT04614246|66684477|FG002|Overall Study|Withdrawal by Subject|4|||
23810556|NCT04614246|66684478|FG003|Overall Study|Withdrawal by Subject|3|||
23810557|NCT04614246|66684479|FG004|Overall Study|Withdrawal by Subject|4|||
23810558|NCT04614246|66684475|FG000|Overall Study|Physician Decision|0|||
23810559|NCT04614246|66684476|FG001|Overall Study|Physician Decision|2|||
23810560|NCT04614246|66684477|FG002|Overall Study|Physician Decision|1|||
23810561|NCT04614246|66684478|FG003|Overall Study|Physician Decision|0|||
23810562|NCT04614246|66684479|FG004|Overall Study|Physician Decision|0|||
23810563|NCT04614246|66684475|FG000|Overall Study|Study terminated by sponsor|10|||
23810564|NCT04614246|66684476|FG001|Overall Study|Study terminated by sponsor|15|||
23810565|NCT04614246|66684477|FG002|Overall Study|Study terminated by sponsor|12|||
23810566|NCT04614246|66684478|FG003|Overall Study|Study terminated by sponsor|13|||
23810567|NCT04614246|66684479|FG004|Overall Study|Study terminated by sponsor|9|||
23810568|NCT04614246|66684475|FG000|Overall Study|Pregnancy|2|||
23810569|NCT04614246|66684476|FG001|Overall Study|Pregnancy|0|||
23810570|NCT04614246|66684477|FG002|Overall Study|Pregnancy|1|||
23810571|NCT04614246|66684478|FG003|Overall Study|Pregnancy|0|||
23810572|NCT04614246|66684479|FG004|Overall Study|Pregnancy|0|||
23810573|NCT01321008|66684480|FG000|Overall Study|Early Study Termination|1|||
23810574|NCT02771795|66684481|FG000|Overall Study|Withdrawal by Subject|47|||
23810575|NCT02771795|66684482|FG001|Overall Study|Withdrawal by Subject|37|||
23810576|NCT02771795|66684481|FG000|Overall Study|Termination by premature discontinuation of study|168|||
23810577|NCT02771795|66684482|FG001|Overall Study|Termination by premature discontinuation of study|185|||
23810578|NCT05304611|66684488|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810579|NCT05304611|66684489|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810580|NCT05304611|66684490|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810581|NCT05304611|66684491|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810582|NCT05304611|66684492|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810583|NCT05304611|66684493|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
23810584|NCT05304611|66684494|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
23810585|NCT05304611|66684495|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
23607057|NCT03678688|65950585|FG004|Overall Study|Physician Decision|0|||
23810586|NCT05304611|66684496|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
23810587|NCT05304611|66684488|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
23810588|NCT05304611|66684489|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
23810589|NCT05304611|66684490|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
23810590|NCT05304611|66684491|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
23810591|NCT05304611|66684492|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
23607058|NCT03678688|65950586|FG005|Overall Study|Physician Decision|1|||
23607059|NCT03678688|65950587|FG006|Overall Study|Physician Decision|0|||
23810592|NCT05304611|66684493|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
23810593|NCT05304611|66684494|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
23810594|NCT05304611|66684495|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
23810595|NCT05304611|66684496|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
23810596|NCT01685073|66687331|FG000|Overall Study|Lost to Follow-up|6|||
23810597|NCT01685073|66687332|FG001|Overall Study|Lost to Follow-up|8|||
23810598|NCT01685073|66687331|FG000|Overall Study|Withdrawal by Subject|24|||
23810599|NCT01685073|66687332|FG001|Overall Study|Withdrawal by Subject|24|||
23810600|NCT04853992|66687333|FG000|Treatment Period A|Adverse Event|0|||
23810601|NCT04853992|66687334|FG001|Treatment Period A|Adverse Event|1|||
23810602|NCT04853992|66687333|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
23810603|NCT04853992|66687334|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
23810604|NCT01346774|66687337|FG000|Overall Study|Did not take a single dose|6|||
23810605|NCT01346774|66687338|FG001|Overall Study|Did not take a single dose|4|||
23810606|NCT01346774|66687337|FG000|Overall Study|Lost to Follow-up|3|||
23810607|NCT01346774|66687338|FG001|Overall Study|Lost to Follow-up|4|||
23607060|NCT03678688|65950588|FG007|Overall Study|Physician Decision|0|||
23607061|NCT03678688|65950589|FG008|Overall Study|Physician Decision|0|||
23607062|NCT03678688|65950581|FG000|Overall Study|Withdrawal by Subject|0|||
23607063|NCT03678688|65950582|FG001|Overall Study|Withdrawal by Subject|0|||
23607064|NCT03678688|65950583|FG002|Overall Study|Withdrawal by Subject|0|||
23607065|NCT03678688|65950584|FG003|Overall Study|Withdrawal by Subject|0|||
23810608|NCT01346774|66687337|FG000|Overall Study|Withdrawal by Subject|1|||
23810609|NCT01346774|66687338|FG001|Overall Study|Withdrawal by Subject|4|||
23810610|NCT01346774|66687337|FG000|Overall Study|Protocol Violation|2|||
23810611|NCT01346774|66687338|FG001|Overall Study|Protocol Violation|3|||
23810612|NCT01346774|66687337|FG000|Overall Study|Adverse Event|1|||
23810613|NCT01346774|66687338|FG001|Overall Study|Adverse Event|2|||
23810614|NCT02288182|66687339|FG000|Overall Study|Adverse Event|0|||
23810615|NCT02288182|66687340|FG001|Overall Study|Adverse Event|1|||
23810616|NCT02288182|66687339|FG000|Overall Study|Lost to Follow-up|0|||
23810617|NCT02288182|66687340|FG001|Overall Study|Lost to Follow-up|1|||
23810618|NCT02005887|66687348|FG000|Overall Study|Protocol Violation|0|||
23810619|NCT02005887|66687349|FG001|Overall Study|Protocol Violation|2|||
23810620|NCT01797835|66687350|FG000|Overall Study|Lost to Follow-up|31|||
23810621|NCT01797835|66687351|FG001|Overall Study|Lost to Follow-up|27|||
23810622|NCT01229735|66687352|FG000|Overall Study|Lack of Efficacy|8|||
23810623|NCT01229735|66687353|FG001|Overall Study|Lack of Efficacy|8|||
23810624|NCT01229735|66687352|FG000|Overall Study|Protocol Violation|13|||
23810625|NCT01229735|66687353|FG001|Overall Study|Protocol Violation|8|||
23810626|NCT01229735|66687352|FG000|Overall Study|Lost to Follow-up|0|||
23810627|NCT01229735|66687353|FG001|Overall Study|Lost to Follow-up|2|||
23810628|NCT01229735|66687352|FG000|Overall Study|Withdrawal by Subject|18|||
23810629|NCT01229735|66687353|FG001|Overall Study|Withdrawal by Subject|17|||
23810630|NCT01229735|66687352|FG000|Overall Study|Other Reason|13|||
23810631|NCT01229735|66687353|FG001|Overall Study|Other Reason|10|||
23810632|NCT01229735|66687352|FG000|Overall Study|SAE, non-fatal|0|||
23810633|NCT01229735|66687353|FG001|Overall Study|SAE, non-fatal|4|||
23810634|NCT01229735|66687352|FG000|Overall Study|AE, non-serious non-fatal|13|||
23810635|NCT01229735|66687353|FG001|Overall Study|AE, non-serious non-fatal|17|||
23810636|NCT01229735|66687352|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23810637|NCT01229735|66687353|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23810638|NCT01103466|66687357|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
23810639|NCT01103466|66687358|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
23810640|NCT01103466|66687359|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
23810641|NCT01103466|66687357|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
23810642|NCT01103466|66687358|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
23810643|NCT01103466|66687359|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
23810644|NCT01103466|66687357|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23810645|NCT01103466|66687358|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23810646|NCT01103466|66687359|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23810647|NCT01103466|66687357|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
23810648|NCT01103466|66687358|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
23810649|NCT01103466|66687359|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
23810650|NCT01103466|66687357|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23810651|NCT01103466|66687358|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23405260|NCT00811954|65230125|FG000|Overall Study|Severe Debilitation|2|||
23607066|NCT03678688|65950585|FG004|Overall Study|Withdrawal by Subject|0|||
23607067|NCT03678688|65950586|FG005|Overall Study|Withdrawal by Subject|0|||
23607068|NCT03678688|65950587|FG006|Overall Study|Withdrawal by Subject|2|||
23505399|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
23505400|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23505401|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
23505402|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
23505403|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
23810652|NCT01103466|66687359|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23405261|NCT00811954|65230126|FG001|Overall Study|Severe Debilitation|0|||
23505404|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
23505405|NCT03033394|65587933|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
23505406|NCT02495168|65587934|FG000|Overall Study|Other than Specified|18|||
23505407|NCT02495168|65587935|FG001|Overall Study|Other than Specified|22|||
23505408|NCT02495168|65587936|FG002|Overall Study|Other than Specified|5|||
23505409|NCT02495168|65587934|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
23505410|NCT02495168|65587935|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
23505411|NCT02495168|65587936|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
23505412|NCT02495168|65587934|FG000|Overall Study|Physician Decision|1|||
23505413|NCT02495168|65587935|FG001|Overall Study|Physician Decision|1|||
23505414|NCT02495168|65587936|FG002|Overall Study|Physician Decision|0|||
23505415|NCT02495168|65587934|FG000|Overall Study|Lost to Follow-up|10|||
23505416|NCT02495168|65587935|FG001|Overall Study|Lost to Follow-up|6|||
23505417|NCT02495168|65587936|FG002|Overall Study|Lost to Follow-up|1|||
23505418|NCT02495168|65587934|FG000|Overall Study|Withdrawal by Subject|1|||
23505419|NCT02495168|65587935|FG001|Overall Study|Withdrawal by Subject|4|||
23505420|NCT02495168|65587936|FG002|Overall Study|Withdrawal by Subject|2|||
23505421|NCT02495168|65587934|FG000|Overall Study|Protocol Violation|0|||
23505422|NCT02495168|65587935|FG001|Overall Study|Protocol Violation|10|||
23505423|NCT02495168|65587936|FG002|Overall Study|Protocol Violation|1|||
23505424|NCT02495168|65587934|FG000|Overall Study|Adverse Event|4|||
23505425|NCT02495168|65587935|FG001|Overall Study|Adverse Event|8|||
23505426|NCT02495168|65587936|FG002|Overall Study|Adverse Event|3|||
23505427|NCT02495168|65587934|FG000|Overall Study|Lack of Efficacy|0|||
23505428|NCT02495168|65587935|FG001|Overall Study|Lack of Efficacy|0|||
23505429|NCT02495168|65587936|FG002|Overall Study|Lack of Efficacy|3|||
23505430|NCT04051008|65587946|FG000|Overall Study|Withdrawal by Subject|2|||
23505431|NCT04051008|65587947|FG001|Overall Study|Withdrawal by Subject|0|||
23505432|NCT04051008|65587948|FG002|Overall Study|Withdrawal by Subject|1|||
23505433|NCT02254486|65587949|FG000|Overall Study|Adverse Event|1|||
23505434|NCT02254486|65587950|FG001|Overall Study|Adverse Event|1|||
23505435|NCT02254486|65587949|FG000|Overall Study|Lack of Efficacy|1|||
23505436|NCT02254486|65587950|FG001|Overall Study|Lack of Efficacy|0|||
23505437|NCT02254486|65587949|FG000|Overall Study|Lost to Follow-up|2|||
23505438|NCT02254486|65587950|FG001|Overall Study|Lost to Follow-up|4|||
23505439|NCT02254486|65587949|FG000|Overall Study|Protocol Violation|1|||
23505440|NCT02254486|65587950|FG001|Overall Study|Protocol Violation|2|||
23505441|NCT02254486|65587949|FG000|Overall Study|Withdrawal by Subject|17|||
23505442|NCT02254486|65587950|FG001|Overall Study|Withdrawal by Subject|15|||
23505443|NCT02254486|65587949|FG000|Overall Study|GFR<60mL/min|16|||
23505444|NCT02254486|65587950|FG001|Overall Study|GFR<60mL/min|21|||
23505445|NCT02254486|65587949|FG000|Overall Study|Various|12|||
23810653|NCT01103466|66687357|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
23810654|NCT01103466|66687358|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
23810655|NCT01103466|66687359|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
23810656|NCT01642914|66687365|FG000|Overall Study|Adverse Event|11|||
23810657|NCT01642914|66687366|FG001|Overall Study|Adverse Event|7|||
23810658|NCT01642914|66687367|FG002|Overall Study|Adverse Event|15|||
23810659|NCT01642914|66687365|FG000|Overall Study|Lack of Efficacy|9|||
23810660|NCT01642914|66687366|FG001|Overall Study|Lack of Efficacy|4|||
23810661|NCT01642914|66687367|FG002|Overall Study|Lack of Efficacy|2|||
23810662|NCT01642914|66687365|FG000|Overall Study|Protocol Violation|15|||
23810663|NCT01642914|66687366|FG001|Overall Study|Protocol Violation|13|||
23810664|NCT01642914|66687367|FG002|Overall Study|Protocol Violation|6|||
23810665|NCT01642914|66687365|FG000|Overall Study|Withdrawal by Subject|5|||
23810666|NCT01642914|66687366|FG001|Overall Study|Withdrawal by Subject|5|||
23810667|NCT01642914|66687367|FG002|Overall Study|Withdrawal by Subject|10|||
23810668|NCT01642914|66687365|FG000|Overall Study|Lost to Follow-up|5|||
23810669|NCT01642914|66687366|FG001|Overall Study|Lost to Follow-up|3|||
23810670|NCT01642914|66687367|FG002|Overall Study|Lost to Follow-up|7|||
23810671|NCT01642914|66687365|FG000|Overall Study|Other Reason|1|||
23810672|NCT01642914|66687366|FG001|Overall Study|Other Reason|0|||
23810673|NCT01642914|66687367|FG002|Overall Study|Other Reason|0|||
23810674|NCT01175811|66687368|FG000|Overall Study|Adverse Event|1|||
23810675|NCT01175811|66687369|FG001|Overall Study|Adverse Event|1|||
23810676|NCT01175811|66687368|FG000|Overall Study|Entry criteria not met|3|||
23810677|NCT01175811|66687369|FG001|Overall Study|Entry criteria not met|1|||
23810678|NCT01175811|66687368|FG000|Overall Study|Lack of Efficacy|1|||
23505446|NCT02254486|65587950|FG001|Overall Study|Various|12|||
23810679|NCT01175811|66687369|FG001|Overall Study|Lack of Efficacy|0|||
23505447|NCT00317356|65587952|FG000|Overall Study|Adverse Event|0|||
23505448|NCT00317356|65587953|FG001|Overall Study|Adverse Event|0|||
23505449|NCT00317356|65587954|FG002|Overall Study|Adverse Event|1|||
23505450|NCT00317356|65587955|FG003|Overall Study|Adverse Event|0|||
23505451|NCT00317356|65587952|FG000|Overall Study|Lack of Efficacy|1|||
23505452|NCT00317356|65587953|FG001|Overall Study|Lack of Efficacy|1|||
23810680|NCT01175811|66687368|FG000|Overall Study|Lost to Follow-up|3|||
23505453|NCT00317356|65587954|FG002|Overall Study|Lack of Efficacy|0|||
23505454|NCT00317356|65587955|FG003|Overall Study|Lack of Efficacy|3|||
23505455|NCT00317356|65587952|FG000|Overall Study|Physician Decision|0|||
23505456|NCT00317356|65587953|FG001|Overall Study|Physician Decision|1|||
23505457|NCT00317356|65587954|FG002|Overall Study|Physician Decision|0|||
23505458|NCT00317356|65587955|FG003|Overall Study|Physician Decision|0|||
23505459|NCT01397084|65587956|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23505460|NCT01397084|65587956|FG000|Overall Study|Protocol Violation|2|||
23505461|NCT01397084|65587956|FG000|Overall Study|Adverse Event|2|||
23505462|NCT01397084|65587956|FG000|Overall Study|Withdrawal by Subject|1|||
23810681|NCT01175811|66687369|FG001|Overall Study|Lost to Follow-up|2|||
23810682|NCT01175811|66687368|FG000|Overall Study|Physician Decision|1|||
23810683|NCT01175811|66687369|FG001|Overall Study|Physician Decision|1|||
23810684|NCT01175811|66687368|FG000|Overall Study|Protocol Violation|1|||
23810685|NCT01175811|66687369|FG001|Overall Study|Protocol Violation|2|||
23810686|NCT01175811|66687368|FG000|Overall Study|Withdrawal by Subject|6|||
23810687|NCT01175811|66687369|FG001|Overall Study|Withdrawal by Subject|7|||
23810688|NCT00251719|66687371|FG000|Overall Study|Adverse Event|14|||
23810689|NCT00251719|66687372|FG001|Overall Study|Adverse Event|8|||
23810690|NCT00251719|66687373|FG002|Overall Study|Adverse Event|7|||
23810691|NCT00251719|66687371|FG000|Overall Study|Protocol Violation|1|||
23810692|NCT00251719|66687372|FG001|Overall Study|Protocol Violation|1|||
23505463|NCT01397084|65587956|FG000|Overall Study|Lost to Follow-up|1|||
23505464|NCT01397084|65587956|FG000|Overall Study|Used other proton pump inhibitor|1|||
23505465|NCT01056653|65587959|FG000|Overall Study|Lost to Follow-up|0|||
23505466|NCT01056653|65587960|FG001|Overall Study|Lost to Follow-up|0|||
23505467|NCT01056653|65587961|FG002|Overall Study|Lost to Follow-up|2|||
23505468|NCT00897104|65587962|FG000|Overall Study|Lost to Follow-up|12|||
23505469|NCT00897104|65587963|FG001|Overall Study|Lost to Follow-up|17|||
23505470|NCT00897104|65587964|FG002|Overall Study|Lost to Follow-up|2|||
23505471|NCT00897104|65587962|FG000|Overall Study|Pregnancy|0|||
23505472|NCT00897104|65587963|FG001|Overall Study|Pregnancy|1|||
23505473|NCT00897104|65587964|FG002|Overall Study|Pregnancy|0|||
23505474|NCT00897104|65587962|FG000|Overall Study|Protocol Violation|0|||
23505475|NCT00897104|65587963|FG001|Overall Study|Protocol Violation|1|||
23505476|NCT00897104|65587964|FG002|Overall Study|Protocol Violation|0|||
23505477|NCT00897104|65587962|FG000|Overall Study|Withdrawal by Subject|23|||
23505478|NCT00897104|65587963|FG001|Overall Study|Withdrawal by Subject|27|||
23810693|NCT00251719|66687373|FG002|Overall Study|Protocol Violation|1|||
23810694|NCT00251719|66687371|FG000|Overall Study|Lost to Follow-up|5|||
23810695|NCT00251719|66687372|FG001|Overall Study|Lost to Follow-up|11|||
23810696|NCT00251719|66687373|FG002|Overall Study|Lost to Follow-up|8|||
23505479|NCT00897104|65587964|FG002|Overall Study|Withdrawal by Subject|3|||
23505480|NCT00897104|65587962|FG000|Overall Study|Abnormal Prestudy Labs|2|||
23505481|NCT00897104|65587963|FG001|Overall Study|Abnormal Prestudy Labs|0|||
23505482|NCT00897104|65587964|FG002|Overall Study|Abnormal Prestudy Labs|0|||
23810697|NCT00251719|66687371|FG000|Overall Study|Withdrawal by Subject|14|||
23810698|NCT00251719|66687372|FG001|Overall Study|Withdrawal by Subject|12|||
23810699|NCT00251719|66687373|FG002|Overall Study|Withdrawal by Subject|11|||
23810700|NCT00251719|66687371|FG000|Overall Study|Lack of Efficacy|2|||
23810701|NCT00251719|66687372|FG001|Overall Study|Lack of Efficacy|1|||
23810702|NCT00251719|66687373|FG002|Overall Study|Lack of Efficacy|0|||
23810703|NCT00251719|66687371|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
23810704|NCT00251719|66687372|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
23810705|NCT00251719|66687373|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
23810706|NCT00251719|66687371|FG000|Overall Study|Investigator decision|1|||
23810707|NCT00251719|66687372|FG001|Overall Study|Investigator decision|1|||
23810708|NCT00251719|66687373|FG002|Overall Study|Investigator decision|0|||
23810709|NCT00251719|66687371|FG000|Overall Study|Noncompliance|2|||
23810710|NCT00251719|66687372|FG001|Overall Study|Noncompliance|3|||
23810711|NCT00251719|66687373|FG002|Overall Study|Noncompliance|1|||
23810712|NCT00251719|66687371|FG000|Overall Study|Barrett's esophagus|2|||
23810713|NCT00251719|66687372|FG001|Overall Study|Barrett's esophagus|2|||
23810714|NCT00251719|66687373|FG002|Overall Study|Barrett's esophagus|0|||
23810715|NCT00321828|66687374|FG000|Overall Study|Ineligible|3|||
23810716|NCT00321828|66687374|FG000|Overall Study|No follow up data|1|||
23810717|NCT02307266|66687375|FG000|Overall Study|Adverse Event|3|||
23810718|NCT02307266|66687376|FG001|Overall Study|Adverse Event|1|||
23810719|NCT02307266|66687377|FG002|Overall Study|Adverse Event|5|||
23810720|NCT02307266|66687375|FG000|Overall Study|Withdrawal by Subject|2|||
23810721|NCT02307266|66687376|FG001|Overall Study|Withdrawal by Subject|0|||
23810722|NCT02307266|66687377|FG002|Overall Study|Withdrawal by Subject|1|||
23810723|NCT02307266|66687375|FG000|Overall Study|Lost to Follow-up|3|||
23405262|NCT00811954|65230127|FG002|Overall Study|Severe Debilitation|1|||
23405263|NCT00811954|65230125|FG000|Overall Study|Complete Protocol: No follow-up|0|||
23405264|NCT00811954|65230126|FG001|Overall Study|Complete Protocol: No follow-up|0|||
23405265|NCT00811954|65230127|FG002|Overall Study|Complete Protocol: No follow-up|1|||
23405266|NCT02504372|65230130|FG000|Overall Study|Death|136|||
23405267|NCT02504372|65230131|FG001|Overall Study|Death|154|||
23405268|NCT02504372|65230130|FG000|Overall Study|Lost to Follow-up|0|||
23405269|NCT02504372|65230131|FG001|Overall Study|Lost to Follow-up|2|||
23405270|NCT02504372|65230130|FG000|Overall Study|Withdrawal of consent|25|||
23405271|NCT02504372|65230131|FG001|Overall Study|Withdrawal of consent|16|||
23405272|NCT02504372|65230130|FG000|Overall Study|Participants ongoing|429|||
23405273|NCT02504372|65230131|FG001|Overall Study|Participants ongoing|415|||
23405274|NCT02549989|65230132|FG000|Overall Study|Adverse Event|4|||
23405275|NCT02549989|65230132|FG000|Overall Study|Death|1|||
23405276|NCT02549989|65230132|FG000|Overall Study|Lack of Efficacy|19|||
23405277|NCT02549989|65230132|FG000|Overall Study|Withdrawal by Subject|3|||
23405278|NCT01151020|65230136|FG000|Overall Study|Death|25|||
23405279|NCT01151020|65230136|FG000|Overall Study|Conversion to open repair|1|||
23405280|NCT01151020|65230136|FG000|Overall Study|Lost to Follow-up|4|||
23405281|NCT01151020|65230136|FG000|Overall Study|Withdrawal by Subject|22|||
23405282|NCT01151020|65230136|FG000|Overall Study|Patients did not receive the device|2|||
23405283|NCT01369199|65230137|FG000|Overall Study|Withdrawal by Subject|1|||
23405284|NCT01369199|65230137|FG000|Overall Study|Lost to Follow-up|2|||
23405285|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Death|0|||
23405286|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Death|1|||
23405287|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Death|1|||
23405288|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Death|0|||
23405289|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Death|0|||
23405290|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Death|0|||
23505483|NCT00897104|65587962|FG000|Overall Study|Abnormal Baseline ECG|2|||
23505484|NCT00897104|65587963|FG001|Overall Study|Abnormal Baseline ECG|2|||
23505485|NCT00897104|65587964|FG002|Overall Study|Abnormal Baseline ECG|0|||
23505486|NCT00897104|65587962|FG000|Overall Study|Need for Concom. Med.|0|||
23405291|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Death|0|||
23405292|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Death|0|||
23405293|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405294|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405295|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
23405296|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405297|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
23405298|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405299|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405300|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405301|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23810724|NCT02307266|66687376|FG001|Overall Study|Lost to Follow-up|0|||
23810725|NCT02307266|66687377|FG002|Overall Study|Lost to Follow-up|0|||
23505487|NCT00897104|65587963|FG001|Overall Study|Need for Concom. Med.|1|||
23810726|NCT01367665|66687378|FG000|Overall Study|Death|102|||
23505488|NCT00897104|65587964|FG002|Overall Study|Need for Concom. Med.|1|||
23505489|NCT00897104|65587962|FG000|Overall Study|Lack of Migraine Attack|20|||
23810727|NCT01367665|66687379|FG001|Overall Study|Death|19|||
23405302|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405303|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405304|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
23405305|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405306|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405307|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405308|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405309|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Other|1|||
23405310|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Other|0|||
23405311|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Other|0|||
23405312|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Other|0|||
23405313|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Other|0|||
23405314|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Other|1|||
23810728|NCT01367665|66687378|FG000|Overall Study|Lost to Follow-up|222|||
23405315|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Other|1|||
23405316|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Other|2|||
23810729|NCT01367665|66687379|FG001|Overall Study|Lost to Follow-up|22|||
23810730|NCT01367665|66687378|FG000|Overall Study|Not Done|118|||
23810731|NCT01367665|66687379|FG001|Overall Study|Not Done|14|||
23810732|NCT01939496|66687382|FG000|Overall Study|Adverse Event|2|||
23810733|NCT01939496|66687383|FG001|Overall Study|Adverse Event|0|||
23810734|NCT01939496|66687384|FG002|Overall Study|Adverse Event|0|||
23810735|NCT01939496|66687382|FG000|Overall Study|Lost to Follow-up|1|||
23810736|NCT01939496|66687383|FG001|Overall Study|Lost to Follow-up|1|||
23810737|NCT01939496|66687384|FG002|Overall Study|Lost to Follow-up|0|||
23810738|NCT01939496|66687382|FG000|Overall Study|Physician Decision|1|||
23810739|NCT01939496|66687383|FG001|Overall Study|Physician Decision|0|||
23810740|NCT01939496|66687384|FG002|Overall Study|Physician Decision|0|||
23405317|NCT02948582|65230146|FG000|Washout Period 1|Adverse Event|0|||
23810741|NCT01939496|66687382|FG000|Overall Study|Protocol Violation|3|||
23810742|NCT01939496|66687383|FG001|Overall Study|Protocol Violation|0|||
23810743|NCT01939496|66687384|FG002|Overall Study|Protocol Violation|0|||
23810744|NCT01939496|66687382|FG000|Overall Study|Withdrawal by Subject|0|||
23810745|NCT01939496|66687383|FG001|Overall Study|Withdrawal by Subject|1|||
23810746|NCT01939496|66687384|FG002|Overall Study|Withdrawal by Subject|1|||
23810747|NCT01939496|66687382|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
23810748|NCT01939496|66687383|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
23405318|NCT02948582|65230147|FG001|Washout Period 1|Adverse Event|2|||
23810749|NCT01939496|66687384|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
23810750|NCT01939496|66687382|FG000|Overall Study|Other|2|||
23810751|NCT01939496|66687383|FG001|Overall Study|Other|0|||
23810752|NCT01939496|66687384|FG002|Overall Study|Other|1|||
23810753|NCT02119819|66687385|FG000|Overall Study|Adverse Event|3|||
23810754|NCT02119819|66687386|FG001|Overall Study|Adverse Event|1|||
23810755|NCT02119819|66687387|FG002|Overall Study|Adverse Event|2|||
23810756|NCT02119819|66687388|FG003|Overall Study|Adverse Event|3|||
23810757|NCT02119819|66687389|FG004|Overall Study|Adverse Event|0|||
23810758|NCT02119819|66687390|FG005|Overall Study|Adverse Event|1|||
23810759|NCT02119819|66687385|FG000|Overall Study|Lack of Efficacy|0|||
23810760|NCT02119819|66687386|FG001|Overall Study|Lack of Efficacy|0|||
23810761|NCT02119819|66687387|FG002|Overall Study|Lack of Efficacy|0|||
23810762|NCT02119819|66687388|FG003|Overall Study|Lack of Efficacy|0|||
23810763|NCT02119819|66687389|FG004|Overall Study|Lack of Efficacy|0|||
23810764|NCT02119819|66687390|FG005|Overall Study|Lack of Efficacy|1|||
23810765|NCT02119819|66687385|FG000|Overall Study|Lost to Follow-up|0|||
23810766|NCT02119819|66687386|FG001|Overall Study|Lost to Follow-up|0|||
23810767|NCT02119819|66687387|FG002|Overall Study|Lost to Follow-up|1|||
23810768|NCT02119819|66687388|FG003|Overall Study|Lost to Follow-up|2|||
23810769|NCT02119819|66687389|FG004|Overall Study|Lost to Follow-up|1|||
23810770|NCT02119819|66687390|FG005|Overall Study|Lost to Follow-up|2|||
23810771|NCT02119819|66687385|FG000|Overall Study|Physician Decision|1|||
23810772|NCT02119819|66687386|FG001|Overall Study|Physician Decision|1|||
23810773|NCT02119819|66687387|FG002|Overall Study|Physician Decision|0|||
23810774|NCT02119819|66687388|FG003|Overall Study|Physician Decision|0|||
23810775|NCT02119819|66687389|FG004|Overall Study|Physician Decision|0|||
23810776|NCT02119819|66687390|FG005|Overall Study|Physician Decision|1|||
23810777|NCT02119819|66687385|FG000|Overall Study|Withdrawal by Subject|5|||
23405319|NCT02948582|65230148|FG002|Washout Period 1|Adverse Event|0|||
23405320|NCT02948582|65230149|FG003|Washout Period 1|Adverse Event|0|||
23405321|NCT02948582|65230150|FG004|Washout Period 1|Adverse Event|0|||
23405322|NCT02948582|65230151|FG005|Washout Period 1|Adverse Event|0|||
23810778|NCT02119819|66687386|FG001|Overall Study|Withdrawal by Subject|3|||
23810779|NCT02119819|66687387|FG002|Overall Study|Withdrawal by Subject|0|||
23810780|NCT02119819|66687388|FG003|Overall Study|Withdrawal by Subject|0|||
23810781|NCT02119819|66687389|FG004|Overall Study|Withdrawal by Subject|6|||
23810782|NCT02119819|66687390|FG005|Overall Study|Withdrawal by Subject|10|||
23405323|NCT02948582|65230146|FG000|Washout Period 1|Protocol Violation|0|||
23810783|NCT02119819|66687385|FG000|Overall Study|Jury Duty|0|||
23810784|NCT02119819|66687386|FG001|Overall Study|Jury Duty|0|||
23810785|NCT02119819|66687387|FG002|Overall Study|Jury Duty|1|||
23810786|NCT02119819|66687388|FG003|Overall Study|Jury Duty|0|||
23810787|NCT02119819|66687389|FG004|Overall Study|Jury Duty|0|||
23810788|NCT02119819|66687390|FG005|Overall Study|Jury Duty|0|||
23810789|NCT02119819|66687385|FG000|Overall Study|Protocol Violation|0|||
23810790|NCT02119819|66687386|FG001|Overall Study|Protocol Violation|0|||
23810791|NCT02119819|66687387|FG002|Overall Study|Protocol Violation|0|||
23810792|NCT02119819|66687388|FG003|Overall Study|Protocol Violation|1|||
23810793|NCT02119819|66687389|FG004|Overall Study|Protocol Violation|0|||
23810794|NCT02119819|66687390|FG005|Overall Study|Protocol Violation|0|||
23810795|NCT02119819|66687385|FG000|Overall Study|Left the city to get a job|0|||
23810796|NCT02119819|66687386|FG001|Overall Study|Left the city to get a job|0|||
23810797|NCT02119819|66687387|FG002|Overall Study|Left the city to get a job|0|||
23810798|NCT02119819|66687388|FG003|Overall Study|Left the city to get a job|1|||
23810799|NCT02119819|66687389|FG004|Overall Study|Left the city to get a job|0|||
23810800|NCT02119819|66687390|FG005|Overall Study|Left the city to get a job|0|||
23810801|NCT01550744|66687391|FG000|Open-Label|Lost to Follow-up|7|||
23810802|NCT01550744|66687392|FG001|Open-Label|Lost to Follow-up|0|||
23810803|NCT01550744|66687393|FG002|Open-Label|Lost to Follow-up|0|||
23810804|NCT01550744|66687391|FG000|Open-Label|Withdrawal by Subject|13|||
23810805|NCT01550744|66687392|FG001|Open-Label|Withdrawal by Subject|0|||
23810806|NCT01550744|66687393|FG002|Open-Label|Withdrawal by Subject|0|||
23810807|NCT01550744|66687391|FG000|Open-Label|Adverse Event|11|||
23810808|NCT01550744|66687392|FG001|Open-Label|Adverse Event|0|||
23810809|NCT01550744|66687393|FG002|Open-Label|Adverse Event|0|||
23810810|NCT01550744|66687391|FG000|Open-Label|Lack of Efficacy|4|||
23810811|NCT01550744|66687392|FG001|Open-Label|Lack of Efficacy|0|||
23810812|NCT01550744|66687393|FG002|Open-Label|Lack of Efficacy|0|||
23405324|NCT02948582|65230147|FG001|Washout Period 1|Protocol Violation|0|||
23405325|NCT02948582|65230148|FG002|Washout Period 1|Protocol Violation|0|||
23405326|NCT02948582|65230149|FG003|Washout Period 1|Protocol Violation|0|||
23405327|NCT02948582|65230150|FG004|Washout Period 1|Protocol Violation|0|||
23505490|NCT00897104|65587963|FG001|Overall Study|Lack of Migraine Attack|22|||
23810813|NCT01550744|66687391|FG000|Open-Label|Protocol Violation|4|||
23405328|NCT02948582|65230151|FG005|Washout Period 1|Protocol Violation|1|||
23405329|NCT02948582|65230146|FG000|Washout Period 2|Adverse Event|0|||
23810814|NCT01550744|66687392|FG001|Open-Label|Protocol Violation|0|||
23810815|NCT01550744|66687393|FG002|Open-Label|Protocol Violation|0|||
23810816|NCT01550744|66687391|FG000|Open-Label|Not all 3 study drug injections received|2|||
23810817|NCT01550744|66687392|FG001|Open-Label|Not all 3 study drug injections received|0|||
23810818|NCT01550744|66687393|FG002|Open-Label|Not all 3 study drug injections received|0|||
23810819|NCT01550744|66687391|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
23810820|NCT01550744|66687392|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
23810821|NCT01550744|66687393|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
23505491|NCT00897104|65587964|FG002|Overall Study|Lack of Migraine Attack|1|||
23505492|NCT00897104|65587962|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23505493|NCT00897104|65587963|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23505494|NCT00897104|65587964|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23505495|NCT00897104|65587962|FG000|Overall Study|Other|3|||
23505496|NCT00897104|65587963|FG001|Overall Study|Other|0|||
23505497|NCT00897104|65587964|FG002|Overall Study|Other|0|||
23505498|NCT00897104|65587962|FG000|Overall Study|Protocol Violation|1|||
23505499|NCT00897104|65587963|FG001|Overall Study|Protocol Violation|0|||
23810822|NCT01550744|66687391|FG000|Open-Label|Other|1|||
23810823|NCT01550744|66687392|FG001|Open-Label|Other|0|||
23810824|NCT01550744|66687393|FG002|Open-Label|Other|0|||
23810825|NCT01550744|66687391|FG000|Double-Blind|Lost to Follow-up|0|||
23810826|NCT01550744|66687392|FG001|Double-Blind|Lost to Follow-up|6|||
23810827|NCT01550744|66687393|FG002|Double-Blind|Lost to Follow-up|12|||
23810828|NCT01550744|66687391|FG000|Double-Blind|Withdrawal by Subject|0|||
23810829|NCT01550744|66687392|FG001|Double-Blind|Withdrawal by Subject|2|||
23810830|NCT01550744|66687393|FG002|Double-Blind|Withdrawal by Subject|15|||
23810831|NCT01550744|66687391|FG000|Double-Blind|Adverse Event|0|||
23810832|NCT01550744|66687392|FG001|Double-Blind|Adverse Event|4|||
23810833|NCT01550744|66687393|FG002|Double-Blind|Adverse Event|15|||
23810834|NCT01550744|66687391|FG000|Double-Blind|Death|0|||
23810835|NCT01550744|66687392|FG001|Double-Blind|Death|1|||
23810836|NCT01550744|66687393|FG002|Double-Blind|Death|0|||
23810837|NCT01550744|66687391|FG000|Double-Blind|Lack of Efficacy|0|||
23505500|NCT00897104|65587964|FG002|Overall Study|Protocol Violation|0|||
23505501|NCT00897104|65587962|FG000|Overall Study|Withdrawal by Subject|0|||
23505502|NCT00897104|65587963|FG001|Overall Study|Withdrawal by Subject|0|||
23505503|NCT00897104|65587964|FG002|Overall Study|Withdrawal by Subject|1|||
23810838|NCT01550744|66687392|FG001|Double-Blind|Lack of Efficacy|2|||
23810839|NCT01550744|66687393|FG002|Double-Blind|Lack of Efficacy|8|||
23810840|NCT01550744|66687391|FG000|Double-Blind|Protocol Violation|0|||
23810841|NCT01550744|66687392|FG001|Double-Blind|Protocol Violation|0|||
23810842|NCT01550744|66687393|FG002|Double-Blind|Protocol Violation|4|||
23810843|NCT01550744|66687391|FG000|Double-Blind|Pregnancy|0|||
23810844|NCT01550744|66687392|FG001|Double-Blind|Pregnancy|0|||
23810845|NCT01550744|66687393|FG002|Double-Blind|Pregnancy|3|||
23810846|NCT01550744|66687391|FG000|Double-Blind|Other|0|||
23810847|NCT01550744|66687392|FG001|Double-Blind|Other|2|||
23810848|NCT01550744|66687393|FG002|Double-Blind|Other|10|||
23810849|NCT00424775|66687396|FG000|Overall Study|Adverse Event|2|||
23810850|NCT00424775|66687397|FG001|Overall Study|Adverse Event|0|||
23810851|NCT00424775|66687396|FG000|Overall Study|Lack of Efficacy|1|||
23405330|NCT02948582|65230147|FG001|Washout Period 2|Adverse Event|1|||
23810852|NCT00424775|66687397|FG001|Overall Study|Lack of Efficacy|0|||
23810853|NCT00895947|66687402|FG000|Overall Study|Adverse Event|3|||
23810854|NCT00895947|66687403|FG001|Overall Study|Adverse Event|4|||
23810855|NCT00895947|66687402|FG000|Overall Study|Lost to Follow-up|3|||
23810856|NCT00895947|66687403|FG001|Overall Study|Lost to Follow-up|4|||
23810857|NCT00895947|66687402|FG000|Overall Study|Protocol Violation|4|||
23810858|NCT00895947|66687403|FG001|Overall Study|Protocol Violation|2|||
23810859|NCT00895947|66687402|FG000|Overall Study|Withdrawal by Subject|2|||
23810860|NCT00895947|66687403|FG001|Overall Study|Withdrawal by Subject|0|||
23810861|NCT02145026|66687404|FG000|Overall Study|Adverse Event|2|||
23505504|NCT02161731|65587965|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
23505505|NCT02161731|65587966|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
23505506|NCT02161731|65587965|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
23810862|NCT02145026|66687404|FG000|Overall Study|Death|4|||
23810863|NCT02145026|66687404|FG000|Overall Study|Withdrawal by Subject|2|||
23810864|NCT02145026|66687404|FG000|Overall Study|Physician Decision|4|||
23810865|NCT01910389|66687413|FG000|Overall Study|Withdrawal by Subject|2|||
23405331|NCT02948582|65230148|FG002|Washout Period 2|Adverse Event|0|||
23405332|NCT02948582|65230149|FG003|Washout Period 2|Adverse Event|0|||
23405333|NCT02948582|65230150|FG004|Washout Period 2|Adverse Event|0|||
23405334|NCT02948582|65230151|FG005|Washout Period 2|Adverse Event|0|||
23405335|NCT02948582|65230146|FG000|Washout Period 2|personal reasons|0|||
23405336|NCT02948582|65230147|FG001|Washout Period 2|personal reasons|0|||
23405337|NCT02948582|65230148|FG002|Washout Period 2|personal reasons|0|||
23405338|NCT02948582|65230149|FG003|Washout Period 2|personal reasons|1|||
23405339|NCT02948582|65230150|FG004|Washout Period 2|personal reasons|0|||
23405340|NCT02948582|65230151|FG005|Washout Period 2|personal reasons|0|||
23405341|NCT02948582|65230146|FG000|Washout Period 4|Adverse Event|1|||
23405342|NCT02948582|65230147|FG001|Washout Period 4|Adverse Event|0|||
23405343|NCT02948582|65230148|FG002|Washout Period 4|Adverse Event|1|||
23405344|NCT02948582|65230149|FG003|Washout Period 4|Adverse Event|0|||
23405345|NCT02948582|65230150|FG004|Washout Period 4|Adverse Event|0|||
23405346|NCT02948582|65230151|FG005|Washout Period 4|Adverse Event|0|||
23405347|NCT00335738|65230152|FG000|Overall Study|Physician Decision|6|||
23405348|NCT00335738|65230153|FG001|Overall Study|Physician Decision|0|||
23405349|NCT00335738|65230152|FG000|Overall Study|Withdrawal by Subject|2|||
23405350|NCT00335738|65230153|FG001|Overall Study|Withdrawal by Subject|0|||
23405351|NCT00335738|65230152|FG000|Overall Study|Ineligible|3|||
23405352|NCT00335738|65230153|FG001|Overall Study|Ineligible|4|||
23405353|NCT02441101|65230155|FG000|Overall Study|Withdrawal by Subject|1|||
23405354|NCT02441101|65230156|FG001|Overall Study|Withdrawal by Subject|0|||
23405355|NCT02441101|65230155|FG000|Overall Study|Lost to Follow-up|1|||
23405356|NCT02441101|65230156|FG001|Overall Study|Lost to Follow-up|0|||
23405357|NCT02441101|65230155|FG000|Overall Study|PI relocated and study terminated|1|||
23405358|NCT02441101|65230156|FG001|Overall Study|PI relocated and study terminated|0|||
23405359|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
23405360|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
23405361|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
23405362|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
23405363|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
23405364|NCT02735421|65230157|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
23405365|NCT02735421|65230157|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
23405366|NCT00427011|65230160|FG000|Overall Study|Adverse Event|10|||
23405367|NCT00427011|65230160|FG000|Overall Study|Withdrawal by Subject|1|||
23405368|NCT00427011|65230160|FG000|Overall Study|Lack of Efficacy|2|||
23405369|NCT00427011|65230160|FG000|Overall Study|Other|12|||
23405370|NCT00803595|65230164|FG000|Overall Study|Adverse Event|3|||
23405371|NCT00803595|65230165|FG001|Overall Study|Adverse Event|4|||
23405372|NCT00803595|65230166|FG002|Overall Study|Adverse Event|1|||
23405373|NCT00803595|65230164|FG000|Overall Study|Protocol Violation|7|||
23405374|NCT00803595|65230165|FG001|Overall Study|Protocol Violation|2|||
23405375|NCT00803595|65230166|FG002|Overall Study|Protocol Violation|12|||
23405376|NCT00803595|65230164|FG000|Overall Study|Withdrawal by Subject|5|||
23405377|NCT00803595|65230165|FG001|Overall Study|Withdrawal by Subject|2|||
23405378|NCT00803595|65230166|FG002|Overall Study|Withdrawal by Subject|3|||
23405379|NCT01534481|65230167|FG000|Overall Study|Lost to Follow-up|29|||
23405380|NCT01534481|65230168|FG001|Overall Study|Lost to Follow-up|24|||
23405381|NCT01534481|65230167|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
23405382|NCT01534481|65230168|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
23405383|NCT00790582|65230169|FG000|Overall Study|Death|14|||
23405384|NCT00790582|65230170|FG001|Overall Study|Death|32|||
23405385|NCT00790582|65230169|FG000|Overall Study|Physician Decision|7|||
23405386|NCT00790582|65230170|FG001|Overall Study|Physician Decision|1|||
23405387|NCT00790582|65230169|FG000|Overall Study|Lost to Follow-up|3|||
23405388|NCT00790582|65230170|FG001|Overall Study|Lost to Follow-up|3|||
23405389|NCT00790582|65230169|FG000|Overall Study|Withdrawal by Subject|7|||
23405390|NCT00790582|65230170|FG001|Overall Study|Withdrawal by Subject|51|||
23405391|NCT01198574|65230174|FG000|Overall Study|Resigned from schools|4|||
23405392|NCT01198574|65230175|FG001|Overall Study|Resigned from schools|1|||
23405393|NCT01198574|65230176|FG002|Overall Study|Resigned from schools|1|||
23405394|NCT01198574|65230177|FG003|Overall Study|Resigned from schools|4|||
23405395|NCT03289533|65230178|FG000|Overall Study|Death|12|||
23405396|NCT03289533|65230178|FG000|Overall Study|Terminated from study by sponsor|10|||
23405397|NCT00661830|65230189|FG000|Overall Study|Death|37|||
23405398|NCT00661830|65230190|FG001|Overall Study|Death|33|||
23405399|NCT00661830|65230189|FG000|Overall Study|Lost to Follow-up|1|||
23405400|NCT00661830|65230190|FG001|Overall Study|Lost to Follow-up|3|||
23405401|NCT00661830|65230189|FG000|Overall Study|Withdrawal by Subject|1|||
23405402|NCT00661830|65230190|FG001|Overall Study|Withdrawal by Subject|1|||
23405403|NCT00661830|65230189|FG000|Overall Study|Other reason|1|||
23405404|NCT00661830|65230190|FG001|Overall Study|Other reason|5|||
23405405|NCT04403919|65230191|FG000|Overall Study|Lost to Follow-up|0|||
23405406|NCT04403919|65230192|FG001|Overall Study|Lost to Follow-up|0|||
23405407|NCT04403919|65230193|FG002|Overall Study|Lost to Follow-up|0|||
23405408|NCT04403919|65230194|FG003|Overall Study|Lost to Follow-up|1|||
23405409|NCT03599518|65230195|FG000|Overall Study|Clinical progression|0|||
23405410|NCT03599518|65230196|FG001|Overall Study|Clinical progression|0|||
23405411|NCT03599518|65230197|FG002|Overall Study|Clinical progression|0|||
23405412|NCT03599518|65230198|FG003|Overall Study|Clinical progression|0|||
23405413|NCT03599518|65230199|FG004|Overall Study|Clinical progression|1|||
23405414|NCT03599518|65230195|FG000|Overall Study|Adverse Event|0|||
23405415|NCT03599518|65230196|FG001|Overall Study|Adverse Event|0|||
23405416|NCT03599518|65230197|FG002|Overall Study|Adverse Event|0|||
23405417|NCT03599518|65230198|FG003|Overall Study|Adverse Event|0|||
23405418|NCT03599518|65230199|FG004|Overall Study|Adverse Event|1|||
23405419|NCT03599518|65230195|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
23405420|NCT03599518|65230196|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
23405421|NCT03599518|65230197|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
23405422|NCT03599518|65230198|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
23405423|NCT03599518|65230199|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
23405424|NCT03599518|65230195|FG000|Overall Study|Participant withdrawal from study treatment|0|||
23405425|NCT03599518|65230196|FG001|Overall Study|Participant withdrawal from study treatment|0|||
23505507|NCT02161731|65587966|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
23505508|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
23505509|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
23505510|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
23505511|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505512|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505513|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505514|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505515|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
23505516|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
23505517|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
23505518|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505519|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505520|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505521|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505522|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
23505523|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505524|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505525|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505526|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505527|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23405426|NCT03599518|65230197|FG002|Overall Study|Participant withdrawal from study treatment|1|||
23405427|NCT03599518|65230198|FG003|Overall Study|Participant withdrawal from study treatment|0|||
23405428|NCT03599518|65230199|FG004|Overall Study|Participant withdrawal from study treatment|0|||
23405429|NCT02477527|65230200|FG000|Overall Study|Lost to Follow-up|2|||
23405430|NCT02477527|65230200|FG000|Overall Study|Withdrawal by Subject|1|||
23405431|NCT02477527|65230200|FG000|Overall Study|Screen Failure|3|||
23405432|NCT00997984|65230201|FG000|Overall Study|Adverse Event|1|||
23405433|NCT00997984|65230202|FG001|Overall Study|Adverse Event|8|||
23405434|NCT00997984|65230203|FG002|Overall Study|Adverse Event|8|||
23505528|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505529|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505530|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505531|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
23505532|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505533|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505534|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505535|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505536|NCT04115839|65587969|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505537|NCT04115839|65587970|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505538|NCT04115839|65587971|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505539|NCT04115839|65587972|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
23505540|NCT04115839|65587973|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
23505541|NCT04115839|65587974|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
23505542|NCT04115839|65587975|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
23505543|NCT04115839|65587969|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505544|NCT04115839|65587970|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505545|NCT04115839|65587971|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505546|NCT04115839|65587972|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
23505547|NCT04115839|65587973|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
23405435|NCT00997984|65230201|FG000|Overall Study|Protocol Violation|1|||
23405436|NCT00997984|65230202|FG001|Overall Study|Protocol Violation|3|||
23505548|NCT04115839|65587974|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505549|NCT04115839|65587975|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505550|NCT03930797|65587976|FG000|Overall Study|Lost to Follow-up|3|||
23505551|NCT03930797|65587977|FG001|Overall Study|Lost to Follow-up|10|||
23505552|NCT01594281|65587978|FG000|Interventional Core Phase|Protocol Deviation|1|||
23505553|NCT01594281|65587979|FG001|Interventional Core Phase|Protocol Deviation|0|||
23505554|NCT01594281|65587980|FG002|Interventional Core Phase|Protocol Deviation|0|||
23505555|NCT01594281|65587978|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
23505556|NCT01594281|65587979|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
23505557|NCT01594281|65587980|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
23505558|NCT01594281|65587978|FG000|Interventional Core Phase|Death|1|||
23505559|NCT01594281|65587979|FG001|Interventional Core Phase|Death|1|||
23505560|NCT01594281|65587980|FG002|Interventional Core Phase|Death|2|||
23505561|NCT01594281|65587978|FG000|Interventional Core Phase|Lost to Follow-up|1|||
23505562|NCT01594281|65587979|FG001|Interventional Core Phase|Lost to Follow-up|4|||
23505563|NCT01594281|65587980|FG002|Interventional Core Phase|Lost to Follow-up|1|||
23505564|NCT01594281|65587978|FG000|Interventional Core Phase|Adverse Event|4|||
23505565|NCT01594281|65587979|FG001|Interventional Core Phase|Adverse Event|4|||
23505566|NCT01594281|65587980|FG002|Interventional Core Phase|Adverse Event|4|||
23505567|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
23810866|NCT01910389|66687414|FG001|Overall Study|Withdrawal by Subject|0|||
23810867|NCT01910389|66687413|FG000|Overall Study|Study Closed|13|||
23505568|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
23505569|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
23505570|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
23505571|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
23505572|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
23505573|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
23405437|NCT00997984|65230203|FG002|Overall Study|Protocol Violation|0|||
23405438|NCT00997984|65230201|FG000|Overall Study|Withdrawal by Subject|6|||
23405439|NCT00997984|65230202|FG001|Overall Study|Withdrawal by Subject|9|||
23405440|NCT00997984|65230203|FG002|Overall Study|Withdrawal by Subject|5|||
23505574|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
23505575|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
23505576|NCT02496611|65587983|FG000|Overall Study|Lost to Follow-up|2|||
23505577|NCT02496611|65587984|FG001|Overall Study|Lost to Follow-up|1|||
23505578|NCT02496611|65587983|FG000|Overall Study|Withdrawal by Subject|5|||
23505579|NCT02496611|65587984|FG001|Overall Study|Withdrawal by Subject|2|||
23505580|NCT00370032|65587985|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
23505581|NCT00370032|65587986|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
23505582|NCT00370032|65587985|FG000|Washout Period|Withdrawal by Subject|0|||
23405441|NCT00997984|65230201|FG000|Overall Study|Lost to Follow-up|8|||
23405442|NCT00997984|65230202|FG001|Overall Study|Lost to Follow-up|5|||
23405443|NCT00997984|65230203|FG002|Overall Study|Lost to Follow-up|4|||
23405444|NCT00997984|65230201|FG000|Overall Study|Lack of Efficacy|20|||
23405445|NCT00997984|65230202|FG001|Overall Study|Lack of Efficacy|6|||
23405446|NCT00997984|65230203|FG002|Overall Study|Lack of Efficacy|3|||
23405447|NCT00997984|65230201|FG000|Overall Study|Met exclusion criteria|1|||
23405448|NCT00997984|65230202|FG001|Overall Study|Met exclusion criteria|0|||
23405449|NCT00997984|65230203|FG002|Overall Study|Met exclusion criteria|0|||
23405450|NCT00997984|65230201|FG000|Overall Study|non-compliance|0|||
23405451|NCT00997984|65230202|FG001|Overall Study|non-compliance|2|||
23405452|NCT00997984|65230203|FG002|Overall Study|non-compliance|3|||
23405453|NCT00997984|65230201|FG000|Overall Study|Wrong medication dispensed|0|||
23405454|NCT00997984|65230202|FG001|Overall Study|Wrong medication dispensed|1|||
23405455|NCT00997984|65230203|FG002|Overall Study|Wrong medication dispensed|0|||
23405456|NCT00997984|65230201|FG000|Overall Study|Suicidal ideation|0|||
23405457|NCT00997984|65230202|FG001|Overall Study|Suicidal ideation|0|||
23405458|NCT00997984|65230203|FG002|Overall Study|Suicidal ideation|1|||
23405459|NCT00997984|65230201|FG000|Overall Study|Work schedule|0|||
23405460|NCT00997984|65230202|FG001|Overall Study|Work schedule|0|||
23405461|NCT00997984|65230203|FG002|Overall Study|Work schedule|2|||
23405462|NCT00326599|65230204|FG000|Overall Study|Withdrawal by Subject|1|||
23405463|NCT00326599|65230205|FG001|Overall Study|Withdrawal by Subject|0|||
23405464|NCT00326599|65230206|FG002|Overall Study|Withdrawal by Subject|5|||
23405465|NCT00326599|65230207|FG003|Overall Study|Withdrawal by Subject|2|||
23405466|NCT00326599|65230204|FG000|Overall Study|Adverse Event|1|||
23405467|NCT00326599|65230205|FG001|Overall Study|Adverse Event|0|||
23505583|NCT00370032|65587986|FG001|Washout Period|Withdrawal by Subject|1|||
23505584|NCT00370032|65587985|FG000|Washout Period|Lost to Follow-up|0|||
23505585|NCT00370032|65587986|FG001|Washout Period|Lost to Follow-up|1|||
23505586|NCT00370032|65587985|FG000|Washout Period|Adverse Event|1|||
23810868|NCT01910389|66687414|FG001|Overall Study|Study Closed|8|||
23405468|NCT00326599|65230206|FG002|Overall Study|Adverse Event|32|||
23505587|NCT00370032|65587986|FG001|Washout Period|Adverse Event|0|||
23810869|NCT00706511|66687415|FG000|Overall Study|Withdrawal by Subject|1|||
23505588|NCT00370032|65587985|FG000|Follow-up Period|Withdrawal by Subject|1|||
23505589|NCT00370032|65587986|FG001|Follow-up Period|Withdrawal by Subject|0|||
23505590|NCT01947582|65587987|FG000|Overall Study|Withdrawal by Subject|1|||
23405469|NCT00326599|65230207|FG003|Overall Study|Adverse Event|3|||
23405470|NCT00326599|65230204|FG000|Overall Study|Disease Progression|3|||
23405471|NCT00326599|65230205|FG001|Overall Study|Disease Progression|1|||
23505591|NCT01806298|65587989|FG000|Overall Study|Adverse Event|3|||
23505592|NCT01806298|65587989|FG000|Overall Study|Protocol Non-compliance|1|||
23505593|NCT01806298|65587989|FG000|Overall Study|Withdrawal by Subject|1|||
23505594|NCT01806298|65587989|FG000|Overall Study|Other|5|||
23505595|NCT05059600|65587990|FG000|Overall Study|Enrolled but not Treated|10|||
23505596|NCT01812174|65587991|FG000|Overall Study|Death|1|||
23810870|NCT00706511|66687416|FG001|Overall Study|Withdrawal by Subject|0|||
23810871|NCT00706511|66687417|FG002|Overall Study|Withdrawal by Subject|0|||
23810872|NCT00706511|66687418|FG003|Overall Study|Withdrawal by Subject|0|||
23810873|NCT02588950|66687419|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
23810874|NCT02588950|66687420|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
23810875|NCT02588950|66687421|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
23810876|NCT02588950|66687422|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
23810877|NCT02588950|66687419|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
23810878|NCT02588950|66687420|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
23810879|NCT02588950|66687421|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
23810880|NCT02588950|66687422|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
23810881|NCT01169532|66687424|FG000|Overall Study|Withdrawal by Subject|1|||
23810882|NCT02731326|66687425|FG000|Overall Study|Withdrawal by Subject|4|||
23810883|NCT02731326|66687426|FG001|Overall Study|Withdrawal by Subject|1|||
23810884|NCT02731326|66687425|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
23810885|NCT02731326|66687426|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
23810886|NCT02731326|66687425|FG000|Overall Study|Discharged without AliveCor|10|||
23810887|NCT02731326|66687426|FG001|Overall Study|Discharged without AliveCor|0|||
23810888|NCT02731326|66687425|FG000|Overall Study|Duplicate Participant|1|||
23810889|NCT02731326|66687426|FG001|Overall Study|Duplicate Participant|1|||
23810890|NCT02440568|66687433|FG000|Overall Study|Death|1|||
23810891|NCT02440568|66687434|FG001|Overall Study|Death|3|||
23810892|NCT02440568|66687435|FG002|Overall Study|Death|4|||
23810893|NCT02440568|66687436|FG003|Overall Study|Death|2|||
23810894|NCT02440568|66687433|FG000|Overall Study|Lack of Efficacy|2|||
23810895|NCT02440568|66687434|FG001|Overall Study|Lack of Efficacy|0|||
23810896|NCT02440568|66687435|FG002|Overall Study|Lack of Efficacy|1|||
23810897|NCT02440568|66687436|FG003|Overall Study|Lack of Efficacy|0|||
23810898|NCT02440568|66687433|FG000|Overall Study|Lost to Follow-up|1|||
23810899|NCT02440568|66687434|FG001|Overall Study|Lost to Follow-up|0|||
23810900|NCT02440568|66687435|FG002|Overall Study|Lost to Follow-up|0|||
23505597|NCT01812174|65587992|FG001|Overall Study|Death|0|||
23505598|NCT01812174|65587991|FG000|Overall Study|Protocol Violation|2|||
23505599|NCT01812174|65587992|FG001|Overall Study|Protocol Violation|0|||
23505600|NCT00630396|65587993|FG000|Overall Study|Death|4|||
23505601|NCT00630396|65587993|FG000|Overall Study|Lost to Follow-up|3|||
23505602|NCT00598832|65587994|FG000|Overall Study|Lack of Efficacy|3|||
23505603|NCT00598832|65587995|FG001|Overall Study|Lack of Efficacy|7|||
23505604|NCT00598832|65587994|FG000|Overall Study|Adverse Event|6|||
23505605|NCT00598832|65587995|FG001|Overall Study|Adverse Event|2|||
23505606|NCT00598832|65587994|FG000|Overall Study|Withdrawal by Subject|25|||
23505607|NCT00598832|65587995|FG001|Overall Study|Withdrawal by Subject|36|||
23505608|NCT00598832|65587994|FG000|Overall Study|Protocol Violation|0|||
23505609|NCT00598832|65587995|FG001|Overall Study|Protocol Violation|2|||
23505610|NCT00598832|65587994|FG000|Overall Study|Lost to Follow-up|24|||
23505611|NCT00598832|65587995|FG001|Overall Study|Lost to Follow-up|29|||
23505612|NCT00598832|65587994|FG000|Overall Study|Pregnancy|2|||
23505613|NCT00598832|65587995|FG001|Overall Study|Pregnancy|2|||
23505614|NCT00598832|65587994|FG000|Overall Study|Physician Decision|1|||
23505615|NCT00598832|65587995|FG001|Overall Study|Physician Decision|4|||
23505616|NCT00598832|65587994|FG000|Overall Study|Non compliance|1|||
23505617|NCT00598832|65587995|FG001|Overall Study|Non compliance|0|||
23505618|NCT04160195|65587998|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
23810901|NCT02440568|66687436|FG003|Overall Study|Lost to Follow-up|0|||
23505619|NCT04160195|65587999|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
23505620|NCT04584645|65588002|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
23505621|NCT04584645|65588003|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
23505622|NCT01496807|65588004|FG000|Overall Study|Progressive Disease|21|||
23505623|NCT01496807|65588004|FG000|Overall Study|Participant preference/toxicity|8|||
23505624|NCT01496807|65588004|FG000|Overall Study|Change in diagnosis|1|||
23810902|NCT02196701|66687446|FG000|Overall Study|Adverse Event|1|||
23810903|NCT02196701|66687446|FG000|Overall Study|Lost to Follow-up|1|||
23505625|NCT00980057|65588007|FG000|Overall Study|Death|13|||
23607069|NCT03678688|65950588|FG007|Overall Study|Withdrawal by Subject|1|||
23505626|NCT00980057|65588008|FG001|Overall Study|Death|3|||
23505627|NCT00980057|65588007|FG000|Overall Study|Adverse Event|0|||
23505628|NCT00980057|65588008|FG001|Overall Study|Adverse Event|1|||
23505629|NCT00980057|65588007|FG000|Overall Study|Physician Decision|4|||
23505630|NCT00980057|65588008|FG001|Overall Study|Physician Decision|0|||
23505631|NCT00980057|65588007|FG000|Overall Study|Lost to Follow-up|1|||
23505632|NCT00980057|65588008|FG001|Overall Study|Lost to Follow-up|0|||
23505633|NCT00980057|65588007|FG000|Overall Study|Withdrawal by Subject|1|||
23505634|NCT00980057|65588008|FG001|Overall Study|Withdrawal by Subject|1|||
23505635|NCT02966028|65588009|FG000|Overall Study|Adverse Event|7|||
23505636|NCT02966028|65588010|FG001|Overall Study|Adverse Event|13|||
23505637|NCT02966028|65588011|FG002|Overall Study|Adverse Event|10|||
23505638|NCT02966028|65588009|FG000|Overall Study|Physician Decision|1|||
23505639|NCT02966028|65588010|FG001|Overall Study|Physician Decision|0|||
23607070|NCT03678688|65950589|FG008|Overall Study|Withdrawal by Subject|0|||
23607071|NCT03150589|65950590|FG000|Overall Study|Withdrawal by Subject|16|||
23607072|NCT03150589|65950591|FG001|Overall Study|Withdrawal by Subject|9|||
23607073|NCT03150589|65950590|FG000|Overall Study|Adverse Event|7|||
23607074|NCT03150589|65950591|FG001|Overall Study|Adverse Event|6|||
23607075|NCT03150589|65950590|FG000|Overall Study|Protocol Violation|4|||
23607076|NCT03150589|65950591|FG001|Overall Study|Protocol Violation|3|||
23607077|NCT03150589|65950590|FG000|Overall Study|Lost to Follow-up|3|||
23607078|NCT03150589|65950591|FG001|Overall Study|Lost to Follow-up|3|||
23607079|NCT03150589|65950590|FG000|Overall Study|Death|2|||
23607080|NCT03150589|65950591|FG001|Overall Study|Death|3|||
23607081|NCT03150589|65950590|FG000|Overall Study|IP non-compliance and other reasons|12|||
23607082|NCT03150589|65950591|FG001|Overall Study|IP non-compliance and other reasons|3|||
23607083|NCT00603798|65950595|FG000|Overall Study|Adverse Event|4|||
23607084|NCT00603798|65950596|FG001|Overall Study|Adverse Event|2|||
23607085|NCT00603798|65950597|FG002|Overall Study|Adverse Event|1|||
23607086|NCT00603798|65950595|FG000|Overall Study|Withdrawal by Subject|4|||
23607087|NCT00603798|65950596|FG001|Overall Study|Withdrawal by Subject|3|||
23607088|NCT00603798|65950597|FG002|Overall Study|Withdrawal by Subject|4|||
23607089|NCT00603798|65950595|FG000|Overall Study|Lost to Follow-up|1|||
23607090|NCT00603798|65950596|FG001|Overall Study|Lost to Follow-up|0|||
23607091|NCT00603798|65950597|FG002|Overall Study|Lost to Follow-up|1|||
23607092|NCT00603798|65950595|FG000|Overall Study|Non-compliance with study procedures|0|||
23607093|NCT00603798|65950596|FG001|Overall Study|Non-compliance with study procedures|1|||
23607094|NCT00603798|65950597|FG002|Overall Study|Non-compliance with study procedures|0|||
23607095|NCT00603798|65950595|FG000|Overall Study|Not due to AE|1|||
23607096|NCT00603798|65950596|FG001|Overall Study|Not due to AE|1|||
23607097|NCT00603798|65950597|FG002|Overall Study|Not due to AE|4|||
23607098|NCT01248715|65950598|FG000|Overall Study|Not influenza positive|501|||
23607099|NCT01248715|65950599|FG001|Overall Study|Not influenza positive|510|||
23607100|NCT00658632|65950600|FG000|Overall Study|Adverse Event|13|||
23607101|NCT00658632|65950601|FG001|Overall Study|Adverse Event|11|||
23607102|NCT00658632|65950600|FG000|Overall Study|Lost to Follow-up|25|||
23607103|NCT00658632|65950601|FG001|Overall Study|Lost to Follow-up|23|||
23607104|NCT00658632|65950600|FG000|Overall Study|Withdrawal by Subject|10|||
23607105|NCT00658632|65950601|FG001|Overall Study|Withdrawal by Subject|7|||
23607106|NCT00658632|65950600|FG000|Overall Study|Lack of Efficacy|0|||
23607107|NCT00658632|65950601|FG001|Overall Study|Lack of Efficacy|1|||
23607108|NCT00658632|65950600|FG000|Overall Study|Withdrawal of consent|8|||
23607109|NCT00658632|65950601|FG001|Overall Study|Withdrawal of consent|14|||
23607110|NCT00658632|65950600|FG000|Overall Study|Pregnancy|1|||
23810904|NCT02196701|66687446|FG000|Overall Study|Non-adherence to Protocol|1|||
23810905|NCT02828241|66687452|FG000|Overall Study|Adverse Event|7|||
23810906|NCT02828241|66687453|FG001|Overall Study|Adverse Event|2|||
23810907|NCT02828241|66687452|FG000|Overall Study|Protocol Violation|1|||
23810908|NCT02828241|66687453|FG001|Overall Study|Protocol Violation|0|||
23810909|NCT01959035|66687454|FG000|Overall Study|Adverse Event|5|||
23607111|NCT00658632|65950601|FG001|Overall Study|Pregnancy|1|||
23607112|NCT00658632|65950600|FG000|Overall Study|Other|7|||
23607113|NCT00658632|65950601|FG001|Overall Study|Other|8|||
23607114|NCT00990314|65950602|FG000|Overall Study|Death|2|||
23607115|NCT00990314|65950602|FG000|Overall Study|Adverse Event|2|||
23607116|NCT00990314|65950602|FG000|Overall Study|Withdrawal by Subject|3|||
23607117|NCT00990314|65950602|FG000|Overall Study|Non-Compliance|1|||
23607118|NCT00990314|65950602|FG000|Overall Study|Physician Decision|3|||
23607119|NCT00990314|65950602|FG000|Overall Study|Lack of Efficacy|1|||
23607120|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
23810910|NCT01959035|66687454|FG000|Overall Study|Withdrawal by Subject|4|||
23505640|NCT02966028|65588011|FG002|Overall Study|Physician Decision|2|||
23607121|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
23607122|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
23607123|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
23810911|NCT01959035|66687454|FG000|Overall Study|Lost to Follow-up|1|||
23810912|NCT01959035|66687454|FG000|Overall Study|Other (no primary reason given)|1|||
23810913|NCT01831765|66687455|FG000|Overall Study|Lack of Efficacy|1|||
23810914|NCT01831765|66687456|FG001|Overall Study|Lack of Efficacy|0|||
23810915|NCT01831765|66687457|FG002|Overall Study|Lack of Efficacy|0|||
23607124|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
23607125|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
23607126|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
23607127|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
23607128|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23607129|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23607130|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
23607131|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
23607132|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
23607133|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
23607134|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
23607135|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
23607136|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
23607137|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
23607138|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
23607139|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
23810916|NCT01831765|66687455|FG000|Overall Study|Other, sponsor withdrew subject|0|||
23810917|NCT01831765|66687456|FG001|Overall Study|Other, sponsor withdrew subject|1|||
23810918|NCT01831765|66687457|FG002|Overall Study|Other, sponsor withdrew subject|0|||
23810919|NCT01831765|66687455|FG000|Overall Study|Pregnancy|1|||
23810920|NCT01831765|66687456|FG001|Overall Study|Pregnancy|1|||
23810921|NCT01831765|66687457|FG002|Overall Study|Pregnancy|2|||
23810922|NCT01831765|66687455|FG000|Overall Study|Death|0|||
23810923|NCT01831765|66687456|FG001|Overall Study|Death|1|||
23810924|NCT01831765|66687457|FG002|Overall Study|Death|1|||
23810925|NCT01831765|66687455|FG000|Overall Study|Other, site closed|1|||
23810926|NCT01831765|66687456|FG001|Overall Study|Other, site closed|1|||
23810927|NCT01831765|66687457|FG002|Overall Study|Other, site closed|0|||
23810928|NCT01831765|66687455|FG000|Overall Study|Adverse Event|5|||
23810929|NCT01831765|66687456|FG001|Overall Study|Adverse Event|3|||
23810930|NCT01831765|66687457|FG002|Overall Study|Adverse Event|3|||
23810931|NCT01831765|66687455|FG000|Overall Study|Withdrawal by Subject|22|||
23810932|NCT01831765|66687456|FG001|Overall Study|Withdrawal by Subject|7|||
23810933|NCT01831765|66687457|FG002|Overall Study|Withdrawal by Subject|17|||
23810934|NCT01831765|66687455|FG000|Overall Study|Withdrawal criteria|12|||
23810935|NCT01831765|66687456|FG001|Overall Study|Withdrawal criteria|10|||
23810936|NCT01831765|66687457|FG002|Overall Study|Withdrawal criteria|16|||
23810937|NCT01831765|66687455|FG000|Overall Study|Lost to Follow-up|2|||
23810938|NCT01831765|66687456|FG001|Overall Study|Lost to Follow-up|3|||
23810939|NCT01831765|66687457|FG002|Overall Study|Lost to Follow-up|3|||
23810940|NCT04730349|66687461|FG000|Overall Study|Participant withdrew consent|1|||
23810941|NCT04730349|66687462|FG001|Overall Study|Participant withdrew consent|0|||
23810942|NCT04730349|66687461|FG000|Overall Study|Disease progression|6|||
23810943|NCT04730349|66687462|FG001|Overall Study|Disease progression|4|||
23810944|NCT04730349|66687461|FG000|Overall Study|Study drug toxicity|0|||
23810945|NCT04730349|66687462|FG001|Overall Study|Study drug toxicity|1|||
23607140|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
23607141|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
23607142|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
23607143|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
23607144|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
23607145|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
23607146|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
23607147|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
23607148|NCT02009332|65950605|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23810946|NCT00977379|66687465|FG000|Overall Study|Withdrawal by Subject|1|||
23810947|NCT00977379|66687466|FG001|Overall Study|Withdrawal by Subject|1|||
23810948|NCT00977379|66687465|FG000|Overall Study|Death|7|||
23810949|NCT00977379|66687466|FG001|Overall Study|Death|9|||
23810950|NCT00977379|66687465|FG000|Overall Study|Premature Study Termination|4|||
23810951|NCT00977379|66687466|FG001|Overall Study|Premature Study Termination|0|||
23810952|NCT00977379|66687465|FG000|Overall Study|Participant Moving House|0|||
23810953|NCT00977379|66687466|FG001|Overall Study|Participant Moving House|1|||
23810954|NCT00977379|66687465|FG000|Overall Study|Randomization Error|0|||
23810955|NCT00977379|66687466|FG001|Overall Study|Randomization Error|1|||
23810956|NCT02351960|66687467|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
23810957|NCT02351960|66687468|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23810958|NCT02351960|66687467|FG000|Overall Study|Voluntary Withdrawal|5|||
23810959|NCT02351960|66687468|FG001|Overall Study|Voluntary Withdrawal|4|||
23607149|NCT02009332|65950606|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
23607150|NCT02009332|65950607|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607151|NCT02009332|65950608|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607152|NCT02009332|65950609|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607153|NCT02009332|65950610|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607154|NCT02009332|65950605|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607155|NCT02009332|65950606|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607156|NCT02009332|65950607|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607157|NCT02009332|65950608|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607158|NCT02009332|65950609|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
23607159|NCT02009332|65950610|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607160|NCT02009332|65950605|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607161|NCT02009332|65950606|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607162|NCT02009332|65950607|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607163|NCT02009332|65950608|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607164|NCT02009332|65950609|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607165|NCT02009332|65950610|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
23607166|NCT00508144|65950611|FG000|Overall Study|Not eligible|6|||
23607167|NCT00508144|65950611|FG000|Overall Study|Death|5|||
23607168|NCT00388726|65950612|FG000|Overall Study|Adverse Event|50|||
23607169|NCT00388726|65950613|FG001|Overall Study|Adverse Event|24|||
23607170|NCT00388726|65950612|FG000|Overall Study|Progressive Disease|336|||
23607171|NCT00388726|65950613|FG001|Overall Study|Progressive Disease|153|||
23607172|NCT00388726|65950612|FG000|Overall Study|Clinical Progression|61|||
23607173|NCT00388726|65950613|FG001|Overall Study|Clinical Progression|36|||
23607174|NCT00388726|65950612|FG000|Overall Study|Withdrawal by Subject|10|||
23607175|NCT00388726|65950613|FG001|Overall Study|Withdrawal by Subject|7|||
23607176|NCT00388726|65950612|FG000|Overall Study|Administrative|6|||
23607177|NCT00388726|65950613|FG001|Overall Study|Administrative|9|||
23607178|NCT00388726|65950612|FG000|Overall Study|Physician Decision|18|||
23607179|NCT00388726|65950613|FG001|Overall Study|Physician Decision|13|||
23607180|NCT00388726|65950612|FG000|Overall Study|Death|3|||
23607181|NCT00388726|65950613|FG001|Overall Study|Death|2|||
23607182|NCT02584257|65950616|FG000|Period 1|Withdrawal by Subject|0|||
23810960|NCT02351960|66687467|FG000|Overall Study|Significant Protocol Deviation|0|||
23810961|NCT02351960|66687468|FG001|Overall Study|Significant Protocol Deviation|5|||
23810962|NCT04234984|66687469|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
23810963|NCT04234984|66687469|FG000|Follow-up at the Second Time Point|Death|1|||
23810964|NCT04234984|66687469|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
23810965|NCT00536263|66687470|FG000|Overall Study|Adverse Event|5|||
23810966|NCT00536263|66687471|FG001|Overall Study|Adverse Event|5|||
23810967|NCT00536263|66687472|FG002|Overall Study|Adverse Event|7|||
23810968|NCT00536263|66687470|FG000|Overall Study|Lost to Follow-up|3|||
23810969|NCT00536263|66687471|FG001|Overall Study|Lost to Follow-up|4|||
23810970|NCT00536263|66687472|FG002|Overall Study|Lost to Follow-up|4|||
23810971|NCT00536263|66687470|FG000|Overall Study|Subject withdrew - not treatment related|2|||
23810972|NCT00536263|66687471|FG001|Overall Study|Subject withdrew - not treatment related|0|||
23810973|NCT00536263|66687472|FG002|Overall Study|Subject withdrew - not treatment related|5|||
23810974|NCT00536263|66687470|FG000|Overall Study|Subject withdrew - treatment related|0|||
23810975|NCT00536263|66687471|FG001|Overall Study|Subject withdrew - treatment related|3|||
23810976|NCT00536263|66687472|FG002|Overall Study|Subject withdrew - treatment related|2|||
23607183|NCT02584257|65950617|FG001|Period 1|Withdrawal by Subject|0|||
23810977|NCT00536263|66687470|FG000|Overall Study|Noncompliance with protocol|0|||
23810978|NCT00536263|66687471|FG001|Overall Study|Noncompliance with protocol|0|||
23810979|NCT00536263|66687472|FG002|Overall Study|Noncompliance with protocol|1|||
23810980|NCT00536263|66687470|FG000|Overall Study|Did not meet protocol eligibility|1|||
23810981|NCT00536263|66687471|FG001|Overall Study|Did not meet protocol eligibility|2|||
23810982|NCT00536263|66687472|FG002|Overall Study|Did not meet protocol eligibility|2|||
23810983|NCT04112173|66687473|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
23810984|NCT03050060|66687474|FG000|Overall Study|Adverse Event|7|||
23810985|NCT03050060|66687474|FG000|Overall Study|Withdrawal by Subject|1|||
23810986|NCT03050060|66687474|FG000|Overall Study|Progression|7|||
23810987|NCT02408068|66687475|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
23810988|NCT02408068|66687476|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
23405472|NCT00326599|65230206|FG002|Overall Study|Disease Progression|13|||
23505641|NCT02966028|65588009|FG000|Overall Study|Withdrawal by Subject|7|||
23505642|NCT02966028|65588010|FG001|Overall Study|Withdrawal by Subject|5|||
23505643|NCT02966028|65588011|FG002|Overall Study|Withdrawal by Subject|5|||
23505644|NCT02966028|65588009|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
23607184|NCT02584257|65950618|FG002|Period 1|Withdrawal by Subject|0|||
23607185|NCT02584257|65950619|FG003|Period 1|Withdrawal by Subject|0|||
23607186|NCT02584257|65950620|FG004|Period 1|Withdrawal by Subject|0|||
23607187|NCT02584257|65950621|FG005|Period 1|Withdrawal by Subject|0|||
23810989|NCT02408068|66687477|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
23810990|NCT02408068|66687478|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
23810991|NCT02408068|66687479|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
23810992|NCT02408068|66687480|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
23810993|NCT00861198|66687483|FG000|Overall Study|SpyGlass Failed|5|||
23810994|NCT00616941|66687484|FG000|Overall Study|Progressive Disease|1|||
23505645|NCT02966028|65588010|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
23505646|NCT02966028|65588011|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
23505647|NCT00907777|65588019|FG000|Overall Study|Withdrawal by Subject|0|||
23505648|NCT00907777|65588020|FG001|Overall Study|Withdrawal by Subject|1|||
23505649|NCT01425281|65588021|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
23607188|NCT02584257|65950622|FG006|Period 1|Withdrawal by Subject|1|||
23810995|NCT00616941|66687485|FG001|Overall Study|Progressive Disease|2|||
23810996|NCT00616941|66687486|FG002|Overall Study|Progressive Disease|1|||
23810997|NCT00616941|66687484|FG000|Overall Study|Adverse Event|0|||
23810998|NCT00616941|66687485|FG001|Overall Study|Adverse Event|1|||
23810999|NCT00616941|66687486|FG002|Overall Study|Adverse Event|1|||
23811000|NCT00616941|66687484|FG000|Overall Study|Subject Non-compliance|0|||
23811001|NCT00616941|66687485|FG001|Overall Study|Subject Non-compliance|0|||
23811002|NCT00616941|66687486|FG002|Overall Study|Subject Non-compliance|1|||
23811003|NCT00616941|66687484|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
23811004|NCT00616941|66687485|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
23811005|NCT00616941|66687486|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
23811006|NCT00616941|66687484|FG000|Overall Study|Vaccination Suspended|0|||
23811007|NCT00616941|66687485|FG001|Overall Study|Vaccination Suspended|0|||
23811008|NCT00616941|66687486|FG002|Overall Study|Vaccination Suspended|3|||
23811009|NCT01183221|66687487|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
23811010|NCT01183221|66687488|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
23811011|NCT00548093|66687489|FG000|Overall Study|Death|33|||
23811012|NCT00548093|66687490|FG001|Overall Study|Death|13|||
23811013|NCT00548093|66687489|FG000|Overall Study|Lost to Follow-up|3|||
23811014|NCT00548093|66687490|FG001|Overall Study|Lost to Follow-up|1|||
23811015|NCT00548093|66687489|FG000|Overall Study|Objective progression or relapse|1|||
23811016|NCT00548093|66687490|FG001|Overall Study|Objective progression or relapse|1|||
23811017|NCT00548093|66687489|FG000|Overall Study|Other|11|||
23811018|NCT00548093|66687490|FG001|Overall Study|Other|1|||
23811019|NCT00548093|66687489|FG000|Overall Study|Withdrawal by Subject|1|||
23811020|NCT00548093|66687490|FG001|Overall Study|Withdrawal by Subject|0|||
23811021|NCT00548093|66687489|FG000|Overall Study|Completed post-treatment follow-up|1|||
23811022|NCT00548093|66687490|FG001|Overall Study|Completed post-treatment follow-up|0|||
23811023|NCT02032706|66687496|FG000|Overall Study|Did not qualify|5|||
23811024|NCT02032706|66687496|FG000|Overall Study|Protocol Violation|1|||
23811025|NCT00584844|66687497|FG000|Overall Study|Withdrawal by Subject|59|||
23811026|NCT00584844|66687497|FG000|Overall Study|Screen Failure|20|||
23811027|NCT00599521|66687498|FG000|Overall Study|Lack of Efficacy|4|||
23811028|NCT00599521|66687499|FG001|Overall Study|Lack of Efficacy|8|||
23811029|NCT00599521|66687498|FG000|Overall Study|Adverse Event|4|||
23811030|NCT00599521|66687499|FG001|Overall Study|Adverse Event|1|||
23811031|NCT00599521|66687498|FG000|Overall Study|Withdrawal by Subject|28|||
23811032|NCT00599521|66687499|FG001|Overall Study|Withdrawal by Subject|34|||
23811033|NCT00599521|66687498|FG000|Overall Study|Protocol Violation|1|||
23811034|NCT00599521|66687499|FG001|Overall Study|Protocol Violation|1|||
23811035|NCT00599521|66687498|FG000|Overall Study|Lost to Follow-up|23|||
23811036|NCT00599521|66687499|FG001|Overall Study|Lost to Follow-up|23|||
23811037|NCT00599521|66687498|FG000|Overall Study|Pregnancy|0|||
23811038|NCT00599521|66687499|FG001|Overall Study|Pregnancy|2|||
23811039|NCT02394730|66687502|FG000|Overall Study|Lost to Follow-up|1|||
23811040|NCT02394730|66687503|FG001|Overall Study|Lost to Follow-up|0|||
23811041|NCT02394730|66687502|FG000|Overall Study|Withdrawal by Subject|0|||
23811042|NCT02394730|66687503|FG001|Overall Study|Withdrawal by Subject|1|||
23811043|NCT00714493|66687504|FG000|Overall Study|Adverse Event|11|||
23811044|NCT00714493|66687504|FG000|Overall Study|Death|3|||
23811045|NCT00714493|66687504|FG000|Overall Study|Lack of Efficacy|10|||
23811046|NCT00714493|66687504|FG000|Overall Study|Lost to Follow-up|3|||
23811047|NCT00714493|66687504|FG000|Overall Study|Protocol Violation|12|||
23607189|NCT02584257|65950623|FG007|Period 1|Withdrawal by Subject|0|||
23811048|NCT00714493|66687504|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
23811049|NCT00714493|66687504|FG000|Overall Study|OTHER|2|||
23811050|NCT00757848|66687505|FG000|Overall Study|Voluntary discontinuation|1|||
23811051|NCT00757848|66687506|FG001|Overall Study|Voluntary discontinuation|0|||
23811052|NCT00757848|66687505|FG000|Overall Study|Adverse Event|1|||
23811053|NCT00757848|66687506|FG001|Overall Study|Adverse Event|2|||
23811054|NCT00757848|66687505|FG000|Overall Study|Incorrect enrolment|1|||
23811055|NCT00757848|66687506|FG001|Overall Study|Incorrect enrolment|0|||
23811056|NCT01629966|66687507|FG000|Overall Study|Pregnancy|0|||
23811057|NCT01629966|66687508|FG001|Overall Study|Pregnancy|1|||
23811058|NCT01629966|66687509|FG002|Overall Study|Pregnancy|0|||
23811059|NCT01629966|66687507|FG000|Overall Study|Lost to Follow-up|10|||
23811060|NCT01629966|66687508|FG001|Overall Study|Lost to Follow-up|13|||
23811061|NCT01629966|66687509|FG002|Overall Study|Lost to Follow-up|9|||
23811062|NCT01629966|66687507|FG000|Overall Study|Withdrawal by Subject|8|||
23811063|NCT01629966|66687508|FG001|Overall Study|Withdrawal by Subject|9|||
23811064|NCT01629966|66687509|FG002|Overall Study|Withdrawal by Subject|16|||
23811065|NCT01629966|66687507|FG000|Overall Study|Protocol Violation|7|||
23811066|NCT01629966|66687508|FG001|Overall Study|Protocol Violation|9|||
23811067|NCT01629966|66687509|FG002|Overall Study|Protocol Violation|7|||
23811068|NCT01629966|66687507|FG000|Overall Study|Lack of Efficacy|5|||
23811069|NCT01629966|66687508|FG001|Overall Study|Lack of Efficacy|2|||
23811070|NCT01629966|66687509|FG002|Overall Study|Lack of Efficacy|4|||
23811071|NCT01629966|66687507|FG000|Overall Study|Adverse Event|11|||
23811072|NCT01629966|66687508|FG001|Overall Study|Adverse Event|18|||
23811073|NCT01629966|66687509|FG002|Overall Study|Adverse Event|30|||
23811074|NCT00725205|66687510|FG000|Overall Study|Adverse Event|22|||
23811075|NCT00725205|66687510|FG000|Overall Study|Investigator Discontinued|1|||
23811076|NCT00725205|66687510|FG000|Overall Study|Non-compliance With Protocol|14|||
23607190|NCT02584257|65950624|FG008|Period 1|Withdrawal by Subject|0|||
23607191|NCT02584257|65950616|FG000|Period 2|Physician Decision|1|||
23505650|NCT01425281|65588022|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
23505651|NCT01425281|65588021|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
23505652|NCT01425281|65588022|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
23811077|NCT00725205|66687510|FG000|Overall Study|Other|8|||
23811078|NCT00725205|66687510|FG000|Overall Study|Protocol Defined Clinical Event|1|||
23505653|NCT01425281|65588021|FG000|At 180-day Clinical Follow-up|Death|0|||
23505654|NCT01425281|65588022|FG001|At 180-day Clinical Follow-up|Death|1|||
23505655|NCT01425281|65588021|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
23505656|NCT01425281|65588022|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
23505657|NCT01425281|65588021|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
23505658|NCT01425281|65588022|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
23505659|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
23505660|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
23505661|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Death|2|||
23505662|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Death|0|||
23505663|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
23505664|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
23505665|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
23505666|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
23505667|NCT01425281|65588021|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
23505668|NCT01425281|65588022|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
23505669|NCT01425281|65588021|FG000|At 3-year Clinical Follow-up|Death|2|||
23505670|NCT01425281|65588022|FG001|At 3-year Clinical Follow-up|Death|3|||
23505671|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Death|7|||
23505672|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Death|3|||
23505673|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
23505674|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
23505675|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
23505676|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
23505677|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
23505678|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
23505679|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
23505680|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
23505681|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Death|2|||
23505682|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Death|0|||
23505683|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
23505684|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
23505685|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
23505686|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
23505687|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
23505688|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
23607192|NCT02584257|65950617|FG001|Period 2|Physician Decision|0|||
23607193|NCT02584257|65950618|FG002|Period 2|Physician Decision|0|||
23811079|NCT00725205|66687510|FG000|Overall Study|Treatment Failure|41|||
23811080|NCT03623386|66687512|FG000|Overall Study|Protocol Violation|3|||
23811081|NCT03623386|66687513|FG001|Overall Study|Protocol Violation|2|||
23811082|NCT03623386|66687514|FG002|Overall Study|Protocol Violation|0|||
23607194|NCT02584257|65950619|FG003|Period 2|Physician Decision|0|||
23811083|NCT03623386|66687512|FG000|Overall Study|Physician Decision|1|||
23811084|NCT03623386|66687513|FG001|Overall Study|Physician Decision|1|||
23811085|NCT03623386|66687514|FG002|Overall Study|Physician Decision|0|||
23505689|NCT00612040|65588025|FG000|Overall Study|Adverse Event|0|||
23811086|NCT03623386|66687512|FG000|Overall Study|Lost to Follow-up|0|||
23607195|NCT02584257|65950620|FG004|Period 2|Physician Decision|0|||
23607196|NCT02584257|65950621|FG005|Period 2|Physician Decision|0|||
23607197|NCT02584257|65950622|FG006|Period 2|Physician Decision|0|||
23607198|NCT02584257|65950623|FG007|Period 2|Physician Decision|0|||
23811087|NCT03623386|66687513|FG001|Overall Study|Lost to Follow-up|2|||
23811088|NCT03623386|66687514|FG002|Overall Study|Lost to Follow-up|0|||
23811089|NCT03623386|66687512|FG000|Overall Study|COVID-19|0|||
23811090|NCT03623386|66687513|FG001|Overall Study|COVID-19|1|||
23811091|NCT03623386|66687514|FG002|Overall Study|COVID-19|0|||
23811092|NCT02924727|66687515|FG000|Overall Study|Withdrawal by Subject|2|||
23811093|NCT02924727|66687516|FG001|Overall Study|Withdrawal by Subject|4|||
23811094|NCT02924727|66687515|FG000|Overall Study|Lost to Follow-up|2|||
23811095|NCT02924727|66687516|FG001|Overall Study|Lost to Follow-up|5|||
23811096|NCT02924727|66687515|FG000|Overall Study|Death|221|||
23811097|NCT02924727|66687516|FG001|Overall Study|Death|247|||
23811098|NCT02924727|66687515|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
23811099|NCT02924727|66687516|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
23811100|NCT00816361|66687521|FG000|Overall Study|Withdrawal by Subject|0|||
23811101|NCT00816361|66687522|FG001|Overall Study|Withdrawal by Subject|0|||
23811102|NCT00816361|66687523|FG002|Overall Study|Withdrawal by Subject|0|||
23811103|NCT00816361|66687524|FG003|Overall Study|Withdrawal by Subject|0|||
23811104|NCT00816361|66687525|FG004|Overall Study|Withdrawal by Subject|1|||
23811105|NCT00816361|66687526|FG005|Overall Study|Withdrawal by Subject|2|||
23811106|NCT00816361|66687527|FG006|Overall Study|Withdrawal by Subject|0|||
23811107|NCT00816361|66687528|FG007|Overall Study|Withdrawal by Subject|2|||
23811108|NCT00816361|66687529|FG008|Overall Study|Withdrawal by Subject|1|||
23811109|NCT00816361|66687521|FG000|Overall Study|Death|4|||
23811110|NCT00816361|66687522|FG001|Overall Study|Death|3|||
23811111|NCT00816361|66687523|FG002|Overall Study|Death|3|||
23811112|NCT00816361|66687524|FG003|Overall Study|Death|3|||
23811113|NCT00816361|66687525|FG004|Overall Study|Death|1|||
23811114|NCT00816361|66687526|FG005|Overall Study|Death|1|||
23811115|NCT00816361|66687527|FG006|Overall Study|Death|3|||
23811116|NCT00816361|66687528|FG007|Overall Study|Death|7|||
23811117|NCT00816361|66687529|FG008|Overall Study|Death|8|||
23811118|NCT00816361|66687521|FG000|Overall Study|Other|0|||
23811119|NCT00816361|66687522|FG001|Overall Study|Other|0|||
23811120|NCT00816361|66687523|FG002|Overall Study|Other|0|||
23811121|NCT00816361|66687524|FG003|Overall Study|Other|0|||
23811122|NCT00816361|66687525|FG004|Overall Study|Other|0|||
23811123|NCT00816361|66687526|FG005|Overall Study|Other|0|||
23811124|NCT00816361|66687527|FG006|Overall Study|Other|0|||
23811125|NCT00816361|66687528|FG007|Overall Study|Other|0|||
23811126|NCT00816361|66687529|FG008|Overall Study|Other|1|||
23811127|NCT01680497|66687532|FG000|Overall Study|Lost to Follow-up|2|||
23811128|NCT00706095|66687533|FG000|Overall Study|Progressive Disease|4|||
23811129|NCT00706095|66687534|FG001|Overall Study|Progressive Disease|5|||
23811130|NCT00706095|66687535|FG002|Overall Study|Progressive Disease|3|||
23811131|NCT00706095|66687533|FG000|Overall Study|Clinical Progression|1|||
23811132|NCT00706095|66687534|FG001|Overall Study|Clinical Progression|2|||
23811133|NCT00706095|66687535|FG002|Overall Study|Clinical Progression|2|||
23811134|NCT00706095|66687533|FG000|Overall Study|Withdrawal by Subject|1|||
23811135|NCT00706095|66687534|FG001|Overall Study|Withdrawal by Subject|0|||
23811136|NCT00706095|66687535|FG002|Overall Study|Withdrawal by Subject|0|||
23811137|NCT00960115|66687536|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
23811138|NCT00960115|66687537|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
23811139|NCT00114166|66687540|FG000|Overall Study|Wrong primary|0|||
23811140|NCT00114166|66687541|FG001|Overall Study|Wrong primary|1|||
23607199|NCT02584257|65950624|FG008|Period 2|Physician Decision|0|||
23607200|NCT02584257|65950616|FG000|Period 2|Adverse Event|0|||
23607201|NCT02584257|65950617|FG001|Period 2|Adverse Event|1|||
23607202|NCT02584257|65950618|FG002|Period 2|Adverse Event|0|||
23607203|NCT02584257|65950619|FG003|Period 2|Adverse Event|0|||
23607204|NCT02584257|65950620|FG004|Period 2|Adverse Event|0|||
23607205|NCT02584257|65950621|FG005|Period 2|Adverse Event|0|||
23607206|NCT02584257|65950622|FG006|Period 2|Adverse Event|0|||
23607207|NCT02584257|65950623|FG007|Period 2|Adverse Event|0|||
23811141|NCT04421586|66687547|FG000|Overall Study|Death|0|||
23811142|NCT04421586|66687548|FG001|Overall Study|Death|1|||
23811143|NCT04421586|66687547|FG000|Overall Study|Lost to Follow-up|2|||
23811144|NCT04421586|66687548|FG001|Overall Study|Lost to Follow-up|2|||
23811145|NCT04421586|66687547|FG000|Overall Study|Withdrawn by PI|1|||
23811146|NCT04421586|66687548|FG001|Overall Study|Withdrawn by PI|0|||
23811147|NCT04421586|66687547|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
23811148|NCT04421586|66687548|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
23811149|NCT02669940|66687549|FG000|Overall Study|Failure to return|0|||
23811150|NCT02669940|66687550|FG001|Overall Study|Failure to return|3|||
23811151|NCT02669940|66687549|FG000|Overall Study|Insufficient follow-up data|1|||
23607208|NCT02584257|65950624|FG008|Period 2|Adverse Event|0|||
23607209|NCT02106325|65950625|FG000|Phase 1|Lost to Follow-up|2|||
23505690|NCT00612040|65588026|FG001|Overall Study|Adverse Event|2|||
23505691|NCT00612040|65588027|FG002|Overall Study|Adverse Event|1|||
23505692|NCT00612040|65588025|FG000|Overall Study|Protocol Violation|1|||
23505693|NCT00612040|65588026|FG001|Overall Study|Protocol Violation|2|||
23505694|NCT00612040|65588027|FG002|Overall Study|Protocol Violation|1|||
23505695|NCT00612040|65588025|FG000|Overall Study|Lack of Efficacy|2|||
23505696|NCT00612040|65588026|FG001|Overall Study|Lack of Efficacy|1|||
23505697|NCT00612040|65588027|FG002|Overall Study|Lack of Efficacy|0|||
23505698|NCT00612040|65588025|FG000|Overall Study|Unclassified|2|||
23505699|NCT00612040|65588026|FG001|Overall Study|Unclassified|2|||
23505700|NCT00612040|65588027|FG002|Overall Study|Unclassified|5|||
23505701|NCT03539081|65588030|FG000|Overall Study|Withdrawal by Subject|2|||
23505702|NCT03539081|65588031|FG001|Overall Study|Withdrawal by Subject|3|||
23505703|NCT03539081|65588032|FG002|Overall Study|Withdrawal by Subject|0|||
23505704|NCT03539081|65588030|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
23811152|NCT02669940|66687550|FG001|Overall Study|Insufficient follow-up data|0|||
23811153|NCT01394952|66687551|FG000|Overall Study|Lost to Follow-up|0|||
23811154|NCT01394952|66687552|FG001|Overall Study|Lost to Follow-up|5|||
23811155|NCT01394952|66687551|FG000|Overall Study|Withdrawal by Subject|10|||
23811156|NCT01394952|66687552|FG001|Overall Study|Withdrawal by Subject|5|||
23811157|NCT01394952|66687551|FG000|Overall Study|Physician Decision|2|||
23811158|NCT01394952|66687552|FG001|Overall Study|Physician Decision|0|||
23811159|NCT01394952|66687551|FG000|Overall Study|Sponsor Decision|5|||
23811160|NCT01394952|66687552|FG001|Overall Study|Sponsor Decision|7|||
23811161|NCT00616629|66687553|FG000|Overall Study|Protocol Violation|1|||
23811162|NCT00616629|66687554|FG001|Overall Study|Protocol Violation|2|||
23811163|NCT00616629|66687555|FG002|Overall Study|Protocol Violation|1|||
23811164|NCT00616629|66687556|FG003|Overall Study|Protocol Violation|0|||
23811165|NCT00616629|66687557|FG004|Overall Study|Protocol Violation|0|||
23811166|NCT00616629|66687553|FG000|Overall Study|AV-block|1|||
23811167|NCT00616629|66687554|FG001|Overall Study|AV-block|0|||
23811168|NCT00616629|66687555|FG002|Overall Study|AV-block|0|||
23811169|NCT00616629|66687556|FG003|Overall Study|AV-block|0|||
23811170|NCT00616629|66687557|FG004|Overall Study|AV-block|0|||
23811171|NCT01155024|66687558|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
23811172|NCT01155024|66687559|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
23811173|NCT01155024|66687558|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
23811174|NCT01155024|66687559|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
23811175|NCT01155024|66687558|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
23811176|NCT01155024|66687559|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
23811177|NCT02669758|66687560|FG000|Overall Study|Withdrawal by Subject|43|||
23811178|NCT02669758|66687560|FG000|Overall Study|Lost to Follow-up|19|||
23811179|NCT02669758|66687560|FG000|Overall Study|Adverse Event|16|||
23811180|NCT02669758|66687560|FG000|Overall Study|Non-Compliance with Study Drug|8|||
23811181|NCT02669758|66687560|FG000|Overall Study|Lack of Efficacy|5|||
23811182|NCT02669758|66687560|FG000|Overall Study|Pregnancy|1|||
23811183|NCT02669758|66687560|FG000|Overall Study|Study noncompliance|1|||
23811184|NCT02669758|66687560|FG000|Overall Study|Protocol Violation|1|||
23811185|NCT02448706|66687565|FG000|Overall Study|Withdrawal by Subject|4|||
23811186|NCT02448706|66687566|FG001|Overall Study|Withdrawal by Subject|3|||
23811187|NCT02448706|66687565|FG000|Overall Study|Protocol Violation|1|||
23811188|NCT02448706|66687566|FG001|Overall Study|Protocol Violation|1|||
23811189|NCT00440466|66687568|FG000|Overall Study|Death|3|||
23811190|NCT00440466|66687569|FG001|Overall Study|Death|2|||
23811191|NCT00440466|66687570|FG002|Overall Study|Death|9|||
23811192|NCT00440466|66687568|FG000|Overall Study|Adverse Event|3|||
23811193|NCT00440466|66687569|FG001|Overall Study|Adverse Event|4|||
23811194|NCT00440466|66687570|FG002|Overall Study|Adverse Event|11|||
23811195|NCT00440466|66687568|FG000|Overall Study|Lost to Follow-up|1|||
23811196|NCT00440466|66687569|FG001|Overall Study|Lost to Follow-up|0|||
23811197|NCT00440466|66687570|FG002|Overall Study|Lost to Follow-up|2|||
23505705|NCT03539081|65588031|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
23811198|NCT00440466|66687568|FG000|Overall Study|Physician Decision|2|||
23505706|NCT03539081|65588032|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
23505707|NCT01826604|65588034|FG000|Overall Study|Lost to Follow-up|8|||
23811199|NCT00440466|66687569|FG001|Overall Study|Physician Decision|0|||
23811200|NCT00440466|66687570|FG002|Overall Study|Physician Decision|1|||
23811201|NCT00440466|66687568|FG000|Overall Study|Protocol Violation|2|||
23811202|NCT00440466|66687569|FG001|Overall Study|Protocol Violation|0|||
23811203|NCT00440466|66687570|FG002|Overall Study|Protocol Violation|4|||
23811204|NCT00440466|66687568|FG000|Overall Study|Withdrawal by Subject|2|||
23811205|NCT00440466|66687569|FG001|Overall Study|Withdrawal by Subject|5|||
23811206|NCT00440466|66687570|FG002|Overall Study|Withdrawal by Subject|9|||
23811207|NCT00440466|66687568|FG000|Overall Study|Began Dialysis|0|||
23811208|NCT00440466|66687569|FG001|Overall Study|Began Dialysis|0|||
23811209|NCT00440466|66687570|FG002|Overall Study|Began Dialysis|1|||
23811210|NCT00440466|66687568|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
23811211|NCT00440466|66687569|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
23811212|NCT00440466|66687570|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
23811213|NCT03251963|66687571|FG000|Overall Study|inappropriate Xa level timing|6|||
23811214|NCT03251963|66687572|FG001|Overall Study|inappropriate Xa level timing|3|||
23811215|NCT03251963|66687571|FG000|Overall Study|no peak Xa level drawn|2|||
23811216|NCT03251963|66687572|FG001|Overall Study|no peak Xa level drawn|0|||
23811217|NCT03251963|66687571|FG000|Overall Study|bled prior to Xa level|1|||
23811218|NCT03251963|66687572|FG001|Overall Study|bled prior to Xa level|2|||
23405473|NCT00326599|65230207|FG003|Overall Study|Disease Progression|11|||
23405474|NCT00326599|65230204|FG000|Overall Study|Alternate Treatment|1|||
23405475|NCT00326599|65230205|FG001|Overall Study|Alternate Treatment|0|||
23405476|NCT00326599|65230206|FG002|Overall Study|Alternate Treatment|0|||
23405477|NCT00326599|65230207|FG003|Overall Study|Alternate Treatment|0|||
23405478|NCT00326599|65230204|FG000|Overall Study|Death|0|||
23405479|NCT00326599|65230205|FG001|Overall Study|Death|0|||
23405480|NCT00326599|65230206|FG002|Overall Study|Death|1|||
23405481|NCT00326599|65230207|FG003|Overall Study|Death|2|||
23405482|NCT00326599|65230204|FG000|Overall Study|Other Unspecified Reason|0|||
23405483|NCT00326599|65230205|FG001|Overall Study|Other Unspecified Reason|0|||
23405484|NCT00326599|65230206|FG002|Overall Study|Other Unspecified Reason|2|||
23405485|NCT00326599|65230207|FG003|Overall Study|Other Unspecified Reason|1|||
23405486|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
23405487|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
23405488|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405489|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405490|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405491|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405492|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
23405493|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
23405494|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405495|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405496|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405497|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405498|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405499|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
23405500|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405501|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405502|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405503|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405504|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
23405505|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
23405506|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405507|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405508|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405509|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405510|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
23405511|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405512|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405513|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23607210|NCT02106325|65950626|FG001|Phase 1|Lost to Follow-up|2|||
23505708|NCT01826604|65588035|FG001|Overall Study|Lost to Follow-up|9|||
23811219|NCT04688931|66687573|FG000|Overall Study|Adverse Event|4|||
23811220|NCT04688931|66687574|FG001|Overall Study|Adverse Event|1|||
23405514|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405515|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405516|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405517|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405518|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
23505709|NCT01408485|65588036|FG000|Overall Study|Withdrawal by Subject|21|||
23811221|NCT04688931|66687573|FG000|Overall Study|Withdrawal by Subject|5|||
23811222|NCT04688931|66687574|FG001|Overall Study|Withdrawal by Subject|16|||
23811223|NCT04688931|66687573|FG000|Overall Study|Physician Decision|3|||
23405519|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
23405520|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405521|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405522|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405523|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405524|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
23405525|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405526|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405527|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405528|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405529|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405530|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
23405531|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
23811224|NCT04688931|66687574|FG001|Overall Study|Physician Decision|5|||
23811225|NCT04688931|66687573|FG000|Overall Study|Noncompliance|0|||
23405532|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405533|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405534|NCT02820844|65230208|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23505710|NCT03547583|65588042|FG000|Overall Study|Adverse Event|16|||
23505711|NCT03547583|65588043|FG001|Overall Study|Adverse Event|11|||
23505712|NCT03547583|65588044|FG002|Overall Study|Adverse Event|10|||
23505713|NCT03547583|65588042|FG000|Overall Study|Death|11|||
23505714|NCT03547583|65588043|FG001|Overall Study|Death|7|||
23811226|NCT04688931|66687574|FG001|Overall Study|Noncompliance|1|||
23405535|NCT02820844|65230209|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405536|NCT02820844|65230210|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405537|NCT02820844|65230211|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23811227|NCT04688931|66687573|FG000|Overall Study|Lost to Follow-up|1|||
23811228|NCT04688931|66687574|FG001|Overall Study|Lost to Follow-up|3|||
23811229|NCT04688931|66687573|FG000|Overall Study|Randomization Error|3|||
23811230|NCT04688931|66687574|FG001|Overall Study|Randomization Error|0|||
23811231|NCT04688931|66687573|FG000|Overall Study|Not Eligible|1|||
23811232|NCT04688931|66687574|FG001|Overall Study|Not Eligible|3|||
23811233|NCT04688931|66687573|FG000|Overall Study|Disease Progression|0|||
23811234|NCT04688931|66687574|FG001|Overall Study|Disease Progression|2|||
23811235|NCT04688931|66687573|FG000|Overall Study|Sponsor Requirement|1|||
23811236|NCT04688931|66687574|FG001|Overall Study|Sponsor Requirement|1|||
23811237|NCT04688931|66687573|FG000|Overall Study|Other Reason|1|||
23811238|NCT04688931|66687574|FG001|Overall Study|Other Reason|2|||
23811239|NCT02906930|66687575|FG000|Overall Study|Withdrawal by Subject|0|||
23811240|NCT02906930|66687576|FG001|Overall Study|Withdrawal by Subject|5|||
23811241|NCT02906930|66687577|FG002|Overall Study|Withdrawal by Subject|5|||
23811242|NCT02906930|66687578|FG003|Overall Study|Withdrawal by Subject|4|||
23811243|NCT02906930|66687575|FG000|Overall Study|Lost to Follow-up|5|||
23405538|NCT02820844|65230212|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
23405539|NCT02820844|65230213|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405540|NCT02820844|65230208|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405541|NCT02820844|65230209|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405542|NCT02820844|65230210|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405543|NCT02820844|65230211|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405544|NCT02820844|65230212|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405545|NCT02820844|65230213|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
23405546|NCT00616642|65230214|FG000|Overall Study|Withdrawal by Subject|0|||
23405547|NCT00616642|65230215|FG001|Overall Study|Withdrawal by Subject|1|||
23405548|NCT02973997|65230218|FG000|Overall Study|Withdrawal by Subject|4|||
23405549|NCT02973997|65230219|FG001|Overall Study|Withdrawal by Subject|0|||
23405550|NCT02973997|65230218|FG000|Overall Study|Adverse Event|4|||
23405551|NCT02973997|65230219|FG001|Overall Study|Adverse Event|1|||
23405552|NCT02973997|65230218|FG000|Overall Study|Disease Progression|11|||
23405553|NCT02973997|65230219|FG001|Overall Study|Disease Progression|20|||
23405554|NCT02973997|65230218|FG000|Overall Study|Alternative Therapy|3|||
23405555|NCT02973997|65230219|FG001|Overall Study|Alternative Therapy|0|||
23405556|NCT02973997|65230218|FG000|Overall Study|Other complicating disease|0|||
23405557|NCT02973997|65230219|FG001|Overall Study|Other complicating disease|1|||
23505715|NCT03547583|65588044|FG002|Overall Study|Death|4|||
23811244|NCT02906930|66687576|FG001|Overall Study|Lost to Follow-up|7|||
23811245|NCT02906930|66687577|FG002|Overall Study|Lost to Follow-up|5|||
23811246|NCT02906930|66687578|FG003|Overall Study|Lost to Follow-up|2|||
23405558|NCT02973997|65230218|FG000|Overall Study|Death|0|||
23405559|NCT02973997|65230219|FG001|Overall Study|Death|1|||
23405560|NCT03606486|65230220|FG000|Overall Study|Unable to collect sample|5|||
23405561|NCT00763256|65230228|FG000|Overall Study|Didn't return for appointments|7|||
23405562|NCT00763256|65230229|FG001|Overall Study|Didn't return for appointments|10|||
23405563|NCT05384834|65230233|FG000|Overall Study|Lost to Follow-up|43|||
23405564|NCT05384834|65230233|FG000|Overall Study|Withdrawal by Subject|5|||
23405565|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
23405566|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405567|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405568|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405569|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405570|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405571|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405572|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405573|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405574|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405575|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
23811247|NCT02906930|66687575|FG000|Overall Study|Death|0|||
23811248|NCT02906930|66687576|FG001|Overall Study|Death|0|||
23811249|NCT02906930|66687577|FG002|Overall Study|Death|1|||
23811250|NCT02906930|66687578|FG003|Overall Study|Death|0|||
23405576|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
23405577|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405578|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405579|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405580|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405581|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405582|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405583|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
23811251|NCT02906930|66687575|FG000|Overall Study|Other|1|||
23811252|NCT02906930|66687576|FG001|Overall Study|Other|2|||
23811253|NCT02906930|66687577|FG002|Overall Study|Other|1|||
23811254|NCT02906930|66687578|FG003|Overall Study|Other|2|||
23811255|NCT00826449|66687587|FG000|Overall Study|Disease Progression|4|||
23405584|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
23405585|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
23405586|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405587|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23811256|NCT00826449|66687587|FG000|Overall Study|Withdrawal by Subject|1|||
23811257|NCT01433549|66687588|FG000|Phase 2: Second Study Product|Adverse Event|0|||
23811258|NCT01433549|66687589|FG001|Phase 2: Second Study Product|Adverse Event|1|||
23811259|NCT03052959|66687590|FG000|Overall Study|Lost to Follow-up|4|||
23811260|NCT03052959|66687591|FG001|Overall Study|Lost to Follow-up|5|||
23811261|NCT00158756|66687592|FG000|Overall Study|Withdrawal by Subject|5|||
23811262|NCT00158756|66687593|FG001|Overall Study|Withdrawal by Subject|0|||
23811263|NCT00158756|66687594|FG002|Overall Study|Withdrawal by Subject|6|||
23811264|NCT00158756|66687595|FG003|Overall Study|Withdrawal by Subject|1|||
23405588|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405589|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405590|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405591|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23811265|NCT00158756|66687596|FG004|Overall Study|Withdrawal by Subject|3|||
23811266|NCT00158756|66687592|FG000|Overall Study|Adverse Event|0|||
23811267|NCT00158756|66687593|FG001|Overall Study|Adverse Event|0|||
23811268|NCT00158756|66687594|FG002|Overall Study|Adverse Event|1|||
23811269|NCT00158756|66687595|FG003|Overall Study|Adverse Event|0|||
23811270|NCT00158756|66687596|FG004|Overall Study|Adverse Event|0|||
23811271|NCT00158756|66687592|FG000|Overall Study|Serious adverse event|0|||
23405592|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
23405593|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
23505716|NCT03547583|65588042|FG000|Overall Study|Lost to Follow-up|1|||
23811272|NCT00158756|66687593|FG001|Overall Study|Serious adverse event|0|||
23811273|NCT00158756|66687594|FG002|Overall Study|Serious adverse event|1|||
23811274|NCT00158756|66687595|FG003|Overall Study|Serious adverse event|0|||
23811275|NCT00158756|66687596|FG004|Overall Study|Serious adverse event|0|||
23811276|NCT00658658|66691673|FG000|Overall Study|Withdrawal by Subject|0|||
23405594|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
23405595|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405596|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405597|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405598|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405599|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405600|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405601|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
23405602|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
23405603|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
23405604|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405605|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405606|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405607|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405608|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405609|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405610|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405611|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405612|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405613|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
23405614|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405615|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405616|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405617|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405618|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405619|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405620|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405621|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405622|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405623|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405624|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405625|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
23405626|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
23405627|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
23405628|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405629|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405630|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405631|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
23405632|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
23405633|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
23405634|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
23405635|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
23405636|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
23405637|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405638|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405639|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405640|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405641|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
23405642|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405643|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405644|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
23405645|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
23405646|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405647|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405648|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405649|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405650|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405651|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
23405652|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
23405653|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405654|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
23405655|NCT00003631|65230243|FG000|Overall Study|Patient not treated|1|||
23405656|NCT00003631|65230244|FG001|Overall Study|Patient not treated|0|||
23405657|NCT00003631|65230245|FG002|Overall Study|Patient not treated|1|||
23405658|NCT00003631|65230243|FG000|Overall Study|Protocol Violation|1|||
23405659|NCT00003631|65230244|FG001|Overall Study|Protocol Violation|0|||
23405660|NCT00003631|65230245|FG002|Overall Study|Protocol Violation|0|||
23405661|NCT00003631|65230243|FG000|Overall Study|Adverse Event|1|||
23405662|NCT00003631|65230244|FG001|Overall Study|Adverse Event|1|||
23405663|NCT00003631|65230245|FG002|Overall Study|Adverse Event|5|||
23405664|NCT00003631|65230243|FG000|Overall Study|Death|0|||
23405665|NCT00003631|65230244|FG001|Overall Study|Death|0|||
23405666|NCT00003631|65230245|FG002|Overall Study|Death|1|||
23405667|NCT00003631|65230243|FG000|Overall Study|Evaluable for toxicity only|0|||
23405668|NCT00003631|65230244|FG001|Overall Study|Evaluable for toxicity only|0|||
23405669|NCT00003631|65230245|FG002|Overall Study|Evaluable for toxicity only|2|||
23405670|NCT03335150|65230247|FG000|Overall Study|Withdrawal by Subject|10|||
23405671|NCT03335150|65230248|FG001|Overall Study|Withdrawal by Subject|4|||
23405672|NCT03335150|65230247|FG000|Overall Study|Adverse Event|0|||
23405673|NCT03335150|65230248|FG001|Overall Study|Adverse Event|1|||
23405674|NCT01133665|65230250|FG000|Overall Study|Physician Decision|2|||
23405675|NCT03341637|65230251|FG000|Overall Study|Lost to Follow-up|1|||
23405676|NCT03341637|65230252|FG001|Overall Study|Lost to Follow-up|0|||
23405677|NCT03341637|65230251|FG000|Overall Study|Withdrawal by Subject|3|||
23405678|NCT03341637|65230252|FG001|Overall Study|Withdrawal by Subject|3|||
23405679|NCT03341637|65230251|FG000|Overall Study|Reason not Specified|1|||
23405680|NCT03341637|65230252|FG001|Overall Study|Reason not Specified|1|||
23405681|NCT02503085|65230264|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
23405682|NCT02503085|65230265|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
23405683|NCT02503085|65230266|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
23405684|NCT02503085|65230267|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
23405685|NCT01444430|65230268|FG000|Overall Study|Withdrawal by Subject|53|||
23405686|NCT01444430|65230269|FG001|Overall Study|Withdrawal by Subject|72|||
23405687|NCT01444430|65230268|FG000|Overall Study|Death|6|||
23405688|NCT01444430|65230269|FG001|Overall Study|Death|8|||
23405689|NCT01444430|65230268|FG000|Overall Study|Lost to Follow-up|2|||
23405690|NCT01444430|65230269|FG001|Overall Study|Lost to Follow-up|0|||
23405691|NCT01444430|65230268|FG000|Overall Study|CRF termination module not completed.|0|||
23405692|NCT01444430|65230269|FG001|Overall Study|CRF termination module not completed.|1|||
23405693|NCT04339413|65230270|FG000|Overall Study|Reason Not Specified|2|||
23405694|NCT04339413|65230271|FG001|Overall Study|Reason Not Specified|7|||
23405695|NCT04339413|65230270|FG000|Overall Study|Study Terminated by Sponsor|30|||
23405696|NCT04339413|65230271|FG001|Overall Study|Study Terminated by Sponsor|33|||
23405697|NCT04339413|65230270|FG000|Overall Study|Progressive Disease|9|||
23405698|NCT04339413|65230271|FG001|Overall Study|Progressive Disease|6|||
23405699|NCT04339413|65230270|FG000|Overall Study|Withdrawal by Subject|9|||
23405700|NCT04339413|65230271|FG001|Overall Study|Withdrawal by Subject|10|||
23405701|NCT04339413|65230270|FG000|Overall Study|Physician Decision|3|||
23405702|NCT04339413|65230271|FG001|Overall Study|Physician Decision|1|||
23405703|NCT04339413|65230270|FG000|Overall Study|Death|2|||
23405704|NCT04339413|65230271|FG001|Overall Study|Death|0|||
23405705|NCT04339413|65230270|FG000|Overall Study|Adverse Event|3|||
23811277|NCT00658658|66691674|FG001|Overall Study|Withdrawal by Subject|1|||
23811278|NCT00658658|66691675|FG002|Overall Study|Withdrawal by Subject|0|||
23811279|NCT00658658|66691676|FG003|Overall Study|Withdrawal by Subject|0|||
23811280|NCT00658658|66691677|FG004|Overall Study|Withdrawal by Subject|0|||
23811281|NCT00658658|66691673|FG000|Overall Study|Death|4|||
23811282|NCT00658658|66691674|FG001|Overall Study|Death|0|||
23811283|NCT00658658|66691675|FG002|Overall Study|Death|0|||
23811284|NCT00658658|66691676|FG003|Overall Study|Death|1|||
23811285|NCT00658658|66691677|FG004|Overall Study|Death|1|||
23811286|NCT00658658|66691673|FG000|Overall Study|Disease Progression|0|||
23811287|NCT00658658|66691674|FG001|Overall Study|Disease Progression|1|||
23811288|NCT00658658|66691675|FG002|Overall Study|Disease Progression|0|||
23811289|NCT00658658|66691676|FG003|Overall Study|Disease Progression|1|||
23811290|NCT00658658|66691677|FG004|Overall Study|Disease Progression|3|||
23811291|NCT00658658|66691673|FG000|Overall Study|Protocol-specified Criteria|1|||
23811292|NCT00658658|66691674|FG001|Overall Study|Protocol-specified Criteria|0|||
23811293|NCT00658658|66691675|FG002|Overall Study|Protocol-specified Criteria|0|||
23811294|NCT00658658|66691676|FG003|Overall Study|Protocol-specified Criteria|0|||
23811295|NCT00658658|66691677|FG004|Overall Study|Protocol-specified Criteria|0|||
23405706|NCT04339413|65230271|FG001|Overall Study|Adverse Event|0|||
23405707|NCT02140970|65233577|FG000|Overall Study|Lost to Follow-up|1|||
23811296|NCT00658658|66691673|FG000|Overall Study|Other|0|||
23811297|NCT00658658|66691674|FG001|Overall Study|Other|0|||
23811298|NCT00658658|66691675|FG002|Overall Study|Other|0|||
23811299|NCT00658658|66691676|FG003|Overall Study|Other|0|||
23405708|NCT02140970|65233578|FG001|Overall Study|Lost to Follow-up|2|||
23405709|NCT02140970|65233577|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
23811300|NCT00658658|66691677|FG004|Overall Study|Other|1|||
23843091|NCT01738503|66805581|FG000|Treatment Period|Withdrawal by Subject|0|||
23811301|NCT02605993|66691678|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23811302|NCT02605993|66691679|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23811303|NCT02605993|66691680|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
23811304|NCT02605993|66691681|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23811305|NCT04126213|66691682|FG000|Overall Study|Lost to Follow-up|9|||
23811306|NCT04126213|66691683|FG001|Overall Study|Lost to Follow-up|1|||
23811307|NCT04126213|66691684|FG002|Overall Study|Lost to Follow-up|5|||
23811308|NCT04126213|66691685|FG003|Overall Study|Lost to Follow-up|10|||
23811309|NCT04126213|66691686|FG004|Overall Study|Lost to Follow-up|4|||
23811310|NCT04126213|66691687|FG005|Overall Study|Lost to Follow-up|7|||
23811311|NCT04126213|66691682|FG000|Overall Study|Withdrawal by Subject|3|||
23811312|NCT04126213|66691683|FG001|Overall Study|Withdrawal by Subject|2|||
23811313|NCT04126213|66691684|FG002|Overall Study|Withdrawal by Subject|1|||
23811314|NCT04126213|66691685|FG003|Overall Study|Withdrawal by Subject|1|||
23811315|NCT04126213|66691686|FG004|Overall Study|Withdrawal by Subject|1|||
23811316|NCT04126213|66691687|FG005|Overall Study|Withdrawal by Subject|1|||
23811317|NCT04126213|66691682|FG000|Overall Study|Other|0|||
23811318|NCT04126213|66691683|FG001|Overall Study|Other|0|||
23811319|NCT04126213|66691684|FG002|Overall Study|Other|2|||
23811320|NCT04126213|66691685|FG003|Overall Study|Other|2|||
23811321|NCT04126213|66691686|FG004|Overall Study|Other|0|||
23811322|NCT04126213|66691687|FG005|Overall Study|Other|1|||
23811323|NCT04126213|66691682|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23811324|NCT04126213|66691683|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23811325|NCT04126213|66691684|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23811326|NCT04126213|66691685|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23811327|NCT04126213|66691686|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23811328|NCT04126213|66691687|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23811329|NCT00918138|66691688|FG000|Overall Study|Subject withdrew consent|1|||
23811330|NCT00918138|66691689|FG001|Overall Study|Subject withdrew consent|1|||
23811331|NCT00918138|66691688|FG000|Overall Study|Death|1|||
23811332|NCT00918138|66691689|FG001|Overall Study|Death|0|||
23811333|NCT01447420|66691690|FG000|Overall Study|Adverse Event|2|||
23811334|NCT01447420|66691691|FG001|Overall Study|Adverse Event|4|||
23405710|NCT02140970|65233578|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
23405711|NCT02140970|65233577|FG000|Overall Study|Did not meet inclusion criteria|0|||
23405712|NCT02140970|65233578|FG001|Overall Study|Did not meet inclusion criteria|1|||
23405713|NCT03554018|65233579|FG000|Overall Study|Lost to Follow-up|3|||
23405714|NCT03554018|65233580|FG001|Overall Study|Lost to Follow-up|7|||
23405715|NCT00984594|65233581|FG000|Overall Study|Lost to Follow-up|1|||
23405716|NCT00984594|65233582|FG001|Overall Study|Lost to Follow-up|0|||
23405717|NCT00984594|65233581|FG000|Overall Study|Withdrawal by Subject|0|||
23405718|NCT00984594|65233582|FG001|Overall Study|Withdrawal by Subject|1|||
23405719|NCT02625220|65233583|FG000|Overall Study|Adverse Event|2|||
23405720|NCT02625220|65233583|FG000|Overall Study|Lost to Follow-up|2|||
23405721|NCT02625220|65233583|FG000|Overall Study|Protocol Violation|1|||
23405722|NCT02625220|65233583|FG000|Overall Study|Study discontinued at site|2|||
23405723|NCT01170273|65233584|FG000|Overall Study|Lost to Follow-up|6|||
23405724|NCT01170273|65233585|FG001|Overall Study|Lost to Follow-up|8|||
23405725|NCT01170273|65233584|FG000|Overall Study|Protocol Violation|1|||
23405726|NCT01170273|65233585|FG001|Overall Study|Protocol Violation|0|||
23405727|NCT01170273|65233584|FG000|Overall Study|Death|1|||
23405728|NCT01170273|65233585|FG001|Overall Study|Death|0|||
23405729|NCT01170273|65233584|FG000|Overall Study|Adverse Event|0|||
23405730|NCT01170273|65233585|FG001|Overall Study|Adverse Event|1|||
23405731|NCT00787839|65233588|FG000|Overall Study|Failure to have the OGTT was most common|404|||
23405732|NCT00573391|65233595|FG000|Overall Study|study stopped|2|||
23405733|NCT00573391|65233596|FG001|Overall Study|study stopped|2|||
23405734|NCT00573391|65233595|FG000|Overall Study|Death|1|||
23405735|NCT00573391|65233596|FG001|Overall Study|Death|0|||
23405736|NCT01747915|65233597|FG000|Overall Study|Other|1|||
23405737|NCT01747915|65233598|FG001|Overall Study|Other|1|||
23405738|NCT01747915|65233599|FG002|Overall Study|Other|1|||
23405739|NCT01747915|65233597|FG000|Overall Study|Adverse Event|8|||
23405740|NCT01747915|65233598|FG001|Overall Study|Adverse Event|5|||
23405741|NCT01747915|65233599|FG002|Overall Study|Adverse Event|2|||
23405742|NCT01747915|65233597|FG000|Overall Study|Death|0|||
23405743|NCT01747915|65233598|FG001|Overall Study|Death|0|||
23405744|NCT01747915|65233599|FG002|Overall Study|Death|1|||
23811335|NCT01447420|66691692|FG002|Overall Study|Adverse Event|2|||
23811336|NCT01447420|66691690|FG000|Overall Study|Protocol Violation|3|||
23811337|NCT01447420|66691691|FG001|Overall Study|Protocol Violation|3|||
23811338|NCT01447420|66691692|FG002|Overall Study|Protocol Violation|0|||
23811339|NCT01447420|66691690|FG000|Overall Study|Withdrawal by Subject|4|||
23811340|NCT01447420|66691691|FG001|Overall Study|Withdrawal by Subject|1|||
23405745|NCT01747915|65233597|FG000|Overall Study|Lack of Efficacy|0|||
23405746|NCT01747915|65233598|FG001|Overall Study|Lack of Efficacy|1|||
23405747|NCT01747915|65233599|FG002|Overall Study|Lack of Efficacy|0|||
23405748|NCT01747915|65233597|FG000|Overall Study|Lost to Follow-up|1|||
23405749|NCT01747915|65233598|FG001|Overall Study|Lost to Follow-up|0|||
23405750|NCT01747915|65233599|FG002|Overall Study|Lost to Follow-up|0|||
23405751|NCT01747915|65233597|FG000|Overall Study|Withdrawal by Subject|4|||
23405752|NCT01747915|65233598|FG001|Overall Study|Withdrawal by Subject|4|||
23405753|NCT01747915|65233599|FG002|Overall Study|Withdrawal by Subject|1|||
23405754|NCT01747915|65233597|FG000|Overall Study|Protocol Violation|1|||
23405755|NCT01747915|65233598|FG001|Overall Study|Protocol Violation|0|||
23405756|NCT01747915|65233599|FG002|Overall Study|Protocol Violation|0|||
23405757|NCT01747915|65233597|FG000|Overall Study|Pregnancy|0|||
23405758|NCT01747915|65233598|FG001|Overall Study|Pregnancy|0|||
23405759|NCT01747915|65233599|FG002|Overall Study|Pregnancy|1|||
23405760|NCT01244035|65233600|FG000|Part 1: Period 1|Adverse Event|0|||
23405761|NCT01244035|65233601|FG001|Part 1: Period 1|Adverse Event|0|||
23811341|NCT01447420|66691692|FG002|Overall Study|Withdrawal by Subject|0|||
23811342|NCT01447420|66691690|FG000|Overall Study|Lack of Efficacy|1|||
23811343|NCT01447420|66691691|FG001|Overall Study|Lack of Efficacy|19|||
23811344|NCT01447420|66691692|FG002|Overall Study|Lack of Efficacy|8|||
23811345|NCT02640053|66691693|FG000|Overall Study|Withdrawal by Subject|2|||
23811346|NCT02640053|66691694|FG001|Overall Study|Withdrawal by Subject|1|||
23811347|NCT02640053|66691693|FG000|Overall Study|Adverse Event|1|||
23811348|NCT02640053|66691694|FG001|Overall Study|Adverse Event|1|||
23811349|NCT02640053|66691693|FG000|Overall Study|Alternative Therapy|1|||
23811350|NCT02640053|66691694|FG001|Overall Study|Alternative Therapy|1|||
23811351|NCT02640053|66691693|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
23811352|NCT02640053|66691694|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
23811353|NCT02105974|66691697|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
23811354|NCT02105974|66691698|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
23811355|NCT02105974|66691699|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
23811356|NCT02105974|66691697|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
23811357|NCT02105974|66691698|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
23811358|NCT02105974|66691699|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
23405762|NCT01244035|65233602|FG002|Part 1: Period 1|Adverse Event|0|||
23405763|NCT01244035|65233603|FG003|Part 1: Period 1|Adverse Event|0|||
23405764|NCT01244035|65233604|FG004|Part 1: Period 1|Adverse Event|0|||
23405765|NCT01244035|65233605|FG005|Part 1: Period 1|Adverse Event|1|||
23405766|NCT01244035|65233600|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
23405767|NCT01244035|65233601|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
23405768|NCT01244035|65233602|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
23405769|NCT01244035|65233603|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
23405770|NCT01244035|65233604|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
23405771|NCT01244035|65233605|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
23405772|NCT01244035|65233600|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405773|NCT01244035|65233601|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
23405774|NCT01244035|65233602|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
23405775|NCT01244035|65233603|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
23405776|NCT01244035|65233604|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405777|NCT01244035|65233605|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405778|NCT01244035|65233600|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405779|NCT01244035|65233601|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405780|NCT01244035|65233602|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
23405781|NCT01244035|65233603|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405782|NCT01244035|65233604|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405783|NCT01244035|65233605|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405784|NCT01244035|65233600|FG000|Part 1: Period 3|Adverse Event|0|||
23405785|NCT01244035|65233601|FG001|Part 1: Period 3|Adverse Event|0|||
23405786|NCT01244035|65233602|FG002|Part 1: Period 3|Adverse Event|0|||
23405787|NCT01244035|65233603|FG003|Part 1: Period 3|Adverse Event|0|||
23405788|NCT01244035|65233604|FG004|Part 1: Period 3|Adverse Event|0|||
23405789|NCT01244035|65233605|FG005|Part 1: Period 3|Adverse Event|1|||
23405790|NCT01244035|65233600|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
23405791|NCT01244035|65233601|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
23405792|NCT01244035|65233602|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
23405793|NCT01244035|65233603|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
23405794|NCT01244035|65233604|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
23405795|NCT01244035|65233605|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
23405796|NCT01244035|65233600|FG000|Part 1: Period 3|Protocol Deviation|0|||
23405797|NCT01244035|65233601|FG001|Part 1: Period 3|Protocol Deviation|1|||
23405798|NCT01244035|65233602|FG002|Part 1: Period 3|Protocol Deviation|0|||
23405799|NCT01244035|65233603|FG003|Part 1: Period 3|Protocol Deviation|0|||
23405800|NCT01244035|65233604|FG004|Part 1: Period 3|Protocol Deviation|0|||
23405801|NCT01244035|65233605|FG005|Part 1: Period 3|Protocol Deviation|0|||
23405802|NCT00131352|65233606|FG000|Initial Treatment Period|Adverse Event|1|||
23405803|NCT00131352|65233607|FG001|Initial Treatment Period|Adverse Event|3|||
23405804|NCT00131352|65233606|FG000|Initial Treatment Period|Non-compliant|1|||
23405805|NCT00131352|65233607|FG001|Initial Treatment Period|Non-compliant|2|||
23405806|NCT00131352|65233606|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
23405807|NCT00131352|65233607|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
23405808|NCT00131352|65233606|FG000|Initial Treatment Period|Lack of Efficacy|6|||
23405809|NCT00131352|65233607|FG001|Initial Treatment Period|Lack of Efficacy|4|||
23405810|NCT00131352|65233606|FG000|Initial Treatment Period|Other|0|||
23405811|NCT00131352|65233607|FG001|Initial Treatment Period|Other|2|||
23405812|NCT00131352|65233606|FG000|Repeat Treatment Period|Adverse Event|1|||
23405813|NCT00131352|65233607|FG001|Repeat Treatment Period|Adverse Event|0|||
23405814|NCT00131352|65233606|FG000|Repeat Treatment Period|Other|1|||
23405815|NCT00131352|65233607|FG001|Repeat Treatment Period|Other|0|||
23405816|NCT03896477|65233608|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
23405817|NCT03896477|65233609|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
23405818|NCT03896477|65233610|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
23405819|NCT03896477|65233608|FG000|Overall Study|Parent Requested Withdrawal|8|||
23405820|NCT03896477|65233609|FG001|Overall Study|Parent Requested Withdrawal|12|||
23405821|NCT03896477|65233610|FG002|Overall Study|Parent Requested Withdrawal|9|||
23405822|NCT03896477|65233608|FG000|Overall Study|Adverse Event|0|||
23405823|NCT03896477|65233609|FG001|Overall Study|Adverse Event|0|||
23405824|NCT03896477|65233610|FG002|Overall Study|Adverse Event|1|||
23405825|NCT03896477|65233608|FG000|Overall Study|Death|1|||
23405826|NCT03896477|65233609|FG001|Overall Study|Death|0|||
23405827|NCT03896477|65233610|FG002|Overall Study|Death|0|||
23405828|NCT03896477|65233608|FG000|Overall Study|Other|5|||
23405829|NCT03896477|65233609|FG001|Overall Study|Other|6|||
23405830|NCT03896477|65233610|FG002|Overall Study|Other|7|||
23405831|NCT03896477|65233608|FG000|Overall Study|Lost to Follow-up|2|||
23405832|NCT03896477|65233609|FG001|Overall Study|Lost to Follow-up|1|||
23405833|NCT03896477|65233610|FG002|Overall Study|Lost to Follow-up|1|||
23405834|NCT01042158|65233611|FG000|Overall Study|Physician Decision|1|||
23405835|NCT00938912|65233612|FG000|Overall Study|Withdrawal by Subject|28|||
23405836|NCT00938912|65233612|FG000|Overall Study|Lost to Follow-up|4|||
23405837|NCT00938912|65233612|FG000|Overall Study|Lack of Efficacy|43|||
23405838|NCT00938912|65233612|FG000|Overall Study|Adverse event, non-fatal|24|||
23405839|NCT00938912|65233612|FG000|Overall Study|Adverse event, fatal|1|||
23405840|NCT00938912|65233612|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
23405841|NCT00938912|65233612|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
23405842|NCT00938912|65233612|FG000|Overall Study|Participant needed prohibit medication|1|||
23405843|NCT00938912|65233612|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
23405844|NCT00938912|65233612|FG000|Overall Study|Did not meet Eligibility criteria|1|||
23405845|NCT00938912|65233612|FG000|Overall Study|Participant relocated not related to AE|1|||
23405846|NCT00938912|65233612|FG000|Overall Study|Participant moved to another city|1|||
23405847|NCT00938912|65233612|FG000|Overall Study|Participant experienced break through seizures|1|||
23405848|NCT00938912|65233612|FG000|Overall Study|No longer wished to participate in the study|1|||
23405849|NCT00938912|65233612|FG000|Overall Study|Protocol Deviation|2|||
23405850|NCT02967679|65233633|FG000|Overall Study|Adverse Event|1|||
23405851|NCT01492426|65233634|FG000|Treatment|Death|0|||
23405852|NCT01492426|65233635|FG001|Treatment|Death|1|||
23405853|NCT01492426|65233634|FG000|Treatment|Other|1|||
23405854|NCT01492426|65233635|FG001|Treatment|Other|0|||
23405855|NCT01492426|65233634|FG000|Treatment|Adverse Event|25|||
23405856|NCT01492426|65233635|FG001|Treatment|Adverse Event|25|||
23405857|NCT01492426|65233634|FG000|Treatment|Lack of Efficacy|38|||
23405858|NCT01492426|65233635|FG001|Treatment|Lack of Efficacy|5|||
23405859|NCT01492426|65233634|FG000|Treatment|Participant withdrew consent|1|||
23405860|NCT01492426|65233635|FG001|Treatment|Participant withdrew consent|2|||
23405861|NCT01492426|65233634|FG000|Treatment|Poor compliance/noncompliance|1|||
23405862|NCT01492426|65233635|FG001|Treatment|Poor compliance/noncompliance|0|||
23405863|NCT01492426|65233634|FG000|Treatment|Subject requested discontinue study drug|7|||
23505717|NCT03547583|65588043|FG001|Overall Study|Lost to Follow-up|0|||
23405864|NCT01492426|65233635|FG001|Treatment|Subject requested discontinue study drug|3|||
23405865|NCT01492426|65233634|FG000|Treatment|Lost to Follow-up|9|||
23405866|NCT01492426|65233635|FG001|Treatment|Lost to Follow-up|4|||
23405867|NCT01492426|65233634|FG000|Treatment|Participant does not meet study criteria|1|||
23405868|NCT01492426|65233635|FG001|Treatment|Participant does not meet study criteria|0|||
23405869|NCT01492426|65233634|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
23405870|NCT01492426|65233635|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
23405871|NCT01492426|65233634|FG000|Follow-Up|Death|1|||
23405872|NCT01492426|65233635|FG001|Follow-Up|Death|0|||
23405873|NCT01492426|65233634|FG000|Follow-Up|Other|4|||
23405874|NCT01492426|65233635|FG001|Follow-Up|Other|2|||
23405875|NCT01492426|65233634|FG000|Follow-Up|Participant Withdrew Consent|6|||
23405876|NCT01492426|65233635|FG001|Follow-Up|Participant Withdrew Consent|1|||
23405877|NCT01492426|65233634|FG000|Follow-Up|Lost to Follow-up|12|||
23405878|NCT01492426|65233635|FG001|Follow-Up|Lost to Follow-up|6|||
23405879|NCT03484429|65233638|FG000|Overall Study|Withdrawal by Subject|1|||
23405880|NCT03484429|65233639|FG001|Overall Study|Withdrawal by Subject|0|||
23405881|NCT03484429|65233638|FG000|Overall Study|Adverse Event|2|||
23405882|NCT03484429|65233639|FG001|Overall Study|Adverse Event|0|||
23405883|NCT00355368|65233640|FG000|Overall Study|Protocol Violation|8|||
23405884|NCT00355368|65233641|FG001|Overall Study|Protocol Violation|7|||
23405885|NCT00355368|65233640|FG000|Overall Study|cardiac arrest prior to intubation|2|||
23405886|NCT00355368|65233641|FG001|Overall Study|cardiac arrest prior to intubation|2|||
23405887|NCT00690430|65233642|FG000|Core Phase|Abnormal Laboratory value|0|||
23405888|NCT00690430|65233643|FG001|Core Phase|Abnormal Laboratory value|1|||
23405889|NCT00690430|65233644|FG002|Core Phase|Abnormal Laboratory value|0|||
23405890|NCT00690430|65233642|FG000|Core Phase|Adverse Event|5|||
23405891|NCT00690430|65233643|FG001|Core Phase|Adverse Event|1|||
23405892|NCT00690430|65233644|FG002|Core Phase|Adverse Event|0|||
23405893|NCT00690430|65233642|FG000|Core Phase|Death|0|||
23405894|NCT00690430|65233643|FG001|Core Phase|Death|2|||
23405895|NCT00690430|65233644|FG002|Core Phase|Death|0|||
23405896|NCT00690430|65233642|FG000|Core Phase|Protocol Violation|1|||
23405897|NCT00690430|65233643|FG001|Core Phase|Protocol Violation|0|||
23405898|NCT00690430|65233644|FG002|Core Phase|Protocol Violation|0|||
23405899|NCT00690430|65233642|FG000|Core Phase|Withdrawal by Subject|3|||
23405900|NCT00690430|65233643|FG001|Core Phase|Withdrawal by Subject|3|||
23405901|NCT00690430|65233644|FG002|Core Phase|Withdrawal by Subject|0|||
23405902|NCT00690430|65233642|FG000|Core Phase|Subject no longer requires study drug|1|||
23405903|NCT00690430|65233643|FG001|Core Phase|Subject no longer requires study drug|0|||
23405904|NCT00690430|65233644|FG002|Core Phase|Subject no longer requires study drug|0|||
23405905|NCT00690430|65233642|FG000|Core Phase|Lack of Efficacy|8|||
23405906|NCT00690430|65233643|FG001|Core Phase|Lack of Efficacy|10|||
23405907|NCT00690430|65233644|FG002|Core Phase|Lack of Efficacy|0|||
23405908|NCT00690430|65233642|FG000|Core Phase|Administrative Problems|0|||
23405909|NCT00690430|65233643|FG001|Core Phase|Administrative Problems|1|||
23405910|NCT00690430|65233644|FG002|Core Phase|Administrative Problems|0|||
23405911|NCT00690430|65233642|FG000|Core Phase|Early Termination|0|||
23405912|NCT00690430|65233643|FG001|Core Phase|Early Termination|5|||
23405913|NCT00690430|65233644|FG002|Core Phase|Early Termination|0|||
23405914|NCT00690430|65233642|FG000|Extension Phase|Lack of Efficacy|3|||
23405915|NCT00690430|65233643|FG001|Extension Phase|Lack of Efficacy|1|||
23405916|NCT00690430|65233644|FG002|Extension Phase|Lack of Efficacy|4|||
23405917|NCT00690430|65233642|FG000|Extension Phase|Abnormal Lab Values|1|||
23405918|NCT00690430|65233643|FG001|Extension Phase|Abnormal Lab Values|0|||
23405919|NCT00690430|65233644|FG002|Extension Phase|Abnormal Lab Values|0|||
23405920|NCT00690430|65233642|FG000|Extension Phase|Abnormal test procedure results|1|||
23405921|NCT00690430|65233643|FG001|Extension Phase|Abnormal test procedure results|0|||
23405922|NCT00690430|65233644|FG002|Extension Phase|Abnormal test procedure results|0|||
23405923|NCT00690430|65233642|FG000|Extension Phase|Administrative Problems|0|||
23405924|NCT00690430|65233643|FG001|Extension Phase|Administrative Problems|1|||
23405925|NCT00690430|65233644|FG002|Extension Phase|Administrative Problems|1|||
23405926|NCT00690430|65233642|FG000|Extension Phase|Adverse Event|2|||
23405927|NCT00690430|65233643|FG001|Extension Phase|Adverse Event|1|||
23405928|NCT00690430|65233644|FG002|Extension Phase|Adverse Event|2|||
23405929|NCT00690430|65233642|FG000|Extension Phase|Death|1|||
23405930|NCT00690430|65233643|FG001|Extension Phase|Death|1|||
23405931|NCT00690430|65233644|FG002|Extension Phase|Death|1|||
23405932|NCT00690430|65233642|FG000|Extension Phase|Withdrawal by Subject|0|||
23405933|NCT00690430|65233643|FG001|Extension Phase|Withdrawal by Subject|0|||
23405934|NCT00690430|65233644|FG002|Extension Phase|Withdrawal by Subject|2|||
23405935|NCT00690430|65233642|FG000|Extension Phase|Early Termination|10|||
23405936|NCT00690430|65233643|FG001|Extension Phase|Early Termination|1|||
23405937|NCT00690430|65233644|FG002|Extension Phase|Early Termination|3|||
23405938|NCT02980107|65233645|FG000|Overall Study|Withdrawal by Subject|51|||
23405939|NCT02980107|65233646|FG001|Overall Study|Withdrawal by Subject|62|||
23405940|NCT01945996|65233647|FG000|Overall Study|Lost to Follow-up|3|||
23405941|NCT01945996|65233648|FG001|Overall Study|Lost to Follow-up|5|||
23405942|NCT01408277|65233654|FG000|Overall Study|Adverse Event|3|||
23405943|NCT01408277|65233655|FG001|Overall Study|Adverse Event|4|||
23405944|NCT01408277|65233654|FG000|Overall Study|Lost to Follow-up|1|||
23405945|NCT01408277|65233655|FG001|Overall Study|Lost to Follow-up|0|||
23405946|NCT01408277|65233654|FG000|Overall Study|Withdrawal by Subject|2|||
23405947|NCT01408277|65233655|FG001|Overall Study|Withdrawal by Subject|0|||
23405948|NCT01408277|65233654|FG000|Overall Study|Protocol Violation|2|||
23405949|NCT01408277|65233655|FG001|Overall Study|Protocol Violation|0|||
23405950|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405951|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
23405952|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
23405953|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405954|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405955|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405956|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Other|0|||
23405957|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Other|1|||
23405958|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Other|1|||
23405959|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Other|0|||
23405960|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Other|0|||
23405961|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Other|0|||
23405962|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
23405963|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
23405964|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
23405965|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405966|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405967|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405968|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405969|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405970|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
23405971|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405972|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405973|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405974|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
23405975|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405976|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405977|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405978|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405979|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405980|NCT02707965|65233679|FG000|Overall Study|Withdrawal by Subject|0|||
23405981|NCT02707965|65233680|FG001|Overall Study|Withdrawal by Subject|0|||
23405982|NCT02707965|65233681|FG002|Overall Study|Withdrawal by Subject|1|||
23405983|NCT02707965|65233682|FG003|Overall Study|Withdrawal by Subject|0|||
23405984|NCT02707965|65233683|FG004|Overall Study|Withdrawal by Subject|0|||
23405985|NCT02707965|65233684|FG005|Overall Study|Withdrawal by Subject|0|||
23405986|NCT02707965|65233685|FG006|Overall Study|Withdrawal by Subject|0|||
23405987|NCT02707965|65233686|FG007|Overall Study|Withdrawal by Subject|2|||
23405988|NCT02707965|65233687|FG008|Overall Study|Withdrawal by Subject|0|||
23405989|NCT02707965|65233688|FG009|Overall Study|Withdrawal by Subject|0|||
23405990|NCT02707965|65233689|FG010|Overall Study|Withdrawal by Subject|0|||
23405991|NCT02707965|65233690|FG011|Overall Study|Withdrawal by Subject|0|||
23405992|NCT02707965|65233691|FG012|Overall Study|Withdrawal by Subject|0|||
23405993|NCT02707965|65233692|FG013|Overall Study|Withdrawal by Subject|0|||
23405994|NCT02707965|65233693|FG014|Overall Study|Withdrawal by Subject|0|||
23405995|NCT02707965|65233694|FG015|Overall Study|Withdrawal by Subject|0|||
23405996|NCT02707965|65233679|FG000|Overall Study|PI decisions|0|||
23405997|NCT02707965|65233680|FG001|Overall Study|PI decisions|0|||
23405998|NCT02707965|65233681|FG002|Overall Study|PI decisions|0|||
23405999|NCT02707965|65233682|FG003|Overall Study|PI decisions|0|||
23406000|NCT02707965|65233683|FG004|Overall Study|PI decisions|0|||
23406001|NCT02707965|65233684|FG005|Overall Study|PI decisions|0|||
23406002|NCT02707965|65233685|FG006|Overall Study|PI decisions|0|||
23406003|NCT02707965|65233686|FG007|Overall Study|PI decisions|0|||
23406004|NCT02707965|65233687|FG008|Overall Study|PI decisions|0|||
23406005|NCT02707965|65233688|FG009|Overall Study|PI decisions|0|||
23406006|NCT02707965|65233689|FG010|Overall Study|PI decisions|0|||
23406007|NCT02707965|65233690|FG011|Overall Study|PI decisions|0|||
23406008|NCT02707965|65233691|FG012|Overall Study|PI decisions|0|||
23406009|NCT02707965|65233692|FG013|Overall Study|PI decisions|0|||
23406010|NCT02707965|65233693|FG014|Overall Study|PI decisions|2|||
23406011|NCT02707965|65233694|FG015|Overall Study|PI decisions|0|||
23406012|NCT02707965|65233679|FG000|Overall Study|Protocol deviation|1|||
23406013|NCT02707965|65233680|FG001|Overall Study|Protocol deviation|1|||
23406014|NCT02707965|65233681|FG002|Overall Study|Protocol deviation|0|||
23406015|NCT02707965|65233682|FG003|Overall Study|Protocol deviation|0|||
23505718|NCT03547583|65588044|FG002|Overall Study|Lost to Follow-up|0|||
23505719|NCT03547583|65588042|FG000|Overall Study|Non-compliance with study drug|0|||
23406016|NCT02707965|65233683|FG004|Overall Study|Protocol deviation|0|||
23406017|NCT02707965|65233684|FG005|Overall Study|Protocol deviation|0|||
23406018|NCT02707965|65233685|FG006|Overall Study|Protocol deviation|0|||
23406019|NCT02707965|65233686|FG007|Overall Study|Protocol deviation|1|||
23406020|NCT02707965|65233687|FG008|Overall Study|Protocol deviation|0|||
23406021|NCT02707965|65233688|FG009|Overall Study|Protocol deviation|0|||
23406022|NCT02707965|65233689|FG010|Overall Study|Protocol deviation|0|||
23406023|NCT02707965|65233690|FG011|Overall Study|Protocol deviation|0|||
23406024|NCT02707965|65233691|FG012|Overall Study|Protocol deviation|0|||
23406025|NCT02707965|65233692|FG013|Overall Study|Protocol deviation|0|||
23406026|NCT02707965|65233693|FG014|Overall Study|Protocol deviation|0|||
23406027|NCT02707965|65233694|FG015|Overall Study|Protocol deviation|0|||
23406028|NCT02840253|65233695|FG000|Overall Study|Unsuccessful block|4|||
23406029|NCT00589797|65233697|FG000|Overall Study|Death|1|||
23406030|NCT00589797|65233698|FG001|Overall Study|Death|0|||
23406031|NCT00589797|65233697|FG000|Overall Study|Lost to Follow-up|12|||
23607211|NCT02106325|65950625|FG000|Phase 2|Lost to Follow-up|2|||
23406032|NCT00589797|65233698|FG001|Overall Study|Lost to Follow-up|9|||
23406033|NCT00589797|65233697|FG000|Overall Study|Physician Decision|8|||
23406034|NCT00589797|65233698|FG001|Overall Study|Physician Decision|3|||
23406035|NCT00589797|65233697|FG000|Overall Study|Withdrawal by Subject|6|||
23406036|NCT00589797|65233698|FG001|Overall Study|Withdrawal by Subject|5|||
23406037|NCT00589797|65233697|FG000|Overall Study|Non-Randomized Training Subjects|46|||
23406038|NCT00589797|65233698|FG001|Overall Study|Non-Randomized Training Subjects|6|||
23406039|NCT00881530|65233701|FG000|Overall Study|Adverse Event|5|||
23406040|NCT00881530|65233702|FG001|Overall Study|Adverse Event|1|||
23406041|NCT00881530|65233703|FG002|Overall Study|Adverse Event|1|||
23406042|NCT00881530|65233704|FG003|Overall Study|Adverse Event|4|||
23406043|NCT00881530|65233705|FG004|Overall Study|Adverse Event|10|||
23406044|NCT00881530|65233706|FG005|Overall Study|Adverse Event|2|||
23406045|NCT00881530|65233701|FG000|Overall Study|Lack of Efficacy|1|||
23406046|NCT00881530|65233702|FG001|Overall Study|Lack of Efficacy|0|||
23406047|NCT00881530|65233703|FG002|Overall Study|Lack of Efficacy|0|||
23406048|NCT00881530|65233704|FG003|Overall Study|Lack of Efficacy|0|||
23406049|NCT00881530|65233705|FG004|Overall Study|Lack of Efficacy|1|||
23406050|NCT00881530|65233706|FG005|Overall Study|Lack of Efficacy|1|||
23406051|NCT00881530|65233701|FG000|Overall Study|Not compliant with the protocol|0|||
23406052|NCT00881530|65233702|FG001|Overall Study|Not compliant with the protocol|0|||
23406053|NCT00881530|65233703|FG002|Overall Study|Not compliant with the protocol|0|||
23406054|NCT00881530|65233704|FG003|Overall Study|Not compliant with the protocol|0|||
23406055|NCT00881530|65233705|FG004|Overall Study|Not compliant with the protocol|2|||
23406056|NCT00881530|65233706|FG005|Overall Study|Not compliant with the protocol|0|||
23406057|NCT00881530|65233701|FG000|Overall Study|Lost to Follow-up|0|||
23406058|NCT00881530|65233702|FG001|Overall Study|Lost to Follow-up|1|||
23406059|NCT00881530|65233703|FG002|Overall Study|Lost to Follow-up|1|||
23406060|NCT00881530|65233704|FG003|Overall Study|Lost to Follow-up|3|||
23406061|NCT00881530|65233705|FG004|Overall Study|Lost to Follow-up|1|||
23406062|NCT00881530|65233706|FG005|Overall Study|Lost to Follow-up|0|||
23406063|NCT00881530|65233701|FG000|Overall Study|Refused to continue medication|7|||
23406064|NCT00881530|65233702|FG001|Overall Study|Refused to continue medication|2|||
23406065|NCT00881530|65233703|FG002|Overall Study|Refused to continue medication|1|||
23406066|NCT00881530|65233704|FG003|Overall Study|Refused to continue medication|2|||
23406067|NCT00881530|65233705|FG004|Overall Study|Refused to continue medication|0|||
23406068|NCT00881530|65233706|FG005|Overall Study|Refused to continue medication|0|||
23406069|NCT00881530|65233701|FG000|Overall Study|Other reason not defined above|1|||
23406070|NCT00881530|65233702|FG001|Overall Study|Other reason not defined above|1|||
23406071|NCT00881530|65233703|FG002|Overall Study|Other reason not defined above|2|||
23406072|NCT00881530|65233704|FG003|Overall Study|Other reason not defined above|0|||
23406073|NCT00881530|65233705|FG004|Overall Study|Other reason not defined above|0|||
23406074|NCT00881530|65233706|FG005|Overall Study|Other reason not defined above|2|||
23406075|NCT00466947|65233707|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
23406076|NCT00466947|65233708|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
23406077|NCT00466947|65233707|FG000|Study End Analysis Period|Adverse Event|35|||
23406078|NCT00466947|65233708|FG001|Study End Analysis Period|Adverse Event|43|||
23406079|NCT00466947|65233707|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
23406080|NCT00466947|65233708|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
23406081|NCT00466947|65233707|FG000|Study End Analysis Period|Physician Decision|29|||
23406082|NCT00466947|65233708|FG001|Study End Analysis Period|Physician Decision|29|||
23406083|NCT00466947|65233707|FG000|Study End Analysis Period|Protocol Violation|9|||
23406084|NCT00466947|65233708|FG001|Study End Analysis Period|Protocol Violation|17|||
23406085|NCT00466947|65233707|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
23406086|NCT00466947|65233708|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
23406087|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
23406088|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
23406089|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
23406090|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
23406091|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
23406092|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
23406093|NCT01853462|65233709|FG000|Overall Study|Withdrawal by Subject|1|||
23406094|NCT01853462|65233710|FG001|Overall Study|Withdrawal by Subject|1|||
23406095|NCT00582712|65233711|FG000|Overall Study|Adverse Event|1|||
23406096|NCT00582712|65233711|FG000|Overall Study|Lack of Efficacy|1|||
23406097|NCT00582712|65233711|FG000|Overall Study|Withdrawal by Subject|1|||
23406098|NCT00582712|65233711|FG000|Overall Study|Complicating disease requiring treatment|1|||
23406099|NCT01791517|65233712|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
23406100|NCT01791517|65233713|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
23406101|NCT01791517|65233714|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
23406102|NCT01791517|65233715|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
23406103|NCT01791517|65233716|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
23406104|NCT01791517|65233717|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
23406105|NCT01791517|65233718|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
23406106|NCT01791517|65233719|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
23406107|NCT01791517|65233720|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
23406108|NCT01791517|65233721|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
23505720|NCT03547583|65588043|FG001|Overall Study|Non-compliance with study drug|0|||
23505721|NCT03547583|65588044|FG002|Overall Study|Non-compliance with study drug|1|||
23505722|NCT03547583|65588042|FG000|Overall Study|Physician Decision|1|||
23505723|NCT03547583|65588043|FG001|Overall Study|Physician Decision|0|||
23505724|NCT03547583|65588044|FG002|Overall Study|Physician Decision|3|||
23505725|NCT03547583|65588042|FG000|Overall Study|Protocol Violation|2|||
23505726|NCT03547583|65588043|FG001|Overall Study|Protocol Violation|1|||
23505727|NCT03547583|65588044|FG002|Overall Study|Protocol Violation|1|||
23505728|NCT03547583|65588042|FG000|Overall Study|Withdrawal by Subject|12|||
23505729|NCT03547583|65588043|FG001|Overall Study|Withdrawal by Subject|19|||
23505730|NCT03547583|65588044|FG002|Overall Study|Withdrawal by Subject|10|||
23505731|NCT03547583|65588042|FG000|Overall Study|Other|2|||
23505732|NCT03547583|65588043|FG001|Overall Study|Other|2|||
23505733|NCT03547583|65588044|FG002|Overall Study|Other|3|||
23505734|NCT03066804|65588045|FG000|Overall Study|Physician Decision|0|||
23505735|NCT03066804|65588046|FG001|Overall Study|Physician Decision|4|||
23505736|NCT03066804|65588045|FG000|Overall Study|Death|23|||
23505737|NCT03066804|65588046|FG001|Overall Study|Death|17|||
23505738|NCT03066804|65588045|FG000|Overall Study|Withdrawal by Subject|19|||
23505739|NCT03066804|65588046|FG001|Overall Study|Withdrawal by Subject|25|||
23505740|NCT03066804|65588045|FG000|Overall Study|Lost to Follow-up|2|||
23505741|NCT03066804|65588046|FG001|Overall Study|Lost to Follow-up|0|||
23406109|NCT01791517|65233722|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
23406110|NCT01791517|65233723|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
23406111|NCT01791517|65233712|FG000|Phase I: Period 1|Adverse Event|0|||
23406112|NCT01791517|65233713|FG001|Phase I: Period 1|Adverse Event|0|||
23406113|NCT01791517|65233714|FG002|Phase I: Period 1|Adverse Event|1|||
23406114|NCT01791517|65233715|FG003|Phase I: Period 1|Adverse Event|1|||
23406115|NCT01791517|65233716|FG004|Phase I: Period 1|Adverse Event|0|||
23505742|NCT03066804|65588045|FG000|Overall Study|Adverse Event|2|||
23505743|NCT03066804|65588046|FG001|Overall Study|Adverse Event|3|||
23505744|NCT03066804|65588045|FG000|Overall Study|Technical problems|5|||
23505745|NCT03066804|65588046|FG001|Overall Study|Technical problems|1|||
23505746|NCT02601469|65588050|FG000|Overall Study|Enrolled in Error|1|||
23505747|NCT02601469|65588051|FG001|Overall Study|Enrolled in Error|0|||
23505748|NCT00217620|65588052|FG000|Overall Study|Adverse Event|2|||
23505749|NCT00217620|65588052|FG000|Overall Study|Progression|31|||
23505750|NCT00217620|65588052|FG000|Overall Study|Not Protocol Specified|4|||
23505751|NCT00217620|65588052|FG000|Overall Study|Ineligible|13|||
23406116|NCT01791517|65233717|FG005|Phase I: Period 1|Adverse Event|0|||
23406117|NCT01791517|65233718|FG006|Phase I: Period 1|Adverse Event|0|||
23406118|NCT01791517|65233719|FG007|Phase I: Period 1|Adverse Event|0|||
23406119|NCT01791517|65233720|FG008|Phase I: Period 1|Adverse Event|0|||
23406120|NCT01791517|65233721|FG009|Phase I: Period 1|Adverse Event|0|||
23406121|NCT01791517|65233722|FG010|Phase I: Period 1|Adverse Event|0|||
23406122|NCT01791517|65233723|FG011|Phase I: Period 1|Adverse Event|0|||
23406123|NCT01791517|65233712|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
23406124|NCT01791517|65233713|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406125|NCT01791517|65233714|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406126|NCT01791517|65233715|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406127|NCT01791517|65233716|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406128|NCT01791517|65233717|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406129|NCT01791517|65233718|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406130|NCT01791517|65233719|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406131|NCT01791517|65233720|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406132|NCT01791517|65233721|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23505752|NCT00217620|65588052|FG000|Overall Study|Never received treatment|1|||
23505753|NCT01709513|65588058|FG000|Overall Study|Randomized but not treated|0|||
23505754|NCT01709513|65588059|FG001|Overall Study|Randomized but not treated|1|||
23406133|NCT01791517|65233722|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406134|NCT01791517|65233723|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406135|NCT01791517|65233712|FG000|Phase I: Period 1|Protocol Violation|0|||
23406136|NCT01791517|65233713|FG001|Phase I: Period 1|Protocol Violation|1|||
23406137|NCT01791517|65233714|FG002|Phase I: Period 1|Protocol Violation|0|||
23406138|NCT01791517|65233715|FG003|Phase I: Period 1|Protocol Violation|0|||
23406139|NCT01791517|65233716|FG004|Phase I: Period 1|Protocol Violation|0|||
23406140|NCT01791517|65233717|FG005|Phase I: Period 1|Protocol Violation|0|||
23406141|NCT01791517|65233718|FG006|Phase I: Period 1|Protocol Violation|0|||
23406142|NCT01791517|65233719|FG007|Phase I: Period 1|Protocol Violation|0|||
23406143|NCT01791517|65233720|FG008|Phase I: Period 1|Protocol Violation|0|||
23406144|NCT01791517|65233721|FG009|Phase I: Period 1|Protocol Violation|0|||
23406145|NCT01791517|65233722|FG010|Phase I: Period 1|Protocol Violation|0|||
23406146|NCT01791517|65233723|FG011|Phase I: Period 1|Protocol Violation|0|||
23406147|NCT01791517|65233712|FG000|Phase I: Period 1|Lost to Follow-up|0|||
23406148|NCT01791517|65233713|FG001|Phase I: Period 1|Lost to Follow-up|0|||
23406149|NCT01791517|65233714|FG002|Phase I: Period 1|Lost to Follow-up|0|||
23406150|NCT01791517|65233715|FG003|Phase I: Period 1|Lost to Follow-up|1|||
23406151|NCT01791517|65233716|FG004|Phase I: Period 1|Lost to Follow-up|0|||
23406152|NCT01791517|65233717|FG005|Phase I: Period 1|Lost to Follow-up|0|||
23406153|NCT01791517|65233718|FG006|Phase I: Period 1|Lost to Follow-up|1|||
23406154|NCT01791517|65233719|FG007|Phase I: Period 1|Lost to Follow-up|0|||
23406155|NCT01791517|65233720|FG008|Phase I: Period 1|Lost to Follow-up|1|||
23406156|NCT01791517|65233721|FG009|Phase I: Period 1|Lost to Follow-up|1|||
23406157|NCT01791517|65233722|FG010|Phase I: Period 1|Lost to Follow-up|0|||
23406158|NCT01791517|65233723|FG011|Phase I: Period 1|Lost to Follow-up|0|||
23406159|NCT01791517|65233712|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406160|NCT01791517|65233713|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406161|NCT01791517|65233714|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406162|NCT01791517|65233715|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406163|NCT01791517|65233716|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406164|NCT01791517|65233717|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406165|NCT01791517|65233718|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406166|NCT01791517|65233719|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406167|NCT01791517|65233720|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406168|NCT01791517|65233721|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406169|NCT01791517|65233722|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406170|NCT01791517|65233723|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
23406171|NCT01791517|65233712|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
23406172|NCT01791517|65233713|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406173|NCT01791517|65233714|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406174|NCT01791517|65233715|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406175|NCT01791517|65233716|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23505755|NCT01709513|65588060|FG002|Overall Study|Randomized but not treated|0|||
23505756|NCT01709513|65588058|FG000|Overall Study|Adverse Event|16|||
23505757|NCT01709513|65588059|FG001|Overall Study|Adverse Event|31|||
23505758|NCT01709513|65588060|FG002|Overall Study|Adverse Event|23|||
23505759|NCT01709513|65588058|FG000|Overall Study|Poor compliance to protocol|2|||
23505760|NCT01709513|65588059|FG001|Overall Study|Poor compliance to protocol|0|||
23505761|NCT01709513|65588060|FG002|Overall Study|Poor compliance to protocol|0|||
23505762|NCT01709513|65588058|FG000|Overall Study|Other|3|||
23505763|NCT01709513|65588059|FG001|Overall Study|Other|11|||
23406176|NCT01791517|65233717|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406177|NCT01791517|65233718|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406178|NCT01791517|65233719|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406179|NCT01791517|65233720|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406180|NCT01791517|65233721|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406181|NCT01791517|65233722|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406182|NCT01791517|65233723|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406183|NCT01791517|65233712|FG000|Phase I: Period 2|Protocol Violation|0|||
23406184|NCT01791517|65233713|FG001|Phase I: Period 2|Protocol Violation|0|||
23406185|NCT01791517|65233714|FG002|Phase I: Period 2|Protocol Violation|0|||
23406186|NCT01791517|65233715|FG003|Phase I: Period 2|Protocol Violation|1|||
23406187|NCT01791517|65233716|FG004|Phase I: Period 2|Protocol Violation|0|||
23406188|NCT01791517|65233717|FG005|Phase I: Period 2|Protocol Violation|0|||
23406189|NCT01791517|65233718|FG006|Phase I: Period 2|Protocol Violation|0|||
23406190|NCT01791517|65233719|FG007|Phase I: Period 2|Protocol Violation|0|||
23406191|NCT01791517|65233720|FG008|Phase I: Period 2|Protocol Violation|0|||
23406192|NCT01791517|65233721|FG009|Phase I: Period 2|Protocol Violation|0|||
23406193|NCT01791517|65233722|FG010|Phase I: Period 2|Protocol Violation|0|||
23406194|NCT01791517|65233723|FG011|Phase I: Period 2|Protocol Violation|0|||
23505764|NCT01709513|65588060|FG002|Overall Study|Other|7|||
23505765|NCT04221009|65588061|FG000|Overall Study|Withdrawal by Subject|4|||
23406195|NCT01791517|65233712|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
23505766|NCT03329573|65588062|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23406196|NCT01791517|65233713|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
23505767|NCT03329573|65588063|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
23505768|NCT03329573|65588064|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23505769|NCT03329573|65588065|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23505770|NCT03329573|65588062|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23505771|NCT03329573|65588063|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
23505772|NCT03329573|65588064|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23505773|NCT03329573|65588065|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23505774|NCT03329573|65588062|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
23505775|NCT03329573|65588063|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505776|NCT03329573|65588064|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505777|NCT03329573|65588065|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505778|NCT03329573|65588062|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505779|NCT03329573|65588063|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
23505780|NCT03329573|65588064|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505781|NCT03329573|65588065|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505782|NCT01977794|65588072|FG000|Overall Study|Adverse Event|2|||
23505783|NCT01977794|65588073|FG001|Overall Study|Adverse Event|2|||
23505784|NCT01977794|65588072|FG000|Overall Study|Lost to Follow-up|2|||
23505785|NCT01977794|65588073|FG001|Overall Study|Lost to Follow-up|1|||
23505786|NCT01977794|65588072|FG000|Overall Study|Protocol Violation|1|||
23505787|NCT01977794|65588073|FG001|Overall Study|Protocol Violation|0|||
23505788|NCT01977794|65588072|FG000|Overall Study|Death|1|||
23505789|NCT01977794|65588073|FG001|Overall Study|Death|1|||
23505790|NCT01977794|65588072|FG000|Overall Study|Withdrew consent|2|||
23505791|NCT01977794|65588073|FG001|Overall Study|Withdrew consent|1|||
23505792|NCT01977794|65588072|FG000|Overall Study|Other|0|||
23505793|NCT01977794|65588073|FG001|Overall Study|Other|1|||
23505794|NCT00165776|65588074|FG000|Overall Study|Lack of Efficacy|0|||
23505795|NCT00165776|65588075|FG001|Overall Study|Lack of Efficacy|0|||
23505796|NCT00165776|65588076|FG002|Overall Study|Lack of Efficacy|0|||
23505797|NCT00165776|65588077|FG003|Overall Study|Lack of Efficacy|1|||
23505798|NCT00165776|65588074|FG000|Overall Study|Withdrawal by Subject|4|||
23505799|NCT00165776|65588075|FG001|Overall Study|Withdrawal by Subject|1|||
23505800|NCT00165776|65588076|FG002|Overall Study|Withdrawal by Subject|2|||
23505801|NCT00165776|65588077|FG003|Overall Study|Withdrawal by Subject|0|||
23505802|NCT00165776|65588074|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
23505803|NCT00165776|65588075|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
23505804|NCT00165776|65588076|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
23505805|NCT00165776|65588077|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
23505806|NCT02706691|65588078|FG000|Overall Study|Adverse Event|1|||
23505807|NCT00289991|65588081|FG000|Overall Study|Death|35|||
23505808|NCT00289991|65588082|FG001|Overall Study|Death|38|||
23505809|NCT00289991|65588081|FG000|Overall Study|Adverse Event|15|||
23505810|NCT00289991|65588082|FG001|Overall Study|Adverse Event|13|||
23505811|NCT00289991|65588081|FG000|Overall Study|Failure of prophylaxis|1|||
23505812|NCT00289991|65588082|FG001|Overall Study|Failure of prophylaxis|1|||
23505813|NCT00289991|65588081|FG000|Overall Study|Fungal breakthrough infection|0|||
23505814|NCT00289991|65588082|FG001|Overall Study|Fungal breakthrough infection|1|||
23505815|NCT00289991|65588081|FG000|Overall Study|Lost to Follow-up|0|||
23505816|NCT00289991|65588082|FG001|Overall Study|Lost to Follow-up|1|||
23505817|NCT00289991|65588081|FG000|Overall Study|Withdrawal by Subject|2|||
23505818|NCT00289991|65588082|FG001|Overall Study|Withdrawal by Subject|12|||
23505819|NCT00289991|65588081|FG000|Overall Study|Other|5|||
23505820|NCT00289991|65588082|FG001|Overall Study|Other|14|||
23505821|NCT01007812|65588083|FG000|Period 1, One Week|Lost to Follow-up|0|||
23505822|NCT01007812|65588084|FG001|Period 1, One Week|Lost to Follow-up|1|||
23505823|NCT01007812|65588083|FG000|Period 1, One Week|Discomfort|1|||
23505824|NCT01007812|65588084|FG001|Period 1, One Week|Discomfort|0|||
23406197|NCT01791517|65233714|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
23406198|NCT01791517|65233715|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
23406199|NCT01791517|65233716|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
23406200|NCT01791517|65233717|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
23406201|NCT01791517|65233718|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
23406202|NCT01791517|65233719|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
23406203|NCT01791517|65233720|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
23406204|NCT01791517|65233721|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
23406205|NCT01791517|65233722|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
23505825|NCT01673867|65588085|FG000|Randomization|Adverse event unrelated to study drug|1|||
23406206|NCT01791517|65233723|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
23505826|NCT01673867|65588086|FG001|Randomization|Adverse event unrelated to study drug|0|||
23505827|NCT01673867|65588085|FG000|Randomization|Participant request to discontinue study treatment|0|||
23505828|NCT01673867|65588086|FG001|Randomization|Participant request to discontinue study treatment|4|||
23505829|NCT01673867|65588085|FG000|Randomization|Withdrawal by participant|0|||
23406207|NCT01791517|65233712|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406208|NCT01791517|65233713|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23505830|NCT01673867|65588086|FG001|Randomization|Withdrawal by participant|12|||
23505831|NCT01673867|65588085|FG000|Randomization|Lost to Follow-up|0|||
23505832|NCT01673867|65588086|FG001|Randomization|Lost to Follow-up|1|||
23505833|NCT01673867|65588085|FG000|Randomization|Participant no longer meets study criteria|4|||
23505834|NCT01673867|65588086|FG001|Randomization|Participant no longer meets study criteria|5|||
23505835|NCT01673867|65588085|FG000|Treatment|Disease Progression|208|||
23505836|NCT01673867|65588086|FG001|Treatment|Disease Progression|178|||
23505837|NCT01673867|65588085|FG000|Treatment|Study Drug Toxicity|23|||
23505838|NCT01673867|65588086|FG001|Treatment|Study Drug Toxicity|43|||
23505839|NCT01673867|65588085|FG000|Treatment|Death|2|||
23505840|NCT01673867|65588086|FG001|Treatment|Death|3|||
23505841|NCT01673867|65588085|FG000|Treatment|Adverse event unrelated to study drug|23|||
23505842|NCT01673867|65588086|FG001|Treatment|Adverse event unrelated to study drug|10|||
23505843|NCT01673867|65588085|FG000|Treatment|Participant request to discontinue study treatment|7|||
23505844|NCT01673867|65588086|FG001|Treatment|Participant request to discontinue study treatment|17|||
23505845|NCT01673867|65588085|FG000|Treatment|Withdrawal by participant|5|||
23505846|NCT01673867|65588086|FG001|Treatment|Withdrawal by participant|5|||
23505847|NCT01673867|65588085|FG000|Treatment|Maximum clinical benefit|1|||
23505848|NCT01673867|65588086|FG001|Treatment|Maximum clinical benefit|10|||
23505849|NCT01673867|65588085|FG000|Treatment|Participant no longer meets study criteria|2|||
23505850|NCT01673867|65588086|FG001|Treatment|Participant no longer meets study criteria|0|||
23505851|NCT01673867|65588085|FG000|Treatment|Administrative reason by sponsor|3|||
23505852|NCT01673867|65588086|FG001|Treatment|Administrative reason by sponsor|0|||
23505853|NCT01673867|65588085|FG000|Treatment|Other reason|11|||
23505854|NCT01673867|65588086|FG001|Treatment|Other reason|2|||
23505855|NCT00541931|65588092|FG000|Overall Study|Adverse Event|1|||
23505856|NCT00541931|65588093|FG001|Overall Study|Adverse Event|0|||
23505857|NCT00541931|65588092|FG000|Overall Study|Lost to Follow-up|3|||
23505858|NCT00541931|65588093|FG001|Overall Study|Lost to Follow-up|3|||
23505859|NCT00541931|65588092|FG000|Overall Study|Withdrawal by Subject|1|||
23505860|NCT00541931|65588093|FG001|Overall Study|Withdrawal by Subject|0|||
23505861|NCT00541931|65588092|FG000|Overall Study|Transportation Issue|0|||
23505862|NCT00541931|65588093|FG001|Overall Study|Transportation Issue|1|||
23505863|NCT00790023|65588094|FG000|Overall Study|Adverse Event|2|||
23505864|NCT00790023|65588095|FG001|Overall Study|Adverse Event|1|||
23505865|NCT00790023|65588096|FG002|Overall Study|Adverse Event|4|||
23505866|NCT00790023|65588094|FG000|Overall Study|Protocol Violation|2|||
23505867|NCT00790023|65588095|FG001|Overall Study|Protocol Violation|4|||
23505868|NCT00790023|65588096|FG002|Overall Study|Protocol Violation|2|||
23505869|NCT00790023|65588094|FG000|Overall Study|Withdrawal by Subject|2|||
23505870|NCT00790023|65588095|FG001|Overall Study|Withdrawal by Subject|0|||
23505871|NCT00790023|65588096|FG002|Overall Study|Withdrawal by Subject|6|||
23505872|NCT00790023|65588094|FG000|Overall Study|Lost to Follow-up|0|||
23505873|NCT00790023|65588095|FG001|Overall Study|Lost to Follow-up|0|||
23505874|NCT00790023|65588096|FG002|Overall Study|Lost to Follow-up|1|||
23505875|NCT00790023|65588094|FG000|Overall Study|Other|5|||
23505876|NCT00790023|65588095|FG001|Overall Study|Other|5|||
23505877|NCT00790023|65588096|FG002|Overall Study|Other|8|||
23505878|NCT02144012|65588097|FG000|Overall Study|Adverse Event|1|||
23505879|NCT02144012|65588098|FG001|Overall Study|Adverse Event|0|||
23505880|NCT02144012|65588097|FG000|Overall Study|Death|1|||
23505881|NCT02144012|65588098|FG001|Overall Study|Death|0|||
23406209|NCT01791517|65233714|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406210|NCT01791517|65233715|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406211|NCT01791517|65233716|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406212|NCT01791517|65233717|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406213|NCT01791517|65233718|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406214|NCT01791517|65233719|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406215|NCT01791517|65233720|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406216|NCT01791517|65233721|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406217|NCT01791517|65233722|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
23505882|NCT02144012|65588097|FG000|Overall Study|Withdrawal by Subject|11|||
23505883|NCT02144012|65588098|FG001|Overall Study|Withdrawal by Subject|3|||
23505884|NCT02144012|65588097|FG000|Overall Study|Study Terminated by Sponsor|18|||
23505885|NCT02144012|65588098|FG001|Overall Study|Study Terminated by Sponsor|12|||
23505886|NCT02144012|65588097|FG000|Overall Study|Other|3|||
23505887|NCT02144012|65588098|FG001|Overall Study|Other|0|||
23505888|NCT03648541|65588106|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
23505889|NCT03648541|65588107|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
23505890|NCT03648541|65588106|FG000|Re-induction Period Only|Lack of Efficacy|7|||
23505891|NCT03648541|65588107|FG001|Re-induction Period Only|Lack of Efficacy|0|||
23505892|NCT03648541|65588106|FG000|Maintenance Period Only|Missing|0|||
23505893|NCT03648541|65588107|FG001|Maintenance Period Only|Missing|1|||
23505894|NCT03648541|65588106|FG000|Maintenance Period Only|Other not listed below|0|||
23406218|NCT01791517|65233723|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406219|NCT01791517|65233712|FG000|Phase I: Period 2|Lens Discomfort|0|||
23406220|NCT01791517|65233713|FG001|Phase I: Period 2|Lens Discomfort|0|||
23406221|NCT01791517|65233714|FG002|Phase I: Period 2|Lens Discomfort|0|||
23406222|NCT01791517|65233715|FG003|Phase I: Period 2|Lens Discomfort|0|||
23406223|NCT01791517|65233716|FG004|Phase I: Period 2|Lens Discomfort|0|||
23406224|NCT01791517|65233717|FG005|Phase I: Period 2|Lens Discomfort|1|||
23406225|NCT01791517|65233718|FG006|Phase I: Period 2|Lens Discomfort|0|||
23406226|NCT01791517|65233719|FG007|Phase I: Period 2|Lens Discomfort|0|||
23406227|NCT01791517|65233720|FG008|Phase I: Period 2|Lens Discomfort|0|||
23406228|NCT01791517|65233721|FG009|Phase I: Period 2|Lens Discomfort|0|||
23406229|NCT01791517|65233722|FG010|Phase I: Period 2|Lens Discomfort|0|||
23406230|NCT01791517|65233723|FG011|Phase I: Period 2|Lens Discomfort|0|||
23406231|NCT01791517|65233712|FG000|Phase I: Period 2|Lost to Follow-up|0|||
23406232|NCT01791517|65233713|FG001|Phase I: Period 2|Lost to Follow-up|3|||
23406233|NCT01791517|65233714|FG002|Phase I: Period 2|Lost to Follow-up|2|||
23406234|NCT01791517|65233715|FG003|Phase I: Period 2|Lost to Follow-up|0|||
23406235|NCT01791517|65233716|FG004|Phase I: Period 2|Lost to Follow-up|0|||
23406236|NCT01791517|65233717|FG005|Phase I: Period 2|Lost to Follow-up|0|||
23406237|NCT01791517|65233718|FG006|Phase I: Period 2|Lost to Follow-up|0|||
23406238|NCT01791517|65233719|FG007|Phase I: Period 2|Lost to Follow-up|0|||
23406239|NCT01791517|65233720|FG008|Phase I: Period 2|Lost to Follow-up|0|||
23406240|NCT01791517|65233721|FG009|Phase I: Period 2|Lost to Follow-up|0|||
23505895|NCT03648541|65588107|FG001|Maintenance Period Only|Other not listed below|4|||
23505896|NCT03648541|65588106|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
23505897|NCT03648541|65588107|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
23505898|NCT03648541|65588106|FG000|Maintenance Period Only|Protocol Violation|0|||
23505899|NCT03648541|65588107|FG001|Maintenance Period Only|Protocol Violation|1|||
23505900|NCT03648541|65588106|FG000|Maintenance Period Only|Lack of Efficacy|0|||
23505901|NCT03648541|65588107|FG001|Maintenance Period Only|Lack of Efficacy|18|||
23505902|NCT03648541|65588106|FG000|Maintenance Period Only|Adverse Event|0|||
23505903|NCT03648541|65588107|FG001|Maintenance Period Only|Adverse Event|4|||
23505904|NCT03648541|65588106|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
23505905|NCT03648541|65588107|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
23505906|NCT01919723|65588108|FG000|Overall Study|Blood Samples Hemolyzed|2|||
23505907|NCT01919723|65588109|FG001|Overall Study|Blood Samples Hemolyzed|2|||
23505908|NCT01844518|65588110|FG000|Overall Study|Adverse Event|7|||
23505909|NCT01844518|65588111|FG001|Overall Study|Adverse Event|1|||
23505910|NCT01844518|65588110|FG000|Overall Study|Lack of Efficacy|17|||
23505911|NCT01844518|65588111|FG001|Overall Study|Lack of Efficacy|5|||
23505912|NCT01844518|65588110|FG000|Overall Study|Participant's request to discontinue|4|||
23406241|NCT01791517|65233722|FG010|Phase I: Period 2|Lost to Follow-up|0|||
23406242|NCT01791517|65233723|FG011|Phase I: Period 2|Lost to Follow-up|0|||
23406243|NCT01791517|65233712|FG000|Phase I: Period 3|Lens Discomfort|0|||
23406244|NCT01791517|65233713|FG001|Phase I: Period 3|Lens Discomfort|0|||
23406245|NCT01791517|65233714|FG002|Phase I: Period 3|Lens Discomfort|0|||
23406246|NCT01791517|65233715|FG003|Phase I: Period 3|Lens Discomfort|0|||
23406247|NCT01791517|65233716|FG004|Phase I: Period 3|Lens Discomfort|0|||
23406248|NCT01791517|65233717|FG005|Phase I: Period 3|Lens Discomfort|0|||
23406249|NCT01791517|65233718|FG006|Phase I: Period 3|Lens Discomfort|0|||
23406250|NCT01791517|65233719|FG007|Phase I: Period 3|Lens Discomfort|0|||
23406251|NCT01791517|65233720|FG008|Phase I: Period 3|Lens Discomfort|0|||
23406252|NCT01791517|65233721|FG009|Phase I: Period 3|Lens Discomfort|0|||
23505913|NCT01844518|65588111|FG001|Overall Study|Participant's request to discontinue|1|||
23505914|NCT01844518|65588110|FG000|Overall Study|Poor/Non-compliance|1|||
23505915|NCT01844518|65588111|FG001|Overall Study|Poor/Non-compliance|0|||
23505916|NCT01844518|65588110|FG000|Overall Study|No Longer Met Study Criteria|2|||
23505917|NCT01844518|65588111|FG001|Overall Study|No Longer Met Study Criteria|0|||
23505918|NCT01844518|65588110|FG000|Overall Study|Withdrawal by Subject|9|||
23505919|NCT01844518|65588111|FG001|Overall Study|Withdrawal by Subject|0|||
23505920|NCT01844518|65588110|FG000|Overall Study|Pregnancy|1|||
23505921|NCT01844518|65588111|FG001|Overall Study|Pregnancy|0|||
23505922|NCT00855920|65590993|FG000|Overall Study|Protocol Violation|0|||
23505923|NCT00855920|65590994|FG001|Overall Study|Protocol Violation|0|||
23505924|NCT00855920|65590995|FG002|Overall Study|Protocol Violation|2|||
23505925|NCT00855920|65590993|FG000|Overall Study|Adverse Event|2|||
23406253|NCT01791517|65233722|FG010|Phase I: Period 3|Lens Discomfort|0|||
23406254|NCT01791517|65233723|FG011|Phase I: Period 3|Lens Discomfort|1|||
23406255|NCT01791517|65233712|FG000|Phase I: Period 3|Lost to Follow-up|0|||
23505926|NCT00855920|65590994|FG001|Overall Study|Adverse Event|1|||
23505927|NCT00855920|65590995|FG002|Overall Study|Adverse Event|1|||
23406256|NCT01791517|65233713|FG001|Phase I: Period 3|Lost to Follow-up|1|||
23406257|NCT01791517|65233714|FG002|Phase I: Period 3|Lost to Follow-up|0|||
23406258|NCT01791517|65233715|FG003|Phase I: Period 3|Lost to Follow-up|0|||
23406259|NCT01791517|65233716|FG004|Phase I: Period 3|Lost to Follow-up|1|||
23406260|NCT01791517|65233717|FG005|Phase I: Period 3|Lost to Follow-up|0|||
23406261|NCT01791517|65233718|FG006|Phase I: Period 3|Lost to Follow-up|0|||
23505928|NCT00855920|65590993|FG000|Overall Study|Lack of Efficacy|2|||
23505929|NCT00855920|65590994|FG001|Overall Study|Lack of Efficacy|2|||
23505930|NCT00855920|65590995|FG002|Overall Study|Lack of Efficacy|2|||
23505931|NCT00855920|65590993|FG000|Overall Study|Withdrawal by Subject|2|||
23505932|NCT00855920|65590994|FG001|Overall Study|Withdrawal by Subject|3|||
23505933|NCT00855920|65590995|FG002|Overall Study|Withdrawal by Subject|2|||
23505934|NCT00855920|65590993|FG000|Overall Study|Lost to Follow-up|1|||
23505935|NCT00855920|65590994|FG001|Overall Study|Lost to Follow-up|0|||
23505936|NCT00855920|65590995|FG002|Overall Study|Lost to Follow-up|2|||
23505937|NCT00855920|65590993|FG000|Overall Study|Death|0|||
23505938|NCT00855920|65590994|FG001|Overall Study|Death|1|||
23505939|NCT00855920|65590995|FG002|Overall Study|Death|0|||
23505940|NCT00855920|65590993|FG000|Overall Study|Decision by the sponsor|0|||
23505941|NCT00855920|65590994|FG001|Overall Study|Decision by the sponsor|1|||
23505942|NCT00855920|65590995|FG002|Overall Study|Decision by the sponsor|1|||
23505943|NCT00855920|65590993|FG000|Overall Study|Other than specified above|1|||
23505944|NCT00855920|65590994|FG001|Overall Study|Other than specified above|1|||
23505945|NCT00855920|65590995|FG002|Overall Study|Other than specified above|1|||
23505946|NCT00160693|65590996|FG000|Overall Study|Adverse Event|97|||
23505947|NCT00160693|65590996|FG000|Overall Study|Lack of Efficacy|30|||
23505948|NCT00160693|65590996|FG000|Overall Study|Protocol Violation|24|||
23505949|NCT00160693|65590996|FG000|Overall Study|Lost to Follow-up|15|||
23406262|NCT01791517|65233719|FG007|Phase I: Period 3|Lost to Follow-up|0|||
23505950|NCT00160693|65590996|FG000|Overall Study|Withdrawal by Subject|54|||
23505951|NCT00160693|65590996|FG000|Overall Study|Study terminated by sponsor|15|||
23505952|NCT02216591|65590997|FG000|Overall Study|Lost to Follow-up|0|||
23505953|NCT02216591|65590998|FG001|Overall Study|Lost to Follow-up|1|||
23505954|NCT04212650|65590999|FG000|Overall Study|Withdrawal by Subject|1|||
23505955|NCT04212650|65591000|FG001|Overall Study|Withdrawal by Subject|0|||
23406263|NCT01791517|65233720|FG008|Phase I: Period 3|Lost to Follow-up|0|||
23406264|NCT01791517|65233721|FG009|Phase I: Period 3|Lost to Follow-up|0|||
23406265|NCT01791517|65233722|FG010|Phase I: Period 3|Lost to Follow-up|0|||
23406266|NCT01791517|65233723|FG011|Phase I: Period 3|Lost to Follow-up|0|||
23406267|NCT01791517|65233712|FG000|Phase I: Period 3|Adverse Event|0|||
23505956|NCT01606436|65591005|FG000|Overall Study|Withdrawal by Subject|0|||
23505957|NCT01606436|65591006|FG001|Overall Study|Withdrawal by Subject|0|||
23505958|NCT01606436|65591007|FG002|Overall Study|Withdrawal by Subject|1|||
23505959|NCT01606436|65591008|FG003|Overall Study|Withdrawal by Subject|1|||
23505960|NCT01606436|65591009|FG004|Overall Study|Withdrawal by Subject|1|||
23505961|NCT01606436|65591010|FG005|Overall Study|Withdrawal by Subject|0|||
23505962|NCT01606436|65591005|FG000|Overall Study|Adverse Event|0|||
23505963|NCT01606436|65591006|FG001|Overall Study|Adverse Event|0|||
23505964|NCT01606436|65591007|FG002|Overall Study|Adverse Event|1|||
23505965|NCT01606436|65591008|FG003|Overall Study|Adverse Event|0|||
23505966|NCT01606436|65591009|FG004|Overall Study|Adverse Event|0|||
23505967|NCT01606436|65591010|FG005|Overall Study|Adverse Event|0|||
23505968|NCT01606436|65591005|FG000|Overall Study|Sponsor Decision|0|||
23505969|NCT01606436|65591006|FG001|Overall Study|Sponsor Decision|0|||
23505970|NCT01606436|65591007|FG002|Overall Study|Sponsor Decision|0|||
23505971|NCT01606436|65591008|FG003|Overall Study|Sponsor Decision|1|||
23505972|NCT01606436|65591009|FG004|Overall Study|Sponsor Decision|0|||
23505973|NCT01606436|65591010|FG005|Overall Study|Sponsor Decision|0|||
23505974|NCT00496054|65591011|FG000|Overall Study|Adverse Event|1|||
23505975|NCT00496054|65591011|FG000|Overall Study|Lost to Follow-up|7|||
23505976|NCT00687323|65591012|FG000|Overall Study|Death|25|||
23505977|NCT00687323|65591012|FG000|Overall Study|Withdrawal by Subject|1|||
23505978|NCT00687323|65591012|FG000|Overall Study|Excluded from efficacy evaluations|6|||
23505979|NCT00687323|65591012|FG000|Overall Study|Screen failure|148|||
23505980|NCT01949506|65591016|FG000|Overall Study|Physician Decision|1|||
23505981|NCT00737282|65591028|FG000|Overall Study|Study prematurely terminated|175|||
23505982|NCT01819831|65591029|FG000|Overall Study|Withdrawal by Subject|1|||
23505983|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
23505984|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
23505985|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
23505986|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505987|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505988|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505989|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505990|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505991|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505992|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505993|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505994|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
23505995|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505996|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
23505997|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505998|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505999|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506000|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506001|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506002|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506003|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506004|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506005|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
23506006|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
23506007|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
23506008|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506009|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23406268|NCT01791517|65233713|FG001|Phase I: Period 3|Adverse Event|0|||
23406269|NCT01791517|65233714|FG002|Phase I: Period 3|Adverse Event|0|||
23406270|NCT01791517|65233715|FG003|Phase I: Period 3|Adverse Event|1|||
23406271|NCT01791517|65233716|FG004|Phase I: Period 3|Adverse Event|0|||
23406272|NCT01791517|65233717|FG005|Phase I: Period 3|Adverse Event|0|||
23506010|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506011|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506012|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506013|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506014|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506015|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23607212|NCT02106325|65950626|FG001|Phase 2|Lost to Follow-up|3|||
23506016|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
23506017|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
23506018|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506019|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506020|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506021|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506022|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506023|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506024|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506025|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506026|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506027|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
23506028|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
23506029|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
23506030|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506031|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506032|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506033|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506034|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506035|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506036|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23406273|NCT01791517|65233718|FG006|Phase I: Period 3|Adverse Event|0|||
23406274|NCT01791517|65233719|FG007|Phase I: Period 3|Adverse Event|0|||
23406275|NCT01791517|65233720|FG008|Phase I: Period 3|Adverse Event|0|||
23406276|NCT01791517|65233721|FG009|Phase I: Period 3|Adverse Event|0|||
23406277|NCT01791517|65233722|FG010|Phase I: Period 3|Adverse Event|0|||
23406278|NCT01791517|65233723|FG011|Phase I: Period 3|Adverse Event|0|||
23406279|NCT01791517|65233712|FG000|Phase II|Lost to Follow-up|1|||
23406280|NCT01791517|65233713|FG001|Phase II|Lost to Follow-up|0|||
23406281|NCT01791517|65233714|FG002|Phase II|Lost to Follow-up|1|||
23406282|NCT01791517|65233715|FG003|Phase II|Lost to Follow-up|0|||
23406283|NCT01791517|65233716|FG004|Phase II|Lost to Follow-up|1|||
23406284|NCT01791517|65233717|FG005|Phase II|Lost to Follow-up|2|||
23406285|NCT01791517|65233718|FG006|Phase II|Lost to Follow-up|0|||
23406286|NCT01791517|65233719|FG007|Phase II|Lost to Follow-up|1|||
23406287|NCT01791517|65233720|FG008|Phase II|Lost to Follow-up|1|||
23406288|NCT01791517|65233721|FG009|Phase II|Lost to Follow-up|1|||
23406289|NCT01791517|65233722|FG010|Phase II|Lost to Follow-up|0|||
23406290|NCT01791517|65233723|FG011|Phase II|Lost to Follow-up|0|||
23406291|NCT01791517|65233712|FG000|Phase II|Withdrawal by Subject|1|||
23406292|NCT01791517|65233713|FG001|Phase II|Withdrawal by Subject|0|||
23406293|NCT01791517|65233714|FG002|Phase II|Withdrawal by Subject|0|||
23406294|NCT01791517|65233715|FG003|Phase II|Withdrawal by Subject|0|||
23406295|NCT01791517|65233716|FG004|Phase II|Withdrawal by Subject|0|||
23406296|NCT01791517|65233717|FG005|Phase II|Withdrawal by Subject|2|||
23406297|NCT01791517|65233718|FG006|Phase II|Withdrawal by Subject|0|||
23406298|NCT01791517|65233719|FG007|Phase II|Withdrawal by Subject|1|||
23506037|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506038|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506039|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
23506040|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
23506041|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506042|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506043|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506044|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506045|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506046|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506047|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506048|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506049|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506050|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
23506051|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506052|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506053|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506054|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506055|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506056|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506057|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506058|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506059|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506060|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506061|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506062|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506063|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506064|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
23607213|NCT02106325|65950625|FG000|Phase 3|Lost to Follow-up|2|||
23607214|NCT02106325|65950626|FG001|Phase 3|Lost to Follow-up|1|||
23607215|NCT02268851|65950627|FG000|Overall Study|Death|0|||
23607216|NCT02268851|65950628|FG001|Overall Study|Death|0|||
23607217|NCT02268851|65950629|FG002|Overall Study|Death|0|||
23607218|NCT02268851|65950630|FG003|Overall Study|Death|1|||
23607219|NCT02268851|65950631|FG004|Overall Study|Death|2|||
23607220|NCT02268851|65950632|FG005|Overall Study|Death|1|||
23607221|NCT02268851|65950627|FG000|Overall Study|Adverse Event|0|||
23607222|NCT02268851|65950628|FG001|Overall Study|Adverse Event|0|||
23607223|NCT02268851|65950629|FG002|Overall Study|Adverse Event|0|||
23607224|NCT02268851|65950630|FG003|Overall Study|Adverse Event|0|||
23607225|NCT02268851|65950631|FG004|Overall Study|Adverse Event|2|||
23607226|NCT02268851|65950632|FG005|Overall Study|Adverse Event|2|||
23607227|NCT02268851|65950627|FG000|Overall Study|Withdrawal by Subject|0|||
23607228|NCT02268851|65950628|FG001|Overall Study|Withdrawal by Subject|0|||
23607229|NCT02268851|65950629|FG002|Overall Study|Withdrawal by Subject|0|||
23607230|NCT02268851|65950630|FG003|Overall Study|Withdrawal by Subject|2|||
23607231|NCT02268851|65950631|FG004|Overall Study|Withdrawal by Subject|0|||
23607232|NCT02268851|65950632|FG005|Overall Study|Withdrawal by Subject|1|||
23607233|NCT02268851|65950627|FG000|Overall Study|Progressive Disease|1|||
23607234|NCT02268851|65950628|FG001|Overall Study|Progressive Disease|3|||
23607235|NCT02268851|65950629|FG002|Overall Study|Progressive Disease|0|||
23607236|NCT02268851|65950630|FG003|Overall Study|Progressive Disease|0|||
23607237|NCT02268851|65950631|FG004|Overall Study|Progressive Disease|1|||
23607238|NCT02268851|65950632|FG005|Overall Study|Progressive Disease|4|||
23607239|NCT02268851|65950627|FG000|Overall Study|Physician Decision|0|||
23607240|NCT02268851|65950628|FG001|Overall Study|Physician Decision|0|||
23607241|NCT02268851|65950629|FG002|Overall Study|Physician Decision|1|||
23607242|NCT02268851|65950630|FG003|Overall Study|Physician Decision|0|||
23607243|NCT02268851|65950631|FG004|Overall Study|Physician Decision|0|||
23607244|NCT02268851|65950632|FG005|Overall Study|Physician Decision|1|||
23607245|NCT02268851|65950627|FG000|Overall Study|Patient Compliance|0|||
23607246|NCT02268851|65950628|FG001|Overall Study|Patient Compliance|0|||
23607247|NCT02268851|65950629|FG002|Overall Study|Patient Compliance|0|||
23607248|NCT02268851|65950630|FG003|Overall Study|Patient Compliance|0|||
23607249|NCT02268851|65950631|FG004|Overall Study|Patient Compliance|1|||
23607250|NCT02268851|65950632|FG005|Overall Study|Patient Compliance|1|||
23607251|NCT02268851|65950627|FG000|Overall Study|Co-Morbid Condition|0|||
23607252|NCT02268851|65950628|FG001|Overall Study|Co-Morbid Condition|0|||
23607253|NCT02268851|65950629|FG002|Overall Study|Co-Morbid Condition|0|||
23607254|NCT02268851|65950630|FG003|Overall Study|Co-Morbid Condition|0|||
23607255|NCT02268851|65950631|FG004|Overall Study|Co-Morbid Condition|1|||
23607256|NCT02268851|65950632|FG005|Overall Study|Co-Morbid Condition|1|||
23607257|NCT01084772|65950633|FG000|Baseline|Withdrawal by Subject|7|||
23607258|NCT01084772|65950634|FG001|Baseline|Withdrawal by Subject|6|||
23607259|NCT01084772|65950633|FG000|3 Months|Death|1|||
23607260|NCT01084772|65950634|FG001|3 Months|Death|0|||
23607261|NCT01084772|65950633|FG000|3 Months|Study Termination|2|||
23607262|NCT01084772|65950634|FG001|3 Months|Study Termination|2|||
23607263|NCT01084772|65950633|FG000|1 Year|Withdrawal by Subject|0|||
23607264|NCT01084772|65950634|FG001|1 Year|Withdrawal by Subject|1|||
23607265|NCT01084772|65950633|FG000|1 Year|Lost to Follow-up|3|||
23607266|NCT01084772|65950634|FG001|1 Year|Lost to Follow-up|0|||
23607267|NCT01084772|65950633|FG000|1 Year|Study Termination|0|||
23607268|NCT01084772|65950634|FG001|1 Year|Study Termination|7|||
23607269|NCT01084772|65950633|FG000|2 Years|Withdrawal by Subject|1|||
23607270|NCT01084772|65950634|FG001|2 Years|Withdrawal by Subject|0|||
23607271|NCT01084772|65950633|FG000|2 Years|Lost to Follow-up|5|||
23607272|NCT01084772|65950634|FG001|2 Years|Lost to Follow-up|2|||
23607273|NCT01084772|65950633|FG000|2 Years|Study Termination|3|||
23607274|NCT01084772|65950634|FG001|2 Years|Study Termination|2|||
23607275|NCT00799409|65950638|FG000|Overall Study|Withdrawal by Subject|1|||
23607276|NCT00799409|65950639|FG001|Overall Study|Withdrawal by Subject|0|||
23607277|NCT00799409|65950640|FG002|Overall Study|Withdrawal by Subject|0|||
23607278|NCT00799409|65950638|FG000|Overall Study|Lost to Follow-up|1|||
23607279|NCT00799409|65950639|FG001|Overall Study|Lost to Follow-up|0|||
23607280|NCT00799409|65950640|FG002|Overall Study|Lost to Follow-up|0|||
23607281|NCT00799409|65950638|FG000|Overall Study|Optimal Dose Not Achieved|2|||
23607282|NCT00799409|65950639|FG001|Overall Study|Optimal Dose Not Achieved|0|||
23607283|NCT00799409|65950640|FG002|Overall Study|Optimal Dose Not Achieved|0|||
23607284|NCT00799409|65950638|FG000|Overall Study|Failure to follow study protocol)|1|||
23607285|NCT00799409|65950639|FG001|Overall Study|Failure to follow study protocol)|0|||
23607286|NCT00799409|65950640|FG002|Overall Study|Failure to follow study protocol)|0|||
23607287|NCT00799409|65950638|FG000|Overall Study|Did not attend lab school day 1|1|||
23607288|NCT00799409|65950639|FG001|Overall Study|Did not attend lab school day 1|0|||
23607289|NCT00799409|65950640|FG002|Overall Study|Did not attend lab school day 1|0|||
23607290|NCT00799409|65950638|FG000|Overall Study|medication compliance|1|||
23607291|NCT00799409|65950639|FG001|Overall Study|medication compliance|0|||
23607292|NCT00799409|65950640|FG002|Overall Study|medication compliance|0|||
23607293|NCT01220999|65950647|FG000|Overall Study|Progressive disease|0|||
23607294|NCT01220999|65950648|FG001|Overall Study|Progressive disease|0|||
23607295|NCT01220999|65950649|FG002|Overall Study|Progressive disease|1|||
23607296|NCT01220999|65950650|FG003|Overall Study|Progressive disease|0|||
23607297|NCT01220999|65950651|FG004|Overall Study|Progressive disease|0|||
23607298|NCT00413283|65950652|FG000|Overall Study|Withdrawal by Subject|1|||
23607299|NCT00413283|65950653|FG001|Overall Study|Withdrawal by Subject|0|||
23506065|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
23506066|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506067|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506068|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23607300|NCT00413283|65950654|FG002|Overall Study|Withdrawal by Subject|0|||
23607301|NCT00413283|65950655|FG003|Overall Study|Withdrawal by Subject|1|||
23607302|NCT00413283|65950652|FG000|Overall Study|Death|0|||
23607303|NCT00413283|65950653|FG001|Overall Study|Death|0|||
23607304|NCT00413283|65950654|FG002|Overall Study|Death|1|||
23607305|NCT00413283|65950655|FG003|Overall Study|Death|1|||
23506069|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506070|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506071|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506072|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506073|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506074|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506075|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506076|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
23506077|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506078|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506079|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506080|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506081|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506082|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506083|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506084|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506085|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
23607306|NCT00413283|65950652|FG000|Overall Study|Adverse Event|0|||
23607307|NCT00413283|65950653|FG001|Overall Study|Adverse Event|0|||
23607308|NCT00413283|65950654|FG002|Overall Study|Adverse Event|0|||
23607309|NCT00413283|65950655|FG003|Overall Study|Adverse Event|1|||
23607310|NCT00413283|65950652|FG000|Overall Study|Ineligibility determined|0|||
23607311|NCT00413283|65950653|FG001|Overall Study|Ineligibility determined|0|||
23607312|NCT00413283|65950654|FG002|Overall Study|Ineligibility determined|0|||
23607313|NCT00413283|65950655|FG003|Overall Study|Ineligibility determined|1|||
23506086|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
23506087|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
23506088|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506089|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506090|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506091|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506092|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506093|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506094|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506095|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506096|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
23506097|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
23506098|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
23506099|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506100|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506101|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506102|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506103|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506104|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23607314|NCT00413283|65950652|FG000|Overall Study|Protocol deviation|0|||
23607315|NCT00413283|65950653|FG001|Overall Study|Protocol deviation|1|||
23607316|NCT00413283|65950654|FG002|Overall Study|Protocol deviation|0|||
23607317|NCT00413283|65950655|FG003|Overall Study|Protocol deviation|0|||
23607318|NCT00413283|65950652|FG000|Overall Study|Requirement for alternative therapy|0|||
23607319|NCT00413283|65950653|FG001|Overall Study|Requirement for alternative therapy|2|||
23607320|NCT00413283|65950654|FG002|Overall Study|Requirement for alternative therapy|0|||
23607321|NCT00413283|65950655|FG003|Overall Study|Requirement for alternative therapy|0|||
23607322|NCT00413283|65950652|FG000|Overall Study|Other|0|||
23607323|NCT00413283|65950653|FG001|Overall Study|Other|0|||
23607324|NCT00413283|65950654|FG002|Overall Study|Other|1|||
23607325|NCT00413283|65950655|FG003|Overall Study|Other|0|||
23607326|NCT00886834|65950658|FG000|Overall Study|Protocol Violation|0|||
23607327|NCT00886834|65950659|FG001|Overall Study|Protocol Violation|3|||
23607328|NCT02002689|65950660|FG000|Overall Study|Disease Progression|7|||
23607329|NCT02002689|65950660|FG000|Overall Study|Adverse Event|3|||
23607330|NCT01000649|65950661|FG000|Overall Study|Adverse Event|5|||
23607331|NCT01000649|65950662|FG001|Overall Study|Adverse Event|1|||
23607332|NCT01000649|65950663|FG002|Overall Study|Adverse Event|2|||
23607333|NCT01000649|65950664|FG003|Overall Study|Adverse Event|4|||
23506105|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506106|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506107|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
23607334|NCT01000649|65950661|FG000|Overall Study|Lost to Follow-up|0|||
23607335|NCT01000649|65950662|FG001|Overall Study|Lost to Follow-up|2|||
23607336|NCT01000649|65950663|FG002|Overall Study|Lost to Follow-up|0|||
23607337|NCT01000649|65950664|FG003|Overall Study|Lost to Follow-up|2|||
23607338|NCT02442622|65950666|FG000|Overall Study|Withdrawal by Subject|3|||
23607339|NCT02442622|65950667|FG001|Overall Study|Withdrawal by Subject|1|||
23607340|NCT04131556|65950678|FG000|Overall Study|Adverse Event|1|||
23607341|NCT04131556|65950678|FG000|Overall Study|Withdrawal by Subject|1|||
23607342|NCT03031782|65950679|FG000|Treatment Period 1|Lack of Efficacy|3|||
23607343|NCT03031782|65950680|FG001|Treatment Period 1|Lack of Efficacy|0|||
23607344|NCT03031782|65950681|FG002|Treatment Period 1|Lack of Efficacy|0|||
23607345|NCT03031782|65950682|FG003|Treatment Period 1|Lack of Efficacy|0|||
23607346|NCT03031782|65950683|FG004|Treatment Period 1|Lack of Efficacy|0|||
23607347|NCT03031782|65950679|FG000|Treatment Period 2|Physician Decision|0|||
23607348|NCT03031782|65950680|FG001|Treatment Period 2|Physician Decision|1|||
23607349|NCT03031782|65950681|FG002|Treatment Period 2|Physician Decision|0|||
23607350|NCT03031782|65950682|FG003|Treatment Period 2|Physician Decision|0|||
23506108|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506109|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
23506110|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506111|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506112|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506113|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506114|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506115|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506116|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506117|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506118|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
23506119|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506120|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506121|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506122|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506123|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506124|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
23607351|NCT03031782|65950683|FG004|Treatment Period 2|Physician Decision|3|||
23607352|NCT03031782|65950679|FG000|Treatment Period 2|Lack of Efficacy|0|||
23607353|NCT03031782|65950680|FG001|Treatment Period 2|Lack of Efficacy|1|||
23607354|NCT03031782|65950681|FG002|Treatment Period 2|Lack of Efficacy|0|||
23607355|NCT03031782|65950682|FG003|Treatment Period 2|Lack of Efficacy|0|||
23506125|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506126|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506127|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506128|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506129|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506130|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506131|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506132|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
23506133|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
23506134|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
23506135|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
23506136|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506137|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506138|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506139|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506140|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506141|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506142|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506143|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506144|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
23506145|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23607356|NCT03031782|65950683|FG004|Treatment Period 2|Lack of Efficacy|1|||
23607357|NCT03031782|65950679|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23607358|NCT03031782|65950680|FG001|Treatment Period 2|Withdrawal by Subject|3|||
23406299|NCT01791517|65233720|FG008|Phase II|Withdrawal by Subject|0|||
23406300|NCT01791517|65233721|FG009|Phase II|Withdrawal by Subject|0|||
23406301|NCT01791517|65233722|FG010|Phase II|Withdrawal by Subject|1|||
23506146|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506147|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23406302|NCT01791517|65233723|FG011|Phase II|Withdrawal by Subject|0|||
23506148|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23406303|NCT01791517|65233712|FG000|Phase II|Lack of Efficacy|0|||
23406304|NCT01791517|65233713|FG001|Phase II|Lack of Efficacy|0|||
23406305|NCT01791517|65233714|FG002|Phase II|Lack of Efficacy|0|||
23406306|NCT01791517|65233715|FG003|Phase II|Lack of Efficacy|0|||
23506149|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23406307|NCT01791517|65233716|FG004|Phase II|Lack of Efficacy|1|||
23406308|NCT01791517|65233717|FG005|Phase II|Lack of Efficacy|0|||
23406309|NCT01791517|65233718|FG006|Phase II|Lack of Efficacy|0|||
23506150|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506151|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23607359|NCT03031782|65950681|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23607360|NCT03031782|65950682|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23406310|NCT01791517|65233719|FG007|Phase II|Lack of Efficacy|0|||
23406311|NCT01791517|65233720|FG008|Phase II|Lack of Efficacy|0|||
23406312|NCT01791517|65233721|FG009|Phase II|Lack of Efficacy|0|||
23406313|NCT01791517|65233722|FG010|Phase II|Lack of Efficacy|0|||
23406314|NCT01791517|65233723|FG011|Phase II|Lack of Efficacy|0|||
23406315|NCT01791517|65233712|FG000|Phase II|Adverse Event|0|||
23406316|NCT01791517|65233713|FG001|Phase II|Adverse Event|0|||
23406317|NCT01791517|65233714|FG002|Phase II|Adverse Event|0|||
23406318|NCT01791517|65233715|FG003|Phase II|Adverse Event|0|||
23406319|NCT01791517|65233716|FG004|Phase II|Adverse Event|0|||
23406320|NCT01791517|65233717|FG005|Phase II|Adverse Event|0|||
23406321|NCT01791517|65233718|FG006|Phase II|Adverse Event|2|||
23406322|NCT01791517|65233719|FG007|Phase II|Adverse Event|1|||
23406323|NCT01791517|65233720|FG008|Phase II|Adverse Event|0|||
23406324|NCT01791517|65233721|FG009|Phase II|Adverse Event|1|||
23406325|NCT01791517|65233722|FG010|Phase II|Adverse Event|0|||
23406326|NCT01791517|65233723|FG011|Phase II|Adverse Event|0|||
23406327|NCT01791517|65233712|FG000|Phase II|Lens Handling Difficulties|0|||
23406328|NCT01791517|65233713|FG001|Phase II|Lens Handling Difficulties|0|||
23406329|NCT01791517|65233714|FG002|Phase II|Lens Handling Difficulties|0|||
23406330|NCT01791517|65233715|FG003|Phase II|Lens Handling Difficulties|0|||
23406331|NCT01791517|65233716|FG004|Phase II|Lens Handling Difficulties|0|||
23406332|NCT01791517|65233717|FG005|Phase II|Lens Handling Difficulties|0|||
23406333|NCT01791517|65233718|FG006|Phase II|Lens Handling Difficulties|0|||
23406334|NCT01791517|65233719|FG007|Phase II|Lens Handling Difficulties|0|||
23406335|NCT01791517|65233720|FG008|Phase II|Lens Handling Difficulties|1|||
23406336|NCT01791517|65233721|FG009|Phase II|Lens Handling Difficulties|0|||
23406337|NCT01791517|65233722|FG010|Phase II|Lens Handling Difficulties|0|||
23406338|NCT01791517|65233723|FG011|Phase II|Lens Handling Difficulties|0|||
23406339|NCT01791517|65233712|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
23406340|NCT01791517|65233713|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
23406341|NCT01791517|65233714|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
23406342|NCT01791517|65233715|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
23406343|NCT01791517|65233716|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
23406344|NCT01791517|65233717|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
23406345|NCT01791517|65233718|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
23406346|NCT01791517|65233719|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
23406347|NCT01791517|65233720|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
23406348|NCT01791517|65233721|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
23406349|NCT01791517|65233722|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
23406350|NCT01791517|65233723|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
23406351|NCT01791517|65233712|FG000|Phase II|Pre-Existing Ocular Issue|0|||
23406352|NCT01791517|65233713|FG001|Phase II|Pre-Existing Ocular Issue|0|||
23406353|NCT01791517|65233714|FG002|Phase II|Pre-Existing Ocular Issue|0|||
23406354|NCT01791517|65233715|FG003|Phase II|Pre-Existing Ocular Issue|0|||
23406355|NCT01791517|65233716|FG004|Phase II|Pre-Existing Ocular Issue|0|||
23406356|NCT01791517|65233717|FG005|Phase II|Pre-Existing Ocular Issue|0|||
23406357|NCT01791517|65233718|FG006|Phase II|Pre-Existing Ocular Issue|0|||
23406358|NCT01791517|65233719|FG007|Phase II|Pre-Existing Ocular Issue|0|||
23406359|NCT01791517|65233720|FG008|Phase II|Pre-Existing Ocular Issue|0|||
23406360|NCT01791517|65233721|FG009|Phase II|Pre-Existing Ocular Issue|0|||
23406361|NCT01791517|65233722|FG010|Phase II|Pre-Existing Ocular Issue|0|||
23406362|NCT01791517|65233723|FG011|Phase II|Pre-Existing Ocular Issue|1|||
23406363|NCT01694433|65233724|FG000|Overall Study|Adverse Event|7|||
23406364|NCT01694433|65233725|FG001|Overall Study|Adverse Event|0|||
23406365|NCT01694433|65233724|FG000|Overall Study|Physician Decision|1|||
23406366|NCT01694433|65233725|FG001|Overall Study|Physician Decision|0|||
23406367|NCT01694433|65233724|FG000|Overall Study|Withdrawal by Subject|3|||
23406368|NCT01694433|65233725|FG001|Overall Study|Withdrawal by Subject|4|||
23406369|NCT03456700|65233726|FG000|Overall Study|Withdrawal by Subject|1|||
23406370|NCT02336815|65233727|FG000|Overall Study|Disease Progression|45|||
23406371|NCT02336815|65233728|FG001|Overall Study|Disease Progression|70|||
23406372|NCT02336815|65233727|FG000|Overall Study|Adverse Event|18|||
23406373|NCT02336815|65233728|FG001|Overall Study|Adverse Event|39|||
23406374|NCT02336815|65233727|FG000|Overall Study|Physician Decision|11|||
23406375|NCT02336815|65233728|FG001|Overall Study|Physician Decision|4|||
23406376|NCT02336815|65233727|FG000|Overall Study|Withdrawal by Subject|3|||
23406377|NCT02336815|65233728|FG001|Overall Study|Withdrawal by Subject|2|||
23406378|NCT02336815|65233727|FG000|Overall Study|Lost to Follow-up|1|||
23406379|NCT02336815|65233728|FG001|Overall Study|Lost to Follow-up|3|||
23406380|NCT02336815|65233727|FG000|Overall Study|Other|1|||
23406381|NCT02336815|65233728|FG001|Overall Study|Other|5|||
23406382|NCT02131662|65233729|FG000|Overall Study|Protocol Violation|1|||
23406383|NCT02131662|65233730|FG001|Overall Study|Protocol Violation|0|||
23406384|NCT02131662|65233731|FG002|Overall Study|Protocol Violation|0|||
23406385|NCT02131662|65233732|FG003|Overall Study|Protocol Violation|0|||
23406386|NCT02131662|65233733|FG004|Overall Study|Protocol Violation|0|||
23406387|NCT02131662|65233729|FG000|Overall Study|Other|2|||
23406388|NCT02131662|65233730|FG001|Overall Study|Other|4|||
23406389|NCT02131662|65233731|FG002|Overall Study|Other|3|||
23406390|NCT02131662|65233732|FG003|Overall Study|Other|3|||
23406391|NCT02131662|65233733|FG004|Overall Study|Other|4|||
23406392|NCT02131662|65233729|FG000|Overall Study|Adverse Event|0|||
23406393|NCT02131662|65233730|FG001|Overall Study|Adverse Event|1|||
23406394|NCT02131662|65233731|FG002|Overall Study|Adverse Event|1|||
23406395|NCT02131662|65233732|FG003|Overall Study|Adverse Event|1|||
23406396|NCT02131662|65233733|FG004|Overall Study|Adverse Event|3|||
23406397|NCT02131662|65233729|FG000|Overall Study|Pregnancy|0|||
23406398|NCT02131662|65233730|FG001|Overall Study|Pregnancy|1|||
23406399|NCT02131662|65233731|FG002|Overall Study|Pregnancy|0|||
23406400|NCT02131662|65233732|FG003|Overall Study|Pregnancy|1|||
23406401|NCT02131662|65233733|FG004|Overall Study|Pregnancy|0|||
23406402|NCT02131662|65233729|FG000|Overall Study|Wish for pregnancy|0|||
23406403|NCT02131662|65233730|FG001|Overall Study|Wish for pregnancy|0|||
23406404|NCT02131662|65233731|FG002|Overall Study|Wish for pregnancy|0|||
23406405|NCT02131662|65233732|FG003|Overall Study|Wish for pregnancy|0|||
23406406|NCT02131662|65233733|FG004|Overall Study|Wish for pregnancy|1|||
23406407|NCT02131662|65233729|FG000|Overall Study|Lack of Efficacy|1|||
23406408|NCT02131662|65233730|FG001|Overall Study|Lack of Efficacy|0|||
23406409|NCT02131662|65233731|FG002|Overall Study|Lack of Efficacy|0|||
23406410|NCT02131662|65233732|FG003|Overall Study|Lack of Efficacy|0|||
23406411|NCT02131662|65233733|FG004|Overall Study|Lack of Efficacy|1|||
23406412|NCT02131662|65233729|FG000|Overall Study|Withdrawal by Subject|1|||
23406413|NCT02131662|65233730|FG001|Overall Study|Withdrawal by Subject|5|||
23406414|NCT02131662|65233731|FG002|Overall Study|Withdrawal by Subject|1|||
23406415|NCT02131662|65233732|FG003|Overall Study|Withdrawal by Subject|5|||
23406416|NCT02131662|65233733|FG004|Overall Study|Withdrawal by Subject|6|||
23406417|NCT02131662|65233729|FG000|Overall Study|Lost to Follow-up|1|||
23406418|NCT02131662|65233730|FG001|Overall Study|Lost to Follow-up|3|||
23406419|NCT02131662|65233731|FG002|Overall Study|Lost to Follow-up|0|||
23406420|NCT02131662|65233732|FG003|Overall Study|Lost to Follow-up|9|||
23406421|NCT02131662|65233733|FG004|Overall Study|Lost to Follow-up|0|||
23406422|NCT02131662|65233729|FG000|Overall Study|Not treated|2|||
23406423|NCT02131662|65233730|FG001|Overall Study|Not treated|0|||
23406424|NCT02131662|65233731|FG002|Overall Study|Not treated|2|||
23406425|NCT02131662|65233732|FG003|Overall Study|Not treated|2|||
23406426|NCT02131662|65233733|FG004|Overall Study|Not treated|3|||
23406427|NCT03943290|65233734|FG000|Overall Study|Sponsor Terminated Study|6|||
23406428|NCT03943290|65233735|FG001|Overall Study|Sponsor Terminated Study|1|||
23406429|NCT03943290|65233736|FG002|Overall Study|Sponsor Terminated Study|11|||
23406430|NCT03943290|65233737|FG003|Overall Study|Sponsor Terminated Study|6|||
23406431|NCT03943290|65233738|FG004|Overall Study|Sponsor Terminated Study|7|||
23406432|NCT03943290|65233739|FG005|Overall Study|Sponsor Terminated Study|6|||
23406433|NCT03943290|65233740|FG006|Overall Study|Sponsor Terminated Study|6|||
23406434|NCT03943290|65233741|FG007|Overall Study|Sponsor Terminated Study|7|||
23406435|NCT03943290|65233742|FG008|Overall Study|Sponsor Terminated Study|8|||
23406436|NCT03943290|65233734|FG000|Overall Study|Lost to Follow-up|1|||
23406437|NCT03943290|65233735|FG001|Overall Study|Lost to Follow-up|0|||
23406438|NCT03943290|65233736|FG002|Overall Study|Lost to Follow-up|1|||
23406439|NCT03943290|65233737|FG003|Overall Study|Lost to Follow-up|0|||
23406440|NCT03943290|65233738|FG004|Overall Study|Lost to Follow-up|0|||
23406441|NCT03943290|65233739|FG005|Overall Study|Lost to Follow-up|0|||
23406442|NCT03943290|65233740|FG006|Overall Study|Lost to Follow-up|0|||
23406443|NCT03943290|65233741|FG007|Overall Study|Lost to Follow-up|1|||
23406444|NCT03943290|65233742|FG008|Overall Study|Lost to Follow-up|0|||
23406445|NCT03943290|65233734|FG000|Overall Study|Withdrawal by Subject|0|||
23406446|NCT03943290|65233735|FG001|Overall Study|Withdrawal by Subject|0|||
23406447|NCT03943290|65233736|FG002|Overall Study|Withdrawal by Subject|1|||
23406448|NCT03943290|65233737|FG003|Overall Study|Withdrawal by Subject|0|||
23406449|NCT03943290|65233738|FG004|Overall Study|Withdrawal by Subject|0|||
23406450|NCT03943290|65233739|FG005|Overall Study|Withdrawal by Subject|0|||
23406451|NCT03943290|65233740|FG006|Overall Study|Withdrawal by Subject|0|||
23406452|NCT03943290|65233741|FG007|Overall Study|Withdrawal by Subject|0|||
23406453|NCT03943290|65233742|FG008|Overall Study|Withdrawal by Subject|0|||
23406454|NCT03154476|65233743|FG000|Overall Study|Lost to Follow-up|4|||
23406455|NCT03154476|65233744|FG001|Overall Study|Lost to Follow-up|4|||
23406456|NCT00120627|65233748|FG000|Overall Study|Withdrawal by Subject|5|||
23406457|NCT00120627|65233749|FG001|Overall Study|Withdrawal by Subject|5|||
23406458|NCT01637584|65233750|FG000|Overall Study|Withdrawal by Subject|1|||
23406459|NCT01637584|65233751|FG001|Overall Study|Withdrawal by Subject|3|||
23406460|NCT00925002|65233755|FG000|Overall Study|Other|1|||
23406461|NCT00925002|65233756|FG001|Overall Study|Other|4|||
23406462|NCT00925002|65233757|FG002|Overall Study|Other|0|||
23406463|NCT00925002|65233755|FG000|Overall Study|Death|1|||
23406464|NCT00925002|65233756|FG001|Overall Study|Death|1|||
23406465|NCT00925002|65233757|FG002|Overall Study|Death|5|||
23406466|NCT00925002|65233755|FG000|Overall Study|Adverse Event|3|||
23406467|NCT00925002|65233756|FG001|Overall Study|Adverse Event|1|||
23406468|NCT00925002|65233757|FG002|Overall Study|Adverse Event|2|||
23406469|NCT00925002|65233755|FG000|Overall Study|Participant withdrew consent|1|||
23406470|NCT00925002|65233756|FG001|Overall Study|Participant withdrew consent|3|||
23406471|NCT00925002|65233757|FG002|Overall Study|Participant withdrew consent|3|||
23406472|NCT01277822|65233761|FG000|Overall Study|Adverse Event|2|||
23406473|NCT01277822|65233762|FG001|Overall Study|Adverse Event|1|||
23406474|NCT01277822|65233761|FG000|Overall Study|Withdrawal by Subject|6|||
23406475|NCT01277822|65233762|FG001|Overall Study|Withdrawal by Subject|7|||
23406476|NCT01277822|65233761|FG000|Overall Study|Physician Decision|1|||
23406477|NCT01277822|65233762|FG001|Overall Study|Physician Decision|1|||
23406478|NCT01277822|65233761|FG000|Overall Study|Protocol Violation|1|||
23406479|NCT01277822|65233762|FG001|Overall Study|Protocol Violation|0|||
23406480|NCT01277822|65233761|FG000|Overall Study|Lost to Follow-up|2|||
23406481|NCT01277822|65233762|FG001|Overall Study|Lost to Follow-up|1|||
23406482|NCT01277822|65233761|FG000|Overall Study|Contraindicated medication used|2|||
23406483|NCT01277822|65233762|FG001|Overall Study|Contraindicated medication used|1|||
23406484|NCT01277822|65233761|FG000|Overall Study|Participant moved|1|||
23406485|NCT01277822|65233762|FG001|Overall Study|Participant moved|0|||
23406486|NCT01737762|65233767|FG000|Overall Study|Adverse Event|2|||
23406487|NCT01737762|65233768|FG001|Overall Study|Adverse Event|2|||
23406488|NCT01737762|65233767|FG000|Overall Study|Lost to Follow-up|1|||
23406489|NCT01737762|65233768|FG001|Overall Study|Lost to Follow-up|0|||
23406490|NCT01737762|65233767|FG000|Overall Study|Withdrawal by Subject|2|||
23406491|NCT01737762|65233768|FG001|Overall Study|Withdrawal by Subject|2|||
23406492|NCT01737762|65233767|FG000|Overall Study|Progressive disease|1|||
23406493|NCT01737762|65233768|FG001|Overall Study|Progressive disease|2|||
23406494|NCT01737762|65233767|FG000|Overall Study|Physician Decision|1|||
23406495|NCT01737762|65233768|FG001|Overall Study|Physician Decision|1|||
23406496|NCT01737762|65233767|FG000|Overall Study|Moved from area|2|||
23406497|NCT01737762|65233768|FG001|Overall Study|Moved from area|1|||
23406498|NCT01737762|65233767|FG000|Overall Study|Trial termination|11|||
23406499|NCT01737762|65233768|FG001|Overall Study|Trial termination|9|||
23406500|NCT00819156|65233769|FG000|Overall Study|Adverse Event|1|||
23406501|NCT00819156|65233770|FG001|Overall Study|Adverse Event|4|||
23406502|NCT00819156|65233771|FG002|Overall Study|Adverse Event|2|||
23406503|NCT00819156|65233772|FG003|Overall Study|Adverse Event|1|||
23406504|NCT00819156|65233773|FG004|Overall Study|Adverse Event|2|||
23406505|NCT00819156|65233774|FG005|Overall Study|Adverse Event|3|||
23406506|NCT00819156|65233769|FG000|Overall Study|Withdrawal by Subject|0|||
23406507|NCT00819156|65233770|FG001|Overall Study|Withdrawal by Subject|3|||
23406508|NCT00819156|65233771|FG002|Overall Study|Withdrawal by Subject|2|||
23406509|NCT00819156|65233772|FG003|Overall Study|Withdrawal by Subject|0|||
23406510|NCT00819156|65233773|FG004|Overall Study|Withdrawal by Subject|1|||
23406511|NCT00819156|65233774|FG005|Overall Study|Withdrawal by Subject|0|||
23406512|NCT00819156|65233769|FG000|Overall Study|Protocol Violation|1|||
23406513|NCT00819156|65233770|FG001|Overall Study|Protocol Violation|0|||
23406514|NCT00819156|65233771|FG002|Overall Study|Protocol Violation|1|||
23406515|NCT00819156|65233772|FG003|Overall Study|Protocol Violation|0|||
23406516|NCT00819156|65233773|FG004|Overall Study|Protocol Violation|0|||
23406517|NCT00819156|65233774|FG005|Overall Study|Protocol Violation|1|||
23406518|NCT00819156|65233769|FG000|Overall Study|Lost to Follow-up|0|||
23406519|NCT00819156|65233770|FG001|Overall Study|Lost to Follow-up|1|||
23406520|NCT00819156|65233771|FG002|Overall Study|Lost to Follow-up|0|||
23406521|NCT00819156|65233772|FG003|Overall Study|Lost to Follow-up|0|||
23406522|NCT00819156|65233773|FG004|Overall Study|Lost to Follow-up|0|||
23406523|NCT00819156|65233774|FG005|Overall Study|Lost to Follow-up|2|||
23406524|NCT00819156|65233769|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
23406525|NCT00819156|65233770|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
23406526|NCT00819156|65233771|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406527|NCT00819156|65233772|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406528|NCT00819156|65233773|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406529|NCT00819156|65233774|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
23406530|NCT00819156|65233769|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
23406531|NCT00819156|65233770|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406532|NCT00819156|65233771|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406533|NCT00819156|65233772|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406534|NCT00819156|65233773|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
23406535|NCT00819156|65233774|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406536|NCT00819156|65233769|FG000|Overall Study|Prostate-specific antigen progression|0|||
23406537|NCT00819156|65233770|FG001|Overall Study|Prostate-specific antigen progression|0|||
23406538|NCT00819156|65233771|FG002|Overall Study|Prostate-specific antigen progression|0|||
23406539|NCT00819156|65233772|FG003|Overall Study|Prostate-specific antigen progression|0|||
23406540|NCT00819156|65233773|FG004|Overall Study|Prostate-specific antigen progression|1|||
23406541|NCT00819156|65233774|FG005|Overall Study|Prostate-specific antigen progression|0|||
23406542|NCT03886493|65233775|FG000|Overall Study|Adverse Event|1|||
23406543|NCT01284959|65233782|FG000|Overall Study|Withdrawal by Subject|1|||
23406544|NCT01284959|65233783|FG001|Overall Study|Withdrawal by Subject|0|||
23406545|NCT01284959|65233784|FG002|Overall Study|Withdrawal by Subject|0|||
23406546|NCT01284959|65233782|FG000|Overall Study|Adverse Event|0|||
23406547|NCT01284959|65233783|FG001|Overall Study|Adverse Event|0|||
23406548|NCT01284959|65233784|FG002|Overall Study|Adverse Event|1|||
23406549|NCT00792740|65233787|FG000|Overall Study|Disease Worsening|3|||
23607361|NCT03031782|65950683|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23406550|NCT00792740|65233788|FG001|Overall Study|Disease Worsening|2|||
23406551|NCT00792740|65233787|FG000|Overall Study|Personal Reason|1|||
23406552|NCT00792740|65233788|FG001|Overall Study|Personal Reason|0|||
23406553|NCT00792740|65233787|FG000|Overall Study|Adverse Event|1|||
23406554|NCT00792740|65233788|FG001|Overall Study|Adverse Event|3|||
23406555|NCT00792740|65233787|FG000|Overall Study|Patient's withdrawal of consent|0|||
23406556|NCT00792740|65233788|FG001|Overall Study|Patient's withdrawal of consent|1|||
23406557|NCT00792740|65233787|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
23406558|NCT00792740|65233788|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
23406559|NCT00792740|65233787|FG000|Overall Study|Other reasons|0|||
23406560|NCT00792740|65233788|FG001|Overall Study|Other reasons|1|||
23406561|NCT01135992|65233789|FG000|Overall Study|Adverse Event|1|||
23406562|NCT01135992|65233789|FG000|Overall Study|Lack of Efficacy|1|||
23406563|NCT01135992|65233789|FG000|Overall Study|Protocol Violation|2|||
23406564|NCT01135992|65233789|FG000|Overall Study|Withdrawal criteria|10|||
23406565|NCT01135992|65233789|FG000|Overall Study|Unclassified|7|||
23406566|NCT00556439|65233790|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
23406567|NCT00556439|65233791|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
23406568|NCT00556439|65233792|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
23406569|NCT00556439|65233793|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
23406570|NCT00556439|65233790|FG000|Study Entry to Week 12|Physician Decision|1|||
23406571|NCT00556439|65233791|FG001|Study Entry to Week 12|Physician Decision|0|||
23406572|NCT00556439|65233792|FG002|Study Entry to Week 12|Physician Decision|0|||
23406573|NCT00556439|65233793|FG003|Study Entry to Week 12|Physician Decision|0|||
23406574|NCT00556439|65233790|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
23406575|NCT00556439|65233791|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
23406576|NCT00556439|65233792|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
23406577|NCT00556439|65233793|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
23406578|NCT00556439|65233790|FG000|Study Entry to Week 12|Recurrent infection|1|||
23406579|NCT00556439|65233791|FG001|Study Entry to Week 12|Recurrent infection|0|||
23406580|NCT00556439|65233792|FG002|Study Entry to Week 12|Recurrent infection|0|||
23406581|NCT00556439|65233793|FG003|Study Entry to Week 12|Recurrent infection|0|||
23406582|NCT00556439|65233790|FG000|Study Entry to Week 12|Malignancy|0|||
23406583|NCT00556439|65233791|FG001|Study Entry to Week 12|Malignancy|0|||
23406584|NCT00556439|65233792|FG002|Study Entry to Week 12|Malignancy|1|||
23406585|NCT00556439|65233793|FG003|Study Entry to Week 12|Malignancy|0|||
23406586|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
23406587|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
23406588|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
23406589|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
23406590|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
23406591|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406592|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406593|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406594|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
23406595|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
23406596|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
23406597|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
23406598|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
23406599|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406600|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406601|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406602|NCT01340664|65233794|FG000|Overall Study|Adverse Event|0|||
23406603|NCT01340664|65233795|FG001|Overall Study|Adverse Event|1|||
23406604|NCT01340664|65233796|FG002|Overall Study|Adverse Event|7|||
23406605|NCT01340664|65233794|FG000|Overall Study|Lost to Follow-up|2|||
23406606|NCT01340664|65233795|FG001|Overall Study|Lost to Follow-up|0|||
23607362|NCT03031782|65950679|FG000|Treatment Period 2|Adverse Event|0|||
23406607|NCT01340664|65233796|FG002|Overall Study|Lost to Follow-up|2|||
23406608|NCT01340664|65233794|FG000|Overall Study|Withdrawal by Subject|2|||
23406609|NCT01340664|65233795|FG001|Overall Study|Withdrawal by Subject|4|||
23406610|NCT01340664|65233796|FG002|Overall Study|Withdrawal by Subject|0|||
23406611|NCT01340664|65233794|FG000|Overall Study|Glycemic withdrawal criteria|2|||
23406612|NCT01340664|65233795|FG001|Overall Study|Glycemic withdrawal criteria|0|||
23406613|NCT01340664|65233796|FG002|Overall Study|Glycemic withdrawal criteria|0|||
23607363|NCT03031782|65950680|FG001|Treatment Period 2|Adverse Event|1|||
23406614|NCT01340664|65233794|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
23406615|NCT01340664|65233795|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
23406616|NCT01340664|65233796|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
23406617|NCT01340664|65233794|FG000|Overall Study|Other|1|||
23406618|NCT01340664|65233795|FG001|Overall Study|Other|2|||
23406619|NCT01340664|65233796|FG002|Overall Study|Other|2|||
23406620|NCT03981744|65233797|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406621|NCT03981744|65233798|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
23406622|NCT03981744|65233799|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406623|NCT03981744|65233800|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406624|NCT03981744|65233797|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406625|NCT03981744|65233798|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406626|NCT03981744|65233799|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
23406627|NCT03981744|65233800|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406628|NCT03981744|65233797|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406629|NCT03981744|65233798|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406630|NCT03981744|65233799|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
23406631|NCT03981744|65233800|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406632|NCT01991483|65233810|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
23406633|NCT01991483|65233811|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
23607364|NCT03031782|65950681|FG002|Treatment Period 2|Adverse Event|2|||
23406634|NCT01991483|65233812|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
23406635|NCT01991483|65233813|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
23607365|NCT03031782|65950682|FG003|Treatment Period 2|Adverse Event|0|||
23406636|NCT01991483|65233810|FG000|Dose Level 600 mg|Physician Decision|0|||
23406637|NCT01991483|65233811|FG001|Dose Level 600 mg|Physician Decision|0|||
23406638|NCT01991483|65233812|FG002|Dose Level 600 mg|Physician Decision|1|||
23406639|NCT01991483|65233813|FG003|Dose Level 600 mg|Physician Decision|0|||
23406640|NCT01991483|65233810|FG000|Dose Level 1000 mg|Protocol Violation|0|||
23406641|NCT01991483|65233811|FG001|Dose Level 1000 mg|Protocol Violation|0|||
23406642|NCT01991483|65233812|FG002|Dose Level 1000 mg|Protocol Violation|0|||
23406643|NCT01991483|65233813|FG003|Dose Level 1000 mg|Protocol Violation|1|||
23406644|NCT00532129|65233814|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
23406645|NCT00532129|65233814|FG000|Treatment Period|Physician Decision|15|||
23406646|NCT00532129|65233814|FG000|Treatment Period|Disease progression|3|||
23406647|NCT00532129|65233814|FG000|Treatment Period|Protocol Violation|1|||
23406648|NCT00532129|65233814|FG000|Treatment Period|Other|5|||
23406649|NCT00532129|65233814|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
23406650|NCT00532129|65233814|FG000|Follow-up Period|Disease progression|57|||
23406651|NCT00532129|65233814|FG000|Follow-up Period|Lost to Follow-up|1|||
23406652|NCT00532129|65233814|FG000|Follow-up Period|Other|6|||
23406653|NCT03768089|65233817|FG000|Part A|Lost to Follow-up|0|||
23406654|NCT03768089|65233818|FG001|Part A|Lost to Follow-up|0|||
23406655|NCT03768089|65233819|FG002|Part A|Lost to Follow-up|0|||
23406656|NCT03768089|65233820|FG003|Part A|Lost to Follow-up|0|||
23406657|NCT03768089|65233821|FG004|Part A|Lost to Follow-up|1|||
23406658|NCT03768089|65233822|FG005|Part A|Lost to Follow-up|0|||
23406659|NCT03768089|65233823|FG006|Part A|Lost to Follow-up|0|||
23406660|NCT03768089|65233824|FG007|Part A|Lost to Follow-up|0|||
23406661|NCT03768089|65233825|FG008|Part A|Lost to Follow-up|0|||
23406662|NCT03768089|65233826|FG009|Part A|Lost to Follow-up|0|||
23406663|NCT03768089|65233827|FG010|Part A|Lost to Follow-up|0|||
23406664|NCT03768089|65233828|FG011|Part A|Lost to Follow-up|0|||
23406665|NCT03768089|65233829|FG012|Part A|Lost to Follow-up|0|||
23406666|NCT03768089|65233830|FG013|Part A|Lost to Follow-up|0|||
23406667|NCT03768089|65233831|FG014|Part A|Lost to Follow-up|0|||
23406668|NCT03768089|65233832|FG015|Part A|Lost to Follow-up|0|||
23406669|NCT03768089|65233833|FG016|Part A|Lost to Follow-up|0|||
23406670|NCT03768089|65233834|FG017|Part A|Lost to Follow-up|0|||
23406671|NCT03768089|65233817|FG000|Part C|Randomized, Never Dosed|0|||
23406672|NCT03768089|65233818|FG001|Part C|Randomized, Never Dosed|0|||
23406673|NCT03768089|65233819|FG002|Part C|Randomized, Never Dosed|0|||
23406674|NCT03768089|65233820|FG003|Part C|Randomized, Never Dosed|0|||
23406675|NCT03768089|65233821|FG004|Part C|Randomized, Never Dosed|0|||
23406676|NCT03768089|65233822|FG005|Part C|Randomized, Never Dosed|0|||
23406677|NCT03768089|65233823|FG006|Part C|Randomized, Never Dosed|0|||
23406678|NCT03768089|65233824|FG007|Part C|Randomized, Never Dosed|0|||
23406679|NCT03768089|65233825|FG008|Part C|Randomized, Never Dosed|0|||
23406680|NCT03768089|65233826|FG009|Part C|Randomized, Never Dosed|0|||
23406681|NCT03768089|65233827|FG010|Part C|Randomized, Never Dosed|0|||
23406682|NCT03768089|65233828|FG011|Part C|Randomized, Never Dosed|0|||
23406683|NCT03768089|65233829|FG012|Part C|Randomized, Never Dosed|0|||
23406684|NCT03768089|65233830|FG013|Part C|Randomized, Never Dosed|0|||
23406685|NCT03768089|65233831|FG014|Part C|Randomized, Never Dosed|1|||
23406686|NCT03768089|65233832|FG015|Part C|Randomized, Never Dosed|0|||
23406687|NCT03768089|65233833|FG016|Part C|Randomized, Never Dosed|0|||
23406688|NCT03768089|65233834|FG017|Part C|Randomized, Never Dosed|0|||
23406689|NCT03008070|65233835|FG000|Overall Study|Adverse Event|3|||
23406690|NCT03008070|65233836|FG001|Overall Study|Adverse Event|3|||
23406691|NCT03008070|65233837|FG002|Overall Study|Adverse Event|3|||
23406692|NCT03008070|65233835|FG000|Overall Study|Lost to Follow-up|1|||
23406693|NCT03008070|65233836|FG001|Overall Study|Lost to Follow-up|1|||
23406694|NCT03008070|65233837|FG002|Overall Study|Lost to Follow-up|0|||
23406695|NCT03008070|65233835|FG000|Overall Study|Non compliance|0|||
23406696|NCT03008070|65233836|FG001|Overall Study|Non compliance|1|||
23406697|NCT03008070|65233837|FG002|Overall Study|Non compliance|1|||
23406698|NCT03008070|65233835|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
23406699|NCT03008070|65233836|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
23406700|NCT03008070|65233837|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
23406701|NCT03008070|65233835|FG000|Overall Study|Withdrawal by Subject|2|||
23406702|NCT03008070|65233836|FG001|Overall Study|Withdrawal by Subject|0|||
23406703|NCT03008070|65233837|FG002|Overall Study|Withdrawal by Subject|1|||
23406704|NCT03008070|65233835|FG000|Overall Study|Use of prohibited drug|0|||
23406705|NCT03008070|65233836|FG001|Overall Study|Use of prohibited drug|0|||
23406706|NCT03008070|65233837|FG002|Overall Study|Use of prohibited drug|2|||
23406707|NCT03497039|65233838|FG000|Overall Study|Withdrawal by Subject|1|||
23406708|NCT03497039|65233839|FG001|Overall Study|Withdrawal by Subject|0|||
23406709|NCT03497039|65233838|FG000|Overall Study|Protocol Violation|0|||
23406710|NCT03497039|65233839|FG001|Overall Study|Protocol Violation|1|||
23406711|NCT01509846|65233840|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23406712|NCT01509846|65233841|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23406713|NCT01509846|65233842|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
23406714|NCT01509846|65233843|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23406715|NCT01509846|65233844|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23406716|NCT01509846|65233840|FG000|Received Vaccination 2|Illness|0|||
23406717|NCT01509846|65233841|FG001|Received Vaccination 2|Illness|0|||
23406718|NCT01509846|65233842|FG002|Received Vaccination 2|Illness|0|||
23406719|NCT01509846|65233843|FG003|Received Vaccination 2|Illness|0|||
23406720|NCT01509846|65233844|FG004|Received Vaccination 2|Illness|1|||
23406721|NCT01509846|65233840|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
23406722|NCT01509846|65233841|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
23406723|NCT01509846|65233842|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
23406724|NCT01509846|65233843|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
23406725|NCT01509846|65233844|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
23406726|NCT01509846|65233840|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
23406727|NCT01509846|65233841|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
23406728|NCT01509846|65233842|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
23406729|NCT01509846|65233843|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
23406730|NCT01509846|65233844|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
23406731|NCT01509846|65233840|FG000|Received Vaccination 3|Pregnancy|0|||
23406732|NCT01509846|65233841|FG001|Received Vaccination 3|Pregnancy|0|||
23406733|NCT01509846|65233842|FG002|Received Vaccination 3|Pregnancy|0|||
23406734|NCT01509846|65233843|FG003|Received Vaccination 3|Pregnancy|1|||
23406735|NCT01509846|65233844|FG004|Received Vaccination 3|Pregnancy|0|||
23406736|NCT01509846|65233840|FG000|Received Vaccination 3|Lost to Follow-up|0|||
23406737|NCT01509846|65233841|FG001|Received Vaccination 3|Lost to Follow-up|0|||
23406738|NCT01509846|65233842|FG002|Received Vaccination 3|Lost to Follow-up|1|||
23406739|NCT01509846|65233843|FG003|Received Vaccination 3|Lost to Follow-up|0|||
23406740|NCT01509846|65233844|FG004|Received Vaccination 3|Lost to Follow-up|0|||
23406741|NCT01978145|65233845|FG000|Treatment Period 1|Adverse Event|1|||
23406742|NCT01978145|65233846|FG001|Treatment Period 1|Adverse Event|9|||
23406743|NCT01978145|65233845|FG000|Treatment Period 1|Physician Decision|1|||
23406744|NCT01978145|65233846|FG001|Treatment Period 1|Physician Decision|0|||
23406745|NCT01978145|65233845|FG000|Treatment Period 1|Withdrawal by Subject|5|||
23406746|NCT01978145|65233846|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23406747|NCT01978145|65233845|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
23406748|NCT01978145|65233846|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
23406749|NCT01978145|65233845|FG000|Washout Period 1|Adverse Event|0|||
23406750|NCT01978145|65233846|FG001|Washout Period 1|Adverse Event|1|||
23406751|NCT01978145|65233845|FG000|Washout Period 1|Withdrawal by Subject|1|||
23406752|NCT01978145|65233846|FG001|Washout Period 1|Withdrawal by Subject|1|||
23406753|NCT01978145|65233845|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
23406754|NCT01978145|65233846|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
23406755|NCT01978145|65233845|FG000|Treatment Period 2|Adverse Event|3|||
23406756|NCT01978145|65233846|FG001|Treatment Period 2|Adverse Event|3|||
23406757|NCT01978145|65233845|FG000|Treatment Period 2|Protocol Violation|0|||
23406758|NCT01978145|65233846|FG001|Treatment Period 2|Protocol Violation|1|||
23406759|NCT01978145|65233845|FG000|Treatment Period 2|Lost to Follow-up|1|||
23406760|NCT01978145|65233846|FG001|Treatment Period 2|Lost to Follow-up|1|||
23406761|NCT01978145|65233845|FG000|Treatment Period 2|Withdrawal by Subject|7|||
23406762|NCT01978145|65233846|FG001|Treatment Period 2|Withdrawal by Subject|4|||
23406763|NCT01978145|65233845|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
23406764|NCT01978145|65233846|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
23406765|NCT01558115|65233850|FG000|Overall Study|Withdrawal by Subject|3|||
23406766|NCT01558115|65233850|FG000|Overall Study|Study closed due to poor enrollment|4|||
23406767|NCT02528942|65233851|FG000|Overall Study|Did not meet imaging criteria|9|||
23406768|NCT02528942|65233851|FG000|Overall Study|Lost to Follow-up|25|||
23406769|NCT00413660|65233852|FG000|Up To Week 12|Adverse Event|1|||
23406770|NCT00413660|65233853|FG001|Up To Week 12|Adverse Event|3|||
23406771|NCT00413660|65233854|FG002|Up To Week 12|Adverse Event|1|||
23406772|NCT00413660|65233855|FG003|Up To Week 12|Adverse Event|4|||
23406773|NCT00413660|65233856|FG004|Up To Week 12|Adverse Event|6|||
23406774|NCT00413660|65233857|FG005|Up To Week 12|Adverse Event|4|||
23406775|NCT00413660|65233858|FG006|Up To Week 12|Adverse Event|1|||
23406776|NCT00413660|65233859|FG007|Up To Week 12|Adverse Event|0|||
23406777|NCT00413660|65233860|FG008|Up To Week 12|Adverse Event|0|||
23406778|NCT00413660|65233861|FG009|Up To Week 12|Adverse Event|0|||
23406779|NCT00413660|65233862|FG010|Up To Week 12|Adverse Event|0|||
23406780|NCT00413660|65233852|FG000|Up To Week 12|Lack of Efficacy|2|||
23406781|NCT00413660|65233853|FG001|Up To Week 12|Lack of Efficacy|0|||
23406782|NCT00413660|65233854|FG002|Up To Week 12|Lack of Efficacy|0|||
23406783|NCT00413660|65233855|FG003|Up To Week 12|Lack of Efficacy|0|||
23406784|NCT00413660|65233856|FG004|Up To Week 12|Lack of Efficacy|0|||
23406785|NCT00413660|65233857|FG005|Up To Week 12|Lack of Efficacy|0|||
23406786|NCT00413660|65233858|FG006|Up To Week 12|Lack of Efficacy|5|||
23406787|NCT00413660|65233859|FG007|Up To Week 12|Lack of Efficacy|0|||
23607366|NCT03031782|65950683|FG004|Treatment Period 2|Adverse Event|0|||
23406788|NCT00413660|65233860|FG008|Up To Week 12|Lack of Efficacy|0|||
23406789|NCT00413660|65233861|FG009|Up To Week 12|Lack of Efficacy|0|||
23406790|NCT00413660|65233862|FG010|Up To Week 12|Lack of Efficacy|0|||
23406791|NCT00413660|65233852|FG000|Up To Week 12|Lost to Follow-up|0|||
23406792|NCT00413660|65233853|FG001|Up To Week 12|Lost to Follow-up|1|||
23406793|NCT00413660|65233854|FG002|Up To Week 12|Lost to Follow-up|0|||
23406794|NCT00413660|65233855|FG003|Up To Week 12|Lost to Follow-up|0|||
23406795|NCT00413660|65233856|FG004|Up To Week 12|Lost to Follow-up|1|||
23406796|NCT00413660|65233857|FG005|Up To Week 12|Lost to Follow-up|0|||
23406797|NCT00413660|65233858|FG006|Up To Week 12|Lost to Follow-up|0|||
23406798|NCT00413660|65233859|FG007|Up To Week 12|Lost to Follow-up|0|||
23406799|NCT00413660|65233860|FG008|Up To Week 12|Lost to Follow-up|0|||
23406800|NCT00413660|65233861|FG009|Up To Week 12|Lost to Follow-up|0|||
23406801|NCT00413660|65233862|FG010|Up To Week 12|Lost to Follow-up|0|||
23406802|NCT00413660|65233852|FG000|Up To Week 12|Withdrawal by Subject|0|||
23406803|NCT00413660|65233853|FG001|Up To Week 12|Withdrawal by Subject|2|||
23406804|NCT00413660|65233854|FG002|Up To Week 12|Withdrawal by Subject|0|||
23406805|NCT00413660|65233855|FG003|Up To Week 12|Withdrawal by Subject|2|||
23406806|NCT00413660|65233856|FG004|Up To Week 12|Withdrawal by Subject|0|||
23406807|NCT00413660|65233857|FG005|Up To Week 12|Withdrawal by Subject|2|||
23406808|NCT00413660|65233858|FG006|Up To Week 12|Withdrawal by Subject|2|||
23406809|NCT00413660|65233859|FG007|Up To Week 12|Withdrawal by Subject|0|||
23406810|NCT00413660|65233860|FG008|Up To Week 12|Withdrawal by Subject|0|||
23406811|NCT00413660|65233861|FG009|Up To Week 12|Withdrawal by Subject|0|||
23406812|NCT00413660|65233862|FG010|Up To Week 12|Withdrawal by Subject|0|||
23406813|NCT00413660|65233852|FG000|Up To Week 12|Randomized, Not Treated|1|||
23406814|NCT00413660|65233853|FG001|Up To Week 12|Randomized, Not Treated|0|||
23406815|NCT00413660|65233854|FG002|Up To Week 12|Randomized, Not Treated|0|||
23406816|NCT00413660|65233855|FG003|Up To Week 12|Randomized, Not Treated|1|||
23406817|NCT00413660|65233856|FG004|Up To Week 12|Randomized, Not Treated|0|||
23406818|NCT00413660|65233857|FG005|Up To Week 12|Randomized, Not Treated|0|||
23406819|NCT00413660|65233858|FG006|Up To Week 12|Randomized, Not Treated|0|||
23406820|NCT00413660|65233859|FG007|Up To Week 12|Randomized, Not Treated|0|||
23406821|NCT00413660|65233860|FG008|Up To Week 12|Randomized, Not Treated|0|||
23406822|NCT00413660|65233861|FG009|Up To Week 12|Randomized, Not Treated|0|||
23406823|NCT00413660|65233862|FG010|Up To Week 12|Randomized, Not Treated|0|||
23406824|NCT00413660|65233852|FG000|Up To Week 12|Other|3|||
23406825|NCT00413660|65233853|FG001|Up To Week 12|Other|1|||
23406826|NCT00413660|65233854|FG002|Up To Week 12|Other|6|||
23406827|NCT00413660|65233855|FG003|Up To Week 12|Other|1|||
23406828|NCT00413660|65233856|FG004|Up To Week 12|Other|2|||
23406829|NCT00413660|65233857|FG005|Up To Week 12|Other|4|||
23406830|NCT00413660|65233858|FG006|Up To Week 12|Other|3|||
23406831|NCT00413660|65233859|FG007|Up To Week 12|Other|0|||
23406832|NCT00413660|65233860|FG008|Up To Week 12|Other|0|||
23406833|NCT00413660|65233861|FG009|Up To Week 12|Other|0|||
23406834|NCT00413660|65233862|FG010|Up To Week 12|Other|0|||
23406835|NCT00413660|65233852|FG000|Post Week 12|Adverse Event|2|||
23406836|NCT00413660|65233853|FG001|Post Week 12|Adverse Event|0|||
23406837|NCT00413660|65233854|FG002|Post Week 12|Adverse Event|2|||
23406838|NCT00413660|65233855|FG003|Post Week 12|Adverse Event|1|||
23406839|NCT00413660|65233856|FG004|Post Week 12|Adverse Event|4|||
23406840|NCT00413660|65233857|FG005|Post Week 12|Adverse Event|2|||
23406841|NCT00413660|65233858|FG006|Post Week 12|Adverse Event|2|||
23406842|NCT00413660|65233859|FG007|Post Week 12|Adverse Event|0|||
23406843|NCT00413660|65233860|FG008|Post Week 12|Adverse Event|0|||
23406844|NCT00413660|65233861|FG009|Post Week 12|Adverse Event|0|||
23406845|NCT00413660|65233862|FG010|Post Week 12|Adverse Event|0|||
23406846|NCT00413660|65233852|FG000|Post Week 12|Lack of Efficacy|0|||
23406847|NCT00413660|65233853|FG001|Post Week 12|Lack of Efficacy|0|||
23406848|NCT00413660|65233854|FG002|Post Week 12|Lack of Efficacy|1|||
23406849|NCT00413660|65233855|FG003|Post Week 12|Lack of Efficacy|0|||
23406850|NCT00413660|65233856|FG004|Post Week 12|Lack of Efficacy|0|||
23406851|NCT00413660|65233857|FG005|Post Week 12|Lack of Efficacy|0|||
23406852|NCT00413660|65233858|FG006|Post Week 12|Lack of Efficacy|0|||
23406853|NCT00413660|65233859|FG007|Post Week 12|Lack of Efficacy|0|||
23406854|NCT00413660|65233860|FG008|Post Week 12|Lack of Efficacy|0|||
23406855|NCT00413660|65233861|FG009|Post Week 12|Lack of Efficacy|1|||
23406856|NCT00413660|65233862|FG010|Post Week 12|Lack of Efficacy|0|||
23406857|NCT00413660|65233852|FG000|Post Week 12|Lost to Follow-up|0|||
23406858|NCT00413660|65233853|FG001|Post Week 12|Lost to Follow-up|1|||
23406859|NCT00413660|65233854|FG002|Post Week 12|Lost to Follow-up|1|||
23406860|NCT00413660|65233855|FG003|Post Week 12|Lost to Follow-up|0|||
23406861|NCT00413660|65233856|FG004|Post Week 12|Lost to Follow-up|0|||
23406862|NCT00413660|65233857|FG005|Post Week 12|Lost to Follow-up|0|||
23406863|NCT00413660|65233858|FG006|Post Week 12|Lost to Follow-up|0|||
23406864|NCT00413660|65233859|FG007|Post Week 12|Lost to Follow-up|0|||
23406865|NCT00413660|65233860|FG008|Post Week 12|Lost to Follow-up|0|||
23406866|NCT00413660|65233861|FG009|Post Week 12|Lost to Follow-up|0|||
23406867|NCT00413660|65233862|FG010|Post Week 12|Lost to Follow-up|0|||
23406868|NCT00413660|65233852|FG000|Post Week 12|Withdrawal by Subject|0|||
23406869|NCT00413660|65233853|FG001|Post Week 12|Withdrawal by Subject|1|||
23406870|NCT00413660|65233854|FG002|Post Week 12|Withdrawal by Subject|1|||
23406871|NCT00413660|65233855|FG003|Post Week 12|Withdrawal by Subject|0|||
23406872|NCT00413660|65233856|FG004|Post Week 12|Withdrawal by Subject|1|||
23406873|NCT00413660|65233857|FG005|Post Week 12|Withdrawal by Subject|0|||
23406874|NCT00413660|65233858|FG006|Post Week 12|Withdrawal by Subject|0|||
23406875|NCT00413660|65233859|FG007|Post Week 12|Withdrawal by Subject|0|||
23406876|NCT00413660|65233860|FG008|Post Week 12|Withdrawal by Subject|0|||
23406877|NCT00413660|65233861|FG009|Post Week 12|Withdrawal by Subject|0|||
23406878|NCT00413660|65233862|FG010|Post Week 12|Withdrawal by Subject|1|||
23406879|NCT00413660|65233852|FG000|Post Week 12|Other|1|||
23406880|NCT00413660|65233853|FG001|Post Week 12|Other|2|||
23406881|NCT00413660|65233854|FG002|Post Week 12|Other|3|||
23406882|NCT00413660|65233855|FG003|Post Week 12|Other|0|||
23406883|NCT00413660|65233856|FG004|Post Week 12|Other|1|||
23406884|NCT00413660|65233857|FG005|Post Week 12|Other|1|||
23406885|NCT00413660|65233858|FG006|Post Week 12|Other|1|||
23406886|NCT00413660|65233859|FG007|Post Week 12|Other|0|||
23406887|NCT00413660|65233860|FG008|Post Week 12|Other|0|||
23406888|NCT00413660|65233861|FG009|Post Week 12|Other|0|||
23406889|NCT00413660|65233862|FG010|Post Week 12|Other|0|||
23406890|NCT02316353|65233863|FG000|Overall Study|Pregnancy|1|||
23406891|NCT02316353|65233864|FG001|Overall Study|Pregnancy|3|||
23406892|NCT02316353|65233863|FG000|Overall Study|Adverse Event|1|||
23406893|NCT02316353|65233864|FG001|Overall Study|Adverse Event|3|||
23406894|NCT02316353|65233863|FG000|Overall Study|Withdrawal by Subject|6|||
23406895|NCT02316353|65233864|FG001|Overall Study|Withdrawal by Subject|2|||
23406896|NCT00592631|65233865|FG000|Overall Study|Lost to Follow-up|0|||
23406897|NCT00592631|65233866|FG001|Overall Study|Lost to Follow-up|2|||
23406898|NCT00892008|65233867|FG000|Overall Study|Death|5|||
23406899|NCT00892008|65233867|FG000|Overall Study|Lack of Efficacy|3|||
23406900|NCT00892008|65233867|FG000|Overall Study|Lost to Follow-up|142|||
23406901|NCT00892008|65233867|FG000|Overall Study|Other|378|||
23406902|NCT00892008|65233867|FG000|Overall Study|Adverse Event|37|||
23406903|NCT01847092|65233868|FG000|Overall Study|Adverse Event|12|||
23406904|NCT01847092|65233869|FG001|Overall Study|Adverse Event|3|||
23406905|NCT01847092|65233868|FG000|Overall Study|Withdrawal by Subject|5|||
23406906|NCT01847092|65233869|FG001|Overall Study|Withdrawal by Subject|5|||
23406907|NCT01847092|65233868|FG000|Overall Study|Protocol Specified|8|||
23406908|NCT01847092|65233869|FG001|Overall Study|Protocol Specified|0|||
23406909|NCT01847092|65233868|FG000|Overall Study|Physician Decision|1|||
23406910|NCT01847092|65233869|FG001|Overall Study|Physician Decision|1|||
23406911|NCT01847092|65233868|FG000|Overall Study|Protocol Violation|0|||
23406912|NCT01847092|65233869|FG001|Overall Study|Protocol Violation|2|||
23406913|NCT03462758|65233870|FG000|Overall Study|Chose no or other method of contraception|20|||
23406914|NCT03462758|65233871|FG001|Overall Study|Chose no or other method of contraception|23|||
23406915|NCT03462758|65233870|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
23406916|NCT03462758|65233871|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
23406917|NCT03462758|65233870|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
23406918|NCT03462758|65233871|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
23406919|NCT03462758|65233870|FG000|Overall Study|Medical contraindication|2|||
23406920|NCT03462758|65233871|FG001|Overall Study|Medical contraindication|2|||
23406921|NCT03462758|65233870|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
23406922|NCT03462758|65233871|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
23406923|NCT02389465|65233872|FG000|Overall Study|Lost to Follow-up|1|||
23406924|NCT02389465|65233873|FG001|Overall Study|Lost to Follow-up|3|||
23406925|NCT02389465|65233874|FG002|Overall Study|Lost to Follow-up|3|||
23406926|NCT02389465|65233875|FG003|Overall Study|Lost to Follow-up|0|||
23406927|NCT02389465|65233872|FG000|Overall Study|Physician Decision|0|||
23406928|NCT02389465|65233873|FG001|Overall Study|Physician Decision|0|||
23406929|NCT02389465|65233874|FG002|Overall Study|Physician Decision|0|||
23406930|NCT02389465|65233875|FG003|Overall Study|Physician Decision|1|||
23406931|NCT02389465|65233872|FG000|Overall Study|Withdrawal by Subject|0|||
23406932|NCT02389465|65233873|FG001|Overall Study|Withdrawal by Subject|1|||
23406933|NCT02389465|65233874|FG002|Overall Study|Withdrawal by Subject|2|||
23406934|NCT02389465|65233875|FG003|Overall Study|Withdrawal by Subject|2|||
23406935|NCT00347932|65233876|FG000|Overall Study|Adverse Event|4|||
23406936|NCT00347932|65233877|FG001|Overall Study|Adverse Event|5|||
23406937|NCT00347932|65233876|FG000|Overall Study|Lack of Efficacy|3|||
23406938|NCT00347932|65233877|FG001|Overall Study|Lack of Efficacy|14|||
23406939|NCT00347932|65233876|FG000|Overall Study|Lost to Follow-up|10|||
23406940|NCT00347932|65233877|FG001|Overall Study|Lost to Follow-up|9|||
23406941|NCT00347932|65233876|FG000|Overall Study|Withdrawal by Subject|10|||
23406942|NCT00347932|65233877|FG001|Overall Study|Withdrawal by Subject|16|||
23406943|NCT00347932|65233876|FG000|Overall Study|Did not meet inclusion criteria|4|||
23406944|NCT00347932|65233877|FG001|Overall Study|Did not meet inclusion criteria|8|||
23406945|NCT02151786|65233880|FG000|Overall Study|Unavailability of Case Report Form|26|||
23607367|NCT03031782|65950679|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23406946|NCT02151786|65233880|FG000|Overall Study|Outside the Contract Period|1|||
23406947|NCT02151786|65233880|FG000|Overall Study|Randomized, not Treated|1|||
23406948|NCT02151786|65233880|FG000|Overall Study|Unavailability of Information|8|||
23406949|NCT02727322|65233881|FG000|Overall Study|Withdrawal by Subject|1|||
23406950|NCT02727322|65233882|FG001|Overall Study|Withdrawal by Subject|1|||
23406951|NCT02727322|65233881|FG000|Overall Study|Protocol Violation|1|||
23406952|NCT02727322|65233882|FG001|Overall Study|Protocol Violation|0|||
23406953|NCT04971967|65233883|FG000|Overall Study|Lost to Follow-up|6|||
23406954|NCT04971967|65233884|FG001|Overall Study|Lost to Follow-up|7|||
23406955|NCT01837680|65233885|FG000|Overall Study|Lost to Follow-up|2|||
23406956|NCT01837680|65233886|FG001|Overall Study|Lost to Follow-up|2|||
23406957|NCT01837680|65233885|FG000|Overall Study|lack of insurance|0|||
23406958|NCT01837680|65233886|FG001|Overall Study|lack of insurance|2|||
23406959|NCT01837680|65233885|FG000|Overall Study|allergic reaction|6|||
23406960|NCT01837680|65233886|FG001|Overall Study|allergic reaction|0|||
23406961|NCT01837680|65233885|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
23406962|NCT01837680|65233886|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
23406963|NCT00251693|65233887|FG000|Overall Study|Adverse Event|17|||
23406964|NCT00251693|65233888|FG001|Overall Study|Adverse Event|9|||
23406965|NCT00251693|65233889|FG002|Overall Study|Adverse Event|9|||
23406966|NCT00251693|65233887|FG000|Overall Study|Protocol Violation|2|||
23406967|NCT00251693|65233888|FG001|Overall Study|Protocol Violation|0|||
23406968|NCT00251693|65233889|FG002|Overall Study|Protocol Violation|2|||
23406969|NCT00251693|65233887|FG000|Overall Study|Lost to Follow-up|12|||
23406970|NCT00251693|65233888|FG001|Overall Study|Lost to Follow-up|7|||
23406971|NCT00251693|65233889|FG002|Overall Study|Lost to Follow-up|8|||
23406972|NCT00251693|65233887|FG000|Overall Study|Withdrawal by Subject|11|||
23406973|NCT00251693|65233888|FG001|Overall Study|Withdrawal by Subject|17|||
23406974|NCT00251693|65233889|FG002|Overall Study|Withdrawal by Subject|14|||
23406975|NCT00251693|65233887|FG000|Overall Study|Lack of Efficacy|0|||
23406976|NCT00251693|65233888|FG001|Overall Study|Lack of Efficacy|1|||
23406977|NCT00251693|65233889|FG002|Overall Study|Lack of Efficacy|0|||
23406978|NCT00251693|65233887|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
23406979|NCT00251693|65233888|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
23406980|NCT00251693|65233889|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
23406981|NCT00251693|65233887|FG000|Overall Study|Noncompliant|0|||
23406982|NCT00251693|65233888|FG001|Overall Study|Noncompliant|0|||
23406983|NCT00251693|65233889|FG002|Overall Study|Noncompliant|2|||
23406984|NCT00251693|65233887|FG000|Overall Study|Possible Barrett's esophagus|3|||
23406985|NCT00251693|65233888|FG001|Overall Study|Possible Barrett's esophagus|5|||
23406986|NCT00251693|65233889|FG002|Overall Study|Possible Barrett's esophagus|2|||
23406987|NCT00251693|65233887|FG000|Overall Study|Subject request/subject unavailable|1|||
23406988|NCT00251693|65233888|FG001|Overall Study|Subject request/subject unavailable|2|||
23406989|NCT00251693|65233889|FG002|Overall Study|Subject request/subject unavailable|0|||
23406990|NCT00251693|65233887|FG000|Overall Study|Abnormal laboratory findings|0|||
23406991|NCT00251693|65233888|FG001|Overall Study|Abnormal laboratory findings|0|||
23406992|NCT00251693|65233889|FG002|Overall Study|Abnormal laboratory findings|1|||
23406993|NCT01333722|65233890|FG000|Overall Study|Lack of Efficacy|0|||
23406994|NCT01333722|65233891|FG001|Overall Study|Lack of Efficacy|2|||
23406995|NCT01333722|65233890|FG000|Overall Study|Withdrawal by Subject|0|||
23406996|NCT01333722|65233891|FG001|Overall Study|Withdrawal by Subject|1|||
23406997|NCT00465972|65233894|FG000|Overall Study|Withdrawal by Subject|2|||
23406998|NCT00465972|65233895|FG001|Overall Study|Withdrawal by Subject|1|||
23406999|NCT01582009|65233896|FG000|Overall Study|Withdrawal by Subject|1|||
23407000|NCT01582009|65233896|FG000|Overall Study|Physician Decision|1|||
23407001|NCT03338400|65233897|FG000|Overall Study|Lost to Follow-up|1|||
23407002|NCT03338400|65233898|FG001|Overall Study|Lost to Follow-up|2|||
23407003|NCT02015481|65233906|FG000|Overall Study|Death|1|||
23407004|NCT03386435|65233914|FG000|Overall Study|Protocol Violation|5|||
23407005|NCT03386435|65233915|FG001|Overall Study|Protocol Violation|7|||
23407006|NCT01146613|65233916|FG000|Overall Study|Lost to Follow-up|3|||
23407007|NCT01146613|65233917|FG001|Overall Study|Lost to Follow-up|8|||
23407008|NCT01146613|65233916|FG000|Overall Study|Lack of Efficacy|0|||
23407009|NCT01146613|65233917|FG001|Overall Study|Lack of Efficacy|1|||
23407010|NCT01146613|65233916|FG000|Overall Study|Death|1|||
23407011|NCT01146613|65233917|FG001|Overall Study|Death|0|||
23407012|NCT01146613|65233916|FG000|Overall Study|Physician Decision|1|||
23407013|NCT01146613|65233917|FG001|Overall Study|Physician Decision|0|||
23407014|NCT01146613|65233916|FG000|Overall Study|Withdrawal by Subject|0|||
23407015|NCT01146613|65233917|FG001|Overall Study|Withdrawal by Subject|3|||
23407016|NCT01146613|65233916|FG000|Overall Study|schedule conflict|1|||
23407017|NCT01146613|65233917|FG001|Overall Study|schedule conflict|0|||
23407018|NCT01146613|65233916|FG000|Overall Study|Outpatient detox|1|||
23407019|NCT01146613|65233917|FG001|Overall Study|Outpatient detox|0|||
23407020|NCT01696773|65236730|FG000|Days 15-27, Washout|Adverse Event|1|||
23407021|NCT01696773|65236731|FG001|Days 15-27, Washout|Adverse Event|0|||
23407022|NCT01127633|65236732|FG000|Overall Study|Adverse Event|74|||
23407023|NCT01127633|65236733|FG001|Overall Study|Adverse Event|73|||
23407024|NCT01127633|65236732|FG000|Overall Study|Death|40|||
23407025|NCT01127633|65236733|FG001|Overall Study|Death|43|||
23407026|NCT01127633|65236732|FG000|Overall Study|Lost to Follow-up|4|||
23407027|NCT01127633|65236733|FG001|Overall Study|Lost to Follow-up|0|||
23407028|NCT01127633|65236732|FG000|Overall Study|Parent/Caregiver Decision|246|||
23407029|NCT01127633|65236733|FG001|Overall Study|Parent/Caregiver Decision|228|||
23407030|NCT01127633|65236732|FG000|Overall Study|Physician Decision|60|||
23407031|NCT01127633|65236733|FG001|Overall Study|Physician Decision|45|||
23407032|NCT01127633|65236732|FG000|Overall Study|Withdrawal by Subject|57|||
23407033|NCT01127633|65236733|FG001|Overall Study|Withdrawal by Subject|72|||
23407034|NCT01127633|65236732|FG000|Overall Study|Sponsor Decision|163|||
23407035|NCT01127633|65236733|FG001|Overall Study|Sponsor Decision|195|||
23407036|NCT01127633|65236732|FG000|Overall Study|Protocol Violation|8|||
23407037|NCT01127633|65236733|FG001|Overall Study|Protocol Violation|16|||
23407038|NCT01127633|65236732|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
23407039|NCT01127633|65236733|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
23407040|NCT01127633|65236732|FG000|Overall Study|Not treated|1|||
23407041|NCT01127633|65236733|FG001|Overall Study|Not treated|0|||
23407042|NCT01063348|65236738|FG000|Overall Study|Lost to Follow-up|3|||
23407043|NCT01063348|65236739|FG001|Overall Study|Lost to Follow-up|10|||
23407044|NCT03276728|65236740|FG000|Overall Study|Lost to Follow-up|0|||
23407045|NCT03276728|65236741|FG001|Overall Study|Lost to Follow-up|0|||
23407046|NCT03276728|65236742|FG002|Overall Study|Lost to Follow-up|2|||
23407047|NCT03276728|65236743|FG003|Overall Study|Lost to Follow-up|2|||
23407048|NCT03276728|65236744|FG004|Overall Study|Lost to Follow-up|0|||
23407049|NCT03276728|65236745|FG005|Overall Study|Lost to Follow-up|0|||
23407050|NCT03276728|65236746|FG006|Overall Study|Lost to Follow-up|0|||
23407051|NCT03276728|65236747|FG007|Overall Study|Lost to Follow-up|0|||
23407052|NCT03276728|65236740|FG000|Overall Study|Withdrawal by Subject|0|||
23407053|NCT03276728|65236741|FG001|Overall Study|Withdrawal by Subject|0|||
23407054|NCT03276728|65236742|FG002|Overall Study|Withdrawal by Subject|0|||
23407055|NCT03276728|65236743|FG003|Overall Study|Withdrawal by Subject|3|||
23407056|NCT03276728|65236744|FG004|Overall Study|Withdrawal by Subject|0|||
23407057|NCT03276728|65236745|FG005|Overall Study|Withdrawal by Subject|0|||
23407058|NCT03276728|65236746|FG006|Overall Study|Withdrawal by Subject|0|||
23407059|NCT03276728|65236747|FG007|Overall Study|Withdrawal by Subject|0|||
23407060|NCT03276728|65236740|FG000|Overall Study|Decision by sponsor|0|||
23407061|NCT03276728|65236741|FG001|Overall Study|Decision by sponsor|0|||
23407062|NCT03276728|65236742|FG002|Overall Study|Decision by sponsor|0|||
23407063|NCT03276728|65236743|FG003|Overall Study|Decision by sponsor|0|||
23407064|NCT03276728|65236744|FG004|Overall Study|Decision by sponsor|1|||
23407065|NCT03276728|65236745|FG005|Overall Study|Decision by sponsor|0|||
23407066|NCT03276728|65236746|FG006|Overall Study|Decision by sponsor|2|||
23407067|NCT03276728|65236747|FG007|Overall Study|Decision by sponsor|1|||
23407068|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407069|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407070|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
23407071|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
23407072|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407073|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407074|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407075|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
23407076|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407077|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407078|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407079|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407080|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407081|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407082|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
23407083|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407084|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407085|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407086|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407087|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407088|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407089|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Other|0|||
23407090|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Other|0|||
23407091|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Other|1|||
23407092|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Other|1|||
23407093|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Other|0|||
23407094|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Other|0|||
23407095|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Other|0|||
23407096|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
23407097|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
23407098|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
23407099|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
23407100|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
23407101|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
23407102|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
23407103|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
23407104|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
23407105|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
23407106|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
23407107|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
23407108|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
23407109|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
23407110|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407111|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407112|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407113|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407114|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
23407115|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
23407116|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
23407117|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Other|0|||
23407118|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Other|0|||
23407119|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Other|0|||
23407120|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Other|0|||
23407121|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Other|2|||
23407122|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Other|0|||
23407123|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Other|3|||
23407124|NCT00992056|65236756|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
23407125|NCT00992056|65236757|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
23407126|NCT00992056|65236756|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
23407127|NCT00992056|65236757|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
23407128|NCT02685826|65236758|FG000|Overall Study|Adverse Event|2|||
23407129|NCT02685826|65236759|FG001|Overall Study|Adverse Event|0|||
23407130|NCT02685826|65236760|FG002|Overall Study|Adverse Event|1|||
23407131|NCT02685826|65236758|FG000|Overall Study|Progressive Disease|2|||
23407132|NCT02685826|65236759|FG001|Overall Study|Progressive Disease|1|||
23407133|NCT02685826|65236760|FG002|Overall Study|Progressive Disease|0|||
23407134|NCT02685826|65236758|FG000|Overall Study|Withdrawal by Subject|2|||
23407135|NCT02685826|65236759|FG001|Overall Study|Withdrawal by Subject|0|||
23407136|NCT02685826|65236760|FG002|Overall Study|Withdrawal by Subject|0|||
23407137|NCT02685826|65236758|FG000|Overall Study|Full Clinical Hold by FDA|19|||
23407138|NCT02685826|65236759|FG001|Overall Study|Full Clinical Hold by FDA|9|||
23407139|NCT02685826|65236760|FG002|Overall Study|Full Clinical Hold by FDA|20|||
23407140|NCT00401843|65236763|FG000|Overall Study|Achieved Complete Response|1|||
23407141|NCT00401843|65236764|FG001|Overall Study|Achieved Complete Response|5|||
23407142|NCT00401843|65236765|FG002|Overall Study|Achieved Complete Response|11|||
23407143|NCT00401843|65236763|FG000|Overall Study|Adverse Event|7|||
23407144|NCT00401843|65236764|FG001|Overall Study|Adverse Event|26|||
23407145|NCT00401843|65236765|FG002|Overall Study|Adverse Event|27|||
23407146|NCT00401843|65236763|FG000|Overall Study|Death|0|||
23407147|NCT00401843|65236764|FG001|Overall Study|Death|8|||
23407148|NCT00401843|65236765|FG002|Overall Study|Death|10|||
23407149|NCT00401843|65236763|FG000|Overall Study|Disease progression|10|||
23407150|NCT00401843|65236764|FG001|Overall Study|Disease progression|60|||
23407151|NCT00401843|65236765|FG002|Overall Study|Disease progression|49|||
23407152|NCT00401843|65236763|FG000|Overall Study|End of Study|1|||
23407153|NCT00401843|65236764|FG001|Overall Study|End of Study|1|||
23407154|NCT00401843|65236765|FG002|Overall Study|End of Study|2|||
23407155|NCT00401843|65236763|FG000|Overall Study|Lost to Follow-up|0|||
23407156|NCT00401843|65236764|FG001|Overall Study|Lost to Follow-up|0|||
23407157|NCT00401843|65236765|FG002|Overall Study|Lost to Follow-up|2|||
23407158|NCT00401843|65236763|FG000|Overall Study|Other Unspecified|0|||
23407159|NCT00401843|65236764|FG001|Overall Study|Other Unspecified|3|||
23407160|NCT00401843|65236765|FG002|Overall Study|Other Unspecified|5|||
23407161|NCT00401843|65236763|FG000|Overall Study|Physician Decision|0|||
23407162|NCT00401843|65236764|FG001|Overall Study|Physician Decision|16|||
23407163|NCT00401843|65236765|FG002|Overall Study|Physician Decision|10|||
23407164|NCT00401843|65236763|FG000|Overall Study|Protocol Violation|0|||
23407165|NCT00401843|65236764|FG001|Overall Study|Protocol Violation|0|||
23407166|NCT00401843|65236765|FG002|Overall Study|Protocol Violation|1|||
23407167|NCT00401843|65236763|FG000|Overall Study|Withdrawal by Subject|1|||
23407168|NCT00401843|65236764|FG001|Overall Study|Withdrawal by Subject|5|||
23407169|NCT00401843|65236765|FG002|Overall Study|Withdrawal by Subject|5|||
23407170|NCT00401843|65236763|FG000|Overall Study|Withdrawal of consent to study agent|1|||
23407171|NCT00401843|65236764|FG001|Overall Study|Withdrawal of consent to study agent|15|||
23407172|NCT00401843|65236765|FG002|Overall Study|Withdrawal of consent to study agent|17|||
23407173|NCT00401843|65236763|FG000|Overall Study|Randomized but not Treated|0|||
23407174|NCT00401843|65236764|FG001|Overall Study|Randomized but not Treated|2|||
23407175|NCT00401843|65236765|FG002|Overall Study|Randomized but not Treated|3|||
23407176|NCT00401843|65236763|FG000|Overall Study|Received incorrect treatment|0|||
23407177|NCT00401843|65236764|FG001|Overall Study|Received incorrect treatment|3|||
23407178|NCT00401843|65236765|FG002|Overall Study|Received incorrect treatment|0|||
23407179|NCT01485796|65236766|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
23407180|NCT01485796|65236766|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
23407181|NCT01485796|65236766|FG000|Period 2: Epoch 2|Adverse Event|3|||
23407182|NCT01485796|65236766|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
23407183|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
23407184|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
23407185|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
23407186|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
23407187|NCT00603941|65236770|FG000|Overall Study|Disease progression|6|||
23407188|NCT00603941|65236771|FG001|Overall Study|Disease progression|7|||
23407189|NCT00603941|65236772|FG002|Overall Study|Disease progression|1|||
23407190|NCT00603941|65236770|FG000|Overall Study|Adverse Event|1|||
23407191|NCT00603941|65236771|FG001|Overall Study|Adverse Event|0|||
23407192|NCT00603941|65236772|FG002|Overall Study|Adverse Event|1|||
23407193|NCT00603941|65236770|FG000|Overall Study|Physician Decision|0|||
23407194|NCT00603941|65236771|FG001|Overall Study|Physician Decision|1|||
23407195|NCT00603941|65236772|FG002|Overall Study|Physician Decision|0|||
23407196|NCT00603941|65236770|FG000|Overall Study|Withdrawal by Subject|0|||
23407197|NCT00603941|65236771|FG001|Overall Study|Withdrawal by Subject|2|||
23407198|NCT00603941|65236772|FG002|Overall Study|Withdrawal by Subject|0|||
23407199|NCT02278341|65236773|FG000|Overall Study|Randomized but never received study drug|1|||
23407200|NCT02278341|65236774|FG001|Overall Study|Randomized but never received study drug|1|||
23407201|NCT02278341|65236773|FG000|Overall Study|Adverse Event|3|||
23407202|NCT02278341|65236774|FG001|Overall Study|Adverse Event|0|||
23407203|NCT02278341|65236773|FG000|Overall Study|Death|68|||
23407204|NCT02278341|65236774|FG001|Overall Study|Death|56|||
23407205|NCT02278341|65236773|FG000|Overall Study|Withdrawal by Subject|30|||
23407206|NCT02278341|65236774|FG001|Overall Study|Withdrawal by Subject|19|||
23407207|NCT02278341|65236773|FG000|Overall Study|Lost to Follow-up|0|||
23407208|NCT02278341|65236774|FG001|Overall Study|Lost to Follow-up|1|||
23407209|NCT02278341|65236773|FG000|Overall Study|Physician Decision|1|||
23407210|NCT02278341|65236774|FG001|Overall Study|Physician Decision|1|||
23407211|NCT02278341|65236773|FG000|Overall Study|Miscellaneous|15|||
23407212|NCT02278341|65236774|FG001|Overall Study|Miscellaneous|14|||
23407213|NCT02454530|65236781|FG000|Overall Study|Other|8|||
23407214|NCT02454530|65236782|FG001|Overall Study|Other|13|||
23407215|NCT02454530|65236781|FG000|Overall Study|Missing information|56|||
23407216|NCT02454530|65236782|FG001|Overall Study|Missing information|69|||
23407217|NCT02454530|65236781|FG000|Overall Study|Death|2|||
23407218|NCT02454530|65236782|FG001|Overall Study|Death|41|||
23407219|NCT02454530|65236781|FG000|Overall Study|Lost to Follow-up|4|||
23407220|NCT02454530|65236782|FG001|Overall Study|Lost to Follow-up|4|||
23407221|NCT04194944|65236783|FG000|Overall Study|Lost to Follow-up|3|||
23407222|NCT04194944|65236784|FG001|Overall Study|Lost to Follow-up|0|||
23407223|NCT04194944|65236783|FG000|Overall Study|Withdrawal by Subject|2|||
23407224|NCT04194944|65236784|FG001|Overall Study|Withdrawal by Subject|2|||
23407225|NCT04194944|65236783|FG000|Overall Study|On Treatment|93|||
23407226|NCT04194944|65236784|FG001|Overall Study|On Treatment|30|||
23407227|NCT03369665|65236785|FG000|Overall Study|Adverse Event|3|||
23407228|NCT03369665|65236785|FG000|Overall Study|Lost to Follow-up|7|||
23407229|NCT03369665|65236785|FG000|Overall Study|Withdrawal by Subject|15|||
23407230|NCT03369665|65236785|FG000|Overall Study|Progression Disease|2|||
23407231|NCT03369665|65236785|FG000|Overall Study|Not classified|3|||
23407232|NCT01970241|65236788|FG000|Overall Study|Withdrawal by Subject|2|||
23407233|NCT01970241|65236789|FG001|Overall Study|Withdrawal by Subject|0|||
23407234|NCT01970241|65236788|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
23407235|NCT01970241|65236789|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
23407236|NCT00114127|65236790|FG000|Overall Study|Adverse Event|2|||
23407237|NCT00114127|65236791|FG001|Overall Study|Adverse Event|1|||
23407238|NCT00114127|65236790|FG000|Overall Study|Lost to Follow-up|1|||
23407239|NCT00114127|65236791|FG001|Overall Study|Lost to Follow-up|0|||
23407240|NCT00114127|65236790|FG000|Overall Study|Withdrawal by Subject|1|||
23407241|NCT00114127|65236791|FG001|Overall Study|Withdrawal by Subject|3|||
23407242|NCT01135459|65236792|FG000|Overall Study|Adverse Event|8|||
23407243|NCT01135459|65236793|FG001|Overall Study|Adverse Event|10|||
23407244|NCT01135459|65236792|FG000|Overall Study|Lack of Efficacy|3|||
23407245|NCT01135459|65236793|FG001|Overall Study|Lack of Efficacy|1|||
23407246|NCT01135459|65236792|FG000|Overall Study|Withdrawal by Subject|2|||
23407247|NCT01135459|65236793|FG001|Overall Study|Withdrawal by Subject|3|||
23407248|NCT01135459|65236792|FG000|Overall Study|Protocol Violation|5|||
23407249|NCT01135459|65236793|FG001|Overall Study|Protocol Violation|3|||
23407250|NCT01135459|65236792|FG000|Overall Study|Lost to Follow-up|2|||
23407251|NCT01135459|65236793|FG001|Overall Study|Lost to Follow-up|1|||
23407252|NCT01135459|65236792|FG000|Overall Study|Non-compliance to study procedures|0|||
23407253|NCT01135459|65236793|FG001|Overall Study|Non-compliance to study procedures|1|||
23407254|NCT01135459|65236792|FG000|Overall Study|Other than specified|1|||
23407255|NCT01135459|65236793|FG001|Overall Study|Other than specified|1|||
23407256|NCT02257242|65236802|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
23407257|NCT02257242|65236803|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407258|NCT02257242|65236804|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407259|NCT02257242|65236805|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407260|NCT02257242|65236806|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407261|NCT02257242|65236807|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407262|NCT02257242|65236808|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407263|NCT02257242|65236809|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407264|NCT02257242|65236810|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407265|NCT01000506|65236814|FG000|Overall Study|Adverse Event|6|||
23407266|NCT01000506|65236815|FG001|Overall Study|Adverse Event|5|||
23407267|NCT01000506|65236816|FG002|Overall Study|Adverse Event|8|||
23407268|NCT01000506|65236817|FG003|Overall Study|Adverse Event|9|||
23407269|NCT01000506|65236814|FG000|Overall Study|Lack of Efficacy|8|||
23407270|NCT01000506|65236815|FG001|Overall Study|Lack of Efficacy|6|||
23407271|NCT01000506|65236816|FG002|Overall Study|Lack of Efficacy|4|||
23407272|NCT01000506|65236817|FG003|Overall Study|Lack of Efficacy|4|||
23407273|NCT01000506|65236814|FG000|Overall Study|Protocol Violation|1|||
23407274|NCT01000506|65236815|FG001|Overall Study|Protocol Violation|1|||
23407275|NCT01000506|65236816|FG002|Overall Study|Protocol Violation|0|||
23407276|NCT01000506|65236817|FG003|Overall Study|Protocol Violation|0|||
23407277|NCT01000506|65236814|FG000|Overall Study|Lost to Follow-up|1|||
23407278|NCT01000506|65236815|FG001|Overall Study|Lost to Follow-up|1|||
23407279|NCT01000506|65236816|FG002|Overall Study|Lost to Follow-up|4|||
23407280|NCT01000506|65236817|FG003|Overall Study|Lost to Follow-up|0|||
23407281|NCT01000506|65236814|FG000|Overall Study|Physician Decision|1|||
23407282|NCT01000506|65236815|FG001|Overall Study|Physician Decision|3|||
23407283|NCT01000506|65236816|FG002|Overall Study|Physician Decision|3|||
23407284|NCT01000506|65236817|FG003|Overall Study|Physician Decision|3|||
23407285|NCT01000506|65236814|FG000|Overall Study|Withdrawal by Subject|11|||
23407286|NCT01000506|65236815|FG001|Overall Study|Withdrawal by Subject|8|||
23407287|NCT01000506|65236816|FG002|Overall Study|Withdrawal by Subject|2|||
23407288|NCT01000506|65236817|FG003|Overall Study|Withdrawal by Subject|7|||
23407289|NCT01393899|65236818|FG000|Overall Study|Study terminated by sponsor|1|||
23407290|NCT01393899|65236819|FG001|Overall Study|Study terminated by sponsor|0|||
23407291|NCT01393899|65236820|FG002|Overall Study|Study terminated by sponsor|1|||
23407292|NCT01393899|65236818|FG000|Overall Study|Other|1|||
23407293|NCT01393899|65236819|FG001|Overall Study|Other|0|||
23407294|NCT01393899|65236820|FG002|Overall Study|Other|0|||
23407295|NCT01393899|65236818|FG000|Overall Study|Withdrawal by Subject|2|||
23407296|NCT01393899|65236819|FG001|Overall Study|Withdrawal by Subject|2|||
23407297|NCT01393899|65236820|FG002|Overall Study|Withdrawal by Subject|1|||
23407298|NCT01393899|65236818|FG000|Overall Study|Lost to Follow-up|0|||
23407299|NCT01393899|65236819|FG001|Overall Study|Lost to Follow-up|0|||
23407300|NCT01393899|65236820|FG002|Overall Study|Lost to Follow-up|1|||
23407301|NCT01393899|65236818|FG000|Overall Study|Does not meet entrance criteria|1|||
23407302|NCT01393899|65236819|FG001|Overall Study|Does not meet entrance criteria|0|||
23407303|NCT01393899|65236820|FG002|Overall Study|Does not meet entrance criteria|1|||
23407304|NCT01393899|65236818|FG000|Overall Study|Lack of Efficacy|26|||
23407305|NCT01393899|65236819|FG001|Overall Study|Lack of Efficacy|21|||
23407306|NCT01393899|65236820|FG002|Overall Study|Lack of Efficacy|16|||
23407307|NCT01393899|65236818|FG000|Overall Study|Adverse Event|1|||
23407308|NCT01393899|65236819|FG001|Overall Study|Adverse Event|5|||
23407309|NCT01393899|65236820|FG002|Overall Study|Adverse Event|3|||
23407310|NCT03159468|65236821|FG000|Overall Study|Withdrawal by Subject|0|||
23407311|NCT03159468|65236822|FG001|Overall Study|Withdrawal by Subject|0|||
23407312|NCT03159468|65236823|FG002|Overall Study|Withdrawal by Subject|3|||
23407313|NCT03159468|65236824|FG003|Overall Study|Withdrawal by Subject|0|||
23407314|NCT03159468|65236825|FG004|Overall Study|Withdrawal by Subject|0|||
23407315|NCT03159468|65236826|FG005|Overall Study|Withdrawal by Subject|0|||
23407316|NCT02819297|65236827|FG000|Overall Study|Withdrawal by Subject|25|||
23407317|NCT02819297|65236828|FG001|Overall Study|Withdrawal by Subject|13|||
23407318|NCT02819297|65236827|FG000|Overall Study|Lost to Follow-up|12|||
23407319|NCT02819297|65236828|FG001|Overall Study|Lost to Follow-up|14|||
23407320|NCT02819297|65236827|FG000|Overall Study|Adverse Event|12|||
23607368|NCT03031782|65950680|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23407321|NCT02819297|65236828|FG001|Overall Study|Adverse Event|10|||
23407322|NCT02819297|65236827|FG000|Overall Study|Physician Decision|5|||
23407323|NCT02819297|65236828|FG001|Overall Study|Physician Decision|5|||
23407324|NCT02819297|65236827|FG000|Overall Study|Lack of Efficacy|5|||
23407325|NCT02819297|65236828|FG001|Overall Study|Lack of Efficacy|8|||
23407326|NCT02819297|65236827|FG000|Overall Study|Protocol Violation|1|||
23407327|NCT02819297|65236828|FG001|Overall Study|Protocol Violation|2|||
23407328|NCT01462929|65236831|FG000|Overall Study|Adverse Event|3|||
23407329|NCT01462929|65236832|FG001|Overall Study|Adverse Event|3|||
23407330|NCT01462929|65236833|FG002|Overall Study|Adverse Event|4|||
23407331|NCT01462929|65236831|FG000|Overall Study|Withdrawal by Subject|2|||
23407332|NCT01462929|65236832|FG001|Overall Study|Withdrawal by Subject|1|||
23407333|NCT01462929|65236833|FG002|Overall Study|Withdrawal by Subject|0|||
23407334|NCT01462929|65236831|FG000|Overall Study|Lack of Efficacy|0|||
23407335|NCT01462929|65236832|FG001|Overall Study|Lack of Efficacy|0|||
23407336|NCT01462929|65236833|FG002|Overall Study|Lack of Efficacy|1|||
23407337|NCT04162470|65236843|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
23407338|NCT02524145|65236844|FG000|Overall Study|Withdrawal by Subject|2|||
23407339|NCT02524145|65236845|FG001|Overall Study|Withdrawal by Subject|2|||
23407340|NCT02524145|65236846|FG002|Overall Study|Withdrawal by Subject|3|||
23407341|NCT03549338|65236847|FG000|Overall Study|Progressive Disease|1|||
23407342|NCT03549338|65236848|FG001|Overall Study|Progressive Disease|0|||
23407343|NCT03549338|65236849|FG002|Overall Study|Progressive Disease|0|||
23407344|NCT03549338|65236847|FG000|Overall Study|Clinical Progression|0|||
23407345|NCT03549338|65236848|FG001|Overall Study|Clinical Progression|1|||
23407346|NCT03549338|65236849|FG002|Overall Study|Clinical Progression|0|||
23407347|NCT03902392|65236850|FG000|Overall Study|Lost to Follow-up|7|||
23407348|NCT03902392|65236851|FG001|Overall Study|Lost to Follow-up|7|||
23407349|NCT00625586|65236856|FG000|Overall Study|Adverse Event|1|||
23407350|NCT00625586|65236856|FG000|Overall Study|Progressive disease|1|||
23407351|NCT02581891|65236857|FG000|Overall Study|Adverse Event|4|||
23407352|NCT02581891|65236858|FG001|Overall Study|Adverse Event|6|||
23407353|NCT02581891|65236857|FG000|Overall Study|Death|3|||
23407354|NCT02581891|65236858|FG001|Overall Study|Death|4|||
23407355|NCT02581891|65236857|FG000|Overall Study|Lost to Follow-up|1|||
23407356|NCT02581891|65236858|FG001|Overall Study|Lost to Follow-up|2|||
23407357|NCT02581891|65236857|FG000|Overall Study|Physician Decision|0|||
23407358|NCT02581891|65236858|FG001|Overall Study|Physician Decision|1|||
23407359|NCT02581891|65236857|FG000|Overall Study|Withdrawal by Subject|4|||
23407360|NCT02581891|65236858|FG001|Overall Study|Withdrawal by Subject|5|||
23407361|NCT02581891|65236857|FG000|Overall Study|Other Reasons|3|||
23407362|NCT02581891|65236858|FG001|Overall Study|Other Reasons|1|||
23407363|NCT02581891|65236857|FG000|Overall Study|Discontinued during followup|1|||
23407364|NCT02581891|65236858|FG001|Overall Study|Discontinued during followup|0|||
23407365|NCT03783962|65236860|FG000|Overall Study|Lost to Follow-up|3|||
23407366|NCT03783962|65236861|FG001|Overall Study|Lost to Follow-up|6|||
23407367|NCT03783962|65236860|FG000|Overall Study|Protocol Violation|0|||
23407368|NCT03783962|65236861|FG001|Overall Study|Protocol Violation|1|||
23407369|NCT00469833|65236866|FG000|Overall Study|No IV access|2|||
23407370|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
23407371|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407372|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407373|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407374|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407375|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
23407376|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407377|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407378|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407379|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407380|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
23407381|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407382|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407383|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407384|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407385|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
23407386|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23506152|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23407387|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23407388|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23407389|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23506153|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506154|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
23407390|NCT01194245|65236867|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23607369|NCT03031782|65950681|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23407391|NCT01194245|65236868|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407392|NCT01194245|65236869|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407393|NCT01194245|65236870|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407394|NCT01194245|65236871|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23407395|NCT01194245|65236867|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23407396|NCT01194245|65236868|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23407397|NCT01194245|65236869|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407398|NCT01194245|65236870|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407399|NCT01194245|65236871|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407400|NCT02484443|65236872|FG000|Overall Study|Lack of Efficacy|28|||
23407401|NCT02484443|65236872|FG000|Overall Study|Physician Decision|2|||
23407402|NCT02484443|65236872|FG000|Overall Study|Ineligible|2|||
23407403|NCT06164691|65236873|FG000|Overall Study|Withdrawal by Subject|2|||
23407404|NCT06164691|65236874|FG001|Overall Study|Withdrawal by Subject|0|||
23407405|NCT06164691|65236875|FG002|Overall Study|Withdrawal by Subject|0|||
23407406|NCT03230318|65236876|FG000|Overall Study|Radiographic disease progression|72|||
23407407|NCT03230318|65236877|FG001|Overall Study|Radiographic disease progression|19|||
23407408|NCT03230318|65236876|FG000|Overall Study|Clinical progression|17|||
23407409|NCT03230318|65236877|FG001|Overall Study|Clinical progression|7|||
23407410|NCT03230318|65236876|FG000|Overall Study|Adverse Event|5|||
23407411|NCT03230318|65236877|FG001|Overall Study|Adverse Event|3|||
23407412|NCT03230318|65236876|FG000|Overall Study|Physician Decision|2|||
23407413|NCT03230318|65236877|FG001|Overall Study|Physician Decision|3|||
23407414|NCT03230318|65236876|FG000|Overall Study|Death|3|||
23407415|NCT03230318|65236877|FG001|Overall Study|Death|2|||
23407416|NCT03230318|65236876|FG000|Overall Study|Lost to Follow-up|1|||
23407417|NCT03230318|65236877|FG001|Overall Study|Lost to Follow-up|0|||
23407418|NCT03230318|65236876|FG000|Overall Study|Withdrawal by Subject|1|||
23407419|NCT03230318|65236877|FG001|Overall Study|Withdrawal by Subject|3|||
23407420|NCT03230318|65236876|FG000|Overall Study|Other|3|||
23407421|NCT03230318|65236877|FG001|Overall Study|Other|7|||
23407422|NCT01664247|65236882|FG000|Overall Study|Adverse Event|5|||
23407423|NCT01664247|65236883|FG001|Overall Study|Adverse Event|3|||
23407424|NCT01664247|65236882|FG000|Overall Study|Protocol Violation|3|||
23407425|NCT01664247|65236883|FG001|Overall Study|Protocol Violation|5|||
23407426|NCT01664247|65236882|FG000|Overall Study|Withdrawal Criteria|1|||
23407427|NCT01664247|65236883|FG001|Overall Study|Withdrawal Criteria|4|||
23407428|NCT01664247|65236882|FG000|Overall Study|Unclassified|5|||
23407429|NCT01664247|65236883|FG001|Overall Study|Unclassified|29|||
23407430|NCT01508910|65236891|FG000|Treatment|Death|2|||
23407431|NCT01508910|65236892|FG001|Treatment|Death|3|||
23407432|NCT01508910|65236893|FG002|Treatment|Death|2|||
23407433|NCT01508910|65236894|FG003|Treatment|Death|0|||
23407434|NCT01508910|65236891|FG000|Treatment|Lost to Follow-up|0|||
23407435|NCT01508910|65236892|FG001|Treatment|Lost to Follow-up|0|||
23407436|NCT01508910|65236893|FG002|Treatment|Lost to Follow-up|2|||
23407437|NCT01508910|65236894|FG003|Treatment|Lost to Follow-up|1|||
23407438|NCT01508910|65236891|FG000|Treatment|Withdrawal by Subject|0|||
23407439|NCT01508910|65236892|FG001|Treatment|Withdrawal by Subject|1|||
23407440|NCT01508910|65236893|FG002|Treatment|Withdrawal by Subject|6|||
23407441|NCT01508910|65236894|FG003|Treatment|Withdrawal by Subject|1|||
23407442|NCT01508910|65236891|FG000|Treatment|Sponsor Decision|0|||
23407443|NCT01508910|65236892|FG001|Treatment|Sponsor Decision|0|||
23407444|NCT01508910|65236893|FG002|Treatment|Sponsor Decision|0|||
23407445|NCT01508910|65236894|FG003|Treatment|Sponsor Decision|1|||
23407446|NCT00996658|65236895|FG000|Overall Study|Adverse Event|2|||
23407447|NCT00996658|65236896|FG001|Overall Study|Adverse Event|5|||
23407448|NCT00996658|65236895|FG000|Overall Study|Protocol Violation|0|||
23407449|NCT00996658|65236896|FG001|Overall Study|Protocol Violation|1|||
23407450|NCT00996658|65236895|FG000|Overall Study|Lost to Follow-up|2|||
23407451|NCT00996658|65236896|FG001|Overall Study|Lost to Follow-up|5|||
23407452|NCT00996658|65236895|FG000|Overall Study|Non-compliance issues|3|||
23407453|NCT00996658|65236896|FG001|Overall Study|Non-compliance issues|3|||
23506155|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
23407454|NCT00996658|65236895|FG000|Overall Study|Other|9|||
23407455|NCT00996658|65236896|FG001|Overall Study|Other|7|||
23407456|NCT01648023|65236900|FG000|Overall Study|Screen Fail Post Randomization|1|||
23407457|NCT01648023|65236901|FG001|Overall Study|Screen Fail Post Randomization|2|||
23407458|NCT01106157|65236902|FG000|Overall Study|Withdrawal by Subject|1|||
23407459|NCT01106157|65236903|FG001|Overall Study|Withdrawal by Subject|0|||
23407460|NCT00642707|65236904|FG000|Overall Study|Adverse Event|0|||
23407461|NCT00642707|65236905|FG001|Overall Study|Adverse Event|0|||
23407462|NCT00642707|65236906|FG002|Overall Study|Adverse Event|0|||
23407463|NCT00642707|65236907|FG003|Overall Study|Adverse Event|2|||
23407464|NCT00642707|65236904|FG000|Overall Study|Withdrawal by Subject|1|||
23607370|NCT03031782|65950682|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23407465|NCT00642707|65236905|FG001|Overall Study|Withdrawal by Subject|0|||
23407466|NCT00642707|65236906|FG002|Overall Study|Withdrawal by Subject|0|||
23407467|NCT00642707|65236907|FG003|Overall Study|Withdrawal by Subject|0|||
23407468|NCT01881009|65236912|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
23407469|NCT01881009|65236913|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
23407470|NCT01722994|65236915|FG000|Overall Study|Missing data|25|||
23407471|NCT01722994|65236916|FG001|Overall Study|Missing data|17|||
23407472|NCT02148263|65236917|FG000|Overall Study|Withdrawal by Subject|3|||
23407473|NCT02148263|65236918|FG001|Overall Study|Withdrawal by Subject|2|||
23407474|NCT00470262|65236919|FG000|Overall Study|Withdrawal by Subject|2|||
23407475|NCT00470262|65236920|FG001|Overall Study|Withdrawal by Subject|0|||
23407476|NCT00699413|65236921|FG000|Overall Study|Withdrawal by Subject|0|||
23407477|NCT00699413|65236922|FG001|Overall Study|Withdrawal by Subject|2|||
23407478|NCT00699413|65236921|FG000|Overall Study|Study terminated by sponsor|4|||
23407479|NCT00699413|65236922|FG001|Overall Study|Study terminated by sponsor|2|||
23407480|NCT03135431|65236923|FG000|Overall Study|Study Surgeon not available|2|||
23407481|NCT03135431|65236924|FG001|Overall Study|Study Surgeon not available|0|||
23407482|NCT02779777|65236925|FG000|Overall Study|Disease Progression|1|||
23407483|NCT02779777|65236926|FG001|Overall Study|Disease Progression|0|||
23407484|NCT02779777|65236927|FG002|Overall Study|Disease Progression|0|||
23407485|NCT02779777|65236925|FG000|Overall Study|Adverse Event|3|||
23407486|NCT02779777|65236926|FG001|Overall Study|Adverse Event|1|||
23407487|NCT02779777|65236927|FG002|Overall Study|Adverse Event|0|||
23407488|NCT02779777|65236925|FG000|Overall Study|Physician Decision|9|||
23407489|NCT02779777|65236926|FG001|Overall Study|Physician Decision|0|||
23407490|NCT02779777|65236927|FG002|Overall Study|Physician Decision|1|||
23407491|NCT02779777|65236925|FG000|Overall Study|Withdrawal by Subject|1|||
23407492|NCT02779777|65236926|FG001|Overall Study|Withdrawal by Subject|0|||
23407493|NCT02779777|65236927|FG002|Overall Study|Withdrawal by Subject|0|||
23407494|NCT00809926|65236928|FG000|Overall Study|Adverse Event|18|||
23407495|NCT00809926|65236929|FG001|Overall Study|Adverse Event|10|||
23407496|NCT00809926|65236928|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23407497|NCT00809926|65236929|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23407498|NCT00809926|65236928|FG000|Overall Study|Patient withdrew consent|8|||
23407499|NCT00809926|65236929|FG001|Overall Study|Patient withdrew consent|6|||
23407500|NCT00809926|65236928|FG000|Overall Study|Lost to Follow-up|2|||
23407501|NCT00809926|65236929|FG001|Overall Study|Lost to Follow-up|1|||
23407502|NCT00809926|65236928|FG000|Overall Study|Administrative Problems|0|||
23407503|NCT00809926|65236929|FG001|Overall Study|Administrative Problems|1|||
23407504|NCT00809926|65236928|FG000|Overall Study|Protocol deviation|0|||
23407505|NCT00809926|65236929|FG001|Overall Study|Protocol deviation|2|||
23407506|NCT00803738|65236933|FG000|Overall Study|Adverse Event|3|||
23407507|NCT00803738|65236934|FG001|Overall Study|Adverse Event|5|||
23407508|NCT00803738|65236933|FG000|Overall Study|Lost to Follow-up|4|||
23407509|NCT00803738|65236934|FG001|Overall Study|Lost to Follow-up|4|||
23407510|NCT00803738|65236933|FG000|Overall Study|Protocol Violation|18|||
23407511|NCT00803738|65236934|FG001|Overall Study|Protocol Violation|10|||
23407512|NCT00803738|65236933|FG000|Overall Study|Withdrawal by Subject|1|||
23407513|NCT00803738|65236934|FG001|Overall Study|Withdrawal by Subject|4|||
23407514|NCT00803738|65236933|FG000|Overall Study|Lack of Efficacy|10|||
23407515|NCT00803738|65236934|FG001|Overall Study|Lack of Efficacy|16|||
23407516|NCT00803738|65236933|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
23407517|NCT00803738|65236934|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
23407518|NCT00803738|65236933|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
23407519|NCT00803738|65236934|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
23407520|NCT02676895|65236938|FG000|Overall Study|Administrative reason|1|||
23407521|NCT02676895|65236939|FG001|Overall Study|Administrative reason|0|||
23407522|NCT02676895|65236940|FG002|Overall Study|Administrative reason|0|||
23407523|NCT02676895|65236938|FG000|Overall Study|Protocol Violation|1|||
23407524|NCT02676895|65236939|FG001|Overall Study|Protocol Violation|0|||
23407525|NCT02676895|65236940|FG002|Overall Study|Protocol Violation|0|||
23407526|NCT02676895|65236938|FG000|Overall Study|Adverse Event|0|||
23407527|NCT02676895|65236939|FG001|Overall Study|Adverse Event|3|||
23407528|NCT02676895|65236940|FG002|Overall Study|Adverse Event|1|||
23407529|NCT02676895|65236938|FG000|Overall Study|Lost to Follow-up|0|||
23407530|NCT02676895|65236939|FG001|Overall Study|Lost to Follow-up|0|||
23407531|NCT02676895|65236940|FG002|Overall Study|Lost to Follow-up|1|||
23407532|NCT02676895|65236938|FG000|Overall Study|Withdrawal by Subject|0|||
23407533|NCT02676895|65236939|FG001|Overall Study|Withdrawal by Subject|0|||
23407534|NCT02676895|65236940|FG002|Overall Study|Withdrawal by Subject|1|||
23407535|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
23407536|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
23407537|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407538|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407539|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407540|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407541|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407542|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407543|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407544|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407545|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
23407546|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
23407547|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407548|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407549|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407550|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407551|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407552|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407553|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407554|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407555|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
23407556|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407557|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407558|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407559|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407560|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407561|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407562|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407563|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407564|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407565|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
23407566|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
23407567|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407568|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407569|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407570|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407571|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407572|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407573|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407574|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407575|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407576|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
23407577|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407578|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407579|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407580|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407581|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407582|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407583|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407584|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407585|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
23407586|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
23407587|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407588|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407589|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407590|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407591|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407592|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407593|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407594|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407595|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
23407596|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
23407597|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407598|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407599|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407600|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407601|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407602|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407603|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407604|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407605|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
23407606|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
23407607|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407608|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407609|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407610|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407611|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407612|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407613|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407614|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407615|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407616|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407617|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
23407618|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
23407619|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407620|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407621|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407622|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407623|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407624|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407625|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407626|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407627|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
23407628|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
23407629|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407630|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407631|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407632|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407633|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407634|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407635|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407636|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407637|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
23407638|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
23407639|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407640|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407641|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407642|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407643|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407644|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407645|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407646|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407647|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
23407648|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
23407649|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407650|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407651|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407652|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407653|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407654|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407655|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407656|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407657|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
23407658|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407659|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407660|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407661|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407662|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407663|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407664|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407665|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407666|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407667|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407668|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
23407669|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407670|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407671|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407672|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407673|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23506156|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
23506157|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
23607371|NCT03031782|65950683|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23407674|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407675|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Other|0|||
23407676|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Other|0|||
23407677|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Other|2|||
23407678|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Other|1|||
23407679|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Other|0|||
23407680|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Other|0|||
23407681|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Other|0|||
23407682|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Other|0|||
23407683|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Other|0|||
23407684|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Other|0|||
23407685|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407686|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407687|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407688|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407689|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407690|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
23407691|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
23407692|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
23407693|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407694|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407695|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407696|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407697|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407698|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407699|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
23407700|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
23407701|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
23407702|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
23407703|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407704|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407705|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407706|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407707|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407708|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407709|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
23407710|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407711|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
23407712|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407713|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407714|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407715|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407716|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407717|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407718|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407719|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
23407720|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407721|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
23407722|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
23407723|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407724|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407725|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407726|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407727|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407728|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407729|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
23407730|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
23407731|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
23407732|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407733|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407734|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407735|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407736|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407737|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407738|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407739|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407740|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407741|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407742|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
23407743|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407744|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407745|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407746|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407747|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407748|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407749|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407750|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407751|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
23407752|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407753|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407754|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407755|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407756|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407757|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407758|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407759|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407760|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407761|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407762|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407763|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
23407764|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
23407765|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407766|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407767|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407768|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407769|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407770|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407771|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407772|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407773|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
23407774|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
23407775|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407776|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407777|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407778|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407779|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407780|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407781|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407782|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407783|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
23407784|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
23407785|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407786|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407787|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407788|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407789|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407790|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407791|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407792|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407793|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
23407794|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
23407795|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
23407796|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
23407797|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
23407798|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
23407799|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
23407800|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
23407801|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
23407802|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
23407803|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
23407804|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
23506158|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506159|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23407805|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407806|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407807|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407808|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407809|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407810|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407811|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407812|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407813|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
23407814|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
23407815|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407816|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407817|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407818|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407819|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407820|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407821|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407822|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407823|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
23407824|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407825|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407826|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407827|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407828|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407829|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407830|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407831|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407832|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407833|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
23407834|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
23407835|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
23407836|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
23407837|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
23407838|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
23407839|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Death|58|||
23407840|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Death|65|||
23407841|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Adverse Event|28|||
23407842|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Adverse Event|40|||
23407843|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Disease Progression|22|||
23407844|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Disease Progression|35|||
23407845|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Other|25|||
23407846|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Other|33|||
23407847|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
23407848|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
23407849|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Noncompliance|8|||
23407850|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Noncompliance|8|||
23407851|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
23407852|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
23407853|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
23407854|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
23407855|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
23407856|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
23407857|NCT00286091|65236959|FG000|Open-label Treatment Phase|Physician Decision|24|||
23407858|NCT00286091|65236960|FG001|Open-label Treatment Phase|Physician Decision|21|||
23407859|NCT00286091|65236959|FG000|Open-label Treatment Phase|Adverse Event|5|||
23407860|NCT00286091|65236960|FG001|Open-label Treatment Phase|Adverse Event|16|||
23407861|NCT00286091|65236959|FG000|Open-label Treatment Phase|Other|11|||
23407862|NCT00286091|65236960|FG001|Open-label Treatment Phase|Other|11|||
23407863|NCT00286091|65236959|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
23407864|NCT00286091|65236960|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
23407865|NCT00286091|65236959|FG000|Open-label Treatment Phase|Death|10|||
23407866|NCT00286091|65236960|FG001|Open-label Treatment Phase|Death|7|||
23407867|NCT00286091|65236959|FG000|Open-label Treatment Phase|Disease Progression|9|||
23407868|NCT00286091|65236960|FG001|Open-label Treatment Phase|Disease Progression|3|||
23407869|NCT00286091|65236959|FG000|Open-label Treatment Phase|Noncompliance|3|||
23407870|NCT00286091|65236960|FG001|Open-label Treatment Phase|Noncompliance|1|||
23407871|NCT00286091|65236959|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23407872|NCT00286091|65236960|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
23407873|NCT00286091|65236959|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
23407874|NCT00286091|65236960|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
23407875|NCT00286091|65236959|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
23407876|NCT00286091|65236960|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
23407877|NCT00414076|65236963|FG000|Overall Study|Progression|1|||
23407878|NCT00414076|65236964|FG001|Overall Study|Progression|2|||
23407879|NCT00414076|65236963|FG000|Overall Study|Withdrawal by Subject|1|||
23407880|NCT00414076|65236964|FG001|Overall Study|Withdrawal by Subject|3|||
23407881|NCT00414076|65236963|FG000|Overall Study|Adverse Event|1|||
23407882|NCT00414076|65236964|FG001|Overall Study|Adverse Event|0|||
23407883|NCT01595529|65236965|FG000|Overall Study|Adverse Event|2|||
23407884|NCT01595529|65236966|FG001|Overall Study|Adverse Event|0|||
23407885|NCT01595529|65236965|FG000|Overall Study|Subject Non-Compliant|2|||
23407886|NCT01595529|65236966|FG001|Overall Study|Subject Non-Compliant|0|||
23407887|NCT01595529|65236965|FG000|Overall Study|Lost to Follow-up|8|||
23407888|NCT01595529|65236966|FG001|Overall Study|Lost to Follow-up|14|||
23407889|NCT01595529|65236965|FG000|Overall Study|Protocol Violation|1|||
23407890|NCT01595529|65236966|FG001|Overall Study|Protocol Violation|2|||
23407891|NCT01595529|65236965|FG000|Overall Study|Physician Decision|1|||
23407892|NCT01595529|65236966|FG001|Overall Study|Physician Decision|0|||
23407893|NCT01595529|65236965|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
23407894|NCT01595529|65236966|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
23407895|NCT01595529|65236965|FG000|Overall Study|Administrative Decision|1|||
23407896|NCT01595529|65236966|FG001|Overall Study|Administrative Decision|0|||
23407897|NCT01595529|65236965|FG000|Overall Study|Entry Failure/Screening Failure|6|||
23407898|NCT01595529|65236966|FG001|Overall Study|Entry Failure/Screening Failure|1|||
23407899|NCT01162473|65236967|FG000|Overall Study|Adverse Event|2|||
23407900|NCT01162473|65236968|FG001|Overall Study|Adverse Event|1|||
23407901|NCT01162473|65236967|FG000|Overall Study|Withdrawal by Subject|0|||
23407902|NCT01162473|65236968|FG001|Overall Study|Withdrawal by Subject|4|||
23407903|NCT02517398|65236969|FG000|Overall Study|Death|2|||
23407904|NCT02517398|65236970|FG001|Overall Study|Death|3|||
23407905|NCT02517398|65236971|FG002|Overall Study|Death|4|||
23407906|NCT02517398|65236972|FG003|Overall Study|Death|2|||
23407907|NCT02517398|65236973|FG004|Overall Study|Death|3|||
23407908|NCT02517398|65236974|FG005|Overall Study|Death|8|||
23407909|NCT02517398|65236975|FG006|Overall Study|Death|3|||
23407910|NCT02517398|65236976|FG007|Overall Study|Death|2|||
23407911|NCT02517398|65236977|FG008|Overall Study|Death|6|||
23407912|NCT02517398|65236978|FG009|Overall Study|Death|24|||
23407913|NCT02517398|65236979|FG010|Overall Study|Death|53|||
23407914|NCT02517398|65236980|FG011|Overall Study|Death|25|||
23407915|NCT02517398|65236981|FG012|Overall Study|Death|73|||
23407916|NCT02517398|65236982|FG013|Overall Study|Death|29|||
23407917|NCT02517398|65236983|FG014|Overall Study|Death|26|||
23407918|NCT02517398|65236984|FG015|Overall Study|Death|23|||
23407919|NCT02517398|65236985|FG016|Overall Study|Death|26|||
23407920|NCT02517398|65236986|FG017|Overall Study|Death|25|||
23407921|NCT02517398|65236987|FG018|Overall Study|Death|22|||
23407922|NCT02517398|65236988|FG019|Overall Study|Death|7|||
23407923|NCT02517398|65236989|FG020|Overall Study|Death|26|||
23407924|NCT02517398|65236990|FG021|Overall Study|Death|30|||
23407925|NCT02517398|65236991|FG022|Overall Study|Death|20|||
23407926|NCT02517398|65236969|FG000|Overall Study|Other|0|||
23407927|NCT02517398|65236970|FG001|Overall Study|Other|0|||
23407928|NCT02517398|65236971|FG002|Overall Study|Other|0|||
23407929|NCT02517398|65236972|FG003|Overall Study|Other|1|||
23407930|NCT02517398|65236973|FG004|Overall Study|Other|0|||
23407931|NCT02517398|65236974|FG005|Overall Study|Other|0|||
23407932|NCT02517398|65236975|FG006|Overall Study|Other|0|||
23407933|NCT02517398|65236976|FG007|Overall Study|Other|0|||
23407934|NCT02517398|65236977|FG008|Overall Study|Other|0|||
23407935|NCT02517398|65236978|FG009|Overall Study|Other|1|||
23407936|NCT02517398|65236979|FG010|Overall Study|Other|0|||
23407937|NCT02517398|65236980|FG011|Overall Study|Other|0|||
23407938|NCT02517398|65236981|FG012|Overall Study|Other|0|||
23407939|NCT02517398|65236982|FG013|Overall Study|Other|1|||
23407940|NCT02517398|65236983|FG014|Overall Study|Other|0|||
23407941|NCT02517398|65236984|FG015|Overall Study|Other|1|||
23407942|NCT02517398|65236985|FG016|Overall Study|Other|1|||
23407943|NCT02517398|65236986|FG017|Overall Study|Other|0|||
23407944|NCT02517398|65236987|FG018|Overall Study|Other|0|||
23407945|NCT02517398|65236988|FG019|Overall Study|Other|1|||
23407946|NCT02517398|65236989|FG020|Overall Study|Other|0|||
23407947|NCT02517398|65236990|FG021|Overall Study|Other|0|||
23407948|NCT02517398|65236991|FG022|Overall Study|Other|0|||
23407949|NCT02517398|65236969|FG000|Overall Study|Lost to Follow-up|0|||
23407950|NCT02517398|65236970|FG001|Overall Study|Lost to Follow-up|0|||
23407951|NCT02517398|65236971|FG002|Overall Study|Lost to Follow-up|0|||
23407952|NCT02517398|65236972|FG003|Overall Study|Lost to Follow-up|0|||
23407953|NCT02517398|65236973|FG004|Overall Study|Lost to Follow-up|0|||
23407954|NCT02517398|65236974|FG005|Overall Study|Lost to Follow-up|0|||
23407955|NCT02517398|65236975|FG006|Overall Study|Lost to Follow-up|0|||
23407956|NCT02517398|65236976|FG007|Overall Study|Lost to Follow-up|0|||
23407957|NCT02517398|65236977|FG008|Overall Study|Lost to Follow-up|0|||
23407958|NCT02517398|65236978|FG009|Overall Study|Lost to Follow-up|1|||
23407959|NCT02517398|65236979|FG010|Overall Study|Lost to Follow-up|0|||
23407960|NCT02517398|65236980|FG011|Overall Study|Lost to Follow-up|2|||
23407961|NCT02517398|65236981|FG012|Overall Study|Lost to Follow-up|2|||
23407962|NCT02517398|65236982|FG013|Overall Study|Lost to Follow-up|0|||
23407963|NCT02517398|65236983|FG014|Overall Study|Lost to Follow-up|1|||
23407964|NCT02517398|65236984|FG015|Overall Study|Lost to Follow-up|1|||
23407965|NCT02517398|65236985|FG016|Overall Study|Lost to Follow-up|0|||
23407966|NCT02517398|65236986|FG017|Overall Study|Lost to Follow-up|3|||
23407967|NCT02517398|65236987|FG018|Overall Study|Lost to Follow-up|1|||
23407968|NCT02517398|65236988|FG019|Overall Study|Lost to Follow-up|0|||
23407969|NCT02517398|65236989|FG020|Overall Study|Lost to Follow-up|1|||
23407970|NCT02517398|65236990|FG021|Overall Study|Lost to Follow-up|0|||
23407971|NCT02517398|65236991|FG022|Overall Study|Lost to Follow-up|2|||
23407972|NCT02517398|65236969|FG000|Overall Study|Withdrew Consent|0|||
23407973|NCT02517398|65236970|FG001|Overall Study|Withdrew Consent|0|||
23407974|NCT02517398|65236971|FG002|Overall Study|Withdrew Consent|0|||
23407975|NCT02517398|65236972|FG003|Overall Study|Withdrew Consent|0|||
23407976|NCT02517398|65236973|FG004|Overall Study|Withdrew Consent|0|||
23407977|NCT02517398|65236974|FG005|Overall Study|Withdrew Consent|0|||
23407978|NCT02517398|65236975|FG006|Overall Study|Withdrew Consent|1|||
23407979|NCT02517398|65236976|FG007|Overall Study|Withdrew Consent|0|||
23407980|NCT02517398|65236977|FG008|Overall Study|Withdrew Consent|0|||
23407981|NCT02517398|65236978|FG009|Overall Study|Withdrew Consent|2|||
23407982|NCT02517398|65236979|FG010|Overall Study|Withdrew Consent|7|||
23407983|NCT02517398|65236980|FG011|Overall Study|Withdrew Consent|1|||
23407984|NCT02517398|65236981|FG012|Overall Study|Withdrew Consent|5|||
23407985|NCT02517398|65236982|FG013|Overall Study|Withdrew Consent|4|||
23407986|NCT02517398|65236983|FG014|Overall Study|Withdrew Consent|2|||
23407987|NCT02517398|65236984|FG015|Overall Study|Withdrew Consent|5|||
23407988|NCT02517398|65236985|FG016|Overall Study|Withdrew Consent|4|||
23407989|NCT02517398|65236986|FG017|Overall Study|Withdrew Consent|2|||
23407990|NCT02517398|65236987|FG018|Overall Study|Withdrew Consent|3|||
23407991|NCT02517398|65236988|FG019|Overall Study|Withdrew Consent|2|||
23407992|NCT02517398|65236989|FG020|Overall Study|Withdrew Consent|9|||
23407993|NCT02517398|65236990|FG021|Overall Study|Withdrew Consent|3|||
23407994|NCT02517398|65236991|FG022|Overall Study|Withdrew Consent|1|||
23407995|NCT00755807|65236992|FG000|Acute Phase|Adverse Event|16|||
23407996|NCT00755807|65236993|FG001|Acute Phase|Adverse Event|5|||
23407997|NCT00755807|65236992|FG000|Acute Phase|Protocol Violation|1|||
23407998|NCT00755807|65236993|FG001|Acute Phase|Protocol Violation|3|||
23407999|NCT00755807|65236992|FG000|Acute Phase|Withdrawal by Subject|1|||
23408000|NCT00755807|65236993|FG001|Acute Phase|Withdrawal by Subject|2|||
23408001|NCT00755807|65236992|FG000|Acute Phase|Lack of Efficacy|0|||
23408002|NCT00755807|65236993|FG001|Acute Phase|Lack of Efficacy|1|||
23607372|NCT00264576|65950684|FG000|Overall Study|Lost to Follow-up|1|||
23408003|NCT00755807|65236992|FG000|Acute Phase|Physician Decision|0|||
23408004|NCT00755807|65236993|FG001|Acute Phase|Physician Decision|1|||
23408005|NCT00755807|65236992|FG000|Open-label Extension Phase|Adverse Event|7|||
23408006|NCT00755807|65236993|FG001|Open-label Extension Phase|Adverse Event|7|||
23408007|NCT00755807|65236992|FG000|Open-label Extension Phase|Protocol Violation|5|||
23408008|NCT00755807|65236993|FG001|Open-label Extension Phase|Protocol Violation|2|||
23408009|NCT00755807|65236992|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
23408010|NCT00755807|65236993|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
23408011|NCT00755807|65236992|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
23408012|NCT00755807|65236993|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
23408013|NCT00755807|65236992|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
23408014|NCT00755807|65236993|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
23408015|NCT00755807|65236992|FG000|Open-label Extension Phase|Sponsor Decision|0|||
23408016|NCT00755807|65236993|FG001|Open-label Extension Phase|Sponsor Decision|1|||
23408017|NCT00375427|65236994|FG000|Overall Study|Adverse Event|21|||
23408018|NCT00375427|65236995|FG001|Overall Study|Adverse Event|27|||
23408019|NCT00375427|65236994|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23408020|NCT00375427|65236995|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23408021|NCT00375427|65236994|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23408022|NCT00375427|65236995|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23408023|NCT00375427|65236994|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23408024|NCT00375427|65236995|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23408025|NCT00375427|65236994|FG000|Overall Study|Patient no longer requires study drug|3|||
23408026|NCT00375427|65236995|FG001|Overall Study|Patient no longer requires study drug|7|||
23408027|NCT00375427|65236994|FG000|Overall Study|Protocol Violation|10|||
23408028|NCT00375427|65236995|FG001|Overall Study|Protocol Violation|8|||
23408029|NCT00375427|65236994|FG000|Overall Study|Withdrawal by Subject|9|||
23408030|NCT00375427|65236995|FG001|Overall Study|Withdrawal by Subject|13|||
23408031|NCT00375427|65236994|FG000|Overall Study|Lost to Follow-up|1|||
23408032|NCT00375427|65236995|FG001|Overall Study|Lost to Follow-up|1|||
23408033|NCT00375427|65236994|FG000|Overall Study|Administrative reasons|0|||
23408034|NCT00375427|65236995|FG001|Overall Study|Administrative reasons|1|||
23408035|NCT00375427|65236994|FG000|Overall Study|Death|11|||
23408036|NCT00375427|65236995|FG001|Overall Study|Death|10|||
23408037|NCT02383862|65236996|FG000|3 Month Follow up|Lost to Follow-up|23|||
23408038|NCT02383862|65236997|FG001|3 Month Follow up|Lost to Follow-up|21|||
23408039|NCT03592771|65236998|FG000|Overall Study|Adverse Event|2|||
23408040|NCT03592771|65236999|FG001|Overall Study|Adverse Event|0|||
23408041|NCT03592771|65237000|FG002|Overall Study|Adverse Event|1|||
23408042|NCT03592771|65236998|FG000|Overall Study|Death|0|||
23408043|NCT03592771|65236999|FG001|Overall Study|Death|1|||
23408044|NCT03592771|65237000|FG002|Overall Study|Death|1|||
23408045|NCT03592771|65236998|FG000|Overall Study|Lost to Follow-up|5|||
23408046|NCT03592771|65236999|FG001|Overall Study|Lost to Follow-up|11|||
23408047|NCT03592771|65237000|FG002|Overall Study|Lost to Follow-up|15|||
23408048|NCT03592771|65236998|FG000|Overall Study|Withdrawal by Subject|0|||
23408049|NCT03592771|65236999|FG001|Overall Study|Withdrawal by Subject|2|||
23408050|NCT03592771|65237000|FG002|Overall Study|Withdrawal by Subject|0|||
23408051|NCT04571060|65237006|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
23408052|NCT04571060|65237007|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
23408053|NCT04571060|65237006|FG000|Overall Study|Never treated migraine|47|||
23408054|NCT04571060|65237007|FG001|Overall Study|Never treated migraine|36|||
23408055|NCT04571060|65237006|FG000|Overall Study|Protocol Violation|4|||
23408056|NCT04571060|65237007|FG001|Overall Study|Protocol Violation|2|||
23408057|NCT04571060|65237006|FG000|Overall Study|Withdrawal by Subject|6|||
23408058|NCT04571060|65237007|FG001|Overall Study|Withdrawal by Subject|2|||
23408059|NCT04571060|65237006|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
23408060|NCT04571060|65237007|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
23408061|NCT02969915|65237008|FG000|Overall Study|Death|104|||
23408062|NCT02969915|65237009|FG001|Overall Study|Death|125|||
23408063|NCT02969915|65237008|FG000|Overall Study|Lost to Follow-up|108|||
23408064|NCT02969915|65237009|FG001|Overall Study|Lost to Follow-up|112|||
23408065|NCT02969915|65237008|FG000|Overall Study|Censored due to COVID-19|481|||
23408066|NCT02969915|65237009|FG001|Overall Study|Censored due to COVID-19|471|||
23408067|NCT00194077|65237012|FG000|Overall Study|Lack of Efficacy|22|||
23408068|NCT00194077|65237013|FG001|Overall Study|Lack of Efficacy|29|||
23408069|NCT00194077|65237012|FG000|Overall Study|Study nonadherence|1|||
23408070|NCT00194077|65237013|FG001|Overall Study|Study nonadherence|0|||
23408071|NCT00194077|65237012|FG000|Overall Study|Withdrawal by Subject|1|||
23408072|NCT00194077|65237013|FG001|Overall Study|Withdrawal by Subject|1|||
23408073|NCT00506454|65237016|FG000|Overall Study|Withdrawal by Subject|1|||
23408074|NCT00506454|65237017|FG001|Overall Study|Withdrawal by Subject|1|||
23408075|NCT00703963|65237022|FG000|Overall Study|Withdrawal by Subject|7|||
23408076|NCT00703963|65237023|FG001|Overall Study|Withdrawal by Subject|13|||
23408077|NCT00703963|65237022|FG000|Overall Study|Physician Decision|0|||
23408078|NCT00703963|65237023|FG001|Overall Study|Physician Decision|1|||
23408079|NCT01815424|65237026|FG000|Week 0 to 16|Adverse Event|1|||
23408080|NCT01815424|65237027|FG001|Week 0 to 16|Adverse Event|3|||
23408081|NCT01815424|65237028|FG002|Week 0 to 16|Adverse Event|3|||
23408082|NCT01815424|65237029|FG003|Week 0 to 16|Adverse Event|0|||
23408083|NCT01815424|65237030|FG004|Week 0 to 16|Adverse Event|0|||
23408084|NCT01815424|65237026|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
23408085|NCT01815424|65237027|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408086|NCT01815424|65237028|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408087|NCT01815424|65237029|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408088|NCT01815424|65237030|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408089|NCT01815424|65237026|FG000|Week 0 to 16|Lost to Follow-up|0|||
23408090|NCT01815424|65237027|FG001|Week 0 to 16|Lost to Follow-up|1|||
23408091|NCT01815424|65237028|FG002|Week 0 to 16|Lost to Follow-up|0|||
23408092|NCT01815424|65237029|FG003|Week 0 to 16|Lost to Follow-up|0|||
23408093|NCT01815424|65237030|FG004|Week 0 to 16|Lost to Follow-up|0|||
23408094|NCT01815424|65237026|FG000|Week 0 to 16|Withdrawal by Subject|0|||
23408095|NCT01815424|65237027|FG001|Week 0 to 16|Withdrawal by Subject|0|||
23408096|NCT01815424|65237028|FG002|Week 0 to 16|Withdrawal by Subject|1|||
23408097|NCT01815424|65237029|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23408098|NCT01815424|65237030|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23408099|NCT01815424|65237026|FG000|Week 0 to 16|Other|1|||
23408100|NCT01815424|65237027|FG001|Week 0 to 16|Other|0|||
23408101|NCT01815424|65237028|FG002|Week 0 to 16|Other|3|||
23408102|NCT01815424|65237029|FG003|Week 0 to 16|Other|0|||
23408103|NCT01815424|65237030|FG004|Week 0 to 16|Other|0|||
23408104|NCT01815424|65237026|FG000|Week 0 to 16|Protocol Violation|1|||
23408105|NCT01815424|65237027|FG001|Week 0 to 16|Protocol Violation|0|||
23408106|NCT01815424|65237028|FG002|Week 0 to 16|Protocol Violation|0|||
23408107|NCT01815424|65237029|FG003|Week 0 to 16|Protocol Violation|0|||
23408108|NCT01815424|65237030|FG004|Week 0 to 16|Protocol Violation|0|||
23408109|NCT01815424|65237026|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
23408110|NCT01815424|65237027|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
23408111|NCT01815424|65237028|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
23408112|NCT01815424|65237029|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
23408113|NCT01815424|65237030|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
23408114|NCT01815424|65237026|FG000|Week 16 to 52|Other|0|||
23408115|NCT01815424|65237027|FG001|Week 16 to 52|Other|1|||
23408116|NCT01815424|65237028|FG002|Week 16 to 52|Other|0|||
23408117|NCT01815424|65237029|FG003|Week 16 to 52|Other|0|||
23408118|NCT01815424|65237030|FG004|Week 16 to 52|Other|0|||
23408119|NCT01815424|65237026|FG000|Week 16 to 52|Adverse Event|0|||
23408120|NCT01815424|65237027|FG001|Week 16 to 52|Adverse Event|0|||
23408121|NCT01815424|65237028|FG002|Week 16 to 52|Adverse Event|0|||
23408122|NCT01815424|65237029|FG003|Week 16 to 52|Adverse Event|0|||
23408123|NCT01815424|65237030|FG004|Week 16 to 52|Adverse Event|1|||
23408124|NCT01815424|65237026|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
23408125|NCT01815424|65237027|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
23408126|NCT01815424|65237028|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
23408127|NCT01815424|65237029|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
23408128|NCT01815424|65237030|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
23408129|NCT01815424|65237026|FG000|Week 16 to 52|Lost to Follow-up|0|||
23408130|NCT01815424|65237027|FG001|Week 16 to 52|Lost to Follow-up|2|||
23408131|NCT01815424|65237028|FG002|Week 16 to 52|Lost to Follow-up|0|||
23408132|NCT01815424|65237029|FG003|Week 16 to 52|Lost to Follow-up|2|||
23408133|NCT01815424|65237030|FG004|Week 16 to 52|Lost to Follow-up|1|||
23408134|NCT01815424|65237026|FG000|Week 16 to 52|Withdrawal by Subject|1|||
23408135|NCT01815424|65237027|FG001|Week 16 to 52|Withdrawal by Subject|2|||
23408136|NCT01815424|65237028|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23408137|NCT01815424|65237029|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23408138|NCT01815424|65237030|FG004|Week 16 to 52|Withdrawal by Subject|0|||
23408139|NCT02079909|65237031|FG000|Overall Study|Adverse Event|23|||
23408140|NCT02079909|65237032|FG001|Overall Study|Adverse Event|23|||
23408141|NCT02079909|65237033|FG002|Overall Study|Adverse Event|7|||
23408142|NCT02079909|65237031|FG000|Overall Study|Withdrawal by Subject|9|||
23408143|NCT02079909|65237032|FG001|Overall Study|Withdrawal by Subject|17|||
23408144|NCT02079909|65237033|FG002|Overall Study|Withdrawal by Subject|4|||
23408145|NCT02079909|65237031|FG000|Overall Study|Lost to Follow-up|2|||
23408146|NCT02079909|65237032|FG001|Overall Study|Lost to Follow-up|3|||
23408147|NCT02079909|65237033|FG002|Overall Study|Lost to Follow-up|1|||
23408148|NCT02079909|65237031|FG000|Overall Study|Death|2|||
23408149|NCT02079909|65237032|FG001|Overall Study|Death|2|||
23408150|NCT02079909|65237033|FG002|Overall Study|Death|0|||
23408151|NCT02079909|65237031|FG000|Overall Study|Lack of Efficacy|0|||
23408152|NCT02079909|65237032|FG001|Overall Study|Lack of Efficacy|0|||
23408153|NCT02079909|65237033|FG002|Overall Study|Lack of Efficacy|1|||
23408154|NCT02079909|65237031|FG000|Overall Study|Protocol Violation|0|||
23408155|NCT02079909|65237032|FG001|Overall Study|Protocol Violation|1|||
23408156|NCT02079909|65237033|FG002|Overall Study|Protocol Violation|1|||
23408157|NCT02079909|65237031|FG000|Overall Study|Physician Decision|0|||
23408158|NCT02079909|65237032|FG001|Overall Study|Physician Decision|1|||
23607373|NCT00264576|65950685|FG001|Overall Study|Lost to Follow-up|1|||
23408159|NCT02079909|65237033|FG002|Overall Study|Physician Decision|1|||
23408160|NCT02079909|65237031|FG000|Overall Study|Relocation etc.|2|||
23408161|NCT02079909|65237032|FG001|Overall Study|Relocation etc.|2|||
23408162|NCT02079909|65237033|FG002|Overall Study|Relocation etc.|3|||
23408163|NCT00407602|65237034|FG000|Overall Study|Death - unrelated to device|1|||
23408164|NCT00407602|65237034|FG000|Overall Study|Device explanted|5|||
23408165|NCT00407602|65237034|FG000|Overall Study|Withdrawal by Subject|1|||
23408166|NCT00402324|65237037|FG000|Overall Study|Lost to Follow-up|11|||
23408167|NCT00402324|65237038|FG001|Overall Study|Lost to Follow-up|11|||
23408168|NCT00402324|65237037|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
23408169|NCT00402324|65237038|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
23408170|NCT00402324|65237037|FG000|Overall Study|Protocol Violation|8|||
23408171|NCT00402324|65237038|FG001|Overall Study|Protocol Violation|7|||
23408172|NCT00402324|65237037|FG000|Overall Study|Withdrawal by Subject|5|||
23408173|NCT00402324|65237038|FG001|Overall Study|Withdrawal by Subject|2|||
23408174|NCT00402324|65237037|FG000|Overall Study|Physician Decision|2|||
23506160|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408175|NCT00402324|65237038|FG001|Overall Study|Physician Decision|4|||
23408176|NCT00402324|65237037|FG000|Overall Study|Sponsor Decision|4|||
23408177|NCT00402324|65237038|FG001|Overall Study|Sponsor Decision|5|||
23408178|NCT00402324|65237037|FG000|Overall Study|Lack of Efficacy|1|||
23408179|NCT00402324|65237038|FG001|Overall Study|Lack of Efficacy|4|||
23408180|NCT00402324|65237037|FG000|Overall Study|Adverse Event|6|||
23408181|NCT00402324|65237038|FG001|Overall Study|Adverse Event|4|||
23408182|NCT00402324|65237037|FG000|Overall Study|Death|1|||
23408183|NCT00402324|65237038|FG001|Overall Study|Death|0|||
23408184|NCT00529243|65239817|FG000|Overall Study|Adverse Event|1|||
23408185|NCT00529243|65239817|FG000|Overall Study|Death|1|||
23408186|NCT00529243|65239817|FG000|Overall Study|Relocated|1|||
23408187|NCT00851890|65239820|FG000|Overall Study|Lost to Follow-up|0|||
23408188|NCT00851890|65239821|FG001|Overall Study|Lost to Follow-up|1|||
23408189|NCT00851890|65239822|FG002|Overall Study|Lost to Follow-up|0|||
23408190|NCT00851890|65239823|FG003|Overall Study|Lost to Follow-up|1|||
23408191|NCT00075764|65239824|FG000|Overall Study|Adverse Event|5|||
23408192|NCT00075764|65239825|FG001|Overall Study|Adverse Event|12|||
23408193|NCT00075764|65239824|FG000|Overall Study|Death|4|||
23408194|NCT00075764|65239825|FG001|Overall Study|Death|8|||
23408195|NCT00075764|65239824|FG000|Overall Study|Withdrawal by Subject|28|||
23408196|NCT00075764|65239825|FG001|Overall Study|Withdrawal by Subject|18|||
23408197|NCT00075764|65239824|FG000|Overall Study|Progression|269|||
23408198|NCT00075764|65239825|FG001|Overall Study|Progression|274|||
23408199|NCT00075764|65239824|FG000|Overall Study|Still on treatment|8|||
23408200|NCT00075764|65239825|FG001|Overall Study|Still on treatment|15|||
23408201|NCT00075764|65239824|FG000|Overall Study|Delinquent|4|||
23408202|NCT00075764|65239825|FG001|Overall Study|Delinquent|2|||
23408203|NCT00075764|65239824|FG000|Overall Study|Not protocol specified|27|||
23408204|NCT00075764|65239825|FG001|Overall Study|Not protocol specified|19|||
23408205|NCT00075764|65239824|FG000|Overall Study|Under review|0|||
23408206|NCT00075764|65239825|FG001|Overall Study|Under review|1|||
23408207|NCT02565147|65239828|FG000|Overall Study|Withdrawal by Subject|5|||
23408208|NCT02565147|65239829|FG001|Overall Study|Withdrawal by Subject|1|||
23408209|NCT02565147|65239828|FG000|Overall Study|Lost to Follow-up|0|||
23408210|NCT02565147|65239829|FG001|Overall Study|Lost to Follow-up|1|||
23408211|NCT02565147|65239828|FG000|Overall Study|Death|1|||
23408212|NCT02565147|65239829|FG001|Overall Study|Death|1|||
23408213|NCT04703192|65239830|FG000|Overall Study|Withdrawal by Subject|2|||
23408214|NCT04703192|65239831|FG001|Overall Study|Withdrawal by Subject|0|||
23408215|NCT04703192|65239830|FG000|Overall Study|Death|3|||
23506161|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408216|NCT04703192|65239831|FG001|Overall Study|Death|1|||
23408217|NCT04703192|65239830|FG000|Overall Study|Adverse Event|13|||
23408218|NCT04703192|65239831|FG001|Overall Study|Adverse Event|2|||
23408219|NCT04703192|65239830|FG000|Overall Study|Progressive or Relapsed Disease|46|||
23408220|NCT04703192|65239831|FG001|Overall Study|Progressive or Relapsed Disease|7|||
23408221|NCT04703192|65239830|FG000|Overall Study|Clinical Progression|19|||
23408222|NCT04703192|65239831|FG001|Overall Study|Clinical Progression|8|||
23408223|NCT04703192|65239830|FG000|Overall Study|Lost to Follow-up|1|||
23408224|NCT04703192|65239831|FG001|Overall Study|Lost to Follow-up|0|||
23408225|NCT04703192|65239830|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
23408226|NCT04703192|65239831|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
23408227|NCT04703192|65239830|FG000|Overall Study|Other|5|||
23408228|NCT04703192|65239831|FG001|Overall Study|Other|1|||
23408229|NCT00244725|65239832|FG000|Overall Study|Lost to Follow-up|3|||
23408230|NCT00244725|65239833|FG001|Overall Study|Lost to Follow-up|4|||
23408231|NCT00244725|65239834|FG002|Overall Study|Lost to Follow-up|9|||
23506162|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408232|NCT00244725|65239835|FG003|Overall Study|Lost to Follow-up|2|||
23408233|NCT00244725|65239832|FG000|Overall Study|Withdrawal by Subject|9|||
23408234|NCT00244725|65239833|FG001|Overall Study|Withdrawal by Subject|7|||
23408235|NCT00244725|65239834|FG002|Overall Study|Withdrawal by Subject|7|||
23408236|NCT00244725|65239835|FG003|Overall Study|Withdrawal by Subject|8|||
23408237|NCT00244725|65239832|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
23408238|NCT00244725|65239833|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
23408239|NCT00244725|65239834|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
23408240|NCT00244725|65239835|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
23408241|NCT00244725|65239832|FG000|Overall Study|Physician Decision|3|||
23408242|NCT00244725|65239833|FG001|Overall Study|Physician Decision|0|||
23408243|NCT00244725|65239834|FG002|Overall Study|Physician Decision|1|||
23408244|NCT00244725|65239835|FG003|Overall Study|Physician Decision|2|||
23408245|NCT00244725|65239832|FG000|Overall Study|Adverse Events|3|||
23408246|NCT00244725|65239833|FG001|Overall Study|Adverse Events|1|||
23408247|NCT00244725|65239834|FG002|Overall Study|Adverse Events|4|||
23408248|NCT00244725|65239835|FG003|Overall Study|Adverse Events|4|||
23408249|NCT00244725|65239832|FG000|Overall Study|Withdrwal by participant|1|||
23408250|NCT00244725|65239833|FG001|Overall Study|Withdrwal by participant|0|||
23408251|NCT00244725|65239834|FG002|Overall Study|Withdrwal by participant|0|||
23408252|NCT00244725|65239835|FG003|Overall Study|Withdrwal by participant|1|||
23408253|NCT00244725|65239832|FG000|Overall Study|Liver function test abnormality|2|||
23408254|NCT00244725|65239833|FG001|Overall Study|Liver function test abnormality|0|||
23408255|NCT00244725|65239834|FG002|Overall Study|Liver function test abnormality|0|||
23408256|NCT00244725|65239835|FG003|Overall Study|Liver function test abnormality|1|||
23408257|NCT00244725|65239832|FG000|Overall Study|Sponsor withdrew the participant|1|||
23408258|NCT00244725|65239833|FG001|Overall Study|Sponsor withdrew the participant|0|||
23408259|NCT00244725|65239834|FG002|Overall Study|Sponsor withdrew the participant|0|||
23408260|NCT00244725|65239835|FG003|Overall Study|Sponsor withdrew the participant|1|||
23408261|NCT00244725|65239832|FG000|Overall Study|Mediciation Error|0|||
23408262|NCT00244725|65239833|FG001|Overall Study|Mediciation Error|1|||
23408263|NCT00244725|65239834|FG002|Overall Study|Mediciation Error|0|||
23408264|NCT00244725|65239835|FG003|Overall Study|Mediciation Error|0|||
23408265|NCT00244725|65239832|FG000|Overall Study|Rehab Refused to allow participantion|0|||
23408266|NCT00244725|65239833|FG001|Overall Study|Rehab Refused to allow participantion|1|||
23408267|NCT00244725|65239834|FG002|Overall Study|Rehab Refused to allow participantion|0|||
23408268|NCT00244725|65239835|FG003|Overall Study|Rehab Refused to allow participantion|0|||
23408269|NCT00244725|65239832|FG000|Overall Study|Headache|0|||
23408270|NCT00244725|65239833|FG001|Overall Study|Headache|1|||
23408271|NCT00244725|65239834|FG002|Overall Study|Headache|0|||
23408272|NCT00244725|65239835|FG003|Overall Study|Headache|0|||
23408273|NCT00244725|65239832|FG000|Overall Study|Received prohibited medication|0|||
23408274|NCT00244725|65239833|FG001|Overall Study|Received prohibited medication|1|||
23408275|NCT00244725|65239834|FG002|Overall Study|Received prohibited medication|0|||
23408276|NCT00244725|65239835|FG003|Overall Study|Received prohibited medication|1|||
23408277|NCT00244725|65239832|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408278|NCT00244725|65239833|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
23408279|NCT00244725|65239834|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408280|NCT00244725|65239835|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408281|NCT00244725|65239832|FG000|Overall Study|Administrative reason|0|||
23408282|NCT00244725|65239833|FG001|Overall Study|Administrative reason|0|||
23408283|NCT00244725|65239834|FG002|Overall Study|Administrative reason|1|||
23408284|NCT00244725|65239835|FG003|Overall Study|Administrative reason|0|||
23408285|NCT00244725|65239832|FG000|Overall Study|Vomit|0|||
23408286|NCT00244725|65239833|FG001|Overall Study|Vomit|0|||
23408287|NCT00244725|65239834|FG002|Overall Study|Vomit|1|||
23408288|NCT00244725|65239835|FG003|Overall Study|Vomit|0|||
23408289|NCT00244725|65239832|FG000|Overall Study|Failed to follow-up|0|||
23408290|NCT00244725|65239833|FG001|Overall Study|Failed to follow-up|0|||
23408291|NCT00244725|65239834|FG002|Overall Study|Failed to follow-up|1|||
23408292|NCT00244725|65239835|FG003|Overall Study|Failed to follow-up|1|||
23408293|NCT01107392|65239837|FG000|Overall Study|Adverse Event|2|||
23408294|NCT01107392|65239838|FG001|Overall Study|Adverse Event|0|||
23408295|NCT01107392|65239837|FG000|Overall Study|Personal Reasons|2|||
23408296|NCT01107392|65239838|FG001|Overall Study|Personal Reasons|3|||
23408297|NCT01107392|65239837|FG000|Overall Study|Administrative decision|1|||
23408298|NCT01107392|65239838|FG001|Overall Study|Administrative decision|0|||
23506163|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506164|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506165|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
23408299|NCT02446769|65239840|FG000|Screening Period|Screen Failure|11|||
23408300|NCT02446769|65239841|FG001|Screening Period|Screen Failure|0|||
23408301|NCT02446769|65239842|FG002|Screening Period|Screen Failure|0|||
23408302|NCT02446769|65239840|FG000|Study Period|Randomized in Error|0|||
23408303|NCT02446769|65239841|FG001|Study Period|Randomized in Error|2|||
23408304|NCT02446769|65239842|FG002|Study Period|Randomized in Error|0|||
23408305|NCT00322049|65239843|FG000|Overall Study|Moved out of area|0|||
23408306|NCT00322049|65239844|FG001|Overall Study|Moved out of area|0|||
23408307|NCT00322049|65239845|FG002|Overall Study|Moved out of area|0|||
23408308|NCT00322049|65239846|FG003|Overall Study|Moved out of area|1|||
23408309|NCT00322049|65239843|FG000|Overall Study|Infected with Dengue during study|0|||
23408310|NCT00322049|65239844|FG001|Overall Study|Infected with Dengue during study|1|||
23408311|NCT00322049|65239845|FG002|Overall Study|Infected with Dengue during study|0|||
23408312|NCT00322049|65239846|FG003|Overall Study|Infected with Dengue during study|0|||
23408313|NCT02553928|65239847|FG000|Overall Study|Adverse Event|2|||
23408314|NCT02553928|65239848|FG001|Overall Study|Adverse Event|1|||
23408315|NCT02553928|65239847|FG000|Overall Study|Lost to Follow-up|0|||
23408316|NCT02553928|65239848|FG001|Overall Study|Lost to Follow-up|1|||
23408317|NCT02553928|65239847|FG000|Overall Study|Administrative reason(s)|0|||
23408318|NCT02553928|65239848|FG001|Overall Study|Administrative reason(s)|1|||
23408319|NCT03012828|65239849|FG000|Overall Study|Lost to Follow-up|1|||
23408320|NCT03012828|65239850|FG001|Overall Study|Lost to Follow-up|0|||
23408321|NCT03012828|65239851|FG002|Overall Study|Lost to Follow-up|1|||
23408322|NCT03012828|65239852|FG003|Overall Study|Lost to Follow-up|0|||
23408323|NCT03012828|65239853|FG004|Overall Study|Lost to Follow-up|1|||
23408324|NCT03012828|65239854|FG005|Overall Study|Lost to Follow-up|0|||
23408325|NCT03012828|65239849|FG000|Overall Study|Withdrawal by Subject|0|||
23506166|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
23506167|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506168|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
23506169|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408326|NCT03012828|65239850|FG001|Overall Study|Withdrawal by Subject|0|||
23408327|NCT03012828|65239851|FG002|Overall Study|Withdrawal by Subject|1|||
23408328|NCT03012828|65239852|FG003|Overall Study|Withdrawal by Subject|0|||
23408329|NCT03012828|65239853|FG004|Overall Study|Withdrawal by Subject|0|||
23408330|NCT03012828|65239854|FG005|Overall Study|Withdrawal by Subject|1|||
23408331|NCT03012828|65239849|FG000|Overall Study|Non-compliance with protocol|0|||
23408332|NCT03012828|65239850|FG001|Overall Study|Non-compliance with protocol|0|||
23408333|NCT03012828|65239851|FG002|Overall Study|Non-compliance with protocol|0|||
23408334|NCT03012828|65239852|FG003|Overall Study|Non-compliance with protocol|0|||
23408335|NCT03012828|65239853|FG004|Overall Study|Non-compliance with protocol|1|||
23408336|NCT03012828|65239854|FG005|Overall Study|Non-compliance with protocol|0|||
23408337|NCT03012828|65239849|FG000|Overall Study|Delay to last visit would delay DBL|0|||
23408338|NCT03012828|65239850|FG001|Overall Study|Delay to last visit would delay DBL|0|||
23408339|NCT03012828|65239851|FG002|Overall Study|Delay to last visit would delay DBL|0|||
23408340|NCT03012828|65239852|FG003|Overall Study|Delay to last visit would delay DBL|0|||
23408341|NCT03012828|65239853|FG004|Overall Study|Delay to last visit would delay DBL|0|||
23408342|NCT03012828|65239854|FG005|Overall Study|Delay to last visit would delay DBL|1|||
23408343|NCT01673646|65239855|FG000|Overall Study|Adverse Event|2|||
23408344|NCT01673646|65239856|FG001|Overall Study|Adverse Event|1|||
23408345|NCT01673646|65239857|FG002|Overall Study|Adverse Event|1|||
23408346|NCT01673646|65239855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23408347|NCT01673646|65239856|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23408348|NCT01673646|65239857|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23408349|NCT01673646|65239855|FG000|Overall Study|Condition no longer requires study drug|0|||
23408350|NCT01673646|65239856|FG001|Overall Study|Condition no longer requires study drug|1|||
23408351|NCT01673646|65239857|FG002|Overall Study|Condition no longer requires study drug|0|||
23408352|NCT01673646|65239855|FG000|Overall Study|Withdrawal by Subject|0|||
23408353|NCT01673646|65239856|FG001|Overall Study|Withdrawal by Subject|2|||
23408354|NCT01673646|65239857|FG002|Overall Study|Withdrawal by Subject|2|||
23408355|NCT01673646|65239855|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
23408356|NCT01673646|65239856|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
23408357|NCT01673646|65239857|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
23408358|NCT03835481|65239859|FG000|Double-blind Period|Other not stated below|0|||
23408359|NCT03835481|65239860|FG001|Double-blind Period|Other not stated below|0|||
23408360|NCT03835481|65239861|FG002|Double-blind Period|Other not stated below|0|||
23408361|NCT03835481|65239862|FG003|Double-blind Period|Other not stated below|1|||
23408362|NCT03835481|65239863|FG004|Double-blind Period|Other not stated below|1|||
23408363|NCT03835481|65239859|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
23408364|NCT03835481|65239860|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
23408365|NCT03835481|65239861|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
23408366|NCT03835481|65239862|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
23408367|NCT03835481|65239863|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
23408368|NCT03835481|65239859|FG000|Double-blind Period|Withdrawal by Subject|0|||
23408369|NCT03835481|65239860|FG001|Double-blind Period|Withdrawal by Subject|0|||
23408370|NCT03835481|65239861|FG002|Double-blind Period|Withdrawal by Subject|1|||
23408371|NCT03835481|65239862|FG003|Double-blind Period|Withdrawal by Subject|0|||
23408372|NCT03835481|65239863|FG004|Double-blind Period|Withdrawal by Subject|5|||
23408373|NCT03835481|65239859|FG000|Double-blind Period|Lost to Follow-up|0|||
23408374|NCT03835481|65239860|FG001|Double-blind Period|Lost to Follow-up|0|||
23408375|NCT03835481|65239861|FG002|Double-blind Period|Lost to Follow-up|0|||
23408376|NCT03835481|65239862|FG003|Double-blind Period|Lost to Follow-up|1|||
23408377|NCT03835481|65239863|FG004|Double-blind Period|Lost to Follow-up|0|||
23408378|NCT03835481|65239859|FG000|Double-blind Period|Protocol Violation|0|||
23408379|NCT03835481|65239860|FG001|Double-blind Period|Protocol Violation|2|||
23408380|NCT03835481|65239861|FG002|Double-blind Period|Protocol Violation|0|||
23408381|NCT03835481|65239862|FG003|Double-blind Period|Protocol Violation|1|||
23408382|NCT03835481|65239863|FG004|Double-blind Period|Protocol Violation|0|||
23408383|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
23408384|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
23408385|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
23408386|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
23408387|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
23408388|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
23408389|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
23408390|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
23408391|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
23408392|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
23408393|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408394|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408395|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
23408396|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
23408397|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408398|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
23408399|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
23408400|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
23408401|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
23408402|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
23408403|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408404|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408405|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408406|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
23408407|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408408|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
23408409|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
23408410|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
23408411|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
23408412|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
23408413|NCT03188263|65239864|FG000|Overall Study|Withdrawal by Subject|3|||
23408414|NCT03188263|65239865|FG001|Overall Study|Withdrawal by Subject|0|||
23408415|NCT03188263|65239864|FG000|Overall Study|Physician Decision|1|||
23408416|NCT03188263|65239865|FG001|Overall Study|Physician Decision|0|||
23408417|NCT01890265|65239866|FG000|Overall Study|Other (Unspecified reason)|0|||
23408418|NCT01890265|65239867|FG001|Overall Study|Other (Unspecified reason)|1|||
23408419|NCT01890265|65239868|FG002|Overall Study|Other (Unspecified reason)|0|||
23408420|NCT01890265|65239869|FG003|Overall Study|Other (Unspecified reason)|0|||
23506170|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506171|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506172|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506173|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506174|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506175|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506176|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506177|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
23506178|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506179|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506180|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506181|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506182|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506183|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506184|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506185|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506186|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506187|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506188|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
23408421|NCT01890265|65239870|FG004|Overall Study|Other (Unspecified reason)|0|||
23408422|NCT01890265|65239871|FG005|Overall Study|Other (Unspecified reason)|0|||
23408423|NCT01890265|65239866|FG000|Overall Study|Progressive disease|6|||
23408424|NCT01890265|65239867|FG001|Overall Study|Progressive disease|6|||
23408425|NCT01890265|65239868|FG002|Overall Study|Progressive disease|0|||
23408426|NCT01890265|65239869|FG003|Overall Study|Progressive disease|0|||
23408427|NCT01890265|65239870|FG004|Overall Study|Progressive disease|0|||
23408428|NCT01890265|65239871|FG005|Overall Study|Progressive disease|0|||
23408429|NCT01890265|65239866|FG000|Overall Study|Adverse Event|2|||
23408430|NCT01890265|65239867|FG001|Overall Study|Adverse Event|1|||
23506189|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
23408431|NCT01890265|65239868|FG002|Overall Study|Adverse Event|0|||
23408432|NCT01890265|65239869|FG003|Overall Study|Adverse Event|0|||
23408433|NCT01890265|65239870|FG004|Overall Study|Adverse Event|0|||
23408434|NCT01890265|65239871|FG005|Overall Study|Adverse Event|0|||
23506190|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506191|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506192|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506193|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506194|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506195|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506196|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506197|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506198|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506199|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23408435|NCT01890265|65239866|FG000|Overall Study|Death|2|||
23408436|NCT01890265|65239867|FG001|Overall Study|Death|3|||
23408437|NCT01890265|65239868|FG002|Overall Study|Death|1|||
23408438|NCT01890265|65239869|FG003|Overall Study|Death|0|||
23408439|NCT01890265|65239870|FG004|Overall Study|Death|0|||
23408440|NCT01890265|65239871|FG005|Overall Study|Death|0|||
23408441|NCT01890265|65239866|FG000|Overall Study|Withdrawal by Subject|0|||
23408442|NCT01890265|65239867|FG001|Overall Study|Withdrawal by Subject|2|||
23408443|NCT01890265|65239868|FG002|Overall Study|Withdrawal by Subject|3|||
23408444|NCT01890265|65239869|FG003|Overall Study|Withdrawal by Subject|0|||
23506200|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
23506201|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23408445|NCT01890265|65239870|FG004|Overall Study|Withdrawal by Subject|2|||
23408446|NCT01890265|65239871|FG005|Overall Study|Withdrawal by Subject|0|||
23408447|NCT00673231|65239872|FG000|Overall Study|Withdrawal by Subject|14|||
23408448|NCT00673231|65239873|FG001|Overall Study|Withdrawal by Subject|10|||
23408449|NCT00673231|65239874|FG002|Overall Study|Withdrawal by Subject|8|||
23506202|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506203|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506204|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506205|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506206|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506207|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23408450|NCT00673231|65239875|FG003|Overall Study|Withdrawal by Subject|6|||
23408451|NCT00673231|65239872|FG000|Overall Study|Adverse Event|6|||
23408452|NCT00673231|65239873|FG001|Overall Study|Adverse Event|5|||
23408453|NCT00673231|65239874|FG002|Overall Study|Adverse Event|9|||
23408454|NCT00673231|65239875|FG003|Overall Study|Adverse Event|6|||
23408455|NCT00673231|65239872|FG000|Overall Study|Lost to Follow-up|1|||
23408456|NCT00673231|65239873|FG001|Overall Study|Lost to Follow-up|2|||
23408457|NCT00673231|65239874|FG002|Overall Study|Lost to Follow-up|1|||
23408458|NCT00673231|65239875|FG003|Overall Study|Lost to Follow-up|2|||
23408459|NCT00673231|65239872|FG000|Overall Study|Death|0|||
23408460|NCT00673231|65239873|FG001|Overall Study|Death|0|||
23408461|NCT00673231|65239874|FG002|Overall Study|Death|1|||
23408462|NCT00673231|65239875|FG003|Overall Study|Death|0|||
23408463|NCT00673231|65239872|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
23408464|NCT00673231|65239873|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
23408465|NCT00673231|65239874|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
23408466|NCT00673231|65239875|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
23408467|NCT01804049|65239876|FG000|Overall Study|Adverse Event|2|||
23408468|NCT01804049|65239877|FG001|Overall Study|Adverse Event|10|||
23408469|NCT01804049|65239876|FG000|Overall Study|Lost to Follow-up|2|||
23408470|NCT01804049|65239877|FG001|Overall Study|Lost to Follow-up|1|||
23408471|NCT01804049|65239876|FG000|Overall Study|Decreased interest/personal|4|||
23408472|NCT01804049|65239877|FG001|Overall Study|Decreased interest/personal|5|||
23408473|NCT01804049|65239876|FG000|Overall Study|Other health concerns|2|||
23408474|NCT01804049|65239877|FG001|Overall Study|Other health concerns|7|||
23408475|NCT01804049|65239876|FG000|Overall Study|Moved out of area|0|||
23408476|NCT01804049|65239877|FG001|Overall Study|Moved out of area|7|||
23408477|NCT01804049|65239876|FG000|Overall Study|other MD recommended|1|||
23408478|NCT01804049|65239877|FG001|Overall Study|other MD recommended|1|||
23408479|NCT01804049|65239876|FG000|Overall Study|Enrollment in dual studies|0|||
23408480|NCT01804049|65239877|FG001|Overall Study|Enrollment in dual studies|1|||
23408481|NCT01309204|65239879|FG000|Overall Study|Adverse Event|48|||
23408482|NCT01309204|65239880|FG001|Overall Study|Adverse Event|58|||
23408483|NCT01309204|65239879|FG000|Overall Study|Lost to Follow-up|2|||
23408484|NCT01309204|65239880|FG001|Overall Study|Lost to Follow-up|2|||
23408485|NCT01309204|65239879|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
23408486|NCT01309204|65239880|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
23506208|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23408487|NCT01309204|65239879|FG000|Overall Study|Inadequate control of IOP|4|||
23408488|NCT01309204|65239880|FG001|Overall Study|Inadequate control of IOP|4|||
23408489|NCT01309204|65239879|FG000|Overall Study|Other|4|||
23506209|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506210|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
23506211|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506212|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506213|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506214|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506215|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506216|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506217|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506218|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506219|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506220|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
23506221|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506222|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506223|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506224|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506225|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506226|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506227|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506228|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506229|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506230|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506231|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506232|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506233|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
23506234|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506235|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
23506236|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506237|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506238|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506239|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506240|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506241|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506242|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506243|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506244|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
23506245|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506246|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
23506247|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506248|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506249|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506250|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506251|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506252|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506253|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506254|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506255|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
23506256|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506257|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
23506258|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506259|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506260|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23607374|NCT00195819|65950686|FG000|Double-Blind|Withdrawal by Subject|1|||
23408490|NCT01309204|65239880|FG001|Overall Study|Other|1|||
23408491|NCT02817776|65239881|FG000|Overall Study|Excluded|33|||
23408492|NCT02817776|65239881|FG000|Overall Study|Lost to Follow-up|20|||
23408493|NCT02817776|65239881|FG000|Overall Study|Withdrawal by Subject|33|||
23408494|NCT02817776|65239881|FG000|Overall Study|Death|2|||
23408495|NCT02522429|65239884|FG000|Overall Study|Lost to Follow-up|8|||
23408496|NCT02522429|65239884|FG000|Overall Study|Adverse Event|2|||
23408497|NCT02522429|65239884|FG000|Overall Study|Death|1|||
23408498|NCT02522429|65239884|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
23506261|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506262|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506263|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506264|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506265|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506266|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
23506267|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506268|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
23506269|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
23506270|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
23506271|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
23506272|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
23506273|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
23506274|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
23506275|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
23506276|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
23506277|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
23506278|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
23506279|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
23506280|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
23506281|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
23506282|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
23506283|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
23506284|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
23506285|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
23506286|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
23506287|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
23506288|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
23506289|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
23506290|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
23506291|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506292|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506293|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506294|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506295|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506296|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506297|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506298|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506299|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506300|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506301|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
23506302|NCT02627144|65591045|FG000|Overall Study|Serious adverse event|32|||
23506303|NCT02627144|65591045|FG000|Overall Study|Cancer progression|171|||
23506304|NCT02627144|65591045|FG000|Overall Study|Death from cancer|20|||
23506305|NCT02627144|65591045|FG000|Overall Study|Death from other cause|8|||
23506306|NCT02627144|65591045|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
23506307|NCT02627144|65591045|FG000|Overall Study|Administrative reasons|65|||
23506308|NCT02627144|65591045|FG000|Overall Study|Lost to Follow-up|8|||
23506309|NCT02627144|65591045|FG000|Overall Study|Enrolled, not treated|6|||
23506310|NCT02627144|65591045|FG000|Overall Study|Other|17|||
23506311|NCT00660023|65591046|FG000|Overall Study|Adverse Event|2|||
23506312|NCT00660023|65591046|FG000|Overall Study|Death|8|||
23506313|NCT00660023|65591046|FG000|Overall Study|Blood Transfusion|5|||
23506314|NCT00660023|65591046|FG000|Overall Study|Renal Transplantation|3|||
23506315|NCT00660023|65591046|FG000|Overall Study|Withdrawal by Subject|1|||
23506316|NCT00660023|65591046|FG000|Overall Study|Missed Pregnancy Test|1|||
23506317|NCT00660023|65591046|FG000|Overall Study|Other Screening Failure|9|||
23506318|NCT03851705|65591052|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
23506319|NCT03851705|65591053|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506320|NCT03851705|65591054|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506321|NCT03851705|65591055|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506322|NCT03851705|65591052|FG000|Part 1: Double-Blind Period|Other reason|1|||
23506323|NCT03851705|65591053|FG001|Part 1: Double-Blind Period|Other reason|0|||
23506324|NCT03851705|65591054|FG002|Part 1: Double-Blind Period|Other reason|0|||
23506325|NCT03851705|65591055|FG003|Part 1: Double-Blind Period|Other reason|0|||
23506326|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Other reason|0|||
23506327|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Other reason|0|||
23506328|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Other reason|0|||
23506329|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Other reason|1|||
23506330|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Death|0|||
23506331|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Death|0|||
23506332|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Death|3|||
23506333|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Death|0|||
23506334|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506335|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506336|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
23506337|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506338|NCT02651922|65591057|FG000|Overall Study|due to exclusion criteria|2|||
23506339|NCT00618072|65591058|FG000|Overall Study|Lost to Follow-up|2|||
23506340|NCT00618072|65591059|FG001|Overall Study|Lost to Follow-up|0|||
23506341|NCT00618072|65591060|FG002|Overall Study|Lost to Follow-up|3|||
23506342|NCT00618072|65591058|FG000|Overall Study|Physician Decision|0|||
23506343|NCT00618072|65591059|FG001|Overall Study|Physician Decision|1|||
23506344|NCT00618072|65591060|FG002|Overall Study|Physician Decision|1|||
23506345|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
23506346|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
23506347|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
23506348|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
23506349|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
23506350|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
23506351|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
23506352|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
23506353|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
23506354|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
23506355|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
23506356|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
23506357|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
23506358|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
23506359|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
23506360|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
23506361|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
23506362|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
23506363|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
23506364|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
23506365|NCT03020160|65591076|FG000|Overall Study|Withdrawal by Subject|1|||
23506366|NCT03020160|65591077|FG001|Overall Study|Withdrawal by Subject|0|||
23506367|NCT02010775|65591078|FG000|Overall Study|Adverse Event|0|||
23506368|NCT02010775|65591079|FG001|Overall Study|Adverse Event|0|||
23506369|NCT02010775|65591080|FG002|Overall Study|Adverse Event|0|||
23506370|NCT02010775|65591081|FG003|Overall Study|Adverse Event|0|||
23506371|NCT02010775|65591082|FG004|Overall Study|Adverse Event|1|||
23506372|NCT02010775|65591078|FG000|Overall Study|Pregnancy|0|||
23506373|NCT02010775|65591079|FG001|Overall Study|Pregnancy|0|||
23506374|NCT02010775|65591080|FG002|Overall Study|Pregnancy|2|||
23506375|NCT02010775|65591081|FG003|Overall Study|Pregnancy|0|||
23506376|NCT02010775|65591082|FG004|Overall Study|Pregnancy|0|||
23408499|NCT00211172|65239885|FG000|Overall Study|Died or lost health plan eligibility|39|||
23408500|NCT00211172|65239886|FG001|Overall Study|Died or lost health plan eligibility|32|||
23408501|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Death|1|||
23408502|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Death|0|||
23408503|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Death|0|||
23408504|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
23408505|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
23408506|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
23408507|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
23408508|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
23408509|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
23408510|NCT02567799|65239890|FG000|Follow-up|Death|1|||
23408511|NCT02567799|65239891|FG001|Follow-up|Death|0|||
23408512|NCT02567799|65239892|FG002|Follow-up|Death|1|||
23408513|NCT02567799|65239890|FG000|Follow-up|Progressive Disease|1|||
23408514|NCT02567799|65239891|FG001|Follow-up|Progressive Disease|1|||
23408515|NCT02567799|65239892|FG002|Follow-up|Progressive Disease|3|||
23408516|NCT00833469|65239893|FG000|Overall Study|Withdrawal by Subject|1|||
23408517|NCT00833469|65239893|FG000|Overall Study|Lost to Follow-up|1|||
23408518|NCT04466384|65239899|FG000|First Phase|Protocol Violation|1|||
23408519|NCT04466384|65239900|FG001|First Phase|Protocol Violation|0|||
23408520|NCT04466384|65239899|FG000|First Phase|Missing data|1|||
23408521|NCT04466384|65239900|FG001|First Phase|Missing data|0|||
23408522|NCT04466384|65239899|FG000|Cross Over Phase|Physician Decision|1|||
23408523|NCT04466384|65239900|FG001|Cross Over Phase|Physician Decision|0|||
23408524|NCT04466384|65239899|FG000|Cross Over Phase|Withdrawal by Subject|0|||
23408525|NCT04466384|65239900|FG001|Cross Over Phase|Withdrawal by Subject|1|||
23408526|NCT02366923|65239903|FG000|Overall Study|Withdrawal by Subject|1|||
23408527|NCT02366923|65239903|FG000|Overall Study|Positive Slit Lamp Findings|2|||
23506377|NCT02010775|65591078|FG000|Overall Study|Lost to Follow-up|2|||
23506378|NCT02010775|65591079|FG001|Overall Study|Lost to Follow-up|0|||
23506379|NCT02010775|65591080|FG002|Overall Study|Lost to Follow-up|0|||
23408528|NCT02366923|65239903|FG000|Overall Study|High Astigmatism|3|||
23408529|NCT01635998|65239906|FG000|Overall Study|Death|1|||
23408530|NCT01635998|65239907|FG001|Overall Study|Death|1|||
23408531|NCT01635998|65239906|FG000|Overall Study|Lost to Follow-up|2|||
23408532|NCT01635998|65239907|FG001|Overall Study|Lost to Follow-up|1|||
23408533|NCT01635998|65239906|FG000|Overall Study|Withdrawal by Subject|1|||
23408534|NCT01635998|65239907|FG001|Overall Study|Withdrawal by Subject|5|||
23408535|NCT00910910|65239908|FG000|Overall Study|Adverse Event|63|||
23408536|NCT00910910|65239909|FG001|Overall Study|Adverse Event|35|||
23408537|NCT00910910|65239908|FG000|Overall Study|PD without histologic change|27|||
23408538|NCT00910910|65239909|FG001|Overall Study|PD without histologic change|23|||
23408539|NCT00910910|65239908|FG000|Overall Study|PD with histologic change|0|||
23408540|NCT00910910|65239909|FG001|Overall Study|PD with histologic change|2|||
23408541|NCT00910910|65239908|FG000|Overall Study|Withdrawal by Subject|7|||
23408542|NCT00910910|65239909|FG001|Overall Study|Withdrawal by Subject|5|||
23408543|NCT00910910|65239908|FG000|Overall Study|Lost to Follow-up|2|||
23408544|NCT00910910|65239909|FG001|Overall Study|Lost to Follow-up|2|||
23408545|NCT00910910|65239908|FG000|Overall Study|Death|9|||
23408546|NCT00910910|65239909|FG001|Overall Study|Death|3|||
23408547|NCT00910910|65239908|FG000|Overall Study|Protocol Violation|2|||
23408548|NCT00910910|65239909|FG001|Overall Study|Protocol Violation|2|||
23408549|NCT00910910|65239908|FG000|Overall Study|Completed 13 cycles of treatment|0|||
23408550|NCT00910910|65239909|FG001|Overall Study|Completed 13 cycles of treatment|118|||
23408551|NCT00910910|65239908|FG000|Overall Study|Other|114|||
23408552|NCT00910910|65239909|FG001|Overall Study|Other|32|||
23408553|NCT00910910|65239908|FG000|Overall Study|Untreated before cycle 1|1|||
23408554|NCT00910910|65239909|FG001|Overall Study|Untreated before cycle 1|2|||
23408555|NCT03072043|65239919|FG000|Overall Study|Death|0|||
23408556|NCT03072043|65239920|FG001|Overall Study|Death|0|||
23408557|NCT03072043|65239921|FG002|Overall Study|Death|3|||
23506380|NCT02010775|65591081|FG003|Overall Study|Lost to Follow-up|1|||
23506381|NCT02010775|65591082|FG004|Overall Study|Lost to Follow-up|1|||
23506382|NCT02010775|65591078|FG000|Overall Study|Personal Reasons|3|||
23506383|NCT02010775|65591079|FG001|Overall Study|Personal Reasons|3|||
23506384|NCT02010775|65591080|FG002|Overall Study|Personal Reasons|1|||
23506385|NCT02010775|65591081|FG003|Overall Study|Personal Reasons|2|||
23506386|NCT02010775|65591082|FG004|Overall Study|Personal Reasons|4|||
23506387|NCT01605877|65591083|FG000|Overall Study|Withdrawal by Subject|1|||
23506388|NCT02088047|65591087|FG000|Overall Study|Withdrawal by Subject|1|||
23506389|NCT02088047|65591088|FG001|Overall Study|Withdrawal by Subject|0|||
23506390|NCT03281577|65591089|FG000|Overall Study|Adverse Event|0|||
23506391|NCT03281577|65591090|FG001|Overall Study|Adverse Event|0|||
23506392|NCT03281577|65591091|FG002|Overall Study|Adverse Event|0|||
23506393|NCT03281577|65591092|FG003|Overall Study|Adverse Event|1|||
23506394|NCT03281577|65591089|FG000|Overall Study|Withdrawal by Subject|1|||
23506395|NCT03281577|65591090|FG001|Overall Study|Withdrawal by Subject|0|||
23506396|NCT03281577|65591091|FG002|Overall Study|Withdrawal by Subject|0|||
23506397|NCT03281577|65591092|FG003|Overall Study|Withdrawal by Subject|0|||
23506398|NCT01731990|65591104|FG000|Overall Study|Adverse Event|1|||
23506399|NCT01731990|65591105|FG001|Overall Study|Adverse Event|5|||
23506400|NCT01731990|65591104|FG000|Overall Study|Withdrawal by Subject|1|||
23506401|NCT01731990|65591105|FG001|Overall Study|Withdrawal by Subject|1|||
23506402|NCT01731990|65591104|FG000|Overall Study|Protocol deviation|1|||
23506403|NCT01731990|65591105|FG001|Overall Study|Protocol deviation|2|||
23506404|NCT01731990|65591104|FG000|Overall Study|Death|1|||
23506405|NCT01731990|65591105|FG001|Overall Study|Death|0|||
23506406|NCT00673465|65591106|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506407|NCT00673465|65591107|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506408|NCT00673465|65591108|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506409|NCT00673465|65591109|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506410|NCT00673465|65591110|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
23506411|NCT00673465|65591111|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
23506412|NCT00673465|65591112|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506413|NCT00673465|65591113|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506414|NCT00673465|65591114|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506415|NCT00673465|65591115|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506416|NCT00673465|65591116|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506417|NCT00673465|65591117|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506418|NCT00673465|65591106|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506419|NCT00673465|65591107|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506420|NCT00673465|65591108|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506421|NCT00673465|65591109|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506422|NCT00673465|65591110|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
23506423|NCT00673465|65591111|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506424|NCT00673465|65591112|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506425|NCT00673465|65591113|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506426|NCT00673465|65591114|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506427|NCT00673465|65591115|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506428|NCT00673465|65591116|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506429|NCT00673465|65591117|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506430|NCT01365910|65591118|FG000|Overall Study|Withdrawal by Subject|7|||
23506431|NCT01365910|65591118|FG000|Overall Study|disease progression|18|||
23506432|NCT01365910|65591118|FG000|Overall Study|Adverse Event|3|||
23506433|NCT01365910|65591118|FG000|Overall Study|other complicating disease|1|||
23506434|NCT01365910|65591118|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
23506435|NCT01654536|65591133|FG000|Overall Study|Lost to Follow-up|5|||
23506436|NCT01654536|65591134|FG001|Overall Study|Lost to Follow-up|5|||
23506437|NCT01654536|65591133|FG000|Overall Study|Physician Decision|12|||
23506438|NCT01654536|65591134|FG001|Overall Study|Physician Decision|8|||
23506439|NCT01654536|65591133|FG000|Overall Study|Withdrawal by Subject|27|||
23506440|NCT01654536|65591134|FG001|Overall Study|Withdrawal by Subject|25|||
23506441|NCT00553644|65591135|FG000|Overall Study|Adverse Event|17|||
23506442|NCT00553644|65591135|FG000|Overall Study|Withdrawal by Subject|4|||
23506443|NCT00553644|65591135|FG000|Overall Study|Physician Decision|1|||
23506444|NCT00553644|65591135|FG000|Overall Study|Alternative therapy|6|||
23506445|NCT01603355|65591138|FG000|Overall Study|Lack of Efficacy|2|||
23506446|NCT03130257|65591140|FG000|Overall Study|Withdrawal by Subject|1|||
23506447|NCT03130257|65591141|FG001|Overall Study|Withdrawal by Subject|0|||
23506448|NCT03130257|65591142|FG002|Overall Study|Withdrawal by Subject|2|||
23506449|NCT01336764|65591143|FG000|Overall Study|Withdrawal by Subject|5|||
23506450|NCT01336764|65591144|FG001|Overall Study|Withdrawal by Subject|5|||
23506451|NCT01129960|65591148|FG000|Overall Study|Withdrawal by Subject|3|||
23506452|NCT01129960|65591149|FG001|Overall Study|Withdrawal by Subject|0|||
23506453|NCT01129960|65591150|FG002|Overall Study|Withdrawal by Subject|3|||
23506454|NCT01129960|65591151|FG003|Overall Study|Withdrawal by Subject|2|||
23506455|NCT01129960|65591148|FG000|Overall Study|Lack of Efficacy|1|||
23506456|NCT01129960|65591149|FG001|Overall Study|Lack of Efficacy|1|||
23506457|NCT01129960|65591150|FG002|Overall Study|Lack of Efficacy|1|||
23506458|NCT01129960|65591151|FG003|Overall Study|Lack of Efficacy|1|||
23506459|NCT01129960|65591148|FG000|Overall Study|Adverse Event|23|||
23506460|NCT01129960|65591149|FG001|Overall Study|Adverse Event|16|||
23506461|NCT01129960|65591150|FG002|Overall Study|Adverse Event|16|||
23506462|NCT01129960|65591151|FG003|Overall Study|Adverse Event|7|||
23506463|NCT01129960|65591148|FG000|Overall Study|Protocol Violation|1|||
23506464|NCT01129960|65591149|FG001|Overall Study|Protocol Violation|2|||
23506465|NCT01129960|65591150|FG002|Overall Study|Protocol Violation|3|||
23506466|NCT01129960|65591151|FG003|Overall Study|Protocol Violation|0|||
23506467|NCT01129960|65591148|FG000|Overall Study|Lost to Follow-up|0|||
23506468|NCT01129960|65591149|FG001|Overall Study|Lost to Follow-up|2|||
23506469|NCT01129960|65591150|FG002|Overall Study|Lost to Follow-up|3|||
23506470|NCT01129960|65591151|FG003|Overall Study|Lost to Follow-up|3|||
23506471|NCT01129960|65591148|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
23506472|NCT01129960|65591149|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
23506473|NCT01129960|65591150|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
23506474|NCT01129960|65591151|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
23506475|NCT01129960|65591148|FG000|Overall Study|Physician Decision|1|||
23506476|NCT01129960|65591149|FG001|Overall Study|Physician Decision|0|||
23506477|NCT01129960|65591150|FG002|Overall Study|Physician Decision|0|||
23506478|NCT01129960|65591151|FG003|Overall Study|Physician Decision|0|||
23506479|NCT01129960|65591148|FG000|Overall Study|Pregnancy|1|||
23506480|NCT01129960|65591149|FG001|Overall Study|Pregnancy|0|||
23506481|NCT01129960|65591150|FG002|Overall Study|Pregnancy|0|||
23506482|NCT01129960|65591151|FG003|Overall Study|Pregnancy|0|||
23506483|NCT02505867|65591153|FG000|Overall Study|Lack of Efficacy|6|||
23506484|NCT02505867|65591154|FG001|Overall Study|Lack of Efficacy|6|||
23506485|NCT00003499|65591156|FG000|Overall Study|Not evaluable|8|||
23506486|NCT00739674|65591161|FG000|Overall Study|Screening failures|19|||
23506487|NCT00739674|65591162|FG001|Overall Study|Screening failures|17|||
23506488|NCT00739674|65591161|FG000|Overall Study|Site 212 removal|19|||
23506489|NCT00739674|65591162|FG001|Overall Study|Site 212 removal|13|||
23506490|NCT00739674|65591161|FG000|Overall Study|No follow-up data|33|||
23506491|NCT00739674|65591162|FG001|Overall Study|No follow-up data|18|||
23506492|NCT00739674|65591161|FG000|Overall Study|Dietician consultation >30 days|1|||
23506493|NCT00739674|65591162|FG001|Overall Study|Dietician consultation >30 days|9|||
23506494|NCT00739674|65591161|FG000|Overall Study|Adverse Event|22|||
23506495|NCT00739674|65591162|FG001|Overall Study|Adverse Event|13|||
23506496|NCT00739674|65591161|FG000|Overall Study|Death|1|||
23506497|NCT00739674|65591162|FG001|Overall Study|Death|0|||
23506498|NCT00739674|65591161|FG000|Overall Study|Lack of Efficacy|1|||
23506499|NCT00739674|65591162|FG001|Overall Study|Lack of Efficacy|0|||
23506500|NCT00739674|65591161|FG000|Overall Study|Lost to Follow-up|52|||
23506501|NCT00739674|65591162|FG001|Overall Study|Lost to Follow-up|30|||
23506502|NCT00739674|65591161|FG000|Overall Study|Protocol Violation|5|||
23506503|NCT00739674|65591162|FG001|Overall Study|Protocol Violation|5|||
23506504|NCT00739674|65591161|FG000|Overall Study|Withdrawal by Subject|9|||
23506505|NCT00739674|65591162|FG001|Overall Study|Withdrawal by Subject|9|||
23506506|NCT00739674|65591161|FG000|Overall Study|Reason missing|2|||
23506507|NCT00739674|65591162|FG001|Overall Study|Reason missing|0|||
23506508|NCT00739674|65591161|FG000|Overall Study|Clinic closed|6|||
23506509|NCT00739674|65591162|FG001|Overall Study|Clinic closed|4|||
23506510|NCT00739674|65591161|FG000|Overall Study|Patient moved|3|||
23506511|NCT00739674|65591162|FG001|Overall Study|Patient moved|2|||
23506512|NCT00739674|65591161|FG000|Overall Study|Non compliant|4|||
23506513|NCT00739674|65591162|FG001|Overall Study|Non compliant|0|||
23506514|NCT00739674|65591161|FG000|Overall Study|Unable to attend visit|3|||
23506515|NCT00739674|65591162|FG001|Overall Study|Unable to attend visit|1|||
23506516|NCT00739674|65591161|FG000|Overall Study|Home monitoring off meds|1|||
23506517|NCT00739674|65591162|FG001|Overall Study|Home monitoring off meds|0|||
23506518|NCT00739674|65591161|FG000|Overall Study|Erectile dysfunction|0|||
23506519|NCT00739674|65591162|FG001|Overall Study|Erectile dysfunction|1|||
23506520|NCT04015336|65591163|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
23506521|NCT02014597|65591164|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
23506522|NCT02014597|65591165|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
23506523|NCT00730132|65591166|FG000|Overall Study|Protocol Violation|154|||
23506524|NCT00730132|65591166|FG000|Overall Study|Death|1|||
23506525|NCT02289898|65591167|FG000|Overall Study|Death|5|||
23506526|NCT02289898|65591168|FG001|Overall Study|Death|4|||
23506527|NCT02289898|65591169|FG002|Overall Study|Death|3|||
23506528|NCT02289898|65591167|FG000|Overall Study|Physician Decision|2|||
23506529|NCT02289898|65591168|FG001|Overall Study|Physician Decision|5|||
23506530|NCT02289898|65591169|FG002|Overall Study|Physician Decision|2|||
23506531|NCT02289898|65591167|FG000|Overall Study|Withdrawal by Subject|0|||
23506532|NCT02289898|65591168|FG001|Overall Study|Withdrawal by Subject|4|||
23506533|NCT02289898|65591169|FG002|Overall Study|Withdrawal by Subject|1|||
23506534|NCT02289898|65591167|FG000|Overall Study|Adverse Event|3|||
23506535|NCT02289898|65591168|FG001|Overall Study|Adverse Event|5|||
23506536|NCT02289898|65591169|FG002|Overall Study|Adverse Event|5|||
23506537|NCT02289898|65591167|FG000|Overall Study|Disease progression|34|||
23506538|NCT02289898|65591168|FG001|Overall Study|Disease progression|28|||
23506539|NCT02289898|65591169|FG002|Overall Study|Disease progression|34|||
23506540|NCT02289898|65591167|FG000|Overall Study|Use of another anticancer therapy|0|||
23506541|NCT02289898|65591168|FG001|Overall Study|Use of another anticancer therapy|0|||
23506542|NCT02289898|65591169|FG002|Overall Study|Use of another anticancer therapy|1|||
23506543|NCT02289898|65591167|FG000|Overall Study|Other|8|||
23506544|NCT02289898|65591168|FG001|Overall Study|Other|7|||
23506545|NCT02289898|65591169|FG002|Overall Study|Other|10|||
23506546|NCT02151591|65591184|FG000|Overall Study|Lost to Follow-up|6|||
23506547|NCT02151591|65591185|FG001|Overall Study|Lost to Follow-up|3|||
23506548|NCT00887978|65591186|FG000|Overall Study|Adverse Event|18|||
23506549|NCT00887978|65591187|FG001|Overall Study|Adverse Event|5|||
23506550|NCT00887978|65591186|FG000|Overall Study|Clinical Worsening|4|||
23506551|NCT00887978|65591187|FG001|Overall Study|Clinical Worsening|4|||
23506552|NCT00887978|65591186|FG000|Overall Study|Death|2|||
23506553|NCT00887978|65591187|FG001|Overall Study|Death|3|||
23506554|NCT00887978|65591186|FG000|Overall Study|Withdrawal by Subject|1|||
23506555|NCT00887978|65591187|FG001|Overall Study|Withdrawal by Subject|2|||
23506556|NCT00887978|65591186|FG000|Overall Study|Lost to Follow-up|0|||
23506557|NCT00887978|65591187|FG001|Overall Study|Lost to Follow-up|1|||
23506558|NCT00573534|65591188|FG000|Overall Study|oppositional behavior|3|||
23506559|NCT01402492|65591189|FG000|Overall Study|Withdrawal by Subject|17|||
23506560|NCT01402492|65591190|FG001|Overall Study|Withdrawal by Subject|11|||
23506561|NCT01402492|65591191|FG002|Overall Study|Withdrawal by Subject|11|||
23506562|NCT01402492|65591189|FG000|Overall Study|Adverse Event|2|||
23506563|NCT01402492|65591190|FG001|Overall Study|Adverse Event|3|||
23506564|NCT01402492|65591191|FG002|Overall Study|Adverse Event|4|||
23506565|NCT01402492|65591189|FG000|Overall Study|Physician Decision|0|||
23506566|NCT01402492|65591190|FG001|Overall Study|Physician Decision|3|||
23506567|NCT01402492|65591191|FG002|Overall Study|Physician Decision|0|||
23506568|NCT01402492|65591189|FG000|Overall Study|Incarcerated (N=3)|2|||
23506569|NCT01402492|65591190|FG001|Overall Study|Incarcerated (N=3)|0|||
23506570|NCT01402492|65591191|FG002|Overall Study|Incarcerated (N=3)|1|||
23506571|NCT02007109|65591192|FG000|Overall Study|Diary not returned or excluded|102|||
23506572|NCT02007109|65591192|FG000|Overall Study|Excluded - Age<7yo|9|||
23506573|NCT01835587|65591196|FG000|Overall Study|Disease Recurrence or Relapse|0|||
23506574|NCT01835587|65591197|FG001|Overall Study|Disease Recurrence or Relapse|3|||
23506575|NCT01835587|65591198|FG002|Overall Study|Disease Recurrence or Relapse|0|||
23506576|NCT01835587|65591199|FG003|Overall Study|Disease Recurrence or Relapse|3|||
23506577|NCT01835587|65591196|FG000|Overall Study|Withdrawal by Subject|2|||
23506578|NCT01835587|65591197|FG001|Overall Study|Withdrawal by Subject|0|||
23506579|NCT01835587|65591198|FG002|Overall Study|Withdrawal by Subject|0|||
23506580|NCT01835587|65591199|FG003|Overall Study|Withdrawal by Subject|3|||
23506581|NCT01835587|65591196|FG000|Overall Study|Adverse Event|0|||
23506582|NCT01835587|65591197|FG001|Overall Study|Adverse Event|0|||
23506583|NCT01835587|65591198|FG002|Overall Study|Adverse Event|2|||
23506584|NCT01835587|65591199|FG003|Overall Study|Adverse Event|2|||
23506585|NCT01835587|65591196|FG000|Overall Study|Death|0|||
23506586|NCT01835587|65591197|FG001|Overall Study|Death|0|||
23506587|NCT01835587|65591198|FG002|Overall Study|Death|0|||
23506588|NCT01835587|65591199|FG003|Overall Study|Death|1|||
23506589|NCT01835587|65591196|FG000|Overall Study|Miscellaneous|0|||
23506590|NCT01835587|65591197|FG001|Overall Study|Miscellaneous|1|||
23506591|NCT01835587|65591198|FG002|Overall Study|Miscellaneous|0|||
23506592|NCT01835587|65591199|FG003|Overall Study|Miscellaneous|0|||
23506593|NCT03064451|65591200|FG000|Overall Study|Lost to Follow-up|1|||
23506594|NCT03064451|65591200|FG000|Overall Study|Mapping Failure|4|||
23506595|NCT03064451|65591200|FG000|Overall Study|Exited prior to procedure|8|||
23506596|NCT03064451|65591200|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
23506597|NCT01385566|65591207|FG000|Overall Study|Lost to Follow-up|1|||
23506598|NCT01385566|65591208|FG001|Overall Study|Lost to Follow-up|0|||
23506599|NCT01385566|65591209|FG002|Overall Study|Lost to Follow-up|0|||
23506600|NCT01385566|65591210|FG003|Overall Study|Lost to Follow-up|0|||
23506601|NCT01385566|65591211|FG004|Overall Study|Lost to Follow-up|0|||
23506602|NCT01385566|65591212|FG005|Overall Study|Lost to Follow-up|0|||
23506603|NCT01385566|65591207|FG000|Overall Study|Withdrawal by Subject|0|||
23506604|NCT01385566|65591208|FG001|Overall Study|Withdrawal by Subject|0|||
23506605|NCT01385566|65591209|FG002|Overall Study|Withdrawal by Subject|0|||
23506606|NCT01385566|65591210|FG003|Overall Study|Withdrawal by Subject|1|||
23506607|NCT01385566|65591211|FG004|Overall Study|Withdrawal by Subject|0|||
23506608|NCT01385566|65591212|FG005|Overall Study|Withdrawal by Subject|0|||
23506609|NCT03715764|65591213|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
23506610|NCT03715764|65591214|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
23506611|NCT03715764|65591213|FG000|3 Month Follow-up|Lost to Follow-up|2|||
23506612|NCT03715764|65591214|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23506613|NCT03715764|65591213|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
23506614|NCT03715764|65591214|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
23506615|NCT03715764|65591213|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23506616|NCT03715764|65591214|FG001|6 Month Follow-up|Lost to Follow-up|0|||
23506617|NCT03715764|65591213|FG000|12 Month Follow-up|Lost to Follow-up|2|||
23506618|NCT03715764|65591214|FG001|12 Month Follow-up|Lost to Follow-up|3|||
23506619|NCT03715764|65591213|FG000|12 Month Follow-up|Pregnancy|0|||
23506620|NCT03715764|65591214|FG001|12 Month Follow-up|Pregnancy|1|||
23506621|NCT03715764|65591213|FG000|12 Month Follow-up|Surgery|2|||
23506622|NCT03715764|65591214|FG001|12 Month Follow-up|Surgery|0|||
23506623|NCT03715764|65591213|FG000|12 Month Follow-up|Wrong address|1|||
23506624|NCT03715764|65591214|FG001|12 Month Follow-up|Wrong address|0|||
23506625|NCT03715764|65591213|FG000|12 Month Follow-up|No symptoms|1|||
23506626|NCT03715764|65591214|FG001|12 Month Follow-up|No symptoms|0|||
23506627|NCT03715764|65591213|FG000|12 Month Follow-up|Changed primary care centre|0|||
23506628|NCT03715764|65591214|FG001|12 Month Follow-up|Changed primary care centre|1|||
23506629|NCT00867568|65591215|FG000|Overall Study|Lack of Efficacy|10|||
23506630|NCT00867568|65591215|FG000|Overall Study|Adverse Event|4|||
23506631|NCT00867568|65591215|FG000|Overall Study|Withdrawal by Subject|1|||
23506632|NCT00390468|65591217|FG000|Overall Study|Protocol Violation|2|||
23506633|NCT00390468|65591217|FG000|Overall Study|Lack of Efficacy|1|||
23506634|NCT03428360|65591218|FG000|Overall Study|Informed consent withdrawn|5|||
23506635|NCT03428360|65591218|FG000|Overall Study|Withdrawal by Subject|4|||
23506636|NCT03428360|65591218|FG000|Overall Study|Lost to Follow-up|5|||
23506637|NCT03428360|65591218|FG000|Overall Study|Physician Decision|2|||
23506638|NCT03428360|65591218|FG000|Overall Study|Informed consent withdrawn|5|||
23506639|NCT03428360|65591218|FG000|Overall Study|Study terminated by sponsor|10|||
23506640|NCT03428360|65591218|FG000|Overall Study|Non-compliant with study|1|||
23506641|NCT03428360|65591218|FG000|Overall Study|Non-compliant with study drug|3|||
23506642|NCT03428360|65591218|FG000|Overall Study|Death|3|||
23506643|NCT03428360|65591218|FG000|Overall Study|Adverse Event|1|||
23506644|NCT03428360|65591218|FG000|Overall Study|Not on antiepileptic drug|1|||
23506645|NCT02550106|65591226|FG000|Overall Study|Adverse Event|1|||
23506646|NCT02550106|65591226|FG000|Overall Study|Lack of Efficacy|3|||
23506647|NCT02550106|65591226|FG000|Overall Study|Protocol Violation|6|||
23506648|NCT02550106|65591226|FG000|Overall Study|Withdrawal by Subject|2|||
23506649|NCT03672747|65591231|FG000|Overall Study|Lost to Follow-up|1|||
23506650|NCT03672747|65591232|FG001|Overall Study|Lost to Follow-up|1|||
23506651|NCT03672747|65591233|FG002|Overall Study|Lost to Follow-up|2|||
23506652|NCT03672747|65591234|FG003|Overall Study|Lost to Follow-up|2|||
23506653|NCT03672747|65591235|FG004|Overall Study|Lost to Follow-up|2|||
23506654|NCT03672747|65591236|FG005|Overall Study|Lost to Follow-up|1|||
23506655|NCT00982878|65591240|FG000|Overall Study|Physician Decision|1|||
23506656|NCT02130570|65591241|FG000|Overall Study|Death|3|||
23506657|NCT02130570|65591242|FG001|Overall Study|Death|5|||
23506658|NCT02130570|65591241|FG000|Overall Study|Withdrawal by Subject|6|||
23506659|NCT02130570|65591242|FG001|Overall Study|Withdrawal by Subject|3|||
23506660|NCT02130570|65591241|FG000|Overall Study|Part of practice that discontinued study|0|||
23506661|NCT02130570|65591242|FG001|Overall Study|Part of practice that discontinued study|5|||
23506662|NCT04997161|65591244|FG000|Overall Study|Study terminated by sponsor|3|||
23506663|NCT02233647|65591245|FG000|Overall Study|Adverse Event|1|||
23506664|NCT04502589|65591246|FG000|Overall Study|Physician Decision|1|||
23506665|NCT04502589|65591247|FG001|Overall Study|Physician Decision|0|||
23506666|NCT00688753|65591248|FG000|Overall Study|Disease progression|55|||
23506667|NCT00688753|65591248|FG000|Overall Study|Missing|1|||
23506668|NCT00688753|65591248|FG000|Overall Study|Death|9|||
23506669|NCT00688753|65591248|FG000|Overall Study|Withdrawal by Subject|3|||
23506670|NCT00688753|65591248|FG000|Overall Study|Adverse Event|20|||
23506671|NCT00688753|65591248|FG000|Overall Study|Protocol Violation|1|||
23506672|NCT00688753|65591248|FG000|Overall Study|Lost to Follow-up|3|||
23506673|NCT01830972|65591249|FG000|Part II|Withdrawal by Subject|2|||
23506674|NCT01830972|65591250|FG001|Part II|Withdrawal by Subject|2|||
23506675|NCT01830972|65591249|FG000|Part III|Withdrawal by Subject|1|||
23506676|NCT01830972|65591250|FG001|Part III|Withdrawal by Subject|0|||
23506677|NCT01830972|65591249|FG000|Part III|Noncompliance|1|||
23506678|NCT01830972|65591250|FG001|Part III|Noncompliance|0|||
23506679|NCT01830972|65591249|FG000|Part IV|Withdrawal by Subject|2|||
23506680|NCT01830972|65591250|FG001|Part IV|Withdrawal by Subject|1|||
23506681|NCT01830972|65591249|FG000|Part IV|Non-Compliance|1|||
23506682|NCT01830972|65591250|FG001|Part IV|Non-Compliance|0|||
23506683|NCT00297830|65591251|FG000|6 Month Visit|Death|1|||
23506684|NCT00297830|65591252|FG001|6 Month Visit|Death|0|||
23506685|NCT00297830|65591253|FG002|6 Month Visit|Death|2|||
23506686|NCT00297830|65591251|FG000|6 Month Visit|Withdrawal by Subject|2|||
23506687|NCT00297830|65591252|FG001|6 Month Visit|Withdrawal by Subject|1|||
23506688|NCT00297830|65591253|FG002|6 Month Visit|Withdrawal by Subject|1|||
23506689|NCT00297830|65591251|FG000|6 Month Visit|Adverse Event|0|||
23506690|NCT00297830|65591252|FG001|6 Month Visit|Adverse Event|1|||
23506691|NCT00297830|65591253|FG002|6 Month Visit|Adverse Event|0|||
23506692|NCT00297830|65591251|FG000|12 Month Visit|Lost to Follow-up|1|||
23506693|NCT00297830|65591252|FG001|12 Month Visit|Lost to Follow-up|0|||
23506694|NCT00297830|65591253|FG002|12 Month Visit|Lost to Follow-up|0|||
23506695|NCT00297830|65591251|FG000|12 Month Visit|Adverse Event|0|||
23506696|NCT00297830|65591252|FG001|12 Month Visit|Adverse Event|3|||
23506697|NCT00297830|65591253|FG002|12 Month Visit|Adverse Event|0|||
23506698|NCT00297830|65591251|FG000|12 Month Visit|Withdrawal by Subject|0|||
23506699|NCT00297830|65591252|FG001|12 Month Visit|Withdrawal by Subject|3|||
23506700|NCT00297830|65591253|FG002|12 Month Visit|Withdrawal by Subject|0|||
23506701|NCT01442675|65591254|FG000|Overall Study|Protocol Violation|6|||
23506702|NCT01442675|65591254|FG000|Overall Study|Lost to Follow-up|2|||
23506703|NCT01442675|65591254|FG000|Overall Study|Withdrawal by Subject|4|||
23506704|NCT02220205|65591259|FG000|Overall Study|Withdrawal by Subject|1|||
23506705|NCT02220205|65591260|FG001|Overall Study|Withdrawal by Subject|0|||
23506706|NCT03217175|65591265|FG000|Overall Study|Physician Decision|4|||
23506707|NCT03217175|65591266|FG001|Overall Study|Physician Decision|1|||
23506708|NCT01537393|65591267|FG000|Overall Study|Exclude prior to study|32|||
23506709|NCT01537393|65591268|FG001|Overall Study|Exclude prior to study|44|||
23506710|NCT01537393|65591267|FG000|Overall Study|Death|20|||
23506711|NCT01537393|65591268|FG001|Overall Study|Death|32|||
23506712|NCT01537393|65591267|FG000|Overall Study|Withdrawal by Subject|18|||
23506713|NCT01537393|65591268|FG001|Overall Study|Withdrawal by Subject|17|||
23506714|NCT01537393|65591267|FG000|Overall Study|Lost to Follow-up|53|||
23506715|NCT01537393|65591268|FG001|Overall Study|Lost to Follow-up|48|||
23506716|NCT01537393|65591267|FG000|Overall Study|Failure - Regrafted|28|||
23506717|NCT01537393|65591268|FG001|Overall Study|Failure - Regrafted|43|||
23506718|NCT01537393|65591267|FG000|Overall Study|Failure - Not regrafted|2|||
23506719|NCT01537393|65591268|FG001|Overall Study|Failure - Not regrafted|6|||
23506720|NCT01537393|65591267|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
23506721|NCT01537393|65591268|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
23506722|NCT02837783|65591269|FG000|Overall Study|Adverse Event|1|||
23506723|NCT02837783|65591270|FG001|Overall Study|Adverse Event|0|||
23506724|NCT02837783|65591269|FG000|Overall Study|Other, Not Specified|1|||
23506725|NCT02837783|65591270|FG001|Overall Study|Other, Not Specified|2|||
23506726|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23506727|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23506728|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23506729|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
23506730|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23506731|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23506732|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
23506733|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
23506734|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Other|1|||
23506735|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Other|4|||
23506736|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Other|3|||
23506737|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Other|6|||
23506738|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
23506739|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
23506740|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
23506741|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
23506742|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
23506743|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
23506744|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
23506745|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
23506746|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23506747|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23506748|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23506749|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
23506750|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506751|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506752|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506753|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
23506754|NCT01384760|65591275|FG000|Overall Study|Lost to Follow-up|0|||
23506755|NCT01384760|65591276|FG001|Overall Study|Lost to Follow-up|6|||
23506756|NCT01384760|65591275|FG000|Overall Study|Protocol Violation|16|||
23506757|NCT01384760|65591276|FG001|Overall Study|Protocol Violation|0|||
23506758|NCT02980601|65591277|FG000|Overall Study|Lost to Follow-up|2|||
23506759|NCT02980601|65591278|FG001|Overall Study|Lost to Follow-up|2|||
23506760|NCT02980601|65591277|FG000|Overall Study|Death|0|||
23506761|NCT02980601|65591278|FG001|Overall Study|Death|1|||
23506762|NCT02980601|65591277|FG000|Overall Study|Graft loss|1|||
23506763|NCT02980601|65591278|FG001|Overall Study|Graft loss|0|||
23506764|NCT02980601|65591277|FG000|Overall Study|Failed to sign consent|2|||
23506765|NCT02980601|65591278|FG001|Overall Study|Failed to sign consent|0|||
23506766|NCT00491075|65591307|FG000|Overall Study|Withdrawal by Subject|1|||
23506767|NCT00491075|65591307|FG000|Overall Study|Physician Decision|1|||
23506768|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506769|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506770|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506771|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506772|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
23506773|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
23506774|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506775|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506776|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506777|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506778|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Other|1|||
23506779|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Other|1|||
23506780|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Other|0|||
23506781|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Other|0|||
23506782|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Other|0|||
23506783|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506784|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506785|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506786|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
23506787|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
23506788|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506789|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506790|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506791|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
23506792|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506793|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506794|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506795|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506796|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
23506797|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506798|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
23506799|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506800|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506801|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
23506802|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506803|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Other|0|||
23506804|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Other|1|||
23506805|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Other|1|||
23506806|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Other|0|||
23506807|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Other|0|||
23506808|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
23506809|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
23607375|NCT00195819|65950687|FG001|Double-Blind|Withdrawal by Subject|0|||
23506810|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
23506811|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
23506812|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
23506813|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506814|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506815|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506816|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
23506817|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506818|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506819|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506820|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506821|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
23506822|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506823|NCT04404361|65591315|FG000|Overall Study|Death|12|||
23506824|NCT04404361|65591316|FG001|Overall Study|Death|12|||
23506825|NCT04404361|65591315|FG000|Overall Study|Withdrawal by Subject|13|||
23506826|NCT04404361|65591316|FG001|Overall Study|Withdrawal by Subject|5|||
23506827|NCT04404361|65591315|FG000|Overall Study|Lost to Follow-up|6|||
23506828|NCT04404361|65591316|FG001|Overall Study|Lost to Follow-up|3|||
23506829|NCT04404361|65591315|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
23506830|NCT04404361|65591316|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
23506831|NCT01664533|65591317|FG000|Overall Study|Death|42|||
23506832|NCT01664533|65591317|FG000|Overall Study|Lost to Follow-up|3|||
23506833|NCT01664533|65591317|FG000|Overall Study|Study termination|9|||
23506834|NCT01664533|65591317|FG000|Overall Study|Protocol Violation|3|||
23506835|NCT01473836|65591318|FG000|Overall Study|Adverse Event|4|||
23506836|NCT01473836|65591318|FG000|Overall Study|Lack of Efficacy|1|||
23506837|NCT01473836|65591318|FG000|Overall Study|Does not meet entrance criteria|1|||
23506838|NCT01530997|65591323|FG000|Overall Study|Physician Decision|1|||
23506839|NCT01530997|65591323|FG000|Overall Study|Withdrawal by Subject|1|||
23506840|NCT03667924|65591329|FG000|Baseline Completed|Lost to Follow-up|0|||
23506841|NCT03667924|65591330|FG001|Baseline Completed|Lost to Follow-up|2|||
23506842|NCT03667924|65591331|FG002|Baseline Completed|Lost to Follow-up|0|||
23506843|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
23506844|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
23506845|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
23506846|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
23506847|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
23506848|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
23506849|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
23506850|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
23506851|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
23506852|NCT03667924|65591329|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
23506853|NCT03667924|65591330|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
23506854|NCT03667924|65591331|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
23506855|NCT03667924|65591329|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
23506856|NCT03667924|65591330|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
23506857|NCT03667924|65591331|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
23506858|NCT03667924|65591329|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
23506859|NCT03667924|65591330|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
23506860|NCT03667924|65591331|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
23506861|NCT00563381|65591332|FG000|Overall Study|Adverse Event|264|||
23506862|NCT00563381|65591333|FG001|Overall Study|Adverse Event|292|||
23506863|NCT00563381|65591332|FG000|Overall Study|Protocol Violation|66|||
23506864|NCT00563381|65591333|FG001|Overall Study|Protocol Violation|74|||
23506865|NCT00563381|65591332|FG000|Overall Study|Lost to Follow-up|7|||
23506866|NCT00563381|65591333|FG001|Overall Study|Lost to Follow-up|15|||
23506867|NCT00563381|65591332|FG000|Overall Study|Withdrawal by Subject|192|||
23506868|NCT00563381|65591333|FG001|Overall Study|Withdrawal by Subject|209|||
23506869|NCT00563381|65591332|FG000|Overall Study|Lack of Efficacy|32|||
23506870|NCT00563381|65591333|FG001|Overall Study|Lack of Efficacy|24|||
23506871|NCT00563381|65591332|FG000|Overall Study|Individual different reasons|24|||
23506872|NCT00563381|65591333|FG001|Overall Study|Individual different reasons|34|||
23506873|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
23506874|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
23506875|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
23506876|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
23506877|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
23506878|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
23506879|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
23506880|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
23506881|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Patient Request|1|||
23506882|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Patient Request|0|||
23506883|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
23506884|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
23506885|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Other|1|||
23506886|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Other|0|||
23506887|NCT04649060|65591334|FG000|Crossover (Arm B)|Adverse Event|0|||
23506888|NCT04649060|65591335|FG001|Crossover (Arm B)|Adverse Event|1|||
23506889|NCT04649060|65591334|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
23506890|NCT04649060|65591335|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
23506891|NCT01663532|65591336|FG000|Overall Study|Lost to Follow-up|9|||
23506892|NCT01663532|65591337|FG001|Overall Study|Lost to Follow-up|10|||
23506893|NCT01663532|65591336|FG000|Overall Study|Adverse Event|7|||
23506894|NCT01663532|65591337|FG001|Overall Study|Adverse Event|13|||
23506895|NCT01663532|65591336|FG000|Overall Study|Met Withdrawal Criteria|7|||
23506896|NCT01663532|65591337|FG001|Overall Study|Met Withdrawal Criteria|6|||
23506897|NCT01663532|65591336|FG000|Overall Study|Physician Decision|1|||
23506898|NCT01663532|65591337|FG001|Overall Study|Physician Decision|1|||
23506899|NCT01663532|65591336|FG000|Overall Study|Withdrawal by Subject|35|||
23506900|NCT01663532|65591337|FG001|Overall Study|Withdrawal by Subject|17|||
23506901|NCT01663532|65591336|FG000|Overall Study|Lack of Efficacy|15|||
23506902|NCT01663532|65591337|FG001|Overall Study|Lack of Efficacy|60|||
23506903|NCT01854710|65594572|FG000|Overall Study|Withdrawal by Subject|2|||
23506904|NCT01854710|65594573|FG001|Overall Study|Withdrawal by Subject|1|||
23506905|NCT01854710|65594574|FG002|Overall Study|Withdrawal by Subject|0|||
23506906|NCT01854710|65594575|FG003|Overall Study|Withdrawal by Subject|0|||
23506907|NCT01854710|65594576|FG004|Overall Study|Withdrawal by Subject|0|||
23506908|NCT01854710|65594577|FG005|Overall Study|Withdrawal by Subject|0|||
23506909|NCT01854710|65594572|FG000|Overall Study|CRI procedural error|2|||
23506910|NCT01854710|65594573|FG001|Overall Study|CRI procedural error|2|||
23506911|NCT01854710|65594574|FG002|Overall Study|CRI procedural error|2|||
23506912|NCT01854710|65594575|FG003|Overall Study|CRI procedural error|2|||
23506913|NCT01854710|65594576|FG004|Overall Study|CRI procedural error|2|||
23506914|NCT01854710|65594577|FG005|Overall Study|CRI procedural error|2|||
23506915|NCT01713686|65594578|FG000|Overall Study|Lost to Follow-up|9|||
23506916|NCT01713686|65594578|FG000|Overall Study|Withdrawal by Subject|6|||
23506917|NCT00840450|65594579|FG000|Overall Study|Adverse Event|1|||
23506918|NCT00840450|65594579|FG000|Overall Study|Lack of Efficacy|2|||
23506919|NCT04203238|65594580|FG000|Overall Study|Withdrawal by Subject|1|||
23506920|NCT04203238|65594581|FG001|Overall Study|Withdrawal by Subject|1|||
23506921|NCT04203238|65594580|FG000|Overall Study|Covid-19|3|||
23506922|NCT04203238|65594581|FG001|Overall Study|Covid-19|0|||
23506923|NCT03132220|65594582|FG000|Overall Study|Lost to Follow-up|17|||
23506924|NCT03132220|65594583|FG001|Overall Study|Lost to Follow-up|8|||
23506925|NCT03132220|65594582|FG000|Overall Study|Withdrawal by Subject|1|||
23506926|NCT03132220|65594583|FG001|Overall Study|Withdrawal by Subject|4|||
23506927|NCT04669600|65594584|FG000|Overall Study|Withdrawal by Subject|1|||
23506928|NCT04669600|65594584|FG000|Overall Study|Other|6|||
23506929|NCT02732119|65594585|FG000|Phase I|Adverse Event|1|||
23506930|NCT02732119|65594586|FG001|Phase I|Adverse Event|3|||
23506931|NCT02732119|65594587|FG002|Phase I|Adverse Event|1|||
23506932|NCT02732119|65594588|FG003|Phase I|Adverse Event|0|||
23506933|NCT02732119|65594589|FG004|Phase I|Adverse Event|0|||
23506934|NCT02732119|65594585|FG000|Phase I|Progressive disease|7|||
23506935|NCT02732119|65594586|FG001|Phase I|Progressive disease|3|||
23506936|NCT02732119|65594587|FG002|Phase I|Progressive disease|2|||
23506937|NCT02732119|65594588|FG003|Phase I|Progressive disease|0|||
23506938|NCT02732119|65594589|FG004|Phase I|Progressive disease|0|||
23408558|NCT03072043|65239919|FG000|Overall Study|Adverse Event|0|||
23408559|NCT03072043|65239920|FG001|Overall Study|Adverse Event|0|||
23408560|NCT03072043|65239921|FG002|Overall Study|Adverse Event|2|||
23408561|NCT03072043|65239919|FG000|Overall Study|Withdrawal by Subject|0|||
23408562|NCT03072043|65239920|FG001|Overall Study|Withdrawal by Subject|0|||
23506939|NCT02732119|65594585|FG000|Phase I|Protocol deviation|0|||
23506940|NCT02732119|65594586|FG001|Phase I|Protocol deviation|1|||
23506941|NCT02732119|65594587|FG002|Phase I|Protocol deviation|0|||
23506942|NCT02732119|65594588|FG003|Phase I|Protocol deviation|0|||
23506943|NCT02732119|65594589|FG004|Phase I|Protocol deviation|0|||
23506944|NCT02732119|65594585|FG000|Phase I|Physician Decision|0|||
23408563|NCT03072043|65239921|FG002|Overall Study|Withdrawal by Subject|4|||
23506945|NCT02732119|65594586|FG001|Phase I|Physician Decision|3|||
23506946|NCT02732119|65594587|FG002|Phase I|Physician Decision|4|||
23506947|NCT02732119|65594588|FG003|Phase I|Physician Decision|0|||
23506948|NCT02732119|65594589|FG004|Phase I|Physician Decision|0|||
23506949|NCT02732119|65594585|FG000|Phase II|Adverse Event|0|||
23506950|NCT02732119|65594586|FG001|Phase II|Adverse Event|0|||
23506951|NCT02732119|65594587|FG002|Phase II|Adverse Event|0|||
23506952|NCT02732119|65594588|FG003|Phase II|Adverse Event|3|||
23506953|NCT02732119|65594589|FG004|Phase II|Adverse Event|3|||
23506954|NCT02732119|65594585|FG000|Phase II|Death|0|||
23506955|NCT02732119|65594586|FG001|Phase II|Death|0|||
23506956|NCT02732119|65594587|FG002|Phase II|Death|0|||
23506957|NCT02732119|65594588|FG003|Phase II|Death|1|||
23506958|NCT02732119|65594589|FG004|Phase II|Death|0|||
23506959|NCT02732119|65594585|FG000|Phase II|Progressive dissease|0|||
23506960|NCT02732119|65594586|FG001|Phase II|Progressive dissease|0|||
23506961|NCT02732119|65594587|FG002|Phase II|Progressive dissease|0|||
23506962|NCT02732119|65594588|FG003|Phase II|Progressive dissease|30|||
23506963|NCT02732119|65594589|FG004|Phase II|Progressive dissease|23|||
23506964|NCT02732119|65594585|FG000|Phase II|Study terminated by sponsor|0|||
23506965|NCT02732119|65594586|FG001|Phase II|Study terminated by sponsor|0|||
23506966|NCT02732119|65594587|FG002|Phase II|Study terminated by sponsor|0|||
23506967|NCT02732119|65594588|FG003|Phase II|Study terminated by sponsor|2|||
23506968|NCT02732119|65594589|FG004|Phase II|Study terminated by sponsor|2|||
23506969|NCT02732119|65594585|FG000|Phase II|Other|0|||
23506970|NCT02732119|65594586|FG001|Phase II|Other|0|||
23506971|NCT02732119|65594587|FG002|Phase II|Other|0|||
23506972|NCT02732119|65594588|FG003|Phase II|Other|2|||
23506973|NCT02732119|65594589|FG004|Phase II|Other|0|||
23506974|NCT02732119|65594585|FG000|Phase II|Physician Decision|0|||
23506975|NCT02732119|65594586|FG001|Phase II|Physician Decision|0|||
23506976|NCT02732119|65594587|FG002|Phase II|Physician Decision|0|||
23506977|NCT02732119|65594588|FG003|Phase II|Physician Decision|8|||
23506978|NCT02732119|65594589|FG004|Phase II|Physician Decision|5|||
23506979|NCT03519932|65594590|FG000|First Intervention|Adverse Event|1|||
23506980|NCT03519932|65594591|FG001|First Intervention|Adverse Event|3|||
23506981|NCT02269241|65594593|FG000|Overall Study|Lost to Follow-up|269|||
23506982|NCT02269241|65594593|FG000|Overall Study|Withdrawal by Subject|155|||
23506983|NCT02269241|65594593|FG000|Overall Study|Protocol Violation|1|||
23506984|NCT02269241|65594593|FG000|Overall Study|Physician Decision|7|||
23506985|NCT02269241|65594593|FG000|Overall Study|Pregnancy|15|||
23506986|NCT02269241|65594593|FG000|Overall Study|Wish for pregnancy|5|||
23506987|NCT02269241|65594593|FG000|Overall Study|Development of an exclusion criteria|16|||
23506988|NCT02269241|65594593|FG000|Overall Study|Adverse Event|113|||
23506989|NCT02269241|65594593|FG000|Overall Study|At the specific request of the sponsor|20|||
23506990|NCT02269241|65594593|FG000|Overall Study|Several reasons not classified|53|||
23506991|NCT02269241|65594593|FG000|Overall Study|Screening failures|546|||
23506992|NCT01340898|65594594|FG000|Primary Phase|Serious Adverse Events|0|||
23506993|NCT01340898|65594595|FG001|Primary Phase|Serious Adverse Events|0|||
23506994|NCT01340898|65594596|FG002|Primary Phase|Serious Adverse Events|1|||
23506995|NCT01340898|65594594|FG000|Primary Phase|Withdrawal by Subject|8|||
23506996|NCT01340898|65594595|FG001|Primary Phase|Withdrawal by Subject|7|||
23506997|NCT01340898|65594596|FG002|Primary Phase|Withdrawal by Subject|5|||
23506998|NCT01340898|65594594|FG000|Primary Phase|Migrated/moved from study area|4|||
23506999|NCT01340898|65594595|FG001|Primary Phase|Migrated/moved from study area|1|||
23507000|NCT01340898|65594596|FG002|Primary Phase|Migrated/moved from study area|0|||
23507001|NCT01340898|65594594|FG000|Primary Phase|Lost to Follow-up|4|||
23507002|NCT01340898|65594595|FG001|Primary Phase|Lost to Follow-up|1|||
23507003|NCT01340898|65594596|FG002|Primary Phase|Lost to Follow-up|0|||
23507004|NCT01340898|65594594|FG000|Booster Phase|Withdrawal by Subject|3|||
23507005|NCT01340898|65594595|FG001|Booster Phase|Withdrawal by Subject|0|||
23507006|NCT01340898|65594596|FG002|Booster Phase|Withdrawal by Subject|4|||
23507007|NCT01340898|65594594|FG000|Booster Phase|Migrated/moved from study area|3|||
23507008|NCT01340898|65594595|FG001|Booster Phase|Migrated/moved from study area|0|||
23507009|NCT01340898|65594596|FG002|Booster Phase|Migrated/moved from study area|0|||
23507010|NCT01340898|65594594|FG000|Booster Phase|Lost to Follow-up|4|||
23507011|NCT01340898|65594595|FG001|Booster Phase|Lost to Follow-up|2|||
23507012|NCT01340898|65594596|FG002|Booster Phase|Lost to Follow-up|3|||
23507013|NCT01315678|65594597|FG000|Overall Study|Withdrawal by Subject|7|||
23507014|NCT01315678|65594598|FG001|Overall Study|Withdrawal by Subject|3|||
23507015|NCT01315678|65594597|FG000|Overall Study|Adverse Event|3|||
23507016|NCT01315678|65594598|FG001|Overall Study|Adverse Event|1|||
23507017|NCT01315678|65594597|FG000|Overall Study|Lost to Follow-up|1|||
23507018|NCT01315678|65594598|FG001|Overall Study|Lost to Follow-up|0|||
23507019|NCT01315678|65594597|FG000|Overall Study|similar reason to those listed above|3|||
23507020|NCT01315678|65594598|FG001|Overall Study|similar reason to those listed above|2|||
23507021|NCT01846416|65594603|FG000|Treatment Phase|Death|2|||
23507022|NCT01846416|65594604|FG001|Treatment Phase|Death|9|||
23507023|NCT01846416|65594605|FG002|Treatment Phase|Death|1|||
23507024|NCT01846416|65594603|FG000|Treatment Phase|Withdrawal by Subject|2|||
23507025|NCT01846416|65594604|FG001|Treatment Phase|Withdrawal by Subject|4|||
23507026|NCT01846416|65594605|FG002|Treatment Phase|Withdrawal by Subject|2|||
23507027|NCT01846416|65594603|FG000|Treatment Phase|Other|1|||
23607376|NCT00195819|65950686|FG000|Double-Blind|Moved|1|||
23507028|NCT01846416|65594604|FG001|Treatment Phase|Other|5|||
23507029|NCT01846416|65594605|FG002|Treatment Phase|Other|1|||
23507030|NCT01846416|65594603|FG000|Treatment Phase|Physician Decision|1|||
23507031|NCT01846416|65594604|FG001|Treatment Phase|Physician Decision|2|||
23507032|NCT01846416|65594605|FG002|Treatment Phase|Physician Decision|0|||
23507033|NCT01846416|65594603|FG000|Treatment Phase|Adverse Event|3|||
23507034|NCT01846416|65594604|FG001|Treatment Phase|Adverse Event|4|||
23507035|NCT01846416|65594605|FG002|Treatment Phase|Adverse Event|0|||
23507036|NCT01846416|65594603|FG000|Treatment Phase|Non-compliance|0|||
23507037|NCT01846416|65594604|FG001|Treatment Phase|Non-compliance|2|||
23507038|NCT01846416|65594605|FG002|Treatment Phase|Non-compliance|0|||
23507039|NCT01846416|65594603|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
23507040|NCT01846416|65594604|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
23507041|NCT01846416|65594605|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
23507042|NCT01846416|65594603|FG000|Treatment Phase|Progressive Disease|21|||
23507043|NCT01846416|65594604|FG001|Treatment Phase|Progressive Disease|63|||
23507044|NCT01846416|65594605|FG002|Treatment Phase|Progressive Disease|9|||
23507045|NCT01846416|65594603|FG000|Survival Follow-up|Death|21|||
23507046|NCT01846416|65594604|FG001|Survival Follow-up|Death|62|||
23507047|NCT01846416|65594605|FG002|Survival Follow-up|Death|9|||
23507048|NCT01846416|65594603|FG000|Survival Follow-up|Lost to Follow-up|0|||
23507049|NCT01846416|65594604|FG001|Survival Follow-up|Lost to Follow-up|2|||
23507050|NCT01846416|65594605|FG002|Survival Follow-up|Lost to Follow-up|2|||
23507051|NCT01846416|65594603|FG000|Survival Follow-up|Withdrawal by Subject|2|||
23507052|NCT01846416|65594604|FG001|Survival Follow-up|Withdrawal by Subject|7|||
23507053|NCT01846416|65594605|FG002|Survival Follow-up|Withdrawal by Subject|0|||
23507054|NCT01846416|65594603|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
23507055|NCT01846416|65594604|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
23507056|NCT01846416|65594605|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
23507057|NCT01846416|65594603|FG000|Survival Follow-up|Other|3|||
23507058|NCT01846416|65594604|FG001|Survival Follow-up|Other|1|||
23507059|NCT01846416|65594605|FG002|Survival Follow-up|Other|1|||
23507060|NCT00646776|65594608|FG000|Overall Study|Adverse Event|1|||
23507061|NCT00646776|65594609|FG001|Overall Study|Adverse Event|9|||
23507062|NCT00646776|65594608|FG000|Overall Study|Investigator discretion|0|||
23507063|NCT00646776|65594609|FG001|Overall Study|Investigator discretion|4|||
23507064|NCT03470441|65594610|FG000|Overall Study|Death|0|||
23507065|NCT03470441|65594611|FG001|Overall Study|Death|1|||
23507066|NCT03470441|65594612|FG002|Overall Study|Death|1|||
23507067|NCT03470441|65594613|FG003|Overall Study|Death|0|||
23507068|NCT03470441|65594610|FG000|Overall Study|Adverse Event|0|||
23507069|NCT03470441|65594611|FG001|Overall Study|Adverse Event|0|||
23507070|NCT03470441|65594612|FG002|Overall Study|Adverse Event|0|||
23507071|NCT03470441|65594613|FG003|Overall Study|Adverse Event|1|||
23507072|NCT03470441|65594610|FG000|Overall Study|Withdrawal by Subject|1|||
23507073|NCT03470441|65594611|FG001|Overall Study|Withdrawal by Subject|4|||
23507074|NCT03470441|65594612|FG002|Overall Study|Withdrawal by Subject|1|||
23507075|NCT03470441|65594613|FG003|Overall Study|Withdrawal by Subject|3|||
23507076|NCT00371137|65594614|FG000|Overall Study|Adverse Event|20|||
23507077|NCT00371137|65594615|FG001|Overall Study|Adverse Event|35|||
23507078|NCT00371137|65594616|FG002|Overall Study|Adverse Event|42|||
23507079|NCT00371137|65594614|FG000|Overall Study|Withdrawal by Subject|11|||
23507080|NCT00371137|65594615|FG001|Overall Study|Withdrawal by Subject|10|||
23507081|NCT00371137|65594616|FG002|Overall Study|Withdrawal by Subject|15|||
23507082|NCT00371137|65594614|FG000|Overall Study|Lost to Follow-up|6|||
23507083|NCT00371137|65594615|FG001|Overall Study|Lost to Follow-up|3|||
23507084|NCT00371137|65594616|FG002|Overall Study|Lost to Follow-up|5|||
23507085|NCT00371137|65594614|FG000|Overall Study|Lack of Efficacy|30|||
23507086|NCT00371137|65594615|FG001|Overall Study|Lack of Efficacy|12|||
23507087|NCT00371137|65594616|FG002|Overall Study|Lack of Efficacy|13|||
23507088|NCT00371137|65594614|FG000|Overall Study|Sponsor Decision|2|||
23507089|NCT00371137|65594615|FG001|Overall Study|Sponsor Decision|1|||
23507090|NCT00371137|65594616|FG002|Overall Study|Sponsor Decision|2|||
23507091|NCT00371137|65594614|FG000|Overall Study|Physician Decision|1|||
23507092|NCT00371137|65594615|FG001|Overall Study|Physician Decision|1|||
23507093|NCT00371137|65594616|FG002|Overall Study|Physician Decision|1|||
23507094|NCT00371137|65594614|FG000|Overall Study|Protocol Violation|2|||
23507095|NCT00371137|65594615|FG001|Overall Study|Protocol Violation|1|||
23507096|NCT00371137|65594616|FG002|Overall Study|Protocol Violation|1|||
23507097|NCT03965962|65594617|FG000|Overall Study|Adverse Event|1|||
23507098|NCT03965962|65594618|FG001|Overall Study|Adverse Event|0|||
23507099|NCT03965962|65594619|FG002|Overall Study|Adverse Event|0|||
23507100|NCT03965962|65594620|FG003|Overall Study|Adverse Event|0|||
23507101|NCT03965962|65594617|FG000|Overall Study|Protocol Violation|21|||
23507102|NCT03965962|65594618|FG001|Overall Study|Protocol Violation|4|||
23507103|NCT03965962|65594619|FG002|Overall Study|Protocol Violation|10|||
23507104|NCT03965962|65594620|FG003|Overall Study|Protocol Violation|5|||
23507105|NCT03965962|65594617|FG000|Overall Study|Lost to Follow-up|0|||
23507106|NCT03965962|65594618|FG001|Overall Study|Lost to Follow-up|1|||
23507107|NCT03965962|65594619|FG002|Overall Study|Lost to Follow-up|0|||
23507108|NCT03965962|65594620|FG003|Overall Study|Lost to Follow-up|0|||
23507109|NCT03965962|65594617|FG000|Overall Study|Withdrawal by Subject|3|||
23507110|NCT03965962|65594618|FG001|Overall Study|Withdrawal by Subject|0|||
23507111|NCT03965962|65594619|FG002|Overall Study|Withdrawal by Subject|0|||
23507112|NCT03965962|65594620|FG003|Overall Study|Withdrawal by Subject|1|||
23507113|NCT00733408|65594621|FG000|Overall Study|Adverse Event|4|||
23507114|NCT01516437|65594622|FG000|Overall Study|Reason not specified|0|||
23507115|NCT01516437|65594623|FG001|Overall Study|Reason not specified|0|||
23507116|NCT01516437|65594624|FG002|Overall Study|Reason not specified|1|||
23507117|NCT01516437|65594625|FG003|Overall Study|Reason not specified|1|||
23507118|NCT02848651|65594626|FG000|Overall Study|Death|85|||
23507119|NCT02848651|65594626|FG000|Overall Study|Lost to Follow-up|1|||
23507120|NCT02848651|65594626|FG000|Overall Study|Non-Compliance|1|||
23507121|NCT02848651|65594626|FG000|Overall Study|Symptomatic Deterioration|1|||
23507122|NCT02848651|65594626|FG000|Overall Study|Physician Decision|4|||
23507123|NCT02848651|65594626|FG000|Overall Study|Withdrawal by Subject|14|||
23507124|NCT00793598|65594627|FG000|Overall Study|Patient Request|0|||
23507125|NCT00793598|65594628|FG001|Overall Study|Patient Request|1|||
23507126|NCT00793598|65594629|FG002|Overall Study|Patient Request|0|||
23507127|NCT00793598|65594630|FG003|Overall Study|Patient Request|0|||
23507128|NCT00793598|65594631|FG004|Overall Study|Patient Request|0|||
23507129|NCT00793598|65594632|FG005|Overall Study|Patient Request|0|||
23507130|NCT00793598|65594633|FG006|Overall Study|Patient Request|0|||
23507131|NCT00793598|65594634|FG007|Overall Study|Patient Request|0|||
23507132|NCT00793598|65594627|FG000|Overall Study|Protocol Violation|0|||
23507133|NCT00793598|65594628|FG001|Overall Study|Protocol Violation|0|||
23507134|NCT00793598|65594629|FG002|Overall Study|Protocol Violation|0|||
23507135|NCT00793598|65594630|FG003|Overall Study|Protocol Violation|0|||
23507136|NCT00793598|65594631|FG004|Overall Study|Protocol Violation|0|||
23507137|NCT00793598|65594632|FG005|Overall Study|Protocol Violation|0|||
23507138|NCT00793598|65594633|FG006|Overall Study|Protocol Violation|0|||
23507139|NCT00793598|65594634|FG007|Overall Study|Protocol Violation|1|||
23507140|NCT00793598|65594627|FG000|Overall Study|Subject not dosed|0|||
23507141|NCT00793598|65594628|FG001|Overall Study|Subject not dosed|0|||
23507142|NCT00793598|65594629|FG002|Overall Study|Subject not dosed|0|||
23507143|NCT00793598|65594630|FG003|Overall Study|Subject not dosed|0|||
23507144|NCT00793598|65594631|FG004|Overall Study|Subject not dosed|0|||
23507145|NCT00793598|65594632|FG005|Overall Study|Subject not dosed|1|||
23507146|NCT00793598|65594633|FG006|Overall Study|Subject not dosed|0|||
23507147|NCT00793598|65594634|FG007|Overall Study|Subject not dosed|0|||
23507148|NCT01652703|65594636|FG000|Overall Study|Withdrawal by Subject|0|||
23507149|NCT01652703|65594637|FG001|Overall Study|Withdrawal by Subject|1|||
23507150|NCT01652703|65594638|FG002|Overall Study|Withdrawal by Subject|3|||
23507151|NCT01652703|65594639|FG003|Overall Study|Withdrawal by Subject|1|||
23507152|NCT01652703|65594640|FG004|Overall Study|Withdrawal by Subject|0|||
23507153|NCT01652703|65594641|FG005|Overall Study|Withdrawal by Subject|1|||
23507154|NCT01652703|65594636|FG000|Overall Study|Other|0|||
23507155|NCT01652703|65594637|FG001|Overall Study|Other|0|||
23507156|NCT01652703|65594638|FG002|Overall Study|Other|0|||
23507157|NCT01652703|65594639|FG003|Overall Study|Other|1|||
23507158|NCT01652703|65594640|FG004|Overall Study|Other|1|||
23507159|NCT01652703|65594641|FG005|Overall Study|Other|1|||
23507160|NCT01438424|65594642|FG000|Overall Study|Continuing treatment|29|||
23507161|NCT01438424|65594642|FG000|Overall Study|Minimal virologic response|95|||
23507162|NCT01438424|65594642|FG000|Overall Study|Not identified|55|||
23507163|NCT01438424|65594642|FG000|Overall Study|Withdrawal by Subject|104|||
23507164|NCT01438424|65594642|FG000|Overall Study|Progression of chronic hepatitis B|22|||
23507165|NCT01438424|65594642|FG000|Overall Study|Death|22|||
23507166|NCT01438424|65594642|FG000|Overall Study|Adverse Event|17|||
23507167|NCT01438424|65594642|FG000|Overall Study|Lost to Follow-up|17|||
23507168|NCT01438424|65594642|FG000|Overall Study|Abnormal laboratory test result|14|||
23507169|NCT01438424|65594642|FG000|Overall Study|Need for drug prohibited by protocol|14|||
23507170|NCT01438424|65594642|FG000|Overall Study|Pregnancy|7|||
23507171|NCT01438424|65594642|FG000|Overall Study|No longer met inclusion criteria|1|||
23507172|NCT01438424|65594642|FG000|Overall Study|Participant noncompliance|20|||
23507173|NCT00599924|65594643|FG000|Overall Study|Lack of Efficacy|3|||
23507174|NCT00599924|65594644|FG001|Overall Study|Lack of Efficacy|5|||
23507175|NCT00599924|65594645|FG002|Overall Study|Lack of Efficacy|1|||
23507176|NCT00599924|65594646|FG003|Overall Study|Lack of Efficacy|2|||
23507177|NCT00599924|65594647|FG004|Overall Study|Lack of Efficacy|3|||
23507178|NCT00599924|65594648|FG005|Overall Study|Lack of Efficacy|2|||
23507179|NCT00599924|65594649|FG006|Overall Study|Lack of Efficacy|0|||
23507180|NCT00599924|65594643|FG000|Overall Study|Adverse Event|0|||
23507181|NCT00599924|65594644|FG001|Overall Study|Adverse Event|0|||
23507182|NCT00599924|65594645|FG002|Overall Study|Adverse Event|0|||
23507183|NCT00599924|65594646|FG003|Overall Study|Adverse Event|2|||
23507184|NCT00599924|65594647|FG004|Overall Study|Adverse Event|0|||
23507185|NCT00599924|65594648|FG005|Overall Study|Adverse Event|0|||
23507186|NCT00599924|65594649|FG006|Overall Study|Adverse Event|2|||
23507187|NCT00599924|65594643|FG000|Overall Study|Death|0|||
23507188|NCT00599924|65594644|FG001|Overall Study|Death|0|||
23507189|NCT00599924|65594645|FG002|Overall Study|Death|0|||
23507190|NCT00599924|65594646|FG003|Overall Study|Death|2|||
23507191|NCT00599924|65594647|FG004|Overall Study|Death|0|||
23507192|NCT00599924|65594648|FG005|Overall Study|Death|2|||
23507193|NCT00599924|65594649|FG006|Overall Study|Death|1|||
23507194|NCT00599924|65594643|FG000|Overall Study|Protocol Violation|0|||
23507195|NCT00599924|65594644|FG001|Overall Study|Protocol Violation|0|||
23507196|NCT00599924|65594645|FG002|Overall Study|Protocol Violation|0|||
23507197|NCT00599924|65594646|FG003|Overall Study|Protocol Violation|1|||
23507198|NCT00599924|65594647|FG004|Overall Study|Protocol Violation|0|||
23507199|NCT00599924|65594648|FG005|Overall Study|Protocol Violation|0|||
23507200|NCT00599924|65594649|FG006|Overall Study|Protocol Violation|0|||
23507201|NCT00599924|65594643|FG000|Overall Study|Withdrawal by Subject|0|||
23507202|NCT00599924|65594644|FG001|Overall Study|Withdrawal by Subject|0|||
23507203|NCT00599924|65594645|FG002|Overall Study|Withdrawal by Subject|1|||
23507204|NCT00599924|65594646|FG003|Overall Study|Withdrawal by Subject|0|||
23507205|NCT00599924|65594647|FG004|Overall Study|Withdrawal by Subject|1|||
23507206|NCT00599924|65594648|FG005|Overall Study|Withdrawal by Subject|0|||
23507207|NCT00599924|65594649|FG006|Overall Study|Withdrawal by Subject|0|||
23507208|NCT00599924|65594643|FG000|Overall Study|Other|0|||
23507209|NCT00599924|65594644|FG001|Overall Study|Other|0|||
23507210|NCT00599924|65594645|FG002|Overall Study|Other|0|||
23507211|NCT00599924|65594646|FG003|Overall Study|Other|1|||
23507212|NCT00599924|65594647|FG004|Overall Study|Other|2|||
23507213|NCT00599924|65594648|FG005|Overall Study|Other|0|||
23507214|NCT00599924|65594649|FG006|Overall Study|Other|2|||
23507215|NCT00001723|65594652|FG000|Overall Study|Lack of Efficacy|6|||
23507216|NCT00001723|65594653|FG001|Overall Study|Lack of Efficacy|7|||
23607377|NCT00195819|65950687|FG001|Double-Blind|Moved|0|||
23507217|NCT00001723|65594652|FG000|Overall Study|Lack of family interest|4|||
23507218|NCT00001723|65594653|FG001|Overall Study|Lack of family interest|5|||
23507219|NCT00001723|65594652|FG000|Overall Study|Lost to Follow-up|2|||
23507220|NCT00001723|65594653|FG001|Overall Study|Lost to Follow-up|2|||
23507221|NCT00001723|65594652|FG000|Overall Study|medication intolerance|1|||
23507222|NCT00001723|65594653|FG001|Overall Study|medication intolerance|2|||
23507223|NCT01411774|65594654|FG000|Overall Study|Withdrawal by Subject|0|||
23507224|NCT01411774|65594655|FG001|Overall Study|Withdrawal by Subject|3|||
23507225|NCT02501473|65594656|FG000|Overall Study|Study Terminated|2|||
23507226|NCT02501473|65594657|FG001|Overall Study|Study Terminated|3|||
23507227|NCT02501473|65594658|FG002|Overall Study|Study Terminated|7|||
23507228|NCT02501473|65594659|FG003|Overall Study|Study Terminated|9|||
23507229|NCT02501473|65594660|FG004|Overall Study|Study Terminated|2|||
23507230|NCT02501473|65594661|FG005|Overall Study|Study Terminated|10|||
23507231|NCT02501473|65594662|FG006|Overall Study|Study Terminated|1|||
23507232|NCT02501473|65594663|FG007|Overall Study|Study Terminated|0|||
23507233|NCT02501473|65594656|FG000|Overall Study|Withdrawal by Subject|0|||
23507234|NCT02501473|65594657|FG001|Overall Study|Withdrawal by Subject|0|||
23507235|NCT02501473|65594658|FG002|Overall Study|Withdrawal by Subject|3|||
23507236|NCT02501473|65594659|FG003|Overall Study|Withdrawal by Subject|3|||
23507237|NCT02501473|65594660|FG004|Overall Study|Withdrawal by Subject|2|||
23507238|NCT02501473|65594661|FG005|Overall Study|Withdrawal by Subject|2|||
23507239|NCT02501473|65594662|FG006|Overall Study|Withdrawal by Subject|0|||
23507240|NCT02501473|65594663|FG007|Overall Study|Withdrawal by Subject|0|||
23507241|NCT02501473|65594656|FG000|Overall Study|Death|0|||
23507242|NCT02501473|65594657|FG001|Overall Study|Death|0|||
23507243|NCT02501473|65594658|FG002|Overall Study|Death|1|||
23507244|NCT02501473|65594659|FG003|Overall Study|Death|1|||
23507245|NCT02501473|65594660|FG004|Overall Study|Death|0|||
23507246|NCT02501473|65594661|FG005|Overall Study|Death|1|||
23507247|NCT02501473|65594662|FG006|Overall Study|Death|0|||
23507248|NCT02501473|65594663|FG007|Overall Study|Death|0|||
23507249|NCT02501473|65594656|FG000|Overall Study|Lost to Follow-up|1|||
23507250|NCT02501473|65594657|FG001|Overall Study|Lost to Follow-up|0|||
23507251|NCT02501473|65594658|FG002|Overall Study|Lost to Follow-up|1|||
23507252|NCT02501473|65594659|FG003|Overall Study|Lost to Follow-up|0|||
23507253|NCT02501473|65594660|FG004|Overall Study|Lost to Follow-up|0|||
23507254|NCT02501473|65594661|FG005|Overall Study|Lost to Follow-up|1|||
23507255|NCT02501473|65594662|FG006|Overall Study|Lost to Follow-up|0|||
23507256|NCT02501473|65594663|FG007|Overall Study|Lost to Follow-up|0|||
23507257|NCT02501473|65594656|FG000|Overall Study|Reason not specified|0|||
23507258|NCT02501473|65594657|FG001|Overall Study|Reason not specified|0|||
23507259|NCT02501473|65594658|FG002|Overall Study|Reason not specified|1|||
23507260|NCT02501473|65594659|FG003|Overall Study|Reason not specified|1|||
23507261|NCT02501473|65594660|FG004|Overall Study|Reason not specified|0|||
23507262|NCT02501473|65594661|FG005|Overall Study|Reason not specified|0|||
23507263|NCT02501473|65594662|FG006|Overall Study|Reason not specified|0|||
23507264|NCT02501473|65594663|FG007|Overall Study|Reason not specified|0|||
23507265|NCT00309387|65594664|FG000|Overall Study|Death|72|||
23607378|NCT00195819|65950686|FG000|Open-label|Adverse Event|0|||
23507266|NCT00309387|65594665|FG001|Overall Study|Death|73|||
23507267|NCT00309387|65594664|FG000|Overall Study|Lost to Follow-up|70|||
23507268|NCT00309387|65594665|FG001|Overall Study|Lost to Follow-up|86|||
23507269|NCT04016285|65594666|FG000|Overall Study|Did not progress to surgery|2|||
23607379|NCT00195819|65950687|FG001|Open-label|Adverse Event|9|||
23507270|NCT04016285|65594667|FG001|Overall Study|Did not progress to surgery|5|||
23507271|NCT04016285|65594666|FG000|Overall Study|Failed to collect outcome data|5|||
23507272|NCT04016285|65594667|FG001|Overall Study|Failed to collect outcome data|3|||
23507273|NCT00844831|65594668|FG000|Overall Study|Withdrawal by Subject|4|||
23507274|NCT00844831|65594668|FG000|Overall Study|Adverse Event|1|||
23507275|NCT00844831|65594668|FG000|Overall Study|Physician Decision|1|||
23507276|NCT02820753|65594669|FG000|2 Month|Withdrawal by Subject|3|||
23507277|NCT02820753|65594670|FG001|2 Month|Withdrawal by Subject|3|||
23507278|NCT02820753|65594669|FG000|2 Month|Lost to Follow-up|24|||
23507279|NCT02820753|65594670|FG001|2 Month|Lost to Follow-up|26|||
23507280|NCT02820753|65594669|FG000|2 Month|Stopped per NIH Hold|51|||
23507281|NCT02820753|65594670|FG001|2 Month|Stopped per NIH Hold|13|||
23507282|NCT02820753|65594669|FG000|6 Month|Withdrawal by Subject|2|||
23507283|NCT02820753|65594670|FG001|6 Month|Withdrawal by Subject|2|||
23507284|NCT02820753|65594669|FG000|6 Month|Lost to Follow-up|20|||
23507285|NCT02820753|65594670|FG001|6 Month|Lost to Follow-up|27|||
23507286|NCT02820753|65594669|FG000|6 Month|Stopped per NIH Hold|81|||
23507287|NCT02820753|65594670|FG001|6 Month|Stopped per NIH Hold|81|||
23507288|NCT02820753|65594669|FG000|6 Month|Death|0|||
23507289|NCT02820753|65594670|FG001|6 Month|Death|1|||
23507290|NCT01524692|65594671|FG000|Overall Study|Withdrawal by Subject|3|||
23507291|NCT02028065|65594672|FG000|Randomization Through Start Treatment|Not treated|1|||
23507292|NCT02028065|65594673|FG001|Randomization Through Start Treatment|Not treated|3|||
23507293|NCT02028065|65594674|FG002|Randomization Through Start Treatment|Not treated|3|||
23507294|NCT02028065|65594672|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
23507295|NCT02028065|65594673|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
23507296|NCT02028065|65594674|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
23507297|NCT02028065|65594672|FG000|Treatment Through Study Completion|Physician Decision|1|||
23507298|NCT02028065|65594673|FG001|Treatment Through Study Completion|Physician Decision|0|||
23507299|NCT02028065|65594674|FG002|Treatment Through Study Completion|Physician Decision|0|||
23507300|NCT02028065|65594672|FG000|Treatment Through Study Completion|Protocol Violation|1|||
23507301|NCT02028065|65594673|FG001|Treatment Through Study Completion|Protocol Violation|4|||
23507302|NCT02028065|65594674|FG002|Treatment Through Study Completion|Protocol Violation|0|||
23507303|NCT02028065|65594672|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
23507304|NCT02028065|65594673|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
23507305|NCT02028065|65594674|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
23507306|NCT02028065|65594672|FG000|Treatment Through Study Completion|Adverse Event|3|||
23507307|NCT02028065|65594673|FG001|Treatment Through Study Completion|Adverse Event|3|||
23507308|NCT02028065|65594674|FG002|Treatment Through Study Completion|Adverse Event|5|||
23507309|NCT00801632|65594676|FG000|Overall Study|Re-transplant|1|||
23507310|NCT04983264|65594677|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
23507311|NCT04983264|65594678|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
23507312|NCT04983264|65594679|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
23507313|NCT04983264|65594677|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
23507314|NCT04983264|65594678|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
23507315|NCT04983264|65594679|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
23507316|NCT02532972|65594680|FG000|Overall Study|Withdrawal by Subject|1|||
23507317|NCT00230607|65594681|FG000|Overall Study|Other|3|||
23507318|NCT04980040|65594682|FG000|Overall Study|Violated the Inclusion Criteria|260|||
23507319|NCT04980040|65594682|FG000|Overall Study|Violated the Administration & Dosage|225|||
23507320|NCT04980040|65594682|FG000|Overall Study|Lost to Safety-Follow-up|4|||
23507321|NCT04980040|65594682|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
23507322|NCT01918085|65594683|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
23507323|NCT01918085|65594684|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
23507324|NCT01828281|65594691|FG000|Overall Study|Withdrawal by Subject|1|||
23507325|NCT01828281|65594692|FG001|Overall Study|Withdrawal by Subject|0|||
23507326|NCT00127660|65594693|FG000|Overall Study|Protocol Violation|3|||
23507327|NCT00127660|65594694|FG001|Overall Study|Protocol Violation|3|||
23507328|NCT00127660|65594695|FG002|Overall Study|Protocol Violation|5|||
23507329|NCT00127660|65594696|FG003|Overall Study|Protocol Violation|0|||
23507330|NCT02380677|65594703|FG000|Overall Study|Adverse Event|0|||
23507331|NCT02380677|65594704|FG001|Overall Study|Adverse Event|0|||
23507332|NCT02380677|65594705|FG002|Overall Study|Adverse Event|0|||
23507333|NCT02380677|65594706|FG003|Overall Study|Adverse Event|1|||
23507334|NCT02380677|65594707|FG004|Overall Study|Adverse Event|1|||
23507335|NCT02380677|65594708|FG005|Overall Study|Adverse Event|4|||
23507336|NCT02380677|65594709|FG006|Overall Study|Adverse Event|2|||
23507337|NCT02380677|65594710|FG007|Overall Study|Adverse Event|2|||
23507338|NCT02380677|65594711|FG008|Overall Study|Adverse Event|2|||
23507339|NCT02380677|65594712|FG009|Overall Study|Adverse Event|1|||
23507340|NCT02380677|65594713|FG010|Overall Study|Adverse Event|2|||
23507341|NCT02380677|65594714|FG011|Overall Study|Adverse Event|1|||
23507342|NCT02380677|65594703|FG000|Overall Study|Physician Decision|1|||
23507343|NCT02380677|65594704|FG001|Overall Study|Physician Decision|0|||
23507344|NCT02380677|65594705|FG002|Overall Study|Physician Decision|1|||
23507345|NCT02380677|65594706|FG003|Overall Study|Physician Decision|1|||
23507346|NCT02380677|65594707|FG004|Overall Study|Physician Decision|0|||
23507347|NCT02380677|65594708|FG005|Overall Study|Physician Decision|0|||
23507348|NCT02380677|65594709|FG006|Overall Study|Physician Decision|0|||
23507349|NCT02380677|65594710|FG007|Overall Study|Physician Decision|0|||
23507350|NCT02380677|65594711|FG008|Overall Study|Physician Decision|0|||
23507351|NCT02380677|65594712|FG009|Overall Study|Physician Decision|0|||
23507352|NCT02380677|65594713|FG010|Overall Study|Physician Decision|0|||
23507353|NCT02380677|65594714|FG011|Overall Study|Physician Decision|0|||
23507354|NCT02380677|65594703|FG000|Overall Study|Lack of Efficacy|0|||
23507355|NCT02380677|65594704|FG001|Overall Study|Lack of Efficacy|1|||
23507356|NCT02380677|65594705|FG002|Overall Study|Lack of Efficacy|2|||
23507357|NCT02380677|65594706|FG003|Overall Study|Lack of Efficacy|0|||
23507358|NCT02380677|65594707|FG004|Overall Study|Lack of Efficacy|4|||
23507359|NCT02380677|65594708|FG005|Overall Study|Lack of Efficacy|1|||
23507360|NCT02380677|65594709|FG006|Overall Study|Lack of Efficacy|1|||
23507361|NCT02380677|65594710|FG007|Overall Study|Lack of Efficacy|2|||
23507362|NCT02380677|65594711|FG008|Overall Study|Lack of Efficacy|2|||
23507363|NCT02380677|65594712|FG009|Overall Study|Lack of Efficacy|0|||
23507364|NCT02380677|65594713|FG010|Overall Study|Lack of Efficacy|2|||
23507365|NCT02380677|65594714|FG011|Overall Study|Lack of Efficacy|1|||
23507366|NCT02380677|65594703|FG000|Overall Study|Withdrawal by Subject|0|||
23507367|NCT02380677|65594704|FG001|Overall Study|Withdrawal by Subject|0|||
23507368|NCT02380677|65594705|FG002|Overall Study|Withdrawal by Subject|0|||
23507369|NCT02380677|65594706|FG003|Overall Study|Withdrawal by Subject|0|||
23507370|NCT02380677|65594707|FG004|Overall Study|Withdrawal by Subject|0|||
23507371|NCT02380677|65594708|FG005|Overall Study|Withdrawal by Subject|0|||
23507372|NCT02380677|65594709|FG006|Overall Study|Withdrawal by Subject|0|||
23507373|NCT02380677|65594710|FG007|Overall Study|Withdrawal by Subject|0|||
23507374|NCT02380677|65594711|FG008|Overall Study|Withdrawal by Subject|0|||
23507375|NCT02380677|65594712|FG009|Overall Study|Withdrawal by Subject|1|||
23507376|NCT02380677|65594713|FG010|Overall Study|Withdrawal by Subject|0|||
23507377|NCT02380677|65594714|FG011|Overall Study|Withdrawal by Subject|3|||
23507378|NCT02380677|65594703|FG000|Overall Study|Other|0|||
23507379|NCT02380677|65594704|FG001|Overall Study|Other|0|||
23507380|NCT02380677|65594705|FG002|Overall Study|Other|0|||
23507381|NCT02380677|65594706|FG003|Overall Study|Other|1|||
23507382|NCT02380677|65594707|FG004|Overall Study|Other|1|||
23507383|NCT02380677|65594708|FG005|Overall Study|Other|1|||
23507384|NCT02380677|65594709|FG006|Overall Study|Other|0|||
23507385|NCT02380677|65594710|FG007|Overall Study|Other|0|||
23507386|NCT02380677|65594711|FG008|Overall Study|Other|0|||
23507387|NCT02380677|65594712|FG009|Overall Study|Other|0|||
23507388|NCT02380677|65594713|FG010|Overall Study|Other|0|||
23507389|NCT02380677|65594714|FG011|Overall Study|Other|0|||
23507390|NCT01877265|65594724|FG000|Treatment Period 1|Sponsor Decision|0|||
23507391|NCT01877265|65594725|FG001|Treatment Period 1|Sponsor Decision|0|||
23507392|NCT01877265|65594726|FG002|Treatment Period 1|Sponsor Decision|1|||
23507393|NCT01877265|65594727|FG003|Treatment Period 1|Sponsor Decision|0|||
23507394|NCT01877265|65594728|FG004|Treatment Period 1|Sponsor Decision|0|||
23507395|NCT01877265|65594729|FG005|Treatment Period 1|Sponsor Decision|0|||
23507396|NCT01877265|65594724|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507397|NCT01877265|65594725|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507398|NCT01877265|65594726|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507399|NCT01877265|65594727|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507400|NCT01877265|65594728|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507401|NCT01877265|65594729|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
23507402|NCT01877265|65594724|FG000|Treatment Period 3|Lost to Follow-up|1|||
23507403|NCT01877265|65594725|FG001|Treatment Period 3|Lost to Follow-up|0|||
23507404|NCT01877265|65594726|FG002|Treatment Period 3|Lost to Follow-up|0|||
23507405|NCT01877265|65594727|FG003|Treatment Period 3|Lost to Follow-up|0|||
23507406|NCT01877265|65594728|FG004|Treatment Period 3|Lost to Follow-up|0|||
23507407|NCT01877265|65594729|FG005|Treatment Period 3|Lost to Follow-up|0|||
23507408|NCT05466682|65594730|FG000|Overall Study|Withdrawal by Subject|0|||
23507409|NCT05466682|65594731|FG001|Overall Study|Withdrawal by Subject|2|||
23507410|NCT05466682|65594730|FG000|Overall Study|Lost to Follow-up|2|||
23507411|NCT05466682|65594731|FG001|Overall Study|Lost to Follow-up|1|||
23507412|NCT02743871|65594734|FG000|Overall Study|Lost to Follow-up|0|||
23507413|NCT02743871|65594735|FG001|Overall Study|Lost to Follow-up|0|||
23507414|NCT02743871|65594736|FG002|Overall Study|Lost to Follow-up|0|||
23507415|NCT02743871|65594737|FG003|Overall Study|Lost to Follow-up|1|||
23507416|NCT02743871|65594738|FG004|Overall Study|Lost to Follow-up|0|||
23507417|NCT02743871|65594739|FG005|Overall Study|Lost to Follow-up|0|||
23507418|NCT02743871|65594740|FG006|Overall Study|Lost to Follow-up|1|||
23507419|NCT02743871|65594741|FG007|Overall Study|Lost to Follow-up|0|||
23507420|NCT02743871|65594742|FG008|Overall Study|Lost to Follow-up|0|||
23507421|NCT02743871|65594743|FG009|Overall Study|Lost to Follow-up|0|||
23507422|NCT02743871|65594744|FG010|Overall Study|Lost to Follow-up|0|||
23507423|NCT02743871|65594745|FG011|Overall Study|Lost to Follow-up|2|||
23507424|NCT02743871|65594746|FG012|Overall Study|Lost to Follow-up|0|||
23507425|NCT02743871|65594747|FG013|Overall Study|Lost to Follow-up|0|||
23507426|NCT02743871|65594734|FG000|Overall Study|Withdrawal by Subject|0|||
23507427|NCT02743871|65594735|FG001|Overall Study|Withdrawal by Subject|0|||
23507428|NCT02743871|65594736|FG002|Overall Study|Withdrawal by Subject|0|||
23507429|NCT02743871|65594737|FG003|Overall Study|Withdrawal by Subject|0|||
23507430|NCT02743871|65594738|FG004|Overall Study|Withdrawal by Subject|0|||
23507431|NCT02743871|65594739|FG005|Overall Study|Withdrawal by Subject|0|||
23507432|NCT02743871|65594740|FG006|Overall Study|Withdrawal by Subject|0|||
23507433|NCT02743871|65594741|FG007|Overall Study|Withdrawal by Subject|0|||
23507434|NCT02743871|65594742|FG008|Overall Study|Withdrawal by Subject|0|||
23507435|NCT02743871|65594743|FG009|Overall Study|Withdrawal by Subject|0|||
23507436|NCT02743871|65594744|FG010|Overall Study|Withdrawal by Subject|1|||
23507437|NCT02743871|65594745|FG011|Overall Study|Withdrawal by Subject|0|||
23507438|NCT02743871|65594746|FG012|Overall Study|Withdrawal by Subject|12|||
23507439|NCT02743871|65594747|FG013|Overall Study|Withdrawal by Subject|6|||
23507440|NCT02743871|65594734|FG000|Overall Study|Adverse Event|1|||
23507441|NCT02743871|65594735|FG001|Overall Study|Adverse Event|0|||
23507442|NCT02743871|65594736|FG002|Overall Study|Adverse Event|0|||
23507443|NCT02743871|65594737|FG003|Overall Study|Adverse Event|0|||
23507444|NCT02743871|65594738|FG004|Overall Study|Adverse Event|0|||
23507445|NCT02743871|65594739|FG005|Overall Study|Adverse Event|0|||
23507446|NCT02743871|65594740|FG006|Overall Study|Adverse Event|0|||
23507447|NCT02743871|65594741|FG007|Overall Study|Adverse Event|0|||
23507448|NCT02743871|65594742|FG008|Overall Study|Adverse Event|0|||
23507449|NCT02743871|65594743|FG009|Overall Study|Adverse Event|0|||
23507450|NCT02743871|65594744|FG010|Overall Study|Adverse Event|0|||
23507451|NCT02743871|65594745|FG011|Overall Study|Adverse Event|0|||
23507452|NCT02743871|65594746|FG012|Overall Study|Adverse Event|0|||
23507453|NCT02743871|65594747|FG013|Overall Study|Adverse Event|0|||
23507454|NCT02743871|65594734|FG000|Overall Study|Other|0|||
23507455|NCT02743871|65594735|FG001|Overall Study|Other|0|||
23507456|NCT02743871|65594736|FG002|Overall Study|Other|0|||
23507457|NCT02743871|65594737|FG003|Overall Study|Other|0|||
23507458|NCT02743871|65594738|FG004|Overall Study|Other|0|||
23507459|NCT02743871|65594739|FG005|Overall Study|Other|0|||
23507460|NCT02743871|65594740|FG006|Overall Study|Other|0|||
23507461|NCT02743871|65594741|FG007|Overall Study|Other|0|||
23507462|NCT02743871|65594742|FG008|Overall Study|Other|0|||
23507463|NCT02743871|65594743|FG009|Overall Study|Other|0|||
23507464|NCT02743871|65594744|FG010|Overall Study|Other|0|||
23507465|NCT02743871|65594745|FG011|Overall Study|Other|1|||
23507466|NCT02743871|65594746|FG012|Overall Study|Other|1|||
23507467|NCT02743871|65594747|FG013|Overall Study|Other|1|||
23507468|NCT02743871|65594734|FG000|Overall Study|Protocol Violation|0|||
23507469|NCT02743871|65594735|FG001|Overall Study|Protocol Violation|0|||
23507470|NCT02743871|65594736|FG002|Overall Study|Protocol Violation|0|||
23507471|NCT02743871|65594737|FG003|Overall Study|Protocol Violation|0|||
23507472|NCT02743871|65594738|FG004|Overall Study|Protocol Violation|0|||
23507473|NCT02743871|65594739|FG005|Overall Study|Protocol Violation|0|||
23507474|NCT02743871|65594740|FG006|Overall Study|Protocol Violation|0|||
23507475|NCT02743871|65594741|FG007|Overall Study|Protocol Violation|0|||
23507476|NCT02743871|65594742|FG008|Overall Study|Protocol Violation|0|||
23507477|NCT02743871|65594743|FG009|Overall Study|Protocol Violation|0|||
23507478|NCT02743871|65594744|FG010|Overall Study|Protocol Violation|0|||
23507479|NCT02743871|65594745|FG011|Overall Study|Protocol Violation|0|||
23507480|NCT02743871|65594746|FG012|Overall Study|Protocol Violation|2|||
23507481|NCT02743871|65594747|FG013|Overall Study|Protocol Violation|0|||
23507482|NCT01366209|65594750|FG000|Overall Study|Adverse Event|6|||
23507483|NCT01366209|65594751|FG001|Overall Study|Adverse Event|7|||
23507484|NCT01366209|65594750|FG000|Overall Study|Withdrawal by Subject|4|||
23507485|NCT01366209|65594751|FG001|Overall Study|Withdrawal by Subject|4|||
23507486|NCT01366209|65594750|FG000|Overall Study|Death|12|||
23507487|NCT01366209|65594751|FG001|Overall Study|Death|19|||
23507488|NCT01366209|65594750|FG000|Overall Study|Lung transplantation|6|||
23507489|NCT01366209|65594751|FG001|Overall Study|Lung transplantation|1|||
23507490|NCT01366209|65594750|FG000|Overall Study|Lost to Follow-up|2|||
23507491|NCT01366209|65594751|FG001|Overall Study|Lost to Follow-up|1|||
23507492|NCT01366209|65594750|FG000|Overall Study|Physician Decision|1|||
23507493|NCT01366209|65594751|FG001|Overall Study|Physician Decision|0|||
23507494|NCT01366209|65594750|FG000|Overall Study|Sponsors decision|0|||
23507495|NCT01366209|65594751|FG001|Overall Study|Sponsors decision|1|||
23507496|NCT01366209|65594750|FG000|Overall Study|Withdrew consent|4|||
23507497|NCT01366209|65594751|FG001|Overall Study|Withdrew consent|3|||
23507498|NCT02324569|65594752|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23607380|NCT00195819|65950686|FG000|Open-label|Lack of Efficacy|0|||
23507499|NCT02324569|65594753|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23507500|NCT02324569|65594752|FG000|Overall Study|Voluntary Withdrawal|3|||
23507501|NCT02324569|65594753|FG001|Overall Study|Voluntary Withdrawal|6|||
23507502|NCT02324569|65594752|FG000|Overall Study|Lack of Efficacy|2|||
23507503|NCT02324569|65594753|FG001|Overall Study|Lack of Efficacy|3|||
23507504|NCT02324569|65594752|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
23507505|NCT02324569|65594753|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
23507506|NCT02324569|65594752|FG000|Overall Study|Inconvenient Schedule|2|||
23507507|NCT02324569|65594753|FG001|Overall Study|Inconvenient Schedule|0|||
23507508|NCT00576927|65594754|FG000|Clinical Assessment|Lack of Efficacy|24|||
23507509|NCT00576927|65594754|FG000|Clinical Assessment|Death|1|||
23507510|NCT00576927|65594754|FG000|Clinical Assessment|Withdrawal by Subject|10|||
23507511|NCT00576927|65594754|FG000|Clinical Assessment|Physician Decision|1|||
23507512|NCT00576927|65594754|FG000|Baseline|Physician Decision|9|||
23507513|NCT00576927|65594754|FG000|Baseline|Medication Change by PCP of subject|1|||
23507514|NCT00576927|65594754|FG000|Baseline|Withdrawal by Subject|3|||
23507515|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
23507516|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
23507517|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
23507518|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
23507519|NCT00576927|65594754|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
23507520|NCT02547649|65594755|FG000|Overall Study|Lost to Follow-up|3|||
23507521|NCT02547649|65594756|FG001|Overall Study|Lost to Follow-up|1|||
23507522|NCT02547649|65594757|FG002|Overall Study|Lost to Follow-up|1|||
23507523|NCT02547649|65594755|FG000|Overall Study|Not vaccinated|0|||
23507524|NCT02547649|65594756|FG001|Overall Study|Not vaccinated|0|||
23507525|NCT02547649|65594757|FG002|Overall Study|Not vaccinated|1|||
23507526|NCT02547649|65594755|FG000|Overall Study|Withdrawal by Subject|0|||
23507527|NCT02547649|65594756|FG001|Overall Study|Withdrawal by Subject|4|||
23507528|NCT02547649|65594757|FG002|Overall Study|Withdrawal by Subject|2|||
23507529|NCT00403234|65594758|FG000|Overall Study|Withdrawal by Subject|0|||
23507530|NCT00403234|65594759|FG001|Overall Study|Withdrawal by Subject|1|||
23507531|NCT00403234|65594760|FG002|Overall Study|Withdrawal by Subject|0|||
23507532|NCT00403234|65594761|FG003|Overall Study|Withdrawal by Subject|0|||
23507533|NCT00403234|65594758|FG000|Overall Study|Adverse Event|1|||
23507534|NCT00403234|65594759|FG001|Overall Study|Adverse Event|0|||
23507535|NCT00403234|65594760|FG002|Overall Study|Adverse Event|1|||
23507536|NCT00403234|65594761|FG003|Overall Study|Adverse Event|0|||
23507537|NCT01658072|65594762|FG000|Overall Study|Protocol Violation|4|||
23507538|NCT01658072|65594763|FG001|Overall Study|Protocol Violation|2|||
23507539|NCT00612690|65594766|FG000|Overall Study|Lost to Follow-up|72|||
23507540|NCT00612690|65594767|FG001|Overall Study|Lost to Follow-up|98|||
23507541|NCT00612690|65594766|FG000|Overall Study|Withdrawal by Subject|32|||
23507542|NCT00612690|65594767|FG001|Overall Study|Withdrawal by Subject|20|||
23507543|NCT00612690|65594766|FG000|Overall Study|Withdrawal by Site|11|||
23507544|NCT00612690|65594767|FG001|Overall Study|Withdrawal by Site|0|||
23507545|NCT02622321|65594768|FG000|Overall Study|Withdrawal by Subject|2|||
23507546|NCT02622321|65594769|FG001|Overall Study|Withdrawal by Subject|0|||
23507547|NCT02622321|65594770|FG002|Overall Study|Withdrawal by Subject|0|||
23507548|NCT02622321|65594771|FG003|Overall Study|Withdrawal by Subject|0|||
23507549|NCT02622321|65594768|FG000|Overall Study|Death|0|||
23507550|NCT02622321|65594769|FG001|Overall Study|Death|0|||
23507551|NCT02622321|65594770|FG002|Overall Study|Death|1|||
23507552|NCT02622321|65594771|FG003|Overall Study|Death|0|||
23507553|NCT02622321|65594768|FG000|Overall Study|Physician Decision|1|||
23507554|NCT02622321|65594769|FG001|Overall Study|Physician Decision|0|||
23507555|NCT02622321|65594770|FG002|Overall Study|Physician Decision|0|||
23507556|NCT02622321|65594771|FG003|Overall Study|Physician Decision|0|||
23507557|NCT03198234|65594772|FG000|Overall Study|Relapse of primary disease|0|||
23507558|NCT03198234|65594773|FG001|Overall Study|Relapse of primary disease|1|||
23507559|NCT03198234|65594774|FG002|Overall Study|Relapse of primary disease|0|||
23507560|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
23507561|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
23507562|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
23507563|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
23507564|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
23507565|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
23507566|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
23507567|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
23507568|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
23507569|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
23507570|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
23507571|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
23507572|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
23507573|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
23507574|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
23507575|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
23507576|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
23507577|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
23507578|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
23507579|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
23507580|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
23507581|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
23507582|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
23507583|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
23507584|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
23507585|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
23507586|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
23507587|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
23507588|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
23507589|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
23507590|NCT01648101|65594777|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
23507591|NCT01648101|65594778|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
23507592|NCT01648101|65594779|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
23507593|NCT01749514|65594780|FG000|Overall Study|Lost to Follow-up|0|||
23507594|NCT01749514|65594781|FG001|Overall Study|Lost to Follow-up|0|||
23507595|NCT01749514|65594782|FG002|Overall Study|Lost to Follow-up|0|||
23507596|NCT01749514|65594783|FG003|Overall Study|Lost to Follow-up|0|||
23507597|NCT01749514|65594784|FG004|Overall Study|Lost to Follow-up|0|||
23507598|NCT01749514|65594785|FG005|Overall Study|Lost to Follow-up|0|||
23507599|NCT01749514|65594786|FG006|Overall Study|Lost to Follow-up|0|||
23507600|NCT01749514|65594787|FG007|Overall Study|Lost to Follow-up|1|||
23507601|NCT01749514|65594780|FG000|Overall Study|Withdrawal by Subject|0|||
23507602|NCT01749514|65594781|FG001|Overall Study|Withdrawal by Subject|0|||
23507603|NCT01749514|65594782|FG002|Overall Study|Withdrawal by Subject|0|||
23507604|NCT01749514|65594783|FG003|Overall Study|Withdrawal by Subject|0|||
23507605|NCT01749514|65594784|FG004|Overall Study|Withdrawal by Subject|0|||
23507606|NCT01749514|65594785|FG005|Overall Study|Withdrawal by Subject|1|||
23507607|NCT01749514|65594786|FG006|Overall Study|Withdrawal by Subject|0|||
23507608|NCT01749514|65594787|FG007|Overall Study|Withdrawal by Subject|1|||
23507609|NCT01749514|65594780|FG000|Overall Study|Not Reported|0|||
23507610|NCT01749514|65594781|FG001|Overall Study|Not Reported|0|||
23507611|NCT01749514|65594782|FG002|Overall Study|Not Reported|0|||
23507612|NCT01749514|65594783|FG003|Overall Study|Not Reported|0|||
23507613|NCT01749514|65594784|FG004|Overall Study|Not Reported|0|||
23507614|NCT01749514|65594785|FG005|Overall Study|Not Reported|0|||
23507615|NCT01749514|65594786|FG006|Overall Study|Not Reported|0|||
23507616|NCT01749514|65594787|FG007|Overall Study|Not Reported|5|||
23507617|NCT03978520|65594789|FG000|Overall Study|Adverse Event|2|||
23507618|NCT03978520|65594790|FG001|Overall Study|Adverse Event|5|||
23507619|NCT03978520|65594791|FG002|Overall Study|Adverse Event|3|||
23507620|NCT03978520|65594792|FG003|Overall Study|Adverse Event|5|||
23507621|NCT03978520|65594793|FG004|Overall Study|Adverse Event|6|||
23507622|NCT03978520|65594789|FG000|Overall Study|Withdrawal by Subject|10|||
23507623|NCT03978520|65594790|FG001|Overall Study|Withdrawal by Subject|4|||
23507624|NCT03978520|65594791|FG002|Overall Study|Withdrawal by Subject|5|||
23507625|NCT03978520|65594792|FG003|Overall Study|Withdrawal by Subject|6|||
23507626|NCT03978520|65594793|FG004|Overall Study|Withdrawal by Subject|5|||
23507627|NCT03978520|65594789|FG000|Overall Study|Lost to Follow-up|2|||
23507628|NCT03978520|65594790|FG001|Overall Study|Lost to Follow-up|2|||
23507629|NCT03978520|65594791|FG002|Overall Study|Lost to Follow-up|2|||
23507630|NCT03978520|65594792|FG003|Overall Study|Lost to Follow-up|0|||
23507631|NCT03978520|65594793|FG004|Overall Study|Lost to Follow-up|1|||
23507632|NCT03978520|65594789|FG000|Overall Study|COVID-19 infection|0|||
23507633|NCT03978520|65594790|FG001|Overall Study|COVID-19 infection|1|||
23507634|NCT03978520|65594791|FG002|Overall Study|COVID-19 infection|0|||
23507635|NCT03978520|65594792|FG003|Overall Study|COVID-19 infection|0|||
23507636|NCT03978520|65594793|FG004|Overall Study|COVID-19 infection|0|||
23507637|NCT03978520|65594789|FG000|Overall Study|Other, not specified|9|||
23507638|NCT03978520|65594790|FG001|Overall Study|Other, not specified|4|||
23507639|NCT03978520|65594791|FG002|Overall Study|Other, not specified|1|||
23507640|NCT03978520|65594792|FG003|Overall Study|Other, not specified|1|||
23507641|NCT03978520|65594793|FG004|Overall Study|Other, not specified|2|||
23507642|NCT03978520|65594789|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507643|NCT03978520|65594790|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507644|NCT03978520|65594791|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507645|NCT03978520|65594792|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
23507646|NCT03978520|65594793|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
23507647|NCT01987505|65594795|FG000|Overall Study|Other|9|||
23507648|NCT01987505|65594795|FG000|Overall Study|Withdrawal by Subject|2|||
23507649|NCT01987505|65594795|FG000|Overall Study|Other Reason|2|||
23507650|NCT01987505|65594795|FG000|Overall Study|Lost to Follow-up|15|||
23507651|NCT01987505|65594795|FG000|Overall Study|Investigator Decision|2|||
23507652|NCT01987505|65594795|FG000|Overall Study|Death|4|||
23507653|NCT02101060|65594799|FG000|Overall Study|Adverse Event|1|||
23507654|NCT02101060|65594800|FG001|Overall Study|Adverse Event|0|||
23507655|NCT02101060|65594799|FG000|Overall Study|Withdrawal by Subject|1|||
23507656|NCT02101060|65594800|FG001|Overall Study|Withdrawal by Subject|1|||
23507657|NCT02101060|65594799|FG000|Overall Study|Lost to Follow-up|3|||
23507658|NCT02101060|65594800|FG001|Overall Study|Lost to Follow-up|3|||
23507659|NCT00171730|65594801|FG000|Overall Study|Adverse Event|3|||
23507660|NCT00171730|65594801|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23507661|NCT00171730|65594801|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
23507662|NCT00171730|65594801|FG000|Overall Study|Withdrawal by Subject|3|||
23507663|NCT00727025|65594802|FG000|Overall Study|Physician Decision|23|||
23507664|NCT02181413|65594805|FG000|Overall Study|Adverse Event|7|||
23507665|NCT02181413|65594806|FG001|Overall Study|Adverse Event|24|||
23507666|NCT02181413|65594805|FG000|Overall Study|Progressive Disease|121|||
23507667|NCT02181413|65594806|FG001|Overall Study|Progressive Disease|143|||
23507668|NCT02181413|65594805|FG000|Overall Study|Withdrawal by Subject|5|||
23507669|NCT02181413|65594806|FG001|Overall Study|Withdrawal by Subject|8|||
23507670|NCT02181413|65594805|FG000|Overall Study|Reason Not Specified|19|||
23507671|NCT02181413|65594806|FG001|Overall Study|Reason Not Specified|20|||
23507672|NCT02181413|65594805|FG000|Overall Study|Ongoing Study Treatment|0|||
23507673|NCT02181413|65594806|FG001|Overall Study|Ongoing Study Treatment|1|||
23507674|NCT02181413|65594805|FG000|Overall Study|Lost to Follow-up|0|||
23507675|NCT02181413|65594806|FG001|Overall Study|Lost to Follow-up|1|||
23507676|NCT03633695|65594807|FG000|Overall Study|Lost to Follow-up|4|||
23507677|NCT03633695|65594808|FG001|Overall Study|Lost to Follow-up|5|||
23507678|NCT03633695|65594807|FG000|Overall Study|Discontinued|8|||
23507679|NCT03633695|65594808|FG001|Overall Study|Discontinued|4|||
23507680|NCT00691015|65594809|FG000|Overall Study|Refused further treatment|1|||
23507681|NCT03031678|65594812|FG000|Overall Study|Study closed prior to completion|1|||
23507682|NCT03761277|65594819|FG000|Enrollment to Implant|Screen Failure|17|||
23507683|NCT03761277|65594819|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
23507684|NCT03761277|65594819|FG000|Enrollment to Implant|Physician Decision|2|||
23507685|NCT03761277|65594819|FG000|Enrollment to Implant|Site Closure|3|||
23507686|NCT03761277|65594819|FG000|Enrollment to Implant|Sponsor Request|2|||
23507687|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Adverse Event|2|||
23507688|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Death|1|||
23507689|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Site Closure|2|||
23507690|NCT03761277|65594819|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
23507691|NCT03761277|65594819|FG000|6 Months to 12 Months|Physician Decision|2|||
23507692|NCT03761277|65594819|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
23507693|NCT00191789|65594820|FG000|Overall Study|Adverse Event|5|||
23507694|NCT00191789|65594820|FG000|Overall Study|Patient: Satisfactory Response|5|||
23507695|NCT00191789|65594820|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
23507696|NCT00191789|65594820|FG000|Overall Study|Withdrawal by Subject|4|||
23507697|NCT00191789|65594820|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
23507698|NCT00191789|65594820|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
23507699|NCT00191789|65594820|FG000|Overall Study|Death - Not Study-Drug Related|1|||
23507700|NCT00482612|65594821|FG000|In-treatment Period|No study medication administered|0|||
23507701|NCT00482612|65594822|FG001|In-treatment Period|No study medication administered|0|||
23507702|NCT00482612|65594823|FG002|In-treatment Period|No study medication administered|1|||
23507703|NCT00482612|65594824|FG003|In-treatment Period|No study medication administered|0|||
23507704|NCT00482612|65594821|FG000|Follow-up Period|Other|4|||
23507705|NCT00482612|65594822|FG001|Follow-up Period|Other|2|||
23507706|NCT00482612|65594823|FG002|Follow-up Period|Other|1|||
23507707|NCT00482612|65594824|FG003|Follow-up Period|Other|2|||
23507708|NCT00482612|65594821|FG000|Follow-up Period|Lack of compliance|0|||
23507709|NCT00482612|65594822|FG001|Follow-up Period|Lack of compliance|0|||
23507710|NCT00482612|65594823|FG002|Follow-up Period|Lack of compliance|1|||
23507711|NCT00482612|65594824|FG003|Follow-up Period|Lack of compliance|0|||
23507712|NCT00482612|65594821|FG000|Follow-up Period|Lost to Follow-up|0|||
23507713|NCT00482612|65594822|FG001|Follow-up Period|Lost to Follow-up|4|||
23507714|NCT00482612|65594823|FG002|Follow-up Period|Lost to Follow-up|2|||
23507715|NCT00482612|65594824|FG003|Follow-up Period|Lost to Follow-up|1|||
23507716|NCT00482612|65594821|FG000|Follow-up Period|Adverse Event|4|||
23507717|NCT00482612|65594822|FG001|Follow-up Period|Adverse Event|7|||
23507718|NCT00482612|65594823|FG002|Follow-up Period|Adverse Event|9|||
23507719|NCT00482612|65594824|FG003|Follow-up Period|Adverse Event|0|||
23507720|NCT00482612|65594821|FG000|Follow-up Period|Lack of Efficacy|2|||
23507721|NCT00482612|65594822|FG001|Follow-up Period|Lack of Efficacy|0|||
23507722|NCT00482612|65594823|FG002|Follow-up Period|Lack of Efficacy|1|||
23507723|NCT00482612|65594824|FG003|Follow-up Period|Lack of Efficacy|0|||
23507724|NCT00482612|65594821|FG000|Follow-up Period|Withdrawal by Subject|3|||
23507725|NCT00482612|65594822|FG001|Follow-up Period|Withdrawal by Subject|5|||
23507726|NCT00482612|65594823|FG002|Follow-up Period|Withdrawal by Subject|7|||
23507727|NCT00482612|65594824|FG003|Follow-up Period|Withdrawal by Subject|2|||
23507728|NCT00482612|65594821|FG000|Follow-up Period|Reasons not related to trial|1|||
23507729|NCT00482612|65594822|FG001|Follow-up Period|Reasons not related to trial|0|||
23507730|NCT00482612|65594823|FG002|Follow-up Period|Reasons not related to trial|1|||
23507731|NCT00482612|65594824|FG003|Follow-up Period|Reasons not related to trial|3|||
23507732|NCT03462082|65594825|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507733|NCT03462082|65594826|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507734|NCT03462082|65594827|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507735|NCT03462082|65594828|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507736|NCT03462082|65594829|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507737|NCT03462082|65594830|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507738|NCT03462082|65594831|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
23507739|NCT03462082|65594832|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
23507740|NCT01350414|65594835|FG000|Overall Study|Lost to Follow-up|13|||
23507741|NCT01350414|65594835|FG000|Overall Study|Withdrawal by Subject|4|||
23507742|NCT01350414|65594835|FG000|Overall Study|Physician Decision|2|||
23507743|NCT01575769|65594855|FG000|Overall Study|Adverse Event|1|||
23507744|NCT01575769|65594855|FG000|Overall Study|Study terminated by sponsor|40|||
23507745|NCT00001596|65594856|FG000|Overall Study|Death|1|||
23507746|NCT00001596|65594857|FG001|Overall Study|Death|0|||
23507747|NCT00001596|65594856|FG000|Overall Study|Withdrawal by Subject|3|||
23507748|NCT00001596|65594857|FG001|Overall Study|Withdrawal by Subject|1|||
23507749|NCT00001596|65594856|FG000|Overall Study|Study Termination|12|||
23507750|NCT00001596|65594857|FG001|Overall Study|Study Termination|9|||
23507751|NCT00001596|65594856|FG000|Overall Study|Adverse Event|1|||
23507752|NCT00001596|65594857|FG001|Overall Study|Adverse Event|0|||
23507753|NCT00644995|65594858|FG000|Overall Study|Lost to Follow-up|1|||
23507754|NCT00644995|65594859|FG001|Overall Study|Lost to Follow-up|4|||
23507755|NCT00644995|65594858|FG000|Overall Study|Refused|1|||
23507756|NCT00644995|65594859|FG001|Overall Study|Refused|0|||
23507757|NCT04656691|65597878|FG000|Overall Study|Adverse Event|1|||
23507758|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
23507759|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
23507760|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
23507761|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
23507762|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
23507763|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
23507764|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Death|3|||
23507765|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Death|2|||
23507766|NCT00489541|65597879|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
23507767|NCT00489541|65597880|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
23507768|NCT00489541|65597879|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
23507769|NCT00489541|65597880|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
23507770|NCT01276353|65597881|FG000|Double-blind|Adverse Event|2|||
23507771|NCT01276353|65597882|FG001|Double-blind|Adverse Event|0|||
23507772|NCT01276353|65597881|FG000|Double-blind|Withdrawal by Subject|1|||
23507773|NCT01276353|65597882|FG001|Double-blind|Withdrawal by Subject|0|||
23507774|NCT01276353|65597881|FG000|Extension|Adverse Event|2|||
23507775|NCT01276353|65597882|FG001|Extension|Adverse Event|5|||
23507776|NCT01276353|65597881|FG000|Extension|Withdrawal by Subject|1|||
23507777|NCT01276353|65597882|FG001|Extension|Withdrawal by Subject|2|||
23507778|NCT01276353|65597881|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
23507779|NCT01276353|65597882|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
23507780|NCT01276353|65597881|FG000|Extension|Physician Decision|1|||
23507781|NCT01276353|65597882|FG001|Extension|Physician Decision|0|||
23507782|NCT01276353|65597881|FG000|Extension|Prohibited concomitant medications|0|||
23507783|NCT01276353|65597882|FG001|Extension|Prohibited concomitant medications|1|||
23507784|NCT00071513|65597883|FG000|Intervention Component|Withdrawal by Subject|2|||
23507785|NCT00071513|65597884|FG001|Intervention Component|Withdrawal by Subject|3|||
23507786|NCT00071513|65597883|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
23507787|NCT00071513|65597884|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
23507788|NCT00752232|65597885|FG000|Overall Study|Protocol Violation|0|||
23507789|NCT00752232|65597886|FG001|Overall Study|Protocol Violation|0|||
23507790|NCT00752232|65597887|FG002|Overall Study|Protocol Violation|0|||
23507791|NCT00752232|65597888|FG003|Overall Study|Protocol Violation|0|||
23507792|NCT00752232|65597889|FG004|Overall Study|Protocol Violation|0|||
23507793|NCT00752232|65597890|FG005|Overall Study|Protocol Violation|1|||
23507794|NCT00752232|65597891|FG006|Overall Study|Protocol Violation|0|||
23507795|NCT00752232|65597885|FG000|Overall Study|Caregiver request|2|||
23507796|NCT00752232|65597886|FG001|Overall Study|Caregiver request|0|||
23507797|NCT00752232|65597887|FG002|Overall Study|Caregiver request|0|||
23507798|NCT00752232|65597888|FG003|Overall Study|Caregiver request|0|||
23507799|NCT00752232|65597889|FG004|Overall Study|Caregiver request|1|||
23507800|NCT00752232|65597890|FG005|Overall Study|Caregiver request|0|||
23507801|NCT00752232|65597891|FG006|Overall Study|Caregiver request|0|||
23507802|NCT00752232|65597885|FG000|Overall Study|Investigator request|0|||
23507803|NCT00752232|65597886|FG001|Overall Study|Investigator request|0|||
23507804|NCT00752232|65597887|FG002|Overall Study|Investigator request|0|||
23507805|NCT00752232|65597888|FG003|Overall Study|Investigator request|0|||
23507806|NCT00752232|65597889|FG004|Overall Study|Investigator request|1|||
23507807|NCT00752232|65597890|FG005|Overall Study|Investigator request|0|||
23507808|NCT00752232|65597891|FG006|Overall Study|Investigator request|0|||
23507809|NCT00752232|65597885|FG000|Overall Study|Subject request|0|||
23507810|NCT00752232|65597886|FG001|Overall Study|Subject request|0|||
23507811|NCT00752232|65597887|FG002|Overall Study|Subject request|1|||
23507812|NCT00752232|65597888|FG003|Overall Study|Subject request|0|||
23507813|NCT00752232|65597889|FG004|Overall Study|Subject request|0|||
23507814|NCT00752232|65597890|FG005|Overall Study|Subject request|0|||
23507815|NCT00752232|65597891|FG006|Overall Study|Subject request|0|||
23507816|NCT00752232|65597885|FG000|Overall Study|Group home admission|0|||
23507817|NCT00752232|65597886|FG001|Overall Study|Group home admission|0|||
23507818|NCT00752232|65597887|FG002|Overall Study|Group home admission|0|||
23507819|NCT00752232|65597888|FG003|Overall Study|Group home admission|1|||
23507820|NCT00752232|65597889|FG004|Overall Study|Group home admission|0|||
23507821|NCT00752232|65597890|FG005|Overall Study|Group home admission|0|||
23507822|NCT00752232|65597891|FG006|Overall Study|Group home admission|0|||
23607381|NCT00195819|65950687|FG001|Open-label|Lack of Efficacy|2|||
23607382|NCT00195819|65950686|FG000|Open-label|Pregnancy|0|||
23607383|NCT00195819|65950687|FG001|Open-label|Pregnancy|1|||
23607384|NCT00195819|65950686|FG000|Open-label|Protocol Violation|0|||
23607385|NCT00195819|65950687|FG001|Open-label|Protocol Violation|2|||
23607386|NCT00195819|65950686|FG000|Open-label|Moved|0|||
23607387|NCT00195819|65950687|FG001|Open-label|Moved|1|||
23607388|NCT00195819|65950686|FG000|Open-label|Withdrawal by Subject|0|||
23607389|NCT00195819|65950687|FG001|Open-label|Withdrawal by Subject|5|||
23507823|NCT00752232|65597885|FG000|Overall Study|Caregiver could not attend the subject|0|||
23507824|NCT00752232|65597886|FG001|Overall Study|Caregiver could not attend the subject|0|||
23507825|NCT00752232|65597887|FG002|Overall Study|Caregiver could not attend the subject|0|||
23507826|NCT00752232|65597888|FG003|Overall Study|Caregiver could not attend the subject|0|||
23507827|NCT00752232|65597889|FG004|Overall Study|Caregiver could not attend the subject|1|||
23507828|NCT00752232|65597890|FG005|Overall Study|Caregiver could not attend the subject|0|||
23507829|NCT00752232|65597891|FG006|Overall Study|Caregiver could not attend the subject|0|||
23507830|NCT01928394|65597892|FG000|Treatment Period|Disease progression|17|||
23507831|NCT01928394|65597893|FG001|Treatment Period|Disease progression|2|||
23507832|NCT01928394|65597894|FG002|Treatment Period|Disease progression|12|||
23507833|NCT01928394|65597895|FG003|Treatment Period|Disease progression|48|||
23507834|NCT01928394|65597896|FG004|Treatment Period|Disease progression|3|||
23507835|NCT01928394|65597897|FG005|Treatment Period|Disease progression|25|||
23507836|NCT01928394|65597898|FG006|Treatment Period|Disease progression|38|||
23507837|NCT01928394|65597899|FG007|Treatment Period|Disease progression|16|||
23507838|NCT01928394|65597900|FG008|Treatment Period|Disease progression|3|||
23507839|NCT01928394|65597901|FG009|Treatment Period|Disease progression|11|||
23507840|NCT01928394|65597902|FG010|Treatment Period|Disease progression|22|||
23507841|NCT01928394|65597903|FG011|Treatment Period|Disease progression|73|||
23507842|NCT01928394|65597904|FG012|Treatment Period|Disease progression|38|||
23507843|NCT01928394|65597905|FG013|Treatment Period|Disease progression|118|||
23507844|NCT01928394|65597906|FG014|Treatment Period|Disease progression|59|||
23507845|NCT01928394|65597907|FG015|Treatment Period|Disease progression|1|||
23507846|NCT01928394|65597908|FG016|Treatment Period|Disease progression|43|||
23507847|NCT01928394|65597909|FG017|Treatment Period|Disease progression|56|||
23507848|NCT01928394|65597910|FG018|Treatment Period|Disease progression|50|||
23507849|NCT01928394|65597911|FG019|Treatment Period|Disease progression|71|||
23507850|NCT01928394|65597912|FG020|Treatment Period|Disease progression|30|||
23507851|NCT01928394|65597913|FG021|Treatment Period|Disease progression|31|||
23507852|NCT01928394|65597914|FG022|Treatment Period|Disease progression|31|||
23507853|NCT01928394|65597892|FG000|Treatment Period|Study drug toxicity|1|||
23507854|NCT01928394|65597893|FG001|Treatment Period|Study drug toxicity|1|||
23507855|NCT01928394|65597894|FG002|Treatment Period|Study drug toxicity|3|||
23507856|NCT01928394|65597895|FG003|Treatment Period|Study drug toxicity|3|||
23507857|NCT01928394|65597896|FG004|Treatment Period|Study drug toxicity|0|||
23507858|NCT01928394|65597897|FG005|Treatment Period|Study drug toxicity|9|||
23507859|NCT01928394|65597898|FG006|Treatment Period|Study drug toxicity|7|||
23507860|NCT01928394|65597899|FG007|Treatment Period|Study drug toxicity|1|||
23507861|NCT01928394|65597900|FG008|Treatment Period|Study drug toxicity|0|||
23507862|NCT01928394|65597901|FG009|Treatment Period|Study drug toxicity|5|||
23507863|NCT01928394|65597902|FG010|Treatment Period|Study drug toxicity|2|||
23507864|NCT01928394|65597903|FG011|Treatment Period|Study drug toxicity|3|||
23507865|NCT01928394|65597904|FG012|Treatment Period|Study drug toxicity|7|||
23507866|NCT01928394|65597905|FG013|Treatment Period|Study drug toxicity|5|||
23507867|NCT01928394|65597906|FG014|Treatment Period|Study drug toxicity|12|||
23507868|NCT01928394|65597907|FG015|Treatment Period|Study drug toxicity|0|||
23507869|NCT01928394|65597908|FG016|Treatment Period|Study drug toxicity|3|||
23507870|NCT01928394|65597909|FG017|Treatment Period|Study drug toxicity|3|||
23607390|NCT00696241|65950688|FG000|Overall Study|Adverse Event|11|||
23607391|NCT00696241|65950689|FG001|Overall Study|Adverse Event|3|||
23507871|NCT01928394|65597910|FG018|Treatment Period|Study drug toxicity|12|||
23507872|NCT01928394|65597911|FG019|Treatment Period|Study drug toxicity|15|||
23507873|NCT01928394|65597912|FG020|Treatment Period|Study drug toxicity|4|||
23507874|NCT01928394|65597913|FG021|Treatment Period|Study drug toxicity|7|||
23507875|NCT01928394|65597914|FG022|Treatment Period|Study drug toxicity|4|||
23507876|NCT01928394|65597892|FG000|Treatment Period|AE unrelated to study drug|0|||
23507877|NCT01928394|65597893|FG001|Treatment Period|AE unrelated to study drug|0|||
23507878|NCT01928394|65597894|FG002|Treatment Period|AE unrelated to study drug|2|||
23507879|NCT01928394|65597895|FG003|Treatment Period|AE unrelated to study drug|3|||
23507880|NCT01928394|65597896|FG004|Treatment Period|AE unrelated to study drug|0|||
23507881|NCT01928394|65597897|FG005|Treatment Period|AE unrelated to study drug|5|||
23507882|NCT01928394|65597898|FG006|Treatment Period|AE unrelated to study drug|1|||
23507883|NCT01928394|65597899|FG007|Treatment Period|AE unrelated to study drug|0|||
23507884|NCT01928394|65597900|FG008|Treatment Period|AE unrelated to study drug|0|||
23507885|NCT01928394|65597901|FG009|Treatment Period|AE unrelated to study drug|2|||
23507886|NCT01928394|65597902|FG010|Treatment Period|AE unrelated to study drug|0|||
23507887|NCT01928394|65597903|FG011|Treatment Period|AE unrelated to study drug|12|||
23507888|NCT01928394|65597904|FG012|Treatment Period|AE unrelated to study drug|6|||
23507889|NCT01928394|65597905|FG013|Treatment Period|AE unrelated to study drug|13|||
23507890|NCT01928394|65597906|FG014|Treatment Period|AE unrelated to study drug|6|||
23507891|NCT01928394|65597907|FG015|Treatment Period|AE unrelated to study drug|1|||
23507892|NCT01928394|65597908|FG016|Treatment Period|AE unrelated to study drug|1|||
23507893|NCT01928394|65597909|FG017|Treatment Period|AE unrelated to study drug|6|||
23507894|NCT01928394|65597910|FG018|Treatment Period|AE unrelated to study drug|3|||
23507895|NCT01928394|65597911|FG019|Treatment Period|AE unrelated to study drug|5|||
23507896|NCT01928394|65597912|FG020|Treatment Period|AE unrelated to study drug|1|||
23507897|NCT01928394|65597913|FG021|Treatment Period|AE unrelated to study drug|1|||
23507898|NCT01928394|65597914|FG022|Treatment Period|AE unrelated to study drug|0|||
23507899|NCT01928394|65597892|FG000|Treatment Period|Participant request to stop therapy|0|||
23507900|NCT01928394|65597893|FG001|Treatment Period|Participant request to stop therapy|0|||
23507901|NCT01928394|65597894|FG002|Treatment Period|Participant request to stop therapy|0|||
23507902|NCT01928394|65597895|FG003|Treatment Period|Participant request to stop therapy|0|||
23507903|NCT01928394|65597896|FG004|Treatment Period|Participant request to stop therapy|0|||
23507904|NCT01928394|65597897|FG005|Treatment Period|Participant request to stop therapy|3|||
23507905|NCT01928394|65597898|FG006|Treatment Period|Participant request to stop therapy|3|||
23507906|NCT01928394|65597899|FG007|Treatment Period|Participant request to stop therapy|0|||
23507907|NCT01928394|65597900|FG008|Treatment Period|Participant request to stop therapy|0|||
23507908|NCT01928394|65597901|FG009|Treatment Period|Participant request to stop therapy|0|||
23507909|NCT01928394|65597902|FG010|Treatment Period|Participant request to stop therapy|3|||
23507910|NCT01928394|65597903|FG011|Treatment Period|Participant request to stop therapy|2|||
23507911|NCT01928394|65597904|FG012|Treatment Period|Participant request to stop therapy|1|||
23507912|NCT01928394|65597905|FG013|Treatment Period|Participant request to stop therapy|2|||
23507913|NCT01928394|65597906|FG014|Treatment Period|Participant request to stop therapy|4|||
23507914|NCT01928394|65597907|FG015|Treatment Period|Participant request to stop therapy|0|||
23507915|NCT01928394|65597908|FG016|Treatment Period|Participant request to stop therapy|1|||
23507916|NCT01928394|65597909|FG017|Treatment Period|Participant request to stop therapy|3|||
23507917|NCT01928394|65597910|FG018|Treatment Period|Participant request to stop therapy|1|||
23507918|NCT01928394|65597911|FG019|Treatment Period|Participant request to stop therapy|1|||
23507919|NCT01928394|65597912|FG020|Treatment Period|Participant request to stop therapy|3|||
23507920|NCT01928394|65597913|FG021|Treatment Period|Participant request to stop therapy|1|||
23507921|NCT01928394|65597914|FG022|Treatment Period|Participant request to stop therapy|3|||
23507922|NCT01928394|65597892|FG000|Treatment Period|Participant withdrew consent|0|||
23507923|NCT01928394|65597893|FG001|Treatment Period|Participant withdrew consent|0|||
23507924|NCT01928394|65597894|FG002|Treatment Period|Participant withdrew consent|1|||
23507925|NCT01928394|65597895|FG003|Treatment Period|Participant withdrew consent|1|||
23507926|NCT01928394|65597896|FG004|Treatment Period|Participant withdrew consent|0|||
23507927|NCT01928394|65597897|FG005|Treatment Period|Participant withdrew consent|1|||
23507928|NCT01928394|65597898|FG006|Treatment Period|Participant withdrew consent|0|||
23507929|NCT01928394|65597899|FG007|Treatment Period|Participant withdrew consent|1|||
23507930|NCT01928394|65597900|FG008|Treatment Period|Participant withdrew consent|0|||
23507931|NCT01928394|65597901|FG009|Treatment Period|Participant withdrew consent|0|||
23507932|NCT01928394|65597902|FG010|Treatment Period|Participant withdrew consent|1|||
23507933|NCT01928394|65597903|FG011|Treatment Period|Participant withdrew consent|1|||
23507934|NCT01928394|65597904|FG012|Treatment Period|Participant withdrew consent|1|||
23507935|NCT01928394|65597905|FG013|Treatment Period|Participant withdrew consent|0|||
23507936|NCT01928394|65597906|FG014|Treatment Period|Participant withdrew consent|2|||
23507937|NCT01928394|65597907|FG015|Treatment Period|Participant withdrew consent|0|||
23507938|NCT01928394|65597908|FG016|Treatment Period|Participant withdrew consent|2|||
23507939|NCT01928394|65597909|FG017|Treatment Period|Participant withdrew consent|1|||
23507940|NCT01928394|65597910|FG018|Treatment Period|Participant withdrew consent|1|||
23507941|NCT01928394|65597911|FG019|Treatment Period|Participant withdrew consent|1|||
23507942|NCT01928394|65597912|FG020|Treatment Period|Participant withdrew consent|0|||
23507943|NCT01928394|65597913|FG021|Treatment Period|Participant withdrew consent|2|||
23507944|NCT01928394|65597914|FG022|Treatment Period|Participant withdrew consent|0|||
23507945|NCT01928394|65597892|FG000|Treatment Period|Poor/non-compliance|0|||
23507946|NCT01928394|65597893|FG001|Treatment Period|Poor/non-compliance|0|||
23507947|NCT01928394|65597894|FG002|Treatment Period|Poor/non-compliance|0|||
23507948|NCT01928394|65597895|FG003|Treatment Period|Poor/non-compliance|1|||
23507949|NCT01928394|65597896|FG004|Treatment Period|Poor/non-compliance|0|||
23507950|NCT01928394|65597897|FG005|Treatment Period|Poor/non-compliance|0|||
23507951|NCT01928394|65597898|FG006|Treatment Period|Poor/non-compliance|0|||
23507952|NCT01928394|65597899|FG007|Treatment Period|Poor/non-compliance|0|||
23507953|NCT01928394|65597900|FG008|Treatment Period|Poor/non-compliance|0|||
23507954|NCT01928394|65597901|FG009|Treatment Period|Poor/non-compliance|0|||
23507955|NCT01928394|65597902|FG010|Treatment Period|Poor/non-compliance|0|||
23507956|NCT01928394|65597903|FG011|Treatment Period|Poor/non-compliance|0|||
23507957|NCT01928394|65597904|FG012|Treatment Period|Poor/non-compliance|1|||
23507958|NCT01928394|65597905|FG013|Treatment Period|Poor/non-compliance|0|||
23507959|NCT01928394|65597906|FG014|Treatment Period|Poor/non-compliance|1|||
23507960|NCT01928394|65597907|FG015|Treatment Period|Poor/non-compliance|0|||
23507961|NCT01928394|65597908|FG016|Treatment Period|Poor/non-compliance|0|||
23507962|NCT01928394|65597909|FG017|Treatment Period|Poor/non-compliance|1|||
23507963|NCT01928394|65597910|FG018|Treatment Period|Poor/non-compliance|0|||
23507964|NCT01928394|65597911|FG019|Treatment Period|Poor/non-compliance|1|||
23507965|NCT01928394|65597912|FG020|Treatment Period|Poor/non-compliance|0|||
23507966|NCT01928394|65597913|FG021|Treatment Period|Poor/non-compliance|0|||
23507967|NCT01928394|65597914|FG022|Treatment Period|Poor/non-compliance|0|||
23507968|NCT01928394|65597892|FG000|Treatment Period|other reason|0|||
23507969|NCT01928394|65597893|FG001|Treatment Period|other reason|0|||
23507970|NCT01928394|65597894|FG002|Treatment Period|other reason|0|||
23507971|NCT01928394|65597895|FG003|Treatment Period|other reason|0|||
23507972|NCT01928394|65597896|FG004|Treatment Period|other reason|0|||
23507973|NCT01928394|65597897|FG005|Treatment Period|other reason|0|||
23507974|NCT01928394|65597898|FG006|Treatment Period|other reason|0|||
23507975|NCT01928394|65597899|FG007|Treatment Period|other reason|0|||
23507976|NCT01928394|65597900|FG008|Treatment Period|other reason|0|||
23507977|NCT01928394|65597901|FG009|Treatment Period|other reason|0|||
23507978|NCT01928394|65597902|FG010|Treatment Period|other reason|1|||
23507979|NCT01928394|65597903|FG011|Treatment Period|other reason|1|||
23507980|NCT01928394|65597904|FG012|Treatment Period|other reason|1|||
23507981|NCT01928394|65597905|FG013|Treatment Period|other reason|0|||
23507982|NCT01928394|65597906|FG014|Treatment Period|other reason|1|||
23507983|NCT01928394|65597907|FG015|Treatment Period|other reason|0|||
23507984|NCT01928394|65597908|FG016|Treatment Period|other reason|0|||
23507985|NCT01928394|65597909|FG017|Treatment Period|other reason|0|||
23507986|NCT01928394|65597910|FG018|Treatment Period|other reason|2|||
23507987|NCT01928394|65597911|FG019|Treatment Period|other reason|2|||
23507988|NCT01928394|65597912|FG020|Treatment Period|other reason|0|||
23507989|NCT01928394|65597913|FG021|Treatment Period|other reason|0|||
23507990|NCT01928394|65597914|FG022|Treatment Period|other reason|0|||
23507991|NCT01928394|65597892|FG000|Treatment Period|Maximum clinical benefit|0|||
23507992|NCT01928394|65597893|FG001|Treatment Period|Maximum clinical benefit|0|||
23507993|NCT01928394|65597894|FG002|Treatment Period|Maximum clinical benefit|0|||
23507994|NCT01928394|65597895|FG003|Treatment Period|Maximum clinical benefit|0|||
23507995|NCT01928394|65597896|FG004|Treatment Period|Maximum clinical benefit|0|||
23507996|NCT01928394|65597897|FG005|Treatment Period|Maximum clinical benefit|0|||
23507997|NCT01928394|65597898|FG006|Treatment Period|Maximum clinical benefit|0|||
23507998|NCT01928394|65597899|FG007|Treatment Period|Maximum clinical benefit|0|||
23507999|NCT01928394|65597900|FG008|Treatment Period|Maximum clinical benefit|0|||
23508000|NCT01928394|65597901|FG009|Treatment Period|Maximum clinical benefit|0|||
23508001|NCT01928394|65597902|FG010|Treatment Period|Maximum clinical benefit|1|||
23508002|NCT01928394|65597903|FG011|Treatment Period|Maximum clinical benefit|1|||
23508003|NCT01928394|65597904|FG012|Treatment Period|Maximum clinical benefit|0|||
23508004|NCT01928394|65597905|FG013|Treatment Period|Maximum clinical benefit|0|||
23508005|NCT01928394|65597906|FG014|Treatment Period|Maximum clinical benefit|1|||
23508006|NCT01928394|65597907|FG015|Treatment Period|Maximum clinical benefit|0|||
23508007|NCT01928394|65597908|FG016|Treatment Period|Maximum clinical benefit|0|||
23508008|NCT01928394|65597909|FG017|Treatment Period|Maximum clinical benefit|1|||
23508009|NCT01928394|65597910|FG018|Treatment Period|Maximum clinical benefit|1|||
23508010|NCT01928394|65597911|FG019|Treatment Period|Maximum clinical benefit|0|||
23508011|NCT01928394|65597912|FG020|Treatment Period|Maximum clinical benefit|2|||
23508012|NCT01928394|65597913|FG021|Treatment Period|Maximum clinical benefit|0|||
23508013|NCT01928394|65597914|FG022|Treatment Period|Maximum clinical benefit|0|||
23508014|NCT01928394|65597892|FG000|Treatment Period|Lost to Follow-up|0|||
23508015|NCT01928394|65597893|FG001|Treatment Period|Lost to Follow-up|0|||
23607392|NCT00696241|65950690|FG002|Overall Study|Adverse Event|6|||
23508016|NCT01928394|65597894|FG002|Treatment Period|Lost to Follow-up|0|||
23508017|NCT01928394|65597895|FG003|Treatment Period|Lost to Follow-up|0|||
23508018|NCT01928394|65597896|FG004|Treatment Period|Lost to Follow-up|0|||
23508019|NCT01928394|65597897|FG005|Treatment Period|Lost to Follow-up|0|||
23508020|NCT01928394|65597898|FG006|Treatment Period|Lost to Follow-up|0|||
23508021|NCT01928394|65597899|FG007|Treatment Period|Lost to Follow-up|0|||
23508022|NCT01928394|65597900|FG008|Treatment Period|Lost to Follow-up|0|||
23508023|NCT01928394|65597901|FG009|Treatment Period|Lost to Follow-up|0|||
23508024|NCT01928394|65597902|FG010|Treatment Period|Lost to Follow-up|0|||
23508025|NCT01928394|65597903|FG011|Treatment Period|Lost to Follow-up|0|||
23508026|NCT01928394|65597904|FG012|Treatment Period|Lost to Follow-up|0|||
23508027|NCT01928394|65597905|FG013|Treatment Period|Lost to Follow-up|0|||
23508028|NCT01928394|65597906|FG014|Treatment Period|Lost to Follow-up|0|||
23508029|NCT01928394|65597907|FG015|Treatment Period|Lost to Follow-up|0|||
23508030|NCT01928394|65597908|FG016|Treatment Period|Lost to Follow-up|0|||
23508031|NCT01928394|65597909|FG017|Treatment Period|Lost to Follow-up|0|||
23508032|NCT01928394|65597910|FG018|Treatment Period|Lost to Follow-up|0|||
23508033|NCT01928394|65597911|FG019|Treatment Period|Lost to Follow-up|0|||
23508034|NCT01928394|65597912|FG020|Treatment Period|Lost to Follow-up|0|||
23508035|NCT01928394|65597913|FG021|Treatment Period|Lost to Follow-up|0|||
23508036|NCT01928394|65597914|FG022|Treatment Period|Lost to Follow-up|1|||
23508037|NCT01928394|65597892|FG000|Treatment Period|Death|0|||
23508038|NCT01928394|65597893|FG001|Treatment Period|Death|0|||
23508039|NCT01928394|65597894|FG002|Treatment Period|Death|0|||
23508040|NCT01928394|65597895|FG003|Treatment Period|Death|0|||
23508041|NCT01928394|65597896|FG004|Treatment Period|Death|0|||
23508042|NCT01928394|65597897|FG005|Treatment Period|Death|0|||
23508043|NCT01928394|65597898|FG006|Treatment Period|Death|0|||
23508044|NCT01928394|65597899|FG007|Treatment Period|Death|0|||
23508045|NCT01928394|65597900|FG008|Treatment Period|Death|0|||
23508046|NCT01928394|65597901|FG009|Treatment Period|Death|0|||
23508047|NCT01928394|65597902|FG010|Treatment Period|Death|0|||
23508048|NCT01928394|65597903|FG011|Treatment Period|Death|0|||
23508049|NCT01928394|65597904|FG012|Treatment Period|Death|0|||
23508050|NCT01928394|65597905|FG013|Treatment Period|Death|1|||
23508051|NCT01928394|65597906|FG014|Treatment Period|Death|2|||
23508052|NCT01928394|65597907|FG015|Treatment Period|Death|0|||
23508053|NCT01928394|65597908|FG016|Treatment Period|Death|0|||
23508054|NCT01928394|65597909|FG017|Treatment Period|Death|0|||
23508055|NCT01928394|65597910|FG018|Treatment Period|Death|0|||
23508056|NCT01928394|65597911|FG019|Treatment Period|Death|0|||
23508057|NCT01928394|65597912|FG020|Treatment Period|Death|0|||
23508058|NCT01928394|65597913|FG021|Treatment Period|Death|0|||
23508059|NCT01928394|65597914|FG022|Treatment Period|Death|0|||
23508060|NCT01928394|65597892|FG000|Follow-up Period|Participant withdrew consent|3|||
23508061|NCT01928394|65597893|FG001|Follow-up Period|Participant withdrew consent|0|||
23508062|NCT01928394|65597894|FG002|Follow-up Period|Participant withdrew consent|1|||
23508063|NCT01928394|65597895|FG003|Follow-up Period|Participant withdrew consent|4|||
23508064|NCT01928394|65597896|FG004|Follow-up Period|Participant withdrew consent|0|||
23508065|NCT01928394|65597897|FG005|Follow-up Period|Participant withdrew consent|2|||
23508066|NCT01928394|65597898|FG006|Follow-up Period|Participant withdrew consent|5|||
23508067|NCT01928394|65597899|FG007|Follow-up Period|Participant withdrew consent|1|||
23508068|NCT01928394|65597900|FG008|Follow-up Period|Participant withdrew consent|0|||
23508069|NCT01928394|65597901|FG009|Follow-up Period|Participant withdrew consent|0|||
23508070|NCT01928394|65597902|FG010|Follow-up Period|Participant withdrew consent|5|||
23508071|NCT01928394|65597903|FG011|Follow-up Period|Participant withdrew consent|8|||
23508072|NCT01928394|65597904|FG012|Follow-up Period|Participant withdrew consent|2|||
23508073|NCT01928394|65597905|FG013|Follow-up Period|Participant withdrew consent|12|||
23508074|NCT01928394|65597906|FG014|Follow-up Period|Participant withdrew consent|7|||
23508075|NCT01928394|65597907|FG015|Follow-up Period|Participant withdrew consent|0|||
23508076|NCT01928394|65597908|FG016|Follow-up Period|Participant withdrew consent|5|||
23508077|NCT01928394|65597909|FG017|Follow-up Period|Participant withdrew consent|3|||
23508078|NCT01928394|65597910|FG018|Follow-up Period|Participant withdrew consent|2|||
23508079|NCT01928394|65597911|FG019|Follow-up Period|Participant withdrew consent|7|||
23508080|NCT01928394|65597912|FG020|Follow-up Period|Participant withdrew consent|4|||
23508081|NCT01928394|65597913|FG021|Follow-up Period|Participant withdrew consent|6|||
23508082|NCT01928394|65597914|FG022|Follow-up Period|Participant withdrew consent|2|||
23508083|NCT01928394|65597892|FG000|Follow-up Period|Death|0|||
23508084|NCT01928394|65597893|FG001|Follow-up Period|Death|0|||
23508085|NCT01928394|65597894|FG002|Follow-up Period|Death|2|||
23508086|NCT01928394|65597895|FG003|Follow-up Period|Death|6|||
23508087|NCT01928394|65597896|FG004|Follow-up Period|Death|0|||
23508088|NCT01928394|65597897|FG005|Follow-up Period|Death|6|||
23508089|NCT01928394|65597898|FG006|Follow-up Period|Death|6|||
23508090|NCT01928394|65597899|FG007|Follow-up Period|Death|2|||
23508091|NCT01928394|65597900|FG008|Follow-up Period|Death|1|||
23508092|NCT01928394|65597901|FG009|Follow-up Period|Death|2|||
23508093|NCT01928394|65597902|FG010|Follow-up Period|Death|4|||
23508094|NCT01928394|65597903|FG011|Follow-up Period|Death|12|||
23508095|NCT01928394|65597904|FG012|Follow-up Period|Death|11|||
23508096|NCT01928394|65597905|FG013|Follow-up Period|Death|25|||
23508097|NCT01928394|65597906|FG014|Follow-up Period|Death|18|||
23508098|NCT01928394|65597907|FG015|Follow-up Period|Death|0|||
23508099|NCT01928394|65597908|FG016|Follow-up Period|Death|6|||
23508100|NCT01928394|65597909|FG017|Follow-up Period|Death|5|||
23508101|NCT01928394|65597910|FG018|Follow-up Period|Death|13|||
23508102|NCT01928394|65597911|FG019|Follow-up Period|Death|13|||
23508103|NCT01928394|65597912|FG020|Follow-up Period|Death|5|||
23508104|NCT01928394|65597913|FG021|Follow-up Period|Death|3|||
23508105|NCT01928394|65597914|FG022|Follow-up Period|Death|2|||
23508106|NCT01928394|65597892|FG000|Follow-up Period|other reason|0|||
23508107|NCT01928394|65597893|FG001|Follow-up Period|other reason|0|||
23508108|NCT01928394|65597894|FG002|Follow-up Period|other reason|0|||
23508109|NCT01928394|65597895|FG003|Follow-up Period|other reason|0|||
23508110|NCT01928394|65597896|FG004|Follow-up Period|other reason|0|||
23508111|NCT01928394|65597897|FG005|Follow-up Period|other reason|0|||
23508112|NCT01928394|65597898|FG006|Follow-up Period|other reason|1|||
23508113|NCT01928394|65597899|FG007|Follow-up Period|other reason|3|||
23508114|NCT01928394|65597900|FG008|Follow-up Period|other reason|0|||
23508115|NCT01928394|65597901|FG009|Follow-up Period|other reason|0|||
23508116|NCT01928394|65597902|FG010|Follow-up Period|other reason|2|||
23508117|NCT01928394|65597903|FG011|Follow-up Period|other reason|1|||
23508118|NCT01928394|65597904|FG012|Follow-up Period|other reason|0|||
23508119|NCT01928394|65597905|FG013|Follow-up Period|other reason|1|||
23508120|NCT01928394|65597906|FG014|Follow-up Period|other reason|4|||
23508121|NCT01928394|65597907|FG015|Follow-up Period|other reason|0|||
23508122|NCT01928394|65597908|FG016|Follow-up Period|other reason|2|||
23508123|NCT01928394|65597909|FG017|Follow-up Period|other reason|0|||
23508124|NCT01928394|65597910|FG018|Follow-up Period|other reason|1|||
23508125|NCT01928394|65597911|FG019|Follow-up Period|other reason|1|||
23508126|NCT01928394|65597912|FG020|Follow-up Period|other reason|0|||
23508127|NCT01928394|65597913|FG021|Follow-up Period|other reason|0|||
23508128|NCT01928394|65597914|FG022|Follow-up Period|other reason|1|||
23508129|NCT01928394|65597892|FG000|Follow-up Period|Lost to Follow-up|0|||
23508130|NCT01928394|65597893|FG001|Follow-up Period|Lost to Follow-up|0|||
23508131|NCT01928394|65597894|FG002|Follow-up Period|Lost to Follow-up|0|||
23508132|NCT01928394|65597895|FG003|Follow-up Period|Lost to Follow-up|0|||
23508133|NCT01928394|65597896|FG004|Follow-up Period|Lost to Follow-up|0|||
23508134|NCT01928394|65597897|FG005|Follow-up Period|Lost to Follow-up|0|||
23508135|NCT01928394|65597898|FG006|Follow-up Period|Lost to Follow-up|0|||
23508136|NCT01928394|65597899|FG007|Follow-up Period|Lost to Follow-up|0|||
23508137|NCT01928394|65597900|FG008|Follow-up Period|Lost to Follow-up|0|||
23508138|NCT01928394|65597901|FG009|Follow-up Period|Lost to Follow-up|0|||
23508139|NCT01928394|65597902|FG010|Follow-up Period|Lost to Follow-up|0|||
23508140|NCT01928394|65597903|FG011|Follow-up Period|Lost to Follow-up|1|||
23508141|NCT01928394|65597904|FG012|Follow-up Period|Lost to Follow-up|1|||
23508142|NCT01928394|65597905|FG013|Follow-up Period|Lost to Follow-up|0|||
23508143|NCT01928394|65597906|FG014|Follow-up Period|Lost to Follow-up|1|||
23508144|NCT01928394|65597907|FG015|Follow-up Period|Lost to Follow-up|0|||
23508145|NCT01928394|65597908|FG016|Follow-up Period|Lost to Follow-up|1|||
23508146|NCT01928394|65597909|FG017|Follow-up Period|Lost to Follow-up|0|||
23508147|NCT01928394|65597910|FG018|Follow-up Period|Lost to Follow-up|0|||
23508148|NCT01928394|65597911|FG019|Follow-up Period|Lost to Follow-up|0|||
23508149|NCT01928394|65597912|FG020|Follow-up Period|Lost to Follow-up|0|||
23508150|NCT01928394|65597913|FG021|Follow-up Period|Lost to Follow-up|0|||
23508151|NCT01928394|65597914|FG022|Follow-up Period|Lost to Follow-up|1|||
23508152|NCT02155608|65597915|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
23508153|NCT02155608|65597916|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
23508154|NCT02155608|65597915|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
23508155|NCT02155608|65597916|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
23508156|NCT01153347|65597919|FG000|Overall Study|Withdrawal by Subject|7|||
23508157|NCT01153347|65597920|FG001|Overall Study|Withdrawal by Subject|7|||
23508158|NCT01153347|65597921|FG002|Overall Study|Withdrawal by Subject|7|||
23508159|NCT01153347|65597922|FG003|Overall Study|Withdrawal by Subject|7|||
23508160|NCT01153347|65597919|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23508161|NCT01153347|65597920|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23508162|NCT01153347|65597921|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23508163|NCT01153347|65597922|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23508164|NCT01153347|65597919|FG000|Overall Study|Adverse Event|3|||
23508165|NCT01153347|65597920|FG001|Overall Study|Adverse Event|9|||
23508166|NCT01153347|65597921|FG002|Overall Study|Adverse Event|21|||
23508167|NCT01153347|65597922|FG003|Overall Study|Adverse Event|7|||
23508168|NCT01153347|65597919|FG000|Overall Study|Severe non-compliance to protocol|6|||
23508169|NCT01153347|65597920|FG001|Overall Study|Severe non-compliance to protocol|7|||
23508170|NCT01153347|65597921|FG002|Overall Study|Severe non-compliance to protocol|4|||
23508171|NCT01153347|65597922|FG003|Overall Study|Severe non-compliance to protocol|3|||
23607393|NCT00696241|65950691|FG003|Overall Study|Adverse Event|4|||
23508172|NCT01153347|65597919|FG000|Overall Study|Condition under investigation worsened|1|||
23508173|NCT01153347|65597920|FG001|Overall Study|Condition under investigation worsened|1|||
23508174|NCT01153347|65597921|FG002|Overall Study|Condition under investigation worsened|0|||
23508175|NCT01153347|65597922|FG003|Overall Study|Condition under investigation worsened|0|||
23508176|NCT01153347|65597919|FG000|Overall Study|Lack of Efficacy|2|||
23508177|NCT01153347|65597920|FG001|Overall Study|Lack of Efficacy|2|||
23508178|NCT01153347|65597921|FG002|Overall Study|Lack of Efficacy|0|||
23508179|NCT01153347|65597922|FG003|Overall Study|Lack of Efficacy|4|||
23508180|NCT01153347|65597919|FG000|Overall Study|Study-specific withdrawal criteria|4|||
23508181|NCT01153347|65597920|FG001|Overall Study|Study-specific withdrawal criteria|3|||
23508182|NCT01153347|65597921|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23508183|NCT01153347|65597922|FG003|Overall Study|Study-specific withdrawal criteria|2|||
23508184|NCT01153347|65597919|FG000|Overall Study|Lost to Follow-up|4|||
23508185|NCT01153347|65597920|FG001|Overall Study|Lost to Follow-up|9|||
23508186|NCT01153347|65597921|FG002|Overall Study|Lost to Follow-up|11|||
23508187|NCT01153347|65597922|FG003|Overall Study|Lost to Follow-up|8|||
23508188|NCT01153347|65597919|FG000|Overall Study|Other|5|||
23508189|NCT01153347|65597920|FG001|Overall Study|Other|5|||
23508190|NCT01153347|65597921|FG002|Overall Study|Other|4|||
23508191|NCT01153347|65597922|FG003|Overall Study|Other|0|||
23508192|NCT01153347|65597919|FG000|Overall Study|Death|1|||
23508193|NCT01153347|65597920|FG001|Overall Study|Death|0|||
23508194|NCT01153347|65597921|FG002|Overall Study|Death|0|||
23508195|NCT01153347|65597922|FG003|Overall Study|Death|0|||
23508196|NCT02728076|65597923|FG000|Overall Study|Physician Decision|4|||
23508197|NCT00357968|65597928|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
23508198|NCT00357968|65597929|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
23508199|NCT00357968|65597928|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
23508200|NCT00357968|65597929|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
23508201|NCT00543140|65597930|FG000|Overall Study|Lost to Follow-up|33|||
23508202|NCT00543140|65597930|FG000|Overall Study|Withdrawal by Subject|13|||
23508203|NCT00543140|65597930|FG000|Overall Study|Protocol Violation|10|||
23508204|NCT00543140|65597930|FG000|Overall Study|Insufficient weight loss|10|||
23508205|NCT00543140|65597930|FG000|Overall Study|SAE leading to explant of SAGB|3|||
23508206|NCT00543140|65597930|FG000|Overall Study|Death|1|||
23508207|NCT00543140|65597930|FG000|Overall Study|Subject moved|1|||
23508208|NCT00543140|65597930|FG000|Overall Study|Conversion to different procedure|1|||
23508209|NCT01871532|65597932|FG000|Overall Study|Withdrawal by Subject|1|||
23508210|NCT01871532|65597933|FG001|Overall Study|Withdrawal by Subject|2|||
23508211|NCT02788357|65597936|FG000|Overall Study|Lost to Follow-up|3|||
23508212|NCT02788357|65597937|FG001|Overall Study|Lost to Follow-up|0|||
23508213|NCT02266225|65597938|FG000|Overall Study|Lost to Follow-up|2|||
23508214|NCT02266225|65597938|FG000|Overall Study|Death|1|||
23508215|NCT02266225|65597938|FG000|Overall Study|Withdrawal by Subject|13|||
23508216|NCT01339429|65597943|FG000|Overall Study|Withdrawal by Subject|1|||
23508217|NCT01339429|65597943|FG000|Overall Study|Physician Decision|3|||
23508218|NCT01025752|65597944|FG000|Overall Study|Lost to Follow-up|7|||
23508219|NCT01025752|65597945|FG001|Overall Study|Lost to Follow-up|10|||
23508220|NCT01025752|65597944|FG000|Overall Study|Physician Decision|1|||
23508221|NCT01025752|65597945|FG001|Overall Study|Physician Decision|3|||
23508222|NCT02507505|65597946|FG000|Overall Study|Withdrawal by Subject|13|||
23508223|NCT02507505|65597947|FG001|Overall Study|Withdrawal by Subject|11|||
23508224|NCT02507505|65597946|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
23508225|NCT02507505|65597947|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
23508226|NCT02507505|65597946|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
23508227|NCT02507505|65597947|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
23508228|NCT02507505|65597946|FG000|Overall Study|Death before receipt of anesthesia|0|||
23508229|NCT02507505|65597947|FG001|Overall Study|Death before receipt of anesthesia|1|||
23508230|NCT02860169|65597948|FG000|Part A|Withdrawal by Subject|1|||
23508231|NCT02860169|65597948|FG000|Part A|Other (Screening failure)|6|||
23508232|NCT02860169|65597948|FG000|Part A|Other (Survey not completed)|3|||
23508233|NCT02860169|65597948|FG000|Part A|Other (did not completed consent)|1|||
23508234|NCT02860169|65597948|FG000|Part B|Other (Screening failure)|10|||
23508235|NCT02860169|65597948|FG000|Part B|Withdrawal by Subject|1|||
23508236|NCT02860169|65597948|FG000|Part C|Other (Screening failure)|1|||
23508237|NCT00307294|65597949|FG000|Overall Study|Withdrawal by Subject|1|||
23508238|NCT04285879|65597950|FG000|Overall Study|Lost to Follow-up|1|||
23508239|NCT04285879|65597951|FG001|Overall Study|Lost to Follow-up|8|||
23508240|NCT04285879|65597950|FG000|Overall Study|medical/surgical exclusion|16|||
23508241|NCT04285879|65597951|FG001|Overall Study|medical/surgical exclusion|0|||
23508242|NCT04232124|65597952|FG000|Overall Study|Lost to Follow-up|3|||
23508243|NCT02239978|65597953|FG000|Overall Study|Withdrawal by Subject|2|||
23508244|NCT02239978|65597954|FG001|Overall Study|Withdrawal by Subject|0|||
23508245|NCT00600483|65597955|FG000|Overall Study|Lost to Follow-up|26|||
23508246|NCT00600483|65597956|FG001|Overall Study|Lost to Follow-up|47|||
23408564|NCT00041470|65239922|FG000|Overall Study|Loss of Funding|38|||
23508247|NCT00600483|65597955|FG000|Overall Study|Randomized but not treated|10|||
23508248|NCT00600483|65597956|FG001|Overall Study|Randomized but not treated|0|||
23508249|NCT01244425|65597957|FG000|Overall Study|Withdrawal by Subject|2|||
23508250|NCT01244425|65597958|FG001|Overall Study|Withdrawal by Subject|2|||
23508251|NCT01244425|65597957|FG000|Overall Study|Adverse Event|1|||
23508252|NCT01244425|65597958|FG001|Overall Study|Adverse Event|1|||
23508253|NCT03535844|65597959|FG000|Overall Study|Withdrawal by Subject|0|||
23508254|NCT03535844|65597960|FG001|Overall Study|Withdrawal by Subject|1|||
23508255|NCT02323113|65597963|FG000|Overall Study|Adverse Event|3|||
23508256|NCT02323113|65597964|FG001|Overall Study|Adverse Event|3|||
23508257|NCT02323113|65597965|FG002|Overall Study|Adverse Event|2|||
23508258|NCT02323113|65597966|FG003|Overall Study|Adverse Event|5|||
23508259|NCT02323113|65597967|FG004|Overall Study|Adverse Event|8|||
23508260|NCT02323113|65597968|FG005|Overall Study|Adverse Event|3|||
23508261|NCT02323113|65597969|FG006|Overall Study|Adverse Event|6|||
23508262|NCT02323113|65597970|FG007|Overall Study|Adverse Event|0|||
23508263|NCT02323113|65597963|FG000|Overall Study|Progressive Disease|0|||
23508264|NCT02323113|65597964|FG001|Overall Study|Progressive Disease|1|||
23508265|NCT02323113|65597965|FG002|Overall Study|Progressive Disease|1|||
23508266|NCT02323113|65597966|FG003|Overall Study|Progressive Disease|0|||
23508267|NCT02323113|65597967|FG004|Overall Study|Progressive Disease|0|||
23508268|NCT02323113|65597968|FG005|Overall Study|Progressive Disease|3|||
23508269|NCT02323113|65597969|FG006|Overall Study|Progressive Disease|0|||
23508270|NCT02323113|65597970|FG007|Overall Study|Progressive Disease|0|||
23508271|NCT02323113|65597963|FG000|Overall Study|Symptomatic Deterioration|0|||
23508272|NCT02323113|65597964|FG001|Overall Study|Symptomatic Deterioration|0|||
23508273|NCT02323113|65597965|FG002|Overall Study|Symptomatic Deterioration|1|||
23508274|NCT02323113|65597966|FG003|Overall Study|Symptomatic Deterioration|0|||
23508275|NCT02323113|65597967|FG004|Overall Study|Symptomatic Deterioration|1|||
23508276|NCT02323113|65597968|FG005|Overall Study|Symptomatic Deterioration|0|||
23508277|NCT02323113|65597969|FG006|Overall Study|Symptomatic Deterioration|0|||
23607394|NCT00696241|65950692|FG004|Overall Study|Adverse Event|5|||
23508278|NCT02323113|65597970|FG007|Overall Study|Symptomatic Deterioration|0|||
23508279|NCT02323113|65597963|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23508280|NCT02323113|65597964|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
23508281|NCT02323113|65597965|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508282|NCT02323113|65597966|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508283|NCT02323113|65597967|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508284|NCT02323113|65597968|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
23508285|NCT02323113|65597969|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508286|NCT02323113|65597970|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508287|NCT02323113|65597963|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508288|NCT02323113|65597964|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
23508289|NCT02323113|65597965|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508290|NCT02323113|65597966|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508291|NCT02323113|65597967|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508292|NCT02323113|65597968|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508293|NCT02323113|65597969|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508294|NCT02323113|65597970|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508295|NCT01979016|65597971|FG000|Overall Study|Withdrawal by Subject|2|||
23508296|NCT01979016|65597972|FG001|Overall Study|Withdrawal by Subject|0|||
23508297|NCT01979016|65597971|FG000|Overall Study|Adverse Event|0|||
23508298|NCT01979016|65597972|FG001|Overall Study|Adverse Event|1|||
23508299|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508300|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
23508301|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508302|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508303|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508304|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508305|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
23508306|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
23508307|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
23508308|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
23508309|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
23508310|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
23508311|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
23508312|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508313|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
23607395|NCT00696241|65950688|FG000|Overall Study|Protocol Violation|1|||
23508314|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508315|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
23508316|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508317|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508318|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508319|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508320|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508321|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
23508322|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508323|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508324|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
23508325|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508326|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508327|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508328|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508329|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
23508330|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508331|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508332|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
23508333|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508334|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
23508335|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508336|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508337|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508338|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
23508339|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508340|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508341|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508342|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508343|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508344|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508345|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508346|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
23508347|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508348|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508349|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508350|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508351|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508352|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
23508353|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508354|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508355|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508356|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508357|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508358|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
23508359|NCT01906008|65597981|FG000|Overall Study|Lost to Follow-up|2|||
23508360|NCT01906008|65597982|FG001|Overall Study|Lost to Follow-up|0|||
23508361|NCT01906008|65597981|FG000|Overall Study|Oxaliplatin toxicity|2|||
23508362|NCT01906008|65597982|FG001|Overall Study|Oxaliplatin toxicity|0|||
23508363|NCT01906008|65597981|FG000|Overall Study|Protocol Violation|0|||
23508364|NCT01906008|65597982|FG001|Overall Study|Protocol Violation|1|||
23508365|NCT01906008|65597981|FG000|Overall Study|Withdrawal by Subject|1|||
23508366|NCT01906008|65597982|FG001|Overall Study|Withdrawal by Subject|5|||
23508367|NCT01906008|65597981|FG000|Overall Study|Did not start study med|3|||
23508368|NCT01906008|65597982|FG001|Overall Study|Did not start study med|4|||
23508369|NCT01906008|65597981|FG000|Overall Study|Oxaliplatin stops|10|||
23508370|NCT01906008|65597982|FG001|Overall Study|Oxaliplatin stops|8|||
23508371|NCT01906008|65597981|FG000|Overall Study|Hospice|1|||
23508372|NCT01906008|65597982|FG001|Overall Study|Hospice|0|||
23508373|NCT01906008|65597981|FG000|Overall Study|Physician Decision|3|||
23508374|NCT01906008|65597982|FG001|Overall Study|Physician Decision|3|||
23508375|NCT01906008|65597981|FG000|Overall Study|Lack of compliance of study med|5|||
23508376|NCT01906008|65597982|FG001|Overall Study|Lack of compliance of study med|3|||
23508377|NCT01906008|65597981|FG000|Overall Study|Adverse Event|0|||
23508378|NCT01906008|65597982|FG001|Overall Study|Adverse Event|3|||
23508379|NCT02167893|65597983|FG000|Overall Study|Investigator transferred|85|||
23508380|NCT02167893|65597983|FG000|Overall Study|Investigator health reasons|10|||
23508381|NCT02167893|65597983|FG000|Overall Study|Case report forms not collected|68|||
23508382|NCT01892293|65597984|FG000|Overall Study|Apheresed but not treated|4|||
23508383|NCT02760069|65597989|FG000|Overall Study|Withdrawal by Subject|0|||
23508384|NCT02760069|65597990|FG001|Overall Study|Withdrawal by Subject|1|||
23508385|NCT02760069|65597991|FG002|Overall Study|Withdrawal by Subject|1|||
23508386|NCT01385202|65597992|FG000|Overall Study|Lost to Follow-up|6|||
23508387|NCT01385202|65597992|FG000|Overall Study|Not Eligible|11|||
23508388|NCT01385202|65597992|FG000|Overall Study|Withdrawn|1|||
23508389|NCT00203996|65598000|FG000|Overall Study|Lost to Follow-up|0|||
23508390|NCT00203996|65598001|FG001|Overall Study|Lost to Follow-up|0|||
23508391|NCT00203996|65598002|FG002|Overall Study|Lost to Follow-up|0|||
23508392|NCT00203996|65598003|FG003|Overall Study|Lost to Follow-up|1|||
23508393|NCT00203996|65598004|FG004|Overall Study|Lost to Follow-up|0|||
23508394|NCT00203996|65598005|FG005|Overall Study|Lost to Follow-up|0|||
23508395|NCT00203996|65598006|FG006|Overall Study|Lost to Follow-up|0|||
23508396|NCT00203996|65598007|FG007|Overall Study|Lost to Follow-up|0|||
23508397|NCT00203996|65598008|FG008|Overall Study|Lost to Follow-up|0|||
23508398|NCT00203996|65598009|FG009|Overall Study|Lost to Follow-up|0|||
23508399|NCT00203996|65598000|FG000|Overall Study|Protocol Violation|0|||
23508400|NCT00203996|65598001|FG001|Overall Study|Protocol Violation|0|||
23508401|NCT00203996|65598002|FG002|Overall Study|Protocol Violation|0|||
23508402|NCT00203996|65598003|FG003|Overall Study|Protocol Violation|6|||
23508403|NCT00203996|65598004|FG004|Overall Study|Protocol Violation|1|||
23508404|NCT00203996|65598005|FG005|Overall Study|Protocol Violation|0|||
23508405|NCT00203996|65598006|FG006|Overall Study|Protocol Violation|0|||
23508406|NCT00203996|65598007|FG007|Overall Study|Protocol Violation|0|||
23508407|NCT00203996|65598008|FG008|Overall Study|Protocol Violation|0|||
23508408|NCT00203996|65598009|FG009|Overall Study|Protocol Violation|0|||
23508409|NCT00203996|65598000|FG000|Overall Study|Physician Decision|0|||
23508410|NCT00203996|65598001|FG001|Overall Study|Physician Decision|0|||
23508411|NCT00203996|65598002|FG002|Overall Study|Physician Decision|0|||
23508412|NCT00203996|65598003|FG003|Overall Study|Physician Decision|2|||
23508413|NCT00203996|65598004|FG004|Overall Study|Physician Decision|0|||
23508414|NCT00203996|65598005|FG005|Overall Study|Physician Decision|0|||
23508415|NCT00203996|65598006|FG006|Overall Study|Physician Decision|0|||
23508416|NCT00203996|65598007|FG007|Overall Study|Physician Decision|0|||
23508417|NCT00203996|65598008|FG008|Overall Study|Physician Decision|0|||
23508418|NCT00203996|65598009|FG009|Overall Study|Physician Decision|1|||
23508419|NCT00203996|65598000|FG000|Overall Study|CPAP machine malfunction|0|||
23508420|NCT00203996|65598001|FG001|Overall Study|CPAP machine malfunction|0|||
23508421|NCT00203996|65598002|FG002|Overall Study|CPAP machine malfunction|0|||
23508422|NCT00203996|65598003|FG003|Overall Study|CPAP machine malfunction|1|||
23508423|NCT00203996|65598004|FG004|Overall Study|CPAP machine malfunction|0|||
23508424|NCT00203996|65598005|FG005|Overall Study|CPAP machine malfunction|0|||
23508425|NCT00203996|65598006|FG006|Overall Study|CPAP machine malfunction|0|||
23508426|NCT00203996|65598007|FG007|Overall Study|CPAP machine malfunction|0|||
23508427|NCT00203996|65598008|FG008|Overall Study|CPAP machine malfunction|0|||
23508428|NCT00203996|65598009|FG009|Overall Study|CPAP machine malfunction|0|||
23508429|NCT00203996|65598000|FG000|Overall Study|Scheduling issue|0|||
23508430|NCT00203996|65598001|FG001|Overall Study|Scheduling issue|0|||
23508431|NCT00203996|65598002|FG002|Overall Study|Scheduling issue|0|||
23508432|NCT00203996|65598003|FG003|Overall Study|Scheduling issue|0|||
23508433|NCT00203996|65598004|FG004|Overall Study|Scheduling issue|0|||
23508434|NCT00203996|65598005|FG005|Overall Study|Scheduling issue|0|||
23508435|NCT00203996|65598006|FG006|Overall Study|Scheduling issue|0|||
23508436|NCT00203996|65598007|FG007|Overall Study|Scheduling issue|2|||
23508437|NCT00203996|65598008|FG008|Overall Study|Scheduling issue|0|||
23508438|NCT00203996|65598009|FG009|Overall Study|Scheduling issue|0|||
23508439|NCT00160251|65598010|FG000|Prior to Amendment 2|Adverse Event|2|||
23508440|NCT00160251|65598011|FG001|Prior to Amendment 2|Adverse Event|1|||
23508441|NCT00160251|65598012|FG002|Prior to Amendment 2|Adverse Event|3|||
23508442|NCT00160251|65598013|FG003|Prior to Amendment 2|Adverse Event|1|||
23508443|NCT00160251|65598014|FG004|Prior to Amendment 2|Adverse Event|1|||
23508444|NCT00160251|65598015|FG005|Prior to Amendment 2|Adverse Event|1|||
23508445|NCT00160251|65598016|FG006|Prior to Amendment 2|Adverse Event|1|||
23508446|NCT00160251|65598017|FG007|Prior to Amendment 2|Adverse Event|0|||
23508447|NCT00160251|65598010|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
23508448|NCT00160251|65598011|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
23508449|NCT00160251|65598012|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
23508450|NCT00160251|65598013|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
23508451|NCT00160251|65598014|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
23508452|NCT00160251|65598015|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
23508453|NCT00160251|65598016|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
23508454|NCT00160251|65598017|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
23508455|NCT00160251|65598010|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
23508456|NCT00160251|65598011|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
23508457|NCT00160251|65598012|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
23508458|NCT00160251|65598013|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
23508459|NCT00160251|65598014|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
23508460|NCT00160251|65598015|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
23508461|NCT00160251|65598016|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
23508462|NCT00160251|65598017|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
23508463|NCT00160251|65598010|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
23508464|NCT00160251|65598011|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
23508465|NCT00160251|65598012|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
23508466|NCT00160251|65598013|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
23508467|NCT00160251|65598014|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
23508468|NCT00160251|65598015|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
23508469|NCT00160251|65598016|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
23508470|NCT00160251|65598017|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
23508471|NCT00160251|65598010|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
23508472|NCT00160251|65598011|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
23508473|NCT00160251|65598012|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
23508474|NCT00160251|65598013|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
23508475|NCT00160251|65598014|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
23508476|NCT00160251|65598015|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
23508477|NCT00160251|65598016|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
23508478|NCT00160251|65598017|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
23508479|NCT00160251|65598010|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
23508480|NCT00160251|65598011|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
23508481|NCT00160251|65598012|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
23508482|NCT00160251|65598013|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
23508483|NCT00160251|65598014|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
23508484|NCT00160251|65598015|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
23508485|NCT00160251|65598016|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
23508486|NCT00160251|65598017|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
23508487|NCT00160251|65598010|FG000|Post-amendment 2|Adverse Event|0|||
23508488|NCT00160251|65598011|FG001|Post-amendment 2|Adverse Event|0|||
23508489|NCT00160251|65598012|FG002|Post-amendment 2|Adverse Event|0|||
23508490|NCT00160251|65598013|FG003|Post-amendment 2|Adverse Event|0|||
23508491|NCT00160251|65598014|FG004|Post-amendment 2|Adverse Event|0|||
23508492|NCT00160251|65598015|FG005|Post-amendment 2|Adverse Event|0|||
23508493|NCT00160251|65598016|FG006|Post-amendment 2|Adverse Event|0|||
23508494|NCT00160251|65598017|FG007|Post-amendment 2|Adverse Event|20|||
23508495|NCT00160251|65598010|FG000|Post-amendment 2|Lack of Efficacy|0|||
23508496|NCT00160251|65598011|FG001|Post-amendment 2|Lack of Efficacy|0|||
23508497|NCT00160251|65598012|FG002|Post-amendment 2|Lack of Efficacy|0|||
23508498|NCT00160251|65598013|FG003|Post-amendment 2|Lack of Efficacy|0|||
23508499|NCT00160251|65598014|FG004|Post-amendment 2|Lack of Efficacy|0|||
23508500|NCT00160251|65598015|FG005|Post-amendment 2|Lack of Efficacy|0|||
23508501|NCT00160251|65598016|FG006|Post-amendment 2|Lack of Efficacy|0|||
23508502|NCT00160251|65598017|FG007|Post-amendment 2|Lack of Efficacy|24|||
23508503|NCT00160251|65598010|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508504|NCT00160251|65598011|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508505|NCT00160251|65598012|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508506|NCT00160251|65598013|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508507|NCT00160251|65598014|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508508|NCT00160251|65598015|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508509|NCT00160251|65598016|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508510|NCT00160251|65598017|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
23508511|NCT02547454|65598018|FG000|Overall Study|Due to hemodialysis|53|||
23508512|NCT02547454|65598018|FG000|Overall Study|Due to transplantation|1|||
23508513|NCT02547454|65598018|FG000|Overall Study|Due to no further need to treat|4|||
23508514|NCT02547454|65598018|FG000|Overall Study|Death|38|||
23508515|NCT02547454|65598018|FG000|Overall Study|Lost to Follow-up|26|||
23508516|NCT02547454|65598018|FG000|Overall Study|Other|39|||
23508517|NCT02547454|65598018|FG000|Overall Study|No data|11|||
23508518|NCT05255068|65598019|FG000|Overall Study|Lost to Follow-up|0|||
23508519|NCT05255068|65598020|FG001|Overall Study|Lost to Follow-up|1|||
23508520|NCT02573350|65598023|FG000|Overall Study|Lost to Follow-up|2|||
23508521|NCT02573350|65598024|FG001|Overall Study|Lost to Follow-up|1|||
23508522|NCT02573350|65598023|FG000|Overall Study|Adverse Event|3|||
23508523|NCT02573350|65598024|FG001|Overall Study|Adverse Event|4|||
23508524|NCT02573350|65598023|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
23508525|NCT02573350|65598024|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
23508526|NCT02573350|65598023|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
23508527|NCT02573350|65598024|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
23508528|NCT02573350|65598023|FG000|Overall Study|Subject withdrew consent to participate|6|||
23508529|NCT02573350|65598024|FG001|Overall Study|Subject withdrew consent to participate|1|||
23508530|NCT02573350|65598023|FG000|Overall Study|Protocol Deviation|1|||
23508531|NCT02573350|65598024|FG001|Overall Study|Protocol Deviation|1|||
23508532|NCT03547687|65598025|FG000|Overall Study|Withdrawal by Subject|1|||
23508533|NCT03547687|65598025|FG000|Overall Study|Death|1|||
23508534|NCT05227027|65598040|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
23508535|NCT05227027|65598041|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
23508536|NCT02480114|65598042|FG000|Overall Study|Not completing surveys|3|||
23508537|NCT02480114|65598043|FG001|Overall Study|Not completing surveys|2|||
23508538|NCT02480114|65598042|FG000|Overall Study|Withdrawal by Subject|2|||
23508539|NCT02480114|65598043|FG001|Overall Study|Withdrawal by Subject|4|||
23508540|NCT02480114|65598042|FG000|Overall Study|Disease progression|3|||
23508541|NCT02480114|65598043|FG001|Overall Study|Disease progression|0|||
23508542|NCT02480114|65598042|FG000|Overall Study|Improper completion of survey|1|||
23508543|NCT02480114|65598043|FG001|Overall Study|Improper completion of survey|1|||
23508544|NCT02480114|65598042|FG000|Overall Study|Not eligible|0|||
23508545|NCT02480114|65598043|FG001|Overall Study|Not eligible|1|||
23508546|NCT01029795|65598044|FG000|Overall Study|Entry Criteria Not Met|2|||
23508547|NCT01029795|65598045|FG001|Overall Study|Entry Criteria Not Met|1|||
23508548|NCT01029795|65598044|FG000|Overall Study|Physician Decision|2|||
23508549|NCT01029795|65598045|FG001|Overall Study|Physician Decision|1|||
23508550|NCT01029795|65598044|FG000|Overall Study|Sponsor Decision|11|||
23508551|NCT01029795|65598045|FG001|Overall Study|Sponsor Decision|17|||
23508552|NCT01029795|65598044|FG000|Overall Study|Withdrawal by Subject|1|||
23508553|NCT01029795|65598045|FG001|Overall Study|Withdrawal by Subject|3|||
23508554|NCT02375113|65598046|FG000|Overall Study|Undisclosed Reason(s).|1|||
23508555|NCT02375113|65598047|FG001|Overall Study|Undisclosed Reason(s).|1|||
23508556|NCT02375113|65598046|FG000|Overall Study|Poor adherence (<70%).|1|||
23508557|NCT02375113|65598047|FG001|Overall Study|Poor adherence (<70%).|0|||
23508558|NCT02375113|65598046|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
23508559|NCT02375113|65598047|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
23508560|NCT03292588|65598048|FG000|Overall Study|Death|1|||
23508561|NCT03292588|65598049|FG001|Overall Study|Death|0|||
23508562|NCT03292588|65598048|FG000|Overall Study|Lost to Follow-up|12|||
23508563|NCT03292588|65598049|FG001|Overall Study|Lost to Follow-up|16|||
23508564|NCT03292588|65598048|FG000|Overall Study|Physician Decision|0|||
23508565|NCT03292588|65598049|FG001|Overall Study|Physician Decision|1|||
23508566|NCT03292588|65598048|FG000|Overall Study|Withdrawal by Subject|4|||
23508567|NCT03292588|65598049|FG001|Overall Study|Withdrawal by Subject|4|||
23508568|NCT03292588|65598048|FG000|Overall Study|Move out of town|1|||
23508569|NCT03292588|65598049|FG001|Overall Study|Move out of town|0|||
23508570|NCT03292588|65598048|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
23508571|NCT03292588|65598049|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
23508572|NCT04868890|65598050|FG000|Overall Study|Death|2|||
23508573|NCT04868890|65598051|FG001|Overall Study|Death|1|||
23508574|NCT04868890|65598050|FG000|Overall Study|Withdrawal by Subject|1|||
23508575|NCT04868890|65598051|FG001|Overall Study|Withdrawal by Subject|5|||
23508576|NCT03694821|65598064|FG000|Overall Study|Study terminated|4|||
23508577|NCT03694821|65598065|FG001|Overall Study|Study terminated|8|||
23508578|NCT03694821|65598066|FG002|Overall Study|Study terminated|4|||
23508579|NCT03018704|65598069|FG000|Overall Study|Lost to Follow-up|1|||
23508580|NCT03018704|65598070|FG001|Overall Study|Lost to Follow-up|1|||
23508581|NCT00439244|65598072|FG000|Overall Study|Adverse Event|5|||
23508582|NCT00439244|65598073|FG001|Overall Study|Adverse Event|2|||
23508583|NCT00439244|65598074|FG002|Overall Study|Adverse Event|3|||
23508584|NCT00439244|65598072|FG000|Overall Study|Withdrawal by Subject|3|||
23508585|NCT00439244|65598073|FG001|Overall Study|Withdrawal by Subject|1|||
23508586|NCT00439244|65598074|FG002|Overall Study|Withdrawal by Subject|2|||
23508587|NCT00439244|65598072|FG000|Overall Study|Lost to Follow-up|2|||
23508588|NCT00439244|65598073|FG001|Overall Study|Lost to Follow-up|1|||
23508589|NCT00439244|65598074|FG002|Overall Study|Lost to Follow-up|2|||
23508590|NCT00439244|65598072|FG000|Overall Study|Death|0|||
23508591|NCT00439244|65598073|FG001|Overall Study|Death|1|||
23508592|NCT00439244|65598074|FG002|Overall Study|Death|0|||
23508593|NCT00439244|65598072|FG000|Overall Study|Protocol Violation|0|||
23508594|NCT00439244|65598073|FG001|Overall Study|Protocol Violation|1|||
23508595|NCT00439244|65598074|FG002|Overall Study|Protocol Violation|0|||
23508596|NCT00439244|65598072|FG000|Overall Study|Administrative problems|1|||
23508597|NCT00439244|65598073|FG001|Overall Study|Administrative problems|0|||
23508598|NCT00439244|65598074|FG002|Overall Study|Administrative problems|0|||
23508599|NCT00965718|65598075|FG000|Overall Study|Withdrawal by Subject|4|||
23508600|NCT00004978|65598085|FG000|Overall Study|Death|107|||
23508601|NCT00004978|65598086|FG001|Overall Study|Death|116|||
23508602|NCT00004978|65598085|FG000|Overall Study|Lost to Follow-up|101|||
23508603|NCT00004978|65598086|FG001|Overall Study|Lost to Follow-up|108|||
23508604|NCT00004978|65598085|FG000|Overall Study|Withdrawal by Subject|17|||
23508605|NCT00004978|65598086|FG001|Overall Study|Withdrawal by Subject|26|||
23508606|NCT00004978|65598085|FG000|Overall Study|site closure - not in analysis cohort|19|||
23607396|NCT00696241|65950689|FG001|Overall Study|Protocol Violation|1|||
23508607|NCT00004978|65598086|FG001|Overall Study|site closure - not in analysis cohort|20|||
23508608|NCT02670837|65598087|FG000|Overall Study|Death|2|||
23508609|NCT02670837|65598088|FG001|Overall Study|Death|0|||
23508610|NCT02670837|65598089|FG002|Overall Study|Death|0|||
23508611|NCT01985867|65598090|FG000|Overall Study|Lost to Follow-up|3|||
23508612|NCT01985867|65598091|FG001|Overall Study|Lost to Follow-up|4|||
23508613|NCT01985867|65598090|FG000|Overall Study|Adverse Event|3|||
23508614|NCT01985867|65598091|FG001|Overall Study|Adverse Event|2|||
23508615|NCT01985867|65598090|FG000|Overall Study|Lack of Efficacy|1|||
23508616|NCT01985867|65598091|FG001|Overall Study|Lack of Efficacy|0|||
23508617|NCT02132130|65598092|FG000|Overall Study|Lost to Follow-up|0|||
23508618|NCT02132130|65598093|FG001|Overall Study|Lost to Follow-up|2|||
23508619|NCT02132130|65598094|FG002|Overall Study|Lost to Follow-up|0|||
23508620|NCT02132130|65598095|FG003|Overall Study|Lost to Follow-up|0|||
23508621|NCT02132130|65598092|FG000|Overall Study|Withdrawal by Subject|0|||
23508622|NCT02132130|65598093|FG001|Overall Study|Withdrawal by Subject|0|||
23508623|NCT02132130|65598094|FG002|Overall Study|Withdrawal by Subject|0|||
23508624|NCT02132130|65598095|FG003|Overall Study|Withdrawal by Subject|1|||
23508625|NCT00023764|65598096|FG000|Overall Study|Other|1|||
23508626|NCT00023764|65598096|FG000|Overall Study|Adverse Event|4|||
23508627|NCT00023764|65598096|FG000|Overall Study|Withdrawal by Subject|1|||
23508628|NCT00023764|65598096|FG000|Overall Study|Progression of disease|6|||
23508629|NCT00023764|65598096|FG000|Overall Study|patient received other treatment|1|||
23508630|NCT00023764|65598096|FG000|Overall Study|delay in obtaining staging images|1|||
23508631|NCT04342897|65598097|FG000|Overall Study|Death|7|||
23508632|NCT04342897|65598098|FG001|Overall Study|Death|4|||
23508633|NCT04342897|65598097|FG000|Overall Study|Lost to Follow-up|6|||
23508634|NCT04342897|65598098|FG001|Overall Study|Lost to Follow-up|6|||
23508635|NCT04342897|65598097|FG000|Overall Study|Withdrawal by Subject|1|||
23508636|NCT04342897|65598098|FG001|Overall Study|Withdrawal by Subject|2|||
23508637|NCT01833520|65598101|FG000|Overall Study|Lack of Efficacy|3|||
23508638|NCT01833520|65598102|FG001|Overall Study|Lack of Efficacy|3|||
23508639|NCT01833520|65598103|FG002|Overall Study|Lack of Efficacy|8|||
23508640|NCT01833520|65598104|FG003|Overall Study|Lack of Efficacy|3|||
23508641|NCT04605484|65598105|FG000|Overall Study|Lost to Follow-up|0|||
23508642|NCT04605484|65598106|FG001|Overall Study|Lost to Follow-up|1|||
23508643|NCT04605484|65598107|FG002|Overall Study|Lost to Follow-up|1|||
23508644|NCT04605484|65598105|FG000|Overall Study|Other|0|||
23508645|NCT04605484|65598106|FG001|Overall Study|Other|1|||
23508646|NCT04605484|65598107|FG002|Overall Study|Other|0|||
23508647|NCT00642460|65598108|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508648|NCT00642460|65598109|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
23508649|NCT00642460|65598110|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
23508650|NCT00642460|65598111|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508651|NCT00642460|65598112|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508652|NCT00642460|65598113|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508653|NCT00642460|65598108|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
23508654|NCT00642460|65598109|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508655|NCT00642460|65598110|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508656|NCT00642460|65598111|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508657|NCT00642460|65598112|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508658|NCT00642460|65598113|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508659|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
23508660|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
23508661|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508662|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508663|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508664|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508665|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Death|0|||
23508666|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Death|1|||
23508667|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Death|0|||
23508668|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Death|2|||
23508669|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Death|0|||
23508670|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Death|0|||
23508671|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
23508672|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
23508673|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508674|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508675|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508676|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508677|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
23508678|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
23508679|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508680|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508681|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508682|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508683|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508684|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
23508685|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508686|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508687|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508688|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508689|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508690|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508691|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508692|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
23508693|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508694|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508695|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508696|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508697|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508698|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508699|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
23508700|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
23508701|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508702|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508703|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508704|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508705|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
23508706|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
23508707|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508708|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508709|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508710|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508711|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
23508712|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
23508713|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508714|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508715|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508716|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508717|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
23508718|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
23508719|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Other|0|||
23508720|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Other|0|||
23508721|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Other|0|||
23508722|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Other|0|||
23508723|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Other|2|||
23508724|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Other|2|||
23508725|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Death|0|||
23508726|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Death|0|||
23508727|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Death|0|||
23508728|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Death|0|||
23508729|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Death|0|||
23508730|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Death|3|||
23508731|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508732|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508733|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508734|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508735|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508736|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
23508737|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508738|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508739|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508740|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508741|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
23508742|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
23508743|NCT01958008|65598114|FG000|Overall Study|Worsening of disease under study|0|||
23508744|NCT01958008|65598115|FG001|Overall Study|Worsening of disease under study|0|||
23508745|NCT01958008|65598116|FG002|Overall Study|Worsening of disease under study|1|||
23508746|NCT01958008|65598117|FG003|Overall Study|Worsening of disease under study|0|||
23508747|NCT01958008|65598114|FG000|Overall Study|Other adverse event|1|||
23508748|NCT01958008|65598115|FG001|Overall Study|Other adverse event|0|||
23508749|NCT01958008|65598116|FG002|Overall Study|Other adverse event|0|||
23508750|NCT01958008|65598117|FG003|Overall Study|Other adverse event|0|||
23508751|NCT04952402|65598118|FG000|Overall Study|Lost to Follow-up|1|||
23508752|NCT04952402|65598119|FG001|Overall Study|Lost to Follow-up|3|||
23508753|NCT04952402|65598118|FG000|Overall Study|Lack Of Venous Access|0|||
23508754|NCT04952402|65598119|FG001|Overall Study|Lack Of Venous Access|1|||
23508755|NCT02450903|65598122|FG000|Overall Study|Adverse Event|3|||
23508756|NCT02450903|65598122|FG000|Overall Study|Progressive disease|15|||
23508757|NCT02450903|65598122|FG000|Overall Study|Switched to commercial drug|1|||
23508758|NCT02450903|65598122|FG000|Overall Study|Subject/guardian decision|1|||
23508759|NCT01053221|65598123|FG000|Overall Study|The study was closed prematurely|5|||
23508760|NCT01053221|65598124|FG001|Overall Study|The study was closed prematurely|9|||
23508761|NCT04118166|65598132|FG000|Overall Study|Adverse Event|1|||
23508762|NCT00420927|65598137|FG000|Period 1|Adverse Event|19|||
23508763|NCT00420927|65598138|FG001|Period 1|Adverse Event|15|||
23508764|NCT00420927|65598139|FG002|Period 1|Adverse Event|0|||
23508765|NCT00420927|65598140|FG003|Period 1|Adverse Event|0|||
23508766|NCT00420927|65598141|FG004|Period 1|Adverse Event|0|||
23508767|NCT00420927|65598142|FG005|Period 1|Adverse Event|0|||
23508768|NCT00420927|65598143|FG006|Period 1|Adverse Event|0|||
23508769|NCT00420927|65598137|FG000|Period 1|Withdrawal by Subject|7|||
23508770|NCT00420927|65598138|FG001|Period 1|Withdrawal by Subject|12|||
23508771|NCT00420927|65598139|FG002|Period 1|Withdrawal by Subject|0|||
23508772|NCT00420927|65598140|FG003|Period 1|Withdrawal by Subject|0|||
23508773|NCT00420927|65598141|FG004|Period 1|Withdrawal by Subject|0|||
23508774|NCT00420927|65598142|FG005|Period 1|Withdrawal by Subject|0|||
23508775|NCT00420927|65598143|FG006|Period 1|Withdrawal by Subject|0|||
23508776|NCT00420927|65598137|FG000|Period 1|Lost to Follow-up|8|||
23508777|NCT00420927|65598138|FG001|Period 1|Lost to Follow-up|6|||
23508778|NCT00420927|65598139|FG002|Period 1|Lost to Follow-up|0|||
23508779|NCT00420927|65598140|FG003|Period 1|Lost to Follow-up|0|||
23508780|NCT00420927|65598141|FG004|Period 1|Lost to Follow-up|0|||
23508781|NCT00420927|65598142|FG005|Period 1|Lost to Follow-up|0|||
23508782|NCT00420927|65598143|FG006|Period 1|Lost to Follow-up|0|||
23508783|NCT00420927|65598137|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
23508784|NCT00420927|65598138|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
23508785|NCT00420927|65598139|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508786|NCT00420927|65598140|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508787|NCT00420927|65598141|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508788|NCT00420927|65598142|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508789|NCT00420927|65598143|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508790|NCT00420927|65598137|FG000|Period 1|Death|2|||
23508791|NCT00420927|65598138|FG001|Period 1|Death|0|||
23508792|NCT00420927|65598139|FG002|Period 1|Death|0|||
23508793|NCT00420927|65598140|FG003|Period 1|Death|0|||
23508794|NCT00420927|65598141|FG004|Period 1|Death|0|||
23508795|NCT00420927|65598142|FG005|Period 1|Death|0|||
23508796|NCT00420927|65598143|FG006|Period 1|Death|0|||
23508797|NCT00420927|65598137|FG000|Period 1|Subject moved/relocated|0|||
23508798|NCT00420927|65598138|FG001|Period 1|Subject moved/relocated|2|||
23508799|NCT00420927|65598139|FG002|Period 1|Subject moved/relocated|0|||
23508800|NCT00420927|65598140|FG003|Period 1|Subject moved/relocated|0|||
23508801|NCT00420927|65598141|FG004|Period 1|Subject moved/relocated|0|||
23508802|NCT00420927|65598142|FG005|Period 1|Subject moved/relocated|0|||
23508803|NCT00420927|65598143|FG006|Period 1|Subject moved/relocated|0|||
23508804|NCT00420927|65598137|FG000|Period 1|Noncompliant with study drug|1|||
23508805|NCT00420927|65598138|FG001|Period 1|Noncompliant with study drug|1|||
23508806|NCT00420927|65598139|FG002|Period 1|Noncompliant with study drug|0|||
23508807|NCT00420927|65598140|FG003|Period 1|Noncompliant with study drug|0|||
23508808|NCT00420927|65598141|FG004|Period 1|Noncompliant with study drug|0|||
23508809|NCT00420927|65598142|FG005|Period 1|Noncompliant with study drug|0|||
23508810|NCT00420927|65598143|FG006|Period 1|Noncompliant with study drug|0|||
23508811|NCT00420927|65598137|FG000|Period 1|Randomization error|1|||
23508812|NCT00420927|65598138|FG001|Period 1|Randomization error|0|||
23508813|NCT00420927|65598139|FG002|Period 1|Randomization error|0|||
23508814|NCT00420927|65598140|FG003|Period 1|Randomization error|0|||
23508815|NCT00420927|65598141|FG004|Period 1|Randomization error|0|||
23508816|NCT00420927|65598142|FG005|Period 1|Randomization error|0|||
23508817|NCT00420927|65598143|FG006|Period 1|Randomization error|0|||
23508818|NCT00420927|65598137|FG000|Period 1|Suspected tuberculosis/positive test|1|||
23508819|NCT00420927|65598138|FG001|Period 1|Suspected tuberculosis/positive test|1|||
23508820|NCT00420927|65598139|FG002|Period 1|Suspected tuberculosis/positive test|0|||
23508821|NCT00420927|65598140|FG003|Period 1|Suspected tuberculosis/positive test|0|||
23508822|NCT00420927|65598141|FG004|Period 1|Suspected tuberculosis/positive test|0|||
23508823|NCT00420927|65598142|FG005|Period 1|Suspected tuberculosis/positive test|0|||
23508824|NCT00420927|65598143|FG006|Period 1|Suspected tuberculosis/positive test|0|||
23508825|NCT00420927|65598137|FG000|Period 1|Study site closure|0|||
23508826|NCT00420927|65598138|FG001|Period 1|Study site closure|1|||
23508827|NCT00420927|65598139|FG002|Period 1|Study site closure|0|||
23508828|NCT00420927|65598140|FG003|Period 1|Study site closure|0|||
23508829|NCT00420927|65598141|FG004|Period 1|Study site closure|0|||
23508830|NCT00420927|65598142|FG005|Period 1|Study site closure|0|||
23508831|NCT00420927|65598143|FG006|Period 1|Study site closure|0|||
23508832|NCT00420927|65598137|FG000|Period 1|Subject received new diagnosis|0|||
23508833|NCT00420927|65598138|FG001|Period 1|Subject received new diagnosis|2|||
23508834|NCT00420927|65598139|FG002|Period 1|Subject received new diagnosis|0|||
23508835|NCT00420927|65598140|FG003|Period 1|Subject received new diagnosis|0|||
23508836|NCT00420927|65598141|FG004|Period 1|Subject received new diagnosis|0|||
23508837|NCT00420927|65598142|FG005|Period 1|Subject received new diagnosis|0|||
23508838|NCT00420927|65598143|FG006|Period 1|Subject received new diagnosis|0|||
23508839|NCT00420927|65598137|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
23508840|NCT00420927|65598138|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
23508841|NCT00420927|65598139|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
23508842|NCT00420927|65598140|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
23508843|NCT00420927|65598141|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
23508844|NCT00420927|65598142|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
23508845|NCT00420927|65598143|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
23508846|NCT00420927|65598137|FG000|Period 1|Failed to meet entry criteria|8|||
23508847|NCT00420927|65598138|FG001|Period 1|Failed to meet entry criteria|7|||
23508848|NCT00420927|65598139|FG002|Period 1|Failed to meet entry criteria|0|||
23508849|NCT00420927|65598140|FG003|Period 1|Failed to meet entry criteria|0|||
23508850|NCT00420927|65598141|FG004|Period 1|Failed to meet entry criteria|0|||
23508851|NCT00420927|65598142|FG005|Period 1|Failed to meet entry criteria|0|||
23508852|NCT00420927|65598143|FG006|Period 1|Failed to meet entry criteria|0|||
23508853|NCT00420927|65598137|FG000|Period 1|Took prohibited medication|1|||
23508854|NCT00420927|65598138|FG001|Period 1|Took prohibited medication|3|||
23508855|NCT00420927|65598139|FG002|Period 1|Took prohibited medication|0|||
23508856|NCT00420927|65598140|FG003|Period 1|Took prohibited medication|0|||
23508857|NCT00420927|65598141|FG004|Period 1|Took prohibited medication|0|||
23508858|NCT00420927|65598142|FG005|Period 1|Took prohibited medication|0|||
23508859|NCT00420927|65598143|FG006|Period 1|Took prohibited medication|0|||
23508860|NCT00420927|65598137|FG000|Period 2|Adverse Event|0|||
23508861|NCT00420927|65598138|FG001|Period 2|Adverse Event|0|||
23508862|NCT00420927|65598139|FG002|Period 2|Adverse Event|7|||
23508863|NCT00420927|65598140|FG003|Period 2|Adverse Event|3|||
23508864|NCT00420927|65598141|FG004|Period 2|Adverse Event|17|||
23508865|NCT00420927|65598142|FG005|Period 2|Adverse Event|6|||
23508866|NCT00420927|65598143|FG006|Period 2|Adverse Event|20|||
23508867|NCT00420927|65598137|FG000|Period 2|Withdrawal by Subject|0|||
23508868|NCT00420927|65598138|FG001|Period 2|Withdrawal by Subject|0|||
23508869|NCT00420927|65598139|FG002|Period 2|Withdrawal by Subject|1|||
23508870|NCT00420927|65598140|FG003|Period 2|Withdrawal by Subject|3|||
23508871|NCT00420927|65598141|FG004|Period 2|Withdrawal by Subject|11|||
23508872|NCT00420927|65598142|FG005|Period 2|Withdrawal by Subject|2|||
23508873|NCT00420927|65598143|FG006|Period 2|Withdrawal by Subject|12|||
23508874|NCT00420927|65598137|FG000|Period 2|Lost to Follow-up|0|||
23508875|NCT00420927|65598138|FG001|Period 2|Lost to Follow-up|0|||
23508876|NCT00420927|65598139|FG002|Period 2|Lost to Follow-up|2|||
23508877|NCT00420927|65598140|FG003|Period 2|Lost to Follow-up|2|||
23508878|NCT00420927|65598141|FG004|Period 2|Lost to Follow-up|6|||
23508879|NCT00420927|65598142|FG005|Period 2|Lost to Follow-up|3|||
23508880|NCT00420927|65598143|FG006|Period 2|Lost to Follow-up|9|||
23508881|NCT00420927|65598137|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
23508882|NCT00420927|65598138|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
23508883|NCT00420927|65598139|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
23508884|NCT00420927|65598140|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
23508885|NCT00420927|65598141|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
23508886|NCT00420927|65598142|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
23508887|NCT00420927|65598143|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
23508888|NCT00420927|65598137|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
23508889|NCT00420927|65598138|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
23508890|NCT00420927|65598139|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
23508891|NCT00420927|65598140|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
23508892|NCT00420927|65598141|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
23408565|NCT03782259|65239923|FG000|Overall Study|Lost to Follow-up|1|||
23508893|NCT00420927|65598142|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
23508894|NCT00420927|65598143|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
23508895|NCT00420927|65598137|FG000|Period 2|Subject unable to find transportation|0|||
23508896|NCT00420927|65598138|FG001|Period 2|Subject unable to find transportation|0|||
23508897|NCT00420927|65598139|FG002|Period 2|Subject unable to find transportation|0|||
23508898|NCT00420927|65598140|FG003|Period 2|Subject unable to find transportation|0|||
23508899|NCT00420927|65598141|FG004|Period 2|Subject unable to find transportation|0|||
23508900|NCT00420927|65598142|FG005|Period 2|Subject unable to find transportation|0|||
23508901|NCT00420927|65598143|FG006|Period 2|Subject unable to find transportation|1|||
23508902|NCT00420927|65598137|FG000|Period 2|Physician Decision|0|||
23508903|NCT00420927|65598138|FG001|Period 2|Physician Decision|0|||
23508904|NCT00420927|65598139|FG002|Period 2|Physician Decision|0|||
23508905|NCT00420927|65598140|FG003|Period 2|Physician Decision|0|||
23508906|NCT00420927|65598141|FG004|Period 2|Physician Decision|1|||
23508907|NCT00420927|65598142|FG005|Period 2|Physician Decision|1|||
23508908|NCT00420927|65598143|FG006|Period 2|Physician Decision|0|||
23508909|NCT00420927|65598137|FG000|Period 2|Sponsor decision|0|||
23508910|NCT00420927|65598138|FG001|Period 2|Sponsor decision|0|||
23508911|NCT00420927|65598139|FG002|Period 2|Sponsor decision|1|||
23508912|NCT00420927|65598140|FG003|Period 2|Sponsor decision|0|||
23508913|NCT00420927|65598141|FG004|Period 2|Sponsor decision|0|||
23508914|NCT00420927|65598142|FG005|Period 2|Sponsor decision|0|||
23508915|NCT00420927|65598143|FG006|Period 2|Sponsor decision|1|||
23508916|NCT00420927|65598137|FG000|Period 2|Randomization error|0|||
23508917|NCT00420927|65598138|FG001|Period 2|Randomization error|0|||
23508918|NCT00420927|65598139|FG002|Period 2|Randomization error|0|||
23508919|NCT00420927|65598140|FG003|Period 2|Randomization error|0|||
23508920|NCT00420927|65598141|FG004|Period 2|Randomization error|1|||
23508921|NCT00420927|65598142|FG005|Period 2|Randomization error|1|||
23508922|NCT00420927|65598143|FG006|Period 2|Randomization error|0|||
23508923|NCT00420927|65598137|FG000|Period 2|Noncompliant with study drug|0|||
23508924|NCT00420927|65598138|FG001|Period 2|Noncompliant with study drug|0|||
23508925|NCT00420927|65598139|FG002|Period 2|Noncompliant with study drug|0|||
23508926|NCT00420927|65598140|FG003|Period 2|Noncompliant with study drug|1|||
23508927|NCT00420927|65598141|FG004|Period 2|Noncompliant with study drug|0|||
23508928|NCT00420927|65598142|FG005|Period 2|Noncompliant with study drug|0|||
23508929|NCT00420927|65598143|FG006|Period 2|Noncompliant with study drug|2|||
23508930|NCT00420927|65598137|FG000|Period 2|Methotrexate intolerance|0|||
23508931|NCT00420927|65598138|FG001|Period 2|Methotrexate intolerance|0|||
23508932|NCT00420927|65598139|FG002|Period 2|Methotrexate intolerance|0|||
23508933|NCT00420927|65598140|FG003|Period 2|Methotrexate intolerance|0|||
23508934|NCT00420927|65598141|FG004|Period 2|Methotrexate intolerance|0|||
23508935|NCT00420927|65598142|FG005|Period 2|Methotrexate intolerance|0|||
23508936|NCT00420927|65598143|FG006|Period 2|Methotrexate intolerance|1|||
23508937|NCT00420927|65598137|FG000|Period 2|Took prohibited medication|0|||
23508938|NCT00420927|65598138|FG001|Period 2|Took prohibited medication|0|||
23508939|NCT00420927|65598139|FG002|Period 2|Took prohibited medication|0|||
23508940|NCT00420927|65598140|FG003|Period 2|Took prohibited medication|0|||
23508941|NCT00420927|65598141|FG004|Period 2|Took prohibited medication|1|||
23508942|NCT00420927|65598142|FG005|Period 2|Took prohibited medication|0|||
23508943|NCT00420927|65598143|FG006|Period 2|Took prohibited medication|0|||
23508944|NCT00211809|65598151|FG000|Overall Study|Lack of Efficacy|1|||
23508945|NCT00211809|65598151|FG000|Overall Study|Lost to Follow-up|2|||
23508946|NCT00211809|65598151|FG000|Overall Study|Pregnancy|1|||
23508947|NCT00211809|65598151|FG000|Overall Study|side effects|2|||
23508948|NCT03982368|65598152|FG000|Overall Study|Adverse Event|6|||
23508949|NCT03982368|65598153|FG001|Overall Study|Adverse Event|4|||
23508950|NCT03982368|65598154|FG002|Overall Study|Adverse Event|3|||
23508951|NCT03982368|65598152|FG000|Overall Study|Lost to Follow-up|2|||
23508952|NCT03982368|65598153|FG001|Overall Study|Lost to Follow-up|1|||
23508953|NCT03982368|65598154|FG002|Overall Study|Lost to Follow-up|0|||
23508954|NCT03982368|65598152|FG000|Overall Study|Withdrawal by Subject|1|||
23508955|NCT03982368|65598153|FG001|Overall Study|Withdrawal by Subject|2|||
23508956|NCT03982368|65598154|FG002|Overall Study|Withdrawal by Subject|0|||
23508957|NCT03982368|65598152|FG000|Overall Study|unknow|4|||
23508958|NCT03982368|65598153|FG001|Overall Study|unknow|0|||
23508959|NCT03982368|65598154|FG002|Overall Study|unknow|2|||
23508960|NCT01850524|65598160|FG000|Overall Study|Lost to Follow-up|5|||
23508961|NCT01850524|65598161|FG001|Overall Study|Lost to Follow-up|10|||
23508962|NCT01850524|65598160|FG000|Overall Study|Withdrawal by Subject|24|||
23508963|NCT01850524|65598161|FG001|Overall Study|Withdrawal by Subject|22|||
23508964|NCT01850524|65598160|FG000|Overall Study|Reason not Specified|142|||
23508965|NCT01850524|65598161|FG001|Overall Study|Reason not Specified|141|||
23508966|NCT02193867|65598164|FG000|Overall Study|Death|2|||
23508967|NCT02193867|65598164|FG000|Overall Study|Sponsor Study Termination|2|||
23508968|NCT02034110|65598173|FG000|Overall Study|Physician Decision|0|||
23508969|NCT02034110|65598174|FG001|Overall Study|Physician Decision|0|||
23508970|NCT02034110|65598175|FG002|Overall Study|Physician Decision|0|||
23508971|NCT02034110|65598176|FG003|Overall Study|Physician Decision|0|||
23508972|NCT02034110|65598177|FG004|Overall Study|Physician Decision|2|||
23508973|NCT02034110|65598178|FG005|Overall Study|Physician Decision|0|||
23508974|NCT02034110|65598179|FG006|Overall Study|Physician Decision|1|||
23508975|NCT02034110|65598180|FG007|Overall Study|Physician Decision|0|||
23508976|NCT02034110|65598173|FG000|Overall Study|Lost to Follow-up|1|||
23508977|NCT02034110|65598174|FG001|Overall Study|Lost to Follow-up|0|||
23508978|NCT02034110|65598175|FG002|Overall Study|Lost to Follow-up|0|||
23508979|NCT02034110|65598176|FG003|Overall Study|Lost to Follow-up|0|||
23508980|NCT02034110|65598177|FG004|Overall Study|Lost to Follow-up|1|||
23508981|NCT02034110|65598178|FG005|Overall Study|Lost to Follow-up|0|||
23508982|NCT02034110|65598179|FG006|Overall Study|Lost to Follow-up|1|||
23508983|NCT02034110|65598180|FG007|Overall Study|Lost to Follow-up|0|||
23508984|NCT02034110|65598173|FG000|Overall Study|Withdrawal by Subject|5|||
23508985|NCT02034110|65598174|FG001|Overall Study|Withdrawal by Subject|7|||
23508986|NCT02034110|65598175|FG002|Overall Study|Withdrawal by Subject|0|||
23508987|NCT02034110|65598176|FG003|Overall Study|Withdrawal by Subject|3|||
23508988|NCT02034110|65598177|FG004|Overall Study|Withdrawal by Subject|7|||
23508989|NCT02034110|65598178|FG005|Overall Study|Withdrawal by Subject|0|||
23508990|NCT02034110|65598179|FG006|Overall Study|Withdrawal by Subject|3|||
23508991|NCT02034110|65598180|FG007|Overall Study|Withdrawal by Subject|1|||
23508992|NCT02034110|65598173|FG000|Overall Study|Study closed by sponsor|6|||
23508993|NCT02034110|65598174|FG001|Overall Study|Study closed by sponsor|2|||
23508994|NCT02034110|65598175|FG002|Overall Study|Study closed by sponsor|0|||
23508995|NCT02034110|65598176|FG003|Overall Study|Study closed by sponsor|6|||
23508996|NCT02034110|65598177|FG004|Overall Study|Study closed by sponsor|7|||
23508997|NCT02034110|65598178|FG005|Overall Study|Study closed by sponsor|0|||
23508998|NCT02034110|65598179|FG006|Overall Study|Study closed by sponsor|42|||
23508999|NCT02034110|65598180|FG007|Overall Study|Study closed by sponsor|0|||
23509000|NCT02692703|65598182|FG000|Overall Study|Lost to Follow-up|1|||
23509001|NCT02692703|65598182|FG000|Overall Study|Other|1|||
23509002|NCT00546637|65598183|FG000|Overall Study|Adverse Event|46|||
23509003|NCT00546637|65598184|FG001|Overall Study|Adverse Event|20|||
23509004|NCT00546637|65598183|FG000|Overall Study|Lack of Efficacy|5|||
23509005|NCT00546637|65598184|FG001|Overall Study|Lack of Efficacy|5|||
23509006|NCT00546637|65598183|FG000|Overall Study|Lost to Follow-up|2|||
23509007|NCT00546637|65598184|FG001|Overall Study|Lost to Follow-up|2|||
23509008|NCT00546637|65598183|FG000|Overall Study|Other|10|||
23509009|NCT00546637|65598184|FG001|Overall Study|Other|12|||
23509010|NCT00546637|65598183|FG000|Overall Study|Withdrawal by Subject|7|||
23509011|NCT00546637|65598184|FG001|Overall Study|Withdrawal by Subject|9|||
23509012|NCT00546637|65598183|FG000|Overall Study|Randomized, but not treated|3|||
23509013|NCT00546637|65598184|FG001|Overall Study|Randomized, but not treated|1|||
23509014|NCT02170051|65598185|FG000|Overall Study|Withdrawal by Subject|10|||
23509015|NCT02170051|65598186|FG001|Overall Study|Withdrawal by Subject|10|||
23509016|NCT02170051|65598185|FG000|Overall Study|Lost to Follow-up|1|||
23509017|NCT02170051|65598186|FG001|Overall Study|Lost to Follow-up|3|||
23509018|NCT04967443|65598187|FG000|Open Label Treatment|Death|1|||
23509019|NCT04967443|65598188|FG001|Open Label Treatment|Death|0|||
23509020|NCT04967443|65598189|FG002|Open Label Treatment|Death|0|||
23509021|NCT04967443|65598190|FG003|Open Label Treatment|Death|0|||
23509022|NCT04967443|65598191|FG004|Open Label Treatment|Death|0|||
23509023|NCT04967443|65598192|FG005|Open Label Treatment|Death|0|||
23509024|NCT04967443|65598193|FG006|Open Label Treatment|Death|0|||
23509025|NCT04967443|65598194|FG007|Open Label Treatment|Death|0|||
23509026|NCT04967443|65598187|FG000|Open Label Treatment|Lost to Follow-up|0|||
23509027|NCT04967443|65598188|FG001|Open Label Treatment|Lost to Follow-up|0|||
23509028|NCT04967443|65598189|FG002|Open Label Treatment|Lost to Follow-up|1|||
23509029|NCT04967443|65598190|FG003|Open Label Treatment|Lost to Follow-up|0|||
23509030|NCT04967443|65598191|FG004|Open Label Treatment|Lost to Follow-up|0|||
23509031|NCT04967443|65598192|FG005|Open Label Treatment|Lost to Follow-up|0|||
23509032|NCT04967443|65598193|FG006|Open Label Treatment|Lost to Follow-up|0|||
23509033|NCT04967443|65598194|FG007|Open Label Treatment|Lost to Follow-up|0|||
23509034|NCT04967443|65598187|FG000|Open Label Treatment|Withdrawal by Subject|0|||
23509035|NCT04967443|65598188|FG001|Open Label Treatment|Withdrawal by Subject|1|||
23509036|NCT04967443|65598189|FG002|Open Label Treatment|Withdrawal by Subject|0|||
23509037|NCT04967443|65598190|FG003|Open Label Treatment|Withdrawal by Subject|1|||
23509038|NCT04967443|65598191|FG004|Open Label Treatment|Withdrawal by Subject|0|||
23509039|NCT04967443|65598192|FG005|Open Label Treatment|Withdrawal by Subject|1|||
23509040|NCT04967443|65598193|FG006|Open Label Treatment|Withdrawal by Subject|2|||
23509041|NCT04967443|65598194|FG007|Open Label Treatment|Withdrawal by Subject|3|||
23509042|NCT04967443|65598187|FG000|Follow-Up|Death|1|||
23509043|NCT04967443|65598188|FG001|Follow-Up|Death|0|||
23509044|NCT04967443|65598189|FG002|Follow-Up|Death|0|||
23509045|NCT04967443|65598190|FG003|Follow-Up|Death|0|||
23509046|NCT04967443|65598191|FG004|Follow-Up|Death|0|||
23509047|NCT04967443|65598192|FG005|Follow-Up|Death|0|||
23509048|NCT04967443|65598193|FG006|Follow-Up|Death|0|||
23509049|NCT04967443|65598194|FG007|Follow-Up|Death|0|||
23509050|NCT04967443|65598187|FG000|Follow-Up|Lost to Follow-up|0|||
23509051|NCT04967443|65598188|FG001|Follow-Up|Lost to Follow-up|0|||
23509052|NCT04967443|65598189|FG002|Follow-Up|Lost to Follow-up|1|||
23509053|NCT04967443|65598190|FG003|Follow-Up|Lost to Follow-up|1|||
23509054|NCT04967443|65598191|FG004|Follow-Up|Lost to Follow-up|0|||
23509055|NCT04967443|65598192|FG005|Follow-Up|Lost to Follow-up|0|||
23509056|NCT04967443|65598193|FG006|Follow-Up|Lost to Follow-up|0|||
23509057|NCT04967443|65598194|FG007|Follow-Up|Lost to Follow-up|0|||
23509058|NCT04967443|65598187|FG000|Follow-Up|Withdrawal by Subject|0|||
23509059|NCT04967443|65598188|FG001|Follow-Up|Withdrawal by Subject|1|||
23509060|NCT04967443|65598189|FG002|Follow-Up|Withdrawal by Subject|0|||
23509061|NCT04967443|65598190|FG003|Follow-Up|Withdrawal by Subject|1|||
23509062|NCT04967443|65598191|FG004|Follow-Up|Withdrawal by Subject|0|||
23509063|NCT04967443|65598192|FG005|Follow-Up|Withdrawal by Subject|1|||
23509064|NCT04967443|65598193|FG006|Follow-Up|Withdrawal by Subject|2|||
23509065|NCT04967443|65598194|FG007|Follow-Up|Withdrawal by Subject|3|||
23509066|NCT02990910|65598195|FG000|Overall Study|Lack of Efficacy|6|||
23509067|NCT02990910|65598196|FG001|Overall Study|Lack of Efficacy|10|||
23509068|NCT01426373|65598198|FG000|Overall Study|Adverse Event|6|||
23509069|NCT01426373|65598198|FG000|Overall Study|Lost to Follow-up|14|||
23509070|NCT01426373|65598198|FG000|Overall Study|Participant Convenience|10|||
23509071|NCT01426373|65598198|FG000|Overall Study|Miscellaneous Reasons|4|||
23509072|NCT02246660|65598199|FG000|Overall Study|Withdrawal by Subject|0|||
23509073|NCT02246660|65598200|FG001|Overall Study|Withdrawal by Subject|1|||
23509074|NCT02246660|65598201|FG002|Overall Study|Withdrawal by Subject|0|||
23509075|NCT02246660|65598199|FG000|Overall Study|Death|0|||
23509076|NCT02246660|65598200|FG001|Overall Study|Death|0|||
23509077|NCT02246660|65598201|FG002|Overall Study|Death|1|||
23509078|NCT01465997|65598202|FG000|Overall Study|Adverse Event|12|||
23509079|NCT01465997|65598203|FG001|Overall Study|Adverse Event|22|||
23509080|NCT01465997|65598202|FG000|Overall Study|Lack of Efficacy|13|||
23509081|NCT01465997|65598203|FG001|Overall Study|Lack of Efficacy|1|||
23509082|NCT01465997|65598202|FG000|Overall Study|Protocol Violation|1|||
23509083|NCT01465997|65598203|FG001|Overall Study|Protocol Violation|4|||
23509084|NCT01465997|65598202|FG000|Overall Study|Lost to Follow-up|6|||
23509085|NCT01465997|65598203|FG001|Overall Study|Lost to Follow-up|9|||
23509086|NCT01465997|65598202|FG000|Overall Study|Withdrawal by Subject|32|||
23509087|NCT01465997|65598203|FG001|Overall Study|Withdrawal by Subject|35|||
23509088|NCT01465997|65598202|FG000|Overall Study|investigator's decision|1|||
23509089|NCT01465997|65598203|FG001|Overall Study|investigator's decision|1|||
23509090|NCT01465997|65598202|FG000|Overall Study|Death|0|||
23509091|NCT01465997|65598203|FG001|Overall Study|Death|1|||
23509092|NCT01465997|65598202|FG000|Overall Study|sponsor's decision|1|||
23509093|NCT01465997|65598203|FG001|Overall Study|sponsor's decision|1|||
23509094|NCT01465997|65598202|FG000|Overall Study|subject withdrew consent|1|||
23509095|NCT01465997|65598203|FG001|Overall Study|subject withdrew consent|0|||
23509096|NCT01465997|65598202|FG000|Overall Study|local lab unblinded site|1|||
23509097|NCT01465997|65598203|FG001|Overall Study|local lab unblinded site|0|||
23509098|NCT01465997|65598202|FG000|Overall Study|withdrew before follow-up|0|||
23509099|NCT01465997|65598203|FG001|Overall Study|withdrew before follow-up|13|||
23509100|NCT01465997|65598202|FG000|Overall Study|decision by site staff|0|||
23509101|NCT01465997|65598203|FG001|Overall Study|decision by site staff|1|||
23509102|NCT01465997|65598202|FG000|Overall Study|subject left participation SP0993|0|||
23509103|NCT01465997|65598203|FG001|Overall Study|subject left participation SP0993|1|||
23509104|NCT01927367|65598204|FG000|Overall Study|Withdrawal by Subject|7|||
23509105|NCT01927367|65598205|FG001|Overall Study|Withdrawal by Subject|4|||
23509106|NCT01927367|65598204|FG000|Overall Study|No baseline data|0|||
23509107|NCT01927367|65598205|FG001|Overall Study|No baseline data|1|||
23509108|NCT02954237|65598212|FG000|Overall Study|Withdrawal by Subject|25|||
23509109|NCT02954237|65598212|FG000|Overall Study|Missed visit|16|||
23509110|NCT02954237|65598212|FG000|Overall Study|Death|2|||
23509111|NCT00743340|65598213|FG000|Overall Study|Study medication non-compliance|1|||
23509112|NCT00743340|65598213|FG000|Overall Study|Lost to Follow-up|1|||
23509113|NCT00743340|65598213|FG000|Overall Study|Withdrawal from the Study|5|||
23509114|NCT00743340|65598213|FG000|Overall Study|Protocol Violation|1|||
23509115|NCT00743340|65598213|FG000|Overall Study|Virologic failure|8|||
23509116|NCT00743340|65598213|FG000|Overall Study|Pregnancy|1|||
23509117|NCT00743340|65598213|FG000|Overall Study|Rolled over to other Gilead Study|23|||
23509118|NCT00743340|65598213|FG000|Overall Study|Participant Relocated|1|||
23509119|NCT00187486|65598214|FG000|Overall Study|Protocol Violation|1|||
23509120|NCT02270957|65598215|FG000|Overall Study|Lack of Efficacy|2|||
23509121|NCT02270957|65598216|FG001|Overall Study|Lack of Efficacy|4|||
23509122|NCT02270957|65598215|FG000|Overall Study|Adverse Event|2|||
23509123|NCT02270957|65598216|FG001|Overall Study|Adverse Event|0|||
23509124|NCT00320411|65601782|FG000|Overall Study|No investigational product admin.|4|||
23509125|NCT00726661|65601785|FG000|Overall Study|Lost to Follow-up|36|||
23509126|NCT00726661|65601786|FG001|Overall Study|Lost to Follow-up|11|||
23509127|NCT00726661|65601785|FG000|Overall Study|Withdrawal by Subject|17|||
23509128|NCT00726661|65601786|FG001|Overall Study|Withdrawal by Subject|13|||
23509129|NCT00726661|65601785|FG000|Overall Study|Trial terminated by sponsor|214|||
23509130|NCT00726661|65601786|FG001|Overall Study|Trial terminated by sponsor|187|||
23509131|NCT00726661|65601785|FG000|Overall Study|Death|475|||
23509132|NCT00726661|65601786|FG001|Overall Study|Death|159|||
23509133|NCT00726661|65601785|FG000|Overall Study|Physician Decision|25|||
23509134|NCT00726661|65601786|FG001|Overall Study|Physician Decision|13|||
23509135|NCT00726661|65601785|FG000|Overall Study|Other|47|||
23509136|NCT00726661|65601786|FG001|Overall Study|Other|35|||
23509137|NCT04900220|65601789|FG000|Overall Study|Lost to Follow-up|1|||
23509138|NCT04900220|65601790|FG001|Overall Study|Lost to Follow-up|1|||
23509139|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
23509140|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
23509141|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
23509142|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
23509143|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
23509144|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
23509145|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
23509146|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
23509147|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
23509148|NCT02196558|65601791|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
23509149|NCT02196558|65601792|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
23509150|NCT02196558|65601793|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
23509151|NCT02196558|65601791|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509152|NCT02196558|65601792|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509153|NCT02196558|65601793|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509154|NCT01867424|65601797|FG000|Overall Study|Patient noncompliance|2|||
23509155|NCT01867424|65601798|FG001|Overall Study|Patient noncompliance|1|||
23509156|NCT01829191|65601801|FG000|Overall Study|Relocation|0|||
23509157|NCT01829191|65601802|FG001|Overall Study|Relocation|1|||
23509158|NCT01829191|65601801|FG000|Overall Study|Lens discomfort|0|||
23509159|NCT01829191|65601802|FG001|Overall Study|Lens discomfort|3|||
23509160|NCT01829191|65601801|FG000|Overall Study|Lens handling difficulty|1|||
23509161|NCT01829191|65601802|FG001|Overall Study|Lens handling difficulty|4|||
23509162|NCT01829191|65601801|FG000|Overall Study|Protocol Violation|4|||
23509163|NCT01829191|65601802|FG001|Overall Study|Protocol Violation|1|||
23509164|NCT01829191|65601801|FG000|Overall Study|Withdrawal by Subject|2|||
23509165|NCT01829191|65601802|FG001|Overall Study|Withdrawal by Subject|3|||
23509166|NCT01829191|65601801|FG000|Overall Study|Lost to Follow-up|0|||
23509167|NCT01829191|65601802|FG001|Overall Study|Lost to Follow-up|1|||
23509168|NCT01829191|65601801|FG000|Overall Study|Subject was fit for ortho - k|0|||
23509169|NCT01829191|65601802|FG001|Overall Study|Subject was fit for ortho - k|1|||
23509170|NCT00720434|65601806|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509171|NCT00720434|65601807|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
23509172|NCT00720434|65601808|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509173|NCT00720434|65601809|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509174|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509175|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509176|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509177|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
23509178|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
23509179|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509180|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509181|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509182|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
23509183|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
23509184|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
23509185|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
23509186|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Other|4|||
23509187|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Other|3|||
23509188|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Other|3|||
23509189|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Other|2|||
23509190|NCT01907815|65601811|FG000|Overall Study|Withdrawal by Subject|1|||
23509191|NCT01907815|65601812|FG001|Overall Study|Withdrawal by Subject|0|||
23509192|NCT03266094|65601813|FG000|Overall Study|Lost to Follow-up|1|||
23509193|NCT03266094|65601813|FG000|Overall Study|Withdrawal by Subject|1|||
23509194|NCT01214629|65601814|FG000|Overall Study|Progressive Disease|1|||
23509195|NCT01214629|65601815|FG001|Overall Study|Progressive Disease|1|||
23509196|NCT01214629|65601816|FG002|Overall Study|Progressive Disease|0|||
23509197|NCT01214629|65601817|FG003|Overall Study|Progressive Disease|1|||
23509198|NCT01214629|65601818|FG004|Overall Study|Progressive Disease|2|||
23509199|NCT01214629|65601819|FG005|Overall Study|Progressive Disease|3|||
23509200|NCT01214629|65601820|FG006|Overall Study|Progressive Disease|1|||
23509201|NCT01214629|65601821|FG007|Overall Study|Progressive Disease|1|||
23509202|NCT01214629|65601822|FG008|Overall Study|Progressive Disease|1|||
23509203|NCT01214629|65601823|FG009|Overall Study|Progressive Disease|5|||
23509204|NCT01214629|65601824|FG010|Overall Study|Progressive Disease|1|||
23509205|NCT01214629|65601814|FG000|Overall Study|Adverse Event|0|||
23509206|NCT01214629|65601815|FG001|Overall Study|Adverse Event|0|||
23509207|NCT01214629|65601816|FG002|Overall Study|Adverse Event|0|||
23509208|NCT01214629|65601817|FG003|Overall Study|Adverse Event|1|||
23509209|NCT01214629|65601818|FG004|Overall Study|Adverse Event|0|||
23509210|NCT01214629|65601819|FG005|Overall Study|Adverse Event|1|||
23509211|NCT01214629|65601820|FG006|Overall Study|Adverse Event|0|||
23509212|NCT01214629|65601821|FG007|Overall Study|Adverse Event|0|||
23509213|NCT01214629|65601822|FG008|Overall Study|Adverse Event|0|||
23509214|NCT01214629|65601823|FG009|Overall Study|Adverse Event|1|||
23509215|NCT01214629|65601824|FG010|Overall Study|Adverse Event|0|||
23509216|NCT01214629|65601814|FG000|Overall Study|Physician Decision|0|||
23509217|NCT01214629|65601815|FG001|Overall Study|Physician Decision|0|||
23509218|NCT01214629|65601816|FG002|Overall Study|Physician Decision|0|||
23509219|NCT01214629|65601817|FG003|Overall Study|Physician Decision|0|||
23509220|NCT01214629|65601818|FG004|Overall Study|Physician Decision|0|||
23509221|NCT01214629|65601819|FG005|Overall Study|Physician Decision|0|||
23509222|NCT01214629|65601820|FG006|Overall Study|Physician Decision|0|||
23509223|NCT01214629|65601821|FG007|Overall Study|Physician Decision|0|||
23509224|NCT01214629|65601822|FG008|Overall Study|Physician Decision|0|||
23509225|NCT01214629|65601823|FG009|Overall Study|Physician Decision|0|||
23509226|NCT01214629|65601824|FG010|Overall Study|Physician Decision|1|||
23509227|NCT01214629|65601814|FG000|Overall Study|Withdrawal by Subject|0|||
23509228|NCT01214629|65601815|FG001|Overall Study|Withdrawal by Subject|0|||
23509229|NCT01214629|65601816|FG002|Overall Study|Withdrawal by Subject|0|||
23509230|NCT01214629|65601817|FG003|Overall Study|Withdrawal by Subject|0|||
23509231|NCT01214629|65601818|FG004|Overall Study|Withdrawal by Subject|0|||
23509232|NCT01214629|65601819|FG005|Overall Study|Withdrawal by Subject|0|||
23509233|NCT01214629|65601820|FG006|Overall Study|Withdrawal by Subject|0|||
23509234|NCT01214629|65601821|FG007|Overall Study|Withdrawal by Subject|0|||
23509235|NCT01214629|65601822|FG008|Overall Study|Withdrawal by Subject|0|||
23509236|NCT01214629|65601823|FG009|Overall Study|Withdrawal by Subject|1|||
23509237|NCT01214629|65601824|FG010|Overall Study|Withdrawal by Subject|0|||
23509238|NCT01634360|65601825|FG000|Overall Study|Adverse Event|10|||
23509239|NCT01634360|65601826|FG001|Overall Study|Adverse Event|34|||
23509240|NCT01634360|65601825|FG000|Overall Study|subject withdrew consent|13|||
23509241|NCT01634360|65601826|FG001|Overall Study|subject withdrew consent|23|||
23509242|NCT01634360|65601825|FG000|Overall Study|Protocol Violation|1|||
23509243|NCT01634360|65601826|FG001|Overall Study|Protocol Violation|1|||
23509244|NCT01634360|65601825|FG000|Overall Study|Lack of Efficacy|4|||
23509245|NCT01634360|65601826|FG001|Overall Study|Lack of Efficacy|14|||
23509246|NCT01634360|65601825|FG000|Overall Study|Other|3|||
23509247|NCT01634360|65601826|FG001|Overall Study|Other|20|||
23509248|NCT01634360|65601825|FG000|Overall Study|Study termination by sponsor|18|||
23509249|NCT01634360|65601826|FG001|Overall Study|Study termination by sponsor|44|||
23509250|NCT02326025|65601828|FG000|Overall Study|Adverse Event|3|||
23509251|NCT02326025|65601829|FG001|Overall Study|Adverse Event|0|||
23509252|NCT02326025|65601828|FG000|Overall Study|Physician Decision|1|||
23509253|NCT02326025|65601829|FG001|Overall Study|Physician Decision|2|||
23509254|NCT02326025|65601828|FG000|Overall Study|Physician and Participant Decision|1|||
23509255|NCT02326025|65601829|FG001|Overall Study|Physician and Participant Decision|0|||
23509256|NCT02326025|65601828|FG000|Overall Study|Withdrawal by Subject|0|||
23509257|NCT02326025|65601829|FG001|Overall Study|Withdrawal by Subject|2|||
23509258|NCT02326025|65601828|FG000|Overall Study|Protocol Violation|0|||
23509259|NCT02326025|65601829|FG001|Overall Study|Protocol Violation|1|||
23509260|NCT00867009|65601830|FG000|Induction Period|Nonserious Adverse Event|5|||
23509261|NCT00867009|65601830|FG000|Induction Period|Serious Adverse Event|10|||
23509262|NCT00867009|65601830|FG000|Induction Period|Death due to serious adverse event|6|||
23509263|NCT00867009|65601830|FG000|Induction Period|Death due to Study Disease|4|||
23509264|NCT00867009|65601830|FG000|Induction Period|Protocol Violation|1|||
23509265|NCT00867009|65601830|FG000|Induction Period|Withdrawal by Subject|8|||
23509266|NCT00867009|65601830|FG000|Induction Period|Physician Decision|3|||
23509267|NCT00867009|65601830|FG000|Induction Period|Progressive Disease (PD)|25|||
23509268|NCT00867009|65601830|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
23509269|NCT00696696|65601833|FG000|Overall Study|Adverse Event|5|||
23509270|NCT00696696|65601833|FG000|Overall Study|Withdrawal by Subject|8|||
23509271|NCT00696696|65601833|FG000|Overall Study|Physician Decision|2|||
23509272|NCT00696696|65601833|FG000|Overall Study|Death|3|||
23509273|NCT00885105|65601836|FG000|Overall Study|Withdrawal by Subject|0|||
23509274|NCT00885105|65601837|FG001|Overall Study|Withdrawal by Subject|8|||
23509275|NCT00885105|65601836|FG000|Overall Study|Adverse Event|1|||
23509276|NCT00885105|65601837|FG001|Overall Study|Adverse Event|0|||
23509277|NCT00885105|65601836|FG000|Overall Study|Protocol Violation|0|||
23509278|NCT00885105|65601837|FG001|Overall Study|Protocol Violation|2|||
23509279|NCT02205814|65601840|FG000|Overall Study|Lost to Follow-up|0|||
23509280|NCT02205814|65601841|FG001|Overall Study|Lost to Follow-up|0|||
23509281|NCT02205814|65601842|FG002|Overall Study|Lost to Follow-up|0|||
23509282|NCT02205814|65601843|FG003|Overall Study|Lost to Follow-up|1|||
23509283|NCT02205814|65601840|FG000|Overall Study|Lack of Efficacy|1|||
23509284|NCT02205814|65601841|FG001|Overall Study|Lack of Efficacy|0|||
23509285|NCT02205814|65601842|FG002|Overall Study|Lack of Efficacy|1|||
23509286|NCT02205814|65601843|FG003|Overall Study|Lack of Efficacy|1|||
23509287|NCT02205814|65601840|FG000|Overall Study|Physician Decision|0|||
23509288|NCT02205814|65601841|FG001|Overall Study|Physician Decision|0|||
23509289|NCT02205814|65601842|FG002|Overall Study|Physician Decision|1|||
23509290|NCT02205814|65601843|FG003|Overall Study|Physician Decision|0|||
23509291|NCT02205814|65601840|FG000|Overall Study|Protocol Violation|1|||
23509292|NCT02205814|65601841|FG001|Overall Study|Protocol Violation|0|||
23509293|NCT02205814|65601842|FG002|Overall Study|Protocol Violation|0|||
23509294|NCT02205814|65601843|FG003|Overall Study|Protocol Violation|1|||
23509295|NCT02205814|65601840|FG000|Overall Study|Withdrawal by Subject|0|||
23509296|NCT02205814|65601841|FG001|Overall Study|Withdrawal by Subject|1|||
23509297|NCT02205814|65601842|FG002|Overall Study|Withdrawal by Subject|2|||
23509298|NCT02205814|65601843|FG003|Overall Study|Withdrawal by Subject|1|||
23509299|NCT02205814|65601840|FG000|Overall Study|not compliant with study procedures|0|||
23509300|NCT02205814|65601841|FG001|Overall Study|not compliant with study procedures|0|||
23509301|NCT02205814|65601842|FG002|Overall Study|not compliant with study procedures|1|||
23509302|NCT02205814|65601843|FG003|Overall Study|not compliant with study procedures|0|||
23509303|NCT03402386|65601844|FG000|Overall Study|Adverse Event|3|||
23509304|NCT03402386|65601844|FG000|Overall Study|Physician Decision|1|||
23509305|NCT03402386|65601844|FG000|Overall Study|Difficult to control Hb|2|||
23509306|NCT03902574|65601848|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
23509307|NCT03902574|65601849|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
23509308|NCT03902574|65601850|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
23509309|NCT00573469|65601853|FG000|Overall Study|Adverse Event|1|||
23509310|NCT00573469|65601854|FG001|Overall Study|Adverse Event|1|||
23509311|NCT00573469|65601855|FG002|Overall Study|Adverse Event|1|||
23509312|NCT00573469|65601853|FG000|Overall Study|Withdrawal by Subject|0|||
23509313|NCT00573469|65601854|FG001|Overall Study|Withdrawal by Subject|2|||
23509314|NCT00573469|65601855|FG002|Overall Study|Withdrawal by Subject|0|||
23509315|NCT00573469|65601853|FG000|Overall Study|Other|5|||
23509316|NCT00573469|65601854|FG001|Overall Study|Other|1|||
23509317|NCT00573469|65601855|FG002|Overall Study|Other|3|||
23509318|NCT00837811|65601856|FG000|Overall Study|Adverse Event|4|||
23509319|NCT00837811|65601857|FG001|Overall Study|Adverse Event|6|||
23509320|NCT00837811|65601858|FG002|Overall Study|Adverse Event|0|||
23509321|NCT00837811|65601856|FG000|Overall Study|Death|1|||
23509322|NCT00837811|65601857|FG001|Overall Study|Death|1|||
23509323|NCT00837811|65601858|FG002|Overall Study|Death|0|||
23509324|NCT00837811|65601856|FG000|Overall Study|Lack of Efficacy|0|||
23509325|NCT00837811|65601857|FG001|Overall Study|Lack of Efficacy|11|||
23509326|NCT00837811|65601858|FG002|Overall Study|Lack of Efficacy|0|||
23509327|NCT00837811|65601856|FG000|Overall Study|Lost to Follow-up|1|||
23607397|NCT00696241|65950690|FG002|Overall Study|Protocol Violation|2|||
23607398|NCT00696241|65950691|FG003|Overall Study|Protocol Violation|0|||
23607399|NCT00696241|65950692|FG004|Overall Study|Protocol Violation|3|||
23607400|NCT00696241|65950688|FG000|Overall Study|Lost to Follow-up|1|||
23607401|NCT00696241|65950689|FG001|Overall Study|Lost to Follow-up|4|||
23607402|NCT00696241|65950690|FG002|Overall Study|Lost to Follow-up|1|||
23607403|NCT00696241|65950691|FG003|Overall Study|Lost to Follow-up|2|||
23607404|NCT00696241|65950692|FG004|Overall Study|Lost to Follow-up|0|||
23607405|NCT00696241|65950688|FG000|Overall Study|Withdrawal by Subject|4|||
23607406|NCT00696241|65950689|FG001|Overall Study|Withdrawal by Subject|8|||
23607407|NCT00696241|65950690|FG002|Overall Study|Withdrawal by Subject|6|||
23607408|NCT00696241|65950691|FG003|Overall Study|Withdrawal by Subject|1|||
23607409|NCT00696241|65950692|FG004|Overall Study|Withdrawal by Subject|0|||
23607410|NCT00696241|65950688|FG000|Overall Study|Lack of Efficacy|1|||
23607411|NCT00696241|65950689|FG001|Overall Study|Lack of Efficacy|5|||
23607412|NCT00696241|65950690|FG002|Overall Study|Lack of Efficacy|4|||
23607413|NCT00696241|65950691|FG003|Overall Study|Lack of Efficacy|5|||
23607414|NCT00696241|65950692|FG004|Overall Study|Lack of Efficacy|3|||
23607415|NCT00696241|65950688|FG000|Overall Study|Other|6|||
23607416|NCT00696241|65950689|FG001|Overall Study|Other|1|||
23607417|NCT00696241|65950690|FG002|Overall Study|Other|5|||
23607418|NCT00696241|65950691|FG003|Overall Study|Other|2|||
23607419|NCT00696241|65950692|FG004|Overall Study|Other|1|||
23607420|NCT02006641|65950694|FG000|Overall Study|Withdrawal before treatment|2|||
23607421|NCT02006641|65950695|FG001|Overall Study|Withdrawal before treatment|5|||
23607422|NCT02006641|65950696|FG002|Overall Study|Withdrawal before treatment|3|||
23607423|NCT02006641|65950694|FG000|Overall Study|Adverse Event|15|||
23607424|NCT02006641|65950695|FG001|Overall Study|Adverse Event|11|||
23607425|NCT02006641|65950696|FG002|Overall Study|Adverse Event|15|||
23509328|NCT00837811|65601857|FG001|Overall Study|Lost to Follow-up|3|||
23509329|NCT00837811|65601858|FG002|Overall Study|Lost to Follow-up|0|||
23509330|NCT00837811|65601856|FG000|Overall Study|Physician Decision|0|||
23509331|NCT00837811|65601857|FG001|Overall Study|Physician Decision|2|||
23509332|NCT00837811|65601858|FG002|Overall Study|Physician Decision|1|||
23509333|NCT00837811|65601856|FG000|Overall Study|Withdrawal by Subject|1|||
23509334|NCT00837811|65601857|FG001|Overall Study|Withdrawal by Subject|9|||
23509335|NCT00837811|65601858|FG002|Overall Study|Withdrawal by Subject|0|||
23509336|NCT00837811|65601856|FG000|Overall Study|Sponsor Decision|0|||
23607426|NCT02006641|65950694|FG000|Overall Study|Protocol Violation|0|||
23607427|NCT02006641|65950695|FG001|Overall Study|Protocol Violation|2|||
23607428|NCT02006641|65950696|FG002|Overall Study|Protocol Violation|2|||
23607429|NCT02006641|65950694|FG000|Overall Study|Lost to Follow-up|0|||
23607430|NCT02006641|65950695|FG001|Overall Study|Lost to Follow-up|1|||
23607431|NCT02006641|65950696|FG002|Overall Study|Lost to Follow-up|0|||
23509337|NCT00837811|65601857|FG001|Overall Study|Sponsor Decision|2|||
23509338|NCT00837811|65601858|FG002|Overall Study|Sponsor Decision|0|||
23509339|NCT01366521|65601859|FG000|Overall Study|Adverse Event|1|||
23509340|NCT01366521|65601860|FG001|Overall Study|Adverse Event|0|||
23509341|NCT01366521|65601861|FG002|Overall Study|Adverse Event|0|||
23509342|NCT01366521|65601862|FG003|Overall Study|Adverse Event|0|||
23509343|NCT01366521|65601859|FG000|Overall Study|Protocol Violation|0|||
23607432|NCT02006641|65950694|FG000|Overall Study|Withdrawal by Subject|7|||
23607433|NCT02006641|65950695|FG001|Overall Study|Withdrawal by Subject|12|||
23607434|NCT02006641|65950696|FG002|Overall Study|Withdrawal by Subject|11|||
23607435|NCT02006641|65950694|FG000|Overall Study|Other reason: patient didn't show up|1|||
23607436|NCT02006641|65950695|FG001|Overall Study|Other reason: patient didn't show up|0|||
23607437|NCT02006641|65950696|FG002|Overall Study|Other reason: patient didn't show up|0|||
23607438|NCT02006641|65950694|FG000|Overall Study|Other reason:patient didn't want to come|0|||
23509344|NCT01366521|65601860|FG001|Overall Study|Protocol Violation|0|||
23509345|NCT01366521|65601861|FG002|Overall Study|Protocol Violation|1|||
23509346|NCT01366521|65601862|FG003|Overall Study|Protocol Violation|0|||
23509347|NCT01366521|65601859|FG000|Overall Study|Physician Decision|0|||
23509348|NCT01366521|65601860|FG001|Overall Study|Physician Decision|0|||
23509349|NCT01366521|65601861|FG002|Overall Study|Physician Decision|1|||
23509350|NCT01366521|65601862|FG003|Overall Study|Physician Decision|0|||
23509351|NCT01366521|65601859|FG000|Overall Study|Withdrawal by Subject|0|||
23509352|NCT01366521|65601860|FG001|Overall Study|Withdrawal by Subject|1|||
23509353|NCT01366521|65601861|FG002|Overall Study|Withdrawal by Subject|0|||
23509354|NCT01366521|65601862|FG003|Overall Study|Withdrawal by Subject|0|||
23509355|NCT01291173|65601863|FG000|Overall Study|Adverse Event|0|||
23607439|NCT02006641|65950695|FG001|Overall Study|Other reason:patient didn't want to come|0|||
23607440|NCT02006641|65950696|FG002|Overall Study|Other reason:patient didn't want to come|1|||
23607441|NCT02006641|65950694|FG000|Overall Study|Other reason: patient has moved|1|||
23607442|NCT02006641|65950695|FG001|Overall Study|Other reason: patient has moved|0|||
23607443|NCT02006641|65950696|FG002|Overall Study|Other reason: patient has moved|1|||
23607444|NCT02006641|65950694|FG000|Overall Study|Other reason: caregiver in hospital|0|||
23607445|NCT02006641|65950695|FG001|Overall Study|Other reason: caregiver in hospital|1|||
23607446|NCT02006641|65950696|FG002|Overall Study|Other reason: caregiver in hospital|0|||
23607447|NCT02006641|65950694|FG000|Overall Study|Other reason: patient's wife has died|0|||
23607448|NCT02006641|65950695|FG001|Overall Study|Other reason: patient's wife has died|0|||
23607449|NCT02006641|65950696|FG002|Overall Study|Other reason: patient's wife has died|1|||
23607450|NCT02006641|65950694|FG000|Overall Study|Other reason: hospitalisation|0|||
23607451|NCT02006641|65950695|FG001|Overall Study|Other reason: hospitalisation|1|||
23607452|NCT02006641|65950696|FG002|Overall Study|Other reason: hospitalisation|0|||
23607453|NCT02006641|65950694|FG000|Overall Study|Other reason: caregiver impossibility|0|||
23607454|NCT02006641|65950695|FG001|Overall Study|Other reason: caregiver impossibility|0|||
23607455|NCT02006641|65950696|FG002|Overall Study|Other reason: caregiver impossibility|1|||
23607456|NCT02006641|65950694|FG000|Overall Study|Other reason: protocol non-compliance|0|||
23607457|NCT02006641|65950695|FG001|Overall Study|Other reason: protocol non-compliance|0|||
23607458|NCT02006641|65950696|FG002|Overall Study|Other reason: protocol non-compliance|1|||
23607459|NCT03456856|65950699|FG000|Overall Study|Lost to Follow-up|2|||
23607460|NCT03456856|65950699|FG000|Overall Study|Withdrawal by Subject|1|||
23607461|NCT03065400|65950704|FG000|Overall Study|Adverse Event|1|||
23607462|NCT03065400|65950704|FG000|Overall Study|Physician Decision|3|||
23607463|NCT03065400|65950704|FG000|Overall Study|Withdrawal by Subject|1|||
23607464|NCT03065400|65950704|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
23607465|NCT02106884|65950715|FG000|Overall Study|Change of diagnosis/exclusion|0|||
23607466|NCT02106884|65950716|FG001|Overall Study|Change of diagnosis/exclusion|1|||
23607467|NCT03442777|65950719|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
23607468|NCT03442777|65950720|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
23607469|NCT03442777|65950721|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
23607470|NCT00878189|65950722|FG000|Overall Study|Death|0|||
23607471|NCT00878189|65950723|FG001|Overall Study|Death|1|||
23607472|NCT00878189|65950724|FG002|Overall Study|Death|0|||
23607473|NCT00878189|65950725|FG003|Overall Study|Death|1|||
23607474|NCT00878189|65950726|FG004|Overall Study|Death|0|||
23607475|NCT00878189|65950727|FG005|Overall Study|Death|0|||
23607476|NCT00878189|65950728|FG006|Overall Study|Death|0|||
23607477|NCT00878189|65950729|FG007|Overall Study|Death|0|||
23607478|NCT00878189|65950730|FG008|Overall Study|Death|1|||
23408566|NCT03782259|65239924|FG001|Overall Study|Lost to Follow-up|1|||
23509356|NCT01291173|65601864|FG001|Overall Study|Adverse Event|3|||
23509357|NCT01291173|65601865|FG002|Overall Study|Adverse Event|1|||
23509358|NCT01291173|65601866|FG003|Overall Study|Adverse Event|3|||
23509359|NCT01291173|65601863|FG000|Overall Study|Protocol Violation|7|||
23509360|NCT01291173|65601864|FG001|Overall Study|Protocol Violation|2|||
23509361|NCT01291173|65601865|FG002|Overall Study|Protocol Violation|2|||
23509362|NCT01291173|65601866|FG003|Overall Study|Protocol Violation|5|||
23509363|NCT01291173|65601863|FG000|Overall Study|Withdrawal by Subject|6|||
23509364|NCT01291173|65601864|FG001|Overall Study|Withdrawal by Subject|4|||
23509365|NCT01291173|65601865|FG002|Overall Study|Withdrawal by Subject|4|||
23509366|NCT01291173|65601866|FG003|Overall Study|Withdrawal by Subject|2|||
23509367|NCT01291173|65601863|FG000|Overall Study|Lost to Follow-up|4|||
23509368|NCT01291173|65601864|FG001|Overall Study|Lost to Follow-up|6|||
23607479|NCT00878189|65950722|FG000|Overall Study|Participant Refused to Follow-up|0|||
23607480|NCT00878189|65950723|FG001|Overall Study|Participant Refused to Follow-up|0|||
23607481|NCT00878189|65950724|FG002|Overall Study|Participant Refused to Follow-up|0|||
23607482|NCT00878189|65950725|FG003|Overall Study|Participant Refused to Follow-up|0|||
23607483|NCT00878189|65950726|FG004|Overall Study|Participant Refused to Follow-up|0|||
23607484|NCT00878189|65950727|FG005|Overall Study|Participant Refused to Follow-up|4|||
23607485|NCT00878189|65950728|FG006|Overall Study|Participant Refused to Follow-up|0|||
23607486|NCT00878189|65950729|FG007|Overall Study|Participant Refused to Follow-up|0|||
23607487|NCT00878189|65950730|FG008|Overall Study|Participant Refused to Follow-up|0|||
23607488|NCT00878189|65950722|FG000|Overall Study|Other|3|||
23607489|NCT00878189|65950723|FG001|Overall Study|Other|2|||
23607490|NCT00878189|65950724|FG002|Overall Study|Other|4|||
23607491|NCT00878189|65950725|FG003|Overall Study|Other|7|||
23607492|NCT00878189|65950726|FG004|Overall Study|Other|4|||
23607493|NCT00878189|65950727|FG005|Overall Study|Other|18|||
23607494|NCT00878189|65950728|FG006|Overall Study|Other|15|||
23607495|NCT00878189|65950729|FG007|Overall Study|Other|3|||
23607496|NCT00878189|65950730|FG008|Overall Study|Other|4|||
23607497|NCT00878189|65950722|FG000|Overall Study|Lost to Follow-up|0|||
23607498|NCT00878189|65950723|FG001|Overall Study|Lost to Follow-up|0|||
23607499|NCT00878189|65950724|FG002|Overall Study|Lost to Follow-up|0|||
23607500|NCT00878189|65950725|FG003|Overall Study|Lost to Follow-up|0|||
23607501|NCT00878189|65950726|FG004|Overall Study|Lost to Follow-up|0|||
23607502|NCT00878189|65950727|FG005|Overall Study|Lost to Follow-up|1|||
23607503|NCT00878189|65950728|FG006|Overall Study|Lost to Follow-up|1|||
23607504|NCT00878189|65950729|FG007|Overall Study|Lost to Follow-up|0|||
23607505|NCT00878189|65950730|FG008|Overall Study|Lost to Follow-up|0|||
23607506|NCT00878189|65950722|FG000|Overall Study|Objection Progression or Relapse|0|||
23607507|NCT00878189|65950723|FG001|Overall Study|Objection Progression or Relapse|0|||
23607508|NCT00878189|65950724|FG002|Overall Study|Objection Progression or Relapse|0|||
23607509|NCT00878189|65950725|FG003|Overall Study|Objection Progression or Relapse|0|||
23607510|NCT00878189|65950726|FG004|Overall Study|Objection Progression or Relapse|0|||
23607511|NCT00878189|65950727|FG005|Overall Study|Objection Progression or Relapse|0|||
23607512|NCT00878189|65950728|FG006|Overall Study|Objection Progression or Relapse|0|||
23607513|NCT00878189|65950729|FG007|Overall Study|Objection Progression or Relapse|0|||
23607514|NCT00878189|65950730|FG008|Overall Study|Objection Progression or Relapse|3|||
23607515|NCT01380145|65950732|FG000|Overall Study|Progressive disease|4|||
23607516|NCT01661972|65950733|FG000|Overall Study|Adverse Event|1|||
23607517|NCT01661972|65950734|FG001|Overall Study|Adverse Event|2|||
23607518|NCT01661972|65950733|FG000|Overall Study|Death during Treatment period|1|||
23607519|NCT01661972|65950734|FG001|Overall Study|Death during Treatment period|1|||
23607520|NCT01661972|65950733|FG000|Overall Study|Withdrawal by Subject|0|||
23607521|NCT01661972|65950734|FG001|Overall Study|Withdrawal by Subject|1|||
23607522|NCT01186809|65950738|FG000|Overall Study|Death|30|||
23607523|NCT01019135|65950739|FG000|Overall Study|Did not receive allocated intervention|12|||
23607524|NCT01019135|65950740|FG001|Overall Study|Did not receive allocated intervention|6|||
23607525|NCT01019135|65950741|FG002|Overall Study|Did not receive allocated intervention|25|||
23607526|NCT01019135|65950739|FG000|Overall Study|Did not attend CR|8|||
23607527|NCT01019135|65950740|FG001|Overall Study|Did not attend CR|13|||
23607528|NCT01019135|65950741|FG002|Overall Study|Did not attend CR|6|||
23607529|NCT00448344|65953390|FG000|Overall Study|Lost to Follow-up|20|||
23607530|NCT00448344|65953391|FG001|Overall Study|Lost to Follow-up|22|||
23607531|NCT00448344|65953390|FG000|Overall Study|Withdrawal by Subject|6|||
23607532|NCT00448344|65953391|FG001|Overall Study|Withdrawal by Subject|8|||
23607533|NCT00448344|65953390|FG000|Overall Study|Death|3|||
23607534|NCT00448344|65953391|FG001|Overall Study|Death|4|||
23607535|NCT00448344|65953390|FG000|Overall Study|Physician Decision|1|||
23509369|NCT01291173|65601865|FG002|Overall Study|Lost to Follow-up|3|||
23509370|NCT01291173|65601866|FG003|Overall Study|Lost to Follow-up|2|||
23607536|NCT00448344|65953391|FG001|Overall Study|Physician Decision|2|||
23607537|NCT00442559|65953393|FG000|Overall Study|Lost to Follow-up|32|||
23607538|NCT00442559|65953394|FG001|Overall Study|Lost to Follow-up|34|||
23607539|NCT00442559|65953393|FG000|Overall Study|Protocol Violation|1|||
23607540|NCT00442559|65953394|FG001|Overall Study|Protocol Violation|1|||
23607541|NCT00442559|65953393|FG000|Overall Study|Withdrawal by Subject|1|||
23509371|NCT01291173|65601863|FG000|Overall Study|Unable to meet visit schedule|0|||
23607542|NCT00442559|65953394|FG001|Overall Study|Withdrawal by Subject|0|||
23509372|NCT01291173|65601864|FG001|Overall Study|Unable to meet visit schedule|0|||
23509373|NCT01291173|65601865|FG002|Overall Study|Unable to meet visit schedule|1|||
23607543|NCT02095145|65953395|FG000|Overall Study|Withdrawal by Subject|1|||
23607544|NCT02095145|65953396|FG001|Overall Study|Withdrawal by Subject|0|||
23607545|NCT04237792|65953400|FG000|Treatment (Day 1)|Adverse Event|1|||
23607546|NCT04237792|65953401|FG001|Treatment (Day 1)|Adverse Event|0|||
23607547|NCT04237792|65953402|FG002|Treatment (Day 1)|Adverse Event|0|||
23607548|NCT04237792|65953403|FG003|Treatment (Day 1)|Adverse Event|0|||
23607549|NCT04237792|65953404|FG004|Treatment (Day 1)|Adverse Event|1|||
23607550|NCT04237792|65953405|FG005|Treatment (Day 1)|Adverse Event|1|||
23607551|NCT04237792|65953400|FG000|Treatment (Day 1)|Other|0|||
23607552|NCT04237792|65953401|FG001|Treatment (Day 1)|Other|0|||
23607553|NCT04237792|65953402|FG002|Treatment (Day 1)|Other|1|||
23607554|NCT04237792|65953403|FG003|Treatment (Day 1)|Other|0|||
23607555|NCT04237792|65953404|FG004|Treatment (Day 1)|Other|0|||
23607556|NCT04237792|65953405|FG005|Treatment (Day 1)|Other|1|||
23607557|NCT04237792|65953400|FG000|Treatment (Day 1)|Not treated|1|||
23607558|NCT04237792|65953401|FG001|Treatment (Day 1)|Not treated|1|||
23607559|NCT04237792|65953402|FG002|Treatment (Day 1)|Not treated|2|||
23607560|NCT04237792|65953403|FG003|Treatment (Day 1)|Not treated|1|||
23607561|NCT04237792|65953404|FG004|Treatment (Day 1)|Not treated|0|||
23607562|NCT04237792|65953405|FG005|Treatment (Day 1)|Not treated|1|||
23607563|NCT01294644|65953406|FG000|Overall Study|Adverse Event|2|||
23607564|NCT01294644|65953407|FG001|Overall Study|Adverse Event|0|||
23607565|NCT01294644|65953408|FG002|Overall Study|Adverse Event|1|||
23607566|NCT01294644|65953406|FG000|Overall Study|Withdrawal by Subject|3|||
23607567|NCT01294644|65953407|FG001|Overall Study|Withdrawal by Subject|7|||
23607568|NCT01294644|65953408|FG002|Overall Study|Withdrawal by Subject|4|||
23607569|NCT01294644|65953406|FG000|Overall Study|Lost to Follow-up|3|||
23509374|NCT01291173|65601866|FG003|Overall Study|Unable to meet visit schedule|0|||
23509375|NCT01291173|65601863|FG000|Overall Study|Lack of compliance|0|||
23509376|NCT01291173|65601864|FG001|Overall Study|Lack of compliance|0|||
23509377|NCT01291173|65601865|FG002|Overall Study|Lack of compliance|0|||
23509378|NCT01291173|65601866|FG003|Overall Study|Lack of compliance|1|||
23509379|NCT01291173|65601863|FG000|Overall Study|Subject was unblinded|0|||
23509380|NCT01291173|65601864|FG001|Overall Study|Subject was unblinded|0|||
23509381|NCT01291173|65601865|FG002|Overall Study|Subject was unblinded|1|||
23509382|NCT01291173|65601866|FG003|Overall Study|Subject was unblinded|0|||
23509383|NCT01291173|65601863|FG000|Overall Study|Excluded therapy|0|||
23509384|NCT01291173|65601864|FG001|Overall Study|Excluded therapy|0|||
23509385|NCT01291173|65601865|FG002|Overall Study|Excluded therapy|1|||
23509386|NCT01291173|65601866|FG003|Overall Study|Excluded therapy|0|||
23509387|NCT01532414|65601869|FG000|Overall Study|Lost to Follow-up|3|||
23509388|NCT01532414|65601870|FG001|Overall Study|Lost to Follow-up|0|||
23509389|NCT01532414|65601871|FG002|Overall Study|Lost to Follow-up|1|||
23509390|NCT01532414|65601869|FG000|Overall Study|Withdrawal by Subject|3|||
23509391|NCT01532414|65601870|FG001|Overall Study|Withdrawal by Subject|0|||
23509392|NCT01532414|65601871|FG002|Overall Study|Withdrawal by Subject|0|||
23509393|NCT01532414|65601869|FG000|Overall Study|No V6 semen sample|0|||
23509394|NCT01532414|65601870|FG001|Overall Study|No V6 semen sample|1|||
23509395|NCT01532414|65601871|FG002|Overall Study|No V6 semen sample|0|||
23509396|NCT01532414|65601869|FG000|Overall Study|Adverse Event|0|||
23509397|NCT01532414|65601870|FG001|Overall Study|Adverse Event|1|||
23509398|NCT01532414|65601871|FG002|Overall Study|Adverse Event|1|||
23509399|NCT01532414|65601869|FG000|Overall Study|Unable to complete 24 hour PK|0|||
23509400|NCT01532414|65601870|FG001|Overall Study|Unable to complete 24 hour PK|0|||
23509401|NCT01532414|65601871|FG002|Overall Study|Unable to complete 24 hour PK|1|||
23509402|NCT01532414|65601869|FG000|Overall Study|Withdrawn by sponsor|1|||
23509403|NCT01532414|65601870|FG001|Overall Study|Withdrawn by sponsor|0|||
23509404|NCT01532414|65601871|FG002|Overall Study|Withdrawn by sponsor|0|||
23509405|NCT02056340|65601872|FG000|Overall Study|Lost to Follow-up|5|||
23509406|NCT02056340|65601873|FG001|Overall Study|Lost to Follow-up|5|||
23509407|NCT02056340|65601872|FG000|Overall Study|Withdrawal by Subject|2|||
23607570|NCT01294644|65953407|FG001|Overall Study|Lost to Follow-up|2|||
23607571|NCT01294644|65953408|FG002|Overall Study|Lost to Follow-up|5|||
23607572|NCT01294644|65953406|FG000|Overall Study|Miscellaneous Reason|2|||
23607573|NCT01294644|65953407|FG001|Overall Study|Miscellaneous Reason|1|||
23509408|NCT02056340|65601873|FG001|Overall Study|Withdrawal by Subject|6|||
23509409|NCT01482884|65601874|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
23509410|NCT01482884|65601875|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
23607574|NCT01294644|65953408|FG002|Overall Study|Miscellaneous Reason|4|||
23607575|NCT00392197|65953409|FG000|Overall Study|Adverse Event|4|||
23509411|NCT01482884|65601874|FG000|Overall Study|Protocol Violation|1|||
23509412|NCT01482884|65601875|FG001|Overall Study|Protocol Violation|0|||
23509413|NCT01482884|65601874|FG000|Overall Study|Lost to Follow-up|2|||
23509414|NCT01482884|65601875|FG001|Overall Study|Lost to Follow-up|2|||
23509415|NCT01482884|65601874|FG000|Overall Study|Lack of Efficacy|0|||
23509416|NCT01482884|65601875|FG001|Overall Study|Lack of Efficacy|1|||
23607576|NCT00392197|65953410|FG001|Overall Study|Adverse Event|12|||
23607577|NCT00392197|65953409|FG000|Overall Study|Lack of Efficacy|3|||
23607578|NCT00392197|65953410|FG001|Overall Study|Lack of Efficacy|4|||
23607579|NCT00392197|65953409|FG000|Overall Study|Lost to Follow-up|0|||
23607580|NCT00392197|65953410|FG001|Overall Study|Lost to Follow-up|1|||
23607581|NCT00392197|65953409|FG000|Overall Study|Physician Decision|3|||
23607582|NCT00392197|65953410|FG001|Overall Study|Physician Decision|2|||
23607583|NCT00392197|65953409|FG000|Overall Study|Protocol Violation|7|||
23607584|NCT00392197|65953410|FG001|Overall Study|Protocol Violation|5|||
23607585|NCT00392197|65953409|FG000|Overall Study|Withdrawal by Subject|4|||
23607586|NCT00392197|65953410|FG001|Overall Study|Withdrawal by Subject|6|||
23607587|NCT00824850|65953411|FG000|Overall Study|Withdrawal by Subject|0|||
23607588|NCT00824850|65953412|FG001|Overall Study|Withdrawal by Subject|1|||
23607589|NCT02713594|65953413|FG000|Overall Study|Withdrawal by Subject|32|||
23607590|NCT02713594|65953414|FG001|Overall Study|Withdrawal by Subject|22|||
23509417|NCT01482884|65601874|FG000|Overall Study|Adverse Event|2|||
23509418|NCT01482884|65601875|FG001|Overall Study|Adverse Event|1|||
23509419|NCT01482884|65601874|FG000|Overall Study|Withdrawal by Subject|8|||
23509420|NCT01482884|65601875|FG001|Overall Study|Withdrawal by Subject|13|||
23509421|NCT00684593|65601876|FG000|Overall Study|Adverse Event|0|||
23509422|NCT00684593|65601877|FG001|Overall Study|Adverse Event|2|||
23607591|NCT02713594|65953413|FG000|Overall Study|Lost to Follow-up|358|||
23607592|NCT02713594|65953414|FG001|Overall Study|Lost to Follow-up|374|||
23607593|NCT01190436|65953415|FG000|Overall Study|Lost to Follow-up|35|||
23607594|NCT01190436|65953415|FG000|Overall Study|Other|4|||
23607595|NCT00220805|65953422|FG000|Overall Study|Adverse Event|1|||
23607596|NCT00220805|65953423|FG001|Overall Study|Adverse Event|3|||
23607597|NCT00220805|65953422|FG000|Overall Study|Withdrawal by Subject|3|||
23607598|NCT00220805|65953423|FG001|Overall Study|Withdrawal by Subject|0|||
23607599|NCT00220805|65953422|FG000|Overall Study|Lack of Efficacy|1|||
23607600|NCT00220805|65953423|FG001|Overall Study|Lack of Efficacy|0|||
23607601|NCT00220805|65953422|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
23607602|NCT00220805|65953423|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
23607603|NCT04710576|65953424|FG000|Overall Study|Participants still in the study|73|||
23607604|NCT04710576|65953425|FG001|Overall Study|Participants still in the study|70|||
23509423|NCT02468414|65601878|FG000|Overall Study|Early Study Termination by Sponsor|1|||
23607605|NCT04710576|65953426|FG002|Overall Study|Participants still in the study|60|||
23607606|NCT04710576|65953424|FG000|Overall Study|Death|2|||
23607607|NCT04710576|65953425|FG001|Overall Study|Death|7|||
23607608|NCT04710576|65953426|FG002|Overall Study|Death|12|||
23607609|NCT04710576|65953424|FG000|Overall Study|Withdrawal by Subject|4|||
23607610|NCT04710576|65953425|FG001|Overall Study|Withdrawal by Subject|3|||
23607611|NCT04710576|65953426|FG002|Overall Study|Withdrawal by Subject|7|||
23607612|NCT04710576|65953424|FG000|Overall Study|Sponsor decision|1|||
23607613|NCT04710576|65953425|FG001|Overall Study|Sponsor decision|0|||
23607614|NCT04710576|65953426|FG002|Overall Study|Sponsor decision|0|||
23607615|NCT01613599|65953427|FG000|Overall Study|Death|9|||
23607616|NCT01613599|65953427|FG000|Overall Study|Lost to Follow-up|5|||
23607617|NCT01613599|65953427|FG000|Overall Study|Withdrawal by Subject|8|||
23607618|NCT01613599|65953427|FG000|Overall Study|Reason not specified|3|||
23607619|NCT01640288|65953428|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
23607620|NCT01640288|65953429|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
23607621|NCT01640288|65953428|FG000|Overall Study|Screen Failure|20|||
23607622|NCT01640288|65953429|FG001|Overall Study|Screen Failure|18|||
23607623|NCT01640288|65953428|FG000|Overall Study|Withdrawn by PI|5|||
23607624|NCT01640288|65953429|FG001|Overall Study|Withdrawn by PI|0|||
23607625|NCT01640288|65953428|FG000|Overall Study|Withdrawal by Subject|1|||
23607626|NCT01640288|65953429|FG001|Overall Study|Withdrawal by Subject|0|||
23607627|NCT01334606|65953432|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
23607628|NCT01428583|65953435|FG000|Overall Study|Adverse Event|75|||
23607629|NCT01428583|65953435|FG000|Overall Study|Withdrawal by Subject|51|||
23607630|NCT01428583|65953435|FG000|Overall Study|Lack of Efficacy|37|||
23607631|NCT01428583|65953435|FG000|Overall Study|Lost to Follow-up|17|||
23607632|NCT01428583|65953435|FG000|Overall Study|Death|1|||
23607633|NCT01428583|65953435|FG000|Overall Study|Pregnancy|1|||
23607634|NCT01428583|65953435|FG000|Overall Study|Protocol Violation|1|||
23607635|NCT01428583|65953435|FG000|Overall Study|Physician Decision|12|||
23607636|NCT01428583|65953435|FG000|Overall Study|Non-compliant|25|||
23607637|NCT01428583|65953435|FG000|Overall Study|Confirmed positive urine drug test|8|||
23607638|NCT01428583|65953435|FG000|Overall Study|Sponsor's request|3|||
23607639|NCT01428583|65953435|FG000|Overall Study|Other|6|||
23607640|NCT05260437|65953443|FG000|Overall Study|Lost to Follow-up|5|||
23509424|NCT02468414|65601879|FG001|Overall Study|Early Study Termination by Sponsor|0|||
23509425|NCT02468414|65601878|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
23607641|NCT05260437|65953444|FG001|Overall Study|Lost to Follow-up|2|||
23607642|NCT05260437|65953445|FG002|Overall Study|Lost to Follow-up|1|||
23607643|NCT05260437|65953446|FG003|Overall Study|Lost to Follow-up|2|||
23607644|NCT05260437|65953447|FG004|Overall Study|Lost to Follow-up|2|||
23607645|NCT05260437|65953443|FG000|Overall Study|Withdrawal by Subject|3|||
23607646|NCT05260437|65953444|FG001|Overall Study|Withdrawal by Subject|0|||
23607647|NCT05260437|65953445|FG002|Overall Study|Withdrawal by Subject|4|||
23607648|NCT05260437|65953446|FG003|Overall Study|Withdrawal by Subject|5|||
23607649|NCT05260437|65953447|FG004|Overall Study|Withdrawal by Subject|0|||
23607650|NCT05260437|65953443|FG000|Overall Study|Vaccine Not Administered|0|||
23607651|NCT05260437|65953444|FG001|Overall Study|Vaccine Not Administered|1|||
23607652|NCT05260437|65953445|FG002|Overall Study|Vaccine Not Administered|0|||
23607653|NCT05260437|65953446|FG003|Overall Study|Vaccine Not Administered|0|||
23607654|NCT05260437|65953447|FG004|Overall Study|Vaccine Not Administered|0|||
23607655|NCT03006393|65953450|FG000|Overall Study|Withdrawal by Subject|1|||
23607656|NCT03006393|65953451|FG001|Overall Study|Withdrawal by Subject|1|||
23607657|NCT03006393|65953450|FG000|Overall Study|Pregnancy|0|||
23607658|NCT03006393|65953451|FG001|Overall Study|Pregnancy|1|||
23607659|NCT03006393|65953450|FG000|Overall Study|Lost to Follow-up|0|||
23607660|NCT03006393|65953451|FG001|Overall Study|Lost to Follow-up|1|||
23607661|NCT00308308|65953452|FG000|Overall Study|Adverse Event|17|||
23607662|NCT00308308|65953453|FG001|Overall Study|Adverse Event|2|||
23607663|NCT00308308|65953452|FG000|Overall Study|Lost to Follow-up|5|||
23607664|NCT00308308|65953453|FG001|Overall Study|Lost to Follow-up|5|||
23607665|NCT00308308|65953452|FG000|Overall Study|Physician Decision|15|||
23607666|NCT00308308|65953453|FG001|Overall Study|Physician Decision|7|||
23607667|NCT00308308|65953452|FG000|Overall Study|Protocol Violation|3|||
23607668|NCT00308308|65953453|FG001|Overall Study|Protocol Violation|14|||
23607669|NCT00308308|65953452|FG000|Overall Study|Withdrawal by Subject|47|||
23607670|NCT00308308|65953453|FG001|Overall Study|Withdrawal by Subject|19|||
23607671|NCT00308308|65953452|FG000|Overall Study|Various|7|||
23607672|NCT00308308|65953453|FG001|Overall Study|Various|5|||
23607673|NCT00308308|65953452|FG000|Overall Study|Randomized but not dosed|8|||
23607674|NCT00308308|65953453|FG001|Overall Study|Randomized but not dosed|16|||
23509426|NCT02468414|65601879|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
23509427|NCT02468414|65601878|FG000|Overall Study|Screen Failure|1|||
23509428|NCT02468414|65601879|FG001|Overall Study|Screen Failure|0|||
23509429|NCT00578812|65601881|FG000|Overall Study|Not treated|6|||
23607675|NCT00308308|65953452|FG000|Overall Study|Other|1|||
23607676|NCT00308308|65953453|FG001|Overall Study|Other|0|||
23509430|NCT00578812|65601882|FG001|Overall Study|Not treated|7|||
23509431|NCT03998189|65601883|FG000|Overall Study|Lack of Efficacy|0|||
23509432|NCT03998189|65601884|FG001|Overall Study|Lack of Efficacy|1|||
23509433|NCT04532164|65601893|FG000|Overall Study|Adverse Event|1|||
23509434|NCT04532164|65601893|FG000|Overall Study|Protocol Violation|5|||
23509435|NCT04532164|65601893|FG000|Overall Study|Lost to Follow-up|1|||
23509436|NCT04532164|65601893|FG000|Overall Study|Found to be Ineligible|3|||
23509437|NCT04532164|65601893|FG000|Overall Study|Withdrawal by Subject|14|||
23509438|NCT00434330|65601894|FG000|Overall Study|Adverse Event|0|||
23509439|NCT00434330|65601895|FG001|Overall Study|Adverse Event|0|||
23509440|NCT00434330|65601896|FG002|Overall Study|Adverse Event|1|||
23509441|NCT00434330|65601897|FG003|Overall Study|Adverse Event|0|||
23509442|NCT00434330|65601898|FG004|Overall Study|Adverse Event|0|||
23509443|NCT00434330|65601899|FG005|Overall Study|Adverse Event|0|||
23509444|NCT00434330|65601894|FG000|Overall Study|Death|1|||
23509445|NCT00434330|65601895|FG001|Overall Study|Death|0|||
23509446|NCT00434330|65601896|FG002|Overall Study|Death|0|||
23509447|NCT00434330|65601897|FG003|Overall Study|Death|0|||
23509448|NCT00434330|65601898|FG004|Overall Study|Death|1|||
23509449|NCT00434330|65601899|FG005|Overall Study|Death|1|||
23509450|NCT00434330|65601894|FG000|Overall Study|Withdrawal by Subject|0|||
23509451|NCT00434330|65601895|FG001|Overall Study|Withdrawal by Subject|0|||
23509452|NCT00434330|65601896|FG002|Overall Study|Withdrawal by Subject|1|||
23509453|NCT00434330|65601897|FG003|Overall Study|Withdrawal by Subject|1|||
23509454|NCT00434330|65601898|FG004|Overall Study|Withdrawal by Subject|0|||
23509455|NCT00434330|65601899|FG005|Overall Study|Withdrawal by Subject|0|||
23509456|NCT00434330|65601894|FG000|Overall Study|Renal transplant|0|||
23607677|NCT00638456|65953454|FG000|Overall Study|Withdrawal by Subject|6|||
23607678|NCT00638456|65953455|FG001|Overall Study|Withdrawal by Subject|2|||
23607679|NCT00489554|65953458|FG000|Overall Study|Adverse Event|2|||
23607680|NCT00489554|65953458|FG000|Overall Study|Withdrawal by Subject|1|||
23607681|NCT00489554|65953458|FG000|Overall Study|Lost to Follow-up|1|||
23607682|NCT04323800|65953460|FG000|Overall Study|Withdrawal by Subject|4|||
23607683|NCT04323800|65953461|FG001|Overall Study|Withdrawal by Subject|4|||
23509457|NCT00434330|65601895|FG001|Overall Study|Renal transplant|0|||
23509458|NCT00434330|65601896|FG002|Overall Study|Renal transplant|0|||
23509459|NCT00434330|65601897|FG003|Overall Study|Renal transplant|1|||
23509460|NCT00434330|65601898|FG004|Overall Study|Renal transplant|0|||
23509461|NCT00434330|65601899|FG005|Overall Study|Renal transplant|0|||
23509462|NCT00434330|65601894|FG000|Overall Study|Subject Not Compliant With Study|0|||
23509463|NCT00434330|65601895|FG001|Overall Study|Subject Not Compliant With Study|0|||
23607684|NCT04323800|65953460|FG000|Overall Study|Incomplete transfusion|1|||
23607685|NCT04323800|65953461|FG001|Overall Study|Incomplete transfusion|0|||
23607686|NCT04323800|65953460|FG000|Overall Study|Other|0|||
23607687|NCT04323800|65953461|FG001|Overall Study|Other|1|||
23509464|NCT00434330|65601896|FG002|Overall Study|Subject Not Compliant With Study|1|||
23509465|NCT00434330|65601897|FG003|Overall Study|Subject Not Compliant With Study|0|||
23509466|NCT00434330|65601898|FG004|Overall Study|Subject Not Compliant With Study|0|||
23607688|NCT04323800|65953460|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
23607689|NCT04323800|65953461|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
23607690|NCT02232737|65953462|FG000|Overall Study|Lost to Follow-up|18|||
23607691|NCT02232737|65953463|FG001|Overall Study|Lost to Follow-up|28|||
23607692|NCT02232737|65953464|FG002|Overall Study|Lost to Follow-up|33|||
23607693|NCT02232737|65953462|FG000|Overall Study|Personal reasons|7|||
23607694|NCT02232737|65953463|FG001|Overall Study|Personal reasons|8|||
23607695|NCT02232737|65953464|FG002|Overall Study|Personal reasons|14|||
23607696|NCT02232737|65953462|FG000|Overall Study|Adverse Event|6|||
23509467|NCT00434330|65601899|FG005|Overall Study|Subject Not Compliant With Study|0|||
23509468|NCT01224431|65601900|FG000|Overall Study|not randomized|0|||
23509469|NCT01224431|65601901|FG001|Overall Study|not randomized|4|||
23509470|NCT01224431|65601900|FG000|Overall Study|no video record|0|||
23607697|NCT02232737|65953463|FG001|Overall Study|Adverse Event|3|||
23607698|NCT02232737|65953464|FG002|Overall Study|Adverse Event|8|||
23607699|NCT02232737|65953462|FG000|Overall Study|Incarcerated|2|||
23607700|NCT02232737|65953463|FG001|Overall Study|Incarcerated|1|||
23607701|NCT02232737|65953464|FG002|Overall Study|Incarcerated|2|||
23607702|NCT02232737|65953462|FG000|Overall Study|Withdrawal by Subject|0|||
23607703|NCT02232737|65953463|FG001|Overall Study|Withdrawal by Subject|1|||
23607704|NCT02232737|65953464|FG002|Overall Study|Withdrawal by Subject|2|||
23607705|NCT02232737|65953462|FG000|Overall Study|Death|0|||
23607706|NCT02232737|65953463|FG001|Overall Study|Death|1|||
23607707|NCT02232737|65953464|FG002|Overall Study|Death|1|||
23607708|NCT02232737|65953462|FG000|Overall Study|Physician Decision|1|||
23607709|NCT02232737|65953463|FG001|Overall Study|Physician Decision|3|||
23607710|NCT02232737|65953464|FG002|Overall Study|Physician Decision|1|||
23607711|NCT02232737|65953462|FG000|Overall Study|Protocol Violation|1|||
23607712|NCT02232737|65953463|FG001|Overall Study|Protocol Violation|0|||
23607713|NCT02232737|65953464|FG002|Overall Study|Protocol Violation|1|||
23607714|NCT02232737|65953462|FG000|Overall Study|Reason unknown|1|||
23607715|NCT02232737|65953463|FG001|Overall Study|Reason unknown|0|||
23607716|NCT02232737|65953464|FG002|Overall Study|Reason unknown|0|||
23607717|NCT03005106|65953465|FG000|Overall Study|Lost to Follow-up|16|||
23607718|NCT03005106|65953465|FG000|Overall Study|Adverse Event|1|||
23607719|NCT03005106|65953465|FG000|Overall Study|Physician Decision|1|||
23607720|NCT03005106|65953465|FG000|Overall Study|Death|2|||
23607721|NCT01124045|65953468|FG000|Overall Study|Lost to Follow-up|0|||
23607722|NCT01124045|65953469|FG001|Overall Study|Lost to Follow-up|1|||
23607723|NCT01124045|65953468|FG000|Overall Study|Physician Decision|0|||
23607724|NCT01124045|65953469|FG001|Overall Study|Physician Decision|2|||
23607725|NCT03693989|65953471|FG000|Overall Study|Protocol Violation|3|||
23607726|NCT03693989|65953472|FG001|Overall Study|Protocol Violation|4|||
23607727|NCT04766996|65953473|FG000|Overall Study|Withdrawal by Subject|1|||
23607728|NCT04766996|65953474|FG001|Overall Study|Withdrawal by Subject|0|||
23607729|NCT04766996|65953475|FG002|Overall Study|Withdrawal by Subject|13|||
23607730|NCT00754325|65953476|FG000|Initial Treatment|Continuing Active Treatment|4|||
23607731|NCT00754325|65953477|FG001|Initial Treatment|Continuing Active Treatment|5|||
23607732|NCT00754325|65953476|FG000|Initial Treatment|Adverse Event|7|||
23607733|NCT00754325|65953477|FG001|Initial Treatment|Adverse Event|6|||
23607734|NCT00754325|65953476|FG000|Initial Treatment|Withdrawal by Subject|2|||
23607735|NCT00754325|65953477|FG001|Initial Treatment|Withdrawal by Subject|2|||
23607736|NCT00754325|65953476|FG000|Initial Treatment|Physician Decision|2|||
23607737|NCT00754325|65953477|FG001|Initial Treatment|Physician Decision|0|||
23607738|NCT00754325|65953476|FG000|Initial Treatment|Sponsor Request|0|||
23607739|NCT00754325|65953477|FG001|Initial Treatment|Sponsor Request|1|||
23607740|NCT00754325|65953476|FG000|Initial Treatment|Disease Progression|35|||
23607741|NCT00754325|65953477|FG001|Initial Treatment|Disease Progression|35|||
23607742|NCT03122548|65953478|FG000|Overall Study|Death|2|||
23607743|NCT03122548|65953478|FG000|Overall Study|Progression - subject went into hospice|1|||
23509471|NCT01224431|65601901|FG001|Overall Study|no video record|1|||
23509472|NCT01543698|65601902|FG000|Phase 1b|Disease progression|2|||
23607744|NCT03122548|65953478|FG000|Overall Study|Study Terminated by Sponsor|2|||
23509473|NCT01543698|65601903|FG001|Phase 1b|Disease progression|4|||
23607745|NCT00942266|65953479|FG000|Overall Study|Withdrawal by Subject|1|||
23607746|NCT00942266|65953480|FG001|Overall Study|Withdrawal by Subject|0|||
23607747|NCT00942266|65953479|FG000|Overall Study|Adverse Event|2|||
23607748|NCT00942266|65953480|FG001|Overall Study|Adverse Event|1|||
23607749|NCT00942266|65953479|FG000|Overall Study|Disease Progression|38|||
23607750|NCT00942266|65953480|FG001|Overall Study|Disease Progression|11|||
23607751|NCT00942266|65953479|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
23607752|NCT00942266|65953480|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
23607753|NCT00942266|65953479|FG000|Overall Study|Intercurrent illness|0|||
23607754|NCT00942266|65953480|FG001|Overall Study|Intercurrent illness|1|||
23607755|NCT00942266|65953479|FG000|Overall Study|Physician Decision|2|||
23509474|NCT01543698|65601904|FG002|Phase 1b|Disease progression|3|||
23509475|NCT01543698|65601905|FG003|Phase 1b|Disease progression|2|||
23607756|NCT00942266|65953480|FG001|Overall Study|Physician Decision|0|||
23607757|NCT00942266|65953479|FG000|Overall Study|medical deterioration (pneumonia)|0|||
23607758|NCT00942266|65953480|FG001|Overall Study|medical deterioration (pneumonia)|1|||
23607759|NCT00595764|65953481|FG000|Overall Study|Protocol Violation|24|||
23607760|NCT00595764|65953482|FG001|Overall Study|Protocol Violation|19|||
23607761|NCT00595764|65953481|FG000|Overall Study|Missed Medication >1 week|10|||
23607762|NCT00595764|65953482|FG001|Overall Study|Missed Medication >1 week|17|||
23607763|NCT00595764|65953481|FG000|Overall Study|Missed 3 PM visits|1|||
23607764|NCT00595764|65953482|FG001|Overall Study|Missed 3 PM visits|7|||
23607765|NCT00595764|65953481|FG000|Overall Study|Withdrawal by Subject|4|||
23607766|NCT00595764|65953482|FG001|Overall Study|Withdrawal by Subject|0|||
23607767|NCT02706483|65953483|FG000|Overall Study|Adverse Event|97|||
23607768|NCT02706483|65953483|FG000|Overall Study|Death|1|||
23607769|NCT02706483|65953483|FG000|Overall Study|Lack of Efficacy|39|||
23607770|NCT02706483|65953483|FG000|Overall Study|Lost to Follow-up|101|||
23607771|NCT02706483|65953483|FG000|Overall Study|Non-compliance with study drug|15|||
23607772|NCT02706483|65953483|FG000|Overall Study|Physician Decision|6|||
23607773|NCT02706483|65953483|FG000|Overall Study|Pregnancy|6|||
23607774|NCT02706483|65953483|FG000|Overall Study|Protocol Violation|18|||
23607775|NCT02706483|65953483|FG000|Overall Study|Withdrawal by Subject|136|||
23607776|NCT02706483|65953483|FG000|Overall Study|Non-compliance with visits|6|||
23607777|NCT02706483|65953483|FG000|Overall Study|Site closure|4|||
23607778|NCT02706483|65953483|FG000|Overall Study|Subject moved|1|||
23607779|NCT00484198|65953486|FG000|Overall Study|Participant Withdrew Consent|12|||
23607780|NCT00484198|65953487|FG001|Overall Study|Participant Withdrew Consent|21|||
23607781|NCT00484198|65953488|FG002|Overall Study|Participant Withdrew Consent|47|||
23607782|NCT00484198|65953489|FG003|Overall Study|Participant Withdrew Consent|59|||
23607783|NCT00484198|65953486|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
23607784|NCT00484198|65953487|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
23607785|NCT00484198|65953488|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
23607786|NCT00484198|65953489|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
23607787|NCT00484198|65953486|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
23607788|NCT00484198|65953487|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
23607789|NCT00484198|65953488|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
23607790|NCT00484198|65953489|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
23607791|NCT00484198|65953486|FG000|Overall Study|Adverse Event|3|||
23607792|NCT00484198|65953487|FG001|Overall Study|Adverse Event|11|||
23607793|NCT00484198|65953488|FG002|Overall Study|Adverse Event|32|||
23607794|NCT00484198|65953489|FG003|Overall Study|Adverse Event|31|||
23607795|NCT00484198|65953486|FG000|Overall Study|Protocol Violation|0|||
23607796|NCT00484198|65953487|FG001|Overall Study|Protocol Violation|5|||
23607797|NCT00484198|65953488|FG002|Overall Study|Protocol Violation|6|||
23607798|NCT00484198|65953489|FG003|Overall Study|Protocol Violation|8|||
23607799|NCT00484198|65953486|FG000|Overall Study|Other|7|||
23607800|NCT00484198|65953487|FG001|Overall Study|Other|10|||
23607801|NCT00484198|65953488|FG002|Overall Study|Other|31|||
23607802|NCT00484198|65953489|FG003|Overall Study|Other|28|||
23607803|NCT00768755|65953490|FG000|Phase 1|Death|6|||
23607804|NCT00768755|65953491|FG001|Phase 1|Death|0|||
23607805|NCT00768755|65953492|FG002|Phase 1|Death|0|||
23607806|NCT00768755|65953493|FG003|Phase 1|Death|0|||
23607807|NCT00768755|65953490|FG000|Phase 1|Other|4|||
23607808|NCT00768755|65953491|FG001|Phase 1|Other|0|||
23607809|NCT00768755|65953492|FG002|Phase 1|Other|0|||
23607810|NCT00768755|65953493|FG003|Phase 1|Other|0|||
23607811|NCT00768755|65953490|FG000|Phase 2|Death|0|||
23607812|NCT00768755|65953491|FG001|Phase 2|Death|37|||
23607813|NCT00768755|65953492|FG002|Phase 2|Death|48|||
23607814|NCT00768755|65953493|FG003|Phase 2|Death|31|||
23509476|NCT01543698|65601906|FG004|Phase 1b|Disease progression|10|||
23607815|NCT00768755|65953490|FG000|Phase 2|Protocol Violation|0|||
23607816|NCT00768755|65953491|FG001|Phase 2|Protocol Violation|2|||
23607817|NCT00768755|65953492|FG002|Phase 2|Protocol Violation|0|||
23607818|NCT00768755|65953493|FG003|Phase 2|Protocol Violation|1|||
23607819|NCT00768755|65953490|FG000|Phase 2|Lost to Follow-up|0|||
23607820|NCT00768755|65953491|FG001|Phase 2|Lost to Follow-up|1|||
23607821|NCT00768755|65953492|FG002|Phase 2|Lost to Follow-up|1|||
23607822|NCT00768755|65953493|FG003|Phase 2|Lost to Follow-up|4|||
23607823|NCT00768755|65953490|FG000|Phase 2|Withdrawal by Subject|0|||
23607824|NCT00768755|65953491|FG001|Phase 2|Withdrawal by Subject|1|||
23607825|NCT00768755|65953492|FG002|Phase 2|Withdrawal by Subject|0|||
23607826|NCT00768755|65953493|FG003|Phase 2|Withdrawal by Subject|1|||
23607827|NCT00768755|65953490|FG000|Phase 2|Other|0|||
23607828|NCT00768755|65953491|FG001|Phase 2|Other|1|||
23607829|NCT00768755|65953492|FG002|Phase 2|Other|2|||
23607830|NCT00768755|65953493|FG003|Phase 2|Other|4|||
23607831|NCT00768755|65953490|FG000|Phase 2|Study Terminated by Sponsor|0|||
23607832|NCT00768755|65953491|FG001|Phase 2|Study Terminated by Sponsor|13|||
23607833|NCT00768755|65953492|FG002|Phase 2|Study Terminated by Sponsor|7|||
23607834|NCT00768755|65953493|FG003|Phase 2|Study Terminated by Sponsor|14|||
23607835|NCT00768755|65953490|FG000|Phase 2|Randomized but not treated|0|||
23607836|NCT00768755|65953491|FG001|Phase 2|Randomized but not treated|0|||
23607837|NCT00768755|65953492|FG002|Phase 2|Randomized but not treated|0|||
23607838|NCT00768755|65953493|FG003|Phase 2|Randomized but not treated|2|||
23607839|NCT00486954|65953497|FG000|Pilot Part|Adverse Event|4|||
23607840|NCT00486954|65953498|FG001|Pilot Part|Adverse Event|0|||
23607841|NCT00486954|65953499|FG002|Pilot Part|Adverse Event|5|||
23607842|NCT00486954|65953500|FG003|Pilot Part|Adverse Event|0|||
23607843|NCT00486954|65953501|FG004|Pilot Part|Adverse Event|0|||
23607844|NCT00486954|65953497|FG000|Pilot Part|Disease Progression|2|||
23607845|NCT00486954|65953498|FG001|Pilot Part|Disease Progression|0|||
23607846|NCT00486954|65953499|FG002|Pilot Part|Disease Progression|1|||
23607847|NCT00486954|65953500|FG003|Pilot Part|Disease Progression|0|||
23607848|NCT00486954|65953501|FG004|Pilot Part|Disease Progression|0|||
23607849|NCT00486954|65953497|FG000|Randomized Part|Lost to Follow-up|0|||
23607850|NCT00486954|65953498|FG001|Randomized Part|Lost to Follow-up|0|||
23607851|NCT00486954|65953499|FG002|Randomized Part|Lost to Follow-up|0|||
23607852|NCT00486954|65953500|FG003|Randomized Part|Lost to Follow-up|0|||
23607853|NCT00486954|65953501|FG004|Randomized Part|Lost to Follow-up|1|||
23607854|NCT00486954|65953497|FG000|Randomized Part|Withdrawal by Subject|0|||
23607855|NCT00486954|65953498|FG001|Randomized Part|Withdrawal by Subject|0|||
23607856|NCT00486954|65953499|FG002|Randomized Part|Withdrawal by Subject|0|||
23607857|NCT00486954|65953500|FG003|Randomized Part|Withdrawal by Subject|1|||
23607858|NCT00486954|65953501|FG004|Randomized Part|Withdrawal by Subject|0|||
23607859|NCT00486954|65953497|FG000|Randomized Part|Sponsor Terminated Study|0|||
23607860|NCT00486954|65953498|FG001|Randomized Part|Sponsor Terminated Study|0|||
23607861|NCT00486954|65953499|FG002|Randomized Part|Sponsor Terminated Study|0|||
23607862|NCT00486954|65953500|FG003|Randomized Part|Sponsor Terminated Study|19|||
23607863|NCT00486954|65953501|FG004|Randomized Part|Sponsor Terminated Study|13|||
23607864|NCT01681511|65953503|FG000|Overall Study|No Treatment Received|1|||
23607865|NCT01681511|65953504|FG001|Overall Study|No Treatment Received|3|||
23607866|NCT01681511|65953503|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
23509477|NCT01543698|65601907|FG005|Phase 1b|Disease progression|6|||
23509478|NCT01543698|65601908|FG006|Phase 1b|Disease progression|5|||
23509479|NCT01543698|65601909|FG007|Phase 1b|Disease progression|3|||
23509480|NCT01543698|65601910|FG008|Phase 1b|Disease progression|4|||
23607867|NCT01681511|65953504|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
23607868|NCT01681511|65953503|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
23607869|NCT01681511|65953504|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
23607870|NCT01681511|65953503|FG000|Overall Study|No Daily Urine Sample Collected|0|||
23607871|NCT01681511|65953504|FG001|Overall Study|No Daily Urine Sample Collected|1|||
23607872|NCT01681511|65953503|FG000|Overall Study|No post-catheter sample collected|11|||
23607873|NCT01681511|65953504|FG001|Overall Study|No post-catheter sample collected|4|||
23607874|NCT02674399|65953505|FG000|Overall Study|Lost to Follow-up|2|||
23607875|NCT02674399|65953506|FG001|Overall Study|Lost to Follow-up|0|||
23509481|NCT01543698|65601911|FG009|Phase 1b|Disease progression|5|||
23509482|NCT01543698|65601912|FG010|Phase 1b|Disease progression|1|||
23509483|NCT01543698|65601913|FG011|Phase 1b|Disease progression|0|||
23509484|NCT01543698|65601914|FG012|Phase 1b|Disease progression|0|||
23509485|NCT01543698|65601915|FG013|Phase 1b|Disease progression|0|||
23607876|NCT03029585|65953509|FG000|Overall Study|Death|1|||
23607877|NCT03029585|65953510|FG001|Overall Study|Death|1|||
23607878|NCT03029585|65953509|FG000|Overall Study|Withdrawal by Subject|1|||
23607879|NCT03029585|65953510|FG001|Overall Study|Withdrawal by Subject|0|||
23607880|NCT02574286|65953511|FG000|Overall Study|Adverse Event|3|||
23607881|NCT02574286|65953511|FG000|Overall Study|Withdrawal by Subject|2|||
23607882|NCT00813709|65953514|FG000|Double Blind Period|Adverse Event|4|||
23607883|NCT00813709|65953515|FG001|Double Blind Period|Adverse Event|1|||
23607884|NCT00813709|65953516|FG002|Double Blind Period|Adverse Event|4|||
23607885|NCT00813709|65953517|FG003|Double Blind Period|Adverse Event|0|||
23607886|NCT00813709|65953518|FG004|Double Blind Period|Adverse Event|0|||
23607887|NCT00813709|65953519|FG005|Double Blind Period|Adverse Event|0|||
23607888|NCT00813709|65953514|FG000|Double Blind Period|Lost to Follow-up|3|||
23607889|NCT00813709|65953515|FG001|Double Blind Period|Lost to Follow-up|2|||
23607890|NCT00813709|65953516|FG002|Double Blind Period|Lost to Follow-up|2|||
23607891|NCT00813709|65953517|FG003|Double Blind Period|Lost to Follow-up|0|||
23607892|NCT00813709|65953518|FG004|Double Blind Period|Lost to Follow-up|0|||
23607893|NCT00813709|65953519|FG005|Double Blind Period|Lost to Follow-up|0|||
23607894|NCT00813709|65953514|FG000|Double Blind Period|Switched to open label phase|9|||
23607895|NCT00813709|65953515|FG001|Double Blind Period|Switched to open label phase|26|||
23607896|NCT00813709|65953516|FG002|Double Blind Period|Switched to open label phase|18|||
23607897|NCT00813709|65953517|FG003|Double Blind Period|Switched to open label phase|0|||
23607898|NCT00813709|65953518|FG004|Double Blind Period|Switched to open label phase|0|||
23607899|NCT00813709|65953519|FG005|Double Blind Period|Switched to open label phase|0|||
23509486|NCT01543698|65601916|FG014|Phase 1b|Disease progression|0|||
23607900|NCT00813709|65953514|FG000|Double Blind Period|Randomized but not treated|1|||
23509487|NCT01543698|65601902|FG000|Phase 1b|Death|0|||
23607901|NCT00813709|65953515|FG001|Double Blind Period|Randomized but not treated|3|||
23607902|NCT00813709|65953516|FG002|Double Blind Period|Randomized but not treated|1|||
23607903|NCT00813709|65953517|FG003|Double Blind Period|Randomized but not treated|0|||
23607904|NCT00813709|65953518|FG004|Double Blind Period|Randomized but not treated|0|||
23607905|NCT00813709|65953519|FG005|Double Blind Period|Randomized but not treated|0|||
23607906|NCT00813709|65953514|FG000|Double Blind Period|Other|14|||
23607907|NCT00813709|65953515|FG001|Double Blind Period|Other|9|||
23607908|NCT00813709|65953516|FG002|Double Blind Period|Other|6|||
23607909|NCT00813709|65953517|FG003|Double Blind Period|Other|0|||
23607910|NCT00813709|65953518|FG004|Double Blind Period|Other|0|||
23607911|NCT00813709|65953519|FG005|Double Blind Period|Other|0|||
23607912|NCT00813709|65953514|FG000|Open Label Period|Adverse Event|0|||
23607913|NCT00813709|65953515|FG001|Open Label Period|Adverse Event|0|||
23607914|NCT00813709|65953516|FG002|Open Label Period|Adverse Event|0|||
23607915|NCT00813709|65953517|FG003|Open Label Period|Adverse Event|5|||
23607916|NCT00813709|65953518|FG004|Open Label Period|Adverse Event|4|||
23607917|NCT00813709|65953519|FG005|Open Label Period|Adverse Event|3|||
23607918|NCT00813709|65953514|FG000|Open Label Period|Lack of Efficacy|0|||
23607919|NCT00813709|65953515|FG001|Open Label Period|Lack of Efficacy|0|||
23607920|NCT00813709|65953516|FG002|Open Label Period|Lack of Efficacy|0|||
23607921|NCT00813709|65953517|FG003|Open Label Period|Lack of Efficacy|3|||
23607922|NCT00813709|65953518|FG004|Open Label Period|Lack of Efficacy|1|||
23607923|NCT00813709|65953519|FG005|Open Label Period|Lack of Efficacy|1|||
23607924|NCT00813709|65953514|FG000|Open Label Period|Randomized but not treated|0|||
23607925|NCT00813709|65953515|FG001|Open Label Period|Randomized but not treated|0|||
23607926|NCT00813709|65953516|FG002|Open Label Period|Randomized but not treated|0|||
23607927|NCT00813709|65953517|FG003|Open Label Period|Randomized but not treated|1|||
23607928|NCT00813709|65953518|FG004|Open Label Period|Randomized but not treated|0|||
23607929|NCT00813709|65953519|FG005|Open Label Period|Randomized but not treated|1|||
23607930|NCT00813709|65953514|FG000|Open Label Period|Other|0|||
23607931|NCT00813709|65953515|FG001|Open Label Period|Other|0|||
23607932|NCT00813709|65953516|FG002|Open Label Period|Other|0|||
23607933|NCT00813709|65953517|FG003|Open Label Period|Other|11|||
23607934|NCT00813709|65953518|FG004|Open Label Period|Other|5|||
23607935|NCT00813709|65953519|FG005|Open Label Period|Other|6|||
23607936|NCT01760876|65953520|FG000|Overall Study|Non-cardiac death (head injury)|1|||
23607937|NCT01760876|65953520|FG000|Overall Study|Carcinoma of prostate|1|||
23607938|NCT01760876|65953520|FG000|Overall Study|Impaired renal function|1|||
23607939|NCT01760876|65953520|FG000|Overall Study|Major depression|1|||
23607940|NCT01760876|65953520|FG000|Overall Study|Very poor baseline OCT quality|2|||
23607941|NCT04633200|65953523|FG000|Overall Study|Lost to Follow-up|3|||
23607942|NCT04633200|65953524|FG001|Overall Study|Lost to Follow-up|5|||
23607943|NCT03431350|65953525|FG000|Overall Study|ONGOING|0|||
23607944|NCT03431350|65953526|FG001|Overall Study|ONGOING|0|||
23607945|NCT03431350|65953527|FG002|Overall Study|ONGOING|2|||
23607946|NCT03431350|65953528|FG003|Overall Study|ONGOING|0|||
23607947|NCT03431350|65953529|FG004|Overall Study|ONGOING|1|||
23607948|NCT03431350|65953530|FG005|Overall Study|ONGOING|3|||
23607949|NCT03431350|65953531|FG006|Overall Study|ONGOING|0|||
23607950|NCT03431350|65953532|FG007|Overall Study|ONGOING|1|||
23607951|NCT03431350|65953533|FG008|Overall Study|ONGOING|3|||
23607952|NCT03431350|65953534|FG009|Overall Study|ONGOING|4|||
23607953|NCT03431350|65953535|FG010|Overall Study|ONGOING|2|||
23607954|NCT03431350|65953536|FG011|Overall Study|ONGOING|1|||
23607955|NCT03431350|65953525|FG000|Overall Study|Death|6|||
23607956|NCT03431350|65953526|FG001|Overall Study|Death|5|||
23607957|NCT03431350|65953527|FG002|Overall Study|Death|18|||
23607958|NCT03431350|65953528|FG003|Overall Study|Death|7|||
23607959|NCT03431350|65953529|FG004|Overall Study|Death|4|||
23607960|NCT03431350|65953530|FG005|Overall Study|Death|3|||
23607961|NCT03431350|65953531|FG006|Overall Study|Death|2|||
23607962|NCT03431350|65953532|FG007|Overall Study|Death|0|||
23607963|NCT03431350|65953533|FG008|Overall Study|Death|0|||
23607964|NCT03431350|65953534|FG009|Overall Study|Death|0|||
23607965|NCT03431350|65953535|FG010|Overall Study|Death|4|||
23607966|NCT03431350|65953536|FG011|Overall Study|Death|0|||
23607967|NCT03431350|65953525|FG000|Overall Study|Lost to Follow-up|0|||
23607968|NCT03431350|65953526|FG001|Overall Study|Lost to Follow-up|1|||
23607969|NCT03431350|65953527|FG002|Overall Study|Lost to Follow-up|0|||
23607970|NCT03431350|65953528|FG003|Overall Study|Lost to Follow-up|0|||
23607971|NCT03431350|65953529|FG004|Overall Study|Lost to Follow-up|0|||
23607972|NCT03431350|65953530|FG005|Overall Study|Lost to Follow-up|0|||
23607973|NCT03431350|65953531|FG006|Overall Study|Lost to Follow-up|0|||
23607974|NCT03431350|65953532|FG007|Overall Study|Lost to Follow-up|0|||
23607975|NCT03431350|65953533|FG008|Overall Study|Lost to Follow-up|0|||
23607976|NCT03431350|65953534|FG009|Overall Study|Lost to Follow-up|0|||
23607977|NCT03431350|65953535|FG010|Overall Study|Lost to Follow-up|0|||
23607978|NCT03431350|65953536|FG011|Overall Study|Lost to Follow-up|0|||
23607979|NCT03431350|65953525|FG000|Overall Study|Withdrawal by Subject|0|||
23607980|NCT03431350|65953526|FG001|Overall Study|Withdrawal by Subject|0|||
23607981|NCT03431350|65953527|FG002|Overall Study|Withdrawal by Subject|0|||
23607982|NCT03431350|65953528|FG003|Overall Study|Withdrawal by Subject|1|||
23607983|NCT03431350|65953529|FG004|Overall Study|Withdrawal by Subject|1|||
23607984|NCT03431350|65953530|FG005|Overall Study|Withdrawal by Subject|1|||
23607985|NCT03431350|65953531|FG006|Overall Study|Withdrawal by Subject|0|||
23607986|NCT03431350|65953532|FG007|Overall Study|Withdrawal by Subject|0|||
23607987|NCT03431350|65953533|FG008|Overall Study|Withdrawal by Subject|0|||
23607988|NCT03431350|65953534|FG009|Overall Study|Withdrawal by Subject|2|||
23607989|NCT03431350|65953535|FG010|Overall Study|Withdrawal by Subject|0|||
23607990|NCT03431350|65953536|FG011|Overall Study|Withdrawal by Subject|1|||
23509488|NCT01543698|65601903|FG001|Phase 1b|Death|0|||
23509489|NCT01543698|65601904|FG002|Phase 1b|Death|1|||
23509490|NCT01543698|65601905|FG003|Phase 1b|Death|1|||
23509491|NCT01543698|65601906|FG004|Phase 1b|Death|0|||
23509492|NCT01543698|65601907|FG005|Phase 1b|Death|0|||
23509493|NCT01543698|65601908|FG006|Phase 1b|Death|0|||
23607991|NCT03431350|65953525|FG000|Overall Study|Other|0|||
23607992|NCT03431350|65953526|FG001|Overall Study|Other|0|||
23607993|NCT03431350|65953527|FG002|Overall Study|Other|1|||
23607994|NCT03431350|65953528|FG003|Overall Study|Other|3|||
23607995|NCT03431350|65953529|FG004|Overall Study|Other|2|||
23607996|NCT03431350|65953530|FG005|Overall Study|Other|2|||
23607997|NCT03431350|65953531|FG006|Overall Study|Other|4|||
23607998|NCT03431350|65953532|FG007|Overall Study|Other|0|||
23607999|NCT03431350|65953533|FG008|Overall Study|Other|14|||
23608000|NCT03431350|65953534|FG009|Overall Study|Other|11|||
23608001|NCT03431350|65953535|FG010|Overall Study|Other|11|||
23608002|NCT03431350|65953536|FG011|Overall Study|Other|15|||
23608003|NCT02332889|65953541|FG000|Overall Study|Physician Decision|1|||
23608004|NCT01316913|65953542|FG000|Overall Study|Adverse Event|17|||
23608005|NCT01316913|65953543|FG001|Overall Study|Adverse Event|20|||
23608006|NCT01316913|65953544|FG002|Overall Study|Adverse Event|15|||
23608007|NCT01316913|65953545|FG003|Overall Study|Adverse Event|11|||
23608008|NCT01316913|65953542|FG000|Overall Study|Lack of Efficacy|22|||
23608009|NCT01316913|65953543|FG001|Overall Study|Lack of Efficacy|12|||
23608010|NCT01316913|65953544|FG002|Overall Study|Lack of Efficacy|9|||
23608011|NCT01316913|65953545|FG003|Overall Study|Lack of Efficacy|13|||
23608012|NCT01316913|65953542|FG000|Overall Study|Protocol Violation|1|||
23608013|NCT01316913|65953543|FG001|Overall Study|Protocol Violation|4|||
23608014|NCT01316913|65953544|FG002|Overall Study|Protocol Violation|4|||
23608015|NCT01316913|65953545|FG003|Overall Study|Protocol Violation|1|||
23608016|NCT01316913|65953542|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
23608017|NCT01316913|65953543|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
23608018|NCT01316913|65953544|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
23608019|NCT01316913|65953545|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
23608020|NCT01316913|65953542|FG000|Overall Study|Lost to Follow-up|0|||
23608021|NCT01316913|65953543|FG001|Overall Study|Lost to Follow-up|1|||
23608022|NCT01316913|65953544|FG002|Overall Study|Lost to Follow-up|0|||
23608023|NCT01316913|65953545|FG003|Overall Study|Lost to Follow-up|2|||
23608024|NCT01316913|65953542|FG000|Overall Study|Withdrawal by Subject|10|||
23608025|NCT01316913|65953543|FG001|Overall Study|Withdrawal by Subject|9|||
23608026|NCT01316913|65953544|FG002|Overall Study|Withdrawal by Subject|10|||
23608027|NCT01316913|65953545|FG003|Overall Study|Withdrawal by Subject|6|||
23608028|NCT01214200|65953546|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
23608029|NCT01214200|65953546|FG000|Overall Study|Withdrawal by Subject|2|||
23608030|NCT04212299|65953547|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
23608031|NCT02721147|65953548|FG000|Overall Study|Lost to Follow-up|2|||
23608032|NCT02721147|65953549|FG001|Overall Study|Lost to Follow-up|0|||
23608033|NCT02721147|65953550|FG002|Overall Study|Lost to Follow-up|0|||
23509494|NCT01543698|65601909|FG007|Phase 1b|Death|0|||
23509495|NCT01543698|65601910|FG008|Phase 1b|Death|0|||
23608034|NCT00617708|65953551|FG000|Overall Study|Adverse Event|0|||
23608035|NCT00617708|65953552|FG001|Overall Study|Adverse Event|6|||
23608036|NCT00617708|65953553|FG002|Overall Study|Adverse Event|9|||
23608037|NCT00617708|65953551|FG000|Overall Study|Withdrawal by Subject|1|||
23608038|NCT00617708|65953552|FG001|Overall Study|Withdrawal by Subject|1|||
23608039|NCT00617708|65953553|FG002|Overall Study|Withdrawal by Subject|7|||
23608040|NCT00617708|65953551|FG000|Overall Study|Death|0|||
23608041|NCT00617708|65953552|FG001|Overall Study|Death|6|||
23608042|NCT00617708|65953553|FG002|Overall Study|Death|5|||
23608043|NCT00617708|65953551|FG000|Overall Study|Progression/Relapse|7|||
23608044|NCT00617708|65953552|FG001|Overall Study|Progression/Relapse|40|||
23608045|NCT00617708|65953553|FG002|Overall Study|Progression/Relapse|36|||
23509496|NCT01543698|65601911|FG009|Phase 1b|Death|0|||
23608046|NCT00617708|65953551|FG000|Overall Study|Not protocol specified|1|||
23608047|NCT00617708|65953552|FG001|Overall Study|Not protocol specified|4|||
23509497|NCT01543698|65601912|FG010|Phase 1b|Death|1|||
23509498|NCT01543698|65601913|FG011|Phase 1b|Death|0|||
23509499|NCT01543698|65601914|FG012|Phase 1b|Death|0|||
23608048|NCT00617708|65953553|FG002|Overall Study|Not protocol specified|2|||
23608049|NCT00617708|65953551|FG000|Overall Study|Not eligible|1|||
23608050|NCT00617708|65953552|FG001|Overall Study|Not eligible|3|||
23509500|NCT01543698|65601915|FG013|Phase 1b|Death|0|||
23608051|NCT00617708|65953553|FG002|Overall Study|Not eligible|5|||
23608052|NCT00670488|65953554|FG000|Overall Study|Adverse Event|0|||
23608053|NCT00670488|65953555|FG001|Overall Study|Adverse Event|7|||
23608054|NCT00670488|65953556|FG002|Overall Study|Adverse Event|0|||
23608055|NCT00670488|65953557|FG003|Overall Study|Adverse Event|3|||
23608056|NCT00670488|65953558|FG004|Overall Study|Adverse Event|1|||
23608057|NCT00670488|65953559|FG005|Overall Study|Adverse Event|1|||
23608058|NCT00670488|65953560|FG006|Overall Study|Adverse Event|5|||
23608059|NCT00670488|65953561|FG007|Overall Study|Adverse Event|1|||
23608060|NCT00670488|65953562|FG008|Overall Study|Adverse Event|0|||
23509501|NCT01543698|65601916|FG014|Phase 1b|Death|0|||
23509502|NCT01543698|65601902|FG000|Phase 1b|Withdrawal by Subject|0|||
23509503|NCT01543698|65601903|FG001|Phase 1b|Withdrawal by Subject|1|||
23509504|NCT01543698|65601904|FG002|Phase 1b|Withdrawal by Subject|0|||
23509505|NCT01543698|65601905|FG003|Phase 1b|Withdrawal by Subject|1|||
23509506|NCT01543698|65601906|FG004|Phase 1b|Withdrawal by Subject|0|||
23509507|NCT01543698|65601907|FG005|Phase 1b|Withdrawal by Subject|0|||
23509508|NCT01543698|65601908|FG006|Phase 1b|Withdrawal by Subject|1|||
23509509|NCT01543698|65601909|FG007|Phase 1b|Withdrawal by Subject|0|||
23509510|NCT01543698|65601910|FG008|Phase 1b|Withdrawal by Subject|0|||
23509511|NCT01543698|65601911|FG009|Phase 1b|Withdrawal by Subject|0|||
23509512|NCT01543698|65601912|FG010|Phase 1b|Withdrawal by Subject|0|||
23509513|NCT01543698|65601913|FG011|Phase 1b|Withdrawal by Subject|0|||
23509514|NCT01543698|65601914|FG012|Phase 1b|Withdrawal by Subject|0|||
23509515|NCT01543698|65601915|FG013|Phase 1b|Withdrawal by Subject|0|||
23509516|NCT01543698|65601916|FG014|Phase 1b|Withdrawal by Subject|0|||
23509517|NCT01543698|65601902|FG000|Phase 1b|Adverse Event|1|||
23509518|NCT01543698|65601903|FG001|Phase 1b|Adverse Event|0|||
23509519|NCT01543698|65601904|FG002|Phase 1b|Adverse Event|0|||
23509520|NCT01543698|65601905|FG003|Phase 1b|Adverse Event|1|||
23509521|NCT01543698|65601906|FG004|Phase 1b|Adverse Event|2|||
23509522|NCT01543698|65601907|FG005|Phase 1b|Adverse Event|2|||
23509523|NCT01543698|65601908|FG006|Phase 1b|Adverse Event|0|||
23509524|NCT01543698|65601909|FG007|Phase 1b|Adverse Event|0|||
23509525|NCT01543698|65601910|FG008|Phase 1b|Adverse Event|1|||
23509526|NCT01543698|65601911|FG009|Phase 1b|Adverse Event|1|||
23509527|NCT01543698|65601912|FG010|Phase 1b|Adverse Event|2|||
23509528|NCT01543698|65601913|FG011|Phase 1b|Adverse Event|0|||
23509529|NCT01543698|65601914|FG012|Phase 1b|Adverse Event|0|||
23509530|NCT01543698|65601915|FG013|Phase 1b|Adverse Event|0|||
23509531|NCT01543698|65601916|FG014|Phase 1b|Adverse Event|0|||
23509532|NCT01543698|65601902|FG000|Phase 1b|Administrative problems|1|||
23509533|NCT01543698|65601903|FG001|Phase 1b|Administrative problems|0|||
23509534|NCT01543698|65601904|FG002|Phase 1b|Administrative problems|0|||
23509535|NCT01543698|65601905|FG003|Phase 1b|Administrative problems|0|||
23509536|NCT01543698|65601906|FG004|Phase 1b|Administrative problems|1|||
23509537|NCT01543698|65601907|FG005|Phase 1b|Administrative problems|0|||
23509538|NCT01543698|65601908|FG006|Phase 1b|Administrative problems|0|||
23509539|NCT01543698|65601909|FG007|Phase 1b|Administrative problems|1|||
23509540|NCT01543698|65601910|FG008|Phase 1b|Administrative problems|0|||
23509541|NCT01543698|65601911|FG009|Phase 1b|Administrative problems|0|||
23509542|NCT01543698|65601912|FG010|Phase 1b|Administrative problems|2|||
23509543|NCT01543698|65601913|FG011|Phase 1b|Administrative problems|0|||
23509544|NCT01543698|65601914|FG012|Phase 1b|Administrative problems|0|||
23509545|NCT01543698|65601915|FG013|Phase 1b|Administrative problems|0|||
23509546|NCT01543698|65601916|FG014|Phase 1b|Administrative problems|0|||
23509547|NCT01543698|65601902|FG000|Phase 1b|Protocol Violation|2|||
23509548|NCT01543698|65601903|FG001|Phase 1b|Protocol Violation|0|||
23509549|NCT01543698|65601904|FG002|Phase 1b|Protocol Violation|0|||
23509550|NCT01543698|65601905|FG003|Phase 1b|Protocol Violation|0|||
23509551|NCT01543698|65601906|FG004|Phase 1b|Protocol Violation|0|||
23509552|NCT01543698|65601907|FG005|Phase 1b|Protocol Violation|0|||
23509553|NCT01543698|65601908|FG006|Phase 1b|Protocol Violation|0|||
23509554|NCT01543698|65601909|FG007|Phase 1b|Protocol Violation|0|||
23509555|NCT01543698|65601910|FG008|Phase 1b|Protocol Violation|0|||
23509556|NCT01543698|65601911|FG009|Phase 1b|Protocol Violation|0|||
23509557|NCT01543698|65601912|FG010|Phase 1b|Protocol Violation|0|||
23509558|NCT01543698|65601913|FG011|Phase 1b|Protocol Violation|0|||
23509559|NCT01543698|65601914|FG012|Phase 1b|Protocol Violation|0|||
23509560|NCT01543698|65601915|FG013|Phase 1b|Protocol Violation|0|||
23509561|NCT01543698|65601916|FG014|Phase 1b|Protocol Violation|0|||
23509562|NCT01543698|65601902|FG000|Phase 2|Protocol Violation|0|||
23509563|NCT01543698|65601903|FG001|Phase 2|Protocol Violation|0|||
23509564|NCT01543698|65601904|FG002|Phase 2|Protocol Violation|0|||
23509565|NCT01543698|65601905|FG003|Phase 2|Protocol Violation|0|||
23509566|NCT01543698|65601906|FG004|Phase 2|Protocol Violation|0|||
23509567|NCT01543698|65601907|FG005|Phase 2|Protocol Violation|0|||
23509568|NCT01543698|65601908|FG006|Phase 2|Protocol Violation|0|||
23509569|NCT01543698|65601909|FG007|Phase 2|Protocol Violation|0|||
23509570|NCT01543698|65601910|FG008|Phase 2|Protocol Violation|0|||
23509571|NCT01543698|65601911|FG009|Phase 2|Protocol Violation|0|||
23608061|NCT00670488|65953563|FG009|Overall Study|Adverse Event|1|||
23608062|NCT00670488|65953554|FG000|Overall Study|Physician Decision|1|||
23608063|NCT00670488|65953555|FG001|Overall Study|Physician Decision|9|||
23608064|NCT00670488|65953556|FG002|Overall Study|Physician Decision|0|||
23608065|NCT00670488|65953557|FG003|Overall Study|Physician Decision|1|||
23608066|NCT00670488|65953558|FG004|Overall Study|Physician Decision|0|||
23608067|NCT00670488|65953559|FG005|Overall Study|Physician Decision|0|||
23608068|NCT00670488|65953560|FG006|Overall Study|Physician Decision|0|||
23608069|NCT00670488|65953561|FG007|Overall Study|Physician Decision|0|||
23608070|NCT00670488|65953562|FG008|Overall Study|Physician Decision|0|||
23608071|NCT00670488|65953563|FG009|Overall Study|Physician Decision|0|||
23608072|NCT00670488|65953554|FG000|Overall Study|Progressive Disease|2|||
23608073|NCT00670488|65953555|FG001|Overall Study|Progressive Disease|41|||
23608074|NCT00670488|65953556|FG002|Overall Study|Progressive Disease|3|||
23608075|NCT00670488|65953557|FG003|Overall Study|Progressive Disease|2|||
23608076|NCT00670488|65953558|FG004|Overall Study|Progressive Disease|2|||
23608077|NCT00670488|65953559|FG005|Overall Study|Progressive Disease|4|||
23608078|NCT00670488|65953560|FG006|Overall Study|Progressive Disease|11|||
23608079|NCT00670488|65953561|FG007|Overall Study|Progressive Disease|2|||
23608080|NCT00670488|65953562|FG008|Overall Study|Progressive Disease|2|||
23608081|NCT00670488|65953563|FG009|Overall Study|Progressive Disease|1|||
23608082|NCT00670488|65953554|FG000|Overall Study|Withdrawal by Subject|0|||
23608083|NCT00670488|65953555|FG001|Overall Study|Withdrawal by Subject|1|||
23608084|NCT00670488|65953556|FG002|Overall Study|Withdrawal by Subject|0|||
23608085|NCT00670488|65953557|FG003|Overall Study|Withdrawal by Subject|1|||
23608086|NCT00670488|65953558|FG004|Overall Study|Withdrawal by Subject|0|||
23608087|NCT00670488|65953559|FG005|Overall Study|Withdrawal by Subject|0|||
23608088|NCT00670488|65953560|FG006|Overall Study|Withdrawal by Subject|1|||
23608089|NCT00670488|65953561|FG007|Overall Study|Withdrawal by Subject|0|||
23608090|NCT00670488|65953562|FG008|Overall Study|Withdrawal by Subject|1|||
23608091|NCT00670488|65953563|FG009|Overall Study|Withdrawal by Subject|0|||
23608092|NCT02555397|65953564|FG000|Overall Study|Withdrawal by Subject|1|||
23608093|NCT02555397|65953565|FG001|Overall Study|Withdrawal by Subject|0|||
23608094|NCT02555397|65953566|FG002|Overall Study|Withdrawal by Subject|0|||
23608095|NCT02555397|65953567|FG003|Overall Study|Withdrawal by Subject|0|||
23608096|NCT02555397|65953568|FG004|Overall Study|Withdrawal by Subject|0|||
23608097|NCT02382640|65953569|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
23608098|NCT02382640|65953570|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608099|NCT02382640|65953571|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608100|NCT02382640|65953572|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608101|NCT01986348|65953573|FG000|Overall Study|Death|8|||
23608102|NCT01986348|65953574|FG001|Overall Study|Death|22|||
23608103|NCT01986348|65953575|FG002|Overall Study|Death|10|||
23608104|NCT01986348|65953576|FG003|Overall Study|Death|21|||
23608105|NCT01986348|65953573|FG000|Overall Study|Lost to Follow-up|0|||
23608106|NCT01986348|65953574|FG001|Overall Study|Lost to Follow-up|0|||
23608107|NCT01986348|65953575|FG002|Overall Study|Lost to Follow-up|0|||
23509572|NCT01543698|65601912|FG010|Phase 2|Protocol Violation|0|||
23509573|NCT01543698|65601913|FG011|Phase 2|Protocol Violation|0|||
23509574|NCT01543698|65601914|FG012|Phase 2|Protocol Violation|1|||
23509575|NCT01543698|65601915|FG013|Phase 2|Protocol Violation|0|||
23509576|NCT01543698|65601916|FG014|Phase 2|Protocol Violation|0|||
23509577|NCT01543698|65601902|FG000|Phase 2|Disease progression|0|||
23509578|NCT01543698|65601903|FG001|Phase 2|Disease progression|0|||
23509579|NCT01543698|65601904|FG002|Phase 2|Disease progression|0|||
23509580|NCT01543698|65601905|FG003|Phase 2|Disease progression|0|||
23509581|NCT01543698|65601906|FG004|Phase 2|Disease progression|0|||
23509582|NCT01543698|65601907|FG005|Phase 2|Disease progression|0|||
23509583|NCT01543698|65601908|FG006|Phase 2|Disease progression|0|||
23509584|NCT01543698|65601909|FG007|Phase 2|Disease progression|0|||
23509585|NCT01543698|65601910|FG008|Phase 2|Disease progression|0|||
23509586|NCT01543698|65601911|FG009|Phase 2|Disease progression|0|||
23509587|NCT01543698|65601912|FG010|Phase 2|Disease progression|0|||
23509588|NCT01543698|65601913|FG011|Phase 2|Disease progression|10|||
23509589|NCT01543698|65601914|FG012|Phase 2|Disease progression|21|||
23509590|NCT01543698|65601915|FG013|Phase 2|Disease progression|30|||
23509591|NCT01543698|65601916|FG014|Phase 2|Disease progression|25|||
23608108|NCT01986348|65953576|FG003|Overall Study|Lost to Follow-up|2|||
23608109|NCT01986348|65953573|FG000|Overall Study|Physician Decision|0|||
23608110|NCT01986348|65953574|FG001|Overall Study|Physician Decision|0|||
23608111|NCT01986348|65953575|FG002|Overall Study|Physician Decision|0|||
23608112|NCT01986348|65953576|FG003|Overall Study|Physician Decision|1|||
23509592|NCT01543698|65601902|FG000|Phase 2|Death|0|||
23509593|NCT01543698|65601903|FG001|Phase 2|Death|0|||
23509594|NCT01543698|65601904|FG002|Phase 2|Death|0|||
23509595|NCT01543698|65601905|FG003|Phase 2|Death|0|||
23509596|NCT01543698|65601906|FG004|Phase 2|Death|0|||
23509597|NCT01543698|65601907|FG005|Phase 2|Death|0|||
23509598|NCT01543698|65601908|FG006|Phase 2|Death|0|||
23509599|NCT01543698|65601909|FG007|Phase 2|Death|0|||
23509600|NCT01543698|65601910|FG008|Phase 2|Death|0|||
23608113|NCT01986348|65953573|FG000|Overall Study|Progressive Disease|0|||
23509601|NCT01543698|65601911|FG009|Phase 2|Death|0|||
23509602|NCT01543698|65601912|FG010|Phase 2|Death|0|||
23509603|NCT01543698|65601913|FG011|Phase 2|Death|0|||
23509604|NCT01543698|65601914|FG012|Phase 2|Death|1|||
23509605|NCT01543698|65601915|FG013|Phase 2|Death|1|||
23509606|NCT01543698|65601916|FG014|Phase 2|Death|1|||
23509607|NCT01543698|65601902|FG000|Phase 2|Administrative problems|0|||
23509608|NCT01543698|65601903|FG001|Phase 2|Administrative problems|0|||
23509609|NCT01543698|65601904|FG002|Phase 2|Administrative problems|0|||
23509610|NCT01543698|65601905|FG003|Phase 2|Administrative problems|0|||
23509611|NCT01543698|65601906|FG004|Phase 2|Administrative problems|0|||
23509612|NCT01543698|65601907|FG005|Phase 2|Administrative problems|0|||
23509613|NCT01543698|65601908|FG006|Phase 2|Administrative problems|0|||
23509614|NCT01543698|65601909|FG007|Phase 2|Administrative problems|0|||
23509615|NCT01543698|65601910|FG008|Phase 2|Administrative problems|0|||
23509616|NCT01543698|65601911|FG009|Phase 2|Administrative problems|0|||
23509617|NCT01543698|65601912|FG010|Phase 2|Administrative problems|0|||
23509618|NCT01543698|65601913|FG011|Phase 2|Administrative problems|0|||
23509619|NCT01543698|65601914|FG012|Phase 2|Administrative problems|0|||
23509620|NCT01543698|65601915|FG013|Phase 2|Administrative problems|3|||
23509621|NCT01543698|65601916|FG014|Phase 2|Administrative problems|1|||
23509622|NCT01543698|65601902|FG000|Phase 2|Withdrawal by Subject|0|||
23509623|NCT01543698|65601903|FG001|Phase 2|Withdrawal by Subject|0|||
23509624|NCT01543698|65601904|FG002|Phase 2|Withdrawal by Subject|0|||
23509625|NCT01543698|65601905|FG003|Phase 2|Withdrawal by Subject|0|||
23509626|NCT01543698|65601906|FG004|Phase 2|Withdrawal by Subject|0|||
23509627|NCT01543698|65601907|FG005|Phase 2|Withdrawal by Subject|0|||
23509628|NCT01543698|65601908|FG006|Phase 2|Withdrawal by Subject|0|||
23509629|NCT01543698|65601909|FG007|Phase 2|Withdrawal by Subject|0|||
23509630|NCT01543698|65601910|FG008|Phase 2|Withdrawal by Subject|0|||
23509631|NCT01543698|65601911|FG009|Phase 2|Withdrawal by Subject|0|||
23509632|NCT01543698|65601912|FG010|Phase 2|Withdrawal by Subject|0|||
23509633|NCT01543698|65601913|FG011|Phase 2|Withdrawal by Subject|0|||
23509634|NCT01543698|65601914|FG012|Phase 2|Withdrawal by Subject|0|||
23509635|NCT01543698|65601915|FG013|Phase 2|Withdrawal by Subject|3|||
23509636|NCT01543698|65601916|FG014|Phase 2|Withdrawal by Subject|1|||
23509637|NCT01543698|65601902|FG000|Phase 2|Adverse Event|0|||
23509638|NCT01543698|65601903|FG001|Phase 2|Adverse Event|0|||
23509639|NCT01543698|65601904|FG002|Phase 2|Adverse Event|0|||
23509640|NCT01543698|65601905|FG003|Phase 2|Adverse Event|0|||
23509641|NCT01543698|65601906|FG004|Phase 2|Adverse Event|0|||
23509642|NCT01543698|65601907|FG005|Phase 2|Adverse Event|0|||
23509643|NCT01543698|65601908|FG006|Phase 2|Adverse Event|0|||
23509644|NCT01543698|65601909|FG007|Phase 2|Adverse Event|0|||
23509645|NCT01543698|65601910|FG008|Phase 2|Adverse Event|0|||
23509646|NCT01543698|65601911|FG009|Phase 2|Adverse Event|0|||
23509647|NCT01543698|65601912|FG010|Phase 2|Adverse Event|0|||
23509648|NCT01543698|65601913|FG011|Phase 2|Adverse Event|1|||
23509649|NCT01543698|65601914|FG012|Phase 2|Adverse Event|3|||
23509650|NCT01543698|65601915|FG013|Phase 2|Adverse Event|5|||
23509651|NCT01543698|65601916|FG014|Phase 2|Adverse Event|14|||
23509652|NCT01874054|65601917|FG000|Overall Study|Withdrawal by Subject|3|||
23509653|NCT01874054|65601917|FG000|Overall Study|Study Termination by Sponsor|42|||
23509654|NCT01874054|65601917|FG000|Overall Study|Lost to Follow-up|5|||
23509655|NCT01874054|65601917|FG000|Overall Study|Death|5|||
23509656|NCT02279420|65601918|FG000|Overall Study|Lost to Follow-up|23|||
23509657|NCT02599129|65601921|FG000|Overall Study|Lack of Efficacy|2|||
23509658|NCT02599129|65601922|FG001|Overall Study|Lack of Efficacy|2|||
23509659|NCT02599129|65601921|FG000|Overall Study|Lost to Follow-up|1|||
23509660|NCT02599129|65601922|FG001|Overall Study|Lost to Follow-up|0|||
23509661|NCT02599129|65601921|FG000|Overall Study|Withdrawal by Subject|2|||
23509662|NCT02599129|65601922|FG001|Overall Study|Withdrawal by Subject|1|||
23509663|NCT02370160|65601926|FG000|Overall Study|Death|3|||
23509664|NCT02370160|65601927|FG001|Overall Study|Death|4|||
23509665|NCT02370160|65601928|FG002|Overall Study|Death|1|||
23509666|NCT00850564|65601929|FG000|Overall Study|Withdrawal by Subject|2|||
23509667|NCT01338792|65601933|FG000|Overall Study|Adverse Event|2|||
23509668|NCT01338792|65601933|FG000|Overall Study|Death|1|||
23509669|NCT01338792|65601933|FG000|Overall Study|Withdrawal by Subject|1|||
23509670|NCT00276744|65601934|FG000|PART A|Reason unknown|98|||
23509671|NCT02268084|65601936|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
23509672|NCT02268084|65601937|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
23509673|NCT02268084|65601936|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
23509674|NCT02268084|65601937|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
23509675|NCT02329730|65601938|FG000|Overall Study|Protocol Violation|0|||
23509676|NCT02329730|65601939|FG001|Overall Study|Protocol Violation|0|||
23509677|NCT02329730|65601940|FG002|Overall Study|Protocol Violation|0|||
23509678|NCT02329730|65601941|FG003|Overall Study|Protocol Violation|0|||
23509679|NCT02329730|65601942|FG004|Overall Study|Protocol Violation|2|||
23509680|NCT02329730|65601943|FG005|Overall Study|Protocol Violation|2|||
23509681|NCT02329730|65601944|FG006|Overall Study|Protocol Violation|0|||
23509682|NCT02329730|65601945|FG007|Overall Study|Protocol Violation|0|||
23608114|NCT01986348|65953574|FG001|Overall Study|Progressive Disease|0|||
23608115|NCT01986348|65953575|FG002|Overall Study|Progressive Disease|2|||
23608116|NCT01986348|65953576|FG003|Overall Study|Progressive Disease|0|||
23608117|NCT01986348|65953573|FG000|Overall Study|Withdrawal by Participant|0|||
23408567|NCT03782259|65239923|FG000|Overall Study|Moved out of state|0|||
23509683|NCT02329730|65601946|FG008|Overall Study|Protocol Violation|0|||
23509684|NCT02329730|65601947|FG009|Overall Study|Protocol Violation|0|||
23509685|NCT02329730|65601948|FG010|Overall Study|Protocol Violation|0|||
23509686|NCT02329730|65601949|FG011|Overall Study|Protocol Violation|0|||
23509687|NCT02329730|65601938|FG000|Overall Study|Withdrawal by Subject|0|||
23509688|NCT02329730|65601939|FG001|Overall Study|Withdrawal by Subject|0|||
23509689|NCT02329730|65601940|FG002|Overall Study|Withdrawal by Subject|0|||
23509690|NCT02329730|65601941|FG003|Overall Study|Withdrawal by Subject|0|||
23509691|NCT02329730|65601942|FG004|Overall Study|Withdrawal by Subject|1|||
23509692|NCT02329730|65601943|FG005|Overall Study|Withdrawal by Subject|0|||
23509693|NCT02329730|65601944|FG006|Overall Study|Withdrawal by Subject|1|||
23509694|NCT02329730|65601945|FG007|Overall Study|Withdrawal by Subject|1|||
23509695|NCT02329730|65601946|FG008|Overall Study|Withdrawal by Subject|1|||
23509696|NCT02329730|65601947|FG009|Overall Study|Withdrawal by Subject|1|||
23509697|NCT02329730|65601948|FG010|Overall Study|Withdrawal by Subject|0|||
23509698|NCT02329730|65601949|FG011|Overall Study|Withdrawal by Subject|0|||
23509699|NCT00296374|65601952|FG000|Overall Study|Adverse Event|14|||
23509700|NCT00296374|65601953|FG001|Overall Study|Adverse Event|10|||
23509701|NCT00296374|65601954|FG002|Overall Study|Adverse Event|7|||
23509702|NCT00296374|65601952|FG000|Overall Study|Withdrawal by Subject|3|||
23509703|NCT00296374|65601953|FG001|Overall Study|Withdrawal by Subject|5|||
23509704|NCT00296374|65601954|FG002|Overall Study|Withdrawal by Subject|11|||
23509705|NCT00296374|65601952|FG000|Overall Study|Incorrect enrollment|3|||
23509706|NCT00296374|65601953|FG001|Overall Study|Incorrect enrollment|3|||
23509707|NCT00296374|65601954|FG002|Overall Study|Incorrect enrollment|4|||
23509708|NCT00296374|65601952|FG000|Overall Study|Protocol Violation|1|||
23509709|NCT00296374|65601953|FG001|Overall Study|Protocol Violation|2|||
23509710|NCT00296374|65601954|FG002|Overall Study|Protocol Violation|3|||
23509711|NCT00296374|65601952|FG000|Overall Study|Lost to Follow-up|3|||
23509712|NCT00296374|65601953|FG001|Overall Study|Lost to Follow-up|1|||
23509713|NCT00296374|65601954|FG002|Overall Study|Lost to Follow-up|1|||
23509714|NCT00296374|65601952|FG000|Overall Study|Relocated to another state|1|||
23509715|NCT00296374|65601953|FG001|Overall Study|Relocated to another state|0|||
23509716|NCT00296374|65601954|FG002|Overall Study|Relocated to another state|0|||
23509717|NCT00296374|65601952|FG000|Overall Study|Stopped drug before end of study visit|0|||
23509718|NCT00296374|65601953|FG001|Overall Study|Stopped drug before end of study visit|1|||
23509719|NCT00296374|65601954|FG002|Overall Study|Stopped drug before end of study visit|0|||
23509720|NCT00296374|65601952|FG000|Overall Study|Nephrologist introduced ACE|0|||
23509721|NCT00296374|65601953|FG001|Overall Study|Nephrologist introduced ACE|1|||
23509722|NCT00296374|65601954|FG002|Overall Study|Nephrologist introduced ACE|0|||
23509723|NCT00296374|65601952|FG000|Overall Study|Pregnancy|0|||
23509724|NCT00296374|65601953|FG001|Overall Study|Pregnancy|0|||
23509725|NCT00296374|65601954|FG002|Overall Study|Pregnancy|2|||
23509726|NCT00296374|65601952|FG000|Overall Study|Other|0|||
23509727|NCT00296374|65601953|FG001|Overall Study|Other|0|||
23509728|NCT00296374|65601954|FG002|Overall Study|Other|1|||
23509729|NCT02483520|65601955|FG000|Overall Study|Lost to Follow-up|3|||
23509730|NCT02483520|65601956|FG001|Overall Study|Lost to Follow-up|4|||
23509731|NCT02483520|65601955|FG000|Overall Study|Withdrawal by Subject|4|||
23509732|NCT02483520|65601956|FG001|Overall Study|Withdrawal by Subject|14|||
23509733|NCT02483520|65601955|FG000|Overall Study|Hospitalized|2|||
23509734|NCT02483520|65601956|FG001|Overall Study|Hospitalized|3|||
23509735|NCT02483520|65601955|FG000|Overall Study|Moved to LTC|2|||
23509736|NCT02483520|65601956|FG001|Overall Study|Moved to LTC|3|||
23509737|NCT00331682|65601957|FG000|Overall Study|Adverse Event|1|||
23509738|NCT00459953|65601958|FG000|Overall Study|not analyzed-household member in study|1|||
23509739|NCT00459953|65601959|FG001|Overall Study|not analyzed-household member in study|1|||
23509740|NCT01074450|65601960|FG000|First Intervention|Emesis in Dosing Interval|0|||
23509741|NCT01074450|65601961|FG001|First Intervention|Emesis in Dosing Interval|2|||
23509742|NCT01074450|65601960|FG000|Second Intervention|Protocol Violation|1|||
23509743|NCT01074450|65601961|FG001|Second Intervention|Protocol Violation|0|||
23509744|NCT01074450|65601960|FG000|Second Intervention|Physician Decision|0|||
23509745|NCT01074450|65601961|FG001|Second Intervention|Physician Decision|1|||
23509746|NCT01134783|65601964|FG000|Overall Study|Pregnancy|16|||
23509747|NCT01134783|65601965|FG001|Overall Study|Pregnancy|8|||
23509748|NCT01134783|65601964|FG000|Overall Study|Withdrawal by Subject|15|||
23509749|NCT01134783|65601965|FG001|Overall Study|Withdrawal by Subject|9|||
23509750|NCT01134783|65601964|FG000|Overall Study|Lost to Follow-up|5|||
23608118|NCT01986348|65953574|FG001|Overall Study|Withdrawal by Participant|1|||
23608119|NCT01986348|65953575|FG002|Overall Study|Withdrawal by Participant|2|||
23608120|NCT01986348|65953576|FG003|Overall Study|Withdrawal by Participant|1|||
23608121|NCT01986348|65953573|FG000|Overall Study|Study Terminated by Sponsor|0|||
23608122|NCT01986348|65953574|FG001|Overall Study|Study Terminated by Sponsor|0|||
23608123|NCT01986348|65953575|FG002|Overall Study|Study Terminated by Sponsor|0|||
23608124|NCT01986348|65953576|FG003|Overall Study|Study Terminated by Sponsor|3|||
23608125|NCT01986348|65953573|FG000|Overall Study|Other-unspecified|0|||
23608126|NCT01986348|65953574|FG001|Overall Study|Other-unspecified|1|||
23608127|NCT01986348|65953575|FG002|Overall Study|Other-unspecified|0|||
23608128|NCT01986348|65953576|FG003|Overall Study|Other-unspecified|2|||
23608129|NCT01071317|65953577|FG000|Overall Study|Lost to Follow-up|2|||
23608130|NCT01071317|65953578|FG001|Overall Study|Lost to Follow-up|2|||
23608131|NCT03390166|65953581|FG000|Overall Study|Death|0|||
23608132|NCT03390166|65953582|FG001|Overall Study|Death|1|||
23608133|NCT03390166|65953581|FG000|Overall Study|Lost to Follow-up|6|||
23608134|NCT03390166|65953582|FG001|Overall Study|Lost to Follow-up|4|||
23608135|NCT03390166|65953581|FG000|Overall Study|Physician Decision|2|||
23608136|NCT03390166|65953582|FG001|Overall Study|Physician Decision|1|||
23608137|NCT03390166|65953581|FG000|Overall Study|Move from study area|3|||
23608138|NCT03390166|65953582|FG001|Overall Study|Move from study area|2|||
23608139|NCT03390166|65953581|FG000|Overall Study|To militarycamp for conscript|1|||
23608140|NCT03390166|65953582|FG001|Overall Study|To militarycamp for conscript|0|||
23608141|NCT03390166|65953581|FG000|Overall Study|To drug therapy course|0|||
23608142|NCT03390166|65953582|FG001|Overall Study|To drug therapy course|1|||
23608143|NCT03390166|65953581|FG000|Overall Study|Move to work oversea|0|||
23608144|NCT03390166|65953582|FG001|Overall Study|Move to work oversea|1|||
23608145|NCT01029925|65953583|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
23608146|NCT01029925|65953583|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
23608147|NCT01029925|65953583|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
23608148|NCT00925548|65953588|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
23608149|NCT00925548|65953589|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
23608150|NCT02245620|65953592|FG000|Overall Study|Physician Decision|1|||
23608151|NCT02245620|65953593|FG001|Overall Study|Physician Decision|1|||
23608152|NCT02085941|65953598|FG000|Overall Study|Lack of Efficacy|1|||
23608153|NCT02085941|65953599|FG001|Overall Study|Lack of Efficacy|0|||
23608154|NCT02085941|65953598|FG000|Overall Study|Death|6|||
23608155|NCT02085941|65953599|FG001|Overall Study|Death|1|||
23608156|NCT02085941|65953598|FG000|Overall Study|Lost to Follow-up|1|||
23608157|NCT02085941|65953599|FG001|Overall Study|Lost to Follow-up|0|||
23608158|NCT02085941|65953598|FG000|Overall Study|Physician Decision|0|||
23608159|NCT02085941|65953599|FG001|Overall Study|Physician Decision|2|||
23608160|NCT01836523|65953600|FG000|Overall Study|Adverse Event|15|||
23608161|NCT01836523|65953601|FG001|Overall Study|Adverse Event|41|||
23608162|NCT01836523|65953602|FG002|Overall Study|Adverse Event|49|||
23608163|NCT01836523|65953603|FG003|Overall Study|Adverse Event|14|||
23608164|NCT01836523|65953600|FG000|Overall Study|Protocol Violation|6|||
23608165|NCT01836523|65953601|FG001|Overall Study|Protocol Violation|3|||
23608166|NCT01836523|65953602|FG002|Overall Study|Protocol Violation|2|||
23608167|NCT01836523|65953603|FG003|Overall Study|Protocol Violation|4|||
23608168|NCT01836523|65953600|FG000|Overall Study|Met Withdrawal Criteria|13|||
23608169|NCT01836523|65953601|FG001|Overall Study|Met Withdrawal Criteria|13|||
23608170|NCT01836523|65953602|FG002|Overall Study|Met Withdrawal Criteria|21|||
23608171|NCT01836523|65953603|FG003|Overall Study|Met Withdrawal Criteria|27|||
23608172|NCT01836523|65953600|FG000|Overall Study|Unclassified|17|||
23608173|NCT01836523|65953601|FG001|Overall Study|Unclassified|28|||
23608174|NCT01836523|65953602|FG002|Overall Study|Unclassified|19|||
23608175|NCT01836523|65953603|FG003|Overall Study|Unclassified|29|||
23608176|NCT03122860|65953604|FG000|Overall Study|Discontinued Before Treatment|1|||
23608177|NCT03122860|65953605|FG001|Overall Study|Discontinued Before Treatment|1|||
23608178|NCT03122860|65953606|FG002|Overall Study|Discontinued Before Treatment|2|||
23608179|NCT03122860|65953607|FG003|Overall Study|Discontinued Before Treatment|0|||
23608180|NCT03122860|65953608|FG004|Overall Study|Discontinued Before Treatment|1|||
23608181|NCT03122860|65953609|FG005|Overall Study|Discontinued Before Treatment|0|||
23608182|NCT03122860|65953604|FG000|Overall Study|Adverse Event|1|||
23608183|NCT03122860|65953605|FG001|Overall Study|Adverse Event|0|||
23608184|NCT03122860|65953606|FG002|Overall Study|Adverse Event|1|||
23608185|NCT03122860|65953607|FG003|Overall Study|Adverse Event|1|||
23608186|NCT03122860|65953608|FG004|Overall Study|Adverse Event|0|||
23608187|NCT03122860|65953609|FG005|Overall Study|Adverse Event|0|||
23608188|NCT03122860|65953604|FG000|Overall Study|Lost to Follow-up|5|||
23608189|NCT03122860|65953605|FG001|Overall Study|Lost to Follow-up|2|||
23608190|NCT03122860|65953606|FG002|Overall Study|Lost to Follow-up|3|||
23608191|NCT03122860|65953607|FG003|Overall Study|Lost to Follow-up|3|||
23608192|NCT03122860|65953608|FG004|Overall Study|Lost to Follow-up|5|||
23608193|NCT03122860|65953609|FG005|Overall Study|Lost to Follow-up|4|||
23608194|NCT03122860|65953604|FG000|Overall Study|Subject Non-Compliance|0|||
23608195|NCT03122860|65953605|FG001|Overall Study|Subject Non-Compliance|0|||
23509751|NCT01134783|65601965|FG001|Overall Study|Lost to Follow-up|20|||
23608196|NCT03122860|65953606|FG002|Overall Study|Subject Non-Compliance|1|||
23608197|NCT03122860|65953607|FG003|Overall Study|Subject Non-Compliance|0|||
23608198|NCT03122860|65953608|FG004|Overall Study|Subject Non-Compliance|0|||
23608199|NCT03122860|65953609|FG005|Overall Study|Subject Non-Compliance|0|||
23608200|NCT03122860|65953604|FG000|Overall Study|Withdrawal by Subject|3|||
23608201|NCT03122860|65953605|FG001|Overall Study|Withdrawal by Subject|2|||
23608202|NCT03122860|65953606|FG002|Overall Study|Withdrawal by Subject|5|||
23608203|NCT03122860|65953607|FG003|Overall Study|Withdrawal by Subject|7|||
23608204|NCT03122860|65953608|FG004|Overall Study|Withdrawal by Subject|9|||
23608205|NCT03122860|65953609|FG005|Overall Study|Withdrawal by Subject|8|||
23608206|NCT01858688|65953610|FG000|Overall Study|Withdrawal by Subject|8|||
23608207|NCT01858688|65953610|FG000|Overall Study|Participant began another therapy|3|||
23608208|NCT01858688|65953610|FG000|Overall Study|Physician Decision|2|||
23608209|NCT01858688|65953610|FG000|Overall Study|Progressive Disease|2|||
23608210|NCT01858688|65953610|FG000|Overall Study|Reason not reproted|5|||
23608211|NCT03137459|65953615|FG000|2-month Assessment|Withdrawal by Subject|13|||
23608212|NCT03137459|65953616|FG001|2-month Assessment|Withdrawal by Subject|3|||
23608213|NCT03137459|65953615|FG000|2-month Assessment|Unable to reach|42|||
23608214|NCT03137459|65953616|FG001|2-month Assessment|Unable to reach|32|||
23608215|NCT03137459|65953615|FG000|2-month Assessment|Refused assessment|7|||
23608216|NCT03137459|65953616|FG001|2-month Assessment|Refused assessment|5|||
23608217|NCT03137459|65953615|FG000|2-month Assessment|Acutely ill|6|||
23608218|NCT03137459|65953616|FG001|2-month Assessment|Acutely ill|2|||
23608219|NCT03137459|65953615|FG000|4-month Assessment|Death|4|||
23608220|NCT03137459|65953616|FG001|4-month Assessment|Death|2|||
23608221|NCT03137459|65953615|FG000|4-month Assessment|Withdrawal by Subject|4|||
23608222|NCT03137459|65953616|FG001|4-month Assessment|Withdrawal by Subject|2|||
23608223|NCT03137459|65953615|FG000|4-month Assessment|Unable to reach|44|||
23608224|NCT03137459|65953616|FG001|4-month Assessment|Unable to reach|29|||
23608225|NCT03137459|65953615|FG000|4-month Assessment|Refused assessment|24|||
23608226|NCT03137459|65953616|FG001|4-month Assessment|Refused assessment|10|||
23608227|NCT03137459|65953615|FG000|4-month Assessment|Acutely ill|2|||
23608228|NCT03137459|65953616|FG001|4-month Assessment|Acutely ill|3|||
23608229|NCT03137459|65953615|FG000|6-months|Lost to Follow-up|14|||
23608230|NCT03137459|65953616|FG001|6-months|Lost to Follow-up|11|||
23608231|NCT03137459|65953615|FG000|6-months|Death|0|||
23608232|NCT03137459|65953616|FG001|6-months|Death|2|||
23608233|NCT03137459|65953615|FG000|6-months|Refused assessment|6|||
23509752|NCT03247530|65601966|FG000|Overall Study|Withdrawal by caregiver|19|||
23509753|NCT03247530|65601967|FG001|Overall Study|Withdrawal by caregiver|8|||
23509754|NCT03247530|65601968|FG002|Overall Study|Withdrawal by caregiver|10|||
23509755|NCT03247530|65601966|FG000|Overall Study|Lost to Follow-up|3|||
23509756|NCT03247530|65601967|FG001|Overall Study|Lost to Follow-up|9|||
23509757|NCT03247530|65601968|FG002|Overall Study|Lost to Follow-up|6|||
23509758|NCT03247530|65601966|FG000|Overall Study|Adverse Event|2|||
23509759|NCT03247530|65601967|FG001|Overall Study|Adverse Event|5|||
23509760|NCT03247530|65601968|FG002|Overall Study|Adverse Event|2|||
23509761|NCT03247530|65601966|FG000|Overall Study|Failure to follow procedure|1|||
23509762|NCT03247530|65601967|FG001|Overall Study|Failure to follow procedure|1|||
23509763|NCT03247530|65601968|FG002|Overall Study|Failure to follow procedure|1|||
23509764|NCT03247530|65601966|FG000|Overall Study|Withdrawal by Subject|1|||
23509765|NCT03247530|65601967|FG001|Overall Study|Withdrawal by Subject|1|||
23509766|NCT03247530|65601968|FG002|Overall Study|Withdrawal by Subject|0|||
23509767|NCT03247530|65601966|FG000|Overall Study|Study medication misuse|0|||
23509768|NCT03247530|65601967|FG001|Overall Study|Study medication misuse|1|||
23509769|NCT03247530|65601968|FG002|Overall Study|Study medication misuse|0|||
23509770|NCT03247530|65601966|FG000|Overall Study|Other, multiple categories|1|||
23509771|NCT03247530|65601967|FG001|Overall Study|Other, multiple categories|3|||
23509772|NCT03247530|65601968|FG002|Overall Study|Other, multiple categories|1|||
23509773|NCT02989194|65601969|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
23509774|NCT02989194|65601970|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
23509775|NCT02989194|65601971|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
23509776|NCT02989194|65601969|FG000|Overall Study|Lost to Follow-up|0|||
23509777|NCT02989194|65601970|FG001|Overall Study|Lost to Follow-up|1|||
23509778|NCT02989194|65601971|FG002|Overall Study|Lost to Follow-up|0|||
23509779|NCT02989194|65601969|FG000|Overall Study|Withdrawal by Subject|0|||
23509780|NCT02989194|65601970|FG001|Overall Study|Withdrawal by Subject|1|||
23509781|NCT02989194|65601971|FG002|Overall Study|Withdrawal by Subject|0|||
23509782|NCT03171415|65601974|FG000|Overall Study|Lost to Follow-up|0|||
23509783|NCT03171415|65601975|FG001|Overall Study|Lost to Follow-up|0|||
23509784|NCT03171415|65601976|FG002|Overall Study|Lost to Follow-up|0|||
23509785|NCT03171415|65601977|FG003|Overall Study|Lost to Follow-up|0|||
23509786|NCT03171415|65601978|FG004|Overall Study|Lost to Follow-up|2|||
23509787|NCT01937559|65601981|FG000|Overall Study|Physician Decision|3|||
23509788|NCT01937559|65601982|FG001|Overall Study|Physician Decision|3|||
23608234|NCT03137459|65953616|FG001|6-months|Refused assessment|3|||
23608235|NCT03137459|65953615|FG000|6-months|Acutely ill|1|||
23608236|NCT03137459|65953616|FG001|6-months|Acutely ill|1|||
23608237|NCT02365597|65953617|FG000|Overall Study|Lost to Follow-up|0|||
23608238|NCT02365597|65953618|FG001|Overall Study|Lost to Follow-up|1|||
23608239|NCT02365597|65953619|FG002|Overall Study|Lost to Follow-up|0|||
23608240|NCT02365597|65953620|FG003|Overall Study|Lost to Follow-up|1|||
23608241|NCT02365597|65953617|FG000|Overall Study|Withdrawal by Subject|1|||
23608242|NCT02365597|65953618|FG001|Overall Study|Withdrawal by Subject|8|||
23608243|NCT02365597|65953619|FG002|Overall Study|Withdrawal by Subject|5|||
23608244|NCT02365597|65953620|FG003|Overall Study|Withdrawal by Subject|1|||
23608245|NCT02365597|65953617|FG000|Overall Study|Sponsor's decision|1|||
23608246|NCT02365597|65953618|FG001|Overall Study|Sponsor's decision|3|||
23608247|NCT02365597|65953619|FG002|Overall Study|Sponsor's decision|13|||
23608248|NCT02365597|65953620|FG003|Overall Study|Sponsor's decision|0|||
23608249|NCT02365597|65953617|FG000|Overall Study|Other|0|||
23608250|NCT02365597|65953618|FG001|Overall Study|Other|4|||
23608251|NCT02365597|65953619|FG002|Overall Study|Other|0|||
23608252|NCT02365597|65953620|FG003|Overall Study|Other|0|||
23608253|NCT02365597|65953617|FG000|Overall Study|Enrolled but not treated|0|||
23608254|NCT02365597|65953618|FG001|Overall Study|Enrolled but not treated|1|||
23608255|NCT02365597|65953619|FG002|Overall Study|Enrolled but not treated|1|||
23608256|NCT02365597|65953620|FG003|Overall Study|Enrolled but not treated|0|||
23608257|NCT02365597|65953617|FG000|Overall Study|Ongoing|0|||
23608258|NCT02365597|65953618|FG001|Overall Study|Ongoing|0|||
23608259|NCT02365597|65953619|FG002|Overall Study|Ongoing|0|||
23608260|NCT02365597|65953620|FG003|Overall Study|Ongoing|17|||
23608261|NCT01065779|65953622|FG000|Overall Study|Duplicate Investigation|1|||
23608262|NCT01065779|65953622|FG000|Overall Study|Investigation Before Contract Date|37|||
23608263|NCT01065779|65953622|FG000|Overall Study|Non-enrollment Period Administration|10|||
23608264|NCT01065779|65953622|FG000|Overall Study|Not Administered With Study Drug|17|||
23608265|NCT01065779|65953622|FG000|Overall Study|Failed to Follow-up|10|||
23608266|NCT01065779|65953622|FG000|Overall Study|Inclusion Criteria Violation|7|||
23608267|NCT01884571|65953627|FG000|Overall Study|Adverse Event|1|||
23608268|NCT01884571|65953627|FG000|Overall Study|Death|2|||
23608269|NCT01884571|65953627|FG000|Overall Study|Withdrawal by Subject|2|||
23608270|NCT01884571|65953627|FG000|Overall Study|Disease progression|3|||
23608271|NCT00663923|65953628|FG000|Overall Study|Lost to Follow-up|2|||
23608272|NCT02133131|65953629|FG000|Overall Study|Adverse Event|0|||
23608273|NCT02133131|65953630|FG001|Overall Study|Adverse Event|0|||
23608274|NCT02133131|65953631|FG002|Overall Study|Adverse Event|0|||
23608275|NCT02133131|65953632|FG003|Overall Study|Adverse Event|1|||
23608276|NCT02133131|65953633|FG004|Overall Study|Adverse Event|0|||
23608277|NCT02133131|65953634|FG005|Overall Study|Adverse Event|0|||
23608278|NCT02133131|65953635|FG006|Overall Study|Adverse Event|0|||
23608279|NCT02133131|65953629|FG000|Overall Study|Lost to Follow-up|1|||
23608280|NCT02133131|65953630|FG001|Overall Study|Lost to Follow-up|0|||
23608281|NCT02133131|65953631|FG002|Overall Study|Lost to Follow-up|0|||
23608282|NCT02133131|65953632|FG003|Overall Study|Lost to Follow-up|1|||
23608283|NCT02133131|65953633|FG004|Overall Study|Lost to Follow-up|0|||
23608284|NCT02133131|65953634|FG005|Overall Study|Lost to Follow-up|0|||
23608285|NCT02133131|65953635|FG006|Overall Study|Lost to Follow-up|0|||
23608286|NCT02133131|65953629|FG000|Overall Study|Status not recorded|4|||
23608287|NCT02133131|65953630|FG001|Overall Study|Status not recorded|5|||
23608288|NCT02133131|65953631|FG002|Overall Study|Status not recorded|1|||
23608289|NCT02133131|65953632|FG003|Overall Study|Status not recorded|4|||
23608290|NCT02133131|65953633|FG004|Overall Study|Status not recorded|0|||
23608291|NCT02133131|65953634|FG005|Overall Study|Status not recorded|0|||
23608292|NCT02133131|65953635|FG006|Overall Study|Status not recorded|0|||
23608293|NCT02133131|65953629|FG000|Overall Study|Ongoing in study|0|||
23608294|NCT02133131|65953630|FG001|Overall Study|Ongoing in study|0|||
23608295|NCT02133131|65953631|FG002|Overall Study|Ongoing in study|0|||
23608296|NCT02133131|65953632|FG003|Overall Study|Ongoing in study|0|||
23608297|NCT02133131|65953633|FG004|Overall Study|Ongoing in study|15|||
23408568|NCT03782259|65239924|FG001|Overall Study|Moved out of state|2|||
23608298|NCT02133131|65953634|FG005|Overall Study|Ongoing in study|14|||
23608299|NCT02133131|65953635|FG006|Overall Study|Ongoing in study|11|||
23608300|NCT02133131|65953629|FG000|Overall Study|Protocol Violation|0|||
23608301|NCT02133131|65953630|FG001|Overall Study|Protocol Violation|0|||
23608302|NCT02133131|65953631|FG002|Overall Study|Protocol Violation|0|||
23608303|NCT02133131|65953632|FG003|Overall Study|Protocol Violation|0|||
23608304|NCT02133131|65953633|FG004|Overall Study|Protocol Violation|0|||
23608305|NCT02133131|65953634|FG005|Overall Study|Protocol Violation|0|||
23608306|NCT02133131|65953635|FG006|Overall Study|Protocol Violation|1|||
23608307|NCT03162614|65953637|FG000|Overall Study|Lost to Follow-up|2|||
23608308|NCT03162614|65953638|FG001|Overall Study|Lost to Follow-up|1|||
23608309|NCT03162614|65953639|FG002|Overall Study|Lost to Follow-up|1|||
23608310|NCT03162614|65953640|FG003|Overall Study|Lost to Follow-up|1|||
23608311|NCT03162614|65953641|FG004|Overall Study|Lost to Follow-up|2|||
23608312|NCT03162614|65953642|FG005|Overall Study|Lost to Follow-up|0|||
23608313|NCT03162614|65953637|FG000|Overall Study|Protocol Violation|0|||
23608314|NCT03162614|65953638|FG001|Overall Study|Protocol Violation|1|||
23608315|NCT03162614|65953639|FG002|Overall Study|Protocol Violation|0|||
23608316|NCT03162614|65953640|FG003|Overall Study|Protocol Violation|1|||
23608317|NCT03162614|65953641|FG004|Overall Study|Protocol Violation|0|||
23608318|NCT03162614|65953642|FG005|Overall Study|Protocol Violation|0|||
23608319|NCT03162614|65953637|FG000|Overall Study|Withdrawal by Subject|2|||
23608320|NCT03162614|65953638|FG001|Overall Study|Withdrawal by Subject|1|||
23608321|NCT03162614|65953639|FG002|Overall Study|Withdrawal by Subject|1|||
23608322|NCT03162614|65953640|FG003|Overall Study|Withdrawal by Subject|1|||
23608323|NCT03162614|65953641|FG004|Overall Study|Withdrawal by Subject|0|||
23608324|NCT03162614|65953642|FG005|Overall Study|Withdrawal by Subject|0|||
23608325|NCT03162614|65953637|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
23608326|NCT03162614|65953638|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
23608327|NCT03162614|65953639|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
23608328|NCT03162614|65953640|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
23608329|NCT03162614|65953641|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
23608330|NCT03162614|65953642|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
23608331|NCT00805792|65953643|FG000|Overall Study|Death|3|||
23608332|NCT00805792|65953643|FG000|Overall Study|Lost to Follow-up|2|||
23608333|NCT01970527|65953644|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
23608334|NCT01970527|65953645|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
23608335|NCT01970527|65953644|FG000|Treatment|Disease progression|0|||
23608336|NCT01970527|65953645|FG001|Treatment|Disease progression|1|||
23608337|NCT01970527|65953644|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
23608338|NCT01970527|65953645|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
23608339|NCT01970527|65953644|FG000|Treatment|Death|0|||
23608340|NCT01970527|65953645|FG001|Treatment|Death|1|||
23608341|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Disease progression|1|||
23608342|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Disease progression|1|||
23608343|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
23608344|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
23608345|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
23608346|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
23608347|NCT01721109|65953646|FG000|Overall Study|Lack of Efficacy|1|||
23608348|NCT01721109|65953646|FG000|Overall Study|Non- Compliance with Study Drug|3|||
23608349|NCT01721109|65953646|FG000|Overall Study|Withdrew Consent|1|||
23608350|NCT01721109|65953646|FG000|Overall Study|Lost to Follow-up|2|||
23608351|NCT01722097|65953647|FG000|Overall Study|Patient sheets not returned|6|||
23608352|NCT01722097|65953648|FG001|Overall Study|Patient sheets not returned|5|||
23608353|NCT02132195|65953649|FG000|Initial Assignment|Relapsed|14|||
23608354|NCT02132195|65953650|FG001|Initial Assignment|Relapsed|0|||
23608355|NCT02132195|65953651|FG002|Initial Assignment|Relapsed|0|||
23608356|NCT02132195|65953649|FG000|Rescue Therapy|Relapsed|0|||
23608357|NCT02132195|65953650|FG001|Rescue Therapy|Relapsed|0|||
23608358|NCT02132195|65953651|FG002|Rescue Therapy|Relapsed|7|||
23608359|NCT02132195|65953649|FG000|Rescue Therapy|Physician Decision|0|||
23608360|NCT02132195|65953650|FG001|Rescue Therapy|Physician Decision|0|||
23608361|NCT02132195|65953651|FG002|Rescue Therapy|Physician Decision|1|||
23608362|NCT02132195|65953649|FG000|Rescue Therapy|Withdrawal by Subject|0|||
23608363|NCT02132195|65953650|FG001|Rescue Therapy|Withdrawal by Subject|0|||
23608364|NCT02132195|65953651|FG002|Rescue Therapy|Withdrawal by Subject|1|||
23608365|NCT02132195|65953649|FG000|Rescue Therapy|Adverse Event|0|||
23608366|NCT02132195|65953650|FG001|Rescue Therapy|Adverse Event|0|||
23608367|NCT02132195|65953651|FG002|Rescue Therapy|Adverse Event|2|||
23608368|NCT00910962|65953652|FG000|Overall Study|Adverse Event|5|||
23608369|NCT00910962|65953653|FG001|Overall Study|Adverse Event|20|||
23608370|NCT00910962|65953654|FG002|Overall Study|Adverse Event|17|||
23608371|NCT00910962|65953652|FG000|Overall Study|Protocol Violation|1|||
23608372|NCT00910962|65953653|FG001|Overall Study|Protocol Violation|3|||
23608373|NCT00910962|65953654|FG002|Overall Study|Protocol Violation|3|||
23608374|NCT00910962|65953652|FG000|Overall Study|Lost to Follow-up|0|||
23608375|NCT00910962|65953653|FG001|Overall Study|Lost to Follow-up|3|||
23608376|NCT00910962|65953654|FG002|Overall Study|Lost to Follow-up|1|||
23608377|NCT00910962|65953652|FG000|Overall Study|Physician Decision|0|||
23608378|NCT00910962|65953653|FG001|Overall Study|Physician Decision|6|||
23608379|NCT00910962|65953654|FG002|Overall Study|Physician Decision|6|||
23608380|NCT00910962|65953652|FG000|Overall Study|Withdrawal by Subject|25|||
23608381|NCT00910962|65953653|FG001|Overall Study|Withdrawal by Subject|32|||
23608382|NCT00910962|65953654|FG002|Overall Study|Withdrawal by Subject|32|||
23608383|NCT00910962|65953652|FG000|Overall Study|Reached defined stopping criteria|12|||
23608384|NCT00910962|65953653|FG001|Overall Study|Reached defined stopping criteria|14|||
23608385|NCT00910962|65953654|FG002|Overall Study|Reached defined stopping criteria|17|||
23608386|NCT02128269|65953655|FG000|Treatment Period|Adverse Event|1|||
23608387|NCT02128269|65953655|FG000|Treatment Period|Physician Decision|1|||
23608388|NCT02170207|65953656|FG000|Overall Study|Case report forms unavailable|5|||
23608389|NCT03236779|65953657|FG000|Overall Study|Lost to Follow-up|13|||
23608390|NCT03236779|65953658|FG001|Overall Study|Lost to Follow-up|21|||
23608391|NCT01802333|65953659|FG000|Overall Study|Ineligible|2|||
23608392|NCT01802333|65953660|FG001|Overall Study|Ineligible|6|||
23608393|NCT01802333|65953661|FG002|Overall Study|Ineligible|8|||
23608394|NCT01802333|65953659|FG000|Overall Study|Adverse Event|1|||
23608395|NCT01802333|65953660|FG001|Overall Study|Adverse Event|8|||
23608396|NCT01802333|65953661|FG002|Overall Study|Adverse Event|8|||
23608397|NCT01802333|65953659|FG000|Overall Study|Withdrawal by Subject|6|||
23608398|NCT01802333|65953660|FG001|Overall Study|Withdrawal by Subject|6|||
23608399|NCT01802333|65953661|FG002|Overall Study|Withdrawal by Subject|5|||
23608400|NCT01802333|65953659|FG000|Overall Study|Progression/relapse|1|||
23608401|NCT01802333|65953660|FG001|Overall Study|Progression/relapse|3|||
23608402|NCT01802333|65953661|FG002|Overall Study|Progression/relapse|0|||
23608403|NCT01802333|65953659|FG000|Overall Study|Death|7|||
23608404|NCT01802333|65953660|FG001|Overall Study|Death|14|||
23608405|NCT01802333|65953661|FG002|Overall Study|Death|13|||
23608406|NCT01802333|65953659|FG000|Overall Study|Other - not protocol specified|32|||
23608407|NCT01802333|65953660|FG001|Overall Study|Other - not protocol specified|22|||
23608408|NCT01802333|65953661|FG002|Overall Study|Other - not protocol specified|24|||
23608409|NCT01802333|65953659|FG000|Overall Study|Did not start treatment|0|||
23608410|NCT01802333|65953660|FG001|Overall Study|Did not start treatment|2|||
23608411|NCT01802333|65953661|FG002|Overall Study|Did not start treatment|5|||
23608412|NCT05124210|65953664|FG000|Overall Study|Lost to Follow-up|1|||
23608413|NCT05124210|65953665|FG001|Overall Study|Lost to Follow-up|0|||
23608414|NCT05124210|65953664|FG000|Overall Study|Withdrawal by Subject|1|||
23608415|NCT05124210|65953665|FG001|Overall Study|Withdrawal by Subject|0|||
23608416|NCT00257556|65953666|FG000|Overall Study|Adverse Event|1|||
23608417|NCT00257556|65953667|FG001|Overall Study|Adverse Event|4|||
23608418|NCT00257556|65953666|FG000|Overall Study|Physician Decision|6|||
23608419|NCT00257556|65953667|FG001|Overall Study|Physician Decision|0|||
23608420|NCT00257556|65953666|FG000|Overall Study|Did not meet hCG criterion|3|||
23608421|NCT00257556|65953667|FG001|Overall Study|Did not meet hCG criterion|0|||
23608422|NCT00257556|65953666|FG000|Overall Study|other reason|4|||
23608423|NCT00257556|65953667|FG001|Overall Study|other reason|6|||
23608424|NCT00578344|65953668|FG000|Overall Study|Insurance problems|1|||
23608425|NCT00578344|65953668|FG000|Overall Study|Graft failure|1|||
23608426|NCT02981953|65953669|FG000|Overall Study|Death|9|||
23608427|NCT02981953|65953669|FG000|Overall Study|Withdrawal by Subject|1|||
23608428|NCT02981953|65953669|FG000|Overall Study|Withdrawal to non-compliance|1|||
23608429|NCT00424476|65956274|FG000|Overall Study|Withdrawal by Subject|7|||
23608430|NCT00424476|65956275|FG001|Overall Study|Withdrawal by Subject|6|||
23608431|NCT00424476|65956276|FG002|Overall Study|Withdrawal by Subject|3|||
23608432|NCT00424476|65956274|FG000|Overall Study|Adverse Event|19|||
23608433|NCT00424476|65956275|FG001|Overall Study|Adverse Event|16|||
23608434|NCT00424476|65956276|FG002|Overall Study|Adverse Event|15|||
23608435|NCT00424476|65956274|FG000|Overall Study|Lack of Efficacy|16|||
23608436|NCT00424476|65956275|FG001|Overall Study|Lack of Efficacy|12|||
23608437|NCT00424476|65956276|FG002|Overall Study|Lack of Efficacy|12|||
23608438|NCT00424476|65956274|FG000|Overall Study|Lack of Compliance|1|||
23608439|NCT00424476|65956275|FG001|Overall Study|Lack of Compliance|1|||
23608440|NCT00424476|65956276|FG002|Overall Study|Lack of Compliance|1|||
23608441|NCT00424476|65956274|FG000|Overall Study|Lost to Follow-up|4|||
23608442|NCT00424476|65956275|FG001|Overall Study|Lost to Follow-up|6|||
23608443|NCT00424476|65956276|FG002|Overall Study|Lost to Follow-up|3|||
23608444|NCT00424476|65956274|FG000|Overall Study|Protocol Violation|7|||
23608445|NCT00424476|65956275|FG001|Overall Study|Protocol Violation|2|||
23608446|NCT00424476|65956276|FG002|Overall Study|Protocol Violation|3|||
23608447|NCT00424476|65956274|FG000|Overall Study|Physician Decision|3|||
23608448|NCT00424476|65956275|FG001|Overall Study|Physician Decision|2|||
23608449|NCT00424476|65956276|FG002|Overall Study|Physician Decision|3|||
23608450|NCT00424476|65956274|FG000|Overall Study|Other|4|||
23608451|NCT00424476|65956275|FG001|Overall Study|Other|3|||
23608452|NCT00424476|65956276|FG002|Overall Study|Other|9|||
23608453|NCT03316170|65956277|FG000|Overall Study|Death|1|||
23608454|NCT03316170|65956278|FG001|Overall Study|Death|0|||
23608455|NCT03316170|65956277|FG000|Overall Study|Lost to Follow-up|6|||
23608456|NCT03316170|65956278|FG001|Overall Study|Lost to Follow-up|7|||
23608457|NCT03262389|65956279|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
23608458|NCT03262389|65956279|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
23608459|NCT03262389|65956279|FG000|Overall Study|opted out of PET/MR|1|||
23608460|NCT02764320|65956280|FG000|Overall Study|Withdrawal by Subject|35|||
23608461|NCT02764320|65956281|FG001|Overall Study|Withdrawal by Subject|38|||
23608462|NCT02764320|65956280|FG000|Overall Study|Protocol Violation|11|||
23608463|NCT02764320|65956281|FG001|Overall Study|Protocol Violation|6|||
23608464|NCT02764320|65956280|FG000|Overall Study|Adverse Event|2|||
23608465|NCT02764320|65956281|FG001|Overall Study|Adverse Event|0|||
23509789|NCT01937559|65601983|FG002|Overall Study|Physician Decision|0|||
23608466|NCT02764320|65956280|FG000|Overall Study|Health Issues unable to continue|2|||
23608467|NCT02764320|65956281|FG001|Overall Study|Health Issues unable to continue|0|||
23608468|NCT02764320|65956280|FG000|Overall Study|Did not meet inclusion criteria|1|||
23509790|NCT01937559|65601981|FG000|Overall Study|Withdrawal by Subject|6|||
23509791|NCT01937559|65601982|FG001|Overall Study|Withdrawal by Subject|4|||
23509792|NCT01937559|65601983|FG002|Overall Study|Withdrawal by Subject|0|||
23509793|NCT01937559|65601981|FG000|Overall Study|screen fail|2|||
23509794|NCT01937559|65601982|FG001|Overall Study|screen fail|4|||
23509795|NCT01937559|65601983|FG002|Overall Study|screen fail|0|||
23509796|NCT02707991|65601984|FG000|Overall Study|Protocol Violation|1|||
23509797|NCT02707991|65601985|FG001|Overall Study|Protocol Violation|0|||
23509798|NCT02707991|65601984|FG000|Overall Study|Became ineligible|0|||
23509799|NCT02707991|65601985|FG001|Overall Study|Became ineligible|1|||
23509800|NCT02064868|65601986|FG000|Overall Study|Lost to Follow-up|14|||
23509801|NCT02064868|65601987|FG001|Overall Study|Lost to Follow-up|8|||
23509802|NCT02064868|65601986|FG000|Overall Study|Physician Decision|1|||
23509803|NCT02064868|65601987|FG001|Overall Study|Physician Decision|0|||
23509804|NCT02064868|65601986|FG000|Overall Study|Withdrawal by Subject|14|||
23509805|NCT02064868|65601987|FG001|Overall Study|Withdrawal by Subject|3|||
23509806|NCT02064868|65601986|FG000|Overall Study|Technical Problems or Missing|5|||
23509807|NCT02064868|65601987|FG001|Overall Study|Technical Problems or Missing|2|||
23509808|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
23509809|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
23509810|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
23509811|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
23509812|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Unclassified|0|||
23509813|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Unclassified|2|||
23509814|NCT01513473|65601992|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
23509815|NCT01513473|65601993|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
23509816|NCT01513473|65601992|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
23509817|NCT01513473|65601993|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
23509818|NCT01085591|65601994|FG000|Overall Study|Adverse Event|0|||
23509819|NCT01085591|65601995|FG001|Overall Study|Adverse Event|1|||
23509820|NCT01085591|65601996|FG002|Overall Study|Adverse Event|3|||
23509821|NCT01085591|65601994|FG000|Overall Study|Physician Decision|1|||
23509822|NCT01085591|65601995|FG001|Overall Study|Physician Decision|0|||
23608469|NCT02764320|65956281|FG001|Overall Study|Did not meet inclusion criteria|0|||
23608470|NCT02764320|65956280|FG000|Overall Study|Subject moved|0|||
23608471|NCT02764320|65956281|FG001|Overall Study|Subject moved|2|||
23608472|NCT02764320|65956280|FG000|Overall Study|Overused medication unavailable|0|||
23509823|NCT01085591|65601996|FG002|Overall Study|Physician Decision|1|||
23509824|NCT01085591|65601994|FG000|Overall Study|Withdrawal by Subject|0|||
23509825|NCT01085591|65601995|FG001|Overall Study|Withdrawal by Subject|2|||
23509826|NCT01085591|65601996|FG002|Overall Study|Withdrawal by Subject|1|||
23509827|NCT01085591|65601994|FG000|Overall Study|Lost to Follow-up|0|||
23509828|NCT01085591|65601995|FG001|Overall Study|Lost to Follow-up|1|||
23509829|NCT01085591|65601996|FG002|Overall Study|Lost to Follow-up|1|||
23509830|NCT01085591|65601994|FG000|Overall Study|Protocol Violation|1|||
23608473|NCT02764320|65956281|FG001|Overall Study|Overused medication unavailable|1|||
23608474|NCT02764320|65956280|FG000|Overall Study|Seeking care outside site|0|||
23608475|NCT02764320|65956281|FG001|Overall Study|Seeking care outside site|1|||
23608476|NCT02764320|65956280|FG000|Overall Study|Technology barriers|0|||
23608477|NCT02764320|65956281|FG001|Overall Study|Technology barriers|1|||
23608478|NCT02362789|65956282|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
23608479|NCT02362789|65956283|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
23608480|NCT02362789|65956284|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
23608481|NCT02362789|65956282|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
23608482|NCT02362789|65956283|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
23608483|NCT02362789|65956284|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
23608484|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
23608485|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
23608486|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
23608487|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
23608488|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
23608489|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
23608490|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
23509831|NCT01085591|65601995|FG001|Overall Study|Protocol Violation|1|||
23509832|NCT01085591|65601996|FG002|Overall Study|Protocol Violation|1|||
23509833|NCT01085591|65601994|FG000|Overall Study|Other|0|||
23509834|NCT01085591|65601995|FG001|Overall Study|Other|1|||
23509835|NCT01085591|65601996|FG002|Overall Study|Other|0|||
23509836|NCT01085591|65601994|FG000|Overall Study|Not Properly Consented|1|||
23509837|NCT01085591|65601995|FG001|Overall Study|Not Properly Consented|0|||
23509838|NCT01085591|65601996|FG002|Overall Study|Not Properly Consented|0|||
23509839|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
23509840|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
23509841|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
23509842|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
23509843|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
23509844|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
23509845|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
23509846|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
23509847|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
23509848|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
23509849|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
23509850|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
23509851|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
23509852|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
23509853|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
23509854|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
23509855|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
23608491|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
23608492|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
23608493|NCT03541369|65956285|FG000|Overall Study|Death|0|||
23608494|NCT03541369|65956286|FG001|Overall Study|Death|0|||
23608495|NCT03541369|65956287|FG002|Overall Study|Death|0|||
23608496|NCT03541369|65956288|FG003|Overall Study|Death|0|||
23608497|NCT03541369|65956289|FG004|Overall Study|Death|1|||
23608498|NCT03541369|65956290|FG005|Overall Study|Death|1|||
23608499|NCT03541369|65956291|FG006|Overall Study|Death|0|||
23608500|NCT03541369|65956292|FG007|Overall Study|Death|2|||
23608501|NCT03541369|65956293|FG008|Overall Study|Death|1|||
23608502|NCT03541369|65956294|FG009|Overall Study|Death|2|||
23608503|NCT03541369|65956295|FG010|Overall Study|Death|1|||
23608504|NCT03541369|65956296|FG011|Overall Study|Death|0|||
23608505|NCT03541369|65956297|FG012|Overall Study|Death|2|||
23608506|NCT03541369|65956298|FG013|Overall Study|Death|1|||
23608507|NCT03541369|65956299|FG014|Overall Study|Death|1|||
23608508|NCT03541369|65956300|FG015|Overall Study|Death|1|||
23608509|NCT03541369|65956301|FG016|Overall Study|Death|0|||
23608510|NCT03541369|65956302|FG017|Overall Study|Death|1|||
23608511|NCT03541369|65956285|FG000|Overall Study|Decision by sponsor|0|||
23608512|NCT03541369|65956286|FG001|Overall Study|Decision by sponsor|0|||
23608513|NCT03541369|65956287|FG002|Overall Study|Decision by sponsor|0|||
23608514|NCT03541369|65956288|FG003|Overall Study|Decision by sponsor|1|||
23608515|NCT03541369|65956289|FG004|Overall Study|Decision by sponsor|0|||
23608516|NCT03541369|65956290|FG005|Overall Study|Decision by sponsor|2|||
23608517|NCT03541369|65956291|FG006|Overall Study|Decision by sponsor|0|||
23608518|NCT03541369|65956292|FG007|Overall Study|Decision by sponsor|1|||
23608519|NCT03541369|65956293|FG008|Overall Study|Decision by sponsor|2|||
23608520|NCT03541369|65956294|FG009|Overall Study|Decision by sponsor|0|||
23608521|NCT03541369|65956295|FG010|Overall Study|Decision by sponsor|0|||
23608522|NCT03541369|65956296|FG011|Overall Study|Decision by sponsor|0|||
23608523|NCT03541369|65956297|FG012|Overall Study|Decision by sponsor|2|||
23608524|NCT03541369|65956298|FG013|Overall Study|Decision by sponsor|2|||
23608525|NCT03541369|65956299|FG014|Overall Study|Decision by sponsor|0|||
23608526|NCT03541369|65956300|FG015|Overall Study|Decision by sponsor|1|||
23608527|NCT03541369|65956301|FG016|Overall Study|Decision by sponsor|1|||
23608528|NCT03541369|65956302|FG017|Overall Study|Decision by sponsor|1|||
23608529|NCT03541369|65956285|FG000|Overall Study|Withdrawal by Subject|0|||
23608530|NCT03541369|65956286|FG001|Overall Study|Withdrawal by Subject|0|||
23608531|NCT03541369|65956287|FG002|Overall Study|Withdrawal by Subject|0|||
23608532|NCT03541369|65956288|FG003|Overall Study|Withdrawal by Subject|0|||
23608533|NCT03541369|65956289|FG004|Overall Study|Withdrawal by Subject|0|||
23608534|NCT03541369|65956290|FG005|Overall Study|Withdrawal by Subject|0|||
23608535|NCT03541369|65956291|FG006|Overall Study|Withdrawal by Subject|1|||
23608536|NCT03541369|65956292|FG007|Overall Study|Withdrawal by Subject|0|||
23608537|NCT03541369|65956293|FG008|Overall Study|Withdrawal by Subject|0|||
23608538|NCT03541369|65956294|FG009|Overall Study|Withdrawal by Subject|0|||
23608539|NCT03541369|65956295|FG010|Overall Study|Withdrawal by Subject|0|||
23608540|NCT03541369|65956296|FG011|Overall Study|Withdrawal by Subject|1|||
23608541|NCT03541369|65956297|FG012|Overall Study|Withdrawal by Subject|0|||
23608542|NCT03541369|65956298|FG013|Overall Study|Withdrawal by Subject|0|||
23608543|NCT03541369|65956299|FG014|Overall Study|Withdrawal by Subject|3|||
23608544|NCT03541369|65956300|FG015|Overall Study|Withdrawal by Subject|0|||
23608545|NCT03541369|65956301|FG016|Overall Study|Withdrawal by Subject|4|||
23608546|NCT03541369|65956302|FG017|Overall Study|Withdrawal by Subject|2|||
23608547|NCT03541369|65956285|FG000|Overall Study|Lost to Follow-up|0|||
23608548|NCT03541369|65956286|FG001|Overall Study|Lost to Follow-up|0|||
23608549|NCT03541369|65956287|FG002|Overall Study|Lost to Follow-up|0|||
23608550|NCT03541369|65956288|FG003|Overall Study|Lost to Follow-up|0|||
23608551|NCT03541369|65956289|FG004|Overall Study|Lost to Follow-up|1|||
23608552|NCT03541369|65956290|FG005|Overall Study|Lost to Follow-up|0|||
23608553|NCT03541369|65956291|FG006|Overall Study|Lost to Follow-up|0|||
23608554|NCT03541369|65956292|FG007|Overall Study|Lost to Follow-up|0|||
23608555|NCT03541369|65956293|FG008|Overall Study|Lost to Follow-up|1|||
23608556|NCT03541369|65956294|FG009|Overall Study|Lost to Follow-up|0|||
23608557|NCT03541369|65956295|FG010|Overall Study|Lost to Follow-up|0|||
23608558|NCT03541369|65956296|FG011|Overall Study|Lost to Follow-up|0|||
23608559|NCT03541369|65956297|FG012|Overall Study|Lost to Follow-up|1|||
23608560|NCT03541369|65956298|FG013|Overall Study|Lost to Follow-up|0|||
23608561|NCT03541369|65956299|FG014|Overall Study|Lost to Follow-up|0|||
23608562|NCT03541369|65956300|FG015|Overall Study|Lost to Follow-up|0|||
23608563|NCT03541369|65956301|FG016|Overall Study|Lost to Follow-up|0|||
23608564|NCT03541369|65956302|FG017|Overall Study|Lost to Follow-up|0|||
23608565|NCT01381549|65956303|FG000|Overall Study|Ineligible: No organisms isolated|0|||
23608566|NCT01381549|65956304|FG001|Overall Study|Ineligible: No organisms isolated|0|||
23608567|NCT01381549|65956305|FG002|Overall Study|Ineligible: No organisms isolated|1|||
23608568|NCT01416285|65956308|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
23608569|NCT01416285|65956309|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
23608570|NCT03989232|65956310|FG000|Overall Study|Lost to Follow-up|3|||
23608571|NCT03989232|65956311|FG001|Overall Study|Lost to Follow-up|10|||
23608572|NCT03989232|65956310|FG000|Overall Study|Withdrawal by Subject|6|||
23608573|NCT03989232|65956311|FG001|Overall Study|Withdrawal by Subject|6|||
23608574|NCT03989232|65956310|FG000|Overall Study|Death|1|||
23608575|NCT03989232|65956311|FG001|Overall Study|Death|2|||
23608576|NCT01137682|65956312|FG000|Overall Study|Adverse Event-CORE|2|||
23608577|NCT01137682|65956313|FG001|Overall Study|Adverse Event-CORE|4|||
23608578|NCT01137682|65956314|FG002|Overall Study|Adverse Event-CORE|0|||
23509856|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
23509857|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
23509858|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
23509859|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
23509860|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
23509861|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
23509862|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
23509863|NCT03789318|65602001|FG000|Overall Study|Adverse Event|0|||
23509864|NCT03789318|65602002|FG001|Overall Study|Adverse Event|0|||
23509865|NCT03789318|65602003|FG002|Overall Study|Adverse Event|1|||
23509866|NCT03789318|65602004|FG003|Overall Study|Adverse Event|1|||
23509867|NCT03789318|65602005|FG004|Overall Study|Adverse Event|0|||
23509868|NCT03789318|65602001|FG000|Overall Study|Lost to Follow-up|0|||
23509869|NCT03789318|65602002|FG001|Overall Study|Lost to Follow-up|0|||
23509870|NCT03789318|65602003|FG002|Overall Study|Lost to Follow-up|1|||
23509871|NCT03789318|65602004|FG003|Overall Study|Lost to Follow-up|0|||
23509872|NCT03789318|65602005|FG004|Overall Study|Lost to Follow-up|0|||
23509873|NCT03789318|65602001|FG000|Overall Study|Withdrawal by Subject|0|||
23509874|NCT03789318|65602002|FG001|Overall Study|Withdrawal by Subject|0|||
23509875|NCT03789318|65602003|FG002|Overall Study|Withdrawal by Subject|1|||
23509876|NCT03789318|65602004|FG003|Overall Study|Withdrawal by Subject|0|||
23509877|NCT03789318|65602005|FG004|Overall Study|Withdrawal by Subject|0|||
23509878|NCT00679302|65602006|FG000|Overall Study|Lost to Follow-up|8|||
23509879|NCT00679302|65602007|FG001|Overall Study|Lost to Follow-up|4|||
23509880|NCT00459667|65602008|FG000|Overall Study|Adverse Event|9|||
23509881|NCT00459667|65602009|FG001|Overall Study|Adverse Event|12|||
23509882|NCT00459667|65602010|FG002|Overall Study|Adverse Event|8|||
23509883|NCT00459667|65602008|FG000|Overall Study|Lost to Follow-up|5|||
23509884|NCT00459667|65602009|FG001|Overall Study|Lost to Follow-up|9|||
23509885|NCT00459667|65602010|FG002|Overall Study|Lost to Follow-up|3|||
23509886|NCT00459667|65602008|FG000|Overall Study|Pregnancy|1|||
23509887|NCT00459667|65602009|FG001|Overall Study|Pregnancy|1|||
23608579|NCT01137682|65956312|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
23608580|NCT01137682|65956313|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
23608581|NCT01137682|65956314|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
23608582|NCT01137682|65956312|FG000|Overall Study|Administrative problems-CORE|2|||
23608583|NCT01137682|65956313|FG001|Overall Study|Administrative problems-CORE|1|||
23608584|NCT01137682|65956314|FG002|Overall Study|Administrative problems-CORE|0|||
23608585|NCT01137682|65956312|FG000|Overall Study|Protocol Violation-CORE|0|||
23608586|NCT01137682|65956313|FG001|Overall Study|Protocol Violation-CORE|1|||
23608587|NCT01137682|65956314|FG002|Overall Study|Protocol Violation-CORE|1|||
23608588|NCT01137682|65956312|FG000|Overall Study|Adverse Event-Extension|4|||
23608589|NCT01137682|65956313|FG001|Overall Study|Adverse Event-Extension|8|||
23509888|NCT00459667|65602010|FG002|Overall Study|Pregnancy|1|||
23509889|NCT00459667|65602008|FG000|Overall Study|Protocol Violation|1|||
23509890|NCT00459667|65602009|FG001|Overall Study|Protocol Violation|0|||
23509891|NCT00459667|65602010|FG002|Overall Study|Protocol Violation|0|||
23509892|NCT00459667|65602008|FG000|Overall Study|Withdrawal by Subject|3|||
23608590|NCT01137682|65956314|FG002|Overall Study|Adverse Event-Extension|7|||
23509893|NCT00459667|65602009|FG001|Overall Study|Withdrawal by Subject|5|||
23509894|NCT00459667|65602010|FG002|Overall Study|Withdrawal by Subject|5|||
23509895|NCT00459667|65602008|FG000|Overall Study|Other disease modifying treatment|1|||
23608591|NCT01137682|65956312|FG000|Overall Study|Lack of Efficacy-Extension|15|||
23608592|NCT01137682|65956313|FG001|Overall Study|Lack of Efficacy-Extension|9|||
23453415|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23509896|NCT00459667|65602009|FG001|Overall Study|Other disease modifying treatment|2|||
23509897|NCT00459667|65602010|FG002|Overall Study|Other disease modifying treatment|1|||
23509898|NCT00459667|65602008|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
23509899|NCT00459667|65602009|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
23509900|NCT00459667|65602010|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
23509901|NCT00459667|65602008|FG000|Overall Study|No treatment administered|6|||
23509902|NCT00459667|65602009|FG001|Overall Study|No treatment administered|3|||
23509903|NCT00459667|65602010|FG002|Overall Study|No treatment administered|1|||
23509904|NCT00429104|65602012|FG000|Overall Study|Protocol Violation|1|||
23509905|NCT01342796|65602015|FG000|Overall Study|Withdrawal by Subject|2|||
23509906|NCT01342796|65602016|FG001|Overall Study|Withdrawal by Subject|0|||
23509907|NCT01342796|65602015|FG000|Overall Study|Lost to Follow-up|0|||
23509908|NCT01342796|65602016|FG001|Overall Study|Lost to Follow-up|3|||
23453416|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453417|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23453418|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
23453419|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
23453420|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
23453421|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
23453422|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
23453423|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
23453424|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
23453425|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
23453426|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
23453427|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
23453428|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
23453429|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
23453430|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
23453431|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
23453432|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
23453433|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453434|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453435|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453436|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453437|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
23453438|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453439|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453440|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453441|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453442|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453443|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453444|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453445|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453446|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453447|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453448|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453449|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453450|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453451|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
23453452|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453453|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453454|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453455|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453456|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453457|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453458|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453459|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453460|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453461|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453462|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453463|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453464|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453465|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453466|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23608593|NCT01137682|65956314|FG002|Overall Study|Lack of Efficacy-Extension|13|||
23608594|NCT01137682|65956312|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
23608595|NCT01137682|65956313|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
23608596|NCT01137682|65956314|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
23608597|NCT01137682|65956312|FG000|Overall Study|Lost to Follow Up-Extension|0|||
23608598|NCT01137682|65956313|FG001|Overall Study|Lost to Follow Up-Extension|1|||
23608599|NCT01137682|65956314|FG002|Overall Study|Lost to Follow Up-Extension|0|||
23608600|NCT01137682|65956312|FG000|Overall Study|Administrative problems-Extension|0|||
23608601|NCT01137682|65956313|FG001|Overall Study|Administrative problems-Extension|2|||
23608602|NCT01137682|65956314|FG002|Overall Study|Administrative problems-Extension|0|||
23608603|NCT01137682|65956312|FG000|Overall Study|Death-Extension|2|||
23608604|NCT01137682|65956313|FG001|Overall Study|Death-Extension|0|||
23608605|NCT01137682|65956314|FG002|Overall Study|Death-Extension|0|||
23608606|NCT01137682|65956312|FG000|Overall Study|Protocol Violation-Extension|2|||
23608607|NCT01137682|65956313|FG001|Overall Study|Protocol Violation-Extension|1|||
23608608|NCT01137682|65956314|FG002|Overall Study|Protocol Violation-Extension|0|||
23608609|NCT01137682|65956312|FG000|Overall Study|Did not enter extension|2|||
23608610|NCT01137682|65956313|FG001|Overall Study|Did not enter extension|3|||
23608611|NCT01137682|65956314|FG002|Overall Study|Did not enter extension|2|||
23608612|NCT01137682|65956312|FG000|Overall Study|Did not receive treatment in extension|0|||
23608613|NCT01137682|65956313|FG001|Overall Study|Did not receive treatment in extension|0|||
23608614|NCT01137682|65956314|FG002|Overall Study|Did not receive treatment in extension|1|||
23608615|NCT02144285|65956315|FG000|Overall Study|Withdrawal by Subject|0|||
23608616|NCT02144285|65956316|FG001|Overall Study|Withdrawal by Subject|0|||
23608617|NCT02144285|65956317|FG002|Overall Study|Withdrawal by Subject|0|||
23608618|NCT02144285|65956318|FG003|Overall Study|Withdrawal by Subject|0|||
23509909|NCT01342796|65602015|FG000|Overall Study|Inappropriate enrollment|1|||
23509910|NCT01342796|65602016|FG001|Overall Study|Inappropriate enrollment|0|||
23608619|NCT02144285|65956319|FG004|Overall Study|Withdrawal by Subject|1|||
23608620|NCT02144285|65956320|FG005|Overall Study|Withdrawal by Subject|0|||
23608621|NCT02144285|65956321|FG006|Overall Study|Withdrawal by Subject|0|||
23608622|NCT02144285|65956322|FG007|Overall Study|Withdrawal by Subject|0|||
23608623|NCT02144285|65956323|FG008|Overall Study|Withdrawal by Subject|0|||
23608624|NCT02144285|65956324|FG009|Overall Study|Withdrawal by Subject|0|||
23608625|NCT00439218|65956325|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
23608626|NCT04311983|65956326|FG000|Overall Study|Lost to Follow-up|421|||
23509911|NCT02117648|65602017|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
23608627|NCT04311983|65956327|FG001|Overall Study|Lost to Follow-up|456|||
23608628|NCT04311983|65956326|FG000|Overall Study|Incomplete survey|7|||
23608629|NCT04311983|65956327|FG001|Overall Study|Incomplete survey|9|||
23608630|NCT04311983|65956326|FG000|Overall Study|Death|1|||
23608631|NCT04311983|65956327|FG001|Overall Study|Death|0|||
23608632|NCT04328467|65956330|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
23608633|NCT04328467|65956331|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
23608634|NCT04328467|65956332|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
23608635|NCT02354417|65956333|FG000|Overall Study|Physician Decision|1|||
23608636|NCT02637063|65956334|FG000|Overall Study|Lost to Follow-up|3|||
23608637|NCT02637063|65956335|FG001|Overall Study|Lost to Follow-up|2|||
23608638|NCT02637063|65956336|FG002|Overall Study|Lost to Follow-up|3|||
23608639|NCT02637063|65956334|FG000|Overall Study|Withdrawal by Subject|2|||
23608640|NCT02637063|65956335|FG001|Overall Study|Withdrawal by Subject|2|||
23608641|NCT02637063|65956336|FG002|Overall Study|Withdrawal by Subject|3|||
23608642|NCT00901459|65956339|FG000|Overall Study|Withdrawal by Subject|6|||
23608643|NCT01205126|65956343|FG000|Titration Phase|Adverse Event|5|||
23608644|NCT01205126|65956344|FG001|Titration Phase|Adverse Event|3|||
23608645|NCT01205126|65956343|FG000|Titration Phase|Withdrawal by Subject|5|||
23608646|NCT01205126|65956344|FG001|Titration Phase|Withdrawal by Subject|5|||
23608647|NCT01205126|65956343|FG000|Titration Phase|Lost to Follow-up|2|||
23608648|NCT01205126|65956344|FG001|Titration Phase|Lost to Follow-up|2|||
23608649|NCT01205126|65956343|FG000|Titration Phase|No stable titration dose|1|||
23608650|NCT01205126|65956344|FG001|Titration Phase|No stable titration dose|0|||
23608651|NCT01205126|65956343|FG000|Titration Phase|More than maximum dosage required|2|||
23608652|NCT01205126|65956344|FG001|Titration Phase|More than maximum dosage required|3|||
23608653|NCT01205126|65956343|FG000|Titration Phase|Other|8|||
23408569|NCT03782259|65239923|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
23509912|NCT02117648|65602017|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
23509913|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
23509914|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
23509915|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
23509916|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
23509917|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
23509918|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
23509919|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
23608654|NCT01205126|65956344|FG001|Titration Phase|Other|6|||
23608655|NCT01205126|65956343|FG000|Between Titration & Maintenance Phase|Other|0|||
23608656|NCT01205126|65956344|FG001|Between Titration & Maintenance Phase|Other|4|||
23608657|NCT01205126|65956343|FG000|Maintenance Phase|Adverse Event|3|||
23608658|NCT01205126|65956344|FG001|Maintenance Phase|Adverse Event|7|||
23608659|NCT01205126|65956343|FG000|Maintenance Phase|Death|4|||
23608660|NCT01205126|65956344|FG001|Maintenance Phase|Death|4|||
23608661|NCT01205126|65956343|FG000|Maintenance Phase|More than the maximum dosage required|5|||
23608662|NCT01205126|65956344|FG001|Maintenance Phase|More than the maximum dosage required|5|||
23608663|NCT01205126|65956343|FG000|Maintenance Phase|Prohibited drugs used|1|||
23509920|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
23509921|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
23509922|NCT01414855|65602018|FG000|Overall Study|Death|17|||
23509923|NCT01414855|65602018|FG000|Overall Study|Lost to Follow-up|5|||
23509924|NCT01414855|65602018|FG000|Overall Study|Withdrawal by Subject|7|||
23509925|NCT01104493|65602019|FG000|Overall Study|Lost to Follow-up|0|||
23509926|NCT01104493|65602020|FG001|Overall Study|Lost to Follow-up|2|||
23509927|NCT00617773|65602022|FG000|Overall Study|Physician Decision|1|||
23509928|NCT00617773|65602022|FG000|Overall Study|Lack of compliance with the protocol|1|||
23509929|NCT00617773|65602022|FG000|Overall Study|Withdrawal by Subject|1|||
23509930|NCT00617773|65602022|FG000|Overall Study|Death|1|||
23509931|NCT00617773|65602022|FG000|Overall Study|Progressive disease|19|||
23509932|NCT00617773|65602022|FG000|Overall Study|Protocol Violation|1|||
23509933|NCT03211416|65602023|FG000|Overall Study|Adverse Event|7|||
23509934|NCT03211416|65602023|FG000|Overall Study|Lack of Efficacy|2|||
23509935|NCT03211416|65602023|FG000|Overall Study|Physician Decision|1|||
23509936|NCT00062374|65602024|FG000|Overall Study|Not treated|12|||
23509937|NCT02670083|65602025|FG000|Overall Study|Adverse Event|16|||
23509938|NCT02670083|65602026|FG001|Overall Study|Adverse Event|13|||
23509939|NCT02670083|65602025|FG000|Overall Study|Death|4|||
23509940|NCT02670083|65602026|FG001|Overall Study|Death|6|||
23509941|NCT02670083|65602025|FG000|Overall Study|Lost to Follow-up|2|||
23509942|NCT02670083|65602026|FG001|Overall Study|Lost to Follow-up|2|||
23509943|NCT02670083|65602025|FG000|Overall Study|Multiple Reasons|9|||
23509944|NCT02670083|65602026|FG001|Overall Study|Multiple Reasons|9|||
23509945|NCT02670083|65602025|FG000|Overall Study|Physician Decision|0|||
23509946|NCT02670083|65602026|FG001|Overall Study|Physician Decision|2|||
23509947|NCT02670083|65602025|FG000|Overall Study|Study Terminated By Sponsor|257|||
23509948|NCT02670083|65602026|FG001|Overall Study|Study Terminated By Sponsor|254|||
23509949|NCT02670083|65602025|FG000|Overall Study|Symptomatic Deterioration|0|||
23509950|NCT02670083|65602026|FG001|Overall Study|Symptomatic Deterioration|2|||
23509951|NCT02670083|65602025|FG000|Overall Study|Withdrawal by Subject|32|||
23509952|NCT02670083|65602026|FG001|Overall Study|Withdrawal by Subject|31|||
23509953|NCT02670083|65602025|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23509954|NCT02670083|65602026|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23509955|NCT01417234|65602029|FG000|Overall Study|Subject non-compliant|3|||
23509956|NCT02573311|65602030|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
23509957|NCT02573311|65602031|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
23509958|NCT02573311|65602030|FG000|Disposition for Part 2|Physician Decision|25|||
23509959|NCT02573311|65602031|FG001|Disposition for Part 2|Physician Decision|7|||
23509960|NCT02573311|65602030|FG000|Disposition for Part 2|Adverse Event|36|||
23509961|NCT02573311|65602031|FG001|Disposition for Part 2|Adverse Event|5|||
23509962|NCT02573311|65602030|FG000|Disposition for Part 2|Lost to Follow-up|76|||
23509963|NCT02573311|65602031|FG001|Disposition for Part 2|Lost to Follow-up|7|||
23509964|NCT02573311|65602030|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
23509965|NCT02573311|65602031|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
23509966|NCT02573311|65602030|FG000|Disposition for Part 2|Investigator decision|0|||
23509967|NCT02573311|65602031|FG001|Disposition for Part 2|Investigator decision|1|||
23509968|NCT02573311|65602030|FG000|Disposition for Part 2|Other than specified above|13|||
23509969|NCT02573311|65602031|FG001|Disposition for Part 2|Other than specified above|3|||
23509970|NCT03068130|65602032|FG000|Overall Study|Adverse Event|19|||
23509971|NCT03068130|65602032|FG000|Overall Study|Death|14|||
23509972|NCT03068130|65602032|FG000|Overall Study|Lost to Follow-up|4|||
23509973|NCT03068130|65602032|FG000|Overall Study|Withdrawal by Subject|26|||
23509974|NCT03068130|65602032|FG000|Overall Study|Administrative Reasons|3|||
23509975|NCT03068130|65602032|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
23509976|NCT03068130|65602032|FG000|Overall Study|Study terminated by sponsor|194|||
23509977|NCT00587639|65602033|FG000|Overall Study|Withdrawal by Subject|1|||
23509978|NCT01401283|65602034|FG000|Overall Study|surgery cancelled|5|||
23509979|NCT01401283|65602035|FG001|Overall Study|surgery cancelled|8|||
23509980|NCT01401283|65602034|FG000|Overall Study|preoperative arrhythmia|5|||
23509981|NCT01401283|65602035|FG001|Overall Study|preoperative arrhythmia|0|||
23509982|NCT01401283|65602034|FG000|Overall Study|no central venous access|0|||
23509983|NCT01401283|65602035|FG001|Overall Study|no central venous access|1|||
23509984|NCT01401283|65602034|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
23509985|NCT01401283|65602035|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
23608664|NCT01205126|65956344|FG001|Maintenance Phase|Prohibited drugs used|0|||
23608665|NCT01205126|65956343|FG000|Maintenance Phase|Other|11|||
23608666|NCT01205126|65956344|FG001|Maintenance Phase|Other|8|||
23608667|NCT01205126|65956343|FG000|Maintenance Phase|Lost to Follow-up|5|||
23608668|NCT01205126|65956344|FG001|Maintenance Phase|Lost to Follow-up|5|||
23608669|NCT01205126|65956343|FG000|Maintenance Phase|Withdrawal by Subject|8|||
23608670|NCT01205126|65956344|FG001|Maintenance Phase|Withdrawal by Subject|11|||
23608671|NCT00952523|65956348|FG000|Overall Study|Withdrawal by Subject|7|||
23608672|NCT01560429|65956349|FG000|Overall Study|Protocol Violation|3|||
23608673|NCT01560429|65956350|FG001|Overall Study|Protocol Violation|6|||
23608674|NCT04938453|65956351|FG000|Washout Period 1|Adverse Event|1|||
23608675|NCT04938453|65956352|FG001|Washout Period 1|Adverse Event|0|||
23608676|NCT04938453|65956351|FG000|Washout Period 1|Physician Decision|0|||
23608677|NCT04938453|65956352|FG001|Washout Period 1|Physician Decision|1|||
23608678|NCT00537914|65956355|FG000|Overall Study|Death|1|||
23608679|NCT00537914|65956355|FG000|Overall Study|Adverse Event|7|||
23608680|NCT00537914|65956355|FG000|Overall Study|Treatment failure|10|||
23608681|NCT00537914|65956355|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
23608682|NCT00537914|65956355|FG000|Overall Study|Lost to Follow-up|19|||
23608683|NCT00537914|65956355|FG000|Overall Study|Withdrawal of informed consent|59|||
23608684|NCT00417885|65956360|FG000|Overall Study|Adverse Event|1|||
23608685|NCT00417885|65956360|FG000|Overall Study|Objective Progression or Relapse|3|||
23608686|NCT00417885|65956360|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
23608687|NCT02607956|65956367|FG000|Double-Blinded Phase|Withdrew Consent|17|||
23608688|NCT02607956|65956368|FG001|Double-Blinded Phase|Withdrew Consent|19|||
23608689|NCT02607956|65956369|FG002|Double-Blinded Phase|Withdrew Consent|0|||
23608690|NCT02607956|65956370|FG003|Double-Blinded Phase|Withdrew Consent|0|||
23608691|NCT02607956|65956367|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
23608692|NCT02607956|65956368|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
23608693|NCT02607956|65956369|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
23608694|NCT02607956|65956370|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
23608695|NCT02607956|65956367|FG000|Double-Blinded Phase|Randomized but never treated|7|||
23608696|NCT02607956|65956368|FG001|Double-Blinded Phase|Randomized but never treated|5|||
23608697|NCT02607956|65956369|FG002|Double-Blinded Phase|Randomized but never treated|0|||
23608698|NCT02607956|65956370|FG003|Double-Blinded Phase|Randomized but never treated|0|||
23608699|NCT02607956|65956367|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
23608700|NCT02607956|65956368|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
23608701|NCT02607956|65956369|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
23608702|NCT02607956|65956370|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
23608703|NCT02607956|65956367|FG000|Double-Blinded Phase|Death|4|||
23608704|NCT02607956|65956368|FG001|Double-Blinded Phase|Death|4|||
23608705|NCT02607956|65956369|FG002|Double-Blinded Phase|Death|0|||
23608706|NCT02607956|65956370|FG003|Double-Blinded Phase|Death|0|||
23608707|NCT02607956|65956367|FG000|Double-Blinded Phase|Adverse Event|4|||
23608708|NCT02607956|65956368|FG001|Double-Blinded Phase|Adverse Event|3|||
23608709|NCT02607956|65956369|FG002|Double-Blinded Phase|Adverse Event|0|||
23608710|NCT02607956|65956370|FG003|Double-Blinded Phase|Adverse Event|0|||
23608711|NCT02607956|65956367|FG000|Double-Blinded Phase|Protocol Violation|3|||
23608712|NCT02607956|65956368|FG001|Double-Blinded Phase|Protocol Violation|1|||
23608713|NCT02607956|65956369|FG002|Double-Blinded Phase|Protocol Violation|0|||
23608714|NCT02607956|65956370|FG003|Double-Blinded Phase|Protocol Violation|0|||
23608715|NCT02607956|65956367|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608716|NCT02607956|65956368|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
23608717|NCT02607956|65956369|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608718|NCT02607956|65956370|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608719|NCT02607956|65956367|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
23608720|NCT02607956|65956368|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
23608721|NCT02607956|65956369|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
23608722|NCT02607956|65956370|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
23608723|NCT02607956|65956367|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23608724|NCT02607956|65956368|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23608725|NCT02607956|65956369|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
23608726|NCT02607956|65956370|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
23608727|NCT02607956|65956367|FG000|Open-Label Extension Phase|Death|0|||
23608728|NCT02607956|65956368|FG001|Open-Label Extension Phase|Death|0|||
23608729|NCT02607956|65956369|FG002|Open-Label Extension Phase|Death|1|||
23608730|NCT02607956|65956370|FG003|Open-Label Extension Phase|Death|3|||
23608731|NCT02607956|65956367|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
23608732|NCT02607956|65956368|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23608733|NCT02607956|65956369|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
23608734|NCT02607956|65956370|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
23608735|NCT02607956|65956367|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608736|NCT02607956|65956368|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608737|NCT02607956|65956369|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
23608738|NCT02607956|65956370|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608739|NCT02607956|65956367|FG000|Open-Label Extension Phase|Protocol Violation|0|||
23608740|NCT02607956|65956368|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23608741|NCT02607956|65956369|FG002|Open-Label Extension Phase|Protocol Violation|0|||
23608742|NCT02607956|65956370|FG003|Open-Label Extension Phase|Protocol Violation|2|||
23608743|NCT02607956|65956367|FG000|Open-Label Extension Phase|Pregnancy|0|||
23608744|NCT02607956|65956368|FG001|Open-Label Extension Phase|Pregnancy|0|||
23608745|NCT02607956|65956369|FG002|Open-Label Extension Phase|Pregnancy|0|||
23608746|NCT02607956|65956370|FG003|Open-Label Extension Phase|Pregnancy|1|||
23608747|NCT01911819|65956373|FG000|Overall Study|Adverse Event|0|||
23608748|NCT01911819|65956374|FG001|Overall Study|Adverse Event|1|||
23608749|NCT01911819|65956375|FG002|Overall Study|Adverse Event|0|||
23608750|NCT01911819|65956373|FG000|Overall Study|Withdrawal by Subject|1|||
23608751|NCT01911819|65956374|FG001|Overall Study|Withdrawal by Subject|1|||
23608752|NCT01911819|65956375|FG002|Overall Study|Withdrawal by Subject|0|||
23608753|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
23608754|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
23608755|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
23608756|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
23608757|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
23608758|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
23509986|NCT00964860|65602042|FG000|Overall Study|Withdrawal by Subject|0|||
23608759|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
23608760|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
23608761|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
23608762|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
23608763|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
23608764|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
23608765|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
23608766|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
23608767|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
23608768|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
23608769|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
23608770|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
23608771|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
23608772|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
23608773|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
23608774|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
23608775|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
23608776|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
23608777|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
23608778|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
23608779|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
23608780|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
23608781|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
23608782|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
23608783|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
23608784|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
23608785|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
23608786|NCT03602053|65956381|FG000|Overall Study|Withdrawal by Subject|7|||
23608787|NCT03602053|65956382|FG001|Overall Study|Withdrawal by Subject|9|||
23608788|NCT03602053|65956383|FG002|Overall Study|Withdrawal by Subject|7|||
23608789|NCT03602053|65956381|FG000|Overall Study|Lost to Follow-up|5|||
23608790|NCT03602053|65956382|FG001|Overall Study|Lost to Follow-up|6|||
23608791|NCT03602053|65956383|FG002|Overall Study|Lost to Follow-up|0|||
23608792|NCT03602053|65956381|FG000|Overall Study|Protocol Violation|3|||
23608793|NCT03602053|65956382|FG001|Overall Study|Protocol Violation|0|||
23608794|NCT03602053|65956383|FG002|Overall Study|Protocol Violation|4|||
23608795|NCT03602053|65956381|FG000|Overall Study|Physician Decision|1|||
23608796|NCT03602053|65956382|FG001|Overall Study|Physician Decision|0|||
23608797|NCT03602053|65956383|FG002|Overall Study|Physician Decision|0|||
23608798|NCT03602053|65956381|FG000|Overall Study|migration|2|||
23608799|NCT03602053|65956382|FG001|Overall Study|migration|3|||
23608800|NCT03602053|65956383|FG002|Overall Study|migration|0|||
23608801|NCT03602053|65956381|FG000|Overall Study|Other|1|||
23608802|NCT03602053|65956382|FG001|Overall Study|Other|0|||
23608803|NCT03602053|65956383|FG002|Overall Study|Other|0|||
23608804|NCT00787176|65956387|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
23608805|NCT00787176|65956388|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
23608806|NCT00787176|65956389|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
23608807|NCT00787176|65956390|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
23608808|NCT01328756|65956391|FG000|Overall Study|Protocol Violation|4|||
23509987|NCT00964860|65602043|FG001|Overall Study|Withdrawal by Subject|1|||
23509988|NCT00638378|65602047|FG000|Overall Study|Death|2|||
23509989|NCT00638378|65602047|FG000|Overall Study|Adverse Event|1|||
23509990|NCT00638378|65602047|FG000|Overall Study|Disease progression|15|||
23509991|NCT00638378|65602047|FG000|Overall Study|Physician Decision|4|||
23509992|NCT03555591|65602048|FG000|Overall Study|Protocol Violation|77|||
23509993|NCT00040664|65602054|FG000|Overall Study|Adverse Event|12|||
23509994|NCT00040664|65602055|FG001|Overall Study|Adverse Event|3|||
23509995|NCT00040664|65602056|FG002|Overall Study|Adverse Event|2|||
23509996|NCT00040664|65602057|FG003|Overall Study|Adverse Event|7|||
23509997|NCT00040664|65602054|FG000|Overall Study|Lack of Efficacy|9|||
23509998|NCT00040664|65602055|FG001|Overall Study|Lack of Efficacy|2|||
23509999|NCT00040664|65602056|FG002|Overall Study|Lack of Efficacy|3|||
23510000|NCT00040664|65602057|FG003|Overall Study|Lack of Efficacy|4|||
23510001|NCT00040664|65602054|FG000|Overall Study|Insufficient CD4 response|1|||
23510002|NCT00040664|65602055|FG001|Overall Study|Insufficient CD4 response|0|||
23510003|NCT00040664|65602056|FG002|Overall Study|Insufficient CD4 response|1|||
23510004|NCT00040664|65602057|FG003|Overall Study|Insufficient CD4 response|0|||
23510005|NCT00040664|65602054|FG000|Overall Study|Lost to Follow-up|4|||
23510006|NCT00040664|65602055|FG001|Overall Study|Lost to Follow-up|2|||
23510007|NCT00040664|65602056|FG002|Overall Study|Lost to Follow-up|0|||
23608809|NCT01328756|65956391|FG000|Overall Study|Adverse Event|39|||
23608810|NCT01328756|65956391|FG000|Overall Study|Lack of Efficacy|5|||
23608811|NCT01328756|65956391|FG000|Overall Study|Withdrawal by Subject|41|||
23608812|NCT01328756|65956391|FG000|Overall Study|Lost to Follow-up|5|||
23608813|NCT01328756|65956391|FG000|Overall Study|Other|29|||
23608814|NCT00923078|65956392|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
23608815|NCT00923078|65956393|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
23608816|NCT00923078|65956394|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
23608817|NCT00923078|65956392|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
23608818|NCT00923078|65956393|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
23608819|NCT00923078|65956394|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
23608820|NCT02291549|65956397|FG000|Overall Study|Lost to Follow-up|1|||
23608821|NCT02291549|65956398|FG001|Overall Study|Lost to Follow-up|0|||
23608822|NCT02291549|65956397|FG000|Overall Study|Withdrawal by Subject|0|||
23608823|NCT02291549|65956398|FG001|Overall Study|Withdrawal by Subject|1|||
23608824|NCT00980538|65956400|FG000|Overall Study|Lost to Follow-up|20|||
23608825|NCT00980538|65956400|FG000|Overall Study|Sponsor's Decision|4|||
23608826|NCT00980538|65956400|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
23608827|NCT00980538|65956400|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
23608828|NCT00980538|65956400|FG000|Overall Study|Switch to Commercially Available Medication|25|||
23608829|NCT00980538|65956400|FG000|Overall Study|Participant Non-Compliant|9|||
23608830|NCT00980538|65956400|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
23608831|NCT00980538|65956400|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
23608832|NCT00980538|65956400|FG000|Overall Study|Other|60|||
23608833|NCT00980538|65956400|FG000|Overall Study|Other|1|||
23608834|NCT00632736|65956402|FG000|Overall Study|Adverse Event|104|||
23608835|NCT00632736|65956402|FG000|Overall Study|Lost to Follow-up|15|||
23608836|NCT00632736|65956402|FG000|Overall Study|Protocol Violation|14|||
23608837|NCT00632736|65956402|FG000|Overall Study|Withdrawal by Subject|99|||
23608838|NCT00632736|65956402|FG000|Overall Study|Lack of Efficacy|5|||
23608839|NCT00632736|65956402|FG000|Overall Study|Sponsor terminated study|5|||
23608840|NCT00632736|65956402|FG000|Overall Study|Non-compliance|10|||
23608841|NCT00632736|65956402|FG000|Overall Study|Other|16|||
23608842|NCT01945086|65956403|FG000|Overall Study|Withdrawal by Subject|1|||
23608843|NCT01945086|65956404|FG001|Overall Study|Withdrawal by Subject|0|||
23608844|NCT01945086|65956405|FG002|Overall Study|Withdrawal by Subject|1|||
23608845|NCT01945086|65956403|FG000|Overall Study|Adverse Event|0|||
23608846|NCT01945086|65956404|FG001|Overall Study|Adverse Event|0|||
23608847|NCT01945086|65956405|FG002|Overall Study|Adverse Event|1|||
23608848|NCT00103857|65956414|FG000|54-Week Base Study|Adverse Event|12|||
23510008|NCT00040664|65602057|FG003|Overall Study|Lost to Follow-up|2|||
23510009|NCT00040664|65602054|FG000|Overall Study|Protocol Violation|2|||
23510010|NCT00040664|65602055|FG001|Overall Study|Protocol Violation|1|||
23608849|NCT00103857|65956415|FG001|54-Week Base Study|Adverse Event|9|||
23608850|NCT00103857|65956416|FG002|54-Week Base Study|Adverse Event|11|||
23608851|NCT00103857|65956417|FG003|54-Week Base Study|Adverse Event|6|||
23608852|NCT00103857|65956418|FG004|54-Week Base Study|Adverse Event|5|||
23510011|NCT00040664|65602056|FG002|Overall Study|Protocol Violation|0|||
23510012|NCT00040664|65602057|FG003|Overall Study|Protocol Violation|1|||
23510013|NCT00040664|65602054|FG000|Overall Study|Withdrawal by Subject|7|||
23510014|NCT00040664|65602055|FG001|Overall Study|Withdrawal by Subject|0|||
23608853|NCT00103857|65956419|FG005|54-Week Base Study|Adverse Event|11|||
23608854|NCT00103857|65956420|FG006|54-Week Base Study|Adverse Event|3|||
23608855|NCT00103857|65956414|FG000|54-Week Base Study|Death|0|||
23608856|NCT00103857|65956415|FG001|54-Week Base Study|Death|0|||
23608857|NCT00103857|65956416|FG002|54-Week Base Study|Death|0|||
23608858|NCT00103857|65956417|FG003|54-Week Base Study|Death|0|||
23608859|NCT00103857|65956418|FG004|54-Week Base Study|Death|1|||
23608860|NCT00103857|65956419|FG005|54-Week Base Study|Death|1|||
23608861|NCT00103857|65956420|FG006|54-Week Base Study|Death|0|||
23608862|NCT00103857|65956414|FG000|54-Week Base Study|Lack of Efficacy|11|||
23608863|NCT00103857|65956415|FG001|54-Week Base Study|Lack of Efficacy|14|||
23608864|NCT00103857|65956416|FG002|54-Week Base Study|Lack of Efficacy|8|||
23608865|NCT00103857|65956417|FG003|54-Week Base Study|Lack of Efficacy|4|||
23608866|NCT00103857|65956418|FG004|54-Week Base Study|Lack of Efficacy|3|||
23608867|NCT00103857|65956419|FG005|54-Week Base Study|Lack of Efficacy|14|||
23608868|NCT00103857|65956420|FG006|54-Week Base Study|Lack of Efficacy|19|||
23608869|NCT00103857|65956414|FG000|54-Week Base Study|Lost to Follow-up|5|||
23608870|NCT00103857|65956415|FG001|54-Week Base Study|Lost to Follow-up|4|||
23608871|NCT00103857|65956416|FG002|54-Week Base Study|Lost to Follow-up|7|||
23608872|NCT00103857|65956417|FG003|54-Week Base Study|Lost to Follow-up|5|||
23608873|NCT00103857|65956418|FG004|54-Week Base Study|Lost to Follow-up|10|||
23608874|NCT00103857|65956419|FG005|54-Week Base Study|Lost to Follow-up|9|||
23608875|NCT00103857|65956420|FG006|54-Week Base Study|Lost to Follow-up|3|||
23608876|NCT00103857|65956414|FG000|54-Week Base Study|Physician Decision|1|||
23608877|NCT00103857|65956415|FG001|54-Week Base Study|Physician Decision|1|||
23608878|NCT00103857|65956416|FG002|54-Week Base Study|Physician Decision|0|||
23608879|NCT00103857|65956417|FG003|54-Week Base Study|Physician Decision|0|||
23608880|NCT00103857|65956418|FG004|54-Week Base Study|Physician Decision|1|||
23608881|NCT00103857|65956419|FG005|54-Week Base Study|Physician Decision|0|||
23608882|NCT00103857|65956420|FG006|54-Week Base Study|Physician Decision|0|||
23608883|NCT00103857|65956414|FG000|54-Week Base Study|Pregnancy|1|||
23608884|NCT00103857|65956415|FG001|54-Week Base Study|Pregnancy|0|||
23608885|NCT00103857|65956416|FG002|54-Week Base Study|Pregnancy|0|||
23608886|NCT00103857|65956417|FG003|54-Week Base Study|Pregnancy|0|||
23608887|NCT00103857|65956418|FG004|54-Week Base Study|Pregnancy|1|||
23608888|NCT00103857|65956419|FG005|54-Week Base Study|Pregnancy|0|||
23608889|NCT00103857|65956420|FG006|54-Week Base Study|Pregnancy|1|||
23608890|NCT00103857|65956414|FG000|54-Week Base Study|Protocol Violation|6|||
23608891|NCT00103857|65956415|FG001|54-Week Base Study|Protocol Violation|4|||
23608892|NCT00103857|65956416|FG002|54-Week Base Study|Protocol Violation|2|||
23608893|NCT00103857|65956417|FG003|54-Week Base Study|Protocol Violation|4|||
23608894|NCT00103857|65956418|FG004|54-Week Base Study|Protocol Violation|0|||
23608895|NCT00103857|65956419|FG005|54-Week Base Study|Protocol Violation|3|||
23608896|NCT00103857|65956420|FG006|54-Week Base Study|Protocol Violation|3|||
23608897|NCT00103857|65956414|FG000|54-Week Base Study|Withdrawal by Subject|17|||
23608898|NCT00103857|65956415|FG001|54-Week Base Study|Withdrawal by Subject|16|||
23608899|NCT00103857|65956416|FG002|54-Week Base Study|Withdrawal by Subject|16|||
23608900|NCT00103857|65956417|FG003|54-Week Base Study|Withdrawal by Subject|15|||
23608901|NCT00103857|65956418|FG004|54-Week Base Study|Withdrawal by Subject|10|||
23608902|NCT00103857|65956419|FG005|54-Week Base Study|Withdrawal by Subject|15|||
23608903|NCT00103857|65956420|FG006|54-Week Base Study|Withdrawal by Subject|4|||
23608904|NCT00103857|65956414|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
23608905|NCT00103857|65956415|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
23608906|NCT00103857|65956416|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
23608907|NCT00103857|65956417|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
23608908|NCT00103857|65956418|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
23608909|NCT00103857|65956419|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
23608910|NCT00103857|65956420|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
23608911|NCT00103857|65956414|FG000|54-Week Base Study|patient moved|0|||
23608912|NCT00103857|65956415|FG001|54-Week Base Study|patient moved|1|||
23608913|NCT00103857|65956416|FG002|54-Week Base Study|patient moved|1|||
23608914|NCT00103857|65956417|FG003|54-Week Base Study|patient moved|2|||
23608915|NCT00103857|65956418|FG004|54-Week Base Study|patient moved|3|||
23608916|NCT00103857|65956419|FG005|54-Week Base Study|patient moved|1|||
23608917|NCT00103857|65956420|FG006|54-Week Base Study|patient moved|0|||
23608918|NCT00103857|65956414|FG000|54-Week Base Study|non-compliance with study procedures|1|||
23608919|NCT00103857|65956415|FG001|54-Week Base Study|non-compliance with study procedures|2|||
23608920|NCT00103857|65956416|FG002|54-Week Base Study|non-compliance with study procedures|0|||
23608921|NCT00103857|65956417|FG003|54-Week Base Study|non-compliance with study procedures|0|||
23608922|NCT00103857|65956418|FG004|54-Week Base Study|non-compliance with study procedures|0|||
23608923|NCT00103857|65956419|FG005|54-Week Base Study|non-compliance with study procedures|2|||
23608924|NCT00103857|65956420|FG006|54-Week Base Study|non-compliance with study procedures|0|||
23608925|NCT00103857|65956414|FG000|54-Week Base Study|patient incarcerated|0|||
23608926|NCT00103857|65956415|FG001|54-Week Base Study|patient incarcerated|0|||
23608927|NCT00103857|65956416|FG002|54-Week Base Study|patient incarcerated|0|||
23608928|NCT00103857|65956417|FG003|54-Week Base Study|patient incarcerated|0|||
23608929|NCT00103857|65956418|FG004|54-Week Base Study|patient incarcerated|1|||
23608930|NCT00103857|65956419|FG005|54-Week Base Study|patient incarcerated|1|||
23608931|NCT00103857|65956420|FG006|54-Week Base Study|patient incarcerated|0|||
23608932|NCT00103857|65956414|FG000|54-Week Base Study|laboratory reporting error|0|||
23608933|NCT00103857|65956415|FG001|54-Week Base Study|laboratory reporting error|0|||
23608934|NCT00103857|65956416|FG002|54-Week Base Study|laboratory reporting error|0|||
23608935|NCT00103857|65956417|FG003|54-Week Base Study|laboratory reporting error|0|||
23608936|NCT00103857|65956418|FG004|54-Week Base Study|laboratory reporting error|1|||
23608937|NCT00103857|65956419|FG005|54-Week Base Study|laboratory reporting error|0|||
23608938|NCT00103857|65956420|FG006|54-Week Base Study|laboratory reporting error|0|||
23608939|NCT00103857|65956414|FG000|54-Week Base Study|site error|0|||
23608940|NCT00103857|65956415|FG001|54-Week Base Study|site error|0|||
23608941|NCT00103857|65956416|FG002|54-Week Base Study|site error|0|||
23608942|NCT00103857|65956417|FG003|54-Week Base Study|site error|0|||
23608943|NCT00103857|65956418|FG004|54-Week Base Study|site error|0|||
23608944|NCT00103857|65956419|FG005|54-Week Base Study|site error|1|||
23608945|NCT00103857|65956420|FG006|54-Week Base Study|site error|0|||
23608946|NCT00103857|65956414|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
23608947|NCT00103857|65956415|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608948|NCT00103857|65956416|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608949|NCT00103857|65956417|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608950|NCT00103857|65956418|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608951|NCT00103857|65956419|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608952|NCT00103857|65956420|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608953|NCT00103857|65956414|FG000|50-Week Extension Study|Adverse Event|2|||
23608954|NCT00103857|65956415|FG001|50-Week Extension Study|Adverse Event|3|||
23608955|NCT00103857|65956416|FG002|50-Week Extension Study|Adverse Event|2|||
23608956|NCT00103857|65956417|FG003|50-Week Extension Study|Adverse Event|0|||
23608957|NCT00103857|65956418|FG004|50-Week Extension Study|Adverse Event|1|||
23608958|NCT00103857|65956419|FG005|50-Week Extension Study|Adverse Event|1|||
23608959|NCT00103857|65956420|FG006|50-Week Extension Study|Adverse Event|0|||
23608960|NCT00103857|65956414|FG000|50-Week Extension Study|Death|0|||
23608961|NCT00103857|65956415|FG001|50-Week Extension Study|Death|0|||
23608962|NCT00103857|65956416|FG002|50-Week Extension Study|Death|0|||
23608963|NCT00103857|65956417|FG003|50-Week Extension Study|Death|1|||
23608964|NCT00103857|65956418|FG004|50-Week Extension Study|Death|0|||
23608965|NCT00103857|65956419|FG005|50-Week Extension Study|Death|1|||
23608966|NCT00103857|65956420|FG006|50-Week Extension Study|Death|0|||
23608967|NCT00103857|65956414|FG000|50-Week Extension Study|Lack of Efficacy|26|||
23608968|NCT00103857|65956415|FG001|50-Week Extension Study|Lack of Efficacy|15|||
23608969|NCT00103857|65956416|FG002|50-Week Extension Study|Lack of Efficacy|13|||
23608970|NCT00103857|65956417|FG003|50-Week Extension Study|Lack of Efficacy|16|||
23608971|NCT00103857|65956418|FG004|50-Week Extension Study|Lack of Efficacy|8|||
23608972|NCT00103857|65956419|FG005|50-Week Extension Study|Lack of Efficacy|8|||
23608973|NCT00103857|65956420|FG006|50-Week Extension Study|Lack of Efficacy|0|||
23608974|NCT00103857|65956414|FG000|50-Week Extension Study|Lost to Follow-up|4|||
23608975|NCT00103857|65956415|FG001|50-Week Extension Study|Lost to Follow-up|0|||
23608976|NCT00103857|65956416|FG002|50-Week Extension Study|Lost to Follow-up|1|||
23608977|NCT00103857|65956417|FG003|50-Week Extension Study|Lost to Follow-up|4|||
23608978|NCT00103857|65956418|FG004|50-Week Extension Study|Lost to Follow-up|3|||
23608979|NCT00103857|65956419|FG005|50-Week Extension Study|Lost to Follow-up|3|||
23608980|NCT00103857|65956420|FG006|50-Week Extension Study|Lost to Follow-up|0|||
23608981|NCT00103857|65956414|FG000|50-Week Extension Study|Physician Decision|0|||
23608982|NCT00103857|65956415|FG001|50-Week Extension Study|Physician Decision|1|||
23608983|NCT00103857|65956416|FG002|50-Week Extension Study|Physician Decision|1|||
23608984|NCT00103857|65956417|FG003|50-Week Extension Study|Physician Decision|0|||
23608985|NCT00103857|65956418|FG004|50-Week Extension Study|Physician Decision|0|||
23608986|NCT00103857|65956419|FG005|50-Week Extension Study|Physician Decision|0|||
23608987|NCT00103857|65956420|FG006|50-Week Extension Study|Physician Decision|0|||
23608988|NCT00103857|65956414|FG000|50-Week Extension Study|Pregnancy|0|||
23608989|NCT00103857|65956415|FG001|50-Week Extension Study|Pregnancy|0|||
23608990|NCT00103857|65956416|FG002|50-Week Extension Study|Pregnancy|1|||
23608991|NCT00103857|65956417|FG003|50-Week Extension Study|Pregnancy|0|||
23608992|NCT00103857|65956418|FG004|50-Week Extension Study|Pregnancy|1|||
23608993|NCT00103857|65956419|FG005|50-Week Extension Study|Pregnancy|0|||
23608994|NCT00103857|65956420|FG006|50-Week Extension Study|Pregnancy|0|||
23608995|NCT00103857|65956414|FG000|50-Week Extension Study|Protocol Violation|1|||
23608996|NCT00103857|65956415|FG001|50-Week Extension Study|Protocol Violation|1|||
23608997|NCT00103857|65956416|FG002|50-Week Extension Study|Protocol Violation|1|||
23608998|NCT00103857|65956417|FG003|50-Week Extension Study|Protocol Violation|2|||
23608999|NCT00103857|65956418|FG004|50-Week Extension Study|Protocol Violation|0|||
23609000|NCT00103857|65956419|FG005|50-Week Extension Study|Protocol Violation|1|||
23609001|NCT00103857|65956420|FG006|50-Week Extension Study|Protocol Violation|0|||
23609002|NCT00103857|65956414|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
23609003|NCT00103857|65956415|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
23510015|NCT00040664|65602056|FG002|Overall Study|Withdrawal by Subject|3|||
23510016|NCT00040664|65602057|FG003|Overall Study|Withdrawal by Subject|4|||
23510017|NCT00040664|65602054|FG000|Overall Study|Pregnancy|3|||
23510018|NCT00040664|65602055|FG001|Overall Study|Pregnancy|0|||
23510019|NCT00040664|65602056|FG002|Overall Study|Pregnancy|0|||
23510020|NCT00040664|65602057|FG003|Overall Study|Pregnancy|3|||
23510021|NCT00040664|65602054|FG000|Overall Study|Medication adherence/compliance problems|8|||
23510022|NCT00040664|65602055|FG001|Overall Study|Medication adherence/compliance problems|2|||
23510023|NCT00040664|65602056|FG002|Overall Study|Medication adherence/compliance problems|1|||
23510024|NCT00040664|65602057|FG003|Overall Study|Medication adherence/compliance problems|5|||
23510025|NCT00040664|65602054|FG000|Overall Study|Poor taste|2|||
23510026|NCT00040664|65602055|FG001|Overall Study|Poor taste|0|||
23510027|NCT00040664|65602056|FG002|Overall Study|Poor taste|2|||
23609004|NCT00103857|65956416|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
23609005|NCT00103857|65956417|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
23609006|NCT00103857|65956418|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
23609007|NCT00103857|65956419|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
23609008|NCT00103857|65956420|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
23609009|NCT00103857|65956414|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
23609010|NCT00103857|65956415|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
23609011|NCT00103857|65956416|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
23609012|NCT00103857|65956417|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
23609013|NCT00103857|65956418|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
23609014|NCT00103857|65956419|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
23609015|NCT00103857|65956420|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
23609016|NCT00103857|65956414|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
23609017|NCT00103857|65956415|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
23609018|NCT00103857|65956416|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
23609019|NCT00103857|65956417|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
23609020|NCT00103857|65956418|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
23609021|NCT00103857|65956419|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
23609022|NCT00103857|65956420|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
23609023|NCT00103857|65956414|FG000|50-Week Extension Study|patient moved|0|||
23609024|NCT00103857|65956415|FG001|50-Week Extension Study|patient moved|0|||
23609025|NCT00103857|65956416|FG002|50-Week Extension Study|patient moved|1|||
23609026|NCT00103857|65956417|FG003|50-Week Extension Study|patient moved|2|||
23609027|NCT00103857|65956418|FG004|50-Week Extension Study|patient moved|0|||
23609028|NCT00103857|65956419|FG005|50-Week Extension Study|patient moved|0|||
23609029|NCT00103857|65956420|FG006|50-Week Extension Study|patient moved|0|||
23609030|NCT00103857|65956414|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609031|NCT00103857|65956415|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609032|NCT00103857|65956416|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
23609033|NCT00103857|65956417|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609034|NCT00103857|65956418|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609035|NCT00103857|65956419|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609036|NCT00103857|65956420|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609037|NCT00103857|65956414|FG000|50-Week Extension Study|reason unspecified|0|||
23609038|NCT00103857|65956415|FG001|50-Week Extension Study|reason unspecified|0|||
23609039|NCT00103857|65956416|FG002|50-Week Extension Study|reason unspecified|0|||
23609040|NCT00103857|65956417|FG003|50-Week Extension Study|reason unspecified|0|||
23609041|NCT00103857|65956418|FG004|50-Week Extension Study|reason unspecified|1|||
23609042|NCT00103857|65956419|FG005|50-Week Extension Study|reason unspecified|0|||
23609043|NCT00103857|65956420|FG006|50-Week Extension Study|reason unspecified|0|||
23609044|NCT00113529|65956427|FG000|Overall Study|Adverse Event|4|||
23609045|NCT00113529|65956427|FG000|Overall Study|Lack of Efficacy|20|||
23609046|NCT00113529|65956427|FG000|Overall Study|Decision of sponsor|6|||
23609047|NCT00113529|65956427|FG000|Overall Study|Withdrawal by Subject|4|||
23609048|NCT00732498|65956428|FG000|Overall Study|Ineligible|1|||
23609049|NCT00732498|65956428|FG000|Overall Study|Adverse Event|2|||
23609050|NCT00732498|65956428|FG000|Overall Study|Physician Decision|3|||
23609051|NCT00608959|65956429|FG000|Part 1|Did not meet eligibility criteria|1|||
23609052|NCT00355784|65956430|FG000|Overall Study|Withdrawal by Subject|0|||
23609053|NCT00355784|65956431|FG001|Overall Study|Withdrawal by Subject|0|||
23609054|NCT00355784|65956432|FG002|Overall Study|Withdrawal by Subject|2|||
23609055|NCT03746015|65956433|FG000|Overall Study|Withdrawal of Consent|1|||
23609056|NCT03746015|65956434|FG001|Overall Study|Withdrawal of Consent|0|||
23609057|NCT03746015|65956435|FG002|Overall Study|Withdrawal of Consent|0|||
23510028|NCT00040664|65602057|FG003|Overall Study|Poor taste|0|||
23510029|NCT00040664|65602054|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
23609058|NCT00403845|65956438|FG000|Treatment Period 1|Subject withdrew consent|1|||
23510030|NCT00040664|65602055|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
23510031|NCT00040664|65602056|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
23510032|NCT00040664|65602057|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
23510033|NCT00040664|65602054|FG000|Overall Study|Change of formulation|2|||
23510034|NCT00040664|65602055|FG001|Overall Study|Change of formulation|2|||
23510035|NCT00040664|65602056|FG002|Overall Study|Change of formulation|0|||
23510036|NCT00040664|65602057|FG003|Overall Study|Change of formulation|0|||
23510037|NCT00040664|65602054|FG000|Overall Study|Non-viability of oral suspension|1|||
23510038|NCT00040664|65602055|FG001|Overall Study|Non-viability of oral suspension|0|||
23510039|NCT00040664|65602056|FG002|Overall Study|Non-viability of oral suspension|1|||
23510040|NCT00040664|65602057|FG003|Overall Study|Non-viability of oral suspension|0|||
23510041|NCT01402544|65602058|FG000|Overall Study|Withdrawal by Subject|6|||
23510042|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23510043|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
23510044|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510045|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510046|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510047|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510048|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510049|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510050|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510051|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510052|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510053|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
23510054|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
23510055|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23510056|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
23510057|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23510058|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23510059|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23510060|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23510061|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
23510062|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
23510063|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
23510064|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
23510065|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
23510066|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
23510067|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
23510068|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
23510069|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
23510070|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
23510071|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
23510072|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
23510073|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
23510074|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
23510075|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510076|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510077|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510078|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510079|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
23510080|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510081|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
23510082|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510083|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510084|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510085|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
23609059|NCT00403845|65956439|FG001|Treatment Period 1|Subject withdrew consent|0|||
23609060|NCT00403845|65956440|FG002|Treatment Period 1|Subject withdrew consent|0|||
23609061|NCT00403845|65956441|FG003|Treatment Period 1|Subject withdrew consent|0|||
23609062|NCT00403845|65956438|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
23609063|NCT00403845|65956439|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
23609064|NCT00403845|65956440|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
23609065|NCT00403845|65956441|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
23609066|NCT00403845|65956438|FG000|Treatment Period 2|Subject withdrew consent|1|||
23609067|NCT00403845|65956439|FG001|Treatment Period 2|Subject withdrew consent|0|||
23609068|NCT00403845|65956440|FG002|Treatment Period 2|Subject withdrew consent|0|||
23609069|NCT00403845|65956441|FG003|Treatment Period 2|Subject withdrew consent|0|||
23609070|NCT00403845|65956438|FG000|Treatment Period 3|Subject withdrew consent|0|||
23609071|NCT00403845|65956439|FG001|Treatment Period 3|Subject withdrew consent|0|||
23609072|NCT00403845|65956440|FG002|Treatment Period 3|Subject withdrew consent|0|||
23609073|NCT00403845|65956441|FG003|Treatment Period 3|Subject withdrew consent|1|||
23609074|NCT00403845|65956438|FG000|Treatment Period 3|Adverse Event|0|||
23609075|NCT00403845|65956439|FG001|Treatment Period 3|Adverse Event|0|||
23609076|NCT00403845|65956440|FG002|Treatment Period 3|Adverse Event|0|||
23609077|NCT00403845|65956441|FG003|Treatment Period 3|Adverse Event|1|||
23609078|NCT05005247|65956443|FG000|Overall Study|Withdrawal by Subject|0|||
23609079|NCT05005247|65956444|FG001|Overall Study|Withdrawal by Subject|1|||
23609080|NCT05005247|65956445|FG002|Overall Study|Withdrawal by Subject|0|||
23609081|NCT01123200|65956446|FG000|Overall Study|Withdrawal by Subject|1|||
23609082|NCT04222088|65956447|FG000|Overall Study|Lost to Follow-up|5|||
23609083|NCT04222088|65956448|FG001|Overall Study|Lost to Follow-up|1|||
23609084|NCT04222088|65956447|FG000|Overall Study|Withdrawal by Subject|4|||
23609085|NCT04222088|65956448|FG001|Overall Study|Withdrawal by Subject|0|||
23609086|NCT01156675|65956449|FG000|Overall Study|Death|5|||
23609087|NCT01156675|65956450|FG001|Overall Study|Death|3|||
23609088|NCT01156675|65956451|FG002|Overall Study|Death|0|||
23609089|NCT01156675|65956449|FG000|Overall Study|No data|29|||
23609090|NCT01156675|65956450|FG001|Overall Study|No data|22|||
23609091|NCT01156675|65956451|FG002|Overall Study|No data|2|||
23609092|NCT02010684|65956456|FG000|Overall Study|Lost to Follow-up|8|||
23609093|NCT02010684|65956457|FG001|Overall Study|Lost to Follow-up|18|||
23510086|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510087|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510088|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510089|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510090|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510091|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
23510092|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510093|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
23510094|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510095|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510096|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510097|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510098|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510099|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510100|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510101|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
23510102|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510103|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
23510104|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
23510105|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
23510106|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23609094|NCT02010684|65956456|FG000|Overall Study|Withdrawal by Subject|4|||
23609095|NCT02010684|65956457|FG001|Overall Study|Withdrawal by Subject|5|||
23609096|NCT02009865|65956458|FG000|Overall Study|Adverse Event|0|||
23609097|NCT02009865|65956459|FG001|Overall Study|Adverse Event|2|||
23609098|NCT02009865|65956458|FG000|Overall Study|Protocol Violation|0|||
23609099|NCT02009865|65956459|FG001|Overall Study|Protocol Violation|2|||
23609100|NCT02009865|65956458|FG000|Overall Study|Withdrawal by Subject|1|||
23609101|NCT02009865|65956459|FG001|Overall Study|Withdrawal by Subject|1|||
23609102|NCT01517282|65956463|FG000|Overall Study|Consent withdrawn|0|||
23609103|NCT01517282|65956464|FG001|Overall Study|Consent withdrawn|1|||
23609104|NCT01517282|65956465|FG002|Overall Study|Consent withdrawn|1|||
23609105|NCT01517282|65956466|FG003|Overall Study|Consent withdrawn|1|||
23609106|NCT01517282|65956463|FG000|Overall Study|Physician Decision|1|||
23609107|NCT01517282|65956464|FG001|Overall Study|Physician Decision|0|||
23609108|NCT01517282|65956465|FG002|Overall Study|Physician Decision|0|||
23609109|NCT01517282|65956466|FG003|Overall Study|Physician Decision|0|||
23609110|NCT00703092|65956467|FG000|Overall Study|Withdrawal by Subject|2|||
23609111|NCT00671853|65956468|FG000|Overall Study|Lack of Efficacy|3|||
23609112|NCT00671853|65956469|FG001|Overall Study|Lack of Efficacy|7|||
23609113|NCT00671853|65956468|FG000|Overall Study|Adverse Event|7|||
23609114|NCT00671853|65956469|FG001|Overall Study|Adverse Event|1|||
23609115|NCT00671853|65956468|FG000|Overall Study|Withdrawal by Subject|1|||
23609116|NCT00671853|65956469|FG001|Overall Study|Withdrawal by Subject|5|||
23609117|NCT00671853|65956468|FG000|Overall Study|Lost to Follow-up|8|||
23510107|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
23510108|NCT00590720|65602072|FG000|Overall Study|Lost to Follow-up|1|||
23510109|NCT00590720|65602073|FG001|Overall Study|Lost to Follow-up|0|||
23510110|NCT00590720|65602072|FG000|Overall Study|Withdrawal by Subject|0|||
23609118|NCT00671853|65956469|FG001|Overall Study|Lost to Follow-up|8|||
23609119|NCT00671853|65956468|FG000|Overall Study|Physician Decision|0|||
23609120|NCT00671853|65956469|FG001|Overall Study|Physician Decision|2|||
23609121|NCT00671853|65956468|FG000|Overall Study|Non-adherence with study procedures|1|||
23609122|NCT00671853|65956469|FG001|Overall Study|Non-adherence with study procedures|4|||
23609123|NCT01322386|65956470|FG000|Overall Study|Protocol Violation|0|||
23510111|NCT00590720|65602073|FG001|Overall Study|Withdrawal by Subject|1|||
23510112|NCT03364023|65602074|FG000|Overall Study|Lost to Follow-up|3|||
23510113|NCT03364023|65602074|FG000|Overall Study|Death|14|||
23510114|NCT00368355|65602075|FG000|Overall Study|Adverse Event|1|||
23510115|NCT00368355|65602076|FG001|Overall Study|Adverse Event|0|||
23510116|NCT00368355|65602075|FG000|Overall Study|Death|2|||
23510117|NCT00368355|65602076|FG001|Overall Study|Death|4|||
23510118|NCT00368355|65602075|FG000|Overall Study|Relapse|6|||
23510119|NCT00368355|65602076|FG001|Overall Study|Relapse|10|||
23510120|NCT00368355|65602075|FG000|Overall Study|Subsequent transplant|0|||
23510121|NCT00368355|65602076|FG001|Overall Study|Subsequent transplant|3|||
23510122|NCT00368355|65602075|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
23510123|NCT00368355|65602076|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
23510124|NCT00290888|65602078|FG000|Overall Study|Physician Decision|3|||
23510125|NCT00290888|65602079|FG001|Overall Study|Physician Decision|1|||
23510126|NCT00284050|65602080|FG000|Overall Study|Adverse Event|1|||
23510127|NCT00284050|65602081|FG001|Overall Study|Adverse Event|1|||
23510128|NCT00284050|65602082|FG002|Overall Study|Adverse Event|1|||
23510129|NCT00284050|65602080|FG000|Overall Study|Lack of Efficacy|0|||
23510130|NCT00284050|65602081|FG001|Overall Study|Lack of Efficacy|1|||
23510131|NCT00284050|65602082|FG002|Overall Study|Lack of Efficacy|3|||
23510132|NCT00284050|65602080|FG000|Overall Study|Protocol Violation|0|||
23510133|NCT00284050|65602081|FG001|Overall Study|Protocol Violation|1|||
23510134|NCT00284050|65602082|FG002|Overall Study|Protocol Violation|2|||
23510135|NCT00284050|65602080|FG000|Overall Study|Withdrawal by Subject|2|||
23510136|NCT00284050|65602081|FG001|Overall Study|Withdrawal by Subject|2|||
23510137|NCT00284050|65602082|FG002|Overall Study|Withdrawal by Subject|2|||
23510138|NCT00284050|65602080|FG000|Overall Study|Lost to Follow-up|1|||
23510139|NCT00284050|65602081|FG001|Overall Study|Lost to Follow-up|0|||
23510140|NCT00284050|65602082|FG002|Overall Study|Lost to Follow-up|1|||
23510141|NCT00284050|65602080|FG000|Overall Study|Death|1|||
23510142|NCT00284050|65602081|FG001|Overall Study|Death|0|||
23510143|NCT00284050|65602082|FG002|Overall Study|Death|0|||
23510144|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Death|3|||
23510145|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Death|3|||
23510146|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Death|0|||
23510147|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Death|0|||
23510148|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
23510149|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
23510150|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
23510151|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
23510152|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
23510153|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
23510154|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
23510155|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
23510156|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
23510157|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
23510158|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
23510159|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
23510160|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
23510161|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
23510162|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
23510163|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
23510164|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510165|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
23510166|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510167|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510168|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
23510169|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
23510170|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
23510171|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
23510172|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Other|6|||
23510173|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Other|3|||
23510174|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Other|0|||
23510175|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Other|0|||
23510176|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
23510177|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
23510178|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
23510179|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
23510180|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Adverse Event|0|||
23510181|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Adverse Event|0|||
23510182|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Adverse Event|6|||
23510183|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Adverse Event|8|||
23510184|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Death|0|||
23510185|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Death|0|||
23510186|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Death|7|||
23510187|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Death|4|||
23510188|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510189|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510190|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510191|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
23510192|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
23510193|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
23510194|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
23510195|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
23510196|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23510197|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23510198|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
23510199|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
23510200|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510201|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510202|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510203|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
23510204|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Physician Decision|0|||
23510205|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Physician Decision|0|||
23510206|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Physician Decision|8|||
23510207|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Physician Decision|5|||
23510208|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Other|0|||
23510209|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Other|0|||
23510210|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Other|9|||
23510211|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Other|9|||
23510212|NCT03716024|65602093|FG000|Overall Study|Randomized, not Treated|7|||
23510213|NCT03716024|65602094|FG001|Overall Study|Randomized, not Treated|8|||
23510214|NCT03716024|65602093|FG000|Overall Study|Adverse Event|1|||
23510215|NCT03716024|65602094|FG001|Overall Study|Adverse Event|2|||
23510216|NCT03716024|65602093|FG000|Overall Study|Treatment Failure|1|||
23510217|NCT03716024|65602094|FG001|Overall Study|Treatment Failure|0|||
23510218|NCT03716024|65602093|FG000|Overall Study|Lost to Follow-up|2|||
23510219|NCT03716024|65602094|FG001|Overall Study|Lost to Follow-up|6|||
23510220|NCT03716024|65602093|FG000|Overall Study|Withdrawal by Subject|0|||
23510221|NCT03716024|65602094|FG001|Overall Study|Withdrawal by Subject|1|||
23510222|NCT03716024|65602093|FG000|Overall Study|Missing Reason|0|||
23510223|NCT03716024|65602094|FG001|Overall Study|Missing Reason|1|||
23510224|NCT02385045|65605942|FG000|Overall Study|Endoscopy could not be completed|4|||
23510225|NCT00715078|65605943|FG000|Overall Study|Death|29|||
23510226|NCT00715078|65605944|FG001|Overall Study|Death|36|||
23510227|NCT00715078|65605945|FG002|Overall Study|Death|36|||
23510228|NCT00715078|65605943|FG000|Overall Study|Withdrawal by Subject|1|||
23510229|NCT00715078|65605944|FG001|Overall Study|Withdrawal by Subject|0|||
23510230|NCT00715078|65605945|FG002|Overall Study|Withdrawal by Subject|1|||
23510231|NCT00715078|65605943|FG000|Overall Study|Unable to start due to disease prog.|0|||
23510232|NCT00715078|65605944|FG001|Overall Study|Unable to start due to disease prog.|0|||
23510233|NCT00715078|65605945|FG002|Overall Study|Unable to start due to disease prog.|1|||
23510234|NCT00779467|65605946|FG000|Overall Study|Lack of Efficacy|11|||
23510235|NCT00779467|65605947|FG001|Overall Study|Lack of Efficacy|2|||
23510236|NCT00779467|65605948|FG002|Overall Study|Lack of Efficacy|6|||
23510237|NCT00779467|65605949|FG003|Overall Study|Lack of Efficacy|11|||
23510238|NCT00779467|65605946|FG000|Overall Study|failed inclusion criteria|3|||
23510239|NCT00779467|65605947|FG001|Overall Study|failed inclusion criteria|3|||
23510240|NCT00779467|65605948|FG002|Overall Study|failed inclusion criteria|1|||
23510241|NCT00779467|65605949|FG003|Overall Study|failed inclusion criteria|2|||
23510242|NCT00779467|65605946|FG000|Overall Study|missing data|1|||
23510243|NCT00779467|65605947|FG001|Overall Study|missing data|0|||
23510244|NCT00779467|65605948|FG002|Overall Study|missing data|1|||
23510245|NCT00779467|65605949|FG003|Overall Study|missing data|4|||
23510246|NCT00779467|65605946|FG000|Overall Study|technical issue|0|||
23510247|NCT00779467|65605947|FG001|Overall Study|technical issue|0|||
23510248|NCT00779467|65605948|FG002|Overall Study|technical issue|2|||
23510249|NCT00779467|65605949|FG003|Overall Study|technical issue|1|||
23510250|NCT00779467|65605946|FG000|Overall Study|unavailable research staff|0|||
23510251|NCT00779467|65605947|FG001|Overall Study|unavailable research staff|0|||
23510252|NCT00779467|65605948|FG002|Overall Study|unavailable research staff|0|||
23510253|NCT00779467|65605949|FG003|Overall Study|unavailable research staff|1|||
23510254|NCT03915496|65605959|FG000|Overall Study|Adverse Event|2|||
23510255|NCT03915496|65605960|FG001|Overall Study|Adverse Event|1|||
23510256|NCT03915496|65605961|FG002|Overall Study|Adverse Event|2|||
23510257|NCT01005745|65605962|FG000|Overall Study|No TIL growth|1|||
23510258|NCT01005745|65605962|FG000|Overall Study|Disease progressed during TIL growth|3|||
23510259|NCT01005745|65605962|FG000|Overall Study|Death prior to treatment|1|||
23510260|NCT01005745|65605962|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
23510261|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
23510262|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
23510263|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
23510264|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
23510265|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
23510266|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
23510267|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510268|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
23510269|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510270|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510271|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Death|2|||
23609124|NCT01322386|65956471|FG001|Overall Study|Protocol Violation|1|||
23609125|NCT01322386|65956470|FG000|Overall Study|Physician Decision|0|||
23609126|NCT01322386|65956471|FG001|Overall Study|Physician Decision|1|||
23609127|NCT02312258|65956472|FG000|Overall Study|Lost to Follow-up|8|||
23609128|NCT02312258|65956473|FG001|Overall Study|Lost to Follow-up|8|||
23609129|NCT02312258|65956472|FG000|Overall Study|Withdrawal by Patient|49|||
23609130|NCT02312258|65956473|FG001|Overall Study|Withdrawal by Patient|76|||
23609131|NCT02312258|65956472|FG000|Overall Study|Reason not Specified|107|||
23609132|NCT02312258|65956473|FG001|Overall Study|Reason not Specified|159|||
23609133|NCT02312258|65956472|FG000|Overall Study|Missing|2|||
23609134|NCT02312258|65956473|FG001|Overall Study|Missing|1|||
23609135|NCT02312258|65956472|FG000|Overall Study|Death|115|||
23609136|NCT02312258|65956473|FG001|Overall Study|Death|181|||
23609137|NCT01020435|65956474|FG000|Overall Study|Lost to Follow-up|0|||
23609138|NCT01020435|65956475|FG001|Overall Study|Lost to Follow-up|1|||
23609139|NCT01090739|65956476|FG000|Enrollment|Withdrawal by Subject|24|||
23609140|NCT01090739|65956476|FG000|Enrollment|Protocol Violation|14|||
23609141|NCT01090739|65956476|FG000|Enrollment|Lost to Follow-up|5|||
23609142|NCT01090739|65956476|FG000|Enrollment|Physician Decision|5|||
23609143|NCT01090739|65956476|FG000|Enrollment|Sponsor termination of site|4|||
23609144|NCT01090739|65956476|FG000|Enrollment|Study implant limit reached|2|||
23609145|NCT01090739|65956476|FG000|Enrollment|Adverse Event|1|||
23609146|NCT01090739|65956476|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
23609147|NCT01090739|65956476|FG000|12 Month Follow-up|Lost to Follow-up|1|||
23609148|NCT01090739|65956476|FG000|12 Month Follow-up|Physician Decision|1|||
23609149|NCT01090739|65956476|FG000|12 Month Follow-up|Death|1|||
23609150|NCT01090739|65956476|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
23609151|NCT01090739|65956476|FG000|24 Month Follow-up|Lost to Follow-up|1|||
23609152|NCT01090739|65956476|FG000|24 Month Follow-up|Death|1|||
23609153|NCT01090739|65956476|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
23609154|NCT01090739|65956476|FG000|36 Month Follow-up|Visit still pending|17|||
23609155|NCT02548585|65956477|FG000|Overall Study|Withdrawal by Subject|0|||
23609156|NCT02548585|65956478|FG001|Overall Study|Withdrawal by Subject|0|||
23609157|NCT02548585|65956479|FG002|Overall Study|Withdrawal by Subject|0|||
23609158|NCT02548585|65956480|FG003|Overall Study|Withdrawal by Subject|0|||
23609159|NCT02548585|65956481|FG004|Overall Study|Withdrawal by Subject|0|||
23609160|NCT02548585|65956482|FG005|Overall Study|Withdrawal by Subject|1|||
23609161|NCT02548585|65956483|FG006|Overall Study|Withdrawal by Subject|0|||
23609162|NCT02548585|65956477|FG000|Overall Study|Lost to Follow-up|1|||
23609163|NCT02548585|65956478|FG001|Overall Study|Lost to Follow-up|0|||
23609164|NCT02548585|65956479|FG002|Overall Study|Lost to Follow-up|0|||
23609165|NCT02548585|65956480|FG003|Overall Study|Lost to Follow-up|0|||
23609166|NCT02548585|65956481|FG004|Overall Study|Lost to Follow-up|0|||
23609167|NCT02548585|65956482|FG005|Overall Study|Lost to Follow-up|0|||
23609168|NCT02548585|65956483|FG006|Overall Study|Lost to Follow-up|0|||
23609169|NCT02548585|65956477|FG000|Overall Study|Other|1|||
23609170|NCT02548585|65956478|FG001|Overall Study|Other|0|||
23609171|NCT02548585|65956479|FG002|Overall Study|Other|0|||
23609172|NCT02548585|65956480|FG003|Overall Study|Other|2|||
23609173|NCT02548585|65956481|FG004|Overall Study|Other|3|||
23609174|NCT02548585|65956482|FG005|Overall Study|Other|0|||
23609175|NCT02548585|65956483|FG006|Overall Study|Other|1|||
23609176|NCT02548585|65956477|FG000|Overall Study|Randomized but not treated|0|||
23609177|NCT02548585|65956478|FG001|Overall Study|Randomized but not treated|0|||
23609178|NCT02548585|65956479|FG002|Overall Study|Randomized but not treated|0|||
23609179|NCT02548585|65956480|FG003|Overall Study|Randomized but not treated|0|||
23609180|NCT02548585|65956481|FG004|Overall Study|Randomized but not treated|0|||
23609181|NCT02548585|65956482|FG005|Overall Study|Randomized but not treated|1|||
23609182|NCT02548585|65956483|FG006|Overall Study|Randomized but not treated|0|||
23609183|NCT02279732|65956484|FG000|Overall Study|Death|23|||
23609184|NCT02279732|65956485|FG001|Overall Study|Death|20|||
23609185|NCT02279732|65956484|FG000|Overall Study|Disease Progression|13|||
23609186|NCT02279732|65956485|FG001|Overall Study|Disease Progression|3|||
23609187|NCT02279732|65956484|FG000|Overall Study|Withdrawal by Subject|2|||
23609188|NCT02279732|65956485|FG001|Overall Study|Withdrawal by Subject|7|||
23609189|NCT02279732|65956484|FG000|Overall Study|Adverse Event|1|||
23609190|NCT02279732|65956485|FG001|Overall Study|Adverse Event|2|||
23609191|NCT02279732|65956484|FG000|Overall Study|Administrative Reason By Sponsor|0|||
23609192|NCT02279732|65956485|FG001|Overall Study|Administrative Reason By Sponsor|2|||
23609193|NCT02279732|65956484|FG000|Overall Study|Study Drug Toxicity|2|||
23609194|NCT02279732|65956485|FG001|Overall Study|Study Drug Toxicity|0|||
23609195|NCT02279732|65956484|FG000|Overall Study|Lost to Follow-up|0|||
23609196|NCT02279732|65956485|FG001|Overall Study|Lost to Follow-up|1|||
23609197|NCT02279732|65956484|FG000|Overall Study|Maximum Clinical Benefit|1|||
23609198|NCT02279732|65956485|FG001|Overall Study|Maximum Clinical Benefit|0|||
23609199|NCT02279732|65956484|FG000|Overall Study|Subject Requested to Discontinue|0|||
23609200|NCT02279732|65956485|FG001|Overall Study|Subject Requested to Discontinue|1|||
23609201|NCT02279732|65956484|FG000|Overall Study|Other|53|||
23609202|NCT02279732|65956485|FG001|Overall Study|Other|67|||
23609203|NCT02279732|65956484|FG000|Overall Study|Other|3|||
23609204|NCT02279732|65956485|FG001|Overall Study|Other|3|||
23609205|NCT02598388|65956488|FG000|Overall Study|Lost to Follow-up|1|||
23609206|NCT02598388|65956489|FG001|Overall Study|Lost to Follow-up|0|||
23609207|NCT02598388|65956490|FG002|Overall Study|Lost to Follow-up|1|||
23609208|NCT02598388|65956491|FG003|Overall Study|Lost to Follow-up|0|||
23609209|NCT02598388|65956492|FG004|Overall Study|Lost to Follow-up|5|||
23609210|NCT02598388|65956493|FG005|Overall Study|Lost to Follow-up|1|||
23609211|NCT02598388|65956494|FG006|Overall Study|Lost to Follow-up|2|||
23609212|NCT02598388|65956495|FG007|Overall Study|Lost to Follow-up|1|||
23609213|NCT02598388|65956496|FG008|Overall Study|Lost to Follow-up|0|||
23609214|NCT02598388|65956497|FG009|Overall Study|Lost to Follow-up|0|||
23609215|NCT02598388|65956498|FG010|Overall Study|Lost to Follow-up|1|||
23609216|NCT02598388|65956499|FG011|Overall Study|Lost to Follow-up|0|||
23609217|NCT02598388|65956488|FG000|Overall Study|Withdrawal by Subject|0|||
23609218|NCT02598388|65956489|FG001|Overall Study|Withdrawal by Subject|0|||
23609219|NCT02598388|65956490|FG002|Overall Study|Withdrawal by Subject|0|||
23609220|NCT02598388|65956491|FG003|Overall Study|Withdrawal by Subject|0|||
23609221|NCT02598388|65956492|FG004|Overall Study|Withdrawal by Subject|2|||
23609222|NCT02598388|65956493|FG005|Overall Study|Withdrawal by Subject|0|||
23609223|NCT02598388|65956494|FG006|Overall Study|Withdrawal by Subject|2|||
23609224|NCT02598388|65956495|FG007|Overall Study|Withdrawal by Subject|0|||
23609225|NCT02598388|65956496|FG008|Overall Study|Withdrawal by Subject|0|||
23609226|NCT02598388|65956497|FG009|Overall Study|Withdrawal by Subject|1|||
23609227|NCT02598388|65956498|FG010|Overall Study|Withdrawal by Subject|0|||
23609228|NCT02598388|65956499|FG011|Overall Study|Withdrawal by Subject|0|||
23609229|NCT02598388|65956488|FG000|Overall Study|Other|0|||
23609230|NCT02598388|65956489|FG001|Overall Study|Other|0|||
23609231|NCT02598388|65956490|FG002|Overall Study|Other|1|||
23609232|NCT02598388|65956491|FG003|Overall Study|Other|0|||
23609233|NCT02598388|65956492|FG004|Overall Study|Other|3|||
23609234|NCT02598388|65956493|FG005|Overall Study|Other|0|||
23609235|NCT02598388|65956494|FG006|Overall Study|Other|1|||
23609236|NCT02598388|65956495|FG007|Overall Study|Other|0|||
23609237|NCT02598388|65956496|FG008|Overall Study|Other|0|||
23609238|NCT02598388|65956497|FG009|Overall Study|Other|0|||
23510272|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Death|1|||
23510273|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Death|4|||
23609239|NCT02598388|65956498|FG010|Overall Study|Other|0|||
23609240|NCT02598388|65956499|FG011|Overall Study|Other|0|||
23609241|NCT01102426|65956500|FG000|Overall Study|Randomized but not treated|4|||
23609242|NCT01102426|65956501|FG001|Overall Study|Randomized but not treated|1|||
23609243|NCT01102426|65956500|FG000|Overall Study|Adverse Events (treatment-related)|15|||
23609244|NCT01102426|65956501|FG001|Overall Study|Adverse Events (treatment-related)|8|||
23609245|NCT01102426|65956500|FG000|Overall Study|Physician Decision|9|||
23609246|NCT01102426|65956501|FG001|Overall Study|Physician Decision|6|||
23609247|NCT01102426|65956500|FG000|Overall Study|Progressive Disease|85|||
23510274|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Death|0|||
23510275|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Death|0|||
23609248|NCT01102426|65956501|FG001|Overall Study|Progressive Disease|44|||
23609249|NCT01102426|65956500|FG000|Overall Study|Adverse Events (unrelated to|9|||
23609250|NCT01102426|65956501|FG001|Overall Study|Adverse Events (unrelated to|1|||
23609251|NCT01102426|65956500|FG000|Overall Study|Patient Refusal|24|||
23510276|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
23609252|NCT01102426|65956501|FG001|Overall Study|Patient Refusal|12|||
23609253|NCT01102426|65956500|FG000|Overall Study|Death (due to adverse events|0|||
23609254|NCT01102426|65956501|FG001|Overall Study|Death (due to adverse events|1|||
23609255|NCT01102426|65956500|FG000|Overall Study|Death (non-related to the study|19|||
23609256|NCT01102426|65956501|FG001|Overall Study|Death (non-related to the study|8|||
23609257|NCT00603278|65956502|FG000|Overall Study|Lack of Efficacy|35|||
23609258|NCT00603278|65956503|FG001|Overall Study|Lack of Efficacy|10|||
23609259|NCT00603278|65956504|FG002|Overall Study|Lack of Efficacy|11|||
23609260|NCT00603278|65956505|FG003|Overall Study|Lack of Efficacy|8|||
23609261|NCT00603278|65956506|FG004|Overall Study|Lack of Efficacy|7|||
23609262|NCT00603278|65956507|FG005|Overall Study|Lack of Efficacy|14|||
23609263|NCT00603278|65956502|FG000|Overall Study|Adverse Event|0|||
23609264|NCT00603278|65956503|FG001|Overall Study|Adverse Event|3|||
23609265|NCT00603278|65956504|FG002|Overall Study|Adverse Event|1|||
23609266|NCT00603278|65956505|FG003|Overall Study|Adverse Event|0|||
23609267|NCT00603278|65956506|FG004|Overall Study|Adverse Event|2|||
23609268|NCT00603278|65956507|FG005|Overall Study|Adverse Event|1|||
23609269|NCT00603278|65956502|FG000|Overall Study|Withdrawal by Subject|2|||
23609270|NCT00603278|65956503|FG001|Overall Study|Withdrawal by Subject|3|||
23609271|NCT00603278|65956504|FG002|Overall Study|Withdrawal by Subject|1|||
23609272|NCT00603278|65956505|FG003|Overall Study|Withdrawal by Subject|2|||
23609273|NCT00603278|65956506|FG004|Overall Study|Withdrawal by Subject|1|||
23609274|NCT00603278|65956507|FG005|Overall Study|Withdrawal by Subject|2|||
23609275|NCT00603278|65956502|FG000|Overall Study|Protocol Violation|3|||
23609276|NCT00603278|65956503|FG001|Overall Study|Protocol Violation|0|||
23609277|NCT00603278|65956504|FG002|Overall Study|Protocol Violation|1|||
23609278|NCT00603278|65956505|FG003|Overall Study|Protocol Violation|1|||
23609279|NCT00603278|65956506|FG004|Overall Study|Protocol Violation|0|||
23609280|NCT00603278|65956507|FG005|Overall Study|Protocol Violation|1|||
23609281|NCT00603278|65956502|FG000|Overall Study|Physician Decision|0|||
23609282|NCT00603278|65956503|FG001|Overall Study|Physician Decision|1|||
23609283|NCT00603278|65956504|FG002|Overall Study|Physician Decision|0|||
23609284|NCT00603278|65956505|FG003|Overall Study|Physician Decision|0|||
23609285|NCT00603278|65956506|FG004|Overall Study|Physician Decision|2|||
23609286|NCT00603278|65956507|FG005|Overall Study|Physician Decision|1|||
23609287|NCT00603278|65956502|FG000|Overall Study|Lost to Follow-up|1|||
23609288|NCT00603278|65956503|FG001|Overall Study|Lost to Follow-up|0|||
23609289|NCT00603278|65956504|FG002|Overall Study|Lost to Follow-up|0|||
23510277|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
23510278|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
23510279|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
23510280|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
23510281|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Other Reason|1|||
23510282|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Other Reason|3|||
23510283|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Other Reason|2|||
23510284|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Other Reason|0|||
23510285|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Other Reason|0|||
23510286|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Never treated|2|||
23510287|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Never treated|3|||
23510288|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Never treated|1|||
23510289|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Never treated|0|||
23510290|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Never treated|4|||
23510291|NCT00555321|65605963|FG000|Long-term Extension Phase|Adverse Event|2|||
23510292|NCT00555321|65605964|FG001|Long-term Extension Phase|Adverse Event|5|||
23510293|NCT00555321|65605965|FG002|Long-term Extension Phase|Adverse Event|2|||
23510294|NCT00555321|65605966|FG003|Long-term Extension Phase|Adverse Event|1|||
23510295|NCT00555321|65605967|FG004|Long-term Extension Phase|Adverse Event|0|||
23510296|NCT00555321|65605963|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
23510297|NCT00555321|65605964|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
23510298|NCT00555321|65605965|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
23510299|NCT00555321|65605966|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
23510300|NCT00555321|65605967|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
23510301|NCT00555321|65605963|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
23510302|NCT00555321|65605964|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
23510303|NCT00555321|65605965|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
23510304|NCT00555321|65605966|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
23510305|NCT00555321|65605967|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
23510306|NCT00555321|65605963|FG000|Long-term Extension Phase|Death|2|||
23510307|NCT00555321|65605964|FG001|Long-term Extension Phase|Death|0|||
23510308|NCT00555321|65605965|FG002|Long-term Extension Phase|Death|0|||
23510309|NCT00555321|65605966|FG003|Long-term Extension Phase|Death|3|||
23510310|NCT00555321|65605967|FG004|Long-term Extension Phase|Death|0|||
23510311|NCT00555321|65605963|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
23510312|NCT00555321|65605964|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
23510313|NCT00555321|65605965|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
23609290|NCT00603278|65956505|FG003|Overall Study|Lost to Follow-up|0|||
23609291|NCT00603278|65956506|FG004|Overall Study|Lost to Follow-up|1|||
23609292|NCT00603278|65956507|FG005|Overall Study|Lost to Follow-up|0|||
23609293|NCT04765046|65956508|FG000|Overall Study|Screen Failure|2|||
23609294|NCT04765046|65956508|FG000|Overall Study|Withdrawal by Subject|4|||
23510314|NCT00555321|65605966|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
23609295|NCT04765046|65956508|FG000|Overall Study|Physician Decision|4|||
23609296|NCT04765046|65956508|FG000|Overall Study|Surgery Cancelled|8|||
23609297|NCT03492177|65956512|FG000|Overall Study|Adverse Event|1|||
23609298|NCT03492177|65956513|FG001|Overall Study|Adverse Event|0|||
23609299|NCT03492177|65956514|FG002|Overall Study|Adverse Event|0|||
23510315|NCT00555321|65605967|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
23510316|NCT00555321|65605963|FG000|Long-term Extension Phase|Other Reason|1|||
23510317|NCT00555321|65605964|FG001|Long-term Extension Phase|Other Reason|0|||
23510318|NCT00555321|65605965|FG002|Long-term Extension Phase|Other Reason|2|||
23510319|NCT00555321|65605966|FG003|Long-term Extension Phase|Other Reason|0|||
23510320|NCT00555321|65605967|FG004|Long-term Extension Phase|Other Reason|0|||
23510321|NCT03562481|65605968|FG000|First Intervention|Lost to Follow-up|1|||
23510322|NCT03562481|65605969|FG001|First Intervention|Lost to Follow-up|0|||
23510323|NCT01955733|65605971|FG000|Period 1|Lost to Follow-up|1|||
23510324|NCT01955733|65605972|FG001|Period 1|Lost to Follow-up|0|||
23510325|NCT01955733|65605973|FG002|Period 1|Lost to Follow-up|0|||
23510326|NCT01955733|65605971|FG000|Period 2|Adverse Event|1|||
23510327|NCT01955733|65605972|FG001|Period 2|Adverse Event|0|||
23510328|NCT01955733|65605973|FG002|Period 2|Adverse Event|0|||
23609300|NCT03492177|65956512|FG000|Overall Study|Death|3|||
23609301|NCT03492177|65956513|FG001|Overall Study|Death|0|||
23609302|NCT03492177|65956514|FG002|Overall Study|Death|3|||
23609303|NCT03492177|65956512|FG000|Overall Study|Lack of Efficacy|1|||
23609304|NCT03492177|65956513|FG001|Overall Study|Lack of Efficacy|2|||
23609305|NCT03492177|65956514|FG002|Overall Study|Lack of Efficacy|0|||
23609306|NCT03492177|65956512|FG000|Overall Study|Other|1|||
23609307|NCT03492177|65956513|FG001|Overall Study|Other|0|||
23609308|NCT03492177|65956514|FG002|Overall Study|Other|0|||
23609309|NCT03492177|65956512|FG000|Overall Study|Ongoing|16|||
23609310|NCT03492177|65956513|FG001|Overall Study|Ongoing|19|||
23609311|NCT03492177|65956514|FG002|Overall Study|Ongoing|17|||
23609312|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
23609313|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
23609314|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
23609315|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
23609316|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
23609317|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
23609318|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
23609319|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
23609320|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
23609321|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
23609322|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
23609323|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
23609324|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
23609325|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
23609326|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
23609327|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
23609328|NCT02058992|65956521|FG000|Overall Study|Lost to Follow-up|4|||
23609329|NCT02058992|65956521|FG000|Overall Study|Protocol Violation|92|||
23609330|NCT02058992|65956521|FG000|Overall Study|CRF Uncollected|20|||
23609331|NCT01697956|65956525|FG000|Overall Study|Protocol Violation|1|||
23609332|NCT01697956|65956526|FG001|Overall Study|Protocol Violation|1|||
23609333|NCT00882050|65956527|FG000|Overall Study|Physician Decision|1|||
23609334|NCT00882050|65956528|FG001|Overall Study|Physician Decision|0|||
23609335|NCT00882050|65956529|FG002|Overall Study|Physician Decision|0|||
23609336|NCT00589628|65956530|FG000|Overall Study|Lost to Follow-up|0|||
23609337|NCT00589628|65956531|FG001|Overall Study|Lost to Follow-up|1|||
23609338|NCT03070301|65956532|FG000|Overall Study|Progression of disease|16|||
23609339|NCT03070301|65956532|FG000|Overall Study|Physician Decision|3|||
23609340|NCT03070301|65956532|FG000|Overall Study|Withdrawal by Subject|1|||
23609341|NCT00460434|65959405|FG000|Overall Study|Lost to Follow-up|3|||
23609342|NCT00460434|65959406|FG001|Overall Study|Lost to Follow-up|7|||
23609343|NCT02710669|65959407|FG000|Overall Study|Physician Decision|2|||
23609344|NCT02710669|65959408|FG001|Overall Study|Physician Decision|1|||
23609345|NCT02710669|65959409|FG002|Overall Study|Physician Decision|0|||
23609346|NCT02710669|65959407|FG000|Overall Study|Institutional delays (including COVID)|2|||
23510329|NCT01955733|65605971|FG000|Period 2|Physician Decision|0|||
23510330|NCT01955733|65605972|FG001|Period 2|Physician Decision|0|||
23510331|NCT01955733|65605973|FG002|Period 2|Physician Decision|1|||
23510332|NCT01955733|65605971|FG000|Period 2|Withdrawal by Subject|1|||
23510333|NCT01955733|65605972|FG001|Period 2|Withdrawal by Subject|3|||
23609347|NCT02710669|65959408|FG001|Overall Study|Institutional delays (including COVID)|2|||
23609348|NCT02710669|65959409|FG002|Overall Study|Institutional delays (including COVID)|0|||
23609349|NCT02710669|65959407|FG000|Overall Study|arrived in afib/aflutter|10|||
23609350|NCT02710669|65959408|FG001|Overall Study|arrived in afib/aflutter|8|||
23609351|NCT02710669|65959409|FG002|Overall Study|arrived in afib/aflutter|2|||
23609352|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609353|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
23609354|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609355|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609356|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23510334|NCT01955733|65605973|FG002|Period 2|Withdrawal by Subject|2|||
23510335|NCT01955733|65605971|FG000|Period 2|Study terminated by sponsor|8|||
23510336|NCT01955733|65605972|FG001|Period 2|Study terminated by sponsor|14|||
23609357|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23609358|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
23609359|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23609360|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609361|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609362|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609363|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
23609364|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609365|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609366|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609367|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
23609368|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609369|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609370|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
23609371|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609372|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609373|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609374|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
23609375|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609376|NCT01393600|65959411|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609377|NCT01393600|65959412|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609378|NCT01393600|65959413|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
23609379|NCT01393600|65959414|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609380|NCT03166215|65959415|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
23609381|NCT03166215|65959416|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
23408570|NCT03782259|65239924|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
23609382|NCT03166215|65959417|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
23609383|NCT03166215|65959415|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
23609384|NCT03166215|65959416|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
23609385|NCT03166215|65959417|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
23609386|NCT02753075|65959419|FG000|Overall Study|Adverse Event|2|||
23609387|NCT02753075|65959420|FG001|Overall Study|Adverse Event|1|||
23609388|NCT02753075|65959421|FG002|Overall Study|Adverse Event|0|||
23609389|NCT02753075|65959419|FG000|Overall Study|Lost to Follow-up|2|||
23609390|NCT02753075|65959420|FG001|Overall Study|Lost to Follow-up|0|||
23609391|NCT02753075|65959421|FG002|Overall Study|Lost to Follow-up|0|||
23609392|NCT02753075|65959419|FG000|Overall Study|Withdrawal of Consent|1|||
23609393|NCT02753075|65959420|FG001|Overall Study|Withdrawal of Consent|1|||
23408571|NCT03782259|65239923|FG000|Overall Study|Subject discontinued intervention|1|||
23408572|NCT03782259|65239924|FG001|Overall Study|Subject discontinued intervention|0|||
23408573|NCT02100423|65239929|FG000|Overall Study|Death|1|||
23408574|NCT02100423|65239929|FG000|Overall Study|Withdrawal by Subject|3|||
23408575|NCT02100423|65239929|FG000|Overall Study|Adverse Event|1|||
23408576|NCT02100423|65239929|FG000|Overall Study|Physician Decision|1|||
23408577|NCT02141672|65239930|FG000|Overall Study|Adverse Event|0|||
23408578|NCT02141672|65239931|FG001|Overall Study|Adverse Event|1|||
23408579|NCT02141672|65239932|FG002|Overall Study|Adverse Event|0|||
23408580|NCT02141672|65239930|FG000|Overall Study|Death|10|||
23408581|NCT02141672|65239931|FG001|Overall Study|Death|2|||
23408582|NCT02141672|65239932|FG002|Overall Study|Death|1|||
23408583|NCT02141672|65239930|FG000|Overall Study|Lack of Efficacy|0|||
23408584|NCT02141672|65239931|FG001|Overall Study|Lack of Efficacy|0|||
23408585|NCT02141672|65239932|FG002|Overall Study|Lack of Efficacy|2|||
23408586|NCT02141672|65239930|FG000|Overall Study|Lost to Follow-up|1|||
23408587|NCT02141672|65239931|FG001|Overall Study|Lost to Follow-up|1|||
23408588|NCT02141672|65239932|FG002|Overall Study|Lost to Follow-up|3|||
23408589|NCT02141672|65239930|FG000|Overall Study|Physician Decision|1|||
23408590|NCT02141672|65239931|FG001|Overall Study|Physician Decision|2|||
23408591|NCT02141672|65239932|FG002|Overall Study|Physician Decision|5|||
23408592|NCT02141672|65239930|FG000|Overall Study|Protocol Violation|0|||
23609394|NCT02753075|65959421|FG002|Overall Study|Withdrawal of Consent|3|||
23408593|NCT02141672|65239931|FG001|Overall Study|Protocol Violation|0|||
23408594|NCT02141672|65239932|FG002|Overall Study|Protocol Violation|1|||
23408595|NCT02141672|65239930|FG000|Overall Study|Withdrawal by Subject|3|||
23408596|NCT02141672|65239931|FG001|Overall Study|Withdrawal by Subject|2|||
23408597|NCT02141672|65239932|FG002|Overall Study|Withdrawal by Subject|5|||
23408598|NCT02141672|65239930|FG000|Overall Study|refused to follow-up|1|||
23609395|NCT02753075|65959419|FG000|Overall Study|Physician Decision|3|||
23609396|NCT02753075|65959420|FG001|Overall Study|Physician Decision|1|||
23609397|NCT02753075|65959421|FG002|Overall Study|Physician Decision|0|||
23609398|NCT03840993|65959422|FG000|Overall Study|Adverse Event|1|||
23609399|NCT03840993|65959423|FG001|Overall Study|Adverse Event|0|||
23609400|NCT03840993|65959422|FG000|Overall Study|Lost to Follow-up|4|||
23609401|NCT03840993|65959423|FG001|Overall Study|Lost to Follow-up|0|||
23609402|NCT03840993|65959422|FG000|Overall Study|Physician Decision|0|||
23609403|NCT03840993|65959423|FG001|Overall Study|Physician Decision|1|||
23609404|NCT03840993|65959422|FG000|Overall Study|Pregnancy|0|||
23609405|NCT03840993|65959423|FG001|Overall Study|Pregnancy|1|||
23609406|NCT03840993|65959422|FG000|Overall Study|Withdrawal by Subject|1|||
23609407|NCT03840993|65959423|FG001|Overall Study|Withdrawal by Subject|3|||
23609408|NCT03840993|65959422|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
23609409|NCT03840993|65959423|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
23609410|NCT03242863|65959424|FG000|Study Week 1|Withdrawal by Subject|0|||
23609411|NCT03242863|65959425|FG001|Study Week 1|Withdrawal by Subject|1|||
23609412|NCT03242863|65959426|FG002|Study Week 1|Withdrawal by Subject|0|||
23609413|NCT03242863|65959427|FG003|Study Week 1|Withdrawal by Subject|0|||
23609414|NCT03242863|65959428|FG004|Study Week 1|Withdrawal by Subject|3|||
23609415|NCT03242863|65959429|FG005|Study Week 1|Withdrawal by Subject|0|||
23609416|NCT01944774|65959432|FG000|Overall Study|Withdrawal by Subject|2|||
23609417|NCT01944774|65959433|FG001|Overall Study|Withdrawal by Subject|3|||
23609418|NCT01944774|65959434|FG002|Overall Study|Withdrawal by Subject|3|||
23609419|NCT01944774|65959432|FG000|Overall Study|Adverse Event|3|||
23609420|NCT01944774|65959433|FG001|Overall Study|Adverse Event|2|||
23609421|NCT01944774|65959434|FG002|Overall Study|Adverse Event|3|||
23609422|NCT01944774|65959432|FG000|Overall Study|Lack of Efficacy|1|||
23609423|NCT01944774|65959433|FG001|Overall Study|Lack of Efficacy|2|||
23609424|NCT01944774|65959434|FG002|Overall Study|Lack of Efficacy|2|||
23609425|NCT01944774|65959432|FG000|Overall Study|Lost to Follow-up|0|||
23609426|NCT01944774|65959433|FG001|Overall Study|Lost to Follow-up|1|||
23609427|NCT01944774|65959434|FG002|Overall Study|Lost to Follow-up|0|||
23609428|NCT02935894|65959441|FG000|Overall Study|Subject dismissed|1|||
23510337|NCT01955733|65605973|FG002|Period 2|Study terminated by sponsor|16|||
23510338|NCT01955733|65605971|FG000|Period 2|Lost to Follow-up|2|||
23510339|NCT01955733|65605972|FG001|Period 2|Lost to Follow-up|0|||
23510340|NCT01955733|65605973|FG002|Period 2|Lost to Follow-up|0|||
23609429|NCT02109172|65959445|FG000|Overall Study|Withdrawal by Subject|1|||
23609430|NCT02109172|65959446|FG001|Overall Study|Withdrawal by Subject|0|||
23609431|NCT02109172|65959447|FG002|Overall Study|Withdrawal by Subject|0|||
23609432|NCT02109172|65959448|FG003|Overall Study|Withdrawal by Subject|1|||
23609433|NCT02109172|65959449|FG004|Overall Study|Withdrawal by Subject|0|||
23609434|NCT02109172|65959450|FG005|Overall Study|Withdrawal by Subject|0|||
23609435|NCT02109172|65959445|FG000|Overall Study|Adverse Event|0|||
23609436|NCT02109172|65959446|FG001|Overall Study|Adverse Event|0|||
23609437|NCT02109172|65959447|FG002|Overall Study|Adverse Event|1|||
23609438|NCT02109172|65959448|FG003|Overall Study|Adverse Event|0|||
23609439|NCT02109172|65959449|FG004|Overall Study|Adverse Event|0|||
23609440|NCT02109172|65959450|FG005|Overall Study|Adverse Event|1|||
23609441|NCT02109172|65959445|FG000|Overall Study|Death|0|||
23609442|NCT02109172|65959446|FG001|Overall Study|Death|0|||
23609443|NCT02109172|65959447|FG002|Overall Study|Death|0|||
23609444|NCT02109172|65959448|FG003|Overall Study|Death|0|||
23609445|NCT02109172|65959449|FG004|Overall Study|Death|1|||
23609446|NCT02109172|65959450|FG005|Overall Study|Death|0|||
23609447|NCT01528605|65959453|FG000|Overall Study|Lost to Follow-up|1|||
23609448|NCT01528605|65959454|FG001|Overall Study|Lost to Follow-up|0|||
23609449|NCT01528605|65959455|FG002|Overall Study|Lost to Follow-up|1|||
23609450|NCT01528605|65959456|FG003|Overall Study|Lost to Follow-up|1|||
23609451|NCT01528605|65959457|FG004|Overall Study|Lost to Follow-up|0|||
23609452|NCT01528605|65959458|FG005|Overall Study|Lost to Follow-up|0|||
23609453|NCT01528605|65959453|FG000|Overall Study|Death|1|||
23609454|NCT01528605|65959454|FG001|Overall Study|Death|0|||
23609455|NCT01528605|65959455|FG002|Overall Study|Death|0|||
23609456|NCT01528605|65959456|FG003|Overall Study|Death|0|||
23609457|NCT01528605|65959457|FG004|Overall Study|Death|0|||
23510341|NCT01955733|65605971|FG000|Period 2|Other not defined above|0|||
23609458|NCT01528605|65959458|FG005|Overall Study|Death|0|||
23609459|NCT02367794|65959459|FG000|Overall Study|Death|252|||
23609460|NCT02367794|65959460|FG001|Overall Study|Death|245|||
23609461|NCT02367794|65959461|FG002|Overall Study|Death|243|||
23609462|NCT02367794|65959459|FG000|Overall Study|Lost to Follow-up|1|||
23609463|NCT02367794|65959460|FG001|Overall Study|Lost to Follow-up|2|||
23609464|NCT02367794|65959461|FG002|Overall Study|Lost to Follow-up|2|||
23609465|NCT02367794|65959459|FG000|Overall Study|Physician Decision|0|||
23609466|NCT02367794|65959460|FG001|Overall Study|Physician Decision|5|||
23609467|NCT02367794|65959461|FG002|Overall Study|Physician Decision|3|||
23609468|NCT02367794|65959459|FG000|Overall Study|Protocol Violation|1|||
23609469|NCT02367794|65959460|FG001|Overall Study|Protocol Violation|0|||
23609470|NCT02367794|65959461|FG002|Overall Study|Protocol Violation|1|||
23609471|NCT02367794|65959459|FG000|Overall Study|Withdrawal by Subject|25|||
23609472|NCT02367794|65959460|FG001|Overall Study|Withdrawal by Subject|12|||
23609473|NCT02367794|65959461|FG002|Overall Study|Withdrawal by Subject|20|||
23609474|NCT02367794|65959459|FG000|Overall Study|Brain metastasis|1|||
23609475|NCT02367794|65959460|FG001|Overall Study|Brain metastasis|0|||
23609476|NCT02367794|65959461|FG002|Overall Study|Brain metastasis|0|||
23609477|NCT02367794|65959459|FG000|Overall Study|Randomized in error|0|||
23609478|NCT02367794|65959460|FG001|Overall Study|Randomized in error|0|||
23609479|NCT02367794|65959461|FG002|Overall Study|Randomized in error|1|||
23609480|NCT02367794|65959459|FG000|Overall Study|Patient unable to receive carboplatin|0|||
23510342|NCT01955733|65605972|FG001|Period 2|Other not defined above|2|||
23609481|NCT02367794|65959460|FG001|Overall Study|Patient unable to receive carboplatin|0|||
23609482|NCT02367794|65959461|FG002|Overall Study|Patient unable to receive carboplatin|1|||
23609483|NCT02367794|65959459|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
23609484|NCT02367794|65959460|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
23609485|NCT02367794|65959461|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
23609486|NCT02367794|65959459|FG000|Overall Study|Adverse Event|0|||
23609487|NCT02367794|65959460|FG001|Overall Study|Adverse Event|0|||
23609488|NCT02367794|65959461|FG002|Overall Study|Adverse Event|2|||
23609489|NCT02367794|65959459|FG000|Overall Study|Study Terminated By Sponsor|0|||
23609490|NCT02367794|65959460|FG001|Overall Study|Study Terminated By Sponsor|1|||
23609491|NCT02367794|65959461|FG002|Overall Study|Study Terminated By Sponsor|1|||
23609492|NCT02367794|65959459|FG000|Overall Study|Moved to Roll-Over Study|0|||
23609493|NCT02367794|65959460|FG001|Overall Study|Moved to Roll-Over Study|15|||
23609494|NCT02367794|65959461|FG002|Overall Study|Moved to Roll-Over Study|13|||
23609495|NCT02367794|65959459|FG000|Overall Study|Sponsor Request|60|||
23609496|NCT02367794|65959460|FG001|Overall Study|Sponsor Request|57|||
23609497|NCT02367794|65959461|FG002|Overall Study|Sponsor Request|45|||
23609498|NCT02367794|65959459|FG000|Overall Study|Moved into PTAP Study|0|||
23609499|NCT02367794|65959460|FG001|Overall Study|Moved into PTAP Study|2|||
23609500|NCT02367794|65959461|FG002|Overall Study|Moved into PTAP Study|3|||
23609501|NCT02367794|65959459|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
23609502|NCT02367794|65959460|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
23609503|NCT02367794|65959461|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
23609504|NCT02367794|65959459|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
23609505|NCT02367794|65959460|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
23609506|NCT02367794|65959461|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
23609507|NCT02367794|65959459|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
23609508|NCT02367794|65959460|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
23609509|NCT02367794|65959461|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
23609510|NCT02367794|65959459|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
23609511|NCT02367794|65959460|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
23609512|NCT02367794|65959461|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
23609513|NCT03708744|65959464|FG000|Overall Study|Withdrawal by Subject|0|||
23609514|NCT03708744|65959465|FG001|Overall Study|Withdrawal by Subject|0|||
23609515|NCT03708744|65959466|FG002|Overall Study|Withdrawal by Subject|1|||
23609516|NCT03708744|65959467|FG003|Overall Study|Withdrawal by Subject|0|||
23609517|NCT02935673|65959470|FG000|Overall Study|Adverse Event|0|||
23609518|NCT02935673|65959471|FG001|Overall Study|Adverse Event|1|||
23609519|NCT02935673|65959472|FG002|Overall Study|Adverse Event|0|||
23609520|NCT02935673|65959470|FG000|Overall Study|Withdrawal by Subject|1|||
23609521|NCT02935673|65959471|FG001|Overall Study|Withdrawal by Subject|2|||
23609522|NCT02935673|65959472|FG002|Overall Study|Withdrawal by Subject|0|||
23609523|NCT03326856|65959477|FG000|Overall Study|Lost to Follow-up|1|||
23609524|NCT03326856|65959478|FG001|Overall Study|Lost to Follow-up|1|||
23609525|NCT03326856|65959479|FG002|Overall Study|Lost to Follow-up|0|||
23609526|NCT03326856|65959480|FG003|Overall Study|Lost to Follow-up|0|||
23609527|NCT03326856|65959481|FG004|Overall Study|Lost to Follow-up|0|||
23609528|NCT01535261|65959482|FG000|Overall Study|Physician Decision|8|||
23609529|NCT01535261|65959482|FG000|Overall Study|Protocol Violation|3|||
23609530|NCT01535261|65959482|FG000|Overall Study|Death|5|||
23609531|NCT01535261|65959482|FG000|Overall Study|Lost to Follow-up|8|||
23609532|NCT01535261|65959482|FG000|Overall Study|Withdrawal by Subject|14|||
23609533|NCT01535261|65959482|FG000|Overall Study|Adverse Event|12|||
23609534|NCT01441596|65959483|FG000|Overall Study|Other reason not defined below|0|||
23609535|NCT01441596|65959484|FG001|Overall Study|Other reason not defined below|2|||
23609536|NCT01441596|65959485|FG002|Overall Study|Other reason not defined below|1|||
23609537|NCT01441596|65959483|FG000|Overall Study|Withdrawal by Subject|4|||
23609538|NCT01441596|65959484|FG001|Overall Study|Withdrawal by Subject|0|||
23609539|NCT01441596|65959485|FG002|Overall Study|Withdrawal by Subject|2|||
23609540|NCT01441596|65959483|FG000|Overall Study|Not treated|0|||
23609541|NCT01441596|65959484|FG001|Overall Study|Not treated|1|||
23609542|NCT01441596|65959485|FG002|Overall Study|Not treated|1|||
23609543|NCT02152384|65959486|FG000|Period 1|Withdrawal by Subject|0|||
23609544|NCT02152384|65959487|FG001|Period 1|Withdrawal by Subject|1|||
23609545|NCT02152384|65959486|FG000|Period 1|Adverse Event|1|||
23609546|NCT02152384|65959487|FG001|Period 1|Adverse Event|1|||
23609547|NCT00749944|65959491|FG000|Overall Study|Lost to Follow-up|2|||
23609548|NCT00749944|65959492|FG001|Overall Study|Lost to Follow-up|1|||
23609549|NCT00749944|65959491|FG000|Overall Study|Other|1|||
23609550|NCT00749944|65959492|FG001|Overall Study|Other|0|||
23609551|NCT00749944|65959491|FG000|Overall Study|Withdrawal by Subject|2|||
23609552|NCT00749944|65959492|FG001|Overall Study|Withdrawal by Subject|0|||
23609553|NCT01437540|65959493|FG000|Overall Study|Not listed below|7|||
23609554|NCT01437540|65959494|FG001|Overall Study|Not listed below|6|||
23609555|NCT01437540|65959493|FG000|Overall Study|COPD exacerbation|13|||
23609556|NCT01437540|65959494|FG001|Overall Study|COPD exacerbation|3|||
23609557|NCT01437540|65959493|FG000|Overall Study|Lost to Follow-up|3|||
23609558|NCT01437540|65959494|FG001|Overall Study|Lost to Follow-up|5|||
23510343|NCT01955733|65605973|FG002|Period 2|Other not defined above|2|||
23609559|NCT01437540|65959493|FG000|Overall Study|Lack of Efficacy|23|||
23609560|NCT01437540|65959494|FG001|Overall Study|Lack of Efficacy|11|||
23609561|NCT01437540|65959493|FG000|Overall Study|Protocol Violation|24|||
23609562|NCT01437540|65959494|FG001|Overall Study|Protocol Violation|12|||
23609563|NCT01437540|65959493|FG000|Overall Study|Adverse Event|26|||
23609564|NCT01437540|65959494|FG001|Overall Study|Adverse Event|13|||
23609565|NCT01437540|65959493|FG000|Overall Study|Withdrawal by Subject|31|||
23609566|NCT01437540|65959494|FG001|Overall Study|Withdrawal by Subject|15|||
23609567|NCT04739306|65959495|FG000|Main Study Period|Adverse Event|6|||
23609568|NCT04739306|65959496|FG001|Main Study Period|Adverse Event|7|||
23609569|NCT04739306|65959495|FG000|Main Study Period|Lost to Follow-up|4|||
23609570|NCT04739306|65959496|FG001|Main Study Period|Lost to Follow-up|6|||
23609571|NCT04739306|65959495|FG000|Main Study Period|Physician Decision|1|||
23609572|NCT04739306|65959496|FG001|Main Study Period|Physician Decision|1|||
23609573|NCT04739306|65959495|FG000|Main Study Period|Withdrawal by Subject|8|||
23609574|NCT04739306|65959496|FG001|Main Study Period|Withdrawal by Subject|6|||
23609575|NCT04739306|65959495|FG000|Main Study Period|Protocol Violation|0|||
23609576|NCT04739306|65959496|FG001|Main Study Period|Protocol Violation|1|||
23609577|NCT04739306|65959495|FG000|Main Study Period|War in Ukraine|1|||
23609578|NCT04739306|65959496|FG001|Main Study Period|War in Ukraine|1|||
23609579|NCT00134056|65959501|FG000|Randomization|Not eligible for assigned treatment|22|||
23609580|NCT00134056|65959502|FG001|Randomization|Not eligible for assigned treatment|20|||
23510344|NCT00883116|65605974|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23510345|NCT00883116|65605975|FG001|Overall Study|Adverse event unrelated to study drug|10|||
23510346|NCT00883116|65605974|FG000|Overall Study|Death|6|||
23609581|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
23609582|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
23609583|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
23609584|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
23609585|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
23609586|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
23609587|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
23609588|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
23609589|NCT02889900|65959506|FG000|Overall Study|Adverse Event|11|||
23609590|NCT02889900|65959506|FG000|Overall Study|Condition under investigation worsened|32|||
23609591|NCT02889900|65959506|FG000|Overall Study|Other|5|||
23609592|NCT02889900|65959506|FG000|Overall Study|Withdrawal by Subject|7|||
23609593|NCT02889900|65959506|FG000|Overall Study|Not treated|2|||
23609594|NCT02449902|65959507|FG000|Overall Study|Adverse Event|0|||
23609595|NCT02449902|65959508|FG001|Overall Study|Adverse Event|1|||
23609596|NCT02449902|65959507|FG000|Overall Study|Withdrawal by Subject|0|||
23609597|NCT02449902|65959508|FG001|Overall Study|Withdrawal by Subject|1|||
23609598|NCT00535626|65959509|FG000|Overall Study|Death|15|||
23609599|NCT00535626|65959509|FG000|Overall Study|Lost to Follow-up|29|||
23609600|NCT00535626|65959509|FG000|Overall Study|Withdrawal by Subject|20|||
23609601|NCT00535626|65959509|FG000|Overall Study|Removal/revision of study component|8|||
23609602|NCT00535626|65959509|FG000|Overall Study|Subject terminated|31|||
23609603|NCT00535626|65959509|FG000|Overall Study|Unable to return|2|||
23609604|NCT02203513|65959510|FG000|Overall Study|Refused further treatment|2|||
23609605|NCT02203513|65959511|FG001|Overall Study|Refused further treatment|0|||
23609606|NCT02203513|65959512|FG002|Overall Study|Refused further treatment|1|||
23609607|NCT02203513|65959513|FG003|Overall Study|Refused further treatment|0|||
23609608|NCT02203513|65959514|FG004|Overall Study|Refused further treatment|0|||
23510347|NCT00883116|65605975|FG001|Overall Study|Death|2|||
23609609|NCT02203513|65959510|FG000|Overall Study|Switched to alternative treatment|3|||
23609610|NCT02203513|65959511|FG001|Overall Study|Switched to alternative treatment|4|||
23609611|NCT02203513|65959512|FG002|Overall Study|Switched to alternative treatment|0|||
23609612|NCT02203513|65959513|FG003|Overall Study|Switched to alternative treatment|0|||
23609613|NCT02203513|65959514|FG004|Overall Study|Switched to alternative treatment|4|||
23609614|NCT02203513|65959510|FG000|Overall Study|Did not receive investigational product (IP)|0|||
23609615|NCT02203513|65959511|FG001|Overall Study|Did not receive investigational product (IP)|1|||
23609616|NCT02203513|65959512|FG002|Overall Study|Did not receive investigational product (IP)|0|||
23609617|NCT02203513|65959513|FG003|Overall Study|Did not receive investigational product (IP)|0|||
23609618|NCT02203513|65959514|FG004|Overall Study|Did not receive investigational product (IP)|0|||
23609619|NCT02203513|65959510|FG000|Overall Study|Death (unrelated to study therapy)|1|||
23609620|NCT02203513|65959511|FG001|Overall Study|Death (unrelated to study therapy)|3|||
23609621|NCT02203513|65959512|FG002|Overall Study|Death (unrelated to study therapy)|1|||
23609622|NCT02203513|65959513|FG003|Overall Study|Death (unrelated to study therapy)|0|||
23609623|NCT02203513|65959514|FG004|Overall Study|Death (unrelated to study therapy)|2|||
23609624|NCT02203513|65959510|FG000|Overall Study|Lost to Follow-up|0|||
23609625|NCT02203513|65959511|FG001|Overall Study|Lost to Follow-up|0|||
23609626|NCT02203513|65959512|FG002|Overall Study|Lost to Follow-up|1|||
23609627|NCT02203513|65959513|FG003|Overall Study|Lost to Follow-up|1|||
23609628|NCT02203513|65959514|FG004|Overall Study|Lost to Follow-up|0|||
23609629|NCT00141271|65959515|FG000|Overall Study|Adverse Event|31|||
23609630|NCT00141271|65959516|FG001|Overall Study|Adverse Event|19|||
23609631|NCT00141271|65959517|FG002|Overall Study|Adverse Event|17|||
23609632|NCT00141271|65959515|FG000|Overall Study|Laboratory Abnormality|2|||
23609633|NCT00141271|65959516|FG001|Overall Study|Laboratory Abnormality|1|||
23609634|NCT00141271|65959517|FG002|Overall Study|Laboratory Abnormality|1|||
23609635|NCT00141271|65959515|FG000|Overall Study|Lack of Efficacy|7|||
23609636|NCT00141271|65959516|FG001|Overall Study|Lack of Efficacy|7|||
23609637|NCT00141271|65959517|FG002|Overall Study|Lack of Efficacy|3|||
23609638|NCT00141271|65959515|FG000|Overall Study|Lost to Follow-up|15|||
23609639|NCT00141271|65959516|FG001|Overall Study|Lost to Follow-up|15|||
23609640|NCT00141271|65959517|FG002|Overall Study|Lost to Follow-up|21|||
23609641|NCT00141271|65959515|FG000|Overall Study|Withdrawal by Subject|14|||
23609642|NCT00141271|65959516|FG001|Overall Study|Withdrawal by Subject|9|||
23609643|NCT00141271|65959517|FG002|Overall Study|Withdrawal by Subject|10|||
23609644|NCT00141271|65959515|FG000|Overall Study|Other|11|||
23609645|NCT00141271|65959516|FG001|Overall Study|Other|12|||
23609646|NCT00141271|65959517|FG002|Overall Study|Other|5|||
23609647|NCT02256553|65959532|FG000|Period I|Adverse Event|5|||
23609648|NCT02256553|65959532|FG000|Period I|Protocol Violation|1|||
23609649|NCT02256553|65959532|FG000|Period II|Adverse Event|1|||
23609650|NCT02256553|65959532|FG000|Period II|Subject Moved|1|||
23609651|NCT02256553|65959532|FG000|Period III|Adverse Event|3|||
23609652|NCT03406507|65959534|FG000|Extension Period|Lack of Efficacy|0|||
23609653|NCT03406507|65959535|FG001|Extension Period|Lack of Efficacy|1|||
23609654|NCT00091572|65959536|FG000|Overall Study|Lost to Follow-up|1|||
23609655|NCT00091572|65959537|FG001|Overall Study|Lost to Follow-up|1|||
23609656|NCT00091572|65959536|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
23609657|NCT00091572|65959537|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
23609658|NCT00091572|65959536|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
23609659|NCT00091572|65959537|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
23609660|NCT00091572|65959536|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
23609661|NCT00091572|65959537|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
23609662|NCT00091572|65959536|FG000|Overall Study|Other Reason|6|||
23609663|NCT00091572|65959537|FG001|Overall Study|Other Reason|13|||
23609664|NCT00091572|65959536|FG000|Overall Study|Ongoing (still on treatment)|8|||
23609665|NCT00091572|65959537|FG001|Overall Study|Ongoing (still on treatment)|12|||
23609666|NCT00091572|65959536|FG000|Overall Study|Major Protocol Violation|2|||
23609667|NCT00091572|65959537|FG001|Overall Study|Major Protocol Violation|0|||
23609668|NCT00091572|65959536|FG000|Overall Study|Toxicity (Related AE)|53|||
23609669|NCT00091572|65959537|FG001|Overall Study|Toxicity (Related AE)|9|||
23609670|NCT00648895|65959538|FG000|Overall Study|Lack of Efficacy|0|||
23609671|NCT00648895|65959539|FG001|Overall Study|Lack of Efficacy|1|||
23609672|NCT01757288|65959542|FG000|Overall Study|Consent withdrawal|0|||
23609673|NCT01757288|65959543|FG001|Overall Study|Consent withdrawal|4|||
23609674|NCT01757288|65959544|FG002|Overall Study|Consent withdrawal|4|||
23609675|NCT01757288|65959542|FG000|Overall Study|Patient off study, IRB hold.|0|||
23609676|NCT01757288|65959543|FG001|Overall Study|Patient off study, IRB hold.|0|||
23609677|NCT01757288|65959544|FG002|Overall Study|Patient off study, IRB hold.|1|||
23609678|NCT01757288|65959542|FG000|Overall Study|Patient death prior to starting treatment|0|||
23609679|NCT01757288|65959543|FG001|Overall Study|Patient death prior to starting treatment|0|||
23609680|NCT01757288|65959544|FG002|Overall Study|Patient death prior to starting treatment|1|||
23609681|NCT01757288|65959542|FG000|Overall Study|Wrong medication administered|0|||
23609682|NCT01757288|65959543|FG001|Overall Study|Wrong medication administered|1|||
23609683|NCT01757288|65959544|FG002|Overall Study|Wrong medication administered|0|||
23609684|NCT01757288|65959542|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
23609685|NCT01757288|65959543|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
23609686|NCT01757288|65959544|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
23609687|NCT01757288|65959542|FG000|Overall Study|Not meeting protocol constraints|0|||
23609688|NCT01757288|65959543|FG001|Overall Study|Not meeting protocol constraints|1|||
23609689|NCT01757288|65959544|FG002|Overall Study|Not meeting protocol constraints|1|||
23609690|NCT01757288|65959542|FG000|Overall Study|Multiple missed appointments|0|||
23609691|NCT01757288|65959543|FG001|Overall Study|Multiple missed appointments|1|||
23609692|NCT01757288|65959544|FG002|Overall Study|Multiple missed appointments|0|||
23510348|NCT00883116|65605974|FG000|Overall Study|Disease progression|130|||
23609693|NCT01757288|65959542|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
23609694|NCT01757288|65959543|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
23609695|NCT01757288|65959544|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
23609696|NCT01757288|65959542|FG000|Overall Study|>2 weeks treatment break|0|||
23609697|NCT01757288|65959543|FG001|Overall Study|>2 weeks treatment break|0|||
23609698|NCT01757288|65959544|FG002|Overall Study|>2 weeks treatment break|1|||
23609699|NCT00818519|65959545|FG000|Overall Study|Adverse Event|2|||
23609700|NCT00818519|65959546|FG001|Overall Study|Adverse Event|2|||
23609701|NCT00818519|65959545|FG000|Overall Study|Lost to Follow-up|4|||
23609702|NCT00818519|65959546|FG001|Overall Study|Lost to Follow-up|6|||
23609703|NCT00818519|65959545|FG000|Overall Study|Protocol Violation|2|||
23609704|NCT00818519|65959546|FG001|Overall Study|Protocol Violation|1|||
23609705|NCT00818519|65959545|FG000|Overall Study|Pregnancy|0|||
23609706|NCT00818519|65959546|FG001|Overall Study|Pregnancy|1|||
23609707|NCT00818519|65959545|FG000|Overall Study|Withdrawal by Subject|4|||
23609708|NCT00818519|65959546|FG001|Overall Study|Withdrawal by Subject|9|||
23609709|NCT00818519|65959545|FG000|Overall Study|participant recovered completely|1|||
23609710|NCT00818519|65959546|FG001|Overall Study|participant recovered completely|0|||
23609711|NCT00818519|65959545|FG000|Overall Study|participant will leave for long tme|1|||
23609712|NCT00818519|65959546|FG001|Overall Study|participant will leave for long tme|0|||
23609713|NCT03884478|65959547|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
23609714|NCT03884478|65959548|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
23609715|NCT03884478|65959549|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
23609716|NCT03884478|65959547|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
23609717|NCT03884478|65959548|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
23609718|NCT03884478|65959549|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
23609719|NCT03884478|65959547|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
23609720|NCT03884478|65959548|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
23609721|NCT03884478|65959549|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
23609722|NCT03884478|65959547|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
23609723|NCT03884478|65959548|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
23609724|NCT03884478|65959549|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
23609725|NCT01377844|65959550|FG000|Overall Study|Withdrawal by Subject|25|||
23609726|NCT01377844|65959551|FG001|Overall Study|Withdrawal by Subject|28|||
23609727|NCT01377844|65959550|FG000|Overall Study|Protocol Violation|2|||
23609728|NCT01377844|65959551|FG001|Overall Study|Protocol Violation|3|||
23609729|NCT01377844|65959550|FG000|Overall Study|Adverse Event|3|||
23609730|NCT01377844|65959551|FG001|Overall Study|Adverse Event|0|||
23609731|NCT01377844|65959550|FG000|Overall Study|Physician Decision|6|||
23609732|NCT01377844|65959551|FG001|Overall Study|Physician Decision|3|||
23609733|NCT01377844|65959550|FG000|Overall Study|Study terminated by Sponsor|0|||
23609734|NCT01377844|65959551|FG001|Overall Study|Study terminated by Sponsor|1|||
23609735|NCT04410445|65959553|FG000|Overall Study|Lost to Follow-up|3|||
23609736|NCT04410445|65959554|FG001|Overall Study|Lost to Follow-up|9|||
23609737|NCT04410445|65959553|FG000|Overall Study|Withdrawal by Subject|27|||
23609738|NCT04410445|65959554|FG001|Overall Study|Withdrawal by Subject|15|||
23609739|NCT01468597|65959555|FG000|Overall Study|Found ineligible|17|||
23609740|NCT01468597|65959555|FG000|Overall Study|concomitant valves|12|||
23609741|NCT01468597|65959555|FG000|Overall Study|off-pump CABG|1|||
23609742|NCT01468597|65959555|FG000|Overall Study|no platelet function data|5|||
23609743|NCT04382053|65959556|FG000|Overall Study|Death|6|||
23510349|NCT00883116|65605975|FG001|Overall Study|Disease progression|128|||
23510350|NCT00883116|65605974|FG000|Overall Study|Lost to Follow-up|0|||
23510351|NCT00883116|65605975|FG001|Overall Study|Lost to Follow-up|1|||
23510352|NCT00883116|65605974|FG000|Overall Study|Maximum clinical benefit|13|||
23609744|NCT04382053|65959557|FG001|Overall Study|Death|8|||
23609745|NCT04382053|65959556|FG000|Overall Study|Lost to Follow-up|0|||
23609746|NCT04382053|65959557|FG001|Overall Study|Lost to Follow-up|2|||
23609747|NCT04382053|65959556|FG000|Overall Study|Protocol Deviation|1|||
23609748|NCT04382053|65959557|FG001|Overall Study|Protocol Deviation|2|||
23609749|NCT04382053|65959556|FG000|Overall Study|Withdrawal by Subject|2|||
23609750|NCT04382053|65959557|FG001|Overall Study|Withdrawal by Subject|1|||
23609751|NCT03349476|65959562|FG000|Overall Study|Physician Decision|3|||
23609752|NCT00316121|65959563|FG000|Overall Study|Death|1|||
23609753|NCT00316121|65959564|FG001|Overall Study|Death|0|||
23609754|NCT00316121|65959563|FG000|Overall Study|Lost to Follow-up|14|||
23609755|NCT00316121|65959564|FG001|Overall Study|Lost to Follow-up|8|||
23609756|NCT00316121|65959563|FG000|Overall Study|Withdrawal by Subject|2|||
23609757|NCT00316121|65959564|FG001|Overall Study|Withdrawal by Subject|0|||
23609758|NCT00316121|65959563|FG000|Overall Study|Reason is missing|1|||
23510353|NCT00883116|65605975|FG001|Overall Study|Maximum clinical benefit|46|||
23609759|NCT00316121|65959564|FG001|Overall Study|Reason is missing|0|||
23609760|NCT00316121|65959563|FG000|Overall Study|Subject relocated|1|||
23609761|NCT00316121|65959564|FG001|Overall Study|Subject relocated|1|||
23609762|NCT00316121|65959563|FG000|Overall Study|Subject refused to return|1|||
23609763|NCT00316121|65959564|FG001|Overall Study|Subject refused to return|0|||
23609764|NCT00316121|65959563|FG000|Overall Study|Subject no show for visit x 3|1|||
23609765|NCT00316121|65959564|FG001|Overall Study|Subject no show for visit x 3|0|||
23609766|NCT00316121|65959563|FG000|Overall Study|Subject did not have 24 month visit|1|||
23609767|NCT00316121|65959564|FG001|Overall Study|Subject did not have 24 month visit|0|||
23609768|NCT00096278|65959565|FG000|Overall Study|No follow-up data|15|||
23609769|NCT00096278|65959566|FG001|Overall Study|No follow-up data|18|||
23609770|NCT00096278|65959565|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
23609771|NCT00096278|65959566|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
23609772|NCT01543204|65959567|FG000|Overall Study|Non-compliance|1|||
23609773|NCT01543204|65959567|FG000|Overall Study|Adverse Event|1|||
23609774|NCT01543204|65959567|FG000|Overall Study|Withdrawal by Subject|4|||
23609775|NCT01543204|65959567|FG000|Overall Study|Requirement for Alternative Therapy|1|||
23609776|NCT01543204|65959567|FG000|Overall Study|Lost to Follow-up|1|||
23609777|NCT00721734|65959568|FG000|Overall Study|Progressive Disease|3|||
23609778|NCT00721734|65959569|FG001|Overall Study|Progressive Disease|10|||
23609779|NCT00721734|65959570|FG002|Overall Study|Progressive Disease|4|||
23609780|NCT00721734|65959571|FG003|Overall Study|Progressive Disease|5|||
23609781|NCT00721734|65959572|FG004|Overall Study|Progressive Disease|2|||
23609782|NCT00721734|65959568|FG000|Overall Study|Adverse Event|3|||
23609783|NCT00721734|65959569|FG001|Overall Study|Adverse Event|1|||
23609784|NCT00721734|65959570|FG002|Overall Study|Adverse Event|4|||
23609785|NCT00721734|65959571|FG003|Overall Study|Adverse Event|0|||
23609786|NCT00721734|65959572|FG004|Overall Study|Adverse Event|3|||
23609787|NCT00721734|65959568|FG000|Overall Study|Withdrawal by Subject|2|||
23609788|NCT00721734|65959569|FG001|Overall Study|Withdrawal by Subject|1|||
23609789|NCT00721734|65959570|FG002|Overall Study|Withdrawal by Subject|0|||
23609790|NCT00721734|65959571|FG003|Overall Study|Withdrawal by Subject|0|||
23609791|NCT00721734|65959572|FG004|Overall Study|Withdrawal by Subject|1|||
23609792|NCT00721734|65959568|FG000|Overall Study|Other|0|||
23609793|NCT00721734|65959569|FG001|Overall Study|Other|0|||
23609794|NCT00721734|65959570|FG002|Overall Study|Other|0|||
23609795|NCT00721734|65959571|FG003|Overall Study|Other|1|||
23609796|NCT00721734|65959572|FG004|Overall Study|Other|0|||
23609797|NCT01768572|65959573|FG000|Overall Study|Adverse Event|7|||
23609798|NCT01768572|65959574|FG001|Overall Study|Adverse Event|8|||
23609799|NCT01768572|65959575|FG002|Overall Study|Adverse Event|4|||
23609800|NCT01768572|65959573|FG000|Overall Study|Lack of Efficacy|1|||
23609801|NCT01768572|65959574|FG001|Overall Study|Lack of Efficacy|3|||
23609802|NCT01768572|65959575|FG002|Overall Study|Lack of Efficacy|1|||
23609803|NCT01768572|65959573|FG000|Overall Study|Other, Not due to an adverse event|1|||
23609804|NCT01768572|65959574|FG001|Overall Study|Other, Not due to an adverse event|1|||
23609805|NCT01768572|65959575|FG002|Overall Study|Other, Not due to an adverse event|1|||
23609806|NCT04184622|65959576|FG000|Overall Study|Adverse Event|7|||
23609807|NCT04184622|65959577|FG001|Overall Study|Adverse Event|7|||
23609808|NCT04184622|65959578|FG002|Overall Study|Adverse Event|11|||
23609809|NCT04184622|65959579|FG003|Overall Study|Adverse Event|8|||
23609810|NCT04184622|65959576|FG000|Overall Study|Death|4|||
23609811|NCT04184622|65959577|FG001|Overall Study|Death|4|||
23609812|NCT04184622|65959578|FG002|Overall Study|Death|2|||
23609813|NCT04184622|65959579|FG003|Overall Study|Death|1|||
23609814|NCT04184622|65959576|FG000|Overall Study|Lost to Follow-up|41|||
23609815|NCT04184622|65959577|FG001|Overall Study|Lost to Follow-up|19|||
23510354|NCT00883116|65605974|FG000|Overall Study|Not identified|3|||
23510355|NCT00883116|65605975|FG001|Overall Study|Not identified|6|||
23609816|NCT04184622|65959578|FG002|Overall Study|Lost to Follow-up|20|||
23609817|NCT04184622|65959579|FG003|Overall Study|Lost to Follow-up|15|||
23609818|NCT04184622|65959576|FG000|Overall Study|Missing Weight at Week 72|1|||
23510356|NCT00883116|65605974|FG000|Overall Study|Study drug toxicity|36|||
23510357|NCT00883116|65605975|FG001|Overall Study|Study drug toxicity|16|||
23510358|NCT00883116|65605974|FG000|Overall Study|Withdrawal by Subject|14|||
23510359|NCT00883116|65605975|FG001|Overall Study|Withdrawal by Subject|8|||
23510360|NCT00883116|65605974|FG000|Overall Study|No longer meets study criteria|2|||
23510361|NCT00883116|65605975|FG001|Overall Study|No longer meets study criteria|2|||
23510362|NCT03855280|65605980|FG000|Treatment Phase|Adverse Event|1|||
23510363|NCT03855280|65605980|FG000|Treatment Phase|Withdrawal by Subject|1|||
23510364|NCT03855280|65605980|FG000|Continuation Phase|Protocol Violation|1|||
23609819|NCT04184622|65959577|FG001|Overall Study|Missing Weight at Week 72|0|||
23609820|NCT04184622|65959578|FG002|Overall Study|Missing Weight at Week 72|1|||
23609821|NCT04184622|65959579|FG003|Overall Study|Missing Weight at Week 72|0|||
23609822|NCT04184622|65959576|FG000|Overall Study|Other - as reported by the investigator|22|||
23609823|NCT04184622|65959577|FG001|Overall Study|Other - as reported by the investigator|7|||
23609824|NCT04184622|65959578|FG002|Overall Study|Other - as reported by the investigator|5|||
23609825|NCT04184622|65959579|FG003|Overall Study|Other - as reported by the investigator|12|||
23609826|NCT04184622|65959576|FG000|Overall Study|Physician Decision|0|||
23609827|NCT04184622|65959577|FG001|Overall Study|Physician Decision|0|||
23609828|NCT04184622|65959578|FG002|Overall Study|Physician Decision|3|||
23609829|NCT04184622|65959579|FG003|Overall Study|Physician Decision|1|||
23510365|NCT03855280|65605980|FG000|Continuation Phase|Adverse Event|1|||
23510366|NCT03855280|65605980|FG000|Continuation Phase|Sponsor Concluded Study|1|||
23510367|NCT03049280|65605993|FG000|Overall Study|Physician Decision|1|||
23510368|NCT00166114|65605998|FG000|Overall Study|Protocol Violation|2|||
23510369|NCT00166114|65605999|FG001|Overall Study|Protocol Violation|1|||
23609830|NCT04184622|65959576|FG000|Overall Study|Pregnancy|4|||
23609831|NCT04184622|65959577|FG001|Overall Study|Pregnancy|4|||
23609832|NCT04184622|65959578|FG002|Overall Study|Pregnancy|3|||
23609833|NCT04184622|65959579|FG003|Overall Study|Pregnancy|5|||
23510370|NCT00166114|65605998|FG000|Overall Study|Withdrawal by Subject|10|||
23510371|NCT00166114|65605999|FG001|Overall Study|Withdrawal by Subject|4|||
23510372|NCT00166114|65605998|FG000|Overall Study|Adverse Event|2|||
23609834|NCT04184622|65959576|FG000|Overall Study|Protocol Deviation|1|||
23609835|NCT04184622|65959577|FG001|Overall Study|Protocol Deviation|0|||
23609836|NCT04184622|65959578|FG002|Overall Study|Protocol Deviation|0|||
23609837|NCT04184622|65959579|FG003|Overall Study|Protocol Deviation|0|||
23609838|NCT04184622|65959576|FG000|Overall Study|Withdrawal by Subject|68|||
23609839|NCT04184622|65959577|FG001|Overall Study|Withdrawal by Subject|28|||
23609840|NCT04184622|65959578|FG002|Overall Study|Withdrawal by Subject|29|||
23609841|NCT04184622|65959579|FG003|Overall Study|Withdrawal by Subject|22|||
23609842|NCT02830893|65959581|FG000|Overall Study|Relocation to out of the country|1|||
23609843|NCT02830893|65959582|FG001|Overall Study|Relocation to out of the country|0|||
23609844|NCT02830893|65959581|FG000|Overall Study|Lost to Follow-up|0|||
23609845|NCT02830893|65959582|FG001|Overall Study|Lost to Follow-up|2|||
23609846|NCT02830893|65959581|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
23609847|NCT02830893|65959582|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
23609848|NCT02708498|65959583|FG000|Overall Study|Death|20|||
23609849|NCT02708498|65959584|FG001|Overall Study|Death|19|||
23609850|NCT02708498|65959585|FG002|Overall Study|Death|0|||
23609851|NCT02708498|65959586|FG003|Overall Study|Death|0|||
23609852|NCT02708498|65959587|FG004|Overall Study|Death|1|||
23609853|NCT02708498|65959588|FG005|Overall Study|Death|0|||
23609854|NCT02708498|65959589|FG006|Overall Study|Death|0|||
23609855|NCT02708498|65959590|FG007|Overall Study|Death|0|||
23609856|NCT02708498|65959583|FG000|Overall Study|Unknown reason, missing data|0|||
23609857|NCT02708498|65959584|FG001|Overall Study|Unknown reason, missing data|0|||
23609858|NCT02708498|65959585|FG002|Overall Study|Unknown reason, missing data|62|||
23609859|NCT02708498|65959586|FG003|Overall Study|Unknown reason, missing data|51|||
23609860|NCT02708498|65959587|FG004|Overall Study|Unknown reason, missing data|195|||
23609861|NCT02708498|65959588|FG005|Overall Study|Unknown reason, missing data|132|||
23609862|NCT02708498|65959589|FG006|Overall Study|Unknown reason, missing data|0|||
23609863|NCT02708498|65959590|FG007|Overall Study|Unknown reason, missing data|0|||
23609864|NCT02865083|65959591|FG000|Overall Study|Early Termination|3|||
23609865|NCT02865083|65959592|FG001|Overall Study|Early Termination|1|||
23609866|NCT01287832|65959600|FG000|Overall Study|Adverse Event|1|||
23609867|NCT01287832|65959601|FG001|Overall Study|Adverse Event|0|||
23609868|NCT01287832|65959600|FG000|Overall Study|Death|0|||
23609869|NCT01287832|65959601|FG001|Overall Study|Death|1|||
23609870|NCT00936065|65959602|FG000|Overall Study|Adverse Event|1|||
23609871|NCT00936065|65959603|FG001|Overall Study|Adverse Event|0|||
23609872|NCT00936065|65959604|FG002|Overall Study|Adverse Event|1|||
23609873|NCT00936065|65959602|FG000|Overall Study|Lack of Efficacy|1|||
23609874|NCT00936065|65959603|FG001|Overall Study|Lack of Efficacy|0|||
23609875|NCT00936065|65959604|FG002|Overall Study|Lack of Efficacy|1|||
23609876|NCT00936065|65959602|FG000|Overall Study|Lost to Follow-up|1|||
23609877|NCT00936065|65959603|FG001|Overall Study|Lost to Follow-up|0|||
23510373|NCT00166114|65605999|FG001|Overall Study|Adverse Event|1|||
23609878|NCT00936065|65959604|FG002|Overall Study|Lost to Follow-up|0|||
23609879|NCT00936065|65959602|FG000|Overall Study|Protocol Violation|1|||
23609880|NCT00936065|65959603|FG001|Overall Study|Protocol Violation|2|||
23609881|NCT00936065|65959604|FG002|Overall Study|Protocol Violation|1|||
23609882|NCT00936065|65959602|FG000|Overall Study|Withdrawal by Subject|0|||
23609883|NCT00936065|65959603|FG001|Overall Study|Withdrawal by Subject|2|||
23609884|NCT00936065|65959604|FG002|Overall Study|Withdrawal by Subject|4|||
23609885|NCT03849300|65959610|FG000|Overall Study|move out to different area|1|||
23609886|NCT03849300|65959611|FG001|Overall Study|move out to different area|3|||
23609887|NCT03849300|65959612|FG002|Overall Study|move out to different area|1|||
23609888|NCT03849300|65959613|FG003|Overall Study|move out to different area|4|||
23609889|NCT03849300|65959610|FG000|Overall Study|scheduling/transportation conflict|4|||
23510374|NCT03194321|65606000|FG000|Overall Study|Withdrawal by Subject|1|||
23609890|NCT03849300|65959611|FG001|Overall Study|scheduling/transportation conflict|4|||
23609891|NCT03849300|65959612|FG002|Overall Study|scheduling/transportation conflict|3|||
23609892|NCT03849300|65959613|FG003|Overall Study|scheduling/transportation conflict|2|||
23609893|NCT00383500|65959614|FG000|Overall Study|Withdrawal by Subject|8|||
23609894|NCT00383500|65959615|FG001|Overall Study|Withdrawal by Subject|3|||
23609895|NCT00383500|65959616|FG002|Overall Study|Withdrawal by Subject|0|||
23609896|NCT00383500|65959614|FG000|Overall Study|Lost to Follow-up|0|||
23609897|NCT00383500|65959615|FG001|Overall Study|Lost to Follow-up|0|||
23609898|NCT00383500|65959616|FG002|Overall Study|Lost to Follow-up|2|||
23609899|NCT02547974|65959620|FG000|Overall Study|Withdrawal by Subject|1|||
23609900|NCT02547974|65959621|FG001|Overall Study|Withdrawal by Subject|0|||
23609901|NCT02547974|65959622|FG002|Overall Study|Withdrawal by Subject|0|||
23609902|NCT02547974|65959623|FG003|Overall Study|Withdrawal by Subject|0|||
23609903|NCT03823703|65959627|FG000|Overall Study|Sponsor request|0|||
23609904|NCT03823703|65959628|FG001|Overall Study|Sponsor request|3|||
23609905|NCT03823703|65959629|FG002|Overall Study|Sponsor request|4|||
23609906|NCT03823703|65959627|FG000|Overall Study|Adverse Event|3|||
23609907|NCT03823703|65959628|FG001|Overall Study|Adverse Event|1|||
23609908|NCT03823703|65959629|FG002|Overall Study|Adverse Event|0|||
23510375|NCT03194321|65606000|FG000|Overall Study|Lost to Follow-up|1|||
23510376|NCT03194321|65606000|FG000|Overall Study|Travel for Follow-up|1|||
23510377|NCT02260921|65606001|FG000|Overall Study|Adverse Event|1|||
23510378|NCT02260921|65606002|FG001|Overall Study|Adverse Event|0|||
23510379|NCT02260921|65606001|FG000|Overall Study|Lost to Follow-up|4|||
23510380|NCT02260921|65606002|FG001|Overall Study|Lost to Follow-up|3|||
23510381|NCT02260921|65606001|FG000|Overall Study|Withdraw Consent|4|||
23510382|NCT02260921|65606002|FG001|Overall Study|Withdraw Consent|1|||
23510383|NCT02260921|65606001|FG000|Overall Study|Death|1|||
23510384|NCT02260921|65606002|FG001|Overall Study|Death|0|||
23510385|NCT02260921|65606001|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
23510386|NCT02260921|65606002|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
23510387|NCT01798004|65606007|FG000|Overall Study|Death|2|||
23510388|NCT01798004|65606007|FG000|Overall Study|Lack of Efficacy|8|||
23510389|NCT01798004|65606007|FG000|Overall Study|Physician Decision|25|||
23510390|NCT01798004|65606007|FG000|Overall Study|Withdrawal by Subject|4|||
23609909|NCT03823703|65959627|FG000|Overall Study|Withdrawal by Subject|0|||
23609910|NCT03823703|65959628|FG001|Overall Study|Withdrawal by Subject|1|||
23609911|NCT03823703|65959629|FG002|Overall Study|Withdrawal by Subject|0|||
23811359|NCT02105974|66691697|FG000|2 Week Run-in Period|Adverse Event|6|||
23811360|NCT02105974|66691698|FG001|2 Week Run-in Period|Adverse Event|0|||
23811361|NCT02105974|66691699|FG002|2 Week Run-in Period|Adverse Event|0|||
23811362|NCT02105974|66691697|FG000|2 Week Run-in Period|Study closed/terminated|1|||
23811363|NCT02105974|66691698|FG001|2 Week Run-in Period|Study closed/terminated|0|||
23811364|NCT02105974|66691699|FG002|2 Week Run-in Period|Study closed/terminated|0|||
23609912|NCT01115309|65959630|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
23609913|NCT01115309|65959630|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
23811365|NCT02105974|66691697|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
23811366|NCT02105974|66691698|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
23811367|NCT02105974|66691699|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
23811368|NCT02105974|66691697|FG000|2 Week Run-in Period|Withdrew consent|23|||
23811369|NCT02105974|66691698|FG001|2 Week Run-in Period|Withdrew consent|0|||
23811370|NCT02105974|66691699|FG002|2 Week Run-in Period|Withdrew consent|0|||
23811371|NCT02105974|66691697|FG000|2 Week Run-in Period|Investigator discretion|8|||
23811372|NCT02105974|66691698|FG001|2 Week Run-in Period|Investigator discretion|0|||
23811373|NCT02105974|66691699|FG002|2 Week Run-in Period|Investigator discretion|0|||
23811374|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
23811375|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
23811376|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
23811377|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
23811378|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
23811379|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
23811380|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
23811381|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
23811382|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
23811383|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
23811384|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
23811385|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
23811386|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
23811387|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
23510391|NCT01798004|65606007|FG000|Overall Study|Ineligible|4|||
23510392|NCT01798004|65606007|FG000|Overall Study|Patient/parent refusal|7|||
23510393|NCT01798004|65606007|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
23510394|NCT01798004|65606007|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
23510395|NCT04294472|65606008|FG000|Overall Study|Adverse Event|0|||
23510396|NCT04294472|65606009|FG001|Overall Study|Adverse Event|1|||
23609914|NCT01115309|65959630|FG000|Long-term Follow-up|Lost to Follow-up|6|||
23609915|NCT00795639|65959631|FG000|Overall Study|Death|1|||
23609916|NCT00795639|65959632|FG001|Overall Study|Death|6|||
23609917|NCT00795639|65959631|FG000|Overall Study|Withdrawal by Subject|1|||
23510397|NCT04294472|65606010|FG002|Overall Study|Adverse Event|1|||
23609918|NCT00795639|65959632|FG001|Overall Study|Withdrawal by Subject|3|||
23609919|NCT00795639|65959631|FG000|Overall Study|Pregnancy|1|||
23811388|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
23811389|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
23811390|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
23811391|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
23811392|NCT02105974|66691697|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
23811393|NCT02105974|66691698|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
23811394|NCT02105974|66691699|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
23811395|NCT02944383|66691700|FG000|Overall Study|Lost to Follow-up|0|||
23811396|NCT02944383|66691701|FG001|Overall Study|Lost to Follow-up|0|||
23811397|NCT02944383|66691702|FG002|Overall Study|Lost to Follow-up|1|||
23811398|NCT02944383|66691700|FG000|Overall Study|Withdrawal by Subject|1|||
23811399|NCT02944383|66691701|FG001|Overall Study|Withdrawal by Subject|0|||
23811400|NCT02944383|66691702|FG002|Overall Study|Withdrawal by Subject|0|||
23811401|NCT03151408|66691704|FG000|Overall Study|Adverse Event|24|||
23811402|NCT03151408|66691705|FG001|Overall Study|Adverse Event|23|||
23811403|NCT03151408|66691704|FG000|Overall Study|Death|46|||
23811404|NCT03151408|66691705|FG001|Overall Study|Death|26|||
23811405|NCT03151408|66691704|FG000|Overall Study|Physician Decision|13|||
23811406|NCT03151408|66691705|FG001|Overall Study|Physician Decision|19|||
23811407|NCT03151408|66691704|FG000|Overall Study|Withdrawal by Subject|16|||
23811408|NCT03151408|66691705|FG001|Overall Study|Withdrawal by Subject|20|||
23811409|NCT03151408|66691704|FG000|Overall Study|Progressive disease|45|||
23811410|NCT03151408|66691705|FG001|Overall Study|Progressive disease|61|||
23811411|NCT03151408|66691704|FG000|Overall Study|non-compliance by patient|1|||
23811412|NCT03151408|66691705|FG001|Overall Study|non-compliance by patient|0|||
23811413|NCT03151408|66691704|FG000|Overall Study|other reasons|56|||
23811414|NCT03151408|66691705|FG001|Overall Study|other reasons|52|||
23811415|NCT03151408|66691704|FG000|Overall Study|randomized and not treated|2|||
23811416|NCT03151408|66691705|FG001|Overall Study|randomized and not treated|2|||
23811417|NCT03402750|66691713|FG000|Overall Study|Lost to Follow-up|2|||
23811418|NCT03402750|66691714|FG001|Overall Study|Lost to Follow-up|1|||
23811419|NCT02655666|66691715|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
23811420|NCT00085423|66691716|FG000|Overall Study|Withdrawal by Subject|1|||
23811421|NCT00085423|66691716|FG000|Overall Study|screen failure|1|||
23811422|NCT01675661|66691717|FG000|Overall Study|Lost to Follow-up|22|||
23811423|NCT01675661|66691718|FG001|Overall Study|Lost to Follow-up|23|||
23811424|NCT01675661|66691717|FG000|Overall Study|Practical problems|9|||
23811425|NCT01675661|66691718|FG001|Overall Study|Practical problems|5|||
23811426|NCT01675661|66691717|FG000|Overall Study|Moved away|5|||
23811427|NCT01675661|66691718|FG001|Overall Study|Moved away|6|||
23811428|NCT01675661|66691717|FG000|Overall Study|Withdrawal by Subject|3|||
23811429|NCT01675661|66691718|FG001|Overall Study|Withdrawal by Subject|7|||
23811430|NCT01675661|66691717|FG000|Overall Study|Physician Decision|0|||
23811431|NCT01675661|66691718|FG001|Overall Study|Physician Decision|2|||
23811432|NCT01675661|66691717|FG000|Overall Study|Death|0|||
23811433|NCT01675661|66691718|FG001|Overall Study|Death|1|||
23811434|NCT01675661|66691717|FG000|Overall Study|Other reason|1|||
23811435|NCT01675661|66691718|FG001|Overall Study|Other reason|2|||
23811436|NCT02038907|66691719|FG000|Overall Study|Protocol Violation|0|||
23811437|NCT02038907|66691720|FG001|Overall Study|Protocol Violation|0|||
23811438|NCT02038907|66691721|FG002|Overall Study|Protocol Violation|0|||
23811439|NCT02038907|66691722|FG003|Overall Study|Protocol Violation|0|||
23811440|NCT02038907|66691723|FG004|Overall Study|Protocol Violation|0|||
23811441|NCT02038907|66691724|FG005|Overall Study|Protocol Violation|0|||
23811442|NCT02038907|66691725|FG006|Overall Study|Protocol Violation|0|||
23811443|NCT02038907|66691726|FG007|Overall Study|Protocol Violation|0|||
23811444|NCT02038907|66691727|FG008|Overall Study|Protocol Violation|0|||
23811445|NCT02038907|66691728|FG009|Overall Study|Protocol Violation|0|||
23811446|NCT02038907|66691729|FG010|Overall Study|Protocol Violation|1|||
23609920|NCT00795639|65959632|FG001|Overall Study|Pregnancy|0|||
23609921|NCT00795639|65959631|FG000|Overall Study|Adverse Event|5|||
23609922|NCT00795639|65959632|FG001|Overall Study|Adverse Event|2|||
23609923|NCT00795639|65959631|FG000|Overall Study|Other|0|||
23609924|NCT00795639|65959632|FG001|Overall Study|Other|2|||
23609925|NCT00795639|65959631|FG000|Overall Study|Terminated by sponsor|13|||
23609926|NCT00795639|65959632|FG001|Overall Study|Terminated by sponsor|12|||
23609927|NCT00795639|65959631|FG000|Overall Study|Randomized and not treated|0|||
23609928|NCT00795639|65959632|FG001|Overall Study|Randomized and not treated|1|||
23609929|NCT00853957|65959633|FG000|Overall Study|Adverse Event|9|||
23609930|NCT00853957|65959634|FG001|Overall Study|Adverse Event|3|||
23811447|NCT02038907|66691730|FG011|Overall Study|Protocol Violation|0|||
23811448|NCT02038907|66691731|FG012|Overall Study|Protocol Violation|0|||
23811449|NCT02038907|66691732|FG013|Overall Study|Protocol Violation|0|||
23811450|NCT02038907|66691719|FG000|Overall Study|Withdrawal by Subject|0|||
23811451|NCT02038907|66691720|FG001|Overall Study|Withdrawal by Subject|0|||
23811452|NCT02038907|66691721|FG002|Overall Study|Withdrawal by Subject|0|||
23811453|NCT02038907|66691722|FG003|Overall Study|Withdrawal by Subject|0|||
23609931|NCT00853957|65959633|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23609932|NCT00853957|65959634|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23609933|NCT00853957|65959633|FG000|Overall Study|Subject withdrew consent|4|||
23609934|NCT00853957|65959634|FG001|Overall Study|Subject withdrew consent|5|||
23811454|NCT02038907|66691723|FG004|Overall Study|Withdrawal by Subject|0|||
23811455|NCT02038907|66691724|FG005|Overall Study|Withdrawal by Subject|0|||
23609935|NCT00853957|65959633|FG000|Overall Study|Lost to Follow-up|1|||
23811456|NCT02038907|66691725|FG006|Overall Study|Withdrawal by Subject|0|||
23408599|NCT02141672|65239931|FG001|Overall Study|refused to follow-up|0|||
23609936|NCT00853957|65959634|FG001|Overall Study|Lost to Follow-up|6|||
23609937|NCT00853957|65959633|FG000|Overall Study|Protocol deviation|0|||
23609938|NCT00853957|65959634|FG001|Overall Study|Protocol deviation|3|||
23609939|NCT00267865|65959635|FG000|Induction Treatment|Died before completing.|2|||
23609940|NCT00267865|65959635|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
23609941|NCT01261793|65959638|FG000|Overall Study|Lack of Efficacy|44|||
23609942|NCT01261793|65959639|FG001|Overall Study|Lack of Efficacy|37|||
23609943|NCT01261793|65959640|FG002|Overall Study|Lack of Efficacy|32|||
23609944|NCT01261793|65959638|FG000|Overall Study|Protocol Violation|3|||
23609945|NCT01261793|65959639|FG001|Overall Study|Protocol Violation|5|||
23609946|NCT01261793|65959640|FG002|Overall Study|Protocol Violation|6|||
23609947|NCT01261793|65959638|FG000|Overall Study|Lost to Follow-up|10|||
23708481|NCT02175771|66308866|FG005|Run-In Period (Pre-assignment)|Other|0|||
23708482|NCT02175771|66308867|FG006|Run-In Period (Pre-assignment)|Other|0|||
23708483|NCT02175771|66308868|FG007|Run-In Period (Pre-assignment)|Other|0|||
23708484|NCT02175771|66308869|FG008|Run-In Period (Pre-assignment)|Other|0|||
23708485|NCT02175771|66308861|FG000|Treatment Period|Adverse Event|0|||
23708486|NCT02175771|66308862|FG001|Treatment Period|Adverse Event|2|||
23708487|NCT02175771|66308863|FG002|Treatment Period|Adverse Event|1|||
23708488|NCT02175771|66308864|FG003|Treatment Period|Adverse Event|1|||
23708489|NCT02175771|66308865|FG004|Treatment Period|Adverse Event|1|||
23708490|NCT02175771|66308866|FG005|Treatment Period|Adverse Event|3|||
23708491|NCT02175771|66308867|FG006|Treatment Period|Adverse Event|2|||
23708492|NCT02175771|66308868|FG007|Treatment Period|Adverse Event|0|||
23708493|NCT02175771|66308869|FG008|Treatment Period|Adverse Event|1|||
23708494|NCT02175771|66308861|FG000|Treatment Period|Withdrawal by Subject|0|||
23708495|NCT02175771|66308862|FG001|Treatment Period|Withdrawal by Subject|9|||
23708496|NCT02175771|66308863|FG002|Treatment Period|Withdrawal by Subject|3|||
23708497|NCT02175771|66308864|FG003|Treatment Period|Withdrawal by Subject|6|||
23510398|NCT04294472|65606008|FG000|Overall Study|Randomized but not treated|0|||
23708498|NCT02175771|66308865|FG004|Treatment Period|Withdrawal by Subject|2|||
23708499|NCT02175771|66308866|FG005|Treatment Period|Withdrawal by Subject|4|||
23708500|NCT02175771|66308867|FG006|Treatment Period|Withdrawal by Subject|2|||
23708501|NCT02175771|66308868|FG007|Treatment Period|Withdrawal by Subject|9|||
23708502|NCT02175771|66308869|FG008|Treatment Period|Withdrawal by Subject|2|||
23708503|NCT02175771|66308861|FG000|Treatment Period|Noncompliance|0|||
23708504|NCT02175771|66308862|FG001|Treatment Period|Noncompliance|1|||
23708505|NCT02175771|66308863|FG002|Treatment Period|Noncompliance|2|||
23708506|NCT02175771|66308864|FG003|Treatment Period|Noncompliance|0|||
23708507|NCT02175771|66308865|FG004|Treatment Period|Noncompliance|0|||
23708508|NCT02175771|66308866|FG005|Treatment Period|Noncompliance|0|||
23708509|NCT02175771|66308867|FG006|Treatment Period|Noncompliance|0|||
23708510|NCT02175771|66308868|FG007|Treatment Period|Noncompliance|0|||
23708511|NCT02175771|66308869|FG008|Treatment Period|Noncompliance|1|||
23708512|NCT02175771|66308861|FG000|Treatment Period|Protocol Violation|0|||
23708513|NCT02175771|66308862|FG001|Treatment Period|Protocol Violation|0|||
23708514|NCT02175771|66308863|FG002|Treatment Period|Protocol Violation|0|||
23708515|NCT02175771|66308864|FG003|Treatment Period|Protocol Violation|0|||
23708516|NCT02175771|66308865|FG004|Treatment Period|Protocol Violation|0|||
23708517|NCT02175771|66308866|FG005|Treatment Period|Protocol Violation|0|||
23708518|NCT02175771|66308867|FG006|Treatment Period|Protocol Violation|0|||
23708519|NCT02175771|66308868|FG007|Treatment Period|Protocol Violation|1|||
23708520|NCT02175771|66308869|FG008|Treatment Period|Protocol Violation|0|||
23708521|NCT02175771|66308861|FG000|Treatment Period|Disease progression|0|||
23708522|NCT02175771|66308862|FG001|Treatment Period|Disease progression|0|||
23708523|NCT02175771|66308863|FG002|Treatment Period|Disease progression|0|||
23708524|NCT02175771|66308864|FG003|Treatment Period|Disease progression|0|||
23708525|NCT02175771|66308865|FG004|Treatment Period|Disease progression|0|||
23708526|NCT02175771|66308866|FG005|Treatment Period|Disease progression|0|||
23708527|NCT02175771|66308867|FG006|Treatment Period|Disease progression|0|||
23708528|NCT02175771|66308868|FG007|Treatment Period|Disease progression|2|||
23708529|NCT02175771|66308869|FG008|Treatment Period|Disease progression|0|||
23510399|NCT04294472|65606009|FG001|Overall Study|Randomized but not treated|1|||
23510400|NCT04294472|65606010|FG002|Overall Study|Randomized but not treated|1|||
23609948|NCT01261793|65959639|FG001|Overall Study|Lost to Follow-up|3|||
23609949|NCT01261793|65959640|FG002|Overall Study|Lost to Follow-up|7|||
23609950|NCT01261793|65959638|FG000|Overall Study|Withdrawal by Subject|12|||
23609951|NCT01261793|65959639|FG001|Overall Study|Withdrawal by Subject|14|||
23708530|NCT02175771|66308861|FG000|Treatment Period|Lost to Follow-up|0|||
23609952|NCT01261793|65959640|FG002|Overall Study|Withdrawal by Subject|14|||
23609953|NCT01261793|65959638|FG000|Overall Study|Death|3|||
23609954|NCT01261793|65959639|FG001|Overall Study|Death|1|||
23609955|NCT01261793|65959640|FG002|Overall Study|Death|0|||
23609956|NCT01261793|65959638|FG000|Overall Study|Adverse Event|9|||
23609957|NCT01261793|65959639|FG001|Overall Study|Adverse Event|24|||
23708531|NCT02175771|66308862|FG001|Treatment Period|Lost to Follow-up|3|||
23708532|NCT02175771|66308863|FG002|Treatment Period|Lost to Follow-up|1|||
23708533|NCT02175771|66308864|FG003|Treatment Period|Lost to Follow-up|3|||
23708534|NCT02175771|66308865|FG004|Treatment Period|Lost to Follow-up|1|||
23708535|NCT02175771|66308866|FG005|Treatment Period|Lost to Follow-up|2|||
23708536|NCT02175771|66308867|FG006|Treatment Period|Lost to Follow-up|1|||
23708537|NCT02175771|66308868|FG007|Treatment Period|Lost to Follow-up|2|||
23510401|NCT00617123|65606011|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
23609958|NCT01261793|65959640|FG002|Overall Study|Adverse Event|19|||
23609959|NCT01261793|65959638|FG000|Overall Study|Patient non-availability|1|||
23609960|NCT01261793|65959639|FG001|Overall Study|Patient non-availability|1|||
23609961|NCT01261793|65959640|FG002|Overall Study|Patient non-availability|1|||
23609962|NCT01261793|65959638|FG000|Overall Study|Suspected pregnancy|1|||
23609963|NCT01261793|65959639|FG001|Overall Study|Suspected pregnancy|1|||
23609964|NCT01261793|65959640|FG002|Overall Study|Suspected pregnancy|0|||
23609965|NCT01261793|65959638|FG000|Overall Study|Patient non-compliance|1|||
23609966|NCT01261793|65959639|FG001|Overall Study|Patient non-compliance|0|||
23609967|NCT01261793|65959640|FG002|Overall Study|Patient non-compliance|1|||
23609968|NCT01261793|65959638|FG000|Overall Study|Patient pregnant|1|||
23609969|NCT01261793|65959639|FG001|Overall Study|Patient pregnant|0|||
23609970|NCT01261793|65959640|FG002|Overall Study|Patient pregnant|0|||
23609971|NCT01261793|65959638|FG000|Overall Study|Outside the study area|0|||
23609972|NCT01261793|65959639|FG001|Overall Study|Outside the study area|2|||
23609973|NCT01261793|65959640|FG002|Overall Study|Outside the study area|1|||
23609974|NCT01261793|65959638|FG000|Overall Study|Lack of efficacy & patient not available|0|||
23609975|NCT01261793|65959639|FG001|Overall Study|Lack of efficacy & patient not available|1|||
23609976|NCT01261793|65959640|FG002|Overall Study|Lack of efficacy & patient not available|0|||
23609977|NCT01261793|65959638|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
23609978|NCT01261793|65959639|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
23609979|NCT01261793|65959640|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
23609980|NCT01261793|65959638|FG000|Overall Study|Randomization error|0|||
23609981|NCT01261793|65959639|FG001|Overall Study|Randomization error|1|||
23609982|NCT01261793|65959640|FG002|Overall Study|Randomization error|0|||
23609983|NCT01261793|65959638|FG000|Overall Study|Patient unable to start IV line|0|||
23609984|NCT01261793|65959639|FG001|Overall Study|Patient unable to start IV line|0|||
23609985|NCT01261793|65959640|FG002|Overall Study|Patient unable to start IV line|1|||
23609986|NCT00529529|65959641|FG000|Overall Study|Adverse Event|12|||
23609987|NCT00529529|65959642|FG001|Overall Study|Adverse Event|17|||
23609988|NCT00529529|65959643|FG002|Overall Study|Adverse Event|8|||
23609989|NCT00529529|65959641|FG000|Overall Study|Subject withdrew consent|12|||
23609990|NCT00529529|65959642|FG001|Overall Study|Subject withdrew consent|9|||
23609991|NCT00529529|65959643|FG002|Overall Study|Subject withdrew consent|12|||
23609992|NCT00529529|65959641|FG000|Overall Study|Protocol deviation|8|||
23609993|NCT00529529|65959642|FG001|Overall Study|Protocol deviation|12|||
23609994|NCT00529529|65959643|FG002|Overall Study|Protocol deviation|5|||
23609995|NCT00529529|65959641|FG000|Overall Study|Lost to Follow-up|5|||
23609996|NCT00529529|65959642|FG001|Overall Study|Lost to Follow-up|3|||
23609997|NCT00529529|65959643|FG002|Overall Study|Lost to Follow-up|1|||
23609998|NCT00529529|65959641|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23609999|NCT00529529|65959642|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23610000|NCT00529529|65959643|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23610001|NCT00529529|65959641|FG000|Overall Study|Death|2|||
23610002|NCT00529529|65959642|FG001|Overall Study|Death|0|||
23610003|NCT00529529|65959643|FG002|Overall Study|Death|0|||
23510402|NCT00617123|65606012|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
23610004|NCT00529529|65959641|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23610005|NCT00529529|65959642|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23610006|NCT00529529|65959643|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23610007|NCT00529529|65959641|FG000|Overall Study|Administrative problems|1|||
23610008|NCT00529529|65959642|FG001|Overall Study|Administrative problems|0|||
23610009|NCT00529529|65959643|FG002|Overall Study|Administrative problems|3|||
23610010|NCT03060525|65959646|FG000|Overall Study|moved out of state|1|||
23510403|NCT00617123|65606011|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
23510404|NCT00617123|65606012|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
23510405|NCT00617123|65606011|FG000|Referral Screening Period|Adverse Event|0|||
23510406|NCT00617123|65606012|FG001|Referral Screening Period|Adverse Event|1|||
23510407|NCT00617123|65606011|FG000|Study Treatment Period|Withdrawal by Subject|8|||
23510408|NCT00617123|65606012|FG001|Study Treatment Period|Withdrawal by Subject|12|||
23510409|NCT00617123|65606011|FG000|Study Treatment Period|Adverse Event|7|||
23610011|NCT03060525|65959647|FG001|Overall Study|moved out of state|1|||
23610012|NCT03060525|65959648|FG002|Overall Study|moved out of state|1|||
23610013|NCT03060525|65959649|FG003|Overall Study|moved out of state|1|||
23610014|NCT03060525|65959646|FG000|Overall Study|unable to meet time commitment required of study|2|||
23610015|NCT03060525|65959647|FG001|Overall Study|unable to meet time commitment required of study|3|||
23610016|NCT03060525|65959648|FG002|Overall Study|unable to meet time commitment required of study|3|||
23610017|NCT03060525|65959649|FG003|Overall Study|unable to meet time commitment required of study|1|||
23610018|NCT03060525|65959646|FG000|Overall Study|no longer interested in doing intervention|0|||
23610019|NCT03060525|65959647|FG001|Overall Study|no longer interested in doing intervention|0|||
23610020|NCT03060525|65959648|FG002|Overall Study|no longer interested in doing intervention|0|||
23610021|NCT03060525|65959649|FG003|Overall Study|no longer interested in doing intervention|1|||
23610022|NCT00742560|65959650|FG000|Overall Study|Adverse Event|0|||
23610023|NCT00742560|65959651|FG001|Overall Study|Adverse Event|0|||
23610024|NCT00742560|65959652|FG002|Overall Study|Adverse Event|1|||
23610025|NCT00742560|65959653|FG003|Overall Study|Adverse Event|1|||
23610026|NCT00742560|65959654|FG004|Overall Study|Adverse Event|1|||
23610027|NCT00742560|65959650|FG000|Overall Study|Death|0|||
23610028|NCT00742560|65959651|FG001|Overall Study|Death|2|||
23610029|NCT00742560|65959652|FG002|Overall Study|Death|0|||
23610030|NCT00742560|65959653|FG003|Overall Study|Death|2|||
23610031|NCT00742560|65959654|FG004|Overall Study|Death|3|||
23610032|NCT00742560|65959650|FG000|Overall Study|Subject's Decision|1|||
23510410|NCT00617123|65606012|FG001|Study Treatment Period|Adverse Event|3|||
23510411|NCT00617123|65606011|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
23610033|NCT00742560|65959651|FG001|Overall Study|Subject's Decision|0|||
23708538|NCT02175771|66308869|FG008|Treatment Period|Lost to Follow-up|2|||
23610034|NCT00742560|65959652|FG002|Overall Study|Subject's Decision|2|||
23610035|NCT00742560|65959653|FG003|Overall Study|Subject's Decision|3|||
23708539|NCT02175771|66308861|FG000|Treatment Period|Lack of Efficacy|0|||
23708540|NCT02175771|66308862|FG001|Treatment Period|Lack of Efficacy|0|||
23708541|NCT02175771|66308863|FG002|Treatment Period|Lack of Efficacy|0|||
23708542|NCT02175771|66308864|FG003|Treatment Period|Lack of Efficacy|0|||
23708543|NCT02175771|66308865|FG004|Treatment Period|Lack of Efficacy|0|||
23708544|NCT02175771|66308866|FG005|Treatment Period|Lack of Efficacy|1|||
23708545|NCT02175771|66308867|FG006|Treatment Period|Lack of Efficacy|0|||
23708546|NCT02175771|66308868|FG007|Treatment Period|Lack of Efficacy|1|||
23708547|NCT02175771|66308869|FG008|Treatment Period|Lack of Efficacy|0|||
23708548|NCT02175771|66308861|FG000|Treatment Period|Other|0|||
23708549|NCT02175771|66308862|FG001|Treatment Period|Other|1|||
23708550|NCT02175771|66308863|FG002|Treatment Period|Other|0|||
23708551|NCT02175771|66308864|FG003|Treatment Period|Other|3|||
23708552|NCT02175771|66308865|FG004|Treatment Period|Other|1|||
23708553|NCT02175771|66308866|FG005|Treatment Period|Other|0|||
23708554|NCT02175771|66308867|FG006|Treatment Period|Other|0|||
23708555|NCT02175771|66308868|FG007|Treatment Period|Other|2|||
23708556|NCT02175771|66308869|FG008|Treatment Period|Other|0|||
23708557|NCT01201798|66308870|FG000|Overall Study|Adverse Event|2|||
23708558|NCT01201798|66308871|FG001|Overall Study|Adverse Event|0|||
23708559|NCT01201798|66308870|FG000|Overall Study|Lost to Follow-up|3|||
23708560|NCT01201798|66308871|FG001|Overall Study|Lost to Follow-up|5|||
23708561|NCT01201798|66308870|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
23708562|NCT01201798|66308871|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
23708563|NCT01201798|66308870|FG000|Overall Study|Noncompliance|1|||
23708564|NCT01201798|66308871|FG001|Overall Study|Noncompliance|0|||
23708565|NCT01201798|66308870|FG000|Overall Study|Protocol Violation|1|||
23708566|NCT01201798|66308871|FG001|Overall Study|Protocol Violation|1|||
23708567|NCT01201798|66308870|FG000|Overall Study|Treatment Failure|1|||
23708568|NCT01201798|66308871|FG001|Overall Study|Treatment Failure|8|||
23708569|NCT00578864|66308875|FG000|Overall Study|Death|1|||
23708570|NCT00578864|66308876|FG001|Overall Study|Death|0|||
23708571|NCT02678741|66308877|FG000|Overall Study|Death|4|||
23708572|NCT02678741|66308877|FG000|Overall Study|Withdrawal by Subject|1|||
23708573|NCT02678741|66308877|FG000|Overall Study|ineligible|3|||
23708574|NCT02678741|66308877|FG000|Overall Study|Not RECIST Measurable|2|||
23708575|NCT02678741|66308877|FG000|Overall Study|Lack of Efficacy|10|||
23708576|NCT00995345|66308879|FG000|Overall Study|Withdrawal by Subject|4|||
23708577|NCT00995345|66308880|FG001|Overall Study|Withdrawal by Subject|2|||
23708578|NCT00995345|66308881|FG002|Overall Study|Withdrawal by Subject|1|||
23510412|NCT00617123|65606012|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
23708579|NCT00995345|66308882|FG003|Overall Study|Withdrawal by Subject|3|||
23708580|NCT00995345|66308883|FG004|Overall Study|Withdrawal by Subject|1|||
23708581|NCT00995345|66308879|FG000|Overall Study|Adverse Event|3|||
23708582|NCT00995345|66308880|FG001|Overall Study|Adverse Event|1|||
23708583|NCT00995345|66308881|FG002|Overall Study|Adverse Event|2|||
23610036|NCT00742560|65959654|FG004|Overall Study|Subject's Decision|3|||
23610037|NCT00742560|65959650|FG000|Overall Study|Investigator's Decision|0|||
23708584|NCT00995345|66308882|FG003|Overall Study|Adverse Event|0|||
23708585|NCT00995345|66308883|FG004|Overall Study|Adverse Event|1|||
23708586|NCT00995345|66308879|FG000|Overall Study|Lost to Follow-up|2|||
23610038|NCT00742560|65959651|FG001|Overall Study|Investigator's Decision|0|||
23610039|NCT00742560|65959652|FG002|Overall Study|Investigator's Decision|4|||
23610040|NCT00742560|65959653|FG003|Overall Study|Investigator's Decision|1|||
23610041|NCT00742560|65959654|FG004|Overall Study|Investigator's Decision|0|||
23610042|NCT00742560|65959650|FG000|Overall Study|Disease Progression|1|||
23610043|NCT00742560|65959651|FG001|Overall Study|Disease Progression|0|||
23610044|NCT00742560|65959652|FG002|Overall Study|Disease Progression|5|||
23610045|NCT00742560|65959653|FG003|Overall Study|Disease Progression|17|||
23610046|NCT00742560|65959654|FG004|Overall Study|Disease Progression|16|||
23610047|NCT00742560|65959650|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
23610048|NCT00742560|65959651|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
23610049|NCT00742560|65959652|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
23610050|NCT00742560|65959653|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
23610051|NCT00742560|65959654|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
23610052|NCT00742560|65959650|FG000|Overall Study|Other|0|||
23610053|NCT00742560|65959651|FG001|Overall Study|Other|1|||
23610054|NCT00742560|65959652|FG002|Overall Study|Other|8|||
23610055|NCT00742560|65959653|FG003|Overall Study|Other|9|||
23610056|NCT00742560|65959654|FG004|Overall Study|Other|9|||
23610057|NCT00742560|65959650|FG000|Overall Study|MIssing|0|||
23610058|NCT00742560|65959651|FG001|Overall Study|MIssing|0|||
23610059|NCT00742560|65959652|FG002|Overall Study|MIssing|0|||
23610060|NCT00742560|65959653|FG003|Overall Study|MIssing|0|||
23610061|NCT00742560|65959654|FG004|Overall Study|MIssing|1|||
23610062|NCT00584909|65959655|FG000|Overall Study|Adverse Event|4|||
23610063|NCT01737398|65959658|FG000|Overall Study|Adverse event or SAE|16|||
23610064|NCT01737398|65959659|FG001|Overall Study|Adverse event or SAE|1|||
23610065|NCT01737398|65959658|FG000|Overall Study|Stopping rule met|2|||
23610066|NCT01737398|65959659|FG001|Overall Study|Stopping rule met|1|||
23610067|NCT01737398|65959658|FG000|Overall Study|Voluntary withdrawal|2|||
23610068|NCT01737398|65959659|FG001|Overall Study|Voluntary withdrawal|3|||
23610069|NCT01737398|65959658|FG000|Overall Study|Ineligibility|1|||
23610070|NCT01737398|65959659|FG001|Overall Study|Ineligibility|0|||
23610071|NCT01737398|65959658|FG000|Overall Study|Liver transplant|1|||
23610072|NCT01737398|65959659|FG001|Overall Study|Liver transplant|0|||
23610073|NCT01737398|65959658|FG000|Overall Study|Disease progression|2|||
23610074|NCT01737398|65959659|FG001|Overall Study|Disease progression|3|||
23610075|NCT01737398|65959658|FG000|Overall Study|Sponsor's decision|2|||
23610076|NCT01737398|65959659|FG001|Overall Study|Sponsor's decision|0|||
23610077|NCT00832650|65959660|FG000|Overall Study|Randomized but not treated|0|||
23610078|NCT00832650|65959661|FG001|Overall Study|Randomized but not treated|0|||
23610079|NCT00832650|65959662|FG002|Overall Study|Randomized but not treated|1|||
23610080|NCT01999335|65959663|FG000|Overall Study|Discontinued before receiving treatment|0|||
23610081|NCT01999335|65959664|FG001|Overall Study|Discontinued before receiving treatment|0|||
23610082|NCT01999335|65959665|FG002|Overall Study|Discontinued before receiving treatment|0|||
23610083|NCT01999335|65959666|FG003|Overall Study|Discontinued before receiving treatment|0|||
23610084|NCT01999335|65959667|FG004|Overall Study|Discontinued before receiving treatment|2|||
23610085|NCT00307489|65959673|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
23610086|NCT00307489|65959674|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
23610087|NCT00307489|65959673|FG000|Baseline Through Week 48|Physician Decision|1|||
23610088|NCT00307489|65959674|FG001|Baseline Through Week 48|Physician Decision|0|||
23610089|NCT00307489|65959673|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
23610090|NCT00307489|65959674|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
23610091|NCT00307489|65959673|FG000|Week 48 Through Week 168|Adverse Event|1|||
23610092|NCT00307489|65959674|FG001|Week 48 Through Week 168|Adverse Event|0|||
23610093|NCT00307489|65959673|FG000|Week 48 Through Week 168|Physician Decision|1|||
23610094|NCT00307489|65959674|FG001|Week 48 Through Week 168|Physician Decision|0|||
23610095|NCT00307489|65959673|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
23610096|NCT00307489|65959674|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
23610097|NCT00307489|65959673|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
23610098|NCT00307489|65959674|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
23610099|NCT00307489|65959673|FG000|Week 48 Through Week 168|Death|0|||
23610100|NCT00307489|65959674|FG001|Week 48 Through Week 168|Death|1|||
23610101|NCT00307489|65959673|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
23610102|NCT00307489|65959674|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
23610103|NCT00307489|65959673|FG000|Week 48 Through Week 168|Seroconversion|1|||
23610104|NCT00307489|65959674|FG001|Week 48 Through Week 168|Seroconversion|0|||
23610105|NCT03747575|65959675|FG000|Overall Study|Withdrawal by Subject|6|||
23610106|NCT03747575|65959676|FG001|Overall Study|Withdrawal by Subject|3|||
23610107|NCT03747575|65959675|FG000|Overall Study|Lost to Follow-up|3|||
23610108|NCT03747575|65959676|FG001|Overall Study|Lost to Follow-up|3|||
23610109|NCT03747575|65959675|FG000|Overall Study|Adverse Event|0|||
23610110|NCT03747575|65959676|FG001|Overall Study|Adverse Event|1|||
23610111|NCT02481934|65959677|FG000|Overall Study|Death|2|||
23610112|NCT00441168|65959678|FG000|Treatment Period|Death|3|||
23610113|NCT00441168|65959679|FG001|Treatment Period|Death|0|||
23610114|NCT00441168|65959678|FG000|Treatment Period|Adverse Event|1|||
23610115|NCT00441168|65959679|FG001|Treatment Period|Adverse Event|2|||
23610116|NCT00441168|65959678|FG000|Treatment Period|Progressive Disease|0|||
23610117|NCT00441168|65959679|FG001|Treatment Period|Progressive Disease|2|||
23610118|NCT00441168|65959678|FG000|Treatment Period|Protocol Violation|0|||
23610119|NCT00441168|65959679|FG001|Treatment Period|Protocol Violation|1|||
23610120|NCT00441168|65959678|FG000|Treatment Period|Lost to Follow-up|0|||
23610121|NCT00441168|65959679|FG001|Treatment Period|Lost to Follow-up|1|||
23610122|NCT00441168|65959678|FG000|Treatment Period|Withdrawal by Subject|3|||
23610123|NCT00441168|65959679|FG001|Treatment Period|Withdrawal by Subject|0|||
23610124|NCT00441168|65959678|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
23610125|NCT00441168|65959679|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
23610126|NCT00441168|65959678|FG000|Treatment Period|refractory disease|1|||
23610127|NCT00441168|65959679|FG001|Treatment Period|refractory disease|0|||
23610128|NCT00441168|65959678|FG000|Follow-up Period|Death|3|||
23708587|NCT00995345|66308880|FG001|Overall Study|Lost to Follow-up|2|||
23708588|NCT00995345|66308881|FG002|Overall Study|Lost to Follow-up|2|||
23708589|NCT00995345|66308882|FG003|Overall Study|Lost to Follow-up|1|||
23708590|NCT00995345|66308883|FG004|Overall Study|Lost to Follow-up|0|||
23708591|NCT00995345|66308879|FG000|Overall Study|all other reasons combined|2|||
23708592|NCT00995345|66308880|FG001|Overall Study|all other reasons combined|2|||
23708593|NCT00995345|66308881|FG002|Overall Study|all other reasons combined|2|||
23708594|NCT00995345|66308882|FG003|Overall Study|all other reasons combined|1|||
23708595|NCT00995345|66308883|FG004|Overall Study|all other reasons combined|3|||
23708596|NCT01029886|66308884|FG000|Overall Study|Adverse Event|12|||
23708597|NCT01029886|66308885|FG001|Overall Study|Adverse Event|25|||
23708598|NCT01029886|66308884|FG000|Overall Study|Lost to Follow-up|1|||
23708599|NCT01029886|66308885|FG001|Overall Study|Lost to Follow-up|0|||
23708600|NCT01029886|66308884|FG000|Overall Study|Physician Decision|2|||
23708601|NCT01029886|66308885|FG001|Overall Study|Physician Decision|6|||
23708602|NCT01029886|66308884|FG000|Overall Study|Protocol Violation|17|||
23708603|NCT01029886|66308885|FG001|Overall Study|Protocol Violation|5|||
23708604|NCT01029886|66308884|FG000|Overall Study|Withdrawal by Subject|8|||
23708605|NCT01029886|66308885|FG001|Overall Study|Withdrawal by Subject|18|||
23708606|NCT01029886|66308884|FG000|Overall Study|Entry Criteria Not Met|13|||
23708607|NCT01029886|66308885|FG001|Overall Study|Entry Criteria Not Met|5|||
23708608|NCT01029886|66308884|FG000|Overall Study|Sponsor Decision|1|||
23708609|NCT01029886|66308885|FG001|Overall Study|Sponsor Decision|0|||
23708610|NCT01029886|66308884|FG000|Overall Study|Loss Glucose Control|7|||
23708611|NCT01029886|66308885|FG001|Overall Study|Loss Glucose Control|1|||
23708612|NCT01079962|66308889|FG000|Overall Study|Adverse Event|2|||
23708613|NCT01079962|66308890|FG001|Overall Study|Adverse Event|2|||
23708614|NCT01079962|66308889|FG000|Overall Study|Withdrawal by Subject|5|||
23708615|NCT01079962|66308890|FG001|Overall Study|Withdrawal by Subject|7|||
23708616|NCT01079962|66308889|FG000|Overall Study|Protocol Violation|2|||
23708617|NCT01079962|66308890|FG001|Overall Study|Protocol Violation|2|||
23708618|NCT01079962|66308889|FG000|Overall Study|No blood pressure (BP) control|3|||
23708619|NCT01079962|66308890|FG001|Overall Study|No blood pressure (BP) control|0|||
23708620|NCT01079962|66308889|FG000|Overall Study|Inclusion/exclusion criteria|1|||
23708621|NCT01079962|66308890|FG001|Overall Study|Inclusion/exclusion criteria|3|||
23708622|NCT01079962|66308889|FG000|Overall Study|Participant not returning for next visit|1|||
23708623|NCT01079962|66308890|FG001|Overall Study|Participant not returning for next visit|0|||
23708624|NCT01079962|66308889|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
23708625|NCT01079962|66308890|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
23708626|NCT02626533|66308895|FG000|Overall Study|Protocol Violation|14|||
23708627|NCT02626533|66308895|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
23708628|NCT02626533|66308895|FG000|Overall Study|Withdrawal by Subject|1|||
23708629|NCT03009539|66308896|FG000|Overall Study|Lost to Follow-up|132|||
23708630|NCT03009539|66308897|FG001|Overall Study|Lost to Follow-up|113|||
23708631|NCT03009539|66308898|FG002|Overall Study|Lost to Follow-up|132|||
23708632|NCT03009539|66308899|FG003|Overall Study|Lost to Follow-up|113|||
23708633|NCT01774344|66308901|FG000|Overall Study|Withdrawal by Subject|3|||
23708634|NCT01774344|66308902|FG001|Overall Study|Withdrawal by Subject|10|||
23708635|NCT01774344|66308901|FG000|Overall Study|Protocol Violation|0|||
23708636|NCT01774344|66308902|FG001|Overall Study|Protocol Violation|1|||
23708637|NCT01774344|66308901|FG000|Overall Study|Lost to Follow-up|4|||
23708638|NCT01774344|66308902|FG001|Overall Study|Lost to Follow-up|10|||
23708639|NCT01774344|66308901|FG000|Overall Study|End of survival follow-up not available|2|||
23708640|NCT01774344|66308902|FG001|Overall Study|End of survival follow-up not available|2|||
23708641|NCT01774344|66308901|FG000|Overall Study|Data collection finished|4|||
23708642|NCT01774344|66308902|FG001|Overall Study|Data collection finished|14|||
23708643|NCT01774344|66308901|FG000|Overall Study|Other|0|||
23708644|NCT01774344|66308902|FG001|Overall Study|Other|1|||
23708645|NCT01774344|66308901|FG000|Overall Study|Did not enter Survival Follow up|49|||
23708646|NCT01774344|66308902|FG001|Overall Study|Did not enter Survival Follow up|83|||
23708647|NCT00916370|66308905|FG000|Overall Study|Death|3|||
23708648|NCT00916370|66308906|FG001|Overall Study|Death|1|||
23708649|NCT00916370|66308905|FG000|Overall Study|Withdrawal by Subject|2|||
23708650|NCT00916370|66308906|FG001|Overall Study|Withdrawal by Subject|0|||
23708651|NCT00916370|66308905|FG000|Overall Study|Physician Decision|0|||
23708652|NCT00916370|66308906|FG001|Overall Study|Physician Decision|1|||
23708653|NCT02128763|66308907|FG000|Overall Study|Death|1|||
23708654|NCT02128763|66308908|FG001|Overall Study|Death|0|||
23708655|NCT02128763|66308907|FG000|Overall Study|Lost to Follow-up|19|||
23708656|NCT02128763|66308908|FG001|Overall Study|Lost to Follow-up|16|||
23708657|NCT01163253|66308910|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
23708658|NCT01163253|66308911|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
23708659|NCT01163253|66308910|FG000|Overall Study|Study Terminated by Sponsor|978|||
23708660|NCT01163253|66308911|FG001|Overall Study|Study Terminated by Sponsor|349|||
23708661|NCT01163253|66308910|FG000|Overall Study|Protocol Violation|43|||
23708662|NCT01163253|66308911|FG001|Overall Study|Protocol Violation|12|||
23708663|NCT01163253|66308910|FG000|Overall Study|Withdrawal by Subject|199|||
23708664|NCT01163253|66308911|FG001|Overall Study|Withdrawal by Subject|50|||
23708665|NCT01163253|66308910|FG000|Overall Study|Medication Error|1|||
23708666|NCT01163253|66308911|FG001|Overall Study|Medication Error|0|||
23708667|NCT01163253|66308910|FG000|Overall Study|Lost to Follow-up|125|||
23708668|NCT01163253|66308911|FG001|Overall Study|Lost to Follow-up|23|||
23708669|NCT01163253|66308910|FG000|Overall Study|Insufficient Clinical Response|423|||
23708670|NCT01163253|66308911|FG001|Overall Study|Insufficient Clinical Response|29|||
23708671|NCT01163253|66308910|FG000|Overall Study|Adverse Event|300|||
23708672|NCT01163253|66308911|FG001|Overall Study|Adverse Event|78|||
23708673|NCT01163253|66308910|FG000|Overall Study|Death|17|||
23708674|NCT01163253|66308911|FG001|Overall Study|Death|5|||
23610129|NCT00441168|65959679|FG001|Follow-up Period|Death|0|||
23610130|NCT00441168|65959678|FG000|Follow-up Period|Lost to Follow-up|5|||
23610131|NCT00441168|65959679|FG001|Follow-up Period|Lost to Follow-up|6|||
23610132|NCT00441168|65959678|FG000|Follow-up Period|Withdrawal by Subject|3|||
23610133|NCT00441168|65959679|FG001|Follow-up Period|Withdrawal by Subject|0|||
23610134|NCT00441168|65959678|FG000|Follow-up Period|Other|1|||
23610135|NCT00441168|65959679|FG001|Follow-up Period|Other|3|||
23610136|NCT03769090|65959680|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
23610137|NCT03769090|65959681|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
23610138|NCT03769090|65959682|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
23510413|NCT00617123|65606011|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
23510414|NCT00617123|65606012|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
23510415|NCT02825992|65606013|FG000|Overall Study|Withdrawal by Subject|4|||
23510416|NCT02825992|65606013|FG000|Overall Study|Lost to Follow-up|2|||
23510417|NCT02825992|65606013|FG000|Overall Study|Procedure terminated|2|||
23510418|NCT02057406|65606015|FG000|Overall Study|Physician Decision|0|||
23510419|NCT02057406|65606016|FG001|Overall Study|Physician Decision|0|||
23510420|NCT02057406|65606017|FG002|Overall Study|Physician Decision|2|||
23510421|NCT02057406|65606015|FG000|Overall Study|Withdrawal by Subject|0|||
23510422|NCT02057406|65606016|FG001|Overall Study|Withdrawal by Subject|2|||
23510423|NCT02057406|65606017|FG002|Overall Study|Withdrawal by Subject|0|||
23510424|NCT02057406|65606015|FG000|Overall Study|Lost to Follow-up|0|||
23510425|NCT02057406|65606016|FG001|Overall Study|Lost to Follow-up|0|||
23510426|NCT02057406|65606017|FG002|Overall Study|Lost to Follow-up|1|||
23510427|NCT02057406|65606015|FG000|Overall Study|Death|1|||
23510428|NCT02057406|65606016|FG001|Overall Study|Death|0|||
23510429|NCT02057406|65606017|FG002|Overall Study|Death|0|||
23510430|NCT02057406|65606015|FG000|Overall Study|Protocol Violation|0|||
23510431|NCT02057406|65606016|FG001|Overall Study|Protocol Violation|1|||
23510432|NCT02057406|65606017|FG002|Overall Study|Protocol Violation|0|||
23510433|NCT02057406|65606015|FG000|Overall Study|Patient transportation issues|0|||
23510434|NCT02057406|65606016|FG001|Overall Study|Patient transportation issues|0|||
23510435|NCT02057406|65606017|FG002|Overall Study|Patient transportation issues|1|||
23610139|NCT03769090|65959680|FG000|Overall Study|Withdrawal by Subject|52|||
23610140|NCT03769090|65959681|FG001|Overall Study|Withdrawal by Subject|62|||
23610141|NCT03769090|65959682|FG002|Overall Study|Withdrawal by Subject|74|||
23610142|NCT03769090|65959680|FG000|Overall Study|Death|4|||
23610143|NCT03769090|65959681|FG001|Overall Study|Death|2|||
23610144|NCT03769090|65959682|FG002|Overall Study|Death|2|||
23510436|NCT02268864|65606021|FG000|Overall Study|Withdrawal by Subject|2|||
23510437|NCT02268864|65606022|FG001|Overall Study|Withdrawal by Subject|0|||
23510438|NCT02268864|65606023|FG002|Overall Study|Withdrawal by Subject|0|||
23510439|NCT02268864|65606021|FG000|Overall Study|Death|0|||
23610145|NCT03769090|65959680|FG000|Overall Study|Adverse Event|7|||
23510440|NCT02268864|65606022|FG001|Overall Study|Death|1|||
23510441|NCT02268864|65606023|FG002|Overall Study|Death|0|||
23610146|NCT03769090|65959681|FG001|Overall Study|Adverse Event|7|||
23610147|NCT03769090|65959682|FG002|Overall Study|Adverse Event|8|||
23610148|NCT03769090|65959680|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
23610149|NCT03769090|65959681|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
23708675|NCT01163253|66308910|FG000|Overall Study|Ongoing|13|||
23708676|NCT01163253|66308911|FG001|Overall Study|Ongoing|4|||
23610150|NCT03769090|65959682|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
23610151|NCT03769090|65959680|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
23610152|NCT03769090|65959681|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
23610153|NCT03769090|65959682|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
23610154|NCT03769090|65959680|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
23610155|NCT03769090|65959681|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
23610156|NCT03769090|65959682|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
23610157|NCT03769090|65959680|FG000|Overall Study|Protocol Violation|5|||
23610158|NCT03769090|65959681|FG001|Overall Study|Protocol Violation|6|||
23610159|NCT03769090|65959682|FG002|Overall Study|Protocol Violation|8|||
23610160|NCT03769090|65959680|FG000|Overall Study|Pregnancy|1|||
23610161|NCT03769090|65959681|FG001|Overall Study|Pregnancy|0|||
23610162|NCT03769090|65959682|FG002|Overall Study|Pregnancy|3|||
23610163|NCT03769090|65959680|FG000|Overall Study|Lost to Follow-up|19|||
23610164|NCT03769090|65959681|FG001|Overall Study|Lost to Follow-up|25|||
23610165|NCT03769090|65959682|FG002|Overall Study|Lost to Follow-up|21|||
23610166|NCT03769090|65959680|FG000|Overall Study|Condition under investigation worsened|2|||
23610167|NCT03769090|65959681|FG001|Overall Study|Condition under investigation worsened|0|||
23610168|NCT03769090|65959682|FG002|Overall Study|Condition under investigation worsened|1|||
23610169|NCT03769090|65959680|FG000|Overall Study|Lack of Efficacy|1|||
23610170|NCT03769090|65959681|FG001|Overall Study|Lack of Efficacy|2|||
23610171|NCT03769090|65959682|FG002|Overall Study|Lack of Efficacy|2|||
23610172|NCT03769090|65959680|FG000|Overall Study|Other reasons|8|||
23610173|NCT03769090|65959681|FG001|Overall Study|Other reasons|12|||
23610174|NCT03769090|65959682|FG002|Overall Study|Other reasons|15|||
23610175|NCT03873038|65962671|FG000|Part 2|Withdrawal by Subject|0|||
23610176|NCT03873038|65962672|FG001|Part 2|Withdrawal by Subject|0|||
23610177|NCT03873038|65962673|FG002|Part 2|Withdrawal by Subject|0|||
23610178|NCT03873038|65962674|FG003|Part 2|Withdrawal by Subject|0|||
23610179|NCT03873038|65962675|FG004|Part 2|Withdrawal by Subject|0|||
23610180|NCT03873038|65962676|FG005|Part 2|Withdrawal by Subject|1|||
23610181|NCT03873038|65962671|FG000|Part 2|Unknon|0|||
23610182|NCT03873038|65962672|FG001|Part 2|Unknon|0|||
23610183|NCT03873038|65962673|FG002|Part 2|Unknon|0|||
23610184|NCT03873038|65962674|FG003|Part 2|Unknon|0|||
23610185|NCT03873038|65962675|FG004|Part 2|Unknon|1|||
23610186|NCT03873038|65962676|FG005|Part 2|Unknon|0|||
23610187|NCT01204775|65962680|FG000|Overall Study|Poor/non-compliance|0|||
23610188|NCT01204775|65962681|FG001|Overall Study|Poor/non-compliance|1|||
23610189|NCT01204775|65962680|FG000|Overall Study|Withdrawal by Subject|1|||
23610190|NCT01204775|65962681|FG001|Overall Study|Withdrawal by Subject|0|||
23610191|NCT01405508|65962682|FG000|Overall Study|AE, non-serious non-fatal|1|||
23610192|NCT01405508|65962683|FG001|Overall Study|AE, non-serious non-fatal|1|||
23610193|NCT01405508|65962684|FG002|Overall Study|AE, non-serious non-fatal|0|||
23610194|NCT01405508|65962685|FG003|Overall Study|AE, non-serious non-fatal|0|||
23610195|NCT03605745|65962686|FG000|Overall Study|Study was terminated for business reasons|47|||
23610196|NCT02418819|65962687|FG000|Overall Study|Adverse Event|0|||
23610197|NCT02418819|65962688|FG001|Overall Study|Adverse Event|0|||
23610198|NCT02418819|65962689|FG002|Overall Study|Adverse Event|1|||
23510442|NCT02669433|65606024|FG000|Overall Study|Protocol Violation|0|||
23510443|NCT02669433|65606025|FG001|Overall Study|Protocol Violation|4|||
23510444|NCT02669433|65606026|FG002|Overall Study|Protocol Violation|1|||
23510445|NCT02669433|65606024|FG000|Overall Study|Disease Progression|1|||
23610199|NCT02418819|65962690|FG003|Overall Study|Adverse Event|0|||
23610200|NCT02418819|65962687|FG000|Overall Study|Lost to Follow-up|1|||
23610201|NCT02418819|65962688|FG001|Overall Study|Lost to Follow-up|0|||
23610202|NCT02418819|65962689|FG002|Overall Study|Lost to Follow-up|0|||
23610203|NCT02418819|65962690|FG003|Overall Study|Lost to Follow-up|0|||
23610204|NCT02418819|65962687|FG000|Overall Study|No longer meets eligibility criteria|0|||
23610205|NCT02418819|65962688|FG001|Overall Study|No longer meets eligibility criteria|0|||
23610206|NCT02418819|65962689|FG002|Overall Study|No longer meets eligibility criteria|1|||
23610207|NCT02418819|65962690|FG003|Overall Study|No longer meets eligibility criteria|0|||
23610208|NCT02418819|65962687|FG000|Overall Study|No longer willing to participate|0|||
23610209|NCT02418819|65962688|FG001|Overall Study|No longer willing to participate|0|||
23610210|NCT02418819|65962689|FG002|Overall Study|No longer willing to participate|2|||
23510446|NCT02669433|65606025|FG001|Overall Study|Disease Progression|0|||
23610211|NCT02418819|65962690|FG003|Overall Study|No longer willing to participate|1|||
23610212|NCT02660086|65962691|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
23610213|NCT02660086|65962692|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
23610214|NCT02660086|65962691|FG000|Overall Study- 12-month|Left full-time employment|12|||
23610215|NCT02660086|65962692|FG001|Overall Study- 12-month|Left full-time employment|20|||
23610216|NCT02660086|65962691|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
23610217|NCT02660086|65962692|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
23610218|NCT02660086|65962691|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
23610219|NCT02660086|65962692|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
23610220|NCT02660086|65962691|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
23610221|NCT02660086|65962692|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
23610222|NCT02660086|65962691|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
23610223|NCT02660086|65962692|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
23610224|NCT04743999|65962693|FG000|3-month Questionnaire|Death|1|||
23610225|NCT04743999|65962693|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
23610226|NCT04743999|65962693|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
23610227|NCT04743999|65962693|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
23610228|NCT01279447|65962694|FG000|Overall Study|Lost to Follow-up|3|||
23610229|NCT01279447|65962695|FG001|Overall Study|Lost to Follow-up|1|||
23610230|NCT01894620|65962697|FG000|Overall Study|Withdrawal by Subject|0|||
23610231|NCT01894620|65962698|FG001|Overall Study|Withdrawal by Subject|1|||
23610232|NCT03689452|65962699|FG000|Overall Study|Lost to Follow-up|1|||
23610233|NCT03689452|65962700|FG001|Overall Study|Lost to Follow-up|1|||
23610234|NCT02612285|65962701|FG000|Overall Study|Withdrawal by Subject|1|||
23610235|NCT01699178|65962702|FG000|Overall Study|Adverse Event|1|||
23610236|NCT01699178|65962703|FG001|Overall Study|Adverse Event|5|||
23610237|NCT01699178|65962702|FG000|Overall Study|Lost to Follow-up|1|||
23610238|NCT01699178|65962703|FG001|Overall Study|Lost to Follow-up|6|||
23610239|NCT01699178|65962702|FG000|Overall Study|Non-compliance with Study Drug|3|||
23610240|NCT01699178|65962703|FG001|Overall Study|Non-compliance with Study Drug|1|||
23610241|NCT01699178|65962702|FG000|Overall Study|Physician Decision|1|||
23610242|NCT01699178|65962703|FG001|Overall Study|Physician Decision|0|||
23610243|NCT01699178|65962702|FG000|Overall Study|Withdrawal by Subject|4|||
23610244|NCT01699178|65962703|FG001|Overall Study|Withdrawal by Subject|12|||
23610245|NCT01699178|65962702|FG000|Overall Study|Hematocrit >54%|1|||
23610246|NCT01699178|65962703|FG001|Overall Study|Hematocrit >54%|1|||
23610247|NCT01699178|65962702|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
23610248|NCT01699178|65962703|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
23610249|NCT01699178|65962702|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
23610250|NCT01699178|65962703|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
23610251|NCT03503188|65962704|FG000|Overall Study|Non eligible in the sub study|0|||
23510447|NCT02669433|65606026|FG002|Overall Study|Disease Progression|0|||
23510448|NCT02669433|65606024|FG000|Overall Study|Physician Decision|1|||
23510449|NCT02669433|65606025|FG001|Overall Study|Physician Decision|1|||
23510450|NCT02669433|65606026|FG002|Overall Study|Physician Decision|0|||
23510451|NCT02669433|65606024|FG000|Overall Study|Adverse Event|6|||
23510452|NCT02669433|65606025|FG001|Overall Study|Adverse Event|7|||
23510453|NCT02669433|65606026|FG002|Overall Study|Adverse Event|10|||
23510454|NCT02669433|65606024|FG000|Overall Study|Sponsor Termination|1|||
23510455|NCT02669433|65606025|FG001|Overall Study|Sponsor Termination|0|||
23510456|NCT02669433|65606026|FG002|Overall Study|Sponsor Termination|1|||
23510457|NCT02669433|65606024|FG000|Overall Study|Withdrawal by Subject|5|||
23510458|NCT02669433|65606025|FG001|Overall Study|Withdrawal by Subject|1|||
23510459|NCT02669433|65606026|FG002|Overall Study|Withdrawal by Subject|0|||
23510460|NCT02669433|65606024|FG000|Overall Study|Withdrawal by Caregiver|1|||
23510461|NCT02669433|65606025|FG001|Overall Study|Withdrawal by Caregiver|0|||
23510462|NCT02669433|65606026|FG002|Overall Study|Withdrawal by Caregiver|2|||
23510463|NCT02669433|65606024|FG000|Overall Study|Death|0|||
23510464|NCT02669433|65606025|FG001|Overall Study|Death|1|||
23510465|NCT02669433|65606026|FG002|Overall Study|Death|1|||
23510466|NCT01824394|65606027|FG000|Overall Study|Early Termination|1|||
23510467|NCT01824394|65606028|FG001|Overall Study|Early Termination|1|||
23510468|NCT01824394|65606029|FG002|Overall Study|Early Termination|3|||
23510469|NCT01824394|65606027|FG000|Overall Study|Withdrawn due to Study Termination|91|||
23510470|NCT01824394|65606028|FG001|Overall Study|Withdrawn due to Study Termination|83|||
23510471|NCT01824394|65606029|FG002|Overall Study|Withdrawn due to Study Termination|41|||
23510472|NCT01824394|65606027|FG000|Overall Study|Lost to Follow-up|0|||
23510473|NCT01824394|65606028|FG001|Overall Study|Lost to Follow-up|9|||
23510474|NCT01824394|65606029|FG002|Overall Study|Lost to Follow-up|3|||
23510475|NCT01824394|65606027|FG000|Overall Study|Death|3|||
23510476|NCT01824394|65606028|FG001|Overall Study|Death|2|||
23510477|NCT01824394|65606029|FG002|Overall Study|Death|4|||
23510478|NCT01824394|65606027|FG000|Overall Study|Discontinued Subjects|1|||
23510479|NCT01824394|65606028|FG001|Overall Study|Discontinued Subjects|1|||
23510480|NCT01824394|65606029|FG002|Overall Study|Discontinued Subjects|2|||
23510481|NCT01824394|65606027|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
23510482|NCT01824394|65606028|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
23510483|NCT01824394|65606029|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
23510484|NCT00545168|65606030|FG000|Overall Study|Lost to Follow-up|5|||
23510485|NCT00545168|65606031|FG001|Overall Study|Lost to Follow-up|5|||
23510486|NCT00545168|65606032|FG002|Overall Study|Lost to Follow-up|5|||
23510487|NCT00545168|65606030|FG000|Overall Study|Withdrawal by Subject|9|||
23510488|NCT00545168|65606031|FG001|Overall Study|Withdrawal by Subject|0|||
23610252|NCT03503188|65962705|FG001|Overall Study|Non eligible in the sub study|1|||
23610253|NCT01562275|65962706|FG000|Stage 1|Adverse Event|0|||
23610254|NCT01562275|65962707|FG001|Stage 1|Adverse Event|0|||
23610255|NCT01562275|65962708|FG002|Stage 1|Adverse Event|0|||
23610256|NCT01562275|65962709|FG003|Stage 1|Adverse Event|1|||
23610257|NCT01562275|65962710|FG004|Stage 1|Adverse Event|1|||
23610258|NCT01562275|65962711|FG005|Stage 1|Adverse Event|0|||
23610259|NCT01562275|65962712|FG006|Stage 1|Adverse Event|0|||
23610260|NCT01562275|65962713|FG007|Stage 1|Adverse Event|0|||
23610261|NCT01562275|65962714|FG008|Stage 1|Adverse Event|0|||
23610262|NCT01562275|65962715|FG009|Stage 1|Adverse Event|1|||
23510489|NCT00545168|65606032|FG002|Overall Study|Withdrawal by Subject|13|||
23510490|NCT00545168|65606030|FG000|Overall Study|Protocol Violation|1|||
23510491|NCT00545168|65606031|FG001|Overall Study|Protocol Violation|0|||
23510492|NCT00545168|65606032|FG002|Overall Study|Protocol Violation|1|||
23510493|NCT00545168|65606030|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
23510494|NCT00545168|65606031|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
23510495|NCT00545168|65606032|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
23510496|NCT02617628|65606033|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
23510497|NCT02617628|65606034|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
23510498|NCT00848081|65606035|FG000|Overall Study|Adverse Event|6|||
23510499|NCT00848081|65606036|FG001|Overall Study|Adverse Event|7|||
23510500|NCT00848081|65606035|FG000|Overall Study|Protocol Violation|8|||
23610263|NCT01562275|65962716|FG010|Stage 1|Adverse Event|0|||
23610264|NCT01562275|65962717|FG011|Stage 1|Adverse Event|0|||
23610265|NCT01562275|65962718|FG012|Stage 1|Adverse Event|0|||
23610266|NCT01562275|65962706|FG000|Stage 1|Death|1|||
23610267|NCT01562275|65962707|FG001|Stage 1|Death|0|||
23610268|NCT01562275|65962708|FG002|Stage 1|Death|0|||
23610269|NCT01562275|65962709|FG003|Stage 1|Death|0|||
23610270|NCT01562275|65962710|FG004|Stage 1|Death|0|||
23610271|NCT01562275|65962711|FG005|Stage 1|Death|0|||
23610272|NCT01562275|65962712|FG006|Stage 1|Death|0|||
23610273|NCT01562275|65962713|FG007|Stage 1|Death|0|||
23610274|NCT01562275|65962714|FG008|Stage 1|Death|0|||
23610275|NCT01562275|65962715|FG009|Stage 1|Death|0|||
23610276|NCT01562275|65962716|FG010|Stage 1|Death|0|||
23510501|NCT00848081|65606036|FG001|Overall Study|Protocol Violation|5|||
23510502|NCT00848081|65606035|FG000|Overall Study|Lost to Follow-up|1|||
23610277|NCT01562275|65962717|FG011|Stage 1|Death|0|||
23610278|NCT01562275|65962718|FG012|Stage 1|Death|0|||
23610279|NCT01562275|65962706|FG000|Stage 1|Non Compliance|0|||
23610280|NCT01562275|65962707|FG001|Stage 1|Non Compliance|0|||
23610281|NCT01562275|65962708|FG002|Stage 1|Non Compliance|1|||
23610282|NCT01562275|65962709|FG003|Stage 1|Non Compliance|0|||
23610283|NCT01562275|65962710|FG004|Stage 1|Non Compliance|0|||
23610284|NCT01562275|65962711|FG005|Stage 1|Non Compliance|0|||
23610285|NCT01562275|65962712|FG006|Stage 1|Non Compliance|0|||
23610286|NCT01562275|65962713|FG007|Stage 1|Non Compliance|0|||
23610287|NCT01562275|65962714|FG008|Stage 1|Non Compliance|0|||
23610288|NCT01562275|65962715|FG009|Stage 1|Non Compliance|0|||
23610289|NCT01562275|65962716|FG010|Stage 1|Non Compliance|0|||
23610290|NCT01562275|65962717|FG011|Stage 1|Non Compliance|0|||
23610291|NCT01562275|65962718|FG012|Stage 1|Non Compliance|0|||
23610292|NCT01562275|65962706|FG000|Stage 1|Physician Decision|0|||
23610293|NCT01562275|65962707|FG001|Stage 1|Physician Decision|0|||
23610294|NCT01562275|65962708|FG002|Stage 1|Physician Decision|0|||
23610295|NCT01562275|65962709|FG003|Stage 1|Physician Decision|0|||
23610296|NCT01562275|65962710|FG004|Stage 1|Physician Decision|1|||
23610297|NCT01562275|65962711|FG005|Stage 1|Physician Decision|0|||
23610298|NCT01562275|65962712|FG006|Stage 1|Physician Decision|1|||
23610299|NCT01562275|65962713|FG007|Stage 1|Physician Decision|0|||
23610300|NCT01562275|65962714|FG008|Stage 1|Physician Decision|1|||
23610301|NCT01562275|65962715|FG009|Stage 1|Physician Decision|0|||
23610302|NCT01562275|65962716|FG010|Stage 1|Physician Decision|0|||
23610303|NCT01562275|65962717|FG011|Stage 1|Physician Decision|0|||
23610304|NCT01562275|65962718|FG012|Stage 1|Physician Decision|0|||
23610305|NCT01562275|65962706|FG000|Stage 1|Progression of Disease|2|||
23610306|NCT01562275|65962707|FG001|Stage 1|Progression of Disease|6|||
23610307|NCT01562275|65962708|FG002|Stage 1|Progression of Disease|2|||
23610308|NCT01562275|65962709|FG003|Stage 1|Progression of Disease|1|||
23610309|NCT01562275|65962710|FG004|Stage 1|Progression of Disease|2|||
23610310|NCT01562275|65962711|FG005|Stage 1|Progression of Disease|4|||
23610311|NCT01562275|65962712|FG006|Stage 1|Progression of Disease|1|||
23610312|NCT01562275|65962713|FG007|Stage 1|Progression of Disease|7|||
23610313|NCT01562275|65962714|FG008|Stage 1|Progression of Disease|2|||
23610314|NCT01562275|65962715|FG009|Stage 1|Progression of Disease|5|||
23610315|NCT01562275|65962716|FG010|Stage 1|Progression of Disease|3|||
23610316|NCT01562275|65962717|FG011|Stage 1|Progression of Disease|0|||
23610317|NCT01562275|65962718|FG012|Stage 1|Progression of Disease|0|||
23610318|NCT01562275|65962706|FG000|Stage 1|Withdrawal by Subject|0|||
23610319|NCT01562275|65962707|FG001|Stage 1|Withdrawal by Subject|1|||
23610320|NCT01562275|65962708|FG002|Stage 1|Withdrawal by Subject|0|||
23610321|NCT01562275|65962709|FG003|Stage 1|Withdrawal by Subject|2|||
23610322|NCT01562275|65962710|FG004|Stage 1|Withdrawal by Subject|0|||
23610323|NCT01562275|65962711|FG005|Stage 1|Withdrawal by Subject|0|||
23610324|NCT01562275|65962712|FG006|Stage 1|Withdrawal by Subject|1|||
23610325|NCT01562275|65962713|FG007|Stage 1|Withdrawal by Subject|0|||
23610326|NCT01562275|65962714|FG008|Stage 1|Withdrawal by Subject|0|||
23610327|NCT01562275|65962715|FG009|Stage 1|Withdrawal by Subject|1|||
23610328|NCT01562275|65962716|FG010|Stage 1|Withdrawal by Subject|0|||
23610329|NCT01562275|65962717|FG011|Stage 1|Withdrawal by Subject|0|||
23610330|NCT01562275|65962718|FG012|Stage 1|Withdrawal by Subject|0|||
23610331|NCT01562275|65962706|FG000|Stage 2|Death|0|||
23610332|NCT01562275|65962707|FG001|Stage 2|Death|0|||
23610333|NCT01562275|65962708|FG002|Stage 2|Death|0|||
23610334|NCT01562275|65962709|FG003|Stage 2|Death|0|||
23610335|NCT01562275|65962710|FG004|Stage 2|Death|0|||
23610336|NCT01562275|65962711|FG005|Stage 2|Death|0|||
23610337|NCT01562275|65962712|FG006|Stage 2|Death|0|||
23610338|NCT01562275|65962713|FG007|Stage 2|Death|0|||
23610339|NCT01562275|65962714|FG008|Stage 2|Death|0|||
23610340|NCT01562275|65962715|FG009|Stage 2|Death|0|||
23610341|NCT01562275|65962716|FG010|Stage 2|Death|0|||
23610342|NCT01562275|65962717|FG011|Stage 2|Death|2|||
23610343|NCT01562275|65962718|FG012|Stage 2|Death|1|||
23610344|NCT01562275|65962706|FG000|Stage 2|Progression of Disease|0|||
23610345|NCT01562275|65962707|FG001|Stage 2|Progression of Disease|0|||
23610346|NCT01562275|65962708|FG002|Stage 2|Progression of Disease|0|||
23610347|NCT01562275|65962709|FG003|Stage 2|Progression of Disease|0|||
23610348|NCT01562275|65962710|FG004|Stage 2|Progression of Disease|0|||
23610349|NCT01562275|65962711|FG005|Stage 2|Progression of Disease|0|||
23610350|NCT01562275|65962712|FG006|Stage 2|Progression of Disease|0|||
23610351|NCT01562275|65962713|FG007|Stage 2|Progression of Disease|0|||
23610352|NCT01562275|65962714|FG008|Stage 2|Progression of Disease|0|||
23610353|NCT01562275|65962715|FG009|Stage 2|Progression of Disease|0|||
23610354|NCT01562275|65962716|FG010|Stage 2|Progression of Disease|0|||
23610355|NCT01562275|65962717|FG011|Stage 2|Progression of Disease|12|||
23610356|NCT01562275|65962718|FG012|Stage 2|Progression of Disease|4|||
23610357|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
23610358|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
23610359|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
23610360|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
23610361|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
23610362|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
23610363|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
23610364|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
23610365|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
23610366|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
23610367|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
23610368|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
23610369|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
23610370|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
23610371|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Death|8|||
23610372|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
23610373|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
23610374|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
23610375|NCT00042939|65962733|FG000|Overall Study|Adverse Event|6|||
23610376|NCT00042939|65962734|FG001|Overall Study|Adverse Event|7|||
23610377|NCT00042939|65962733|FG000|Overall Study|Death|3|||
23610378|NCT00042939|65962734|FG001|Overall Study|Death|2|||
23510503|NCT00848081|65606036|FG001|Overall Study|Lost to Follow-up|0|||
23610379|NCT00042939|65962733|FG000|Overall Study|Withdrawal by Subject|3|||
23610380|NCT00042939|65962734|FG001|Overall Study|Withdrawal by Subject|4|||
23610381|NCT00042939|65962733|FG000|Overall Study|Other disease|1|||
23610382|NCT00042939|65962734|FG001|Overall Study|Other disease|0|||
23408600|NCT02141672|65239932|FG002|Overall Study|refused to follow-up|1|||
23610383|NCT00042939|65962733|FG000|Overall Study|Ineligible|2|||
23610384|NCT00042939|65962734|FG001|Overall Study|Ineligible|2|||
23610385|NCT00042939|65962733|FG000|Overall Study|Deterioration of health|3|||
23610386|NCT00042939|65962734|FG001|Overall Study|Deterioration of health|4|||
23610387|NCT00042939|65962733|FG000|Overall Study|QOL diminished|1|||
23610388|NCT00042939|65962734|FG001|Overall Study|QOL diminished|0|||
23610389|NCT00042939|65962733|FG000|Overall Study|Rising ca 19-9|1|||
23408601|NCT01766037|65239938|FG000|Overall Study|Adverse Event|1|||
23610390|NCT00042939|65962734|FG001|Overall Study|Rising ca 19-9|0|||
23610391|NCT00042939|65962733|FG000|Overall Study|Patient non-compliance|1|||
23610392|NCT00042939|65962734|FG001|Overall Study|Patient non-compliance|0|||
23610393|NCT00042939|65962733|FG000|Overall Study|Still on treatment|1|||
23610394|NCT00042939|65962734|FG001|Overall Study|Still on treatment|0|||
23610395|NCT00042939|65962733|FG000|Overall Study|Treatment break > 4 weeks|0|||
23610396|NCT00042939|65962734|FG001|Overall Study|Treatment break > 4 weeks|1|||
23610397|NCT00042939|65962733|FG000|Overall Study|Did not start treatment|2|||
23610398|NCT00042939|65962734|FG001|Overall Study|Did not start treatment|1|||
23610399|NCT00905255|65962735|FG000|Overall Study|Adverse Event|7|||
23610400|NCT00905255|65962736|FG001|Overall Study|Adverse Event|5|||
23610401|NCT00905255|65962735|FG000|Overall Study|Withdrawal by Subject|5|||
23610402|NCT00905255|65962736|FG001|Overall Study|Withdrawal by Subject|4|||
23510504|NCT00848081|65606035|FG000|Overall Study|Physician Decision|0|||
23610403|NCT00905255|65962735|FG000|Overall Study|Familial and Personal Reasons|1|||
23610404|NCT00905255|65962736|FG001|Overall Study|Familial and Personal Reasons|0|||
23610405|NCT01241448|65962737|FG000|Overall Study|Adverse Event|1|||
23510505|NCT00848081|65606036|FG001|Overall Study|Physician Decision|3|||
23510506|NCT00848081|65606035|FG000|Overall Study|Withdrawal by Subject|5|||
23510507|NCT00848081|65606036|FG001|Overall Study|Withdrawal by Subject|3|||
23510508|NCT01995825|65606041|FG000|Overall Study|Withdrawal by Subject|1|||
23510509|NCT01995825|65606042|FG001|Overall Study|Withdrawal by Subject|0|||
23510510|NCT01648205|65606043|FG000|Placebo|Pregnancy|1|||
23510511|NCT01648205|65606043|FG000|Placebo|Withdrawal by Subject|1|||
23510512|NCT01648205|65606043|FG000|Placebo|Protocol Violation|2|||
23510513|NCT01648205|65606043|FG000|Ranolazine|Death|1|||
23510514|NCT01648205|65606043|FG000|Ranolazine|Withdrawal by Subject|1|||
23510515|NCT01648205|65606043|FG000|Ranolazine|Protocol Violation|3|||
23510516|NCT00477971|65606044|FG000|Overall Study|Disease progression|6|||
23510517|NCT00477971|65606045|FG001|Overall Study|Disease progression|0|||
23610406|NCT01241448|65962738|FG001|Overall Study|Adverse Event|0|||
23610407|NCT01241448|65962739|FG002|Overall Study|Adverse Event|2|||
23610408|NCT01241448|65962740|FG003|Overall Study|Adverse Event|2|||
23610409|NCT01241448|65962737|FG000|Overall Study|Lost to Follow-up|2|||
23610410|NCT01241448|65962738|FG001|Overall Study|Lost to Follow-up|1|||
23610411|NCT01241448|65962739|FG002|Overall Study|Lost to Follow-up|1|||
23610412|NCT01241448|65962740|FG003|Overall Study|Lost to Follow-up|1|||
23610413|NCT01241448|65962737|FG000|Overall Study|Physician Decision|0|||
23610414|NCT01241448|65962738|FG001|Overall Study|Physician Decision|2|||
23610415|NCT01241448|65962739|FG002|Overall Study|Physician Decision|0|||
23510518|NCT00477971|65606044|FG000|Overall Study|Withdrawal by Subject|3|||
23510519|NCT00477971|65606045|FG001|Overall Study|Withdrawal by Subject|1|||
23510520|NCT00477971|65606044|FG000|Overall Study|Adverse Event|3|||
23510521|NCT00477971|65606045|FG001|Overall Study|Adverse Event|0|||
23510522|NCT00477971|65606044|FG000|Overall Study|Death|2|||
23510523|NCT00477971|65606045|FG001|Overall Study|Death|4|||
23510524|NCT00477971|65606044|FG000|Overall Study|Alternative treatment|3|||
23510525|NCT00477971|65606045|FG001|Overall Study|Alternative treatment|1|||
23510526|NCT03055260|65606057|FG000|Overall Study|Withdrawal by Subject|1|||
23510527|NCT03055260|65606058|FG001|Overall Study|Withdrawal by Subject|0|||
23510528|NCT02674529|65606059|FG000|Overall Study|Lost to Follow-up|1|||
23510529|NCT02674529|65606060|FG001|Overall Study|Lost to Follow-up|2|||
23510530|NCT02674529|65606059|FG000|Overall Study|Withdrawal by Subject|2|||
23510531|NCT02674529|65606060|FG001|Overall Study|Withdrawal by Subject|1|||
23510532|NCT02674529|65606059|FG000|Overall Study|Physician Decision|0|||
23510533|NCT02674529|65606060|FG001|Overall Study|Physician Decision|1|||
23510534|NCT02674529|65606059|FG000|Overall Study|Protocol Violation|0|||
23510535|NCT02674529|65606060|FG001|Overall Study|Protocol Violation|1|||
23510536|NCT00390858|65606066|FG000|Overall Study|Adverse Event|6|||
23510537|NCT00390858|65606067|FG001|Overall Study|Adverse Event|2|||
23510538|NCT00390858|65606066|FG000|Overall Study|Lack of Efficacy|0|||
23510539|NCT00390858|65606067|FG001|Overall Study|Lack of Efficacy|1|||
23510540|NCT00390858|65606066|FG000|Overall Study|Withdrawal by Subject|3|||
23510541|NCT00390858|65606067|FG001|Overall Study|Withdrawal by Subject|4|||
23510542|NCT00667368|65606076|FG000|Overall Study|Lost to Follow-up|176|||
23510543|NCT00667368|65606077|FG001|Overall Study|Lost to Follow-up|155|||
23510544|NCT00667368|65606076|FG000|Overall Study|Discontinued early|24|||
23510545|NCT00667368|65606077|FG001|Overall Study|Discontinued early|17|||
23510546|NCT01782495|65606078|FG000|Overall Study|Adverse Event|0|||
23510547|NCT01782495|65606079|FG001|Overall Study|Adverse Event|0|||
23510548|NCT01782495|65606080|FG002|Overall Study|Adverse Event|0|||
23510549|NCT01782495|65606081|FG003|Overall Study|Adverse Event|0|||
23510550|NCT01782495|65606082|FG004|Overall Study|Adverse Event|0|||
23510551|NCT01782495|65606083|FG005|Overall Study|Adverse Event|0|||
23510552|NCT01782495|65606084|FG006|Overall Study|Adverse Event|0|||
23510553|NCT01782495|65606085|FG007|Overall Study|Adverse Event|2|||
23510554|NCT01782495|65606086|FG008|Overall Study|Adverse Event|0|||
23510555|NCT01782495|65606087|FG009|Overall Study|Adverse Event|0|||
23510556|NCT01782495|65606088|FG010|Overall Study|Adverse Event|0|||
23510557|NCT01782495|65606078|FG000|Overall Study|Withdrew Consent|0|||
23510558|NCT01782495|65606079|FG001|Overall Study|Withdrew Consent|1|||
23510559|NCT01782495|65606080|FG002|Overall Study|Withdrew Consent|0|||
23510560|NCT01782495|65606081|FG003|Overall Study|Withdrew Consent|0|||
23510561|NCT01782495|65606082|FG004|Overall Study|Withdrew Consent|0|||
23610416|NCT01241448|65962740|FG003|Overall Study|Physician Decision|0|||
23610417|NCT01241448|65962737|FG000|Overall Study|Protocol Violation|10|||
23610418|NCT01241448|65962738|FG001|Overall Study|Protocol Violation|5|||
23610419|NCT01241448|65962739|FG002|Overall Study|Protocol Violation|3|||
23610420|NCT01241448|65962740|FG003|Overall Study|Protocol Violation|6|||
23610421|NCT01241448|65962737|FG000|Overall Study|Sponsor Decision|17|||
23610422|NCT01241448|65962738|FG001|Overall Study|Sponsor Decision|14|||
23610423|NCT01241448|65962739|FG002|Overall Study|Sponsor Decision|12|||
23610424|NCT01241448|65962740|FG003|Overall Study|Sponsor Decision|6|||
23610425|NCT01241448|65962737|FG000|Overall Study|Withdrawal by Subject|4|||
23610426|NCT01241448|65962738|FG001|Overall Study|Withdrawal by Subject|5|||
23610427|NCT01241448|65962739|FG002|Overall Study|Withdrawal by Subject|3|||
23610428|NCT01241448|65962740|FG003|Overall Study|Withdrawal by Subject|6|||
23610429|NCT01241448|65962737|FG000|Overall Study|Excluded due to data integrity issues|3|||
23610430|NCT01241448|65962738|FG001|Overall Study|Excluded due to data integrity issues|2|||
23610431|NCT01241448|65962739|FG002|Overall Study|Excluded due to data integrity issues|2|||
23610432|NCT01241448|65962740|FG003|Overall Study|Excluded due to data integrity issues|2|||
23610433|NCT02691702|65962741|FG000|Overall Study|Adverse Event|1|||
23610434|NCT02691702|65962742|FG001|Overall Study|Adverse Event|0|||
23610435|NCT02691702|65962743|FG002|Overall Study|Adverse Event|0|||
23610436|NCT02691702|65962744|FG003|Overall Study|Adverse Event|0|||
23610437|NCT02691702|65962745|FG004|Overall Study|Adverse Event|0|||
23610438|NCT02691702|65962746|FG005|Overall Study|Adverse Event|0|||
23610439|NCT02691702|65962747|FG006|Overall Study|Adverse Event|0|||
23610440|NCT02691702|65962748|FG007|Overall Study|Adverse Event|0|||
23610441|NCT02691702|65962749|FG008|Overall Study|Adverse Event|1|||
23610442|NCT02691702|65962750|FG009|Overall Study|Adverse Event|0|||
23610443|NCT02691702|65962751|FG010|Overall Study|Adverse Event|1|||
23610444|NCT02691702|65962741|FG000|Overall Study|Lost to Follow-up|0|||
23610445|NCT02691702|65962742|FG001|Overall Study|Lost to Follow-up|0|||
23610446|NCT02691702|65962743|FG002|Overall Study|Lost to Follow-up|1|||
23610447|NCT02691702|65962744|FG003|Overall Study|Lost to Follow-up|0|||
23610448|NCT02691702|65962745|FG004|Overall Study|Lost to Follow-up|0|||
23610449|NCT02691702|65962746|FG005|Overall Study|Lost to Follow-up|2|||
23610450|NCT02691702|65962747|FG006|Overall Study|Lost to Follow-up|0|||
23610451|NCT02691702|65962748|FG007|Overall Study|Lost to Follow-up|0|||
23610452|NCT02691702|65962749|FG008|Overall Study|Lost to Follow-up|0|||
23610453|NCT02691702|65962750|FG009|Overall Study|Lost to Follow-up|0|||
23610454|NCT02691702|65962751|FG010|Overall Study|Lost to Follow-up|1|||
23610455|NCT02691702|65962741|FG000|Overall Study|Withdrawal by Subject|1|||
23610456|NCT02691702|65962742|FG001|Overall Study|Withdrawal by Subject|1|||
23610457|NCT02691702|65962743|FG002|Overall Study|Withdrawal by Subject|0|||
23510562|NCT01782495|65606083|FG005|Overall Study|Withdrew Consent|0|||
23510563|NCT01782495|65606084|FG006|Overall Study|Withdrew Consent|0|||
23510564|NCT01782495|65606085|FG007|Overall Study|Withdrew Consent|1|||
23510565|NCT01782495|65606086|FG008|Overall Study|Withdrew Consent|0|||
23510566|NCT01782495|65606087|FG009|Overall Study|Withdrew Consent|0|||
23510567|NCT01782495|65606088|FG010|Overall Study|Withdrew Consent|0|||
23510568|NCT00005937|65606092|FG000|Overall Study|Lack of Efficacy|5|||
23510569|NCT00609492|65606094|FG000|Overall Study|Withdrawal by Subject|0|||
23510570|NCT00609492|65606095|FG001|Overall Study|Withdrawal by Subject|2|||
23510571|NCT00609492|65606096|FG002|Overall Study|Withdrawal by Subject|3|||
23510572|NCT00609492|65606094|FG000|Overall Study|Lost to Follow-up|1|||
23510573|NCT00609492|65606095|FG001|Overall Study|Lost to Follow-up|1|||
23510574|NCT00609492|65606096|FG002|Overall Study|Lost to Follow-up|4|||
23510575|NCT00759031|65606097|FG000|First Intervention (1 Day)|Physician Decision|1|||
23510576|NCT00759031|65606098|FG001|First Intervention (1 Day)|Physician Decision|0|||
23510577|NCT00759031|65606097|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23510578|NCT00759031|65606098|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23510579|NCT00759031|65606097|FG000|First Intervention (1 Day)|Screening failure|1|||
23510580|NCT00759031|65606098|FG001|First Intervention (1 Day)|Screening failure|0|||
23510581|NCT00911820|65606105|FG000|Overall Study|RECIST progression|12|||
23510582|NCT00911820|65606106|FG001|Overall Study|RECIST progression|8|||
23510583|NCT00911820|65606105|FG000|Overall Study|Adverse Event|8|||
23510584|NCT00911820|65606106|FG001|Overall Study|Adverse Event|8|||
23510585|NCT00911820|65606105|FG000|Overall Study|Clinical Progression|7|||
23510586|NCT00911820|65606106|FG001|Overall Study|Clinical Progression|5|||
23510587|NCT00911820|65606105|FG000|Overall Study|Physician Decision|5|||
23510588|NCT00911820|65606106|FG001|Overall Study|Physician Decision|9|||
23510589|NCT00911820|65606105|FG000|Overall Study|Decline in Performance Status|4|||
23510590|NCT00911820|65606106|FG001|Overall Study|Decline in Performance Status|2|||
23510591|NCT00911820|65606105|FG000|Overall Study|Withdrawal by Subject|3|||
23510592|NCT00911820|65606106|FG001|Overall Study|Withdrawal by Subject|4|||
23510593|NCT00911820|65606105|FG000|Overall Study|Death|1|||
23610458|NCT02691702|65962744|FG003|Overall Study|Withdrawal by Subject|0|||
23610459|NCT02691702|65962745|FG004|Overall Study|Withdrawal by Subject|0|||
23610460|NCT02691702|65962746|FG005|Overall Study|Withdrawal by Subject|1|||
23610461|NCT02691702|65962747|FG006|Overall Study|Withdrawal by Subject|2|||
23610462|NCT02691702|65962748|FG007|Overall Study|Withdrawal by Subject|0|||
23610463|NCT02691702|65962749|FG008|Overall Study|Withdrawal by Subject|0|||
23610464|NCT02691702|65962750|FG009|Overall Study|Withdrawal by Subject|0|||
23610465|NCT02691702|65962751|FG010|Overall Study|Withdrawal by Subject|0|||
23510594|NCT00911820|65606106|FG001|Overall Study|Death|2|||
23510595|NCT00911820|65606105|FG000|Overall Study|Pursue surgery|1|||
23510596|NCT00911820|65606106|FG001|Overall Study|Pursue surgery|1|||
23510597|NCT00911820|65606105|FG000|Overall Study|Pursue Radiation|1|||
23510598|NCT00911820|65606106|FG001|Overall Study|Pursue Radiation|0|||
23510599|NCT00911820|65606105|FG000|Overall Study|Still on Therapy|2|||
23510600|NCT00911820|65606106|FG001|Overall Study|Still on Therapy|2|||
23510601|NCT00911820|65606105|FG000|Overall Study|Pathology Not Confirmed|1|||
23510602|NCT00911820|65606106|FG001|Overall Study|Pathology Not Confirmed|0|||
23510603|NCT00911820|65606105|FG000|Overall Study|Withdraw before Receive Treatment|0|||
23510604|NCT00911820|65606106|FG001|Overall Study|Withdraw before Receive Treatment|2|||
23610466|NCT02691702|65962741|FG000|Overall Study|Other|0|||
23610467|NCT02691702|65962742|FG001|Overall Study|Other|0|||
23610468|NCT02691702|65962743|FG002|Overall Study|Other|0|||
23610469|NCT02691702|65962744|FG003|Overall Study|Other|0|||
23610470|NCT02691702|65962745|FG004|Overall Study|Other|0|||
23610471|NCT02691702|65962746|FG005|Overall Study|Other|0|||
23610472|NCT02691702|65962747|FG006|Overall Study|Other|1|||
23610473|NCT02691702|65962748|FG007|Overall Study|Other|0|||
23610474|NCT02691702|65962749|FG008|Overall Study|Other|1|||
23610475|NCT02691702|65962750|FG009|Overall Study|Other|0|||
23610476|NCT02691702|65962751|FG010|Overall Study|Other|0|||
23610477|NCT02691702|65962741|FG000|Overall Study|Protocol Violation|0|||
23610478|NCT02691702|65962742|FG001|Overall Study|Protocol Violation|0|||
23610479|NCT02691702|65962743|FG002|Overall Study|Protocol Violation|0|||
23610480|NCT02691702|65962744|FG003|Overall Study|Protocol Violation|0|||
23610481|NCT02691702|65962745|FG004|Overall Study|Protocol Violation|0|||
23610482|NCT02691702|65962746|FG005|Overall Study|Protocol Violation|0|||
23610483|NCT02691702|65962747|FG006|Overall Study|Protocol Violation|0|||
23610484|NCT02691702|65962748|FG007|Overall Study|Protocol Violation|0|||
23610485|NCT02691702|65962749|FG008|Overall Study|Protocol Violation|0|||
23610486|NCT02691702|65962750|FG009|Overall Study|Protocol Violation|2|||
23610487|NCT02691702|65962751|FG010|Overall Study|Protocol Violation|0|||
23610488|NCT02659059|65962757|FG000|Overall Study|Other reasons|6|||
23610489|NCT02659059|65962758|FG001|Overall Study|Other reasons|1|||
23610490|NCT02659059|65962757|FG000|Overall Study|Disease Progression|143|||
23610491|NCT02659059|65962758|FG001|Overall Study|Disease Progression|16|||
23610492|NCT02659059|65962757|FG000|Overall Study|Study Drug toxicity|56|||
23610493|NCT02659059|65962758|FG001|Overall Study|Study Drug toxicity|9|||
23610494|NCT02659059|65962757|FG000|Overall Study|Death|3|||
23610495|NCT02659059|65962758|FG001|Overall Study|Death|1|||
23610496|NCT02659059|65962757|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
23610497|NCT02659059|65962758|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
23610498|NCT02659059|65962757|FG000|Overall Study|Participant request to discontinue study treatment|5|||
23610499|NCT02659059|65962758|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23610500|NCT02659059|65962757|FG000|Overall Study|Participant withdrew consent|6|||
23610501|NCT02659059|65962758|FG001|Overall Study|Participant withdrew consent|1|||
23610502|NCT03928821|65962768|FG000|Overall Study|Death|0|||
23610503|NCT03928821|65962769|FG001|Overall Study|Death|1|||
23610504|NCT03928821|65962770|FG002|Overall Study|Death|0|||
23610505|NCT03928821|65962771|FG003|Overall Study|Death|0|||
23610506|NCT03928821|65962768|FG000|Overall Study|Lost to Follow-up|0|||
23610507|NCT03928821|65962769|FG001|Overall Study|Lost to Follow-up|2|||
23610508|NCT03928821|65962770|FG002|Overall Study|Lost to Follow-up|3|||
23610509|NCT03928821|65962771|FG003|Overall Study|Lost to Follow-up|0|||
23610510|NCT03928821|65962768|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610511|NCT03928821|65962769|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610512|NCT03928821|65962770|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610513|NCT03928821|65962771|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23610514|NCT02889809|65962772|FG000|Overall Study|Withdrawal by Subject|30|||
23610515|NCT02889809|65962773|FG001|Overall Study|Withdrawal by Subject|21|||
23610516|NCT02889809|65962772|FG000|Overall Study|Lost to Follow-up|1|||
23610517|NCT02889809|65962773|FG001|Overall Study|Lost to Follow-up|1|||
23610518|NCT02889809|65962772|FG000|Overall Study|Site Closed|12|||
23610519|NCT02889809|65962773|FG001|Overall Study|Site Closed|11|||
23610520|NCT00396409|65962774|FG000|Period 1 - 2007|Adverse Event|0|||
23610521|NCT00396409|65962775|FG001|Period 1 - 2007|Adverse Event|1|||
23510605|NCT01581931|65606108|FG000|Washout|Adverse Event|0|||
23510606|NCT01581931|65606109|FG001|Washout|Adverse Event|1|||
23510607|NCT02835820|65606110|FG000|Overall Study|Baseline Screen Failure|0|||
23610522|NCT00396409|65962774|FG000|Period 1 - 2007|Lack of Efficacy|0|||
23610523|NCT00396409|65962775|FG001|Period 1 - 2007|Lack of Efficacy|1|||
23610524|NCT00396409|65962774|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
23610525|NCT00396409|65962775|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
23610526|NCT00396409|65962774|FG000|Period 1 - 2007|Lost to Follow-up|2|||
23610527|NCT00396409|65962775|FG001|Period 1 - 2007|Lost to Follow-up|3|||
23610528|NCT00396409|65962774|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
23610529|NCT00396409|65962775|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
23610530|NCT00396409|65962774|FG000|Period 2 - 2008|Protocol Violation|1|||
23510608|NCT02835820|65606111|FG001|Overall Study|Baseline Screen Failure|3|||
23510609|NCT00938639|65606123|FG000|Overall Study|Moved away from study area|0|||
23510610|NCT00938639|65606124|FG001|Overall Study|Moved away from study area|1|||
23510611|NCT00938639|65606123|FG000|Overall Study|Lost to Follow-up|1|||
23510612|NCT00938639|65606124|FG001|Overall Study|Lost to Follow-up|2|||
23510613|NCT00938639|65606123|FG000|Overall Study|Family issues|1|||
23510614|NCT00938639|65606124|FG001|Overall Study|Family issues|1|||
23510615|NCT00938639|65606123|FG000|Overall Study|Participant noncompliance|1|||
23510616|NCT00938639|65606124|FG001|Overall Study|Participant noncompliance|0|||
23510617|NCT04557371|65606125|FG000|Overall Study|Covid-19-related|0|||
23510618|NCT04557371|65606126|FG001|Overall Study|Covid-19-related|1|||
23510619|NCT04557371|65606127|FG002|Overall Study|Covid-19-related|0|||
23510620|NCT04557371|65606125|FG000|Overall Study|Withdrawal by Subject|0|||
23510621|NCT04557371|65606126|FG001|Overall Study|Withdrawal by Subject|1|||
23510622|NCT04557371|65606127|FG002|Overall Study|Withdrawal by Subject|0|||
23510623|NCT04557371|65606125|FG000|Overall Study|Adverse Event|1|||
23510624|NCT04557371|65606126|FG001|Overall Study|Adverse Event|0|||
23510625|NCT04557371|65606127|FG002|Overall Study|Adverse Event|0|||
23510626|NCT02407704|65606128|FG000|Overall Study|Lost to Follow-up|0|||
23510627|NCT02407704|65606129|FG001|Overall Study|Lost to Follow-up|0|||
23510628|NCT02407704|65606130|FG002|Overall Study|Lost to Follow-up|0|||
23510629|NCT02407704|65606131|FG003|Overall Study|Lost to Follow-up|2|||
23510630|NCT02407704|65606128|FG000|Overall Study|Protocol Violation|0|||
23510631|NCT02407704|65606129|FG001|Overall Study|Protocol Violation|0|||
23510632|NCT02407704|65606130|FG002|Overall Study|Protocol Violation|0|||
23510633|NCT02407704|65606131|FG003|Overall Study|Protocol Violation|1|||
23708677|NCT01163253|66308910|FG000|Overall Study|Other Unspecified|170|||
23708678|NCT01163253|66308911|FG001|Overall Study|Other Unspecified|34|||
23610531|NCT00396409|65962775|FG001|Period 2 - 2008|Protocol Violation|0|||
23610532|NCT00396409|65962774|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
23510634|NCT02407704|65606128|FG000|Overall Study|Withdrawal by Subject|0|||
23510635|NCT02407704|65606129|FG001|Overall Study|Withdrawal by Subject|0|||
23510636|NCT02407704|65606130|FG002|Overall Study|Withdrawal by Subject|1|||
23510637|NCT02407704|65606131|FG003|Overall Study|Withdrawal by Subject|0|||
23510638|NCT00553514|65606132|FG000|Overall Study|Protocol deviation|0|||
23510639|NCT00553514|65606133|FG001|Overall Study|Protocol deviation|0|||
23510640|NCT00553514|65606134|FG002|Overall Study|Protocol deviation|0|||
23510641|NCT00553514|65606135|FG003|Overall Study|Protocol deviation|1|||
23510642|NCT00553514|65606136|FG004|Overall Study|Protocol deviation|0|||
23510643|NCT00553514|65606132|FG000|Overall Study|Lack of ovarian response|4|||
23510644|NCT00553514|65606133|FG001|Overall Study|Lack of ovarian response|5|||
23510645|NCT00553514|65606134|FG002|Overall Study|Lack of ovarian response|5|||
23510646|NCT00553514|65606135|FG003|Overall Study|Lack of ovarian response|5|||
23510647|NCT00553514|65606136|FG004|Overall Study|Lack of ovarian response|6|||
23510648|NCT00553514|65606132|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23510649|NCT00553514|65606133|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510650|NCT00553514|65606134|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23510651|NCT00553514|65606135|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510652|NCT00553514|65606136|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510653|NCT00553514|65606132|FG000|Overall Study|Risk of multiple pregnancy|0|||
23510654|NCT00553514|65606133|FG001|Overall Study|Risk of multiple pregnancy|2|||
23510655|NCT00553514|65606134|FG002|Overall Study|Risk of multiple pregnancy|0|||
23610533|NCT00396409|65962775|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
23510656|NCT00553514|65606135|FG003|Overall Study|Risk of multiple pregnancy|1|||
23610534|NCT00396409|65962774|FG000|Period 2 - 2008|Lost to Follow-up|3|||
23610535|NCT00396409|65962775|FG001|Period 2 - 2008|Lost to Follow-up|1|||
23610536|NCT04454125|65962776|FG000|Overall Study|Lost to Follow-up|0|||
23610537|NCT04454125|65962777|FG001|Overall Study|Lost to Follow-up|1|||
23610538|NCT03508830|65962778|FG000|Overall Study|Withdrawal by Subject|3|||
23610539|NCT03508830|65962779|FG001|Overall Study|Withdrawal by Subject|4|||
23610540|NCT03508830|65962778|FG000|Overall Study|Physician Decision|2|||
23610541|NCT03508830|65962779|FG001|Overall Study|Physician Decision|2|||
23510657|NCT00553514|65606136|FG004|Overall Study|Risk of multiple pregnancy|0|||
23510658|NCT00553514|65606132|FG000|Overall Study|Other|1|||
23510659|NCT00553514|65606133|FG001|Overall Study|Other|1|||
23510660|NCT00553514|65606134|FG002|Overall Study|Other|0|||
23510661|NCT00553514|65606135|FG003|Overall Study|Other|0|||
23510662|NCT00553514|65606136|FG004|Overall Study|Other|1|||
23510663|NCT01320085|65606137|FG000|Overall Study|Disease Progression|26|||
23510664|NCT01320085|65606138|FG001|Overall Study|Disease Progression|93|||
23610542|NCT01215253|65962784|FG000|Overall Study|Withdrawal by Subject|57|||
23610543|NCT01215253|65962785|FG001|Overall Study|Withdrawal by Subject|35|||
23610544|NCT01215253|65962784|FG000|Overall Study|Physician Decision|9|||
23610545|NCT01215253|65962785|FG001|Overall Study|Physician Decision|12|||
23510665|NCT01320085|65606139|FG002|Overall Study|Disease Progression|17|||
23510666|NCT01320085|65606137|FG000|Overall Study|Adverse Event|12|||
23610546|NCT01215253|65962784|FG000|Overall Study|Lost to Follow-up|6|||
23510667|NCT01320085|65606138|FG001|Overall Study|Adverse Event|20|||
23610547|NCT01215253|65962785|FG001|Overall Study|Lost to Follow-up|4|||
23610548|NCT01215253|65962784|FG000|Overall Study|Other|14|||
23610549|NCT01215253|65962785|FG001|Overall Study|Other|12|||
23610550|NCT02135445|65962792|FG000|Overall Study|Lost to Follow-up|1|||
23610551|NCT02135445|65962793|FG001|Overall Study|Lost to Follow-up|0|||
23610552|NCT02135445|65962792|FG000|Overall Study|Withdrawal by Subject|1|||
23610553|NCT02135445|65962793|FG001|Overall Study|Withdrawal by Subject|0|||
23610554|NCT02335242|65962795|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
23610555|NCT02335242|65962796|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
23610556|NCT02335242|65962795|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
23610557|NCT02335242|65962796|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23610558|NCT02335242|65962795|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
23610559|NCT02335242|65962796|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
23708679|NCT01716533|66308912|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
23708680|NCT01716533|66308913|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
23708681|NCT01716533|66308914|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
23708682|NCT01716533|66308915|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
23708683|NCT01716533|66308912|FG000|Overall Study|Withdrawal by Subject|0|||
23708684|NCT01716533|66308913|FG001|Overall Study|Withdrawal by Subject|0|||
23708685|NCT01716533|66308914|FG002|Overall Study|Withdrawal by Subject|0|||
23708686|NCT01716533|66308915|FG003|Overall Study|Withdrawal by Subject|5|||
23708687|NCT01716533|66308912|FG000|Overall Study|Death|0|||
23708688|NCT01716533|66308913|FG001|Overall Study|Death|0|||
23708689|NCT01716533|66308914|FG002|Overall Study|Death|0|||
23708690|NCT01716533|66308915|FG003|Overall Study|Death|2|||
23708691|NCT01716533|66308912|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
23708692|NCT01716533|66308913|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
23708693|NCT01716533|66308914|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
23708694|NCT01716533|66308915|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
23708695|NCT02491073|66308916|FG000|Overall Study|screen failure|1|||
23708696|NCT02491073|66308917|FG001|Overall Study|screen failure|0|||
23708697|NCT00752609|66308918|FG000|Overall Study|Adverse Event|2|||
23708698|NCT00752609|66308919|FG001|Overall Study|Adverse Event|2|||
23708699|NCT00752609|66308918|FG000|Overall Study|Withdrawal by Subject|3|||
23708700|NCT00752609|66308919|FG001|Overall Study|Withdrawal by Subject|0|||
23708701|NCT00752609|66308918|FG000|Overall Study|Physician Decision|1|||
23708702|NCT00752609|66308919|FG001|Overall Study|Physician Decision|0|||
23708703|NCT00752609|66308918|FG000|Overall Study|Death|1|||
23708704|NCT00752609|66308919|FG001|Overall Study|Death|0|||
23708705|NCT00752609|66308918|FG000|Overall Study|Met exclusion criteria|1|||
23708706|NCT00752609|66308919|FG001|Overall Study|Met exclusion criteria|0|||
23708707|NCT00752609|66308918|FG000|Overall Study|Received Aranesp in error|1|||
23708708|NCT00752609|66308919|FG001|Overall Study|Received Aranesp in error|0|||
23708709|NCT01842308|66308921|FG000|Overall Study|Withdrawal by Subject|0|||
23708710|NCT01842308|66308922|FG001|Overall Study|Withdrawal by Subject|0|||
23708711|NCT01842308|66308923|FG002|Overall Study|Withdrawal by Subject|0|||
23708712|NCT01842308|66308924|FG003|Overall Study|Withdrawal by Subject|0|||
23708713|NCT01842308|66308925|FG004|Overall Study|Withdrawal by Subject|1|||
23708714|NCT03364608|66308926|FG000|Overall Study|Withdrawal by Subject|4|||
23708715|NCT03364608|66308926|FG000|Overall Study|Protocol Violation|2|||
23708716|NCT03364608|66308926|FG000|Overall Study|Lost to Follow-up|2|||
23708717|NCT03731364|66312177|FG000|Overall Study|Adverse Event|0|||
23708718|NCT03731364|66312178|FG001|Overall Study|Adverse Event|0|||
23708719|NCT03731364|66312179|FG002|Overall Study|Adverse Event|1|||
23708720|NCT03731364|66312180|FG003|Overall Study|Adverse Event|2|||
23708721|NCT03731364|66312181|FG004|Overall Study|Adverse Event|1|||
23708722|NCT03150095|66312184|FG000|Overall Study|Death|0|||
23708723|NCT03150095|66312185|FG001|Overall Study|Death|1|||
23708724|NCT03150095|66312184|FG000|Overall Study|Lost to Follow-up|1|||
23708725|NCT03150095|66312185|FG001|Overall Study|Lost to Follow-up|1|||
23708726|NCT03150095|66312184|FG000|Overall Study|Withdrawal by Subject|4|||
23708727|NCT03150095|66312185|FG001|Overall Study|Withdrawal by Subject|0|||
23510668|NCT01320085|65606139|FG002|Overall Study|Adverse Event|5|||
23708728|NCT03150095|66312184|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
23708729|NCT03150095|66312185|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
23708730|NCT02078713|66312188|FG000|Overall Study|Lost to Follow-up|49|||
23708731|NCT02078713|66312189|FG001|Overall Study|Lost to Follow-up|55|||
23708732|NCT02078713|66312190|FG002|Overall Study|Lost to Follow-up|0|||
23708733|NCT02078713|66312191|FG003|Overall Study|Lost to Follow-up|0|||
23708734|NCT02078713|66312188|FG000|Overall Study|Pregnant at baseline|3|||
23708735|NCT02078713|66312189|FG001|Overall Study|Pregnant at baseline|5|||
23708736|NCT02078713|66312190|FG002|Overall Study|Pregnant at baseline|0|||
23510669|NCT01320085|65606137|FG000|Overall Study|Withdrawal by Subject|2|||
23610560|NCT04626128|65962797|FG000|Overall Study|Withdrawal by Subject|0|||
23708737|NCT02078713|66312191|FG003|Overall Study|Pregnant at baseline|0|||
23708738|NCT02078713|66312188|FG000|Overall Study|Enrolled twice|0|||
23708739|NCT02078713|66312189|FG001|Overall Study|Enrolled twice|1|||
23708740|NCT02078713|66312190|FG002|Overall Study|Enrolled twice|0|||
23610561|NCT04626128|65962798|FG001|Overall Study|Withdrawal by Subject|1|||
23610562|NCT04626128|65962799|FG002|Overall Study|Withdrawal by Subject|0|||
23708741|NCT02078713|66312191|FG003|Overall Study|Enrolled twice|0|||
23708742|NCT03509207|66312194|FG000|Overall Study|Death|2|||
23708743|NCT00406783|66312195|FG000|Overall Study|Adverse Event|4|||
23708744|NCT00406783|66312196|FG001|Overall Study|Adverse Event|4|||
23708745|NCT00406783|66312195|FG000|Overall Study|Treatment Failure|2|||
23708746|NCT00406783|66312196|FG001|Overall Study|Treatment Failure|3|||
23708747|NCT00406783|66312195|FG000|Overall Study|Lost to Follow-up|3|||
23708748|NCT00406783|66312196|FG001|Overall Study|Lost to Follow-up|0|||
23708749|NCT00406783|66312195|FG000|Overall Study|Withdrawal by Subject|1|||
23708750|NCT00406783|66312196|FG001|Overall Study|Withdrawal by Subject|4|||
23708751|NCT00406783|66312195|FG000|Overall Study|Protocol Violation|4|||
23708752|NCT00406783|66312196|FG001|Overall Study|Protocol Violation|4|||
23708753|NCT02112994|66312204|FG000|Overall Study|Progressive Disease|0|||
23708754|NCT02112994|66312205|FG001|Overall Study|Progressive Disease|0|||
23708755|NCT02112994|66312206|FG002|Overall Study|Progressive Disease|1|||
23708756|NCT02112994|66312204|FG000|Overall Study|Pregnancy|0|||
23708757|NCT02112994|66312205|FG001|Overall Study|Pregnancy|1|||
23708758|NCT02112994|66312206|FG002|Overall Study|Pregnancy|1|||
23708759|NCT02112994|66312204|FG000|Overall Study|Liver Transplant|0|||
23708760|NCT02112994|66312205|FG001|Overall Study|Liver Transplant|1|||
23708761|NCT02112994|66312206|FG002|Overall Study|Liver Transplant|0|||
23708762|NCT02112994|66312204|FG000|Overall Study|Withdrawal by Subject|0|||
23708763|NCT02112994|66312205|FG001|Overall Study|Withdrawal by Subject|0|||
23708764|NCT02112994|66312206|FG002|Overall Study|Withdrawal by Subject|1|||
23708765|NCT02723604|66312207|FG000|Overall Study|ineligible|1|||
23708766|NCT02723604|66312207|FG000|Overall Study|never received treatment|1|||
23708767|NCT00358917|66312208|FG000|Overall Study|Adverse Event|14|||
23708768|NCT00358917|66312209|FG001|Overall Study|Adverse Event|21|||
23708769|NCT00358917|66312208|FG000|Overall Study|Withdrawal by Subject|5|||
23708770|NCT00358917|66312209|FG001|Overall Study|Withdrawal by Subject|7|||
23510670|NCT01320085|65606138|FG001|Overall Study|Withdrawal by Subject|4|||
23510671|NCT01320085|65606139|FG002|Overall Study|Withdrawal by Subject|1|||
23510672|NCT01320085|65606137|FG000|Overall Study|Protocol Deviation|1|||
23510673|NCT01320085|65606138|FG001|Overall Study|Protocol Deviation|0|||
23708771|NCT00358917|66312208|FG000|Overall Study|Lost to Follow-up|20|||
23708772|NCT00358917|66312209|FG001|Overall Study|Lost to Follow-up|17|||
23708773|NCT00358917|66312208|FG000|Overall Study|Noncompliance|12|||
23708774|NCT00358917|66312209|FG001|Overall Study|Noncompliance|11|||
23708775|NCT00358917|66312208|FG000|Overall Study|Death|2|||
23708776|NCT00358917|66312209|FG001|Overall Study|Death|3|||
23708777|NCT00358917|66312208|FG000|Overall Study|Virologic failure|11|||
23708778|NCT00358917|66312209|FG001|Overall Study|Virologic failure|8|||
23708779|NCT00358917|66312208|FG000|Overall Study|Unable to Continue Participation|2|||
23708780|NCT00358917|66312209|FG001|Overall Study|Unable to Continue Participation|2|||
23708781|NCT01409031|66312211|FG000|Overall Study|transferred to other hosp|1|||
23708782|NCT01409031|66312212|FG001|Overall Study|transferred to other hosp|0|||
23708783|NCT03453151|66312213|FG000|Overall Study|Withdrawal by Subject|1|||
23708784|NCT03453151|66312213|FG000|Overall Study|Physician Decision|3|||
23708785|NCT00543569|66312220|FG000|Overall Study|Death|2|||
23708786|NCT00543569|66312221|FG001|Overall Study|Death|2|||
23708787|NCT00543569|66312222|FG002|Overall Study|Death|3|||
23708788|NCT00543569|66312223|FG003|Overall Study|Death|1|||
23708789|NCT00543569|66312220|FG000|Overall Study|Lost to Follow-up|0|||
23708790|NCT00543569|66312221|FG001|Overall Study|Lost to Follow-up|0|||
23708791|NCT00543569|66312222|FG002|Overall Study|Lost to Follow-up|1|||
23708792|NCT00543569|66312223|FG003|Overall Study|Lost to Follow-up|1|||
23708793|NCT00543569|66312220|FG000|Overall Study|Miscellaneous Reasons|7|||
23708794|NCT00543569|66312221|FG001|Overall Study|Miscellaneous Reasons|3|||
23708795|NCT00543569|66312222|FG002|Overall Study|Miscellaneous Reasons|11|||
23708796|NCT00543569|66312223|FG003|Overall Study|Miscellaneous Reasons|4|||
23510674|NCT01320085|65606139|FG002|Overall Study|Protocol Deviation|1|||
23510675|NCT01320085|65606137|FG000|Overall Study|Administrative problems|0|||
23708797|NCT00543569|66312220|FG000|Overall Study|Randomized but never received study drug|3|||
23708798|NCT00543569|66312221|FG001|Overall Study|Randomized but never received study drug|3|||
23510676|NCT01320085|65606138|FG001|Overall Study|Administrative problems|0|||
23708799|NCT00543569|66312222|FG002|Overall Study|Randomized but never received study drug|5|||
23708800|NCT00543569|66312223|FG003|Overall Study|Randomized but never received study drug|3|||
23708801|NCT03314519|66312224|FG000|Overall Study|Protocol Violation|3|||
23510677|NCT01320085|65606139|FG002|Overall Study|Administrative problems|1|||
23708802|NCT03314519|66312225|FG001|Overall Study|Protocol Violation|2|||
23708803|NCT00879814|66312226|FG000|Overall Study|Adverse Event|0|||
23708804|NCT00879814|66312227|FG001|Overall Study|Adverse Event|1|||
23708805|NCT00879814|66312228|FG002|Overall Study|Adverse Event|0|||
23708806|NCT00879814|66312229|FG003|Overall Study|Adverse Event|0|||
23708807|NCT00879814|66312226|FG000|Overall Study|Lost to Follow-up|1|||
23708808|NCT00879814|66312227|FG001|Overall Study|Lost to Follow-up|0|||
23708809|NCT00879814|66312228|FG002|Overall Study|Lost to Follow-up|0|||
23708810|NCT00879814|66312229|FG003|Overall Study|Lost to Follow-up|2|||
23510678|NCT00967798|65606142|FG000|Overall Study|Withdrawal by Subject|5|||
23510679|NCT00967798|65606143|FG001|Overall Study|Withdrawal by Subject|2|||
23510680|NCT00967798|65606142|FG000|Overall Study|Lost to Follow-up|4|||
23510681|NCT00967798|65606143|FG001|Overall Study|Lost to Follow-up|1|||
23708811|NCT00879814|66312226|FG000|Overall Study|Participant Failed to Return|0|||
23708812|NCT00879814|66312227|FG001|Overall Study|Participant Failed to Return|0|||
23708813|NCT00879814|66312228|FG002|Overall Study|Participant Failed to Return|0|||
23708814|NCT00879814|66312229|FG003|Overall Study|Participant Failed to Return|1|||
23708815|NCT00879814|66312226|FG000|Overall Study|Withdrawal by Subject|3|||
23708816|NCT00879814|66312227|FG001|Overall Study|Withdrawal by Subject|1|||
23708817|NCT00879814|66312228|FG002|Overall Study|Withdrawal by Subject|1|||
23708818|NCT00879814|66312229|FG003|Overall Study|Withdrawal by Subject|2|||
23708819|NCT00879814|66312226|FG000|Overall Study|Physician Decision|0|||
23708820|NCT00879814|66312227|FG001|Overall Study|Physician Decision|0|||
23708821|NCT00879814|66312228|FG002|Overall Study|Physician Decision|1|||
23708822|NCT00879814|66312229|FG003|Overall Study|Physician Decision|0|||
23510682|NCT01018186|65606144|FG000|2-week Run-in Period|Protocol Violation|1|||
23510683|NCT01018186|65606145|FG001|2-week Run-in Period|Protocol Violation|0|||
23510684|NCT01018186|65606146|FG002|2-week Run-in Period|Protocol Violation|0|||
23708823|NCT00879814|66312226|FG000|Overall Study|Other|0|||
23708824|NCT00879814|66312227|FG001|Overall Study|Other|0|||
23708825|NCT00879814|66312228|FG002|Overall Study|Other|1|||
23708826|NCT00879814|66312229|FG003|Overall Study|Other|0|||
23708827|NCT00882999|66312230|FG000|Overall Study|Adverse Event|0|||
23708828|NCT00882999|66312231|FG001|Overall Study|Adverse Event|0|||
23708829|NCT00882999|66312232|FG002|Overall Study|Adverse Event|0|||
23708830|NCT00882999|66312233|FG003|Overall Study|Adverse Event|0|||
23708831|NCT00882999|66312234|FG004|Overall Study|Adverse Event|1|||
23708832|NCT00882999|66312235|FG005|Overall Study|Adverse Event|0|||
23708833|NCT00882999|66312236|FG006|Overall Study|Adverse Event|0|||
23708834|NCT00882999|66312230|FG000|Overall Study|Death|0|||
23708835|NCT00882999|66312231|FG001|Overall Study|Death|1|||
23708836|NCT00882999|66312232|FG002|Overall Study|Death|0|||
23708837|NCT00882999|66312233|FG003|Overall Study|Death|0|||
23708838|NCT00882999|66312234|FG004|Overall Study|Death|0|||
23708839|NCT00882999|66312235|FG005|Overall Study|Death|0|||
23708840|NCT00882999|66312236|FG006|Overall Study|Death|0|||
23708841|NCT00882999|66312230|FG000|Overall Study|Withdrawal by Subject|7|||
23708842|NCT00882999|66312231|FG001|Overall Study|Withdrawal by Subject|6|||
23708843|NCT00882999|66312232|FG002|Overall Study|Withdrawal by Subject|3|||
23708844|NCT00882999|66312233|FG003|Overall Study|Withdrawal by Subject|3|||
23708845|NCT00882999|66312234|FG004|Overall Study|Withdrawal by Subject|6|||
23708846|NCT00882999|66312235|FG005|Overall Study|Withdrawal by Subject|5|||
23708847|NCT00882999|66312236|FG006|Overall Study|Withdrawal by Subject|5|||
23708848|NCT00882999|66312230|FG000|Overall Study|Lost to Follow-up|0|||
23708849|NCT00882999|66312231|FG001|Overall Study|Lost to Follow-up|1|||
23708850|NCT00882999|66312232|FG002|Overall Study|Lost to Follow-up|1|||
23708851|NCT00882999|66312233|FG003|Overall Study|Lost to Follow-up|2|||
23708852|NCT00882999|66312234|FG004|Overall Study|Lost to Follow-up|1|||
23708853|NCT00882999|66312235|FG005|Overall Study|Lost to Follow-up|1|||
23708854|NCT00882999|66312236|FG006|Overall Study|Lost to Follow-up|2|||
23708855|NCT00882999|66312230|FG000|Overall Study|Physician Decision|1|||
23708856|NCT00882999|66312231|FG001|Overall Study|Physician Decision|0|||
23708857|NCT00882999|66312232|FG002|Overall Study|Physician Decision|0|||
23708858|NCT00882999|66312233|FG003|Overall Study|Physician Decision|0|||
23708859|NCT00882999|66312234|FG004|Overall Study|Physician Decision|0|||
23708860|NCT00882999|66312235|FG005|Overall Study|Physician Decision|1|||
23708861|NCT00882999|66312236|FG006|Overall Study|Physician Decision|1|||
23708862|NCT02121756|66312237|FG000|Overall Study|Adverse Event|3|||
23510685|NCT01018186|65606147|FG003|2-week Run-in Period|Protocol Violation|0|||
23708863|NCT02121756|66312238|FG001|Overall Study|Adverse Event|0|||
23708864|NCT02121756|66312237|FG000|Overall Study|Protocol Violation|1|||
23510686|NCT01018186|65606144|FG000|2-week Run-in Period|Lost to Follow-up|2|||
23510687|NCT01018186|65606145|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23708865|NCT02121756|66312238|FG001|Overall Study|Protocol Violation|1|||
23708866|NCT02121756|66312237|FG000|Overall Study|Physician Decision|2|||
23708867|NCT02121756|66312238|FG001|Overall Study|Physician Decision|1|||
23708868|NCT02364947|66312239|FG000|Overall Study|Withdrawal by Subject|10|||
23708869|NCT02364947|66312240|FG001|Overall Study|Withdrawal by Subject|8|||
23708870|NCT02364947|66312241|FG002|Overall Study|Withdrawal by Subject|9|||
23708871|NCT02364947|66312239|FG000|Overall Study|Adverse Event|45|||
23708872|NCT02364947|66312240|FG001|Overall Study|Adverse Event|33|||
23708873|NCT02364947|66312241|FG002|Overall Study|Adverse Event|11|||
23708874|NCT02364947|66312239|FG000|Overall Study|Protocol Violation|1|||
23708875|NCT02364947|66312240|FG001|Overall Study|Protocol Violation|1|||
23708876|NCT02364947|66312241|FG002|Overall Study|Protocol Violation|1|||
23708877|NCT02364947|66312239|FG000|Overall Study|Physician Decision|3|||
23708878|NCT02364947|66312240|FG001|Overall Study|Physician Decision|2|||
23708879|NCT02364947|66312241|FG002|Overall Study|Physician Decision|5|||
23708880|NCT02364947|66312239|FG000|Overall Study|Death|0|||
23708881|NCT02364947|66312240|FG001|Overall Study|Death|1|||
23708882|NCT02364947|66312241|FG002|Overall Study|Death|0|||
23708883|NCT00617409|66312242|FG000|Overall Study|Withdrawal by Subject|4|||
23708884|NCT00617409|66312243|FG001|Overall Study|Withdrawal by Subject|1|||
23708885|NCT00617409|66312244|FG002|Overall Study|Withdrawal by Subject|2|||
23708886|NCT00617409|66312242|FG000|Overall Study|Adverse Event|0|||
23708887|NCT00617409|66312243|FG001|Overall Study|Adverse Event|2|||
23708888|NCT00617409|66312244|FG002|Overall Study|Adverse Event|3|||
23708889|NCT00617409|66312242|FG000|Overall Study|Disease Progression|8|||
23708890|NCT00617409|66312243|FG001|Overall Study|Disease Progression|8|||
23708891|NCT00617409|66312244|FG002|Overall Study|Disease Progression|18|||
23708892|NCT00617409|66312242|FG000|Overall Study|Death|3|||
23708893|NCT00617409|66312243|FG001|Overall Study|Death|5|||
23708894|NCT00617409|66312244|FG002|Overall Study|Death|4|||
23708895|NCT00617409|66312242|FG000|Overall Study|Alternative Therapy|1|||
23708896|NCT00617409|66312243|FG001|Overall Study|Alternative Therapy|2|||
23708897|NCT00617409|66312244|FG002|Overall Study|Alternative Therapy|0|||
23708898|NCT01525849|66312247|FG000|Overall Study|Lost to Follow-up|3|||
23708899|NCT01525849|66312248|FG001|Overall Study|Lost to Follow-up|2|||
23708900|NCT01525849|66312247|FG000|Overall Study|Withdrawal by Subject|1|||
23708901|NCT01525849|66312248|FG001|Overall Study|Withdrawal by Subject|9|||
23708902|NCT01525849|66312247|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
23708903|NCT01525849|66312248|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
23708904|NCT01525849|66312247|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
23708905|NCT01525849|66312248|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
23708906|NCT00142519|66312251|FG000|Overall Study|Not Treated|7|||
23708907|NCT00142519|66312252|FG001|Overall Study|Not Treated|9|||
23708908|NCT00142519|66312251|FG000|Overall Study|Protocol Violation|1|||
23708909|NCT00142519|66312252|FG001|Overall Study|Protocol Violation|0|||
23708910|NCT00142519|66312251|FG000|Overall Study|Withdrawal by Subject|10|||
23708911|NCT00142519|66312252|FG001|Overall Study|Withdrawal by Subject|7|||
23708912|NCT01603641|66312253|FG000|Overall Study|Did not Receive Treatment|3|||
23708913|NCT01603641|66312253|FG000|Overall Study|Adverse Event|1|||
23708914|NCT01603641|66312253|FG000|Overall Study|Lack of Efficacy|1|||
23708915|NCT01603641|66312253|FG000|Overall Study|Lost to Follow-up|6|||
23708916|NCT01603641|66312253|FG000|Overall Study|Personal Reasons|18|||
23708917|NCT01603641|66312253|FG000|Overall Study|Other Miscellaneous Reasons|6|||
23708918|NCT01328249|66312257|FG000|Overall Study|Adverse Event|3|||
23708919|NCT01328249|66312258|FG001|Overall Study|Adverse Event|0|||
23708920|NCT01328249|66312257|FG000|Overall Study|Disease progression|1|||
23708921|NCT01328249|66312258|FG001|Overall Study|Disease progression|0|||
23708922|NCT01328249|66312257|FG000|Overall Study|Withdrawal by Subject|1|||
23708923|NCT01328249|66312258|FG001|Overall Study|Withdrawal by Subject|1|||
23708924|NCT01328249|66312257|FG000|Overall Study|Moved before end of treatment visit|1|||
23708925|NCT01328249|66312258|FG001|Overall Study|Moved before end of treatment visit|0|||
23708926|NCT01328249|66312257|FG000|Overall Study|Subject choice|1|||
23708927|NCT01328249|66312258|FG001|Overall Study|Subject choice|1|||
23708928|NCT01328249|66312257|FG000|Overall Study|Protocol Violation|0|||
23708929|NCT01328249|66312258|FG001|Overall Study|Protocol Violation|1|||
23708930|NCT01553916|66312259|FG000|Overall Study|Withdrawal by Subject|2|||
23708931|NCT01553916|66312259|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
23708932|NCT00195260|66312262|FG000|Part 1: Dose Escalation|Adverse Event|0|||
23708933|NCT00195260|66312263|FG001|Part 1: Dose Escalation|Adverse Event|1|||
23708934|NCT00195260|66312264|FG002|Part 1: Dose Escalation|Adverse Event|0|||
23708935|NCT00195260|66312265|FG003|Part 1: Dose Escalation|Adverse Event|1|||
23708936|NCT00195260|66312266|FG004|Part 1: Dose Escalation|Adverse Event|1|||
23708937|NCT00195260|66312267|FG005|Part 1: Dose Escalation|Adverse Event|0|||
23708938|NCT00195260|66312268|FG006|Part 1: Dose Escalation|Adverse Event|3|||
23708939|NCT00195260|66312269|FG007|Part 1: Dose Escalation|Adverse Event|0|||
23708940|NCT00195260|66312270|FG008|Part 1: Dose Escalation|Adverse Event|0|||
23708941|NCT00195260|66312271|FG009|Part 1: Dose Escalation|Adverse Event|0|||
23610563|NCT04626128|65962800|FG003|Overall Study|Withdrawal by Subject|0|||
23610564|NCT01426217|65962801|FG000|Overall Study|lost sample|8|||
23610565|NCT01426217|65962802|FG001|Overall Study|lost sample|14|||
23610566|NCT01964547|65962804|FG000|Overall Study|Adverse Event|8|||
23708942|NCT00195260|66312272|FG010|Part 1: Dose Escalation|Adverse Event|0|||
23708943|NCT00195260|66312262|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708944|NCT00195260|66312263|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708945|NCT00195260|66312264|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708946|NCT00195260|66312265|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708947|NCT00195260|66312266|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
23708948|NCT00195260|66312267|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708949|NCT00195260|66312268|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708950|NCT00195260|66312269|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
23708951|NCT00195260|66312270|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708952|NCT00195260|66312271|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708953|NCT00195260|66312272|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23708954|NCT00195260|66312262|FG000|Part 1: Dose Escalation|Death|0|||
23708955|NCT00195260|66312263|FG001|Part 1: Dose Escalation|Death|0|||
23811457|NCT02038907|66691726|FG007|Overall Study|Withdrawal by Subject|0|||
23811458|NCT02038907|66691727|FG008|Overall Study|Withdrawal by Subject|0|||
23811459|NCT02038907|66691728|FG009|Overall Study|Withdrawal by Subject|0|||
23811460|NCT02038907|66691729|FG010|Overall Study|Withdrawal by Subject|1|||
23811461|NCT02038907|66691730|FG011|Overall Study|Withdrawal by Subject|0|||
23811462|NCT02038907|66691731|FG012|Overall Study|Withdrawal by Subject|0|||
23811463|NCT02038907|66691732|FG013|Overall Study|Withdrawal by Subject|0|||
23811464|NCT01957176|66691733|FG000|Overall Study|Adverse Event|2|||
23811465|NCT01957176|66691734|FG001|Overall Study|Adverse Event|0|||
23811466|NCT01957176|66691733|FG000|Overall Study|Physician Decision|2|||
23811467|NCT01957176|66691734|FG001|Overall Study|Physician Decision|1|||
23811468|NCT01957176|66691733|FG000|Overall Study|Withdrawal by Subject|1|||
23811469|NCT01957176|66691734|FG001|Overall Study|Withdrawal by Subject|0|||
23811470|NCT03233230|66691737|FG000|Overall Study|Adverse Event|6|||
23811471|NCT03233230|66691738|FG001|Overall Study|Adverse Event|3|||
23811472|NCT03233230|66691739|FG002|Overall Study|Adverse Event|6|||
23811473|NCT03233230|66691740|FG003|Overall Study|Adverse Event|3|||
23811474|NCT03233230|66691737|FG000|Overall Study|Protocol Violation|1|||
23811475|NCT03233230|66691738|FG001|Overall Study|Protocol Violation|2|||
23811476|NCT03233230|66691739|FG002|Overall Study|Protocol Violation|1|||
23811477|NCT03233230|66691740|FG003|Overall Study|Protocol Violation|1|||
23811478|NCT03233230|66691737|FG000|Overall Study|Lack of Efficacy|1|||
23708956|NCT00195260|66312264|FG002|Part 1: Dose Escalation|Death|0|||
23708957|NCT00195260|66312265|FG003|Part 1: Dose Escalation|Death|0|||
23708958|NCT00195260|66312266|FG004|Part 1: Dose Escalation|Death|0|||
23708959|NCT00195260|66312267|FG005|Part 1: Dose Escalation|Death|0|||
23708960|NCT00195260|66312268|FG006|Part 1: Dose Escalation|Death|0|||
23708961|NCT00195260|66312269|FG007|Part 1: Dose Escalation|Death|1|||
23708962|NCT00195260|66312270|FG008|Part 1: Dose Escalation|Death|0|||
23708963|NCT00195260|66312271|FG009|Part 1: Dose Escalation|Death|0|||
23708964|NCT00195260|66312272|FG010|Part 1: Dose Escalation|Death|0|||
23708965|NCT00195260|66312262|FG000|Part 1: Dose Escalation|Disease Progression|3|||
23708966|NCT00195260|66312263|FG001|Part 1: Dose Escalation|Disease Progression|2|||
23708967|NCT00195260|66312264|FG002|Part 1: Dose Escalation|Disease Progression|5|||
23708968|NCT00195260|66312265|FG003|Part 1: Dose Escalation|Disease Progression|6|||
23708969|NCT00195260|66312266|FG004|Part 1: Dose Escalation|Disease Progression|4|||
23708970|NCT00195260|66312267|FG005|Part 1: Dose Escalation|Disease Progression|6|||
23708971|NCT00195260|66312268|FG006|Part 1: Dose Escalation|Disease Progression|7|||
23708972|NCT00195260|66312269|FG007|Part 1: Dose Escalation|Disease Progression|4|||
23708973|NCT00195260|66312270|FG008|Part 1: Dose Escalation|Disease Progression|0|||
23708974|NCT00195260|66312271|FG009|Part 1: Dose Escalation|Disease Progression|0|||
23708975|NCT00195260|66312272|FG010|Part 1: Dose Escalation|Disease Progression|0|||
23708976|NCT00195260|66312262|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23708977|NCT00195260|66312263|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23708978|NCT00195260|66312264|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23811479|NCT03233230|66691738|FG001|Overall Study|Lack of Efficacy|0|||
23811480|NCT03233230|66691739|FG002|Overall Study|Lack of Efficacy|0|||
23811481|NCT03233230|66691740|FG003|Overall Study|Lack of Efficacy|0|||
23811482|NCT03233230|66691737|FG000|Overall Study|Other|5|||
23811483|NCT03233230|66691738|FG001|Overall Study|Other|5|||
23811484|NCT03233230|66691739|FG002|Overall Study|Other|5|||
23811485|NCT03233230|66691740|FG003|Overall Study|Other|3|||
23811486|NCT03233230|66691737|FG000|Overall Study|Withdrawal by Subject|2|||
23811487|NCT03233230|66691738|FG001|Overall Study|Withdrawal by Subject|2|||
23811488|NCT03233230|66691739|FG002|Overall Study|Withdrawal by Subject|0|||
23811489|NCT03233230|66691740|FG003|Overall Study|Withdrawal by Subject|1|||
23811490|NCT03233230|66691737|FG000|Overall Study|Lost to Follow-up|0|||
23811491|NCT03233230|66691738|FG001|Overall Study|Lost to Follow-up|3|||
23811492|NCT03233230|66691739|FG002|Overall Study|Lost to Follow-up|0|||
23811493|NCT03233230|66691740|FG003|Overall Study|Lost to Follow-up|0|||
23811494|NCT01297465|66691741|FG000|Overall Study|Lack of Ovarian Response|1|||
23811495|NCT01297465|66691742|FG001|Overall Study|Lack of Ovarian Response|1|||
23811496|NCT01297465|66691741|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23811497|NCT01297465|66691742|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23811498|NCT01297465|66691741|FG000|Overall Study|No Oocytes Retrieved|1|||
23811499|NCT01297465|66691742|FG001|Overall Study|No Oocytes Retrieved|1|||
23811500|NCT01297465|66691741|FG000|Overall Study|Poor oocyte quality|0|||
23811501|NCT01297465|66691742|FG001|Overall Study|Poor oocyte quality|1|||
23708979|NCT00195260|66312265|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23811502|NCT01297465|66691741|FG000|Overall Study|No Fertilization|6|||
23811503|NCT01297465|66691742|FG001|Overall Study|No Fertilization|4|||
23811504|NCT01297465|66691741|FG000|Overall Study|All Embryos Discarded|0|||
23811505|NCT01297465|66691742|FG001|Overall Study|All Embryos Discarded|1|||
23811506|NCT01297465|66691741|FG000|Overall Study|Intention to Freeze all Embryos|0|||
23811507|NCT01297465|66691742|FG001|Overall Study|Intention to Freeze all Embryos|1|||
23811508|NCT01602965|66691743|FG000|Overall Study|Lost to Follow-up|4|||
23811509|NCT01602965|66691744|FG001|Overall Study|Lost to Follow-up|2|||
23811510|NCT04625725|66691745|FG000|Overall Study|Adverse Event|2|||
23811511|NCT04625725|66691746|FG001|Overall Study|Adverse Event|1|||
23811512|NCT04625725|66691745|FG000|Overall Study|Death|22|||
23811513|NCT04625725|66691746|FG001|Overall Study|Death|10|||
23811514|NCT04625725|66691745|FG000|Overall Study|Lost to Follow-up|357|||
23811515|NCT04625725|66691746|FG001|Overall Study|Lost to Follow-up|200|||
23811516|NCT04625725|66691745|FG000|Overall Study|Dosed in sub-study|310|||
23811517|NCT04625725|66691746|FG001|Overall Study|Dosed in sub-study|193|||
23811518|NCT04625725|66691745|FG000|Overall Study|Physician Decision|5|||
23811519|NCT04625725|66691746|FG001|Overall Study|Physician Decision|0|||
23811520|NCT04625725|66691745|FG000|Overall Study|Protocol Violation|1|||
23811521|NCT04625725|66691746|FG001|Overall Study|Protocol Violation|0|||
23811522|NCT04625725|66691745|FG000|Overall Study|Withdrawal by Subject|242|||
23811523|NCT04625725|66691746|FG001|Overall Study|Withdrawal by Subject|144|||
23811524|NCT04625725|66691745|FG000|Overall Study|Not specified otherwise|31|||
23811525|NCT04625725|66691746|FG001|Overall Study|Not specified otherwise|9|||
23811526|NCT04625725|66691745|FG000|Overall Study|Missing|0|||
23811527|NCT04625725|66691746|FG001|Overall Study|Missing|1|||
23811528|NCT00742924|66691747|FG000|Overall Study|Adverse Event|0|||
23811529|NCT00742924|66691748|FG001|Overall Study|Adverse Event|0|||
23811530|NCT00742924|66691749|FG002|Overall Study|Adverse Event|1|||
23811531|NCT00742924|66691750|FG003|Overall Study|Adverse Event|1|||
23811532|NCT00742924|66691747|FG000|Overall Study|Lack of Efficacy|5|||
23811533|NCT00742924|66691748|FG001|Overall Study|Lack of Efficacy|1|||
23811534|NCT00742924|66691749|FG002|Overall Study|Lack of Efficacy|2|||
23811535|NCT00742924|66691750|FG003|Overall Study|Lack of Efficacy|4|||
23811536|NCT00742924|66691747|FG000|Overall Study|Physician Decision|0|||
23811537|NCT00742924|66691748|FG001|Overall Study|Physician Decision|0|||
23811538|NCT00742924|66691749|FG002|Overall Study|Physician Decision|0|||
23811539|NCT00742924|66691750|FG003|Overall Study|Physician Decision|1|||
23811540|NCT00742924|66691747|FG000|Overall Study|Withdrawal by Subject|0|||
23811541|NCT00742924|66691748|FG001|Overall Study|Withdrawal by Subject|1|||
23811542|NCT00742924|66691749|FG002|Overall Study|Withdrawal by Subject|1|||
23811543|NCT00742924|66691750|FG003|Overall Study|Withdrawal by Subject|0|||
23811544|NCT03321630|66691751|FG000|Overall Study|Adverse Event|1|||
23811545|NCT03321630|66691751|FG000|Overall Study|Investigator Discretion|2|||
23811546|NCT03321630|66691751|FG000|Overall Study|Withdrawal by Subject|1|||
23811547|NCT03255655|66691752|FG000|Overall Study|Lost to Follow-up|7|||
23811548|NCT03255655|66691753|FG001|Overall Study|Lost to Follow-up|4|||
23811549|NCT02352779|66691758|FG000|Overall Study|Personal Issues|1|||
23811550|NCT02352779|66691759|FG001|Overall Study|Personal Issues|1|||
23811551|NCT02352779|66691760|FG002|Overall Study|Personal Issues|0|||
23811552|NCT02352779|66691758|FG000|Overall Study|Too Many Forms|2|||
23811553|NCT02352779|66691759|FG001|Overall Study|Too Many Forms|0|||
23811554|NCT02352779|66691760|FG002|Overall Study|Too Many Forms|0|||
23811555|NCT02352779|66691758|FG000|Overall Study|Feeling Overwhelmed|1|||
23811556|NCT02352779|66691759|FG001|Overall Study|Feeling Overwhelmed|0|||
23811557|NCT02352779|66691760|FG002|Overall Study|Feeling Overwhelmed|0|||
23811558|NCT02352779|66691758|FG000|Overall Study|Disliked Intervention|1|||
23811559|NCT02352779|66691759|FG001|Overall Study|Disliked Intervention|0|||
23811560|NCT02352779|66691760|FG002|Overall Study|Disliked Intervention|0|||
23811561|NCT02352779|66691758|FG000|Overall Study|Changed Mind|1|||
23811562|NCT02352779|66691759|FG001|Overall Study|Changed Mind|0|||
23811563|NCT02352779|66691760|FG002|Overall Study|Changed Mind|0|||
23811564|NCT02352779|66691758|FG000|Overall Study|Study Related Symptoms|1|||
23811565|NCT02352779|66691759|FG001|Overall Study|Study Related Symptoms|0|||
23811566|NCT02352779|66691760|FG002|Overall Study|Study Related Symptoms|0|||
23811567|NCT02352779|66691758|FG000|Overall Study|Absence of Symptoms|1|||
23811568|NCT02352779|66691759|FG001|Overall Study|Absence of Symptoms|0|||
23811569|NCT02352779|66691760|FG002|Overall Study|Absence of Symptoms|0|||
23811570|NCT02352779|66691758|FG000|Overall Study|Other Medical Reason|0|||
23811571|NCT02352779|66691759|FG001|Overall Study|Other Medical Reason|0|||
23811572|NCT02352779|66691760|FG002|Overall Study|Other Medical Reason|1|||
23811573|NCT02352779|66691758|FG000|Overall Study|No Reason|0|||
23811574|NCT02352779|66691759|FG001|Overall Study|No Reason|0|||
23811575|NCT02352779|66691760|FG002|Overall Study|No Reason|1|||
23811576|NCT04492020|66691761|FG000|Overall Study|Adverse Event|1|||
23811577|NCT04492020|66691762|FG001|Overall Study|Adverse Event|3|||
23811578|NCT04492020|66691761|FG000|Overall Study|Withdrawal by Subject|4|||
23811579|NCT04492020|66691762|FG001|Overall Study|Withdrawal by Subject|3|||
23811580|NCT04492020|66691761|FG000|Overall Study|Lost to Follow-up|4|||
23811581|NCT04492020|66691762|FG001|Overall Study|Lost to Follow-up|3|||
23811582|NCT04492020|66691761|FG000|Overall Study|Protocol Violation|5|||
23811583|NCT04492020|66691762|FG001|Overall Study|Protocol Violation|2|||
23811584|NCT04492020|66691761|FG000|Overall Study|Lack of Qualifying Event|25|||
23811585|NCT04492020|66691762|FG001|Overall Study|Lack of Qualifying Event|27|||
23811586|NCT04492020|66691761|FG000|Overall Study|Non-compliance with Study Drug|2|||
23811587|NCT04492020|66691762|FG001|Overall Study|Non-compliance with Study Drug|1|||
23811588|NCT01083810|66691765|FG000|Overall Study|Lost to Follow-up|23|||
23811589|NCT01083810|66691766|FG001|Overall Study|Lost to Follow-up|11|||
23811590|NCT01083810|66691767|FG002|Overall Study|Lost to Follow-up|4|||
23811591|NCT01083810|66691765|FG000|Overall Study|Adverse Event|15|||
23811592|NCT01083810|66691766|FG001|Overall Study|Adverse Event|11|||
23811593|NCT01083810|66691767|FG002|Overall Study|Adverse Event|4|||
23811594|NCT01083810|66691765|FG000|Overall Study|Withdrawal by Subject|7|||
23811595|NCT01083810|66691766|FG001|Overall Study|Withdrawal by Subject|2|||
23811596|NCT01083810|66691767|FG002|Overall Study|Withdrawal by Subject|4|||
23811597|NCT01083810|66691765|FG000|Overall Study|Reason not reported|6|||
23811598|NCT01083810|66691766|FG001|Overall Study|Reason not reported|1|||
23811599|NCT01083810|66691767|FG002|Overall Study|Reason not reported|1|||
23811600|NCT01083810|66691765|FG000|Overall Study|Non-compliance|4|||
23811601|NCT01083810|66691766|FG001|Overall Study|Non-compliance|7|||
23811602|NCT01083810|66691767|FG002|Overall Study|Non-compliance|2|||
23811603|NCT01083810|66691765|FG000|Overall Study|Simplification|4|||
23811604|NCT01083810|66691766|FG001|Overall Study|Simplification|1|||
23811605|NCT01083810|66691767|FG002|Overall Study|Simplification|0|||
23811606|NCT01083810|66691765|FG000|Overall Study|Death|2|||
23811607|NCT01083810|66691766|FG001|Overall Study|Death|2|||
23811608|NCT01083810|66691767|FG002|Overall Study|Death|3|||
23811609|NCT01083810|66691765|FG000|Overall Study|Co-morbidities|1|||
23811610|NCT01083810|66691766|FG001|Overall Study|Co-morbidities|0|||
23811611|NCT01083810|66691767|FG002|Overall Study|Co-morbidities|0|||
23811612|NCT01083810|66691765|FG000|Overall Study|Participation in study|1|||
23811613|NCT01083810|66691766|FG001|Overall Study|Participation in study|0|||
23811614|NCT01083810|66691767|FG002|Overall Study|Participation in study|0|||
23811615|NCT01083810|66691765|FG000|Overall Study|Therapy break|1|||
23811616|NCT01083810|66691766|FG001|Overall Study|Therapy break|2|||
23811617|NCT01083810|66691767|FG002|Overall Study|Therapy break|2|||
23811618|NCT01083810|66691765|FG000|Overall Study|Virologic failure|1|||
23811619|NCT01083810|66691766|FG001|Overall Study|Virologic failure|8|||
23811620|NCT01083810|66691767|FG002|Overall Study|Virologic failure|0|||
23510688|NCT01018186|65606146|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23811621|NCT03246646|66691768|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
23811622|NCT03246646|66691769|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
23811623|NCT03246646|66691768|FG000|Overall Study|Withdrawal by Subject|3|||
23510689|NCT01018186|65606147|FG003|2-week Run-in Period|Lost to Follow-up|0|||
23510690|NCT01018186|65606144|FG000|2-week Run-in Period|Physician Decision|3|||
23510691|NCT01018186|65606145|FG001|2-week Run-in Period|Physician Decision|0|||
23811624|NCT03246646|66691769|FG001|Overall Study|Withdrawal by Subject|0|||
23811625|NCT03246646|66691768|FG000|Overall Study|Lost to Follow-up|7|||
23811626|NCT03246646|66691769|FG001|Overall Study|Lost to Follow-up|0|||
23811627|NCT01268501|66691770|FG000|Overall Study|Lost to Follow-up|1|||
23811628|NCT01268501|66691770|FG000|Overall Study|Withdrawal by Subject|3|||
23811629|NCT01268501|66691770|FG000|Overall Study|Unacceptable Subjective Vision|3|||
23811630|NCT01268501|66691770|FG000|Overall Study|Handling Difficulties|2|||
23811631|NCT00852969|66691771|FG000|Overall Study|Adverse Event|0|||
23811632|NCT00852969|66691772|FG001|Overall Study|Adverse Event|1|||
23811633|NCT00852969|66691771|FG000|Overall Study|Lost to Follow-up|0|||
23811634|NCT00852969|66691772|FG001|Overall Study|Lost to Follow-up|1|||
23811635|NCT04505293|66691778|FG000|Overall Study|Lost to Follow-up|2|||
23811636|NCT04505293|66691778|FG000|Overall Study|Withdrawal by Subject|6|||
23811637|NCT04505293|66691778|FG000|Overall Study|CT scan unreadable|277|||
23811638|NCT04271735|66691782|FG000|Overall Study|Physician Decision|2|||
23811639|NCT04271735|66691783|FG001|Overall Study|Physician Decision|0|||
23811640|NCT04663295|66691786|FG000|Run-in Period|Withdrawal by Subject|3|||
23811641|NCT04663295|66691786|FG000|Overall Study Period|Pregnancy|1|||
23811642|NCT04663295|66691786|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
23811643|NCT01996332|66691787|FG000|Overall Study|Adverse Event|117|||
23811644|NCT01996332|66691787|FG000|Overall Study|Lack of Efficacy|1245|||
23811645|NCT01996332|66691787|FG000|Overall Study|Death|264|||
23811646|NCT01996332|66691787|FG000|Overall Study|Protocol Violation|9|||
23811647|NCT01996332|66691787|FG000|Overall Study|Withdrawal by Subject|71|||
23811648|NCT01996332|66691787|FG000|Overall Study|Other|20|||
23811649|NCT01996332|66691787|FG000|Overall Study|Clinical Deterioration|28|||
23811650|NCT01996332|66691787|FG000|Overall Study|Physician Decision|17|||
23811651|NCT01996332|66691787|FG000|Overall Study|Lost to Follow-up|34|||
23811652|NCT02730351|66691788|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
23811653|NCT02730351|66691789|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
23811654|NCT02730351|66691788|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
23811655|NCT02730351|66691789|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
23811656|NCT02730351|66691788|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
23811657|NCT02730351|66691789|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
23811658|NCT02730351|66691788|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
23811659|NCT02730351|66691789|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
23811660|NCT02730351|66691788|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
23811661|NCT02730351|66691789|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
23811662|NCT00540293|66691790|FG000|Overall Study|Adverse event related to study drug|10|||
23811663|NCT00540293|66691790|FG000|Overall Study|Adverse event not related to study drug|7|||
23811664|NCT00540293|66691790|FG000|Overall Study|Withdrawal by Subject|6|||
23811665|NCT00540293|66691790|FG000|Overall Study|Protocol violation, & subject schedule|12|||
23811666|NCT01267994|66691795|FG000|Overall Study|Adverse Event|2|||
23811667|NCT01288053|66691798|FG000|Overall Study|Death|1|||
23811668|NCT00699374|66691799|FG000|Overall Study|Death|93|||
23811669|NCT00699374|66691800|FG001|Overall Study|Death|83|||
23811670|NCT00699374|66691799|FG000|Overall Study|Adverse Event|70|||
23811671|NCT00699374|66691800|FG001|Overall Study|Adverse Event|67|||
23811672|NCT00699374|66691799|FG000|Overall Study|Global deterioration of health status|7|||
23811673|NCT00699374|66691800|FG001|Overall Study|Global deterioration of health status|8|||
23811674|NCT00699374|66691799|FG000|Overall Study|Lost to Follow-up|3|||
23811675|NCT00699374|66691800|FG001|Overall Study|Lost to Follow-up|5|||
23811676|NCT00699374|66691799|FG000|Overall Study|Withdrawal by Subject|34|||
23811677|NCT00699374|66691800|FG001|Overall Study|Withdrawal by Subject|44|||
23811678|NCT00699374|66691799|FG000|Overall Study|Objective progression or relapse|281|||
23811679|NCT00699374|66691800|FG001|Overall Study|Objective progression or relapse|277|||
23811680|NCT00699374|66691799|FG000|Overall Study|Other|18|||
23811681|NCT00699374|66691800|FG001|Overall Study|Other|15|||
23811682|NCT00699374|66691799|FG000|Overall Study|Protocol Violation|2|||
23811683|NCT00699374|66691800|FG001|Overall Study|Protocol Violation|6|||
23811684|NCT00699374|66691799|FG000|Overall Study|Study terminated by sponsor|13|||
23811685|NCT00699374|66691800|FG001|Overall Study|Study terminated by sponsor|28|||
23811686|NCT00699374|66691799|FG000|Overall Study|Randomized but not treated|4|||
23811687|NCT00699374|66691800|FG001|Overall Study|Randomized but not treated|2|||
23811688|NCT00699374|66691799|FG000|Overall Study|Died 28 days after last dose|5|||
23811689|NCT00699374|66691800|FG001|Overall Study|Died 28 days after last dose|9|||
23510692|NCT01018186|65606146|FG002|2-week Run-in Period|Physician Decision|0|||
23510693|NCT01018186|65606147|FG003|2-week Run-in Period|Physician Decision|0|||
23510694|NCT01018186|65606144|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
23510695|NCT01018186|65606145|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23510696|NCT01018186|65606146|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23510697|NCT01018186|65606147|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
23510698|NCT01018186|65606144|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
23510699|NCT01018186|65606145|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510700|NCT01018186|65606146|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510701|NCT01018186|65606147|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510702|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
23510703|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
23811690|NCT02119286|66691801|FG000|Overall Study|Adverse Event|9|||
23811691|NCT02119286|66691802|FG001|Overall Study|Adverse Event|7|||
23811692|NCT02119286|66691803|FG002|Overall Study|Adverse Event|2|||
23811693|NCT02119286|66691801|FG000|Overall Study|Lack of Efficacy|11|||
23811694|NCT02119286|66691802|FG001|Overall Study|Lack of Efficacy|3|||
23811695|NCT02119286|66691803|FG002|Overall Study|Lack of Efficacy|4|||
23811696|NCT02119286|66691801|FG000|Overall Study|Lost to Follow-up|2|||
23811697|NCT02119286|66691802|FG001|Overall Study|Lost to Follow-up|0|||
23811698|NCT02119286|66691803|FG002|Overall Study|Lost to Follow-up|1|||
23811699|NCT02119286|66691801|FG000|Overall Study|Withdrawal by Subject|4|||
23811700|NCT02119286|66691802|FG001|Overall Study|Withdrawal by Subject|1|||
23811701|NCT02119286|66691803|FG002|Overall Study|Withdrawal by Subject|0|||
23811702|NCT00688376|66691804|FG000|Double-Blind Phase|Adverse Event|4|||
23811703|NCT00688376|66691805|FG001|Double-Blind Phase|Adverse Event|4|||
23811704|NCT00688376|66691804|FG000|Double-Blind Phase|Protocol Violation|1|||
23811705|NCT00688376|66691805|FG001|Double-Blind Phase|Protocol Violation|2|||
23811706|NCT00688376|66691804|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
23811707|NCT00688376|66691805|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
23811708|NCT00688376|66691804|FG000|Double-Blind Phase|Not treated|0|||
23811709|NCT00688376|66691805|FG001|Double-Blind Phase|Not treated|1|||
23811710|NCT00688376|66691804|FG000|Blinded Extension Phase|Adverse Event|3|||
23811711|NCT00688376|66691805|FG001|Blinded Extension Phase|Adverse Event|4|||
23811712|NCT00688376|66691804|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
23811713|NCT00688376|66691805|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
23811714|NCT00688376|66691804|FG000|Blinded Extension Phase|Physician Decision|1|||
23811715|NCT00688376|66691805|FG001|Blinded Extension Phase|Physician Decision|0|||
23811716|NCT00688376|66691804|FG000|Blinded Extension Phase|Other|1|||
23811717|NCT00688376|66691805|FG001|Blinded Extension Phase|Other|0|||
23811718|NCT03579966|66691808|FG000|Overall Study|Adverse Event|6|||
23811719|NCT03579966|66691808|FG000|Overall Study|Lost to Follow-up|4|||
23811720|NCT03579966|66691808|FG000|Overall Study|Physician Decision|10|||
23811721|NCT03579966|66691808|FG000|Overall Study|Pregnancy|1|||
23811722|NCT03579966|66691808|FG000|Overall Study|Withdrawal by Subject|16|||
23811723|NCT03579966|66691808|FG000|Overall Study|Study terminated by Sponsor|22|||
23811724|NCT03579966|66691808|FG000|Overall Study|Protocol Violation|1|||
23811725|NCT05012163|66691811|FG000|Overall Study|Protocol Violation|0|||
23811726|NCT05012163|66691812|FG001|Overall Study|Protocol Violation|0|||
23510704|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
23510705|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
23811727|NCT05012163|66691813|FG002|Overall Study|Protocol Violation|1|||
23811728|NCT05012163|66691814|FG003|Overall Study|Protocol Violation|1|||
23811729|NCT00315731|66691815|FG000|Overall Study|Lost to Follow-up|1|||
23811730|NCT00315731|66691815|FG000|Overall Study|Death|5|||
23811731|NCT04295135|66691816|FG000|Overall Study|Withdrawal by Subject|2|||
23510706|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23510707|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
23510708|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
23510709|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
23510710|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
23510711|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
23510712|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
23510713|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
23510714|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
23510715|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
23510716|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
23510717|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
23510718|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
23510719|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
23510720|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
23510721|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
23811732|NCT04295135|66691817|FG001|Overall Study|Withdrawal by Subject|1|||
23811733|NCT04295135|66691816|FG000|Overall Study|Subject left organization|8|||
23811734|NCT04295135|66691817|FG001|Overall Study|Subject left organization|4|||
23811735|NCT04188301|66691818|FG000|Month 3|Lost to Follow-up|0|||
23811736|NCT04188301|66691819|FG001|Month 3|Lost to Follow-up|0|||
23811737|NCT04188301|66691820|FG002|Month 3|Lost to Follow-up|1|||
23811738|NCT04188301|66691818|FG000|Month 12|Lost to Follow-up|0|||
23811739|NCT04188301|66691819|FG001|Month 12|Lost to Follow-up|0|||
23811740|NCT04188301|66691820|FG002|Month 12|Lost to Follow-up|2|||
23811741|NCT04188301|66691818|FG000|Month 12|Death|1|||
23811742|NCT04188301|66691819|FG001|Month 12|Death|1|||
23811743|NCT04188301|66691820|FG002|Month 12|Death|0|||
23811744|NCT04188301|66691818|FG000|Month 18|Lost to Follow-up|6|||
23811745|NCT04188301|66691819|FG001|Month 18|Lost to Follow-up|0|||
23811746|NCT04188301|66691820|FG002|Month 18|Lost to Follow-up|0|||
23811747|NCT03107026|66691823|FG000|Overall Study|Adverse Event|2|||
23811748|NCT03107026|66691824|FG001|Overall Study|Adverse Event|14|||
23811749|NCT03107026|66691825|FG002|Overall Study|Adverse Event|23|||
23811750|NCT03107026|66691823|FG000|Overall Study|Lost to Follow-up|12|||
23811751|NCT03107026|66691824|FG001|Overall Study|Lost to Follow-up|12|||
23811752|NCT03107026|66691825|FG002|Overall Study|Lost to Follow-up|13|||
23811753|NCT03107026|66691823|FG000|Overall Study|Protocol Violation|1|||
23811754|NCT03107026|66691824|FG001|Overall Study|Protocol Violation|2|||
23811755|NCT03107026|66691825|FG002|Overall Study|Protocol Violation|0|||
23811756|NCT03107026|66691823|FG000|Overall Study|Pregnancy|1|||
23811757|NCT03107026|66691824|FG001|Overall Study|Pregnancy|0|||
23811758|NCT03107026|66691825|FG002|Overall Study|Pregnancy|0|||
23811759|NCT03107026|66691823|FG000|Overall Study|Withdrawal by Subject|13|||
23811760|NCT03107026|66691824|FG001|Overall Study|Withdrawal by Subject|5|||
23708980|NCT00195260|66312266|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23708981|NCT00195260|66312267|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23708982|NCT00195260|66312268|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23811761|NCT03107026|66691825|FG002|Overall Study|Withdrawal by Subject|17|||
23811762|NCT03107026|66691823|FG000|Overall Study|non compliance with study visits|1|||
23811763|NCT03107026|66691824|FG001|Overall Study|non compliance with study visits|2|||
23811764|NCT03107026|66691825|FG002|Overall Study|non compliance with study visits|0|||
23510722|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
23510723|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
23510724|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
23811765|NCT03107026|66691823|FG000|Overall Study|non-compliance with study drug|2|||
23510725|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
23408602|NCT01766037|65239939|FG001|Overall Study|Adverse Event|0|||
23811766|NCT03107026|66691824|FG001|Overall Study|non-compliance with study drug|2|||
23811767|NCT03107026|66691825|FG002|Overall Study|non-compliance with study drug|3|||
23811768|NCT03107026|66691823|FG000|Overall Study|Physician Decision|0|||
23811769|NCT03107026|66691824|FG001|Overall Study|Physician Decision|1|||
23510726|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23510727|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
23510728|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
23510729|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
23510730|NCT01386554|65606148|FG000|Overall Study|Lost to Follow-up|0|||
23510731|NCT01386554|65606149|FG001|Overall Study|Lost to Follow-up|0|||
23510732|NCT01386554|65606150|FG002|Overall Study|Lost to Follow-up|1|||
23510733|NCT01386554|65606148|FG000|Overall Study|Adverse Event|2|||
23510734|NCT01386554|65606149|FG001|Overall Study|Adverse Event|5|||
23510735|NCT01386554|65606150|FG002|Overall Study|Adverse Event|2|||
23510736|NCT01386554|65606148|FG000|Overall Study|Progressive disease|1|||
23510737|NCT01386554|65606149|FG001|Overall Study|Progressive disease|2|||
23510738|NCT01386554|65606150|FG002|Overall Study|Progressive disease|2|||
23510739|NCT01386554|65606148|FG000|Overall Study|Administration of live vaccines|0|||
23510740|NCT01386554|65606149|FG001|Overall Study|Administration of live vaccines|1|||
23510741|NCT01386554|65606150|FG002|Overall Study|Administration of live vaccines|0|||
23510742|NCT01386554|65606148|FG000|Overall Study|Investigator discretion|0|||
23510743|NCT01386554|65606149|FG001|Overall Study|Investigator discretion|0|||
23510744|NCT01386554|65606150|FG002|Overall Study|Investigator discretion|1|||
23510745|NCT01386554|65606148|FG000|Overall Study|Reason not collected|0|||
23510746|NCT01386554|65606149|FG001|Overall Study|Reason not collected|1|||
23510747|NCT01386554|65606150|FG002|Overall Study|Reason not collected|0|||
23510748|NCT03187197|65606151|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
23510749|NCT03187197|65606152|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
23510750|NCT03187197|65606153|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
23510751|NCT03187197|65606151|FG000|Overall Study|Withdrawal by Subject|8|||
23510752|NCT03187197|65606152|FG001|Overall Study|Withdrawal by Subject|63|||
23510753|NCT03187197|65606153|FG002|Overall Study|Withdrawal by Subject|4|||
23510754|NCT03187197|65606151|FG000|Overall Study|Lost to Follow-up|1|||
23510755|NCT03187197|65606152|FG001|Overall Study|Lost to Follow-up|60|||
23510756|NCT03187197|65606153|FG002|Overall Study|Lost to Follow-up|7|||
23510757|NCT03187197|65606151|FG000|Overall Study|Adverse Event|6|||
23510758|NCT03187197|65606152|FG001|Overall Study|Adverse Event|29|||
23510759|NCT03187197|65606153|FG002|Overall Study|Adverse Event|0|||
23510760|NCT03187197|65606151|FG000|Overall Study|Death|0|||
23510761|NCT03187197|65606152|FG001|Overall Study|Death|11|||
23510762|NCT03187197|65606153|FG002|Overall Study|Death|0|||
23510763|NCT03187197|65606151|FG000|Overall Study|Administrative problem|1|||
23510764|NCT03187197|65606152|FG001|Overall Study|Administrative problem|1|||
23510765|NCT03187197|65606153|FG002|Overall Study|Administrative problem|0|||
23510766|NCT03187197|65606151|FG000|Overall Study|Reason not listed|2|||
23510767|NCT03187197|65606152|FG001|Overall Study|Reason not listed|54|||
23510768|NCT03187197|65606153|FG002|Overall Study|Reason not listed|1|||
23510769|NCT03187197|65606151|FG000|Overall Study|Missing|1|||
23510770|NCT03187197|65606152|FG001|Overall Study|Missing|32|||
23510771|NCT03187197|65606153|FG002|Overall Study|Missing|3|||
23510772|NCT03187197|65606151|FG000|Overall Study|Status missing|2|||
23510773|NCT03187197|65606152|FG001|Overall Study|Status missing|33|||
23510774|NCT03187197|65606153|FG002|Overall Study|Status missing|3|||
23510775|NCT03187197|65606151|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
23510776|NCT03187197|65606152|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
23510777|NCT03187197|65606153|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
23510778|NCT03552198|65606154|FG000|Overall Study|Lost to Follow-up|42|||
23510779|NCT03552198|65606155|FG001|Overall Study|Lost to Follow-up|48|||
23510780|NCT03552198|65606156|FG002|Overall Study|Lost to Follow-up|15|||
23510781|NCT03552198|65606157|FG003|Overall Study|Lost to Follow-up|19|||
23510782|NCT03552198|65606154|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
23510783|NCT03552198|65606155|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
23510784|NCT03552198|65606156|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
23510785|NCT03552198|65606157|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
23510786|NCT03552198|65606154|FG000|Overall Study|Did not receive air alerts|1|||
23510787|NCT03552198|65606155|FG001|Overall Study|Did not receive air alerts|0|||
23510788|NCT03552198|65606156|FG002|Overall Study|Did not receive air alerts|0|||
23510789|NCT03552198|65606157|FG003|Overall Study|Did not receive air alerts|1|||
23510790|NCT02692716|65606158|FG000|Overall Study|Lost to Follow-up|2|||
23510791|NCT02692716|65606159|FG001|Overall Study|Lost to Follow-up|5|||
23510792|NCT02692716|65606158|FG000|Overall Study|Withdrawal by Subject|3|||
23510793|NCT02692716|65606159|FG001|Overall Study|Withdrawal by Subject|1|||
23510794|NCT00936910|65606161|FG000|Overall Study|Lack of Efficacy|3|||
23510795|NCT00903695|65606162|FG000|Overall Study|medical exclusion after 1st testing|1|||
23811770|NCT03107026|66691825|FG002|Overall Study|Physician Decision|0|||
23510796|NCT00903695|65606163|FG001|Overall Study|medical exclusion after 1st testing|0|||
23510797|NCT00903695|65606162|FG000|Overall Study|lung cancer|1|||
23510798|NCT00903695|65606163|FG001|Overall Study|lung cancer|0|||
23510799|NCT01535053|65606164|FG000|Overall Study|Ineligible|1|||
23510800|NCT01535053|65606165|FG001|Overall Study|Ineligible|2|||
23510801|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
23510802|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
23510803|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
23510804|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
23510805|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
23510806|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
23510807|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
23510808|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
23510809|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
23510810|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
23510811|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
23811771|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
23811772|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
23811773|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
23811774|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
23811775|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
23811776|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
23811777|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
23811778|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
23811779|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
23811780|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
23811781|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
23811782|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
23811783|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
23811784|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
23811785|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
23811786|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
23811787|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23811788|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23811789|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
23811790|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23811791|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23811792|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23811793|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23811794|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23811795|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
23811796|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23811797|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23510812|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
23510813|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
23510814|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
23510815|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
23811798|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
23811799|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23811800|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23811801|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
23811802|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
23811803|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
23811804|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23811805|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23811806|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23811807|NCT00773734|66691826|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23811808|NCT00773734|66691827|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23811809|NCT00773734|66691828|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23811810|NCT00773734|66691829|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23811811|NCT00773734|66691830|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
23811812|NCT00773734|66691831|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
23811813|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23811814|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
23811815|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23811816|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23811817|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
23811818|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
23811819|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23811820|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
23811821|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
23510816|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
23510817|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
23510818|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
23510819|NCT03291808|65606170|FG000|Overall Study|Lost to Follow-up|6|||
23510820|NCT03291808|65606170|FG000|Overall Study|Research burden|4|||
23510821|NCT04840615|65606172|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
23510822|NCT04840615|65606173|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
23408603|NCT01766037|65239938|FG000|Overall Study|Lack of Efficacy|1|||
23408604|NCT01766037|65239939|FG001|Overall Study|Lack of Efficacy|0|||
23408605|NCT01766037|65239938|FG000|Overall Study|Lost to Follow-up|0|||
23408606|NCT01766037|65239939|FG001|Overall Study|Lost to Follow-up|10|||
23408607|NCT01766037|65239938|FG000|Overall Study|Physician Decision|0|||
23408608|NCT01766037|65239939|FG001|Overall Study|Physician Decision|1|||
23408609|NCT01766037|65239938|FG000|Overall Study|Withdrawal by Subject|18|||
23408610|NCT01766037|65239939|FG001|Overall Study|Withdrawal by Subject|16|||
23408611|NCT01766037|65239938|FG000|Overall Study|Moved from area|5|||
23408612|NCT01766037|65239939|FG001|Overall Study|Moved from area|0|||
23408613|NCT01766037|65239938|FG000|Overall Study|medical - unrelated|1|||
23408614|NCT01766037|65239939|FG001|Overall Study|medical - unrelated|2|||
23408615|NCT01766037|65239938|FG000|Overall Study|nausea / discomfort|3|||
23408616|NCT01766037|65239939|FG001|Overall Study|nausea / discomfort|0|||
23408617|NCT01575808|65239940|FG000|Overall Study|Death|2|||
23408618|NCT01575808|65239941|FG001|Overall Study|Death|0|||
23408619|NCT01575808|65239940|FG000|Overall Study|Withdrawal by Subject|1|||
23408620|NCT01575808|65239941|FG001|Overall Study|Withdrawal by Subject|0|||
23408621|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
23408622|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
23408623|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
23408624|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
23408625|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
23408626|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
23408627|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
23408628|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
23408629|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
23408630|NCT00662831|65239952|FG000|Overall Study|Death|4|||
23408631|NCT00662831|65239953|FG001|Overall Study|Death|1|||
23408632|NCT00662831|65239952|FG000|Overall Study|Lack of Efficacy|6|||
23408633|NCT00662831|65239953|FG001|Overall Study|Lack of Efficacy|6|||
23408634|NCT00662831|65239952|FG000|Overall Study|Lost to Follow-up|1|||
23408635|NCT00662831|65239953|FG001|Overall Study|Lost to Follow-up|0|||
23408636|NCT00662831|65239952|FG000|Overall Study|Withdrawal by Subject|2|||
23408637|NCT00662831|65239953|FG001|Overall Study|Withdrawal by Subject|1|||
23408638|NCT00662831|65239952|FG000|Overall Study|Other|62|||
23408639|NCT00662831|65239953|FG001|Overall Study|Other|31|||
23408640|NCT00662831|65239952|FG000|Overall Study|Protocol Violation|8|||
23408641|NCT00662831|65239953|FG001|Overall Study|Protocol Violation|4|||
23408642|NCT00662831|65239952|FG000|Overall Study|Adverse Event|23|||
23408643|NCT00662831|65239953|FG001|Overall Study|Adverse Event|16|||
23408644|NCT02038946|65239957|FG000|Overall Study|Death|5|||
23408645|NCT02038946|65239957|FG000|Overall Study|Withdrawal by Subject|3|||
23408646|NCT02038946|65239957|FG000|Overall Study|Lost to Follow-up|2|||
23408647|NCT02038946|65239957|FG000|Overall Study|Other reasons|2|||
23408648|NCT01119066|65239961|FG000|Overall Study|Withdrawal by Subject|4|||
23408649|NCT01119066|65239962|FG001|Overall Study|Withdrawal by Subject|6|||
23408650|NCT01119066|65239963|FG002|Overall Study|Withdrawal by Subject|0|||
23408651|NCT01119066|65239964|FG003|Overall Study|Withdrawal by Subject|0|||
23408652|NCT01119066|65239961|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
23408653|NCT01119066|65239962|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
23408654|NCT01119066|65239963|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
23408655|NCT01119066|65239964|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
23408656|NCT01119066|65239961|FG000|Overall Study|Relapse identified before transplant|1|||
23408657|NCT01119066|65239962|FG001|Overall Study|Relapse identified before transplant|0|||
23408658|NCT01119066|65239963|FG002|Overall Study|Relapse identified before transplant|0|||
23408659|NCT01119066|65239964|FG003|Overall Study|Relapse identified before transplant|0|||
23408660|NCT01119066|65239961|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408661|NCT01119066|65239962|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
23408662|NCT01119066|65239963|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408663|NCT01119066|65239964|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408664|NCT01119066|65239961|FG000|Overall Study|Relapse identified before transplant|0|||
23408665|NCT01119066|65239962|FG001|Overall Study|Relapse identified before transplant|4|||
23610567|NCT01964547|65962805|FG001|Overall Study|Adverse Event|2|||
23610568|NCT01964547|65962804|FG000|Overall Study|Withdrawal by Subject|4|||
23408666|NCT01119066|65239963|FG002|Overall Study|Relapse identified before transplant|0|||
23408667|NCT01119066|65239964|FG003|Overall Study|Relapse identified before transplant|0|||
23408668|NCT01833494|65239967|FG000|Overall Study|Adverse Event|24|||
23408669|NCT01833494|65239967|FG000|Overall Study|Physician Decision|6|||
23408670|NCT01833494|65239967|FG000|Overall Study|Withdrawal by Subject|6|||
23408671|NCT01833494|65239967|FG000|Overall Study|Decrease in serum phosphorus|4|||
23408672|NCT01833494|65239967|FG000|Overall Study|Decrease in serum calcium|4|||
23408673|NCT01833494|65239967|FG000|Overall Study|Increase in serum ferritin|1|||
23408674|NCT00326001|65239968|FG000|Overall Study|Adverse Event|4|||
23408675|NCT00326001|65239969|FG001|Overall Study|Adverse Event|5|||
23408676|NCT00326001|65239968|FG000|Overall Study|Physician Decision|3|||
23408677|NCT00326001|65239969|FG001|Overall Study|Physician Decision|3|||
23408678|NCT05332392|65239970|FG000|Overall Study|Did not meet inclusion criteria|25|||
23408679|NCT05332392|65239970|FG000|Overall Study|Principal Investigator's decision|17|||
23408680|NCT05332392|65239970|FG000|Overall Study|Adverse Event|1|||
23408681|NCT05332392|65239970|FG000|Overall Study|Subject's decision|1|||
23408682|NCT00334737|65239971|FG000|Hospital Phase|Death|1|||
23408683|NCT00334737|65239972|FG001|Hospital Phase|Death|2|||
23408684|NCT00334737|65239973|FG002|Hospital Phase|Death|3|||
23408685|NCT00334737|65239971|FG000|Hospital Phase|Withdrawal by Subject|0|||
23408686|NCT00334737|65239972|FG001|Hospital Phase|Withdrawal by Subject|0|||
23408687|NCT00334737|65239973|FG002|Hospital Phase|Withdrawal by Subject|1|||
23408688|NCT00334737|65239971|FG000|Hospital Phase|Did not receive study drug|1|||
23708983|NCT00195260|66312269|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23708984|NCT00195260|66312270|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23708985|NCT00195260|66312271|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23708986|NCT00195260|66312272|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23708987|NCT00195260|66312262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708988|NCT00195260|66312263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708989|NCT00195260|66312264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708990|NCT00195260|66312265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708991|NCT00195260|66312266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708992|NCT00195260|66312267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708993|NCT00195260|66312268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708994|NCT00195260|66312269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23708995|NCT00195260|66312270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
23708996|NCT00195260|66312271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
23708997|NCT00195260|66312272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
23708998|NCT00195260|66312262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23708999|NCT00195260|66312263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709000|NCT00195260|66312264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709001|NCT00195260|66312265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709002|NCT00195260|66312266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709003|NCT00195260|66312267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709004|NCT00195260|66312268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709005|NCT00195260|66312269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23709006|NCT00195260|66312270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
23709007|NCT00195260|66312271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
23709008|NCT00195260|66312272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
23709009|NCT00195260|66312262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709010|NCT00195260|66312263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709011|NCT00195260|66312264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709012|NCT00195260|66312265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709013|NCT00195260|66312266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709014|NCT00195260|66312267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709015|NCT00195260|66312268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709016|NCT00195260|66312269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23709017|NCT00195260|66312270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
23709018|NCT00195260|66312271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
23709019|NCT00195260|66312272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
23709020|NCT00195260|66312262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709021|NCT00195260|66312263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23408689|NCT00334737|65239972|FG001|Hospital Phase|Did not receive study drug|0|||
23408690|NCT00334737|65239973|FG002|Hospital Phase|Did not receive study drug|0|||
23408691|NCT00334737|65239971|FG000|Follow up Phase|Lost to Follow-up|5|||
23408692|NCT00334737|65239972|FG001|Follow up Phase|Lost to Follow-up|3|||
23408693|NCT00334737|65239973|FG002|Follow up Phase|Lost to Follow-up|6|||
23408694|NCT02168101|65239978|FG000|Overall Study|Death|2|||
23408695|NCT02168101|65239979|FG001|Overall Study|Death|2|||
23709022|NCT00195260|66312264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709023|NCT00195260|66312265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709024|NCT00195260|66312266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709025|NCT00195260|66312267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709026|NCT00195260|66312268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709027|NCT00195260|66312269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23709028|NCT00195260|66312270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
23709029|NCT00195260|66312271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
23709030|NCT00195260|66312272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
23709031|NCT00717366|66312273|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
23709032|NCT00717366|66312274|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
23709033|NCT00717366|66312273|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
23709034|NCT00717366|66312274|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
23510823|NCT04840615|65606174|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
23510824|NCT01442493|65606175|FG000|Overall Study|withdrawn from study|3|||
23510825|NCT01442493|65606176|FG001|Overall Study|withdrawn from study|2|||
23510826|NCT02049957|65606183|FG000|Overall Study|Progressive Disease|5|||
23510827|NCT02049957|65606184|FG001|Overall Study|Progressive Disease|4|||
23510828|NCT02049957|65606185|FG002|Overall Study|Progressive Disease|2|||
23510829|NCT02049957|65606186|FG003|Overall Study|Progressive Disease|2|||
23709035|NCT00717366|66312273|FG000|Core Study Period (20 Weeks)|Death|0|||
23709036|NCT00717366|66312274|FG001|Core Study Period (20 Weeks)|Death|1|||
23709037|NCT00717366|66312273|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
23709038|NCT00717366|66312274|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
23709039|NCT00717366|66312273|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
23709040|NCT00717366|66312274|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
23709041|NCT00717366|66312273|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
23709042|NCT00717366|66312274|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
23709043|NCT00717366|66312273|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
23709044|NCT00717366|66312274|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
23709045|NCT00592852|66312275|FG000|Overall Study|Non-compliance|1|||
23709046|NCT00592852|66312275|FG000|Overall Study|Adverse Event|3|||
23811822|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
23811823|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23811824|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23408696|NCT02168101|65239980|FG002|Overall Study|Death|1|||
23408697|NCT01995526|65239981|FG000|Overall Study|Physician Decision|1|||
23408698|NCT00383331|65239982|FG000|Overall Study|Protocol Violation|0|||
23408699|NCT00383331|65239983|FG001|Overall Study|Protocol Violation|1|||
23510830|NCT02049957|65606187|FG004|Overall Study|Progressive Disease|6|||
23709047|NCT00592852|66312275|FG000|Overall Study|Found ineligible|1|||
23709048|NCT00592852|66312275|FG000|Overall Study|Withdrawal by Subject|1|||
23709049|NCT02034474|66312276|FG000|Overall Study|Adverse Event|3|||
23709050|NCT02034474|66312277|FG001|Overall Study|Adverse Event|2|||
23709051|NCT02034474|66312276|FG000|Overall Study|Withdrawal by Subject|1|||
23709052|NCT02034474|66312277|FG001|Overall Study|Withdrawal by Subject|2|||
23709053|NCT03448224|66312278|FG000|Overall Study|Provided same answer to every question|1|||
23709054|NCT03448224|66312279|FG001|Overall Study|Provided same answer to every question|0|||
23709055|NCT00366548|66312280|FG000|Infant Series|Adverse Event|1|||
23709056|NCT00366548|66312281|FG001|Infant Series|Adverse Event|3|||
23709057|NCT00366548|66312280|FG000|Infant Series|Protocol Violation|0|||
23709058|NCT00366548|66312281|FG001|Infant Series|Protocol Violation|1|||
23709059|NCT00366548|66312280|FG000|Infant Series|Withdrawal by Subject|3|||
23408700|NCT00682929|65239984|FG000|Overall Study|Adverse Event|4|||
23510831|NCT02049957|65606188|FG005|Overall Study|Progressive Disease|35|||
23510832|NCT02049957|65606189|FG006|Overall Study|Progressive Disease|7|||
23709060|NCT00366548|66312281|FG001|Infant Series|Withdrawal by Subject|1|||
23709061|NCT00366548|66312280|FG000|After Infant Series|Withdrawal by Subject|3|||
23709062|NCT00366548|66312281|FG001|After Infant Series|Withdrawal by Subject|1|||
23709063|NCT00366548|66312280|FG000|After Infant Series|Adverse Event|2|||
23709064|NCT00366548|66312281|FG001|After Infant Series|Adverse Event|0|||
23709065|NCT00366548|66312280|FG000|After Infant Series|Lost to Follow-up|1|||
23709066|NCT00366548|66312281|FG001|After Infant Series|Lost to Follow-up|0|||
23709067|NCT00912015|66312286|FG000|Overall Study|Lack of Efficacy|1|||
23709068|NCT00912015|66312287|FG001|Overall Study|Lack of Efficacy|0|||
23709069|NCT00912015|66312288|FG002|Overall Study|Lack of Efficacy|0|||
23709070|NCT00912015|66312289|FG003|Overall Study|Lack of Efficacy|0|||
23709071|NCT00912015|66312286|FG000|Overall Study|Withdrawal by Subject|8|||
23709072|NCT00912015|66312287|FG001|Overall Study|Withdrawal by Subject|8|||
23709073|NCT00912015|66312288|FG002|Overall Study|Withdrawal by Subject|3|||
23709074|NCT00912015|66312289|FG003|Overall Study|Withdrawal by Subject|0|||
23709075|NCT00912015|66312286|FG000|Overall Study|Protocol Violation|1|||
23709076|NCT00912015|66312287|FG001|Overall Study|Protocol Violation|0|||
23709077|NCT00912015|66312288|FG002|Overall Study|Protocol Violation|0|||
23709078|NCT00912015|66312289|FG003|Overall Study|Protocol Violation|1|||
23709079|NCT00912015|66312286|FG000|Overall Study|Adverse Event|6|||
23709080|NCT00912015|66312287|FG001|Overall Study|Adverse Event|0|||
23709081|NCT00912015|66312288|FG002|Overall Study|Adverse Event|0|||
23709082|NCT00912015|66312289|FG003|Overall Study|Adverse Event|1|||
23408701|NCT00682929|65239985|FG001|Overall Study|Adverse Event|1|||
23408702|NCT00682929|65239986|FG002|Overall Study|Adverse Event|1|||
23408703|NCT00682929|65239984|FG000|Overall Study|Withdrawal by Subject|1|||
23408704|NCT00682929|65239985|FG001|Overall Study|Withdrawal by Subject|2|||
23408705|NCT00682929|65239986|FG002|Overall Study|Withdrawal by Subject|1|||
23408706|NCT00682929|65239984|FG000|Overall Study|dosing compliance < 80%|0|||
23408707|NCT00682929|65239985|FG001|Overall Study|dosing compliance < 80%|2|||
23408708|NCT00682929|65239986|FG002|Overall Study|dosing compliance < 80%|0|||
23408709|NCT00682929|65239984|FG000|Overall Study|lag in DEA renewal|1|||
23709083|NCT00028002|66312290|FG000|Overall Study|Withdrawal by Subject|3|||
23709084|NCT00028002|66312290|FG000|Overall Study|Ineligible|8|||
23709085|NCT01627067|66312292|FG000|Overall Study|Screen Failure|1|||
23709086|NCT03282357|66312293|FG000|Overall Study|Lost to Follow-up|3|||
23709087|NCT03282357|66312293|FG000|Overall Study|Withdrawal by Subject|4|||
23709088|NCT03282357|66312293|FG000|Overall Study|Adverse Event|1|||
23709089|NCT03282357|66312293|FG000|Overall Study|Other|9|||
23408710|NCT00682929|65239985|FG001|Overall Study|lag in DEA renewal|0|||
23408711|NCT00682929|65239986|FG002|Overall Study|lag in DEA renewal|0|||
23408712|NCT01453036|65239987|FG000|Overall Study|Lost to Follow-up|26|||
23408713|NCT01453036|65239988|FG001|Overall Study|Lost to Follow-up|115|||
23408714|NCT01453036|65239989|FG002|Overall Study|Lost to Follow-up|31|||
23408715|NCT03035864|65239993|FG000|Treatment Period|Adverse Event|1|||
23408716|NCT03035864|65239994|FG001|Treatment Period|Adverse Event|0|||
23709090|NCT01232894|66312298|FG000|Overall Study|Lost to Follow-up|0|||
23709091|NCT01232894|66312299|FG001|Overall Study|Lost to Follow-up|1|||
23709092|NCT01232894|66312298|FG000|Overall Study|Death|1|||
23709093|NCT01232894|66312299|FG001|Overall Study|Death|0|||
23709094|NCT01232894|66312298|FG000|Overall Study|Protocol Violation|1|||
23709095|NCT01232894|66312299|FG001|Overall Study|Protocol Violation|1|||
23709096|NCT01232894|66312298|FG000|Overall Study|Withdrawal by Subject|8|||
23709097|NCT01232894|66312299|FG001|Overall Study|Withdrawal by Subject|5|||
23709098|NCT01232894|66312298|FG000|Overall Study|Physician Decision|2|||
23709099|NCT01232894|66312299|FG001|Overall Study|Physician Decision|1|||
23709100|NCT00099359|66312300|FG000|Overall Study|Death|11|||
23709101|NCT00099359|66312301|FG001|Overall Study|Death|15|||
23408717|NCT03035864|65239993|FG000|Treatment Period|Other|3|||
23408718|NCT03035864|65239994|FG001|Treatment Period|Other|1|||
23408719|NCT03035864|65239993|FG000|Follow-up Period|Adverse Event|1|||
23709102|NCT00099359|66312302|FG002|Overall Study|Death|17|||
23408720|NCT03035864|65239994|FG001|Follow-up Period|Adverse Event|0|||
23408721|NCT03035864|65239993|FG000|Follow-up Period|Lost to Follow-up|6|||
23408722|NCT03035864|65239994|FG001|Follow-up Period|Lost to Follow-up|2|||
23408723|NCT03035864|65239993|FG000|Follow-up Period|Physician Decision|1|||
23408724|NCT03035864|65239994|FG001|Follow-up Period|Physician Decision|0|||
23408725|NCT03035864|65239993|FG000|Follow-up Period|Other|3|||
23408726|NCT03035864|65239994|FG001|Follow-up Period|Other|2|||
23408727|NCT00288015|65239995|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
23408728|NCT00288015|65239995|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
23709103|NCT00099359|66312300|FG000|Overall Study|Withdrawal by Subject|19|||
23709104|NCT00099359|66312301|FG001|Overall Study|Withdrawal by Subject|19|||
23709105|NCT00099359|66312302|FG002|Overall Study|Withdrawal by Subject|23|||
23709106|NCT00099359|66312300|FG000|Overall Study|Lost to Follow-up|15|||
23709107|NCT00099359|66312301|FG001|Overall Study|Lost to Follow-up|24|||
23709108|NCT00099359|66312302|FG002|Overall Study|Lost to Follow-up|24|||
23709109|NCT00099359|66312300|FG000|Overall Study|moved out of area|9|||
23709110|NCT00099359|66312301|FG001|Overall Study|moved out of area|7|||
23709111|NCT00099359|66312302|FG002|Overall Study|moved out of area|4|||
23709112|NCT02410772|66312307|FG000|Overall Study|Death|3|||
23709113|NCT02410772|66312308|FG001|Overall Study|Death|4|||
23408729|NCT00288015|65239995|FG000|First Response Assessment|Withdrawal by Subject|1|||
23408730|NCT00288015|65239995|FG000|First Response Assessment|Death|1|||
23408731|NCT00288015|65239995|FG000|First Response Assessment|Physician Decision|2|||
23408732|NCT00288015|65239995|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
23408733|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Death|13|||
23408734|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
23408735|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Other|9|||
23408736|NCT03663569|65239998|FG000|Overall Study|Discontinuation of study|11|||
23408737|NCT03663569|65239998|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
23408738|NCT03663569|65239998|FG000|Overall Study|Deceased patient|6|||
23408739|NCT03663569|65239998|FG000|Overall Study|Lost to Follow-up|18|||
23408740|NCT03663569|65239998|FG000|Overall Study|Withdrawal of consent|5|||
23408741|NCT03663569|65239998|FG000|Overall Study|Patient's request|11|||
23408742|NCT03663569|65239998|FG000|Overall Study|Adverse Event|4|||
23408743|NCT03663569|65239998|FG000|Overall Study|Not come to second visit|3|||
23709114|NCT02410772|66312309|FG002|Overall Study|Death|8|||
23709115|NCT02410772|66312307|FG000|Overall Study|Lost to Follow-up|31|||
23709116|NCT02410772|66312308|FG001|Overall Study|Lost to Follow-up|23|||
23709117|NCT02410772|66312309|FG002|Overall Study|Lost to Follow-up|22|||
23408744|NCT03663569|65239998|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
23408745|NCT03663569|65239998|FG000|Overall Study|Serious adverse event|1|||
23408746|NCT00078806|65239999|FG000|Part 1A|Adverse Event|2|||
23408747|NCT00078806|65240000|FG001|Part 1A|Adverse Event|0|||
23408748|NCT00078806|65240001|FG002|Part 1A|Adverse Event|0|||
23709118|NCT02410772|66312307|FG000|Overall Study|Pregnancy|8|||
23709119|NCT02410772|66312308|FG001|Overall Study|Pregnancy|4|||
23408749|NCT00078806|65240002|FG003|Part 1A|Adverse Event|0|||
23408750|NCT00078806|65239999|FG000|Part 1A|Lack of Efficacy|7|||
23709120|NCT02410772|66312309|FG002|Overall Study|Pregnancy|5|||
23709121|NCT02410772|66312307|FG000|Overall Study|Protocol Violation|8|||
23811825|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23811826|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
23811827|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
23811828|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23811829|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23811830|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
23811831|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23811832|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
23811833|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
23811834|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23811835|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23811836|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23811837|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
23811838|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23811839|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23811840|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23811841|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
23811842|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23811843|NCT00773734|66691826|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
23811844|NCT00773734|66691827|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
23811845|NCT00773734|66691828|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
23408751|NCT00078806|65240000|FG001|Part 1A|Lack of Efficacy|0|||
23408752|NCT00078806|65240001|FG002|Part 1A|Lack of Efficacy|0|||
23408753|NCT00078806|65240002|FG003|Part 1A|Lack of Efficacy|0|||
23408754|NCT00078806|65239999|FG000|Part 1A|Other|1|||
23408755|NCT00078806|65240000|FG001|Part 1A|Other|0|||
23408756|NCT00078806|65240001|FG002|Part 1A|Other|0|||
23408757|NCT00078806|65240002|FG003|Part 1A|Other|0|||
23408758|NCT00078806|65239999|FG000|Part 1B|Adverse Event|1|||
23408759|NCT00078806|65240000|FG001|Part 1B|Adverse Event|0|||
23408760|NCT00078806|65240001|FG002|Part 1B|Adverse Event|0|||
23408761|NCT00078806|65240002|FG003|Part 1B|Adverse Event|0|||
23408762|NCT00078806|65239999|FG000|Part 1B|Lack of Efficacy|7|||
23408763|NCT00078806|65240000|FG001|Part 1B|Lack of Efficacy|0|||
23408764|NCT00078806|65240001|FG002|Part 1B|Lack of Efficacy|0|||
23709122|NCT02410772|66312308|FG001|Overall Study|Protocol Violation|8|||
23408765|NCT00078806|65240002|FG003|Part 1B|Lack of Efficacy|0|||
23408766|NCT00078806|65239999|FG000|Part 2|Adverse Event|0|||
23408767|NCT00078806|65240000|FG001|Part 2|Adverse Event|1|||
23408768|NCT00078806|65240001|FG002|Part 2|Adverse Event|0|||
23408769|NCT00078806|65240002|FG003|Part 2|Adverse Event|0|||
23408770|NCT03367403|65240003|FG000|Overall Study|Adverse Event|20|||
23408771|NCT03367403|65240004|FG001|Overall Study|Adverse Event|6|||
23408772|NCT03367403|65240005|FG002|Overall Study|Adverse Event|2|||
23408773|NCT03367403|65240003|FG000|Overall Study|Withdrawal by Subject|12|||
23408774|NCT03367403|65240004|FG001|Overall Study|Withdrawal by Subject|13|||
23408775|NCT03367403|65240005|FG002|Overall Study|Withdrawal by Subject|1|||
23408776|NCT03367403|65240003|FG000|Overall Study|Death|1|||
23408777|NCT03367403|65240004|FG001|Overall Study|Death|2|||
23408778|NCT03367403|65240005|FG002|Overall Study|Death|0|||
23408779|NCT03367403|65240003|FG000|Overall Study|Physician Decision|0|||
23408780|NCT03367403|65240004|FG001|Overall Study|Physician Decision|1|||
23408781|NCT03367403|65240005|FG002|Overall Study|Physician Decision|0|||
23408782|NCT03367403|65240003|FG000|Overall Study|Protocol Violation|1|||
23408783|NCT03367403|65240004|FG001|Overall Study|Protocol Violation|1|||
23408784|NCT03367403|65240005|FG002|Overall Study|Protocol Violation|0|||
23408785|NCT03367403|65240003|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
23408786|NCT03367403|65240004|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
23408787|NCT03367403|65240005|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
23408788|NCT03367403|65240003|FG000|Overall Study|COVID-19|3|||
23408789|NCT03367403|65240004|FG001|Overall Study|COVID-19|6|||
23408790|NCT03367403|65240005|FG002|Overall Study|COVID-19|0|||
23408791|NCT03367403|65240003|FG000|Overall Study|Abuse of Alcohol Intake|0|||
23408792|NCT03367403|65240004|FG001|Overall Study|Abuse of Alcohol Intake|1|||
23408793|NCT03367403|65240005|FG002|Overall Study|Abuse of Alcohol Intake|0|||
23408794|NCT03367403|65240003|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
23408795|NCT03367403|65240004|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
23408796|NCT03367403|65240005|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
23408797|NCT01772550|65240006|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
23709123|NCT02410772|66312309|FG002|Overall Study|Protocol Violation|4|||
23709124|NCT02410772|66312307|FG000|Overall Study|Baseline Drug Resistance|49|||
23709125|NCT02410772|66312308|FG001|Overall Study|Baseline Drug Resistance|40|||
23709126|NCT02410772|66312309|FG002|Overall Study|Baseline Drug Resistance|51|||
23709127|NCT02410772|66312307|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
23709128|NCT02410772|66312308|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
23709129|NCT02410772|66312309|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
23709130|NCT02410772|66312307|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
23709131|NCT02410772|66312308|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
23709132|NCT02410772|66312309|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
23709133|NCT00074412|66312314|FG000|Overall Study|Death|30|||
23709134|NCT00074412|66312315|FG001|Overall Study|Death|26|||
23709135|NCT00074412|66312314|FG000|Overall Study|Lost to Follow-up|52|||
23709136|NCT00074412|66312315|FG001|Overall Study|Lost to Follow-up|58|||
23709137|NCT03666858|66312319|FG000|Cohort 1|Adverse Event|1|||
23709138|NCT03666858|66312320|FG001|Cohort 1|Adverse Event|0|||
23709139|NCT03666858|66312319|FG000|Cohort 2|Adverse Event|0|||
23709140|NCT03666858|66312320|FG001|Cohort 2|Adverse Event|1|||
23709141|NCT00502307|66312321|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
23709142|NCT00502307|66312322|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
23709143|NCT00502307|66312323|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
23709144|NCT00502307|66312321|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
23709145|NCT00502307|66312322|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
23709146|NCT00502307|66312323|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
23709147|NCT00502307|66312321|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
23709148|NCT00502307|66312322|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
23709149|NCT00502307|66312323|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
23709150|NCT00502307|66312321|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
23709151|NCT00502307|66312322|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
23709152|NCT00502307|66312323|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
23709153|NCT00502307|66312321|FG000|Maintenance Period|Progressive disease|80|||
23709154|NCT00502307|66312322|FG001|Maintenance Period|Progressive disease|0|||
23709155|NCT00502307|66312323|FG002|Maintenance Period|Progressive disease|0|||
23709156|NCT00502307|66312321|FG000|Maintenance Period|Discontinued due to other reasons|68|||
23709157|NCT00502307|66312322|FG001|Maintenance Period|Discontinued due to other reasons|0|||
23709158|NCT00502307|66312323|FG002|Maintenance Period|Discontinued due to other reasons|0|||
23709159|NCT00625365|66312324|FG000|Overall Study|Withdrawal by Subject|1|||
23709160|NCT00625365|66312324|FG000|Overall Study|No IV access|5|||
23709161|NCT00625365|66312324|FG000|Overall Study|VSD|1|||
23709162|NCT00364845|66312328|FG000|Overall Study|Adverse Event|1|||
23510833|NCT02049957|65606190|FG007|Overall Study|Progressive Disease|26|||
23709163|NCT00364845|66312329|FG001|Overall Study|Adverse Event|0|||
23709164|NCT00364845|66312328|FG000|Overall Study|Withdrawal by Subject|2|||
23709165|NCT00364845|66312329|FG001|Overall Study|Withdrawal by Subject|1|||
23709166|NCT00364845|66312328|FG000|Overall Study|Physician Decision|8|||
23510834|NCT02049957|65606191|FG008|Overall Study|Progressive Disease|6|||
23709167|NCT00364845|66312329|FG001|Overall Study|Physician Decision|8|||
23510835|NCT02049957|65606183|FG000|Overall Study|Adverse Event|1|||
23709168|NCT00364845|66312328|FG000|Overall Study|Lost to Follow-up|0|||
23709169|NCT00364845|66312329|FG001|Overall Study|Lost to Follow-up|1|||
23709170|NCT00364845|66312328|FG000|Overall Study|Death|0|||
23709171|NCT00364845|66312329|FG001|Overall Study|Death|1|||
23709172|NCT00986427|66312330|FG000|Overall Study|Lost to Follow-up|2|||
23709173|NCT00986427|66312331|FG001|Overall Study|Lost to Follow-up|0|||
23709174|NCT00986427|66312330|FG000|Overall Study|Lack of Efficacy|1|||
23709175|NCT00986427|66312331|FG001|Overall Study|Lack of Efficacy|0|||
23709176|NCT00986427|66312330|FG000|Overall Study|Withdrawal by Subject|1|||
23709177|NCT00986427|66312331|FG001|Overall Study|Withdrawal by Subject|0|||
23709178|NCT00621855|66312336|FG000|Overall Study|Adverse Event|32|||
23709179|NCT00621855|66312337|FG001|Overall Study|Adverse Event|31|||
23709180|NCT00621855|66312338|FG002|Overall Study|Adverse Event|48|||
23709181|NCT00621855|66312339|FG003|Overall Study|Adverse Event|34|||
23709182|NCT00621855|66312340|FG004|Overall Study|Adverse Event|31|||
23709183|NCT00621855|66312336|FG000|Overall Study|Lost to Follow-up|0|||
23709184|NCT00621855|66312337|FG001|Overall Study|Lost to Follow-up|1|||
23709185|NCT00621855|66312338|FG002|Overall Study|Lost to Follow-up|3|||
23709186|NCT00621855|66312339|FG003|Overall Study|Lost to Follow-up|4|||
23709187|NCT00621855|66312340|FG004|Overall Study|Lost to Follow-up|1|||
23709188|NCT00621855|66312336|FG000|Overall Study|Protocol Violation|16|||
23709189|NCT00621855|66312337|FG001|Overall Study|Protocol Violation|8|||
23709190|NCT00621855|66312338|FG002|Overall Study|Protocol Violation|6|||
23709191|NCT00621855|66312339|FG003|Overall Study|Protocol Violation|7|||
23510836|NCT02049957|65606184|FG001|Overall Study|Adverse Event|1|||
23510837|NCT02049957|65606185|FG002|Overall Study|Adverse Event|1|||
23510838|NCT02049957|65606186|FG003|Overall Study|Adverse Event|0|||
23510839|NCT02049957|65606187|FG004|Overall Study|Adverse Event|0|||
23510840|NCT02049957|65606188|FG005|Overall Study|Adverse Event|5|||
23510841|NCT02049957|65606189|FG006|Overall Study|Adverse Event|0|||
23510842|NCT02049957|65606190|FG007|Overall Study|Adverse Event|6|||
23510843|NCT02049957|65606191|FG008|Overall Study|Adverse Event|1|||
23510844|NCT02049957|65606183|FG000|Overall Study|Study Terminated by Sponsor|0|||
23510845|NCT02049957|65606184|FG001|Overall Study|Study Terminated by Sponsor|1|||
23510846|NCT02049957|65606185|FG002|Overall Study|Study Terminated by Sponsor|0|||
23510847|NCT02049957|65606186|FG003|Overall Study|Study Terminated by Sponsor|0|||
23510848|NCT02049957|65606187|FG004|Overall Study|Study Terminated by Sponsor|0|||
23510849|NCT02049957|65606188|FG005|Overall Study|Study Terminated by Sponsor|0|||
23510850|NCT02049957|65606189|FG006|Overall Study|Study Terminated by Sponsor|1|||
23510851|NCT02049957|65606190|FG007|Overall Study|Study Terminated by Sponsor|0|||
23510852|NCT02049957|65606191|FG008|Overall Study|Study Terminated by Sponsor|0|||
23510853|NCT02049957|65606183|FG000|Overall Study|Withdrawal by Subject|0|||
23510854|NCT02049957|65606184|FG001|Overall Study|Withdrawal by Subject|0|||
23510855|NCT02049957|65606185|FG002|Overall Study|Withdrawal by Subject|0|||
23510856|NCT02049957|65606186|FG003|Overall Study|Withdrawal by Subject|1|||
23510857|NCT02049957|65606187|FG004|Overall Study|Withdrawal by Subject|0|||
23510858|NCT02049957|65606188|FG005|Overall Study|Withdrawal by Subject|2|||
23510859|NCT02049957|65606189|FG006|Overall Study|Withdrawal by Subject|0|||
23510860|NCT02049957|65606190|FG007|Overall Study|Withdrawal by Subject|3|||
23510861|NCT02049957|65606191|FG008|Overall Study|Withdrawal by Subject|1|||
23510862|NCT02049957|65606183|FG000|Overall Study|Physician Decision|0|||
23510863|NCT02049957|65606184|FG001|Overall Study|Physician Decision|0|||
23510864|NCT02049957|65606185|FG002|Overall Study|Physician Decision|0|||
23510865|NCT02049957|65606186|FG003|Overall Study|Physician Decision|0|||
23510866|NCT02049957|65606187|FG004|Overall Study|Physician Decision|0|||
23510867|NCT02049957|65606188|FG005|Overall Study|Physician Decision|1|||
23709192|NCT00621855|66312340|FG004|Overall Study|Protocol Violation|8|||
23709193|NCT00621855|66312336|FG000|Overall Study|Withdrawal by Subject|16|||
23709194|NCT00621855|66312337|FG001|Overall Study|Withdrawal by Subject|11|||
23709195|NCT00621855|66312338|FG002|Overall Study|Withdrawal by Subject|13|||
23709196|NCT00621855|66312339|FG003|Overall Study|Withdrawal by Subject|13|||
23709197|NCT00621855|66312340|FG004|Overall Study|Withdrawal by Subject|9|||
23709198|NCT00621855|66312336|FG000|Overall Study|Other|9|||
23709199|NCT00621855|66312337|FG001|Overall Study|Other|7|||
23709200|NCT00621855|66312338|FG002|Overall Study|Other|6|||
23709201|NCT00621855|66312339|FG003|Overall Study|Other|5|||
23709202|NCT00621855|66312340|FG004|Overall Study|Other|4|||
23709203|NCT00621855|66312336|FG000|Overall Study|Patients did not receive study drug|3|||
23709204|NCT00621855|66312337|FG001|Overall Study|Patients did not receive study drug|3|||
23709205|NCT00621855|66312338|FG002|Overall Study|Patients did not receive study drug|5|||
23709206|NCT00621855|66312339|FG003|Overall Study|Patients did not receive study drug|4|||
23709207|NCT00621855|66312340|FG004|Overall Study|Patients did not receive study drug|2|||
23709208|NCT03050359|66312343|FG000|Overall Study|Randomized But Not Treated|2|||
23709209|NCT03050359|66312344|FG001|Overall Study|Randomized But Not Treated|0|||
23709210|NCT03050359|66312343|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
23709211|NCT03050359|66312344|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23709212|NCT03050359|66312343|FG000|Overall Study|Significant Protocol Deviation|2|||
23709213|NCT03050359|66312344|FG001|Overall Study|Significant Protocol Deviation|3|||
23709214|NCT03050359|66312343|FG000|Overall Study|Lost to Follow-up|2|||
23709215|NCT03050359|66312344|FG001|Overall Study|Lost to Follow-up|1|||
23709216|NCT03050359|66312343|FG000|Overall Study|Voluntary Withdrawal|4|||
23709217|NCT03050359|66312344|FG001|Overall Study|Voluntary Withdrawal|6|||
23709218|NCT03050359|66312343|FG000|Overall Study|Pregnancy|1|||
23709219|NCT03050359|66312344|FG001|Overall Study|Pregnancy|0|||
23709220|NCT03050359|66312343|FG000|Overall Study|Reason Not Specified|1|||
23709221|NCT03050359|66312344|FG001|Overall Study|Reason Not Specified|0|||
23709222|NCT00782418|66312345|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
23709223|NCT00782418|66312346|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709224|NCT00782418|66312347|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709225|NCT00782418|66312348|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709226|NCT00782418|66312349|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709227|NCT00782418|66312350|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709228|NCT00782418|66312351|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23709229|NCT00782418|66312345|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23709230|NCT00782418|66312346|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23709231|NCT00782418|66312347|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23709232|NCT00782418|66312348|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23709233|NCT00782418|66312349|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23709234|NCT00782418|66312350|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23709235|NCT00782418|66312351|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23709236|NCT04580394|66312358|FG000|First Intervention|Incorrectly Randomized|1|||
23709237|NCT04580394|66312358|FG000|First Intervention|Physician Decision|1|||
23709238|NCT04580394|66312358|FG000|First Intervention|Lost to Follow-up|1|||
23709239|NCT04580394|66312358|FG000|Washout (One Week)|Withdrawal by Subject|1|||
23709240|NCT04580394|66312358|FG000|Washout (One Week)|Adverse Event|1|||
23709241|NCT04580394|66312358|FG000|Washout (One Week)|Withdrawal by Subject|2|||
23709242|NCT04580394|66312358|FG000|Third Intervention|Adverse Event|1|||
23709243|NCT04580394|66312358|FG000|Third Intervention|Withdrawal by Subject|1|||
23709244|NCT04580394|66312358|FG000|Washout (One Week)|Withdrawal by Subject|2|||
23709245|NCT04032171|66312359|FG000|Overall Study|Study Termination|1|||
23709246|NCT04032171|66312360|FG001|Overall Study|Study Termination|0|||
23709247|NCT02509494|66312362|FG000|Overall Study|Lost to Follow-up|8|||
23709248|NCT02509494|66312363|FG001|Overall Study|Lost to Follow-up|47|||
23709249|NCT02509494|66312364|FG002|Overall Study|Lost to Follow-up|19|||
23709250|NCT02509494|66312365|FG003|Overall Study|Lost to Follow-up|6|||
23709251|NCT02509494|66312366|FG004|Overall Study|Lost to Follow-up|3|||
23709252|NCT02509494|66312367|FG005|Overall Study|Lost to Follow-up|3|||
23709253|NCT02509494|66312368|FG006|Overall Study|Lost to Follow-up|1|||
23709254|NCT02509494|66312369|FG007|Overall Study|Lost to Follow-up|3|||
23709255|NCT02509494|66312370|FG008|Overall Study|Lost to Follow-up|1|||
23709256|NCT02509494|66312362|FG000|Overall Study|Physician Decision|2|||
23709257|NCT02509494|66312363|FG001|Overall Study|Physician Decision|1|||
23709258|NCT02509494|66312364|FG002|Overall Study|Physician Decision|0|||
23709259|NCT02509494|66312365|FG003|Overall Study|Physician Decision|0|||
23709260|NCT02509494|66312366|FG004|Overall Study|Physician Decision|0|||
23709261|NCT02509494|66312367|FG005|Overall Study|Physician Decision|0|||
23709262|NCT02509494|66312368|FG006|Overall Study|Physician Decision|0|||
23709263|NCT02509494|66312369|FG007|Overall Study|Physician Decision|0|||
23709264|NCT02509494|66312370|FG008|Overall Study|Physician Decision|0|||
23709265|NCT02509494|66312362|FG000|Overall Study|Withdrawal by Subject|4|||
23709266|NCT02509494|66312363|FG001|Overall Study|Withdrawal by Subject|17|||
23709267|NCT02509494|66312364|FG002|Overall Study|Withdrawal by Subject|7|||
23709268|NCT02509494|66312365|FG003|Overall Study|Withdrawal by Subject|5|||
23709269|NCT02509494|66312366|FG004|Overall Study|Withdrawal by Subject|0|||
23709270|NCT02509494|66312367|FG005|Overall Study|Withdrawal by Subject|6|||
23709271|NCT02509494|66312368|FG006|Overall Study|Withdrawal by Subject|1|||
23709272|NCT02509494|66312369|FG007|Overall Study|Withdrawal by Subject|2|||
23709273|NCT02509494|66312370|FG008|Overall Study|Withdrawal by Subject|1|||
23709274|NCT02509494|66312362|FG000|Overall Study|Death|0|||
23709275|NCT02509494|66312363|FG001|Overall Study|Death|1|||
23709276|NCT02509494|66312364|FG002|Overall Study|Death|0|||
23709277|NCT02509494|66312365|FG003|Overall Study|Death|0|||
23709278|NCT02509494|66312366|FG004|Overall Study|Death|1|||
23709279|NCT02509494|66312367|FG005|Overall Study|Death|0|||
23709280|NCT02509494|66312368|FG006|Overall Study|Death|0|||
23709281|NCT02509494|66312369|FG007|Overall Study|Death|1|||
23709282|NCT02509494|66312370|FG008|Overall Study|Death|0|||
23709283|NCT02509494|66312362|FG000|Overall Study|Other|0|||
23709284|NCT02509494|66312363|FG001|Overall Study|Other|4|||
23709285|NCT02509494|66312364|FG002|Overall Study|Other|5|||
23709286|NCT02509494|66312365|FG003|Overall Study|Other|0|||
23709287|NCT02509494|66312366|FG004|Overall Study|Other|0|||
23709288|NCT02509494|66312367|FG005|Overall Study|Other|0|||
23709289|NCT02509494|66312368|FG006|Overall Study|Other|0|||
23709290|NCT02509494|66312369|FG007|Overall Study|Other|0|||
23709291|NCT02509494|66312370|FG008|Overall Study|Other|0|||
23709292|NCT02509494|66312362|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23709293|NCT02509494|66312363|FG001|Overall Study|Non-Compliance With Study Drug|11|||
23709294|NCT02509494|66312364|FG002|Overall Study|Non-Compliance With Study Drug|7|||
23709295|NCT02509494|66312365|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23709296|NCT02509494|66312366|FG004|Overall Study|Non-Compliance With Study Drug|1|||
23709297|NCT02509494|66312367|FG005|Overall Study|Non-Compliance With Study Drug|2|||
23709298|NCT02509494|66312368|FG006|Overall Study|Non-Compliance With Study Drug|1|||
23709299|NCT02509494|66312369|FG007|Overall Study|Non-Compliance With Study Drug|1|||
23709300|NCT02509494|66312370|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23709301|NCT01151579|66312371|FG000|Overall Study|Physician Decision|3|||
23709302|NCT01151579|66312372|FG001|Overall Study|Physician Decision|1|||
23709303|NCT01151579|66312371|FG000|Overall Study|Withdrawal by Subject|3|||
23709304|NCT01151579|66312372|FG001|Overall Study|Withdrawal by Subject|2|||
23709305|NCT01151579|66312371|FG000|Overall Study|Not meet inclusion criteria|6|||
23709306|NCT01151579|66312372|FG001|Overall Study|Not meet inclusion criteria|4|||
23709307|NCT03571256|66312373|FG000|Overall Study|Adverse Event|3|||
23709308|NCT03571256|66312374|FG001|Overall Study|Adverse Event|0|||
23709309|NCT03571256|66312375|FG002|Overall Study|Adverse Event|1|||
23709310|NCT03571256|66312373|FG000|Overall Study|Withdrawal by Subject|3|||
23709311|NCT03571256|66312374|FG001|Overall Study|Withdrawal by Subject|1|||
23709312|NCT03571256|66312375|FG002|Overall Study|Withdrawal by Subject|1|||
23709313|NCT03571256|66312373|FG000|Overall Study|Other than specified|0|||
23709314|NCT03571256|66312374|FG001|Overall Study|Other than specified|1|||
23709315|NCT03571256|66312375|FG002|Overall Study|Other than specified|1|||
23709316|NCT03571256|66312373|FG000|Overall Study|Protocol Violation|0|||
23709317|NCT03571256|66312374|FG001|Overall Study|Protocol Violation|1|||
23709318|NCT03571256|66312375|FG002|Overall Study|Protocol Violation|1|||
23709319|NCT04715230|66312376|FG000|Overall Study|Withdrawal by Subject|1|||
23709320|NCT04715230|66312377|FG001|Overall Study|Withdrawal by Subject|0|||
23709321|NCT04715230|66312378|FG002|Overall Study|Withdrawal by Subject|0|||
23709322|NCT04715230|66312376|FG000|Overall Study|Lost to Follow-up|0|||
23709323|NCT04715230|66312377|FG001|Overall Study|Lost to Follow-up|5|||
23709324|NCT04715230|66312378|FG002|Overall Study|Lost to Follow-up|1|||
23709325|NCT01842607|66312379|FG000|Overall Study|Adverse Event|11|||
23709326|NCT01842607|66312379|FG000|Overall Study|Lack of Efficacy|19|||
23709327|NCT01842607|66312379|FG000|Overall Study|Protocol Violation|8|||
23709328|NCT01842607|66312379|FG000|Overall Study|Protocol defined stopping criteria|2|||
23709329|NCT01842607|66312379|FG000|Overall Study|Lost to Follow-up|3|||
23709330|NCT01842607|66312379|FG000|Overall Study|Physician Decision|9|||
23709331|NCT01842607|66312379|FG000|Overall Study|Withdrawal by Subject|14|||
23709332|NCT03629041|66312380|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23610569|NCT01964547|65962805|FG001|Overall Study|Withdrawal by Subject|7|||
23811846|NCT00773734|66691829|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
23811847|NCT00773734|66691830|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
23811848|NCT00773734|66691831|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
23811849|NCT00773734|66691826|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23811850|NCT00773734|66691827|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23709333|NCT03629041|66312381|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
23709334|NCT03629041|66312382|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23709335|NCT03629041|66312383|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23709336|NCT03888391|66312388|FG000|Overall Study|Lost to Follow-up|15|||
23811851|NCT00773734|66691828|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23811852|NCT00773734|66691829|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23811853|NCT00773734|66691830|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
23811854|NCT00773734|66691831|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
23811855|NCT00773734|66691826|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
23811856|NCT00773734|66691827|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
23811857|NCT00773734|66691828|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
23811858|NCT00773734|66691829|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
23811859|NCT00773734|66691830|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
23811860|NCT00773734|66691831|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
23811861|NCT00773734|66691826|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
23811862|NCT00773734|66691827|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
23811863|NCT00773734|66691828|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
23811864|NCT00773734|66691829|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
23811865|NCT00773734|66691830|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
23811866|NCT00773734|66691831|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
23811867|NCT00773734|66691826|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
23811868|NCT00773734|66691827|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
23811869|NCT00773734|66691828|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
23811870|NCT00773734|66691829|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
23811871|NCT00773734|66691830|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
23811872|NCT00773734|66691831|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
23811873|NCT00773734|66691826|FG000|Extension: Active Treatment Week 24-52|Other|0|||
23811874|NCT00773734|66691827|FG001|Extension: Active Treatment Week 24-52|Other|0|||
23811875|NCT00773734|66691828|FG002|Extension: Active Treatment Week 24-52|Other|1|||
23811876|NCT00773734|66691829|FG003|Extension: Active Treatment Week 24-52|Other|2|||
23811877|NCT00773734|66691830|FG004|Extension: Active Treatment Week 24-52|Other|0|||
23811878|NCT00773734|66691831|FG005|Extension: Active Treatment Week 24-52|Other|1|||
23811879|NCT00773734|66691826|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23811880|NCT00773734|66691827|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23811881|NCT00773734|66691828|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23811882|NCT00773734|66691829|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
23811883|NCT00773734|66691830|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23811884|NCT00773734|66691831|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23811885|NCT00773734|66691826|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23811886|NCT00773734|66691827|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23811887|NCT00773734|66691828|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
23811888|NCT00773734|66691829|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
23811889|NCT00773734|66691830|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23811890|NCT00773734|66691831|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23811891|NCT00773734|66691826|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23811892|NCT00773734|66691827|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23811893|NCT00773734|66691828|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
23811894|NCT00773734|66691829|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
23811895|NCT00773734|66691830|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23811896|NCT00773734|66691831|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23811897|NCT00773734|66691826|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23811898|NCT00773734|66691827|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23811899|NCT00773734|66691828|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
23811900|NCT00773734|66691829|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
23811901|NCT00773734|66691830|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23811902|NCT00773734|66691831|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23811903|NCT02266134|66691832|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
23811904|NCT02266134|66691833|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
23811905|NCT02266134|66691834|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
23811906|NCT02266134|66691835|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
23811907|NCT02266134|66691832|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
23811908|NCT02266134|66691833|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
23811909|NCT02266134|66691834|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
23811910|NCT02266134|66691835|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
23811911|NCT02266134|66691832|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
23811912|NCT02266134|66691833|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
23811913|NCT02266134|66691834|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
23811914|NCT02266134|66691835|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
23811915|NCT02266134|66691832|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
23811916|NCT02266134|66691833|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23811917|NCT02266134|66691834|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23811918|NCT02266134|66691835|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23811919|NCT02266134|66691832|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
23811920|NCT02266134|66691833|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
23811921|NCT02266134|66691834|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
23811922|NCT02266134|66691835|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
23811923|NCT02266134|66691832|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
23811924|NCT02266134|66691833|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23811925|NCT02266134|66691834|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23811926|NCT02266134|66691835|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23811927|NCT00856973|66691836|FG000|Overall Study|Adverse Event|5|||
23811928|NCT00856973|66691837|FG001|Overall Study|Adverse Event|5|||
23811929|NCT00856973|66691838|FG002|Overall Study|Adverse Event|3|||
23811930|NCT00856973|66691836|FG000|Overall Study|Lost to Follow-up|6|||
23811931|NCT00856973|66691837|FG001|Overall Study|Lost to Follow-up|3|||
23811932|NCT00856973|66691838|FG002|Overall Study|Lost to Follow-up|5|||
23811933|NCT00856973|66691836|FG000|Overall Study|Physician Decision|0|||
23811934|NCT00856973|66691837|FG001|Overall Study|Physician Decision|3|||
23811935|NCT00856973|66691838|FG002|Overall Study|Physician Decision|1|||
23811936|NCT00856973|66691836|FG000|Overall Study|Protocol Violation|1|||
23811937|NCT00856973|66691837|FG001|Overall Study|Protocol Violation|2|||
23811938|NCT00856973|66691838|FG002|Overall Study|Protocol Violation|1|||
23811939|NCT00856973|66691836|FG000|Overall Study|Withdrawal by Subject|13|||
23811940|NCT00856973|66691837|FG001|Overall Study|Withdrawal by Subject|16|||
23811941|NCT00856973|66691838|FG002|Overall Study|Withdrawal by Subject|15|||
23811942|NCT00856973|66691836|FG000|Overall Study|Other|11|||
23811943|NCT00856973|66691837|FG001|Overall Study|Other|12|||
23811944|NCT00856973|66691838|FG002|Overall Study|Other|13|||
23811945|NCT04091659|66691839|FG000|Overall Study|Protocol Violation|3|||
23811946|NCT04091659|66691840|FG001|Overall Study|Protocol Violation|0|||
23811947|NCT04091659|66691839|FG000|Overall Study|Lost to Follow-up|0|||
23811948|NCT04091659|66691840|FG001|Overall Study|Lost to Follow-up|1|||
23811949|NCT01868893|66691842|FG000|Overall Study|Adverse Event|2|||
23811950|NCT01868893|66691842|FG000|Overall Study|Commercial availability of study drug|17|||
23811951|NCT01868893|66691842|FG000|Overall Study|Neutropenia|1|||
23811952|NCT02317614|66691843|FG000|Overall Study|Lost to Follow-up|1|||
23811953|NCT02317614|66691844|FG001|Overall Study|Lost to Follow-up|1|||
23811954|NCT02317614|66691843|FG000|Overall Study|Withdrawal by Subject|1|||
23811955|NCT02317614|66691844|FG001|Overall Study|Withdrawal by Subject|0|||
23811956|NCT02317614|66691843|FG000|Overall Study|Death|1|||
23811957|NCT02317614|66691844|FG001|Overall Study|Death|1|||
23510868|NCT02049957|65606189|FG006|Overall Study|Physician Decision|0|||
23709337|NCT01727713|66312393|FG000|Overall Study|Lost to Follow-up|5|||
23709338|NCT01727713|66312393|FG000|Overall Study|Adverse Event|10|||
23709339|NCT01727713|66312393|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
23709340|NCT01727713|66312393|FG000|Overall Study|Withdrawal by Subject|13|||
23709341|NCT01727713|66312393|FG000|Overall Study|Protocol Deviation|2|||
23709342|NCT00115804|66312394|FG000|Overall Study|Adverse Event|2|||
23709343|NCT03622593|66312397|FG000|Overall Study|Withdrawal by Subject|11|||
23709344|NCT03622593|66312398|FG001|Overall Study|Withdrawal by Subject|9|||
23709345|NCT03622593|66312399|FG002|Overall Study|Withdrawal by Subject|13|||
23709346|NCT03622593|66312397|FG000|Overall Study|Death|12|||
23709347|NCT03622593|66312398|FG001|Overall Study|Death|9|||
23709348|NCT03622593|66312399|FG002|Overall Study|Death|10|||
23709349|NCT03622593|66312397|FG000|Overall Study|Lost to Follow-up|11|||
23709350|NCT03622593|66312398|FG001|Overall Study|Lost to Follow-up|5|||
23709351|NCT03622593|66312399|FG002|Overall Study|Lost to Follow-up|8|||
23510869|NCT02049957|65606190|FG007|Overall Study|Physician Decision|0|||
23510870|NCT02049957|65606191|FG008|Overall Study|Physician Decision|0|||
23510871|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Physician Decision|0|||
23709352|NCT03622593|66312397|FG000|Overall Study|Adverse Event|4|||
23709353|NCT03622593|66312398|FG001|Overall Study|Adverse Event|5|||
23709354|NCT03622593|66312399|FG002|Overall Study|Adverse Event|6|||
23510872|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Physician Decision|1|||
23510873|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Physician Decision|0|||
23709355|NCT03622593|66312397|FG000|Overall Study|Physician Decision|2|||
23408798|NCT01772550|65240007|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
23510874|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
23610570|NCT01964547|65962804|FG000|Overall Study|Lost to Follow-up|0|||
23408799|NCT01772550|65240008|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
23408800|NCT01772550|65240006|FG000|Overall Study|Adverse Event|0|||
23408801|NCT01772550|65240007|FG001|Overall Study|Adverse Event|0|||
23408802|NCT01772550|65240008|FG002|Overall Study|Adverse Event|1|||
23408803|NCT00902850|65240016|FG000|Overall Study|Physician Decision|2|||
23408804|NCT00902850|65240017|FG001|Overall Study|Physician Decision|2|||
23408805|NCT01467466|65240018|FG000|Overall Study|Withdrawal by Subject|15|||
23408806|NCT01467466|65240019|FG001|Overall Study|Withdrawal by Subject|18|||
23408807|NCT01467466|65240020|FG002|Overall Study|Withdrawal by Subject|13|||
23408808|NCT01467466|65240021|FG003|Overall Study|Withdrawal by Subject|11|||
23408809|NCT01467466|65240018|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
23408810|NCT01467466|65240019|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
23408811|NCT01467466|65240020|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
23408812|NCT01467466|65240021|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
23510875|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
23510876|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
23510877|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
23510878|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
23510879|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
23510880|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Other|4|||
23510881|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Other|4|||
23510882|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Other|0|||
23510883|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
23510884|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
23510885|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
23510886|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Screen Failure|0|||
23510887|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Screen Failure|0|||
23510888|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Screen Failure|1|||
23510889|NCT02585960|65606194|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
23510890|NCT02585960|65606195|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
23510891|NCT02585960|65606196|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
23709356|NCT03622593|66312398|FG001|Overall Study|Physician Decision|1|||
23510892|NCT02585960|65606194|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
23510893|NCT02585960|65606195|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
23408813|NCT01467466|65240018|FG000|Overall Study|Procedure Cancelled|46|||
23408814|NCT01467466|65240019|FG001|Overall Study|Procedure Cancelled|45|||
23510894|NCT02585960|65606196|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
23510895|NCT00241280|65606197|FG000|Overall Study|Adverse Event|2|||
23510896|NCT00241280|65606198|FG001|Overall Study|Adverse Event|6|||
23510897|NCT00241280|65606197|FG000|Overall Study|Discomfort|11|||
23510898|NCT00241280|65606198|FG001|Overall Study|Discomfort|16|||
23510899|NCT00241280|65606197|FG000|Overall Study|Pregnancy|1|||
23510900|NCT00241280|65606198|FG001|Overall Study|Pregnancy|5|||
23510901|NCT00241280|65606197|FG000|Overall Study|Lost to Follow-up|5|||
23510902|NCT00241280|65606198|FG001|Overall Study|Lost to Follow-up|8|||
23510903|NCT00241280|65606197|FG000|Overall Study|Withdrawal by Subject|7|||
23510904|NCT00241280|65606198|FG001|Overall Study|Withdrawal by Subject|4|||
23510905|NCT00241280|65606197|FG000|Overall Study|Protocol Violation|4|||
23510906|NCT00241280|65606198|FG001|Overall Study|Protocol Violation|10|||
23510907|NCT00241280|65606197|FG000|Overall Study|Relocation|4|||
23510908|NCT00241280|65606198|FG001|Overall Study|Relocation|4|||
23510909|NCT00241280|65606197|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
23510910|NCT00241280|65606198|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
23510911|NCT00241280|65606197|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23510912|NCT00241280|65606198|FG001|Overall Study|Unsatisfactory Visual Response|1|||
23510913|NCT00241280|65606197|FG000|Overall Study|Diabetic|1|||
23510914|NCT00241280|65606198|FG001|Overall Study|Diabetic|0|||
23510915|NCT00241280|65606197|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
23510916|NCT00241280|65606198|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
23510917|NCT00241280|65606197|FG000|Overall Study|Dispensed incorrect test article|1|||
23510918|NCT00241280|65606198|FG001|Overall Study|Dispensed incorrect test article|2|||
23510919|NCT00241280|65606197|FG000|Overall Study|Unacceptable Fit|0|||
23510920|NCT00241280|65606198|FG001|Overall Study|Unacceptable Fit|1|||
23510921|NCT00241280|65606197|FG000|Overall Study|Scheduling Conflict|0|||
23510922|NCT00241280|65606198|FG001|Overall Study|Scheduling Conflict|2|||
23510923|NCT00241280|65606197|FG000|Overall Study|History of Ocular Surgery|0|||
23510924|NCT00241280|65606198|FG001|Overall Study|History of Ocular Surgery|1|||
23510925|NCT00241280|65606197|FG000|Overall Study|Coating on Lens|1|||
23510926|NCT00241280|65606198|FG001|Overall Study|Coating on Lens|0|||
23510927|NCT00241280|65606197|FG000|Overall Study|Excessive Dryness|0|||
23510928|NCT00241280|65606198|FG001|Overall Study|Excessive Dryness|1|||
23510929|NCT00464087|65606199|FG000|Overall Study|No PCI per inclusion criteria|0|||
23510930|NCT00464087|65606200|FG001|Overall Study|No PCI per inclusion criteria|0|||
23510931|NCT00464087|65606201|FG002|Overall Study|No PCI per inclusion criteria|29|||
23510932|NCT00126568|65606208|FG000|Overall Study|Death|2|||
23510933|NCT00674700|65606209|FG000|Year 1|Adverse Event|17|||
23510934|NCT00674700|65606210|FG001|Year 1|Adverse Event|20|||
23510935|NCT00674700|65606211|FG002|Year 1|Adverse Event|5|||
23510936|NCT00674700|65606209|FG000|Year 1|Withdrawal by Subject|7|||
23510937|NCT00674700|65606210|FG001|Year 1|Withdrawal by Subject|7|||
23510938|NCT00674700|65606211|FG002|Year 1|Withdrawal by Subject|6|||
23510939|NCT00674700|65606209|FG000|Year 1|Any other reason not above-mentioned|7|||
23510940|NCT00674700|65606210|FG001|Year 1|Any other reason not above-mentioned|7|||
23510941|NCT00674700|65606211|FG002|Year 1|Any other reason not above-mentioned|6|||
23510942|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
23510943|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
23510944|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
23510945|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
23510946|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
23510947|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
23510948|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
23510949|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
23510950|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
23510951|NCT01709162|65606212|FG000|Overall Study|Disease progression|3|||
23510952|NCT01709162|65606213|FG001|Overall Study|Disease progression|3|||
23510953|NCT01709162|65606212|FG000|Overall Study|Study drug toxicity|2|||
23709357|NCT03622593|66312399|FG002|Overall Study|Physician Decision|6|||
23709358|NCT03622593|66312397|FG000|Overall Study|Other|2|||
23709359|NCT03622593|66312398|FG001|Overall Study|Other|2|||
23510954|NCT01709162|65606213|FG001|Overall Study|Study drug toxicity|0|||
23510955|NCT01709162|65606212|FG000|Overall Study|Administrative reason by sponsor|0|||
23510956|NCT01709162|65606213|FG001|Overall Study|Administrative reason by sponsor|1|||
23510957|NCT01709162|65606212|FG000|Overall Study|Other|1|||
23510958|NCT01709162|65606213|FG001|Overall Study|Other|0|||
23510959|NCT01709162|65606212|FG000|Overall Study|Withdrawal by Subject|0|||
23510960|NCT01709162|65606213|FG001|Overall Study|Withdrawal by Subject|1|||
23510961|NCT00381095|65606214|FG000|Overall Study|Death|3|||
23510962|NCT00381095|65606215|FG001|Overall Study|Death|4|||
23510963|NCT00381095|65606214|FG000|Overall Study|Lack of Efficacy|2|||
23510964|NCT00381095|65606215|FG001|Overall Study|Lack of Efficacy|4|||
23709360|NCT03622593|66312399|FG002|Overall Study|Other|3|||
23709361|NCT03622593|66312397|FG000|Overall Study|Protocol Violation|0|||
23510965|NCT00381095|65606214|FG000|Overall Study|Other|2|||
23510966|NCT00381095|65606215|FG001|Overall Study|Other|2|||
23510967|NCT00381095|65606214|FG000|Overall Study|Protocol Violation|1|||
23510968|NCT00381095|65606215|FG001|Overall Study|Protocol Violation|1|||
23510969|NCT00381095|65606214|FG000|Overall Study|Withdrawal by Subject|3|||
23510970|NCT00381095|65606215|FG001|Overall Study|Withdrawal by Subject|3|||
23510971|NCT00381095|65606214|FG000|Overall Study|Adverse Event|2|||
23510972|NCT00381095|65606215|FG001|Overall Study|Adverse Event|7|||
23510973|NCT01191801|65606218|FG000|Overall Study|Death|36|||
23510974|NCT01191801|65606219|FG001|Overall Study|Death|12|||
23510975|NCT01191801|65606218|FG000|Overall Study|Lack of Efficacy|176|||
23510976|NCT01191801|65606219|FG001|Overall Study|Lack of Efficacy|258|||
23510977|NCT01191801|65606218|FG000|Overall Study|Adverse Event|9|||
23510978|NCT01191801|65606219|FG001|Overall Study|Adverse Event|8|||
23510979|NCT01191801|65606218|FG000|Overall Study|Protocol Violation|2|||
23510980|NCT01191801|65606219|FG001|Overall Study|Protocol Violation|4|||
23510981|NCT01191801|65606218|FG000|Overall Study|Physician Decision|47|||
23510982|NCT01191801|65606219|FG001|Overall Study|Physician Decision|24|||
23510983|NCT01191801|65606218|FG000|Overall Study|Withdrawal by Subject|1|||
23510984|NCT01191801|65606219|FG001|Overall Study|Withdrawal by Subject|4|||
23510985|NCT01191801|65606218|FG000|Overall Study|Not Provided|45|||
23510986|NCT01191801|65606219|FG001|Overall Study|Not Provided|27|||
23510987|NCT02782780|65606220|FG000|Overall Study|dropped out after randomization.|7|||
23510988|NCT02782780|65606221|FG001|Overall Study|dropped out after randomization.|5|||
23510989|NCT02782780|65606220|FG000|Overall Study|Protocol Violation|0|||
23510990|NCT02782780|65606221|FG001|Overall Study|Protocol Violation|2|||
23510991|NCT01001377|65606222|FG000|Overall Study|Ineligibility determined|2|||
23510992|NCT01001377|65606223|FG001|Overall Study|Ineligibility determined|0|||
23510993|NCT01001377|65606222|FG000|Overall Study|Withdrawal by Subject|19|||
23510994|NCT01001377|65606223|FG001|Overall Study|Withdrawal by Subject|20|||
23510995|NCT01001377|65606222|FG000|Overall Study|Lost to Follow-up|14|||
23510996|NCT01001377|65606223|FG001|Overall Study|Lost to Follow-up|17|||
23510997|NCT01001377|65606222|FG000|Overall Study|Death|391|||
23510998|NCT01001377|65606223|FG001|Overall Study|Death|384|||
23510999|NCT05131646|65606227|FG000|Overall Study|Withdrawal by Subject|1|||
23511000|NCT05131646|65606228|FG001|Overall Study|Withdrawal by Subject|0|||
23511001|NCT05131646|65606229|FG002|Overall Study|Withdrawal by Subject|0|||
23511002|NCT03334448|65606232|FG000|Washout|Personal Reason|0|||
23511003|NCT03334448|65606233|FG001|Washout|Personal Reason|1|||
23511004|NCT03334448|65606234|FG002|Washout|Personal Reason|0|||
23511005|NCT03334448|65606235|FG003|Washout|Personal Reason|0|||
23511006|NCT03334448|65606232|FG000|Washout|Protocol Violation|0|||
23511007|NCT03334448|65606233|FG001|Washout|Protocol Violation|0|||
23511008|NCT03334448|65606234|FG002|Washout|Protocol Violation|0|||
23511009|NCT03334448|65606235|FG003|Washout|Protocol Violation|1|||
23511010|NCT02664441|65606238|FG000|Randomization|Withdrawal by Subject|0|||
23511011|NCT02664441|65606239|FG001|Randomization|Withdrawal by Subject|1|||
23511012|NCT02664441|65606238|FG000|36-week Randomized Trial|Adverse Event|2|||
23511013|NCT02664441|65606239|FG001|36-week Randomized Trial|Adverse Event|0|||
23511014|NCT02664441|65606238|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
23511015|NCT02664441|65606239|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
23511016|NCT02664441|65606238|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
23511017|NCT02664441|65606239|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
23511018|NCT02664441|65606238|FG000|18-week Open Label Extension|Adverse Event|1|||
23511019|NCT02664441|65606239|FG001|18-week Open Label Extension|Adverse Event|0|||
23511020|NCT02664441|65606238|FG000|18-week Open Label Extension|Physician Decision|1|||
23511021|NCT02664441|65606239|FG001|18-week Open Label Extension|Physician Decision|0|||
23511022|NCT02664441|65606238|FG000|18-week Open Label Extension|Death|1|||
23511023|NCT02664441|65606239|FG001|18-week Open Label Extension|Death|0|||
23511024|NCT02664441|65606238|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
23511025|NCT02664441|65606239|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
23511026|NCT03156543|65606241|FG000|Overall Study|Withdrawal by Subject|1|||
23511027|NCT03156543|65606242|FG001|Overall Study|Withdrawal by Subject|0|||
23511028|NCT02763189|65606245|FG000|Overall Study|Device failure|0|||
23511029|NCT02763189|65606246|FG001|Overall Study|Device failure|2|||
23511030|NCT04140292|65606247|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
23511031|NCT04140292|65606248|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
23511032|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511033|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511034|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511035|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
23511036|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
23511037|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
23511038|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
23511039|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
23511040|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511041|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
23511042|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511043|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511044|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511045|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
23511046|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511047|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511048|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
23511049|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
23511050|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
23511051|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
23511052|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
23511053|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
23511054|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
23511055|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
23511056|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511057|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
23511058|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511059|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511060|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
23511061|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
23511062|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
23511063|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
23511064|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23610571|NCT01964547|65962805|FG001|Overall Study|Lost to Follow-up|1|||
23709362|NCT03622593|66312398|FG001|Overall Study|Protocol Violation|0|||
23709363|NCT03622593|66312399|FG002|Overall Study|Protocol Violation|1|||
23709364|NCT03622593|66312397|FG000|Overall Study|Pregnancy|0|||
23511065|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
23511066|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23511067|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23511068|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
23511069|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
23511070|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
23511071|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
23511072|NCT02709785|65606253|FG000|Overall Study|Withdrawal by Subject|1|||
23511073|NCT02709785|65606254|FG001|Overall Study|Withdrawal by Subject|2|||
23511074|NCT02709785|65606255|FG002|Overall Study|Withdrawal by Subject|1|||
23511075|NCT02846779|65606258|FG000|Overall Study|Lost Enrollment|83|||
23511076|NCT02846779|65606259|FG001|Overall Study|Lost Enrollment|82|||
23511077|NCT02846779|65606260|FG002|Overall Study|Lost Enrollment|86|||
23511078|NCT02846779|65606258|FG000|Overall Study|Less than 31 days of follow-up|56|||
23511079|NCT02846779|65606259|FG001|Overall Study|Less than 31 days of follow-up|45|||
23511080|NCT02846779|65606260|FG002|Overall Study|Less than 31 days of follow-up|52|||
23511081|NCT03454893|65606261|FG000|Overall Study|Study Terminated by the Sponsor|5|||
23511082|NCT03454893|65606261|FG000|Overall Study|Did not pass screening|4|||
23511083|NCT03274440|65606262|FG000|Overall Study|Time commitment too great|1|||
23511084|NCT03274440|65606263|FG001|Overall Study|Time commitment too great|0|||
23511085|NCT03274440|65606264|FG002|Overall Study|Time commitment too great|0|||
23511086|NCT03274440|65606265|FG003|Overall Study|Time commitment too great|1|||
23511087|NCT03274440|65606266|FG004|Overall Study|Time commitment too great|0|||
23511088|NCT03274440|65606267|FG005|Overall Study|Time commitment too great|0|||
23511089|NCT02509156|65606268|FG000|Randomized Phase|Death|1|||
23511090|NCT02509156|65606269|FG001|Randomized Phase|Death|0|||
23511091|NCT02509156|65606268|FG000|Randomized Phase|Withdrawal by Subject|1|||
23511092|NCT02509156|65606269|FG001|Randomized Phase|Withdrawal by Subject|1|||
23511093|NCT03700671|65606274|FG000|Overall Study|Lack of Efficacy|1|||
23511094|NCT03700671|65606275|FG001|Overall Study|Lack of Efficacy|2|||
23511095|NCT02708121|65606276|FG000|Overall Study|Withdrawn by Study Team|1|||
23511096|NCT02708121|65606277|FG001|Overall Study|Withdrawn by Study Team|1|||
23511097|NCT02708121|65606276|FG000|Overall Study|Withdrawal by Subject|0|||
23511098|NCT02708121|65606277|FG001|Overall Study|Withdrawal by Subject|4|||
23511099|NCT02041286|65606279|FG000|Overall Study|Adverse Event|1|||
23511100|NCT00456521|65606282|FG000|Overall Study|Adverse Event|150|||
23511101|NCT00456521|65606283|FG001|Overall Study|Adverse Event|25|||
23511102|NCT00456521|65606282|FG000|Overall Study|Withdrawal by Subject|43|||
23511103|NCT00456521|65606283|FG001|Overall Study|Withdrawal by Subject|24|||
23511104|NCT00456521|65606282|FG000|Overall Study|Lost to Follow-up|22|||
23511105|NCT00456521|65606283|FG001|Overall Study|Lost to Follow-up|17|||
23511106|NCT00456521|65606282|FG000|Overall Study|Lack of Efficacy|3|||
23511107|NCT00456521|65606283|FG001|Overall Study|Lack of Efficacy|6|||
23511108|NCT00456521|65606282|FG000|Overall Study|Protocol Violation|4|||
23511109|NCT00456521|65606283|FG001|Overall Study|Protocol Violation|0|||
23511110|NCT00456521|65606282|FG000|Overall Study|Pregnancy|1|||
23511111|NCT00456521|65606283|FG001|Overall Study|Pregnancy|1|||
23408815|NCT01467466|65240020|FG002|Overall Study|Procedure Cancelled|25|||
23408816|NCT01467466|65240021|FG003|Overall Study|Procedure Cancelled|29|||
23511112|NCT00456521|65606282|FG000|Overall Study|Drug non-compliance, moved, other|26|||
23511113|NCT00456521|65606283|FG001|Overall Study|Drug non-compliance, moved, other|11|||
23511114|NCT02433483|65606286|FG000|Overall Study|Unacceptable toxicity|1|||
23511115|NCT02433483|65606286|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
23408817|NCT01467466|65240018|FG000|Overall Study|No Endpoint Blood Draw|38|||
23709365|NCT03622593|66312398|FG001|Overall Study|Pregnancy|0|||
23709366|NCT03622593|66312399|FG002|Overall Study|Pregnancy|1|||
23709367|NCT01640925|66312400|FG000|Overall Study|Withdrawal by Subject|1|||
23709368|NCT01640925|66312401|FG001|Overall Study|Withdrawal by Subject|0|||
23709369|NCT01640925|66312400|FG000|Overall Study|Previously enrolled in this trial|13|||
23709370|NCT01640925|66312401|FG001|Overall Study|Previously enrolled in this trial|11|||
23709371|NCT03456713|66312402|FG000|Overall Study|Lost to Follow-up|1|||
23709372|NCT03456713|66312403|FG001|Overall Study|Lost to Follow-up|0|||
23709373|NCT03456713|66312404|FG002|Overall Study|Lost to Follow-up|0|||
23709374|NCT03456713|66312405|FG003|Overall Study|Lost to Follow-up|0|||
23709375|NCT02176291|66312406|FG000|Overall Study|Death|1|||
23709376|NCT02176291|66312407|FG001|Overall Study|Death|0|||
23709377|NCT02176291|66312406|FG000|Overall Study|non compliance with protocol|2|||
23709378|NCT02176291|66312407|FG001|Overall Study|non compliance with protocol|0|||
23709379|NCT02176291|66312406|FG000|Overall Study|Withdrawal by Subject|2|||
23709380|NCT02176291|66312407|FG001|Overall Study|Withdrawal by Subject|0|||
23709381|NCT02683525|66312415|FG000|Overall Study|Lost to Follow-up|1|||
23709382|NCT02683525|66312415|FG000|Overall Study|Physician Decision|1|||
23709383|NCT02683525|66312415|FG000|Overall Study|Disease Progression|6|||
23709384|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
23709385|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
23709386|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
23709387|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
23709388|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
23709389|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
23709390|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
23709391|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
23709392|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
23709393|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
23709394|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
23709395|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
23709396|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
23709397|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
23709398|NCT00848549|66312416|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
23511200|NCT00137046|65606303|FG000|Overall Study|Death|2|||
23511201|NCT00137046|65606304|FG001|Overall Study|Death|1|||
23511202|NCT00137046|65606303|FG000|Overall Study|Adverse Event|16|||
23511203|NCT00137046|65606304|FG001|Overall Study|Adverse Event|5|||
23511204|NCT00137046|65606303|FG000|Overall Study|Laboratory Abnormality|2|||
23511205|NCT00137046|65606304|FG001|Overall Study|Laboratory Abnormality|0|||
23511206|NCT00137046|65606303|FG000|Overall Study|Lack of Efficacy|13|||
23511207|NCT00137046|65606304|FG001|Overall Study|Lack of Efficacy|1|||
23511208|NCT00137046|65606303|FG000|Overall Study|Lost to Follow-up|8|||
23511209|NCT00137046|65606304|FG001|Overall Study|Lost to Follow-up|24|||
23511210|NCT00137046|65606303|FG000|Overall Study|Other|23|||
23511211|NCT00137046|65606304|FG001|Overall Study|Other|19|||
23511212|NCT00137046|65606303|FG000|Overall Study|Withdrawal by Subject|33|||
23511213|NCT00137046|65606304|FG001|Overall Study|Withdrawal by Subject|42|||
23511214|NCT00137046|65606303|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
23511215|NCT00137046|65606304|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
23511216|NCT00137046|65606303|FG000|Overall Study|Withdrew prior to study treatment|1|||
23511217|NCT00137046|65606304|FG001|Overall Study|Withdrew prior to study treatment|1|||
23511218|NCT03070782|65606310|FG000|Overall Study|Adverse Event|3|||
23511219|NCT03070782|65606311|FG001|Overall Study|Adverse Event|0|||
23511220|NCT03070782|65606312|FG002|Overall Study|Adverse Event|3|||
23511221|NCT03070782|65606313|FG003|Overall Study|Adverse Event|1|||
23511222|NCT03070782|65606314|FG004|Overall Study|Adverse Event|6|||
23511223|NCT03070782|65606315|FG005|Overall Study|Adverse Event|2|||
23511224|NCT03070782|65606310|FG000|Overall Study|Withdrawal by Subject|2|||
23511225|NCT03070782|65606311|FG001|Overall Study|Withdrawal by Subject|1|||
23511226|NCT03070782|65606312|FG002|Overall Study|Withdrawal by Subject|1|||
23511227|NCT03070782|65606313|FG003|Overall Study|Withdrawal by Subject|0|||
23511228|NCT03070782|65606314|FG004|Overall Study|Withdrawal by Subject|4|||
23511229|NCT03070782|65606315|FG005|Overall Study|Withdrawal by Subject|3|||
23511230|NCT03070782|65606310|FG000|Overall Study|Reason Not Specified|2|||
23511231|NCT03070782|65606311|FG001|Overall Study|Reason Not Specified|0|||
23511232|NCT03070782|65606312|FG002|Overall Study|Reason Not Specified|0|||
23511233|NCT03070782|65606313|FG003|Overall Study|Reason Not Specified|1|||
23511234|NCT03070782|65606314|FG004|Overall Study|Reason Not Specified|2|||
23511235|NCT03070782|65606315|FG005|Overall Study|Reason Not Specified|1|||
23511236|NCT03070782|65606310|FG000|Overall Study|Ineligibility|0|||
23511237|NCT03070782|65606311|FG001|Overall Study|Ineligibility|0|||
23511238|NCT03070782|65606312|FG002|Overall Study|Ineligibility|0|||
23511239|NCT03070782|65606313|FG003|Overall Study|Ineligibility|1|||
23511240|NCT03070782|65606314|FG004|Overall Study|Ineligibility|0|||
23511241|NCT03070782|65606315|FG005|Overall Study|Ineligibility|1|||
23511242|NCT03070782|65606310|FG000|Overall Study|Pregnancy|0|||
23511243|NCT03070782|65606311|FG001|Overall Study|Pregnancy|0|||
23511244|NCT03070782|65606312|FG002|Overall Study|Pregnancy|0|||
23511245|NCT03070782|65606313|FG003|Overall Study|Pregnancy|1|||
23511246|NCT03070782|65606314|FG004|Overall Study|Pregnancy|0|||
23511247|NCT03070782|65606315|FG005|Overall Study|Pregnancy|0|||
23511248|NCT03070782|65606310|FG000|Overall Study|Investigator Judgement|0|||
23511249|NCT03070782|65606311|FG001|Overall Study|Investigator Judgement|0|||
23511250|NCT03070782|65606312|FG002|Overall Study|Investigator Judgement|0|||
23511251|NCT03070782|65606313|FG003|Overall Study|Investigator Judgement|1|||
23511252|NCT03070782|65606314|FG004|Overall Study|Investigator Judgement|0|||
23511253|NCT03070782|65606315|FG005|Overall Study|Investigator Judgement|0|||
23511254|NCT03406104|65609258|FG000|Overall Study|Lost to Follow-up|2|||
23511255|NCT03406104|65609258|FG000|Overall Study|Withdrawal by Subject|2|||
23511256|NCT03406104|65609258|FG000|Overall Study|due to Covid patient did not want to travel|1|||
23511257|NCT03406104|65609258|FG000|Overall Study|Death|2|||
23511258|NCT02425046|65609260|FG000|Overall Study|Lost to Follow-up|52|||
23511259|NCT02425046|65609261|FG001|Overall Study|Lost to Follow-up|50|||
23511260|NCT02425046|65609262|FG002|Overall Study|Lost to Follow-up|56|||
23511261|NCT02425046|65609260|FG000|Overall Study|Withdrawal by Subject|16|||
23511262|NCT02425046|65609261|FG001|Overall Study|Withdrawal by Subject|12|||
23511263|NCT02425046|65609262|FG002|Overall Study|Withdrawal by Subject|0|||
23511264|NCT00931762|65609272|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
23511265|NCT00931762|65609272|FG000|Overall Study|Administrative Problems|5|||
23511266|NCT00931762|65609272|FG000|Overall Study|Death|1|||
23511267|NCT00931762|65609272|FG000|Overall Study|Disease Progression|3|||
23511268|NCT00931762|65609272|FG000|Overall Study|Adverse Event (s)|11|||
23511269|NCT00931762|65609272|FG000|Overall Study|Subject withdrew consent|13|||
23511270|NCT01113801|65609274|FG000|Overall Study|Adverse Event|4|||
23511271|NCT01113801|65609275|FG001|Overall Study|Adverse Event|0|||
23511272|NCT01113801|65609276|FG002|Overall Study|Adverse Event|2|||
23511273|NCT01113801|65609277|FG003|Overall Study|Adverse Event|6|||
23511274|NCT01113801|65609274|FG000|Overall Study|Death|4|||
23511275|NCT01113801|65609275|FG001|Overall Study|Death|5|||
23511276|NCT01113801|65609276|FG002|Overall Study|Death|3|||
23511277|NCT01113801|65609277|FG003|Overall Study|Death|4|||
23511278|NCT01113801|65609274|FG000|Overall Study|Protocol Violation|0|||
23511279|NCT01113801|65609275|FG001|Overall Study|Protocol Violation|1|||
23511280|NCT01113801|65609276|FG002|Overall Study|Protocol Violation|0|||
23511281|NCT01113801|65609277|FG003|Overall Study|Protocol Violation|0|||
23511282|NCT01113801|65609274|FG000|Overall Study|Withdrawal by Subject|9|||
23511283|NCT01113801|65609275|FG001|Overall Study|Withdrawal by Subject|7|||
23511284|NCT01113801|65609276|FG002|Overall Study|Withdrawal by Subject|7|||
23511285|NCT01113801|65609277|FG003|Overall Study|Withdrawal by Subject|8|||
23511286|NCT01113801|65609274|FG000|Overall Study|Physician Decision|2|||
23511287|NCT01113801|65609275|FG001|Overall Study|Physician Decision|2|||
23511288|NCT01113801|65609276|FG002|Overall Study|Physician Decision|3|||
23511289|NCT01113801|65609277|FG003|Overall Study|Physician Decision|3|||
23511290|NCT01113801|65609274|FG000|Overall Study|Sponsor Decision|15|||
23709399|NCT00848549|66312417|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
23709400|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
23511291|NCT01113801|65609275|FG001|Overall Study|Sponsor Decision|21|||
23511292|NCT01113801|65609276|FG002|Overall Study|Sponsor Decision|20|||
23511293|NCT01113801|65609277|FG003|Overall Study|Sponsor Decision|15|||
23511294|NCT01113801|65609274|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
23511295|NCT01113801|65609275|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
23511296|NCT01113801|65609276|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
23511297|NCT01113801|65609277|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
23511298|NCT00418314|65609278|FG000|Overall Study|Withdrawal by Subject|1|||
23511299|NCT00418314|65609279|FG001|Overall Study|Withdrawal by Subject|2|||
23511300|NCT00142584|65609283|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
23511301|NCT00142584|65609284|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
23511302|NCT00142584|65609283|FG000|Overall Study|Withdrawal by Subject|30|||
23511303|NCT00142584|65609284|FG001|Overall Study|Withdrawal by Subject|16|||
23511304|NCT00142584|65609283|FG000|Overall Study|Lost to Follow-up|22|||
23511305|NCT00142584|65609284|FG001|Overall Study|Lost to Follow-up|12|||
23511306|NCT00142584|65609283|FG000|Overall Study|Adverse Event|14|||
23511307|NCT00142584|65609284|FG001|Overall Study|Adverse Event|5|||
23709401|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
23511308|NCT00142584|65609283|FG000|Overall Study|Protocol Violation|4|||
23511309|NCT00142584|65609284|FG001|Overall Study|Protocol Violation|7|||
23511310|NCT00142584|65609283|FG000|Overall Study|Treatment Failure|2|||
23511311|NCT00142584|65609284|FG001|Overall Study|Treatment Failure|0|||
23511312|NCT04977583|65609285|FG000|Overall Study|Lost to Follow-up|8|||
23511313|NCT04977583|65609286|FG001|Overall Study|Lost to Follow-up|4|||
23511314|NCT04977583|65609287|FG002|Overall Study|Lost to Follow-up|13|||
23511315|NCT04977583|65609285|FG000|Overall Study|Withdrawal by Subject|3|||
23511316|NCT04977583|65609286|FG001|Overall Study|Withdrawal by Subject|2|||
23511317|NCT04977583|65609287|FG002|Overall Study|Withdrawal by Subject|1|||
23511318|NCT00416078|65609288|FG000|Overall Study|Death|3|||
23511319|NCT00416078|65609289|FG001|Overall Study|Death|4|||
23511320|NCT00416078|65609288|FG000|Overall Study|Withdrawal by Subject|3|||
23511321|NCT00416078|65609289|FG001|Overall Study|Withdrawal by Subject|2|||
23511322|NCT00416078|65609288|FG000|Overall Study|Physician Decision|1|||
23511323|NCT00416078|65609289|FG001|Overall Study|Physician Decision|0|||
23511324|NCT00416078|65609288|FG000|Overall Study|Lost to Follow-up|4|||
23511325|NCT00416078|65609289|FG001|Overall Study|Lost to Follow-up|2|||
23511326|NCT00514540|65609290|FG000|First-Line Chemo|Withdrawal by Subject|1|||
23511327|NCT00514540|65609290|FG000|First-Line Chemo|Protocol Violation|7|||
23511328|NCT00514540|65609290|FG000|Second-Line|Physician/Patient Decision|31|||
23511329|NCT01852110|65609291|FG000|Overall Study|Adverse Event|12|||
23511330|NCT01852110|65609292|FG001|Overall Study|Adverse Event|5|||
23511331|NCT01852110|65609293|FG002|Overall Study|Adverse Event|0|||
23511332|NCT01852110|65609294|FG003|Overall Study|Adverse Event|0|||
23511333|NCT01852110|65609295|FG004|Overall Study|Adverse Event|0|||
23511334|NCT01852110|65609296|FG005|Overall Study|Adverse Event|0|||
23511335|NCT01852110|65609291|FG000|Overall Study|Lost to Follow-up|1|||
23511336|NCT01852110|65609292|FG001|Overall Study|Lost to Follow-up|3|||
23511337|NCT01852110|65609293|FG002|Overall Study|Lost to Follow-up|0|||
23511338|NCT01852110|65609294|FG003|Overall Study|Lost to Follow-up|0|||
23511339|NCT01852110|65609295|FG004|Overall Study|Lost to Follow-up|0|||
23511340|NCT01852110|65609296|FG005|Overall Study|Lost to Follow-up|0|||
23511341|NCT01852110|65609291|FG000|Overall Study|Non-compliance with Study Drug|2|||
23511342|NCT01852110|65609292|FG001|Overall Study|Non-compliance with Study Drug|1|||
23511343|NCT01852110|65609293|FG002|Overall Study|Non-compliance with Study Drug|0|||
23511344|NCT01852110|65609294|FG003|Overall Study|Non-compliance with Study Drug|0|||
23511345|NCT01852110|65609295|FG004|Overall Study|Non-compliance with Study Drug|0|||
23511346|NCT01852110|65609296|FG005|Overall Study|Non-compliance with Study Drug|0|||
23511347|NCT01852110|65609291|FG000|Overall Study|Physician Decision|1|||
23511348|NCT01852110|65609292|FG001|Overall Study|Physician Decision|0|||
23511349|NCT01852110|65609293|FG002|Overall Study|Physician Decision|0|||
23511350|NCT01852110|65609294|FG003|Overall Study|Physician Decision|0|||
23511351|NCT01852110|65609295|FG004|Overall Study|Physician Decision|0|||
23511352|NCT01852110|65609296|FG005|Overall Study|Physician Decision|0|||
23511353|NCT01852110|65609291|FG000|Overall Study|Protocol Violation|0|||
23511354|NCT01852110|65609292|FG001|Overall Study|Protocol Violation|1|||
23511355|NCT01852110|65609293|FG002|Overall Study|Protocol Violation|0|||
23511356|NCT01852110|65609294|FG003|Overall Study|Protocol Violation|0|||
23511357|NCT01852110|65609295|FG004|Overall Study|Protocol Violation|0|||
23511358|NCT01852110|65609296|FG005|Overall Study|Protocol Violation|0|||
23511359|NCT01852110|65609291|FG000|Overall Study|Study Terminated by Sponsor|30|||
23511360|NCT01852110|65609292|FG001|Overall Study|Study Terminated by Sponsor|32|||
23511361|NCT01852110|65609293|FG002|Overall Study|Study Terminated by Sponsor|0|||
23511362|NCT01852110|65609294|FG003|Overall Study|Study Terminated by Sponsor|0|||
23511363|NCT01852110|65609295|FG004|Overall Study|Study Terminated by Sponsor|0|||
23511364|NCT01852110|65609296|FG005|Overall Study|Study Terminated by Sponsor|0|||
23511365|NCT01852110|65609291|FG000|Overall Study|Withdrawal by Subject|4|||
23511366|NCT01852110|65609292|FG001|Overall Study|Withdrawal by Subject|4|||
23511367|NCT01852110|65609293|FG002|Overall Study|Withdrawal by Subject|0|||
23511368|NCT01852110|65609294|FG003|Overall Study|Withdrawal by Subject|0|||
23511369|NCT01852110|65609295|FG004|Overall Study|Withdrawal by Subject|0|||
23511370|NCT01852110|65609296|FG005|Overall Study|Withdrawal by Subject|0|||
23511371|NCT03506815|65609297|FG000|Overall Study|Adverse Event|8|||
23511372|NCT03506815|65609298|FG001|Overall Study|Adverse Event|0|||
23511373|NCT03506815|65609297|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
23511374|NCT03506815|65609298|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
23511375|NCT03506815|65609297|FG000|Overall Study|Protocol Violation|1|||
23511376|NCT03506815|65609298|FG001|Overall Study|Protocol Violation|0|||
23511377|NCT03506815|65609297|FG000|Overall Study|Elective Surgery|1|||
23340850|NCT01936181|64992871|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
23511378|NCT03506815|65609298|FG001|Overall Study|Elective Surgery|0|||
23511379|NCT02496533|65609299|FG000|Overall Study|Lack of data on outcome|3|||
23511380|NCT02496533|65609300|FG001|Overall Study|Lack of data on outcome|0|||
23511381|NCT02496533|65609299|FG000|Overall Study|Patient did not complete all measures|0|||
23511382|NCT02496533|65609300|FG001|Overall Study|Patient did not complete all measures|4|||
23511383|NCT02496533|65609299|FG000|Overall Study|Late for radiologic testing|0|||
23511384|NCT02496533|65609300|FG001|Overall Study|Late for radiologic testing|2|||
23511385|NCT04533438|65609316|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
23511386|NCT04533438|65609317|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
23511387|NCT03128892|65609318|FG000|Overall Study|Withdrawal by Subject|2|||
23511388|NCT03128892|65609318|FG000|Overall Study|Physician Decision|1|||
23511389|NCT03557151|65609319|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
23511390|NCT03557151|65609320|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
23511391|NCT03557151|65609319|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
23511392|NCT03557151|65609320|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
23511393|NCT03557151|65609319|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
23709402|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
23709403|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
23709404|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
23709405|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
23408818|NCT01467466|65240019|FG001|Overall Study|No Endpoint Blood Draw|32|||
23408819|NCT01467466|65240020|FG002|Overall Study|No Endpoint Blood Draw|51|||
23408820|NCT01467466|65240021|FG003|Overall Study|No Endpoint Blood Draw|43|||
23408821|NCT04644276|65240022|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
23408822|NCT04644276|65240023|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
23408823|NCT04644276|65240024|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
23408824|NCT01063062|65240025|FG000|Overall Study|Patient withdrew consent|0|||
23408825|NCT01063062|65240026|FG001|Overall Study|Patient withdrew consent|1|||
23408826|NCT01063062|65240025|FG000|Overall Study|Adverse Event|2|||
23408827|NCT01063062|65240026|FG001|Overall Study|Adverse Event|4|||
23408828|NCT01063062|65240025|FG000|Overall Study|Protocol Violation|5|||
23408829|NCT01063062|65240026|FG001|Overall Study|Protocol Violation|4|||
23408830|NCT01063062|65240025|FG000|Overall Study|Investigator's request|1|||
23408831|NCT01063062|65240026|FG001|Overall Study|Investigator's request|0|||
23408832|NCT01063062|65240025|FG000|Overall Study|Lost to Follow-up|0|||
23408833|NCT01063062|65240026|FG001|Overall Study|Lost to Follow-up|2|||
23408834|NCT01063062|65240025|FG000|Overall Study|Miscellaneous reason|0|||
23408835|NCT01063062|65240026|FG001|Overall Study|Miscellaneous reason|1|||
23408836|NCT01665911|65240027|FG000|Overall Study|Protocol Violation|4|||
23408837|NCT01665911|65240027|FG000|Overall Study|Withdrawal by Subject|1|||
23408838|NCT01665911|65240027|FG000|Overall Study|Adverse Event|1|||
23408839|NCT04396795|65240028|FG000|Month 1|Lost to Follow-up|2|||
23408840|NCT04396795|65240029|FG001|Month 1|Lost to Follow-up|3|||
23408841|NCT04396795|65240028|FG000|Month 3|Lost to Follow-up|1|||
23408842|NCT04396795|65240029|FG001|Month 3|Lost to Follow-up|3|||
23408843|NCT04396795|65240028|FG000|Month 6|Lost to Follow-up|3|||
23408844|NCT04396795|65240029|FG001|Month 6|Lost to Follow-up|3|||
23408845|NCT02010593|65240032|FG000|Overall Study|Lost to Follow-up|1|||
23408846|NCT02010593|65240033|FG001|Overall Study|Lost to Follow-up|0|||
23408847|NCT02010593|65240032|FG000|Overall Study|Physician Decision|1|||
23408848|NCT02010593|65240033|FG001|Overall Study|Physician Decision|0|||
23408849|NCT02010593|65240032|FG000|Overall Study|Unable to adhere to visit schedule|0|||
23408850|NCT02010593|65240033|FG001|Overall Study|Unable to adhere to visit schedule|2|||
23408851|NCT01253369|65240034|FG000|Overall Study|Adverse Event|4|||
23408852|NCT01253369|65240034|FG000|Overall Study|Withdrawal by Subject|2|||
23408853|NCT01253369|65240034|FG000|Overall Study|Death|1|||
23511394|NCT03557151|65609320|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
23511395|NCT01829230|65609321|FG000|Overall Study|Protocol Violation|0|||
23709406|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
23408854|NCT01253369|65240034|FG000|Overall Study|Progressive disease|23|||
23408855|NCT01253369|65240034|FG000|Overall Study|Not Evaluable|3|||
23408856|NCT03900728|65240035|FG000|Overall Study|No text responses|0|||
23408857|NCT03900728|65240036|FG001|Overall Study|No text responses|0|||
23408858|NCT03900728|65240037|FG002|Overall Study|No text responses|4|||
23408859|NCT00690794|65240038|FG000|Overall Study|Adverse Event|12|||
23408860|NCT00690794|65240039|FG001|Overall Study|Adverse Event|10|||
23408861|NCT00690794|65240038|FG000|Overall Study|Lost to Follow-up|1|||
23408862|NCT00690794|65240039|FG001|Overall Study|Lost to Follow-up|4|||
23408863|NCT00690794|65240038|FG000|Overall Study|Withdrawal by Subject|0|||
23408864|NCT00690794|65240039|FG001|Overall Study|Withdrawal by Subject|9|||
23408865|NCT00690794|65240038|FG000|Overall Study|Protocol Violation|6|||
23408866|NCT00690794|65240039|FG001|Overall Study|Protocol Violation|7|||
23408867|NCT00690794|65240038|FG000|Overall Study|Noncompliance|1|||
23408868|NCT00690794|65240039|FG001|Overall Study|Noncompliance|2|||
23709407|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
23709408|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
23709409|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
23709410|NCT00848549|66312416|FG000|E2090-E044-314 (Extension Study)|Other|5|||
23709411|NCT00848549|66312417|FG001|E2090-E044-314 (Extension Study)|Other|6|||
23709412|NCT01259856|66312419|FG000|Overall Study|Adverse Event|12|||
23709413|NCT01259856|66312420|FG001|Overall Study|Adverse Event|9|||
23408869|NCT00690794|65240038|FG000|Overall Study|Other not specified|1|||
23408870|NCT00690794|65240039|FG001|Overall Study|Other not specified|3|||
23408871|NCT02595866|65240041|FG000|Overall Study|Adverse Event|2|||
23408872|NCT02595866|65240042|FG001|Overall Study|Adverse Event|5|||
23408873|NCT02595866|65240041|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
23408874|NCT02595866|65240042|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
23408875|NCT02595866|65240041|FG000|Overall Study|Death|0|||
23408876|NCT02595866|65240042|FG001|Overall Study|Death|1|||
23408877|NCT02595866|65240041|FG000|Overall Study|Incarceration|1|||
23408878|NCT02595866|65240042|FG001|Overall Study|Incarceration|0|||
23408879|NCT02595866|65240041|FG000|Overall Study|Lack of Efficacy|17|||
23408880|NCT02595866|65240042|FG001|Overall Study|Lack of Efficacy|7|||
23408881|NCT02595866|65240041|FG000|Overall Study|Physician Decision|4|||
23408882|NCT02595866|65240042|FG001|Overall Study|Physician Decision|3|||
23408883|NCT02595866|65240041|FG000|Overall Study|Switched to Alternative Treatment|1|||
23408884|NCT02595866|65240042|FG001|Overall Study|Switched to Alternative Treatment|0|||
23408885|NCT02595866|65240041|FG000|Overall Study|Study Terminated|0|||
23408886|NCT02595866|65240042|FG001|Overall Study|Study Terminated|4|||
23408887|NCT02595866|65240041|FG000|Overall Study|Withdrawal by Subject|6|||
23408888|NCT02595866|65240042|FG001|Overall Study|Withdrawal by Subject|1|||
23408889|NCT00430989|65240048|FG000|Overall Study|Lost to Follow-up|2|||
23408890|NCT00430989|65240049|FG001|Overall Study|Lost to Follow-up|3|||
23408891|NCT00430989|65240048|FG000|Overall Study|Withdrawal by Subject|15|||
23408892|NCT00430989|65240049|FG001|Overall Study|Withdrawal by Subject|14|||
23408893|NCT00430989|65240048|FG000|Overall Study|Protocol Violation|30|||
23408894|NCT00430989|65240049|FG001|Overall Study|Protocol Violation|37|||
23408895|NCT00430989|65240048|FG000|Overall Study|Not eligible|13|||
23408896|NCT00430989|65240049|FG001|Overall Study|Not eligible|6|||
23408897|NCT03559517|65240050|FG000|Overall Study|Withdrawal by Subject|1|||
23408898|NCT03559517|65240051|FG001|Overall Study|Withdrawal by Subject|0|||
23408899|NCT03559517|65240052|FG002|Overall Study|Withdrawal by Subject|0|||
23408900|NCT02229825|65240053|FG000|Overall Study|Personal Reasons|0|||
23709414|NCT01259856|66312419|FG000|Overall Study|Death|0|||
23709415|NCT01259856|66312420|FG001|Overall Study|Death|1|||
23709416|NCT01259856|66312419|FG000|Overall Study|Lack of Efficacy|3|||
23709417|NCT01259856|66312420|FG001|Overall Study|Lack of Efficacy|1|||
23709418|NCT01259856|66312419|FG000|Overall Study|Lost to Follow-up|1|||
23408901|NCT02229825|65240054|FG001|Overall Study|Personal Reasons|1|||
23408902|NCT02229825|65240053|FG000|Overall Study|Refused continuing medication|7|||
23408903|NCT02229825|65240054|FG001|Overall Study|Refused continuing medication|6|||
23408904|NCT02229825|65240053|FG000|Overall Study|Lost to Follow-up|1|||
23408905|NCT02229825|65240054|FG001|Overall Study|Lost to Follow-up|2|||
23408906|NCT02229825|65240053|FG000|Overall Study|Protocol Violation|1|||
23709419|NCT01259856|66312420|FG001|Overall Study|Lost to Follow-up|1|||
23408907|NCT02229825|65240054|FG001|Overall Study|Protocol Violation|1|||
23709420|NCT01259856|66312419|FG000|Overall Study|Physician Decision|2|||
23709421|NCT01259856|66312420|FG001|Overall Study|Physician Decision|1|||
23709422|NCT01259856|66312419|FG000|Overall Study|Withdrawal by Subject|9|||
23709423|NCT01259856|66312420|FG001|Overall Study|Withdrawal by Subject|10|||
23709424|NCT01259856|66312419|FG000|Overall Study|Treatment never started|0|||
23709425|NCT01259856|66312420|FG001|Overall Study|Treatment never started|6|||
23709426|NCT01259856|66312419|FG000|Overall Study|Study closure by sponsor|40|||
23709427|NCT01259856|66312420|FG001|Overall Study|Study closure by sponsor|41|||
23709428|NCT01259856|66312419|FG000|Overall Study|Patient developed other disease|0|||
23709429|NCT01259856|66312420|FG001|Overall Study|Patient developed other disease|1|||
23709430|NCT01259856|66312419|FG000|Overall Study|Transfer to another study|0|||
23709431|NCT01259856|66312420|FG001|Overall Study|Transfer to another study|1|||
23709432|NCT01259856|66312419|FG000|Overall Study|Unknown/missing|2|||
23709433|NCT01259856|66312420|FG001|Overall Study|Unknown/missing|2|||
23709434|NCT04664855|66312425|FG000|Overall Study|Withdrawal by Subject|0|||
23709435|NCT04664855|66312426|FG001|Overall Study|Withdrawal by Subject|2|||
23709436|NCT01753076|66312427|FG000|Overall Study|Adverse Event|17|||
23408908|NCT02229825|65240053|FG000|Overall Study|Lack of Efficacy|4|||
23408909|NCT02229825|65240054|FG001|Overall Study|Lack of Efficacy|10|||
23408910|NCT02229825|65240053|FG000|Overall Study|Adverse Event|11|||
23408911|NCT02229825|65240054|FG001|Overall Study|Adverse Event|9|||
23408912|NCT02229825|65240053|FG000|Overall Study|Not treated|0|||
23408913|NCT02229825|65240054|FG001|Overall Study|Not treated|1|||
23408914|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
23408915|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
23408916|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Death|2|||
23408917|NCT00049257|65240055|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
23408918|NCT00135330|65240056|FG000|Overall Study|Adverse Event|2|||
23408919|NCT00135330|65240057|FG001|Overall Study|Adverse Event|5|||
23408920|NCT00135330|65240058|FG002|Overall Study|Adverse Event|1|||
23408921|NCT00135330|65240056|FG000|Overall Study|Lost to Follow-up|0|||
23408922|NCT00135330|65240057|FG001|Overall Study|Lost to Follow-up|2|||
23709437|NCT01753076|66312428|FG001|Overall Study|Adverse Event|18|||
23709438|NCT01753076|66312427|FG000|Overall Study|Lack of Efficacy|3|||
23709439|NCT01753076|66312428|FG001|Overall Study|Lack of Efficacy|1|||
23709440|NCT01753076|66312427|FG000|Overall Study|Lost to Follow-up|2|||
23408923|NCT00135330|65240058|FG002|Overall Study|Lost to Follow-up|3|||
23408924|NCT00135330|65240056|FG000|Overall Study|Physician Decision|1|||
23408925|NCT00135330|65240057|FG001|Overall Study|Physician Decision|1|||
23408926|NCT00135330|65240058|FG002|Overall Study|Physician Decision|0|||
23408927|NCT00135330|65240056|FG000|Overall Study|Protocol Violation|4|||
23408928|NCT00135330|65240057|FG001|Overall Study|Protocol Violation|3|||
23408929|NCT00135330|65240058|FG002|Overall Study|Protocol Violation|3|||
23408930|NCT00135330|65240056|FG000|Overall Study|Patient Decision|5|||
23408931|NCT00135330|65240057|FG001|Overall Study|Patient Decision|1|||
23408932|NCT00135330|65240058|FG002|Overall Study|Patient Decision|4|||
23408933|NCT00135330|65240056|FG000|Overall Study|Sponsor Decision|0|||
23408934|NCT00135330|65240057|FG001|Overall Study|Sponsor Decision|1|||
23408935|NCT00135330|65240058|FG002|Overall Study|Sponsor Decision|0|||
23408936|NCT01248728|65240059|FG000|Overall Study|Adverse Event|1|||
23408937|NCT01248728|65240060|FG001|Overall Study|Adverse Event|1|||
23408938|NCT01248728|65240059|FG000|Overall Study|Withdrawal by Subject|2|||
23408939|NCT01248728|65240060|FG001|Overall Study|Withdrawal by Subject|1|||
23408940|NCT01248728|65240059|FG000|Overall Study|Lack of Efficacy|1|||
23408941|NCT01248728|65240060|FG001|Overall Study|Lack of Efficacy|0|||
23408942|NCT00923351|65242483|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
23408943|NCT00923351|65242484|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
23408944|NCT00923351|65242485|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
23408945|NCT00887159|65242486|FG000|Overall Study|Disease progression|6|||
23408946|NCT00887159|65242487|FG001|Overall Study|Disease progression|39|||
23408947|NCT00887159|65242488|FG002|Overall Study|Disease progression|33|||
23408948|NCT00887159|65242486|FG000|Overall Study|Adverse Event|3|||
23408949|NCT00887159|65242487|FG001|Overall Study|Adverse Event|4|||
23408950|NCT00887159|65242488|FG002|Overall Study|Adverse Event|17|||
23408951|NCT00887159|65242486|FG000|Overall Study|Death|2|||
23408952|NCT00887159|65242487|FG001|Overall Study|Death|2|||
23408953|NCT00887159|65242488|FG002|Overall Study|Death|0|||
23408954|NCT00887159|65242486|FG000|Overall Study|Withdrawal by Subject|4|||
23408955|NCT00887159|65242487|FG001|Overall Study|Withdrawal by Subject|4|||
23408956|NCT00887159|65242488|FG002|Overall Study|Withdrawal by Subject|2|||
23408957|NCT00887159|65242486|FG000|Overall Study|Alternative therapy|2|||
23408958|NCT00887159|65242487|FG001|Overall Study|Alternative therapy|0|||
23408959|NCT00887159|65242488|FG002|Overall Study|Alternative therapy|0|||
23408960|NCT00887159|65242486|FG000|Overall Study|Physician Decision|1|||
23408961|NCT00887159|65242487|FG001|Overall Study|Physician Decision|1|||
23408962|NCT00887159|65242488|FG002|Overall Study|Physician Decision|0|||
23408963|NCT00887159|65242486|FG000|Overall Study|Sympomatic deterioration|1|||
23408964|NCT00887159|65242487|FG001|Overall Study|Sympomatic deterioration|0|||
23408965|NCT00887159|65242488|FG002|Overall Study|Sympomatic deterioration|0|||
23408966|NCT00887159|65242486|FG000|Overall Study|Treatment delayed|1|||
23408967|NCT00887159|65242487|FG001|Overall Study|Treatment delayed|1|||
23408968|NCT00887159|65242488|FG002|Overall Study|Treatment delayed|0|||
23408969|NCT00887159|65242486|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
23408970|NCT00887159|65242487|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
23408971|NCT00887159|65242488|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
23408972|NCT00887159|65242486|FG000|Overall Study|Received more tx instead of observation|1|||
23408973|NCT00887159|65242487|FG001|Overall Study|Received more tx instead of observation|0|||
23408974|NCT00887159|65242488|FG002|Overall Study|Received more tx instead of observation|0|||
23408975|NCT00887159|65242486|FG000|Overall Study|Ineligible|5|||
23408976|NCT00887159|65242487|FG001|Overall Study|Ineligible|1|||
23408977|NCT00887159|65242488|FG002|Overall Study|Ineligible|0|||
23408978|NCT00887159|65242486|FG000|Overall Study|Never started assigned therapy|3|||
23408979|NCT00887159|65242487|FG001|Overall Study|Never started assigned therapy|3|||
23408980|NCT00887159|65242488|FG002|Overall Study|Never started assigned therapy|4|||
23408981|NCT00375505|65242489|FG000|Overall Study|Adverse Event|1|||
23408982|NCT00375505|65242490|FG001|Overall Study|Adverse Event|2|||
23408983|NCT01846299|65242497|FG000|Overall Study|Physician Decision|4|||
23408984|NCT01846299|65242498|FG001|Overall Study|Physician Decision|2|||
23408985|NCT01846299|65242497|FG000|Overall Study|Protocol deviation|1|||
23408986|NCT01846299|65242498|FG001|Overall Study|Protocol deviation|0|||
23408987|NCT01846299|65242497|FG000|Overall Study|Death|1|||
23408988|NCT01846299|65242498|FG001|Overall Study|Death|2|||
23408989|NCT01846299|65242497|FG000|Overall Study|Lost to Follow-up|3|||
23408990|NCT01846299|65242498|FG001|Overall Study|Lost to Follow-up|0|||
23408991|NCT01846299|65242497|FG000|Overall Study|Withdrawal by Subject|1|||
23408992|NCT01846299|65242498|FG001|Overall Study|Withdrawal by Subject|6|||
23408993|NCT01846299|65242497|FG000|Overall Study|Adverse Event|2|||
23408994|NCT01846299|65242498|FG001|Overall Study|Adverse Event|0|||
23408995|NCT01234480|65242499|FG000|Overall Study|Pregnancy|88|||
23408996|NCT01234480|65242499|FG000|Overall Study|>36/Normal History|50|||
23408997|NCT01234480|65242499|FG000|Overall Study|Age|3|||
23408998|NCT01234480|65242499|FG000|Overall Study|HPV Vaccine History|28|||
23408999|NCT01234480|65242499|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
23409000|NCT01234480|65242499|FG000|Overall Study|Hysterectomy|2|||
23409001|NCT01234480|65242499|FG000|Overall Study|Hysterectomy post enrollment|1|||
23409002|NCT01234480|65242499|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
23409003|NCT01234480|65242499|FG000|Overall Study|Informed Consent Form Violation|30|||
23409004|NCT01234480|65242499|FG000|Overall Study|Incorrect Visit|3|||
23409005|NCT01234480|65242499|FG000|Overall Study|No Florida Lab License|20|||
23409006|NCT01234480|65242499|FG000|Overall Study|Out of Window|42|||
23409007|NCT01234480|65242499|FG000|Overall Study|Sample Processing/Storage|92|||
23409008|NCT01234480|65242499|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
23409009|NCT01234480|65242499|FG000|Overall Study|Site/Subject non-compliance|44|||
23409010|NCT01234480|65242499|FG000|Overall Study|Missing Sample|9|||
23409011|NCT01118780|65242500|FG000|Overall Study|Adverse Event|15|||
23409012|NCT01118780|65242501|FG001|Overall Study|Adverse Event|15|||
23409013|NCT01118780|65242500|FG000|Overall Study|Death|1|||
23409014|NCT01118780|65242501|FG001|Overall Study|Death|0|||
23409015|NCT01118780|65242500|FG000|Overall Study|Lack of Efficacy|2|||
23409016|NCT01118780|65242501|FG001|Overall Study|Lack of Efficacy|6|||
23409017|NCT01118780|65242500|FG000|Overall Study|Physician Decision|2|||
23409018|NCT01118780|65242501|FG001|Overall Study|Physician Decision|0|||
23409019|NCT01118780|65242500|FG000|Overall Study|Protocol Violation|3|||
23409020|NCT01118780|65242501|FG001|Overall Study|Protocol Violation|6|||
23409021|NCT01118780|65242500|FG000|Overall Study|Withdrawal by Subject|13|||
23409022|NCT01118780|65242501|FG001|Overall Study|Withdrawal by Subject|8|||
23409023|NCT01295944|65242502|FG000|Overall Study|Switched to alternative treatment|1|||
23409024|NCT01295944|65242502|FG000|Overall Study|Ineligible|9|||
23409025|NCT01295944|65242502|FG000|Overall Study|Withdrawal by Subject|4|||
23409026|NCT01295944|65242502|FG000|Overall Study|Participant chose to be treated in Peru|1|||
23409027|NCT01295944|65242502|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
23409028|NCT01295944|65242502|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
23409029|NCT01295944|65242502|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
23409030|NCT02151903|65242503|FG000|Overall Study|Withdrawal by Subject|1|||
23409031|NCT02151903|65242504|FG001|Overall Study|Withdrawal by Subject|0|||
23409032|NCT02151903|65242503|FG000|Overall Study|Progressive disease|2|||
23409033|NCT02151903|65242504|FG001|Overall Study|Progressive disease|1|||
23409034|NCT01916824|65242505|FG000|Overall Study|Lost to Follow-up|3|||
23409035|NCT01916824|65242506|FG001|Overall Study|Lost to Follow-up|6|||
23409036|NCT01916824|65242505|FG000|Overall Study|Physician Decision|2|||
23409037|NCT01916824|65242506|FG001|Overall Study|Physician Decision|0|||
23409038|NCT01916824|65242505|FG000|Overall Study|Withdrawal by Subject|2|||
23409039|NCT01916824|65242506|FG001|Overall Study|Withdrawal by Subject|3|||
23709441|NCT01753076|66312428|FG001|Overall Study|Lost to Follow-up|1|||
23709442|NCT01753076|66312427|FG000|Overall Study|Physician Decision|4|||
23709443|NCT01753076|66312428|FG001|Overall Study|Physician Decision|2|||
23709444|NCT01753076|66312427|FG000|Overall Study|Withdrawal by Subject|14|||
23709445|NCT01753076|66312428|FG001|Overall Study|Withdrawal by Subject|24|||
23709446|NCT01753076|66312427|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
23709447|NCT01753076|66312428|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
23709448|NCT01432262|66312429|FG000|Overall Study|Withdrawal by Subject|2|||
23709449|NCT01432262|66312430|FG001|Overall Study|Withdrawal by Subject|1|||
23709450|NCT02855411|66312431|FG000|Overall Study|Study terminated by sponsor|21|||
23709451|NCT02855411|66312431|FG000|Overall Study|Does not meet entrance criteria|14|||
23709452|NCT00444626|66312439|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
23409040|NCT00349349|65242509|FG000|Overall Study|Adverse Event|5|||
23409041|NCT00349349|65242510|FG001|Overall Study|Adverse Event|6|||
23409042|NCT00349349|65242511|FG002|Overall Study|Adverse Event|2|||
23409043|NCT00349349|65242509|FG000|Overall Study|Withdrawal by Subject|5|||
23409044|NCT00349349|65242510|FG001|Overall Study|Withdrawal by Subject|2|||
23709453|NCT00444626|66312439|FG000|Initial Treatment Period|Adverse Event|1|||
23409045|NCT00349349|65242511|FG002|Overall Study|Withdrawal by Subject|1|||
23409046|NCT00349349|65242509|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
23409047|NCT00349349|65242510|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
23409048|NCT00349349|65242511|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
23709454|NCT00444626|66312439|FG000|Initial Treatment Period|Lost to Follow-up|9|||
23409049|NCT00349349|65242509|FG000|Overall Study|Death|13|||
23409050|NCT00349349|65242510|FG001|Overall Study|Death|10|||
23409051|NCT00349349|65242511|FG002|Overall Study|Death|1|||
23409052|NCT00349349|65242509|FG000|Overall Study|Other Treatment Selected|2|||
23409053|NCT00349349|65242510|FG001|Overall Study|Other Treatment Selected|0|||
23409054|NCT00349349|65242511|FG002|Overall Study|Other Treatment Selected|0|||
23409055|NCT00349349|65242509|FG000|Overall Study|Participant Reduced General Condition|0|||
23409056|NCT00349349|65242510|FG001|Overall Study|Participant Reduced General Condition|1|||
23409057|NCT00349349|65242511|FG002|Overall Study|Participant Reduced General Condition|0|||
23409058|NCT00349349|65242509|FG000|Overall Study|Physician Decision|1|||
23409059|NCT00349349|65242510|FG001|Overall Study|Physician Decision|2|||
23409060|NCT00349349|65242511|FG002|Overall Study|Physician Decision|1|||
23409061|NCT00349349|65242509|FG000|Overall Study|No Response|0|||
23409062|NCT00349349|65242510|FG001|Overall Study|No Response|3|||
23409063|NCT00349349|65242511|FG002|Overall Study|No Response|0|||
23709455|NCT02868216|66312442|FG000|Overall Study|Death|0|||
23709456|NCT02868216|66312443|FG001|Overall Study|Death|1|||
23709457|NCT02868216|66312442|FG000|Overall Study|coronary artery bypass|1|||
23709458|NCT02868216|66312443|FG001|Overall Study|coronary artery bypass|0|||
23709459|NCT02868216|66312442|FG000|Overall Study|Withdrawal by Subject|7|||
23709460|NCT02868216|66312443|FG001|Overall Study|Withdrawal by Subject|5|||
23709461|NCT03025217|66312444|FG000|Overall Study|Pregnancy|1|||
23709462|NCT03025217|66312444|FG000|Overall Study|Lost to Follow-up|1|||
23709463|NCT03025217|66312444|FG000|Overall Study|Not eligible, poor English|2|||
23709464|NCT02586233|66312445|FG000|Overall Study|Randomized but did not receive treatment|0|||
23709465|NCT02586233|66312446|FG001|Overall Study|Randomized but did not receive treatment|1|||
23709466|NCT02586233|66312447|FG002|Overall Study|Randomized but did not receive treatment|0|||
23709467|NCT02586233|66312448|FG003|Overall Study|Randomized but did not receive treatment|0|||
23709468|NCT02586233|66312449|FG004|Overall Study|Randomized but did not receive treatment|0|||
23709469|NCT02586233|66312450|FG005|Overall Study|Randomized but did not receive treatment|2|||
23709470|NCT02586233|66312451|FG006|Overall Study|Randomized but did not receive treatment|2|||
23709471|NCT02586233|66312445|FG000|Overall Study|Death|0|||
23709472|NCT02586233|66312446|FG001|Overall Study|Death|1|||
23709473|NCT02586233|66312447|FG002|Overall Study|Death|0|||
23709474|NCT02586233|66312448|FG003|Overall Study|Death|0|||
23709475|NCT02586233|66312449|FG004|Overall Study|Death|2|||
23709476|NCT02586233|66312450|FG005|Overall Study|Death|0|||
23709477|NCT02586233|66312451|FG006|Overall Study|Death|0|||
23709478|NCT02918266|66312452|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
23709479|NCT02918266|66312453|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709480|NCT02918266|66312454|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709481|NCT02918266|66312455|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709482|NCT02918266|66312456|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709483|NCT02918266|66312457|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709484|NCT02918266|66312458|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
23709485|NCT02918266|66312459|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709486|NCT02918266|66312460|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
23709487|NCT02918266|66312461|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23409064|NCT00349349|65242509|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
23409065|NCT00349349|65242510|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
23409066|NCT00349349|65242511|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
23409067|NCT03583359|65242517|FG000|Overall Study|Withdrawal by Subject|15|||
23409068|NCT03583359|65242518|FG001|Overall Study|Withdrawal by Subject|6|||
23409069|NCT03583359|65242517|FG000|Overall Study|Lost to Follow-up|12|||
23409070|NCT03583359|65242518|FG001|Overall Study|Lost to Follow-up|3|||
23409071|NCT03583359|65242517|FG000|Overall Study|Adverse Event|0|||
23409072|NCT03583359|65242518|FG001|Overall Study|Adverse Event|1|||
23409073|NCT03583359|65242517|FG000|Overall Study|Protocol Violation|0|||
23409074|NCT03583359|65242518|FG001|Overall Study|Protocol Violation|1|||
23409075|NCT03583359|65242517|FG000|Overall Study|Other|2|||
23409076|NCT03583359|65242518|FG001|Overall Study|Other|1|||
23409077|NCT02466425|65242519|FG000|Overall Study|Adverse Event|3|||
23409078|NCT02466425|65242520|FG001|Overall Study|Adverse Event|11|||
23409079|NCT02466425|65242519|FG000|Overall Study|Lack of Efficacy|4|||
23709488|NCT02918266|66312462|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23709489|NCT02417233|66312463|FG000|Overall Study|Death|4|||
23709490|NCT02417233|66312464|FG001|Overall Study|Death|10|||
23409080|NCT02466425|65242520|FG001|Overall Study|Lack of Efficacy|1|||
23409081|NCT02466425|65242519|FG000|Overall Study|Lost to Follow-up|3|||
23511396|NCT01829230|65609322|FG001|Overall Study|Protocol Violation|2|||
23709491|NCT02417233|66312465|FG002|Overall Study|Death|14|||
23709492|NCT02417233|66312463|FG000|Overall Study|Lost to Follow-up|27|||
23409082|NCT02466425|65242520|FG001|Overall Study|Lost to Follow-up|0|||
23409083|NCT02466425|65242519|FG000|Overall Study|Protocol Violation|1|||
23511397|NCT01829230|65609321|FG000|Overall Study|Withdrawal by Subject|0|||
23409084|NCT02466425|65242520|FG001|Overall Study|Protocol Violation|0|||
23409085|NCT02466425|65242519|FG000|Overall Study|Withdrawal by Subject|0|||
23409086|NCT02466425|65242520|FG001|Overall Study|Withdrawal by Subject|1|||
23409087|NCT02466425|65242519|FG000|Overall Study|Other|1|||
23409088|NCT02466425|65242520|FG001|Overall Study|Other|3|||
23409089|NCT02466425|65242519|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23409090|NCT02466425|65242520|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23409091|NCT01144416|65242525|FG000|Intervention Period|Adverse Event|5|||
23409092|NCT01144416|65242526|FG001|Intervention Period|Adverse Event|6|||
23409093|NCT01144416|65242525|FG000|Intervention Period|Insufficient ovarian response|11|||
23409094|NCT01144416|65242526|FG001|Intervention Period|Insufficient ovarian response|17|||
23409095|NCT01144416|65242525|FG000|Intervention Period|Risk of OHSS|0|||
23409096|NCT01144416|65242526|FG001|Intervention Period|Risk of OHSS|1|||
23409097|NCT01144416|65242525|FG000|Intervention Period|Too high ovarian response|4|||
23409098|NCT01144416|65242526|FG001|Intervention Period|Too high ovarian response|2|||
23409099|NCT01144416|65242525|FG000|Intervention Period|No/too few/bad oocytes|7|||
23409100|NCT01144416|65242526|FG001|Intervention Period|No/too few/bad oocytes|5|||
23409101|NCT01144416|65242525|FG000|Intervention Period|No or abnormal fertilization|25|||
23409102|NCT01144416|65242526|FG001|Intervention Period|No or abnormal fertilization|10|||
23409103|NCT01144416|65242525|FG000|Intervention Period|No/too few/bad quality embryos|3|||
23409104|NCT01144416|65242526|FG001|Intervention Period|No/too few/bad quality embryos|3|||
23409105|NCT01144416|65242525|FG000|Intervention Period|Other|7|||
23409106|NCT01144416|65242526|FG001|Intervention Period|Other|5|||
23409107|NCT00437268|65242527|FG000|Overall Study|Adverse Event|1|||
23409108|NCT00437268|65242528|FG001|Overall Study|Adverse Event|1|||
23409109|NCT00437268|65242527|FG000|Overall Study|Withdrawal by Subject|2|||
23409110|NCT00437268|65242528|FG001|Overall Study|Withdrawal by Subject|2|||
23409111|NCT00437268|65242527|FG000|Overall Study|Progressive disease|9|||
23409112|NCT00437268|65242528|FG001|Overall Study|Progressive disease|9|||
23409113|NCT00437268|65242527|FG000|Overall Study|Physician Decision|1|||
23409114|NCT00437268|65242528|FG001|Overall Study|Physician Decision|0|||
23409115|NCT00437268|65242527|FG000|Overall Study|Death|0|||
23409116|NCT00437268|65242528|FG001|Overall Study|Death|1|||
23409117|NCT02063984|65242529|FG000|Overall Study|Lost to Follow-up|6|||
23409118|NCT02063984|65242530|FG001|Overall Study|Lost to Follow-up|5|||
23409119|NCT00124072|65242531|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
23409120|NCT00124072|65242532|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
23409121|NCT00124072|65242533|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
23409122|NCT00124072|65242534|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
23409123|NCT00124072|65242531|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
23409124|NCT00124072|65242532|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
23409125|NCT00124072|65242533|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
23409126|NCT00124072|65242534|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
23409127|NCT00124072|65242531|FG000|Overall Study|Death|499|||
23409128|NCT00124072|65242532|FG001|Overall Study|Death|484|||
23409129|NCT00124072|65242533|FG002|Overall Study|Death|471|||
23409130|NCT00124072|65242534|FG003|Overall Study|Death|480|||
23409131|NCT00040742|65242535|FG000|Overall Study|Death|0|||
23409132|NCT00040742|65242536|FG001|Overall Study|Death|0|||
23409133|NCT00040742|65242537|FG002|Overall Study|Death|1|||
23409134|NCT00040742|65242538|FG003|Overall Study|Death|0|||
23409135|NCT00040742|65242535|FG000|Overall Study|Adverse Event|15|||
23409136|NCT00040742|65242536|FG001|Overall Study|Adverse Event|16|||
23409137|NCT00040742|65242537|FG002|Overall Study|Adverse Event|21|||
23409138|NCT00040742|65242538|FG003|Overall Study|Adverse Event|9|||
23409139|NCT00040742|65242535|FG000|Overall Study|Withdrawal by Subject|7|||
23409140|NCT00040742|65242536|FG001|Overall Study|Withdrawal by Subject|15|||
23409141|NCT00040742|65242537|FG002|Overall Study|Withdrawal by Subject|10|||
23409142|NCT00040742|65242538|FG003|Overall Study|Withdrawal by Subject|13|||
23409143|NCT00040742|65242535|FG000|Overall Study|Chemotoxicity|4|||
23409144|NCT00040742|65242536|FG001|Overall Study|Chemotoxicity|3|||
23409145|NCT00040742|65242537|FG002|Overall Study|Chemotoxicity|5|||
23409146|NCT00040742|65242538|FG003|Overall Study|Chemotoxicity|2|||
23409147|NCT00040742|65242535|FG000|Overall Study|Incomplete Forms|6|||
23409148|NCT00040742|65242536|FG001|Overall Study|Incomplete Forms|10|||
23409149|NCT00040742|65242537|FG002|Overall Study|Incomplete Forms|4|||
23409150|NCT00040742|65242538|FG003|Overall Study|Incomplete Forms|5|||
23409151|NCT00040742|65242535|FG000|Overall Study|Other medical|7|||
23409152|NCT00040742|65242536|FG001|Overall Study|Other medical|5|||
23409153|NCT00040742|65242537|FG002|Overall Study|Other medical|5|||
23409154|NCT00040742|65242538|FG003|Overall Study|Other medical|5|||
23409155|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
23409156|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
23409157|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
23409158|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
23409159|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
23409160|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
23409161|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
23409162|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409163|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409164|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
23409165|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
23409166|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
23409167|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
23409168|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
23409169|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
23409170|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
23409171|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
23409172|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
23409173|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Other|4|||
23409174|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Other|0|||
23409175|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Other|0|||
23409176|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
23409177|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
23409178|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
23409179|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Death|0|||
23409180|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Death|0|||
23409181|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Death|2|||
23409182|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
23409183|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
23409184|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
23409185|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
23409186|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
23409187|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
23409188|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
23409189|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
23409190|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
23409191|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Other|0|||
23409192|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Other|2|||
23409193|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Other|5|||
23409194|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409195|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
23409196|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
23409197|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
23409198|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
23409199|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
23409200|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
23409201|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
23409202|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
23409203|NCT01206140|65242542|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
23409204|NCT01206140|65242543|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
23409205|NCT02195700|65242544|FG000|Overall Study|Protocol Violation|0|||
23409206|NCT02195700|65242545|FG001|Overall Study|Protocol Violation|2|||
23409207|NCT02195700|65242544|FG000|Overall Study|Noncompliance|1|||
23409208|NCT02195700|65242545|FG001|Overall Study|Noncompliance|0|||
23409209|NCT02195700|65242544|FG000|Overall Study|Adverse Event|1|||
23409210|NCT02195700|65242545|FG001|Overall Study|Adverse Event|2|||
23409211|NCT02195700|65242544|FG000|Overall Study|Withdrawal by Subject|3|||
23409212|NCT02195700|65242545|FG001|Overall Study|Withdrawal by Subject|2|||
23409213|NCT02195700|65242544|FG000|Overall Study|Lost to Follow-up|1|||
23409214|NCT02195700|65242545|FG001|Overall Study|Lost to Follow-up|1|||
23409215|NCT01498692|65242551|FG000|Overall Study|Death|4|||
23409216|NCT01498692|65242551|FG000|Overall Study|Withdrawal by Subject|1|||
23409217|NCT01498692|65242551|FG000|Overall Study|Missed 12-month visit|3|||
23409218|NCT00399568|65242554|FG000|Overall Study|Adverse Event|1|||
23409219|NCT00399568|65242555|FG001|Overall Study|Adverse Event|2|||
23409220|NCT00399568|65242554|FG000|Overall Study|Withdrawal by Subject|7|||
23409221|NCT00399568|65242555|FG001|Overall Study|Withdrawal by Subject|3|||
23409222|NCT00399568|65242554|FG000|Overall Study|Protocol non-compliance|2|||
23409223|NCT00399568|65242555|FG001|Overall Study|Protocol non-compliance|2|||
23409224|NCT00399568|65242554|FG000|Overall Study|Lost to Follow-up|2|||
23409225|NCT00399568|65242555|FG001|Overall Study|Lost to Follow-up|2|||
23409226|NCT02036580|65242556|FG000|Overall Study|Withdrawal by Subject|0|||
23409227|NCT02036580|65242557|FG001|Overall Study|Withdrawal by Subject|1|||
23409228|NCT02036580|65242558|FG002|Overall Study|Withdrawal by Subject|0|||
23409229|NCT02036580|65242556|FG000|Overall Study|Adverse Event|1|||
23409230|NCT02036580|65242557|FG001|Overall Study|Adverse Event|0|||
23409231|NCT02036580|65242558|FG002|Overall Study|Adverse Event|0|||
23409232|NCT02709577|65242569|FG000|Overall Study|non-accommodating anatomy|0|||
23409233|NCT02709577|65242570|FG001|Overall Study|non-accommodating anatomy|1|||
23409234|NCT02709577|65242571|FG002|Overall Study|non-accommodating anatomy|0|||
23409235|NCT02709577|65242572|FG003|Overall Study|non-accommodating anatomy|0|||
23409236|NCT02709577|65242569|FG000|Overall Study|procedural complication|0|||
23409237|NCT02709577|65242570|FG001|Overall Study|procedural complication|1|||
23409238|NCT02709577|65242571|FG002|Overall Study|procedural complication|0|||
23409239|NCT02709577|65242572|FG003|Overall Study|procedural complication|0|||
23409240|NCT02709577|65242569|FG000|Overall Study|Withdrawal by Subject|2|||
23409241|NCT02709577|65242570|FG001|Overall Study|Withdrawal by Subject|3|||
23409242|NCT02709577|65242571|FG002|Overall Study|Withdrawal by Subject|2|||
23409243|NCT02709577|65242572|FG003|Overall Study|Withdrawal by Subject|0|||
23409244|NCT05010070|65242573|FG000|Overall Study|Lost to Follow-up|1|||
23409245|NCT05010070|65242573|FG000|Overall Study|Withdrawal by Subject|1|||
23409246|NCT02998671|65242575|FG000|Period 1|Study Terminated By Sponsor|2|||
23409247|NCT02998671|65242576|FG001|Period 1|Study Terminated By Sponsor|1|||
23409248|NCT02998671|65242577|FG002|Period 1|Study Terminated By Sponsor|0|||
23409249|NCT02998671|65242578|FG003|Period 1|Study Terminated By Sponsor|0|||
23409250|NCT02998671|65242579|FG004|Period 1|Study Terminated By Sponsor|1|||
23409251|NCT02998671|65242575|FG000|Period 1|Withdrawal by Subject|1|||
23409252|NCT02998671|65242576|FG001|Period 1|Withdrawal by Subject|2|||
23409253|NCT02998671|65242577|FG002|Period 1|Withdrawal by Subject|0|||
23409254|NCT02998671|65242578|FG003|Period 1|Withdrawal by Subject|0|||
23409255|NCT02998671|65242579|FG004|Period 1|Withdrawal by Subject|2|||
23409256|NCT02998671|65242575|FG000|Period 1|Pregnancy|1|||
23409257|NCT02998671|65242576|FG001|Period 1|Pregnancy|0|||
23409258|NCT02998671|65242577|FG002|Period 1|Pregnancy|0|||
23409259|NCT02998671|65242578|FG003|Period 1|Pregnancy|0|||
23409260|NCT02998671|65242579|FG004|Period 1|Pregnancy|0|||
23409261|NCT02998671|65242575|FG000|Period 1|Adverse Event|0|||
23409262|NCT02998671|65242576|FG001|Period 1|Adverse Event|0|||
23409263|NCT02998671|65242577|FG002|Period 1|Adverse Event|0|||
23409264|NCT02998671|65242578|FG003|Period 1|Adverse Event|0|||
23409265|NCT02998671|65242579|FG004|Period 1|Adverse Event|1|||
23409266|NCT02998671|65242575|FG000|Period 2|Adverse Event|0|||
23409267|NCT02998671|65242576|FG001|Period 2|Adverse Event|1|||
23409268|NCT02998671|65242577|FG002|Period 2|Adverse Event|0|||
23409269|NCT02998671|65242578|FG003|Period 2|Adverse Event|0|||
23409270|NCT02998671|65242579|FG004|Period 2|Adverse Event|0|||
23409271|NCT02998671|65242575|FG000|Period 2|Study Terminated By Sponsor|3|||
23409272|NCT02998671|65242576|FG001|Period 2|Study Terminated By Sponsor|5|||
23409273|NCT02998671|65242577|FG002|Period 2|Study Terminated By Sponsor|1|||
23409274|NCT02998671|65242578|FG003|Period 2|Study Terminated By Sponsor|3|||
23409275|NCT02998671|65242579|FG004|Period 2|Study Terminated By Sponsor|0|||
23409276|NCT02998671|65242575|FG000|Period 2|Withdrawal by Subject|0|||
23409277|NCT02998671|65242576|FG001|Period 2|Withdrawal by Subject|1|||
23409278|NCT02998671|65242577|FG002|Period 2|Withdrawal by Subject|0|||
23409279|NCT02998671|65242578|FG003|Period 2|Withdrawal by Subject|0|||
23409280|NCT02998671|65242579|FG004|Period 2|Withdrawal by Subject|0|||
23409281|NCT02998671|65242575|FG000|Period 2|Lost to Follow-up|0|||
23409282|NCT02998671|65242576|FG001|Period 2|Lost to Follow-up|0|||
23409283|NCT02998671|65242577|FG002|Period 2|Lost to Follow-up|0|||
23409284|NCT02998671|65242578|FG003|Period 2|Lost to Follow-up|1|||
23409285|NCT02998671|65242579|FG004|Period 2|Lost to Follow-up|0|||
23409286|NCT01823107|65242580|FG000|Overall Study|Withdrawal by Subject|1|||
23409287|NCT02623205|65242581|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
23409288|NCT02623205|65242582|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
23409289|NCT00570778|65242583|FG000|Overall Study|Protocol deviation|2|||
23409290|NCT00570778|65242584|FG001|Overall Study|Protocol deviation|1|||
23511398|NCT01829230|65609322|FG001|Overall Study|Withdrawal by Subject|1|||
23409291|NCT00570778|65242585|FG002|Overall Study|Protocol deviation|2|||
23409292|NCT00570778|65242586|FG003|Overall Study|Protocol deviation|2|||
23610572|NCT01964547|65962804|FG000|Overall Study|Withdrawal by Investigator|0|||
23409293|NCT00570778|65242583|FG000|Overall Study|Adverse Event|0|||
23409294|NCT00570778|65242584|FG001|Overall Study|Adverse Event|1|||
23409295|NCT00570778|65242585|FG002|Overall Study|Adverse Event|4|||
23409296|NCT00570778|65242586|FG003|Overall Study|Adverse Event|1|||
23409297|NCT00570778|65242583|FG000|Overall Study|Subject withdrew consent|0|||
23409298|NCT00570778|65242584|FG001|Overall Study|Subject withdrew consent|1|||
23409299|NCT00570778|65242585|FG002|Overall Study|Subject withdrew consent|0|||
23409300|NCT00570778|65242586|FG003|Overall Study|Subject withdrew consent|1|||
23409301|NCT00570778|65242583|FG000|Overall Study|Abnormal test procedure|1|||
23409302|NCT00570778|65242584|FG001|Overall Study|Abnormal test procedure|0|||
23409303|NCT00570778|65242585|FG002|Overall Study|Abnormal test procedure|0|||
23409304|NCT00570778|65242586|FG003|Overall Study|Abnormal test procedure|0|||
23409305|NCT00570778|65242583|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23409306|NCT00570778|65242584|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23409307|NCT00570778|65242585|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23409308|NCT00570778|65242586|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23409309|NCT00570778|65242583|FG000|Overall Study|Lost to Follow-up|0|||
23409310|NCT00570778|65242584|FG001|Overall Study|Lost to Follow-up|0|||
23409311|NCT00570778|65242585|FG002|Overall Study|Lost to Follow-up|1|||
23409312|NCT00570778|65242586|FG003|Overall Study|Lost to Follow-up|0|||
23409313|NCT00570778|65242583|FG000|Overall Study|Subject no longer requires study drug|0|||
23409314|NCT00570778|65242584|FG001|Overall Study|Subject no longer requires study drug|1|||
23409315|NCT00570778|65242585|FG002|Overall Study|Subject no longer requires study drug|0|||
23409316|NCT00570778|65242586|FG003|Overall Study|Subject no longer requires study drug|0|||
23409317|NCT03083665|65242587|FG000|Double-Blind Period|Adverse Event|5|||
23409318|NCT03083665|65242588|FG001|Double-Blind Period|Adverse Event|4|||
23409319|NCT03083665|65242589|FG002|Double-Blind Period|Adverse Event|5|||
23409320|NCT03083665|65242590|FG003|Double-Blind Period|Adverse Event|0|||
23409321|NCT03083665|65242591|FG004|Double-Blind Period|Adverse Event|0|||
23409322|NCT03083665|65242592|FG005|Double-Blind Period|Adverse Event|0|||
23409323|NCT03083665|65242587|FG000|Double-Blind Period|Lack of Efficacy|0|||
23409324|NCT03083665|65242588|FG001|Double-Blind Period|Lack of Efficacy|0|||
23409325|NCT03083665|65242589|FG002|Double-Blind Period|Lack of Efficacy|1|||
23409326|NCT03083665|65242590|FG003|Double-Blind Period|Lack of Efficacy|0|||
23409327|NCT03083665|65242591|FG004|Double-Blind Period|Lack of Efficacy|0|||
23409328|NCT03083665|65242592|FG005|Double-Blind Period|Lack of Efficacy|0|||
23409329|NCT03083665|65242587|FG000|Double-Blind Period|Protocol Violation|1|||
23409330|NCT03083665|65242588|FG001|Double-Blind Period|Protocol Violation|0|||
23409331|NCT03083665|65242589|FG002|Double-Blind Period|Protocol Violation|1|||
23409332|NCT03083665|65242590|FG003|Double-Blind Period|Protocol Violation|0|||
23409333|NCT03083665|65242591|FG004|Double-Blind Period|Protocol Violation|0|||
23409334|NCT03083665|65242592|FG005|Double-Blind Period|Protocol Violation|0|||
23409335|NCT03083665|65242587|FG000|Double-Blind Period|Lost to Follow-up|1|||
23409336|NCT03083665|65242588|FG001|Double-Blind Period|Lost to Follow-up|0|||
23409337|NCT03083665|65242589|FG002|Double-Blind Period|Lost to Follow-up|1|||
23409338|NCT03083665|65242590|FG003|Double-Blind Period|Lost to Follow-up|0|||
23409339|NCT03083665|65242591|FG004|Double-Blind Period|Lost to Follow-up|0|||
23409340|NCT03083665|65242592|FG005|Double-Blind Period|Lost to Follow-up|0|||
23409341|NCT03083665|65242587|FG000|Double-Blind Period|Withdrawal by Subject|3|||
23409342|NCT03083665|65242588|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23409343|NCT03083665|65242589|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23409344|NCT03083665|65242590|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23409345|NCT03083665|65242591|FG004|Double-Blind Period|Withdrawal by Subject|0|||
23409346|NCT03083665|65242592|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23409347|NCT03083665|65242587|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
23409348|NCT03083665|65242588|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409349|NCT03083665|65242589|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409350|NCT03083665|65242590|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409351|NCT03083665|65242591|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409352|NCT03083665|65242592|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409353|NCT03083665|65242587|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409354|NCT03083665|65242588|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
23409355|NCT03083665|65242589|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409356|NCT03083665|65242590|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409357|NCT03083665|65242591|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409358|NCT03083665|65242592|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409359|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409360|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409361|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409362|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
23409363|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409364|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409365|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409366|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409367|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409368|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409369|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409370|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
23409371|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409372|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409373|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409374|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409375|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409376|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409377|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409378|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409379|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409380|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409381|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409382|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
23409383|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409384|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409385|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409386|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
23409387|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409388|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409389|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409390|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409391|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409392|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409393|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409394|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
23409395|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409396|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409397|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409398|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409399|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409400|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
23409401|NCT00709319|65242593|FG000|Overall Study|Death|4|||
23409402|NCT00709319|65242593|FG000|Overall Study|Withdrawal by Subject|2|||
23409403|NCT05141175|65242602|FG000|Overall Study|Withdrawal by Subject|1|||
23409404|NCT03183063|65242605|FG000|Overall Study|Withdrawal by Subject|2|||
23409405|NCT03183063|65242606|FG001|Overall Study|Withdrawal by Subject|0|||
23409406|NCT03183063|65242607|FG002|Overall Study|Withdrawal by Subject|0|||
23409407|NCT03183063|65242605|FG000|Overall Study|Physician Decision|3|||
23409408|NCT03183063|65242606|FG001|Overall Study|Physician Decision|4|||
23409409|NCT03183063|65242607|FG002|Overall Study|Physician Decision|4|||
23409410|NCT03525600|65242614|FG000|Overall Study|Adverse Event|9|||
23409411|NCT03525600|65242615|FG001|Overall Study|Adverse Event|6|||
23409412|NCT03525600|65242616|FG002|Overall Study|Adverse Event|5|||
23409413|NCT03525600|65242617|FG003|Overall Study|Adverse Event|3|||
23409414|NCT03525600|65242614|FG000|Overall Study|Lost to Follow-up|2|||
23409415|NCT03525600|65242615|FG001|Overall Study|Lost to Follow-up|4|||
23409416|NCT03525600|65242616|FG002|Overall Study|Lost to Follow-up|4|||
23409417|NCT03525600|65242617|FG003|Overall Study|Lost to Follow-up|0|||
23409418|NCT03525600|65242614|FG000|Overall Study|Physician Decision|1|||
23409419|NCT03525600|65242615|FG001|Overall Study|Physician Decision|0|||
23409420|NCT03525600|65242616|FG002|Overall Study|Physician Decision|2|||
23409421|NCT03525600|65242617|FG003|Overall Study|Physician Decision|0|||
23409422|NCT03525600|65242614|FG000|Overall Study|Consent withdrawal|36|||
23409423|NCT03525600|65242615|FG001|Overall Study|Consent withdrawal|20|||
23409424|NCT03525600|65242616|FG002|Overall Study|Consent withdrawal|6|||
23409425|NCT03525600|65242617|FG003|Overall Study|Consent withdrawal|13|||
23409426|NCT03525600|65242614|FG000|Overall Study|Death|7|||
23409427|NCT03525600|65242615|FG001|Overall Study|Death|6|||
23409428|NCT03525600|65242616|FG002|Overall Study|Death|4|||
23409429|NCT03525600|65242617|FG003|Overall Study|Death|3|||
23409430|NCT03525600|65242614|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
23409431|NCT03525600|65242615|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
23409432|NCT03525600|65242616|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
23409433|NCT03525600|65242617|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
23409434|NCT03525600|65242614|FG000|Overall Study|Other|0|||
23409435|NCT03525600|65242615|FG001|Overall Study|Other|1|||
23409436|NCT03525600|65242616|FG002|Overall Study|Other|0|||
23409437|NCT03525600|65242617|FG003|Overall Study|Other|0|||
23409438|NCT03470194|65242618|FG000|Overall Study|Lost to Follow-up|11|||
23409439|NCT03470194|65242619|FG001|Overall Study|Lost to Follow-up|17|||
23409440|NCT01977729|65242620|FG000|Overall Study|Study terminated|1|||
23409441|NCT03036852|65242621|FG000|Overall Study|Death|2|||
23409442|NCT03036852|65242621|FG000|Overall Study|Lack of Efficacy|2|||
23409443|NCT03036852|65242621|FG000|Overall Study|Adverse Event|1|||
23409444|NCT03036852|65242621|FG000|Overall Study|Lost to Follow-up|1|||
23409445|NCT01336712|65242622|FG000|Overall Study|Death|2|||
23409446|NCT01336712|65242622|FG000|Overall Study|Lack of Efficacy|1|||
23409447|NCT02923531|65242623|FG000|Overall Study|Adverse Event|4|||
23409448|NCT02923531|65242623|FG000|Overall Study|Clinical Deterioration|1|||
23409449|NCT02923531|65242623|FG000|Overall Study|Disease Progression|3|||
23409450|NCT02923531|65242623|FG000|Overall Study|Study Termination|1|||
23409451|NCT00104728|65242625|FG000|Overall Study|screen failures|19|||
23409452|NCT01532921|65242626|FG000|Overall Study|Death|3|||
23409453|NCT01532921|65242626|FG000|Overall Study|Withdrawal by Subject|2|||
23409454|NCT01532921|65242626|FG000|Overall Study|Lost to Follow-up|3|||
23409455|NCT01532921|65242626|FG000|Overall Study|Physician Decision|7|||
23409456|NCT01532921|65242626|FG000|Overall Study|Device was explanted during procedure|1|||
23409457|NCT02997865|65242628|FG000|Overall Study|Death|2|||
23409458|NCT02997865|65242629|FG001|Overall Study|Death|1|||
23409459|NCT02997865|65242628|FG000|Overall Study|Lost to Follow-up|6|||
23409460|NCT02997865|65242629|FG001|Overall Study|Lost to Follow-up|3|||
23409461|NCT02997865|65242628|FG000|Overall Study|Withdrawal by Subject|5|||
23409462|NCT02997865|65242629|FG001|Overall Study|Withdrawal by Subject|0|||
23409463|NCT03265145|65242630|FG000|Overall Study|Protocol Violation|2|||
23409464|NCT03265145|65242631|FG001|Overall Study|Protocol Violation|0|||
23409465|NCT03265145|65242630|FG000|Overall Study|Adverse Event|1|||
23409466|NCT03265145|65242631|FG001|Overall Study|Adverse Event|0|||
23409467|NCT03265145|65242630|FG000|Overall Study|Withdrawal by Subject|23|||
23409468|NCT03265145|65242631|FG001|Overall Study|Withdrawal by Subject|19|||
23409469|NCT03265145|65242630|FG000|Overall Study|Death|12|||
23409470|NCT03265145|65242631|FG001|Overall Study|Death|12|||
23409471|NCT03265145|65242630|FG000|Overall Study|Lost to Follow-up|13|||
23409472|NCT03265145|65242631|FG001|Overall Study|Lost to Follow-up|9|||
23409473|NCT03265145|65242630|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
23409474|NCT03265145|65242631|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
23409475|NCT03265145|65242630|FG000|Overall Study|Switched back to previous medication|1|||
23409476|NCT03265145|65242631|FG001|Overall Study|Switched back to previous medication|0|||
23409477|NCT03265145|65242630|FG000|Overall Study|Did not want to take medication|1|||
23409478|NCT03265145|65242631|FG001|Overall Study|Did not want to take medication|0|||
23409479|NCT03265145|65242630|FG000|Overall Study|Subject could not afford medication|0|||
23409480|NCT03265145|65242631|FG001|Overall Study|Subject could not afford medication|1|||
23409481|NCT03265145|65242630|FG000|Overall Study|Site closed|2|||
23409482|NCT03265145|65242631|FG001|Overall Study|Site closed|3|||
23409483|NCT03265145|65242630|FG000|Overall Study|Incorrectly randomized|16|||
23409484|NCT03265145|65242631|FG001|Overall Study|Incorrectly randomized|6|||
23409485|NCT03265145|65242630|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
23409486|NCT03265145|65242631|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
23409487|NCT03265145|65242630|FG000|Overall Study|Physician Decision|0|||
23409488|NCT03265145|65242631|FG001|Overall Study|Physician Decision|3|||
23409489|NCT03265145|65242630|FG000|Overall Study|Subject transferred to another facility|0|||
23409490|NCT03265145|65242631|FG001|Overall Study|Subject transferred to another facility|1|||
23409491|NCT02318368|65242632|FG000|Overall Study|Withdrawal by Subject|2|||
23409492|NCT02318368|65242633|FG001|Overall Study|Withdrawal by Subject|0|||
23409493|NCT02318368|65242632|FG000|Overall Study|Study terminated by the sponsor|5|||
23409494|NCT02318368|65242633|FG001|Overall Study|Study terminated by the sponsor|2|||
23409495|NCT02318368|65242632|FG000|Overall Study|Death|0|||
23409496|NCT02318368|65242633|FG001|Overall Study|Death|1|||
23409497|NCT00770562|65242634|FG000|Overall Study|Did not take treatment|1|||
23409498|NCT00770562|65242635|FG001|Overall Study|Did not take treatment|1|||
23409499|NCT00735553|65242639|FG000|Overall Study|Study prematurely terminated|77|||
23409500|NCT03799952|65242643|FG000|Overall Study|Program was too easy, discontinued|1|||
23409501|NCT03799952|65242644|FG001|Overall Study|Program was too easy, discontinued|0|||
23409502|NCT03799952|65242643|FG000|Overall Study|Lost to Follow-up|0|||
23409503|NCT03799952|65242644|FG001|Overall Study|Lost to Follow-up|2|||
23409504|NCT03146663|65242645|FG000|Overall Study|Did not receive study treatment|1|||
23409505|NCT03146663|65242646|FG001|Overall Study|Did not receive study treatment|1|||
23409506|NCT04721158|65242653|FG000|Overall Study|Lost to Follow-up|4|||
23409507|NCT04721158|65242653|FG000|Overall Study|Device did not connect|1|||
23409508|NCT03374358|65242654|FG000|Overall Study|Withdrawal by Subject|0|||
23409509|NCT03374358|65242655|FG001|Overall Study|Withdrawal by Subject|2|||
23409510|NCT02688192|65242659|FG000|Overall Study|Lost to Follow-up|11|||
23409511|NCT02688192|65242660|FG001|Overall Study|Lost to Follow-up|5|||
23409512|NCT02688192|65242659|FG000|Overall Study|Physician Decision|1|||
23409513|NCT02688192|65242660|FG001|Overall Study|Physician Decision|0|||
23409514|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23511399|NCT01829230|65609321|FG000|Overall Study|Lost to Follow-up|1|||
23409515|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23409516|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23409517|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
23409518|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
23409519|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
23409520|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23409521|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
23409522|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
23409523|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23409524|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
23409525|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
23409526|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
23409527|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
23409528|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
23409529|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
23409530|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
23409531|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
23409532|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
23409533|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
23409534|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
23409535|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
23409536|NCT03122145|65242665|FG000|Overall Study|Concurrent respiratory disease|3|||
23409537|NCT03122145|65242666|FG001|Overall Study|Concurrent respiratory disease|0|||
23409538|NCT01104545|65242667|FG000|Overall Study|Adverse Event|0|||
23409539|NCT01104545|65242668|FG001|Overall Study|Adverse Event|1|||
23409540|NCT01104545|65242669|FG002|Overall Study|Adverse Event|2|||
23409541|NCT01973231|65242670|FG000|Overall Study|Protocol Violation|1|||
23409542|NCT01973231|65242671|FG001|Overall Study|Protocol Violation|1|||
23409543|NCT01973231|65242670|FG000|Overall Study|Lost to Follow-up|1|||
23409544|NCT01973231|65242671|FG001|Overall Study|Lost to Follow-up|1|||
23409545|NCT01973231|65242670|FG000|Overall Study|unclassified|2|||
23409546|NCT01973231|65242671|FG001|Overall Study|unclassified|1|||
23409547|NCT01973231|65242670|FG000|Overall Study|Withdrawal by Subject|7|||
23409548|NCT01973231|65242671|FG001|Overall Study|Withdrawal by Subject|9|||
23409549|NCT02388165|65242672|FG000|Overall Study|Study terminated by sponsor|5|||
23409550|NCT02388165|65242673|FG001|Overall Study|Study terminated by sponsor|5|||
23409551|NCT02388165|65242672|FG000|Overall Study|Other|11|||
23409552|NCT02388165|65242673|FG001|Overall Study|Other|13|||
23409553|NCT02388165|65242672|FG000|Overall Study|No longer meet eligibility criteria|40|||
23409554|NCT02388165|65242673|FG001|Overall Study|No longer meet eligibility criteria|43|||
23409555|NCT02388165|65242672|FG000|Overall Study|Withdrawal of consent|31|||
23409556|NCT02388165|65242673|FG001|Overall Study|Withdrawal of consent|32|||
23409557|NCT02388165|65242672|FG000|Overall Study|Lost to Follow-up|19|||
23409558|NCT02388165|65242673|FG001|Overall Study|Lost to Follow-up|20|||
23409559|NCT02388165|65242672|FG000|Overall Study|Death|13|||
23409560|NCT02388165|65242673|FG001|Overall Study|Death|10|||
23409561|NCT02388165|65242672|FG000|Overall Study|Adverse Event|3|||
23409562|NCT02388165|65242673|FG001|Overall Study|Adverse Event|5|||
23409563|NCT02388165|65242672|FG000|Overall Study|Did not meet entrance criteria|5|||
23409564|NCT02388165|65242673|FG001|Overall Study|Did not meet entrance criteria|2|||
23409565|NCT03050450|65242675|FG000|Overall Study|Physician Decision|1|||
23409566|NCT03050450|65242676|FG001|Overall Study|Physician Decision|0|||
23409567|NCT03050450|65242677|FG002|Overall Study|Physician Decision|0|||
23409568|NCT03050450|65242678|FG003|Overall Study|Physician Decision|0|||
23409569|NCT03050450|65242679|FG004|Overall Study|Physician Decision|0|||
23409570|NCT01642901|65242689|FG000|12-month Follow-up|Withdrawal by Subject|1|||
23409571|NCT01642901|65242690|FG001|12-month Follow-up|Withdrawal by Subject|0|||
23409572|NCT02544750|65242691|FG000|Overall Study|Physician Decision|3|||
23409573|NCT02544750|65242692|FG001|Overall Study|Physician Decision|1|||
23409574|NCT02544750|65242691|FG000|Overall Study|Other reasons|69|||
23409575|NCT02544750|65242692|FG001|Overall Study|Other reasons|39|||
23409576|NCT02544750|65242691|FG000|Overall Study|Met withdrawal criteria|2|||
23409577|NCT02544750|65242692|FG001|Overall Study|Met withdrawal criteria|2|||
23409578|NCT02544750|65242691|FG000|Overall Study|Transition To Commercial Product|1|||
23409579|NCT02544750|65242692|FG001|Overall Study|Transition To Commercial Product|0|||
23409580|NCT02544750|65242691|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
23409581|NCT02544750|65242692|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
23811958|NCT00837473|66691849|FG000|Overall Study|Lost to Follow-up|1|||
23409582|NCT02544750|65242691|FG000|Overall Study|Adverse Event|8|||
23409583|NCT02544750|65242692|FG001|Overall Study|Adverse Event|10|||
23409584|NCT02544750|65242691|FG000|Overall Study|Withdrawal by Subject|10|||
23409585|NCT02544750|65242692|FG001|Overall Study|Withdrawal by Subject|4|||
23409586|NCT02544750|65242691|FG000|Overall Study|Lost to Follow-up|1|||
23409587|NCT02544750|65242692|FG001|Overall Study|Lost to Follow-up|0|||
23409588|NCT01871545|65242696|FG000|Overall Study|Death|2|||
23409589|NCT01871545|65242697|FG001|Overall Study|Death|0|||
23409590|NCT01871545|65242696|FG000|Overall Study|Lack of Efficacy|11|||
23409591|NCT01871545|65242697|FG001|Overall Study|Lack of Efficacy|2|||
23409592|NCT01871545|65242696|FG000|Overall Study|Physician Decision|4|||
23409593|NCT01871545|65242697|FG001|Overall Study|Physician Decision|0|||
23409594|NCT01871545|65242696|FG000|Overall Study|Withdrawal by Subject|0|||
23409595|NCT01871545|65242697|FG001|Overall Study|Withdrawal by Subject|1|||
23409596|NCT01901614|65242698|FG000|Overall Study|Adverse Event|0|||
23409597|NCT01901614|65242699|FG001|Overall Study|Adverse Event|1|||
23409598|NCT01901614|65242698|FG000|Overall Study|Lost to Follow-up|1|||
23409599|NCT01901614|65242699|FG001|Overall Study|Lost to Follow-up|0|||
23409600|NCT01901614|65242698|FG000|Overall Study|Screen Fail|1|||
23409601|NCT01901614|65242699|FG001|Overall Study|Screen Fail|0|||
23409602|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
23409603|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409604|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409605|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409606|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409607|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
23409608|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409609|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409610|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
23409611|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
23409612|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
23409613|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
23409614|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409615|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409616|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409617|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
23409618|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
23409619|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
23409620|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
23409621|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
23409622|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
23409623|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
23409624|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
23409625|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
23409626|NCT03462641|65242708|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
23409627|NCT03462641|65242709|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
23409628|NCT03462641|65242708|FG000|Visit 2|Withdrawal by Subject|0|||
23409629|NCT03462641|65242709|FG001|Visit 2|Withdrawal by Subject|1|||
23409630|NCT00814580|65242710|FG000|Overall Study|Adverse Event|6|||
23409631|NCT00814580|65242711|FG001|Overall Study|Adverse Event|15|||
23409632|NCT00814580|65242710|FG000|Overall Study|Lack of Efficacy|18|||
23409633|NCT00814580|65242711|FG001|Overall Study|Lack of Efficacy|25|||
23409634|NCT00814580|65242710|FG000|Overall Study|Protocol Violation|2|||
23409635|NCT00814580|65242711|FG001|Overall Study|Protocol Violation|0|||
23409636|NCT00814580|65242710|FG000|Overall Study|Withdrawal by Subject|2|||
23409637|NCT00814580|65242711|FG001|Overall Study|Withdrawal by Subject|2|||
23409638|NCT00814580|65242710|FG000|Overall Study|Other|1|||
23409639|NCT00814580|65242711|FG001|Overall Study|Other|3|||
23409640|NCT00814580|65242710|FG000|Overall Study|Did Not Take Drug|2|||
23409641|NCT00814580|65242711|FG001|Overall Study|Did Not Take Drug|2|||
23409642|NCT04072835|65242715|FG000|Overall Study|Overall trial ended|603|||
23409643|NCT04072835|65242715|FG000|Overall Study|Ablation|97|||
23409644|NCT04072835|65242715|FG000|Overall Study|Withdrawal of consent|66|||
23409645|NCT04072835|65242715|FG000|Overall Study|Physician Decision|50|||
23409646|NCT04072835|65242715|FG000|Overall Study|Lost to Follow-up|39|||
23409647|NCT04072835|65242715|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
23409648|NCT04072835|65242715|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
23409649|NCT04072835|65242715|FG000|Overall Study|Adverse Event|25|||
23409650|NCT04072835|65242715|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
23409651|NCT04072835|65242715|FG000|Overall Study|Death|11|||
23409652|NCT04072835|65242715|FG000|Overall Study|Participant felt the drug did not work|8|||
23409653|NCT04072835|65242715|FG000|Overall Study|Participant tolerability|5|||
23409654|NCT04072835|65242715|FG000|Overall Study|Missing|5|||
23409655|NCT04072835|65242715|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
23409656|NCT04072835|65242715|FG000|Overall Study|Pregnancy|3|||
23409657|NCT02236572|65242718|FG000|Overall Study|Withdrawal by Subject|1|||
23409658|NCT02236572|65242718|FG000|Overall Study|Protocol Violation|1|||
23409659|NCT02236572|65242718|FG000|Overall Study|Lost to Follow-up|1|||
23409660|NCT02725476|65242721|FG000|Overall Study|Physician Decision|2|||
23409661|NCT02725476|65242722|FG001|Overall Study|Physician Decision|0|||
23409662|NCT02725476|65242721|FG000|Overall Study|Adverse Event|1|||
23409663|NCT02725476|65242722|FG001|Overall Study|Adverse Event|1|||
23409664|NCT01926444|65242723|FG000|Overall Study|Colonoscopy not performed|0|||
23409665|NCT01926444|65242724|FG001|Overall Study|Colonoscopy not performed|0|||
23409666|NCT01926444|65242725|FG002|Overall Study|Colonoscopy not performed|4|||
23409667|NCT01926444|65242726|FG003|Overall Study|Colonoscopy not performed|2|||
23409668|NCT00988052|65242729|FG000|Overall Study|Missing|1|||
23409669|NCT00988052|65242730|FG001|Overall Study|Missing|0|||
23409670|NCT00988052|65242729|FG000|Overall Study|Teva requested subject withdrawal|3|||
23409671|NCT00988052|65242730|FG001|Overall Study|Teva requested subject withdrawal|1|||
23409672|NCT00988052|65242729|FG000|Overall Study|Death|1|||
23709493|NCT02417233|66312464|FG001|Overall Study|Lost to Follow-up|39|||
23709494|NCT02417233|66312465|FG002|Overall Study|Lost to Follow-up|34|||
23709495|NCT02417233|66312463|FG000|Overall Study|Protocol Violation|2|||
23709496|NCT02417233|66312464|FG001|Overall Study|Protocol Violation|0|||
23709497|NCT02417233|66312465|FG002|Overall Study|Protocol Violation|2|||
23709498|NCT02417233|66312463|FG000|Overall Study|Withdrawal by Subject|2|||
23709499|NCT02417233|66312464|FG001|Overall Study|Withdrawal by Subject|1|||
23709500|NCT02417233|66312465|FG002|Overall Study|Withdrawal by Subject|8|||
23709501|NCT02417233|66312463|FG000|Overall Study|Relocation out of study area|1|||
23709502|NCT02417233|66312464|FG001|Overall Study|Relocation out of study area|0|||
23709503|NCT02417233|66312465|FG002|Overall Study|Relocation out of study area|1|||
23709504|NCT02417233|66312463|FG000|Overall Study|Mentally unstable|0|||
23709505|NCT02417233|66312464|FG001|Overall Study|Mentally unstable|1|||
23709506|NCT02417233|66312465|FG002|Overall Study|Mentally unstable|0|||
23709507|NCT01511419|66312469|FG000|Dose 2|Physician Decision|1|||
23709508|NCT01511419|66312470|FG001|Dose 2|Physician Decision|0|||
23709509|NCT02512068|66312471|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
23709510|NCT02512068|66312472|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23709511|NCT02512068|66312471|FG000|Overall Study|Major Protocol Deviation|1|||
23709512|NCT02512068|66312472|FG001|Overall Study|Major Protocol Deviation|0|||
23709513|NCT02512068|66312471|FG000|Overall Study|Voluntary Withdrawal|0|||
23709514|NCT02512068|66312472|FG001|Overall Study|Voluntary Withdrawal|1|||
23709515|NCT02512068|66312471|FG000|Overall Study|Lack of Efficacy|0|||
23709516|NCT02512068|66312472|FG001|Overall Study|Lack of Efficacy|1|||
23709517|NCT02512068|66312471|FG000|Overall Study|Reason Not Specified|3|||
23709518|NCT02512068|66312472|FG001|Overall Study|Reason Not Specified|5|||
23709519|NCT01718509|66312473|FG000|Overall Study|Lost to Follow-up|18|||
23709520|NCT01718509|66312474|FG001|Overall Study|Lost to Follow-up|15|||
23709521|NCT01718509|66312473|FG000|Overall Study|Withdrawal by Subject|7|||
23709522|NCT01718509|66312474|FG001|Overall Study|Withdrawal by Subject|13|||
23709523|NCT01718509|66312473|FG000|Overall Study|Adverse Event|5|||
23709524|NCT01718509|66312474|FG001|Overall Study|Adverse Event|7|||
23709525|NCT01718509|66312473|FG000|Overall Study|Other|13|||
23709526|NCT01718509|66312474|FG001|Overall Study|Other|11|||
23709527|NCT01718509|66312473|FG000|Overall Study|Protocol Violation|4|||
23709528|NCT01718509|66312474|FG001|Overall Study|Protocol Violation|2|||
23709529|NCT01718509|66312473|FG000|Overall Study|Lack of Efficacy|1|||
23709530|NCT01718509|66312474|FG001|Overall Study|Lack of Efficacy|0|||
23811959|NCT00837473|66691849|FG000|Overall Study|Withdrawal by Subject|2|||
23409673|NCT00988052|65242730|FG001|Overall Study|Death|3|||
23409674|NCT00988052|65242729|FG000|Overall Study|Protocol Violation|6|||
23409675|NCT00988052|65242730|FG001|Overall Study|Protocol Violation|5|||
23409676|NCT00988052|65242729|FG000|Overall Study|Pregnancy|6|||
23409677|NCT00988052|65242730|FG001|Overall Study|Pregnancy|6|||
23409678|NCT00988052|65242729|FG000|Overall Study|Lack of Efficacy|8|||
23409679|NCT00988052|65242730|FG001|Overall Study|Lack of Efficacy|7|||
23409680|NCT00988052|65242729|FG000|Overall Study|Lost to Follow-up|6|||
23409681|NCT00988052|65242730|FG001|Overall Study|Lost to Follow-up|11|||
23409682|NCT00988052|65242729|FG000|Overall Study|Physician Decision|27|||
23409683|NCT00988052|65242730|FG001|Overall Study|Physician Decision|28|||
23709531|NCT00903032|66312475|FG000|Overall Study|Withdrawal by Subject|5|||
23709532|NCT00903032|66312476|FG001|Overall Study|Withdrawal by Subject|3|||
23709533|NCT00903032|66312475|FG000|Overall Study|Lost to Follow-up|2|||
23709534|NCT00903032|66312476|FG001|Overall Study|Lost to Follow-up|2|||
23709535|NCT04876599|66315164|FG000|Overall Study|Missed|2|||
23709536|NCT04876599|66315165|FG001|Overall Study|Missed|0|||
23709537|NCT04876599|66315164|FG000|Overall Study|Declined|2|||
23709538|NCT04876599|66315165|FG001|Overall Study|Declined|3|||
23709539|NCT00239837|66315166|FG000|Overall Study|Lost to Follow-up|3|||
23709540|NCT00239837|66315167|FG001|Overall Study|Lost to Follow-up|7|||
23709541|NCT01449682|66315168|FG000|Overall Study|Death|0|||
23709542|NCT01449682|66315169|FG001|Overall Study|Death|1|||
23709543|NCT01449682|66315168|FG000|Overall Study|Adverse Event|1|||
23709544|NCT01449682|66315169|FG001|Overall Study|Adverse Event|0|||
23709545|NCT04937816|66315176|FG000|Overall Study|Study drug stopped, reason missing|5|||
23709546|NCT04937816|66315177|FG001|Overall Study|Study drug stopped, reason missing|3|||
23709547|NCT04937816|66315178|FG002|Overall Study|Study drug stopped, reason missing|4|||
23709548|NCT04937816|66315179|FG003|Overall Study|Study drug stopped, reason missing|6|||
23409684|NCT00988052|65242729|FG000|Overall Study|Adverse Event|35|||
23409685|NCT00988052|65242730|FG001|Overall Study|Adverse Event|28|||
23709549|NCT04937816|66315180|FG004|Overall Study|Study drug stopped, reason missing|1|||
23709550|NCT04937816|66315181|FG005|Overall Study|Study drug stopped, reason missing|0|||
23409686|NCT00988052|65242729|FG000|Overall Study|Withdrawal by Subject|90|||
23409687|NCT00988052|65242730|FG001|Overall Study|Withdrawal by Subject|91|||
23409688|NCT00988052|65242729|FG000|Overall Study|Study terminated by sponsor|240|||
23409689|NCT00988052|65242730|FG001|Overall Study|Study terminated by sponsor|236|||
23409690|NCT01445613|65242731|FG000|30-day Follow-up|Withdrawal by Subject|6|||
23409691|NCT01445613|65242731|FG000|30-day Follow-up|Physician Decision|3|||
23409692|NCT01445613|65242731|FG000|30-day Follow-up|Missed visit|23|||
23409693|NCT01445613|65242731|FG000|30-day Follow-up|Death|3|||
23409694|NCT01445613|65242731|FG000|1-year Follow-up|Withdrawal by Subject|12|||
23409695|NCT01445613|65242731|FG000|1-year Follow-up|Missed visit|29|||
23409696|NCT01445613|65242731|FG000|1-year Follow-up|Lost to Follow-up|2|||
23409697|NCT01445613|65242731|FG000|1-year Follow-up|Death|30|||
23409698|NCT01445613|65242731|FG000|1-year Follow-up|Physician Decision|2|||
23409699|NCT01445613|65242731|FG000|1-year Follow-up|Received a non-study stent|2|||
23409700|NCT03046446|65242732|FG000|Overall Study|Lack of Efficacy|7|||
23409701|NCT03046446|65242732|FG000|Overall Study|Adverse Event|6|||
23409702|NCT03046446|65242732|FG000|Overall Study|Lost to Follow-up|3|||
23409703|NCT03046446|65242732|FG000|Overall Study|Withdrawal by Subject|14|||
23409704|NCT03046446|65242732|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
23409705|NCT03046446|65242732|FG000|Overall Study|Disease Progression (see caveats)|25|||
23409706|NCT03046446|65242732|FG000|Overall Study|Non OA related knee surgery|1|||
23409707|NCT03850093|65242733|FG000|Overall Study|Withdrawal by Subject|1|||
23409708|NCT03850093|65242734|FG001|Overall Study|Withdrawal by Subject|0|||
23409709|NCT03850093|65242735|FG002|Overall Study|Withdrawal by Subject|2|||
23409710|NCT00995436|65242737|FG000|Overall Study|Withdrawal by Subject|2|||
23409711|NCT00995436|65242738|FG001|Overall Study|Withdrawal by Subject|5|||
23409712|NCT00995436|65242739|FG002|Overall Study|Withdrawal by Subject|0|||
23409713|NCT00325130|65242741|FG000|Overall Study|Lost to Follow-up|6|||
23409714|NCT00325130|65242742|FG001|Overall Study|Lost to Follow-up|14|||
23409715|NCT00325130|65242741|FG000|Overall Study|Withdrawal by Subject|12|||
23409716|NCT00325130|65242742|FG001|Overall Study|Withdrawal by Subject|14|||
23409717|NCT00325130|65242741|FG000|Overall Study|Protocol Deviation|0|||
23409718|NCT00325130|65242742|FG001|Overall Study|Protocol Deviation|1|||
23409719|NCT00325130|65242741|FG000|Overall Study|Moved|0|||
23409720|NCT00325130|65242742|FG001|Overall Study|Moved|1|||
23409721|NCT00325130|65242741|FG000|Overall Study|Patient Discontinued for Other|1|||
23409722|NCT00325130|65242742|FG001|Overall Study|Patient Discontinued for Other|0|||
23409723|NCT01232127|65242744|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
23409724|NCT01232127|65242745|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
23409725|NCT01232127|65242746|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
23409726|NCT00438360|65245561|FG000|Overall Study|Adverse Event|6|||
23409727|NCT00438360|65245562|FG001|Overall Study|Adverse Event|1|||
23409728|NCT00438360|65245561|FG000|Overall Study|Lack of Efficacy|42|||
23511400|NCT01829230|65609322|FG001|Overall Study|Lost to Follow-up|1|||
23511401|NCT03227029|65609327|FG000|Overall Study|Child Wheezed (no treatment)|0|||
23511402|NCT03227029|65609328|FG001|Overall Study|Child Wheezed (no treatment)|1|||
23409729|NCT00438360|65245562|FG001|Overall Study|Lack of Efficacy|27|||
23409730|NCT00438360|65245561|FG000|Overall Study|Other|24|||
23409731|NCT00438360|65245562|FG001|Overall Study|Other|15|||
23409732|NCT02526212|65245563|FG000|Overall Study|Incarceration|1|||
23409733|NCT02526212|65245564|FG001|Overall Study|Incarceration|0|||
23709551|NCT04937816|66315182|FG006|Overall Study|Study drug stopped, reason missing|0|||
23409734|NCT02526212|65245563|FG000|Overall Study|Lost to Follow-up|1|||
23409735|NCT02526212|65245564|FG001|Overall Study|Lost to Follow-up|0|||
23409736|NCT02526212|65245563|FG000|Overall Study|Death|0|||
23709552|NCT04937816|66315176|FG000|Overall Study|Other than stated below|173|||
23409737|NCT02526212|65245564|FG001|Overall Study|Death|1|||
23409738|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
23409739|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
23409740|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
23409741|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
23409742|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
23409743|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
23409744|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
23409745|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
23409746|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
23409747|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
23409748|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23409749|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23409750|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
23409751|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
23409752|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23409753|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
23409754|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23409755|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23409756|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
23409757|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
23409758|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
23409759|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
23409760|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
23409761|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
23409762|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
23409763|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
23409764|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
23409765|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
23409766|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
23409767|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
23409768|NCT03162796|65245565|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
23409769|NCT03162796|65245566|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
23409770|NCT03162796|65245567|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
23409771|NCT01437111|65245568|FG000|Overall Study|Adverse Event|2|||
23409772|NCT01437111|65245568|FG000|Overall Study|Withdrawal by Subject|4|||
23409773|NCT01437111|65245568|FG000|Overall Study|Not reported|5|||
23409774|NCT01437111|65245568|FG000|Overall Study|Physician Decision|1|||
23409775|NCT01437111|65245568|FG000|Overall Study|Lost to Follow-up|5|||
23409776|NCT01437111|65245568|FG000|Overall Study|Protocol Violation|1|||
23409777|NCT02263326|65245572|FG000|Overall Study|Lost to Follow-up|1|||
23409778|NCT02263326|65245573|FG001|Overall Study|Lost to Follow-up|1|||
23409779|NCT00880269|65245574|FG000|Overall Study|Protocol Violation|1|||
23409780|NCT00880269|65245575|FG001|Overall Study|Protocol Violation|0|||
23409781|NCT00880269|65245574|FG000|Overall Study|Disease Progression|13|||
23709553|NCT04937816|66315177|FG001|Overall Study|Other than stated below|143|||
23709554|NCT04937816|66315178|FG002|Overall Study|Other than stated below|125|||
23709555|NCT04937816|66315179|FG003|Overall Study|Other than stated below|44|||
23709556|NCT04937816|66315180|FG004|Overall Study|Other than stated below|45|||
23709557|NCT04937816|66315181|FG005|Overall Study|Other than stated below|28|||
23409782|NCT00880269|65245575|FG001|Overall Study|Disease Progression|11|||
23409783|NCT00880269|65245574|FG000|Overall Study|New Cancer Therapy|1|||
23409784|NCT00880269|65245575|FG001|Overall Study|New Cancer Therapy|0|||
23409785|NCT00880269|65245574|FG000|Overall Study|Death|4|||
23409786|NCT00880269|65245575|FG001|Overall Study|Death|2|||
23409787|NCT00880269|65245574|FG000|Overall Study|Lost to Follow-up|0|||
23409788|NCT00880269|65245575|FG001|Overall Study|Lost to Follow-up|1|||
23409789|NCT00880269|65245574|FG000|Overall Study|Withdrawal by Subject|3|||
23511403|NCT03227029|65609329|FG002|Overall Study|Child Wheezed (no treatment)|0|||
23511404|NCT03227029|65609327|FG000|Overall Study|No post RSV season visit due to COVID|3|||
23709558|NCT04937816|66315182|FG006|Overall Study|Other than stated below|31|||
23709559|NCT04937816|66315176|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
23709560|NCT04937816|66315177|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
23709561|NCT04937816|66315178|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
23709562|NCT04937816|66315179|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
23709563|NCT04937816|66315180|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
23409790|NCT00880269|65245575|FG001|Overall Study|Withdrawal by Subject|4|||
23409791|NCT00880269|65245574|FG000|Overall Study|Adverse Event|10|||
23409792|NCT00880269|65245575|FG001|Overall Study|Adverse Event|9|||
23409793|NCT00739310|65245580|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
23409794|NCT00739310|65245580|FG000|Overall Study|Withdrawal by Subject|1|||
23409795|NCT00739310|65245580|FG000|Overall Study|Lost to Follow-up|2|||
23409796|NCT01048242|65245591|FG000|Overall Study|See study flow chart|4|||
23511405|NCT03227029|65609328|FG001|Overall Study|No post RSV season visit due to COVID|3|||
23709564|NCT04937816|66315181|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
23811960|NCT01121666|66691850|FG000|Overall Study|Protocol Violation|29|||
23409797|NCT01048242|65245592|FG001|Overall Study|See study flow chart|2|||
23409798|NCT00161616|65245593|FG000|Overall Study|Withdrawal by Subject|6|||
23409799|NCT00161616|65245594|FG001|Overall Study|Withdrawal by Subject|5|||
23409800|NCT00161616|65245593|FG000|Overall Study|Physician Decision|1|||
23409801|NCT00161616|65245594|FG001|Overall Study|Physician Decision|0|||
23409802|NCT00161616|65245593|FG000|Overall Study|Death|1|||
23409803|NCT00161616|65245594|FG001|Overall Study|Death|1|||
23409804|NCT00161616|65245593|FG000|Overall Study|Lost to Follow-up|17|||
23409805|NCT00161616|65245594|FG001|Overall Study|Lost to Follow-up|13|||
23409806|NCT00161616|65245593|FG000|Overall Study|Protocol deviation|1|||
23409807|NCT00161616|65245594|FG001|Overall Study|Protocol deviation|0|||
23409808|NCT00780143|65245595|FG000|Overall Study|Progressive disease|1|||
23409809|NCT00780143|65245595|FG000|Overall Study|Toxicity|1|||
23409810|NCT00780143|65245595|FG000|Overall Study|Adverse Event|1|||
23409811|NCT01650831|65245600|FG000|Overall Study|Screen failure|1|||
23709565|NCT04937816|66315182|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
23709566|NCT04937816|66315176|FG000|Overall Study|Lost to Follow-up|15|||
23409812|NCT00255723|65245601|FG000|Overall Study|Adverse Event|1|||
23409813|NCT00255723|65245602|FG001|Overall Study|Adverse Event|1|||
23409814|NCT00255723|65245601|FG000|Overall Study|Death|0|||
23409815|NCT00255723|65245602|FG001|Overall Study|Death|1|||
23409816|NCT00255723|65245601|FG000|Overall Study|Response Data Not Available|1|||
23409817|NCT00255723|65245602|FG001|Overall Study|Response Data Not Available|0|||
23409818|NCT04830215|65245603|FG000|Overall Study|Adverse Event|6|||
23409819|NCT04830215|65245603|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
23409820|NCT04830215|65245603|FG000|Overall Study|Withdrawal by Subject|3|||
23409821|NCT04830215|65245603|FG000|Overall Study|Protocol Deviation|1|||
23409822|NCT00600106|65245604|FG000|Overall Study|Withdrawal by Subject|1|||
23409823|NCT00600106|65245605|FG001|Overall Study|Withdrawal by Subject|1|||
23409824|NCT00583752|65245607|FG000|Overall Study|Lost to Follow-up|5|||
23409825|NCT00583752|65245608|FG001|Overall Study|Lost to Follow-up|5|||
23409826|NCT01693250|65245609|FG000|Overall Study|Lost to Follow-up|2|||
23409827|NCT01693250|65245610|FG001|Overall Study|Lost to Follow-up|2|||
23409828|NCT04474197|65245612|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409829|NCT04474197|65245613|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
23409830|NCT04474197|65245614|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409831|NCT04474197|65245615|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409832|NCT02974140|65245616|FG000|Overall Study|Adverse Event|2|||
23409833|NCT02974140|65245616|FG000|Overall Study|Lost to Follow-up|1|||
23409834|NCT02974140|65245616|FG000|Overall Study|Study Terminated by Sponsor|36|||
23409835|NCT01732510|65245617|FG000|Overall Study|Adverse Event|0|||
23409836|NCT01732510|65245618|FG001|Overall Study|Adverse Event|1|||
23409837|NCT01732510|65245619|FG002|Overall Study|Adverse Event|1|||
23409838|NCT01732510|65245620|FG003|Overall Study|Adverse Event|0|||
23409839|NCT01732510|65245621|FG004|Overall Study|Adverse Event|0|||
23409840|NCT01732510|65245622|FG005|Overall Study|Adverse Event|0|||
23409841|NCT01732510|65245623|FG006|Overall Study|Adverse Event|1|||
23409842|NCT01732510|65245617|FG000|Overall Study|Protocol Violation|0|||
23409843|NCT01732510|65245618|FG001|Overall Study|Protocol Violation|0|||
23409844|NCT01732510|65245619|FG002|Overall Study|Protocol Violation|0|||
23409845|NCT01732510|65245620|FG003|Overall Study|Protocol Violation|1|||
23409846|NCT01732510|65245621|FG004|Overall Study|Protocol Violation|0|||
23409847|NCT01732510|65245622|FG005|Overall Study|Protocol Violation|0|||
23409848|NCT01732510|65245623|FG006|Overall Study|Protocol Violation|0|||
23409849|NCT01732510|65245617|FG000|Overall Study|Withdrawal by Subject|1|||
23409850|NCT01732510|65245618|FG001|Overall Study|Withdrawal by Subject|3|||
23409851|NCT01732510|65245619|FG002|Overall Study|Withdrawal by Subject|2|||
23409852|NCT01732510|65245620|FG003|Overall Study|Withdrawal by Subject|1|||
23409853|NCT01732510|65245621|FG004|Overall Study|Withdrawal by Subject|5|||
23409854|NCT01732510|65245622|FG005|Overall Study|Withdrawal by Subject|0|||
23409855|NCT01732510|65245623|FG006|Overall Study|Withdrawal by Subject|1|||
23409856|NCT01732510|65245617|FG000|Overall Study|Lost to Follow-up|0|||
23409857|NCT01732510|65245618|FG001|Overall Study|Lost to Follow-up|0|||
23409858|NCT01732510|65245619|FG002|Overall Study|Lost to Follow-up|1|||
23409859|NCT01732510|65245620|FG003|Overall Study|Lost to Follow-up|1|||
23409860|NCT01732510|65245621|FG004|Overall Study|Lost to Follow-up|0|||
23409861|NCT01732510|65245622|FG005|Overall Study|Lost to Follow-up|1|||
23409862|NCT01732510|65245623|FG006|Overall Study|Lost to Follow-up|0|||
23409863|NCT01732510|65245617|FG000|Overall Study|Physician Decision|0|||
23409864|NCT01732510|65245618|FG001|Overall Study|Physician Decision|1|||
23409865|NCT01732510|65245619|FG002|Overall Study|Physician Decision|0|||
23409866|NCT01732510|65245620|FG003|Overall Study|Physician Decision|0|||
23409867|NCT01732510|65245621|FG004|Overall Study|Physician Decision|0|||
23409868|NCT01732510|65245622|FG005|Overall Study|Physician Decision|0|||
23409869|NCT01732510|65245623|FG006|Overall Study|Physician Decision|0|||
23409870|NCT01732510|65245617|FG000|Overall Study|Pregnancy|0|||
23409871|NCT01732510|65245618|FG001|Overall Study|Pregnancy|0|||
23409872|NCT01732510|65245619|FG002|Overall Study|Pregnancy|0|||
23409873|NCT01732510|65245620|FG003|Overall Study|Pregnancy|1|||
23709567|NCT04937816|66315177|FG001|Overall Study|Lost to Follow-up|9|||
23709568|NCT04937816|66315178|FG002|Overall Study|Lost to Follow-up|6|||
23409874|NCT01732510|65245621|FG004|Overall Study|Pregnancy|0|||
23409875|NCT01732510|65245622|FG005|Overall Study|Pregnancy|0|||
23409876|NCT01732510|65245623|FG006|Overall Study|Pregnancy|0|||
23409877|NCT01732510|65245617|FG000|Overall Study|Study Terminated By Sponsor|0|||
23409878|NCT01732510|65245618|FG001|Overall Study|Study Terminated By Sponsor|0|||
23409879|NCT01732510|65245619|FG002|Overall Study|Study Terminated By Sponsor|0|||
23409880|NCT01732510|65245620|FG003|Overall Study|Study Terminated By Sponsor|1|||
23409881|NCT01732510|65245621|FG004|Overall Study|Study Terminated By Sponsor|0|||
23709569|NCT04937816|66315179|FG003|Overall Study|Lost to Follow-up|6|||
23409882|NCT01732510|65245622|FG005|Overall Study|Study Terminated By Sponsor|12|||
23409883|NCT01732510|65245623|FG006|Overall Study|Study Terminated By Sponsor|6|||
23409884|NCT02201329|65245626|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
23709570|NCT04937816|66315180|FG004|Overall Study|Lost to Follow-up|16|||
23409885|NCT02201329|65245626|FG000|Overall Study|Withdrawal by Subject|2|||
23409886|NCT01500252|65245627|FG000|Overall Study|Death|4|||
23409887|NCT01500252|65245628|FG001|Overall Study|Death|2|||
23409888|NCT01500252|65245627|FG000|Overall Study|Lost to Follow-up|5|||
23709571|NCT04937816|66315181|FG005|Overall Study|Lost to Follow-up|11|||
23409889|NCT01500252|65245628|FG001|Overall Study|Lost to Follow-up|4|||
23409890|NCT02298868|65245633|FG000|Overall Study|Adverse Event|1|||
23409891|NCT02298868|65245633|FG000|Overall Study|Death|1|||
23409892|NCT02298868|65245633|FG000|Overall Study|Patient underwent transplant|1|||
23409893|NCT01262560|65245634|FG000|Overall Study|Protocol Violation|0|||
23409894|NCT01262560|65245635|FG001|Overall Study|Protocol Violation|1|||
23409895|NCT01262560|65245636|FG002|Overall Study|Protocol Violation|2|||
23409896|NCT02364037|65245640|FG000|Overall Study|Withdrawal by Subject|7|||
23409897|NCT02364037|65245641|FG001|Overall Study|Withdrawal by Subject|4|||
23409898|NCT02364037|65245640|FG000|Overall Study|Lost to Follow-up|37|||
23409899|NCT02364037|65245641|FG001|Overall Study|Lost to Follow-up|49|||
23409900|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
23409901|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409902|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409903|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409904|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
23409905|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409906|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409907|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409908|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409909|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
23409910|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409911|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409912|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23409913|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23409914|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
23409915|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
23409916|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23409917|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23409918|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
23409919|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
23409920|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409921|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409922|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409923|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
23409924|NCT01947283|65245649|FG000|Overall Study|Death|1|||
23409925|NCT01947283|65245650|FG001|Overall Study|Death|1|||
23409926|NCT01947283|65245651|FG002|Overall Study|Death|1|||
23409927|NCT01947283|65245652|FG003|Overall Study|Death|0|||
23709572|NCT04937816|66315182|FG006|Overall Study|Lost to Follow-up|17|||
23709573|NCT04937816|66315176|FG000|Overall Study|Protocol Violation|15|||
23709574|NCT04937816|66315177|FG001|Overall Study|Protocol Violation|15|||
23709575|NCT04937816|66315178|FG002|Overall Study|Protocol Violation|12|||
23709576|NCT04937816|66315179|FG003|Overall Study|Protocol Violation|30|||
23709577|NCT04937816|66315180|FG004|Overall Study|Protocol Violation|24|||
23709578|NCT04937816|66315181|FG005|Overall Study|Protocol Violation|5|||
23709579|NCT04937816|66315182|FG006|Overall Study|Protocol Violation|5|||
23409928|NCT01947283|65245653|FG004|Overall Study|Death|0|||
23409929|NCT01947283|65245654|FG005|Overall Study|Death|0|||
23409930|NCT01947283|65245655|FG006|Overall Study|Death|0|||
23409931|NCT01947283|65245649|FG000|Overall Study|Lost to Follow-up|4|||
23709580|NCT04937816|66315176|FG000|Overall Study|Adverse Event|303|||
23709581|NCT04937816|66315177|FG001|Overall Study|Adverse Event|267|||
23709582|NCT04937816|66315178|FG002|Overall Study|Adverse Event|273|||
23709583|NCT04937816|66315179|FG003|Overall Study|Adverse Event|553|||
23709584|NCT04937816|66315180|FG004|Overall Study|Adverse Event|575|||
23709585|NCT04937816|66315181|FG005|Overall Study|Adverse Event|343|||
23709586|NCT04937816|66315182|FG006|Overall Study|Adverse Event|337|||
23709587|NCT04937816|66315176|FG000|Overall Study|Not treated|4|||
23709588|NCT04937816|66315177|FG001|Overall Study|Not treated|2|||
23709589|NCT04937816|66315178|FG002|Overall Study|Not treated|2|||
23709590|NCT04937816|66315179|FG003|Overall Study|Not treated|2|||
23709591|NCT04937816|66315180|FG004|Overall Study|Not treated|1|||
23709592|NCT04937816|66315181|FG005|Overall Study|Not treated|4|||
23709593|NCT04937816|66315182|FG006|Overall Study|Not treated|0|||
23709594|NCT01533935|66315183|FG000|Overall Study|Adverse Event|5|||
23409932|NCT01947283|65245650|FG001|Overall Study|Lost to Follow-up|6|||
23409933|NCT01947283|65245651|FG002|Overall Study|Lost to Follow-up|5|||
23409934|NCT01947283|65245652|FG003|Overall Study|Lost to Follow-up|5|||
23409935|NCT01947283|65245653|FG004|Overall Study|Lost to Follow-up|0|||
23409936|NCT01947283|65245654|FG005|Overall Study|Lost to Follow-up|2|||
23409937|NCT01947283|65245655|FG006|Overall Study|Lost to Follow-up|5|||
23709595|NCT01533935|66315184|FG001|Overall Study|Adverse Event|7|||
23709596|NCT01533935|66315185|FG002|Overall Study|Adverse Event|1|||
23409938|NCT01947283|65245649|FG000|Overall Study|Withdrawal by Subject|10|||
23709597|NCT01533935|66315186|FG003|Overall Study|Adverse Event|5|||
23709598|NCT01533935|66315187|FG004|Overall Study|Adverse Event|3|||
23709599|NCT01533935|66315183|FG000|Overall Study|Protocol Violation|0|||
23709600|NCT01533935|66315184|FG001|Overall Study|Protocol Violation|2|||
23709601|NCT01533935|66315185|FG002|Overall Study|Protocol Violation|0|||
23709602|NCT01533935|66315186|FG003|Overall Study|Protocol Violation|0|||
23709603|NCT01533935|66315187|FG004|Overall Study|Protocol Violation|0|||
23709604|NCT01533935|66315183|FG000|Overall Study|Lost to Follow-up|0|||
23709605|NCT01533935|66315184|FG001|Overall Study|Lost to Follow-up|0|||
23709606|NCT01533935|66315185|FG002|Overall Study|Lost to Follow-up|1|||
23709607|NCT01533935|66315186|FG003|Overall Study|Lost to Follow-up|0|||
23709608|NCT01533935|66315187|FG004|Overall Study|Lost to Follow-up|0|||
23709609|NCT01533935|66315183|FG000|Overall Study|Withdrawal by Subject|0|||
23709610|NCT01533935|66315184|FG001|Overall Study|Withdrawal by Subject|4|||
23709611|NCT01533935|66315185|FG002|Overall Study|Withdrawal by Subject|5|||
23709612|NCT01533935|66315186|FG003|Overall Study|Withdrawal by Subject|2|||
23709613|NCT01533935|66315187|FG004|Overall Study|Withdrawal by Subject|4|||
23709614|NCT01533935|66315183|FG000|Overall Study|Other reason not defined above|1|||
23709615|NCT01533935|66315184|FG001|Overall Study|Other reason not defined above|0|||
23709616|NCT01533935|66315185|FG002|Overall Study|Other reason not defined above|1|||
23709617|NCT01533935|66315186|FG003|Overall Study|Other reason not defined above|0|||
23409939|NCT01947283|65245650|FG001|Overall Study|Withdrawal by Subject|8|||
23409940|NCT01947283|65245651|FG002|Overall Study|Withdrawal by Subject|4|||
23409941|NCT01947283|65245652|FG003|Overall Study|Withdrawal by Subject|1|||
23409942|NCT01947283|65245653|FG004|Overall Study|Withdrawal by Subject|0|||
23409943|NCT01947283|65245654|FG005|Overall Study|Withdrawal by Subject|0|||
23409944|NCT01947283|65245655|FG006|Overall Study|Withdrawal by Subject|2|||
23409945|NCT01947283|65245649|FG000|Overall Study|No Clinical Recording|12|||
23409946|NCT01947283|65245650|FG001|Overall Study|No Clinical Recording|6|||
23409947|NCT01947283|65245651|FG002|Overall Study|No Clinical Recording|8|||
23409948|NCT01947283|65245652|FG003|Overall Study|No Clinical Recording|10|||
23409949|NCT01947283|65245653|FG004|Overall Study|No Clinical Recording|0|||
23409950|NCT01947283|65245654|FG005|Overall Study|No Clinical Recording|0|||
23409951|NCT01947283|65245655|FG006|Overall Study|No Clinical Recording|0|||
23409952|NCT01947283|65245649|FG000|Overall Study|Non-coding Clinical Recording language|0|||
23409953|NCT01947283|65245650|FG001|Overall Study|Non-coding Clinical Recording language|0|||
23409954|NCT01947283|65245651|FG002|Overall Study|Non-coding Clinical Recording language|0|||
23409955|NCT01947283|65245652|FG003|Overall Study|Non-coding Clinical Recording language|1|||
23409956|NCT01947283|65245653|FG004|Overall Study|Non-coding Clinical Recording language|0|||
23409957|NCT01947283|65245654|FG005|Overall Study|Non-coding Clinical Recording language|0|||
23409958|NCT01947283|65245655|FG006|Overall Study|Non-coding Clinical Recording language|0|||
23409959|NCT01947283|65245649|FG000|Overall Study|Missing Follow-up Assessment|2|||
23409960|NCT01947283|65245650|FG001|Overall Study|Missing Follow-up Assessment|2|||
23409961|NCT01947283|65245651|FG002|Overall Study|Missing Follow-up Assessment|3|||
23409962|NCT01947283|65245652|FG003|Overall Study|Missing Follow-up Assessment|0|||
23409963|NCT01947283|65245653|FG004|Overall Study|Missing Follow-up Assessment|0|||
23409964|NCT01947283|65245654|FG005|Overall Study|Missing Follow-up Assessment|2|||
23409965|NCT01947283|65245655|FG006|Overall Study|Missing Follow-up Assessment|0|||
23409966|NCT01947283|65245649|FG000|Overall Study|No patients were enrolled in study|0|||
23409967|NCT01947283|65245650|FG001|Overall Study|No patients were enrolled in study|0|||
23709618|NCT01533935|66315187|FG004|Overall Study|Other reason not defined above|1|||
23709619|NCT00805545|66315190|FG000|Overall Study|Protocol Violation|3|||
23709620|NCT00805545|66315191|FG001|Overall Study|Protocol Violation|2|||
23709621|NCT00805545|66315190|FG000|Overall Study|Protocol Violation|3|||
23709622|NCT00805545|66315191|FG001|Overall Study|Protocol Violation|1|||
23709623|NCT00683475|66315192|FG000|Overall Study|Withdrawal by Subject|1|||
23409968|NCT01947283|65245651|FG002|Overall Study|No patients were enrolled in study|0|||
23409969|NCT01947283|65245652|FG003|Overall Study|No patients were enrolled in study|0|||
23409970|NCT01947283|65245653|FG004|Overall Study|No patients were enrolled in study|0|||
23409971|NCT01947283|65245654|FG005|Overall Study|No patients were enrolled in study|3|||
23409972|NCT01947283|65245655|FG006|Overall Study|No patients were enrolled in study|1|||
23409973|NCT04560816|65245656|FG000|Overall Study|Withdrawal by Subject|1|||
23709624|NCT00683475|66315193|FG001|Overall Study|Withdrawal by Subject|0|||
23709625|NCT00683475|66315192|FG000|Overall Study|Never Treated: Adverse Event|2|||
23409974|NCT04560816|65245657|FG001|Overall Study|Withdrawal by Subject|1|||
23409975|NCT04560816|65245658|FG002|Overall Study|Withdrawal by Subject|1|||
23409976|NCT04560816|65245659|FG003|Overall Study|Withdrawal by Subject|0|||
23709626|NCT00683475|66315193|FG001|Overall Study|Never Treated: Adverse Event|3|||
23409977|NCT04560816|65245660|FG004|Overall Study|Withdrawal by Subject|3|||
23409978|NCT04560816|65245661|FG005|Overall Study|Withdrawal by Subject|0|||
23409979|NCT04560816|65245656|FG000|Overall Study|Lost to Follow-up|1|||
23409980|NCT04560816|65245657|FG001|Overall Study|Lost to Follow-up|0|||
23409981|NCT04560816|65245658|FG002|Overall Study|Lost to Follow-up|0|||
23409982|NCT04560816|65245659|FG003|Overall Study|Lost to Follow-up|0|||
23409983|NCT04560816|65245660|FG004|Overall Study|Lost to Follow-up|0|||
23409984|NCT04560816|65245661|FG005|Overall Study|Lost to Follow-up|0|||
23409985|NCT04560816|65245656|FG000|Overall Study|Protocol Violation|1|||
23409986|NCT04560816|65245657|FG001|Overall Study|Protocol Violation|0|||
23409987|NCT04560816|65245658|FG002|Overall Study|Protocol Violation|0|||
23409988|NCT04560816|65245659|FG003|Overall Study|Protocol Violation|0|||
23409989|NCT04560816|65245660|FG004|Overall Study|Protocol Violation|0|||
23409990|NCT04560816|65245661|FG005|Overall Study|Protocol Violation|0|||
23409991|NCT02689206|65245665|FG000|Overall Study|Adverse Event|0|||
23409992|NCT02689206|65245666|FG001|Overall Study|Adverse Event|0|||
23409993|NCT02689206|65245667|FG002|Overall Study|Adverse Event|1|||
23409994|NCT02689206|65245668|FG003|Overall Study|Adverse Event|0|||
23409995|NCT02689206|65245669|FG004|Overall Study|Adverse Event|2|||
23409996|NCT02689206|65245665|FG000|Overall Study|Protocol Violation|1|||
23409997|NCT02689206|65245666|FG001|Overall Study|Protocol Violation|0|||
23409998|NCT02689206|65245667|FG002|Overall Study|Protocol Violation|0|||
23409999|NCT02689206|65245668|FG003|Overall Study|Protocol Violation|1|||
23410000|NCT02689206|65245669|FG004|Overall Study|Protocol Violation|2|||
23410001|NCT02689206|65245665|FG000|Overall Study|Other: Reached stopping criteria|0|||
23410002|NCT02689206|65245666|FG001|Overall Study|Other: Reached stopping criteria|1|||
23410003|NCT02689206|65245667|FG002|Overall Study|Other: Reached stopping criteria|2|||
23410004|NCT02689206|65245668|FG003|Overall Study|Other: Reached stopping criteria|3|||
23410005|NCT02689206|65245669|FG004|Overall Study|Other: Reached stopping criteria|4|||
23410006|NCT02689206|65245665|FG000|Overall Study|Physician Decision|1|||
23410007|NCT02689206|65245666|FG001|Overall Study|Physician Decision|0|||
23410008|NCT02689206|65245667|FG002|Overall Study|Physician Decision|0|||
23410009|NCT02689206|65245668|FG003|Overall Study|Physician Decision|0|||
23410010|NCT02689206|65245669|FG004|Overall Study|Physician Decision|0|||
23410011|NCT02689206|65245665|FG000|Overall Study|Withdrawal by Subject|1|||
23410012|NCT02689206|65245666|FG001|Overall Study|Withdrawal by Subject|0|||
23410013|NCT02689206|65245667|FG002|Overall Study|Withdrawal by Subject|1|||
23410014|NCT02689206|65245668|FG003|Overall Study|Withdrawal by Subject|0|||
23410015|NCT02689206|65245669|FG004|Overall Study|Withdrawal by Subject|0|||
23410016|NCT05002985|65245670|FG000|Overall Study|Withdrawal by Subject|1|||
23410017|NCT01270880|65245671|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
23410018|NCT00661726|65245672|FG000|Overall Study|Adverse Event|1|||
23410019|NCT02702609|65245673|FG000|Overall Study|Lost to Follow-up|8|||
23410020|NCT02702609|65245674|FG001|Overall Study|Lost to Follow-up|4|||
23410021|NCT02702609|65245673|FG000|Overall Study|Physician Decision|1|||
23410022|NCT02702609|65245674|FG001|Overall Study|Physician Decision|0|||
23410023|NCT02253433|65245675|FG000|Overall Study|Unable to Contact|9|||
23410024|NCT02253433|65245676|FG001|Overall Study|Unable to Contact|16|||
23410025|NCT02253433|65245675|FG000|Overall Study|Death|1|||
23410026|NCT02253433|65245676|FG001|Overall Study|Death|1|||
23410027|NCT02253433|65245675|FG000|Overall Study|No Longer Interested|3|||
23410028|NCT02253433|65245676|FG001|Overall Study|No Longer Interested|15|||
23410029|NCT02253433|65245675|FG000|Overall Study|Out of Study Area|2|||
23410030|NCT02253433|65245676|FG001|Overall Study|Out of Study Area|7|||
23410031|NCT02253433|65245675|FG000|Overall Study|Uncomfortable with home visitors|0|||
23410032|NCT02253433|65245676|FG001|Overall Study|Uncomfortable with home visitors|3|||
23410033|NCT02253433|65245675|FG000|Overall Study|Unstable Housing/Homeless|0|||
23410034|NCT02253433|65245676|FG001|Overall Study|Unstable Housing/Homeless|7|||
23410035|NCT02253433|65245675|FG000|Overall Study|Too Busy|0|||
23410036|NCT02253433|65245676|FG001|Overall Study|Too Busy|4|||
23410037|NCT02253433|65245675|FG000|Overall Study|Medical or Other Concerns|1|||
23410038|NCT02253433|65245676|FG001|Overall Study|Medical or Other Concerns|2|||
23410039|NCT00224120|65245679|FG000|Overall Study|Adverse Event|10|||
23410040|NCT00224120|65245680|FG001|Overall Study|Adverse Event|4|||
23410041|NCT00224120|65245679|FG000|Overall Study|Protocol Violation|1|||
23511406|NCT03227029|65609329|FG002|Overall Study|No post RSV season visit due to COVID|2|||
23511407|NCT03227029|65609327|FG000|Overall Study|Not able to get to clinic|0|||
23511408|NCT03227029|65609328|FG001|Overall Study|Not able to get to clinic|0|||
23410042|NCT00224120|65245680|FG001|Overall Study|Protocol Violation|0|||
23410043|NCT00224120|65245679|FG000|Overall Study|Withdrawal by Subject|5|||
23410044|NCT00224120|65245680|FG001|Overall Study|Withdrawal by Subject|10|||
23410045|NCT00224120|65245679|FG000|Overall Study|Lack of Efficacy|0|||
23410046|NCT00224120|65245680|FG001|Overall Study|Lack of Efficacy|2|||
23410047|NCT00224120|65245679|FG000|Overall Study|Lost to Follow-up|2|||
23410048|NCT00224120|65245680|FG001|Overall Study|Lost to Follow-up|3|||
23410049|NCT00224120|65245679|FG000|Overall Study|Other|4|||
23410050|NCT00224120|65245680|FG001|Overall Study|Other|5|||
23410051|NCT01643408|65245681|FG000|Overall Study|Adverse Event|12|||
23410052|NCT01643408|65245681|FG000|Overall Study|Other|2|||
23410053|NCT01864148|65245689|FG000|Overall Study|Other|2|||
23410054|NCT01864148|65245690|FG001|Overall Study|Other|1|||
23410055|NCT01864148|65245691|FG002|Overall Study|Other|1|||
23410056|NCT01864148|65245692|FG003|Overall Study|Other|3|||
23410057|NCT01864148|65245693|FG004|Overall Study|Other|1|||
23410058|NCT01864148|65245689|FG000|Overall Study|Death|0|||
23410059|NCT01864148|65245690|FG001|Overall Study|Death|0|||
23410060|NCT01864148|65245691|FG002|Overall Study|Death|0|||
23410061|NCT01864148|65245692|FG003|Overall Study|Death|1|||
23410062|NCT01864148|65245693|FG004|Overall Study|Death|0|||
23410063|NCT01864148|65245689|FG000|Overall Study|Investigator Decision|5|||
23709627|NCT00683475|66315192|FG000|Overall Study|Never Treated: Progressive Disease|1|||
23709628|NCT00683475|66315193|FG001|Overall Study|Never Treated: Progressive Disease|0|||
23709629|NCT02125331|66315194|FG000|Overall Study|Protocol Violation|1|||
23709630|NCT02125331|66315195|FG001|Overall Study|Protocol Violation|0|||
23709631|NCT02125331|66315194|FG000|Overall Study|technical problem|2|||
23709632|NCT02125331|66315195|FG001|Overall Study|technical problem|0|||
23709633|NCT02125331|66315194|FG000|Overall Study|screen failure|2|||
23709634|NCT02125331|66315195|FG001|Overall Study|screen failure|0|||
23709635|NCT01115738|66315196|FG000|Overall Study|Death|1|||
23709636|NCT01115738|66315197|FG001|Overall Study|Death|0|||
23709637|NCT01115738|66315198|FG002|Overall Study|Death|0|||
23709638|NCT01115738|66315196|FG000|Overall Study|Lost to Follow-up|0|||
23709639|NCT01115738|66315197|FG001|Overall Study|Lost to Follow-up|0|||
23709640|NCT01115738|66315198|FG002|Overall Study|Lost to Follow-up|1|||
23709641|NCT01115738|66315196|FG000|Overall Study|Physician Decision|18|||
23709642|NCT01115738|66315197|FG001|Overall Study|Physician Decision|15|||
23709643|NCT01115738|66315198|FG002|Overall Study|Physician Decision|17|||
23410064|NCT01864148|65245690|FG001|Overall Study|Investigator Decision|0|||
23410065|NCT01864148|65245691|FG002|Overall Study|Investigator Decision|0|||
23410066|NCT01864148|65245692|FG003|Overall Study|Investigator Decision|4|||
23709644|NCT01115738|66315196|FG000|Overall Study|Withdrawal by Subject|6|||
23709645|NCT01115738|66315197|FG001|Overall Study|Withdrawal by Subject|6|||
23709646|NCT01115738|66315198|FG002|Overall Study|Withdrawal by Subject|9|||
23709647|NCT03076190|66315203|FG000|Overall Study|Lost to Follow-up|9|||
23709648|NCT03076190|66315204|FG001|Overall Study|Lost to Follow-up|34|||
23410067|NCT01864148|65245693|FG004|Overall Study|Investigator Decision|6|||
23410068|NCT01864148|65245689|FG000|Overall Study|Withdrawal by Subject|9|||
23410069|NCT01864148|65245690|FG001|Overall Study|Withdrawal by Subject|2|||
23410070|NCT01864148|65245691|FG002|Overall Study|Withdrawal by Subject|6|||
23410071|NCT01864148|65245692|FG003|Overall Study|Withdrawal by Subject|8|||
23410072|NCT01864148|65245693|FG004|Overall Study|Withdrawal by Subject|8|||
23410073|NCT01864148|65245689|FG000|Overall Study|Lost to Follow-up|0|||
23410074|NCT01864148|65245690|FG001|Overall Study|Lost to Follow-up|0|||
23410075|NCT01864148|65245691|FG002|Overall Study|Lost to Follow-up|0|||
23410076|NCT01864148|65245692|FG003|Overall Study|Lost to Follow-up|2|||
23410077|NCT01864148|65245693|FG004|Overall Study|Lost to Follow-up|1|||
23410078|NCT01864148|65245689|FG000|Overall Study|Adverse Event|4|||
23410079|NCT01864148|65245690|FG001|Overall Study|Adverse Event|2|||
23410080|NCT01864148|65245691|FG002|Overall Study|Adverse Event|4|||
23410081|NCT01864148|65245692|FG003|Overall Study|Adverse Event|7|||
23410082|NCT01864148|65245693|FG004|Overall Study|Adverse Event|7|||
23410083|NCT01864148|65245689|FG000|Overall Study|Not Dosed|0|||
23410084|NCT01864148|65245690|FG001|Overall Study|Not Dosed|0|||
23410085|NCT01864148|65245691|FG002|Overall Study|Not Dosed|0|||
23410086|NCT01864148|65245692|FG003|Overall Study|Not Dosed|1|||
23410087|NCT01864148|65245693|FG004|Overall Study|Not Dosed|0|||
23410088|NCT01803880|65245694|FG000|Overall Study|Adverse Event|1|||
23410089|NCT01803880|65245695|FG001|Overall Study|Adverse Event|0|||
23410090|NCT01803880|65245696|FG002|Overall Study|Adverse Event|0|||
23410091|NCT01803880|65245694|FG000|Overall Study|Withdrawal by Subject|1|||
23410092|NCT01803880|65245695|FG001|Overall Study|Withdrawal by Subject|1|||
23410093|NCT01803880|65245696|FG002|Overall Study|Withdrawal by Subject|4|||
23410094|NCT01803880|65245694|FG000|Overall Study|Physician Decision|0|||
23410095|NCT01803880|65245695|FG001|Overall Study|Physician Decision|0|||
23410096|NCT01803880|65245696|FG002|Overall Study|Physician Decision|1|||
23410097|NCT01803880|65245694|FG000|Overall Study|Unable to return for follow-up visits|0|||
23410098|NCT01803880|65245695|FG001|Overall Study|Unable to return for follow-up visits|1|||
23410099|NCT01803880|65245696|FG002|Overall Study|Unable to return for follow-up visits|2|||
23410100|NCT01803880|65245694|FG000|Overall Study|Lost to Follow-up|1|||
23410101|NCT01803880|65245695|FG001|Overall Study|Lost to Follow-up|2|||
23410102|NCT01803880|65245696|FG002|Overall Study|Lost to Follow-up|3|||
23410103|NCT01803880|65245694|FG000|Overall Study|Protocol Violation|1|||
23410104|NCT01803880|65245695|FG001|Overall Study|Protocol Violation|0|||
23410105|NCT01803880|65245696|FG002|Overall Study|Protocol Violation|0|||
23410106|NCT01803880|65245694|FG000|Overall Study|Early study termination|0|||
23410107|NCT01803880|65245695|FG001|Overall Study|Early study termination|6|||
23410108|NCT01803880|65245696|FG002|Overall Study|Early study termination|5|||
23410109|NCT01803880|65245694|FG000|Overall Study|Incomplete data entry by sites|2|||
23410110|NCT01803880|65245695|FG001|Overall Study|Incomplete data entry by sites|0|||
23410111|NCT01803880|65245696|FG002|Overall Study|Incomplete data entry by sites|0|||
23410112|NCT03248167|65245697|FG000|Overall Study|Withdrawal by Subject|2|||
23410113|NCT03248167|65245698|FG001|Overall Study|Withdrawal by Subject|2|||
23709649|NCT03076190|66315203|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
23709650|NCT03076190|66315204|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
23709651|NCT00798694|66315205|FG000|Overall Study|Lost to Follow-up|1|||
23410114|NCT03248167|65245697|FG000|Overall Study|Physician Decision|0|||
23410115|NCT03248167|65245698|FG001|Overall Study|Physician Decision|1|||
23410116|NCT03248167|65245697|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
23410117|NCT03248167|65245698|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
23410118|NCT03248167|65245697|FG000|Overall Study|Lost to Follow-up|1|||
23410119|NCT03248167|65245698|FG001|Overall Study|Lost to Follow-up|0|||
23410120|NCT02674464|65245701|FG000|Overall Study|Death|10|||
23410121|NCT02674464|65245702|FG001|Overall Study|Death|21|||
23410122|NCT02674464|65245701|FG000|Overall Study|Withdrawal by Subject|24|||
23410123|NCT02674464|65245702|FG001|Overall Study|Withdrawal by Subject|44|||
23410124|NCT02674464|65245701|FG000|Overall Study|Lost to Follow-up|97|||
23410125|NCT02674464|65245702|FG001|Overall Study|Lost to Follow-up|92|||
23410126|NCT02674464|65245701|FG000|Overall Study|Outside survey window|6|||
23410127|NCT02674464|65245702|FG001|Overall Study|Outside survey window|3|||
23410128|NCT00082368|65245703|FG000|Overall Study|Not treated-pt had poor IV access|1|||
23410129|NCT02277691|65245704|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
23410130|NCT02277691|65245704|FG000|Overall Study|Voluntary Withdrawal|7|||
23410131|NCT02277691|65245704|FG000|Overall Study|Lack of Efficacy|5|||
23410132|NCT02277691|65245704|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
23709652|NCT00798694|66315206|FG001|Overall Study|Lost to Follow-up|1|||
23709653|NCT00798694|66315205|FG000|Overall Study|Physician Decision|1|||
23410133|NCT00294671|65245705|FG000|Overall Study|Lack of Efficacy|11|||
23410134|NCT00294671|65245706|FG001|Overall Study|Lack of Efficacy|23|||
23511409|NCT03227029|65609329|FG002|Overall Study|Not able to get to clinic|1|||
23511410|NCT03227029|65609327|FG000|Overall Study|Withdrawal by Subject|1|||
23410135|NCT00294671|65245705|FG000|Overall Study|Liver transplant|7|||
23410136|NCT00294671|65245706|FG001|Overall Study|Liver transplant|9|||
23410137|NCT00294671|65245705|FG000|Overall Study|Drug related adverse event (AE)|4|||
23410138|NCT00294671|65245706|FG001|Overall Study|Drug related adverse event (AE)|2|||
23410139|NCT00294671|65245705|FG000|Overall Study|Non-drug related AE|3|||
23410140|NCT00294671|65245706|FG001|Overall Study|Non-drug related AE|2|||
23410141|NCT00294671|65245705|FG000|Overall Study|Lost to Follow-up|1|||
23410142|NCT00294671|65245706|FG001|Overall Study|Lost to Follow-up|3|||
23410143|NCT00294671|65245705|FG000|Overall Study|Non-compliance|1|||
23410144|NCT00294671|65245706|FG001|Overall Study|Non-compliance|0|||
23410145|NCT00294671|65245705|FG000|Overall Study|Death|0|||
23410146|NCT00294671|65245706|FG001|Overall Study|Death|1|||
23410147|NCT01901289|65245709|FG000|Overall Study|Death|32|||
23709654|NCT00798694|66315206|FG001|Overall Study|Physician Decision|0|||
23709655|NCT00418834|66315207|FG000|Overall Study|Adverse Event|16|||
23709656|NCT00418834|66315208|FG001|Overall Study|Adverse Event|9|||
23709657|NCT00418834|66315207|FG000|Overall Study|Lost to Follow-up|0|||
23709658|NCT00418834|66315208|FG001|Overall Study|Lost to Follow-up|1|||
23709659|NCT00418834|66315207|FG000|Overall Study|Protocol Violation|4|||
23709660|NCT00418834|66315208|FG001|Overall Study|Protocol Violation|3|||
23709661|NCT00418834|66315207|FG000|Overall Study|Withdrawal by Subject|3|||
23709662|NCT00418834|66315208|FG001|Overall Study|Withdrawal by Subject|7|||
23709663|NCT00492856|66315209|FG000|Induction|Adverse Event|2|||
23709664|NCT00492856|66315210|FG001|Induction|Adverse Event|0|||
23709665|NCT00492856|66315211|FG002|Induction|Adverse Event|0|||
23709666|NCT00492856|66315212|FG003|Induction|Adverse Event|0|||
23709667|NCT00492856|66315209|FG000|Induction|Withdrawal by Subject|1|||
23709668|NCT00492856|66315210|FG001|Induction|Withdrawal by Subject|0|||
23709669|NCT00492856|66315211|FG002|Induction|Withdrawal by Subject|0|||
23709670|NCT00492856|66315212|FG003|Induction|Withdrawal by Subject|0|||
23709671|NCT00492856|66315209|FG000|Induction|Death|3|||
23709672|NCT00492856|66315210|FG001|Induction|Death|0|||
23709673|NCT00492856|66315211|FG002|Induction|Death|0|||
23709674|NCT00492856|66315212|FG003|Induction|Death|0|||
23709675|NCT00492856|66315209|FG000|Consolidation|Adverse Event|6|||
23709676|NCT00492856|66315210|FG001|Consolidation|Adverse Event|0|||
23709677|NCT00492856|66315211|FG002|Consolidation|Adverse Event|0|||
23709678|NCT00492856|66315212|FG003|Consolidation|Adverse Event|0|||
23709679|NCT00492856|66315209|FG000|Consolidation|Not protocol specified|2|||
23709680|NCT00492856|66315210|FG001|Consolidation|Not protocol specified|0|||
23709681|NCT00492856|66315211|FG002|Consolidation|Not protocol specified|0|||
23709682|NCT00492856|66315212|FG003|Consolidation|Not protocol specified|0|||
23709683|NCT00492856|66315209|FG000|Consolidation|Lost to Follow-up|1|||
23709684|NCT00492856|66315210|FG001|Consolidation|Lost to Follow-up|0|||
23709685|NCT00492856|66315211|FG002|Consolidation|Lost to Follow-up|0|||
23709686|NCT00492856|66315212|FG003|Consolidation|Lost to Follow-up|0|||
23709687|NCT00492856|66315209|FG000|Post-consolidation|Adverse Event|0|||
23709688|NCT00492856|66315210|FG001|Post-consolidation|Adverse Event|4|||
23709689|NCT00492856|66315211|FG002|Post-consolidation|Adverse Event|0|||
23709690|NCT00492856|66315212|FG003|Post-consolidation|Adverse Event|1|||
23709691|NCT00492856|66315209|FG000|Post-consolidation|Withdrawal by Subject|0|||
23709692|NCT00492856|66315210|FG001|Post-consolidation|Withdrawal by Subject|4|||
23709693|NCT00492856|66315211|FG002|Post-consolidation|Withdrawal by Subject|0|||
23709694|NCT00492856|66315212|FG003|Post-consolidation|Withdrawal by Subject|0|||
23709695|NCT00492856|66315209|FG000|Post-consolidation|Death|0|||
23709696|NCT00492856|66315210|FG001|Post-consolidation|Death|1|||
23709697|NCT00492856|66315211|FG002|Post-consolidation|Death|0|||
23709698|NCT00492856|66315212|FG003|Post-consolidation|Death|0|||
23709699|NCT00492856|66315209|FG000|Post-consolidation|Not protocol specified|0|||
23709700|NCT00492856|66315210|FG001|Post-consolidation|Not protocol specified|1|||
23709701|NCT00492856|66315211|FG002|Post-consolidation|Not protocol specified|0|||
23709702|NCT00492856|66315212|FG003|Post-consolidation|Not protocol specified|0|||
23709703|NCT00492856|66315209|FG000|Post-consolidation|Lost to Follow-up|0|||
23709704|NCT00492856|66315210|FG001|Post-consolidation|Lost to Follow-up|2|||
23709705|NCT00492856|66315211|FG002|Post-consolidation|Lost to Follow-up|0|||
23709706|NCT00492856|66315212|FG003|Post-consolidation|Lost to Follow-up|0|||
23410148|NCT01901289|65245709|FG000|Overall Study|Lost to Follow-up|16|||
23410149|NCT01901289|65245709|FG000|Overall Study|Withdrawal by Subject|35|||
23410150|NCT01901289|65245709|FG000|Overall Study|Other type of endpoint met|2|||
23709707|NCT00492856|66315209|FG000|Post-consolidation|Observation Arm|0|||
23709708|NCT00492856|66315210|FG001|Post-consolidation|Observation Arm|0|||
23709709|NCT00492856|66315211|FG002|Post-consolidation|Observation Arm|27|||
23709710|NCT00492856|66315212|FG003|Post-consolidation|Observation Arm|0|||
23410151|NCT00620373|65245710|FG000|Overall Study|Unverified cancer status|33|||
23410152|NCT00107900|65245711|FG000|Overall Study|Adverse Event|3|||
23410153|NCT00107900|65245712|FG001|Overall Study|Adverse Event|2|||
23511411|NCT03227029|65609328|FG001|Overall Study|Withdrawal by Subject|0|||
23709711|NCT02279524|66315213|FG000|Overall Study|Withdrawal by Subject|3|||
23709712|NCT02279524|66315214|FG001|Overall Study|Withdrawal by Subject|6|||
23709713|NCT02279524|66315215|FG002|Overall Study|Withdrawal by Subject|3|||
23709714|NCT02279524|66315213|FG000|Overall Study|Adverse Event|4|||
23709715|NCT02279524|66315214|FG001|Overall Study|Adverse Event|3|||
23410154|NCT00107900|65245713|FG002|Overall Study|Adverse Event|10|||
23410155|NCT00107900|65245714|FG003|Overall Study|Adverse Event|3|||
23410156|NCT00107900|65245715|FG004|Overall Study|Adverse Event|5|||
23410157|NCT00107900|65245716|FG005|Overall Study|Adverse Event|3|||
23410158|NCT00107900|65245711|FG000|Overall Study|Death|0|||
23410159|NCT00107900|65245712|FG001|Overall Study|Death|0|||
23410160|NCT00107900|65245713|FG002|Overall Study|Death|0|||
23410161|NCT00107900|65245714|FG003|Overall Study|Death|0|||
23410162|NCT00107900|65245715|FG004|Overall Study|Death|1|||
23410163|NCT00107900|65245716|FG005|Overall Study|Death|0|||
23410164|NCT00107900|65245711|FG000|Overall Study|Lost to Follow-up|4|||
23410165|NCT00107900|65245712|FG001|Overall Study|Lost to Follow-up|1|||
23410166|NCT00107900|65245713|FG002|Overall Study|Lost to Follow-up|3|||
23410167|NCT00107900|65245714|FG003|Overall Study|Lost to Follow-up|2|||
23410168|NCT00107900|65245715|FG004|Overall Study|Lost to Follow-up|5|||
23410169|NCT00107900|65245716|FG005|Overall Study|Lost to Follow-up|5|||
23410170|NCT00107900|65245711|FG000|Overall Study|Protocol Violation|1|||
23410171|NCT00107900|65245712|FG001|Overall Study|Protocol Violation|0|||
23410172|NCT00107900|65245713|FG002|Overall Study|Protocol Violation|5|||
23410173|NCT00107900|65245714|FG003|Overall Study|Protocol Violation|5|||
23410174|NCT00107900|65245715|FG004|Overall Study|Protocol Violation|7|||
23410175|NCT00107900|65245716|FG005|Overall Study|Protocol Violation|0|||
23410176|NCT00107900|65245711|FG000|Overall Study|Withdrawal by Subject|1|||
23410177|NCT00107900|65245712|FG001|Overall Study|Withdrawal by Subject|0|||
23410178|NCT00107900|65245713|FG002|Overall Study|Withdrawal by Subject|5|||
23410179|NCT00107900|65245714|FG003|Overall Study|Withdrawal by Subject|0|||
23410180|NCT00107900|65245715|FG004|Overall Study|Withdrawal by Subject|1|||
23410181|NCT00107900|65245716|FG005|Overall Study|Withdrawal by Subject|1|||
23410182|NCT00107900|65245711|FG000|Overall Study|Administrative Reasons|1|||
23410183|NCT00107900|65245712|FG001|Overall Study|Administrative Reasons|0|||
23410184|NCT00107900|65245713|FG002|Overall Study|Administrative Reasons|2|||
23410185|NCT00107900|65245714|FG003|Overall Study|Administrative Reasons|2|||
23410186|NCT00107900|65245715|FG004|Overall Study|Administrative Reasons|2|||
23410187|NCT00107900|65245716|FG005|Overall Study|Administrative Reasons|0|||
23410188|NCT01030952|65245717|FG000|Overall Study|Protocol Violation|0|||
23410189|NCT01030952|65245718|FG001|Overall Study|Protocol Violation|1|||
23410190|NCT01030952|65245717|FG000|Overall Study|Informed consent withdrawal|1|||
23410191|NCT01030952|65245718|FG001|Overall Study|Informed consent withdrawal|0|||
23410192|NCT01030952|65245717|FG000|Overall Study|Lost to Follow-up|0|||
23410193|NCT01030952|65245718|FG001|Overall Study|Lost to Follow-up|1|||
23410194|NCT01030952|65245717|FG000|Overall Study|Unexplained|1|||
23709716|NCT02279524|66315215|FG002|Overall Study|Adverse Event|2|||
23709717|NCT02279524|66315213|FG000|Overall Study|Lost to Follow-up|1|||
23709718|NCT02279524|66315214|FG001|Overall Study|Lost to Follow-up|1|||
23709719|NCT02279524|66315215|FG002|Overall Study|Lost to Follow-up|0|||
23709720|NCT02279524|66315213|FG000|Overall Study|Disallowed medication|1|||
23709721|NCT02279524|66315214|FG001|Overall Study|Disallowed medication|1|||
23410195|NCT01030952|65245718|FG001|Overall Study|Unexplained|1|||
23410196|NCT00282087|65245719|FG000|Overall Study|Death|1|||
23410197|NCT02125838|65245720|FG000|Overall Study|Lost to Follow-up|4|||
23410198|NCT02125838|65245721|FG001|Overall Study|Lost to Follow-up|4|||
23410199|NCT04294459|65245722|FG000|Overall Study|Adverse Event|0|||
23410200|NCT04294459|65245723|FG001|Overall Study|Adverse Event|1|||
23410201|NCT00771927|65245730|FG000|Overall Study|Adverse Event|100|||
23410202|NCT00771927|65245731|FG001|Overall Study|Adverse Event|105|||
23410203|NCT00771927|65245730|FG000|Overall Study|Lack of Efficacy|70|||
23410204|NCT00771927|65245731|FG001|Overall Study|Lack of Efficacy|42|||
23410205|NCT00771927|65245730|FG000|Overall Study|Lost to Follow-up|46|||
23410206|NCT00771927|65245731|FG001|Overall Study|Lost to Follow-up|46|||
23410207|NCT00771927|65245730|FG000|Overall Study|Withdrawal by Subject|16|||
23410208|NCT00771927|65245731|FG001|Overall Study|Withdrawal by Subject|17|||
23709722|NCT02279524|66315215|FG002|Overall Study|Disallowed medication|2|||
23709723|NCT02279524|66315213|FG000|Overall Study|Bariatric surgery|1|||
23709724|NCT02279524|66315214|FG001|Overall Study|Bariatric surgery|0|||
23410209|NCT00771927|65245730|FG000|Overall Study|Other reason|23|||
23410210|NCT00771927|65245731|FG001|Overall Study|Other reason|27|||
23410211|NCT02413996|65245733|FG000|Overall Study|not comfortable with the intervention|9|||
23410212|NCT02413996|65245734|FG001|Overall Study|not comfortable with the intervention|2|||
23410213|NCT03472495|65245735|FG000|Overall Study|Treatment no longer indicated|1|||
23410214|NCT03472495|65245736|FG001|Overall Study|Treatment no longer indicated|2|||
23410215|NCT03472495|65245735|FG000|Overall Study|Physician Decision|0|||
23511412|NCT03227029|65609329|FG002|Overall Study|Withdrawal by Subject|0|||
23511413|NCT03227029|65609327|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
23511414|NCT03227029|65609328|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
23610573|NCT01964547|65962805|FG001|Overall Study|Withdrawal by Investigator|1|||
23610574|NCT03562117|65962806|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
23610575|NCT03562117|65962807|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
23610576|NCT03562117|65962808|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
23610577|NCT02676778|65962809|FG000|Overall Study|Disease Progression|7|||
23610578|NCT02676778|65962810|FG001|Overall Study|Disease Progression|3|||
23709725|NCT02279524|66315215|FG002|Overall Study|Bariatric surgery|0|||
23709726|NCT04494633|66315217|FG000|Overall Study|Lost to Follow-up|5|||
23709727|NCT04494633|66315218|FG001|Overall Study|Lost to Follow-up|3|||
23709728|NCT04494633|66315217|FG000|Overall Study|Protocol Violation|1|||
23709729|NCT04494633|66315218|FG001|Overall Study|Protocol Violation|1|||
23709730|NCT02486952|66315225|FG000|Overall Study|Not Started Induction Therapy|3|||
23709731|NCT02486952|66315225|FG000|Overall Study|Adverse Event|1|||
23709732|NCT02486952|66315225|FG000|Overall Study|Death|15|||
23709733|NCT02486952|66315225|FG000|Overall Study|Lack of Efficacy|3|||
23709734|NCT02486952|66315225|FG000|Overall Study|Lost to Follow-up|26|||
23709735|NCT02486952|66315225|FG000|Overall Study|Other|2|||
23709736|NCT00006604|66315229|FG000|Overall Study|Met study objective - no further FU|1|||
23709737|NCT00006604|66315230|FG001|Overall Study|Met study objective - no further FU|0|||
23709738|NCT00006604|66315231|FG002|Overall Study|Met study objective - no further FU|0|||
23709739|NCT00006604|66315232|FG003|Overall Study|Met study objective - no further FU|0|||
23709740|NCT00006604|66315233|FG004|Overall Study|Met study objective - no further FU|0|||
23709741|NCT00006604|66315234|FG005|Overall Study|Met study objective - no further FU|0|||
23709742|NCT00006604|66315235|FG006|Overall Study|Met study objective - no further FU|0|||
23709743|NCT00006604|66315236|FG007|Overall Study|Met study objective - no further FU|0|||
23709744|NCT00006604|66315237|FG008|Overall Study|Met study objective - no further FU|0|||
23709745|NCT00006604|66315238|FG009|Overall Study|Met study objective - no further FU|0|||
23410216|NCT03472495|65245736|FG001|Overall Study|Physician Decision|2|||
23410217|NCT01208324|65245737|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
23410218|NCT01208324|65245738|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
23410219|NCT01208324|65245739|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
23410220|NCT01208324|65245740|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
23410221|NCT00456755|65245746|FG000|Overall Study|Lost to Follow-up|2|||
23410222|NCT00456755|65245747|FG001|Overall Study|Lost to Follow-up|1|||
23410223|NCT00391053|65245750|FG000|Overall Study|Serious Adverse Events|1|||
23410224|NCT00391053|65245751|FG001|Overall Study|Serious Adverse Events|0|||
23410225|NCT00391053|65245752|FG002|Overall Study|Serious Adverse Events|1|||
23410226|NCT00391053|65245753|FG003|Overall Study|Serious Adverse Events|4|||
23410227|NCT00391053|65245750|FG000|Overall Study|Protocol Violation|2|||
23410228|NCT00391053|65245751|FG001|Overall Study|Protocol Violation|0|||
23410229|NCT00391053|65245752|FG002|Overall Study|Protocol Violation|0|||
23410230|NCT00391053|65245753|FG003|Overall Study|Protocol Violation|0|||
23410231|NCT00391053|65245750|FG000|Overall Study|Lost to Follow-up|1|||
23410232|NCT00391053|65245751|FG001|Overall Study|Lost to Follow-up|0|||
23410233|NCT00391053|65245752|FG002|Overall Study|Lost to Follow-up|0|||
23410234|NCT00391053|65245753|FG003|Overall Study|Lost to Follow-up|5|||
23410235|NCT00391053|65245750|FG000|Overall Study|Withdrawal by Subject|5|||
23410236|NCT00391053|65245751|FG001|Overall Study|Withdrawal by Subject|1|||
23410237|NCT00391053|65245752|FG002|Overall Study|Withdrawal by Subject|1|||
23410238|NCT00391053|65245753|FG003|Overall Study|Withdrawal by Subject|1|||
23410239|NCT00703846|65245754|FG000|Overall Study|Adverse Event|8|||
23410240|NCT00703846|65245754|FG000|Overall Study|Lost to Follow-up|55|||
23410241|NCT00703846|65245754|FG000|Overall Study|Lack of Efficacy|15|||
23410242|NCT00703846|65245754|FG000|Overall Study|Noncompliance with Study Treatment|2|||
23410243|NCT00703846|65245754|FG000|Overall Study|Withdrawal by Subject|40|||
23410244|NCT00703846|65245754|FG000|Overall Study|Death|1|||
23410245|NCT00703846|65245754|FG000|Overall Study|Other|14|||
23410246|NCT00703846|65245754|FG000|Overall Study|Did Not Receive Study Drug|2|||
23410247|NCT02391311|65245755|FG000|Overall Study|Lost to Follow-up|2|||
23410248|NCT02391311|65245756|FG001|Overall Study|Lost to Follow-up|1|||
23410249|NCT02391311|65245755|FG000|Overall Study|deemed ineligible after baseline|1|||
23410250|NCT02391311|65245756|FG001|Overall Study|deemed ineligible after baseline|1|||
23410251|NCT04512001|65245760|FG000|Week 0 to Week 24|Adverse Event|14|||
23410252|NCT04512001|65245761|FG001|Week 0 to Week 24|Adverse Event|10|||
23410253|NCT04512001|65245762|FG002|Week 0 to Week 24|Adverse Event|0|||
23410254|NCT04512001|65245763|FG003|Week 0 to Week 24|Adverse Event|0|||
23410255|NCT04512001|65245764|FG004|Week 0 to Week 24|Adverse Event|0|||
23511415|NCT03227029|65609329|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
23709746|NCT00006604|66315239|FG010|Overall Study|Met study objective - no further FU|0|||
23709747|NCT00006604|66315240|FG011|Overall Study|Met study objective - no further FU|0|||
23709748|NCT00006604|66315241|FG012|Overall Study|Met study objective - no further FU|0|||
23811961|NCT01121666|66691851|FG001|Overall Study|Protocol Violation|10|||
23410256|NCT04512001|65245760|FG000|Week 0 to Week 24|Death|0|||
23410257|NCT04512001|65245761|FG001|Week 0 to Week 24|Death|2|||
23410258|NCT04512001|65245762|FG002|Week 0 to Week 24|Death|0|||
23410259|NCT04512001|65245763|FG003|Week 0 to Week 24|Death|0|||
23410260|NCT04512001|65245764|FG004|Week 0 to Week 24|Death|0|||
23511416|NCT01195415|65609330|FG000|Overall Study|No repeat biopsy due to progression|2|||
23511417|NCT04343261|65609333|FG000|Overall Study|Adverse Event|1|||
23410261|NCT04512001|65245760|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
23410262|NCT04512001|65245761|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
23410263|NCT04512001|65245762|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
23410264|NCT04512001|65245763|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
23410265|NCT04512001|65245764|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
23410266|NCT04512001|65245760|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
23410267|NCT04512001|65245761|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
23410268|NCT04512001|65245762|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410269|NCT04512001|65245763|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410270|NCT04512001|65245764|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410271|NCT04512001|65245760|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
23410272|NCT04512001|65245761|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410273|NCT04512001|65245762|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410274|NCT04512001|65245763|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410275|NCT04512001|65245764|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410276|NCT04512001|65245760|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410277|NCT04512001|65245761|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
23410278|NCT04512001|65245762|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410279|NCT04512001|65245763|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410280|NCT04512001|65245764|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410281|NCT04512001|65245760|FG000|Week 24 to Week 63|Adverse Event|0|||
23410282|NCT04512001|65245761|FG001|Week 24 to Week 63|Adverse Event|0|||
23410283|NCT04512001|65245762|FG002|Week 24 to Week 63|Adverse Event|13|||
23410284|NCT04512001|65245763|FG003|Week 24 to Week 63|Adverse Event|8|||
23410285|NCT04512001|65245764|FG004|Week 24 to Week 63|Adverse Event|6|||
23410286|NCT04512001|65245760|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
23410287|NCT04512001|65245761|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
23410288|NCT04512001|65245762|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
23410289|NCT04512001|65245763|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
23410290|NCT04512001|65245764|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
23410291|NCT04512001|65245760|FG000|Week 24 to Week 63|Death|0|||
23410292|NCT04512001|65245761|FG001|Week 24 to Week 63|Death|0|||
23410293|NCT04512001|65245762|FG002|Week 24 to Week 63|Death|0|||
23410294|NCT04512001|65245763|FG003|Week 24 to Week 63|Death|1|||
23410295|NCT04512001|65245764|FG004|Week 24 to Week 63|Death|1|||
23709749|NCT00006604|66315242|FG013|Overall Study|Met study objective - no further FU|0|||
23709750|NCT00006604|66315243|FG014|Overall Study|Met study objective - no further FU|1|||
23709751|NCT00006604|66315244|FG015|Overall Study|Met study objective - no further FU|1|||
23709752|NCT00006604|66315245|FG016|Overall Study|Met study objective - no further FU|0|||
23709753|NCT00006604|66315229|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
23709754|NCT00006604|66315230|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
23709755|NCT00006604|66315231|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
23709756|NCT00006604|66315232|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
23709757|NCT00006604|66315233|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
23709758|NCT00006604|66315234|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
23709759|NCT00006604|66315235|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
23709760|NCT00006604|66315236|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
23709761|NCT00006604|66315237|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
23709762|NCT00006604|66315238|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
23709763|NCT00006604|66315239|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
23709764|NCT00006604|66315240|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
23709765|NCT00006604|66315241|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
23410296|NCT04512001|65245760|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
23410297|NCT04512001|65245761|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
23410298|NCT04512001|65245762|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
23410299|NCT04512001|65245763|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
23410300|NCT04512001|65245764|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
23410301|NCT04512001|65245760|FG000|Week 24 to Week 63|Miscellaneous|0|||
23410302|NCT04512001|65245761|FG001|Week 24 to Week 63|Miscellaneous|0|||
23410303|NCT04512001|65245762|FG002|Week 24 to Week 63|Miscellaneous|3|||
23410304|NCT04512001|65245763|FG003|Week 24 to Week 63|Miscellaneous|2|||
23410305|NCT04512001|65245764|FG004|Week 24 to Week 63|Miscellaneous|1|||
23410306|NCT02013778|65245767|FG000|Overall Study|Death|4|||
23410307|NCT02013778|65245767|FG000|Overall Study|Withdrawal by Subject|1|||
23410308|NCT02013778|65245767|FG000|Overall Study|Physician Decision|1|||
23709766|NCT00006604|66315242|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
23709767|NCT00006604|66315243|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
23410309|NCT02013778|65245767|FG000|Overall Study|Adverse Event|1|||
23410310|NCT03604497|65245772|FG000|Overall Study|Protocol Violation|52|||
23410311|NCT04482439|65245773|FG000|Overall Study|Lost to Follow-up|1|||
23410312|NCT04482439|65245773|FG000|Overall Study|Unrelated illness|1|||
23410313|NCT01773967|65245774|FG000|Overall Study|Lost to Follow-up|15|||
23410314|NCT01773967|65245775|FG001|Overall Study|Lost to Follow-up|13|||
23410315|NCT01670279|65245776|FG000|Overall Study|Adverse Event|0|||
23410316|NCT01670279|65245777|FG001|Overall Study|Adverse Event|1|||
23410317|NCT01670279|65245778|FG002|Overall Study|Adverse Event|0|||
23410318|NCT01670279|65245779|FG003|Overall Study|Adverse Event|0|||
23410319|NCT01670279|65245776|FG000|Overall Study|Physician Decision|0|||
23709768|NCT00006604|66315244|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
23709769|NCT00006604|66315245|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
23709770|NCT00006604|66315229|FG000|Overall Study|Death|0|||
23709771|NCT00006604|66315230|FG001|Overall Study|Death|0|||
23709772|NCT00006604|66315231|FG002|Overall Study|Death|0|||
23709773|NCT00006604|66315232|FG003|Overall Study|Death|0|||
23709774|NCT00006604|66315233|FG004|Overall Study|Death|0|||
23709775|NCT00006604|66315234|FG005|Overall Study|Death|0|||
23709776|NCT00006604|66315235|FG006|Overall Study|Death|0|||
23709777|NCT00006604|66315236|FG007|Overall Study|Death|0|||
23709778|NCT00006604|66315237|FG008|Overall Study|Death|0|||
23410320|NCT01670279|65245777|FG001|Overall Study|Physician Decision|1|||
23410321|NCT01670279|65245778|FG002|Overall Study|Physician Decision|0|||
23410322|NCT01670279|65245779|FG003|Overall Study|Physician Decision|0|||
23410323|NCT01670279|65245776|FG000|Overall Study|Participant met withdrawal criteria|0|||
23709779|NCT00006604|66315238|FG009|Overall Study|Death|1|||
23709780|NCT00006604|66315239|FG010|Overall Study|Death|1|||
23709781|NCT00006604|66315240|FG011|Overall Study|Death|1|||
23709782|NCT00006604|66315241|FG012|Overall Study|Death|0|||
23709783|NCT00006604|66315242|FG013|Overall Study|Death|0|||
23709784|NCT00006604|66315243|FG014|Overall Study|Death|0|||
23709785|NCT00006604|66315244|FG015|Overall Study|Death|0|||
23709786|NCT00006604|66315245|FG016|Overall Study|Death|0|||
23709787|NCT00006604|66315229|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23709788|NCT00006604|66315230|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23709789|NCT00006604|66315231|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23709790|NCT00006604|66315232|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23709791|NCT00006604|66315233|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23709792|NCT00006604|66315234|FG005|Overall Study|Severe debilitation, unable to continue|0|||
23709793|NCT00006604|66315235|FG006|Overall Study|Severe debilitation, unable to continue|3|||
23709794|NCT00006604|66315236|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23410324|NCT01670279|65245777|FG001|Overall Study|Participant met withdrawal criteria|0|||
23410325|NCT01670279|65245778|FG002|Overall Study|Participant met withdrawal criteria|0|||
23410326|NCT01670279|65245779|FG003|Overall Study|Participant met withdrawal criteria|1|||
23410327|NCT02936869|65245780|FG000|Overall Study|Lost to Follow-up|1|||
23410328|NCT02936869|65245781|FG001|Overall Study|Lost to Follow-up|3|||
23410329|NCT02936869|65245780|FG000|Overall Study|Death|0|||
23410330|NCT02936869|65245781|FG001|Overall Study|Death|1|||
23410331|NCT02936869|65245780|FG000|Overall Study|Legal Case|0|||
23410332|NCT02936869|65245781|FG001|Overall Study|Legal Case|1|||
23410333|NCT02936869|65245780|FG000|Overall Study|Protocol Violation|1|||
23410334|NCT02936869|65245781|FG001|Overall Study|Protocol Violation|0|||
23410335|NCT00606411|65245783|FG000|Overall Study|Adverse Event|1|||
23410336|NCT00606411|65245784|FG001|Overall Study|Adverse Event|2|||
23410337|NCT00606411|65245783|FG000|Overall Study|Lack of Adherence|1|||
23410338|NCT00606411|65245784|FG001|Overall Study|Lack of Adherence|1|||
23410339|NCT00606411|65245783|FG000|Overall Study|Lack of Efficacy|1|||
23410340|NCT00606411|65245784|FG001|Overall Study|Lack of Efficacy|1|||
23410341|NCT00606411|65245783|FG000|Overall Study|Withdrawal by Subject|2|||
23410342|NCT00606411|65245784|FG001|Overall Study|Withdrawal by Subject|0|||
23410343|NCT00606411|65245783|FG000|Overall Study|Lost to Follow-up|1|||
23410344|NCT00606411|65245784|FG001|Overall Study|Lost to Follow-up|2|||
23410345|NCT00606411|65245783|FG000|Overall Study|Move out of state|0|||
23709795|NCT00006604|66315237|FG008|Overall Study|Severe debilitation, unable to continue|0|||
23709796|NCT00006604|66315238|FG009|Overall Study|Severe debilitation, unable to continue|5|||
23410346|NCT00606411|65245784|FG001|Overall Study|Move out of state|1|||
23410347|NCT04262882|65245786|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
23709797|NCT00006604|66315239|FG010|Overall Study|Severe debilitation, unable to continue|0|||
23709798|NCT00006604|66315240|FG011|Overall Study|Severe debilitation, unable to continue|2|||
23709799|NCT00006604|66315241|FG012|Overall Study|Severe debilitation, unable to continue|1|||
23709800|NCT00006604|66315242|FG013|Overall Study|Severe debilitation, unable to continue|0|||
23709801|NCT00006604|66315243|FG014|Overall Study|Severe debilitation, unable to continue|2|||
23709802|NCT00006604|66315244|FG015|Overall Study|Severe debilitation, unable to continue|0|||
23709803|NCT00006604|66315245|FG016|Overall Study|Severe debilitation, unable to continue|0|||
23410348|NCT04262882|65245787|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
23410349|NCT04262882|65245786|FG000|Overall Study|Lost to Follow-up|1|||
23410350|NCT04262882|65245787|FG001|Overall Study|Lost to Follow-up|0|||
23410351|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Adverse Event|1|||
23410352|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Adverse Event|0|||
23410353|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
23410354|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
23709804|NCT00006604|66315229|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
23709805|NCT00006604|66315230|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
23709806|NCT00006604|66315231|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
23709807|NCT00006604|66315232|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
23709808|NCT00006604|66315233|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
23709809|NCT00006604|66315234|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
23709810|NCT00006604|66315235|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
23709811|NCT00006604|66315236|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
23709812|NCT00006604|66315237|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
23709813|NCT00006604|66315238|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
23709814|NCT00006604|66315239|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
23709815|NCT00006604|66315240|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
23709816|NCT00006604|66315241|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
23709817|NCT00006604|66315242|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
23709818|NCT00006604|66315243|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
23709819|NCT00006604|66315244|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
23709820|NCT00006604|66315245|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
23709821|NCT00006604|66315229|FG000|Overall Study|Site closing|0|||
23709822|NCT00006604|66315230|FG001|Overall Study|Site closing|0|||
23709823|NCT00006604|66315231|FG002|Overall Study|Site closing|1|||
23709824|NCT00006604|66315232|FG003|Overall Study|Site closing|1|||
23709825|NCT00006604|66315233|FG004|Overall Study|Site closing|0|||
23709826|NCT00006604|66315234|FG005|Overall Study|Site closing|0|||
23709827|NCT00006604|66315235|FG006|Overall Study|Site closing|0|||
23709828|NCT00006604|66315236|FG007|Overall Study|Site closing|1|||
23709829|NCT00006604|66315237|FG008|Overall Study|Site closing|0|||
23511418|NCT04343261|65609333|FG000|Overall Study|received inadequate amount of antibodies|7|||
23511419|NCT01549860|65609337|FG000|Overall Study|Withdrawal by Subject|1|||
23511420|NCT01549860|65609338|FG001|Overall Study|Withdrawal by Subject|0|||
23511421|NCT01549860|65609337|FG000|Overall Study|Physician Decision|1|||
23709830|NCT00006604|66315238|FG009|Overall Study|Site closing|0|||
23709831|NCT00006604|66315239|FG010|Overall Study|Site closing|0|||
23709832|NCT00006604|66315240|FG011|Overall Study|Site closing|1|||
23709833|NCT00006604|66315241|FG012|Overall Study|Site closing|1|||
23709834|NCT00006604|66315242|FG013|Overall Study|Site closing|1|||
23709835|NCT00006604|66315243|FG014|Overall Study|Site closing|0|||
23709836|NCT00006604|66315244|FG015|Overall Study|Site closing|0|||
23709837|NCT00006604|66315245|FG016|Overall Study|Site closing|1|||
23811962|NCT01884311|66691852|FG000|Overall Study|Withdrawal by Subject|3|||
23811963|NCT01884311|66691852|FG000|Overall Study|withdrew consent due to AEs|1|||
23709838|NCT00006604|66315229|FG000|Overall Study|Withdrawal by Subject|1|||
23709839|NCT00006604|66315230|FG001|Overall Study|Withdrawal by Subject|0|||
23709840|NCT00006604|66315231|FG002|Overall Study|Withdrawal by Subject|2|||
23709841|NCT00006604|66315232|FG003|Overall Study|Withdrawal by Subject|0|||
23709842|NCT00006604|66315233|FG004|Overall Study|Withdrawal by Subject|1|||
23709843|NCT00006604|66315234|FG005|Overall Study|Withdrawal by Subject|2|||
23709844|NCT00006604|66315235|FG006|Overall Study|Withdrawal by Subject|2|||
23709845|NCT00006604|66315236|FG007|Overall Study|Withdrawal by Subject|0|||
23709846|NCT00006604|66315237|FG008|Overall Study|Withdrawal by Subject|1|||
23709847|NCT00006604|66315238|FG009|Overall Study|Withdrawal by Subject|3|||
23709848|NCT00006604|66315239|FG010|Overall Study|Withdrawal by Subject|2|||
23709849|NCT00006604|66315240|FG011|Overall Study|Withdrawal by Subject|0|||
23709850|NCT00006604|66315241|FG012|Overall Study|Withdrawal by Subject|1|||
23709851|NCT00006604|66315242|FG013|Overall Study|Withdrawal by Subject|2|||
23709852|NCT00006604|66315243|FG014|Overall Study|Withdrawal by Subject|1|||
23709853|NCT00006604|66315244|FG015|Overall Study|Withdrawal by Subject|0|||
23709854|NCT00006604|66315245|FG016|Overall Study|Withdrawal by Subject|1|||
23709855|NCT00006604|66315229|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
23709856|NCT00006604|66315230|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
23709857|NCT00006604|66315231|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
23709858|NCT00006604|66315232|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
23709859|NCT00006604|66315233|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
23709860|NCT00006604|66315234|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
23709861|NCT00006604|66315235|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
23709862|NCT00006604|66315236|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
23709863|NCT00006604|66315237|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
23709864|NCT00006604|66315238|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
23709865|NCT00006604|66315239|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
23709866|NCT00006604|66315240|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
23709867|NCT00006604|66315241|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
23709868|NCT00006604|66315242|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
23709869|NCT00006604|66315243|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
23709870|NCT00006604|66315244|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
23709871|NCT00006604|66315245|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
23709872|NCT00006604|66315229|FG000|Overall Study|Lost to Follow-up|0|||
23709873|NCT00006604|66315230|FG001|Overall Study|Lost to Follow-up|0|||
23709874|NCT00006604|66315231|FG002|Overall Study|Lost to Follow-up|0|||
23709875|NCT00006604|66315232|FG003|Overall Study|Lost to Follow-up|0|||
23709876|NCT00006604|66315233|FG004|Overall Study|Lost to Follow-up|0|||
23709877|NCT00006604|66315234|FG005|Overall Study|Lost to Follow-up|0|||
23410355|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
23410356|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
23410357|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
23410358|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
23410359|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Other|1|||
23410360|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Other|4|||
23410361|NCT00301262|65245788|FG000|Open Label Phase (OL)|Adverse Event|1|||
23410362|NCT00301262|65245789|FG001|Open Label Phase (OL)|Adverse Event|0|||
23410363|NCT00301262|65245788|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
23410364|NCT00301262|65245789|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
23410365|NCT00301262|65245788|FG000|Open Label Phase (OL)|Other|2|||
23410366|NCT00301262|65245789|FG001|Open Label Phase (OL)|Other|0|||
23410367|NCT00292045|65245793|FG000|Core Study (Through Week 13)|Adverse Event|1|||
23410368|NCT00292045|65245793|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
23410369|NCT02016716|65245798|FG000|Overall Study|Withdrawal by Subject|5|||
23410370|NCT02016716|65245799|FG001|Overall Study|Withdrawal by Subject|5|||
23410371|NCT02016716|65245800|FG002|Overall Study|Withdrawal by Subject|5|||
23410372|NCT02016716|65245798|FG000|Overall Study|Protocol-specified Criteria|0|||
23410373|NCT02016716|65245799|FG001|Overall Study|Protocol-specified Criteria|1|||
23410374|NCT02016716|65245800|FG002|Overall Study|Protocol-specified Criteria|0|||
23410375|NCT02016716|65245798|FG000|Overall Study|Lost to Follow-up|1|||
23410376|NCT02016716|65245799|FG001|Overall Study|Lost to Follow-up|2|||
23410377|NCT02016716|65245800|FG002|Overall Study|Lost to Follow-up|1|||
23709878|NCT00006604|66315235|FG006|Overall Study|Lost to Follow-up|0|||
23709879|NCT00006604|66315236|FG007|Overall Study|Lost to Follow-up|1|||
23709880|NCT00006604|66315237|FG008|Overall Study|Lost to Follow-up|0|||
23709881|NCT00006604|66315238|FG009|Overall Study|Lost to Follow-up|2|||
23410378|NCT01032070|65245803|FG000|Overall Study|Disease progression|13|||
23410379|NCT01032070|65245804|FG001|Overall Study|Disease progression|8|||
23410380|NCT01032070|65245803|FG000|Overall Study|Medical or ethical reasons|0|||
23410381|NCT01032070|65245804|FG001|Overall Study|Medical or ethical reasons|2|||
23410382|NCT01032070|65245803|FG000|Overall Study|Withdrawal by Subject|0|||
23410383|NCT01032070|65245804|FG001|Overall Study|Withdrawal by Subject|2|||
23709882|NCT00006604|66315239|FG010|Overall Study|Lost to Follow-up|0|||
23410384|NCT01496287|65245805|FG000|Overall Study|Lost to Follow-up|1|||
23410385|NCT01496287|65245805|FG000|Overall Study|Incomplete anesthesia|5|||
23410386|NCT00967694|65245806|FG000|Overall Study|Withdrawal by Subject|6|||
23410387|NCT00705250|65245807|FG000|Overall Study|Withdrawal by Subject|1|||
23410388|NCT00705250|65245807|FG000|Overall Study|Patient died in car accident|1|||
23410389|NCT04493424|65245808|FG000|Overall Study|Termination of the trial by the sponsor|89|||
23410390|NCT04493424|65245808|FG000|Overall Study|Withdrawal by Subject|9|||
23410391|NCT04493424|65245808|FG000|Overall Study|Lost to Follow-up|2|||
23410392|NCT04493424|65245808|FG000|Overall Study|Lack of Efficacy|3|||
23410393|NCT04493424|65245808|FG000|Overall Study|Adverse Event|5|||
23410394|NCT01823198|65245809|FG000|Overall Study|Physician Decision|0|||
23410395|NCT01823198|65245810|FG001|Overall Study|Physician Decision|1|||
23410396|NCT01823198|65245811|FG002|Overall Study|Physician Decision|0|||
23410397|NCT01823198|65245812|FG003|Overall Study|Physician Decision|0|||
23410398|NCT01823198|65245813|FG004|Overall Study|Physician Decision|0|||
23709883|NCT00006604|66315240|FG011|Overall Study|Lost to Follow-up|0|||
23709884|NCT00006604|66315241|FG012|Overall Study|Lost to Follow-up|0|||
23709885|NCT00006604|66315242|FG013|Overall Study|Lost to Follow-up|0|||
23709886|NCT00006604|66315243|FG014|Overall Study|Lost to Follow-up|0|||
23709887|NCT00006604|66315244|FG015|Overall Study|Lost to Follow-up|1|||
23709888|NCT00006604|66315245|FG016|Overall Study|Lost to Follow-up|3|||
23709889|NCT00006604|66315229|FG000|Overall Study|Other Reason|0|||
23709890|NCT00006604|66315230|FG001|Overall Study|Other Reason|0|||
23709891|NCT00006604|66315231|FG002|Overall Study|Other Reason|0|||
23709892|NCT00006604|66315232|FG003|Overall Study|Other Reason|0|||
23709893|NCT00006604|66315233|FG004|Overall Study|Other Reason|0|||
23709894|NCT00006604|66315234|FG005|Overall Study|Other Reason|1|||
23709895|NCT00006604|66315235|FG006|Overall Study|Other Reason|0|||
23709896|NCT00006604|66315236|FG007|Overall Study|Other Reason|0|||
23709897|NCT00006604|66315237|FG008|Overall Study|Other Reason|0|||
23709898|NCT00006604|66315238|FG009|Overall Study|Other Reason|1|||
23709899|NCT00006604|66315239|FG010|Overall Study|Other Reason|0|||
23709900|NCT00006604|66315240|FG011|Overall Study|Other Reason|0|||
23709901|NCT00006604|66315241|FG012|Overall Study|Other Reason|0|||
23709902|NCT00006604|66315242|FG013|Overall Study|Other Reason|0|||
23709903|NCT00006604|66315243|FG014|Overall Study|Other Reason|0|||
23709904|NCT00006604|66315244|FG015|Overall Study|Other Reason|0|||
23709905|NCT00006604|66315245|FG016|Overall Study|Other Reason|0|||
23709906|NCT00788775|66315248|FG000|Overall Study|Progressive Disease|8|||
23709907|NCT00788775|66315249|FG001|Overall Study|Progressive Disease|6|||
23709908|NCT00788775|66315248|FG000|Overall Study|Withdrawal by Subject|0|||
23709909|NCT00788775|66315249|FG001|Overall Study|Withdrawal by Subject|2|||
23709910|NCT00788775|66315248|FG000|Overall Study|Patient Non-Compliance|1|||
23709911|NCT00788775|66315249|FG001|Overall Study|Patient Non-Compliance|0|||
23709912|NCT00788775|66315248|FG000|Overall Study|Patient's measurable disease resected.|1|||
23709913|NCT00788775|66315249|FG001|Overall Study|Patient's measurable disease resected.|0|||
23709914|NCT02922634|66315250|FG000|Overall Study|Withdrawal by Subject|5|||
23709915|NCT02922634|66315250|FG000|Overall Study|Did not have their surgery|5|||
23709916|NCT03591146|66315251|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23709917|NCT03591146|66315252|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23709918|NCT03591146|66315253|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23709919|NCT03591146|66315254|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23709920|NCT03591146|66315255|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
23709921|NCT03591146|66315251|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23709922|NCT03591146|66315252|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
23709923|NCT03591146|66315253|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23709924|NCT03591146|66315254|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23709925|NCT03591146|66315255|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23709926|NCT03591146|66315251|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23709927|NCT03591146|66315252|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23709928|NCT03591146|66315253|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23410399|NCT01823198|65245814|FG005|Overall Study|Physician Decision|3|||
23410400|NCT01823198|65245815|FG006|Overall Study|Physician Decision|3|||
23410401|NCT03370419|65245818|FG000|Overall Study|Lost to Follow-up|16|||
23511422|NCT01549860|65609338|FG001|Overall Study|Physician Decision|1|||
23709929|NCT03591146|66315254|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23709930|NCT03591146|66315255|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
23709931|NCT03591146|66315251|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23709932|NCT03591146|66315252|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23709933|NCT03591146|66315253|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
23811964|NCT01884311|66691852|FG000|Overall Study|Precautionary measure|1|||
23410402|NCT03198767|65245820|FG000|Overall Study|Protocol Violation|0|||
23410403|NCT03198767|65245821|FG001|Overall Study|Protocol Violation|0|||
23410404|NCT03198767|65245822|FG002|Overall Study|Protocol Violation|0|||
23410405|NCT03198767|65245823|FG003|Overall Study|Protocol Violation|6|||
23410406|NCT03198767|65245824|FG004|Overall Study|Protocol Violation|0|||
23709934|NCT03591146|66315254|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23709935|NCT03591146|66315255|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
23709936|NCT01767194|66315256|FG000|Overall Study|Adverse Event|1|||
23709937|NCT01767194|66315257|FG001|Overall Study|Adverse Event|1|||
23709938|NCT01767194|66315256|FG000|Overall Study|Death|0|||
23709939|NCT01767194|66315257|FG001|Overall Study|Death|1|||
23709940|NCT01767194|66315256|FG000|Overall Study|Lack of Efficacy|12|||
23709941|NCT01767194|66315257|FG001|Overall Study|Lack of Efficacy|11|||
23709942|NCT01767194|66315256|FG000|Overall Study|Physician Decision|2|||
23709943|NCT01767194|66315257|FG001|Overall Study|Physician Decision|23|||
23709944|NCT01767194|66315256|FG000|Overall Study|Withdrawal by Subject|0|||
23709945|NCT01767194|66315257|FG001|Overall Study|Withdrawal by Subject|1|||
23709946|NCT01767194|66315256|FG000|Overall Study|Ineligible|1|||
23709947|NCT01767194|66315257|FG001|Overall Study|Ineligible|1|||
23709948|NCT01767194|66315256|FG000|Overall Study|Refusal by patient/parent|2|||
23709949|NCT01767194|66315257|FG001|Overall Study|Refusal by patient/parent|4|||
23709950|NCT01767194|66315256|FG000|Overall Study|Criteria not met on time for next cycle|0|||
23709951|NCT01767194|66315257|FG001|Overall Study|Criteria not met on time for next cycle|1|||
23709952|NCT00712322|66315258|FG000|Overall Study|Protocol deviation|0|||
23709953|NCT00712322|66315259|FG001|Overall Study|Protocol deviation|1|||
23709954|NCT00712322|66315260|FG002|Overall Study|Protocol deviation|0|||
23709955|NCT00138424|66315264|FG000|Overall Study|Physician Decision|0|||
23709956|NCT00138424|66315265|FG001|Overall Study|Physician Decision|1|||
23709957|NCT00138424|66315266|FG002|Overall Study|Physician Decision|0|||
23709958|NCT00138424|66315267|FG003|Overall Study|Physician Decision|0|||
23709959|NCT00608530|66315268|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
23709960|NCT00608530|66315269|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
23709961|NCT00608530|66315270|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
23709962|NCT00608530|66315271|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
23709963|NCT00608530|66315268|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
23709964|NCT00608530|66315269|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
23709965|NCT00608530|66315270|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
23709966|NCT00608530|66315271|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
23709967|NCT00608530|66315268|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
23709968|NCT00608530|66315269|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
23410407|NCT03198767|65245825|FG005|Overall Study|Protocol Violation|0|||
23410408|NCT03198767|65245826|FG006|Overall Study|Protocol Violation|0|||
23410409|NCT00778336|65245827|FG000|Index Procedure-Discharge|Death|6|||
23410410|NCT00778336|65245828|FG001|Index Procedure-Discharge|Death|3|||
23410411|NCT00778336|65245829|FG002|Index Procedure-Discharge|Death|2|||
23410412|NCT00778336|65245830|FG003|Index Procedure-Discharge|Death|0|||
23410413|NCT00778336|65245827|FG000|3 Month Follow Up|Lost to Follow-up|15|||
23410414|NCT00778336|65245828|FG001|3 Month Follow Up|Lost to Follow-up|20|||
23410415|NCT00778336|65245829|FG002|3 Month Follow Up|Lost to Follow-up|3|||
23410416|NCT00778336|65245830|FG003|3 Month Follow Up|Lost to Follow-up|0|||
23410417|NCT00778336|65245827|FG000|3 Month Follow Up|Death|8|||
23410418|NCT00778336|65245828|FG001|3 Month Follow Up|Death|3|||
23410419|NCT00778336|65245829|FG002|3 Month Follow Up|Death|2|||
23410420|NCT00778336|65245830|FG003|3 Month Follow Up|Death|0|||
23410421|NCT02520388|65245831|FG000|Overall Study|Physician Decision|1|||
23410422|NCT02520388|65245832|FG001|Overall Study|Physician Decision|0|||
23410423|NCT02520388|65245831|FG000|Overall Study|Subject or parent/guardian request|0|||
23410424|NCT02520388|65245832|FG001|Overall Study|Subject or parent/guardian request|6|||
23410425|NCT02520388|65245831|FG000|Overall Study|Adverse Event|1|||
23410426|NCT02520388|65245832|FG001|Overall Study|Adverse Event|4|||
23410427|NCT02520388|65245831|FG000|Overall Study|Lost to Follow-up|3|||
23410428|NCT02520388|65245832|FG001|Overall Study|Lost to Follow-up|2|||
23410429|NCT02520388|65245831|FG000|Overall Study|Other (reason not defined)|4|||
23410430|NCT02520388|65245832|FG001|Overall Study|Other (reason not defined)|4|||
23410431|NCT01713582|65245833|FG000|Overall Study|Disease progression|3|||
23410432|NCT01713582|65245834|FG001|Overall Study|Disease progression|3|||
23410433|NCT01713582|65245835|FG002|Overall Study|Disease progression|3|||
23709969|NCT00608530|66315270|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
23709970|NCT00608530|66315271|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
23511423|NCT00450450|65609340|FG000|Overall Study|Death|1|||
23709971|NCT00608530|66315268|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23709972|NCT00608530|66315269|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23811965|NCT03301623|66691855|FG000|Overall Study|Death|3|||
23410434|NCT01713582|65245836|FG003|Overall Study|Disease progression|2|||
23410435|NCT01713582|65245837|FG004|Overall Study|Disease progression|3|||
23410436|NCT01713582|65245838|FG005|Overall Study|Disease progression|3|||
23410437|NCT01713582|65245839|FG006|Overall Study|Disease progression|3|||
23410438|NCT01713582|65245840|FG007|Overall Study|Disease progression|3|||
23410439|NCT01713582|65245841|FG008|Overall Study|Disease progression|3|||
23709973|NCT00608530|66315270|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
23410440|NCT01713582|65245842|FG009|Overall Study|Disease progression|11|||
23410441|NCT01713582|65245843|FG010|Overall Study|Disease progression|10|||
23410442|NCT01713582|65245844|FG011|Overall Study|Disease progression|5|||
23410443|NCT01713582|65245845|FG012|Overall Study|Disease progression|3|||
23410444|NCT01713582|65245846|FG013|Overall Study|Disease progression|3|||
23709974|NCT00608530|66315271|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23709975|NCT00608530|66315268|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
23709976|NCT00608530|66315269|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
23709977|NCT00608530|66315270|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
23709978|NCT00608530|66315271|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
23709979|NCT00608530|66315268|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23709980|NCT00608530|66315269|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23709981|NCT00608530|66315270|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
23709982|NCT00608530|66315271|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23709983|NCT01766817|66315272|FG000|Overall Study|Drug-related adverse event|1|||
23709984|NCT01766817|66315273|FG001|Overall Study|Drug-related adverse event|2|||
23709985|NCT01766817|66315274|FG002|Overall Study|Drug-related adverse event|1|||
23709986|NCT01766817|66315272|FG000|Overall Study|Drug-unrelated adverse event|3|||
23709987|NCT01766817|66315273|FG001|Overall Study|Drug-unrelated adverse event|3|||
23410445|NCT01713582|65245847|FG014|Overall Study|Disease progression|6|||
23410446|NCT01713582|65245848|FG015|Overall Study|Disease progression|6|||
23410447|NCT01713582|65245849|FG016|Overall Study|Disease progression|5|||
23410448|NCT01713582|65245850|FG017|Overall Study|Disease progression|2|||
23410449|NCT01713582|65245851|FG018|Overall Study|Disease progression|3|||
23709988|NCT01766817|66315274|FG002|Overall Study|Drug-unrelated adverse event|3|||
23709989|NCT01766817|66315272|FG000|Overall Study|Death|1|||
23709990|NCT01766817|66315273|FG001|Overall Study|Death|1|||
23709991|NCT01766817|66315274|FG002|Overall Study|Death|0|||
23709992|NCT01766817|66315272|FG000|Overall Study|Unable to take study drug|0|||
23709993|NCT01766817|66315273|FG001|Overall Study|Unable to take study drug|1|||
23410450|NCT01713582|65245852|FG019|Overall Study|Disease progression|5|||
23410451|NCT01713582|65245853|FG020|Overall Study|Disease progression|15|||
23410452|NCT01713582|65245833|FG000|Overall Study|Death|0|||
23410453|NCT01713582|65245834|FG001|Overall Study|Death|0|||
23410454|NCT01713582|65245835|FG002|Overall Study|Death|0|||
23410455|NCT01713582|65245836|FG003|Overall Study|Death|1|||
23410456|NCT01713582|65245837|FG004|Overall Study|Death|1|||
23410457|NCT01713582|65245838|FG005|Overall Study|Death|3|||
23410458|NCT01713582|65245839|FG006|Overall Study|Death|3|||
23410459|NCT01713582|65245840|FG007|Overall Study|Death|2|||
23410460|NCT01713582|65245841|FG008|Overall Study|Death|3|||
23410461|NCT01713582|65245842|FG009|Overall Study|Death|4|||
23410462|NCT01713582|65245843|FG010|Overall Study|Death|3|||
23410463|NCT01713582|65245844|FG011|Overall Study|Death|0|||
23410464|NCT01713582|65245845|FG012|Overall Study|Death|0|||
23410465|NCT01713582|65245846|FG013|Overall Study|Death|0|||
23410466|NCT01713582|65245847|FG014|Overall Study|Death|0|||
23410467|NCT01713582|65245848|FG015|Overall Study|Death|0|||
23410468|NCT01713582|65245849|FG016|Overall Study|Death|0|||
23410469|NCT01713582|65245850|FG017|Overall Study|Death|0|||
23410470|NCT01713582|65245851|FG018|Overall Study|Death|0|||
23410471|NCT01713582|65245852|FG019|Overall Study|Death|0|||
23410472|NCT01713582|65245853|FG020|Overall Study|Death|0|||
23410473|NCT01713582|65245833|FG000|Overall Study|Adverse event-related|0|||
23410474|NCT01713582|65245834|FG001|Overall Study|Adverse event-related|0|||
23410475|NCT01713582|65245835|FG002|Overall Study|Adverse event-related|0|||
23410476|NCT01713582|65245836|FG003|Overall Study|Adverse event-related|0|||
23410477|NCT01713582|65245837|FG004|Overall Study|Adverse event-related|0|||
23410478|NCT01713582|65245838|FG005|Overall Study|Adverse event-related|0|||
23410479|NCT01713582|65245839|FG006|Overall Study|Adverse event-related|0|||
23410480|NCT01713582|65245840|FG007|Overall Study|Adverse event-related|0|||
23410481|NCT01713582|65245841|FG008|Overall Study|Adverse event-related|0|||
23410482|NCT01713582|65245842|FG009|Overall Study|Adverse event-related|1|||
23410483|NCT01713582|65245843|FG010|Overall Study|Adverse event-related|1|||
23511424|NCT00450450|65609341|FG001|Overall Study|Death|3|||
23511425|NCT00450450|65609340|FG000|Overall Study|Relapse|2|||
23511426|NCT00450450|65609341|FG001|Overall Study|Relapse|0|||
23709994|NCT01766817|66315274|FG002|Overall Study|Unable to take study drug|0|||
23709995|NCT01766817|66315272|FG000|Overall Study|Withdrawal by Subject|2|||
23410484|NCT01713582|65245844|FG011|Overall Study|Adverse event-related|0|||
23410485|NCT01713582|65245845|FG012|Overall Study|Adverse event-related|0|||
23410486|NCT01713582|65245846|FG013|Overall Study|Adverse event-related|0|||
23410487|NCT01713582|65245847|FG014|Overall Study|Adverse event-related|0|||
23410488|NCT01713582|65245848|FG015|Overall Study|Adverse event-related|0|||
23410489|NCT01713582|65245849|FG016|Overall Study|Adverse event-related|0|||
23410490|NCT01713582|65245850|FG017|Overall Study|Adverse event-related|0|||
23410491|NCT01713582|65245851|FG018|Overall Study|Adverse event-related|1|||
23709996|NCT01766817|66315273|FG001|Overall Study|Withdrawal by Subject|0|||
23811966|NCT03301623|66691856|FG001|Overall Study|Death|1|||
23410492|NCT01713582|65245852|FG019|Overall Study|Adverse event-related|0|||
23410493|NCT01713582|65245853|FG020|Overall Study|Adverse event-related|0|||
23410494|NCT01713582|65245833|FG000|Overall Study|Adverse event-unrelated|0|||
23410495|NCT01713582|65245834|FG001|Overall Study|Adverse event-unrelated|0|||
23410496|NCT01713582|65245835|FG002|Overall Study|Adverse event-unrelated|0|||
23410497|NCT01713582|65245836|FG003|Overall Study|Adverse event-unrelated|0|||
23410498|NCT01713582|65245837|FG004|Overall Study|Adverse event-unrelated|0|||
23410499|NCT01713582|65245838|FG005|Overall Study|Adverse event-unrelated|1|||
23410500|NCT01713582|65245839|FG006|Overall Study|Adverse event-unrelated|1|||
23511427|NCT00450450|65609340|FG000|Overall Study|Missing Data|2|||
23511428|NCT00450450|65609341|FG001|Overall Study|Missing Data|0|||
23511429|NCT00085631|65609342|FG000|Overall Study|Missing Data|4|||
23511430|NCT00085631|65609343|FG001|Overall Study|Missing Data|11|||
23511431|NCT00085631|65609344|FG002|Overall Study|Missing Data|7|||
23511432|NCT02373202|65609349|FG000|Overall Study|Adverse Event|2|||
23511433|NCT02373202|65609350|FG001|Overall Study|Adverse Event|5|||
23511434|NCT02373202|65609351|FG002|Overall Study|Adverse Event|2|||
23511435|NCT02373202|65609352|FG003|Overall Study|Adverse Event|1|||
23511436|NCT02373202|65609349|FG000|Overall Study|Lack of Efficacy|0|||
23511437|NCT02373202|65609350|FG001|Overall Study|Lack of Efficacy|0|||
23511438|NCT02373202|65609351|FG002|Overall Study|Lack of Efficacy|1|||
23511439|NCT02373202|65609352|FG003|Overall Study|Lack of Efficacy|0|||
23511440|NCT02373202|65609349|FG000|Overall Study|Other|0|||
23410501|NCT01713582|65245840|FG007|Overall Study|Adverse event-unrelated|1|||
23410502|NCT01713582|65245841|FG008|Overall Study|Adverse event-unrelated|0|||
23410503|NCT01713582|65245842|FG009|Overall Study|Adverse event-unrelated|0|||
23511441|NCT02373202|65609350|FG001|Overall Study|Other|1|||
23709997|NCT01766817|66315274|FG002|Overall Study|Withdrawal by Subject|3|||
23709998|NCT01766817|66315272|FG000|Overall Study|Subject non-compliance|0|||
23709999|NCT01766817|66315273|FG001|Overall Study|Subject non-compliance|1|||
23710000|NCT01766817|66315274|FG002|Overall Study|Subject non-compliance|2|||
23710001|NCT01766817|66315272|FG000|Overall Study|Physician Decision|3|||
23410504|NCT01713582|65245843|FG010|Overall Study|Adverse event-unrelated|0|||
23710002|NCT01766817|66315273|FG001|Overall Study|Physician Decision|3|||
23710003|NCT01766817|66315274|FG002|Overall Study|Physician Decision|4|||
23710004|NCT01766817|66315272|FG000|Overall Study|Other|1|||
23710005|NCT01766817|66315273|FG001|Overall Study|Other|0|||
23710006|NCT01766817|66315274|FG002|Overall Study|Other|0|||
23710007|NCT00910429|66315283|FG000|Overall Study|Death|18|||
23710008|NCT00910429|66315284|FG001|Overall Study|Death|12|||
23710009|NCT00910429|66315283|FG000|Overall Study|Withdrawal by Subject|3|||
23710010|NCT00910429|66315284|FG001|Overall Study|Withdrawal by Subject|2|||
23710011|NCT00910429|66315283|FG000|Overall Study|Protocol Violation|1|||
23710012|NCT00910429|66315284|FG001|Overall Study|Protocol Violation|0|||
23410505|NCT01713582|65245844|FG011|Overall Study|Adverse event-unrelated|0|||
23410506|NCT01713582|65245845|FG012|Overall Study|Adverse event-unrelated|0|||
23410507|NCT01713582|65245846|FG013|Overall Study|Adverse event-unrelated|1|||
23410508|NCT01713582|65245847|FG014|Overall Study|Adverse event-unrelated|1|||
23410509|NCT01713582|65245848|FG015|Overall Study|Adverse event-unrelated|0|||
23410510|NCT01713582|65245849|FG016|Overall Study|Adverse event-unrelated|0|||
23410511|NCT01713582|65245850|FG017|Overall Study|Adverse event-unrelated|0|||
23410512|NCT01713582|65245851|FG018|Overall Study|Adverse event-unrelated|0|||
23410513|NCT01713582|65245852|FG019|Overall Study|Adverse event-unrelated|0|||
23410514|NCT01713582|65245853|FG020|Overall Study|Adverse event-unrelated|0|||
23410515|NCT01713582|65245833|FG000|Overall Study|Withdrawal of consent|0|||
23340851|NCT01936181|64992872|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
23410516|NCT01713582|65245834|FG001|Overall Study|Withdrawal of consent|0|||
23811967|NCT03301623|66691855|FG000|Overall Study|Withdrawal by Subject|11|||
23410517|NCT01713582|65245835|FG002|Overall Study|Withdrawal of consent|1|||
23710013|NCT00910429|66315283|FG000|Overall Study|Lost to Follow-up|2|||
23710014|NCT00910429|66315284|FG001|Overall Study|Lost to Follow-up|1|||
23410518|NCT01713582|65245836|FG003|Overall Study|Withdrawal of consent|0|||
23410519|NCT01713582|65245837|FG004|Overall Study|Withdrawal of consent|0|||
23410520|NCT01713582|65245838|FG005|Overall Study|Withdrawal of consent|1|||
23410521|NCT01713582|65245839|FG006|Overall Study|Withdrawal of consent|0|||
23410522|NCT01713582|65245840|FG007|Overall Study|Withdrawal of consent|0|||
23410523|NCT01713582|65245841|FG008|Overall Study|Withdrawal of consent|0|||
23410524|NCT01713582|65245842|FG009|Overall Study|Withdrawal of consent|1|||
23410525|NCT01713582|65245843|FG010|Overall Study|Withdrawal of consent|0|||
23410526|NCT01713582|65245844|FG011|Overall Study|Withdrawal of consent|0|||
23410527|NCT01713582|65245845|FG012|Overall Study|Withdrawal of consent|0|||
23410528|NCT01713582|65245846|FG013|Overall Study|Withdrawal of consent|0|||
23410529|NCT01713582|65245847|FG014|Overall Study|Withdrawal of consent|0|||
23410530|NCT01713582|65245848|FG015|Overall Study|Withdrawal of consent|0|||
23710015|NCT00910429|66315283|FG000|Overall Study|Adverse Event|10|||
23710016|NCT00910429|66315284|FG001|Overall Study|Adverse Event|5|||
23710017|NCT00910429|66315283|FG000|Overall Study|Drug non-compliance|1|||
23710018|NCT00910429|66315284|FG001|Overall Study|Drug non-compliance|0|||
23710019|NCT00910429|66315283|FG000|Overall Study|Lack of Efficacy|4|||
23710020|NCT00910429|66315284|FG001|Overall Study|Lack of Efficacy|1|||
23710021|NCT02625324|66315285|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
23710022|NCT02625324|66315285|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
23710023|NCT02625324|66315285|FG000|6-Month Follow-up Subject Accountability|Death|5|||
23710024|NCT02625324|66315285|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
23710025|NCT02625324|66315285|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
23710026|NCT02625324|66315285|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
23710027|NCT02625324|66315285|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
23710028|NCT02625324|66315285|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
23710029|NCT02625324|66315285|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
23710030|NCT02625324|66315285|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
23710031|NCT02625324|66315285|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
23710032|NCT02625324|66315285|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23710033|NCT02625324|66315285|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
23710034|NCT02625324|66315285|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23710035|NCT02625324|66315285|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23710036|NCT02625324|66315285|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
23710037|NCT02625324|66315285|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23710038|NCT00471536|66315286|FG000|Overall Study|Withdrawal by Subject|1|||
23710039|NCT02365584|66315287|FG000|Overall Study|Adverse Event|2|||
23710040|NCT02365584|66315288|FG001|Overall Study|Adverse Event|2|||
23710041|NCT02365584|66315287|FG000|Overall Study|Withdrawal by Subject|1|||
23710042|NCT02365584|66315288|FG001|Overall Study|Withdrawal by Subject|0|||
23710043|NCT02365584|66315287|FG000|Overall Study|Disease Progression|9|||
23710044|NCT02365584|66315288|FG001|Overall Study|Disease Progression|12|||
23710045|NCT00414960|66315289|FG000|Overall Study|Adverse Event|4|||
23710046|NCT00414960|66315290|FG001|Overall Study|Adverse Event|0|||
23710047|NCT00414960|66315289|FG000|Overall Study|Withdrawal by Subject|3|||
23710048|NCT00414960|66315290|FG001|Overall Study|Withdrawal by Subject|0|||
23710049|NCT00414960|66315289|FG000|Overall Study|Physician Decision|0|||
23710050|NCT00414960|66315290|FG001|Overall Study|Physician Decision|1|||
23710051|NCT04191967|66315291|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
23710052|NCT04191967|66315291|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
23710053|NCT02921919|66315292|FG000|Overall Study|Other|5|||
23710054|NCT02921919|66315293|FG001|Overall Study|Other|6|||
23710055|NCT02921919|66315292|FG000|Overall Study|Lost to Follow-up|0|||
23710056|NCT02921919|66315293|FG001|Overall Study|Lost to Follow-up|1|||
23710057|NCT02921919|66315292|FG000|Overall Study|Withdrawal by Subject|5|||
23710058|NCT02921919|66315293|FG001|Overall Study|Withdrawal by Subject|1|||
23710059|NCT02921919|66315292|FG000|Overall Study|Disease Progression|47|||
23710060|NCT02921919|66315293|FG001|Overall Study|Disease Progression|38|||
23710061|NCT02921919|66315292|FG000|Overall Study|Physician Decision|3|||
23710062|NCT02921919|66315293|FG001|Overall Study|Physician Decision|2|||
23710063|NCT02921919|66315292|FG000|Overall Study|Adverse Event|6|||
23511442|NCT02373202|65609351|FG002|Overall Study|Other|0|||
23511443|NCT02373202|65609352|FG003|Overall Study|Other|0|||
23710064|NCT02921919|66315293|FG001|Overall Study|Adverse Event|4|||
23710065|NCT04501679|66315294|FG000|Overall Study|Pregnancy|0|||
23710066|NCT04501679|66315295|FG001|Overall Study|Pregnancy|1|||
23710067|NCT04501679|66315294|FG000|Overall Study|Adverse Event|4|||
23710068|NCT04501679|66315295|FG001|Overall Study|Adverse Event|2|||
23410531|NCT01713582|65245849|FG016|Overall Study|Withdrawal of consent|0|||
23410532|NCT01713582|65245850|FG017|Overall Study|Withdrawal of consent|0|||
23511444|NCT01170091|65609353|FG000|Overall Study|Missing efficacy evaluation|3|||
23710069|NCT04501679|66315294|FG000|Overall Study|Withdrawal by Subject|2|||
23710070|NCT04501679|66315295|FG001|Overall Study|Withdrawal by Subject|0|||
23710071|NCT04501679|66315294|FG000|Overall Study|Physician Decision|1|||
23710072|NCT04501679|66315295|FG001|Overall Study|Physician Decision|0|||
23710073|NCT04501679|66315294|FG000|Overall Study|Lost to Follow-up|2|||
23710074|NCT04501679|66315295|FG001|Overall Study|Lost to Follow-up|0|||
23710075|NCT00125190|66315297|FG000|Overall Study|Subject/Parent Decision|7|||
23811968|NCT03301623|66691856|FG001|Overall Study|Withdrawal by Subject|13|||
23410533|NCT01713582|65245851|FG018|Overall Study|Withdrawal of consent|1|||
23410534|NCT01713582|65245852|FG019|Overall Study|Withdrawal of consent|0|||
23410535|NCT01713582|65245853|FG020|Overall Study|Withdrawal of consent|0|||
23410536|NCT01713582|65245833|FG000|Overall Study|Lack of Efficacy|0|||
23410537|NCT01713582|65245834|FG001|Overall Study|Lack of Efficacy|0|||
23410538|NCT01713582|65245835|FG002|Overall Study|Lack of Efficacy|0|||
23410539|NCT01713582|65245836|FG003|Overall Study|Lack of Efficacy|0|||
23410540|NCT01713582|65245837|FG004|Overall Study|Lack of Efficacy|0|||
23410541|NCT01713582|65245838|FG005|Overall Study|Lack of Efficacy|0|||
23410542|NCT01713582|65245839|FG006|Overall Study|Lack of Efficacy|0|||
23410543|NCT01713582|65245840|FG007|Overall Study|Lack of Efficacy|0|||
23410544|NCT01713582|65245841|FG008|Overall Study|Lack of Efficacy|0|||
23410545|NCT01713582|65245842|FG009|Overall Study|Lack of Efficacy|1|||
23410546|NCT01713582|65245843|FG010|Overall Study|Lack of Efficacy|2|||
23410547|NCT01713582|65245844|FG011|Overall Study|Lack of Efficacy|0|||
23410548|NCT01713582|65245845|FG012|Overall Study|Lack of Efficacy|0|||
23410549|NCT01713582|65245846|FG013|Overall Study|Lack of Efficacy|0|||
23410550|NCT01713582|65245847|FG014|Overall Study|Lack of Efficacy|0|||
23410551|NCT01713582|65245848|FG015|Overall Study|Lack of Efficacy|0|||
23410552|NCT01713582|65245849|FG016|Overall Study|Lack of Efficacy|0|||
23410553|NCT01713582|65245850|FG017|Overall Study|Lack of Efficacy|0|||
23410554|NCT01713582|65245851|FG018|Overall Study|Lack of Efficacy|0|||
23410555|NCT01713582|65245852|FG019|Overall Study|Lack of Efficacy|0|||
23410556|NCT01713582|65245853|FG020|Overall Study|Lack of Efficacy|0|||
23410557|NCT01713582|65245833|FG000|Overall Study|Withdrawal by Subject|0|||
23410558|NCT01713582|65245834|FG001|Overall Study|Withdrawal by Subject|0|||
23410559|NCT01713582|65245835|FG002|Overall Study|Withdrawal by Subject|0|||
23410560|NCT01713582|65245836|FG003|Overall Study|Withdrawal by Subject|0|||
23410561|NCT01713582|65245837|FG004|Overall Study|Withdrawal by Subject|0|||
23410562|NCT01713582|65245838|FG005|Overall Study|Withdrawal by Subject|0|||
23410563|NCT01713582|65245839|FG006|Overall Study|Withdrawal by Subject|0|||
23410564|NCT01713582|65245840|FG007|Overall Study|Withdrawal by Subject|0|||
23410565|NCT01713582|65245841|FG008|Overall Study|Withdrawal by Subject|0|||
23410566|NCT01713582|65245842|FG009|Overall Study|Withdrawal by Subject|0|||
23410567|NCT01713582|65245843|FG010|Overall Study|Withdrawal by Subject|0|||
23410568|NCT01713582|65245844|FG011|Overall Study|Withdrawal by Subject|0|||
23410569|NCT01713582|65245845|FG012|Overall Study|Withdrawal by Subject|0|||
23410570|NCT01713582|65245846|FG013|Overall Study|Withdrawal by Subject|0|||
23410571|NCT01713582|65245847|FG014|Overall Study|Withdrawal by Subject|0|||
23410572|NCT01713582|65245848|FG015|Overall Study|Withdrawal by Subject|0|||
23410573|NCT01713582|65245849|FG016|Overall Study|Withdrawal by Subject|0|||
23410574|NCT01713582|65245850|FG017|Overall Study|Withdrawal by Subject|1|||
23410575|NCT01713582|65245851|FG018|Overall Study|Withdrawal by Subject|0|||
23410576|NCT01713582|65245852|FG019|Overall Study|Withdrawal by Subject|0|||
23410577|NCT01713582|65245853|FG020|Overall Study|Withdrawal by Subject|0|||
23410578|NCT01713582|65245833|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
23410579|NCT01713582|65245834|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
23410580|NCT01713582|65245835|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
23410581|NCT01713582|65245836|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
23410582|NCT01713582|65245837|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
23410583|NCT01713582|65245838|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
23410584|NCT01713582|65245839|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
23610579|NCT02676778|65962811|FG002|Overall Study|Disease Progression|1|||
23610580|NCT02676778|65962809|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
23610581|NCT02676778|65962810|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
23610582|NCT02676778|65962811|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
23410585|NCT01713582|65245840|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
23410586|NCT01713582|65245841|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
23410587|NCT01713582|65245842|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
23410588|NCT01713582|65245843|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
23410589|NCT01713582|65245844|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
23410590|NCT01713582|65245845|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
23410591|NCT01713582|65245846|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
23410592|NCT01713582|65245847|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
23410593|NCT01713582|65245848|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
23410594|NCT01713582|65245849|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
23410595|NCT01713582|65245850|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
23410596|NCT01713582|65245851|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
23410597|NCT01713582|65245852|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
23410598|NCT01713582|65245853|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
23410599|NCT01713582|65245833|FG000|Overall Study|Disease progression and adverse event|0|||
23410600|NCT01713582|65245834|FG001|Overall Study|Disease progression and adverse event|0|||
23410601|NCT01713582|65245835|FG002|Overall Study|Disease progression and adverse event|0|||
23410602|NCT01713582|65245836|FG003|Overall Study|Disease progression and adverse event|0|||
23410603|NCT01713582|65245837|FG004|Overall Study|Disease progression and adverse event|0|||
23410604|NCT01713582|65245838|FG005|Overall Study|Disease progression and adverse event|0|||
23410605|NCT01713582|65245839|FG006|Overall Study|Disease progression and adverse event|0|||
23410606|NCT01713582|65245840|FG007|Overall Study|Disease progression and adverse event|0|||
23410607|NCT01713582|65245841|FG008|Overall Study|Disease progression and adverse event|0|||
23410608|NCT01713582|65245842|FG009|Overall Study|Disease progression and adverse event|0|||
23410609|NCT01713582|65245843|FG010|Overall Study|Disease progression and adverse event|0|||
23410610|NCT01713582|65245844|FG011|Overall Study|Disease progression and adverse event|0|||
23410611|NCT01713582|65245845|FG012|Overall Study|Disease progression and adverse event|0|||
23410612|NCT01713582|65245846|FG013|Overall Study|Disease progression and adverse event|0|||
23410613|NCT01713582|65245847|FG014|Overall Study|Disease progression and adverse event|0|||
23410614|NCT01713582|65245848|FG015|Overall Study|Disease progression and adverse event|0|||
23410615|NCT01713582|65245849|FG016|Overall Study|Disease progression and adverse event|1|||
23410616|NCT01713582|65245850|FG017|Overall Study|Disease progression and adverse event|0|||
23410617|NCT01713582|65245851|FG018|Overall Study|Disease progression and adverse event|0|||
23410618|NCT01713582|65245852|FG019|Overall Study|Disease progression and adverse event|0|||
23410619|NCT01713582|65245853|FG020|Overall Study|Disease progression and adverse event|0|||
23410620|NCT02147197|65245854|FG000|Overall Study|Adverse Event|1|||
23410621|NCT02147197|65245855|FG001|Overall Study|Adverse Event|0|||
23410622|NCT02147197|65245856|FG002|Overall Study|Adverse Event|0|||
23410623|NCT02147197|65245854|FG000|Overall Study|Withdrawal of Consent|4|||
23410624|NCT02147197|65245855|FG001|Overall Study|Withdrawal of Consent|3|||
23410625|NCT02147197|65245856|FG002|Overall Study|Withdrawal of Consent|2|||
23410626|NCT02147197|65245854|FG000|Overall Study|Lost to Follow-up|2|||
23410627|NCT02147197|65245855|FG001|Overall Study|Lost to Follow-up|3|||
23410628|NCT02147197|65245856|FG002|Overall Study|Lost to Follow-up|1|||
23410629|NCT02147197|65245854|FG000|Overall Study|Protocol Violation|1|||
23410630|NCT02147197|65245855|FG001|Overall Study|Protocol Violation|0|||
23410631|NCT02147197|65245856|FG002|Overall Study|Protocol Violation|3|||
23410632|NCT02147197|65245854|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23410633|NCT02147197|65245855|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23410634|NCT02147197|65245856|FG002|Overall Study|Other Miscellaneous Reasons|3|||
23410635|NCT01534351|65245857|FG000|Overall Study|Study Terminated Early|1|||
23410636|NCT01534351|65245858|FG001|Overall Study|Study Terminated Early|0|||
23410637|NCT01534351|65245859|FG002|Overall Study|Study Terminated Early|0|||
23410638|NCT02097719|65248870|FG000|Overall Study|Subject Withdrew Consent|1|||
23410639|NCT02097719|65248871|FG001|Overall Study|Subject Withdrew Consent|0|||
23410640|NCT02097719|65248870|FG000|Overall Study|Lost to Follow-up|0|||
23410641|NCT02097719|65248871|FG001|Overall Study|Lost to Follow-up|1|||
23410642|NCT02097719|65248870|FG000|Overall Study|Adverse Event|2|||
23410643|NCT02097719|65248871|FG001|Overall Study|Adverse Event|0|||
23410644|NCT02323126|65248872|FG000|Overall Study|Patient / guardian decision|0|||
23410645|NCT02323126|65248873|FG001|Overall Study|Patient / guardian decision|1|||
23410646|NCT02323126|65248874|FG002|Overall Study|Patient / guardian decision|2|||
23410647|NCT02323126|65248872|FG000|Overall Study|Progressive disease|14|||
23410648|NCT02323126|65248873|FG001|Overall Study|Progressive disease|8|||
23410649|NCT02323126|65248874|FG002|Overall Study|Progressive disease|14|||
23710076|NCT00125190|66315297|FG000|Overall Study|Non-compliance|2|||
23410650|NCT02323126|65248872|FG000|Overall Study|Physician Decision|0|||
23410651|NCT02323126|65248873|FG001|Overall Study|Physician Decision|1|||
23410652|NCT02323126|65248874|FG002|Overall Study|Physician Decision|3|||
23410653|NCT02323126|65248872|FG000|Overall Study|Death|1|||
23410654|NCT02323126|65248873|FG001|Overall Study|Death|1|||
23410655|NCT02323126|65248874|FG002|Overall Study|Death|4|||
23410656|NCT02323126|65248872|FG000|Overall Study|Adverse Event|3|||
23410657|NCT02323126|65248873|FG001|Overall Study|Adverse Event|5|||
23410658|NCT02323126|65248874|FG002|Overall Study|Adverse Event|7|||
23410659|NCT00783835|65248875|FG000|Overall Study|Adverse Event|3|||
23410660|NCT00783835|65248875|FG000|Overall Study|Medical Criteria|1|||
23410661|NCT00783835|65248875|FG000|Overall Study|Withdrawal by Subject|2|||
23410662|NCT00783835|65248875|FG000|Overall Study|Lost to Follow-up|1|||
23410663|NCT00783835|65248875|FG000|Overall Study|Participant not Adherent|3|||
23410664|NCT01463696|65248878|FG000|Overall Study|Adverse Event|0|||
23410665|NCT01463696|65248879|FG001|Overall Study|Adverse Event|1|||
23410666|NCT01463696|65248880|FG002|Overall Study|Adverse Event|0|||
23410667|NCT01463696|65248881|FG003|Overall Study|Adverse Event|2|||
23410668|NCT01463696|65248882|FG004|Overall Study|Adverse Event|0|||
23410669|NCT01463696|65248883|FG005|Overall Study|Adverse Event|1|||
23410670|NCT01463696|65248884|FG006|Overall Study|Adverse Event|3|||
23410671|NCT01463696|65248885|FG007|Overall Study|Adverse Event|2|||
23410672|NCT01463696|65248878|FG000|Overall Study|Lost to Follow-up|0|||
23410673|NCT01463696|65248879|FG001|Overall Study|Lost to Follow-up|0|||
23410674|NCT01463696|65248880|FG002|Overall Study|Lost to Follow-up|1|||
23410675|NCT01463696|65248881|FG003|Overall Study|Lost to Follow-up|0|||
23410676|NCT01463696|65248882|FG004|Overall Study|Lost to Follow-up|0|||
23410677|NCT01463696|65248883|FG005|Overall Study|Lost to Follow-up|0|||
23410678|NCT01463696|65248884|FG006|Overall Study|Lost to Follow-up|0|||
23410679|NCT01463696|65248885|FG007|Overall Study|Lost to Follow-up|0|||
23410680|NCT01463696|65248878|FG000|Overall Study|Progressive Disease|0|||
23410681|NCT01463696|65248879|FG001|Overall Study|Progressive Disease|1|||
23410682|NCT01463696|65248880|FG002|Overall Study|Progressive Disease|0|||
23410683|NCT01463696|65248881|FG003|Overall Study|Progressive Disease|1|||
23410684|NCT01463696|65248882|FG004|Overall Study|Progressive Disease|0|||
23410685|NCT01463696|65248883|FG005|Overall Study|Progressive Disease|1|||
23410686|NCT01463696|65248884|FG006|Overall Study|Progressive Disease|4|||
23410687|NCT01463696|65248885|FG007|Overall Study|Progressive Disease|2|||
23410688|NCT01463696|65248878|FG000|Overall Study|Withdrawal by Subject|0|||
23410689|NCT01463696|65248879|FG001|Overall Study|Withdrawal by Subject|0|||
23410690|NCT01463696|65248880|FG002|Overall Study|Withdrawal by Subject|0|||
23410691|NCT01463696|65248881|FG003|Overall Study|Withdrawal by Subject|1|||
23410692|NCT01463696|65248882|FG004|Overall Study|Withdrawal by Subject|1|||
23410693|NCT01463696|65248883|FG005|Overall Study|Withdrawal by Subject|1|||
23410694|NCT01463696|65248884|FG006|Overall Study|Withdrawal by Subject|2|||
23410695|NCT01463696|65248885|FG007|Overall Study|Withdrawal by Subject|0|||
23410696|NCT01463696|65248878|FG000|Overall Study|Not Treated|0|||
23410697|NCT01463696|65248879|FG001|Overall Study|Not Treated|0|||
23410698|NCT01463696|65248880|FG002|Overall Study|Not Treated|0|||
23410699|NCT01463696|65248881|FG003|Overall Study|Not Treated|0|||
23410700|NCT01463696|65248882|FG004|Overall Study|Not Treated|0|||
23410701|NCT01463696|65248883|FG005|Overall Study|Not Treated|0|||
23410702|NCT01463696|65248884|FG006|Overall Study|Not Treated|1|||
23410703|NCT01463696|65248885|FG007|Overall Study|Not Treated|0|||
23410704|NCT01169701|65248886|FG000|Overall Study|Lost to Follow-up|1|||
23410705|NCT01169701|65248887|FG001|Overall Study|Lost to Follow-up|1|||
23410706|NCT01169701|65248886|FG000|Overall Study|Withdrawal by Subject|1|||
23410707|NCT01169701|65248887|FG001|Overall Study|Withdrawal by Subject|3|||
23410708|NCT01169701|65248886|FG000|Overall Study|Adverse Event|1|||
23410709|NCT01169701|65248887|FG001|Overall Study|Adverse Event|2|||
23410710|NCT01169701|65248886|FG000|Overall Study|Exclusion criteria|2|||
23410711|NCT01169701|65248887|FG001|Overall Study|Exclusion criteria|0|||
23410712|NCT01169701|65248886|FG000|Overall Study|Death|0|||
23410713|NCT01169701|65248887|FG001|Overall Study|Death|1|||
23410714|NCT01169701|65248886|FG000|Overall Study|Administrative problems|0|||
23410715|NCT01169701|65248887|FG001|Overall Study|Administrative problems|1|||
23410716|NCT01169701|65248886|FG000|Overall Study|Serious adverse event|0|||
23410717|NCT01169701|65248887|FG001|Overall Study|Serious adverse event|1|||
23410718|NCT01169701|65248886|FG000|Overall Study|Sponsor decision|0|||
23410719|NCT01169701|65248887|FG001|Overall Study|Sponsor decision|1|||
23410720|NCT02314156|65248889|FG000|Overall Study|Adverse Event|1|||
23511445|NCT01170091|65609353|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
23511446|NCT02485574|65609354|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
23410721|NCT02314156|65248890|FG001|Overall Study|Adverse Event|0|||
23410722|NCT02314156|65248889|FG000|Overall Study|Withdrawal by Subject|1|||
23410723|NCT02314156|65248890|FG001|Overall Study|Withdrawal by Subject|0|||
23410724|NCT02644096|65248893|FG000|Overall Study|Withdrawal by Subject|28|||
23410725|NCT02644096|65248894|FG001|Overall Study|Withdrawal by Subject|25|||
23410726|NCT02342288|65248895|FG000|Overall Study|no protocol anesthesiologist available|3|||
23410727|NCT02342288|65248896|FG001|Overall Study|no protocol anesthesiologist available|2|||
23410728|NCT02342288|65248895|FG000|Overall Study|anesthesia leak in system|1|||
23410729|NCT02342288|65248896|FG001|Overall Study|anesthesia leak in system|0|||
23410730|NCT02342288|65248895|FG000|Overall Study|Withdrawal by Subject|1|||
23410731|NCT02342288|65248896|FG001|Overall Study|Withdrawal by Subject|0|||
23410732|NCT02342288|65248895|FG000|Overall Study|coordinator contaminated with blood|0|||
23410733|NCT02342288|65248896|FG001|Overall Study|coordinator contaminated with blood|1|||
23410734|NCT02342288|65248895|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
23410735|NCT02342288|65248896|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
23410736|NCT02342288|65248895|FG000|Overall Study|coordinator not available|0|||
23410737|NCT02342288|65248896|FG001|Overall Study|coordinator not available|2|||
23410738|NCT03820986|65248898|FG000|Overall Study|Death|177|||
23410739|NCT03820986|65248899|FG001|Overall Study|Death|156|||
23410740|NCT03820986|65248898|FG000|Overall Study|Lost to Follow-up|0|||
23410741|NCT03820986|65248899|FG001|Overall Study|Lost to Follow-up|1|||
23410742|NCT03820986|65248898|FG000|Overall Study|Withdrawal by Subject|8|||
23410743|NCT03820986|65248899|FG001|Overall Study|Withdrawal by Subject|3|||
23410744|NCT03820986|65248898|FG000|Overall Study|Ongoing|149|||
23410745|NCT03820986|65248899|FG001|Overall Study|Ongoing|180|||
23410746|NCT00182078|65248900|FG000|Overall Study|Withdrawal by Subject|1|||
23410747|NCT00182078|65248901|FG001|Overall Study|Withdrawal by Subject|0|||
23410748|NCT02297815|65248906|FG000|Overall Study|Lost to Follow-up|236|||
23410749|NCT02297815|65248907|FG001|Overall Study|Lost to Follow-up|140|||
23410750|NCT02817594|65248910|FG000|Overall Study|Withdrawal by Subject|1|||
23410751|NCT02817594|65248910|FG000|Overall Study|Other|1|||
23410752|NCT02817594|65248910|FG000|Overall Study|Did Not Receive Treatment|1|||
23410753|NCT00293813|65248911|FG000|Overall Study|Physician Decision|0|||
23410754|NCT00293813|65248912|FG001|Overall Study|Physician Decision|1|||
23410755|NCT00293813|65248913|FG002|Overall Study|Physician Decision|0|||
23410756|NCT00293813|65248911|FG000|Overall Study|Adverse Event|3|||
23410757|NCT00293813|65248912|FG001|Overall Study|Adverse Event|1|||
23410758|NCT00293813|65248913|FG002|Overall Study|Adverse Event|1|||
23410759|NCT00293813|65248911|FG000|Overall Study|Withdrawal by Subject|7|||
23410760|NCT00293813|65248912|FG001|Overall Study|Withdrawal by Subject|4|||
23410761|NCT00293813|65248913|FG002|Overall Study|Withdrawal by Subject|4|||
23410762|NCT00293813|65248911|FG000|Overall Study|Lost to Follow-up|3|||
23410763|NCT00293813|65248912|FG001|Overall Study|Lost to Follow-up|2|||
23410764|NCT00293813|65248913|FG002|Overall Study|Lost to Follow-up|3|||
23410765|NCT00293813|65248911|FG000|Overall Study|Noncompliance|0|||
23410766|NCT00293813|65248912|FG001|Overall Study|Noncompliance|1|||
23410767|NCT00293813|65248913|FG002|Overall Study|Noncompliance|0|||
23410768|NCT01061723|65248914|FG000|Overall Study|Adverse Event|0|||
23410769|NCT01061723|65248915|FG001|Overall Study|Adverse Event|2|||
23410770|NCT01061723|65248916|FG002|Overall Study|Adverse Event|5|||
23410771|NCT01061723|65248917|FG003|Overall Study|Adverse Event|5|||
23410772|NCT01061723|65248918|FG004|Overall Study|Adverse Event|2|||
23410773|NCT01061723|65248919|FG005|Overall Study|Adverse Event|6|||
23410774|NCT01061723|65248914|FG000|Overall Study|Lack of Efficacy|2|||
23410775|NCT01061723|65248915|FG001|Overall Study|Lack of Efficacy|3|||
23410776|NCT01061723|65248916|FG002|Overall Study|Lack of Efficacy|4|||
23410777|NCT01061723|65248917|FG003|Overall Study|Lack of Efficacy|2|||
23410778|NCT01061723|65248918|FG004|Overall Study|Lack of Efficacy|1|||
23410779|NCT01061723|65248919|FG005|Overall Study|Lack of Efficacy|1|||
23410780|NCT01061723|65248914|FG000|Overall Study|Randomized but not treated|0|||
23410781|NCT01061723|65248915|FG001|Overall Study|Randomized but not treated|0|||
23410782|NCT01061723|65248916|FG002|Overall Study|Randomized but not treated|0|||
23410783|NCT01061723|65248917|FG003|Overall Study|Randomized but not treated|0|||
23410784|NCT01061723|65248918|FG004|Overall Study|Randomized but not treated|0|||
23410785|NCT01061723|65248919|FG005|Overall Study|Randomized but not treated|1|||
23410786|NCT01061723|65248914|FG000|Overall Study|Other than specified above|2|||
23410787|NCT01061723|65248915|FG001|Overall Study|Other than specified above|1|||
23410788|NCT01061723|65248916|FG002|Overall Study|Other than specified above|1|||
23410789|NCT01061723|65248917|FG003|Overall Study|Other than specified above|1|||
23410790|NCT01061723|65248918|FG004|Overall Study|Other than specified above|0|||
23410791|NCT01061723|65248919|FG005|Overall Study|Other than specified above|1|||
23410792|NCT03726658|65248920|FG000|Overall Study|Lost to Follow-up|0|||
23410793|NCT03726658|65248921|FG001|Overall Study|Lost to Follow-up|0|||
23410794|NCT03726658|65248922|FG002|Overall Study|Lost to Follow-up|2|||
23410795|NCT03726658|65248923|FG003|Overall Study|Lost to Follow-up|0|||
23410796|NCT03726658|65248924|FG004|Overall Study|Lost to Follow-up|0|||
23410797|NCT03726658|65248925|FG005|Overall Study|Lost to Follow-up|1|||
23410798|NCT03726658|65248926|FG006|Overall Study|Lost to Follow-up|1|||
23410799|NCT03726658|65248920|FG000|Overall Study|Withdrawal by Subject|1|||
23410800|NCT03726658|65248921|FG001|Overall Study|Withdrawal by Subject|0|||
23410801|NCT03726658|65248922|FG002|Overall Study|Withdrawal by Subject|0|||
23410802|NCT03726658|65248923|FG003|Overall Study|Withdrawal by Subject|0|||
23410803|NCT03726658|65248924|FG004|Overall Study|Withdrawal by Subject|6|||
23410804|NCT03726658|65248925|FG005|Overall Study|Withdrawal by Subject|4|||
23410805|NCT03726658|65248926|FG006|Overall Study|Withdrawal by Subject|2|||
23410806|NCT03726658|65248920|FG000|Overall Study|Pregnancy|0|||
23410807|NCT03726658|65248921|FG001|Overall Study|Pregnancy|0|||
23410808|NCT03726658|65248922|FG002|Overall Study|Pregnancy|0|||
23410809|NCT03726658|65248923|FG003|Overall Study|Pregnancy|0|||
23410810|NCT03726658|65248924|FG004|Overall Study|Pregnancy|0|||
23410811|NCT03726658|65248925|FG005|Overall Study|Pregnancy|0|||
23410812|NCT03726658|65248926|FG006|Overall Study|Pregnancy|1|||
23410813|NCT03726658|65248920|FG000|Overall Study|Not Reported|0|||
23410814|NCT03726658|65248921|FG001|Overall Study|Not Reported|0|||
23410815|NCT03726658|65248922|FG002|Overall Study|Not Reported|0|||
23410816|NCT03726658|65248923|FG003|Overall Study|Not Reported|0|||
23410817|NCT03726658|65248924|FG004|Overall Study|Not Reported|0|||
23410818|NCT03726658|65248925|FG005|Overall Study|Not Reported|0|||
23410819|NCT03726658|65248926|FG006|Overall Study|Not Reported|1|||
23410820|NCT00260832|65248927|FG000|Overall Study|Adverse Event|26|||
23410821|NCT00260832|65248928|FG001|Overall Study|Adverse Event|19|||
23410822|NCT00260832|65248927|FG000|Overall Study|Progression|116|||
23410823|NCT00260832|65248928|FG001|Overall Study|Progression|96|||
23410824|NCT00260832|65248927|FG000|Overall Study|Withdrawal by Subject|15|||
23410825|NCT00260832|65248928|FG001|Overall Study|Withdrawal by Subject|17|||
23410826|NCT00260832|65248927|FG000|Overall Study|Physician Decision|15|||
23410827|NCT00260832|65248928|FG001|Overall Study|Physician Decision|9|||
23410828|NCT00260832|65248927|FG000|Overall Study|Death|43|||
23410829|NCT00260832|65248928|FG001|Overall Study|Death|62|||
23410830|NCT00260832|65248927|FG000|Overall Study|Other|10|||
23410831|NCT00260832|65248928|FG001|Overall Study|Other|7|||
23410832|NCT00260832|65248927|FG000|Overall Study|Protocol Violation|3|||
23410833|NCT00260832|65248928|FG001|Overall Study|Protocol Violation|1|||
23410834|NCT00851552|65248929|FG000|Overall Study|Death|2|||
23410835|NCT00851552|65248929|FG000|Overall Study|Adverse Event|1|||
23410836|NCT00851552|65248929|FG000|Overall Study|Disease Progression|4|||
23410837|NCT02982772|65248930|FG000|Intervention|Lost to Follow-up|19|||
23410838|NCT02982772|65248931|FG001|Intervention|Lost to Follow-up|13|||
23410839|NCT02982772|65248930|FG000|1M Follow-Up|Lost to Follow-up|21|||
23410840|NCT02982772|65248931|FG001|1M Follow-Up|Lost to Follow-up|18|||
23410841|NCT02982772|65248930|FG000|3M Follow-Up|Lost to Follow-up|17|||
23410842|NCT02982772|65248931|FG001|3M Follow-Up|Lost to Follow-up|11|||
23410843|NCT02982772|65248930|FG000|6M Follow-Up|Lost to Follow-up|11|||
23410844|NCT02982772|65248931|FG001|6M Follow-Up|Lost to Follow-up|9|||
23410845|NCT02982772|65248930|FG000|12M Follow-Up|Lost to Follow-up|11|||
23410846|NCT02982772|65248931|FG001|12M Follow-Up|Lost to Follow-up|5|||
23410847|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
23410848|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
23410849|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
23410850|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
23410851|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
23410852|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
23410853|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
23410854|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
23410855|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
23410856|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
23410857|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
23410858|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
23410859|NCT01681186|65248933|FG000|Washout Period From Second Intervention|Adverse Event|0|||
23410860|NCT01681186|65248934|FG001|Washout Period From Second Intervention|Adverse Event|0|||
23410861|NCT01681186|65248935|FG002|Washout Period From Second Intervention|Adverse Event|0|||
23410862|NCT01681186|65248936|FG003|Washout Period From Second Intervention|Adverse Event|0|||
23410863|NCT01681186|65248937|FG004|Washout Period From Second Intervention|Adverse Event|0|||
23410864|NCT01681186|65248938|FG005|Washout Period From Second Intervention|Adverse Event|0|||
23410865|NCT01681186|65248939|FG006|Washout Period From Second Intervention|Adverse Event|1|||
23410866|NCT01681186|65248940|FG007|Washout Period From Second Intervention|Adverse Event|0|||
23410867|NCT01681186|65248933|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
23410868|NCT01681186|65248934|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
23410869|NCT01681186|65248935|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
23410870|NCT01681186|65248936|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
23410871|NCT01681186|65248937|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
23410872|NCT01681186|65248938|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
23410873|NCT01681186|65248939|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
23410874|NCT01681186|65248940|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
23410875|NCT01681186|65248933|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410876|NCT01681186|65248934|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410877|NCT01681186|65248935|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410878|NCT01681186|65248936|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410879|NCT01681186|65248937|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410880|NCT01681186|65248938|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410881|NCT01681186|65248939|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
23410882|NCT01681186|65248940|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410883|NCT01681186|65248933|FG000|Fourth Intervention|Protocol Violation|0|||
23410884|NCT01681186|65248934|FG001|Fourth Intervention|Protocol Violation|0|||
23410885|NCT01681186|65248935|FG002|Fourth Intervention|Protocol Violation|0|||
23410886|NCT01681186|65248936|FG003|Fourth Intervention|Protocol Violation|0|||
23410887|NCT01681186|65248937|FG004|Fourth Intervention|Protocol Violation|0|||
23410888|NCT01681186|65248938|FG005|Fourth Intervention|Protocol Violation|0|||
23410889|NCT01681186|65248939|FG006|Fourth Intervention|Protocol Violation|0|||
23410890|NCT01681186|65248940|FG007|Fourth Intervention|Protocol Violation|1|||
23410891|NCT02836717|65248941|FG000|Test Phase|Lack of Efficacy|14|||
23410892|NCT02836717|65248942|FG001|Test Phase|Lack of Efficacy|8|||
23410893|NCT02836717|65248943|FG002|Test Phase|Lack of Efficacy|0|||
23410894|NCT02836717|65248941|FG000|Study Phase|Adverse Event|2|||
23410895|NCT02836717|65248942|FG001|Study Phase|Adverse Event|0|||
23410896|NCT02836717|65248943|FG002|Study Phase|Adverse Event|0|||
23410897|NCT02836717|65248941|FG000|Study Phase|Lack of Efficacy|8|||
23410898|NCT02836717|65248942|FG001|Study Phase|Lack of Efficacy|6|||
23410899|NCT02836717|65248943|FG002|Study Phase|Lack of Efficacy|1|||
23410900|NCT02836717|65248941|FG000|Study Phase|Withdrawal by Subject|1|||
23410901|NCT02836717|65248942|FG001|Study Phase|Withdrawal by Subject|0|||
23410902|NCT02836717|65248943|FG002|Study Phase|Withdrawal by Subject|0|||
23410903|NCT02836717|65248941|FG000|Study Phase|Death|1|||
23410904|NCT02836717|65248942|FG001|Study Phase|Death|0|||
23410905|NCT02836717|65248943|FG002|Study Phase|Death|0|||
23410906|NCT02836717|65248941|FG000|Study Phase|abdominal surgeries|2|||
23410907|NCT02836717|65248942|FG001|Study Phase|abdominal surgeries|1|||
23410908|NCT02836717|65248943|FG002|Study Phase|abdominal surgeries|0|||
23410909|NCT01014767|65248944|FG000|Overall Study|PI left institution, data unavailable|12|||
23410910|NCT01014767|65248945|FG001|Overall Study|PI left institution, data unavailable|1|||
23410911|NCT01014767|65248946|FG002|Overall Study|PI left institution, data unavailable|4|||
23410912|NCT01014767|65248947|FG003|Overall Study|PI left institution, data unavailable|1|||
23410913|NCT03423238|65248958|FG000|Overall Study|Lost to Follow-up|1|||
23410914|NCT03423238|65248959|FG001|Overall Study|Lost to Follow-up|0|||
23410915|NCT03423238|65248958|FG000|Overall Study|Withdrawal by Subject|1|||
23410916|NCT03423238|65248959|FG001|Overall Study|Withdrawal by Subject|0|||
23410917|NCT00615719|65248960|FG000|Overall Study|Physician Decision|5|||
23511447|NCT01396148|65609355|FG000|Overall Study|Patient Decision|1|||
23511448|NCT04128267|65609358|FG000|Overall Study|Withdrawal by Subject|6|||
23511449|NCT04128267|65609358|FG000|Overall Study|Death|2|||
23511450|NCT04128267|65609358|FG000|Overall Study|Disease progression|1|||
23511451|NCT04128267|65609358|FG000|Overall Study|Participant had other medical issues|4|||
23511452|NCT04128267|65609358|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
23410918|NCT01268046|65248961|FG000|Overall Study|Withdrawal by Subject|1|||
23410919|NCT01268046|65248962|FG001|Overall Study|Withdrawal by Subject|0|||
23511453|NCT02013791|65609359|FG000|Period 1|Lost to Follow-up|0|||
23511454|NCT02013791|65609360|FG001|Period 1|Lost to Follow-up|0|||
23410920|NCT01268046|65248963|FG002|Overall Study|Withdrawal by Subject|0|||
23410921|NCT01268046|65248964|FG003|Overall Study|Withdrawal by Subject|1|||
23410922|NCT01268046|65248961|FG000|Overall Study|Lost to Follow-up|0|||
23410923|NCT01268046|65248962|FG001|Overall Study|Lost to Follow-up|0|||
23410924|NCT01268046|65248963|FG002|Overall Study|Lost to Follow-up|1|||
23410925|NCT01268046|65248964|FG003|Overall Study|Lost to Follow-up|0|||
23410926|NCT02597452|65248965|FG000|Overall Study|testing incomplete|30|||
23410927|NCT00861757|65248966|FG000|Overall Study|Adverse Event|1|||
23410928|NCT00861757|65248967|FG001|Overall Study|Adverse Event|5|||
23410929|NCT00861757|65248968|FG002|Overall Study|Adverse Event|7|||
23410930|NCT00861757|65248969|FG003|Overall Study|Adverse Event|2|||
23410931|NCT00861757|65248966|FG000|Overall Study|Entry Criteria Not Met|1|||
23410932|NCT00861757|65248967|FG001|Overall Study|Entry Criteria Not Met|2|||
23410933|NCT00861757|65248968|FG002|Overall Study|Entry Criteria Not Met|1|||
23410934|NCT00861757|65248969|FG003|Overall Study|Entry Criteria Not Met|1|||
23410935|NCT00861757|65248966|FG000|Overall Study|Lack of Efficacy|3|||
23410936|NCT00861757|65248967|FG001|Overall Study|Lack of Efficacy|1|||
23410937|NCT00861757|65248968|FG002|Overall Study|Lack of Efficacy|0|||
23410938|NCT00861757|65248969|FG003|Overall Study|Lack of Efficacy|1|||
23410939|NCT00861757|65248966|FG000|Overall Study|Lost to Follow-up|1|||
23410940|NCT00861757|65248967|FG001|Overall Study|Lost to Follow-up|0|||
23410941|NCT00861757|65248968|FG002|Overall Study|Lost to Follow-up|1|||
23410942|NCT00861757|65248969|FG003|Overall Study|Lost to Follow-up|1|||
23410943|NCT00861757|65248966|FG000|Overall Study|Physician Decision|0|||
23410944|NCT00861757|65248967|FG001|Overall Study|Physician Decision|0|||
23410945|NCT00861757|65248968|FG002|Overall Study|Physician Decision|0|||
23410946|NCT00861757|65248969|FG003|Overall Study|Physician Decision|1|||
23410947|NCT00861757|65248966|FG000|Overall Study|Protocol Violation|2|||
23410948|NCT00861757|65248967|FG001|Overall Study|Protocol Violation|2|||
23410949|NCT00861757|65248968|FG002|Overall Study|Protocol Violation|4|||
23410950|NCT00861757|65248969|FG003|Overall Study|Protocol Violation|1|||
23410951|NCT00861757|65248966|FG000|Overall Study|Withdrawal by Subject|1|||
23410952|NCT00861757|65248967|FG001|Overall Study|Withdrawal by Subject|5|||
23410953|NCT00861757|65248968|FG002|Overall Study|Withdrawal by Subject|5|||
23410954|NCT00861757|65248969|FG003|Overall Study|Withdrawal by Subject|2|||
23410955|NCT03458325|65248971|FG000|Overall Study|Withdrawal by Subject|1|||
23410956|NCT02243371|65248982|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
23410957|NCT02243371|65248983|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
23410958|NCT02243371|65248982|FG000|Overall Study|Death (unrelated)|2|||
23410959|NCT02243371|65248983|FG001|Overall Study|Death (unrelated)|4|||
23410960|NCT02243371|65248982|FG000|Overall Study|Adverse Event (unrelated)|0|||
23410961|NCT02243371|65248983|FG001|Overall Study|Adverse Event (unrelated)|1|||
23410962|NCT02243371|65248982|FG000|Overall Study|Lack of Clinical Benefit|0|||
23410963|NCT02243371|65248983|FG001|Overall Study|Lack of Clinical Benefit|1|||
23410964|NCT02243371|65248982|FG000|Overall Study|Withdrawal by Subject|0|||
23410965|NCT02243371|65248983|FG001|Overall Study|Withdrawal by Subject|2|||
23453467|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453468|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453469|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453470|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453471|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453472|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453473|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453474|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453475|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453476|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453477|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453478|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453479|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453480|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453481|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
23453482|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453483|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453484|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453485|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453486|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453487|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453488|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
23453489|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453490|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453491|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23511455|NCT02013791|65609361|FG002|Period 1|Lost to Follow-up|0|||
23511456|NCT02013791|65609362|FG003|Period 1|Lost to Follow-up|1|||
23511457|NCT02013791|65609363|FG004|Period 1|Lost to Follow-up|0|||
23511458|NCT02013791|65609364|FG005|Period 1|Lost to Follow-up|0|||
23511459|NCT02013791|65609365|FG006|Period 1|Lost to Follow-up|1|||
23511460|NCT02013791|65609366|FG007|Period 1|Lost to Follow-up|1|||
23511461|NCT02013791|65609367|FG008|Period 1|Lost to Follow-up|0|||
23511462|NCT02013791|65609359|FG000|Period 1|Other Miscellaneous Reasons|0|||
23511463|NCT02013791|65609360|FG001|Period 1|Other Miscellaneous Reasons|2|||
23511464|NCT02013791|65609361|FG002|Period 1|Other Miscellaneous Reasons|0|||
23511465|NCT02013791|65609362|FG003|Period 1|Other Miscellaneous Reasons|0|||
23511466|NCT02013791|65609363|FG004|Period 1|Other Miscellaneous Reasons|0|||
23511467|NCT02013791|65609364|FG005|Period 1|Other Miscellaneous Reasons|0|||
23511468|NCT02013791|65609365|FG006|Period 1|Other Miscellaneous Reasons|0|||
23511469|NCT02013791|65609366|FG007|Period 1|Other Miscellaneous Reasons|0|||
23511470|NCT02013791|65609367|FG008|Period 1|Other Miscellaneous Reasons|0|||
23511471|NCT02279173|65609371|FG000|Overall Study|Protocol-specified Criteria|67|||
23511472|NCT02279173|65609371|FG000|Overall Study|Withdrawal by Subject|20|||
23511473|NCT02279173|65609371|FG000|Overall Study|Decision by Sponsor|4|||
23511474|NCT02279173|65609371|FG000|Overall Study|Lost to Follow-up|3|||
23511475|NCT01896531|65609372|FG000|Overall Study|Death|57|||
23511476|NCT01896531|65609373|FG001|Overall Study|Death|59|||
23511477|NCT01896531|65609372|FG000|Overall Study|Lost to Follow-up|3|||
23511478|NCT01896531|65609373|FG001|Overall Study|Lost to Follow-up|0|||
23511479|NCT01896531|65609372|FG000|Overall Study|Non-compliance|0|||
23511480|NCT01896531|65609373|FG001|Overall Study|Non-compliance|1|||
23511481|NCT01896531|65609372|FG000|Overall Study|Study Ended by Sponsor|7|||
23511482|NCT01896531|65609373|FG001|Overall Study|Study Ended by Sponsor|20|||
23511483|NCT01896531|65609372|FG000|Overall Study|Withdrawal by Subject|3|||
23511484|NCT01896531|65609373|FG001|Overall Study|Withdrawal by Subject|2|||
23511485|NCT01896531|65609372|FG000|Overall Study|Death Prior to Treatment|1|||
23511486|NCT01896531|65609373|FG001|Overall Study|Death Prior to Treatment|0|||
23511487|NCT02157298|65609376|FG000|Overall Study|Adverse Event|1|||
23511488|NCT02157298|65609377|FG001|Overall Study|Adverse Event|0|||
23511489|NCT02157298|65609376|FG000|Overall Study|Subject no longer meets study criteria|1|||
23511490|NCT02157298|65609377|FG001|Overall Study|Subject no longer meets study criteria|2|||
23511491|NCT02157298|65609376|FG000|Overall Study|Poor/Non-compliance|1|||
23511492|NCT02157298|65609377|FG001|Overall Study|Poor/Non-compliance|0|||
23511493|NCT02157298|65609376|FG000|Overall Study|Withdrawal by Subject|1|||
23511494|NCT02157298|65609377|FG001|Overall Study|Withdrawal by Subject|0|||
23511495|NCT01721330|65609378|FG000|Overall Study|Withdrawal by Subject|0|||
23511496|NCT01721330|65609379|FG001|Overall Study|Withdrawal by Subject|1|||
23511497|NCT01698801|65609384|FG000|Treatment Phase|Adverse Event|4|||
23511498|NCT01698801|65609384|FG000|Treatment Phase|Protocol Violation|1|||
23511499|NCT01698801|65609384|FG000|Treatment Phase|Other|4|||
23511500|NCT01698801|65609384|FG000|Treatment Phase|Withdrawal by Subject|1|||
23511501|NCT01698801|65609384|FG000|Treatment Phase|Disease progression|1|||
23511502|NCT01698801|65609384|FG000|Follow Up Phase|Withdrawal by Subject|1|||
23511503|NCT01698801|65609384|FG000|Follow Up Phase|Death|4|||
23511504|NCT01986985|65609385|FG000|Overall Study|Withdrawal by Subject|4|||
23511505|NCT01986985|65609385|FG000|Overall Study|Scan not completed due to malfunction|3|||
23511506|NCT00856284|65609389|FG000|Overall Study|Hyperglycemic rescue|231|||
23511507|NCT00856284|65609390|FG001|Overall Study|Hyperglycemic rescue|201|||
23511508|NCT00856284|65609391|FG002|Overall Study|Hyperglycemic rescue|235|||
23511509|NCT00856284|65609389|FG000|Overall Study|Adverse Event|60|||
23511510|NCT00856284|65609390|FG001|Overall Study|Adverse Event|74|||
23511511|NCT00856284|65609391|FG002|Overall Study|Adverse Event|82|||
23511512|NCT00856284|65609389|FG000|Overall Study|Major protocol deviation|24|||
23511513|NCT00856284|65609390|FG001|Overall Study|Major protocol deviation|16|||
23511514|NCT00856284|65609391|FG002|Overall Study|Major protocol deviation|15|||
23511515|NCT00856284|65609389|FG000|Overall Study|Lost to Follow-up|20|||
23511516|NCT00856284|65609390|FG001|Overall Study|Lost to Follow-up|22|||
23511517|NCT00856284|65609391|FG002|Overall Study|Lost to Follow-up|28|||
23511518|NCT00856284|65609389|FG000|Overall Study|Voluntary withdrawal|48|||
23511519|NCT00856284|65609390|FG001|Overall Study|Voluntary withdrawal|52|||
23511520|NCT00856284|65609391|FG002|Overall Study|Voluntary withdrawal|62|||
23511521|NCT00856284|65609389|FG000|Overall Study|Pregnancy|1|||
23511522|NCT00856284|65609390|FG001|Overall Study|Pregnancy|2|||
23511523|NCT00856284|65609391|FG002|Overall Study|Pregnancy|0|||
23511524|NCT00856284|65609389|FG000|Overall Study|Investigator discretion|9|||
23511525|NCT00856284|65609390|FG001|Overall Study|Investigator discretion|8|||
23511526|NCT00856284|65609391|FG002|Overall Study|Investigator discretion|10|||
23511527|NCT00856284|65609389|FG000|Overall Study|Other|15|||
23511528|NCT00856284|65609390|FG001|Overall Study|Other|17|||
23511529|NCT00856284|65609391|FG002|Overall Study|Other|14|||
23511530|NCT00856284|65609389|FG000|Overall Study|Randomized in error|0|||
23511531|NCT00856284|65609390|FG001|Overall Study|Randomized in error|0|||
23511532|NCT00856284|65609391|FG002|Overall Study|Randomized in error|1|||
23511533|NCT02891850|65609392|FG000|Overall Study|Adverse Event|3|||
23511534|NCT02891850|65609393|FG001|Overall Study|Adverse Event|0|||
23511535|NCT02891850|65609392|FG000|Overall Study|Death|0|||
23511536|NCT02891850|65609393|FG001|Overall Study|Death|4|||
23511537|NCT02891850|65609392|FG000|Overall Study|Physician Decision|1|||
23511538|NCT02891850|65609393|FG001|Overall Study|Physician Decision|0|||
23511539|NCT02891850|65609392|FG000|Overall Study|Pregnancy|1|||
23511540|NCT02891850|65609393|FG001|Overall Study|Pregnancy|0|||
23511541|NCT02891850|65609392|FG000|Overall Study|Withdrawal by Subject|2|||
23511542|NCT02891850|65609393|FG001|Overall Study|Withdrawal by Subject|3|||
23511543|NCT00556712|65609394|FG000|Overall Study|Adverse Event|7|||
23511544|NCT00556712|65609395|FG001|Overall Study|Adverse Event|19|||
23410966|NCT02485639|65248987|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
23410967|NCT02485639|65248987|FG000|Overall Study|Early termination|4|||
23410968|NCT02485639|65248987|FG000|Overall Study|Withdrawal by Subject|4|||
23410969|NCT02684617|65248988|FG000|Overall Study|Adverse Event|1|||
23410970|NCT02684617|65248989|FG001|Overall Study|Adverse Event|0|||
23410971|NCT02684617|65248990|FG002|Overall Study|Adverse Event|1|||
23410972|NCT02684617|65248988|FG000|Overall Study|Death|8|||
23410973|NCT02684617|65248989|FG001|Overall Study|Death|16|||
23410974|NCT02684617|65248990|FG002|Overall Study|Death|28|||
23410975|NCT02684617|65248988|FG000|Overall Study|Withdrawal by Subject|2|||
23410976|NCT02684617|65248989|FG001|Overall Study|Withdrawal by Subject|0|||
23410977|NCT02684617|65248990|FG002|Overall Study|Withdrawal by Subject|4|||
23410978|NCT02684617|65248988|FG000|Overall Study|Screen Failure|1|||
23410979|NCT02684617|65248989|FG001|Overall Study|Screen Failure|0|||
23410980|NCT02684617|65248990|FG002|Overall Study|Screen Failure|2|||
23410981|NCT02684617|65248988|FG000|Overall Study|Study Terminated by Sponsor|6|||
23410982|NCT02684617|65248989|FG001|Overall Study|Study Terminated by Sponsor|1|||
23410983|NCT02684617|65248990|FG002|Overall Study|Study Terminated by Sponsor|5|||
23410984|NCT00656058|65248991|FG000|Overall Study|Withdrawal by Subject|2|||
23410985|NCT00656058|65248991|FG000|Overall Study|Withdrawal by Subject|4|||
23410986|NCT00005947|65248992|FG000|Overall Study|Death|54|||
23410987|NCT00005947|65248993|FG001|Overall Study|Death|40|||
23410988|NCT00005947|65248992|FG000|Overall Study|Patient Refused to Continue|2|||
23410989|NCT00005947|65248993|FG001|Overall Study|Patient Refused to Continue|1|||
23410990|NCT00005947|65248992|FG000|Overall Study|Site Closure|1|||
23410991|NCT00005947|65248993|FG001|Overall Study|Site Closure|0|||
23410992|NCT02103062|65248999|FG000|Overall Study|Adverse Event|1|||
23410993|NCT02103062|65249000|FG001|Overall Study|Adverse Event|2|||
23410994|NCT02103062|65248999|FG000|Overall Study|Progressive Disease|17|||
23410995|NCT02103062|65249000|FG001|Overall Study|Progressive Disease|20|||
23410996|NCT02103062|65248999|FG000|Overall Study|Death|0|||
23410997|NCT02103062|65249000|FG001|Overall Study|Death|1|||
23410998|NCT01843673|65249001|FG000|Overall Study|Lack of Efficacy|2|||
23410999|NCT01843673|65249001|FG000|Overall Study|Withdrawal by Subject|4|||
23411000|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Adverse Event|21|||
23411001|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Adverse Event|34|||
23411002|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Adverse Event|14|||
23411003|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Adverse Event|17|||
23411004|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Adverse Event|0|||
23411005|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
23411006|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
23411007|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
23411008|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
23411009|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
23411010|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
23411011|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
23411012|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
23411013|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
23411014|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
23411015|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Physician Decision|2|||
23411016|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Physician Decision|4|||
23411017|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Physician Decision|4|||
23411018|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Physician Decision|4|||
23411019|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Physician Decision|0|||
23411020|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
23411021|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
23411022|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
23411023|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
23411024|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
23411025|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
23411026|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
23411027|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
23411028|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
23411029|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
23511545|NCT00556712|65609394|FG000|Overall Study|Death|5|||
23511546|NCT00556712|65609395|FG001|Overall Study|Death|10|||
23411030|NCT00564733|65249010|FG000|Overall Study|Withdrawal by Subject|4|||
23411031|NCT00564733|65249010|FG000|Overall Study|Ineligible|5|||
23411032|NCT00652743|65249011|FG000|Months 12-18|Lost to Follow-up|1|||
23411033|NCT00652743|65249012|FG001|Months 12-18|Lost to Follow-up|2|||
23411034|NCT00652743|65249013|FG002|Months 12-18|Lost to Follow-up|7|||
23411035|NCT00652743|65249011|FG000|Months 24-30|Other|5|||
23411036|NCT00652743|65249012|FG001|Months 24-30|Other|1|||
23411037|NCT00652743|65249013|FG002|Months 24-30|Other|11|||
23411038|NCT00652743|65249011|FG000|Months 36-42|Serious Adverse Events|0|||
23411039|NCT00652743|65249012|FG001|Months 36-42|Serious Adverse Events|1|||
23411040|NCT00652743|65249013|FG002|Months 36-42|Serious Adverse Events|1|||
23411041|NCT00652743|65249011|FG000|Months 36-42|Withdrawal by Subject|1|||
23411042|NCT00652743|65249012|FG001|Months 36-42|Withdrawal by Subject|1|||
23411043|NCT00652743|65249013|FG002|Months 36-42|Withdrawal by Subject|0|||
23411044|NCT00652743|65249011|FG000|Months 36-42|Lost to Follow-up|0|||
23411045|NCT00652743|65249012|FG001|Months 36-42|Lost to Follow-up|1|||
23411046|NCT00652743|65249013|FG002|Months 36-42|Lost to Follow-up|0|||
23411047|NCT00652743|65249011|FG000|Months 36-42|Migrated/moved from study area|1|||
23411048|NCT00652743|65249012|FG001|Months 36-42|Migrated/moved from study area|0|||
23411049|NCT00652743|65249013|FG002|Months 36-42|Migrated/moved from study area|0|||
23411050|NCT00652743|65249011|FG000|Months 36-42|Other|4|||
23411051|NCT00652743|65249012|FG001|Months 36-42|Other|2|||
23411052|NCT00652743|65249013|FG002|Months 36-42|Other|8|||
23411053|NCT00368745|65249016|FG000|Double-blind Treatment Period|Adverse Event|6|||
23411054|NCT00368745|65249017|FG001|Double-blind Treatment Period|Adverse Event|6|||
23411055|NCT00368745|65249016|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
23411056|NCT00368745|65249017|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
23411057|NCT00368745|65249016|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23411058|NCT00368745|65249017|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23411059|NCT00368745|65249016|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
23411060|NCT00368745|65249017|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
23411061|NCT00368745|65249016|FG000|Double-blind Treatment Period|Other|7|||
23411062|NCT00368745|65249017|FG001|Double-blind Treatment Period|Other|6|||
23411063|NCT04601532|65249018|FG000|Overall Study|Lost to Follow-up|1|||
23411064|NCT04601532|65249019|FG001|Overall Study|Lost to Follow-up|2|||
23411065|NCT04601532|65249018|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
23411066|NCT04601532|65249019|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
23411067|NCT03275246|65249020|FG000|Overall Study|Protocol Violation|5|||
23411068|NCT03275246|65249020|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
23411069|NCT02943070|65249021|FG000|Overall Study|Physician Decision|1|||
23411070|NCT02943070|65249021|FG000|Overall Study|Adverse Event|2|||
23411071|NCT02943070|65249021|FG000|Overall Study|Death|2|||
23411072|NCT02943070|65249021|FG000|Overall Study|Withdrawal by Subject|3|||
23411073|NCT02943070|65249021|FG000|Overall Study|Lost to Follow-up|4|||
23411074|NCT02943070|65249021|FG000|Overall Study|Retreatment or TURP|13|||
23411075|NCT02943070|65249021|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
23411076|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
23411077|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411078|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411079|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411080|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411081|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411082|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
23411083|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
23411084|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411085|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411086|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411087|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411088|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
23411089|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
23411090|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23710077|NCT00125190|66315297|FG000|Overall Study|Adverse Event|1|||
23710078|NCT00125190|66315297|FG000|Overall Study|Other|1|||
23411091|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411092|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411093|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411094|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
23411095|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
23411096|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411097|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23710079|NCT00125190|66315297|FG000|Overall Study|Lost to Follow-up|4|||
23411098|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411099|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411100|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
23411101|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
23411102|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411103|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411104|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411105|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411106|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
23411107|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411108|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411109|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411110|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411111|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411112|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
23411113|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
23411114|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411115|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411116|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411117|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411118|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23411119|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23411120|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
23411121|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
23411122|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23411123|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23411124|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23411125|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23411126|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23411127|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
23411128|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23411129|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
23411130|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23411131|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23411132|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
23411133|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
23411134|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
23411135|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
23411136|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411137|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411138|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23411139|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411140|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
23411141|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411142|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411143|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411144|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411145|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411146|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411147|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411148|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
23411149|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
23411150|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
23710080|NCT03544268|66315298|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
23710081|NCT03544268|66315299|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
23411151|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
23411152|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
23411153|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
23710082|NCT04504032|66315301|FG000|Overall Study|Adverse Event|1|||
23710083|NCT04504032|66315302|FG001|Overall Study|Adverse Event|2|||
23710084|NCT04504032|66315301|FG000|Overall Study|Lost to Follow-up|6|||
23710085|NCT04504032|66315302|FG001|Overall Study|Lost to Follow-up|9|||
23710086|NCT04504032|66315301|FG000|Overall Study|Protocol Violation|2|||
23411154|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411155|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411156|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411157|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411158|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411159|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411160|NCT02808897|65249033|FG000|Overall Study|Lost to Follow-up|9|||
23411161|NCT02808897|65249034|FG001|Overall Study|Lost to Follow-up|11|||
23411162|NCT03941964|65249035|FG000|Overall Study|Adverse Event|1|||
23411163|NCT03941964|65249036|FG001|Overall Study|Adverse Event|8|||
23411164|NCT03941964|65249035|FG000|Overall Study|Progressive disease|7|||
23411165|NCT03941964|65249036|FG001|Overall Study|Progressive disease|3|||
23411166|NCT03941964|65249035|FG000|Overall Study|Lack of Efficacy|0|||
23411167|NCT03941964|65249036|FG001|Overall Study|Lack of Efficacy|1|||
23411168|NCT03941964|65249035|FG000|Overall Study|Death|3|||
23411169|NCT03941964|65249036|FG001|Overall Study|Death|1|||
23411170|NCT03941964|65249035|FG000|Overall Study|Withdrew consent|1|||
23411171|NCT03941964|65249036|FG001|Overall Study|Withdrew consent|3|||
23411172|NCT03941964|65249035|FG000|Overall Study|Physician Decision|9|||
23411173|NCT03941964|65249036|FG001|Overall Study|Physician Decision|2|||
23411174|NCT03941964|65249035|FG000|Overall Study|Other, not specified|2|||
23411175|NCT03941964|65249036|FG001|Overall Study|Other, not specified|1|||
23411176|NCT02038777|65249037|FG000|Overall Study|Death|0|||
23411177|NCT02038777|65249038|FG001|Overall Study|Death|2|||
23411178|NCT02038777|65249039|FG002|Overall Study|Death|0|||
23411179|NCT02038777|65249040|FG003|Overall Study|Death|1|||
23411180|NCT02038777|65249041|FG004|Overall Study|Death|2|||
23411181|NCT02038777|65249042|FG005|Overall Study|Death|4|||
23411182|NCT02038777|65249043|FG006|Overall Study|Death|0|||
23411183|NCT02038777|65249044|FG007|Overall Study|Death|10|||
23411184|NCT02038777|65249037|FG000|Overall Study|Lost to Follow-up|0|||
23411185|NCT02038777|65249038|FG001|Overall Study|Lost to Follow-up|0|||
23411186|NCT02038777|65249039|FG002|Overall Study|Lost to Follow-up|0|||
23411187|NCT02038777|65249040|FG003|Overall Study|Lost to Follow-up|1|||
23411188|NCT02038777|65249041|FG004|Overall Study|Lost to Follow-up|0|||
23411189|NCT02038777|65249042|FG005|Overall Study|Lost to Follow-up|0|||
23411190|NCT02038777|65249043|FG006|Overall Study|Lost to Follow-up|0|||
23411191|NCT02038777|65249044|FG007|Overall Study|Lost to Follow-up|0|||
23411192|NCT02038777|65249037|FG000|Overall Study|Other|0|||
23411193|NCT02038777|65249038|FG001|Overall Study|Other|1|||
23411194|NCT02038777|65249039|FG002|Overall Study|Other|0|||
23411195|NCT02038777|65249040|FG003|Overall Study|Other|2|||
23411196|NCT02038777|65249041|FG004|Overall Study|Other|1|||
23411197|NCT02038777|65249042|FG005|Overall Study|Other|0|||
23411198|NCT02038777|65249043|FG006|Overall Study|Other|0|||
23411199|NCT02038777|65249044|FG007|Overall Study|Other|0|||
23411200|NCT02038777|65249037|FG000|Overall Study|Randomized but not treated|0|||
23411201|NCT02038777|65249038|FG001|Overall Study|Randomized but not treated|1|||
23411202|NCT02038777|65249039|FG002|Overall Study|Randomized but not treated|0|||
23411203|NCT02038777|65249040|FG003|Overall Study|Randomized but not treated|0|||
23411204|NCT02038777|65249041|FG004|Overall Study|Randomized but not treated|0|||
23411205|NCT02038777|65249042|FG005|Overall Study|Randomized but not treated|0|||
23411206|NCT02038777|65249043|FG006|Overall Study|Randomized but not treated|0|||
23411207|NCT02038777|65249044|FG007|Overall Study|Randomized but not treated|0|||
23411208|NCT02038777|65249037|FG000|Overall Study|Started Chemotherapy|1|||
23411209|NCT02038777|65249038|FG001|Overall Study|Started Chemotherapy|0|||
23411210|NCT02038777|65249039|FG002|Overall Study|Started Chemotherapy|3|||
23411211|NCT02038777|65249040|FG003|Overall Study|Started Chemotherapy|0|||
23411212|NCT02038777|65249041|FG004|Overall Study|Started Chemotherapy|0|||
23411213|NCT02038777|65249042|FG005|Overall Study|Started Chemotherapy|0|||
23411214|NCT02038777|65249043|FG006|Overall Study|Started Chemotherapy|0|||
23411215|NCT02038777|65249044|FG007|Overall Study|Started Chemotherapy|0|||
23411216|NCT00758069|65249045|FG000|Overall Study|Lack of Efficacy|0|||
23411217|NCT00758069|65249046|FG001|Overall Study|Lack of Efficacy|0|||
23411218|NCT00758069|65249047|FG002|Overall Study|Lack of Efficacy|1|||
23411219|NCT00758069|65249045|FG000|Overall Study|Incorrect Study Drug|1|||
23411220|NCT00758069|65249046|FG001|Overall Study|Incorrect Study Drug|0|||
23411221|NCT00758069|65249047|FG002|Overall Study|Incorrect Study Drug|0|||
23411222|NCT05059301|65249050|FG000|Overall Study|Adverse Event|0|||
23411223|NCT05059301|65249051|FG001|Overall Study|Adverse Event|2|||
23411224|NCT05059301|65249052|FG002|Overall Study|Adverse Event|2|||
23411225|NCT05059301|65249050|FG000|Overall Study|Lost to Follow-up|2|||
23411226|NCT05059301|65249051|FG001|Overall Study|Lost to Follow-up|3|||
23411227|NCT05059301|65249052|FG002|Overall Study|Lost to Follow-up|3|||
23411228|NCT05069597|65249053|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
23411229|NCT05069597|65249054|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
23411230|NCT02628600|65249055|FG000|Overall Study|Death|2|||
23411231|NCT02628600|65249056|FG001|Overall Study|Death|1|||
23411232|NCT02628600|65249055|FG000|Overall Study|Adverse Event|3|||
23411233|NCT02628600|65249056|FG001|Overall Study|Adverse Event|20|||
23411234|NCT02628600|65249055|FG000|Overall Study|Protocol Violation|0|||
23411235|NCT02628600|65249056|FG001|Overall Study|Protocol Violation|1|||
23411236|NCT02628600|65249055|FG000|Overall Study|Lack of Efficacy|2|||
23411237|NCT02628600|65249056|FG001|Overall Study|Lack of Efficacy|0|||
23411238|NCT02628600|65249055|FG000|Overall Study|Withdrawal by Subject|13|||
23411239|NCT02628600|65249056|FG001|Overall Study|Withdrawal by Subject|8|||
23710087|NCT04504032|66315302|FG001|Overall Study|Protocol Violation|0|||
23710088|NCT04504032|66315301|FG000|Overall Study|Study terminated by sponsor|1|||
23710089|NCT04504032|66315302|FG001|Overall Study|Study terminated by sponsor|2|||
23710090|NCT04504032|66315301|FG000|Overall Study|Withdrawal by Subject|9|||
23710091|NCT04504032|66315302|FG001|Overall Study|Withdrawal by Subject|11|||
23710092|NCT04504032|66315301|FG000|Overall Study|Disease progression prior to dosing|15|||
23710093|NCT04504032|66315302|FG001|Overall Study|Disease progression prior to dosing|3|||
23710094|NCT04504032|66315301|FG000|Overall Study|Drug supply issues|1|||
23710095|NCT04504032|66315302|FG001|Overall Study|Drug supply issues|1|||
23710096|NCT04504032|66315301|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
23411240|NCT02628600|65249055|FG000|Overall Study|Lost to Follow-up|1|||
23411241|NCT02628600|65249056|FG001|Overall Study|Lost to Follow-up|0|||
23411242|NCT02628600|65249055|FG000|Overall Study|Physician Decision|2|||
23411243|NCT02628600|65249056|FG001|Overall Study|Physician Decision|2|||
23411244|NCT02628600|65249055|FG000|Overall Study|Other not specified|1|||
23411245|NCT02628600|65249056|FG001|Overall Study|Other not specified|0|||
23411246|NCT02858440|65249057|FG000|Overall Study|Lost to Follow-up|3|||
23411247|NCT02858440|65249057|FG000|Overall Study|Protocol Violation|2|||
23411248|NCT02858440|65249057|FG000|Overall Study|Consent withdrawal|3|||
23411249|NCT02858440|65249057|FG000|Overall Study|Migrated/moved from study area|4|||
23411250|NCT00720356|65249058|FG000|Registration to Study|Determined to have methylated MGMT|67|||
23411251|NCT00720356|65249058|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23411252|NCT00720356|65249058|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
23411253|NCT00720356|65249058|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
23411254|NCT00720356|65249058|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
23411255|NCT00720356|65249058|FG000|Follow up Until Death|Withdrawal by Subject|1|||
23411256|NCT00720356|65249058|FG000|Follow up Until Death|Alive at last data collection|4|||
23411257|NCT00958360|65249060|FG000|Overall Study|Withdrawal by Subject|3|||
23411258|NCT00958360|65249061|FG001|Overall Study|Withdrawal by Subject|1|||
23411259|NCT00958360|65249060|FG000|Overall Study|Death|6|||
23411260|NCT00958360|65249061|FG001|Overall Study|Death|7|||
23411261|NCT00958360|65249060|FG000|Overall Study|Physician Decision|2|||
23411262|NCT00958360|65249061|FG001|Overall Study|Physician Decision|1|||
23411263|NCT00958360|65249060|FG000|Overall Study|Lost to Follow-up|0|||
23411264|NCT00958360|65249061|FG001|Overall Study|Lost to Follow-up|1|||
23411265|NCT03028129|65249066|FG000|Overall Study|Adverse Event|13|||
23710097|NCT04504032|66315302|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
23710098|NCT00077376|66315303|FG000|Overall Study|Adverse Event|8|||
23710099|NCT00077376|66315303|FG000|Overall Study|Withdrawal by Subject|2|||
23710100|NCT00077376|66315303|FG000|Overall Study|Death|1|||
23710101|NCT00077376|66315303|FG000|Overall Study|Physician Decision|1|||
23710102|NCT00077376|66315303|FG000|Overall Study|Alternative therapy|5|||
23710103|NCT00077376|66315303|FG000|Overall Study|Complicating disease|1|||
23710104|NCT00077376|66315303|FG000|Overall Study|Still on treatment|1|||
23710105|NCT00077376|66315303|FG000|Overall Study|Symptomatic deterioration|1|||
23710106|NCT00077376|66315303|FG000|Overall Study|Surgery|1|||
23710107|NCT00077376|66315303|FG000|Overall Study|Insurance ran out|1|||
23710108|NCT00585923|66315306|FG000|Overall Study|Physician decided not to continue|31|||
23710109|NCT00585923|66315307|FG001|Overall Study|Physician decided not to continue|33|||
23710110|NCT03053427|66315308|FG000|Overall Study|Adverse Event|4|||
23710111|NCT03053427|66315309|FG001|Overall Study|Adverse Event|4|||
23710112|NCT03053427|66315308|FG000|Overall Study|Lack of Efficacy|1|||
23710113|NCT03053427|66315309|FG001|Overall Study|Lack of Efficacy|3|||
23710114|NCT03053427|66315308|FG000|Overall Study|Lost to Follow-up|2|||
23710115|NCT03053427|66315309|FG001|Overall Study|Lost to Follow-up|2|||
23710116|NCT03053427|66315308|FG000|Overall Study|Worsening of the target disease|0|||
23411266|NCT03028129|65249067|FG001|Overall Study|Adverse Event|2|||
23411267|NCT03028129|65249066|FG000|Overall Study|Lost to Follow-up|50|||
23710117|NCT03053427|66315309|FG001|Overall Study|Worsening of the target disease|1|||
23710118|NCT03053427|66315308|FG000|Overall Study|Protocol Deviation|3|||
23511547|NCT00556712|65609394|FG000|Overall Study|Progressive Disease|383|||
23710119|NCT03053427|66315309|FG001|Overall Study|Protocol Deviation|3|||
23710120|NCT03053427|66315308|FG000|Overall Study|Withdrawal by Subject|3|||
23710121|NCT03053427|66315309|FG001|Overall Study|Withdrawal by Subject|2|||
23411268|NCT03028129|65249067|FG001|Overall Study|Lost to Follow-up|38|||
23411269|NCT03028129|65249066|FG000|Overall Study|Physician Decision|0|||
23411270|NCT03028129|65249067|FG001|Overall Study|Physician Decision|1|||
23411271|NCT03028129|65249066|FG000|Overall Study|Protocol Violation|1|||
23411272|NCT03028129|65249067|FG001|Overall Study|Protocol Violation|1|||
23710122|NCT03053427|66315308|FG000|Overall Study|Miscellaneous|0|||
23710123|NCT03053427|66315309|FG001|Overall Study|Miscellaneous|1|||
23710124|NCT01617187|66315311|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23710125|NCT01617187|66315312|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23710126|NCT01617187|66315313|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23710127|NCT01617187|66315314|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
23710128|NCT01617187|66315311|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23710129|NCT01617187|66315312|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23710130|NCT01617187|66315313|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23710131|NCT01617187|66315314|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
23710132|NCT01617187|66315311|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
23710133|NCT01617187|66315312|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23411273|NCT03028129|65249066|FG000|Overall Study|Withdrawal by Subject|62|||
23411274|NCT03028129|65249067|FG001|Overall Study|Withdrawal by Subject|45|||
23411275|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
23411276|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
23411277|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
23411278|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
23411279|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
23411280|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
23411281|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
23411282|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
23411283|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
23411284|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
23411285|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
23411286|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
23411287|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
23411288|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
23411289|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
23411290|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
23411291|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
23411292|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
23411293|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
23411294|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
23411295|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
23411296|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
23411297|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
23411298|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
23411299|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
23411300|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
23411301|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
23411302|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
23411303|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
23411304|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
23411305|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
23411306|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
23411307|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
23411308|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
23411309|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
23411310|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
23411311|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
23411312|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
23411313|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
23411314|NCT01047007|65249071|FG000|Overall Study|Adverse Event|0|||
23411315|NCT01047007|65249072|FG001|Overall Study|Adverse Event|2|||
23411316|NCT01047007|65249073|FG002|Overall Study|Adverse Event|1|||
23411317|NCT01047007|65249074|FG003|Overall Study|Adverse Event|0|||
23411318|NCT01047007|65249071|FG000|Overall Study|Progressive Disease|2|||
23411319|NCT01047007|65249072|FG001|Overall Study|Progressive Disease|4|||
23411320|NCT01047007|65249073|FG002|Overall Study|Progressive Disease|1|||
23411321|NCT01047007|65249074|FG003|Overall Study|Progressive Disease|0|||
23411322|NCT00809835|65249075|FG000|Overall Study|Lost to Follow-up|7|||
23411323|NCT00809835|65249076|FG001|Overall Study|Lost to Follow-up|6|||
23411324|NCT00809835|65249077|FG002|Overall Study|Lost to Follow-up|10|||
23411325|NCT00809835|65249078|FG003|Overall Study|Lost to Follow-up|2|||
23411326|NCT00809835|65249075|FG000|Overall Study|Withdrawal by Subject|1|||
23411327|NCT00809835|65249076|FG001|Overall Study|Withdrawal by Subject|1|||
23411328|NCT00809835|65249077|FG002|Overall Study|Withdrawal by Subject|1|||
23411329|NCT00809835|65249078|FG003|Overall Study|Withdrawal by Subject|0|||
23411330|NCT05559905|65249079|FG000|Overall Study|Withdrawal by Subject|1|||
23411331|NCT05559905|65249080|FG001|Overall Study|Withdrawal by Subject|0|||
23411332|NCT05559905|65249081|FG002|Overall Study|Withdrawal by Subject|0|||
23411333|NCT05559905|65249079|FG000|Overall Study|Not Reported|1|||
23411334|NCT05559905|65249080|FG001|Overall Study|Not Reported|0|||
23411335|NCT05559905|65249081|FG002|Overall Study|Not Reported|0|||
23411336|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
23411337|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
23411338|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
23411339|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
23411340|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
23411341|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
23411342|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
23411343|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
23411344|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
23411345|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
23411346|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
23411347|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
23411348|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411349|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411350|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
23411351|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411352|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411353|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411354|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411355|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411356|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411357|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411358|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411359|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411360|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
23411361|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
23411362|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
23411363|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
23411364|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
23411365|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
23411366|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
23710134|NCT01617187|66315313|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23710135|NCT01617187|66315314|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23710136|NCT01617187|66315311|FG000|Treatment Through Study Completion|Adverse Event|1|||
23710137|NCT01617187|66315312|FG001|Treatment Through Study Completion|Adverse Event|1|||
23710138|NCT01617187|66315313|FG002|Treatment Through Study Completion|Adverse Event|0|||
23710139|NCT01617187|66315314|FG003|Treatment Through Study Completion|Adverse Event|1|||
23710140|NCT01617187|66315311|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
23710141|NCT01617187|66315312|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
23710142|NCT01617187|66315313|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
23710143|NCT01617187|66315314|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
23710144|NCT01617187|66315311|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
23710145|NCT01617187|66315312|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
23710146|NCT01617187|66315313|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
23710147|NCT01617187|66315314|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
23710148|NCT01617187|66315311|FG000|Treatment Through Study Completion|Protocol Violation|1|||
23710149|NCT01617187|66315312|FG001|Treatment Through Study Completion|Protocol Violation|0|||
23710150|NCT01617187|66315313|FG002|Treatment Through Study Completion|Protocol Violation|0|||
23710151|NCT01617187|66315314|FG003|Treatment Through Study Completion|Protocol Violation|1|||
23710152|NCT00793819|66315315|FG000|Overall Study|Adverse Event|8|||
23710153|NCT00793819|66315316|FG001|Overall Study|Adverse Event|4|||
23710154|NCT00793819|66315315|FG000|Overall Study|Lack of Efficacy|1|||
23710155|NCT00793819|66315316|FG001|Overall Study|Lack of Efficacy|1|||
23710156|NCT00793819|66315315|FG000|Overall Study|Withdrawal by Subject|4|||
23710157|NCT00793819|66315316|FG001|Overall Study|Withdrawal by Subject|3|||
23710158|NCT00793819|66315315|FG000|Overall Study|Lost to Follow-up|1|||
23710159|NCT00793819|66315316|FG001|Overall Study|Lost to Follow-up|1|||
23710160|NCT00862849|66315317|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23411367|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
23811969|NCT03301623|66691855|FG000|Overall Study|Lost to Follow-up|3|||
23411368|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
23411369|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
23411370|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
23511548|NCT00556712|65609395|FG001|Overall Study|Progressive Disease|320|||
23411371|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
23511549|NCT00556712|65609394|FG000|Overall Study|Protocol Violation|3|||
23710161|NCT00862849|66315318|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
23710162|NCT00862849|66315319|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23710163|NCT00862849|66315320|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23710164|NCT00862849|66315321|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23710165|NCT00862849|66315322|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23411372|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411373|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411374|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411375|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
23411376|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411377|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411378|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411379|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411380|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411381|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411382|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411383|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411384|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
23411385|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
23411386|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
23411387|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
23411388|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
23411389|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
23411390|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
23411391|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
23411392|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
23411393|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
23411394|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
23411395|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
23411396|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411397|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411398|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411399|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411400|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411401|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411402|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411403|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411404|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411405|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
23411406|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411407|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411408|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
23411409|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
23411410|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
23411411|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
23411412|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
23411413|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
23411414|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
23710166|NCT00862849|66315317|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23710167|NCT00862849|66315318|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
23710168|NCT00862849|66315319|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23710169|NCT00862849|66315320|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23710170|NCT00862849|66315321|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23710171|NCT00862849|66315322|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23710172|NCT03095521|66315325|FG000|Overall Study|Withdrawal by Subject|0|||
23710173|NCT03095521|66315326|FG001|Overall Study|Withdrawal by Subject|1|||
23710174|NCT03095521|66315325|FG000|Overall Study|Lost to Follow-up|0|||
23710175|NCT03095521|66315326|FG001|Overall Study|Lost to Follow-up|1|||
23710176|NCT04167306|66315327|FG000|Overall Study|Lost to Follow-up|2|||
23710177|NCT04167306|66315328|FG001|Overall Study|Lost to Follow-up|2|||
23710178|NCT04167306|66315329|FG002|Overall Study|Lost to Follow-up|5|||
23710179|NCT04167306|66315330|FG003|Overall Study|Lost to Follow-up|5|||
23710180|NCT04167306|66315327|FG000|Overall Study|Adverse Event|13|||
23710181|NCT04167306|66315328|FG001|Overall Study|Adverse Event|14|||
23710182|NCT04167306|66315329|FG002|Overall Study|Adverse Event|5|||
23411415|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
23411416|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
23411417|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
23411418|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
23411419|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
23511550|NCT00556712|65609395|FG001|Overall Study|Protocol Violation|2|||
23710183|NCT04167306|66315330|FG003|Overall Study|Adverse Event|4|||
23710184|NCT04167306|66315327|FG000|Overall Study|Withdrawal by Subject|4|||
23411420|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411421|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411422|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411423|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411424|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411425|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411426|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411427|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411428|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411429|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
23411430|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411431|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411432|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Death|0|||
23411433|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Death|0|||
23411434|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Death|0|||
23411435|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Death|0|||
23411436|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Death|0|||
23411437|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Death|0|||
23411438|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Death|0|||
23411439|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Death|0|||
23511551|NCT00556712|65609394|FG000|Overall Study|Refused Treatment|17|||
23710185|NCT04167306|66315328|FG001|Overall Study|Withdrawal by Subject|6|||
23710186|NCT04167306|66315329|FG002|Overall Study|Withdrawal by Subject|8|||
23710187|NCT04167306|66315330|FG003|Overall Study|Withdrawal by Subject|3|||
23710188|NCT04167306|66315327|FG000|Overall Study|covid|1|||
23710189|NCT04167306|66315328|FG001|Overall Study|covid|1|||
23710190|NCT04167306|66315329|FG002|Overall Study|covid|2|||
23710191|NCT04167306|66315330|FG003|Overall Study|covid|1|||
23710192|NCT04167306|66315327|FG000|Overall Study|concomitant medication|0|||
23710193|NCT04167306|66315328|FG001|Overall Study|concomitant medication|0|||
23710194|NCT04167306|66315329|FG002|Overall Study|concomitant medication|0|||
23710195|NCT04167306|66315330|FG003|Overall Study|concomitant medication|1|||
23710196|NCT04167306|66315327|FG000|Overall Study|Alcohol treatment|0|||
23710197|NCT04167306|66315328|FG001|Overall Study|Alcohol treatment|4|||
23710198|NCT04167306|66315329|FG002|Overall Study|Alcohol treatment|3|||
23710199|NCT04167306|66315330|FG003|Overall Study|Alcohol treatment|2|||
23710200|NCT04167306|66315327|FG000|Overall Study|non-compliance|0|||
23710201|NCT04167306|66315328|FG001|Overall Study|non-compliance|0|||
23710202|NCT04167306|66315329|FG002|Overall Study|non-compliance|1|||
23710203|NCT04167306|66315330|FG003|Overall Study|non-compliance|0|||
23710204|NCT04167306|66315327|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
23710205|NCT04167306|66315328|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
23710206|NCT04167306|66315329|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
23710207|NCT04167306|66315330|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
23710208|NCT02065622|66315331|FG000|Induction Study|Adverse Event|13|||
23710209|NCT02065622|66315332|FG001|Induction Study|Adverse Event|19|||
23710210|NCT02065622|66315333|FG002|Induction Study|Adverse Event|0|||
23710211|NCT02065622|66315334|FG003|Induction Study|Adverse Event|0|||
23710212|NCT02065622|66315335|FG004|Induction Study|Adverse Event|0|||
23710213|NCT02065622|66315331|FG000|Induction Study|Withdrawal by Subject|3|||
23710214|NCT02065622|66315332|FG001|Induction Study|Withdrawal by Subject|5|||
23710215|NCT02065622|66315333|FG002|Induction Study|Withdrawal by Subject|0|||
23710216|NCT02065622|66315334|FG003|Induction Study|Withdrawal by Subject|0|||
23710217|NCT02065622|66315335|FG004|Induction Study|Withdrawal by Subject|0|||
23710218|NCT02065622|66315331|FG000|Induction Study|Lost to Follow-up|1|||
23710219|NCT02065622|66315332|FG001|Induction Study|Lost to Follow-up|0|||
23710220|NCT02065622|66315333|FG002|Induction Study|Lost to Follow-up|0|||
23710221|NCT02065622|66315334|FG003|Induction Study|Lost to Follow-up|0|||
23710222|NCT02065622|66315335|FG004|Induction Study|Lost to Follow-up|0|||
23710223|NCT02065622|66315331|FG000|Induction Study|Lack of Efficacy|22|||
23710224|NCT02065622|66315332|FG001|Induction Study|Lack of Efficacy|27|||
23710225|NCT02065622|66315333|FG002|Induction Study|Lack of Efficacy|0|||
23710226|NCT02065622|66315334|FG003|Induction Study|Lack of Efficacy|0|||
23710227|NCT02065622|66315335|FG004|Induction Study|Lack of Efficacy|0|||
23710228|NCT02065622|66315331|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
23710229|NCT02065622|66315332|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
23710230|NCT02065622|66315333|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23710231|NCT02065622|66315334|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23710232|NCT02065622|66315335|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23411440|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Death|0|||
23411441|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Death|1|||
23411442|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Death|0|||
23411443|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Death|0|||
23411444|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Other|0|||
23411445|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Other|0|||
23411446|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Other|0|||
23411447|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Other|0|||
23411448|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Other|0|||
23411449|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Other|0|||
23411450|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Other|0|||
23411451|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Other|0|||
23411452|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Other|0|||
23411453|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Other|0|||
23411454|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Other|0|||
23411455|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Other|1|||
23411456|NCT00269113|65249099|FG000|Overall Study|Adverse Event|14|||
23411457|NCT00269113|65249100|FG001|Overall Study|Adverse Event|7|||
23411458|NCT00269113|65249099|FG000|Overall Study|Lack of Efficacy|35|||
23411459|NCT00269113|65249100|FG001|Overall Study|Lack of Efficacy|18|||
23411460|NCT00269113|65249099|FG000|Overall Study|Early Improvement|2|||
23411461|NCT00269113|65249100|FG001|Overall Study|Early Improvement|0|||
23411462|NCT00269113|65249099|FG000|Overall Study|Withdrawal by Subject|0|||
23411463|NCT00269113|65249100|FG001|Overall Study|Withdrawal by Subject|2|||
23411464|NCT00269113|65249099|FG000|Overall Study|Death|6|||
23411465|NCT00269113|65249100|FG001|Overall Study|Death|2|||
23411466|NCT00269113|65249099|FG000|Overall Study|Lost to Follow-up|2|||
23411467|NCT00269113|65249100|FG001|Overall Study|Lost to Follow-up|1|||
23411468|NCT00269113|65249099|FG000|Overall Study|Protocol Violation|15|||
23411469|NCT00269113|65249100|FG001|Overall Study|Protocol Violation|5|||
23411470|NCT00269113|65249099|FG000|Overall Study|Other|0|||
23411471|NCT00269113|65249100|FG001|Overall Study|Other|2|||
23411472|NCT01309997|65249108|FG000|Overall Study|Adverse Event|1|||
23411473|NCT01309997|65249109|FG001|Overall Study|Adverse Event|0|||
23411474|NCT01309997|65249108|FG000|Overall Study|Death|1|||
23411475|NCT01309997|65249109|FG001|Overall Study|Death|3|||
23411476|NCT01309997|65249108|FG000|Overall Study|Lack of Efficacy|2|||
23411477|NCT01309997|65249109|FG001|Overall Study|Lack of Efficacy|2|||
23411478|NCT01309997|65249108|FG000|Overall Study|Withdrawal by Subject|1|||
23411479|NCT01309997|65249109|FG001|Overall Study|Withdrawal by Subject|1|||
23411480|NCT00935493|65249110|FG000|Overall Study|Lost to Follow-up|1|||
23411481|NCT00935493|65249111|FG001|Overall Study|Lost to Follow-up|1|||
23411482|NCT00935493|65249112|FG002|Overall Study|Lost to Follow-up|1|||
23411483|NCT00935493|65249110|FG000|Overall Study|Treatment Discontinued|0|||
23411484|NCT00935493|65249111|FG001|Overall Study|Treatment Discontinued|1|||
23411485|NCT00935493|65249112|FG002|Overall Study|Treatment Discontinued|0|||
23411486|NCT03107052|65249114|FG000|Overall Study|Adverse Event|6|||
23411487|NCT03107052|65249115|FG001|Overall Study|Adverse Event|1|||
23411488|NCT03107052|65249116|FG002|Overall Study|Adverse Event|2|||
23511552|NCT00556712|65609395|FG001|Overall Study|Refused Treatment|16|||
23710233|NCT02065622|66315331|FG000|Induction Study|Subject Noncompliance|1|||
23710234|NCT02065622|66315332|FG001|Induction Study|Subject Noncompliance|1|||
23710235|NCT02065622|66315333|FG002|Induction Study|Subject Noncompliance|0|||
23710236|NCT02065622|66315334|FG003|Induction Study|Subject Noncompliance|0|||
23710237|NCT02065622|66315335|FG004|Induction Study|Subject Noncompliance|0|||
23710238|NCT02065622|66315331|FG000|Induction Study|Other, Not Specified|3|||
23710239|NCT02065622|66315332|FG001|Induction Study|Other, Not Specified|2|||
23710240|NCT02065622|66315333|FG002|Induction Study|Other, Not Specified|0|||
23710241|NCT02065622|66315334|FG003|Induction Study|Other, Not Specified|0|||
23710242|NCT02065622|66315335|FG004|Induction Study|Other, Not Specified|0|||
23710243|NCT02065622|66315331|FG000|Maintenance Study|Adverse Event|0|||
23710244|NCT02065622|66315332|FG001|Maintenance Study|Adverse Event|0|||
23710245|NCT02065622|66315333|FG002|Maintenance Study|Adverse Event|25|||
23710246|NCT02065622|66315334|FG003|Maintenance Study|Adverse Event|22|||
23710247|NCT02065622|66315335|FG004|Maintenance Study|Adverse Event|11|||
23710248|NCT02065622|66315331|FG000|Maintenance Study|Withdrawal by Subject|0|||
23710249|NCT02065622|66315332|FG001|Maintenance Study|Withdrawal by Subject|0|||
23710250|NCT02065622|66315333|FG002|Maintenance Study|Withdrawal by Subject|11|||
23710251|NCT02065622|66315334|FG003|Maintenance Study|Withdrawal by Subject|5|||
23710252|NCT02065622|66315335|FG004|Maintenance Study|Withdrawal by Subject|7|||
23710253|NCT02065622|66315331|FG000|Maintenance Study|Lost to Follow-up|0|||
23710254|NCT02065622|66315332|FG001|Maintenance Study|Lost to Follow-up|0|||
23411489|NCT03107052|65249114|FG000|Overall Study|Withdrawal by Subject|9|||
23411490|NCT03107052|65249115|FG001|Overall Study|Withdrawal by Subject|5|||
23411491|NCT03107052|65249116|FG002|Overall Study|Withdrawal by Subject|8|||
23411492|NCT03107052|65249114|FG000|Overall Study|Protocol Violation|6|||
23411493|NCT03107052|65249115|FG001|Overall Study|Protocol Violation|0|||
23411494|NCT03107052|65249116|FG002|Overall Study|Protocol Violation|3|||
23411495|NCT03107052|65249114|FG000|Overall Study|Lost to Follow-up|4|||
23411496|NCT03107052|65249115|FG001|Overall Study|Lost to Follow-up|0|||
23411497|NCT03107052|65249116|FG002|Overall Study|Lost to Follow-up|1|||
23411498|NCT03107052|65249114|FG000|Overall Study|Lack of Efficacy|23|||
23411499|NCT03107052|65249115|FG001|Overall Study|Lack of Efficacy|7|||
23411500|NCT03107052|65249116|FG002|Overall Study|Lack of Efficacy|4|||
23710255|NCT02065622|66315333|FG002|Maintenance Study|Lost to Follow-up|4|||
23411501|NCT03107052|65249114|FG000|Overall Study|Other than specified|4|||
23511553|NCT00556712|65609394|FG000|Overall Study|Failure to Return|2|||
23511554|NCT00556712|65609395|FG001|Overall Study|Failure to Return|3|||
23511555|NCT00556712|65609394|FG000|Overall Study|Other|2|||
23511556|NCT00556712|65609395|FG001|Overall Study|Other|2|||
23511557|NCT00556712|65609394|FG000|Overall Study|Ongoing at Data Cutoff|32|||
23511558|NCT00556712|65609395|FG001|Overall Study|Ongoing at Data Cutoff|66|||
23511559|NCT02663674|65609396|FG000|Overall Study|Lost to Follow-up|5|||
23511560|NCT02663674|65609397|FG001|Overall Study|Lost to Follow-up|4|||
23511561|NCT02663674|65609396|FG000|Overall Study|Withdrawal by Subject|1|||
23511562|NCT02663674|65609397|FG001|Overall Study|Withdrawal by Subject|4|||
23511563|NCT02663674|65609396|FG000|Overall Study|Physician Decision|1|||
23511564|NCT02663674|65609397|FG001|Overall Study|Physician Decision|1|||
23511565|NCT02663674|65609396|FG000|Overall Study|Other Event (Health Related)|0|||
23511566|NCT02663674|65609397|FG001|Overall Study|Other Event (Health Related)|1|||
23511567|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
23511568|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
23511569|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
23511570|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
23511571|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Death|7|||
23511572|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Death|5|||
23511573|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
23511574|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
23511575|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
23511576|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
23511577|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
23511578|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
23511579|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
23511580|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
23411502|NCT03107052|65249115|FG001|Overall Study|Other than specified|2|||
23411503|NCT03107052|65249116|FG002|Overall Study|Other than specified|0|||
23411504|NCT03107052|65249114|FG000|Overall Study|Study terminated due to futility|67|||
23411505|NCT03107052|65249115|FG001|Overall Study|Study terminated due to futility|31|||
23411506|NCT03107052|65249116|FG002|Overall Study|Study terminated due to futility|23|||
23411507|NCT03951766|65249117|FG000|Treatment Phase|Lost to Follow-up|1|||
23411508|NCT03951766|65249117|FG000|Follow-up Phase|Lost to Follow-up|10|||
23411509|NCT02467192|65249118|FG000|Overall Study|Death|1|||
23411510|NCT02467192|65249118|FG000|Overall Study|revealed to have pneumonia before|2|||
23411511|NCT02920528|65249119|FG000|Overall Study|Incomplete Data|1|||
23411512|NCT02920528|65249120|FG001|Overall Study|Incomplete Data|1|||
23411513|NCT02920528|65249121|FG002|Overall Study|Incomplete Data|1|||
23411514|NCT02920528|65249119|FG000|Overall Study|Adverse Event|0|||
23411515|NCT02920528|65249120|FG001|Overall Study|Adverse Event|0|||
23411516|NCT02920528|65249121|FG002|Overall Study|Adverse Event|3|||
23411517|NCT02920528|65249119|FG000|Overall Study|Did not meet inclusion criteria|2|||
23411518|NCT02920528|65249120|FG001|Overall Study|Did not meet inclusion criteria|0|||
23411519|NCT02920528|65249121|FG002|Overall Study|Did not meet inclusion criteria|1|||
23411520|NCT05005273|65249124|FG000|Overall Study|Study Terminated|1|||
23411521|NCT05005273|65249125|FG001|Overall Study|Study Terminated|0|||
23411522|NCT02443337|65249126|FG000|Overall Study|Adverse Event|0|||
23411523|NCT02443337|65249127|FG001|Overall Study|Adverse Event|1|||
23411524|NCT02443337|65249126|FG000|Overall Study|Clinical Progressive Disease|3|||
23411525|NCT02443337|65249127|FG001|Overall Study|Clinical Progressive Disease|0|||
23411526|NCT02443337|65249126|FG000|Overall Study|Withdrawal by Subject|2|||
23411527|NCT02443337|65249127|FG001|Overall Study|Withdrawal by Subject|1|||
23411528|NCT03748706|65249128|FG000|Overall Study|Lost to Follow-up|1|||
23411529|NCT03098433|65249134|FG000|Overall Study|Withdrawal by Subject|10|||
23411530|NCT04660552|65249135|FG000|Overall Study|Withdrawal by Subject|3|||
23411531|NCT04660552|65249136|FG001|Overall Study|Withdrawal by Subject|1|||
23411532|NCT00579553|65249137|FG000|Overall Study|Lost to Follow-up|16|||
23411533|NCT00579553|65249138|FG001|Overall Study|Lost to Follow-up|13|||
23411534|NCT00861692|65249139|FG000|Overall Study|Death|6|||
23511581|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
23511582|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
23511583|NCT02743520|65609409|FG000|Overall Study|Withdrawal by Subject|1|||
23511584|NCT02733991|65609415|FG000|Overall Study|Adverse Event|1|||
23511585|NCT02733991|65609416|FG001|Overall Study|Adverse Event|0|||
23411535|NCT04153981|65249140|FG000|Overall Study|Death|1|||
23411536|NCT04153981|65249140|FG000|Overall Study|Withdrawal by Subject|24|||
23411537|NCT04153981|65249140|FG000|Overall Study|Lost to Follow-up|1|||
23411538|NCT04153981|65249140|FG000|Overall Study|Physician Decision|1|||
23411539|NCT04153981|65249140|FG000|Overall Study|Due to Unavailable Glucometer|1|||
23411540|NCT04153981|65249140|FG000|Overall Study|Covid 19|52|||
23511586|NCT02733991|65609415|FG000|Overall Study|Withdrawal by Subject|0|||
23511587|NCT02733991|65609416|FG001|Overall Study|Withdrawal by Subject|5|||
23411541|NCT04153981|65249140|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
23411542|NCT04153981|65249140|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
23411543|NCT04776161|65249141|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
23411544|NCT04776161|65249142|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
23411545|NCT04776161|65249143|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
23411546|NCT04776161|65249141|FG000|Overall Study|Withdrawal by Subject|1|||
23411547|NCT04776161|65249142|FG001|Overall Study|Withdrawal by Subject|0|||
23411548|NCT04776161|65249143|FG002|Overall Study|Withdrawal by Subject|1|||
23411549|NCT04776161|65249141|FG000|Overall Study|Adverse Event|0|||
23411550|NCT04776161|65249142|FG001|Overall Study|Adverse Event|1|||
23411551|NCT04776161|65249143|FG002|Overall Study|Adverse Event|1|||
23411552|NCT00711594|65249146|FG000|Overall Study|Progressive disease|2|||
23411553|NCT00711594|65249147|FG001|Overall Study|Progressive disease|2|||
23411554|NCT00711594|65249148|FG002|Overall Study|Progressive disease|6|||
23411555|NCT00711594|65249149|FG003|Overall Study|Progressive disease|44|||
23411556|NCT00711594|65249146|FG000|Overall Study|Other Adverse Event|1|||
23411557|NCT00711594|65249147|FG001|Overall Study|Other Adverse Event|0|||
23411558|NCT00711594|65249148|FG002|Overall Study|Other Adverse Event|0|||
23411559|NCT00711594|65249149|FG003|Overall Study|Other Adverse Event|16|||
23411560|NCT00711594|65249146|FG000|Overall Study|Withdrawal by Subject|0|||
23411561|NCT00711594|65249147|FG001|Overall Study|Withdrawal by Subject|1|||
23411562|NCT00711594|65249148|FG002|Overall Study|Withdrawal by Subject|0|||
23411563|NCT00711594|65249149|FG003|Overall Study|Withdrawal by Subject|2|||
23411564|NCT01831466|65249150|FG000|Overall Study|Protocol Violation|1|||
23411565|NCT01831466|65249151|FG001|Overall Study|Protocol Violation|1|||
23411566|NCT01831466|65249152|FG002|Overall Study|Protocol Violation|2|||
23411567|NCT01831466|65249153|FG003|Overall Study|Protocol Violation|0|||
23411568|NCT01831466|65249154|FG004|Overall Study|Protocol Violation|0|||
23411569|NCT01831466|65249155|FG005|Overall Study|Protocol Violation|1|||
23411570|NCT01831466|65249156|FG006|Overall Study|Protocol Violation|0|||
23411571|NCT01831466|65249157|FG007|Overall Study|Protocol Violation|0|||
23411572|NCT01831466|65249158|FG008|Overall Study|Protocol Violation|0|||
23411573|NCT01831466|65249159|FG009|Overall Study|Protocol Violation|0|||
23411574|NCT01831466|65249160|FG010|Overall Study|Protocol Violation|0|||
23411575|NCT01831466|65249161|FG011|Overall Study|Protocol Violation|0|||
23411576|NCT01831466|65249150|FG000|Overall Study|Other|2|||
23411577|NCT01831466|65249151|FG001|Overall Study|Other|3|||
23411578|NCT01831466|65249152|FG002|Overall Study|Other|2|||
23411579|NCT01831466|65249153|FG003|Overall Study|Other|2|||
23411580|NCT01831466|65249154|FG004|Overall Study|Other|2|||
23411581|NCT01831466|65249155|FG005|Overall Study|Other|1|||
23411582|NCT01831466|65249156|FG006|Overall Study|Other|0|||
23411583|NCT01831466|65249157|FG007|Overall Study|Other|0|||
23411584|NCT01831466|65249158|FG008|Overall Study|Other|0|||
23411585|NCT01831466|65249159|FG009|Overall Study|Other|0|||
23511588|NCT01031069|65609422|FG000|Overall Study|Serious Adverse Event|0|||
23511589|NCT01031069|65609423|FG001|Overall Study|Serious Adverse Event|1|||
23511590|NCT01031069|65609424|FG002|Overall Study|Serious Adverse Event|0|||
23511591|NCT01031069|65609425|FG003|Overall Study|Serious Adverse Event|0|||
23511592|NCT01031069|65609422|FG000|Overall Study|Withdrawal by Subject|2|||
23511593|NCT01031069|65609423|FG001|Overall Study|Withdrawal by Subject|3|||
23511594|NCT01031069|65609424|FG002|Overall Study|Withdrawal by Subject|18|||
23511595|NCT01031069|65609425|FG003|Overall Study|Withdrawal by Subject|18|||
23511596|NCT01031069|65609422|FG000|Overall Study|Migrated/moved from study area|1|||
23511597|NCT01031069|65609423|FG001|Overall Study|Migrated/moved from study area|2|||
23511598|NCT01031069|65609424|FG002|Overall Study|Migrated/moved from study area|1|||
23511599|NCT01031069|65609425|FG003|Overall Study|Migrated/moved from study area|1|||
23511600|NCT01031069|65609422|FG000|Overall Study|Lost to Follow-up|9|||
23511601|NCT01031069|65609423|FG001|Overall Study|Lost to Follow-up|5|||
23511602|NCT01031069|65609424|FG002|Overall Study|Lost to Follow-up|21|||
23511603|NCT01031069|65609425|FG003|Overall Study|Lost to Follow-up|15|||
23511604|NCT01031069|65609422|FG000|Overall Study|Other|0|||
23511605|NCT01031069|65609423|FG001|Overall Study|Other|0|||
23511606|NCT01031069|65609424|FG002|Overall Study|Other|1|||
23511607|NCT01031069|65609425|FG003|Overall Study|Other|0|||
23411586|NCT01831466|65249160|FG010|Overall Study|Other|0|||
23411587|NCT01831466|65249161|FG011|Overall Study|Other|0|||
23411588|NCT01831466|65249150|FG000|Overall Study|Non-compliance with study treatment|2|||
23411589|NCT01831466|65249151|FG001|Overall Study|Non-compliance with study treatment|1|||
23411590|NCT01831466|65249152|FG002|Overall Study|Non-compliance with study treatment|1|||
23411591|NCT01831466|65249153|FG003|Overall Study|Non-compliance with study treatment|0|||
23411592|NCT01831466|65249154|FG004|Overall Study|Non-compliance with study treatment|0|||
23511608|NCT02511184|65609426|FG000|Overall Study|Death|1|||
23511609|NCT02511184|65609427|FG001|Overall Study|Death|0|||
23511610|NCT02511184|65609426|FG000|Overall Study|Lost to Follow-up|0|||
23511611|NCT02511184|65609427|FG001|Overall Study|Lost to Follow-up|1|||
23511612|NCT02511184|65609426|FG000|Overall Study|Study terminated by sponsor|1|||
23511613|NCT02511184|65609427|FG001|Overall Study|Study terminated by sponsor|5|||
23511614|NCT02511184|65609426|FG000|Overall Study|Withdrawal by Subject|0|||
23511615|NCT02511184|65609427|FG001|Overall Study|Withdrawal by Subject|1|||
23511616|NCT03559257|65609430|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
23511617|NCT03559257|65609431|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23511618|NCT03559257|65609430|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23511619|NCT03559257|65609431|FG001|Double Blind Treatment Period|Protocol Violation|4|||
23511620|NCT03559257|65609430|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23511621|NCT03559257|65609431|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
23511622|NCT03559257|65609430|FG000|Double Blind Treatment Period|Adverse Event|0|||
23511623|NCT03559257|65609431|FG001|Double Blind Treatment Period|Adverse Event|1|||
23511624|NCT03559257|65609430|FG000|Double Blind Treatment Period|Screen Failure|0|||
23511625|NCT03559257|65609431|FG001|Double Blind Treatment Period|Screen Failure|1|||
23511626|NCT03559257|65609430|FG000|Open-label Treatment Period|Adverse Event|1|||
23511627|NCT03559257|65609431|FG001|Open-label Treatment Period|Adverse Event|4|||
23511628|NCT03559257|65609430|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
23511629|NCT03559257|65609431|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
23511630|NCT03559257|65609430|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
23511631|NCT03559257|65609431|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23511632|NCT03559257|65609430|FG000|Open-label Treatment Period|Protocol Violation|2|||
23710256|NCT02065622|66315334|FG003|Maintenance Study|Lost to Follow-up|1|||
23710257|NCT02065622|66315335|FG004|Maintenance Study|Lost to Follow-up|1|||
23411593|NCT01831466|65249155|FG005|Overall Study|Non-compliance with study treatment|1|||
23411594|NCT01831466|65249156|FG006|Overall Study|Non-compliance with study treatment|0|||
23511633|NCT03559257|65609431|FG001|Open-label Treatment Period|Protocol Violation|0|||
23511634|NCT03559257|65609430|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
23511635|NCT03559257|65609431|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23511636|NCT03559257|65609430|FG000|Open-label Treatment Period|Physician Decision|0|||
23511637|NCT03559257|65609431|FG001|Open-label Treatment Period|Physician Decision|1|||
23511638|NCT01327885|65609435|FG000|Overall Study|Disease progression-according to RECIST|173|||
23511639|NCT01327885|65609436|FG001|Overall Study|Disease progression-according to RECIST|165|||
23511640|NCT01327885|65609435|FG000|Overall Study|Clinical progression|24|||
23511641|NCT01327885|65609436|FG001|Overall Study|Clinical progression|27|||
23511642|NCT01327885|65609435|FG000|Overall Study|Adverse Event|14|||
23511643|NCT01327885|65609436|FG001|Overall Study|Adverse Event|10|||
23511644|NCT01327885|65609435|FG000|Overall Study|Subject choice|5|||
23511645|NCT01327885|65609436|FG001|Overall Study|Subject choice|10|||
23511646|NCT01327885|65609435|FG000|Overall Study|Other|8|||
23511647|NCT01327885|65609436|FG001|Overall Study|Other|6|||
23511648|NCT01327885|65609435|FG000|Overall Study|Withdrawal of consent from study|3|||
23610583|NCT02676778|65962809|FG000|Overall Study|Withdrawal by Subject|3|||
23411595|NCT01831466|65249157|FG007|Overall Study|Non-compliance with study treatment|0|||
23411596|NCT01831466|65249158|FG008|Overall Study|Non-compliance with study treatment|0|||
23411597|NCT01831466|65249159|FG009|Overall Study|Non-compliance with study treatment|0|||
23411598|NCT01831466|65249160|FG010|Overall Study|Non-compliance with study treatment|0|||
23411599|NCT01831466|65249161|FG011|Overall Study|Non-compliance with study treatment|0|||
23411600|NCT01831466|65249150|FG000|Overall Study|Death|0|||
23411601|NCT01831466|65249151|FG001|Overall Study|Death|1|||
23411602|NCT01831466|65249152|FG002|Overall Study|Death|0|||
23411603|NCT01831466|65249153|FG003|Overall Study|Death|0|||
23411604|NCT01831466|65249154|FG004|Overall Study|Death|0|||
23411605|NCT01831466|65249155|FG005|Overall Study|Death|0|||
23411606|NCT01831466|65249156|FG006|Overall Study|Death|0|||
23411607|NCT01831466|65249157|FG007|Overall Study|Death|0|||
23411608|NCT01831466|65249158|FG008|Overall Study|Death|0|||
23411609|NCT01831466|65249159|FG009|Overall Study|Death|0|||
23411610|NCT01831466|65249160|FG010|Overall Study|Death|0|||
23411611|NCT01831466|65249161|FG011|Overall Study|Death|0|||
23411612|NCT01831466|65249150|FG000|Overall Study|Withdrawal by Subject|6|||
23411613|NCT01831466|65249151|FG001|Overall Study|Withdrawal by Subject|3|||
23411614|NCT01831466|65249152|FG002|Overall Study|Withdrawal by Subject|3|||
23411615|NCT01831466|65249153|FG003|Overall Study|Withdrawal by Subject|3|||
23411616|NCT01831466|65249154|FG004|Overall Study|Withdrawal by Subject|3|||
23411617|NCT01831466|65249155|FG005|Overall Study|Withdrawal by Subject|5|||
23411618|NCT01831466|65249156|FG006|Overall Study|Withdrawal by Subject|0|||
23710258|NCT02065622|66315331|FG000|Maintenance Study|Lack of Efficacy|0|||
23710259|NCT02065622|66315332|FG001|Maintenance Study|Lack of Efficacy|0|||
23710260|NCT02065622|66315333|FG002|Maintenance Study|Lack of Efficacy|70|||
23710261|NCT02065622|66315334|FG003|Maintenance Study|Lack of Efficacy|55|||
23710262|NCT02065622|66315335|FG004|Maintenance Study|Lack of Efficacy|19|||
23710263|NCT02065622|66315331|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
23411619|NCT01831466|65249157|FG007|Overall Study|Withdrawal by Subject|0|||
23411620|NCT01831466|65249158|FG008|Overall Study|Withdrawal by Subject|0|||
23411621|NCT01831466|65249159|FG009|Overall Study|Withdrawal by Subject|1|||
23411622|NCT01831466|65249160|FG010|Overall Study|Withdrawal by Subject|0|||
23411623|NCT01831466|65249161|FG011|Overall Study|Withdrawal by Subject|1|||
23411624|NCT01831466|65249150|FG000|Overall Study|Lost to Follow-up|0|||
23411625|NCT01831466|65249151|FG001|Overall Study|Lost to Follow-up|1|||
23411626|NCT01831466|65249152|FG002|Overall Study|Lost to Follow-up|4|||
23411627|NCT01831466|65249153|FG003|Overall Study|Lost to Follow-up|2|||
23411628|NCT01831466|65249154|FG004|Overall Study|Lost to Follow-up|0|||
23411629|NCT01831466|65249155|FG005|Overall Study|Lost to Follow-up|3|||
23411630|NCT01831466|65249156|FG006|Overall Study|Lost to Follow-up|0|||
23411631|NCT01831466|65249157|FG007|Overall Study|Lost to Follow-up|0|||
23411632|NCT01831466|65249158|FG008|Overall Study|Lost to Follow-up|0|||
23411633|NCT01831466|65249159|FG009|Overall Study|Lost to Follow-up|1|||
23411634|NCT01831466|65249160|FG010|Overall Study|Lost to Follow-up|0|||
23411635|NCT01831466|65249161|FG011|Overall Study|Lost to Follow-up|1|||
23411636|NCT01831466|65249150|FG000|Overall Study|Lack of Efficacy|5|||
23411637|NCT01831466|65249151|FG001|Overall Study|Lack of Efficacy|8|||
23411638|NCT01831466|65249152|FG002|Overall Study|Lack of Efficacy|7|||
23411639|NCT01831466|65249153|FG003|Overall Study|Lack of Efficacy|6|||
23710264|NCT02065622|66315332|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
23710265|NCT02065622|66315333|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
23710266|NCT02065622|66315334|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
23710267|NCT02065622|66315335|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
23710268|NCT02065622|66315331|FG000|Maintenance Study|Subject Non-Compliance|0|||
23710269|NCT02065622|66315332|FG001|Maintenance Study|Subject Non-Compliance|0|||
23710270|NCT02065622|66315333|FG002|Maintenance Study|Subject Non-Compliance|1|||
23710271|NCT02065622|66315334|FG003|Maintenance Study|Subject Non-Compliance|3|||
23710272|NCT02065622|66315335|FG004|Maintenance Study|Subject Non-Compliance|2|||
23710273|NCT02065622|66315331|FG000|Maintenance Study|Other, Not Specified|0|||
23710274|NCT02065622|66315332|FG001|Maintenance Study|Other, Not Specified|0|||
23710275|NCT02065622|66315333|FG002|Maintenance Study|Other, Not Specified|6|||
23710276|NCT02065622|66315334|FG003|Maintenance Study|Other, Not Specified|14|||
23710277|NCT02065622|66315335|FG004|Maintenance Study|Other, Not Specified|2|||
23710278|NCT02065622|66315331|FG000|Maintenance Study|Unknown Reason|0|||
23710279|NCT02065622|66315332|FG001|Maintenance Study|Unknown Reason|0|||
23710280|NCT02065622|66315333|FG002|Maintenance Study|Unknown Reason|0|||
23710281|NCT02065622|66315334|FG003|Maintenance Study|Unknown Reason|1|||
23710282|NCT02065622|66315335|FG004|Maintenance Study|Unknown Reason|0|||
23710283|NCT01826422|66315336|FG000|Overall Study|Withdrawal by Subject|1|||
23710284|NCT01826422|66315337|FG001|Overall Study|Withdrawal by Subject|3|||
23710285|NCT02457182|66315338|FG000|Overall Study|Lost to Follow-up|1|||
23710286|NCT02457182|66315339|FG001|Overall Study|Lost to Follow-up|0|||
23710287|NCT00751114|66315340|FG000|Overall Study|Adverse Event|2|||
23710288|NCT00751114|66315341|FG001|Overall Study|Adverse Event|4|||
23710289|NCT00751114|66315340|FG000|Overall Study|Protocol Violation|8|||
23710290|NCT00751114|66315341|FG001|Overall Study|Protocol Violation|9|||
23710291|NCT00751114|66315340|FG000|Overall Study|Withdrawal by Subject|9|||
23710292|NCT00751114|66315341|FG001|Overall Study|Withdrawal by Subject|4|||
23710293|NCT00751114|66315340|FG000|Overall Study|Lost to Follow-up|4|||
23710294|NCT00751114|66315341|FG001|Overall Study|Lost to Follow-up|7|||
23710295|NCT00751114|66315340|FG000|Overall Study|Lack of Efficacy|0|||
23710296|NCT00751114|66315341|FG001|Overall Study|Lack of Efficacy|7|||
23710297|NCT00751114|66315340|FG000|Overall Study|Not Treated|13|||
23710298|NCT00751114|66315341|FG001|Overall Study|Not Treated|1|||
23710299|NCT00751114|66315340|FG000|Overall Study|Out of country for 2 months|1|||
23411640|NCT01831466|65249154|FG004|Overall Study|Lack of Efficacy|9|||
23411641|NCT01831466|65249155|FG005|Overall Study|Lack of Efficacy|8|||
23411642|NCT01831466|65249156|FG006|Overall Study|Lack of Efficacy|1|||
23411643|NCT01831466|65249157|FG007|Overall Study|Lack of Efficacy|1|||
23411644|NCT01831466|65249158|FG008|Overall Study|Lack of Efficacy|2|||
23411645|NCT01831466|65249159|FG009|Overall Study|Lack of Efficacy|2|||
23411646|NCT01831466|65249160|FG010|Overall Study|Lack of Efficacy|2|||
23411647|NCT01831466|65249161|FG011|Overall Study|Lack of Efficacy|0|||
23411648|NCT01831466|65249150|FG000|Overall Study|Adverse Event|0|||
23411649|NCT01831466|65249151|FG001|Overall Study|Adverse Event|0|||
23411650|NCT01831466|65249152|FG002|Overall Study|Adverse Event|4|||
23411651|NCT01831466|65249153|FG003|Overall Study|Adverse Event|6|||
23411652|NCT01831466|65249154|FG004|Overall Study|Adverse Event|3|||
23411653|NCT01831466|65249155|FG005|Overall Study|Adverse Event|7|||
23710300|NCT00751114|66315341|FG001|Overall Study|Out of country for 2 months|0|||
23710301|NCT00751114|66315340|FG000|Overall Study|Move to another city|1|||
23411654|NCT01831466|65249156|FG006|Overall Study|Adverse Event|0|||
23411655|NCT01831466|65249157|FG007|Overall Study|Adverse Event|1|||
23710302|NCT00751114|66315341|FG001|Overall Study|Move to another city|0|||
23411656|NCT01831466|65249158|FG008|Overall Study|Adverse Event|1|||
23710303|NCT01944969|66315344|FG000|Overall Study|Adverse Event|1|||
23710304|NCT01944969|66315344|FG000|Overall Study|Lack of Efficacy|1|||
23411657|NCT01831466|65249159|FG009|Overall Study|Adverse Event|1|||
23411658|NCT01831466|65249160|FG010|Overall Study|Adverse Event|0|||
23411659|NCT01831466|65249161|FG011|Overall Study|Adverse Event|2|||
23411660|NCT03604172|65249162|FG000|Overall Study|Lost to Follow-up|1|||
23411661|NCT03604172|65249163|FG001|Overall Study|Lost to Follow-up|2|||
23411662|NCT02370368|65252234|FG000|Overall Study|Adverse Event|1|||
23411663|NCT02370368|65252235|FG001|Overall Study|Adverse Event|2|||
23411664|NCT02370368|65252234|FG000|Overall Study|Withdrawal by Subject|5|||
23411665|NCT02370368|65252235|FG001|Overall Study|Withdrawal by Subject|4|||
23411666|NCT01700959|65252239|FG000|Overall Study|Adverse Event|0|||
23411667|NCT01700959|65252240|FG001|Overall Study|Adverse Event|1|||
23411668|NCT01700959|65252241|FG002|Overall Study|Adverse Event|1|||
23411669|NCT01700959|65252242|FG003|Overall Study|Adverse Event|2|||
23411670|NCT01700959|65252243|FG004|Overall Study|Adverse Event|0|||
23411671|NCT01700959|65252244|FG005|Overall Study|Adverse Event|2|||
23411672|NCT01700959|65252239|FG000|Overall Study|Withdrawal by Subject|15|||
23411673|NCT01700959|65252240|FG001|Overall Study|Withdrawal by Subject|9|||
23411674|NCT01700959|65252241|FG002|Overall Study|Withdrawal by Subject|12|||
23411675|NCT01700959|65252242|FG003|Overall Study|Withdrawal by Subject|11|||
23411676|NCT01700959|65252243|FG004|Overall Study|Withdrawal by Subject|8|||
23411677|NCT01700959|65252244|FG005|Overall Study|Withdrawal by Subject|12|||
23411678|NCT01700959|65252239|FG000|Overall Study|Ineligible|2|||
23411679|NCT01700959|65252240|FG001|Overall Study|Ineligible|1|||
23411680|NCT01700959|65252241|FG002|Overall Study|Ineligible|2|||
23411681|NCT01700959|65252242|FG003|Overall Study|Ineligible|0|||
23411682|NCT01700959|65252243|FG004|Overall Study|Ineligible|0|||
23411683|NCT01700959|65252244|FG005|Overall Study|Ineligible|1|||
23411684|NCT01700959|65252239|FG000|Overall Study|Noncompliant|9|||
23411685|NCT01700959|65252240|FG001|Overall Study|Noncompliant|9|||
23411686|NCT01700959|65252241|FG002|Overall Study|Noncompliant|17|||
23411687|NCT01700959|65252242|FG003|Overall Study|Noncompliant|18|||
23411688|NCT01700959|65252243|FG004|Overall Study|Noncompliant|15|||
23411689|NCT01700959|65252244|FG005|Overall Study|Noncompliant|9|||
23411690|NCT01700959|65252239|FG000|Overall Study|Side effects|1|||
23411691|NCT01700959|65252240|FG001|Overall Study|Side effects|4|||
23511649|NCT01327885|65609436|FG001|Overall Study|Withdrawal of consent from study|4|||
23511650|NCT01327885|65609435|FG000|Overall Study|Not treated|1|||
23511651|NCT01327885|65609436|FG001|Overall Study|Not treated|1|||
23511652|NCT01327885|65609435|FG000|Overall Study|Administrative decision|0|||
23511653|NCT01327885|65609436|FG001|Overall Study|Administrative decision|1|||
23511654|NCT03090152|65609437|FG000|Overall Study|Withdrawal by Subject|0|||
23511655|NCT03090152|65609438|FG001|Overall Study|Withdrawal by Subject|2|||
23511656|NCT03090152|65609439|FG002|Overall Study|Withdrawal by Subject|1|||
23511657|NCT03090152|65609437|FG000|Overall Study|Surgery Canceled|1|||
23511658|NCT03090152|65609438|FG001|Overall Study|Surgery Canceled|0|||
23710305|NCT01944969|66315344|FG000|Overall Study|Non-compliance with IMP|1|||
23710306|NCT01944969|66315344|FG000|Overall Study|Administrative or other reasons|23|||
23710307|NCT02106455|66315345|FG000|Overall Study|Case Report Form Uncollected|6|||
23710308|NCT02106455|66315345|FG000|Overall Study|Protocol Deviation|2|||
23710309|NCT03105700|66315347|FG000|Overall Study|screen fail|3|||
23710310|NCT03105700|66315347|FG000|Overall Study|Lost to Follow-up|4|||
23710311|NCT02546674|66315362|FG000|Overall Study|Adverse Event|19|||
23710312|NCT02546674|66315362|FG000|Overall Study|Death|1|||
23710313|NCT02546674|66315362|FG000|Overall Study|Lost to Follow-up|1|||
23710314|NCT02546674|66315362|FG000|Overall Study|Physician Decision|13|||
23710315|NCT02546674|66315362|FG000|Overall Study|Pregnancy|1|||
23710316|NCT02546674|66315362|FG000|Overall Study|Progressive Disease|2|||
23710317|NCT02546674|66315362|FG000|Overall Study|Protocol Deviation|2|||
23710318|NCT02546674|66315362|FG000|Overall Study|Subject/Guardian Decision|6|||
23710319|NCT02546674|66315362|FG000|Overall Study|Withdrawal of Informed Consent|3|||
23710320|NCT05216406|66315367|FG000|Overall Study|Lost to Follow-up|8|||
23710321|NCT05216406|66315368|FG001|Overall Study|Lost to Follow-up|9|||
23710322|NCT04348591|66315369|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
23710323|NCT04348591|66315370|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
23710324|NCT04348591|66315369|FG000|Imaging Session (120 Min)|Physician Decision|0|||
23710325|NCT04348591|66315370|FG001|Imaging Session (120 Min)|Physician Decision|1|||
23710326|NCT04348591|66315369|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
23710327|NCT04348591|66315370|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
23411692|NCT01700959|65252241|FG002|Overall Study|Side effects|8|||
23411693|NCT01700959|65252242|FG003|Overall Study|Side effects|4|||
23511659|NCT03090152|65609439|FG002|Overall Study|Surgery Canceled|0|||
23511660|NCT03090152|65609437|FG000|Overall Study|Epidural catheter could not be placed|0|||
23710328|NCT01669811|66315379|FG000|Overall Study|Investigator decision|0|||
23710329|NCT01669811|66315380|FG001|Overall Study|Investigator decision|1|||
23710330|NCT01669811|66315379|FG000|Overall Study|Withdrawal by Subject|1|||
23710331|NCT01669811|66315380|FG001|Overall Study|Withdrawal by Subject|2|||
23610584|NCT02676778|65962810|FG001|Overall Study|Withdrawal by Subject|2|||
23811970|NCT03301623|66691856|FG001|Overall Study|Lost to Follow-up|1|||
23411694|NCT01700959|65252243|FG004|Overall Study|Side effects|4|||
23411695|NCT01700959|65252244|FG005|Overall Study|Side effects|1|||
23411696|NCT01188551|65252245|FG000|Overall Study|Pharmacy issues|1|||
23411697|NCT01188551|65252246|FG001|Overall Study|Pharmacy issues|0|||
23411698|NCT01188551|65252247|FG002|Overall Study|Pharmacy issues|0|||
23411699|NCT01188551|65252248|FG003|Overall Study|Pharmacy issues|0|||
23511661|NCT03090152|65609438|FG001|Overall Study|Epidural catheter could not be placed|2|||
23511662|NCT03090152|65609439|FG002|Overall Study|Epidural catheter could not be placed|0|||
23511663|NCT01059799|65609446|FG000|Overall Study|Adverse Event|2|||
23511664|NCT01059799|65609447|FG001|Overall Study|Adverse Event|3|||
23511665|NCT01059799|65609446|FG000|Overall Study|Lack of Efficacy|1|||
23511666|NCT01059799|65609447|FG001|Overall Study|Lack of Efficacy|0|||
23710332|NCT01669811|66315379|FG000|Overall Study|Adverse Event|2|||
23710333|NCT01669811|66315380|FG001|Overall Study|Adverse Event|6|||
23710334|NCT01669811|66315379|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23710335|NCT01669811|66315380|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23710336|NCT03136367|66315384|FG000|T1 Consultation|discontinued mistakenly included|2|||
23710337|NCT03136367|66315385|FG001|T1 Consultation|discontinued mistakenly included|6|||
23710338|NCT03136367|66315386|FG002|T1 Consultation|discontinued mistakenly included|1|||
23710339|NCT03136367|66315384|FG000|T1 Consultation|Discontinued other|0|||
23710340|NCT03136367|66315385|FG001|T1 Consultation|Discontinued other|1|||
23710341|NCT03136367|66315386|FG002|T1 Consultation|Discontinued other|0|||
23710342|NCT03136367|66315384|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
23710343|NCT03136367|66315385|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
23710344|NCT03136367|66315386|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
23411700|NCT02120781|65252258|FG000|Overall Study|Physician Decision|2|||
23411701|NCT02120781|65252259|FG001|Overall Study|Physician Decision|0|||
23411702|NCT02120781|65252258|FG000|Overall Study|Completion not documented|2|||
23411703|NCT02120781|65252259|FG001|Overall Study|Completion not documented|1|||
23411704|NCT00249808|65252260|FG000|Overall Study|Other|27|||
23411705|NCT00249808|65252260|FG000|Overall Study|Protocol Violation|3|||
23411706|NCT00249808|65252260|FG000|Overall Study|Lost to Follow-up|8|||
23411707|NCT00249808|65252260|FG000|Overall Study|Adverse Event|81|||
23411708|NCT00249808|65252260|FG000|Overall Study|Lack of Efficacy|52|||
23411709|NCT00249808|65252260|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
23411710|NCT03711370|65252261|FG000|Overall Study|Lost to Follow-up|16|||
23411711|NCT03711370|65252262|FG001|Overall Study|Lost to Follow-up|10|||
23411712|NCT03711370|65252261|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
23411713|NCT03711370|65252262|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
23411714|NCT04245449|65252263|FG000|Overall Study|COVID shutdown|7|||
23411715|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23411716|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23511667|NCT01059799|65609446|FG000|Overall Study|Protocol Violation|3|||
23511668|NCT01059799|65609447|FG001|Overall Study|Protocol Violation|2|||
23511669|NCT01059799|65609446|FG000|Overall Study|Withdrawal criteria|13|||
23511670|NCT01059799|65609447|FG001|Overall Study|Withdrawal criteria|2|||
23511671|NCT01059799|65609446|FG000|Overall Study|Other|12|||
23511672|NCT01059799|65609447|FG001|Overall Study|Other|3|||
23511673|NCT01996982|65609459|FG000|Overall Study|PI/team left institution|7|||
23511674|NCT00750204|65609460|FG000|Overall Study|study halted prematurely|1|||
23511675|NCT00750204|65609461|FG001|Overall Study|study halted prematurely|1|||
23511676|NCT04626297|65609473|FG000|Overall Study|Adverse Event|5|||
23511677|NCT04626297|65609474|FG001|Overall Study|Adverse Event|3|||
23511678|NCT04626297|65609473|FG000|Overall Study|Lost to Follow-up|7|||
23511679|NCT04626297|65609474|FG001|Overall Study|Lost to Follow-up|3|||
23511680|NCT04626297|65609473|FG000|Overall Study|Protocol Violation|5|||
23511681|NCT04626297|65609474|FG001|Overall Study|Protocol Violation|1|||
23511682|NCT04626297|65609473|FG000|Overall Study|Withdrawal by Subject|20|||
23511683|NCT04626297|65609474|FG001|Overall Study|Withdrawal by Subject|6|||
23511684|NCT04626297|65609473|FG000|Overall Study|Sponsor decision|2|||
23511685|NCT04626297|65609474|FG001|Overall Study|Sponsor decision|1|||
23511686|NCT04876274|65609475|FG000|Overall Study|Lost to Follow-up|9|||
23511687|NCT04876274|65609476|FG001|Overall Study|Lost to Follow-up|12|||
23511688|NCT01314443|65609477|FG000|Overall Study|Withdrawal by Subject|2|||
23511689|NCT01314443|65609478|FG001|Overall Study|Withdrawal by Subject|1|||
23511690|NCT01314443|65609479|FG002|Overall Study|Withdrawal by Subject|1|||
23511691|NCT01314443|65609480|FG003|Overall Study|Withdrawal by Subject|1|||
23511692|NCT01314443|65609477|FG000|Overall Study|Protocol Violation|2|||
23511693|NCT01314443|65609478|FG001|Overall Study|Protocol Violation|2|||
23710345|NCT03136367|66315384|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
23710346|NCT03136367|66315385|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
23710347|NCT03136367|66315386|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
23411717|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23411718|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Adverse Event|1|||
23511694|NCT01314443|65609479|FG002|Overall Study|Protocol Violation|1|||
23511695|NCT01314443|65609480|FG003|Overall Study|Protocol Violation|1|||
23411719|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Adverse Event|0|||
23411720|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Adverse Event|0|||
23411721|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Adverse Event|0|||
23411722|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23511696|NCT02282020|65609485|FG000|Overall Study|Objective Disease Progression|128|||
23411723|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411724|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411725|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411726|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
23411727|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411728|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411729|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
23411730|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23411731|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
23411732|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23411733|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
23411734|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
23411735|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
23411736|NCT01147250|65252276|FG000|Overall Study|Lost to Follow-up|14|||
23411737|NCT01147250|65252277|FG001|Overall Study|Lost to Follow-up|11|||
23411738|NCT01147250|65252276|FG000|Overall Study|Withdrawal by Subject|83|||
23411739|NCT01147250|65252277|FG001|Overall Study|Withdrawal by Subject|88|||
23411740|NCT01147250|65252276|FG000|Overall Study|Site termination by sponsor|13|||
23411741|NCT01147250|65252277|FG001|Overall Study|Site termination by sponsor|5|||
23411742|NCT01147250|65252276|FG000|Overall Study|Other than specified|0|||
23411743|NCT01147250|65252277|FG001|Overall Study|Other than specified|1|||
23411744|NCT02574078|65252286|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411745|NCT02574078|65252287|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411746|NCT02574078|65252288|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411747|NCT02574078|65252289|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411748|NCT02574078|65252290|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411749|NCT02574078|65252291|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23411750|NCT02574078|65252292|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
23411751|NCT02574078|65252293|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411752|NCT02574078|65252294|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23411753|NCT02574078|65252295|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411754|NCT02574078|65252296|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411755|NCT02574078|65252297|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411756|NCT02574078|65252298|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411757|NCT02574078|65252286|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23411758|NCT02574078|65252287|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23411759|NCT02574078|65252288|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
23411760|NCT02574078|65252289|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
23411761|NCT02574078|65252290|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
23411762|NCT02574078|65252291|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
23411763|NCT02574078|65252292|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
23411764|NCT02574078|65252293|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
23411765|NCT02574078|65252294|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
23411766|NCT02574078|65252295|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
23511697|NCT02282020|65609486|FG001|Overall Study|Objective Disease Progression|30|||
23511698|NCT02282020|65609485|FG000|Overall Study|Adverse Event|18|||
23511699|NCT02282020|65609486|FG001|Overall Study|Adverse Event|15|||
23511700|NCT02282020|65609485|FG000|Overall Study|Withdrawal by Subject|7|||
23511701|NCT02282020|65609486|FG001|Overall Study|Withdrawal by Subject|10|||
23511702|NCT02282020|65609485|FG000|Overall Study|Miscellaneous|5|||
23511703|NCT02282020|65609486|FG001|Overall Study|Miscellaneous|19|||
23511704|NCT02282020|65609485|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
23511705|NCT02282020|65609486|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
23511706|NCT02282020|65609485|FG000|Overall Study|Developed Discontinuation Criteria|0|||
23511707|NCT02282020|65609486|FG001|Overall Study|Developed Discontinuation Criteria|2|||
23511708|NCT02282020|65609485|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
23511709|NCT02282020|65609486|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
23511710|NCT01585194|65609487|FG000|Overall Study|Withdrawal by Subject|1|||
23511711|NCT01585194|65609487|FG000|Overall Study|Physician Decision|2|||
23710348|NCT03136367|66315384|FG000|T2 Post-consultation|Discontinued other|0|||
23511712|NCT01585194|65609487|FG000|Overall Study|Lack of insurance|1|||
23411767|NCT02574078|65252296|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
23411768|NCT02574078|65252297|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
23411769|NCT02574078|65252298|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
23411770|NCT02574078|65252286|FG000|Pre-Treatment Period|Other reasons|0|||
23411771|NCT02574078|65252287|FG001|Pre-Treatment Period|Other reasons|0|||
23411772|NCT02574078|65252288|FG002|Pre-Treatment Period|Other reasons|0|||
23411773|NCT02574078|65252289|FG003|Pre-Treatment Period|Other reasons|0|||
23411774|NCT02574078|65252290|FG004|Pre-Treatment Period|Other reasons|0|||
23511713|NCT00877383|65609491|FG000|Overall Study|Adverse Event|13|||
23411775|NCT02574078|65252291|FG005|Pre-Treatment Period|Other reasons|0|||
23411776|NCT02574078|65252292|FG006|Pre-Treatment Period|Other reasons|2|||
23411777|NCT02574078|65252293|FG007|Pre-Treatment Period|Other reasons|0|||
23411778|NCT02574078|65252294|FG008|Pre-Treatment Period|Other reasons|0|||
23411779|NCT02574078|65252295|FG009|Pre-Treatment Period|Other reasons|0|||
23411780|NCT02574078|65252296|FG010|Pre-Treatment Period|Other reasons|2|||
23411781|NCT02574078|65252297|FG011|Pre-Treatment Period|Other reasons|0|||
23411782|NCT02574078|65252298|FG012|Pre-Treatment Period|Other reasons|0|||
23411783|NCT02574078|65252286|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
23411784|NCT02574078|65252287|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
23411785|NCT02574078|65252288|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
23411786|NCT02574078|65252289|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
23411787|NCT02574078|65252290|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
23411788|NCT02574078|65252291|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
23411789|NCT02574078|65252292|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
23411790|NCT02574078|65252293|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
23411791|NCT02574078|65252294|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
23411792|NCT02574078|65252295|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
23411793|NCT02574078|65252296|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
23411794|NCT02574078|65252297|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
23411795|NCT02574078|65252298|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
23411796|NCT02574078|65252286|FG000|Treatment Period|Disease progression|6|||
23411797|NCT02574078|65252287|FG001|Treatment Period|Disease progression|4|||
23411798|NCT02574078|65252288|FG002|Treatment Period|Disease progression|7|||
23411799|NCT02574078|65252289|FG003|Treatment Period|Disease progression|18|||
23411800|NCT02574078|65252290|FG004|Treatment Period|Disease progression|16|||
23411801|NCT02574078|65252291|FG005|Treatment Period|Disease progression|26|||
23411802|NCT02574078|65252292|FG006|Treatment Period|Disease progression|5|||
23411803|NCT02574078|65252293|FG007|Treatment Period|Disease progression|9|||
23411804|NCT02574078|65252294|FG008|Treatment Period|Disease progression|8|||
23411805|NCT02574078|65252295|FG009|Treatment Period|Disease progression|5|||
23411806|NCT02574078|65252296|FG010|Treatment Period|Disease progression|20|||
23411807|NCT02574078|65252297|FG011|Treatment Period|Disease progression|29|||
23411808|NCT02574078|65252298|FG012|Treatment Period|Disease progression|2|||
23411809|NCT02574078|65252286|FG000|Treatment Period|Study drug toxicity|1|||
23411810|NCT02574078|65252287|FG001|Treatment Period|Study drug toxicity|1|||
23411811|NCT02574078|65252288|FG002|Treatment Period|Study drug toxicity|0|||
23411812|NCT02574078|65252289|FG003|Treatment Period|Study drug toxicity|5|||
23411813|NCT02574078|65252290|FG004|Treatment Period|Study drug toxicity|3|||
23411814|NCT02574078|65252291|FG005|Treatment Period|Study drug toxicity|1|||
23411815|NCT02574078|65252292|FG006|Treatment Period|Study drug toxicity|2|||
23411816|NCT02574078|65252293|FG007|Treatment Period|Study drug toxicity|0|||
23411817|NCT02574078|65252294|FG008|Treatment Period|Study drug toxicity|2|||
23411818|NCT02574078|65252295|FG009|Treatment Period|Study drug toxicity|1|||
23411819|NCT02574078|65252296|FG010|Treatment Period|Study drug toxicity|16|||
23411820|NCT02574078|65252297|FG011|Treatment Period|Study drug toxicity|2|||
23411821|NCT02574078|65252298|FG012|Treatment Period|Study drug toxicity|4|||
23411822|NCT02574078|65252286|FG000|Treatment Period|Death|2|||
23411823|NCT02574078|65252287|FG001|Treatment Period|Death|0|||
23411824|NCT02574078|65252288|FG002|Treatment Period|Death|0|||
23411825|NCT02574078|65252289|FG003|Treatment Period|Death|0|||
23411826|NCT02574078|65252290|FG004|Treatment Period|Death|1|||
23411827|NCT02574078|65252291|FG005|Treatment Period|Death|1|||
23411828|NCT02574078|65252292|FG006|Treatment Period|Death|1|||
23411829|NCT02574078|65252293|FG007|Treatment Period|Death|1|||
23411830|NCT02574078|65252294|FG008|Treatment Period|Death|7|||
23411831|NCT02574078|65252295|FG009|Treatment Period|Death|1|||
23411832|NCT02574078|65252296|FG010|Treatment Period|Death|0|||
23411833|NCT02574078|65252297|FG011|Treatment Period|Death|2|||
23411834|NCT02574078|65252298|FG012|Treatment Period|Death|1|||
23411835|NCT02574078|65252286|FG000|Treatment Period|Adverse event unrelated to drug|0|||
23411836|NCT02574078|65252287|FG001|Treatment Period|Adverse event unrelated to drug|0|||
23411837|NCT02574078|65252288|FG002|Treatment Period|Adverse event unrelated to drug|1|||
23411838|NCT02574078|65252289|FG003|Treatment Period|Adverse event unrelated to drug|0|||
23411839|NCT02574078|65252290|FG004|Treatment Period|Adverse event unrelated to drug|2|||
23511714|NCT00877383|65609492|FG001|Overall Study|Adverse Event|14|||
23511715|NCT00877383|65609491|FG000|Overall Study|Lost to Follow-up|5|||
23411840|NCT02574078|65252291|FG005|Treatment Period|Adverse event unrelated to drug|3|||
23411841|NCT02574078|65252292|FG006|Treatment Period|Adverse event unrelated to drug|0|||
23411842|NCT02574078|65252293|FG007|Treatment Period|Adverse event unrelated to drug|0|||
23411843|NCT02574078|65252294|FG008|Treatment Period|Adverse event unrelated to drug|1|||
23411844|NCT02574078|65252295|FG009|Treatment Period|Adverse event unrelated to drug|2|||
23411845|NCT02574078|65252296|FG010|Treatment Period|Adverse event unrelated to drug|4|||
23411846|NCT02574078|65252297|FG011|Treatment Period|Adverse event unrelated to drug|1|||
23411847|NCT02574078|65252298|FG012|Treatment Period|Adverse event unrelated to drug|0|||
23411848|NCT02574078|65252286|FG000|Treatment Period|Administrative reason by Sponsor|0|||
23411849|NCT02574078|65252287|FG001|Treatment Period|Administrative reason by Sponsor|1|||
23411850|NCT02574078|65252288|FG002|Treatment Period|Administrative reason by Sponsor|0|||
23411851|NCT02574078|65252289|FG003|Treatment Period|Administrative reason by Sponsor|0|||
23411852|NCT02574078|65252290|FG004|Treatment Period|Administrative reason by Sponsor|0|||
23411853|NCT02574078|65252291|FG005|Treatment Period|Administrative reason by Sponsor|0|||
23411854|NCT02574078|65252292|FG006|Treatment Period|Administrative reason by Sponsor|1|||
23411855|NCT02574078|65252293|FG007|Treatment Period|Administrative reason by Sponsor|0|||
23411856|NCT02574078|65252294|FG008|Treatment Period|Administrative reason by Sponsor|0|||
23411857|NCT02574078|65252295|FG009|Treatment Period|Administrative reason by Sponsor|0|||
23411858|NCT02574078|65252296|FG010|Treatment Period|Administrative reason by Sponsor|0|||
23411859|NCT02574078|65252297|FG011|Treatment Period|Administrative reason by Sponsor|0|||
23411860|NCT02574078|65252298|FG012|Treatment Period|Administrative reason by Sponsor|3|||
23411861|NCT02574078|65252286|FG000|Treatment Period|Other reasons|1|||
23411862|NCT02574078|65252287|FG001|Treatment Period|Other reasons|0|||
23411863|NCT02574078|65252288|FG002|Treatment Period|Other reasons|1|||
23411864|NCT02574078|65252289|FG003|Treatment Period|Other reasons|3|||
23411865|NCT02574078|65252290|FG004|Treatment Period|Other reasons|3|||
23411866|NCT02574078|65252291|FG005|Treatment Period|Other reasons|1|||
23411867|NCT02574078|65252292|FG006|Treatment Period|Other reasons|2|||
23411868|NCT02574078|65252293|FG007|Treatment Period|Other reasons|1|||
23411869|NCT02574078|65252294|FG008|Treatment Period|Other reasons|3|||
23411870|NCT02574078|65252295|FG009|Treatment Period|Other reasons|1|||
23411871|NCT02574078|65252296|FG010|Treatment Period|Other reasons|1|||
23411872|NCT02574078|65252297|FG011|Treatment Period|Other reasons|3|||
23411873|NCT02574078|65252298|FG012|Treatment Period|Other reasons|1|||
23411874|NCT02574078|65252286|FG000|Treatment Period|Participant request to stop drug|0|||
23411875|NCT02574078|65252287|FG001|Treatment Period|Participant request to stop drug|0|||
23411876|NCT02574078|65252288|FG002|Treatment Period|Participant request to stop drug|0|||
23411877|NCT02574078|65252289|FG003|Treatment Period|Participant request to stop drug|2|||
23411878|NCT02574078|65252290|FG004|Treatment Period|Participant request to stop drug|4|||
23411879|NCT02574078|65252291|FG005|Treatment Period|Participant request to stop drug|0|||
23411880|NCT02574078|65252292|FG006|Treatment Period|Participant request to stop drug|1|||
23411881|NCT02574078|65252293|FG007|Treatment Period|Participant request to stop drug|0|||
23411882|NCT02574078|65252294|FG008|Treatment Period|Participant request to stop drug|3|||
23411883|NCT02574078|65252295|FG009|Treatment Period|Participant request to stop drug|2|||
23411884|NCT02574078|65252296|FG010|Treatment Period|Participant request to stop drug|2|||
23411885|NCT02574078|65252297|FG011|Treatment Period|Participant request to stop drug|4|||
23411886|NCT02574078|65252298|FG012|Treatment Period|Participant request to stop drug|1|||
23411887|NCT02574078|65252286|FG000|Treatment Period|Participant withdrew consent|0|||
23411888|NCT02574078|65252287|FG001|Treatment Period|Participant withdrew consent|0|||
23411889|NCT02574078|65252288|FG002|Treatment Period|Participant withdrew consent|0|||
23411890|NCT02574078|65252289|FG003|Treatment Period|Participant withdrew consent|0|||
23411891|NCT02574078|65252290|FG004|Treatment Period|Participant withdrew consent|1|||
23411892|NCT02574078|65252291|FG005|Treatment Period|Participant withdrew consent|1|||
23411893|NCT02574078|65252292|FG006|Treatment Period|Participant withdrew consent|0|||
23411894|NCT02574078|65252293|FG007|Treatment Period|Participant withdrew consent|1|||
23411895|NCT02574078|65252294|FG008|Treatment Period|Participant withdrew consent|0|||
23411896|NCT02574078|65252295|FG009|Treatment Period|Participant withdrew consent|2|||
23411897|NCT02574078|65252296|FG010|Treatment Period|Participant withdrew consent|1|||
23411898|NCT02574078|65252297|FG011|Treatment Period|Participant withdrew consent|4|||
23411899|NCT02574078|65252298|FG012|Treatment Period|Participant withdrew consent|1|||
23411900|NCT02574078|65252286|FG000|Treatment Period|Participant no longer meets criteria|0|||
23411901|NCT02574078|65252287|FG001|Treatment Period|Participant no longer meets criteria|0|||
23411902|NCT02574078|65252288|FG002|Treatment Period|Participant no longer meets criteria|0|||
23411903|NCT02574078|65252289|FG003|Treatment Period|Participant no longer meets criteria|0|||
23411904|NCT02574078|65252290|FG004|Treatment Period|Participant no longer meets criteria|1|||
23411905|NCT02574078|65252291|FG005|Treatment Period|Participant no longer meets criteria|0|||
23411906|NCT02574078|65252292|FG006|Treatment Period|Participant no longer meets criteria|0|||
23411907|NCT02574078|65252293|FG007|Treatment Period|Participant no longer meets criteria|0|||
23411908|NCT02574078|65252294|FG008|Treatment Period|Participant no longer meets criteria|0|||
23411909|NCT02574078|65252295|FG009|Treatment Period|Participant no longer meets criteria|1|||
23411910|NCT02574078|65252296|FG010|Treatment Period|Participant no longer meets criteria|1|||
23411911|NCT02574078|65252297|FG011|Treatment Period|Participant no longer meets criteria|1|||
23411912|NCT02574078|65252298|FG012|Treatment Period|Participant no longer meets criteria|0|||
23411913|NCT02574078|65252286|FG000|Treatment Period|Lost to Follow-up|0|||
23411914|NCT02574078|65252287|FG001|Treatment Period|Lost to Follow-up|0|||
23411915|NCT02574078|65252288|FG002|Treatment Period|Lost to Follow-up|0|||
23411916|NCT02574078|65252289|FG003|Treatment Period|Lost to Follow-up|0|||
23411917|NCT02574078|65252290|FG004|Treatment Period|Lost to Follow-up|0|||
23411918|NCT02574078|65252291|FG005|Treatment Period|Lost to Follow-up|0|||
23411919|NCT02574078|65252292|FG006|Treatment Period|Lost to Follow-up|0|||
23411920|NCT02574078|65252293|FG007|Treatment Period|Lost to Follow-up|0|||
23411921|NCT02574078|65252294|FG008|Treatment Period|Lost to Follow-up|0|||
23411922|NCT02574078|65252295|FG009|Treatment Period|Lost to Follow-up|1|||
23411923|NCT02574078|65252296|FG010|Treatment Period|Lost to Follow-up|0|||
23411924|NCT02574078|65252297|FG011|Treatment Period|Lost to Follow-up|1|||
23411925|NCT02574078|65252298|FG012|Treatment Period|Lost to Follow-up|0|||
23710349|NCT03136367|66315385|FG001|T2 Post-consultation|Discontinued other|2|||
23710350|NCT03136367|66315386|FG002|T2 Post-consultation|Discontinued other|6|||
23710351|NCT03136367|66315384|FG000|T2 Post-consultation|Discontinued transferred care|0|||
23710352|NCT03136367|66315385|FG001|T2 Post-consultation|Discontinued transferred care|0|||
23411926|NCT02574078|65252286|FG000|Treatment Period|Maximum clinical benefit|0|||
23411927|NCT02574078|65252287|FG001|Treatment Period|Maximum clinical benefit|0|||
23411928|NCT02574078|65252288|FG002|Treatment Period|Maximum clinical benefit|0|||
23411929|NCT02574078|65252289|FG003|Treatment Period|Maximum clinical benefit|0|||
23411930|NCT02574078|65252290|FG004|Treatment Period|Maximum clinical benefit|0|||
23411931|NCT02574078|65252291|FG005|Treatment Period|Maximum clinical benefit|0|||
23411932|NCT02574078|65252292|FG006|Treatment Period|Maximum clinical benefit|0|||
23411933|NCT02574078|65252293|FG007|Treatment Period|Maximum clinical benefit|0|||
23411934|NCT02574078|65252294|FG008|Treatment Period|Maximum clinical benefit|0|||
23411935|NCT02574078|65252295|FG009|Treatment Period|Maximum clinical benefit|1|||
23411936|NCT02574078|65252296|FG010|Treatment Period|Maximum clinical benefit|0|||
23411937|NCT02574078|65252297|FG011|Treatment Period|Maximum clinical benefit|0|||
23411938|NCT02574078|65252298|FG012|Treatment Period|Maximum clinical benefit|0|||
23411939|NCT03292874|65252299|FG000|Overall Study|Due to pandemic|5|||
23411940|NCT00553436|65252300|FG000|Overall Study|Conversion to another procedure|1|||
23411941|NCT01054560|65252303|FG000|Overall Study|Death|10|||
23411942|NCT01054560|65252304|FG001|Overall Study|Death|21|||
23411943|NCT01054560|65252303|FG000|Overall Study|Lost to Follow-up|2|||
23411944|NCT01054560|65252304|FG001|Overall Study|Lost to Follow-up|5|||
23411945|NCT01054560|65252303|FG000|Overall Study|Withdrawal by Subject|0|||
23411946|NCT01054560|65252304|FG001|Overall Study|Withdrawal by Subject|2|||
23411947|NCT01054560|65252303|FG000|Overall Study|Physician Decision|1|||
23411948|NCT01054560|65252304|FG001|Overall Study|Physician Decision|0|||
23411949|NCT03818607|65252305|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
23411950|NCT03818607|65252306|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
23411951|NCT03818607|65252305|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
23411952|NCT03818607|65252306|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
23411953|NCT03818607|65252305|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
23411954|NCT03818607|65252306|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
23411955|NCT02231892|65252312|FG000|Overall Study|Lost to Follow-up|1|||
23411956|NCT02231892|65252313|FG001|Overall Study|Lost to Follow-up|0|||
23411957|NCT02231892|65252314|FG002|Overall Study|Lost to Follow-up|3|||
23411958|NCT02231892|65252312|FG000|Overall Study|Withdrawal by Subject|4|||
23411959|NCT02231892|65252313|FG001|Overall Study|Withdrawal by Subject|3|||
23411960|NCT02231892|65252314|FG002|Overall Study|Withdrawal by Subject|15|||
23411961|NCT02231892|65252312|FG000|Overall Study|Physician Decision|0|||
23411962|NCT02231892|65252313|FG001|Overall Study|Physician Decision|2|||
23411963|NCT02231892|65252314|FG002|Overall Study|Physician Decision|4|||
23411964|NCT02231892|65252312|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
23411965|NCT02231892|65252313|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
23411966|NCT02231892|65252314|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
23411967|NCT02231892|65252312|FG000|Overall Study|Participant motor threshold was >83%|0|||
23411968|NCT02231892|65252313|FG001|Overall Study|Participant motor threshold was >83%|0|||
23411969|NCT02231892|65252314|FG002|Overall Study|Participant motor threshold was >83%|9|||
23411970|NCT02231892|65252312|FG000|Overall Study|Could not find motor threshold|2|||
23411971|NCT02231892|65252313|FG001|Overall Study|Could not find motor threshold|0|||
23411972|NCT02231892|65252314|FG002|Overall Study|Could not find motor threshold|1|||
23411973|NCT02231892|65252312|FG000|Overall Study|Could not find reliable motor hotspot|0|||
23411974|NCT02231892|65252313|FG001|Overall Study|Could not find reliable motor hotspot|0|||
23411975|NCT02231892|65252314|FG002|Overall Study|Could not find reliable motor hotspot|1|||
23411976|NCT01562314|65252315|FG000|Overall Study|Adverse Event|10|||
23411977|NCT01562314|65252316|FG001|Overall Study|Adverse Event|5|||
23411978|NCT01562314|65252315|FG000|Overall Study|Met Withdrawal Criteria|3|||
23411979|NCT01562314|65252316|FG001|Overall Study|Met Withdrawal Criteria|2|||
23411980|NCT01562314|65252315|FG000|Overall Study|Withdrawal by Subject|0|||
23411981|NCT01562314|65252316|FG001|Overall Study|Withdrawal by Subject|1|||
23411982|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
23411983|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
23411984|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
23411985|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
23411986|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
23411987|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
23411988|NCT01202188|65252318|FG000|Overall Study|Protocol deviation|14|||
23411989|NCT01202188|65252319|FG001|Overall Study|Protocol deviation|8|||
23411990|NCT01202188|65252320|FG002|Overall Study|Protocol deviation|12|||
23411991|NCT01202188|65252321|FG003|Overall Study|Protocol deviation|10|||
23411992|NCT01202188|65252322|FG004|Overall Study|Protocol deviation|11|||
23411993|NCT01202188|65252318|FG000|Overall Study|Subject withdrew consent|12|||
23411994|NCT01202188|65252319|FG001|Overall Study|Subject withdrew consent|13|||
23411995|NCT01202188|65252320|FG002|Overall Study|Subject withdrew consent|22|||
23411996|NCT01202188|65252321|FG003|Overall Study|Subject withdrew consent|11|||
23411997|NCT01202188|65252322|FG004|Overall Study|Subject withdrew consent|13|||
23411998|NCT01202188|65252318|FG000|Overall Study|Adverse Event|5|||
23411999|NCT01202188|65252319|FG001|Overall Study|Adverse Event|23|||
23412000|NCT01202188|65252320|FG002|Overall Study|Adverse Event|13|||
23412001|NCT01202188|65252321|FG003|Overall Study|Adverse Event|10|||
23412002|NCT01202188|65252322|FG004|Overall Study|Adverse Event|10|||
23412003|NCT01202188|65252318|FG000|Overall Study|Administrative problems|3|||
23412004|NCT01202188|65252319|FG001|Overall Study|Administrative problems|2|||
23412005|NCT01202188|65252320|FG002|Overall Study|Administrative problems|1|||
23412006|NCT01202188|65252321|FG003|Overall Study|Administrative problems|1|||
23412007|NCT01202188|65252322|FG004|Overall Study|Administrative problems|2|||
23412008|NCT01202188|65252318|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23412009|NCT01202188|65252319|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23412010|NCT01202188|65252320|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23412011|NCT01202188|65252321|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
23412012|NCT01202188|65252322|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
23412013|NCT01202188|65252318|FG000|Overall Study|Lost to Follow-up|1|||
23412014|NCT01202188|65252319|FG001|Overall Study|Lost to Follow-up|1|||
23412015|NCT01202188|65252320|FG002|Overall Study|Lost to Follow-up|0|||
23412016|NCT01202188|65252321|FG003|Overall Study|Lost to Follow-up|4|||
23412017|NCT01202188|65252322|FG004|Overall Study|Lost to Follow-up|1|||
23412018|NCT01202188|65252318|FG000|Overall Study|Death|1|||
23412019|NCT01202188|65252319|FG001|Overall Study|Death|1|||
23412020|NCT01202188|65252320|FG002|Overall Study|Death|1|||
23412021|NCT01202188|65252321|FG003|Overall Study|Death|1|||
23412022|NCT01202188|65252322|FG004|Overall Study|Death|0|||
23412023|NCT01202188|65252318|FG000|Overall Study|Abnormal test procedure result (s)|0|||
23412024|NCT01202188|65252319|FG001|Overall Study|Abnormal test procedure result (s)|0|||
23412025|NCT01202188|65252320|FG002|Overall Study|Abnormal test procedure result (s)|2|||
23710353|NCT03136367|66315386|FG002|T2 Post-consultation|Discontinued transferred care|3|||
23710354|NCT03136367|66315384|FG000|T2 Post-consultation|Discontinued lost contact|0|||
23710355|NCT03136367|66315385|FG001|T2 Post-consultation|Discontinued lost contact|1|||
23710356|NCT03136367|66315386|FG002|T2 Post-consultation|Discontinued lost contact|0|||
23710357|NCT03136367|66315384|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
23710358|NCT03136367|66315385|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
23710359|NCT03136367|66315386|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
23412026|NCT01202188|65252321|FG003|Overall Study|Abnormal test procedure result (s)|0|||
23412027|NCT01202188|65252322|FG004|Overall Study|Abnormal test procedure result (s)|0|||
23412028|NCT04154293|65252323|FG000|Overall Study|Withdrawal by Subject|2|||
23412029|NCT04154293|65252324|FG001|Overall Study|Withdrawal by Subject|3|||
23412030|NCT04154293|65252325|FG002|Overall Study|Withdrawal by Subject|1|||
23412031|NCT04154293|65252323|FG000|Overall Study|Physician Decision|0|||
23412032|NCT04154293|65252324|FG001|Overall Study|Physician Decision|0|||
23412033|NCT04154293|65252325|FG002|Overall Study|Physician Decision|1|||
23412034|NCT03028415|65252329|FG000|Overall Study|Lost to Follow-up|6|||
23412035|NCT03028415|65252330|FG001|Overall Study|Lost to Follow-up|3|||
23412036|NCT03028415|65252329|FG000|Overall Study|Withdrawal by Subject|1|||
23412037|NCT03028415|65252330|FG001|Overall Study|Withdrawal by Subject|0|||
23412038|NCT03028415|65252329|FG000|Overall Study|Discontinued due to COVID-19|1|||
23412039|NCT03028415|65252330|FG001|Overall Study|Discontinued due to COVID-19|0|||
23412040|NCT00964002|65252331|FG000|Overall Study|Protocol Violation|8|||
23412041|NCT03286543|65252332|FG000|Consented|Screen failure before randomization|2|||
23412042|NCT03286543|65252333|FG001|Consented|Screen failure before randomization|0|||
23412043|NCT03286543|65252334|FG002|Consented|Screen failure before randomization|0|||
23412044|NCT03286543|65252332|FG000|Consented|Screen failure before enrollment|4|||
23412045|NCT03286543|65252333|FG001|Consented|Screen failure before enrollment|0|||
23412046|NCT03286543|65252334|FG002|Consented|Screen failure before enrollment|0|||
23412047|NCT03286543|65252332|FG000|Consented|TKA cancelled after enrollment|1|||
23412048|NCT03286543|65252333|FG001|Consented|TKA cancelled after enrollment|0|||
23412049|NCT03286543|65252334|FG002|Consented|TKA cancelled after enrollment|0|||
23710360|NCT03136367|66315384|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
23412050|NCT03286543|65252332|FG000|Consented|Withdrawn from study|12|||
23412051|NCT03286543|65252333|FG001|Consented|Withdrawn from study|0|||
23412052|NCT03286543|65252334|FG002|Consented|Withdrawn from study|0|||
23412053|NCT03286543|65252332|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
23412054|NCT03286543|65252333|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
23412055|NCT03286543|65252334|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
23412056|NCT03286543|65252332|FG000|Study Enrollment|Withdrawn from study|0|||
23412057|NCT03286543|65252333|FG001|Study Enrollment|Withdrawn from study|6|||
23412058|NCT03286543|65252334|FG002|Study Enrollment|Withdrawn from study|6|||
23412059|NCT01001767|65252335|FG000|Overall Study|no baseline study performed|1|||
23412060|NCT01001767|65252336|FG001|Overall Study|no baseline study performed|0|||
23412061|NCT01001767|65252335|FG000|Overall Study|Protocol Violation|1|||
23412062|NCT01001767|65252336|FG001|Overall Study|Protocol Violation|0|||
23412063|NCT01001767|65252335|FG000|Overall Study|Lost to Follow-up|1|||
23412064|NCT01001767|65252336|FG001|Overall Study|Lost to Follow-up|0|||
23412065|NCT01001767|65252335|FG000|Overall Study|Physician Decision|1|||
23412066|NCT01001767|65252336|FG001|Overall Study|Physician Decision|0|||
23412067|NCT03640507|65252337|FG000|Overall Study|Withdrawal by Subject|0|||
23412068|NCT03640507|65252338|FG001|Overall Study|Withdrawal by Subject|0|||
23412069|NCT03640507|65252339|FG002|Overall Study|Withdrawal by Subject|1|||
23412070|NCT02516982|65252340|FG000|Overall Study|Called in to antenatal appointment|32|||
23412071|NCT02516982|65252341|FG001|Overall Study|Called in to antenatal appointment|35|||
23412072|NCT02516982|65252342|FG002|Overall Study|Called in to antenatal appointment|0|||
23412073|NCT02516982|65252343|FG003|Overall Study|Called in to antenatal appointment|0|||
23412074|NCT02516982|65252340|FG000|Overall Study|Withdrawal by Subject|0|||
23412075|NCT02516982|65252341|FG001|Overall Study|Withdrawal by Subject|0|||
23412076|NCT02516982|65252342|FG002|Overall Study|Withdrawal by Subject|1|||
23412077|NCT02516982|65252343|FG003|Overall Study|Withdrawal by Subject|2|||
23412078|NCT02516982|65252340|FG000|Overall Study|Protocol Violation|0|||
23412079|NCT02516982|65252341|FG001|Overall Study|Protocol Violation|0|||
23412080|NCT02516982|65252342|FG002|Overall Study|Protocol Violation|1|||
23412081|NCT02516982|65252343|FG003|Overall Study|Protocol Violation|1|||
23412082|NCT02516982|65252340|FG000|Overall Study|Did not install the app|0|||
23412083|NCT02516982|65252341|FG001|Overall Study|Did not install the app|0|||
23412084|NCT02516982|65252342|FG002|Overall Study|Did not install the app|46|||
23412085|NCT02516982|65252343|FG003|Overall Study|Did not install the app|47|||
23412086|NCT00500357|65252351|FG000|Overall Study|Death|1|||
23412087|NCT04209634|65252352|FG000|Overall Study|Ongoing|10|||
23412088|NCT00688467|65252355|FG000|Treatment Period 1|Adverse Event|2|||
23412089|NCT00688467|65252356|FG001|Treatment Period 1|Adverse Event|1|||
23412090|NCT00688467|65252355|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
23412091|NCT00688467|65252356|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
23412092|NCT00688467|65252355|FG000|Treatment Period 2|Protocol Violation|0|||
23412093|NCT00688467|65252356|FG001|Treatment Period 2|Protocol Violation|1|||
23412094|NCT00688467|65252355|FG000|Treatment Period 2|Adverse Event|0|||
23412095|NCT00688467|65252356|FG001|Treatment Period 2|Adverse Event|1|||
23412096|NCT02798315|65252357|FG000|Overall Study|Failure to return|1|||
23412097|NCT00577707|65252358|FG000|Overall Study|Withdrawal by Subject|3|||
23412098|NCT04188834|65252363|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
23412099|NCT03326063|65252364|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
23412100|NCT03326063|65252365|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
23412101|NCT02582814|65252366|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23412102|NCT02582814|65252367|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23412103|NCT02582814|65252366|FG000|Overall Study|Withdrawal by Subject|4|||
23412104|NCT02582814|65252367|FG001|Overall Study|Withdrawal by Subject|3|||
23412105|NCT02582814|65252366|FG000|Overall Study|Adverse Event|4|||
23412106|NCT02582814|65252367|FG001|Overall Study|Adverse Event|4|||
23412107|NCT00610857|65252368|FG000|Overall Study|Not evaluable for response|2|||
23412108|NCT00104416|65252371|FG000|Double-Blind Phase|Adverse Event|2|||
23412109|NCT00104416|65252372|FG001|Double-Blind Phase|Adverse Event|1|||
23412110|NCT00104416|65252373|FG002|Double-Blind Phase|Adverse Event|0|||
23412111|NCT00104416|65252374|FG003|Double-Blind Phase|Adverse Event|0|||
23412112|NCT00104416|65252375|FG004|Double-Blind Phase|Adverse Event|0|||
23412113|NCT00104416|65252371|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23412114|NCT00104416|65252372|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23412115|NCT00104416|65252373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23511716|NCT00877383|65609492|FG001|Overall Study|Lost to Follow-up|3|||
23511717|NCT00877383|65609491|FG000|Overall Study|Subject withdrew consent|3|||
23511718|NCT00877383|65609492|FG001|Overall Study|Subject withdrew consent|12|||
23511719|NCT00877383|65609491|FG000|Overall Study|Subject no longer requires study drug|2|||
23511720|NCT00877383|65609492|FG001|Overall Study|Subject no longer requires study drug|0|||
23511721|NCT00877383|65609491|FG000|Overall Study|Administrative problems|2|||
23511722|NCT00877383|65609492|FG001|Overall Study|Administrative problems|0|||
23511723|NCT00877383|65609491|FG000|Overall Study|Protocol deviation|2|||
23412116|NCT00104416|65252374|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23412117|NCT00104416|65252375|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23412118|NCT00104416|65252371|FG000|Double-Blind Phase|Protocol Violation|0|||
23412119|NCT00104416|65252372|FG001|Double-Blind Phase|Protocol Violation|1|||
23412120|NCT00104416|65252373|FG002|Double-Blind Phase|Protocol Violation|0|||
23412121|NCT00104416|65252374|FG003|Double-Blind Phase|Protocol Violation|0|||
23511724|NCT00877383|65609492|FG001|Overall Study|Protocol deviation|6|||
23511725|NCT00877383|65609491|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23511726|NCT00877383|65609492|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23511727|NCT00877383|65609491|FG000|Overall Study|Death|1|||
23511728|NCT00877383|65609492|FG001|Overall Study|Death|2|||
23511729|NCT01943292|65609493|FG000|Overall Study|Withdrawal by Subject|1|||
23412122|NCT00104416|65252375|FG004|Double-Blind Phase|Protocol Violation|0|||
23412123|NCT00104416|65252371|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23412124|NCT00104416|65252372|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
23511730|NCT01943292|65609494|FG001|Overall Study|Withdrawal by Subject|0|||
23511731|NCT01943292|65609495|FG002|Overall Study|Withdrawal by Subject|0|||
23511732|NCT00110149|65609498|FG000|Overall Study|Physician Decision|3|||
23511733|NCT01722071|65609499|FG000|Overall Study|Protocol Violation|1|||
23511734|NCT01722071|65609500|FG001|Overall Study|Protocol Violation|0|||
23511735|NCT03473808|65609504|FG000|Overall Study|Withdrawal by Subject|1|||
23511736|NCT00684307|65609505|FG000|Overall Study|Adverse Event|11|||
23511737|NCT00684307|65609506|FG001|Overall Study|Adverse Event|6|||
23511738|NCT00684307|65609507|FG002|Overall Study|Adverse Event|15|||
23511739|NCT00684307|65609508|FG003|Overall Study|Adverse Event|16|||
23511740|NCT00684307|65609509|FG004|Overall Study|Adverse Event|8|||
23511741|NCT00684307|65609505|FG000|Overall Study|Development of increasing Liver Function|0|||
23511742|NCT00684307|65609506|FG001|Overall Study|Development of increasing Liver Function|2|||
23511743|NCT00684307|65609507|FG002|Overall Study|Development of increasing Liver Function|0|||
23511744|NCT00684307|65609508|FG003|Overall Study|Development of increasing Liver Function|1|||
23511745|NCT00684307|65609509|FG004|Overall Study|Development of increasing Liver Function|0|||
23511746|NCT00684307|65609505|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
23511747|NCT00684307|65609506|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
23511748|NCT00684307|65609507|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
23511749|NCT00684307|65609508|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
23511750|NCT00684307|65609509|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
23511751|NCT00684307|65609505|FG000|Overall Study|Incorrect enrolment or randomization|4|||
23511752|NCT00684307|65609506|FG001|Overall Study|Incorrect enrolment or randomization|0|||
23511753|NCT00684307|65609507|FG002|Overall Study|Incorrect enrolment or randomization|0|||
23511754|NCT00684307|65609508|FG003|Overall Study|Incorrect enrolment or randomization|0|||
23511755|NCT00684307|65609509|FG004|Overall Study|Incorrect enrolment or randomization|0|||
23511756|NCT00684307|65609505|FG000|Overall Study|Interupted IP for more than 7 days|0|||
23511757|NCT00684307|65609506|FG001|Overall Study|Interupted IP for more than 7 days|4|||
23511758|NCT00684307|65609507|FG002|Overall Study|Interupted IP for more than 7 days|1|||
23710361|NCT03136367|66315385|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
23710362|NCT03136367|66315386|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
23710363|NCT03136367|66315384|FG000|T3 1 Week After Surgery|other discontinued|2|||
23710364|NCT03136367|66315385|FG001|T3 1 Week After Surgery|other discontinued|4|||
23710365|NCT03136367|66315386|FG002|T3 1 Week After Surgery|other discontinued|3|||
23710366|NCT03136367|66315384|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
23710367|NCT03136367|66315385|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
23710368|NCT03136367|66315386|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
23710369|NCT03136367|66315384|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
23710370|NCT03136367|66315385|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
23412125|NCT00104416|65252373|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23412126|NCT00104416|65252374|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23412127|NCT00104416|65252375|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23412128|NCT00104416|65252371|FG000|Double-Blind Phase|Pregnancy|1|||
23412129|NCT00104416|65252372|FG001|Double-Blind Phase|Pregnancy|0|||
23412130|NCT00104416|65252373|FG002|Double-Blind Phase|Pregnancy|0|||
23412131|NCT00104416|65252374|FG003|Double-Blind Phase|Pregnancy|0|||
23412132|NCT00104416|65252375|FG004|Double-Blind Phase|Pregnancy|0|||
23412133|NCT00104416|65252371|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
23412134|NCT00104416|65252372|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
23412135|NCT00104416|65252373|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412136|NCT00104416|65252374|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412137|NCT00104416|65252375|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412138|NCT00104416|65252371|FG000|Continuation Phase|Adverse Event|0|||
23412139|NCT00104416|65252372|FG001|Continuation Phase|Adverse Event|0|||
23412140|NCT00104416|65252373|FG002|Continuation Phase|Adverse Event|2|||
23412141|NCT00104416|65252374|FG003|Continuation Phase|Adverse Event|0|||
23412142|NCT00104416|65252375|FG004|Continuation Phase|Adverse Event|2|||
23412143|NCT00104416|65252371|FG000|Continuation Phase|Lost to Follow-up|0|||
23412144|NCT00104416|65252372|FG001|Continuation Phase|Lost to Follow-up|0|||
23412145|NCT00104416|65252373|FG002|Continuation Phase|Lost to Follow-up|1|||
23412146|NCT00104416|65252374|FG003|Continuation Phase|Lost to Follow-up|0|||
23412147|NCT00104416|65252375|FG004|Continuation Phase|Lost to Follow-up|1|||
23412148|NCT00104416|65252371|FG000|Continuation Phase|Withdrawal by Subject|0|||
23412149|NCT00104416|65252372|FG001|Continuation Phase|Withdrawal by Subject|0|||
23511759|NCT00684307|65609508|FG003|Overall Study|Interupted IP for more than 7 days|3|||
23511760|NCT00684307|65609509|FG004|Overall Study|Interupted IP for more than 7 days|3|||
23511761|NCT00684307|65609505|FG000|Overall Study|Severe non compliance to protocol|1|||
23511762|NCT00684307|65609506|FG001|Overall Study|Severe non compliance to protocol|0|||
23511763|NCT00684307|65609507|FG002|Overall Study|Severe non compliance to protocol|0|||
23511764|NCT00684307|65609508|FG003|Overall Study|Severe non compliance to protocol|1|||
23511765|NCT00684307|65609509|FG004|Overall Study|Severe non compliance to protocol|2|||
23412150|NCT00104416|65252373|FG002|Continuation Phase|Withdrawal by Subject|2|||
23412151|NCT00104416|65252374|FG003|Continuation Phase|Withdrawal by Subject|1|||
23710371|NCT03136367|66315386|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
23710372|NCT03136367|66315384|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
23710373|NCT03136367|66315385|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
23710374|NCT03136367|66315386|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
23710375|NCT03136367|66315384|FG000|T4 12 Weeks After Surgery|Death|0|||
23710376|NCT03136367|66315385|FG001|T4 12 Weeks After Surgery|Death|1|||
23710377|NCT03136367|66315386|FG002|T4 12 Weeks After Surgery|Death|3|||
23710378|NCT03136367|66315384|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
23710379|NCT03136367|66315385|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
23412152|NCT00104416|65252375|FG004|Continuation Phase|Withdrawal by Subject|1|||
23412153|NCT00104416|65252371|FG000|Continuation Phase|Pregnancy|0|||
23412154|NCT00104416|65252372|FG001|Continuation Phase|Pregnancy|0|||
23412155|NCT00104416|65252373|FG002|Continuation Phase|Pregnancy|1|||
23412156|NCT00104416|65252374|FG003|Continuation Phase|Pregnancy|1|||
23412157|NCT00104416|65252375|FG004|Continuation Phase|Pregnancy|0|||
23412158|NCT00104416|65252371|FG000|Continuation Phase|Non-compliance|0|||
23412159|NCT00104416|65252372|FG001|Continuation Phase|Non-compliance|0|||
23412160|NCT00104416|65252373|FG002|Continuation Phase|Non-compliance|0|||
23412161|NCT00104416|65252374|FG003|Continuation Phase|Non-compliance|0|||
23412162|NCT00104416|65252375|FG004|Continuation Phase|Non-compliance|1|||
23412163|NCT03015363|65252376|FG000|Overall Study|Physician Decision|14|||
23412164|NCT03015363|65252376|FG000|Overall Study|Withdrawal by Subject|3|||
23412165|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
23412166|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
23412167|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
23412168|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
23412169|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
23412170|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
23412171|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
23412172|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
23412173|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
23412174|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
23412175|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
23412176|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
23412177|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
23412178|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
23412179|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
23412180|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
23412181|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
23412182|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
23710380|NCT03136367|66315386|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
23710381|NCT03136367|66315384|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
23412183|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
23412184|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
23412185|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
23412186|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
23412187|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
23412188|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
23412189|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
23412190|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
23412191|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
23412192|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
23412193|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
23412194|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
23412195|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
23412196|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
23412197|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
23412198|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Other|6|||
23412199|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Other|0|||
23412200|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Other|0|||
23412201|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
23710382|NCT03136367|66315385|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
23412202|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
23412203|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
23412204|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
23412205|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
23610585|NCT02676778|65962811|FG002|Overall Study|Withdrawal by Subject|0|||
23710383|NCT03136367|66315386|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
23710384|NCT03136367|66315384|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
23412206|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
23412207|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
23412208|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
23412209|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
23412210|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
23412211|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
23412212|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
23412213|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
23412214|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
23412215|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
23412216|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
23412217|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
23412218|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
23412219|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
23412220|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
23412221|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
23412222|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412223|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
23412224|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412225|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412226|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412227|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412228|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
23412229|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
23412230|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412231|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412232|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412233|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412234|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
23412235|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
23412236|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412237|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412238|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412239|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412240|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
23412241|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
23412242|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412243|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412244|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412245|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412246|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412247|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
23412248|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412249|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412250|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412251|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412252|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
23412253|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
23412254|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412255|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412256|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412257|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412258|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412259|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
23412260|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412261|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412262|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412263|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412264|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412265|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
23412266|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23610586|NCT02676778|65962809|FG000|Overall Study|Other|4|||
23710385|NCT03136367|66315385|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
23412267|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412268|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412269|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412270|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23412271|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23412272|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
23412273|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23412274|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
23412275|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
23412276|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23412277|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23412278|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412279|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23412280|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412281|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412282|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
23412283|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
23412284|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
23412285|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
23412286|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
23412287|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
23412288|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412289|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412290|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412291|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412292|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412293|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412294|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412295|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412296|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
23412297|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412298|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
23412299|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412300|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
23412301|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
23412302|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
23412303|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
23412304|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
23412305|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
23412306|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
23412307|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
23412308|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
23412309|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
23412310|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
23412311|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
23412312|NCT00269087|65252388|FG000|Overall Study|Adverse Event|20|||
23412313|NCT00269087|65252388|FG000|Overall Study|Withdrawal by Subject|1|||
23412314|NCT00269087|65252388|FG000|Overall Study|Exacerbation of COPD|13|||
23412315|NCT01701362|65252389|FG000|Overall Study|Adverse events not related to study drug|1|||
23412316|NCT01701362|65252390|FG001|Overall Study|Adverse events not related to study drug|6|||
23412317|NCT01701362|65252389|FG000|Overall Study|Adverse events related to study drug|12|||
23412318|NCT01701362|65252390|FG001|Overall Study|Adverse events related to study drug|10|||
23412319|NCT01701362|65252389|FG000|Overall Study|Protocol Violation|5|||
23412320|NCT01701362|65252390|FG001|Overall Study|Protocol Violation|3|||
23412321|NCT01701362|65252389|FG000|Overall Study|No longer willing to participate|8|||
23412322|NCT01701362|65252390|FG001|Overall Study|No longer willing to participate|14|||
23412323|NCT01701362|65252389|FG000|Overall Study|Lost to Follow-up|6|||
23412324|NCT01701362|65252390|FG001|Overall Study|Lost to Follow-up|9|||
23412325|NCT01701362|65252389|FG000|Overall Study|Insufficient clinical response|6|||
23412326|NCT01701362|65252390|FG001|Overall Study|Insufficient clinical response|6|||
23412327|NCT01701362|65252389|FG000|Overall Study|Death|0|||
23412328|NCT01701362|65252390|FG001|Overall Study|Death|1|||
23710386|NCT03136367|66315386|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
23710387|NCT03136367|66315384|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23710388|NCT03136367|66315385|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23710389|NCT03136367|66315386|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23610587|NCT02676778|65962810|FG001|Overall Study|Other|3|||
23412329|NCT01701362|65252389|FG000|Overall Study|Randomized but not treated|1|||
23412330|NCT01701362|65252390|FG001|Overall Study|Randomized but not treated|2|||
23412331|NCT01701362|65252389|FG000|Overall Study|Reasons other than those mentioned above|3|||
23412332|NCT01701362|65252390|FG001|Overall Study|Reasons other than those mentioned above|5|||
23412333|NCT01734785|65252398|FG000|Open-Label Period|Adverse Event|0|||
23412334|NCT01734785|65252399|FG001|Open-Label Period|Adverse Event|0|||
23412335|NCT01734785|65252400|FG002|Open-Label Period|Adverse Event|0|||
23412336|NCT01734785|65252401|FG003|Open-Label Period|Adverse Event|9|||
23412337|NCT01734785|65252398|FG000|Open-Label Period|Lack of Efficacy|0|||
23412338|NCT01734785|65252399|FG001|Open-Label Period|Lack of Efficacy|0|||
23412339|NCT01734785|65252400|FG002|Open-Label Period|Lack of Efficacy|0|||
23412340|NCT01734785|65252401|FG003|Open-Label Period|Lack of Efficacy|1|||
23412341|NCT01734785|65252398|FG000|Open-Label Period|Protocol Violation|0|||
23412342|NCT01734785|65252399|FG001|Open-Label Period|Protocol Violation|0|||
23412343|NCT01734785|65252400|FG002|Open-Label Period|Protocol Violation|0|||
23412344|NCT01734785|65252401|FG003|Open-Label Period|Protocol Violation|13|||
23412345|NCT01734785|65252398|FG000|Open-Label Period|Lost to Follow-up|0|||
23412346|NCT01734785|65252399|FG001|Open-Label Period|Lost to Follow-up|0|||
23412347|NCT01734785|65252400|FG002|Open-Label Period|Lost to Follow-up|0|||
23412348|NCT01734785|65252401|FG003|Open-Label Period|Lost to Follow-up|14|||
23412349|NCT01734785|65252398|FG000|Open-Label Period|Withdrawal by Subject|0|||
23412350|NCT01734785|65252399|FG001|Open-Label Period|Withdrawal by Subject|0|||
23412351|NCT01734785|65252400|FG002|Open-Label Period|Withdrawal by Subject|0|||
23412352|NCT01734785|65252401|FG003|Open-Label Period|Withdrawal by Subject|12|||
23412353|NCT01734785|65252398|FG000|Open-Label Period|Other Reasons|0|||
23412354|NCT01734785|65252399|FG001|Open-Label Period|Other Reasons|0|||
23412355|NCT01734785|65252400|FG002|Open-Label Period|Other Reasons|0|||
23710390|NCT03136367|66315384|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
23710391|NCT03136367|66315385|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
23412356|NCT01734785|65252401|FG003|Open-Label Period|Other Reasons|224|||
23412357|NCT01734785|65252398|FG000|Double-Blind Period|Adverse Event|0|||
23412358|NCT01734785|65252399|FG001|Double-Blind Period|Adverse Event|3|||
23412359|NCT01734785|65252400|FG002|Double-Blind Period|Adverse Event|2|||
23412360|NCT01734785|65252401|FG003|Double-Blind Period|Adverse Event|0|||
23412361|NCT01734785|65252398|FG000|Double-Blind Period|Lack of Efficacy|0|||
23412362|NCT01734785|65252399|FG001|Double-Blind Period|Lack of Efficacy|1|||
23412363|NCT01734785|65252400|FG002|Double-Blind Period|Lack of Efficacy|0|||
23412364|NCT01734785|65252401|FG003|Double-Blind Period|Lack of Efficacy|0|||
23412365|NCT01734785|65252398|FG000|Double-Blind Period|Protocol Violation|0|||
23412366|NCT01734785|65252399|FG001|Double-Blind Period|Protocol Violation|1|||
23412367|NCT01734785|65252400|FG002|Double-Blind Period|Protocol Violation|1|||
23412368|NCT01734785|65252401|FG003|Double-Blind Period|Protocol Violation|0|||
23412369|NCT01734785|65252398|FG000|Double-Blind Period|Lost to Follow-up|2|||
23412370|NCT01734785|65252399|FG001|Double-Blind Period|Lost to Follow-up|4|||
23710392|NCT03136367|66315386|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
23710393|NCT03136367|66315384|FG000|T5 1 Year After Surgery|Death|0|||
23710394|NCT03136367|66315385|FG001|T5 1 Year After Surgery|Death|0|||
23710395|NCT03136367|66315386|FG002|T5 1 Year After Surgery|Death|1|||
23710396|NCT03136367|66315384|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
23710397|NCT03136367|66315385|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
23710398|NCT03136367|66315386|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
23710399|NCT03136367|66315384|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
23710400|NCT03136367|66315385|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
23710401|NCT03136367|66315386|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
23710402|NCT03136367|66315384|FG000|T5 1 Year After Surgery|study ended before due|31|||
23710403|NCT03136367|66315385|FG001|T5 1 Year After Surgery|study ended before due|103|||
23710404|NCT03136367|66315386|FG002|T5 1 Year After Surgery|study ended before due|110|||
23710405|NCT03136367|66315384|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
23710406|NCT03136367|66315385|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
23710407|NCT03136367|66315386|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
23710408|NCT02985450|66315388|FG000|Overall Study|Lost to Follow-up|7|||
23710409|NCT02142894|66315389|FG000|Overall Study|Protocol Violation|8|||
23710410|NCT02605447|66315390|FG000|Overall Study|Death|66|||
23710411|NCT02605447|66315390|FG000|Overall Study|Physician Decision|1|||
23710412|NCT02605447|66315390|FG000|Overall Study|Lost to Follow-up|24|||
23412371|NCT01734785|65252400|FG002|Double-Blind Period|Lost to Follow-up|2|||
23412372|NCT01734785|65252401|FG003|Double-Blind Period|Lost to Follow-up|0|||
23412373|NCT01734785|65252398|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23412374|NCT01734785|65252399|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23412375|NCT01734785|65252400|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23412376|NCT01734785|65252401|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23412377|NCT01734785|65252398|FG000|Double-Blind Period|Not treated|1|||
23511766|NCT00684307|65609505|FG000|Overall Study|Participant not willing to continue|7|||
23710413|NCT02605447|66315390|FG000|Overall Study|Withdrawal by Subject|10|||
23710414|NCT02605447|66315390|FG000|Overall Study|Not disclosed|1|||
23412378|NCT01734785|65252399|FG001|Double-Blind Period|Not treated|0|||
23412379|NCT01734785|65252400|FG002|Double-Blind Period|Not treated|0|||
23412380|NCT01734785|65252401|FG003|Double-Blind Period|Not treated|0|||
23412381|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
23412382|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
23412383|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
23412384|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
23412385|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
23412386|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
23511767|NCT00684307|65609506|FG001|Overall Study|Participant not willing to continue|10|||
23710415|NCT02939937|66315393|FG000|Overall Study|Adverse Event|5|||
23710416|NCT02939937|66315394|FG001|Overall Study|Adverse Event|0|||
23710417|NCT02939937|66315393|FG000|Overall Study|Lost to Follow-up|1|||
23710418|NCT02939937|66315394|FG001|Overall Study|Lost to Follow-up|3|||
23710419|NCT01651052|66315395|FG000|Overall Study|Death|21|||
23710420|NCT01651052|66315395|FG000|Overall Study|Explant|1|||
23710421|NCT01651052|66315395|FG000|Overall Study|Withdrawal by Subject|1|||
23511768|NCT00684307|65609507|FG002|Overall Study|Participant not willing to continue|11|||
23511769|NCT00684307|65609508|FG003|Overall Study|Participant not willing to continue|5|||
23511770|NCT00684307|65609509|FG004|Overall Study|Participant not willing to continue|8|||
23511771|NCT00684307|65609505|FG000|Overall Study|Criteria from the CSR|0|||
23511772|NCT00684307|65609506|FG001|Overall Study|Criteria from the CSR|0|||
23511773|NCT00684307|65609507|FG002|Overall Study|Criteria from the CSR|1|||
23511774|NCT00684307|65609508|FG003|Overall Study|Criteria from the CSR|3|||
23511775|NCT00684307|65609509|FG004|Overall Study|Criteria from the CSR|3|||
23511776|NCT04492618|65609510|FG000|Overall Study|Withdrawal by Subject|1|||
23511777|NCT00592384|65609511|FG000|Overall Study|Withdrawal by Subject|5|||
23511778|NCT00592384|65609512|FG001|Overall Study|Withdrawal by Subject|6|||
23511779|NCT02107482|65609513|FG000|Overall Study|inconveinence|2|||
23511780|NCT02107482|65609513|FG000|Overall Study|Lost to Follow-up|1|||
23511781|NCT02107482|65609513|FG000|Overall Study|Lack of Efficacy|1|||
23511782|NCT04166435|65609518|FG000|Overall Study|2 patients ineligible for response|2|||
23511783|NCT00937157|65609521|FG000|Overall Study|Pregnancy|1|||
23511784|NCT00937157|65609521|FG000|Overall Study|Lost to Follow-up|3|||
23511785|NCT02548650|65609522|FG000|Triple Therapy|Adverse Event|1|||
23511786|NCT02548650|65609523|FG001|Triple Therapy|Adverse Event|0|||
23511787|NCT02548650|65609522|FG000|Triple Therapy|Withdrawal by Subject|0|||
23511788|NCT02548650|65609523|FG001|Triple Therapy|Withdrawal by Subject|4|||
23511789|NCT02548650|65609522|FG000|Double Therapy|Adverse Event|1|||
23511790|NCT02548650|65609523|FG001|Double Therapy|Adverse Event|1|||
23511791|NCT02548650|65609522|FG000|Double Therapy|Withdrawal by Subject|0|||
23511792|NCT02548650|65609523|FG001|Double Therapy|Withdrawal by Subject|1|||
23710422|NCT01651052|66315395|FG000|Overall Study|Lost to Follow-up|3|||
23710423|NCT02045212|66315396|FG000|Overall Study|Adverse Event|0|||
23710424|NCT02045212|66315397|FG001|Overall Study|Adverse Event|1|||
23710425|NCT02045212|66315396|FG000|Overall Study|Withdrawal by Subject|1|||
23710426|NCT02045212|66315397|FG001|Overall Study|Withdrawal by Subject|0|||
23412387|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
23412388|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
23511793|NCT00754624|65609524|FG000|Overall Study|Adverse Event|16|||
23511794|NCT00754624|65609524|FG000|Overall Study|Death|1|||
23511795|NCT00754624|65609524|FG000|Overall Study|Physician Decision|8|||
23511796|NCT00754624|65609524|FG000|Overall Study|Protocol Violation|1|||
23511797|NCT00754624|65609524|FG000|Overall Study|Withdrawal by Subject|28|||
23511798|NCT00754624|65609524|FG000|Overall Study|Various|12|||
23511799|NCT00754624|65609524|FG000|Overall Study|Lost to Follow-up|3|||
23511800|NCT04481750|65609527|FG000|Period 1 (Fasted)|Adverse Event|0|||
23511801|NCT04481750|65609528|FG001|Period 1 (Fasted)|Adverse Event|0|||
23511802|NCT04481750|65609529|FG002|Period 1 (Fasted)|Adverse Event|1|||
23511803|NCT04481750|65609530|FG003|Period 1 (Fasted)|Adverse Event|0|||
23511804|NCT04481750|65609531|FG004|Period 1 (Fasted)|Adverse Event|0|||
23511805|NCT04481750|65609532|FG005|Period 1 (Fasted)|Adverse Event|0|||
23511806|NCT04481750|65609533|FG006|Period 1 (Fasted)|Adverse Event|0|||
23511807|NCT04481750|65609534|FG007|Period 1 (Fasted)|Adverse Event|0|||
23511808|NCT04481750|65609535|FG008|Period 1 (Fasted)|Adverse Event|0|||
23511809|NCT04481750|65609536|FG009|Period 1 (Fasted)|Adverse Event|0|||
23511810|NCT04481750|65609537|FG010|Period 1 (Fasted)|Adverse Event|0|||
23511811|NCT02005445|65609538|FG000|Overall Study|Dual study enrollment|0|||
23511812|NCT02005445|65609539|FG001|Overall Study|Dual study enrollment|1|||
23511813|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
23511814|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
23511815|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
23710427|NCT02045212|66315396|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
23710428|NCT02045212|66315397|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
23710429|NCT04105244|66315398|FG000|Overall Study|Withdrawal by Subject|10|||
23412389|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
23412390|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
23412391|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
23412392|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
23412393|NCT03333928|65252402|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
23412394|NCT03333928|65252403|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
23412395|NCT03333928|65252404|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
23412396|NCT03333928|65252402|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
23412397|NCT03333928|65252403|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
23412398|NCT03333928|65252404|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
23412399|NCT03333928|65252402|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
23412400|NCT03333928|65252403|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
23412401|NCT03333928|65252404|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
23412402|NCT03333928|65252402|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
23412403|NCT03333928|65252403|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
23412404|NCT03333928|65252404|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
23412405|NCT00889603|65252409|FG000|Overall Study|Adverse Event|7|||
23412406|NCT00889603|65252409|FG000|Overall Study|Death|3|||
23412407|NCT00889603|65252409|FG000|Overall Study|Lost to Follow-up|19|||
23412408|NCT00889603|65252409|FG000|Overall Study|No longer willing to participant in stud|4|||
23412409|NCT00889603|65252409|FG000|Overall Study|Other|4|||
23412410|NCT00854724|65252410|FG000|First Intervention|Withdrawal by Subject|1|||
23412411|NCT00854724|65252411|FG001|First Intervention|Withdrawal by Subject|1|||
23412412|NCT00854724|65252410|FG000|Washout|Protocol Violation|1|||
23412413|NCT00854724|65252411|FG001|Washout|Protocol Violation|0|||
23412414|NCT00854724|65252410|FG000|Washout|Withdrawal by Subject|0|||
23412415|NCT00854724|65252411|FG001|Washout|Withdrawal by Subject|1|||
23412416|NCT00854724|65252410|FG000|Second Intervention|Protocol Violation|1|||
23412417|NCT00854724|65252411|FG001|Second Intervention|Protocol Violation|0|||
23412418|NCT00854724|65252410|FG000|Second Intervention|Physician Decision|0|||
23412419|NCT00854724|65252411|FG001|Second Intervention|Physician Decision|1|||
23412420|NCT01606176|65252414|FG000|Overall Study|Adverse Event|2|||
23511816|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
23511817|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
23511818|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
23511819|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
23511820|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
23511821|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
23511822|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
23511823|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
23511824|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
23511825|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
23511826|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
23511827|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
23511828|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
23511829|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
23412421|NCT01606176|65252415|FG001|Overall Study|Adverse Event|3|||
23412422|NCT01606176|65252414|FG000|Overall Study|Disease progression|1|||
23412423|NCT01606176|65252415|FG001|Overall Study|Disease progression|0|||
23412424|NCT01606176|65252414|FG000|Overall Study|Withdrawal by Subject|1|||
23412425|NCT01606176|65252415|FG001|Overall Study|Withdrawal by Subject|0|||
23412426|NCT01523743|65252416|FG000|Period 1|Adverse Event|1|||
23412427|NCT01523743|65252417|FG001|Period 1|Adverse Event|0|||
23412428|NCT01523743|65252416|FG000|Period 1|Withdrawal by Subject|6|||
23412429|NCT01523743|65252417|FG001|Period 1|Withdrawal by Subject|2|||
23412430|NCT01523743|65252416|FG000|Period 1|Lost to Follow-up|1|||
23412431|NCT01523743|65252417|FG001|Period 1|Lost to Follow-up|0|||
23412432|NCT01523743|65252416|FG000|Period 1|Lack of Efficacy|1|||
23412433|NCT01523743|65252417|FG001|Period 1|Lack of Efficacy|0|||
23412434|NCT01523743|65252416|FG000|Period 1|Felt unable to empty bladder|1|||
23412435|NCT01523743|65252417|FG001|Period 1|Felt unable to empty bladder|0|||
23412436|NCT01523743|65252416|FG000|Period 2|Withdrawal by Subject|0|||
23412437|NCT01523743|65252417|FG001|Period 2|Withdrawal by Subject|2|||
23710430|NCT04105244|66315399|FG001|Overall Study|Withdrawal by Subject|12|||
23710431|NCT04105244|66315398|FG000|Overall Study|Lost to Follow-up|20|||
23412438|NCT01523743|65252416|FG000|Period 2|Adverse Event|1|||
23511830|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
23610588|NCT02676778|65962811|FG002|Overall Study|Other|0|||
23412439|NCT01523743|65252417|FG001|Period 2|Adverse Event|0|||
23412440|NCT01220401|65252428|FG000|Overall Study|Withdrawal by Subject|2|||
23412441|NCT01220401|65252428|FG000|Overall Study|Protocol Violation|1|||
23412442|NCT01262638|65252429|FG000|Overall Study|Adverse Event|3|||
23412443|NCT01262638|65252430|FG001|Overall Study|Adverse Event|4|||
23412444|NCT01262638|65252431|FG002|Overall Study|Adverse Event|3|||
23511831|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
23511832|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
23511833|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
23511834|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
23511835|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
23511836|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
23511837|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
23511838|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
23511839|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
23511840|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
23511841|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
23511842|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
23511843|NCT01714635|65609547|FG000|Overall Study|Discontinued|1|||
23511844|NCT01714635|65609548|FG001|Overall Study|Discontinued|0|||
23511845|NCT01714635|65609549|FG002|Overall Study|Discontinued|2|||
23511846|NCT01714635|65609547|FG000|Overall Study|Missed 6-month exam|1|||
23511847|NCT01714635|65609548|FG001|Overall Study|Missed 6-month exam|0|||
23511848|NCT01714635|65609549|FG002|Overall Study|Missed 6-month exam|0|||
23511849|NCT01324999|65609550|FG000|Overall Study|Adverse Event|3|||
23511850|NCT01324999|65609550|FG000|Overall Study|Withdrawal by Subject|2|||
23511851|NCT03241342|65609551|FG000|Overall Study|Adverse Event|5|||
23511852|NCT03241342|65609552|FG001|Overall Study|Adverse Event|8|||
23511853|NCT03241342|65609553|FG002|Overall Study|Adverse Event|4|||
23511854|NCT03241342|65609551|FG000|Overall Study|Lack of Efficacy|0|||
23511855|NCT03241342|65609552|FG001|Overall Study|Lack of Efficacy|0|||
23511856|NCT03241342|65609553|FG002|Overall Study|Lack of Efficacy|1|||
23511857|NCT03241342|65609551|FG000|Overall Study|noncompliance with study drug|2|||
23511858|NCT03241342|65609552|FG001|Overall Study|noncompliance with study drug|1|||
23511859|NCT03241342|65609553|FG002|Overall Study|noncompliance with study drug|1|||
23511860|NCT03241342|65609551|FG000|Overall Study|sponsor decision|0|||
23511861|NCT03241342|65609552|FG001|Overall Study|sponsor decision|1|||
23511862|NCT03241342|65609553|FG002|Overall Study|sponsor decision|2|||
23511863|NCT03241342|65609551|FG000|Overall Study|not reported|15|||
23511864|NCT03241342|65609552|FG001|Overall Study|not reported|21|||
23511865|NCT03241342|65609553|FG002|Overall Study|not reported|19|||
23511866|NCT02887521|65612539|FG000|Overall Study|Withdrawal by Subject|0|||
23511867|NCT02887521|65612540|FG001|Overall Study|Withdrawal by Subject|3|||
23511868|NCT01948050|65612541|FG000|Overall Study|Withdrawal by Subject|0|||
23511869|NCT01948050|65612542|FG001|Overall Study|Withdrawal by Subject|1|||
23511870|NCT02557646|65612543|FG000|Overall Study|Adverse Event|40|||
23511871|NCT02557646|65612543|FG000|Overall Study|Death|1|||
23511872|NCT02557646|65612543|FG000|Overall Study|Lack of Efficacy|186|||
23511873|NCT02557646|65612543|FG000|Overall Study|Withdrawal by Subject|18|||
23710432|NCT04105244|66315399|FG001|Overall Study|Lost to Follow-up|15|||
23710433|NCT04105244|66315398|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
23710434|NCT04105244|66315399|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
23412445|NCT01262638|65252432|FG003|Overall Study|Adverse Event|4|||
23412446|NCT01262638|65252429|FG000|Overall Study|Protocol Violation|1|||
23412447|NCT01262638|65252430|FG001|Overall Study|Protocol Violation|0|||
23412448|NCT01262638|65252431|FG002|Overall Study|Protocol Violation|0|||
23412449|NCT01262638|65252432|FG003|Overall Study|Protocol Violation|1|||
23412450|NCT01262638|65252429|FG000|Overall Study|Withdrawal by Subject|2|||
23412451|NCT01262638|65252430|FG001|Overall Study|Withdrawal by Subject|1|||
23412452|NCT01262638|65252431|FG002|Overall Study|Withdrawal by Subject|0|||
23412453|NCT01262638|65252432|FG003|Overall Study|Withdrawal by Subject|1|||
23412454|NCT01262638|65252429|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412455|NCT01262638|65252430|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412456|NCT01262638|65252431|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
23412457|NCT01262638|65252432|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412458|NCT01262638|65252429|FG000|Overall Study|Lost to Follow-up|1|||
23412459|NCT01262638|65252430|FG001|Overall Study|Lost to Follow-up|1|||
23412460|NCT01262638|65252431|FG002|Overall Study|Lost to Follow-up|1|||
23412461|NCT01262638|65252432|FG003|Overall Study|Lost to Follow-up|1|||
23412462|NCT01262638|65252429|FG000|Overall Study|Participant Went Out of Town|0|||
23412463|NCT01262638|65252430|FG001|Overall Study|Participant Went Out of Town|0|||
23412464|NCT01262638|65252431|FG002|Overall Study|Participant Went Out of Town|1|||
23511874|NCT02557646|65612543|FG000|Overall Study|Lost to Follow-up|17|||
23511875|NCT02557646|65612543|FG000|Overall Study|Other|14|||
23511876|NCT01083576|65612544|FG000|Overall Study|Treatment Failure|6|||
23511877|NCT01083576|65612545|FG001|Overall Study|Treatment Failure|1|||
23511878|NCT02066233|65612546|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
23511879|NCT02066233|65612547|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
23511880|NCT01753856|65612548|FG000|Overall Study|Adverse Event|1|||
23511881|NCT01753856|65612549|FG001|Overall Study|Adverse Event|0|||
23412465|NCT01262638|65252432|FG003|Overall Study|Participant Went Out of Town|0|||
23412466|NCT02455336|65252433|FG000|Overall Study|Withdrawal by Subject|0|||
23412467|NCT02455336|65252434|FG001|Overall Study|Withdrawal by Subject|2|||
23412468|NCT02455336|65252433|FG000|Overall Study|Adverse Event|3|||
23412469|NCT02455336|65252434|FG001|Overall Study|Adverse Event|0|||
23412470|NCT02455336|65252433|FG000|Overall Study|Non-responder to treatment|2|||
23412471|NCT02455336|65252434|FG001|Overall Study|Non-responder to treatment|0|||
23412472|NCT01905943|65252435|FG000|Overall Study|Withdrawal of consent|90|||
23412473|NCT01905943|65252435|FG000|Overall Study|Lost to Follow-up|16|||
23412474|NCT01905943|65252435|FG000|Overall Study|Investigator discretion|7|||
23412475|NCT01905943|65252435|FG000|Overall Study|Death|186|||
23412476|NCT01905943|65252435|FG000|Overall Study|Adverse Event|3|||
23412477|NCT01905943|65252435|FG000|Overall Study|Other|12|||
23412478|NCT01140867|65252436|FG000|Overall Study|Adverse Event|22|||
23412479|NCT01140867|65252436|FG000|Overall Study|Lack of Efficacy|3|||
23412480|NCT01140867|65252436|FG000|Overall Study|Lost to Follow-up|2|||
23412481|NCT01140867|65252436|FG000|Overall Study|Withdrawal by Subject|1|||
23412482|NCT01140867|65252436|FG000|Overall Study|Protocol Violation|1|||
23412483|NCT01140867|65252436|FG000|Overall Study|Uncooperative patient|2|||
23412484|NCT01140867|65252436|FG000|Overall Study|Medication Noncompliance|2|||
23412485|NCT03530995|65252437|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
23412486|NCT03530995|65252438|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
23412487|NCT03530995|65252437|FG000|Part 1 Period 3|Protocol Violation|1|||
23412488|NCT03530995|65252438|FG001|Part 1 Period 3|Protocol Violation|0|||
23412489|NCT03530995|65252437|FG000|Part 1 Period 4|Physician Decision|1|||
23412490|NCT03530995|65252438|FG001|Part 1 Period 4|Physician Decision|0|||
23412491|NCT03530995|65252437|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
23412492|NCT03530995|65252438|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
23412493|NCT00289289|65252439|FG000|Overall Study|Withdrawal by Subject|5|||
23412494|NCT00289289|65252440|FG001|Overall Study|Withdrawal by Subject|3|||
23412495|NCT00289289|65252441|FG002|Overall Study|Withdrawal by Subject|15|||
23412496|NCT00289289|65252439|FG000|Overall Study|Lost to Follow-up|1|||
23412497|NCT00289289|65252440|FG001|Overall Study|Lost to Follow-up|0|||
23412498|NCT00289289|65252441|FG002|Overall Study|Lost to Follow-up|1|||
23412499|NCT00289289|65252439|FG000|Overall Study|Death|4|||
23412500|NCT00289289|65252440|FG001|Overall Study|Death|2|||
23412501|NCT00289289|65252441|FG002|Overall Study|Death|5|||
23412502|NCT00289289|65252439|FG000|Overall Study|No implant attempted|0|||
23412503|NCT00289289|65252440|FG001|Overall Study|No implant attempted|0|||
23412504|NCT00289289|65252441|FG002|Overall Study|No implant attempted|1|||
23412505|NCT00289289|65252439|FG000|Overall Study|Physician Decision|1|||
23412506|NCT00289289|65252440|FG001|Overall Study|Physician Decision|0|||
23412507|NCT00289289|65252441|FG002|Overall Study|Physician Decision|6|||
23412508|NCT00289289|65252439|FG000|Overall Study|Non-study device implanted|2|||
23412509|NCT00289289|65252440|FG001|Overall Study|Non-study device implanted|1|||
23412510|NCT00289289|65252441|FG002|Overall Study|Non-study device implanted|3|||
23412511|NCT00289289|65252439|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
23412512|NCT00289289|65252440|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
23412513|NCT00289289|65252441|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
23412514|NCT00289289|65252439|FG000|Overall Study|Other Exit Reason|6|||
23412515|NCT00289289|65252440|FG001|Overall Study|Other Exit Reason|4|||
23412516|NCT00289289|65252441|FG002|Overall Study|Other Exit Reason|12|||
23412517|NCT00759876|65252443|FG000|Overall Study|Sponsor terminated study early|36|||
23412518|NCT03802630|65252444|FG000|Overall Study|Study terminated by sponsor|130|||
23412519|NCT03802630|65252445|FG001|Overall Study|Study terminated by sponsor|134|||
23412520|NCT03802630|65252444|FG000|Overall Study|Subject decision|16|||
23412521|NCT03802630|65252445|FG001|Overall Study|Subject decision|9|||
23412522|NCT03802630|65252444|FG000|Overall Study|Adverse Event|3|||
23412523|NCT03802630|65252445|FG001|Overall Study|Adverse Event|1|||
23412524|NCT03802630|65252444|FG000|Overall Study|Lost to Follow-up|2|||
23412525|NCT03802630|65252445|FG001|Overall Study|Lost to Follow-up|2|||
23412526|NCT03802630|65252444|FG000|Overall Study|Physician Decision|2|||
23412527|NCT03802630|65252445|FG001|Overall Study|Physician Decision|0|||
23412528|NCT03802630|65252444|FG000|Overall Study|Death|0|||
23412529|NCT03802630|65252445|FG001|Overall Study|Death|2|||
23412530|NCT03226249|65252454|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
23412531|NCT03226249|65252454|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
23412532|NCT03226249|65252454|FG000|Survival Follow-up|Patients still in follow-up.|30|||
23412533|NCT00559104|65252456|FG000|Overall Study|Lack of Efficacy|9|||
23412534|NCT00559104|65252457|FG001|Overall Study|Lack of Efficacy|0|||
23412535|NCT04097028|65252458|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
23412536|NCT04097028|65252458|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
23412537|NCT04097028|65252458|FG000|Overall Study|Disease Progression prior to Surgery|2|||
23412538|NCT04097028|65252458|FG000|Overall Study|Adverse Event prior to Surgery|1|||
23412539|NCT00613327|65252459|FG000|Overall Study|Adverse Event|38|||
23412540|NCT00613327|65252459|FG000|Overall Study|Lost to Follow-up|8|||
23412541|NCT00613327|65252459|FG000|Overall Study|Withdrawal by Subject|6|||
23412542|NCT00613327|65252459|FG000|Overall Study|Protocol Violation|2|||
23412543|NCT00613327|65252459|FG000|Overall Study|Other|47|||
23412544|NCT01221753|65252460|FG000|Overall Study|Adverse Event|1|||
23412545|NCT01802580|65252461|FG000|Overall Study|Physician Decision|1|||
23412546|NCT01802580|65252462|FG001|Overall Study|Physician Decision|0|||
23412547|NCT01802580|65252461|FG000|Overall Study|Protocol Violation|2|||
23412548|NCT01802580|65252462|FG001|Overall Study|Protocol Violation|0|||
23511882|NCT01753856|65612548|FG000|Overall Study|Withdrawal by Subject|0|||
23511883|NCT01753856|65612549|FG001|Overall Study|Withdrawal by Subject|2|||
23511884|NCT01753856|65612548|FG000|Overall Study|Sponsor Decision|2|||
23511885|NCT01753856|65612549|FG001|Overall Study|Sponsor Decision|0|||
23511886|NCT03045328|65612550|FG000|Overall Study|Withdrawal by Subject|2|||
23412549|NCT01802580|65252461|FG000|Overall Study|Withdrawal by Subject|5|||
23412550|NCT01802580|65252462|FG001|Overall Study|Withdrawal by Subject|6|||
23511887|NCT00461682|65612561|FG000|Overall Study|Protocol Violation|1|||
23511888|NCT03061331|65612567|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
23511889|NCT03061331|65612568|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
23511890|NCT04160091|65612569|FG000|Overall Study|Terminated by Sponsor|7|||
23412551|NCT01802580|65252461|FG000|Overall Study|Other|1|||
23412552|NCT01802580|65252462|FG001|Overall Study|Other|3|||
23412553|NCT01802580|65252461|FG000|Overall Study|Lack of Efficacy|0|||
23412554|NCT01802580|65252462|FG001|Overall Study|Lack of Efficacy|2|||
23412555|NCT02237001|65252463|FG000|Overall Study|Lost to Follow-up|2|||
23412556|NCT02237001|65252463|FG000|Overall Study|Withdrawal by Subject|1|||
23412557|NCT02237001|65252463|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
23412558|NCT02237001|65252463|FG000|Overall Study|Re-operation|4|||
23412559|NCT02237001|65252463|FG000|Overall Study|Incarceration|1|||
23412560|NCT02752633|65252464|FG000|Overall Study|Withdrawal by Subject|1|||
23412561|NCT00175916|65252468|FG000|Overall Study|Death|19|||
23412562|NCT00175916|65252468|FG000|Overall Study|Adverse Event|81|||
23412563|NCT00175916|65252468|FG000|Overall Study|Lack of Efficacy|354|||
23412564|NCT00175916|65252468|FG000|Overall Study|Lost to Follow-up|17|||
23412565|NCT00175916|65252468|FG000|Overall Study|Subject Choice|98|||
23412566|NCT00175916|65252468|FG000|Overall Study|Lack of compliance|8|||
23412567|NCT00175916|65252468|FG000|Overall Study|Patient cannot record seizures|1|||
23412568|NCT00175916|65252468|FG000|Overall Study|Sponsor decision|17|||
23412569|NCT00175916|65252468|FG000|Overall Study|Vigabatrin intake|1|||
23412570|NCT00175916|65252468|FG000|Overall Study|Suicidal behaviour|1|||
23412571|NCT00175916|65252468|FG000|Overall Study|Withdrawal by Subject|1|||
23412572|NCT00175916|65252468|FG000|Overall Study|Seizure - free|4|||
23412573|NCT00175916|65252468|FG000|Overall Study|Administrative reason|1|||
23412574|NCT00175916|65252468|FG000|Overall Study|Pregnancy|1|||
23412575|NCT00175916|65252468|FG000|Overall Study|Patient's request|2|||
23412576|NCT00175916|65252468|FG000|Overall Study|Treating physiciant's choice|1|||
23412577|NCT00175916|65252468|FG000|Overall Study|Moved overseas|1|||
23412578|NCT00175916|65252468|FG000|Overall Study|Loss of job and economic burden|1|||
23412579|NCT00175916|65252468|FG000|Overall Study|Site was closed|9|||
23412580|NCT00175916|65252468|FG000|Overall Study|Patient went to prison|1|||
23412581|NCT00588237|65252469|FG000|Overall Study|Evaluable for toxicity only|3|||
23412582|NCT00588237|65252469|FG000|Overall Study|Patien not treated|1|||
23412583|NCT01071252|65252470|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
23412584|NCT01071252|65252471|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
23412585|NCT01071252|65252472|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
23412586|NCT01071252|65252473|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
23412587|NCT01071252|65252474|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
23412588|NCT01071252|65252470|FG000|Overall Study|Withdrawal by Subject|8|||
23412589|NCT01071252|65252471|FG001|Overall Study|Withdrawal by Subject|2|||
23412590|NCT01071252|65252472|FG002|Overall Study|Withdrawal by Subject|1|||
23412591|NCT01071252|65252473|FG003|Overall Study|Withdrawal by Subject|2|||
23412592|NCT01071252|65252474|FG004|Overall Study|Withdrawal by Subject|3|||
23412593|NCT01071252|65252470|FG000|Overall Study|administrative problems|1|||
23412594|NCT01071252|65252471|FG001|Overall Study|administrative problems|1|||
23412595|NCT01071252|65252472|FG002|Overall Study|administrative problems|0|||
23412596|NCT01071252|65252473|FG003|Overall Study|administrative problems|2|||
23412597|NCT01071252|65252474|FG004|Overall Study|administrative problems|1|||
23412598|NCT01071252|65252470|FG000|Overall Study|Lost to Follow-up|1|||
23412599|NCT01071252|65252471|FG001|Overall Study|Lost to Follow-up|0|||
23412600|NCT01071252|65252472|FG002|Overall Study|Lost to Follow-up|1|||
23412601|NCT01071252|65252473|FG003|Overall Study|Lost to Follow-up|2|||
23412602|NCT01071252|65252474|FG004|Overall Study|Lost to Follow-up|0|||
23412603|NCT01071252|65252470|FG000|Overall Study|Adverse Event|1|||
23412604|NCT01071252|65252471|FG001|Overall Study|Adverse Event|1|||
23412605|NCT01071252|65252472|FG002|Overall Study|Adverse Event|0|||
23412606|NCT01071252|65252473|FG003|Overall Study|Adverse Event|1|||
23412607|NCT01071252|65252474|FG004|Overall Study|Adverse Event|0|||
23511891|NCT04160091|65612570|FG001|Overall Study|Terminated by Sponsor|3|||
23412608|NCT01071252|65252470|FG000|Overall Study|Death|0|||
23412609|NCT01071252|65252471|FG001|Overall Study|Death|0|||
23412610|NCT01071252|65252472|FG002|Overall Study|Death|0|||
23412611|NCT01071252|65252473|FG003|Overall Study|Death|0|||
23412612|NCT01071252|65252474|FG004|Overall Study|Death|1|||
23412613|NCT00344318|65252475|FG000|Overall Study|Adverse Event|0|||
23412614|NCT00344318|65252476|FG001|Overall Study|Adverse Event|3|||
23412615|NCT00344318|65252477|FG002|Overall Study|Adverse Event|0|||
23412616|NCT00344318|65252478|FG003|Overall Study|Adverse Event|1|||
23412617|NCT00344318|65252475|FG000|Overall Study|Withdrawal by Subject|2|||
23412618|NCT00344318|65252476|FG001|Overall Study|Withdrawal by Subject|2|||
23412619|NCT00344318|65252477|FG002|Overall Study|Withdrawal by Subject|0|||
23412620|NCT00344318|65252478|FG003|Overall Study|Withdrawal by Subject|2|||
23412621|NCT00344318|65252475|FG000|Overall Study|Lost to Follow-up|2|||
23412622|NCT00344318|65252476|FG001|Overall Study|Lost to Follow-up|0|||
23412623|NCT00344318|65252477|FG002|Overall Study|Lost to Follow-up|1|||
23412624|NCT00344318|65252478|FG003|Overall Study|Lost to Follow-up|0|||
23412625|NCT02907216|65252479|FG000|Overall Study|No benefit to be obtained by continuing|0|||
23412626|NCT02907216|65252480|FG001|Overall Study|No benefit to be obtained by continuing|1|||
23412627|NCT02907216|65252479|FG000|Overall Study|Withdrawal by Subject|1|||
23412628|NCT02907216|65252480|FG001|Overall Study|Withdrawal by Subject|0|||
23412629|NCT01897727|65252484|FG000|Overall Study|Exclusion: central sleep apnea|0|||
23412630|NCT01897727|65252485|FG001|Overall Study|Exclusion: central sleep apnea|1|||
23412631|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
23412632|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
23412633|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
23412634|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
23412635|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
23412636|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
23412637|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
23412638|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
23412639|NCT03490292|65252486|FG000|1 Year Follow Up Post Last Dose|Death|1|||
23412640|NCT03490292|65252487|FG001|1 Year Follow Up Post Last Dose|Death|1|||
23412641|NCT01691105|65252488|FG000|1 Month Follow-up|Lost to Follow-up|41|||
23412642|NCT01691105|65252489|FG001|1 Month Follow-up|Lost to Follow-up|38|||
23412643|NCT01691105|65252488|FG000|1 Month Follow-up|Death|2|||
23412644|NCT01691105|65252489|FG001|1 Month Follow-up|Death|3|||
23511892|NCT04160091|65612571|FG002|Overall Study|Terminated by Sponsor|5|||
23511893|NCT04160091|65612572|FG003|Overall Study|Terminated by Sponsor|2|||
23511894|NCT04160091|65612569|FG000|Overall Study|Noncompliance|0|||
23511895|NCT04160091|65612570|FG001|Overall Study|Noncompliance|0|||
23511896|NCT04160091|65612571|FG002|Overall Study|Noncompliance|0|||
23511897|NCT04160091|65612572|FG003|Overall Study|Noncompliance|1|||
23511898|NCT04160091|65612569|FG000|Overall Study|Withdrawal by Subject|0|||
23511899|NCT04160091|65612570|FG001|Overall Study|Withdrawal by Subject|0|||
23511900|NCT04160091|65612571|FG002|Overall Study|Withdrawal by Subject|0|||
23511901|NCT04160091|65612572|FG003|Overall Study|Withdrawal by Subject|1|||
23511902|NCT03585504|65612573|FG000|Overall Study|Lost to Follow-up|26|||
23511903|NCT03585504|65612574|FG001|Overall Study|Lost to Follow-up|29|||
23511904|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
23511905|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
23511906|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
23511907|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
23511908|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
23511909|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
23511910|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
23511911|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
23412645|NCT01691105|65252488|FG000|6 Month Follow-up|Lost to Follow-up|39|||
23412646|NCT01691105|65252489|FG001|6 Month Follow-up|Lost to Follow-up|58|||
23412647|NCT01691105|65252488|FG000|6 Month Follow-up|Death|13|||
23710435|NCT04105244|66315398|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
23412648|NCT01691105|65252489|FG001|6 Month Follow-up|Death|13|||
23412649|NCT01691105|65252488|FG000|12 Month Follow-up|Lost to Follow-up|50|||
23412650|NCT01691105|65252489|FG001|12 Month Follow-up|Lost to Follow-up|71|||
23412651|NCT01691105|65252488|FG000|12 Month Follow-up|Death|22|||
23412652|NCT01691105|65252489|FG001|12 Month Follow-up|Death|30|||
23412653|NCT01691105|65252488|FG000|12 Month Biochemical Verification|Death|22|||
23511912|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
23511913|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
23511914|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
23412654|NCT01691105|65252489|FG001|12 Month Biochemical Verification|Death|30|||
23412655|NCT01691105|65252488|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
23412656|NCT01691105|65252489|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
23412657|NCT01691105|65252488|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
23412658|NCT01691105|65252489|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
23412659|NCT00342628|65252490|FG000|Overall Study|Withdrawal by Subject|19|||
23412660|NCT00342628|65252491|FG001|Overall Study|Withdrawal by Subject|19|||
23412661|NCT00342628|65252492|FG002|Overall Study|Withdrawal by Subject|18|||
23412662|NCT00342628|65252490|FG000|Overall Study|Death|1|||
23412663|NCT00342628|65252491|FG001|Overall Study|Death|1|||
23412664|NCT00342628|65252492|FG002|Overall Study|Death|0|||
23412665|NCT00342628|65252490|FG000|Overall Study|moved residence|0|||
23412666|NCT00342628|65252491|FG001|Overall Study|moved residence|1|||
23412667|NCT00342628|65252492|FG002|Overall Study|moved residence|1|||
23412668|NCT02249091|65252495|FG000|Overall Study|Lack of Efficacy|8|||
23412669|NCT02249091|65252496|FG001|Overall Study|Lack of Efficacy|3|||
23412670|NCT02249091|65252495|FG000|Overall Study|Physician Decision|4|||
23412671|NCT02249091|65252496|FG001|Overall Study|Physician Decision|1|||
23412672|NCT02249091|65252495|FG000|Overall Study|Withdrawal by Subject|2|||
23412673|NCT02249091|65252496|FG001|Overall Study|Withdrawal by Subject|2|||
23412674|NCT02249091|65252495|FG000|Overall Study|Death|3|||
23412675|NCT02249091|65252496|FG001|Overall Study|Death|4|||
23412676|NCT02249091|65252495|FG000|Overall Study|Adverse Event|1|||
23412677|NCT02249091|65252496|FG001|Overall Study|Adverse Event|0|||
23412678|NCT02249091|65252495|FG000|Overall Study|Stable disease with following SCT|0|||
23412679|NCT02249091|65252496|FG001|Overall Study|Stable disease with following SCT|1|||
23412680|NCT02249091|65252495|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
23412681|NCT02249091|65252496|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
23412682|NCT02249091|65252495|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
23412683|NCT02249091|65252496|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
23412684|NCT02249091|65252495|FG000|Overall Study|Refractory AML|1|||
23412685|NCT02249091|65252496|FG001|Overall Study|Refractory AML|1|||
23412686|NCT00830375|65252498|FG000|Overall Study|Lost to Follow-up|1|||
23412687|NCT00090779|65252499|FG000|Step 1|Withdrawal by Subject|4|||
23412688|NCT00090779|65252500|FG001|Step 1|Withdrawal by Subject|2|||
23412689|NCT00090779|65252499|FG000|Step 1|Lost to Follow-up|3|||
23412690|NCT00090779|65252500|FG001|Step 1|Lost to Follow-up|2|||
23412691|NCT00090779|65252499|FG000|Step 1|Death|0|||
23412692|NCT00090779|65252500|FG001|Step 1|Death|2|||
23412693|NCT00090779|65252499|FG000|Step 1|Physician Decision|1|||
23412694|NCT00090779|65252500|FG001|Step 1|Physician Decision|0|||
23412695|NCT00090779|65252499|FG000|Step 1|Pregnancy|1|||
23412696|NCT00090779|65252500|FG001|Step 1|Pregnancy|0|||
23412697|NCT00090779|65252499|FG000|Step 1|Non-compliance to study requirements|0|||
23412698|NCT00090779|65252500|FG001|Step 1|Non-compliance to study requirements|1|||
23412699|NCT00090779|65252499|FG000|Step 1|Subject relocated|2|||
23412700|NCT00090779|65252500|FG001|Step 1|Subject relocated|8|||
23412701|NCT00090779|65252499|FG000|Step 2|Off study per study closure|6|||
23412702|NCT00090779|65252500|FG001|Step 2|Off study per study closure|16|||
23412703|NCT00090779|65252499|FG000|Step 2|Subject relocated|0|||
23412704|NCT00090779|65252500|FG001|Step 2|Subject relocated|1|||
23412705|NCT00090779|65252499|FG000|Step 2|Non-compliance to study requirements|0|||
23412706|NCT00090779|65252500|FG001|Step 2|Non-compliance to study requirements|1|||
23412707|NCT00090779|65252499|FG000|Step 3|Initiation of ART and off extended study|3|||
23412708|NCT00090779|65252500|FG001|Step 3|Initiation of ART and off extended study|2|||
23412709|NCT00090779|65252499|FG000|Step 3|Off extended study due to study closure|4|||
23412710|NCT00090779|65252500|FG001|Step 3|Off extended study due to study closure|3|||
23412711|NCT01238991|65252504|FG000|Overall Study|Adverse Event|1|||
23412712|NCT01238991|65252505|FG001|Overall Study|Adverse Event|0|||
23412713|NCT01238991|65252506|FG002|Overall Study|Adverse Event|3|||
23412714|NCT01238991|65252507|FG003|Overall Study|Adverse Event|1|||
23412715|NCT01238991|65252508|FG004|Overall Study|Adverse Event|1|||
23412716|NCT01238991|65252509|FG005|Overall Study|Adverse Event|0|||
23412717|NCT01238991|65252510|FG006|Overall Study|Adverse Event|1|||
23412718|NCT01238991|65252511|FG007|Overall Study|Adverse Event|1|||
23412719|NCT01238991|65252512|FG008|Overall Study|Adverse Event|0|||
23412720|NCT01238991|65252513|FG009|Overall Study|Adverse Event|0|||
23710436|NCT04105244|66315399|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
23710437|NCT04387136|66315401|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
23412721|NCT01238991|65252504|FG000|Overall Study|Death|0|||
23412722|NCT01238991|65252505|FG001|Overall Study|Death|0|||
23412723|NCT01238991|65252506|FG002|Overall Study|Death|0|||
23412724|NCT01238991|65252507|FG003|Overall Study|Death|1|||
23412725|NCT01238991|65252508|FG004|Overall Study|Death|0|||
23412726|NCT01238991|65252509|FG005|Overall Study|Death|0|||
23412727|NCT01238991|65252510|FG006|Overall Study|Death|0|||
23412728|NCT01238991|65252511|FG007|Overall Study|Death|0|||
23412729|NCT01238991|65252512|FG008|Overall Study|Death|0|||
23412730|NCT01238991|65252513|FG009|Overall Study|Death|0|||
23412731|NCT01238991|65252504|FG000|Overall Study|Lack of Efficacy|0|||
23412732|NCT01238991|65252505|FG001|Overall Study|Lack of Efficacy|0|||
23412733|NCT01238991|65252506|FG002|Overall Study|Lack of Efficacy|1|||
23412734|NCT01238991|65252507|FG003|Overall Study|Lack of Efficacy|0|||
23412735|NCT01238991|65252508|FG004|Overall Study|Lack of Efficacy|0|||
23412736|NCT01238991|65252509|FG005|Overall Study|Lack of Efficacy|0|||
23412737|NCT01238991|65252510|FG006|Overall Study|Lack of Efficacy|0|||
23412738|NCT01238991|65252511|FG007|Overall Study|Lack of Efficacy|0|||
23412739|NCT01238991|65252512|FG008|Overall Study|Lack of Efficacy|1|||
23412740|NCT01238991|65252513|FG009|Overall Study|Lack of Efficacy|0|||
23412741|NCT01238991|65252504|FG000|Overall Study|Withdrawal by Subject|0|||
23412742|NCT01238991|65252505|FG001|Overall Study|Withdrawal by Subject|0|||
23412743|NCT01238991|65252506|FG002|Overall Study|Withdrawal by Subject|1|||
23412744|NCT01238991|65252507|FG003|Overall Study|Withdrawal by Subject|0|||
23412745|NCT01238991|65252508|FG004|Overall Study|Withdrawal by Subject|0|||
23412746|NCT01238991|65252509|FG005|Overall Study|Withdrawal by Subject|0|||
23412747|NCT01238991|65252510|FG006|Overall Study|Withdrawal by Subject|0|||
23412748|NCT01238991|65252511|FG007|Overall Study|Withdrawal by Subject|0|||
23412749|NCT01238991|65252512|FG008|Overall Study|Withdrawal by Subject|0|||
23412750|NCT01238991|65252513|FG009|Overall Study|Withdrawal by Subject|0|||
23412751|NCT01238991|65252504|FG000|Overall Study|Study Terminated by Sponsor|0|||
23412752|NCT01238991|65252505|FG001|Overall Study|Study Terminated by Sponsor|0|||
23412753|NCT01238991|65252506|FG002|Overall Study|Study Terminated by Sponsor|0|||
23412754|NCT01238991|65252507|FG003|Overall Study|Study Terminated by Sponsor|0|||
23412755|NCT01238991|65252508|FG004|Overall Study|Study Terminated by Sponsor|1|||
23412756|NCT01238991|65252509|FG005|Overall Study|Study Terminated by Sponsor|0|||
23412757|NCT01238991|65252510|FG006|Overall Study|Study Terminated by Sponsor|7|||
23412758|NCT01238991|65252511|FG007|Overall Study|Study Terminated by Sponsor|4|||
23412759|NCT01238991|65252512|FG008|Overall Study|Study Terminated by Sponsor|2|||
23412760|NCT01238991|65252513|FG009|Overall Study|Study Terminated by Sponsor|2|||
23412761|NCT01238991|65252504|FG000|Overall Study|Caregiver's request|0|||
23412762|NCT01238991|65252505|FG001|Overall Study|Caregiver's request|0|||
23412763|NCT01238991|65252506|FG002|Overall Study|Caregiver's request|0|||
23412764|NCT01238991|65252507|FG003|Overall Study|Caregiver's request|0|||
23412765|NCT01238991|65252508|FG004|Overall Study|Caregiver's request|0|||
23412766|NCT01238991|65252509|FG005|Overall Study|Caregiver's request|0|||
23412767|NCT01238991|65252510|FG006|Overall Study|Caregiver's request|0|||
23412768|NCT01238991|65252511|FG007|Overall Study|Caregiver's request|0|||
23412769|NCT01238991|65252512|FG008|Overall Study|Caregiver's request|1|||
23412770|NCT01238991|65252513|FG009|Overall Study|Caregiver's request|0|||
23412771|NCT01238991|65252504|FG000|Overall Study|Admission to a nursing home|1|||
23412772|NCT01238991|65252505|FG001|Overall Study|Admission to a nursing home|0|||
23412773|NCT01238991|65252506|FG002|Overall Study|Admission to a nursing home|1|||
23412774|NCT01238991|65252507|FG003|Overall Study|Admission to a nursing home|0|||
23412775|NCT01238991|65252508|FG004|Overall Study|Admission to a nursing home|0|||
23412776|NCT01238991|65252509|FG005|Overall Study|Admission to a nursing home|0|||
23412777|NCT01238991|65252510|FG006|Overall Study|Admission to a nursing home|0|||
23412778|NCT01238991|65252511|FG007|Overall Study|Admission to a nursing home|0|||
23412779|NCT01238991|65252512|FG008|Overall Study|Admission to a nursing home|0|||
23412780|NCT01238991|65252513|FG009|Overall Study|Admission to a nursing home|0|||
23412781|NCT00526656|65252514|FG000|Overall Study|Death|1|||
23412782|NCT00526656|65252514|FG000|Overall Study|Refused surgery|1|||
23412783|NCT03248531|65252515|FG000|Overall Study|Adverse Event|0|||
23412784|NCT03248531|65252516|FG001|Overall Study|Adverse Event|0|||
23412785|NCT03248531|65252517|FG002|Overall Study|Adverse Event|1|||
23412786|NCT03248531|65252515|FG000|Overall Study|Lost to Follow-up|1|||
23412787|NCT03248531|65252516|FG001|Overall Study|Lost to Follow-up|0|||
23412788|NCT03248531|65252517|FG002|Overall Study|Lost to Follow-up|5|||
23412789|NCT03248531|65252515|FG000|Overall Study|Withdrawal by Subject|3|||
23412790|NCT03248531|65252516|FG001|Overall Study|Withdrawal by Subject|3|||
23412791|NCT03248531|65252517|FG002|Overall Study|Withdrawal by Subject|2|||
23412792|NCT03248531|65252515|FG000|Overall Study|Sponsor Request|0|||
23412793|NCT03248531|65252516|FG001|Overall Study|Sponsor Request|2|||
23412794|NCT03248531|65252517|FG002|Overall Study|Sponsor Request|0|||
23412795|NCT04075513|65252518|FG000|Overall Study|Withdrawal by Subject|2|||
23412796|NCT04075513|65252519|FG001|Overall Study|Withdrawal by Subject|2|||
23412797|NCT04075513|65252518|FG000|Overall Study|Lack of Efficacy|1|||
23412798|NCT04075513|65252519|FG001|Overall Study|Lack of Efficacy|0|||
23412799|NCT04075513|65252518|FG000|Overall Study|Lost to Follow-up|4|||
23412800|NCT04075513|65252519|FG001|Overall Study|Lost to Follow-up|2|||
23412801|NCT04075513|65252518|FG000|Overall Study|Switch to insulin pump|1|||
23412802|NCT04075513|65252519|FG001|Overall Study|Switch to insulin pump|0|||
23412803|NCT02482298|65252523|FG000|Overall Study|Withdrawal by Subject|2|||
23412804|NCT02482298|65252524|FG001|Overall Study|Withdrawal by Subject|1|||
23412805|NCT02482298|65252525|FG002|Overall Study|Withdrawal by Subject|2|||
23412806|NCT02482298|65252523|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
23412807|NCT02482298|65252524|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
23412808|NCT02482298|65252525|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
23412809|NCT02482298|65252523|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
23412810|NCT02482298|65252524|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
23412811|NCT02482298|65252525|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
23412812|NCT02482298|65252523|FG000|Overall Study|Lost to Follow-up|0|||
23412813|NCT02482298|65252524|FG001|Overall Study|Lost to Follow-up|1|||
23412814|NCT02482298|65252525|FG002|Overall Study|Lost to Follow-up|0|||
23412815|NCT02241733|65252526|FG000|Overall Study|Lost to Follow-up|9|||
23412816|NCT02241733|65252527|FG001|Overall Study|Lost to Follow-up|4|||
23412817|NCT02241733|65252526|FG000|Overall Study|Physician Decision|6|||
23412818|NCT02241733|65252527|FG001|Overall Study|Physician Decision|2|||
23412819|NCT02241733|65252526|FG000|Overall Study|Withdrawal by Subject|0|||
23412820|NCT02241733|65252527|FG001|Overall Study|Withdrawal by Subject|2|||
23412821|NCT02241733|65252526|FG000|Overall Study|Death|0|||
23412822|NCT02241733|65252527|FG001|Overall Study|Death|2|||
23412823|NCT01521923|65252528|FG000|Overall Study|AE, serious fatal|1|||
23412824|NCT01521923|65252529|FG001|Overall Study|AE, serious fatal|0|||
23412825|NCT01521923|65252530|FG002|Overall Study|AE, serious fatal|0|||
23412826|NCT01521923|65252531|FG003|Overall Study|AE, serious fatal|0|||
23412827|NCT01521923|65252528|FG000|Overall Study|SAE, non-fatal|0|||
23412828|NCT01521923|65252529|FG001|Overall Study|SAE, non-fatal|2|||
23412829|NCT01521923|65252530|FG002|Overall Study|SAE, non-fatal|2|||
23412830|NCT01521923|65252531|FG003|Overall Study|SAE, non-fatal|0|||
23412831|NCT01521923|65252528|FG000|Overall Study|AE, non-serious, non-fatal|1|||
23412832|NCT01521923|65252529|FG001|Overall Study|AE, non-serious, non-fatal|3|||
23412833|NCT01521923|65252530|FG002|Overall Study|AE, non-serious, non-fatal|6|||
23412834|NCT01521923|65252531|FG003|Overall Study|AE, non-serious, non-fatal|2|||
23412835|NCT01521923|65252528|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412836|NCT01521923|65252529|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412837|NCT01521923|65252530|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412838|NCT01521923|65252531|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
23412839|NCT01521923|65252528|FG000|Overall Study|Lack of Efficacy|1|||
23412840|NCT01521923|65252529|FG001|Overall Study|Lack of Efficacy|1|||
23412841|NCT01521923|65252530|FG002|Overall Study|Lack of Efficacy|0|||
23412842|NCT01521923|65252531|FG003|Overall Study|Lack of Efficacy|0|||
23412843|NCT01521923|65252528|FG000|Overall Study|Protocol Violation|0|||
23412844|NCT01521923|65252529|FG001|Overall Study|Protocol Violation|0|||
23412845|NCT01521923|65252530|FG002|Overall Study|Protocol Violation|1|||
23412846|NCT01521923|65252531|FG003|Overall Study|Protocol Violation|0|||
23412847|NCT01521923|65252528|FG000|Overall Study|Lost to Follow-up|1|||
23412848|NCT01521923|65252529|FG001|Overall Study|Lost to Follow-up|0|||
23412849|NCT01521923|65252530|FG002|Overall Study|Lost to Follow-up|2|||
23412850|NCT01521923|65252531|FG003|Overall Study|Lost to Follow-up|1|||
23412851|NCT01521923|65252528|FG000|Overall Study|Withdrawal by Subject|1|||
23412852|NCT01521923|65252529|FG001|Overall Study|Withdrawal by Subject|1|||
23412853|NCT01521923|65252530|FG002|Overall Study|Withdrawal by Subject|1|||
23412854|NCT01521923|65252531|FG003|Overall Study|Withdrawal by Subject|2|||
23412855|NCT01521923|65252528|FG000|Overall Study|Other|2|||
23412856|NCT01521923|65252529|FG001|Overall Study|Other|1|||
23412857|NCT01521923|65252530|FG002|Overall Study|Other|3|||
23412858|NCT01521923|65252531|FG003|Overall Study|Other|6|||
23412859|NCT01521923|65252528|FG000|Overall Study|AE, captured in Period 1|0|||
23412860|NCT01521923|65252529|FG001|Overall Study|AE, captured in Period 1|1|||
23412861|NCT01521923|65252530|FG002|Overall Study|AE, captured in Period 1|0|||
23412862|NCT01521923|65252531|FG003|Overall Study|AE, captured in Period 1|1|||
23412863|NCT00904670|65252533|FG000|Open Label Phase|Withdrawal by Subject|2|||
23412864|NCT00904670|65252534|FG001|Open Label Phase|Withdrawal by Subject|0|||
23412865|NCT00904670|65252533|FG000|Open Label Phase|Adverse Event|2|||
23412866|NCT00904670|65252534|FG001|Open Label Phase|Adverse Event|0|||
23412867|NCT00904670|65252533|FG000|Open Label Phase|Lack of Efficacy|1|||
23412868|NCT00904670|65252534|FG001|Open Label Phase|Lack of Efficacy|0|||
23412869|NCT00904670|65252533|FG000|Open Label Phase|Lost to Follow-up|1|||
23412870|NCT00904670|65252534|FG001|Open Label Phase|Lost to Follow-up|0|||
23412871|NCT03650413|65252537|FG000|Overall Study|Adverse Event|1|||
23412872|NCT03650413|65252537|FG000|Overall Study|Lack of Efficacy|17|||
23412873|NCT03650413|65252537|FG000|Overall Study|Other|9|||
23412874|NCT03650413|65252537|FG000|Overall Study|Physician Decision|2|||
23412875|NCT03650413|65252537|FG000|Overall Study|Study Terminated By Sponsor|16|||
23412876|NCT03650413|65252537|FG000|Overall Study|Withdrawal by Subject|16|||
23412877|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Physician Decision|0|||
23412878|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Physician Decision|0|||
23412879|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Physician Decision|1|||
23412880|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Physician Decision|0|||
23412881|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
23412882|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
23412883|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
23412884|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
23412885|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
23412886|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
23412887|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
23412888|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
23412889|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Other|1|||
23412890|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Other|1|||
23412891|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Other|0|||
23412892|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Other|0|||
23412893|NCT02266147|65252540|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
23412894|NCT02266147|65252541|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
23412895|NCT02266147|65252542|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
23412896|NCT02266147|65252543|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
23412897|NCT02266147|65252540|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
23412898|NCT02266147|65252541|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
23412899|NCT02266147|65252542|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
23412900|NCT02266147|65252543|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
23710438|NCT04387136|66315402|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
23412901|NCT01221623|65252544|FG000|Overall Study|Withdrawal by Subject|19|||
23412902|NCT01221623|65252545|FG001|Overall Study|Withdrawal by Subject|8|||
23412903|NCT01221623|65252544|FG000|Overall Study|Lost to Follow-up|7|||
23412904|NCT01221623|65252545|FG001|Overall Study|Lost to Follow-up|1|||
23412905|NCT01221623|65252544|FG000|Overall Study|Adverse Event|6|||
23412906|NCT01221623|65252545|FG001|Overall Study|Adverse Event|3|||
23412907|NCT01221623|65252544|FG000|Overall Study|Death|1|||
23412908|NCT01221623|65252545|FG001|Overall Study|Death|0|||
23412909|NCT01221623|65252544|FG000|Overall Study|Other|5|||
23412910|NCT01221623|65252545|FG001|Overall Study|Other|2|||
23412911|NCT01076205|65252546|FG000|Overall Study|Adverse Drug Reaction|299|||
23412912|NCT01076205|65252546|FG000|Overall Study|Lack of Effectiveness|1423|||
23412913|NCT01076205|65252546|FG000|Overall Study|Other Reason|1075|||
23412914|NCT01076205|65252546|FG000|Overall Study|Unknown Reason|71|||
23412915|NCT01076205|65252546|FG000|Overall Study|Lost to Follow-up|3151|||
23412916|NCT00635349|65255228|FG000|Overall Study|Other|8|||
23412917|NCT00635349|65255229|FG001|Overall Study|Other|6|||
23412918|NCT00635349|65255228|FG000|Overall Study|Protocol Violation|18|||
23412919|NCT00635349|65255229|FG001|Overall Study|Protocol Violation|22|||
23412920|NCT00635349|65255228|FG000|Overall Study|Withdrawal by Subject|3|||
23412921|NCT00635349|65255229|FG001|Overall Study|Withdrawal by Subject|8|||
23412922|NCT00635349|65255228|FG000|Overall Study|Lost to Follow-up|4|||
23412923|NCT00635349|65255229|FG001|Overall Study|Lost to Follow-up|3|||
23710439|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
23710440|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23710441|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23710442|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23412924|NCT00635349|65255228|FG000|Overall Study|Adverse Event|11|||
23412925|NCT00635349|65255229|FG001|Overall Study|Adverse Event|9|||
23412926|NCT00372619|65255230|FG000|Overall Study|Ineligible|0|||
23412927|NCT00372619|65255231|FG001|Overall Study|Ineligible|0|||
23412928|NCT00372619|65255232|FG002|Overall Study|Ineligible|0|||
23412929|NCT00372619|65255233|FG003|Overall Study|Ineligible|0|||
23412930|NCT00372619|65255234|FG004|Overall Study|Ineligible|0|||
23412931|NCT00372619|65255235|FG005|Overall Study|Ineligible|2|||
23412932|NCT00372619|65255236|FG006|Overall Study|Ineligible|0|||
23412933|NCT00372619|65255230|FG000|Overall Study|Inevaluable|0|||
23412934|NCT00372619|65255231|FG001|Overall Study|Inevaluable|0|||
23412935|NCT00372619|65255232|FG002|Overall Study|Inevaluable|0|||
23412936|NCT00372619|65255233|FG003|Overall Study|Inevaluable|0|||
23412937|NCT00372619|65255234|FG004|Overall Study|Inevaluable|0|||
23412938|NCT00372619|65255235|FG005|Overall Study|Inevaluable|1|||
23412939|NCT00372619|65255236|FG006|Overall Study|Inevaluable|0|||
23412940|NCT01555073|65255237|FG000|Overall Study|Lost to Follow-up|1|||
23710443|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23710444|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
23412941|NCT01555073|65255238|FG001|Overall Study|Lost to Follow-up|2|||
23412942|NCT01555073|65255239|FG002|Overall Study|Lost to Follow-up|0|||
23412943|NCT01555073|65255240|FG003|Overall Study|Lost to Follow-up|5|||
23412944|NCT00361231|65255241|FG000|Overall Study|Physician Decision|3|||
23412945|NCT00361231|65255241|FG000|Overall Study|Symptomatic deterioration|5|||
23412946|NCT00361231|65255241|FG000|Overall Study|Radiographic disease progression|16|||
23412947|NCT00361231|65255241|FG000|Overall Study|Withdrawal by Subject|4|||
23412948|NCT00361231|65255241|FG000|Overall Study|Adverse Event|6|||
23412949|NCT02096952|65255244|FG000|Overall Study|Adverse Event|1|||
23412950|NCT01390298|65255246|FG000|Overall Study|Death|1|||
23412951|NCT01390298|65255246|FG000|Overall Study|long term ICU admission|1|||
23412952|NCT01390298|65255246|FG000|Overall Study|Withdrawal by Subject|14|||
23412953|NCT01390298|65255246|FG000|Overall Study|Lost to Follow-up|7|||
23412954|NCT01390298|65255246|FG000|Overall Study|Surgery cancelled|1|||
23412955|NCT02675751|65255252|FG000|Overall Study|Lost to Follow-up|16|||
23412956|NCT03143153|65255253|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
23412957|NCT03143153|65255254|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
23412958|NCT03143153|65255255|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
23412959|NCT03143153|65255253|FG000|Pre-Treatment|Participant withdrew consent|0|||
23412960|NCT03143153|65255254|FG001|Pre-Treatment|Participant withdrew consent|1|||
23412961|NCT03143153|65255255|FG002|Pre-Treatment|Participant withdrew consent|12|||
23412962|NCT03143153|65255253|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
23412963|NCT03143153|65255254|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
23412964|NCT03143153|65255255|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
23412965|NCT03143153|65255253|FG000|Pre-Treatment|Other Reasons|1|||
23412966|NCT03143153|65255254|FG001|Pre-Treatment|Other Reasons|2|||
23412967|NCT03143153|65255255|FG002|Pre-Treatment|Other Reasons|1|||
23412968|NCT03143153|65255253|FG000|Pre-Treatment|Disease Progression|1|||
23412969|NCT03143153|65255254|FG001|Pre-Treatment|Disease Progression|1|||
23412970|NCT03143153|65255255|FG002|Pre-Treatment|Disease Progression|2|||
23412971|NCT03143153|65255253|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23412972|NCT03143153|65255254|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
23412973|NCT03143153|65255255|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
23412974|NCT03143153|65255253|FG000|Treatment|Disease progression|174|||
23412975|NCT03143153|65255254|FG001|Treatment|Disease progression|184|||
23412976|NCT03143153|65255255|FG002|Treatment|Disease progression|193|||
23412977|NCT03143153|65255253|FG000|Treatment|Study drug toxicity|59|||
23412978|NCT03143153|65255254|FG001|Treatment|Study drug toxicity|33|||
23412979|NCT03143153|65255255|FG002|Treatment|Study drug toxicity|40|||
23412980|NCT03143153|65255253|FG000|Treatment|Death|5|||
23412981|NCT03143153|65255254|FG001|Treatment|Death|3|||
23412982|NCT03143153|65255255|FG002|Treatment|Death|4|||
23412983|NCT03143153|65255253|FG000|Treatment|Adverse event unrelated to study drug|19|||
23412984|NCT03143153|65255254|FG001|Treatment|Adverse event unrelated to study drug|28|||
23412985|NCT03143153|65255255|FG002|Treatment|Adverse event unrelated to study drug|12|||
23412986|NCT03143153|65255253|FG000|Treatment|Participant request to discontinue study treatment|13|||
23412987|NCT03143153|65255254|FG001|Treatment|Participant request to discontinue study treatment|15|||
23412988|NCT03143153|65255255|FG002|Treatment|Participant request to discontinue study treatment|20|||
23412989|NCT03143153|65255253|FG000|Treatment|Participant withdrew consent|3|||
23412990|NCT03143153|65255254|FG001|Treatment|Participant withdrew consent|4|||
23511915|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23710445|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23710446|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23710447|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23710448|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23710449|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
23710450|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23511916|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
23511917|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23511918|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23511919|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
23511920|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
23511921|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
23511922|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
23511923|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
23511924|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23511925|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
23511926|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
23710451|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23412991|NCT03143153|65255255|FG002|Treatment|Participant withdrew consent|12|||
23412992|NCT03143153|65255253|FG000|Treatment|Pregnancy|1|||
23412993|NCT03143153|65255254|FG001|Treatment|Pregnancy|0|||
23412994|NCT03143153|65255255|FG002|Treatment|Pregnancy|0|||
23412995|NCT03143153|65255253|FG000|Treatment|Maximum clinical benefit|1|||
23412996|NCT03143153|65255254|FG001|Treatment|Maximum clinical benefit|3|||
23412997|NCT03143153|65255255|FG002|Treatment|Maximum clinical benefit|4|||
23511927|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23710452|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23412998|NCT03143153|65255253|FG000|Treatment|Completed treatment as per Protocol|13|||
23412999|NCT03143153|65255254|FG001|Treatment|Completed treatment as per Protocol|8|||
23413000|NCT03143153|65255255|FG002|Treatment|Completed treatment as per Protocol|0|||
23413001|NCT03143153|65255253|FG000|Treatment|Other reasons|12|||
23413002|NCT03143153|65255254|FG001|Treatment|Other reasons|7|||
23413003|NCT03143153|65255255|FG002|Treatment|Other reasons|15|||
23413004|NCT03143153|65255253|FG000|Treatment|Not reported|1|||
23413005|NCT03143153|65255254|FG001|Treatment|Not reported|0|||
23413006|NCT03143153|65255255|FG002|Treatment|Not reported|0|||
23413007|NCT02482428|65255256|FG000|Overall Study|Lost to Follow-up|4|||
23413008|NCT02482428|65255257|FG001|Overall Study|Lost to Follow-up|9|||
23413009|NCT02482428|65255258|FG002|Overall Study|Lost to Follow-up|1|||
23413010|NCT02482428|65255259|FG003|Overall Study|Lost to Follow-up|2|||
23413011|NCT02482428|65255260|FG004|Overall Study|Lost to Follow-up|4|||
23413012|NCT02482428|65255256|FG000|Overall Study|Physician Decision|0|||
23413013|NCT02482428|65255257|FG001|Overall Study|Physician Decision|0|||
23413014|NCT02482428|65255258|FG002|Overall Study|Physician Decision|0|||
23413015|NCT02482428|65255259|FG003|Overall Study|Physician Decision|0|||
23413016|NCT02482428|65255260|FG004|Overall Study|Physician Decision|1|||
23413017|NCT02482428|65255256|FG000|Overall Study|protocol deviation|1|||
23413018|NCT02482428|65255257|FG001|Overall Study|protocol deviation|1|||
23413019|NCT02482428|65255258|FG002|Overall Study|protocol deviation|0|||
23413020|NCT02482428|65255259|FG003|Overall Study|protocol deviation|0|||
23413021|NCT02482428|65255260|FG004|Overall Study|protocol deviation|0|||
23413022|NCT02482428|65255256|FG000|Overall Study|subject/guardian decision|4|||
23413023|NCT02482428|65255257|FG001|Overall Study|subject/guardian decision|2|||
23413024|NCT02482428|65255258|FG002|Overall Study|subject/guardian decision|0|||
23413025|NCT02482428|65255259|FG003|Overall Study|subject/guardian decision|0|||
23413026|NCT02482428|65255260|FG004|Overall Study|subject/guardian decision|2|||
23413027|NCT03292640|65255272|FG000|Overall Study|Withdrawal by Subject|17|||
23413028|NCT03292640|65255273|FG001|Overall Study|Withdrawal by Subject|16|||
23413029|NCT03292640|65255272|FG000|Overall Study|Adverse Event|20|||
23511928|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23511929|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
23511930|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23511931|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
23511932|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23511933|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23710453|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23710454|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
23710455|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23710456|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23710457|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23710458|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23710459|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
23710460|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23710461|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23710462|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23413030|NCT03292640|65255273|FG001|Overall Study|Adverse Event|2|||
23413031|NCT03292640|65255272|FG000|Overall Study|Lost to Follow-up|24|||
23413032|NCT03292640|65255273|FG001|Overall Study|Lost to Follow-up|24|||
23413033|NCT02993822|65255278|FG000|Overall Study|Lack of Efficacy|1|||
23413034|NCT02993822|65255279|FG001|Overall Study|Lack of Efficacy|1|||
23413035|NCT02993822|65255280|FG002|Overall Study|Lack of Efficacy|0|||
23511934|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
23511935|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
23511936|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
23511937|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
23511938|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
23413036|NCT02993822|65255281|FG003|Overall Study|Lack of Efficacy|0|||
23413037|NCT02993822|65255278|FG000|Overall Study|Protocol Violation|1|||
23511939|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
23511940|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
23710463|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23710464|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
23710465|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23710466|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23710467|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23413038|NCT02993822|65255279|FG001|Overall Study|Protocol Violation|0|||
23413039|NCT02993822|65255280|FG002|Overall Study|Protocol Violation|0|||
23413040|NCT02993822|65255281|FG003|Overall Study|Protocol Violation|0|||
23413041|NCT02993822|65255278|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
23413042|NCT02993822|65255279|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
23413043|NCT02993822|65255280|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
23511941|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
23413044|NCT02993822|65255281|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
23413045|NCT02993822|65255278|FG000|Overall Study|Adverse Event|3|||
23413046|NCT02993822|65255279|FG001|Overall Study|Adverse Event|1|||
23413047|NCT02993822|65255280|FG002|Overall Study|Adverse Event|7|||
23413048|NCT02993822|65255281|FG003|Overall Study|Adverse Event|0|||
23413049|NCT02993822|65255278|FG000|Overall Study|Withdrawal by Subject|4|||
23413050|NCT02993822|65255279|FG001|Overall Study|Withdrawal by Subject|2|||
23413051|NCT02993822|65255280|FG002|Overall Study|Withdrawal by Subject|2|||
23413052|NCT02993822|65255281|FG003|Overall Study|Withdrawal by Subject|3|||
23413053|NCT02993822|65255278|FG000|Overall Study|Lost to Follow-up|1|||
23413054|NCT02993822|65255279|FG001|Overall Study|Lost to Follow-up|0|||
23413055|NCT02993822|65255280|FG002|Overall Study|Lost to Follow-up|1|||
23413056|NCT02993822|65255281|FG003|Overall Study|Lost to Follow-up|0|||
23413057|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
23413058|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
23413059|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
23413060|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
23413061|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
23413062|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
23413063|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
23413064|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
23413065|NCT00810277|65255285|FG000|Overall Study|Adverse Event|1|||
23413066|NCT03832322|65255286|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
23413067|NCT03832322|65255287|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
23413068|NCT01681069|65255288|FG000|Overall Study|Withdrawal by Subject|4|||
23413069|NCT01681069|65255289|FG001|Overall Study|Withdrawal by Subject|5|||
23413070|NCT01681069|65255288|FG000|Overall Study|Protocol Violation|1|||
23413071|NCT01681069|65255289|FG001|Overall Study|Protocol Violation|1|||
23413072|NCT01681069|65255288|FG000|Overall Study|Adverse Event|0|||
23413073|NCT01681069|65255289|FG001|Overall Study|Adverse Event|1|||
23413074|NCT01832493|65255290|FG000|Overall Study|Physician Decision|2|||
23413075|NCT01832493|65255290|FG000|Overall Study|Protocol Violation|4|||
23413076|NCT01832493|65255290|FG000|Overall Study|Unable to place LV lead|2|||
23413077|NCT00958347|65255291|FG000|Overall Study|Death|43|||
23511942|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
23511943|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
23413078|NCT00958347|65255291|FG000|Overall Study|Withdrawal by Subject|23|||
23413079|NCT00958347|65255291|FG000|Overall Study|Lost to Follow-up|15|||
23413080|NCT00958347|65255291|FG000|Overall Study|revision/removal|10|||
23413081|NCT00958347|65255291|FG000|Overall Study|study termination|135|||
23413082|NCT00956007|65255298|FG000|Overall Study|Protocol Violation|27|||
23413083|NCT00956007|65255299|FG001|Overall Study|Protocol Violation|23|||
23413084|NCT00624468|65255300|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
23413085|NCT00624468|65255301|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
23413086|NCT00624468|65255302|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
23413087|NCT00624468|65255303|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
23413088|NCT00624468|65255300|FG000|Double-blind Period|Withdrew Prematurely|1|||
23413089|NCT00624468|65255301|FG001|Double-blind Period|Withdrew Prematurely|1|||
23413090|NCT00624468|65255302|FG002|Double-blind Period|Withdrew Prematurely|0|||
23413091|NCT00624468|65255303|FG003|Double-blind Period|Withdrew Prematurely|0|||
23413092|NCT00624468|65255300|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
23413093|NCT00624468|65255301|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
23413094|NCT00624468|65255302|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
23413095|NCT00624468|65255303|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
23413096|NCT00624468|65255300|FG000|Safety Follow-up (SFU) Period|Other|0|||
23413097|NCT00624468|65255301|FG001|Safety Follow-up (SFU) Period|Other|0|||
23413098|NCT00624468|65255302|FG002|Safety Follow-up (SFU) Period|Other|1|||
23413099|NCT00624468|65255303|FG003|Safety Follow-up (SFU) Period|Other|1|||
23413100|NCT03350035|65255304|FG000|Overall Study|Lack of Efficacy|2|||
23413101|NCT03350035|65255305|FG001|Overall Study|Lack of Efficacy|0|||
23511944|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
23710468|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23710469|NCT01111539|66315404|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
23413102|NCT03350035|65255306|FG002|Overall Study|Lack of Efficacy|0|||
23413103|NCT03350035|65255304|FG000|Overall Study|Subject discharged to hospice|0|||
23413104|NCT03350035|65255305|FG001|Overall Study|Subject discharged to hospice|0|||
23413105|NCT03350035|65255306|FG002|Overall Study|Subject discharged to hospice|1|||
23413106|NCT03718884|65255307|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
23413107|NCT03718884|65255308|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
23413108|NCT03718884|65255307|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
23413109|NCT03718884|65255308|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
23413110|NCT00425698|65255309|FG000|Overall Study|Adverse Event|3|||
23413111|NCT00425698|65255310|FG001|Overall Study|Adverse Event|1|||
23413112|NCT00425698|65255309|FG000|Overall Study|Withdrawal by Subject|0|||
23413113|NCT00425698|65255310|FG001|Overall Study|Withdrawal by Subject|1|||
23413114|NCT02222688|65255311|FG000|Overall Study|Withdrawal by Subject|0|||
23413115|NCT02222688|65255312|FG001|Overall Study|Withdrawal by Subject|0|||
23413116|NCT02222688|65255313|FG002|Overall Study|Withdrawal by Subject|0|||
23413117|NCT02222688|65255314|FG003|Overall Study|Withdrawal by Subject|2|||
23413118|NCT02222688|65255315|FG004|Overall Study|Withdrawal by Subject|1|||
23413119|NCT02222688|65255316|FG005|Overall Study|Withdrawal by Subject|0|||
23413120|NCT02222688|65255317|FG006|Overall Study|Withdrawal by Subject|1|||
23413121|NCT02222688|65255311|FG000|Overall Study|Disease progression|1|||
23413122|NCT02222688|65255312|FG001|Overall Study|Disease progression|0|||
23413123|NCT02222688|65255313|FG002|Overall Study|Disease progression|0|||
23413124|NCT02222688|65255314|FG003|Overall Study|Disease progression|0|||
23413125|NCT02222688|65255315|FG004|Overall Study|Disease progression|0|||
23413126|NCT02222688|65255316|FG005|Overall Study|Disease progression|0|||
23413127|NCT02222688|65255317|FG006|Overall Study|Disease progression|0|||
23413128|NCT02957747|65255321|FG000|Overall Study|Withdrawal by Subject|0|||
23413129|NCT02957747|65255322|FG001|Overall Study|Withdrawal by Subject|3|||
23413130|NCT02957747|65255321|FG000|Overall Study|Lost to Follow-up|10|||
23413131|NCT02957747|65255322|FG001|Overall Study|Lost to Follow-up|5|||
23413132|NCT02248649|65255323|FG000|Overall Study|Death|7|||
23413133|NCT02248649|65255324|FG001|Overall Study|Death|11|||
23413134|NCT02248649|65255323|FG000|Overall Study|Lost to Follow-up|14|||
23413135|NCT02248649|65255324|FG001|Overall Study|Lost to Follow-up|10|||
23413136|NCT00700882|65255325|FG000|Overall Study|Never received treatment|6|||
23413137|NCT00700882|65255325|FG000|Overall Study|Ineligible|2|||
23413138|NCT00700882|65255325|FG000|Overall Study|No KIT mutation|51|||
23413139|NCT04091581|65255328|FG000|Overall Study|Lost to Follow-up|0|||
23413140|NCT04091581|65255329|FG001|Overall Study|Lost to Follow-up|1|||
23413141|NCT01951586|65255330|FG000|Overall Study|Death|61|||
23413142|NCT01951586|65255331|FG001|Overall Study|Death|120|||
23413143|NCT01951586|65255330|FG000|Overall Study|Withdrawal by Subject|8|||
23413144|NCT01951586|65255331|FG001|Overall Study|Withdrawal by Subject|17|||
23413145|NCT01951586|65255330|FG000|Overall Study|Lost to Follow-up|0|||
23413146|NCT01951586|65255331|FG001|Overall Study|Lost to Follow-up|1|||
23413147|NCT01951586|65255330|FG000|Overall Study|Sponsor Decision|9|||
23413148|NCT01951586|65255331|FG001|Overall Study|Sponsor Decision|10|||
23413149|NCT01891396|65255332|FG000|Overall Study|Withdrawal by Subject|4|||
23413150|NCT01891396|65255333|FG001|Overall Study|Withdrawal by Subject|4|||
23413151|NCT01891396|65255334|FG002|Overall Study|Withdrawal by Subject|3|||
23413152|NCT01891396|65255332|FG000|Overall Study|Lost to Follow-up|0|||
23413153|NCT01891396|65255333|FG001|Overall Study|Lost to Follow-up|1|||
23413154|NCT01891396|65255334|FG002|Overall Study|Lost to Follow-up|0|||
23413155|NCT00177294|65255335|FG000|Overall Study|Withdrawal by Subject|7|||
23413156|NCT00177294|65255336|FG001|Overall Study|Withdrawal by Subject|5|||
23413157|NCT04599803|65255341|FG000|Overall Study|Withdrawal by Subject|5|||
23413158|NCT04599803|65255341|FG000|Overall Study|Lost to Follow-up|26|||
23413159|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Adverse Event|7|||
23413160|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Adverse Event|0|||
23413161|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Adverse Event|0|||
23413162|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
23413163|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
23413164|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
23413165|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
23413166|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
23413167|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
23413168|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
23413169|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
23413170|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
23413171|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
23413172|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
23413173|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
23413174|NCT01059864|65255342|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23413175|NCT01059864|65255343|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23413176|NCT01059864|65255344|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
23413177|NCT00070109|65255353|FG000|Overall Study|Death|1|||
23413178|NCT00070109|65255354|FG001|Overall Study|Death|1|||
23413179|NCT00070109|65255355|FG002|Overall Study|Death|0|||
23511945|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
23413180|NCT00070109|65255356|FG003|Overall Study|Death|0|||
23413181|NCT00070109|65255357|FG004|Overall Study|Death|1|||
23413182|NCT00070109|65255353|FG000|Overall Study|Lack of Efficacy|6|||
23413183|NCT00070109|65255354|FG001|Overall Study|Lack of Efficacy|4|||
23413184|NCT00070109|65255355|FG002|Overall Study|Lack of Efficacy|5|||
23413185|NCT00070109|65255356|FG003|Overall Study|Lack of Efficacy|15|||
23413186|NCT00070109|65255357|FG004|Overall Study|Lack of Efficacy|5|||
23511946|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
23413187|NCT00070109|65255353|FG000|Overall Study|Physician Decision|1|||
23413188|NCT00070109|65255354|FG001|Overall Study|Physician Decision|0|||
23413189|NCT00070109|65255355|FG002|Overall Study|Physician Decision|0|||
23413190|NCT00070109|65255356|FG003|Overall Study|Physician Decision|0|||
23413191|NCT00070109|65255357|FG004|Overall Study|Physician Decision|0|||
23413192|NCT00070109|65255353|FG000|Overall Study|Withdrawal by Subject|0|||
23413193|NCT00070109|65255354|FG001|Overall Study|Withdrawal by Subject|1|||
23413194|NCT00070109|65255355|FG002|Overall Study|Withdrawal by Subject|1|||
23413195|NCT00070109|65255356|FG003|Overall Study|Withdrawal by Subject|0|||
23413196|NCT00070109|65255357|FG004|Overall Study|Withdrawal by Subject|0|||
23413197|NCT00070109|65255353|FG000|Overall Study|Adverse Event|0|||
23710470|NCT01111539|66315405|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23710471|NCT01111539|66315406|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23710472|NCT01111539|66315407|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23413198|NCT00070109|65255354|FG001|Overall Study|Adverse Event|0|||
23413199|NCT00070109|65255355|FG002|Overall Study|Adverse Event|2|||
23413200|NCT00070109|65255356|FG003|Overall Study|Adverse Event|4|||
23413201|NCT00070109|65255357|FG004|Overall Study|Adverse Event|2|||
23413202|NCT00070109|65255353|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
23413203|NCT00070109|65255354|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
23413204|NCT00070109|65255355|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
23413205|NCT00070109|65255356|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
23413206|NCT00070109|65255357|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
23413207|NCT02712983|65255358|FG000|Treatment Phase|Adverse Event|3|||
23413208|NCT02712983|65255359|FG001|Treatment Phase|Adverse Event|1|||
23413209|NCT02712983|65255360|FG002|Treatment Phase|Adverse Event|1|||
23413210|NCT02712983|65255361|FG003|Treatment Phase|Adverse Event|4|||
23413211|NCT02712983|65255362|FG004|Treatment Phase|Adverse Event|3|||
23413212|NCT02712983|65255363|FG005|Treatment Phase|Adverse Event|0|||
23413213|NCT02712983|65255364|FG006|Treatment Phase|Adverse Event|6|||
23413214|NCT02712983|65255365|FG007|Treatment Phase|Adverse Event|6|||
23413215|NCT02712983|65255366|FG008|Treatment Phase|Adverse Event|1|||
23413216|NCT02712983|65255358|FG000|Treatment Phase|Protocol Deviation|0|||
23413217|NCT02712983|65255359|FG001|Treatment Phase|Protocol Deviation|0|||
23413218|NCT02712983|65255360|FG002|Treatment Phase|Protocol Deviation|0|||
23413219|NCT02712983|65255361|FG003|Treatment Phase|Protocol Deviation|2|||
23413220|NCT02712983|65255362|FG004|Treatment Phase|Protocol Deviation|0|||
23413221|NCT02712983|65255363|FG005|Treatment Phase|Protocol Deviation|0|||
23413222|NCT02712983|65255364|FG006|Treatment Phase|Protocol Deviation|1|||
23413223|NCT02712983|65255365|FG007|Treatment Phase|Protocol Deviation|0|||
23413224|NCT02712983|65255366|FG008|Treatment Phase|Protocol Deviation|0|||
23413225|NCT02712983|65255358|FG000|Treatment Phase|Technical Problems|0|||
23413226|NCT02712983|65255359|FG001|Treatment Phase|Technical Problems|0|||
23413227|NCT02712983|65255360|FG002|Treatment Phase|Technical Problems|0|||
23413228|NCT02712983|65255361|FG003|Treatment Phase|Technical Problems|0|||
23413229|NCT02712983|65255362|FG004|Treatment Phase|Technical Problems|0|||
23413230|NCT02712983|65255363|FG005|Treatment Phase|Technical Problems|0|||
23413231|NCT02712983|65255364|FG006|Treatment Phase|Technical Problems|1|||
23413232|NCT02712983|65255365|FG007|Treatment Phase|Technical Problems|0|||
23413233|NCT02712983|65255366|FG008|Treatment Phase|Technical Problems|0|||
23413234|NCT02712983|65255358|FG000|Treatment Phase|Physician Decision|0|||
23413235|NCT02712983|65255359|FG001|Treatment Phase|Physician Decision|0|||
23413236|NCT02712983|65255360|FG002|Treatment Phase|Physician Decision|0|||
23413237|NCT02712983|65255361|FG003|Treatment Phase|Physician Decision|0|||
23413238|NCT02712983|65255362|FG004|Treatment Phase|Physician Decision|0|||
23413239|NCT02712983|65255363|FG005|Treatment Phase|Physician Decision|0|||
23413240|NCT02712983|65255364|FG006|Treatment Phase|Physician Decision|0|||
23413241|NCT02712983|65255365|FG007|Treatment Phase|Physician Decision|1|||
23413242|NCT02712983|65255366|FG008|Treatment Phase|Physician Decision|1|||
23413243|NCT02712983|65255358|FG000|Treatment Phase|Subject Decision|2|||
23413244|NCT02712983|65255359|FG001|Treatment Phase|Subject Decision|0|||
23413245|NCT02712983|65255360|FG002|Treatment Phase|Subject Decision|0|||
23413246|NCT02712983|65255361|FG003|Treatment Phase|Subject Decision|2|||
23413247|NCT02712983|65255362|FG004|Treatment Phase|Subject Decision|1|||
23413248|NCT02712983|65255363|FG005|Treatment Phase|Subject Decision|0|||
23413249|NCT02712983|65255364|FG006|Treatment Phase|Subject Decision|1|||
23413250|NCT02712983|65255365|FG007|Treatment Phase|Subject Decision|2|||
23413251|NCT02712983|65255366|FG008|Treatment Phase|Subject Decision|0|||
23413252|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413253|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413254|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413255|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413256|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413257|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413258|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413259|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413260|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413261|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413262|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413263|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413264|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
23413265|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413266|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413267|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413268|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413269|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413270|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413271|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413272|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413273|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413274|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
23413275|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
23413276|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
23413277|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
23413278|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413279|NCT02584452|65255367|FG000|Overall Study|Physician Decision|1|||
23413280|NCT02584452|65255368|FG001|Overall Study|Physician Decision|1|||
23413281|NCT02584452|65255367|FG000|Overall Study|Lost to Follow-up|1|||
23413282|NCT02584452|65255368|FG001|Overall Study|Lost to Follow-up|1|||
23413283|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413284|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413285|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413286|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
23413287|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413288|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413289|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413290|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413291|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413292|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
23413293|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413294|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413295|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413296|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
23413297|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413298|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413299|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413300|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413301|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413302|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
23413303|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413304|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413305|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413306|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413307|NCT03629223|65255369|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
23413308|NCT03629223|65255370|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413309|NCT03629223|65255371|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23511947|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
23511948|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
23511949|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
23511950|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
23413310|NCT03629223|65255372|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413311|NCT03629223|65255373|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413312|NCT03629223|65255374|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413313|NCT00933608|65255377|FG000|Overall Study|Adverse Event|4|||
23413314|NCT00933608|65255378|FG001|Overall Study|Adverse Event|2|||
23413315|NCT00933608|65255377|FG000|Overall Study|Physician Decision|1|||
23413316|NCT00933608|65255378|FG001|Overall Study|Physician Decision|0|||
23413317|NCT00412958|65255380|FG000|Overall Study|Withdrawal by Subject|3|||
23413318|NCT00412958|65255381|FG001|Overall Study|Withdrawal by Subject|0|||
23413319|NCT00412958|65255382|FG002|Overall Study|Withdrawal by Subject|0|||
23511951|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
23710473|NCT01111539|66315408|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23413320|NCT00412958|65255383|FG003|Overall Study|Withdrawal by Subject|1|||
23413321|NCT00412958|65255380|FG000|Overall Study|Adverse Event|0|||
23710474|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23511952|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
23511953|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
23511954|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
23511955|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
23511956|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
23511957|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
23511958|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
23511959|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
23511960|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511961|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511962|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511963|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
23511964|NCT01164956|65612581|FG000|Overall Study|Side Effects|1|||
23511965|NCT01164956|65612582|FG001|Overall Study|Side Effects|0|||
23511966|NCT01164956|65612583|FG002|Overall Study|Side Effects|1|||
23710475|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23710476|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23710477|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23413322|NCT00412958|65255381|FG001|Overall Study|Adverse Event|1|||
23413323|NCT00412958|65255382|FG002|Overall Study|Adverse Event|0|||
23413324|NCT00412958|65255383|FG003|Overall Study|Adverse Event|0|||
23413325|NCT00412958|65255380|FG000|Overall Study|Lost to Follow-up|0|||
23413326|NCT00412958|65255381|FG001|Overall Study|Lost to Follow-up|1|||
23413327|NCT00412958|65255382|FG002|Overall Study|Lost to Follow-up|0|||
23413328|NCT00412958|65255383|FG003|Overall Study|Lost to Follow-up|0|||
23413329|NCT00412958|65255380|FG000|Overall Study|Death|0|||
23511967|NCT00969150|65612585|FG000|Overall Study|Adverse Event|4|||
23511968|NCT00969150|65612586|FG001|Overall Study|Adverse Event|14|||
23511969|NCT00969150|65612585|FG000|Overall Study|Lack of Efficacy|1|||
23511970|NCT00969150|65612586|FG001|Overall Study|Lack of Efficacy|1|||
23511971|NCT00969150|65612585|FG000|Overall Study|Protocol Violation|9|||
23511972|NCT00969150|65612586|FG001|Overall Study|Protocol Violation|12|||
23511973|NCT00969150|65612585|FG000|Overall Study|Withdrawal by Subject|13|||
23511974|NCT00969150|65612586|FG001|Overall Study|Withdrawal by Subject|9|||
23511975|NCT00969150|65612585|FG000|Overall Study|Lost to Follow-up|5|||
23511976|NCT00969150|65612586|FG001|Overall Study|Lost to Follow-up|4|||
23511977|NCT00969150|65612585|FG000|Overall Study|Other reasons|1|||
23511978|NCT00969150|65612586|FG001|Overall Study|Other reasons|0|||
23511979|NCT00643682|65612588|FG000|Overall Study|did not keep appointment|522|||
23511980|NCT00643682|65612589|FG001|Overall Study|did not keep appointment|509|||
23511981|NCT02446990|65612590|FG000|Overall Study|Death|485|||
23511982|NCT02446990|65612591|FG001|Overall Study|Death|458|||
23511983|NCT02446990|65612590|FG000|Overall Study|Lost to Follow-up|3|||
23511984|NCT02446990|65612591|FG001|Overall Study|Lost to Follow-up|1|||
23511985|NCT02446990|65612590|FG000|Overall Study|Physician Decision|1|||
23511986|NCT02446990|65612591|FG001|Overall Study|Physician Decision|0|||
23511987|NCT02446990|65612590|FG000|Overall Study|Withdrawal by Subject|231|||
23511988|NCT02446990|65612591|FG001|Overall Study|Withdrawal by Subject|199|||
23511989|NCT03944954|65612592|FG000|Overall Study|Withdrawal by Subject|22|||
23511990|NCT03944954|65612593|FG001|Overall Study|Withdrawal by Subject|4|||
23511991|NCT03944954|65612592|FG000|Overall Study|Lost to Follow-up|18|||
23511992|NCT03944954|65612593|FG001|Overall Study|Lost to Follow-up|0|||
23511993|NCT03944954|65612592|FG000|Overall Study|Failed Medical Screening|7|||
23511994|NCT03944954|65612593|FG001|Overall Study|Failed Medical Screening|0|||
23511995|NCT01957644|65612594|FG000|Overall Study|Adverse Event|4|||
23511996|NCT01957644|65612595|FG001|Overall Study|Adverse Event|2|||
23511997|NCT01957644|65612596|FG002|Overall Study|Adverse Event|0|||
23511998|NCT01957644|65612597|FG003|Overall Study|Adverse Event|0|||
23710478|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23710479|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23710480|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23413330|NCT00412958|65255381|FG001|Overall Study|Death|1|||
23413331|NCT00412958|65255382|FG002|Overall Study|Death|0|||
23511999|NCT01957644|65612598|FG004|Overall Study|Adverse Event|1|||
23512000|NCT01957644|65612594|FG000|Overall Study|Progressive disease / relapse|0|||
23512001|NCT01957644|65612595|FG001|Overall Study|Progressive disease / relapse|1|||
23512002|NCT01957644|65612596|FG002|Overall Study|Progressive disease / relapse|0|||
23512003|NCT01957644|65612597|FG003|Overall Study|Progressive disease / relapse|1|||
23610589|NCT02676778|65962809|FG000|Overall Study|Adverse Event|2|||
23413332|NCT00412958|65255383|FG003|Overall Study|Death|0|||
23512004|NCT01957644|65612598|FG004|Overall Study|Progressive disease / relapse|0|||
23512005|NCT01957644|65612594|FG000|Overall Study|Other reason|1|||
23512006|NCT01957644|65612595|FG001|Overall Study|Other reason|2|||
23512007|NCT01957644|65612596|FG002|Overall Study|Other reason|1|||
23512008|NCT01957644|65612597|FG003|Overall Study|Other reason|1|||
23512009|NCT01957644|65612598|FG004|Overall Study|Other reason|0|||
23512010|NCT01957644|65612594|FG000|Overall Study|Withdrawal by Subject|1|||
23512011|NCT01957644|65612595|FG001|Overall Study|Withdrawal by Subject|0|||
23512012|NCT01957644|65612596|FG002|Overall Study|Withdrawal by Subject|0|||
23512013|NCT01957644|65612597|FG003|Overall Study|Withdrawal by Subject|0|||
23512014|NCT01957644|65612598|FG004|Overall Study|Withdrawal by Subject|0|||
23512015|NCT01957644|65612594|FG000|Overall Study|Protocol Violation|0|||
23512016|NCT01957644|65612595|FG001|Overall Study|Protocol Violation|1|||
23512017|NCT01957644|65612596|FG002|Overall Study|Protocol Violation|0|||
23512018|NCT01957644|65612597|FG003|Overall Study|Protocol Violation|0|||
23512019|NCT01957644|65612598|FG004|Overall Study|Protocol Violation|0|||
23512020|NCT01252940|65612600|FG000|Main Study Phase|Randomized but not treated|4|||
23512021|NCT01252940|65612601|FG001|Main Study Phase|Randomized but not treated|2|||
23512022|NCT01252940|65612600|FG000|Main Study Phase|Adverse Event|3|||
23512023|NCT01252940|65612601|FG001|Main Study Phase|Adverse Event|1|||
23512024|NCT01252940|65612600|FG000|Main Study Phase|Lack of Efficacy|1|||
23512025|NCT01252940|65612601|FG001|Main Study Phase|Lack of Efficacy|0|||
23512026|NCT01252940|65612600|FG000|Main Study Phase|Lost to Follow-up|6|||
23512027|NCT01252940|65612601|FG001|Main Study Phase|Lost to Follow-up|1|||
23512028|NCT01252940|65612600|FG000|Main Study Phase|Physician Decision|1|||
23512029|NCT01252940|65612601|FG001|Main Study Phase|Physician Decision|0|||
23512030|NCT01252940|65612600|FG000|Main Study Phase|Protocol Violation|4|||
23512031|NCT01252940|65612601|FG001|Main Study Phase|Protocol Violation|2|||
23512032|NCT01252940|65612600|FG000|Main Study Phase|Withdrawal by Subject|6|||
23512033|NCT01252940|65612601|FG001|Main Study Phase|Withdrawal by Subject|5|||
23512034|NCT01252940|65612600|FG000|Main Study Phase|Subject Non-compliance|1|||
23512035|NCT01252940|65612601|FG001|Main Study Phase|Subject Non-compliance|1|||
23512036|NCT01252940|65612600|FG000|Extension Phase|Adverse Event|2|||
23512037|NCT01252940|65612601|FG001|Extension Phase|Adverse Event|1|||
23512038|NCT01252940|65612600|FG000|Extension Phase|Lack of Efficacy|1|||
23512039|NCT01252940|65612601|FG001|Extension Phase|Lack of Efficacy|0|||
23512040|NCT01252940|65612600|FG000|Extension Phase|Lost to Follow-up|5|||
23512041|NCT01252940|65612601|FG001|Extension Phase|Lost to Follow-up|0|||
23512042|NCT01252940|65612600|FG000|Extension Phase|Physician Decision|0|||
23512043|NCT01252940|65612601|FG001|Extension Phase|Physician Decision|1|||
23512044|NCT01252940|65612600|FG000|Extension Phase|Subject Non-compliance|1|||
23512045|NCT01252940|65612601|FG001|Extension Phase|Subject Non-compliance|0|||
23512046|NCT01252940|65612600|FG000|Extension Phase|Withdrawal by Subject|1|||
23512047|NCT01252940|65612601|FG001|Extension Phase|Withdrawal by Subject|1|||
23512048|NCT02057198|65612602|FG000|Overall Study|Death|0|||
23512049|NCT02057198|65612603|FG001|Overall Study|Death|0|||
23512050|NCT02057198|65612604|FG002|Overall Study|Death|1|||
23512051|NCT02057198|65612602|FG000|Overall Study|Discharged early; lost to followup|0|||
23512052|NCT02057198|65612603|FG001|Overall Study|Discharged early; lost to followup|1|||
23512053|NCT02057198|65612604|FG002|Overall Study|Discharged early; lost to followup|0|||
23512054|NCT04690751|65612605|FG000|Overall Study|Protocol Violation|0|||
23512055|NCT04690751|65612606|FG001|Overall Study|Protocol Violation|1|||
23512056|NCT04690751|65612607|FG002|Overall Study|Protocol Violation|0|||
23512057|NCT04690751|65612608|FG003|Overall Study|Protocol Violation|1|||
23512058|NCT04690751|65612609|FG004|Overall Study|Protocol Violation|2|||
23512059|NCT04690751|65612610|FG005|Overall Study|Protocol Violation|0|||
23512060|NCT04690751|65612605|FG000|Overall Study|Adverse Event|0|||
23413333|NCT00412958|65255380|FG000|Overall Study|Transport issue|0|||
23413334|NCT00412958|65255381|FG001|Overall Study|Transport issue|1|||
23413335|NCT00412958|65255382|FG002|Overall Study|Transport issue|0|||
23413336|NCT00412958|65255383|FG003|Overall Study|Transport issue|0|||
23413337|NCT02954887|65255387|FG000|Overall Study|Withdrawal by Subject|3|||
23512061|NCT04690751|65612606|FG001|Overall Study|Adverse Event|0|||
23512062|NCT04690751|65612607|FG002|Overall Study|Adverse Event|1|||
23512063|NCT04690751|65612608|FG003|Overall Study|Adverse Event|0|||
23512064|NCT04690751|65612609|FG004|Overall Study|Adverse Event|0|||
23512065|NCT04690751|65612610|FG005|Overall Study|Adverse Event|0|||
23512066|NCT04690751|65612605|FG000|Overall Study|Positive urine drug screen test|0|||
23512067|NCT04690751|65612606|FG001|Overall Study|Positive urine drug screen test|0|||
23512068|NCT04690751|65612607|FG002|Overall Study|Positive urine drug screen test|0|||
23512069|NCT04690751|65612608|FG003|Overall Study|Positive urine drug screen test|0|||
23413338|NCT02954887|65255387|FG000|Overall Study|Lack of Efficacy|3|||
23413339|NCT02954887|65255387|FG000|Overall Study|Other|1|||
23413340|NCT00617084|65255393|FG000|Overall Study|Withdrawal by Subject|5|||
23413341|NCT00617084|65255394|FG001|Overall Study|Withdrawal by Subject|7|||
23413342|NCT00617084|65255393|FG000|Overall Study|Missed 12 Months visit|16|||
23512070|NCT04690751|65612609|FG004|Overall Study|Positive urine drug screen test|1|||
23512071|NCT04690751|65612610|FG005|Overall Study|Positive urine drug screen test|0|||
23512072|NCT03527966|65612611|FG000|Overall Study|Lost to Follow-up|3|||
23512073|NCT03527966|65612612|FG001|Overall Study|Lost to Follow-up|0|||
23413343|NCT00617084|65255394|FG001|Overall Study|Missed 12 Months visit|19|||
23413344|NCT04908384|65255399|FG000|Overall Study|Lost to Follow-up|4|||
23413345|NCT04908384|65255400|FG001|Overall Study|Lost to Follow-up|4|||
23512074|NCT02865187|65612613|FG000|Overall Study|Lost to Follow-up|12|||
23512075|NCT02865187|65612614|FG001|Overall Study|Lost to Follow-up|7|||
23512076|NCT02865187|65612613|FG000|Overall Study|Adverse Event|1|||
23512077|NCT02865187|65612614|FG001|Overall Study|Adverse Event|0|||
23512078|NCT00180414|65612615|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
23512079|NCT00180414|65612616|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
23512080|NCT02642614|65612617|FG000|Overall Study|Adverse Event|1|||
23512081|NCT02642614|65612618|FG001|Overall Study|Adverse Event|1|||
23512082|NCT02642614|65612619|FG002|Overall Study|Adverse Event|2|||
23413346|NCT04908384|65255401|FG002|Overall Study|Lost to Follow-up|0|||
23413347|NCT04908384|65255402|FG003|Overall Study|Lost to Follow-up|0|||
23413348|NCT02397915|65255403|FG000|Period 1|Protocol Violation|0|||
23413349|NCT02397915|65255404|FG001|Period 1|Protocol Violation|1|||
23413350|NCT02397915|65255405|FG002|Period 1|Protocol Violation|0|||
23413351|NCT02397915|65255406|FG003|Period 1|Protocol Violation|0|||
23413352|NCT02397915|65255403|FG000|Period 1|Physician Decision|1|||
23413353|NCT02397915|65255404|FG001|Period 1|Physician Decision|0|||
23413354|NCT02397915|65255405|FG002|Period 1|Physician Decision|0|||
23413355|NCT02397915|65255406|FG003|Period 1|Physician Decision|0|||
23413356|NCT05479097|65255409|FG000|Overall Study|Withdrawal by Subject|2|||
23413357|NCT01318135|65255410|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23413358|NCT01318135|65255411|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413359|NCT01318135|65255412|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413360|NCT01318135|65255413|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413361|NCT01318135|65255414|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413362|NCT01318135|65255415|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413363|NCT01318135|65255416|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413364|NCT01318135|65255417|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413365|NCT01318135|65255410|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
23413366|NCT01318135|65255411|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413367|NCT01318135|65255412|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413368|NCT01318135|65255413|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413369|NCT01318135|65255414|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413370|NCT01318135|65255415|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413371|NCT01318135|65255416|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413372|NCT01318135|65255417|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413373|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
23413374|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
23413375|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
23413376|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
23413377|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
23413378|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
23413379|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
23413380|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
23413381|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413382|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413383|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413384|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413385|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413386|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413387|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413388|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413389|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413390|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413391|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413392|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23413393|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413394|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23413395|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23512083|NCT02642614|65612620|FG003|Overall Study|Adverse Event|2|||
23413396|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23413397|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
23413398|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
23413399|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413400|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
23512084|NCT02642614|65612617|FG000|Overall Study|Lost to Follow-up|1|||
23512085|NCT02642614|65612618|FG001|Overall Study|Lost to Follow-up|0|||
23512086|NCT02642614|65612619|FG002|Overall Study|Lost to Follow-up|0|||
23512087|NCT02642614|65612620|FG003|Overall Study|Lost to Follow-up|0|||
23710481|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
23710482|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23710483|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
23710484|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23710485|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
23710486|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
23710487|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23710488|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23710489|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23710490|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23413401|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413402|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413403|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23413404|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23413405|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413406|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413407|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413408|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413409|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413410|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413411|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413412|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
23413413|NCT01703091|65255420|FG000|Overall Study|Adverse Event|5|||
23413414|NCT01703091|65255421|FG001|Overall Study|Adverse Event|3|||
23413415|NCT01703091|65255420|FG000|Overall Study|Physician Decision|2|||
23413416|NCT01703091|65255421|FG001|Overall Study|Physician Decision|1|||
23413417|NCT01703091|65255420|FG000|Overall Study|Withdrawal by Subject|1|||
23413418|NCT01703091|65255421|FG001|Overall Study|Withdrawal by Subject|0|||
23413419|NCT01703091|65255420|FG000|Overall Study|Sponsor Decision|1|||
23413420|NCT01703091|65255421|FG001|Overall Study|Sponsor Decision|0|||
23413421|NCT00576628|65255422|FG000|Overall Study|Adverse Event|11|||
23413422|NCT00576628|65255422|FG000|Overall Study|Death|2|||
23413423|NCT00576628|65255422|FG000|Overall Study|Failure to return|1|||
23413424|NCT00576628|65255422|FG000|Overall Study|Refused Treatment|8|||
23413425|NCT00576628|65255422|FG000|Overall Study|Pregnancy|1|||
23413426|NCT00576628|65255422|FG000|Overall Study|RBC transfusion|1|||
23413427|NCT00576628|65255422|FG000|Overall Study|Progression of Kidney Disease|1|||
23413428|NCT00576628|65255422|FG000|Overall Study|Progression of Renal Failure|1|||
23413429|NCT00576628|65255422|FG000|Overall Study|The patient move into other town|1|||
23413430|NCT00576628|65255422|FG000|Overall Study|Transplantation|1|||
23413431|NCT00576628|65255422|FG000|Overall Study|Dialysis|15|||
23413432|NCT01814397|65255423|FG000|Overall Study|Adverse Event|7|||
23413433|NCT01814397|65255423|FG000|Overall Study|Withdrawal by Subject|7|||
23413434|NCT01814046|65255425|FG000|Drug Administration|Death due to complications of RSV|1|||
23413435|NCT01814046|65255426|FG001|Drug Administration|Death due to complications of RSV|0|||
23413436|NCT01814046|65255427|FG002|Drug Administration|Death due to complications of RSV|0|||
23413437|NCT01709110|65255430|FG000|Overall Study|Adverse Event|56|||
23413438|NCT01709110|65255431|FG001|Overall Study|Adverse Event|48|||
23413439|NCT01709110|65255430|FG000|Overall Study|Death|14|||
23413440|NCT01709110|65255431|FG001|Overall Study|Death|6|||
23413441|NCT01709110|65255430|FG000|Overall Study|Lost to Follow-up|7|||
23413442|NCT01709110|65255431|FG001|Overall Study|Lost to Follow-up|5|||
23413443|NCT01709110|65255430|FG000|Overall Study|Protocol Violation|4|||
23413444|NCT01709110|65255431|FG001|Overall Study|Protocol Violation|6|||
23413445|NCT01709110|65255430|FG000|Overall Study|Withdrawal by Subject|96|||
23413446|NCT01709110|65255431|FG001|Overall Study|Withdrawal by Subject|89|||
23413447|NCT01709110|65255430|FG000|Overall Study|Physician Decision|4|||
23413448|NCT01709110|65255431|FG001|Overall Study|Physician Decision|10|||
23413449|NCT01709110|65255430|FG000|Overall Study|Sponsor Decision|2|||
23710491|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23413450|NCT01709110|65255431|FG001|Overall Study|Sponsor Decision|2|||
23413451|NCT01709110|65255430|FG000|Overall Study|Lack of Efficacy|1|||
23413452|NCT01709110|65255431|FG001|Overall Study|Lack of Efficacy|1|||
23413453|NCT01709110|65255430|FG000|Overall Study|Caregiver Decision|1|||
23413454|NCT01709110|65255431|FG001|Overall Study|Caregiver Decision|1|||
23413455|NCT02952313|65255439|FG000|Primary Endpoint|Lost to Follow-up|4|||
23413456|NCT02952313|65255439|FG000|Primary Endpoint|Withdrawal by Subject|1|||
23413457|NCT02952313|65255439|FG000|Primary Endpoint|Lack of Efficacy|1|||
23413458|NCT02952313|65255439|FG000|Primary Endpoint|Missed visit|1|||
23413459|NCT02952313|65255439|FG000|Long-term Follow-up|Lost to Follow-up|12|||
23413460|NCT02952313|65255439|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
23413461|NCT02952313|65255439|FG000|Long-term Follow-up|Lack of Efficacy|6|||
23413462|NCT02952313|65255439|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
23413463|NCT02952313|65255439|FG000|Long-term Follow-up|Physician Decision|1|||
23413464|NCT02952313|65255439|FG000|Long-term Follow-up|Death|1|||
23413465|NCT01108731|65255446|FG000|Overall Study|Withdrawal by Subject|1|||
23413466|NCT01108731|65255447|FG001|Overall Study|Withdrawal by Subject|1|||
23413467|NCT01108731|65255446|FG000|Overall Study|Adverse Event|3|||
23413468|NCT01108731|65255447|FG001|Overall Study|Adverse Event|3|||
23413469|NCT00395486|65255448|FG000|Overall Study|Adverse Event|1|||
23413470|NCT00395486|65255449|FG001|Overall Study|Adverse Event|2|||
23413471|NCT00395486|65255448|FG000|Overall Study|Withdrawal by Subject|5|||
23413472|NCT00395486|65255449|FG001|Overall Study|Withdrawal by Subject|2|||
23413473|NCT00395486|65255448|FG000|Overall Study|Lost to Follow-up|0|||
23413474|NCT00395486|65255449|FG001|Overall Study|Lost to Follow-up|1|||
23413475|NCT01822899|65255450|FG000|Overall Study|Adverse Event|6|||
23413476|NCT01822899|65255451|FG001|Overall Study|Adverse Event|5|||
23413477|NCT01822899|65255450|FG000|Overall Study|Lack of Efficacy|6|||
23413478|NCT01822899|65255451|FG001|Overall Study|Lack of Efficacy|3|||
23413479|NCT01822899|65255450|FG000|Overall Study|Protocol Violation|6|||
23413480|NCT01822899|65255451|FG001|Overall Study|Protocol Violation|3|||
23413481|NCT01822899|65255450|FG000|Overall Study|Lost to Follow-up|1|||
23413482|NCT01822899|65255451|FG001|Overall Study|Lost to Follow-up|0|||
23512088|NCT02642614|65612617|FG000|Overall Study|Withdrawal by Subject|1|||
23512089|NCT02642614|65612618|FG001|Overall Study|Withdrawal by Subject|1|||
23512090|NCT02642614|65612619|FG002|Overall Study|Withdrawal by Subject|0|||
23512091|NCT02642614|65612620|FG003|Overall Study|Withdrawal by Subject|0|||
23512092|NCT04271605|65612621|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
23512093|NCT00884312|65612623|FG000|Overall Study|Non-fatal Progressive Disease|0|||
23512094|NCT00884312|65612624|FG001|Overall Study|Non-fatal Progressive Disease|8|||
23512095|NCT00884312|65612623|FG000|Overall Study|Fatal Progressive Disease|0|||
23413483|NCT01822899|65255450|FG000|Overall Study|Withdrawal by Subject|5|||
23413484|NCT01822899|65255451|FG001|Overall Study|Withdrawal by Subject|7|||
23413485|NCT02027311|65255453|FG000|Overall Study|Protocol Violation|3|||
23413486|NCT02027311|65255454|FG001|Overall Study|Protocol Violation|2|||
23413487|NCT04222699|65255455|FG000|Overall Study|Lost to Follow-up|2|||
23413488|NCT01645735|65255462|FG000|Overall Study|Physician Decision|2|||
23413489|NCT01645735|65255463|FG001|Overall Study|Physician Decision|0|||
23413490|NCT01645735|65255462|FG000|Overall Study|Withdrawal by Subject|1|||
23413491|NCT01645735|65255463|FG001|Overall Study|Withdrawal by Subject|0|||
23413492|NCT01645735|65255462|FG000|Overall Study|Protocol Violation|1|||
23413493|NCT01645735|65255463|FG001|Overall Study|Protocol Violation|0|||
23413494|NCT01645735|65255462|FG000|Overall Study|Adverse Event|0|||
23413495|NCT01645735|65255463|FG001|Overall Study|Adverse Event|1|||
23413496|NCT03299244|65255464|FG000|Overall Study|Withdrawal by Subject|34|||
23413497|NCT03299244|65255465|FG001|Overall Study|Withdrawal by Subject|29|||
23413498|NCT03299244|65255464|FG000|Overall Study|Decision by Sponsor|4|||
23413499|NCT03299244|65255465|FG001|Overall Study|Decision by Sponsor|5|||
23413500|NCT03299244|65255464|FG000|Overall Study|Death|9|||
23413501|NCT03299244|65255465|FG001|Overall Study|Death|4|||
23413502|NCT02705105|65255467|FG000|Treatment|Objective Disease Progression|1|||
23413503|NCT02705105|65255468|FG001|Treatment|Objective Disease Progression|50|||
23413504|NCT02705105|65255467|FG000|Treatment|Withdrawal by Subject|3|||
23413505|NCT02705105|65255468|FG001|Treatment|Withdrawal by Subject|5|||
23413506|NCT02705105|65255467|FG000|Treatment|Adverse Event|0|||
23413507|NCT02705105|65255468|FG001|Treatment|Adverse Event|17|||
23413508|NCT02705105|65255467|FG000|Treatment|Clinical Disease Progression|0|||
23413509|NCT02705105|65255468|FG001|Treatment|Clinical Disease Progression|32|||
23413510|NCT02705105|65255467|FG000|Treatment|Physician Decision|0|||
23413511|NCT02705105|65255468|FG001|Treatment|Physician Decision|3|||
23413512|NCT02705105|65255467|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
23413513|NCT02705105|65255468|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
23413514|NCT02705105|65255467|FG000|Follow-Up|Death|3|||
23413515|NCT02705105|65255468|FG001|Follow-Up|Death|68|||
23413516|NCT02705105|65255467|FG000|Follow-Up|Withdrawal by Subject|1|||
23413517|NCT02705105|65255468|FG001|Follow-Up|Withdrawal by Subject|14|||
23413518|NCT02705105|65255467|FG000|Follow-Up|Study Terminated|0|||
23413519|NCT02705105|65255468|FG001|Follow-Up|Study Terminated|26|||
23413520|NCT02705105|65255467|FG000|Follow-Up|Discontinued per Amendment 3|0|||
23413521|NCT02705105|65255468|FG001|Follow-Up|Discontinued per Amendment 3|2|||
23710492|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23710493|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
23710494|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23710495|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23710496|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23710497|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
23710498|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23413522|NCT01301066|65255469|FG000|Overall Study|Lost to Follow-up|5|||
23413523|NCT01301066|65255470|FG001|Overall Study|Lost to Follow-up|11|||
23413524|NCT01301066|65255469|FG000|Overall Study|Protocol Violation|8|||
23413525|NCT01301066|65255470|FG001|Overall Study|Protocol Violation|7|||
23413526|NCT01301066|65255469|FG000|Overall Study|Withdrawal by Subject|4|||
23413527|NCT01301066|65255470|FG001|Overall Study|Withdrawal by Subject|9|||
23413528|NCT01301066|65255469|FG000|Overall Study|Adverse Event|6|||
23413529|NCT01301066|65255470|FG001|Overall Study|Adverse Event|6|||
23413530|NCT01301066|65255469|FG000|Overall Study|Sponsor Decision|2|||
23413531|NCT01301066|65255470|FG001|Overall Study|Sponsor Decision|1|||
23413532|NCT01301066|65255469|FG000|Overall Study|Physician Decision|0|||
23413533|NCT01301066|65255470|FG001|Overall Study|Physician Decision|1|||
23413534|NCT01301066|65255469|FG000|Overall Study|Other|2|||
23413535|NCT01301066|65255470|FG001|Overall Study|Other|0|||
23413536|NCT00632827|65255475|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
23413537|NCT00632827|65255475|FG000|Overall Study|Death|2|||
23413538|NCT00632827|65255475|FG000|Overall Study|Adverse Event|5|||
23413539|NCT00632827|65255475|FG000|Overall Study|Lost to Follow-up|1|||
23413540|NCT04003207|65255477|FG000|Overall Study|Protocol Violation|1|||
23413541|NCT02091362|65255478|FG000|Period 1|Protocol Violation|1|||
23413542|NCT02091362|65255479|FG001|Period 1|Protocol Violation|0|||
23710499|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23710500|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23413543|NCT02091362|65255478|FG000|Period 1|Withdrawal by Subject|2|||
23413544|NCT02091362|65255479|FG001|Period 1|Withdrawal by Subject|3|||
23413545|NCT02091362|65255478|FG000|Period 1|Lost to Follow-up|0|||
23413546|NCT02091362|65255479|FG001|Period 1|Lost to Follow-up|1|||
23413547|NCT02091362|65255478|FG000|Period 1|Adverse Event|2|||
23413548|NCT02091362|65255479|FG001|Period 1|Adverse Event|0|||
23413549|NCT02091362|65255478|FG000|Wash-out|Lost to Follow-up|1|||
23413550|NCT02091362|65255479|FG001|Wash-out|Lost to Follow-up|1|||
23413551|NCT02091362|65255478|FG000|Wash-out|Withdrawal by Subject|0|||
23413552|NCT02091362|65255479|FG001|Wash-out|Withdrawal by Subject|2|||
23413553|NCT02091362|65255478|FG000|Period 2|Adverse Event|1|||
23413554|NCT02091362|65255479|FG001|Period 2|Adverse Event|0|||
23413555|NCT02091362|65255478|FG000|Period 2|Lost to Follow-up|0|||
23413556|NCT02091362|65255479|FG001|Period 2|Lost to Follow-up|1|||
23413557|NCT02091362|65255478|FG000|Period 2|Withdrawal by Subject|1|||
23413558|NCT02091362|65255479|FG001|Period 2|Withdrawal by Subject|1|||
23413559|NCT01811485|65255490|FG000|Overall Study|Adverse Event|1|||
23413560|NCT01811485|65255491|FG001|Overall Study|Adverse Event|3|||
23413561|NCT01811485|65255492|FG002|Overall Study|Adverse Event|2|||
23413562|NCT01811485|65255490|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23413563|NCT01811485|65255491|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23413564|NCT01811485|65255492|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23413565|NCT01811485|65255490|FG000|Overall Study|Administrative problems|1|||
23413566|NCT01811485|65255491|FG001|Overall Study|Administrative problems|0|||
23413567|NCT01811485|65255492|FG002|Overall Study|Administrative problems|0|||
23413568|NCT01811485|65255490|FG000|Overall Study|Protocol Deviation|0|||
23413569|NCT01811485|65255491|FG001|Overall Study|Protocol Deviation|1|||
23413570|NCT01811485|65255492|FG002|Overall Study|Protocol Deviation|0|||
23413571|NCT03300024|65255493|FG000|Overall Study|Physician Decision|4|||
23413572|NCT03300024|65255494|FG001|Overall Study|Physician Decision|6|||
23413573|NCT02547038|65255495|FG000|Overall Study|Lost to Follow-up|3|||
23413574|NCT02547038|65255496|FG001|Overall Study|Lost to Follow-up|2|||
23413575|NCT00313144|65255497|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
23413576|NCT00313144|65255497|FG000|Overall Study|Death|7|||
23413577|NCT00313144|65255497|FG000|Overall Study|Lost to Follow-up|5|||
23413578|NCT00313144|65255497|FG000|Overall Study|Withdrawal by Subject|4|||
23413579|NCT00313144|65255497|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
23413580|NCT00313144|65255497|FG000|Overall Study|Physician Decision|4|||
23413581|NCT00313144|65255497|FG000|Overall Study|Adverse event - transient|5|||
23413582|NCT00313144|65255497|FG000|Overall Study|Liver transplant|1|||
23413583|NCT00313144|65255497|FG000|Overall Study|Insurance (homecare provider) change|1|||
23413584|NCT00313144|65255497|FG000|Overall Study|Change to different product|1|||
23413585|NCT00313144|65255497|FG000|Overall Study|Due to termination of the study|66|||
23413586|NCT01939977|65255498|FG000|Overall Study|Adverse Event|4|||
23413587|NCT01939977|65255499|FG001|Overall Study|Adverse Event|3|||
23413588|NCT01939977|65255498|FG000|Overall Study|Lack of Efficacy|3|||
23413589|NCT01939977|65255499|FG001|Overall Study|Lack of Efficacy|0|||
23413590|NCT01939977|65255498|FG000|Overall Study|Physician Decision|1|||
23413591|NCT01939977|65255499|FG001|Overall Study|Physician Decision|1|||
23413592|NCT01939977|65255498|FG000|Overall Study|Withdrawal by Subject|0|||
23413593|NCT01939977|65255499|FG001|Overall Study|Withdrawal by Subject|2|||
23413594|NCT01939977|65255498|FG000|Overall Study|Did not meet inclusion criteria|1|||
23413595|NCT01939977|65255499|FG001|Overall Study|Did not meet inclusion criteria|0|||
23413596|NCT01939977|65255498|FG000|Overall Study|Did not receive study medication|0|||
23413597|NCT01939977|65255499|FG001|Overall Study|Did not receive study medication|1|||
23413598|NCT01581021|65255500|FG000|Overall Study|Lost to Follow-up|4|||
23413599|NCT01581021|65255501|FG001|Overall Study|Lost to Follow-up|6|||
23413600|NCT01581021|65255500|FG000|Overall Study|More than 2 hooks in thoracic|3|||
23413601|NCT01581021|65255501|FG001|Overall Study|More than 2 hooks in thoracic|0|||
23413602|NCT01581021|65255500|FG000|Overall Study|Neuromuscular|2|||
23413603|NCT01581021|65255501|FG001|Overall Study|Neuromuscular|1|||
23413604|NCT01581021|65255500|FG000|Overall Study|Not Randomized|1|||
23413605|NCT01581021|65255501|FG001|Overall Study|Not Randomized|2|||
23413606|NCT01581021|65255500|FG000|Overall Study|Lenke 6 Classification|0|||
23413607|NCT01581021|65255501|FG001|Overall Study|Lenke 6 Classification|1|||
23413608|NCT01581021|65255500|FG000|Overall Study|Lack of Efficacy|0|||
23413609|NCT01581021|65255501|FG001|Overall Study|Lack of Efficacy|1|||
23413610|NCT01450696|65255505|FG000|Overall Study|Never Treated|1|||
23413611|NCT01450696|65255506|FG001|Overall Study|Never Treated|1|||
23413612|NCT01450696|65255505|FG000|Overall Study|Death|77|||
23413613|NCT01450696|65255506|FG001|Overall Study|Death|84|||
23413614|NCT01450696|65255505|FG000|Overall Study|Lost to Follow-up|3|||
23413615|NCT01450696|65255506|FG001|Overall Study|Lost to Follow-up|3|||
23413616|NCT01450696|65255505|FG000|Overall Study|Non-Compliance|1|||
23413617|NCT01450696|65255506|FG001|Overall Study|Non-Compliance|0|||
23413618|NCT01450696|65255505|FG000|Overall Study|Withdrawal by Subject|13|||
23413619|NCT01450696|65255506|FG001|Overall Study|Withdrawal by Subject|2|||
23413620|NCT01450696|65255505|FG000|Overall Study|Study Terminated by Sponsor|53|||
23413621|NCT01450696|65255506|FG001|Overall Study|Study Terminated by Sponsor|58|||
23413622|NCT00841776|65255509|FG000|Overall Study|Lack of Efficacy|0|||
23413623|NCT00841776|65255510|FG001|Overall Study|Lack of Efficacy|1|||
23413624|NCT00841776|65255509|FG000|Overall Study|Lost to Follow-up|2|||
23413625|NCT00841776|65255510|FG001|Overall Study|Lost to Follow-up|1|||
23413626|NCT00841776|65255509|FG000|Overall Study|Withdrawal by Subject|0|||
23413627|NCT00841776|65255510|FG001|Overall Study|Withdrawal by Subject|1|||
23413628|NCT00566982|65255511|FG000|Overall Study|Adverse Event|6|||
23413629|NCT00566982|65255512|FG001|Overall Study|Adverse Event|48|||
23413630|NCT00566982|65255511|FG000|Overall Study|Withdrawal by Subject|1|||
23413631|NCT00566982|65255512|FG001|Overall Study|Withdrawal by Subject|14|||
23413632|NCT00566982|65255511|FG000|Overall Study|Protocol Violation|1|||
23413633|NCT00566982|65255512|FG001|Overall Study|Protocol Violation|4|||
23413634|NCT00566982|65255511|FG000|Overall Study|Lost to Follow-up|0|||
23413635|NCT00566982|65255512|FG001|Overall Study|Lost to Follow-up|1|||
23413636|NCT00566982|65255511|FG000|Overall Study|Other-family problems & doctor's request|0|||
23413637|NCT00566982|65255512|FG001|Overall Study|Other-family problems & doctor's request|2|||
23453492|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453493|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453494|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453495|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453496|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23710501|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23453497|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453498|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453499|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453500|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453501|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453502|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453503|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453504|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23710502|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
23710503|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23710504|NCT01111539|66315404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23710505|NCT01111539|66315405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23710506|NCT01111539|66315406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23710507|NCT01111539|66315407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23710508|NCT01111539|66315408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
23710509|NCT00495495|66315409|FG000|Overall Study|Protocol Violation|99|||
23710510|NCT00008138|66315414|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
23710511|NCT00008138|66315414|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
23710512|NCT00008138|66315414|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
23710513|NCT00008138|66315414|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
23710514|NCT00008138|66315414|FG000|Interval Debulking|Withdrawal by Subject|2|||
23710515|NCT00008138|66315414|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
23710516|NCT00008138|66315414|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
23453505|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
23453506|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453507|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23710517|NCT00008138|66315414|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
23453508|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453509|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23610590|NCT02676778|65962810|FG001|Overall Study|Adverse Event|3|||
23413638|NCT02489318|65258190|FG000|Randomized|Withdrawal by Subject|0|||
23413639|NCT02489318|65258191|FG001|Randomized|Withdrawal by Subject|1|||
23413640|NCT02489318|65258190|FG000|Treated|Adverse Event|19|||
23413641|NCT02489318|65258191|FG001|Treated|Adverse Event|62|||
23413642|NCT02489318|65258190|FG000|Treated|Death|13|||
23413643|NCT02489318|65258191|FG001|Treated|Death|11|||
23413644|NCT02489318|65258190|FG000|Treated|Physician Decision|4|||
23413645|NCT02489318|65258191|FG001|Treated|Physician Decision|6|||
23413646|NCT02489318|65258190|FG000|Treated|Protocol Violation|1|||
23413647|NCT02489318|65258191|FG001|Treated|Protocol Violation|2|||
23413648|NCT02489318|65258190|FG000|Treated|Withdrawal by Subject|37|||
23413649|NCT02489318|65258191|FG001|Treated|Withdrawal by Subject|36|||
23413650|NCT02489318|65258190|FG000|Treated|Other: Progressive Disease|245|||
23413651|NCT02489318|65258191|FG001|Treated|Other: Progressive Disease|138|||
23413652|NCT02489318|65258190|FG000|Treated|Other|0|||
23413653|NCT02489318|65258191|FG001|Treated|Other|2|||
23413654|NCT02489318|65258190|FG000|Treated|Ongoing|0|||
23413655|NCT02489318|65258191|FG001|Treated|Ongoing|267|||
23610591|NCT02676778|65962811|FG002|Overall Study|Adverse Event|0|||
23610592|NCT02604199|65962812|FG000|Overall Study|Pregnancy|0|||
23610593|NCT02604199|65962813|FG001|Overall Study|Pregnancy|0|||
23610594|NCT02604199|65962814|FG002|Overall Study|Pregnancy|0|||
23413660|NCT04551898|65258211|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
23413661|NCT04551898|65258212|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
23413662|NCT04551898|65258213|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
23413663|NCT04551898|65258214|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
23413664|NCT04551898|65258211|FG000|Overall Study|Withdrawal by Subject|5|||
23413665|NCT04551898|65258212|FG001|Overall Study|Withdrawal by Subject|1|||
23413666|NCT04551898|65258213|FG002|Overall Study|Withdrawal by Subject|2|||
23413667|NCT04551898|65258214|FG003|Overall Study|Withdrawal by Subject|2|||
23413668|NCT04551898|65258211|FG000|Overall Study|Lost to Follow-up|2|||
23413669|NCT04551898|65258212|FG001|Overall Study|Lost to Follow-up|1|||
23413670|NCT04551898|65258213|FG002|Overall Study|Lost to Follow-up|2|||
23413671|NCT04551898|65258214|FG003|Overall Study|Lost to Follow-up|2|||
23413672|NCT04551898|65258211|FG000|Overall Study|Death|1|||
23413673|NCT04551898|65258212|FG001|Overall Study|Death|0|||
23413674|NCT04551898|65258213|FG002|Overall Study|Death|0|||
23413675|NCT04551898|65258214|FG003|Overall Study|Death|0|||
23413676|NCT04551898|65258211|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413677|NCT04551898|65258212|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413678|NCT04551898|65258213|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
23413679|NCT04551898|65258214|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413680|NCT05425732|65258215|FG000|Overall Study|Death|4|||
23413681|NCT05425732|65258216|FG001|Overall Study|Death|2|||
23413682|NCT05425732|65258217|FG002|Overall Study|Death|0|||
23413683|NCT05425732|65258218|FG003|Overall Study|Death|0|||
23413684|NCT05425732|65258215|FG000|Overall Study|Lost to Follow-up|10|||
23413685|NCT05425732|65258216|FG001|Overall Study|Lost to Follow-up|15|||
23413686|NCT05425732|65258217|FG002|Overall Study|Lost to Follow-up|5|||
23413687|NCT05425732|65258218|FG003|Overall Study|Lost to Follow-up|3|||
23413688|NCT05425732|65258215|FG000|Overall Study|Physician Decision|0|||
23413689|NCT05425732|65258216|FG001|Overall Study|Physician Decision|2|||
23413690|NCT05425732|65258217|FG002|Overall Study|Physician Decision|0|||
23413691|NCT05425732|65258218|FG003|Overall Study|Physician Decision|0|||
23413692|NCT05425732|65258215|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23413693|NCT05425732|65258216|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
23413694|NCT05425732|65258217|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23413695|NCT05425732|65258218|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23413696|NCT05425732|65258215|FG000|Overall Study|Withdrawal by Subject|4|||
23413697|NCT05425732|65258216|FG001|Overall Study|Withdrawal by Subject|8|||
23413698|NCT05425732|65258217|FG002|Overall Study|Withdrawal by Subject|1|||
23413699|NCT05425732|65258218|FG003|Overall Study|Withdrawal by Subject|1|||
23413700|NCT05425732|65258215|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
23413701|NCT05425732|65258216|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413702|NCT05425732|65258217|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413703|NCT05425732|65258218|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413704|NCT02506153|65258219|FG000|Overall Study|Adverse Event|359|||
23413705|NCT02506153|65258220|FG001|Overall Study|Adverse Event|114|||
23413706|NCT02506153|65258219|FG000|Overall Study|Refused unrelated to adverse event|127|||
23413707|NCT02506153|65258220|FG001|Overall Study|Refused unrelated to adverse event|18|||
23413708|NCT02506153|65258219|FG000|Overall Study|Progression/relapse|91|||
23413709|NCT02506153|65258220|FG001|Overall Study|Progression/relapse|136|||
23413710|NCT02506153|65258219|FG000|Overall Study|Death|2|||
23413711|NCT02506153|65258220|FG001|Overall Study|Death|1|||
23610595|NCT02604199|65962815|FG003|Overall Study|Pregnancy|1|||
23413712|NCT02506153|65258219|FG000|Overall Study|Other - not protocol specified|23|||
23413713|NCT02506153|65258220|FG001|Overall Study|Other - not protocol specified|12|||
23413714|NCT00861705|65258221|FG000|Overall Study|Never Began Treatment|7|||
23413715|NCT00861705|65258222|FG001|Overall Study|Never Began Treatment|3|||
23413716|NCT00861705|65258223|FG002|Overall Study|Never Began Treatment|0|||
23413717|NCT00861705|65258224|FG003|Overall Study|Never Began Treatment|1|||
23610596|NCT02604199|65962812|FG000|Overall Study|Study terminated by sponsor|0|||
23413719|NCT03427814|65258234|FG000|Overall Study|Withdrawal by Subject|4|||
23413720|NCT03427814|65258235|FG001|Overall Study|Withdrawal by Subject|4|||
23413721|NCT03427814|65258234|FG000|Overall Study|Lost to Follow-up|0|||
23413722|NCT03427814|65258235|FG001|Overall Study|Lost to Follow-up|2|||
23413723|NCT03427814|65258234|FG000|Overall Study|Death|42|||
23413724|NCT03427814|65258235|FG001|Overall Study|Death|31|||
23413725|NCT03427814|65258234|FG000|Overall Study|Sponsor's Decision|1|||
23413726|NCT03427814|65258235|FG001|Overall Study|Sponsor's Decision|0|||
23413727|NCT03427814|65258234|FG000|Overall Study|Investigator's Decision|1|||
23413728|NCT03427814|65258235|FG001|Overall Study|Investigator's Decision|2|||
23413729|NCT03427814|65258234|FG000|Overall Study|Disease progression|1|||
23413730|NCT03427814|65258235|FG001|Overall Study|Disease progression|0|||
23413731|NCT03427814|65258234|FG000|Overall Study|Treatment Completed|0|||
23413732|NCT03427814|65258235|FG001|Overall Study|Treatment Completed|1|||
23413733|NCT03427814|65258234|FG000|Overall Study|Sponsor's Decision to End study|21|||
23413734|NCT03427814|65258235|FG001|Overall Study|Sponsor's Decision to End study|25|||
23413735|NCT03427814|65258234|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
23413736|NCT03427814|65258235|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
23413737|NCT03145064|65258236|FG000|Overall Study|Death|24|||
23413738|NCT03145064|65258236|FG000|Overall Study|Lost to Follow-up|3|||
23413739|NCT03145064|65258236|FG000|Overall Study|Withdrawal by Subject|6|||
23413740|NCT03145064|65258236|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
23413741|NCT03145064|65258236|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
23413742|NCT03846427|65258237|FG000|Overall Study|Death|13|||
23413743|NCT03846427|65258237|FG000|Overall Study|Withdrawal by Subject|3|||
23413744|NCT03846427|65258237|FG000|Overall Study|Physician Decision|1|||
23413745|NCT04723355|65258241|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
23413746|NCT04723355|65258241|FG000|Overall Study|Errors in the informed consent form|2|||
23610597|NCT02604199|65962813|FG001|Overall Study|Study terminated by sponsor|2|||
23610598|NCT02604199|65962814|FG002|Overall Study|Study terminated by sponsor|0|||
23610599|NCT02604199|65962815|FG003|Overall Study|Study terminated by sponsor|2|||
23610600|NCT02604199|65962812|FG000|Overall Study|Withdrawal by Subject|0|||
23610601|NCT02604199|65962813|FG001|Overall Study|Withdrawal by Subject|1|||
23610602|NCT02604199|65962814|FG002|Overall Study|Withdrawal by Subject|0|||
23610603|NCT02604199|65962815|FG003|Overall Study|Withdrawal by Subject|0|||
23610604|NCT00321555|65962816|FG000|Overall Study|Developed antibodies|1|||
23610605|NCT00321555|65962816|FG000|Overall Study|Switched to alternative treatment|3|||
23610606|NCT00321555|65962816|FG000|Overall Study|Physician Decision|1|||
23610607|NCT00321555|65962816|FG000|Overall Study|Disease progression on study|1|||
23610608|NCT00409747|65962829|FG000|Overall Study|Withdrawal by Subject|1|||
23610609|NCT04930263|65962833|FG000|Overall Study|Withdrawal by Subject|3|||
23610610|NCT04930263|65962834|FG001|Overall Study|Withdrawal by Subject|5|||
23610611|NCT00731692|65962835|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
23610612|NCT00731692|65962836|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
23610613|NCT00731692|65962837|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
23610614|NCT00731692|65962835|FG000|Core Study (36 Months)|Physician Decision|1|||
23610615|NCT00731692|65962836|FG001|Core Study (36 Months)|Physician Decision|0|||
23610616|NCT00731692|65962837|FG002|Core Study (36 Months)|Physician Decision|2|||
23610617|NCT00731692|65962835|FG000|Core Study (36 Months)|Death|2|||
23610618|NCT00731692|65962836|FG001|Core Study (36 Months)|Death|1|||
23610619|NCT00731692|65962837|FG002|Core Study (36 Months)|Death|2|||
23610620|NCT00731692|65962835|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
23610621|NCT00731692|65962836|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
23610622|NCT00731692|65962837|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
23610623|NCT00731692|65962835|FG000|Core Study (36 Months)|Administrative|2|||
23610624|NCT00731692|65962836|FG001|Core Study (36 Months)|Administrative|2|||
23610625|NCT00731692|65962837|FG002|Core Study (36 Months)|Administrative|6|||
23610626|NCT00731692|65962835|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
23610627|NCT00731692|65962836|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
23610628|NCT00731692|65962837|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
23610629|NCT00731692|65962835|FG000|Core Study (36 Months)|Protocol Violation|4|||
23610630|NCT00731692|65962836|FG001|Core Study (36 Months)|Protocol Violation|5|||
23610631|NCT00731692|65962837|FG002|Core Study (36 Months)|Protocol Violation|8|||
23610632|NCT00731692|65962835|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
23512096|NCT00884312|65612624|FG001|Overall Study|Fatal Progressive Disease|1|||
23512097|NCT00884312|65612623|FG000|Overall Study|Non-fatal Adverse Event|1|||
23610633|NCT00731692|65962836|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
23610634|NCT00731692|65962837|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
23413787|NCT03053440|65258250|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
23413788|NCT03053440|65258251|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
23413789|NCT03053440|65258250|FG000|Overall Study|Death|18|||
23413790|NCT03053440|65258251|FG001|Overall Study|Death|14|||
23413791|NCT03053440|65258250|FG000|Overall Study|Withdrawal by Subject|9|||
23413792|NCT03053440|65258251|FG001|Overall Study|Withdrawal by Subject|8|||
23413793|NCT03053440|65258250|FG000|Overall Study|Lost to Follow-up|1|||
23413794|NCT03053440|65258251|FG001|Overall Study|Lost to Follow-up|0|||
23413795|NCT03053440|65258250|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
23413796|NCT03053440|65258251|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
23413797|NCT03053440|65258250|FG000|Overall Study|Physician Decision|2|||
23413798|NCT03053440|65258251|FG001|Overall Study|Physician Decision|1|||
23413799|NCT03053440|65258250|FG000|Overall Study|Participant Randomized but died before dosing|1|||
23413800|NCT03053440|65258251|FG001|Overall Study|Participant Randomized but died before dosing|0|||
23413801|NCT02890355|65258254|FG000|Overall Study|Adverse Event|5|||
23413802|NCT02890355|65258255|FG001|Overall Study|Adverse Event|5|||
23413803|NCT02890355|65258254|FG000|Overall Study|Refusal unrelated to adverse event|5|||
23413804|NCT02890355|65258255|FG001|Overall Study|Refusal unrelated to adverse event|10|||
23413805|NCT02890355|65258254|FG000|Overall Study|Progression/relapse|46|||
23413806|NCT02890355|65258255|FG001|Overall Study|Progression/relapse|39|||
23413807|NCT02890355|65258254|FG000|Overall Study|Not protocol specified|3|||
23413808|NCT02890355|65258255|FG001|Overall Study|Not protocol specified|4|||
23610635|NCT00731692|65962835|FG000|Core Study (36 Months)|Adverse Event|25|||
23413810|NCT03332017|65258257|FG000|Overall Study|Lost to Follow-up|1|||
23413811|NCT03332017|65258258|FG001|Overall Study|Lost to Follow-up|2|||
23413812|NCT03332017|65258257|FG000|Overall Study|Death|17|||
23413813|NCT03332017|65258258|FG001|Overall Study|Death|16|||
23413814|NCT03332017|65258257|FG000|Overall Study|Withdrawal by Subject|6|||
23413815|NCT03332017|65258258|FG001|Overall Study|Withdrawal by Subject|14|||
23413816|NCT03332017|65258257|FG000|Overall Study|Other|1|||
23413817|NCT03332017|65258258|FG001|Overall Study|Other|3|||
23710518|NCT01093755|66315417|FG000|Overall Study|Withdrawal by Subject|3|||
23710519|NCT01093755|66315418|FG001|Overall Study|Withdrawal by Subject|4|||
23710520|NCT01996904|66315419|FG000|Overall Study|Lost to Follow-up|38|||
23710521|NCT01996904|66315420|FG001|Overall Study|Lost to Follow-up|27|||
23710522|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
23710523|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
23710524|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
23710525|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
23710526|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
23710527|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
23710528|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
23710529|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23710530|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
23710531|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
23710532|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
23413818|NCT03332017|65258257|FG000|Overall Study|Remained in Study (Ongoing)|47|||
23413819|NCT03332017|65258258|FG001|Overall Study|Remained in Study (Ongoing)|110|||
23610636|NCT00731692|65962836|FG001|Core Study (36 Months)|Adverse Event|28|||
23610637|NCT00731692|65962837|FG002|Core Study (36 Months)|Adverse Event|29|||
23610638|NCT00731692|65962835|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
23610639|NCT00731692|65962836|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
23610640|NCT00731692|65962837|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
23610641|NCT00731692|65962835|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
23610642|NCT00731692|65962836|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
23610643|NCT00731692|65962837|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
23610644|NCT00731692|65962835|FG000|Extension Phase|Abnormal test procedure|0|||
23610645|NCT00731692|65962836|FG001|Extension Phase|Abnormal test procedure|0|||
23610646|NCT00731692|65962837|FG002|Extension Phase|Abnormal test procedure|1|||
23610647|NCT00731692|65962835|FG000|Extension Phase|Abnormal lab values|0|||
23610648|NCT00731692|65962836|FG001|Extension Phase|Abnormal lab values|0|||
23610649|NCT00731692|65962837|FG002|Extension Phase|Abnormal lab values|1|||
23610650|NCT00731692|65962835|FG000|Extension Phase|Lost to Follow-up|0|||
23610651|NCT00731692|65962836|FG001|Extension Phase|Lost to Follow-up|1|||
23610652|NCT00731692|65962837|FG002|Extension Phase|Lost to Follow-up|4|||
23610653|NCT00731692|65962835|FG000|Extension Phase|Withdrawal by Subject|4|||
23610654|NCT00731692|65962836|FG001|Extension Phase|Withdrawal by Subject|5|||
23610655|NCT00731692|65962837|FG002|Extension Phase|Withdrawal by Subject|3|||
23610656|NCT00731692|65962835|FG000|Extension Phase|Adverse Event|1|||
23610657|NCT00731692|65962836|FG001|Extension Phase|Adverse Event|1|||
23610658|NCT00731692|65962837|FG002|Extension Phase|Adverse Event|15|||
23610659|NCT04425252|65962842|FG000|Overall Study|Withdrawal by Subject|2|||
23610660|NCT04425252|65962843|FG001|Overall Study|Withdrawal by Subject|1|||
23610661|NCT04425252|65962842|FG000|Overall Study|Lost to Follow-up|1|||
23610662|NCT04425252|65962843|FG001|Overall Study|Lost to Follow-up|0|||
23610663|NCT04425252|65962842|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
23610664|NCT04425252|65962843|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
23610665|NCT00596960|65962849|FG000|Overall Study|Death|1|||
23610666|NCT00596960|65962850|FG001|Overall Study|Death|2|||
23610667|NCT00596960|65962849|FG000|Overall Study|Lost to Follow-up|6|||
23610668|NCT00596960|65962850|FG001|Overall Study|Lost to Follow-up|5|||
23610669|NCT00596960|65962849|FG000|Overall Study|Withdrawal by Subject|1|||
23413852|NCT05784129|65258267|FG000|Overall Study|Study terminated by sponsor|2|||
23413853|NCT05784129|65258268|FG001|Overall Study|Study terminated by sponsor|2|||
23413854|NCT01436656|65258269|FG000|Dose Escalation|Death|1|||
23413855|NCT01436656|65258270|FG001|Dose Escalation|Death|3|||
23413856|NCT01436656|65258271|FG002|Dose Escalation|Death|1|||
23413857|NCT01436656|65258272|FG003|Dose Escalation|Death|0|||
23413858|NCT01436656|65258273|FG004|Dose Escalation|Death|2|||
23413859|NCT01436656|65258274|FG005|Dose Escalation|Death|1|||
23413860|NCT01436656|65258275|FG006|Dose Escalation|Death|1|||
23413861|NCT01436656|65258276|FG007|Dose Escalation|Death|1|||
23413862|NCT01436656|65258277|FG008|Dose Escalation|Death|1|||
23413863|NCT01436656|65258278|FG009|Dose Escalation|Death|0|||
23413864|NCT01436656|65258279|FG010|Dose Escalation|Death|0|||
23413865|NCT01436656|65258280|FG011|Dose Escalation|Death|0|||
23413866|NCT01436656|65258281|FG012|Dose Escalation|Death|0|||
23413867|NCT01436656|65258282|FG013|Dose Escalation|Death|0|||
23413868|NCT01436656|65258283|FG014|Dose Escalation|Death|0|||
23413869|NCT01436656|65258284|FG015|Dose Escalation|Death|0|||
23413870|NCT01436656|65258285|FG016|Dose Escalation|Death|0|||
23413871|NCT01436656|65258286|FG017|Dose Escalation|Death|0|||
23413872|NCT01436656|65258269|FG000|Dose Escalation|Protocol Violation|0|||
23413873|NCT01436656|65258270|FG001|Dose Escalation|Protocol Violation|0|||
23413874|NCT01436656|65258271|FG002|Dose Escalation|Protocol Violation|0|||
23413875|NCT01436656|65258272|FG003|Dose Escalation|Protocol Violation|0|||
23413876|NCT01436656|65258273|FG004|Dose Escalation|Protocol Violation|0|||
23413877|NCT01436656|65258274|FG005|Dose Escalation|Protocol Violation|1|||
23413878|NCT01436656|65258275|FG006|Dose Escalation|Protocol Violation|0|||
23413879|NCT01436656|65258276|FG007|Dose Escalation|Protocol Violation|0|||
23413880|NCT01436656|65258277|FG008|Dose Escalation|Protocol Violation|0|||
23413881|NCT01436656|65258278|FG009|Dose Escalation|Protocol Violation|0|||
23413882|NCT01436656|65258279|FG010|Dose Escalation|Protocol Violation|0|||
23413883|NCT01436656|65258280|FG011|Dose Escalation|Protocol Violation|0|||
23413884|NCT01436656|65258281|FG012|Dose Escalation|Protocol Violation|0|||
23413885|NCT01436656|65258282|FG013|Dose Escalation|Protocol Violation|0|||
23413886|NCT01436656|65258283|FG014|Dose Escalation|Protocol Violation|0|||
23413887|NCT01436656|65258284|FG015|Dose Escalation|Protocol Violation|0|||
23413888|NCT01436656|65258285|FG016|Dose Escalation|Protocol Violation|0|||
23413889|NCT01436656|65258286|FG017|Dose Escalation|Protocol Violation|0|||
23413890|NCT01436656|65258269|FG000|Dose Escalation|Withdrawal by Subject|0|||
23413891|NCT01436656|65258270|FG001|Dose Escalation|Withdrawal by Subject|0|||
23413892|NCT01436656|65258271|FG002|Dose Escalation|Withdrawal by Subject|0|||
23413893|NCT01436656|65258272|FG003|Dose Escalation|Withdrawal by Subject|0|||
23413894|NCT01436656|65258273|FG004|Dose Escalation|Withdrawal by Subject|1|||
23413895|NCT01436656|65258274|FG005|Dose Escalation|Withdrawal by Subject|0|||
23413896|NCT01436656|65258275|FG006|Dose Escalation|Withdrawal by Subject|0|||
23413897|NCT01436656|65258276|FG007|Dose Escalation|Withdrawal by Subject|2|||
23413898|NCT01436656|65258277|FG008|Dose Escalation|Withdrawal by Subject|0|||
23413899|NCT01436656|65258278|FG009|Dose Escalation|Withdrawal by Subject|1|||
23413900|NCT01436656|65258279|FG010|Dose Escalation|Withdrawal by Subject|1|||
23710533|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23413901|NCT01436656|65258280|FG011|Dose Escalation|Withdrawal by Subject|0|||
23413902|NCT01436656|65258281|FG012|Dose Escalation|Withdrawal by Subject|0|||
23413903|NCT01436656|65258282|FG013|Dose Escalation|Withdrawal by Subject|0|||
23413904|NCT01436656|65258283|FG014|Dose Escalation|Withdrawal by Subject|0|||
23413905|NCT01436656|65258284|FG015|Dose Escalation|Withdrawal by Subject|0|||
23413906|NCT01436656|65258285|FG016|Dose Escalation|Withdrawal by Subject|0|||
23413907|NCT01436656|65258286|FG017|Dose Escalation|Withdrawal by Subject|0|||
23413908|NCT01436656|65258269|FG000|Dose Escalation|Administrative problems|0|||
23710534|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
23413909|NCT01436656|65258270|FG001|Dose Escalation|Administrative problems|1|||
23413910|NCT01436656|65258271|FG002|Dose Escalation|Administrative problems|0|||
23413911|NCT01436656|65258272|FG003|Dose Escalation|Administrative problems|0|||
23413912|NCT01436656|65258273|FG004|Dose Escalation|Administrative problems|0|||
23413913|NCT01436656|65258274|FG005|Dose Escalation|Administrative problems|0|||
23610670|NCT00596960|65962850|FG001|Overall Study|Withdrawal by Subject|0|||
23610671|NCT00596960|65962849|FG000|Overall Study|Incarcerated|2|||
23413914|NCT01436656|65258275|FG006|Dose Escalation|Administrative problems|0|||
23413915|NCT01436656|65258276|FG007|Dose Escalation|Administrative problems|0|||
23413916|NCT01436656|65258277|FG008|Dose Escalation|Administrative problems|0|||
23413917|NCT01436656|65258278|FG009|Dose Escalation|Administrative problems|0|||
23413918|NCT01436656|65258279|FG010|Dose Escalation|Administrative problems|0|||
23413919|NCT01436656|65258280|FG011|Dose Escalation|Administrative problems|0|||
23413920|NCT01436656|65258281|FG012|Dose Escalation|Administrative problems|0|||
23413921|NCT01436656|65258282|FG013|Dose Escalation|Administrative problems|0|||
23413922|NCT01436656|65258283|FG014|Dose Escalation|Administrative problems|0|||
23413923|NCT01436656|65258284|FG015|Dose Escalation|Administrative problems|0|||
23413924|NCT01436656|65258285|FG016|Dose Escalation|Administrative problems|0|||
23413925|NCT01436656|65258286|FG017|Dose Escalation|Administrative problems|0|||
23413926|NCT01436656|65258269|FG000|Dose Escalation|Lost to Follow-up|1|||
23413927|NCT01436656|65258270|FG001|Dose Escalation|Lost to Follow-up|0|||
23413928|NCT01436656|65258271|FG002|Dose Escalation|Lost to Follow-up|0|||
23413929|NCT01436656|65258272|FG003|Dose Escalation|Lost to Follow-up|0|||
23413930|NCT01436656|65258273|FG004|Dose Escalation|Lost to Follow-up|1|||
23413931|NCT01436656|65258274|FG005|Dose Escalation|Lost to Follow-up|0|||
23413932|NCT01436656|65258275|FG006|Dose Escalation|Lost to Follow-up|0|||
23413933|NCT01436656|65258276|FG007|Dose Escalation|Lost to Follow-up|0|||
23413934|NCT01436656|65258277|FG008|Dose Escalation|Lost to Follow-up|0|||
23413935|NCT01436656|65258278|FG009|Dose Escalation|Lost to Follow-up|0|||
23413936|NCT01436656|65258279|FG010|Dose Escalation|Lost to Follow-up|0|||
23413937|NCT01436656|65258280|FG011|Dose Escalation|Lost to Follow-up|0|||
23413938|NCT01436656|65258281|FG012|Dose Escalation|Lost to Follow-up|0|||
23413939|NCT01436656|65258282|FG013|Dose Escalation|Lost to Follow-up|0|||
23413940|NCT01436656|65258283|FG014|Dose Escalation|Lost to Follow-up|0|||
23413941|NCT01436656|65258284|FG015|Dose Escalation|Lost to Follow-up|0|||
23413942|NCT01436656|65258285|FG016|Dose Escalation|Lost to Follow-up|0|||
23413943|NCT01436656|65258286|FG017|Dose Escalation|Lost to Follow-up|0|||
23413944|NCT01436656|65258269|FG000|Dose Escalation|New anti-cancer therapy|1|||
23413945|NCT01436656|65258270|FG001|Dose Escalation|New anti-cancer therapy|0|||
23413946|NCT01436656|65258271|FG002|Dose Escalation|New anti-cancer therapy|0|||
23413947|NCT01436656|65258272|FG003|Dose Escalation|New anti-cancer therapy|0|||
23413948|NCT01436656|65258273|FG004|Dose Escalation|New anti-cancer therapy|0|||
23413949|NCT01436656|65258274|FG005|Dose Escalation|New anti-cancer therapy|0|||
23413950|NCT01436656|65258275|FG006|Dose Escalation|New anti-cancer therapy|0|||
23413951|NCT01436656|65258276|FG007|Dose Escalation|New anti-cancer therapy|0|||
23413952|NCT01436656|65258277|FG008|Dose Escalation|New anti-cancer therapy|1|||
23413953|NCT01436656|65258278|FG009|Dose Escalation|New anti-cancer therapy|1|||
23413954|NCT01436656|65258279|FG010|Dose Escalation|New anti-cancer therapy|0|||
23413955|NCT01436656|65258280|FG011|Dose Escalation|New anti-cancer therapy|0|||
23413956|NCT01436656|65258281|FG012|Dose Escalation|New anti-cancer therapy|0|||
23413957|NCT01436656|65258282|FG013|Dose Escalation|New anti-cancer therapy|0|||
23413958|NCT01436656|65258283|FG014|Dose Escalation|New anti-cancer therapy|0|||
23413959|NCT01436656|65258284|FG015|Dose Escalation|New anti-cancer therapy|0|||
23413960|NCT01436656|65258285|FG016|Dose Escalation|New anti-cancer therapy|0|||
23413961|NCT01436656|65258286|FG017|Dose Escalation|New anti-cancer therapy|0|||
23413962|NCT01436656|65258269|FG000|Dose Expansion|Adverse Event|0|||
23413963|NCT01436656|65258270|FG001|Dose Expansion|Adverse Event|0|||
23413964|NCT01436656|65258271|FG002|Dose Expansion|Adverse Event|0|||
23413965|NCT01436656|65258272|FG003|Dose Expansion|Adverse Event|0|||
23413966|NCT01436656|65258273|FG004|Dose Expansion|Adverse Event|0|||
23413967|NCT01436656|65258274|FG005|Dose Expansion|Adverse Event|0|||
23413968|NCT01436656|65258275|FG006|Dose Expansion|Adverse Event|0|||
23413969|NCT01436656|65258276|FG007|Dose Expansion|Adverse Event|0|||
23413970|NCT01436656|65258277|FG008|Dose Expansion|Adverse Event|0|||
23413971|NCT01436656|65258278|FG009|Dose Expansion|Adverse Event|0|||
23413972|NCT01436656|65258279|FG010|Dose Expansion|Adverse Event|0|||
23413973|NCT01436656|65258280|FG011|Dose Expansion|Adverse Event|1|||
23413974|NCT01436656|65258281|FG012|Dose Expansion|Adverse Event|0|||
23413975|NCT01436656|65258282|FG013|Dose Expansion|Adverse Event|0|||
23413976|NCT01436656|65258283|FG014|Dose Expansion|Adverse Event|0|||
23413977|NCT01436656|65258284|FG015|Dose Expansion|Adverse Event|0|||
23413978|NCT01436656|65258285|FG016|Dose Expansion|Adverse Event|0|||
23413979|NCT01436656|65258286|FG017|Dose Expansion|Adverse Event|0|||
23413980|NCT01436656|65258269|FG000|Dose Expansion|Withdrawal by Subject|0|||
23413981|NCT01436656|65258270|FG001|Dose Expansion|Withdrawal by Subject|0|||
23413982|NCT01436656|65258271|FG002|Dose Expansion|Withdrawal by Subject|0|||
23413983|NCT01436656|65258272|FG003|Dose Expansion|Withdrawal by Subject|0|||
23413984|NCT01436656|65258273|FG004|Dose Expansion|Withdrawal by Subject|0|||
23413985|NCT01436656|65258274|FG005|Dose Expansion|Withdrawal by Subject|0|||
23413986|NCT01436656|65258275|FG006|Dose Expansion|Withdrawal by Subject|0|||
23413987|NCT01436656|65258276|FG007|Dose Expansion|Withdrawal by Subject|0|||
23413988|NCT01436656|65258277|FG008|Dose Expansion|Withdrawal by Subject|0|||
23413989|NCT01436656|65258278|FG009|Dose Expansion|Withdrawal by Subject|0|||
23413990|NCT01436656|65258279|FG010|Dose Expansion|Withdrawal by Subject|0|||
23413991|NCT01436656|65258280|FG011|Dose Expansion|Withdrawal by Subject|1|||
23413992|NCT01436656|65258281|FG012|Dose Expansion|Withdrawal by Subject|3|||
23413993|NCT01436656|65258282|FG013|Dose Expansion|Withdrawal by Subject|1|||
23413994|NCT01436656|65258283|FG014|Dose Expansion|Withdrawal by Subject|2|||
23413995|NCT01436656|65258284|FG015|Dose Expansion|Withdrawal by Subject|0|||
23413996|NCT01436656|65258285|FG016|Dose Expansion|Withdrawal by Subject|1|||
23413997|NCT01436656|65258286|FG017|Dose Expansion|Withdrawal by Subject|1|||
23413998|NCT01436656|65258269|FG000|Dose Expansion|Death|0|||
23413999|NCT01436656|65258270|FG001|Dose Expansion|Death|0|||
23414000|NCT01436656|65258271|FG002|Dose Expansion|Death|0|||
23414001|NCT01436656|65258272|FG003|Dose Expansion|Death|0|||
23414002|NCT01436656|65258273|FG004|Dose Expansion|Death|0|||
23414003|NCT01436656|65258274|FG005|Dose Expansion|Death|0|||
23414004|NCT01436656|65258275|FG006|Dose Expansion|Death|0|||
23414005|NCT01436656|65258276|FG007|Dose Expansion|Death|0|||
23414006|NCT01436656|65258277|FG008|Dose Expansion|Death|0|||
23414007|NCT01436656|65258278|FG009|Dose Expansion|Death|0|||
23414008|NCT01436656|65258279|FG010|Dose Expansion|Death|0|||
23414009|NCT01436656|65258280|FG011|Dose Expansion|Death|0|||
23414010|NCT01436656|65258281|FG012|Dose Expansion|Death|1|||
23414011|NCT01436656|65258282|FG013|Dose Expansion|Death|0|||
23414012|NCT01436656|65258283|FG014|Dose Expansion|Death|3|||
23414013|NCT01436656|65258284|FG015|Dose Expansion|Death|0|||
23414014|NCT01436656|65258285|FG016|Dose Expansion|Death|3|||
23414015|NCT01436656|65258286|FG017|Dose Expansion|Death|3|||
23414016|NCT01436656|65258269|FG000|Dose Expansion|Lost to Follow-up|0|||
23414017|NCT01436656|65258270|FG001|Dose Expansion|Lost to Follow-up|0|||
23414018|NCT01436656|65258271|FG002|Dose Expansion|Lost to Follow-up|0|||
23414019|NCT01436656|65258272|FG003|Dose Expansion|Lost to Follow-up|0|||
23414020|NCT01436656|65258273|FG004|Dose Expansion|Lost to Follow-up|0|||
23414021|NCT01436656|65258274|FG005|Dose Expansion|Lost to Follow-up|0|||
23414022|NCT01436656|65258275|FG006|Dose Expansion|Lost to Follow-up|0|||
23414023|NCT01436656|65258276|FG007|Dose Expansion|Lost to Follow-up|0|||
23414024|NCT01436656|65258277|FG008|Dose Expansion|Lost to Follow-up|0|||
23414025|NCT01436656|65258278|FG009|Dose Expansion|Lost to Follow-up|0|||
23414026|NCT01436656|65258279|FG010|Dose Expansion|Lost to Follow-up|0|||
23414027|NCT01436656|65258280|FG011|Dose Expansion|Lost to Follow-up|0|||
23414028|NCT01436656|65258281|FG012|Dose Expansion|Lost to Follow-up|0|||
23414029|NCT01436656|65258282|FG013|Dose Expansion|Lost to Follow-up|0|||
23414030|NCT01436656|65258283|FG014|Dose Expansion|Lost to Follow-up|0|||
23414031|NCT01436656|65258284|FG015|Dose Expansion|Lost to Follow-up|0|||
23414032|NCT01436656|65258285|FG016|Dose Expansion|Lost to Follow-up|0|||
23414033|NCT01436656|65258286|FG017|Dose Expansion|Lost to Follow-up|3|||
23414034|NCT01436656|65258269|FG000|Dose Expansion|Disease progression|0|||
23414035|NCT01436656|65258270|FG001|Dose Expansion|Disease progression|0|||
23414036|NCT01436656|65258271|FG002|Dose Expansion|Disease progression|0|||
23414037|NCT01436656|65258272|FG003|Dose Expansion|Disease progression|0|||
23414038|NCT01436656|65258273|FG004|Dose Expansion|Disease progression|0|||
23414039|NCT01436656|65258274|FG005|Dose Expansion|Disease progression|0|||
23414040|NCT01436656|65258275|FG006|Dose Expansion|Disease progression|0|||
23414041|NCT01436656|65258276|FG007|Dose Expansion|Disease progression|0|||
23414042|NCT01436656|65258277|FG008|Dose Expansion|Disease progression|0|||
23414043|NCT01436656|65258278|FG009|Dose Expansion|Disease progression|0|||
23414044|NCT01436656|65258279|FG010|Dose Expansion|Disease progression|0|||
23414045|NCT01436656|65258280|FG011|Dose Expansion|Disease progression|3|||
23414046|NCT01436656|65258281|FG012|Dose Expansion|Disease progression|1|||
23414047|NCT01436656|65258282|FG013|Dose Expansion|Disease progression|0|||
23414048|NCT01436656|65258283|FG014|Dose Expansion|Disease progression|1|||
23414049|NCT01436656|65258284|FG015|Dose Expansion|Disease progression|0|||
23414050|NCT01436656|65258285|FG016|Dose Expansion|Disease progression|0|||
23414051|NCT01436656|65258286|FG017|Dose Expansion|Disease progression|1|||
23414052|NCT01436656|65258269|FG000|Dose Expansion|New cancer therapy|0|||
23414053|NCT01436656|65258270|FG001|Dose Expansion|New cancer therapy|0|||
23414054|NCT01436656|65258271|FG002|Dose Expansion|New cancer therapy|0|||
23414055|NCT01436656|65258272|FG003|Dose Expansion|New cancer therapy|0|||
23414056|NCT01436656|65258273|FG004|Dose Expansion|New cancer therapy|0|||
23414057|NCT01436656|65258274|FG005|Dose Expansion|New cancer therapy|0|||
23414058|NCT01436656|65258275|FG006|Dose Expansion|New cancer therapy|0|||
23414059|NCT01436656|65258276|FG007|Dose Expansion|New cancer therapy|0|||
23414060|NCT01436656|65258277|FG008|Dose Expansion|New cancer therapy|0|||
23512098|NCT00884312|65612624|FG001|Overall Study|Non-fatal Adverse Event|0|||
23414061|NCT01436656|65258278|FG009|Dose Expansion|New cancer therapy|0|||
23414062|NCT01436656|65258279|FG010|Dose Expansion|New cancer therapy|0|||
23414063|NCT01436656|65258280|FG011|Dose Expansion|New cancer therapy|1|||
23414064|NCT01436656|65258281|FG012|Dose Expansion|New cancer therapy|1|||
23414065|NCT01436656|65258282|FG013|Dose Expansion|New cancer therapy|0|||
23414066|NCT01436656|65258283|FG014|Dose Expansion|New cancer therapy|2|||
23414067|NCT01436656|65258284|FG015|Dose Expansion|New cancer therapy|0|||
23414068|NCT01436656|65258285|FG016|Dose Expansion|New cancer therapy|0|||
23414069|NCT01436656|65258286|FG017|Dose Expansion|New cancer therapy|0|||
23414070|NCT03206970|65258302|FG000|Overall Study|Death|21|||
23414071|NCT03206970|65258302|FG000|Overall Study|Withdrawal by Subject|13|||
23414072|NCT03206970|65258302|FG000|Overall Study|Lost to Follow-up|3|||
23414073|NCT03206970|65258302|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
23610672|NCT00596960|65962850|FG001|Overall Study|Incarcerated|0|||
23610673|NCT00596960|65962849|FG000|Overall Study|Physician Decision|1|||
23610674|NCT00596960|65962850|FG001|Overall Study|Physician Decision|0|||
23710535|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
23710536|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
23710537|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
23710538|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
23610675|NCT00596960|65962849|FG000|Overall Study|Protocol Violation|0|||
23610676|NCT00596960|65962850|FG001|Overall Study|Protocol Violation|1|||
23610677|NCT00596960|65962849|FG000|Overall Study|No alcohol use data|0|||
23610678|NCT00596960|65962850|FG001|Overall Study|No alcohol use data|1|||
23610679|NCT01399905|65962851|FG000|Overall Study|Withdrawal by Subject|1|||
23610680|NCT01399905|65962852|FG001|Overall Study|Withdrawal by Subject|1|||
23610681|NCT02092909|65962870|FG000|Overall Study|Adverse Event|0|||
23610682|NCT02092909|65962871|FG001|Overall Study|Adverse Event|0|||
23610683|NCT02092909|65962872|FG002|Overall Study|Adverse Event|4|||
23610684|NCT02092909|65962873|FG003|Overall Study|Adverse Event|2|||
23610685|NCT02092909|65962870|FG000|Overall Study|Lack of Efficacy|0|||
23610686|NCT02092909|65962871|FG001|Overall Study|Lack of Efficacy|2|||
23610687|NCT02092909|65962872|FG002|Overall Study|Lack of Efficacy|1|||
23610688|NCT02092909|65962873|FG003|Overall Study|Lack of Efficacy|0|||
23610689|NCT02092909|65962870|FG000|Overall Study|Withdrawal by Subject|0|||
23610690|NCT02092909|65962871|FG001|Overall Study|Withdrawal by Subject|0|||
23610691|NCT02092909|65962872|FG002|Overall Study|Withdrawal by Subject|2|||
23610692|NCT02092909|65962873|FG003|Overall Study|Withdrawal by Subject|1|||
23610693|NCT02092909|65962870|FG000|Overall Study|Study terminated by Sponsor|0|||
23414096|NCT04551963|65258305|FG000|Overall Study|Physician Decision|1|||
23414097|NCT04551963|65258306|FG001|Overall Study|Physician Decision|1|||
23414098|NCT04551963|65258305|FG000|Overall Study|Death|1|||
23414099|NCT04551963|65258306|FG001|Overall Study|Death|0|||
23414100|NCT03379259|65258307|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
23414101|NCT03379259|65258308|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
23414102|NCT03379259|65258309|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
23414103|NCT03379259|65258310|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
23414104|NCT03379259|65258311|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
23414105|NCT03379259|65258312|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
23414106|NCT03379259|65258307|FG000|Overall Study|Death|0|||
23414107|NCT03379259|65258308|FG001|Overall Study|Death|1|||
23414108|NCT03379259|65258309|FG002|Overall Study|Death|2|||
23414109|NCT03379259|65258310|FG003|Overall Study|Death|1|||
23414110|NCT03379259|65258311|FG004|Overall Study|Death|4|||
23414111|NCT03379259|65258312|FG005|Overall Study|Death|2|||
23414112|NCT03379259|65258307|FG000|Overall Study|Withdrawal by Subject|0|||
23414113|NCT03379259|65258308|FG001|Overall Study|Withdrawal by Subject|0|||
23414114|NCT03379259|65258309|FG002|Overall Study|Withdrawal by Subject|1|||
23414115|NCT03379259|65258310|FG003|Overall Study|Withdrawal by Subject|0|||
23414116|NCT03379259|65258311|FG004|Overall Study|Withdrawal by Subject|2|||
23414117|NCT03379259|65258312|FG005|Overall Study|Withdrawal by Subject|0|||
23414118|NCT03379259|65258307|FG000|Overall Study|Study terminated by sponsor|0|||
23414119|NCT03379259|65258308|FG001|Overall Study|Study terminated by sponsor|0|||
23414120|NCT03379259|65258309|FG002|Overall Study|Study terminated by sponsor|0|||
23414121|NCT03379259|65258310|FG003|Overall Study|Study terminated by sponsor|1|||
23414122|NCT03379259|65258311|FG004|Overall Study|Study terminated by sponsor|1|||
23414123|NCT03379259|65258312|FG005|Overall Study|Study terminated by sponsor|4|||
23414124|NCT03379259|65258307|FG000|Overall Study|Disease progression|0|||
23414125|NCT03379259|65258308|FG001|Overall Study|Disease progression|0|||
23414126|NCT03379259|65258309|FG002|Overall Study|Disease progression|0|||
23414127|NCT03379259|65258310|FG003|Overall Study|Disease progression|1|||
23414128|NCT03379259|65258311|FG004|Overall Study|Disease progression|0|||
23414129|NCT03379259|65258312|FG005|Overall Study|Disease progression|1|||
23512099|NCT00884312|65612623|FG000|Overall Study|Fatal Adverse Event|1|||
23512100|NCT00884312|65612624|FG001|Overall Study|Fatal Adverse Event|4|||
23710539|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
23414130|NCT03379259|65258307|FG000|Overall Study|Lost to Follow-up|0|||
23414131|NCT03379259|65258308|FG001|Overall Study|Lost to Follow-up|0|||
23414132|NCT03379259|65258309|FG002|Overall Study|Lost to Follow-up|0|||
23414133|NCT03379259|65258310|FG003|Overall Study|Lost to Follow-up|0|||
23414134|NCT03379259|65258311|FG004|Overall Study|Lost to Follow-up|1|||
23414135|NCT03379259|65258312|FG005|Overall Study|Lost to Follow-up|0|||
23414136|NCT03379259|65258307|FG000|Overall Study|Deteriorating condition|0|||
23610694|NCT02092909|65962871|FG001|Overall Study|Study terminated by Sponsor|0|||
23610695|NCT02092909|65962872|FG002|Overall Study|Study terminated by Sponsor|0|||
23610696|NCT02092909|65962873|FG003|Overall Study|Study terminated by Sponsor|2|||
23610697|NCT02092909|65962870|FG000|Overall Study|Miscellaneous|1|||
23414137|NCT03379259|65258308|FG001|Overall Study|Deteriorating condition|0|||
23710540|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
23710541|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
23710542|NCT00423085|66315421|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
23710543|NCT00423085|66315422|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23414138|NCT03379259|65258309|FG002|Overall Study|Deteriorating condition|0|||
23414139|NCT03379259|65258310|FG003|Overall Study|Deteriorating condition|0|||
23414140|NCT03379259|65258311|FG004|Overall Study|Deteriorating condition|1|||
23414141|NCT03379259|65258312|FG005|Overall Study|Deteriorating condition|0|||
23414142|NCT03332173|65258313|FG000|Overall Study|Death|7|||
23414143|NCT03332173|65258313|FG000|Overall Study|Withdrawal by Subject|6|||
23414144|NCT03332173|65258313|FG000|Overall Study|Lost to Follow-up|2|||
23414145|NCT03332173|65258313|FG000|Overall Study|Transferred to long-term extension study|29|||
23414146|NCT02152982|65258314|FG000|Overall Study|Ineligible|4|||
23414147|NCT02152982|65258315|FG001|Overall Study|Ineligible|4|||
23414148|NCT02152982|65258314|FG000|Overall Study|Did not start treatment|12|||
23414149|NCT02152982|65258315|FG001|Overall Study|Did not start treatment|6|||
23710544|NCT00423085|66315423|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23710545|NCT00423085|66315424|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23710546|NCT00423085|66315421|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
23710547|NCT00423085|66315422|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
23710548|NCT00423085|66315423|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
23710549|NCT00423085|66315424|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
23710550|NCT00423085|66315421|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23710551|NCT00423085|66315422|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23710552|NCT00423085|66315423|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23710553|NCT00423085|66315424|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
23710554|NCT00423085|66315421|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23710555|NCT00423085|66315422|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23710556|NCT00423085|66315423|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23710557|NCT00423085|66315424|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
23710558|NCT00423085|66315421|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23710559|NCT00423085|66315422|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23710560|NCT00423085|66315423|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23710561|NCT00423085|66315424|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
23710562|NCT00423085|66315421|FG000|52-Week Open-Label Extension Phase|Death|0|||
23414150|NCT00748618|65258318|FG000|Overall Study|Adverse Event|1|||
23414151|NCT00748618|65258319|FG001|Overall Study|Adverse Event|0|||
23414152|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
23414153|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
23414154|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
23414155|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
23414156|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
23414157|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
23414158|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
23414159|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
23414160|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
23512101|NCT00884312|65612623|FG000|Overall Study|Withdrawal by Subject|0|||
23512102|NCT00884312|65612624|FG001|Overall Study|Withdrawal by Subject|6|||
23512103|NCT00884312|65612623|FG000|Overall Study|Physician Decision|0|||
23512104|NCT00884312|65612624|FG001|Overall Study|Physician Decision|1|||
23512105|NCT00884312|65612623|FG000|Overall Study|Other|0|||
23512106|NCT00884312|65612624|FG001|Overall Study|Other|4|||
23512107|NCT00884312|65612623|FG000|Overall Study|Did Not Receive Study Drug|0|||
23512108|NCT00884312|65612624|FG001|Overall Study|Did Not Receive Study Drug|1|||
23512109|NCT04044716|65612627|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
23512110|NCT04044716|65612628|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
23512111|NCT04044716|65612629|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
23512112|NCT04044716|65612627|FG000|Overall Study|Lost to Follow-up|2|||
23512113|NCT04044716|65612628|FG001|Overall Study|Lost to Follow-up|3|||
23512114|NCT04044716|65612629|FG002|Overall Study|Lost to Follow-up|0|||
23512115|NCT03358290|65612636|FG000|Overall Study|Study discontinued by Sponsor|0|||
23512116|NCT03358290|65612637|FG001|Overall Study|Study discontinued by Sponsor|1|||
23512117|NCT03358290|65612638|FG002|Overall Study|Study discontinued by Sponsor|1|||
23512118|NCT03358290|65612639|FG003|Overall Study|Study discontinued by Sponsor|0|||
23512119|NCT03358290|65612640|FG004|Overall Study|Study discontinued by Sponsor|0|||
23512120|NCT03358290|65612636|FG000|Overall Study|Adverse Event|0|||
23512121|NCT03358290|65612637|FG001|Overall Study|Adverse Event|0|||
23512122|NCT03358290|65612638|FG002|Overall Study|Adverse Event|1|||
23512123|NCT03358290|65612639|FG003|Overall Study|Adverse Event|2|||
23512124|NCT03358290|65612640|FG004|Overall Study|Adverse Event|0|||
23512125|NCT03358290|65612636|FG000|Overall Study|Withdrawal by Subject|0|||
23512126|NCT03358290|65612637|FG001|Overall Study|Withdrawal by Subject|0|||
23512127|NCT03358290|65612638|FG002|Overall Study|Withdrawal by Subject|0|||
23512128|NCT03358290|65612639|FG003|Overall Study|Withdrawal by Subject|0|||
23512129|NCT03358290|65612640|FG004|Overall Study|Withdrawal by Subject|1|||
23512130|NCT00710710|65612641|FG000|Overall Study|Consent withdrawn|2|||
23512131|NCT00710710|65612642|FG001|Overall Study|Consent withdrawn|2|||
23512132|NCT00710710|65612641|FG000|Overall Study|Protocol Violation|0|||
23512133|NCT00710710|65612642|FG001|Overall Study|Protocol Violation|1|||
23512134|NCT00710710|65612641|FG000|Overall Study|Adverse Event|3|||
23512135|NCT00710710|65612642|FG001|Overall Study|Adverse Event|3|||
23710563|NCT00423085|66315422|FG001|52-Week Open-Label Extension Phase|Death|0|||
23710564|NCT00423085|66315423|FG002|52-Week Open-Label Extension Phase|Death|0|||
23710565|NCT00423085|66315424|FG003|52-Week Open-Label Extension Phase|Death|2|||
23710566|NCT04321252|66315427|FG000|Overall Study|Withdrawal by Subject|0|||
23512136|NCT00710710|65612641|FG000|Overall Study|Progressive disease|40|||
23512137|NCT00710710|65612642|FG001|Overall Study|Progressive disease|38|||
23414161|NCT05507567|65258322|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
23414162|NCT05507567|65258323|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
23414163|NCT05507567|65258324|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
23414164|NCT02921230|65258325|FG000|Overall Study|Withdrawal by Subject|20|||
23414165|NCT02921230|65258326|FG001|Overall Study|Withdrawal by Subject|8|||
23414166|NCT02921230|65258325|FG000|Overall Study|Death|12|||
23414167|NCT02921230|65258326|FG001|Overall Study|Death|3|||
23414168|NCT02921230|65258325|FG000|Overall Study|Protocol Violation|17|||
23414169|NCT02921230|65258326|FG001|Overall Study|Protocol Violation|6|||
23414170|NCT02921230|65258325|FG000|Overall Study|Early completion|5|||
23414171|NCT02921230|65258326|FG001|Overall Study|Early completion|1|||
23414172|NCT02921230|65258325|FG000|Overall Study|Pending data entry|1|||
23414173|NCT02921230|65258326|FG001|Overall Study|Pending data entry|0|||
23414174|NCT03520920|65258337|FG000|Overall Study|Death|13|||
23414175|NCT03520920|65258338|FG001|Overall Study|Death|1|||
23414176|NCT03520920|65258339|FG002|Overall Study|Death|0|||
23414177|NCT03520920|65258337|FG000|Overall Study|Withdrawal by Subject|2|||
23414178|NCT03520920|65258338|FG001|Overall Study|Withdrawal by Subject|1|||
23414179|NCT03520920|65258339|FG002|Overall Study|Withdrawal by Subject|0|||
23414180|NCT03520920|65258337|FG000|Overall Study|Study Terminated by the Sponsor|5|||
23414181|NCT03520920|65258338|FG001|Overall Study|Study Terminated by the Sponsor|14|||
23414182|NCT03520920|65258339|FG002|Overall Study|Study Terminated by the Sponsor|5|||
23414183|NCT01708941|65258341|FG000|Overall Study|Adverse Event|4|||
23414184|NCT01708941|65258342|FG001|Overall Study|Adverse Event|6|||
23414185|NCT01708941|65258343|FG002|Overall Study|Adverse Event|1|||
23414186|NCT01708941|65258344|FG003|Overall Study|Adverse Event|0|||
23414187|NCT01708941|65258341|FG000|Overall Study|Death|1|||
23414188|NCT01708941|65258342|FG001|Overall Study|Death|1|||
23414189|NCT01708941|65258343|FG002|Overall Study|Death|2|||
23414190|NCT01708941|65258344|FG003|Overall Study|Death|14|||
23414191|NCT01708941|65258341|FG000|Overall Study|Withdrawal by Subject|1|||
23414192|NCT01708941|65258342|FG001|Overall Study|Withdrawal by Subject|0|||
23414193|NCT01708941|65258343|FG002|Overall Study|Withdrawal by Subject|3|||
23414194|NCT01708941|65258344|FG003|Overall Study|Withdrawal by Subject|4|||
23414195|NCT01708941|65258341|FG000|Overall Study|Disease progression|9|||
23414196|NCT01708941|65258342|FG001|Overall Study|Disease progression|10|||
23414197|NCT01708941|65258343|FG002|Overall Study|Disease progression|8|||
23414198|NCT01708941|65258344|FG003|Overall Study|Disease progression|0|||
23414199|NCT01708941|65258341|FG000|Overall Study|Alternative therapy|0|||
23414200|NCT01708941|65258342|FG001|Overall Study|Alternative therapy|0|||
23414201|NCT01708941|65258343|FG002|Overall Study|Alternative therapy|2|||
23414202|NCT01708941|65258344|FG003|Overall Study|Alternative therapy|0|||
23414203|NCT01708941|65258341|FG000|Overall Study|Ineligible and never started treatment|1|||
23414204|NCT01708941|65258342|FG001|Overall Study|Ineligible and never started treatment|0|||
23414205|NCT01708941|65258343|FG002|Overall Study|Ineligible and never started treatment|1|||
23414206|NCT01708941|65258344|FG003|Overall Study|Ineligible and never started treatment|0|||
23414207|NCT01708941|65258341|FG000|Overall Study|Never started treatment|2|||
23414208|NCT01708941|65258342|FG001|Overall Study|Never started treatment|1|||
23414209|NCT01708941|65258343|FG002|Overall Study|Never started treatment|0|||
23414210|NCT01708941|65258344|FG003|Overall Study|Never started treatment|0|||
23414211|NCT01708941|65258341|FG000|Overall Study|Ineligible|0|||
23414212|NCT01708941|65258342|FG001|Overall Study|Ineligible|0|||
23414213|NCT01708941|65258343|FG002|Overall Study|Ineligible|2|||
23414214|NCT01708941|65258344|FG003|Overall Study|Ineligible|0|||
23414215|NCT01575548|65258345|FG000|Overall Study|Adverse Event|15|||
23414216|NCT01575548|65258346|FG001|Overall Study|Adverse Event|2|||
23414217|NCT01575548|65258345|FG000|Overall Study|Disease progression|12|||
23414218|NCT01575548|65258346|FG001|Overall Study|Disease progression|25|||
23414219|NCT01575548|65258345|FG000|Overall Study|Death|1|||
23414220|NCT01575548|65258346|FG001|Overall Study|Death|0|||
23414221|NCT01575548|65258345|FG000|Overall Study|Other complicating disease|1|||
23414222|NCT01575548|65258346|FG001|Overall Study|Other complicating disease|0|||
23414223|NCT01575548|65258345|FG000|Overall Study|Withdrawal by Subject|7|||
23414224|NCT01575548|65258346|FG001|Overall Study|Withdrawal by Subject|3|||
23414225|NCT01575548|65258345|FG000|Overall Study|Noncompliance|1|||
23414226|NCT01575548|65258346|FG001|Overall Study|Noncompliance|0|||
23414227|NCT01575548|65258345|FG000|Overall Study|Anticipated surgery|0|||
23414228|NCT01575548|65258346|FG001|Overall Study|Anticipated surgery|1|||
23414229|NCT01575548|65258345|FG000|Overall Study|Never started protocol therapy|3|||
23414230|NCT01575548|65258346|FG001|Overall Study|Never started protocol therapy|2|||
23414231|NCT05027971|65258347|FG000|Overall Study|Physician Decision|7|||
23414232|NCT05027971|65258348|FG001|Overall Study|Physician Decision|3|||
23414233|NCT05027971|65258347|FG000|Overall Study|Lost to Follow-up|1|||
23414234|NCT05027971|65258348|FG001|Overall Study|Lost to Follow-up|1|||
23414235|NCT05027971|65258347|FG000|Overall Study|Withdrawal by Subject|0|||
23414236|NCT05027971|65258348|FG001|Overall Study|Withdrawal by Subject|2|||
23414237|NCT05027971|65258347|FG000|Overall Study|Non-study fiber used.|0|||
23414238|NCT05027971|65258348|FG001|Overall Study|Non-study fiber used.|1|||
23414239|NCT05027971|65258347|FG000|Overall Study|Protocol Violation|0|||
23414240|NCT05027971|65258348|FG001|Overall Study|Protocol Violation|2|||
23414241|NCT04952597|65258349|FG000|Overall Study|Death|12|||
23414242|NCT04952597|65258350|FG001|Overall Study|Death|13|||
23414243|NCT04952597|65258351|FG002|Overall Study|Death|14|||
23414244|NCT04952597|65258349|FG000|Overall Study|Withdrawal by Subject|1|||
23414245|NCT04952597|65258350|FG001|Overall Study|Withdrawal by Subject|0|||
23414246|NCT04952597|65258351|FG002|Overall Study|Withdrawal by Subject|3|||
23414247|NCT04952597|65258349|FG000|Overall Study|Lost to Follow-up|0|||
23414248|NCT04952597|65258350|FG001|Overall Study|Lost to Follow-up|1|||
23414249|NCT04952597|65258351|FG002|Overall Study|Lost to Follow-up|1|||
23414250|NCT03983382|65258355|FG000|Overall Study|Death|1|||
23414251|NCT03983382|65258355|FG000|Overall Study|Lost to Follow-up|3|||
23414252|NCT03983382|65258355|FG000|Overall Study|Physician Decision|2|||
23414253|NCT03983382|65258355|FG000|Overall Study|Withdrawal by Subject|10|||
23414254|NCT03983382|65258355|FG000|Overall Study|Change in cancer treatment|2|||
23610698|NCT02092909|65962871|FG001|Overall Study|Miscellaneous|1|||
23610699|NCT02092909|65962872|FG002|Overall Study|Miscellaneous|2|||
23610700|NCT02092909|65962873|FG003|Overall Study|Miscellaneous|1|||
23610701|NCT00157209|65962874|FG000|Overall Study|Ongoing at data cut-off|10|||
23610702|NCT00157209|65962875|FG001|Overall Study|Ongoing at data cut-off|0|||
23610703|NCT00390806|65962876|FG000|Overall Study|Lost to Follow-up|7|||
23610704|NCT00390806|65962877|FG001|Overall Study|Lost to Follow-up|6|||
23512138|NCT03266107|65612643|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
23512139|NCT03266107|65612643|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
23512140|NCT03266107|65612643|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
23512141|NCT03266107|65612643|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
23512142|NCT01601626|65612646|FG000|Overall Study|Death|1|||
23512143|NCT01601626|65612647|FG001|Overall Study|Death|1|||
23512144|NCT01601626|65612648|FG002|Overall Study|Death|1|||
23512145|NCT01601626|65612646|FG000|Overall Study|Lost to Follow-up|1|||
23512146|NCT01601626|65612647|FG001|Overall Study|Lost to Follow-up|2|||
23512147|NCT01601626|65612648|FG002|Overall Study|Lost to Follow-up|0|||
23610705|NCT00390806|65962876|FG000|Overall Study|Protocol Violation|2|||
23610706|NCT00390806|65962877|FG001|Overall Study|Protocol Violation|2|||
23610707|NCT00390806|65962876|FG000|Overall Study|Withdrawal by Subject|12|||
23610708|NCT00390806|65962877|FG001|Overall Study|Withdrawal by Subject|15|||
23610709|NCT00390806|65962876|FG000|Overall Study|Investigator Decision|4|||
23610710|NCT00390806|65962877|FG001|Overall Study|Investigator Decision|6|||
23610711|NCT00390806|65962876|FG000|Overall Study|Death|1|||
23610712|NCT00390806|65962877|FG001|Overall Study|Death|0|||
23610713|NCT00390806|65962876|FG000|Overall Study|Physician Decision|0|||
23610714|NCT00390806|65962877|FG001|Overall Study|Physician Decision|1|||
23610715|NCT00390806|65962876|FG000|Overall Study|Ongoing|4|||
23610716|NCT00390806|65962877|FG001|Overall Study|Ongoing|2|||
23610717|NCT01207453|65962883|FG000|First Intervention|Adverse Event|2|||
23610718|NCT01207453|65962884|FG001|First Intervention|Adverse Event|1|||
23610719|NCT01207453|65962883|FG000|Washout|Adverse Event|1|||
23610720|NCT01207453|65962884|FG001|Washout|Adverse Event|0|||
23610721|NCT01207453|65962883|FG000|Washout|Lost to Follow-up|1|||
23610722|NCT01207453|65962884|FG001|Washout|Lost to Follow-up|0|||
23610723|NCT01207453|65962883|FG000|2nd Intervention|Adverse Event|1|||
23610724|NCT01207453|65962884|FG001|2nd Intervention|Adverse Event|2|||
23610725|NCT01207453|65962883|FG000|2nd Intervention|Lost to Follow-up|1|||
23610726|NCT01207453|65962884|FG001|2nd Intervention|Lost to Follow-up|0|||
23610727|NCT02037568|65962888|FG000|Overall Study|Withdrawal by Subject|17|||
23610728|NCT02037568|65962889|FG001|Overall Study|Withdrawal by Subject|24|||
23610729|NCT02037568|65962888|FG000|Overall Study|Lost to Follow-up|16|||
23512148|NCT01601626|65612646|FG000|Overall Study|Unable to Get to Clinic|0|||
23512149|NCT01601626|65612647|FG001|Overall Study|Unable to Get to Clinic|1|||
23610730|NCT02037568|65962889|FG001|Overall Study|Lost to Follow-up|13|||
23610731|NCT02037568|65962888|FG000|Overall Study|Screen Failure|3|||
23610732|NCT02037568|65962889|FG001|Overall Study|Screen Failure|1|||
23610733|NCT02037568|65962888|FG000|Overall Study|Patient did not receive transplant|0|||
23610734|NCT02037568|65962889|FG001|Overall Study|Patient did not receive transplant|1|||
23610735|NCT01732757|65962890|FG000|Overall Study|Lost to Follow-up|1|||
23610736|NCT01732757|65962891|FG001|Overall Study|Lost to Follow-up|0|||
23610737|NCT01732757|65962892|FG002|Overall Study|Lost to Follow-up|0|||
23414295|NCT01708954|65258360|FG000|Step 1|Disease progression|26|||
23414296|NCT01708954|65258361|FG001|Step 1|Disease progression|17|||
23414297|NCT01708954|65258362|FG002|Step 1|Disease progression|14|||
23414298|NCT01708954|65258360|FG000|Step 1|Adverse Event|3|||
23414299|NCT01708954|65258361|FG001|Step 1|Adverse Event|11|||
23414300|NCT01708954|65258362|FG002|Step 1|Adverse Event|13|||
23414301|NCT01708954|65258360|FG000|Step 1|Death|3|||
23414302|NCT01708954|65258361|FG001|Step 1|Death|2|||
23414303|NCT01708954|65258362|FG002|Step 1|Death|3|||
23512150|NCT01601626|65612648|FG002|Overall Study|Unable to Get to Clinic|0|||
23512151|NCT01601626|65612646|FG000|Overall Study|Withdrawal by Subject|0|||
23512152|NCT01601626|65612647|FG001|Overall Study|Withdrawal by Subject|1|||
23414304|NCT01708954|65258360|FG000|Step 1|Withdrawal by Subject|2|||
23414305|NCT01708954|65258361|FG001|Step 1|Withdrawal by Subject|5|||
23414306|NCT01708954|65258362|FG002|Step 1|Withdrawal by Subject|3|||
23414307|NCT01708954|65258360|FG000|Step 1|Other complicating disease|0|||
23414308|NCT01708954|65258361|FG001|Step 1|Other complicating disease|2|||
23414309|NCT01708954|65258362|FG002|Step 1|Other complicating disease|0|||
23414310|NCT01708954|65258360|FG000|Step 1|Crossed over to Step 2|2|||
23414311|NCT01708954|65258361|FG001|Step 1|Crossed over to Step 2|0|||
23414312|NCT01708954|65258362|FG002|Step 1|Crossed over to Step 2|0|||
23414313|NCT01708954|65258360|FG000|Step 1|Symptomatic deterioration|1|||
23414314|NCT01708954|65258361|FG001|Step 1|Symptomatic deterioration|0|||
23414315|NCT01708954|65258362|FG002|Step 1|Symptomatic deterioration|1|||
23414316|NCT01708954|65258360|FG000|Step 1|Off-treatment reason not submitted|1|||
23414317|NCT01708954|65258361|FG001|Step 1|Off-treatment reason not submitted|1|||
23414318|NCT01708954|65258362|FG002|Step 1|Off-treatment reason not submitted|1|||
23414319|NCT01708954|65258360|FG000|Step 1|Ineligible or never received treatment|4|||
23414320|NCT01708954|65258361|FG001|Step 1|Ineligible or never received treatment|2|||
23414321|NCT01708954|65258362|FG002|Step 1|Ineligible or never received treatment|8|||
23414322|NCT01708954|65258360|FG000|Step 2|Disease progression|9|||
23414323|NCT01708954|65258361|FG001|Step 2|Disease progression|4|||
23414324|NCT01708954|65258362|FG002|Step 2|Disease progression|0|||
23414325|NCT01708954|65258360|FG000|Step 2|Adverse Event|3|||
23414326|NCT01708954|65258361|FG001|Step 2|Adverse Event|2|||
23414327|NCT01708954|65258362|FG002|Step 2|Adverse Event|0|||
23414328|NCT01708954|65258360|FG000|Step 2|Withdrawal by Subject|1|||
23414329|NCT01708954|65258361|FG001|Step 2|Withdrawal by Subject|1|||
23414330|NCT01708954|65258362|FG002|Step 2|Withdrawal by Subject|0|||
23610738|NCT01288729|65962897|FG000|Overall Study|Withdrawal by Subject|1|||
23610739|NCT01288729|65962898|FG001|Overall Study|Withdrawal by Subject|0|||
23610740|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
23610741|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610742|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610743|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610744|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
23610745|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23610746|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23610747|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23512153|NCT01601626|65612648|FG002|Overall Study|Withdrawal by Subject|1|||
23512154|NCT01601626|65612646|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
23512155|NCT01601626|65612647|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
23512156|NCT01601626|65612648|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
23512157|NCT03235154|65612649|FG000|Overall Study|Withdrawal by Subject|1|||
23512158|NCT03235154|65612649|FG000|Overall Study|Adverse Event|1|||
23512159|NCT03235154|65612649|FG000|Overall Study|Lost to Follow-up|2|||
23512160|NCT02759471|65612654|FG000|Overall Study|discomfort|2|||
23512161|NCT04350788|65612657|FG000|Overall Study|Lost to Follow-up|6|||
23512162|NCT04350788|65612658|FG001|Overall Study|Lost to Follow-up|2|||
23512163|NCT04350788|65612657|FG000|Overall Study|Withdrawal by Subject|2|||
23512164|NCT04350788|65612658|FG001|Overall Study|Withdrawal by Subject|4|||
23512165|NCT04350788|65612657|FG000|Overall Study|Protocol Violation|4|||
23512166|NCT04350788|65612658|FG001|Overall Study|Protocol Violation|0|||
23512167|NCT03489720|65612659|FG000|Overall Study|Withdrawal by Subject|2|||
23512168|NCT03489720|65612660|FG001|Overall Study|Withdrawal by Subject|0|||
23512169|NCT02154490|65612661|FG000|Overall Study|No tissue submitted|23|||
23512170|NCT02154490|65612661|FG000|Overall Study|No biomarker results|167|||
23512171|NCT02154490|65612661|FG000|Overall Study|Not assigned to a sub-study|270|||
23512172|NCT02154490|65612661|FG000|Overall Study|Did not register to a sub-study|749|||
23610748|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
23610749|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610750|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610751|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610752|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
23610753|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23512173|NCT03934931|65612663|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
23512174|NCT03934931|65612664|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
23610754|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23610755|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23610756|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
23610757|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23610758|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23512175|NCT03934931|65612665|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
23512176|NCT04059094|65612666|FG000|Overall Study|Adverse Event|0|||
23512177|NCT04059094|65612667|FG001|Overall Study|Adverse Event|0|||
23610759|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23610760|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
23610761|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610762|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610763|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610764|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
23610765|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610766|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610767|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610768|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23610769|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23610770|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
23610771|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23610772|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23610773|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
23512178|NCT04059094|65612668|FG002|Overall Study|Adverse Event|0|||
23512179|NCT04059094|65612669|FG003|Overall Study|Adverse Event|0|||
23512180|NCT04059094|65612670|FG004|Overall Study|Adverse Event|1|||
23512181|NCT04059094|65612666|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512182|NCT04059094|65612667|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
23512183|NCT04059094|65612668|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512184|NCT04059094|65612669|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512185|NCT04059094|65612670|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23610774|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
23610775|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
23610776|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23610777|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
23610778|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
23610779|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
23610780|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23610781|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23610782|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23610783|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23610784|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23610785|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23610786|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
23610787|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23610788|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23610789|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
23610790|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
23610791|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
23610792|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23610793|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23610794|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
23610795|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
23610796|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
23610797|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
23610798|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
23610799|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
23512186|NCT01463878|65612671|FG000|Overall Study|no longer met criteria for tube feed|2|||
23512187|NCT01463878|65612672|FG001|Overall Study|no longer met criteria for tube feed|2|||
23512188|NCT03182829|65612673|FG000|Overall Study|Protocol Violation|12|||
23512189|NCT03182829|65612674|FG001|Overall Study|Protocol Violation|12|||
23512190|NCT03182829|65612673|FG000|Overall Study|Other|4|||
23512191|NCT03182829|65612674|FG001|Overall Study|Other|3|||
23512192|NCT02772081|65612682|FG000|Overall Study|Physician Decision|1|||
23512193|NCT02772081|65612683|FG001|Overall Study|Physician Decision|1|||
23512194|NCT02772081|65612682|FG000|Overall Study|Death|1|||
23512195|NCT02772081|65612683|FG001|Overall Study|Death|1|||
23610800|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Adverse Event|7|||
23610801|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Adverse Event|8|||
23512196|NCT00330616|65612688|FG000|Overall Study|Adverse Event|13|||
23512197|NCT00330616|65612688|FG000|Overall Study|Lack of Efficacy|1|||
23512198|NCT00330616|65612688|FG000|Overall Study|Lost to Follow-up|2|||
23610802|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Adverse Event|8|||
23610803|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Adverse Event|9|||
23610804|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
23610805|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
23610806|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
23610807|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
23610808|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
23610809|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
23610810|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
23610811|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
23610812|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Pregnancy|0|||
23610813|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Pregnancy|2|||
23610814|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Pregnancy|2|||
23610815|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Pregnancy|0|||
23610816|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Non-compliance|1|||
23610817|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Non-compliance|0|||
23610818|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Non-compliance|0|||
23610819|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Non-compliance|3|||
23610820|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Other|3|||
23610821|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Other|0|||
23610822|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Other|3|||
23610823|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Other|2|||
23610824|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610825|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610826|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610827|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
23610828|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
23610829|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610830|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610831|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610832|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
23610833|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
23610834|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
23610835|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
23610836|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
23610837|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
23610838|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23610839|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
23610840|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610841|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610842|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
23610843|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610844|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
23610845|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
23610846|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
23610847|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
23610848|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
23512199|NCT00330616|65612688|FG000|Overall Study|Withdrawal by Subject|4|||
23512200|NCT00330616|65612688|FG000|Overall Study|Other|1|||
23512201|NCT03226392|65612689|FG000|Overall Study|Protocol Deviation|1|||
23512202|NCT03226392|65612690|FG001|Overall Study|Protocol Deviation|0|||
23512203|NCT03226392|65612689|FG000|Overall Study|Physician Decision|1|||
23512204|NCT03226392|65612690|FG001|Overall Study|Physician Decision|0|||
23512205|NCT03226392|65612689|FG000|Overall Study|Lost to Follow-up|1|||
23512206|NCT03226392|65612690|FG001|Overall Study|Lost to Follow-up|0|||
23710567|NCT04321252|66315428|FG001|Overall Study|Withdrawal by Subject|0|||
23710568|NCT04321252|66315429|FG002|Overall Study|Withdrawal by Subject|0|||
23710569|NCT04321252|66315430|FG003|Overall Study|Withdrawal by Subject|0|||
23512207|NCT03226392|65612689|FG000|Overall Study|Adverse Event|1|||
23512208|NCT03226392|65612690|FG001|Overall Study|Adverse Event|0|||
23512209|NCT03226392|65612689|FG000|Overall Study|Technical Problems|0|||
23512210|NCT03226392|65612690|FG001|Overall Study|Technical Problems|2|||
23512211|NCT03226392|65612689|FG000|Overall Study|Subject/Guardian Decision|7|||
23512212|NCT03226392|65612690|FG001|Overall Study|Subject/Guardian Decision|6|||
23512213|NCT02259582|65612691|FG000|Overall Study|Physician Decision|0|||
23512214|NCT02259582|65612692|FG001|Overall Study|Physician Decision|1|||
23512215|NCT02259582|65612693|FG002|Overall Study|Physician Decision|0|||
23512216|NCT02259582|65612691|FG000|Overall Study|Death|0|||
23512217|NCT02259582|65612692|FG001|Overall Study|Death|0|||
23512218|NCT02259582|65612693|FG002|Overall Study|Death|1|||
23610849|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
23710570|NCT04321252|66315431|FG004|Overall Study|Withdrawal by Subject|0|||
23710571|NCT04321252|66315432|FG005|Overall Study|Withdrawal by Subject|1|||
23710572|NCT04321252|66315433|FG006|Overall Study|Withdrawal by Subject|0|||
23512219|NCT02259582|65612691|FG000|Overall Study|Adverse Event|1|||
23512220|NCT02259582|65612692|FG001|Overall Study|Adverse Event|0|||
23512221|NCT02259582|65612693|FG002|Overall Study|Adverse Event|1|||
23512222|NCT02259582|65612691|FG000|Overall Study|Withdrawal by Subject|0|||
23710573|NCT04321252|66315434|FG007|Overall Study|Withdrawal by Subject|0|||
23710574|NCT04321252|66315435|FG008|Overall Study|Withdrawal by Subject|0|||
23610850|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
23610851|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
23610852|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
23610853|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
23610854|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
23610855|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
23610856|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
23610857|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
23610858|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
23610859|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
23610860|NCT02727998|65962910|FG000|Overall Study|Lost to Follow-up|3|||
23610861|NCT02727998|65962911|FG001|Overall Study|Lost to Follow-up|3|||
23610862|NCT02727998|65962910|FG000|Overall Study|Withdrawal by Subject|0|||
23610863|NCT02727998|65962911|FG001|Overall Study|Withdrawal by Subject|1|||
23610864|NCT02825550|65962913|FG000|Overall Study|Physician Decision|1|||
23610865|NCT01668355|65962914|FG000|Overall Study|Death|3|||
23710575|NCT00302718|66315436|FG000|Overall Study|Participant left the hospital|1|||
23710576|NCT00302718|66315437|FG001|Overall Study|Participant left the hospital|0|||
23710577|NCT00302718|66315438|FG002|Overall Study|Participant left the hospital|0|||
23710578|NCT00302718|66315439|FG003|Overall Study|Participant left the hospital|1|||
23414465|NCT04860869|65258382|FG000|Overall Study|Withdrawal by Subject|1|||
23414466|NCT04860869|65258383|FG001|Overall Study|Withdrawal by Subject|0|||
23610866|NCT01668355|65962915|FG001|Overall Study|Death|1|||
23610867|NCT01668355|65962914|FG000|Overall Study|Withdrawal by Subject|6|||
23610868|NCT01668355|65962915|FG001|Overall Study|Withdrawal by Subject|1|||
23610869|NCT00636168|65962917|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
23610870|NCT00636168|65962918|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
23610871|NCT00636168|65962917|FG000|Randomized to Study Drug|Adverse Event|1|||
23610872|NCT00636168|65962918|FG001|Randomized to Study Drug|Adverse Event|0|||
23610873|NCT00636168|65962917|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
23610874|NCT00636168|65962918|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
23610875|NCT00636168|65962917|FG000|Treated With Study Drug|Recurrence of disease|135|||
23610876|NCT00636168|65962918|FG001|Treated With Study Drug|Recurrence of disease|282|||
23610877|NCT00636168|65962917|FG000|Treated With Study Drug|Adverse Event|250|||
23610878|NCT00636168|65962918|FG001|Treated With Study Drug|Adverse Event|22|||
23610879|NCT00636168|65962917|FG000|Treated With Study Drug|Participant withdrew consent|16|||
23610880|NCT00636168|65962918|FG001|Treated With Study Drug|Participant withdrew consent|21|||
23610881|NCT00636168|65962917|FG000|Treated With Study Drug|Poor/non-compliance|1|||
23610882|NCT00636168|65962918|FG001|Treated With Study Drug|Poor/non-compliance|3|||
23610883|NCT00636168|65962917|FG000|Treated With Study Drug|Death|3|||
23610884|NCT00636168|65962918|FG001|Treated With Study Drug|Death|0|||
23414487|NCT05040971|65258391|FG000|Overall Study|Withdrawal by Subject|0|||
23414488|NCT05040971|65258392|FG001|Overall Study|Withdrawal by Subject|2|||
23414489|NCT05040971|65258391|FG000|Overall Study|Lost to Follow-up|8|||
23414490|NCT05040971|65258392|FG001|Overall Study|Lost to Follow-up|3|||
23414491|NCT05040971|65258391|FG000|Overall Study|Death|2|||
23414492|NCT05040971|65258392|FG001|Overall Study|Death|0|||
23414493|NCT01522976|65258393|FG000|Overall Study|Ineligible|4|||
23414494|NCT01522976|65258394|FG001|Overall Study|Ineligible|0|||
23414495|NCT01522976|65258395|FG002|Overall Study|Ineligible|1|||
23414496|NCT01522976|65258393|FG000|Overall Study|Death|7|||
23414497|NCT01522976|65258394|FG001|Overall Study|Death|6|||
23414498|NCT01522976|65258395|FG002|Overall Study|Death|2|||
23414499|NCT01522976|65258393|FG000|Overall Study|Still on treatment|9|||
23414500|NCT01522976|65258394|FG001|Overall Study|Still on treatment|9|||
23414501|NCT01522976|65258395|FG002|Overall Study|Still on treatment|6|||
23512223|NCT02259582|65612692|FG001|Overall Study|Withdrawal by Subject|0|||
23414502|NCT01522976|65258393|FG000|Overall Study|Disease progression|28|||
23414503|NCT01522976|65258394|FG001|Overall Study|Disease progression|30|||
23414504|NCT01522976|65258395|FG002|Overall Study|Disease progression|25|||
23414505|NCT01522976|65258393|FG000|Overall Study|Adverse Event|17|||
23414506|NCT01522976|65258394|FG001|Overall Study|Adverse Event|7|||
23414507|NCT01522976|65258395|FG002|Overall Study|Adverse Event|18|||
23414508|NCT01522976|65258393|FG000|Overall Study|Refusal unrelated to adverse event|10|||
23414509|NCT01522976|65258394|FG001|Overall Study|Refusal unrelated to adverse event|13|||
23414510|NCT01522976|65258395|FG002|Overall Study|Refusal unrelated to adverse event|14|||
23414511|NCT01522976|65258393|FG000|Overall Study|Not protocol specified|22|||
23414512|NCT01522976|65258394|FG001|Overall Study|Not protocol specified|27|||
23414513|NCT01522976|65258395|FG002|Overall Study|Not protocol specified|27|||
23414514|NCT01013649|65258396|FG000|First Step|Withdrawal by Subject|36|||
23414515|NCT01013649|65258397|FG001|First Step|Withdrawal by Subject|19|||
23414516|NCT01013649|65258398|FG002|First Step|Withdrawal by Subject|0|||
23414517|NCT01013649|65258399|FG003|First Step|Withdrawal by Subject|0|||
23414518|NCT01013649|65258396|FG000|First Step|Progression|58|||
23414519|NCT01013649|65258397|FG001|First Step|Progression|23|||
23414520|NCT01013649|65258398|FG002|First Step|Progression|0|||
23414521|NCT01013649|65258399|FG003|First Step|Progression|0|||
23414522|NCT01013649|65258396|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
23414523|NCT01013649|65258397|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
23414524|NCT01013649|65258398|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
23414525|NCT01013649|65258399|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
23414526|NCT01013649|65258396|FG000|First Step|Death|3|||
23414527|NCT01013649|65258397|FG001|First Step|Death|4|||
23414528|NCT01013649|65258398|FG002|First Step|Death|0|||
23414529|NCT01013649|65258399|FG003|First Step|Death|0|||
23414530|NCT01013649|65258396|FG000|First Step|Adverse Event|9|||
23414531|NCT01013649|65258397|FG001|First Step|Adverse Event|5|||
23414532|NCT01013649|65258398|FG002|First Step|Adverse Event|0|||
23414533|NCT01013649|65258399|FG003|First Step|Adverse Event|0|||
23414534|NCT01013649|65258396|FG000|First Step|Other|4|||
23414535|NCT01013649|65258397|FG001|First Step|Other|6|||
23414536|NCT01013649|65258398|FG002|First Step|Other|0|||
23414537|NCT01013649|65258399|FG003|First Step|Other|0|||
23414538|NCT04550832|65258400|FG000|Overall Study|Adverse Event|0|||
23414539|NCT04550832|65258401|FG001|Overall Study|Adverse Event|0|||
23414540|NCT04550832|65258402|FG002|Overall Study|Adverse Event|2|||
23414541|NCT04550832|65258403|FG003|Overall Study|Adverse Event|0|||
23414542|NCT04550832|65258404|FG004|Overall Study|Adverse Event|1|||
23610885|NCT00636168|65962917|FG000|Treated With Study Drug|Pregnancy|1|||
23610886|NCT00636168|65962918|FG001|Treated With Study Drug|Pregnancy|0|||
23610887|NCT00636168|65962917|FG000|Treated With Study Drug|No longer meets study criteria|1|||
23610888|NCT00636168|65962918|FG001|Treated With Study Drug|No longer meets study criteria|0|||
23610889|NCT00636168|65962917|FG000|Treated With Study Drug|Other reason|1|||
23610890|NCT00636168|65962918|FG001|Treated With Study Drug|Other reason|3|||
23610891|NCT00636168|65962917|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
23610892|NCT00636168|65962918|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
23610893|NCT00636168|65962917|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
23610894|NCT00636168|65962918|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
23610895|NCT00636168|65962917|FG000|Long Term Follow-Up|Death|8|||
23610896|NCT00636168|65962918|FG001|Long Term Follow-Up|Death|9|||
23610897|NCT02991456|65962923|FG000|Overall Study|Adverse Event|2|||
23610898|NCT02991456|65962924|FG001|Overall Study|Adverse Event|0|||
23610899|NCT02991456|65962923|FG000|Overall Study|Lost to Follow-up|0|||
23610900|NCT02991456|65962924|FG001|Overall Study|Lost to Follow-up|2|||
23610901|NCT02991456|65962923|FG000|Overall Study|Withdrawal by Subject|1|||
23610902|NCT02991456|65962924|FG001|Overall Study|Withdrawal by Subject|0|||
23610903|NCT02784834|65962927|FG000|Overall Study|Lack of Efficacy|1|||
23610904|NCT02964234|65962931|FG000|Overall Study|Lost to Follow-up|22|||
23610905|NCT02964234|65962932|FG001|Overall Study|Lost to Follow-up|13|||
23610906|NCT00828139|65962935|FG000|Overall Study|Adverse Event|8|||
23512224|NCT02259582|65612693|FG002|Overall Study|Withdrawal by Subject|1|||
23512225|NCT02259582|65612691|FG000|Overall Study|Disease progression|14|||
23512226|NCT02259582|65612692|FG001|Overall Study|Disease progression|15|||
23512227|NCT02259582|65612693|FG002|Overall Study|Disease progression|17|||
23512228|NCT02259582|65612691|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
23610907|NCT00828139|65962936|FG001|Overall Study|Adverse Event|1|||
23710579|NCT00302718|66315436|FG000|Overall Study|Withdrawal by Subject|0|||
23710580|NCT00302718|66315437|FG001|Overall Study|Withdrawal by Subject|1|||
23610908|NCT00828139|65962937|FG002|Overall Study|Adverse Event|10|||
23414567|NCT03594747|65258407|FG000|Overall Study|Death|78|||
23414568|NCT03594747|65258408|FG001|Overall Study|Death|86|||
23414569|NCT03594747|65258409|FG002|Overall Study|Death|87|||
23414570|NCT03594747|65258407|FG000|Overall Study|Withdrawal by Subject|5|||
23414571|NCT03594747|65258408|FG001|Overall Study|Withdrawal by Subject|2|||
23414572|NCT03594747|65258409|FG002|Overall Study|Withdrawal by Subject|11|||
23414573|NCT03594747|65258407|FG000|Overall Study|Lost to Follow-up|4|||
23414574|NCT03594747|65258408|FG001|Overall Study|Lost to Follow-up|1|||
23414575|NCT03594747|65258409|FG002|Overall Study|Lost to Follow-up|1|||
23414576|NCT03594747|65258407|FG000|Overall Study|Physician Decision|0|||
23414577|NCT03594747|65258408|FG001|Overall Study|Physician Decision|1|||
23414578|NCT03594747|65258409|FG002|Overall Study|Physician Decision|0|||
23414579|NCT03594747|65258407|FG000|Overall Study|Sponsor decision|23|||
23414580|NCT03594747|65258408|FG001|Overall Study|Sponsor decision|17|||
23414581|NCT03594747|65258409|FG002|Overall Study|Sponsor decision|16|||
23414582|NCT03594747|65258407|FG000|Overall Study|Did not meet inclusion criteria|0|||
23414583|NCT03594747|65258408|FG001|Overall Study|Did not meet inclusion criteria|0|||
23414584|NCT03594747|65258409|FG002|Overall Study|Did not meet inclusion criteria|1|||
23414585|NCT03594747|65258407|FG000|Overall Study|Transfer to long term extension study|10|||
23414586|NCT03594747|65258408|FG001|Overall Study|Transfer to long term extension study|12|||
23414587|NCT03594747|65258409|FG002|Overall Study|Transfer to long term extension study|5|||
23414588|NCT04295681|65258411|FG000|Overall Study|Eligibility error|1|||
23414589|NCT04295681|65258412|FG001|Overall Study|Eligibility error|3|||
23512229|NCT02259582|65612692|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
23512230|NCT02259582|65612693|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
23710581|NCT00302718|66315438|FG002|Overall Study|Withdrawal by Subject|0|||
23414590|NCT02569476|65258415|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
23414591|NCT02569476|65258415|FG000|Overall Study|Death|33|||
23414592|NCT02569476|65258415|FG000|Overall Study|Withdrawal by Subject|9|||
23414593|NCT02569476|65258415|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
23414594|NCT02569476|65258415|FG000|Overall Study|Palliative care|1|||
23414595|NCT02569476|65258415|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
23414596|NCT02569476|65258415|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
23610909|NCT00828139|65962938|FG003|Overall Study|Adverse Event|5|||
23610910|NCT00828139|65962935|FG000|Overall Study|Death|2|||
23610911|NCT00828139|65962936|FG001|Overall Study|Death|1|||
23610912|NCT00828139|65962937|FG002|Overall Study|Death|0|||
23610913|NCT00828139|65962938|FG003|Overall Study|Death|2|||
23610914|NCT00828139|65962935|FG000|Overall Study|Refusal unrelated to toxicity|3|||
23610915|NCT00828139|65962936|FG001|Overall Study|Refusal unrelated to toxicity|4|||
23610916|NCT00828139|65962937|FG002|Overall Study|Refusal unrelated to toxicity|5|||
23610917|NCT00828139|65962938|FG003|Overall Study|Refusal unrelated to toxicity|3|||
23610918|NCT00828139|65962935|FG000|Overall Study|Disease Progression|24|||
23610919|NCT00828139|65962936|FG001|Overall Study|Disease Progression|33|||
23610920|NCT00828139|65962937|FG002|Overall Study|Disease Progression|35|||
23610921|NCT00828139|65962938|FG003|Overall Study|Disease Progression|39|||
23610922|NCT00828139|65962935|FG000|Overall Study|Other|4|||
23610923|NCT00828139|65962936|FG001|Overall Study|Other|2|||
23610924|NCT00828139|65962937|FG002|Overall Study|Other|5|||
23610925|NCT00828139|65962938|FG003|Overall Study|Other|2|||
23610926|NCT03344458|65962942|FG000|Overall Study|Physician Decision|1|||
23610927|NCT03344458|65962942|FG000|Overall Study|Withdrawal by Subject|16|||
23610928|NCT03344458|65962942|FG000|Overall Study|Other reasons|10|||
23414617|NCT05420961|65258427|FG000|Overall Study|Withdrawal by Subject|2|||
23414618|NCT05420961|65258428|FG001|Overall Study|Withdrawal by Subject|1|||
23414619|NCT05420961|65258429|FG002|Overall Study|Withdrawal by Subject|1|||
23414620|NCT05420961|65258430|FG003|Overall Study|Withdrawal by Subject|0|||
23414621|NCT05420961|65258431|FG004|Overall Study|Withdrawal by Subject|0|||
23414622|NCT05420961|65258427|FG000|Overall Study|Lost to Follow-up|0|||
23414623|NCT05420961|65258428|FG001|Overall Study|Lost to Follow-up|0|||
23414624|NCT05420961|65258429|FG002|Overall Study|Lost to Follow-up|1|||
23414625|NCT05420961|65258430|FG003|Overall Study|Lost to Follow-up|0|||
23414626|NCT05420961|65258431|FG004|Overall Study|Lost to Follow-up|0|||
23414627|NCT05420961|65258427|FG000|Overall Study|Randomized by mistake without study treatment|0|||
23414628|NCT05420961|65258428|FG001|Overall Study|Randomized by mistake without study treatment|0|||
23414629|NCT05420961|65258429|FG002|Overall Study|Randomized by mistake without study treatment|1|||
23414630|NCT05420961|65258430|FG003|Overall Study|Randomized by mistake without study treatment|0|||
23414631|NCT05420961|65258431|FG004|Overall Study|Randomized by mistake without study treatment|1|||
23610929|NCT03344458|65962942|FG000|Overall Study|Lost to Follow-up|9|||
23610930|NCT03344458|65962942|FG000|Overall Study|Protocol Violation|3|||
23610931|NCT00889863|65962944|FG000|Part I: Open Label|Death|1|||
23610932|NCT00889863|65962945|FG001|Part I: Open Label|Death|0|||
23610933|NCT00889863|65962944|FG000|Part I: Open Label|Adverse Event|4|||
23710582|NCT00302718|66315439|FG003|Overall Study|Withdrawal by Subject|0|||
23610934|NCT00889863|65962945|FG001|Part I: Open Label|Adverse Event|0|||
23610935|NCT00889863|65962944|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
23512231|NCT00105482|65612694|FG000|Overall Study|Adverse Event|1|||
23610936|NCT00889863|65962945|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
23610937|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
23414640|NCT04790279|65260697|FG000|Overall Study|Did not meet medication start criteria|27|||
23414641|NCT04790279|65260698|FG001|Overall Study|Did not meet medication start criteria|15|||
23414642|NCT04790279|65260697|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
23414643|NCT04790279|65260698|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
23414644|NCT04790279|65260697|FG000|Overall Study|Protocol Violation|8|||
23414645|NCT04790279|65260698|FG001|Overall Study|Protocol Violation|3|||
23414646|NCT04790279|65260697|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
23414647|NCT04790279|65260698|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
23610938|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
23414650|NCT01274338|65260701|FG000|Overall Study|Lack of Efficacy|72|||
23414651|NCT01274338|65260702|FG001|Overall Study|Lack of Efficacy|108|||
23414652|NCT01274338|65260703|FG002|Overall Study|Lack of Efficacy|116|||
23414653|NCT01274338|65260704|FG003|Overall Study|Lack of Efficacy|0|||
23414654|NCT01274338|65260705|FG004|Overall Study|Lack of Efficacy|0|||
23414655|NCT01274338|65260706|FG005|Overall Study|Lack of Efficacy|0|||
23414656|NCT01274338|65260701|FG000|Overall Study|Adverse Event|272|||
23414657|NCT01274338|65260702|FG001|Overall Study|Adverse Event|105|||
23414658|NCT01274338|65260703|FG002|Overall Study|Adverse Event|180|||
23414659|NCT01274338|65260704|FG003|Overall Study|Adverse Event|1|||
23414660|NCT01274338|65260705|FG004|Overall Study|Adverse Event|0|||
23414661|NCT01274338|65260706|FG005|Overall Study|Adverse Event|0|||
23414662|NCT01274338|65260701|FG000|Overall Study|Death|8|||
23414663|NCT01274338|65260702|FG001|Overall Study|Death|1|||
23414664|NCT01274338|65260703|FG002|Overall Study|Death|0|||
23414665|NCT01274338|65260704|FG003|Overall Study|Death|0|||
23414666|NCT01274338|65260705|FG004|Overall Study|Death|0|||
23414667|NCT01274338|65260706|FG005|Overall Study|Death|0|||
23414668|NCT01274338|65260701|FG000|Overall Study|Withdrawal by Subject|27|||
23414669|NCT01274338|65260702|FG001|Overall Study|Withdrawal by Subject|99|||
23414670|NCT01274338|65260703|FG002|Overall Study|Withdrawal by Subject|17|||
23414671|NCT01274338|65260704|FG003|Overall Study|Withdrawal by Subject|0|||
23414672|NCT01274338|65260705|FG004|Overall Study|Withdrawal by Subject|0|||
23414673|NCT01274338|65260706|FG005|Overall Study|Withdrawal by Subject|0|||
23414674|NCT01274338|65260701|FG000|Overall Study|Did not start treatment|8|||
23414675|NCT01274338|65260702|FG001|Overall Study|Did not start treatment|116|||
23414676|NCT01274338|65260703|FG002|Overall Study|Did not start treatment|7|||
23414677|NCT01274338|65260704|FG003|Overall Study|Did not start treatment|0|||
23414678|NCT01274338|65260705|FG004|Overall Study|Did not start treatment|0|||
23414679|NCT01274338|65260706|FG005|Overall Study|Did not start treatment|0|||
23414680|NCT01274338|65260701|FG000|Overall Study|Alternative therapy|0|||
23414681|NCT01274338|65260702|FG001|Overall Study|Alternative therapy|1|||
23414682|NCT01274338|65260703|FG002|Overall Study|Alternative therapy|0|||
23414683|NCT01274338|65260704|FG003|Overall Study|Alternative therapy|0|||
23414684|NCT01274338|65260705|FG004|Overall Study|Alternative therapy|0|||
23414685|NCT01274338|65260706|FG005|Overall Study|Alternative therapy|0|||
23414686|NCT01274338|65260701|FG000|Overall Study|Other complicating diseases|0|||
23414687|NCT01274338|65260702|FG001|Overall Study|Other complicating diseases|3|||
23414688|NCT01274338|65260703|FG002|Overall Study|Other complicating diseases|1|||
23414689|NCT01274338|65260704|FG003|Overall Study|Other complicating diseases|0|||
23414690|NCT01274338|65260705|FG004|Overall Study|Other complicating diseases|0|||
23414691|NCT01274338|65260706|FG005|Overall Study|Other complicating diseases|0|||
23414692|NCT01274338|65260701|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
23414693|NCT01274338|65260702|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414694|NCT01274338|65260703|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414695|NCT01274338|65260704|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414696|NCT01274338|65260705|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414697|NCT01274338|65260706|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414698|NCT01274338|65260701|FG000|Overall Study|Pregnancy|0|||
23414699|NCT01274338|65260702|FG001|Overall Study|Pregnancy|0|||
23414700|NCT01274338|65260703|FG002|Overall Study|Pregnancy|1|||
23414701|NCT01274338|65260704|FG003|Overall Study|Pregnancy|0|||
23414702|NCT01274338|65260705|FG004|Overall Study|Pregnancy|0|||
23414703|NCT01274338|65260706|FG005|Overall Study|Pregnancy|0|||
23414704|NCT01274338|65260701|FG000|Overall Study|Reason not reported|12|||
23414705|NCT01274338|65260702|FG001|Overall Study|Reason not reported|21|||
23414706|NCT01274338|65260703|FG002|Overall Study|Reason not reported|3|||
23414707|NCT01274338|65260704|FG003|Overall Study|Reason not reported|0|||
23414708|NCT01274338|65260705|FG004|Overall Study|Reason not reported|1|||
23414709|NCT01274338|65260706|FG005|Overall Study|Reason not reported|0|||
23414710|NCT03419897|65260709|FG000|Overall Study|Death|180|||
23414711|NCT03419897|65260709|FG000|Overall Study|Lost to Follow-up|1|||
23414712|NCT03419897|65260709|FG000|Overall Study|Withdrawal by Subject|6|||
23414713|NCT03419897|65260709|FG000|Overall Study|Sponsor Decision|61|||
23414714|NCT03419897|65260709|FG000|Overall Study|Physician Decision|1|||
23414715|NCT03640325|65260710|FG000|Overall Study|Withdrawal by Subject|4|||
23414716|NCT03640325|65260711|FG001|Overall Study|Withdrawal by Subject|1|||
23414717|NCT03640325|65260712|FG002|Overall Study|Withdrawal by Subject|0|||
23414718|NCT03640325|65260710|FG000|Overall Study|Lost to Follow-up|4|||
23414719|NCT03640325|65260711|FG001|Overall Study|Lost to Follow-up|5|||
23414720|NCT03640325|65260712|FG002|Overall Study|Lost to Follow-up|21|||
23414721|NCT03640325|65260710|FG000|Overall Study|Death|5|||
23414722|NCT03640325|65260711|FG001|Overall Study|Death|5|||
23414723|NCT03640325|65260712|FG002|Overall Study|Death|0|||
23414724|NCT03493451|65260713|FG000|Overall Study|Death|11|||
23414725|NCT03493451|65260714|FG001|Overall Study|Death|26|||
23414726|NCT03493451|65260715|FG002|Overall Study|Death|3|||
23414727|NCT03493451|65260713|FG000|Overall Study|Lost to Follow-up|1|||
23512232|NCT00105482|65612695|FG001|Overall Study|Adverse Event|1|||
23512233|NCT00105482|65612694|FG000|Overall Study|Lost to Follow-up|26|||
23512234|NCT00105482|65612695|FG001|Overall Study|Lost to Follow-up|17|||
23512235|NCT00105482|65612694|FG000|Overall Study|Withdrawal by Subject|0|||
23512236|NCT00105482|65612695|FG001|Overall Study|Withdrawal by Subject|1|||
23512237|NCT00105482|65612694|FG000|Overall Study|Lost Interest|29|||
23512238|NCT00105482|65612695|FG001|Overall Study|Lost Interest|32|||
23512239|NCT00105482|65612694|FG000|Overall Study|Scheduling Conflict|2|||
23512240|NCT00105482|65612695|FG001|Overall Study|Scheduling Conflict|3|||
23512241|NCT00105482|65612694|FG000|Overall Study|Withdrawn by PI|1|||
23512242|NCT00105482|65612695|FG001|Overall Study|Withdrawn by PI|1|||
23512243|NCT01411228|65612696|FG000|Overall Study|Lost to Follow-up|0|||
23512244|NCT01411228|65612697|FG001|Overall Study|Lost to Follow-up|0|||
23414728|NCT03493451|65260714|FG001|Overall Study|Lost to Follow-up|4|||
23414729|NCT03493451|65260715|FG002|Overall Study|Lost to Follow-up|1|||
23414730|NCT03493451|65260713|FG000|Overall Study|Withdrawal by Subject|1|||
23414731|NCT03493451|65260714|FG001|Overall Study|Withdrawal by Subject|1|||
23414732|NCT03493451|65260715|FG002|Overall Study|Withdrawal by Subject|2|||
23414733|NCT03493451|65260713|FG000|Overall Study|Progressive Disease|1|||
23414734|NCT03493451|65260714|FG001|Overall Study|Progressive Disease|0|||
23414735|NCT03493451|65260715|FG002|Overall Study|Progressive Disease|0|||
23414736|NCT03493451|65260713|FG000|Overall Study|Transferred to long term extension study|8|||
23414737|NCT03493451|65260714|FG001|Overall Study|Transferred to long term extension study|13|||
23414738|NCT03493451|65260715|FG002|Overall Study|Transferred to long term extension study|5|||
23414739|NCT03430843|65260716|FG000|Overall Study|Death|233|||
23414740|NCT03430843|65260717|FG001|Overall Study|Death|233|||
23414741|NCT03430843|65260716|FG000|Overall Study|Sponsor Decision|17|||
23414742|NCT03430843|65260717|FG001|Overall Study|Sponsor Decision|6|||
23414743|NCT03430843|65260716|FG000|Overall Study|Withdrawal by Subject|5|||
23414744|NCT03430843|65260717|FG001|Overall Study|Withdrawal by Subject|14|||
23414745|NCT03430843|65260716|FG000|Overall Study|Lost to Follow-up|1|||
23414746|NCT03430843|65260717|FG001|Overall Study|Lost to Follow-up|3|||
23610939|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
23610940|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
23610941|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
23610942|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
23610943|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
23610944|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
23610945|NCT01912599|65962950|FG000|Overall Study|Withdrawal by Subject|0|||
23610946|NCT01912599|65962951|FG001|Overall Study|Withdrawal by Subject|1|||
23610947|NCT01280721|65962954|FG000|Overall Study|Adverse Event|4|||
23610948|NCT01280721|65962954|FG000|Overall Study|Physician Decision|3|||
23610949|NCT01280721|65962954|FG000|Overall Study|Withdrawal by Subject|6|||
23610950|NCT01280721|65962954|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
23610951|NCT01280721|65962954|FG000|Overall Study|No tolerability for the lowest dose|2|||
23610952|NCT00753896|65962957|FG000|Overall Study|Adverse Event|4|||
23610953|NCT00753896|65962957|FG000|Overall Study|Death|1|||
23610954|NCT00753896|65962957|FG000|Overall Study|Lost to Follow-up|2|||
23610955|NCT00753896|65962957|FG000|Overall Study|Protocol Violation|1|||
23610956|NCT00753896|65962957|FG000|Overall Study|Withdrawal by Subject|4|||
23610957|NCT00753896|65962957|FG000|Overall Study|Entry Criteria Not Met|4|||
23610958|NCT01077284|65962958|FG000|Overall Study|Adverse Event|2|||
23610959|NCT01077284|65962959|FG001|Overall Study|Adverse Event|0|||
23610960|NCT01077284|65962960|FG002|Overall Study|Adverse Event|1|||
23610961|NCT01077284|65962958|FG000|Overall Study|Lost to Follow-up|1|||
23610962|NCT01077284|65962959|FG001|Overall Study|Lost to Follow-up|2|||
23610963|NCT01077284|65962960|FG002|Overall Study|Lost to Follow-up|0|||
23610964|NCT01077284|65962958|FG000|Overall Study|Withdrawal by Subject|2|||
23610965|NCT01077284|65962959|FG001|Overall Study|Withdrawal by Subject|3|||
23610966|NCT01077284|65962960|FG002|Overall Study|Withdrawal by Subject|1|||
23610967|NCT01077284|65962958|FG000|Overall Study|Other|0|||
23610968|NCT01077284|65962959|FG001|Overall Study|Other|0|||
23512245|NCT01411228|65612698|FG002|Overall Study|Lost to Follow-up|1|||
23610969|NCT01077284|65962960|FG002|Overall Study|Other|1|||
23610970|NCT04085614|65962963|FG000|Overall Study|Protocol Violation|9|||
23610971|NCT04085614|65962964|FG001|Overall Study|Protocol Violation|6|||
23610972|NCT02213094|65962971|FG000|Overall Study|Adverse Event|1|||
23710583|NCT00302718|66315436|FG000|Overall Study|Participant left primary care setting|0|||
23610973|NCT02213094|65962972|FG001|Overall Study|Adverse Event|0|||
23610974|NCT02066389|65966674|FG000|Overall Study|Adverse Event|1|||
23610975|NCT02066389|65966675|FG001|Overall Study|Adverse Event|1|||
23610976|NCT02066389|65966676|FG002|Overall Study|Adverse Event|1|||
23610977|NCT02066389|65966677|FG003|Overall Study|Adverse Event|1|||
23610978|NCT02066389|65966678|FG004|Overall Study|Adverse Event|5|||
23512246|NCT01411228|65612696|FG000|Overall Study|Withdrawal by Subject|1|||
23512247|NCT01411228|65612697|FG001|Overall Study|Withdrawal by Subject|0|||
23610979|NCT02066389|65966679|FG005|Overall Study|Adverse Event|1|||
23610980|NCT02066389|65966674|FG000|Overall Study|Withdrawal by Subject|4|||
23610981|NCT02066389|65966675|FG001|Overall Study|Withdrawal by Subject|0|||
23610982|NCT02066389|65966676|FG002|Overall Study|Withdrawal by Subject|5|||
23610983|NCT02066389|65966677|FG003|Overall Study|Withdrawal by Subject|1|||
23610984|NCT02066389|65966678|FG004|Overall Study|Withdrawal by Subject|1|||
23610985|NCT02066389|65966679|FG005|Overall Study|Withdrawal by Subject|2|||
23610986|NCT02066389|65966674|FG000|Overall Study|Lost to Follow-up|0|||
23610987|NCT02066389|65966675|FG001|Overall Study|Lost to Follow-up|0|||
23414795|NCT03941873|65260732|FG000|Overall Study|Death|0|||
23414796|NCT03941873|65260733|FG001|Overall Study|Death|12|||
23414797|NCT03941873|65260734|FG002|Overall Study|Death|2|||
23414798|NCT03941873|65260735|FG003|Overall Study|Death|53|||
23414799|NCT03941873|65260732|FG000|Overall Study|Withdrawal by Subject|1|||
23414800|NCT03941873|65260733|FG001|Overall Study|Withdrawal by Subject|1|||
23414801|NCT03941873|65260734|FG002|Overall Study|Withdrawal by Subject|0|||
23414802|NCT03941873|65260735|FG003|Overall Study|Withdrawal by Subject|5|||
23414803|NCT03941873|65260732|FG000|Overall Study|Lost to Follow-up|1|||
23414804|NCT03941873|65260733|FG001|Overall Study|Lost to Follow-up|2|||
23414805|NCT03941873|65260734|FG002|Overall Study|Lost to Follow-up|0|||
23414806|NCT03941873|65260735|FG003|Overall Study|Lost to Follow-up|0|||
23414807|NCT03941873|65260732|FG000|Overall Study|Sponsor Decision|0|||
23414808|NCT03941873|65260733|FG001|Overall Study|Sponsor Decision|6|||
23414809|NCT03941873|65260734|FG002|Overall Study|Sponsor Decision|0|||
23414810|NCT03941873|65260735|FG003|Overall Study|Sponsor Decision|15|||
23414811|NCT03062280|65260736|FG000|Overall Study|Adverse Event|1|||
23414812|NCT03062280|65260736|FG000|Overall Study|Death|1|||
23414813|NCT03062280|65260736|FG000|Overall Study|Fertility Treatment|2|||
23414814|NCT03062280|65260736|FG000|Overall Study|Physician Decision|2|||
23414815|NCT03062280|65260736|FG000|Overall Study|Pregnancy|5|||
23414816|NCT03062280|65260736|FG000|Overall Study|Withdrawal by Subject|11|||
23414817|NCT04472650|65260737|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
23414818|NCT04472650|65260738|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
23414819|NCT00937937|65260741|FG000|Overall Study|Adverse Event|6|||
23414820|NCT00937937|65260741|FG000|Overall Study|Withdrawal by Subject|2|||
23414821|NCT00937937|65260741|FG000|Overall Study|Progression/relapse|61|||
23414822|NCT00937937|65260741|FG000|Overall Study|Death|1|||
23414823|NCT00937937|65260741|FG000|Overall Study|Other|2|||
23610988|NCT02066389|65966676|FG002|Overall Study|Lost to Follow-up|0|||
23610989|NCT02066389|65966677|FG003|Overall Study|Lost to Follow-up|1|||
23610990|NCT02066389|65966678|FG004|Overall Study|Lost to Follow-up|1|||
23414827|NCT03505788|65260745|FG000|Overall Study|Lost to Follow-up|2|||
23414828|NCT03505788|65260746|FG001|Overall Study|Lost to Follow-up|1|||
23414829|NCT03505788|65260745|FG000|Overall Study|Withdrawal by Subject|1|||
23414830|NCT03505788|65260746|FG001|Overall Study|Withdrawal by Subject|3|||
23414831|NCT03505788|65260745|FG000|Overall Study|Physician Decision|0|||
23414832|NCT03505788|65260746|FG001|Overall Study|Physician Decision|1|||
23512248|NCT01411228|65612698|FG002|Overall Study|Withdrawal by Subject|0|||
23512249|NCT02598076|65612699|FG000|Overall Study|Lost to Follow-up|2|||
23512250|NCT02598076|65612700|FG001|Overall Study|Lost to Follow-up|3|||
23512251|NCT02255981|65612709|FG000|Overall Study|Lost to Follow-up|3|||
23512252|NCT02255981|65612709|FG000|Overall Study|Withdrawal by Subject|1|||
23512253|NCT01599234|65612710|FG000|Overall Study|Adverse Event|9|||
23512254|NCT01599234|65612711|FG001|Overall Study|Adverse Event|5|||
23512255|NCT01599234|65612710|FG000|Overall Study|Withdrawal by Subject|2|||
23512256|NCT01599234|65612711|FG001|Overall Study|Withdrawal by Subject|1|||
23512257|NCT01599234|65612710|FG000|Overall Study|Lost to Follow-up|1|||
23512258|NCT01599234|65612711|FG001|Overall Study|Lost to Follow-up|2|||
23512259|NCT01599234|65612710|FG000|Overall Study|Lack of Efficacy|2|||
23710584|NCT00302718|66315437|FG001|Overall Study|Participant left primary care setting|0|||
23414833|NCT03931382|65260747|FG000|Overall Study|Equipment malfunction|2|||
23414834|NCT03931382|65260748|FG001|Overall Study|Equipment malfunction|0|||
23414835|NCT03931382|65260749|FG002|Overall Study|Equipment malfunction|2|||
23414836|NCT03931382|65260747|FG000|Overall Study|Withdrawal by Subject|0|||
23414837|NCT03931382|65260748|FG001|Overall Study|Withdrawal by Subject|1|||
23414838|NCT03931382|65260749|FG002|Overall Study|Withdrawal by Subject|0|||
23414839|NCT03575065|65260750|FG000|Overall Study|Death|31|||
23414840|NCT03575065|65260751|FG001|Overall Study|Death|12|||
23414841|NCT03575065|65260750|FG000|Overall Study|Sponsor's Decision|28|||
23512260|NCT01599234|65612711|FG001|Overall Study|Lack of Efficacy|4|||
23414842|NCT03575065|65260751|FG001|Overall Study|Sponsor's Decision|13|||
23414843|NCT03575065|65260750|FG000|Overall Study|Withdrawal by Subject|2|||
23414844|NCT03575065|65260751|FG001|Overall Study|Withdrawal by Subject|1|||
23512261|NCT01599234|65612710|FG000|Overall Study|Unable to operate spray|1|||
23512262|NCT01599234|65612711|FG001|Overall Study|Unable to operate spray|0|||
23512263|NCT01599234|65612710|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
23512264|NCT01599234|65612711|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
23414845|NCT03575065|65260750|FG000|Overall Study|Lost to Follow-up|1|||
23414846|NCT03575065|65260751|FG001|Overall Study|Lost to Follow-up|0|||
23610991|NCT02066389|65966679|FG005|Overall Study|Lost to Follow-up|1|||
23414847|NCT03473743|65260754|FG000|Overall Study|Withdrawal by Subject|0|||
23414848|NCT03473743|65260755|FG001|Overall Study|Withdrawal by Subject|0|||
23414849|NCT03473743|65260756|FG002|Overall Study|Withdrawal by Subject|0|||
23414850|NCT03473743|65260757|FG003|Overall Study|Withdrawal by Subject|0|||
23414851|NCT03473743|65260758|FG004|Overall Study|Withdrawal by Subject|0|||
23414852|NCT03473743|65260759|FG005|Overall Study|Withdrawal by Subject|0|||
23414853|NCT03473743|65260760|FG006|Overall Study|Withdrawal by Subject|0|||
23414854|NCT03473743|65260761|FG007|Overall Study|Withdrawal by Subject|3|||
23414855|NCT03473743|65260754|FG000|Overall Study|Other|0|||
23414856|NCT03473743|65260755|FG001|Overall Study|Other|0|||
23414857|NCT03473743|65260756|FG002|Overall Study|Other|0|||
23414858|NCT03473743|65260757|FG003|Overall Study|Other|1|||
23414859|NCT03473743|65260758|FG004|Overall Study|Other|0|||
23414860|NCT03473743|65260759|FG005|Overall Study|Other|0|||
23414861|NCT03473743|65260760|FG006|Overall Study|Other|0|||
23414862|NCT03473743|65260761|FG007|Overall Study|Other|0|||
23414863|NCT03473743|65260754|FG000|Overall Study|Ongoing|0|||
23414864|NCT03473743|65260755|FG001|Overall Study|Ongoing|0|||
23414865|NCT03473743|65260756|FG002|Overall Study|Ongoing|6|||
23414866|NCT03473743|65260757|FG003|Overall Study|Ongoing|8|||
23414867|NCT03473743|65260758|FG004|Overall Study|Ongoing|1|||
23414868|NCT03473743|65260759|FG005|Overall Study|Ongoing|1|||
23414869|NCT03473743|65260760|FG006|Overall Study|Ongoing|22|||
23414870|NCT03473743|65260761|FG007|Overall Study|Ongoing|24|||
23512265|NCT01599234|65612710|FG000|Overall Study|Death|1|||
23512266|NCT01599234|65612711|FG001|Overall Study|Death|0|||
23512267|NCT01599234|65612710|FG000|Overall Study|Patient would not stop driving|1|||
23512268|NCT01599234|65612711|FG001|Overall Study|Patient would not stop driving|0|||
23512269|NCT01599234|65612710|FG000|Overall Study|Contra-indication discovered|0|||
23512270|NCT01599234|65612711|FG001|Overall Study|Contra-indication discovered|1|||
23512271|NCT01599234|65612710|FG000|Overall Study|Pregnancy|0|||
23710585|NCT00302718|66315438|FG002|Overall Study|Participant left primary care setting|2|||
23710586|NCT00302718|66315439|FG003|Overall Study|Participant left primary care setting|1|||
23710587|NCT02622724|66315440|FG000|Overall Study|Death|51|||
23710588|NCT02622724|66315441|FG001|Overall Study|Death|53|||
23710589|NCT02622724|66315440|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
23710590|NCT02622724|66315441|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
23710591|NCT02622724|66315440|FG000|Overall Study|Early termination of study|38|||
23710592|NCT02622724|66315441|FG001|Overall Study|Early termination of study|43|||
23710593|NCT01067508|66315442|FG000|Overall Study|Physician Decision|0|||
23710594|NCT01067508|66315443|FG001|Overall Study|Physician Decision|1|||
23710595|NCT01067508|66315442|FG000|Overall Study|Withdrawal by Subject|0|||
23710596|NCT01067508|66315443|FG001|Overall Study|Withdrawal by Subject|1|||
23414871|NCT03473743|65260754|FG000|Overall Study|Randomized but not treated|0|||
23414872|NCT03473743|65260755|FG001|Overall Study|Randomized but not treated|0|||
23414873|NCT03473743|65260756|FG002|Overall Study|Randomized but not treated|0|||
23414874|NCT03473743|65260757|FG003|Overall Study|Randomized but not treated|0|||
23414875|NCT03473743|65260758|FG004|Overall Study|Randomized but not treated|0|||
23414876|NCT03473743|65260759|FG005|Overall Study|Randomized but not treated|0|||
23512272|NCT01599234|65612711|FG001|Overall Study|Pregnancy|1|||
23512273|NCT01905657|65612712|FG000|Overall Study|Adverse Event|23|||
23512274|NCT01905657|65612713|FG001|Overall Study|Adverse Event|17|||
23512275|NCT01905657|65612714|FG002|Overall Study|Adverse Event|18|||
23512276|NCT01905657|65612712|FG000|Overall Study|Clinical Progression|103|||
23512277|NCT01905657|65612713|FG001|Overall Study|Clinical Progression|78|||
23512278|NCT01905657|65612714|FG002|Overall Study|Clinical Progression|59|||
23512279|NCT01905657|65612712|FG000|Overall Study|Death|40|||
23512280|NCT01905657|65612713|FG001|Overall Study|Death|43|||
23512281|NCT01905657|65612714|FG002|Overall Study|Death|47|||
23512282|NCT01905657|65612712|FG000|Overall Study|Excluded Medication|13|||
23512283|NCT01905657|65612713|FG001|Overall Study|Excluded Medication|16|||
23414877|NCT03473743|65260760|FG006|Overall Study|Randomized but not treated|1|||
23414878|NCT03473743|65260761|FG007|Overall Study|Randomized but not treated|1|||
23414879|NCT03994211|65260766|FG000|Core Phase|Adverse Event|0|||
23414880|NCT03994211|65260767|FG001|Core Phase|Adverse Event|1|||
23512284|NCT01905657|65612714|FG002|Overall Study|Excluded Medication|9|||
23512285|NCT01905657|65612712|FG000|Overall Study|Lost to Follow-up|1|||
23710597|NCT00786032|66315444|FG000|Overall Study|Death|4|||
23710598|NCT00786032|66315444|FG000|Overall Study|Withdrawal by Subject|14|||
23710599|NCT00786032|66315444|FG000|Overall Study|Did not complete in the timeframe|6|||
23710600|NCT01606761|66315445|FG000|Prior to Week 24|Lost to Follow-up|0|||
23710601|NCT01606761|66315446|FG001|Prior to Week 24|Lost to Follow-up|3|||
23414881|NCT03994211|65260768|FG002|Core Phase|Adverse Event|0|||
23414882|NCT03994211|65260766|FG000|Extension Phase|Adverse Event|0|||
23512286|NCT01905657|65612713|FG001|Overall Study|Lost to Follow-up|2|||
23512287|NCT01905657|65612714|FG002|Overall Study|Lost to Follow-up|1|||
23414883|NCT03994211|65260767|FG001|Extension Phase|Adverse Event|0|||
23414884|NCT03994211|65260768|FG002|Extension Phase|Adverse Event|1|||
23414885|NCT03994211|65260766|FG000|Extension Phase|Physician Decision|0|||
23512288|NCT01905657|65612712|FG000|Overall Study|Physician Decision|5|||
23414886|NCT03994211|65260767|FG001|Extension Phase|Physician Decision|0|||
23414887|NCT03994211|65260768|FG002|Extension Phase|Physician Decision|1|||
23414888|NCT03994211|65260766|FG000|Extension Phase|Progressive Disease|0|||
23414889|NCT03994211|65260767|FG001|Extension Phase|Progressive Disease|0|||
23414890|NCT03994211|65260768|FG002|Extension Phase|Progressive Disease|20|||
23414891|NCT03994211|65260766|FG000|Extension Phase|Withdrawal by Subject|0|||
23414892|NCT03994211|65260767|FG001|Extension Phase|Withdrawal by Subject|0|||
23414893|NCT03994211|65260768|FG002|Extension Phase|Withdrawal by Subject|2|||
23610992|NCT02066389|65966674|FG000|Overall Study|Randomized in Error|0|||
23610993|NCT02066389|65966675|FG001|Overall Study|Randomized in Error|0|||
23610994|NCT02066389|65966676|FG002|Overall Study|Randomized in Error|0|||
23610995|NCT02066389|65966677|FG003|Overall Study|Randomized in Error|0|||
23610996|NCT02066389|65966678|FG004|Overall Study|Randomized in Error|0|||
23610997|NCT02066389|65966679|FG005|Overall Study|Randomized in Error|1|||
23610998|NCT00472199|65966683|FG000|Overall Study|Adverse Event|19|||
23610999|NCT00472199|65966684|FG001|Overall Study|Adverse Event|23|||
23611000|NCT00472199|65966683|FG000|Overall Study|Lack of Efficacy|4|||
23611001|NCT00472199|65966684|FG001|Overall Study|Lack of Efficacy|25|||
23611002|NCT00472199|65966683|FG000|Overall Study|Lost to Follow-up|2|||
23611003|NCT00472199|65966684|FG001|Overall Study|Lost to Follow-up|4|||
23611004|NCT00472199|65966683|FG000|Overall Study|Protocol Violation|3|||
23611005|NCT00472199|65966684|FG001|Overall Study|Protocol Violation|2|||
23414908|NCT01272037|65260771|FG000|Overall Study|Death|25|||
23414909|NCT01272037|65260772|FG001|Overall Study|Death|28|||
23414910|NCT01272037|65260771|FG000|Overall Study|Adverse Event|12|||
23414911|NCT01272037|65260772|FG001|Overall Study|Adverse Event|7|||
23414912|NCT01272037|65260771|FG000|Overall Study|Withdrawal by Subject|175|||
23414913|NCT01272037|65260772|FG001|Overall Study|Withdrawal by Subject|93|||
23414914|NCT01272037|65260771|FG000|Overall Study|Disease progression|70|||
23512289|NCT01905657|65612713|FG001|Overall Study|Physician Decision|8|||
23512290|NCT01905657|65612714|FG002|Overall Study|Physician Decision|12|||
23710602|NCT01606761|66315447|FG002|Prior to Week 24|Lost to Follow-up|2|||
23710603|NCT01606761|66315448|FG003|Prior to Week 24|Lost to Follow-up|0|||
23710604|NCT01606761|66315449|FG004|Prior to Week 24|Lost to Follow-up|0|||
23710605|NCT01606761|66315445|FG000|Prior to Week 24|Withdrawal by Subject|12|||
23710606|NCT01606761|66315446|FG001|Prior to Week 24|Withdrawal by Subject|10|||
23710607|NCT01606761|66315447|FG002|Prior to Week 24|Withdrawal by Subject|9|||
23710608|NCT01606761|66315448|FG003|Prior to Week 24|Withdrawal by Subject|0|||
23710609|NCT01606761|66315449|FG004|Prior to Week 24|Withdrawal by Subject|0|||
23710610|NCT01606761|66315445|FG000|Prior to Week 24|Adverse Event|11|||
23710611|NCT01606761|66315446|FG001|Prior to Week 24|Adverse Event|18|||
23710612|NCT01606761|66315447|FG002|Prior to Week 24|Adverse Event|22|||
23710613|NCT01606761|66315448|FG003|Prior to Week 24|Adverse Event|0|||
23710614|NCT01606761|66315449|FG004|Prior to Week 24|Adverse Event|0|||
23710615|NCT01606761|66315445|FG000|Prior to Week 24|Lack of Efficacy|15|||
23710616|NCT01606761|66315446|FG001|Prior to Week 24|Lack of Efficacy|14|||
23710617|NCT01606761|66315447|FG002|Prior to Week 24|Lack of Efficacy|8|||
23710618|NCT01606761|66315448|FG003|Prior to Week 24|Lack of Efficacy|0|||
23710619|NCT01606761|66315449|FG004|Prior to Week 24|Lack of Efficacy|0|||
23710620|NCT01606761|66315445|FG000|Prior to Week 24|Physician Decision|0|||
23710621|NCT01606761|66315446|FG001|Prior to Week 24|Physician Decision|3|||
23710622|NCT01606761|66315447|FG002|Prior to Week 24|Physician Decision|1|||
23710623|NCT01606761|66315448|FG003|Prior to Week 24|Physician Decision|0|||
23710624|NCT01606761|66315449|FG004|Prior to Week 24|Physician Decision|0|||
23710625|NCT01606761|66315445|FG000|Prior to Week 24|Other|4|||
23710626|NCT01606761|66315446|FG001|Prior to Week 24|Other|7|||
23710627|NCT01606761|66315447|FG002|Prior to Week 24|Other|5|||
23710628|NCT01606761|66315448|FG003|Prior to Week 24|Other|0|||
23710629|NCT01606761|66315449|FG004|Prior to Week 24|Other|0|||
23710630|NCT01606761|66315445|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
23710631|NCT01606761|66315446|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
23710632|NCT01606761|66315447|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
23710633|NCT01606761|66315448|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
23414915|NCT01272037|65260772|FG001|Overall Study|Disease progression|111|||
23512291|NCT01905657|65612712|FG000|Overall Study|Protocol Violation|2|||
23710634|NCT01606761|66315449|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
23414916|NCT01272037|65260771|FG000|Overall Study|Other reason|42|||
23414917|NCT01272037|65260772|FG001|Overall Study|Other reason|41|||
23414918|NCT01272037|65260771|FG000|Overall Study|Delinquent data|24|||
23414919|NCT01272037|65260772|FG001|Overall Study|Delinquent data|19|||
23414920|NCT01272037|65260771|FG000|Overall Study|Reason under review|33|||
23414921|NCT01272037|65260772|FG001|Overall Study|Reason under review|29|||
23512292|NCT01905657|65612713|FG001|Overall Study|Protocol Violation|1|||
23710635|NCT01606761|66315445|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
23710636|NCT01606761|66315446|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
23710637|NCT01606761|66315447|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
23710638|NCT01606761|66315448|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
23710639|NCT01606761|66315449|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
23710640|NCT01606761|66315445|FG000|Week 24 to Week 52|Adverse Event|0|||
23710641|NCT01606761|66315446|FG001|Week 24 to Week 52|Adverse Event|11|||
23710642|NCT01606761|66315447|FG002|Week 24 to Week 52|Adverse Event|14|||
23710643|NCT01606761|66315448|FG003|Week 24 to Week 52|Adverse Event|3|||
23710644|NCT01606761|66315449|FG004|Week 24 to Week 52|Adverse Event|15|||
23710645|NCT01606761|66315445|FG000|Week 24 to Week 52|Death|0|||
23710646|NCT01606761|66315446|FG001|Week 24 to Week 52|Death|0|||
23710647|NCT01606761|66315447|FG002|Week 24 to Week 52|Death|2|||
23710648|NCT01606761|66315448|FG003|Week 24 to Week 52|Death|1|||
23710649|NCT01606761|66315449|FG004|Week 24 to Week 52|Death|0|||
23710650|NCT01606761|66315445|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
23710651|NCT01606761|66315446|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
23710652|NCT01606761|66315447|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
23710653|NCT01606761|66315448|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
23710654|NCT01606761|66315449|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
23710655|NCT01606761|66315445|FG000|Week 24 to Week 52|Physician Decision|0|||
23710656|NCT01606761|66315446|FG001|Week 24 to Week 52|Physician Decision|1|||
23710657|NCT01606761|66315447|FG002|Week 24 to Week 52|Physician Decision|1|||
23710658|NCT01606761|66315448|FG003|Week 24 to Week 52|Physician Decision|0|||
23710659|NCT01606761|66315449|FG004|Week 24 to Week 52|Physician Decision|0|||
23710660|NCT01606761|66315445|FG000|Week 24 to Week 52|Other|0|||
23414922|NCT01272037|65260771|FG000|Overall Study|On treatment|626|||
23710661|NCT01606761|66315446|FG001|Week 24 to Week 52|Other|1|||
23710662|NCT01606761|66315447|FG002|Week 24 to Week 52|Other|5|||
23710663|NCT01606761|66315448|FG003|Week 24 to Week 52|Other|2|||
23414923|NCT01272037|65260772|FG001|Overall Study|On treatment|632|||
23414924|NCT04004221|65260773|FG000|Overall Study|Death|89|||
23414925|NCT04004221|65260773|FG000|Overall Study|Withdrawal by Subject|5|||
23414926|NCT04004221|65260773|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
23414927|NCT04004221|65260773|FG000|Overall Study|Sponsor Decision|9|||
23414928|NCT04004221|65260773|FG000|Overall Study|Participant refused to enter LTE|1|||
23414929|NCT01302834|65260781|FG000|Overall Study|Protocol Violation|17|||
23414930|NCT01302834|65260782|FG001|Overall Study|Protocol Violation|23|||
23414931|NCT01302834|65260781|FG000|Overall Study|HIV positive|1|||
23414932|NCT01302834|65260782|FG001|Overall Study|HIV positive|3|||
23414933|NCT00588770|65260785|FG000|Overall Study|Disease progression|85|||
23414934|NCT00588770|65260786|FG001|Overall Study|Disease progression|68|||
23414935|NCT00588770|65260785|FG000|Overall Study|Adverse Event|29|||
23414936|NCT00588770|65260786|FG001|Overall Study|Adverse Event|58|||
23414937|NCT00588770|65260785|FG000|Overall Study|Death|13|||
23414938|NCT00588770|65260786|FG001|Overall Study|Death|22|||
23414939|NCT00588770|65260785|FG000|Overall Study|Withdrawal by Subject|15|||
23414940|NCT00588770|65260786|FG001|Overall Study|Withdrawal by Subject|25|||
23414941|NCT00588770|65260785|FG000|Overall Study|Alternative therapy|2|||
23414942|NCT00588770|65260786|FG001|Overall Study|Alternative therapy|4|||
23414943|NCT00588770|65260785|FG000|Overall Study|Other complicating disease|3|||
23414944|NCT00588770|65260786|FG001|Overall Study|Other complicating disease|2|||
23414945|NCT00588770|65260785|FG000|Overall Study|Not start protocol therapy|0|||
23414946|NCT00588770|65260786|FG001|Overall Study|Not start protocol therapy|9|||
23414947|NCT00588770|65260785|FG000|Overall Study|Lack of Efficacy|8|||
23414948|NCT00588770|65260786|FG001|Overall Study|Lack of Efficacy|10|||
23414949|NCT00588770|65260785|FG000|Overall Study|Physician discretion|2|||
23414950|NCT00588770|65260786|FG001|Overall Study|Physician discretion|0|||
23414951|NCT00588770|65260785|FG000|Overall Study|Patient non-compliance|2|||
23414952|NCT00588770|65260786|FG001|Overall Study|Patient non-compliance|2|||
23414953|NCT00324805|65260787|FG000|Overall Study|Adverse Event|62|||
23414954|NCT00324805|65260788|FG001|Overall Study|Adverse Event|203|||
23414955|NCT00324805|65260787|FG000|Overall Study|Progression|7|||
23414956|NCT00324805|65260788|FG001|Overall Study|Progression|35|||
23414957|NCT00324805|65260787|FG000|Overall Study|Withdrawal by Subject|51|||
23414958|NCT00324805|65260788|FG001|Overall Study|Withdrawal by Subject|174|||
23710664|NCT01606761|66315449|FG004|Week 24 to Week 52|Other|2|||
23414959|NCT00324805|65260787|FG000|Overall Study|Death|6|||
23414960|NCT00324805|65260788|FG001|Overall Study|Death|9|||
23414961|NCT00324805|65260787|FG000|Overall Study|Alternative therapy|4|||
23414962|NCT00324805|65260788|FG001|Overall Study|Alternative therapy|8|||
23414963|NCT00324805|65260787|FG000|Overall Study|Other complicating disease|1|||
23414964|NCT00324805|65260788|FG001|Overall Study|Other complicating disease|9|||
23414965|NCT00324805|65260787|FG000|Overall Study|Other reasons|7|||
23414966|NCT00324805|65260788|FG001|Overall Study|Other reasons|26|||
23414967|NCT00324805|65260787|FG000|Overall Study|Other|0|||
23414968|NCT00324805|65260788|FG001|Overall Study|Other|2|||
23414969|NCT00324805|65260787|FG000|Overall Study|Did not start therapy|12|||
23710665|NCT01606761|66315445|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
23710666|NCT01606761|66315446|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
23710667|NCT01606761|66315447|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
23710668|NCT01606761|66315448|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
23710669|NCT01606761|66315449|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
23414970|NCT00324805|65260788|FG001|Overall Study|Did not start therapy|17|||
23414971|NCT00569127|65260789|FG000|Overall Study|Adverse Event|57|||
23414972|NCT00569127|65260790|FG001|Overall Study|Adverse Event|47|||
23414973|NCT00569127|65260789|FG000|Overall Study|Withdrawal by Subject|13|||
23414974|NCT00569127|65260790|FG001|Overall Study|Withdrawal by Subject|27|||
23710670|NCT01606761|66315445|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
23710671|NCT01606761|66315446|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
23710672|NCT01606761|66315447|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
23710673|NCT01606761|66315448|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
23710674|NCT01606761|66315449|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
23710675|NCT01606761|66315445|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
23710676|NCT01606761|66315446|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
23710677|NCT01606761|66315447|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
23710678|NCT01606761|66315448|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
23710679|NCT01606761|66315449|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
23710680|NCT01606761|66315445|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
23710681|NCT01606761|66315446|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
23710682|NCT01606761|66315447|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
23710683|NCT01606761|66315448|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
23710684|NCT01606761|66315449|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
23710685|NCT00632541|66315450|FG000|Overall Study|Adverse Event|7|||
23710686|NCT00645567|66315456|FG000|Overall Study|Adverse Event|1|||
23710687|NCT01072539|66315461|FG000|Overall Study|Treated prior to the Site Initiation|1|||
23710688|NCT01072539|66315461|FG000|Overall Study|Protocol Violation|2|||
23710689|NCT05674344|66315462|FG000|Overall Study|Screen Fail|21|||
23710690|NCT05674344|66315462|FG000|Overall Study|Incomplete study procedures|3|||
23710691|NCT00808249|66319148|FG000|Overall Study|Adverse Event|4|||
23710692|NCT00808249|66319149|FG001|Overall Study|Adverse Event|7|||
23710693|NCT00808249|66319150|FG002|Overall Study|Adverse Event|10|||
23710694|NCT00808249|66319151|FG003|Overall Study|Adverse Event|6|||
23710695|NCT00808249|66319148|FG000|Overall Study|Lost to Follow-up|2|||
23710696|NCT00808249|66319149|FG001|Overall Study|Lost to Follow-up|3|||
23710697|NCT00808249|66319150|FG002|Overall Study|Lost to Follow-up|3|||
23414975|NCT00569127|65260789|FG000|Overall Study|Progression|99|||
23414976|NCT00569127|65260790|FG001|Overall Study|Progression|100|||
23414977|NCT00569127|65260789|FG000|Overall Study|Death|4|||
23414978|NCT00569127|65260790|FG001|Overall Study|Death|3|||
23414979|NCT00569127|65260789|FG000|Overall Study|Other|20|||
23414980|NCT00569127|65260790|FG001|Overall Study|Other|19|||
23414981|NCT00569127|65260789|FG000|Overall Study|Lost to Follow-up|0|||
23414982|NCT00569127|65260790|FG001|Overall Study|Lost to Follow-up|3|||
23414983|NCT00569127|65260789|FG000|Overall Study|Not Eligible|14|||
23414984|NCT00569127|65260790|FG001|Overall Study|Not Eligible|11|||
23414985|NCT00569127|65260789|FG000|Overall Study|Still on Treatment|7|||
23414986|NCT00569127|65260790|FG001|Overall Study|Still on Treatment|3|||
23611006|NCT00472199|65966683|FG000|Overall Study|Withdrawal by Subject|6|||
23611007|NCT00472199|65966684|FG001|Overall Study|Withdrawal by Subject|5|||
23611008|NCT00472199|65966683|FG000|Overall Study|personal reason|0|||
23611009|NCT00472199|65966684|FG001|Overall Study|personal reason|1|||
23611010|NCT00472199|65966683|FG000|Overall Study|patient was asymptomatic|1|||
23611011|NCT00472199|65966684|FG001|Overall Study|patient was asymptomatic|0|||
23611012|NCT02268526|65966685|FG000|Overall Study|Adverse Event|0|||
23611013|NCT02268526|65966686|FG001|Overall Study|Adverse Event|2|||
23611014|NCT02268526|65966687|FG002|Overall Study|Adverse Event|1|||
23611015|NCT02268526|65966685|FG000|Overall Study|Death|1|||
23611016|NCT02268526|65966686|FG001|Overall Study|Death|11|||
23611017|NCT02268526|65966687|FG002|Overall Study|Death|0|||
23611018|NCT02268526|65966685|FG000|Overall Study|protocol deviation|0|||
23611019|NCT02268526|65966686|FG001|Overall Study|protocol deviation|1|||
23611020|NCT02268526|65966687|FG002|Overall Study|protocol deviation|0|||
23611021|NCT02268526|65966685|FG000|Overall Study|Physician Decision|0|||
23611022|NCT02268526|65966686|FG001|Overall Study|Physician Decision|0|||
23611023|NCT02268526|65966687|FG002|Overall Study|Physician Decision|1|||
23611024|NCT02268526|65966685|FG000|Overall Study|Subject/guardian decision|0|||
23512293|NCT01905657|65612714|FG002|Overall Study|Protocol Violation|1|||
23710698|NCT00808249|66319151|FG003|Overall Study|Lost to Follow-up|5|||
23710699|NCT00808249|66319148|FG000|Overall Study|Withdrawal by Subject|4|||
23611025|NCT02268526|65966686|FG001|Overall Study|Subject/guardian decision|7|||
23611026|NCT02268526|65966687|FG002|Overall Study|Subject/guardian decision|3|||
23611027|NCT00555620|65966688|FG000|Overall Study|Death|0|||
23611028|NCT00555620|65966689|FG001|Overall Study|Death|1|||
23611029|NCT00555620|65966690|FG002|Overall Study|Death|0|||
23611030|NCT00555620|65966691|FG003|Overall Study|Death|0|||
23512294|NCT01905657|65612712|FG000|Overall Study|Screen Failure|0|||
23611031|NCT00555620|65966692|FG004|Overall Study|Death|0|||
23611032|NCT00555620|65966693|FG005|Overall Study|Death|1|||
23611033|NCT00555620|65966688|FG000|Overall Study|Study terminated by sponsor|0|||
23710700|NCT00808249|66319149|FG001|Overall Study|Withdrawal by Subject|0|||
23710701|NCT00808249|66319150|FG002|Overall Study|Withdrawal by Subject|2|||
23710702|NCT00808249|66319151|FG003|Overall Study|Withdrawal by Subject|4|||
23710703|NCT00808249|66319148|FG000|Overall Study|Protocol Violation|3|||
23710704|NCT00808249|66319149|FG001|Overall Study|Protocol Violation|3|||
23710705|NCT00808249|66319150|FG002|Overall Study|Protocol Violation|3|||
23710706|NCT00808249|66319151|FG003|Overall Study|Protocol Violation|0|||
23710707|NCT00808249|66319148|FG000|Overall Study|Lack of Efficacy|1|||
23710708|NCT00808249|66319149|FG001|Overall Study|Lack of Efficacy|1|||
23710709|NCT00808249|66319150|FG002|Overall Study|Lack of Efficacy|0|||
23710710|NCT00808249|66319151|FG003|Overall Study|Lack of Efficacy|0|||
23710711|NCT00808249|66319148|FG000|Overall Study|study specific discontinuation criteria|1|||
23611034|NCT00555620|65966689|FG001|Overall Study|Study terminated by sponsor|0|||
23611035|NCT00555620|65966690|FG002|Overall Study|Study terminated by sponsor|1|||
23611036|NCT00555620|65966691|FG003|Overall Study|Study terminated by sponsor|0|||
23611037|NCT00555620|65966692|FG004|Overall Study|Study terminated by sponsor|0|||
23611038|NCT00555620|65966693|FG005|Overall Study|Study terminated by sponsor|0|||
23611039|NCT00555620|65966688|FG000|Overall Study|Adverse Event|0|||
23611040|NCT00555620|65966689|FG001|Overall Study|Adverse Event|0|||
23611041|NCT00555620|65966690|FG002|Overall Study|Adverse Event|1|||
23611042|NCT00555620|65966691|FG003|Overall Study|Adverse Event|5|||
23611043|NCT00555620|65966692|FG004|Overall Study|Adverse Event|0|||
23611044|NCT00555620|65966693|FG005|Overall Study|Adverse Event|1|||
23611045|NCT00555620|65966688|FG000|Overall Study|Objective progression or relapse|6|||
23611046|NCT00555620|65966689|FG001|Overall Study|Objective progression or relapse|5|||
23611047|NCT00555620|65966690|FG002|Overall Study|Objective progression or relapse|12|||
23611048|NCT00555620|65966691|FG003|Overall Study|Objective progression or relapse|17|||
23611049|NCT00555620|65966692|FG004|Overall Study|Objective progression or relapse|3|||
23611050|NCT00555620|65966693|FG005|Overall Study|Objective progression or relapse|16|||
23611051|NCT00555620|65966688|FG000|Overall Study|Participant refused treatment|0|||
23611052|NCT00555620|65966689|FG001|Overall Study|Participant refused treatment|1|||
23611053|NCT00555620|65966690|FG002|Overall Study|Participant refused treatment|1|||
23611054|NCT00555620|65966691|FG003|Overall Study|Participant refused treatment|0|||
23611055|NCT00555620|65966692|FG004|Overall Study|Participant refused treatment|0|||
23611056|NCT00555620|65966693|FG005|Overall Study|Participant refused treatment|1|||
23611057|NCT00555620|65966688|FG000|Overall Study|Other|0|||
23611058|NCT00555620|65966689|FG001|Overall Study|Other|0|||
23611059|NCT00555620|65966690|FG002|Overall Study|Other|0|||
23611060|NCT00555620|65966691|FG003|Overall Study|Other|1|||
23611061|NCT00555620|65966692|FG004|Overall Study|Other|0|||
23611062|NCT00555620|65966693|FG005|Overall Study|Other|3|||
23611063|NCT01825785|65966698|FG000|Overall Study|Adverse Event|0|||
23611064|NCT01825785|65966699|FG001|Overall Study|Adverse Event|0|||
23611065|NCT01825785|65966700|FG002|Overall Study|Adverse Event|0|||
23611066|NCT01825785|65966701|FG003|Overall Study|Adverse Event|0|||
23611067|NCT01825785|65966702|FG004|Overall Study|Adverse Event|1|||
23611068|NCT01825785|65966703|FG005|Overall Study|Adverse Event|0|||
23611069|NCT01825785|65966704|FG006|Overall Study|Adverse Event|0|||
23611070|NCT01825785|65966698|FG000|Overall Study|Withdrawal by Subject|0|||
23611071|NCT01825785|65966699|FG001|Overall Study|Withdrawal by Subject|0|||
23611072|NCT01825785|65966700|FG002|Overall Study|Withdrawal by Subject|0|||
23611073|NCT01825785|65966701|FG003|Overall Study|Withdrawal by Subject|0|||
23611074|NCT01825785|65966702|FG004|Overall Study|Withdrawal by Subject|1|||
23611075|NCT01825785|65966703|FG005|Overall Study|Withdrawal by Subject|1|||
23611076|NCT01825785|65966704|FG006|Overall Study|Withdrawal by Subject|0|||
23611077|NCT00668746|65966705|FG000|Overall Study|Lost to Follow-up|2|||
23611078|NCT00668746|65966706|FG001|Overall Study|Lost to Follow-up|1|||
23611079|NCT03436797|65966709|FG000|Main Study|Withdrawal by Subject|2|||
23611080|NCT03436797|65966709|FG000|Main Study|Adverse Event|4|||
23611081|NCT03436797|65966709|FG000|Main Study|Lost to Follow-up|1|||
23611082|NCT03436797|65966709|FG000|Main Study|Death|1|||
23611083|NCT03436797|65966709|FG000|Main Study|Non-Specific|2|||
23611084|NCT03436797|65966709|FG000|Extended Dosing|Patient decision|1|||
23611085|NCT03020914|65966710|FG000|Overall Study|Surgery Cancelled|1|||
23611086|NCT03020914|65966711|FG001|Overall Study|Surgery Cancelled|0|||
23611087|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611088|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611089|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23611090|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611091|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611092|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611093|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611094|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611095|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23710712|NCT00808249|66319149|FG001|Overall Study|study specific discontinuation criteria|0|||
23710713|NCT00808249|66319150|FG002|Overall Study|study specific discontinuation criteria|1|||
23710714|NCT00808249|66319151|FG003|Overall Study|study specific discontinuation criteria|0|||
23710715|NCT00808249|66319148|FG000|Overall Study|All other reasons|2|||
23710716|NCT00808249|66319149|FG001|Overall Study|All other reasons|1|||
23710717|NCT00808249|66319150|FG002|Overall Study|All other reasons|3|||
23710718|NCT00808249|66319151|FG003|Overall Study|All other reasons|1|||
23611096|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611097|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611098|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23512295|NCT01905657|65612713|FG001|Overall Study|Screen Failure|1|||
23512296|NCT01905657|65612714|FG002|Overall Study|Screen Failure|0|||
23512297|NCT01905657|65612712|FG000|Overall Study|Withdrawal by Subject|15|||
23512298|NCT01905657|65612713|FG001|Overall Study|Withdrawal by Subject|21|||
23512299|NCT01905657|65612714|FG002|Overall Study|Withdrawal by Subject|53|||
23512300|NCT01905657|65612712|FG000|Overall Study|Sponsor Decision|1|||
23512301|NCT01905657|65612713|FG001|Overall Study|Sponsor Decision|0|||
23512302|NCT01905657|65612714|FG002|Overall Study|Sponsor Decision|0|||
23512303|NCT05035550|65612715|FG000|Overall Study|Withdrawal by Subject|3|||
23512304|NCT05035550|65612716|FG001|Overall Study|Withdrawal by Subject|0|||
23512305|NCT03414424|65612721|FG000|Overall Study|Screened out after consent|0|||
23512306|NCT03414424|65612722|FG001|Overall Study|Screened out after consent|2|||
23512307|NCT03414424|65612721|FG000|Overall Study|Lost to Follow-up|0|||
23512308|NCT03414424|65612722|FG001|Overall Study|Lost to Follow-up|1|||
23710719|NCT04507867|66319160|FG000|Overall Study|Death|7|||
23611099|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611100|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611101|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611102|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611103|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611104|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611105|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611106|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611107|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611108|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611109|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611110|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611111|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611112|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23512309|NCT04501666|65612723|FG000|Overall Study|Physician Decision|0|||
23512310|NCT04501666|65612724|FG001|Overall Study|Physician Decision|1|||
23512311|NCT04501666|65612723|FG000|Overall Study|Adverse Event|12|||
23512312|NCT04501666|65612724|FG001|Overall Study|Adverse Event|4|||
23512313|NCT04501666|65612723|FG000|Overall Study|Subject's request|10|||
23512314|NCT04501666|65612724|FG001|Overall Study|Subject's request|6|||
23512315|NCT04501666|65612723|FG000|Overall Study|Protocol Deviation|2|||
23512316|NCT04501666|65612724|FG001|Overall Study|Protocol Deviation|1|||
23512317|NCT04501666|65612723|FG000|Overall Study|Other-- site permanently closing|0|||
23512318|NCT04501666|65612724|FG001|Overall Study|Other-- site permanently closing|1|||
23512319|NCT02730455|65612725|FG000|Overall Study|Death|5|||
23512320|NCT02730455|65612726|FG001|Overall Study|Death|6|||
23512321|NCT02730455|65612727|FG002|Overall Study|Death|4|||
23512322|NCT02730455|65612725|FG000|Overall Study|Consent withdrawn|2|||
23512323|NCT02730455|65612726|FG001|Overall Study|Consent withdrawn|4|||
23512324|NCT02730455|65612727|FG002|Overall Study|Consent withdrawn|1|||
23512325|NCT02730455|65612725|FG000|Overall Study|Lost to Follow-up|3|||
23512326|NCT02730455|65612726|FG001|Overall Study|Lost to Follow-up|1|||
23512327|NCT02730455|65612727|FG002|Overall Study|Lost to Follow-up|4|||
23512328|NCT02730455|65612725|FG000|Overall Study|Other|1|||
23512329|NCT02730455|65612726|FG001|Overall Study|Other|1|||
23512330|NCT02730455|65612727|FG002|Overall Study|Other|2|||
23512331|NCT02730455|65612725|FG000|Overall Study|Other|2|||
23512332|NCT02730455|65612726|FG001|Overall Study|Other|2|||
23512333|NCT02730455|65612727|FG002|Overall Study|Other|0|||
23512334|NCT03336333|65612728|FG000|Overall Study|Remained on study at time of data cut-off|202|||
23512335|NCT03336333|65612729|FG001|Overall Study|Remained on study at time of data cut-off|219|||
23512336|NCT03336333|65612730|FG002|Overall Study|Remained on study at time of data cut-off|102|||
23512337|NCT03336333|65612728|FG000|Overall Study|Death|14|||
23512338|NCT03336333|65612729|FG001|Overall Study|Death|16|||
23512339|NCT03336333|65612730|FG002|Overall Study|Death|8|||
23512340|NCT03336333|65612728|FG000|Overall Study|Withdrawal by Subject|16|||
23512341|NCT03336333|65612729|FG001|Overall Study|Withdrawal by Subject|5|||
23611113|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23512342|NCT03336333|65612730|FG002|Overall Study|Withdrawal by Subject|1|||
23512343|NCT03336333|65612728|FG000|Overall Study|Physician Decision|5|||
23512344|NCT03336333|65612729|FG001|Overall Study|Physician Decision|1|||
23611114|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611115|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611116|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611117|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611118|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611119|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611120|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611121|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611122|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
23611123|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611124|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611125|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611126|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611127|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611128|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611129|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611130|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611131|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23710720|NCT04507867|66319161|FG001|Overall Study|Death|1|||
23415055|NCT04659174|65260803|FG000|Overall Study|Sponsor decision to discontinue study|0|||
23415056|NCT04659174|65260804|FG001|Overall Study|Sponsor decision to discontinue study|2|||
23415057|NCT04659174|65260803|FG000|Overall Study|Lost to Follow-up|9|||
23415058|NCT04659174|65260804|FG001|Overall Study|Lost to Follow-up|11|||
23415059|NCT04659174|65260803|FG000|Overall Study|Adverse Event|8|||
23415060|NCT04659174|65260804|FG001|Overall Study|Adverse Event|5|||
23415061|NCT04659174|65260803|FG000|Overall Study|Withdrawal by Subject|17|||
23415062|NCT04659174|65260804|FG001|Overall Study|Withdrawal by Subject|33|||
23415063|NCT04659174|65260803|FG000|Overall Study|Progressive disease|0|||
23415064|NCT04659174|65260804|FG001|Overall Study|Progressive disease|2|||
23415065|NCT04659174|65260803|FG000|Overall Study|Other reasons|0|||
23512345|NCT03336333|65612730|FG002|Overall Study|Physician Decision|0|||
23512346|NCT03336333|65612728|FG000|Overall Study|Lost to Follow-up|1|||
23512347|NCT03336333|65612729|FG001|Overall Study|Lost to Follow-up|0|||
23512348|NCT03336333|65612730|FG002|Overall Study|Lost to Follow-up|0|||
23512349|NCT00662363|65612731|FG000|Overall Study|Withdrawal by Subject|6|||
23512350|NCT00662363|65612732|FG001|Overall Study|Withdrawal by Subject|5|||
23512351|NCT00662363|65612731|FG000|Overall Study|Adverse Event|0|||
23512352|NCT00662363|65612732|FG001|Overall Study|Adverse Event|3|||
23512353|NCT00662363|65612731|FG000|Overall Study|Discharged early from rehab|4|||
23512354|NCT00662363|65612732|FG001|Overall Study|Discharged early from rehab|1|||
23512355|NCT00662363|65612731|FG000|Overall Study|Protocol Violation|1|||
23512356|NCT00662363|65612732|FG001|Overall Study|Protocol Violation|1|||
23512357|NCT05620563|65612733|FG000|Overall Study|Adverse Event|3|||
23512358|NCT05620563|65612734|FG001|Overall Study|Adverse Event|1|||
23512359|NCT05620563|65612733|FG000|Overall Study|Lost to Follow-up|0|||
23512360|NCT05620563|65612734|FG001|Overall Study|Lost to Follow-up|2|||
23512361|NCT05620563|65612733|FG000|Overall Study|Protocol Deviation|1|||
23512362|NCT05620563|65612734|FG001|Overall Study|Protocol Deviation|2|||
23512363|NCT05620563|65612733|FG000|Overall Study|Withdrawal by Subject|3|||
23512364|NCT05620563|65612734|FG001|Overall Study|Withdrawal by Subject|3|||
23512365|NCT05620563|65612733|FG000|Overall Study|Physician Decision|0|||
23512366|NCT05620563|65612734|FG001|Overall Study|Physician Decision|1|||
23512367|NCT00865124|65612739|FG000|Overall Study|Physician Decision|2|||
23512368|NCT00865124|65612740|FG001|Overall Study|Physician Decision|1|||
23512369|NCT00865124|65612741|FG002|Overall Study|Physician Decision|0|||
23415066|NCT04659174|65260804|FG001|Overall Study|Other reasons|2|||
23415067|NCT04659174|65260803|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
23415068|NCT04659174|65260804|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
23415069|NCT04659174|65260803|FG000|Overall Study|Alcohol or illegal drug use|0|||
23512370|NCT00865124|65612739|FG000|Overall Study|Withdrawn consent|2|||
23512371|NCT00865124|65612740|FG001|Overall Study|Withdrawn consent|0|||
23512372|NCT00865124|65612741|FG002|Overall Study|Withdrawn consent|0|||
23512373|NCT01806545|65612742|FG000|Overall Study|Adverse Event|2|||
23415070|NCT04659174|65260804|FG001|Overall Study|Alcohol or illegal drug use|3|||
23415071|NCT04659174|65260803|FG000|Overall Study|Violation of entry criteria|1|||
23415072|NCT04659174|65260804|FG001|Overall Study|Violation of entry criteria|0|||
23415073|NCT04659174|65260803|FG000|Overall Study|Death|0|||
23415074|NCT04659174|65260804|FG001|Overall Study|Death|1|||
23710721|NCT03970395|66319162|FG000|Overall Study|Withdrawal by Subject|3|||
23415075|NCT04238481|65260809|FG000|Overall Study|Miscellaneous|0|||
23512374|NCT01806545|65612743|FG001|Overall Study|Adverse Event|3|||
23512375|NCT01806545|65612742|FG000|Overall Study|Lost to Follow-up|1|||
23512376|NCT01806545|65612743|FG001|Overall Study|Lost to Follow-up|0|||
23512377|NCT01806545|65612742|FG000|Overall Study|Withdrawal by Subject|3|||
23512378|NCT01806545|65612743|FG001|Overall Study|Withdrawal by Subject|2|||
23512379|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23415076|NCT04238481|65260810|FG001|Overall Study|Miscellaneous|1|||
23415077|NCT04238481|65260811|FG002|Overall Study|Miscellaneous|0|||
23415078|NCT04238481|65260812|FG003|Overall Study|Miscellaneous|0|||
23415079|NCT03462719|65260813|FG000|Overall Study|Withdrawal by Subject|4|||
23415080|NCT03462719|65260814|FG001|Overall Study|Withdrawal by Subject|3|||
23415081|NCT03462719|65260813|FG000|Overall Study|Ongoing|87|||
23415082|NCT03462719|65260814|FG001|Overall Study|Ongoing|72|||
23415083|NCT03006848|65260815|FG000|Overall Study|Adverse Event|1|||
23415084|NCT03006848|65260815|FG000|Overall Study|Physician Decision|1|||
23415085|NCT03006848|65260815|FG000|Overall Study|Lack of Efficacy|16|||
23415086|NCT03783442|65260816|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
23415087|NCT03783442|65260817|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
23415088|NCT03783442|65260816|FG000|Overall Study|Death|196|||
23415089|NCT03783442|65260817|FG001|Overall Study|Death|226|||
23415090|NCT03783442|65260816|FG000|Overall Study|Withdrawal by Subject|14|||
23415091|NCT03783442|65260817|FG001|Overall Study|Withdrawal by Subject|17|||
23415092|NCT03783442|65260816|FG000|Overall Study|Lost to Follow-up|2|||
23415093|NCT03783442|65260817|FG001|Overall Study|Lost to Follow-up|3|||
23415094|NCT01932372|65260820|FG000|Overall Study|Not meeting eligibility criteria|33|||
23415095|NCT01932372|65260821|FG001|Overall Study|Not meeting eligibility criteria|179|||
23415096|NCT05145322|65260822|FG000|Overall Study|Lost to Follow-up|4|||
23415097|NCT05145322|65260823|FG001|Overall Study|Lost to Follow-up|5|||
23611132|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611133|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
23611134|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611135|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611136|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611137|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611138|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611139|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611140|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611141|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611142|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
23611143|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611144|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611145|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415112|NCT04382586|65260826|FG000|Overall Study|Death|3|||
23415113|NCT04382586|65260827|FG001|Overall Study|Death|4|||
23415114|NCT04382586|65260826|FG000|Overall Study|Lost to Follow-up|11|||
23415115|NCT04382586|65260827|FG001|Overall Study|Lost to Follow-up|8|||
23415116|NCT04382586|65260826|FG000|Overall Study|Withdrawal by Subject|3|||
23415117|NCT04382586|65260827|FG001|Overall Study|Withdrawal by Subject|1|||
23415118|NCT04382586|65260826|FG000|Overall Study|Physician Decision|0|||
23415119|NCT04382586|65260827|FG001|Overall Study|Physician Decision|3|||
23415120|NCT04532294|65260828|FG000|Overall Study|Withdrawal by Subject|0|||
23415121|NCT04532294|65260829|FG001|Overall Study|Withdrawal by Subject|0|||
23415122|NCT04532294|65260830|FG002|Overall Study|Withdrawal by Subject|1|||
23415123|NCT04532294|65260828|FG000|Overall Study|Participants Not Dosed|0|||
23415124|NCT04532294|65260829|FG001|Overall Study|Participants Not Dosed|0|||
23415125|NCT04532294|65260830|FG002|Overall Study|Participants Not Dosed|2|||
23611146|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611147|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611148|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611149|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23710722|NCT03970395|66319163|FG001|Overall Study|Withdrawal by Subject|4|||
23710723|NCT03970395|66319162|FG000|Overall Study|Lost to Follow-up|4|||
23710724|NCT03970395|66319163|FG001|Overall Study|Lost to Follow-up|8|||
23710725|NCT01069523|66319164|FG000|Overall Study|Withdrawal by Subject|4|||
23710726|NCT01069523|66319165|FG001|Overall Study|Withdrawal by Subject|7|||
23710727|NCT00701727|66319166|FG000|First Treatment Period|Adverse Event|0|||
23710728|NCT00701727|66319167|FG001|First Treatment Period|Adverse Event|0|||
23710729|NCT00701727|66319166|FG000|First Treatment Period|Withdrawal by Subject|1|||
23415132|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
23415133|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
23415134|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
23415135|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
23415136|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
23415137|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
23415138|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Death|1|||
23415139|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Death|4|||
23415140|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
23415141|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
23710730|NCT00701727|66319167|FG001|First Treatment Period|Withdrawal by Subject|0|||
23710731|NCT00701727|66319166|FG000|First Treatment Period|sponsor decision|0|||
23710732|NCT00701727|66319167|FG001|First Treatment Period|sponsor decision|1|||
23710733|NCT00701727|66319166|FG000|First Treatment Period|Lost to Follow-up|0|||
23710734|NCT00701727|66319167|FG001|First Treatment Period|Lost to Follow-up|1|||
23710735|NCT00701727|66319166|FG000|Second Treatment Period|Withdrawal by Subject|2|||
23710736|NCT00701727|66319167|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23710737|NCT01702363|66319168|FG000|Overall Study|Adverse Event|14|||
23710738|NCT01702363|66319168|FG000|Overall Study|Lack of Efficacy|4|||
23710739|NCT01702363|66319168|FG000|Overall Study|Withdrawal by Subject|2|||
23710740|NCT01357915|66319169|FG000|Overall Study|Lost to Follow-up|3|||
23710741|NCT01357915|66319170|FG001|Overall Study|Lost to Follow-up|0|||
23710742|NCT01875367|66319171|FG000|Overall Study|Not complete at least 2 questionaries|4|||
23710743|NCT01875367|66319172|FG001|Overall Study|Not complete at least 2 questionaries|2|||
23710744|NCT01875367|66319171|FG000|Overall Study|Not receive study treatment|1|||
23710745|NCT01875367|66319172|FG001|Overall Study|Not receive study treatment|0|||
23710746|NCT00171314|66319173|FG000|Overall Study|Adverse Event|44|||
23710747|NCT00171314|66319174|FG001|Overall Study|Adverse Event|41|||
23710748|NCT00171314|66319173|FG000|Overall Study|Lack of Efficacy|19|||
23710749|NCT00171314|66319174|FG001|Overall Study|Lack of Efficacy|14|||
23710750|NCT00171314|66319173|FG000|Overall Study|Withdrawal by Subject|9|||
23710751|NCT00171314|66319174|FG001|Overall Study|Withdrawal by Subject|6|||
23710752|NCT00171314|66319173|FG000|Overall Study|Abnormal Test Procedure Results|9|||
23710753|NCT00171314|66319174|FG001|Overall Study|Abnormal Test Procedure Results|3|||
23710754|NCT00171314|66319173|FG000|Overall Study|Protocol Violation|3|||
23710755|NCT00171314|66319174|FG001|Overall Study|Protocol Violation|7|||
23710756|NCT00171314|66319173|FG000|Overall Study|Administrative Problems|4|||
23710757|NCT00171314|66319174|FG001|Overall Study|Administrative Problems|3|||
23710758|NCT00171314|66319173|FG000|Overall Study|Lost to Follow-up|1|||
23710759|NCT00171314|66319174|FG001|Overall Study|Lost to Follow-up|3|||
23710760|NCT00171314|66319173|FG000|Overall Study|Death|2|||
23710761|NCT00171314|66319174|FG001|Overall Study|Death|1|||
23710762|NCT04465396|66319182|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
23710763|NCT04465396|66319183|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
23710764|NCT04465396|66319184|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
23710765|NCT04465396|66319185|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
23710766|NCT01000727|66319186|FG000|Overall Study|Lost to Follow-up|41|||
23710767|NCT01000727|66319187|FG001|Overall Study|Lost to Follow-up|43|||
23710768|NCT01000727|66319186|FG000|Overall Study|Withdrawal by Subject|111|||
23710769|NCT01000727|66319187|FG001|Overall Study|Withdrawal by Subject|109|||
23710770|NCT01000727|66319186|FG000|Overall Study|Study closed/terminated|23|||
23710771|NCT01000727|66319187|FG001|Overall Study|Study closed/terminated|24|||
23710772|NCT01626352|66319188|FG000|Overall Study|Disease Progression|3|||
23710773|NCT01626352|66319188|FG000|Overall Study|Intercurrent Illness|2|||
23710774|NCT01626352|66319188|FG000|Overall Study|Death|2|||
23710775|NCT01626352|66319188|FG000|Overall Study|Withdrawal by Subject|1|||
23710776|NCT01626352|66319188|FG000|Overall Study|Non-Compliance|1|||
23710777|NCT01626352|66319188|FG000|Overall Study|Never Treated|1|||
23710778|NCT00262080|66319189|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
23415142|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Not eligible|1|||
23415143|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Not eligible|2|||
23415144|NCT00658814|65260844|FG000|Consolidation Therapy|Not protocol specified|0|||
23415145|NCT00658814|65260845|FG001|Consolidation Therapy|Not protocol specified|1|||
23415146|NCT00658814|65260844|FG000|Consolidation Therapy|Not eligible|2|||
23415147|NCT00658814|65260845|FG001|Consolidation Therapy|Not eligible|2|||
23415148|NCT00658814|65260844|FG000|Maintenance Therapy|Adverse Event|1|||
23415149|NCT00658814|65260845|FG001|Maintenance Therapy|Adverse Event|1|||
23415150|NCT00658814|65260844|FG000|Maintenance Therapy|Not protocol specified|1|||
23415151|NCT00658814|65260845|FG001|Maintenance Therapy|Not protocol specified|0|||
23415152|NCT00658814|65260844|FG000|Maintenance Therapy|Not eligible|1|||
23415153|NCT00658814|65260845|FG001|Maintenance Therapy|Not eligible|0|||
23415154|NCT00769379|65260846|FG000|Overall Study|No follow up data mapped to Other.|3|||
23415155|NCT00769379|65260847|FG001|Overall Study|No follow up data mapped to Other.|13|||
23415156|NCT02265536|65260848|FG000|Overall Study|Adverse Event|1|||
23415157|NCT02265536|65260849|FG001|Overall Study|Adverse Event|0|||
23710779|NCT00262080|66319190|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23710780|NCT00262080|66319191|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
23710781|NCT00262080|66319189|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
23710782|NCT00262080|66319190|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
23710783|NCT00262080|66319191|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
23415158|NCT02265536|65260850|FG002|Overall Study|Adverse Event|0|||
23415159|NCT02265536|65260851|FG003|Overall Study|Adverse Event|0|||
23710784|NCT00262080|66319189|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
23710785|NCT00262080|66319190|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
23710786|NCT00262080|66319191|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
23415160|NCT02265536|65260852|FG004|Overall Study|Adverse Event|1|||
23415161|NCT02265536|65260853|FG005|Overall Study|Adverse Event|0|||
23415162|NCT02265536|65260848|FG000|Overall Study|Physician Decision|0|||
23415163|NCT02265536|65260849|FG001|Overall Study|Physician Decision|0|||
23415164|NCT02265536|65260850|FG002|Overall Study|Physician Decision|0|||
23415165|NCT02265536|65260851|FG003|Overall Study|Physician Decision|0|||
23415166|NCT02265536|65260852|FG004|Overall Study|Physician Decision|2|||
23415167|NCT02265536|65260853|FG005|Overall Study|Physician Decision|0|||
23415168|NCT02265536|65260848|FG000|Overall Study|Withdrawal by Subject|0|||
23415169|NCT02265536|65260849|FG001|Overall Study|Withdrawal by Subject|3|||
23415170|NCT02265536|65260850|FG002|Overall Study|Withdrawal by Subject|0|||
23415171|NCT02265536|65260851|FG003|Overall Study|Withdrawal by Subject|0|||
23415172|NCT02265536|65260852|FG004|Overall Study|Withdrawal by Subject|0|||
23415173|NCT02265536|65260853|FG005|Overall Study|Withdrawal by Subject|0|||
23415174|NCT03562975|65260863|FG000|Overall Study|Death|1|||
23415175|NCT03562975|65260863|FG000|Overall Study|Lost to Follow-up|1|||
23415176|NCT03562975|65260863|FG000|Overall Study|Withdrawal by Subject|1|||
23415177|NCT02470585|65260864|FG000|Overall Study|Death|224|||
23415178|NCT02470585|65260865|FG001|Overall Study|Death|227|||
23415179|NCT02470585|65260866|FG002|Overall Study|Death|199|||
23415180|NCT02470585|65260864|FG000|Overall Study|Withdrew consent|21|||
23415181|NCT02470585|65260865|FG001|Overall Study|Withdrew consent|22|||
23415182|NCT02470585|65260866|FG002|Overall Study|Withdrew consent|31|||
23415183|NCT02470585|65260864|FG000|Overall Study|Lost to Follow-up|8|||
23415184|NCT02470585|65260865|FG001|Overall Study|Lost to Follow-up|15|||
23415185|NCT02470585|65260866|FG002|Overall Study|Lost to Follow-up|13|||
23415186|NCT02470585|65260864|FG000|Overall Study|Sponsor discontinued study|117|||
23415187|NCT02470585|65260865|FG001|Overall Study|Sponsor discontinued study|110|||
23415188|NCT02470585|65260866|FG002|Overall Study|Sponsor discontinued study|122|||
23415189|NCT02470585|65260864|FG000|Overall Study|Other, not specified|5|||
23415190|NCT02470585|65260865|FG001|Overall Study|Other, not specified|7|||
23415191|NCT02470585|65260866|FG002|Overall Study|Other, not specified|14|||
23415192|NCT02470585|65260864|FG000|Overall Study|Missing due to site non-compliance|0|||
23415193|NCT02470585|65260865|FG001|Overall Study|Missing due to site non-compliance|2|||
23415194|NCT02470585|65260866|FG002|Overall Study|Missing due to site non-compliance|3|||
23415195|NCT01096368|65260876|FG000|Overall Study|Death|0|||
23415196|NCT01096368|65260877|FG001|Overall Study|Death|1|||
23512380|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512381|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512382|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512383|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512384|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512385|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
23512386|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512387|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512388|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512389|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512390|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512391|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512392|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
23512393|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512394|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512395|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512396|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512397|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512398|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512399|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
23512400|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512401|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512402|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512403|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23415197|NCT01096368|65260878|FG002|Overall Study|Death|0|||
23415198|NCT01096368|65260879|FG003|Overall Study|Death|0|||
23415199|NCT01096368|65260880|FG004|Overall Study|Death|0|||
23415200|NCT01096368|65260876|FG000|Overall Study|Physician Decision|0|||
23415201|NCT01096368|65260877|FG001|Overall Study|Physician Decision|13|||
23415202|NCT01096368|65260878|FG002|Overall Study|Physician Decision|2|||
23415203|NCT01096368|65260879|FG003|Overall Study|Physician Decision|4|||
23415204|NCT01096368|65260880|FG004|Overall Study|Physician Decision|6|||
23415205|NCT01096368|65260876|FG000|Overall Study|Withdrawal by Subject|0|||
23415206|NCT01096368|65260877|FG001|Overall Study|Withdrawal by Subject|52|||
23415207|NCT01096368|65260878|FG002|Overall Study|Withdrawal by Subject|0|||
23512404|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512405|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23415208|NCT01096368|65260879|FG003|Overall Study|Withdrawal by Subject|10|||
23512406|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
23512407|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
23512408|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
23512409|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
23512410|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
23512411|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
23512412|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
23512413|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
23512414|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
23512415|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
23512416|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
23512417|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
23512418|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
23512419|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
23512420|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
23512421|NCT01059825|65612744|FG000|Treatment Period|Lost to Follow-up|2|||
23512422|NCT01059825|65612745|FG001|Treatment Period|Lost to Follow-up|1|||
23512423|NCT01059825|65612746|FG002|Treatment Period|Lost to Follow-up|0|||
23512424|NCT01059825|65612747|FG003|Treatment Period|Lost to Follow-up|1|||
23512425|NCT01059825|65612748|FG004|Treatment Period|Lost to Follow-up|2|||
23512426|NCT01059825|65612749|FG005|Treatment Period|Lost to Follow-up|0|||
23512427|NCT01059825|65612750|FG006|Treatment Period|Lost to Follow-up|0|||
23512428|NCT01059825|65612744|FG000|Treatment Period|Withdrawal by Subject|3|||
23512429|NCT01059825|65612745|FG001|Treatment Period|Withdrawal by Subject|0|||
23512430|NCT01059825|65612746|FG002|Treatment Period|Withdrawal by Subject|1|||
23512431|NCT01059825|65612747|FG003|Treatment Period|Withdrawal by Subject|5|||
23512432|NCT01059825|65612748|FG004|Treatment Period|Withdrawal by Subject|4|||
23512433|NCT01059825|65612749|FG005|Treatment Period|Withdrawal by Subject|1|||
23512434|NCT01059825|65612750|FG006|Treatment Period|Withdrawal by Subject|0|||
23512435|NCT01059825|65612744|FG000|Treatment Period|Other reason not specified|1|||
23512436|NCT01059825|65612745|FG001|Treatment Period|Other reason not specified|2|||
23512437|NCT01059825|65612746|FG002|Treatment Period|Other reason not specified|1|||
23512438|NCT01059825|65612747|FG003|Treatment Period|Other reason not specified|2|||
23512439|NCT01059825|65612748|FG004|Treatment Period|Other reason not specified|0|||
23512440|NCT01059825|65612749|FG005|Treatment Period|Other reason not specified|0|||
23512441|NCT01059825|65612750|FG006|Treatment Period|Other reason not specified|0|||
23512442|NCT01059825|65612744|FG000|Treatment Period|Protocol Violation|0|||
23512443|NCT01059825|65612745|FG001|Treatment Period|Protocol Violation|0|||
23512444|NCT01059825|65612746|FG002|Treatment Period|Protocol Violation|1|||
23512445|NCT01059825|65612747|FG003|Treatment Period|Protocol Violation|1|||
23512446|NCT01059825|65612748|FG004|Treatment Period|Protocol Violation|1|||
23512447|NCT01059825|65612749|FG005|Treatment Period|Protocol Violation|1|||
23512448|NCT01059825|65612750|FG006|Treatment Period|Protocol Violation|0|||
23512449|NCT01059825|65612744|FG000|Treatment Period|Adverse event related to study drug|1|||
23512450|NCT01059825|65612745|FG001|Treatment Period|Adverse event related to study drug|0|||
23512451|NCT01059825|65612746|FG002|Treatment Period|Adverse event related to study drug|1|||
23512452|NCT01059825|65612747|FG003|Treatment Period|Adverse event related to study drug|1|||
23512453|NCT01059825|65612748|FG004|Treatment Period|Adverse event related to study drug|0|||
23512454|NCT01059825|65612749|FG005|Treatment Period|Adverse event related to study drug|0|||
23512455|NCT01059825|65612750|FG006|Treatment Period|Adverse event related to study drug|0|||
23512456|NCT01059825|65612744|FG000|Treatment Period|Insufficient clinical response|3|||
23512457|NCT01059825|65612745|FG001|Treatment Period|Insufficient clinical response|0|||
23512458|NCT01059825|65612746|FG002|Treatment Period|Insufficient clinical response|0|||
23512459|NCT01059825|65612747|FG003|Treatment Period|Insufficient clinical response|0|||
23512460|NCT01059825|65612748|FG004|Treatment Period|Insufficient clinical response|0|||
23512461|NCT01059825|65612749|FG005|Treatment Period|Insufficient clinical response|0|||
23512462|NCT01059825|65612750|FG006|Treatment Period|Insufficient clinical response|0|||
23512463|NCT01059825|65612744|FG000|Treatment Period|Adverse event not related to study drug|0|||
23611150|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415209|NCT01096368|65260880|FG004|Overall Study|Withdrawal by Subject|14|||
23415210|NCT01096368|65260876|FG000|Overall Study|Ineligible|0|||
23415211|NCT01096368|65260877|FG001|Overall Study|Ineligible|3|||
23415212|NCT01096368|65260878|FG002|Overall Study|Ineligible|2|||
23415213|NCT01096368|65260879|FG003|Overall Study|Ineligible|0|||
23415214|NCT01096368|65260880|FG004|Overall Study|Ineligible|25|||
23415215|NCT01096368|65260876|FG000|Overall Study|Did not start treatment|0|||
23415216|NCT01096368|65260877|FG001|Overall Study|Did not start treatment|4|||
23415217|NCT01096368|65260878|FG002|Overall Study|Did not start treatment|4|||
23415218|NCT01096368|65260879|FG003|Overall Study|Did not start treatment|0|||
23415219|NCT01096368|65260880|FG004|Overall Study|Did not start treatment|0|||
23415220|NCT01096368|65260876|FG000|Overall Study|Progressive disease|0|||
23415221|NCT01096368|65260877|FG001|Overall Study|Progressive disease|6|||
23415222|NCT01096368|65260878|FG002|Overall Study|Progressive disease|0|||
23415223|NCT01096368|65260879|FG003|Overall Study|Progressive disease|10|||
23415224|NCT01096368|65260880|FG004|Overall Study|Progressive disease|3|||
23415225|NCT01096368|65260876|FG000|Overall Study|Other|0|||
23415226|NCT01096368|65260877|FG001|Overall Study|Other|0|||
23415227|NCT01096368|65260878|FG002|Overall Study|Other|1|||
23415228|NCT01096368|65260879|FG003|Overall Study|Other|0|||
23415229|NCT01096368|65260880|FG004|Overall Study|Other|0|||
23415230|NCT01096368|65260876|FG000|Overall Study|Treated with institutional review|0|||
23415231|NCT01096368|65260877|FG001|Overall Study|Treated with institutional review|0|||
23415232|NCT01096368|65260878|FG002|Overall Study|Treated with institutional review|0|||
23415233|NCT01096368|65260879|FG003|Overall Study|Treated with institutional review|0|||
23415234|NCT01096368|65260880|FG004|Overall Study|Treated with institutional review|1|||
23415235|NCT00309985|65260881|FG000|Overall Study|Disease progression|12|||
23415236|NCT00309985|65260882|FG001|Overall Study|Disease progression|0|||
23512464|NCT01059825|65612745|FG001|Treatment Period|Adverse event not related to study drug|1|||
23512465|NCT01059825|65612746|FG002|Treatment Period|Adverse event not related to study drug|2|||
23512466|NCT01059825|65612747|FG003|Treatment Period|Adverse event not related to study drug|1|||
23512467|NCT01059825|65612748|FG004|Treatment Period|Adverse event not related to study drug|1|||
23512468|NCT01059825|65612749|FG005|Treatment Period|Adverse event not related to study drug|1|||
23512469|NCT01059825|65612750|FG006|Treatment Period|Adverse event not related to study drug|0|||
23512470|NCT01831544|65612751|FG000|Overall Study|Death|1|||
23512471|NCT01831544|65612751|FG000|Overall Study|Still on original MVAD device|2|||
23512472|NCT03958955|65612752|FG000|Overall Study|Adverse Event|1|||
23512473|NCT03187262|65612753|FG000|Induction|Lack of Efficacy|2|||
23512474|NCT03187262|65612753|FG000|Induction|Progressive Disease|4|||
23512475|NCT03187262|65612753|FG000|Consolidation|Progressive Disease|5|||
23512476|NCT01409564|65612754|FG000|Overall Study|low medication compliance|4|||
23512477|NCT01409564|65612755|FG001|Overall Study|low medication compliance|3|||
23512478|NCT01409564|65612754|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
23512479|NCT01409564|65612755|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
23512480|NCT01508650|65612756|FG000|Overall Study|Lost to Follow-up|0|||
23512481|NCT01508650|65612757|FG001|Overall Study|Lost to Follow-up|3|||
23512482|NCT02769247|65612758|FG000|Overall Study|Withdrawal by Subject|1|||
23512483|NCT02769247|65612759|FG001|Overall Study|Withdrawal by Subject|0|||
23512484|NCT02769247|65612760|FG002|Overall Study|Withdrawal by Subject|0|||
23512485|NCT02769247|65612761|FG003|Overall Study|Withdrawal by Subject|1|||
23512486|NCT02769247|65612758|FG000|Overall Study|Protocol Violation|0|||
23512487|NCT02769247|65612759|FG001|Overall Study|Protocol Violation|0|||
23512488|NCT02769247|65612760|FG002|Overall Study|Protocol Violation|1|||
23512489|NCT02769247|65612761|FG003|Overall Study|Protocol Violation|0|||
23512490|NCT02769247|65612758|FG000|Overall Study|Physician Decision|1|||
23512491|NCT02769247|65612759|FG001|Overall Study|Physician Decision|0|||
23512492|NCT02769247|65612760|FG002|Overall Study|Physician Decision|0|||
23512493|NCT02769247|65612761|FG003|Overall Study|Physician Decision|0|||
23512494|NCT00143403|65612763|FG000|Overall Study|Adverse Event|3|||
23512495|NCT00143403|65612764|FG001|Overall Study|Adverse Event|8|||
23512496|NCT00143403|65612763|FG000|Overall Study|Death|1|||
23512497|NCT00143403|65612764|FG001|Overall Study|Death|0|||
23512498|NCT00143403|65612763|FG000|Overall Study|Withdrawal by Subject|3|||
23512499|NCT00143403|65612764|FG001|Overall Study|Withdrawal by Subject|12|||
23512500|NCT00143403|65612763|FG000|Overall Study|Relapse|15|||
23512501|NCT00143403|65612764|FG001|Overall Study|Relapse|7|||
23512502|NCT00143403|65612763|FG000|Overall Study|Protocol Violation|2|||
23512503|NCT00143403|65612764|FG001|Overall Study|Protocol Violation|2|||
23512504|NCT00143403|65612763|FG000|Overall Study|specified by site|4|||
23512505|NCT00143403|65612764|FG001|Overall Study|specified by site|9|||
23512506|NCT00143403|65612763|FG000|Overall Study|Randomized Not Treated|7|||
23512507|NCT00143403|65612764|FG001|Overall Study|Randomized Not Treated|8|||
23512508|NCT02927080|65612765|FG000|Overall Study|Withdrawal by Subject|0|||
23512509|NCT02927080|65612766|FG001|Overall Study|Withdrawal by Subject|0|||
23512510|NCT02927080|65612767|FG002|Overall Study|Withdrawal by Subject|0|||
23512511|NCT02927080|65612768|FG003|Overall Study|Withdrawal by Subject|0|||
23415237|NCT00309985|65260881|FG000|Overall Study|Adverse Event|30|||
23512512|NCT02927080|65612769|FG004|Overall Study|Withdrawal by Subject|1|||
23512513|NCT02927080|65612770|FG005|Overall Study|Withdrawal by Subject|0|||
23512514|NCT02927080|65612771|FG006|Overall Study|Withdrawal by Subject|1|||
23512515|NCT02927080|65612772|FG007|Overall Study|Withdrawal by Subject|1|||
23512516|NCT02927080|65612773|FG008|Overall Study|Withdrawal by Subject|0|||
23512517|NCT02927080|65612774|FG009|Overall Study|Withdrawal by Subject|2|||
23512518|NCT02927080|65612765|FG000|Overall Study|Willingness to comply with protocol|0|||
23512519|NCT02927080|65612766|FG001|Overall Study|Willingness to comply with protocol|0|||
23512520|NCT02927080|65612767|FG002|Overall Study|Willingness to comply with protocol|0|||
23512521|NCT02927080|65612768|FG003|Overall Study|Willingness to comply with protocol|0|||
23512522|NCT02927080|65612769|FG004|Overall Study|Willingness to comply with protocol|0|||
23512523|NCT02927080|65612770|FG005|Overall Study|Willingness to comply with protocol|0|||
23512524|NCT02927080|65612771|FG006|Overall Study|Willingness to comply with protocol|0|||
23512525|NCT02927080|65612772|FG007|Overall Study|Willingness to comply with protocol|0|||
23512526|NCT02927080|65612773|FG008|Overall Study|Willingness to comply with protocol|0|||
23512527|NCT02927080|65612774|FG009|Overall Study|Willingness to comply with protocol|1|||
23512528|NCT02927080|65612765|FG000|Overall Study|Study terminated by Sponsor|0|||
23512529|NCT02927080|65612766|FG001|Overall Study|Study terminated by Sponsor|0|||
23512530|NCT02927080|65612767|FG002|Overall Study|Study terminated by Sponsor|0|||
23512531|NCT02927080|65612768|FG003|Overall Study|Study terminated by Sponsor|0|||
23512532|NCT02927080|65612769|FG004|Overall Study|Study terminated by Sponsor|0|||
23512533|NCT02927080|65612770|FG005|Overall Study|Study terminated by Sponsor|0|||
23512534|NCT02927080|65612771|FG006|Overall Study|Study terminated by Sponsor|6|||
23512535|NCT02927080|65612772|FG007|Overall Study|Study terminated by Sponsor|7|||
23512536|NCT02927080|65612773|FG008|Overall Study|Study terminated by Sponsor|2|||
23512537|NCT02927080|65612774|FG009|Overall Study|Study terminated by Sponsor|3|||
23512538|NCT02927080|65612765|FG000|Overall Study|Adverse Event|0|||
23415238|NCT00309985|65260882|FG001|Overall Study|Adverse Event|0|||
23415239|NCT00309985|65260881|FG000|Overall Study|Death|2|||
23415240|NCT00309985|65260882|FG001|Overall Study|Death|0|||
23512539|NCT02927080|65612766|FG001|Overall Study|Adverse Event|1|||
23512540|NCT02927080|65612767|FG002|Overall Study|Adverse Event|0|||
23512541|NCT02927080|65612768|FG003|Overall Study|Adverse Event|0|||
23512542|NCT02927080|65612769|FG004|Overall Study|Adverse Event|0|||
23512543|NCT02927080|65612770|FG005|Overall Study|Adverse Event|0|||
23512544|NCT02927080|65612771|FG006|Overall Study|Adverse Event|0|||
23512545|NCT02927080|65612772|FG007|Overall Study|Adverse Event|1|||
23512546|NCT02927080|65612773|FG008|Overall Study|Adverse Event|0|||
23512547|NCT02927080|65612774|FG009|Overall Study|Adverse Event|1|||
23415241|NCT00309985|65260881|FG000|Overall Study|Withdrawal by Subject|5|||
23415242|NCT00309985|65260882|FG001|Overall Study|Withdrawal by Subject|1|||
23415243|NCT00309985|65260881|FG000|Overall Study|Physician Decision|3|||
23415244|NCT00309985|65260882|FG001|Overall Study|Physician Decision|0|||
23415245|NCT00309985|65260881|FG000|Overall Study|Never started treatment|7|||
23415246|NCT00309985|65260882|FG001|Overall Study|Never started treatment|0|||
23415247|NCT00309985|65260881|FG000|Overall Study|Complicating disease|1|||
23415248|NCT00309985|65260882|FG001|Overall Study|Complicating disease|0|||
23415249|NCT00309985|65260881|FG000|Overall Study|Non-compliance|1|||
23415250|NCT00309985|65260882|FG001|Overall Study|Non-compliance|0|||
23415251|NCT00309985|65260881|FG000|Overall Study|Chemotherapy discontinued only|1|||
23415252|NCT00309985|65260882|FG001|Overall Study|Chemotherapy discontinued only|0|||
23415253|NCT04730635|65260886|FG000|Overall Study|Lost to Follow-up|1|||
23415254|NCT04730635|65260887|FG001|Overall Study|Lost to Follow-up|0|||
23415255|NCT04730635|65260886|FG000|Overall Study|Withdrawal by Subject|0|||
23415256|NCT04730635|65260887|FG001|Overall Study|Withdrawal by Subject|1|||
23415257|NCT03070223|65260888|FG000|Overall Study|Lost to Follow-up|34|||
23415258|NCT03070223|65260889|FG001|Overall Study|Lost to Follow-up|27|||
23415259|NCT03070223|65260888|FG000|Overall Study|Withdrawal by Subject|12|||
23415260|NCT03070223|65260889|FG001|Overall Study|Withdrawal by Subject|22|||
23415261|NCT03070223|65260888|FG000|Overall Study|Protocol Violation|0|||
23415262|NCT03070223|65260889|FG001|Overall Study|Protocol Violation|1|||
23415263|NCT02308163|65260890|FG000|Overall Study|Not fulfill eligible criteria|1|||
23415264|NCT02308163|65260891|FG001|Overall Study|Not fulfill eligible criteria|2|||
23415265|NCT02308163|65260892|FG002|Overall Study|Not fulfill eligible criteria|0|||
23415266|NCT02308163|65260893|FG003|Overall Study|Not fulfill eligible criteria|1|||
23415267|NCT02308163|65260894|FG004|Overall Study|Not fulfill eligible criteria|1|||
23415268|NCT02308163|65260890|FG000|Overall Study|Adverse Event|9|||
23415269|NCT02308163|65260891|FG001|Overall Study|Adverse Event|5|||
23415270|NCT02308163|65260892|FG002|Overall Study|Adverse Event|2|||
23415271|NCT02308163|65260893|FG003|Overall Study|Adverse Event|2|||
23415272|NCT02308163|65260894|FG004|Overall Study|Adverse Event|11|||
23415273|NCT02308163|65260890|FG000|Overall Study|Lack of Efficacy|11|||
23415274|NCT02308163|65260891|FG001|Overall Study|Lack of Efficacy|3|||
23415275|NCT02308163|65260892|FG002|Overall Study|Lack of Efficacy|8|||
23415276|NCT02308163|65260893|FG003|Overall Study|Lack of Efficacy|4|||
23415277|NCT02308163|65260894|FG004|Overall Study|Lack of Efficacy|6|||
23512548|NCT02927080|65612765|FG000|Overall Study|Other|0|||
23415278|NCT02308163|65260890|FG000|Overall Study|Withdrawal of consent|2|||
23415279|NCT02308163|65260891|FG001|Overall Study|Withdrawal of consent|3|||
23415280|NCT02308163|65260892|FG002|Overall Study|Withdrawal of consent|0|||
23415281|NCT02308163|65260893|FG003|Overall Study|Withdrawal of consent|2|||
23415282|NCT02308163|65260894|FG004|Overall Study|Withdrawal of consent|6|||
23415283|NCT02308163|65260890|FG000|Overall Study|Protocol Violation|3|||
23415284|NCT02308163|65260891|FG001|Overall Study|Protocol Violation|3|||
23415285|NCT02308163|65260892|FG002|Overall Study|Protocol Violation|3|||
23512549|NCT02927080|65612766|FG001|Overall Study|Other|0|||
23512550|NCT02927080|65612767|FG002|Overall Study|Other|0|||
23512551|NCT02927080|65612768|FG003|Overall Study|Other|0|||
23512552|NCT02927080|65612769|FG004|Overall Study|Other|0|||
23512553|NCT02927080|65612770|FG005|Overall Study|Other|0|||
23512554|NCT02927080|65612771|FG006|Overall Study|Other|1|||
23512555|NCT02927080|65612772|FG007|Overall Study|Other|0|||
23512556|NCT02927080|65612773|FG008|Overall Study|Other|1|||
23512557|NCT02927080|65612774|FG009|Overall Study|Other|0|||
23512558|NCT02671422|65612777|FG000|Overall Study|Lost to Follow-up|1|||
23512559|NCT02671422|65612777|FG000|Overall Study|Adverse Event|68|||
23512560|NCT02671422|65612777|FG000|Overall Study|Lack of Efficacy|1|||
23512561|NCT02671422|65612777|FG000|Overall Study|Lost to Follow-up|4|||
23512562|NCT02671422|65612777|FG000|Overall Study|Withdrawal by Subject|7|||
23512563|NCT02671422|65612777|FG000|Overall Study|Progressive Disease|156|||
23512564|NCT02671422|65612777|FG000|Overall Study|Worsening of Disease|4|||
23512565|NCT02671422|65612777|FG000|Overall Study|Sponsor decision|5|||
23512566|NCT02671422|65612777|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
23512567|NCT02671422|65612777|FG000|Overall Study|Not treated with Vargatef®|3|||
23512568|NCT02671422|65612777|FG000|Overall Study|Other not defined above|3|||
23512569|NCT00580606|65612782|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
23512570|NCT00580606|65612783|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
23512571|NCT00580606|65612782|FG000|Open Label (OL)|Withdrawal by Subject|4|||
23512572|NCT00580606|65612783|FG001|Open Label (OL)|Withdrawal by Subject|6|||
23512573|NCT00580606|65612782|FG000|Open Label (OL)|Dosing Symptoms|0|||
23512574|NCT00580606|65612783|FG001|Open Label (OL)|Dosing Symptoms|1|||
23512575|NCT00580606|65612782|FG000|Open Label (OL)|Lost to Follow-up|0|||
23512576|NCT00580606|65612783|FG001|Open Label (OL)|Lost to Follow-up|1|||
23512577|NCT00580606|65612782|FG000|Open Label (OL)|Pregnancy|0|||
23512578|NCT00580606|65612783|FG001|Open Label (OL)|Pregnancy|1|||
23512579|NCT00580606|65612782|FG000|Open Label (OL)|Non-compliance|2|||
23512580|NCT00580606|65612783|FG001|Open Label (OL)|Non-compliance|0|||
23512581|NCT00580606|65612782|FG000|Open Label (OL)|Physician Decision|1|||
23512582|NCT00580606|65612783|FG001|Open Label (OL)|Physician Decision|1|||
23512583|NCT00580606|65612782|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
23512584|NCT00580606|65612783|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
23512585|NCT02452398|65612784|FG000|Overall Study|Adverse Event|1|||
23512586|NCT02452398|65612784|FG000|Overall Study|Lost to Follow-up|28|||
23512587|NCT02452398|65612784|FG000|Overall Study|Physician Decision|2|||
23512588|NCT02452398|65612784|FG000|Overall Study|Withdrawal by Subject|6|||
23512589|NCT02452398|65612784|FG000|Overall Study|Moved away|4|||
23512590|NCT00793403|65612789|FG000|Overall Study|Other|73|||
23512591|NCT02289079|65612790|FG000|Overall Study|Physician Decision|2|||
23512592|NCT02289079|65612791|FG001|Overall Study|Physician Decision|0|||
23512593|NCT02289079|65612790|FG000|Overall Study|Lost to Follow-up|0|||
23512594|NCT02289079|65612791|FG001|Overall Study|Lost to Follow-up|1|||
23512595|NCT00267046|65612793|FG000|Overall Study|Disease progression|4|||
23512596|NCT00267046|65612794|FG001|Overall Study|Disease progression|2|||
23512597|NCT00267046|65612793|FG000|Overall Study|Chemotoxicity|2|||
23512598|NCT00267046|65612794|FG001|Overall Study|Chemotoxicity|0|||
23512599|NCT00267046|65612793|FG000|Overall Study|Open-label palifermin|2|||
23512600|NCT00267046|65612794|FG001|Overall Study|Open-label palifermin|7|||
23512601|NCT00267046|65612793|FG000|Overall Study|Surgery|3|||
23512602|NCT00267046|65612794|FG001|Overall Study|Surgery|1|||
23512603|NCT00267046|65612793|FG000|Overall Study|Withdrawal by Subject|1|||
23512604|NCT00267046|65612794|FG001|Overall Study|Withdrawal by Subject|0|||
23512605|NCT00267046|65612793|FG000|Overall Study|Radiation|0|||
23512606|NCT00267046|65612794|FG001|Overall Study|Radiation|1|||
23512607|NCT01506479|65612795|FG000|Overall Study|Lost to Follow-up|1|||
23512608|NCT01506479|65612796|FG001|Overall Study|Lost to Follow-up|2|||
23512609|NCT01506479|65612797|FG002|Overall Study|Lost to Follow-up|2|||
23512610|NCT01506479|65612795|FG000|Overall Study|Withdrawal by Subject|1|||
23512611|NCT01506479|65612796|FG001|Overall Study|Withdrawal by Subject|2|||
23512612|NCT01506479|65612797|FG002|Overall Study|Withdrawal by Subject|1|||
23512613|NCT01506479|65612795|FG000|Overall Study|Missing assessment|1|||
23710787|NCT00262080|66319189|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
23512614|NCT01506479|65612796|FG001|Overall Study|Missing assessment|0|||
23512615|NCT01506479|65612797|FG002|Overall Study|Missing assessment|0|||
23512616|NCT01506479|65612795|FG000|Overall Study|Adverse Event|0|||
23512617|NCT01506479|65612796|FG001|Overall Study|Adverse Event|1|||
23512618|NCT01506479|65612797|FG002|Overall Study|Adverse Event|0|||
23512619|NCT00533845|65612799|FG000|Overall Study|Physician Decision|1|||
23512620|NCT00533845|65612800|FG001|Overall Study|Physician Decision|0|||
23512621|NCT02864953|65612801|FG000|Overall Study|Adverse Event|22|||
23512622|NCT02864953|65612802|FG001|Overall Study|Adverse Event|19|||
23512623|NCT02864953|65612801|FG000|Overall Study|Withdrawal by Subject|1|||
23512624|NCT02864953|65612802|FG001|Overall Study|Withdrawal by Subject|0|||
23512625|NCT02864953|65612801|FG000|Overall Study|Physician Decision|4|||
23512626|NCT02864953|65612802|FG001|Overall Study|Physician Decision|2|||
23512627|NCT02864953|65612801|FG000|Overall Study|Death|3|||
23512628|NCT02864953|65612802|FG001|Overall Study|Death|13|||
23512629|NCT02864953|65612801|FG000|Overall Study|Reason not specified|14|||
23512630|NCT02864953|65612802|FG001|Overall Study|Reason not specified|12|||
23512631|NCT02864953|65612801|FG000|Overall Study|Withdrew Prior to Dosing|9|||
23512632|NCT02864953|65612802|FG001|Overall Study|Withdrew Prior to Dosing|8|||
23512633|NCT01064401|65612803|FG000|Overall Study|Adverse Event|47|||
23512634|NCT01064401|65612804|FG001|Overall Study|Adverse Event|56|||
23512635|NCT01064401|65612803|FG000|Overall Study|Lack of Efficacy|46|||
23512636|NCT01064401|65612804|FG001|Overall Study|Lack of Efficacy|23|||
23512637|NCT01064401|65612803|FG000|Overall Study|Lost to Follow-up|12|||
23512638|NCT01064401|65612804|FG001|Overall Study|Lost to Follow-up|9|||
23512639|NCT01064401|65612803|FG000|Overall Study|Consent Withdrawn|98|||
23512640|NCT01064401|65612804|FG001|Overall Study|Consent Withdrawn|80|||
23512641|NCT01064401|65612803|FG000|Overall Study|Investigator Decision|4|||
23512642|NCT01064401|65612804|FG001|Overall Study|Investigator Decision|6|||
23512643|NCT01064401|65612803|FG000|Overall Study|Death|4|||
23512644|NCT01064401|65612804|FG001|Overall Study|Death|0|||
23512645|NCT01064401|65612803|FG000|Overall Study|Pregnancy|4|||
23512646|NCT01064401|65612804|FG001|Overall Study|Pregnancy|7|||
23415286|NCT02308163|65260893|FG003|Overall Study|Protocol Violation|2|||
23415287|NCT02308163|65260894|FG004|Overall Study|Protocol Violation|5|||
23415288|NCT02308163|65260890|FG000|Overall Study|Lab data met discontinuation criteria|3|||
23415289|NCT02308163|65260891|FG001|Overall Study|Lab data met discontinuation criteria|0|||
23415290|NCT02308163|65260892|FG002|Overall Study|Lab data met discontinuation criteria|0|||
23415291|NCT02308163|65260893|FG003|Overall Study|Lab data met discontinuation criteria|2|||
23512647|NCT01064401|65612803|FG000|Overall Study|Noncompliance|7|||
23512648|NCT01064401|65612804|FG001|Overall Study|Noncompliance|8|||
23512649|NCT01064401|65612803|FG000|Overall Study|Site Closure|4|||
23512650|NCT01064401|65612804|FG001|Overall Study|Site Closure|5|||
23512651|NCT01064401|65612803|FG000|Overall Study|Other|2|||
23512652|NCT01064401|65612804|FG001|Overall Study|Other|1|||
23512653|NCT00362115|65612805|FG000|Overall Study|Adverse Event|0|||
23512654|NCT00362115|65612806|FG001|Overall Study|Adverse Event|1|||
23512655|NCT00362115|65612807|FG002|Overall Study|Adverse Event|1|||
23512656|NCT00362115|65612808|FG003|Overall Study|Adverse Event|1|||
23512657|NCT00362115|65612809|FG004|Overall Study|Adverse Event|2|||
23512658|NCT00362115|65612810|FG005|Overall Study|Adverse Event|2|||
23512659|NCT00362115|65612811|FG006|Overall Study|Adverse Event|1|||
23512660|NCT00362115|65612805|FG000|Overall Study|Protocol Violation|0|||
23512661|NCT00362115|65612806|FG001|Overall Study|Protocol Violation|0|||
23512662|NCT00362115|65612807|FG002|Overall Study|Protocol Violation|0|||
23512663|NCT00362115|65612808|FG003|Overall Study|Protocol Violation|0|||
23512664|NCT00362115|65612809|FG004|Overall Study|Protocol Violation|0|||
23710788|NCT00262080|66319190|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
23710789|NCT00262080|66319191|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
23710790|NCT00262080|66319189|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
23415292|NCT02308163|65260894|FG004|Overall Study|Lab data met discontinuation criteria|0|||
23415293|NCT02308163|65260890|FG000|Overall Study|Miscellaneous|2|||
23415294|NCT02308163|65260891|FG001|Overall Study|Miscellaneous|2|||
23415295|NCT02308163|65260892|FG002|Overall Study|Miscellaneous|1|||
23512665|NCT00362115|65612810|FG005|Overall Study|Protocol Violation|1|||
23415296|NCT02308163|65260893|FG003|Overall Study|Miscellaneous|0|||
23415297|NCT02308163|65260894|FG004|Overall Study|Miscellaneous|5|||
23415298|NCT00516906|65261597|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
23415299|NCT00516906|65261598|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
23415300|NCT03734016|65261599|FG000|Overall Study|Participants Remaining in the Study|260|||
23415301|NCT03734016|65261600|FG001|Overall Study|Participants Remaining in the Study|240|||
23415302|NCT03734016|65261599|FG000|Overall Study|Death|48|||
23415303|NCT03734016|65261600|FG001|Overall Study|Death|60|||
23415304|NCT03734016|65261599|FG000|Overall Study|Withdrawal by Subject|14|||
23415305|NCT03734016|65261600|FG001|Overall Study|Withdrawal by Subject|16|||
23415306|NCT03734016|65261599|FG000|Overall Study|Physician Decision|0|||
23415307|NCT03734016|65261600|FG001|Overall Study|Physician Decision|7|||
23415308|NCT03734016|65261599|FG000|Overall Study|Lost to Follow-up|3|||
23415309|NCT03734016|65261600|FG001|Overall Study|Lost to Follow-up|1|||
23415310|NCT03734016|65261599|FG000|Overall Study|Adverse Event|2|||
23415311|NCT03734016|65261600|FG001|Overall Study|Adverse Event|1|||
23415312|NCT03268954|65261608|FG000|Overall Study|Ongoing|23|||
23415313|NCT03268954|65261609|FG001|Overall Study|Ongoing|31|||
23415314|NCT03268954|65261608|FG000|Overall Study|Adverse Event|53|||
23512666|NCT00362115|65612811|FG006|Overall Study|Protocol Violation|0|||
23512667|NCT00362115|65612805|FG000|Overall Study|Lost to Follow-up|0|||
23512668|NCT00362115|65612806|FG001|Overall Study|Lost to Follow-up|1|||
23512669|NCT00362115|65612807|FG002|Overall Study|Lost to Follow-up|0|||
23415315|NCT03268954|65261609|FG001|Overall Study|Adverse Event|62|||
23415316|NCT03268954|65261608|FG000|Overall Study|Withdrawal by Subject|25|||
23512670|NCT00362115|65612808|FG003|Overall Study|Lost to Follow-up|0|||
23512671|NCT00362115|65612809|FG004|Overall Study|Lost to Follow-up|2|||
23512672|NCT00362115|65612810|FG005|Overall Study|Lost to Follow-up|0|||
23512673|NCT00362115|65612811|FG006|Overall Study|Lost to Follow-up|1|||
23512674|NCT00362115|65612805|FG000|Overall Study|Withdrawal by Subject|1|||
23512675|NCT00362115|65612806|FG001|Overall Study|Withdrawal by Subject|3|||
23512676|NCT00362115|65612807|FG002|Overall Study|Withdrawal by Subject|1|||
23512677|NCT00362115|65612808|FG003|Overall Study|Withdrawal by Subject|0|||
23512678|NCT00362115|65612809|FG004|Overall Study|Withdrawal by Subject|1|||
23512679|NCT00362115|65612810|FG005|Overall Study|Withdrawal by Subject|3|||
23512680|NCT00362115|65612811|FG006|Overall Study|Withdrawal by Subject|4|||
23512681|NCT00362115|65612805|FG000|Overall Study|Lack of Efficacy|1|||
23512682|NCT00362115|65612806|FG001|Overall Study|Lack of Efficacy|0|||
23512683|NCT00362115|65612807|FG002|Overall Study|Lack of Efficacy|5|||
23512684|NCT00362115|65612808|FG003|Overall Study|Lack of Efficacy|2|||
23512685|NCT00362115|65612809|FG004|Overall Study|Lack of Efficacy|2|||
23512686|NCT00362115|65612810|FG005|Overall Study|Lack of Efficacy|0|||
23512687|NCT00362115|65612811|FG006|Overall Study|Lack of Efficacy|3|||
23512688|NCT00362115|65612805|FG000|Overall Study|Physician Decision|0|||
23512689|NCT00362115|65612806|FG001|Overall Study|Physician Decision|0|||
23512690|NCT00362115|65612807|FG002|Overall Study|Physician Decision|0|||
23512691|NCT00362115|65612808|FG003|Overall Study|Physician Decision|0|||
23512692|NCT00362115|65612809|FG004|Overall Study|Physician Decision|0|||
23512693|NCT00362115|65612810|FG005|Overall Study|Physician Decision|0|||
23512694|NCT00362115|65612811|FG006|Overall Study|Physician Decision|3|||
23512695|NCT00362115|65612805|FG000|Overall Study|Other|0|||
23512696|NCT00362115|65612806|FG001|Overall Study|Other|1|||
23512697|NCT00362115|65612807|FG002|Overall Study|Other|0|||
23512698|NCT00362115|65612808|FG003|Overall Study|Other|1|||
23512699|NCT00362115|65612809|FG004|Overall Study|Other|0|||
23512700|NCT00362115|65612810|FG005|Overall Study|Other|1|||
23512701|NCT00362115|65612811|FG006|Overall Study|Other|0|||
23512702|NCT02700815|65612814|FG000|Overall Study|Adverse Event|0|||
23512703|NCT02700815|65612815|FG001|Overall Study|Adverse Event|6|||
23512704|NCT02700815|65612816|FG002|Overall Study|Adverse Event|2|||
23512705|NCT02700815|65612817|FG003|Overall Study|Adverse Event|3|||
23512706|NCT02700815|65612814|FG000|Overall Study|Lack of Efficacy|0|||
23512707|NCT02700815|65612815|FG001|Overall Study|Lack of Efficacy|0|||
23512708|NCT02700815|65612816|FG002|Overall Study|Lack of Efficacy|1|||
23512709|NCT02700815|65612817|FG003|Overall Study|Lack of Efficacy|2|||
23512710|NCT02700815|65612814|FG000|Overall Study|Lost to Follow-up|1|||
23512711|NCT02700815|65612815|FG001|Overall Study|Lost to Follow-up|0|||
23512712|NCT02700815|65612816|FG002|Overall Study|Lost to Follow-up|0|||
23512713|NCT02700815|65612817|FG003|Overall Study|Lost to Follow-up|1|||
23512714|NCT02700815|65612814|FG000|Overall Study|Refusal to continue medication|0|||
23512715|NCT02700815|65612815|FG001|Overall Study|Refusal to continue medication|1|||
23512716|NCT02700815|65612816|FG002|Overall Study|Refusal to continue medication|0|||
23512717|NCT02700815|65612817|FG003|Overall Study|Refusal to continue medication|1|||
23512718|NCT02700815|65612814|FG000|Overall Study|Withdrawal by Subject|0|||
23512719|NCT02700815|65612815|FG001|Overall Study|Withdrawal by Subject|0|||
23512720|NCT02700815|65612816|FG002|Overall Study|Withdrawal by Subject|1|||
23512721|NCT02700815|65612817|FG003|Overall Study|Withdrawal by Subject|0|||
23512722|NCT00742001|65612818|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
23512723|NCT00742001|65612819|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
23512724|NCT00742001|65612820|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
23512725|NCT03655691|65612823|FG000|Overall Study|Adverse Event|0|||
23512726|NCT03655691|65612824|FG001|Overall Study|Adverse Event|0|||
23512727|NCT03655691|65612825|FG002|Overall Study|Adverse Event|1|||
23512728|NCT03655691|65612823|FG000|Overall Study|Lost to Follow-up|1|||
23512729|NCT03655691|65612824|FG001|Overall Study|Lost to Follow-up|1|||
23512730|NCT03655691|65612825|FG002|Overall Study|Lost to Follow-up|2|||
23512731|NCT03655691|65612823|FG000|Overall Study|Protocol Violation|0|||
23512732|NCT03655691|65612824|FG001|Overall Study|Protocol Violation|1|||
23512733|NCT03655691|65612825|FG002|Overall Study|Protocol Violation|0|||
23512734|NCT03655691|65612823|FG000|Overall Study|Withdrawal by Subject|1|||
23512735|NCT03655691|65612824|FG001|Overall Study|Withdrawal by Subject|1|||
23512736|NCT03655691|65612825|FG002|Overall Study|Withdrawal by Subject|0|||
23512737|NCT00558025|65612828|FG000|Overall Study|Adverse Event|1|||
23512738|NCT00558025|65612829|FG001|Overall Study|Adverse Event|1|||
23512739|NCT00558025|65612828|FG000|Overall Study|Withdrawal by Subject|2|||
23512740|NCT00558025|65612829|FG001|Overall Study|Withdrawal by Subject|2|||
23512741|NCT00558025|65612828|FG000|Overall Study|Protocol Violation|1|||
23512742|NCT00558025|65612829|FG001|Overall Study|Protocol Violation|0|||
23512743|NCT02345850|65612830|FG000|Overall Study|Not transplanted|10|||
23512744|NCT02345850|65612831|FG001|Overall Study|Not transplanted|5|||
23512745|NCT02345850|65612832|FG002|Overall Study|Not transplanted|4|||
23512746|NCT02345850|65612830|FG000|Overall Study|Lost to Follow-up|2|||
23611151|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23512747|NCT02345850|65612831|FG001|Overall Study|Lost to Follow-up|3|||
23512748|NCT02345850|65612832|FG002|Overall Study|Lost to Follow-up|2|||
23512749|NCT02345850|65612830|FG000|Overall Study|Withdrawal by Subject|1|||
23512750|NCT02345850|65612831|FG001|Overall Study|Withdrawal by Subject|0|||
23512751|NCT02345850|65612832|FG002|Overall Study|Withdrawal by Subject|0|||
23512752|NCT00996216|65612833|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
23512753|NCT00996216|65612833|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
23512754|NCT00996216|65612833|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
23512755|NCT00065507|65612834|FG000|Overall Study|Death|16|||
23512756|NCT00065507|65612835|FG001|Overall Study|Death|17|||
23512757|NCT00065507|65612834|FG000|Overall Study|Adverse Event|4|||
23512758|NCT00065507|65612835|FG001|Overall Study|Adverse Event|3|||
23512759|NCT00065507|65612834|FG000|Overall Study|Lack of Efficacy|0|||
23512760|NCT00065507|65612835|FG001|Overall Study|Lack of Efficacy|6|||
23512761|NCT00065507|65612834|FG000|Overall Study|Poor/Non-compliance|3|||
23512762|NCT00065507|65612835|FG001|Overall Study|Poor/Non-compliance|2|||
23512763|NCT00065507|65612834|FG000|Overall Study|Lost to Follow-up|3|||
23512764|NCT00065507|65612835|FG001|Overall Study|Lost to Follow-up|0|||
23512765|NCT00065507|65612834|FG000|Overall Study|Subject Withdrew Consent|2|||
23512766|NCT00065507|65612835|FG001|Overall Study|Subject Withdrew Consent|1|||
23512767|NCT00065507|65612834|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
23512768|NCT00065507|65612835|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
23512769|NCT04326231|65612837|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
23512770|NCT00429273|65612838|FG000|Overall Study|Lost to Follow-up|1|||
23512771|NCT00429273|65612839|FG001|Overall Study|Lost to Follow-up|2|||
23512772|NCT00429273|65612840|FG002|Overall Study|Lost to Follow-up|2|||
23512773|NCT00429273|65612838|FG000|Overall Study|Physician Decision|6|||
23512774|NCT00429273|65612839|FG001|Overall Study|Physician Decision|5|||
23512775|NCT00429273|65612840|FG002|Overall Study|Physician Decision|5|||
23512776|NCT00429273|65612838|FG000|Overall Study|Adverse Event|1|||
23512777|NCT00429273|65612839|FG001|Overall Study|Adverse Event|1|||
23512778|NCT00429273|65612840|FG002|Overall Study|Adverse Event|2|||
23512779|NCT00518986|65615996|FG000|Overall Study|Adverse Event|12|||
23512780|NCT00518986|65615997|FG001|Overall Study|Adverse Event|7|||
23512781|NCT00518986|65615996|FG000|Overall Study|Lack of Efficacy|0|||
23512782|NCT00518986|65615997|FG001|Overall Study|Lack of Efficacy|2|||
23512783|NCT00518986|65615996|FG000|Overall Study|Lost to Follow-up|3|||
23512784|NCT00518986|65615997|FG001|Overall Study|Lost to Follow-up|2|||
23512785|NCT00518986|65615996|FG000|Overall Study|Physician Decision|0|||
23512786|NCT00518986|65615997|FG001|Overall Study|Physician Decision|3|||
23512787|NCT00518986|65615996|FG000|Overall Study|Protocol Violation|5|||
23512788|NCT00518986|65615997|FG001|Overall Study|Protocol Violation|7|||
23512789|NCT00518986|65615996|FG000|Overall Study|Withdrawal by Subject|4|||
23512790|NCT00518986|65615997|FG001|Overall Study|Withdrawal by Subject|4|||
23512791|NCT00518986|65615996|FG000|Overall Study|Non-Specific|2|||
23512792|NCT00518986|65615997|FG001|Overall Study|Non-Specific|1|||
23512793|NCT00524368|65616003|FG000|Overall Study|Adverse Event|10|||
23512794|NCT00524368|65616004|FG001|Overall Study|Adverse Event|12|||
23512795|NCT00524368|65616003|FG000|Overall Study|Lost to Follow-up|9|||
23512796|NCT00524368|65616004|FG001|Overall Study|Lost to Follow-up|13|||
23512797|NCT00524368|65616003|FG000|Overall Study|Withdrawal by Subject|4|||
23512798|NCT00524368|65616004|FG001|Overall Study|Withdrawal by Subject|5|||
23512799|NCT00524368|65616003|FG000|Overall Study|Non-compliant|8|||
23512800|NCT00524368|65616004|FG001|Overall Study|Non-compliant|9|||
23512801|NCT00524368|65616003|FG000|Overall Study|Reached a Virologic Endpoint|3|||
23512802|NCT00524368|65616004|FG001|Overall Study|Reached a Virologic Endpoint|2|||
23512803|NCT00524368|65616003|FG000|Overall Study|Sponsor's Decision|2|||
23512804|NCT00524368|65616004|FG001|Overall Study|Sponsor's Decision|0|||
23512805|NCT00524368|65616003|FG000|Overall Study|Ineligible to Continue the study|2|||
23512806|NCT00524368|65616004|FG001|Overall Study|Ineligible to Continue the study|5|||
23512807|NCT00524368|65616003|FG000|Overall Study|Other|3|||
23512808|NCT00524368|65616004|FG001|Overall Study|Other|2|||
23512809|NCT03316131|65616005|FG000|Treatment Period 2|Protocol deviation|1|||
23512810|NCT03316131|65616006|FG001|Treatment Period 2|Protocol deviation|0|||
23512811|NCT03158051|65616014|FG000|Overall Study|Lost to Follow-up|41|||
23512812|NCT03158051|65616015|FG001|Overall Study|Lost to Follow-up|47|||
23512813|NCT03158051|65616014|FG000|Overall Study|Physician Decision|6|||
23710791|NCT00262080|66319190|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
23512814|NCT03158051|65616015|FG001|Overall Study|Physician Decision|7|||
23512815|NCT03158051|65616014|FG000|Overall Study|Withdrawal by Subject|24|||
23512816|NCT03158051|65616015|FG001|Overall Study|Withdrawal by Subject|15|||
23512817|NCT03158051|65616014|FG000|Overall Study|Death|0|||
23512818|NCT03158051|65616015|FG001|Overall Study|Death|1|||
23512819|NCT01702454|65616016|FG000|Overall Study|Consent withdrawal|0|||
23512820|NCT01702454|65616017|FG001|Overall Study|Consent withdrawal|1|||
23512821|NCT01702454|65616016|FG000|Overall Study|Migrated/moved from study area|0|||
23512822|NCT01702454|65616017|FG001|Overall Study|Migrated/moved from study area|1|||
23512823|NCT01702454|65616016|FG000|Overall Study|Lost to Follow-up|3|||
23512824|NCT01702454|65616017|FG001|Overall Study|Lost to Follow-up|6|||
23512825|NCT00513474|65616018|FG000|Overall Study|Death|6|||
23512826|NCT00513474|65616019|FG001|Overall Study|Death|9|||
23512827|NCT00513474|65616018|FG000|Overall Study|Participant Withdrew Consent|1|||
23512828|NCT00513474|65616019|FG001|Overall Study|Participant Withdrew Consent|0|||
23512829|NCT00449540|65616020|FG000|Pretreatment Phase|No migraine experienced|66|||
23512830|NCT00449540|65616021|FG001|Pretreatment Phase|No migraine experienced|0|||
23512831|NCT00449540|65616022|FG002|Pretreatment Phase|No migraine experienced|0|||
23512832|NCT00449540|65616020|FG000|Treatment Phase|did not experience or treat migraine|0|||
23512833|NCT00449540|65616021|FG001|Treatment Phase|did not experience or treat migraine|20|||
23512834|NCT00449540|65616022|FG002|Treatment Phase|did not experience or treat migraine|17|||
23512835|NCT02902965|65616023|FG000|Overall Study|Withdrawal by Subject|10|||
23512836|NCT01574326|65616024|FG000|Overall Study|Randomized but not treated|0|||
23512837|NCT01574326|65616025|FG001|Overall Study|Randomized but not treated|1|||
23512838|NCT01574326|65616024|FG000|Overall Study|Withdrawal by Participant|2|||
23512839|NCT01574326|65616025|FG001|Overall Study|Withdrawal by Participant|4|||
23512840|NCT01574326|65616024|FG000|Overall Study|Physician Decision|5|||
23512841|NCT01574326|65616025|FG001|Overall Study|Physician Decision|3|||
23512842|NCT01574326|65616024|FG000|Overall Study|Adverse Event|1|||
23512843|NCT01574326|65616025|FG001|Overall Study|Adverse Event|3|||
23512844|NCT01574326|65616024|FG000|Overall Study|Other: Mainly kidney transplant|8|||
23512845|NCT01574326|65616025|FG001|Overall Study|Other: Mainly kidney transplant|8|||
23512846|NCT03804879|65616028|FG000|Overall Study|Adverse Event|3|||
23415317|NCT03268954|65261609|FG001|Overall Study|Withdrawal by Subject|16|||
23415318|NCT03268954|65261608|FG000|Overall Study|Progressive Disease|61|||
23415319|NCT03268954|65261609|FG001|Overall Study|Progressive Disease|48|||
23512847|NCT03804879|65616029|FG001|Overall Study|Adverse Event|0|||
23415320|NCT03268954|65261608|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
23415321|NCT03268954|65261609|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
23415322|NCT03268954|65261608|FG000|Overall Study|Reason not Specified|40|||
23415323|NCT03268954|65261609|FG001|Overall Study|Reason not Specified|40|||
23415324|NCT01974206|65261610|FG000|Overall Study|Did Not Take Study Drug|0|||
23415325|NCT01974206|65261611|FG001|Overall Study|Did Not Take Study Drug|1|||
23415326|NCT01974206|65261610|FG000|Overall Study|Physician Decision|1|||
23415327|NCT01974206|65261611|FG001|Overall Study|Physician Decision|0|||
23415328|NCT01974206|65261610|FG000|Overall Study|Withdrawal by Subject|3|||
23415329|NCT01974206|65261611|FG001|Overall Study|Withdrawal by Subject|0|||
23415330|NCT01974206|65261610|FG000|Overall Study|Lost to Follow-up|1|||
23415331|NCT01974206|65261611|FG001|Overall Study|Lost to Follow-up|0|||
23415332|NCT01974206|65261610|FG000|Overall Study|Death|1|||
23415333|NCT01974206|65261611|FG001|Overall Study|Death|0|||
23415334|NCT05111002|65261612|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
23415335|NCT05111002|65261613|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
23415336|NCT05111002|65261612|FG000|Secondary Outcome|Lost to Follow-up|1|||
23415337|NCT05111002|65261613|FG001|Secondary Outcome|Lost to Follow-up|0|||
23415338|NCT03201965|65261616|FG000|Overall Study|Death|5|||
23415339|NCT03201965|65261617|FG001|Overall Study|Death|27|||
23415340|NCT03201965|65261618|FG002|Overall Study|Death|27|||
23415341|NCT03201965|65261616|FG000|Overall Study|Lost to Follow-up|0|||
23415342|NCT03201965|65261617|FG001|Overall Study|Lost to Follow-up|1|||
23415343|NCT03201965|65261618|FG002|Overall Study|Lost to Follow-up|0|||
23415344|NCT03201965|65261616|FG000|Overall Study|Withdrawal by Subject|3|||
23415345|NCT03201965|65261617|FG001|Overall Study|Withdrawal by Subject|13|||
23415346|NCT03201965|65261618|FG002|Overall Study|Withdrawal by Subject|4|||
23415347|NCT03201965|65261616|FG000|Overall Study|Ongoing|20|||
23415348|NCT03201965|65261617|FG001|Overall Study|Ongoing|152|||
23415349|NCT03201965|65261618|FG002|Overall Study|Ongoing|164|||
23415350|NCT03635424|65261619|FG000|Overall Study|Adverse Event|1|||
23415351|NCT03635424|65261619|FG000|Overall Study|Death|1|||
23415352|NCT03635424|65261619|FG000|Overall Study|Device not implanted|1|||
23415353|NCT04644237|65261620|FG000|Overall Study|Death|3|||
23512848|NCT03804879|65616028|FG000|Overall Study|Study Terminated By Sponsor|10|||
23512849|NCT03804879|65616029|FG001|Overall Study|Study Terminated By Sponsor|12|||
23512850|NCT03804879|65616028|FG000|Overall Study|Withdrawal by Subject|3|||
23512851|NCT03804879|65616029|FG001|Overall Study|Withdrawal by Subject|1|||
23512852|NCT00268996|65616030|FG000|Overall Study|Adverse Event|11|||
23415354|NCT04644237|65261621|FG001|Overall Study|Death|2|||
23415355|NCT04644237|65261620|FG000|Overall Study|Adverse Event|15|||
23415356|NCT04644237|65261621|FG001|Overall Study|Adverse Event|12|||
23415357|NCT04644237|65261620|FG000|Overall Study|Progressive Disease|47|||
23415358|NCT04644237|65261621|FG001|Overall Study|Progressive Disease|19|||
23415359|NCT04644237|65261620|FG000|Overall Study|Clinical Progression|4|||
23415360|NCT04644237|65261621|FG001|Overall Study|Clinical Progression|1|||
23415361|NCT04644237|65261620|FG000|Overall Study|Withdrawal by Subject|1|||
23415362|NCT04644237|65261621|FG001|Overall Study|Withdrawal by Subject|2|||
23415363|NCT04644237|65261620|FG000|Overall Study|Physician Decision|3|||
23512853|NCT00268996|65616031|FG001|Overall Study|Adverse Event|7|||
23512854|NCT00268996|65616030|FG000|Overall Study|Lost to Follow-up|3|||
23512855|NCT00268996|65616031|FG001|Overall Study|Lost to Follow-up|1|||
23512856|NCT00268996|65616030|FG000|Overall Study|Withdrawal by Subject|5|||
23512857|NCT00268996|65616031|FG001|Overall Study|Withdrawal by Subject|11|||
23512858|NCT00268996|65616030|FG000|Overall Study|Non-compliance|1|||
23512859|NCT00268996|65616031|FG001|Overall Study|Non-compliance|0|||
23512860|NCT00268996|65616030|FG000|Overall Study|Other|1|||
23512861|NCT00268996|65616031|FG001|Overall Study|Other|1|||
23512862|NCT00512707|65616032|FG000|Overall Study|Lost to Follow-up|5|||
23512863|NCT00512707|65616033|FG001|Overall Study|Lost to Follow-up|11|||
23512864|NCT00512707|65616032|FG000|Overall Study|Developed skin irritation|2|||
23512865|NCT00512707|65616033|FG001|Overall Study|Developed skin irritation|1|||
23512866|NCT00512707|65616032|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
23512867|NCT00512707|65616033|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
23512868|NCT00512707|65616032|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
23512869|NCT00512707|65616033|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
23512870|NCT04517253|65616034|FG000|Overall Study|Adverse Event|1|||
23512871|NCT04517253|65616035|FG001|Overall Study|Adverse Event|0|||
23512872|NCT04517253|65616036|FG002|Overall Study|Adverse Event|0|||
23512873|NCT04517253|65616034|FG000|Overall Study|Death|0|||
23512874|NCT04517253|65616035|FG001|Overall Study|Death|1|||
23512875|NCT04517253|65616036|FG002|Overall Study|Death|0|||
23512876|NCT00799487|65616037|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
23512877|NCT00799487|65616038|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
23512878|NCT00799487|65616039|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
23512879|NCT00799487|65616037|FG000|Dose Adjustment Period|Adverse Event|2|||
23512880|NCT00799487|65616038|FG001|Dose Adjustment Period|Adverse Event|0|||
23512881|NCT00799487|65616039|FG002|Dose Adjustment Period|Adverse Event|0|||
23512882|NCT00799487|65616037|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
23512883|NCT00799487|65616038|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
23512884|NCT00799487|65616039|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
23512885|NCT00799487|65616037|FG000|Dose Adjustment Period|Investigator Discretion|2|||
23512886|NCT00799487|65616038|FG001|Dose Adjustment Period|Investigator Discretion|0|||
23512887|NCT00799487|65616039|FG002|Dose Adjustment Period|Investigator Discretion|0|||
23512888|NCT00799487|65616037|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
23512889|NCT00799487|65616038|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
23512890|NCT00799487|65616039|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
23512891|NCT00799487|65616037|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
23512892|NCT00799487|65616038|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
23512893|NCT00799487|65616039|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
23710792|NCT00262080|66319191|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
23415364|NCT04644237|65261621|FG001|Overall Study|Physician Decision|0|||
23415365|NCT04644237|65261620|FG000|Overall Study|Other|1|||
23415366|NCT04644237|65261621|FG001|Overall Study|Other|0|||
23415367|NCT04644237|65261620|FG000|Overall Study|Randomized but not Treated|1|||
23415368|NCT04644237|65261621|FG001|Overall Study|Randomized but not Treated|0|||
23415369|NCT02438683|65261625|FG000|Overall Study|Adverse Event|1|||
23415370|NCT02438683|65261626|FG001|Overall Study|Adverse Event|0|||
23415371|NCT02438683|65261627|FG002|Overall Study|Adverse Event|0|||
23415372|NCT02438683|65261628|FG003|Overall Study|Adverse Event|0|||
23415373|NCT02438683|65261629|FG004|Overall Study|Adverse Event|0|||
23415374|NCT02438683|65261630|FG005|Overall Study|Adverse Event|0|||
23611152|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611153|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611154|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611155|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611156|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611157|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415381|NCT03988621|65261632|FG000|Overall Study|Lost to Follow-up|16|||
23415382|NCT03988621|65261633|FG001|Overall Study|Lost to Follow-up|17|||
23415383|NCT03988621|65261632|FG000|Overall Study|Withdrawal by Subject|14|||
23415384|NCT03988621|65261633|FG001|Overall Study|Withdrawal by Subject|7|||
23415385|NCT03988621|65261632|FG000|Overall Study|Patient Lost to Follow Up|1|||
23415386|NCT03988621|65261633|FG001|Overall Study|Patient Lost to Follow Up|8|||
23415387|NCT03988621|65261632|FG000|Overall Study|Patient death|15|||
23415388|NCT03988621|65261633|FG001|Overall Study|Patient death|12|||
23415389|NCT02257528|65261636|FG000|Overall Study|Never received study treatment|1|||
23415390|NCT02254278|65261639|FG000|Overall Study|Protocol Violation|1|||
23415391|NCT02254278|65261640|FG001|Overall Study|Protocol Violation|1|||
23611158|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611159|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23512894|NCT00799487|65616037|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
23512895|NCT00799487|65616038|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
23512896|NCT00799487|65616039|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
23512897|NCT00799487|65616037|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
23611160|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611161|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23611162|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611163|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23512898|NCT00799487|65616038|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
23512899|NCT00799487|65616039|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
23512900|NCT00799487|65616037|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
23512901|NCT00799487|65616038|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
23512902|NCT00799487|65616039|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
23512903|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
23512904|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
23512905|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
23512906|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
23512907|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
23512908|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
23512909|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
23512910|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
23710793|NCT00262080|66319189|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
23710794|NCT00262080|66319190|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
23710795|NCT00262080|66319191|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
23710796|NCT00352755|66319192|FG000|Overall Study|Physician Decision|1|||
23710797|NCT00352755|66319192|FG000|Overall Study|Adverse Event|1|||
23710798|NCT03137121|66319193|FG000|Overall Study|Withdrawal by Subject|0|||
23710799|NCT03137121|66319194|FG001|Overall Study|Withdrawal by Subject|1|||
23710800|NCT00165841|66319195|FG000|Overall Study|Adverse Event|2|||
23710801|NCT00165841|66319196|FG001|Overall Study|Adverse Event|3|||
23710802|NCT00165841|66319195|FG000|Overall Study|Lack of Efficacy|6|||
23710803|NCT00165841|66319196|FG001|Overall Study|Lack of Efficacy|33|||
23710804|NCT00165841|66319195|FG000|Overall Study|Lost to Follow-up|4|||
23710805|NCT00165841|66319196|FG001|Overall Study|Lost to Follow-up|4|||
23710806|NCT00165841|66319195|FG000|Overall Study|Withdrawal by Subject|7|||
23710807|NCT00165841|66319196|FG001|Overall Study|Withdrawal by Subject|8|||
23710808|NCT00165841|66319195|FG000|Overall Study|Physician Decision|1|||
23710809|NCT00165841|66319196|FG001|Overall Study|Physician Decision|0|||
23512911|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
23512912|NCT01110707|65616041|FG000|Overall Study|Protocol Violation|0|||
23512913|NCT01110707|65616042|FG001|Overall Study|Protocol Violation|3|||
23512914|NCT01413191|65616046|FG000|Overall Study|Lost to Follow-up|5|||
23512915|NCT01413191|65616046|FG000|Overall Study|Disease Progression|5|||
23512916|NCT01413191|65616046|FG000|Overall Study|Death|1|||
23512917|NCT00759863|65616047|FG000|Overall Study|Death, moved, or lost contact|20|||
23512918|NCT00759863|65616048|FG001|Overall Study|Death, moved, or lost contact|18|||
23512919|NCT01922089|65616049|FG000|Overall Study|Adverse Event|18|||
23512920|NCT01922089|65616050|FG001|Overall Study|Adverse Event|13|||
23512921|NCT01922089|65616049|FG000|Overall Study|Protocol Deviation|10|||
23512922|NCT01922089|65616050|FG001|Overall Study|Protocol Deviation|7|||
23512923|NCT01922089|65616049|FG000|Overall Study|Withdrawal by Subject|3|||
23512924|NCT01922089|65616050|FG001|Overall Study|Withdrawal by Subject|4|||
23512925|NCT01922089|65616049|FG000|Overall Study|administrative problems|4|||
23512926|NCT01922089|65616050|FG001|Overall Study|administrative problems|1|||
23512927|NCT01922089|65616049|FG000|Overall Study|Physician Decision|2|||
23512928|NCT01922089|65616050|FG001|Overall Study|Physician Decision|3|||
23512929|NCT01922089|65616049|FG000|Overall Study|Death|2|||
23512930|NCT01922089|65616050|FG001|Overall Study|Death|1|||
23512931|NCT01922089|65616049|FG000|Overall Study|Lost to Follow-up|0|||
23512932|NCT01922089|65616050|FG001|Overall Study|Lost to Follow-up|1|||
23512933|NCT03042533|65616051|FG000|Overall Study|MD left program|1|||
23710810|NCT00165841|66319195|FG000|Overall Study|Protocol Violation|6|||
23512934|NCT03042533|65616052|FG001|Overall Study|MD left program|4|||
23512935|NCT03042533|65616053|FG002|Overall Study|MD left program|1|||
23512936|NCT00642941|65616056|FG000|Overall Study|Physician Decision|3|||
23512937|NCT00642941|65616057|FG001|Overall Study|Physician Decision|1|||
23512938|NCT00642941|65616058|FG002|Overall Study|Physician Decision|0|||
23512939|NCT00642941|65616059|FG003|Overall Study|Physician Decision|0|||
23512940|NCT00642941|65616060|FG004|Overall Study|Physician Decision|0|||
23512941|NCT00642941|65616061|FG005|Overall Study|Physician Decision|0|||
23512942|NCT00642941|65616062|FG006|Overall Study|Physician Decision|1|||
23512943|NCT00642941|65616063|FG007|Overall Study|Physician Decision|0|||
23512944|NCT00642941|65616064|FG008|Overall Study|Physician Decision|0|||
23512945|NCT00642941|65616065|FG009|Overall Study|Physician Decision|1|||
23512946|NCT00642941|65616066|FG010|Overall Study|Physician Decision|0|||
23512947|NCT00642941|65616067|FG011|Overall Study|Physician Decision|1|||
23710811|NCT00165841|66319196|FG001|Overall Study|Protocol Violation|8|||
23512948|NCT00642941|65616056|FG000|Overall Study|Death|4|||
23512949|NCT00642941|65616057|FG001|Overall Study|Death|0|||
23512950|NCT00642941|65616058|FG002|Overall Study|Death|1|||
23512951|NCT00642941|65616059|FG003|Overall Study|Death|1|||
23512952|NCT00642941|65616060|FG004|Overall Study|Death|2|||
23710812|NCT00165841|66319195|FG000|Overall Study|Other|3|||
23710813|NCT00165841|66319196|FG001|Overall Study|Other|5|||
23710814|NCT00165841|66319195|FG000|Overall Study|Medication Noncompliance|1|||
23512953|NCT00642941|65616061|FG005|Overall Study|Death|1|||
23512954|NCT00642941|65616062|FG006|Overall Study|Death|0|||
23512955|NCT00642941|65616063|FG007|Overall Study|Death|0|||
23512956|NCT00642941|65616064|FG008|Overall Study|Death|0|||
23512957|NCT00642941|65616065|FG009|Overall Study|Death|0|||
23512958|NCT00642941|65616066|FG010|Overall Study|Death|0|||
23512959|NCT00642941|65616067|FG011|Overall Study|Death|1|||
23512960|NCT00642941|65616056|FG000|Overall Study|Study closed by Sponsor|0|||
23710815|NCT00165841|66319196|FG001|Overall Study|Medication Noncompliance|1|||
23710816|NCT02345252|66319197|FG000|Double-Blind Phase|Adverse Event|2|||
23710817|NCT02345252|66319198|FG001|Double-Blind Phase|Adverse Event|3|||
23710818|NCT02345252|66319197|FG000|Double-Blind Phase|Death|1|||
23710819|NCT02345252|66319198|FG001|Double-Blind Phase|Death|2|||
23710820|NCT02345252|66319197|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23710821|NCT02345252|66319198|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23710822|NCT02345252|66319197|FG000|Double-Blind Phase|Investigator's Discretion|4|||
23710823|NCT02345252|66319198|FG001|Double-Blind Phase|Investigator's Discretion|6|||
23710824|NCT02345252|66319197|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23710825|NCT02345252|66319198|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
23710826|NCT02345252|66319197|FG000|Double-Blind Phase|Protocol Violation|2|||
23710827|NCT02345252|66319198|FG001|Double-Blind Phase|Protocol Violation|1|||
23710828|NCT02345252|66319197|FG000|Double-Blind Phase|Withdrew Consent|21|||
23710829|NCT02345252|66319198|FG001|Double-Blind Phase|Withdrew Consent|23|||
23710830|NCT02345252|66319197|FG000|Double-Blind Phase|Lost to Follow-up|8|||
23710831|NCT02345252|66319198|FG001|Double-Blind Phase|Lost to Follow-up|10|||
23710832|NCT02345252|66319197|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
23710833|NCT02345252|66319198|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
23710834|NCT00356863|66319200|FG000|Overall Study|Death|16|||
23710835|NCT00356863|66319201|FG001|Overall Study|Death|32|||
23710836|NCT00356863|66319200|FG000|Overall Study|Lost to Follow-up|76|||
23710837|NCT00356863|66319201|FG001|Overall Study|Lost to Follow-up|43|||
23710838|NCT01104558|66319204|FG000|Overall Study|Protocol Violation|6|||
23710839|NCT01104558|66319204|FG000|Overall Study|Missing of primary efficacy assessment|10|||
23710840|NCT01104558|66319204|FG000|Overall Study|Missing of genetic analysis results|1|||
23710841|NCT02815293|66319207|FG000|Overall Study|Study termination by sponsor|10|||
23710842|NCT02815293|66319208|FG001|Overall Study|Study termination by sponsor|7|||
23710843|NCT02815293|66319209|FG002|Overall Study|Study termination by sponsor|0|||
23710844|NCT02815293|66319207|FG000|Overall Study|Participants not randomized|0|||
23710845|NCT02815293|66319208|FG001|Overall Study|Participants not randomized|0|||
23710846|NCT02815293|66319209|FG002|Overall Study|Participants not randomized|18|||
23710847|NCT02815293|66319207|FG000|Overall Study|Adverse Event|0|||
23710848|NCT02815293|66319208|FG001|Overall Study|Adverse Event|1|||
23710849|NCT02815293|66319209|FG002|Overall Study|Adverse Event|0|||
23710850|NCT00353496|66319210|FG000|Overall Study|Adverse Event|1|||
23710851|NCT00353496|66319211|FG001|Overall Study|Adverse Event|0|||
23710852|NCT00353496|66319210|FG000|Overall Study|Protocol Violation|2|||
23710853|NCT00353496|66319211|FG001|Overall Study|Protocol Violation|2|||
23710854|NCT00353496|66319210|FG000|Overall Study|Withdrawal by Subject|3|||
23710855|NCT00353496|66319211|FG001|Overall Study|Withdrawal by Subject|4|||
23710856|NCT00353496|66319210|FG000|Overall Study|Physician Decision|6|||
23710857|NCT00353496|66319211|FG001|Overall Study|Physician Decision|9|||
23710858|NCT00353496|66319210|FG000|Overall Study|Not otherwise specified|4|||
23710859|NCT00353496|66319211|FG001|Overall Study|Not otherwise specified|2|||
23710860|NCT00296725|66319212|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
23512961|NCT00642941|65616057|FG001|Overall Study|Study closed by Sponsor|1|||
23512962|NCT00642941|65616058|FG002|Overall Study|Study closed by Sponsor|0|||
23512963|NCT00642941|65616059|FG003|Overall Study|Study closed by Sponsor|0|||
23512964|NCT00642941|65616060|FG004|Overall Study|Study closed by Sponsor|0|||
23710861|NCT00296725|66319212|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
23710862|NCT00296725|66319212|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
23710863|NCT00948818|66319213|FG000|Overall Study|Adverse Event|10|||
23710864|NCT00948818|66319214|FG001|Overall Study|Adverse Event|32|||
23710865|NCT00948818|66319213|FG000|Overall Study|Protocol Violation|9|||
23710866|NCT00948818|66319214|FG001|Overall Study|Protocol Violation|10|||
23710867|NCT00948818|66319213|FG000|Overall Study|Withdrawal by Subject|25|||
23710868|NCT00948818|66319214|FG001|Overall Study|Withdrawal by Subject|25|||
23710869|NCT00948818|66319213|FG000|Overall Study|Lost to Follow-up|10|||
23512965|NCT00642941|65616061|FG005|Overall Study|Study closed by Sponsor|0|||
23512966|NCT00642941|65616062|FG006|Overall Study|Study closed by Sponsor|0|||
23512967|NCT00642941|65616063|FG007|Overall Study|Study closed by Sponsor|0|||
23710870|NCT00948818|66319214|FG001|Overall Study|Lost to Follow-up|17|||
23710871|NCT00948818|66319213|FG000|Overall Study|Lack of Efficacy|4|||
23710872|NCT00948818|66319214|FG001|Overall Study|Lack of Efficacy|5|||
23710873|NCT00948818|66319213|FG000|Overall Study|Other Reason|4|||
23710874|NCT00948818|66319214|FG001|Overall Study|Other Reason|5|||
23512968|NCT00642941|65616064|FG008|Overall Study|Study closed by Sponsor|0|||
23710875|NCT00976950|66319215|FG000|Overall Study|Adverse Event|3|||
23710876|NCT00976950|66319215|FG000|Overall Study|Events with no relationship to Aptivus|3|||
23710877|NCT04587453|66319216|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
23710878|NCT04587453|66319217|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
23710879|NCT02927873|66319218|FG000|Overall Study|Lost to Follow-up|0|||
23710880|NCT02927873|66319219|FG001|Overall Study|Lost to Follow-up|1|||
23710881|NCT02927873|66319220|FG002|Overall Study|Lost to Follow-up|0|||
23710882|NCT02927873|66319221|FG003|Overall Study|Lost to Follow-up|0|||
23710883|NCT02927873|66319222|FG004|Overall Study|Lost to Follow-up|0|||
23710884|NCT02927873|66319223|FG005|Overall Study|Lost to Follow-up|0|||
23710885|NCT02927873|66319218|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23710886|NCT02927873|66319219|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23710887|NCT02927873|66319220|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23710888|NCT02927873|66319221|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23710889|NCT02927873|66319222|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23710890|NCT02927873|66319223|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23710891|NCT02927873|66319218|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23710892|NCT02927873|66319219|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23710893|NCT02927873|66319220|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23710894|NCT02927873|66319221|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23710895|NCT02927873|66319222|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23710896|NCT02927873|66319223|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23710897|NCT02927873|66319218|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23710898|NCT02927873|66319219|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
23710899|NCT02927873|66319220|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23710900|NCT02927873|66319221|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23710901|NCT02927873|66319222|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23710902|NCT02927873|66319223|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23710903|NCT02927873|66319218|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
23710904|NCT02927873|66319219|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23710905|NCT02927873|66319220|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23710906|NCT02927873|66319221|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23710907|NCT02927873|66319222|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23710908|NCT02927873|66319223|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23710909|NCT02927873|66319218|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
23710910|NCT02927873|66319219|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23710911|NCT02927873|66319220|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23710912|NCT02927873|66319221|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23710913|NCT02927873|66319222|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23710914|NCT02927873|66319223|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23710915|NCT01561560|66319224|FG000|First Two Weeks of Wear|Time/job conflict|0|||
23710916|NCT01561560|66319225|FG001|First Two Weeks of Wear|Time/job conflict|1|||
23710917|NCT01561560|66319224|FG000|First Two Weeks of Wear|Adverse Event|0|||
23710918|NCT01561560|66319225|FG001|First Two Weeks of Wear|Adverse Event|1|||
23710919|NCT01561560|66319224|FG000|Second Two Weeks of Wear|Adverse Event|0|||
23710920|NCT01561560|66319225|FG001|Second Two Weeks of Wear|Adverse Event|1|||
23710921|NCT01051986|66319226|FG000|Overall Study|Death|1|||
23710922|NCT01051986|66319227|FG001|Overall Study|Death|0|||
23710923|NCT01051986|66319226|FG000|Overall Study|Withdrawal by Subject|2|||
23710924|NCT01051986|66319227|FG001|Overall Study|Withdrawal by Subject|1|||
23710925|NCT01051986|66319226|FG000|Overall Study|Protocol Violation|2|||
23710926|NCT01051986|66319227|FG001|Overall Study|Protocol Violation|3|||
23710927|NCT00377611|66319229|FG000|Overall Study|Adverse Event|2|||
23710928|NCT00377611|66319230|FG001|Overall Study|Adverse Event|9|||
23710929|NCT00377611|66319229|FG000|Overall Study|Protocol Violation|2|||
23710930|NCT00377611|66319230|FG001|Overall Study|Protocol Violation|0|||
23710931|NCT00377611|66319229|FG000|Overall Study|Withdrawal by Subject|0|||
23710932|NCT00377611|66319230|FG001|Overall Study|Withdrawal by Subject|5|||
23710933|NCT00377611|66319229|FG000|Overall Study|Lost to Follow-up|18|||
23710934|NCT00377611|66319230|FG001|Overall Study|Lost to Follow-up|16|||
23710935|NCT00377611|66319229|FG000|Overall Study|Other|0|||
23710936|NCT00377611|66319230|FG001|Overall Study|Other|3|||
23710937|NCT03649321|66319231|FG000|Overall Study|Withdrawal by Subject|1|||
23710938|NCT03649321|66319232|FG001|Overall Study|Withdrawal by Subject|0|||
23710939|NCT03649321|66319231|FG000|Overall Study|Death|1|||
23710940|NCT03649321|66319232|FG001|Overall Study|Death|0|||
23710941|NCT03151148|66319235|FG000|Overall Study|Lost to Follow-up|1|||
23710942|NCT03151148|66319236|FG001|Overall Study|Lost to Follow-up|0|||
23710943|NCT03151148|66319235|FG000|Overall Study|Withdrawal by Subject|1|||
23710944|NCT03151148|66319236|FG001|Overall Study|Withdrawal by Subject|0|||
23710945|NCT00511342|66319237|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
23710946|NCT00511342|66319238|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
23710947|NCT00511342|66319237|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
23710948|NCT00511342|66319238|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
23710949|NCT00511342|66319237|FG000|Overall Study|Pregnancy|0|||
23512969|NCT00642941|65616065|FG009|Overall Study|Study closed by Sponsor|0|||
23512970|NCT00642941|65616066|FG010|Overall Study|Study closed by Sponsor|0|||
23512971|NCT00642941|65616067|FG011|Overall Study|Study closed by Sponsor|0|||
23512972|NCT00642941|65616056|FG000|Overall Study|Withdrawal by Subject|1|||
23512973|NCT00642941|65616057|FG001|Overall Study|Withdrawal by Subject|0|||
23512974|NCT00642941|65616058|FG002|Overall Study|Withdrawal by Subject|0|||
23512975|NCT00642941|65616059|FG003|Overall Study|Withdrawal by Subject|2|||
23512976|NCT00642941|65616060|FG004|Overall Study|Withdrawal by Subject|0|||
23512977|NCT00642941|65616061|FG005|Overall Study|Withdrawal by Subject|0|||
23512978|NCT00642941|65616062|FG006|Overall Study|Withdrawal by Subject|2|||
23512979|NCT00642941|65616063|FG007|Overall Study|Withdrawal by Subject|0|||
23512980|NCT00642941|65616064|FG008|Overall Study|Withdrawal by Subject|1|||
23512981|NCT00642941|65616065|FG009|Overall Study|Withdrawal by Subject|0|||
23512982|NCT00642941|65616066|FG010|Overall Study|Withdrawal by Subject|0|||
23512983|NCT00642941|65616067|FG011|Overall Study|Withdrawal by Subject|1|||
23512984|NCT00642941|65616056|FG000|Overall Study|Protocol Violation|0|||
23512985|NCT00642941|65616057|FG001|Overall Study|Protocol Violation|0|||
23512986|NCT00642941|65616058|FG002|Overall Study|Protocol Violation|0|||
23512987|NCT00642941|65616059|FG003|Overall Study|Protocol Violation|0|||
23512988|NCT00642941|65616060|FG004|Overall Study|Protocol Violation|0|||
23512989|NCT00642941|65616061|FG005|Overall Study|Protocol Violation|0|||
23512990|NCT00642941|65616062|FG006|Overall Study|Protocol Violation|1|||
23512991|NCT00642941|65616063|FG007|Overall Study|Protocol Violation|0|||
23512992|NCT00642941|65616064|FG008|Overall Study|Protocol Violation|0|||
23512993|NCT00642941|65616065|FG009|Overall Study|Protocol Violation|0|||
23512994|NCT00642941|65616066|FG010|Overall Study|Protocol Violation|0|||
23512995|NCT00642941|65616067|FG011|Overall Study|Protocol Violation|0|||
23512996|NCT00642941|65616056|FG000|Overall Study|Adverse Event|1|||
23512997|NCT00642941|65616057|FG001|Overall Study|Adverse Event|1|||
23512998|NCT00642941|65616058|FG002|Overall Study|Adverse Event|0|||
23512999|NCT00642941|65616059|FG003|Overall Study|Adverse Event|0|||
23513000|NCT00642941|65616060|FG004|Overall Study|Adverse Event|0|||
23513001|NCT00642941|65616061|FG005|Overall Study|Adverse Event|0|||
23513002|NCT00642941|65616062|FG006|Overall Study|Adverse Event|1|||
23513003|NCT00642941|65616063|FG007|Overall Study|Adverse Event|1|||
23513004|NCT00642941|65616064|FG008|Overall Study|Adverse Event|0|||
23513005|NCT00642941|65616065|FG009|Overall Study|Adverse Event|1|||
23513006|NCT00642941|65616066|FG010|Overall Study|Adverse Event|0|||
23513007|NCT00642941|65616067|FG011|Overall Study|Adverse Event|0|||
23513008|NCT00642941|65616056|FG000|Overall Study|Other|1|||
23513009|NCT00642941|65616057|FG001|Overall Study|Other|1|||
23513010|NCT00642941|65616058|FG002|Overall Study|Other|1|||
23513011|NCT00642941|65616059|FG003|Overall Study|Other|1|||
23513012|NCT00642941|65616060|FG004|Overall Study|Other|0|||
23513013|NCT00642941|65616061|FG005|Overall Study|Other|1|||
23513014|NCT00642941|65616062|FG006|Overall Study|Other|0|||
23513015|NCT00642941|65616063|FG007|Overall Study|Other|1|||
23513016|NCT00642941|65616064|FG008|Overall Study|Other|0|||
23513017|NCT00642941|65616065|FG009|Overall Study|Other|0|||
23513018|NCT00642941|65616066|FG010|Overall Study|Other|0|||
23513019|NCT00642941|65616067|FG011|Overall Study|Other|1|||
23513020|NCT00642941|65616056|FG000|Overall Study|Disease progression|60|||
23513021|NCT00642941|65616057|FG001|Overall Study|Disease progression|50|||
23513022|NCT00642941|65616058|FG002|Overall Study|Disease progression|5|||
23513023|NCT00642941|65616059|FG003|Overall Study|Disease progression|36|||
23513024|NCT00642941|65616060|FG004|Overall Study|Disease progression|23|||
23513025|NCT00642941|65616061|FG005|Overall Study|Disease progression|39|||
23710950|NCT00511342|66319238|FG001|Overall Study|Pregnancy|1|||
23513026|NCT00642941|65616062|FG006|Overall Study|Disease progression|18|||
23513027|NCT00642941|65616063|FG007|Overall Study|Disease progression|12|||
23513028|NCT00642941|65616064|FG008|Overall Study|Disease progression|10|||
23513029|NCT00642941|65616065|FG009|Overall Study|Disease progression|7|||
23513030|NCT00642941|65616066|FG010|Overall Study|Disease progression|12|||
23513031|NCT00642941|65616067|FG011|Overall Study|Disease progression|7|||
23513032|NCT00770289|65616071|FG000|Overall Study|Other|6|||
23513033|NCT03021265|65616081|FG000|Overall Study|Adverse Event|29|||
23513034|NCT03021265|65616081|FG000|Overall Study|Lack of Efficacy|3|||
23710951|NCT00511342|66319237|FG000|Overall Study|Pregnancy wish|0|||
23513035|NCT03021265|65616081|FG000|Overall Study|Improved|17|||
23513036|NCT03021265|65616081|FG000|Overall Study|Lost to Follow-up|67|||
23513037|NCT03021265|65616081|FG000|Overall Study|No reason given|2|||
23710952|NCT00511342|66319238|FG001|Overall Study|Pregnancy wish|1|||
23710953|NCT00511342|66319237|FG000|Overall Study|Lost to Follow-up|1|||
23710954|NCT00511342|66319238|FG001|Overall Study|Lost to Follow-up|5|||
23710955|NCT00511342|66319237|FG000|Overall Study|Other Reason|2|||
23710956|NCT00511342|66319238|FG001|Overall Study|Other Reason|2|||
23710957|NCT00772382|66319239|FG000|Overall Study|Adverse Event|19|||
23710958|NCT00772382|66319239|FG000|Overall Study|Death|6|||
23710959|NCT00772382|66319239|FG000|Overall Study|Lack of Efficacy|4|||
23415400|NCT03763656|65261654|FG000|Overall Study|Physician Decision|1|||
23415401|NCT03763656|65261654|FG000|Overall Study|Protocol Violation|1|||
23415402|NCT03763656|65261654|FG000|Overall Study|Withdrawal by Subject|7|||
23415403|NCT02701283|65261655|FG000|Overall Study|Death|25|||
23415404|NCT02701283|65261656|FG001|Overall Study|Death|29|||
23415405|NCT02701283|65261657|FG002|Overall Study|Death|19|||
23415406|NCT02701283|65261655|FG000|Overall Study|Lost to Follow-up|3|||
23415407|NCT02701283|65261656|FG001|Overall Study|Lost to Follow-up|8|||
23415408|NCT02701283|65261657|FG002|Overall Study|Lost to Follow-up|1|||
23415409|NCT02701283|65261655|FG000|Overall Study|Withdrawal by Subject|12|||
23415410|NCT02701283|65261656|FG001|Overall Study|Withdrawal by Subject|41|||
23415411|NCT02701283|65261657|FG002|Overall Study|Withdrawal by Subject|1|||
23415412|NCT02701283|65261655|FG000|Overall Study|Missed 2-year visit|22|||
23415413|NCT02701283|65261656|FG001|Overall Study|Missed 2-year visit|27|||
23415414|NCT02701283|65261657|FG002|Overall Study|Missed 2-year visit|0|||
23415415|NCT02701283|65261655|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
23415416|NCT02701283|65261656|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
23415417|NCT02701283|65261657|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
23415418|NCT00211757|65261658|FG000|Overall Study|Withdrawal by Subject|1|||
23415419|NCT00211757|65261659|FG001|Overall Study|Withdrawal by Subject|1|||
23415420|NCT00211757|65261658|FG000|Overall Study|Lack of Efficacy|0|||
23415421|NCT00211757|65261659|FG001|Overall Study|Lack of Efficacy|1|||
23415422|NCT04669262|65262426|FG000|Overall Study|Withdrawal by Subject|0|||
23415423|NCT04669262|65262427|FG001|Overall Study|Withdrawal by Subject|0|||
23415424|NCT04669262|65262428|FG002|Overall Study|Withdrawal by Subject|0|||
23415425|NCT04669262|65262429|FG003|Overall Study|Withdrawal by Subject|1|||
23415426|NCT04669262|65262426|FG000|Overall Study|Randomized but Not Treated|0|||
23415427|NCT04669262|65262427|FG001|Overall Study|Randomized but Not Treated|1|||
23415428|NCT04669262|65262428|FG002|Overall Study|Randomized but Not Treated|0|||
23415429|NCT04669262|65262429|FG003|Overall Study|Randomized but Not Treated|0|||
23415430|NCT05151445|65262430|FG000|Overall Study|Withdrawal by Subject|3|||
23415431|NCT01638013|65262431|FG000|Overall Study|Adverse Event|36|||
23415432|NCT01638013|65262432|FG001|Overall Study|Adverse Event|29|||
23415433|NCT01638013|65262433|FG002|Overall Study|Adverse Event|48|||
23415434|NCT01638013|65262431|FG000|Overall Study|Lack of Efficacy|39|||
23415435|NCT01638013|65262432|FG001|Overall Study|Lack of Efficacy|11|||
23415436|NCT01638013|65262433|FG002|Overall Study|Lack of Efficacy|14|||
23415437|NCT01638013|65262431|FG000|Overall Study|Protocol Violation|10|||
23415438|NCT01638013|65262432|FG001|Overall Study|Protocol Violation|7|||
23415439|NCT01638013|65262433|FG002|Overall Study|Protocol Violation|11|||
23415440|NCT01638013|65262431|FG000|Overall Study|Met discontinuation criteria|4|||
23415441|NCT01638013|65262432|FG001|Overall Study|Met discontinuation criteria|0|||
23415442|NCT01638013|65262433|FG002|Overall Study|Met discontinuation criteria|7|||
23415443|NCT01638013|65262431|FG000|Overall Study|Subject Lost to Follow up|1|||
23415444|NCT01638013|65262432|FG001|Overall Study|Subject Lost to Follow up|0|||
23415445|NCT01638013|65262433|FG002|Overall Study|Subject Lost to Follow up|1|||
23415446|NCT01638013|65262431|FG000|Overall Study|Miscellaneous|25|||
23415447|NCT01638013|65262432|FG001|Overall Study|Miscellaneous|19|||
23415448|NCT01638013|65262433|FG002|Overall Study|Miscellaneous|23|||
23415449|NCT01638013|65262431|FG000|Overall Study|Withdrawal of Consent|16|||
23415450|NCT01638013|65262432|FG001|Overall Study|Withdrawal of Consent|12|||
23415451|NCT01638013|65262433|FG002|Overall Study|Withdrawal of Consent|16|||
23415452|NCT01638013|65262431|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
23415453|NCT01638013|65262432|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
23415454|NCT01638013|65262433|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
23415455|NCT04647253|65262436|FG000|Overall Study|Death ≤ 365 Days|16|||
23415456|NCT04647253|65262437|FG001|Overall Study|Death ≤ 365 Days|7|||
23415457|NCT04647253|65262436|FG000|Overall Study|Physician Decision|0|||
23415458|NCT04647253|65262437|FG001|Overall Study|Physician Decision|1|||
23415459|NCT04647253|65262436|FG000|Overall Study|Withdrawal by Subject|7|||
23415460|NCT04647253|65262437|FG001|Overall Study|Withdrawal by Subject|2|||
23415461|NCT04647253|65262436|FG000|Overall Study|Missed 12-Month Visit|9|||
23415462|NCT04647253|65262437|FG001|Overall Study|Missed 12-Month Visit|7|||
23415463|NCT04647253|65262436|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
23453510|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23415464|NCT04647253|65262437|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
23415465|NCT00977574|65262438|FG000|Overall Study|Never Treated|4|||
23415466|NCT00977574|65262439|FG001|Overall Study|Never Treated|2|||
23415467|NCT00977574|65262440|FG002|Overall Study|Never Treated|4|||
23415468|NCT04470908|65262444|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
23415469|NCT03206918|65262445|FG000|Overall Study|Death|11|||
23415470|NCT03206918|65262445|FG000|Overall Study|Withdrawal by Subject|5|||
23415471|NCT03206918|65262445|FG000|Overall Study|Study terminated by sponsor|12|||
23415472|NCT03206918|65262445|FG000|Overall Study|Lost to Follow-up|3|||
23415473|NCT03206918|65262445|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
23611164|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611165|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611166|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611167|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611168|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611169|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611170|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611171|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611172|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611173|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611174|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611175|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611176|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611177|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611178|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611179|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611180|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611181|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611182|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611183|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611184|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
23710960|NCT00772382|66319239|FG000|Overall Study|Physician Decision|5|||
23710961|NCT00772382|66319239|FG000|Overall Study|Protocol Violation|1|||
23415498|NCT02305849|65262448|FG000|Overall Study|Adverse Event|10|||
23415499|NCT02305849|65262449|FG001|Overall Study|Adverse Event|12|||
23415500|NCT02305849|65262450|FG002|Overall Study|Adverse Event|7|||
23415501|NCT02305849|65262451|FG003|Overall Study|Adverse Event|3|||
23415502|NCT02305849|65262448|FG000|Overall Study|Lack of Efficacy|10|||
23415503|NCT02305849|65262449|FG001|Overall Study|Lack of Efficacy|6|||
23415504|NCT02305849|65262450|FG002|Overall Study|Lack of Efficacy|3|||
23415505|NCT02305849|65262451|FG003|Overall Study|Lack of Efficacy|9|||
23415506|NCT02305849|65262448|FG000|Overall Study|Withdrawal by Subject|2|||
23415507|NCT02305849|65262449|FG001|Overall Study|Withdrawal by Subject|2|||
23415508|NCT02305849|65262450|FG002|Overall Study|Withdrawal by Subject|1|||
23415509|NCT02305849|65262451|FG003|Overall Study|Withdrawal by Subject|4|||
23415510|NCT02305849|65262448|FG000|Overall Study|Lost to Follow-up|0|||
23415511|NCT02305849|65262449|FG001|Overall Study|Lost to Follow-up|2|||
23415512|NCT02305849|65262450|FG002|Overall Study|Lost to Follow-up|0|||
23415513|NCT02305849|65262451|FG003|Overall Study|Lost to Follow-up|0|||
23415514|NCT02305849|65262448|FG000|Overall Study|Protocol Violation|3|||
23415515|NCT02305849|65262449|FG001|Overall Study|Protocol Violation|2|||
23415516|NCT02305849|65262450|FG002|Overall Study|Protocol Violation|1|||
23415517|NCT02305849|65262451|FG003|Overall Study|Protocol Violation|1|||
23415518|NCT02305849|65262448|FG000|Overall Study|Lab data met discontinuation criteria|0|||
23415519|NCT02305849|65262449|FG001|Overall Study|Lab data met discontinuation criteria|1|||
23415520|NCT02305849|65262450|FG002|Overall Study|Lab data met discontinuation criteria|2|||
23415521|NCT02305849|65262451|FG003|Overall Study|Lab data met discontinuation criteria|1|||
23415522|NCT02305849|65262448|FG000|Overall Study|Miscellaneous|1|||
23415523|NCT02305849|65262449|FG001|Overall Study|Miscellaneous|2|||
23415524|NCT02305849|65262450|FG002|Overall Study|Miscellaneous|4|||
23415525|NCT02305849|65262451|FG003|Overall Study|Miscellaneous|1|||
23415526|NCT02305849|65262448|FG000|Overall Study|Not fulfill eligibility criteria|1|||
23513038|NCT03021265|65616081|FG000|Overall Study|No visit since the first visit|4|||
23415527|NCT02305849|65262449|FG001|Overall Study|Not fulfill eligibility criteria|1|||
23415528|NCT02305849|65262450|FG002|Overall Study|Not fulfill eligibility criteria|0|||
23415529|NCT02305849|65262451|FG003|Overall Study|Not fulfill eligibility criteria|0|||
23415530|NCT04068519|65262463|FG000|Dose Verification|Death|15|||
23415531|NCT04068519|65262463|FG000|Dose Verification|Withdrawal by Subject|1|||
23415532|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Death|35|||
23415533|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
23415534|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
23415535|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
23415536|NCT04068519|65262463|FG000|Indication Expansion|Death|152|||
23513039|NCT01502423|65616082|FG000|Overall Study|Withdrawal by Subject|0|||
23513040|NCT01502423|65616083|FG001|Overall Study|Withdrawal by Subject|1|||
23513041|NCT00842712|65616084|FG000|Safety Run-in Part|Adverse Event|0|||
23513042|NCT00842712|65616085|FG001|Safety Run-in Part|Adverse Event|1|||
23513043|NCT00842712|65616086|FG002|Safety Run-in Part|Adverse Event|0|||
23513044|NCT00842712|65616087|FG003|Safety Run-in Part|Adverse Event|0|||
23513045|NCT00842712|65616088|FG004|Safety Run-in Part|Adverse Event|0|||
23513046|NCT00842712|65616089|FG005|Safety Run-in Part|Adverse Event|0|||
23513047|NCT00842712|65616090|FG006|Safety Run-in Part|Adverse Event|0|||
23513048|NCT00842712|65616084|FG000|Safety Run-in Part|Progressive disease|3|||
23513049|NCT00842712|65616085|FG001|Safety Run-in Part|Progressive disease|1|||
23513050|NCT00842712|65616086|FG002|Safety Run-in Part|Progressive disease|0|||
23513051|NCT00842712|65616087|FG003|Safety Run-in Part|Progressive disease|1|||
23513052|NCT00842712|65616088|FG004|Safety Run-in Part|Progressive disease|0|||
23513053|NCT00842712|65616089|FG005|Safety Run-in Part|Progressive disease|0|||
23513054|NCT00842712|65616090|FG006|Safety Run-in Part|Progressive disease|0|||
23513055|NCT00842712|65616084|FG000|Randomized Part|Randomized but not treated|0|||
23513056|NCT00842712|65616085|FG001|Randomized Part|Randomized but not treated|0|||
23513057|NCT00842712|65616086|FG002|Randomized Part|Randomized but not treated|0|||
23513058|NCT00842712|65616087|FG003|Randomized Part|Randomized but not treated|0|||
23513059|NCT00842712|65616088|FG004|Randomized Part|Randomized but not treated|0|||
23513060|NCT00842712|65616089|FG005|Randomized Part|Randomized but not treated|1|||
23513061|NCT00842712|65616090|FG006|Randomized Part|Randomized but not treated|4|||
23513062|NCT00842712|65616084|FG000|Randomized Part|Ongoing at cut-off date|0|||
23513063|NCT00842712|65616085|FG001|Randomized Part|Ongoing at cut-off date|0|||
23513064|NCT00842712|65616086|FG002|Randomized Part|Ongoing at cut-off date|0|||
23710962|NCT00772382|66319239|FG000|Overall Study|Withdrawal by Subject|10|||
23710963|NCT00772382|66319239|FG000|Overall Study|Other Reasons|10|||
23710964|NCT00448916|66319245|FG000|Overall Study|Adverse Event|2|||
23710965|NCT00448916|66319246|FG001|Overall Study|Adverse Event|2|||
23710966|NCT00448916|66319247|FG002|Overall Study|Adverse Event|3|||
23710967|NCT00448916|66319248|FG003|Overall Study|Adverse Event|2|||
23710968|NCT00448916|66319245|FG000|Overall Study|Lack of Efficacy|1|||
23710969|NCT00448916|66319246|FG001|Overall Study|Lack of Efficacy|0|||
23710970|NCT00448916|66319247|FG002|Overall Study|Lack of Efficacy|2|||
23710971|NCT00448916|66319248|FG003|Overall Study|Lack of Efficacy|1|||
23710972|NCT00448916|66319245|FG000|Overall Study|Withdrawal by Subject|3|||
23710973|NCT00448916|66319246|FG001|Overall Study|Withdrawal by Subject|3|||
23513065|NCT00842712|65616087|FG003|Randomized Part|Ongoing at cut-off date|0|||
23513066|NCT00842712|65616088|FG004|Randomized Part|Ongoing at cut-off date|0|||
23710974|NCT00448916|66319247|FG002|Overall Study|Withdrawal by Subject|1|||
23710975|NCT00448916|66319248|FG003|Overall Study|Withdrawal by Subject|1|||
23710976|NCT00448916|66319245|FG000|Overall Study|Other|1|||
23710977|NCT00448916|66319246|FG001|Overall Study|Other|0|||
23710978|NCT00448916|66319247|FG002|Overall Study|Other|0|||
23710979|NCT00448916|66319248|FG003|Overall Study|Other|0|||
23710980|NCT00448916|66319245|FG000|Overall Study|Lost to Follow-up|0|||
23710981|NCT00448916|66319246|FG001|Overall Study|Lost to Follow-up|1|||
23710982|NCT00448916|66319247|FG002|Overall Study|Lost to Follow-up|0|||
23710983|NCT00448916|66319248|FG003|Overall Study|Lost to Follow-up|1|||
23710984|NCT00448916|66319245|FG000|Overall Study|Protocol Violation|0|||
23710985|NCT00448916|66319246|FG001|Overall Study|Protocol Violation|0|||
23710986|NCT00448916|66319247|FG002|Overall Study|Protocol Violation|0|||
23710987|NCT00448916|66319248|FG003|Overall Study|Protocol Violation|1|||
23710988|NCT00980343|66319249|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
23710989|NCT00980343|66319250|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
23710990|NCT00471445|66319254|FG000|Overall Study|Withdrawal by Subject|1|||
23710991|NCT00471445|66319255|FG001|Overall Study|Withdrawal by Subject|1|||
23513067|NCT00842712|65616089|FG005|Randomized Part|Ongoing at cut-off date|0|||
23513068|NCT00842712|65616090|FG006|Randomized Part|Ongoing at cut-off date|2|||
23710992|NCT00471445|66319254|FG000|Overall Study|Ineligible|1|||
23710993|NCT00471445|66319255|FG001|Overall Study|Ineligible|0|||
23513069|NCT00656474|65616093|FG000|Overall Study|Other Reason|1|||
23513070|NCT00540514|65616094|FG000|Overall Study|Still on treatment|3|||
23513071|NCT00540514|65616095|FG001|Overall Study|Still on treatment|0|||
23513072|NCT00540514|65616094|FG000|Overall Study|Unacceptable Toxicity|61|||
23513073|NCT00540514|65616095|FG001|Overall Study|Unacceptable Toxicity|62|||
23513074|NCT00540514|65616094|FG000|Overall Study|Adverse Event|20|||
23513075|NCT00540514|65616095|FG001|Overall Study|Adverse Event|24|||
23513076|NCT00540514|65616094|FG000|Overall Study|Physician Decision|86|||
23513077|NCT00540514|65616095|FG001|Overall Study|Physician Decision|99|||
23513078|NCT00540514|65616094|FG000|Overall Study|Protocol Deviation|3|||
23513079|NCT00540514|65616095|FG001|Overall Study|Protocol Deviation|4|||
23513080|NCT00540514|65616094|FG000|Overall Study|Lost to Follow-up|1|||
23513081|NCT00540514|65616095|FG001|Overall Study|Lost to Follow-up|1|||
23710994|NCT00471445|66319254|FG000|Overall Study|Protocol Violation|0|||
23710995|NCT00471445|66319255|FG001|Overall Study|Protocol Violation|1|||
23710996|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
23513082|NCT00540514|65616094|FG000|Overall Study|Withdrawal by Subject|65|||
23513083|NCT00540514|65616095|FG001|Overall Study|Withdrawal by Subject|67|||
23513084|NCT00540514|65616094|FG000|Overall Study|Excluded prior to treatment|7|||
23513085|NCT00540514|65616095|FG001|Overall Study|Excluded prior to treatment|7|||
23513086|NCT00540514|65616094|FG000|Overall Study|Paclitaxel not available|0|||
23513087|NCT00540514|65616095|FG001|Overall Study|Paclitaxel not available|2|||
23513088|NCT00511667|65616096|FG000|Overall Study|Adverse Event|1|||
23513089|NCT00511667|65616097|FG001|Overall Study|Adverse Event|0|||
23513090|NCT00511667|65616096|FG000|Overall Study|Protocol Violation|1|||
23513091|NCT00511667|65616097|FG001|Overall Study|Protocol Violation|1|||
23513092|NCT00511667|65616096|FG000|Overall Study|Withdrawal by Subject|2|||
23513093|NCT00511667|65616097|FG001|Overall Study|Withdrawal by Subject|0|||
23513094|NCT00511667|65616096|FG000|Overall Study|Site terminated|6|||
23513095|NCT00511667|65616097|FG001|Overall Study|Site terminated|1|||
23513096|NCT00511667|65616096|FG000|Overall Study|Other|2|||
23513097|NCT00511667|65616097|FG001|Overall Study|Other|1|||
23513098|NCT00592839|65616098|FG000|Overall Study|Withdrawal by Subject|1|||
23513099|NCT00592839|65616099|FG001|Overall Study|Withdrawal by Subject|1|||
23513100|NCT00592839|65616100|FG002|Overall Study|Withdrawal by Subject|3|||
23710997|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23710998|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
23710999|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
23711000|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23711001|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23711002|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23711003|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
23711004|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
23711005|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
23711006|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23711007|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23711008|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23711009|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23711010|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
23711011|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23711012|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23711013|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23711014|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23711015|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23711016|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
23711017|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
23711018|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23711019|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23711020|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
23711021|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
23711022|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
23711023|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
23513101|NCT00592839|65616098|FG000|Overall Study|Protocol Violation|1|||
23513102|NCT00592839|65616099|FG001|Overall Study|Protocol Violation|1|||
23513103|NCT00592839|65616100|FG002|Overall Study|Protocol Violation|2|||
23513104|NCT00592839|65616098|FG000|Overall Study|Adverse Event|0|||
23513105|NCT00592839|65616099|FG001|Overall Study|Adverse Event|1|||
23513106|NCT00592839|65616100|FG002|Overall Study|Adverse Event|0|||
23513107|NCT00592839|65616098|FG000|Overall Study|Lost to Follow-up|0|||
23513108|NCT00592839|65616099|FG001|Overall Study|Lost to Follow-up|1|||
23513109|NCT00592839|65616100|FG002|Overall Study|Lost to Follow-up|1|||
23513110|NCT01846611|65616102|FG000|Overall Study|Lost to Follow-up|4|||
23513111|NCT01846611|65616103|FG001|Overall Study|Lost to Follow-up|6|||
23513112|NCT01846611|65616102|FG000|Overall Study|Withdrawal by Subject|15|||
23513113|NCT01846611|65616103|FG001|Overall Study|Withdrawal by Subject|19|||
23513114|NCT01846611|65616102|FG000|Overall Study|Other|19|||
23513115|NCT01846611|65616103|FG001|Overall Study|Other|18|||
23513116|NCT01414075|65616104|FG000|Overall Study|Adverse Event|1|||
23513117|NCT01414075|65616105|FG001|Overall Study|Adverse Event|0|||
23513118|NCT01414075|65616106|FG002|Overall Study|Adverse Event|1|||
23711024|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
23513119|NCT01414075|65616107|FG003|Overall Study|Adverse Event|0|||
23513120|NCT01414075|65616104|FG000|Overall Study|Death|1|||
23513121|NCT01414075|65616105|FG001|Overall Study|Death|0|||
23513122|NCT01414075|65616106|FG002|Overall Study|Death|0|||
23513123|NCT01414075|65616107|FG003|Overall Study|Death|1|||
23513124|NCT01414075|65616104|FG000|Overall Study|Withdrawal by Subject|0|||
23513125|NCT01414075|65616105|FG001|Overall Study|Withdrawal by Subject|0|||
23513126|NCT01414075|65616106|FG002|Overall Study|Withdrawal by Subject|0|||
23513127|NCT01414075|65616107|FG003|Overall Study|Withdrawal by Subject|1|||
23513128|NCT01414075|65616104|FG000|Overall Study|Other than specified|1|||
23513129|NCT01414075|65616105|FG001|Overall Study|Other than specified|0|||
23513130|NCT01414075|65616106|FG002|Overall Study|Other than specified|1|||
23513131|NCT01414075|65616107|FG003|Overall Study|Other than specified|0|||
23513132|NCT02392247|65616108|FG000|Overall Study|Withdrawal by Subject|1|||
23513133|NCT02392247|65616108|FG000|Overall Study|Surgery cancelled; no data|1|||
23513134|NCT01499667|65616109|FG000|Overall Study|administrative problems|4|||
23513135|NCT01499667|65616110|FG001|Overall Study|administrative problems|5|||
23513136|NCT01499667|65616111|FG002|Overall Study|administrative problems|5|||
23513137|NCT01499667|65616109|FG000|Overall Study|Protocol Violation|1|||
23513138|NCT01499667|65616110|FG001|Overall Study|Protocol Violation|3|||
23513139|NCT01499667|65616111|FG002|Overall Study|Protocol Violation|2|||
23513140|NCT01499667|65616109|FG000|Overall Study|Adverse Event|0|||
23513141|NCT01499667|65616110|FG001|Overall Study|Adverse Event|2|||
23513142|NCT01499667|65616111|FG002|Overall Study|Adverse Event|2|||
23513143|NCT01499667|65616109|FG000|Overall Study|Withdrawal by Subject|2|||
23513144|NCT01499667|65616110|FG001|Overall Study|Withdrawal by Subject|1|||
23513145|NCT01499667|65616111|FG002|Overall Study|Withdrawal by Subject|1|||
23513146|NCT01499667|65616109|FG000|Overall Study|Lack of Efficacy|2|||
23513147|NCT01499667|65616110|FG001|Overall Study|Lack of Efficacy|0|||
23513148|NCT01499667|65616111|FG002|Overall Study|Lack of Efficacy|0|||
23513149|NCT04007094|65616112|FG000|Overall Study|Lost to Follow-up|1|||
23513150|NCT04007094|65616113|FG001|Overall Study|Lost to Follow-up|1|||
23513151|NCT00728130|65616114|FG000|Overall Study|Withdrawal by Subject|1|||
23513152|NCT00728130|65616114|FG000|Overall Study|Paperwork not completed in time|1|||
23513153|NCT00728130|65616114|FG000|Overall Study|Physician Decision|1|||
23513154|NCT01344161|65616116|FG000|Overall Study|Lost to Follow-up|4|||
23513155|NCT01344161|65616117|FG001|Overall Study|Lost to Follow-up|1|||
23513156|NCT01344161|65616116|FG000|Overall Study|Pregnancy|0|||
23513157|NCT01344161|65616117|FG001|Overall Study|Pregnancy|1|||
23513158|NCT01344161|65616116|FG000|Overall Study|Protocol Violation|1|||
23513159|NCT01344161|65616117|FG001|Overall Study|Protocol Violation|1|||
23513160|NCT03342690|65616120|FG000|Overall Study|Missing Information|9|||
23513161|NCT03342690|65616120|FG000|Overall Study|Protocol Violation|16|||
23513162|NCT01949051|65616123|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
23513163|NCT01949051|65616124|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513164|NCT01949051|65616125|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513165|NCT01949051|65616126|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
23513166|NCT01949051|65616127|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513167|NCT01949051|65616128|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513168|NCT01949051|65616123|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
23513169|NCT01949051|65616124|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513170|NCT01949051|65616125|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513171|NCT01949051|65616126|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513172|NCT01949051|65616127|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513173|NCT01949051|65616128|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513174|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513175|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513176|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513177|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513178|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513179|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
23513180|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513181|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
23513182|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513183|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513184|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513185|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513186|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513187|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513188|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
23513189|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513190|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513191|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513192|NCT01286012|65616133|FG000|Overall Study|Adverse Event|3|||
23513193|NCT01286012|65616134|FG001|Overall Study|Adverse Event|3|||
23513194|NCT01286012|65616133|FG000|Overall Study|Death|2|||
23513195|NCT01286012|65616134|FG001|Overall Study|Death|3|||
23513196|NCT01286012|65616133|FG000|Overall Study|Protocol Violation|1|||
23513197|NCT01286012|65616134|FG001|Overall Study|Protocol Violation|1|||
23513198|NCT01286012|65616133|FG000|Overall Study|Withdrawal by Subject|4|||
23513199|NCT01286012|65616134|FG001|Overall Study|Withdrawal by Subject|4|||
23513200|NCT01286012|65616133|FG000|Overall Study|Physician Decision|2|||
23513201|NCT01286012|65616134|FG001|Overall Study|Physician Decision|0|||
23513202|NCT01286012|65616133|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
23711025|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
23711026|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23711027|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23711028|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23711029|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
23711030|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23711031|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23711032|NCT01963208|66319257|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23711033|NCT01963208|66319258|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23711034|NCT01963208|66319259|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23711035|NCT01963208|66319260|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
23711036|NCT01963208|66319261|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23711037|NCT01963208|66319262|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23711038|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23711039|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23711040|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23711041|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23711042|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
23711043|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
23711044|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23711045|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23711046|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23711047|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23711048|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
23711049|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
23711050|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23711051|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23711052|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23711053|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23415537|NCT04068519|65262463|FG000|Indication Expansion|Withdrawal by Subject|10|||
23415538|NCT04068519|65262463|FG000|Indication Expansion|Lost to Follow-up|7|||
23611185|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611186|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611187|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611188|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611189|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611190|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611191|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
23453511|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453512|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453513|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453514|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453515|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453516|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453517|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453518|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453519|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453520|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
23453521|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453522|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
23453523|NCT01419769|65403346|FG000|Overall Study|Did not receive the AXIOS stent|3|||
23453524|NCT01419769|65403346|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
23453525|NCT00561652|65403347|FG000|Overall Study|Withdrawal by Subject|0|||
23453526|NCT00561652|65403348|FG001|Overall Study|Withdrawal by Subject|1|||
23453527|NCT03367858|65403352|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
23453528|NCT03367858|65403353|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
23453529|NCT03367858|65403352|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
23453530|NCT03367858|65403353|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
23453531|NCT03367858|65403352|FG000|3 Month Follow Up|Lost to Follow-up|8|||
23453532|NCT03367858|65403353|FG001|3 Month Follow Up|Lost to Follow-up|3|||
23453533|NCT03367858|65403352|FG000|3 Month Follow Up|Moved out of study area|2|||
23453534|NCT03367858|65403353|FG001|3 Month Follow Up|Moved out of study area|6|||
23453535|NCT03367858|65403352|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
23453536|NCT03367858|65403353|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
23453537|NCT03367858|65403352|FG000|3 Month Follow Up|MRI contraindication|2|||
23453538|NCT03367858|65403353|FG001|3 Month Follow Up|MRI contraindication|1|||
23453539|NCT03367858|65403352|FG000|3 Month Follow Up|Incarcerated|0|||
23513203|NCT01286012|65616134|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
23513204|NCT00423150|65616135|FG000|Overall Study|Adverse Event|11|||
23513205|NCT00423150|65616135|FG000|Overall Study|Progression of disease being studied|69|||
23415547|NCT02684058|65265924|FG000|Treatment Period|Progressive disease|4|||
23415548|NCT02684058|65265925|FG001|Treatment Period|Progressive disease|10|||
23415549|NCT02684058|65265926|FG002|Treatment Period|Progressive disease|19|||
23415550|NCT02684058|65265924|FG000|Treatment Period|Adverse Event|3|||
23415551|NCT02684058|65265925|FG001|Treatment Period|Adverse Event|8|||
23415552|NCT02684058|65265926|FG002|Treatment Period|Adverse Event|1|||
23415553|NCT02684058|65265924|FG000|Treatment Period|Physician Decision|5|||
23415554|NCT02684058|65265925|FG001|Treatment Period|Physician Decision|1|||
23415555|NCT02684058|65265926|FG002|Treatment Period|Physician Decision|2|||
23415556|NCT02684058|65265924|FG000|Treatment Period|New therapy for study indication|1|||
23415557|NCT02684058|65265925|FG001|Treatment Period|New therapy for study indication|0|||
23415558|NCT02684058|65265926|FG002|Treatment Period|New therapy for study indication|0|||
23415559|NCT02684058|65265924|FG000|Treatment Period|Protocol deviation|0|||
23415560|NCT02684058|65265925|FG001|Treatment Period|Protocol deviation|1|||
23415561|NCT02684058|65265926|FG002|Treatment Period|Protocol deviation|0|||
23415562|NCT02684058|65265924|FG000|Treatment Period|Subject/guardian decision|4|||
23415563|NCT02684058|65265925|FG001|Treatment Period|Subject/guardian decision|3|||
23415564|NCT02684058|65265926|FG002|Treatment Period|Subject/guardian decision|0|||
23415565|NCT02684058|65265924|FG000|Treatment Period|Death|0|||
23415566|NCT02684058|65265925|FG001|Treatment Period|Death|0|||
23415567|NCT02684058|65265926|FG002|Treatment Period|Death|2|||
23415568|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23415569|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23415570|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23415571|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
23415572|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23415573|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
23415574|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23415575|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23415576|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23415577|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23415578|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Death|0|||
23415579|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Death|3|||
23415580|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
23415581|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
23415582|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
23415583|NCT02684058|65265924|FG000|Post-treatment Survival Follow-up|Death|0|||
23415584|NCT02684058|65265925|FG001|Post-treatment Survival Follow-up|Death|0|||
23415585|NCT02684058|65265926|FG002|Post-treatment Survival Follow-up|Death|7|||
23415586|NCT02684058|65265924|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
23415587|NCT02684058|65265925|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
23415588|NCT02684058|65265926|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
23415589|NCT02684058|65265924|FG000|Crossover Treatment Period|Progressive disease|0|||
23415590|NCT02684058|65265925|FG001|Crossover Treatment Period|Progressive disease|1|||
23415591|NCT02684058|65265926|FG002|Crossover Treatment Period|Progressive disease|0|||
23415592|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
23415593|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
23415594|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
23415595|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
23415596|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
23415597|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
23415598|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
23415599|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
23415600|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
23415601|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
23415602|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
23415603|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
23415604|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
23415605|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
23415606|NCT00054327|65265931|FG000|Overall Study|Engraftment failure|1|||
23513206|NCT00423150|65616135|FG000|Overall Study|Withdrawal by Subject|1|||
23513207|NCT00423150|65616135|FG000|Overall Study|Non-compliance with protocol|1|||
23513208|NCT00423150|65616135|FG000|Overall Study|Administrative|4|||
23513209|NCT02998840|65616136|FG000|Overall Study|Lost to Follow-up|1|||
23513210|NCT02998840|65616137|FG001|Overall Study|Lost to Follow-up|1|||
23415607|NCT00054327|65265932|FG001|Overall Study|Engraftment failure|0|||
23415608|NCT00054327|65265933|FG002|Overall Study|Engraftment failure|0|||
23415609|NCT00054327|65265934|FG003|Overall Study|Engraftment failure|0|||
23513211|NCT02998840|65616138|FG002|Overall Study|Lost to Follow-up|2|||
23513212|NCT02998840|65616139|FG003|Overall Study|Lost to Follow-up|3|||
23513213|NCT02998840|65616136|FG000|Overall Study|Withdrawal by Subject|1|||
23513214|NCT02998840|65616137|FG001|Overall Study|Withdrawal by Subject|1|||
23513215|NCT02998840|65616138|FG002|Overall Study|Withdrawal by Subject|0|||
23513216|NCT02998840|65616139|FG003|Overall Study|Withdrawal by Subject|1|||
23513217|NCT02998840|65616136|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
23513218|NCT02998840|65616137|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
23513219|NCT02998840|65616138|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
23513220|NCT02998840|65616139|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
23513221|NCT01218204|65616142|FG000|Part B Washout|Adverse Event|0|||
23513222|NCT01218204|65616143|FG001|Part B Washout|Adverse Event|1|||
23513223|NCT01218204|65616144|FG002|Part B Washout|Adverse Event|0|||
23513224|NCT01218204|65616145|FG003|Part B Washout|Adverse Event|0|||
23513225|NCT01218204|65616142|FG000|Part B Washout|Lost to Follow-up|0|||
23513226|NCT01218204|65616143|FG001|Part B Washout|Lost to Follow-up|2|||
23513227|NCT01218204|65616144|FG002|Part B Washout|Lost to Follow-up|0|||
23513228|NCT01218204|65616145|FG003|Part B Washout|Lost to Follow-up|0|||
23513229|NCT01218204|65616142|FG000|Part B Washout|Physician Decision|0|||
23513230|NCT01218204|65616143|FG001|Part B Washout|Physician Decision|14|||
23513231|NCT01218204|65616144|FG002|Part B Washout|Physician Decision|0|||
23513232|NCT01218204|65616145|FG003|Part B Washout|Physician Decision|0|||
23513233|NCT01218204|65616142|FG000|Part B Washout|Withdrawal by Subject|0|||
23513234|NCT01218204|65616143|FG001|Part B Washout|Withdrawal by Subject|14|||
23513235|NCT01218204|65616144|FG002|Part B Washout|Withdrawal by Subject|0|||
23513236|NCT01218204|65616145|FG003|Part B Washout|Withdrawal by Subject|0|||
23513237|NCT01218204|65616142|FG000|Part B Washout|Reached defined stopping criteria|0|||
23513238|NCT01218204|65616143|FG001|Part B Washout|Reached defined stopping criteria|2|||
23513239|NCT01218204|65616144|FG002|Part B Washout|Reached defined stopping criteria|0|||
23513240|NCT01218204|65616145|FG003|Part B Washout|Reached defined stopping criteria|0|||
23513241|NCT01218204|65616142|FG000|Part B Washout|Did not meet continuation criteria|0|||
23513242|NCT01218204|65616143|FG001|Part B Washout|Did not meet continuation criteria|112|||
23513243|NCT01218204|65616144|FG002|Part B Washout|Did not meet continuation criteria|0|||
23513244|NCT01218204|65616145|FG003|Part B Washout|Did not meet continuation criteria|0|||
23711054|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23711055|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
23711056|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23711057|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23711058|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23711059|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23711060|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23711061|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
23711062|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
23711063|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
23711064|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
23711065|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
23711066|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
23711067|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
23711068|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23711069|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23711070|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23711071|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23711072|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
23711073|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
23711074|NCT01963208|66319257|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
23711075|NCT01963208|66319258|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
23711076|NCT01963208|66319259|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
23711077|NCT01963208|66319260|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
23711078|NCT01963208|66319261|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
23711079|NCT01963208|66319262|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
23711080|NCT00059215|66319271|FG000|Overall Study|Adverse Event|5|||
23711081|NCT00059215|66319272|FG001|Overall Study|Adverse Event|5|||
23711082|NCT00059215|66319273|FG002|Overall Study|Adverse Event|9|||
23711083|NCT00059215|66319274|FG003|Overall Study|Adverse Event|9|||
23513245|NCT01218204|65616142|FG000|Part B Run-in|Adverse Event|0|||
23513246|NCT01218204|65616143|FG001|Part B Run-in|Adverse Event|0|||
23711084|NCT00059215|66319271|FG000|Overall Study|Death|0|||
23513247|NCT01218204|65616144|FG002|Part B Run-in|Adverse Event|1|||
23513248|NCT01218204|65616145|FG003|Part B Run-in|Adverse Event|0|||
23513249|NCT01218204|65616142|FG000|Part B Run-in|Protocol Violation|0|||
23513250|NCT01218204|65616143|FG001|Part B Run-in|Protocol Violation|0|||
23513251|NCT01218204|65616144|FG002|Part B Run-in|Protocol Violation|2|||
23711085|NCT00059215|66319272|FG001|Overall Study|Death|0|||
23711086|NCT00059215|66319273|FG002|Overall Study|Death|3|||
23711087|NCT00059215|66319274|FG003|Overall Study|Death|0|||
23711088|NCT00059215|66319271|FG000|Overall Study|Lost to Follow-up|1|||
23711089|NCT00059215|66319272|FG001|Overall Study|Lost to Follow-up|2|||
23711090|NCT00059215|66319273|FG002|Overall Study|Lost to Follow-up|0|||
23711091|NCT00059215|66319274|FG003|Overall Study|Lost to Follow-up|0|||
23711092|NCT00059215|66319271|FG000|Overall Study|Withdrawal by Subject|4|||
23711093|NCT00059215|66319272|FG001|Overall Study|Withdrawal by Subject|4|||
23711094|NCT00059215|66319273|FG002|Overall Study|Withdrawal by Subject|1|||
23711095|NCT00059215|66319274|FG003|Overall Study|Withdrawal by Subject|3|||
23711096|NCT00059215|66319271|FG000|Overall Study|Protocol Violation|1|||
23711097|NCT00059215|66319272|FG001|Overall Study|Protocol Violation|0|||
23711098|NCT00059215|66319273|FG002|Overall Study|Protocol Violation|1|||
23711099|NCT00059215|66319274|FG003|Overall Study|Protocol Violation|0|||
23711100|NCT00059215|66319271|FG000|Overall Study|Protocol entry criteria not met|1|||
23711101|NCT00059215|66319272|FG001|Overall Study|Protocol entry criteria not met|1|||
23711102|NCT00059215|66319273|FG002|Overall Study|Protocol entry criteria not met|0|||
23711103|NCT00059215|66319274|FG003|Overall Study|Protocol entry criteria not met|2|||
23711104|NCT00059215|66319271|FG000|Overall Study|Physician Decision|1|||
23711105|NCT00059215|66319272|FG001|Overall Study|Physician Decision|2|||
23711106|NCT00059215|66319273|FG002|Overall Study|Physician Decision|1|||
23711107|NCT00059215|66319274|FG003|Overall Study|Physician Decision|1|||
23711108|NCT01885078|66319277|FG000|Treatment Period|Adverse Event|52|||
23711109|NCT01885078|66319278|FG001|Treatment Period|Adverse Event|136|||
23711110|NCT01885078|66319279|FG002|Treatment Period|Adverse Event|30|||
23711111|NCT01885078|66319280|FG003|Treatment Period|Adverse Event|73|||
23711112|NCT01885078|66319281|FG004|Treatment Period|Adverse Event|17|||
23711113|NCT01885078|66319282|FG005|Treatment Period|Adverse Event|72|||
23711114|NCT01885078|66319283|FG006|Treatment Period|Adverse Event|24|||
23711115|NCT01885078|66319284|FG007|Treatment Period|Adverse Event|5|||
23711116|NCT01885078|66319285|FG008|Treatment Period|Adverse Event|0|||
23513252|NCT01218204|65616145|FG003|Part B Run-in|Protocol Violation|0|||
23513253|NCT01218204|65616142|FG000|Part B Run-in|Withdrawal by Subject|0|||
23513254|NCT01218204|65616143|FG001|Part B Run-in|Withdrawal by Subject|0|||
23513255|NCT01218204|65616144|FG002|Part B Run-in|Withdrawal by Subject|3|||
23513256|NCT01218204|65616145|FG003|Part B Run-in|Withdrawal by Subject|0|||
23513257|NCT01218204|65616142|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
23513258|NCT01218204|65616143|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
23513259|NCT01218204|65616144|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
23513260|NCT01218204|65616145|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
23513261|NCT01218204|65616142|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513262|NCT01218204|65616143|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513263|NCT01218204|65616144|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513264|NCT01218204|65616145|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
23513265|NCT02064894|65616146|FG000|Overall Study|Withdrawal by Subject|43|||
23513266|NCT02064894|65616147|FG001|Overall Study|Withdrawal by Subject|102|||
23513267|NCT02064894|65616148|FG002|Overall Study|Withdrawal by Subject|115|||
23513268|NCT00459108|65616153|FG000|Overall Study|Withdrawal by Subject|5|||
23513269|NCT00459108|65616153|FG000|Overall Study|Adverse Event|3|||
23513270|NCT00459108|65616153|FG000|Overall Study|Death|2|||
23513271|NCT00459108|65616153|FG000|Overall Study|Progression|1|||
23513272|NCT01414114|65616154|FG000|Overall Study|Adverse Event|2|||
23513273|NCT01414114|65616154|FG000|Overall Study|Withdrawal by Subject|1|||
23513274|NCT01414114|65616154|FG000|Overall Study|Other|2|||
23513275|NCT02953314|65616155|FG000|Overall Study|Adverse Event|0|||
23513276|NCT02953314|65616156|FG001|Overall Study|Adverse Event|1|||
23513277|NCT02953314|65616155|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23513278|NCT02953314|65616156|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
23513279|NCT01338493|65616159|FG000|Enrolled|Withdrawal by Subject|1|||
23513280|NCT01338493|65616159|FG000|Enrolled|Patient not implanted|4|||
23711117|NCT01885078|66319286|FG009|Treatment Period|Adverse Event|0|||
23711118|NCT01885078|66319277|FG000|Treatment Period|Death|13|||
23513281|NCT01338493|65616159|FG000|Discharge|Death|1|||
23513282|NCT01338493|65616159|FG000|Discharge|Missed visit|1|||
23711119|NCT01885078|66319278|FG001|Treatment Period|Death|33|||
23711120|NCT01885078|66319279|FG002|Treatment Period|Death|5|||
23711121|NCT01885078|66319280|FG003|Treatment Period|Death|9|||
23711122|NCT01885078|66319281|FG004|Treatment Period|Death|2|||
23711123|NCT01885078|66319282|FG005|Treatment Period|Death|10|||
23711124|NCT01885078|66319283|FG006|Treatment Period|Death|3|||
23711125|NCT01885078|66319284|FG007|Treatment Period|Death|2|||
23711126|NCT01885078|66319285|FG008|Treatment Period|Death|0|||
23711127|NCT01885078|66319286|FG009|Treatment Period|Death|0|||
23513283|NCT01338493|65616159|FG000|6 Months Follow up|Lost to Follow-up|11|||
23513284|NCT01338493|65616159|FG000|6 Months Follow up|Missed visit|8|||
23513285|NCT01338493|65616159|FG000|12 Months Follow up|Lost to Follow-up|9|||
23513286|NCT03641651|65616160|FG000|Overall Study|organizational issues at one study site|1|||
23513287|NCT00894322|65616161|FG000|Overall Study|Withdrawal by Subject|1|||
23513288|NCT00894322|65616162|FG001|Overall Study|Withdrawal by Subject|0|||
23513289|NCT00894322|65616163|FG002|Overall Study|Withdrawal by Subject|0|||
23513290|NCT02485301|65616168|FG000|Overall Study|Serious Adverse Events|2|||
23513291|NCT02485301|65616169|FG001|Overall Study|Serious Adverse Events|1|||
23513292|NCT02485301|65616168|FG000|Overall Study|Protocol Violation|0|||
23513293|NCT02485301|65616169|FG001|Overall Study|Protocol Violation|1|||
23513294|NCT02485301|65616168|FG000|Overall Study|Withdrawal by Subject|6|||
23513295|NCT02485301|65616169|FG001|Overall Study|Withdrawal by Subject|7|||
23513296|NCT02485301|65616168|FG000|Overall Study|Migrated/moved from study area|10|||
23513297|NCT02485301|65616169|FG001|Overall Study|Migrated/moved from study area|19|||
23513298|NCT02485301|65616168|FG000|Overall Study|Lost to Follow-up|17|||
23513299|NCT02485301|65616169|FG001|Overall Study|Lost to Follow-up|17|||
23513300|NCT02485301|65616168|FG000|Overall Study|Other|3|||
23513301|NCT02485301|65616169|FG001|Overall Study|Other|4|||
23513302|NCT00680043|65616170|FG000|Overall Study|Withdrawal by Subject|1|||
23711128|NCT01885078|66319277|FG000|Treatment Period|Lack of Efficacy|12|||
23415610|NCT00054327|65265935|FG004|Overall Study|Engraftment failure|0|||
23711129|NCT01885078|66319278|FG001|Treatment Period|Lack of Efficacy|33|||
23711130|NCT01885078|66319279|FG002|Treatment Period|Lack of Efficacy|10|||
23415611|NCT00054327|65265936|FG005|Overall Study|Engraftment failure|0|||
23415612|NCT00716482|65265940|FG000|Overall Study|Lost to Follow-up|6|||
23415613|NCT00716482|65265940|FG000|Overall Study|Inadequate acquisition or analysis|50|||
23415614|NCT00716482|65265940|FG000|Overall Study|no pathology obtained|10|||
23415615|NCT00716482|65265940|FG000|Overall Study|technical/machine error|28|||
23415616|NCT00716482|65265940|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
23415617|NCT01885208|65265941|FG000|Overall Study|Unclassified|32|||
23415618|NCT01885208|65265942|FG001|Overall Study|Unclassified|38|||
23415619|NCT00487942|65265946|FG000|Overall Study|Adverse Event|1|||
23415620|NCT00487942|65265947|FG001|Overall Study|Adverse Event|1|||
23415621|NCT00487942|65265948|FG002|Overall Study|Adverse Event|1|||
23415622|NCT00487942|65265949|FG003|Overall Study|Adverse Event|1|||
23415623|NCT00487942|65265946|FG000|Overall Study|Lost to Follow-up|1|||
23415624|NCT00487942|65265947|FG001|Overall Study|Lost to Follow-up|0|||
23415625|NCT00487942|65265948|FG002|Overall Study|Lost to Follow-up|0|||
23415626|NCT00487942|65265949|FG003|Overall Study|Lost to Follow-up|1|||
23415627|NCT00487942|65265946|FG000|Overall Study|Protocol Violation|1|||
23415628|NCT00487942|65265947|FG001|Overall Study|Protocol Violation|1|||
23415629|NCT00487942|65265948|FG002|Overall Study|Protocol Violation|0|||
23415630|NCT00487942|65265949|FG003|Overall Study|Protocol Violation|0|||
23415631|NCT00487942|65265946|FG000|Overall Study|Withdrawal by Subject|0|||
23415632|NCT00487942|65265947|FG001|Overall Study|Withdrawal by Subject|1|||
23415633|NCT00487942|65265948|FG002|Overall Study|Withdrawal by Subject|2|||
23415634|NCT00487942|65265949|FG003|Overall Study|Withdrawal by Subject|0|||
23415635|NCT00118846|65265953|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
23415636|NCT00118846|65265954|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
23415637|NCT00118846|65265953|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
23415638|NCT00118846|65265954|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
23415639|NCT00118846|65265953|FG000|Overall Study|Physician Decision|1|||
23415640|NCT00118846|65265954|FG001|Overall Study|Physician Decision|0|||
23415641|NCT00118846|65265953|FG000|Overall Study|Medical condition|2|||
23415642|NCT00118846|65265954|FG001|Overall Study|Medical condition|2|||
23415643|NCT00118846|65265953|FG000|Overall Study|Lost to Follow-up|0|||
23415644|NCT00118846|65265954|FG001|Overall Study|Lost to Follow-up|2|||
23415645|NCT00118846|65265953|FG000|Overall Study|Personal reason|4|||
23415646|NCT00118846|65265954|FG001|Overall Study|Personal reason|5|||
23415647|NCT02120300|65265955|FG000|Overall Study|Enrolled but Never Treated|2|||
23415648|NCT02120300|65265956|FG001|Overall Study|Enrolled but Never Treated|0|||
23513303|NCT00680043|65616171|FG001|Overall Study|Withdrawal by Subject|0|||
23711131|NCT01885078|66319280|FG003|Treatment Period|Lack of Efficacy|23|||
23711132|NCT01885078|66319281|FG004|Treatment Period|Lack of Efficacy|24|||
23711133|NCT01885078|66319282|FG005|Treatment Period|Lack of Efficacy|58|||
23711134|NCT01885078|66319283|FG006|Treatment Period|Lack of Efficacy|9|||
23711135|NCT01885078|66319284|FG007|Treatment Period|Lack of Efficacy|5|||
23415649|NCT02120300|65265957|FG002|Overall Study|Enrolled but Never Treated|0|||
23415650|NCT02120300|65265958|FG003|Overall Study|Enrolled but Never Treated|0|||
23415651|NCT02120300|65265955|FG000|Overall Study|Lack of Efficacy|0|||
23415652|NCT02120300|65265956|FG001|Overall Study|Lack of Efficacy|0|||
23415653|NCT02120300|65265957|FG002|Overall Study|Lack of Efficacy|0|||
23415654|NCT02120300|65265958|FG003|Overall Study|Lack of Efficacy|1|||
23415655|NCT02120300|65265955|FG000|Overall Study|Lost to Follow-up|1|||
23415656|NCT02120300|65265956|FG001|Overall Study|Lost to Follow-up|0|||
23415657|NCT02120300|65265957|FG002|Overall Study|Lost to Follow-up|0|||
23415658|NCT02120300|65265958|FG003|Overall Study|Lost to Follow-up|0|||
23415659|NCT00405392|65265959|FG000|Overall Study|Adverse Event|15|||
23513304|NCT00680043|65616172|FG002|Overall Study|Withdrawal by Subject|0|||
23513305|NCT00680043|65616170|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
23513306|NCT00680043|65616171|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
23711136|NCT01885078|66319285|FG008|Treatment Period|Lack of Efficacy|0|||
23711137|NCT01885078|66319286|FG009|Treatment Period|Lack of Efficacy|0|||
23711138|NCT01885078|66319277|FG000|Treatment Period|Lost to Follow-up|16|||
23711139|NCT01885078|66319278|FG001|Treatment Period|Lost to Follow-up|19|||
23711140|NCT01885078|66319279|FG002|Treatment Period|Lost to Follow-up|7|||
23711141|NCT01885078|66319280|FG003|Treatment Period|Lost to Follow-up|9|||
23711142|NCT01885078|66319281|FG004|Treatment Period|Lost to Follow-up|2|||
23711143|NCT01885078|66319282|FG005|Treatment Period|Lost to Follow-up|8|||
23711144|NCT01885078|66319283|FG006|Treatment Period|Lost to Follow-up|2|||
23711145|NCT01885078|66319284|FG007|Treatment Period|Lost to Follow-up|0|||
23711146|NCT01885078|66319285|FG008|Treatment Period|Lost to Follow-up|0|||
23711147|NCT01885078|66319286|FG009|Treatment Period|Lost to Follow-up|0|||
23711148|NCT01885078|66319277|FG000|Treatment Period|Physician Decision|19|||
23711149|NCT01885078|66319278|FG001|Treatment Period|Physician Decision|21|||
23711150|NCT01885078|66319279|FG002|Treatment Period|Physician Decision|5|||
23711151|NCT01885078|66319280|FG003|Treatment Period|Physician Decision|12|||
23711152|NCT01885078|66319281|FG004|Treatment Period|Physician Decision|9|||
23711153|NCT01885078|66319282|FG005|Treatment Period|Physician Decision|24|||
23711154|NCT01885078|66319283|FG006|Treatment Period|Physician Decision|4|||
23711155|NCT01885078|66319284|FG007|Treatment Period|Physician Decision|3|||
23711156|NCT01885078|66319285|FG008|Treatment Period|Physician Decision|0|||
23711157|NCT01885078|66319286|FG009|Treatment Period|Physician Decision|0|||
23711158|NCT01885078|66319277|FG000|Treatment Period|Protocol Violation|3|||
23711159|NCT01885078|66319278|FG001|Treatment Period|Protocol Violation|5|||
23711160|NCT01885078|66319279|FG002|Treatment Period|Protocol Violation|0|||
23711161|NCT01885078|66319280|FG003|Treatment Period|Protocol Violation|3|||
23711162|NCT01885078|66319281|FG004|Treatment Period|Protocol Violation|1|||
23711163|NCT01885078|66319282|FG005|Treatment Period|Protocol Violation|6|||
23711164|NCT01885078|66319283|FG006|Treatment Period|Protocol Violation|0|||
23415660|NCT00405392|65265960|FG001|Overall Study|Adverse Event|14|||
23415661|NCT00405392|65265959|FG000|Overall Study|Did not meet Eligibility criteria|7|||
23415662|NCT00405392|65265960|FG001|Overall Study|Did not meet Eligibility criteria|2|||
23415663|NCT00405392|65265959|FG000|Overall Study|Withdrawal by Subject|4|||
23415664|NCT00405392|65265960|FG001|Overall Study|Withdrawal by Subject|3|||
23415665|NCT00405392|65265959|FG000|Overall Study|Lost to Follow-up|1|||
23415666|NCT00405392|65265960|FG001|Overall Study|Lost to Follow-up|2|||
23415667|NCT00405392|65265959|FG000|Overall Study|Data missing|2|||
23711165|NCT01885078|66319284|FG007|Treatment Period|Protocol Violation|0|||
23711166|NCT01885078|66319285|FG008|Treatment Period|Protocol Violation|0|||
23711167|NCT01885078|66319286|FG009|Treatment Period|Protocol Violation|0|||
23415668|NCT00405392|65265960|FG001|Overall Study|Data missing|0|||
23415669|NCT00405392|65265959|FG000|Overall Study|Non-compliance|0|||
23415670|NCT00405392|65265960|FG001|Overall Study|Non-compliance|1|||
23415671|NCT00405392|65265959|FG000|Overall Study|Other|1|||
23415672|NCT00405392|65265960|FG001|Overall Study|Other|5|||
23415673|NCT00623233|65265972|FG000|Overall Study|Adverse Event|10|||
23415674|NCT00623233|65265972|FG000|Overall Study|Physician Decision|10|||
23415675|NCT00623233|65265972|FG000|Overall Study|Lost to Follow-up|1|||
23415676|NCT00623233|65265972|FG000|Overall Study|Withdrawal by Subject|3|||
23415677|NCT00443872|65265975|FG000|Overall Study|Protocol Violation|7|||
23415678|NCT00443872|65265975|FG000|Overall Study|Lost to Follow-up|2|||
23415679|NCT00443872|65265975|FG000|Overall Study|Adverse Event|8|||
23415680|NCT04556591|65265978|FG000|Overall Study|Lost to Follow-up|1|||
23415681|NCT04556591|65265979|FG001|Overall Study|Lost to Follow-up|0|||
23415682|NCT04556591|65265978|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
23415683|NCT04556591|65265979|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
23415684|NCT02791516|65265982|FG000|Overall Study|Withdrawal by Subject|1|||
23415685|NCT02791516|65265983|FG001|Overall Study|Withdrawal by Subject|1|||
23513307|NCT00680043|65616172|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
23513308|NCT00680043|65616170|FG000|Overall Study|Renal Transplant|1|||
23513309|NCT00680043|65616171|FG001|Overall Study|Renal Transplant|0|||
23513310|NCT00680043|65616172|FG002|Overall Study|Renal Transplant|4|||
23513311|NCT00661622|65616173|FG000|Overall Study|Protocol Violation|1|||
23513312|NCT00661622|65616174|FG001|Overall Study|Protocol Violation|0|||
23513313|NCT01288469|65616177|FG000|Overall Study|Adverse Event|4|||
23711168|NCT01885078|66319277|FG000|Treatment Period|Sponsor Decision|245|||
23711169|NCT01885078|66319278|FG001|Treatment Period|Sponsor Decision|648|||
23711170|NCT01885078|66319279|FG002|Treatment Period|Sponsor Decision|49|||
23711171|NCT01885078|66319280|FG003|Treatment Period|Sponsor Decision|90|||
23415686|NCT01133756|65265984|FG000|Overall Study|Adverse Event|1|||
23415687|NCT01133756|65265985|FG001|Overall Study|Adverse Event|2|||
23415688|NCT01133756|65265986|FG002|Overall Study|Adverse Event|1|||
23415689|NCT01133756|65265984|FG000|Overall Study|Investigator Decision|1|||
23415690|NCT01133756|65265985|FG001|Overall Study|Investigator Decision|0|||
23513314|NCT01288469|65616178|FG001|Overall Study|Adverse Event|1|||
23513315|NCT01288469|65616179|FG002|Overall Study|Adverse Event|1|||
23711172|NCT01885078|66319281|FG004|Treatment Period|Sponsor Decision|20|||
23711173|NCT01885078|66319282|FG005|Treatment Period|Sponsor Decision|38|||
23513316|NCT01288469|65616177|FG000|Overall Study|Poor compliance to protocol|0|||
23513317|NCT01288469|65616178|FG001|Overall Study|Poor compliance to protocol|1|||
23513318|NCT01288469|65616179|FG002|Overall Study|Poor compliance to protocol|0|||
23513319|NCT01288469|65616177|FG000|Overall Study|Participant Moved|1|||
23513320|NCT01288469|65616178|FG001|Overall Study|Participant Moved|0|||
23513321|NCT01288469|65616179|FG002|Overall Study|Participant Moved|0|||
23513322|NCT01288469|65616177|FG000|Overall Study|Consent withdrawn by subject|1|||
23513323|NCT01288469|65616178|FG001|Overall Study|Consent withdrawn by subject|1|||
23513324|NCT01288469|65616179|FG002|Overall Study|Consent withdrawn by subject|1|||
23513325|NCT01288469|65616177|FG000|Overall Study|Exclusion criteria finally met|1|||
23513326|NCT01288469|65616178|FG001|Overall Study|Exclusion criteria finally met|0|||
23513327|NCT01288469|65616179|FG002|Overall Study|Exclusion criteria finally met|0|||
23513328|NCT00467259|65616180|FG000|Overall Study|Adverse Event|24|||
23513329|NCT00467259|65616181|FG001|Overall Study|Adverse Event|90|||
23513330|NCT00467259|65616180|FG000|Overall Study|Protocol Violation|1|||
23513331|NCT00467259|65616181|FG001|Overall Study|Protocol Violation|7|||
23513332|NCT00467259|65616180|FG000|Overall Study|Withdrawal by Subject|34|||
23513333|NCT00467259|65616181|FG001|Overall Study|Withdrawal by Subject|108|||
23513334|NCT00467259|65616180|FG000|Overall Study|Physician Decision|0|||
23513335|NCT00467259|65616181|FG001|Overall Study|Physician Decision|2|||
23513336|NCT00467259|65616180|FG000|Overall Study|Lost to Follow-up|14|||
23513337|NCT00467259|65616181|FG001|Overall Study|Lost to Follow-up|34|||
23711174|NCT01885078|66319283|FG006|Treatment Period|Sponsor Decision|162|||
23711175|NCT01885078|66319284|FG007|Treatment Period|Sponsor Decision|3|||
23711176|NCT01885078|66319285|FG008|Treatment Period|Sponsor Decision|0|||
23711177|NCT01885078|66319286|FG009|Treatment Period|Sponsor Decision|0|||
23711178|NCT01885078|66319277|FG000|Treatment Period|Withdrawal by Subject|72|||
23711179|NCT01885078|66319278|FG001|Treatment Period|Withdrawal by Subject|132|||
23711180|NCT01885078|66319279|FG002|Treatment Period|Withdrawal by Subject|25|||
23711181|NCT01885078|66319280|FG003|Treatment Period|Withdrawal by Subject|63|||
23711182|NCT01885078|66319281|FG004|Treatment Period|Withdrawal by Subject|15|||
23711183|NCT01885078|66319282|FG005|Treatment Period|Withdrawal by Subject|34|||
23711184|NCT01885078|66319283|FG006|Treatment Period|Withdrawal by Subject|17|||
23711185|NCT01885078|66319284|FG007|Treatment Period|Withdrawal by Subject|10|||
23711186|NCT01885078|66319285|FG008|Treatment Period|Withdrawal by Subject|0|||
23711187|NCT01885078|66319286|FG009|Treatment Period|Withdrawal by Subject|0|||
23711188|NCT01885078|66319277|FG000|Treatment Period|Other|0|||
23711189|NCT01885078|66319278|FG001|Treatment Period|Other|0|||
23711190|NCT01885078|66319279|FG002|Treatment Period|Other|0|||
23711191|NCT01885078|66319280|FG003|Treatment Period|Other|1|||
23711192|NCT01885078|66319281|FG004|Treatment Period|Other|0|||
23711193|NCT01885078|66319282|FG005|Treatment Period|Other|0|||
23513338|NCT00467259|65616180|FG000|Overall Study|Site Closed|2|||
23513339|NCT00467259|65616181|FG001|Overall Study|Site Closed|1|||
23513340|NCT01438957|65616182|FG000|Overall Study|Physician Decision|1|||
23513341|NCT01438957|65616183|FG001|Overall Study|Physician Decision|1|||
23513342|NCT01438957|65616184|FG002|Overall Study|Physician Decision|0|||
23513343|NCT01438957|65616185|FG003|Overall Study|Physician Decision|1|||
23513344|NCT01438957|65616186|FG004|Overall Study|Physician Decision|0|||
23513345|NCT02892760|65616187|FG000|Overall Study|Withdrawal by Subject|3|||
23513346|NCT02457910|65616188|FG000|Overall Study|Withdrawal by Subject|0|||
23513347|NCT02457910|65616189|FG001|Overall Study|Withdrawal by Subject|0|||
23513348|NCT02457910|65616190|FG002|Overall Study|Withdrawal by Subject|0|||
23513349|NCT02457910|65616191|FG003|Overall Study|Withdrawal by Subject|0|||
23513350|NCT02457910|65616192|FG004|Overall Study|Withdrawal by Subject|0|||
23513351|NCT02457910|65616193|FG005|Overall Study|Withdrawal by Subject|1|||
23513352|NCT02457910|65616188|FG000|Overall Study|Adverse Event|0|||
23513353|NCT02457910|65616189|FG001|Overall Study|Adverse Event|2|||
23513354|NCT02457910|65616190|FG002|Overall Study|Adverse Event|1|||
23513355|NCT02457910|65616191|FG003|Overall Study|Adverse Event|1|||
23513356|NCT02457910|65616192|FG004|Overall Study|Adverse Event|1|||
23711194|NCT01885078|66319283|FG006|Treatment Period|Other|0|||
23711195|NCT01885078|66319284|FG007|Treatment Period|Other|0|||
23513357|NCT02457910|65616193|FG005|Overall Study|Adverse Event|3|||
23513358|NCT02457910|65616188|FG000|Overall Study|Disease progression|3|||
23513359|NCT02457910|65616189|FG001|Overall Study|Disease progression|3|||
23513360|NCT02457910|65616190|FG002|Overall Study|Disease progression|1|||
23711196|NCT01885078|66319285|FG008|Treatment Period|Other|0|||
23513361|NCT02457910|65616191|FG003|Overall Study|Disease progression|1|||
23513362|NCT02457910|65616192|FG004|Overall Study|Disease progression|4|||
23513363|NCT02457910|65616193|FG005|Overall Study|Disease progression|6|||
23513364|NCT02457910|65616188|FG000|Overall Study|Other complicating illness|0|||
23513365|NCT02457910|65616189|FG001|Overall Study|Other complicating illness|0|||
23711197|NCT01885078|66319286|FG009|Treatment Period|Other|0|||
23711198|NCT01885078|66319277|FG000|Step-down Period|Sponsor Decision|0|||
23513366|NCT02457910|65616190|FG002|Overall Study|Other complicating illness|0|||
23513367|NCT02457910|65616191|FG003|Overall Study|Other complicating illness|0|||
23513368|NCT02457910|65616192|FG004|Overall Study|Other complicating illness|0|||
23513369|NCT02457910|65616193|FG005|Overall Study|Other complicating illness|1|||
23711199|NCT01885078|66319278|FG001|Step-down Period|Sponsor Decision|0|||
23711200|NCT01885078|66319279|FG002|Step-down Period|Sponsor Decision|0|||
23711201|NCT01885078|66319280|FG003|Step-down Period|Sponsor Decision|0|||
23711202|NCT01885078|66319281|FG004|Step-down Period|Sponsor Decision|0|||
23711203|NCT01885078|66319282|FG005|Step-down Period|Sponsor Decision|0|||
23711204|NCT01885078|66319283|FG006|Step-down Period|Sponsor Decision|0|||
23711205|NCT01885078|66319284|FG007|Step-down Period|Sponsor Decision|0|||
23711206|NCT01885078|66319285|FG008|Step-down Period|Sponsor Decision|1|||
23711207|NCT01885078|66319286|FG009|Step-down Period|Sponsor Decision|1|||
23711208|NCT01885078|66319277|FG000|Step-down Period|Adverse Event|0|||
23711209|NCT01885078|66319278|FG001|Step-down Period|Adverse Event|0|||
23711210|NCT01885078|66319279|FG002|Step-down Period|Adverse Event|0|||
23711211|NCT01885078|66319280|FG003|Step-down Period|Adverse Event|0|||
23711212|NCT01885078|66319281|FG004|Step-down Period|Adverse Event|0|||
23711213|NCT01885078|66319282|FG005|Step-down Period|Adverse Event|0|||
23711214|NCT01885078|66319283|FG006|Step-down Period|Adverse Event|0|||
23711215|NCT01885078|66319284|FG007|Step-down Period|Adverse Event|0|||
23711216|NCT01885078|66319285|FG008|Step-down Period|Adverse Event|29|||
23711217|NCT01885078|66319286|FG009|Step-down Period|Adverse Event|38|||
23711218|NCT01885078|66319277|FG000|Step-down Period|Withdrawal by Subject|0|||
23711219|NCT01885078|66319278|FG001|Step-down Period|Withdrawal by Subject|0|||
23711220|NCT01885078|66319279|FG002|Step-down Period|Withdrawal by Subject|0|||
23711221|NCT01885078|66319280|FG003|Step-down Period|Withdrawal by Subject|0|||
23711222|NCT01885078|66319281|FG004|Step-down Period|Withdrawal by Subject|0|||
23711223|NCT01885078|66319282|FG005|Step-down Period|Withdrawal by Subject|0|||
23711224|NCT01885078|66319283|FG006|Step-down Period|Withdrawal by Subject|0|||
23711225|NCT01885078|66319284|FG007|Step-down Period|Withdrawal by Subject|0|||
23711226|NCT01885078|66319285|FG008|Step-down Period|Withdrawal by Subject|25|||
23711227|NCT01885078|66319286|FG009|Step-down Period|Withdrawal by Subject|15|||
23415691|NCT01133756|65265986|FG002|Overall Study|Investigator Decision|0|||
23711228|NCT01885078|66319277|FG000|Step-down Period|Physician Decision|0|||
23711229|NCT01885078|66319278|FG001|Step-down Period|Physician Decision|0|||
23711230|NCT01885078|66319279|FG002|Step-down Period|Physician Decision|0|||
23711231|NCT01885078|66319280|FG003|Step-down Period|Physician Decision|0|||
23711232|NCT01885078|66319281|FG004|Step-down Period|Physician Decision|0|||
23711233|NCT01885078|66319282|FG005|Step-down Period|Physician Decision|0|||
23711234|NCT01885078|66319283|FG006|Step-down Period|Physician Decision|0|||
23711235|NCT01885078|66319284|FG007|Step-down Period|Physician Decision|0|||
23711236|NCT01885078|66319285|FG008|Step-down Period|Physician Decision|7|||
23711237|NCT01885078|66319286|FG009|Step-down Period|Physician Decision|2|||
23711238|NCT01885078|66319277|FG000|Step-down Period|Death|0|||
23711239|NCT01885078|66319278|FG001|Step-down Period|Death|0|||
23711240|NCT01885078|66319279|FG002|Step-down Period|Death|0|||
23711241|NCT01885078|66319280|FG003|Step-down Period|Death|0|||
23711242|NCT01885078|66319281|FG004|Step-down Period|Death|0|||
23711243|NCT01885078|66319282|FG005|Step-down Period|Death|0|||
23711244|NCT01885078|66319283|FG006|Step-down Period|Death|0|||
23711245|NCT01885078|66319284|FG007|Step-down Period|Death|0|||
23711246|NCT01885078|66319285|FG008|Step-down Period|Death|4|||
23711247|NCT01885078|66319286|FG009|Step-down Period|Death|3|||
23711248|NCT01885078|66319277|FG000|Step-down Period|Lost to Follow-up|0|||
23711249|NCT01885078|66319278|FG001|Step-down Period|Lost to Follow-up|0|||
23711250|NCT01885078|66319279|FG002|Step-down Period|Lost to Follow-up|0|||
23711251|NCT01885078|66319280|FG003|Step-down Period|Lost to Follow-up|0|||
23711252|NCT01885078|66319281|FG004|Step-down Period|Lost to Follow-up|0|||
23711253|NCT01885078|66319282|FG005|Step-down Period|Lost to Follow-up|0|||
23711254|NCT01885078|66319283|FG006|Step-down Period|Lost to Follow-up|0|||
23711255|NCT01885078|66319284|FG007|Step-down Period|Lost to Follow-up|0|||
23711256|NCT01885078|66319285|FG008|Step-down Period|Lost to Follow-up|1|||
23711257|NCT01885078|66319286|FG009|Step-down Period|Lost to Follow-up|1|||
23711258|NCT01885078|66319277|FG000|Step-down Period|Lack of Efficacy|0|||
23711259|NCT01885078|66319278|FG001|Step-down Period|Lack of Efficacy|0|||
23711260|NCT01885078|66319279|FG002|Step-down Period|Lack of Efficacy|0|||
23711261|NCT01885078|66319280|FG003|Step-down Period|Lack of Efficacy|0|||
23711262|NCT01885078|66319281|FG004|Step-down Period|Lack of Efficacy|0|||
23711263|NCT01885078|66319282|FG005|Step-down Period|Lack of Efficacy|0|||
23711264|NCT01885078|66319283|FG006|Step-down Period|Lack of Efficacy|0|||
23711265|NCT01885078|66319284|FG007|Step-down Period|Lack of Efficacy|0|||
23711266|NCT01885078|66319285|FG008|Step-down Period|Lack of Efficacy|1|||
23711267|NCT01885078|66319286|FG009|Step-down Period|Lack of Efficacy|0|||
23415692|NCT01133756|65265984|FG000|Overall Study|Withdrawal by Subject|0|||
23415693|NCT01133756|65265985|FG001|Overall Study|Withdrawal by Subject|1|||
23415694|NCT01133756|65265986|FG002|Overall Study|Withdrawal by Subject|0|||
23711268|NCT01885078|66319277|FG000|Step-down Period|Protocol Violation|0|||
23415695|NCT01133756|65265984|FG000|Overall Study|Progression of Disease|0|||
23415696|NCT01133756|65265985|FG001|Overall Study|Progression of Disease|0|||
23415697|NCT01133756|65265986|FG002|Overall Study|Progression of Disease|1|||
23415698|NCT05243745|65265987|FG000|Overall Study|Withdrawal by Subject|0|||
23415699|NCT05243745|65265988|FG001|Overall Study|Withdrawal by Subject|0|||
23711269|NCT01885078|66319278|FG001|Step-down Period|Protocol Violation|0|||
23711270|NCT01885078|66319279|FG002|Step-down Period|Protocol Violation|0|||
23711271|NCT01885078|66319280|FG003|Step-down Period|Protocol Violation|0|||
23711272|NCT01885078|66319281|FG004|Step-down Period|Protocol Violation|0|||
23711273|NCT01885078|66319282|FG005|Step-down Period|Protocol Violation|0|||
23711274|NCT01885078|66319283|FG006|Step-down Period|Protocol Violation|0|||
23711275|NCT01885078|66319284|FG007|Step-down Period|Protocol Violation|0|||
23711276|NCT01885078|66319285|FG008|Step-down Period|Protocol Violation|1|||
23711277|NCT01885078|66319286|FG009|Step-down Period|Protocol Violation|1|||
23513370|NCT02457910|65616188|FG000|Overall Study|Death|0|||
23513371|NCT02457910|65616189|FG001|Overall Study|Death|0|||
23513372|NCT02457910|65616190|FG002|Overall Study|Death|1|||
23513373|NCT02457910|65616191|FG003|Overall Study|Death|0|||
23513374|NCT02457910|65616192|FG004|Overall Study|Death|0|||
23513375|NCT02457910|65616193|FG005|Overall Study|Death|0|||
23513376|NCT02744391|65616198|FG000|Overall Study|Lost to Follow-up|9|||
23513377|NCT02744391|65616198|FG000|Overall Study|Physician Decision|2|||
23513378|NCT02744391|65616198|FG000|Overall Study|Withdrawal by Subject|3|||
23513379|NCT03051607|65616200|FG000|Overall Study|Adverse Event|66|||
23513380|NCT02415127|65616211|FG000|Overall Study|Adverse Event|1|||
23513381|NCT02415127|65616212|FG001|Overall Study|Adverse Event|0|||
23513382|NCT02626520|65616213|FG000|Overall Study|Physician Decision|1|||
23513383|NCT02626520|65616214|FG001|Overall Study|Physician Decision|1|||
23513384|NCT02626520|65616213|FG000|Overall Study|Adverse Event|0|||
23513385|NCT02626520|65616214|FG001|Overall Study|Adverse Event|4|||
23513386|NCT02626520|65616213|FG000|Overall Study|Lack of Efficacy|0|||
23513387|NCT02626520|65616214|FG001|Overall Study|Lack of Efficacy|2|||
23513388|NCT02626520|65616213|FG000|Overall Study|Did not start protocol therapy|0|||
23513389|NCT02626520|65616214|FG001|Overall Study|Did not start protocol therapy|2|||
23513390|NCT02626520|65616213|FG000|Overall Study|Study terminated|0|||
23513391|NCT02626520|65616214|FG001|Overall Study|Study terminated|1|||
23513392|NCT00498602|65616215|FG000|Overall Study|Death|0|||
23513393|NCT00498602|65616216|FG001|Overall Study|Death|0|||
23513394|NCT00498602|65616217|FG002|Overall Study|Death|0|||
23513395|NCT00498602|65616218|FG003|Overall Study|Death|0|||
23513396|NCT00498602|65616219|FG004|Overall Study|Death|0|||
23513397|NCT00498602|65616220|FG005|Overall Study|Death|1|||
23513398|NCT00498602|65616221|FG006|Overall Study|Death|0|||
23513399|NCT00498602|65616215|FG000|Overall Study|Lack of Efficacy|1|||
23513400|NCT00498602|65616216|FG001|Overall Study|Lack of Efficacy|0|||
23513401|NCT00498602|65616217|FG002|Overall Study|Lack of Efficacy|0|||
23513402|NCT00498602|65616218|FG003|Overall Study|Lack of Efficacy|0|||
23513403|NCT00498602|65616219|FG004|Overall Study|Lack of Efficacy|0|||
23513404|NCT00498602|65616220|FG005|Overall Study|Lack of Efficacy|0|||
23513405|NCT00498602|65616221|FG006|Overall Study|Lack of Efficacy|0|||
23513406|NCT00498602|65616215|FG000|Overall Study|Lost to Follow-up|0|||
23513407|NCT00498602|65616216|FG001|Overall Study|Lost to Follow-up|2|||
23513408|NCT00498602|65616217|FG002|Overall Study|Lost to Follow-up|0|||
23513409|NCT00498602|65616218|FG003|Overall Study|Lost to Follow-up|2|||
23513410|NCT00498602|65616219|FG004|Overall Study|Lost to Follow-up|0|||
23513411|NCT00498602|65616220|FG005|Overall Study|Lost to Follow-up|0|||
23513412|NCT00498602|65616221|FG006|Overall Study|Lost to Follow-up|0|||
23513413|NCT00498602|65616215|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23513414|NCT00498602|65616216|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513415|NCT00498602|65616217|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
23513416|NCT00498602|65616218|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
23513417|NCT00498602|65616219|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513418|NCT00498602|65616220|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23513419|NCT00498602|65616221|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513420|NCT00498602|65616215|FG000|Overall Study|AE not related to Study Drug|1|||
23513421|NCT00498602|65616216|FG001|Overall Study|AE not related to Study Drug|3|||
23513422|NCT00498602|65616217|FG002|Overall Study|AE not related to Study Drug|0|||
23513423|NCT00498602|65616218|FG003|Overall Study|AE not related to Study Drug|0|||
23711278|NCT00434512|66319287|FG000|Overall Study|Migrated/moved from study area|0|||
23711279|NCT00434512|66319288|FG001|Overall Study|Migrated/moved from study area|0|||
23513424|NCT00498602|65616219|FG004|Overall Study|AE not related to Study Drug|2|||
23513425|NCT00498602|65616220|FG005|Overall Study|AE not related to Study Drug|2|||
23513426|NCT00498602|65616221|FG006|Overall Study|AE not related to Study Drug|1|||
23513427|NCT00498602|65616215|FG000|Overall Study|Caregiver Request|2|||
23611192|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
23711280|NCT00434512|66319289|FG002|Overall Study|Migrated/moved from study area|0|||
23711281|NCT00434512|66319290|FG003|Overall Study|Migrated/moved from study area|1|||
23711282|NCT00434512|66319291|FG004|Overall Study|Migrated/moved from study area|1|||
23513428|NCT00498602|65616216|FG001|Overall Study|Caregiver Request|2|||
23513429|NCT00498602|65616217|FG002|Overall Study|Caregiver Request|2|||
23513430|NCT00498602|65616218|FG003|Overall Study|Caregiver Request|0|||
23711283|NCT00434512|66319292|FG005|Overall Study|Migrated/moved from study area|1|||
23711284|NCT00434512|66319287|FG000|Overall Study|Other|0|||
23711285|NCT00434512|66319288|FG001|Overall Study|Other|1|||
23711286|NCT00434512|66319289|FG002|Overall Study|Other|0|||
23415700|NCT05243745|65265989|FG002|Overall Study|Withdrawal by Subject|0|||
23415701|NCT05243745|65265990|FG003|Overall Study|Withdrawal by Subject|1|||
23415702|NCT05243745|65265987|FG000|Overall Study|Unable to Attend Visit 6|0|||
23415703|NCT05243745|65265988|FG001|Overall Study|Unable to Attend Visit 6|0|||
23415704|NCT05243745|65265989|FG002|Overall Study|Unable to Attend Visit 6|1|||
23415705|NCT05243745|65265990|FG003|Overall Study|Unable to Attend Visit 6|0|||
23415706|NCT02910401|65265991|FG000|Overall Study|Study closure Study closure|0|||
23415707|NCT02910401|65265992|FG001|Overall Study|Study closure Study closure|0|||
23415708|NCT02910401|65265993|FG002|Overall Study|Study closure Study closure|2|||
23415709|NCT02910401|65265991|FG000|Overall Study|Physician Decision|1|||
23415710|NCT02910401|65265992|FG001|Overall Study|Physician Decision|0|||
23415711|NCT02910401|65265993|FG002|Overall Study|Physician Decision|0|||
23415712|NCT03249909|65265994|FG000|Overall Study|Withdrawal by Subject|3|||
23415713|NCT03249909|65265995|FG001|Overall Study|Withdrawal by Subject|0|||
23415714|NCT03249909|65265996|FG002|Overall Study|Withdrawal by Subject|0|||
23415715|NCT03249909|65265994|FG000|Overall Study|Adverse Event|3|||
23415716|NCT03249909|65265995|FG001|Overall Study|Adverse Event|0|||
23415717|NCT03249909|65265996|FG002|Overall Study|Adverse Event|0|||
23415718|NCT03249909|65265994|FG000|Overall Study|Lost to Follow-up|0|||
23415719|NCT03249909|65265995|FG001|Overall Study|Lost to Follow-up|1|||
23415720|NCT03249909|65265996|FG002|Overall Study|Lost to Follow-up|0|||
23415721|NCT02321319|65265997|FG000|Overall Study|Product discontinued|5|||
23415722|NCT03006458|65265998|FG000|First Intervention|Unsatisfied Vision|0|||
23415723|NCT03006458|65265999|FG001|First Intervention|Unsatisfied Vision|3|||
23415724|NCT03077438|65266000|FG000|Overall Study|Protocol Violation|3|||
23415725|NCT03077438|65266001|FG001|Overall Study|Protocol Violation|5|||
23415726|NCT03077438|65266000|FG000|Overall Study|Withdrawal by Subject|3|||
23415727|NCT03077438|65266001|FG001|Overall Study|Withdrawal by Subject|6|||
23415728|NCT03077438|65266000|FG000|Overall Study|Lost to Follow-up|6|||
23415729|NCT03077438|65266001|FG001|Overall Study|Lost to Follow-up|3|||
23415730|NCT03305081|65266002|FG000|Overall Study|Lost to Follow-up|10|||
23415731|NCT03305081|65266003|FG001|Overall Study|Lost to Follow-up|15|||
23415732|NCT01208961|65266004|FG000|High-Fat Period III|Protocol Violation|1|||
23415733|NCT01208961|65266005|FG001|High-Fat Period III|Protocol Violation|0|||
23415734|NCT01439971|65266010|FG000|Overall Study|Required number in cohort dosed|0|||
23415735|NCT01439971|65266011|FG001|Overall Study|Required number in cohort dosed|1|||
23415736|NCT01439971|65266012|FG002|Overall Study|Required number in cohort dosed|2|||
23415737|NCT01439971|65266013|FG003|Overall Study|Required number in cohort dosed|0|||
23415738|NCT01439971|65266014|FG004|Overall Study|Required number in cohort dosed|1|||
23415739|NCT01942161|65266015|FG000|Overall Study|Adverse Event|1|||
23415740|NCT01942161|65266016|FG001|Overall Study|Adverse Event|2|||
23415741|NCT01942161|65266017|FG002|Overall Study|Adverse Event|5|||
23415742|NCT01942161|65266015|FG000|Overall Study|Physician Decision|3|||
23415743|NCT01942161|65266016|FG001|Overall Study|Physician Decision|1|||
23415744|NCT01942161|65266017|FG002|Overall Study|Physician Decision|0|||
23415745|NCT01942161|65266015|FG000|Overall Study|Protocol Violation|1|||
23415746|NCT01942161|65266016|FG001|Overall Study|Protocol Violation|0|||
23415747|NCT01942161|65266017|FG002|Overall Study|Protocol Violation|0|||
23415748|NCT01942161|65266015|FG000|Overall Study|Withdrawal by Subject|3|||
23415749|NCT01942161|65266016|FG001|Overall Study|Withdrawal by Subject|3|||
23415750|NCT01942161|65266017|FG002|Overall Study|Withdrawal by Subject|1|||
23415751|NCT00271856|65266022|FG000|Overall Study|Withdrawal by Subject|1|||
23415752|NCT00271856|65266023|FG001|Overall Study|Withdrawal by Subject|7|||
23513431|NCT00498602|65616219|FG004|Overall Study|Caregiver Request|1|||
23513432|NCT00498602|65616220|FG005|Overall Study|Caregiver Request|2|||
23513433|NCT00498602|65616221|FG006|Overall Study|Caregiver Request|0|||
23513434|NCT00498602|65616215|FG000|Overall Study|Investigator Request|0|||
23711287|NCT00434512|66319290|FG003|Overall Study|Other|0|||
23711288|NCT00434512|66319291|FG004|Overall Study|Other|0|||
23711289|NCT00434512|66319292|FG005|Overall Study|Other|0|||
23711290|NCT00310388|66319293|FG000|Primary Reporting Phase|Adverse Event|101|||
23711291|NCT00310388|66319294|FG001|Primary Reporting Phase|Adverse Event|0|||
23711292|NCT00310388|66319293|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
23711293|NCT00310388|66319294|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
23711294|NCT00310388|66319293|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
23711295|NCT00310388|66319294|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
23711296|NCT00310388|66319293|FG000|Primary Reporting Phase|Protocol Violation|10|||
23415753|NCT00271856|65266022|FG000|Overall Study|Lost to Follow-up|10|||
23415754|NCT00271856|65266023|FG001|Overall Study|Lost to Follow-up|11|||
23415755|NCT00443053|65266026|FG000|Overall Study|Adverse Event|2|||
23415756|NCT00443053|65266027|FG001|Overall Study|Adverse Event|1|||
23415757|NCT00443053|65266026|FG000|Overall Study|Withdrawal by Subject|9|||
23415758|NCT00443053|65266027|FG001|Overall Study|Withdrawal by Subject|18|||
23415759|NCT00443053|65266026|FG000|Overall Study|Lost to Follow-up|4|||
23415760|NCT00443053|65266027|FG001|Overall Study|Lost to Follow-up|5|||
23415761|NCT00443053|65266026|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23415762|NCT00443053|65266027|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23415763|NCT00443053|65266026|FG000|Overall Study|Noncompliance|2|||
23415764|NCT00443053|65266027|FG001|Overall Study|Noncompliance|1|||
23415765|NCT00443053|65266026|FG000|Overall Study|Other|3|||
23415766|NCT00443053|65266027|FG001|Overall Study|Other|4|||
23415767|NCT00443053|65266026|FG000|Overall Study|Physician Decision|0|||
23415768|NCT00443053|65266027|FG001|Overall Study|Physician Decision|4|||
23415769|NCT03219034|65266028|FG000|Overall Study|Lost to Follow-up|9|||
23415770|NCT03219034|65266029|FG001|Overall Study|Lost to Follow-up|13|||
23415771|NCT03219034|65266028|FG000|Overall Study|Additional dental work needed|1|||
23415772|NCT03219034|65266029|FG001|Overall Study|Additional dental work needed|0|||
23415773|NCT03219034|65266028|FG000|Overall Study|UPPP Surgery|1|||
23415774|NCT03219034|65266029|FG001|Overall Study|UPPP Surgery|0|||
23415775|NCT03219034|65266028|FG000|Overall Study|Dental sensitivity|0|||
23415776|NCT03219034|65266029|FG001|Overall Study|Dental sensitivity|1|||
23415777|NCT03219034|65266028|FG000|Overall Study|Death in family|0|||
23415778|NCT03219034|65266029|FG001|Overall Study|Death in family|1|||
23415779|NCT03403361|65266031|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
23415780|NCT01406938|65266037|FG000|Induction Period|Subject/guardian decision|6|||
23415781|NCT01406938|65266038|FG001|Induction Period|Subject/guardian decision|8|||
23415782|NCT01406938|65266039|FG002|Induction Period|Subject/guardian decision|0|||
23415783|NCT01406938|65266040|FG003|Induction Period|Subject/guardian decision|0|||
23415784|NCT01406938|65266041|FG004|Induction Period|Subject/guardian decision|0|||
23415785|NCT01406938|65266042|FG005|Induction Period|Subject/guardian decision|0|||
23415786|NCT01406938|65266037|FG000|Induction Period|Protocol deviation|1|||
23415787|NCT01406938|65266038|FG001|Induction Period|Protocol deviation|0|||
23415788|NCT01406938|65266039|FG002|Induction Period|Protocol deviation|0|||
23415789|NCT01406938|65266040|FG003|Induction Period|Protocol deviation|0|||
23415790|NCT01406938|65266041|FG004|Induction Period|Protocol deviation|0|||
23415791|NCT01406938|65266042|FG005|Induction Period|Protocol deviation|0|||
23415792|NCT01406938|65266037|FG000|Induction Period|Adverse Event|8|||
23415793|NCT01406938|65266038|FG001|Induction Period|Adverse Event|9|||
23415794|NCT01406938|65266039|FG002|Induction Period|Adverse Event|0|||
23415795|NCT01406938|65266040|FG003|Induction Period|Adverse Event|0|||
23415796|NCT01406938|65266041|FG004|Induction Period|Adverse Event|0|||
23415797|NCT01406938|65266042|FG005|Induction Period|Adverse Event|0|||
23415798|NCT01406938|65266037|FG000|Induction Period|Lack of Efficacy|1|||
23415799|NCT01406938|65266038|FG001|Induction Period|Lack of Efficacy|0|||
23415800|NCT01406938|65266039|FG002|Induction Period|Lack of Efficacy|0|||
23415801|NCT01406938|65266040|FG003|Induction Period|Lack of Efficacy|0|||
23415802|NCT01406938|65266041|FG004|Induction Period|Lack of Efficacy|0|||
23415803|NCT01406938|65266042|FG005|Induction Period|Lack of Efficacy|0|||
23415804|NCT01406938|65266037|FG000|Induction Period|Lost to Follow-up|2|||
23415805|NCT01406938|65266038|FG001|Induction Period|Lost to Follow-up|3|||
23513435|NCT00498602|65616216|FG001|Overall Study|Investigator Request|0|||
23513436|NCT00498602|65616217|FG002|Overall Study|Investigator Request|1|||
23513437|NCT00498602|65616218|FG003|Overall Study|Investigator Request|0|||
23513438|NCT00498602|65616219|FG004|Overall Study|Investigator Request|0|||
23415806|NCT01406938|65266039|FG002|Induction Period|Lost to Follow-up|0|||
23415807|NCT01406938|65266040|FG003|Induction Period|Lost to Follow-up|0|||
23415808|NCT01406938|65266041|FG004|Induction Period|Lost to Follow-up|0|||
23415809|NCT01406938|65266042|FG005|Induction Period|Lost to Follow-up|0|||
23415810|NCT01406938|65266037|FG000|Maintenance Period|Adverse Event|0|||
23415811|NCT01406938|65266038|FG001|Maintenance Period|Adverse Event|0|||
23711297|NCT00310388|66319294|FG001|Primary Reporting Phase|Protocol Violation|0|||
23711298|NCT00310388|66319293|FG000|Primary Reporting Phase|Pregnancy|3|||
23711299|NCT00310388|66319294|FG001|Primary Reporting Phase|Pregnancy|0|||
23711300|NCT00310388|66319293|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
23711301|NCT00310388|66319294|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
23711302|NCT00310388|66319293|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
23711303|NCT00310388|66319294|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
23711304|NCT00310388|66319293|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
23711305|NCT00310388|66319294|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
23711306|NCT00310388|66319293|FG000|Primary Reporting Phase|Physician Decision|2|||
23711307|NCT00310388|66319294|FG001|Primary Reporting Phase|Physician Decision|0|||
23711308|NCT00310388|66319293|FG000|Primary Reporting Phase|Request of the sponsor|19|||
23711309|NCT00310388|66319294|FG001|Primary Reporting Phase|Request of the sponsor|0|||
23711310|NCT00310388|66319293|FG000|Primary Reporting Phase|Failed to return|8|||
23711311|NCT00310388|66319294|FG001|Primary Reporting Phase|Failed to return|0|||
23711312|NCT00310388|66319293|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
23711313|NCT00310388|66319294|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
23711314|NCT00310388|66319293|FG000|Primary Reporting Phase|Participant request|2|||
23711315|NCT00310388|66319294|FG001|Primary Reporting Phase|Participant request|0|||
23711316|NCT00310388|66319293|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
23711317|NCT00310388|66319294|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
23711318|NCT00310388|66319293|FG000|Primary Reporting Phase|Discontinuation of study|1|||
23711319|NCT00310388|66319294|FG001|Primary Reporting Phase|Discontinuation of study|0|||
23711320|NCT00310388|66319293|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
23711321|NCT00310388|66319294|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
23711322|NCT00310388|66319293|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
23711323|NCT00310388|66319294|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
23711324|NCT00310388|66319293|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
23711325|NCT00310388|66319294|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
23711326|NCT00310388|66319293|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
23711327|NCT00310388|66319294|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
23711328|NCT00310388|66319293|FG000|Primary Reporting Phase|Participant passed away|1|||
23711329|NCT00310388|66319294|FG001|Primary Reporting Phase|Participant passed away|0|||
23711330|NCT00310388|66319293|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
23711331|NCT00310388|66319294|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
23711332|NCT00310388|66319293|FG000|Primary Reporting Phase|Missing|1|||
23711333|NCT00310388|66319294|FG001|Primary Reporting Phase|Missing|0|||
23711334|NCT00310388|66319293|FG000|Primary Reporting Phase|Other|1|||
23711335|NCT00310388|66319294|FG001|Primary Reporting Phase|Other|0|||
23711336|NCT00310388|66319293|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
23711337|NCT00310388|66319294|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
23711338|NCT00310388|66319293|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
23711339|NCT00310388|66319294|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
23711340|NCT00310388|66319293|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
23711341|NCT00310388|66319294|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
23711342|NCT00310388|66319293|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
23711343|NCT00310388|66319294|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
23415812|NCT01406938|65266039|FG002|Maintenance Period|Adverse Event|2|||
23415813|NCT01406938|65266040|FG003|Maintenance Period|Adverse Event|8|||
23711344|NCT01999946|66319295|FG000|Overall Study|Participant not released from jail|2|||
23711345|NCT01999946|66319296|FG001|Overall Study|Participant not released from jail|2|||
23711346|NCT01999946|66319297|FG002|Overall Study|Participant not released from jail|0|||
23711347|NCT01999946|66319295|FG000|Overall Study|Not included in primary outcome analysis|0|||
23711348|NCT01999946|66319296|FG001|Overall Study|Not included in primary outcome analysis|0|||
23711349|NCT01999946|66319297|FG002|Overall Study|Not included in primary outcome analysis|79|||
23711350|NCT04402008|66319298|FG000|Overall Study|Adverse Event|0|||
23415814|NCT01406938|65266041|FG004|Maintenance Period|Adverse Event|4|||
23415815|NCT01406938|65266042|FG005|Maintenance Period|Adverse Event|2|||
23415816|NCT01406938|65266037|FG000|Maintenance Period|Death|0|||
23415817|NCT01406938|65266038|FG001|Maintenance Period|Death|0|||
23415818|NCT01406938|65266039|FG002|Maintenance Period|Death|0|||
23415819|NCT01406938|65266040|FG003|Maintenance Period|Death|0|||
23415820|NCT01406938|65266041|FG004|Maintenance Period|Death|1|||
23415821|NCT01406938|65266042|FG005|Maintenance Period|Death|0|||
23415822|NCT01406938|65266037|FG000|Maintenance Period|Subject/guardian decision|0|||
23415823|NCT01406938|65266038|FG001|Maintenance Period|Subject/guardian decision|0|||
23415824|NCT01406938|65266039|FG002|Maintenance Period|Subject/guardian decision|11|||
23415825|NCT01406938|65266040|FG003|Maintenance Period|Subject/guardian decision|7|||
23415826|NCT01406938|65266041|FG004|Maintenance Period|Subject/guardian decision|10|||
23711351|NCT04402008|66319299|FG001|Overall Study|Adverse Event|0|||
23711352|NCT04402008|66319300|FG002|Overall Study|Adverse Event|0|||
23711353|NCT04402008|66319301|FG003|Overall Study|Adverse Event|1|||
23711354|NCT04402008|66319302|FG004|Overall Study|Adverse Event|0|||
23711355|NCT04402008|66319303|FG005|Overall Study|Adverse Event|0|||
23711356|NCT04402008|66319304|FG006|Overall Study|Adverse Event|0|||
23711357|NCT04402008|66319298|FG000|Overall Study|Disease Progression|3|||
23711358|NCT04402008|66319299|FG001|Overall Study|Disease Progression|2|||
23711359|NCT04402008|66319300|FG002|Overall Study|Disease Progression|3|||
23711360|NCT04402008|66319301|FG003|Overall Study|Disease Progression|3|||
23711361|NCT04402008|66319302|FG004|Overall Study|Disease Progression|4|||
23711362|NCT04402008|66319303|FG005|Overall Study|Disease Progression|3|||
23513439|NCT00498602|65616220|FG005|Overall Study|Investigator Request|0|||
23513440|NCT00498602|65616221|FG006|Overall Study|Investigator Request|0|||
23513441|NCT00498602|65616215|FG000|Overall Study|Subject Request|3|||
23513442|NCT00498602|65616216|FG001|Overall Study|Subject Request|0|||
23513443|NCT00498602|65616217|FG002|Overall Study|Subject Request|1|||
23513444|NCT00498602|65616218|FG003|Overall Study|Subject Request|1|||
23513445|NCT00498602|65616219|FG004|Overall Study|Subject Request|1|||
23513446|NCT00498602|65616220|FG005|Overall Study|Subject Request|4|||
23513447|NCT00498602|65616221|FG006|Overall Study|Subject Request|1|||
23513448|NCT00498602|65616215|FG000|Overall Study|Other|2|||
23513449|NCT00498602|65616216|FG001|Overall Study|Other|3|||
23513450|NCT00498602|65616217|FG002|Overall Study|Other|1|||
23513451|NCT00498602|65616218|FG003|Overall Study|Other|0|||
23513452|NCT00498602|65616219|FG004|Overall Study|Other|0|||
23513453|NCT00498602|65616220|FG005|Overall Study|Other|3|||
23513454|NCT00498602|65616221|FG006|Overall Study|Other|0|||
23513455|NCT00619801|65616222|FG000|Overall Study|Lack of Efficacy|0|||
23513456|NCT00619801|65616223|FG001|Overall Study|Lack of Efficacy|1|||
23513457|NCT00619801|65616222|FG000|Overall Study|Withdrawal by Subject|1|||
23513458|NCT00619801|65616223|FG001|Overall Study|Withdrawal by Subject|1|||
23513459|NCT00619801|65616222|FG000|Overall Study|Loss of efficacy|0|||
23513460|NCT00619801|65616223|FG001|Overall Study|Loss of efficacy|1|||
23513461|NCT02961751|65616226|FG000|Overall Study|Lost to Follow-up|11|||
23513462|NCT02961751|65616226|FG000|Overall Study|Physician Decision|2|||
23513463|NCT02961751|65616226|FG000|Overall Study|Not Eligible at Enrollment|1|||
23513464|NCT02961751|65616226|FG000|Overall Study|Protocol Violation|1|||
23513465|NCT01244906|65616227|FG000|Overall Study|Death|2|||
23513466|NCT01244906|65616227|FG000|Overall Study|Progression of disease post treatment|6|||
23513467|NCT02436889|65616243|FG000|Overall Study|No improvement in symptoms|1|||
23513468|NCT02436889|65616244|FG001|Overall Study|No improvement in symptoms|0|||
23711363|NCT04402008|66319304|FG006|Overall Study|Disease Progression|10|||
23711364|NCT04402008|66319298|FG000|Overall Study|Withdrawal by Subject|0|||
23711365|NCT04402008|66319299|FG001|Overall Study|Withdrawal by Subject|1|||
23711366|NCT04402008|66319300|FG002|Overall Study|Withdrawal by Subject|0|||
23711367|NCT04402008|66319301|FG003|Overall Study|Withdrawal by Subject|0|||
23711368|NCT04402008|66319302|FG004|Overall Study|Withdrawal by Subject|1|||
23711369|NCT04402008|66319303|FG005|Overall Study|Withdrawal by Subject|0|||
23711370|NCT04402008|66319304|FG006|Overall Study|Withdrawal by Subject|0|||
23711371|NCT04402008|66319298|FG000|Overall Study|Sponsor Decision|0|||
23711372|NCT04402008|66319299|FG001|Overall Study|Sponsor Decision|0|||
23711373|NCT04402008|66319300|FG002|Overall Study|Sponsor Decision|0|||
23711374|NCT04402008|66319301|FG003|Overall Study|Sponsor Decision|0|||
23711375|NCT04402008|66319302|FG004|Overall Study|Sponsor Decision|0|||
23711376|NCT04402008|66319303|FG005|Overall Study|Sponsor Decision|0|||
23711377|NCT04402008|66319304|FG006|Overall Study|Sponsor Decision|3|||
23513469|NCT02436889|65616243|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
23513470|NCT02436889|65616244|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
23513471|NCT03824912|65616247|FG000|Overall Study|Lost to Follow-up|18|||
23711378|NCT04402008|66319298|FG000|Overall Study|Death|0|||
23711379|NCT04402008|66319299|FG001|Overall Study|Death|0|||
23711380|NCT04402008|66319300|FG002|Overall Study|Death|0|||
23711381|NCT04402008|66319301|FG003|Overall Study|Death|0|||
23711382|NCT04402008|66319302|FG004|Overall Study|Death|1|||
23711383|NCT04402008|66319303|FG005|Overall Study|Death|0|||
23513472|NCT03824912|65616248|FG001|Overall Study|Lost to Follow-up|15|||
23513473|NCT03824912|65616249|FG002|Overall Study|Lost to Follow-up|8|||
23513474|NCT03824912|65616247|FG000|Overall Study|Negative Baseline Culture Result|118|||
23513475|NCT03824912|65616248|FG001|Overall Study|Negative Baseline Culture Result|112|||
23711384|NCT04402008|66319304|FG006|Overall Study|Death|2|||
23711385|NCT04402008|66319298|FG000|Overall Study|Other|0|||
23711386|NCT04402008|66319299|FG001|Overall Study|Other|0|||
23513476|NCT03824912|65616249|FG002|Overall Study|Negative Baseline Culture Result|57|||
23711387|NCT04402008|66319300|FG002|Overall Study|Other|0|||
23513477|NCT03824912|65616247|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23513478|NCT03824912|65616248|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23513479|NCT03824912|65616249|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23513480|NCT03824912|65616247|FG000|Overall Study|Protocol Violation|1|||
23711388|NCT04402008|66319301|FG003|Overall Study|Other|0|||
23711389|NCT04402008|66319302|FG004|Overall Study|Other|0|||
23711390|NCT04402008|66319303|FG005|Overall Study|Other|0|||
23711391|NCT04402008|66319304|FG006|Overall Study|Other|5|||
23711392|NCT00501046|66319305|FG000|Overall Study|Adverse Event|21|||
23711393|NCT00501046|66319306|FG001|Overall Study|Adverse Event|25|||
23711394|NCT00501046|66319305|FG000|Overall Study|Death|23|||
23711395|NCT00501046|66319306|FG001|Overall Study|Death|30|||
23711396|NCT00501046|66319305|FG000|Overall Study|Lost to Follow-up|14|||
23711397|NCT00501046|66319306|FG001|Overall Study|Lost to Follow-up|13|||
23711398|NCT00501046|66319305|FG000|Overall Study|Physician Decision|7|||
23711399|NCT00501046|66319306|FG001|Overall Study|Physician Decision|2|||
23711400|NCT00501046|66319305|FG000|Overall Study|Pregnancy|0|||
23711401|NCT00501046|66319306|FG001|Overall Study|Pregnancy|3|||
23711402|NCT00501046|66319305|FG000|Overall Study|Protocol Violation|2|||
23711403|NCT00501046|66319306|FG001|Overall Study|Protocol Violation|1|||
23711404|NCT00501046|66319305|FG000|Overall Study|Withdrawal by Subject|84|||
23711405|NCT00501046|66319306|FG001|Overall Study|Withdrawal by Subject|83|||
23513481|NCT03824912|65616248|FG001|Overall Study|Protocol Violation|4|||
23513482|NCT03824912|65616249|FG002|Overall Study|Protocol Violation|1|||
23513483|NCT03824912|65616247|FG000|Overall Study|Withdrawal by Subject|3|||
23513484|NCT03824912|65616248|FG001|Overall Study|Withdrawal by Subject|2|||
23513485|NCT03824912|65616249|FG002|Overall Study|Withdrawal by Subject|1|||
23513486|NCT03824912|65616247|FG000|Overall Study|Participation in another study|0|||
23513487|NCT03824912|65616248|FG001|Overall Study|Participation in another study|1|||
23513488|NCT03824912|65616249|FG002|Overall Study|Participation in another study|0|||
23513489|NCT04080297|65616250|FG000|Overall Study|Adverse Event|1|||
23513490|NCT04080297|65616251|FG001|Overall Study|Adverse Event|3|||
23513491|NCT04080297|65616250|FG000|Overall Study|concurrent illness|1|||
23513492|NCT04080297|65616251|FG001|Overall Study|concurrent illness|0|||
23513493|NCT00232817|65616252|FG000|Overall Study|Protocol Violation|2|||
23513494|NCT00232817|65616253|FG001|Overall Study|Protocol Violation|1|||
23513495|NCT00463346|65616254|FG000|Overall Study|Withdrawal by Subject|3|||
23513496|NCT00463346|65616255|FG001|Overall Study|Withdrawal by Subject|3|||
23513497|NCT04053023|65616256|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
23513498|NCT04053023|65616257|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
23513499|NCT02738151|65616258|FG000|Overall Study|Randomized but not treated|4|||
23513500|NCT02738151|65616259|FG001|Overall Study|Randomized but not treated|1|||
23513501|NCT02738151|65616258|FG000|Overall Study|Adverse Event|4|||
23513502|NCT02738151|65616259|FG001|Overall Study|Adverse Event|5|||
23513503|NCT02738151|65616258|FG000|Overall Study|Hypoglycemia|0|||
23513504|NCT02738151|65616259|FG001|Overall Study|Hypoglycemia|1|||
23513505|NCT02738151|65616258|FG000|Overall Study|Poor Compliance to Protocol|4|||
23513506|NCT02738151|65616259|FG001|Overall Study|Poor Compliance to Protocol|3|||
23513507|NCT02738151|65616258|FG000|Overall Study|Other than specified above|11|||
23513508|NCT02738151|65616259|FG001|Overall Study|Other than specified above|21|||
23513509|NCT00788151|65616264|FG000|Overall Study|Other adverse event|0|||
23513510|NCT00788151|65616265|FG001|Overall Study|Other adverse event|2|||
23513511|NCT00788151|65616264|FG000|Overall Study|Protocol Violation|0|||
23513512|NCT00788151|65616265|FG001|Overall Study|Protocol Violation|1|||
23513513|NCT00788151|65616264|FG000|Overall Study|Withdrawal by Subject|13|||
23513514|NCT00788151|65616265|FG001|Overall Study|Withdrawal by Subject|6|||
23513515|NCT00788151|65616264|FG000|Overall Study|Enrolled but not treated|1|||
23513516|NCT00788151|65616265|FG001|Overall Study|Enrolled but not treated|1|||
23513517|NCT01387347|65616266|FG000|Overall Study|Lost to Follow-up|2|||
23513518|NCT01387347|65616267|FG001|Overall Study|Lost to Follow-up|1|||
23513519|NCT00535223|65619470|FG000|Overall Study|Withdrawal by Subject|4|||
23513520|NCT00535223|65619471|FG001|Overall Study|Withdrawal by Subject|1|||
23513521|NCT01751867|65619479|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
23513522|NCT01751867|65619480|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
23513523|NCT01751867|65619479|FG000|Overall Study|Diease Progression|4|||
23513524|NCT01751867|65619480|FG001|Overall Study|Diease Progression|18|||
23513525|NCT01751867|65619479|FG000|Overall Study|Adverse Event|8|||
23513526|NCT01751867|65619480|FG001|Overall Study|Adverse Event|15|||
23513527|NCT01751867|65619479|FG000|Overall Study|Poor Compliance|0|||
23513528|NCT01751867|65619480|FG001|Overall Study|Poor Compliance|5|||
23513529|NCT01751867|65619479|FG000|Overall Study|Withdrawal by Subject|3|||
23513530|NCT01751867|65619480|FG001|Overall Study|Withdrawal by Subject|1|||
23711406|NCT00501046|66319305|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
23711407|NCT00501046|66319306|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
23711408|NCT04169061|66319307|FG000|Overall Study|Adverse Event|2|||
23711409|NCT04169061|66319307|FG000|Overall Study|Death|1|||
23711410|NCT04169061|66319307|FG000|Overall Study|Withdrawal by Subject|1|||
23711411|NCT04169061|66319307|FG000|Overall Study|Protocol Violation|1|||
23513531|NCT01751867|65619479|FG000|Overall Study|Physician Decision|4|||
23513532|NCT01751867|65619480|FG001|Overall Study|Physician Decision|7|||
23513533|NCT01751867|65619479|FG000|Overall Study|Protocol Violation|0|||
23711412|NCT03259490|66319308|FG000|Period 1|Withdrawal by Subject|0|||
23711413|NCT03259490|66319309|FG001|Period 1|Withdrawal by Subject|1|||
23513534|NCT01751867|65619480|FG001|Overall Study|Protocol Violation|2|||
23513535|NCT01751867|65619479|FG000|Overall Study|Death|0|||
23513536|NCT01751867|65619480|FG001|Overall Study|Death|5|||
23513537|NCT01751867|65619479|FG000|Overall Study|Other|11|||
23513538|NCT01751867|65619480|FG001|Overall Study|Other|37|||
23513539|NCT01751867|65619479|FG000|Overall Study|Randomized but not treated.|2|||
23513540|NCT01751867|65619480|FG001|Overall Study|Randomized but not treated.|1|||
23513541|NCT00396591|65619481|FG000|Overall Study|Disease Progression|13|||
23513542|NCT00396591|65619481|FG000|Overall Study|Adverse Event|2|||
23513543|NCT00396591|65619481|FG000|Overall Study|Participant request|1|||
23513544|NCT00254540|65619482|FG000|Overall Study|Adverse Event|6|||
23513545|NCT00254540|65619483|FG001|Overall Study|Adverse Event|7|||
23513546|NCT00254540|65619482|FG000|Overall Study|Lack of Efficacy|13|||
23513547|NCT00254540|65619483|FG001|Overall Study|Lack of Efficacy|13|||
23513548|NCT00254540|65619482|FG000|Overall Study|Death|0|||
23513549|NCT00254540|65619483|FG001|Overall Study|Death|1|||
23513550|NCT00254540|65619482|FG000|Overall Study|Laboratory Test Abnormality|0|||
23513551|NCT00254540|65619483|FG001|Overall Study|Laboratory Test Abnormality|1|||
23513552|NCT01408914|65619484|FG000|Overall Study|Could not complete tx in protocol period|5|||
23513553|NCT01408914|65619485|FG001|Overall Study|Could not complete tx in protocol period|5|||
23513554|NCT01408914|65619486|FG002|Overall Study|Could not complete tx in protocol period|6|||
23513555|NCT01408914|65619484|FG000|Overall Study|Lost to Follow-up|4|||
23513556|NCT01408914|65619485|FG001|Overall Study|Lost to Follow-up|1|||
23513557|NCT01408914|65619486|FG002|Overall Study|Lost to Follow-up|2|||
23513558|NCT01408914|65619484|FG000|Overall Study|Physician Decision|1|||
23513559|NCT01408914|65619485|FG001|Overall Study|Physician Decision|1|||
23513560|NCT01408914|65619486|FG002|Overall Study|Physician Decision|0|||
23513561|NCT01408914|65619484|FG000|Overall Study|Withdrawal by Subject|1|||
23513562|NCT01408914|65619485|FG001|Overall Study|Withdrawal by Subject|0|||
23513563|NCT01408914|65619486|FG002|Overall Study|Withdrawal by Subject|1|||
23513564|NCT01408914|65619484|FG000|Overall Study|Moved out of study jurisdiction|1|||
23513565|NCT01408914|65619485|FG001|Overall Study|Moved out of study jurisdiction|1|||
23513566|NCT01408914|65619486|FG002|Overall Study|Moved out of study jurisdiction|0|||
23513567|NCT01408914|65619484|FG000|Overall Study|Late exclusion|0|||
23513568|NCT01408914|65619485|FG001|Overall Study|Late exclusion|3|||
23513569|NCT01408914|65619486|FG002|Overall Study|Late exclusion|3|||
23513570|NCT01408914|65619484|FG000|Overall Study|Change in local TB/HIV norms|0|||
23513571|NCT01408914|65619485|FG001|Overall Study|Change in local TB/HIV norms|1|||
23513572|NCT01408914|65619486|FG002|Overall Study|Change in local TB/HIV norms|1|||
23513573|NCT02643082|65619488|FG000|Period 1|Adverse Event|1|||
23513574|NCT02643082|65619489|FG001|Period 1|Adverse Event|0|||
23513575|NCT03635957|65619492|FG000|Run-In Period|Lost to Follow-up|1|||
23513576|NCT03635957|65619492|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
23513577|NCT01892501|65619493|FG000|Overall Study|Protocol Violation|2|||
23513578|NCT01892501|65619493|FG000|Overall Study|Puncture not carried out|9|||
23513579|NCT01892501|65619493|FG000|Overall Study|Radiological monitoring not carried out|5|||
23513580|NCT01892501|65619493|FG000|Overall Study|Non-contributory histological result|12|||
23513581|NCT00469092|65619494|FG000|Overall Study|Adverse Event|5|||
23513582|NCT00469092|65619495|FG001|Overall Study|Adverse Event|4|||
23513583|NCT00469092|65619494|FG000|Overall Study|Lack of Efficacy|1|||
23513584|NCT00469092|65619495|FG001|Overall Study|Lack of Efficacy|0|||
23513585|NCT00469092|65619494|FG000|Overall Study|Lost to Follow-up|1|||
23513586|NCT00469092|65619495|FG001|Overall Study|Lost to Follow-up|2|||
23513587|NCT00469092|65619494|FG000|Overall Study|Protocol Violation|3|||
23513588|NCT00469092|65619495|FG001|Overall Study|Protocol Violation|3|||
23513589|NCT00469092|65619494|FG000|Overall Study|Withdrawal by Subject|4|||
23513590|NCT00469092|65619495|FG001|Overall Study|Withdrawal by Subject|4|||
23513591|NCT00469092|65619494|FG000|Overall Study|Withdrawal Criteria|3|||
23513592|NCT00469092|65619495|FG001|Overall Study|Withdrawal Criteria|4|||
23513593|NCT00469092|65619494|FG000|Overall Study|Incorrectly Randomised|4|||
23513594|NCT00469092|65619495|FG001|Overall Study|Incorrectly Randomised|3|||
23513595|NCT00469092|65619494|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
23513596|NCT00469092|65619495|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
23513597|NCT00469092|65619494|FG000|Overall Study|Use of lipid lowering drug|1|||
23513598|NCT00469092|65619495|FG001|Overall Study|Use of lipid lowering drug|0|||
23513599|NCT00469092|65619494|FG000|Overall Study|Hypoglycaemic Episodes|1|||
23513600|NCT00469092|65619495|FG001|Overall Study|Hypoglycaemic Episodes|1|||
23513601|NCT00469092|65619494|FG000|Overall Study|Abnormal lab value|1|||
23513602|NCT00469092|65619495|FG001|Overall Study|Abnormal lab value|0|||
23513603|NCT00469092|65619494|FG000|Overall Study|Use of Corticosteroid|1|||
23513604|NCT00469092|65619495|FG001|Overall Study|Use of Corticosteroid|0|||
23513605|NCT02728895|65619496|FG000|Overall Study|Other|1|||
23513606|NCT02728895|65619497|FG001|Overall Study|Other|2|||
23513607|NCT02728895|65619496|FG000|Overall Study|Withdrawal by Subject|0|||
23513608|NCT02728895|65619497|FG001|Overall Study|Withdrawal by Subject|3|||
23513609|NCT00003479|65619499|FG000|Overall Study|Not evaluable|3|||
23513610|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
23711414|NCT03259490|66319308|FG000|Period 2|Protocol Violation|1|||
23711415|NCT03259490|66319309|FG001|Period 2|Protocol Violation|0|||
23711416|NCT01056341|66319310|FG000|Overall Study|Treatment Intolerance|0|||
23711417|NCT01056341|66319311|FG001|Overall Study|Treatment Intolerance|2|||
23513611|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
23513612|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
23513613|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23513614|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
23513615|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
23513616|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23513617|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23513618|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
23513619|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23513620|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
23513621|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23513622|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
23513623|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
23513624|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
23513625|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
23513626|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
23513627|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
23513628|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Death|4|||
23513629|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Death|1|||
23513630|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
23513631|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
23513632|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
23513633|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
23513634|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
23513635|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
23513636|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
23513637|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
23513638|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
23513639|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
23513640|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
23513641|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
23513642|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
23513643|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
23513644|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
23513645|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
23513646|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
23513647|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
23513648|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
23513649|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
23513650|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
23513651|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
23513652|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
23513653|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
23513654|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
23513655|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
23513656|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
23513657|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
23513658|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
23513659|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
23513660|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
23513661|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
23513662|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
23513663|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
23513664|NCT00391274|65619512|FG000|Overall Study|Death Due to Study Disease|55|||
23513665|NCT00391274|65619513|FG001|Overall Study|Death Due to Study Disease|45|||
23513666|NCT00391274|65619512|FG000|Overall Study|Lost to Follow-up|0|||
23513667|NCT00391274|65619513|FG001|Overall Study|Lost to Follow-up|3|||
23513668|NCT00391274|65619512|FG000|Overall Study|Physician Decision|4|||
23513669|NCT00391274|65619513|FG001|Overall Study|Physician Decision|2|||
23513670|NCT00391274|65619512|FG000|Overall Study|Withdrawal by Subject|0|||
23513671|NCT00391274|65619513|FG001|Overall Study|Withdrawal by Subject|3|||
23711418|NCT01056341|66319312|FG002|Overall Study|Treatment Intolerance|0|||
23711419|NCT01056341|66319313|FG003|Overall Study|Treatment Intolerance|2|||
23513672|NCT00391274|65619512|FG000|Overall Study|Death Due to Adverse Event|1|||
23513673|NCT00391274|65619513|FG001|Overall Study|Death Due to Adverse Event|3|||
23513674|NCT00391274|65619512|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
23513675|NCT00391274|65619513|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
23513676|NCT00391274|65619512|FG000|Overall Study|Death Not Study Related|0|||
23513677|NCT00391274|65619513|FG001|Overall Study|Death Not Study Related|1|||
23513678|NCT00003492|65619514|FG000|Overall Study|Not evaluable|6|||
23513679|NCT01119131|65619522|FG000|Overall Study|Adverse Event|1|||
23513680|NCT01119131|65619523|FG001|Overall Study|Adverse Event|1|||
23513681|NCT01119131|65619524|FG002|Overall Study|Adverse Event|1|||
23513682|NCT01119131|65619522|FG000|Overall Study|Non-Compliance|1|||
23513683|NCT01119131|65619523|FG001|Overall Study|Non-Compliance|0|||
23513684|NCT01119131|65619524|FG002|Overall Study|Non-Compliance|4|||
23513685|NCT01119131|65619522|FG000|Overall Study|Physician Decision|0|||
23513686|NCT01119131|65619523|FG001|Overall Study|Physician Decision|0|||
23513687|NCT01119131|65619524|FG002|Overall Study|Physician Decision|1|||
23513688|NCT02200445|65619528|FG000|Overall Study|Lack of Efficacy|1|||
23513689|NCT02200445|65619529|FG001|Overall Study|Lack of Efficacy|2|||
23513690|NCT02200445|65619530|FG002|Overall Study|Lack of Efficacy|2|||
23513691|NCT02200445|65619528|FG000|Overall Study|Adverse Event|0|||
23513692|NCT02200445|65619529|FG001|Overall Study|Adverse Event|2|||
23513693|NCT02200445|65619530|FG002|Overall Study|Adverse Event|0|||
23513694|NCT00881712|65619533|FG000|Overall Study|Death|1|||
23513695|NCT00881712|65619534|FG001|Overall Study|Death|0|||
23513696|NCT00881712|65619535|FG002|Overall Study|Death|0|||
23513697|NCT00881712|65619533|FG000|Overall Study|Withdrawal by Subject|1|||
23513698|NCT00881712|65619534|FG001|Overall Study|Withdrawal by Subject|0|||
23513699|NCT00881712|65619535|FG002|Overall Study|Withdrawal by Subject|0|||
23513700|NCT02625259|65619536|FG000|First Intervention (Day 1)|Other|0|||
23513701|NCT02625259|65619537|FG001|First Intervention (Day 1)|Other|0|||
23513702|NCT02625259|65619538|FG002|First Intervention (Day 1)|Other|1|||
23513703|NCT02625259|65619539|FG003|First Intervention (Day 1)|Other|0|||
23513704|NCT02625259|65619540|FG004|First Intervention (Day 1)|Other|0|||
23513705|NCT02625259|65619536|FG000|First Intervention (Day 1)|Adverse Event|2|||
23513706|NCT02625259|65619537|FG001|First Intervention (Day 1)|Adverse Event|1|||
23513707|NCT02625259|65619538|FG002|First Intervention (Day 1)|Adverse Event|0|||
23513708|NCT02625259|65619539|FG003|First Intervention (Day 1)|Adverse Event|0|||
23513709|NCT02625259|65619540|FG004|First Intervention (Day 1)|Adverse Event|0|||
23513710|NCT02625259|65619536|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513711|NCT02625259|65619537|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513712|NCT02625259|65619538|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513713|NCT02625259|65619539|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
23513714|NCT02625259|65619540|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513715|NCT02288559|65619541|FG000|Overall Study|Adverse Event|1|||
23513716|NCT02288559|65619542|FG001|Overall Study|Adverse Event|1|||
23513717|NCT02288559|65619543|FG002|Overall Study|Adverse Event|5|||
23513718|NCT02288559|65619544|FG003|Overall Study|Adverse Event|0|||
23513719|NCT02288559|65619541|FG000|Overall Study|Death|0|||
23513720|NCT02288559|65619542|FG001|Overall Study|Death|0|||
23513721|NCT02288559|65619543|FG002|Overall Study|Death|1|||
23513722|NCT02288559|65619544|FG003|Overall Study|Death|0|||
23513723|NCT02288559|65619541|FG000|Overall Study|Lost to Follow-up|0|||
23513724|NCT02288559|65619542|FG001|Overall Study|Lost to Follow-up|0|||
23513725|NCT02288559|65619543|FG002|Overall Study|Lost to Follow-up|0|||
23513726|NCT02288559|65619544|FG003|Overall Study|Lost to Follow-up|1|||
23513727|NCT02288559|65619541|FG000|Overall Study|Withdrawal by Subject|0|||
23513728|NCT02288559|65619542|FG001|Overall Study|Withdrawal by Subject|0|||
23513729|NCT02288559|65619543|FG002|Overall Study|Withdrawal by Subject|2|||
23513730|NCT02288559|65619544|FG003|Overall Study|Withdrawal by Subject|1|||
23513731|NCT02288559|65619541|FG000|Overall Study|Reason Not Specified|0|||
23513732|NCT02288559|65619542|FG001|Overall Study|Reason Not Specified|0|||
23513733|NCT02288559|65619543|FG002|Overall Study|Reason Not Specified|3|||
23513734|NCT02288559|65619544|FG003|Overall Study|Reason Not Specified|0|||
23513735|NCT02631850|65619545|FG000|Treatment Period|Lost to Follow-up|0|||
23513736|NCT02631850|65619546|FG001|Treatment Period|Lost to Follow-up|1|||
23513737|NCT02631850|65619547|FG002|Treatment Period|Lost to Follow-up|0|||
23513738|NCT02631850|65619548|FG003|Treatment Period|Lost to Follow-up|0|||
23513739|NCT02631850|65619545|FG000|Treatment Period|Protocol Violation|1|||
23513740|NCT02631850|65619546|FG001|Treatment Period|Protocol Violation|0|||
23513741|NCT02631850|65619547|FG002|Treatment Period|Protocol Violation|0|||
23513742|NCT02631850|65619548|FG003|Treatment Period|Protocol Violation|0|||
23513743|NCT02631850|65619545|FG000|Treatment Period|Withdrawal by Subject|0|||
23513744|NCT02631850|65619546|FG001|Treatment Period|Withdrawal by Subject|5|||
23513745|NCT02631850|65619547|FG002|Treatment Period|Withdrawal by Subject|2|||
23513746|NCT02631850|65619548|FG003|Treatment Period|Withdrawal by Subject|2|||
23513747|NCT02631850|65619545|FG000|Treatment Period|Adverse Event|1|||
23513748|NCT02631850|65619546|FG001|Treatment Period|Adverse Event|0|||
23513749|NCT02631850|65619547|FG002|Treatment Period|Adverse Event|2|||
23513750|NCT02631850|65619548|FG003|Treatment Period|Adverse Event|3|||
23513751|NCT02631850|65619545|FG000|Treatment Period|Family medical issue|1|||
23513752|NCT02631850|65619546|FG001|Treatment Period|Family medical issue|0|||
23513753|NCT02631850|65619547|FG002|Treatment Period|Family medical issue|0|||
23513754|NCT02631850|65619548|FG003|Treatment Period|Family medical issue|0|||
23513755|NCT02631850|65619545|FG000|6 Month Follow up|Lost to Follow-up|5|||
23513756|NCT02631850|65619546|FG001|6 Month Follow up|Lost to Follow-up|8|||
23513757|NCT02631850|65619547|FG002|6 Month Follow up|Lost to Follow-up|3|||
23513758|NCT02631850|65619548|FG003|6 Month Follow up|Lost to Follow-up|5|||
23513759|NCT02631850|65619545|FG000|6 Month Follow up|Withdrawal by Subject|1|||
23513760|NCT02631850|65619546|FG001|6 Month Follow up|Withdrawal by Subject|0|||
23513761|NCT02631850|65619547|FG002|6 Month Follow up|Withdrawal by Subject|0|||
23513762|NCT02631850|65619548|FG003|6 Month Follow up|Withdrawal by Subject|2|||
23513763|NCT02631850|65619545|FG000|6 Month Follow up|Adverse Event|1|||
23513764|NCT02631850|65619546|FG001|6 Month Follow up|Adverse Event|4|||
23513765|NCT02631850|65619547|FG002|6 Month Follow up|Adverse Event|1|||
23513766|NCT02631850|65619548|FG003|6 Month Follow up|Adverse Event|3|||
23513767|NCT02631850|65619545|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
23513768|NCT02631850|65619546|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
23513769|NCT02631850|65619547|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
23513770|NCT02631850|65619548|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
23513771|NCT00249444|65619549|FG000|Overall Study|Lost to Follow-up|2|||
23513772|NCT00249444|65619550|FG001|Overall Study|Lost to Follow-up|2|||
23513773|NCT00249444|65619549|FG000|Overall Study|non-compliant|9|||
23513774|NCT00249444|65619550|FG001|Overall Study|non-compliant|11|||
23513775|NCT00249444|65619549|FG000|Overall Study|Adverse Event|1|||
23513776|NCT00249444|65619550|FG001|Overall Study|Adverse Event|1|||
23513777|NCT00249444|65619549|FG000|Overall Study|life event|0|||
23513778|NCT00249444|65619550|FG001|Overall Study|life event|1|||
23513779|NCT01750242|65619554|FG000|Overall Study|Unreadable Images|3|||
23513780|NCT00531050|65619555|FG000|Part 1: Period 1|Adverse Event|0|||
23513781|NCT00531050|65619556|FG001|Part 1: Period 1|Adverse Event|1|||
23513782|NCT00531050|65619557|FG002|Part 1: Period 1|Adverse Event|0|||
23513783|NCT00531050|65619558|FG003|Part 1: Period 1|Adverse Event|0|||
23513784|NCT00531050|65619559|FG004|Part 1: Period 1|Adverse Event|0|||
23513785|NCT00531050|65619560|FG005|Part 1: Period 1|Adverse Event|0|||
23513786|NCT00531050|65619555|FG000|Part 1: Period 1|Protocol Deviation|0|||
23513787|NCT00531050|65619556|FG001|Part 1: Period 1|Protocol Deviation|0|||
23513788|NCT00531050|65619557|FG002|Part 1: Period 1|Protocol Deviation|0|||
23513789|NCT00531050|65619558|FG003|Part 1: Period 1|Protocol Deviation|1|||
23513790|NCT00531050|65619559|FG004|Part 1: Period 1|Protocol Deviation|0|||
23513791|NCT00531050|65619560|FG005|Part 1: Period 1|Protocol Deviation|0|||
23513792|NCT00531050|65619555|FG000|Part 1: Period 3|Adverse Event|1|||
23513793|NCT00531050|65619556|FG001|Part 1: Period 3|Adverse Event|0|||
23513794|NCT00531050|65619557|FG002|Part 1: Period 3|Adverse Event|0|||
23513795|NCT00531050|65619558|FG003|Part 1: Period 3|Adverse Event|0|||
23513796|NCT00531050|65619559|FG004|Part 1: Period 3|Adverse Event|0|||
23513797|NCT00531050|65619560|FG005|Part 1: Period 3|Adverse Event|0|||
23513798|NCT00531050|65619555|FG000|Part 2: Period 1|Adverse Event|0|||
23513799|NCT00531050|65619556|FG001|Part 2: Period 1|Adverse Event|0|||
23513800|NCT00531050|65619557|FG002|Part 2: Period 1|Adverse Event|0|||
23513801|NCT00531050|65619558|FG003|Part 2: Period 1|Adverse Event|0|||
23513802|NCT00531050|65619559|FG004|Part 2: Period 1|Adverse Event|0|||
23513803|NCT00531050|65619560|FG005|Part 2: Period 1|Adverse Event|1|||
23513804|NCT00531050|65619555|FG000|Part 2: Period 3|Abnormal test procedure|1|||
23513805|NCT00531050|65619556|FG001|Part 2: Period 3|Abnormal test procedure|0|||
23513806|NCT00531050|65619557|FG002|Part 2: Period 3|Abnormal test procedure|0|||
23513807|NCT00531050|65619558|FG003|Part 2: Period 3|Abnormal test procedure|0|||
23513808|NCT00531050|65619559|FG004|Part 2: Period 3|Abnormal test procedure|0|||
23513809|NCT00531050|65619560|FG005|Part 2: Period 3|Abnormal test procedure|1|||
23513810|NCT00909389|65619561|FG000|Overall Study|Adverse Event|6|||
23513811|NCT00909389|65619561|FG000|Overall Study|Death|4|||
23513812|NCT00909389|65619561|FG000|Overall Study|Poor Compliance|16|||
23513813|NCT00909389|65619561|FG000|Overall Study|Lost to Follow-up|4|||
23513814|NCT00909389|65619561|FG000|Overall Study|No Information|103|||
23513815|NCT03303079|65619562|FG000|Overall Study|Adverse Event|0|||
23513816|NCT03303079|65619563|FG001|Overall Study|Adverse Event|1|||
23513817|NCT03303079|65619564|FG002|Overall Study|Adverse Event|3|||
23513818|NCT03303079|65619562|FG000|Overall Study|Protocol Violation|5|||
23513819|NCT03303079|65619563|FG001|Overall Study|Protocol Violation|4|||
23513820|NCT03303079|65619564|FG002|Overall Study|Protocol Violation|7|||
23513821|NCT03303079|65619562|FG000|Overall Study|Withdrawal by Subject|2|||
23513822|NCT03303079|65619563|FG001|Overall Study|Withdrawal by Subject|4|||
23513823|NCT03303079|65619564|FG002|Overall Study|Withdrawal by Subject|2|||
23513824|NCT03303079|65619562|FG000|Overall Study|Other than specified|0|||
23513825|NCT03303079|65619563|FG001|Overall Study|Other than specified|2|||
23513826|NCT03303079|65619564|FG002|Overall Study|Other than specified|0|||
23513827|NCT02733367|65619565|FG000|Overall Study|Withdrawal by Subject|6|||
23513828|NCT00309842|65619566|FG000|Overall Study|Lost to Follow-up|1|||
23513829|NCT04814433|65619567|FG000|Overall Study|Survey not returned|4|||
23513830|NCT04814433|65619568|FG001|Overall Study|Survey not returned|8|||
23513831|NCT04814433|65619569|FG002|Overall Study|Survey not returned|4|||
23513832|NCT04814433|65619570|FG003|Overall Study|Survey not returned|5|||
23513833|NCT03232281|65619573|FG000|Overall Study|Adverse Event|1|||
23513834|NCT03232281|65619574|FG001|Overall Study|Adverse Event|1|||
23513835|NCT03232281|65619573|FG000|Overall Study|Withdrawal by Subject|5|||
23513836|NCT03232281|65619574|FG001|Overall Study|Withdrawal by Subject|4|||
23513837|NCT03232281|65619573|FG000|Overall Study|Protocol Deviation|1|||
23513838|NCT03232281|65619574|FG001|Overall Study|Protocol Deviation|1|||
23513839|NCT01712854|65619575|FG000|Overall Study|Physician Decision|1|||
23513840|NCT02233309|65619576|FG000|Overall Study|Physician Decision|5|||
23513841|NCT01961323|65619578|FG000|Overall Study|Withdrawal by Subject|7|||
23513842|NCT01961323|65619578|FG000|Overall Study|Lost to Follow-up|8|||
23513843|NCT01961323|65619578|FG000|Overall Study|screen failure|34|||
23513844|NCT03480750|65619579|FG000|Overall Study|Withdrawal by Subject|0|||
23513845|NCT03480750|65619580|FG001|Overall Study|Withdrawal by Subject|1|||
23513846|NCT03480750|65619581|FG002|Overall Study|Withdrawal by Subject|0|||
23513847|NCT03480750|65619582|FG003|Overall Study|Withdrawal by Subject|0|||
23513848|NCT03480750|65619583|FG004|Overall Study|Withdrawal by Subject|0|||
23513849|NCT03480750|65619584|FG005|Overall Study|Withdrawal by Subject|0|||
23513850|NCT03480750|65619579|FG000|Overall Study|The interruption in Trientine shippment|0|||
23513851|NCT03480750|65619580|FG001|Overall Study|The interruption in Trientine shippment|0|||
23513852|NCT03480750|65619581|FG002|Overall Study|The interruption in Trientine shippment|0|||
23513853|NCT03480750|65619582|FG003|Overall Study|The interruption in Trientine shippment|0|||
23513854|NCT03480750|65619583|FG004|Overall Study|The interruption in Trientine shippment|0|||
23513855|NCT03480750|65619584|FG005|Overall Study|The interruption in Trientine shippment|1|||
23513856|NCT02554812|65619585|FG000|Overall Study|Adverse Event|2|||
23513857|NCT02554812|65619586|FG001|Overall Study|Adverse Event|5|||
23513858|NCT02554812|65619587|FG002|Overall Study|Adverse Event|3|||
23513859|NCT02554812|65619588|FG003|Overall Study|Adverse Event|0|||
23513860|NCT02554812|65619589|FG004|Overall Study|Adverse Event|5|||
23513861|NCT02554812|65619590|FG005|Overall Study|Adverse Event|0|||
23513862|NCT02554812|65619591|FG006|Overall Study|Adverse Event|1|||
23513863|NCT02554812|65619592|FG007|Overall Study|Adverse Event|6|||
23513864|NCT02554812|65619593|FG008|Overall Study|Adverse Event|2|||
23513865|NCT02554812|65619594|FG009|Overall Study|Adverse Event|2|||
23513866|NCT02554812|65619595|FG010|Overall Study|Adverse Event|1|||
23513867|NCT02554812|65619596|FG011|Overall Study|Adverse Event|2|||
23513868|NCT02554812|65619597|FG012|Overall Study|Adverse Event|0|||
23513869|NCT02554812|65619598|FG013|Overall Study|Adverse Event|3|||
23513870|NCT02554812|65619599|FG014|Overall Study|Adverse Event|2|||
23513871|NCT02554812|65619600|FG015|Overall Study|Adverse Event|1|||
23513872|NCT02554812|65619601|FG016|Overall Study|Adverse Event|0|||
23513873|NCT02554812|65619602|FG017|Overall Study|Adverse Event|1|||
23513874|NCT02554812|65619603|FG018|Overall Study|Adverse Event|0|||
23513875|NCT02554812|65619604|FG019|Overall Study|Adverse Event|0|||
23513876|NCT02554812|65619605|FG020|Overall Study|Adverse Event|0|||
23513877|NCT02554812|65619606|FG021|Overall Study|Adverse Event|2|||
23513878|NCT02554812|65619607|FG022|Overall Study|Adverse Event|1|||
23513879|NCT02554812|65619608|FG023|Overall Study|Adverse Event|1|||
23513880|NCT02554812|65619609|FG024|Overall Study|Adverse Event|1|||
23513881|NCT02554812|65619610|FG025|Overall Study|Adverse Event|2|||
23513882|NCT02554812|65619611|FG026|Overall Study|Adverse Event|1|||
23513883|NCT02554812|65619585|FG000|Overall Study|Death|1|||
23513884|NCT02554812|65619586|FG001|Overall Study|Death|2|||
23513885|NCT02554812|65619587|FG002|Overall Study|Death|2|||
23513886|NCT02554812|65619588|FG003|Overall Study|Death|2|||
23513887|NCT02554812|65619589|FG004|Overall Study|Death|0|||
23513888|NCT02554812|65619590|FG005|Overall Study|Death|1|||
23513889|NCT02554812|65619591|FG006|Overall Study|Death|1|||
23513890|NCT02554812|65619592|FG007|Overall Study|Death|1|||
23513891|NCT02554812|65619593|FG008|Overall Study|Death|0|||
23513892|NCT02554812|65619594|FG009|Overall Study|Death|0|||
23513893|NCT02554812|65619595|FG010|Overall Study|Death|0|||
23513894|NCT02554812|65619596|FG011|Overall Study|Death|0|||
23513895|NCT02554812|65619597|FG012|Overall Study|Death|0|||
23513896|NCT02554812|65619598|FG013|Overall Study|Death|0|||
23513897|NCT02554812|65619599|FG014|Overall Study|Death|1|||
23513898|NCT02554812|65619600|FG015|Overall Study|Death|1|||
23513899|NCT02554812|65619601|FG016|Overall Study|Death|1|||
23513900|NCT02554812|65619602|FG017|Overall Study|Death|0|||
23513901|NCT02554812|65619603|FG018|Overall Study|Death|1|||
23513902|NCT02554812|65619604|FG019|Overall Study|Death|2|||
23513903|NCT02554812|65619605|FG020|Overall Study|Death|0|||
23513904|NCT02554812|65619606|FG021|Overall Study|Death|1|||
23513905|NCT02554812|65619607|FG022|Overall Study|Death|1|||
23513906|NCT02554812|65619608|FG023|Overall Study|Death|0|||
23513907|NCT02554812|65619609|FG024|Overall Study|Death|0|||
23513908|NCT02554812|65619610|FG025|Overall Study|Death|0|||
23513909|NCT02554812|65619611|FG026|Overall Study|Death|0|||
23513910|NCT02554812|65619585|FG000|Overall Study|Lost to Follow-up|0|||
23513911|NCT02554812|65619586|FG001|Overall Study|Lost to Follow-up|1|||
23513912|NCT02554812|65619587|FG002|Overall Study|Lost to Follow-up|0|||
23513913|NCT02554812|65619588|FG003|Overall Study|Lost to Follow-up|0|||
23513914|NCT02554812|65619589|FG004|Overall Study|Lost to Follow-up|0|||
23513915|NCT02554812|65619590|FG005|Overall Study|Lost to Follow-up|0|||
23513916|NCT02554812|65619591|FG006|Overall Study|Lost to Follow-up|0|||
23513917|NCT02554812|65619592|FG007|Overall Study|Lost to Follow-up|0|||
23513918|NCT02554812|65619593|FG008|Overall Study|Lost to Follow-up|0|||
23513919|NCT02554812|65619594|FG009|Overall Study|Lost to Follow-up|0|||
23513920|NCT02554812|65619595|FG010|Overall Study|Lost to Follow-up|0|||
23513921|NCT02554812|65619596|FG011|Overall Study|Lost to Follow-up|0|||
23513922|NCT02554812|65619597|FG012|Overall Study|Lost to Follow-up|0|||
23513923|NCT02554812|65619598|FG013|Overall Study|Lost to Follow-up|0|||
23513924|NCT02554812|65619599|FG014|Overall Study|Lost to Follow-up|0|||
23415827|NCT01406938|65266042|FG005|Maintenance Period|Subject/guardian decision|7|||
23415828|NCT01406938|65266037|FG000|Maintenance Period|Protocol Violation|0|||
23415829|NCT01406938|65266038|FG001|Maintenance Period|Protocol Violation|0|||
23415830|NCT01406938|65266039|FG002|Maintenance Period|Protocol Violation|2|||
23415831|NCT01406938|65266040|FG003|Maintenance Period|Protocol Violation|2|||
23415832|NCT01406938|65266041|FG004|Maintenance Period|Protocol Violation|2|||
23415833|NCT01406938|65266042|FG005|Maintenance Period|Protocol Violation|2|||
23415834|NCT01406938|65266037|FG000|Maintenance Period|Pregnancy|0|||
23415835|NCT01406938|65266038|FG001|Maintenance Period|Pregnancy|0|||
23415836|NCT01406938|65266039|FG002|Maintenance Period|Pregnancy|0|||
23415837|NCT01406938|65266040|FG003|Maintenance Period|Pregnancy|0|||
23415838|NCT01406938|65266041|FG004|Maintenance Period|Pregnancy|1|||
23415839|NCT01406938|65266042|FG005|Maintenance Period|Pregnancy|0|||
23415840|NCT01406938|65266037|FG000|Maintenance Period|Lost to Follow-up|0|||
23415841|NCT01406938|65266038|FG001|Maintenance Period|Lost to Follow-up|0|||
23415842|NCT01406938|65266039|FG002|Maintenance Period|Lost to Follow-up|0|||
23415843|NCT01406938|65266040|FG003|Maintenance Period|Lost to Follow-up|0|||
23415844|NCT01406938|65266041|FG004|Maintenance Period|Lost to Follow-up|4|||
23415845|NCT01406938|65266042|FG005|Maintenance Period|Lost to Follow-up|0|||
23415846|NCT01406938|65266037|FG000|Maintenance Period|Lack of Efficacy|0|||
23415847|NCT01406938|65266038|FG001|Maintenance Period|Lack of Efficacy|0|||
23415848|NCT01406938|65266039|FG002|Maintenance Period|Lack of Efficacy|2|||
23415849|NCT01406938|65266040|FG003|Maintenance Period|Lack of Efficacy|1|||
23415850|NCT01406938|65266041|FG004|Maintenance Period|Lack of Efficacy|3|||
23415851|NCT01406938|65266042|FG005|Maintenance Period|Lack of Efficacy|5|||
23415852|NCT01406938|65266037|FG000|Follow up|Lack of Efficacy|3|||
23415853|NCT01406938|65266038|FG001|Follow up|Lack of Efficacy|2|||
23415854|NCT01406938|65266039|FG002|Follow up|Lack of Efficacy|1|||
23415855|NCT01406938|65266040|FG003|Follow up|Lack of Efficacy|0|||
23415856|NCT01406938|65266041|FG004|Follow up|Lack of Efficacy|0|||
23415857|NCT01406938|65266042|FG005|Follow up|Lack of Efficacy|0|||
23415858|NCT01406938|65266037|FG000|Follow up|Patient/guardian decision|4|||
23415859|NCT01406938|65266038|FG001|Follow up|Patient/guardian decision|2|||
23415860|NCT01406938|65266039|FG002|Follow up|Patient/guardian decision|4|||
23415861|NCT01406938|65266040|FG003|Follow up|Patient/guardian decision|2|||
23415862|NCT01406938|65266041|FG004|Follow up|Patient/guardian decision|4|||
23415863|NCT01406938|65266042|FG005|Follow up|Patient/guardian decision|1|||
23415864|NCT01406938|65266037|FG000|Follow up|Protocol Violation|0|||
23415865|NCT01406938|65266038|FG001|Follow up|Protocol Violation|0|||
23415866|NCT01406938|65266039|FG002|Follow up|Protocol Violation|1|||
23415867|NCT01406938|65266040|FG003|Follow up|Protocol Violation|0|||
23415868|NCT01406938|65266041|FG004|Follow up|Protocol Violation|0|||
23415869|NCT01406938|65266042|FG005|Follow up|Protocol Violation|0|||
23415870|NCT01406938|65266037|FG000|Follow up|Physician Decision|0|||
23415871|NCT01406938|65266038|FG001|Follow up|Physician Decision|0|||
23415872|NCT01406938|65266039|FG002|Follow up|Physician Decision|2|||
23415873|NCT01406938|65266040|FG003|Follow up|Physician Decision|0|||
23415874|NCT01406938|65266041|FG004|Follow up|Physician Decision|3|||
23415875|NCT01406938|65266042|FG005|Follow up|Physician Decision|1|||
23415876|NCT01406938|65266037|FG000|Follow up|Lost to Follow-up|1|||
23415877|NCT01406938|65266038|FG001|Follow up|Lost to Follow-up|1|||
23415878|NCT01406938|65266039|FG002|Follow up|Lost to Follow-up|0|||
23415879|NCT01406938|65266040|FG003|Follow up|Lost to Follow-up|1|||
23415880|NCT01406938|65266041|FG004|Follow up|Lost to Follow-up|2|||
23415881|NCT01406938|65266042|FG005|Follow up|Lost to Follow-up|1|||
23415882|NCT01813058|65266047|FG000|Overall Study|Withdrawal by Subject|5|||
23415883|NCT01813058|65266048|FG001|Overall Study|Withdrawal by Subject|4|||
23415884|NCT01252186|65266050|FG000|Overall Study|Adverse Event|9|||
23415885|NCT01252186|65266051|FG001|Overall Study|Adverse Event|6|||
23415886|NCT01252186|65266052|FG002|Overall Study|Adverse Event|8|||
23415887|NCT01252186|65266050|FG000|Overall Study|Withdrawal by Subject|2|||
23513925|NCT02554812|65619600|FG015|Overall Study|Lost to Follow-up|0|||
23513926|NCT02554812|65619601|FG016|Overall Study|Lost to Follow-up|0|||
23513927|NCT02554812|65619602|FG017|Overall Study|Lost to Follow-up|0|||
23513928|NCT02554812|65619603|FG018|Overall Study|Lost to Follow-up|0|||
23513929|NCT02554812|65619604|FG019|Overall Study|Lost to Follow-up|0|||
23513930|NCT02554812|65619605|FG020|Overall Study|Lost to Follow-up|0|||
23513931|NCT02554812|65619606|FG021|Overall Study|Lost to Follow-up|0|||
23513932|NCT02554812|65619607|FG022|Overall Study|Lost to Follow-up|0|||
23513933|NCT02554812|65619608|FG023|Overall Study|Lost to Follow-up|0|||
23513934|NCT02554812|65619609|FG024|Overall Study|Lost to Follow-up|0|||
23513935|NCT02554812|65619610|FG025|Overall Study|Lost to Follow-up|0|||
23513936|NCT02554812|65619611|FG026|Overall Study|Lost to Follow-up|0|||
23513937|NCT02554812|65619585|FG000|Overall Study|Global deterioration of health status|4|||
23513938|NCT02554812|65619586|FG001|Overall Study|Global deterioration of health status|3|||
23513939|NCT02554812|65619587|FG002|Overall Study|Global deterioration of health status|3|||
23513940|NCT02554812|65619588|FG003|Overall Study|Global deterioration of health status|2|||
23513941|NCT02554812|65619589|FG004|Overall Study|Global deterioration of health status|5|||
23513942|NCT02554812|65619590|FG005|Overall Study|Global deterioration of health status|0|||
23513943|NCT02554812|65619591|FG006|Overall Study|Global deterioration of health status|2|||
23513944|NCT02554812|65619592|FG007|Overall Study|Global deterioration of health status|1|||
23513945|NCT02554812|65619593|FG008|Overall Study|Global deterioration of health status|1|||
23513946|NCT02554812|65619594|FG009|Overall Study|Global deterioration of health status|1|||
23513947|NCT02554812|65619595|FG010|Overall Study|Global deterioration of health status|2|||
23513948|NCT02554812|65619596|FG011|Overall Study|Global deterioration of health status|1|||
23513949|NCT02554812|65619597|FG012|Overall Study|Global deterioration of health status|0|||
23513950|NCT02554812|65619598|FG013|Overall Study|Global deterioration of health status|0|||
23513951|NCT02554812|65619599|FG014|Overall Study|Global deterioration of health status|0|||
23513952|NCT02554812|65619600|FG015|Overall Study|Global deterioration of health status|1|||
23513953|NCT02554812|65619601|FG016|Overall Study|Global deterioration of health status|0|||
23513954|NCT02554812|65619602|FG017|Overall Study|Global deterioration of health status|0|||
23513955|NCT02554812|65619603|FG018|Overall Study|Global deterioration of health status|0|||
23513956|NCT02554812|65619604|FG019|Overall Study|Global deterioration of health status|0|||
23513957|NCT02554812|65619605|FG020|Overall Study|Global deterioration of health status|0|||
23513958|NCT02554812|65619606|FG021|Overall Study|Global deterioration of health status|0|||
23513959|NCT02554812|65619607|FG022|Overall Study|Global deterioration of health status|0|||
23513960|NCT02554812|65619608|FG023|Overall Study|Global deterioration of health status|0|||
23513961|NCT02554812|65619609|FG024|Overall Study|Global deterioration of health status|0|||
23513962|NCT02554812|65619610|FG025|Overall Study|Global deterioration of health status|0|||
23513963|NCT02554812|65619611|FG026|Overall Study|Global deterioration of health status|0|||
23513964|NCT02554812|65619585|FG000|Overall Study|Progressive disease|20|||
23513965|NCT02554812|65619586|FG001|Overall Study|Progressive disease|16|||
23513966|NCT02554812|65619587|FG002|Overall Study|Progressive disease|19|||
23513967|NCT02554812|65619588|FG003|Overall Study|Progressive disease|18|||
23513968|NCT02554812|65619589|FG004|Overall Study|Progressive disease|21|||
23513969|NCT02554812|65619590|FG005|Overall Study|Progressive disease|15|||
23513970|NCT02554812|65619591|FG006|Overall Study|Progressive disease|6|||
23513971|NCT02554812|65619592|FG007|Overall Study|Progressive disease|13|||
23513972|NCT02554812|65619593|FG008|Overall Study|Progressive disease|6|||
23513973|NCT02554812|65619594|FG009|Overall Study|Progressive disease|6|||
23513974|NCT02554812|65619595|FG010|Overall Study|Progressive disease|8|||
23513975|NCT02554812|65619596|FG011|Overall Study|Progressive disease|8|||
23513976|NCT02554812|65619597|FG012|Overall Study|Progressive disease|6|||
23513977|NCT02554812|65619598|FG013|Overall Study|Progressive disease|10|||
23513978|NCT02554812|65619599|FG014|Overall Study|Progressive disease|20|||
23513979|NCT02554812|65619600|FG015|Overall Study|Progressive disease|6|||
23513980|NCT02554812|65619601|FG016|Overall Study|Progressive disease|3|||
23513981|NCT02554812|65619602|FG017|Overall Study|Progressive disease|3|||
23513982|NCT02554812|65619603|FG018|Overall Study|Progressive disease|11|||
23513983|NCT02554812|65619604|FG019|Overall Study|Progressive disease|7|||
23513984|NCT02554812|65619605|FG020|Overall Study|Progressive disease|11|||
23513985|NCT02554812|65619606|FG021|Overall Study|Progressive disease|6|||
23513986|NCT02554812|65619607|FG022|Overall Study|Progressive disease|9|||
23513987|NCT02554812|65619608|FG023|Overall Study|Progressive disease|9|||
23513988|NCT02554812|65619609|FG024|Overall Study|Progressive disease|4|||
23513989|NCT02554812|65619610|FG025|Overall Study|Progressive disease|5|||
23513990|NCT02554812|65619611|FG026|Overall Study|Progressive disease|5|||
23513991|NCT02554812|65619585|FG000|Overall Study|Other|0|||
23513992|NCT02554812|65619586|FG001|Overall Study|Other|0|||
23513993|NCT02554812|65619587|FG002|Overall Study|Other|2|||
23513994|NCT02554812|65619588|FG003|Overall Study|Other|3|||
23513995|NCT02554812|65619589|FG004|Overall Study|Other|2|||
23513996|NCT02554812|65619590|FG005|Overall Study|Other|1|||
23513997|NCT02554812|65619591|FG006|Overall Study|Other|0|||
23513998|NCT02554812|65619592|FG007|Overall Study|Other|0|||
23513999|NCT02554812|65619593|FG008|Overall Study|Other|1|||
23611193|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
23514000|NCT02554812|65619594|FG009|Overall Study|Other|1|||
23514001|NCT02554812|65619595|FG010|Overall Study|Other|0|||
23514002|NCT02554812|65619596|FG011|Overall Study|Other|0|||
23514003|NCT02554812|65619597|FG012|Overall Study|Other|1|||
23514004|NCT02554812|65619598|FG013|Overall Study|Other|0|||
23514005|NCT02554812|65619599|FG014|Overall Study|Other|1|||
23514006|NCT02554812|65619600|FG015|Overall Study|Other|0|||
23514007|NCT02554812|65619601|FG016|Overall Study|Other|0|||
23514008|NCT02554812|65619602|FG017|Overall Study|Other|0|||
23514009|NCT02554812|65619603|FG018|Overall Study|Other|0|||
23514010|NCT02554812|65619604|FG019|Overall Study|Other|0|||
23514011|NCT02554812|65619605|FG020|Overall Study|Other|0|||
23514012|NCT02554812|65619606|FG021|Overall Study|Other|2|||
23514013|NCT02554812|65619607|FG022|Overall Study|Other|0|||
23514014|NCT02554812|65619608|FG023|Overall Study|Other|0|||
23514015|NCT02554812|65619609|FG024|Overall Study|Other|0|||
23514016|NCT02554812|65619610|FG025|Overall Study|Other|0|||
23514017|NCT02554812|65619611|FG026|Overall Study|Other|0|||
23514018|NCT02554812|65619585|FG000|Overall Study|Withdrawal by Subject|1|||
23514019|NCT02554812|65619586|FG001|Overall Study|Withdrawal by Subject|0|||
23514020|NCT02554812|65619587|FG002|Overall Study|Withdrawal by Subject|0|||
23514021|NCT02554812|65619588|FG003|Overall Study|Withdrawal by Subject|2|||
23514022|NCT02554812|65619589|FG004|Overall Study|Withdrawal by Subject|2|||
23514023|NCT02554812|65619590|FG005|Overall Study|Withdrawal by Subject|3|||
23514024|NCT02554812|65619591|FG006|Overall Study|Withdrawal by Subject|0|||
23514025|NCT02554812|65619592|FG007|Overall Study|Withdrawal by Subject|0|||
23514026|NCT02554812|65619593|FG008|Overall Study|Withdrawal by Subject|1|||
23514027|NCT02554812|65619594|FG009|Overall Study|Withdrawal by Subject|1|||
23514028|NCT02554812|65619595|FG010|Overall Study|Withdrawal by Subject|0|||
23514029|NCT02554812|65619596|FG011|Overall Study|Withdrawal by Subject|1|||
23514030|NCT02554812|65619597|FG012|Overall Study|Withdrawal by Subject|1|||
23514031|NCT02554812|65619598|FG013|Overall Study|Withdrawal by Subject|1|||
23514032|NCT02554812|65619599|FG014|Overall Study|Withdrawal by Subject|1|||
23514033|NCT02554812|65619600|FG015|Overall Study|Withdrawal by Subject|1|||
23514034|NCT02554812|65619601|FG016|Overall Study|Withdrawal by Subject|3|||
23514035|NCT02554812|65619602|FG017|Overall Study|Withdrawal by Subject|1|||
23514036|NCT02554812|65619603|FG018|Overall Study|Withdrawal by Subject|0|||
23514037|NCT02554812|65619604|FG019|Overall Study|Withdrawal by Subject|2|||
23514038|NCT02554812|65619605|FG020|Overall Study|Withdrawal by Subject|0|||
23514039|NCT02554812|65619606|FG021|Overall Study|Withdrawal by Subject|1|||
23514040|NCT02554812|65619607|FG022|Overall Study|Withdrawal by Subject|0|||
23514041|NCT02554812|65619608|FG023|Overall Study|Withdrawal by Subject|1|||
23514042|NCT02554812|65619609|FG024|Overall Study|Withdrawal by Subject|0|||
23514043|NCT02554812|65619610|FG025|Overall Study|Withdrawal by Subject|0|||
23514044|NCT02554812|65619611|FG026|Overall Study|Withdrawal by Subject|1|||
23514045|NCT02554812|65619585|FG000|Overall Study|Physician Decision|1|||
23514046|NCT02554812|65619586|FG001|Overall Study|Physician Decision|0|||
23514047|NCT02554812|65619587|FG002|Overall Study|Physician Decision|0|||
23514048|NCT02554812|65619588|FG003|Overall Study|Physician Decision|1|||
23514049|NCT02554812|65619589|FG004|Overall Study|Physician Decision|0|||
23514050|NCT02554812|65619590|FG005|Overall Study|Physician Decision|1|||
23514051|NCT02554812|65619591|FG006|Overall Study|Physician Decision|0|||
23514052|NCT02554812|65619592|FG007|Overall Study|Physician Decision|0|||
23514053|NCT02554812|65619593|FG008|Overall Study|Physician Decision|0|||
23514054|NCT02554812|65619594|FG009|Overall Study|Physician Decision|0|||
23711420|NCT01056341|66319314|FG004|Overall Study|Treatment Intolerance|0|||
23711421|NCT01056341|66319310|FG000|Overall Study|Lack of Efficacy|32|||
23514055|NCT02554812|65619595|FG010|Overall Study|Physician Decision|1|||
23514056|NCT02554812|65619596|FG011|Overall Study|Physician Decision|0|||
23514057|NCT02554812|65619597|FG012|Overall Study|Physician Decision|0|||
23514058|NCT02554812|65619598|FG013|Overall Study|Physician Decision|0|||
23514059|NCT02554812|65619599|FG014|Overall Study|Physician Decision|0|||
23514060|NCT02554812|65619600|FG015|Overall Study|Physician Decision|0|||
23514061|NCT02554812|65619601|FG016|Overall Study|Physician Decision|1|||
23514062|NCT02554812|65619602|FG017|Overall Study|Physician Decision|1|||
23514063|NCT02554812|65619603|FG018|Overall Study|Physician Decision|0|||
23514064|NCT02554812|65619604|FG019|Overall Study|Physician Decision|1|||
23514065|NCT02554812|65619605|FG020|Overall Study|Physician Decision|1|||
23514066|NCT02554812|65619606|FG021|Overall Study|Physician Decision|0|||
23514067|NCT02554812|65619607|FG022|Overall Study|Physician Decision|1|||
23514068|NCT02554812|65619608|FG023|Overall Study|Physician Decision|0|||
23514069|NCT02554812|65619609|FG024|Overall Study|Physician Decision|0|||
23514070|NCT02554812|65619610|FG025|Overall Study|Physician Decision|0|||
23514071|NCT02554812|65619611|FG026|Overall Study|Physician Decision|0|||
23514072|NCT02554812|65619585|FG000|Overall Study|Study terminated by sponsor|0|||
23514073|NCT02554812|65619586|FG001|Overall Study|Study terminated by sponsor|0|||
23514074|NCT02554812|65619587|FG002|Overall Study|Study terminated by sponsor|0|||
23514075|NCT02554812|65619588|FG003|Overall Study|Study terminated by sponsor|0|||
23514076|NCT02554812|65619589|FG004|Overall Study|Study terminated by sponsor|0|||
23514077|NCT02554812|65619590|FG005|Overall Study|Study terminated by sponsor|0|||
23514078|NCT02554812|65619591|FG006|Overall Study|Study terminated by sponsor|0|||
23514079|NCT02554812|65619592|FG007|Overall Study|Study terminated by sponsor|0|||
23514080|NCT02554812|65619593|FG008|Overall Study|Study terminated by sponsor|0|||
23514081|NCT02554812|65619594|FG009|Overall Study|Study terminated by sponsor|0|||
23514082|NCT02554812|65619595|FG010|Overall Study|Study terminated by sponsor|0|||
23514083|NCT02554812|65619596|FG011|Overall Study|Study terminated by sponsor|0|||
23514084|NCT02554812|65619597|FG012|Overall Study|Study terminated by sponsor|0|||
23514085|NCT02554812|65619598|FG013|Overall Study|Study terminated by sponsor|0|||
23514086|NCT02554812|65619599|FG014|Overall Study|Study terminated by sponsor|0|||
23514087|NCT02554812|65619600|FG015|Overall Study|Study terminated by sponsor|0|||
23514088|NCT02554812|65619601|FG016|Overall Study|Study terminated by sponsor|0|||
23514089|NCT02554812|65619602|FG017|Overall Study|Study terminated by sponsor|0|||
23514090|NCT02554812|65619603|FG018|Overall Study|Study terminated by sponsor|0|||
23514091|NCT02554812|65619604|FG019|Overall Study|Study terminated by sponsor|0|||
23514092|NCT02554812|65619605|FG020|Overall Study|Study terminated by sponsor|0|||
23514093|NCT02554812|65619606|FG021|Overall Study|Study terminated by sponsor|0|||
23514094|NCT02554812|65619607|FG022|Overall Study|Study terminated by sponsor|0|||
23514095|NCT02554812|65619608|FG023|Overall Study|Study terminated by sponsor|0|||
23514096|NCT02554812|65619609|FG024|Overall Study|Study terminated by sponsor|1|||
23514097|NCT02554812|65619610|FG025|Overall Study|Study terminated by sponsor|0|||
23514098|NCT02554812|65619611|FG026|Overall Study|Study terminated by sponsor|0|||
23514099|NCT02554812|65619585|FG000|Overall Study|No longer meets eligibility criteria|0|||
23514100|NCT02554812|65619586|FG001|Overall Study|No longer meets eligibility criteria|1|||
23514101|NCT02554812|65619587|FG002|Overall Study|No longer meets eligibility criteria|0|||
23514102|NCT02554812|65619588|FG003|Overall Study|No longer meets eligibility criteria|0|||
23514103|NCT02554812|65619589|FG004|Overall Study|No longer meets eligibility criteria|0|||
23514104|NCT02554812|65619590|FG005|Overall Study|No longer meets eligibility criteria|0|||
23514105|NCT02554812|65619591|FG006|Overall Study|No longer meets eligibility criteria|0|||
23514106|NCT02554812|65619592|FG007|Overall Study|No longer meets eligibility criteria|0|||
23514107|NCT02554812|65619593|FG008|Overall Study|No longer meets eligibility criteria|0|||
23514108|NCT02554812|65619594|FG009|Overall Study|No longer meets eligibility criteria|0|||
23514109|NCT02554812|65619595|FG010|Overall Study|No longer meets eligibility criteria|0|||
23514110|NCT02554812|65619596|FG011|Overall Study|No longer meets eligibility criteria|0|||
23514111|NCT02554812|65619597|FG012|Overall Study|No longer meets eligibility criteria|0|||
23514112|NCT02554812|65619598|FG013|Overall Study|No longer meets eligibility criteria|0|||
23514113|NCT02554812|65619599|FG014|Overall Study|No longer meets eligibility criteria|0|||
23514114|NCT02554812|65619600|FG015|Overall Study|No longer meets eligibility criteria|0|||
23514115|NCT02554812|65619601|FG016|Overall Study|No longer meets eligibility criteria|0|||
23514116|NCT02554812|65619602|FG017|Overall Study|No longer meets eligibility criteria|0|||
23514117|NCT02554812|65619603|FG018|Overall Study|No longer meets eligibility criteria|0|||
23514118|NCT02554812|65619604|FG019|Overall Study|No longer meets eligibility criteria|0|||
23514119|NCT02554812|65619605|FG020|Overall Study|No longer meets eligibility criteria|0|||
23514120|NCT02554812|65619606|FG021|Overall Study|No longer meets eligibility criteria|0|||
23514121|NCT02554812|65619607|FG022|Overall Study|No longer meets eligibility criteria|0|||
23514122|NCT02554812|65619608|FG023|Overall Study|No longer meets eligibility criteria|0|||
23514123|NCT02554812|65619609|FG024|Overall Study|No longer meets eligibility criteria|0|||
23514124|NCT02554812|65619610|FG025|Overall Study|No longer meets eligibility criteria|0|||
23514125|NCT02554812|65619611|FG026|Overall Study|No longer meets eligibility criteria|0|||
23514126|NCT02673489|65619616|FG000|Treatment Period|Lost to Follow-up|3|||
23514127|NCT02673489|65619617|FG001|Treatment Period|Lost to Follow-up|0|||
23514128|NCT02673489|65619616|FG000|Treatment Period|Participant request to discontinue|1|||
23514129|NCT02673489|65619617|FG001|Treatment Period|Participant request to discontinue|1|||
23514130|NCT02673489|65619616|FG000|Treatment Period|Participant moved to another province|1|||
23514131|NCT02673489|65619617|FG001|Treatment Period|Participant moved to another province|0|||
23514132|NCT02673489|65619616|FG000|Treatment Period|Participant was incarcerated|0|||
23514133|NCT02673489|65619617|FG001|Treatment Period|Participant was incarcerated|1|||
23514134|NCT02673489|65619616|FG000|Treatment Period|Adverse Event|0|||
23711422|NCT01056341|66319311|FG001|Overall Study|Lack of Efficacy|30|||
23711423|NCT01056341|66319312|FG002|Overall Study|Lack of Efficacy|7|||
23514135|NCT02673489|65619617|FG001|Treatment Period|Adverse Event|1|||
23514136|NCT02673489|65619616|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
23711424|NCT01056341|66319313|FG003|Overall Study|Lack of Efficacy|25|||
23514137|NCT02673489|65619617|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
23514138|NCT02673489|65619616|FG000|Follow Up Period|Unable to return for follow-up|0|||
23514139|NCT02673489|65619617|FG001|Follow Up Period|Unable to return for follow-up|1|||
23514140|NCT02738450|65619620|FG000|Overall Study|Withdrawal by Subject|0|||
23514141|NCT02738450|65619621|FG001|Overall Study|Withdrawal by Subject|2|||
23514142|NCT02738450|65619622|FG002|Overall Study|Withdrawal by Subject|0|||
23514143|NCT00412854|65619623|FG000|Overall Study|Withdrawn due to adverse events|1|||
23514144|NCT00412854|65619624|FG001|Overall Study|Withdrawn due to adverse events|5|||
23514145|NCT00412854|65619623|FG000|Overall Study|Withdrawn for other reasons|13|||
23514146|NCT00412854|65619624|FG001|Overall Study|Withdrawn for other reasons|11|||
23514147|NCT00674661|65619626|FG000|Overall Study|Other|5|||
23514148|NCT00674661|65619627|FG001|Overall Study|Other|7|||
23514149|NCT00674661|65619626|FG000|Overall Study|Lost to Follow-up|6|||
23514150|NCT00674661|65619627|FG001|Overall Study|Lost to Follow-up|3|||
23514151|NCT00674661|65619626|FG000|Overall Study|Withdrawal by Subject|0|||
23514152|NCT00674661|65619627|FG001|Overall Study|Withdrawal by Subject|5|||
23514153|NCT00103142|65619630|FG000|Overall Study|Adverse Event|1|||
23514154|NCT00103142|65619631|FG001|Overall Study|Adverse Event|0|||
23514155|NCT00103142|65619630|FG000|Overall Study|Progression of disease|2|||
23514156|NCT00103142|65619631|FG001|Overall Study|Progression of disease|1|||
23514157|NCT03341533|65619634|FG000|Overall Study|Withdrawal by Subject|1|||
23514158|NCT03341533|65619635|FG001|Overall Study|Withdrawal by Subject|1|||
23514159|NCT03341533|65619634|FG000|Overall Study|Not eligible after randomization|2|||
23514160|NCT03341533|65619635|FG001|Overall Study|Not eligible after randomization|1|||
23514161|NCT03263442|65619636|FG000|Inpatient Phase|Death|1|||
23514162|NCT03263442|65619637|FG001|Inpatient Phase|Death|0|||
23514163|NCT03263442|65619636|FG000|Inpatient Phase|Withdrawal by Subject|1|||
23514164|NCT03263442|65619637|FG001|Inpatient Phase|Withdrawal by Subject|0|||
23514165|NCT03263442|65619636|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
23514166|NCT03263442|65619637|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
23514167|NCT03263442|65619636|FG000|1-month Follow-Up|Lost to Follow-up|1|||
23514168|NCT03263442|65619637|FG001|1-month Follow-Up|Lost to Follow-up|0|||
23514169|NCT03263442|65619636|FG000|3-month Follow-Up|Lost to Follow-up|1|||
23514170|NCT03263442|65619637|FG001|3-month Follow-Up|Lost to Follow-up|3|||
23514171|NCT03263442|65619636|FG000|6-month Follow-Up|Lost to Follow-up|2|||
23514172|NCT03263442|65619637|FG001|6-month Follow-Up|Lost to Follow-up|2|||
23514173|NCT01333059|65619644|FG000|Overall Study|Physician Decision|3|||
23514174|NCT01333059|65619645|FG001|Overall Study|Physician Decision|3|||
23514175|NCT01333059|65619644|FG000|Overall Study|Protocol Violation|3|||
23514176|NCT01333059|65619645|FG001|Overall Study|Protocol Violation|0|||
23514177|NCT02188589|65619646|FG000|Overall Study|Withdrawal by Subject|5|||
23514178|NCT00818662|65619647|FG000|Overall Study|Adverse Event|5|||
23514179|NCT00818662|65619648|FG001|Overall Study|Adverse Event|14|||
23514180|NCT00818662|65619649|FG002|Overall Study|Adverse Event|4|||
23514181|NCT00818662|65619650|FG003|Overall Study|Adverse Event|3|||
23514182|NCT00818662|65619647|FG000|Overall Study|Withdrawal by Subject|5|||
23514183|NCT00818662|65619648|FG001|Overall Study|Withdrawal by Subject|4|||
23514184|NCT00818662|65619649|FG002|Overall Study|Withdrawal by Subject|2|||
23514185|NCT00818662|65619650|FG003|Overall Study|Withdrawal by Subject|2|||
23514186|NCT00818662|65619647|FG000|Overall Study|Death|1|||
23514187|NCT00818662|65619648|FG001|Overall Study|Death|3|||
23514188|NCT00818662|65619649|FG002|Overall Study|Death|0|||
23514189|NCT00818662|65619650|FG003|Overall Study|Death|0|||
23514190|NCT00818662|65619647|FG000|Overall Study|Physician Decision|1|||
23514191|NCT00818662|65619648|FG001|Overall Study|Physician Decision|0|||
23514192|NCT00818662|65619649|FG002|Overall Study|Physician Decision|0|||
23514193|NCT00818662|65619650|FG003|Overall Study|Physician Decision|0|||
23514194|NCT00818662|65619647|FG000|Overall Study|Lost to Follow-up|0|||
23514195|NCT00818662|65619648|FG001|Overall Study|Lost to Follow-up|0|||
23514196|NCT00818662|65619649|FG002|Overall Study|Lost to Follow-up|0|||
23514197|NCT00818662|65619650|FG003|Overall Study|Lost to Follow-up|1|||
23514198|NCT00818662|65619647|FG000|Overall Study|Unwilling or Unable to Participate|4|||
23514199|NCT00818662|65619648|FG001|Overall Study|Unwilling or Unable to Participate|6|||
23514200|NCT00818662|65619649|FG002|Overall Study|Unwilling or Unable to Participate|2|||
23711425|NCT01056341|66319314|FG004|Overall Study|Lack of Efficacy|9|||
23711426|NCT01056341|66319310|FG000|Overall Study|Other reasons|4|||
23514201|NCT00818662|65619650|FG003|Overall Study|Unwilling or Unable to Participate|4|||
23514202|NCT00818662|65619647|FG000|Overall Study|Protocol Violation|1|||
23514203|NCT00818662|65619648|FG001|Overall Study|Protocol Violation|1|||
23514204|NCT00818662|65619649|FG002|Overall Study|Protocol Violation|0|||
23514205|NCT00818662|65619650|FG003|Overall Study|Protocol Violation|0|||
23514206|NCT00818662|65619647|FG000|Overall Study|Requires a Prohibited Medication|1|||
23514207|NCT00818662|65619648|FG001|Overall Study|Requires a Prohibited Medication|0|||
23514208|NCT00818662|65619649|FG002|Overall Study|Requires a Prohibited Medication|0|||
23514209|NCT00818662|65619650|FG003|Overall Study|Requires a Prohibited Medication|0|||
23514210|NCT00818662|65619647|FG000|Overall Study|Safety Risk|1|||
23514211|NCT00818662|65619648|FG001|Overall Study|Safety Risk|1|||
23514212|NCT00818662|65619649|FG002|Overall Study|Safety Risk|0|||
23514213|NCT00818662|65619650|FG003|Overall Study|Safety Risk|1|||
23514214|NCT00818662|65619647|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
23514215|NCT00818662|65619648|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
23514216|NCT00818662|65619649|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
23514217|NCT00818662|65619650|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
23514218|NCT00818662|65619647|FG000|Overall Study|Participant's health declined|0|||
23514219|NCT00818662|65619648|FG001|Overall Study|Participant's health declined|0|||
23514220|NCT00818662|65619649|FG002|Overall Study|Participant's health declined|0|||
23514221|NCT00818662|65619650|FG003|Overall Study|Participant's health declined|1|||
23514222|NCT00818662|65619647|FG000|Overall Study|Caregiver to pursue other treatment|0|||
23514223|NCT00818662|65619648|FG001|Overall Study|Caregiver to pursue other treatment|1|||
23514224|NCT00818662|65619649|FG002|Overall Study|Caregiver to pursue other treatment|0|||
23514225|NCT00818662|65619650|FG003|Overall Study|Caregiver to pursue other treatment|0|||
23514226|NCT00818662|65619647|FG000|Overall Study|Moving out of state|0|||
23514227|NCT00818662|65619648|FG001|Overall Study|Moving out of state|0|||
23514228|NCT00818662|65619649|FG002|Overall Study|Moving out of state|0|||
23514229|NCT00818662|65619650|FG003|Overall Study|Moving out of state|1|||
23514230|NCT00818662|65619647|FG000|Overall Study|Declined move to another study site|1|||
23514231|NCT00818662|65619648|FG001|Overall Study|Declined move to another study site|0|||
23514232|NCT00818662|65619649|FG002|Overall Study|Declined move to another study site|0|||
23514233|NCT00818662|65619650|FG003|Overall Study|Declined move to another study site|0|||
23514234|NCT00818662|65619647|FG000|Overall Study|Change in living situation|0|||
23514235|NCT00818662|65619648|FG001|Overall Study|Change in living situation|0|||
23514236|NCT00818662|65619649|FG002|Overall Study|Change in living situation|0|||
23514237|NCT00818662|65619650|FG003|Overall Study|Change in living situation|1|||
23514238|NCT00818662|65619647|FG000|Overall Study|Study partner decision|0|||
23514239|NCT00818662|65619648|FG001|Overall Study|Study partner decision|0|||
23514240|NCT00818662|65619649|FG002|Overall Study|Study partner decision|0|||
23514241|NCT00818662|65619650|FG003|Overall Study|Study partner decision|1|||
23514242|NCT00818662|65619647|FG000|Overall Study|Admitted to long term nursing care|0|||
23514243|NCT00818662|65619648|FG001|Overall Study|Admitted to long term nursing care|1|||
23514244|NCT00818662|65619649|FG002|Overall Study|Admitted to long term nursing care|0|||
23514245|NCT00818662|65619650|FG003|Overall Study|Admitted to long term nursing care|0|||
23514246|NCT03649711|65619651|FG000|Overall Study|Adverse Event|0|||
23514247|NCT03649711|65619652|FG001|Overall Study|Adverse Event|1|||
23514248|NCT03649711|65619653|FG002|Overall Study|Adverse Event|0|||
23514249|NCT03649711|65619651|FG000|Overall Study|Kidney Transplant|1|||
23514250|NCT03649711|65619652|FG001|Overall Study|Kidney Transplant|0|||
23514251|NCT03649711|65619653|FG002|Overall Study|Kidney Transplant|0|||
23514252|NCT03138889|65619654|FG000|Overall Study|Withdrawal by Subject|5|||
23514253|NCT03138889|65619655|FG001|Overall Study|Withdrawal by Subject|5|||
23514254|NCT03138889|65619656|FG002|Overall Study|Withdrawal by Subject|0|||
23514255|NCT03138889|65619657|FG003|Overall Study|Withdrawal by Subject|2|||
23514256|NCT03138889|65619658|FG004|Overall Study|Withdrawal by Subject|1|||
23514257|NCT03138889|65619659|FG005|Overall Study|Withdrawal by Subject|3|||
23514258|NCT03138889|65619660|FG006|Overall Study|Withdrawal by Subject|0|||
23514259|NCT03138889|65619661|FG007|Overall Study|Withdrawal by Subject|1|||
23514260|NCT00460408|65619662|FG000|Overall Study|Adverse Event|1|||
23514261|NCT00460408|65619663|FG001|Overall Study|Adverse Event|0|||
23514262|NCT00460408|65619664|FG002|Overall Study|Adverse Event|0|||
23514263|NCT00460408|65619665|FG003|Overall Study|Adverse Event|0|||
23514264|NCT00460408|65619662|FG000|Overall Study|Death|7|||
23514265|NCT00460408|65619663|FG001|Overall Study|Death|0|||
23514266|NCT00460408|65619664|FG002|Overall Study|Death|0|||
23514267|NCT00460408|65619665|FG003|Overall Study|Death|0|||
23514268|NCT00460408|65619662|FG000|Overall Study|Lost to Follow-up|11|||
23514269|NCT00460408|65619663|FG001|Overall Study|Lost to Follow-up|0|||
23514270|NCT00460408|65619664|FG002|Overall Study|Lost to Follow-up|1|||
23514271|NCT00460408|65619665|FG003|Overall Study|Lost to Follow-up|0|||
23711427|NCT01056341|66319311|FG001|Overall Study|Other reasons|4|||
23711428|NCT01056341|66319312|FG002|Overall Study|Other reasons|8|||
23711429|NCT01056341|66319313|FG003|Overall Study|Other reasons|9|||
23514272|NCT00460408|65619662|FG000|Overall Study|Withdrawal by Subject|31|||
23514273|NCT00460408|65619663|FG001|Overall Study|Withdrawal by Subject|0|||
23514274|NCT00460408|65619664|FG002|Overall Study|Withdrawal by Subject|0|||
23514275|NCT00460408|65619665|FG003|Overall Study|Withdrawal by Subject|0|||
23514276|NCT00460408|65619662|FG000|Overall Study|Insufficient clinical response|5|||
23514277|NCT00460408|65619663|FG001|Overall Study|Insufficient clinical response|1|||
23514278|NCT00460408|65619664|FG002|Overall Study|Insufficient clinical response|5|||
23514279|NCT00460408|65619665|FG003|Overall Study|Insufficient clinical response|0|||
23514280|NCT00460408|65619662|FG000|Overall Study|Other|12|||
23514281|NCT00460408|65619663|FG001|Overall Study|Other|2|||
23514282|NCT00460408|65619664|FG002|Overall Study|Other|0|||
23514283|NCT00460408|65619665|FG003|Overall Study|Other|0|||
23514284|NCT05286307|65619666|FG000|Overall Study|Incomplete outcome assessments|2|||
23514285|NCT05286307|65619667|FG001|Overall Study|Incomplete outcome assessments|1|||
23514286|NCT05286307|65619666|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
23514287|NCT05286307|65619667|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
23514288|NCT05286307|65619666|FG000|Overall Study|Lost to follow up at 6 months|25|||
23514289|NCT05286307|65619667|FG001|Overall Study|Lost to follow up at 6 months|35|||
23514290|NCT05286307|65619666|FG000|Overall Study|Study medication not available|1|||
23514291|NCT05286307|65619667|FG001|Overall Study|Study medication not available|1|||
23514292|NCT00553150|65619668|FG000|Overall Study|Withdrawal by Subject|0|||
23514293|NCT00553150|65619669|FG001|Overall Study|Withdrawal by Subject|0|||
23514294|NCT00553150|65619670|FG002|Overall Study|Withdrawal by Subject|0|||
23514295|NCT00553150|65619671|FG003|Overall Study|Withdrawal by Subject|2|||
23514296|NCT00553150|65619668|FG000|Overall Study|Protocol Violation|0|||
23514297|NCT00553150|65619669|FG001|Overall Study|Protocol Violation|0|||
23514298|NCT00553150|65619670|FG002|Overall Study|Protocol Violation|0|||
23514299|NCT00553150|65619671|FG003|Overall Study|Protocol Violation|1|||
23514300|NCT00553150|65619668|FG000|Overall Study|Ineligible|0|||
23514301|NCT00553150|65619669|FG001|Overall Study|Ineligible|0|||
23514302|NCT00553150|65619670|FG002|Overall Study|Ineligible|0|||
23514303|NCT00553150|65619671|FG003|Overall Study|Ineligible|1|||
23514304|NCT02514447|65619672|FG000|Overall Study|Withdrawal by Subject|3|||
23711430|NCT01056341|66319314|FG004|Overall Study|Other reasons|5|||
23711431|NCT04570657|66319319|FG000|Overall Study|Adverse Event|0|||
23711432|NCT04570657|66319320|FG001|Overall Study|Adverse Event|0|||
23711433|NCT04570657|66319321|FG002|Overall Study|Adverse Event|1|||
23711434|NCT04570657|66319319|FG000|Overall Study|Lost to Follow-up|0|||
23711435|NCT04570657|66319320|FG001|Overall Study|Lost to Follow-up|0|||
23711436|NCT04570657|66319321|FG002|Overall Study|Lost to Follow-up|1|||
23711437|NCT04570657|66319319|FG000|Overall Study|Physician Decision|0|||
23711438|NCT04570657|66319320|FG001|Overall Study|Physician Decision|1|||
23711439|NCT04570657|66319321|FG002|Overall Study|Physician Decision|0|||
23711440|NCT04570657|66319319|FG000|Overall Study|Withdrawal by Subject|1|||
23711441|NCT04570657|66319320|FG001|Overall Study|Withdrawal by Subject|2|||
23711442|NCT04570657|66319321|FG002|Overall Study|Withdrawal by Subject|2|||
23711443|NCT02841787|66319322|FG000|Overall Study|Lost to Follow-up|1|||
23711444|NCT02841787|66319323|FG001|Overall Study|Lost to Follow-up|0|||
23711445|NCT02841787|66319324|FG002|Overall Study|Lost to Follow-up|0|||
23711446|NCT02841787|66319322|FG000|Overall Study|Symptoms dropped below threshold|1|||
23711447|NCT02841787|66319323|FG001|Overall Study|Symptoms dropped below threshold|0|||
23711448|NCT02841787|66319324|FG002|Overall Study|Symptoms dropped below threshold|0|||
23711449|NCT02841787|66319322|FG000|Overall Study|Withdrawal by Subject|1|||
23711450|NCT02841787|66319323|FG001|Overall Study|Withdrawal by Subject|4|||
23711451|NCT02841787|66319324|FG002|Overall Study|Withdrawal by Subject|0|||
23453540|NCT03367858|65403353|FG001|3 Month Follow Up|Incarcerated|1|||
23453541|NCT03367858|65403352|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
23453542|NCT03367858|65403353|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
23453543|NCT03367858|65403352|FG000|6 Month Follow Up|Lost to Follow-up|5|||
23453544|NCT03367858|65403353|FG001|6 Month Follow Up|Lost to Follow-up|2|||
23453545|NCT03367858|65403352|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
23453546|NCT03367858|65403353|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
23453547|NCT03367858|65403352|FG000|12 Month Follow Up|Lost to Follow-up|3|||
23453548|NCT03367858|65403353|FG001|12 Month Follow Up|Lost to Follow-up|3|||
23453549|NCT03367858|65403352|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
23453550|NCT03367858|65403353|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
23453551|NCT00740220|65403357|FG000|Overall Study|screen failures (non-COPD patients)|9|||
23453552|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453553|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453554|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453555|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
23453556|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453557|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453558|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453559|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453560|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453561|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453562|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
23453563|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
23453564|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453565|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
23453566|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
23453567|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
23514305|NCT02514447|65619673|FG001|Overall Study|Withdrawal by Subject|1|||
23514306|NCT02514447|65619674|FG002|Overall Study|Withdrawal by Subject|1|||
23514307|NCT02514447|65619675|FG003|Overall Study|Withdrawal by Subject|0|||
23514308|NCT02514447|65619676|FG004|Overall Study|Withdrawal by Subject|0|||
23514309|NCT02514447|65619677|FG005|Overall Study|Withdrawal by Subject|0|||
23514310|NCT02514447|65619678|FG006|Overall Study|Withdrawal by Subject|0|||
23514311|NCT02514447|65619679|FG007|Overall Study|Withdrawal by Subject|1|||
23514312|NCT02514447|65619680|FG008|Overall Study|Withdrawal by Subject|1|||
23514313|NCT02514447|65619672|FG000|Overall Study|Death|24|||
23514314|NCT02514447|65619673|FG001|Overall Study|Death|28|||
23514315|NCT02514447|65619674|FG002|Overall Study|Death|29|||
23514316|NCT02514447|65619675|FG003|Overall Study|Death|0|||
23514317|NCT02514447|65619676|FG004|Overall Study|Death|3|||
23514318|NCT02514447|65619677|FG005|Overall Study|Death|4|||
23514319|NCT02514447|65619678|FG006|Overall Study|Death|8|||
23514320|NCT02514447|65619679|FG007|Overall Study|Death|6|||
23514321|NCT02514447|65619680|FG008|Overall Study|Death|5|||
23514322|NCT02514447|65619672|FG000|Overall Study|Lost to Follow-up|1|||
23514323|NCT02514447|65619673|FG001|Overall Study|Lost to Follow-up|0|||
23514324|NCT02514447|65619674|FG002|Overall Study|Lost to Follow-up|0|||
23514325|NCT02514447|65619675|FG003|Overall Study|Lost to Follow-up|0|||
23514326|NCT02514447|65619676|FG004|Overall Study|Lost to Follow-up|0|||
23514327|NCT02514447|65619677|FG005|Overall Study|Lost to Follow-up|0|||
23514328|NCT02514447|65619678|FG006|Overall Study|Lost to Follow-up|0|||
23514329|NCT02514447|65619679|FG007|Overall Study|Lost to Follow-up|0|||
23514330|NCT02514447|65619680|FG008|Overall Study|Lost to Follow-up|1|||
23514331|NCT02514447|65619672|FG000|Overall Study|Sponsor Termination of Study|0|||
23514332|NCT02514447|65619673|FG001|Overall Study|Sponsor Termination of Study|1|||
23514333|NCT02514447|65619674|FG002|Overall Study|Sponsor Termination of Study|1|||
23514334|NCT02514447|65619675|FG003|Overall Study|Sponsor Termination of Study|0|||
23514335|NCT02514447|65619676|FG004|Overall Study|Sponsor Termination of Study|0|||
23514336|NCT02514447|65619677|FG005|Overall Study|Sponsor Termination of Study|0|||
23514337|NCT02514447|65619678|FG006|Overall Study|Sponsor Termination of Study|0|||
23514338|NCT02514447|65619679|FG007|Overall Study|Sponsor Termination of Study|0|||
23514339|NCT02514447|65619680|FG008|Overall Study|Sponsor Termination of Study|0|||
23514340|NCT02514447|65619672|FG000|Overall Study|Study completion per Investigator|1|||
23514341|NCT02514447|65619673|FG001|Overall Study|Study completion per Investigator|0|||
23514342|NCT02514447|65619674|FG002|Overall Study|Study completion per Investigator|1|||
23514343|NCT02514447|65619675|FG003|Overall Study|Study completion per Investigator|2|||
23514344|NCT02514447|65619676|FG004|Overall Study|Study completion per Investigator|0|||
23514345|NCT02514447|65619677|FG005|Overall Study|Study completion per Investigator|0|||
23514346|NCT02514447|65619678|FG006|Overall Study|Study completion per Investigator|0|||
23514347|NCT02514447|65619679|FG007|Overall Study|Study completion per Investigator|0|||
23514348|NCT02514447|65619680|FG008|Overall Study|Study completion per Investigator|1|||
23514349|NCT03065244|65619681|FG000|Overall Study|Lost to Follow-up|1|||
23514350|NCT03065244|65619682|FG001|Overall Study|Lost to Follow-up|1|||
23514351|NCT03065244|65619681|FG000|Overall Study|Diagnosed with a different disease|1|||
23514352|NCT03065244|65619682|FG001|Overall Study|Diagnosed with a different disease|1|||
23514353|NCT03065244|65619681|FG000|Overall Study|Protocol Violation|0|||
23514354|NCT03065244|65619682|FG001|Overall Study|Protocol Violation|1|||
23514355|NCT03065244|65619681|FG000|Overall Study|Withdrawal by Subject|1|||
23514356|NCT03065244|65619682|FG001|Overall Study|Withdrawal by Subject|1|||
23514357|NCT02339740|65619683|FG000|Overall Study|Death|1|||
23514358|NCT02339740|65619684|FG001|Overall Study|Death|0|||
23711452|NCT02796391|66319325|FG000|Overall Study|Lost to Follow-up|2|||
23711453|NCT02796391|66319326|FG001|Overall Study|Lost to Follow-up|2|||
23711454|NCT02796391|66319327|FG002|Overall Study|Lost to Follow-up|13|||
23711455|NCT02796391|66319328|FG003|Overall Study|Lost to Follow-up|8|||
23711456|NCT02796391|66319329|FG004|Overall Study|Lost to Follow-up|14|||
23514359|NCT02339740|65619683|FG000|Overall Study|Physician Decision|0|||
23514360|NCT02339740|65619684|FG001|Overall Study|Physician Decision|2|||
23514361|NCT02339740|65619683|FG000|Overall Study|Withdrawal by Subject|5|||
23514362|NCT02339740|65619684|FG001|Overall Study|Withdrawal by Subject|1|||
23514363|NCT02339740|65619683|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
23514364|NCT02339740|65619684|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
23514365|NCT00224055|65619685|FG000|Overall Study|Adverse Event|9|||
23514366|NCT00224055|65619686|FG001|Overall Study|Adverse Event|3|||
23514367|NCT00224055|65619685|FG000|Overall Study|Lost to Follow-up|1|||
23514368|NCT00224055|65619686|FG001|Overall Study|Lost to Follow-up|2|||
23514369|NCT00224055|65619685|FG000|Overall Study|Protocol Violation|1|||
23514370|NCT00224055|65619686|FG001|Overall Study|Protocol Violation|1|||
23514371|NCT00224055|65619685|FG000|Overall Study|Inclusion Violation|3|||
23514372|NCT00224055|65619686|FG001|Overall Study|Inclusion Violation|6|||
23514373|NCT00224055|65619685|FG000|Overall Study|Withdrawal by Subject|0|||
23514374|NCT00224055|65619686|FG001|Overall Study|Withdrawal by Subject|2|||
23514375|NCT00224055|65619685|FG000|Overall Study|Other|1|||
23514376|NCT00224055|65619686|FG001|Overall Study|Other|0|||
23711457|NCT02796391|66319330|FG005|Overall Study|Lost to Follow-up|13|||
23711458|NCT02796391|66319325|FG000|Overall Study|COVID|0|||
23711459|NCT02796391|66319326|FG001|Overall Study|COVID|0|||
23711460|NCT02796391|66319327|FG002|Overall Study|COVID|5|||
23711461|NCT02796391|66319328|FG003|Overall Study|COVID|5|||
23514377|NCT01770379|65619687|FG000|Overall Study|Technical issues|1|||
23514378|NCT01770379|65619688|FG001|Overall Study|Technical issues|0|||
23514379|NCT01770379|65619689|FG002|Overall Study|Technical issues|0|||
23514380|NCT01770379|65619687|FG000|Overall Study|Withdrawal by Subject|7|||
23514381|NCT01770379|65619688|FG001|Overall Study|Withdrawal by Subject|10|||
23514382|NCT01770379|65619689|FG002|Overall Study|Withdrawal by Subject|7|||
23514383|NCT01770379|65619687|FG000|Overall Study|study terminated by sponsor|22|||
23514384|NCT01770379|65619688|FG001|Overall Study|study terminated by sponsor|23|||
23514385|NCT01770379|65619689|FG002|Overall Study|study terminated by sponsor|22|||
23514386|NCT01770379|65619687|FG000|Overall Study|Protocol Violation|0|||
23514387|NCT01770379|65619688|FG001|Overall Study|Protocol Violation|1|||
23514388|NCT01770379|65619689|FG002|Overall Study|Protocol Violation|1|||
23514389|NCT01770379|65619687|FG000|Overall Study|Physician Decision|0|||
23514390|NCT01770379|65619688|FG001|Overall Study|Physician Decision|1|||
23514391|NCT01770379|65619689|FG002|Overall Study|Physician Decision|2|||
23514392|NCT01770379|65619687|FG000|Overall Study|Lost to Follow-up|0|||
23514393|NCT01770379|65619688|FG001|Overall Study|Lost to Follow-up|0|||
23514394|NCT01770379|65619689|FG002|Overall Study|Lost to Follow-up|2|||
23514395|NCT01770379|65619687|FG000|Overall Study|Lack of Efficacy|8|||
23514396|NCT01770379|65619688|FG001|Overall Study|Lack of Efficacy|6|||
23514397|NCT01770379|65619689|FG002|Overall Study|Lack of Efficacy|6|||
23514398|NCT01770379|65619687|FG000|Overall Study|Adverse Event|1|||
23514399|NCT01770379|65619688|FG001|Overall Study|Adverse Event|3|||
23514400|NCT01770379|65619689|FG002|Overall Study|Adverse Event|2|||
23514401|NCT02062879|65619690|FG000|Overall Study|Withdrawal by Subject|4|||
23514402|NCT02062879|65619691|FG001|Overall Study|Withdrawal by Subject|1|||
23514403|NCT01059786|65619696|FG000|Overall Study|Did not receive 6 cycles.|0|||
23514404|NCT01059786|65619697|FG001|Overall Study|Did not receive 6 cycles.|0|||
23514405|NCT01059786|65619698|FG002|Overall Study|Did not receive 6 cycles.|4|||
23514406|NCT01059786|65619699|FG003|Overall Study|Did not receive 6 cycles.|1|||
23514407|NCT01059786|65619700|FG004|Overall Study|Did not receive 6 cycles.|0|||
23514408|NCT00410046|65619701|FG000|Overall Study|Adverse Event|3|||
23514409|NCT00410046|65619701|FG000|Overall Study|Withdrawal by Subject|1|||
23514410|NCT00410046|65619701|FG000|Overall Study|Lost to Follow-up|1|||
23514411|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
23514412|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
23514413|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
23514414|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
23514415|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
23514416|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
23514417|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
23514418|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
23514419|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
23514420|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
23514421|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
23514422|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
23514423|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
23514424|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
23514425|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
23514426|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
23514427|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
23514428|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
23514429|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
23514430|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
23514431|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
23514432|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
23514433|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
23514434|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
23514435|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Other|1|||
23514436|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Other|1|||
23514437|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Other|1|||
23514438|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Other|1|||
23711462|NCT02796391|66319329|FG004|Overall Study|COVID|2|||
23711463|NCT02796391|66319330|FG005|Overall Study|COVID|4|||
23514439|NCT04984993|65619706|FG000|Overall Study|Withdrawal by Subject|8|||
23514440|NCT04984993|65619707|FG001|Overall Study|Withdrawal by Subject|2|||
23514441|NCT04984993|65619706|FG000|Overall Study|Lost to Follow-up|2|||
23514442|NCT04984993|65619707|FG001|Overall Study|Lost to Follow-up|2|||
23514443|NCT04984993|65619706|FG000|Overall Study|Both patients moved to another country|4|||
23711464|NCT02796391|66319325|FG000|Overall Study|Participant did not like study cigarettes|0|||
23711465|NCT02796391|66319326|FG001|Overall Study|Participant did not like study cigarettes|0|||
23514444|NCT04984993|65619707|FG001|Overall Study|Both patients moved to another country|0|||
23514445|NCT01867021|65619708|FG000|Overall Study|Adverse Event|0|||
23514446|NCT01867021|65619709|FG001|Overall Study|Adverse Event|1|||
23514447|NCT01867021|65619708|FG000|Overall Study|Not Eligible|0|||
23514448|NCT01867021|65619709|FG001|Overall Study|Not Eligible|1|||
23514449|NCT01867021|65619708|FG000|Overall Study|Death|1|||
23514450|NCT01867021|65619709|FG001|Overall Study|Death|0|||
23514451|NCT01867021|65619708|FG000|Overall Study|Lost to Follow-up|0|||
23514452|NCT01867021|65619709|FG001|Overall Study|Lost to Follow-up|2|||
23514453|NCT01867021|65619708|FG000|Overall Study|Withdrawal by Subject|1|||
23514454|NCT01867021|65619709|FG001|Overall Study|Withdrawal by Subject|6|||
23514455|NCT03089606|65619711|FG000|Overall Study|Progression after Cycle 1|1|||
23514456|NCT04772755|65619712|FG000|Overall Study|Withdrawal by Subject|1|||
23514457|NCT04772755|65619713|FG001|Overall Study|Withdrawal by Subject|0|||
23514458|NCT04772755|65619712|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
23514459|NCT04772755|65619713|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
23514460|NCT02289690|65619718|FG000|Overall Study|Adverse Event Related to Progression|0|||
23514461|NCT02289690|65619719|FG001|Overall Study|Adverse Event Related to Progression|1|||
23514462|NCT02289690|65619720|FG002|Overall Study|Adverse Event Related to Progression|1|||
23514463|NCT02289690|65619721|FG003|Overall Study|Adverse Event Related to Progression|0|||
23514464|NCT02289690|65619722|FG004|Overall Study|Adverse Event Related to Progression|1|||
23514465|NCT02289690|65619723|FG005|Overall Study|Adverse Event Related to Progression|0|||
23514466|NCT02289690|65619724|FG006|Overall Study|Adverse Event Related to Progression|1|||
23514467|NCT02289690|65619725|FG007|Overall Study|Adverse Event Related to Progression|0|||
23514468|NCT02289690|65619726|FG008|Overall Study|Adverse Event Related to Progression|0|||
23514469|NCT02289690|65619727|FG009|Overall Study|Adverse Event Related to Progression|0|||
23514470|NCT02289690|65619718|FG000|Overall Study|Withdrawal by Subject|1|||
23514471|NCT02289690|65619719|FG001|Overall Study|Withdrawal by Subject|0|||
23514472|NCT02289690|65619720|FG002|Overall Study|Withdrawal by Subject|0|||
23514473|NCT02289690|65619721|FG003|Overall Study|Withdrawal by Subject|0|||
23514474|NCT02289690|65619722|FG004|Overall Study|Withdrawal by Subject|1|||
23514475|NCT02289690|65619723|FG005|Overall Study|Withdrawal by Subject|1|||
23514476|NCT02289690|65619724|FG006|Overall Study|Withdrawal by Subject|0|||
23514477|NCT02289690|65619725|FG007|Overall Study|Withdrawal by Subject|0|||
23514478|NCT02289690|65619726|FG008|Overall Study|Withdrawal by Subject|4|||
23514479|NCT02289690|65619727|FG009|Overall Study|Withdrawal by Subject|2|||
23514480|NCT02289690|65619718|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
23514481|NCT02289690|65619719|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
23514482|NCT02289690|65619720|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
23514483|NCT02289690|65619721|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
23514484|NCT02289690|65619722|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
23514485|NCT02289690|65619723|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
23514486|NCT02289690|65619724|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
23514487|NCT02289690|65619725|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
23514488|NCT02289690|65619726|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
23514489|NCT02289690|65619727|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
23514490|NCT02289690|65619718|FG000|Overall Study|Lost to Follow-up|0|||
23514491|NCT02289690|65619719|FG001|Overall Study|Lost to Follow-up|0|||
23514492|NCT02289690|65619720|FG002|Overall Study|Lost to Follow-up|0|||
23514493|NCT02289690|65619721|FG003|Overall Study|Lost to Follow-up|0|||
23514494|NCT02289690|65619722|FG004|Overall Study|Lost to Follow-up|0|||
23514495|NCT02289690|65619723|FG005|Overall Study|Lost to Follow-up|0|||
23514496|NCT02289690|65619724|FG006|Overall Study|Lost to Follow-up|0|||
23514497|NCT02289690|65619725|FG007|Overall Study|Lost to Follow-up|1|||
23514498|NCT02289690|65619726|FG008|Overall Study|Lost to Follow-up|0|||
23514499|NCT02289690|65619727|FG009|Overall Study|Lost to Follow-up|2|||
23514500|NCT02289690|65619718|FG000|Overall Study|Death|0|||
23514501|NCT02289690|65619719|FG001|Overall Study|Death|0|||
23514502|NCT02289690|65619720|FG002|Overall Study|Death|0|||
23514503|NCT02289690|65619721|FG003|Overall Study|Death|0|||
23514504|NCT02289690|65619722|FG004|Overall Study|Death|0|||
23514505|NCT02289690|65619723|FG005|Overall Study|Death|0|||
23514506|NCT02289690|65619724|FG006|Overall Study|Death|0|||
23514507|NCT02289690|65619725|FG007|Overall Study|Death|49|||
23514508|NCT02289690|65619726|FG008|Overall Study|Death|45|||
23514509|NCT02289690|65619727|FG009|Overall Study|Death|41|||
23514510|NCT02289690|65619718|FG000|Overall Study|Sponsor Discontinued Study|0|||
23514511|NCT02289690|65619719|FG001|Overall Study|Sponsor Discontinued Study|0|||
23514512|NCT02289690|65619720|FG002|Overall Study|Sponsor Discontinued Study|0|||
23514513|NCT02289690|65619721|FG003|Overall Study|Sponsor Discontinued Study|0|||
23514514|NCT02289690|65619722|FG004|Overall Study|Sponsor Discontinued Study|0|||
23514515|NCT02289690|65619723|FG005|Overall Study|Sponsor Discontinued Study|0|||
23711466|NCT02796391|66319327|FG002|Overall Study|Participant did not like study cigarettes|3|||
23711467|NCT02796391|66319328|FG003|Overall Study|Participant did not like study cigarettes|0|||
23514516|NCT02289690|65619724|FG006|Overall Study|Sponsor Discontinued Study|0|||
23514517|NCT02289690|65619725|FG007|Overall Study|Sponsor Discontinued Study|9|||
23514518|NCT02289690|65619726|FG008|Overall Study|Sponsor Discontinued Study|7|||
23514519|NCT02289690|65619727|FG009|Overall Study|Sponsor Discontinued Study|15|||
23514520|NCT02289690|65619718|FG000|Overall Study|Other|0|||
23514521|NCT02289690|65619719|FG001|Overall Study|Other|0|||
23514522|NCT02289690|65619720|FG002|Overall Study|Other|0|||
23514523|NCT02289690|65619721|FG003|Overall Study|Other|1|||
23514524|NCT02289690|65619722|FG004|Overall Study|Other|1|||
23514525|NCT02289690|65619723|FG005|Overall Study|Other|0|||
23514526|NCT02289690|65619724|FG006|Overall Study|Other|1|||
23514527|NCT02289690|65619725|FG007|Overall Study|Other|2|||
23514528|NCT02289690|65619726|FG008|Overall Study|Other|3|||
23514529|NCT02289690|65619727|FG009|Overall Study|Other|1|||
23514530|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
23514531|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
23514532|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
23514533|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
23514534|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
23514535|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
23514536|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
23514537|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
23514538|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
23514539|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
23514540|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
23514541|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
23514542|NCT00748033|65619733|FG000|Overall Study|Adverse Event|0|||
23514543|NCT00748033|65619734|FG001|Overall Study|Adverse Event|1|||
23514544|NCT00759954|65619735|FG000|Overall Study|Personal reason|1|||
23514545|NCT00759954|65619736|FG001|Overall Study|Personal reason|0|||
23514546|NCT00759954|65619735|FG000|Overall Study|Adverse Event|1|||
23514547|NCT00759954|65619736|FG001|Overall Study|Adverse Event|2|||
23514548|NCT01525550|65619737|FG000|Overall Study|Lost to Follow-up|8|||
23514549|NCT01525550|65619738|FG001|Overall Study|Lost to Follow-up|2|||
23514550|NCT01525550|65619737|FG000|Overall Study|Death|19|||
23514551|NCT01525550|65619738|FG001|Overall Study|Death|28|||
23514552|NCT01525550|65619737|FG000|Overall Study|Other|0|||
23514553|NCT01525550|65619738|FG001|Overall Study|Other|4|||
23514554|NCT01525550|65619737|FG000|Overall Study|Sponsor's Decision|30|||
23514555|NCT01525550|65619738|FG001|Overall Study|Sponsor's Decision|11|||
23514556|NCT01525550|65619737|FG000|Overall Study|Withdrawal by Subject|4|||
23514557|NCT01525550|65619738|FG001|Overall Study|Withdrawal by Subject|0|||
23514558|NCT00372112|65619739|FG000|Overall Study|Adverse Event|0|||
23514559|NCT00372112|65619740|FG001|Overall Study|Adverse Event|1|||
23514560|NCT00372112|65619741|FG002|Overall Study|Adverse Event|1|||
23514561|NCT00372112|65619742|FG003|Overall Study|Adverse Event|1|||
23514562|NCT00372112|65619739|FG000|Overall Study|Withdrawal by Subject|0|||
23514563|NCT00372112|65619740|FG001|Overall Study|Withdrawal by Subject|0|||
23514564|NCT00372112|65619741|FG002|Overall Study|Withdrawal by Subject|2|||
23514565|NCT00372112|65619742|FG003|Overall Study|Withdrawal by Subject|1|||
23514566|NCT00372112|65619739|FG000|Overall Study|Exacerbation|0|||
23514567|NCT00372112|65619740|FG001|Overall Study|Exacerbation|0|||
23514568|NCT00372112|65619741|FG002|Overall Study|Exacerbation|0|||
23514569|NCT00372112|65619742|FG003|Overall Study|Exacerbation|1|||
23514570|NCT00372112|65619739|FG000|Overall Study|PR >240 at Visit 3|0|||
23514571|NCT00372112|65619740|FG001|Overall Study|PR >240 at Visit 3|0|||
23514572|NCT00372112|65619741|FG002|Overall Study|PR >240 at Visit 3|0|||
23514573|NCT00372112|65619742|FG003|Overall Study|PR >240 at Visit 3|1|||
23514574|NCT00372112|65619739|FG000|Overall Study|Hepatitis B|1|||
23514575|NCT00372112|65619740|FG001|Overall Study|Hepatitis B|0|||
23514576|NCT00372112|65619741|FG002|Overall Study|Hepatitis B|0|||
23514577|NCT00372112|65619742|FG003|Overall Study|Hepatitis B|0|||
23514578|NCT00372112|65619739|FG000|Overall Study|Other-protocol violation|0|||
23514579|NCT00372112|65619740|FG001|Overall Study|Other-protocol violation|0|||
23514580|NCT00372112|65619741|FG002|Overall Study|Other-protocol violation|1|||
23514581|NCT00372112|65619742|FG003|Overall Study|Other-protocol violation|0|||
23514582|NCT00271609|65619747|FG000|Overall Study|Adverse Event|11|||
23514583|NCT00271609|65619748|FG001|Overall Study|Adverse Event|3|||
23514584|NCT00271609|65619747|FG000|Overall Study|Withdrawal by Subject|2|||
23514585|NCT00271609|65619748|FG001|Overall Study|Withdrawal by Subject|0|||
23514586|NCT01356966|65619749|FG000|Overall Study|Withdrawal by Subject|1|||
23514587|NCT01356966|65619750|FG001|Overall Study|Withdrawal by Subject|2|||
23514588|NCT01356966|65619749|FG000|Overall Study|Physician Decision|1|||
23514589|NCT01356966|65619750|FG001|Overall Study|Physician Decision|0|||
23514590|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
23514591|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
23514592|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
23514593|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
23415888|NCT01252186|65266051|FG001|Overall Study|Withdrawal by Subject|5|||
23415889|NCT01252186|65266052|FG002|Overall Study|Withdrawal by Subject|2|||
23514594|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
23514595|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
23514596|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
23514597|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
23514598|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
23514599|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
23514600|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
23514601|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
23514602|NCT02528643|65619751|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
23514603|NCT02528643|65619752|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
23514604|NCT00386776|65619754|FG000|Overall Study|Withdrawal by Subject|8|||
23415890|NCT01252186|65266050|FG000|Overall Study|Physician Decision|0|||
23415891|NCT01252186|65266051|FG001|Overall Study|Physician Decision|0|||
23415892|NCT01252186|65266052|FG002|Overall Study|Physician Decision|1|||
23415893|NCT01252186|65266050|FG000|Overall Study|Non-compliance|0|||
23415894|NCT01252186|65266051|FG001|Overall Study|Non-compliance|3|||
23415895|NCT01252186|65266052|FG002|Overall Study|Non-compliance|4|||
23415896|NCT01252186|65266050|FG000|Overall Study|Protocol Violation|0|||
23415897|NCT01252186|65266051|FG001|Overall Study|Protocol Violation|0|||
23415898|NCT01252186|65266052|FG002|Overall Study|Protocol Violation|1|||
23415899|NCT01252186|65266050|FG000|Overall Study|Pregnancy|2|||
23415900|NCT01252186|65266051|FG001|Overall Study|Pregnancy|2|||
23415901|NCT01252186|65266052|FG002|Overall Study|Pregnancy|0|||
23415902|NCT01252186|65266050|FG000|Overall Study|Sponsor Request|2|||
23415903|NCT01252186|65266051|FG001|Overall Study|Sponsor Request|1|||
23415904|NCT01252186|65266052|FG002|Overall Study|Sponsor Request|0|||
23415905|NCT01252186|65266050|FG000|Overall Study|Lost to Follow-up|10|||
23415906|NCT01252186|65266051|FG001|Overall Study|Lost to Follow-up|10|||
23415907|NCT01252186|65266052|FG002|Overall Study|Lost to Follow-up|11|||
23415908|NCT01252186|65266050|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
23415909|NCT01252186|65266051|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
23415910|NCT01252186|65266052|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
23415911|NCT02680041|65266053|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
23415912|NCT02680041|65266053|FG000|Overall Study|Lost to Follow-up|2|||
23415913|NCT01795495|65266054|FG000|Overall Study|Protocol Violation|1|||
23415914|NCT01795495|65266055|FG001|Overall Study|Protocol Violation|0|||
23415915|NCT01795495|65266056|FG002|Overall Study|Protocol Violation|1|||
23415916|NCT01795495|65266054|FG000|Overall Study|Physician Decision|0|||
23415917|NCT01795495|65266055|FG001|Overall Study|Physician Decision|0|||
23415918|NCT01795495|65266056|FG002|Overall Study|Physician Decision|1|||
23415919|NCT00485758|65266057|FG000|Overall Study|Adverse Event|102|||
23415920|NCT00485758|65266058|FG001|Overall Study|Adverse Event|31|||
23415921|NCT00485758|65266057|FG000|Overall Study|Death|0|||
23415922|NCT00485758|65266058|FG001|Overall Study|Death|1|||
23415923|NCT00485758|65266057|FG000|Overall Study|Lost to Follow-up|5|||
23415924|NCT00485758|65266058|FG001|Overall Study|Lost to Follow-up|1|||
23415925|NCT00485758|65266057|FG000|Overall Study|Physician Decision|3|||
23415926|NCT00485758|65266058|FG001|Overall Study|Physician Decision|3|||
23415927|NCT00485758|65266057|FG000|Overall Study|Protocol Violation|11|||
23415928|NCT00485758|65266058|FG001|Overall Study|Protocol Violation|2|||
23415929|NCT00485758|65266057|FG000|Overall Study|Withdrawal by Subject|32|||
23415930|NCT00485758|65266058|FG001|Overall Study|Withdrawal by Subject|27|||
23415931|NCT00485758|65266057|FG000|Overall Study|Study Terminated by Sponsor|3|||
23415932|NCT00485758|65266058|FG001|Overall Study|Study Terminated by Sponsor|0|||
23415933|NCT02543281|65266059|FG000|Overall Study|Lost to Follow-up|0|||
23415934|NCT02543281|65266060|FG001|Overall Study|Lost to Follow-up|0|||
23415935|NCT02543281|65266061|FG002|Overall Study|Lost to Follow-up|1|||
23415936|NCT00675441|65266069|FG000|Overall Study|Withdrawal by Subject|2|||
23415937|NCT00675441|65266069|FG000|Overall Study|Death|1|||
23415938|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
23415939|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
23415940|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
23415941|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
23514605|NCT00137423|65619755|FG000|Overall Study|Adverse Event|7|||
23415942|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
23415943|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
23415944|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
23611194|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
23415945|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
23415946|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
23415947|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
23711468|NCT02796391|66319329|FG004|Overall Study|Participant did not like study cigarettes|0|||
23711469|NCT02796391|66319330|FG005|Overall Study|Participant did not like study cigarettes|0|||
23711470|NCT02796391|66319325|FG000|Overall Study|Withdrawal by Subject|1|||
23711471|NCT02796391|66319326|FG001|Overall Study|Withdrawal by Subject|1|||
23711472|NCT02796391|66319327|FG002|Overall Study|Withdrawal by Subject|4|||
23711473|NCT02796391|66319328|FG003|Overall Study|Withdrawal by Subject|3|||
23711474|NCT02796391|66319329|FG004|Overall Study|Withdrawal by Subject|4|||
23711475|NCT02796391|66319330|FG005|Overall Study|Withdrawal by Subject|3|||
23711476|NCT02796391|66319325|FG000|Overall Study|Adverse Event|0|||
23711477|NCT02796391|66319326|FG001|Overall Study|Adverse Event|0|||
23711478|NCT02796391|66319327|FG002|Overall Study|Adverse Event|0|||
23711479|NCT02796391|66319328|FG003|Overall Study|Adverse Event|1|||
23711480|NCT02796391|66319329|FG004|Overall Study|Adverse Event|0|||
23711481|NCT02796391|66319330|FG005|Overall Study|Adverse Event|0|||
23711482|NCT02796391|66319325|FG000|Overall Study|Protocol Violation|0|||
23415948|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
23415949|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
23415950|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
23415951|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
23415952|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
23415953|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
23415954|NCT02290691|65266082|FG000|Overall Study|Noncompliance|0|||
23415955|NCT02290691|65266083|FG001|Overall Study|Noncompliance|1|||
23415956|NCT02290691|65266082|FG000|Overall Study|Withdrawal by Subject|1|||
23415957|NCT02290691|65266083|FG001|Overall Study|Withdrawal by Subject|1|||
23415958|NCT02290691|65266082|FG000|Overall Study|Lost to Follow-up|7|||
23415959|NCT02290691|65266083|FG001|Overall Study|Lost to Follow-up|7|||
23415960|NCT01597908|65266084|FG000|Randomized Phase|Death|217|||
23415961|NCT01597908|65266085|FG001|Randomized Phase|Death|238|||
23415962|NCT01597908|65266086|FG002|Randomized Phase|Death|0|||
23415963|NCT01597908|65266084|FG000|Randomized Phase|Sponsor Decision|93|||
23415964|NCT01597908|65266085|FG001|Randomized Phase|Sponsor Decision|39|||
23415965|NCT01597908|65266086|FG002|Randomized Phase|Sponsor Decision|0|||
23415966|NCT01597908|65266084|FG000|Randomized Phase|Lost to Follow-up|9|||
23415967|NCT01597908|65266085|FG001|Randomized Phase|Lost to Follow-up|16|||
23415968|NCT01597908|65266086|FG002|Randomized Phase|Lost to Follow-up|0|||
23415969|NCT01597908|65266084|FG000|Randomized Phase|Physician Decision|6|||
23415970|NCT01597908|65266085|FG001|Randomized Phase|Physician Decision|3|||
23415971|NCT01597908|65266086|FG002|Randomized Phase|Physician Decision|0|||
23415972|NCT01597908|65266084|FG000|Randomized Phase|Withdrawal by Subject|26|||
23415973|NCT01597908|65266085|FG001|Randomized Phase|Withdrawal by Subject|22|||
23415974|NCT01597908|65266086|FG002|Randomized Phase|Withdrawal by Subject|0|||
23415975|NCT01597908|65266084|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
23415976|NCT01597908|65266085|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
23415977|NCT01597908|65266086|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
23415978|NCT01597908|65266084|FG000|Crossover Phase|Death|0|||
23415979|NCT01597908|65266085|FG001|Crossover Phase|Death|0|||
23415980|NCT01597908|65266086|FG002|Crossover Phase|Death|11|||
23415981|NCT01597908|65266084|FG000|Crossover Phase|Withdrawal by Subject|0|||
23415982|NCT01597908|65266085|FG001|Crossover Phase|Withdrawal by Subject|0|||
23415983|NCT01597908|65266086|FG002|Crossover Phase|Withdrawal by Subject|3|||
23415984|NCT01597908|65266084|FG000|Crossover Phase|Sponsor Decision|0|||
23415985|NCT01597908|65266085|FG001|Crossover Phase|Sponsor Decision|0|||
23415986|NCT01597908|65266086|FG002|Crossover Phase|Sponsor Decision|20|||
23415987|NCT01576146|65266089|FG000|Extension Period 1|Adverse Event|2|||
23415988|NCT01576146|65266089|FG000|Extension Period 1|Death|2|||
23415989|NCT01576146|65266089|FG000|Extension Period 1|Physician Decision|2|||
23415990|NCT01576146|65266089|FG000|Extension Period 1|Withdrawal by Subject|1|||
23415991|NCT01576146|65266089|FG000|Extension Period 1|Lost to Follow-up|1|||
23415992|NCT01576146|65266089|FG000|Extension Period 1|Parathyroidectomy|1|||
23415993|NCT01576146|65266089|FG000|Extension Period 1|Renal Transplant|1|||
23415994|NCT01576146|65266089|FG000|Extension Period 2|Sponsor Decision|13|||
23415995|NCT01576146|65266089|FG000|Extension Period 2|Death|1|||
23415996|NCT01576146|65266089|FG000|Extension Period 2|Adverse Event|1|||
23415997|NCT01576146|65266089|FG000|Extension Period 2|Renal Transplant|1|||
23415998|NCT01576146|65266089|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
23415999|NCT04537208|65266090|FG000|Overall Study|Adverse Event|0|||
23416000|NCT04537208|65266091|FG001|Overall Study|Adverse Event|0|||
23416001|NCT04537208|65266092|FG002|Overall Study|Adverse Event|0|||
23416002|NCT04537208|65266093|FG003|Overall Study|Adverse Event|0|||
23416003|NCT04537208|65266094|FG004|Overall Study|Adverse Event|0|||
23416004|NCT04537208|65266095|FG005|Overall Study|Adverse Event|0|||
23416005|NCT04537208|65266096|FG006|Overall Study|Adverse Event|0|||
23416006|NCT04537208|65266097|FG007|Overall Study|Adverse Event|0|||
23416007|NCT04537208|65266098|FG008|Overall Study|Adverse Event|1|||
23514606|NCT00137423|65619756|FG001|Overall Study|Adverse Event|9|||
23514607|NCT00137423|65619755|FG000|Overall Study|consent withdrawn|1|||
23514608|NCT00137423|65619756|FG001|Overall Study|consent withdrawn|1|||
23514609|NCT00137423|65619755|FG000|Overall Study|Lack of Efficacy|31|||
23514610|NCT00137423|65619756|FG001|Overall Study|Lack of Efficacy|33|||
23514611|NCT00137423|65619755|FG000|Overall Study|Death|0|||
23514612|NCT00137423|65619756|FG001|Overall Study|Death|1|||
23514613|NCT00847704|65619757|FG000|Overall Study|Withdrawal by Subject|1|||
23514614|NCT00503009|65619758|FG000|Overall Study|Protocol Violation|1|||
23514615|NCT00503009|65619759|FG001|Overall Study|Protocol Violation|0|||
23514616|NCT00503009|65619760|FG002|Overall Study|Protocol Violation|1|||
23514617|NCT00503009|65619758|FG000|Overall Study|Withdrawal by Subject|0|||
23514618|NCT00503009|65619759|FG001|Overall Study|Withdrawal by Subject|1|||
23514619|NCT00503009|65619760|FG002|Overall Study|Withdrawal by Subject|1|||
23514620|NCT00503009|65619758|FG000|Overall Study|Physician Decision|0|||
23514621|NCT00503009|65619759|FG001|Overall Study|Physician Decision|1|||
23514622|NCT00503009|65619760|FG002|Overall Study|Physician Decision|1|||
23514623|NCT01313767|65619761|FG000|Overall Study|Adverse Event|1|||
23514624|NCT01313767|65619762|FG001|Overall Study|Adverse Event|0|||
23514625|NCT01313767|65619761|FG000|Overall Study|Lost to Follow-up|1|||
23514626|NCT01313767|65619762|FG001|Overall Study|Lost to Follow-up|0|||
23514627|NCT01313767|65619761|FG000|Overall Study|Withdrawal by Subject|2|||
23514628|NCT01313767|65619762|FG001|Overall Study|Withdrawal by Subject|1|||
23514629|NCT01313767|65619761|FG000|Overall Study|Protocol Violation|3|||
23514630|NCT01313767|65619762|FG001|Overall Study|Protocol Violation|1|||
23514631|NCT02140567|65619765|FG000|Overall Study|Problems with recording equipment|6|||
23514632|NCT01084174|65619766|FG000|Overall Study|gastrointestinal symptoms|1|||
23514633|NCT01084174|65619767|FG001|Overall Study|gastrointestinal symptoms|1|||
23514634|NCT01084174|65619766|FG000|Overall Study|Eosinophilic esophagitis|0|||
23514635|NCT01084174|65619767|FG001|Overall Study|Eosinophilic esophagitis|1|||
23514636|NCT01084174|65619766|FG000|Overall Study|Anaphylaxis|0|||
23514637|NCT01084174|65619767|FG001|Overall Study|Anaphylaxis|1|||
23514638|NCT01084174|65619766|FG000|Overall Study|Participant noncompliance|0|||
23514639|NCT01084174|65619767|FG001|Overall Study|Participant noncompliance|1|||
23514640|NCT03518073|65619768|FG000|Overall Study|Adverse Event|2|||
23514641|NCT03518073|65619769|FG001|Overall Study|Adverse Event|4|||
23514642|NCT03518073|65619770|FG002|Overall Study|Adverse Event|2|||
23514643|NCT03518073|65619768|FG000|Overall Study|Death|2|||
23514644|NCT03518073|65619769|FG001|Overall Study|Death|1|||
23514645|NCT03518073|65619770|FG002|Overall Study|Death|3|||
23711483|NCT02796391|66319326|FG001|Overall Study|Protocol Violation|0|||
23711484|NCT02796391|66319327|FG002|Overall Study|Protocol Violation|0|||
23514646|NCT03518073|65619768|FG000|Overall Study|Lost to Follow-up|1|||
23514647|NCT03518073|65619769|FG001|Overall Study|Lost to Follow-up|0|||
23514648|NCT03518073|65619770|FG002|Overall Study|Lost to Follow-up|1|||
23514649|NCT03518073|65619768|FG000|Overall Study|Physician Decision|5|||
23514650|NCT03518073|65619769|FG001|Overall Study|Physician Decision|0|||
23514651|NCT03518073|65619770|FG002|Overall Study|Physician Decision|2|||
23514652|NCT03518073|65619768|FG000|Overall Study|Progressive disease|1|||
23514653|NCT03518073|65619769|FG001|Overall Study|Progressive disease|1|||
23514654|NCT03518073|65619770|FG002|Overall Study|Progressive disease|1|||
23514655|NCT03518073|65619768|FG000|Overall Study|Protocol Violation|1|||
23514656|NCT03518073|65619769|FG001|Overall Study|Protocol Violation|0|||
23514657|NCT03518073|65619770|FG002|Overall Study|Protocol Violation|0|||
23514658|NCT03518073|65619768|FG000|Overall Study|Withdrawal by Subject|30|||
23514659|NCT03518073|65619769|FG001|Overall Study|Withdrawal by Subject|34|||
23514660|NCT03518073|65619770|FG002|Overall Study|Withdrawal by Subject|29|||
23514661|NCT03518073|65619768|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
23514662|NCT03518073|65619769|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
23514663|NCT03518073|65619770|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
23514664|NCT03518073|65619768|FG000|Overall Study|Covid-19|1|||
23514665|NCT03518073|65619769|FG001|Overall Study|Covid-19|2|||
23514666|NCT03518073|65619770|FG002|Overall Study|Covid-19|1|||
23514667|NCT01519960|65619771|FG000|Overall Study|Withdrawal from the study|26|||
23514668|NCT01519960|65619772|FG001|Overall Study|Withdrawal from the study|22|||
23514669|NCT01519960|65619773|FG002|Overall Study|Withdrawal from the study|5|||
23514670|NCT02810392|65619774|FG000|Overall Study|Subject too ill to continue|1|||
23514671|NCT02810392|65619775|FG001|Overall Study|Subject too ill to continue|0|||
23514672|NCT02810392|65619774|FG000|Overall Study|COVID 19 research restrictions|0|||
23514673|NCT02810392|65619775|FG001|Overall Study|COVID 19 research restrictions|1|||
23514674|NCT02111850|65619778|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514675|NCT02111850|65619779|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23711485|NCT02796391|66319328|FG003|Overall Study|Protocol Violation|1|||
23711486|NCT02796391|66319329|FG004|Overall Study|Protocol Violation|0|||
23711487|NCT02796391|66319330|FG005|Overall Study|Protocol Violation|0|||
23711488|NCT01575197|66319331|FG000|Overall Study|Migration out of study area|1|||
23711489|NCT01575197|66319332|FG001|Overall Study|Migration out of study area|5|||
23416008|NCT04537208|65266099|FG009|Overall Study|Adverse Event|0|||
23416009|NCT04537208|65266100|FG010|Overall Study|Adverse Event|0|||
23416010|NCT04537208|65266090|FG000|Overall Study|Protocol deviation|0|||
23416011|NCT04537208|65266091|FG001|Overall Study|Protocol deviation|0|||
23416012|NCT04537208|65266092|FG002|Overall Study|Protocol deviation|2|||
23416013|NCT04537208|65266093|FG003|Overall Study|Protocol deviation|0|||
23416014|NCT04537208|65266094|FG004|Overall Study|Protocol deviation|0|||
23416015|NCT04537208|65266095|FG005|Overall Study|Protocol deviation|2|||
23416016|NCT04537208|65266096|FG006|Overall Study|Protocol deviation|4|||
23416017|NCT04537208|65266097|FG007|Overall Study|Protocol deviation|0|||
23416018|NCT04537208|65266098|FG008|Overall Study|Protocol deviation|1|||
23416019|NCT04537208|65266099|FG009|Overall Study|Protocol deviation|0|||
23416020|NCT04537208|65266100|FG010|Overall Study|Protocol deviation|2|||
23416021|NCT04537208|65266090|FG000|Overall Study|Withdrawal by Subject|4|||
23416022|NCT04537208|65266091|FG001|Overall Study|Withdrawal by Subject|2|||
23416023|NCT04537208|65266092|FG002|Overall Study|Withdrawal by Subject|1|||
23416024|NCT04537208|65266093|FG003|Overall Study|Withdrawal by Subject|3|||
23416025|NCT04537208|65266094|FG004|Overall Study|Withdrawal by Subject|5|||
23416026|NCT04537208|65266095|FG005|Overall Study|Withdrawal by Subject|1|||
23416027|NCT04537208|65266096|FG006|Overall Study|Withdrawal by Subject|6|||
23416028|NCT04537208|65266097|FG007|Overall Study|Withdrawal by Subject|1|||
23416029|NCT04537208|65266098|FG008|Overall Study|Withdrawal by Subject|7|||
23416030|NCT04537208|65266099|FG009|Overall Study|Withdrawal by Subject|2|||
23416031|NCT04537208|65266100|FG010|Overall Study|Withdrawal by Subject|4|||
23416032|NCT04537208|65266090|FG000|Overall Study|Lost to Follow-up|4|||
23416033|NCT04537208|65266091|FG001|Overall Study|Lost to Follow-up|1|||
23416034|NCT04537208|65266092|FG002|Overall Study|Lost to Follow-up|3|||
23416035|NCT04537208|65266093|FG003|Overall Study|Lost to Follow-up|4|||
23416036|NCT04537208|65266094|FG004|Overall Study|Lost to Follow-up|3|||
23416037|NCT04537208|65266095|FG005|Overall Study|Lost to Follow-up|2|||
23416038|NCT04537208|65266096|FG006|Overall Study|Lost to Follow-up|3|||
23416039|NCT04537208|65266097|FG007|Overall Study|Lost to Follow-up|2|||
23416040|NCT04537208|65266098|FG008|Overall Study|Lost to Follow-up|7|||
23416041|NCT04537208|65266099|FG009|Overall Study|Lost to Follow-up|2|||
23416042|NCT04537208|65266100|FG010|Overall Study|Lost to Follow-up|2|||
23416043|NCT01355679|65266107|FG000|Overall Study|benign tumor types found at biopsy|2|||
23416044|NCT02379988|65266108|FG000|Overall Study|Not eligible|1|||
23416045|NCT00791479|65266124|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416046|NCT00791479|65266125|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416047|NCT00791479|65266126|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416048|NCT00791479|65266127|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416049|NCT00791479|65266128|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
23416050|NCT00791479|65266129|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416051|NCT00791479|65266124|FG000|Overall Study|Adverse Event|0|||
23416052|NCT00791479|65266125|FG001|Overall Study|Adverse Event|1|||
23416053|NCT00791479|65266126|FG002|Overall Study|Adverse Event|0|||
23416054|NCT00791479|65266127|FG003|Overall Study|Adverse Event|2|||
23416055|NCT00791479|65266128|FG004|Overall Study|Adverse Event|0|||
23416056|NCT00791479|65266129|FG005|Overall Study|Adverse Event|1|||
23416057|NCT00791479|65266124|FG000|Overall Study|Lost to Follow-up|0|||
23416058|NCT00791479|65266125|FG001|Overall Study|Lost to Follow-up|1|||
23416059|NCT00791479|65266126|FG002|Overall Study|Lost to Follow-up|0|||
23416060|NCT00791479|65266127|FG003|Overall Study|Lost to Follow-up|0|||
23416061|NCT00791479|65266128|FG004|Overall Study|Lost to Follow-up|0|||
23416062|NCT00791479|65266129|FG005|Overall Study|Lost to Follow-up|1|||
23416063|NCT00791479|65266124|FG000|Overall Study|Protocol Violation|2|||
23416064|NCT00791479|65266125|FG001|Overall Study|Protocol Violation|1|||
23416065|NCT00791479|65266126|FG002|Overall Study|Protocol Violation|0|||
23416066|NCT00791479|65266127|FG003|Overall Study|Protocol Violation|1|||
23416067|NCT00791479|65266128|FG004|Overall Study|Protocol Violation|0|||
23416068|NCT00791479|65266129|FG005|Overall Study|Protocol Violation|0|||
23416069|NCT00791479|65266124|FG000|Overall Study|Withdrawal by Subject|0|||
23416070|NCT00791479|65266125|FG001|Overall Study|Withdrawal by Subject|0|||
23416071|NCT00791479|65266126|FG002|Overall Study|Withdrawal by Subject|0|||
23416072|NCT00791479|65266127|FG003|Overall Study|Withdrawal by Subject|1|||
23416073|NCT00791479|65266128|FG004|Overall Study|Withdrawal by Subject|0|||
23416074|NCT00791479|65266129|FG005|Overall Study|Withdrawal by Subject|1|||
23416075|NCT02719691|65266130|FG000|Overall Study|Physician Decision|0|||
23416076|NCT02719691|65266131|FG001|Overall Study|Physician Decision|0|||
23711490|NCT01575197|66319333|FG002|Overall Study|Migration out of study area|4|||
23416077|NCT02719691|65266132|FG002|Overall Study|Physician Decision|1|||
23416078|NCT02719691|65266133|FG003|Overall Study|Physician Decision|0|||
23416079|NCT02719691|65266134|FG004|Overall Study|Physician Decision|0|||
23416080|NCT02719691|65266135|FG005|Overall Study|Physician Decision|0|||
23514676|NCT02111850|65619780|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514677|NCT02111850|65619781|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514678|NCT02111850|65619782|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
23514679|NCT02111850|65619783|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514680|NCT02111850|65619784|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514681|NCT02111850|65619785|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514682|NCT02111850|65619786|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514683|NCT02111850|65619787|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514684|NCT02111850|65619788|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514685|NCT03566823|65619792|FG000|Overall Study|Lack of Efficacy|0|||
23514686|NCT03566823|65619793|FG001|Overall Study|Lack of Efficacy|1|||
23514687|NCT03566823|65619794|FG002|Overall Study|Lack of Efficacy|0|||
23514688|NCT03566823|65619792|FG000|Overall Study|Withdrawal by Subject|1|||
23514689|NCT03566823|65619793|FG001|Overall Study|Withdrawal by Subject|2|||
23514690|NCT03566823|65619794|FG002|Overall Study|Withdrawal by Subject|0|||
23514691|NCT03566823|65619792|FG000|Overall Study|Adverse Event|1|||
23514692|NCT03566823|65619793|FG001|Overall Study|Adverse Event|0|||
23514693|NCT03566823|65619794|FG002|Overall Study|Adverse Event|2|||
23514694|NCT02436356|65624015|FG000|Overall Study|Excluded by MRI Screening|0|||
23514695|NCT02436356|65624016|FG001|Overall Study|Excluded by MRI Screening|0|||
23514696|NCT02436356|65624017|FG002|Overall Study|Excluded by MRI Screening|2|||
23514697|NCT02436356|65624015|FG000|Overall Study|Lost to Follow-up|0|||
23514698|NCT02436356|65624016|FG001|Overall Study|Lost to Follow-up|1|||
23514699|NCT02436356|65624017|FG002|Overall Study|Lost to Follow-up|0|||
23514700|NCT02436356|65624015|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
23514701|NCT02436356|65624016|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
23514702|NCT02436356|65624017|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
23514703|NCT02436356|65624015|FG000|Overall Study|Excluded due to other medical conditions|3|||
23514704|NCT02436356|65624016|FG001|Overall Study|Excluded due to other medical conditions|0|||
23514705|NCT02436356|65624017|FG002|Overall Study|Excluded due to other medical conditions|0|||
23514706|NCT02436356|65624015|FG000|Overall Study|Withdrawal by Subject|1|||
23514707|NCT02436356|65624016|FG001|Overall Study|Withdrawal by Subject|0|||
23514708|NCT02436356|65624017|FG002|Overall Study|Withdrawal by Subject|0|||
23514709|NCT00225251|65624018|FG000|Overall Study|Withdrawal by Subject|1|||
23514710|NCT00225251|65624019|FG001|Overall Study|Withdrawal by Subject|1|||
23514711|NCT02377466|65624020|FG000|Overall Study|Other: Randomized and not treated|0|||
23514712|NCT02377466|65624021|FG001|Overall Study|Other: Randomized and not treated|2|||
23514713|NCT02672423|65624022|FG000|Period 1|Adverse Event|0|||
23514714|NCT02672423|65624023|FG001|Period 1|Adverse Event|0|||
23514715|NCT02672423|65624024|FG002|Period 1|Adverse Event|0|||
23514716|NCT02672423|65624025|FG003|Period 1|Adverse Event|0|||
23514717|NCT02672423|65624026|FG004|Period 1|Adverse Event|1|||
23514718|NCT02672423|65624027|FG005|Period 1|Adverse Event|0|||
23514719|NCT02672423|65624028|FG006|Period 1|Adverse Event|0|||
23514720|NCT02672423|65624029|FG007|Period 1|Adverse Event|0|||
23514721|NCT02672423|65624030|FG008|Period 1|Adverse Event|0|||
23514722|NCT02672423|65624031|FG009|Period 1|Adverse Event|0|||
23514723|NCT02672423|65624022|FG000|Period 2|Withdrawal by Subject|0|||
23514724|NCT02672423|65624023|FG001|Period 2|Withdrawal by Subject|0|||
23514725|NCT02672423|65624024|FG002|Period 2|Withdrawal by Subject|1|||
23514726|NCT02672423|65624025|FG003|Period 2|Withdrawal by Subject|0|||
23514727|NCT02672423|65624026|FG004|Period 2|Withdrawal by Subject|0|||
23514728|NCT02672423|65624027|FG005|Period 2|Withdrawal by Subject|0|||
23514729|NCT02672423|65624028|FG006|Period 2|Withdrawal by Subject|0|||
23514730|NCT02672423|65624029|FG007|Period 2|Withdrawal by Subject|0|||
23514731|NCT02672423|65624030|FG008|Period 2|Withdrawal by Subject|0|||
23514732|NCT02672423|65624031|FG009|Period 2|Withdrawal by Subject|0|||
23514733|NCT02672423|65624022|FG000|Period 3|Withdrawal by Subject|0|||
23514734|NCT02672423|65624023|FG001|Period 3|Withdrawal by Subject|0|||
23514735|NCT02672423|65624024|FG002|Period 3|Withdrawal by Subject|0|||
23514736|NCT02672423|65624025|FG003|Period 3|Withdrawal by Subject|0|||
23514737|NCT02672423|65624026|FG004|Period 3|Withdrawal by Subject|0|||
23514738|NCT02672423|65624027|FG005|Period 3|Withdrawal by Subject|0|||
23514739|NCT02672423|65624028|FG006|Period 3|Withdrawal by Subject|0|||
23514740|NCT02672423|65624029|FG007|Period 3|Withdrawal by Subject|1|||
23514741|NCT02672423|65624030|FG008|Period 3|Withdrawal by Subject|0|||
23514742|NCT02672423|65624031|FG009|Period 3|Withdrawal by Subject|0|||
23514743|NCT02672423|65624022|FG000|Period 3|Physician Decision|0|||
23514744|NCT02672423|65624023|FG001|Period 3|Physician Decision|0|||
23514745|NCT02672423|65624024|FG002|Period 3|Physician Decision|0|||
23514746|NCT02672423|65624025|FG003|Period 3|Physician Decision|0|||
23514747|NCT02672423|65624026|FG004|Period 3|Physician Decision|0|||
23514748|NCT02672423|65624027|FG005|Period 3|Physician Decision|1|||
23514749|NCT02672423|65624028|FG006|Period 3|Physician Decision|0|||
23514750|NCT02672423|65624029|FG007|Period 3|Physician Decision|0|||
23514751|NCT02672423|65624030|FG008|Period 3|Physician Decision|0|||
23514752|NCT02672423|65624031|FG009|Period 3|Physician Decision|0|||
23514753|NCT00255047|65624032|FG000|Overall Study|Serious Adverse Events|2|||
23514754|NCT00255047|65624033|FG001|Overall Study|Serious Adverse Events|1|||
23514755|NCT00255047|65624034|FG002|Overall Study|Serious Adverse Events|2|||
23514756|NCT00255047|65624035|FG003|Overall Study|Serious Adverse Events|1|||
23514757|NCT00255047|65624032|FG000|Overall Study|Adverse Event|0|||
23514758|NCT00255047|65624033|FG001|Overall Study|Adverse Event|3|||
23514759|NCT00255047|65624034|FG002|Overall Study|Adverse Event|2|||
23514760|NCT00255047|65624035|FG003|Overall Study|Adverse Event|1|||
23514761|NCT00255047|65624032|FG000|Overall Study|Protocol Violation|13|||
23514762|NCT00255047|65624033|FG001|Overall Study|Protocol Violation|13|||
23514763|NCT00255047|65624034|FG002|Overall Study|Protocol Violation|16|||
23514764|NCT00255047|65624035|FG003|Overall Study|Protocol Violation|20|||
23514765|NCT00255047|65624032|FG000|Overall Study|Lost to Follow-up|9|||
23514766|NCT00255047|65624033|FG001|Overall Study|Lost to Follow-up|8|||
23514767|NCT00255047|65624034|FG002|Overall Study|Lost to Follow-up|5|||
23514768|NCT00255047|65624035|FG003|Overall Study|Lost to Follow-up|6|||
23514769|NCT00255047|65624032|FG000|Overall Study|Withdrawal by Subject|24|||
23514770|NCT00255047|65624033|FG001|Overall Study|Withdrawal by Subject|23|||
23514771|NCT00255047|65624034|FG002|Overall Study|Withdrawal by Subject|25|||
23514772|NCT00255047|65624035|FG003|Overall Study|Withdrawal by Subject|18|||
23514773|NCT01572909|65624036|FG000|Overall Study|Adverse Event|7|||
23514774|NCT01572909|65624037|FG001|Overall Study|Adverse Event|2|||
23514775|NCT01572909|65624036|FG000|Overall Study|Death|3|||
23514776|NCT01572909|65624037|FG001|Overall Study|Death|1|||
23514777|NCT01572909|65624036|FG000|Overall Study|Lost to Follow-up|8|||
23514778|NCT01572909|65624037|FG001|Overall Study|Lost to Follow-up|7|||
23514779|NCT01572909|65624036|FG000|Overall Study|Physician Decision|1|||
23514780|NCT01572909|65624037|FG001|Overall Study|Physician Decision|1|||
23514781|NCT01572909|65624036|FG000|Overall Study|Technical Issues|1|||
23514782|NCT01572909|65624037|FG001|Overall Study|Technical Issues|0|||
23514783|NCT01572909|65624036|FG000|Overall Study|Withdrawal by Subject|12|||
23514784|NCT01572909|65624037|FG001|Overall Study|Withdrawal by Subject|11|||
23514785|NCT01572909|65624036|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
23514786|NCT01572909|65624037|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
23711491|NCT01575197|66319331|FG000|Overall Study|SAE|0|||
23711492|NCT01575197|66319332|FG001|Overall Study|SAE|1|||
23711493|NCT01575197|66319333|FG002|Overall Study|SAE|0|||
23711494|NCT01575197|66319331|FG000|Overall Study|Lost to Follow-up|0|||
23711495|NCT01575197|66319332|FG001|Overall Study|Lost to Follow-up|1|||
23711496|NCT01575197|66319333|FG002|Overall Study|Lost to Follow-up|0|||
23711497|NCT01575197|66319331|FG000|Overall Study|Withdrawal by Subject|0|||
23711498|NCT01575197|66319332|FG001|Overall Study|Withdrawal by Subject|1|||
23711499|NCT01575197|66319333|FG002|Overall Study|Withdrawal by Subject|1|||
23711500|NCT01575197|66319331|FG000|Overall Study|Protocol Violation|2|||
23711501|NCT01575197|66319332|FG001|Overall Study|Protocol Violation|1|||
23711502|NCT01575197|66319333|FG002|Overall Study|Protocol Violation|1|||
23711503|NCT01021852|66319334|FG000|Treatment Period 1|Adverse Event|3|||
23711504|NCT01021852|66319335|FG001|Treatment Period 1|Adverse Event|1|||
23711505|NCT01021852|66319336|FG002|Treatment Period 1|Adverse Event|1|||
23711506|NCT01021852|66319337|FG003|Treatment Period 1|Adverse Event|0|||
23711507|NCT01021852|66319338|FG004|Treatment Period 1|Adverse Event|2|||
23514787|NCT00503308|65624040|FG000|Overall Study|Protocol Violation|2|||
23514788|NCT00503308|65624041|FG001|Overall Study|Protocol Violation|1|||
23514789|NCT01846507|65624049|FG000|Overall Study|Lost to Follow-up|4|||
23514790|NCT01846507|65624049|FG000|Overall Study|Protocol Violation|1|||
23514791|NCT01846507|65624049|FG000|Overall Study|Missing data|2|||
23514792|NCT03654651|65624050|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23711508|NCT01021852|66319339|FG005|Treatment Period 1|Adverse Event|2|||
23711509|NCT01021852|66319340|FG006|Treatment Period 1|Adverse Event|0|||
23711510|NCT01021852|66319341|FG007|Treatment Period 1|Adverse Event|0|||
23711511|NCT01021852|66319334|FG000|Treatment Period 1|Pregnancy|0|||
23711512|NCT01021852|66319335|FG001|Treatment Period 1|Pregnancy|0|||
23514793|NCT03654651|65624051|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23514794|NCT01705652|65624052|FG000|Overall Study|Adverse Event|1|||
23514795|NCT01705652|65624053|FG001|Overall Study|Adverse Event|0|||
23514796|NCT01705652|65624052|FG000|Overall Study|Withdrawal by Subject|1|||
23514797|NCT01705652|65624053|FG001|Overall Study|Withdrawal by Subject|2|||
23514798|NCT01705652|65624052|FG000|Overall Study|non-compliance|1|||
23514799|NCT01705652|65624053|FG001|Overall Study|non-compliance|1|||
23514800|NCT00588848|65624062|FG000|Overall Study|Physician Decision|0|||
23514801|NCT00588848|65624063|FG001|Overall Study|Physician Decision|3|||
23514802|NCT03036072|65624064|FG000|Overall Study|Death|0|||
23514803|NCT03036072|65624065|FG001|Overall Study|Death|1|||
23514804|NCT03036072|65624064|FG000|Overall Study|Withdrawal by Subject|0|||
23514805|NCT03036072|65624065|FG001|Overall Study|Withdrawal by Subject|1|||
23514806|NCT03036072|65624064|FG000|Overall Study|Physician Decision|0|||
23514807|NCT03036072|65624065|FG001|Overall Study|Physician Decision|1|||
23514808|NCT00975481|65624066|FG000|Second Intervention Period|Adverse Event|2|||
23514809|NCT00975481|65624067|FG001|Second Intervention Period|Adverse Event|1|||
23514810|NCT00975481|65624068|FG002|Second Intervention Period|Adverse Event|0|||
23514811|NCT00975481|65624069|FG003|Second Intervention Period|Adverse Event|0|||
23514812|NCT00975481|65624070|FG004|Second Intervention Period|Adverse Event|0|||
23514813|NCT00975481|65624071|FG005|Second Intervention Period|Adverse Event|0|||
23514814|NCT00975481|65624066|FG000|Second Intervention Period|Withdrawal by Subject|0|||
23514815|NCT00975481|65624067|FG001|Second Intervention Period|Withdrawal by Subject|0|||
23514816|NCT00975481|65624068|FG002|Second Intervention Period|Withdrawal by Subject|1|||
23514817|NCT00975481|65624069|FG003|Second Intervention Period|Withdrawal by Subject|0|||
23514818|NCT00975481|65624070|FG004|Second Intervention Period|Withdrawal by Subject|0|||
23514819|NCT00975481|65624071|FG005|Second Intervention Period|Withdrawal by Subject|0|||
23514820|NCT00975481|65624066|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
23514821|NCT00975481|65624067|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
23514822|NCT00975481|65624068|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
23514823|NCT00975481|65624069|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
23514824|NCT00975481|65624070|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
23514825|NCT00975481|65624071|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
23514826|NCT00975481|65624066|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
23514827|NCT00975481|65624067|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
23514828|NCT00975481|65624068|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
23514829|NCT00975481|65624069|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
23514830|NCT00975481|65624070|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
23514831|NCT00975481|65624071|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
23514832|NCT00927784|65624072|FG000|Overall Study|Death|1|||
23514833|NCT00927784|65624073|FG001|Overall Study|Death|0|||
23514834|NCT00927784|65624072|FG000|Overall Study|Withdrawal by Subject|1|||
23514835|NCT00927784|65624073|FG001|Overall Study|Withdrawal by Subject|0|||
23514836|NCT01484873|65624074|FG000|Overall Study|Withdrawal by Subject|2|||
23514837|NCT03251079|65624075|FG000|Overall Study|Withdrawal by Subject|1|||
23514838|NCT04461015|65624080|FG000|Overall Study|IV access lost during the study|0|||
23514839|NCT04461015|65624081|FG001|Overall Study|IV access lost during the study|1|||
23514840|NCT04461015|65624080|FG000|Overall Study|Withdrawal by Subject|0|||
23514841|NCT04461015|65624081|FG001|Overall Study|Withdrawal by Subject|1|||
23711513|NCT01021852|66319336|FG002|Treatment Period 1|Pregnancy|1|||
23711514|NCT01021852|66319337|FG003|Treatment Period 1|Pregnancy|0|||
23711515|NCT01021852|66319338|FG004|Treatment Period 1|Pregnancy|0|||
23711516|NCT01021852|66319339|FG005|Treatment Period 1|Pregnancy|0|||
23711517|NCT01021852|66319340|FG006|Treatment Period 1|Pregnancy|0|||
23711518|NCT01021852|66319341|FG007|Treatment Period 1|Pregnancy|0|||
23711519|NCT01021852|66319334|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23514842|NCT01594125|65624082|FG000|Overall Study|Withdrawal by Subject|1|||
23514843|NCT01594125|65624083|FG001|Overall Study|Withdrawal by Subject|0|||
23514844|NCT01594125|65624084|FG002|Overall Study|Withdrawal by Subject|0|||
23514845|NCT01594125|65624085|FG003|Overall Study|Withdrawal by Subject|1|||
23514846|NCT01594125|65624086|FG004|Overall Study|Withdrawal by Subject|0|||
23514847|NCT01594125|65624082|FG000|Overall Study|Progressive Disease|3|||
23514848|NCT01594125|65624083|FG001|Overall Study|Progressive Disease|12|||
23514849|NCT01594125|65624084|FG002|Overall Study|Progressive Disease|3|||
23514850|NCT01594125|65624085|FG003|Overall Study|Progressive Disease|3|||
23514851|NCT01594125|65624086|FG004|Overall Study|Progressive Disease|7|||
23514852|NCT00323115|65624089|FG000|Vaccine Administration|Adverse Event|1|||
23611195|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
23611196|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
23611197|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
23611198|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
23611199|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
23611200|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
23611201|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
23611202|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
23611203|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
23611204|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
23611205|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
23611206|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
23611207|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
23611208|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
23611209|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
23611210|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
23611211|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
23611212|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
23611213|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23514853|NCT00323115|65624089|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
23514854|NCT02904512|65624090|FG000|Overall Study|Withdrawal by Subject|1|||
23514855|NCT02904512|65624091|FG001|Overall Study|Withdrawal by Subject|0|||
23514856|NCT02904512|65624090|FG000|Overall Study|Transferred to ICU|1|||
23514857|NCT02904512|65624091|FG001|Overall Study|Transferred to ICU|0|||
23711520|NCT01021852|66319335|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23711521|NCT01021852|66319336|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23514858|NCT02904512|65624090|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
23514859|NCT02904512|65624091|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
23514860|NCT02484729|65624092|FG000|Overall Study|Failure of IntelliCap Error|0|||
23514861|NCT02484729|65624093|FG001|Overall Study|Failure of IntelliCap Error|0|||
23514862|NCT02484729|65624094|FG002|Overall Study|Failure of IntelliCap Error|0|||
23514863|NCT02484729|65624095|FG003|Overall Study|Failure of IntelliCap Error|0|||
23711522|NCT01021852|66319337|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23416081|NCT02719691|65266136|FG006|Overall Study|Physician Decision|0|||
23416082|NCT02719691|65266130|FG000|Overall Study|Withdrawal by Subject|0|||
23416083|NCT02719691|65266131|FG001|Overall Study|Withdrawal by Subject|0|||
23416084|NCT02719691|65266132|FG002|Overall Study|Withdrawal by Subject|0|||
23416085|NCT02719691|65266133|FG003|Overall Study|Withdrawal by Subject|0|||
23416086|NCT02719691|65266134|FG004|Overall Study|Withdrawal by Subject|0|||
23416087|NCT02719691|65266135|FG005|Overall Study|Withdrawal by Subject|1|||
23416088|NCT02719691|65266136|FG006|Overall Study|Withdrawal by Subject|0|||
23416089|NCT02003638|65266137|FG000|Overall Study|Withdrawal by Subject|1|||
23416090|NCT02003638|65266138|FG001|Overall Study|Withdrawal by Subject|0|||
23416091|NCT01132651|65266144|FG000|Overall Study|Lost to Follow-up|1|||
23416092|NCT01132651|65266145|FG001|Overall Study|Lost to Follow-up|1|||
23416093|NCT03655054|65266147|FG000|Overall Study|Lost to Follow-up|1|||
23416094|NCT01923363|65266148|FG000|Overall Study|Protocol Violation|1|||
23416095|NCT02218697|65266149|FG000|Overall Study|Adverse Event|0|||
23416096|NCT02218697|65266150|FG001|Overall Study|Adverse Event|2|||
23416097|NCT02218697|65266149|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
23711523|NCT01021852|66319338|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23711524|NCT01021852|66319339|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23711525|NCT01021852|66319340|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23711526|NCT01021852|66319341|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23711527|NCT01021852|66319334|FG000|Treatment Period 1|Not Treated|0|||
23711528|NCT01021852|66319335|FG001|Treatment Period 1|Not Treated|0|||
23711529|NCT01021852|66319336|FG002|Treatment Period 1|Not Treated|0|||
23711530|NCT01021852|66319337|FG003|Treatment Period 1|Not Treated|2|||
23711531|NCT01021852|66319338|FG004|Treatment Period 1|Not Treated|0|||
23711532|NCT01021852|66319339|FG005|Treatment Period 1|Not Treated|0|||
23711533|NCT01021852|66319340|FG006|Treatment Period 1|Not Treated|0|||
23711534|NCT01021852|66319341|FG007|Treatment Period 1|Not Treated|0|||
23711535|NCT01021852|66319334|FG000|Washout Period-Placebo|Adverse Event|0|||
23711536|NCT01021852|66319335|FG001|Washout Period-Placebo|Adverse Event|0|||
23711537|NCT01021852|66319336|FG002|Washout Period-Placebo|Adverse Event|0|||
23711538|NCT01021852|66319337|FG003|Washout Period-Placebo|Adverse Event|1|||
23711539|NCT01021852|66319338|FG004|Washout Period-Placebo|Adverse Event|0|||
23711540|NCT01021852|66319339|FG005|Washout Period-Placebo|Adverse Event|1|||
23711541|NCT01021852|66319340|FG006|Washout Period-Placebo|Adverse Event|0|||
23711542|NCT01021852|66319341|FG007|Washout Period-Placebo|Adverse Event|0|||
23711543|NCT01021852|66319334|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
23711544|NCT01021852|66319335|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
23711545|NCT01021852|66319336|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
23711546|NCT01021852|66319337|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
23711547|NCT01021852|66319338|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
23711548|NCT01021852|66319339|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
23711549|NCT01021852|66319340|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
23711550|NCT01021852|66319341|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
23711551|NCT01021852|66319334|FG000|Washout Period-Placebo|Protocol Violation|0|||
23711552|NCT01021852|66319335|FG001|Washout Period-Placebo|Protocol Violation|0|||
23416098|NCT02218697|65266150|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
23416099|NCT02218697|65266149|FG000|Overall Study|Withdrawal by Subject|2|||
23416100|NCT02218697|65266150|FG001|Overall Study|Withdrawal by Subject|3|||
23416101|NCT00316706|65266151|FG000|Overall Study|Lost to Follow-up|38|||
23416102|NCT00316706|65266152|FG001|Overall Study|Lost to Follow-up|48|||
23416103|NCT00413894|65266153|FG000|Overall Study|Withdrawal by Subject|10|||
23416104|NCT00413894|65266153|FG000|Overall Study|Administrative Reasons|1|||
23416105|NCT00413894|65266153|FG000|Overall Study|Hb <10 grams/deciliter|12|||
23416106|NCT00413894|65266153|FG000|Overall Study|Adverse Event|28|||
23711553|NCT01021852|66319336|FG002|Washout Period-Placebo|Protocol Violation|0|||
23514864|NCT02484729|65624096|FG004|Overall Study|Failure of IntelliCap Error|0|||
23514865|NCT02484729|65624097|FG005|Overall Study|Failure of IntelliCap Error|0|||
23711554|NCT01021852|66319337|FG003|Washout Period-Placebo|Protocol Violation|0|||
23711555|NCT01021852|66319338|FG004|Washout Period-Placebo|Protocol Violation|0|||
23711556|NCT01021852|66319339|FG005|Washout Period-Placebo|Protocol Violation|0|||
23514866|NCT02484729|65624098|FG006|Overall Study|Failure of IntelliCap Error|0|||
23514867|NCT02484729|65624099|FG007|Overall Study|Failure of IntelliCap Error|0|||
23514868|NCT02484729|65624100|FG008|Overall Study|Failure of IntelliCap Error|0|||
23514869|NCT02484729|65624101|FG009|Overall Study|Failure of IntelliCap Error|1|||
23514870|NCT01647282|65624102|FG000|Overall Study|Physician Decision|7|||
23514871|NCT01647282|65624103|FG001|Overall Study|Physician Decision|5|||
23514872|NCT00613938|65624104|FG000|Overall Study|Withdrawal by Subject|2|||
23514873|NCT00613938|65624105|FG001|Overall Study|Withdrawal by Subject|4|||
23514874|NCT00613938|65624106|FG002|Overall Study|Withdrawal by Subject|9|||
23514875|NCT00613938|65624107|FG003|Overall Study|Withdrawal by Subject|9|||
23514876|NCT00613938|65624104|FG000|Overall Study|Adverse Event|1|||
23514877|NCT00613938|65624105|FG001|Overall Study|Adverse Event|4|||
23514878|NCT00613938|65624106|FG002|Overall Study|Adverse Event|8|||
23514879|NCT00613938|65624107|FG003|Overall Study|Adverse Event|5|||
23514880|NCT00613938|65624104|FG000|Overall Study|Lack of Efficacy|16|||
23514881|NCT00613938|65624105|FG001|Overall Study|Lack of Efficacy|18|||
23514882|NCT00613938|65624106|FG002|Overall Study|Lack of Efficacy|5|||
23514883|NCT00613938|65624107|FG003|Overall Study|Lack of Efficacy|9|||
23514884|NCT00613938|65624104|FG000|Overall Study|Other|1|||
23514885|NCT00613938|65624105|FG001|Overall Study|Other|2|||
23514886|NCT00613938|65624106|FG002|Overall Study|Other|1|||
23514887|NCT00613938|65624107|FG003|Overall Study|Other|3|||
23514888|NCT01614067|65624108|FG000|Overall Study|Pregnancy|1|||
23514889|NCT01614067|65624109|FG001|Overall Study|Pregnancy|0|||
23514890|NCT01614067|65624108|FG000|Overall Study|Physician Decision|6|||
23514891|NCT01614067|65624109|FG001|Overall Study|Physician Decision|5|||
23514892|NCT01614067|65624108|FG000|Overall Study|Withdrawal by Subject|0|||
23514893|NCT01614067|65624109|FG001|Overall Study|Withdrawal by Subject|1|||
23514894|NCT01614067|65624108|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
23514895|NCT01614067|65624109|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
23514896|NCT01013701|65624110|FG000|Overall Study|study prematurely terminated|7|||
23514897|NCT03909295|65624111|FG000|Overall Study|Adverse Event|2|||
23514898|NCT03909295|65624111|FG000|Overall Study|Study terminated by sponsor|50|||
23514899|NCT01349803|65624114|FG000|Overall Study|Adverse Event|0|||
23514900|NCT01349803|65624115|FG001|Overall Study|Adverse Event|0|||
23514901|NCT01349803|65624116|FG002|Overall Study|Adverse Event|0|||
23514902|NCT01349803|65624117|FG003|Overall Study|Adverse Event|2|||
23514903|NCT01349803|65624114|FG000|Overall Study|Withdrawal by Subject|1|||
23514904|NCT01349803|65624115|FG001|Overall Study|Withdrawal by Subject|0|||
23514905|NCT01349803|65624116|FG002|Overall Study|Withdrawal by Subject|0|||
23514906|NCT01349803|65624117|FG003|Overall Study|Withdrawal by Subject|0|||
23514907|NCT01349803|65624114|FG000|Overall Study|Protocol-specified criteria|0|||
23711557|NCT01021852|66319340|FG006|Washout Period-Placebo|Protocol Violation|1|||
23711558|NCT01021852|66319341|FG007|Washout Period-Placebo|Protocol Violation|0|||
23711559|NCT01021852|66319334|FG000|Washout Period-No Drug|Adverse Event|1|||
23711560|NCT01021852|66319335|FG001|Washout Period-No Drug|Adverse Event|0|||
23711561|NCT01021852|66319336|FG002|Washout Period-No Drug|Adverse Event|0|||
23711562|NCT01021852|66319337|FG003|Washout Period-No Drug|Adverse Event|0|||
23711563|NCT01021852|66319338|FG004|Washout Period-No Drug|Adverse Event|0|||
23711564|NCT01021852|66319339|FG005|Washout Period-No Drug|Adverse Event|1|||
23711565|NCT01021852|66319340|FG006|Washout Period-No Drug|Adverse Event|0|||
23711566|NCT01021852|66319341|FG007|Washout Period-No Drug|Adverse Event|0|||
23711567|NCT01021852|66319334|FG000|Treatment Period 2|Adverse Event|0|||
23711568|NCT01021852|66319335|FG001|Treatment Period 2|Adverse Event|1|||
23711569|NCT01021852|66319336|FG002|Treatment Period 2|Adverse Event|0|||
23711570|NCT01021852|66319337|FG003|Treatment Period 2|Adverse Event|0|||
23711571|NCT01021852|66319338|FG004|Treatment Period 2|Adverse Event|1|||
23711572|NCT01021852|66319339|FG005|Treatment Period 2|Adverse Event|0|||
23711573|NCT01021852|66319340|FG006|Treatment Period 2|Adverse Event|1|||
23711574|NCT01021852|66319341|FG007|Treatment Period 2|Adverse Event|0|||
23711575|NCT01021852|66319334|FG000|Treatment Period 2|Lack of Efficacy|0|||
23711576|NCT01021852|66319335|FG001|Treatment Period 2|Lack of Efficacy|0|||
23711577|NCT01021852|66319336|FG002|Treatment Period 2|Lack of Efficacy|0|||
23711578|NCT01021852|66319337|FG003|Treatment Period 2|Lack of Efficacy|0|||
23514908|NCT01349803|65624115|FG001|Overall Study|Protocol-specified criteria|1|||
23514909|NCT01349803|65624116|FG002|Overall Study|Protocol-specified criteria|3|||
23514910|NCT01349803|65624117|FG003|Overall Study|Protocol-specified criteria|0|||
23514911|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
23514912|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
23514913|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
23514914|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
23514915|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
23711579|NCT01021852|66319338|FG004|Treatment Period 2|Lack of Efficacy|0|||
23711580|NCT01021852|66319339|FG005|Treatment Period 2|Lack of Efficacy|1|||
23711581|NCT01021852|66319340|FG006|Treatment Period 2|Lack of Efficacy|0|||
23711582|NCT01021852|66319341|FG007|Treatment Period 2|Lack of Efficacy|0|||
23711583|NCT01021852|66319334|FG000|Treatment Period 2|Physician Decision|0|||
23711584|NCT01021852|66319335|FG001|Treatment Period 2|Physician Decision|0|||
23711585|NCT01021852|66319336|FG002|Treatment Period 2|Physician Decision|1|||
23711586|NCT01021852|66319337|FG003|Treatment Period 2|Physician Decision|0|||
23711587|NCT01021852|66319338|FG004|Treatment Period 2|Physician Decision|0|||
23711588|NCT01021852|66319339|FG005|Treatment Period 2|Physician Decision|0|||
23711589|NCT01021852|66319340|FG006|Treatment Period 2|Physician Decision|0|||
23711590|NCT01021852|66319341|FG007|Treatment Period 2|Physician Decision|0|||
23711591|NCT01021852|66319334|FG000|Treatment Period 2|Protocol Violation|0|||
23711592|NCT01021852|66319335|FG001|Treatment Period 2|Protocol Violation|0|||
23711593|NCT01021852|66319336|FG002|Treatment Period 2|Protocol Violation|0|||
23711594|NCT01021852|66319337|FG003|Treatment Period 2|Protocol Violation|0|||
23711595|NCT01021852|66319338|FG004|Treatment Period 2|Protocol Violation|1|||
23711596|NCT01021852|66319339|FG005|Treatment Period 2|Protocol Violation|0|||
23711597|NCT01021852|66319340|FG006|Treatment Period 2|Protocol Violation|1|||
23711598|NCT01021852|66319341|FG007|Treatment Period 2|Protocol Violation|0|||
23711599|NCT01021852|66319334|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23711600|NCT01021852|66319335|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23711601|NCT01021852|66319336|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23711602|NCT01021852|66319337|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23711603|NCT01021852|66319338|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23711604|NCT01021852|66319339|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23711605|NCT01021852|66319340|FG006|Treatment Period 2|Withdrawal by Subject|1|||
23711606|NCT01021852|66319341|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23711607|NCT01982773|66319344|FG000|Overall Study|Withdrawal by Subject|1|||
23711608|NCT01982773|66319345|FG001|Overall Study|Withdrawal by Subject|3|||
23711609|NCT01982773|66319344|FG000|Overall Study|Lost to Follow-up|7|||
23711610|NCT01982773|66319345|FG001|Overall Study|Lost to Follow-up|1|||
23711611|NCT04397718|66319347|FG000|Overall Study|Death|7|||
23711612|NCT04397718|66319348|FG001|Overall Study|Death|11|||
23711613|NCT04397718|66319347|FG000|Overall Study|Lost to Follow-up|0|||
23711614|NCT04397718|66319348|FG001|Overall Study|Lost to Follow-up|4|||
23711615|NCT01658579|66319349|FG000|Treatment Period A|Other|0|||
23711616|NCT01658579|66319350|FG001|Treatment Period A|Other|0|||
23711617|NCT01658579|66319351|FG002|Treatment Period A|Other|1|||
23711618|NCT01658579|66319352|FG003|Treatment Period A|Other|1|||
23711619|NCT01658579|66319349|FG000|Treatment Period A|Adverse Event|1|||
23711620|NCT01658579|66319350|FG001|Treatment Period A|Adverse Event|0|||
23711621|NCT01658579|66319351|FG002|Treatment Period A|Adverse Event|0|||
23711622|NCT01658579|66319352|FG003|Treatment Period A|Adverse Event|0|||
23711623|NCT01658579|66319349|FG000|Treatment Period B|Other|0|||
23711624|NCT01658579|66319350|FG001|Treatment Period B|Other|0|||
23711625|NCT01658579|66319351|FG002|Treatment Period B|Other|0|||
23711626|NCT01658579|66319352|FG003|Treatment Period B|Other|1|||
23711627|NCT00579501|66319353|FG000|Overall Study|Death|1|||
23711628|NCT00579501|66319353|FG000|Overall Study|End of neoadjuvant therapy|25|||
23711629|NCT00579501|66319353|FG000|Overall Study|toxicity|1|||
23711630|NCT00579501|66319353|FG000|Overall Study|Secondary lesion|1|||
23711631|NCT00579501|66319353|FG000|Overall Study|Radiation therapy before surgery|1|||
23711632|NCT02669862|66319354|FG000|Overall Study|Lost to Follow-up|0|||
23711633|NCT02669862|66319355|FG001|Overall Study|Lost to Follow-up|2|||
23711634|NCT02669862|66319356|FG002|Overall Study|Lost to Follow-up|1|||
23711635|NCT02669862|66319354|FG000|Overall Study|Withdrawal by Subject|2|||
23711636|NCT02669862|66319355|FG001|Overall Study|Withdrawal by Subject|2|||
23711637|NCT02669862|66319356|FG002|Overall Study|Withdrawal by Subject|3|||
23711638|NCT02669862|66319354|FG000|Overall Study|moved|0|||
23711639|NCT02669862|66319355|FG001|Overall Study|moved|1|||
23711640|NCT02669862|66319356|FG002|Overall Study|moved|0|||
23711641|NCT02669862|66319354|FG000|Overall Study|Protocol Violation|0|||
23711642|NCT02669862|66319355|FG001|Overall Study|Protocol Violation|0|||
23711643|NCT02669862|66319356|FG002|Overall Study|Protocol Violation|1|||
23711644|NCT02662985|66319360|FG000|Treatment Period 1|Adverse Event|0|||
23711645|NCT02662985|66319361|FG001|Treatment Period 1|Adverse Event|2|||
23711646|NCT02662985|66319360|FG000|Treatment Period 1|Protocol Violation|0|||
23711647|NCT02662985|66319361|FG001|Treatment Period 1|Protocol Violation|1|||
23711648|NCT02662985|66319360|FG000|Treatment Period 1|Physician Decision|1|||
23711649|NCT02662985|66319361|FG001|Treatment Period 1|Physician Decision|0|||
23711650|NCT02662985|66319360|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23711651|NCT02662985|66319361|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23711652|NCT02662985|66319360|FG000|Treatment Period 2|Lack of Efficacy|0|||
23711653|NCT02662985|66319361|FG001|Treatment Period 2|Lack of Efficacy|1|||
23711654|NCT02662985|66319360|FG000|Treatment Period 2|Lost to Follow-up|1|||
23711655|NCT02662985|66319361|FG001|Treatment Period 2|Lost to Follow-up|0|||
23711656|NCT02662985|66319360|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
23711657|NCT02662985|66319361|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
23711658|NCT02662985|66319360|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
23711659|NCT02662985|66319361|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
23711660|NCT02662985|66319360|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
23711661|NCT02662985|66319361|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
23514916|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
23514917|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
23514918|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
23514919|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
23514920|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
23514921|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
23514922|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
23514923|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
23514924|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
23514925|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
23514926|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Other|0|||
23514927|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Other|2|||
23514928|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Other|1|||
23514929|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
23514930|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
23514931|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
23514932|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
23514933|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
23514934|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
23514935|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
23514936|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
23514937|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
23514938|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
23514939|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
23514940|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
23514941|NCT02659631|65624121|FG000|Overall Study|Lost to Follow-up|0|||
23514942|NCT02659631|65624122|FG001|Overall Study|Lost to Follow-up|0|||
23514943|NCT02659631|65624123|FG002|Overall Study|Lost to Follow-up|2|||
23514944|NCT02659631|65624124|FG003|Overall Study|Lost to Follow-up|0|||
23514945|NCT02659631|65624125|FG004|Overall Study|Lost to Follow-up|0|||
23514946|NCT02659631|65624126|FG005|Overall Study|Lost to Follow-up|1|||
23514947|NCT02659631|65624127|FG006|Overall Study|Lost to Follow-up|0|||
23514948|NCT02659631|65624128|FG007|Overall Study|Lost to Follow-up|0|||
23514949|NCT02659631|65624129|FG008|Overall Study|Lost to Follow-up|0|||
23514950|NCT02659631|65624130|FG009|Overall Study|Lost to Follow-up|0|||
23514951|NCT02659631|65624121|FG000|Overall Study|Withdrawal prior to treatment|0|||
23514952|NCT02659631|65624122|FG001|Overall Study|Withdrawal prior to treatment|0|||
23514953|NCT02659631|65624123|FG002|Overall Study|Withdrawal prior to treatment|0|||
23514954|NCT02659631|65624124|FG003|Overall Study|Withdrawal prior to treatment|0|||
23514955|NCT02659631|65624125|FG004|Overall Study|Withdrawal prior to treatment|1|||
23514956|NCT02659631|65624126|FG005|Overall Study|Withdrawal prior to treatment|0|||
23514957|NCT02659631|65624127|FG006|Overall Study|Withdrawal prior to treatment|0|||
23514958|NCT02659631|65624128|FG007|Overall Study|Withdrawal prior to treatment|0|||
23514959|NCT02659631|65624129|FG008|Overall Study|Withdrawal prior to treatment|0|||
23514960|NCT02659631|65624130|FG009|Overall Study|Withdrawal prior to treatment|0|||
23514961|NCT02659631|65624121|FG000|Overall Study|Participant refused further follow-up|0|||
23514962|NCT02659631|65624122|FG001|Overall Study|Participant refused further follow-up|0|||
23514963|NCT02659631|65624123|FG002|Overall Study|Participant refused further follow-up|0|||
23514964|NCT02659631|65624124|FG003|Overall Study|Participant refused further follow-up|1|||
23514965|NCT02659631|65624125|FG004|Overall Study|Participant refused further follow-up|0|||
23514966|NCT02659631|65624126|FG005|Overall Study|Participant refused further follow-up|0|||
23514967|NCT02659631|65624127|FG006|Overall Study|Participant refused further follow-up|0|||
23514968|NCT02659631|65624128|FG007|Overall Study|Participant refused further follow-up|0|||
23514969|NCT02659631|65624129|FG008|Overall Study|Participant refused further follow-up|1|||
23514970|NCT02659631|65624130|FG009|Overall Study|Participant refused further follow-up|0|||
23514971|NCT02659631|65624121|FG000|Overall Study|Death (follow-up phase)|1|||
23514972|NCT02659631|65624122|FG001|Overall Study|Death (follow-up phase)|2|||
23514973|NCT02659631|65624123|FG002|Overall Study|Death (follow-up phase)|1|||
23514974|NCT02659631|65624124|FG003|Overall Study|Death (follow-up phase)|1|||
23514975|NCT02659631|65624125|FG004|Overall Study|Death (follow-up phase)|3|||
23514976|NCT02659631|65624126|FG005|Overall Study|Death (follow-up phase)|2|||
23514977|NCT02659631|65624127|FG006|Overall Study|Death (follow-up phase)|0|||
23514978|NCT02659631|65624128|FG007|Overall Study|Death (follow-up phase)|3|||
23514979|NCT02659631|65624129|FG008|Overall Study|Death (follow-up phase)|1|||
23514980|NCT02659631|65624130|FG009|Overall Study|Death (follow-up phase)|0|||
23514981|NCT02659631|65624121|FG000|Overall Study|Death (treatment phase)|0|||
23514982|NCT02659631|65624122|FG001|Overall Study|Death (treatment phase)|0|||
23514983|NCT02659631|65624123|FG002|Overall Study|Death (treatment phase)|0|||
23514984|NCT02659631|65624124|FG003|Overall Study|Death (treatment phase)|0|||
23514985|NCT02659631|65624125|FG004|Overall Study|Death (treatment phase)|1|||
23514986|NCT02659631|65624126|FG005|Overall Study|Death (treatment phase)|0|||
23514987|NCT02659631|65624127|FG006|Overall Study|Death (treatment phase)|1|||
23514988|NCT02659631|65624128|FG007|Overall Study|Death (treatment phase)|0|||
23514989|NCT02659631|65624129|FG008|Overall Study|Death (treatment phase)|0|||
23514990|NCT02659631|65624130|FG009|Overall Study|Death (treatment phase)|0|||
23514991|NCT01034462|65624131|FG000|Overall Study|Adverse Event|7|||
23514992|NCT01034462|65624132|FG001|Overall Study|Adverse Event|17|||
23514993|NCT01034462|65624131|FG000|Overall Study|Lack of Efficacy|4|||
23514994|NCT01034462|65624132|FG001|Overall Study|Lack of Efficacy|4|||
23514995|NCT01034462|65624131|FG000|Overall Study|Protocol Violation|10|||
23514996|NCT01034462|65624132|FG001|Overall Study|Protocol Violation|7|||
23514997|NCT01034462|65624131|FG000|Overall Study|Withdrawal by Subject|9|||
23514998|NCT01034462|65624132|FG001|Overall Study|Withdrawal by Subject|8|||
23514999|NCT01034462|65624131|FG000|Overall Study|Lost to Follow-up|14|||
23515000|NCT01034462|65624132|FG001|Overall Study|Lost to Follow-up|16|||
23515001|NCT01034462|65624131|FG000|Overall Study|Other reasons|1|||
23515002|NCT01034462|65624132|FG001|Overall Study|Other reasons|2|||
23515003|NCT01585428|65624135|FG000|Overall Study|Death during treatment|1|||
23515004|NCT01585428|65624136|FG001|Overall Study|Death during treatment|0|||
23515005|NCT01287897|65624139|FG000|Overall Study|Adverse Event|5|||
23515006|NCT01287897|65624140|FG001|Overall Study|Adverse Event|3|||
23515007|NCT01287897|65624141|FG002|Overall Study|Adverse Event|6|||
23515008|NCT01287897|65624142|FG003|Overall Study|Adverse Event|4|||
23515009|NCT01287897|65624139|FG000|Overall Study|Lack of Efficacy|2|||
23515010|NCT01287897|65624140|FG001|Overall Study|Lack of Efficacy|0|||
23515011|NCT01287897|65624141|FG002|Overall Study|Lack of Efficacy|0|||
23515012|NCT01287897|65624142|FG003|Overall Study|Lack of Efficacy|0|||
23515013|NCT01287897|65624139|FG000|Overall Study|Protocol Violation|1|||
23515014|NCT01287897|65624140|FG001|Overall Study|Protocol Violation|1|||
23515015|NCT01287897|65624141|FG002|Overall Study|Protocol Violation|0|||
23515016|NCT01287897|65624142|FG003|Overall Study|Protocol Violation|1|||
23515017|NCT01287897|65624139|FG000|Overall Study|Lost to Follow-up|0|||
23515018|NCT01287897|65624140|FG001|Overall Study|Lost to Follow-up|0|||
23515019|NCT01287897|65624141|FG002|Overall Study|Lost to Follow-up|2|||
23515020|NCT01287897|65624142|FG003|Overall Study|Lost to Follow-up|0|||
23515021|NCT01287897|65624139|FG000|Overall Study|Withdrawal by Subject|1|||
23515022|NCT01287897|65624140|FG001|Overall Study|Withdrawal by Subject|5|||
23515023|NCT01287897|65624141|FG002|Overall Study|Withdrawal by Subject|3|||
23515024|NCT01287897|65624142|FG003|Overall Study|Withdrawal by Subject|2|||
23515025|NCT01287897|65624139|FG000|Overall Study|Not consented properly|0|||
23515026|NCT01287897|65624140|FG001|Overall Study|Not consented properly|1|||
23515027|NCT01287897|65624141|FG002|Overall Study|Not consented properly|0|||
23515028|NCT01287897|65624142|FG003|Overall Study|Not consented properly|0|||
23515029|NCT01287897|65624139|FG000|Overall Study|Not meeting entrance criteria|1|||
23515030|NCT01287897|65624140|FG001|Overall Study|Not meeting entrance criteria|1|||
23515031|NCT01287897|65624141|FG002|Overall Study|Not meeting entrance criteria|0|||
23515032|NCT01287897|65624142|FG003|Overall Study|Not meeting entrance criteria|0|||
23515033|NCT01287897|65624139|FG000|Overall Study|Other|1|||
23515034|NCT01287897|65624140|FG001|Overall Study|Other|0|||
23515035|NCT01287897|65624141|FG002|Overall Study|Other|1|||
23515036|NCT01287897|65624142|FG003|Overall Study|Other|0|||
23515037|NCT00773292|65624145|FG000|Treatment 48 Weeks|Adverse Event|1|||
23515038|NCT00773292|65624145|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
23515039|NCT03261947|65624146|FG000|Overall Study|Death|10|||
23515040|NCT03261947|65624147|FG001|Overall Study|Death|13|||
23515041|NCT03261947|65624148|FG002|Overall Study|Death|17|||
23515042|NCT03261947|65624149|FG003|Overall Study|Death|12|||
23515043|NCT03261947|65624150|FG004|Overall Study|Death|8|||
23515044|NCT03261947|65624146|FG000|Overall Study|Lost to Follow-up|0|||
23515045|NCT03261947|65624147|FG001|Overall Study|Lost to Follow-up|0|||
23515046|NCT03261947|65624148|FG002|Overall Study|Lost to Follow-up|2|||
23515047|NCT03261947|65624149|FG003|Overall Study|Lost to Follow-up|1|||
23515048|NCT03261947|65624150|FG004|Overall Study|Lost to Follow-up|0|||
23515049|NCT03261947|65624146|FG000|Overall Study|Withdrawal by Subject|0|||
23515050|NCT03261947|65624147|FG001|Overall Study|Withdrawal by Subject|0|||
23515051|NCT03261947|65624148|FG002|Overall Study|Withdrawal by Subject|3|||
23515052|NCT03261947|65624149|FG003|Overall Study|Withdrawal by Subject|0|||
23515053|NCT03261947|65624150|FG004|Overall Study|Withdrawal by Subject|1|||
23515054|NCT03261947|65624146|FG000|Overall Study|Site Terminated by Sponsor|0|||
23515055|NCT03261947|65624147|FG001|Overall Study|Site Terminated by Sponsor|0|||
23515056|NCT03261947|65624148|FG002|Overall Study|Site Terminated by Sponsor|4|||
23515057|NCT03261947|65624149|FG003|Overall Study|Site Terminated by Sponsor|7|||
23515058|NCT03261947|65624150|FG004|Overall Study|Site Terminated by Sponsor|5|||
23515059|NCT03261947|65624146|FG000|Overall Study|Reason not Specified|2|||
23515060|NCT03261947|65624147|FG001|Overall Study|Reason not Specified|0|||
23515061|NCT03261947|65624148|FG002|Overall Study|Reason not Specified|4|||
23515062|NCT03261947|65624149|FG003|Overall Study|Reason not Specified|1|||
23515063|NCT03261947|65624150|FG004|Overall Study|Reason not Specified|3|||
23515064|NCT00849381|65624151|FG000|Overall Study|Adverse Event|1|||
23515065|NCT00849381|65624151|FG000|Overall Study|Lost to Follow-up|129|||
23515066|NCT00849381|65624151|FG000|Overall Study|Protocol Violation|5|||
23515067|NCT00849381|65624151|FG000|Overall Study|Withdrawal by Subject|6|||
23515068|NCT00849381|65624151|FG000|Overall Study|Other|4|||
23515069|NCT02564042|65624153|FG000|Overall Study|Adverse Event|4|||
23515070|NCT02564042|65624154|FG001|Overall Study|Adverse Event|4|||
23515071|NCT02564042|65624155|FG002|Overall Study|Adverse Event|3|||
23515072|NCT02564042|65624156|FG003|Overall Study|Adverse Event|0|||
23515073|NCT02564042|65624157|FG004|Overall Study|Adverse Event|0|||
23515074|NCT02564042|65624158|FG005|Overall Study|Adverse Event|1|||
23515075|NCT02564042|65624153|FG000|Overall Study|Lost to Follow-up|1|||
23515076|NCT02564042|65624154|FG001|Overall Study|Lost to Follow-up|1|||
23515077|NCT02564042|65624155|FG002|Overall Study|Lost to Follow-up|1|||
23515078|NCT02564042|65624156|FG003|Overall Study|Lost to Follow-up|0|||
23515079|NCT02564042|65624157|FG004|Overall Study|Lost to Follow-up|1|||
23515080|NCT02564042|65624158|FG005|Overall Study|Lost to Follow-up|1|||
23515081|NCT02564042|65624153|FG000|Overall Study|Physician Decision|1|||
23515082|NCT02564042|65624154|FG001|Overall Study|Physician Decision|0|||
23515083|NCT02564042|65624155|FG002|Overall Study|Physician Decision|0|||
23515084|NCT02564042|65624156|FG003|Overall Study|Physician Decision|1|||
23515085|NCT02564042|65624157|FG004|Overall Study|Physician Decision|0|||
23515086|NCT02564042|65624158|FG005|Overall Study|Physician Decision|0|||
23515087|NCT02564042|65624153|FG000|Overall Study|Withdrawal by Subject|5|||
23515088|NCT02564042|65624154|FG001|Overall Study|Withdrawal by Subject|3|||
23515089|NCT02564042|65624155|FG002|Overall Study|Withdrawal by Subject|2|||
23515090|NCT02564042|65624156|FG003|Overall Study|Withdrawal by Subject|2|||
23515091|NCT02564042|65624157|FG004|Overall Study|Withdrawal by Subject|10|||
23515092|NCT02564042|65624158|FG005|Overall Study|Withdrawal by Subject|12|||
23515093|NCT00708643|65624161|FG000|Overall Study|Adverse Event|0|||
23515094|NCT00708643|65624162|FG001|Overall Study|Adverse Event|1|||
23515095|NCT01741701|65624163|FG000|Overall Study|Adverse Event|5|||
23515096|NCT01741701|65624164|FG001|Overall Study|Adverse Event|1|||
23515097|NCT01741701|65624163|FG000|Overall Study|Withdrawal by Subject|0|||
23515098|NCT01741701|65624164|FG001|Overall Study|Withdrawal by Subject|1|||
23515099|NCT01998633|65624167|FG000|Overall Study|Death|1|||
23515100|NCT00529542|65624168|FG000|Overall Study|Withdrawal by Subject|1|||
23515101|NCT00529542|65624169|FG001|Overall Study|Withdrawal by Subject|0|||
23515102|NCT00529542|65624168|FG000|Overall Study|Lost to Follow-up|0|||
23515103|NCT00529542|65624169|FG001|Overall Study|Lost to Follow-up|1|||
23515104|NCT00356369|65624170|FG000|Active Phase|Withdrawal by Subject|2|||
23515105|NCT00356369|65624171|FG001|Active Phase|Withdrawal by Subject|1|||
23515106|NCT03277105|65624172|FG000|Overall Study|Death|129|||
23515107|NCT03277105|65624173|FG001|Overall Study|Death|124|||
23515108|NCT03277105|65624172|FG000|Overall Study|Lost to Follow-up|2|||
23515109|NCT03277105|65624173|FG001|Overall Study|Lost to Follow-up|4|||
23515110|NCT03277105|65624172|FG000|Overall Study|Withdrawal by Subject|10|||
23515111|NCT03277105|65624173|FG001|Overall Study|Withdrawal by Subject|10|||
23515112|NCT03277105|65624172|FG000|Overall Study|Other|118|||
23515113|NCT03277105|65624173|FG001|Overall Study|Other|125|||
23515114|NCT01500629|65624174|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
23515115|NCT01500629|65624175|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
23515116|NCT03108027|65624176|FG000|Period 1|Subject/Guardian Decision|0|||
23515117|NCT03108027|65624177|FG001|Period 1|Subject/Guardian Decision|0|||
23515118|NCT03108027|65624178|FG002|Period 1|Subject/Guardian Decision|0|||
23515119|NCT03108027|65624179|FG003|Period 1|Subject/Guardian Decision|2|||
23515120|NCT03108027|65624180|FG004|Period 1|Subject/Guardian Decision|0|||
23515121|NCT03108027|65624181|FG005|Period 1|Subject/Guardian Decision|0|||
23515122|NCT03108027|65624176|FG000|Period 3|Adverse Event|0|||
23515123|NCT03108027|65624177|FG001|Period 3|Adverse Event|1|||
23515124|NCT03108027|65624178|FG002|Period 3|Adverse Event|0|||
23515125|NCT03108027|65624179|FG003|Period 3|Adverse Event|0|||
23515126|NCT03108027|65624180|FG004|Period 3|Adverse Event|0|||
23515127|NCT03108027|65624181|FG005|Period 3|Adverse Event|0|||
23515128|NCT00202644|65624182|FG000|Overall Study|Adverse Event|12|||
23515129|NCT00202644|65624183|FG001|Overall Study|Adverse Event|13|||
23515130|NCT00202644|65624182|FG000|Overall Study|Withdrawal by Subject|8|||
23515131|NCT00202644|65624183|FG001|Overall Study|Withdrawal by Subject|6|||
23515132|NCT00202644|65624182|FG000|Overall Study|Lack of Efficacy|6|||
23515133|NCT00202644|65624183|FG001|Overall Study|Lack of Efficacy|6|||
23515134|NCT00202644|65624182|FG000|Overall Study|Lost to Follow-up|0|||
23515135|NCT00202644|65624183|FG001|Overall Study|Lost to Follow-up|1|||
23515136|NCT00202644|65624182|FG000|Overall Study|Other|9|||
23515137|NCT00202644|65624183|FG001|Overall Study|Other|1|||
23711662|NCT02662985|66319360|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
23515138|NCT01752907|65624192|FG000|Overall Study|Withdrawal by Subject|4|||
23515139|NCT01752907|65624193|FG001|Overall Study|Withdrawal by Subject|10|||
23515140|NCT01752907|65624192|FG000|Overall Study|Lost to Follow-up|2|||
23711663|NCT02662985|66319361|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
23711664|NCT02662985|66319360|FG000|Treatment Period 3 (Extension Period)|Death|0|||
23711665|NCT02662985|66319361|FG001|Treatment Period 3 (Extension Period)|Death|1|||
23711666|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
23711667|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
23711668|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
23711669|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
23711670|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
23711671|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
23711672|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
23711673|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23711674|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
23711675|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
23711676|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
23711677|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
23711678|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
23711679|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
23711680|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
23711681|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
23711682|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Missing|3|||
23711683|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Missing|1|||
23711684|NCT00838916|66319363|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
23711685|NCT00838916|66319364|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23711686|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
23711687|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
23711688|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
23711689|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
23711690|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
23711691|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
23711692|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
23711693|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
23711694|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
23711695|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
23711696|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
23711697|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
23711698|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
23711699|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
23711700|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
23711701|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
23711702|NCT00838916|66319363|FG000|Follow-up Period (8 Weeks)|Missing|3|||
23711703|NCT00838916|66319364|FG001|Follow-up Period (8 Weeks)|Missing|0|||
23711704|NCT02559713|66319369|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
23711705|NCT00575094|66319370|FG000|Overall Study|Adverse Event|2|||
23711706|NCT00575094|66319370|FG000|Overall Study|Withdrawal by Subject|1|||
23711707|NCT00748553|66319373|FG000|Overall Study|Adverse Event|0|||
23711708|NCT00748553|66319374|FG001|Overall Study|Adverse Event|1|||
23711709|NCT00748553|66319373|FG000|Overall Study|disease progression|2|||
23711710|NCT00748553|66319374|FG001|Overall Study|disease progression|0|||
23711711|NCT00748553|66319373|FG000|Overall Study|noncompliance|1|||
23711712|NCT00748553|66319374|FG001|Overall Study|noncompliance|0|||
23711713|NCT00446446|66319375|FG000|Overall Study|Death|10|||
23711714|NCT00446446|66319375|FG000|Overall Study|Withdrawal by Subject|6|||
23711715|NCT00446446|66319375|FG000|Overall Study|Other|4|||
23711716|NCT00446446|66319375|FG000|Overall Study|Disease Progession|2|||
23711717|NCT00446446|66319375|FG000|Overall Study|Adverse Event|1|||
23711718|NCT00446446|66319375|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
23711719|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
23711720|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
23711721|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
23711722|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
23711723|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
23711724|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
23711725|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23711726|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23711727|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
23711728|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
23711729|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23711730|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23711731|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23711732|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23711733|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
23711734|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
23711735|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
23711736|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
23711737|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
23711738|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
23711739|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
23711740|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23515141|NCT01752907|65624193|FG001|Overall Study|Lost to Follow-up|1|||
23515142|NCT01752907|65624192|FG000|Overall Study|Decision by Sponsor|6|||
23515143|NCT01752907|65624193|FG001|Overall Study|Decision by Sponsor|9|||
23515144|NCT04741074|65624196|FG000|Overall Study|Withdrawal by Subject|1|||
23515145|NCT04741074|65624197|FG001|Overall Study|Withdrawal by Subject|1|||
23515146|NCT04741074|65624196|FG000|Overall Study|Study terminated prematurely|1|||
23515147|NCT04741074|65624197|FG001|Overall Study|Study terminated prematurely|0|||
23515148|NCT04446377|65624198|FG000|Overall Study|Withdrawal by Subject|6|||
23515149|NCT04446377|65624199|FG001|Overall Study|Withdrawal by Subject|1|||
23515150|NCT04446377|65624198|FG000|Overall Study|Physician Decision|1|||
23515151|NCT04446377|65624199|FG001|Overall Study|Physician Decision|1|||
23515152|NCT04446377|65624198|FG000|Overall Study|Lost to Follow-up|0|||
23515153|NCT04446377|65624199|FG001|Overall Study|Lost to Follow-up|2|||
23515154|NCT04446377|65624198|FG000|Overall Study|Not eligible|0|||
23515155|NCT04446377|65624199|FG001|Overall Study|Not eligible|1|||
23515156|NCT01686633|65624201|FG000|Overall Study|Lack of Efficacy|33|||
23515157|NCT01686633|65624202|FG001|Overall Study|Lack of Efficacy|13|||
23515158|NCT01686633|65624203|FG002|Overall Study|Lack of Efficacy|11|||
23515159|NCT01686633|65624201|FG000|Overall Study|Withdrawal by Subject|8|||
23515160|NCT01686633|65624202|FG001|Overall Study|Withdrawal by Subject|8|||
23515161|NCT01686633|65624203|FG002|Overall Study|Withdrawal by Subject|5|||
23515162|NCT01686633|65624201|FG000|Overall Study|Physician Decision|3|||
23515163|NCT01686633|65624202|FG001|Overall Study|Physician Decision|4|||
23515164|NCT01686633|65624203|FG002|Overall Study|Physician Decision|4|||
23515165|NCT01686633|65624201|FG000|Overall Study|Adverse Event|4|||
23515166|NCT01686633|65624202|FG001|Overall Study|Adverse Event|3|||
23515167|NCT01686633|65624203|FG002|Overall Study|Adverse Event|3|||
23515168|NCT01686633|65624201|FG000|Overall Study|Protocol Violation|2|||
23515169|NCT01686633|65624202|FG001|Overall Study|Protocol Violation|3|||
23711741|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
23711742|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
23711743|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
23711744|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
23711745|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23711746|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
23711747|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
23711748|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
23711749|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23711750|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
23711751|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
23711752|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
23711753|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
23711754|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
23711755|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
23711756|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
23711757|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
23711758|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
23711759|NCT00383721|66319376|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
23711760|NCT00383721|66319377|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
23711761|NCT00383721|66319378|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
23711762|NCT00383721|66319379|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
23711763|NCT00383721|66319380|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
23711764|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
23515170|NCT01686633|65624203|FG002|Overall Study|Protocol Violation|0|||
23515171|NCT01686633|65624201|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
23515172|NCT01686633|65624202|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23515173|NCT01686633|65624203|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
23515174|NCT01686633|65624201|FG000|Overall Study|Lost to Follow-up|0|||
23515175|NCT01686633|65624202|FG001|Overall Study|Lost to Follow-up|1|||
23515176|NCT01686633|65624203|FG002|Overall Study|Lost to Follow-up|1|||
23711765|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
23711766|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
23711767|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
23711768|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
23711769|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23711770|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
23711771|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
23711772|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23711773|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23711774|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
23711775|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23515177|NCT02877082|65624204|FG000|Overall Study|Trial was closed early|5|||
23515178|NCT01026792|65624205|FG000|Overall Study|Protocol Violation|1|||
23515179|NCT01529346|65624206|FG000|Overall Study|Lost to Follow-up|2|||
23515180|NCT01529346|65624207|FG001|Overall Study|Lost to Follow-up|0|||
23515181|NCT01529346|65624208|FG002|Overall Study|Lost to Follow-up|1|||
23515182|NCT01529346|65624209|FG003|Overall Study|Lost to Follow-up|0|||
23515183|NCT01529346|65624210|FG004|Overall Study|Lost to Follow-up|0|||
23515184|NCT01529346|65624206|FG000|Overall Study|Other|0|||
23515185|NCT01529346|65624207|FG001|Overall Study|Other|1|||
23515186|NCT01529346|65624208|FG002|Overall Study|Other|1|||
23711776|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23711777|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23711778|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23711779|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23711780|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
23711781|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23711782|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
23711783|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
23711784|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23711785|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23711786|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23711787|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23711788|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23711789|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
23711790|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23711791|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23711792|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
23711793|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
23711794|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23711795|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23711796|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23711797|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23711798|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23711799|NCT00383721|66319376|FG000|26-Week Treatment Safety Extension|Administrative|1|||
23711800|NCT00383721|66319377|FG001|26-Week Treatment Safety Extension|Administrative|2|||
23711801|NCT00383721|66319378|FG002|26-Week Treatment Safety Extension|Administrative|3|||
23711802|NCT00383721|66319379|FG003|26-Week Treatment Safety Extension|Administrative|1|||
23711803|NCT00383721|66319380|FG004|26-Week Treatment Safety Extension|Administrative|0|||
23711804|NCT01324622|66319381|FG000|Overall Study|Lost to Follow-up|7|||
23711805|NCT01324622|66319382|FG001|Overall Study|Lost to Follow-up|7|||
23515187|NCT01529346|65624209|FG003|Overall Study|Other|0|||
23515188|NCT01529346|65624210|FG004|Overall Study|Other|0|||
23515189|NCT00723892|65624211|FG000|Overall Study|Participant not tracked|33|||
23515190|NCT00723892|65624212|FG001|Overall Study|Participant not tracked|35|||
23515191|NCT00723892|65624211|FG000|Overall Study|Virological criterion|24|||
23515192|NCT00723892|65624212|FG001|Overall Study|Virological criterion|9|||
23515193|NCT00723892|65624211|FG000|Overall Study|Withdrawal by Subject|6|||
23515194|NCT00723892|65624212|FG001|Overall Study|Withdrawal by Subject|9|||
23515195|NCT00723892|65624211|FG000|Overall Study|End planned|11|||
23515196|NCT00723892|65624212|FG001|Overall Study|End planned|7|||
23515197|NCT00723892|65624211|FG000|Overall Study|Bad tolerance|5|||
23515198|NCT00723892|65624212|FG001|Overall Study|Bad tolerance|5|||
23515199|NCT00723892|65624211|FG000|Overall Study|Multiple reasons|17|||
23515200|NCT00723892|65624212|FG001|Overall Study|Multiple reasons|12|||
23515201|NCT00723892|65624211|FG000|Overall Study|Other|6|||
23711806|NCT01324622|66319381|FG000|Overall Study|Death|1|||
23711807|NCT01324622|66319382|FG001|Overall Study|Death|0|||
23515202|NCT00723892|65624212|FG001|Overall Study|Other|3|||
23515203|NCT00723892|65624211|FG000|Overall Study|Study end|1|||
23515204|NCT00723892|65624212|FG001|Overall Study|Study end|3|||
23515205|NCT00723892|65624211|FG000|Overall Study|Weight loss|1|||
23515206|NCT00723892|65624212|FG001|Overall Study|Weight loss|3|||
23515207|NCT00723892|65624211|FG000|Overall Study|Alcohol abuse|0|||
23515208|NCT00723892|65624212|FG001|Overall Study|Alcohol abuse|1|||
23515209|NCT00723892|65624211|FG000|Overall Study|Intercurrent infection|2|||
23515210|NCT00723892|65624212|FG001|Overall Study|Intercurrent infection|0|||
23515211|NCT00723892|65624211|FG000|Overall Study|Drug addiction|1|||
23515212|NCT00723892|65624212|FG001|Overall Study|Drug addiction|0|||
23515213|NCT01472081|65624214|FG000|Overall Study|Continuing treatment at time of analysis|1|||
23515214|NCT01472081|65624215|FG001|Overall Study|Continuing treatment at time of analysis|4|||
23515215|NCT01472081|65624216|FG002|Overall Study|Continuing treatment at time of analysis|1|||
23515216|NCT01472081|65624217|FG003|Overall Study|Continuing treatment at time of analysis|8|||
23515217|NCT01472081|65624218|FG004|Overall Study|Continuing treatment at time of analysis|9|||
23515218|NCT01472081|65624219|FG005|Overall Study|Continuing treatment at time of analysis|0|||
23515219|NCT01472081|65624214|FG000|Overall Study|Disease Progression|4|||
23515220|NCT01472081|65624215|FG001|Overall Study|Disease Progression|10|||
23515221|NCT01472081|65624216|FG002|Overall Study|Disease Progression|12|||
23515222|NCT01472081|65624217|FG003|Overall Study|Disease Progression|31|||
23515223|NCT01472081|65624218|FG004|Overall Study|Disease Progression|22|||
23515224|NCT01472081|65624219|FG005|Overall Study|Disease Progression|3|||
23515225|NCT01472081|65624214|FG000|Overall Study|Study drug toxicity|2|||
23515226|NCT01472081|65624215|FG001|Overall Study|Study drug toxicity|9|||
23515227|NCT01472081|65624216|FG002|Overall Study|Study drug toxicity|4|||
23515228|NCT01472081|65624217|FG003|Overall Study|Study drug toxicity|6|||
23515229|NCT01472081|65624218|FG004|Overall Study|Study drug toxicity|13|||
23515230|NCT01472081|65624219|FG005|Overall Study|Study drug toxicity|2|||
23515231|NCT01472081|65624214|FG000|Overall Study|Death|0|||
23515232|NCT01472081|65624215|FG001|Overall Study|Death|0|||
23515233|NCT01472081|65624216|FG002|Overall Study|Death|0|||
23515234|NCT01472081|65624217|FG003|Overall Study|Death|0|||
23515235|NCT01472081|65624218|FG004|Overall Study|Death|1|||
23515236|NCT01472081|65624219|FG005|Overall Study|Death|0|||
23515237|NCT01472081|65624214|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23515238|NCT01472081|65624215|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23515239|NCT01472081|65624216|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23515240|NCT01472081|65624217|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
23515241|NCT01472081|65624218|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
23515242|NCT01472081|65624219|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
23515243|NCT01472081|65624214|FG000|Overall Study|Withdrawal by Subject|0|||
23515244|NCT01472081|65624215|FG001|Overall Study|Withdrawal by Subject|0|||
23515245|NCT01472081|65624216|FG002|Overall Study|Withdrawal by Subject|0|||
23515246|NCT01472081|65624217|FG003|Overall Study|Withdrawal by Subject|0|||
23515247|NCT01472081|65624218|FG004|Overall Study|Withdrawal by Subject|0|||
23515248|NCT01472081|65624219|FG005|Overall Study|Withdrawal by Subject|1|||
23515249|NCT01472081|65624214|FG000|Overall Study|Poor/non-compliance|0|||
23515250|NCT01472081|65624215|FG001|Overall Study|Poor/non-compliance|0|||
23515251|NCT01472081|65624216|FG002|Overall Study|Poor/non-compliance|1|||
23515252|NCT01472081|65624217|FG003|Overall Study|Poor/non-compliance|0|||
23515253|NCT01472081|65624218|FG004|Overall Study|Poor/non-compliance|1|||
23515254|NCT01472081|65624219|FG005|Overall Study|Poor/non-compliance|0|||
23515255|NCT01472081|65624214|FG000|Overall Study|No longer meets study criteria|0|||
23515256|NCT01472081|65624215|FG001|Overall Study|No longer meets study criteria|0|||
23515257|NCT01472081|65624216|FG002|Overall Study|No longer meets study criteria|1|||
23515258|NCT01472081|65624217|FG003|Overall Study|No longer meets study criteria|0|||
23515259|NCT01472081|65624218|FG004|Overall Study|No longer meets study criteria|0|||
23515260|NCT01472081|65624219|FG005|Overall Study|No longer meets study criteria|0|||
23515261|NCT01472081|65624214|FG000|Overall Study|Subject request to discontinue treatment|0|||
23515262|NCT01472081|65624215|FG001|Overall Study|Subject request to discontinue treatment|3|||
23515263|NCT01472081|65624216|FG002|Overall Study|Subject request to discontinue treatment|1|||
23515264|NCT01472081|65624217|FG003|Overall Study|Subject request to discontinue treatment|1|||
23515265|NCT01472081|65624218|FG004|Overall Study|Subject request to discontinue treatment|0|||
23515266|NCT01472081|65624219|FG005|Overall Study|Subject request to discontinue treatment|0|||
23515267|NCT03447990|65624228|FG000|Overall Study|Withdrawal by Subject|0|||
23515268|NCT03447990|65624229|FG001|Overall Study|Withdrawal by Subject|0|||
23515269|NCT03447990|65624230|FG002|Overall Study|Withdrawal by Subject|0|||
23515270|NCT03447990|65624231|FG003|Overall Study|Withdrawal by Subject|0|||
23515271|NCT03447990|65624232|FG004|Overall Study|Withdrawal by Subject|0|||
23515272|NCT03447990|65624233|FG005|Overall Study|Withdrawal by Subject|0|||
23515273|NCT03447990|65624234|FG006|Overall Study|Withdrawal by Subject|1|||
23515274|NCT00744627|65624235|FG000|Overall Study|Adverse Event|6|||
23515275|NCT00744627|65624236|FG001|Overall Study|Adverse Event|9|||
23515276|NCT00744627|65624235|FG000|Overall Study|Lack of Efficacy|7|||
23515277|NCT00744627|65624236|FG001|Overall Study|Lack of Efficacy|3|||
23515278|NCT00744627|65624235|FG000|Overall Study|Noncompliance|0|||
23515279|NCT00744627|65624236|FG001|Overall Study|Noncompliance|1|||
23515280|NCT00744627|65624235|FG000|Overall Study|Protocol Deviations|0|||
23515281|NCT00744627|65624236|FG001|Overall Study|Protocol Deviations|2|||
23515282|NCT00744627|65624235|FG000|Overall Study|Voluntary Withdrawal|9|||
23515283|NCT00744627|65624236|FG001|Overall Study|Voluntary Withdrawal|6|||
23515284|NCT00744627|65624235|FG000|Overall Study|Lost to Follow-up|2|||
23515285|NCT00744627|65624236|FG001|Overall Study|Lost to Follow-up|1|||
23515286|NCT00744627|65624235|FG000|Overall Study|Other|1|||
23515287|NCT00744627|65624236|FG001|Overall Study|Other|0|||
23515288|NCT04483011|65624239|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23515289|NCT04483011|65624240|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23515290|NCT01103284|65624244|FG000|Overall Study|Death|2|||
23515291|NCT01103284|65624245|FG001|Overall Study|Death|0|||
23515292|NCT01103284|65624244|FG000|Overall Study|Lost to Follow-up|9|||
23515293|NCT01103284|65624245|FG001|Overall Study|Lost to Follow-up|10|||
23515294|NCT01103284|65624244|FG000|Overall Study|Pregnancy|3|||
23515295|NCT01103284|65624245|FG001|Overall Study|Pregnancy|1|||
23515296|NCT01103284|65624244|FG000|Overall Study|Protocol Violation|12|||
23515297|NCT01103284|65624245|FG001|Overall Study|Protocol Violation|5|||
23515298|NCT01103284|65624244|FG000|Overall Study|Adverse Event|0|||
23515299|NCT01103284|65624245|FG001|Overall Study|Adverse Event|5|||
23515300|NCT01103284|65624244|FG000|Overall Study|Withdrawal by Subject|14|||
23515301|NCT01103284|65624245|FG001|Overall Study|Withdrawal by Subject|18|||
23515302|NCT01103284|65624244|FG000|Overall Study|Dermal Hypersensitivity|0|||
23515303|NCT01103284|65624245|FG001|Overall Study|Dermal Hypersensitivity|1|||
23515304|NCT01103284|65624244|FG000|Overall Study|Termination by the Sponsor|0|||
23515305|NCT01103284|65624245|FG001|Overall Study|Termination by the Sponsor|1|||
23515306|NCT01103284|65624244|FG000|Overall Study|Not described|2|||
23515307|NCT01103284|65624245|FG001|Overall Study|Not described|1|||
23515308|NCT01103284|65624244|FG000|Overall Study|Missing CRF entries for study completion|0|||
23515309|NCT01103284|65624245|FG001|Overall Study|Missing CRF entries for study completion|2|||
23515310|NCT02588833|65624246|FG000|Part 1|Withdrawal by Subject|1|||
23515311|NCT02588833|65624247|FG001|Part 1|Withdrawal by Subject|0|||
23515312|NCT02588833|65624246|FG000|Part 2A|Physician Decision|0|||
23515313|NCT02588833|65624247|FG001|Part 2A|Physician Decision|1|||
23515314|NCT02588833|65624246|FG000|Part 2A|Withdrawal by Subject|0|||
23515315|NCT02588833|65624247|FG001|Part 2A|Withdrawal by Subject|1|||
23515316|NCT02588833|65624246|FG000|Part 2B|Adverse Event|0|||
23515317|NCT02588833|65624247|FG001|Part 2B|Adverse Event|1|||
23515318|NCT02588833|65624246|FG000|Part 2C|Adverse Event|0|||
23515319|NCT02588833|65624247|FG001|Part 2C|Adverse Event|1|||
23515320|NCT02588833|65624246|FG000|Part 2C|Withdrawal by Subject|0|||
23515321|NCT02588833|65624247|FG001|Part 2C|Withdrawal by Subject|1|||
23515322|NCT02588833|65624246|FG000|Part 3 (Safety Follow-up)|Other|0|||
23515323|NCT02588833|65624247|FG001|Part 3 (Safety Follow-up)|Other|2|||
23515324|NCT03338855|65624248|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
23515325|NCT03338855|65624249|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
23611214|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611215|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611216|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611217|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23711808|NCT01324622|66319381|FG000|Overall Study|Lack of Efficacy|1|||
23711809|NCT01324622|66319382|FG001|Overall Study|Lack of Efficacy|0|||
23711810|NCT01980706|66319383|FG000|Overall Study|Withdrawal by Subject|9|||
23711811|NCT01980706|66319384|FG001|Overall Study|Withdrawal by Subject|6|||
23711812|NCT01980706|66319385|FG002|Overall Study|Withdrawal by Subject|2|||
23711813|NCT01980706|66319383|FG000|Overall Study|Adverse Event|1|||
23711814|NCT01980706|66319384|FG001|Overall Study|Adverse Event|2|||
23711815|NCT01980706|66319385|FG002|Overall Study|Adverse Event|5|||
23711816|NCT01980706|66319383|FG000|Overall Study|Lost to Follow-up|3|||
23711817|NCT01980706|66319384|FG001|Overall Study|Lost to Follow-up|4|||
23711818|NCT01980706|66319385|FG002|Overall Study|Lost to Follow-up|3|||
23611218|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611219|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611220|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23711819|NCT01980706|66319383|FG000|Overall Study|miscellaneous|4|||
23711820|NCT01980706|66319384|FG001|Overall Study|miscellaneous|5|||
23711821|NCT01980706|66319385|FG002|Overall Study|miscellaneous|3|||
23711822|NCT02431468|66319386|FG000|Overall Study|Adverse Event|2|||
23515334|NCT02335489|65624285|FG000|Overall Study|Sponsor terminated study|4|||
23515335|NCT02335489|65624285|FG000|Overall Study|Lost to Follow-up|1|||
23515336|NCT02335489|65624285|FG000|Overall Study|Withdrawal by Subject|2|||
23515337|NCT02335489|65624285|FG000|Overall Study|Physician Decision|2|||
23515338|NCT02335489|65624285|FG000|Overall Study|Lack of Efficacy|1|||
23515339|NCT02611778|65624286|FG000|Overall Study|Withdrawal by Subject|2|||
23515340|NCT02611778|65624287|FG001|Overall Study|Withdrawal by Subject|8|||
23515341|NCT02611778|65624286|FG000|Overall Study|Adverse Event|1|||
23515342|NCT02611778|65624287|FG001|Overall Study|Adverse Event|2|||
23711823|NCT02431468|66319387|FG001|Overall Study|Adverse Event|4|||
23515343|NCT02611778|65624286|FG000|Overall Study|Death|2|||
23515344|NCT02611778|65624287|FG001|Overall Study|Death|1|||
23515345|NCT02611778|65624286|FG000|Overall Study|Protocol Violation|1|||
23515346|NCT02611778|65624287|FG001|Overall Study|Protocol Violation|0|||
23515347|NCT02611778|65624286|FG000|Overall Study|Lost to Follow-up|3|||
23515348|NCT02611778|65624287|FG001|Overall Study|Lost to Follow-up|1|||
23515349|NCT02611778|65624286|FG000|Overall Study|Need for alternative treatment|1|||
23515350|NCT02611778|65624287|FG001|Overall Study|Need for alternative treatment|0|||
23515351|NCT02611778|65624286|FG000|Overall Study|Other Reason|2|||
23515352|NCT02611778|65624287|FG001|Overall Study|Other Reason|1|||
23515353|NCT00549302|65624288|FG000|Double-Blind|Death|2|||
23515354|NCT00549302|65624289|FG001|Double-Blind|Death|9|||
23515355|NCT00549302|65624290|FG002|Double-Blind|Death|0|||
23515356|NCT00549302|65624288|FG000|Double-Blind|Adverse Event|3|||
23515357|NCT00549302|65624289|FG001|Double-Blind|Adverse Event|16|||
23515358|NCT00549302|65624290|FG002|Double-Blind|Adverse Event|0|||
23515359|NCT00549302|65624288|FG000|Double-Blind|Withdrawal by Subject|3|||
23515360|NCT00549302|65624289|FG001|Double-Blind|Withdrawal by Subject|8|||
23515361|NCT00549302|65624290|FG002|Double-Blind|Withdrawal by Subject|0|||
23515362|NCT00549302|65624288|FG000|Double-Blind|Investigator Decision|1|||
23515363|NCT00549302|65624289|FG001|Double-Blind|Investigator Decision|5|||
23515364|NCT00549302|65624290|FG002|Double-Blind|Investigator Decision|0|||
23515365|NCT00549302|65624288|FG000|Double-Blind|Sponsor Decision|0|||
23515366|NCT00549302|65624289|FG001|Double-Blind|Sponsor Decision|1|||
23515367|NCT00549302|65624290|FG002|Double-Blind|Sponsor Decision|0|||
23515368|NCT00549302|65624288|FG000|Double-Blind|Lost to Follow-up|1|||
23515369|NCT00549302|65624289|FG001|Double-Blind|Lost to Follow-up|2|||
23515370|NCT00549302|65624290|FG002|Double-Blind|Lost to Follow-up|0|||
23515371|NCT00549302|65624288|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
23515372|NCT00549302|65624289|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
23515373|NCT00549302|65624290|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
23515374|NCT00549302|65624288|FG000|Double-Blind|New condition or starts new therapy|0|||
23515375|NCT00549302|65624289|FG001|Double-Blind|New condition or starts new therapy|2|||
23515376|NCT00549302|65624290|FG002|Double-Blind|New condition or starts new therapy|0|||
23515377|NCT00549302|65624288|FG000|Open-Label|Adverse Event|0|||
23515378|NCT00549302|65624289|FG001|Open-Label|Adverse Event|0|||
23515379|NCT00549302|65624290|FG002|Open-Label|Adverse Event|11|||
23515380|NCT00549302|65624288|FG000|Open-Label|Death|0|||
23515381|NCT00549302|65624289|FG001|Open-Label|Death|0|||
23515382|NCT00549302|65624290|FG002|Open-Label|Death|40|||
23515383|NCT00549302|65624288|FG000|Open-Label|Investigator Decision|0|||
23515384|NCT00549302|65624289|FG001|Open-Label|Investigator Decision|0|||
23515385|NCT00549302|65624290|FG002|Open-Label|Investigator Decision|5|||
23515386|NCT00549302|65624288|FG000|Open-Label|Lost to Follow-up|0|||
23515387|NCT00549302|65624289|FG001|Open-Label|Lost to Follow-up|0|||
23515388|NCT00549302|65624290|FG002|Open-Label|Lost to Follow-up|2|||
23515389|NCT00549302|65624288|FG000|Open-Label|Other|0|||
23515390|NCT00549302|65624289|FG001|Open-Label|Other|0|||
23515391|NCT00549302|65624290|FG002|Open-Label|Other|3|||
23515392|NCT00549302|65624288|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
23515393|NCT00549302|65624289|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
23515394|NCT00549302|65624290|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
23515395|NCT00549302|65624288|FG000|Open-Label|Withdrawal by Subject|0|||
23515396|NCT00549302|65624289|FG001|Open-Label|Withdrawal by Subject|0|||
23515397|NCT00549302|65624290|FG002|Open-Label|Withdrawal by Subject|6|||
23515398|NCT00157950|65624293|FG000|Overall Study|Death|1|||
23515399|NCT00157950|65624294|FG001|Overall Study|Death|0|||
23515400|NCT02169739|65624302|FG000|Overall Study|Lost to Follow-up|0|||
23515401|NCT02169739|65624303|FG001|Overall Study|Lost to Follow-up|4|||
23515402|NCT00492115|65624304|FG000|Overall Study|Withdrawal by Subject|3|||
23515403|NCT00492115|65624305|FG001|Overall Study|Withdrawal by Subject|4|||
23515404|NCT00616655|65624306|FG000|Overall Study|Adverse Event|10|||
23515405|NCT00616655|65624307|FG001|Overall Study|Adverse Event|7|||
23515406|NCT00616655|65624308|FG002|Overall Study|Adverse Event|12|||
23515407|NCT00616655|65624306|FG000|Overall Study|Lack of Efficacy|5|||
23515408|NCT00616655|65624307|FG001|Overall Study|Lack of Efficacy|5|||
23515409|NCT00616655|65624308|FG002|Overall Study|Lack of Efficacy|5|||
23515410|NCT00616655|65624306|FG000|Overall Study|Lost to Follow-up|3|||
23515411|NCT00616655|65624307|FG001|Overall Study|Lost to Follow-up|12|||
23515412|NCT00616655|65624308|FG002|Overall Study|Lost to Follow-up|10|||
23515413|NCT00616655|65624306|FG000|Overall Study|Protocol Violation|2|||
23515414|NCT00616655|65624307|FG001|Overall Study|Protocol Violation|4|||
23515415|NCT00616655|65624308|FG002|Overall Study|Protocol Violation|3|||
23515416|NCT00616655|65624306|FG000|Overall Study|Withdrawal by Subject|9|||
23515417|NCT00616655|65624307|FG001|Overall Study|Withdrawal by Subject|7|||
23515418|NCT00616655|65624308|FG002|Overall Study|Withdrawal by Subject|11|||
23515419|NCT00616655|65624306|FG000|Overall Study|Does not meet in/ex criteria|0|||
23515420|NCT00616655|65624307|FG001|Overall Study|Does not meet in/ex criteria|0|||
23515421|NCT00616655|65624308|FG002|Overall Study|Does not meet in/ex criteria|2|||
23515422|NCT00616655|65624306|FG000|Overall Study|Other|6|||
23515423|NCT00616655|65624307|FG001|Overall Study|Other|6|||
23515424|NCT00616655|65624308|FG002|Overall Study|Other|5|||
23515425|NCT01462084|65624309|FG000|Overall Study|Withdrawal by Subject|1|||
23515426|NCT01462084|65624310|FG001|Overall Study|Withdrawal by Subject|0|||
23515427|NCT01462084|65624309|FG000|Overall Study|Protocol Violation|1|||
23515428|NCT01462084|65624310|FG001|Overall Study|Protocol Violation|1|||
23515429|NCT01881776|65624311|FG000|Overall Study|Lost to Follow-up|1|||
23515430|NCT01881776|65624312|FG001|Overall Study|Lost to Follow-up|2|||
23515431|NCT01881776|65624313|FG002|Overall Study|Lost to Follow-up|1|||
23515432|NCT01881776|65624311|FG000|Overall Study|Protocol Violation|0|||
23515433|NCT01881776|65624312|FG001|Overall Study|Protocol Violation|2|||
23515434|NCT01881776|65624313|FG002|Overall Study|Protocol Violation|1|||
23515435|NCT03070392|65624314|FG000|Overall Study|Not Treated|7|||
23515436|NCT03070392|65624315|FG001|Overall Study|Not Treated|0|||
23515437|NCT03070392|65624316|FG002|Overall Study|Not Treated|3|||
23515438|NCT03070392|65624317|FG003|Overall Study|Not Treated|12|||
23515439|NCT03070392|65624314|FG000|Overall Study|Death|3|||
23515440|NCT03070392|65624315|FG001|Overall Study|Death|0|||
23515441|NCT03070392|65624316|FG002|Overall Study|Death|0|||
23515442|NCT03070392|65624317|FG003|Overall Study|Death|1|||
23515443|NCT03070392|65624314|FG000|Overall Study|Withdrawal by Subject|7|||
23515444|NCT03070392|65624315|FG001|Overall Study|Withdrawal by Subject|0|||
23515445|NCT03070392|65624316|FG002|Overall Study|Withdrawal by Subject|0|||
23515446|NCT03070392|65624317|FG003|Overall Study|Withdrawal by Subject|3|||
23515447|NCT03070392|65624314|FG000|Overall Study|Physician Decision|1|||
23515448|NCT03070392|65624315|FG001|Overall Study|Physician Decision|0|||
23515449|NCT03070392|65624316|FG002|Overall Study|Physician Decision|0|||
23515450|NCT03070392|65624317|FG003|Overall Study|Physician Decision|2|||
23515451|NCT03070392|65624314|FG000|Overall Study|Progressive Disease|154|||
23515452|NCT03070392|65624315|FG001|Overall Study|Progressive Disease|6|||
23515453|NCT03070392|65624316|FG002|Overall Study|Progressive Disease|2|||
23515454|NCT03070392|65624317|FG003|Overall Study|Progressive Disease|70|||
23515455|NCT03070392|65624314|FG000|Overall Study|Adverse Event|6|||
23515456|NCT03070392|65624315|FG001|Overall Study|Adverse Event|1|||
23515457|NCT03070392|65624316|FG002|Overall Study|Adverse Event|1|||
23515458|NCT03070392|65624317|FG003|Overall Study|Adverse Event|3|||
23515459|NCT03070392|65624314|FG000|Overall Study|Alternate anticancer treatment|1|||
23515460|NCT03070392|65624315|FG001|Overall Study|Alternate anticancer treatment|0|||
23515461|NCT03070392|65624316|FG002|Overall Study|Alternate anticancer treatment|0|||
23515462|NCT03070392|65624317|FG003|Overall Study|Alternate anticancer treatment|1|||
23515463|NCT03070392|65624314|FG000|Overall Study|Ongoing|73|||
23515464|NCT03070392|65624315|FG001|Overall Study|Ongoing|0|||
23515465|NCT03070392|65624316|FG002|Overall Study|Ongoing|0|||
23711824|NCT02431468|66319388|FG002|Overall Study|Adverse Event|5|||
23711825|NCT02431468|66319386|FG000|Overall Study|Withdrawal by Subject|4|||
23711826|NCT02431468|66319387|FG001|Overall Study|Withdrawal by Subject|12|||
23711827|NCT02431468|66319388|FG002|Overall Study|Withdrawal by Subject|2|||
23711828|NCT02431468|66319386|FG000|Overall Study|noncompliance, investigator termination,|2|||
23711829|NCT02431468|66319387|FG001|Overall Study|noncompliance, investigator termination,|2|||
23711830|NCT02431468|66319388|FG002|Overall Study|noncompliance, investigator termination,|2|||
23711831|NCT01253044|66319389|FG000|Overall Study|Lost to Follow-up|38|||
23711832|NCT01253044|66319390|FG001|Overall Study|Lost to Follow-up|29|||
23711833|NCT00288860|66319391|FG000|Overall Study|Did not complete intake|4|||
23711834|NCT00288860|66319392|FG001|Overall Study|Did not complete intake|8|||
23711835|NCT00288860|66319391|FG000|Overall Study|Death|4|||
23711836|NCT00288860|66319392|FG001|Overall Study|Death|3|||
23711837|NCT00288860|66319391|FG000|Overall Study|Withdrawal by Subject|20|||
23515466|NCT03070392|65624317|FG003|Overall Study|Ongoing|11|||
23515467|NCT01165554|65624319|FG000|Overall Study|Withdrawal by Subject|23|||
23515468|NCT00380978|65624320|FG000|Overall Study|Refused allocated intervention|0|||
23515469|NCT00380978|65624321|FG001|Overall Study|Refused allocated intervention|6|||
23515470|NCT00380978|65624320|FG000|Overall Study|Wrong study envelope|0|||
23515471|NCT00380978|65624321|FG001|Overall Study|Wrong study envelope|2|||
23515472|NCT00380978|65624320|FG000|Overall Study|Allocation prior to analgesia request|1|||
23515473|NCT00380978|65624321|FG001|Overall Study|Allocation prior to analgesia request|2|||
23515474|NCT00380978|65624320|FG000|Overall Study|Parous patient|1|||
23711838|NCT00288860|66319392|FG001|Overall Study|Withdrawal by Subject|15|||
23711839|NCT00288860|66319391|FG000|Overall Study|Lost to Follow-up|74|||
23515475|NCT00380978|65624321|FG001|Overall Study|Parous patient|0|||
23515476|NCT00383149|65624322|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
23515477|NCT00383149|65624322|FG000|Overall Study|Death|2|||
23515478|NCT00383149|65624322|FG000|Overall Study|Disease Progression|38|||
23515479|NCT00383149|65624322|FG000|Overall Study|Lost to Follow-up|1|||
23515480|NCT00383149|65624322|FG000|Overall Study|Other|1|||
23515481|NCT00383149|65624322|FG000|Overall Study|Study Drug Toxicity|4|||
23711840|NCT00288860|66319392|FG001|Overall Study|Lost to Follow-up|71|||
23711841|NCT04311177|66319395|FG000|Overall Study|Adverse Event|3|||
23711842|NCT04311177|66319396|FG001|Overall Study|Adverse Event|1|||
23416107|NCT00413894|65266153|FG000|Overall Study|Protocol Violation|11|||
23515482|NCT00383149|65624322|FG000|Overall Study|Request to Discontinue Treatment|4|||
23515483|NCT00383149|65624322|FG000|Overall Study|Participant Withdrew Consent|1|||
23515484|NCT00082355|65624323|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
23515485|NCT00082355|65624323|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
23515486|NCT00082355|65624323|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
23515487|NCT02357901|65624324|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
23515488|NCT02357901|65624325|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515489|NCT02357901|65624326|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515490|NCT02357901|65624327|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515491|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
23515492|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
23515493|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
23515494|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
23515495|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
23515496|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
23515497|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
23515498|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
23515499|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23515500|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
23515501|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
23515502|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
23515503|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
23515504|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
23515505|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
23515506|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
23515507|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
23515508|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
23515509|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
23515510|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
23515511|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
23515512|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
23515513|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
23515514|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
23515515|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
23515516|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
23515517|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
23515518|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
23515519|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
23515520|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
23515521|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
23515522|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
23515523|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
23515524|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
23515525|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
23515526|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
23515527|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
23515528|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
23515529|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
23515530|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
23515531|NCT03630120|65624328|FG000|Overall Study|Disease progression|0|||
23515532|NCT03630120|65624329|FG001|Overall Study|Disease progression|1|||
23515533|NCT03630120|65624330|FG002|Overall Study|Disease progression|1|||
23515534|NCT03630120|65624331|FG003|Overall Study|Disease progression|1|||
23515535|NCT04577118|65624332|FG000|Overall Study|Withdrawal by Subject|4|||
23515536|NCT02153112|65624338|FG000|Overall Study|Adverse Event|0|||
23515537|NCT02153112|65624339|FG001|Overall Study|Adverse Event|0|||
23515538|NCT02153112|65624340|FG002|Overall Study|Adverse Event|1|||
23515539|NCT02153112|65624341|FG003|Overall Study|Adverse Event|0|||
23515540|NCT02153112|65624342|FG004|Overall Study|Adverse Event|0|||
23515541|NCT02153112|65624343|FG005|Overall Study|Adverse Event|0|||
23515542|NCT02153112|65624344|FG006|Overall Study|Adverse Event|0|||
23515543|NCT02153112|65624345|FG007|Overall Study|Adverse Event|0|||
23515544|NCT02153112|65624346|FG008|Overall Study|Adverse Event|0|||
23515545|NCT02153112|65624347|FG009|Overall Study|Adverse Event|0|||
23515546|NCT02153112|65624338|FG000|Overall Study|Lost to Follow-up|1|||
23515547|NCT02153112|65624339|FG001|Overall Study|Lost to Follow-up|1|||
23515548|NCT02153112|65624340|FG002|Overall Study|Lost to Follow-up|0|||
23515549|NCT02153112|65624341|FG003|Overall Study|Lost to Follow-up|0|||
23515550|NCT02153112|65624342|FG004|Overall Study|Lost to Follow-up|2|||
23515551|NCT02153112|65624343|FG005|Overall Study|Lost to Follow-up|1|||
23515552|NCT02153112|65624344|FG006|Overall Study|Lost to Follow-up|1|||
23515553|NCT02153112|65624345|FG007|Overall Study|Lost to Follow-up|0|||
23515554|NCT02153112|65624346|FG008|Overall Study|Lost to Follow-up|1|||
23515555|NCT02153112|65624347|FG009|Overall Study|Lost to Follow-up|1|||
23515556|NCT02153112|65624338|FG000|Overall Study|Withdrawal by Subject|3|||
23515557|NCT02153112|65624339|FG001|Overall Study|Withdrawal by Subject|1|||
23515558|NCT02153112|65624340|FG002|Overall Study|Withdrawal by Subject|2|||
23515559|NCT02153112|65624341|FG003|Overall Study|Withdrawal by Subject|2|||
23515560|NCT02153112|65624342|FG004|Overall Study|Withdrawal by Subject|1|||
23515561|NCT02153112|65624343|FG005|Overall Study|Withdrawal by Subject|1|||
23515562|NCT02153112|65624344|FG006|Overall Study|Withdrawal by Subject|7|||
23515563|NCT02153112|65624345|FG007|Overall Study|Withdrawal by Subject|2|||
23515564|NCT02153112|65624346|FG008|Overall Study|Withdrawal by Subject|13|||
23515565|NCT02153112|65624347|FG009|Overall Study|Withdrawal by Subject|12|||
23515566|NCT02153112|65624338|FG000|Overall Study|Reason not Specified|0|||
23515567|NCT02153112|65624339|FG001|Overall Study|Reason not Specified|0|||
23515568|NCT02153112|65624340|FG002|Overall Study|Reason not Specified|0|||
23515569|NCT02153112|65624341|FG003|Overall Study|Reason not Specified|0|||
23515570|NCT02153112|65624342|FG004|Overall Study|Reason not Specified|0|||
23515571|NCT02153112|65624343|FG005|Overall Study|Reason not Specified|0|||
23515572|NCT02153112|65624344|FG006|Overall Study|Reason not Specified|0|||
23515573|NCT02153112|65624345|FG007|Overall Study|Reason not Specified|0|||
23515574|NCT02153112|65624346|FG008|Overall Study|Reason not Specified|1|||
23515575|NCT02153112|65624347|FG009|Overall Study|Reason not Specified|1|||
23515576|NCT02864251|65624356|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
23515577|NCT02864251|65624357|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
23515578|NCT02864251|65624358|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
23515579|NCT02864251|65624356|FG000|Pre-Treatment|Withdrawal by Participant|0|||
23515580|NCT02864251|65624357|FG001|Pre-Treatment|Withdrawal by Participant|0|||
23515581|NCT02864251|65624358|FG002|Pre-Treatment|Withdrawal by Participant|4|||
23515582|NCT02864251|65624356|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
23515583|NCT02864251|65624357|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
23515584|NCT02864251|65624358|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
23515585|NCT02864251|65624356|FG000|Pre-Treatment|Other Reasons|0|||
23515586|NCT02864251|65624357|FG001|Pre-Treatment|Other Reasons|1|||
23515587|NCT02864251|65624358|FG002|Pre-Treatment|Other Reasons|1|||
23515588|NCT02864251|65624356|FG000|Treatment|Disease Progression|109|||
23515589|NCT02864251|65624357|FG001|Treatment|Disease Progression|52|||
23515590|NCT02864251|65624358|FG002|Treatment|Disease Progression|101|||
23515591|NCT02864251|65624356|FG000|Treatment|Study Drug Toxicity|9|||
23515592|NCT02864251|65624357|FG001|Treatment|Study Drug Toxicity|4|||
23515593|NCT02864251|65624358|FG002|Treatment|Study Drug Toxicity|10|||
23515594|NCT02864251|65624356|FG000|Treatment|Death|0|||
23515595|NCT02864251|65624357|FG001|Treatment|Death|2|||
23515596|NCT02864251|65624358|FG002|Treatment|Death|3|||
23515597|NCT02864251|65624356|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
23515598|NCT02864251|65624357|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
23515599|NCT02864251|65624358|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
23515600|NCT02864251|65624356|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
23515601|NCT02864251|65624357|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
23711843|NCT04311177|66319395|FG000|Overall Study|Physician Decision|4|||
23711844|NCT04311177|66319396|FG001|Overall Study|Physician Decision|3|||
23515602|NCT02864251|65624358|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
23515603|NCT02864251|65624356|FG000|Treatment|Withdrawal by Participant|8|||
23515604|NCT02864251|65624357|FG001|Treatment|Withdrawal by Participant|5|||
23515605|NCT02864251|65624358|FG002|Treatment|Withdrawal by Participant|13|||
23515606|NCT02864251|65624356|FG000|Treatment|Maximum Clinical Benefit|1|||
23515607|NCT02864251|65624357|FG001|Treatment|Maximum Clinical Benefit|0|||
23515608|NCT02864251|65624358|FG002|Treatment|Maximum Clinical Benefit|1|||
23515609|NCT02864251|65624356|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
23515610|NCT02864251|65624357|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
23515611|NCT02864251|65624358|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
23515612|NCT02864251|65624356|FG000|Treatment|Other Reasons|1|||
23515613|NCT02864251|65624357|FG001|Treatment|Other Reasons|1|||
23515614|NCT02864251|65624358|FG002|Treatment|Other Reasons|4|||
23711845|NCT04311177|66319395|FG000|Overall Study|Withdrawal by Subject|1|||
23711846|NCT04311177|66319396|FG001|Overall Study|Withdrawal by Subject|0|||
23515615|NCT02864251|65624356|FG000|Treatment|Administrative Reason by Sponsor|1|||
23515616|NCT02864251|65624357|FG001|Treatment|Administrative Reason by Sponsor|0|||
23515617|NCT02864251|65624358|FG002|Treatment|Administrative Reason by Sponsor|0|||
23515618|NCT01189812|65624359|FG000|Overall Study|Withdrawal by Subject|2|||
23515619|NCT01189812|65624360|FG001|Overall Study|Withdrawal by Subject|3|||
23515620|NCT01189812|65624359|FG000|Overall Study|Adverse Event|1|||
23515621|NCT01189812|65624360|FG001|Overall Study|Adverse Event|0|||
23515622|NCT01189812|65624359|FG000|Overall Study|Out of Window|4|||
23515623|NCT01189812|65624360|FG001|Overall Study|Out of Window|3|||
23515624|NCT01189812|65624359|FG000|Overall Study|Moved out of State|1|||
23515625|NCT01189812|65624360|FG001|Overall Study|Moved out of State|2|||
23515626|NCT00455429|65624361|FG000|Overall Study|Study Terminated by Sponsor|0|||
23515627|NCT00455429|65624362|FG001|Overall Study|Study Terminated by Sponsor|0|||
23515628|NCT00455429|65624363|FG002|Overall Study|Study Terminated by Sponsor|0|||
23515629|NCT00455429|65624364|FG003|Overall Study|Study Terminated by Sponsor|3|||
23515630|NCT00455429|65624361|FG000|Overall Study|Lost to Follow-up|1|||
23515631|NCT00455429|65624362|FG001|Overall Study|Lost to Follow-up|0|||
23515632|NCT00455429|65624363|FG002|Overall Study|Lost to Follow-up|0|||
23515633|NCT00455429|65624364|FG003|Overall Study|Lost to Follow-up|3|||
23515634|NCT00455429|65624361|FG000|Overall Study|Withdrawal by Subject|0|||
23515635|NCT00455429|65624362|FG001|Overall Study|Withdrawal by Subject|1|||
23515636|NCT00455429|65624363|FG002|Overall Study|Withdrawal by Subject|1|||
23515637|NCT00455429|65624364|FG003|Overall Study|Withdrawal by Subject|0|||
23515638|NCT00455429|65624361|FG000|Overall Study|Lack of Efficacy|0|||
23515639|NCT00455429|65624362|FG001|Overall Study|Lack of Efficacy|1|||
23515640|NCT00455429|65624363|FG002|Overall Study|Lack of Efficacy|0|||
23515641|NCT00455429|65624364|FG003|Overall Study|Lack of Efficacy|1|||
23515642|NCT00455429|65624361|FG000|Overall Study|Adverse Event|0|||
23515643|NCT00455429|65624362|FG001|Overall Study|Adverse Event|1|||
23515644|NCT00455429|65624363|FG002|Overall Study|Adverse Event|0|||
23515645|NCT00455429|65624364|FG003|Overall Study|Adverse Event|3|||
23515646|NCT00455429|65624361|FG000|Overall Study|Randomly assigned but not treated|0|||
23515647|NCT00455429|65624362|FG001|Overall Study|Randomly assigned but not treated|0|||
23515648|NCT00455429|65624363|FG002|Overall Study|Randomly assigned but not treated|0|||
23515649|NCT00455429|65624364|FG003|Overall Study|Randomly assigned but not treated|2|||
23515650|NCT00455429|65624361|FG000|Overall Study|Personal Reason|1|||
23515651|NCT00455429|65624362|FG001|Overall Study|Personal Reason|0|||
23515652|NCT00455429|65624363|FG002|Overall Study|Personal Reason|0|||
23515653|NCT00455429|65624364|FG003|Overall Study|Personal Reason|0|||
23515654|NCT00455429|65624361|FG000|Overall Study|Non-compliance|0|||
23515655|NCT00455429|65624362|FG001|Overall Study|Non-compliance|0|||
23515656|NCT00455429|65624363|FG002|Overall Study|Non-compliance|0|||
23515657|NCT00455429|65624364|FG003|Overall Study|Non-compliance|1|||
23515658|NCT00455429|65624361|FG000|Overall Study|Other|0|||
23515659|NCT00455429|65624362|FG001|Overall Study|Other|2|||
23515660|NCT00455429|65624363|FG002|Overall Study|Other|0|||
23515661|NCT00455429|65624364|FG003|Overall Study|Other|1|||
23515662|NCT01358357|65627783|FG000|Open Label Phase|Adverse Event|0|||
23515663|NCT01358357|65627784|FG001|Open Label Phase|Adverse Event|0|||
23515664|NCT01358357|65627785|FG002|Open Label Phase|Adverse Event|59|||
23515665|NCT01358357|65627783|FG000|Open Label Phase|Lack of Efficacy|0|||
23515666|NCT01358357|65627784|FG001|Open Label Phase|Lack of Efficacy|0|||
23515667|NCT01358357|65627785|FG002|Open Label Phase|Lack of Efficacy|107|||
23515668|NCT01358357|65627783|FG000|Open Label Phase|Lost to Follow-up|0|||
23515669|NCT01358357|65627784|FG001|Open Label Phase|Lost to Follow-up|0|||
23515670|NCT01358357|65627785|FG002|Open Label Phase|Lost to Follow-up|76|||
23515671|NCT01358357|65627783|FG000|Open Label Phase|Protocol Violation|0|||
23515672|NCT01358357|65627784|FG001|Open Label Phase|Protocol Violation|0|||
23515673|NCT01358357|65627785|FG002|Open Label Phase|Protocol Violation|45|||
23515674|NCT01358357|65627783|FG000|Open Label Phase|Withdrawal by Subject|0|||
23515675|NCT01358357|65627784|FG001|Open Label Phase|Withdrawal by Subject|0|||
23515676|NCT01358357|65627785|FG002|Open Label Phase|Withdrawal by Subject|112|||
23515677|NCT01358357|65627783|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
23515678|NCT01358357|65627784|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
23711847|NCT02695524|66319400|FG000|Overall Study|Lost to Follow-up|3|||
23515679|NCT01358357|65627785|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
23515680|NCT01358357|65627783|FG000|Open Label Phase|Terminated at study completion|0|||
23515681|NCT01358357|65627784|FG001|Open Label Phase|Terminated at study completion|0|||
23515682|NCT01358357|65627785|FG002|Open Label Phase|Terminated at study completion|5|||
23515683|NCT01358357|65627783|FG000|Open Label Phase|Mood episode|0|||
23515684|NCT01358357|65627784|FG001|Open Label Phase|Mood episode|0|||
23515685|NCT01358357|65627785|FG002|Open Label Phase|Mood episode|42|||
23515686|NCT01358357|65627783|FG000|Double-Blind Phase|Adverse Event|8|||
23515687|NCT01358357|65627784|FG001|Double-Blind Phase|Adverse Event|5|||
23515688|NCT01358357|65627785|FG002|Double-Blind Phase|Adverse Event|0|||
23515689|NCT01358357|65627783|FG000|Double-Blind Phase|Lost to Follow-up|5|||
23515690|NCT01358357|65627784|FG001|Double-Blind Phase|Lost to Follow-up|7|||
23515691|NCT01358357|65627785|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23515692|NCT01358357|65627783|FG000|Double-Blind Phase|Protocol Violation|1|||
23515693|NCT01358357|65627784|FG001|Double-Blind Phase|Protocol Violation|11|||
23515694|NCT01358357|65627785|FG002|Double-Blind Phase|Protocol Violation|0|||
23515695|NCT01358357|65627783|FG000|Double-Blind Phase|Protocol Violation|16|||
23515696|NCT01358357|65627784|FG001|Double-Blind Phase|Protocol Violation|12|||
23515697|NCT01358357|65627785|FG002|Double-Blind Phase|Protocol Violation|0|||
23515698|NCT01358357|65627783|FG000|Double-Blind Phase|Terminated at study completion|2|||
23515699|NCT01358357|65627784|FG001|Double-Blind Phase|Terminated at study completion|0|||
23515700|NCT01358357|65627785|FG002|Double-Blind Phase|Terminated at study completion|0|||
23515701|NCT01358357|65627783|FG000|Double-Blind Phase|Recurrence of mood event|48|||
23515702|NCT01358357|65627784|FG001|Double-Blind Phase|Recurrence of mood event|64|||
23515703|NCT01358357|65627785|FG002|Double-Blind Phase|Recurrence of mood event|0|||
23515704|NCT01358357|65627783|FG000|Double-Blind Phase|Administrative|0|||
23515705|NCT01358357|65627784|FG001|Double-Blind Phase|Administrative|1|||
23515706|NCT01358357|65627785|FG002|Double-Blind Phase|Administrative|0|||
23515707|NCT02320149|65627786|FG000|Overall Study|Adverse Event|3|||
23515708|NCT02320149|65627787|FG001|Overall Study|Adverse Event|7|||
23515709|NCT02320149|65627786|FG000|Overall Study|Withdrawal of Consent|28|||
23515710|NCT02320149|65627787|FG001|Overall Study|Withdrawal of Consent|32|||
23515711|NCT02320149|65627786|FG000|Overall Study|Lost to Follow-up|21|||
23515712|NCT02320149|65627787|FG001|Overall Study|Lost to Follow-up|34|||
23515713|NCT02320149|65627786|FG000|Overall Study|Protocol Violation|2|||
23515714|NCT02320149|65627787|FG001|Overall Study|Protocol Violation|1|||
23515715|NCT02320149|65627786|FG000|Overall Study|Noncompliance with Study Treatment|7|||
23515716|NCT02320149|65627787|FG001|Overall Study|Noncompliance with Study Treatment|2|||
23515717|NCT02320149|65627786|FG000|Overall Study|Lack of Efficacy|0|||
23515718|NCT02320149|65627787|FG001|Overall Study|Lack of Efficacy|1|||
23515719|NCT02320149|65627786|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23515720|NCT02320149|65627787|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23515721|NCT01505868|65627788|FG000|Overall Study|Withdrawal by Subject|1|||
23515722|NCT01505868|65627789|FG001|Overall Study|Withdrawal by Subject|0|||
23515723|NCT01505868|65627790|FG002|Overall Study|Withdrawal by Subject|0|||
23515724|NCT01505868|65627791|FG003|Overall Study|Withdrawal by Subject|0|||
23515725|NCT01505868|65627792|FG004|Overall Study|Withdrawal by Subject|0|||
23711848|NCT02695524|66319401|FG001|Overall Study|Lost to Follow-up|2|||
23711849|NCT02695524|66319400|FG000|Overall Study|Death|0|||
23711850|NCT02695524|66319401|FG001|Overall Study|Death|1|||
23711851|NCT00448760|66319402|FG000|Overall Study|Death|3|||
23711852|NCT03806179|66319403|FG000|Overall Study|Progressive disease|0|||
23711853|NCT03806179|66319404|FG001|Overall Study|Progressive disease|2|||
23711854|NCT01098461|66319405|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
23711855|NCT01098461|66319406|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
23711856|NCT01098461|66319407|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
23515726|NCT02278263|65627793|FG000|Overall Study|Protocol Violation|7|||
23515727|NCT02278263|65627794|FG001|Overall Study|Protocol Violation|0|||
23515728|NCT02278263|65627795|FG002|Overall Study|Protocol Violation|9|||
23515729|NCT02882854|65627796|FG000|Overall Study|Lost to Follow-up|1|||
23515730|NCT02882854|65627797|FG001|Overall Study|Lost to Follow-up|2|||
23515731|NCT02882854|65627796|FG000|Overall Study|Physician Decision|0|||
23515732|NCT02882854|65627797|FG001|Overall Study|Physician Decision|1|||
23515733|NCT00732615|65627799|FG000|Overall Study|Withdrawal by Subject|3|||
23515734|NCT00732615|65627800|FG001|Overall Study|Withdrawal by Subject|1|||
23515735|NCT00732615|65627799|FG000|Overall Study|Lost to Follow-up|0|||
23515736|NCT00732615|65627800|FG001|Overall Study|Lost to Follow-up|1|||
23515737|NCT00732615|65627799|FG000|Overall Study|Adverse Event|0|||
23515738|NCT00732615|65627800|FG001|Overall Study|Adverse Event|2|||
23515739|NCT00732615|65627799|FG000|Overall Study|Physician Decision|3|||
23515740|NCT00732615|65627800|FG001|Overall Study|Physician Decision|0|||
23515741|NCT00732615|65627799|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
23515742|NCT00732615|65627800|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
23515743|NCT00010374|65627801|FG000|Overall Study|False positive phrenic nerve test|1|||
23515744|NCT00597766|65627803|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
23515745|NCT00597766|65627804|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
23515746|NCT00597766|65627805|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
23711857|NCT01098461|66319408|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
23711858|NCT01098461|66319405|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
23515747|NCT00597766|65627803|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
23515748|NCT00597766|65627804|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
23515749|NCT00597766|65627805|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
23515750|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Adverse Event|82|||
23515751|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Death|6|||
23515752|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
23515753|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
23515754|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
23515755|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
23515756|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
23515757|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Other reasons|68|||
23515758|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
23515759|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
23515760|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
23515761|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
23515762|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
23515763|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
23515764|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
23515765|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
23515766|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
23515767|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
23515768|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
23515769|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
23515770|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
23515771|NCT02946047|65627807|FG000|Overall Study|Adverse Event|1|||
23515772|NCT02946047|65627808|FG001|Overall Study|Adverse Event|0|||
23515773|NCT02946047|65627809|FG002|Overall Study|Adverse Event|0|||
23515774|NCT02946047|65627810|FG003|Overall Study|Adverse Event|0|||
23515775|NCT03164928|65627812|FG000|Overall Study|Lost to Follow-up|1|||
23515776|NCT03164928|65627813|FG001|Overall Study|Lost to Follow-up|0|||
23515777|NCT00541034|65627814|FG000|Overall Study|Non-Compliance|3|||
23515778|NCT02802592|65627815|FG000|Overall Study|Study terminated due to loss of funding|4|||
23515779|NCT03020407|65627818|FG000|Overall Study|Withdrawal by Subject|2|||
23515780|NCT03020407|65627819|FG001|Overall Study|Withdrawal by Subject|1|||
23515781|NCT03020407|65627818|FG000|Overall Study|Lost to Follow-up|2|||
23515782|NCT03020407|65627819|FG001|Overall Study|Lost to Follow-up|3|||
23515783|NCT03020407|65627818|FG000|Overall Study|Protocol Violation|0|||
23515784|NCT03020407|65627819|FG001|Overall Study|Protocol Violation|1|||
23515785|NCT01853046|65627820|FG000|Overall Study|Withdrawal by Subject|1|||
23515786|NCT01853046|65627821|FG001|Overall Study|Withdrawal by Subject|1|||
23515787|NCT01853046|65627820|FG000|Overall Study|Adverse Event|4|||
23515788|NCT01853046|65627821|FG001|Overall Study|Adverse Event|2|||
23515789|NCT01853046|65627820|FG000|Overall Study|Disease progression|13|||
23515790|NCT01853046|65627821|FG001|Overall Study|Disease progression|3|||
23515791|NCT01946425|65627822|FG000|Overall Study|Protocol Violation|1|||
23515792|NCT01946425|65627823|FG001|Overall Study|Protocol Violation|0|||
23515793|NCT01946425|65627822|FG000|Overall Study|Withdrawal by Subject|1|||
23515794|NCT01946425|65627823|FG001|Overall Study|Withdrawal by Subject|0|||
23515795|NCT05517382|65627824|FG000|Overall Study|Lost to Follow-up|0|||
23515796|NCT05517382|65627825|FG001|Overall Study|Lost to Follow-up|1|||
23515797|NCT03686384|65627826|FG000|Overall Study|Lack of Efficacy|4|||
23515798|NCT03686384|65627827|FG001|Overall Study|Lack of Efficacy|13|||
23515799|NCT03686384|65627826|FG000|Overall Study|Lost to Follow-up|3|||
23515800|NCT03686384|65627827|FG001|Overall Study|Lost to Follow-up|0|||
23515801|NCT03686384|65627826|FG000|Overall Study|Physician Decision|0|||
23515802|NCT03686384|65627827|FG001|Overall Study|Physician Decision|1|||
23515803|NCT03686384|65627826|FG000|Overall Study|Took prohibited medication|0|||
23515804|NCT03686384|65627827|FG001|Overall Study|Took prohibited medication|1|||
23515805|NCT00462761|65627830|FG000|Overall Study|Adverse Event|6|||
23515806|NCT00462761|65627830|FG000|Overall Study|Withdrawal by Subject|9|||
23515807|NCT00462761|65627830|FG000|Overall Study|Physician Decision|5|||
23515808|NCT00462761|65627830|FG000|Overall Study|Disease progression|43|||
23515809|NCT00462761|65627830|FG000|Overall Study|Death|12|||
23515810|NCT00462761|65627830|FG000|Overall Study|Other|1|||
23515811|NCT00708162|65627831|FG000|Randomized Phase|Randomized but Not Treated|7|||
23515812|NCT00708162|65627832|FG001|Randomized Phase|Randomized but Not Treated|5|||
23515813|NCT00708162|65627831|FG000|Randomized Phase|Participant Noncompliance|40|||
23515814|NCT00708162|65627832|FG001|Randomized Phase|Participant Noncompliance|32|||
23515815|NCT00708162|65627831|FG000|Randomized Phase|Lost to Follow-up|34|||
23515816|NCT00708162|65627832|FG001|Randomized Phase|Lost to Follow-up|34|||
23515817|NCT00708162|65627831|FG000|Randomized Phase|Withdrew Consent|31|||
23515818|NCT00708162|65627832|FG001|Randomized Phase|Withdrew Consent|22|||
23515819|NCT00708162|65627831|FG000|Randomized Phase|Lack of Efficacy|14|||
23711859|NCT01098461|66319406|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
23515820|NCT00708162|65627832|FG001|Randomized Phase|Lack of Efficacy|19|||
23515821|NCT00708162|65627831|FG000|Randomized Phase|Protocol Violation|10|||
23515822|NCT00708162|65627832|FG001|Randomized Phase|Protocol Violation|11|||
23515823|NCT00708162|65627831|FG000|Randomized Phase|Adverse Event|8|||
23515824|NCT00708162|65627832|FG001|Randomized Phase|Adverse Event|12|||
23711860|NCT01098461|66319407|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
23416108|NCT00413894|65266153|FG000|Overall Study|Other|18|||
23416109|NCT00152477|65266154|FG000|Chemotherapy Period|Adverse Event|9|||
23416110|NCT00152477|65266155|FG001|Chemotherapy Period|Adverse Event|4|||
23416111|NCT00152477|65266156|FG002|Chemotherapy Period|Adverse Event|5|||
23416112|NCT00152477|65266154|FG000|Chemotherapy Period|Death|1|||
23416113|NCT00152477|65266155|FG001|Chemotherapy Period|Death|3|||
23416114|NCT00152477|65266156|FG002|Chemotherapy Period|Death|3|||
23515825|NCT00708162|65627831|FG000|Randomized Phase|Investigator's Discretion|7|||
23515826|NCT00708162|65627832|FG001|Randomized Phase|Investigator's Discretion|10|||
23515827|NCT00708162|65627831|FG000|Randomized Phase|Death|2|||
23515828|NCT00708162|65627832|FG001|Randomized Phase|Death|9|||
23515829|NCT00708162|65627831|FG000|Randomized Phase|Pregnancy|3|||
23515830|NCT00708162|65627832|FG001|Randomized Phase|Pregnancy|0|||
23515831|NCT00708162|65627831|FG000|Open-Label Phase|Lost to Follow-up|10|||
23515832|NCT00708162|65627832|FG001|Open-Label Phase|Lost to Follow-up|8|||
23515833|NCT00708162|65627831|FG000|Open-Label Phase|Withdrew Consent|12|||
23515834|NCT00708162|65627832|FG001|Open-Label Phase|Withdrew Consent|6|||
23515835|NCT00708162|65627831|FG000|Open-Label Phase|Participant Noncompliance|7|||
23515836|NCT00708162|65627832|FG001|Open-Label Phase|Participant Noncompliance|7|||
23515837|NCT00708162|65627831|FG000|Open-Label Phase|Lack of Efficacy|7|||
23515838|NCT00708162|65627832|FG001|Open-Label Phase|Lack of Efficacy|4|||
23515839|NCT00708162|65627831|FG000|Open-Label Phase|Investigator's Discretion|3|||
23515840|NCT00708162|65627832|FG001|Open-Label Phase|Investigator's Discretion|2|||
23515841|NCT00708162|65627831|FG000|Open-Label Phase|Death|3|||
23515842|NCT00708162|65627832|FG001|Open-Label Phase|Death|1|||
23515843|NCT00708162|65627831|FG000|Open-Label Phase|Adverse Event|1|||
23515844|NCT00708162|65627832|FG001|Open-Label Phase|Adverse Event|2|||
23515845|NCT00708162|65627831|FG000|Open-Label Phase|Other|1|||
23515846|NCT00708162|65627832|FG001|Open-Label Phase|Other|0|||
23515847|NCT00227903|65627833|FG000|Overall Study|Withdrawal by Subject|2|||
23515848|NCT00227903|65627834|FG001|Overall Study|Withdrawal by Subject|5|||
23515849|NCT00227903|65627833|FG000|Overall Study|Subject moved out of area|1|||
23515850|NCT00227903|65627834|FG001|Overall Study|Subject moved out of area|2|||
23515851|NCT00227903|65627833|FG000|Overall Study|Lost to Follow-up|1|||
23515852|NCT00227903|65627834|FG001|Overall Study|Lost to Follow-up|3|||
23515853|NCT00227903|65627833|FG000|Overall Study|Miscarriage|1|||
23515854|NCT00227903|65627834|FG001|Overall Study|Miscarriage|0|||
23515855|NCT02118012|65627838|FG000|Overall Study|Adverse Event|0|||
23515856|NCT02118012|65627839|FG001|Overall Study|Adverse Event|1|||
23515857|NCT02118012|65627838|FG000|Overall Study|Physician Decision|0|||
23515858|NCT02118012|65627839|FG001|Overall Study|Physician Decision|1|||
23515859|NCT00156533|65627843|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
23515860|NCT00156533|65627844|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
23515861|NCT00156533|65627845|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
23515862|NCT00156533|65627846|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
23515863|NCT00156533|65627843|FG000|Overall Study|Withdrawal by Subject|1|||
23515864|NCT00156533|65627844|FG001|Overall Study|Withdrawal by Subject|0|||
23515865|NCT00156533|65627845|FG002|Overall Study|Withdrawal by Subject|0|||
23515866|NCT00156533|65627846|FG003|Overall Study|Withdrawal by Subject|1|||
23515867|NCT00156533|65627843|FG000|Overall Study|Failed Screening|1|||
23515868|NCT00156533|65627844|FG001|Overall Study|Failed Screening|0|||
23515869|NCT00156533|65627845|FG002|Overall Study|Failed Screening|1|||
23515870|NCT00156533|65627846|FG003|Overall Study|Failed Screening|1|||
23515871|NCT01166178|65627850|FG000|Overall Study|Withdrawal by Subject|1|||
23515872|NCT01166178|65627851|FG001|Overall Study|Withdrawal by Subject|0|||
23515873|NCT01166178|65627850|FG000|Overall Study|Study was terminated|20|||
23515874|NCT01166178|65627851|FG001|Overall Study|Study was terminated|8|||
23515875|NCT04210310|65627855|FG000|Overall Study|Lost to Follow-up|32|||
23515876|NCT04210310|65627856|FG001|Overall Study|Lost to Follow-up|1|||
23515877|NCT01254227|65627862|FG000|Overall Study|Withdrawal by Subject|6|||
23515878|NCT01254227|65627862|FG000|Overall Study|Lost to Follow-up|6|||
23711861|NCT01098461|66319408|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
23711862|NCT01098461|66319405|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
23711863|NCT01098461|66319406|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
23711864|NCT01098461|66319407|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
23711865|NCT01098461|66319408|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
23711866|NCT01098461|66319405|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23711867|NCT01098461|66319406|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
23515879|NCT01254227|65627862|FG000|Overall Study|Adverse Event|5|||
23515880|NCT01254227|65627862|FG000|Overall Study|Abnormal test procedure result|5|||
23515881|NCT01254227|65627862|FG000|Overall Study|Administrative problems|2|||
23515882|NCT01254227|65627862|FG000|Overall Study|Death|1|||
23515883|NCT01254227|65627862|FG000|Overall Study|Protocol deviation|1|||
23515884|NCT00311623|65627865|FG000|Overall Study|Physician Decision|0|||
23515885|NCT00311623|65627866|FG001|Overall Study|Physician Decision|0|||
23515886|NCT00311623|65627867|FG002|Overall Study|Physician Decision|2|||
23515887|NCT00056407|65627868|FG000|Overall Study|Adverse Event|282|||
23711868|NCT01098461|66319407|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23515888|NCT00056407|65627869|FG001|Overall Study|Adverse Event|364|||
23515889|NCT00056407|65627868|FG000|Overall Study|Withdrawal by Subject|377|||
23515890|NCT00056407|65627869|FG001|Overall Study|Withdrawal by Subject|361|||
23515891|NCT00056407|65627868|FG000|Overall Study|Lost to Follow-up|123|||
23515892|NCT00056407|65627869|FG001|Overall Study|Lost to Follow-up|113|||
23515893|NCT00056407|65627868|FG000|Overall Study|Protocol Violation|104|||
23515894|NCT00056407|65627869|FG001|Overall Study|Protocol Violation|95|||
23711869|NCT01098461|66319408|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23711870|NCT01098461|66319405|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23711871|NCT01098461|66319406|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
23711872|NCT01098461|66319407|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23711873|NCT01098461|66319408|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23711874|NCT01098461|66319405|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23711875|NCT01098461|66319406|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
23711876|NCT01098461|66319407|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23711877|NCT01098461|66319408|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23711878|NCT01098461|66319405|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
23711879|NCT01098461|66319406|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
23711880|NCT01098461|66319407|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
23711881|NCT01098461|66319408|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
23711882|NCT02657551|66319409|FG000|Overall Study|Adverse Event|2|||
23711883|NCT02657551|66319409|FG000|Overall Study|Withdrawal by Subject|1|||
23515895|NCT00056407|65627868|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
23515896|NCT00056407|65627869|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
23515897|NCT00056407|65627868|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
23515898|NCT00056407|65627869|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
23515899|NCT00056407|65627868|FG000|Overall Study|Missing|25|||
23515900|NCT00056407|65627869|FG001|Overall Study|Missing|34|||
23515901|NCT01199289|65627870|FG000|Overall Study|Ineligibility determined|2|||
23515902|NCT01199289|65627871|FG001|Overall Study|Ineligibility determined|1|||
23515903|NCT01199289|65627872|FG002|Overall Study|Ineligibility determined|0|||
23515904|NCT01199289|65627873|FG003|Overall Study|Ineligibility determined|0|||
23515905|NCT01199289|65627870|FG000|Overall Study|Protocol Violation|1|||
23515906|NCT01199289|65627871|FG001|Overall Study|Protocol Violation|0|||
23515907|NCT01199289|65627872|FG002|Overall Study|Protocol Violation|0|||
23515908|NCT01199289|65627873|FG003|Overall Study|Protocol Violation|1|||
23515909|NCT01199289|65627870|FG000|Overall Study|Noncompliance|1|||
23515910|NCT01199289|65627871|FG001|Overall Study|Noncompliance|0|||
23515911|NCT01199289|65627872|FG002|Overall Study|Noncompliance|2|||
23515912|NCT01199289|65627873|FG003|Overall Study|Noncompliance|0|||
23515913|NCT01199289|65627870|FG000|Overall Study|Adverse Event|0|||
23515914|NCT01199289|65627871|FG001|Overall Study|Adverse Event|3|||
23515915|NCT01199289|65627872|FG002|Overall Study|Adverse Event|1|||
23515916|NCT01199289|65627873|FG003|Overall Study|Adverse Event|4|||
23515917|NCT01199289|65627870|FG000|Overall Study|Full consent withdrawn|2|||
23515918|NCT01199289|65627871|FG001|Overall Study|Full consent withdrawn|2|||
23515919|NCT01199289|65627872|FG002|Overall Study|Full consent withdrawn|2|||
23515920|NCT01199289|65627873|FG003|Overall Study|Full consent withdrawn|3|||
23515921|NCT01199289|65627870|FG000|Overall Study|Administrative decision|0|||
23515922|NCT01199289|65627871|FG001|Overall Study|Administrative decision|0|||
23515923|NCT01199289|65627872|FG002|Overall Study|Administrative decision|0|||
23515924|NCT01199289|65627873|FG003|Overall Study|Administrative decision|1|||
23515925|NCT01199289|65627870|FG000|Overall Study|Lost to Follow-up|0|||
23515926|NCT01199289|65627871|FG001|Overall Study|Lost to Follow-up|0|||
23515927|NCT01199289|65627872|FG002|Overall Study|Lost to Follow-up|0|||
23515928|NCT01199289|65627873|FG003|Overall Study|Lost to Follow-up|1|||
23515929|NCT01199289|65627870|FG000|Overall Study|Protocol-specified criteria|3|||
23515930|NCT01199289|65627871|FG001|Overall Study|Protocol-specified criteria|0|||
23515931|NCT01199289|65627872|FG002|Overall Study|Protocol-specified criteria|0|||
23515932|NCT01199289|65627873|FG003|Overall Study|Protocol-specified criteria|1|||
23515933|NCT01199289|65627870|FG000|Overall Study|Pregnancy|0|||
23515934|NCT01199289|65627871|FG001|Overall Study|Pregnancy|1|||
23515935|NCT01199289|65627872|FG002|Overall Study|Pregnancy|0|||
23515936|NCT01199289|65627873|FG003|Overall Study|Pregnancy|1|||
23515937|NCT01641692|65627874|FG000|Treatment Period 1|Adverse Event|1|||
23515938|NCT01641692|65627875|FG001|Treatment Period 1|Adverse Event|0|||
23515939|NCT01641692|65627876|FG002|Treatment Period 1|Adverse Event|0|||
23515940|NCT01641692|65627877|FG003|Treatment Period 1|Adverse Event|0|||
23515941|NCT01641692|65627878|FG004|Treatment Period 1|Adverse Event|0|||
23515942|NCT01641692|65627879|FG005|Treatment Period 1|Adverse Event|0|||
23515943|NCT01641692|65627880|FG006|Treatment Period 1|Adverse Event|0|||
23515944|NCT01641692|65627881|FG007|Treatment Period 1|Adverse Event|0|||
23515945|NCT01641692|65627874|FG000|Treatment Period 1|Lack of Efficacy|0|||
23515946|NCT01641692|65627875|FG001|Treatment Period 1|Lack of Efficacy|0|||
23515947|NCT01641692|65627876|FG002|Treatment Period 1|Lack of Efficacy|0|||
23515948|NCT01641692|65627877|FG003|Treatment Period 1|Lack of Efficacy|0|||
23515949|NCT01641692|65627878|FG004|Treatment Period 1|Lack of Efficacy|0|||
23515950|NCT01641692|65627879|FG005|Treatment Period 1|Lack of Efficacy|0|||
23515951|NCT01641692|65627880|FG006|Treatment Period 1|Lack of Efficacy|0|||
23515952|NCT01641692|65627881|FG007|Treatment Period 1|Lack of Efficacy|1|||
23515953|NCT01641692|65627874|FG000|Treatment Period 1|Protocol Violation|1|||
23515954|NCT01641692|65627875|FG001|Treatment Period 1|Protocol Violation|0|||
23515955|NCT01641692|65627876|FG002|Treatment Period 1|Protocol Violation|0|||
23515956|NCT01641692|65627877|FG003|Treatment Period 1|Protocol Violation|0|||
23515957|NCT01641692|65627878|FG004|Treatment Period 1|Protocol Violation|2|||
23515958|NCT01641692|65627879|FG005|Treatment Period 1|Protocol Violation|0|||
23515959|NCT01641692|65627880|FG006|Treatment Period 1|Protocol Violation|0|||
23515960|NCT01641692|65627881|FG007|Treatment Period 1|Protocol Violation|0|||
23515961|NCT01641692|65627874|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515962|NCT01641692|65627875|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515963|NCT01641692|65627876|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515964|NCT01641692|65627877|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515965|NCT01641692|65627878|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
23515966|NCT01641692|65627879|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515967|NCT01641692|65627880|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515968|NCT01641692|65627881|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
23515969|NCT01641692|65627874|FG000|Treatment Period 1|Lost to Follow-up|0|||
23515970|NCT01641692|65627875|FG001|Treatment Period 1|Lost to Follow-up|0|||
23515971|NCT01641692|65627876|FG002|Treatment Period 1|Lost to Follow-up|1|||
23515972|NCT01641692|65627877|FG003|Treatment Period 1|Lost to Follow-up|0|||
23515973|NCT01641692|65627878|FG004|Treatment Period 1|Lost to Follow-up|0|||
23515974|NCT01641692|65627879|FG005|Treatment Period 1|Lost to Follow-up|0|||
23515975|NCT01641692|65627880|FG006|Treatment Period 1|Lost to Follow-up|0|||
23515976|NCT01641692|65627881|FG007|Treatment Period 1|Lost to Follow-up|0|||
23515977|NCT01641692|65627874|FG000|Treatment Period 1|Physician Decision|0|||
23515978|NCT01641692|65627875|FG001|Treatment Period 1|Physician Decision|0|||
23515979|NCT01641692|65627876|FG002|Treatment Period 1|Physician Decision|0|||
23515980|NCT01641692|65627877|FG003|Treatment Period 1|Physician Decision|0|||
23515981|NCT01641692|65627878|FG004|Treatment Period 1|Physician Decision|1|||
23515982|NCT01641692|65627879|FG005|Treatment Period 1|Physician Decision|0|||
23515983|NCT01641692|65627880|FG006|Treatment Period 1|Physician Decision|0|||
23515984|NCT01641692|65627881|FG007|Treatment Period 1|Physician Decision|0|||
23515985|NCT01641692|65627874|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23515986|NCT01641692|65627875|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23515987|NCT01641692|65627876|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23515988|NCT01641692|65627877|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23515989|NCT01641692|65627878|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23515990|NCT01641692|65627879|FG005|Treatment Period 1|Withdrawal by Subject|2|||
23515991|NCT01641692|65627880|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23515992|NCT01641692|65627881|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23515993|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
23515994|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515995|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515996|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515997|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515998|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515999|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23516000|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23516001|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516002|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516003|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516004|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516005|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516006|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516007|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23516008|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516009|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516010|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516011|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516012|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516013|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516014|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516015|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516016|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516017|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516018|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516019|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23516020|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516021|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516022|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23711884|NCT02657551|66319409|FG000|Overall Study|Non-Compliance|1|||
23711885|NCT02657551|66319409|FG000|Overall Study|Progression / Relapse|4|||
23711886|NCT02492997|66319412|FG000|Overall Study|Withdrawal by Subject|1|||
23516023|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23711887|NCT02492997|66319413|FG001|Overall Study|Withdrawal by Subject|0|||
23711888|NCT02492997|66319412|FG000|Overall Study|Gained Weight|1|||
23711889|NCT02492997|66319413|FG001|Overall Study|Gained Weight|0|||
23711890|NCT02492997|66319412|FG000|Overall Study|Lost to Follow-up|0|||
23711891|NCT02492997|66319413|FG001|Overall Study|Lost to Follow-up|1|||
23711892|NCT02504268|66319416|FG000|Overall Study|Adverse Event|18|||
23711893|NCT02504268|66319417|FG001|Overall Study|Adverse Event|8|||
23711894|NCT02504268|66319418|FG002|Overall Study|Adverse Event|14|||
23711895|NCT02504268|66319419|FG003|Overall Study|Adverse Event|0|||
23711896|NCT02504268|66319420|FG004|Overall Study|Adverse Event|0|||
23516024|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23516025|NCT01641692|65627874|FG000|Treatment Period 2|Lack of Efficacy|1|||
23516026|NCT01641692|65627875|FG001|Treatment Period 2|Lack of Efficacy|0|||
23516027|NCT01641692|65627876|FG002|Treatment Period 2|Lack of Efficacy|0|||
23516028|NCT01641692|65627877|FG003|Treatment Period 2|Lack of Efficacy|0|||
23516029|NCT01641692|65627878|FG004|Treatment Period 2|Lack of Efficacy|0|||
23516030|NCT01641692|65627879|FG005|Treatment Period 2|Lack of Efficacy|0|||
23516031|NCT01641692|65627880|FG006|Treatment Period 2|Lack of Efficacy|0|||
23516032|NCT01641692|65627881|FG007|Treatment Period 2|Lack of Efficacy|0|||
23516033|NCT01641692|65627874|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
23516034|NCT01641692|65627875|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516035|NCT01641692|65627876|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516036|NCT01641692|65627877|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516037|NCT01641692|65627878|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516038|NCT01641692|65627879|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516039|NCT01641692|65627880|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516040|NCT01641692|65627881|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516041|NCT01641692|65627874|FG000|Treatment Period 2|Lost to Follow-up|0|||
23516042|NCT01641692|65627875|FG001|Treatment Period 2|Lost to Follow-up|0|||
23711897|NCT02504268|66319421|FG005|Overall Study|Adverse Event|0|||
23711898|NCT02504268|66319422|FG006|Overall Study|Adverse Event|0|||
23711899|NCT02504268|66319423|FG007|Overall Study|Adverse Event|0|||
23711900|NCT02504268|66319424|FG008|Overall Study|Adverse Event|0|||
23711901|NCT02504268|66319416|FG000|Overall Study|Withdrawal of Consent|11|||
23711902|NCT02504268|66319417|FG001|Overall Study|Withdrawal of Consent|10|||
23711903|NCT02504268|66319418|FG002|Overall Study|Withdrawal of Consent|3|||
23711904|NCT02504268|66319419|FG003|Overall Study|Withdrawal of Consent|0|||
23711905|NCT02504268|66319420|FG004|Overall Study|Withdrawal of Consent|0|||
23516043|NCT01641692|65627876|FG002|Treatment Period 2|Lost to Follow-up|0|||
23516044|NCT01641692|65627877|FG003|Treatment Period 2|Lost to Follow-up|0|||
23516045|NCT01641692|65627878|FG004|Treatment Period 2|Lost to Follow-up|0|||
23516046|NCT01641692|65627879|FG005|Treatment Period 2|Lost to Follow-up|1|||
23516047|NCT01641692|65627880|FG006|Treatment Period 2|Lost to Follow-up|0|||
23516048|NCT01641692|65627881|FG007|Treatment Period 2|Lost to Follow-up|0|||
23516049|NCT01641692|65627874|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23516050|NCT01641692|65627875|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23516051|NCT01641692|65627876|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23516052|NCT01641692|65627877|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23516053|NCT01641692|65627878|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23516054|NCT01641692|65627879|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23516055|NCT01641692|65627880|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23516056|NCT01641692|65627881|FG007|Treatment Period 2|Withdrawal by Subject|1|||
23516057|NCT01641692|65627874|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23711906|NCT02504268|66319421|FG005|Overall Study|Withdrawal of Consent|0|||
23711907|NCT02504268|66319422|FG006|Overall Study|Withdrawal of Consent|0|||
23711908|NCT02504268|66319423|FG007|Overall Study|Withdrawal of Consent|0|||
23516058|NCT01641692|65627875|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516059|NCT01641692|65627876|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516060|NCT01641692|65627877|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23711909|NCT02504268|66319424|FG008|Overall Study|Withdrawal of Consent|0|||
23711910|NCT02504268|66319416|FG000|Overall Study|Pregnancy|2|||
23711911|NCT02504268|66319417|FG001|Overall Study|Pregnancy|0|||
23711912|NCT02504268|66319418|FG002|Overall Study|Pregnancy|0|||
23516061|NCT01641692|65627878|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516062|NCT01641692|65627879|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516063|NCT01641692|65627880|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516064|NCT01641692|65627881|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516065|NCT01641692|65627874|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516066|NCT01641692|65627875|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516067|NCT01641692|65627876|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516068|NCT01641692|65627877|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516069|NCT01641692|65627878|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516070|NCT01641692|65627879|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516071|NCT01641692|65627880|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516072|NCT01641692|65627881|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516073|NCT01641692|65627874|FG000|Treatment Period 3|Adverse Event|0|||
23516074|NCT01641692|65627875|FG001|Treatment Period 3|Adverse Event|0|||
23516075|NCT01641692|65627876|FG002|Treatment Period 3|Adverse Event|0|||
23516076|NCT01641692|65627877|FG003|Treatment Period 3|Adverse Event|0|||
23516077|NCT01641692|65627878|FG004|Treatment Period 3|Adverse Event|0|||
23516078|NCT01641692|65627879|FG005|Treatment Period 3|Adverse Event|0|||
23516079|NCT01641692|65627880|FG006|Treatment Period 3|Adverse Event|1|||
23516080|NCT01641692|65627881|FG007|Treatment Period 3|Adverse Event|0|||
23516081|NCT01641692|65627874|FG000|Treatment Period 3|Protocol Violation|0|||
23516082|NCT01641692|65627875|FG001|Treatment Period 3|Protocol Violation|0|||
23516083|NCT01641692|65627876|FG002|Treatment Period 3|Protocol Violation|1|||
23516084|NCT01641692|65627877|FG003|Treatment Period 3|Protocol Violation|0|||
23516085|NCT01641692|65627878|FG004|Treatment Period 3|Protocol Violation|0|||
23516086|NCT01641692|65627879|FG005|Treatment Period 3|Protocol Violation|0|||
23516087|NCT01641692|65627880|FG006|Treatment Period 3|Protocol Violation|0|||
23516088|NCT01641692|65627881|FG007|Treatment Period 3|Protocol Violation|0|||
23516089|NCT01641692|65627874|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516090|NCT01641692|65627875|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516091|NCT01641692|65627876|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516092|NCT01641692|65627877|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516093|NCT01641692|65627878|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516094|NCT01641692|65627879|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516095|NCT01641692|65627880|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23516096|NCT01641692|65627881|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516097|NCT01641692|65627874|FG000|Treatment Period 3|Lost to Follow-up|0|||
23516098|NCT01641692|65627875|FG001|Treatment Period 3|Lost to Follow-up|1|||
23516099|NCT01641692|65627876|FG002|Treatment Period 3|Lost to Follow-up|0|||
23516100|NCT01641692|65627877|FG003|Treatment Period 3|Lost to Follow-up|0|||
23516101|NCT01641692|65627878|FG004|Treatment Period 3|Lost to Follow-up|0|||
23516102|NCT01641692|65627879|FG005|Treatment Period 3|Lost to Follow-up|0|||
23516103|NCT01641692|65627880|FG006|Treatment Period 3|Lost to Follow-up|0|||
23516104|NCT01641692|65627881|FG007|Treatment Period 3|Lost to Follow-up|0|||
23516105|NCT01641692|65627874|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516106|NCT01641692|65627875|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516107|NCT01641692|65627876|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516108|NCT01641692|65627877|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516109|NCT01641692|65627878|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516110|NCT01641692|65627879|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
23516111|NCT01641692|65627880|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516112|NCT01641692|65627881|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516113|NCT01641692|65627874|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516114|NCT01641692|65627875|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516115|NCT01641692|65627876|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516116|NCT01641692|65627877|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516117|NCT01641692|65627878|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516118|NCT01641692|65627879|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516119|NCT01641692|65627880|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516120|NCT01641692|65627881|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516121|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
23516122|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
23516123|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
23516124|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
23516125|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
23516126|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
23516127|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
23516128|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
23516129|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
23516130|NCT02905331|65627882|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
23516131|NCT02905331|65627883|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
23516132|NCT02905331|65627884|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
23516133|NCT02905331|65627882|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
23516134|NCT02905331|65627883|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
23516135|NCT02905331|65627884|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
23516136|NCT01359449|65627885|FG000|Overall Study|Lost to Follow-up|1|||
23516137|NCT01359449|65627886|FG001|Overall Study|Lost to Follow-up|0|||
23516138|NCT01359449|65627885|FG000|Overall Study|Protocol Violation|0|||
23516139|NCT01359449|65627886|FG001|Overall Study|Protocol Violation|2|||
23711913|NCT02504268|66319419|FG003|Overall Study|Pregnancy|0|||
23711914|NCT02504268|66319420|FG004|Overall Study|Pregnancy|0|||
23711915|NCT02504268|66319421|FG005|Overall Study|Pregnancy|0|||
23711916|NCT02504268|66319422|FG006|Overall Study|Pregnancy|0|||
23711917|NCT02504268|66319423|FG007|Overall Study|Pregnancy|0|||
23711918|NCT02504268|66319424|FG008|Overall Study|Pregnancy|0|||
23711919|NCT02504268|66319416|FG000|Overall Study|Lost to Follow-up|3|||
23711920|NCT02504268|66319417|FG001|Overall Study|Lost to Follow-up|6|||
23711921|NCT02504268|66319418|FG002|Overall Study|Lost to Follow-up|4|||
23516140|NCT01359449|65627885|FG000|Overall Study|Withdrawal by Subject|3|||
23516141|NCT01359449|65627886|FG001|Overall Study|Withdrawal by Subject|2|||
23516142|NCT03010254|65627887|FG000|Overall Study|Adverse Event|0|||
23516143|NCT03010254|65627888|FG001|Overall Study|Adverse Event|1|||
23516144|NCT03010254|65627887|FG000|Overall Study|Lost to Follow-up|4|||
23516145|NCT03010254|65627888|FG001|Overall Study|Lost to Follow-up|0|||
23516146|NCT03010254|65627887|FG000|Overall Study|Withdrawal by Subject|1|||
23516147|NCT03010254|65627888|FG001|Overall Study|Withdrawal by Subject|1|||
23516148|NCT03010254|65627887|FG000|Overall Study|Other|2|||
23516149|NCT03010254|65627888|FG001|Overall Study|Other|3|||
23516150|NCT02154581|65627902|FG000|Overall Study|Lost to Follow-up|7|||
23516151|NCT02154581|65627903|FG001|Overall Study|Lost to Follow-up|8|||
23516152|NCT01991067|65627911|FG000|Overall Study|Lost to Follow-up|6|||
23516153|NCT01991067|65627912|FG001|Overall Study|Lost to Follow-up|5|||
23516154|NCT02189473|65627916|FG000|Overall Study|Death|22|||
23516155|NCT02189473|65627917|FG001|Overall Study|Death|23|||
23516156|NCT02189473|65627916|FG000|Overall Study|Lost to Follow-up|1|||
23516157|NCT02189473|65627917|FG001|Overall Study|Lost to Follow-up|2|||
23516158|NCT02197806|65627925|FG000|Overall Study|Adverse Event|0|||
23516159|NCT02197806|65627926|FG001|Overall Study|Adverse Event|1|||
23516160|NCT02197806|65627927|FG002|Overall Study|Adverse Event|0|||
23516161|NCT02197806|65627928|FG003|Overall Study|Adverse Event|1|||
23516162|NCT00100815|65627929|FG000|Overall Study|Progression|24|||
23516163|NCT00100815|65627929|FG000|Overall Study|Adverse Event|18|||
23516164|NCT00100815|65627929|FG000|Overall Study|Death|4|||
23516165|NCT00100815|65627929|FG000|Overall Study|Other|3|||
23516166|NCT03519347|65627932|FG000|Interventional Crossover Period 1|Death|0|||
23516167|NCT03519347|65627933|FG001|Interventional Crossover Period 1|Death|0|||
23516168|NCT03519347|65627934|FG002|Interventional Crossover Period 1|Death|0|||
23516169|NCT03519347|65627935|FG003|Interventional Crossover Period 1|Death|1|||
23711922|NCT02504268|66319419|FG003|Overall Study|Lost to Follow-up|0|||
23516170|NCT03312933|65627936|FG000|Overall Study|Protocol Violation|15|||
23516171|NCT03312933|65627936|FG000|Overall Study|Lost to Follow-up|36|||
23516172|NCT03312933|65627936|FG000|Overall Study|Withdrawal by Subject|3|||
23516173|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
23516174|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
23516175|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
23711923|NCT02504268|66319420|FG004|Overall Study|Lost to Follow-up|0|||
23711924|NCT02504268|66319421|FG005|Overall Study|Lost to Follow-up|0|||
23516176|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
23516177|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
23516178|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
23516179|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
23516180|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
23516181|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
23516182|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
23516183|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
23516184|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
23516185|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
23516186|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
23516187|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
23516188|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
23516189|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
23516190|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
23516191|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
23516192|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
23516193|NCT02063854|65627939|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
23516194|NCT02063854|65627940|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23516195|NCT02063854|65627941|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
23516196|NCT02063854|65627942|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
23516197|NCT02063854|65627943|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
23516198|NCT02063854|65627944|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
23516199|NCT02063854|65627945|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
23516200|NCT02063854|65627939|FG000|Overall Study|Major Protocol Deviation|0|||
23516201|NCT02063854|65627940|FG001|Overall Study|Major Protocol Deviation|0|||
23516202|NCT02063854|65627941|FG002|Overall Study|Major Protocol Deviation|3|||
23516203|NCT02063854|65627942|FG003|Overall Study|Major Protocol Deviation|0|||
23516204|NCT02063854|65627943|FG004|Overall Study|Major Protocol Deviation|0|||
23516205|NCT02063854|65627944|FG005|Overall Study|Major Protocol Deviation|0|||
23516206|NCT02063854|65627945|FG006|Overall Study|Major Protocol Deviation|0|||
23516207|NCT02063854|65627939|FG000|Overall Study|Voluntary Withdrawal|2|||
23516208|NCT02063854|65627940|FG001|Overall Study|Voluntary Withdrawal|0|||
23516209|NCT02063854|65627941|FG002|Overall Study|Voluntary Withdrawal|8|||
23516210|NCT02063854|65627942|FG003|Overall Study|Voluntary Withdrawal|1|||
23516211|NCT02063854|65627943|FG004|Overall Study|Voluntary Withdrawal|3|||
23516212|NCT02063854|65627944|FG005|Overall Study|Voluntary Withdrawal|6|||
23516213|NCT02063854|65627945|FG006|Overall Study|Voluntary Withdrawal|1|||
23516214|NCT02063854|65627939|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
23516215|NCT02063854|65627940|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
23516216|NCT02063854|65627941|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
23516217|NCT02063854|65627942|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516218|NCT02063854|65627943|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516219|NCT02063854|65627944|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
23516220|NCT02063854|65627945|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516221|NCT02063854|65627939|FG000|Overall Study|Reason Not Specified|1|||
23516222|NCT02063854|65627940|FG001|Overall Study|Reason Not Specified|0|||
23516223|NCT02063854|65627941|FG002|Overall Study|Reason Not Specified|0|||
23516224|NCT02063854|65627942|FG003|Overall Study|Reason Not Specified|0|||
23516225|NCT02063854|65627943|FG004|Overall Study|Reason Not Specified|0|||
23516226|NCT02063854|65627944|FG005|Overall Study|Reason Not Specified|0|||
23516227|NCT02063854|65627945|FG006|Overall Study|Reason Not Specified|0|||
23516228|NCT02063854|65627939|FG000|Overall Study|Did Not Receive Study Drug|0|||
23516229|NCT02063854|65627940|FG001|Overall Study|Did Not Receive Study Drug|0|||
23516230|NCT02063854|65627941|FG002|Overall Study|Did Not Receive Study Drug|0|||
23516231|NCT02063854|65627942|FG003|Overall Study|Did Not Receive Study Drug|0|||
23516232|NCT02063854|65627943|FG004|Overall Study|Did Not Receive Study Drug|0|||
23516233|NCT02063854|65627944|FG005|Overall Study|Did Not Receive Study Drug|1|||
23516234|NCT02063854|65627945|FG006|Overall Study|Did Not Receive Study Drug|0|||
23516235|NCT03178773|65627946|FG000|Overall Study|Death|0|||
23516236|NCT03178773|65627947|FG001|Overall Study|Death|1|||
23516237|NCT03178773|65627946|FG000|Overall Study|Lost to Follow-up|29|||
23711925|NCT02504268|66319422|FG006|Overall Study|Lost to Follow-up|0|||
23516238|NCT03178773|65627947|FG001|Overall Study|Lost to Follow-up|25|||
23516239|NCT03178773|65627946|FG000|Overall Study|Withdrawal by Subject|10|||
23516240|NCT03178773|65627947|FG001|Overall Study|Withdrawal by Subject|14|||
23516241|NCT00378209|65627948|FG000|Overall Study|Progressive disease|11|||
23516242|NCT00378209|65627948|FG000|Overall Study|Adverse Event|3|||
23516243|NCT00378209|65627948|FG000|Overall Study|Initiation of non-protocol therapy|3|||
23516244|NCT00378209|65627948|FG000|Overall Study|Physician Decision|3|||
23516245|NCT00378209|65627948|FG000|Overall Study|Death|1|||
23516246|NCT00378209|65627948|FG000|Overall Study|Treatment delay|1|||
23516247|NCT02335099|65627949|FG000|Treatment|Withdrawal by Subject|1|||
23516248|NCT02335099|65627950|FG001|Treatment|Withdrawal by Subject|3|||
23516249|NCT02335099|65627949|FG000|Treatment|Lost to Follow-up|2|||
23516250|NCT02335099|65627950|FG001|Treatment|Lost to Follow-up|0|||
23516251|NCT02335099|65627949|FG000|Treatment|Death|1|||
23516252|NCT02335099|65627950|FG001|Treatment|Death|0|||
23516253|NCT02335099|65627949|FG000|Treatment|Adverse Event|1|||
23516254|NCT02335099|65627950|FG001|Treatment|Adverse Event|2|||
23516255|NCT02335099|65627949|FG000|Follow-up|Death|0|||
23516256|NCT02335099|65627950|FG001|Follow-up|Death|1|||
23516257|NCT01404325|65627956|FG000|Overall Study|Lost to Follow-up|1|||
23516258|NCT01404325|65627957|FG001|Overall Study|Lost to Follow-up|0|||
23516259|NCT01404325|65627956|FG000|Overall Study|Death|2|||
23516260|NCT01404325|65627957|FG001|Overall Study|Death|0|||
23516261|NCT01404325|65627956|FG000|Overall Study|Graft loss/Retransplantation|1|||
23516262|NCT01404325|65627957|FG001|Overall Study|Graft loss/Retransplantation|0|||
23516263|NCT01404325|65627956|FG000|Overall Study|non-specified reason|0|||
23516264|NCT01404325|65627957|FG001|Overall Study|non-specified reason|2|||
23516265|NCT01994629|65627958|FG000|Overall Study|Withdrawal by Subject|1|||
23516266|NCT01994629|65627959|FG001|Overall Study|Withdrawal by Subject|0|||
23516267|NCT01994629|65627958|FG000|Overall Study|Lost to Follow-up|0|||
23516268|NCT01994629|65627959|FG001|Overall Study|Lost to Follow-up|3|||
23516269|NCT03204305|65627960|FG000|Overall Study|Lost to Follow-up|6|||
23516270|NCT03204305|65627961|FG001|Overall Study|Lost to Follow-up|4|||
23516271|NCT03204305|65627962|FG002|Overall Study|Lost to Follow-up|0|||
23516272|NCT03204305|65627963|FG003|Overall Study|Lost to Follow-up|0|||
23516273|NCT03204305|65627960|FG000|Overall Study|Physician Decision|1|||
23516274|NCT03204305|65627961|FG001|Overall Study|Physician Decision|0|||
23516275|NCT03204305|65627962|FG002|Overall Study|Physician Decision|0|||
23516276|NCT03204305|65627963|FG003|Overall Study|Physician Decision|0|||
23516277|NCT03204305|65627960|FG000|Overall Study|failure to place arterial line|2|||
23516278|NCT03204305|65627961|FG001|Overall Study|failure to place arterial line|1|||
23516279|NCT03204305|65627962|FG002|Overall Study|failure to place arterial line|0|||
23516280|NCT03204305|65627963|FG003|Overall Study|failure to place arterial line|0|||
23516281|NCT03204305|65627960|FG000|Overall Study|Withdrawal by Subject|2|||
23516282|NCT03204305|65627961|FG001|Overall Study|Withdrawal by Subject|0|||
23516283|NCT03204305|65627962|FG002|Overall Study|Withdrawal by Subject|0|||
23516284|NCT03204305|65627963|FG003|Overall Study|Withdrawal by Subject|0|||
23516285|NCT01558752|65627965|FG000|Overall Study|Physician Decision|2|||
23516286|NCT01558752|65627966|FG001|Overall Study|Physician Decision|0|||
23516287|NCT01980875|65627967|FG000|Overall Study|Withdrew Consent|1|||
23516288|NCT01980875|65627968|FG001|Overall Study|Withdrew Consent|1|||
23516289|NCT01980875|65627969|FG002|Overall Study|Withdrew Consent|1|||
23516290|NCT01980875|65627967|FG000|Overall Study|Study Terminated by Sponsor|7|||
23516291|NCT01980875|65627968|FG001|Overall Study|Study Terminated by Sponsor|24|||
23516292|NCT01980875|65627969|FG002|Overall Study|Study Terminated by Sponsor|22|||
23516293|NCT01980875|65627967|FG000|Overall Study|Lost to Follow-up|0|||
23516294|NCT01980875|65627968|FG001|Overall Study|Lost to Follow-up|0|||
23516295|NCT01980875|65627969|FG002|Overall Study|Lost to Follow-up|1|||
23516296|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
23516297|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516298|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516299|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516300|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516301|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
23516302|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516303|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516304|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
23516305|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
23516306|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
23516307|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
23516308|NCT00695396|65627974|FG000|Overall Study|Study Closed Prematurely|5|||
23516309|NCT00695396|65627975|FG001|Overall Study|Study Closed Prematurely|6|||
23516310|NCT00695396|65627976|FG002|Overall Study|Study Closed Prematurely|8|||
23516311|NCT00695396|65627974|FG000|Overall Study|Withdrawal by Subject|2|||
23516312|NCT00695396|65627975|FG001|Overall Study|Withdrawal by Subject|2|||
23516313|NCT00695396|65627976|FG002|Overall Study|Withdrawal by Subject|0|||
23516314|NCT01349790|65627977|FG000|Overall Study|Investigator Judgement|3|||
23711926|NCT02504268|66319423|FG007|Overall Study|Lost to Follow-up|0|||
23711927|NCT02504268|66319424|FG008|Overall Study|Lost to Follow-up|0|||
23711928|NCT02504268|66319416|FG000|Overall Study|Death|1|||
23711929|NCT02504268|66319417|FG001|Overall Study|Death|1|||
23711930|NCT02504268|66319418|FG002|Overall Study|Death|0|||
23711931|NCT02504268|66319419|FG003|Overall Study|Death|0|||
23711932|NCT02504268|66319420|FG004|Overall Study|Death|0|||
23711933|NCT02504268|66319421|FG005|Overall Study|Death|0|||
23711934|NCT02504268|66319422|FG006|Overall Study|Death|0|||
23711935|NCT02504268|66319423|FG007|Overall Study|Death|0|||
23711936|NCT02504268|66319424|FG008|Overall Study|Death|0|||
23711937|NCT02504268|66319416|FG000|Overall Study|Subject Request to Discontinue|11|||
23711938|NCT02504268|66319417|FG001|Overall Study|Subject Request to Discontinue|3|||
23711939|NCT02504268|66319418|FG002|Overall Study|Subject Request to Discontinue|6|||
23711940|NCT02504268|66319419|FG003|Overall Study|Subject Request to Discontinue|0|||
23516315|NCT01349790|65627977|FG000|Overall Study|Death|2|||
23516316|NCT01349790|65627977|FG000|Overall Study|Withdrawal by Patient|2|||
23516317|NCT01349790|65627977|FG000|Overall Study|Adverse Event|1|||
23516318|NCT01349790|65627977|FG000|Overall Study|Lost to Follow-up|1|||
23516319|NCT00006903|65627981|FG000|Overall Study|Still receiving treatment|0|||
23711941|NCT02504268|66319420|FG004|Overall Study|Subject Request to Discontinue|0|||
23711942|NCT02504268|66319421|FG005|Overall Study|Subject Request to Discontinue|0|||
23711943|NCT02504268|66319422|FG006|Overall Study|Subject Request to Discontinue|0|||
23711944|NCT02504268|66319423|FG007|Overall Study|Subject Request to Discontinue|0|||
23711945|NCT02504268|66319424|FG008|Overall Study|Subject Request to Discontinue|0|||
23711946|NCT02504268|66319416|FG000|Overall Study|No Longer Meets Study Criteria|2|||
23711947|NCT02504268|66319417|FG001|Overall Study|No Longer Meets Study Criteria|3|||
23711948|NCT02504268|66319418|FG002|Overall Study|No Longer Meets Study Criteria|0|||
23516320|NCT00006903|65627982|FG001|Overall Study|Still receiving treatment|0|||
23516321|NCT00006903|65627983|FG002|Overall Study|Still receiving treatment|1|||
23516322|NCT00006903|65627981|FG000|Overall Study|Refused further treatment|0|||
23516323|NCT00006903|65627982|FG001|Overall Study|Refused further treatment|2|||
23516324|NCT00006903|65627983|FG002|Overall Study|Refused further treatment|1|||
23516325|NCT00006903|65627981|FG000|Overall Study|Adverse Event|0|||
23516326|NCT00006903|65627982|FG001|Overall Study|Adverse Event|0|||
23516327|NCT00006903|65627983|FG002|Overall Study|Adverse Event|1|||
23516328|NCT00006903|65627981|FG000|Overall Study|Death|0|||
23516329|NCT00006903|65627982|FG001|Overall Study|Death|1|||
23516330|NCT00006903|65627983|FG002|Overall Study|Death|0|||
23516331|NCT00006903|65627981|FG000|Overall Study|Patient never treated|0|||
23516332|NCT00006903|65627982|FG001|Overall Study|Patient never treated|0|||
23516333|NCT00006903|65627983|FG002|Overall Study|Patient never treated|1|||
23516334|NCT00006903|65627981|FG000|Overall Study|Ineligible|10|||
23516335|NCT00006903|65627982|FG001|Overall Study|Ineligible|1|||
23516336|NCT00006903|65627983|FG002|Overall Study|Ineligible|2|||
23516337|NCT00276159|65627984|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
23516338|NCT00422591|65627985|FG000|Overall Study|Physician Decision|4|||
23516339|NCT00422591|65627985|FG000|Overall Study|Withdrawal by Subject|2|||
23516340|NCT00665847|65627986|FG000|Overall Study|Adverse Event|8|||
23516341|NCT00665847|65627986|FG000|Overall Study|Withdrawal by Subject|2|||
23516342|NCT00665847|65627986|FG000|Overall Study|Subject non-compliant|8|||
23516343|NCT00665847|65627986|FG000|Overall Study|Subject reached a virologic endpoint|4|||
23516344|NCT00665847|65627986|FG000|Overall Study|Resistance to TMC125|1|||
23516345|NCT00665847|65627986|FG000|Overall Study|Subject ineligible to continue the trial|1|||
23516346|NCT00665847|65627986|FG000|Overall Study|Switch to Commercial Medication|1|||
23711949|NCT02504268|66319419|FG003|Overall Study|No Longer Meets Study Criteria|0|||
23711950|NCT02504268|66319420|FG004|Overall Study|No Longer Meets Study Criteria|0|||
23711951|NCT02504268|66319421|FG005|Overall Study|No Longer Meets Study Criteria|0|||
23711952|NCT02504268|66319422|FG006|Overall Study|No Longer Meets Study Criteria|0|||
23711953|NCT02504268|66319423|FG007|Overall Study|No Longer Meets Study Criteria|0|||
23711954|NCT02504268|66319424|FG008|Overall Study|No Longer Meets Study Criteria|0|||
23711955|NCT02504268|66319416|FG000|Overall Study|Lack of Efficacy|11|||
23711956|NCT02504268|66319417|FG001|Overall Study|Lack of Efficacy|35|||
23711957|NCT02504268|66319418|FG002|Overall Study|Lack of Efficacy|9|||
23711958|NCT02504268|66319419|FG003|Overall Study|Lack of Efficacy|0|||
23711959|NCT02504268|66319420|FG004|Overall Study|Lack of Efficacy|0|||
23711960|NCT02504268|66319421|FG005|Overall Study|Lack of Efficacy|0|||
23711961|NCT02504268|66319422|FG006|Overall Study|Lack of Efficacy|0|||
23711962|NCT02504268|66319423|FG007|Overall Study|Lack of Efficacy|0|||
23711963|NCT02504268|66319424|FG008|Overall Study|Lack of Efficacy|0|||
23711964|NCT02504268|66319416|FG000|Overall Study|Poor/Non-Compliance|3|||
23711965|NCT02504268|66319417|FG001|Overall Study|Poor/Non-Compliance|2|||
23711966|NCT02504268|66319418|FG002|Overall Study|Poor/Non-Compliance|3|||
23711967|NCT02504268|66319419|FG003|Overall Study|Poor/Non-Compliance|0|||
23711968|NCT02504268|66319420|FG004|Overall Study|Poor/Non-Compliance|0|||
23516347|NCT01372501|65627987|FG000|Overall Study|Adverse Event|4|||
23516348|NCT01372501|65627987|FG000|Overall Study|Device migration|1|||
23516349|NCT01106898|65627988|FG000|Overall Study|Adverse Event|6|||
23516350|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Death|3|||
23516351|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Death|2|||
23516352|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Death|0|||
23516353|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Death|0|||
23516354|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Death|0|||
23516355|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Death|0|||
23711969|NCT02504268|66319421|FG005|Overall Study|Poor/Non-Compliance|0|||
23711970|NCT02504268|66319422|FG006|Overall Study|Poor/Non-Compliance|0|||
23711971|NCT02504268|66319423|FG007|Overall Study|Poor/Non-Compliance|0|||
23516356|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Death|0|||
23711972|NCT02504268|66319424|FG008|Overall Study|Poor/Non-Compliance|0|||
23711973|NCT02504268|66319416|FG000|Overall Study|Not Disclosed|1|||
23711974|NCT02504268|66319417|FG001|Overall Study|Not Disclosed|0|||
23711975|NCT02504268|66319418|FG002|Overall Study|Not Disclosed|2|||
23711976|NCT02504268|66319419|FG003|Overall Study|Not Disclosed|0|||
23711977|NCT02504268|66319420|FG004|Overall Study|Not Disclosed|0|||
23711978|NCT02504268|66319421|FG005|Overall Study|Not Disclosed|0|||
23711979|NCT02504268|66319422|FG006|Overall Study|Not Disclosed|0|||
23711980|NCT02504268|66319423|FG007|Overall Study|Not Disclosed|0|||
23711981|NCT02504268|66319424|FG008|Overall Study|Not Disclosed|0|||
23711982|NCT03580382|66319425|FG000|Overall Study|Early Termination of Study|0|||
23711983|NCT03580382|66319426|FG001|Overall Study|Early Termination of Study|3|||
23711984|NCT01969799|66319427|FG000|Overall Study|Adverse Event|0|||
23711985|NCT01969799|66319428|FG001|Overall Study|Adverse Event|1|||
23711986|NCT01969799|66319427|FG000|Overall Study|Death|16|||
23711987|NCT01969799|66319428|FG001|Overall Study|Death|11|||
23711988|NCT01969799|66319427|FG000|Overall Study|Lost to Follow-up|0|||
23711989|NCT01969799|66319428|FG001|Overall Study|Lost to Follow-up|2|||
23711990|NCT01969799|66319427|FG000|Overall Study|Physician Decision|1|||
23711991|NCT01969799|66319428|FG001|Overall Study|Physician Decision|0|||
23711992|NCT01795898|66319431|FG000|Overall Study|Adverse Event|27|||
23711993|NCT01795898|66319431|FG000|Overall Study|Lost to Follow-up|20|||
23711994|NCT01795898|66319431|FG000|Overall Study|Withdrawal of consent|6|||
23711995|NCT01795898|66319431|FG000|Overall Study|Diagnosed with metastasis|1|||
23711996|NCT01795898|66319431|FG000|Overall Study|No pain|1|||
23711997|NCT01795898|66319431|FG000|Overall Study|Death|1|||
23711998|NCT01795898|66319431|FG000|Overall Study|Withdrew consent & had adverse events|3|||
23711999|NCT01795898|66319431|FG000|Overall Study|Physician Decision|1|||
23712000|NCT01397552|66319432|FG000|Overall Study|Adverse Event|1|||
23712001|NCT01397552|66319433|FG001|Overall Study|Adverse Event|0|||
23712002|NCT01397552|66319432|FG000|Overall Study|Withdrawal by Subject|2|||
23516357|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Death|0|||
23516358|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
23516359|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516360|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516361|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516362|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516363|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516364|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516365|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516366|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516367|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
23516368|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516369|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516370|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516371|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516372|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516373|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516374|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
23516375|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
23516376|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
23516377|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
23516378|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
23516379|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
23516380|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
23516381|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
23516382|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516383|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516384|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
23516385|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
23516386|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
23516387|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516388|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516389|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516390|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516391|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23712003|NCT01397552|66319433|FG001|Overall Study|Withdrawal by Subject|1|||
23712004|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
23712005|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
23712006|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
23712007|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
23712008|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Death|8|||
23712009|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Death|3|||
23712010|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
23516392|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
23516393|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516394|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516395|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516396|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516397|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516398|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Death|0|||
23516399|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Death|0|||
23516400|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Death|1|||
23516401|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Death|0|||
23516402|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Death|0|||
23516403|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Death|0|||
23516404|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Death|0|||
23516405|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Death|0|||
23516406|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Not treated|0|||
23516407|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Not treated|0|||
23516408|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Not treated|0|||
23516409|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Not treated|1|||
23516410|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Not treated|0|||
23516411|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Not treated|0|||
23516412|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Not treated|0|||
23516413|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Not treated|0|||
23516414|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Adverse Event|0|||
23516415|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Adverse Event|0|||
23516416|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Adverse Event|0|||
23516417|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Adverse Event|0|||
23516418|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Adverse Event|0|||
23516419|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Adverse Event|4|||
23516420|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Adverse Event|0|||
23516421|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Adverse Event|2|||
23516422|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Death|0|||
23516423|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Death|0|||
23516424|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Death|0|||
23516425|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Death|0|||
23516426|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Death|0|||
23516427|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Death|24|||
23516428|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Death|0|||
23516429|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Death|3|||
23516430|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516431|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516432|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516433|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516434|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516435|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516436|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516437|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
23516438|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Physician Decision|0|||
23516439|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Physician Decision|0|||
23516440|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Physician Decision|0|||
23516441|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Physician Decision|0|||
23516442|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Physician Decision|0|||
23516443|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Physician Decision|1|||
23516444|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Physician Decision|0|||
23516445|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Physician Decision|0|||
23516446|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
23516447|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
23516448|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
23516449|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
23516450|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
23516451|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
23516452|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
23516453|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
23516454|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516455|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516456|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516457|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516458|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516459|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
23516460|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516461|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
23516462|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516463|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516464|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516465|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516466|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516467|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
23516468|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
23516469|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
23516470|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Not Treated|0|||
23516471|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Not Treated|0|||
23516472|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Not Treated|0|||
23516473|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Not Treated|0|||
23516474|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Not Treated|0|||
23516475|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Not Treated|2|||
23516476|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Not Treated|0|||
23516477|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Not Treated|0|||
23516478|NCT01361464|65627999|FG000|Overall Study|Death|1|||
23516479|NCT01361464|65627999|FG000|Overall Study|Withdrawal by Subject|2|||
23516480|NCT02587065|65628001|FG000|Overall Study|Adverse Event|14|||
23516481|NCT02587065|65628001|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
23516482|NCT02587065|65628001|FG000|Overall Study|Non-adherence to the Protocol|3|||
23516483|NCT02587065|65628001|FG000|Overall Study|Discontinuation of Study Medication|2|||
23516484|NCT02587065|65628001|FG000|Overall Study|Reason not Specified|3|||
23516485|NCT01928329|65628002|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
23516486|NCT01928329|65628003|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
23516487|NCT01928329|65628002|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
23516488|NCT01928329|65628003|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
23516489|NCT01928329|65628002|FG000|Overall Study|Adverse Event|5|||
23516490|NCT01928329|65628003|FG001|Overall Study|Adverse Event|3|||
23516491|NCT01928329|65628002|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
23516492|NCT01928329|65628003|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
23516493|NCT01928329|65628002|FG000|Overall Study|Withdrawal by Subject|1|||
23516494|NCT01928329|65628003|FG001|Overall Study|Withdrawal by Subject|5|||
23516495|NCT01928329|65628002|FG000|Overall Study|Physician Decision|1|||
23516496|NCT01928329|65628003|FG001|Overall Study|Physician Decision|1|||
23516497|NCT03340025|65628004|FG000|Overall Study|Lost to Follow-up|2|||
23516498|NCT03340025|65628005|FG001|Overall Study|Lost to Follow-up|2|||
23516499|NCT02746874|65628007|FG000|Overall Study|Withdrawal by Subject|0|||
23516500|NCT02746874|65628008|FG001|Overall Study|Withdrawal by Subject|1|||
23516501|NCT02746874|65628007|FG000|Overall Study|Surgery Date Changed|0|||
23516502|NCT02746874|65628008|FG001|Overall Study|Surgery Date Changed|2|||
23516503|NCT00488345|65628009|FG000|Overall Study|Adverse Event|0|||
23516504|NCT00488345|65628010|FG001|Overall Study|Adverse Event|1|||
23516505|NCT00488345|65628011|FG002|Overall Study|Adverse Event|1|||
23516506|NCT00488345|65628009|FG000|Overall Study|Unable to administer antibiotics at home|0|||
23516507|NCT00488345|65628010|FG001|Overall Study|Unable to administer antibiotics at home|1|||
23516508|NCT00488345|65628011|FG002|Overall Study|Unable to administer antibiotics at home|0|||
23516509|NCT00488345|65628009|FG000|Overall Study|Institutional Review Board review|0|||
23516510|NCT00488345|65628010|FG001|Overall Study|Institutional Review Board review|0|||
23516511|NCT00488345|65628011|FG002|Overall Study|Institutional Review Board review|1|||
23516512|NCT00488345|65628009|FG000|Overall Study|Surgical team recommendation|0|||
23516513|NCT00488345|65628010|FG001|Overall Study|Surgical team recommendation|1|||
23516514|NCT00488345|65628011|FG002|Overall Study|Surgical team recommendation|0|||
23516515|NCT00488345|65628009|FG000|Overall Study|Parent/legal guardian request|0|||
23416115|NCT00152477|65266154|FG000|Chemotherapy Period|Lack of Efficacy|4|||
23416116|NCT00152477|65266155|FG001|Chemotherapy Period|Lack of Efficacy|5|||
23416117|NCT00152477|65266156|FG002|Chemotherapy Period|Lack of Efficacy|6|||
23416118|NCT00152477|65266154|FG000|Chemotherapy Period|Lost to Follow-up|1|||
23416119|NCT00152477|65266155|FG001|Chemotherapy Period|Lost to Follow-up|0|||
23416120|NCT00152477|65266156|FG002|Chemotherapy Period|Lost to Follow-up|1|||
23416121|NCT00152477|65266154|FG000|Chemotherapy Period|Protocol Violation|1|||
23416122|NCT00152477|65266155|FG001|Chemotherapy Period|Protocol Violation|1|||
23416123|NCT00152477|65266156|FG002|Chemotherapy Period|Protocol Violation|0|||
23416124|NCT00152477|65266154|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
23416125|NCT00152477|65266155|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
23416126|NCT00152477|65266156|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
23416127|NCT00152477|65266154|FG000|Chemotherapy Period|Progression of Disease|6|||
23516516|NCT00488345|65628010|FG001|Overall Study|Parent/legal guardian request|1|||
23516517|NCT00488345|65628011|FG002|Overall Study|Parent/legal guardian request|1|||
23516518|NCT00810407|65628013|FG000|Overall Study|Protocol Violation|3|||
23516519|NCT00810407|65628013|FG000|Overall Study|No Visit After First Day of Treatment|3|||
23516520|NCT00481195|65628014|FG000|Overall Study|Adverse Event|16|||
23516521|NCT00481195|65628015|FG001|Overall Study|Adverse Event|11|||
23516522|NCT00481195|65628014|FG000|Overall Study|Lack of Efficacy|1|||
23516523|NCT00481195|65628015|FG001|Overall Study|Lack of Efficacy|3|||
23516524|NCT00481195|65628014|FG000|Overall Study|Lost to Follow-up|4|||
23516525|NCT00481195|65628015|FG001|Overall Study|Lost to Follow-up|6|||
23516526|NCT00481195|65628014|FG000|Overall Study|Physician Decision|3|||
23516527|NCT00481195|65628015|FG001|Overall Study|Physician Decision|1|||
23516528|NCT00481195|65628014|FG000|Overall Study|Protocol Violation|10|||
23516529|NCT00481195|65628015|FG001|Overall Study|Protocol Violation|7|||
23516530|NCT00481195|65628014|FG000|Overall Study|Withdrawal by Subject|3|||
23516531|NCT00481195|65628015|FG001|Overall Study|Withdrawal by Subject|9|||
23516532|NCT00481195|65628014|FG000|Overall Study|Miscellaneous|2|||
23516533|NCT00481195|65628015|FG001|Overall Study|Miscellaneous|2|||
23516534|NCT02677922|65628016|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23516535|NCT02677922|65628017|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
23516536|NCT02677922|65628018|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
23516537|NCT02677922|65628019|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
23516538|NCT02677922|65628020|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
23516539|NCT02677922|65628021|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
23516540|NCT02677922|65628016|FG000|Treatment Period|Adverse Event|0|||
23516541|NCT02677922|65628017|FG001|Treatment Period|Adverse Event|0|||
23516542|NCT02677922|65628018|FG002|Treatment Period|Adverse Event|1|||
23516543|NCT02677922|65628019|FG003|Treatment Period|Adverse Event|3|||
23516544|NCT02677922|65628020|FG004|Treatment Period|Adverse Event|5|||
23516545|NCT02677922|65628021|FG005|Treatment Period|Adverse Event|2|||
23516546|NCT02677922|65628016|FG000|Treatment Period|Progressive Disease|1|||
23516547|NCT02677922|65628017|FG001|Treatment Period|Progressive Disease|1|||
23516548|NCT02677922|65628018|FG002|Treatment Period|Progressive Disease|0|||
23516549|NCT02677922|65628019|FG003|Treatment Period|Progressive Disease|0|||
23516550|NCT02677922|65628020|FG004|Treatment Period|Progressive Disease|8|||
23516551|NCT02677922|65628021|FG005|Treatment Period|Progressive Disease|7|||
23516552|NCT02677922|65628016|FG000|Treatment Period|Lack of Efficacy|0|||
23516553|NCT02677922|65628017|FG001|Treatment Period|Lack of Efficacy|0|||
23516554|NCT02677922|65628018|FG002|Treatment Period|Lack of Efficacy|0|||
23516555|NCT02677922|65628019|FG003|Treatment Period|Lack of Efficacy|1|||
23516556|NCT02677922|65628020|FG004|Treatment Period|Lack of Efficacy|1|||
23516557|NCT02677922|65628021|FG005|Treatment Period|Lack of Efficacy|6|||
23516558|NCT02677922|65628016|FG000|Treatment Period|Withdrawal by Subject|0|||
23516559|NCT02677922|65628017|FG001|Treatment Period|Withdrawal by Subject|0|||
23516560|NCT02677922|65628018|FG002|Treatment Period|Withdrawal by Subject|1|||
23516561|NCT02677922|65628019|FG003|Treatment Period|Withdrawal by Subject|3|||
23712011|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
23712012|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
23712013|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
23712014|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
23516562|NCT02677922|65628020|FG004|Treatment Period|Withdrawal by Subject|5|||
23516563|NCT02677922|65628021|FG005|Treatment Period|Withdrawal by Subject|5|||
23516564|NCT02677922|65628016|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
23516565|NCT02677922|65628017|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
23516566|NCT02677922|65628018|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
23516567|NCT02677922|65628019|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
23516568|NCT02677922|65628020|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
23516569|NCT02677922|65628021|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
23516570|NCT02677922|65628016|FG000|Treatment Period|Disease Relapse|0|||
23516571|NCT02677922|65628017|FG001|Treatment Period|Disease Relapse|0|||
23516572|NCT02677922|65628018|FG002|Treatment Period|Disease Relapse|0|||
23516573|NCT02677922|65628019|FG003|Treatment Period|Disease Relapse|3|||
23516574|NCT02677922|65628020|FG004|Treatment Period|Disease Relapse|6|||
23516575|NCT02677922|65628021|FG005|Treatment Period|Disease Relapse|1|||
23516576|NCT02677922|65628016|FG000|Treatment Period|Allogeneic HSCT|1|||
23516577|NCT02677922|65628017|FG001|Treatment Period|Allogeneic HSCT|0|||
23516578|NCT02677922|65628018|FG002|Treatment Period|Allogeneic HSCT|0|||
23516579|NCT02677922|65628019|FG003|Treatment Period|Allogeneic HSCT|1|||
23516580|NCT02677922|65628020|FG004|Treatment Period|Allogeneic HSCT|4|||
23516581|NCT02677922|65628021|FG005|Treatment Period|Allogeneic HSCT|1|||
23516582|NCT02677922|65628016|FG000|Treatment Period|Other Reasons|0|||
23516583|NCT02677922|65628017|FG001|Treatment Period|Other Reasons|0|||
23516584|NCT02677922|65628018|FG002|Treatment Period|Other Reasons|0|||
23516585|NCT02677922|65628019|FG003|Treatment Period|Other Reasons|1|||
23516586|NCT02677922|65628020|FG004|Treatment Period|Other Reasons|3|||
23516587|NCT02677922|65628021|FG005|Treatment Period|Other Reasons|5|||
23516588|NCT02677922|65628016|FG000|Treatment Period|Death|0|||
23516589|NCT02677922|65628017|FG001|Treatment Period|Death|0|||
23516590|NCT02677922|65628018|FG002|Treatment Period|Death|0|||
23516591|NCT02677922|65628019|FG003|Treatment Period|Death|0|||
23516592|NCT02677922|65628020|FG004|Treatment Period|Death|12|||
23516593|NCT02677922|65628021|FG005|Treatment Period|Death|1|||
23516594|NCT02677922|65628016|FG000|Treatment Period|Non-compliance with Study Drug|0|||
23516595|NCT02677922|65628017|FG001|Treatment Period|Non-compliance with Study Drug|0|||
23516596|NCT02677922|65628018|FG002|Treatment Period|Non-compliance with Study Drug|0|||
23516597|NCT02677922|65628019|FG003|Treatment Period|Non-compliance with Study Drug|0|||
23516598|NCT02677922|65628020|FG004|Treatment Period|Non-compliance with Study Drug|1|||
23516599|NCT02677922|65628021|FG005|Treatment Period|Non-compliance with Study Drug|0|||
23516600|NCT02677922|65628016|FG000|Treatment Period|Physician Decision|0|||
23516601|NCT02677922|65628017|FG001|Treatment Period|Physician Decision|0|||
23516602|NCT02677922|65628018|FG002|Treatment Period|Physician Decision|0|||
23516603|NCT02677922|65628019|FG003|Treatment Period|Physician Decision|0|||
23516604|NCT02677922|65628020|FG004|Treatment Period|Physician Decision|0|||
23516605|NCT02677922|65628021|FG005|Treatment Period|Physician Decision|1|||
23516606|NCT02677922|65628016|FG000|Treatment Period|Symptomatic Deterioration|0|||
23516607|NCT02677922|65628017|FG001|Treatment Period|Symptomatic Deterioration|0|||
23516608|NCT02677922|65628018|FG002|Treatment Period|Symptomatic Deterioration|0|||
23516609|NCT02677922|65628019|FG003|Treatment Period|Symptomatic Deterioration|0|||
23516610|NCT02677922|65628020|FG004|Treatment Period|Symptomatic Deterioration|1|||
23516611|NCT02677922|65628021|FG005|Treatment Period|Symptomatic Deterioration|0|||
23516612|NCT01729754|65628022|FG000|Part 1|Adverse Event|2|||
23516613|NCT01729754|65628023|FG001|Part 1|Adverse Event|0|||
23516614|NCT01729754|65628024|FG002|Part 1|Adverse Event|0|||
23516615|NCT01729754|65628025|FG003|Part 1|Adverse Event|1|||
23516616|NCT01729754|65628026|FG004|Part 1|Adverse Event|0|||
23516617|NCT01729754|65628027|FG005|Part 1|Adverse Event|0|||
23516618|NCT01729754|65628028|FG006|Part 1|Adverse Event|2|||
23516619|NCT01729754|65628029|FG007|Part 1|Adverse Event|0|||
23516620|NCT01729754|65628030|FG008|Part 1|Adverse Event|0|||
23516621|NCT01729754|65628031|FG009|Part 1|Adverse Event|5|||
23516622|NCT01729754|65628022|FG000|Part 1|Lack of Efficacy|1|||
23516623|NCT01729754|65628023|FG001|Part 1|Lack of Efficacy|0|||
23516624|NCT01729754|65628024|FG002|Part 1|Lack of Efficacy|0|||
23516625|NCT01729754|65628025|FG003|Part 1|Lack of Efficacy|0|||
23516626|NCT01729754|65628026|FG004|Part 1|Lack of Efficacy|0|||
23516627|NCT01729754|65628027|FG005|Part 1|Lack of Efficacy|0|||
23516628|NCT01729754|65628028|FG006|Part 1|Lack of Efficacy|2|||
23516629|NCT01729754|65628029|FG007|Part 1|Lack of Efficacy|0|||
23516630|NCT01729754|65628030|FG008|Part 1|Lack of Efficacy|0|||
23516631|NCT01729754|65628031|FG009|Part 1|Lack of Efficacy|0|||
23516632|NCT01729754|65628022|FG000|Part 1|Lost to Follow-up|1|||
23516633|NCT01729754|65628023|FG001|Part 1|Lost to Follow-up|0|||
23516634|NCT01729754|65628024|FG002|Part 1|Lost to Follow-up|0|||
23516635|NCT01729754|65628025|FG003|Part 1|Lost to Follow-up|2|||
23516636|NCT01729754|65628026|FG004|Part 1|Lost to Follow-up|0|||
23516637|NCT01729754|65628027|FG005|Part 1|Lost to Follow-up|0|||
23516638|NCT01729754|65628028|FG006|Part 1|Lost to Follow-up|3|||
23516639|NCT01729754|65628029|FG007|Part 1|Lost to Follow-up|0|||
23516640|NCT01729754|65628030|FG008|Part 1|Lost to Follow-up|0|||
23516641|NCT01729754|65628031|FG009|Part 1|Lost to Follow-up|3|||
23516642|NCT01729754|65628022|FG000|Part 1|Non-compliance with Study Drug|1|||
23516643|NCT01729754|65628023|FG001|Part 1|Non-compliance with Study Drug|0|||
23516644|NCT01729754|65628024|FG002|Part 1|Non-compliance with Study Drug|0|||
23516645|NCT01729754|65628025|FG003|Part 1|Non-compliance with Study Drug|0|||
23516646|NCT01729754|65628026|FG004|Part 1|Non-compliance with Study Drug|0|||
23516647|NCT01729754|65628027|FG005|Part 1|Non-compliance with Study Drug|0|||
23516648|NCT01729754|65628028|FG006|Part 1|Non-compliance with Study Drug|0|||
23516649|NCT01729754|65628029|FG007|Part 1|Non-compliance with Study Drug|0|||
23516650|NCT01729754|65628030|FG008|Part 1|Non-compliance with Study Drug|0|||
23516651|NCT01729754|65628031|FG009|Part 1|Non-compliance with Study Drug|0|||
23516652|NCT01729754|65628022|FG000|Part 1|Physician Decision|0|||
23516653|NCT01729754|65628023|FG001|Part 1|Physician Decision|0|||
23516654|NCT01729754|65628024|FG002|Part 1|Physician Decision|0|||
23516655|NCT01729754|65628025|FG003|Part 1|Physician Decision|0|||
23516656|NCT01729754|65628026|FG004|Part 1|Physician Decision|0|||
23516657|NCT01729754|65628027|FG005|Part 1|Physician Decision|0|||
23516658|NCT01729754|65628028|FG006|Part 1|Physician Decision|0|||
23516659|NCT01729754|65628029|FG007|Part 1|Physician Decision|0|||
23516660|NCT01729754|65628030|FG008|Part 1|Physician Decision|0|||
23516661|NCT01729754|65628031|FG009|Part 1|Physician Decision|4|||
23516662|NCT01729754|65628022|FG000|Part 1|Pregnancy|0|||
23516663|NCT01729754|65628023|FG001|Part 1|Pregnancy|0|||
23516664|NCT01729754|65628024|FG002|Part 1|Pregnancy|0|||
23516665|NCT01729754|65628025|FG003|Part 1|Pregnancy|1|||
23516666|NCT01729754|65628026|FG004|Part 1|Pregnancy|0|||
23516667|NCT01729754|65628027|FG005|Part 1|Pregnancy|0|||
23516668|NCT01729754|65628028|FG006|Part 1|Pregnancy|0|||
23516669|NCT01729754|65628029|FG007|Part 1|Pregnancy|0|||
23516670|NCT01729754|65628030|FG008|Part 1|Pregnancy|0|||
23516671|NCT01729754|65628031|FG009|Part 1|Pregnancy|1|||
23516672|NCT01729754|65628022|FG000|Part 1|Progressive Disease|0|||
23516673|NCT01729754|65628023|FG001|Part 1|Progressive Disease|0|||
23516674|NCT01729754|65628024|FG002|Part 1|Progressive Disease|0|||
23712015|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
23712016|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
23712017|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
23712018|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
23712019|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
23712020|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
23712021|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
23712022|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
23416128|NCT00152477|65266155|FG001|Chemotherapy Period|Progression of Disease|8|||
23416129|NCT00152477|65266156|FG002|Chemotherapy Period|Progression of Disease|4|||
23416130|NCT00152477|65266154|FG000|Chemotherapy Period|Investigator decision|0|||
23416131|NCT00152477|65266155|FG001|Chemotherapy Period|Investigator decision|0|||
23416132|NCT00152477|65266156|FG002|Chemotherapy Period|Investigator decision|1|||
23416133|NCT00152477|65266154|FG000|Chemotherapy Period|Patient condition worsened|1|||
23416134|NCT00152477|65266155|FG001|Chemotherapy Period|Patient condition worsened|0|||
23416135|NCT00152477|65266156|FG002|Chemotherapy Period|Patient condition worsened|0|||
23416136|NCT00152477|65266154|FG000|Monotherapy Period|Adverse Event|1|||
23416137|NCT00152477|65266155|FG001|Monotherapy Period|Adverse Event|0|||
23416138|NCT00152477|65266156|FG002|Monotherapy Period|Adverse Event|5|||
23416139|NCT00152477|65266154|FG000|Monotherapy Period|Death|2|||
23416140|NCT00152477|65266155|FG001|Monotherapy Period|Death|0|||
23416141|NCT00152477|65266156|FG002|Monotherapy Period|Death|1|||
23416142|NCT00152477|65266154|FG000|Monotherapy Period|Lack of Efficacy|7|||
23416143|NCT00152477|65266155|FG001|Monotherapy Period|Lack of Efficacy|16|||
23416144|NCT00152477|65266156|FG002|Monotherapy Period|Lack of Efficacy|10|||
23416145|NCT00152477|65266154|FG000|Monotherapy Period|Protocol Violation|0|||
23416146|NCT00152477|65266155|FG001|Monotherapy Period|Protocol Violation|1|||
23416147|NCT00152477|65266156|FG002|Monotherapy Period|Protocol Violation|0|||
23416148|NCT00152477|65266154|FG000|Monotherapy Period|Withdrawal by Subject|0|||
23416149|NCT00152477|65266155|FG001|Monotherapy Period|Withdrawal by Subject|0|||
23416150|NCT00152477|65266156|FG002|Monotherapy Period|Withdrawal by Subject|4|||
23416151|NCT00152477|65266154|FG000|Monotherapy Period|Progression of Disease|5|||
23416152|NCT00152477|65266155|FG001|Monotherapy Period|Progression of Disease|11|||
23416153|NCT00152477|65266156|FG002|Monotherapy Period|Progression of Disease|12|||
23416154|NCT00152477|65266154|FG000|Monotherapy Period|Patient decision|0|||
23416155|NCT00152477|65266155|FG001|Monotherapy Period|Patient decision|1|||
23416156|NCT00152477|65266156|FG002|Monotherapy Period|Patient decision|1|||
23416157|NCT00152477|65266154|FG000|Monotherapy Period|Study personel decision|0|||
23416158|NCT00152477|65266155|FG001|Monotherapy Period|Study personel decision|0|||
23416159|NCT00152477|65266156|FG002|Monotherapy Period|Study personel decision|1|||
23416160|NCT02851797|65266157|FG000|Overall Study|Withdrawal by Subject|4|||
23416161|NCT02851797|65266158|FG001|Overall Study|Withdrawal by Subject|2|||
23416162|NCT02851797|65266157|FG000|Overall Study|Adverse Event|3|||
23416163|NCT02851797|65266158|FG001|Overall Study|Adverse Event|0|||
23416164|NCT00113399|65266161|FG000|Overall Study|Death|1|||
23416165|NCT00113399|65266162|FG001|Overall Study|Death|1|||
23416166|NCT00113399|65266161|FG000|Overall Study|Withdrawal by Subject|1|||
23416167|NCT00113399|65266162|FG001|Overall Study|Withdrawal by Subject|2|||
23416168|NCT00113399|65266161|FG000|Overall Study|Complete Response|0|||
23416169|NCT00113399|65266162|FG001|Overall Study|Complete Response|1|||
23416170|NCT00113399|65266161|FG000|Overall Study|Other|0|||
23416171|NCT00113399|65266162|FG001|Overall Study|Other|1|||
23416172|NCT01893411|65266165|FG000|Overall Study|Protocol Violation|1|||
23416173|NCT01893411|65266166|FG001|Overall Study|Protocol Violation|0|||
23416174|NCT01893411|65266167|FG002|Overall Study|Protocol Violation|0|||
23416175|NCT01893411|65266165|FG000|Overall Study|Physician Decision|1|||
23416176|NCT01893411|65266166|FG001|Overall Study|Physician Decision|1|||
23416177|NCT01893411|65266167|FG002|Overall Study|Physician Decision|2|||
23416178|NCT01893411|65266165|FG000|Overall Study|Lack of Efficacy|2|||
23416179|NCT01893411|65266166|FG001|Overall Study|Lack of Efficacy|1|||
23416180|NCT01893411|65266167|FG002|Overall Study|Lack of Efficacy|0|||
23416181|NCT01893411|65266165|FG000|Overall Study|Other|3|||
23416182|NCT01893411|65266166|FG001|Overall Study|Other|1|||
23416183|NCT01893411|65266167|FG002|Overall Study|Other|3|||
23416184|NCT01893411|65266165|FG000|Overall Study|Adverse Event|1|||
23416185|NCT01893411|65266166|FG001|Overall Study|Adverse Event|0|||
23416186|NCT01893411|65266167|FG002|Overall Study|Adverse Event|0|||
23416187|NCT01893411|65266165|FG000|Overall Study|Withdrawal by Subject|7|||
23416188|NCT01893411|65266166|FG001|Overall Study|Withdrawal by Subject|4|||
23416189|NCT01893411|65266167|FG002|Overall Study|Withdrawal by Subject|3|||
23416190|NCT01893411|65266165|FG000|Overall Study|Lost to Follow-up|2|||
23516675|NCT01729754|65628025|FG003|Part 1|Progressive Disease|0|||
23516676|NCT01729754|65628026|FG004|Part 1|Progressive Disease|0|||
23516677|NCT01729754|65628027|FG005|Part 1|Progressive Disease|0|||
23516678|NCT01729754|65628028|FG006|Part 1|Progressive Disease|0|||
23516679|NCT01729754|65628029|FG007|Part 1|Progressive Disease|0|||
23516680|NCT01729754|65628030|FG008|Part 1|Progressive Disease|0|||
23516681|NCT01729754|65628031|FG009|Part 1|Progressive Disease|1|||
23516682|NCT01729754|65628022|FG000|Part 1|Protocol Violation|2|||
23516683|NCT01729754|65628023|FG001|Part 1|Protocol Violation|0|||
23516684|NCT01729754|65628024|FG002|Part 1|Protocol Violation|0|||
23516685|NCT01729754|65628025|FG003|Part 1|Protocol Violation|1|||
23516686|NCT01729754|65628026|FG004|Part 1|Protocol Violation|0|||
23516687|NCT01729754|65628027|FG005|Part 1|Protocol Violation|0|||
23516688|NCT01729754|65628028|FG006|Part 1|Protocol Violation|1|||
23516689|NCT01729754|65628029|FG007|Part 1|Protocol Violation|0|||
23516690|NCT01729754|65628030|FG008|Part 1|Protocol Violation|0|||
23516691|NCT01729754|65628031|FG009|Part 1|Protocol Violation|0|||
23516692|NCT01729754|65628022|FG000|Part 1|Withdrawal by Subject|5|||
23516693|NCT01729754|65628023|FG001|Part 1|Withdrawal by Subject|0|||
23516694|NCT01729754|65628024|FG002|Part 1|Withdrawal by Subject|0|||
23516695|NCT01729754|65628025|FG003|Part 1|Withdrawal by Subject|7|||
23516696|NCT01729754|65628026|FG004|Part 1|Withdrawal by Subject|0|||
23516697|NCT01729754|65628027|FG005|Part 1|Withdrawal by Subject|0|||
23516698|NCT01729754|65628028|FG006|Part 1|Withdrawal by Subject|5|||
23516699|NCT01729754|65628029|FG007|Part 1|Withdrawal by Subject|0|||
23516700|NCT01729754|65628030|FG008|Part 1|Withdrawal by Subject|0|||
23516701|NCT01729754|65628031|FG009|Part 1|Withdrawal by Subject|6|||
23516702|NCT01729754|65628022|FG000|Part 1|Other Protocol Specified Criteria|2|||
23516703|NCT01729754|65628023|FG001|Part 1|Other Protocol Specified Criteria|0|||
23516704|NCT01729754|65628024|FG002|Part 1|Other Protocol Specified Criteria|0|||
23516705|NCT01729754|65628025|FG003|Part 1|Other Protocol Specified Criteria|0|||
23516706|NCT01729754|65628026|FG004|Part 1|Other Protocol Specified Criteria|0|||
23516707|NCT01729754|65628027|FG005|Part 1|Other Protocol Specified Criteria|0|||
23516708|NCT01729754|65628028|FG006|Part 1|Other Protocol Specified Criteria|1|||
23516709|NCT01729754|65628029|FG007|Part 1|Other Protocol Specified Criteria|0|||
23516710|NCT01729754|65628030|FG008|Part 1|Other Protocol Specified Criteria|0|||
23516711|NCT01729754|65628031|FG009|Part 1|Other Protocol Specified Criteria|4|||
23516712|NCT01729754|65628022|FG000|Part 2|Adverse Event|2|||
23516713|NCT01729754|65628023|FG001|Part 2|Adverse Event|0|||
23516714|NCT01729754|65628024|FG002|Part 2|Adverse Event|0|||
23516715|NCT01729754|65628025|FG003|Part 2|Adverse Event|0|||
23516716|NCT01729754|65628026|FG004|Part 2|Adverse Event|0|||
23516717|NCT01729754|65628027|FG005|Part 2|Adverse Event|0|||
23516718|NCT01729754|65628028|FG006|Part 2|Adverse Event|0|||
23516719|NCT01729754|65628029|FG007|Part 2|Adverse Event|0|||
23516720|NCT01729754|65628030|FG008|Part 2|Adverse Event|1|||
23516721|NCT01729754|65628031|FG009|Part 2|Adverse Event|2|||
23516722|NCT01729754|65628022|FG000|Part 2|Lack of Efficacy|0|||
23516723|NCT01729754|65628023|FG001|Part 2|Lack of Efficacy|0|||
23516724|NCT01729754|65628024|FG002|Part 2|Lack of Efficacy|0|||
23516725|NCT01729754|65628025|FG003|Part 2|Lack of Efficacy|0|||
23516726|NCT01729754|65628026|FG004|Part 2|Lack of Efficacy|0|||
23516727|NCT01729754|65628027|FG005|Part 2|Lack of Efficacy|0|||
23516728|NCT01729754|65628028|FG006|Part 2|Lack of Efficacy|0|||
23516729|NCT01729754|65628029|FG007|Part 2|Lack of Efficacy|0|||
23516730|NCT01729754|65628030|FG008|Part 2|Lack of Efficacy|2|||
23712023|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
23712024|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
23712025|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
23712026|NCT00494871|66319434|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
23712027|NCT00494871|66319435|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
23712028|NCT00494871|66319434|FG000|Follow-up (FU) Period|Adverse Event|1|||
23712029|NCT00494871|66319435|FG001|Follow-up (FU) Period|Adverse Event|1|||
23712030|NCT00494871|66319434|FG000|Follow-up (FU) Period|Death|13|||
23516731|NCT01729754|65628031|FG009|Part 2|Lack of Efficacy|2|||
23516732|NCT01729754|65628022|FG000|Part 2|Lost to Follow-up|0|||
23516733|NCT01729754|65628023|FG001|Part 2|Lost to Follow-up|0|||
23516734|NCT01729754|65628024|FG002|Part 2|Lost to Follow-up|0|||
23516735|NCT01729754|65628025|FG003|Part 2|Lost to Follow-up|2|||
23516736|NCT01729754|65628026|FG004|Part 2|Lost to Follow-up|0|||
23516737|NCT01729754|65628027|FG005|Part 2|Lost to Follow-up|0|||
23516738|NCT01729754|65628028|FG006|Part 2|Lost to Follow-up|0|||
23516739|NCT01729754|65628029|FG007|Part 2|Lost to Follow-up|1|||
23516740|NCT01729754|65628030|FG008|Part 2|Lost to Follow-up|0|||
23516741|NCT01729754|65628031|FG009|Part 2|Lost to Follow-up|2|||
23516742|NCT01729754|65628022|FG000|Part 2|Non-Compliance with Study Drug|0|||
23516743|NCT01729754|65628023|FG001|Part 2|Non-Compliance with Study Drug|0|||
23516744|NCT01729754|65628024|FG002|Part 2|Non-Compliance with Study Drug|0|||
23516745|NCT01729754|65628025|FG003|Part 2|Non-Compliance with Study Drug|0|||
23516746|NCT01729754|65628026|FG004|Part 2|Non-Compliance with Study Drug|0|||
23516747|NCT01729754|65628027|FG005|Part 2|Non-Compliance with Study Drug|0|||
23516748|NCT01729754|65628028|FG006|Part 2|Non-Compliance with Study Drug|0|||
23516749|NCT01729754|65628029|FG007|Part 2|Non-Compliance with Study Drug|0|||
23516750|NCT01729754|65628030|FG008|Part 2|Non-Compliance with Study Drug|0|||
23516751|NCT01729754|65628031|FG009|Part 2|Non-Compliance with Study Drug|1|||
23516752|NCT01729754|65628022|FG000|Part 2|Pregnancy|0|||
23516753|NCT01729754|65628023|FG001|Part 2|Pregnancy|0|||
23516754|NCT01729754|65628024|FG002|Part 2|Pregnancy|0|||
23516755|NCT01729754|65628025|FG003|Part 2|Pregnancy|1|||
23516756|NCT01729754|65628026|FG004|Part 2|Pregnancy|0|||
23516757|NCT01729754|65628027|FG005|Part 2|Pregnancy|0|||
23516758|NCT01729754|65628028|FG006|Part 2|Pregnancy|0|||
23516759|NCT01729754|65628029|FG007|Part 2|Pregnancy|0|||
23516760|NCT01729754|65628030|FG008|Part 2|Pregnancy|0|||
23516761|NCT01729754|65628031|FG009|Part 2|Pregnancy|1|||
23516762|NCT01729754|65628022|FG000|Part 2|Withdrawal by Subject|3|||
23516763|NCT01729754|65628023|FG001|Part 2|Withdrawal by Subject|0|||
23516764|NCT01729754|65628024|FG002|Part 2|Withdrawal by Subject|0|||
23516765|NCT01729754|65628025|FG003|Part 2|Withdrawal by Subject|2|||
23516766|NCT01729754|65628026|FG004|Part 2|Withdrawal by Subject|0|||
23516767|NCT01729754|65628027|FG005|Part 2|Withdrawal by Subject|0|||
23516768|NCT01729754|65628028|FG006|Part 2|Withdrawal by Subject|0|||
23516769|NCT01729754|65628029|FG007|Part 2|Withdrawal by Subject|1|||
23516770|NCT01729754|65628030|FG008|Part 2|Withdrawal by Subject|1|||
23516771|NCT01729754|65628031|FG009|Part 2|Withdrawal by Subject|4|||
23516772|NCT01729754|65628022|FG000|Part 2|Other Protocol Specified Criteria|1|||
23516773|NCT01729754|65628023|FG001|Part 2|Other Protocol Specified Criteria|0|||
23516774|NCT01729754|65628024|FG002|Part 2|Other Protocol Specified Criteria|0|||
23516775|NCT01729754|65628025|FG003|Part 2|Other Protocol Specified Criteria|0|||
23516776|NCT01729754|65628026|FG004|Part 2|Other Protocol Specified Criteria|0|||
23516777|NCT01729754|65628027|FG005|Part 2|Other Protocol Specified Criteria|0|||
23516778|NCT01729754|65628028|FG006|Part 2|Other Protocol Specified Criteria|0|||
23516779|NCT01729754|65628029|FG007|Part 2|Other Protocol Specified Criteria|1|||
23516780|NCT01729754|65628030|FG008|Part 2|Other Protocol Specified Criteria|0|||
23516781|NCT01729754|65628031|FG009|Part 2|Other Protocol Specified Criteria|0|||
23516782|NCT01729754|65628022|FG000|Part 3|Adverse Event|0|||
23516783|NCT01729754|65628023|FG001|Part 3|Adverse Event|0|||
23516784|NCT01729754|65628024|FG002|Part 3|Adverse Event|1|||
23516785|NCT01729754|65628025|FG003|Part 3|Adverse Event|0|||
23516786|NCT01729754|65628026|FG004|Part 3|Adverse Event|0|||
23516787|NCT01729754|65628027|FG005|Part 3|Adverse Event|5|||
23516788|NCT01729754|65628028|FG006|Part 3|Adverse Event|0|||
23516789|NCT01729754|65628029|FG007|Part 3|Adverse Event|0|||
23516790|NCT01729754|65628030|FG008|Part 3|Adverse Event|0|||
23516791|NCT01729754|65628031|FG009|Part 3|Adverse Event|3|||
23516792|NCT01729754|65628022|FG000|Part 3|Death|0|||
23516793|NCT01729754|65628023|FG001|Part 3|Death|0|||
23516794|NCT01729754|65628024|FG002|Part 3|Death|0|||
23516795|NCT01729754|65628025|FG003|Part 3|Death|0|||
23516796|NCT01729754|65628026|FG004|Part 3|Death|0|||
23516797|NCT01729754|65628027|FG005|Part 3|Death|2|||
23516798|NCT01729754|65628028|FG006|Part 3|Death|0|||
23516799|NCT01729754|65628029|FG007|Part 3|Death|0|||
23516800|NCT01729754|65628030|FG008|Part 3|Death|0|||
23516801|NCT01729754|65628031|FG009|Part 3|Death|0|||
23516802|NCT01729754|65628022|FG000|Part 3|Lack of Efficacy|0|||
23516803|NCT01729754|65628023|FG001|Part 3|Lack of Efficacy|0|||
23516804|NCT01729754|65628024|FG002|Part 3|Lack of Efficacy|0|||
23516805|NCT01729754|65628025|FG003|Part 3|Lack of Efficacy|0|||
23516806|NCT01729754|65628026|FG004|Part 3|Lack of Efficacy|2|||
23516807|NCT01729754|65628027|FG005|Part 3|Lack of Efficacy|0|||
23516808|NCT01729754|65628028|FG006|Part 3|Lack of Efficacy|0|||
23516809|NCT01729754|65628029|FG007|Part 3|Lack of Efficacy|0|||
23516810|NCT01729754|65628030|FG008|Part 3|Lack of Efficacy|0|||
23516811|NCT01729754|65628031|FG009|Part 3|Lack of Efficacy|4|||
23516812|NCT01729754|65628022|FG000|Part 3|Lost to Follow-up|0|||
23516813|NCT01729754|65628023|FG001|Part 3|Lost to Follow-up|1|||
23516814|NCT01729754|65628024|FG002|Part 3|Lost to Follow-up|2|||
23516815|NCT01729754|65628025|FG003|Part 3|Lost to Follow-up|0|||
23516816|NCT01729754|65628026|FG004|Part 3|Lost to Follow-up|0|||
23516817|NCT01729754|65628027|FG005|Part 3|Lost to Follow-up|3|||
23516818|NCT01729754|65628028|FG006|Part 3|Lost to Follow-up|0|||
23516819|NCT01729754|65628029|FG007|Part 3|Lost to Follow-up|0|||
23516820|NCT01729754|65628030|FG008|Part 3|Lost to Follow-up|1|||
23516821|NCT01729754|65628031|FG009|Part 3|Lost to Follow-up|0|||
23516822|NCT01729754|65628022|FG000|Part 3|Physician Decision|0|||
23516823|NCT01729754|65628023|FG001|Part 3|Physician Decision|0|||
23516824|NCT01729754|65628024|FG002|Part 3|Physician Decision|1|||
23516825|NCT01729754|65628025|FG003|Part 3|Physician Decision|0|||
23516826|NCT01729754|65628026|FG004|Part 3|Physician Decision|0|||
23516827|NCT01729754|65628027|FG005|Part 3|Physician Decision|0|||
23516828|NCT01729754|65628028|FG006|Part 3|Physician Decision|0|||
23516829|NCT01729754|65628029|FG007|Part 3|Physician Decision|0|||
23516830|NCT01729754|65628030|FG008|Part 3|Physician Decision|0|||
23516831|NCT01729754|65628031|FG009|Part 3|Physician Decision|0|||
23516832|NCT01729754|65628022|FG000|Part 3|Withdrawal by Subject|0|||
23516833|NCT01729754|65628023|FG001|Part 3|Withdrawal by Subject|4|||
23516834|NCT01729754|65628024|FG002|Part 3|Withdrawal by Subject|1|||
23516835|NCT01729754|65628025|FG003|Part 3|Withdrawal by Subject|0|||
23516836|NCT01729754|65628026|FG004|Part 3|Withdrawal by Subject|2|||
23516837|NCT01729754|65628027|FG005|Part 3|Withdrawal by Subject|1|||
23516838|NCT01729754|65628028|FG006|Part 3|Withdrawal by Subject|0|||
23516839|NCT01729754|65628029|FG007|Part 3|Withdrawal by Subject|2|||
23516840|NCT01729754|65628030|FG008|Part 3|Withdrawal by Subject|0|||
23516841|NCT01729754|65628031|FG009|Part 3|Withdrawal by Subject|0|||
23516842|NCT01729754|65628022|FG000|Part 3|Other Protocol Specified Criteria|0|||
23516843|NCT01729754|65628023|FG001|Part 3|Other Protocol Specified Criteria|0|||
23516844|NCT01729754|65628024|FG002|Part 3|Other Protocol Specified Criteria|0|||
23516845|NCT01729754|65628025|FG003|Part 3|Other Protocol Specified Criteria|0|||
23516846|NCT01729754|65628026|FG004|Part 3|Other Protocol Specified Criteria|0|||
23516847|NCT01729754|65628027|FG005|Part 3|Other Protocol Specified Criteria|2|||
23516848|NCT01729754|65628028|FG006|Part 3|Other Protocol Specified Criteria|0|||
23516849|NCT01729754|65628029|FG007|Part 3|Other Protocol Specified Criteria|1|||
23516850|NCT01729754|65628030|FG008|Part 3|Other Protocol Specified Criteria|0|||
23516851|NCT01729754|65628031|FG009|Part 3|Other Protocol Specified Criteria|0|||
23516852|NCT02743806|65628032|FG000|Overall Study|Adverse Event|9|||
23516853|NCT02743806|65628032|FG000|Overall Study|Lost to Follow-up|8|||
23516854|NCT02743806|65628032|FG000|Overall Study|Voluntary Withdrawal|54|||
23516855|NCT02743806|65628032|FG000|Overall Study|Study Termination|65|||
23516856|NCT02743806|65628032|FG000|Overall Study|Pregnancy|6|||
23516857|NCT02743806|65628032|FG000|Overall Study|No Longer Clinically Benefiting|27|||
23516858|NCT02743806|65628032|FG000|Overall Study|Reason Not Specified|12|||
23516859|NCT02736409|65628038|FG000|Overall Study|Withdrawal by Subject|4|||
23516860|NCT02736409|65628039|FG001|Overall Study|Withdrawal by Subject|2|||
23516861|NCT02736409|65628040|FG002|Overall Study|Withdrawal by Subject|17|||
23516862|NCT02736409|65628041|FG003|Overall Study|Withdrawal by Subject|3|||
23516863|NCT02736409|65628038|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23516864|NCT02736409|65628039|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23516865|NCT02736409|65628040|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23516866|NCT02736409|65628041|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23516867|NCT02736409|65628038|FG000|Overall Study|Adverse Event|0|||
23516868|NCT02736409|65628039|FG001|Overall Study|Adverse Event|1|||
23516869|NCT02736409|65628040|FG002|Overall Study|Adverse Event|5|||
23516870|NCT02736409|65628041|FG003|Overall Study|Adverse Event|4|||
23516871|NCT02736409|65628038|FG000|Overall Study|Other|0|||
23516872|NCT02736409|65628039|FG001|Overall Study|Other|0|||
23516873|NCT02736409|65628040|FG002|Overall Study|Other|1|||
23516874|NCT02736409|65628041|FG003|Overall Study|Other|1|||
23516875|NCT02736409|65628038|FG000|Overall Study|Pregnancy|0|||
23516876|NCT02736409|65628039|FG001|Overall Study|Pregnancy|0|||
23516877|NCT02736409|65628040|FG002|Overall Study|Pregnancy|1|||
23516878|NCT02736409|65628041|FG003|Overall Study|Pregnancy|0|||
23516879|NCT02736409|65628038|FG000|Overall Study|Lost to Follow-up|0|||
23516880|NCT02736409|65628039|FG001|Overall Study|Lost to Follow-up|0|||
23516881|NCT02736409|65628040|FG002|Overall Study|Lost to Follow-up|2|||
23516882|NCT02736409|65628041|FG003|Overall Study|Lost to Follow-up|1|||
23516883|NCT02736409|65628038|FG000|Overall Study|Physician Decision|0|||
23516884|NCT02736409|65628039|FG001|Overall Study|Physician Decision|0|||
23516885|NCT02736409|65628040|FG002|Overall Study|Physician Decision|0|||
23516886|NCT02736409|65628041|FG003|Overall Study|Physician Decision|2|||
23516887|NCT01581307|65628042|FG000|Overall Study|Withdrawal by Subject|1|||
23516888|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
23516889|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
23516890|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
23516891|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
23516892|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
23516893|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
23516894|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
23516895|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
23516896|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
23516897|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
23516898|NCT02150954|65628046|FG000|Overall Study|Protocol Violation|1|||
23516899|NCT02150954|65628047|FG001|Overall Study|Protocol Violation|0|||
23516900|NCT03045081|65628051|FG000|Overall Study|Withdrawal by Subject|6|||
23516901|NCT03045081|65628052|FG001|Overall Study|Withdrawal by Subject|11|||
23516902|NCT00453544|65628054|FG000|Overall Study|Withdrawal by Subject|1|||
23516903|NCT00453544|65628055|FG001|Overall Study|Withdrawal by Subject|0|||
23516904|NCT00453544|65628056|FG002|Overall Study|Withdrawal by Subject|0|||
23516905|NCT00453544|65628057|FG003|Overall Study|Withdrawal by Subject|0|||
23516906|NCT00453544|65628054|FG000|Overall Study|Primary outcome measure not completed|1|||
23516907|NCT00453544|65628055|FG001|Overall Study|Primary outcome measure not completed|1|||
23516908|NCT00453544|65628056|FG002|Overall Study|Primary outcome measure not completed|0|||
23516909|NCT00453544|65628057|FG003|Overall Study|Primary outcome measure not completed|1|||
23516910|NCT00993291|65628058|FG000|Overall Study|Withdrawal by Subject|1|||
23516911|NCT03538158|65628059|FG000|Overall Study|Lost to Follow-up|13|||
23516912|NCT03538158|65628060|FG001|Overall Study|Lost to Follow-up|7|||
23516913|NCT03538158|65628059|FG000|Overall Study|Withdrawal by Subject|2|||
23516914|NCT03538158|65628060|FG001|Overall Study|Withdrawal by Subject|1|||
23516915|NCT03761147|65628061|FG000|Overall Study|Withdrawal by Subject|6|||
23516916|NCT03761147|65628062|FG001|Overall Study|Withdrawal by Subject|1|||
23516917|NCT03761147|65628061|FG000|Overall Study|Adverse Event|1|||
23516918|NCT03761147|65628062|FG001|Overall Study|Adverse Event|3|||
23516919|NCT01485640|65632464|FG000|Overall Study|Adverse Event|10|||
23516920|NCT01485640|65632464|FG000|Overall Study|Lack of Efficacy|2|||
23516921|NCT01485640|65632464|FG000|Overall Study|Protocol Violation|1|||
23516922|NCT01485640|65632464|FG000|Overall Study|Withdrawal by Subject|14|||
23516923|NCT01485640|65632464|FG000|Overall Study|Terminated by Sponsor|95|||
23516924|NCT03315208|65632467|FG000|Overall Study|Lost to Follow-up|11|||
23516925|NCT03315208|65632468|FG001|Overall Study|Lost to Follow-up|6|||
23516926|NCT03315208|65632467|FG000|Overall Study|Withdrawal by Subject|2|||
23516927|NCT03315208|65632468|FG001|Overall Study|Withdrawal by Subject|0|||
23516928|NCT01405963|65632469|FG000|Overall Study|Moved Away|2|||
23516929|NCT01405963|65632470|FG001|Overall Study|Moved Away|0|||
23516930|NCT01405963|65632469|FG000|Overall Study|Adverse Event|0|||
23516931|NCT01405963|65632470|FG001|Overall Study|Adverse Event|1|||
23516932|NCT01405963|65632469|FG000|Overall Study|Lost to Follow-up|0|||
23516933|NCT01405963|65632470|FG001|Overall Study|Lost to Follow-up|1|||
23516934|NCT01111149|65632472|FG000|Overall Study|Protocol Violation|1|||
23516935|NCT01111149|65632473|FG001|Overall Study|Protocol Violation|1|||
23516936|NCT01111149|65632474|FG002|Overall Study|Protocol Violation|2|||
23516937|NCT01111149|65632472|FG000|Overall Study|Withdrawal by Subject|1|||
23516938|NCT01111149|65632473|FG001|Overall Study|Withdrawal by Subject|0|||
23516939|NCT01111149|65632474|FG002|Overall Study|Withdrawal by Subject|2|||
23516940|NCT02699554|65632477|FG000|Overall Study|Lost to Follow-up|9|||
23516941|NCT01826487|65632478|FG000|Overall Study|Adverse Event|1|||
23516942|NCT01826487|65632479|FG001|Overall Study|Adverse Event|1|||
23516943|NCT01826487|65632478|FG000|Overall Study|Lost to Follow-up|1|||
23516944|NCT01826487|65632479|FG001|Overall Study|Lost to Follow-up|0|||
23712031|NCT00494871|66319435|FG001|Follow-up (FU) Period|Death|12|||
23712032|NCT00494871|66319434|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
23712033|NCT00494871|66319435|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
23712034|NCT00494871|66319434|FG000|Follow-up (FU) Period|Physician Decision|0|||
23712035|NCT00494871|66319435|FG001|Follow-up (FU) Period|Physician Decision|1|||
23712036|NCT00494871|66319434|FG000|Follow-up (FU) Period|Protocol Violation|1|||
23712037|NCT00494871|66319435|FG001|Follow-up (FU) Period|Protocol Violation|0|||
23712038|NCT00494871|66319434|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
23712039|NCT00494871|66319435|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
23712040|NCT00494871|66319434|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
23712041|NCT00494871|66319435|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
23712042|NCT02349789|66319436|FG000|Overall Study|Withdrawal by Subject|2|||
23712043|NCT00082758|66319437|FG000|Overall Study|Adverse Event|0|||
23712044|NCT00082758|66319438|FG001|Overall Study|Adverse Event|2|||
23712045|NCT00082758|66319439|FG002|Overall Study|Adverse Event|0|||
23712046|NCT00082758|66319437|FG000|Overall Study|Lack of Efficacy|12|||
23712047|NCT00082758|66319438|FG001|Overall Study|Lack of Efficacy|13|||
23712048|NCT00082758|66319439|FG002|Overall Study|Lack of Efficacy|0|||
23712049|NCT00082758|66319437|FG000|Overall Study|Physician Decision|0|||
23712050|NCT00082758|66319438|FG001|Overall Study|Physician Decision|1|||
23712051|NCT00082758|66319439|FG002|Overall Study|Physician Decision|0|||
23712052|NCT00082758|66319437|FG000|Overall Study|Withdrawal by Subject|3|||
23712053|NCT00082758|66319438|FG001|Overall Study|Withdrawal by Subject|0|||
23712054|NCT00082758|66319439|FG002|Overall Study|Withdrawal by Subject|0|||
23516945|NCT01826487|65632478|FG000|Overall Study|Withdrawal by Subject|1|||
23516946|NCT01826487|65632479|FG001|Overall Study|Withdrawal by Subject|3|||
23516947|NCT01826487|65632478|FG000|Overall Study|Protocol Violation|1|||
23516948|NCT01826487|65632479|FG001|Overall Study|Protocol Violation|1|||
23516949|NCT00537381|65632480|FG000|Overall Study|Adverse Event|13|||
23516950|NCT00537381|65632481|FG001|Overall Study|Adverse Event|9|||
23712055|NCT00082758|66319437|FG000|Overall Study|Protocol Violation|0|||
23516951|NCT00537381|65632480|FG000|Overall Study|Death|3|||
23516952|NCT00537381|65632481|FG001|Overall Study|Death|3|||
23712056|NCT00082758|66319438|FG001|Overall Study|Protocol Violation|1|||
23712057|NCT00082758|66319439|FG002|Overall Study|Protocol Violation|0|||
23712058|NCT02397694|66319440|FG000|Double-Blinded Phase|Adverse Event|1|||
23712059|NCT02397694|66319441|FG001|Double-Blinded Phase|Adverse Event|0|||
23516953|NCT00537381|65632480|FG000|Overall Study|Withdrawal by Subject|5|||
23516954|NCT00537381|65632481|FG001|Overall Study|Withdrawal by Subject|14|||
23516955|NCT00537381|65632480|FG000|Overall Study|Physician Decision|7|||
23516956|NCT00537381|65632481|FG001|Overall Study|Physician Decision|6|||
23516957|NCT00537381|65632480|FG000|Overall Study|Disease Progression|9|||
23516958|NCT00537381|65632481|FG001|Overall Study|Disease Progression|18|||
23516959|NCT00537381|65632480|FG000|Overall Study|Sponsor decision|14|||
23516960|NCT00537381|65632481|FG001|Overall Study|Sponsor decision|9|||
23516961|NCT00537381|65632480|FG000|Overall Study|Other|5|||
23516962|NCT00537381|65632481|FG001|Overall Study|Other|3|||
23516963|NCT02221284|65632485|FG000|Overall Study|Case Report Forms Uncollected|56|||
23516964|NCT02221284|65632485|FG000|Overall Study|Protocol Deviation|5|||
23516965|NCT01172847|65632486|FG000|Overall Study|Withdrawal by Subject|3|||
23516966|NCT01475331|65632487|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
23516967|NCT01475331|65632488|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
23516968|NCT01475331|65632487|FG000|Overall Study|excessive main duct communication|1|||
23712060|NCT02397694|66319440|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
23712061|NCT02397694|66319441|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
23712062|NCT02397694|66319440|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
23712063|NCT02397694|66319441|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
23712064|NCT02397694|66319440|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
23712065|NCT02397694|66319441|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
23712066|NCT02397694|66319440|FG000|Open Label Extension Phase|Protocol Violation|1|||
23712067|NCT02397694|66319441|FG001|Open Label Extension Phase|Protocol Violation|0|||
23712068|NCT02397694|66319440|FG000|Open Label Extension Phase|Withdrew Consent|3|||
23712069|NCT02397694|66319441|FG001|Open Label Extension Phase|Withdrew Consent|1|||
23712070|NCT02397694|66319440|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
23712071|NCT02397694|66319441|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
23712072|NCT02723591|66319444|FG000|Overall Study|Adverse Event|48|||
23712073|NCT02723591|66319445|FG001|Overall Study|Adverse Event|40|||
23712074|NCT02723591|66319444|FG000|Overall Study|Death|2|||
23712075|NCT02723591|66319445|FG001|Overall Study|Death|2|||
23712076|NCT02723591|66319444|FG000|Overall Study|Lack of Efficacy|4|||
23712077|NCT02723591|66319445|FG001|Overall Study|Lack of Efficacy|3|||
23712078|NCT02723591|66319444|FG000|Overall Study|Lost to Follow-up|1|||
23712079|NCT02723591|66319445|FG001|Overall Study|Lost to Follow-up|7|||
23712080|NCT02723591|66319444|FG000|Overall Study|Protocol Violation|20|||
23712081|NCT02723591|66319445|FG001|Overall Study|Protocol Violation|23|||
23712082|NCT02723591|66319444|FG000|Overall Study|Withdrawal by Subject|4|||
23712083|NCT02723591|66319445|FG001|Overall Study|Withdrawal by Subject|8|||
23712084|NCT02723591|66319444|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
23712085|NCT02723591|66319445|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
23712086|NCT02723591|66319444|FG000|Overall Study|Miscellaneous|5|||
23712087|NCT02723591|66319445|FG001|Overall Study|Miscellaneous|6|||
23712088|NCT05086289|66319451|FG000|Overall Study|Adverse Event|4|||
23712089|NCT05086289|66319452|FG001|Overall Study|Adverse Event|2|||
23712090|NCT05086289|66319451|FG000|Overall Study|Lost to Follow-up|2|||
23516969|NCT01475331|65632488|FG001|Overall Study|excessive main duct communication|1|||
23516970|NCT01475331|65632487|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
23516971|NCT01475331|65632488|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
23516972|NCT01475331|65632487|FG000|Overall Study|Sign of malignancy during the procedure|2|||
23516973|NCT01475331|65632488|FG001|Overall Study|Sign of malignancy during the procedure|0|||
23516974|NCT01475331|65632487|FG000|Overall Study|cyst found to be prohibitively small|0|||
23516975|NCT01475331|65632488|FG001|Overall Study|cyst found to be prohibitively small|1|||
23516976|NCT05089682|65632489|FG000|Overall Study|Withdrawal by Subject|2|||
23516977|NCT00322842|65632498|FG000|Overall Study|Withdrawal by Subject|0|||
23516978|NCT00322842|65632499|FG001|Overall Study|Withdrawal by Subject|1|||
23516979|NCT00322842|65632498|FG000|Overall Study|Lost to Follow-up|0|||
23516980|NCT00322842|65632499|FG001|Overall Study|Lost to Follow-up|1|||
23516981|NCT00322842|65632498|FG000|Overall Study|Refused transplant|1|||
23516982|NCT00322842|65632499|FG001|Overall Study|Refused transplant|0|||
23516983|NCT00322842|65632498|FG000|Overall Study|Death|1|||
23516984|NCT00322842|65632499|FG001|Overall Study|Death|0|||
23516985|NCT00450333|65632500|FG000|Overall Study|Study terminated|47|||
23712091|NCT05086289|66319452|FG001|Overall Study|Lost to Follow-up|0|||
23516986|NCT00450333|65632501|FG001|Overall Study|Study terminated|54|||
23712092|NCT05086289|66319451|FG000|Overall Study|Non-compliance with study drug|2|||
23712093|NCT05086289|66319452|FG001|Overall Study|Non-compliance with study drug|1|||
23712094|NCT05086289|66319451|FG000|Overall Study|Physician Decision|2|||
23712095|NCT05086289|66319452|FG001|Overall Study|Physician Decision|0|||
23516987|NCT00450333|65632502|FG002|Overall Study|Study terminated|16|||
23516988|NCT00450333|65632503|FG003|Overall Study|Study terminated|21|||
23516989|NCT00450333|65632500|FG000|Overall Study|Adverse Event|1|||
23712096|NCT05086289|66319451|FG000|Overall Study|Withdrawal by Subject|5|||
23712097|NCT05086289|66319452|FG001|Overall Study|Withdrawal by Subject|2|||
23712098|NCT01025817|66319453|FG000|Completed Study Medication|Adverse Event|66|||
23516990|NCT00450333|65632501|FG001|Overall Study|Adverse Event|7|||
23516991|NCT00450333|65632502|FG002|Overall Study|Adverse Event|2|||
23516992|NCT00450333|65632503|FG003|Overall Study|Adverse Event|2|||
23516993|NCT00450333|65632500|FG000|Overall Study|Protocol Violation|1|||
23516994|NCT00450333|65632501|FG001|Overall Study|Protocol Violation|0|||
23516995|NCT00450333|65632502|FG002|Overall Study|Protocol Violation|1|||
23516996|NCT00450333|65632503|FG003|Overall Study|Protocol Violation|0|||
23516997|NCT00450333|65632500|FG000|Overall Study|Withdrawal by Subject|1|||
23516998|NCT00450333|65632501|FG001|Overall Study|Withdrawal by Subject|0|||
23516999|NCT00450333|65632502|FG002|Overall Study|Withdrawal by Subject|3|||
23517000|NCT00450333|65632503|FG003|Overall Study|Withdrawal by Subject|0|||
23517001|NCT00450333|65632500|FG000|Overall Study|Kidney transplant|1|||
23517002|NCT00450333|65632501|FG001|Overall Study|Kidney transplant|0|||
23517003|NCT00450333|65632502|FG002|Overall Study|Kidney transplant|1|||
23517004|NCT00450333|65632503|FG003|Overall Study|Kidney transplant|3|||
23517005|NCT00450333|65632500|FG000|Overall Study|Death|3|||
23517006|NCT00450333|65632501|FG001|Overall Study|Death|2|||
23517007|NCT00450333|65632502|FG002|Overall Study|Death|2|||
23517008|NCT00450333|65632503|FG003|Overall Study|Death|2|||
23517009|NCT01394523|65632504|FG000|Overall Study|Unable to place block|1|||
23517010|NCT01394523|65632505|FG001|Overall Study|Unable to place block|0|||
23517011|NCT01394523|65632506|FG002|Overall Study|Unable to place block|0|||
23517012|NCT03045887|65632507|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
23517013|NCT03045887|65632508|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517014|NCT03045887|65632509|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517015|NCT03045887|65632510|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517016|NCT03045887|65632511|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23712099|NCT01025817|66319454|FG001|Completed Study Medication|Adverse Event|39|||
23712100|NCT01025817|66319453|FG000|Completed Study Medication|Protocol Deviation|9|||
23712101|NCT01025817|66319454|FG001|Completed Study Medication|Protocol Deviation|8|||
23712102|NCT01025817|66319453|FG000|Completed Study Medication|Withdrawal by Subject|8|||
23517017|NCT03045887|65632512|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517018|NCT03045887|65632513|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517019|NCT03045887|65632514|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517020|NCT03045887|65632515|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517021|NCT03045887|65632516|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517022|NCT03045887|65632507|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517023|NCT03045887|65632508|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517024|NCT03045887|65632509|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517025|NCT03045887|65632510|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
23712103|NCT01025817|66319454|FG001|Completed Study Medication|Withdrawal by Subject|9|||
23712104|NCT01025817|66319453|FG000|Completed Study Medication|Administrative problems|7|||
23712105|NCT01025817|66319454|FG001|Completed Study Medication|Administrative problems|5|||
23712106|NCT01025817|66319453|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
23712107|NCT01025817|66319454|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
23712108|NCT01025817|66319453|FG000|Completed Study Medication|Abnormal test procedure|4|||
23712109|NCT01025817|66319454|FG001|Completed Study Medication|Abnormal test procedure|0|||
23712110|NCT01025817|66319453|FG000|Completed Study Medication|Graft loss|2|||
23712111|NCT01025817|66319454|FG001|Completed Study Medication|Graft loss|5|||
23712112|NCT01025817|66319453|FG000|Completed Study Medication|Death|2|||
23712113|NCT01025817|66319454|FG001|Completed Study Medication|Death|2|||
23712114|NCT01025817|66319453|FG000|Completed Study Medication|Abnormal lab values|0|||
23712115|NCT01025817|66319454|FG001|Completed Study Medication|Abnormal lab values|2|||
23712116|NCT01025817|66319453|FG000|Completed Study Medication|Subject no longer required study drug|0|||
23712117|NCT01025817|66319454|FG001|Completed Study Medication|Subject no longer required study drug|1|||
23712118|NCT01025817|66319453|FG000|Completed Study Medication|Lost to Follow-up|0|||
23712119|NCT01025817|66319454|FG001|Completed Study Medication|Lost to Follow-up|1|||
23712120|NCT01025817|66319453|FG000|Completed Study|Withdrawal by Subject|8|||
23712121|NCT01025817|66319454|FG001|Completed Study|Withdrawal by Subject|16|||
23712122|NCT01025817|66319453|FG000|Completed Study|Death|6|||
23712123|NCT01025817|66319454|FG001|Completed Study|Death|5|||
23712124|NCT01025817|66319453|FG000|Completed Study|Missing|2|||
23712125|NCT01025817|66319454|FG001|Completed Study|Missing|0|||
23712126|NCT01025817|66319453|FG000|Completed Study|Lost to Follow-up|0|||
23517026|NCT03045887|65632511|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517027|NCT03045887|65632512|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517028|NCT03045887|65632513|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517029|NCT03045887|65632514|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23712127|NCT01025817|66319454|FG001|Completed Study|Lost to Follow-up|1|||
23712128|NCT00764478|66319457|FG000|Overall Study|Adverse Event|1|||
23712129|NCT00764478|66319458|FG001|Overall Study|Adverse Event|1|||
23712130|NCT00764478|66319459|FG002|Overall Study|Adverse Event|1|||
23517030|NCT03045887|65632515|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23712131|NCT00764478|66319457|FG000|Overall Study|Withdrawal by Subject|7|||
23712132|NCT00764478|66319458|FG001|Overall Study|Withdrawal by Subject|12|||
23712133|NCT00764478|66319459|FG002|Overall Study|Withdrawal by Subject|1|||
23712134|NCT00764478|66319457|FG000|Overall Study|Lost to Follow-up|7|||
23712135|NCT00764478|66319458|FG001|Overall Study|Lost to Follow-up|8|||
23712136|NCT00764478|66319459|FG002|Overall Study|Lost to Follow-up|5|||
23712137|NCT00764478|66319457|FG000|Overall Study|Protocol Violation|0|||
23712138|NCT00764478|66319458|FG001|Overall Study|Protocol Violation|1|||
23712139|NCT00764478|66319459|FG002|Overall Study|Protocol Violation|1|||
23712140|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
23712141|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
23712142|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
23712143|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
23712144|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
23712145|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
23712146|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
23712147|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
23712148|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
23712149|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
23712150|NCT00710034|66319460|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
23712151|NCT00710034|66319461|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
23712152|NCT00710034|66319460|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
23712153|NCT00710034|66319461|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
23712154|NCT00710034|66319460|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
23712155|NCT00710034|66319461|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
23712156|NCT00710034|66319460|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
23712157|NCT00710034|66319461|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
23712158|NCT00710034|66319460|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
23712159|NCT00710034|66319461|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
23712160|NCT00710034|66319460|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
23712161|NCT00710034|66319461|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
23712162|NCT01953328|66319464|FG000|Overall Study|Withdrawal by Subject|0|||
23712163|NCT01953328|66319465|FG001|Overall Study|Withdrawal by Subject|0|||
23712164|NCT01953328|66319466|FG002|Overall Study|Withdrawal by Subject|0|||
23712165|NCT01953328|66319467|FG003|Overall Study|Withdrawal by Subject|0|||
23712166|NCT01953328|66319468|FG004|Overall Study|Withdrawal by Subject|1|||
23517031|NCT03045887|65632516|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517032|NCT03045887|65632507|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
23517033|NCT03045887|65632508|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517034|NCT03045887|65632509|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517035|NCT03045887|65632510|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517036|NCT03045887|65632511|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517037|NCT03045887|65632512|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517038|NCT03045887|65632513|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517039|NCT03045887|65632514|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517040|NCT03045887|65632515|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517041|NCT03045887|65632516|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517042|NCT03045887|65632507|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517043|NCT03045887|65632508|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517044|NCT03045887|65632509|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
23517045|NCT03045887|65632510|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
23517046|NCT03045887|65632511|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517047|NCT03045887|65632512|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517048|NCT03045887|65632513|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517049|NCT03045887|65632514|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517050|NCT03045887|65632515|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517051|NCT03045887|65632516|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517052|NCT03045887|65632507|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517053|NCT03045887|65632508|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517054|NCT03045887|65632509|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517055|NCT03045887|65632510|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
23517056|NCT03045887|65632511|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517057|NCT03045887|65632512|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517058|NCT03045887|65632513|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517059|NCT03045887|65632514|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517060|NCT03045887|65632515|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517061|NCT03045887|65632516|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517062|NCT01996826|65632517|FG000|Overall Study|Lost to Follow-up|6|||
23517063|NCT01996826|65632518|FG001|Overall Study|Lost to Follow-up|2|||
23712167|NCT01953328|66319469|FG005|Overall Study|Withdrawal by Subject|0|||
23517064|NCT01996826|65632517|FG000|Overall Study|Physician Decision|1|||
23517065|NCT01996826|65632518|FG001|Overall Study|Physician Decision|1|||
23517066|NCT01365507|65632519|FG000|Overall Study|Withdrawal Criteria|8|||
23517067|NCT01365507|65632520|FG001|Overall Study|Withdrawal Criteria|5|||
23517068|NCT01365507|65632519|FG000|Overall Study|Unclassified|1|||
23517069|NCT01365507|65632520|FG001|Overall Study|Unclassified|4|||
23517070|NCT01154218|65632521|FG000|Third Intervention Period|Adverse Event|0|||
23517071|NCT01154218|65632522|FG001|Third Intervention Period|Adverse Event|1|||
23517072|NCT01154218|65632523|FG002|Third Intervention Period|Adverse Event|0|||
23517073|NCT01154218|65632524|FG003|Third Intervention Period|Adverse Event|0|||
23517074|NCT01154218|65632521|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517075|NCT01154218|65632522|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517076|NCT01154218|65632523|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517077|NCT01154218|65632524|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
23517078|NCT01154218|65632521|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
23517079|NCT01154218|65632522|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
23517080|NCT01154218|65632523|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
23517081|NCT01154218|65632524|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
23517082|NCT02951156|65632525|FG000|Overall Study|Death|3|||
23517083|NCT02951156|65632526|FG001|Overall Study|Death|8|||
23517084|NCT02951156|65632527|FG002|Overall Study|Death|5|||
23517085|NCT02951156|65632525|FG000|Overall Study|Progressive disease|1|||
23517086|NCT02951156|65632526|FG001|Overall Study|Progressive disease|0|||
23517087|NCT02951156|65632527|FG002|Overall Study|Progressive disease|1|||
23517088|NCT02951156|65632525|FG000|Overall Study|Withdrawal by Subject|0|||
23517089|NCT02951156|65632526|FG001|Overall Study|Withdrawal by Subject|0|||
23517090|NCT02951156|65632527|FG002|Overall Study|Withdrawal by Subject|1|||
23517091|NCT02951156|65632525|FG000|Overall Study|Study terminated by sponsor|0|||
23517092|NCT02951156|65632526|FG001|Overall Study|Study terminated by sponsor|0|||
23517093|NCT02951156|65632527|FG002|Overall Study|Study terminated by sponsor|1|||
23517094|NCT02951156|65632525|FG000|Overall Study|Other|5|||
23517095|NCT02951156|65632526|FG001|Overall Study|Other|1|||
23517096|NCT02951156|65632527|FG002|Overall Study|Other|2|||
23517097|NCT02426892|65632535|FG000|Overall Study|Adverse Event|2|||
23517098|NCT02426892|65632535|FG000|Overall Study|Lack of Efficacy|17|||
23517099|NCT02426892|65632535|FG000|Overall Study|Withdrawal by Subject|1|||
23517100|NCT02921776|65632536|FG000|Overall Study|patient deterioration, fatigue|2|||
23517101|NCT02921776|65632537|FG001|Overall Study|patient deterioration, fatigue|6|||
23517102|NCT02921776|65632538|FG002|Overall Study|patient deterioration, fatigue|0|||
23517103|NCT02921776|65632539|FG003|Overall Study|patient deterioration, fatigue|0|||
23517104|NCT02921776|65632540|FG004|Overall Study|patient deterioration, fatigue|0|||
23517105|NCT02921776|65632541|FG005|Overall Study|patient deterioration, fatigue|0|||
23517106|NCT02921776|65632542|FG006|Overall Study|patient deterioration, fatigue|0|||
23517107|NCT02921776|65632543|FG007|Overall Study|patient deterioration, fatigue|0|||
23517108|NCT02921776|65632536|FG000|Overall Study|Withdrawal by Subject|0|||
23517109|NCT02921776|65632537|FG001|Overall Study|Withdrawal by Subject|2|||
23517110|NCT02921776|65632538|FG002|Overall Study|Withdrawal by Subject|0|||
23517111|NCT02921776|65632539|FG003|Overall Study|Withdrawal by Subject|1|||
23517112|NCT02921776|65632540|FG004|Overall Study|Withdrawal by Subject|1|||
23517113|NCT02921776|65632541|FG005|Overall Study|Withdrawal by Subject|0|||
23517114|NCT02921776|65632542|FG006|Overall Study|Withdrawal by Subject|8|||
23517115|NCT02921776|65632543|FG007|Overall Study|Withdrawal by Subject|1|||
23517116|NCT02921776|65632536|FG000|Overall Study|Death|0|||
23517117|NCT02921776|65632537|FG001|Overall Study|Death|0|||
23517118|NCT02921776|65632538|FG002|Overall Study|Death|0|||
23517119|NCT02921776|65632539|FG003|Overall Study|Death|2|||
23517120|NCT02921776|65632540|FG004|Overall Study|Death|0|||
23517121|NCT02921776|65632541|FG005|Overall Study|Death|0|||
23517122|NCT02921776|65632542|FG006|Overall Study|Death|0|||
23517123|NCT02921776|65632543|FG007|Overall Study|Death|0|||
23517124|NCT02921776|65632536|FG000|Overall Study|extubation or early discharge|0|||
23517125|NCT02921776|65632537|FG001|Overall Study|extubation or early discharge|0|||
23517126|NCT02921776|65632538|FG002|Overall Study|extubation or early discharge|0|||
23517127|NCT02921776|65632539|FG003|Overall Study|extubation or early discharge|5|||
23517128|NCT02921776|65632540|FG004|Overall Study|extubation or early discharge|5|||
23517129|NCT02921776|65632541|FG005|Overall Study|extubation or early discharge|0|||
23517130|NCT02921776|65632542|FG006|Overall Study|extubation or early discharge|0|||
23517131|NCT02921776|65632543|FG007|Overall Study|extubation or early discharge|0|||
23517132|NCT02921776|65632536|FG000|Overall Study|Lost to Follow-up|0|||
23517133|NCT02921776|65632537|FG001|Overall Study|Lost to Follow-up|0|||
23517134|NCT02921776|65632538|FG002|Overall Study|Lost to Follow-up|0|||
23517135|NCT02921776|65632539|FG003|Overall Study|Lost to Follow-up|0|||
23517136|NCT02921776|65632540|FG004|Overall Study|Lost to Follow-up|0|||
23517137|NCT02921776|65632541|FG005|Overall Study|Lost to Follow-up|2|||
23517138|NCT02921776|65632542|FG006|Overall Study|Lost to Follow-up|3|||
23517139|NCT02921776|65632543|FG007|Overall Study|Lost to Follow-up|6|||
23517140|NCT01675128|65632545|FG000|Overall Study|Disease progression on study|1|||
23517141|NCT01675128|65632546|FG001|Overall Study|Disease progression on study|1|||
23517142|NCT01675128|65632547|FG002|Overall Study|Disease progression on study|1|||
23517143|NCT01675128|65632545|FG000|Overall Study|Refused further treatment|1|||
23517144|NCT01675128|65632546|FG001|Overall Study|Refused further treatment|0|||
23517145|NCT01675128|65632547|FG002|Overall Study|Refused further treatment|0|||
23517146|NCT01675128|65632545|FG000|Overall Study|Pulmonary complication; off study|0|||
23517147|NCT01675128|65632546|FG001|Overall Study|Pulmonary complication; off study|1|||
23517148|NCT01675128|65632547|FG002|Overall Study|Pulmonary complication; off study|0|||
23517149|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
23517150|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
23517151|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
23517152|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
23517153|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
23517154|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
23712168|NCT01953328|66319470|FG006|Overall Study|Withdrawal by Subject|0|||
23712169|NCT01953328|66319471|FG007|Overall Study|Withdrawal by Subject|0|||
23712170|NCT01953328|66319464|FG000|Overall Study|Lost to Follow-up|0|||
23517155|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
23517156|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
23517157|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
23517158|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
23517159|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
23517160|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
23517161|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
23517162|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
23517163|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
23517164|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
23517165|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
23517166|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
23517167|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
23517168|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
23517169|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
23517170|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
23517171|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
23517172|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
23517173|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
23517174|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
23517175|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
23517176|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
23517177|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
23517178|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
23517179|NCT02068443|65632550|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23517180|NCT02068443|65632551|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
23517181|NCT02068443|65632552|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
23517182|NCT02068443|65632550|FG000|Overall Study|Voluntary Withdrawal|4|||
23517183|NCT02068443|65632551|FG001|Overall Study|Voluntary Withdrawal|0|||
23517184|NCT02068443|65632552|FG002|Overall Study|Voluntary Withdrawal|1|||
23517185|NCT02068443|65632550|FG000|Overall Study|Lack of Efficacy|2|||
23517186|NCT02068443|65632551|FG001|Overall Study|Lack of Efficacy|1|||
23517187|NCT02068443|65632552|FG002|Overall Study|Lack of Efficacy|0|||
23517188|NCT02068443|65632550|FG000|Overall Study|Other Reason Not Specified|1|||
23517189|NCT02068443|65632551|FG001|Overall Study|Other Reason Not Specified|0|||
23517190|NCT02068443|65632552|FG002|Overall Study|Other Reason Not Specified|0|||
23517191|NCT02069366|65632554|FG000|Overall Study|Lost to Follow-up|0|||
23517192|NCT02069366|65632555|FG001|Overall Study|Lost to Follow-up|0|||
23517193|NCT02069366|65632556|FG002|Overall Study|Lost to Follow-up|1|||
23517194|NCT02069366|65632557|FG003|Overall Study|Lost to Follow-up|0|||
23517195|NCT02069366|65632558|FG004|Overall Study|Lost to Follow-up|0|||
23517196|NCT02069366|65632559|FG005|Overall Study|Lost to Follow-up|2|||
23517197|NCT02069366|65632554|FG000|Overall Study|Protocol Violation|0|||
23517198|NCT02069366|65632555|FG001|Overall Study|Protocol Violation|0|||
23712171|NCT01953328|66319465|FG001|Overall Study|Lost to Follow-up|0|||
23712172|NCT01953328|66319466|FG002|Overall Study|Lost to Follow-up|0|||
23712173|NCT01953328|66319467|FG003|Overall Study|Lost to Follow-up|0|||
23517199|NCT02069366|65632556|FG002|Overall Study|Protocol Violation|1|||
23517200|NCT02069366|65632557|FG003|Overall Study|Protocol Violation|0|||
23517201|NCT02069366|65632558|FG004|Overall Study|Protocol Violation|0|||
23517202|NCT02069366|65632559|FG005|Overall Study|Protocol Violation|0|||
23517203|NCT02069366|65632554|FG000|Overall Study|Withdrawal by Subject|1|||
23712174|NCT01953328|66319468|FG004|Overall Study|Lost to Follow-up|1|||
23712175|NCT01953328|66319469|FG005|Overall Study|Lost to Follow-up|0|||
23712176|NCT01953328|66319470|FG006|Overall Study|Lost to Follow-up|0|||
23712177|NCT01953328|66319471|FG007|Overall Study|Lost to Follow-up|0|||
23712178|NCT03337139|66322172|FG000|Phase I|Withdrawal by Subject|10|||
23712179|NCT03337139|66322173|FG001|Phase I|Withdrawal by Subject|0|||
23712180|NCT01114373|66322174|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
23712181|NCT01114373|66322175|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
23712182|NCT01114373|66322174|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
23712183|NCT01114373|66322175|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
23712184|NCT01114373|66322174|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
23712185|NCT01114373|66322175|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
23712186|NCT01114373|66322174|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
23712187|NCT01114373|66322175|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
23712188|NCT05554471|66322181|FG000|Overall Study|Physician Decision|2|||
23712189|NCT05554471|66322182|FG001|Overall Study|Physician Decision|1|||
23712190|NCT05554471|66322181|FG000|Overall Study|Lost to Follow-up|2|||
23712191|NCT05554471|66322182|FG001|Overall Study|Lost to Follow-up|1|||
23712192|NCT05554471|66322181|FG000|Overall Study|Death|0|||
23712193|NCT05554471|66322182|FG001|Overall Study|Death|1|||
23712194|NCT00438399|66322183|FG000|Overall Study|Lost to Follow-up|2|||
23712195|NCT00438399|66322184|FG001|Overall Study|Lost to Follow-up|2|||
23712196|NCT00438399|66322185|FG002|Overall Study|Lost to Follow-up|1|||
23712197|NCT00438399|66322186|FG003|Overall Study|Lost to Follow-up|1|||
23712198|NCT00438399|66322187|FG004|Overall Study|Lost to Follow-up|1|||
23712199|NCT00438399|66322188|FG005|Overall Study|Lost to Follow-up|1|||
23712200|NCT00438399|66322183|FG000|Overall Study|Adverse Event|0|||
23712201|NCT00438399|66322184|FG001|Overall Study|Adverse Event|0|||
23712202|NCT00438399|66322185|FG002|Overall Study|Adverse Event|1|||
23712203|NCT00438399|66322186|FG003|Overall Study|Adverse Event|1|||
23712204|NCT00438399|66322187|FG004|Overall Study|Adverse Event|0|||
23712205|NCT00438399|66322188|FG005|Overall Study|Adverse Event|1|||
23712206|NCT00438399|66322183|FG000|Overall Study|Withdrawal by Subject|5|||
23712207|NCT00438399|66322184|FG001|Overall Study|Withdrawal by Subject|6|||
23712208|NCT00438399|66322185|FG002|Overall Study|Withdrawal by Subject|3|||
23712209|NCT00438399|66322186|FG003|Overall Study|Withdrawal by Subject|2|||
23517204|NCT02069366|65632555|FG001|Overall Study|Withdrawal by Subject|0|||
23517205|NCT02069366|65632556|FG002|Overall Study|Withdrawal by Subject|1|||
23517206|NCT02069366|65632557|FG003|Overall Study|Withdrawal by Subject|2|||
23517207|NCT02069366|65632558|FG004|Overall Study|Withdrawal by Subject|0|||
23517208|NCT02069366|65632559|FG005|Overall Study|Withdrawal by Subject|0|||
23517209|NCT02120950|65632560|FG000|Overall Study|Adverse Event|5|||
23517210|NCT02120950|65632561|FG001|Overall Study|Adverse Event|4|||
23517211|NCT02120950|65632562|FG002|Overall Study|Adverse Event|3|||
23517212|NCT02120950|65632560|FG000|Overall Study|Death|3|||
23517213|NCT02120950|65632561|FG001|Overall Study|Death|0|||
23517214|NCT02120950|65632562|FG002|Overall Study|Death|1|||
23517215|NCT02120950|65632560|FG000|Overall Study|Withdrawal by Subject|6|||
23517216|NCT02120950|65632561|FG001|Overall Study|Withdrawal by Subject|3|||
23517217|NCT02120950|65632562|FG002|Overall Study|Withdrawal by Subject|2|||
23517218|NCT02120950|65632560|FG000|Overall Study|Protocol Violation|1|||
23517219|NCT02120950|65632561|FG001|Overall Study|Protocol Violation|1|||
23517220|NCT02120950|65632562|FG002|Overall Study|Protocol Violation|7|||
23517221|NCT02120950|65632560|FG000|Overall Study|Other reasons|5|||
23517222|NCT02120950|65632561|FG001|Overall Study|Other reasons|4|||
23517223|NCT02120950|65632562|FG002|Overall Study|Other reasons|1|||
23517224|NCT02120950|65632560|FG000|Overall Study|Lost to Follow-up|0|||
23517225|NCT02120950|65632561|FG001|Overall Study|Lost to Follow-up|2|||
23517226|NCT02120950|65632562|FG002|Overall Study|Lost to Follow-up|1|||
23517227|NCT02617511|65632563|FG000|Overall Study|Withdrawal by Subject|1|||
23517228|NCT02617511|65632564|FG001|Overall Study|Withdrawal by Subject|0|||
23712210|NCT00438399|66322187|FG004|Overall Study|Withdrawal by Subject|2|||
23712211|NCT00438399|66322188|FG005|Overall Study|Withdrawal by Subject|2|||
23712212|NCT00438399|66322183|FG000|Overall Study|Protocol Violation|0|||
23712213|NCT00438399|66322184|FG001|Overall Study|Protocol Violation|0|||
23712214|NCT00438399|66322185|FG002|Overall Study|Protocol Violation|1|||
23712215|NCT00438399|66322186|FG003|Overall Study|Protocol Violation|0|||
23712216|NCT00438399|66322187|FG004|Overall Study|Protocol Violation|0|||
23712217|NCT00438399|66322188|FG005|Overall Study|Protocol Violation|1|||
23712218|NCT00438399|66322183|FG000|Overall Study|Subje stopped study|0|||
23712219|NCT00438399|66322184|FG001|Overall Study|Subje stopped study|0|||
23712220|NCT00438399|66322185|FG002|Overall Study|Subje stopped study|1|||
23517229|NCT04351087|65632566|FG000|Overall Study|Lost to Follow-up|7|||
23517230|NCT04351087|65632567|FG001|Overall Study|Lost to Follow-up|3|||
23712221|NCT00438399|66322186|FG003|Overall Study|Subje stopped study|0|||
23712222|NCT00438399|66322187|FG004|Overall Study|Subje stopped study|0|||
23517231|NCT04351087|65632566|FG000|Overall Study|Withdrawal by Subject|3|||
23517232|NCT04351087|65632567|FG001|Overall Study|Withdrawal by Subject|4|||
23517233|NCT04351087|65632566|FG000|Overall Study|Lack of Efficacy|3|||
23517234|NCT04351087|65632567|FG001|Overall Study|Lack of Efficacy|2|||
23517235|NCT00624052|65632570|FG000|Overall Study|Adverse Event|7|||
23517236|NCT00624052|65632571|FG001|Overall Study|Adverse Event|6|||
23517237|NCT00624052|65632572|FG002|Overall Study|Adverse Event|0|||
23517238|NCT00624052|65632573|FG003|Overall Study|Adverse Event|3|||
23517239|NCT00624052|65632570|FG000|Overall Study|Lack of Efficacy|1|||
23517240|NCT00624052|65632571|FG001|Overall Study|Lack of Efficacy|1|||
23517241|NCT00624052|65632572|FG002|Overall Study|Lack of Efficacy|0|||
23517242|NCT00624052|65632573|FG003|Overall Study|Lack of Efficacy|0|||
23517243|NCT00624052|65632570|FG000|Overall Study|Lost to Follow-up|2|||
23517244|NCT00624052|65632571|FG001|Overall Study|Lost to Follow-up|3|||
23517245|NCT00624052|65632572|FG002|Overall Study|Lost to Follow-up|1|||
23517246|NCT00624052|65632573|FG003|Overall Study|Lost to Follow-up|0|||
23517247|NCT00624052|65632570|FG000|Overall Study|Non compliant with the protocol|2|||
23517248|NCT00624052|65632571|FG001|Overall Study|Non compliant with the protocol|1|||
23517249|NCT00624052|65632572|FG002|Overall Study|Non compliant with the protocol|1|||
23517250|NCT00624052|65632573|FG003|Overall Study|Non compliant with the protocol|1|||
23517251|NCT00624052|65632570|FG000|Overall Study|Consent withdrawn|3|||
23517252|NCT00624052|65632571|FG001|Overall Study|Consent withdrawn|1|||
23517253|NCT00624052|65632572|FG002|Overall Study|Consent withdrawn|1|||
23517254|NCT00624052|65632573|FG003|Overall Study|Consent withdrawn|0|||
23517255|NCT00624052|65632570|FG000|Overall Study|Changed job/ran out if meds|0|||
23517256|NCT00624052|65632571|FG001|Overall Study|Changed job/ran out if meds|2|||
23517257|NCT00624052|65632572|FG002|Overall Study|Changed job/ran out if meds|0|||
23517258|NCT00624052|65632573|FG003|Overall Study|Changed job/ran out if meds|0|||
23712223|NCT00438399|66322188|FG005|Overall Study|Subje stopped study|0|||
23712224|NCT00438399|66322183|FG000|Overall Study|Pregnancy|0|||
23712225|NCT00438399|66322184|FG001|Overall Study|Pregnancy|0|||
23712226|NCT00438399|66322185|FG002|Overall Study|Pregnancy|0|||
23712227|NCT00438399|66322186|FG003|Overall Study|Pregnancy|0|||
23712228|NCT00438399|66322187|FG004|Overall Study|Pregnancy|0|||
23712229|NCT00438399|66322188|FG005|Overall Study|Pregnancy|1|||
23712230|NCT00438399|66322183|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
23712231|NCT00438399|66322184|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
23712232|NCT00438399|66322185|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
23712233|NCT00438399|66322186|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
23712234|NCT00438399|66322187|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
23712235|NCT00438399|66322188|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
23712236|NCT03074149|66322189|FG000|Overall Study|Reason unknown|22|||
23712237|NCT03074149|66322190|FG001|Overall Study|Reason unknown|35|||
23712238|NCT03074149|66322189|FG000|Overall Study|Death|10|||
23712239|NCT03074149|66322190|FG001|Overall Study|Death|45|||
23712240|NCT02864940|66322191|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
23712241|NCT02864940|66322192|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
23712242|NCT00238303|66322193|FG000|Overall Study|Withdrawal by Subject|11|||
23712243|NCT00238303|66322194|FG001|Overall Study|Withdrawal by Subject|1|||
23712244|NCT00238303|66322195|FG002|Overall Study|Withdrawal by Subject|2|||
23712245|NCT00238303|66322193|FG000|Overall Study|Death|1|||
23712246|NCT00238303|66322194|FG001|Overall Study|Death|0|||
23517259|NCT01782859|65632575|FG000|Overall Study|Protocol Violation|6|||
23517260|NCT01782859|65632576|FG001|Overall Study|Protocol Violation|6|||
23517261|NCT01782859|65632575|FG000|Overall Study|Withdrawal by Subject|0|||
23517262|NCT01782859|65632576|FG001|Overall Study|Withdrawal by Subject|1|||
23517263|NCT00411645|65632578|FG000|Overall Study|Consent Withdrawn|13|||
23517264|NCT00411645|65632579|FG001|Overall Study|Consent Withdrawn|22|||
23517265|NCT00411645|65632578|FG000|Overall Study|Death|56|||
23517266|NCT00411645|65632579|FG001|Overall Study|Death|135|||
23517267|NCT00411645|65632578|FG000|Overall Study|Investigator/Sponsor Decision|10|||
23517268|NCT00411645|65632579|FG001|Overall Study|Investigator/Sponsor Decision|7|||
23517269|NCT00411645|65632578|FG000|Overall Study|Lost to Follow-up|2|||
23517270|NCT00411645|65632579|FG001|Overall Study|Lost to Follow-up|0|||
23517271|NCT02723084|65632580|FG000|Overall Study|Withdrawal by Subject|1|||
23517272|NCT02723084|65632581|FG001|Overall Study|Withdrawal by Subject|1|||
23517273|NCT02723084|65632580|FG000|Overall Study|Lost to Follow-up|3|||
23517274|NCT02723084|65632581|FG001|Overall Study|Lost to Follow-up|0|||
23517275|NCT00560950|65632582|FG000|Overall Study|Lost to Follow-up|1|||
23517276|NCT00560950|65632583|FG001|Overall Study|Lost to Follow-up|0|||
23517277|NCT01428453|65632587|FG000|Overall Study|Adverse Event|2|||
23517278|NCT01428453|65632588|FG001|Overall Study|Adverse Event|7|||
23517279|NCT01428453|65632587|FG000|Overall Study|Protocol Violation|1|||
23712247|NCT00238303|66322195|FG002|Overall Study|Death|1|||
23517280|NCT01428453|65632588|FG001|Overall Study|Protocol Violation|0|||
23517281|NCT01428453|65632587|FG000|Overall Study|Lost to Follow-up|0|||
23517282|NCT01428453|65632588|FG001|Overall Study|Lost to Follow-up|1|||
23517283|NCT01428453|65632587|FG000|Overall Study|Withdrawal by Subject|3|||
23517284|NCT01428453|65632588|FG001|Overall Study|Withdrawal by Subject|1|||
23712248|NCT00238303|66322193|FG000|Overall Study|Other Medical Problems|2|||
23416191|NCT01893411|65266166|FG001|Overall Study|Lost to Follow-up|0|||
23517285|NCT02968563|65632589|FG000|Overall Study|Adverse Event|0|||
23517286|NCT02968563|65632590|FG001|Overall Study|Adverse Event|6|||
23517287|NCT02968563|65632589|FG000|Overall Study|Death|1|||
23517288|NCT02968563|65632590|FG001|Overall Study|Death|1|||
23517289|NCT02968563|65632589|FG000|Overall Study|Lost to Follow-up|0|||
23517290|NCT02968563|65632590|FG001|Overall Study|Lost to Follow-up|1|||
23517291|NCT00003901|65632591|FG000|Overall Study|Adverse Event|1|||
23517292|NCT00003901|65632591|FG000|Overall Study|Withdrawal by Subject|1|||
23517293|NCT00003901|65632591|FG000|Overall Study|Ineligible|6|||
23517294|NCT00003901|65632591|FG000|Overall Study|CT Scan not within protocol requirement|2|||
23517295|NCT00003901|65632591|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
23517296|NCT00003901|65632591|FG000|Overall Study|Medical problems|6|||
23517297|NCT01275833|65632592|FG000|Overall Study|Study terminated|1|||
23517298|NCT01275833|65632593|FG001|Overall Study|Study terminated|1|||
23517299|NCT01466348|65632594|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
23517300|NCT01466348|65632595|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
23712249|NCT00238303|66322194|FG001|Overall Study|Other Medical Problems|0|||
23712250|NCT00238303|66322195|FG002|Overall Study|Other Medical Problems|2|||
23712251|NCT00238303|66322193|FG000|Overall Study|Poor tolerance of study treatment|1|||
23712252|NCT00238303|66322194|FG001|Overall Study|Poor tolerance of study treatment|0|||
23712253|NCT00238303|66322195|FG002|Overall Study|Poor tolerance of study treatment|1|||
23712254|NCT00238303|66322193|FG000|Overall Study|Adverse Event|0|||
23712255|NCT00238303|66322194|FG001|Overall Study|Adverse Event|1|||
23712256|NCT00238303|66322195|FG002|Overall Study|Adverse Event|3|||
23712257|NCT01188564|66322196|FG000|Double-blind Phase|randomized not treated|1|||
23712258|NCT01188564|66322197|FG001|Double-blind Phase|randomized not treated|0|||
23712259|NCT02112916|66322198|FG000|Overall Study|Adverse Event|6|||
23712260|NCT02112916|66322199|FG001|Overall Study|Adverse Event|9|||
23712261|NCT02112916|66322200|FG002|Overall Study|Adverse Event|3|||
23712262|NCT02112916|66322201|FG003|Overall Study|Adverse Event|2|||
23517301|NCT02551731|65632598|FG000|Overall Study|Withdrawal by Subject|2|||
23517302|NCT02141282|65632599|FG000|Overall Study|Adverse event, not related to progression|8|||
23517303|NCT02141282|65632600|FG001|Overall Study|Adverse event, not related to progression|1|||
23517304|NCT02141282|65632601|FG002|Overall Study|Adverse event, not related to progression|3|||
23517305|NCT02141282|65632602|FG003|Overall Study|Adverse event, not related to progression|1|||
23517306|NCT02141282|65632599|FG000|Overall Study|Adverse event, related to progression|1|||
23517307|NCT02141282|65632600|FG001|Overall Study|Adverse event, related to progression|0|||
23517308|NCT02141282|65632601|FG002|Overall Study|Adverse event, related to progression|2|||
23517309|NCT02141282|65632602|FG003|Overall Study|Adverse event, related to progression|0|||
23517310|NCT02141282|65632599|FG000|Overall Study|COVID-19 infection|1|||
23517311|NCT02141282|65632600|FG001|Overall Study|COVID-19 infection|0|||
23517312|NCT02141282|65632601|FG002|Overall Study|COVID-19 infection|0|||
23517313|NCT02141282|65632602|FG003|Overall Study|COVID-19 infection|0|||
23517314|NCT02141282|65632599|FG000|Overall Study|Lost to Follow-up|0|||
23517315|NCT02141282|65632600|FG001|Overall Study|Lost to Follow-up|0|||
23517316|NCT02141282|65632601|FG002|Overall Study|Lost to Follow-up|4|||
23517317|NCT02141282|65632602|FG003|Overall Study|Lost to Follow-up|2|||
23517318|NCT02141282|65632599|FG000|Overall Study|Other, not specified|14|||
23517319|NCT02141282|65632600|FG001|Overall Study|Other, not specified|11|||
23517320|NCT02141282|65632601|FG002|Overall Study|Other, not specified|23|||
23517321|NCT02141282|65632602|FG003|Overall Study|Other, not specified|9|||
23517322|NCT02141282|65632599|FG000|Overall Study|Progressive disease, Richter's|4|||
23517323|NCT02141282|65632600|FG001|Overall Study|Progressive disease, Richter's|1|||
23517324|NCT02141282|65632601|FG002|Overall Study|Progressive disease, Richter's|1|||
23517325|NCT02141282|65632602|FG003|Overall Study|Progressive disease, Richter's|1|||
23517326|NCT02141282|65632599|FG000|Overall Study|Progressive disease per protocol|12|||
23517327|NCT02141282|65632600|FG001|Overall Study|Progressive disease per protocol|7|||
23517328|NCT02141282|65632601|FG002|Overall Study|Progressive disease per protocol|9|||
23517329|NCT02141282|65632602|FG003|Overall Study|Progressive disease per protocol|2|||
23517330|NCT02141282|65632599|FG000|Overall Study|Stem cell transplant|1|||
23517331|NCT02141282|65632600|FG001|Overall Study|Stem cell transplant|0|||
23517332|NCT02141282|65632601|FG002|Overall Study|Stem cell transplant|1|||
23517333|NCT02141282|65632602|FG003|Overall Study|Stem cell transplant|0|||
23517334|NCT02141282|65632599|FG000|Overall Study|Study terminated by Sponsor|0|||
23517335|NCT02141282|65632600|FG001|Overall Study|Study terminated by Sponsor|1|||
23712263|NCT02112916|66322198|FG000|Overall Study|Death|9|||
23712264|NCT02112916|66322199|FG001|Overall Study|Death|9|||
23517336|NCT02141282|65632601|FG002|Overall Study|Study terminated by Sponsor|0|||
23517337|NCT02141282|65632602|FG003|Overall Study|Study terminated by Sponsor|0|||
23517338|NCT02141282|65632599|FG000|Overall Study|Subject non-compliance|0|||
23517339|NCT02141282|65632600|FG001|Overall Study|Subject non-compliance|0|||
23517340|NCT02141282|65632601|FG002|Overall Study|Subject non-compliance|1|||
23517341|NCT02141282|65632602|FG003|Overall Study|Subject non-compliance|0|||
23517342|NCT02141282|65632599|FG000|Overall Study|Withdrew consent|2|||
23517343|NCT02141282|65632600|FG001|Overall Study|Withdrew consent|0|||
23517344|NCT02141282|65632601|FG002|Overall Study|Withdrew consent|4|||
23517345|NCT02141282|65632602|FG003|Overall Study|Withdrew consent|0|||
23517346|NCT01881230|65632603|FG000|Overall Study|Death|2|||
23517347|NCT01881230|65632604|FG001|Overall Study|Death|0|||
23517348|NCT01881230|65632605|FG002|Overall Study|Death|1|||
23517349|NCT01881230|65632603|FG000|Overall Study|Adverse Event|9|||
23517350|NCT01881230|65632604|FG001|Overall Study|Adverse Event|13|||
23517351|NCT01881230|65632605|FG002|Overall Study|Adverse Event|12|||
23517352|NCT01881230|65632603|FG000|Overall Study|Progressive Disease|31|||
23517353|NCT01881230|65632604|FG001|Overall Study|Progressive Disease|35|||
23517354|NCT01881230|65632605|FG002|Overall Study|Progressive Disease|36|||
23517355|NCT01881230|65632603|FG000|Overall Study|Symptomatic Deterioration|3|||
23517356|NCT01881230|65632604|FG001|Overall Study|Symptomatic Deterioration|3|||
23517357|NCT01881230|65632605|FG002|Overall Study|Symptomatic Deterioration|1|||
23517358|NCT01881230|65632603|FG000|Overall Study|Withdrawal by Subject|6|||
23517359|NCT01881230|65632604|FG001|Overall Study|Withdrawal by Subject|4|||
23517360|NCT01881230|65632605|FG002|Overall Study|Withdrawal by Subject|6|||
23712265|NCT02112916|66322200|FG002|Overall Study|Death|3|||
23712266|NCT02112916|66322201|FG003|Overall Study|Death|4|||
23712267|NCT02112916|66322198|FG000|Overall Study|Lost to Follow-up|1|||
23712268|NCT02112916|66322199|FG001|Overall Study|Lost to Follow-up|0|||
23712269|NCT02112916|66322200|FG002|Overall Study|Lost to Follow-up|0|||
23712270|NCT02112916|66322201|FG003|Overall Study|Lost to Follow-up|0|||
23712271|NCT02112916|66322198|FG000|Overall Study|Physician Decision|94|||
23712272|NCT02112916|66322199|FG001|Overall Study|Physician Decision|72|||
23712273|NCT02112916|66322200|FG002|Overall Study|Physician Decision|24|||
23712274|NCT02112916|66322201|FG003|Overall Study|Physician Decision|15|||
23712275|NCT02112916|66322198|FG000|Overall Study|Withdrawal by Subject|5|||
23517361|NCT01881230|65632603|FG000|Overall Study|Physician Decision|4|||
23517362|NCT01881230|65632604|FG001|Overall Study|Physician Decision|3|||
23517363|NCT01881230|65632605|FG002|Overall Study|Physician Decision|6|||
23517364|NCT01881230|65632603|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23517365|NCT01881230|65632604|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23517366|NCT01881230|65632605|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23517367|NCT01881230|65632603|FG000|Overall Study|Given Commercially Available Drug|0|||
23517368|NCT01881230|65632604|FG001|Overall Study|Given Commercially Available Drug|0|||
23517369|NCT01881230|65632605|FG002|Overall Study|Given Commercially Available Drug|2|||
23517370|NCT01881230|65632603|FG000|Overall Study|Protocol Violation|1|||
23517371|NCT01881230|65632604|FG001|Overall Study|Protocol Violation|1|||
23517372|NCT01881230|65632605|FG002|Overall Study|Protocol Violation|0|||
23517373|NCT01881230|65632603|FG000|Overall Study|Miscellaneous|3|||
23517374|NCT01881230|65632604|FG001|Overall Study|Miscellaneous|3|||
23517375|NCT01881230|65632605|FG002|Overall Study|Miscellaneous|0|||
23517376|NCT01881230|65632603|FG000|Overall Study|Untreated: Other|0|||
23517377|NCT01881230|65632604|FG001|Overall Study|Untreated: Other|0|||
23517378|NCT01881230|65632605|FG002|Overall Study|Untreated: Other|1|||
23517379|NCT01881230|65632603|FG000|Overall Study|Untreated: Death|0|||
23517380|NCT01881230|65632604|FG001|Overall Study|Untreated: Death|0|||
23517381|NCT01881230|65632605|FG002|Overall Study|Untreated: Death|1|||
23517382|NCT01881230|65632603|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
23517383|NCT01881230|65632604|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
23517384|NCT01881230|65632605|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
23517385|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Death|3|||
23517386|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Death|2|||
23517387|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Death|4|||
23517388|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Death|3|||
23517389|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Death|0|||
23517390|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Death|0|||
23517391|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517392|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
23517393|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
23517394|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23712276|NCT02112916|66322199|FG001|Overall Study|Withdrawal by Subject|3|||
23517395|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517396|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517397|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
23517398|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23712277|NCT02112916|66322200|FG002|Overall Study|Withdrawal by Subject|1|||
23712278|NCT02112916|66322201|FG003|Overall Study|Withdrawal by Subject|1|||
23712279|NCT02112916|66322198|FG000|Overall Study|Ineligible|4|||
23517399|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517400|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517401|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517402|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23712280|NCT02112916|66322199|FG001|Overall Study|Ineligible|8|||
23517403|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
23517404|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517405|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
23517406|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
23517407|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517408|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517409|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517410|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517411|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
23517412|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
23517413|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517414|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517415|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
23517416|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
23517417|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
23517418|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
23517419|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
23517420|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
23517421|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517422|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517423|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
23517424|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517425|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517426|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517427|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
23517428|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
23517429|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
23517430|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
23517431|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
23517432|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
23517433|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517434|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517435|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517436|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517437|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
23517438|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
23517439|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517440|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517441|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517442|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517443|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
23517444|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517445|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517446|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517447|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517448|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517449|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
23517450|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
23517451|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517452|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517453|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517454|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517455|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
23517456|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
23517457|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517458|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517459|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517460|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517461|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
23517462|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
23712281|NCT02112916|66322200|FG002|Overall Study|Ineligible|3|||
23416192|NCT01893411|65266167|FG002|Overall Study|Lost to Follow-up|1|||
23712282|NCT02112916|66322201|FG003|Overall Study|Ineligible|8|||
23712283|NCT02112916|66322198|FG000|Overall Study|Inevaluable|6|||
23712284|NCT02112916|66322199|FG001|Overall Study|Inevaluable|4|||
23712285|NCT02112916|66322200|FG002|Overall Study|Inevaluable|5|||
23712286|NCT02112916|66322201|FG003|Overall Study|Inevaluable|5|||
23712287|NCT02112916|66322198|FG000|Overall Study|Refusal of further protocol therapy|19|||
23712288|NCT02112916|66322199|FG001|Overall Study|Refusal of further protocol therapy|16|||
23712289|NCT02112916|66322200|FG002|Overall Study|Refusal of further protocol therapy|1|||
23712290|NCT02112916|66322201|FG003|Overall Study|Refusal of further protocol therapy|7|||
23712291|NCT02112916|66322198|FG000|Overall Study|Development of SMN|1|||
23712292|NCT02112916|66322199|FG001|Overall Study|Development of SMN|0|||
23712293|NCT02112916|66322200|FG002|Overall Study|Development of SMN|0|||
23712294|NCT02112916|66322201|FG003|Overall Study|Development of SMN|1|||
23712295|NCT02112916|66322198|FG000|Overall Study|Relapse/Progression|10|||
23712296|NCT02112916|66322199|FG001|Overall Study|Relapse/Progression|18|||
23712297|NCT02112916|66322200|FG002|Overall Study|Relapse/Progression|15|||
23712298|NCT02112916|66322201|FG003|Overall Study|Relapse/Progression|2|||
23712299|NCT02112916|66322198|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
23712300|NCT02112916|66322199|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
23712301|NCT02112916|66322200|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
23517463|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517464|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517465|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517466|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517467|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
23517468|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517469|NCT01166763|65632612|FG000|Overall Study|Withdrawal by Subject|3|||
23517470|NCT02393547|65632613|FG000|Overall Study|Adverse Event|2|||
23517471|NCT02393547|65632613|FG000|Overall Study|Withdrawal by Subject|3|||
23517472|NCT02393547|65632613|FG000|Overall Study|Lost to Follow-up|1|||
23517473|NCT02206828|65632614|FG000|Overall Study|Lost to Follow-up|7|||
23517474|NCT04256785|65632615|FG000|Overall Study|Adverse Event|8|||
23517475|NCT04256785|65632616|FG001|Overall Study|Adverse Event|6|||
23517476|NCT04256785|65632615|FG000|Overall Study|Lack of Efficacy|3|||
23517477|NCT04256785|65632616|FG001|Overall Study|Lack of Efficacy|4|||
23517478|NCT04256785|65632615|FG000|Overall Study|Lost to Follow-up|7|||
23517479|NCT04256785|65632616|FG001|Overall Study|Lost to Follow-up|7|||
23517480|NCT04256785|65632615|FG000|Overall Study|Protocol Violation|1|||
23517481|NCT04256785|65632616|FG001|Overall Study|Protocol Violation|0|||
23517482|NCT04256785|65632615|FG000|Overall Study|Withdrawal by Subject|4|||
23517483|NCT04256785|65632616|FG001|Overall Study|Withdrawal by Subject|1|||
23517484|NCT04256785|65632615|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
23517485|NCT04256785|65632616|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
23517486|NCT02276872|65632621|FG000|Overall Study|Adverse Event|1|||
23517487|NCT02276872|65632622|FG001|Overall Study|Adverse Event|0|||
23517488|NCT02276872|65632623|FG002|Overall Study|Adverse Event|0|||
23517489|NCT02039674|65632625|FG000|Overall Study|Adverse Event|0|||
23517490|NCT02039674|65632626|FG001|Overall Study|Adverse Event|0|||
23517491|NCT02039674|65632627|FG002|Overall Study|Adverse Event|0|||
23517492|NCT02039674|65632628|FG003|Overall Study|Adverse Event|1|||
23517493|NCT02039674|65632629|FG004|Overall Study|Adverse Event|0|||
23517494|NCT02039674|65632630|FG005|Overall Study|Adverse Event|0|||
23517495|NCT02039674|65632631|FG006|Overall Study|Adverse Event|0|||
23517496|NCT02039674|65632632|FG007|Overall Study|Adverse Event|0|||
23517497|NCT02039674|65632633|FG008|Overall Study|Adverse Event|2|||
23517498|NCT02039674|65632634|FG009|Overall Study|Adverse Event|1|||
23517499|NCT02039674|65632635|FG010|Overall Study|Adverse Event|0|||
23517500|NCT02039674|65632636|FG011|Overall Study|Adverse Event|2|||
23517501|NCT02039674|65632637|FG012|Overall Study|Adverse Event|3|||
23517502|NCT02039674|65632638|FG013|Overall Study|Adverse Event|1|||
23517503|NCT02039674|65632625|FG000|Overall Study|Death|2|||
23517504|NCT02039674|65632626|FG001|Overall Study|Death|0|||
23517505|NCT02039674|65632627|FG002|Overall Study|Death|2|||
23517506|NCT02039674|65632628|FG003|Overall Study|Death|3|||
23517507|NCT02039674|65632629|FG004|Overall Study|Death|0|||
23517508|NCT02039674|65632630|FG005|Overall Study|Death|0|||
23517509|NCT02039674|65632631|FG006|Overall Study|Death|1|||
23712302|NCT02112916|66322201|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
23712303|NCT02112916|66322198|FG000|Overall Study|Still on Therapy|44|||
23517510|NCT02039674|65632632|FG007|Overall Study|Death|0|||
23517511|NCT02039674|65632633|FG008|Overall Study|Death|2|||
23517512|NCT02039674|65632634|FG009|Overall Study|Death|0|||
23517513|NCT02039674|65632635|FG010|Overall Study|Death|1|||
23517514|NCT02039674|65632636|FG011|Overall Study|Death|3|||
23517515|NCT02039674|65632637|FG012|Overall Study|Death|2|||
23517516|NCT02039674|65632638|FG013|Overall Study|Death|8|||
23517517|NCT02039674|65632625|FG000|Overall Study|Excluded Medication|1|||
23517518|NCT02039674|65632626|FG001|Overall Study|Excluded Medication|1|||
23517519|NCT02039674|65632627|FG002|Overall Study|Excluded Medication|0|||
23517520|NCT02039674|65632628|FG003|Overall Study|Excluded Medication|1|||
23517521|NCT02039674|65632629|FG004|Overall Study|Excluded Medication|0|||
23517522|NCT02039674|65632630|FG005|Overall Study|Excluded Medication|1|||
23517523|NCT02039674|65632631|FG006|Overall Study|Excluded Medication|0|||
23517524|NCT02039674|65632632|FG007|Overall Study|Excluded Medication|0|||
23517525|NCT02039674|65632633|FG008|Overall Study|Excluded Medication|2|||
23517526|NCT02039674|65632634|FG009|Overall Study|Excluded Medication|3|||
23517527|NCT02039674|65632635|FG010|Overall Study|Excluded Medication|5|||
23517528|NCT02039674|65632636|FG011|Overall Study|Excluded Medication|6|||
23517529|NCT02039674|65632637|FG012|Overall Study|Excluded Medication|8|||
23517530|NCT02039674|65632638|FG013|Overall Study|Excluded Medication|3|||
23517531|NCT02039674|65632625|FG000|Overall Study|Lost to Follow-up|0|||
23517532|NCT02039674|65632626|FG001|Overall Study|Lost to Follow-up|0|||
23517533|NCT02039674|65632627|FG002|Overall Study|Lost to Follow-up|0|||
23517534|NCT02039674|65632628|FG003|Overall Study|Lost to Follow-up|0|||
23517535|NCT02039674|65632629|FG004|Overall Study|Lost to Follow-up|1|||
23517536|NCT02039674|65632630|FG005|Overall Study|Lost to Follow-up|1|||
23517537|NCT02039674|65632631|FG006|Overall Study|Lost to Follow-up|0|||
23517538|NCT02039674|65632632|FG007|Overall Study|Lost to Follow-up|0|||
23517539|NCT02039674|65632633|FG008|Overall Study|Lost to Follow-up|0|||
23517540|NCT02039674|65632634|FG009|Overall Study|Lost to Follow-up|0|||
23517541|NCT02039674|65632635|FG010|Overall Study|Lost to Follow-up|0|||
23517542|NCT02039674|65632636|FG011|Overall Study|Lost to Follow-up|2|||
23517543|NCT02039674|65632637|FG012|Overall Study|Lost to Follow-up|2|||
23517544|NCT02039674|65632638|FG013|Overall Study|Lost to Follow-up|1|||
23517545|NCT02039674|65632625|FG000|Overall Study|Physician Decision|0|||
23517546|NCT02039674|65632626|FG001|Overall Study|Physician Decision|0|||
23517547|NCT02039674|65632627|FG002|Overall Study|Physician Decision|0|||
23517548|NCT02039674|65632628|FG003|Overall Study|Physician Decision|0|||
23517549|NCT02039674|65632629|FG004|Overall Study|Physician Decision|0|||
23517550|NCT02039674|65632630|FG005|Overall Study|Physician Decision|0|||
23517551|NCT02039674|65632631|FG006|Overall Study|Physician Decision|0|||
23517552|NCT02039674|65632632|FG007|Overall Study|Physician Decision|0|||
23517553|NCT02039674|65632633|FG008|Overall Study|Physician Decision|0|||
23517554|NCT02039674|65632634|FG009|Overall Study|Physician Decision|0|||
23517555|NCT02039674|65632635|FG010|Overall Study|Physician Decision|0|||
23517556|NCT02039674|65632636|FG011|Overall Study|Physician Decision|1|||
23517557|NCT02039674|65632637|FG012|Overall Study|Physician Decision|1|||
23517558|NCT02039674|65632638|FG013|Overall Study|Physician Decision|0|||
23517559|NCT02039674|65632625|FG000|Overall Study|Progressive Disease|8|||
23517560|NCT02039674|65632626|FG001|Overall Study|Progressive Disease|8|||
23517561|NCT02039674|65632627|FG002|Overall Study|Progressive Disease|6|||
23517562|NCT02039674|65632628|FG003|Overall Study|Progressive Disease|7|||
23517563|NCT02039674|65632629|FG004|Overall Study|Progressive Disease|9|||
23517564|NCT02039674|65632630|FG005|Overall Study|Progressive Disease|10|||
23517565|NCT02039674|65632631|FG006|Overall Study|Progressive Disease|1|||
23517566|NCT02039674|65632632|FG007|Overall Study|Progressive Disease|3|||
23517567|NCT02039674|65632633|FG008|Overall Study|Progressive Disease|6|||
23517568|NCT02039674|65632634|FG009|Overall Study|Progressive Disease|4|||
23517569|NCT02039674|65632635|FG010|Overall Study|Progressive Disease|0|||
23517570|NCT02039674|65632636|FG011|Overall Study|Progressive Disease|34|||
23517571|NCT02039674|65632637|FG012|Overall Study|Progressive Disease|34|||
23517572|NCT02039674|65632638|FG013|Overall Study|Progressive Disease|18|||
23517573|NCT02039674|65632625|FG000|Overall Study|Withdrawal by Subject|1|||
23517574|NCT02039674|65632626|FG001|Overall Study|Withdrawal by Subject|2|||
23517575|NCT02039674|65632627|FG002|Overall Study|Withdrawal by Subject|3|||
23517576|NCT02039674|65632628|FG003|Overall Study|Withdrawal by Subject|0|||
23517577|NCT02039674|65632629|FG004|Overall Study|Withdrawal by Subject|1|||
23517578|NCT02039674|65632630|FG005|Overall Study|Withdrawal by Subject|0|||
23517579|NCT02039674|65632631|FG006|Overall Study|Withdrawal by Subject|0|||
23517580|NCT02039674|65632632|FG007|Overall Study|Withdrawal by Subject|0|||
23517581|NCT02039674|65632633|FG008|Overall Study|Withdrawal by Subject|0|||
23517582|NCT02039674|65632634|FG009|Overall Study|Withdrawal by Subject|1|||
23517583|NCT02039674|65632635|FG010|Overall Study|Withdrawal by Subject|1|||
23517584|NCT02039674|65632636|FG011|Overall Study|Withdrawal by Subject|4|||
23517585|NCT02039674|65632637|FG012|Overall Study|Withdrawal by Subject|6|||
23517586|NCT02039674|65632638|FG013|Overall Study|Withdrawal by Subject|2|||
23517587|NCT02039674|65632625|FG000|Overall Study|Clinical Progression|0|||
23517588|NCT02039674|65632626|FG001|Overall Study|Clinical Progression|0|||
23517589|NCT02039674|65632627|FG002|Overall Study|Clinical Progression|0|||
23712304|NCT02112916|66322199|FG001|Overall Study|Still on Therapy|47|||
23517590|NCT02039674|65632628|FG003|Overall Study|Clinical Progression|0|||
23517591|NCT02039674|65632629|FG004|Overall Study|Clinical Progression|0|||
23517592|NCT02039674|65632630|FG005|Overall Study|Clinical Progression|0|||
23517593|NCT02039674|65632631|FG006|Overall Study|Clinical Progression|1|||
23517594|NCT02039674|65632632|FG007|Overall Study|Clinical Progression|0|||
23517595|NCT02039674|65632633|FG008|Overall Study|Clinical Progression|0|||
23517596|NCT02039674|65632634|FG009|Overall Study|Clinical Progression|0|||
23712305|NCT02112916|66322200|FG002|Overall Study|Still on Therapy|3|||
23712306|NCT02112916|66322201|FG003|Overall Study|Still on Therapy|2|||
23712307|NCT02112916|66322198|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
23712308|NCT02112916|66322199|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
23712309|NCT02112916|66322200|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
23712310|NCT02112916|66322201|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
23712311|NCT02112916|66322198|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
23712312|NCT02112916|66322199|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
23712313|NCT02112916|66322200|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
23712314|NCT02112916|66322201|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
23712315|NCT01608724|66322202|FG000|Overall Study|Withdrawal by Subject|131|||
23712316|NCT01608724|66322202|FG000|Overall Study|Lost to Follow-up|41|||
23712317|NCT01608724|66322202|FG000|Overall Study|Study-specific discontinuation criteria|32|||
23712318|NCT01608724|66322202|FG000|Overall Study|Adverse Event|29|||
23712319|NCT01608724|66322202|FG000|Overall Study|Protocol Violation|6|||
23712320|NCT01608724|66322202|FG000|Overall Study|bood sugar too high, etc.|3|||
23712321|NCT01608724|66322202|FG000|Overall Study|Safety reasons|1|||
23712322|NCT00992784|66322204|FG000|Overall Study|Adverse Event|2|||
23712323|NCT00992784|66322205|FG001|Overall Study|Adverse Event|1|||
23712324|NCT00992784|66322206|FG002|Overall Study|Adverse Event|0|||
23712325|NCT00992784|66322204|FG000|Overall Study|Withdrawal by Subject|1|||
23712326|NCT00992784|66322205|FG001|Overall Study|Withdrawal by Subject|1|||
23712327|NCT00992784|66322206|FG002|Overall Study|Withdrawal by Subject|1|||
23712328|NCT01094730|66322207|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
23712329|NCT01094730|66322208|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
23712330|NCT01094730|66322207|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
23712331|NCT01094730|66322208|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
23712332|NCT01094730|66322207|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
23712333|NCT01094730|66322208|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
23517597|NCT02039674|65632635|FG010|Overall Study|Clinical Progression|0|||
23517598|NCT02039674|65632636|FG011|Overall Study|Clinical Progression|0|||
23517599|NCT02039674|65632637|FG012|Overall Study|Clinical Progression|1|||
23517600|NCT02039674|65632638|FG013|Overall Study|Clinical Progression|0|||
23517601|NCT02039674|65632625|FG000|Overall Study|Sponsor Decision|1|||
23517602|NCT02039674|65632626|FG001|Overall Study|Sponsor Decision|1|||
23517603|NCT02039674|65632627|FG002|Overall Study|Sponsor Decision|1|||
23517604|NCT02039674|65632628|FG003|Overall Study|Sponsor Decision|1|||
23517605|NCT02039674|65632629|FG004|Overall Study|Sponsor Decision|1|||
23517606|NCT02039674|65632630|FG005|Overall Study|Sponsor Decision|0|||
23517607|NCT02039674|65632631|FG006|Overall Study|Sponsor Decision|0|||
23517608|NCT02039674|65632632|FG007|Overall Study|Sponsor Decision|0|||
23517609|NCT02039674|65632633|FG008|Overall Study|Sponsor Decision|0|||
23517610|NCT02039674|65632634|FG009|Overall Study|Sponsor Decision|3|||
23517611|NCT02039674|65632635|FG010|Overall Study|Sponsor Decision|0|||
23517612|NCT02039674|65632636|FG011|Overall Study|Sponsor Decision|8|||
23517613|NCT02039674|65632637|FG012|Overall Study|Sponsor Decision|5|||
23517614|NCT02039674|65632638|FG013|Overall Study|Sponsor Decision|0|||
23517615|NCT02039674|65632625|FG000|Overall Study|Other|0|||
23517616|NCT02039674|65632626|FG001|Overall Study|Other|0|||
23517617|NCT02039674|65632627|FG002|Overall Study|Other|0|||
23517618|NCT02039674|65632628|FG003|Overall Study|Other|0|||
23517619|NCT02039674|65632629|FG004|Overall Study|Other|0|||
23517620|NCT02039674|65632630|FG005|Overall Study|Other|0|||
23517621|NCT02039674|65632631|FG006|Overall Study|Other|0|||
23517622|NCT02039674|65632632|FG007|Overall Study|Other|0|||
23517623|NCT02039674|65632633|FG008|Overall Study|Other|0|||
23517624|NCT02039674|65632634|FG009|Overall Study|Other|0|||
23517625|NCT02039674|65632635|FG010|Overall Study|Other|0|||
23517626|NCT02039674|65632636|FG011|Overall Study|Other|0|||
23517627|NCT02039674|65632637|FG012|Overall Study|Other|1|||
23712334|NCT01094730|66322207|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
23712335|NCT01094730|66322208|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
23712336|NCT01094730|66322207|FG000|Period 2 (14 Days)|Protocol Violation|2|||
23517628|NCT02039674|65632638|FG013|Overall Study|Other|0|||
23517629|NCT02081079|65632639|FG000|Overall Study|Lack of Efficacy|3|||
23517630|NCT02081079|65632640|FG001|Overall Study|Lack of Efficacy|2|||
23517631|NCT02081079|65632639|FG000|Overall Study|Lost to Follow-up|1|||
23517632|NCT02081079|65632640|FG001|Overall Study|Lost to Follow-up|0|||
23517633|NCT00680745|65632641|FG000|Overall Study|Withdrawal by Subject|8|||
23517634|NCT00680745|65632642|FG001|Overall Study|Withdrawal by Subject|3|||
23517635|NCT00680745|65632643|FG002|Overall Study|Withdrawal by Subject|2|||
23517636|NCT00680745|65632644|FG003|Overall Study|Withdrawal by Subject|8|||
23517637|NCT00680745|65632641|FG000|Overall Study|Lost to Follow-up|0|||
23517638|NCT00680745|65632642|FG001|Overall Study|Lost to Follow-up|1|||
23712337|NCT01094730|66322208|FG001|Period 2 (14 Days)|Protocol Violation|0|||
23517639|NCT00680745|65632643|FG002|Overall Study|Lost to Follow-up|1|||
23517640|NCT00680745|65632644|FG003|Overall Study|Lost to Follow-up|0|||
23517641|NCT00680745|65632641|FG000|Overall Study|Death|1|||
23517642|NCT00680745|65632642|FG001|Overall Study|Death|0|||
23517643|NCT00680745|65632643|FG002|Overall Study|Death|1|||
23517644|NCT00680745|65632644|FG003|Overall Study|Death|0|||
23517645|NCT00680745|65632641|FG000|Overall Study|Adverse Event|5|||
23517646|NCT00680745|65632642|FG001|Overall Study|Adverse Event|3|||
23517647|NCT00680745|65632643|FG002|Overall Study|Adverse Event|3|||
23517648|NCT00680745|65632644|FG003|Overall Study|Adverse Event|3|||
23517649|NCT00680745|65632641|FG000|Overall Study|Poor/Non-compliance|0|||
23517650|NCT00680745|65632642|FG001|Overall Study|Poor/Non-compliance|3|||
23517651|NCT00680745|65632643|FG002|Overall Study|Poor/Non-compliance|0|||
23517652|NCT00680745|65632644|FG003|Overall Study|Poor/Non-compliance|0|||
23517653|NCT00680745|65632641|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23517654|NCT00680745|65632642|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23517655|NCT00680745|65632643|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23517656|NCT00680745|65632644|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
23517657|NCT00680745|65632641|FG000|Overall Study|False Treatment|0|||
23517658|NCT00680745|65632642|FG001|Overall Study|False Treatment|1|||
23517659|NCT00680745|65632643|FG002|Overall Study|False Treatment|3|||
23517660|NCT00680745|65632644|FG003|Overall Study|False Treatment|0|||
23517661|NCT00730912|65632645|FG000|Overall Study|Discontinued|0|||
23517662|NCT00730912|65632646|FG001|Overall Study|Discontinued|0|||
23517663|NCT00730912|65632647|FG002|Overall Study|Discontinued|1|||
23517664|NCT02024867|65632650|FG000|Overall Study|Protocol Violation|3|||
23517665|NCT02024867|65632651|FG001|Overall Study|Protocol Violation|3|||
23517666|NCT02024867|65632650|FG000|Overall Study|Lost to Follow-up|6|||
23517667|NCT02024867|65632651|FG001|Overall Study|Lost to Follow-up|4|||
23517668|NCT01549392|65632652|FG000|Overall Study|Withdrawal by Subject|1|||
23517669|NCT01549392|65632653|FG001|Overall Study|Withdrawal by Subject|0|||
23517670|NCT00664742|65632660|FG000|Overall Study|Withdrawn due to adverse events|3|||
23517671|NCT00664742|65632660|FG000|Overall Study|Withdrawal by Subject|31|||
23517672|NCT00664742|65632660|FG000|Overall Study|Lost to Follow-up|92|||
23517673|NCT02677987|65632661|FG000|Overall Study|Withdrawal by Subject|3|||
23517674|NCT02677987|65632662|FG001|Overall Study|Withdrawal by Subject|0|||
23517675|NCT02677987|65632661|FG000|Overall Study|Lost to Follow-up|1|||
23517676|NCT02677987|65632662|FG001|Overall Study|Lost to Follow-up|0|||
23517677|NCT04200456|65632663|FG000|Overall Study|Physician Decision|0|||
23517678|NCT04200456|65632664|FG001|Overall Study|Physician Decision|1|||
23517679|NCT04200456|65632663|FG000|Overall Study|Withdrawal by Subject|2|||
23517680|NCT04200456|65632664|FG001|Overall Study|Withdrawal by Subject|2|||
23517681|NCT04200456|65632663|FG000|Overall Study|Lack of Efficacy|1|||
23517682|NCT04200456|65632664|FG001|Overall Study|Lack of Efficacy|1|||
23517683|NCT04200456|65632663|FG000|Overall Study|Adverse event, non-fatal|0|||
23517684|NCT04200456|65632664|FG001|Overall Study|Adverse event, non-fatal|1|||
23712338|NCT01094730|66322207|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
23517685|NCT04200456|65632663|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
23517686|NCT04200456|65632664|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
23517687|NCT03897179|65632674|FG000|Overall Study|Withdrawal by Subject|1|||
23517688|NCT01348347|65632677|FG000|Overall Study|Withdrawal by Subject|1|||
23517689|NCT01348347|65632678|FG001|Overall Study|Withdrawal by Subject|1|||
23517690|NCT01348347|65632679|FG002|Overall Study|Withdrawal by Subject|1|||
23517691|NCT01348347|65632677|FG000|Overall Study|Progressive disease|2|||
23517692|NCT01348347|65632678|FG001|Overall Study|Progressive disease|5|||
23517693|NCT01348347|65632679|FG002|Overall Study|Progressive disease|5|||
23517694|NCT03721276|65632680|FG000|Overall Study|Lost to Follow-up|5|||
23517695|NCT03721276|65632681|FG001|Overall Study|Lost to Follow-up|3|||
23517696|NCT03721276|65632680|FG000|Overall Study|Adverse Event|0|||
23517697|NCT03721276|65632681|FG001|Overall Study|Adverse Event|1|||
23517698|NCT00909779|65632683|FG000|Overall Study|Adverse Event|53|||
23517699|NCT00909779|65632684|FG001|Overall Study|Adverse Event|55|||
23517700|NCT00909779|65632683|FG000|Overall Study|Lack of Efficacy|7|||
23517701|NCT00909779|65632684|FG001|Overall Study|Lack of Efficacy|4|||
23517702|NCT00909779|65632683|FG000|Overall Study|Lost to Follow-up|19|||
23517703|NCT00909779|65632684|FG001|Overall Study|Lost to Follow-up|15|||
23712339|NCT01094730|66322208|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
23517704|NCT00909779|65632683|FG000|Overall Study|Physician Decision|8|||
23517705|NCT00909779|65632684|FG001|Overall Study|Physician Decision|2|||
23517706|NCT00909779|65632683|FG000|Overall Study|Protocol Violation|2|||
23517707|NCT00909779|65632684|FG001|Overall Study|Protocol Violation|5|||
23517708|NCT00909779|65632683|FG000|Overall Study|Withdrawal by Subject|116|||
23517709|NCT00909779|65632684|FG001|Overall Study|Withdrawal by Subject|80|||
23517710|NCT00909779|65632683|FG000|Overall Study|Site Ceasing Operation|2|||
23517711|NCT00909779|65632684|FG001|Overall Study|Site Ceasing Operation|2|||
23517712|NCT00909779|65632683|FG000|Overall Study|Medical Monitor Decision|1|||
23517713|NCT00909779|65632684|FG001|Overall Study|Medical Monitor Decision|0|||
23517714|NCT00909779|65632683|FG000|Overall Study|Noncompliance|1|||
23517715|NCT00909779|65632684|FG001|Overall Study|Noncompliance|1|||
23517716|NCT00909779|65632683|FG000|Overall Study|Randomized in error|1|||
23517717|NCT00909779|65632684|FG001|Overall Study|Randomized in error|1|||
23712340|NCT01094730|66322207|FG000|Period 2 (14 Days)|Adverse Event|0|||
23712341|NCT01094730|66322208|FG001|Period 2 (14 Days)|Adverse Event|1|||
23712342|NCT01094730|66322207|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
23712343|NCT01094730|66322208|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
23712344|NCT02163993|66322209|FG000|Treatment Period|Adverse Event|0|||
23712345|NCT02163993|66322210|FG001|Treatment Period|Adverse Event|1|||
23712346|NCT02163993|66322211|FG002|Treatment Period|Adverse Event|0|||
23712347|NCT02163993|66322212|FG003|Treatment Period|Adverse Event|0|||
23712348|NCT02163993|66322213|FG004|Treatment Period|Adverse Event|1|||
23712349|NCT02163993|66322209|FG000|Treatment Period|Lost to Follow-up|2|||
23712350|NCT02163993|66322210|FG001|Treatment Period|Lost to Follow-up|3|||
23712351|NCT02163993|66322211|FG002|Treatment Period|Lost to Follow-up|1|||
23712352|NCT02163993|66322212|FG003|Treatment Period|Lost to Follow-up|3|||
23712353|NCT02163993|66322213|FG004|Treatment Period|Lost to Follow-up|1|||
23712354|NCT02163993|66322209|FG000|Treatment Period|Physician Decision|1|||
23712355|NCT02163993|66322210|FG001|Treatment Period|Physician Decision|0|||
23712356|NCT02163993|66322211|FG002|Treatment Period|Physician Decision|0|||
23712357|NCT02163993|66322212|FG003|Treatment Period|Physician Decision|0|||
23712358|NCT02163993|66322213|FG004|Treatment Period|Physician Decision|0|||
23712359|NCT02163993|66322209|FG000|Treatment Period|Protocol Violation|2|||
23712360|NCT02163993|66322210|FG001|Treatment Period|Protocol Violation|1|||
23712361|NCT02163993|66322211|FG002|Treatment Period|Protocol Violation|0|||
23517718|NCT02045797|65632685|FG000|Overall Study|Adverse Event|3|||
23517719|NCT02045797|65632686|FG001|Overall Study|Adverse Event|1|||
23712362|NCT02163993|66322212|FG003|Treatment Period|Protocol Violation|1|||
23712363|NCT02163993|66322213|FG004|Treatment Period|Protocol Violation|2|||
23712364|NCT02163993|66322209|FG000|Treatment Period|Withdrawal by Subject|6|||
23712365|NCT02163993|66322210|FG001|Treatment Period|Withdrawal by Subject|4|||
23517720|NCT02045797|65632687|FG002|Overall Study|Adverse Event|0|||
23517721|NCT02045797|65632685|FG000|Overall Study|Lack of Efficacy|1|||
23517722|NCT02045797|65632686|FG001|Overall Study|Lack of Efficacy|0|||
23517723|NCT02045797|65632687|FG002|Overall Study|Lack of Efficacy|0|||
23517724|NCT02045797|65632685|FG000|Overall Study|Lost to Follow-up|2|||
23517725|NCT02045797|65632686|FG001|Overall Study|Lost to Follow-up|3|||
23517726|NCT02045797|65632687|FG002|Overall Study|Lost to Follow-up|1|||
23517727|NCT02045797|65632685|FG000|Overall Study|Physician Decision|0|||
23517728|NCT02045797|65632686|FG001|Overall Study|Physician Decision|1|||
23517729|NCT02045797|65632687|FG002|Overall Study|Physician Decision|0|||
23517730|NCT02045797|65632685|FG000|Overall Study|Withdrawal by Subject|1|||
23517731|NCT02045797|65632686|FG001|Overall Study|Withdrawal by Subject|2|||
23517732|NCT02045797|65632687|FG002|Overall Study|Withdrawal by Subject|0|||
23517733|NCT01266460|65632697|FG000|Overall Study|Adverse Event|3|||
23517734|NCT01266460|65632697|FG000|Overall Study|Withdrawal by Subject|5|||
23517735|NCT01266460|65632697|FG000|Overall Study|Disease Progression|18|||
23517736|NCT01266460|65632697|FG000|Overall Study|Not otherwise specified|8|||
23517737|NCT02956486|65632698|FG000|Core Phase|Adverse Event|51|||
23517738|NCT02956486|65632699|FG001|Core Phase|Adverse Event|88|||
23517739|NCT02956486|65632700|FG002|Core Phase|Adverse Event|0|||
23517740|NCT02956486|65632698|FG000|Core Phase|Lost to Follow-up|8|||
23517741|NCT02956486|65632699|FG001|Core Phase|Lost to Follow-up|6|||
23517742|NCT02956486|65632700|FG002|Core Phase|Lost to Follow-up|0|||
23517743|NCT02956486|65632698|FG000|Core Phase|Inadequate therapeutic effect|4|||
23517744|NCT02956486|65632699|FG001|Core Phase|Inadequate therapeutic effect|5|||
23517745|NCT02956486|65632700|FG002|Core Phase|Inadequate therapeutic effect|0|||
23517746|NCT02956486|65632698|FG000|Core Phase|Withdrawal by Subject|101|||
23517747|NCT02956486|65632699|FG001|Core Phase|Withdrawal by Subject|104|||
23517748|NCT02956486|65632700|FG002|Core Phase|Withdrawal by Subject|0|||
23517749|NCT02956486|65632698|FG000|Core Phase|Study terminated by sponsor|888|||
23517750|NCT02956486|65632699|FG001|Core Phase|Study terminated by sponsor|848|||
23517751|NCT02956486|65632700|FG002|Core Phase|Study terminated by sponsor|0|||
23517752|NCT02956486|65632698|FG000|Core Phase|Other|27|||
23517753|NCT02956486|65632699|FG001|Core Phase|Other|18|||
23517754|NCT02956486|65632700|FG002|Core Phase|Other|0|||
23517755|NCT02956486|65632698|FG000|Core Phase|Not treated|0|||
23517756|NCT02956486|65632699|FG001|Core Phase|Not treated|3|||
23517757|NCT02956486|65632700|FG002|Core Phase|Not treated|0|||
23517758|NCT02956486|65632698|FG000|Extension Phase|Adverse Event|0|||
23517759|NCT02956486|65632699|FG001|Extension Phase|Adverse Event|0|||
23712366|NCT02163993|66322211|FG002|Treatment Period|Withdrawal by Subject|1|||
23517760|NCT02956486|65632700|FG002|Extension Phase|Adverse Event|2|||
23517761|NCT02956486|65632698|FG000|Extension Phase|Study terminated by sponsor|0|||
23517762|NCT02956486|65632699|FG001|Extension Phase|Study terminated by sponsor|0|||
23517763|NCT02956486|65632700|FG002|Extension Phase|Study terminated by sponsor|16|||
23517764|NCT02956486|65632698|FG000|Extension Phase|Not Treated|0|||
23712367|NCT02163993|66322212|FG003|Treatment Period|Withdrawal by Subject|4|||
23712368|NCT02163993|66322213|FG004|Treatment Period|Withdrawal by Subject|1|||
23517765|NCT02956486|65632699|FG001|Extension Phase|Not Treated|0|||
23712369|NCT02163993|66322209|FG000|Treatment Period|Not treated|1|||
23712370|NCT02163993|66322210|FG001|Treatment Period|Not treated|0|||
23712371|NCT02163993|66322211|FG002|Treatment Period|Not treated|0|||
23712372|NCT02163993|66322212|FG003|Treatment Period|Not treated|1|||
23712373|NCT02163993|66322213|FG004|Treatment Period|Not treated|2|||
23712374|NCT02163993|66322209|FG000|Post-treatment Period|Adverse Event|0|||
23712375|NCT02163993|66322210|FG001|Post-treatment Period|Adverse Event|0|||
23712376|NCT02163993|66322211|FG002|Post-treatment Period|Adverse Event|1|||
23712377|NCT02163993|66322212|FG003|Post-treatment Period|Adverse Event|0|||
23712378|NCT02163993|66322213|FG004|Post-treatment Period|Adverse Event|0|||
23712379|NCT02163993|66322209|FG000|Post-treatment Period|Lost to Follow-up|2|||
23712380|NCT02163993|66322210|FG001|Post-treatment Period|Lost to Follow-up|2|||
23712381|NCT02163993|66322211|FG002|Post-treatment Period|Lost to Follow-up|3|||
23712382|NCT02163993|66322212|FG003|Post-treatment Period|Lost to Follow-up|1|||
23712383|NCT02163993|66322213|FG004|Post-treatment Period|Lost to Follow-up|0|||
23712384|NCT02163993|66322209|FG000|Post-treatment Period|Protocol Violation|0|||
23712385|NCT02163993|66322210|FG001|Post-treatment Period|Protocol Violation|0|||
23712386|NCT02163993|66322211|FG002|Post-treatment Period|Protocol Violation|0|||
23712387|NCT02163993|66322212|FG003|Post-treatment Period|Protocol Violation|0|||
23712388|NCT02163993|66322213|FG004|Post-treatment Period|Protocol Violation|1|||
23712389|NCT02163993|66322209|FG000|Post-treatment Period|Withdrawal by Subject|2|||
23712390|NCT02163993|66322210|FG001|Post-treatment Period|Withdrawal by Subject|4|||
23712391|NCT02163993|66322211|FG002|Post-treatment Period|Withdrawal by Subject|0|||
23712392|NCT02163993|66322212|FG003|Post-treatment Period|Withdrawal by Subject|1|||
23712393|NCT02163993|66322213|FG004|Post-treatment Period|Withdrawal by Subject|2|||
23712394|NCT01714817|66322224|FG000|Year 1 Period|Lack of Efficacy|11|||
23712395|NCT01714817|66322225|FG001|Year 1 Period|Lack of Efficacy|9|||
23712396|NCT01714817|66322224|FG000|Year 1 Period|Adverse Event|20|||
23712397|NCT01714817|66322225|FG001|Year 1 Period|Adverse Event|17|||
23712398|NCT01714817|66322224|FG000|Year 1 Period|Withdrawal by Subject|6|||
23712399|NCT01714817|66322225|FG001|Year 1 Period|Withdrawal by Subject|7|||
23712400|NCT01714817|66322224|FG000|Year 1 Period|Death|1|||
23712401|NCT01714817|66322225|FG001|Year 1 Period|Death|1|||
23712402|NCT01714817|66322224|FG000|Year 1 Period|Lost to Follow-up|0|||
23712403|NCT01714817|66322225|FG001|Year 1 Period|Lost to Follow-up|2|||
23712404|NCT01714817|66322224|FG000|Year 1 Period|Poor / non-compliance|0|||
23416193|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
23416194|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
23416195|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
23416196|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
23416197|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
23416198|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
23416199|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
23416200|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
23416201|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
23416202|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
23416203|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
23416204|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
23811971|NCT02963441|66691857|FG000|Overall Study|Protocol violation or withdrawn|8|||
23811972|NCT02963441|66691857|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
23811973|NCT02963441|66691857|FG000|Overall Study|IDx-DR insufficient quality|33|||
23811974|NCT00859586|66691862|FG000|Overall Study|Donors|4|||
23811975|NCT00587990|66691863|FG000|Overall Study|Death|0|||
23811976|NCT00587990|66691864|FG001|Overall Study|Death|0|||
23811977|NCT00587990|66691865|FG002|Overall Study|Death|1|||
23811978|NCT01388166|66691866|FG000|Overall Study|Adverse Event|16|||
23811979|NCT01388166|66691866|FG000|Overall Study|Lost to Follow-up|30|||
23811980|NCT01388166|66691866|FG000|Overall Study|Others than specified above|13|||
23811981|NCT03493386|66691867|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23811982|NCT03493386|66691868|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23811983|NCT03493386|66691869|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23811984|NCT03493386|66691870|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23811985|NCT01246011|66691872|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
23811986|NCT01246011|66691873|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
23811987|NCT01246011|66691874|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
23811988|NCT01246011|66691872|FG000|Overall Study|Withdrawal by Subject|0|||
23811989|NCT01246011|66691873|FG001|Overall Study|Withdrawal by Subject|0|||
23712405|NCT01714817|66322225|FG001|Year 1 Period|Poor / non-compliance|1|||
23712406|NCT01714817|66322224|FG000|Year 1 Period|Pregnancy|2|||
23712407|NCT01714817|66322225|FG001|Year 1 Period|Pregnancy|0|||
23712408|NCT01714817|66322224|FG000|Year 1 Period|Participant no longer meets criteria|6|||
23712409|NCT01714817|66322225|FG001|Year 1 Period|Participant no longer meets criteria|2|||
23712410|NCT01714817|66322224|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
23517766|NCT02956486|65632700|FG002|Extension Phase|Not Treated|1|||
23517767|NCT02094261|65632701|FG000|Overall Study|Death|24|||
23517768|NCT02094261|65632701|FG000|Overall Study|Lost to Follow-up|1|||
23517769|NCT02094261|65632701|FG000|Overall Study|Withdrawal by Subject|4|||
23517770|NCT02094261|65632701|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
23517771|NCT00326950|65632703|FG000|Overall Study|Progressive Disease|1|||
23517772|NCT00567892|65632704|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517773|NCT00567892|65632705|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517774|NCT00567892|65632706|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
23517775|NCT00567892|65632707|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
23517776|NCT00567892|65632704|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517777|NCT00567892|65632705|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517778|NCT00567892|65632706|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517779|NCT00567892|65632707|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
23517780|NCT02355691|65632710|FG000|Overall Study|Loss of Research Personnel|7|||
23517781|NCT02355691|65632711|FG001|Overall Study|Loss of Research Personnel|9|||
23517782|NCT00589914|65632715|FG000|Overall Study|Adverse Event|19|||
23517783|NCT00589914|65632716|FG001|Overall Study|Adverse Event|10|||
23517784|NCT00589914|65632715|FG000|Overall Study|Death|2|||
23517785|NCT00589914|65632716|FG001|Overall Study|Death|0|||
23517786|NCT00589914|65632715|FG000|Overall Study|Lack of Efficacy|40|||
23517787|NCT00589914|65632716|FG001|Overall Study|Lack of Efficacy|43|||
23517788|NCT00589914|65632715|FG000|Overall Study|Lost to Follow-up|11|||
23517789|NCT00589914|65632716|FG001|Overall Study|Lost to Follow-up|18|||
23517790|NCT00589914|65632715|FG000|Overall Study|Pregnancy|1|||
23517791|NCT00589914|65632716|FG001|Overall Study|Pregnancy|0|||
23517792|NCT00589914|65632715|FG000|Overall Study|Withdrawal by Subject|55|||
23517793|NCT00589914|65632716|FG001|Overall Study|Withdrawal by Subject|49|||
23517794|NCT00589914|65632715|FG000|Overall Study|Other|22|||
23517795|NCT00589914|65632716|FG001|Overall Study|Other|17|||
23517796|NCT03287804|65632717|FG000|Overall Study|Death|1|||
23517797|NCT03287804|65632717|FG000|Overall Study|Physician Decision|2|||
23517798|NCT03287804|65632717|FG000|Overall Study|Progressive disease|8|||
23517799|NCT00518323|65632718|FG000|Overall Study|Lack of Efficacy|14|||
23517800|NCT00518323|65632719|FG001|Overall Study|Lack of Efficacy|2|||
23517801|NCT00518323|65632720|FG002|Overall Study|Lack of Efficacy|4|||
23517802|NCT00518323|65632721|FG003|Overall Study|Lack of Efficacy|20|||
23517803|NCT00518323|65632718|FG000|Overall Study|Withdrawal by Subject|1|||
23517804|NCT00518323|65632719|FG001|Overall Study|Withdrawal by Subject|2|||
23517805|NCT00518323|65632720|FG002|Overall Study|Withdrawal by Subject|4|||
23517806|NCT00518323|65632721|FG003|Overall Study|Withdrawal by Subject|2|||
23517807|NCT00518323|65632718|FG000|Overall Study|Lost to Follow-up|0|||
23517808|NCT00518323|65632719|FG001|Overall Study|Lost to Follow-up|2|||
23517809|NCT00518323|65632720|FG002|Overall Study|Lost to Follow-up|1|||
23517810|NCT00518323|65632721|FG003|Overall Study|Lost to Follow-up|3|||
23517811|NCT00518323|65632718|FG000|Overall Study|Adverse Event|1|||
23517812|NCT00518323|65632719|FG001|Overall Study|Adverse Event|1|||
23517813|NCT00518323|65632720|FG002|Overall Study|Adverse Event|1|||
23517814|NCT00518323|65632721|FG003|Overall Study|Adverse Event|0|||
23712411|NCT01714817|66322225|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
23712412|NCT01714817|66322224|FG000|Year 1 Period|Change in Concomitant Medication|0|||
23712413|NCT01714817|66322225|FG001|Year 1 Period|Change in Concomitant Medication|1|||
23712414|NCT01714817|66322224|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
23517815|NCT00518323|65632718|FG000|Overall Study|Prohibited medication and others|3|||
23517816|NCT00518323|65632719|FG001|Overall Study|Prohibited medication and others|1|||
23517817|NCT00518323|65632720|FG002|Overall Study|Prohibited medication and others|1|||
23517818|NCT00518323|65632721|FG003|Overall Study|Prohibited medication and others|0|||
23517819|NCT02632552|65632722|FG000|Overall Study|Lost to Follow-up|14|||
23517820|NCT02632552|65632723|FG001|Overall Study|Lost to Follow-up|8|||
23517821|NCT02632552|65632722|FG000|Overall Study|Withdrawal by Subject|2|||
23517822|NCT02632552|65632723|FG001|Overall Study|Withdrawal by Subject|0|||
23517823|NCT02632552|65632722|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
23517824|NCT02632552|65632723|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
23517825|NCT01986855|65632724|FG000|Overall Study|Adverse Event|1|||
23517826|NCT01986855|65632725|FG001|Overall Study|Adverse Event|0|||
23517827|NCT01986855|65632726|FG002|Overall Study|Adverse Event|0|||
23517828|NCT01986855|65632724|FG000|Overall Study|Death|3|||
23517829|NCT01986855|65632725|FG001|Overall Study|Death|4|||
23517830|NCT01986855|65632726|FG002|Overall Study|Death|4|||
23517831|NCT01986855|65632724|FG000|Overall Study|Lost to Follow-up|2|||
23811990|NCT01246011|66691874|FG002|Overall Study|Withdrawal by Subject|1|||
23517832|NCT01986855|65632725|FG001|Overall Study|Lost to Follow-up|1|||
23517833|NCT01986855|65632726|FG002|Overall Study|Lost to Follow-up|0|||
23517834|NCT01986855|65632724|FG000|Overall Study|Screen Failure|0|||
23517835|NCT01986855|65632725|FG001|Overall Study|Screen Failure|1|||
23517836|NCT01986855|65632726|FG002|Overall Study|Screen Failure|0|||
23517837|NCT01986855|65632724|FG000|Overall Study|Participant Moved|0|||
23517838|NCT01986855|65632725|FG001|Overall Study|Participant Moved|0|||
23517839|NCT01986855|65632726|FG002|Overall Study|Participant Moved|2|||
23517840|NCT01986855|65632724|FG000|Overall Study|Withdrawal by Subject|7|||
23517841|NCT01986855|65632725|FG001|Overall Study|Withdrawal by Subject|8|||
23517842|NCT01986855|65632726|FG002|Overall Study|Withdrawal by Subject|5|||
23517843|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
23517844|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
23517845|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
23517846|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
23517847|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
23517848|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
23517849|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
23517850|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
23517851|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Other|4|||
23517852|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Other|1|||
23517853|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
23517854|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
23517855|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
23517856|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
23517857|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
23517858|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
23517859|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Death|1|||
23517860|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Death|0|||
23517861|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
23517862|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
23517863|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
23517864|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
23517865|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
23517866|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
23517867|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
23517868|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
23517869|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Other|1|||
23517870|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Other|0|||
23517871|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
23517872|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
23517873|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
23517874|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
23517875|NCT00483379|65632732|FG000|Treatment Period|Adverse Event|1|||
23517876|NCT00483379|65632733|FG001|Treatment Period|Adverse Event|0|||
23517877|NCT00483379|65632732|FG000|Treatment Period|Withdrawal by Subject|1|||
23517878|NCT00483379|65632733|FG001|Treatment Period|Withdrawal by Subject|0|||
23517879|NCT04964128|65632734|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
23517880|NCT04964128|65632734|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
23517881|NCT03564145|65632735|FG000|Overall Study|Adverse Event|4|||
23517882|NCT03564145|65632735|FG000|Overall Study|Lost to Follow-up|21|||
23517883|NCT03564145|65632735|FG000|Overall Study|Protocol Violation|2|||
23517884|NCT03564145|65632735|FG000|Overall Study|Withdrawal by Subject|48|||
23517885|NCT03564145|65632735|FG000|Overall Study|Study Terminated by Sponsor|146|||
23517886|NCT03564145|65632735|FG000|Overall Study|Physician Decision|1|||
23517887|NCT03564145|65632735|FG000|Overall Study|Other Than Specified|1|||
23517888|NCT03564145|65632735|FG000|Overall Study|Pregnancy|1|||
23517889|NCT02268786|65632749|FG000|Overall Study|No Euploid Embryos available|42|||
23517890|NCT02268786|65632750|FG001|Overall Study|No Euploid Embryos available|0|||
23517891|NCT02268786|65632749|FG000|Overall Study|Withdrawal by Subject|7|||
23517892|NCT02268786|65632750|FG001|Overall Study|Withdrawal by Subject|14|||
23517893|NCT02268786|65632749|FG000|Overall Study|Thaw Failure|6|||
23517894|NCT02268786|65632750|FG001|Overall Study|Thaw Failure|4|||
23517895|NCT02268786|65632749|FG000|Overall Study|Protocol Violation|1|||
23517896|NCT02268786|65632750|FG001|Overall Study|Protocol Violation|0|||
23517897|NCT00405587|65632751|FG000|Overall Study|Death|0|||
23517898|NCT00405587|65632752|FG001|Overall Study|Death|0|||
23517899|NCT00405587|65632753|FG002|Overall Study|Death|0|||
23517900|NCT00405587|65632754|FG003|Overall Study|Death|1|||
23517901|NCT00405587|65632751|FG000|Overall Study|Disease Progression|22|||
23517902|NCT00405587|65632752|FG001|Overall Study|Disease Progression|23|||
23517903|NCT00405587|65632753|FG002|Overall Study|Disease Progression|21|||
23517904|NCT00405587|65632754|FG003|Overall Study|Disease Progression|17|||
23517905|NCT00405587|65632751|FG000|Overall Study|Physician Decision|3|||
23517906|NCT00405587|65632752|FG001|Overall Study|Physician Decision|2|||
23517907|NCT00405587|65632753|FG002|Overall Study|Physician Decision|0|||
23517908|NCT00405587|65632754|FG003|Overall Study|Physician Decision|0|||
23517909|NCT00405587|65632751|FG000|Overall Study|Adverse Event|1|||
23517910|NCT00405587|65632752|FG001|Overall Study|Adverse Event|0|||
23712415|NCT01714817|66322225|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
23712416|NCT01714817|66322224|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
23712417|NCT01714817|66322225|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
23712418|NCT01714817|66322224|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
23712419|NCT01714817|66322225|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
23712420|NCT01714817|66322224|FG000|Year 2 Period|Lack of Efficacy|4|||
23712421|NCT01714817|66322225|FG001|Year 2 Period|Lack of Efficacy|12|||
23712422|NCT01714817|66322224|FG000|Year 2 Period|Adverse Event|7|||
23712423|NCT01714817|66322225|FG001|Year 2 Period|Adverse Event|6|||
23712424|NCT01714817|66322224|FG000|Year 2 Period|Participant request to stop treatment|4|||
23712425|NCT01714817|66322225|FG001|Year 2 Period|Participant request to stop treatment|4|||
23712426|NCT01714817|66322224|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
23712427|NCT01714817|66322225|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
23712428|NCT01714817|66322224|FG000|Year 2 Period|Participant withdrew consent|1|||
23712429|NCT01714817|66322225|FG001|Year 2 Period|Participant withdrew consent|5|||
23712430|NCT01714817|66322224|FG000|Year 2 Period|Participant no longer meets criteria|1|||
23811991|NCT02516553|66691875|FG000|Overall Study|Progressive disease|2|||
23517911|NCT00405587|65632753|FG002|Overall Study|Adverse Event|0|||
23517912|NCT00405587|65632754|FG003|Overall Study|Adverse Event|0|||
23517913|NCT00405587|65632751|FG000|Overall Study|Lost to Follow-up|0|||
23517914|NCT00405587|65632752|FG001|Overall Study|Lost to Follow-up|1|||
23517915|NCT00405587|65632753|FG002|Overall Study|Lost to Follow-up|1|||
23517916|NCT00405587|65632754|FG003|Overall Study|Lost to Follow-up|0|||
23517917|NCT00405587|65632751|FG000|Overall Study|Radiation induced necrosis|0|||
23517918|NCT00405587|65632752|FG001|Overall Study|Radiation induced necrosis|1|||
23517919|NCT00405587|65632753|FG002|Overall Study|Radiation induced necrosis|0|||
23517920|NCT00405587|65632754|FG003|Overall Study|Radiation induced necrosis|0|||
23517921|NCT00405587|65632751|FG000|Overall Study|Withdrawal by Subject|0|||
23517922|NCT00405587|65632752|FG001|Overall Study|Withdrawal by Subject|0|||
23517923|NCT00405587|65632753|FG002|Overall Study|Withdrawal by Subject|0|||
23517924|NCT00405587|65632754|FG003|Overall Study|Withdrawal by Subject|2|||
23517925|NCT00405587|65632751|FG000|Overall Study|Participant not dosed|0|||
23517926|NCT00405587|65632752|FG001|Overall Study|Participant not dosed|1|||
23517927|NCT00405587|65632753|FG002|Overall Study|Participant not dosed|0|||
23517928|NCT00405587|65632754|FG003|Overall Study|Participant not dosed|0|||
23517929|NCT01082965|65632755|FG000|Overall Study|Protocol Violation|0|||
23517930|NCT01082965|65632756|FG001|Overall Study|Protocol Violation|1|||
23517931|NCT01082965|65632755|FG000|Overall Study|Other|1|||
23517932|NCT01082965|65632756|FG001|Overall Study|Other|1|||
23517933|NCT01382446|65632757|FG000|Overall Study|Withdrawal by Subject|0|||
23517934|NCT01382446|65632758|FG001|Overall Study|Withdrawal by Subject|1|||
23517935|NCT01382446|65632757|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
23517936|NCT01382446|65632758|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
23517937|NCT01710033|65632763|FG000|Stage 2|Adverse Event|0|||
23517938|NCT01710033|65632764|FG001|Stage 2|Adverse Event|0|||
23517939|NCT01710033|65632765|FG002|Stage 2|Adverse Event|0|||
23517940|NCT01710033|65632766|FG003|Stage 2|Adverse Event|0|||
23517941|NCT01710033|65632767|FG004|Stage 2|Adverse Event|1|||
23517942|NCT02710045|65632768|FG000|Overall Study|Death|1|||
23517943|NCT02710045|65632769|FG001|Overall Study|Death|2|||
23517944|NCT02710045|65632770|FG002|Overall Study|Death|0|||
23517945|NCT02710045|65632768|FG000|Overall Study|Withdrawal by Subject|6|||
23517946|NCT02710045|65632769|FG001|Overall Study|Withdrawal by Subject|6|||
23517947|NCT02710045|65632770|FG002|Overall Study|Withdrawal by Subject|2|||
23517948|NCT02710045|65632768|FG000|Overall Study|Protocol Violation|1|||
23517949|NCT02710045|65632769|FG001|Overall Study|Protocol Violation|2|||
23517950|NCT02710045|65632770|FG002|Overall Study|Protocol Violation|3|||
23517951|NCT02710045|65632768|FG000|Overall Study|Lost to Follow-up|3|||
23517952|NCT02710045|65632769|FG001|Overall Study|Lost to Follow-up|6|||
23517953|NCT02710045|65632770|FG002|Overall Study|Lost to Follow-up|7|||
23517954|NCT02710045|65632768|FG000|Overall Study|Physician Decision|0|||
23517955|NCT02710045|65632769|FG001|Overall Study|Physician Decision|0|||
23517956|NCT02710045|65632770|FG002|Overall Study|Physician Decision|1|||
23517957|NCT02710045|65632768|FG000|Overall Study|Poor Attendance|0|||
23517958|NCT02710045|65632769|FG001|Overall Study|Poor Attendance|1|||
23517959|NCT02710045|65632770|FG002|Overall Study|Poor Attendance|0|||
23517960|NCT00811473|65632773|FG000|Overall Study|Adverse Event|3|||
23517961|NCT00811473|65632774|FG001|Overall Study|Adverse Event|12|||
23517962|NCT00811473|65632773|FG000|Overall Study|Lost to Follow-up|5|||
23517963|NCT00811473|65632774|FG001|Overall Study|Lost to Follow-up|1|||
23517964|NCT00811473|65632773|FG000|Overall Study|Withdrawal by Subject|2|||
23712431|NCT01714817|66322225|FG001|Year 2 Period|Participant no longer meets criteria|4|||
23712432|NCT01714817|66322224|FG000|Year 2 Period|Lost to Follow-up|2|||
23517965|NCT00811473|65632774|FG001|Overall Study|Withdrawal by Subject|4|||
23517966|NCT00811473|65632773|FG000|Overall Study|Severe non-compliance to protocol|2|||
23517967|NCT00811473|65632774|FG001|Overall Study|Severe non-compliance to protocol|4|||
23517968|NCT00811473|65632773|FG000|Overall Study|Lack of therapeutic response|4|||
23712433|NCT01714817|66322225|FG001|Year 2 Period|Lost to Follow-up|0|||
23712434|NCT01714817|66322224|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
23712435|NCT01714817|66322225|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
23712436|NCT01714817|66322224|FG000|Year 2 Period|Pregnancy|1|||
23712437|NCT01714817|66322225|FG001|Year 2 Period|Pregnancy|1|||
23712438|NCT01714817|66322224|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
23712439|NCT01714817|66322225|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
23712440|NCT01714817|66322224|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
23712441|NCT01714817|66322225|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
23712442|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
23712443|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
23712444|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
23712445|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
23712446|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
23712447|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
23712448|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
23712449|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
23712450|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
23712451|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
23712452|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
23712453|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
23712454|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23712455|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
23712456|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
23712457|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
23712458|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
23712459|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
23712460|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
23712461|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
23712462|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
23712463|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
23712464|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
23712465|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
23712466|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
23712467|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
23712468|NCT01714817|66322224|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
23712469|NCT01714817|66322225|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
23712470|NCT00960934|66322228|FG000|Overall Study|Adverse Event|2|||
23712471|NCT00960934|66322229|FG001|Overall Study|Adverse Event|3|||
23712472|NCT00960934|66322230|FG002|Overall Study|Adverse Event|3|||
23712473|NCT00960934|66322231|FG003|Overall Study|Adverse Event|2|||
23712474|NCT00960934|66322232|FG004|Overall Study|Adverse Event|4|||
23712475|NCT00960934|66322233|FG005|Overall Study|Adverse Event|3|||
23712476|NCT00960934|66322228|FG000|Overall Study|Lack of Efficacy|1|||
23712477|NCT00960934|66322229|FG001|Overall Study|Lack of Efficacy|0|||
23517969|NCT00811473|65632774|FG001|Overall Study|Lack of therapeutic response|1|||
23517970|NCT00811473|65632773|FG000|Overall Study|Condition under investigation worsened|1|||
23517971|NCT00811473|65632774|FG001|Overall Study|Condition under investigation worsened|3|||
23517972|NCT00811473|65632773|FG000|Overall Study|Other 2|4|||
23517973|NCT00811473|65632774|FG001|Overall Study|Other 2|1|||
23517974|NCT00811473|65632773|FG000|Overall Study|Incorrect Enrollment|1|||
23517975|NCT00811473|65632774|FG001|Overall Study|Incorrect Enrollment|0|||
23517976|NCT00811473|65632773|FG000|Overall Study|Safety Reasons|1|||
23517977|NCT00811473|65632774|FG001|Overall Study|Safety Reasons|0|||
23517978|NCT02608268|65632775|FG000|Overall Study|Adverse Event|0|||
23517979|NCT02608268|65632776|FG001|Overall Study|Adverse Event|0|||
23517980|NCT02608268|65632777|FG002|Overall Study|Adverse Event|1|||
23517981|NCT02608268|65632778|FG003|Overall Study|Adverse Event|0|||
23517982|NCT02608268|65632779|FG004|Overall Study|Adverse Event|0|||
23517983|NCT02608268|65632780|FG005|Overall Study|Adverse Event|0|||
23517984|NCT02608268|65632781|FG006|Overall Study|Adverse Event|0|||
23712478|NCT00960934|66322230|FG002|Overall Study|Lack of Efficacy|0|||
23712479|NCT00960934|66322231|FG003|Overall Study|Lack of Efficacy|0|||
23712480|NCT00960934|66322232|FG004|Overall Study|Lack of Efficacy|0|||
23712481|NCT00960934|66322233|FG005|Overall Study|Lack of Efficacy|0|||
23712482|NCT00960934|66322228|FG000|Overall Study|Lost to Follow-up|0|||
23712483|NCT00960934|66322229|FG001|Overall Study|Lost to Follow-up|1|||
23517985|NCT02608268|65632782|FG007|Overall Study|Adverse Event|0|||
23517986|NCT02608268|65632783|FG008|Overall Study|Adverse Event|0|||
23517987|NCT02608268|65632784|FG009|Overall Study|Adverse Event|0|||
23517988|NCT02608268|65632785|FG010|Overall Study|Adverse Event|0|||
23517989|NCT02608268|65632786|FG011|Overall Study|Adverse Event|0|||
23517990|NCT02608268|65632787|FG012|Overall Study|Adverse Event|2|||
23517991|NCT02608268|65632788|FG013|Overall Study|Adverse Event|0|||
23517992|NCT02608268|65632789|FG014|Overall Study|Adverse Event|0|||
23517993|NCT02608268|65632790|FG015|Overall Study|Adverse Event|0|||
23517994|NCT02608268|65632791|FG016|Overall Study|Adverse Event|0|||
23517995|NCT02608268|65632792|FG017|Overall Study|Adverse Event|0|||
23517996|NCT02608268|65632793|FG018|Overall Study|Adverse Event|0|||
23517997|NCT02608268|65632794|FG019|Overall Study|Adverse Event|0|||
23517998|NCT02608268|65632795|FG020|Overall Study|Adverse Event|1|||
23517999|NCT02608268|65632796|FG021|Overall Study|Adverse Event|1|||
23518000|NCT02608268|65632797|FG022|Overall Study|Adverse Event|0|||
23518001|NCT02608268|65632798|FG023|Overall Study|Adverse Event|0|||
23518002|NCT02608268|65632799|FG024|Overall Study|Adverse Event|1|||
23518003|NCT02608268|65632800|FG025|Overall Study|Adverse Event|0|||
23518004|NCT02608268|65632801|FG026|Overall Study|Adverse Event|0|||
23518005|NCT02608268|65632802|FG027|Overall Study|Adverse Event|0|||
23518006|NCT02608268|65632803|FG028|Overall Study|Adverse Event|1|||
23518007|NCT02608268|65632804|FG029|Overall Study|Adverse Event|0|||
23518008|NCT02608268|65632775|FG000|Overall Study|Death|1|||
23518009|NCT02608268|65632776|FG001|Overall Study|Death|0|||
23518010|NCT02608268|65632777|FG002|Overall Study|Death|0|||
23518011|NCT02608268|65632778|FG003|Overall Study|Death|0|||
23518012|NCT02608268|65632779|FG004|Overall Study|Death|0|||
23518013|NCT02608268|65632780|FG005|Overall Study|Death|0|||
23518014|NCT02608268|65632781|FG006|Overall Study|Death|0|||
23518015|NCT02608268|65632782|FG007|Overall Study|Death|0|||
23518016|NCT02608268|65632783|FG008|Overall Study|Death|1|||
23518017|NCT02608268|65632784|FG009|Overall Study|Death|1|||
23518018|NCT02608268|65632785|FG010|Overall Study|Death|0|||
23518019|NCT02608268|65632786|FG011|Overall Study|Death|0|||
23518020|NCT02608268|65632787|FG012|Overall Study|Death|0|||
23518021|NCT02608268|65632788|FG013|Overall Study|Death|0|||
23518022|NCT02608268|65632789|FG014|Overall Study|Death|0|||
23518023|NCT02608268|65632790|FG015|Overall Study|Death|1|||
23518024|NCT02608268|65632791|FG016|Overall Study|Death|0|||
23518025|NCT02608268|65632792|FG017|Overall Study|Death|1|||
23518026|NCT02608268|65632793|FG018|Overall Study|Death|0|||
23518027|NCT02608268|65632794|FG019|Overall Study|Death|1|||
23518028|NCT02608268|65632795|FG020|Overall Study|Death|1|||
23518029|NCT02608268|65632796|FG021|Overall Study|Death|0|||
23518030|NCT02608268|65632797|FG022|Overall Study|Death|0|||
23518031|NCT02608268|65632798|FG023|Overall Study|Death|0|||
23518032|NCT02608268|65632799|FG024|Overall Study|Death|1|||
23518033|NCT02608268|65632800|FG025|Overall Study|Death|2|||
23518034|NCT02608268|65632801|FG026|Overall Study|Death|0|||
23518035|NCT02608268|65632802|FG027|Overall Study|Death|1|||
23518036|NCT02608268|65632803|FG028|Overall Study|Death|4|||
23518037|NCT02608268|65632804|FG029|Overall Study|Death|0|||
23518038|NCT02608268|65632775|FG000|Overall Study|Physician Decision|0|||
23518039|NCT02608268|65632776|FG001|Overall Study|Physician Decision|0|||
23518040|NCT02608268|65632777|FG002|Overall Study|Physician Decision|0|||
23518041|NCT02608268|65632778|FG003|Overall Study|Physician Decision|0|||
23518042|NCT02608268|65632779|FG004|Overall Study|Physician Decision|0|||
23518043|NCT02608268|65632780|FG005|Overall Study|Physician Decision|0|||
23518044|NCT02608268|65632781|FG006|Overall Study|Physician Decision|0|||
23518045|NCT02608268|65632782|FG007|Overall Study|Physician Decision|0|||
23518046|NCT02608268|65632783|FG008|Overall Study|Physician Decision|0|||
23518047|NCT02608268|65632784|FG009|Overall Study|Physician Decision|0|||
23518048|NCT02608268|65632785|FG010|Overall Study|Physician Decision|1|||
23518049|NCT02608268|65632786|FG011|Overall Study|Physician Decision|0|||
23518050|NCT02608268|65632787|FG012|Overall Study|Physician Decision|0|||
23518051|NCT02608268|65632788|FG013|Overall Study|Physician Decision|1|||
23518052|NCT02608268|65632789|FG014|Overall Study|Physician Decision|0|||
23518053|NCT02608268|65632790|FG015|Overall Study|Physician Decision|0|||
23518054|NCT02608268|65632791|FG016|Overall Study|Physician Decision|0|||
23518055|NCT02608268|65632792|FG017|Overall Study|Physician Decision|0|||
23518056|NCT02608268|65632793|FG018|Overall Study|Physician Decision|0|||
23518057|NCT02608268|65632794|FG019|Overall Study|Physician Decision|0|||
23518058|NCT02608268|65632795|FG020|Overall Study|Physician Decision|0|||
23518059|NCT02608268|65632796|FG021|Overall Study|Physician Decision|0|||
23518060|NCT02608268|65632797|FG022|Overall Study|Physician Decision|1|||
23518061|NCT02608268|65632798|FG023|Overall Study|Physician Decision|1|||
23518062|NCT02608268|65632799|FG024|Overall Study|Physician Decision|1|||
23518063|NCT02608268|65632800|FG025|Overall Study|Physician Decision|0|||
23518064|NCT02608268|65632801|FG026|Overall Study|Physician Decision|0|||
23518065|NCT02608268|65632802|FG027|Overall Study|Physician Decision|2|||
23518066|NCT02608268|65632803|FG028|Overall Study|Physician Decision|1|||
23518067|NCT02608268|65632804|FG029|Overall Study|Physician Decision|1|||
23518068|NCT02608268|65632775|FG000|Overall Study|Progressive disease|12|||
23518069|NCT02608268|65632776|FG001|Overall Study|Progressive disease|8|||
23518070|NCT02608268|65632777|FG002|Overall Study|Progressive disease|13|||
23518071|NCT02608268|65632778|FG003|Overall Study|Progressive disease|5|||
23518072|NCT02608268|65632779|FG004|Overall Study|Progressive disease|2|||
23518073|NCT02608268|65632780|FG005|Overall Study|Progressive disease|4|||
23518074|NCT02608268|65632781|FG006|Overall Study|Progressive disease|6|||
23518075|NCT02608268|65632782|FG007|Overall Study|Progressive disease|2|||
23518076|NCT02608268|65632783|FG008|Overall Study|Progressive disease|5|||
23518077|NCT02608268|65632784|FG009|Overall Study|Progressive disease|6|||
23518078|NCT02608268|65632785|FG010|Overall Study|Progressive disease|5|||
23518079|NCT02608268|65632786|FG011|Overall Study|Progressive disease|5|||
23518080|NCT02608268|65632787|FG012|Overall Study|Progressive disease|4|||
23518081|NCT02608268|65632788|FG013|Overall Study|Progressive disease|11|||
23518082|NCT02608268|65632789|FG014|Overall Study|Progressive disease|6|||
23518083|NCT02608268|65632790|FG015|Overall Study|Progressive disease|3|||
23518084|NCT02608268|65632791|FG016|Overall Study|Progressive disease|5|||
23518085|NCT02608268|65632792|FG017|Overall Study|Progressive disease|5|||
23518086|NCT02608268|65632793|FG018|Overall Study|Progressive disease|5|||
23518087|NCT02608268|65632794|FG019|Overall Study|Progressive disease|2|||
23518088|NCT02608268|65632795|FG020|Overall Study|Progressive disease|10|||
23518089|NCT02608268|65632796|FG021|Overall Study|Progressive disease|4|||
23518090|NCT02608268|65632797|FG022|Overall Study|Progressive disease|5|||
23518091|NCT02608268|65632798|FG023|Overall Study|Progressive disease|5|||
23518092|NCT02608268|65632799|FG024|Overall Study|Progressive disease|3|||
23518093|NCT02608268|65632800|FG025|Overall Study|Progressive disease|11|||
23518094|NCT02608268|65632801|FG026|Overall Study|Progressive disease|16|||
23518095|NCT02608268|65632802|FG027|Overall Study|Progressive disease|11|||
23518096|NCT02608268|65632803|FG028|Overall Study|Progressive disease|10|||
23518097|NCT02608268|65632804|FG029|Overall Study|Progressive disease|15|||
23518098|NCT02608268|65632775|FG000|Overall Study|Subject/guardian decision|1|||
23518099|NCT02608268|65632776|FG001|Overall Study|Subject/guardian decision|1|||
23518100|NCT02608268|65632777|FG002|Overall Study|Subject/guardian decision|2|||
23518101|NCT02608268|65632778|FG003|Overall Study|Subject/guardian decision|0|||
23518102|NCT02608268|65632779|FG004|Overall Study|Subject/guardian decision|0|||
23518103|NCT02608268|65632780|FG005|Overall Study|Subject/guardian decision|0|||
23518104|NCT02608268|65632781|FG006|Overall Study|Subject/guardian decision|0|||
23518105|NCT02608268|65632782|FG007|Overall Study|Subject/guardian decision|0|||
23518106|NCT02608268|65632783|FG008|Overall Study|Subject/guardian decision|2|||
23518107|NCT02608268|65632784|FG009|Overall Study|Subject/guardian decision|2|||
23518108|NCT02608268|65632785|FG010|Overall Study|Subject/guardian decision|0|||
23518109|NCT02608268|65632786|FG011|Overall Study|Subject/guardian decision|1|||
23518110|NCT02608268|65632787|FG012|Overall Study|Subject/guardian decision|0|||
23518111|NCT02608268|65632788|FG013|Overall Study|Subject/guardian decision|1|||
23518112|NCT02608268|65632789|FG014|Overall Study|Subject/guardian decision|0|||
23518113|NCT02608268|65632790|FG015|Overall Study|Subject/guardian decision|1|||
23518114|NCT02608268|65632791|FG016|Overall Study|Subject/guardian decision|0|||
23518115|NCT02608268|65632792|FG017|Overall Study|Subject/guardian decision|0|||
23518116|NCT02608268|65632793|FG018|Overall Study|Subject/guardian decision|1|||
23518117|NCT02608268|65632794|FG019|Overall Study|Subject/guardian decision|0|||
23518118|NCT02608268|65632795|FG020|Overall Study|Subject/guardian decision|0|||
23518119|NCT02608268|65632796|FG021|Overall Study|Subject/guardian decision|0|||
23518120|NCT02608268|65632797|FG022|Overall Study|Subject/guardian decision|1|||
23518121|NCT02608268|65632798|FG023|Overall Study|Subject/guardian decision|0|||
23518122|NCT02608268|65632799|FG024|Overall Study|Subject/guardian decision|0|||
23518123|NCT02608268|65632800|FG025|Overall Study|Subject/guardian decision|1|||
23518124|NCT02608268|65632801|FG026|Overall Study|Subject/guardian decision|1|||
23518125|NCT02608268|65632802|FG027|Overall Study|Subject/guardian decision|1|||
23518126|NCT02608268|65632803|FG028|Overall Study|Subject/guardian decision|1|||
23518127|NCT02608268|65632804|FG029|Overall Study|Subject/guardian decision|0|||
23518128|NCT00832585|65632814|FG000|Overall Study|Withdrawal by Subject|1|||
23518129|NCT00832585|65632814|FG000|Overall Study|Lost to Follow-up|1|||
23518130|NCT01894581|65632815|FG000|Overall Study|Withdrawal by Subject|2|||
23518131|NCT01894581|65632816|FG001|Overall Study|Withdrawal by Subject|3|||
23518132|NCT01894581|65632815|FG000|Overall Study|Screen Failure|3|||
23518133|NCT01894581|65632816|FG001|Overall Study|Screen Failure|4|||
23518134|NCT03103919|65632821|FG000|Overall Study|Adverse Event|2|||
23518135|NCT03103919|65632822|FG001|Overall Study|Adverse Event|2|||
23518136|NCT00350636|65632823|FG000|Overall Study|Adverse Event|19|||
23712484|NCT00960934|66322230|FG002|Overall Study|Lost to Follow-up|0|||
23712485|NCT00960934|66322231|FG003|Overall Study|Lost to Follow-up|0|||
23518137|NCT00350636|65632824|FG001|Overall Study|Adverse Event|13|||
23518138|NCT00350636|65632823|FG000|Overall Study|Protocol Violation|1|||
23518139|NCT00350636|65632824|FG001|Overall Study|Protocol Violation|3|||
23518140|NCT00350636|65632823|FG000|Overall Study|Withdrawal by Subject|13|||
23518141|NCT00350636|65632824|FG001|Overall Study|Withdrawal by Subject|17|||
23518142|NCT00350636|65632823|FG000|Overall Study|Lost to Follow-up|9|||
23518143|NCT00350636|65632824|FG001|Overall Study|Lost to Follow-up|8|||
23518144|NCT00350636|65632823|FG000|Overall Study|Physician Decision|0|||
23518145|NCT00350636|65632824|FG001|Overall Study|Physician Decision|2|||
23518146|NCT00350636|65632823|FG000|Overall Study|Other|1|||
23518147|NCT00350636|65632824|FG001|Overall Study|Other|2|||
23611221|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23518148|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
23518149|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
23518150|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
23518151|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
23518152|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Physician Decision|0|||
23518153|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Physician Decision|1|||
23518154|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Physician Decision|0|||
23518155|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Physician Decision|0|||
23518156|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Other|1|||
23518157|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Other|0|||
23518158|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Other|0|||
23518159|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Other|0|||
23518160|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
23518161|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
23518162|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
23518163|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
23518164|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518165|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518166|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
23518167|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518168|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
23518169|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
23518170|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
23518171|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
23518172|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
23518173|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
23518174|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
23518175|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
23518176|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Other|0|||
23518177|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Other|0|||
23518178|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Other|1|||
23518179|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Other|2|||
23518180|NCT00413192|65632829|FG000|Overall Study|Disease progression|26|||
23518181|NCT00413192|65632830|FG001|Overall Study|Disease progression|31|||
23518182|NCT00413192|65632831|FG002|Overall Study|Disease progression|16|||
23518183|NCT00413192|65632832|FG003|Overall Study|Disease progression|25|||
23518184|NCT00413192|65632829|FG000|Overall Study|Toxicity|3|||
23518185|NCT00413192|65632830|FG001|Overall Study|Toxicity|2|||
23518186|NCT00413192|65632831|FG002|Overall Study|Toxicity|2|||
23518187|NCT00413192|65632832|FG003|Overall Study|Toxicity|2|||
23518188|NCT00413192|65632829|FG000|Overall Study|Withdrawal by Subject|3|||
23518189|NCT00413192|65632830|FG001|Overall Study|Withdrawal by Subject|5|||
23518190|NCT00413192|65632831|FG002|Overall Study|Withdrawal by Subject|0|||
23518191|NCT00413192|65632832|FG003|Overall Study|Withdrawal by Subject|1|||
23518192|NCT00413192|65632829|FG000|Overall Study|Intercurrent illness|0|||
23518193|NCT00413192|65632830|FG001|Overall Study|Intercurrent illness|0|||
23518194|NCT00413192|65632831|FG002|Overall Study|Intercurrent illness|0|||
23518195|NCT00413192|65632832|FG003|Overall Study|Intercurrent illness|1|||
23518196|NCT00413192|65632829|FG000|Overall Study|Intercurrent death|0|||
23518197|NCT00413192|65632830|FG001|Overall Study|Intercurrent death|1|||
23518198|NCT00413192|65632831|FG002|Overall Study|Intercurrent death|0|||
23518199|NCT00413192|65632832|FG003|Overall Study|Intercurrent death|0|||
23518200|NCT00413192|65632829|FG000|Overall Study|Other|5|||
23518201|NCT00413192|65632830|FG001|Overall Study|Other|1|||
23518202|NCT00413192|65632831|FG002|Overall Study|Other|1|||
23518203|NCT00413192|65632832|FG003|Overall Study|Other|2|||
23518204|NCT00413192|65632829|FG000|Overall Study|Not treated|0|||
23518205|NCT00413192|65632830|FG001|Overall Study|Not treated|0|||
23518206|NCT00413192|65632831|FG002|Overall Study|Not treated|0|||
23518207|NCT00413192|65632832|FG003|Overall Study|Not treated|1|||
23518208|NCT00487747|65632833|FG000|Overall Study|Adverse Event|1|||
23518209|NCT00487747|65632833|FG000|Overall Study|Lost to Follow-up|9|||
23518210|NCT00487747|65632833|FG000|Overall Study|Lack of Efficacy|1|||
23518211|NCT01963403|65632836|FG000|Overall Study|Lost to Follow-up|2|||
23518212|NCT01963403|65632837|FG001|Overall Study|Lost to Follow-up|3|||
23518213|NCT01963403|65632836|FG000|Overall Study|Implant removal|0|||
23518214|NCT01963403|65632837|FG001|Overall Study|Implant removal|1|||
23518215|NCT03605303|65632841|FG000|Period 1|Study Terminated|2|||
23518216|NCT03605303|65632842|FG001|Period 1|Study Terminated|1|||
23518217|NCT00495170|65632843|FG000|Overall Study|Lost to Follow-up|9|||
23518218|NCT00495170|65632843|FG000|Overall Study|Withdrawal by Subject|3|||
23518219|NCT00495170|65632843|FG000|Overall Study|Inappropriate staging|8|||
23518220|NCT02522286|65636109|FG000|Overall Study|Withdrawal by Subject|3|||
23518221|NCT02522286|65636110|FG001|Overall Study|Withdrawal by Subject|0|||
23518222|NCT02522286|65636111|FG002|Overall Study|Withdrawal by Subject|0|||
23518223|NCT02522286|65636112|FG003|Overall Study|Withdrawal by Subject|3|||
23518224|NCT01857934|65636116|FG000|Overall Study|Relapse or progression|2|||
23518225|NCT01857934|65636116|FG000|Overall Study|Unacceptable toxicity|3|||
23518226|NCT01857934|65636116|FG000|Overall Study|Unwillingness or inability to comply|2|||
23518227|NCT01857934|65636116|FG000|Overall Study|Physician Decision|3|||
23518228|NCT00741039|65636117|FG000|Overall Study|Patient non-compliance|2|||
23518229|NCT00741039|65636118|FG001|Overall Study|Patient non-compliance|0|||
23518230|NCT01696994|65636119|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
23518231|NCT01696994|65636120|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
23518232|NCT01696994|65636119|FG000|Overall Study|Died Before Randomization|1|||
23518233|NCT01696994|65636120|FG001|Overall Study|Died Before Randomization|2|||
23518234|NCT01696994|65636119|FG000|Overall Study|Died Before ASU (Control)|73|||
23518235|NCT01696994|65636120|FG001|Overall Study|Died Before ASU (Control)|0|||
23518236|NCT01696994|65636119|FG000|Overall Study|No Ovaries at Baseline|4807|||
23518237|NCT01696994|65636120|FG001|Overall Study|No Ovaries at Baseline|4851|||
23518238|NCT01696994|65636119|FG000|Overall Study|Refused ASU (Control)|311|||
23518239|NCT01696994|65636120|FG001|Overall Study|Refused ASU (Control)|0|||
23518240|NCT01696994|65636119|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
23518241|NCT01696994|65636120|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
23518242|NCT02136576|65636121|FG000|Overall Study|Lost to Follow-up|2|||
23518243|NCT02136576|65636122|FG001|Overall Study|Lost to Follow-up|0|||
23518244|NCT02136576|65636123|FG002|Overall Study|Lost to Follow-up|0|||
23518245|NCT02081690|65636126|FG000|Overall Study|Death|3|||
23518246|NCT02081690|65636126|FG000|Overall Study|Physician Decision|3|||
23518247|NCT02081690|65636126|FG000|Overall Study|Withdrawal by Subject|1|||
23518248|NCT01092182|65636128|FG000|Overall Study|Death|0|||
23518249|NCT01092182|65636129|FG001|Overall Study|Death|5|||
23518250|NCT01092182|65636130|FG002|Overall Study|Death|3|||
23518251|NCT01092182|65636128|FG000|Overall Study|participant safety|1|||
23518252|NCT01092182|65636129|FG001|Overall Study|participant safety|2|||
23518253|NCT01092182|65636130|FG002|Overall Study|participant safety|0|||
23518254|NCT01092182|65636128|FG000|Overall Study|Physician Decision|0|||
23518255|NCT01092182|65636129|FG001|Overall Study|Physician Decision|6|||
23518256|NCT01092182|65636130|FG002|Overall Study|Physician Decision|0|||
23518257|NCT01092182|65636128|FG000|Overall Study|Did not meet criteria|0|||
23518258|NCT01092182|65636129|FG001|Overall Study|Did not meet criteria|0|||
23518259|NCT01092182|65636130|FG002|Overall Study|Did not meet criteria|25|||
23518260|NCT01092182|65636128|FG000|Overall Study|Non-compliance|0|||
23518261|NCT01092182|65636129|FG001|Overall Study|Non-compliance|3|||
23518262|NCT01092182|65636130|FG002|Overall Study|Non-compliance|0|||
23518263|NCT01092182|65636128|FG000|Overall Study|Participant refused follow-up|0|||
23518264|NCT01092182|65636129|FG001|Overall Study|Participant refused follow-up|2|||
23518265|NCT01092182|65636130|FG002|Overall Study|Participant refused follow-up|0|||
23518266|NCT00623727|65636131|FG000|Double Blind (DB)|Adverse Event|1|||
23518267|NCT00623727|65636132|FG001|Double Blind (DB)|Adverse Event|3|||
23518268|NCT00623727|65636131|FG000|Double Blind (DB)|Physician Decision|0|||
23518269|NCT00623727|65636132|FG001|Double Blind (DB)|Physician Decision|1|||
23518270|NCT00623727|65636131|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
23518271|NCT00623727|65636132|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
23518272|NCT00623727|65636131|FG000|Double Blind (DB)|Lack of Efficacy|2|||
23518273|NCT00623727|65636132|FG001|Double Blind (DB)|Lack of Efficacy|2|||
23518274|NCT00623727|65636131|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
23518275|NCT00623727|65636132|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
23518276|NCT00623727|65636131|FG000|Double Blind (DB)|Lost to Follow-up|1|||
23518277|NCT00623727|65636132|FG001|Double Blind (DB)|Lost to Follow-up|1|||
23518278|NCT00623727|65636131|FG000|Double Blind (DB)|Protocol Violation|2|||
23518279|NCT00623727|65636132|FG001|Double Blind (DB)|Protocol Violation|2|||
23518280|NCT00623727|65636131|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
23518281|NCT00623727|65636132|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
23518282|NCT00623727|65636131|FG000|Open Label Follow-up|Study termination|0|||
23518283|NCT00623727|65636132|FG001|Open Label Follow-up|Study termination|6|||
23518284|NCT00623727|65636131|FG000|Open Label Follow-up|Participant convenience|0|||
23518285|NCT00623727|65636132|FG001|Open Label Follow-up|Participant convenience|1|||
23518286|NCT02005250|65636133|FG000|Overall Study|Lost to Follow-up|15|||
23518287|NCT02005250|65636134|FG001|Overall Study|Lost to Follow-up|5|||
23518288|NCT00878709|65636135|FG000|Overall Study|Withdrawal by Subject|197|||
23518289|NCT00878709|65636136|FG001|Overall Study|Withdrawal by Subject|120|||
23518290|NCT00878709|65636135|FG000|Overall Study|Lost to Follow-up|35|||
23518291|NCT00878709|65636136|FG001|Overall Study|Lost to Follow-up|33|||
23518292|NCT00878709|65636135|FG000|Overall Study|Other Reasons|93|||
23518293|NCT00878709|65636136|FG001|Overall Study|Other Reasons|84|||
23518294|NCT00507442|65636139|FG000|Overall Study|Adverse Event|8|||
23518295|NCT00507442|65636140|FG001|Overall Study|Adverse Event|11|||
23518296|NCT00507442|65636141|FG002|Overall Study|Adverse Event|4|||
23712486|NCT00960934|66322232|FG004|Overall Study|Lost to Follow-up|0|||
23712487|NCT00960934|66322233|FG005|Overall Study|Lost to Follow-up|0|||
23518297|NCT00507442|65636142|FG003|Overall Study|Adverse Event|1|||
23518298|NCT00507442|65636139|FG000|Overall Study|Protocol Violation|0|||
23518299|NCT00507442|65636140|FG001|Overall Study|Protocol Violation|1|||
23518300|NCT00507442|65636141|FG002|Overall Study|Protocol Violation|0|||
23518301|NCT00507442|65636142|FG003|Overall Study|Protocol Violation|0|||
23518302|NCT00507442|65636139|FG000|Overall Study|Lost to Follow-up|0|||
23518303|NCT00507442|65636140|FG001|Overall Study|Lost to Follow-up|0|||
23518304|NCT00507442|65636141|FG002|Overall Study|Lost to Follow-up|1|||
23518305|NCT00507442|65636142|FG003|Overall Study|Lost to Follow-up|0|||
23518306|NCT00507442|65636139|FG000|Overall Study|Physician Decision|0|||
23518307|NCT00507442|65636140|FG001|Overall Study|Physician Decision|2|||
23518308|NCT00507442|65636141|FG002|Overall Study|Physician Decision|4|||
23518309|NCT00507442|65636142|FG003|Overall Study|Physician Decision|1|||
23518310|NCT00507442|65636139|FG000|Overall Study|Progressive Disease|2|||
23518311|NCT00507442|65636140|FG001|Overall Study|Progressive Disease|4|||
23518312|NCT00507442|65636141|FG002|Overall Study|Progressive Disease|2|||
23518313|NCT00507442|65636142|FG003|Overall Study|Progressive Disease|0|||
23518314|NCT00507442|65636139|FG000|Overall Study|Withdrawal by Subject|4|||
23518315|NCT00507442|65636140|FG001|Overall Study|Withdrawal by Subject|4|||
23518316|NCT00507442|65636141|FG002|Overall Study|Withdrawal by Subject|2|||
23518317|NCT00507442|65636142|FG003|Overall Study|Withdrawal by Subject|1|||
23518318|NCT00507442|65636139|FG000|Overall Study|Other|2|||
23518319|NCT00507442|65636140|FG001|Overall Study|Other|5|||
23518320|NCT00507442|65636141|FG002|Overall Study|Other|2|||
23518321|NCT00507442|65636142|FG003|Overall Study|Other|2|||
23518322|NCT04007523|65636143|FG000|Overall Study|Withdrawal by Subject|0|||
23518323|NCT04007523|65636144|FG001|Overall Study|Withdrawal by Subject|1|||
23518324|NCT04007523|65636145|FG002|Overall Study|Withdrawal by Subject|1|||
23518325|NCT04007523|65636146|FG003|Overall Study|Withdrawal by Subject|0|||
23518326|NCT04007523|65636143|FG000|Overall Study|ICU Transfer|0|||
23518327|NCT04007523|65636144|FG001|Overall Study|ICU Transfer|1|||
23518328|NCT04007523|65636145|FG002|Overall Study|ICU Transfer|0|||
23518329|NCT04007523|65636146|FG003|Overall Study|ICU Transfer|0|||
23518330|NCT04007523|65636143|FG000|Overall Study|COVID hospital closure|0|||
23518331|NCT04007523|65636144|FG001|Overall Study|COVID hospital closure|0|||
23518332|NCT04007523|65636145|FG002|Overall Study|COVID hospital closure|1|||
23518333|NCT04007523|65636146|FG003|Overall Study|COVID hospital closure|2|||
23518334|NCT04007523|65636143|FG000|Overall Study|Surgery cancelled|0|||
23518335|NCT04007523|65636144|FG001|Overall Study|Surgery cancelled|0|||
23518336|NCT04007523|65636145|FG002|Overall Study|Surgery cancelled|1|||
23518337|NCT04007523|65636146|FG003|Overall Study|Surgery cancelled|1|||
23518338|NCT02092662|65636147|FG000|Overall Study|Lost to Follow-up|13|||
23518339|NCT02092662|65636148|FG001|Overall Study|Lost to Follow-up|0|||
23518340|NCT01046682|65636149|FG000|Overall Study|Adverse Event|2|||
23518341|NCT01046682|65636150|FG001|Overall Study|Adverse Event|0|||
23518342|NCT01062555|65636151|FG000|Phase 1|Death|10|||
23518343|NCT01062555|65636152|FG001|Phase 1|Death|17|||
23518344|NCT01062555|65636153|FG002|Phase 1|Death|0|||
23518345|NCT01062555|65636154|FG003|Phase 1|Death|0|||
23518346|NCT01062555|65636151|FG000|Phase 1|Graft Failure|12|||
23518347|NCT01062555|65636152|FG001|Phase 1|Graft Failure|8|||
23518348|NCT01062555|65636153|FG002|Phase 1|Graft Failure|0|||
23518349|NCT01062555|65636154|FG003|Phase 1|Graft Failure|0|||
23518350|NCT01062555|65636151|FG000|Phase 1|Withdrawal by Subject|1|||
23518351|NCT01062555|65636152|FG001|Phase 1|Withdrawal by Subject|1|||
23712488|NCT00960934|66322228|FG000|Overall Study|Other|2|||
23712489|NCT00960934|66322229|FG001|Overall Study|Other|1|||
23712490|NCT00960934|66322230|FG002|Overall Study|Other|5|||
23712491|NCT00960934|66322231|FG003|Overall Study|Other|4|||
23712492|NCT00960934|66322232|FG004|Overall Study|Other|2|||
23518352|NCT01062555|65636153|FG002|Phase 1|Withdrawal by Subject|0|||
23518353|NCT01062555|65636154|FG003|Phase 1|Withdrawal by Subject|0|||
23518354|NCT01062555|65636151|FG000|Phase 2|Death|0|||
23518355|NCT01062555|65636152|FG001|Phase 2|Death|0|||
23518356|NCT01062555|65636153|FG002|Phase 2|Death|8|||
23518357|NCT01062555|65636154|FG003|Phase 2|Death|3|||
23518358|NCT01062555|65636151|FG000|Phase 2|Graft failure|0|||
23518359|NCT01062555|65636152|FG001|Phase 2|Graft failure|0|||
23518360|NCT01062555|65636153|FG002|Phase 2|Graft failure|7|||
23518361|NCT01062555|65636154|FG003|Phase 2|Graft failure|4|||
23518362|NCT01062555|65636151|FG000|Phase 2|Withdrawal by Subject|0|||
23518363|NCT01062555|65636152|FG001|Phase 2|Withdrawal by Subject|0|||
23518364|NCT01062555|65636153|FG002|Phase 2|Withdrawal by Subject|0|||
23518365|NCT01062555|65636154|FG003|Phase 2|Withdrawal by Subject|7|||
23518366|NCT01062555|65636151|FG000|Phase 2|Protocol Violation|0|||
23712493|NCT00960934|66322233|FG005|Overall Study|Other|2|||
23518367|NCT01062555|65636152|FG001|Phase 2|Protocol Violation|0|||
23518368|NCT01062555|65636153|FG002|Phase 2|Protocol Violation|0|||
23518369|NCT01062555|65636154|FG003|Phase 2|Protocol Violation|3|||
23518370|NCT01062555|65636151|FG000|Phase 2|Physician Decision|0|||
23518371|NCT01062555|65636152|FG001|Phase 2|Physician Decision|0|||
23518372|NCT01062555|65636153|FG002|Phase 2|Physician Decision|0|||
23518373|NCT01062555|65636154|FG003|Phase 2|Physician Decision|17|||
23518374|NCT00333866|65636155|FG000|Overall Study|Adverse Event|23|||
23712494|NCT00960934|66322228|FG000|Overall Study|Physician Decision|0|||
23518375|NCT00333866|65636156|FG001|Overall Study|Adverse Event|37|||
23518376|NCT00333866|65636157|FG002|Overall Study|Adverse Event|38|||
23518377|NCT00333866|65636158|FG003|Overall Study|Adverse Event|47|||
23518378|NCT00333866|65636155|FG000|Overall Study|Other|3|||
23518379|NCT00333866|65636156|FG001|Overall Study|Other|2|||
23518380|NCT00333866|65636157|FG002|Overall Study|Other|2|||
23518381|NCT00333866|65636158|FG003|Overall Study|Other|2|||
23518382|NCT00333866|65636155|FG000|Overall Study|Lack of Efficacy|8|||
23518383|NCT00333866|65636156|FG001|Overall Study|Lack of Efficacy|6|||
23518384|NCT00333866|65636157|FG002|Overall Study|Lack of Efficacy|3|||
23518385|NCT00333866|65636158|FG003|Overall Study|Lack of Efficacy|5|||
23518386|NCT00333866|65636155|FG000|Overall Study|Lost to Follow-up|1|||
23518387|NCT00333866|65636156|FG001|Overall Study|Lost to Follow-up|2|||
23518388|NCT00333866|65636157|FG002|Overall Study|Lost to Follow-up|2|||
23518389|NCT00333866|65636158|FG003|Overall Study|Lost to Follow-up|2|||
23518390|NCT00333866|65636155|FG000|Overall Study|Withdrawal by Subject|8|||
23518391|NCT00333866|65636156|FG001|Overall Study|Withdrawal by Subject|14|||
23518392|NCT00333866|65636157|FG002|Overall Study|Withdrawal by Subject|4|||
23518393|NCT00333866|65636158|FG003|Overall Study|Withdrawal by Subject|9|||
23518394|NCT00333866|65636155|FG000|Overall Study|Randomized but not Treated|5|||
23518395|NCT00333866|65636156|FG001|Overall Study|Randomized but not Treated|3|||
23518396|NCT00333866|65636157|FG002|Overall Study|Randomized but not Treated|2|||
23518397|NCT00333866|65636158|FG003|Overall Study|Randomized but not Treated|1|||
23518398|NCT01951157|65636162|FG000|Overall Study|Progressive Disease|12|||
23518399|NCT01951157|65636163|FG001|Overall Study|Progressive Disease|13|||
23518400|NCT01951157|65636164|FG002|Overall Study|Progressive Disease|10|||
23518401|NCT01951157|65636162|FG000|Overall Study|Treatment-unrelated AE|1|||
23518402|NCT01951157|65636163|FG001|Overall Study|Treatment-unrelated AE|0|||
23518403|NCT01951157|65636164|FG002|Overall Study|Treatment-unrelated AE|3|||
23518404|NCT01951157|65636162|FG000|Overall Study|Study Termination|0|||
23518405|NCT01951157|65636163|FG001|Overall Study|Study Termination|0|||
23518406|NCT01951157|65636164|FG002|Overall Study|Study Termination|1|||
23518407|NCT01951157|65636162|FG000|Overall Study|Physician Decision|5|||
23518408|NCT01951157|65636163|FG001|Overall Study|Physician Decision|3|||
23518409|NCT01951157|65636164|FG002|Overall Study|Physician Decision|2|||
23518410|NCT01951157|65636162|FG000|Overall Study|Non-treatmentrelated death|2|||
23518411|NCT01951157|65636163|FG001|Overall Study|Non-treatmentrelated death|2|||
23518412|NCT01951157|65636164|FG002|Overall Study|Non-treatmentrelated death|2|||
23518413|NCT01951157|65636162|FG000|Overall Study|No treated|0|||
23518414|NCT01951157|65636163|FG001|Overall Study|No treated|1|||
23518415|NCT01951157|65636164|FG002|Overall Study|No treated|0|||
23518416|NCT01951157|65636162|FG000|Overall Study|Treatment-related AE|2|||
23518417|NCT01951157|65636163|FG001|Overall Study|Treatment-related AE|0|||
23518418|NCT01951157|65636164|FG002|Overall Study|Treatment-related AE|4|||
23518419|NCT01951157|65636162|FG000|Overall Study|Consent withdrawn by subject|0|||
23518420|NCT01951157|65636163|FG001|Overall Study|Consent withdrawn by subject|1|||
23518421|NCT01951157|65636164|FG002|Overall Study|Consent withdrawn by subject|3|||
23518422|NCT01951157|65636162|FG000|Overall Study|Treatment-related death|0|||
23518423|NCT01951157|65636163|FG001|Overall Study|Treatment-related death|2|||
23518424|NCT01951157|65636164|FG002|Overall Study|Treatment-related death|0|||
23518425|NCT00228917|65636165|FG000|Overall Study|Migrated/moved from study area|0|||
23518426|NCT00228917|65636166|FG001|Overall Study|Migrated/moved from study area|0|||
23518427|NCT00228917|65636167|FG002|Overall Study|Migrated/moved from study area|0|||
23518428|NCT00228917|65636168|FG003|Overall Study|Migrated/moved from study area|0|||
23518429|NCT00228917|65636169|FG004|Overall Study|Migrated/moved from study area|0|||
23518430|NCT00228917|65636170|FG005|Overall Study|Migrated/moved from study area|2|||
23518431|NCT00228917|65636171|FG006|Overall Study|Migrated/moved from study area|0|||
23518432|NCT00228917|65636172|FG007|Overall Study|Migrated/moved from study area|0|||
23518433|NCT02636868|65636174|FG000|Overall Study|Death|0|||
23518434|NCT02636868|65636175|FG001|Overall Study|Death|1|||
23518435|NCT02636868|65636176|FG002|Overall Study|Death|2|||
23518436|NCT03255382|65636177|FG000|Overall Study|Adverse Event|3|||
23518437|NCT03255382|65636178|FG001|Overall Study|Adverse Event|0|||
23518438|NCT03255382|65636177|FG000|Overall Study|Lost to Follow-up|2|||
23518439|NCT03255382|65636178|FG001|Overall Study|Lost to Follow-up|0|||
23518440|NCT03255382|65636177|FG000|Overall Study|Withdrawal by Subject|2|||
23518441|NCT03255382|65636178|FG001|Overall Study|Withdrawal by Subject|0|||
23518442|NCT03255382|65636177|FG000|Overall Study|Other|6|||
23518443|NCT03255382|65636178|FG001|Overall Study|Other|0|||
23518444|NCT04779489|65636179|FG000|Overall Study|Physician Decision|1|||
23518445|NCT00536107|65636180|FG000|Overall Study|Death|5|||
23518446|NCT00536107|65636181|FG001|Overall Study|Death|1|||
23518447|NCT00536107|65636180|FG000|Overall Study|Incorrect enrolment|1|||
23518448|NCT00536107|65636181|FG001|Overall Study|Incorrect enrolment|0|||
23518449|NCT00536107|65636180|FG000|Overall Study|Withdrawal by Subject|0|||
23518450|NCT00536107|65636181|FG001|Overall Study|Withdrawal by Subject|1|||
23518451|NCT00536107|65636180|FG000|Overall Study|Study Termination|2|||
23518452|NCT00536107|65636181|FG001|Overall Study|Study Termination|4|||
23518453|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518454|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
23518455|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
23518456|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518457|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518458|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
23518459|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
23518460|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
23518461|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
23518462|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
23518463|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
23518464|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
23518465|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
23518466|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
23518467|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
23518468|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Other|1|||
23518469|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Other|1|||
23518470|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Other|0|||
23518471|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Other|0|||
23518472|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Other|0|||
23518473|NCT03970733|65636190|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518474|NCT03970733|65636191|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518475|NCT03970733|65636192|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518476|NCT03970733|65636193|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518477|NCT03970733|65636194|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
23518478|NCT00415909|65636197|FG000|Overall Study|Withdrawal by Subject|2|||
23518479|NCT00415909|65636197|FG000|Overall Study|Death|1|||
23518480|NCT00475176|65636210|FG000|Overall Study|Adverse Event|2|||
23518481|NCT00475176|65636210|FG000|Overall Study|Withdrawal by Subject|1|||
23518482|NCT00475176|65636210|FG000|Overall Study|Protocol Violation|1|||
23518483|NCT04568590|65636211|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
23518484|NCT03265249|65636212|FG000|Overall Study|Withdrawal by Subject|0|||
23518485|NCT03265249|65636213|FG001|Overall Study|Withdrawal by Subject|1|||
23518486|NCT00108160|65636214|FG000|Overall Study|Lost to Follow-up|25|||
23518487|NCT00108160|65636215|FG001|Overall Study|Lost to Follow-up|12|||
23518488|NCT00108160|65636214|FG000|Overall Study|Death|1|||
23518489|NCT00108160|65636215|FG001|Overall Study|Death|2|||
23518490|NCT00108160|65636214|FG000|Overall Study|Withdrawal by Subject|4|||
23518491|NCT00108160|65636215|FG001|Overall Study|Withdrawal by Subject|2|||
23518492|NCT00108160|65636214|FG000|Overall Study|Protocol Violation|9|||
23518493|NCT00108160|65636215|FG001|Overall Study|Protocol Violation|5|||
23518494|NCT02794103|65636216|FG000|Overall Study|Loss to follow up due to high sedation|3|||
23518495|NCT02411292|65636217|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
23518496|NCT02411292|65636217|FG000|Overall Study|Death|2|||
23518497|NCT02411292|65636217|FG000|Overall Study|Lost to Follow-up|3|||
23518498|NCT00945009|65636218|FG000|Overall Study|Lack of Efficacy|10|||
23518499|NCT00945009|65636219|FG001|Overall Study|Lack of Efficacy|0|||
23518500|NCT00945009|65636220|FG002|Overall Study|Lack of Efficacy|0|||
23518501|NCT00945009|65636218|FG000|Overall Study|Physician Decision|21|||
23518502|NCT00945009|65636219|FG001|Overall Study|Physician Decision|4|||
23518503|NCT00945009|65636220|FG002|Overall Study|Physician Decision|3|||
23518504|NCT00945009|65636218|FG000|Overall Study|Protocol Violation|6|||
23518505|NCT00945009|65636219|FG001|Overall Study|Protocol Violation|1|||
23518506|NCT00945009|65636220|FG002|Overall Study|Protocol Violation|0|||
23518507|NCT00945009|65636218|FG000|Overall Study|Withdrawal by Subject|1|||
23518508|NCT00945009|65636219|FG001|Overall Study|Withdrawal by Subject|0|||
23518509|NCT00945009|65636220|FG002|Overall Study|Withdrawal by Subject|0|||
23518510|NCT00945009|65636218|FG000|Overall Study|Ineligible|6|||
23518511|NCT00945009|65636219|FG001|Overall Study|Ineligible|1|||
23518512|NCT00945009|65636220|FG002|Overall Study|Ineligible|0|||
23518513|NCT00945009|65636218|FG000|Overall Study|Inevaluable|0|||
23518514|NCT00945009|65636219|FG001|Overall Study|Inevaluable|1|||
23518515|NCT00945009|65636220|FG002|Overall Study|Inevaluable|0|||
23518516|NCT00945009|65636218|FG000|Overall Study|Refusal of further protocol|1|||
23518517|NCT00945009|65636219|FG001|Overall Study|Refusal of further protocol|0|||
23518518|NCT00945009|65636220|FG002|Overall Study|Refusal of further protocol|0|||
23518519|NCT02255500|65636221|FG000|Overall Study|Withdrawal by Subject|1|||
23518520|NCT02255500|65636222|FG001|Overall Study|Withdrawal by Subject|0|||
23518521|NCT00271947|65636223|FG000|Overall Study|Lost to Follow-up|1|||
23518522|NCT00352846|65636224|FG000|Overall Study|Disease progression|0|||
23518523|NCT00352846|65636225|FG001|Overall Study|Disease progression|2|||
23518524|NCT00352846|65636224|FG000|Overall Study|Withdrawal by Subject|3|||
23518525|NCT00352846|65636225|FG001|Overall Study|Withdrawal by Subject|8|||
23518526|NCT00352846|65636224|FG000|Overall Study|Ineligible|3|||
23518527|NCT00352846|65636225|FG001|Overall Study|Ineligible|2|||
23518528|NCT00352846|65636224|FG000|Overall Study|Non-compliance|2|||
23518529|NCT00352846|65636225|FG001|Overall Study|Non-compliance|0|||
23518530|NCT00352846|65636224|FG000|Overall Study|Death|0|||
23518531|NCT00352846|65636225|FG001|Overall Study|Death|1|||
23518532|NCT03311659|65636226|FG000|Overall Study|Protocol Violation|1|||
23518533|NCT00501293|65636227|FG000|Optimization Period|Enrolled in error|1|||
23518534|NCT00501293|65636228|FG001|Optimization Period|Enrolled in error|0|||
23518535|NCT00501293|65636227|FG000|Maintenance Period|Withdrawal by Subject|14|||
23518536|NCT00501293|65636228|FG001|Maintenance Period|Withdrawal by Subject|13|||
23518537|NCT00501293|65636227|FG000|Maintenance Period|Lost to Follow-up|12|||
23518538|NCT00501293|65636228|FG001|Maintenance Period|Lost to Follow-up|7|||
23518539|NCT00501293|65636227|FG000|Maintenance Period|Adverse Event|6|||
23518540|NCT00501293|65636228|FG001|Maintenance Period|Adverse Event|6|||
23518541|NCT00501293|65636227|FG000|Maintenance Period|Protocol Violation|2|||
23518542|NCT00501293|65636228|FG001|Maintenance Period|Protocol Violation|1|||
23518543|NCT00501293|65636227|FG000|Maintenance Period|Lack of Efficacy|4|||
23518544|NCT00501293|65636228|FG001|Maintenance Period|Lack of Efficacy|1|||
23518545|NCT00501293|65636227|FG000|Maintenance Period|Noncompliant with study medication|5|||
23518546|NCT00501293|65636228|FG001|Maintenance Period|Noncompliant with study medication|0|||
23518547|NCT00501293|65636227|FG000|Maintenance Period|Went into rehabilitation|1|||
23518548|NCT00501293|65636228|FG001|Maintenance Period|Went into rehabilitation|0|||
23518549|NCT00501293|65636227|FG000|Maintenance Period|Would not wear patch|1|||
23518550|NCT00501293|65636228|FG001|Maintenance Period|Would not wear patch|0|||
23518551|NCT00501293|65636227|FG000|Maintenance Period|Application site reaction|1|||
23518552|NCT00501293|65636228|FG001|Maintenance Period|Application site reaction|0|||
23518553|NCT00491387|65636230|FG000|Overall Study|study terminated|20|||
23518554|NCT02385084|65636233|FG000|Period 2|Protocol Violation|0|||
23518555|NCT02385084|65636234|FG001|Period 2|Protocol Violation|0|||
23518556|NCT02385084|65636235|FG002|Period 2|Protocol Violation|1|||
23518557|NCT02385084|65636236|FG003|Period 2|Protocol Violation|0|||
23518558|NCT02385084|65636237|FG004|Period 2|Protocol Violation|0|||
23518559|NCT02385084|65636238|FG005|Period 2|Protocol Violation|0|||
23518560|NCT00939809|65636240|FG000|Overall Study|Adverse Event|2|||
23518561|NCT00939809|65636240|FG000|Overall Study|Death|1|||
23518562|NCT01514760|65636242|FG000|Overall Study|Lost to Follow-up|2|||
23518563|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
23518564|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
23518565|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
23518566|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
23518567|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
23518568|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
23518569|NCT02389998|65636251|FG000|Overall Study|car accident|1|||
23518570|NCT02389998|65636252|FG001|Overall Study|car accident|0|||
23518571|NCT00768300|65636253|FG000|Overall Study|Randomized but not treated|1|||
23518572|NCT00768300|65636254|FG001|Overall Study|Randomized but not treated|1|||
23518573|NCT00768300|65636253|FG000|Overall Study|Adverse Event|10|||
23518574|NCT00768300|65636254|FG001|Overall Study|Adverse Event|2|||
23518575|NCT00768300|65636253|FG000|Overall Study|Protocol Violation|6|||
23518576|NCT00768300|65636254|FG001|Overall Study|Protocol Violation|1|||
23518577|NCT00768300|65636253|FG000|Overall Study|Withdrawal by Subject|13|||
23518578|NCT00768300|65636254|FG001|Overall Study|Withdrawal by Subject|7|||
23518579|NCT00768300|65636253|FG000|Overall Study|Physician Decision|2|||
23518580|NCT00768300|65636254|FG001|Overall Study|Physician Decision|3|||
23518581|NCT00768300|65636253|FG000|Overall Study|Study discontinued by Sponsor|271|||
23712495|NCT00960934|66322229|FG001|Overall Study|Physician Decision|1|||
23712496|NCT00960934|66322230|FG002|Overall Study|Physician Decision|0|||
23712497|NCT00960934|66322231|FG003|Overall Study|Physician Decision|0|||
23712498|NCT00960934|66322232|FG004|Overall Study|Physician Decision|0|||
23712499|NCT00960934|66322233|FG005|Overall Study|Physician Decision|0|||
23712500|NCT00960934|66322228|FG000|Overall Study|Progressive Disease|1|||
23712501|NCT00960934|66322229|FG001|Overall Study|Progressive Disease|1|||
23712502|NCT00960934|66322230|FG002|Overall Study|Progressive Disease|0|||
23518582|NCT00768300|65636254|FG001|Overall Study|Study discontinued by Sponsor|140|||
23518583|NCT00768300|65636253|FG000|Overall Study|Death|21|||
23518584|NCT00768300|65636254|FG001|Overall Study|Death|5|||
23518585|NCT00768300|65636253|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
23712503|NCT00960934|66322231|FG003|Overall Study|Progressive Disease|0|||
23712504|NCT00960934|66322232|FG004|Overall Study|Progressive Disease|1|||
23712505|NCT00960934|66322233|FG005|Overall Study|Progressive Disease|1|||
23712506|NCT00960934|66322228|FG000|Overall Study|Protocol Violation|3|||
23518586|NCT00768300|65636254|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
23518587|NCT00768300|65636253|FG000|Overall Study|Screen failure following randomization|1|||
23518588|NCT00768300|65636254|FG001|Overall Study|Screen failure following randomization|0|||
23712507|NCT00960934|66322229|FG001|Overall Study|Protocol Violation|4|||
23712508|NCT00960934|66322230|FG002|Overall Study|Protocol Violation|0|||
23712509|NCT00960934|66322231|FG003|Overall Study|Protocol Violation|3|||
23518589|NCT00768300|65636253|FG000|Overall Study|Received lung transplant|1|||
23518590|NCT00768300|65636254|FG001|Overall Study|Received lung transplant|1|||
23518591|NCT00768300|65636253|FG000|Overall Study|Lost to Follow-up|0|||
23518592|NCT00768300|65636254|FG001|Overall Study|Lost to Follow-up|1|||
23518593|NCT00768300|65636253|FG000|Overall Study|Began prohibited concomitant medication|0|||
23518594|NCT00768300|65636254|FG001|Overall Study|Began prohibited concomitant medication|1|||
23518595|NCT00768300|65636253|FG000|Overall Study|Treated but never dosed with Study drug|1|||
23518596|NCT00768300|65636254|FG001|Overall Study|Treated but never dosed with Study drug|0|||
23518597|NCT00768300|65636253|FG000|Overall Study|Missing data|1|||
23518598|NCT00768300|65636254|FG001|Overall Study|Missing data|0|||
23518599|NCT02741700|65636257|FG000|Overall Study|Lost to Follow-up|17|||
23518600|NCT02741700|65636258|FG001|Overall Study|Lost to Follow-up|8|||
23518601|NCT02741700|65636257|FG000|Overall Study|Withdrawal by Subject|2|||
23518602|NCT02741700|65636258|FG001|Overall Study|Withdrawal by Subject|5|||
23518603|NCT02741700|65636257|FG000|Overall Study|Physician Decision|3|||
23518604|NCT02741700|65636258|FG001|Overall Study|Physician Decision|0|||
23518605|NCT02741700|65636257|FG000|Overall Study|Moved out of State|0|||
23518606|NCT02741700|65636258|FG001|Overall Study|Moved out of State|1|||
23518607|NCT02741700|65636257|FG000|Overall Study|Death|4|||
23518608|NCT02741700|65636258|FG001|Overall Study|Death|5|||
23518609|NCT02085785|65636259|FG000|Overall Study|Withdrawal by Subject|2|||
23518610|NCT02085785|65636260|FG001|Overall Study|Withdrawal by Subject|1|||
23518611|NCT02085785|65636259|FG000|Overall Study|Lost to Follow-up|0|||
23518612|NCT02085785|65636260|FG001|Overall Study|Lost to Follow-up|1|||
23518613|NCT04251221|65636265|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
23518614|NCT04251221|65636266|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
23518615|NCT01471379|65636269|FG000|Overall Study|Adverse Event|1|||
23518616|NCT01471379|65636270|FG001|Overall Study|Adverse Event|0|||
23518617|NCT01471379|65636271|FG002|Overall Study|Adverse Event|0|||
23518618|NCT01471379|65636269|FG000|Overall Study|Study terminated|0|||
23518619|NCT01471379|65636270|FG001|Overall Study|Study terminated|1|||
23518620|NCT01471379|65636271|FG002|Overall Study|Study terminated|0|||
23518621|NCT01412021|65636272|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
23518622|NCT01412021|65636272|FG000|Overall Study|Treatment Prior to Approval|3|||
23518623|NCT01412021|65636272|FG000|Overall Study|Transferred to Other Hospital|9|||
23518624|NCT04267133|65636278|FG000|Overall Study|Withdrawal by Subject|1|||
23518625|NCT04267133|65636278|FG000|Overall Study|Adverse Event|4|||
23518626|NCT00853723|65636289|FG000|Overall Study|Adverse Event|3|||
23518627|NCT00853723|65636290|FG001|Overall Study|Adverse Event|4|||
23518628|NCT00853723|65636291|FG002|Overall Study|Adverse Event|1|||
23518629|NCT00853723|65636289|FG000|Overall Study|Withdrawal by Subject|2|||
23518630|NCT00853723|65636290|FG001|Overall Study|Withdrawal by Subject|1|||
23518631|NCT00853723|65636291|FG002|Overall Study|Withdrawal by Subject|0|||
23518632|NCT00853723|65636289|FG000|Overall Study|Protocol Violation|1|||
23518633|NCT00853723|65636290|FG001|Overall Study|Protocol Violation|2|||
23518634|NCT00853723|65636291|FG002|Overall Study|Protocol Violation|1|||
23518635|NCT02447081|65636295|FG000|Overall Study|Death|161|||
23518636|NCT02447081|65636295|FG000|Overall Study|Lost to Follow-up|36|||
23518637|NCT02447081|65636295|FG000|Overall Study|Visit not completed|17|||
23518638|NCT02447081|65636295|FG000|Overall Study|unsuccessful implant procedure|10|||
23518639|NCT01374087|65636297|FG000|Overall Study|Adverse Event|1|||
23518640|NCT01374087|65636298|FG001|Overall Study|Adverse Event|0|||
23518641|NCT01374087|65636297|FG000|Overall Study|Disease progression|2|||
23518642|NCT01374087|65636298|FG001|Overall Study|Disease progression|2|||
23518643|NCT01374087|65636297|FG000|Overall Study|Study discontinued|13|||
23518644|NCT01374087|65636298|FG001|Overall Study|Study discontinued|13|||
23518645|NCT03204981|65636299|FG000|Overall Study|Physician Decision|2|||
23518646|NCT03204981|65636299|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
23518647|NCT02424383|65636300|FG000|Overall Study|Withdrawal by Subject|32|||
23518648|NCT02424383|65636300|FG000|Overall Study|Death|170|||
23518649|NCT02424383|65636300|FG000|Overall Study|Sponsor's decision|3|||
23518650|NCT02424383|65636300|FG000|Overall Study|Investigator's decision|44|||
23518651|NCT02424383|65636300|FG000|Overall Study|Lost to Follow-up|81|||
23518652|NCT02424383|65636300|FG000|Overall Study|Other|7|||
23518653|NCT02424383|65636300|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
23611222|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23518654|NCT02542631|65636304|FG000|Overall Study|Adverse Event|1|||
23518655|NCT02542631|65636305|FG001|Overall Study|Adverse Event|1|||
23518656|NCT02542631|65636304|FG000|Overall Study|Sponsor Termination|1|||
23518657|NCT02542631|65636305|FG001|Overall Study|Sponsor Termination|0|||
23518658|NCT02542631|65636304|FG000|Overall Study|Withdrawal by Subject|11|||
23518659|NCT02542631|65636305|FG001|Overall Study|Withdrawal by Subject|16|||
23518660|NCT02542631|65636304|FG000|Overall Study|Protocol Violation|1|||
23518661|NCT02542631|65636305|FG001|Overall Study|Protocol Violation|1|||
23712510|NCT00960934|66322232|FG004|Overall Study|Protocol Violation|3|||
23518662|NCT02542631|65636304|FG000|Overall Study|Physician Decision|6|||
23518663|NCT02542631|65636305|FG001|Overall Study|Physician Decision|4|||
23518664|NCT02542631|65636304|FG000|Overall Study|Lost to Follow-up|6|||
23518665|NCT02542631|65636305|FG001|Overall Study|Lost to Follow-up|5|||
23518666|NCT02542631|65636304|FG000|Overall Study|Death|1|||
23518667|NCT02542631|65636305|FG001|Overall Study|Death|2|||
23518668|NCT02542631|65636304|FG000|Overall Study|Other|2|||
23518669|NCT02542631|65636305|FG001|Overall Study|Other|1|||
23518670|NCT02542631|65636304|FG000|Overall Study|Used Prohibited Medication|2|||
23518671|NCT02542631|65636305|FG001|Overall Study|Used Prohibited Medication|1|||
23518672|NCT00772707|65636307|FG000|Overall Study|Withdrawn|3|||
23518673|NCT01603459|65636308|FG000|Overall Study|Adverse Event|5|||
23518674|NCT01603459|65636308|FG000|Overall Study|Withdrawal by Subject|5|||
23518675|NCT01603459|65636308|FG000|Overall Study|Lost to Follow-up|3|||
23518676|NCT01603459|65636308|FG000|Overall Study|Predefined discontinuation criteria|3|||
23518677|NCT01603459|65636308|FG000|Overall Study|Non-compliance|1|||
23518678|NCT01603459|65636308|FG000|Overall Study|Administrative reason|1|||
23518679|NCT00399360|65636312|FG000|Overall Study|Lost to Follow-up|2|||
23518680|NCT00399360|65636313|FG001|Overall Study|Lost to Follow-up|1|||
23518681|NCT00399360|65636314|FG002|Overall Study|Lost to Follow-up|2|||
23518682|NCT00399360|65636315|FG003|Overall Study|Lost to Follow-up|4|||
23518683|NCT00399360|65636312|FG000|Overall Study|Adverse Event|0|||
23518684|NCT00399360|65636313|FG001|Overall Study|Adverse Event|0|||
23518685|NCT00399360|65636314|FG002|Overall Study|Adverse Event|1|||
23518686|NCT00399360|65636315|FG003|Overall Study|Adverse Event|0|||
23518687|NCT00399360|65636312|FG000|Overall Study|Withdrawal by Subject|0|||
23518688|NCT00399360|65636313|FG001|Overall Study|Withdrawal by Subject|2|||
23518689|NCT00399360|65636314|FG002|Overall Study|Withdrawal by Subject|0|||
23518690|NCT00399360|65636315|FG003|Overall Study|Withdrawal by Subject|2|||
23518691|NCT00484939|65636320|FG000|Overall Study|Death|9|||
23518692|NCT00484939|65636321|FG001|Overall Study|Death|13|||
23518693|NCT00484939|65636320|FG000|Overall Study|Adverse Event|22|||
23518694|NCT00484939|65636321|FG001|Overall Study|Adverse Event|12|||
23518695|NCT00484939|65636320|FG000|Overall Study|Patient Withdrew Consent|19|||
23518696|NCT00484939|65636321|FG001|Overall Study|Patient Withdrew Consent|10|||
23518697|NCT00484939|65636320|FG000|Overall Study|Protocol Violation|3|||
23518698|NCT00484939|65636321|FG001|Overall Study|Protocol Violation|3|||
23518699|NCT00484939|65636320|FG000|Overall Study|Lost to Follow-up|0|||
23518700|NCT00484939|65636321|FG001|Overall Study|Lost to Follow-up|3|||
23518701|NCT00484939|65636320|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
23518702|NCT00484939|65636321|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
23518703|NCT00484939|65636320|FG000|Overall Study|Disease progression|67|||
23518704|NCT00484939|65636321|FG001|Overall Study|Disease progression|88|||
23518705|NCT00484939|65636320|FG000|Overall Study|Screen Failure|2|||
23518706|NCT00484939|65636321|FG001|Overall Study|Screen Failure|2|||
23518707|NCT00484939|65636320|FG000|Overall Study|Reason Not Specified|11|||
23518708|NCT00484939|65636321|FG001|Overall Study|Reason Not Specified|6|||
23518709|NCT02532647|65636322|FG000|Overall Study|Did not receive trial medication|1|||
23518710|NCT02532647|65636323|FG001|Overall Study|Did not receive trial medication|0|||
23518711|NCT02532647|65636324|FG002|Overall Study|Did not receive trial medication|1|||
23518712|NCT02875860|65636325|FG000|Overall Study|Withdrawal by Subject|0|||
23518713|NCT02875860|65636326|FG001|Overall Study|Withdrawal by Subject|1|||
23518714|NCT01042236|65636327|FG000|Treatment Period 1|Adverse Event|0|||
23518715|NCT01042236|65636328|FG001|Treatment Period 1|Adverse Event|1|||
23518716|NCT01042236|65636329|FG002|Treatment Period 1|Adverse Event|0|||
23518717|NCT01042236|65636330|FG003|Treatment Period 1|Adverse Event|0|||
23518718|NCT01042236|65636331|FG004|Treatment Period 1|Adverse Event|1|||
23518719|NCT01042236|65636332|FG005|Treatment Period 1|Adverse Event|0|||
23518720|NCT01042236|65636327|FG000|Treatment Period 3|Adverse Event|0|||
23518721|NCT01042236|65636328|FG001|Treatment Period 3|Adverse Event|0|||
23518722|NCT01042236|65636329|FG002|Treatment Period 3|Adverse Event|0|||
23518723|NCT01042236|65636330|FG003|Treatment Period 3|Adverse Event|1|||
23518724|NCT01042236|65636331|FG004|Treatment Period 3|Adverse Event|0|||
23518725|NCT01042236|65636332|FG005|Treatment Period 3|Adverse Event|0|||
23518726|NCT01042236|65636327|FG000|Treatment Period 3|Protocol Violation|0|||
23518727|NCT01042236|65636328|FG001|Treatment Period 3|Protocol Violation|0|||
23518728|NCT01042236|65636329|FG002|Treatment Period 3|Protocol Violation|0|||
23518729|NCT01042236|65636330|FG003|Treatment Period 3|Protocol Violation|1|||
23518730|NCT01042236|65636331|FG004|Treatment Period 3|Protocol Violation|0|||
23518731|NCT01042236|65636332|FG005|Treatment Period 3|Protocol Violation|0|||
23518732|NCT00022633|65636335|FG000|Overall Study|Adverse Event|11|||
23518733|NCT00022633|65636336|FG001|Overall Study|Adverse Event|1|||
23518734|NCT00022633|65636335|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23518735|NCT00022633|65636336|FG001|Overall Study|Refusal unrelated to adverse event|0|||
23518736|NCT00022633|65636335|FG000|Overall Study|Progression/relapse|9|||
23518737|NCT00022633|65636336|FG001|Overall Study|Progression/relapse|2|||
23518738|NCT00022633|65636335|FG000|Overall Study|Death|4|||
23518739|NCT00022633|65636336|FG001|Overall Study|Death|0|||
23518740|NCT00022633|65636335|FG000|Overall Study|Other - not protocol specified|3|||
23518741|NCT00022633|65636336|FG001|Overall Study|Other - not protocol specified|2|||
23518742|NCT00022633|65636335|FG000|Overall Study|Ineligible|4|||
23518743|NCT00022633|65636336|FG001|Overall Study|Ineligible|0|||
23518744|NCT04273217|65636341|FG000|Overall Study|Lost to Follow-up|0|||
23518745|NCT04273217|65636342|FG001|Overall Study|Lost to Follow-up|0|||
23518746|NCT04273217|65636343|FG002|Overall Study|Lost to Follow-up|0|||
23518747|NCT04273217|65636344|FG003|Overall Study|Lost to Follow-up|0|||
23518748|NCT04273217|65636345|FG004|Overall Study|Lost to Follow-up|0|||
23518749|NCT04273217|65636346|FG005|Overall Study|Lost to Follow-up|1|||
23518750|NCT04273217|65636341|FG000|Overall Study|Participant non-compliance|0|||
23518751|NCT04273217|65636342|FG001|Overall Study|Participant non-compliance|0|||
23518752|NCT04273217|65636343|FG002|Overall Study|Participant non-compliance|0|||
23518753|NCT04273217|65636344|FG003|Overall Study|Participant non-compliance|0|||
23518754|NCT04273217|65636345|FG004|Overall Study|Participant non-compliance|1|||
23518755|NCT04273217|65636346|FG005|Overall Study|Participant non-compliance|0|||
23518756|NCT04273217|65636341|FG000|Overall Study|Positive urine drug screen|1|||
23518757|NCT04273217|65636342|FG001|Overall Study|Positive urine drug screen|0|||
23518758|NCT04273217|65636343|FG002|Overall Study|Positive urine drug screen|1|||
23518759|NCT04273217|65636344|FG003|Overall Study|Positive urine drug screen|0|||
23518760|NCT04273217|65636345|FG004|Overall Study|Positive urine drug screen|0|||
23518761|NCT04273217|65636346|FG005|Overall Study|Positive urine drug screen|1|||
23518762|NCT00768144|65636347|FG000|Overall Study|Adverse Event|13|||
23518763|NCT00768144|65636347|FG000|Overall Study|Progressive Disease|21|||
23518764|NCT00768144|65636347|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
23518765|NCT00768144|65636347|FG000|Overall Study|Pt Withdrew Consent|1|||
23518766|NCT00520975|65636350|FG000|Overall Study|Disease progression|31|||
23518767|NCT00520975|65636351|FG001|Overall Study|Disease progression|23|||
23518768|NCT00520975|65636350|FG000|Overall Study|Adverse Event|7|||
23518769|NCT00520975|65636351|FG001|Overall Study|Adverse Event|10|||
23518770|NCT00520975|65636350|FG000|Overall Study|Death|0|||
23518771|NCT00520975|65636351|FG001|Overall Study|Death|2|||
23518772|NCT00520975|65636350|FG000|Overall Study|Withdrawal by Subject|3|||
23518773|NCT00520975|65636351|FG001|Overall Study|Withdrawal by Subject|5|||
23518774|NCT00520975|65636350|FG000|Overall Study|Other therapy|2|||
23518775|NCT00520975|65636351|FG001|Overall Study|Other therapy|4|||
23518776|NCT00520975|65636350|FG000|Overall Study|Other reasons|4|||
23518777|NCT00520975|65636351|FG001|Overall Study|Other reasons|2|||
23518778|NCT00520975|65636350|FG000|Overall Study|Not start protocol therapy|1|||
23518779|NCT00520975|65636351|FG001|Overall Study|Not start protocol therapy|2|||
23518780|NCT00951665|65636363|FG000|Phase 1b|Adverse Event|2|||
23518781|NCT00951665|65636364|FG001|Phase 1b|Adverse Event|1|||
23518782|NCT00951665|65636365|FG002|Phase 1b|Adverse Event|0|||
23518783|NCT00951665|65636366|FG003|Phase 1b|Adverse Event|1|||
23518784|NCT00951665|65636367|FG004|Phase 1b|Adverse Event|0|||
23518785|NCT00951665|65636368|FG005|Phase 1b|Adverse Event|0|||
23518786|NCT00951665|65636363|FG000|Phase 1b|Death|1|||
23518787|NCT00951665|65636364|FG001|Phase 1b|Death|0|||
23518788|NCT00951665|65636365|FG002|Phase 1b|Death|2|||
23518789|NCT00951665|65636366|FG003|Phase 1b|Death|0|||
23518790|NCT00951665|65636367|FG004|Phase 1b|Death|0|||
23518791|NCT00951665|65636368|FG005|Phase 1b|Death|0|||
23518792|NCT00951665|65636363|FG000|Phase 1b|Physician Decision|4|||
23518793|NCT00951665|65636364|FG001|Phase 1b|Physician Decision|0|||
23518794|NCT00951665|65636365|FG002|Phase 1b|Physician Decision|1|||
23518795|NCT00951665|65636366|FG003|Phase 1b|Physician Decision|0|||
23518796|NCT00951665|65636367|FG004|Phase 1b|Physician Decision|0|||
23518797|NCT00951665|65636368|FG005|Phase 1b|Physician Decision|0|||
23518798|NCT00951665|65636363|FG000|Phase 1b|Withdrawal by Subject|0|||
23518799|NCT00951665|65636364|FG001|Phase 1b|Withdrawal by Subject|1|||
23518800|NCT00951665|65636365|FG002|Phase 1b|Withdrawal by Subject|0|||
23518801|NCT00951665|65636366|FG003|Phase 1b|Withdrawal by Subject|0|||
23811992|NCT02516553|66691876|FG001|Overall Study|Progressive disease|2|||
23518802|NCT00951665|65636367|FG004|Phase 1b|Withdrawal by Subject|0|||
23518803|NCT00951665|65636368|FG005|Phase 1b|Withdrawal by Subject|0|||
23518804|NCT00951665|65636363|FG000|Phase 1b|Disease Progression|13|||
23518805|NCT00951665|65636364|FG001|Phase 1b|Disease Progression|2|||
23518806|NCT00951665|65636365|FG002|Phase 1b|Disease Progression|14|||
23518807|NCT00951665|65636366|FG003|Phase 1b|Disease Progression|0|||
23518808|NCT00951665|65636367|FG004|Phase 1b|Disease Progression|0|||
23518809|NCT00951665|65636368|FG005|Phase 1b|Disease Progression|0|||
23518810|NCT00951665|65636363|FG000|Phase 1b|Protocol Violation|2|||
23518811|NCT00951665|65636364|FG001|Phase 1b|Protocol Violation|0|||
23518812|NCT00951665|65636365|FG002|Phase 1b|Protocol Violation|0|||
23518813|NCT00951665|65636366|FG003|Phase 1b|Protocol Violation|0|||
23518814|NCT00951665|65636367|FG004|Phase 1b|Protocol Violation|0|||
23518815|NCT00951665|65636368|FG005|Phase 1b|Protocol Violation|0|||
23518816|NCT00951665|65636363|FG000|Phase 2a|Adverse Event|0|||
23518817|NCT00951665|65636364|FG001|Phase 2a|Adverse Event|0|||
23518818|NCT00951665|65636365|FG002|Phase 2a|Adverse Event|0|||
23518819|NCT00951665|65636366|FG003|Phase 2a|Adverse Event|0|||
23518820|NCT00951665|65636367|FG004|Phase 2a|Adverse Event|2|||
23518821|NCT00951665|65636368|FG005|Phase 2a|Adverse Event|0|||
23518822|NCT00951665|65636363|FG000|Phase 2a|Death|0|||
23518823|NCT00951665|65636364|FG001|Phase 2a|Death|0|||
23518824|NCT00951665|65636365|FG002|Phase 2a|Death|0|||
23518825|NCT00951665|65636366|FG003|Phase 2a|Death|0|||
23518826|NCT00951665|65636367|FG004|Phase 2a|Death|1|||
23518827|NCT00951665|65636368|FG005|Phase 2a|Death|1|||
23518828|NCT00951665|65636363|FG000|Phase 2a|Lost to Follow-up|0|||
23518829|NCT00951665|65636364|FG001|Phase 2a|Lost to Follow-up|0|||
23518830|NCT00951665|65636365|FG002|Phase 2a|Lost to Follow-up|0|||
23518831|NCT00951665|65636366|FG003|Phase 2a|Lost to Follow-up|0|||
23518832|NCT00951665|65636367|FG004|Phase 2a|Lost to Follow-up|1|||
23518833|NCT00951665|65636368|FG005|Phase 2a|Lost to Follow-up|0|||
23518834|NCT00951665|65636363|FG000|Phase 2a|Physician Decision|0|||
23518835|NCT00951665|65636364|FG001|Phase 2a|Physician Decision|0|||
23712511|NCT00960934|66322233|FG005|Overall Study|Protocol Violation|2|||
23712512|NCT00960934|66322228|FG000|Overall Study|Withdrawal by Subject|5|||
23712513|NCT00960934|66322229|FG001|Overall Study|Withdrawal by Subject|6|||
23712514|NCT00960934|66322230|FG002|Overall Study|Withdrawal by Subject|4|||
23712515|NCT00960934|66322231|FG003|Overall Study|Withdrawal by Subject|5|||
23712516|NCT00960934|66322232|FG004|Overall Study|Withdrawal by Subject|5|||
23518836|NCT00951665|65636365|FG002|Phase 2a|Physician Decision|0|||
23518837|NCT00951665|65636366|FG003|Phase 2a|Physician Decision|0|||
23712517|NCT00960934|66322233|FG005|Overall Study|Withdrawal by Subject|7|||
23712518|NCT00960934|66322228|FG000|Overall Study|Study Terminated by Sponsor|50|||
23712519|NCT00960934|66322229|FG001|Overall Study|Study Terminated by Sponsor|46|||
23712520|NCT00960934|66322230|FG002|Overall Study|Study Terminated by Sponsor|52|||
23712521|NCT00960934|66322231|FG003|Overall Study|Study Terminated by Sponsor|50|||
23712522|NCT00960934|66322232|FG004|Overall Study|Study Terminated by Sponsor|49|||
23712523|NCT00960934|66322233|FG005|Overall Study|Study Terminated by Sponsor|49|||
23712524|NCT01536119|66322234|FG000|Overall Study|Lost to Follow-up|17|||
23712525|NCT01536119|66322235|FG001|Overall Study|Lost to Follow-up|14|||
23712526|NCT00650091|66322236|FG000|Amended Study Design|Withdrawal by Subject|12|||
23712527|NCT00650091|66322237|FG001|Amended Study Design|Withdrawal by Subject|11|||
23712528|NCT00650091|66322238|FG002|Amended Study Design|Withdrawal by Subject|0|||
23712529|NCT00650091|66322236|FG000|Amended Study Design|Physician Decision|5|||
23712530|NCT00650091|66322237|FG001|Amended Study Design|Physician Decision|0|||
23712531|NCT00650091|66322238|FG002|Amended Study Design|Physician Decision|0|||
23712532|NCT00650091|66322236|FG000|Amended Study Design|Adverse Event|1|||
23712533|NCT00650091|66322237|FG001|Amended Study Design|Adverse Event|4|||
23712534|NCT00650091|66322238|FG002|Amended Study Design|Adverse Event|0|||
23712535|NCT00650091|66322236|FG000|Amended Study Design|Lung transplantation|4|||
23712536|NCT00650091|66322237|FG001|Amended Study Design|Lung transplantation|2|||
23712537|NCT00650091|66322238|FG002|Amended Study Design|Lung transplantation|0|||
23712538|NCT00650091|66322236|FG000|Amended Study Design|Other|1|||
23712539|NCT00650091|66322237|FG001|Amended Study Design|Other|3|||
23712540|NCT00650091|66322238|FG002|Amended Study Design|Other|0|||
23712541|NCT04533815|66322239|FG000|Overall Study|Adverse Event|2|||
23712542|NCT04533815|66322239|FG000|Overall Study|Site withdrew|5|||
23712543|NCT02681055|66322241|FG000|Weeks 5-12|Adverse Event|1|||
23712544|NCT03288493|66322246|FG000|Overall Study|Withdrawal by Subject|4|||
23712545|NCT03288493|66322247|FG001|Overall Study|Withdrawal by Subject|0|||
23712546|NCT03288493|66322248|FG002|Overall Study|Withdrawal by Subject|0|||
23712547|NCT03288493|66322249|FG003|Overall Study|Withdrawal by Subject|0|||
23712548|NCT03288493|66322250|FG004|Overall Study|Withdrawal by Subject|0|||
23712549|NCT03288493|66322251|FG005|Overall Study|Withdrawal by Subject|2|||
23712550|NCT03288493|66322252|FG006|Overall Study|Withdrawal by Subject|0|||
23712551|NCT03288493|66322246|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
23712552|NCT03288493|66322247|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
23712553|NCT03288493|66322248|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
23712554|NCT03288493|66322249|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
23712555|NCT03288493|66322250|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
23712556|NCT03288493|66322251|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
23712557|NCT03288493|66322252|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
23712558|NCT03288493|66322246|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
23811993|NCT02516553|66691877|FG002|Overall Study|Progressive disease|3|||
23416205|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
23518838|NCT00951665|65636367|FG004|Phase 2a|Physician Decision|0|||
23518839|NCT00951665|65636368|FG005|Phase 2a|Physician Decision|1|||
23518840|NCT00951665|65636363|FG000|Phase 2a|Withdrawal by Subject|0|||
23712559|NCT03288493|66322247|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23712560|NCT03288493|66322248|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23712561|NCT03288493|66322249|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
23712562|NCT03288493|66322250|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23712563|NCT03288493|66322251|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
23712564|NCT03288493|66322252|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23712565|NCT03288493|66322246|FG000|Overall Study|Death|2|||
23712566|NCT03288493|66322247|FG001|Overall Study|Death|0|||
23712567|NCT03288493|66322248|FG002|Overall Study|Death|0|||
23712568|NCT03288493|66322249|FG003|Overall Study|Death|0|||
23712569|NCT03288493|66322250|FG004|Overall Study|Death|0|||
23712570|NCT03288493|66322251|FG005|Overall Study|Death|0|||
23712571|NCT03288493|66322252|FG006|Overall Study|Death|0|||
23712572|NCT03288493|66322246|FG000|Overall Study|other reason not listed above|2|||
23712573|NCT03288493|66322247|FG001|Overall Study|other reason not listed above|0|||
23712574|NCT03288493|66322248|FG002|Overall Study|other reason not listed above|0|||
23712575|NCT03288493|66322249|FG003|Overall Study|other reason not listed above|0|||
23712576|NCT03288493|66322250|FG004|Overall Study|other reason not listed above|0|||
23712577|NCT03288493|66322251|FG005|Overall Study|other reason not listed above|0|||
23712578|NCT03288493|66322252|FG006|Overall Study|other reason not listed above|0|||
23712579|NCT01588353|66322253|FG000|Step2|Withdrawal by Subject|0|||
23712580|NCT01588353|66322254|FG001|Step2|Withdrawal by Subject|1|||
23712581|NCT01588353|66322255|FG002|Step2|Withdrawal by Subject|0|||
23712582|NCT01588353|66322253|FG000|Step3|Adverse Event|0|||
23712583|NCT01588353|66322254|FG001|Step3|Adverse Event|0|||
23712584|NCT01588353|66322255|FG002|Step3|Adverse Event|2|||
23712585|NCT02953782|66322259|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
23712586|NCT02953782|66322260|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
23712587|NCT02953782|66322261|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
23712588|NCT02953782|66322262|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
23712589|NCT02953782|66322263|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
23712590|NCT02953782|66322264|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23712591|NCT02953782|66322265|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23712592|NCT02953782|66322266|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23712593|NCT02953782|66322259|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
23712594|NCT02953782|66322260|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23712595|NCT02953782|66322261|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
23712596|NCT02953782|66322262|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23712597|NCT02953782|66322263|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
23712598|NCT02953782|66322264|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23712599|NCT02953782|66322265|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23712600|NCT02953782|66322266|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23712601|NCT02953782|66322259|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23712602|NCT02953782|66322260|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23712603|NCT02953782|66322261|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23712604|NCT02953782|66322262|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23712605|NCT02953782|66322263|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23712606|NCT02953782|66322264|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23712607|NCT02953782|66322265|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23712608|NCT02953782|66322266|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23712609|NCT02953782|66322259|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712610|NCT02953782|66322260|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712611|NCT02953782|66322261|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
23712612|NCT02953782|66322262|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
23712613|NCT02953782|66322263|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712614|NCT02953782|66322264|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712615|NCT02953782|66322265|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712616|NCT02953782|66322266|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23712617|NCT02953782|66322259|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23712618|NCT02953782|66322260|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23712619|NCT02953782|66322261|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23712620|NCT02953782|66322262|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23712621|NCT02953782|66322263|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23712622|NCT02953782|66322264|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
23712623|NCT02953782|66322265|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
23712624|NCT02953782|66322266|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
23712625|NCT02953782|66322259|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23712626|NCT02953782|66322260|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23712627|NCT02953782|66322261|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23712628|NCT02953782|66322262|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23712629|NCT02953782|66322263|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23712630|NCT02953782|66322264|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
23712631|NCT02953782|66322265|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
23712632|NCT02953782|66322266|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
23712633|NCT02953782|66322259|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23712634|NCT02953782|66322260|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23712635|NCT02953782|66322261|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23712636|NCT02953782|66322262|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23712637|NCT02953782|66322263|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23712638|NCT02953782|66322264|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
23712639|NCT02953782|66322265|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
23712640|NCT02953782|66322266|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
23712641|NCT02953782|66322259|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712642|NCT02953782|66322260|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712643|NCT02953782|66322261|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712644|NCT02953782|66322262|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712645|NCT02953782|66322263|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712646|NCT02953782|66322264|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712647|NCT02953782|66322265|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
23712648|NCT02953782|66322266|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23712649|NCT03004469|66322269|FG000|Overall Study|Adverse Event|6|||
23712650|NCT03004469|66322270|FG001|Overall Study|Adverse Event|4|||
23712651|NCT03004469|66322271|FG002|Overall Study|Adverse Event|6|||
23712652|NCT03004469|66322269|FG000|Overall Study|Lack of Efficacy|1|||
23712653|NCT03004469|66322270|FG001|Overall Study|Lack of Efficacy|0|||
23712654|NCT03004469|66322271|FG002|Overall Study|Lack of Efficacy|1|||
23712655|NCT03004469|66322269|FG000|Overall Study|Lost to Follow-up|23|||
23712656|NCT03004469|66322270|FG001|Overall Study|Lost to Follow-up|14|||
23712657|NCT03004469|66322271|FG002|Overall Study|Lost to Follow-up|6|||
23712658|NCT03004469|66322269|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23712659|NCT03004469|66322270|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23712660|NCT03004469|66322271|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23712661|NCT03004469|66322269|FG000|Overall Study|Protocol Violation|0|||
23712662|NCT03004469|66322270|FG001|Overall Study|Protocol Violation|0|||
23712663|NCT03004469|66322271|FG002|Overall Study|Protocol Violation|1|||
23712664|NCT03004469|66322269|FG000|Overall Study|Withdrawal by Subject|29|||
23712665|NCT03004469|66322270|FG001|Overall Study|Withdrawal by Subject|27|||
23712666|NCT03004469|66322271|FG002|Overall Study|Withdrawal by Subject|10|||
23712667|NCT03004469|66322269|FG000|Overall Study|Other unspecified reason|0|||
23712668|NCT03004469|66322270|FG001|Overall Study|Other unspecified reason|4|||
23712669|NCT03004469|66322271|FG002|Overall Study|Other unspecified reason|1|||
23712670|NCT01397448|66322275|FG000|Overall Study|Adverse Event|4|||
23712671|NCT01397448|66322276|FG001|Overall Study|Adverse Event|4|||
23712672|NCT01397448|66322277|FG002|Overall Study|Adverse Event|6|||
23712673|NCT01397448|66322275|FG000|Overall Study|Withdrawal by Subject|4|||
23712674|NCT01397448|66322276|FG001|Overall Study|Withdrawal by Subject|4|||
23712675|NCT01397448|66322277|FG002|Overall Study|Withdrawal by Subject|3|||
23712676|NCT01397448|66322275|FG000|Overall Study|Lack of Efficacy|2|||
23712677|NCT01397448|66322276|FG001|Overall Study|Lack of Efficacy|0|||
23712678|NCT01397448|66322277|FG002|Overall Study|Lack of Efficacy|5|||
23712679|NCT01397448|66322275|FG000|Overall Study|Other|8|||
23518841|NCT00951665|65636364|FG001|Phase 2a|Withdrawal by Subject|0|||
23712680|NCT01397448|66322276|FG001|Overall Study|Other|7|||
23712681|NCT01397448|66322277|FG002|Overall Study|Other|4|||
23712682|NCT01195363|66322283|FG000|Overall Study|Lost to Follow-up|7|||
23712683|NCT01195363|66322284|FG001|Overall Study|Lost to Follow-up|4|||
23712684|NCT01195363|66322283|FG000|Overall Study|Adverse Event|3|||
23712685|NCT01195363|66322284|FG001|Overall Study|Adverse Event|1|||
23712686|NCT01195363|66322283|FG000|Overall Study|Lack of Efficacy|0|||
23712687|NCT01195363|66322284|FG001|Overall Study|Lack of Efficacy|4|||
23712688|NCT01195363|66322283|FG000|Overall Study|incarceration|1|||
23712689|NCT01195363|66322284|FG001|Overall Study|incarceration|0|||
23712690|NCT01797965|66322285|FG000|Overall Study|Adverse Event|104|||
23712691|NCT01797965|66322286|FG001|Overall Study|Adverse Event|129|||
23712692|NCT01797965|66322287|FG002|Overall Study|Adverse Event|4|||
23712693|NCT01797965|66322288|FG003|Overall Study|Adverse Event|21|||
23712694|NCT01797965|66322285|FG000|Overall Study|Lost to Follow-up|9|||
23712695|NCT01797965|66322286|FG001|Overall Study|Lost to Follow-up|8|||
23712696|NCT01797965|66322287|FG002|Overall Study|Lost to Follow-up|1|||
23712697|NCT01797965|66322288|FG003|Overall Study|Lost to Follow-up|2|||
23712698|NCT01797965|66322285|FG000|Overall Study|Consent withdrawn|130|||
23712699|NCT01797965|66322286|FG001|Overall Study|Consent withdrawn|117|||
23712700|NCT01797965|66322287|FG002|Overall Study|Consent withdrawn|3|||
23712701|NCT01797965|66322288|FG003|Overall Study|Consent withdrawn|35|||
23712702|NCT01797965|66322285|FG000|Overall Study|Investigator decision|21|||
23712703|NCT01797965|66322286|FG001|Overall Study|Investigator decision|15|||
23712704|NCT01797965|66322287|FG002|Overall Study|Investigator decision|0|||
23712705|NCT01797965|66322288|FG003|Overall Study|Investigator decision|0|||
23712706|NCT01797965|66322285|FG000|Overall Study|Death|2|||
23712707|NCT01797965|66322286|FG001|Overall Study|Death|4|||
23712708|NCT01797965|66322287|FG002|Overall Study|Death|0|||
23712709|NCT01797965|66322288|FG003|Overall Study|Death|0|||
23712710|NCT01797965|66322285|FG000|Overall Study|Disease progression, defined by protocol|3|||
23712711|NCT01797965|66322286|FG001|Overall Study|Disease progression, defined by protocol|1|||
23712712|NCT01797965|66322287|FG002|Overall Study|Disease progression, defined by protocol|0|||
23712713|NCT01797965|66322288|FG003|Overall Study|Disease progression, defined by protocol|0|||
23712714|NCT01797965|66322285|FG000|Overall Study|Reason Not Specified|280|||
23712715|NCT01797965|66322286|FG001|Overall Study|Reason Not Specified|295|||
23712716|NCT01797965|66322287|FG002|Overall Study|Reason Not Specified|0|||
23712717|NCT01797965|66322288|FG003|Overall Study|Reason Not Specified|15|||
23712718|NCT03583372|66322289|FG000|Overall Study|Withdrawal by Subject|6|||
23712719|NCT03583372|66322290|FG001|Overall Study|Withdrawal by Subject|11|||
23712720|NCT03583372|66322291|FG002|Overall Study|Withdrawal by Subject|7|||
23712721|NCT03583372|66322292|FG003|Overall Study|Withdrawal by Subject|8|||
23712722|NCT03583372|66322289|FG000|Overall Study|Lost to Follow-up|4|||
23712723|NCT03583372|66322290|FG001|Overall Study|Lost to Follow-up|6|||
23712724|NCT03583372|66322291|FG002|Overall Study|Lost to Follow-up|3|||
23712725|NCT03583372|66322292|FG003|Overall Study|Lost to Follow-up|2|||
23712726|NCT03583372|66322289|FG000|Overall Study|Adverse Event|1|||
23712727|NCT03583372|66322290|FG001|Overall Study|Adverse Event|3|||
23712728|NCT03583372|66322291|FG002|Overall Study|Adverse Event|4|||
23712729|NCT03583372|66322292|FG003|Overall Study|Adverse Event|4|||
23712730|NCT03583372|66322289|FG000|Overall Study|Physician Decision|0|||
23712731|NCT03583372|66322290|FG001|Overall Study|Physician Decision|1|||
23518842|NCT00951665|65636365|FG002|Phase 2a|Withdrawal by Subject|0|||
23518843|NCT00951665|65636366|FG003|Phase 2a|Withdrawal by Subject|0|||
23518844|NCT00951665|65636367|FG004|Phase 2a|Withdrawal by Subject|2|||
23518845|NCT00951665|65636368|FG005|Phase 2a|Withdrawal by Subject|0|||
23518846|NCT00951665|65636363|FG000|Phase 2a|Disease Progression|0|||
23518847|NCT00951665|65636364|FG001|Phase 2a|Disease Progression|0|||
23518848|NCT00951665|65636365|FG002|Phase 2a|Disease Progression|0|||
23518849|NCT00951665|65636366|FG003|Phase 2a|Disease Progression|0|||
23518850|NCT00951665|65636367|FG004|Phase 2a|Disease Progression|6|||
23518851|NCT00951665|65636368|FG005|Phase 2a|Disease Progression|5|||
23518852|NCT00840294|65636369|FG000|Overall Study|Withdrawal by Subject|2|||
23518853|NCT00840294|65636370|FG001|Overall Study|Withdrawal by Subject|1|||
23518854|NCT00840294|65636369|FG000|Overall Study|Protocol Violation|1|||
23518855|NCT00840294|65636370|FG001|Overall Study|Protocol Violation|3|||
23518856|NCT00840294|65636369|FG000|Overall Study|Illness|0|||
23518857|NCT00840294|65636370|FG001|Overall Study|Illness|1|||
23518858|NCT01909479|65636371|FG000|From Baseline to Week 26|Adverse Event|3|||
23712732|NCT03583372|66322291|FG002|Overall Study|Physician Decision|1|||
23712733|NCT03583372|66322292|FG003|Overall Study|Physician Decision|1|||
23712734|NCT03583372|66322289|FG000|Overall Study|Lack of Efficacy|0|||
23712735|NCT03583372|66322290|FG001|Overall Study|Lack of Efficacy|1|||
23712736|NCT03583372|66322291|FG002|Overall Study|Lack of Efficacy|0|||
23712737|NCT03583372|66322292|FG003|Overall Study|Lack of Efficacy|1|||
23712738|NCT03583372|66322289|FG000|Overall Study|Death|1|||
23712739|NCT03583372|66322290|FG001|Overall Study|Death|0|||
23712740|NCT03583372|66322291|FG002|Overall Study|Death|0|||
23712741|NCT03583372|66322292|FG003|Overall Study|Death|0|||
23712742|NCT03583372|66322289|FG000|Overall Study|Protocol Violation|0|||
23518859|NCT01909479|65636372|FG001|From Baseline to Week 26|Adverse Event|2|||
23518860|NCT01909479|65636371|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
23518861|NCT01909479|65636372|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
23712743|NCT03583372|66322290|FG001|Overall Study|Protocol Violation|1|||
23712744|NCT03583372|66322291|FG002|Overall Study|Protocol Violation|0|||
23712745|NCT03583372|66322292|FG003|Overall Study|Protocol Violation|0|||
23712746|NCT03583372|66322289|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
23712747|NCT03583372|66322290|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
23712748|NCT03583372|66322291|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
23712749|NCT03583372|66322292|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
23811994|NCT02516553|66691878|FG003|Overall Study|Progressive disease|5|||
23712750|NCT03583372|66322289|FG000|Overall Study|Did Not Receive Study Drug|0|||
23518862|NCT01909479|65636371|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
23712751|NCT03583372|66322290|FG001|Overall Study|Did Not Receive Study Drug|1|||
23712752|NCT03583372|66322291|FG002|Overall Study|Did Not Receive Study Drug|0|||
23712753|NCT03583372|66322292|FG003|Overall Study|Did Not Receive Study Drug|0|||
23712754|NCT03583372|66322289|FG000|Overall Study|Captured as Other in the Database|1|||
23712755|NCT03583372|66322290|FG001|Overall Study|Captured as Other in the Database|2|||
23712756|NCT03583372|66322291|FG002|Overall Study|Captured as Other in the Database|4|||
23712757|NCT03583372|66322292|FG003|Overall Study|Captured as Other in the Database|1|||
23712758|NCT00305253|66322298|FG000|Overall Study|Withdrawal by Subject|0|||
23712759|NCT00305253|66322299|FG001|Overall Study|Withdrawal by Subject|1|||
23712760|NCT01348425|66322303|FG000|Overall Study|Imaging was not taken.|1|||
23712761|NCT01348425|66322304|FG001|Overall Study|Imaging was not taken.|1|||
23712762|NCT01429792|66322305|FG000|Overall Study|Other Reasons|67|||
23712763|NCT01429792|66322305|FG000|Overall Study|Unknown Disposition|94|||
23712764|NCT01429792|66322305|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
23712765|NCT01429792|66322305|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
23712766|NCT01429792|66322305|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
23712767|NCT01429792|66322305|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
23712768|NCT01429792|66322305|FG000|Overall Study|Withdrawal by Subject|70|||
23712769|NCT01429792|66322305|FG000|Overall Study|Lost to Follow-up|88|||
23712770|NCT00789958|66322306|FG000|Overall Study|Adverse Event|3|||
23712771|NCT00789958|66322306|FG000|Overall Study|Withdrawal by Subject|4|||
23712772|NCT00789958|66322306|FG000|Overall Study|Progression|3|||
23712773|NCT00789958|66322306|FG000|Overall Study|not protocol specified|1|||
23712774|NCT00789958|66322306|FG000|Overall Study|Not eligible/not analyzable|26|||
23712775|NCT02062463|66322307|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
23712776|NCT02062463|66322308|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
23712777|NCT02062463|66322309|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
23712778|NCT02062463|66322310|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
23712779|NCT02062463|66322307|FG000|Stage 2|Adverse Event|0|||
23712780|NCT02062463|66322308|FG001|Stage 2|Adverse Event|0|||
23712781|NCT02062463|66322309|FG002|Stage 2|Adverse Event|12|||
23712782|NCT02062463|66322310|FG003|Stage 2|Adverse Event|20|||
23712783|NCT02062463|66322307|FG000|Stage 2|Lack of Efficacy|0|||
23712784|NCT02062463|66322308|FG001|Stage 2|Lack of Efficacy|0|||
23712785|NCT02062463|66322309|FG002|Stage 2|Lack of Efficacy|3|||
23712786|NCT02062463|66322310|FG003|Stage 2|Lack of Efficacy|4|||
23712787|NCT02062463|66322307|FG000|Stage 2|Lost to Follow-up|0|||
23712788|NCT02062463|66322308|FG001|Stage 2|Lost to Follow-up|0|||
23712789|NCT02062463|66322309|FG002|Stage 2|Lost to Follow-up|20|||
23712790|NCT02062463|66322310|FG003|Stage 2|Lost to Follow-up|20|||
23712791|NCT02062463|66322307|FG000|Stage 2|Non-Compliance|0|||
23712792|NCT02062463|66322308|FG001|Stage 2|Non-Compliance|0|||
23712793|NCT02062463|66322309|FG002|Stage 2|Non-Compliance|0|||
23712794|NCT02062463|66322310|FG003|Stage 2|Non-Compliance|1|||
23712795|NCT02062463|66322307|FG000|Stage 2|Other than specified|0|||
23712796|NCT02062463|66322308|FG001|Stage 2|Other than specified|0|||
23712797|NCT02062463|66322309|FG002|Stage 2|Other than specified|3|||
23712798|NCT02062463|66322310|FG003|Stage 2|Other than specified|1|||
23712799|NCT02062463|66322307|FG000|Stage 2|Withdrawal by Subject|0|||
23712800|NCT02062463|66322308|FG001|Stage 2|Withdrawal by Subject|0|||
23712801|NCT02062463|66322309|FG002|Stage 2|Withdrawal by Subject|15|||
23712802|NCT02062463|66322310|FG003|Stage 2|Withdrawal by Subject|10|||
23712803|NCT03225716|66322311|FG000|Overall Study|Withdrawal by Subject|2|||
23811995|NCT02516553|66691879|FG004|Overall Study|Progressive disease|3|||
23811996|NCT02516553|66691880|FG005|Overall Study|Progressive disease|0|||
23811997|NCT02516553|66691881|FG006|Overall Study|Progressive disease|5|||
23811998|NCT02516553|66691882|FG007|Overall Study|Progressive disease|5|||
23811999|NCT02516553|66691883|FG008|Overall Study|Progressive disease|11|||
23812000|NCT02516553|66691884|FG009|Overall Study|Progressive disease|3|||
23812001|NCT02516553|66691885|FG010|Overall Study|Progressive disease|10|||
23812002|NCT02516553|66691886|FG011|Overall Study|Progressive disease|8|||
23812003|NCT02516553|66691887|FG012|Overall Study|Progressive disease|8|||
23812004|NCT02516553|66691888|FG013|Overall Study|Progressive disease|2|||
23812005|NCT02516553|66691889|FG014|Overall Study|Progressive disease|2|||
23712804|NCT03225716|66322312|FG001|Overall Study|Withdrawal by Subject|2|||
23712805|NCT03225716|66322313|FG002|Overall Study|Withdrawal by Subject|0|||
23712806|NCT03225716|66322311|FG000|Overall Study|Lack of Efficacy|1|||
23812006|NCT02516553|66691890|FG015|Overall Study|Progressive disease|2|||
23812007|NCT02516553|66691891|FG016|Overall Study|Progressive disease|1|||
23812008|NCT02516553|66691892|FG017|Overall Study|Progressive disease|9|||
23712807|NCT03225716|66322312|FG001|Overall Study|Lack of Efficacy|0|||
23712808|NCT03225716|66322313|FG002|Overall Study|Lack of Efficacy|0|||
23712809|NCT03225716|66322311|FG000|Overall Study|Adverse Event|2|||
23812009|NCT02516553|66691893|FG018|Overall Study|Progressive disease|12|||
23712810|NCT03225716|66322312|FG001|Overall Study|Adverse Event|0|||
23712811|NCT03225716|66322313|FG002|Overall Study|Adverse Event|1|||
23712812|NCT03225716|66322311|FG000|Overall Study|Study early termination by Sponsor|0|||
23812010|NCT02516553|66691894|FG019|Overall Study|Progressive disease|7|||
23812011|NCT02516553|66691895|FG020|Overall Study|Progressive disease|16|||
23518863|NCT01909479|65636372|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
23518864|NCT01909479|65636371|FG000|26 - 52 Weeks|Adverse Event|0|||
23518865|NCT01909479|65636372|FG001|26 - 52 Weeks|Adverse Event|1|||
23518866|NCT01909479|65636371|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
23518867|NCT01909479|65636372|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
23518868|NCT01909479|65636371|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
23518869|NCT01909479|65636372|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
23518870|NCT01909479|65636371|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
23518871|NCT01909479|65636372|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
23518872|NCT01909479|65636371|FG000|52 Weeks to End of Study|Adverse Event|2|||
23518873|NCT01909479|65636372|FG001|52 Weeks to End of Study|Adverse Event|1|||
23518874|NCT01909479|65636371|FG000|52 Weeks to End of Study|Death|0|||
23518875|NCT01909479|65636372|FG001|52 Weeks to End of Study|Death|1|||
23518876|NCT01909479|65636371|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
23518877|NCT01909479|65636372|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
23518878|NCT01909479|65636371|FG000|52 Weeks to End of Study|Protocol Violation|1|||
23518879|NCT01909479|65636372|FG001|52 Weeks to End of Study|Protocol Violation|0|||
23518880|NCT01909479|65636371|FG000|52 Weeks to End of Study|Progressive disease|1|||
23518881|NCT01909479|65636372|FG001|52 Weeks to End of Study|Progressive disease|1|||
23518882|NCT01909479|65636371|FG000|52 Weeks to End of Study|Personal reasons|2|||
23518883|NCT01909479|65636372|FG001|52 Weeks to End of Study|Personal reasons|1|||
23518884|NCT01909479|65636371|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
23518885|NCT01909479|65636372|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
23518886|NCT01909479|65636371|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
23518887|NCT01909479|65636372|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
23518888|NCT01909479|65636371|FG000|52 Weeks to End of Study|Lack of contact|1|||
23518889|NCT01909479|65636372|FG001|52 Weeks to End of Study|Lack of contact|0|||
23518890|NCT01909479|65636371|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
23518891|NCT01909479|65636372|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
23518892|NCT01909479|65636371|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
23518893|NCT01909479|65636372|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
23518894|NCT02016482|65636373|FG000|Period A|Adverse Event|3|||
23518895|NCT02016482|65636374|FG001|Period A|Adverse Event|5|||
23712813|NCT03225716|66322312|FG001|Overall Study|Study early termination by Sponsor|0|||
23712814|NCT03225716|66322313|FG002|Overall Study|Study early termination by Sponsor|2|||
23712815|NCT00946881|66322314|FG000|First Treatment|Withdrawal by Subject|1|||
23712816|NCT00946881|66322314|FG000|First Treatment|Patient relocated to another state|1|||
23712817|NCT00946881|66322314|FG000|Retreatment|Withdrawal by Subject|1|||
23712818|NCT01019486|66322316|FG000|Overall Study|Withdrawal by Subject|1|||
23712819|NCT01019486|66322317|FG001|Overall Study|Withdrawal by Subject|1|||
23712820|NCT01019486|66322318|FG002|Overall Study|Withdrawal by Subject|1|||
23518896|NCT02016482|65636373|FG000|Period A|Withdrawal by Subject|3|||
23518897|NCT02016482|65636374|FG001|Period A|Withdrawal by Subject|4|||
23518898|NCT02016482|65636373|FG000|Period A|Lost to Follow-up|3|||
23518899|NCT02016482|65636374|FG001|Period A|Lost to Follow-up|3|||
23518900|NCT02016482|65636373|FG000|Period A|Lack of Efficacy|2|||
23518901|NCT02016482|65636374|FG001|Period A|Lack of Efficacy|1|||
23518902|NCT02016482|65636373|FG000|Period A|Other|3|||
23518903|NCT02016482|65636374|FG001|Period A|Other|0|||
23518904|NCT02016482|65636373|FG000|Period A|Protocol Violation|0|||
23518905|NCT02016482|65636374|FG001|Period A|Protocol Violation|1|||
23518906|NCT02016482|65636373|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
23712821|NCT01935336|66322319|FG000|Overall Study|Adverse Event|1|||
23712822|NCT01935336|66322320|FG001|Overall Study|Adverse Event|0|||
23712823|NCT01935336|66322321|FG002|Overall Study|Adverse Event|0|||
23712824|NCT01935336|66322322|FG003|Overall Study|Adverse Event|0|||
23712825|NCT01935336|66322319|FG000|Overall Study|Progressive disease|5|||
23712826|NCT01935336|66322320|FG001|Overall Study|Progressive disease|3|||
23712827|NCT01935336|66322321|FG002|Overall Study|Progressive disease|47|||
23712828|NCT01935336|66322322|FG003|Overall Study|Progressive disease|66|||
23712829|NCT00315705|66322325|FG000|Phase 1|Refused further treatment|1|||
23712830|NCT00315705|66322325|FG000|Phase 1|Failure to achieve response|8|||
23712831|NCT00315705|66322325|FG000|Phase 1|Disease relapse|4|||
23712832|NCT00315705|66322325|FG000|Phase 1|Scheduled for transplant|9|||
23518907|NCT02016482|65636374|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
23518908|NCT02016482|65636373|FG000|Period B|Withdrawal by Subject|1|||
23518909|NCT02016482|65636374|FG001|Period B|Withdrawal by Subject|1|||
23712833|NCT00315705|66322325|FG000|Phase 1|Death|3|||
23712834|NCT00315705|66322325|FG000|Phase 2|Physician Decision|4|||
23712835|NCT00315705|66322325|FG000|Phase 2|Adverse Event|1|||
23712836|NCT00315705|66322325|FG000|Phase 2|Failure to achieve response|3|||
23712837|NCT00315705|66322325|FG000|Phase 2|Disease relapse|1|||
23518910|NCT02016482|65636373|FG000|Period B|Lost to Follow-up|2|||
23712838|NCT00315705|66322325|FG000|Phase 2|Scheduled for transplant|8|||
23712839|NCT00315705|66322325|FG000|Phase 2|Other|1|||
23712840|NCT00315705|66322325|FG000|Phase 2|Death|7|||
23712841|NCT04831515|66322331|FG000|First Intervention|Adverse Event|0|||
23712842|NCT04831515|66322332|FG001|First Intervention|Adverse Event|1|||
23712843|NCT00393913|66322335|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
23712844|NCT00393913|66322335|FG000|Initial Assessment|Withdrawal by Subject|16|||
23712845|NCT00393913|66322335|FG000|CPAP|Withdrawal by Subject|3|||
23712846|NCT00393913|66322335|FG000|CPAP|Physician Decision|1|||
23712847|NCT00393913|66322335|FG000|CPAP|TEchnical problem with CPAP|3|||
23712848|NCT01934894|66322336|FG000|Overall Study|Adverse Event|1|||
23712849|NCT01934894|66322337|FG001|Overall Study|Adverse Event|2|||
23712850|NCT01934894|66322336|FG000|Overall Study|Death|2|||
23712851|NCT01934894|66322337|FG001|Overall Study|Death|0|||
23712852|NCT01934894|66322336|FG000|Overall Study|Withdrawal by Subject|0|||
23712853|NCT01934894|66322337|FG001|Overall Study|Withdrawal by Subject|1|||
23712854|NCT01934894|66322336|FG000|Overall Study|Progressive Disease|3|||
23712855|NCT01934894|66322337|FG001|Overall Study|Progressive Disease|2|||
23712856|NCT01778127|66322342|FG000|Overall Study|Lost to Follow-up|5|||
23712857|NCT01778127|66322343|FG001|Overall Study|Lost to Follow-up|1|||
23712858|NCT01778127|66322344|FG002|Overall Study|Lost to Follow-up|2|||
23712859|NCT01778127|66322342|FG000|Overall Study|Withdrawal by Subject|3|||
23712860|NCT01778127|66322343|FG001|Overall Study|Withdrawal by Subject|1|||
23712861|NCT01778127|66322344|FG002|Overall Study|Withdrawal by Subject|4|||
23712862|NCT02237157|66322345|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
23712863|NCT02237157|66322346|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23518911|NCT02016482|65636374|FG001|Period B|Lost to Follow-up|0|||
23518912|NCT02016482|65636373|FG000|Period B|Lack of Efficacy|6|||
23518913|NCT02016482|65636374|FG001|Period B|Lack of Efficacy|4|||
23518914|NCT02016482|65636373|FG000|Period B|Other|4|||
23518915|NCT02016482|65636374|FG001|Period B|Other|0|||
23518916|NCT02016482|65636373|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
23518917|NCT02016482|65636374|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
23518918|NCT02232425|65636381|FG000|Overall Study|Lost to Follow-up|6|||
23518919|NCT02232425|65636382|FG001|Overall Study|Lost to Follow-up|2|||
23518920|NCT02232425|65636381|FG000|Overall Study|Adverse Event|2|||
23518921|NCT02232425|65636382|FG001|Overall Study|Adverse Event|0|||
23518922|NCT02232425|65636381|FG000|Overall Study|Withdrawal by Subject|5|||
23518923|NCT02232425|65636382|FG001|Overall Study|Withdrawal by Subject|6|||
23518924|NCT02232425|65636381|FG000|Overall Study|Lack of Efficacy|1|||
23518925|NCT02232425|65636382|FG001|Overall Study|Lack of Efficacy|0|||
23518926|NCT00704535|65636383|FG000|Overall Study|Adverse Event|2|||
23518927|NCT00704535|65636383|FG000|Overall Study|Death|2|||
23518928|NCT00704535|65636383|FG000|Overall Study|Lost to Follow-up|8|||
23518929|NCT00704535|65636383|FG000|Overall Study|Protocol Violation|10|||
23518930|NCT00704535|65636383|FG000|Overall Study|Completed status not on Case Report Form|124|||
23518931|NCT01077804|65636388|FG000|Overall Study|Unreachable|102|||
23518932|NCT01077804|65636388|FG000|Overall Study|Refused to continue|79|||
23518933|NCT01077804|65636388|FG000|Overall Study|Other|18|||
23518934|NCT03316885|65636389|FG000|Overall Study|Adverse Event|1|||
23518935|NCT03316885|65636389|FG000|Overall Study|Death|10|||
23518936|NCT03316885|65636389|FG000|Overall Study|Lost to Follow-up|4|||
23518937|NCT03316885|65636389|FG000|Overall Study|Withdrawal by Subject|9|||
23518938|NCT03316885|65636389|FG000|Overall Study|COVID related|8|||
23518939|NCT01782664|65636395|FG000|Overall Study|Adverse Event|2|||
23518940|NCT01782664|65636396|FG001|Overall Study|Adverse Event|2|||
23518941|NCT01782664|65636397|FG002|Overall Study|Adverse Event|2|||
23518942|NCT01782664|65636398|FG003|Overall Study|Adverse Event|2|||
23518943|NCT01782664|65636399|FG004|Overall Study|Adverse Event|0|||
23518944|NCT01782664|65636400|FG005|Overall Study|Adverse Event|0|||
23518945|NCT01782664|65636395|FG000|Overall Study|Lack of Efficacy|2|||
23518946|NCT01782664|65636396|FG001|Overall Study|Lack of Efficacy|0|||
23518947|NCT01782664|65636397|FG002|Overall Study|Lack of Efficacy|2|||
23518948|NCT01782664|65636398|FG003|Overall Study|Lack of Efficacy|2|||
23518949|NCT01782664|65636399|FG004|Overall Study|Lack of Efficacy|0|||
23518950|NCT01782664|65636400|FG005|Overall Study|Lack of Efficacy|0|||
23518951|NCT01782664|65636395|FG000|Overall Study|Protocol Violation|0|||
23518952|NCT01782664|65636396|FG001|Overall Study|Protocol Violation|1|||
23518953|NCT01782664|65636397|FG002|Overall Study|Protocol Violation|0|||
23712864|NCT02237157|66322347|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23518954|NCT01782664|65636398|FG003|Overall Study|Protocol Violation|1|||
23518955|NCT01782664|65636399|FG004|Overall Study|Protocol Violation|0|||
23518956|NCT01782664|65636400|FG005|Overall Study|Protocol Violation|0|||
23712865|NCT02237157|66322348|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23712866|NCT02237157|66322345|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
23712867|NCT02237157|66322346|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23812012|NCT02516553|66691896|FG021|Overall Study|Progressive disease|18|||
23518957|NCT01782664|65636395|FG000|Overall Study|Withdrawal by Subject|2|||
23518958|NCT01782664|65636396|FG001|Overall Study|Withdrawal by Subject|2|||
23518959|NCT01782664|65636397|FG002|Overall Study|Withdrawal by Subject|0|||
23518960|NCT01782664|65636398|FG003|Overall Study|Withdrawal by Subject|0|||
23518961|NCT01782664|65636399|FG004|Overall Study|Withdrawal by Subject|0|||
23518962|NCT01782664|65636400|FG005|Overall Study|Withdrawal by Subject|0|||
23518963|NCT02406651|65636401|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
23518964|NCT02009046|65636402|FG000|Overall Study|Lost to Follow-up|256|||
23518965|NCT02009046|65636403|FG001|Overall Study|Lost to Follow-up|206|||
23518966|NCT00075582|65636406|FG000|Overall Study|Adverse Event|3|||
23518967|NCT00075582|65636407|FG001|Overall Study|Adverse Event|1|||
23518968|NCT00075582|65636406|FG000|Overall Study|Lack of Efficacy|4|||
23518969|NCT00075582|65636407|FG001|Overall Study|Lack of Efficacy|8|||
23518970|NCT00075582|65636406|FG000|Overall Study|Physician Decision|5|||
23518971|NCT00075582|65636407|FG001|Overall Study|Physician Decision|8|||
23712868|NCT02237157|66322347|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23712869|NCT02237157|66322348|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23518972|NCT00075582|65636406|FG000|Overall Study|Withdrawal by Subject|2|||
23518973|NCT00075582|65636407|FG001|Overall Study|Withdrawal by Subject|2|||
23518974|NCT00075582|65636406|FG000|Overall Study|Ineligible for study|36|||
23518975|NCT00075582|65636407|FG001|Overall Study|Ineligible for study|16|||
23518976|NCT01990495|65636408|FG000|Overall Study|Physician Decision|5|||
23518977|NCT01990495|65636409|FG001|Overall Study|Physician Decision|4|||
23518978|NCT01955161|65636410|FG000|Overall Study|Withdrawal before treatment|2|||
23518979|NCT01955161|65636411|FG001|Overall Study|Withdrawal before treatment|0|||
23518980|NCT01955161|65636412|FG002|Overall Study|Withdrawal before treatment|1|||
23518981|NCT01955161|65636410|FG000|Overall Study|Adverse Event|10|||
23518982|NCT01955161|65636411|FG001|Overall Study|Adverse Event|14|||
23518983|NCT01955161|65636412|FG002|Overall Study|Adverse Event|15|||
23518984|NCT01955161|65636410|FG000|Overall Study|Death|1|||
23518985|NCT01955161|65636411|FG001|Overall Study|Death|1|||
23518986|NCT01955161|65636412|FG002|Overall Study|Death|3|||
23518987|NCT01955161|65636410|FG000|Overall Study|Withdrawal by Subject|9|||
23518988|NCT01955161|65636411|FG001|Overall Study|Withdrawal by Subject|8|||
23518989|NCT01955161|65636412|FG002|Overall Study|Withdrawal by Subject|12|||
23518990|NCT01955161|65636410|FG000|Overall Study|Protocol Violation|2|||
23518991|NCT01955161|65636411|FG001|Overall Study|Protocol Violation|0|||
23518992|NCT01955161|65636412|FG002|Overall Study|Protocol Violation|0|||
23518993|NCT01955161|65636410|FG000|Overall Study|Other reason: physician decision|0|||
23518994|NCT01955161|65636411|FG001|Overall Study|Other reason: physician decision|1|||
23518995|NCT01955161|65636412|FG002|Overall Study|Other reason: physician decision|1|||
23518996|NCT01955161|65636410|FG000|Overall Study|Other reason: disallowed medication|1|||
23518997|NCT01955161|65636411|FG001|Overall Study|Other reason: disallowed medication|0|||
23518998|NCT01955161|65636412|FG002|Overall Study|Other reason: disallowed medication|1|||
23518999|NCT01955161|65636410|FG000|Overall Study|Other reason: caregiver unavailable|1|||
23519000|NCT01955161|65636411|FG001|Overall Study|Other reason: caregiver unavailable|0|||
23519001|NCT01955161|65636412|FG002|Overall Study|Other reason: caregiver unavailable|0|||
23519002|NCT01955161|65636410|FG000|Overall Study|Other reason: moved to nursing home|0|||
23519003|NCT01955161|65636411|FG001|Overall Study|Other reason: moved to nursing home|1|||
23712870|NCT02358369|66322349|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
23416206|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
23519004|NCT01955161|65636412|FG002|Overall Study|Other reason: moved to nursing home|0|||
23519005|NCT01955161|65636410|FG000|Overall Study|Other reason: insufficient compliance|0|||
23519006|NCT01955161|65636411|FG001|Overall Study|Other reason: insufficient compliance|0|||
23519007|NCT01955161|65636412|FG002|Overall Study|Other reason: insufficient compliance|1|||
23519008|NCT01955161|65636410|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
23519009|NCT01955161|65636411|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
23519010|NCT01955161|65636412|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
23519011|NCT01955161|65636410|FG000|Overall Study|Other reason: patient's will|0|||
23519012|NCT01955161|65636411|FG001|Overall Study|Other reason: patient's will|0|||
23519013|NCT01955161|65636412|FG002|Overall Study|Other reason: patient's will|1|||
23519014|NCT02574247|65636415|FG000|Overall Study|Withdrawal by Subject|1|||
23519015|NCT02574247|65636416|FG001|Overall Study|Withdrawal by Subject|0|||
23519016|NCT02574247|65636417|FG002|Overall Study|Withdrawal by Subject|0|||
23519017|NCT02574247|65636415|FG000|Overall Study|Did not meet inclusion criteria|4|||
23519018|NCT02574247|65636416|FG001|Overall Study|Did not meet inclusion criteria|3|||
23519019|NCT02574247|65636417|FG002|Overall Study|Did not meet inclusion criteria|5|||
23519020|NCT00281684|65636419|FG000|Overall Study|Lost to Follow-up|0|||
23519021|NCT00281684|65636420|FG001|Overall Study|Lost to Follow-up|0|||
23519022|NCT00281684|65636421|FG002|Overall Study|Lost to Follow-up|1|||
23519023|NCT00281684|65636422|FG003|Overall Study|Lost to Follow-up|0|||
23519024|NCT00281684|65636419|FG000|Overall Study|Withdrawal by Subject|1|||
23519025|NCT00281684|65636420|FG001|Overall Study|Withdrawal by Subject|0|||
23519026|NCT00281684|65636421|FG002|Overall Study|Withdrawal by Subject|0|||
23519027|NCT00281684|65636422|FG003|Overall Study|Withdrawal by Subject|0|||
23519028|NCT04339296|65636423|FG000|Overall Study|Refuse to participate after allocation|1|||
23519029|NCT04339296|65636424|FG001|Overall Study|Refuse to participate after allocation|1|||
23519030|NCT04339296|65636423|FG000|Overall Study|Withdrew after completion of baseline|2|||
23519031|NCT04339296|65636424|FG001|Overall Study|Withdrew after completion of baseline|1|||
23712871|NCT02358369|66322350|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23712872|NCT02358369|66322351|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23712873|NCT02358369|66322352|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23712874|NCT02358369|66322353|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23712875|NCT02358369|66322349|FG000|Treatment Period A/B|Adverse Event|0|||
23712876|NCT02358369|66322350|FG001|Treatment Period A/B|Adverse Event|0|||
23712877|NCT02358369|66322351|FG002|Treatment Period A/B|Adverse Event|1|||
23712878|NCT02358369|66322352|FG003|Treatment Period A/B|Adverse Event|2|||
23712879|NCT02358369|66322353|FG004|Treatment Period A/B|Adverse Event|0|||
23712880|NCT02358369|66322349|FG000|Treatment Period A/B|Death|0|||
23712881|NCT02358369|66322350|FG001|Treatment Period A/B|Death|0|||
23712882|NCT02358369|66322351|FG002|Treatment Period A/B|Death|1|||
23712883|NCT02358369|66322352|FG003|Treatment Period A/B|Death|0|||
23712884|NCT02358369|66322353|FG004|Treatment Period A/B|Death|0|||
23712885|NCT02358369|66322349|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
23712886|NCT02358369|66322350|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
23519032|NCT04339296|65636423|FG000|Overall Study|Lost to Follow-up|0|||
23519033|NCT04339296|65636424|FG001|Overall Study|Lost to Follow-up|4|||
23519034|NCT04339296|65636423|FG000|Overall Study|Discontinued intervention|5|||
23519035|NCT04339296|65636424|FG001|Overall Study|Discontinued intervention|3|||
23519036|NCT00930579|65636425|FG000|Overall Study|Withdrawal by Subject|1|||
23519037|NCT00930579|65636425|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
23519038|NCT03839212|65636426|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
23519039|NCT03717480|65636427|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
23519040|NCT02066467|65636428|FG000|Overall Study|Did not undergo implant procedure|24|||
23519041|NCT02066467|65636428|FG000|Overall Study|Attempted to implant withoput success|43|||
23519042|NCT02066467|65636428|FG000|Overall Study|Consent ineligible|1|||
23519043|NCT02066467|65636428|FG000|Overall Study|Death|54|||
23519044|NCT02066467|65636428|FG000|Overall Study|Lost to Follow-up|51|||
23519045|NCT02066467|65636428|FG000|Overall Study|Adverse Event|20|||
23519046|NCT02066467|65636428|FG000|Overall Study|Withdrawal by Subject|16|||
23519047|NCT02066467|65636428|FG000|Overall Study|Physician Decision|2|||
23519048|NCT02066467|65636428|FG000|Overall Study|Not defined|4|||
23519049|NCT00736723|65636429|FG000|Overall Study|Withdrawal by Subject|4|||
23519050|NCT00736723|65636430|FG001|Overall Study|Withdrawal by Subject|3|||
23519051|NCT01132547|65639844|FG000|Overall Study|Withdrawal by Subject|3|||
23519052|NCT01132547|65639845|FG001|Overall Study|Withdrawal by Subject|1|||
23519053|NCT01132547|65639844|FG000|Overall Study|Death|1|||
23519054|NCT01132547|65639845|FG001|Overall Study|Death|0|||
23519055|NCT00613015|65639846|FG000|Overall Study|Lost to Follow-up|0|||
23519056|NCT00613015|65639847|FG001|Overall Study|Lost to Follow-up|1|||
23519057|NCT00613015|65639848|FG002|Overall Study|Lost to Follow-up|3|||
23519058|NCT00613015|65639849|FG003|Overall Study|Lost to Follow-up|3|||
23519059|NCT00613015|65639850|FG004|Overall Study|Lost to Follow-up|2|||
23519060|NCT00613015|65639851|FG005|Overall Study|Lost to Follow-up|3|||
23519061|NCT00811577|65639852|FG000|Overall Study|Lost to Follow-up|7|||
23519062|NCT00811577|65639853|FG001|Overall Study|Lost to Follow-up|1|||
23519063|NCT00811577|65639852|FG000|Overall Study|Withdrawal by Subject|3|||
23519064|NCT00811577|65639853|FG001|Overall Study|Withdrawal by Subject|0|||
23519065|NCT00329407|65639857|FG000|Overall Study|Withdrawal by Subject|1|||
23519066|NCT00335972|65639858|FG000|Overall Study|not given treatments|0|||
23519067|NCT00335972|65639859|FG001|Overall Study|not given treatments|3|||
23519068|NCT01288287|65639860|FG000|Overall Study|Lost to Follow-up|8|||
23519069|NCT01288287|65639860|FG000|Overall Study|Withdrawal by Subject|4|||
23519070|NCT01288287|65639860|FG000|Overall Study|Lack of Efficacy|13|||
23519071|NCT01288287|65639860|FG000|Overall Study|Other Reason|13|||
23712887|NCT02358369|66322351|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
23712888|NCT02358369|66322352|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
23712889|NCT02358369|66322353|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
23712890|NCT02358369|66322349|FG000|Treatment Period C|Adverse Event|0|||
23712891|NCT02358369|66322350|FG001|Treatment Period C|Adverse Event|0|||
23712892|NCT02358369|66322351|FG002|Treatment Period C|Adverse Event|0|||
23712893|NCT02358369|66322352|FG003|Treatment Period C|Adverse Event|0|||
23712894|NCT02358369|66322353|FG004|Treatment Period C|Adverse Event|7|||
23712895|NCT01401465|66322354|FG000|Treatment Period 1|Adverse Event|4|||
23519072|NCT01288287|65639860|FG000|Overall Study|Unknown Reason|1|||
23712896|NCT01401465|66322355|FG001|Treatment Period 1|Adverse Event|1|||
23712897|NCT01401465|66322354|FG000|Treatment Period 1|Pregnancy|0|||
23712898|NCT01401465|66322355|FG001|Treatment Period 1|Pregnancy|1|||
23712899|NCT01401465|66322354|FG000|Treatment Period 1|Protocol Violation|5|||
23712900|NCT01401465|66322355|FG001|Treatment Period 1|Protocol Violation|0|||
23812013|NCT02516553|66691875|FG000|Overall Study|Dose limiting toxicity|0|||
23519073|NCT01288287|65639860|FG000|Overall Study|Unknown Status|7|||
23519074|NCT02750592|65639863|FG000|Overall Study|Adverse Event|3|||
23519075|NCT02750592|65639863|FG000|Overall Study|Lack of Efficacy|2|||
23519076|NCT03406858|65639864|FG000|Overall Study|Failure to receive treatment drug.|1|||
23712901|NCT01401465|66322354|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23712902|NCT01401465|66322355|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23712903|NCT01401465|66322354|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
23712904|NCT01401465|66322355|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
23712905|NCT01401465|66322354|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
23712906|NCT01401465|66322355|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
23712907|NCT01401465|66322354|FG000|Treatment Period 1|Scheduling Difficulties|1|||
23712908|NCT01401465|66322355|FG001|Treatment Period 1|Scheduling Difficulties|1|||
23712909|NCT01401465|66322354|FG000|Treatment Period 2|Lost to Follow-up|0|||
23712910|NCT01401465|66322355|FG001|Treatment Period 2|Lost to Follow-up|1|||
23712911|NCT01401465|66322354|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23712912|NCT01401465|66322355|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23712913|NCT01361919|66322356|FG000|Overall Study|technical issues|10|||
23712914|NCT01361919|66322357|FG001|Overall Study|technical issues|12|||
23712915|NCT01361919|66322358|FG002|Overall Study|technical issues|10|||
23712916|NCT01911845|66322359|FG000|Overall Study|Adverse Event|2|||
23712917|NCT01911845|66322359|FG000|Overall Study|Lost to Follow-up|1|||
23712918|NCT01911845|66322359|FG000|Overall Study|Other (not specified)|3|||
23712919|NCT04550221|66322360|FG000|Overall Study|Lost to Follow-up|0|||
23712920|NCT04550221|66322361|FG001|Overall Study|Lost to Follow-up|4|||
23712921|NCT04550221|66322360|FG000|Overall Study|Withdrawn|3|||
23712922|NCT04550221|66322361|FG001|Overall Study|Withdrawn|0|||
23712923|NCT04550221|66322360|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
23712924|NCT04550221|66322361|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
23712925|NCT03497429|66322364|FG000|Overall Study|Progressive disease|3|||
23712926|NCT03497429|66322365|FG001|Overall Study|Progressive disease|4|||
23712927|NCT03497429|66322364|FG000|Overall Study|Adverse Event|0|||
23712928|NCT03497429|66322365|FG001|Overall Study|Adverse Event|2|||
23712929|NCT02232087|66322367|FG000|Overall Study|Withdrawal by Subject|2|||
23712930|NCT02232087|66322368|FG001|Overall Study|Withdrawal by Subject|0|||
23712931|NCT02232087|66322369|FG002|Overall Study|Withdrawal by Subject|0|||
23712932|NCT02232087|66322370|FG003|Overall Study|Withdrawal by Subject|0|||
23712933|NCT02232087|66322371|FG004|Overall Study|Withdrawal by Subject|0|||
23712934|NCT02232087|66322372|FG005|Overall Study|Withdrawal by Subject|1|||
23712935|NCT02232087|66322367|FG000|Overall Study|poor inhalation technique|0|||
23712936|NCT02232087|66322368|FG001|Overall Study|poor inhalation technique|1|||
23519077|NCT03406858|65639864|FG000|Overall Study|ineligible|1|||
23519078|NCT02489344|65639865|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
23519079|NCT02489344|65639865|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
23519080|NCT02489344|65639865|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
23519081|NCT02489344|65639865|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
23519082|NCT01086540|65639870|FG000|Overall Study|Death|3|||
23519083|NCT01086540|65639871|FG001|Overall Study|Death|1|||
23519084|NCT01086540|65639870|FG000|Overall Study|Physician Decision|2|||
23519085|NCT01086540|65639871|FG001|Overall Study|Physician Decision|1|||
23519086|NCT01086540|65639870|FG000|Overall Study|Addition of new therapy for PAH|1|||
23519087|NCT01086540|65639871|FG001|Overall Study|Addition of new therapy for PAH|0|||
23519088|NCT01528254|65639872|FG000|Overall Study|Administrative problems|96|||
23519089|NCT01528254|65639873|FG001|Overall Study|Administrative problems|94|||
23519090|NCT01528254|65639872|FG000|Overall Study|Adverse Event|28|||
23519091|NCT01528254|65639873|FG001|Overall Study|Adverse Event|44|||
23519092|NCT01528254|65639872|FG000|Overall Study|Lost to Follow-up|17|||
23519093|NCT01528254|65639873|FG001|Overall Study|Lost to Follow-up|24|||
23519094|NCT01528254|65639872|FG000|Overall Study|Death|13|||
23519095|NCT01528254|65639873|FG001|Overall Study|Death|9|||
23519096|NCT01528254|65639872|FG000|Overall Study|Protocol deviation|9|||
23519097|NCT01528254|65639873|FG001|Overall Study|Protocol deviation|19|||
23519098|NCT01528254|65639872|FG000|Overall Study|New therapy for study indication|8|||
23519099|NCT01528254|65639873|FG001|Overall Study|New therapy for study indication|6|||
23519100|NCT01528254|65639872|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23519101|NCT01528254|65639873|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23519102|NCT01528254|65639872|FG000|Overall Study|Withdrawal by Subject|5|||
23519103|NCT01528254|65639873|FG001|Overall Study|Withdrawal by Subject|4|||
23519104|NCT01528254|65639872|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23519105|NCT01528254|65639873|FG001|Overall Study|Abnormal laboratory value(s)|7|||
23519106|NCT01528254|65639872|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23712937|NCT02232087|66322369|FG002|Overall Study|poor inhalation technique|0|||
23712938|NCT02232087|66322370|FG003|Overall Study|poor inhalation technique|0|||
23712939|NCT02232087|66322371|FG004|Overall Study|poor inhalation technique|0|||
23712940|NCT02232087|66322372|FG005|Overall Study|poor inhalation technique|2|||
23712941|NCT02232087|66322367|FG000|Overall Study|protocol stop criteria|0|||
23519107|NCT01528254|65639873|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23519108|NCT01528254|65639872|FG000|Overall Study|No longer requires study drug|1|||
23712942|NCT02232087|66322368|FG001|Overall Study|protocol stop criteria|1|||
23519109|NCT01528254|65639873|FG001|Overall Study|No longer requires study drug|1|||
23519110|NCT01614990|65639878|FG000|Overall Study|Protocol Violation|1|||
23519111|NCT01614990|65639879|FG001|Overall Study|Protocol Violation|1|||
23519112|NCT02268812|65639880|FG000|Overall Study|Adverse Event|8|||
23519113|NCT02268812|65639881|FG001|Overall Study|Adverse Event|26|||
23519114|NCT02268812|65639882|FG002|Overall Study|Adverse Event|7|||
23519115|NCT02268812|65639883|FG003|Overall Study|Adverse Event|10|||
23519116|NCT02268812|65639880|FG000|Overall Study|Protocol deviation|0|||
23519117|NCT02268812|65639881|FG001|Overall Study|Protocol deviation|0|||
23519118|NCT02268812|65639882|FG002|Overall Study|Protocol deviation|1|||
23519119|NCT02268812|65639883|FG003|Overall Study|Protocol deviation|0|||
23519120|NCT02268812|65639880|FG000|Overall Study|Withdrawal by Subject|0|||
23519121|NCT02268812|65639881|FG001|Overall Study|Withdrawal by Subject|1|||
23519122|NCT02268812|65639882|FG002|Overall Study|Withdrawal by Subject|0|||
23519123|NCT02268812|65639883|FG003|Overall Study|Withdrawal by Subject|0|||
23519124|NCT02268812|65639880|FG000|Overall Study|Physician Decision|3|||
23519125|NCT02268812|65639881|FG001|Overall Study|Physician Decision|1|||
23519126|NCT02268812|65639882|FG002|Overall Study|Physician Decision|0|||
23519127|NCT02268812|65639883|FG003|Overall Study|Physician Decision|1|||
23519128|NCT02268812|65639880|FG000|Overall Study|Other|5|||
23519129|NCT02268812|65639881|FG001|Overall Study|Other|4|||
23519130|NCT02268812|65639882|FG002|Overall Study|Other|1|||
23519131|NCT02268812|65639883|FG003|Overall Study|Other|3|||
23519132|NCT03774433|65639884|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
23519133|NCT01852942|65639885|FG000|Overall Study|Physician Decision|1|||
23519134|NCT01852942|65639886|FG001|Overall Study|Physician Decision|0|||
23519135|NCT01852942|65639885|FG000|Overall Study|Death|1|||
23519136|NCT01852942|65639886|FG001|Overall Study|Death|1|||
23519137|NCT01852942|65639885|FG000|Overall Study|Withdrawal by Subject|2|||
23519138|NCT01852942|65639886|FG001|Overall Study|Withdrawal by Subject|3|||
23519139|NCT01852942|65639885|FG000|Overall Study|Lost to Follow-up|1|||
23519140|NCT01852942|65639886|FG001|Overall Study|Lost to Follow-up|2|||
23519141|NCT03571581|65639887|FG000|Overall Study|Death|2|||
23519142|NCT03571581|65639887|FG000|Overall Study|Withdrawal by Subject|2|||
23519143|NCT02345811|65639889|FG000|First Intervention|Withdrawal by Subject|1|||
23519144|NCT02345811|65639890|FG001|First Intervention|Withdrawal by Subject|1|||
23519145|NCT02419742|65639893|FG000|Overall Study|Adverse Event|2|||
23519146|NCT02419742|65639894|FG001|Overall Study|Adverse Event|0|||
23519147|NCT02419742|65639893|FG000|Overall Study|Disease Progression|0|||
23519148|NCT02419742|65639894|FG001|Overall Study|Disease Progression|1|||
23519149|NCT02419742|65639893|FG000|Overall Study|Withdrew Consent|2|||
23519150|NCT02419742|65639894|FG001|Overall Study|Withdrew Consent|1|||
23519151|NCT02419742|65639893|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
23519152|NCT02419742|65639894|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
23519153|NCT01288911|65639895|FG000|Double-blind Period|Death|11|||
23519154|NCT01288911|65639896|FG001|Double-blind Period|Death|7|||
23519155|NCT01288911|65639895|FG000|Double-blind Period|Lost to Follow-up|0|||
23519156|NCT01288911|65639896|FG001|Double-blind Period|Lost to Follow-up|2|||
23519157|NCT01288911|65639895|FG000|Double-blind Period|Progressive Disease|75|||
23519158|NCT01288911|65639896|FG001|Double-blind Period|Progressive Disease|103|||
23519159|NCT01288911|65639895|FG000|Double-blind Period|Protocol Violation|1|||
23519160|NCT01288911|65639896|FG001|Double-blind Period|Protocol Violation|0|||
23519161|NCT01288911|65639895|FG000|Double-blind Period|Withdrawal by Subject|25|||
23519162|NCT01288911|65639896|FG001|Double-blind Period|Withdrawal by Subject|26|||
23519163|NCT01288911|65639895|FG000|Double-blind Period|Miscellaneous Reason|29|||
23519164|NCT01288911|65639896|FG001|Double-blind Period|Miscellaneous Reason|42|||
23519165|NCT01288911|65639895|FG000|Double-blind Period|Randomized but never received study drug|1|||
23519166|NCT01288911|65639896|FG001|Double-blind Period|Randomized but never received study drug|2|||
23519167|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Death|0|||
23519168|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Death|1|||
23519169|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
23519170|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
23519171|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
23519172|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
23519173|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
23519174|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
23519175|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
23519176|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
23519177|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
23519178|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
23519179|NCT02784821|65639897|FG000|Overall Study|Death|0|||
23519180|NCT02784821|65639898|FG001|Overall Study|Death|5|||
23519181|NCT02784821|65639899|FG002|Overall Study|Death|4|||
23519182|NCT02784821|65639900|FG003|Overall Study|Death|5|||
23519183|NCT01173718|65639909|FG000|Overall Study|Death|17|||
23519184|NCT01173718|65639909|FG000|Overall Study|Abandonment of study graft|27|||
23519185|NCT00923559|65639910|FG000|Overall Study|Lost to Follow-up|2|||
23519186|NCT00923559|65639911|FG001|Overall Study|Lost to Follow-up|3|||
23519187|NCT01998737|65639913|FG000|Overall Study|Corrupted database|23|||
23712943|NCT02232087|66322369|FG002|Overall Study|protocol stop criteria|0|||
23712944|NCT02232087|66322370|FG003|Overall Study|protocol stop criteria|1|||
23712945|NCT02232087|66322371|FG004|Overall Study|protocol stop criteria|0|||
23712946|NCT02232087|66322372|FG005|Overall Study|protocol stop criteria|0|||
23712947|NCT02232087|66322367|FG000|Overall Study|Adverse Event|0|||
23712948|NCT02232087|66322368|FG001|Overall Study|Adverse Event|0|||
23712949|NCT02232087|66322369|FG002|Overall Study|Adverse Event|0|||
23712950|NCT02232087|66322370|FG003|Overall Study|Adverse Event|0|||
23712951|NCT02232087|66322371|FG004|Overall Study|Adverse Event|1|||
23712952|NCT02232087|66322372|FG005|Overall Study|Adverse Event|0|||
23712953|NCT00254293|66322377|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23712954|NCT00254293|66322378|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
23712955|NCT00254293|66322379|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23712956|NCT00254293|66322380|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
23712957|NCT00254293|66322381|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23712958|NCT00254293|66322382|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23712959|NCT00254293|66322383|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23712960|NCT00254293|66322377|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712961|NCT00254293|66322378|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712962|NCT00254293|66322379|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
23712963|NCT00254293|66322380|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712964|NCT00254293|66322381|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712965|NCT00254293|66322382|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712966|NCT00254293|66322383|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23712967|NCT00254293|66322377|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712968|NCT00254293|66322378|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712969|NCT00254293|66322379|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
23712970|NCT00254293|66322380|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712971|NCT00254293|66322381|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712972|NCT00254293|66322382|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712973|NCT00254293|66322383|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23712974|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Death|0|||
23712975|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Death|0|||
23712976|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Death|1|||
23712977|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Death|0|||
23712978|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Death|0|||
23712979|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Death|0|||
23712980|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Death|0|||
23712981|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
23712982|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23712983|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
23712984|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23712985|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
23712986|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23712987|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23712988|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
23712989|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23712990|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
23712991|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23712992|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
23712993|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23712994|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23519188|NCT01998737|65639914|FG001|Overall Study|Corrupted database|0|||
23712995|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23712996|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23712997|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
23712998|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23712999|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23713000|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23519189|NCT01644175|65639917|FG000|Overall Study|Randomized But Not Treated|0|||
23519190|NCT01644175|65639918|FG001|Overall Study|Randomized But Not Treated|2|||
23713001|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23713002|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713003|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713004|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
23713005|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713006|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713007|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713008|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23713009|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713010|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713011|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
23713012|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713013|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713014|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713015|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23713016|NCT00254293|66322377|FG000|LTE Open Label Variable SC Dosing|Other|0|||
23713017|NCT00254293|66322378|FG001|LTE Open Label Variable SC Dosing|Other|0|||
23519191|NCT01644175|65639917|FG000|Overall Study|Adverse Event|8|||
23519192|NCT01644175|65639918|FG001|Overall Study|Adverse Event|13|||
23519193|NCT01644175|65639917|FG000|Overall Study|Death|1|||
23519194|NCT01644175|65639918|FG001|Overall Study|Death|2|||
23519195|NCT01644175|65639917|FG000|Overall Study|Poor compliance to protocol|9|||
23519196|NCT01644175|65639918|FG001|Overall Study|Poor compliance to protocol|10|||
23713018|NCT00254293|66322379|FG002|LTE Open Label Variable SC Dosing|Other|2|||
23713019|NCT00254293|66322380|FG003|LTE Open Label Variable SC Dosing|Other|0|||
23713020|NCT00254293|66322381|FG004|LTE Open Label Variable SC Dosing|Other|0|||
23713021|NCT00254293|66322382|FG005|LTE Open Label Variable SC Dosing|Other|0|||
23713022|NCT00254293|66322383|FG006|LTE Open Label Variable SC Dosing|Other|0|||
23713023|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Death|0|||
23713024|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Death|0|||
23713025|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Death|0|||
23713026|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Death|0|||
23713027|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Death|0|||
23713028|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Death|0|||
23713029|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Death|3|||
23713030|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713031|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713032|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713033|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713034|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713035|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
23713036|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
23713037|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713038|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713039|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713040|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713041|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713042|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23713043|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
23713044|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713045|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713046|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713047|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713048|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713049|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23713050|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
23713051|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23713052|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23713053|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23713054|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23713055|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23713056|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23519197|NCT01644175|65639917|FG000|Overall Study|Physician Decision|1|||
23519198|NCT01644175|65639918|FG001|Overall Study|Physician Decision|2|||
23713057|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
23713058|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23713059|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23713060|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23713061|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23519199|NCT01644175|65639917|FG000|Overall Study|Participant Moved|1|||
23519200|NCT01644175|65639918|FG001|Overall Study|Participant Moved|2|||
23713062|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23713063|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23713064|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
23713065|NCT00254293|66322377|FG000|LTE Open Label Fixed Dosing|Other|0|||
23713066|NCT00254293|66322378|FG001|LTE Open Label Fixed Dosing|Other|0|||
23713067|NCT00254293|66322379|FG002|LTE Open Label Fixed Dosing|Other|0|||
23713068|NCT00254293|66322380|FG003|LTE Open Label Fixed Dosing|Other|0|||
23713069|NCT00254293|66322381|FG004|LTE Open Label Fixed Dosing|Other|0|||
23713070|NCT00254293|66322382|FG005|LTE Open Label Fixed Dosing|Other|0|||
23713071|NCT00254293|66322383|FG006|LTE Open Label Fixed Dosing|Other|1|||
23713072|NCT01623531|66322386|FG000|Overall Study|Death|1|||
23713073|NCT01623531|66322387|FG001|Overall Study|Death|0|||
23713074|NCT01623531|66322386|FG000|Overall Study|Protocol Violation|2|||
23713075|NCT01623531|66322387|FG001|Overall Study|Protocol Violation|1|||
23713076|NCT01623531|66322386|FG000|Overall Study|Missing data at primary outcome time poi|1|||
23713077|NCT01623531|66322387|FG001|Overall Study|Missing data at primary outcome time poi|1|||
23713078|NCT03115476|66322391|FG000|LP0084-1369|Death|1|||
23713079|NCT03115476|66322392|FG001|LP0084-1369|Death|0|||
23713080|NCT03115476|66322393|FG002|LP0084-1369|Death|2|||
23713081|NCT03115476|66322391|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
23713082|NCT03115476|66322392|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
23713083|NCT03115476|66322393|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
23713084|NCT04017442|66322401|FG000|Overall Study|Withdrawal by Subject|0|||
23713085|NCT04017442|66322402|FG001|Overall Study|Withdrawal by Subject|3|||
23713086|NCT04017442|66322401|FG000|Overall Study|Lost to Follow-up|21|||
23713087|NCT04017442|66322402|FG001|Overall Study|Lost to Follow-up|19|||
23713088|NCT00064350|66322403|FG000|Induction Treatment|Disease Progression|5|||
23713089|NCT00064350|66322404|FG001|Induction Treatment|Disease Progression|1|||
23713090|NCT00064350|66322405|FG002|Induction Treatment|Disease Progression|110|||
23713091|NCT00064350|66322403|FG000|Induction Treatment|Adverse Event|0|||
23713092|NCT00064350|66322404|FG001|Induction Treatment|Adverse Event|2|||
23713093|NCT00064350|66322405|FG002|Induction Treatment|Adverse Event|49|||
23812014|NCT02516553|66691876|FG001|Overall Study|Dose limiting toxicity|0|||
23812015|NCT02516553|66691877|FG002|Overall Study|Dose limiting toxicity|0|||
23812016|NCT02516553|66691878|FG003|Overall Study|Dose limiting toxicity|0|||
23812017|NCT02516553|66691879|FG004|Overall Study|Dose limiting toxicity|3|||
23812018|NCT02516553|66691880|FG005|Overall Study|Dose limiting toxicity|1|||
23812019|NCT02516553|66691881|FG006|Overall Study|Dose limiting toxicity|1|||
23812020|NCT02516553|66691882|FG007|Overall Study|Dose limiting toxicity|0|||
23812021|NCT02516553|66691883|FG008|Overall Study|Dose limiting toxicity|1|||
23812022|NCT02516553|66691884|FG009|Overall Study|Dose limiting toxicity|0|||
23812023|NCT02516553|66691885|FG010|Overall Study|Dose limiting toxicity|0|||
23812024|NCT02516553|66691886|FG011|Overall Study|Dose limiting toxicity|1|||
23812025|NCT02516553|66691887|FG012|Overall Study|Dose limiting toxicity|0|||
23812026|NCT02516553|66691888|FG013|Overall Study|Dose limiting toxicity|1|||
23812027|NCT02516553|66691889|FG014|Overall Study|Dose limiting toxicity|0|||
23812028|NCT02516553|66691890|FG015|Overall Study|Dose limiting toxicity|0|||
23812029|NCT02516553|66691891|FG016|Overall Study|Dose limiting toxicity|1|||
23812030|NCT02516553|66691892|FG017|Overall Study|Dose limiting toxicity|1|||
23812031|NCT02516553|66691893|FG018|Overall Study|Dose limiting toxicity|0|||
23812032|NCT02516553|66691894|FG019|Overall Study|Dose limiting toxicity|2|||
23812033|NCT02516553|66691895|FG020|Overall Study|Dose limiting toxicity|0|||
23812034|NCT02516553|66691896|FG021|Overall Study|Dose limiting toxicity|0|||
23812035|NCT02516553|66691875|FG000|Overall Study|Other Adverse Events|0|||
23812036|NCT02516553|66691876|FG001|Overall Study|Other Adverse Events|0|||
23812037|NCT02516553|66691877|FG002|Overall Study|Other Adverse Events|0|||
23812038|NCT02516553|66691878|FG003|Overall Study|Other Adverse Events|1|||
23812039|NCT02516553|66691879|FG004|Overall Study|Other Adverse Events|0|||
23812040|NCT02516553|66691880|FG005|Overall Study|Other Adverse Events|1|||
23812041|NCT02516553|66691881|FG006|Overall Study|Other Adverse Events|0|||
23812042|NCT02516553|66691882|FG007|Overall Study|Other Adverse Events|0|||
23812043|NCT02516553|66691883|FG008|Overall Study|Other Adverse Events|0|||
23812044|NCT02516553|66691884|FG009|Overall Study|Other Adverse Events|1|||
23812045|NCT02516553|66691885|FG010|Overall Study|Other Adverse Events|3|||
23812046|NCT02516553|66691886|FG011|Overall Study|Other Adverse Events|2|||
23812047|NCT02516553|66691887|FG012|Overall Study|Other Adverse Events|0|||
23812048|NCT02516553|66691888|FG013|Overall Study|Other Adverse Events|1|||
23416207|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
23713094|NCT00064350|66322403|FG000|Induction Treatment|Death|0|||
23713095|NCT00064350|66322404|FG001|Induction Treatment|Death|0|||
23713096|NCT00064350|66322405|FG002|Induction Treatment|Death|9|||
23713097|NCT00064350|66322403|FG000|Induction Treatment|Withdrawal by Subject|0|||
23713098|NCT00064350|66322404|FG001|Induction Treatment|Withdrawal by Subject|0|||
23713099|NCT00064350|66322405|FG002|Induction Treatment|Withdrawal by Subject|21|||
23713100|NCT00064350|66322403|FG000|Induction Treatment|Ineligible or never started treatment|3|||
23713101|NCT00064350|66322404|FG001|Induction Treatment|Ineligible or never started treatment|6|||
23713102|NCT00064350|66322405|FG002|Induction Treatment|Ineligible or never started treatment|34|||
23713103|NCT00064350|66322403|FG000|Induction Treatment|Other|0|||
23812049|NCT02516553|66691889|FG014|Overall Study|Other Adverse Events|0|||
23812050|NCT02516553|66691890|FG015|Overall Study|Other Adverse Events|0|||
23519201|NCT01644175|65639917|FG000|Overall Study|Consent withdrawn by participant|3|||
23519202|NCT01644175|65639918|FG001|Overall Study|Consent withdrawn by participant|4|||
23519203|NCT01644175|65639917|FG000|Overall Study|Related to Autoinjector Administration|2|||
23519204|NCT01644175|65639918|FG001|Overall Study|Related to Autoinjector Administration|1|||
23519205|NCT01644175|65639917|FG000|Overall Study|Last visit outside protocol visit window|4|||
23519206|NCT01644175|65639918|FG001|Overall Study|Last visit outside protocol visit window|11|||
23519207|NCT01644175|65639917|FG000|Overall Study|Selection criteria finally not met|0|||
23519208|NCT01644175|65639918|FG001|Overall Study|Selection criteria finally not met|1|||
23519209|NCT01644175|65639917|FG000|Overall Study|Site closure|2|||
23519210|NCT01644175|65639918|FG001|Overall Study|Site closure|2|||
23519211|NCT01644175|65639917|FG000|Overall Study|Lost to Follow-up|1|||
23519212|NCT01644175|65639918|FG001|Overall Study|Lost to Follow-up|0|||
23519213|NCT01644175|65639917|FG000|Overall Study|Other than specified above|0|||
23519214|NCT01644175|65639918|FG001|Overall Study|Other than specified above|3|||
23519215|NCT00605813|65639921|FG000|Overall Study|Protocol Violation|25|||
23519216|NCT02446236|65639922|FG000|Overall Study|Screen Failure|1|||
23519217|NCT02446236|65639923|FG001|Overall Study|Screen Failure|0|||
23519218|NCT02446236|65639924|FG002|Overall Study|Screen Failure|1|||
23519219|NCT02446236|65639922|FG000|Overall Study|Actively Receiving Therapy|0|||
23519220|NCT02446236|65639923|FG001|Overall Study|Actively Receiving Therapy|0|||
23519221|NCT02446236|65639924|FG002|Overall Study|Actively Receiving Therapy|1|||
23519222|NCT02064166|65639925|FG000|Overall Study|Adverse Event|1|||
23519223|NCT02064166|65639926|FG001|Overall Study|Adverse Event|0|||
23519224|NCT00453921|65639929|FG000|Overall Study|Withdrawal by Subject|1|||
23519225|NCT00453921|65639930|FG001|Overall Study|Withdrawal by Subject|1|||
23519226|NCT00453921|65639931|FG002|Overall Study|Withdrawal by Subject|1|||
23519227|NCT00453921|65639932|FG003|Overall Study|Withdrawal by Subject|1|||
23519228|NCT00453921|65639929|FG000|Overall Study|Lost to Follow-up|0|||
23519229|NCT00453921|65639930|FG001|Overall Study|Lost to Follow-up|0|||
23519230|NCT00453921|65639931|FG002|Overall Study|Lost to Follow-up|1|||
23519231|NCT00453921|65639932|FG003|Overall Study|Lost to Follow-up|0|||
23519232|NCT03060447|65639933|FG000|Overall Study|Withdrawal by Subject|2|||
23519233|NCT03060447|65639934|FG001|Overall Study|Withdrawal by Subject|0|||
23519234|NCT01838642|65639935|FG000|Overall Study|Died on study|1|||
23519235|NCT03320564|65639936|FG000|Overall Study|Protocol Violation|1|||
23519236|NCT02788981|65639937|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
23519237|NCT02788981|65639938|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
23519238|NCT03220217|65639946|FG000|Overall Study|Withdrawal by Subject|0|||
23519239|NCT03220217|65639947|FG001|Overall Study|Withdrawal by Subject|1|||
23519240|NCT03220217|65639948|FG002|Overall Study|Withdrawal by Subject|0|||
23519241|NCT03220217|65639946|FG000|Overall Study|Subject Missed Procedure|0|||
23519242|NCT03220217|65639947|FG001|Overall Study|Subject Missed Procedure|0|||
23519243|NCT03220217|65639948|FG002|Overall Study|Subject Missed Procedure|1|||
23519244|NCT02068222|65639951|FG000|Overall Study|Lost to Follow-up|1|||
23519245|NCT01912287|65639953|FG000|Overall Study|Ineligible|1|||
23519246|NCT01912287|65639954|FG001|Overall Study|Ineligible|0|||
23519247|NCT01912287|65639955|FG002|Overall Study|Ineligible|1|||
23519248|NCT01912287|65639953|FG000|Overall Study|No-show|0|||
23519249|NCT01912287|65639954|FG001|Overall Study|No-show|0|||
23519250|NCT01912287|65639955|FG002|Overall Study|No-show|1|||
23519251|NCT01912287|65639953|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
23519252|NCT01912287|65639954|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
23519253|NCT01912287|65639955|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
23713104|NCT00064350|66322404|FG001|Induction Treatment|Other|0|||
23713105|NCT00064350|66322405|FG002|Induction Treatment|Other|13|||
23713106|NCT00064350|66322403|FG000|Randomization|Adverse Event|8|||
23713107|NCT00064350|66322404|FG001|Randomization|Adverse Event|3|||
23713108|NCT00064350|66322405|FG002|Randomization|Adverse Event|0|||
23713109|NCT00064350|66322403|FG000|Randomization|Death|3|||
23713110|NCT00064350|66322404|FG001|Randomization|Death|0|||
23713111|NCT00064350|66322405|FG002|Randomization|Death|0|||
23713112|NCT00064350|66322403|FG000|Randomization|Withdrawal by Subject|1|||
23713113|NCT00064350|66322404|FG001|Randomization|Withdrawal by Subject|0|||
23713114|NCT00064350|66322405|FG002|Randomization|Withdrawal by Subject|0|||
23812051|NCT02516553|66691891|FG016|Overall Study|Other Adverse Events|0|||
23519254|NCT01912287|65639953|FG000|Overall Study|Felt treatment no longer needed|0|||
23519255|NCT01912287|65639954|FG001|Overall Study|Felt treatment no longer needed|1|||
23519256|NCT01912287|65639955|FG002|Overall Study|Felt treatment no longer needed|0|||
23519257|NCT01912287|65639953|FG000|Overall Study|Life circumstances|4|||
23519258|NCT01912287|65639954|FG001|Overall Study|Life circumstances|2|||
23713115|NCT00064350|66322403|FG000|Randomization|Ineligible or never started treatment|9|||
23713116|NCT00064350|66322404|FG001|Randomization|Ineligible or never started treatment|15|||
23713117|NCT00064350|66322405|FG002|Randomization|Ineligible or never started treatment|0|||
23713118|NCT00064350|66322403|FG000|Randomization|Other|5|||
23519259|NCT01912287|65639955|FG002|Overall Study|Life circumstances|0|||
23519260|NCT01912287|65639953|FG000|Overall Study|Lost Interest|1|||
23519261|NCT01912287|65639954|FG001|Overall Study|Lost Interest|0|||
23519262|NCT01912287|65639955|FG002|Overall Study|Lost Interest|0|||
23519263|NCT01912287|65639953|FG000|Overall Study|Uknown reason - subject drop out|5|||
23519264|NCT01912287|65639954|FG001|Overall Study|Uknown reason - subject drop out|7|||
23519265|NCT01912287|65639955|FG002|Overall Study|Uknown reason - subject drop out|3|||
23519266|NCT01912287|65639953|FG000|Overall Study|Missed Assesment|1|||
23519267|NCT01912287|65639954|FG001|Overall Study|Missed Assesment|1|||
23519268|NCT01912287|65639955|FG002|Overall Study|Missed Assesment|1|||
23519269|NCT01912287|65639953|FG000|Overall Study|Scheduling/change in availability|17|||
23519270|NCT01912287|65639954|FG001|Overall Study|Scheduling/change in availability|10|||
23519271|NCT01912287|65639955|FG002|Overall Study|Scheduling/change in availability|8|||
23519272|NCT01277523|65639969|FG000|Overall Study|Adverse Event|1|||
23519273|NCT01277523|65639970|FG001|Overall Study|Adverse Event|0|||
23519274|NCT01277523|65639971|FG002|Overall Study|Adverse Event|0|||
23519275|NCT01277523|65639969|FG000|Overall Study|Protocol Violation|2|||
23519276|NCT01277523|65639970|FG001|Overall Study|Protocol Violation|0|||
23519277|NCT01277523|65639971|FG002|Overall Study|Protocol Violation|0|||
23519278|NCT01277523|65639969|FG000|Overall Study|Other Reason not Defined|0|||
23519279|NCT01277523|65639970|FG001|Overall Study|Other Reason not Defined|1|||
23519280|NCT01277523|65639971|FG002|Overall Study|Other Reason not Defined|0|||
23519281|NCT03245008|65639976|FG000|Overall Study|Adverse Event|15|||
23519282|NCT03245008|65639977|FG001|Overall Study|Adverse Event|18|||
23519283|NCT03245008|65639978|FG002|Overall Study|Adverse Event|15|||
23519284|NCT03245008|65639979|FG003|Overall Study|Adverse Event|0|||
23519285|NCT03245008|65639980|FG004|Overall Study|Adverse Event|1|||
23519286|NCT03245008|65639976|FG000|Overall Study|Lack of Efficacy|0|||
23519287|NCT03245008|65639977|FG001|Overall Study|Lack of Efficacy|1|||
23519288|NCT03245008|65639978|FG002|Overall Study|Lack of Efficacy|0|||
23519289|NCT03245008|65639979|FG003|Overall Study|Lack of Efficacy|0|||
23519290|NCT03245008|65639980|FG004|Overall Study|Lack of Efficacy|0|||
23519291|NCT03245008|65639976|FG000|Overall Study|Lost to Follow-up|4|||
23519292|NCT03245008|65639977|FG001|Overall Study|Lost to Follow-up|1|||
23519293|NCT03245008|65639978|FG002|Overall Study|Lost to Follow-up|0|||
23519294|NCT03245008|65639979|FG003|Overall Study|Lost to Follow-up|0|||
23519295|NCT03245008|65639980|FG004|Overall Study|Lost to Follow-up|1|||
23519296|NCT03245008|65639976|FG000|Overall Study|Physician Decision|1|||
23519297|NCT03245008|65639977|FG001|Overall Study|Physician Decision|3|||
23519298|NCT03245008|65639978|FG002|Overall Study|Physician Decision|4|||
23519299|NCT03245008|65639979|FG003|Overall Study|Physician Decision|0|||
23519300|NCT03245008|65639980|FG004|Overall Study|Physician Decision|0|||
23519301|NCT03245008|65639976|FG000|Overall Study|Protocol Violation|0|||
23519302|NCT03245008|65639977|FG001|Overall Study|Protocol Violation|1|||
23519303|NCT03245008|65639978|FG002|Overall Study|Protocol Violation|0|||
23519304|NCT03245008|65639979|FG003|Overall Study|Protocol Violation|0|||
23519305|NCT03245008|65639980|FG004|Overall Study|Protocol Violation|0|||
23519306|NCT03245008|65639976|FG000|Overall Study|Withdrawal by Subject|20|||
23519307|NCT03245008|65639977|FG001|Overall Study|Withdrawal by Subject|19|||
23519308|NCT03245008|65639978|FG002|Overall Study|Withdrawal by Subject|11|||
23519309|NCT03245008|65639979|FG003|Overall Study|Withdrawal by Subject|0|||
23519310|NCT03245008|65639980|FG004|Overall Study|Withdrawal by Subject|0|||
23519311|NCT03245008|65639976|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519312|NCT03245008|65639977|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519313|NCT03245008|65639978|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519314|NCT03245008|65639979|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
23519315|NCT03245008|65639980|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
23519316|NCT03245008|65639976|FG000|Overall Study|Failure to meet randomization criteria|0|||
23519317|NCT03245008|65639977|FG001|Overall Study|Failure to meet randomization criteria|1|||
23519318|NCT03245008|65639978|FG002|Overall Study|Failure to meet randomization criteria|0|||
23519319|NCT03245008|65639979|FG003|Overall Study|Failure to meet randomization criteria|1|||
23519320|NCT03245008|65639980|FG004|Overall Study|Failure to meet randomization criteria|0|||
23519321|NCT01265849|65639987|FG000|Overall Study|Randomized//Treatment not initiated|1|||
23519322|NCT01265849|65639988|FG001|Overall Study|Randomized//Treatment not initiated|4|||
23519323|NCT01265849|65639989|FG002|Overall Study|Randomized//Treatment not initiated|0|||
23519324|NCT01265849|65639987|FG000|Overall Study|Physician Decision|1|||
23519325|NCT01265849|65639988|FG001|Overall Study|Physician Decision|2|||
23519326|NCT01265849|65639989|FG002|Overall Study|Physician Decision|0|||
23519327|NCT01265849|65639987|FG000|Overall Study|Lost to Follow-up|18|||
23519328|NCT01265849|65639988|FG001|Overall Study|Lost to Follow-up|15|||
23519329|NCT01265849|65639989|FG002|Overall Study|Lost to Follow-up|5|||
23519330|NCT01265849|65639987|FG000|Overall Study|Not otherwise specified|1|||
23519331|NCT01265849|65639988|FG001|Overall Study|Not otherwise specified|6|||
23519332|NCT01265849|65639989|FG002|Overall Study|Not otherwise specified|1|||
23519333|NCT01265849|65639987|FG000|Overall Study|Withdrawal by Subject|25|||
23519334|NCT01265849|65639988|FG001|Overall Study|Withdrawal by Subject|34|||
23519335|NCT01265849|65639989|FG002|Overall Study|Withdrawal by Subject|13|||
23519336|NCT02747420|65639990|FG000|Overall Study|Lost to Follow-up|4|||
23519337|NCT02747420|65639991|FG001|Overall Study|Lost to Follow-up|2|||
23519338|NCT02747420|65639990|FG000|Overall Study|Withdrawal by Subject|3|||
23519339|NCT02747420|65639991|FG001|Overall Study|Withdrawal by Subject|2|||
23519340|NCT00238121|65640004|FG000|Overall Study|Withdrawal by Subject|1|||
23519341|NCT00238121|65640005|FG001|Overall Study|Withdrawal by Subject|1|||
23519342|NCT00238121|65640004|FG000|Overall Study|Adverse Event|2|||
23519343|NCT00238121|65640005|FG001|Overall Study|Adverse Event|1|||
23519344|NCT00651755|65640006|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
23519345|NCT00651755|65640007|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
23519346|NCT00651755|65640006|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
23519347|NCT00651755|65640007|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
23519348|NCT01132482|65640008|FG000|Overall Study|Adverse Event|1|||
23519349|NCT01132482|65640009|FG001|Overall Study|Adverse Event|0|||
23519350|NCT00500292|65640010|FG000|Overall Study|Adverse Event|3|||
23519351|NCT00500292|65640011|FG001|Overall Study|Adverse Event|6|||
23713119|NCT00064350|66322404|FG001|Randomization|Other|0|||
23713120|NCT00064350|66322405|FG002|Randomization|Other|0|||
23713121|NCT00064350|66322403|FG000|Cross-Over|Adverse Event|0|||
23713122|NCT00064350|66322404|FG001|Cross-Over|Adverse Event|1|||
23713123|NCT00064350|66322405|FG002|Cross-Over|Adverse Event|0|||
23713124|NCT00064350|66322403|FG000|Cross-Over|Death|1|||
23713125|NCT00064350|66322404|FG001|Cross-Over|Death|3|||
23713126|NCT00064350|66322405|FG002|Cross-Over|Death|0|||
23713127|NCT00064350|66322403|FG000|Cross-Over|Withdrawal by Subject|2|||
23713128|NCT00064350|66322404|FG001|Cross-Over|Withdrawal by Subject|2|||
23519352|NCT00500292|65640012|FG002|Overall Study|Adverse Event|4|||
23519353|NCT00500292|65640010|FG000|Overall Study|Condition under investigation worsened|21|||
23519354|NCT00500292|65640011|FG001|Overall Study|Condition under investigation worsened|23|||
23519355|NCT00500292|65640012|FG002|Overall Study|Condition under investigation worsened|19|||
23519356|NCT00500292|65640010|FG000|Overall Study|Withdrawal by Subject|0|||
23519357|NCT00500292|65640011|FG001|Overall Study|Withdrawal by Subject|1|||
23519358|NCT00500292|65640012|FG002|Overall Study|Withdrawal by Subject|0|||
23519359|NCT00500292|65640010|FG000|Overall Study|Other|1|||
23519360|NCT00500292|65640011|FG001|Overall Study|Other|1|||
23519361|NCT00500292|65640012|FG002|Overall Study|Other|4|||
23519362|NCT04117347|65640013|FG000|Overall Study|Adverse Event|0|||
23519363|NCT04117347|65640014|FG001|Overall Study|Adverse Event|0|||
23519364|NCT04117347|65640015|FG002|Overall Study|Adverse Event|1|||
23519365|NCT04117347|65640013|FG000|Overall Study|No time for study|0|||
23519366|NCT04117347|65640014|FG001|Overall Study|No time for study|2|||
23519367|NCT04117347|65640015|FG002|Overall Study|No time for study|0|||
23519368|NCT04117347|65640013|FG000|Overall Study|Family emergency|1|||
23519369|NCT04117347|65640014|FG001|Overall Study|Family emergency|0|||
23519370|NCT04117347|65640015|FG002|Overall Study|Family emergency|0|||
23519371|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
23519372|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
23519373|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
23519374|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
23519375|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
23519376|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
23519377|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519378|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519379|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519380|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
23519381|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519382|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
23519383|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
23519384|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
23519385|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
23519386|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
23519387|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
23519388|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
23519389|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519390|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519391|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519392|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23713129|NCT00064350|66322405|FG002|Cross-Over|Withdrawal by Subject|0|||
23519393|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
23519394|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
23713130|NCT00064350|66322403|FG000|Cross-Over|Ineligible or never started treatment|3|||
23713131|NCT00064350|66322404|FG001|Cross-Over|Ineligible or never started treatment|6|||
23713132|NCT00064350|66322405|FG002|Cross-Over|Ineligible or never started treatment|0|||
23519395|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519396|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
23519397|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
23519398|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519399|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519400|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
23519401|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
23519402|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
23519403|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
23519404|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
23519405|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
23519406|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
23519407|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519408|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519409|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519410|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
23519411|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
23519412|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519413|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
23519414|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
23519415|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
23519416|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
23519417|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
23519418|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
23519419|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519420|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519421|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519422|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519423|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519424|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
23519425|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23713133|NCT00064350|66322403|FG000|Cross-Over|Other|0|||
23713134|NCT00064350|66322404|FG001|Cross-Over|Other|2|||
23416208|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
23416209|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
23416210|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
23416211|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
23519426|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23519427|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23519428|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
23519429|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
23519430|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
23519431|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519432|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519433|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
23713135|NCT00064350|66322405|FG002|Cross-Over|Other|0|||
23713136|NCT00622869|66322410|FG000|Overall Study|Subject Withdrew Consent|13|||
23713137|NCT00622869|66322411|FG001|Overall Study|Subject Withdrew Consent|17|||
23713138|NCT00622869|66322412|FG002|Overall Study|Subject Withdrew Consent|11|||
23713139|NCT00622869|66322410|FG000|Overall Study|Administrative Problems|11|||
23416212|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
23416213|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
23416214|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
23519434|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519435|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23713140|NCT00622869|66322411|FG001|Overall Study|Administrative Problems|17|||
23713141|NCT00622869|66322412|FG002|Overall Study|Administrative Problems|13|||
23519436|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519437|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519438|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519439|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519440|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
23713142|NCT00622869|66322410|FG000|Overall Study|Death|12|||
23713143|NCT00622869|66322411|FG001|Overall Study|Death|15|||
23713144|NCT00622869|66322412|FG002|Overall Study|Death|10|||
23713145|NCT00622869|66322410|FG000|Overall Study|Lost to Follow-up|2|||
23713146|NCT00622869|66322411|FG001|Overall Study|Lost to Follow-up|4|||
23713147|NCT00622869|66322412|FG002|Overall Study|Lost to Follow-up|2|||
23713148|NCT00622869|66322410|FG000|Overall Study|Graft Loss|5|||
23713149|NCT00622869|66322411|FG001|Overall Study|Graft Loss|3|||
23713150|NCT00622869|66322412|FG002|Overall Study|Graft Loss|2|||
23713151|NCT00622869|66322410|FG000|Overall Study|Missing|0|||
23713152|NCT00622869|66322411|FG001|Overall Study|Missing|1|||
23713153|NCT00622869|66322412|FG002|Overall Study|Missing|1|||
23713154|NCT01124448|66322413|FG000|Overall Study|Lost to Follow-up|0|||
23713155|NCT01124448|66322414|FG001|Overall Study|Lost to Follow-up|3|||
23713156|NCT01124448|66322413|FG000|Overall Study|Protocol Violation|2|||
23713157|NCT01124448|66322414|FG001|Overall Study|Protocol Violation|0|||
23713158|NCT01511107|66322418|FG000|Overall Study|Ineligible|3|||
23713159|NCT01511107|66322419|FG001|Overall Study|Ineligible|2|||
23713160|NCT01511107|66322418|FG000|Overall Study|Lost to Follow-up|10|||
23713161|NCT01511107|66322419|FG001|Overall Study|Lost to Follow-up|19|||
23713162|NCT01511107|66322418|FG000|Overall Study|Withdrawal by Subject|9|||
23713163|NCT01511107|66322419|FG001|Overall Study|Withdrawal by Subject|20|||
23713164|NCT01755195|66322421|FG000|Overall Study|Participant noncompliance|2|||
23713165|NCT01755195|66322421|FG000|Overall Study|Switched to alternative treatment|4|||
23713166|NCT01755195|66322421|FG000|Overall Study|Withdrawal by Subject|1|||
23713167|NCT01755195|66322421|FG000|Overall Study|Participant refused to start treatment|1|||
23713168|NCT01755195|66322421|FG000|Overall Study|Participant has been consented for another trial|1|||
23713169|NCT01755195|66322421|FG000|Overall Study|Refused further treatment|3|||
23713170|NCT01755195|66322421|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
23713171|NCT01441115|66322422|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
23713172|NCT01694420|66322426|FG000|Overall Study|Lost to Follow-up|3|||
23713173|NCT00343291|66322427|FG000|Overall Study|Adverse Event|13|||
23713174|NCT00343291|66322428|FG001|Overall Study|Adverse Event|13|||
23713175|NCT00343291|66322427|FG000|Overall Study|Death|3|||
23713176|NCT00343291|66322428|FG001|Overall Study|Death|2|||
23713177|NCT00343291|66322427|FG000|Overall Study|Progressive disease|33|||
23713178|NCT00343291|66322428|FG001|Overall Study|Progressive disease|34|||
23713179|NCT00343291|66322427|FG000|Overall Study|Withdrawal by Subject|0|||
23713180|NCT00343291|66322428|FG001|Overall Study|Withdrawal by Subject|2|||
23713181|NCT00343291|66322427|FG000|Overall Study|Other|8|||
23713182|NCT00343291|66322428|FG001|Overall Study|Other|5|||
23713183|NCT00929734|66322433|FG000|Overall Study|Lost to Follow-up|2|||
23713184|NCT00929734|66322434|FG001|Overall Study|Lost to Follow-up|1|||
23713185|NCT00929734|66322433|FG000|Overall Study|Withdrawal by Subject|0|||
23713186|NCT00929734|66322434|FG001|Overall Study|Withdrawal by Subject|2|||
23713187|NCT03493685|66322435|FG000|Overall Study|Death|4|||
23713188|NCT03493685|66322436|FG001|Overall Study|Death|3|||
23713189|NCT03493685|66322435|FG000|Overall Study|Lost to Follow-up|3|||
23713190|NCT03493685|66322436|FG001|Overall Study|Lost to Follow-up|2|||
23713191|NCT03493685|66322435|FG000|Overall Study|Physician Decision|2|||
23713192|NCT03493685|66322436|FG001|Overall Study|Physician Decision|0|||
23713193|NCT03493685|66322435|FG000|Overall Study|Withdrawal by Subject|7|||
23713194|NCT03493685|66322436|FG001|Overall Study|Withdrawal by Subject|11|||
23713195|NCT02670330|66322441|FG000|Overall Study|Protocol Deviation|1|||
23713196|NCT02670330|66322442|FG001|Overall Study|Protocol Deviation|0|||
23713197|NCT02670330|66322441|FG000|Overall Study|Study Terminated By Sponsor|36|||
23713198|NCT02670330|66322442|FG001|Overall Study|Study Terminated By Sponsor|43|||
23713199|NCT02670330|66322441|FG000|Overall Study|Adverse Event|1|||
23713200|NCT02670330|66322442|FG001|Overall Study|Adverse Event|3|||
23416215|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
23416216|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
23416217|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
23416218|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
23416219|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
23416220|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
23713201|NCT02670330|66322441|FG000|Overall Study|Withdrawal by Subject|34|||
23713202|NCT02670330|66322442|FG001|Overall Study|Withdrawal by Subject|29|||
23713203|NCT02670330|66322441|FG000|Overall Study|Lost to Follow-up|3|||
23713204|NCT02670330|66322442|FG001|Overall Study|Lost to Follow-up|2|||
23713205|NCT00574119|66322445|FG000|Overall Study|Adverse Event|1|||
23713206|NCT00574119|66322445|FG000|Overall Study|Protocol Violation|1|||
23713207|NCT00574119|66322445|FG000|Overall Study|Withdrawal by Subject|1|||
23713208|NCT00574119|66322445|FG000|Overall Study|Physician Decision|1|||
23713209|NCT00738374|66322447|FG000|Induction Treatment Phase|Adverse Event|14|||
23713210|NCT00738374|66322448|FG001|Induction Treatment Phase|Adverse Event|0|||
23713211|NCT00738374|66322449|FG002|Induction Treatment Phase|Adverse Event|0|||
23713212|NCT00738374|66322450|FG003|Induction Treatment Phase|Adverse Event|0|||
23713213|NCT00738374|66322447|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
23713214|NCT00738374|66322448|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23713215|NCT00738374|66322449|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23713216|NCT00738374|66322450|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23713217|NCT00738374|66322447|FG000|Induction Treatment Phase|Physician Decision|2|||
23519441|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519442|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
23519443|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519444|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519445|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519446|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519447|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519448|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
23519449|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519450|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519451|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
23519452|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519453|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519454|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519455|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
23519456|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
23519457|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
23519458|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519459|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519460|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519461|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Other|0|||
23519462|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Other|1|||
23519463|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Other|0|||
23519464|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Other|2|||
23519465|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Other|1|||
23519466|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Other|0|||
23519467|NCT00857220|65640028|FG000|Overall Study|Adverse Event|35|||
23519468|NCT00857220|65640028|FG000|Overall Study|Death|1|||
23519469|NCT00857220|65640028|FG000|Overall Study|Lack of Efficacy|11|||
23519470|NCT00857220|65640028|FG000|Overall Study|Lost to Follow-up|30|||
23519471|NCT00857220|65640028|FG000|Overall Study|Physician Decision|4|||
23519472|NCT00857220|65640028|FG000|Overall Study|Protocol Violation|16|||
23519473|NCT00857220|65640028|FG000|Overall Study|Withdrawal by Subject|67|||
23519474|NCT00857220|65640028|FG000|Overall Study|Clinical Hold|6|||
23519475|NCT00857220|65640028|FG000|Overall Study|Site Closed|5|||
23519476|NCT00857220|65640028|FG000|Overall Study|Miscellaneous|8|||
23519477|NCT01536379|65640032|FG000|Overall Study|Adverse Event|1|||
23519478|NCT01536379|65640033|FG001|Overall Study|Adverse Event|2|||
23519479|NCT01536379|65640032|FG000|Overall Study|Withdrawal by Subject|1|||
23519480|NCT01536379|65640033|FG001|Overall Study|Withdrawal by Subject|1|||
23519481|NCT02939560|65640034|FG000|Overall Study|Withdrawal by Subject|2|||
23519482|NCT02939560|65640034|FG000|Overall Study|Protocol Violation|1|||
23519483|NCT00149747|65640035|FG000|Overall Study|Death|1|||
23519484|NCT00149747|65640036|FG001|Overall Study|Death|0|||
23519485|NCT00149747|65640035|FG000|Overall Study|Withdrawal by Subject|3|||
23519486|NCT00149747|65640036|FG001|Overall Study|Withdrawal by Subject|3|||
23519487|NCT02580357|65640037|FG000|Overall Study|Lost to Follow-up|2|||
23519488|NCT02580357|65640038|FG001|Overall Study|Lost to Follow-up|0|||
23519489|NCT02580357|65640039|FG002|Overall Study|Lost to Follow-up|0|||
23519490|NCT02580357|65640037|FG000|Overall Study|Protocol Violation|1|||
23713218|NCT00738374|66322448|FG001|Induction Treatment Phase|Physician Decision|0|||
23519491|NCT02580357|65640038|FG001|Overall Study|Protocol Violation|0|||
23519492|NCT02580357|65640039|FG002|Overall Study|Protocol Violation|0|||
23519493|NCT01474876|65640040|FG000|Overall Study|Adverse Event|11|||
23519494|NCT01474876|65640041|FG001|Overall Study|Adverse Event|5|||
23519495|NCT01474876|65640042|FG002|Overall Study|Adverse Event|0|||
23519496|NCT01474876|65640040|FG000|Overall Study|Serious Adverse Event|2|||
23519497|NCT01474876|65640041|FG001|Overall Study|Serious Adverse Event|3|||
23519498|NCT01474876|65640042|FG002|Overall Study|Serious Adverse Event|0|||
23519499|NCT01474876|65640040|FG000|Overall Study|Lost to Follow-up|5|||
23519500|NCT01474876|65640041|FG001|Overall Study|Lost to Follow-up|4|||
23519501|NCT01474876|65640042|FG002|Overall Study|Lost to Follow-up|0|||
23519502|NCT01474876|65640040|FG000|Overall Study|Investigator's decision|28|||
23519503|NCT01474876|65640041|FG001|Overall Study|Investigator's decision|6|||
23519504|NCT01474876|65640042|FG002|Overall Study|Investigator's decision|0|||
23519505|NCT01474876|65640040|FG000|Overall Study|Patient's request|19|||
23519506|NCT01474876|65640041|FG001|Overall Study|Patient's request|5|||
23519507|NCT01474876|65640042|FG002|Overall Study|Patient's request|0|||
23519508|NCT01474876|65640040|FG000|Overall Study|Investigator's decision and pt request|1|||
23519509|NCT01474876|65640041|FG001|Overall Study|Investigator's decision and pt request|0|||
23519510|NCT01474876|65640042|FG002|Overall Study|Investigator's decision and pt request|0|||
23519511|NCT00227305|65640043|FG000|Overall Study|Adverse Event|40|||
23713219|NCT00738374|66322449|FG002|Induction Treatment Phase|Physician Decision|0|||
23713220|NCT00738374|66322450|FG003|Induction Treatment Phase|Physician Decision|0|||
23713221|NCT00738374|66322447|FG000|Induction Treatment Phase|Protocol Violation|2|||
23713222|NCT00738374|66322448|FG001|Induction Treatment Phase|Protocol Violation|0|||
23713223|NCT00738374|66322449|FG002|Induction Treatment Phase|Protocol Violation|0|||
23713224|NCT00738374|66322450|FG003|Induction Treatment Phase|Protocol Violation|0|||
23713225|NCT00738374|66322447|FG000|Induction Treatment Phase|Non-compliance|1|||
23713226|NCT00738374|66322448|FG001|Induction Treatment Phase|Non-compliance|0|||
23713227|NCT00738374|66322449|FG002|Induction Treatment Phase|Non-compliance|0|||
23713228|NCT00738374|66322450|FG003|Induction Treatment Phase|Non-compliance|0|||
23713229|NCT00738374|66322447|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
23713230|NCT00738374|66322448|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
23713231|NCT00738374|66322449|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
23713232|NCT00738374|66322450|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
23519512|NCT00227305|65640043|FG000|Overall Study|Withdrawal by Subject|42|||
23519513|NCT00227305|65640043|FG000|Overall Study|Lost to Follow-up|33|||
23519514|NCT00227305|65640043|FG000|Overall Study|Study specific discontinuation|13|||
23519515|NCT00227305|65640043|FG000|Overall Study|MOVED OUT OF AREA|3|||
23519516|NCT00227305|65640043|FG000|Overall Study|Lack of Efficacy|7|||
23519517|NCT00227305|65640043|FG000|Overall Study|Physician Decision|3|||
23519518|NCT00227305|65640043|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
23519519|NCT00227305|65640043|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
23519520|NCT00227305|65640043|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
23519521|NCT05024058|65640044|FG000|Treatment|Study terminated by sponsor|5|||
23519522|NCT05024058|65640045|FG001|Treatment|Study terminated by sponsor|6|||
23519523|NCT05024058|65640046|FG002|Treatment|Study terminated by sponsor|4|||
23519524|NCT05024058|65640047|FG003|Treatment|Study terminated by sponsor|2|||
23519525|NCT05024058|65640048|FG004|Treatment|Study terminated by sponsor|3|||
23519526|NCT05024058|65640049|FG005|Treatment|Study terminated by sponsor|3|||
23519527|NCT05024058|65640050|FG006|Treatment|Study terminated by sponsor|1|||
23519528|NCT05024058|65640051|FG007|Treatment|Study terminated by sponsor|3|||
23519529|NCT05024058|65640052|FG008|Treatment|Study terminated by sponsor|6|||
23519530|NCT05024058|65640053|FG009|Treatment|Study terminated by sponsor|6|||
23519531|NCT05024058|65640044|FG000|Follow-up|Withdrawal by Subject|1|||
23519532|NCT05024058|65640045|FG001|Follow-up|Withdrawal by Subject|0|||
23519533|NCT05024058|65640046|FG002|Follow-up|Withdrawal by Subject|1|||
23519534|NCT05024058|65640047|FG003|Follow-up|Withdrawal by Subject|0|||
23519535|NCT05024058|65640048|FG004|Follow-up|Withdrawal by Subject|0|||
23519536|NCT05024058|65640049|FG005|Follow-up|Withdrawal by Subject|0|||
23519537|NCT05024058|65640050|FG006|Follow-up|Withdrawal by Subject|0|||
23519538|NCT05024058|65640051|FG007|Follow-up|Withdrawal by Subject|1|||
23519539|NCT05024058|65640052|FG008|Follow-up|Withdrawal by Subject|0|||
23519540|NCT05024058|65640053|FG009|Follow-up|Withdrawal by Subject|1|||
23519541|NCT02205333|65640054|FG000|Overall Study|Death|5|||
23519542|NCT02205333|65640055|FG001|Overall Study|Death|6|||
23519543|NCT02205333|65640056|FG002|Overall Study|Death|2|||
23519544|NCT02205333|65640057|FG003|Overall Study|Death|6|||
23519545|NCT02205333|65640058|FG004|Overall Study|Death|5|||
23519546|NCT02205333|65640059|FG005|Overall Study|Death|3|||
23519547|NCT02205333|65640060|FG006|Overall Study|Death|3|||
23519548|NCT02205333|65640061|FG007|Overall Study|Death|2|||
23519549|NCT02205333|65640062|FG008|Overall Study|Death|0|||
23519550|NCT02205333|65640054|FG000|Overall Study|Withdrawal by Subject|1|||
23519551|NCT02205333|65640055|FG001|Overall Study|Withdrawal by Subject|0|||
23519552|NCT02205333|65640056|FG002|Overall Study|Withdrawal by Subject|0|||
23519553|NCT02205333|65640057|FG003|Overall Study|Withdrawal by Subject|1|||
23519554|NCT02205333|65640058|FG004|Overall Study|Withdrawal by Subject|0|||
23519555|NCT02205333|65640059|FG005|Overall Study|Withdrawal by Subject|0|||
23713233|NCT00738374|66322447|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
23713234|NCT00738374|66322448|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
23713235|NCT00738374|66322449|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
23713236|NCT00738374|66322450|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
23519556|NCT02205333|65640060|FG006|Overall Study|Withdrawal by Subject|2|||
23519557|NCT02205333|65640061|FG007|Overall Study|Withdrawal by Subject|0|||
23519558|NCT02205333|65640062|FG008|Overall Study|Withdrawal by Subject|0|||
23519559|NCT02515045|65640063|FG000|Overall Study|Adverse Event|0|||
23519560|NCT02515045|65640064|FG001|Overall Study|Adverse Event|3|||
23519561|NCT02515045|65640065|FG002|Overall Study|Adverse Event|3|||
23519562|NCT02515045|65640063|FG000|Overall Study|Lost to Follow-up|0|||
23519563|NCT02515045|65640064|FG001|Overall Study|Lost to Follow-up|1|||
23519564|NCT02515045|65640065|FG002|Overall Study|Lost to Follow-up|1|||
23519565|NCT00720057|65640067|FG000|Overall Study|Lost to Follow-up|0|||
23519566|NCT00720057|65640068|FG001|Overall Study|Lost to Follow-up|2|||
23519567|NCT00720057|65640067|FG000|Overall Study|Protocol Violation|1|||
23519568|NCT00720057|65640068|FG001|Overall Study|Protocol Violation|0|||
23519569|NCT00720057|65640067|FG000|Overall Study|Withdrawal by Subject|0|||
23519570|NCT00720057|65640068|FG001|Overall Study|Withdrawal by Subject|1|||
23713237|NCT00738374|66322447|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
23713238|NCT00738374|66322448|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
23713239|NCT00738374|66322449|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
23713240|NCT00738374|66322450|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
23713241|NCT00738374|66322447|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23713242|NCT00738374|66322448|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23713243|NCT00738374|66322449|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23713244|NCT00738374|66322450|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
23713245|NCT00738374|66322447|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23713246|NCT00738374|66322448|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
23713247|NCT00738374|66322449|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23713248|NCT00738374|66322450|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23713249|NCT00738374|66322447|FG000|Maintenance Treatment/Observation Phase|Other|0|||
23713250|NCT00738374|66322448|FG001|Maintenance Treatment/Observation Phase|Other|1|||
23713251|NCT00738374|66322449|FG002|Maintenance Treatment/Observation Phase|Other|0|||
23713252|NCT00738374|66322450|FG003|Maintenance Treatment/Observation Phase|Other|0|||
23713253|NCT00192036|66322455|FG000|Overall Study|Protocol Violation|3|||
23713254|NCT00192036|66322455|FG000|Overall Study|Adverse Event|6|||
23713255|NCT00192036|66322455|FG000|Overall Study|Patient/Physician Perception|1|||
23713256|NCT00192036|66322455|FG000|Overall Study|Objective Tumor Progression|4|||
23713257|NCT00192036|66322455|FG000|Overall Study|Clinical Disease Progression|1|||
23713258|NCT00192036|66322455|FG000|Overall Study|Death|1|||
23713259|NCT00192036|66322455|FG000|Overall Study|Unknown or Not Specified|5|||
23713260|NCT05294211|66322461|FG000|Overall Study|Withdrawal by Subject|3|||
23713261|NCT05294211|66322461|FG000|Overall Study|Physician Decision|2|||
23713262|NCT05294211|66322461|FG000|Overall Study|Progressed to active labor|1|||
23519571|NCT00949325|65640069|FG000|Overall Study|Adverse Event|0|||
23519572|NCT00949325|65640070|FG001|Overall Study|Adverse Event|2|||
23519573|NCT00949325|65640071|FG002|Overall Study|Adverse Event|0|||
23519574|NCT02018458|65640073|FG000|Overall Study|Death|4|||
23519575|NCT01455012|65640074|FG000|Overall Study|Adverse Event|0|||
23519576|NCT01455012|65640075|FG001|Overall Study|Adverse Event|2|||
23519577|NCT01455012|65640074|FG000|Overall Study|Lack of Efficacy|6|||
23519578|NCT01455012|65640075|FG001|Overall Study|Lack of Efficacy|1|||
23519579|NCT01455012|65640074|FG000|Overall Study|Withdrawal by Subject|3|||
23519580|NCT01455012|65640075|FG001|Overall Study|Withdrawal by Subject|1|||
23519581|NCT01455012|65640074|FG000|Overall Study|Unknown reason|2|||
23519582|NCT01455012|65640075|FG001|Overall Study|Unknown reason|0|||
23519583|NCT03683758|65640076|FG000|Overall Study|Non-study commitment conflict|1|||
23519584|NCT03683758|65640077|FG001|Overall Study|Non-study commitment conflict|3|||
23519585|NCT03683758|65640076|FG000|Overall Study|Illness preventing participation|1|||
23519586|NCT03683758|65640077|FG001|Overall Study|Illness preventing participation|0|||
23519587|NCT03683758|65640076|FG000|Overall Study|Adverse Event|1|||
23519588|NCT03683758|65640077|FG001|Overall Study|Adverse Event|0|||
23519589|NCT03745937|65640079|FG000|Overall Study|Withdrawal by Subject|0|||
23519590|NCT03745937|65640080|FG001|Overall Study|Withdrawal by Subject|0|||
23519591|NCT03745937|65640081|FG002|Overall Study|Withdrawal by Subject|0|||
23519592|NCT03745937|65640082|FG003|Overall Study|Withdrawal by Subject|1|||
23519593|NCT03745937|65640079|FG000|Overall Study|Not-specifed|0|||
23519594|NCT03745937|65640080|FG001|Overall Study|Not-specifed|1|||
23519595|NCT03745937|65640081|FG002|Overall Study|Not-specifed|0|||
23519596|NCT03745937|65640082|FG003|Overall Study|Not-specifed|1|||
23519597|NCT01996709|65640083|FG000|Overall Study|Withdrawal by Subject|1|||
23519598|NCT01996709|65640084|FG001|Overall Study|Withdrawal by Subject|0|||
23519599|NCT01996709|65640083|FG000|Overall Study|Lost to Follow-up|3|||
23519600|NCT01996709|65640084|FG001|Overall Study|Lost to Follow-up|0|||
23519601|NCT01996709|65640083|FG000|Overall Study|Subject Non-Compliant|1|||
23519602|NCT01996709|65640084|FG001|Overall Study|Subject Non-Compliant|0|||
23519603|NCT01996709|65640083|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23519604|NCT01996709|65640084|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
23519605|NCT04120974|65640085|FG000|Overall Study|Death|1|||
23519606|NCT04120974|65640085|FG000|Overall Study|Physician Decision|1|||
23519607|NCT04120974|65640085|FG000|Overall Study|Lost to Follow-up|6|||
23519608|NCT03082599|65640086|FG000|Overall Study|Lost to Follow-up|1|||
23519609|NCT03082599|65640087|FG001|Overall Study|Lost to Follow-up|0|||
23519610|NCT05045144|65640088|FG000|Overall Study|Lost to Follow-up|3|||
23519611|NCT05045144|65640089|FG001|Overall Study|Lost to Follow-up|2|||
23519612|NCT05045144|65640090|FG002|Overall Study|Lost to Follow-up|3|||
23519613|NCT05045144|65640091|FG003|Overall Study|Lost to Follow-up|5|||
23713263|NCT05294211|66322461|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
23713264|NCT05294211|66322461|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
23519614|NCT05045144|65640092|FG004|Overall Study|Lost to Follow-up|13|||
23519615|NCT05045144|65640088|FG000|Overall Study|Withdrawal by Subject|0|||
23519616|NCT05045144|65640089|FG001|Overall Study|Withdrawal by Subject|1|||
23519617|NCT05045144|65640090|FG002|Overall Study|Withdrawal by Subject|0|||
23519618|NCT05045144|65640091|FG003|Overall Study|Withdrawal by Subject|0|||
23519619|NCT05045144|65640092|FG004|Overall Study|Withdrawal by Subject|0|||
23519620|NCT05045144|65640088|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519621|NCT05045144|65640089|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519622|NCT05045144|65640090|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23519623|NCT05045144|65640091|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519624|NCT05045144|65640092|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519625|NCT02738333|65640093|FG000|Overall Study|Death|1|||
23519626|NCT02738333|65640094|FG001|Overall Study|Death|0|||
23519627|NCT02738333|65640095|FG002|Overall Study|Death|0|||
23519628|NCT02738333|65640093|FG000|Overall Study|Lost to Follow-up|1|||
23519629|NCT02738333|65640094|FG001|Overall Study|Lost to Follow-up|0|||
23519630|NCT02738333|65640095|FG002|Overall Study|Lost to Follow-up|0|||
23519631|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
23519632|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
23519633|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
23519634|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
23519635|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
23519636|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
23519637|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
23519638|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
23519639|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
23519640|NCT02225743|65640099|FG000|Overall Study|Withdrawal by Subject|18|||
23519641|NCT02132767|65640100|FG000|Overall Study|Death|3|||
23519642|NCT02132767|65640101|FG001|Overall Study|Death|2|||
23519643|NCT02132767|65640100|FG000|Overall Study|Withdrawal by Subject|10|||
23519644|NCT02132767|65640101|FG001|Overall Study|Withdrawal by Subject|9|||
23519645|NCT02132767|65640100|FG000|Overall Study|Lost to Follow-up|4|||
23519646|NCT02132767|65640101|FG001|Overall Study|Lost to Follow-up|4|||
23519647|NCT00071760|65640102|FG000|Overall Study|Adverse Event|2|||
23519648|NCT00071760|65640103|FG001|Overall Study|Adverse Event|1|||
23519649|NCT00071760|65640102|FG000|Overall Study|Lost to Follow-up|0|||
23713265|NCT03498287|66322467|FG000|Overall Study|Withdrawal by Subject|3|||
23713266|NCT03498287|66322468|FG001|Overall Study|Withdrawal by Subject|0|||
23713267|NCT03498287|66322467|FG000|Overall Study|Protocol Violation|0|||
23713268|NCT03498287|66322468|FG001|Overall Study|Protocol Violation|4|||
23713269|NCT03498287|66322467|FG000|Overall Study|Adverse Event|0|||
23713270|NCT03498287|66322468|FG001|Overall Study|Adverse Event|1|||
23713271|NCT02056834|66322469|FG000|Overall Study|Lost to Follow-up|7|||
23713272|NCT00589979|66322470|FG000|Run-In Period|Adverse Event|5|||
23713273|NCT00589979|66322471|FG001|Run-In Period|Adverse Event|0|||
23713274|NCT00589979|66322472|FG002|Run-In Period|Adverse Event|0|||
23713275|NCT00589979|66322470|FG000|Run-In Period|Protocol Violation|3|||
23713276|NCT00589979|66322471|FG001|Run-In Period|Protocol Violation|0|||
23713277|NCT00589979|66322472|FG002|Run-In Period|Protocol Violation|0|||
23713278|NCT00589979|66322470|FG000|Run-In Period|Did not qualify for randomization|54|||
23713279|NCT00589979|66322471|FG001|Run-In Period|Did not qualify for randomization|0|||
23713280|NCT00589979|66322472|FG002|Run-In Period|Did not qualify for randomization|0|||
23713281|NCT00589979|66322470|FG000|Run-In Period|Withdrawal by Subject|10|||
23713282|NCT00589979|66322471|FG001|Run-In Period|Withdrawal by Subject|0|||
23713283|NCT00589979|66322472|FG002|Run-In Period|Withdrawal by Subject|0|||
23713284|NCT00589979|66322470|FG000|Run-In Period|Informed Consent Withdrawn|4|||
23713285|NCT00589979|66322471|FG001|Run-In Period|Informed Consent Withdrawn|0|||
23713286|NCT00589979|66322472|FG002|Run-In Period|Informed Consent Withdrawn|0|||
23416221|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
23519650|NCT00071760|65640103|FG001|Overall Study|Lost to Follow-up|3|||
23519651|NCT00071760|65640102|FG000|Overall Study|Protocol Violation|1|||
23519652|NCT00071760|65640103|FG001|Overall Study|Protocol Violation|0|||
23519653|NCT00071760|65640102|FG000|Overall Study|Withdrawal by Subject|0|||
23519654|NCT00071760|65640103|FG001|Overall Study|Withdrawal by Subject|1|||
23519655|NCT00071760|65640102|FG000|Overall Study|Insufficient Viral Load Response|1|||
23519656|NCT00071760|65640103|FG001|Overall Study|Insufficient Viral Load Response|1|||
23519657|NCT00071760|65640102|FG000|Overall Study|Lack of availability of RTV|1|||
23519658|NCT00071760|65640103|FG001|Overall Study|Lack of availability of RTV|0|||
23519659|NCT00071760|65640102|FG000|Overall Study|Physician Decision|2|||
23519660|NCT00071760|65640103|FG001|Overall Study|Physician Decision|1|||
23519661|NCT00071760|65640102|FG000|Overall Study|Relocation|0|||
23519662|NCT00071760|65640103|FG001|Overall Study|Relocation|1|||
23713287|NCT00589979|66322470|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
23713288|NCT00589979|66322471|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
23713289|NCT00589979|66322472|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
23713290|NCT00589979|66322470|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
23713291|NCT00589979|66322471|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
23713292|NCT00589979|66322472|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
23713293|NCT00589979|66322470|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23713294|NCT00589979|66322471|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23713295|NCT00589979|66322472|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
23713296|NCT00589979|66322470|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
23713297|NCT00589979|66322471|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
23713298|NCT00589979|66322472|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
23713299|NCT00589979|66322470|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23713300|NCT00589979|66322471|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23713301|NCT00589979|66322472|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
23713302|NCT00589979|66322470|FG000|Double-Blind Treatment Period 2|Other|0|||
23713303|NCT00589979|66322471|FG001|Double-Blind Treatment Period 2|Other|0|||
23713304|NCT00589979|66322472|FG002|Double-Blind Treatment Period 2|Other|1|||
23713305|NCT00589979|66322470|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
23713306|NCT00589979|66322471|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
23713307|NCT00589979|66322472|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
23713308|NCT00589979|66322470|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
23713309|NCT00589979|66322471|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
23713310|NCT00589979|66322472|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
23713311|NCT01954251|66325318|FG000|Overall Study|Adverse Event|5|||
23713312|NCT01954251|66325319|FG001|Overall Study|Adverse Event|7|||
23713313|NCT01954251|66325318|FG000|Overall Study|Lost to Follow-up|6|||
23713314|NCT01954251|66325319|FG001|Overall Study|Lost to Follow-up|6|||
23519663|NCT03054870|65640113|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
23519664|NCT03054870|65640113|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
23519665|NCT00600938|65640120|FG000|Core Study|Abnormal test procedure result(s)|3|||
23519666|NCT00600938|65640121|FG001|Core Study|Abnormal test procedure result(s)|2|||
23519667|NCT00600938|65640122|FG002|Core Study|Abnormal test procedure result(s)|0|||
23519668|NCT00600938|65640123|FG003|Core Study|Abnormal test procedure result(s)|0|||
23519669|NCT00600938|65640120|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
23519670|NCT00600938|65640121|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
23519671|NCT00600938|65640122|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
23519672|NCT00600938|65640123|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
23519673|NCT00600938|65640120|FG000|Core Study|Patient withdrew consent|7|||
23519674|NCT00600938|65640121|FG001|Core Study|Patient withdrew consent|12|||
23519675|NCT00600938|65640122|FG002|Core Study|Patient withdrew consent|0|||
23519676|NCT00600938|65640123|FG003|Core Study|Patient withdrew consent|0|||
23713315|NCT01954251|66325318|FG000|Overall Study|Withdrawal by Subject|2|||
23713316|NCT01954251|66325319|FG001|Overall Study|Withdrawal by Subject|6|||
23713317|NCT00623467|66325320|FG000|Overall Study|Lost to Follow-up|1|||
23713318|NCT00623467|66325320|FG000|Overall Study|Protocol Violation|4|||
23713319|NCT00623467|66325320|FG000|Overall Study|Withdrawal by Subject|2|||
23713320|NCT00593840|66325321|FG000|Overall Study|Withdrawal by Subject|1|||
23713321|NCT00390416|66325322|FG000|Overall Study|Withdrawal by Subject|1|||
23713322|NCT00390416|66325322|FG000|Overall Study|Not treated|3|||
23713323|NCT01860534|66325323|FG000|ROP #1|Needed treatment for ROP|0|||
23713324|NCT01860534|66325324|FG001|ROP #1|Needed treatment for ROP|1|||
23713325|NCT01860534|66325323|FG000|ROP #2|discharged prior to ROP #2|1|||
23713326|NCT01860534|66325324|FG001|ROP #2|discharged prior to ROP #2|0|||
23713327|NCT00280150|66325326|FG000|Overall Study|Adverse Event|0|||
23713328|NCT00280150|66325327|FG001|Overall Study|Adverse Event|1|||
23713329|NCT00280150|66325328|FG002|Overall Study|Adverse Event|2|||
23713330|NCT00280150|66325329|FG003|Overall Study|Adverse Event|3|||
23713331|NCT00280150|66325326|FG000|Overall Study|Lack of Efficacy|0|||
23713332|NCT00280150|66325327|FG001|Overall Study|Lack of Efficacy|0|||
23713333|NCT00280150|66325328|FG002|Overall Study|Lack of Efficacy|0|||
23713334|NCT00280150|66325329|FG003|Overall Study|Lack of Efficacy|3|||
23713335|NCT00280150|66325326|FG000|Overall Study|Physician Decision|0|||
23713336|NCT00280150|66325327|FG001|Overall Study|Physician Decision|0|||
23713337|NCT00280150|66325328|FG002|Overall Study|Physician Decision|0|||
23713338|NCT00280150|66325329|FG003|Overall Study|Physician Decision|1|||
23519677|NCT00600938|65640120|FG000|Core Study|Lost to Follow-up|3|||
23519678|NCT00600938|65640121|FG001|Core Study|Lost to Follow-up|2|||
23519679|NCT00600938|65640122|FG002|Core Study|Lost to Follow-up|0|||
23519680|NCT00600938|65640123|FG003|Core Study|Lost to Follow-up|0|||
23519681|NCT00600938|65640120|FG000|Core Study|Death|1|||
23713339|NCT00280150|66325326|FG000|Overall Study|Protocol Violation|0|||
23713340|NCT00280150|66325327|FG001|Overall Study|Protocol Violation|0|||
23713341|NCT00280150|66325328|FG002|Overall Study|Protocol Violation|0|||
23713342|NCT00280150|66325329|FG003|Overall Study|Protocol Violation|1|||
23713343|NCT00280150|66325326|FG000|Overall Study|Withdrawal by Subject|0|||
23713344|NCT00280150|66325327|FG001|Overall Study|Withdrawal by Subject|0|||
23713345|NCT00280150|66325328|FG002|Overall Study|Withdrawal by Subject|0|||
23519682|NCT00600938|65640121|FG001|Core Study|Death|1|||
23519683|NCT00600938|65640122|FG002|Core Study|Death|0|||
23519684|NCT00600938|65640123|FG003|Core Study|Death|0|||
23519685|NCT00600938|65640120|FG000|Core Study|Protocol Violation|1|||
23519686|NCT00600938|65640121|FG001|Core Study|Protocol Violation|2|||
23519687|NCT00600938|65640122|FG002|Core Study|Protocol Violation|0|||
23519688|NCT00600938|65640123|FG003|Core Study|Protocol Violation|0|||
23519689|NCT00600938|65640120|FG000|Extension Study|Adverse Event|1|||
23519690|NCT00600938|65640121|FG001|Extension Study|Adverse Event|0|||
23519691|NCT00600938|65640122|FG002|Extension Study|Adverse Event|2|||
23519692|NCT00600938|65640123|FG003|Extension Study|Adverse Event|0|||
23519693|NCT00600938|65640120|FG000|Extension Study|Abnormal test procedure results|0|||
23519694|NCT00600938|65640121|FG001|Extension Study|Abnormal test procedure results|1|||
23519695|NCT00600938|65640122|FG002|Extension Study|Abnormal test procedure results|1|||
23519696|NCT00600938|65640123|FG003|Extension Study|Abnormal test procedure results|1|||
23519697|NCT00600938|65640120|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
23519698|NCT00600938|65640121|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
23519699|NCT00600938|65640122|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
23519700|NCT00600938|65640123|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
23519701|NCT00600938|65640120|FG000|Extension Study|Withdrawal by Subject|2|||
23519702|NCT00600938|65640121|FG001|Extension Study|Withdrawal by Subject|2|||
23519703|NCT00600938|65640122|FG002|Extension Study|Withdrawal by Subject|3|||
23519704|NCT00600938|65640123|FG003|Extension Study|Withdrawal by Subject|0|||
23519705|NCT00600938|65640120|FG000|Extension Study|Lost to Follow-up|1|||
23519706|NCT00600938|65640121|FG001|Extension Study|Lost to Follow-up|1|||
23519707|NCT00600938|65640122|FG002|Extension Study|Lost to Follow-up|2|||
23519708|NCT00600938|65640123|FG003|Extension Study|Lost to Follow-up|0|||
23519709|NCT00600938|65640120|FG000|Extension Study|Death|1|||
23519710|NCT00600938|65640121|FG001|Extension Study|Death|0|||
23519711|NCT00600938|65640122|FG002|Extension Study|Death|0|||
23519712|NCT00600938|65640123|FG003|Extension Study|Death|0|||
23519713|NCT02250443|65640125|FG000|Overall Study|Administrative problems|7|||
23519714|NCT02250443|65640125|FG000|Overall Study|Adverse Event|3|||
23519715|NCT00265343|65640132|FG000|Overall Study|Adverse Event|10|||
23519716|NCT00265343|65640133|FG001|Overall Study|Adverse Event|7|||
23519717|NCT00265343|65640132|FG000|Overall Study|Withdrawal by Subject|3|||
23519718|NCT00265343|65640133|FG001|Overall Study|Withdrawal by Subject|9|||
23519719|NCT00265343|65640132|FG000|Overall Study|Other|8|||
23519720|NCT00265343|65640133|FG001|Overall Study|Other|3|||
23519721|NCT01030523|65640134|FG000|Initial Study (5 Years)|Death|1|||
23519722|NCT01030523|65640135|FG001|Initial Study (5 Years)|Death|0|||
23519723|NCT01030523|65640134|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
23519724|NCT01030523|65640135|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
23519725|NCT01030523|65640134|FG000|Initial Study (5 Years)|Implant failure|1|||
23519726|NCT01030523|65640135|FG001|Initial Study (5 Years)|Implant failure|0|||
23519727|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
23519728|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
23519729|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
23519730|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
23519731|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
23519732|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
23519733|NCT02420691|65640138|FG000|Overall Study|Adverse Event|3|||
23519734|NCT02420691|65640138|FG000|Overall Study|Withdrawal by Subject|3|||
23519735|NCT04668950|65640139|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
23416222|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
23519736|NCT04668950|65640140|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
23519737|NCT04668950|65640139|FG000|Overall Study|Could not confirm started study medication|15|||
23519738|NCT04668950|65640140|FG001|Overall Study|Could not confirm started study medication|15|||
23519739|NCT04668950|65640139|FG000|Overall Study|Could not confirm baseline status|6|||
23519740|NCT04668950|65640140|FG001|Overall Study|Could not confirm baseline status|2|||
23519741|NCT04668950|65640139|FG000|Overall Study|Drop out and did not start medication|15|||
23519742|NCT04668950|65640140|FG001|Overall Study|Drop out and did not start medication|17|||
23519743|NCT04668950|65640139|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
23519744|NCT04668950|65640140|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
23519745|NCT04668950|65640139|FG000|Overall Study|Other|2|||
23519746|NCT04668950|65640140|FG001|Overall Study|Other|4|||
23519747|NCT00665353|65640151|FG000|Study Step 1|Adverse Event|1|||
23519748|NCT00665353|65640151|FG000|Study Step 1|Withdrawal by Subject|2|||
23519749|NCT00665353|65640151|FG000|Study Step 2|Lost to Follow-up|2|||
23519750|NCT00665353|65640151|FG000|Study Step 2|Lack of Efficacy|12|||
23519751|NCT04824131|65640152|FG000|CAB LA Oral Phase|Adverse Event|1|||
23519752|NCT04824131|65640152|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
23519753|NCT04824131|65640152|FG000|Step 3|Withdrawal by Subject|2|||
23519754|NCT02981342|65643260|FG000|Overall Study|Adverse Event|0|||
23519755|NCT02981342|65643261|FG001|Overall Study|Adverse Event|0|||
23519756|NCT02981342|65643262|FG002|Overall Study|Adverse Event|0|||
23519757|NCT02981342|65643263|FG003|Overall Study|Adverse Event|1|||
23519758|NCT02981342|65643260|FG000|Overall Study|Death|0|||
23519759|NCT02981342|65643261|FG001|Overall Study|Death|9|||
23519760|NCT02981342|65643262|FG002|Overall Study|Death|9|||
23519761|NCT02981342|65643263|FG003|Overall Study|Death|4|||
23519762|NCT02981342|65643260|FG000|Overall Study|Withdrawal by Subject|0|||
23519763|NCT02981342|65643261|FG001|Overall Study|Withdrawal by Subject|0|||
23519764|NCT02981342|65643262|FG002|Overall Study|Withdrawal by Subject|3|||
23519765|NCT02981342|65643263|FG003|Overall Study|Withdrawal by Subject|1|||
23519766|NCT02981342|65643260|FG000|Overall Study|Study closed by sponsor|0|||
23519767|NCT02981342|65643261|FG001|Overall Study|Study closed by sponsor|0|||
23519768|NCT02981342|65643262|FG002|Overall Study|Study closed by sponsor|1|||
23519769|NCT02981342|65643263|FG003|Overall Study|Study closed by sponsor|1|||
23519770|NCT02981342|65643260|FG000|Overall Study|Randomized, Never Treated|0|||
23519771|NCT02981342|65643261|FG001|Overall Study|Randomized, Never Treated|1|||
23519772|NCT02981342|65643262|FG002|Overall Study|Randomized, Never Treated|0|||
23519773|NCT02981342|65643263|FG003|Overall Study|Randomized, Never Treated|7|||
23519774|NCT02981342|65643260|FG000|Overall Study|Lost to Follow-up|0|||
23713346|NCT00280150|66325329|FG003|Overall Study|Withdrawal by Subject|1|||
23713347|NCT00280150|66325326|FG000|Overall Study|Did not get consolidation therapy|3|||
23713348|NCT00280150|66325327|FG001|Overall Study|Did not get consolidation therapy|0|||
23713349|NCT00280150|66325328|FG002|Overall Study|Did not get consolidation therapy|3|||
23713350|NCT00280150|66325329|FG003|Overall Study|Did not get consolidation therapy|0|||
23713351|NCT00280150|66325326|FG000|Overall Study|Declining Performance Status|0|||
23713352|NCT00280150|66325327|FG001|Overall Study|Declining Performance Status|0|||
23713353|NCT00280150|66325328|FG002|Overall Study|Declining Performance Status|0|||
23713354|NCT00280150|66325329|FG003|Overall Study|Declining Performance Status|1|||
23713355|NCT01293032|66325340|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23713356|NCT01293032|66325341|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23713357|NCT01293032|66325342|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
23713358|NCT01293032|66325343|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23713359|NCT01293032|66325340|FG000|Treatment|Adverse Event|0|||
23713360|NCT01293032|66325341|FG001|Treatment|Adverse Event|0|||
23713361|NCT01293032|66325342|FG002|Treatment|Adverse Event|1|||
23713362|NCT01293032|66325343|FG003|Treatment|Adverse Event|1|||
23713363|NCT01293032|66325340|FG000|Treatment|Withdrawal by Subject|2|||
23713364|NCT01293032|66325341|FG001|Treatment|Withdrawal by Subject|4|||
23713365|NCT01293032|66325342|FG002|Treatment|Withdrawal by Subject|0|||
23713366|NCT01293032|66325343|FG003|Treatment|Withdrawal by Subject|0|||
23713367|NCT01293032|66325340|FG000|Treatment|Disease Progression, relapse|0|||
23713368|NCT01293032|66325341|FG001|Treatment|Disease Progression, relapse|1|||
23812052|NCT02516553|66691892|FG017|Overall Study|Other Adverse Events|2|||
23812053|NCT02516553|66691893|FG018|Overall Study|Other Adverse Events|1|||
23812054|NCT02516553|66691894|FG019|Overall Study|Other Adverse Events|2|||
23812055|NCT02516553|66691895|FG020|Overall Study|Other Adverse Events|2|||
23812056|NCT02516553|66691896|FG021|Overall Study|Other Adverse Events|1|||
23812057|NCT02516553|66691875|FG000|Overall Study|Refused to continue trial medication|0|||
23519775|NCT02981342|65643261|FG001|Overall Study|Lost to Follow-up|1|||
23519776|NCT02981342|65643262|FG002|Overall Study|Lost to Follow-up|0|||
23519777|NCT02981342|65643263|FG003|Overall Study|Lost to Follow-up|0|||
23519778|NCT01480076|65643264|FG000|Overall Study|Run-in Failure|52|||
23519779|NCT01480076|65643264|FG000|Overall Study|Adverse Event|39|||
23519780|NCT01480076|65643264|FG000|Overall Study|Death|2|||
23519781|NCT01480076|65643264|FG000|Overall Study|Disease Progression|5|||
23519782|NCT01480076|65643264|FG000|Overall Study|Non-compliance With Study Protocol|15|||
23519783|NCT01480076|65643264|FG000|Overall Study|Withdrawal by Subject|105|||
23713369|NCT01293032|66325342|FG002|Treatment|Disease Progression, relapse|0|||
23713370|NCT01293032|66325343|FG003|Treatment|Disease Progression, relapse|0|||
23713371|NCT01905150|66325349|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
23713372|NCT01905150|66325350|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
23713373|NCT00115765|66325351|FG000|Overall Study|Withdrawal by Subject|22|||
23713374|NCT00115765|66325352|FG001|Overall Study|Withdrawal by Subject|53|||
23713375|NCT00115765|66325353|FG002|Overall Study|Withdrawal by Subject|76|||
23812058|NCT02516553|66691876|FG001|Overall Study|Refused to continue trial medication|0|||
23812059|NCT02516553|66691877|FG002|Overall Study|Refused to continue trial medication|0|||
23812060|NCT02516553|66691878|FG003|Overall Study|Refused to continue trial medication|0|||
23519784|NCT01480076|65643264|FG000|Overall Study|Lost to Follow-up|7|||
23519785|NCT01480076|65643264|FG000|Overall Study|Investigator Decision|13|||
23519786|NCT01480076|65643264|FG000|Overall Study|Other|52|||
23519787|NCT01413360|65643265|FG000|Overall Study|Lost to Follow-up|2|||
23519788|NCT01413360|65643265|FG000|Overall Study|Adverse Event|1|||
23519789|NCT02590939|65643266|FG000|Overall Study|Withdrawal by Subject|3|||
23519790|NCT02590939|65643267|FG001|Overall Study|Withdrawal by Subject|1|||
23713376|NCT00115765|66325354|FG003|Overall Study|Withdrawal by Subject|15|||
23519791|NCT02590939|65643266|FG000|Overall Study|Failed the nociceptive test|2|||
23519792|NCT02590939|65643267|FG001|Overall Study|Failed the nociceptive test|1|||
23519793|NCT01476696|65643268|FG000|Overall Study|Sponsor decision|2|||
23519794|NCT01476696|65643269|FG001|Overall Study|Sponsor decision|1|||
23519795|NCT01476696|65643270|FG002|Overall Study|Sponsor decision|0|||
23519796|NCT01476696|65643268|FG000|Overall Study|Withdrawal by Subject|1|||
23519797|NCT01476696|65643269|FG001|Overall Study|Withdrawal by Subject|0|||
23519798|NCT01476696|65643270|FG002|Overall Study|Withdrawal by Subject|0|||
23519799|NCT01586819|65643277|FG000|Overall Study|Withdrawal by Subject|1|||
23713377|NCT00115765|66325351|FG000|Overall Study|Physician Decision|4|||
23713378|NCT00115765|66325352|FG001|Overall Study|Physician Decision|15|||
23713379|NCT00115765|66325353|FG002|Overall Study|Physician Decision|18|||
23519800|NCT01586819|65643278|FG001|Overall Study|Withdrawal by Subject|0|||
23519801|NCT01068509|65643279|FG000|Overall Study|Death|0|||
23519802|NCT01068509|65643280|FG001|Overall Study|Death|0|||
23519803|NCT01068509|65643281|FG002|Overall Study|Death|1|||
23519804|NCT01068509|65643279|FG000|Overall Study|Disease Progression|5|||
23519805|NCT01068509|65643280|FG001|Overall Study|Disease Progression|20|||
23519806|NCT01068509|65643281|FG002|Overall Study|Disease Progression|18|||
23519807|NCT01068509|65643279|FG000|Overall Study|Lost to Follow-up|1|||
23519808|NCT01068509|65643280|FG001|Overall Study|Lost to Follow-up|0|||
23519809|NCT01068509|65643281|FG002|Overall Study|Lost to Follow-up|0|||
23519810|NCT01068509|65643279|FG000|Overall Study|Withdrew Consent|0|||
23519811|NCT01068509|65643280|FG001|Overall Study|Withdrew Consent|1|||
23519812|NCT01068509|65643281|FG002|Overall Study|Withdrew Consent|2|||
23519813|NCT01068509|65643279|FG000|Overall Study|Reason Not Specified|0|||
23519814|NCT01068509|65643280|FG001|Overall Study|Reason Not Specified|1|||
23519815|NCT01068509|65643281|FG002|Overall Study|Reason Not Specified|0|||
23519816|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|5|||
23519817|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519818|NCT00304356|65643282|FG000|Nitazoxanide|number is 0|1|||
23519819|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519820|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519821|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519822|NCT02775344|65643297|FG000|Overall Study|No ovarian cyst identified|3|||
23519823|NCT02775344|65643298|FG001|Overall Study|No ovarian cyst identified|2|||
23519824|NCT05333900|65643299|FG000|Overall Study|Protocol Violation|0|||
23519825|NCT05333900|65643300|FG001|Overall Study|Protocol Violation|1|||
23519826|NCT05333900|65643299|FG000|Overall Study|Withdrawal by Subject|0|||
23519827|NCT05333900|65643300|FG001|Overall Study|Withdrawal by Subject|1|||
23519828|NCT05333900|65643299|FG000|Overall Study|COVID-19 Pandemic|1|||
23519829|NCT05333900|65643300|FG001|Overall Study|COVID-19 Pandemic|1|||
23519830|NCT03886220|65643301|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
23519831|NCT03886220|65643302|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
23519832|NCT03886220|65643301|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23519833|NCT03886220|65643302|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23519834|NCT03886220|65643301|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23519835|NCT03886220|65643302|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23519836|NCT01454570|65643307|FG000|Overall Study|Withdrawal by Subject|2|||
23519837|NCT01454570|65643307|FG000|Overall Study|Screen Failure|7|||
23519838|NCT02503332|65643308|FG000|Overall Study|Adverse Event|17|||
23519839|NCT02503332|65643309|FG001|Overall Study|Adverse Event|5|||
23519840|NCT02503332|65643310|FG002|Overall Study|Adverse Event|3|||
23519841|NCT02503332|65643311|FG003|Overall Study|Adverse Event|1|||
23519842|NCT02503332|65643308|FG000|Overall Study|Investigator's Decision|5|||
23519843|NCT02503332|65643309|FG001|Overall Study|Investigator's Decision|1|||
23713380|NCT00115765|66325354|FG003|Overall Study|Physician Decision|13|||
23713381|NCT00115765|66325351|FG000|Overall Study|Lost to Follow-up|3|||
23713382|NCT00115765|66325352|FG001|Overall Study|Lost to Follow-up|20|||
23713383|NCT00115765|66325353|FG002|Overall Study|Lost to Follow-up|18|||
23713384|NCT00115765|66325354|FG003|Overall Study|Lost to Follow-up|1|||
23713385|NCT00115765|66325351|FG000|Overall Study|Other|6|||
23713386|NCT00115765|66325352|FG001|Overall Study|Other|12|||
23713387|NCT00115765|66325353|FG002|Overall Study|Other|9|||
23713388|NCT00115765|66325354|FG003|Overall Study|Other|2|||
23713389|NCT01968954|66325358|FG000|Overall Study|Adverse Event|6|||
23519844|NCT02503332|65643310|FG002|Overall Study|Investigator's Decision|0|||
23519845|NCT02503332|65643311|FG003|Overall Study|Investigator's Decision|0|||
23519846|NCT02503332|65643308|FG000|Overall Study|Sponsor's Decision|1|||
23519847|NCT02503332|65643309|FG001|Overall Study|Sponsor's Decision|0|||
23519848|NCT02503332|65643310|FG002|Overall Study|Sponsor's Decision|0|||
23519849|NCT02503332|65643311|FG003|Overall Study|Sponsor's Decision|1|||
23519850|NCT02503332|65643308|FG000|Overall Study|Subject Request|6|||
23519851|NCT02503332|65643309|FG001|Overall Study|Subject Request|5|||
23519852|NCT02503332|65643310|FG002|Overall Study|Subject Request|2|||
23713390|NCT01968954|66325359|FG001|Overall Study|Adverse Event|3|||
23713391|NCT01968954|66325358|FG000|Overall Study|Death|1|||
23713392|NCT01968954|66325359|FG001|Overall Study|Death|2|||
23713393|NCT01968954|66325358|FG000|Overall Study|Lost to Follow-up|6|||
23519853|NCT02503332|65643311|FG003|Overall Study|Subject Request|1|||
23519854|NCT02503332|65643308|FG000|Overall Study|Death|0|||
23519855|NCT02503332|65643309|FG001|Overall Study|Death|2|||
23519856|NCT02503332|65643310|FG002|Overall Study|Death|2|||
23519857|NCT02503332|65643311|FG003|Overall Study|Death|0|||
23519858|NCT02503332|65643308|FG000|Overall Study|Other|5|||
23519859|NCT02503332|65643309|FG001|Overall Study|Other|6|||
23519860|NCT02503332|65643310|FG002|Overall Study|Other|1|||
23519861|NCT02503332|65643311|FG003|Overall Study|Other|1|||
23519862|NCT01464346|65643312|FG000|Overall Study|Withdrawal by Subject|0|||
23519863|NCT01464346|65643313|FG001|Overall Study|Withdrawal by Subject|0|||
23519864|NCT01464346|65643314|FG002|Overall Study|Withdrawal by Subject|1|||
23519865|NCT02385266|65643315|FG000|Overall Study|Withdrawal by Subject|1|||
23519866|NCT02385266|65643316|FG001|Overall Study|Withdrawal by Subject|3|||
23519867|NCT01708174|65643317|FG000|Treatment Period|Withdrawal by Subject|1|||
23519868|NCT01708174|65643318|FG001|Treatment Period|Withdrawal by Subject|0|||
23519869|NCT01708174|65643319|FG002|Treatment Period|Withdrawal by Subject|0|||
23519870|NCT01708174|65643317|FG000|Treatment Period|Progressive disease|0|||
23519871|NCT01708174|65643318|FG001|Treatment Period|Progressive disease|1|||
23519872|NCT01708174|65643319|FG002|Treatment Period|Progressive disease|0|||
23519873|NCT01708174|65643317|FG000|Treatment Period|Death|0|||
23519874|NCT01708174|65643318|FG001|Treatment Period|Death|0|||
23519875|NCT01708174|65643319|FG002|Treatment Period|Death|1|||
23519876|NCT01708174|65643317|FG000|Treatment Period|Adverse Event|0|||
23519877|NCT01708174|65643318|FG001|Treatment Period|Adverse Event|1|||
23519878|NCT01708174|65643319|FG002|Treatment Period|Adverse Event|0|||
23519879|NCT01528072|65643320|FG000|Overall Study|Withdrawal by Subject|5|||
23519880|NCT01528072|65643320|FG000|Overall Study|Physician Decision|1|||
23519881|NCT01528072|65643320|FG000|Overall Study|Determined not eligible by AEAC|1|||
23519882|NCT01528072|65643320|FG000|Overall Study|Missed Visit|2|||
23519883|NCT01528072|65643320|FG000|Overall Study|Lost to Follow-up|5|||
23519884|NCT01528072|65643320|FG000|Overall Study|Explanted|2|||
23519885|NCT01528072|65643320|FG000|Overall Study|Site Closure|4|||
23519886|NCT01528072|65643320|FG000|Overall Study|Death|2|||
23519887|NCT01528072|65643320|FG000|Overall Study|Early Termination of Study|52|||
23519888|NCT03318315|65643321|FG000|Overall Study|Lost to Follow-up|3|||
23519889|NCT03318315|65643322|FG001|Overall Study|Lost to Follow-up|2|||
23713394|NCT01968954|66325359|FG001|Overall Study|Lost to Follow-up|4|||
23713395|NCT01968954|66325358|FG000|Overall Study|Withdrawal by Subject|20|||
23713396|NCT01968954|66325359|FG001|Overall Study|Withdrawal by Subject|23|||
23713397|NCT01968954|66325358|FG000|Overall Study|Other|7|||
23713398|NCT01968954|66325359|FG001|Overall Study|Other|8|||
23713399|NCT01968954|66325358|FG000|Overall Study|Protocol Violation|0|||
23713400|NCT01968954|66325359|FG001|Overall Study|Protocol Violation|1|||
23713401|NCT01968954|66325358|FG000|Overall Study|Did not met inclusion criteria|0|||
23713402|NCT01968954|66325359|FG001|Overall Study|Did not met inclusion criteria|2|||
23713403|NCT00819585|66325369|FG000|Core Study|Adverse Event|2|||
23713404|NCT00819585|66325370|FG001|Core Study|Adverse Event|1|||
23713405|NCT00819585|66325371|FG002|Core Study|Adverse Event|1|||
23713406|NCT00819585|66325372|FG003|Core Study|Adverse Event|4|||
23713407|NCT00819585|66325373|FG004|Core Study|Adverse Event|1|||
23713408|NCT00819585|66325374|FG005|Core Study|Adverse Event|0|||
23713409|NCT00819585|66325375|FG006|Core Study|Adverse Event|2|||
23713410|NCT00819585|66325376|FG007|Core Study|Adverse Event|0|||
23713411|NCT00819585|66325377|FG008|Core Study|Adverse Event|0|||
23713412|NCT00819585|66325378|FG009|Core Study|Adverse Event|0|||
23713413|NCT00819585|66325379|FG010|Core Study|Adverse Event|0|||
23713414|NCT00819585|66325369|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
23713415|NCT00819585|66325370|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
23713416|NCT00819585|66325371|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
23713417|NCT00819585|66325372|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
23713418|NCT00819585|66325373|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
23713419|NCT00819585|66325374|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
23713420|NCT00819585|66325375|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
23812061|NCT02516553|66691879|FG004|Overall Study|Refused to continue trial medication|0|||
23519890|NCT03318315|65643323|FG002|Overall Study|Lost to Follow-up|1|||
23519891|NCT03318315|65643321|FG000|Overall Study|Protocol Violation|1|||
23519892|NCT03318315|65643322|FG001|Overall Study|Protocol Violation|1|||
23519893|NCT03318315|65643323|FG002|Overall Study|Protocol Violation|1|||
23519894|NCT03318315|65643321|FG000|Overall Study|Withdrawal by Subject|0|||
23519895|NCT03318315|65643322|FG001|Overall Study|Withdrawal by Subject|0|||
23519896|NCT03318315|65643323|FG002|Overall Study|Withdrawal by Subject|2|||
23713421|NCT00819585|66325376|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
23713422|NCT00819585|66325377|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
23713423|NCT00819585|66325378|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
23713424|NCT00819585|66325379|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
23713425|NCT00819585|66325369|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713426|NCT00819585|66325370|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
23713427|NCT00819585|66325371|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713428|NCT00819585|66325372|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713429|NCT00819585|66325373|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713430|NCT00819585|66325374|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713431|NCT00819585|66325375|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
23713432|NCT00819585|66325376|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713433|NCT00819585|66325377|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713434|NCT00819585|66325378|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
23713435|NCT00819585|66325379|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
23519897|NCT02874742|65643324|FG000|Overall Study|Death|0|||
23519898|NCT02874742|65643325|FG001|Overall Study|Death|1|||
23519899|NCT02874742|65643326|FG002|Overall Study|Death|0|||
23519900|NCT02874742|65643324|FG000|Overall Study|Lost to Follow-up|5|||
23519901|NCT02874742|65643325|FG001|Overall Study|Lost to Follow-up|4|||
23519902|NCT02874742|65643326|FG002|Overall Study|Lost to Follow-up|1|||
23519903|NCT02874742|65643324|FG000|Overall Study|Withdrawal by Subject|17|||
23519904|NCT02874742|65643325|FG001|Overall Study|Withdrawal by Subject|8|||
23713436|NCT00819585|66325369|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
23519905|NCT02874742|65643326|FG002|Overall Study|Withdrawal by Subject|0|||
23519906|NCT02874742|65643324|FG000|Overall Study|Other|4|||
23519907|NCT02874742|65643325|FG001|Overall Study|Other|1|||
23519908|NCT02874742|65643326|FG002|Overall Study|Other|0|||
23519909|NCT02874742|65643324|FG000|Overall Study|Progressive Disease|1|||
23519910|NCT02874742|65643325|FG001|Overall Study|Progressive Disease|0|||
23519911|NCT02874742|65643326|FG002|Overall Study|Progressive Disease|0|||
23519912|NCT02874742|65643324|FG000|Overall Study|Screen Failure|0|||
23519913|NCT02874742|65643325|FG001|Overall Study|Screen Failure|2|||
23519914|NCT02874742|65643326|FG002|Overall Study|Screen Failure|0|||
23519915|NCT03165110|65643327|FG000|Overall Study|Anroid phone software incompatibility|1|||
23519916|NCT02410954|65643328|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
23519917|NCT02410954|65643329|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
23519918|NCT02410954|65643328|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
23519919|NCT02410954|65643329|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
23519920|NCT01085097|65643330|FG000|Overall Study|Adverse Event|0|||
23519921|NCT01085097|65643331|FG001|Overall Study|Adverse Event|0|||
23519922|NCT01085097|65643332|FG002|Overall Study|Adverse Event|2|||
23519923|NCT01085097|65643330|FG000|Overall Study|Treatment failure|2|||
23519924|NCT01085097|65643331|FG001|Overall Study|Treatment failure|0|||
23519925|NCT01085097|65643332|FG002|Overall Study|Treatment failure|0|||
23519926|NCT02053753|65643341|FG000|Overall Study|Withdrawal by Subject|2|||
23519927|NCT02053753|65643342|FG001|Overall Study|Withdrawal by Subject|4|||
23519928|NCT02053753|65643341|FG000|Overall Study|Decision by Sponsor|1|||
23519929|NCT02053753|65643342|FG001|Overall Study|Decision by Sponsor|1|||
23519930|NCT02053753|65643341|FG000|Overall Study|Lost to Follow-up|4|||
23519931|NCT02053753|65643342|FG001|Overall Study|Lost to Follow-up|3|||
23519932|NCT01774786|65643343|FG000|Overall Study|Death|300|||
23519933|NCT01774786|65643344|FG001|Overall Study|Death|319|||
23519934|NCT01774786|65643343|FG000|Overall Study|Lost to Follow-up|6|||
23519935|NCT01774786|65643344|FG001|Overall Study|Lost to Follow-up|7|||
23519936|NCT01774786|65643343|FG000|Overall Study|Withdrawal by Subject|18|||
23519937|NCT01774786|65643344|FG001|Overall Study|Withdrawal by Subject|14|||
23519938|NCT01774786|65643343|FG000|Overall Study|Physician Decision|2|||
23519939|NCT01774786|65643344|FG001|Overall Study|Physician Decision|0|||
23519940|NCT01774786|65643343|FG000|Overall Study|Non-compliance|0|||
23519941|NCT01774786|65643344|FG001|Overall Study|Non-compliance|1|||
23519942|NCT01774786|65643343|FG000|Overall Study|Reason Not Specified|2|||
23519943|NCT01774786|65643344|FG001|Overall Study|Reason Not Specified|5|||
23519944|NCT01859494|65643345|FG000|Overall Study|Adverse Event|1|||
23519945|NCT02275481|65643346|FG000|Overall Study|Death|2|||
23519946|NCT02275481|65643347|FG001|Overall Study|Death|1|||
23519947|NCT02275481|65643346|FG000|Overall Study|Lost to Follow-up|2|||
23519948|NCT02275481|65643347|FG001|Overall Study|Lost to Follow-up|0|||
23519949|NCT02275481|65643346|FG000|Overall Study|Withdrawal by Subject|3|||
23519950|NCT02275481|65643347|FG001|Overall Study|Withdrawal by Subject|0|||
23519951|NCT02275481|65643346|FG000|Overall Study|all other reasons combined|2|||
23519952|NCT02275481|65643347|FG001|Overall Study|all other reasons combined|1|||
23519953|NCT02275481|65643346|FG000|Overall Study|Physician Decision|0|||
23519954|NCT02275481|65643347|FG001|Overall Study|Physician Decision|1|||
23519955|NCT00698581|65643348|FG000|Overall Study|Lack of Efficacy|23|||
23519956|NCT00698581|65643349|FG001|Overall Study|Lack of Efficacy|11|||
23519957|NCT00698581|65643348|FG000|Overall Study|Withdrawal by Subject|6|||
23519958|NCT00698581|65643349|FG001|Overall Study|Withdrawal by Subject|0|||
23519959|NCT00698581|65643348|FG000|Overall Study|Other reason|9|||
23519960|NCT00698581|65643349|FG001|Overall Study|Other reason|1|||
23519961|NCT00698581|65643348|FG000|Overall Study|SAE, non-fatal|1|||
23519962|NCT00698581|65643349|FG001|Overall Study|SAE, non-fatal|0|||
23519963|NCT00698581|65643348|FG000|Overall Study|AE, non-serious non-fatal|4|||
23713437|NCT00819585|66325370|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
23519964|NCT00698581|65643349|FG001|Overall Study|AE, non-serious non-fatal|0|||
23519965|NCT00698581|65643348|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23519966|NCT00698581|65643349|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23519967|NCT00698581|65643348|FG000|Overall Study|AE of unknown type|1|||
23519968|NCT00698581|65643349|FG001|Overall Study|AE of unknown type|0|||
23519969|NCT01163279|65643350|FG000|Overall Study|Withdrawal by Subject|2|||
23519970|NCT01163279|65643351|FG001|Overall Study|Withdrawal by Subject|0|||
23519971|NCT00192504|65643352|FG000|Overall Study|Lost to Follow-up|1|||
23519972|NCT00192504|65643353|FG001|Overall Study|Lost to Follow-up|0|||
23519973|NCT00192504|65643354|FG002|Overall Study|Lost to Follow-up|0|||
23519974|NCT00192504|65643355|FG003|Overall Study|Lost to Follow-up|0|||
23519975|NCT00192504|65643352|FG000|Overall Study|Dosing window missed|0|||
23519976|NCT00192504|65643353|FG001|Overall Study|Dosing window missed|0|||
23519977|NCT00192504|65643354|FG002|Overall Study|Dosing window missed|1|||
23519978|NCT00192504|65643355|FG003|Overall Study|Dosing window missed|0|||
23519979|NCT02625090|65643356|FG000|Overall Study|Participant wants to be pregnant|2|||
23519980|NCT02625090|65643356|FG000|Overall Study|For the Promoter|1|||
23519981|NCT02625090|65643356|FG000|Overall Study|Sponsor's Decision|9|||
23519982|NCT02625090|65643356|FG000|Overall Study|Somnolence|1|||
23519983|NCT02625090|65643356|FG000|Overall Study|Study terminated by Sponsor|7|||
23519984|NCT02625090|65643356|FG000|Overall Study|Negative Benefit/Risk|1|||
23519985|NCT02625090|65643356|FG000|Overall Study|Protocol Deviation|2|||
23519986|NCT02625090|65643356|FG000|Overall Study|Lack of Efficacy|16|||
23519987|NCT02625090|65643356|FG000|Overall Study|Adverse Event|3|||
23519988|NCT00112502|65643357|FG000|Overall Study|Withdrawal by Subject|0|||
23519989|NCT00112502|65643358|FG001|Overall Study|Withdrawal by Subject|1|||
23519990|NCT00112502|65643359|FG002|Overall Study|Withdrawal by Subject|1|||
23519991|NCT00112502|65643360|FG003|Overall Study|Withdrawal by Subject|4|||
23519992|NCT00112502|65643361|FG004|Overall Study|Withdrawal by Subject|2|||
23519993|NCT00112502|65643362|FG005|Overall Study|Withdrawal by Subject|5|||
23519994|NCT00112502|65643363|FG006|Overall Study|Withdrawal by Subject|3|||
23519995|NCT00112502|65643364|FG007|Overall Study|Withdrawal by Subject|7|||
23519996|NCT04248933|65643365|FG000|Overall Study|Lost to Follow-up|9|||
23519997|NCT04248933|65643365|FG000|Overall Study|Withdrawal by Subject|2|||
23519998|NCT01465022|65643376|FG000|Overall Study|Lost to Follow-up|15|||
23519999|NCT01465022|65643377|FG001|Overall Study|Lost to Follow-up|14|||
23520000|NCT01465022|65643378|FG002|Overall Study|Lost to Follow-up|0|||
23520001|NCT01465022|65643376|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
23520002|NCT01465022|65643377|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
23520003|NCT01465022|65643378|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
23520004|NCT01465022|65643376|FG000|Overall Study|Not Randomized|0|||
23520005|NCT01465022|65643377|FG001|Overall Study|Not Randomized|0|||
23520006|NCT01465022|65643378|FG002|Overall Study|Not Randomized|70|||
23520007|NCT02917031|65643379|FG000|Overall Study|Reason not specified|7|||
23520008|NCT02917031|65643380|FG001|Overall Study|Reason not specified|5|||
23520009|NCT02917031|65643381|FG002|Overall Study|Reason not specified|6|||
23520010|NCT02917031|65643379|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
23520011|NCT02917031|65643380|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
23520012|NCT02917031|65643381|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
23713438|NCT00819585|66325371|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
23713439|NCT00819585|66325372|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
23713440|NCT00819585|66325373|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
23713441|NCT00819585|66325374|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
23713442|NCT00819585|66325375|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
23713443|NCT00819585|66325376|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
23713444|NCT00819585|66325377|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
23713445|NCT00819585|66325378|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
23713446|NCT00819585|66325379|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
23713447|NCT00819585|66325369|FG000|Core Study|Subject Withdrew Consent|0|||
23713448|NCT00819585|66325370|FG001|Core Study|Subject Withdrew Consent|3|||
23713449|NCT00819585|66325371|FG002|Core Study|Subject Withdrew Consent|2|||
23713450|NCT00819585|66325372|FG003|Core Study|Subject Withdrew Consent|1|||
23520013|NCT02917031|65643379|FG000|Overall Study|Withdrawal by Subject|3|||
23520014|NCT02917031|65643380|FG001|Overall Study|Withdrawal by Subject|3|||
23520015|NCT02917031|65643381|FG002|Overall Study|Withdrawal by Subject|0|||
23520016|NCT02917031|65643379|FG000|Overall Study|Physician Decision|1|||
23520017|NCT02917031|65643380|FG001|Overall Study|Physician Decision|0|||
23520018|NCT02917031|65643381|FG002|Overall Study|Physician Decision|0|||
23520019|NCT02917031|65643379|FG000|Overall Study|Adverse Event|4|||
23520020|NCT02917031|65643380|FG001|Overall Study|Adverse Event|1|||
23520021|NCT02917031|65643381|FG002|Overall Study|Adverse Event|5|||
23520022|NCT02917031|65643379|FG000|Overall Study|Death|2|||
23713451|NCT00819585|66325373|FG004|Core Study|Subject Withdrew Consent|0|||
23713452|NCT00819585|66325374|FG005|Core Study|Subject Withdrew Consent|0|||
23520023|NCT02917031|65643380|FG001|Overall Study|Death|3|||
23520024|NCT02917031|65643381|FG002|Overall Study|Death|4|||
23520025|NCT00101907|65643386|FG000|Overall Study|Adverse Event|1|||
23520026|NCT00101907|65643387|FG001|Overall Study|Adverse Event|0|||
23520027|NCT00101907|65643388|FG002|Overall Study|Adverse Event|0|||
23520028|NCT00101907|65643389|FG003|Overall Study|Adverse Event|0|||
23520029|NCT00101907|65643390|FG004|Overall Study|Adverse Event|0|||
23520030|NCT00101907|65643391|FG005|Overall Study|Adverse Event|0|||
23520031|NCT00101907|65643386|FG000|Overall Study|Death|0|||
23520032|NCT00101907|65643387|FG001|Overall Study|Death|1|||
23520033|NCT00101907|65643388|FG002|Overall Study|Death|0|||
23713453|NCT00819585|66325375|FG006|Core Study|Subject Withdrew Consent|3|||
23713454|NCT00819585|66325376|FG007|Core Study|Subject Withdrew Consent|0|||
23713455|NCT00819585|66325377|FG008|Core Study|Subject Withdrew Consent|0|||
23713456|NCT00819585|66325378|FG009|Core Study|Subject Withdrew Consent|0|||
23713457|NCT00819585|66325379|FG010|Core Study|Subject Withdrew Consent|0|||
23713458|NCT00819585|66325369|FG000|Core Study|Lost to Follow-up|2|||
23713459|NCT00819585|66325370|FG001|Core Study|Lost to Follow-up|1|||
23713460|NCT00819585|66325371|FG002|Core Study|Lost to Follow-up|2|||
23713461|NCT00819585|66325372|FG003|Core Study|Lost to Follow-up|0|||
23713462|NCT00819585|66325373|FG004|Core Study|Lost to Follow-up|1|||
23713463|NCT00819585|66325374|FG005|Core Study|Lost to Follow-up|1|||
23713464|NCT00819585|66325375|FG006|Core Study|Lost to Follow-up|1|||
23713465|NCT00819585|66325376|FG007|Core Study|Lost to Follow-up|0|||
23713466|NCT00819585|66325377|FG008|Core Study|Lost to Follow-up|0|||
23713467|NCT00819585|66325378|FG009|Core Study|Lost to Follow-up|0|||
23713468|NCT00819585|66325379|FG010|Core Study|Lost to Follow-up|0|||
23713469|NCT00819585|66325369|FG000|Core Study|Administrative Problems|0|||
23713470|NCT00819585|66325370|FG001|Core Study|Administrative Problems|0|||
23713471|NCT00819585|66325371|FG002|Core Study|Administrative Problems|0|||
23713472|NCT00819585|66325372|FG003|Core Study|Administrative Problems|0|||
23713473|NCT00819585|66325373|FG004|Core Study|Administrative Problems|0|||
23713474|NCT00819585|66325374|FG005|Core Study|Administrative Problems|0|||
23713475|NCT00819585|66325375|FG006|Core Study|Administrative Problems|2|||
23713476|NCT00819585|66325376|FG007|Core Study|Administrative Problems|0|||
23713477|NCT00819585|66325377|FG008|Core Study|Administrative Problems|0|||
23713478|NCT00819585|66325378|FG009|Core Study|Administrative Problems|0|||
23713479|NCT00819585|66325379|FG010|Core Study|Administrative Problems|0|||
23713480|NCT00819585|66325369|FG000|Core Study|Death|0|||
23713481|NCT00819585|66325370|FG001|Core Study|Death|0|||
23713482|NCT00819585|66325371|FG002|Core Study|Death|0|||
23520034|NCT00101907|65643389|FG003|Overall Study|Death|0|||
23520035|NCT00101907|65643390|FG004|Overall Study|Death|3|||
23520036|NCT00101907|65643391|FG005|Overall Study|Death|0|||
23520037|NCT00101907|65643386|FG000|Overall Study|Physician Decision|0|||
23520038|NCT00101907|65643387|FG001|Overall Study|Physician Decision|0|||
23520039|NCT00101907|65643388|FG002|Overall Study|Physician Decision|0|||
23520040|NCT00101907|65643389|FG003|Overall Study|Physician Decision|1|||
23520041|NCT00101907|65643390|FG004|Overall Study|Physician Decision|1|||
23520042|NCT00101907|65643391|FG005|Overall Study|Physician Decision|0|||
23520043|NCT00101907|65643386|FG000|Overall Study|Withdrawal by Subject|1|||
23520044|NCT00101907|65643387|FG001|Overall Study|Withdrawal by Subject|0|||
23520045|NCT00101907|65643388|FG002|Overall Study|Withdrawal by Subject|1|||
23520046|NCT00101907|65643389|FG003|Overall Study|Withdrawal by Subject|0|||
23520047|NCT00101907|65643390|FG004|Overall Study|Withdrawal by Subject|1|||
23520048|NCT00101907|65643391|FG005|Overall Study|Withdrawal by Subject|0|||
23520049|NCT01852812|65643399|FG000|Overall Study|Adverse Event|0|||
23520050|NCT01852812|65643400|FG001|Overall Study|Adverse Event|0|||
23520051|NCT01852812|65643401|FG002|Overall Study|Adverse Event|1|||
23520052|NCT01852812|65643399|FG000|Overall Study|Non-compliance With Study Drug|0|||
23520053|NCT01852812|65643400|FG001|Overall Study|Non-compliance With Study Drug|1|||
23520054|NCT01852812|65643401|FG002|Overall Study|Non-compliance With Study Drug|0|||
23520055|NCT00994240|65643402|FG000|Overall Study|Lost to Follow-up|3|||
23520056|NCT00994240|65643403|FG001|Overall Study|Lost to Follow-up|2|||
23520057|NCT00994240|65643402|FG000|Overall Study|Withdrawal by Subject|1|||
23713483|NCT00819585|66325372|FG003|Core Study|Death|0|||
23520058|NCT00994240|65643403|FG001|Overall Study|Withdrawal by Subject|0|||
23520059|NCT00994240|65643402|FG000|Overall Study|study termination|2|||
23520060|NCT00994240|65643403|FG001|Overall Study|study termination|3|||
23520061|NCT00791518|65643404|FG000|Overall Study|Protocol Violation|93|||
23520062|NCT04127786|65643407|FG000|Primary Series|Adverse Event|1|||
23520063|NCT04127786|65643408|FG001|Primary Series|Adverse Event|0|||
23520064|NCT04127786|65643409|FG002|Primary Series|Adverse Event|0|||
23713484|NCT00819585|66325373|FG004|Core Study|Death|0|||
23713485|NCT00819585|66325374|FG005|Core Study|Death|0|||
23713486|NCT00819585|66325375|FG006|Core Study|Death|1|||
23713487|NCT00819585|66325376|FG007|Core Study|Death|0|||
23713488|NCT00819585|66325377|FG008|Core Study|Death|0|||
23713489|NCT00819585|66325378|FG009|Core Study|Death|0|||
23713490|NCT00819585|66325379|FG010|Core Study|Death|0|||
23713491|NCT00819585|66325369|FG000|Core Study|Protocol Violation|0|||
23520065|NCT04127786|65643410|FG003|Primary Series|Adverse Event|1|||
23520066|NCT04127786|65643411|FG004|Primary Series|Adverse Event|0|||
23520067|NCT04127786|65643412|FG005|Primary Series|Adverse Event|1|||
23520068|NCT04127786|65643407|FG000|Primary Series|Protocol Violation|5|||
23713492|NCT00819585|66325370|FG001|Core Study|Protocol Violation|0|||
23713493|NCT00819585|66325371|FG002|Core Study|Protocol Violation|1|||
23713494|NCT00819585|66325372|FG003|Core Study|Protocol Violation|0|||
23713495|NCT00819585|66325373|FG004|Core Study|Protocol Violation|0|||
23713496|NCT00819585|66325374|FG005|Core Study|Protocol Violation|1|||
23713497|NCT00819585|66325375|FG006|Core Study|Protocol Violation|3|||
23713498|NCT00819585|66325376|FG007|Core Study|Protocol Violation|0|||
23713499|NCT00819585|66325377|FG008|Core Study|Protocol Violation|0|||
23713500|NCT00819585|66325378|FG009|Core Study|Protocol Violation|0|||
23713501|NCT00819585|66325379|FG010|Core Study|Protocol Violation|0|||
23713502|NCT00819585|66325369|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
23713503|NCT00819585|66325370|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
23713504|NCT00819585|66325371|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
23713505|NCT00819585|66325372|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
23713506|NCT00819585|66325373|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
23713507|NCT00819585|66325374|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
23713508|NCT00819585|66325375|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
23713509|NCT00819585|66325376|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
23520069|NCT04127786|65643408|FG001|Primary Series|Protocol Violation|3|||
23520070|NCT04127786|65643409|FG002|Primary Series|Protocol Violation|4|||
23520071|NCT04127786|65643410|FG003|Primary Series|Protocol Violation|3|||
23520072|NCT04127786|65643411|FG004|Primary Series|Protocol Violation|2|||
23520073|NCT04127786|65643412|FG005|Primary Series|Protocol Violation|0|||
23520074|NCT04127786|65643407|FG000|Primary Series|Withdrawal by Subject|0|||
23520075|NCT04127786|65643408|FG001|Primary Series|Withdrawal by Subject|0|||
23520076|NCT04127786|65643409|FG002|Primary Series|Withdrawal by Subject|0|||
23520077|NCT04127786|65643410|FG003|Primary Series|Withdrawal by Subject|1|||
23520078|NCT04127786|65643411|FG004|Primary Series|Withdrawal by Subject|0|||
23520079|NCT04127786|65643412|FG005|Primary Series|Withdrawal by Subject|0|||
23520080|NCT04127786|65643407|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
23520081|NCT04127786|65643408|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
23520082|NCT04127786|65643409|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
23520083|NCT04127786|65643410|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
23520084|NCT04127786|65643411|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
23520085|NCT04127786|65643412|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
23520086|NCT04127786|65643407|FG000|Booster Phase|Withdrawal by Subject|2|||
23520087|NCT04127786|65643408|FG001|Booster Phase|Withdrawal by Subject|0|||
23520088|NCT04127786|65643409|FG002|Booster Phase|Withdrawal by Subject|0|||
23520089|NCT04127786|65643410|FG003|Booster Phase|Withdrawal by Subject|0|||
23520090|NCT04127786|65643411|FG004|Booster Phase|Withdrawal by Subject|0|||
23520091|NCT04127786|65643412|FG005|Booster Phase|Withdrawal by Subject|0|||
23520092|NCT01367158|65643413|FG000|Overall Study|Withdrew consent|0|||
23520093|NCT01367158|65643414|FG001|Overall Study|Withdrew consent|2|||
23520094|NCT01367158|65643415|FG002|Overall Study|Withdrew consent|1|||
23520095|NCT01367158|65643416|FG003|Overall Study|Withdrew consent|0|||
23520096|NCT01367158|65643417|FG004|Overall Study|Withdrew consent|2|||
23812062|NCT02516553|66691880|FG005|Overall Study|Refused to continue trial medication|0|||
23812063|NCT02516553|66691881|FG006|Overall Study|Refused to continue trial medication|0|||
23520097|NCT01367158|65643418|FG005|Overall Study|Withdrew consent|0|||
23520098|NCT01367158|65643419|FG006|Overall Study|Withdrew consent|0|||
23520099|NCT01367158|65643420|FG007|Overall Study|Withdrew consent|1|||
23520100|NCT01367158|65643421|FG008|Overall Study|Withdrew consent|0|||
23520101|NCT01367158|65643422|FG009|Overall Study|Withdrew consent|0|||
23520102|NCT01367158|65643423|FG010|Overall Study|Withdrew consent|0|||
23520103|NCT01367158|65643413|FG000|Overall Study|Lost to Follow-up|0|||
23520104|NCT01367158|65643414|FG001|Overall Study|Lost to Follow-up|0|||
23520105|NCT01367158|65643415|FG002|Overall Study|Lost to Follow-up|0|||
23520106|NCT01367158|65643416|FG003|Overall Study|Lost to Follow-up|1|||
23520107|NCT01367158|65643417|FG004|Overall Study|Lost to Follow-up|0|||
23520108|NCT01367158|65643418|FG005|Overall Study|Lost to Follow-up|2|||
23520109|NCT01367158|65643419|FG006|Overall Study|Lost to Follow-up|0|||
23520110|NCT01367158|65643420|FG007|Overall Study|Lost to Follow-up|1|||
23520111|NCT01367158|65643421|FG008|Overall Study|Lost to Follow-up|0|||
23520112|NCT01367158|65643422|FG009|Overall Study|Lost to Follow-up|0|||
23520113|NCT01367158|65643423|FG010|Overall Study|Lost to Follow-up|1|||
23520114|NCT01367158|65643413|FG000|Overall Study|Protocol Violation|0|||
23520115|NCT01367158|65643414|FG001|Overall Study|Protocol Violation|1|||
23520116|NCT01367158|65643415|FG002|Overall Study|Protocol Violation|0|||
23520117|NCT01367158|65643416|FG003|Overall Study|Protocol Violation|0|||
23713510|NCT00819585|66325377|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
23713511|NCT00819585|66325378|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
23713512|NCT00819585|66325379|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
23520118|NCT01367158|65643417|FG004|Overall Study|Protocol Violation|0|||
23520119|NCT01367158|65643418|FG005|Overall Study|Protocol Violation|0|||
23520120|NCT01367158|65643419|FG006|Overall Study|Protocol Violation|0|||
23520121|NCT01367158|65643420|FG007|Overall Study|Protocol Violation|0|||
23520122|NCT01367158|65643421|FG008|Overall Study|Protocol Violation|0|||
23520123|NCT01367158|65643422|FG009|Overall Study|Protocol Violation|0|||
23520124|NCT01367158|65643423|FG010|Overall Study|Protocol Violation|0|||
23520125|NCT01324349|65643424|FG000|Overall Study|Death|1|||
23520126|NCT01324349|65643425|FG001|Overall Study|Death|1|||
23713513|NCT00819585|66325369|FG000|Extension Study|Subject Withdrew Consent|0|||
23713514|NCT00819585|66325370|FG001|Extension Study|Subject Withdrew Consent|0|||
23713515|NCT00819585|66325371|FG002|Extension Study|Subject Withdrew Consent|0|||
23520127|NCT01324349|65643424|FG000|Overall Study|Withdrawal by Subject|0|||
23520128|NCT01324349|65643425|FG001|Overall Study|Withdrawal by Subject|1|||
23520129|NCT00323492|65643426|FG000|Study Phase 1|Adverse Event|2|||
23520130|NCT00323492|65643427|FG001|Study Phase 1|Adverse Event|0|||
23520131|NCT00323492|65643428|FG002|Study Phase 1|Adverse Event|0|||
23520132|NCT00323492|65643426|FG000|Study Phase 2|Adverse Event|1|||
23520133|NCT00323492|65643427|FG001|Study Phase 2|Adverse Event|0|||
23520134|NCT00323492|65643428|FG002|Study Phase 2|Adverse Event|0|||
23520135|NCT00323492|65643426|FG000|Study Phase 2|Physician Decision|1|||
23520136|NCT00323492|65643427|FG001|Study Phase 2|Physician Decision|0|||
23520137|NCT00323492|65643428|FG002|Study Phase 2|Physician Decision|0|||
23520138|NCT00323492|65643426|FG000|Study Phase 2|Lost to Follow-up|1|||
23520139|NCT00323492|65643427|FG001|Study Phase 2|Lost to Follow-up|0|||
23520140|NCT00323492|65643428|FG002|Study Phase 2|Lost to Follow-up|0|||
23520141|NCT00323492|65643426|FG000|Study Phase 2|Withdrawal by Subject|0|||
23520142|NCT00323492|65643427|FG001|Study Phase 2|Withdrawal by Subject|1|||
23520143|NCT00323492|65643428|FG002|Study Phase 2|Withdrawal by Subject|0|||
23520144|NCT00323492|65643426|FG000|Study Phase 2|Noncompliance with study schedule|0|||
23520145|NCT00323492|65643427|FG001|Study Phase 2|Noncompliance with study schedule|0|||
23520146|NCT00323492|65643428|FG002|Study Phase 2|Noncompliance with study schedule|1|||
23520147|NCT00323492|65643426|FG000|Study Phase 2|Protocol Violation|1|||
23520148|NCT00323492|65643427|FG001|Study Phase 2|Protocol Violation|0|||
23520149|NCT00323492|65643428|FG002|Study Phase 2|Protocol Violation|0|||
23520150|NCT04404855|65643429|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
23520151|NCT04404855|65643430|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
23520152|NCT00409617|65643431|FG000|Overall Study|Adverse Event|57|||
23520153|NCT00409617|65643431|FG000|Overall Study|Lack of Efficacy|54|||
23520154|NCT00409617|65643431|FG000|Overall Study|Lost to Follow-up|2|||
23520155|NCT00409617|65643431|FG000|Overall Study|Protocol Violation|24|||
23520156|NCT00409617|65643431|FG000|Overall Study|Withdrawal by Subject|8|||
23520157|NCT00409617|65643431|FG000|Overall Study|Administrative reasons|1|||
23520158|NCT00409617|65643431|FG000|Overall Study|Not described|14|||
23520159|NCT01012622|65643433|FG000|Overall Study|Withdrawal by Subject|6|||
23520160|NCT01012622|65643433|FG000|Overall Study|Lost to Follow-up|5|||
23520161|NCT01012622|65643433|FG000|Overall Study|Adverse Event|7|||
23520162|NCT01012622|65643433|FG000|Overall Study|non-compliance with the drug|9|||
23520163|NCT01012622|65643433|FG000|Overall Study|Other|1|||
23520164|NCT01012622|65643433|FG000|Overall Study|screening failure|1|||
23520165|NCT01012622|65643433|FG000|Overall Study|withdrawal of consent by a parent|2|||
23520166|NCT01179477|65643435|FG000|Overall Study|Death|542|||
23520167|NCT01179477|65643435|FG000|Overall Study|Unsuccessful implant|80|||
23520168|NCT01179477|65643435|FG000|Overall Study|Non-death withdrawal|438|||
23520169|NCT01179477|65643435|FG000|Overall Study|Did not complete final visit|27|||
23520170|NCT01327300|65643442|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
23520171|NCT01327300|65643443|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
23520172|NCT02075658|65643444|FG000|Overall Study|Physician Decision|2|||
23520173|NCT02075658|65643445|FG001|Overall Study|Physician Decision|2|||
23520174|NCT01176266|65643446|FG000|Overall Study|Death|6|||
23520175|NCT01176266|65643446|FG000|Overall Study|Withdrawal by Subject|3|||
23520176|NCT01150123|65643447|FG000|Overall Study|Withdrawal by Subject|1|||
23520177|NCT01150123|65643448|FG001|Overall Study|Withdrawal by Subject|1|||
23520178|NCT01150123|65643449|FG002|Overall Study|Withdrawal by Subject|2|||
23520179|NCT01150123|65643450|FG003|Overall Study|Withdrawal by Subject|1|||
23520180|NCT01150123|65643451|FG004|Overall Study|Withdrawal by Subject|1|||
23520181|NCT01150123|65643452|FG005|Overall Study|Withdrawal by Subject|1|||
23713516|NCT00819585|66325372|FG003|Extension Study|Subject Withdrew Consent|0|||
23520182|NCT01150123|65643453|FG006|Overall Study|Withdrawal by Subject|0|||
23520183|NCT01150123|65643454|FG007|Overall Study|Withdrawal by Subject|3|||
23520184|NCT01150123|65643455|FG008|Overall Study|Withdrawal by Subject|2|||
23520185|NCT01150123|65643456|FG009|Overall Study|Withdrawal by Subject|0|||
23520186|NCT01150123|65643457|FG010|Overall Study|Withdrawal by Subject|1|||
23520187|NCT01150123|65643458|FG011|Overall Study|Withdrawal by Subject|0|||
23520188|NCT01150123|65643459|FG012|Overall Study|Withdrawal by Subject|1|||
23713517|NCT00819585|66325373|FG004|Extension Study|Subject Withdrew Consent|0|||
23520189|NCT01150123|65643460|FG013|Overall Study|Withdrawal by Subject|0|||
23520190|NCT01150123|65643461|FG014|Overall Study|Withdrawal by Subject|0|||
23520191|NCT01150123|65643462|FG015|Overall Study|Withdrawal by Subject|1|||
23520192|NCT01150123|65643463|FG016|Overall Study|Withdrawal by Subject|0|||
23520193|NCT01150123|65643464|FG017|Overall Study|Withdrawal by Subject|1|||
23520194|NCT01150123|65643447|FG000|Overall Study|Lost to Follow-up|2|||
23520195|NCT01150123|65643448|FG001|Overall Study|Lost to Follow-up|1|||
23520196|NCT01150123|65643449|FG002|Overall Study|Lost to Follow-up|2|||
23520197|NCT01150123|65643450|FG003|Overall Study|Lost to Follow-up|2|||
23520198|NCT01150123|65643451|FG004|Overall Study|Lost to Follow-up|2|||
23520199|NCT01150123|65643452|FG005|Overall Study|Lost to Follow-up|5|||
23520200|NCT01150123|65643453|FG006|Overall Study|Lost to Follow-up|0|||
23520201|NCT01150123|65643454|FG007|Overall Study|Lost to Follow-up|0|||
23520202|NCT01150123|65643455|FG008|Overall Study|Lost to Follow-up|3|||
23520203|NCT01150123|65643456|FG009|Overall Study|Lost to Follow-up|1|||
23520204|NCT01150123|65643457|FG010|Overall Study|Lost to Follow-up|1|||
23520205|NCT01150123|65643458|FG011|Overall Study|Lost to Follow-up|1|||
23520206|NCT01150123|65643459|FG012|Overall Study|Lost to Follow-up|2|||
23520207|NCT01150123|65643460|FG013|Overall Study|Lost to Follow-up|0|||
23520208|NCT01150123|65643461|FG014|Overall Study|Lost to Follow-up|0|||
23713518|NCT00819585|66325374|FG005|Extension Study|Subject Withdrew Consent|0|||
23713519|NCT00819585|66325375|FG006|Extension Study|Subject Withdrew Consent|0|||
23713520|NCT00819585|66325376|FG007|Extension Study|Subject Withdrew Consent|0|||
23713521|NCT00819585|66325377|FG008|Extension Study|Subject Withdrew Consent|3|||
23713522|NCT00819585|66325378|FG009|Extension Study|Subject Withdrew Consent|0|||
23713523|NCT00819585|66325379|FG010|Extension Study|Subject Withdrew Consent|1|||
23713524|NCT00819585|66325369|FG000|Extension Study|Lost to Follow-up|0|||
23713525|NCT00819585|66325370|FG001|Extension Study|Lost to Follow-up|0|||
23713526|NCT00819585|66325371|FG002|Extension Study|Lost to Follow-up|0|||
23713527|NCT00819585|66325372|FG003|Extension Study|Lost to Follow-up|0|||
23713528|NCT00819585|66325373|FG004|Extension Study|Lost to Follow-up|0|||
23713529|NCT00819585|66325374|FG005|Extension Study|Lost to Follow-up|0|||
23713530|NCT00819585|66325375|FG006|Extension Study|Lost to Follow-up|0|||
23713531|NCT00819585|66325376|FG007|Extension Study|Lost to Follow-up|0|||
23713532|NCT00819585|66325377|FG008|Extension Study|Lost to Follow-up|2|||
23713533|NCT00819585|66325378|FG009|Extension Study|Lost to Follow-up|1|||
23713534|NCT00819585|66325379|FG010|Extension Study|Lost to Follow-up|1|||
23713535|NCT00819585|66325369|FG000|Extension Study|Death|0|||
23713536|NCT00819585|66325370|FG001|Extension Study|Death|0|||
23713537|NCT00819585|66325371|FG002|Extension Study|Death|0|||
23713538|NCT00819585|66325372|FG003|Extension Study|Death|0|||
23713539|NCT00819585|66325373|FG004|Extension Study|Death|0|||
23713540|NCT00819585|66325374|FG005|Extension Study|Death|0|||
23713541|NCT00819585|66325375|FG006|Extension Study|Death|0|||
23713542|NCT00819585|66325376|FG007|Extension Study|Death|0|||
23713543|NCT00819585|66325377|FG008|Extension Study|Death|2|||
23713544|NCT00819585|66325378|FG009|Extension Study|Death|0|||
23713545|NCT00819585|66325379|FG010|Extension Study|Death|0|||
23713546|NCT01844830|66325382|FG000|Overall Study|Withdrawal by Subject|1|||
23713547|NCT01844830|66325383|FG001|Overall Study|Withdrawal by Subject|0|||
23713548|NCT01429077|66325386|FG000|Overall Study|Lost to Follow-up|0|||
23713549|NCT01429077|66325387|FG001|Overall Study|Lost to Follow-up|3|||
23713550|NCT03628417|66325388|FG000|Overall Study|Death|1|||
23713551|NCT03628417|66325389|FG001|Overall Study|Death|1|||
23713552|NCT02156492|66325392|FG000|Period 1|No Reason Given|0|||
23713553|NCT02156492|66325393|FG001|Period 1|No Reason Given|1|||
23713554|NCT02156492|66325394|FG002|Period 1|No Reason Given|0|||
23713555|NCT02156492|66325392|FG000|Period 3|Adverse Event|0|||
23713556|NCT02156492|66325393|FG001|Period 3|Adverse Event|1|||
23713557|NCT02156492|66325394|FG002|Period 3|Adverse Event|0|||
23713558|NCT01996748|66325396|FG000|Overall Study|Personal reason|1|||
23713559|NCT01996748|66325397|FG001|Overall Study|Personal reason|0|||
23713560|NCT01996748|66325396|FG000|Overall Study|Physician Decision|2|||
23713561|NCT01996748|66325397|FG001|Overall Study|Physician Decision|0|||
23713562|NCT01996748|66325396|FG000|Overall Study|Adverse Event|1|||
23713563|NCT01996748|66325397|FG001|Overall Study|Adverse Event|4|||
23713564|NCT01996748|66325396|FG000|Overall Study|Withdrawal by Subject|0|||
23520209|NCT01150123|65643462|FG015|Overall Study|Lost to Follow-up|0|||
23520210|NCT01150123|65643463|FG016|Overall Study|Lost to Follow-up|0|||
23520211|NCT01150123|65643464|FG017|Overall Study|Lost to Follow-up|0|||
23520212|NCT01527682|65643465|FG000|Overall Study|Protocol Violation|8|||
23713565|NCT01996748|66325397|FG001|Overall Study|Withdrawal by Subject|1|||
23713566|NCT01996748|66325396|FG000|Overall Study|Lost to Follow-up|4|||
23713567|NCT01996748|66325397|FG001|Overall Study|Lost to Follow-up|1|||
23713568|NCT00789191|66325398|FG000|Overall Study|Adverse Event|2|||
23713569|NCT00789191|66325399|FG001|Overall Study|Adverse Event|4|||
23713570|NCT00789191|66325398|FG000|Overall Study|Lack of Efficacy|0|||
23713571|NCT00789191|66325399|FG001|Overall Study|Lack of Efficacy|5|||
23713572|NCT00789191|66325398|FG000|Overall Study|Protocol Violation|5|||
23713573|NCT00789191|66325399|FG001|Overall Study|Protocol Violation|3|||
23713574|NCT00789191|66325398|FG000|Overall Study|Withdrawal Criteria|2|||
23713575|NCT00789191|66325399|FG001|Overall Study|Withdrawal Criteria|4|||
23713576|NCT00789191|66325398|FG000|Overall Study|Unclassified|5|||
23713577|NCT00789191|66325399|FG001|Overall Study|Unclassified|3|||
23713578|NCT00111917|66325400|FG000|Overall Study|Withdrawal by Subject|1|||
23713579|NCT00111917|66325401|FG001|Overall Study|Withdrawal by Subject|1|||
23713580|NCT02227108|66325402|FG000|Overall Study|Did not receive treatment|2|||
23713581|NCT02227108|66325402|FG000|Overall Study|Other|3|||
23520213|NCT04809220|65643466|FG000|Overall Study|Adverse Event|4|||
23520214|NCT04809220|65643467|FG001|Overall Study|Adverse Event|0|||
23713582|NCT02227108|66325402|FG000|Overall Study|Progressive disease|17|||
23713583|NCT02227108|66325402|FG000|Overall Study|Initiation of alternative therapy|2|||
23713584|NCT02227108|66325402|FG000|Overall Study|Investigator discretion|1|||
23713585|NCT02227108|66325402|FG000|Overall Study|Adverse Event|6|||
23713586|NCT01736254|66325403|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
23713587|NCT01736254|66325403|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
23713588|NCT01928485|66325404|FG000|Overall Study|Physician Decision|0|||
23713589|NCT01928485|66325405|FG001|Overall Study|Physician Decision|1|||
23713590|NCT01895452|66325406|FG000|Overall Study|Adverse Event|1|||
23713591|NCT01895452|66325407|FG001|Overall Study|Adverse Event|4|||
23713592|NCT01895452|66325406|FG000|Overall Study|Lost to Follow-up|1|||
23713593|NCT01895452|66325407|FG001|Overall Study|Lost to Follow-up|5|||
23713594|NCT01895452|66325406|FG000|Overall Study|Pregnancy|0|||
23713595|NCT01895452|66325407|FG001|Overall Study|Pregnancy|1|||
23713596|NCT01895452|66325406|FG000|Overall Study|Withdrawal by Subject|2|||
23713597|NCT01895452|66325407|FG001|Overall Study|Withdrawal by Subject|14|||
23713598|NCT01895452|66325406|FG000|Overall Study|Underlying disease|0|||
23713599|NCT01895452|66325407|FG001|Overall Study|Underlying disease|3|||
23713600|NCT01895452|66325406|FG000|Overall Study|Noncompliance with study drug|0|||
23520215|NCT04809220|65643466|FG000|Overall Study|Death|1|||
23520216|NCT04809220|65643467|FG001|Overall Study|Death|0|||
23520217|NCT04809220|65643466|FG000|Overall Study|Lost to Follow-up|3|||
23520218|NCT04809220|65643467|FG001|Overall Study|Lost to Follow-up|0|||
23520219|NCT04809220|65643466|FG000|Overall Study|Physician Decision|0|||
23520220|NCT04809220|65643467|FG001|Overall Study|Physician Decision|1|||
23520221|NCT04809220|65643466|FG000|Overall Study|Withdrawal by Subject|9|||
23520222|NCT04809220|65643467|FG001|Overall Study|Withdrawal by Subject|5|||
23520223|NCT04809220|65643466|FG000|Overall Study|Due to long-term overseas business trips|1|||
23520224|NCT04809220|65643467|FG001|Overall Study|Due to long-term overseas business trips|0|||
23520225|NCT01050257|65643468|FG000|Overall Study|Adverse Event|4|||
23520226|NCT01050257|65643469|FG001|Overall Study|Adverse Event|4|||
23520227|NCT01050257|65643470|FG002|Overall Study|Adverse Event|2|||
23520228|NCT01050257|65643468|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
23520229|NCT01050257|65643469|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
23520230|NCT01050257|65643470|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
23520231|NCT01050257|65643468|FG000|Overall Study|Withdrawal by Subject|0|||
23520232|NCT01050257|65643469|FG001|Overall Study|Withdrawal by Subject|3|||
23520233|NCT01050257|65643470|FG002|Overall Study|Withdrawal by Subject|0|||
23520234|NCT01050257|65643468|FG000|Overall Study|No reason specified|0|||
23520235|NCT01050257|65643469|FG001|Overall Study|No reason specified|0|||
23520236|NCT01050257|65643470|FG002|Overall Study|No reason specified|2|||
23520237|NCT01050257|65643468|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
23520238|NCT01050257|65643469|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
23520239|NCT01050257|65643470|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
23520240|NCT01050257|65643468|FG000|Overall Study|Violation criteria|0|||
23520241|NCT01050257|65643469|FG001|Overall Study|Violation criteria|1|||
23520242|NCT01050257|65643470|FG002|Overall Study|Violation criteria|0|||
23520243|NCT01050257|65643468|FG000|Overall Study|Failure to return|0|||
23520244|NCT01050257|65643469|FG001|Overall Study|Failure to return|2|||
23520245|NCT01050257|65643470|FG002|Overall Study|Failure to return|0|||
23520246|NCT01050257|65643468|FG000|Overall Study|Death|0|||
23520247|NCT01050257|65643469|FG001|Overall Study|Death|0|||
23520248|NCT01050257|65643470|FG002|Overall Study|Death|1|||
23520249|NCT02520011|65643471|FG000|Overall Study|Adverse Event|0|||
23520250|NCT02520011|65643472|FG001|Overall Study|Adverse Event|1|||
23520251|NCT02520011|65643473|FG002|Overall Study|Adverse Event|2|||
23713601|NCT01895452|66325407|FG001|Overall Study|Noncompliance with study drug|1|||
23713602|NCT01185249|66325409|FG000|Overall Study|Patients discharged or change in status|42|||
23520252|NCT02520011|65643471|FG000|Overall Study|Death|0|||
23520253|NCT02520011|65643472|FG001|Overall Study|Death|8|||
23520254|NCT02520011|65643473|FG002|Overall Study|Death|1|||
23520255|NCT02520011|65643471|FG000|Overall Study|Lack of Efficacy|4|||
23520256|NCT02520011|65643472|FG001|Overall Study|Lack of Efficacy|26|||
23520257|NCT02520011|65643473|FG002|Overall Study|Lack of Efficacy|4|||
23520258|NCT02520011|65643471|FG000|Overall Study|Physician Decision|0|||
23713603|NCT00373490|66325414|FG000|Overall Study|Adverse Event|0|||
23713604|NCT00373490|66325415|FG001|Overall Study|Adverse Event|1|||
23713605|NCT00373490|66325414|FG000|Overall Study|Lack of Efficacy|9|||
23713606|NCT00373490|66325415|FG001|Overall Study|Lack of Efficacy|4|||
23520259|NCT02520011|65643472|FG001|Overall Study|Physician Decision|2|||
23520260|NCT02520011|65643473|FG002|Overall Study|Physician Decision|0|||
23520261|NCT02520011|65643471|FG000|Overall Study|Withdrawal by Subject|1|||
23520262|NCT02520011|65643472|FG001|Overall Study|Withdrawal by Subject|3|||
23520263|NCT02520011|65643473|FG002|Overall Study|Withdrawal by Subject|0|||
23520264|NCT02520011|65643471|FG000|Overall Study|Protocol Deviation|0|||
23520265|NCT02520011|65643472|FG001|Overall Study|Protocol Deviation|1|||
23520266|NCT02520011|65643473|FG002|Overall Study|Protocol Deviation|0|||
23520267|NCT02520011|65643471|FG000|Overall Study|Patient went to hospice|0|||
23520268|NCT02520011|65643472|FG001|Overall Study|Patient went to hospice|1|||
23520269|NCT02520011|65643473|FG002|Overall Study|Patient went to hospice|0|||
23520270|NCT02520011|65643471|FG000|Overall Study|Progressive disease following response|0|||
23520271|NCT02520011|65643472|FG001|Overall Study|Progressive disease following response|4|||
23520272|NCT02520011|65643473|FG002|Overall Study|Progressive disease following response|2|||
23520273|NCT00644969|65643474|FG000|Treatment Phase|Randomized, not treated|1|||
23520274|NCT00644969|65643475|FG001|Treatment Phase|Randomized, not treated|0|||
23520275|NCT00644969|65643474|FG000|Treatment Phase|Adverse Event|3|||
23520276|NCT00644969|65643475|FG001|Treatment Phase|Adverse Event|0|||
23520277|NCT00644969|65643474|FG000|Treatment Phase|Withdrawal by Subject|4|||
23520278|NCT00644969|65643475|FG001|Treatment Phase|Withdrawal by Subject|0|||
23520279|NCT00644969|65643474|FG000|Treatment Phase|Lost to Follow-up|2|||
23520280|NCT00644969|65643475|FG001|Treatment Phase|Lost to Follow-up|2|||
23520281|NCT00644969|65643474|FG000|Treatment Phase|Other|4|||
23520282|NCT00644969|65643475|FG001|Treatment Phase|Other|1|||
23520283|NCT00644969|65643474|FG000|Post Treatment Phase|Death|1|||
23520284|NCT00644969|65643475|FG001|Post Treatment Phase|Death|0|||
23520285|NCT00644969|65643474|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
23520286|NCT00644969|65643475|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
23520287|NCT00644969|65643474|FG000|Post Treatment Phase|Lost to Follow-up|4|||
23520288|NCT00644969|65643475|FG001|Post Treatment Phase|Lost to Follow-up|1|||
23520289|NCT00644969|65643474|FG000|Post Treatment Phase|Other|1|||
23520290|NCT00644969|65643475|FG001|Post Treatment Phase|Other|0|||
23520291|NCT02171260|65643476|FG000|Overall Study|Death|0|||
23520292|NCT02171260|65643477|FG001|Overall Study|Death|0|||
23520293|NCT02171260|65643478|FG002|Overall Study|Death|0|||
23520294|NCT02171260|65643479|FG003|Overall Study|Death|1|||
23520295|NCT02171260|65643476|FG000|Overall Study|Physician Decision|1|||
23520296|NCT02171260|65643477|FG001|Overall Study|Physician Decision|0|||
23520297|NCT02171260|65643478|FG002|Overall Study|Physician Decision|1|||
23520298|NCT02171260|65643479|FG003|Overall Study|Physician Decision|0|||
23520299|NCT02171260|65643476|FG000|Overall Study|Withdrawal by Subject|1|||
23520300|NCT02171260|65643477|FG001|Overall Study|Withdrawal by Subject|0|||
23520301|NCT02171260|65643478|FG002|Overall Study|Withdrawal by Subject|0|||
23520302|NCT02171260|65643479|FG003|Overall Study|Withdrawal by Subject|0|||
23520303|NCT02171260|65643476|FG000|Overall Study|Evidence of progressive disease|4|||
23520304|NCT02171260|65643477|FG001|Overall Study|Evidence of progressive disease|6|||
23520305|NCT02171260|65643478|FG002|Overall Study|Evidence of progressive disease|4|||
23520306|NCT02171260|65643479|FG003|Overall Study|Evidence of progressive disease|4|||
23520307|NCT02762266|65643482|FG000|Overall Study|Physician Decision|2|||
23520308|NCT02762266|65643483|FG001|Overall Study|Physician Decision|0|||
23520309|NCT00460031|65643484|FG000|Overall Study|Adverse Event|5|||
23520310|NCT00460031|65643484|FG000|Overall Study|Withdrawal by Subject|5|||
23520311|NCT00460031|65643484|FG000|Overall Study|Death|1|||
23520312|NCT00256698|65643486|FG000|Overall Study|Withdrawal by Subject|7|||
23520313|NCT00256698|65643487|FG001|Overall Study|Withdrawal by Subject|7|||
23520314|NCT00256698|65643486|FG000|Overall Study|Adverse Event|13|||
23520315|NCT00256698|65643487|FG001|Overall Study|Adverse Event|6|||
23520316|NCT00256698|65643486|FG000|Overall Study|Protocol Violation|6|||
23520317|NCT00256698|65643487|FG001|Overall Study|Protocol Violation|5|||
23520318|NCT00256698|65643486|FG000|Overall Study|Lost to Follow-up|1|||
23520319|NCT00256698|65643487|FG001|Overall Study|Lost to Follow-up|3|||
23520320|NCT00256698|65643486|FG000|Overall Study|disease progression|97|||
23713607|NCT00373490|66325414|FG000|Overall Study|Withdrawal by Subject|0|||
23713608|NCT00373490|66325415|FG001|Overall Study|Withdrawal by Subject|1|||
23713609|NCT03303092|66325416|FG000|Overall Study|Adverse Event|1|||
23713610|NCT03303092|66325417|FG001|Overall Study|Adverse Event|0|||
23520321|NCT00256698|65643487|FG001|Overall Study|disease progression|105|||
23520322|NCT00256698|65643486|FG000|Overall Study|still ongoing at data cut-off|41|||
23520323|NCT00256698|65643487|FG001|Overall Study|still ongoing at data cut-off|46|||
23812064|NCT02516553|66691882|FG007|Overall Study|Refused to continue trial medication|0|||
23520324|NCT00256698|65643486|FG000|Overall Study|withdrawn due to osteoporosis|1|||
23520325|NCT00256698|65643487|FG001|Overall Study|withdrawn due to osteoporosis|0|||
23520326|NCT00256698|65643486|FG000|Overall Study|Prematurely Discontinued|1|||
23520327|NCT00256698|65643487|FG001|Overall Study|Prematurely Discontinued|0|||
23520328|NCT01466387|65643488|FG000|Overall Study|Adverse Event|0|||
23520329|NCT01466387|65643489|FG001|Overall Study|Adverse Event|0|||
23520330|NCT01466387|65643490|FG002|Overall Study|Adverse Event|1|||
23520331|NCT01466387|65643491|FG003|Overall Study|Adverse Event|1|||
23520332|NCT01466387|65643492|FG004|Overall Study|Adverse Event|0|||
23520333|NCT01466387|65643493|FG005|Overall Study|Adverse Event|0|||
23520334|NCT01466387|65643488|FG000|Overall Study|Lost to Follow-up|0|||
23520335|NCT01466387|65643489|FG001|Overall Study|Lost to Follow-up|0|||
23520336|NCT01466387|65643490|FG002|Overall Study|Lost to Follow-up|0|||
23520337|NCT01466387|65643491|FG003|Overall Study|Lost to Follow-up|0|||
23520338|NCT01466387|65643492|FG004|Overall Study|Lost to Follow-up|0|||
23520339|NCT01466387|65643493|FG005|Overall Study|Lost to Follow-up|1|||
23520340|NCT01466387|65643488|FG000|Overall Study|Protocol Violation|1|||
23520341|NCT01466387|65643489|FG001|Overall Study|Protocol Violation|0|||
23520342|NCT01466387|65643490|FG002|Overall Study|Protocol Violation|0|||
23520343|NCT01466387|65643491|FG003|Overall Study|Protocol Violation|1|||
23520344|NCT01466387|65643492|FG004|Overall Study|Protocol Violation|0|||
23520345|NCT01466387|65643493|FG005|Overall Study|Protocol Violation|0|||
23520346|NCT01623596|65643494|FG000|Overall Study|Abnormal laboratory values|2|||
23520347|NCT01623596|65643495|FG001|Overall Study|Abnormal laboratory values|0|||
23520348|NCT01623596|65643494|FG000|Overall Study|Administrative problems|9|||
23520349|NCT01623596|65643495|FG001|Overall Study|Administrative problems|13|||
23520350|NCT01623596|65643494|FG000|Overall Study|Adverse Event|20|||
23520351|NCT01623596|65643495|FG001|Overall Study|Adverse Event|29|||
23520352|NCT01623596|65643494|FG000|Overall Study|Death|0|||
23520353|NCT01623596|65643495|FG001|Overall Study|Death|2|||
23520354|NCT01623596|65643494|FG000|Overall Study|Lost to Follow-up|12|||
23520355|NCT01623596|65643495|FG001|Overall Study|Lost to Follow-up|16|||
23520356|NCT01623596|65643494|FG000|Overall Study|Withdrawal by Subject|13|||
23520357|NCT01623596|65643495|FG001|Overall Study|Withdrawal by Subject|31|||
23520358|NCT01623596|65643494|FG000|Overall Study|Patient no longer requires study drug|1|||
23520359|NCT01623596|65643495|FG001|Overall Study|Patient no longer requires study drug|0|||
23520360|NCT01623596|65643494|FG000|Overall Study|Protocol Violation|0|||
23520361|NCT01623596|65643495|FG001|Overall Study|Protocol Violation|6|||
23520362|NCT01623596|65643494|FG000|Overall Study|Lack of Efficacy|5|||
23520363|NCT01623596|65643495|FG001|Overall Study|Lack of Efficacy|3|||
23520364|NCT01316276|65643496|FG000|Overall Study|Death|1|||
23520365|NCT01316276|65643496|FG000|Overall Study|Adverse Event|19|||
23520366|NCT01316276|65643496|FG000|Overall Study|Withdrawal of consent|24|||
23520367|NCT01316276|65643496|FG000|Overall Study|Lost to Follow-up|1|||
23520368|NCT01316276|65643496|FG000|Overall Study|Other|22|||
23520369|NCT01139450|65643499|FG000|Overall Study|Withdrawal by Subject|7|||
23520370|NCT01139450|65643500|FG001|Overall Study|Withdrawal by Subject|10|||
23520371|NCT01139450|65643501|FG002|Overall Study|Withdrawal by Subject|13|||
23520372|NCT01139450|65643499|FG000|Overall Study|Lack of Efficacy|3|||
23520373|NCT01139450|65643500|FG001|Overall Study|Lack of Efficacy|1|||
23520374|NCT01139450|65643501|FG002|Overall Study|Lack of Efficacy|8|||
23520375|NCT01139450|65643499|FG000|Overall Study|Protocol Violation|6|||
23520376|NCT01139450|65643500|FG001|Overall Study|Protocol Violation|5|||
23520377|NCT01139450|65643501|FG002|Overall Study|Protocol Violation|2|||
23520378|NCT01139450|65643499|FG000|Overall Study|Lost to Follow-up|9|||
23520379|NCT01139450|65643500|FG001|Overall Study|Lost to Follow-up|7|||
23520380|NCT01139450|65643501|FG002|Overall Study|Lost to Follow-up|11|||
23520381|NCT01139450|65643499|FG000|Overall Study|Administrative|0|||
23520382|NCT01139450|65643500|FG001|Overall Study|Administrative|0|||
23520383|NCT01139450|65643501|FG002|Overall Study|Administrative|1|||
23520384|NCT01139450|65643499|FG000|Overall Study|Adverse Event|2|||
23520385|NCT01139450|65643500|FG001|Overall Study|Adverse Event|2|||
23520386|NCT01139450|65643501|FG002|Overall Study|Adverse Event|3|||
23520387|NCT01290666|65643503|FG000|Overall Study|Lost to Follow-up|11|||
23520388|NCT01290666|65643503|FG000|Overall Study|Withdrawal by Subject|23|||
23520389|NCT01290666|65643503|FG000|Overall Study|Early Termination of Study|4|||
23520390|NCT03989440|65643504|FG000|Overall Study|COVID-19 travel restrictions|0|||
23520391|NCT03989440|65643505|FG001|Overall Study|COVID-19 travel restrictions|0|||
23520392|NCT03989440|65643506|FG002|Overall Study|COVID-19 travel restrictions|1|||
23520393|NCT03989440|65643507|FG003|Overall Study|COVID-19 travel restrictions|0|||
23520394|NCT03989440|65643508|FG004|Overall Study|COVID-19 travel restrictions|0|||
23520395|NCT03989440|65643509|FG005|Overall Study|COVID-19 travel restrictions|0|||
23520396|NCT03989440|65643504|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
23520397|NCT03989440|65643505|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
23520398|NCT03989440|65643506|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
23520399|NCT03989440|65643507|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
23520400|NCT03989440|65643508|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
23520401|NCT03989440|65643509|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
23416223|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
23520402|NCT02604212|65643510|FG000|Overall Study|Study Terminated by Sponsor|2|||
23520403|NCT02604212|65643511|FG001|Overall Study|Study Terminated by Sponsor|1|||
23520404|NCT02604212|65643512|FG002|Overall Study|Study Terminated by Sponsor|3|||
23520405|NCT02604212|65643513|FG003|Overall Study|Study Terminated by Sponsor|3|||
23520406|NCT02604212|65643510|FG000|Overall Study|Withdrawal by Subject|0|||
23520407|NCT02604212|65643511|FG001|Overall Study|Withdrawal by Subject|0|||
23520408|NCT02604212|65643512|FG002|Overall Study|Withdrawal by Subject|1|||
23520409|NCT02604212|65643513|FG003|Overall Study|Withdrawal by Subject|0|||
23520410|NCT03424265|65643514|FG000|Overall Study|screening failure|1|||
23520411|NCT03424265|65643515|FG001|Overall Study|screening failure|0|||
23520412|NCT03424265|65643514|FG000|Overall Study|Withdrawal by Subject|0|||
23520413|NCT03424265|65643515|FG001|Overall Study|Withdrawal by Subject|2|||
23520414|NCT03025542|65643521|FG000|Overall Study|Adverse Event|0|||
23520415|NCT03025542|65643522|FG001|Overall Study|Adverse Event|2|||
23520416|NCT03025542|65643521|FG000|Overall Study|Lost to Follow-up|1|||
23520417|NCT03025542|65643522|FG001|Overall Study|Lost to Follow-up|0|||
23520418|NCT03025542|65643521|FG000|Overall Study|Withdrawal by Subject|1|||
23520419|NCT03025542|65643522|FG001|Overall Study|Withdrawal by Subject|0|||
23520420|NCT01224639|65643523|FG000|Overall Study|Withdrawal by Subject|0|||
23520421|NCT01224639|65643524|FG001|Overall Study|Withdrawal by Subject|0|||
23520422|NCT01224639|65643525|FG002|Overall Study|Withdrawal by Subject|0|||
23520423|NCT01224639|65643526|FG003|Overall Study|Withdrawal by Subject|0|||
23520424|NCT01224639|65643527|FG004|Overall Study|Withdrawal by Subject|2|||
23520425|NCT01224639|65643528|FG005|Overall Study|Withdrawal by Subject|0|||
23520426|NCT01224639|65643529|FG006|Overall Study|Withdrawal by Subject|1|||
23520427|NCT01224639|65643530|FG007|Overall Study|Withdrawal by Subject|1|||
23520428|NCT01224639|65643523|FG000|Overall Study|Adverse Event|0|||
23520429|NCT01224639|65643524|FG001|Overall Study|Adverse Event|0|||
23520430|NCT01224639|65643525|FG002|Overall Study|Adverse Event|0|||
23520431|NCT01224639|65643526|FG003|Overall Study|Adverse Event|0|||
23520432|NCT01224639|65643527|FG004|Overall Study|Adverse Event|0|||
23520433|NCT01224639|65643528|FG005|Overall Study|Adverse Event|0|||
23520434|NCT01224639|65643529|FG006|Overall Study|Adverse Event|0|||
23520435|NCT01224639|65643530|FG007|Overall Study|Adverse Event|1|||
23520436|NCT00679263|65643536|FG000|Visit 2/Dose 1|Adverse Event|1|||
23520437|NCT00679263|65643537|FG001|Visit 2/Dose 1|Adverse Event|0|||
23520438|NCT00679263|65643538|FG002|Visit 2/Dose 1|Adverse Event|0|||
23520439|NCT00679263|65643536|FG000|Visit 2/Dose 1|subject not compliance|1|||
23520440|NCT00679263|65643537|FG001|Visit 2/Dose 1|subject not compliance|1|||
23520441|NCT00679263|65643538|FG002|Visit 2/Dose 1|subject not compliance|0|||
23520442|NCT01148511|65643542|FG000|Exposed to Study Drug|Protocol Violation|2|||
23520443|NCT01148511|65643543|FG001|Exposed to Study Drug|Protocol Violation|0|||
23520444|NCT01148511|65643544|FG002|Exposed to Study Drug|Protocol Violation|0|||
23520445|NCT01148511|65643542|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
23520446|NCT01148511|65643543|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
23520447|NCT01148511|65643544|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
23520448|NCT01148511|65643542|FG000|Randomized|Adverse Event|0|||
23520449|NCT01148511|65643543|FG001|Randomized|Adverse Event|1|||
23520450|NCT01148511|65643544|FG002|Randomized|Adverse Event|0|||
23520451|NCT01148511|65643542|FG000|Randomized|Protocol Violation|0|||
23520452|NCT01148511|65643543|FG001|Randomized|Protocol Violation|2|||
23520453|NCT01148511|65643544|FG002|Randomized|Protocol Violation|1|||
23520454|NCT01148511|65643542|FG000|Randomized|Lost to Follow-up|0|||
23520455|NCT01148511|65643543|FG001|Randomized|Lost to Follow-up|1|||
23520456|NCT01148511|65643544|FG002|Randomized|Lost to Follow-up|1|||
23520457|NCT01148511|65643542|FG000|Randomized|Consent withdrawal|0|||
23520458|NCT01148511|65643543|FG001|Randomized|Consent withdrawal|5|||
23520459|NCT01148511|65643544|FG002|Randomized|Consent withdrawal|3|||
23520460|NCT01148511|65643542|FG000|Randomized|Other|0|||
23520461|NCT01148511|65643543|FG001|Randomized|Other|1|||
23520462|NCT01148511|65643544|FG002|Randomized|Other|1|||
23520463|NCT02337907|65643545|FG000|Overall Study|Other than listed|1|||
23520464|NCT02337907|65643546|FG001|Overall Study|Other than listed|0|||
23520465|NCT02337907|65643547|FG002|Overall Study|Other than listed|0|||
23520466|NCT02337907|65643548|FG003|Overall Study|Other than listed|1|||
23520467|NCT02337907|65643549|FG004|Overall Study|Other than listed|1|||
23520468|NCT02337907|65643550|FG005|Overall Study|Other than listed|0|||
23520469|NCT02337907|65643545|FG000|Overall Study|Withdrawal by Subject|2|||
23520470|NCT02337907|65643546|FG001|Overall Study|Withdrawal by Subject|3|||
23713611|NCT03303092|66325418|FG002|Overall Study|Adverse Event|1|||
23713612|NCT03303092|66325416|FG000|Overall Study|Protocol Violation|1|||
23812065|NCT02516553|66691883|FG008|Overall Study|Refused to continue trial medication|0|||
23520471|NCT02337907|65643547|FG002|Overall Study|Withdrawal by Subject|0|||
23520472|NCT02337907|65643548|FG003|Overall Study|Withdrawal by Subject|2|||
23520473|NCT02337907|65643549|FG004|Overall Study|Withdrawal by Subject|5|||
23520474|NCT02337907|65643550|FG005|Overall Study|Withdrawal by Subject|0|||
23520475|NCT02337907|65643545|FG000|Overall Study|Lost to Follow-up|0|||
23520476|NCT02337907|65643546|FG001|Overall Study|Lost to Follow-up|0|||
23520477|NCT02337907|65643547|FG002|Overall Study|Lost to Follow-up|0|||
23520478|NCT02337907|65643548|FG003|Overall Study|Lost to Follow-up|0|||
23520479|NCT02337907|65643549|FG004|Overall Study|Lost to Follow-up|0|||
23520480|NCT02337907|65643550|FG005|Overall Study|Lost to Follow-up|1|||
23520481|NCT02337907|65643545|FG000|Overall Study|Adverse Event|1|||
23520482|NCT02337907|65643546|FG001|Overall Study|Adverse Event|1|||
23520483|NCT02337907|65643547|FG002|Overall Study|Adverse Event|1|||
23713613|NCT03303092|66325417|FG001|Overall Study|Protocol Violation|5|||
23713614|NCT03303092|66325418|FG002|Overall Study|Protocol Violation|1|||
23713615|NCT03303092|66325416|FG000|Overall Study|Withdrawal by Subject|1|||
23520484|NCT02337907|65643548|FG003|Overall Study|Adverse Event|1|||
23520485|NCT02337907|65643549|FG004|Overall Study|Adverse Event|4|||
23520486|NCT02337907|65643550|FG005|Overall Study|Adverse Event|0|||
23520487|NCT00171223|65643551|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
23520488|NCT00171223|65643552|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
23520489|NCT00171223|65643553|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
23520490|NCT00171223|65643551|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
23520491|NCT00171223|65643552|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
23520492|NCT00171223|65643553|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
23520493|NCT00171223|65643551|FG000|Overall Study|Abnormal Procedure|1|||
23520494|NCT00171223|65643552|FG001|Overall Study|Abnormal Procedure|0|||
23520495|NCT00171223|65643553|FG002|Overall Study|Abnormal Procedure|0|||
23520496|NCT00171223|65643551|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
23520497|NCT00171223|65643552|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
23520498|NCT00171223|65643553|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
23520499|NCT00171223|65643551|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
23520500|NCT00171223|65643552|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
23520501|NCT00171223|65643553|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
23520502|NCT00171223|65643551|FG000|Overall Study|Protocol Violation|2|||
23520503|NCT00171223|65643552|FG001|Overall Study|Protocol Violation|2|||
23520504|NCT00171223|65643553|FG002|Overall Study|Protocol Violation|3|||
23520505|NCT00171223|65643551|FG000|Overall Study|Participant Withdrew Consent|12|||
23520506|NCT00171223|65643552|FG001|Overall Study|Participant Withdrew Consent|21|||
23520507|NCT00171223|65643553|FG002|Overall Study|Participant Withdrew Consent|15|||
23520508|NCT00171223|65643551|FG000|Overall Study|Lost to Follow-up|5|||
23520509|NCT00171223|65643552|FG001|Overall Study|Lost to Follow-up|2|||
23520510|NCT00171223|65643553|FG002|Overall Study|Lost to Follow-up|3|||
23520511|NCT00171223|65643551|FG000|Overall Study|Administrative Problems|4|||
23520512|NCT00171223|65643552|FG001|Overall Study|Administrative Problems|7|||
23520513|NCT00171223|65643553|FG002|Overall Study|Administrative Problems|6|||
23520514|NCT00171223|65643551|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
23520515|NCT00171223|65643552|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
23520516|NCT00171223|65643553|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
23520517|NCT00171223|65643551|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
23520518|NCT00171223|65643552|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
23520519|NCT00171223|65643553|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
23520520|NCT00914810|65643554|FG000|Overall Study|Withdrawal by Subject|1|||
23520521|NCT00914810|65643555|FG001|Overall Study|Withdrawal by Subject|0|||
23520522|NCT00914810|65643554|FG000|Overall Study|Relocated out of state|1|||
23520523|NCT00914810|65643555|FG001|Overall Study|Relocated out of state|0|||
23520524|NCT00914810|65643554|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
23520525|NCT00914810|65643555|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
23520526|NCT03200899|65643556|FG000|Overall Study|Lost to Follow-up|10|||
23520527|NCT03200899|65643557|FG001|Overall Study|Lost to Follow-up|23|||
23520528|NCT00858442|65643561|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
23520529|NCT00858442|65643562|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
23520530|NCT04865354|65643566|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
23520531|NCT04865354|65643567|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
23520532|NCT04865354|65643566|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
23520533|NCT04865354|65643567|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
23520534|NCT04865354|65643566|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
23520535|NCT04865354|65643567|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
23520536|NCT00982488|65643570|FG000|Overall Study|Administrative reason by sponsor|81|||
23520537|NCT00982488|65643571|FG001|Overall Study|Administrative reason by sponsor|3|||
23520538|NCT00982488|65643572|FG002|Overall Study|Administrative reason by sponsor|11|||
23520539|NCT00982488|65643573|FG003|Overall Study|Administrative reason by sponsor|0|||
23520540|NCT00982488|65643574|FG004|Overall Study|Administrative reason by sponsor|0|||
23520541|NCT00982488|65643570|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23520542|NCT00982488|65643571|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23520543|NCT00982488|65643572|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23713616|NCT03303092|66325417|FG001|Overall Study|Withdrawal by Subject|1|||
23713617|NCT03303092|66325418|FG002|Overall Study|Withdrawal by Subject|3|||
23416224|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
23520544|NCT00982488|65643573|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23520545|NCT00982488|65643574|FG004|Overall Study|Adverse event unrelated to study drug|0|||
23520546|NCT00982488|65643570|FG000|Overall Study|Death|11|||
23520547|NCT00982488|65643571|FG001|Overall Study|Death|0|||
23520548|NCT00982488|65643572|FG002|Overall Study|Death|2|||
23713618|NCT02807363|66325426|FG000|Dosing Period|Adverse Event|0|||
23520549|NCT00982488|65643573|FG003|Overall Study|Death|0|||
23520550|NCT00982488|65643574|FG004|Overall Study|Death|0|||
23520551|NCT00982488|65643570|FG000|Overall Study|Disease progression|30|||
23520552|NCT00982488|65643571|FG001|Overall Study|Disease progression|5|||
23520553|NCT00982488|65643572|FG002|Overall Study|Disease progression|10|||
23520554|NCT00982488|65643573|FG003|Overall Study|Disease progression|1|||
23520555|NCT00982488|65643574|FG004|Overall Study|Disease progression|1|||
23520556|NCT00982488|65643570|FG000|Overall Study|Lost to Follow-up|1|||
23520557|NCT00982488|65643571|FG001|Overall Study|Lost to Follow-up|0|||
23520558|NCT00982488|65643572|FG002|Overall Study|Lost to Follow-up|0|||
23520559|NCT00982488|65643573|FG003|Overall Study|Lost to Follow-up|0|||
23520560|NCT00982488|65643574|FG004|Overall Study|Lost to Follow-up|0|||
23520561|NCT00982488|65643570|FG000|Overall Study|Maximum clinical benefit|1|||
23520562|NCT00982488|65643571|FG001|Overall Study|Maximum clinical benefit|1|||
23520563|NCT00982488|65643572|FG002|Overall Study|Maximum clinical benefit|1|||
23520564|NCT00982488|65643573|FG003|Overall Study|Maximum clinical benefit|0|||
23520565|NCT00982488|65643574|FG004|Overall Study|Maximum clinical benefit|0|||
23520566|NCT00982488|65643570|FG000|Overall Study|Other|15|||
23520567|NCT00982488|65643571|FG001|Overall Study|Other|1|||
23520568|NCT00982488|65643572|FG002|Overall Study|Other|3|||
23520569|NCT00982488|65643573|FG003|Overall Study|Other|1|||
23520570|NCT00982488|65643574|FG004|Overall Study|Other|0|||
23520571|NCT00982488|65643570|FG000|Overall Study|Poor compliance/noncompliance|0|||
23520572|NCT00982488|65643571|FG001|Overall Study|Poor compliance/noncompliance|1|||
23520573|NCT00982488|65643572|FG002|Overall Study|Poor compliance/noncompliance|0|||
23520574|NCT00982488|65643573|FG003|Overall Study|Poor compliance/noncompliance|0|||
23520575|NCT00982488|65643574|FG004|Overall Study|Poor compliance/noncompliance|0|||
23520576|NCT00982488|65643570|FG000|Overall Study|Stem cell transplant|2|||
23520577|NCT00982488|65643571|FG001|Overall Study|Stem cell transplant|0|||
23520578|NCT00982488|65643572|FG002|Overall Study|Stem cell transplant|0|||
23520579|NCT00982488|65643573|FG003|Overall Study|Stem cell transplant|1|||
23520580|NCT00982488|65643574|FG004|Overall Study|Stem cell transplant|0|||
23520581|NCT00982488|65643570|FG000|Overall Study|Study drug toxicity|34|||
23520582|NCT00982488|65643571|FG001|Overall Study|Study drug toxicity|1|||
23520583|NCT00982488|65643572|FG002|Overall Study|Study drug toxicity|6|||
23520584|NCT00982488|65643573|FG003|Overall Study|Study drug toxicity|0|||
23520585|NCT00982488|65643574|FG004|Overall Study|Study drug toxicity|0|||
23520586|NCT00982488|65643570|FG000|Overall Study|Withdrawal by Subject|5|||
23520587|NCT00982488|65643571|FG001|Overall Study|Withdrawal by Subject|1|||
23520588|NCT00982488|65643572|FG002|Overall Study|Withdrawal by Subject|1|||
23520589|NCT00982488|65643573|FG003|Overall Study|Withdrawal by Subject|0|||
23520590|NCT00982488|65643574|FG004|Overall Study|Withdrawal by Subject|0|||
23520591|NCT01522365|65643575|FG000|Overall Study|Withdrawal by Subject|1|||
23520592|NCT01522365|65643576|FG001|Overall Study|Withdrawal by Subject|1|||
23520593|NCT01522365|65643575|FG000|Overall Study|Lost to Follow-up|1|||
23520594|NCT01522365|65643576|FG001|Overall Study|Lost to Follow-up|1|||
23520595|NCT00445965|65643577|FG000|Overall Study|Adverse Event|2|||
23520596|NCT00445965|65643577|FG000|Overall Study|Physician Decision|1|||
23520597|NCT00445965|65643577|FG000|Overall Study|Enrolled but not treated|1|||
23520598|NCT00445965|65643577|FG000|Overall Study|Removed due to progressive disease|29|||
23520599|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
23520600|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
23520601|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
23520602|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
23520603|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
23520604|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
23520605|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
23520606|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
23520607|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
23520608|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
23812066|NCT02516553|66691884|FG009|Overall Study|Refused to continue trial medication|0|||
23812067|NCT02516553|66691885|FG010|Overall Study|Refused to continue trial medication|1|||
23812068|NCT02516553|66691886|FG011|Overall Study|Refused to continue trial medication|0|||
23812069|NCT02516553|66691887|FG012|Overall Study|Refused to continue trial medication|0|||
23520609|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
23520610|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
23520611|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
23812070|NCT02516553|66691888|FG013|Overall Study|Refused to continue trial medication|0|||
23520612|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23520613|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23520614|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
23520615|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
23520616|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
23520617|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
23520618|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
23520619|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520620|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
23520621|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
23520622|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520623|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520624|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
23520625|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
23520626|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
23520627|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
23520628|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
23520629|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
23520630|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
23520631|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
23520632|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
23520633|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
23520634|NCT01523886|65643583|FG000|Overall Study|surgery cancelled|0|||
23520635|NCT01523886|65643584|FG001|Overall Study|surgery cancelled|1|||
23520636|NCT05778786|65643585|FG000|Period 1|COVID-19 Related|3|||
23520637|NCT05778786|65643586|FG001|Period 1|COVID-19 Related|3|||
23520638|NCT05778786|65643585|FG000|Period 1|Withdrew Consent during Study|1|||
23520639|NCT05778786|65643586|FG001|Period 1|Withdrew Consent during Study|0|||
23520640|NCT05778786|65643585|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
23520641|NCT05778786|65643586|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
23520642|NCT05778786|65643585|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
23520643|NCT05778786|65643586|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
23520644|NCT00946712|65643587|FG000|Overall Study|Adverse Event|118|||
23713619|NCT02807363|66325427|FG001|Dosing Period|Adverse Event|1|||
23713620|NCT02807363|66325428|FG002|Dosing Period|Adverse Event|0|||
23713621|NCT02807363|66325429|FG003|Dosing Period|Adverse Event|0|||
23713622|NCT03956225|66325430|FG000|Overall Study|Lack of Efficacy|1|||
23713623|NCT03956225|66325431|FG001|Overall Study|Lack of Efficacy|1|||
23713624|NCT03956225|66325430|FG000|Overall Study|Lost to Follow-up|0|||
23713625|NCT03956225|66325431|FG001|Overall Study|Lost to Follow-up|1|||
23713626|NCT03956225|66325430|FG000|Overall Study|Withdrawal by Subject|2|||
23713627|NCT03956225|66325431|FG001|Overall Study|Withdrawal by Subject|1|||
23713628|NCT03956225|66325430|FG000|Overall Study|Other Reasons|2|||
23713629|NCT03956225|66325431|FG001|Overall Study|Other Reasons|1|||
23713630|NCT00567541|66325434|FG000|Overall Study|Adverse Event|0|||
23713631|NCT00567541|66325435|FG001|Overall Study|Adverse Event|1|||
23713632|NCT00413062|66325436|FG000|Overall Study|Adverse event/serious adverse event|289|||
23520645|NCT00946712|65643588|FG001|Overall Study|Adverse Event|124|||
23520646|NCT00946712|65643587|FG000|Overall Study|Disease progression|308|||
23520647|NCT00946712|65643588|FG001|Overall Study|Disease progression|404|||
23520648|NCT00946712|65643587|FG000|Overall Study|Death|21|||
23520649|NCT00946712|65643588|FG001|Overall Study|Death|22|||
23520650|NCT00946712|65643587|FG000|Overall Study|No treatment given|25|||
23520651|NCT00946712|65643588|FG001|Overall Study|No treatment given|29|||
23520652|NCT00946712|65643587|FG000|Overall Study|Other reasons|61|||
23520653|NCT00946712|65643588|FG001|Overall Study|Other reasons|73|||
23520654|NCT00946712|65643587|FG000|Overall Study|On Treatment|0|||
23520655|NCT00946712|65643588|FG001|Overall Study|On Treatment|4|||
23520656|NCT00946712|65643587|FG000|Overall Study|Ineligible|14|||
23520657|NCT00946712|65643588|FG001|Overall Study|Ineligible|6|||
23520658|NCT03739112|65643589|FG000|Overall Study|Adverse Event|2|||
23520659|NCT03739112|65643590|FG001|Overall Study|Adverse Event|2|||
23520660|NCT03739112|65643589|FG000|Overall Study|Withdrawal by Subject|38|||
23520661|NCT03739112|65643590|FG001|Overall Study|Withdrawal by Subject|19|||
23520662|NCT03739112|65643589|FG000|Overall Study|Lost to Follow-up|31|||
23520663|NCT03739112|65643590|FG001|Overall Study|Lost to Follow-up|33|||
23520664|NCT03739112|65643589|FG000|Overall Study|Protocol Deviation|12|||
23520665|NCT03739112|65643590|FG001|Overall Study|Protocol Deviation|9|||
23520666|NCT03739112|65643589|FG000|Overall Study|Physician Decision|1|||
23520667|NCT03739112|65643590|FG001|Overall Study|Physician Decision|0|||
23520668|NCT03739112|65643589|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
23520669|NCT03739112|65643590|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
23713633|NCT00413062|66325437|FG001|Overall Study|Adverse event/serious adverse event|56|||
23713634|NCT00413062|66325436|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
23520670|NCT03739112|65643589|FG000|Overall Study|Site went on hold|65|||
23520671|NCT03739112|65643590|FG001|Overall Study|Site went on hold|67|||
23713635|NCT00413062|66325437|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
23713636|NCT00413062|66325436|FG000|Overall Study|Withdrawal of informed consent|111|||
23520672|NCT03739112|65643589|FG000|Overall Study|Other than specified|8|||
23520673|NCT03739112|65643590|FG001|Overall Study|Other than specified|5|||
23520674|NCT03739112|65643589|FG000|Overall Study|Randomized but not vaccinated|31|||
23520675|NCT03739112|65643590|FG001|Overall Study|Randomized but not vaccinated|25|||
23520676|NCT00673179|65647425|FG000|Overall Study|Toxicity/Complications|3|||
23520677|NCT00673179|65647426|FG001|Overall Study|Toxicity/Complications|0|||
23713637|NCT00413062|66325437|FG001|Overall Study|Withdrawal of informed consent|36|||
23713638|NCT00413062|66325436|FG000|Overall Study|Pregnancy|15|||
23713639|NCT00413062|66325437|FG001|Overall Study|Pregnancy|5|||
23713640|NCT00413062|66325436|FG000|Overall Study|Pregnancy wish|17|||
23520678|NCT02486042|65647431|FG000|Overall Study|Physician Decision|1|||
23520679|NCT02486042|65647432|FG001|Overall Study|Physician Decision|7|||
23520680|NCT02486042|65647431|FG000|Overall Study|Hospital transfer|2|||
23520681|NCT02486042|65647432|FG001|Overall Study|Hospital transfer|2|||
23520682|NCT02486042|65647431|FG000|Overall Study|Withdrawal by Subject|0|||
23520683|NCT02486042|65647432|FG001|Overall Study|Withdrawal by Subject|2|||
23520684|NCT00278954|65647438|FG000|Overall Study|Adverse Event|3|||
23520685|NCT00278954|65647438|FG000|Overall Study|Lost to Follow-up|1|||
23520686|NCT00278954|65647438|FG000|Overall Study|Withdrawal by Subject|1|||
23520687|NCT00735878|65647442|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
23520688|NCT00735878|65647443|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
23520689|NCT00735878|65647444|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
23520690|NCT02291055|65647446|FG000|Overall Study|Death|2|||
23520691|NCT02291055|65647447|FG001|Overall Study|Death|2|||
23520692|NCT02291055|65647448|FG002|Overall Study|Death|5|||
23520693|NCT02291055|65647449|FG003|Overall Study|Death|8|||
23520694|NCT02291055|65647450|FG004|Overall Study|Death|12|||
23520695|NCT02291055|65647446|FG000|Overall Study|Lost to Follow-up|0|||
23520696|NCT02291055|65647447|FG001|Overall Study|Lost to Follow-up|0|||
23520697|NCT02291055|65647448|FG002|Overall Study|Lost to Follow-up|0|||
23520698|NCT02291055|65647449|FG003|Overall Study|Lost to Follow-up|1|||
23520699|NCT02291055|65647450|FG004|Overall Study|Lost to Follow-up|2|||
23520700|NCT02291055|65647446|FG000|Overall Study|Withdrawal by Subject|3|||
23520701|NCT02291055|65647447|FG001|Overall Study|Withdrawal by Subject|1|||
23520702|NCT02291055|65647448|FG002|Overall Study|Withdrawal by Subject|1|||
23520703|NCT02291055|65647449|FG003|Overall Study|Withdrawal by Subject|5|||
23520704|NCT02291055|65647450|FG004|Overall Study|Withdrawal by Subject|10|||
23520705|NCT02291055|65647446|FG000|Overall Study|Progressive Disease|0|||
23520706|NCT02291055|65647447|FG001|Overall Study|Progressive Disease|0|||
23520707|NCT02291055|65647448|FG002|Overall Study|Progressive Disease|1|||
23520708|NCT02291055|65647449|FG003|Overall Study|Progressive Disease|4|||
23520709|NCT02291055|65647450|FG004|Overall Study|Progressive Disease|2|||
23520710|NCT02291055|65647446|FG000|Overall Study|Study Terminated by Sponsor|0|||
23520711|NCT02291055|65647447|FG001|Overall Study|Study Terminated by Sponsor|0|||
23520712|NCT02291055|65647448|FG002|Overall Study|Study Terminated by Sponsor|0|||
23520713|NCT02291055|65647449|FG003|Overall Study|Study Terminated by Sponsor|5|||
23520714|NCT02291055|65647450|FG004|Overall Study|Study Terminated by Sponsor|1|||
23520715|NCT02291055|65647446|FG000|Overall Study|Other|0|||
23520716|NCT02291055|65647447|FG001|Overall Study|Other|2|||
23520717|NCT02291055|65647448|FG002|Overall Study|Other|1|||
23520718|NCT02291055|65647449|FG003|Overall Study|Other|4|||
23520719|NCT02291055|65647450|FG004|Overall Study|Other|0|||
23520720|NCT03131440|65647452|FG000|Overall Study|Withdrawal by Subject|1|||
23520721|NCT03131440|65647453|FG001|Overall Study|Withdrawal by Subject|3|||
23520722|NCT03131440|65647454|FG002|Overall Study|Withdrawal by Subject|0|||
23520723|NCT03131440|65647455|FG003|Overall Study|Withdrawal by Subject|0|||
23520724|NCT03131440|65647456|FG004|Overall Study|Withdrawal by Subject|1|||
23520725|NCT03131440|65647457|FG005|Overall Study|Withdrawal by Subject|0|||
23520726|NCT03131440|65647458|FG006|Overall Study|Withdrawal by Subject|0|||
23520727|NCT03131440|65647459|FG007|Overall Study|Withdrawal by Subject|1|||
23520728|NCT03131440|65647460|FG008|Overall Study|Withdrawal by Subject|1|||
23520729|NCT03131440|65647461|FG009|Overall Study|Withdrawal by Subject|1|||
23520730|NCT03131440|65647462|FG010|Overall Study|Withdrawal by Subject|0|||
23713641|NCT00413062|66325437|FG001|Overall Study|Pregnancy wish|6|||
23713642|NCT00413062|66325436|FG000|Overall Study|Lost to Follow-up|175|||
23520731|NCT03131440|65647463|FG011|Overall Study|Withdrawal by Subject|1|||
23520732|NCT03131440|65647464|FG012|Overall Study|Withdrawal by Subject|1|||
23520733|NCT03131440|65647465|FG013|Overall Study|Withdrawal by Subject|0|||
23520734|NCT03131440|65647466|FG014|Overall Study|Withdrawal by Subject|1|||
23520735|NCT03131440|65647467|FG015|Overall Study|Withdrawal by Subject|0|||
23520736|NCT03131440|65647468|FG016|Overall Study|Withdrawal by Subject|0|||
23520737|NCT03131440|65647469|FG017|Overall Study|Withdrawal by Subject|0|||
23520738|NCT03131440|65647470|FG018|Overall Study|Withdrawal by Subject|1|||
23713643|NCT00413062|66325437|FG001|Overall Study|Lost to Follow-up|73|||
23713644|NCT00413062|66325436|FG000|Overall Study|Other reason|70|||
23520739|NCT03131440|65647471|FG019|Overall Study|Withdrawal by Subject|0|||
23520740|NCT03131440|65647472|FG020|Overall Study|Withdrawal by Subject|1|||
23520741|NCT03131440|65647473|FG021|Overall Study|Withdrawal by Subject|1|||
23520742|NCT03131440|65647474|FG022|Overall Study|Withdrawal by Subject|1|||
23520743|NCT03131440|65647475|FG023|Overall Study|Withdrawal by Subject|0|||
23520744|NCT03131440|65647476|FG024|Overall Study|Withdrawal by Subject|0|||
23520745|NCT03131440|65647477|FG025|Overall Study|Withdrawal by Subject|0|||
23520746|NCT03131440|65647478|FG026|Overall Study|Withdrawal by Subject|0|||
23520747|NCT03131440|65647479|FG027|Overall Study|Withdrawal by Subject|0|||
23520748|NCT03131440|65647480|FG028|Overall Study|Withdrawal by Subject|0|||
23520749|NCT03131440|65647481|FG029|Overall Study|Withdrawal by Subject|0|||
23520750|NCT03131440|65647482|FG030|Overall Study|Withdrawal by Subject|1|||
23520751|NCT03131440|65647483|FG031|Overall Study|Withdrawal by Subject|0|||
23520752|NCT03131440|65647452|FG000|Overall Study|Lost to Follow-up|0|||
23520753|NCT03131440|65647453|FG001|Overall Study|Lost to Follow-up|0|||
23520754|NCT03131440|65647454|FG002|Overall Study|Lost to Follow-up|0|||
23520755|NCT03131440|65647455|FG003|Overall Study|Lost to Follow-up|0|||
23520756|NCT03131440|65647456|FG004|Overall Study|Lost to Follow-up|0|||
23520757|NCT03131440|65647457|FG005|Overall Study|Lost to Follow-up|1|||
23520758|NCT03131440|65647458|FG006|Overall Study|Lost to Follow-up|0|||
23520759|NCT03131440|65647459|FG007|Overall Study|Lost to Follow-up|0|||
23520760|NCT03131440|65647460|FG008|Overall Study|Lost to Follow-up|0|||
23520761|NCT03131440|65647461|FG009|Overall Study|Lost to Follow-up|0|||
23520762|NCT03131440|65647462|FG010|Overall Study|Lost to Follow-up|0|||
23520763|NCT03131440|65647463|FG011|Overall Study|Lost to Follow-up|0|||
23520764|NCT03131440|65647464|FG012|Overall Study|Lost to Follow-up|0|||
23520765|NCT03131440|65647465|FG013|Overall Study|Lost to Follow-up|0|||
23520766|NCT03131440|65647466|FG014|Overall Study|Lost to Follow-up|0|||
23520767|NCT03131440|65647467|FG015|Overall Study|Lost to Follow-up|0|||
23520768|NCT03131440|65647468|FG016|Overall Study|Lost to Follow-up|0|||
23520769|NCT03131440|65647469|FG017|Overall Study|Lost to Follow-up|0|||
23520770|NCT03131440|65647470|FG018|Overall Study|Lost to Follow-up|0|||
23520771|NCT03131440|65647471|FG019|Overall Study|Lost to Follow-up|2|||
23520772|NCT03131440|65647472|FG020|Overall Study|Lost to Follow-up|1|||
23520773|NCT03131440|65647473|FG021|Overall Study|Lost to Follow-up|0|||
23520774|NCT03131440|65647474|FG022|Overall Study|Lost to Follow-up|1|||
23520775|NCT03131440|65647475|FG023|Overall Study|Lost to Follow-up|0|||
23520776|NCT03131440|65647476|FG024|Overall Study|Lost to Follow-up|1|||
23520777|NCT03131440|65647477|FG025|Overall Study|Lost to Follow-up|0|||
23520778|NCT03131440|65647478|FG026|Overall Study|Lost to Follow-up|0|||
23520779|NCT03131440|65647479|FG027|Overall Study|Lost to Follow-up|2|||
23520780|NCT03131440|65647480|FG028|Overall Study|Lost to Follow-up|0|||
23520781|NCT03131440|65647481|FG029|Overall Study|Lost to Follow-up|2|||
23713645|NCT00413062|66325437|FG001|Overall Study|Other reason|34|||
23713646|NCT01354353|66325438|FG000|Overall Study|Adverse Event|1|||
23713647|NCT01354353|66325439|FG001|Overall Study|Adverse Event|0|||
23713648|NCT01354353|66325440|FG002|Overall Study|Adverse Event|0|||
23713649|NCT01354353|66325441|FG003|Overall Study|Adverse Event|4|||
23713650|NCT01354353|66325442|FG004|Overall Study|Adverse Event|0|||
23713651|NCT01354353|66325443|FG005|Overall Study|Adverse Event|5|||
23713652|NCT01354353|66325438|FG000|Overall Study|Entry Criteria Not Met|0|||
23713653|NCT01354353|66325439|FG001|Overall Study|Entry Criteria Not Met|0|||
23713654|NCT01354353|66325440|FG002|Overall Study|Entry Criteria Not Met|0|||
23713655|NCT01354353|66325441|FG003|Overall Study|Entry Criteria Not Met|1|||
23713656|NCT01354353|66325442|FG004|Overall Study|Entry Criteria Not Met|1|||
23713657|NCT01354353|66325443|FG005|Overall Study|Entry Criteria Not Met|0|||
23713658|NCT01354353|66325438|FG000|Overall Study|Physician Decision|0|||
23713659|NCT01354353|66325439|FG001|Overall Study|Physician Decision|1|||
23713660|NCT01354353|66325440|FG002|Overall Study|Physician Decision|1|||
23713661|NCT01354353|66325441|FG003|Overall Study|Physician Decision|0|||
23713662|NCT01354353|66325442|FG004|Overall Study|Physician Decision|0|||
23713663|NCT01354353|66325443|FG005|Overall Study|Physician Decision|0|||
23713664|NCT01354353|66325438|FG000|Overall Study|Withdrawal by Subject|2|||
23713665|NCT01354353|66325439|FG001|Overall Study|Withdrawal by Subject|0|||
23713666|NCT01354353|66325440|FG002|Overall Study|Withdrawal by Subject|1|||
23713667|NCT01354353|66325441|FG003|Overall Study|Withdrawal by Subject|0|||
23713668|NCT01354353|66325442|FG004|Overall Study|Withdrawal by Subject|0|||
23713669|NCT01354353|66325443|FG005|Overall Study|Withdrawal by Subject|1|||
23520782|NCT03131440|65647482|FG030|Overall Study|Lost to Follow-up|0|||
23520783|NCT03131440|65647483|FG031|Overall Study|Lost to Follow-up|0|||
23520784|NCT03131440|65647452|FG000|Overall Study|Death|0|||
23520785|NCT03131440|65647453|FG001|Overall Study|Death|0|||
23520786|NCT03131440|65647454|FG002|Overall Study|Death|0|||
23520787|NCT03131440|65647455|FG003|Overall Study|Death|0|||
23520788|NCT03131440|65647456|FG004|Overall Study|Death|0|||
23520789|NCT03131440|65647457|FG005|Overall Study|Death|0|||
23713670|NCT00747617|66325444|FG000|Overall Study|Lost to Follow-up|3|||
23713671|NCT00747617|66325445|FG001|Overall Study|Lost to Follow-up|1|||
23520790|NCT03131440|65647458|FG006|Overall Study|Death|0|||
23520791|NCT03131440|65647459|FG007|Overall Study|Death|0|||
23520792|NCT03131440|65647460|FG008|Overall Study|Death|0|||
23520793|NCT03131440|65647461|FG009|Overall Study|Death|0|||
23713672|NCT02947022|66325447|FG000|Overall Study|Study Stopped|1|||
23713673|NCT00995670|66325448|FG000|Overall Study|Failed arterial cannulation|1|||
23713674|NCT00995670|66325449|FG001|Overall Study|Failed arterial cannulation|0|||
23713675|NCT00995670|66325450|FG002|Overall Study|Failed arterial cannulation|3|||
23520794|NCT03131440|65647462|FG010|Overall Study|Death|0|||
23520795|NCT03131440|65647463|FG011|Overall Study|Death|0|||
23520796|NCT03131440|65647464|FG012|Overall Study|Death|0|||
23520797|NCT03131440|65647465|FG013|Overall Study|Death|0|||
23713676|NCT00878215|66325453|FG000|Overall Study|Determined to be ineligible|0|||
23713677|NCT00878215|66325454|FG001|Overall Study|Determined to be ineligible|10|||
23713678|NCT00878215|66325455|FG002|Overall Study|Determined to be ineligible|0|||
23713679|NCT00878215|66325456|FG003|Overall Study|Determined to be ineligible|0|||
23713680|NCT00012012|66325457|FG000|Overall Study|Protocol Violation|1|||
23713681|NCT00012012|66325458|FG001|Overall Study|Protocol Violation|1|||
23713682|NCT00012012|66325457|FG000|Overall Study|Withdrawal by Subject|0|||
23713683|NCT00012012|66325458|FG001|Overall Study|Withdrawal by Subject|2|||
23713684|NCT00798655|66325459|FG000|Overall Study|Did not receive at least one dose of pan|2|||
23713685|NCT01518244|66325460|FG000|Overall Study|Adverse Event|3|||
23713686|NCT04092816|66325461|FG000|Overall Study|Lost to Follow-up|1|||
23713687|NCT04092816|66325462|FG001|Overall Study|Lost to Follow-up|2|||
23713688|NCT04410198|66325465|FG000|Overall Study|Death|10|||
23713689|NCT04410198|66325465|FG000|Overall Study|Withdrawal by Subject|7|||
23713690|NCT04410198|66325465|FG000|Overall Study|Transferred/Relocation|4|||
23713691|NCT04410198|66325465|FG000|Overall Study|Kidney Transplant|9|||
23713692|NCT04410198|66325465|FG000|Overall Study|Adverse Event|4|||
23713693|NCT04410198|66325465|FG000|Overall Study|Physician Decision|2|||
23713694|NCT04410198|66325465|FG000|Overall Study|Other than specified|1|||
23713695|NCT00424528|66325466|FG000|Overall Study|Adverse Event|2|||
23713696|NCT00424528|66325467|FG001|Overall Study|Adverse Event|1|||
23812071|NCT02516553|66691889|FG014|Overall Study|Refused to continue trial medication|0|||
23812072|NCT02516553|66691890|FG015|Overall Study|Refused to continue trial medication|0|||
23812073|NCT02516553|66691891|FG016|Overall Study|Refused to continue trial medication|0|||
23520798|NCT03131440|65647466|FG014|Overall Study|Death|0|||
23713697|NCT00424528|66325468|FG002|Overall Study|Adverse Event|2|||
23520799|NCT03131440|65647467|FG015|Overall Study|Death|0|||
23520800|NCT03131440|65647468|FG016|Overall Study|Death|0|||
23520801|NCT03131440|65647469|FG017|Overall Study|Death|0|||
23520802|NCT03131440|65647470|FG018|Overall Study|Death|0|||
23520803|NCT03131440|65647471|FG019|Overall Study|Death|0|||
23520804|NCT03131440|65647472|FG020|Overall Study|Death|0|||
23520805|NCT03131440|65647473|FG021|Overall Study|Death|0|||
23520806|NCT03131440|65647474|FG022|Overall Study|Death|0|||
23520807|NCT03131440|65647475|FG023|Overall Study|Death|0|||
23520808|NCT03131440|65647476|FG024|Overall Study|Death|0|||
23520809|NCT03131440|65647477|FG025|Overall Study|Death|1|||
23520810|NCT03131440|65647478|FG026|Overall Study|Death|0|||
23520811|NCT03131440|65647479|FG027|Overall Study|Death|0|||
23520812|NCT03131440|65647480|FG028|Overall Study|Death|0|||
23520813|NCT03131440|65647481|FG029|Overall Study|Death|0|||
23520814|NCT03131440|65647482|FG030|Overall Study|Death|0|||
23520815|NCT03131440|65647483|FG031|Overall Study|Death|0|||
23520816|NCT00605475|65647490|FG000|Overall Study|Abnormal Laboratory Values|0|||
23520817|NCT00605475|65647491|FG001|Overall Study|Abnormal Laboratory Values|0|||
23520818|NCT00605475|65647492|FG002|Overall Study|Abnormal Laboratory Values|0|||
23520819|NCT00605475|65647493|FG003|Overall Study|Abnormal Laboratory Values|0|||
23520820|NCT00605475|65647494|FG004|Overall Study|Abnormal Laboratory Values|0|||
23520821|NCT00605475|65647495|FG005|Overall Study|Abnormal Laboratory Values|0|||
23520822|NCT00605475|65647496|FG006|Overall Study|Abnormal Laboratory Values|0|||
23520823|NCT00605475|65647497|FG007|Overall Study|Abnormal Laboratory Values|0|||
23520824|NCT00605475|65647498|FG008|Overall Study|Abnormal Laboratory Values|1|||
23520825|NCT00605475|65647499|FG009|Overall Study|Abnormal Laboratory Values|0|||
23520826|NCT00605475|65647490|FG000|Overall Study|Administrative problems|0|||
23520827|NCT00605475|65647491|FG001|Overall Study|Administrative problems|0|||
23520828|NCT00605475|65647492|FG002|Overall Study|Administrative problems|0|||
23520829|NCT00605475|65647493|FG003|Overall Study|Administrative problems|0|||
23520830|NCT00605475|65647494|FG004|Overall Study|Administrative problems|0|||
23520831|NCT00605475|65647495|FG005|Overall Study|Administrative problems|0|||
23713698|NCT00424528|66325466|FG000|Overall Study|Protocol Violation|1|||
23520832|NCT00605475|65647496|FG006|Overall Study|Administrative problems|1|||
23713699|NCT00424528|66325467|FG001|Overall Study|Protocol Violation|1|||
23713700|NCT00424528|66325468|FG002|Overall Study|Protocol Violation|0|||
23713701|NCT00424528|66325466|FG000|Overall Study|Lost to Follow-up|0|||
23713702|NCT00424528|66325467|FG001|Overall Study|Lost to Follow-up|1|||
23520833|NCT00605475|65647497|FG007|Overall Study|Administrative problems|0|||
23520834|NCT00605475|65647498|FG008|Overall Study|Administrative problems|0|||
23520835|NCT00605475|65647499|FG009|Overall Study|Administrative problems|0|||
23520836|NCT00605475|65647490|FG000|Overall Study|Lost to Follow-up|0|||
23520837|NCT00605475|65647491|FG001|Overall Study|Lost to Follow-up|0|||
23713703|NCT00424528|66325468|FG002|Overall Study|Lost to Follow-up|0|||
23520838|NCT00605475|65647492|FG002|Overall Study|Lost to Follow-up|0|||
23520839|NCT00605475|65647493|FG003|Overall Study|Lost to Follow-up|0|||
23520840|NCT00605475|65647494|FG004|Overall Study|Lost to Follow-up|0|||
23713704|NCT00424528|66325466|FG000|Overall Study|noncompliance with study requirements|2|||
23713705|NCT00424528|66325467|FG001|Overall Study|noncompliance with study requirements|1|||
23713706|NCT00424528|66325468|FG002|Overall Study|noncompliance with study requirements|2|||
23713707|NCT01021813|66325469|FG000|DB Treatment Phase|Adverse Event|60|||
23713708|NCT01021813|66325470|FG001|DB Treatment Phase|Adverse Event|22|||
23713709|NCT01021813|66325471|FG002|DB Treatment Phase|Adverse Event|0|||
23713710|NCT01021813|66325472|FG003|DB Treatment Phase|Adverse Event|0|||
23713711|NCT01021813|66325473|FG004|DB Treatment Phase|Adverse Event|0|||
23713712|NCT01021813|66325469|FG000|DB Treatment Phase|Lack of Efficacy|44|||
23713713|NCT01021813|66325470|FG001|DB Treatment Phase|Lack of Efficacy|28|||
23713714|NCT01021813|66325471|FG002|DB Treatment Phase|Lack of Efficacy|0|||
23713715|NCT01021813|66325472|FG003|DB Treatment Phase|Lack of Efficacy|0|||
23713716|NCT01021813|66325473|FG004|DB Treatment Phase|Lack of Efficacy|0|||
23713717|NCT01021813|66325469|FG000|DB Treatment Phase|Lost to Follow-up|14|||
23713718|NCT01021813|66325470|FG001|DB Treatment Phase|Lost to Follow-up|12|||
23713719|NCT01021813|66325471|FG002|DB Treatment Phase|Lost to Follow-up|0|||
23713720|NCT01021813|66325472|FG003|DB Treatment Phase|Lost to Follow-up|0|||
23713721|NCT01021813|66325473|FG004|DB Treatment Phase|Lost to Follow-up|0|||
23713722|NCT01021813|66325469|FG000|DB Treatment Phase|Physician Decision|17|||
23713723|NCT01021813|66325470|FG001|DB Treatment Phase|Physician Decision|8|||
23713724|NCT01021813|66325471|FG002|DB Treatment Phase|Physician Decision|0|||
23713725|NCT01021813|66325472|FG003|DB Treatment Phase|Physician Decision|0|||
23713726|NCT01021813|66325473|FG004|DB Treatment Phase|Physician Decision|0|||
23520841|NCT00605475|65647495|FG005|Overall Study|Lost to Follow-up|0|||
23520842|NCT00605475|65647496|FG006|Overall Study|Lost to Follow-up|0|||
23520843|NCT00605475|65647497|FG007|Overall Study|Lost to Follow-up|0|||
23520844|NCT00605475|65647498|FG008|Overall Study|Lost to Follow-up|1|||
23520845|NCT00605475|65647499|FG009|Overall Study|Lost to Follow-up|1|||
23520846|NCT00605475|65647490|FG000|Overall Study|Protocol Violation|0|||
23520847|NCT00605475|65647491|FG001|Overall Study|Protocol Violation|0|||
23520848|NCT00605475|65647492|FG002|Overall Study|Protocol Violation|0|||
23520849|NCT00605475|65647493|FG003|Overall Study|Protocol Violation|0|||
23520850|NCT00605475|65647494|FG004|Overall Study|Protocol Violation|1|||
23520851|NCT00605475|65647495|FG005|Overall Study|Protocol Violation|0|||
23520852|NCT00605475|65647496|FG006|Overall Study|Protocol Violation|0|||
23520853|NCT00605475|65647497|FG007|Overall Study|Protocol Violation|0|||
23520854|NCT00605475|65647498|FG008|Overall Study|Protocol Violation|0|||
23520855|NCT00605475|65647499|FG009|Overall Study|Protocol Violation|0|||
23520856|NCT00605475|65647490|FG000|Overall Study|Withdrawal by Subject|0|||
23520857|NCT00605475|65647491|FG001|Overall Study|Withdrawal by Subject|0|||
23520858|NCT00605475|65647492|FG002|Overall Study|Withdrawal by Subject|0|||
23520859|NCT00605475|65647493|FG003|Overall Study|Withdrawal by Subject|0|||
23520860|NCT00605475|65647494|FG004|Overall Study|Withdrawal by Subject|0|||
23520861|NCT00605475|65647495|FG005|Overall Study|Withdrawal by Subject|2|||
23520862|NCT00605475|65647496|FG006|Overall Study|Withdrawal by Subject|0|||
23520863|NCT00605475|65647497|FG007|Overall Study|Withdrawal by Subject|0|||
23520864|NCT00605475|65647498|FG008|Overall Study|Withdrawal by Subject|0|||
23520865|NCT00605475|65647499|FG009|Overall Study|Withdrawal by Subject|1|||
23520866|NCT00371254|65647501|FG000|Overall Study|Disease progression|13|||
23520867|NCT00371254|65647502|FG001|Overall Study|Disease progression|13|||
23520868|NCT00371254|65647501|FG000|Overall Study|Study drug toxicity|3|||
23520869|NCT00371254|65647502|FG001|Overall Study|Study drug toxicity|5|||
23520870|NCT00371254|65647501|FG000|Overall Study|Subject request|5|||
23520871|NCT00371254|65647502|FG001|Overall Study|Subject request|0|||
23520872|NCT00371254|65647501|FG000|Overall Study|Investigator Decision|2|||
23520873|NCT00371254|65647502|FG001|Overall Study|Investigator Decision|0|||
23520874|NCT00371254|65647501|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23520875|NCT00371254|65647502|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23713727|NCT01021813|66325469|FG000|DB Treatment Phase|Pregnancy|1|||
23713728|NCT01021813|66325470|FG001|DB Treatment Phase|Pregnancy|0|||
23713729|NCT01021813|66325471|FG002|DB Treatment Phase|Pregnancy|0|||
23713730|NCT01021813|66325472|FG003|DB Treatment Phase|Pregnancy|0|||
23713731|NCT01021813|66325473|FG004|DB Treatment Phase|Pregnancy|0|||
23520876|NCT00371254|65647501|FG000|Overall Study|Lost to Follow-up|0|||
23520877|NCT00371254|65647502|FG001|Overall Study|Lost to Follow-up|1|||
23520878|NCT00371254|65647501|FG000|Overall Study|Withdrawal by Subject|0|||
23520879|NCT00371254|65647502|FG001|Overall Study|Withdrawal by Subject|1|||
23520880|NCT01894152|65647503|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
23520881|NCT02442778|65647504|FG000|Overall Study|Adverse Event|2|||
23520882|NCT02442778|65647505|FG001|Overall Study|Adverse Event|6|||
23520883|NCT02442778|65647506|FG002|Overall Study|Adverse Event|6|||
23520884|NCT02442778|65647504|FG000|Overall Study|Death|0|||
23520885|NCT02442778|65647505|FG001|Overall Study|Death|2|||
23520886|NCT02442778|65647506|FG002|Overall Study|Death|0|||
23520887|NCT02442778|65647504|FG000|Overall Study|Lack of Efficacy|1|||
23520888|NCT02442778|65647505|FG001|Overall Study|Lack of Efficacy|0|||
23520889|NCT02442778|65647506|FG002|Overall Study|Lack of Efficacy|0|||
23520890|NCT02442778|65647504|FG000|Overall Study|Lost to Follow-up|1|||
23520891|NCT02442778|65647505|FG001|Overall Study|Lost to Follow-up|1|||
23520892|NCT02442778|65647506|FG002|Overall Study|Lost to Follow-up|1|||
23520893|NCT02442778|65647504|FG000|Overall Study|Non-compliance with study drug|2|||
23520894|NCT02442778|65647505|FG001|Overall Study|Non-compliance with study drug|0|||
23520895|NCT02442778|65647506|FG002|Overall Study|Non-compliance with study drug|1|||
23520896|NCT02442778|65647504|FG000|Overall Study|Physician Decision|1|||
23520897|NCT02442778|65647505|FG001|Overall Study|Physician Decision|1|||
23520898|NCT02442778|65647506|FG002|Overall Study|Physician Decision|1|||
23520899|NCT02442778|65647504|FG000|Overall Study|Protocol Deviation|3|||
23520900|NCT02442778|65647505|FG001|Overall Study|Protocol Deviation|0|||
23520901|NCT02442778|65647506|FG002|Overall Study|Protocol Deviation|1|||
23520902|NCT02442778|65647504|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
23520903|NCT02442778|65647505|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
23520904|NCT02442778|65647506|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
23520905|NCT02442778|65647504|FG000|Overall Study|Withdrawal by Subject|4|||
23520906|NCT02442778|65647505|FG001|Overall Study|Withdrawal by Subject|4|||
23520907|NCT02442778|65647506|FG002|Overall Study|Withdrawal by Subject|3|||
23520908|NCT02442778|65647504|FG000|Overall Study|Reason not specified|1|||
23520909|NCT02442778|65647505|FG001|Overall Study|Reason not specified|4|||
23520910|NCT02442778|65647506|FG002|Overall Study|Reason not specified|0|||
23520911|NCT02120794|65647507|FG000|Overall Study|Withdrawal by Subject|43|||
23520912|NCT02120794|65647507|FG000|Overall Study|Adverse Event|10|||
23520913|NCT02120794|65647507|FG000|Overall Study|Physician Decision|4|||
23520914|NCT02120794|65647507|FG000|Overall Study|Due to insurance coverage|1|||
23520915|NCT02369341|65647516|FG000|Overall Study|Migrated/moved from study area|1|||
23520916|NCT02369341|65647517|FG001|Overall Study|Migrated/moved from study area|0|||
23520917|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
23520918|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
23520919|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
23520920|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
23520921|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
23520922|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
23520923|NCT03274986|65647523|FG000|Overall Study|Withdrawal by Subject|0|||
23520924|NCT03274986|65647524|FG001|Overall Study|Withdrawal by Subject|1|||
23520925|NCT03274986|65647523|FG000|Overall Study|Lost to Follow-up|0|||
23520926|NCT03274986|65647524|FG001|Overall Study|Lost to Follow-up|1|||
23520927|NCT03526458|65647525|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
23520928|NCT03526458|65647526|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
23520929|NCT03526458|65647525|FG000|Overall Study|Stone passed, surgery cancelled|2|||
23520930|NCT03526458|65647526|FG001|Overall Study|Stone passed, surgery cancelled|1|||
23520931|NCT03526458|65647525|FG000|Overall Study|Withdrawal by Subject|1|||
23520932|NCT03526458|65647526|FG001|Overall Study|Withdrawal by Subject|0|||
23520933|NCT03526458|65647525|FG000|Overall Study|Physician Decision|2|||
23520934|NCT03526458|65647526|FG001|Overall Study|Physician Decision|1|||
23520935|NCT03526458|65647525|FG000|Overall Study|Lack of equipment|1|||
23520936|NCT03526458|65647526|FG001|Overall Study|Lack of equipment|1|||
23520937|NCT04898673|65647527|FG000|Overall Study|Screenfail|1|||
23520938|NCT04898673|65647528|FG001|Overall Study|Screenfail|0|||
23520939|NCT00733746|65647529|FG000|Overall Study|Ineligible|5|||
23520940|NCT01592344|65647532|FG000|Overall Study|Adverse Event|1|||
23520941|NCT01592344|65647533|FG001|Overall Study|Adverse Event|1|||
23520942|NCT01592344|65647532|FG000|Overall Study|Lack of Efficacy|1|||
23520943|NCT01592344|65647533|FG001|Overall Study|Lack of Efficacy|0|||
23520944|NCT01592344|65647532|FG000|Overall Study|not available at primary outcome visit|2|||
23520945|NCT01592344|65647533|FG001|Overall Study|not available at primary outcome visit|4|||
23520946|NCT05071183|65647538|FG000|Overall Study|Death|1|||
23520947|NCT05071183|65647539|FG001|Overall Study|Death|2|||
23520948|NCT05071183|65647540|FG002|Overall Study|Death|0|||
23520949|NCT05071183|65647538|FG000|Overall Study|Other Reasons|1|||
23520950|NCT05071183|65647539|FG001|Overall Study|Other Reasons|3|||
23520951|NCT05071183|65647540|FG002|Overall Study|Other Reasons|2|||
23520952|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
23520953|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
23520954|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
23520955|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
23520956|NCT01478321|65647543|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
23520957|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
23520958|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
23520959|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
23520960|NCT04532099|65647544|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
23520961|NCT04532099|65647545|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
23520962|NCT04532099|65647546|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
23520963|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
23520964|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
23520965|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
23520966|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
23520967|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
23520968|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
23520969|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
23520970|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
23520971|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
23520972|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Death|0|||
23520973|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Death|0|||
23520974|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Death|1|||
23520975|NCT00885755|65647547|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
23520976|NCT00885755|65647548|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
23520977|NCT00885755|65647549|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
23520978|NCT01712256|65647552|FG000|Overall Study|Lost to Follow-up|1|||
23520979|NCT02968979|65647554|FG000|Overall Study|Protocol Violation|7|||
23520980|NCT02968979|65647554|FG000|Overall Study|Withdrawal by Subject|1|||
23520981|NCT01870583|65647557|FG000|Overall Study|Protocol Violation|0|||
23520982|NCT01870583|65647558|FG001|Overall Study|Protocol Violation|5|||
23520983|NCT01870583|65647559|FG002|Overall Study|Protocol Violation|3|||
23520984|NCT01870583|65647557|FG000|Overall Study|Lost to Follow-up|11|||
23520985|NCT01870583|65647558|FG001|Overall Study|Lost to Follow-up|13|||
23520986|NCT01870583|65647559|FG002|Overall Study|Lost to Follow-up|5|||
23520987|NCT01848756|65647564|FG000|Overall Study|Adverse Event|1|||
23520988|NCT01848756|65647564|FG000|Overall Study|Withdrawal by Subject|1|||
23520989|NCT01848756|65647564|FG000|Overall Study|Enrolled in Error|1|||
23520990|NCT00798369|65647565|FG000|Overall Study|Subject withdrew consent|0|||
23520991|NCT00798369|65647566|FG001|Overall Study|Subject withdrew consent|0|||
23520992|NCT00798369|65647567|FG002|Overall Study|Subject withdrew consent|1|||
23520993|NCT00798369|65647568|FG003|Overall Study|Subject withdrew consent|1|||
23520994|NCT00798369|65647569|FG004|Overall Study|Subject withdrew consent|0|||
23520995|NCT00798369|65647570|FG005|Overall Study|Subject withdrew consent|2|||
23520996|NCT00798369|65647565|FG000|Overall Study|Lost to Follow-up|1|||
23520997|NCT00798369|65647566|FG001|Overall Study|Lost to Follow-up|1|||
23520998|NCT00798369|65647567|FG002|Overall Study|Lost to Follow-up|1|||
23520999|NCT00798369|65647568|FG003|Overall Study|Lost to Follow-up|0|||
23521000|NCT00798369|65647569|FG004|Overall Study|Lost to Follow-up|1|||
23521001|NCT00798369|65647570|FG005|Overall Study|Lost to Follow-up|0|||
23521002|NCT00798369|65647565|FG000|Overall Study|Adminstrative problems|0|||
23521003|NCT00798369|65647566|FG001|Overall Study|Adminstrative problems|0|||
23521004|NCT00798369|65647567|FG002|Overall Study|Adminstrative problems|0|||
23521005|NCT00798369|65647568|FG003|Overall Study|Adminstrative problems|0|||
23521006|NCT00798369|65647569|FG004|Overall Study|Adminstrative problems|0|||
23521007|NCT00798369|65647570|FG005|Overall Study|Adminstrative problems|1|||
23521008|NCT01251380|65647571|FG000|Overall Study|Other (Not otherwise specified)|12|||
23521009|NCT01251380|65647571|FG000|Overall Study|Withdrawal by Subject|6|||
23521010|NCT01251380|65647571|FG000|Overall Study|Lack of Efficacy|1|||
23521011|NCT01251380|65647571|FG000|Overall Study|Adverse Event|1|||
23521012|NCT01251380|65647571|FG000|Overall Study|Lost to Follow-up|2|||
23521013|NCT02063737|65647572|FG000|Overall Study|Lost to Follow-up|11|||
23521014|NCT02063737|65647573|FG001|Overall Study|Lost to Follow-up|4|||
23521015|NCT00451321|65647575|FG000|Overall Study|Lost to Follow-up|3|||
23521016|NCT00451321|65647576|FG001|Overall Study|Lost to Follow-up|3|||
23521017|NCT00451321|65647577|FG002|Overall Study|Lost to Follow-up|1|||
23521018|NCT00451321|65647578|FG003|Overall Study|Lost to Follow-up|3|||
23521019|NCT00451321|65647579|FG004|Overall Study|Lost to Follow-up|0|||
23521020|NCT00451321|65647580|FG005|Overall Study|Lost to Follow-up|1|||
23521021|NCT00451321|65647581|FG006|Overall Study|Lost to Follow-up|0|||
23521022|NCT00451321|65647582|FG007|Overall Study|Lost to Follow-up|0|||
23521023|NCT00451321|65647575|FG000|Overall Study|Withdrawal by Subject|3|||
23521024|NCT00451321|65647576|FG001|Overall Study|Withdrawal by Subject|1|||
23521025|NCT00451321|65647577|FG002|Overall Study|Withdrawal by Subject|0|||
23521026|NCT00451321|65647578|FG003|Overall Study|Withdrawal by Subject|4|||
23521027|NCT00451321|65647579|FG004|Overall Study|Withdrawal by Subject|0|||
23521028|NCT00451321|65647580|FG005|Overall Study|Withdrawal by Subject|0|||
23521029|NCT00451321|65647581|FG006|Overall Study|Withdrawal by Subject|0|||
23521030|NCT00451321|65647582|FG007|Overall Study|Withdrawal by Subject|0|||
23521031|NCT00451321|65647575|FG000|Overall Study|Study closed/terminated|1|||
23521032|NCT00451321|65647576|FG001|Overall Study|Study closed/terminated|1|||
23521033|NCT00451321|65647577|FG002|Overall Study|Study closed/terminated|17|||
23521034|NCT00451321|65647578|FG003|Overall Study|Study closed/terminated|5|||
23521035|NCT00451321|65647579|FG004|Overall Study|Study closed/terminated|7|||
23521036|NCT00451321|65647580|FG005|Overall Study|Study closed/terminated|7|||
23521037|NCT00451321|65647581|FG006|Overall Study|Study closed/terminated|5|||
23521038|NCT00451321|65647582|FG007|Overall Study|Study closed/terminated|3|||
23521039|NCT00451321|65647575|FG000|Overall Study|Sponsor decision to amend protocol|0|||
23521040|NCT00451321|65647576|FG001|Overall Study|Sponsor decision to amend protocol|0|||
23521041|NCT00451321|65647577|FG002|Overall Study|Sponsor decision to amend protocol|0|||
23521042|NCT00451321|65647578|FG003|Overall Study|Sponsor decision to amend protocol|0|||
23521043|NCT00451321|65647579|FG004|Overall Study|Sponsor decision to amend protocol|0|||
23521044|NCT00451321|65647580|FG005|Overall Study|Sponsor decision to amend protocol|1|||
23521045|NCT00451321|65647581|FG006|Overall Study|Sponsor decision to amend protocol|1|||
23521046|NCT00451321|65647582|FG007|Overall Study|Sponsor decision to amend protocol|3|||
23521047|NCT03412084|65647585|FG000|Overall Study|Withdrawal by Subject|2|||
23521048|NCT03412084|65647586|FG001|Overall Study|Withdrawal by Subject|0|||
23521049|NCT03412084|65647585|FG000|Overall Study|Participant moved|1|||
23521050|NCT03412084|65647586|FG001|Overall Study|Participant moved|0|||
23521051|NCT03412084|65647585|FG000|Overall Study|Lost to Follow-up|1|||
23521052|NCT03412084|65647586|FG001|Overall Study|Lost to Follow-up|1|||
23521053|NCT00778700|65647587|FG000|Overall Study|Adverse Event|6|||
23521054|NCT00778700|65647588|FG001|Overall Study|Adverse Event|1|||
23521055|NCT00778700|65647589|FG002|Overall Study|Adverse Event|3|||
23521056|NCT00778700|65647590|FG003|Overall Study|Adverse Event|5|||
23521057|NCT00778700|65647587|FG000|Overall Study|Protocol Violation|1|||
23521058|NCT00778700|65647588|FG001|Overall Study|Protocol Violation|1|||
23521059|NCT00778700|65647589|FG002|Overall Study|Protocol Violation|0|||
23521060|NCT00778700|65647590|FG003|Overall Study|Protocol Violation|0|||
23521061|NCT00778700|65647587|FG000|Overall Study|Subject Withdrew Consent|6|||
23521062|NCT00778700|65647588|FG001|Overall Study|Subject Withdrew Consent|4|||
23521063|NCT00778700|65647589|FG002|Overall Study|Subject Withdrew Consent|1|||
23521064|NCT00778700|65647590|FG003|Overall Study|Subject Withdrew Consent|4|||
23521065|NCT00778700|65647587|FG000|Overall Study|Lost to Follow-up|3|||
23521066|NCT00778700|65647588|FG001|Overall Study|Lost to Follow-up|1|||
23521067|NCT00778700|65647589|FG002|Overall Study|Lost to Follow-up|0|||
23521068|NCT00778700|65647590|FG003|Overall Study|Lost to Follow-up|1|||
23521069|NCT00778700|65647587|FG000|Overall Study|Reason not Specified|2|||
23521070|NCT00778700|65647588|FG001|Overall Study|Reason not Specified|0|||
23521071|NCT00778700|65647589|FG002|Overall Study|Reason not Specified|1|||
23521072|NCT00778700|65647590|FG003|Overall Study|Reason not Specified|3|||
23521073|NCT00778700|65647587|FG000|Overall Study|Other|0|||
23521074|NCT00778700|65647588|FG001|Overall Study|Other|0|||
23521075|NCT00778700|65647589|FG002|Overall Study|Other|1|||
23521076|NCT00778700|65647590|FG003|Overall Study|Other|0|||
23521077|NCT01452412|65647591|FG000|Overall Study|Withdrawal by Subject|15|||
23521078|NCT01452412|65647592|FG001|Overall Study|Withdrawal by Subject|11|||
23521079|NCT01452412|65647591|FG000|Overall Study|Adverse Event|4|||
23521080|NCT01452412|65647592|FG001|Overall Study|Adverse Event|3|||
23521081|NCT01452412|65647591|FG000|Overall Study|Lost to Follow-up|5|||
23521082|NCT01452412|65647592|FG001|Overall Study|Lost to Follow-up|3|||
23521083|NCT01452412|65647591|FG000|Overall Study|Death|1|||
23521084|NCT01452412|65647592|FG001|Overall Study|Death|0|||
23521085|NCT01452412|65647591|FG000|Overall Study|Initiated dialysis|1|||
23521086|NCT01452412|65647592|FG001|Overall Study|Initiated dialysis|0|||
23521087|NCT01452412|65647591|FG000|Overall Study|Other|2|||
23521088|NCT01452412|65647592|FG001|Overall Study|Other|0|||
23521089|NCT02466555|65647598|FG000|Overall Study|Lost to Follow-up|2|||
23521090|NCT01822132|65647614|FG000|Overall Study|Lost to Follow-up|4|||
23521091|NCT01822132|65647615|FG001|Overall Study|Lost to Follow-up|2|||
23521092|NCT02579265|65647616|FG000|Overall Study|Weaned off earlier than 28 days|44|||
23521093|NCT02579265|65647617|FG001|Overall Study|Weaned off earlier than 28 days|43|||
23521094|NCT02579265|65647616|FG000|Overall Study|Adverse Event|2|||
23521095|NCT02579265|65647617|FG001|Overall Study|Adverse Event|0|||
23521096|NCT02579265|65647616|FG000|Overall Study|Any other reason not specified|0|||
23521097|NCT02579265|65647617|FG001|Overall Study|Any other reason not specified|2|||
23521098|NCT02579265|65647616|FG000|Overall Study|Withdrawal by Subject|2|||
23521099|NCT02579265|65647617|FG001|Overall Study|Withdrawal by Subject|0|||
23521100|NCT02579265|65647616|FG000|Overall Study|Physician Decision|1|||
23521101|NCT02579265|65647617|FG001|Overall Study|Physician Decision|0|||
23521102|NCT02579265|65647616|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
23521103|NCT02579265|65647617|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
23521104|NCT00218296|65647618|FG000|Overall Study|Lost to Follow-up|9|||
23521105|NCT00218296|65647619|FG001|Overall Study|Lost to Follow-up|7|||
23521106|NCT00218296|65647618|FG000|Overall Study|Withdrawal by Subject|36|||
23521107|NCT00218296|65647619|FG001|Overall Study|Withdrawal by Subject|47|||
23521108|NCT00218296|65647618|FG000|Overall Study|Randomized but did not enter treatment|66|||
23521109|NCT00218296|65647619|FG001|Overall Study|Randomized but did not enter treatment|67|||
23521110|NCT00729183|65647621|FG000|Overall Study|Adverse Event|11|||
23521111|NCT00729183|65647622|FG001|Overall Study|Adverse Event|5|||
23521112|NCT00729183|65647621|FG000|Overall Study|Lack of Efficacy|0|||
23521113|NCT00729183|65647622|FG001|Overall Study|Lack of Efficacy|1|||
23521114|NCT00729183|65647621|FG000|Overall Study|Lost to Follow-up|3|||
23521115|NCT00729183|65647622|FG001|Overall Study|Lost to Follow-up|1|||
23521116|NCT00729183|65647621|FG000|Overall Study|Physician Decision|1|||
23521117|NCT00729183|65647622|FG001|Overall Study|Physician Decision|1|||
23521118|NCT00729183|65647621|FG000|Overall Study|Protocol Violation|1|||
23521119|NCT00729183|65647622|FG001|Overall Study|Protocol Violation|0|||
23521120|NCT00729183|65647621|FG000|Overall Study|Withdrawal by Subject|9|||
23521121|NCT00729183|65647622|FG001|Overall Study|Withdrawal by Subject|7|||
23521122|NCT01921179|65647625|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
23521123|NCT01921179|65647626|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
23521124|NCT01921179|65647625|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
23521125|NCT01921179|65647626|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
23521126|NCT02642432|65647627|FG000|Overall Study|Adverse Event|2|||
23521127|NCT02642432|65647627|FG000|Overall Study|Withdrew Consent|1|||
23521128|NCT02642432|65647627|FG000|Overall Study|Lost to Follow-up|2|||
23521129|NCT02642432|65647627|FG000|Overall Study|Other|3|||
23521130|NCT02347189|65647628|FG000|Overall Study|No implant attempted of study device|9|||
23521131|NCT02347189|65647628|FG000|Overall Study|No primary outcome data available|2|||
23521132|NCT01165138|65647629|FG000|Overall Study|Adverse Event|0|||
23521133|NCT01165138|65647630|FG001|Overall Study|Adverse Event|1|||
23521134|NCT01165138|65647631|FG002|Overall Study|Adverse Event|0|||
23521135|NCT01165138|65647632|FG003|Overall Study|Adverse Event|2|||
23521136|NCT01165138|65647629|FG000|Overall Study|Lack of Efficacy|0|||
23521137|NCT01165138|65647630|FG001|Overall Study|Lack of Efficacy|32|||
23521138|NCT01165138|65647631|FG002|Overall Study|Lack of Efficacy|6|||
23521139|NCT01165138|65647632|FG003|Overall Study|Lack of Efficacy|7|||
23521140|NCT01165138|65647629|FG000|Overall Study|Protocol Violation|0|||
23521141|NCT01165138|65647630|FG001|Overall Study|Protocol Violation|7|||
23521142|NCT01165138|65647631|FG002|Overall Study|Protocol Violation|0|||
23521143|NCT01165138|65647632|FG003|Overall Study|Protocol Violation|2|||
23521144|NCT01165138|65647629|FG000|Overall Study|Lost to Follow-up|0|||
23521145|NCT01165138|65647630|FG001|Overall Study|Lost to Follow-up|0|||
23521146|NCT01165138|65647631|FG002|Overall Study|Lost to Follow-up|1|||
23521147|NCT01165138|65647632|FG003|Overall Study|Lost to Follow-up|2|||
23521148|NCT01165138|65647629|FG000|Overall Study|Physician Decision|0|||
23521149|NCT01165138|65647630|FG001|Overall Study|Physician Decision|6|||
23521150|NCT01165138|65647631|FG002|Overall Study|Physician Decision|7|||
23521151|NCT01165138|65647632|FG003|Overall Study|Physician Decision|6|||
23521152|NCT01165138|65647629|FG000|Overall Study|Withdrawal by Subject|0|||
23521153|NCT01165138|65647630|FG001|Overall Study|Withdrawal by Subject|6|||
23521154|NCT01165138|65647631|FG002|Overall Study|Withdrawal by Subject|6|||
23521155|NCT01165138|65647632|FG003|Overall Study|Withdrawal by Subject|3|||
23521156|NCT03745144|65647639|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
23521157|NCT03745144|65647640|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
23521158|NCT03745144|65647641|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
23521159|NCT03745144|65647639|FG000|Period 1|Other|0|||
23521160|NCT03745144|65647640|FG001|Period 1|Other|0|||
23521161|NCT03745144|65647641|FG002|Period 1|Other|1|||
23521162|NCT01365273|65647649|FG000|Overall Study|Lost to Follow-up|1|||
23521163|NCT01365273|65647650|FG001|Overall Study|Lost to Follow-up|0|||
23521164|NCT01365273|65647649|FG000|Overall Study|Protocol Violation|0|||
23521165|NCT01365273|65647650|FG001|Overall Study|Protocol Violation|1|||
23521166|NCT01365273|65647649|FG000|Overall Study|Physician Decision|1|||
23521167|NCT01365273|65647650|FG001|Overall Study|Physician Decision|0|||
23521168|NCT00464568|65647657|FG000|Overall Study|Adverse Event|2|||
23521169|NCT03329690|65647659|FG000|Overall Study|Progressive disease per RECIST|85|||
23521170|NCT03329690|65647660|FG001|Overall Study|Progressive disease per RECIST|44|||
23521171|NCT03329690|65647661|FG002|Overall Study|Progressive disease per RECIST|6|||
23521172|NCT03329690|65647662|FG003|Overall Study|Progressive disease per RECIST|16|||
23521173|NCT03329690|65647663|FG004|Overall Study|Progressive disease per RECIST|20|||
23521174|NCT03329690|65647659|FG000|Overall Study|Clinical progression|7|||
23521175|NCT03329690|65647660|FG001|Overall Study|Clinical progression|4|||
23521176|NCT03329690|65647661|FG002|Overall Study|Clinical progression|1|||
23521177|NCT03329690|65647662|FG003|Overall Study|Clinical progression|1|||
23521178|NCT03329690|65647663|FG004|Overall Study|Clinical progression|1|||
23521179|NCT03329690|65647659|FG000|Overall Study|Adverse Event|22|||
23521180|NCT03329690|65647660|FG001|Overall Study|Adverse Event|4|||
23521181|NCT03329690|65647661|FG002|Overall Study|Adverse Event|0|||
23521182|NCT03329690|65647662|FG003|Overall Study|Adverse Event|1|||
23521183|NCT03329690|65647663|FG004|Overall Study|Adverse Event|2|||
23521184|NCT03329690|65647659|FG000|Overall Study|Death|2|||
23521185|NCT03329690|65647660|FG001|Overall Study|Death|0|||
23521186|NCT03329690|65647661|FG002|Overall Study|Death|0|||
23521187|NCT03329690|65647662|FG003|Overall Study|Death|1|||
23521188|NCT03329690|65647663|FG004|Overall Study|Death|0|||
23521189|NCT03329690|65647659|FG000|Overall Study|Withdrawal by Subject|2|||
23521190|NCT03329690|65647660|FG001|Overall Study|Withdrawal by Subject|3|||
23521191|NCT03329690|65647661|FG002|Overall Study|Withdrawal by Subject|0|||
23521192|NCT03329690|65647662|FG003|Overall Study|Withdrawal by Subject|1|||
23521193|NCT03329690|65647663|FG004|Overall Study|Withdrawal by Subject|0|||
23521194|NCT03329690|65647659|FG000|Overall Study|Physician Decision|1|||
23521195|NCT03329690|65647660|FG001|Overall Study|Physician Decision|0|||
23521196|NCT03329690|65647661|FG002|Overall Study|Physician Decision|0|||
23521197|NCT03329690|65647662|FG003|Overall Study|Physician Decision|0|||
23521198|NCT03329690|65647663|FG004|Overall Study|Physician Decision|1|||
23521199|NCT03329690|65647659|FG000|Overall Study|Miscellaneous|6|||
23521200|NCT03329690|65647660|FG001|Overall Study|Miscellaneous|0|||
23521201|NCT03329690|65647661|FG002|Overall Study|Miscellaneous|0|||
23521202|NCT03329690|65647662|FG003|Overall Study|Miscellaneous|0|||
23521203|NCT03329690|65647663|FG004|Overall Study|Miscellaneous|0|||
23521204|NCT03329690|65647659|FG000|Overall Study|Did not receive treatment|1|||
23521205|NCT03329690|65647660|FG001|Overall Study|Did not receive treatment|0|||
23521206|NCT03329690|65647661|FG002|Overall Study|Did not receive treatment|0|||
23521207|NCT03329690|65647662|FG003|Overall Study|Did not receive treatment|1|||
23521208|NCT03329690|65647663|FG004|Overall Study|Did not receive treatment|0|||
23521209|NCT02246673|65647664|FG000|Overall Study|Sponsor Decision|1|||
23521210|NCT02246673|65647665|FG001|Overall Study|Sponsor Decision|0|||
23521211|NCT02246673|65647666|FG002|Overall Study|Sponsor Decision|0|||
23521212|NCT02246673|65647667|FG003|Overall Study|Sponsor Decision|0|||
23521213|NCT02246673|65647668|FG004|Overall Study|Sponsor Decision|0|||
23521214|NCT02246673|65647664|FG000|Overall Study|Withdrawal by Subject|0|||
23521215|NCT02246673|65647665|FG001|Overall Study|Withdrawal by Subject|0|||
23521216|NCT02246673|65647666|FG002|Overall Study|Withdrawal by Subject|0|||
23521217|NCT02246673|65647667|FG003|Overall Study|Withdrawal by Subject|0|||
23521218|NCT02246673|65647668|FG004|Overall Study|Withdrawal by Subject|1|||
23521219|NCT02246673|65647664|FG000|Overall Study|Lost to Follow-up|0|||
23521220|NCT02246673|65647665|FG001|Overall Study|Lost to Follow-up|0|||
23521221|NCT02246673|65647666|FG002|Overall Study|Lost to Follow-up|0|||
23521222|NCT02246673|65647667|FG003|Overall Study|Lost to Follow-up|1|||
23521223|NCT02246673|65647668|FG004|Overall Study|Lost to Follow-up|0|||
23521224|NCT02246673|65647664|FG000|Overall Study|Protocol Violation|0|||
23521225|NCT02246673|65647665|FG001|Overall Study|Protocol Violation|0|||
23521226|NCT02246673|65647666|FG002|Overall Study|Protocol Violation|0|||
23521227|NCT02246673|65647667|FG003|Overall Study|Protocol Violation|1|||
23521228|NCT02246673|65647668|FG004|Overall Study|Protocol Violation|0|||
23521229|NCT03034954|65647673|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
23521230|NCT03034954|65647674|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
23521231|NCT00477672|65647677|FG000|Overall Study|Adverse Event|3|||
23521232|NCT00477672|65647678|FG001|Overall Study|Adverse Event|5|||
23521233|NCT00477672|65647679|FG002|Overall Study|Adverse Event|6|||
23521234|NCT00477672|65647677|FG000|Overall Study|Death|0|||
23521235|NCT00477672|65647678|FG001|Overall Study|Death|1|||
23521236|NCT00477672|65647679|FG002|Overall Study|Death|0|||
23521237|NCT00477672|65647677|FG000|Overall Study|Disease progression|0|||
23521238|NCT00477672|65647678|FG001|Overall Study|Disease progression|1|||
23521239|NCT00477672|65647679|FG002|Overall Study|Disease progression|0|||
23521240|NCT00477672|65647677|FG000|Overall Study|Physician Decision|1|||
23521241|NCT00477672|65647678|FG001|Overall Study|Physician Decision|0|||
23521242|NCT00477672|65647679|FG002|Overall Study|Physician Decision|0|||
23521243|NCT00477672|65647677|FG000|Overall Study|Protocol noncompliance|0|||
23521244|NCT00477672|65647678|FG001|Overall Study|Protocol noncompliance|2|||
23521245|NCT00477672|65647679|FG002|Overall Study|Protocol noncompliance|0|||
23521246|NCT00477672|65647677|FG000|Overall Study|Consent withdrawn|2|||
23521247|NCT00477672|65647678|FG001|Overall Study|Consent withdrawn|5|||
23713732|NCT01021813|66325469|FG000|DB Treatment Phase|Protocol Violation|4|||
23713733|NCT01021813|66325470|FG001|DB Treatment Phase|Protocol Violation|3|||
23521248|NCT00477672|65647679|FG002|Overall Study|Consent withdrawn|10|||
23521249|NCT00477672|65647677|FG000|Overall Study|Discretion of Sponsor|1|||
23521250|NCT00477672|65647678|FG001|Overall Study|Discretion of Sponsor|2|||
23521251|NCT00477672|65647679|FG002|Overall Study|Discretion of Sponsor|0|||
23521252|NCT02073279|65647682|FG000|Double-blind Period|Adverse Event|1|||
23521253|NCT02073279|65647683|FG001|Double-blind Period|Adverse Event|1|||
23521254|NCT02073279|65647682|FG000|Double-blind Period|Switched to another treatment|1|||
23521255|NCT02073279|65647683|FG001|Double-blind Period|Switched to another treatment|2|||
23521256|NCT02073279|65647682|FG000|Double-blind Period|Protocol Violation|0|||
23521257|NCT02073279|65647683|FG001|Double-blind Period|Protocol Violation|1|||
23521258|NCT02073279|65647682|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
23521259|NCT02073279|65647683|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
23521260|NCT02073279|65647682|FG000|Double-blind Period|Withdrawal by Subject|2|||
23521261|NCT02073279|65647683|FG001|Double-blind Period|Withdrawal by Subject|2|||
23521262|NCT02073279|65647682|FG000|Open-label Extension Period|Adverse Event|1|||
23521263|NCT02073279|65647683|FG001|Open-label Extension Period|Adverse Event|0|||
23521264|NCT02073279|65647682|FG000|Open-label Extension Period|Lack of Efficacy|1|||
23521265|NCT02073279|65647683|FG001|Open-label Extension Period|Lack of Efficacy|0|||
23521266|NCT02073279|65647682|FG000|Open-label Extension Period|Lost to Follow-up|0|||
23521267|NCT02073279|65647683|FG001|Open-label Extension Period|Lost to Follow-up|4|||
23521268|NCT02073279|65647682|FG000|Open-label Extension Period|Switched to another treatment|1|||
23521269|NCT02073279|65647683|FG001|Open-label Extension Period|Switched to another treatment|4|||
23521270|NCT02073279|65647682|FG000|Open-label Extension Period|Protocol Violation|0|||
23521271|NCT02073279|65647683|FG001|Open-label Extension Period|Protocol Violation|1|||
23521272|NCT02073279|65647682|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23521273|NCT02073279|65647683|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
23521274|NCT02073279|65647682|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
23521275|NCT02073279|65647683|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
23521276|NCT01498458|65647684|FG000|Overall Study|Adverse Event|4|||
23521277|NCT01498458|65647684|FG000|Overall Study|Physician Decision|3|||
23521278|NCT03560531|65647685|FG000|Overall Study|Death|4|||
23521279|NCT03560531|65647686|FG001|Overall Study|Death|1|||
23521280|NCT03560531|65647687|FG002|Overall Study|Death|1|||
23521281|NCT03560531|65647688|FG003|Overall Study|Death|2|||
23521282|NCT03560531|65647689|FG004|Overall Study|Death|6|||
23521283|NCT03560531|65647690|FG005|Overall Study|Death|1|||
23521284|NCT03560531|65647691|FG006|Overall Study|Death|4|||
23521285|NCT03560531|65647692|FG007|Overall Study|Death|8|||
23521286|NCT03560531|65647693|FG008|Overall Study|Death|1|||
23521287|NCT03560531|65647694|FG009|Overall Study|Death|3|||
23521288|NCT03560531|65647695|FG010|Overall Study|Death|2|||
23521289|NCT03560531|65647696|FG011|Overall Study|Death|0|||
23521290|NCT03560531|65647697|FG012|Overall Study|Death|4|||
23521291|NCT03560531|65647698|FG013|Overall Study|Death|1|||
23521292|NCT03560531|65647685|FG000|Overall Study|Lost to Follow-up|1|||
23521293|NCT03560531|65647686|FG001|Overall Study|Lost to Follow-up|1|||
23521294|NCT03560531|65647687|FG002|Overall Study|Lost to Follow-up|0|||
23521295|NCT03560531|65647688|FG003|Overall Study|Lost to Follow-up|0|||
23521296|NCT03560531|65647689|FG004|Overall Study|Lost to Follow-up|0|||
23521297|NCT03560531|65647690|FG005|Overall Study|Lost to Follow-up|0|||
23521298|NCT03560531|65647691|FG006|Overall Study|Lost to Follow-up|1|||
23521299|NCT03560531|65647692|FG007|Overall Study|Lost to Follow-up|0|||
23521300|NCT03560531|65647693|FG008|Overall Study|Lost to Follow-up|0|||
23521301|NCT03560531|65647694|FG009|Overall Study|Lost to Follow-up|0|||
23521302|NCT03560531|65647695|FG010|Overall Study|Lost to Follow-up|0|||
23521303|NCT03560531|65647696|FG011|Overall Study|Lost to Follow-up|0|||
23521304|NCT03560531|65647697|FG012|Overall Study|Lost to Follow-up|0|||
23521305|NCT03560531|65647698|FG013|Overall Study|Lost to Follow-up|0|||
23521306|NCT03560531|65647685|FG000|Overall Study|Withdrawal by Subject|1|||
23521307|NCT03560531|65647686|FG001|Overall Study|Withdrawal by Subject|0|||
23521308|NCT03560531|65647687|FG002|Overall Study|Withdrawal by Subject|0|||
23521309|NCT03560531|65647688|FG003|Overall Study|Withdrawal by Subject|0|||
23521310|NCT03560531|65647689|FG004|Overall Study|Withdrawal by Subject|0|||
23521311|NCT03560531|65647690|FG005|Overall Study|Withdrawal by Subject|0|||
23521312|NCT03560531|65647691|FG006|Overall Study|Withdrawal by Subject|0|||
23521313|NCT03560531|65647692|FG007|Overall Study|Withdrawal by Subject|3|||
23521314|NCT03560531|65647693|FG008|Overall Study|Withdrawal by Subject|2|||
23521315|NCT03560531|65647694|FG009|Overall Study|Withdrawal by Subject|0|||
23521316|NCT03560531|65647695|FG010|Overall Study|Withdrawal by Subject|0|||
23521317|NCT03560531|65647696|FG011|Overall Study|Withdrawal by Subject|0|||
23521318|NCT03560531|65647697|FG012|Overall Study|Withdrawal by Subject|2|||
23521319|NCT03560531|65647698|FG013|Overall Study|Withdrawal by Subject|0|||
23521320|NCT03560531|65647685|FG000|Overall Study|Study end per-protocol|1|||
23521321|NCT03560531|65647686|FG001|Overall Study|Study end per-protocol|1|||
23521322|NCT03560531|65647687|FG002|Overall Study|Study end per-protocol|2|||
23521323|NCT03560531|65647688|FG003|Overall Study|Study end per-protocol|0|||
23521324|NCT03560531|65647689|FG004|Overall Study|Study end per-protocol|1|||
23521325|NCT03560531|65647690|FG005|Overall Study|Study end per-protocol|0|||
23521326|NCT03560531|65647691|FG006|Overall Study|Study end per-protocol|0|||
23521327|NCT03560531|65647692|FG007|Overall Study|Study end per-protocol|0|||
23521328|NCT03560531|65647693|FG008|Overall Study|Study end per-protocol|0|||
23521329|NCT03560531|65647694|FG009|Overall Study|Study end per-protocol|0|||
23521330|NCT03560531|65647695|FG010|Overall Study|Study end per-protocol|0|||
23521331|NCT03560531|65647696|FG011|Overall Study|Study end per-protocol|0|||
23521332|NCT03560531|65647697|FG012|Overall Study|Study end per-protocol|0|||
23521333|NCT03560531|65647698|FG013|Overall Study|Study end per-protocol|0|||
23521334|NCT03560531|65647685|FG000|Overall Study|Early study termination by sponsor|9|||
23521335|NCT03560531|65647686|FG001|Overall Study|Early study termination by sponsor|0|||
23521336|NCT03560531|65647687|FG002|Overall Study|Early study termination by sponsor|0|||
23521337|NCT03560531|65647688|FG003|Overall Study|Early study termination by sponsor|4|||
23521338|NCT03560531|65647689|FG004|Overall Study|Early study termination by sponsor|8|||
23521339|NCT03560531|65647690|FG005|Overall Study|Early study termination by sponsor|2|||
23521340|NCT03560531|65647691|FG006|Overall Study|Early study termination by sponsor|5|||
23521341|NCT03560531|65647692|FG007|Overall Study|Early study termination by sponsor|64|||
23521342|NCT03560531|65647693|FG008|Overall Study|Early study termination by sponsor|7|||
23521343|NCT03560531|65647694|FG009|Overall Study|Early study termination by sponsor|2|||
23521344|NCT03560531|65647695|FG010|Overall Study|Early study termination by sponsor|16|||
23521345|NCT03560531|65647696|FG011|Overall Study|Early study termination by sponsor|2|||
23521346|NCT03560531|65647697|FG012|Overall Study|Early study termination by sponsor|6|||
23521347|NCT03560531|65647698|FG013|Overall Study|Early study termination by sponsor|2|||
23521348|NCT01816893|65647699|FG000|Washout Period|Withdrawal by Subject|2|||
23521349|NCT01816893|65647700|FG001|Washout Period|Withdrawal by Subject|0|||
23521350|NCT00453999|65647701|FG000|Overall Study|Adverse Event|1|||
23521351|NCT00453999|65647702|FG001|Overall Study|Adverse Event|2|||
23521352|NCT00453999|65647703|FG002|Overall Study|Adverse Event|1|||
23521353|NCT00453999|65647701|FG000|Overall Study|Lost to Follow-up|0|||
23521354|NCT00453999|65647702|FG001|Overall Study|Lost to Follow-up|1|||
23521355|NCT00453999|65647703|FG002|Overall Study|Lost to Follow-up|1|||
23521356|NCT00453999|65647701|FG000|Overall Study|Withdrawal by Subject|2|||
23521357|NCT00453999|65647702|FG001|Overall Study|Withdrawal by Subject|1|||
23521358|NCT00453999|65647703|FG002|Overall Study|Withdrawal by Subject|1|||
23521359|NCT00453999|65647701|FG000|Overall Study|Subject Request|2|||
23521360|NCT00453999|65647702|FG001|Overall Study|Subject Request|1|||
23521361|NCT00453999|65647703|FG002|Overall Study|Subject Request|0|||
23521362|NCT03020823|65647704|FG000|Overall Study|Physician Decision|4|||
23521363|NCT03020823|65647704|FG000|Overall Study|Lack of Efficacy|4|||
23521364|NCT03020823|65647704|FG000|Overall Study|Adverse Event|2|||
23521365|NCT01293240|65647707|FG000|Overall Study|Noncompliance|2|||
23521366|NCT00746941|65647712|FG000|Overall Study|Death|2|||
23521367|NCT00746941|65647713|FG001|Overall Study|Death|0|||
23521368|NCT00746941|65647714|FG002|Overall Study|Death|0|||
23521369|NCT00746941|65647715|FG003|Overall Study|Death|6|||
23521370|NCT00746941|65647712|FG000|Overall Study|Physician Decision|0|||
23521371|NCT00746941|65647713|FG001|Overall Study|Physician Decision|0|||
23521372|NCT00746941|65647714|FG002|Overall Study|Physician Decision|2|||
23521373|NCT00746941|65647715|FG003|Overall Study|Physician Decision|0|||
23521374|NCT00746941|65647712|FG000|Overall Study|Withdrawal by Subject|3|||
23521375|NCT00746941|65647713|FG001|Overall Study|Withdrawal by Subject|0|||
23812074|NCT02516553|66691892|FG017|Overall Study|Refused to continue trial medication|0|||
23521376|NCT00746941|65647714|FG002|Overall Study|Withdrawal by Subject|0|||
23521377|NCT00746941|65647715|FG003|Overall Study|Withdrawal by Subject|2|||
23521378|NCT00746941|65647712|FG000|Overall Study|Other, reason not provided|2|||
23521379|NCT00746941|65647713|FG001|Overall Study|Other, reason not provided|4|||
23521380|NCT00746941|65647714|FG002|Overall Study|Other, reason not provided|0|||
23521381|NCT00746941|65647715|FG003|Overall Study|Other, reason not provided|4|||
23521382|NCT00746941|65647712|FG000|Overall Study|Adverse Event|0|||
23521383|NCT00746941|65647713|FG001|Overall Study|Adverse Event|0|||
23521384|NCT00746941|65647714|FG002|Overall Study|Adverse Event|0|||
23521385|NCT00746941|65647715|FG003|Overall Study|Adverse Event|1|||
23521386|NCT04782856|65647716|FG000|Overall Study|Withdrawal by Subject|0|||
23521387|NCT04782856|65647717|FG001|Overall Study|Withdrawal by Subject|1|||
23521388|NCT01359254|65647718|FG000|Overall Study|Death|1|||
23713734|NCT01021813|66325471|FG002|DB Treatment Phase|Protocol Violation|0|||
23713735|NCT01021813|66325472|FG003|DB Treatment Phase|Protocol Violation|0|||
23713736|NCT01021813|66325473|FG004|DB Treatment Phase|Protocol Violation|0|||
23713737|NCT01021813|66325469|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
23713738|NCT01021813|66325470|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
23713739|NCT01021813|66325471|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
23713740|NCT01021813|66325472|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
23713741|NCT01021813|66325473|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
23521389|NCT01359254|65647719|FG001|Overall Study|Death|0|||
23521390|NCT03760146|65647722|FG000|Overall Study|Adverse Event|11|||
23521391|NCT03760146|65647723|FG001|Overall Study|Adverse Event|8|||
23713742|NCT01021813|66325469|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
23713743|NCT01021813|66325470|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
23713744|NCT01021813|66325471|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
23521392|NCT03760146|65647724|FG002|Overall Study|Adverse Event|0|||
23521393|NCT03760146|65647725|FG003|Overall Study|Adverse Event|0|||
23521394|NCT03760146|65647726|FG004|Overall Study|Adverse Event|0|||
23521395|NCT03760146|65647727|FG005|Overall Study|Adverse Event|0|||
23521396|NCT03760146|65647722|FG000|Overall Study|Death|1|||
23521397|NCT03760146|65647723|FG001|Overall Study|Death|0|||
23521398|NCT03760146|65647724|FG002|Overall Study|Death|0|||
23521399|NCT03760146|65647725|FG003|Overall Study|Death|0|||
23521400|NCT03760146|65647726|FG004|Overall Study|Death|0|||
23521401|NCT03760146|65647727|FG005|Overall Study|Death|0|||
23521402|NCT03760146|65647722|FG000|Overall Study|Lost to Follow-up|41|||
23521403|NCT03760146|65647723|FG001|Overall Study|Lost to Follow-up|28|||
23521404|NCT03760146|65647724|FG002|Overall Study|Lost to Follow-up|9|||
23713745|NCT01021813|66325472|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
23713746|NCT01021813|66325473|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
23416225|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
23416226|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
23416227|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
23416228|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
23416229|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
23416230|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
23416231|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
23416232|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
23416233|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
23416234|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
23416235|NCT01529515|65266172|FG000|TRANSITION PHASE|Adverse Event|16|||
23416236|NCT01529515|65266173|FG001|TRANSITION PHASE|Adverse Event|0|||
23416237|NCT01529515|65266174|FG002|TRANSITION PHASE|Adverse Event|0|||
23416238|NCT01529515|65266175|FG003|TRANSITION PHASE|Adverse Event|0|||
23416239|NCT01529515|65266172|FG000|TRANSITION PHASE|Death|1|||
23416240|NCT01529515|65266173|FG001|TRANSITION PHASE|Death|0|||
23416241|NCT01529515|65266174|FG002|TRANSITION PHASE|Death|0|||
23416242|NCT01529515|65266175|FG003|TRANSITION PHASE|Death|0|||
23521405|NCT03760146|65647725|FG003|Overall Study|Lost to Follow-up|2|||
23521406|NCT03760146|65647726|FG004|Overall Study|Lost to Follow-up|14|||
23521407|NCT03760146|65647727|FG005|Overall Study|Lost to Follow-up|8|||
23521408|NCT03760146|65647722|FG000|Overall Study|No longer met eligibility criteria|3|||
23521409|NCT03760146|65647723|FG001|Overall Study|No longer met eligibility criteria|9|||
23521410|NCT03760146|65647724|FG002|Overall Study|No longer met eligibility criteria|0|||
23521411|NCT03760146|65647725|FG003|Overall Study|No longer met eligibility criteria|0|||
23521412|NCT03760146|65647726|FG004|Overall Study|No longer met eligibility criteria|1|||
23521413|NCT03760146|65647727|FG005|Overall Study|No longer met eligibility criteria|0|||
23521414|NCT03760146|65647722|FG000|Overall Study|Protocol Violation|21|||
23521415|NCT03760146|65647723|FG001|Overall Study|Protocol Violation|13|||
23521416|NCT03760146|65647724|FG002|Overall Study|Protocol Violation|1|||
23521417|NCT03760146|65647725|FG003|Overall Study|Protocol Violation|0|||
23521418|NCT03760146|65647726|FG004|Overall Study|Protocol Violation|1|||
23521419|NCT03760146|65647727|FG005|Overall Study|Protocol Violation|0|||
23521420|NCT03760146|65647722|FG000|Overall Study|Withdrawal by Subject|19|||
23521421|NCT03760146|65647723|FG001|Overall Study|Withdrawal by Subject|20|||
23521422|NCT03760146|65647724|FG002|Overall Study|Withdrawal by Subject|1|||
23521423|NCT03760146|65647725|FG003|Overall Study|Withdrawal by Subject|0|||
23521424|NCT03760146|65647726|FG004|Overall Study|Withdrawal by Subject|1|||
23521425|NCT03760146|65647727|FG005|Overall Study|Withdrawal by Subject|0|||
23521426|NCT04552587|65647736|FG000|Overall Study|Lost to Follow-up|4|||
23521427|NCT04475588|65647741|FG000|Overall Study|Adverse Event|2|||
23521428|NCT04475588|65647742|FG001|Overall Study|Adverse Event|0|||
23521429|NCT02357147|65647749|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
23521430|NCT02357147|65647750|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
23521431|NCT02357147|65647749|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
23521432|NCT02357147|65647750|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
23521433|NCT02357147|65647749|FG000|Combination Treatment Phase|Investigator Discretion|1|||
23521434|NCT02357147|65647750|FG001|Combination Treatment Phase|Investigator Discretion|1|||
23521435|NCT02357147|65647749|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
23521436|NCT02357147|65647750|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
23521437|NCT02357147|65647749|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
23521438|NCT02357147|65647750|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
23521439|NCT02357147|65647749|FG000|Combination Treatment Phase|Adverse Event|12|||
23521440|NCT02357147|65647750|FG001|Combination Treatment Phase|Adverse Event|4|||
23521441|NCT02357147|65647749|FG000|Combination Treatment Phase|Death|1|||
23521442|NCT02357147|65647750|FG001|Combination Treatment Phase|Death|1|||
23521443|NCT02357147|65647749|FG000|Combination Treatment Phase|Sponsor Decision|0|||
23521444|NCT02357147|65647750|FG001|Combination Treatment Phase|Sponsor Decision|12|||
23521445|NCT02357147|65647749|FG000|Combination Treatment Phase|Other|1|||
23713747|NCT01021813|66325469|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23713748|NCT01021813|66325470|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23713749|NCT01021813|66325471|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23713750|NCT01021813|66325472|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
23713751|NCT01021813|66325473|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23713752|NCT01021813|66325469|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23713753|NCT01021813|66325470|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23713754|NCT01021813|66325471|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23713755|NCT01021813|66325472|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23713756|NCT01021813|66325473|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
23713757|NCT01021813|66325469|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23713758|NCT01021813|66325470|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23713759|NCT01021813|66325471|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
23713760|NCT01021813|66325472|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23713761|NCT01021813|66325473|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23713762|NCT01021813|66325469|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
23713763|NCT01021813|66325470|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
23713764|NCT01021813|66325471|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
23713765|NCT01021813|66325472|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
23713766|NCT01021813|66325473|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
23713767|NCT02326467|66325474|FG000|Overall Study|Withdrawal by Subject|1|||
23713768|NCT01030458|66325475|FG000|Overall Study|Lost to Follow-up|9|||
23713769|NCT01030458|66325476|FG001|Overall Study|Lost to Follow-up|10|||
23713770|NCT01030458|66325475|FG000|Overall Study|Withdrawal by Subject|2|||
23713771|NCT01030458|66325476|FG001|Overall Study|Withdrawal by Subject|3|||
23713772|NCT01030458|66325475|FG000|Overall Study|Logistical reasons|9|||
23713773|NCT01030458|66325476|FG001|Overall Study|Logistical reasons|5|||
23713774|NCT01030458|66325475|FG000|Overall Study|Moved or changed job|6|||
23521446|NCT02357147|65647750|FG001|Combination Treatment Phase|Other|0|||
23521447|NCT02357147|65647749|FG000|Combination Treatment Phase|Not treated|0|||
23521448|NCT02357147|65647750|FG001|Combination Treatment Phase|Not treated|2|||
23521449|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
23521450|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
23713775|NCT01030458|66325476|FG001|Overall Study|Moved or changed job|13|||
23713776|NCT01030458|66325475|FG000|Overall Study|Side effect of medication|1|||
23713777|NCT01030458|66325476|FG001|Overall Study|Side effect of medication|1|||
23713778|NCT03089216|66325477|FG000|Overall Study|Adverse Event|0|||
23713779|NCT03089216|66325478|FG001|Overall Study|Adverse Event|0|||
23521451|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23713780|NCT03089216|66325479|FG002|Overall Study|Adverse Event|0|||
23713781|NCT03089216|66325480|FG003|Overall Study|Adverse Event|1|||
23713782|NCT00190983|66325481|FG000|Overall Study|Inevaluable (never treated)|2|||
23521452|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
23521453|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
23521454|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
23521455|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23521456|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Adverse Event|3|||
23521457|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
23521458|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
23521459|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Not Treated|1|||
23521460|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Not Treated|0|||
23521461|NCT00004888|65647751|FG000|Overall Study|Adverse Event|5|||
23521462|NCT00004888|65647752|FG001|Overall Study|Adverse Event|10|||
23521463|NCT00004888|65647751|FG000|Overall Study|Withdrawal by Subject|0|||
23521464|NCT00004888|65647752|FG001|Overall Study|Withdrawal by Subject|3|||
23713783|NCT00788697|66325483|FG000|Overall Study|No study drug administered|12|||
23713784|NCT00788697|66325483|FG000|Overall Study|Training Patients|74|||
23713785|NCT00788697|66325483|FG000|Overall Study|no truth standard procedure available|5|||
23713786|NCT00788697|66325483|FG000|Overall Study|Technically inadequate truth standard|1|||
23713787|NCT00788697|66325483|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
23713788|NCT00423735|66325486|FG000|Overall Study|Ineligible / No protocol treatment|8|||
23713789|NCT00423735|66325487|FG001|Overall Study|Ineligible / No protocol treatment|6|||
23713790|NCT00423735|66325488|FG002|Overall Study|Ineligible / No protocol treatment|0|||
23713791|NCT03589885|66325491|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
23713792|NCT03589885|66325492|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
23713793|NCT03589885|66325493|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
23713794|NCT03589885|66325494|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
23713795|NCT03589885|66325495|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
23713796|NCT03589885|66325491|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23521465|NCT00004888|65647751|FG000|Overall Study|Physician Decision|1|||
23521466|NCT00004888|65647752|FG001|Overall Study|Physician Decision|1|||
23521467|NCT00004888|65647751|FG000|Overall Study|Progressive Disease|4|||
23521468|NCT00004888|65647752|FG001|Overall Study|Progressive Disease|9|||
23521469|NCT00004888|65647751|FG000|Overall Study|Death without progressive disease|0|||
23521470|NCT00004888|65647752|FG001|Overall Study|Death without progressive disease|1|||
23521471|NCT00004888|65647751|FG000|Overall Study|Toxic death|1|||
23521472|NCT00004888|65647752|FG001|Overall Study|Toxic death|0|||
23521473|NCT03608774|65647756|FG000|Overall Study|Lost to Follow-up|5|||
23521474|NCT03608774|65647757|FG001|Overall Study|Lost to Follow-up|5|||
23521475|NCT03608774|65647756|FG000|Overall Study|Withdrawal by Subject|1|||
23521476|NCT03608774|65647757|FG001|Overall Study|Withdrawal by Subject|0|||
23521477|NCT03608774|65647756|FG000|Overall Study|Protocol Violation|1|||
23521478|NCT03608774|65647757|FG001|Overall Study|Protocol Violation|0|||
23521479|NCT03608774|65647756|FG000|Overall Study|Not eligible at enrollment|0|||
23521480|NCT03608774|65647757|FG001|Overall Study|Not eligible at enrollment|1|||
23521481|NCT03608774|65647756|FG000|Overall Study|Health related event|0|||
23521482|NCT03608774|65647757|FG001|Overall Study|Health related event|1|||
23521483|NCT00316199|65647758|FG000|Overall Study|Adverse Event|2|||
23521484|NCT00316199|65647758|FG000|Overall Study|Death|8|||
23521485|NCT00316199|65647758|FG000|Overall Study|Lost to Follow-up|2|||
23521486|NCT02357940|65647761|FG000|Overall Study|Adverse Event|0|||
23521487|NCT02357940|65647762|FG001|Overall Study|Adverse Event|1|||
23521488|NCT02357940|65647761|FG000|Overall Study|Investigator's judgement|0|||
23521489|NCT02357940|65647762|FG001|Overall Study|Investigator's judgement|1|||
23521490|NCT03343483|65647770|FG000|Overall Study|Death|0|||
23521491|NCT03343483|65647771|FG001|Overall Study|Death|3|||
23521492|NCT03343483|65647770|FG000|Overall Study|Lost to Follow-up|9|||
23521493|NCT03343483|65647771|FG001|Overall Study|Lost to Follow-up|13|||
23521494|NCT03343483|65647770|FG000|Overall Study|Withdrawal by Subject|8|||
23521495|NCT03343483|65647771|FG001|Overall Study|Withdrawal by Subject|17|||
23521496|NCT00325754|65647772|FG000|Overall Study|Adverse Event|4|||
23521497|NCT00325754|65647773|FG001|Overall Study|Adverse Event|1|||
23521498|NCT02211131|65647774|FG000|Overall Study|Death|26|||
23521499|NCT02211131|65647775|FG001|Overall Study|Death|16|||
23521500|NCT02211131|65647774|FG000|Overall Study|Lost to Follow-up|4|||
23713797|NCT03589885|66325492|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23713798|NCT03589885|66325493|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
23713799|NCT03589885|66325494|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23713800|NCT03589885|66325495|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23713801|NCT03589885|66325491|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23521501|NCT02211131|65647775|FG001|Overall Study|Lost to Follow-up|3|||
23521502|NCT02211131|65647774|FG000|Overall Study|Decision by Sponsor|1|||
23521503|NCT02211131|65647775|FG001|Overall Study|Decision by Sponsor|1|||
23521504|NCT02211131|65647774|FG000|Overall Study|Withdrawal by Subject|3|||
23521505|NCT02211131|65647775|FG001|Overall Study|Withdrawal by Subject|8|||
23521506|NCT02678676|65647776|FG000|Overall Study|Death|619|||
23521507|NCT02678676|65647777|FG001|Overall Study|Death|649|||
23521508|NCT02678676|65647776|FG000|Overall Study|Withdrawal by Subject|13|||
23521509|NCT02678676|65647777|FG001|Overall Study|Withdrawal by Subject|5|||
23713802|NCT03589885|66325492|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
23713803|NCT03589885|66325493|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23713804|NCT03589885|66325494|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23713805|NCT03589885|66325495|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23713806|NCT03589885|66325491|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23713807|NCT03589885|66325492|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23713808|NCT03589885|66325493|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
23713809|NCT03589885|66325494|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23416243|NCT01529515|65266172|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
23416244|NCT01529515|65266173|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
23416245|NCT01529515|65266174|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
23416246|NCT01529515|65266175|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
23416247|NCT01529515|65266172|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
23416248|NCT01529515|65266173|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
23416249|NCT01529515|65266174|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
23416250|NCT01529515|65266175|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
23416251|NCT01529515|65266172|FG000|TRANSITION PHASE|Protocol Violation|4|||
23416252|NCT01529515|65266173|FG001|TRANSITION PHASE|Protocol Violation|0|||
23416253|NCT01529515|65266174|FG002|TRANSITION PHASE|Protocol Violation|0|||
23416254|NCT01529515|65266175|FG003|TRANSITION PHASE|Protocol Violation|0|||
23416255|NCT01529515|65266172|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
23416256|NCT01529515|65266173|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
23416257|NCT01529515|65266174|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
23416258|NCT01529515|65266175|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
23416259|NCT01529515|65266172|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
23416260|NCT01529515|65266173|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416261|NCT01529515|65266174|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416262|NCT01529515|65266175|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416263|NCT01529515|65266172|FG000|TRANSITION PHASE|Other|9|||
23416264|NCT01529515|65266173|FG001|TRANSITION PHASE|Other|0|||
23416265|NCT01529515|65266174|FG002|TRANSITION PHASE|Other|0|||
23416266|NCT01529515|65266175|FG003|TRANSITION PHASE|Other|0|||
23416267|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Adverse Event|0|||
23416268|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Adverse Event|10|||
23416269|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Adverse Event|0|||
23416270|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Adverse Event|0|||
23416271|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416272|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
23416273|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416274|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416275|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416276|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
23416277|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416278|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416279|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
23416280|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
23416281|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
23416282|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
23416283|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416284|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
23416285|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416286|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416287|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416288|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
23416289|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416290|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416291|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Other|0|||
23521510|NCT02678676|65647776|FG000|Overall Study|Lost to Follow-up|171|||
23521511|NCT02678676|65647777|FG001|Overall Study|Lost to Follow-up|151|||
23713810|NCT03589885|66325495|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23713811|NCT03589885|66325491|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
23416292|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Other|10|||
23416293|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Other|0|||
23416294|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Other|0|||
23416295|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
23521512|NCT02678676|65647776|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
23521513|NCT02678676|65647777|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
23521514|NCT02618434|65647778|FG000|Overall Study|Withdrawal by Subject|0|||
23713812|NCT03589885|66325492|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
23416296|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
23416297|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
23416298|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
23416299|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
23416300|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
23416301|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
23416302|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
23416303|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
23416304|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
23416305|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
23416306|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
23416307|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
23416308|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
23416309|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
23416310|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
23416311|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416312|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416313|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
23416314|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416315|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Other|0|||
23416316|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Other|0|||
23416317|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Other|9|||
23416318|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Other|2|||
23416319|NCT01453205|65266182|FG000|Overall Study|Lost to Follow-up|3|||
23416320|NCT01453205|65266183|FG001|Overall Study|Lost to Follow-up|0|||
23416321|NCT01453205|65266184|FG002|Overall Study|Lost to Follow-up|1|||
23416322|NCT01453205|65266182|FG000|Overall Study|Withdrawal by Subject|8|||
23416323|NCT01453205|65266183|FG001|Overall Study|Withdrawal by Subject|3|||
23416324|NCT01453205|65266184|FG002|Overall Study|Withdrawal by Subject|0|||
23416325|NCT01453205|65266182|FG000|Overall Study|Death|24|||
23416326|NCT01453205|65266183|FG001|Overall Study|Death|22|||
23416327|NCT01453205|65266184|FG002|Overall Study|Death|18|||
23416328|NCT01453205|65266182|FG000|Overall Study|Other|45|||
23416329|NCT01453205|65266183|FG001|Overall Study|Other|27|||
23416330|NCT01453205|65266184|FG002|Overall Study|Other|35|||
23416331|NCT00391430|65266185|FG000|Overall Study|Withdrawal by Subject|3|||
23416332|NCT00391430|65266186|FG001|Overall Study|Withdrawal by Subject|0|||
23416333|NCT00391430|65266187|FG002|Overall Study|Withdrawal by Subject|12|||
23416334|NCT01610557|65266194|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416335|NCT01610557|65266195|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
23416336|NCT01610557|65266196|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416337|NCT01610557|65266197|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416338|NCT01610557|65266198|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416339|NCT01610557|65266194|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416340|NCT01610557|65266195|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416341|NCT01610557|65266196|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416342|NCT01610557|65266197|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416343|NCT01610557|65266198|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
23416344|NCT00245050|65266199|FG000|Overall Study|Adverse Event|3|||
23416345|NCT00245050|65266200|FG001|Overall Study|Adverse Event|2|||
23416346|NCT00730041|65266203|FG000|Overall Study|Lost to Follow-up|0|||
23416347|NCT00730041|65266204|FG001|Overall Study|Lost to Follow-up|2|||
23416348|NCT01126437|65266205|FG000|Overall Study|Not treated|11|||
23416349|NCT01126437|65266206|FG001|Overall Study|Not treated|18|||
23416350|NCT01126437|65266207|FG002|Overall Study|Not treated|19|||
23416351|NCT01126437|65266205|FG000|Overall Study|Sites with data irregularities/fraud|6|||
23416352|NCT01126437|65266206|FG001|Overall Study|Sites with data irregularities/fraud|6|||
23416353|NCT01126437|65266207|FG002|Overall Study|Sites with data irregularities/fraud|7|||
23521515|NCT02618434|65647779|FG001|Overall Study|Withdrawal by Subject|2|||
23521516|NCT02618434|65647780|FG002|Overall Study|Withdrawal by Subject|3|||
23521517|NCT02618434|65647778|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
23521518|NCT02618434|65647779|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23521519|NCT02618434|65647780|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
23521520|NCT02618434|65647778|FG000|Overall Study|Lost to Follow-up|3|||
23521521|NCT02618434|65647779|FG001|Overall Study|Lost to Follow-up|1|||
23416354|NCT01126437|65266205|FG000|Overall Study|Adverse Event|602|||
23416355|NCT01126437|65266206|FG001|Overall Study|Adverse Event|606|||
23416356|NCT01126437|65266207|FG002|Overall Study|Adverse Event|635|||
23416357|NCT01126437|65266205|FG000|Overall Study|Lack of Efficacy|65|||
23416358|NCT01126437|65266206|FG001|Overall Study|Lack of Efficacy|60|||
23416359|NCT01126437|65266207|FG002|Overall Study|Lack of Efficacy|59|||
23416360|NCT01126437|65266205|FG000|Overall Study|Protocol Violation|64|||
23416361|NCT01126437|65266206|FG001|Overall Study|Protocol Violation|66|||
23416362|NCT01126437|65266207|FG002|Overall Study|Protocol Violation|41|||
23416363|NCT01126437|65266205|FG000|Overall Study|Lost to Follow-up|52|||
23416364|NCT01126437|65266206|FG001|Overall Study|Lost to Follow-up|63|||
23521522|NCT02618434|65647780|FG002|Overall Study|Lost to Follow-up|3|||
23416365|NCT01126437|65266207|FG002|Overall Study|Lost to Follow-up|55|||
23416366|NCT01126437|65266205|FG000|Overall Study|Withdrawal by Subject|331|||
23416367|NCT01126437|65266206|FG001|Overall Study|Withdrawal by Subject|335|||
23416368|NCT01126437|65266207|FG002|Overall Study|Withdrawal by Subject|319|||
23416369|NCT01126437|65266205|FG000|Overall Study|Other reason not specified|210|||
23416370|NCT01126437|65266206|FG001|Overall Study|Other reason not specified|176|||
23416371|NCT01126437|65266207|FG002|Overall Study|Other reason not specified|178|||
23416372|NCT01694121|65266208|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
23713813|NCT03589885|66325493|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
23713814|NCT03589885|66325494|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
23713815|NCT03589885|66325495|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
23713816|NCT03589885|66325491|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
23713817|NCT03589885|66325492|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
23713818|NCT03589885|66325493|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
23713819|NCT03589885|66325494|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
23713820|NCT03589885|66325495|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
23713821|NCT03589885|66325491|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
23713822|NCT03589885|66325492|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
23713823|NCT03589885|66325493|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
23713824|NCT03589885|66325494|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
23713825|NCT03589885|66325495|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
23713826|NCT03589885|66325491|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23713827|NCT03589885|66325492|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
23416373|NCT01694121|65266209|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
23416374|NCT03333252|65266216|FG000|Overall Study|Adverse Event|10|||
23416375|NCT03333252|65266217|FG001|Overall Study|Adverse Event|6|||
23416376|NCT03333252|65266218|FG002|Overall Study|Adverse Event|5|||
23416377|NCT03333252|65266219|FG003|Overall Study|Adverse Event|2|||
23416378|NCT03333252|65266216|FG000|Overall Study|Death|1|||
23416379|NCT03333252|65266217|FG001|Overall Study|Death|3|||
23416380|NCT03333252|65266218|FG002|Overall Study|Death|0|||
23416381|NCT03333252|65266219|FG003|Overall Study|Death|0|||
23416382|NCT03333252|65266216|FG000|Overall Study|Lack of Efficacy|8|||
23416383|NCT03333252|65266217|FG001|Overall Study|Lack of Efficacy|4|||
23416384|NCT03333252|65266218|FG002|Overall Study|Lack of Efficacy|0|||
23416385|NCT03333252|65266219|FG003|Overall Study|Lack of Efficacy|7|||
23416386|NCT03333252|65266216|FG000|Overall Study|Lost to Follow-up|0|||
23416387|NCT03333252|65266217|FG001|Overall Study|Lost to Follow-up|5|||
23416388|NCT03333252|65266218|FG002|Overall Study|Lost to Follow-up|9|||
23416389|NCT03333252|65266219|FG003|Overall Study|Lost to Follow-up|3|||
23416390|NCT03333252|65266216|FG000|Overall Study|Withdrawal by Subject|14|||
23416391|NCT03333252|65266217|FG001|Overall Study|Withdrawal by Subject|24|||
23416392|NCT03333252|65266218|FG002|Overall Study|Withdrawal by Subject|11|||
23416393|NCT03333252|65266219|FG003|Overall Study|Withdrawal by Subject|17|||
23416394|NCT00316225|65266220|FG000|Overall Study|Adverse Event|2|||
23416395|NCT00316225|65266220|FG000|Overall Study|Physician Decision|3|||
23416396|NCT00316225|65266220|FG000|Overall Study|Progressive Disease|15|||
23416397|NCT00316225|65266220|FG000|Overall Study|Withdrawal by Subject|3|||
23416398|NCT00316225|65266220|FG000|Overall Study|Death|2|||
23416399|NCT00079391|65266221|FG000|Overall Study|Withdrawal by Subject|1|||
23416400|NCT02998203|65266222|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
23416401|NCT02998203|65266223|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
23416402|NCT02998203|65266222|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
23416403|NCT02998203|65266223|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
23416404|NCT01352221|65266226|FG000|Double-blind Phase|Adverse Event|6|||
23521523|NCT02618434|65647778|FG000|Overall Study|Adverse Event|1|||
23713828|NCT03589885|66325493|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23713829|NCT03589885|66325494|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23713830|NCT03589885|66325495|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23713831|NCT02721251|66325496|FG000|Overall Study|Withdrawal by Subject|8|||
23713832|NCT02721251|66325497|FG001|Overall Study|Withdrawal by Subject|7|||
23713833|NCT02721251|66325498|FG002|Overall Study|Withdrawal by Subject|9|||
23416405|NCT01352221|65266227|FG001|Double-blind Phase|Adverse Event|4|||
23416406|NCT01352221|65266228|FG002|Double-blind Phase|Adverse Event|0|||
23416407|NCT01352221|65266229|FG003|Double-blind Phase|Adverse Event|0|||
23521524|NCT02618434|65647779|FG001|Overall Study|Adverse Event|0|||
23416408|NCT01352221|65266226|FG000|Double-blind Phase|Withdrawal by Subject|3|||
23416409|NCT01352221|65266227|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23416410|NCT01352221|65266228|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23416411|NCT01352221|65266229|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23416412|NCT01352221|65266226|FG000|Double-blind Phase|Lost to Follow-up|0|||
23416413|NCT01352221|65266227|FG001|Double-blind Phase|Lost to Follow-up|1|||
23416414|NCT01352221|65266228|FG002|Double-blind Phase|Lost to Follow-up|0|||
23416415|NCT01352221|65266229|FG003|Double-blind Phase|Lost to Follow-up|0|||
23713834|NCT02721251|66325496|FG000|Overall Study|poor adherence|2|||
23416416|NCT01352221|65266226|FG000|Double-blind Phase|Protocol Violation|0|||
23416417|NCT01352221|65266227|FG001|Double-blind Phase|Protocol Violation|1|||
23416418|NCT01352221|65266228|FG002|Double-blind Phase|Protocol Violation|0|||
23416419|NCT01352221|65266229|FG003|Double-blind Phase|Protocol Violation|0|||
23416420|NCT01352221|65266226|FG000|Open-label Phase|Physician Decision|0|||
23416421|NCT01352221|65266227|FG001|Open-label Phase|Physician Decision|0|||
23416422|NCT01352221|65266228|FG002|Open-label Phase|Physician Decision|2|||
23416423|NCT01352221|65266229|FG003|Open-label Phase|Physician Decision|1|||
23416424|NCT01352221|65266226|FG000|Open-label Phase|Pregnancy|0|||
23416425|NCT01352221|65266227|FG001|Open-label Phase|Pregnancy|0|||
23416426|NCT01352221|65266228|FG002|Open-label Phase|Pregnancy|1|||
23416427|NCT01352221|65266229|FG003|Open-label Phase|Pregnancy|0|||
23416428|NCT01352221|65266226|FG000|Open-label Phase|Adverse Event|0|||
23416429|NCT01352221|65266227|FG001|Open-label Phase|Adverse Event|0|||
23416430|NCT01352221|65266228|FG002|Open-label Phase|Adverse Event|8|||
23416431|NCT01352221|65266229|FG003|Open-label Phase|Adverse Event|4|||
23416432|NCT01352221|65266226|FG000|Open-label Phase|Withdrawal by Subject|0|||
23416433|NCT01352221|65266227|FG001|Open-label Phase|Withdrawal by Subject|0|||
23416434|NCT01352221|65266228|FG002|Open-label Phase|Withdrawal by Subject|1|||
23416435|NCT01352221|65266229|FG003|Open-label Phase|Withdrawal by Subject|6|||
23416436|NCT01352221|65266226|FG000|Open-label Phase|Worsening of IBD|0|||
23416437|NCT01352221|65266227|FG001|Open-label Phase|Worsening of IBD|0|||
23416438|NCT01352221|65266228|FG002|Open-label Phase|Worsening of IBD|1|||
23416439|NCT01352221|65266229|FG003|Open-label Phase|Worsening of IBD|0|||
23416440|NCT01092780|65266230|FG000|Washout Period 1|Adverse Event|0|||
23416441|NCT01092780|65266231|FG001|Washout Period 1|Adverse Event|1|||
23416442|NCT01092780|65266232|FG002|Washout Period 1|Adverse Event|0|||
23416443|NCT01092780|65266233|FG003|Washout Period 1|Adverse Event|0|||
23713835|NCT02721251|66325497|FG001|Overall Study|poor adherence|2|||
23713836|NCT02721251|66325498|FG002|Overall Study|poor adherence|2|||
23713837|NCT02159469|66325499|FG000|Overall Study|Missing Completion status|1|||
23713838|NCT02159469|66325499|FG000|Overall Study|Adverse Event|5|||
23713839|NCT02159469|66325499|FG000|Overall Study|Non-compliance|2|||
23416444|NCT01092780|65266230|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
23416445|NCT01092780|65266231|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
23416446|NCT01092780|65266232|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
23416447|NCT01092780|65266233|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
23416448|NCT01092780|65266230|FG000|Washout Period 2|Adverse Event|0|||
23416449|NCT01092780|65266231|FG001|Washout Period 2|Adverse Event|1|||
23416450|NCT01092780|65266232|FG002|Washout Period 2|Adverse Event|1|||
23416451|NCT01092780|65266233|FG003|Washout Period 2|Adverse Event|0|||
23416452|NCT02566785|65266235|FG000|Overall Study|Lost to Follow-up|0|||
23416453|NCT02566785|65266236|FG001|Overall Study|Lost to Follow-up|2|||
23416454|NCT02566785|65266235|FG000|Overall Study|Worsening condition|1|||
23416455|NCT02566785|65266236|FG001|Overall Study|Worsening condition|1|||
23416456|NCT00516893|65266242|FG000|Overall Study|Lost to Follow-up|4|||
23416457|NCT00516893|65266242|FG000|Overall Study|Adverse Event|3|||
23416458|NCT00516893|65266242|FG000|Overall Study|Withdrawal by Subject|2|||
23416459|NCT00516893|65266242|FG000|Overall Study|Noncompliance|2|||
23416460|NCT00516893|65266242|FG000|Overall Study|Death|1|||
23416461|NCT00516893|65266242|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
23416462|NCT00516893|65266242|FG000|Overall Study|Relocated|1|||
23416463|NCT00516893|65266242|FG000|Overall Study|Pregnancy|1|||
23416464|NCT00516893|65266242|FG000|Overall Study|Received Medication From Another Study|1|||
23416465|NCT00920387|65266243|FG000|Stage 1|Adverse Event|1|||
23416466|NCT00920387|65266244|FG001|Stage 1|Adverse Event|0|||
23416467|NCT00920387|65266245|FG002|Stage 1|Adverse Event|0|||
23416468|NCT00327015|65271169|FG000|Overall Study|Lack of Efficacy|18|||
23416469|NCT00327015|65271170|FG001|Overall Study|Lack of Efficacy|18|||
23521525|NCT02618434|65647780|FG002|Overall Study|Adverse Event|12|||
23521526|NCT02618434|65647778|FG000|Overall Study|Physician Decision|0|||
23521527|NCT02618434|65647779|FG001|Overall Study|Physician Decision|1|||
23521528|NCT02618434|65647780|FG002|Overall Study|Physician Decision|0|||
23416470|NCT00327015|65271171|FG002|Overall Study|Lack of Efficacy|35|||
23416471|NCT00327015|65271172|FG003|Overall Study|Lack of Efficacy|29|||
23416472|NCT00327015|65271169|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
23416473|NCT00327015|65271170|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
23416474|NCT00327015|65271171|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
23416475|NCT00327015|65271172|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
23416476|NCT00327015|65271169|FG000|Overall Study|Lost to Follow-up|22|||
23416477|NCT00327015|65271170|FG001|Overall Study|Lost to Follow-up|23|||
23521529|NCT02618434|65647778|FG000|Overall Study|Protocol Violation|0|||
23416478|NCT00327015|65271171|FG002|Overall Study|Lost to Follow-up|29|||
23713840|NCT02159469|66325499|FG000|Overall Study|Withdrawal by Subject|9|||
23713841|NCT02159469|66325499|FG000|Overall Study|Lost to Follow-up|1|||
23713842|NCT02159469|66325499|FG000|Overall Study|Sponsor's request|2|||
23416479|NCT00327015|65271172|FG003|Overall Study|Lost to Follow-up|22|||
23416480|NCT00327015|65271169|FG000|Overall Study|Adverse Event|14|||
23521530|NCT02618434|65647779|FG001|Overall Study|Protocol Violation|0|||
23416481|NCT00327015|65271170|FG001|Overall Study|Adverse Event|10|||
23416482|NCT00327015|65271171|FG002|Overall Study|Adverse Event|14|||
23416483|NCT00327015|65271172|FG003|Overall Study|Adverse Event|14|||
23416484|NCT00327015|65271169|FG000|Overall Study|Subject no longer meets study criteria|4|||
23416485|NCT00327015|65271170|FG001|Overall Study|Subject no longer meets study criteria|2|||
23416486|NCT00327015|65271171|FG002|Overall Study|Subject no longer meets study criteria|8|||
23416487|NCT00327015|65271172|FG003|Overall Study|Subject no longer meets study criteria|7|||
23713843|NCT02159469|66325499|FG000|Overall Study|Met Stopping Criteria|3|||
23521531|NCT02618434|65647780|FG002|Overall Study|Protocol Violation|1|||
23521532|NCT02618434|65647778|FG000|Overall Study|Other, Multiple categories|1|||
23521533|NCT02618434|65647779|FG001|Overall Study|Other, Multiple categories|1|||
23521534|NCT02618434|65647780|FG002|Overall Study|Other, Multiple categories|1|||
23521535|NCT03509675|65650544|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
23521536|NCT03509675|65650545|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
23521537|NCT03509675|65650544|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
23521538|NCT03509675|65650545|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
23521539|NCT03509675|65650544|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
23521540|NCT03509675|65650545|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
23521541|NCT03509675|65650544|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
23521542|NCT03509675|65650545|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
23521543|NCT03299192|65650546|FG000|Overall Study|Fell before classes started|1|||
23521544|NCT03299192|65650547|FG001|Overall Study|Fell before classes started|0|||
23521545|NCT03299192|65650548|FG002|Overall Study|Fell before classes started|0|||
23521546|NCT03299192|65650546|FG000|Overall Study|Other|0|||
23521547|NCT03299192|65650547|FG001|Overall Study|Other|2|||
23521548|NCT03299192|65650548|FG002|Overall Study|Other|1|||
23521549|NCT03873987|65650551|FG000|Overall Study|Adverse Event|1|||
23521550|NCT03873987|65650552|FG001|Overall Study|Adverse Event|0|||
23521551|NCT03873987|65650551|FG000|Overall Study|staff was unable to start a new IV line|1|||
23521552|NCT03873987|65650552|FG001|Overall Study|staff was unable to start a new IV line|0|||
23521553|NCT03873987|65650551|FG000|Overall Study|Lost to Follow-up|0|||
23521554|NCT03873987|65650552|FG001|Overall Study|Lost to Follow-up|1|||
23521555|NCT01113879|65650563|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
23521556|NCT01113879|65650564|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
23521557|NCT01215227|65650565|FG000|Overall Study|Adverse Event|11|||
23521558|NCT01215227|65650566|FG001|Overall Study|Adverse Event|11|||
23521559|NCT01215227|65650567|FG002|Overall Study|Adverse Event|4|||
23521560|NCT01215227|65650568|FG003|Overall Study|Adverse Event|8|||
23521561|NCT01215227|65650569|FG004|Overall Study|Adverse Event|7|||
23521562|NCT01215227|65650570|FG005|Overall Study|Adverse Event|6|||
23713844|NCT02159469|66325499|FG000|Overall Study|Other|1|||
23713845|NCT02159469|66325499|FG000|Overall Study|Multiple|29|||
23713846|NCT02862548|66325500|FG000|Randomized Phase (Up to Week 48)|Death|0|||
23416488|NCT00327015|65271169|FG000|Overall Study|Poor/Noncompliance|11|||
23416489|NCT00327015|65271170|FG001|Overall Study|Poor/Noncompliance|8|||
23416490|NCT00327015|65271171|FG002|Overall Study|Poor/Noncompliance|4|||
23416491|NCT00327015|65271172|FG003|Overall Study|Poor/Noncompliance|5|||
23416492|NCT00327015|65271169|FG000|Overall Study|Physician Decision|0|||
23416493|NCT00327015|65271170|FG001|Overall Study|Physician Decision|1|||
23416494|NCT00327015|65271171|FG002|Overall Study|Physician Decision|3|||
23416495|NCT00327015|65271172|FG003|Overall Study|Physician Decision|2|||
23416496|NCT00327015|65271169|FG000|Overall Study|Death|1|||
23416497|NCT00327015|65271170|FG001|Overall Study|Death|2|||
23416498|NCT00327015|65271171|FG002|Overall Study|Death|2|||
23416499|NCT00327015|65271172|FG003|Overall Study|Death|3|||
23416500|NCT00327015|65271169|FG000|Overall Study|Pregnancy|0|||
23416501|NCT00327015|65271170|FG001|Overall Study|Pregnancy|2|||
23416502|NCT00327015|65271171|FG002|Overall Study|Pregnancy|1|||
23416503|NCT00327015|65271172|FG003|Overall Study|Pregnancy|1|||
23416504|NCT00327015|65271169|FG000|Overall Study|Administrative Reason by Sponsor|1|||
23416505|NCT00327015|65271170|FG001|Overall Study|Administrative Reason by Sponsor|2|||
23416506|NCT00327015|65271171|FG002|Overall Study|Administrative Reason by Sponsor|2|||
23416507|NCT00327015|65271172|FG003|Overall Study|Administrative Reason by Sponsor|1|||
23416508|NCT01164891|65271174|FG000|Overall Study|Disease Progression|5|||
23416509|NCT01164891|65271174|FG000|Overall Study|Adverse Event|1|||
23416510|NCT04308239|65271176|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
23713847|NCT02862548|66325501|FG001|Randomized Phase (Up to Week 48)|Death|1|||
23416511|NCT04308239|65271177|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
23416512|NCT04308239|65271176|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
23416513|NCT04308239|65271177|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
23416514|NCT04308239|65271176|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
23521563|NCT01215227|65650565|FG000|Overall Study|Treatment Failure|8|||
23521564|NCT01215227|65650566|FG001|Overall Study|Treatment Failure|4|||
23521565|NCT01215227|65650567|FG002|Overall Study|Treatment Failure|1|||
23416515|NCT04308239|65271177|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
23713848|NCT02862548|66325500|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
23521566|NCT01215227|65650568|FG003|Overall Study|Treatment Failure|5|||
23521567|NCT01215227|65650569|FG004|Overall Study|Treatment Failure|1|||
23521568|NCT01215227|65650570|FG005|Overall Study|Treatment Failure|1|||
23521569|NCT01215227|65650565|FG000|Overall Study|Lost to Follow-up|1|||
23521570|NCT01215227|65650566|FG001|Overall Study|Lost to Follow-up|4|||
23521571|NCT01215227|65650567|FG002|Overall Study|Lost to Follow-up|1|||
23521572|NCT01215227|65650568|FG003|Overall Study|Lost to Follow-up|1|||
23521573|NCT01215227|65650569|FG004|Overall Study|Lost to Follow-up|1|||
23521574|NCT01215227|65650570|FG005|Overall Study|Lost to Follow-up|2|||
23521575|NCT01215227|65650565|FG000|Overall Study|Subject Withdrew Consent|16|||
23521576|NCT01215227|65650566|FG001|Overall Study|Subject Withdrew Consent|20|||
23521577|NCT01215227|65650567|FG002|Overall Study|Subject Withdrew Consent|7|||
23521578|NCT01215227|65650568|FG003|Overall Study|Subject Withdrew Consent|10|||
23521579|NCT01215227|65650569|FG004|Overall Study|Subject Withdrew Consent|11|||
23521580|NCT01215227|65650570|FG005|Overall Study|Subject Withdrew Consent|8|||
23521581|NCT01215227|65650565|FG000|Overall Study|Non-Compliance With Protocol|2|||
23521582|NCT01215227|65650566|FG001|Overall Study|Non-Compliance With Protocol|6|||
23521583|NCT01215227|65650567|FG002|Overall Study|Non-Compliance With Protocol|1|||
23521584|NCT01215227|65650568|FG003|Overall Study|Non-Compliance With Protocol|0|||
23521585|NCT01215227|65650569|FG004|Overall Study|Non-Compliance With Protocol|0|||
23521586|NCT01215227|65650570|FG005|Overall Study|Non-Compliance With Protocol|0|||
23521587|NCT01215227|65650565|FG000|Overall Study|Administrative|83|||
23521588|NCT01215227|65650566|FG001|Overall Study|Administrative|73|||
23521589|NCT01215227|65650567|FG002|Overall Study|Administrative|42|||
23521590|NCT01215227|65650568|FG003|Overall Study|Administrative|24|||
23521591|NCT01215227|65650569|FG004|Overall Study|Administrative|28|||
23521592|NCT01215227|65650570|FG005|Overall Study|Administrative|40|||
23521593|NCT01215227|65650565|FG000|Overall Study|Missing Status|0|||
23521594|NCT01215227|65650566|FG001|Overall Study|Missing Status|1|||
23521595|NCT01215227|65650567|FG002|Overall Study|Missing Status|0|||
23521596|NCT01215227|65650568|FG003|Overall Study|Missing Status|0|||
23521597|NCT01215227|65650569|FG004|Overall Study|Missing Status|0|||
23521598|NCT01215227|65650570|FG005|Overall Study|Missing Status|0|||
23521599|NCT01215227|65650565|FG000|Overall Study|Randomized but not treated|0|||
23521600|NCT01215227|65650566|FG001|Overall Study|Randomized but not treated|0|||
23521601|NCT01215227|65650567|FG002|Overall Study|Randomized but not treated|1|||
23521602|NCT01215227|65650568|FG003|Overall Study|Randomized but not treated|1|||
23521603|NCT01215227|65650569|FG004|Overall Study|Randomized but not treated|0|||
23521604|NCT01215227|65650570|FG005|Overall Study|Randomized but not treated|1|||
23521605|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
23521606|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521607|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521608|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521609|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521610|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521611|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521612|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521613|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521614|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521615|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
23521616|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521617|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521618|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521619|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521620|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521621|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521622|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521623|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
23521624|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
23521625|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
23521626|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
23713849|NCT02862548|66325501|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
23713850|NCT02862548|66325500|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
23713851|NCT02862548|66325501|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
23521627|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
23521628|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
23521629|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
23521630|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
23521631|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
23812075|NCT02516553|66691893|FG018|Overall Study|Refused to continue trial medication|1|||
23713852|NCT02862548|66325500|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
23713853|NCT02862548|66325501|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
23713854|NCT00870818|66325504|FG000|Overall Study|Lost to Follow-up|3|||
23713855|NCT00870818|66325505|FG001|Overall Study|Lost to Follow-up|2|||
23713856|NCT00870818|66325506|FG002|Overall Study|Lost to Follow-up|1|||
23713857|NCT00870818|66325507|FG003|Overall Study|Lost to Follow-up|0|||
23713858|NCT00870818|66325508|FG004|Overall Study|Lost to Follow-up|0|||
23713859|NCT00870818|66325504|FG000|Overall Study|Withdrawal by Subject|0|||
23713860|NCT00870818|66325505|FG001|Overall Study|Withdrawal by Subject|0|||
23713861|NCT00870818|66325506|FG002|Overall Study|Withdrawal by Subject|1|||
23521632|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
23521633|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521634|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521635|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521636|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521637|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521638|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521639|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521640|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521641|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521642|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521643|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521644|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521645|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521646|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
23521647|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521648|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521649|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521650|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521651|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521652|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521653|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
23521654|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
23521655|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521656|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521657|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521658|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521659|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521660|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521661|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521662|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
23521663|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
23521664|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
23521665|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521666|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521667|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521668|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521669|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521670|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521671|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521672|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
23521673|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
23521674|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521675|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23713862|NCT00870818|66325507|FG003|Overall Study|Withdrawal by Subject|2|||
23713863|NCT00870818|66325508|FG004|Overall Study|Withdrawal by Subject|0|||
23713864|NCT00870818|66325504|FG000|Overall Study|Terminated by sponsor|29|||
23713865|NCT00870818|66325505|FG001|Overall Study|Terminated by sponsor|70|||
23713866|NCT00870818|66325506|FG002|Overall Study|Terminated by sponsor|36|||
23713867|NCT00870818|66325507|FG003|Overall Study|Terminated by sponsor|36|||
23713868|NCT00870818|66325508|FG004|Overall Study|Terminated by sponsor|38|||
23713869|NCT00870818|66325504|FG000|Overall Study|Other|0|||
23713870|NCT00870818|66325505|FG001|Overall Study|Other|1|||
23521676|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23713871|NCT00870818|66325506|FG002|Overall Study|Other|0|||
23713872|NCT00870818|66325507|FG003|Overall Study|Other|0|||
23713873|NCT00870818|66325508|FG004|Overall Study|Other|0|||
23713874|NCT01107405|66325510|FG000|Overall Study|Adverse Event|1|||
23713875|NCT01107405|66325511|FG001|Overall Study|Adverse Event|1|||
23812076|NCT02516553|66691894|FG019|Overall Study|Refused to continue trial medication|0|||
23521677|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521678|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23713876|NCT01107405|66325512|FG002|Overall Study|Adverse Event|0|||
23521679|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521680|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521681|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521682|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
23521683|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521684|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521685|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521686|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521687|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521688|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521689|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
23713877|NCT01107405|66325513|FG003|Overall Study|Adverse Event|0|||
23713878|NCT01107405|66325514|FG004|Overall Study|Adverse Event|2|||
23713879|NCT01107405|66325510|FG000|Overall Study|Withdrawal by Subject|1|||
23713880|NCT01107405|66325511|FG001|Overall Study|Withdrawal by Subject|0|||
23713881|NCT01107405|66325512|FG002|Overall Study|Withdrawal by Subject|1|||
23713882|NCT01107405|66325513|FG003|Overall Study|Withdrawal by Subject|2|||
23713883|NCT01107405|66325514|FG004|Overall Study|Withdrawal by Subject|1|||
23713884|NCT01107405|66325510|FG000|Overall Study|Protocol Violation|0|||
23713885|NCT01107405|66325511|FG001|Overall Study|Protocol Violation|0|||
23713886|NCT01107405|66325512|FG002|Overall Study|Protocol Violation|1|||
23521690|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521691|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521692|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521693|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
23521694|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521695|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521696|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521697|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521698|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521699|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521700|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521701|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
23521702|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521703|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
23521704|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521705|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521706|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521707|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521708|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521709|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521710|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
23521711|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521712|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
23521713|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521714|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
23713887|NCT01107405|66325513|FG003|Overall Study|Protocol Violation|1|||
23713888|NCT01107405|66325514|FG004|Overall Study|Protocol Violation|0|||
23713889|NCT01767519|66325515|FG000|Overall Study|Other Reasons|4|||
23713890|NCT01767519|66325516|FG001|Overall Study|Other Reasons|4|||
23713891|NCT01767519|66325517|FG002|Overall Study|Other Reasons|2|||
23713892|NCT01767519|66325515|FG000|Overall Study|Protocol Violation|0|||
23713893|NCT01767519|66325516|FG001|Overall Study|Protocol Violation|3|||
23713894|NCT01767519|66325517|FG002|Overall Study|Protocol Violation|0|||
23713895|NCT01767519|66325515|FG000|Overall Study|Personal Reasons|1|||
23713896|NCT01767519|66325516|FG001|Overall Study|Personal Reasons|0|||
23713897|NCT01767519|66325517|FG002|Overall Study|Personal Reasons|0|||
23713898|NCT01767519|66325515|FG000|Overall Study|Lost to Follow-up|3|||
23713899|NCT01767519|66325516|FG001|Overall Study|Lost to Follow-up|1|||
23713900|NCT01767519|66325517|FG002|Overall Study|Lost to Follow-up|2|||
23713901|NCT01767519|66325515|FG000|Overall Study|Lack of Efficacy|1|||
23713902|NCT01767519|66325516|FG001|Overall Study|Lack of Efficacy|0|||
23713903|NCT01767519|66325517|FG002|Overall Study|Lack of Efficacy|0|||
23713904|NCT01767519|66325515|FG000|Overall Study|Adverse Event|5|||
23713905|NCT01767519|66325516|FG001|Overall Study|Adverse Event|5|||
23713906|NCT01767519|66325517|FG002|Overall Study|Adverse Event|1|||
23713907|NCT02432040|66325518|FG000|Overall Study|Lack of Efficacy|3|||
23521715|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521716|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521717|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
23713908|NCT02432040|66325519|FG001|Overall Study|Lack of Efficacy|0|||
23713909|NCT02432040|66325518|FG000|Overall Study|Lost to Follow-up|4|||
23713910|NCT02432040|66325519|FG001|Overall Study|Lost to Follow-up|5|||
23713911|NCT02432040|66325518|FG000|Overall Study|Physician Decision|1|||
23713912|NCT02432040|66325519|FG001|Overall Study|Physician Decision|1|||
23713913|NCT01265420|66325520|FG000|Overall Study|Lost to Follow-up|1|||
23713914|NCT03488251|66325534|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
23713915|NCT03488251|66325535|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23713916|NCT03488251|66325536|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23713917|NCT03488251|66325537|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23521718|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521719|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
23521720|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
23521721|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
23713918|NCT03488251|66325534|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
23521722|NCT00978068|65650580|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
23521723|NCT00978068|65650581|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
23713919|NCT03488251|66325535|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23713920|NCT03488251|66325536|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23713921|NCT03488251|66325537|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23713922|NCT03488251|66325534|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
23713923|NCT03488251|66325535|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23713924|NCT03488251|66325536|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23713925|NCT03488251|66325537|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23713926|NCT03488251|66325534|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
23713927|NCT03488251|66325535|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23713928|NCT03488251|66325536|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23713929|NCT03488251|66325537|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23713930|NCT03488251|66325534|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
23713931|NCT03488251|66325535|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23713932|NCT03488251|66325536|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23713933|NCT03488251|66325537|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23713934|NCT03337152|66325538|FG000|Overall Study|Physician Decision|1|||
23713935|NCT03337152|66325539|FG001|Overall Study|Physician Decision|0|||
23713936|NCT03337152|66325538|FG000|Overall Study|Lost to Follow-up|1|||
23713937|NCT03337152|66325539|FG001|Overall Study|Lost to Follow-up|3|||
23713938|NCT03337152|66325538|FG000|Overall Study|Adverse Event|3|||
23713939|NCT03337152|66325539|FG001|Overall Study|Adverse Event|1|||
23713940|NCT03337152|66325538|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
23713941|NCT03337152|66325539|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
23713942|NCT02115113|66325554|FG000|Participants in Run-in Period|Death|0|||
23713943|NCT02115113|66325555|FG001|Participants in Run-in Period|Death|0|||
23713944|NCT02115113|66325556|FG002|Participants in Run-in Period|Death|1|||
23713945|NCT02115113|66325554|FG000|Participants in Run-in Period|Administrative problems|0|||
23521724|NCT00978068|65650580|FG000|Overall Study|Death|1|||
23521725|NCT00978068|65650581|FG001|Overall Study|Death|2|||
23521726|NCT00978068|65650580|FG000|Overall Study|Lost to Follow-up|1|||
23521727|NCT00978068|65650581|FG001|Overall Study|Lost to Follow-up|2|||
23521728|NCT00978068|65650580|FG000|Overall Study|Physician Decision|0|||
23521729|NCT00978068|65650581|FG001|Overall Study|Physician Decision|1|||
23521730|NCT00978068|65650580|FG000|Overall Study|Unable to Comply with Study|0|||
23521731|NCT00978068|65650581|FG001|Overall Study|Unable to Comply with Study|2|||
23521732|NCT02159521|65650582|FG000|Overall Study|Enrolled but not treated|3|||
23521733|NCT02159521|65650582|FG000|Overall Study|Withdrawal by Subject|7|||
23521734|NCT02159521|65650582|FG000|Overall Study|Lost to Follow-up|6|||
23521735|NCT02159521|65650582|FG000|Overall Study|Death|1|||
23713946|NCT02115113|66325555|FG001|Participants in Run-in Period|Administrative problems|0|||
23713947|NCT02115113|66325556|FG002|Participants in Run-in Period|Administrative problems|1|||
23453568|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453569|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453570|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453571|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453572|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
23453573|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453574|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453575|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453576|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
23453577|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453578|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453579|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453580|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453581|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453582|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
23713948|NCT02115113|66325554|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
23713949|NCT02115113|66325555|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
23521736|NCT02159521|65650582|FG000|Overall Study|Other than specified|1|||
23521737|NCT05129488|65650586|FG000|Overall Study|Protocol Violation|3|||
23521738|NCT01559012|65650588|FG000|Overall Study|Withdrawal by Subject|0|||
23521739|NCT01559012|65650589|FG001|Overall Study|Withdrawal by Subject|1|||
23521740|NCT02689258|65650592|FG000|Overall Study|Subject Non-Compliance|0|||
23521741|NCT02689258|65650593|FG001|Overall Study|Subject Non-Compliance|1|||
23521742|NCT02689258|65650594|FG002|Overall Study|Subject Non-Compliance|0|||
23521743|NCT02689258|65650595|FG003|Overall Study|Subject Non-Compliance|0|||
23521744|NCT02689258|65650596|FG004|Overall Study|Subject Non-Compliance|0|||
23521745|NCT02689258|65650597|FG005|Overall Study|Subject Non-Compliance|0|||
23521746|NCT02689258|65650598|FG006|Overall Study|Subject Non-Compliance|0|||
23521747|NCT02689258|65650599|FG007|Overall Study|Subject Non-Compliance|0|||
23521748|NCT02689258|65650600|FG008|Overall Study|Subject Non-Compliance|0|||
23521749|NCT02689258|65650601|FG009|Overall Study|Subject Non-Compliance|0|||
23521750|NCT02689258|65650602|FG010|Overall Study|Subject Non-Compliance|0|||
23521751|NCT02689258|65650603|FG011|Overall Study|Subject Non-Compliance|0|||
23521752|NCT02689258|65650592|FG000|Overall Study|Subject Refusal to Continue|0|||
23521753|NCT02689258|65650593|FG001|Overall Study|Subject Refusal to Continue|1|||
23521754|NCT02689258|65650594|FG002|Overall Study|Subject Refusal to Continue|0|||
23521755|NCT02689258|65650595|FG003|Overall Study|Subject Refusal to Continue|0|||
23521756|NCT02689258|65650596|FG004|Overall Study|Subject Refusal to Continue|0|||
23521757|NCT02689258|65650597|FG005|Overall Study|Subject Refusal to Continue|0|||
23521758|NCT02689258|65650598|FG006|Overall Study|Subject Refusal to Continue|0|||
23521759|NCT02689258|65650599|FG007|Overall Study|Subject Refusal to Continue|0|||
23521760|NCT02689258|65650600|FG008|Overall Study|Subject Refusal to Continue|1|||
23521761|NCT02689258|65650601|FG009|Overall Study|Subject Refusal to Continue|0|||
23521762|NCT02689258|65650602|FG010|Overall Study|Subject Refusal to Continue|0|||
23521763|NCT02689258|65650603|FG011|Overall Study|Subject Refusal to Continue|1|||
23713950|NCT02115113|66325556|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
23713951|NCT02115113|66325554|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
23713952|NCT02115113|66325555|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
23713953|NCT02115113|66325556|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
23713954|NCT02115113|66325554|FG000|Participants Randomized|Lost to Follow-up|1|||
23713955|NCT02115113|66325555|FG001|Participants Randomized|Lost to Follow-up|0|||
23713956|NCT02115113|66325556|FG002|Participants Randomized|Lost to Follow-up|0|||
23713957|NCT02115113|66325554|FG000|Participants Randomized|Death|1|||
23713958|NCT02115113|66325555|FG001|Participants Randomized|Death|0|||
23713959|NCT02115113|66325556|FG002|Participants Randomized|Death|0|||
23713960|NCT00434122|66325560|FG000|Overall Study|Non-compliance with protocol|0|||
23713961|NCT00434122|66325561|FG001|Overall Study|Non-compliance with protocol|1|||
23713962|NCT00434122|66325560|FG000|Overall Study|loss of subject contact|1|||
23713963|NCT00434122|66325561|FG001|Overall Study|loss of subject contact|1|||
23713964|NCT00434122|66325560|FG000|Overall Study|Personal reasons|1|||
23713965|NCT00434122|66325561|FG001|Overall Study|Personal reasons|1|||
23713966|NCT00434122|66325560|FG000|Overall Study|Large follicle size|2|||
23713967|NCT00434122|66325561|FG001|Overall Study|Large follicle size|2|||
23713968|NCT00434122|66325560|FG000|Overall Study|Low follicular response.|1|||
23713969|NCT00434122|66325561|FG001|Overall Study|Low follicular response.|2|||
23713970|NCT00434122|66325560|FG000|Overall Study|Travelling of subject.|1|||
23713971|NCT00434122|66325561|FG001|Overall Study|Travelling of subject.|0|||
23713972|NCT02648724|66325562|FG000|Overall Study|Withdrawal by Subject|0|||
23713973|NCT02648724|66325563|FG001|Overall Study|Withdrawal by Subject|1|||
23713974|NCT02648724|66325564|FG002|Overall Study|Withdrawal by Subject|1|||
23713975|NCT02648724|66325565|FG003|Overall Study|Withdrawal by Subject|0|||
23713976|NCT02648724|66325566|FG004|Overall Study|Withdrawal by Subject|1|||
23713977|NCT02648724|66325567|FG005|Overall Study|Withdrawal by Subject|0|||
23713978|NCT02648724|66325568|FG006|Overall Study|Withdrawal by Subject|0|||
23713979|NCT02648724|66325562|FG000|Overall Study|Progressive disease|2|||
23521764|NCT02689258|65650592|FG000|Overall Study|Other|0|||
23521765|NCT02689258|65650593|FG001|Overall Study|Other|2|||
23521766|NCT02689258|65650594|FG002|Overall Study|Other|0|||
23713980|NCT02648724|66325563|FG001|Overall Study|Progressive disease|2|||
23713981|NCT02648724|66325564|FG002|Overall Study|Progressive disease|2|||
23713982|NCT02648724|66325565|FG003|Overall Study|Progressive disease|3|||
23713983|NCT02648724|66325566|FG004|Overall Study|Progressive disease|22|||
23521767|NCT02689258|65650595|FG003|Overall Study|Other|0|||
23521768|NCT02689258|65650596|FG004|Overall Study|Other|1|||
23521769|NCT02689258|65650597|FG005|Overall Study|Other|0|||
23521770|NCT02689258|65650598|FG006|Overall Study|Other|0|||
23521771|NCT02689258|65650599|FG007|Overall Study|Other|0|||
23521772|NCT02689258|65650600|FG008|Overall Study|Other|1|||
23713984|NCT02648724|66325567|FG005|Overall Study|Progressive disease|7|||
23713985|NCT02648724|66325568|FG006|Overall Study|Progressive disease|8|||
23713986|NCT02648724|66325562|FG000|Overall Study|Other reason (unknown)|1|||
23713987|NCT02648724|66325563|FG001|Overall Study|Other reason (unknown)|0|||
23521773|NCT02689258|65650601|FG009|Overall Study|Other|0|||
23521774|NCT02689258|65650602|FG010|Overall Study|Other|0|||
23521775|NCT02689258|65650603|FG011|Overall Study|Other|0|||
23521776|NCT02641379|65650606|FG000|Overall Study|Exclusion criterion during screening|1|||
23521777|NCT02641379|65650607|FG001|Overall Study|Exclusion criterion during screening|0|||
23521778|NCT02641379|65650608|FG002|Overall Study|Exclusion criterion during screening|0|||
23521779|NCT02641379|65650609|FG003|Overall Study|Exclusion criterion during screening|1|||
23521780|NCT02641379|65650610|FG004|Overall Study|Exclusion criterion during screening|2|||
23521781|NCT02641379|65650611|FG005|Overall Study|Exclusion criterion during screening|0|||
23521782|NCT02641379|65650612|FG006|Overall Study|Exclusion criterion during screening|0|||
23521783|NCT02641379|65650613|FG007|Overall Study|Exclusion criterion during screening|0|||
23521784|NCT02641379|65650614|FG008|Overall Study|Exclusion criterion during screening|0|||
23521785|NCT02641379|65650615|FG009|Overall Study|Exclusion criterion during screening|0|||
23521786|NCT02641379|65650616|FG010|Overall Study|Exclusion criterion during screening|0|||
23521787|NCT02641379|65650606|FG000|Overall Study|Withdrawal of informed consent|0|||
23521788|NCT02641379|65650607|FG001|Overall Study|Withdrawal of informed consent|1|||
23521789|NCT02641379|65650608|FG002|Overall Study|Withdrawal of informed consent|0|||
23521790|NCT02641379|65650609|FG003|Overall Study|Withdrawal of informed consent|0|||
23521791|NCT02641379|65650610|FG004|Overall Study|Withdrawal of informed consent|0|||
23521792|NCT02641379|65650611|FG005|Overall Study|Withdrawal of informed consent|0|||
23521793|NCT02641379|65650612|FG006|Overall Study|Withdrawal of informed consent|0|||
23521794|NCT02641379|65650613|FG007|Overall Study|Withdrawal of informed consent|1|||
23521795|NCT02641379|65650614|FG008|Overall Study|Withdrawal of informed consent|0|||
23521796|NCT02641379|65650615|FG009|Overall Study|Withdrawal of informed consent|0|||
23521797|NCT02641379|65650616|FG010|Overall Study|Withdrawal of informed consent|0|||
23521798|NCT02641379|65650606|FG000|Overall Study|Adverse Event|7|||
23521799|NCT02641379|65650607|FG001|Overall Study|Adverse Event|8|||
23521800|NCT02641379|65650608|FG002|Overall Study|Adverse Event|2|||
23521801|NCT02641379|65650609|FG003|Overall Study|Adverse Event|2|||
23521802|NCT02641379|65650610|FG004|Overall Study|Adverse Event|5|||
23521803|NCT02641379|65650611|FG005|Overall Study|Adverse Event|1|||
23521804|NCT02641379|65650612|FG006|Overall Study|Adverse Event|5|||
23521805|NCT02641379|65650613|FG007|Overall Study|Adverse Event|0|||
23521806|NCT02641379|65650614|FG008|Overall Study|Adverse Event|1|||
23521807|NCT02641379|65650615|FG009|Overall Study|Adverse Event|1|||
23713988|NCT02648724|66325564|FG002|Overall Study|Other reason (unknown)|0|||
23521808|NCT02641379|65650616|FG010|Overall Study|Adverse Event|5|||
23521809|NCT02641379|65650606|FG000|Overall Study|Lack of Efficacy|0|||
23521810|NCT02641379|65650607|FG001|Overall Study|Lack of Efficacy|0|||
23521811|NCT02641379|65650608|FG002|Overall Study|Lack of Efficacy|2|||
23521812|NCT02641379|65650609|FG003|Overall Study|Lack of Efficacy|0|||
23521813|NCT02641379|65650610|FG004|Overall Study|Lack of Efficacy|0|||
23713989|NCT02648724|66325565|FG003|Overall Study|Other reason (unknown)|0|||
23713990|NCT02648724|66325566|FG004|Overall Study|Other reason (unknown)|0|||
23713991|NCT02648724|66325567|FG005|Overall Study|Other reason (unknown)|0|||
23713992|NCT02648724|66325568|FG006|Overall Study|Other reason (unknown)|0|||
23713993|NCT02648724|66325562|FG000|Overall Study|Protocol Violation|0|||
23713994|NCT02648724|66325563|FG001|Overall Study|Protocol Violation|0|||
23713995|NCT02648724|66325564|FG002|Overall Study|Protocol Violation|0|||
23713996|NCT02648724|66325565|FG003|Overall Study|Protocol Violation|0|||
23713997|NCT02648724|66325566|FG004|Overall Study|Protocol Violation|1|||
23521814|NCT02641379|65650611|FG005|Overall Study|Lack of Efficacy|2|||
23713998|NCT02648724|66325567|FG005|Overall Study|Protocol Violation|0|||
23713999|NCT02648724|66325568|FG006|Overall Study|Protocol Violation|0|||
23714000|NCT02648724|66325562|FG000|Overall Study|Death|0|||
23714001|NCT02648724|66325563|FG001|Overall Study|Death|0|||
23714002|NCT02648724|66325564|FG002|Overall Study|Death|0|||
23714003|NCT02648724|66325565|FG003|Overall Study|Death|0|||
23714004|NCT02648724|66325566|FG004|Overall Study|Death|0|||
23714005|NCT02648724|66325567|FG005|Overall Study|Death|0|||
23714006|NCT02648724|66325568|FG006|Overall Study|Death|3|||
23714007|NCT02648724|66325562|FG000|Overall Study|Physician Decision|0|||
23714008|NCT02648724|66325563|FG001|Overall Study|Physician Decision|0|||
23714009|NCT02648724|66325564|FG002|Overall Study|Physician Decision|0|||
23714010|NCT02648724|66325565|FG003|Overall Study|Physician Decision|0|||
23714011|NCT02648724|66325566|FG004|Overall Study|Physician Decision|1|||
23714012|NCT02648724|66325567|FG005|Overall Study|Physician Decision|0|||
23714013|NCT02648724|66325568|FG006|Overall Study|Physician Decision|1|||
23714014|NCT02648724|66325562|FG000|Overall Study|Transferred to named patient program|0|||
23812077|NCT02516553|66691895|FG020|Overall Study|Refused to continue trial medication|0|||
23812078|NCT02516553|66691896|FG021|Overall Study|Refused to continue trial medication|1|||
23812079|NCT02516553|66691875|FG000|Overall Study|other reasons than listed|0|||
23416516|NCT04308239|65271176|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
23714015|NCT02648724|66325563|FG001|Overall Study|Transferred to named patient program|0|||
23714016|NCT02648724|66325564|FG002|Overall Study|Transferred to named patient program|0|||
23714017|NCT02648724|66325565|FG003|Overall Study|Transferred to named patient program|0|||
23714018|NCT02648724|66325566|FG004|Overall Study|Transferred to named patient program|0|||
23714019|NCT02648724|66325567|FG005|Overall Study|Transferred to named patient program|1|||
23714020|NCT02648724|66325568|FG006|Overall Study|Transferred to named patient program|0|||
23714021|NCT03325556|66325572|FG000|Open-label Period|Lack of Response in OL period|70|||
23714022|NCT03325556|66325573|FG001|Open-label Period|Lack of Response in OL period|0|||
23714023|NCT03325556|66325574|FG002|Open-label Period|Lack of Response in OL period|0|||
23714024|NCT03325556|66325572|FG000|Open-label Period|Adverse Event|27|||
23714025|NCT03325556|66325573|FG001|Open-label Period|Adverse Event|0|||
23714026|NCT03325556|66325574|FG002|Open-label Period|Adverse Event|0|||
23714027|NCT03325556|66325572|FG000|Open-label Period|Death|1|||
23714028|NCT03325556|66325573|FG001|Open-label Period|Death|0|||
23714029|NCT03325556|66325574|FG002|Open-label Period|Death|0|||
23714030|NCT03325556|66325572|FG000|Open-label Period|Lost to Follow-up|1|||
23714031|NCT03325556|66325573|FG001|Open-label Period|Lost to Follow-up|0|||
23714032|NCT03325556|66325574|FG002|Open-label Period|Lost to Follow-up|0|||
23714033|NCT03325556|66325572|FG000|Open-label Period|Non-compliance with study drug|5|||
23714034|NCT03325556|66325573|FG001|Open-label Period|Non-compliance with study drug|0|||
23714035|NCT03325556|66325574|FG002|Open-label Period|Non-compliance with study drug|0|||
23714036|NCT03325556|66325572|FG000|Open-label Period|Use of prohibited medication|1|||
23714037|NCT03325556|66325573|FG001|Open-label Period|Use of prohibited medication|0|||
23714038|NCT03325556|66325574|FG002|Open-label Period|Use of prohibited medication|0|||
23714039|NCT03325556|66325572|FG000|Open-label Period|Protocol Violation|4|||
23714040|NCT03325556|66325573|FG001|Open-label Period|Protocol Violation|0|||
23714041|NCT03325556|66325574|FG002|Open-label Period|Protocol Violation|0|||
23714042|NCT03325556|66325572|FG000|Open-label Period|Withdrawal by Subject|17|||
23714043|NCT03325556|66325573|FG001|Open-label Period|Withdrawal by Subject|0|||
23714044|NCT03325556|66325574|FG002|Open-label Period|Withdrawal by Subject|0|||
23714045|NCT03325556|66325572|FG000|Open-label Period|Not otherwise specified|8|||
23521815|NCT02641379|65650612|FG006|Overall Study|Lack of Efficacy|0|||
23521816|NCT02641379|65650613|FG007|Overall Study|Lack of Efficacy|5|||
23521817|NCT02641379|65650614|FG008|Overall Study|Lack of Efficacy|0|||
23521818|NCT02641379|65650615|FG009|Overall Study|Lack of Efficacy|0|||
23714046|NCT03325556|66325573|FG001|Open-label Period|Not otherwise specified|0|||
23812080|NCT02516553|66691876|FG001|Overall Study|other reasons than listed|0|||
23812081|NCT02516553|66691877|FG002|Overall Study|other reasons than listed|0|||
23812082|NCT02516553|66691878|FG003|Overall Study|other reasons than listed|0|||
23812083|NCT02516553|66691879|FG004|Overall Study|other reasons than listed|0|||
23714047|NCT03325556|66325574|FG002|Open-label Period|Not otherwise specified|0|||
23714048|NCT03325556|66325572|FG000|Open-label Period|Administrative discont. at study termination|41|||
23714049|NCT03325556|66325573|FG001|Open-label Period|Administrative discont. at study termination|0|||
23714050|NCT03325556|66325574|FG002|Open-label Period|Administrative discont. at study termination|0|||
23714051|NCT03325556|66325572|FG000|Double-blind Period|Relapse|0|||
23714052|NCT03325556|66325573|FG001|Double-blind Period|Relapse|15|||
23714053|NCT03325556|66325574|FG002|Double-blind Period|Relapse|34|||
23714054|NCT03325556|66325572|FG000|Double-blind Period|Adverse Event|0|||
23714055|NCT03325556|66325573|FG001|Double-blind Period|Adverse Event|3|||
23714056|NCT03325556|66325574|FG002|Double-blind Period|Adverse Event|1|||
23714057|NCT03325556|66325572|FG000|Double-blind Period|Noncompliance with study drug|0|||
23714058|NCT03325556|66325573|FG001|Double-blind Period|Noncompliance with study drug|0|||
23714059|NCT03325556|66325574|FG002|Double-blind Period|Noncompliance with study drug|1|||
23714060|NCT03325556|66325572|FG000|Double-blind Period|Use of prohibited medication|0|||
23714061|NCT03325556|66325573|FG001|Double-blind Period|Use of prohibited medication|1|||
23714062|NCT03325556|66325574|FG002|Double-blind Period|Use of prohibited medication|0|||
23714063|NCT03325556|66325572|FG000|Double-blind Period|Physician Decision|0|||
23714064|NCT03325556|66325573|FG001|Double-blind Period|Physician Decision|0|||
23714065|NCT03325556|66325574|FG002|Double-blind Period|Physician Decision|1|||
23714066|NCT03325556|66325572|FG000|Double-blind Period|Withdrawal by Subject|0|||
23714067|NCT03325556|66325573|FG001|Double-blind Period|Withdrawal by Subject|6|||
23714068|NCT03325556|66325574|FG002|Double-blind Period|Withdrawal by Subject|4|||
23714069|NCT03325556|66325572|FG000|Double-blind Period|Not otherwise specified|0|||
23714070|NCT03325556|66325573|FG001|Double-blind Period|Not otherwise specified|1|||
23714071|NCT03325556|66325574|FG002|Double-blind Period|Not otherwise specified|5|||
23714072|NCT03325556|66325572|FG000|Double-blind Period|Administrative discont. at study termination|0|||
23812084|NCT02516553|66691880|FG005|Overall Study|other reasons than listed|0|||
23812085|NCT02516553|66691881|FG006|Overall Study|other reasons than listed|0|||
23812086|NCT02516553|66691882|FG007|Overall Study|other reasons than listed|1|||
23812087|NCT02516553|66691883|FG008|Overall Study|other reasons than listed|1|||
23812088|NCT02516553|66691884|FG009|Overall Study|other reasons than listed|0|||
23812089|NCT02516553|66691885|FG010|Overall Study|other reasons than listed|1|||
23521819|NCT02641379|65650616|FG010|Overall Study|Lack of Efficacy|0|||
23714073|NCT03325556|66325573|FG001|Double-blind Period|Administrative discont. at study termination|35|||
23714074|NCT03325556|66325574|FG002|Double-blind Period|Administrative discont. at study termination|31|||
23714075|NCT00507416|66325575|FG000|Overall Study|Adverse Event|58|||
23714076|NCT00507416|66325576|FG001|Overall Study|Adverse Event|67|||
23714077|NCT00507416|66325577|FG002|Overall Study|Adverse Event|65|||
23714078|NCT00507416|66325575|FG000|Overall Study|Protocol Violation|1|||
23714079|NCT00507416|66325576|FG001|Overall Study|Protocol Violation|2|||
23714080|NCT00507416|66325577|FG002|Overall Study|Protocol Violation|0|||
23714081|NCT00507416|66325575|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
23714082|NCT00507416|66325576|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
23714083|NCT00507416|66325577|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
23714084|NCT00507416|66325575|FG000|Overall Study|Progressive Disease|20|||
23714085|NCT00507416|66325576|FG001|Overall Study|Progressive Disease|10|||
23714086|NCT00507416|66325577|FG002|Overall Study|Progressive Disease|13|||
23714087|NCT00507416|66325575|FG000|Overall Study|Patient declined further treatment|18|||
23714088|NCT00507416|66325576|FG001|Overall Study|Patient declined further treatment|14|||
23714089|NCT00507416|66325577|FG002|Overall Study|Patient declined further treatment|11|||
23714090|NCT00507416|66325575|FG000|Overall Study|Other|11|||
23521820|NCT02641379|65650606|FG000|Overall Study|Participant unable to attend study visit|4|||
23521821|NCT02641379|65650607|FG001|Overall Study|Participant unable to attend study visit|10|||
23714091|NCT00507416|66325576|FG001|Overall Study|Other|16|||
23714092|NCT00507416|66325577|FG002|Overall Study|Other|13|||
23714093|NCT00507416|66325575|FG000|Overall Study|Did not Receive Study Treatment|3|||
23714094|NCT00507416|66325576|FG001|Overall Study|Did not Receive Study Treatment|9|||
23714095|NCT00507416|66325577|FG002|Overall Study|Did not Receive Study Treatment|4|||
23714096|NCT03103906|66325578|FG000|Overall Study|Adverse Event|2|||
23714097|NCT03103906|66325579|FG001|Overall Study|Adverse Event|3|||
23521822|NCT02641379|65650608|FG002|Overall Study|Participant unable to attend study visit|1|||
23521823|NCT02641379|65650609|FG003|Overall Study|Participant unable to attend study visit|2|||
23521824|NCT02641379|65650610|FG004|Overall Study|Participant unable to attend study visit|5|||
23521825|NCT02641379|65650611|FG005|Overall Study|Participant unable to attend study visit|1|||
23521826|NCT02641379|65650612|FG006|Overall Study|Participant unable to attend study visit|1|||
23521827|NCT02641379|65650613|FG007|Overall Study|Participant unable to attend study visit|1|||
23521828|NCT02641379|65650614|FG008|Overall Study|Participant unable to attend study visit|0|||
23521829|NCT02641379|65650615|FG009|Overall Study|Participant unable to attend study visit|2|||
23521830|NCT02641379|65650616|FG010|Overall Study|Participant unable to attend study visit|0|||
23521831|NCT02641379|65650606|FG000|Overall Study|Participant's compliance|0|||
23521832|NCT02641379|65650607|FG001|Overall Study|Participant's compliance|1|||
23521833|NCT02641379|65650608|FG002|Overall Study|Participant's compliance|0|||
23521834|NCT02641379|65650609|FG003|Overall Study|Participant's compliance|1|||
23521835|NCT02641379|65650610|FG004|Overall Study|Participant's compliance|0|||
23521836|NCT02641379|65650611|FG005|Overall Study|Participant's compliance|2|||
23521837|NCT02641379|65650612|FG006|Overall Study|Participant's compliance|0|||
23521838|NCT02641379|65650613|FG007|Overall Study|Participant's compliance|0|||
23521839|NCT02641379|65650614|FG008|Overall Study|Participant's compliance|1|||
23521840|NCT02641379|65650615|FG009|Overall Study|Participant's compliance|1|||
23521841|NCT02641379|65650616|FG010|Overall Study|Participant's compliance|1|||
23521842|NCT02641379|65650606|FG000|Overall Study|Participant cannot be reached|4|||
23521843|NCT02641379|65650607|FG001|Overall Study|Participant cannot be reached|4|||
23521844|NCT02641379|65650608|FG002|Overall Study|Participant cannot be reached|0|||
23521845|NCT02641379|65650609|FG003|Overall Study|Participant cannot be reached|8|||
23521846|NCT02641379|65650610|FG004|Overall Study|Participant cannot be reached|2|||
23521847|NCT02641379|65650611|FG005|Overall Study|Participant cannot be reached|1|||
23521848|NCT02641379|65650612|FG006|Overall Study|Participant cannot be reached|0|||
23521849|NCT02641379|65650613|FG007|Overall Study|Participant cannot be reached|1|||
23521850|NCT02641379|65650614|FG008|Overall Study|Participant cannot be reached|0|||
23521851|NCT02641379|65650615|FG009|Overall Study|Participant cannot be reached|2|||
23521852|NCT02641379|65650616|FG010|Overall Study|Participant cannot be reached|1|||
23521853|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 24|15|||
23521854|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 24|21|||
23521855|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 24|62|||
23521856|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 24|0|||
23521857|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 24|0|||
23521858|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 24|6|||
23521859|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 24|3|||
23521860|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 24|8|||
23521861|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 24|0|||
23521862|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 24|1|||
23521863|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 24|0|||
23521864|NCT02641379|65650606|FG000|Overall Study|PCR positive at follow up 2|1|||
23521865|NCT02641379|65650607|FG001|Overall Study|PCR positive at follow up 2|0|||
23714098|NCT03103906|66325578|FG000|Overall Study|Other|2|||
23714099|NCT03103906|66325579|FG001|Overall Study|Other|0|||
23714100|NCT01086150|66325580|FG000|Overall Study|Withdrawal by Subject|0|||
23714101|NCT01086150|66325581|FG001|Overall Study|Withdrawal by Subject|4|||
23714102|NCT01086150|66325582|FG002|Overall Study|Withdrawal by Subject|1|||
23714103|NCT01086150|66325580|FG000|Overall Study|Lost to Follow-up|0|||
23714104|NCT01086150|66325581|FG001|Overall Study|Lost to Follow-up|1|||
23714105|NCT01086150|66325582|FG002|Overall Study|Lost to Follow-up|0|||
23714106|NCT01086150|66325580|FG000|Overall Study|Screen Failure|0|||
23714107|NCT01086150|66325581|FG001|Overall Study|Screen Failure|1|||
23714108|NCT01086150|66325582|FG002|Overall Study|Screen Failure|0|||
23714109|NCT02702011|66325583|FG000|Overall Study|Withdrawal by Subject|0|||
23714110|NCT02702011|66325584|FG001|Overall Study|Withdrawal by Subject|1|||
23714111|NCT02702011|66325585|FG002|Overall Study|Withdrawal by Subject|0|||
23714112|NCT02702011|66325586|FG003|Overall Study|Withdrawal by Subject|0|||
23714113|NCT00667251|66325589|FG000|Overall Study|Adverse Event|13|||
23714114|NCT00667251|66325590|FG001|Overall Study|Adverse Event|4|||
23714115|NCT00667251|66325589|FG000|Overall Study|Withdrawal by Subject|6|||
23714116|NCT00667251|66325590|FG001|Overall Study|Withdrawal by Subject|2|||
23714117|NCT00667251|66325589|FG000|Overall Study|Other/missing|46|||
23714118|NCT00667251|66325590|FG001|Overall Study|Other/missing|84|||
23714119|NCT00667251|66325589|FG000|Overall Study|Intercurrent Illness|4|||
23714120|NCT00667251|66325590|FG001|Overall Study|Intercurrent Illness|3|||
23714121|NCT00667251|66325589|FG000|Overall Study|Symptomatic progression|1|||
23714122|NCT00667251|66325590|FG001|Overall Study|Symptomatic progression|2|||
23714123|NCT02124707|66325592|FG000|Overall Study|Adverse Event|5|||
23714124|NCT02124707|66325592|FG000|Overall Study|Physician Decision|1|||
23714125|NCT02124707|66325592|FG000|Overall Study|Death|1|||
23714126|NCT00848250|66325593|FG000|Overall Study|surgery was completed without cardiopulm|0|||
23714127|NCT00848250|66325594|FG001|Overall Study|surgery was completed without cardiopulm|1|||
23714128|NCT02932332|66325595|FG000|Overall Study|Withdrawal by Subject|1|||
23714129|NCT02932332|66325596|FG001|Overall Study|Withdrawal by Subject|1|||
23714130|NCT02932332|66325597|FG002|Overall Study|Withdrawal by Subject|0|||
23714131|NCT02932332|66325598|FG003|Overall Study|Withdrawal by Subject|1|||
23714132|NCT02932332|66325595|FG000|Overall Study|Chest pain|0|||
23714133|NCT02932332|66325596|FG001|Overall Study|Chest pain|0|||
23812090|NCT02516553|66691886|FG011|Overall Study|other reasons than listed|1|||
23812091|NCT02516553|66691887|FG012|Overall Study|other reasons than listed|0|||
23714134|NCT02932332|66325597|FG002|Overall Study|Chest pain|0|||
23714135|NCT02932332|66325598|FG003|Overall Study|Chest pain|1|||
23714136|NCT02932332|66325595|FG000|Overall Study|Not Dyspneic cough|1|||
23812092|NCT02516553|66691888|FG013|Overall Study|other reasons than listed|0|||
23812093|NCT02516553|66691889|FG014|Overall Study|other reasons than listed|0|||
23812094|NCT02516553|66691890|FG015|Overall Study|other reasons than listed|0|||
23812095|NCT02516553|66691891|FG016|Overall Study|other reasons than listed|0|||
23521866|NCT02641379|65650608|FG002|Overall Study|PCR positive at follow up 2|0|||
23521867|NCT02641379|65650609|FG003|Overall Study|PCR positive at follow up 2|0|||
23521868|NCT02641379|65650610|FG004|Overall Study|PCR positive at follow up 2|0|||
23521869|NCT02641379|65650611|FG005|Overall Study|PCR positive at follow up 2|0|||
23521870|NCT02641379|65650612|FG006|Overall Study|PCR positive at follow up 2|0|||
23521871|NCT02641379|65650613|FG007|Overall Study|PCR positive at follow up 2|0|||
23714137|NCT02932332|66325596|FG001|Overall Study|Not Dyspneic cough|2|||
23714138|NCT02932332|66325597|FG002|Overall Study|Not Dyspneic cough|1|||
23714139|NCT02932332|66325598|FG003|Overall Study|Not Dyspneic cough|0|||
23714140|NCT00165646|66325599|FG000|Overall Study|Adverse Event|1|||
23714141|NCT00165646|66325600|FG001|Overall Study|Adverse Event|1|||
23714142|NCT00165646|66325601|FG002|Overall Study|Adverse Event|1|||
23714143|NCT00165646|66325599|FG000|Overall Study|Lack of Efficacy|1|||
23714144|NCT00165646|66325600|FG001|Overall Study|Lack of Efficacy|2|||
23714145|NCT00165646|66325601|FG002|Overall Study|Lack of Efficacy|0|||
23714146|NCT00165646|66325599|FG000|Overall Study|Withdrawal by Subject|0|||
23714147|NCT00165646|66325600|FG001|Overall Study|Withdrawal by Subject|2|||
23714148|NCT00165646|66325601|FG002|Overall Study|Withdrawal by Subject|1|||
23812096|NCT02516553|66691892|FG017|Overall Study|other reasons than listed|0|||
23812097|NCT02516553|66691893|FG018|Overall Study|other reasons than listed|0|||
23714149|NCT00165646|66325599|FG000|Overall Study|Physician Decision|2|||
23714150|NCT00165646|66325600|FG001|Overall Study|Physician Decision|0|||
23714151|NCT00165646|66325601|FG002|Overall Study|Physician Decision|2|||
23714152|NCT00165646|66325599|FG000|Overall Study|Protocol Violation|1|||
23714153|NCT00165646|66325600|FG001|Overall Study|Protocol Violation|0|||
23714154|NCT00165646|66325601|FG002|Overall Study|Protocol Violation|0|||
23812098|NCT02516553|66691894|FG019|Overall Study|other reasons than listed|0|||
23812099|NCT02516553|66691895|FG020|Overall Study|other reasons than listed|2|||
23812100|NCT02516553|66691896|FG021|Overall Study|other reasons than listed|2|||
23521872|NCT02641379|65650614|FG008|Overall Study|PCR positive at follow up 2|0|||
23714155|NCT00831441|66325602|FG000|Randomized|Death|82|||
23714156|NCT00831441|66325603|FG001|Randomized|Death|81|||
23714157|NCT00831441|66325602|FG000|Randomized|Adverse Event|248|||
23714158|NCT00831441|66325603|FG001|Randomized|Adverse Event|321|||
23714159|NCT00831441|66325602|FG000|Randomized|Emergency procedure|2|||
23714160|NCT00831441|66325603|FG001|Randomized|Emergency procedure|2|||
23714161|NCT00831441|66325602|FG000|Randomized|Elective procedure|26|||
23812101|NCT02585934|66691897|FG000|Overall Study|Lost to Follow-up|2|||
23521873|NCT02641379|65650615|FG009|Overall Study|PCR positive at follow up 2|0|||
23521874|NCT02641379|65650616|FG010|Overall Study|PCR positive at follow up 2|0|||
23521875|NCT02641379|65650606|FG000|Overall Study|Participant showed relapse|1|||
23521876|NCT02641379|65650607|FG001|Overall Study|Participant showed relapse|0|||
23521877|NCT02641379|65650608|FG002|Overall Study|Participant showed relapse|0|||
23521878|NCT02641379|65650609|FG003|Overall Study|Participant showed relapse|0|||
23521879|NCT02641379|65650610|FG004|Overall Study|Participant showed relapse|0|||
23521880|NCT02641379|65650611|FG005|Overall Study|Participant showed relapse|0|||
23521881|NCT02641379|65650612|FG006|Overall Study|Participant showed relapse|1|||
23521882|NCT02641379|65650613|FG007|Overall Study|Participant showed relapse|0|||
23521883|NCT02641379|65650614|FG008|Overall Study|Participant showed relapse|0|||
23521884|NCT02641379|65650615|FG009|Overall Study|Participant showed relapse|0|||
23521885|NCT02641379|65650616|FG010|Overall Study|Participant showed relapse|0|||
23521886|NCT02641379|65650606|FG000|Overall Study|Participant stopped study/treatment|1|||
23521887|NCT02641379|65650607|FG001|Overall Study|Participant stopped study/treatment|3|||
23521888|NCT02641379|65650608|FG002|Overall Study|Participant stopped study/treatment|1|||
23521889|NCT02641379|65650609|FG003|Overall Study|Participant stopped study/treatment|0|||
23521890|NCT02641379|65650610|FG004|Overall Study|Participant stopped study/treatment|0|||
23521891|NCT02641379|65650611|FG005|Overall Study|Participant stopped study/treatment|1|||
23521892|NCT02641379|65650612|FG006|Overall Study|Participant stopped study/treatment|2|||
23521893|NCT02641379|65650613|FG007|Overall Study|Participant stopped study/treatment|0|||
23521894|NCT02641379|65650614|FG008|Overall Study|Participant stopped study/treatment|1|||
23521895|NCT02641379|65650615|FG009|Overall Study|Participant stopped study/treatment|0|||
23521896|NCT02641379|65650616|FG010|Overall Study|Participant stopped study/treatment|0|||
23521897|NCT02641379|65650606|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
23521898|NCT02641379|65650607|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
23521899|NCT02641379|65650608|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
23521900|NCT02641379|65650609|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
23521901|NCT02641379|65650610|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
23521902|NCT02641379|65650611|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
23521903|NCT02641379|65650612|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
23521904|NCT02641379|65650613|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
23521905|NCT02641379|65650614|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
23521906|NCT02641379|65650615|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
23521907|NCT02641379|65650616|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
23521908|NCT02641379|65650606|FG000|Overall Study|Financial problems|0|||
23521909|NCT02641379|65650607|FG001|Overall Study|Financial problems|1|||
23521910|NCT02641379|65650608|FG002|Overall Study|Financial problems|0|||
23521911|NCT02641379|65650609|FG003|Overall Study|Financial problems|0|||
23521912|NCT02641379|65650610|FG004|Overall Study|Financial problems|0|||
23521913|NCT02641379|65650611|FG005|Overall Study|Financial problems|0|||
23521914|NCT02641379|65650612|FG006|Overall Study|Financial problems|0|||
23521915|NCT02641379|65650613|FG007|Overall Study|Financial problems|0|||
23521916|NCT02641379|65650614|FG008|Overall Study|Financial problems|0|||
23521917|NCT02641379|65650615|FG009|Overall Study|Financial problems|0|||
23521918|NCT02641379|65650616|FG010|Overall Study|Financial problems|0|||
23521919|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 68|0|||
23521920|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 68|1|||
23521921|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 68|0|||
23521922|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 68|0|||
23521923|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 68|0|||
23521924|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 68|0|||
23521925|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 68|0|||
23521926|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 68|0|||
23521927|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 68|0|||
23521928|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 68|0|||
23521929|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 68|0|||
23521930|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 48|0|||
23521931|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 48|1|||
23521932|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 48|0|||
23521933|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 48|0|||
23521934|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 48|0|||
23521935|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 48|0|||
23521936|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 48|0|||
23521937|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 48|0|||
23521938|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 48|0|||
23521939|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 48|0|||
23521940|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 48|0|||
23521941|NCT02641379|65650606|FG000|Overall Study|PCR not performed at Week 12|0|||
23521942|NCT02641379|65650607|FG001|Overall Study|PCR not performed at Week 12|0|||
23521943|NCT02641379|65650608|FG002|Overall Study|PCR not performed at Week 12|1|||
23521944|NCT02641379|65650609|FG003|Overall Study|PCR not performed at Week 12|0|||
23521945|NCT02641379|65650610|FG004|Overall Study|PCR not performed at Week 12|0|||
23521946|NCT02641379|65650611|FG005|Overall Study|PCR not performed at Week 12|0|||
23521947|NCT02641379|65650612|FG006|Overall Study|PCR not performed at Week 12|0|||
23812102|NCT02585934|66691898|FG001|Overall Study|Lost to Follow-up|2|||
23812103|NCT02585934|66691897|FG000|Overall Study|Protocol Violation|14|||
23812104|NCT02585934|66691898|FG001|Overall Study|Protocol Violation|11|||
23812105|NCT02585934|66691897|FG000|Overall Study|Adverse Event|21|||
23812106|NCT02585934|66691898|FG001|Overall Study|Adverse Event|22|||
23812107|NCT02585934|66691897|FG000|Overall Study|Physician Decision|3|||
23812108|NCT02585934|66691898|FG001|Overall Study|Physician Decision|2|||
23812109|NCT02585934|66691897|FG000|Overall Study|Withdrawal by Subject|7|||
23812110|NCT02585934|66691898|FG001|Overall Study|Withdrawal by Subject|21|||
23812111|NCT02585934|66691897|FG000|Overall Study|Lack of Efficacy|2|||
23812112|NCT02585934|66691898|FG001|Overall Study|Lack of Efficacy|1|||
23812113|NCT02585934|66691897|FG000|Overall Study|Death|2|||
23812114|NCT02585934|66691898|FG001|Overall Study|Death|0|||
23812115|NCT02585934|66691897|FG000|Overall Study|Caregiver Withdrew Consent|7|||
23812116|NCT02585934|66691898|FG001|Overall Study|Caregiver Withdrew Consent|7|||
23521948|NCT02641379|65650613|FG007|Overall Study|PCR not performed at Week 12|0|||
23521949|NCT02641379|65650614|FG008|Overall Study|PCR not performed at Week 12|0|||
23521950|NCT02641379|65650615|FG009|Overall Study|PCR not performed at Week 12|0|||
23521951|NCT02641379|65650616|FG010|Overall Study|PCR not performed at Week 12|0|||
23521952|NCT02641379|65650606|FG000|Overall Study|No PCR at baseline|0|||
23521953|NCT02641379|65650607|FG001|Overall Study|No PCR at baseline|0|||
23521954|NCT02641379|65650608|FG002|Overall Study|No PCR at baseline|1|||
23521955|NCT02641379|65650609|FG003|Overall Study|No PCR at baseline|0|||
23521956|NCT02641379|65650610|FG004|Overall Study|No PCR at baseline|0|||
23521957|NCT02641379|65650611|FG005|Overall Study|No PCR at baseline|0|||
23521958|NCT02641379|65650612|FG006|Overall Study|No PCR at baseline|0|||
23521959|NCT02641379|65650613|FG007|Overall Study|No PCR at baseline|0|||
23521960|NCT02641379|65650614|FG008|Overall Study|No PCR at baseline|0|||
23521961|NCT02641379|65650615|FG009|Overall Study|No PCR at baseline|0|||
23521962|NCT02641379|65650616|FG010|Overall Study|No PCR at baseline|0|||
23521963|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 28|0|||
23521964|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 28|0|||
23521965|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 28|1|||
23521966|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 28|0|||
23521967|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 28|0|||
23521968|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 28|0|||
23521969|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 28|0|||
23521970|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 28|0|||
23521971|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 28|0|||
23521972|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 28|0|||
23521973|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 28|0|||
23521974|NCT02641379|65650606|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
23521975|NCT02641379|65650607|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
23521976|NCT02641379|65650608|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
23521977|NCT02641379|65650609|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
23521978|NCT02641379|65650610|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
23521979|NCT02641379|65650611|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
23521980|NCT02641379|65650612|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
23521981|NCT02641379|65650613|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
23521982|NCT02641379|65650614|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
23521983|NCT02641379|65650615|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
23714162|NCT00831441|66325603|FG001|Randomized|Elective procedure|25|||
23714163|NCT00831441|66325602|FG000|Randomized|Physician Decision|26|||
23714164|NCT00831441|66325603|FG001|Randomized|Physician Decision|35|||
23714165|NCT00831441|66325602|FG000|Randomized|No longer met criteria|13|||
23714166|NCT00831441|66325603|FG001|Randomized|No longer met criteria|19|||
23714167|NCT00831441|66325602|FG000|Randomized|Withdrawal by Subject|178|||
23714168|NCT00831441|66325603|FG001|Randomized|Withdrawal by Subject|212|||
23714169|NCT00831441|66325602|FG000|Randomized|Lost to Follow-up|26|||
23714170|NCT00831441|66325603|FG001|Randomized|Lost to Follow-up|35|||
23714171|NCT00831441|66325602|FG000|Randomized|Administrative reason by sponsor|2780|||
23812117|NCT02585934|66691897|FG000|Overall Study|Sponsor Termination|1|||
23521984|NCT02641379|65650616|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
23714172|NCT00831441|66325603|FG001|Randomized|Administrative reason by sponsor|2671|||
23812118|NCT02585934|66691898|FG001|Overall Study|Sponsor Termination|2|||
23812119|NCT02585934|66691897|FG000|Overall Study|Another Reason|10|||
23521985|NCT02641379|65650606|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
23521986|NCT02641379|65650607|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
23521987|NCT02641379|65650608|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
23521988|NCT02641379|65650609|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
23521989|NCT02641379|65650610|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
23521990|NCT02641379|65650611|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
23521991|NCT02641379|65650612|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
23521992|NCT02641379|65650613|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
23521993|NCT02641379|65650614|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
23521994|NCT02641379|65650615|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
23521995|NCT02641379|65650616|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
23521996|NCT02641379|65650606|FG000|Overall Study|Baseline viral load unavailable|0|||
23521997|NCT02641379|65650607|FG001|Overall Study|Baseline viral load unavailable|0|||
23521998|NCT02641379|65650608|FG002|Overall Study|Baseline viral load unavailable|0|||
23521999|NCT02641379|65650609|FG003|Overall Study|Baseline viral load unavailable|1|||
23522000|NCT02641379|65650610|FG004|Overall Study|Baseline viral load unavailable|0|||
23522001|NCT02641379|65650611|FG005|Overall Study|Baseline viral load unavailable|0|||
23522002|NCT02641379|65650612|FG006|Overall Study|Baseline viral load unavailable|0|||
23522003|NCT02641379|65650613|FG007|Overall Study|Baseline viral load unavailable|0|||
23522004|NCT02641379|65650614|FG008|Overall Study|Baseline viral load unavailable|0|||
23522005|NCT02641379|65650615|FG009|Overall Study|Baseline viral load unavailable|0|||
23522006|NCT02641379|65650616|FG010|Overall Study|Baseline viral load unavailable|0|||
23522007|NCT02641379|65650606|FG000|Overall Study|Blood could not be drawn|0|||
23522008|NCT02641379|65650607|FG001|Overall Study|Blood could not be drawn|0|||
23522009|NCT02641379|65650608|FG002|Overall Study|Blood could not be drawn|0|||
23522010|NCT02641379|65650609|FG003|Overall Study|Blood could not be drawn|0|||
23522011|NCT02641379|65650610|FG004|Overall Study|Blood could not be drawn|1|||
23522012|NCT02641379|65650611|FG005|Overall Study|Blood could not be drawn|0|||
23522013|NCT02641379|65650612|FG006|Overall Study|Blood could not be drawn|0|||
23522014|NCT02641379|65650613|FG007|Overall Study|Blood could not be drawn|0|||
23522015|NCT02641379|65650614|FG008|Overall Study|Blood could not be drawn|0|||
23522016|NCT02641379|65650615|FG009|Overall Study|Blood could not be drawn|0|||
23522017|NCT02641379|65650616|FG010|Overall Study|Blood could not be drawn|0|||
23522018|NCT02641379|65650606|FG000|Overall Study|Protocol Violation|0|||
23522019|NCT02641379|65650607|FG001|Overall Study|Protocol Violation|0|||
23522020|NCT02641379|65650608|FG002|Overall Study|Protocol Violation|0|||
23522021|NCT02641379|65650609|FG003|Overall Study|Protocol Violation|0|||
23522022|NCT02641379|65650610|FG004|Overall Study|Protocol Violation|2|||
23522023|NCT02641379|65650611|FG005|Overall Study|Protocol Violation|0|||
23522024|NCT02641379|65650612|FG006|Overall Study|Protocol Violation|0|||
23522025|NCT02641379|65650613|FG007|Overall Study|Protocol Violation|0|||
23522026|NCT02641379|65650614|FG008|Overall Study|Protocol Violation|1|||
23522027|NCT02641379|65650615|FG009|Overall Study|Protocol Violation|0|||
23522028|NCT02641379|65650616|FG010|Overall Study|Protocol Violation|0|||
23522029|NCT02641379|65650606|FG000|Overall Study|Participation in sili rescue study|0|||
23522030|NCT02641379|65650607|FG001|Overall Study|Participation in sili rescue study|0|||
23522031|NCT02641379|65650608|FG002|Overall Study|Participation in sili rescue study|0|||
23522032|NCT02641379|65650609|FG003|Overall Study|Participation in sili rescue study|0|||
23522033|NCT02641379|65650610|FG004|Overall Study|Participation in sili rescue study|0|||
23522034|NCT02641379|65650611|FG005|Overall Study|Participation in sili rescue study|1|||
23522035|NCT02641379|65650612|FG006|Overall Study|Participation in sili rescue study|0|||
23522036|NCT02641379|65650613|FG007|Overall Study|Participation in sili rescue study|0|||
23522037|NCT02641379|65650614|FG008|Overall Study|Participation in sili rescue study|0|||
23522038|NCT02641379|65650615|FG009|Overall Study|Participation in sili rescue study|0|||
23522039|NCT02641379|65650616|FG010|Overall Study|Participation in sili rescue study|0|||
23522040|NCT02641379|65650606|FG000|Overall Study|Lost to Follow-up|0|||
23522041|NCT02641379|65650607|FG001|Overall Study|Lost to Follow-up|0|||
23522042|NCT02641379|65650608|FG002|Overall Study|Lost to Follow-up|0|||
23522043|NCT02641379|65650609|FG003|Overall Study|Lost to Follow-up|0|||
23522044|NCT02641379|65650610|FG004|Overall Study|Lost to Follow-up|0|||
23522045|NCT02641379|65650611|FG005|Overall Study|Lost to Follow-up|0|||
23522046|NCT02641379|65650612|FG006|Overall Study|Lost to Follow-up|0|||
23522047|NCT02641379|65650613|FG007|Overall Study|Lost to Follow-up|0|||
23522048|NCT02641379|65650614|FG008|Overall Study|Lost to Follow-up|1|||
23522049|NCT02641379|65650615|FG009|Overall Study|Lost to Follow-up|0|||
23522050|NCT02641379|65650616|FG010|Overall Study|Lost to Follow-up|0|||
23522051|NCT02641379|65650606|FG000|Overall Study|Source data not found|0|||
23522052|NCT02641379|65650607|FG001|Overall Study|Source data not found|0|||
23522053|NCT02641379|65650608|FG002|Overall Study|Source data not found|0|||
23522054|NCT02641379|65650609|FG003|Overall Study|Source data not found|0|||
23522055|NCT02641379|65650610|FG004|Overall Study|Source data not found|0|||
23522056|NCT02641379|65650611|FG005|Overall Study|Source data not found|1|||
23522057|NCT02641379|65650612|FG006|Overall Study|Source data not found|0|||
23522058|NCT02641379|65650613|FG007|Overall Study|Source data not found|0|||
23522059|NCT02641379|65650614|FG008|Overall Study|Source data not found|0|||
23812120|NCT02585934|66691898|FG001|Overall Study|Another Reason|5|||
23812121|NCT01284621|66691900|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23812122|NCT01284621|66691901|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23812123|NCT01284621|66691902|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23522060|NCT02641379|65650615|FG009|Overall Study|Source data not found|0|||
23522061|NCT02641379|65650616|FG010|Overall Study|Source data not found|0|||
23522062|NCT02641379|65650606|FG000|Overall Study|Participant showed weight reduction|0|||
23522063|NCT02641379|65650607|FG001|Overall Study|Participant showed weight reduction|0|||
23522064|NCT02641379|65650608|FG002|Overall Study|Participant showed weight reduction|0|||
23522065|NCT02641379|65650609|FG003|Overall Study|Participant showed weight reduction|0|||
23522066|NCT02641379|65650610|FG004|Overall Study|Participant showed weight reduction|0|||
23522067|NCT02641379|65650611|FG005|Overall Study|Participant showed weight reduction|0|||
23522068|NCT02641379|65650612|FG006|Overall Study|Participant showed weight reduction|0|||
23522069|NCT02641379|65650613|FG007|Overall Study|Participant showed weight reduction|1|||
23522070|NCT02641379|65650614|FG008|Overall Study|Participant showed weight reduction|0|||
23522071|NCT02641379|65650615|FG009|Overall Study|Participant showed weight reduction|0|||
23522072|NCT02641379|65650616|FG010|Overall Study|Participant showed weight reduction|0|||
23522073|NCT02641379|65650606|FG000|Overall Study|Non-response Week 12|0|||
23522074|NCT02641379|65650607|FG001|Overall Study|Non-response Week 12|0|||
23522075|NCT02641379|65650608|FG002|Overall Study|Non-response Week 12|0|||
23522076|NCT02641379|65650609|FG003|Overall Study|Non-response Week 12|0|||
23522077|NCT02641379|65650610|FG004|Overall Study|Non-response Week 12|0|||
23522078|NCT02641379|65650611|FG005|Overall Study|Non-response Week 12|0|||
23522079|NCT02641379|65650612|FG006|Overall Study|Non-response Week 12|0|||
23522080|NCT02641379|65650613|FG007|Overall Study|Non-response Week 12|1|||
23522081|NCT02641379|65650614|FG008|Overall Study|Non-response Week 12|0|||
23522082|NCT02641379|65650615|FG009|Overall Study|Non-response Week 12|0|||
23522083|NCT02641379|65650616|FG010|Overall Study|Non-response Week 12|0|||
23522084|NCT02641379|65650606|FG000|Overall Study|No 2 Log drop at Week 12|0|||
23522085|NCT02641379|65650607|FG001|Overall Study|No 2 Log drop at Week 12|0|||
23522086|NCT02641379|65650608|FG002|Overall Study|No 2 Log drop at Week 12|0|||
23522087|NCT02641379|65650609|FG003|Overall Study|No 2 Log drop at Week 12|0|||
23522088|NCT02641379|65650610|FG004|Overall Study|No 2 Log drop at Week 12|0|||
23522089|NCT02641379|65650611|FG005|Overall Study|No 2 Log drop at Week 12|0|||
23522090|NCT02641379|65650612|FG006|Overall Study|No 2 Log drop at Week 12|0|||
23522091|NCT02641379|65650613|FG007|Overall Study|No 2 Log drop at Week 12|0|||
23522092|NCT02641379|65650614|FG008|Overall Study|No 2 Log drop at Week 12|0|||
23522093|NCT02641379|65650615|FG009|Overall Study|No 2 Log drop at Week 12|0|||
23522094|NCT02641379|65650616|FG010|Overall Study|No 2 Log drop at Week 12|1|||
23522095|NCT02641379|65650606|FG000|Overall Study|Negative PCR result|0|||
23522096|NCT02641379|65650607|FG001|Overall Study|Negative PCR result|0|||
23522097|NCT02641379|65650608|FG002|Overall Study|Negative PCR result|0|||
23522098|NCT02641379|65650609|FG003|Overall Study|Negative PCR result|0|||
23522099|NCT02641379|65650610|FG004|Overall Study|Negative PCR result|0|||
23522100|NCT02641379|65650611|FG005|Overall Study|Negative PCR result|0|||
23522101|NCT02641379|65650612|FG006|Overall Study|Negative PCR result|0|||
23522102|NCT02641379|65650613|FG007|Overall Study|Negative PCR result|0|||
23522103|NCT02641379|65650614|FG008|Overall Study|Negative PCR result|0|||
23522104|NCT02641379|65650615|FG009|Overall Study|Negative PCR result|1|||
23522105|NCT02641379|65650616|FG010|Overall Study|Negative PCR result|0|||
23522106|NCT02641379|65650606|FG000|Overall Study|Participant's PCR high|0|||
23522107|NCT02641379|65650607|FG001|Overall Study|Participant's PCR high|0|||
23522108|NCT02641379|65650608|FG002|Overall Study|Participant's PCR high|0|||
23522109|NCT02641379|65650609|FG003|Overall Study|Participant's PCR high|0|||
23522110|NCT02641379|65650610|FG004|Overall Study|Participant's PCR high|0|||
23522111|NCT02641379|65650611|FG005|Overall Study|Participant's PCR high|0|||
23611223|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23812124|NCT01284621|66691903|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23812125|NCT01284621|66691904|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
23812126|NCT01284621|66691905|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23812127|NCT04319718|66691906|FG000|Overall Study|Adverse Event|0|||
23522112|NCT02641379|65650612|FG006|Overall Study|Participant's PCR high|0|||
23522113|NCT02641379|65650613|FG007|Overall Study|Participant's PCR high|1|||
23522114|NCT02641379|65650614|FG008|Overall Study|Participant's PCR high|0|||
23522115|NCT02641379|65650615|FG009|Overall Study|Participant's PCR high|0|||
23522116|NCT02641379|65650616|FG010|Overall Study|Participant's PCR high|0|||
23522117|NCT02641379|65650606|FG000|Overall Study|Participant treated after Week 24|0|||
23522118|NCT02641379|65650607|FG001|Overall Study|Participant treated after Week 24|0|||
23522119|NCT02641379|65650608|FG002|Overall Study|Participant treated after Week 24|0|||
23522120|NCT02641379|65650609|FG003|Overall Study|Participant treated after Week 24|0|||
23522121|NCT02641379|65650610|FG004|Overall Study|Participant treated after Week 24|0|||
23522122|NCT02641379|65650611|FG005|Overall Study|Participant treated after Week 24|0|||
23812128|NCT04319718|66691907|FG001|Overall Study|Adverse Event|2|||
23812129|NCT04319718|66691906|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
23812130|NCT04319718|66691907|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
23812131|NCT00372411|66691916|FG000|Overall Study|Withdrawal by Subject|3|||
23812132|NCT00372411|66691917|FG001|Overall Study|Withdrawal by Subject|4|||
23812133|NCT00372411|66691918|FG002|Overall Study|Withdrawal by Subject|1|||
23812134|NCT00372411|66691916|FG000|Overall Study|Death|0|||
23812135|NCT00372411|66691917|FG001|Overall Study|Death|2|||
23812136|NCT00372411|66691918|FG002|Overall Study|Death|1|||
23812137|NCT00372411|66691916|FG000|Overall Study|Lost to Follow-up|1|||
23812138|NCT00372411|66691917|FG001|Overall Study|Lost to Follow-up|1|||
23522123|NCT02641379|65650612|FG006|Overall Study|Participant treated after Week 24|0|||
23522124|NCT02641379|65650613|FG007|Overall Study|Participant treated after Week 24|0|||
23522125|NCT02641379|65650614|FG008|Overall Study|Participant treated after Week 24|1|||
23522126|NCT02641379|65650615|FG009|Overall Study|Participant treated after Week 24|0|||
23522127|NCT02641379|65650616|FG010|Overall Study|Participant treated after Week 24|0|||
23522128|NCT02641379|65650606|FG000|Overall Study|Missing PCR result at Week 8|0|||
23522129|NCT02641379|65650607|FG001|Overall Study|Missing PCR result at Week 8|0|||
23522130|NCT02641379|65650608|FG002|Overall Study|Missing PCR result at Week 8|0|||
23522131|NCT02641379|65650609|FG003|Overall Study|Missing PCR result at Week 8|0|||
23522132|NCT02641379|65650610|FG004|Overall Study|Missing PCR result at Week 8|0|||
23522133|NCT02641379|65650611|FG005|Overall Study|Missing PCR result at Week 8|0|||
23522134|NCT02641379|65650612|FG006|Overall Study|Missing PCR result at Week 8|0|||
23522135|NCT02641379|65650613|FG007|Overall Study|Missing PCR result at Week 8|0|||
23522136|NCT02641379|65650614|FG008|Overall Study|Missing PCR result at Week 8|0|||
23522137|NCT02641379|65650615|FG009|Overall Study|Missing PCR result at Week 8|1|||
23522138|NCT02641379|65650616|FG010|Overall Study|Missing PCR result at Week 8|0|||
23522139|NCT02641379|65650606|FG000|Overall Study|PCR positive|0|||
23522140|NCT02641379|65650607|FG001|Overall Study|PCR positive|0|||
23522141|NCT02641379|65650608|FG002|Overall Study|PCR positive|0|||
23522142|NCT02641379|65650609|FG003|Overall Study|PCR positive|0|||
23522143|NCT02641379|65650610|FG004|Overall Study|PCR positive|0|||
23522144|NCT02641379|65650611|FG005|Overall Study|PCR positive|0|||
23522145|NCT02641379|65650612|FG006|Overall Study|PCR positive|1|||
23522146|NCT02641379|65650613|FG007|Overall Study|PCR positive|0|||
23522147|NCT02641379|65650614|FG008|Overall Study|PCR positive|0|||
23522148|NCT02641379|65650615|FG009|Overall Study|PCR positive|0|||
23522149|NCT02641379|65650616|FG010|Overall Study|PCR positive|0|||
23522150|NCT02436759|65650617|FG000|Overall Study|Adverse Event|3|||
23522151|NCT02436759|65650618|FG001|Overall Study|Adverse Event|0|||
23522152|NCT02436759|65650617|FG000|Overall Study|Protocol Violation|1|||
23714173|NCT00831441|66325602|FG000|Randomized|poor/non-compliance|30|||
23714174|NCT00831441|66325603|FG001|Randomized|poor/non-compliance|38|||
23714175|NCT00831441|66325602|FG000|Randomized|non-specified|276|||
23714176|NCT00831441|66325603|FG001|Randomized|non-specified|266|||
23714177|NCT00831441|66325602|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
23714178|NCT00831441|66325603|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
23714179|NCT00831441|66325602|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
23714180|NCT00831441|66325603|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
23714181|NCT00831441|66325602|FG000|Follow Up (30 Days)|Death|63|||
23714182|NCT00831441|66325603|FG001|Follow Up (30 Days)|Death|86|||
23714183|NCT00831441|66325602|FG000|Follow Up (30 Days)|non-specified|16|||
23714184|NCT00831441|66325603|FG001|Follow Up (30 Days)|non-specified|26|||
23714185|NCT00831441|66325602|FG000|Follow Up (30 Days)|missing end of study status|0|||
23714186|NCT00831441|66325603|FG001|Follow Up (30 Days)|missing end of study status|1|||
23714187|NCT03558555|66325604|FG000|Overall Study|Lost to Follow-up|2|||
23714188|NCT03558555|66325605|FG001|Overall Study|Lost to Follow-up|1|||
23714189|NCT03198754|66325608|FG000|Overall Study|Withdrawal by Subject|5|||
23714190|NCT03198754|66325609|FG001|Overall Study|Withdrawal by Subject|4|||
23714191|NCT03198754|66325608|FG000|Overall Study|Lost to Follow-up|4|||
23714192|NCT03198754|66325609|FG001|Overall Study|Lost to Follow-up|3|||
23714193|NCT03198754|66325608|FG000|Overall Study|Ineligible|2|||
23714194|NCT03198754|66325609|FG001|Overall Study|Ineligible|1|||
23714195|NCT01592409|66325610|FG000|Overall Study|Withdrawal by Subject|0|||
23714196|NCT01592409|66325611|FG001|Overall Study|Withdrawal by Subject|1|||
23714197|NCT00642746|66325612|FG000|Overall Study|Patient unevaluable|1|||
23714198|NCT00642746|66325613|FG001|Overall Study|Patient unevaluable|0|||
23812139|NCT00372411|66691918|FG002|Overall Study|Lost to Follow-up|1|||
23812140|NCT00372411|66691916|FG000|Overall Study|Adverse Event|1|||
23812141|NCT00372411|66691917|FG001|Overall Study|Adverse Event|1|||
23522153|NCT02436759|65650618|FG001|Overall Study|Protocol Violation|0|||
23522154|NCT02436759|65650617|FG000|Overall Study|Withdrawal by Subject|0|||
23714199|NCT00675103|66325618|FG000|Overall Study|Lack of Efficacy|2|||
23714200|NCT00675103|66325618|FG000|Overall Study|Adverse Event|1|||
23714201|NCT00264849|66325622|FG000|Overall Study|Adverse Event|7|||
23714202|NCT00264849|66325623|FG001|Overall Study|Adverse Event|2|||
23522155|NCT02436759|65650618|FG001|Overall Study|Withdrawal by Subject|1|||
23522156|NCT02281552|65650623|FG000|Overall Study|Medication error|1|||
23522157|NCT02281552|65650624|FG001|Overall Study|Medication error|0|||
23522158|NCT02281552|65650623|FG000|Overall Study|Insufficient clinical response|0|||
23522159|NCT02281552|65650624|FG001|Overall Study|Insufficient clinical response|1|||
23522160|NCT02281552|65650623|FG000|Overall Study|Adverse Event|3|||
23522161|NCT02281552|65650624|FG001|Overall Study|Adverse Event|9|||
23522162|NCT00573755|65650629|FG000|Overall Study|Still receiving treatment|1|||
23522163|NCT00573755|65650630|FG001|Overall Study|Still receiving treatment|0|||
23522164|NCT00480779|65650636|FG000|Overall Study|Other|2|||
23522165|NCT00480779|65650637|FG001|Overall Study|Other|0|||
23522166|NCT00480779|65650636|FG000|Overall Study|Job and Health-related|0|||
23522167|NCT00480779|65650637|FG001|Overall Study|Job and Health-related|3|||
23522168|NCT01859507|65650638|FG000|Overall Study|left the country|4|||
23522169|NCT02519712|65650639|FG000|Overall Study|Disease Relapse|1|||
23522170|NCT02519712|65650639|FG000|Overall Study|Disease Progression|1|||
23522171|NCT02519712|65650639|FG000|Overall Study|Accruals are donors|2|||
23522172|NCT00896337|65650640|FG000|Overall Study|Death|7|||
23522173|NCT00896337|65650640|FG000|Overall Study|Withdrawal by Subject|7|||
23522174|NCT00896337|65650640|FG000|Overall Study|Lost to Follow-up|11|||
23522175|NCT02276612|65650643|FG000|Overall Study|Death|1|||
23522176|NCT02276612|65650644|FG001|Overall Study|Death|0|||
23522177|NCT02276612|65650643|FG000|Overall Study|Pregnancy|1|||
23522178|NCT02276612|65650644|FG001|Overall Study|Pregnancy|0|||
23522179|NCT02276612|65650643|FG000|Overall Study|Withdrew Consent|1|||
23522180|NCT02276612|65650644|FG001|Overall Study|Withdrew Consent|0|||
23522181|NCT02276612|65650643|FG000|Overall Study|Lost to Follow-up|1|||
23522182|NCT02276612|65650644|FG001|Overall Study|Lost to Follow-up|0|||
23522183|NCT00026793|65650646|FG000|Overall Study|Death on study due to underlying disease|4|||
23522184|NCT00026793|65650646|FG000|Overall Study|Physician Decision|2|||
23522185|NCT00026793|65650646|FG000|Overall Study|Off study|2|||
23522186|NCT04356963|65650647|FG000|First Session|Withdrawal by Subject|1|||
23522187|NCT04356963|65650647|FG000|Second Session|Withdrawal by Subject|3|||
23522188|NCT04356963|65650647|FG000|Second Session|Lost to Follow-up|1|||
23522189|NCT04356963|65650647|FG000|Third Session|Lost to Follow-up|6|||
23522190|NCT04356963|65650647|FG000|Third Session|Withdrawal by Subject|1|||
23522191|NCT03724812|65650650|FG000|Overall Study|Missed Visit|1|||
23522192|NCT03724812|65650650|FG000|Overall Study|Death|2|||
23522193|NCT03724812|65650650|FG000|Overall Study|Withdrawal by Subject|1|||
23522194|NCT01574612|65650651|FG000|Overall Study|Adverse Event|3|||
23522195|NCT01574612|65650651|FG000|Overall Study|non compliant with drug|2|||
23522196|NCT01574612|65650651|FG000|Overall Study|Withdrawal by Subject|1|||
23522197|NCT01574612|65650651|FG000|Overall Study|Lost to Follow-up|2|||
23522198|NCT02295995|65650654|FG000|Overall Study|Lost to Follow-up|5|||
23522199|NCT02295995|65650655|FG001|Overall Study|Lost to Follow-up|1|||
23522200|NCT03999892|65650659|FG000|Overall Study|Lost to Follow-up|1|||
23522201|NCT03642717|65650660|FG000|Overall Study|Lost to Follow-up|2|||
23522202|NCT03642717|65650660|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
23522203|NCT03642717|65650660|FG000|Overall Study|Taken study drug prior to contract date|3|||
23522204|NCT01289847|65650663|FG000|Overall Study|Patient could not comply with visits|1|||
23522205|NCT04059146|65650664|FG000|Overall Study|Withdrawal by Subject|0|||
23522206|NCT04059146|65650665|FG001|Overall Study|Withdrawal by Subject|1|||
23522207|NCT01526889|65650667|FG000|Treatment Period|Adverse Event|2|||
23522208|NCT01526889|65650668|FG001|Treatment Period|Adverse Event|0|||
23522209|NCT01526889|65650667|FG000|Treatment Extension Period|Administrative problems|1|||
23522210|NCT01526889|65650668|FG001|Treatment Extension Period|Administrative problems|0|||
23522211|NCT01549964|65650669|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
23522212|NCT01549964|65650670|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
23522213|NCT01549964|65650671|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
23522214|NCT01549964|65650672|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
23522215|NCT01549964|65650669|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
23522216|NCT01549964|65650670|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
23522217|NCT01549964|65650671|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
23522218|NCT01549964|65650672|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
23522219|NCT01549964|65650669|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
23522220|NCT01549964|65650670|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522221|NCT01549964|65650671|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522222|NCT01549964|65650672|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522223|NCT01549964|65650669|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
23522224|NCT01549964|65650670|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
23522225|NCT01549964|65650671|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
23522226|NCT01549964|65650672|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
23522227|NCT01549964|65650669|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
23714203|NCT00264849|66325622|FG000|Overall Study|Withdrawal by Subject|7|||
23714204|NCT00264849|66325623|FG001|Overall Study|Withdrawal by Subject|11|||
23714205|NCT00264849|66325622|FG000|Overall Study|Protocol Violation|5|||
23714206|NCT00264849|66325623|FG001|Overall Study|Protocol Violation|3|||
23714207|NCT00264849|66325622|FG000|Overall Study|Lack of Efficacy|1|||
23714208|NCT00264849|66325623|FG001|Overall Study|Lack of Efficacy|6|||
23714209|NCT00264849|66325622|FG000|Overall Study|Lost to Follow-up|0|||
23714210|NCT00264849|66325623|FG001|Overall Study|Lost to Follow-up|2|||
23714211|NCT00264849|66325622|FG000|Overall Study|Death|0|||
23714212|NCT00264849|66325623|FG001|Overall Study|Death|1|||
23714213|NCT00264849|66325622|FG000|Overall Study|Administrative Problems|2|||
23714214|NCT00264849|66325623|FG001|Overall Study|Administrative Problems|0|||
23714215|NCT00592553|66325626|FG000|Overall Study|Protocol Noncompliance|1|||
23714216|NCT00592553|66325627|FG001|Overall Study|Protocol Noncompliance|0|||
23714217|NCT00592553|66325628|FG002|Overall Study|Protocol Noncompliance|0|||
23714218|NCT01208038|66325629|FG000|Overall Study|Withdrawal by Subject|1|||
23714219|NCT02855450|66325630|FG000|Overall Study|Adverse Event|1|||
23714220|NCT02855450|66325631|FG001|Overall Study|Adverse Event|0|||
23714221|NCT02855450|66325630|FG000|Overall Study|Lost to Follow-up|4|||
23714222|NCT02855450|66325631|FG001|Overall Study|Lost to Follow-up|0|||
23714223|NCT01303380|66325632|FG000|Overall Study|Lack of compliance to study procedures|1|||
23714224|NCT00311181|66325633|FG000|Overall Study|Final DFTs were not obtained|96|||
23714225|NCT01089582|66325634|FG000|Overall Study|Death|2|||
23714226|NCT01089582|66325634|FG000|Overall Study|Adverse Event|15|||
23714227|NCT01089582|66325634|FG000|Overall Study|Lost to Follow-up|8|||
23714228|NCT01089582|66325634|FG000|Overall Study|Other|4|||
23714229|NCT01089582|66325634|FG000|Overall Study|Withdrawal by Subject|1|||
23714230|NCT04543955|66325638|FG000|Overall Study|Company cancelled study|1|||
23714231|NCT04543955|66325639|FG001|Overall Study|Company cancelled study|0|||
23714232|NCT03722784|66325640|FG000|Overall Study|Withdrawal by Subject|1|||
23714233|NCT03722784|66325641|FG001|Overall Study|Withdrawal by Subject|0|||
23714234|NCT03722784|66325640|FG000|Overall Study|Physician Decision|1|||
23714235|NCT03722784|66325641|FG001|Overall Study|Physician Decision|1|||
23714236|NCT03722784|66325640|FG000|Overall Study|Protocol Violation|0|||
23714237|NCT03722784|66325641|FG001|Overall Study|Protocol Violation|1|||
23714238|NCT01956240|66325642|FG000|Overall Study|Lost to Follow-up|6|||
23714239|NCT01956240|66325643|FG001|Overall Study|Lost to Follow-up|20|||
23714240|NCT01956240|66325642|FG000|Overall Study|Adverse Event|17|||
23714241|NCT01956240|66325643|FG001|Overall Study|Adverse Event|4|||
23714242|NCT00844649|66325648|FG000|Overall Study|Progressive Disease|196|||
23714243|NCT00844649|66325649|FG001|Overall Study|Progressive Disease|245|||
23714244|NCT00844649|66325648|FG000|Overall Study|Adverse Event|128|||
23714245|NCT00844649|66325649|FG001|Overall Study|Adverse Event|73|||
23714246|NCT00844649|66325648|FG000|Overall Study|Physician Decision|25|||
23522228|NCT01549964|65650670|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
23522229|NCT01549964|65650671|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
23522230|NCT01549964|65650672|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
23522231|NCT01549964|65650669|FG000|24-Week Treatment Period|Other|1|||
23522232|NCT01549964|65650670|FG001|24-Week Treatment Period|Other|0|||
23522233|NCT01549964|65650671|FG002|24-Week Treatment Period|Other|1|||
23714247|NCT00844649|66325649|FG001|Overall Study|Physician Decision|18|||
23714248|NCT00844649|66325648|FG000|Overall Study|Protocol Violation|10|||
23714249|NCT00844649|66325649|FG001|Overall Study|Protocol Violation|6|||
23714250|NCT00844649|66325648|FG000|Overall Study|Withdrawal by Subject|28|||
23714251|NCT00844649|66325649|FG001|Overall Study|Withdrawal by Subject|39|||
23714252|NCT00844649|66325648|FG000|Overall Study|Other|7|||
23522234|NCT01549964|65650672|FG003|24-Week Treatment Period|Other|0|||
23714253|NCT00844649|66325649|FG001|Overall Study|Other|10|||
23714254|NCT00844649|66325648|FG000|Overall Study|Withdrew prior to starting treatment|11|||
23714255|NCT00844649|66325649|FG001|Overall Study|Withdrew prior to starting treatment|27|||
23714256|NCT02808312|66325650|FG000|Overall Study|Enrolled but Never Treated|0|||
23714257|NCT02808312|66325651|FG001|Overall Study|Enrolled but Never Treated|0|||
23714258|NCT02808312|66325652|FG002|Overall Study|Enrolled but Never Treated|1|||
23714259|NCT02808312|66325653|FG003|Overall Study|Enrolled but Never Treated|0|||
23714260|NCT02808312|66325654|FG004|Overall Study|Enrolled but Never Treated|0|||
23714261|NCT02208024|66325655|FG000|Overall Study|Withdrawal by Subject|1|||
23714262|NCT01740388|66325657|FG000|Overall Study|Withdrawal by Subject|1|||
23714263|NCT01740388|66325658|FG001|Overall Study|Withdrawal by Subject|2|||
23714264|NCT01740388|66325657|FG000|Overall Study|Lost to Follow-up|2|||
23714265|NCT01740388|66325658|FG001|Overall Study|Lost to Follow-up|0|||
23714266|NCT01740388|66325657|FG000|Overall Study|Physician Decision|2|||
23714267|NCT01740388|66325658|FG001|Overall Study|Physician Decision|6|||
23714268|NCT01740388|66325657|FG000|Overall Study|Subjects missing data, completed|41|||
23714269|NCT01740388|66325658|FG001|Overall Study|Subjects missing data, completed|36|||
23714270|NCT03730194|66329427|FG000|First Stage Treatment|Withdrawal by Subject|1|||
23714271|NCT03730194|66329428|FG001|First Stage Treatment|Withdrawal by Subject|1|||
23714272|NCT03730194|66329429|FG002|First Stage Treatment|Withdrawal by Subject|0|||
23714273|NCT03730194|66329430|FG003|First Stage Treatment|Withdrawal by Subject|0|||
23714274|NCT03730194|66329431|FG004|First Stage Treatment|Withdrawal by Subject|0|||
23714275|NCT03730194|66329432|FG005|First Stage Treatment|Withdrawal by Subject|0|||
23714276|NCT03730194|66329427|FG000|First Stage Treatment|Protocol Violation|3|||
23714277|NCT03730194|66329428|FG001|First Stage Treatment|Protocol Violation|3|||
23714278|NCT03730194|66329429|FG002|First Stage Treatment|Protocol Violation|0|||
23714279|NCT03730194|66329430|FG003|First Stage Treatment|Protocol Violation|0|||
23714280|NCT03730194|66329431|FG004|First Stage Treatment|Protocol Violation|0|||
23714281|NCT03730194|66329432|FG005|First Stage Treatment|Protocol Violation|0|||
23714282|NCT01309841|66329433|FG000|Overall Study|Other|0|||
23714283|NCT01309841|66329434|FG001|Overall Study|Other|1|||
23714284|NCT01309841|66329435|FG002|Overall Study|Other|1|||
23714285|NCT01309841|66329433|FG000|Overall Study|Lost to Follow-up|7|||
23714286|NCT01309841|66329434|FG001|Overall Study|Lost to Follow-up|6|||
23714287|NCT01309841|66329435|FG002|Overall Study|Lost to Follow-up|4|||
23714288|NCT01309841|66329433|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
23714289|NCT01309841|66329434|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23522235|NCT01549964|65650669|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23714290|NCT01309841|66329435|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
23714291|NCT01309841|66329433|FG000|Overall Study|Lack of Efficacy|0|||
23714292|NCT01309841|66329434|FG001|Overall Study|Lack of Efficacy|0|||
23714293|NCT01309841|66329435|FG002|Overall Study|Lack of Efficacy|2|||
23714294|NCT01309841|66329433|FG000|Overall Study|Adverse Event|9|||
23714295|NCT01309841|66329434|FG001|Overall Study|Adverse Event|22|||
23714296|NCT01309841|66329435|FG002|Overall Study|Adverse Event|11|||
23714297|NCT01309841|66329433|FG000|Overall Study|Death|1|||
23714298|NCT01309841|66329434|FG001|Overall Study|Death|0|||
23714299|NCT01309841|66329435|FG002|Overall Study|Death|0|||
23714300|NCT01309841|66329433|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23714301|NCT01309841|66329434|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23714302|NCT01309841|66329435|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23714303|NCT01309841|66329433|FG000|Overall Study|Withdrawal by Subject|17|||
23714304|NCT01309841|66329434|FG001|Overall Study|Withdrawal by Subject|6|||
23714305|NCT01309841|66329435|FG002|Overall Study|Withdrawal by Subject|13|||
23714306|NCT01309841|66329433|FG000|Overall Study|Did Not Receive Treatment|2|||
23714307|NCT01309841|66329434|FG001|Overall Study|Did Not Receive Treatment|0|||
23714308|NCT01309841|66329435|FG002|Overall Study|Did Not Receive Treatment|1|||
23714309|NCT01309841|66329433|FG000|Overall Study|Severe non-compliance with protocol|0|||
23714310|NCT01309841|66329434|FG001|Overall Study|Severe non-compliance with protocol|5|||
23714311|NCT01309841|66329435|FG002|Overall Study|Severe non-compliance with protocol|2|||
23714312|NCT00111475|66329438|FG000|Overall Study|Lost to Follow-up|0|||
23714313|NCT00111475|66329439|FG001|Overall Study|Lost to Follow-up|0|||
23714314|NCT00111475|66329440|FG002|Overall Study|Lost to Follow-up|0|||
23714315|NCT00111475|66329441|FG003|Overall Study|Lost to Follow-up|0|||
23714316|NCT00111475|66329442|FG004|Overall Study|Lost to Follow-up|0|||
23714317|NCT00111475|66329443|FG005|Overall Study|Lost to Follow-up|1|||
23714318|NCT00111475|66329444|FG006|Overall Study|Lost to Follow-up|0|||
23714319|NCT00111475|66329445|FG007|Overall Study|Lost to Follow-up|0|||
23714320|NCT00111475|66329446|FG008|Overall Study|Lost to Follow-up|0|||
23714321|NCT00111475|66329447|FG009|Overall Study|Lost to Follow-up|0|||
23714322|NCT00405821|66329453|FG000|Overall Study|Death|5|||
23714323|NCT00405821|66329454|FG001|Overall Study|Death|7|||
23714324|NCT00405821|66329453|FG000|Overall Study|Lost to Follow-up|7|||
23714325|NCT00405821|66329454|FG001|Overall Study|Lost to Follow-up|7|||
23714326|NCT00405821|66329453|FG000|Overall Study|Protocol Violation|1|||
23714327|NCT00405821|66329454|FG001|Overall Study|Protocol Violation|0|||
23714328|NCT00405821|66329453|FG000|Overall Study|initiated ART|9|||
23714329|NCT00405821|66329454|FG001|Overall Study|initiated ART|8|||
23714330|NCT02785952|66329457|FG000|Overall Study|Adverse Event|31|||
23714331|NCT02785952|66329458|FG001|Overall Study|Adverse Event|19|||
23714332|NCT02785952|66329457|FG000|Overall Study|Refusal unrelated to adverse events|10|||
23714333|NCT02785952|66329458|FG001|Overall Study|Refusal unrelated to adverse events|5|||
23714334|NCT02785952|66329457|FG000|Overall Study|Disease progression/relapse|61|||
23714335|NCT02785952|66329458|FG001|Overall Study|Disease progression/relapse|89|||
23714336|NCT02785952|66329457|FG000|Overall Study|Death|11|||
23714337|NCT02785952|66329458|FG001|Overall Study|Death|7|||
23714338|NCT02785952|66329457|FG000|Overall Study|Other- not protocol specified|6|||
23714339|NCT02785952|66329458|FG001|Overall Study|Other- not protocol specified|4|||
23714340|NCT02785952|66329457|FG000|Overall Study|On protocol treatment|6|||
23714341|NCT02785952|66329458|FG001|Overall Study|On protocol treatment|3|||
23714342|NCT01195831|66329459|FG000|Overall Study|Lost to Follow-up|2|||
23714343|NCT01195831|66329460|FG001|Overall Study|Lost to Follow-up|4|||
23714344|NCT01195831|66329459|FG000|Overall Study|Withdrawal by Subject|2|||
23714345|NCT01195831|66329460|FG001|Overall Study|Withdrawal by Subject|2|||
23714346|NCT01195831|66329459|FG000|Overall Study|Adverse Event|4|||
23714347|NCT01195831|66329460|FG001|Overall Study|Adverse Event|2|||
23714348|NCT01195831|66329459|FG000|Overall Study|Protocol Violation|0|||
23714349|NCT01195831|66329460|FG001|Overall Study|Protocol Violation|2|||
23714350|NCT00255086|66329461|FG000|Overall Study|Adverse Event|1|||
23714351|NCT00255086|66329462|FG001|Overall Study|Adverse Event|1|||
23714352|NCT00255086|66329461|FG000|Overall Study|Protocol Violation|1|||
23714353|NCT00255086|66329462|FG001|Overall Study|Protocol Violation|1|||
23714354|NCT01391819|66329463|FG000|Overall Study|Withdrawal by Subject|56|||
23714355|NCT01391819|66329463|FG000|Overall Study|Migrated/moved from study area|82|||
23714356|NCT01391819|66329463|FG000|Overall Study|Lost to Follow-up|252|||
23714357|NCT01391819|66329463|FG000|Overall Study|Death|3|||
23714358|NCT01391819|66329463|FG000|Overall Study|Other|9|||
23714359|NCT00349752|66329464|FG000|Overall Study|Adverse Event|8|||
23714360|NCT00349752|66329465|FG001|Overall Study|Adverse Event|12|||
23714361|NCT00349752|66329464|FG000|Overall Study|Lack of Efficacy|37|||
23714362|NCT00349752|66329465|FG001|Overall Study|Lack of Efficacy|42|||
23714363|NCT00349752|66329464|FG000|Overall Study|Lost to Follow-up|4|||
23714364|NCT00349752|66329465|FG001|Overall Study|Lost to Follow-up|2|||
23714365|NCT00349752|66329464|FG000|Overall Study|Personal reasons|6|||
23714366|NCT00349752|66329465|FG001|Overall Study|Personal reasons|5|||
23714367|NCT00349752|66329464|FG000|Overall Study|Other: Required exclusionary medication|0|||
23714368|NCT00349752|66329465|FG001|Overall Study|Other: Required exclusionary medication|1|||
23714369|NCT00349752|66329464|FG000|Overall Study|Other: Non compliance|0|||
23714370|NCT00349752|66329465|FG001|Overall Study|Other: Non compliance|1|||
23714371|NCT00349752|66329464|FG000|Overall Study|Other: Patient stopped steroids|0|||
23714372|NCT00349752|66329465|FG001|Overall Study|Other: Patient stopped steroids|1|||
23714373|NCT00349752|66329464|FG000|Overall Study|Other: Patient's steroid use|1|||
23714374|NCT00349752|66329465|FG001|Overall Study|Other: Patient's steroid use|0|||
23714375|NCT00349752|66329464|FG000|Overall Study|Other: Ineligible|1|||
23522236|NCT01549964|65650670|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23714376|NCT00349752|66329465|FG001|Overall Study|Other: Ineligible|0|||
23714377|NCT00349752|66329464|FG000|Overall Study|Other: Inadvertently unblinded|1|||
23714378|NCT00349752|66329465|FG001|Overall Study|Other: Inadvertently unblinded|0|||
23714379|NCT00349752|66329464|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
23714380|NCT00349752|66329465|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
23714381|NCT00229203|66329469|FG000|Overall Study|Progressive disease|18|||
23522237|NCT01549964|65650671|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
23522238|NCT01549964|65650672|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23522239|NCT01549964|65650669|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
23522240|NCT01549964|65650670|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
23522241|NCT01549964|65650671|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
23522242|NCT01549964|65650672|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
23522243|NCT01549964|65650669|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
23522244|NCT01549964|65650670|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
23522245|NCT01549964|65650671|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
23522246|NCT01549964|65650672|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
23522247|NCT01549964|65650669|FG000|80-Week Extension Period|Pregnancy|0|||
23522248|NCT01549964|65650670|FG001|80-Week Extension Period|Pregnancy|0|||
23522249|NCT01549964|65650671|FG002|80-Week Extension Period|Pregnancy|1|||
23522250|NCT01549964|65650672|FG003|80-Week Extension Period|Pregnancy|0|||
23714382|NCT00229203|66329470|FG001|Overall Study|Progressive disease|9|||
23714383|NCT00229203|66329469|FG000|Overall Study|Toxicity|6|||
23714384|NCT00229203|66329470|FG001|Overall Study|Toxicity|1|||
23714385|NCT00229203|66329469|FG000|Overall Study|Death|4|||
23714386|NCT00229203|66329470|FG001|Overall Study|Death|2|||
23714387|NCT00229203|66329469|FG000|Overall Study|Other|3|||
23714388|NCT00229203|66329470|FG001|Overall Study|Other|3|||
23714389|NCT00229203|66329469|FG000|Overall Study|Withdrawal by Subject|1|||
23714390|NCT00229203|66329470|FG001|Overall Study|Withdrawal by Subject|4|||
23714391|NCT01217190|66329471|FG000|Second Dosing|Withdrawal by Subject|0|||
23522251|NCT01549964|65650669|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
23522252|NCT01549964|65650670|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
23714392|NCT01217190|66329472|FG001|Second Dosing|Withdrawal by Subject|2|||
23714393|NCT02294318|66329473|FG000|Overall Study|Worsening of drinking|3|||
23714394|NCT02294318|66329474|FG001|Overall Study|Worsening of drinking|0|||
23714395|NCT02294318|66329473|FG000|Overall Study|Not exposed to intervention|0|||
23714396|NCT02294318|66329474|FG001|Overall Study|Not exposed to intervention|2|||
23714397|NCT00363246|66329476|FG000|Overall Study|Death|40|||
23714398|NCT00363246|66329476|FG000|Overall Study|Withdrawal by Subject|19|||
23714399|NCT00363246|66329476|FG000|Overall Study|Lost to Follow-up|14|||
23714400|NCT00363246|66329476|FG000|Overall Study|Bad health|6|||
23714401|NCT00363246|66329476|FG000|Overall Study|Stopped using wheelchair|11|||
23714402|NCT00363246|66329476|FG000|Overall Study|Subject expressed security concerns|2|||
23714403|NCT00363246|66329476|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
23714404|NCT02193828|66329477|FG000|Overall Study|Withdrawal by Subject|0|||
23714405|NCT02193828|66329478|FG001|Overall Study|Withdrawal by Subject|0|||
23714406|NCT02193828|66329479|FG002|Overall Study|Withdrawal by Subject|1|||
23714407|NCT02193828|66329480|FG003|Overall Study|Withdrawal by Subject|1|||
23714408|NCT01764256|66329492|FG000|Received All Vaccinations|Adverse Event|1|||
23714409|NCT01764256|66329493|FG001|Received All Vaccinations|Adverse Event|1|||
23714410|NCT01764256|66329494|FG002|Received All Vaccinations|Adverse Event|0|||
23714411|NCT01764256|66329495|FG003|Received All Vaccinations|Adverse Event|0|||
23714412|NCT01764256|66329492|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
23714413|NCT01764256|66329493|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
23714414|NCT01764256|66329494|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
23714415|NCT01764256|66329495|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
23714416|NCT01764256|66329492|FG000|Received All Vaccinations|Lost to Follow-up|1|||
23714417|NCT01764256|66329493|FG001|Received All Vaccinations|Lost to Follow-up|0|||
23714418|NCT01764256|66329494|FG002|Received All Vaccinations|Lost to Follow-up|0|||
23714419|NCT01764256|66329495|FG003|Received All Vaccinations|Lost to Follow-up|0|||
23714420|NCT01764256|66329492|FG000|Completed Study|Lost to Follow-up|0|||
23714421|NCT01764256|66329493|FG001|Completed Study|Lost to Follow-up|0|||
23714422|NCT01764256|66329494|FG002|Completed Study|Lost to Follow-up|0|||
23714423|NCT01764256|66329495|FG003|Completed Study|Lost to Follow-up|1|||
23714424|NCT04682353|66329496|FG000|Overall Study|Lost to Follow-up|0|||
23714425|NCT04682353|66329497|FG001|Overall Study|Lost to Follow-up|1|||
23714426|NCT04682353|66329498|FG002|Overall Study|Lost to Follow-up|0|||
23714427|NCT04682353|66329499|FG003|Overall Study|Lost to Follow-up|1|||
23714428|NCT04682353|66329496|FG000|Overall Study|Personal reasons|0|||
23714429|NCT04682353|66329497|FG001|Overall Study|Personal reasons|1|||
23714430|NCT04682353|66329498|FG002|Overall Study|Personal reasons|0|||
23714431|NCT04682353|66329499|FG003|Overall Study|Personal reasons|0|||
23714432|NCT01009983|66329500|FG000|Overall Study|necessary scans not completed|1|||
23714433|NCT03695393|66329505|FG000|Overall Study|Death|3|||
23714434|NCT03695393|66329506|FG001|Overall Study|Death|1|||
23714435|NCT03695393|66329505|FG000|Overall Study|Lost to Follow-up|0|||
23714436|NCT03695393|66329506|FG001|Overall Study|Lost to Follow-up|1|||
23714437|NCT02310906|66329507|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23714438|NCT02310906|66329508|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23714439|NCT02310906|66329509|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23714440|NCT02310906|66329510|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
23714441|NCT02310906|66329507|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
23714442|NCT02310906|66329508|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
23714443|NCT02310906|66329509|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
23714444|NCT02310906|66329510|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
23714445|NCT02310906|66329507|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23714446|NCT02310906|66329508|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23714447|NCT02310906|66329509|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23714448|NCT02310906|66329510|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
23714449|NCT02310906|66329507|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23714450|NCT02310906|66329508|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23714451|NCT02310906|66329509|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23714452|NCT02310906|66329510|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
23714453|NCT02530671|66329511|FG000|Overall Study|Lost to Follow-up|2|||
23714454|NCT02530671|66329512|FG001|Overall Study|Lost to Follow-up|0|||
23714455|NCT02530671|66329511|FG000|Overall Study|Withdrawal by Subject|1|||
23714456|NCT02530671|66329512|FG001|Overall Study|Withdrawal by Subject|0|||
23714457|NCT00964158|66329513|FG000|Overall Study|Lost to Follow-up|0|||
23714458|NCT00964158|66329514|FG001|Overall Study|Lost to Follow-up|1|||
23714459|NCT00964158|66329515|FG002|Overall Study|Lost to Follow-up|2|||
23714460|NCT00964158|66329513|FG000|Overall Study|Withdrawal by Subject|0|||
23714461|NCT00964158|66329514|FG001|Overall Study|Withdrawal by Subject|0|||
23522253|NCT01549964|65650671|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
23522254|NCT01549964|65650672|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
23522255|NCT01549964|65650669|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
23522256|NCT01549964|65650670|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
23522257|NCT01549964|65650671|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
23714462|NCT00964158|66329515|FG002|Overall Study|Withdrawal by Subject|6|||
23714463|NCT00259740|66329516|FG000|Overall Study|Physician Decision|1|||
23522258|NCT01549964|65650672|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
23522259|NCT01549964|65650669|FG000|80-Week Extension Period|Lost to Follow-up|1|||
23522260|NCT01549964|65650670|FG001|80-Week Extension Period|Lost to Follow-up|0|||
23522261|NCT01549964|65650671|FG002|80-Week Extension Period|Lost to Follow-up|2|||
23522262|NCT01549964|65650672|FG003|80-Week Extension Period|Lost to Follow-up|1|||
23522263|NCT01549964|65650669|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
23522264|NCT01549964|65650670|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
23522265|NCT01549964|65650671|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
23522266|NCT01549964|65650672|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
23522267|NCT01520363|65650675|FG000|Overall Study|Withdrawal by Subject|2|||
23522268|NCT01520363|65650676|FG001|Overall Study|Withdrawal by Subject|0|||
23522269|NCT02028988|65650680|FG000|Overall Study|Withdrawal by Subject|2|||
23522270|NCT00549562|65650698|FG000|Overall Study|Adverse Event|1|||
23522271|NCT00549562|65650698|FG000|Overall Study|Lack of Efficacy|1|||
23522272|NCT00235872|65650699|FG000|Overall Study|Adverse Event|34|||
23522273|NCT00235872|65650699|FG000|Overall Study|Death|1|||
23522274|NCT00235872|65650699|FG000|Overall Study|Lost to Follow-up|1|||
23522275|NCT00235872|65650699|FG000|Overall Study|Withdrawal by Subject|50|||
23522276|NCT00235872|65650699|FG000|Overall Study|Administrative reason|61|||
23522277|NCT02726074|65650700|FG000|Overall Study|Withdrawal by Subject|4|||
23522278|NCT02726074|65650700|FG000|Overall Study|Adverse Event|14|||
23522279|NCT02726074|65650700|FG000|Overall Study|Protocol Violation|3|||
23522280|NCT02726074|65650700|FG000|Overall Study|Lost to Follow-up|2|||
23522281|NCT02726074|65650700|FG000|Overall Study|Others|3|||
23522282|NCT01120756|65650701|FG000|Overall Study|Withdrawal by Subject|1|||
23522283|NCT01120756|65650702|FG001|Overall Study|Withdrawal by Subject|1|||
23522284|NCT04649164|65650703|FG000|Overall Study|Withdrawal by Subject|1|||
23522285|NCT04649164|65650704|FG001|Overall Study|Withdrawal by Subject|1|||
23522286|NCT04649164|65650705|FG002|Overall Study|Withdrawal by Subject|2|||
23522287|NCT04649164|65650703|FG000|Overall Study|Participant's care recipient expired|0|||
23522288|NCT04649164|65650704|FG001|Overall Study|Participant's care recipient expired|0|||
23522289|NCT04649164|65650705|FG002|Overall Study|Participant's care recipient expired|2|||
23522290|NCT01319877|65650706|FG000|Overall Study|Lost to Follow-up|100|||
23522291|NCT01319877|65650707|FG001|Overall Study|Lost to Follow-up|37|||
23522292|NCT01319877|65650706|FG000|Overall Study|Physician Decision|2|||
23522293|NCT01319877|65650707|FG001|Overall Study|Physician Decision|0|||
23522294|NCT01319877|65650706|FG000|Overall Study|Disease Progression|2|||
23522295|NCT01319877|65650707|FG001|Overall Study|Disease Progression|2|||
23522296|NCT01319877|65650706|FG000|Overall Study|Withdrawal by Subject|0|||
23522297|NCT01319877|65650707|FG001|Overall Study|Withdrawal by Subject|1|||
23522298|NCT01319877|65650706|FG000|Overall Study|Reason Not Specified|4|||
23522299|NCT01319877|65650707|FG001|Overall Study|Reason Not Specified|5|||
23522300|NCT03979638|65650709|FG000|Period 1|Physician Decision|1|||
23522301|NCT03979638|65650710|FG001|Period 1|Physician Decision|1|||
23522302|NCT03979638|65650709|FG000|Period 1|Withdrawal by Subject|4|||
23522303|NCT03979638|65650710|FG001|Period 1|Withdrawal by Subject|3|||
23522304|NCT03979638|65650709|FG000|Period 1|Study terminated by Sponsor|1|||
23522305|NCT03979638|65650710|FG001|Period 1|Study terminated by Sponsor|3|||
23522306|NCT03979638|65650709|FG000|Period 1|Protocol Violation|1|||
23522307|NCT03979638|65650710|FG001|Period 1|Protocol Violation|0|||
23522308|NCT03979638|65650709|FG000|Period 2|Study terminated by Sponsor|1|||
23522309|NCT03979638|65650710|FG001|Period 2|Study terminated by Sponsor|1|||
23522310|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
23522311|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
23522312|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
23522313|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
23522314|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
23522315|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
23714464|NCT00259740|66329517|FG001|Overall Study|Physician Decision|1|||
23522316|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
23522317|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23714465|NCT00259740|66329516|FG000|Overall Study|Adverse Event|0|||
23522318|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23522319|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23522320|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
23522321|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
23714466|NCT00259740|66329517|FG001|Overall Study|Adverse Event|2|||
23714467|NCT00259740|66329516|FG000|Overall Study|Withdrawal by Subject|2|||
23522322|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
23522323|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
23522324|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
23522325|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
23522326|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522327|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522328|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522329|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522330|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
23522331|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522332|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
23522333|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522334|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522335|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522336|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
23522337|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522338|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522339|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522340|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522341|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522342|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522343|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
23522344|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522345|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
23522346|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
23522347|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
23522348|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
23522349|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
23522350|NCT03373383|65650713|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
23522351|NCT03373383|65650714|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522352|NCT03373383|65650715|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522353|NCT03373383|65650716|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522354|NCT03373383|65650717|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522355|NCT05620576|65650719|FG000|Overall Study|Adverse Event|1|||
23522356|NCT05620576|65650720|FG001|Overall Study|Adverse Event|1|||
23522357|NCT05620576|65650719|FG000|Overall Study|Lost to Follow-up|3|||
23522358|NCT05620576|65650720|FG001|Overall Study|Lost to Follow-up|1|||
23522359|NCT05620576|65650719|FG000|Overall Study|Physician Decision|0|||
23522360|NCT05620576|65650720|FG001|Overall Study|Physician Decision|1|||
23522361|NCT05620576|65650719|FG000|Overall Study|Protocol Deviation|1|||
23522362|NCT05620576|65650720|FG001|Overall Study|Protocol Deviation|1|||
23522363|NCT05620576|65650719|FG000|Overall Study|Withdrawal by Subject|2|||
23522364|NCT05620576|65650720|FG001|Overall Study|Withdrawal by Subject|3|||
23522365|NCT02910167|65650740|FG000|Overall Study|Adverse Event|1|||
23522366|NCT02910167|65650740|FG000|Overall Study|Lost to Follow-up|18|||
23522367|NCT04327999|65650741|FG000|Overall Study|Protocol Violation|1|||
23522368|NCT02013167|65650742|FG000|Overall Study|Withdrawal by Subject|15|||
23522369|NCT02013167|65650743|FG001|Overall Study|Withdrawal by Subject|14|||
23522370|NCT02013167|65650742|FG000|Overall Study|Sponsor Decision|1|||
23522371|NCT02013167|65650743|FG001|Overall Study|Sponsor Decision|3|||
23522372|NCT02013167|65650742|FG000|Overall Study|Lost to Follow-up|0|||
23522373|NCT02013167|65650743|FG001|Overall Study|Lost to Follow-up|1|||
23522374|NCT02013167|65650742|FG000|Overall Study|Death|85|||
23522375|NCT02013167|65650743|FG001|Overall Study|Death|160|||
23522376|NCT01498952|65650754|FG000|Overall Study|Death|2|||
23522377|NCT01498952|65650755|FG001|Overall Study|Death|2|||
23522378|NCT01498952|65650756|FG002|Overall Study|Death|0|||
23522379|NCT01498952|65650757|FG003|Overall Study|Death|0|||
23522380|NCT01498952|65650758|FG004|Overall Study|Death|0|||
23714468|NCT00259740|66329517|FG001|Overall Study|Withdrawal by Subject|6|||
23714469|NCT00259740|66329516|FG000|Overall Study|Death|1|||
23714470|NCT00259740|66329517|FG001|Overall Study|Death|1|||
23714471|NCT00259740|66329516|FG000|Overall Study|Disease progression|19|||
23522381|NCT03025828|65650759|FG000|Overall Study|Lost to Follow-up|1|||
23522382|NCT01498640|65650760|FG000|Overall Study|Lost to Follow-up|1|||
23522383|NCT01498640|65650760|FG000|Overall Study|Death|1|||
23522384|NCT01498640|65650760|FG000|Overall Study|Other|3|||
23714472|NCT00259740|66329517|FG001|Overall Study|Disease progression|36|||
23416517|NCT04308239|65271177|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
23416518|NCT00580034|65271178|FG000|Overall Study|Toxicity|10|||
23416519|NCT00580034|65271179|FG001|Overall Study|Toxicity|0|||
23416520|NCT01961297|65271189|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
23416521|NCT01961297|65271190|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
23416522|NCT00338286|65271195|FG000|Overall Study|Withdrawal by Subject|50|||
23416523|NCT00338286|65271196|FG001|Overall Study|Withdrawal by Subject|54|||
23416524|NCT00338286|65271195|FG000|Overall Study|Lost to Follow-up|80|||
23416525|NCT00338286|65271196|FG001|Overall Study|Lost to Follow-up|66|||
23416526|NCT00338286|65271195|FG000|Overall Study|Other|103|||
23416527|NCT00338286|65271196|FG001|Overall Study|Other|93|||
23416528|NCT00185380|65271202|FG000|Overall Study|Adverse Event|41|||
23416529|NCT00185380|65271203|FG001|Overall Study|Adverse Event|43|||
23416530|NCT00185380|65271204|FG002|Overall Study|Adverse Event|48|||
23416531|NCT00185380|65271202|FG000|Overall Study|Lost to Follow-up|0|||
23416532|NCT00185380|65271203|FG001|Overall Study|Lost to Follow-up|4|||
23522385|NCT04656132|65650761|FG000|Overall Study|Lost to Follow-up|4|||
23522386|NCT04656132|65650761|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
23522387|NCT00244712|65650763|FG000|Overall Study|Adverse Event|20|||
23522388|NCT00244712|65650764|FG001|Overall Study|Adverse Event|21|||
23522389|NCT00244712|65650763|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
23522390|NCT00244712|65650764|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
23522391|NCT00244712|65650763|FG000|Overall Study|Lack of Compliance|10|||
23522392|NCT00244712|65650764|FG001|Overall Study|Lack of Compliance|11|||
23522393|NCT00244712|65650763|FG000|Overall Study|Lost to Follow-up|45|||
23522394|NCT00244712|65650764|FG001|Overall Study|Lost to Follow-up|52|||
23522395|NCT00244712|65650763|FG000|Overall Study|Withdrawal by Subject|13|||
23522396|NCT00244712|65650764|FG001|Overall Study|Withdrawal by Subject|23|||
23416533|NCT00185380|65271204|FG002|Overall Study|Lost to Follow-up|3|||
23416534|NCT00185380|65271202|FG000|Overall Study|Pregnancy|1|||
23416535|NCT00185380|65271203|FG001|Overall Study|Pregnancy|4|||
23416536|NCT00185380|65271204|FG002|Overall Study|Pregnancy|0|||
23416537|NCT00185380|65271202|FG000|Overall Study|Protocol Violation|2|||
23416538|NCT00185380|65271203|FG001|Overall Study|Protocol Violation|2|||
23522397|NCT00244712|65650763|FG000|Overall Study|Protocol Violation, disease progression|13|||
23522398|NCT00244712|65650764|FG001|Overall Study|Protocol Violation, disease progression|11|||
23522399|NCT00278109|65650770|FG000|Overall Study|Adverse Event|3|||
23522400|NCT00278109|65650770|FG000|Overall Study|social circumstances|1|||
23522401|NCT02867709|65650771|FG000|Treatment Period|Adverse Event|1|||
23522402|NCT02867709|65650772|FG001|Treatment Period|Adverse Event|1|||
23522403|NCT02867709|65650773|FG002|Treatment Period|Adverse Event|2|||
23522404|NCT02867709|65650771|FG000|Treatment Period|Withdrawal of Consent|7|||
23522405|NCT02867709|65650772|FG001|Treatment Period|Withdrawal of Consent|9|||
23522406|NCT02867709|65650773|FG002|Treatment Period|Withdrawal of Consent|8|||
23522407|NCT02867709|65650771|FG000|Treatment Period|Lost to Follow-up|17|||
23522408|NCT02867709|65650772|FG001|Treatment Period|Lost to Follow-up|20|||
23522409|NCT02867709|65650773|FG002|Treatment Period|Lost to Follow-up|20|||
23522410|NCT02867709|65650771|FG000|Treatment Period|Lack of Qualifying Event|42|||
23522411|NCT02867709|65650772|FG001|Treatment Period|Lack of Qualifying Event|55|||
23522412|NCT02867709|65650773|FG002|Treatment Period|Lack of Qualifying Event|42|||
23522413|NCT02867709|65650771|FG000|Treatment Period|Protocol Violation|3|||
23522414|NCT02867709|65650772|FG001|Treatment Period|Protocol Violation|2|||
23522415|NCT02867709|65650773|FG002|Treatment Period|Protocol Violation|3|||
23522416|NCT02867709|65650771|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
23522417|NCT02867709|65650772|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
23522418|NCT02867709|65650773|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
23522419|NCT02867709|65650771|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
23522420|NCT02867709|65650772|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
23522421|NCT02867709|65650773|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
23522422|NCT02867709|65650771|FG000|Safety Follow-up Period|Pregnancy|0|||
23522423|NCT02867709|65650772|FG001|Safety Follow-up Period|Pregnancy|1|||
23522424|NCT02867709|65650773|FG002|Safety Follow-up Period|Pregnancy|0|||
23522425|NCT02867709|65650771|FG000|Safety Follow-up Period|Protocol Violation|0|||
23714473|NCT00259740|66329516|FG000|Overall Study|Ongoing|17|||
23714474|NCT00259740|66329517|FG001|Overall Study|Ongoing|3|||
23522426|NCT02867709|65650772|FG001|Safety Follow-up Period|Protocol Violation|1|||
23522427|NCT02867709|65650773|FG002|Safety Follow-up Period|Protocol Violation|1|||
23522428|NCT00851799|65650774|FG000|Overall Study|Death|1|||
23416539|NCT00185380|65271204|FG002|Overall Study|Protocol Violation|1|||
23416540|NCT00185380|65271202|FG000|Overall Study|Withdrawal by Subject|1|||
23416541|NCT00185380|65271203|FG001|Overall Study|Withdrawal by Subject|2|||
23416542|NCT00185380|65271204|FG002|Overall Study|Withdrawal by Subject|0|||
23416543|NCT00185380|65271202|FG000|Overall Study|Failed insertion|1|||
23522429|NCT00851799|65650775|FG001|Overall Study|Death|0|||
23522430|NCT00851799|65650776|FG002|Overall Study|Death|1|||
23522431|NCT00851799|65650774|FG000|Overall Study|Lost to Follow-up|5|||
23522432|NCT00851799|65650775|FG001|Overall Study|Lost to Follow-up|3|||
23714475|NCT00259740|66329516|FG000|Overall Study|Other|3|||
23416544|NCT00185380|65271203|FG001|Overall Study|Failed insertion|1|||
23416545|NCT00185380|65271204|FG002|Overall Study|Failed insertion|2|||
23416546|NCT00185380|65271202|FG000|Overall Study|Planned pregnancy|9|||
23416547|NCT00185380|65271203|FG001|Overall Study|Planned pregnancy|12|||
23416548|NCT00185380|65271204|FG002|Overall Study|Planned pregnancy|12|||
23416549|NCT00185380|65271202|FG000|Overall Study|No need for contraception|3|||
23416550|NCT00185380|65271203|FG001|Overall Study|No need for contraception|3|||
23416551|NCT00185380|65271204|FG002|Overall Study|No need for contraception|3|||
23416552|NCT00185380|65271202|FG000|Overall Study|Could not attend visits|2|||
23416553|NCT00185380|65271203|FG001|Overall Study|Could not attend visits|0|||
23416554|NCT00185380|65271204|FG002|Overall Study|Could not attend visits|4|||
23416555|NCT00185380|65271202|FG000|Overall Study|personal reason|6|||
23416556|NCT00185380|65271203|FG001|Overall Study|personal reason|1|||
23416557|NCT00185380|65271204|FG002|Overall Study|personal reason|1|||
23416558|NCT01524224|65271205|FG000|Overall Study|Progressive Disease|1|||
23416559|NCT01524224|65271206|FG001|Overall Study|Progressive Disease|0|||
23416560|NCT01524224|65271207|FG002|Overall Study|Progressive Disease|2|||
23416561|NCT01524224|65271208|FG003|Overall Study|Progressive Disease|1|||
23416562|NCT01524224|65271209|FG004|Overall Study|Progressive Disease|2|||
23416563|NCT01524224|65271210|FG005|Overall Study|Progressive Disease|1|||
23416564|NCT01524224|65271211|FG006|Overall Study|Progressive Disease|1|||
23416565|NCT01524224|65271212|FG007|Overall Study|Progressive Disease|5|||
23416566|NCT01524224|65271205|FG000|Overall Study|Withdrawal by Subject|2|||
23416567|NCT01524224|65271206|FG001|Overall Study|Withdrawal by Subject|0|||
23416568|NCT01524224|65271207|FG002|Overall Study|Withdrawal by Subject|0|||
23416569|NCT01524224|65271208|FG003|Overall Study|Withdrawal by Subject|0|||
23416570|NCT01524224|65271209|FG004|Overall Study|Withdrawal by Subject|0|||
23416571|NCT01524224|65271210|FG005|Overall Study|Withdrawal by Subject|0|||
23416572|NCT01524224|65271211|FG006|Overall Study|Withdrawal by Subject|2|||
23416573|NCT01524224|65271212|FG007|Overall Study|Withdrawal by Subject|0|||
23416574|NCT01524224|65271205|FG000|Overall Study|Adverse Event|0|||
23416575|NCT01524224|65271206|FG001|Overall Study|Adverse Event|1|||
23416576|NCT01524224|65271207|FG002|Overall Study|Adverse Event|0|||
23416577|NCT01524224|65271208|FG003|Overall Study|Adverse Event|0|||
23416578|NCT01524224|65271209|FG004|Overall Study|Adverse Event|0|||
23714476|NCT00259740|66329517|FG001|Overall Study|Other|0|||
23714477|NCT00259740|66329516|FG000|Overall Study|Requirement for alternative therapy|0|||
23714478|NCT00259740|66329517|FG001|Overall Study|Requirement for alternative therapy|4|||
23714479|NCT01927419|66329520|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23416579|NCT01524224|65271210|FG005|Overall Study|Adverse Event|1|||
23416580|NCT01524224|65271211|FG006|Overall Study|Adverse Event|0|||
23416581|NCT01524224|65271212|FG007|Overall Study|Adverse Event|0|||
23416582|NCT01524224|65271205|FG000|Overall Study|Physician Decision|0|||
23416583|NCT01524224|65271206|FG001|Overall Study|Physician Decision|0|||
23416584|NCT01524224|65271207|FG002|Overall Study|Physician Decision|0|||
23416585|NCT01524224|65271208|FG003|Overall Study|Physician Decision|1|||
23416586|NCT01524224|65271209|FG004|Overall Study|Physician Decision|1|||
23416587|NCT01524224|65271210|FG005|Overall Study|Physician Decision|0|||
23416588|NCT01524224|65271211|FG006|Overall Study|Physician Decision|0|||
23416589|NCT01524224|65271212|FG007|Overall Study|Physician Decision|1|||
23416590|NCT01524224|65271205|FG000|Overall Study|Sponsor Decision|0|||
23416591|NCT01524224|65271206|FG001|Overall Study|Sponsor Decision|0|||
23416592|NCT01524224|65271207|FG002|Overall Study|Sponsor Decision|0|||
23416593|NCT01524224|65271208|FG003|Overall Study|Sponsor Decision|0|||
23416594|NCT01524224|65271209|FG004|Overall Study|Sponsor Decision|1|||
23714480|NCT01927419|66329521|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23714481|NCT01927419|66329520|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
23714482|NCT01927419|66329521|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
23714483|NCT01927419|66329520|FG000|Treatment Period|Disease progression|17|||
23714484|NCT01927419|66329521|FG001|Treatment Period|Disease progression|20|||
23714485|NCT01927419|66329520|FG000|Treatment Period|Study drug toxicity|48|||
23714486|NCT01927419|66329521|FG001|Treatment Period|Study drug toxicity|10|||
23714487|NCT01927419|66329520|FG000|Treatment Period|Death|0|||
23416595|NCT01524224|65271210|FG005|Overall Study|Sponsor Decision|0|||
23416596|NCT01524224|65271211|FG006|Overall Study|Sponsor Decision|0|||
23416597|NCT01524224|65271212|FG007|Overall Study|Sponsor Decision|0|||
23522433|NCT00851799|65650776|FG002|Overall Study|Lost to Follow-up|10|||
23416598|NCT04776720|65271213|FG000|Overall Study|COVID Related|4|||
23416599|NCT04776720|65271214|FG001|Overall Study|COVID Related|2|||
23416600|NCT04776720|65271213|FG000|Overall Study|Adverse Event|2|||
23416601|NCT04776720|65271214|FG001|Overall Study|Adverse Event|0|||
23416602|NCT04776720|65271213|FG000|Overall Study|Serious Adverse Event|0|||
23416603|NCT04776720|65271214|FG001|Overall Study|Serious Adverse Event|1|||
23416604|NCT04776720|65271213|FG000|Overall Study|Too Busy|3|||
23416605|NCT04776720|65271214|FG001|Overall Study|Too Busy|1|||
23416606|NCT04776720|65271213|FG000|Overall Study|Lost to Follow-up|1|||
23714488|NCT01927419|66329521|FG001|Treatment Period|Death|1|||
23714489|NCT01927419|66329520|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
23714490|NCT01927419|66329521|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
23714491|NCT01927419|66329520|FG000|Treatment Period|Participant request to discontinue|12|||
23714492|NCT01927419|66329521|FG001|Treatment Period|Participant request to discontinue|4|||
23714493|NCT01927419|66329520|FG000|Treatment Period|Withdrawal by Subject|1|||
23714494|NCT01927419|66329521|FG001|Treatment Period|Withdrawal by Subject|1|||
23714495|NCT01927419|66329520|FG000|Treatment Period|Maximum Clinical Benefit|6|||
23714496|NCT01927419|66329521|FG001|Treatment Period|Maximum Clinical Benefit|2|||
23714497|NCT01927419|66329520|FG000|Treatment Period|Other reasons|3|||
23416607|NCT04776720|65271214|FG001|Overall Study|Lost to Follow-up|2|||
23416608|NCT04776720|65271213|FG000|Overall Study|Family|2|||
23416609|NCT04776720|65271214|FG001|Overall Study|Family|2|||
23522434|NCT00851799|65650774|FG000|Overall Study|Not able to get to clinic|8|||
23522435|NCT00851799|65650775|FG001|Overall Study|Not able to get to clinic|5|||
23714498|NCT01927419|66329521|FG001|Treatment Period|Other reasons|4|||
23416610|NCT04776720|65271213|FG000|Overall Study|No remote technology access|0|||
23416611|NCT04776720|65271214|FG001|Overall Study|No remote technology access|1|||
23714499|NCT01927419|66329520|FG000|Treatment Period|Not Reported|1|||
23714500|NCT01927419|66329521|FG001|Treatment Period|Not Reported|1|||
23714501|NCT02726113|66329522|FG000|Total Enrollment|Physician Decision|0|||
23416612|NCT04776720|65271213|FG000|Overall Study|Withdrawal by Subject|1|||
23416613|NCT04776720|65271214|FG001|Overall Study|Withdrawal by Subject|0|||
23416614|NCT04776720|65271213|FG000|Overall Study|Cannot tolerate intervention|1|||
23416615|NCT04776720|65271214|FG001|Overall Study|Cannot tolerate intervention|0|||
23416616|NCT04776720|65271213|FG000|Overall Study|Incomplete outcome data|6|||
23416617|NCT04776720|65271214|FG001|Overall Study|Incomplete outcome data|1|||
23522436|NCT00851799|65650776|FG002|Overall Study|Not able to get to clinic|9|||
23522437|NCT00851799|65650774|FG000|Overall Study|Not willing to adhere to requirements|1|||
23416618|NCT01468233|65271218|FG000|Treatment Period 1|Adverse Event|5|||
23416619|NCT01468233|65271219|FG001|Treatment Period 1|Adverse Event|3|||
23416620|NCT01468233|65271220|FG002|Treatment Period 1|Adverse Event|0|||
23416621|NCT01468233|65271221|FG003|Treatment Period 1|Adverse Event|0|||
23416622|NCT01468233|65271222|FG004|Treatment Period 1|Adverse Event|0|||
23416623|NCT01468233|65271223|FG005|Treatment Period 1|Adverse Event|0|||
23416624|NCT01468233|65271218|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23416625|NCT01468233|65271219|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23416626|NCT01468233|65271220|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23416627|NCT01468233|65271221|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23416628|NCT01468233|65271222|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23416629|NCT01468233|65271223|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23416630|NCT01468233|65271218|FG000|Treatment Period 1|Lost to Follow-up|3|||
23416631|NCT01468233|65271219|FG001|Treatment Period 1|Lost to Follow-up|0|||
23416632|NCT01468233|65271220|FG002|Treatment Period 1|Lost to Follow-up|0|||
23416633|NCT01468233|65271221|FG003|Treatment Period 1|Lost to Follow-up|0|||
23416634|NCT01468233|65271222|FG004|Treatment Period 1|Lost to Follow-up|0|||
23416635|NCT01468233|65271223|FG005|Treatment Period 1|Lost to Follow-up|0|||
23416636|NCT01468233|65271218|FG000|Treatment Period 1|Other|1|||
23416637|NCT01468233|65271219|FG001|Treatment Period 1|Other|1|||
23416638|NCT01468233|65271220|FG002|Treatment Period 1|Other|0|||
23416639|NCT01468233|65271221|FG003|Treatment Period 1|Other|0|||
23416640|NCT01468233|65271222|FG004|Treatment Period 1|Other|0|||
23416641|NCT01468233|65271223|FG005|Treatment Period 1|Other|0|||
23416642|NCT01468233|65271218|FG000|Treatment Period 2|Adverse Event|0|||
23416643|NCT01468233|65271219|FG001|Treatment Period 2|Adverse Event|0|||
23416644|NCT01468233|65271220|FG002|Treatment Period 2|Adverse Event|3|||
23416645|NCT01468233|65271221|FG003|Treatment Period 2|Adverse Event|0|||
23416646|NCT01468233|65271222|FG004|Treatment Period 2|Adverse Event|2|||
23416647|NCT01468233|65271223|FG005|Treatment Period 2|Adverse Event|1|||
23416648|NCT01468233|65271218|FG000|Treatment Period 2|Lack of Efficacy|0|||
23416649|NCT01468233|65271219|FG001|Treatment Period 2|Lack of Efficacy|0|||
23522438|NCT00851799|65650775|FG001|Overall Study|Not willing to adhere to requirements|2|||
23522439|NCT00851799|65650776|FG002|Overall Study|Not willing to adhere to requirements|2|||
23522440|NCT00851799|65650774|FG000|Overall Study|Withdrew consent prior study completion|1|||
23522441|NCT00851799|65650775|FG001|Overall Study|Withdrew consent prior study completion|2|||
23522442|NCT00851799|65650776|FG002|Overall Study|Withdrew consent prior study completion|1|||
23416650|NCT01468233|65271220|FG002|Treatment Period 2|Lack of Efficacy|9|||
23416651|NCT01468233|65271221|FG003|Treatment Period 2|Lack of Efficacy|2|||
23416652|NCT01468233|65271222|FG004|Treatment Period 2|Lack of Efficacy|0|||
23522443|NCT00851799|65650774|FG000|Overall Study|Severe Debilitation|0|||
23522444|NCT00851799|65650775|FG001|Overall Study|Severe Debilitation|1|||
23714502|NCT02726113|66329523|FG001|Total Enrollment|Physician Decision|1|||
23714503|NCT02726113|66329522|FG000|Total Enrollment|Protocol Violation|1|||
23416653|NCT01468233|65271223|FG005|Treatment Period 2|Lack of Efficacy|1|||
23416654|NCT01468233|65271218|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23416655|NCT01468233|65271219|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23416656|NCT01468233|65271220|FG002|Treatment Period 2|Withdrawal by Subject|9|||
23416657|NCT01468233|65271221|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23522445|NCT00851799|65650776|FG002|Overall Study|Severe Debilitation|0|||
23522446|NCT00851799|65650774|FG000|Overall Study|Completed protocol due to pregnancy|0|||
23522447|NCT00851799|65650775|FG001|Overall Study|Completed protocol due to pregnancy|0|||
23522448|NCT00851799|65650776|FG002|Overall Study|Completed protocol due to pregnancy|1|||
23522449|NCT00908960|65650777|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
23522450|NCT00908960|65650778|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
23522451|NCT00908960|65650779|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
23522452|NCT02319031|65650780|FG000|Treatment Period|Death|1|||
23522453|NCT02319031|65650781|FG001|Treatment Period|Death|0|||
23522454|NCT00174915|65650782|FG000|Overall Study|Lost to Follow-up|19|||
23522455|NCT00174915|65650783|FG001|Overall Study|Lost to Follow-up|17|||
23522456|NCT00174915|65650784|FG002|Overall Study|Lost to Follow-up|9|||
23522457|NCT00174915|65650785|FG003|Overall Study|Lost to Follow-up|17|||
23522458|NCT00174915|65650786|FG004|Overall Study|Lost to Follow-up|10|||
23522459|NCT00174915|65650782|FG000|Overall Study|Adverse Event|18|||
23522460|NCT00174915|65650783|FG001|Overall Study|Adverse Event|16|||
23522461|NCT00174915|65650784|FG002|Overall Study|Adverse Event|11|||
23522462|NCT00174915|65650785|FG003|Overall Study|Adverse Event|18|||
23522463|NCT00174915|65650786|FG004|Overall Study|Adverse Event|5|||
23522464|NCT00174915|65650782|FG000|Overall Study|Personal Reason(s)|16|||
23522465|NCT00174915|65650783|FG001|Overall Study|Personal Reason(s)|16|||
23522466|NCT00174915|65650784|FG002|Overall Study|Personal Reason(s)|9|||
23522467|NCT00174915|65650785|FG003|Overall Study|Personal Reason(s)|9|||
23522468|NCT00174915|65650786|FG004|Overall Study|Personal Reason(s)|9|||
23522469|NCT00174915|65650782|FG000|Overall Study|Other|15|||
23522470|NCT00174915|65650783|FG001|Overall Study|Other|8|||
23522471|NCT00174915|65650784|FG002|Overall Study|Other|6|||
23522472|NCT00174915|65650785|FG003|Overall Study|Other|5|||
23522473|NCT00174915|65650786|FG004|Overall Study|Other|3|||
23522474|NCT00174915|65650782|FG000|Overall Study|Gout Flare|13|||
23522475|NCT00174915|65650783|FG001|Overall Study|Gout Flare|6|||
23522476|NCT00174915|65650784|FG002|Overall Study|Gout Flare|8|||
23522477|NCT00174915|65650785|FG003|Overall Study|Gout Flare|1|||
23522478|NCT00174915|65650786|FG004|Overall Study|Gout Flare|0|||
23522479|NCT00174915|65650782|FG000|Overall Study|Protocol Violation|6|||
23522480|NCT00174915|65650783|FG001|Overall Study|Protocol Violation|3|||
23522481|NCT00174915|65650784|FG002|Overall Study|Protocol Violation|3|||
23522482|NCT00174915|65650785|FG003|Overall Study|Protocol Violation|6|||
23522483|NCT00174915|65650786|FG004|Overall Study|Protocol Violation|3|||
23522484|NCT00174915|65650782|FG000|Overall Study|Therapeutic Failure|6|||
23522485|NCT00174915|65650783|FG001|Overall Study|Therapeutic Failure|3|||
23522486|NCT00174915|65650784|FG002|Overall Study|Therapeutic Failure|2|||
23522487|NCT00174915|65650785|FG003|Overall Study|Therapeutic Failure|1|||
23522488|NCT00174915|65650786|FG004|Overall Study|Therapeutic Failure|3|||
23522489|NCT04608500|65650787|FG000|Overall Study|Adverse Event|2|||
23522490|NCT04608500|65650788|FG001|Overall Study|Adverse Event|0|||
23522491|NCT04608500|65650787|FG000|Overall Study|Lost to Follow-up|15|||
23714504|NCT02726113|66329523|FG001|Total Enrollment|Protocol Violation|0|||
23714505|NCT02726113|66329522|FG000|Total Enrollment|Withdrawal by Subject|2|||
23714506|NCT02726113|66329523|FG001|Total Enrollment|Withdrawal by Subject|1|||
23714507|NCT02726113|66329522|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
23714508|NCT02726113|66329523|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
23714509|NCT02726113|66329522|FG000|Genomic Analysis|Protocol Violation|1|||
23714510|NCT02726113|66329523|FG001|Genomic Analysis|Protocol Violation|0|||
23714511|NCT02726113|66329522|FG000|Genomic Analysis|Withdrawal by Subject|2|||
23714512|NCT02726113|66329523|FG001|Genomic Analysis|Withdrawal by Subject|1|||
23714513|NCT02726113|66329522|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
23714514|NCT02726113|66329523|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
23714515|NCT01486784|66329527|FG000|Overall Study|Withdrawal by Subject|0|||
23714516|NCT01486784|66329528|FG001|Overall Study|Withdrawal by Subject|0|||
23714517|NCT01486784|66329529|FG002|Overall Study|Withdrawal by Subject|1|||
23416658|NCT01468233|65271222|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23522492|NCT04608500|65650788|FG001|Overall Study|Lost to Follow-up|9|||
23522493|NCT04608500|65650787|FG000|Overall Study|Participant request|11|||
23522494|NCT04608500|65650788|FG001|Overall Study|Participant request|7|||
23522495|NCT04608500|65650787|FG000|Overall Study|Protocol Violation|1|||
23522496|NCT04608500|65650788|FG001|Overall Study|Protocol Violation|0|||
23522497|NCT04608500|65650787|FG000|Overall Study|Other|6|||
23522498|NCT04608500|65650788|FG001|Overall Study|Other|2|||
23714518|NCT01486784|66329530|FG003|Overall Study|Withdrawal by Subject|0|||
23522499|NCT01023581|65650789|FG000|Overall Study|Adverse Event|4|||
23522500|NCT01023581|65650790|FG001|Overall Study|Adverse Event|4|||
23522501|NCT01023581|65650791|FG002|Overall Study|Adverse Event|7|||
23522502|NCT01023581|65650792|FG003|Overall Study|Adverse Event|3|||
23522503|NCT01023581|65650793|FG004|Overall Study|Adverse Event|2|||
23522504|NCT01023581|65650794|FG005|Overall Study|Adverse Event|5|||
23522505|NCT01023581|65650795|FG006|Overall Study|Adverse Event|11|||
23522506|NCT01023581|65650789|FG000|Overall Study|Major protocol deviation|2|||
23522507|NCT01023581|65650790|FG001|Overall Study|Major protocol deviation|0|||
23714519|NCT01486784|66329531|FG004|Overall Study|Withdrawal by Subject|1|||
23714520|NCT01486784|66329532|FG005|Overall Study|Withdrawal by Subject|2|||
23714521|NCT01486784|66329527|FG000|Overall Study|Subject did not meet entry criteria|0|||
23714522|NCT01486784|66329528|FG001|Overall Study|Subject did not meet entry criteria|0|||
23714523|NCT01486784|66329529|FG002|Overall Study|Subject did not meet entry criteria|0|||
23714524|NCT01486784|66329530|FG003|Overall Study|Subject did not meet entry criteria|0|||
23714525|NCT01486784|66329531|FG004|Overall Study|Subject did not meet entry criteria|1|||
23714526|NCT01486784|66329532|FG005|Overall Study|Subject did not meet entry criteria|0|||
23714527|NCT01486784|66329527|FG000|Overall Study|Death|0|||
23714528|NCT01486784|66329528|FG001|Overall Study|Death|0|||
23714529|NCT01486784|66329529|FG002|Overall Study|Death|0|||
23714530|NCT01486784|66329530|FG003|Overall Study|Death|0|||
23714531|NCT01486784|66329531|FG004|Overall Study|Death|0|||
23714532|NCT01486784|66329532|FG005|Overall Study|Death|1|||
23714533|NCT00502320|66329533|FG000|Overall Study|Lost to Follow-up|1|||
23714534|NCT00502320|66329534|FG001|Overall Study|Lost to Follow-up|1|||
23714535|NCT00502320|66329533|FG000|Overall Study|Withdrew Consent|1|||
23522508|NCT01023581|65650791|FG002|Overall Study|Major protocol deviation|3|||
23522509|NCT01023581|65650792|FG003|Overall Study|Major protocol deviation|0|||
23522510|NCT01023581|65650793|FG004|Overall Study|Major protocol deviation|0|||
23522511|NCT01023581|65650794|FG005|Overall Study|Major protocol deviation|0|||
23522512|NCT01023581|65650795|FG006|Overall Study|Major protocol deviation|0|||
23522513|NCT01023581|65650789|FG000|Overall Study|Lost to Follow-up|4|||
23522514|NCT01023581|65650790|FG001|Overall Study|Lost to Follow-up|8|||
23522515|NCT01023581|65650791|FG002|Overall Study|Lost to Follow-up|7|||
23522516|NCT01023581|65650792|FG003|Overall Study|Lost to Follow-up|2|||
23522517|NCT01023581|65650793|FG004|Overall Study|Lost to Follow-up|5|||
23522518|NCT01023581|65650794|FG005|Overall Study|Lost to Follow-up|2|||
23522519|NCT01023581|65650795|FG006|Overall Study|Lost to Follow-up|2|||
23522520|NCT01023581|65650789|FG000|Overall Study|Withdrawal by Subject|13|||
23522521|NCT01023581|65650790|FG001|Overall Study|Withdrawal by Subject|8|||
23522522|NCT01023581|65650791|FG002|Overall Study|Withdrawal by Subject|16|||
23522523|NCT01023581|65650792|FG003|Overall Study|Withdrawal by Subject|10|||
23522524|NCT01023581|65650793|FG004|Overall Study|Withdrawal by Subject|6|||
23522525|NCT01023581|65650794|FG005|Overall Study|Withdrawal by Subject|8|||
23522526|NCT01023581|65650795|FG006|Overall Study|Withdrawal by Subject|5|||
23522527|NCT01023581|65650789|FG000|Overall Study|Pregnancy|0|||
23522528|NCT01023581|65650790|FG001|Overall Study|Pregnancy|0|||
23714536|NCT00502320|66329534|FG001|Overall Study|Withdrew Consent|0|||
23714537|NCT00502320|66329533|FG000|Overall Study|No longer met criteria|1|||
23714538|NCT00502320|66329534|FG001|Overall Study|No longer met criteria|0|||
23522529|NCT01023581|65650791|FG002|Overall Study|Pregnancy|0|||
23522530|NCT01023581|65650792|FG003|Overall Study|Pregnancy|2|||
23522531|NCT01023581|65650793|FG004|Overall Study|Pregnancy|0|||
23522532|NCT01023581|65650794|FG005|Overall Study|Pregnancy|1|||
23522533|NCT01023581|65650795|FG006|Overall Study|Pregnancy|0|||
23522534|NCT01023581|65650789|FG000|Overall Study|Lack of Efficacy|9|||
23522535|NCT01023581|65650790|FG001|Overall Study|Lack of Efficacy|3|||
23522536|NCT01023581|65650791|FG002|Overall Study|Lack of Efficacy|6|||
23522537|NCT01023581|65650792|FG003|Overall Study|Lack of Efficacy|2|||
23522538|NCT01023581|65650793|FG004|Overall Study|Lack of Efficacy|1|||
23522539|NCT01023581|65650794|FG005|Overall Study|Lack of Efficacy|2|||
23522540|NCT01023581|65650795|FG006|Overall Study|Lack of Efficacy|1|||
23522541|NCT01023581|65650789|FG000|Overall Study|Physician Decision|2|||
23522542|NCT01023581|65650790|FG001|Overall Study|Physician Decision|0|||
23522543|NCT01023581|65650791|FG002|Overall Study|Physician Decision|2|||
23522544|NCT01023581|65650792|FG003|Overall Study|Physician Decision|1|||
23522545|NCT01023581|65650793|FG004|Overall Study|Physician Decision|1|||
23522546|NCT01023581|65650794|FG005|Overall Study|Physician Decision|1|||
23522547|NCT01023581|65650795|FG006|Overall Study|Physician Decision|1|||
23522548|NCT01023581|65650789|FG000|Overall Study|Other|1|||
23522549|NCT01023581|65650790|FG001|Overall Study|Other|0|||
23522550|NCT01023581|65650791|FG002|Overall Study|Other|1|||
23522551|NCT01023581|65650792|FG003|Overall Study|Other|0|||
23522552|NCT01023581|65650793|FG004|Overall Study|Other|1|||
23522553|NCT01023581|65650794|FG005|Overall Study|Other|0|||
23522554|NCT01023581|65650795|FG006|Overall Study|Other|0|||
23522555|NCT00291668|65650796|FG000|Overall Study|Lack of Efficacy|1|||
23522556|NCT00291668|65650797|FG001|Overall Study|Lack of Efficacy|0|||
23522557|NCT00291668|65650798|FG002|Overall Study|Lack of Efficacy|0|||
23522558|NCT00291668|65650796|FG000|Overall Study|SAE, non-fatal|1|||
23522559|NCT00291668|65650797|FG001|Overall Study|SAE, non-fatal|1|||
23522560|NCT00291668|65650798|FG002|Overall Study|SAE, non-fatal|1|||
23522561|NCT00291668|65650796|FG000|Overall Study|AE, non-serious non-fatal|1|||
23522562|NCT00291668|65650797|FG001|Overall Study|AE, non-serious non-fatal|0|||
23714539|NCT00502320|66329533|FG000|Overall Study|Screen Failure|0|||
23714540|NCT00502320|66329534|FG001|Overall Study|Screen Failure|1|||
23714541|NCT00502320|66329533|FG000|Overall Study|Adverse Event|3|||
23714542|NCT00502320|66329534|FG001|Overall Study|Adverse Event|5|||
23714543|NCT00441441|66329535|FG000|Overall Study|Adverse Event|2|||
23522563|NCT00291668|65650798|FG002|Overall Study|AE, non-serious non-fatal|0|||
23714544|NCT00441441|66329536|FG001|Overall Study|Adverse Event|1|||
23714545|NCT00441441|66329535|FG000|Overall Study|Protocol Violation|4|||
23714546|NCT00441441|66329536|FG001|Overall Study|Protocol Violation|6|||
23714547|NCT00441441|66329535|FG000|Overall Study|Exacerbation of asthma|1|||
23714548|NCT00441441|66329536|FG001|Overall Study|Exacerbation of asthma|2|||
23714549|NCT00441441|66329535|FG000|Overall Study|Withdrawal by Subject|1|||
23714550|NCT00441441|66329536|FG001|Overall Study|Withdrawal by Subject|2|||
23714551|NCT00441441|66329535|FG000|Overall Study|Other|3|||
23714552|NCT00441441|66329536|FG001|Overall Study|Other|3|||
23714553|NCT05590767|66329537|FG000|Overall Study|Protocol Violation|1|||
23714554|NCT05590767|66329537|FG000|Overall Study|surgery canceled|1|||
23714555|NCT05590767|66329537|FG000|Overall Study|interscalene brachial block not performed|1|||
23714556|NCT02387372|66329538|FG000|Overall Study|Not Treated|1|||
23714557|NCT02387372|66329539|FG001|Overall Study|Not Treated|0|||
23714558|NCT03162055|66329541|FG000|Overall Study|Adverse Event|6|||
23714559|NCT03162055|66329542|FG001|Overall Study|Adverse Event|5|||
23714560|NCT03162055|66329541|FG000|Overall Study|Death|3|||
23714561|NCT03162055|66329542|FG001|Overall Study|Death|3|||
23714562|NCT03162055|66329541|FG000|Overall Study|Lost to Follow-up|0|||
23416659|NCT01468233|65271223|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23416660|NCT01468233|65271218|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
23416661|NCT01468233|65271219|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
23416662|NCT01468233|65271220|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
23416663|NCT01468233|65271221|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
23416664|NCT01468233|65271222|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
23416665|NCT01468233|65271223|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
23416666|NCT01468233|65271218|FG000|Treatment Period 2|Lost to Follow-up|0|||
23416667|NCT01468233|65271219|FG001|Treatment Period 2|Lost to Follow-up|0|||
23416668|NCT01468233|65271220|FG002|Treatment Period 2|Lost to Follow-up|3|||
23416669|NCT01468233|65271221|FG003|Treatment Period 2|Lost to Follow-up|0|||
23416670|NCT01468233|65271222|FG004|Treatment Period 2|Lost to Follow-up|2|||
23416671|NCT01468233|65271223|FG005|Treatment Period 2|Lost to Follow-up|0|||
23416672|NCT01468233|65271218|FG000|Treatment Period 2|Other|0|||
23416673|NCT01468233|65271219|FG001|Treatment Period 2|Other|0|||
23416674|NCT01468233|65271220|FG002|Treatment Period 2|Other|3|||
23416675|NCT01468233|65271221|FG003|Treatment Period 2|Other|0|||
23416676|NCT01468233|65271222|FG004|Treatment Period 2|Other|1|||
23416677|NCT01468233|65271223|FG005|Treatment Period 2|Other|0|||
23714563|NCT03162055|66329542|FG001|Overall Study|Lost to Follow-up|1|||
23416678|NCT00939029|65271232|FG000|Overall Study|Withdrawal by Subject|3|||
23416679|NCT00939029|65271233|FG001|Overall Study|Withdrawal by Subject|7|||
23416680|NCT00939029|65271232|FG000|Overall Study|Lost to Follow-up|3|||
23416681|NCT00939029|65271233|FG001|Overall Study|Lost to Follow-up|4|||
23416682|NCT00939029|65271232|FG000|Overall Study|Adverse Event|0|||
23416683|NCT00939029|65271233|FG001|Overall Study|Adverse Event|1|||
23416684|NCT02550288|65271244|FG000|Overall Study|Adverse Event|0|||
23416685|NCT02550288|65271245|FG001|Overall Study|Adverse Event|1|||
23416686|NCT02550288|65271246|FG002|Overall Study|Adverse Event|0|||
23416687|NCT02550288|65271247|FG003|Overall Study|Adverse Event|0|||
23416688|NCT02550288|65271248|FG004|Overall Study|Adverse Event|0|||
23416689|NCT02550288|65271244|FG000|Overall Study|Physician Decision|0|||
23416690|NCT02550288|65271245|FG001|Overall Study|Physician Decision|0|||
23416691|NCT02550288|65271246|FG002|Overall Study|Physician Decision|0|||
23416692|NCT02550288|65271247|FG003|Overall Study|Physician Decision|1|||
23522564|NCT00291668|65650796|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23522565|NCT00291668|65650797|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23522566|NCT00291668|65650798|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23522567|NCT03168464|65650799|FG000|Overall Study|Death|9|||
23522568|NCT03168464|65650799|FG000|Overall Study|Progression of disease|6|||
23522569|NCT04105998|65650800|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
23522570|NCT04105998|65650801|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
23522571|NCT05402995|65650802|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
23522572|NCT05402995|65650803|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23714564|NCT03162055|66329541|FG000|Overall Study|Study-specific withdrawal criteria|22|||
23714565|NCT03162055|66329542|FG001|Overall Study|Study-specific withdrawal criteria|14|||
23416693|NCT02550288|65271248|FG004|Overall Study|Physician Decision|0|||
23416694|NCT02550288|65271244|FG000|Overall Study|Protocol Violation|2|||
23416695|NCT02550288|65271245|FG001|Overall Study|Protocol Violation|2|||
23416696|NCT02550288|65271246|FG002|Overall Study|Protocol Violation|1|||
23416697|NCT02550288|65271247|FG003|Overall Study|Protocol Violation|0|||
23416698|NCT02550288|65271248|FG004|Overall Study|Protocol Violation|3|||
23714566|NCT03162055|66329541|FG000|Overall Study|Withdrawal by Subject|17|||
23714567|NCT03162055|66329542|FG001|Overall Study|Withdrawal by Subject|2|||
23714568|NCT03162055|66329541|FG000|Overall Study|Did not receive treatment|2|||
23714569|NCT03162055|66329542|FG001|Overall Study|Did not receive treatment|0|||
23522573|NCT05402995|65650804|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23522574|NCT05402995|65650805|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23522575|NCT01124643|65650807|FG000|Overall Study|Death|1|||
23522576|NCT01531387|65650809|FG000|Overall Study|Early termination of study|11|||
23522577|NCT01531387|65650810|FG001|Overall Study|Early termination of study|11|||
23522578|NCT05179421|65650811|FG000|First Infusion Day|Adverse Event|1|||
23522579|NCT05179421|65650812|FG001|First Infusion Day|Adverse Event|0|||
23522580|NCT02865915|65650813|FG000|Overall Study|Pregnancy|1|||
23522581|NCT02865915|65650814|FG001|Overall Study|Pregnancy|0|||
23522582|NCT02865915|65650813|FG000|Overall Study|Withdrawal by Subject|1|||
23522583|NCT02865915|65650814|FG001|Overall Study|Withdrawal by Subject|1|||
23522584|NCT02865915|65650813|FG000|Overall Study|Adverse Event|0|||
23522585|NCT02865915|65650814|FG001|Overall Study|Adverse Event|4|||
23522586|NCT02865915|65650813|FG000|Overall Study|Lost to Follow-up|0|||
23522587|NCT02865915|65650814|FG001|Overall Study|Lost to Follow-up|1|||
23522588|NCT02865915|65650813|FG000|Overall Study|Protocol Violation|0|||
23522589|NCT02865915|65650814|FG001|Overall Study|Protocol Violation|1|||
23522590|NCT02865915|65650813|FG000|Overall Study|Study terminated by sponsor|23|||
23522591|NCT02865915|65650814|FG001|Overall Study|Study terminated by sponsor|18|||
23522592|NCT02865915|65650813|FG000|Overall Study|Dosing group discontinued|0|||
23522593|NCT02865915|65650814|FG001|Overall Study|Dosing group discontinued|5|||
23522594|NCT04307446|65650815|FG000|Overall Study|Lost to Follow-up|2|||
23522595|NCT04307446|65650816|FG001|Overall Study|Lost to Follow-up|0|||
23522596|NCT02226003|65650817|FG000|Overall Study|Lost to Follow-up|2|||
23522597|NCT02226003|65650818|FG001|Overall Study|Lost to Follow-up|1|||
23522598|NCT02226003|65650819|FG002|Overall Study|Lost to Follow-up|3|||
23522599|NCT02226003|65650817|FG000|Overall Study|Withdrawal by Subject|0|||
23522600|NCT02226003|65650818|FG001|Overall Study|Withdrawal by Subject|0|||
23522601|NCT02226003|65650819|FG002|Overall Study|Withdrawal by Subject|3|||
23522602|NCT00451035|65650820|FG000|Overall Study|Disease progression|11|||
23714570|NCT03162055|66329541|FG000|Overall Study|Incorrect randomization|4|||
23714571|NCT03162055|66329542|FG001|Overall Study|Incorrect randomization|3|||
23714572|NCT03162055|66329541|FG000|Overall Study|Other|8|||
23522603|NCT00451035|65650820|FG000|Overall Study|Death|3|||
23714573|NCT03162055|66329542|FG001|Overall Study|Other|15|||
23522604|NCT00451035|65650820|FG000|Overall Study|New anti-neoplastic therapy|3|||
23522605|NCT01524627|65650821|FG000|Overall Study|Physician Decision|0|||
23522606|NCT01524627|65650822|FG001|Overall Study|Physician Decision|1|||
23522607|NCT01524627|65650821|FG000|Overall Study|Lost to Follow-up|1|||
23522608|NCT01524627|65650822|FG001|Overall Study|Lost to Follow-up|1|||
23522609|NCT04211337|65650823|FG000|Overall Study|On Treatment|175|||
23522610|NCT04211337|65650824|FG001|Overall Study|On Treatment|40|||
23522611|NCT04211337|65650823|FG000|Overall Study|Withdrawal by Subject|0|||
23522612|NCT04211337|65650824|FG001|Overall Study|Withdrawal by Subject|2|||
23522613|NCT01350128|65650825|FG000|Overall Study|Withdrawal by Subject|3|||
23522614|NCT01350128|65650825|FG000|Overall Study|Protocol discontinuation criteria|8|||
23522615|NCT01350128|65650825|FG000|Overall Study|Physician Decision|1|||
23522616|NCT01350128|65650825|FG000|Overall Study|Lost to Follow-up|2|||
23714574|NCT00126581|66329544|FG000|Overall Study|Adverse Event|3|||
23714575|NCT00126581|66329545|FG001|Overall Study|Adverse Event|7|||
23714576|NCT00126581|66329544|FG000|Overall Study|Death|3|||
23714577|NCT00126581|66329545|FG001|Overall Study|Death|2|||
23714578|NCT00126581|66329544|FG000|Overall Study|Withdrawal by Subject|1|||
23714579|NCT00126581|66329545|FG001|Overall Study|Withdrawal by Subject|4|||
23714580|NCT00126581|66329544|FG000|Overall Study|Alternative therapy|3|||
23714581|NCT00126581|66329545|FG001|Overall Study|Alternative therapy|3|||
23714582|NCT00126581|66329544|FG000|Overall Study|Other illness/MD discretion|3|||
23714583|NCT00126581|66329545|FG001|Overall Study|Other illness/MD discretion|4|||
23714584|NCT01594333|66329546|FG000|Overall Study|Death|96|||
23714585|NCT01594333|66329547|FG001|Overall Study|Death|83|||
23714586|NCT01594333|66329546|FG000|Overall Study|Lost to Follow-up|5|||
23714587|NCT01594333|66329547|FG001|Overall Study|Lost to Follow-up|5|||
23714588|NCT01594333|66329546|FG000|Overall Study|Withdrawal by Subject|60|||
23714589|NCT01594333|66329547|FG001|Overall Study|Withdrawal by Subject|63|||
23714590|NCT04176445|66329548|FG000|Overall Study|Adverse Event|0|||
23714591|NCT04176445|66329549|FG001|Overall Study|Adverse Event|1|||
23714592|NCT04176445|66329548|FG000|Overall Study|change plans weaning after first intervention|0|||
23714593|NCT04176445|66329549|FG001|Overall Study|change plans weaning after first intervention|1|||
23522617|NCT02253810|65650826|FG000|Overall Study|Withdrawal by Subject|2|||
23522618|NCT02253810|65650827|FG001|Overall Study|Withdrawal by Subject|1|||
23522619|NCT02253810|65650826|FG000|Overall Study|Unknown concomitant procedure|3|||
23714594|NCT03457103|66329550|FG000|Overall Study|illness/hospitalization|4|||
23714595|NCT03457103|66329551|FG001|Overall Study|illness/hospitalization|2|||
23714596|NCT03457103|66329550|FG000|Overall Study|Lost to Follow-up|2|||
23714597|NCT03457103|66329551|FG001|Overall Study|Lost to Follow-up|1|||
23714598|NCT03457103|66329550|FG000|Overall Study|Withdrawal by Subject|1|||
23714599|NCT03457103|66329551|FG001|Overall Study|Withdrawal by Subject|2|||
23714600|NCT03457103|66329550|FG000|Overall Study|financial/ insurance issues|1|||
23522620|NCT02253810|65650827|FG001|Overall Study|Unknown concomitant procedure|2|||
23522621|NCT01400516|65650829|FG000|Primary Trial|Withdrawal by Subject|0|||
23522622|NCT01400516|65650830|FG001|Primary Trial|Withdrawal by Subject|2|||
23522623|NCT02174848|65650832|FG000|Overall Study|Adverse Event|2|||
23522624|NCT02174848|65650833|FG001|Overall Study|Adverse Event|1|||
23522625|NCT02174848|65650832|FG000|Overall Study|Withdrawal by Subject|3|||
23522626|NCT02174848|65650833|FG001|Overall Study|Withdrawal by Subject|3|||
23522627|NCT02174848|65650832|FG000|Overall Study|Lost to Follow-up|0|||
23522628|NCT02174848|65650833|FG001|Overall Study|Lost to Follow-up|1|||
23522629|NCT02174848|65650832|FG000|Overall Study|Worsening of disease|1|||
23522630|NCT02174848|65650833|FG001|Overall Study|Worsening of disease|1|||
23522631|NCT02174848|65650832|FG000|Overall Study|Unable to comply with study requirements|1|||
23522632|NCT02174848|65650833|FG001|Overall Study|Unable to comply with study requirements|0|||
23522633|NCT01765153|65650834|FG000|Training Phase 1|Format of intervention differed|1|||
23522634|NCT01765153|65650835|FG001|Training Phase 1|Format of intervention differed|0|||
23522635|NCT01765153|65650834|FG000|Training Phase 1|Poor participation in intervention|0|||
23522636|NCT01765153|65650835|FG001|Training Phase 1|Poor participation in intervention|1|||
23522637|NCT01765153|65650834|FG000|Rest Phase 1|Withdrawal by Subject|0|||
23522638|NCT01765153|65650835|FG001|Rest Phase 1|Withdrawal by Subject|1|||
23714601|NCT03457103|66329551|FG001|Overall Study|financial/ insurance issues|1|||
23714602|NCT00333619|66329552|FG000|Overall Study|Death|12|||
23714603|NCT00333619|66329553|FG001|Overall Study|Death|6|||
23812142|NCT00372411|66691918|FG002|Overall Study|Adverse Event|0|||
23812143|NCT00895414|66691923|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
23812144|NCT00895414|66691924|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
23522639|NCT01765153|65650834|FG000|Training Phase 2|Withdrawal by Subject|0|||
23522640|NCT01765153|65650835|FG001|Training Phase 2|Withdrawal by Subject|1|||
23522641|NCT01765153|65650834|FG000|Rest Phase 2|Lost to Follow-up|2|||
23522642|NCT01765153|65650835|FG001|Rest Phase 2|Lost to Follow-up|1|||
23522643|NCT03144674|65650844|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
23522644|NCT03144674|65650845|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
23522645|NCT03144674|65650846|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
23714604|NCT00333619|66329552|FG000|Overall Study|Withdrawal by Subject|6|||
23714605|NCT00333619|66329553|FG001|Overall Study|Withdrawal by Subject|1|||
23714606|NCT00333619|66329552|FG000|Overall Study|Lost to Follow-up|3|||
23714607|NCT00333619|66329553|FG001|Overall Study|Lost to Follow-up|3|||
23714608|NCT01654523|66329554|FG000|Overall Study|Withdrawal by Subject|1|||
23714609|NCT02559206|66329555|FG000|Overall Study|Adverse Event|0|||
23714610|NCT02559206|66329556|FG001|Overall Study|Adverse Event|4|||
23416699|NCT02550288|65271244|FG000|Overall Study|Participant moved|0|||
23522646|NCT03144674|65650847|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
23522647|NCT03144674|65650844|FG000|Overall Study|Death|3|||
23522648|NCT03144674|65650845|FG001|Overall Study|Death|1|||
23714611|NCT02559206|66329557|FG002|Overall Study|Adverse Event|1|||
23714612|NCT02559206|66329558|FG003|Overall Study|Adverse Event|5|||
23812145|NCT00895414|66691923|FG000|First Intervention (14 Days)|Physician Decision|0|||
23812146|NCT00895414|66691924|FG001|First Intervention (14 Days)|Physician Decision|1|||
23812147|NCT01561430|66691926|FG000|Overall Study|Adverse Event|0|||
23812148|NCT01561430|66691927|FG001|Overall Study|Adverse Event|0|||
23812149|NCT01561430|66691928|FG002|Overall Study|Adverse Event|3|||
23812150|NCT01561430|66691929|FG003|Overall Study|Adverse Event|1|||
23812151|NCT01561430|66691926|FG000|Overall Study|Withdrawal by Subject|0|||
23812152|NCT01561430|66691927|FG001|Overall Study|Withdrawal by Subject|0|||
23812153|NCT01561430|66691928|FG002|Overall Study|Withdrawal by Subject|1|||
23812154|NCT01561430|66691929|FG003|Overall Study|Withdrawal by Subject|0|||
23812155|NCT01561430|66691926|FG000|Overall Study|Physician Decision|0|||
23812156|NCT01561430|66691927|FG001|Overall Study|Physician Decision|1|||
23812157|NCT01561430|66691928|FG002|Overall Study|Physician Decision|0|||
23812158|NCT01561430|66691929|FG003|Overall Study|Physician Decision|0|||
23812159|NCT01561430|66691926|FG000|Overall Study|Sponsor Decision|1|||
23812160|NCT01561430|66691927|FG001|Overall Study|Sponsor Decision|14|||
23812161|NCT01561430|66691928|FG002|Overall Study|Sponsor Decision|13|||
23812162|NCT01561430|66691929|FG003|Overall Study|Sponsor Decision|12|||
23812163|NCT03127644|66691930|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23522649|NCT03144674|65650846|FG002|Overall Study|Death|1|||
23522650|NCT03144674|65650847|FG003|Overall Study|Death|10|||
23522651|NCT03144674|65650844|FG000|Overall Study|Lost to Follow-up|0|||
23522652|NCT03144674|65650845|FG001|Overall Study|Lost to Follow-up|1|||
23522653|NCT03144674|65650846|FG002|Overall Study|Lost to Follow-up|1|||
23522654|NCT03144674|65650847|FG003|Overall Study|Lost to Follow-up|1|||
23522655|NCT03144674|65650844|FG000|Overall Study|Withdrawal by Participant|0|||
23522656|NCT03144674|65650845|FG001|Overall Study|Withdrawal by Participant|0|||
23522657|NCT03144674|65650846|FG002|Overall Study|Withdrawal by Participant|0|||
23522658|NCT03144674|65650847|FG003|Overall Study|Withdrawal by Participant|3|||
23522659|NCT03144674|65650844|FG000|Overall Study|Reason not Specified|0|||
23522660|NCT03144674|65650845|FG001|Overall Study|Reason not Specified|0|||
23522661|NCT03144674|65650846|FG002|Overall Study|Reason not Specified|2|||
23522662|NCT03144674|65650847|FG003|Overall Study|Reason not Specified|4|||
23522663|NCT00902564|65650848|FG000|Overall Study|Withdrawal by Subject|2|||
23522664|NCT00697515|65650849|FG000|Dose Optimization Period|Adverse Event|4|||
23522665|NCT00697515|65650850|FG001|Dose Optimization Period|Adverse Event|0|||
23522666|NCT00697515|65650849|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
23522667|NCT00697515|65650850|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
23522668|NCT00697515|65650849|FG000|Dose Optimization Period|Lost to Follow-up|2|||
23522669|NCT00697515|65650850|FG001|Dose Optimization Period|Lost to Follow-up|0|||
23522670|NCT00697515|65650849|FG000|Dose Optimization Period|sponsor request|2|||
23522671|NCT00697515|65650850|FG001|Dose Optimization Period|sponsor request|0|||
23522672|NCT00697515|65650849|FG000|Dose Optimization Period|called to active duty|1|||
23522673|NCT00697515|65650850|FG001|Dose Optimization Period|called to active duty|0|||
23522674|NCT00697515|65650849|FG000|Dose Optimization Period|elevated QTc|1|||
23522675|NCT00697515|65650850|FG001|Dose Optimization Period|elevated QTc|0|||
23522676|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
23522677|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
23522678|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
23812164|NCT03127644|66691931|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23522679|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
23522680|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
23522681|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522682|NCT00697515|65650849|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522683|NCT00697515|65650850|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522684|NCT02113956|65650851|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
23522685|NCT02113956|65650852|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
23522686|NCT02113956|65650851|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
23522687|NCT02113956|65650852|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
23522688|NCT02113956|65650851|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
23522689|NCT02113956|65650852|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
23522690|NCT01334866|65653886|FG000|Overall Study|Withdrawal by Subject|10|||
23522691|NCT01334866|65653886|FG000|Overall Study|Lost to Follow-up|3|||
23812165|NCT03127644|66691932|FG002|Overall Study|Study-specific withdrawal criteria|2|||
23812166|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
23812167|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
23812168|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
23812169|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
23812170|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
23812171|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
23812172|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
23812173|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
23812174|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
23522692|NCT01334866|65653886|FG000|Overall Study|Physician Decision|3|||
23522693|NCT01334866|65653886|FG000|Overall Study|medically necessary prior to procedure|2|||
23522694|NCT01334866|65653886|FG000|Overall Study|medically necessary post-procedure|1|||
23522695|NCT01736696|65653889|FG000|Overall Study|Withdrawal by Subject|0|||
23522696|NCT01736696|65653890|FG001|Overall Study|Withdrawal by Subject|0|||
23522697|NCT01736696|65653891|FG002|Overall Study|Withdrawal by Subject|1|||
23522698|NCT01736696|65653892|FG003|Overall Study|Withdrawal by Subject|0|||
23522699|NCT01736696|65653893|FG004|Overall Study|Withdrawal by Subject|0|||
23522700|NCT01736696|65653894|FG005|Overall Study|Withdrawal by Subject|0|||
23522701|NCT01736696|65653895|FG006|Overall Study|Withdrawal by Subject|0|||
23522702|NCT02596854|65653896|FG000|Overall Study|Withdrawn|8|||
23522703|NCT01104636|65653898|FG000|Overall Study|Lack of Efficacy|43|||
23522704|NCT01104636|65653898|FG000|Overall Study|Lost to Follow-up|24|||
23714613|NCT02559206|66329559|FG004|Overall Study|Adverse Event|3|||
23714614|NCT02559206|66329560|FG005|Overall Study|Adverse Event|0|||
23714615|NCT02559206|66329561|FG006|Overall Study|Adverse Event|1|||
23714616|NCT02559206|66329562|FG007|Overall Study|Adverse Event|0|||
23714617|NCT02559206|66329555|FG000|Overall Study|Protocol Violation|1|||
23714618|NCT02559206|66329556|FG001|Overall Study|Protocol Violation|0|||
23714619|NCT02559206|66329557|FG002|Overall Study|Protocol Violation|1|||
23714620|NCT02559206|66329558|FG003|Overall Study|Protocol Violation|0|||
23714621|NCT02559206|66329559|FG004|Overall Study|Protocol Violation|0|||
23714622|NCT02559206|66329560|FG005|Overall Study|Protocol Violation|2|||
23714623|NCT02559206|66329561|FG006|Overall Study|Protocol Violation|0|||
23714624|NCT02559206|66329562|FG007|Overall Study|Protocol Violation|0|||
23714625|NCT02559206|66329555|FG000|Overall Study|Withdrawal by Subject|3|||
23714626|NCT02559206|66329556|FG001|Overall Study|Withdrawal by Subject|3|||
23714627|NCT02559206|66329557|FG002|Overall Study|Withdrawal by Subject|1|||
23714628|NCT02559206|66329558|FG003|Overall Study|Withdrawal by Subject|3|||
23714629|NCT02559206|66329559|FG004|Overall Study|Withdrawal by Subject|5|||
23714630|NCT02559206|66329560|FG005|Overall Study|Withdrawal by Subject|4|||
23714631|NCT02559206|66329561|FG006|Overall Study|Withdrawal by Subject|1|||
23714632|NCT02559206|66329562|FG007|Overall Study|Withdrawal by Subject|2|||
23714633|NCT02559206|66329555|FG000|Overall Study|Lost to Follow-up|3|||
23714634|NCT02559206|66329556|FG001|Overall Study|Lost to Follow-up|5|||
23714635|NCT02559206|66329557|FG002|Overall Study|Lost to Follow-up|3|||
23714636|NCT02559206|66329558|FG003|Overall Study|Lost to Follow-up|3|||
23714637|NCT02559206|66329559|FG004|Overall Study|Lost to Follow-up|2|||
23714638|NCT02559206|66329560|FG005|Overall Study|Lost to Follow-up|5|||
23714639|NCT02559206|66329561|FG006|Overall Study|Lost to Follow-up|1|||
23812175|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
23522705|NCT01104636|65653898|FG000|Overall Study|Withdrawal by Subject|4|||
23522706|NCT01104636|65653898|FG000|Overall Study|Other|43|||
23714640|NCT02559206|66329562|FG007|Overall Study|Lost to Follow-up|4|||
23714641|NCT02559206|66329555|FG000|Overall Study|Lack of Efficacy|1|||
23812176|NCT04771403|66691933|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
23812177|NCT04771403|66691934|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
23812178|NCT04771403|66691933|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
23812179|NCT04771403|66691934|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
23812180|NCT04771403|66691933|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
23812181|NCT04771403|66691934|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
23812182|NCT04647721|66691938|FG000|Overall Study|Withdrawal by Subject|0|||
23812183|NCT04647721|66691939|FG001|Overall Study|Withdrawal by Subject|2|||
23812184|NCT04647721|66691938|FG000|Overall Study|Lost to Follow-up|2|||
23812185|NCT04647721|66691939|FG001|Overall Study|Lost to Follow-up|0|||
23812186|NCT01259115|66691940|FG000|Period 1|Adverse Event|1|||
23812187|NCT01259115|66691941|FG001|Period 1|Adverse Event|0|||
23812188|NCT01259115|66691940|FG000|Period 1|Protocol Violation|2|||
23812189|NCT01259115|66691941|FG001|Period 1|Protocol Violation|0|||
23812190|NCT01259115|66691940|FG000|Period 1|Lost to Follow-up|0|||
23812191|NCT01259115|66691941|FG001|Period 1|Lost to Follow-up|1|||
23812192|NCT01259115|66691940|FG000|Period 2|Adverse Event|1|||
23812193|NCT01259115|66691941|FG001|Period 2|Adverse Event|0|||
23812194|NCT03596151|66691942|FG000|Overall Study|Withdrawal by Subject|1|||
23416700|NCT02550288|65271245|FG001|Overall Study|Participant moved|0|||
23416701|NCT02550288|65271246|FG002|Overall Study|Participant moved|0|||
23416702|NCT02550288|65271247|FG003|Overall Study|Participant moved|1|||
23522707|NCT01104636|65653898|FG000|Overall Study|Study terminated by sponsor|1|||
23714642|NCT02559206|66329556|FG001|Overall Study|Lack of Efficacy|0|||
23714643|NCT02559206|66329557|FG002|Overall Study|Lack of Efficacy|3|||
23714644|NCT02559206|66329558|FG003|Overall Study|Lack of Efficacy|2|||
23714645|NCT02559206|66329559|FG004|Overall Study|Lack of Efficacy|2|||
23714646|NCT02559206|66329560|FG005|Overall Study|Lack of Efficacy|3|||
23714647|NCT02559206|66329561|FG006|Overall Study|Lack of Efficacy|3|||
23714648|NCT02559206|66329562|FG007|Overall Study|Lack of Efficacy|3|||
23416703|NCT02550288|65271248|FG004|Overall Study|Participant moved|0|||
23522708|NCT01104636|65653898|FG000|Overall Study|Pregnancy|2|||
23522709|NCT01104636|65653898|FG000|Overall Study|Adverse Event|40|||
23714649|NCT02559206|66329555|FG000|Overall Study|Other Not Specified|0|||
23714650|NCT02559206|66329556|FG001|Overall Study|Other Not Specified|0|||
23714651|NCT02559206|66329557|FG002|Overall Study|Other Not Specified|0|||
23714652|NCT02559206|66329558|FG003|Overall Study|Other Not Specified|1|||
23714653|NCT02559206|66329559|FG004|Overall Study|Other Not Specified|0|||
23714654|NCT02559206|66329560|FG005|Overall Study|Other Not Specified|0|||
23714655|NCT02559206|66329561|FG006|Overall Study|Other Not Specified|0|||
23714656|NCT02559206|66329562|FG007|Overall Study|Other Not Specified|0|||
23714657|NCT03543358|66329563|FG000|Overall Study|Death|1|||
23714658|NCT03543358|66329564|FG001|Overall Study|Death|0|||
23714659|NCT03543358|66329563|FG000|Overall Study|Disease Progression|1|||
23714660|NCT03543358|66329564|FG001|Overall Study|Disease Progression|0|||
23714661|NCT03543358|66329563|FG000|Overall Study|Parent Study Closure|1|||
23714662|NCT03543358|66329564|FG001|Overall Study|Parent Study Closure|0|||
23714663|NCT00762372|66329566|FG000|Overall Study|Adverse Event|1|||
23714664|NCT00762372|66329567|FG001|Overall Study|Adverse Event|0|||
23714665|NCT00762372|66329568|FG002|Overall Study|Adverse Event|0|||
23714666|NCT03017846|66329573|FG000|Overall Study|Lost to Follow-up|3|||
23714667|NCT03017846|66329573|FG000|Overall Study|Adverse Event|2|||
23416704|NCT02550288|65271244|FG000|Overall Study|Withdrawal by Subject|0|||
23416705|NCT02550288|65271245|FG001|Overall Study|Withdrawal by Subject|0|||
23416706|NCT02550288|65271246|FG002|Overall Study|Withdrawal by Subject|0|||
23416707|NCT02550288|65271247|FG003|Overall Study|Withdrawal by Subject|1|||
23416708|NCT02550288|65271248|FG004|Overall Study|Withdrawal by Subject|0|||
23416709|NCT00290771|65271249|FG000|Overall Study|Disease progression|95|||
23416710|NCT00290771|65271250|FG001|Overall Study|Disease progression|73|||
23416711|NCT00290771|65271249|FG000|Overall Study|Death|11|||
23416712|NCT00290771|65271250|FG001|Overall Study|Death|10|||
23416713|NCT00290771|65271249|FG000|Overall Study|Adverse Event|12|||
23416714|NCT00290771|65271250|FG001|Overall Study|Adverse Event|6|||
23416715|NCT00290771|65271249|FG000|Overall Study|Withdrawal by Subject|5|||
23416716|NCT00290771|65271250|FG001|Overall Study|Withdrawal by Subject|6|||
23416717|NCT00290771|65271249|FG000|Overall Study|Administrative problems|2|||
23416718|NCT00290771|65271250|FG001|Overall Study|Administrative problems|1|||
23416719|NCT00290771|65271249|FG000|Overall Study|Protocol Violation|2|||
23714668|NCT03954444|66329576|FG000|Overall Study|Withdrawal by Subject|5|||
23714669|NCT03954444|66329577|FG001|Overall Study|Withdrawal by Subject|5|||
23714670|NCT03954444|66329578|FG002|Overall Study|Withdrawal by Subject|5|||
23714671|NCT03954444|66329576|FG000|Overall Study|Adverse Event|1|||
23714672|NCT03954444|66329577|FG001|Overall Study|Adverse Event|3|||
23714673|NCT03954444|66329578|FG002|Overall Study|Adverse Event|2|||
23714674|NCT03954444|66329576|FG000|Overall Study|Protocol Violation|0|||
23714675|NCT03954444|66329577|FG001|Overall Study|Protocol Violation|3|||
23416720|NCT00290771|65271250|FG001|Overall Study|Protocol Violation|0|||
23416721|NCT00290771|65271249|FG000|Overall Study|Lost to Follow-up|0|||
23522710|NCT01104636|65653898|FG000|Overall Study|Ongoing|21|||
23522711|NCT00302458|65653899|FG000|Overall Study|Lost to Follow-up|1|||
23522712|NCT00302458|65653899|FG000|Overall Study|Ineligible after screening|1|||
23522713|NCT00302458|65653899|FG000|Overall Study|Withdrawal by Subject|1|||
23522714|NCT01727141|65653923|FG000|Overall Study|Physician Decision|0|||
23522715|NCT01727141|65653924|FG001|Overall Study|Physician Decision|1|||
23522716|NCT01727141|65653925|FG002|Overall Study|Physician Decision|0|||
23522717|NCT01727141|65653926|FG003|Overall Study|Physician Decision|2|||
23522718|NCT01727141|65653923|FG000|Overall Study|Lost to Follow-up|0|||
23522719|NCT01727141|65653924|FG001|Overall Study|Lost to Follow-up|2|||
23522720|NCT01727141|65653925|FG002|Overall Study|Lost to Follow-up|0|||
23522721|NCT01727141|65653926|FG003|Overall Study|Lost to Follow-up|0|||
23522722|NCT01727141|65653923|FG000|Overall Study|Death|0|||
23522723|NCT01727141|65653924|FG001|Overall Study|Death|1|||
23522724|NCT01727141|65653925|FG002|Overall Study|Death|1|||
23522725|NCT01727141|65653926|FG003|Overall Study|Death|1|||
23522726|NCT01727141|65653923|FG000|Overall Study|Protocol deviation|1|||
23522727|NCT01727141|65653924|FG001|Overall Study|Protocol deviation|1|||
23522728|NCT01727141|65653925|FG002|Overall Study|Protocol deviation|0|||
23522729|NCT01727141|65653926|FG003|Overall Study|Protocol deviation|1|||
23522730|NCT01727141|65653923|FG000|Overall Study|Withdrawal by Subject|4|||
23522731|NCT01727141|65653924|FG001|Overall Study|Withdrawal by Subject|4|||
23416722|NCT00290771|65271250|FG001|Overall Study|Lost to Follow-up|1|||
23714676|NCT03954444|66329578|FG002|Overall Study|Protocol Violation|5|||
23714677|NCT03954444|66329576|FG000|Overall Study|Use of prohibited therapy|1|||
23714678|NCT03954444|66329577|FG001|Overall Study|Use of prohibited therapy|1|||
23522732|NCT01727141|65653925|FG002|Overall Study|Withdrawal by Subject|2|||
23714679|NCT03954444|66329578|FG002|Overall Study|Use of prohibited therapy|2|||
23714680|NCT03954444|66329576|FG000|Overall Study|Lost to Follow-up|1|||
23416723|NCT01895543|65271251|FG000|Overall Study|Withdrawal by Subject|43|||
23416724|NCT01895543|65271251|FG000|Overall Study|Lost to Follow-up|25|||
23416725|NCT01895543|65271251|FG000|Overall Study|Adverse Event|28|||
23416726|NCT01895543|65271251|FG000|Overall Study|Subject's substantial non-compliance|6|||
23416727|NCT01895543|65271251|FG000|Overall Study|Protocol Violation|1|||
23522733|NCT01727141|65653926|FG003|Overall Study|Withdrawal by Subject|11|||
23522734|NCT01462357|65653934|FG000|Overall Study|Death|0|||
23714681|NCT03954444|66329577|FG001|Overall Study|Lost to Follow-up|0|||
23522735|NCT01462357|65653935|FG001|Overall Study|Death|0|||
23522736|NCT01462357|65653936|FG002|Overall Study|Death|1|||
23522737|NCT01462357|65653934|FG000|Overall Study|Withdrawal by Subject|3|||
23522738|NCT01462357|65653935|FG001|Overall Study|Withdrawal by Subject|11|||
23522739|NCT01462357|65653936|FG002|Overall Study|Withdrawal by Subject|3|||
23522740|NCT01462357|65653934|FG000|Overall Study|Migrated/moved from study area|2|||
23522741|NCT01462357|65653935|FG001|Overall Study|Migrated/moved from study area|3|||
23522742|NCT01462357|65653936|FG002|Overall Study|Migrated/moved from study area|1|||
23522743|NCT01462357|65653934|FG000|Overall Study|Lost to Follow-up|3|||
23522744|NCT01462357|65653935|FG001|Overall Study|Lost to Follow-up|5|||
23522745|NCT01462357|65653936|FG002|Overall Study|Lost to Follow-up|7|||
23522746|NCT01398956|65653944|FG000|Overall Study|Withdrawal by Subject|4|||
23522747|NCT01398956|65653944|FG000|Overall Study|AE, non-serious non-fatal|4|||
23522748|NCT01398956|65653944|FG000|Overall Study|Withdrawal Criteria No.3|1|||
23522749|NCT01398956|65653944|FG000|Overall Study|Subject moved a long distance|1|||
23522750|NCT00706641|65653948|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
23522751|NCT00706641|65653948|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
23522752|NCT00706641|65653948|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
23522753|NCT01851720|65653949|FG000|Overall Study|Lost to Follow-up|0|||
23522754|NCT01851720|65653950|FG001|Overall Study|Lost to Follow-up|1|||
23522755|NCT04248816|65653952|FG000|Overall Study|Ineligible post-randomization|7|||
23522756|NCT04248816|65653953|FG001|Overall Study|Ineligible post-randomization|21|||
23522757|NCT04248816|65653954|FG002|Overall Study|Ineligible post-randomization|25|||
23522758|NCT02141997|65653958|FG000|Overall Study|Adverse Event|0|||
23522759|NCT02141997|65653959|FG001|Overall Study|Adverse Event|2|||
23522760|NCT02141997|65653960|FG002|Overall Study|Adverse Event|0|||
23522761|NCT02141997|65653961|FG003|Overall Study|Adverse Event|1|||
23522762|NCT02141997|65653958|FG000|Overall Study|Participant noncompliance|1|||
23416728|NCT01895543|65271251|FG000|Overall Study|Physician Decision|2|||
23416729|NCT01895543|65271251|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
23416730|NCT02789345|65271258|FG000|Overall Study|Adverse Event|0|||
23416731|NCT02789345|65271259|FG001|Overall Study|Adverse Event|0|||
23416732|NCT02789345|65271260|FG002|Overall Study|Adverse Event|1|||
23416733|NCT02789345|65271258|FG000|Overall Study|Death|0|||
23416734|NCT02789345|65271259|FG001|Overall Study|Death|0|||
23416735|NCT02789345|65271260|FG002|Overall Study|Death|1|||
23416736|NCT02789345|65271258|FG000|Overall Study|Physician Decision|2|||
23416737|NCT02789345|65271259|FG001|Overall Study|Physician Decision|0|||
23416738|NCT02789345|65271260|FG002|Overall Study|Physician Decision|1|||
23416739|NCT02789345|65271258|FG000|Overall Study|Progressive Disease|1|||
23416740|NCT02789345|65271259|FG001|Overall Study|Progressive Disease|3|||
23416741|NCT02789345|65271260|FG002|Overall Study|Progressive Disease|14|||
23416742|NCT00441142|65271261|FG000|Overall Study|Adverse Event|2|||
23416743|NCT00441142|65271262|FG001|Overall Study|Adverse Event|3|||
23416744|NCT00441142|65271263|FG002|Overall Study|Adverse Event|3|||
23416745|NCT00441142|65271264|FG003|Overall Study|Adverse Event|22|||
23416746|NCT00441142|65271261|FG000|Overall Study|Lack of Efficacy|3|||
23416747|NCT00441142|65271262|FG001|Overall Study|Lack of Efficacy|3|||
23416748|NCT00441142|65271263|FG002|Overall Study|Lack of Efficacy|17|||
23416749|NCT00441142|65271264|FG003|Overall Study|Lack of Efficacy|32|||
23416750|NCT00441142|65271261|FG000|Overall Study|Withdrawal by Subject|0|||
23416751|NCT00441142|65271262|FG001|Overall Study|Withdrawal by Subject|0|||
23416752|NCT00441142|65271263|FG002|Overall Study|Withdrawal by Subject|2|||
23416753|NCT00441142|65271264|FG003|Overall Study|Withdrawal by Subject|10|||
23416754|NCT00441142|65271261|FG000|Overall Study|Patient still receiving active study tx|1|||
23416755|NCT00441142|65271262|FG001|Overall Study|Patient still receiving active study tx|0|||
23416756|NCT00441142|65271263|FG002|Overall Study|Patient still receiving active study tx|0|||
23416757|NCT00441142|65271264|FG003|Overall Study|Patient still receiving active study tx|2|||
23416758|NCT00441142|65271261|FG000|Overall Study|Physician Decision|0|||
23416759|NCT00441142|65271262|FG001|Overall Study|Physician Decision|1|||
23416760|NCT00441142|65271263|FG002|Overall Study|Physician Decision|0|||
23416761|NCT00441142|65271264|FG003|Overall Study|Physician Decision|1|||
23522763|NCT02141997|65653959|FG001|Overall Study|Participant noncompliance|0|||
23522764|NCT02141997|65653960|FG002|Overall Study|Participant noncompliance|0|||
23522765|NCT02141997|65653961|FG003|Overall Study|Participant noncompliance|0|||
23522766|NCT02141997|65653958|FG000|Overall Study|Withdrew consent|1|||
23416762|NCT00441142|65271261|FG000|Overall Study|Death|0|||
23416763|NCT00441142|65271262|FG001|Overall Study|Death|0|||
23416764|NCT00441142|65271263|FG002|Overall Study|Death|0|||
23416765|NCT00441142|65271264|FG003|Overall Study|Death|1|||
23416766|NCT01190475|65271265|FG000|Overall Study|Withdrawal by Subject|0|||
23416767|NCT01190475|65271266|FG001|Overall Study|Withdrawal by Subject|0|||
23416768|NCT01190475|65271267|FG002|Overall Study|Withdrawal by Subject|1|||
23416769|NCT03928418|65271268|FG000|Overall Study|Lost to Follow-up|5|||
23416770|NCT03928418|65271269|FG001|Overall Study|Lost to Follow-up|3|||
23522767|NCT02141997|65653959|FG001|Overall Study|Withdrew consent|0|||
23522768|NCT02141997|65653960|FG002|Overall Study|Withdrew consent|3|||
23522769|NCT02141997|65653961|FG003|Overall Study|Withdrew consent|0|||
23522770|NCT02141997|65653958|FG000|Overall Study|Other|1|||
23522771|NCT02141997|65653959|FG001|Overall Study|Other|4|||
23522772|NCT02141997|65653960|FG002|Overall Study|Other|0|||
23522773|NCT02141997|65653961|FG003|Overall Study|Other|0|||
23522774|NCT02622828|65653964|FG000|Overall Study|participant withdrew|3|||
23522775|NCT01817725|65653967|FG000|Overall Study|Withdrawal by Subject|1|||
23522776|NCT01324388|65653968|FG000|Part 1 of Study|Adverse Event|2|||
23522777|NCT01324388|65653969|FG001|Part 1 of Study|Adverse Event|0|||
23522778|NCT01324388|65653970|FG002|Part 1 of Study|Adverse Event|0|||
23522779|NCT01324388|65653971|FG003|Part 1 of Study|Adverse Event|0|||
23522780|NCT01324388|65653968|FG000|Part 1 of Study|Protocol Violation|1|||
23522781|NCT01324388|65653969|FG001|Part 1 of Study|Protocol Violation|2|||
23522782|NCT01324388|65653970|FG002|Part 1 of Study|Protocol Violation|0|||
23522783|NCT01324388|65653971|FG003|Part 1 of Study|Protocol Violation|0|||
23522784|NCT01324388|65653968|FG000|Part 1 of Study|Physician Decision|1|||
23522785|NCT01324388|65653969|FG001|Part 1 of Study|Physician Decision|0|||
23522786|NCT01324388|65653970|FG002|Part 1 of Study|Physician Decision|0|||
23522787|NCT01324388|65653971|FG003|Part 1 of Study|Physician Decision|0|||
23522788|NCT01324388|65653968|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522789|NCT01324388|65653969|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522790|NCT01324388|65653970|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522791|NCT01324388|65653971|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
23522792|NCT01324388|65653968|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522793|NCT01324388|65653969|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522794|NCT01324388|65653970|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
23522795|NCT01324388|65653971|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522796|NCT00048542|65653972|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23522797|NCT00048542|65653973|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23522798|NCT00048542|65653974|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23522799|NCT00048542|65653975|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23522800|NCT00048542|65653976|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23522801|NCT00048542|65653977|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
23522802|NCT00048542|65653978|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
23522803|NCT00048542|65653979|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
23522804|NCT00048542|65653972|FG000|Double-Blind Phase|Protocol Violation|0|||
23522805|NCT00048542|65653973|FG001|Double-Blind Phase|Protocol Violation|0|||
23522806|NCT00048542|65653974|FG002|Double-Blind Phase|Protocol Violation|1|||
23522807|NCT00048542|65653975|FG003|Double-Blind Phase|Protocol Violation|0|||
23522808|NCT00048542|65653976|FG004|Double-Blind Phase|Protocol Violation|0|||
23522809|NCT00048542|65653977|FG005|Double-Blind Phase|Protocol Violation|0|||
23522810|NCT00048542|65653978|FG006|Double-Blind Phase|Protocol Violation|0|||
23812195|NCT00160641|66691947|FG000|Overall Study|Adverse Event|102|||
23812196|NCT00160641|66691947|FG000|Overall Study|Withdrawal by Subject|87|||
23812197|NCT00160641|66691947|FG000|Overall Study|Lost to Follow-up|8|||
23812198|NCT00160641|66691947|FG000|Overall Study|Lack of Efficacy|12|||
23812199|NCT00160641|66691947|FG000|Overall Study|Protocol Violation|3|||
23812200|NCT00160641|66691947|FG000|Overall Study|Other|9|||
23812201|NCT00311402|66691948|FG000|Overall Study|Adverse Event|118|||
23812202|NCT00311402|66691949|FG001|Overall Study|Adverse Event|105|||
23812203|NCT00311402|66691948|FG000|Overall Study|Lost to Follow-up|0|||
23812204|NCT00311402|66691949|FG001|Overall Study|Lost to Follow-up|3|||
23812205|NCT00311402|66691948|FG000|Overall Study|Withdrawal by Subject|17|||
23812206|NCT00311402|66691949|FG001|Overall Study|Withdrawal by Subject|18|||
23812207|NCT00311402|66691948|FG000|Overall Study|Lack of Efficacy|58|||
23812208|NCT00311402|66691949|FG001|Overall Study|Lack of Efficacy|42|||
23812209|NCT00311402|66691948|FG000|Overall Study|Protocol Violation|7|||
23812210|NCT00311402|66691949|FG001|Overall Study|Protocol Violation|6|||
23812211|NCT00311402|66691948|FG000|Overall Study|IRB's rejection etc.|10|||
23812212|NCT00311402|66691949|FG001|Overall Study|IRB's rejection etc.|3|||
23812213|NCT02149108|66691950|FG000|Overall Study|Not treated|1|||
23812214|NCT02149108|66691951|FG001|Overall Study|Not treated|2|||
23812215|NCT02149108|66691950|FG000|Overall Study|Progressive Disease (PD)|324|||
23812216|NCT02149108|66691951|FG001|Overall Study|Progressive Disease (PD)|318|||
23522811|NCT00048542|65653979|FG007|Double-Blind Phase|Protocol Violation|0|||
23522812|NCT00048542|65653972|FG000|Double-Blind Phase|Sponsor request or decision|2|||
23812217|NCT02149108|66691950|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
23812218|NCT02149108|66691951|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
23416771|NCT03928418|65271270|FG002|Overall Study|Lost to Follow-up|5|||
23522813|NCT00048542|65653973|FG001|Double-Blind Phase|Sponsor request or decision|0|||
23522814|NCT00048542|65653974|FG002|Double-Blind Phase|Sponsor request or decision|0|||
23522815|NCT00048542|65653975|FG003|Double-Blind Phase|Sponsor request or decision|0|||
23812219|NCT02149108|66691950|FG000|Overall Study|Other Adverse Event (AE)|8|||
23812220|NCT02149108|66691951|FG001|Overall Study|Other Adverse Event (AE)|18|||
23812221|NCT02149108|66691950|FG000|Overall Study|Other not defined above|0|||
23812222|NCT02149108|66691951|FG001|Overall Study|Other not defined above|2|||
23416772|NCT03928418|65271268|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
23416773|NCT03928418|65271269|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
23416774|NCT03928418|65271270|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
23416775|NCT00218634|65271271|FG000|Overall Study|Lost to Follow-up|8|||
23416776|NCT00218634|65271272|FG001|Overall Study|Lost to Follow-up|15|||
23416777|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
23416778|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
23416779|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
23416780|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
23416781|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
23416782|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
23522816|NCT00048542|65653976|FG004|Double-Blind Phase|Sponsor request or decision|0|||
23522817|NCT00048542|65653977|FG005|Double-Blind Phase|Sponsor request or decision|0|||
23522818|NCT00048542|65653978|FG006|Double-Blind Phase|Sponsor request or decision|0|||
23522819|NCT00048542|65653979|FG007|Double-Blind Phase|Sponsor request or decision|0|||
23416783|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
23416784|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
23416785|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
23522820|NCT00048542|65653972|FG000|Double-Blind Phase|Randomized in error|1|||
23522821|NCT00048542|65653973|FG001|Double-Blind Phase|Randomized in error|0|||
23522822|NCT00048542|65653974|FG002|Double-Blind Phase|Randomized in error|0|||
23522823|NCT00048542|65653975|FG003|Double-Blind Phase|Randomized in error|0|||
23522824|NCT00048542|65653976|FG004|Double-Blind Phase|Randomized in error|0|||
23522825|NCT00048542|65653977|FG005|Double-Blind Phase|Randomized in error|0|||
23522826|NCT00048542|65653978|FG006|Double-Blind Phase|Randomized in error|0|||
23522827|NCT00048542|65653979|FG007|Double-Blind Phase|Randomized in error|0|||
23522828|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522829|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522830|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522831|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522832|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
23522833|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
23522834|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522835|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522836|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522837|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522838|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522839|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522840|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522841|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
23522842|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522843|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522844|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522845|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522846|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522847|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522848|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
23522849|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
23522850|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522851|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23714682|NCT03954444|66329578|FG002|Overall Study|Lost to Follow-up|1|||
23714683|NCT03954444|66329576|FG000|Overall Study|Non-compliant with study drug application|2|||
23714684|NCT03954444|66329577|FG001|Overall Study|Non-compliant with study drug application|2|||
23714685|NCT03954444|66329578|FG002|Overall Study|Non-compliant with study drug application|0|||
23714686|NCT03954444|66329576|FG000|Overall Study|Administrative reasons|0|||
23714687|NCT03954444|66329577|FG001|Overall Study|Administrative reasons|0|||
23714688|NCT03954444|66329578|FG002|Overall Study|Administrative reasons|1|||
23714689|NCT03954444|66329576|FG000|Overall Study|Miscellaneous|3|||
23714690|NCT03954444|66329577|FG001|Overall Study|Miscellaneous|2|||
23714691|NCT03954444|66329578|FG002|Overall Study|Miscellaneous|1|||
23714692|NCT00565058|66329579|FG000|Overall Study|Adverse Event|1|||
23714693|NCT00565058|66329580|FG001|Overall Study|Adverse Event|0|||
23714694|NCT03550131|66329581|FG000|Overall Study|Lost to Follow-up|16|||
23714695|NCT03550131|66329582|FG001|Overall Study|Lost to Follow-up|24|||
23714696|NCT03550131|66329581|FG000|Overall Study|Withdrawal by Subject|36|||
23714697|NCT03550131|66329582|FG001|Overall Study|Withdrawal by Subject|28|||
23416786|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
23714698|NCT03550131|66329581|FG000|Overall Study|Illness of dyad member|10|||
23416787|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
23714699|NCT03550131|66329582|FG001|Overall Study|Illness of dyad member|2|||
23714700|NCT03550131|66329581|FG000|Overall Study|Death of person with dementia|4|||
23714701|NCT03550131|66329582|FG001|Overall Study|Death of person with dementia|8|||
23714702|NCT00433446|66329583|FG000|Overall Study|Adverse Event|4|||
23714703|NCT00433446|66329583|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23522852|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
23522853|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
23522854|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
23522855|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
23522856|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
23522857|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
23522858|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
23522859|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
23522860|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522861|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522862|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522863|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522864|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
23522865|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
23522866|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522867|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522868|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522869|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522870|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522871|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522872|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522873|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522874|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
23522875|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
23522876|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522877|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522878|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522879|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522880|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522881|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522882|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
23522883|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
23522884|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522885|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522886|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522887|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522888|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522889|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522890|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
23522891|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
23522892|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522893|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522894|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522895|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522896|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522897|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522898|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
23522899|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
23522900|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522901|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522902|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522903|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522904|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522905|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522906|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
23522907|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
23522908|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23714704|NCT00433446|66329583|FG000|Overall Study|Progression|44|||
23714705|NCT00433446|66329583|FG000|Overall Study|Other - Not Protocol specified|3|||
23812223|NCT02149108|66691950|FG000|Overall Study|Refusal to continue trial medication|15|||
23812224|NCT02149108|66691951|FG001|Overall Study|Refusal to continue trial medication|11|||
23522909|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522910|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522911|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522912|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522913|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522914|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
23522915|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
23522916|NCT02098109|65653980|FG000|Overall Study|Protocol Violation|3|||
23522917|NCT02098109|65653981|FG001|Overall Study|Protocol Violation|0|||
23522918|NCT01505608|65653982|FG000|Phase I|Lack of Efficacy|0|||
23522919|NCT01505608|65653983|FG001|Phase I|Lack of Efficacy|4|||
23522920|NCT01505608|65653982|FG000|Phase I|Adverse Event|0|||
23522921|NCT01505608|65653983|FG001|Phase I|Adverse Event|1|||
23522922|NCT01505608|65653982|FG000|Phase I|Withdrawal by Subject|0|||
23522923|NCT01505608|65653983|FG001|Phase I|Withdrawal by Subject|1|||
23522924|NCT01505608|65653982|FG000|Phase II|Lack of Efficacy|2|||
23522925|NCT01505608|65653983|FG001|Phase II|Lack of Efficacy|1|||
23522926|NCT01505608|65653982|FG000|Phase II|Protocol Violation|0|||
23522927|NCT01505608|65653983|FG001|Phase II|Protocol Violation|1|||
23522928|NCT00314366|65653984|FG000|Overall Study|not treated due to patient medical condi|1|||
23714706|NCT00433446|66329583|FG000|Overall Study|Ineligible|9|||
23714707|NCT01757405|66329584|FG000|Overall Study|Lost to Follow-up|1|||
23714708|NCT01757405|66329585|FG001|Overall Study|Lost to Follow-up|1|||
23714709|NCT01757405|66329584|FG000|Overall Study|Withdrawal by Subject|0|||
23714710|NCT01757405|66329585|FG001|Overall Study|Withdrawal by Subject|1|||
23522929|NCT00314366|65653985|FG001|Overall Study|not treated due to patient medical condi|0|||
23522930|NCT00542919|65653986|FG000|Overall Study|Adverse Event|1|||
23522931|NCT00542919|65653987|FG001|Overall Study|Adverse Event|5|||
23522932|NCT00542919|65653988|FG002|Overall Study|Adverse Event|1|||
23522933|NCT00542919|65653986|FG000|Overall Study|Withdrawal by Subject|1|||
23522934|NCT00542919|65653987|FG001|Overall Study|Withdrawal by Subject|0|||
23522935|NCT00542919|65653988|FG002|Overall Study|Withdrawal by Subject|3|||
23522936|NCT00542919|65653986|FG000|Overall Study|Physician Decision|2|||
23522937|NCT00542919|65653987|FG001|Overall Study|Physician Decision|2|||
23522938|NCT00542919|65653988|FG002|Overall Study|Physician Decision|1|||
23522939|NCT00542919|65653986|FG000|Overall Study|Sponsor Decision|1|||
23522940|NCT00542919|65653987|FG001|Overall Study|Sponsor Decision|0|||
23522941|NCT00542919|65653988|FG002|Overall Study|Sponsor Decision|0|||
23522942|NCT00542919|65653986|FG000|Overall Study|Lost to Follow-up|2|||
23522943|NCT00542919|65653987|FG001|Overall Study|Lost to Follow-up|0|||
23522944|NCT00542919|65653988|FG002|Overall Study|Lost to Follow-up|1|||
23522945|NCT02046148|65653993|FG000|Overall Study|Lost to Follow-up|1|||
23522946|NCT02046148|65653994|FG001|Overall Study|Lost to Follow-up|1|||
23522947|NCT02046148|65653993|FG000|Overall Study|Withdrawal by Subject|0|||
23714711|NCT04124692|66329586|FG000|Overall Study|Medical reason|0|||
23714712|NCT04124692|66329587|FG001|Overall Study|Medical reason|1|||
23714713|NCT04124692|66329586|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
23714714|NCT04124692|66329587|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
23714715|NCT04124692|66329586|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
23714716|NCT04124692|66329587|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
23714717|NCT04124692|66329586|FG000|Overall Study|Lost to Follow-up|2|||
23714718|NCT04124692|66329587|FG001|Overall Study|Lost to Follow-up|4|||
23714719|NCT04124692|66329586|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
23714720|NCT04124692|66329587|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
23812225|NCT02149108|66691950|FG000|Overall Study|Lost to Follow-up|1|||
23812226|NCT02149108|66691951|FG001|Overall Study|Lost to Follow-up|0|||
23522948|NCT02046148|65653994|FG001|Overall Study|Withdrawal by Subject|2|||
23522949|NCT01928862|65653996|FG000|Overall Study|Lost to Follow-up|1|||
23522950|NCT01928862|65653997|FG001|Overall Study|Lost to Follow-up|0|||
23522951|NCT01928862|65653998|FG002|Overall Study|Lost to Follow-up|0|||
23522952|NCT01928862|65653999|FG003|Overall Study|Lost to Follow-up|0|||
23522953|NCT01928862|65654000|FG004|Overall Study|Lost to Follow-up|1|||
23522954|NCT04753164|65654001|FG000|Overall Study|Adverse Event|0|||
23522955|NCT04753164|65654002|FG001|Overall Study|Adverse Event|2|||
23522956|NCT04753164|65654001|FG000|Overall Study|Withdrawal by Subject|9|||
23522957|NCT04753164|65654002|FG001|Overall Study|Withdrawal by Subject|7|||
23812227|NCT02303041|66691953|FG000|Overall Study|Adverse Event|1|||
23812228|NCT02303041|66691954|FG001|Overall Study|Adverse Event|2|||
23522958|NCT04753164|65654001|FG000|Overall Study|Lost to Follow-up|6|||
23522959|NCT04753164|65654002|FG001|Overall Study|Lost to Follow-up|6|||
23522960|NCT04753164|65654001|FG000|Overall Study|Other|12|||
23522961|NCT04753164|65654002|FG001|Overall Study|Other|5|||
23522962|NCT04014075|65654005|FG000|Overall Study|Progressive Disease|48|||
23522963|NCT04014075|65654005|FG000|Overall Study|Adverse Event|11|||
23522964|NCT04014075|65654005|FG000|Overall Study|Clinical Progression|4|||
23714721|NCT00634114|66329588|FG000|Overall Study|Adverse Event|6|||
23522965|NCT04014075|65654005|FG000|Overall Study|Death|2|||
23522966|NCT04014075|65654005|FG000|Overall Study|Withdrawal by Subject|2|||
23522967|NCT04014075|65654005|FG000|Overall Study|Miscellaneous|1|||
23522968|NCT04014075|65654005|FG000|Overall Study|Physician Decision|1|||
23522969|NCT01660412|65654006|FG000|Overall Study|Protocol Violation|0|||
23522970|NCT01660412|65654007|FG001|Overall Study|Protocol Violation|3|||
23522971|NCT00588822|65654009|FG000|Overall Study|progression of disease|8|||
23522972|NCT03465878|65654010|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522973|NCT03465878|65654011|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
23522974|NCT03465878|65654012|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522975|NCT03465878|65654013|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522976|NCT03465878|65654010|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522977|NCT03465878|65654011|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522978|NCT03465878|65654012|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522979|NCT03465878|65654013|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
23522980|NCT03465878|65654010|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522981|NCT03465878|65654011|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522982|NCT03465878|65654012|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522983|NCT03465878|65654013|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
23522984|NCT03388138|65654014|FG000|Overall Study|Protocol Violation|1|||
23522985|NCT03388138|65654015|FG001|Overall Study|Protocol Violation|0|||
23522986|NCT01187043|65654017|FG000|Overall Study|Adverse Event|0|||
23522987|NCT01187043|65654018|FG001|Overall Study|Adverse Event|0|||
23522988|NCT01187043|65654019|FG002|Overall Study|Adverse Event|0|||
23522989|NCT01187043|65654020|FG003|Overall Study|Adverse Event|0|||
23522990|NCT01187043|65654021|FG004|Overall Study|Adverse Event|1|||
23522991|NCT01187043|65654017|FG000|Overall Study|Unable to make scheduled visits|1|||
23522992|NCT01187043|65654018|FG001|Overall Study|Unable to make scheduled visits|0|||
23522993|NCT01187043|65654019|FG002|Overall Study|Unable to make scheduled visits|4|||
23522994|NCT01187043|65654020|FG003|Overall Study|Unable to make scheduled visits|0|||
23522995|NCT01187043|65654021|FG004|Overall Study|Unable to make scheduled visits|1|||
23522996|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
23522997|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
23522998|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
23522999|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
23523000|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
23523001|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
23523002|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
23523003|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
23523004|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
23523005|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
23523006|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
23523007|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
23523008|NCT00634088|65654022|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
23523009|NCT00634088|65654023|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
23523010|NCT00634088|65654024|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
23523011|NCT00634088|65654025|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
23523012|NCT00634088|65654022|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
23523013|NCT00634088|65654023|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
23523014|NCT00634088|65654024|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
23523015|NCT00634088|65654025|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
23714722|NCT00634114|66329589|FG001|Overall Study|Adverse Event|8|||
23714723|NCT00634114|66329590|FG002|Overall Study|Adverse Event|3|||
23714724|NCT00634114|66329588|FG000|Overall Study|Withdrawal by Subject|9|||
23714725|NCT00634114|66329589|FG001|Overall Study|Withdrawal by Subject|6|||
23714726|NCT00634114|66329590|FG002|Overall Study|Withdrawal by Subject|11|||
23714727|NCT00634114|66329588|FG000|Overall Study|Lost to Follow-up|0|||
23714728|NCT00634114|66329589|FG001|Overall Study|Lost to Follow-up|0|||
23714729|NCT00634114|66329590|FG002|Overall Study|Lost to Follow-up|1|||
23714730|NCT00634114|66329588|FG000|Overall Study|Protocol Violation|3|||
23523016|NCT00634088|65654022|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
23523017|NCT00634088|65654023|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
23523018|NCT00634088|65654024|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
23523019|NCT00634088|65654025|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
23523020|NCT00445328|65654026|FG000|Overall Study|Death|0|||
23523021|NCT00445328|65654027|FG001|Overall Study|Death|1|||
23523022|NCT00445328|65654026|FG000|Overall Study|Adverse Event|0|||
23523023|NCT00445328|65654027|FG001|Overall Study|Adverse Event|3|||
23523024|NCT00445328|65654026|FG000|Overall Study|Other|0|||
23523025|NCT00445328|65654027|FG001|Overall Study|Other|2|||
23523026|NCT00445328|65654026|FG000|Overall Study|Withdrawal by Subject|2|||
23714731|NCT00634114|66329589|FG001|Overall Study|Protocol Violation|3|||
23714732|NCT00634114|66329590|FG002|Overall Study|Protocol Violation|1|||
23523027|NCT00445328|65654027|FG001|Overall Study|Withdrawal by Subject|0|||
23523028|NCT00445328|65654026|FG000|Overall Study|Protocol Violation|1|||
23523029|NCT00445328|65654027|FG001|Overall Study|Protocol Violation|0|||
23523030|NCT02586493|65654029|FG000|Overall Study|Adverse Event|4|||
23523031|NCT02586493|65654029|FG000|Overall Study|Protocol Violation|6|||
23523032|NCT02586493|65654029|FG000|Overall Study|Lost to Follow-up|1|||
23523033|NCT02586493|65654029|FG000|Overall Study|Withdrawal by Subject|1|||
23523034|NCT00312494|65654035|FG000|Overall Study|Randomized; not treated with study drug|9|||
23523035|NCT00312494|65654036|FG001|Overall Study|Randomized; not treated with study drug|10|||
23523036|NCT00312494|65654037|FG002|Overall Study|Randomized; not treated with study drug|5|||
23523037|NCT00312494|65654035|FG000|Overall Study|Adverse Event|33|||
23523038|NCT00312494|65654036|FG001|Overall Study|Adverse Event|15|||
23523039|NCT00312494|65654037|FG002|Overall Study|Adverse Event|11|||
23523040|NCT00312494|65654035|FG000|Overall Study|Lack of Efficacy|4|||
23523041|NCT00312494|65654036|FG001|Overall Study|Lack of Efficacy|6|||
23523042|NCT00312494|65654037|FG002|Overall Study|Lack of Efficacy|8|||
23523043|NCT00312494|65654035|FG000|Overall Study|Laboratory abnormality|1|||
23523044|NCT00312494|65654036|FG001|Overall Study|Laboratory abnormality|0|||
23523045|NCT00312494|65654037|FG002|Overall Study|Laboratory abnormality|0|||
23523046|NCT00312494|65654035|FG000|Overall Study|Lost to Follow-up|8|||
23523047|NCT00312494|65654036|FG001|Overall Study|Lost to Follow-up|8|||
23523048|NCT00312494|65654037|FG002|Overall Study|Lost to Follow-up|8|||
23523049|NCT00312494|65654035|FG000|Overall Study|Withdrawal by Subject|6|||
23523050|NCT00312494|65654036|FG001|Overall Study|Withdrawal by Subject|9|||
23523051|NCT00312494|65654037|FG002|Overall Study|Withdrawal by Subject|10|||
23523052|NCT00312494|65654035|FG000|Overall Study|Other|10|||
23523053|NCT00312494|65654036|FG001|Overall Study|Other|10|||
23523054|NCT00312494|65654037|FG002|Overall Study|Other|1|||
23523055|NCT00006478|65654038|FG000|Overall Study|Vaccine could not be produced|1|||
23523056|NCT00006478|65654038|FG000|Overall Study|Physician Decision|6|||
23523057|NCT00006489|65654047|FG000|Overall Study|Adverse Event|3|||
23523058|NCT00006489|65654048|FG001|Overall Study|Adverse Event|2|||
23523059|NCT00006489|65654049|FG002|Overall Study|Adverse Event|4|||
23523060|NCT00006489|65654050|FG003|Overall Study|Adverse Event|3|||
23523061|NCT00006489|65654047|FG000|Overall Study|Withdrawal by Subject|10|||
23523062|NCT00006489|65654048|FG001|Overall Study|Withdrawal by Subject|9|||
23523063|NCT00006489|65654049|FG002|Overall Study|Withdrawal by Subject|9|||
23523064|NCT00006489|65654050|FG003|Overall Study|Withdrawal by Subject|6|||
23523065|NCT00006489|65654047|FG000|Overall Study|Scheduling Conflict|0|||
23523066|NCT00006489|65654048|FG001|Overall Study|Scheduling Conflict|3|||
23523067|NCT00006489|65654049|FG002|Overall Study|Scheduling Conflict|2|||
23523068|NCT00006489|65654050|FG003|Overall Study|Scheduling Conflict|1|||
23523069|NCT00006489|65654047|FG000|Overall Study|Death|0|||
23523070|NCT00006489|65654048|FG001|Overall Study|Death|0|||
23523071|NCT00006489|65654049|FG002|Overall Study|Death|0|||
23523072|NCT00006489|65654050|FG003|Overall Study|Death|1|||
23523073|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
23523074|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Death|1|||
23523075|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Physician Decision|1|||
23523076|NCT00854581|65654053|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
23523077|NCT01652664|65654054|FG000|Overall Study|Treatment Failure|5|||
23523078|NCT01652664|65654055|FG001|Overall Study|Treatment Failure|1|||
23523079|NCT01652664|65654054|FG000|Overall Study|Inadequate IOP control|1|||
23523080|NCT01652664|65654055|FG001|Overall Study|Inadequate IOP control|0|||
23523081|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
23523082|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
23523083|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
23523084|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
23523085|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
23523086|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
23523087|NCT01063595|65654056|FG000|First Intervention|Adverse Event|1|||
23523088|NCT01063595|65654057|FG001|First Intervention|Adverse Event|4|||
23523089|NCT01063595|65654056|FG000|First Intervention|Withdrawal by Subject|1|||
23523090|NCT01063595|65654057|FG001|First Intervention|Withdrawal by Subject|0|||
23523091|NCT01063595|65654056|FG000|First Intervention|Reason not Specified|0|||
23523092|NCT01063595|65654057|FG001|First Intervention|Reason not Specified|1|||
23523093|NCT02082210|65654060|FG000|Overall Study|Death|0|||
23416788|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
23523094|NCT02082210|65654061|FG001|Overall Study|Death|0|||
23523095|NCT02082210|65654062|FG002|Overall Study|Death|1|||
23523096|NCT02082210|65654063|FG003|Overall Study|Death|1|||
23523097|NCT02082210|65654064|FG004|Overall Study|Death|1|||
23523098|NCT02082210|65654065|FG005|Overall Study|Death|0|||
23523099|NCT02082210|65654060|FG000|Overall Study|Withdrawal by Subject|0|||
23523100|NCT02082210|65654061|FG001|Overall Study|Withdrawal by Subject|0|||
23523101|NCT02082210|65654062|FG002|Overall Study|Withdrawal by Subject|0|||
23523102|NCT02082210|65654063|FG003|Overall Study|Withdrawal by Subject|1|||
23523103|NCT02082210|65654064|FG004|Overall Study|Withdrawal by Subject|2|||
23523104|NCT02082210|65654065|FG005|Overall Study|Withdrawal by Subject|2|||
23523105|NCT02082210|65654060|FG000|Overall Study|Clinical Progression|0|||
23523106|NCT02082210|65654061|FG001|Overall Study|Clinical Progression|0|||
23523107|NCT02082210|65654062|FG002|Overall Study|Clinical Progression|0|||
23523108|NCT02082210|65654063|FG003|Overall Study|Clinical Progression|1|||
23523109|NCT02082210|65654064|FG004|Overall Study|Clinical Progression|0|||
23523110|NCT02082210|65654065|FG005|Overall Study|Clinical Progression|0|||
23523111|NCT02082210|65654060|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523112|NCT02082210|65654061|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523113|NCT02082210|65654062|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
23523114|NCT02082210|65654063|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
23523115|NCT02082210|65654064|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523116|NCT02082210|65654065|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523117|NCT02082210|65654060|FG000|Overall Study|Physician Decision|0|||
23523118|NCT02082210|65654061|FG001|Overall Study|Physician Decision|0|||
23523119|NCT02082210|65654062|FG002|Overall Study|Physician Decision|1|||
23523120|NCT02082210|65654063|FG003|Overall Study|Physician Decision|1|||
23523121|NCT02082210|65654064|FG004|Overall Study|Physician Decision|0|||
23523122|NCT02082210|65654065|FG005|Overall Study|Physician Decision|0|||
23523123|NCT00788827|65654066|FG000|Overall Study|Lack of Efficacy|2|||
23523124|NCT00694369|65654068|FG000|Overall Study|Adverse Event|0|||
23523125|NCT00694369|65654069|FG001|Overall Study|Adverse Event|1|||
23523126|NCT00694369|65654070|FG002|Overall Study|Adverse Event|0|||
23523127|NCT00694369|65654071|FG003|Overall Study|Adverse Event|1|||
23523128|NCT00694369|65654072|FG004|Overall Study|Adverse Event|3|||
23523129|NCT00694369|65654068|FG000|Overall Study|Lost to Follow-up|0|||
23523130|NCT00694369|65654069|FG001|Overall Study|Lost to Follow-up|0|||
23523131|NCT00694369|65654070|FG002|Overall Study|Lost to Follow-up|1|||
23523132|NCT00694369|65654071|FG003|Overall Study|Lost to Follow-up|1|||
23523133|NCT00694369|65654072|FG004|Overall Study|Lost to Follow-up|0|||
23523134|NCT00694369|65654068|FG000|Overall Study|Physician Decision|0|||
23523135|NCT00694369|65654069|FG001|Overall Study|Physician Decision|0|||
23523136|NCT00694369|65654070|FG002|Overall Study|Physician Decision|0|||
23523137|NCT00694369|65654071|FG003|Overall Study|Physician Decision|0|||
23523138|NCT00694369|65654072|FG004|Overall Study|Physician Decision|1|||
23523139|NCT00694369|65654068|FG000|Overall Study|Protocol Violation|0|||
23523140|NCT00694369|65654069|FG001|Overall Study|Protocol Violation|1|||
23523141|NCT00694369|65654070|FG002|Overall Study|Protocol Violation|0|||
23523142|NCT00694369|65654071|FG003|Overall Study|Protocol Violation|0|||
23523143|NCT00694369|65654072|FG004|Overall Study|Protocol Violation|0|||
23523144|NCT00694369|65654068|FG000|Overall Study|Withdrawal by Subject|1|||
23523145|NCT00694369|65654069|FG001|Overall Study|Withdrawal by Subject|1|||
23523146|NCT00694369|65654070|FG002|Overall Study|Withdrawal by Subject|1|||
23523147|NCT00694369|65654071|FG003|Overall Study|Withdrawal by Subject|1|||
23523148|NCT00694369|65654072|FG004|Overall Study|Withdrawal by Subject|2|||
23523149|NCT01177540|65654073|FG000|Overall Study|Adverse Event|1|||
23523150|NCT01177540|65654074|FG001|Overall Study|Adverse Event|0|||
23523151|NCT02612428|65654075|FG000|VTL-308|Death|14|||
23523152|NCT02612428|65654076|FG001|VTL-308|Death|16|||
23523153|NCT02612428|65654075|FG000|VTL-308|Withdrawal by Subject|0|||
23523154|NCT02612428|65654076|FG001|VTL-308|Withdrawal by Subject|1|||
23523155|NCT02612428|65654075|FG000|VTL-308E|Death|9|||
23523156|NCT02612428|65654076|FG001|VTL-308E|Death|7|||
23523157|NCT02612428|65654075|FG000|VTL-308E|Lost to Follow-up|2|||
23523158|NCT02612428|65654076|FG001|VTL-308E|Lost to Follow-up|0|||
23523159|NCT00751348|65654077|FG000|Overall Study|Withdrawal by Subject|5|||
23523160|NCT00751348|65654078|FG001|Overall Study|Withdrawal by Subject|2|||
23523161|NCT00751348|65654077|FG000|Overall Study|Migration from study area|1|||
23523162|NCT00751348|65654078|FG001|Overall Study|Migration from study area|0|||
23523163|NCT00314574|65654079|FG000|Overall Study|Death|3|||
23523164|NCT00314574|65654080|FG001|Overall Study|Death|0|||
23523165|NCT00314574|65654079|FG000|Overall Study|Adverse Event|11|||
23523166|NCT00314574|65654080|FG001|Overall Study|Adverse Event|16|||
23523167|NCT00314574|65654079|FG000|Overall Study|Lost to Follow-up|19|||
23523168|NCT00314574|65654080|FG001|Overall Study|Lost to Follow-up|25|||
23523169|NCT00314574|65654079|FG000|Overall Study|Withdrawal by Subject|33|||
23523170|NCT00314574|65654080|FG001|Overall Study|Withdrawal by Subject|22|||
23523171|NCT00314574|65654079|FG000|Overall Study|Physician Decision|22|||
23523172|NCT00314574|65654080|FG001|Overall Study|Physician Decision|15|||
23812229|NCT03201250|66691955|FG000|Overall Study|screen failures|3|||
23523173|NCT00314574|65654079|FG000|Overall Study|Pregnancy|6|||
23523174|NCT00314574|65654080|FG001|Overall Study|Pregnancy|4|||
23523175|NCT00314574|65654079|FG000|Overall Study|Data unknown at database lock|0|||
23523176|NCT00314574|65654080|FG001|Overall Study|Data unknown at database lock|1|||
23523177|NCT03323658|65654083|FG000|Overall Study|Adverse Event|0|||
23523178|NCT03323658|65654084|FG001|Overall Study|Adverse Event|1|||
23523179|NCT03323658|65654085|FG002|Overall Study|Adverse Event|0|||
23523180|NCT03792672|65654086|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
23714733|NCT00634114|66329588|FG000|Overall Study|Pregnancy|1|||
23714734|NCT00634114|66329589|FG001|Overall Study|Pregnancy|0|||
23523181|NCT03792672|65654087|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523182|NCT03792672|65654088|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523183|NCT03792672|65654089|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
23523184|NCT03792672|65654090|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23714735|NCT00634114|66329590|FG002|Overall Study|Pregnancy|0|||
23714736|NCT00634114|66329588|FG000|Overall Study|Incorrect enrolment|0|||
23714737|NCT00634114|66329589|FG001|Overall Study|Incorrect enrolment|1|||
23714738|NCT00634114|66329590|FG002|Overall Study|Incorrect enrolment|0|||
23714739|NCT00634114|66329588|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
23714740|NCT00634114|66329589|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
23714741|NCT00634114|66329590|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
23714742|NCT00634114|66329588|FG000|Overall Study|Difficult to continue|3|||
23714743|NCT00634114|66329589|FG001|Overall Study|Difficult to continue|1|||
23714744|NCT00634114|66329590|FG002|Overall Study|Difficult to continue|1|||
23714745|NCT00634114|66329588|FG000|Overall Study|Other reason|1|||
23714746|NCT00634114|66329589|FG001|Overall Study|Other reason|1|||
23714747|NCT00634114|66329590|FG002|Overall Study|Other reason|1|||
23714748|NCT00973921|66329593|FG000|Overall Study|IVUS results were not available|9|||
23812230|NCT03201250|66691956|FG001|Overall Study|screen failures|0|||
23523185|NCT03792672|65654091|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523186|NCT03792672|65654086|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
23523187|NCT03792672|65654087|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
23523188|NCT03792672|65654088|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
23523189|NCT03792672|65654089|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
23523190|NCT03792672|65654090|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
23523191|NCT03792672|65654091|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
23523192|NCT03792672|65654086|FG000|Treatment Period 4 (2 Days)|Other|1|||
23523193|NCT03792672|65654087|FG001|Treatment Period 4 (2 Days)|Other|0|||
23523194|NCT03792672|65654088|FG002|Treatment Period 4 (2 Days)|Other|0|||
23523195|NCT03792672|65654089|FG003|Treatment Period 4 (2 Days)|Other|0|||
23523196|NCT03792672|65654090|FG004|Treatment Period 4 (2 Days)|Other|0|||
23523197|NCT03792672|65654091|FG005|Treatment Period 4 (2 Days)|Other|0|||
23523198|NCT00066066|65654095|FG000|Overall Study|Lost to Follow-up|6|||
23523199|NCT00066066|65654096|FG001|Overall Study|Lost to Follow-up|4|||
23523200|NCT00066066|65654097|FG002|Overall Study|Lost to Follow-up|7|||
23523201|NCT00066066|65654098|FG003|Overall Study|Lost to Follow-up|4|||
23523202|NCT00066066|65654099|FG004|Overall Study|Lost to Follow-up|3|||
23523203|NCT00066066|65654100|FG005|Overall Study|Lost to Follow-up|5|||
23523204|NCT03257631|65654101|FG000|Overall Study|Death|1|||
23523205|NCT03257631|65654102|FG001|Overall Study|Death|0|||
23523206|NCT03257631|65654103|FG002|Overall Study|Death|1|||
23523207|NCT03257631|65654104|FG003|Overall Study|Death|1|||
23523208|NCT03257631|65654101|FG000|Overall Study|Progressive Disease|10|||
23523209|NCT03257631|65654102|FG001|Overall Study|Progressive Disease|9|||
23523210|NCT03257631|65654103|FG002|Overall Study|Progressive Disease|17|||
23523211|NCT03257631|65654104|FG003|Overall Study|Progressive Disease|8|||
23523212|NCT03257631|65654101|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23523213|NCT03257631|65654102|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23523214|NCT03257631|65654103|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23523215|NCT03257631|65654104|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
23523216|NCT03257631|65654101|FG000|Overall Study|Adverse Event|0|||
23523217|NCT03257631|65654102|FG001|Overall Study|Adverse Event|0|||
23523218|NCT03257631|65654103|FG002|Overall Study|Adverse Event|2|||
23523219|NCT03257631|65654104|FG003|Overall Study|Adverse Event|0|||
23523220|NCT00718328|65654105|FG000|Overall Study|Lost to Follow-up|1|||
23523221|NCT00718328|65654106|FG001|Overall Study|Lost to Follow-up|0|||
23523222|NCT01869192|65654109|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
23523223|NCT01869192|65654110|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
23523224|NCT01869192|65654109|FG000|Postoperative Chemotherapy|Physician Decision|0|||
23523225|NCT01869192|65654110|FG001|Postoperative Chemotherapy|Physician Decision|2|||
23523226|NCT02290821|65654113|FG000|Overall Study|Withdrawal by Subject|1|||
23523227|NCT02290821|65654114|FG001|Overall Study|Withdrawal by Subject|1|||
23523228|NCT02290821|65654113|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
23812231|NCT03201250|66691957|FG002|Overall Study|screen failures|0|||
23523229|NCT02290821|65654114|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
23523230|NCT02290821|65654113|FG000|Overall Study|Lost to Follow-up|3|||
23523231|NCT02290821|65654114|FG001|Overall Study|Lost to Follow-up|2|||
23714749|NCT00755846|66329594|FG000|Overall Study|Adverse Event|0|||
23523232|NCT01752855|65654116|FG000|Overall Study|Adverse Event|1|||
23523233|NCT01752855|65654117|FG001|Overall Study|Adverse Event|0|||
23523234|NCT01752855|65654116|FG000|Overall Study|Withdrew Consent|0|||
23523235|NCT01752855|65654117|FG001|Overall Study|Withdrew Consent|2|||
23523236|NCT01752855|65654116|FG000|Overall Study|Lack of Efficacy|0|||
23523237|NCT01752855|65654117|FG001|Overall Study|Lack of Efficacy|2|||
23714750|NCT00755846|66329595|FG001|Overall Study|Adverse Event|0|||
23714751|NCT00755846|66329596|FG002|Overall Study|Adverse Event|0|||
23714752|NCT00755846|66329597|FG003|Overall Study|Adverse Event|1|||
23714753|NCT00755846|66329598|FG004|Overall Study|Adverse Event|3|||
23714754|NCT00755846|66329599|FG005|Overall Study|Adverse Event|2|||
23714755|NCT00755846|66329594|FG000|Overall Study|Protocol Violation|1|||
23714756|NCT00755846|66329595|FG001|Overall Study|Protocol Violation|1|||
23714757|NCT00755846|66329596|FG002|Overall Study|Protocol Violation|1|||
23714758|NCT00755846|66329597|FG003|Overall Study|Protocol Violation|1|||
23714759|NCT00755846|66329598|FG004|Overall Study|Protocol Violation|1|||
23714760|NCT00755846|66329599|FG005|Overall Study|Protocol Violation|1|||
23714761|NCT00755846|66329594|FG000|Overall Study|Lost to Follow-up|0|||
23714762|NCT00755846|66329595|FG001|Overall Study|Lost to Follow-up|2|||
23523238|NCT02780804|65654118|FG000|Overall Study|Death|1|||
23523239|NCT02780804|65654119|FG001|Overall Study|Death|0|||
23523240|NCT02780804|65654120|FG002|Overall Study|Death|0|||
23523241|NCT02780804|65654118|FG000|Overall Study|Lack of Efficacy|5|||
23523242|NCT02780804|65654119|FG001|Overall Study|Lack of Efficacy|8|||
23523243|NCT02780804|65654120|FG002|Overall Study|Lack of Efficacy|4|||
23523244|NCT02780804|65654118|FG000|Overall Study|Physician Decision|0|||
23523245|NCT02780804|65654119|FG001|Overall Study|Physician Decision|0|||
23523246|NCT02780804|65654120|FG002|Overall Study|Physician Decision|2|||
23523247|NCT02780804|65654118|FG000|Overall Study|Withdrawal by Subject|0|||
23523248|NCT02780804|65654119|FG001|Overall Study|Withdrawal by Subject|1|||
23523249|NCT02780804|65654120|FG002|Overall Study|Withdrawal by Subject|0|||
23523250|NCT00603746|65654121|FG000|Overall Study|Adverse Event|2|||
23523251|NCT00603746|65654122|FG001|Overall Study|Adverse Event|3|||
23523252|NCT00603746|65654123|FG002|Overall Study|Adverse Event|0|||
23714763|NCT00755846|66329596|FG002|Overall Study|Lost to Follow-up|1|||
23714764|NCT00755846|66329597|FG003|Overall Study|Lost to Follow-up|0|||
23714765|NCT00755846|66329598|FG004|Overall Study|Lost to Follow-up|4|||
23714766|NCT00755846|66329599|FG005|Overall Study|Lost to Follow-up|2|||
23714767|NCT00755846|66329594|FG000|Overall Study|Withdrawal by Subject|2|||
23812232|NCT01682863|66691958|FG000|Overall Study|Subject/guardian decision|19|||
23812233|NCT01682863|66691959|FG001|Overall Study|Subject/guardian decision|12|||
23812234|NCT01682863|66691960|FG002|Overall Study|Subject/guardian decision|10|||
23812235|NCT01682863|66691958|FG000|Overall Study|Lost to Follow-up|5|||
23812236|NCT01682863|66691959|FG001|Overall Study|Lost to Follow-up|1|||
23812237|NCT01682863|66691960|FG002|Overall Study|Lost to Follow-up|6|||
23812238|NCT01682863|66691958|FG000|Overall Study|Death|1|||
23812239|NCT01682863|66691959|FG001|Overall Study|Death|3|||
23812240|NCT01682863|66691960|FG002|Overall Study|Death|4|||
23812241|NCT01682863|66691958|FG000|Overall Study|Protocol deviation|1|||
23812242|NCT01682863|66691959|FG001|Overall Study|Protocol deviation|0|||
23812243|NCT01682863|66691960|FG002|Overall Study|Protocol deviation|1|||
23812244|NCT01682863|66691958|FG000|Overall Study|Technical problems|1|||
23812245|NCT01682863|66691959|FG001|Overall Study|Technical problems|0|||
23812246|NCT01682863|66691960|FG002|Overall Study|Technical problems|0|||
23812247|NCT01682863|66691958|FG000|Overall Study|Adverse Event|0|||
23812248|NCT01682863|66691959|FG001|Overall Study|Adverse Event|1|||
23812249|NCT01682863|66691960|FG002|Overall Study|Adverse Event|2|||
23812250|NCT01682863|66691958|FG000|Overall Study|Physician Decision|0|||
23812251|NCT01682863|66691959|FG001|Overall Study|Physician Decision|0|||
23812252|NCT01682863|66691960|FG002|Overall Study|Physician Decision|1|||
23812253|NCT00506129|66691970|FG000|Overall Study|Disease Progression/Relapse|15|||
23812254|NCT00506129|66691970|FG000|Overall Study|Death|7|||
23812255|NCT00807248|66691971|FG000|Overall Study|Adverse Event|1|||
23812256|NCT00807248|66691972|FG001|Overall Study|Adverse Event|2|||
23812257|NCT00807248|66691973|FG002|Overall Study|Adverse Event|2|||
23812258|NCT00807248|66691974|FG003|Overall Study|Adverse Event|6|||
23812259|NCT00807248|66691971|FG000|Overall Study|Lack of Efficacy|14|||
23812260|NCT00807248|66691972|FG001|Overall Study|Lack of Efficacy|4|||
23812261|NCT00807248|66691973|FG002|Overall Study|Lack of Efficacy|8|||
23812262|NCT00807248|66691974|FG003|Overall Study|Lack of Efficacy|3|||
23812263|NCT00807248|66691971|FG000|Overall Study|Protocol Violation|0|||
23812264|NCT00807248|66691972|FG001|Overall Study|Protocol Violation|1|||
23812265|NCT00807248|66691973|FG002|Overall Study|Protocol Violation|1|||
23812266|NCT00807248|66691974|FG003|Overall Study|Protocol Violation|0|||
23812267|NCT00807248|66691971|FG000|Overall Study|Withdrawal of Consent|5|||
23812268|NCT00807248|66691972|FG001|Overall Study|Withdrawal of Consent|5|||
23714768|NCT00755846|66329595|FG001|Overall Study|Withdrawal by Subject|3|||
23714769|NCT00755846|66329596|FG002|Overall Study|Withdrawal by Subject|5|||
23714770|NCT00755846|66329597|FG003|Overall Study|Withdrawal by Subject|2|||
23714771|NCT00755846|66329598|FG004|Overall Study|Withdrawal by Subject|0|||
23523253|NCT00603746|65654124|FG003|Overall Study|Adverse Event|1|||
23523254|NCT00603746|65654125|FG004|Overall Study|Adverse Event|0|||
23523255|NCT00603746|65654126|FG005|Overall Study|Adverse Event|4|||
23523256|NCT00603746|65654121|FG000|Overall Study|Lack of Efficacy|34|||
23523257|NCT00603746|65654122|FG001|Overall Study|Lack of Efficacy|11|||
23812269|NCT00807248|66691973|FG002|Overall Study|Withdrawal of Consent|5|||
23812270|NCT00807248|66691974|FG003|Overall Study|Withdrawal of Consent|5|||
23523258|NCT00603746|65654123|FG002|Overall Study|Lack of Efficacy|6|||
23523259|NCT00603746|65654124|FG003|Overall Study|Lack of Efficacy|11|||
23523260|NCT00603746|65654125|FG004|Overall Study|Lack of Efficacy|12|||
23523261|NCT00603746|65654126|FG005|Overall Study|Lack of Efficacy|8|||
23523262|NCT00603746|65654121|FG000|Overall Study|Protocol Violation|0|||
23523263|NCT00603746|65654122|FG001|Overall Study|Protocol Violation|3|||
23523264|NCT00603746|65654123|FG002|Overall Study|Protocol Violation|1|||
23523265|NCT00603746|65654124|FG003|Overall Study|Protocol Violation|0|||
23523266|NCT00603746|65654125|FG004|Overall Study|Protocol Violation|1|||
23523267|NCT00603746|65654126|FG005|Overall Study|Protocol Violation|0|||
23523268|NCT00603746|65654121|FG000|Overall Study|Lost to Follow-up|0|||
23523269|NCT00603746|65654122|FG001|Overall Study|Lost to Follow-up|1|||
23523270|NCT00603746|65654123|FG002|Overall Study|Lost to Follow-up|1|||
23523271|NCT00603746|65654124|FG003|Overall Study|Lost to Follow-up|0|||
23523272|NCT00603746|65654125|FG004|Overall Study|Lost to Follow-up|0|||
23523273|NCT00603746|65654126|FG005|Overall Study|Lost to Follow-up|0|||
23523274|NCT00603746|65654121|FG000|Overall Study|Physician Decision|1|||
23523275|NCT00603746|65654122|FG001|Overall Study|Physician Decision|0|||
23523276|NCT00603746|65654123|FG002|Overall Study|Physician Decision|0|||
23523277|NCT00603746|65654124|FG003|Overall Study|Physician Decision|0|||
23523278|NCT00603746|65654125|FG004|Overall Study|Physician Decision|1|||
23523279|NCT00603746|65654126|FG005|Overall Study|Physician Decision|0|||
23523280|NCT00603746|65654121|FG000|Overall Study|Withdrawal by Subject|1|||
23523281|NCT00603746|65654122|FG001|Overall Study|Withdrawal by Subject|0|||
23523282|NCT00603746|65654123|FG002|Overall Study|Withdrawal by Subject|0|||
23523283|NCT00603746|65654124|FG003|Overall Study|Withdrawal by Subject|1|||
23523284|NCT00603746|65654125|FG004|Overall Study|Withdrawal by Subject|3|||
23523285|NCT00603746|65654126|FG005|Overall Study|Withdrawal by Subject|1|||
23523286|NCT02818777|65654128|FG000|Overall Study|Adverse Event|3|||
23523287|NCT02086110|65654133|FG000|Overall Study|Withdrawal by Subject|1|||
23523288|NCT02086110|65654134|FG001|Overall Study|Withdrawal by Subject|1|||
23523289|NCT00702403|65654135|FG000|From Consent to Engraftment|Progressive leukemia|6|||
23523290|NCT00702403|65654135|FG000|From Consent to Engraftment|Critically ill|2|||
23523291|NCT00702403|65654135|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
23523292|NCT00702403|65654135|FG000|From Consent to Engraftment|Myocardial infarction|1|||
23523293|NCT00702403|65654135|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
23523294|NCT00702403|65654135|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
23523295|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
23523296|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
23523297|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Non-compliance|2|||
23523298|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
23523299|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
23523300|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Suicide|1|||
23523301|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
23523302|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
23523303|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
23523304|NCT04056195|65654138|FG000|Overall Study|Adverse Event|1|||
23523305|NCT04056195|65654139|FG001|Overall Study|Adverse Event|0|||
23523306|NCT04056195|65654140|FG002|Overall Study|Adverse Event|0|||
23523307|NCT04056195|65654138|FG000|Overall Study|Withdrawal by Subject|0|||
23523308|NCT04056195|65654139|FG001|Overall Study|Withdrawal by Subject|1|||
23523309|NCT04056195|65654140|FG002|Overall Study|Withdrawal by Subject|1|||
23523310|NCT04056195|65654138|FG000|Overall Study|Physician Decision|1|||
23523311|NCT04056195|65654139|FG001|Overall Study|Physician Decision|1|||
23523312|NCT04056195|65654140|FG002|Overall Study|Physician Decision|1|||
23523313|NCT01217060|65654141|FG000|Overall Study|Withdrawal by Subject|1|||
23523314|NCT00666757|65654142|FG000|Overall Study|Lost to Follow-up|39|||
23523315|NCT00666757|65654143|FG001|Overall Study|Lost to Follow-up|35|||
23523316|NCT00666757|65654142|FG000|Overall Study|Protocol Violation|23|||
23523317|NCT00666757|65654143|FG001|Overall Study|Protocol Violation|24|||
23523318|NCT00666757|65654142|FG000|Overall Study|Adverse Event|22|||
23523319|NCT00666757|65654143|FG001|Overall Study|Adverse Event|12|||
23523320|NCT00666757|65654142|FG000|Overall Study|Withdrawal by Subject|13|||
23523321|NCT00666757|65654143|FG001|Overall Study|Withdrawal by Subject|17|||
23523322|NCT00666757|65654142|FG000|Overall Study|Lack of Efficacy|3|||
23523323|NCT00666757|65654143|FG001|Overall Study|Lack of Efficacy|6|||
23523324|NCT00666757|65654142|FG000|Overall Study|Physician Decision|0|||
23523325|NCT00666757|65654143|FG001|Overall Study|Physician Decision|2|||
23523326|NCT00666757|65654142|FG000|Overall Study|Sponsor decision|0|||
23523327|NCT00666757|65654143|FG001|Overall Study|Sponsor decision|1|||
23523328|NCT00663052|65654144|FG000|Overall Study|Adverse Event|6|||
23523329|NCT00663052|65654145|FG001|Overall Study|Adverse Event|3|||
23523330|NCT00663052|65654144|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
23523331|NCT00663052|65654145|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23523332|NCT00663052|65654144|FG000|Overall Study|Protocol Violation|1|||
23714772|NCT00755846|66329599|FG005|Overall Study|Withdrawal by Subject|1|||
23714773|NCT00755846|66329594|FG000|Overall Study|Hyperglycemic Rescue|21|||
23714774|NCT00755846|66329595|FG001|Overall Study|Hyperglycemic Rescue|7|||
23714775|NCT00755846|66329596|FG002|Overall Study|Hyperglycemic Rescue|5|||
23714776|NCT00755846|66329597|FG003|Overall Study|Hyperglycemic Rescue|8|||
23714777|NCT00755846|66329598|FG004|Overall Study|Hyperglycemic Rescue|8|||
23714778|NCT00755846|66329599|FG005|Overall Study|Hyperglycemic Rescue|7|||
23714779|NCT00755846|66329594|FG000|Overall Study|Physician Decision|1|||
23714780|NCT00755846|66329595|FG001|Overall Study|Physician Decision|3|||
23714781|NCT00755846|66329596|FG002|Overall Study|Physician Decision|0|||
23714782|NCT00755846|66329597|FG003|Overall Study|Physician Decision|1|||
23714783|NCT00755846|66329598|FG004|Overall Study|Physician Decision|0|||
23714784|NCT00755846|66329599|FG005|Overall Study|Physician Decision|1|||
23714785|NCT00755846|66329594|FG000|Overall Study|Administrative Error|0|||
23714786|NCT00755846|66329595|FG001|Overall Study|Administrative Error|1|||
23714787|NCT00755846|66329596|FG002|Overall Study|Administrative Error|0|||
23714788|NCT00755846|66329597|FG003|Overall Study|Administrative Error|0|||
23714789|NCT00755846|66329598|FG004|Overall Study|Administrative Error|0|||
23714790|NCT00755846|66329599|FG005|Overall Study|Administrative Error|0|||
23714791|NCT00755846|66329594|FG000|Overall Study|Participant Non-compliance|0|||
23714792|NCT00755846|66329595|FG001|Overall Study|Participant Non-compliance|0|||
23714793|NCT00755846|66329596|FG002|Overall Study|Participant Non-compliance|0|||
23714794|NCT00755846|66329597|FG003|Overall Study|Participant Non-compliance|0|||
23714795|NCT00755846|66329598|FG004|Overall Study|Participant Non-compliance|1|||
23714796|NCT00755846|66329599|FG005|Overall Study|Participant Non-compliance|0|||
23714797|NCT03943953|66329600|FG000|Trial of ITG 1|Lost to Follow-up|19|||
23714798|NCT03943953|66329601|FG001|Trial of ITG 1|Lost to Follow-up|1|||
23714799|NCT03943953|66329600|FG000|Trial of ITG 2|Lost to Follow-up|8|||
23714800|NCT03943953|66329601|FG001|Trial of ITG 2|Lost to Follow-up|0|||
23714801|NCT03943953|66329600|FG000|Trial of ITG 3|Lost to Follow-up|2|||
23714802|NCT03943953|66329601|FG001|Trial of ITG 3|Lost to Follow-up|0|||
23714803|NCT03943953|66329600|FG000|Trial of ITG 4|Lost to Follow-up|2|||
23714804|NCT03943953|66329601|FG001|Trial of ITG 4|Lost to Follow-up|0|||
23714805|NCT03712345|66329610|FG000|Overall Study|Failure to meet randomization criteria|0|||
23714806|NCT03712345|66329611|FG001|Overall Study|Failure to meet randomization criteria|0|||
23714807|NCT03712345|66329612|FG002|Overall Study|Failure to meet randomization criteria|1|||
23714808|NCT02157506|66329616|FG000|Overall Study|Adverse Event|0|||
23714809|NCT02157506|66329617|FG001|Overall Study|Adverse Event|1|||
23714810|NCT02157506|66329618|FG002|Overall Study|Adverse Event|0|||
23714811|NCT02157506|66329619|FG003|Overall Study|Adverse Event|0|||
23714812|NCT02157506|66329620|FG004|Overall Study|Adverse Event|0|||
23714813|NCT02157506|66329616|FG000|Overall Study|Lost to Follow-up|0|||
23714814|NCT02157506|66329617|FG001|Overall Study|Lost to Follow-up|0|||
23714815|NCT02157506|66329618|FG002|Overall Study|Lost to Follow-up|1|||
23714816|NCT02157506|66329619|FG003|Overall Study|Lost to Follow-up|0|||
23714817|NCT02157506|66329620|FG004|Overall Study|Lost to Follow-up|0|||
23714818|NCT00642018|66329622|FG000|Overall Study|Adverse Event|11|||
23714819|NCT00642018|66329623|FG001|Overall Study|Adverse Event|36|||
23714820|NCT00642018|66329622|FG000|Overall Study|Withdrawal by Subject|4|||
23714821|NCT00642018|66329623|FG001|Overall Study|Withdrawal by Subject|10|||
23714822|NCT00642018|66329622|FG000|Overall Study|Progressive Disease|13|||
23714823|NCT00642018|66329623|FG001|Overall Study|Progressive Disease|18|||
23714824|NCT00642018|66329622|FG000|Overall Study|Physician Decision|0|||
23714825|NCT00642018|66329623|FG001|Overall Study|Physician Decision|10|||
23714826|NCT00642018|66329622|FG000|Overall Study|Protocol Violation|0|||
23714827|NCT00642018|66329623|FG001|Overall Study|Protocol Violation|1|||
23714828|NCT00642018|66329622|FG000|Overall Study|Death|0|||
23812271|NCT00807248|66691971|FG000|Overall Study|Lost to Follow-up|1|||
23812272|NCT00807248|66691972|FG001|Overall Study|Lost to Follow-up|0|||
23812273|NCT00807248|66691973|FG002|Overall Study|Lost to Follow-up|0|||
23714829|NCT00642018|66329623|FG001|Overall Study|Death|3|||
23714830|NCT00642018|66329622|FG000|Overall Study|Entry Criteria Not Met|0|||
23714831|NCT00642018|66329623|FG001|Overall Study|Entry Criteria Not Met|1|||
23714832|NCT00946530|66329624|FG000|Overall Study|Withdrawal by Subject|0|||
23714833|NCT00946530|66329625|FG001|Overall Study|Withdrawal by Subject|3|||
23812274|NCT00807248|66691974|FG003|Overall Study|Lost to Follow-up|0|||
23714834|NCT00946530|66329626|FG002|Overall Study|Withdrawal by Subject|0|||
23714835|NCT00946530|66329627|FG003|Overall Study|Withdrawal by Subject|3|||
23714836|NCT00946530|66329624|FG000|Overall Study|Physician Decision|1|||
23714837|NCT00946530|66329625|FG001|Overall Study|Physician Decision|1|||
23714838|NCT00946530|66329626|FG002|Overall Study|Physician Decision|1|||
23714839|NCT00946530|66329627|FG003|Overall Study|Physician Decision|1|||
23714840|NCT00718666|66329628|FG000|Booster Phase Year 5|No active participation request|0|||
23812275|NCT00807248|66691971|FG000|Overall Study|Other Reason|0|||
23812276|NCT00807248|66691972|FG001|Overall Study|Other Reason|0|||
23714841|NCT00718666|66329629|FG001|Booster Phase Year 5|No active participation request|0|||
23812277|NCT00807248|66691973|FG002|Overall Study|Other Reason|2|||
23523333|NCT00663052|65654145|FG001|Overall Study|Protocol Violation|0|||
23523334|NCT00663052|65654144|FG000|Overall Study|Withdrawal by Subject|2|||
23523335|NCT00663052|65654145|FG001|Overall Study|Withdrawal by Subject|5|||
23523336|NCT00663052|65654144|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
23523337|NCT00663052|65654145|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
23523338|NCT00663052|65654144|FG000|Overall Study|Other|0|||
23523339|NCT00663052|65654145|FG001|Overall Study|Other|1|||
23523340|NCT03093428|65654156|FG000|Overall Study|Not eligible for treatment|2|||
23523341|NCT03093428|65654157|FG001|Overall Study|Not eligible for treatment|1|||
23523342|NCT03093428|65654156|FG000|Overall Study|Progression|14|||
23523343|NCT03093428|65654157|FG001|Overall Study|Progression|4|||
23523344|NCT03093428|65654156|FG000|Overall Study|Death|1|||
23523345|NCT03093428|65654157|FG001|Overall Study|Death|0|||
23523346|NCT03093428|65654156|FG000|Overall Study|Adverse Event|1|||
23523347|NCT03093428|65654157|FG001|Overall Study|Adverse Event|0|||
23523348|NCT03093428|65654156|FG000|Overall Study|Withdrawal by Subject|1|||
23523349|NCT03093428|65654157|FG001|Overall Study|Withdrawal by Subject|1|||
23523350|NCT04151290|65654158|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
23523351|NCT01945489|65654161|FG000|Cycle 1|Adverse Event|2|||
23523352|NCT01945489|65654162|FG001|Cycle 1|Adverse Event|0|||
23523353|NCT01945489|65654161|FG000|Cycle 1|Lost to Follow-up|4|||
23523354|NCT01945489|65654162|FG001|Cycle 1|Lost to Follow-up|0|||
23523355|NCT01945489|65654161|FG000|Cycle 1|Personal Reasons|4|||
23523356|NCT01945489|65654162|FG001|Cycle 1|Personal Reasons|2|||
23523357|NCT01945489|65654161|FG000|Cycle 1|Protocol Violation|0|||
23523358|NCT01945489|65654162|FG001|Cycle 1|Protocol Violation|1|||
23523359|NCT01945489|65654161|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
23523360|NCT01945489|65654162|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
23523361|NCT01945489|65654161|FG000|Cycle 2|Adverse Event|1|||
23523362|NCT01945489|65654162|FG001|Cycle 2|Adverse Event|0|||
23523363|NCT01945489|65654161|FG000|Cycle 2|Lost to Follow-up|0|||
23523364|NCT01945489|65654162|FG001|Cycle 2|Lost to Follow-up|1|||
23523365|NCT00696137|65654163|FG000|Overall Study|Withdrawal by Subject|2|||
23523366|NCT00642668|65654164|FG000|Overall Study|Lost to Follow-up|1|||
23523367|NCT00642668|65654164|FG000|Overall Study|Adverse Event|2|||
23523368|NCT00642668|65654164|FG000|Overall Study|Death|2|||
23523369|NCT00642668|65654164|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23523370|NCT00642668|65654164|FG000|Overall Study|Failure to Return|1|||
23523371|NCT00642668|65654164|FG000|Overall Study|Dialysis Initiation|5|||
23523372|NCT00642668|65654164|FG000|Overall Study|Blood Transfusion|2|||
23523373|NCT01200797|65654168|FG000|Overall Study|symptomatic deterioration|2|||
23523374|NCT01200797|65654168|FG000|Overall Study|Adverse Event|4|||
23523375|NCT01200797|65654168|FG000|Overall Study|Disease Progression|13|||
23523376|NCT01675882|65654169|FG000|Overall Study|Adverse Event|0|||
23523377|NCT01675882|65654170|FG001|Overall Study|Adverse Event|2|||
23523378|NCT01675882|65654171|FG002|Overall Study|Adverse Event|1|||
23523379|NCT01675882|65654172|FG003|Overall Study|Adverse Event|0|||
23523380|NCT01675882|65654169|FG000|Overall Study|Participant unwilling to continue|2|||
23523381|NCT01675882|65654170|FG001|Overall Study|Participant unwilling to continue|4|||
23523382|NCT01675882|65654171|FG002|Overall Study|Participant unwilling to continue|2|||
23523383|NCT01675882|65654172|FG003|Overall Study|Participant unwilling to continue|1|||
23523384|NCT01675882|65654169|FG000|Overall Study|Lost to Follow-up|0|||
23523385|NCT01675882|65654170|FG001|Overall Study|Lost to Follow-up|1|||
23523386|NCT01675882|65654171|FG002|Overall Study|Lost to Follow-up|0|||
23523387|NCT01675882|65654172|FG003|Overall Study|Lost to Follow-up|0|||
23523388|NCT01675882|65654169|FG000|Overall Study|Non-compliance|0|||
23523389|NCT01675882|65654170|FG001|Overall Study|Non-compliance|0|||
23523390|NCT01675882|65654171|FG002|Overall Study|Non-compliance|0|||
23523391|NCT01675882|65654172|FG003|Overall Study|Non-compliance|1|||
23523392|NCT04327986|65654173|FG000|Overall Study|Physician Decision|2|||
23523393|NCT04327986|65654174|FG001|Overall Study|Physician Decision|0|||
23523394|NCT04327986|65654175|FG002|Overall Study|Physician Decision|0|||
23523395|NCT04327986|65654173|FG000|Overall Study|Death|1|||
23523396|NCT04327986|65654174|FG001|Overall Study|Death|0|||
23523397|NCT04327986|65654175|FG002|Overall Study|Death|0|||
23523398|NCT01380184|65654179|FG000|Part 1 (19 Days)|Adverse Event|1|||
23523399|NCT01380184|65654179|FG000|Part 2|Adverse Event|5|||
23523400|NCT01380184|65654179|FG000|Part 2|Disease Progression|8|||
23523401|NCT01380184|65654179|FG000|Part 2|Lost to Follow-up|1|||
23523402|NCT03818516|65654180|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
23523403|NCT04098458|65657600|FG000|Overall Study|Death|1|||
23523404|NCT04098458|65657600|FG000|Overall Study|did not meet study inclusion criteria|3|||
23523405|NCT00558103|65657601|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
23523406|NCT00558103|65657602|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
23523407|NCT00558103|65657603|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
23523408|NCT00558103|65657604|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
23523409|NCT00558103|65657605|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
23523410|NCT00558103|65657606|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
23523411|NCT00558103|65657601|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
23714842|NCT00718666|66329630|FG002|Booster Phase Year 5|No active participation request|1|||
23714843|NCT00718666|66329628|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
23714844|NCT00718666|66329629|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
23714845|NCT00718666|66329630|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
23714846|NCT00718666|66329628|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
23714847|NCT00718666|66329629|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
23714848|NCT00718666|66329630|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
23714849|NCT00718666|66329628|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
23523412|NCT00558103|65657602|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
23523413|NCT00558103|65657603|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
23523414|NCT00558103|65657604|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
23523415|NCT00558103|65657605|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
23523416|NCT00558103|65657606|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
23812278|NCT00807248|66691974|FG003|Overall Study|Other Reason|0|||
23812279|NCT02563106|66691975|FG000|Overall Study|Withdrawal by Subject|7|||
23812280|NCT02563106|66691976|FG001|Overall Study|Withdrawal by Subject|8|||
23812281|NCT02563106|66691975|FG000|Overall Study|Adverse Event|17|||
23812282|NCT02563106|66691976|FG001|Overall Study|Adverse Event|15|||
23812283|NCT02563106|66691975|FG000|Overall Study|Protocol Violation|1|||
23812284|NCT02563106|66691976|FG001|Overall Study|Protocol Violation|0|||
23812285|NCT02563106|66691975|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
23812286|NCT02563106|66691976|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
23812287|NCT02563106|66691975|FG000|Overall Study|Lost to Follow-up|3|||
23812288|NCT02563106|66691976|FG001|Overall Study|Lost to Follow-up|2|||
23812289|NCT02563106|66691975|FG000|Overall Study|Physician Decision|3|||
23812290|NCT02563106|66691976|FG001|Overall Study|Physician Decision|1|||
23812291|NCT02563106|66691975|FG000|Overall Study|Other reason - not specified|2|||
23812292|NCT02563106|66691976|FG001|Overall Study|Other reason - not specified|1|||
23812293|NCT01616953|66691977|FG000|Overall Study|Lost to Follow-up|1|||
23812294|NCT01616953|66691978|FG001|Overall Study|Lost to Follow-up|0|||
23812295|NCT01616953|66691977|FG000|Overall Study|lack of bone and soft tissue|1|||
23812296|NCT01616953|66691978|FG001|Overall Study|lack of bone and soft tissue|0|||
23812297|NCT00259272|66691983|FG000|Overall Study|Adverse Event|2|||
23812298|NCT00259272|66691984|FG001|Overall Study|Adverse Event|1|||
23812299|NCT00259272|66691985|FG002|Overall Study|Adverse Event|0|||
23812300|NCT00259272|66691986|FG003|Overall Study|Adverse Event|3|||
23812301|NCT00259272|66691983|FG000|Overall Study|Lack of Efficacy|5|||
23812302|NCT00259272|66691984|FG001|Overall Study|Lack of Efficacy|1|||
23812303|NCT00259272|66691985|FG002|Overall Study|Lack of Efficacy|2|||
23812304|NCT00259272|66691986|FG003|Overall Study|Lack of Efficacy|6|||
23812305|NCT00259272|66691983|FG000|Overall Study|Physician Decision|1|||
23812306|NCT00259272|66691984|FG001|Overall Study|Physician Decision|2|||
23812307|NCT00259272|66691985|FG002|Overall Study|Physician Decision|1|||
23812308|NCT00259272|66691986|FG003|Overall Study|Physician Decision|3|||
23812309|NCT00259272|66691983|FG000|Overall Study|Protocol Violation|2|||
23812310|NCT00259272|66691984|FG001|Overall Study|Protocol Violation|0|||
23812311|NCT00259272|66691985|FG002|Overall Study|Protocol Violation|0|||
23812312|NCT00259272|66691986|FG003|Overall Study|Protocol Violation|1|||
23812313|NCT00259272|66691983|FG000|Overall Study|Sponsor Decision|0|||
23812314|NCT00259272|66691984|FG001|Overall Study|Sponsor Decision|1|||
23812315|NCT00259272|66691985|FG002|Overall Study|Sponsor Decision|0|||
23812316|NCT00259272|66691986|FG003|Overall Study|Sponsor Decision|0|||
23812317|NCT00259272|66691983|FG000|Overall Study|Withdrawal by Subject|4|||
23812318|NCT00259272|66691984|FG001|Overall Study|Withdrawal by Subject|2|||
23812319|NCT00259272|66691985|FG002|Overall Study|Withdrawal by Subject|2|||
23812320|NCT00259272|66691986|FG003|Overall Study|Withdrawal by Subject|7|||
23812321|NCT00259272|66691983|FG000|Overall Study|Lost to Follow-up|1|||
23812322|NCT00259272|66691984|FG001|Overall Study|Lost to Follow-up|0|||
23812323|NCT00259272|66691985|FG002|Overall Study|Lost to Follow-up|0|||
23812324|NCT00259272|66691986|FG003|Overall Study|Lost to Follow-up|1|||
23812325|NCT02912650|66695826|FG000|Overall Study|Withdrawal by Subject|1|||
23812326|NCT02912650|66695827|FG001|Overall Study|Withdrawal by Subject|0|||
23812327|NCT02912650|66695828|FG002|Overall Study|Withdrawal by Subject|1|||
23812328|NCT02912650|66695829|FG003|Overall Study|Withdrawal by Subject|5|||
23812329|NCT02912650|66695826|FG000|Overall Study|Adverse Event|0|||
23812330|NCT02912650|66695827|FG001|Overall Study|Adverse Event|0|||
23812331|NCT02912650|66695828|FG002|Overall Study|Adverse Event|1|||
23812332|NCT02912650|66695829|FG003|Overall Study|Adverse Event|0|||
23812333|NCT01156142|66695830|FG000|Overall Study|Withdrawal by Subject|8|||
23812334|NCT01156142|66695831|FG001|Overall Study|Withdrawal by Subject|6|||
23812335|NCT01156142|66695830|FG000|Overall Study|Ineligible|0|||
23523417|NCT00558103|65657601|FG000|Randomized Treatment Phase|Disease Progression|1|||
23523418|NCT00558103|65657602|FG001|Randomized Treatment Phase|Disease Progression|0|||
23523419|NCT00558103|65657603|FG002|Randomized Treatment Phase|Disease Progression|1|||
23523420|NCT00558103|65657604|FG003|Randomized Treatment Phase|Disease Progression|0|||
23523421|NCT00558103|65657605|FG004|Randomized Treatment Phase|Disease Progression|0|||
23523422|NCT00558103|65657606|FG005|Randomized Treatment Phase|Disease Progression|0|||
23523423|NCT00558103|65657601|FG000|Randomized Treatment Phase|Adverse Event|0|||
23523424|NCT00558103|65657602|FG001|Randomized Treatment Phase|Adverse Event|0|||
23523425|NCT00558103|65657603|FG002|Randomized Treatment Phase|Adverse Event|0|||
23523426|NCT00558103|65657604|FG003|Randomized Treatment Phase|Adverse Event|1|||
23523427|NCT00558103|65657605|FG004|Randomized Treatment Phase|Adverse Event|1|||
23523428|NCT00558103|65657606|FG005|Randomized Treatment Phase|Adverse Event|0|||
23523429|NCT00558103|65657601|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
23523430|NCT00558103|65657602|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
23523431|NCT00558103|65657603|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
23523432|NCT00558103|65657604|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
23523433|NCT00558103|65657605|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
23523434|NCT00558103|65657606|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
23523435|NCT00558103|65657601|FG000|Monotherapy Extension Phase|Disease Progression|0|||
23523436|NCT00558103|65657602|FG001|Monotherapy Extension Phase|Disease Progression|0|||
23523437|NCT00558103|65657603|FG002|Monotherapy Extension Phase|Disease Progression|0|||
23523438|NCT00558103|65657604|FG003|Monotherapy Extension Phase|Disease Progression|0|||
23812336|NCT01156142|66695831|FG001|Overall Study|Ineligible|1|||
23812337|NCT02272634|66695833|FG000|Overall Study|Adverse Event|1|||
23812338|NCT02272634|66695834|FG001|Overall Study|Adverse Event|0|||
23812339|NCT02272634|66695835|FG002|Overall Study|Adverse Event|0|||
23812340|NCT02272634|66695833|FG000|Overall Study|Protocol Violation|0|||
23812341|NCT02272634|66695834|FG001|Overall Study|Protocol Violation|0|||
23812342|NCT02272634|66695835|FG002|Overall Study|Protocol Violation|1|||
23812343|NCT02272634|66695833|FG000|Overall Study|Withdrawal by Subject|0|||
23812344|NCT02272634|66695834|FG001|Overall Study|Withdrawal by Subject|1|||
23812345|NCT02272634|66695835|FG002|Overall Study|Withdrawal by Subject|0|||
23812346|NCT01177059|66695849|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
23812347|NCT01177059|66695849|FG000|Overall Study|Withdrew consent|2|||
23812348|NCT01177059|66695849|FG000|Overall Study|Lost to Follow-up|18|||
23812349|NCT01584843|66695850|FG000|First Treatment Period|Adverse Event|0|||
23812350|NCT01584843|66695851|FG001|First Treatment Period|Adverse Event|0|||
23812351|NCT01584843|66695852|FG002|First Treatment Period|Adverse Event|1|||
23812352|NCT01584843|66695853|FG003|First Treatment Period|Adverse Event|0|||
23812353|NCT01584843|66695854|FG004|First Treatment Period|Adverse Event|0|||
23812354|NCT01584843|66695855|FG005|First Treatment Period|Adverse Event|0|||
23812355|NCT01584843|66695850|FG000|First Treatment Period|Protocol Violation|0|||
23812356|NCT01584843|66695851|FG001|First Treatment Period|Protocol Violation|0|||
23812357|NCT01584843|66695852|FG002|First Treatment Period|Protocol Violation|0|||
23812358|NCT01584843|66695853|FG003|First Treatment Period|Protocol Violation|0|||
23812359|NCT01584843|66695854|FG004|First Treatment Period|Protocol Violation|0|||
23812360|NCT01584843|66695855|FG005|First Treatment Period|Protocol Violation|1|||
23812361|NCT01584843|66695850|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23812362|NCT01584843|66695851|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23812363|NCT01584843|66695852|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23812364|NCT01584843|66695853|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23812365|NCT01584843|66695854|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23812366|NCT01584843|66695855|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
23523439|NCT00558103|65657605|FG004|Monotherapy Extension Phase|Disease Progression|0|||
23523440|NCT00558103|65657606|FG005|Monotherapy Extension Phase|Disease Progression|8|||
23523441|NCT02734810|65657607|FG000|Overall Study|Adverse Event|1|||
23523442|NCT02734810|65657608|FG001|Overall Study|Adverse Event|0|||
23523443|NCT02734810|65657607|FG000|Overall Study|Lack of Efficacy|1|||
23523444|NCT02734810|65657608|FG001|Overall Study|Lack of Efficacy|0|||
23523445|NCT02346136|65657611|FG000|Overall Study|Withdrawal by Subject|7|||
23523446|NCT02346136|65657612|FG001|Overall Study|Withdrawal by Subject|5|||
23523447|NCT02346136|65657611|FG000|Overall Study|Death|1|||
23523448|NCT02346136|65657612|FG001|Overall Study|Death|0|||
23523449|NCT02346136|65657611|FG000|Overall Study|Study termination|14|||
23523450|NCT02346136|65657612|FG001|Overall Study|Study termination|18|||
23523451|NCT00486265|65657613|FG000|Overall Study|Adverse Event|1|||
23523452|NCT00486265|65657613|FG000|Overall Study|Lack of Efficacy|8|||
23523453|NCT02449239|65657614|FG000|Induction Phase|Lack of Efficacy|64|||
23523454|NCT02449239|65657614|FG000|Induction Phase|Adverse Event|1|||
23523455|NCT02449239|65657614|FG000|Induction Phase|Lost to Follow-up|1|||
23523456|NCT02449239|65657614|FG000|Induction Phase|Protocol Violation|1|||
23523457|NCT02449239|65657614|FG000|Induction Phase|Physician Decision|1|||
23523458|NCT02449239|65657614|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
23523459|NCT02449239|65657614|FG000|Induction Phase|Withdrawal by Subject|1|||
23523460|NCT02449239|65657614|FG000|Maintenance Month 3|Lack of Efficacy|14|||
23523461|NCT02449239|65657614|FG000|Maintenance Month 6|Lack of Efficacy|10|||
23523462|NCT02449239|65657614|FG000|Maintenance Month 6|Adverse Event|2|||
23523463|NCT02449239|65657614|FG000|Maintenance Month 6|Physician Decision|1|||
23523464|NCT02449239|65657614|FG000|Maintenance Month 9|Lack of Efficacy|2|||
23523465|NCT02449239|65657614|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
23523466|NCT02449239|65657614|FG000|Maintenance Month 12|Lack of Efficacy|5|||
23523467|NCT02449239|65657614|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
23523468|NCT02449239|65657614|FG000|Maintenance Month 12|Subject moved from area|1|||
23523469|NCT02449239|65657614|FG000|Maintenance Month 15|Lack of Efficacy|1|||
23523470|NCT02449239|65657614|FG000|Maintenance Month 21|Lack of Efficacy|1|||
23523471|NCT02449239|65657614|FG000|Maintenance Month 21|Sponsor decision|1|||
23523472|NCT03925727|65657624|FG000|Overall Study|Adverse Event|4|||
23523473|NCT03925727|65657625|FG001|Overall Study|Adverse Event|0|||
23523474|NCT03925727|65657626|FG002|Overall Study|Adverse Event|3|||
23523475|NCT03925727|65657624|FG000|Overall Study|Protocol Violation|1|||
23523476|NCT03925727|65657625|FG001|Overall Study|Protocol Violation|2|||
23523477|NCT03925727|65657626|FG002|Overall Study|Protocol Violation|2|||
23523478|NCT03925727|65657624|FG000|Overall Study|Withdrawal by Subject|3|||
23523479|NCT03925727|65657625|FG001|Overall Study|Withdrawal by Subject|2|||
23523480|NCT03925727|65657626|FG002|Overall Study|Withdrawal by Subject|4|||
23523481|NCT03925727|65657624|FG000|Overall Study|Administrative Reasons|3|||
23523482|NCT03925727|65657625|FG001|Overall Study|Administrative Reasons|1|||
23523483|NCT03925727|65657626|FG002|Overall Study|Administrative Reasons|2|||
23523484|NCT03925727|65657624|FG000|Overall Study|Randomized in error or Disqualified|8|||
23523485|NCT03925727|65657625|FG001|Overall Study|Randomized in error or Disqualified|1|||
23523486|NCT03925727|65657626|FG002|Overall Study|Randomized in error or Disqualified|7|||
23523487|NCT01070316|65657627|FG000|Extension Phase|Lack of Efficacy|3|||
23523488|NCT01070316|65657627|FG000|Extension Phase|Withdrawal by Subject|1|||
23523489|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
23523490|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
23523491|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
23523492|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
23523493|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
23523494|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
23523495|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
23523496|NCT00097721|65657637|FG000|Overall Study|Adverse Event|8|||
23523497|NCT00097721|65657638|FG001|Overall Study|Adverse Event|1|||
23523498|NCT00097721|65657637|FG000|Overall Study|Withdrawal by Subject|6|||
23523499|NCT00097721|65657638|FG001|Overall Study|Withdrawal by Subject|1|||
23523500|NCT00097721|65657637|FG000|Overall Study|Progressive Disease|55|||
23523501|NCT00097721|65657638|FG001|Overall Study|Progressive Disease|27|||
23523502|NCT00097721|65657637|FG000|Overall Study|Physician Decision|1|||
23523503|NCT00097721|65657638|FG001|Overall Study|Physician Decision|3|||
23523504|NCT00097721|65657637|FG000|Overall Study|Reason not given|1|||
23523505|NCT00097721|65657638|FG001|Overall Study|Reason not given|1|||
23523506|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
23523507|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
23523508|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
23523509|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
23523510|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
23523511|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
23523512|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
23714850|NCT00718666|66329629|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
23714851|NCT00718666|66329630|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
23714852|NCT00781599|66329631|FG000|Overall Study|Lost to Follow-up|7|||
23714853|NCT00781599|66329632|FG001|Overall Study|Lost to Follow-up|4|||
23714854|NCT02680587|66329633|FG000|Overall Study|Withdrawal by Subject|1|||
23714855|NCT02680587|66329634|FG001|Overall Study|Withdrawal by Subject|0|||
23714856|NCT01409993|66329635|FG000|Overall Study|Adverse Event|4|||
23714857|NCT01409993|66329636|FG001|Overall Study|Adverse Event|4|||
23714858|NCT01409993|66329637|FG002|Overall Study|Adverse Event|3|||
23714859|NCT01409993|66329638|FG003|Overall Study|Adverse Event|1|||
23714860|NCT01409993|66329635|FG000|Overall Study|Withdrawal by Subject|0|||
23714861|NCT01409993|66329636|FG001|Overall Study|Withdrawal by Subject|0|||
23714862|NCT01409993|66329637|FG002|Overall Study|Withdrawal by Subject|0|||
23714863|NCT01409993|66329638|FG003|Overall Study|Withdrawal by Subject|4|||
23714864|NCT01409993|66329635|FG000|Overall Study|Lost to Follow-up|0|||
23714865|NCT01409993|66329636|FG001|Overall Study|Lost to Follow-up|1|||
23714866|NCT01409993|66329637|FG002|Overall Study|Lost to Follow-up|0|||
23714867|NCT01409993|66329638|FG003|Overall Study|Lost to Follow-up|0|||
23714868|NCT02429258|66329642|FG000|Overall Study|Withdrawal by Subject|2|||
23714869|NCT02429258|66329643|FG001|Overall Study|Withdrawal by Subject|0|||
23812367|NCT01584843|66695850|FG000|Second Treatment Period|Withdrawal by Subject|0|||
23714870|NCT02429258|66329642|FG000|Overall Study|Protocol Violation|0|||
23812368|NCT01584843|66695851|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23812369|NCT01584843|66695852|FG002|Second Treatment Period|Withdrawal by Subject|0|||
23812370|NCT01584843|66695853|FG003|Second Treatment Period|Withdrawal by Subject|0|||
23812371|NCT01584843|66695854|FG004|Second Treatment Period|Withdrawal by Subject|0|||
23812372|NCT01584843|66695855|FG005|Second Treatment Period|Withdrawal by Subject|1|||
23812373|NCT04516759|66695856|FG000|Overall Study|Withdrawal by Subject|1|||
23812374|NCT04516759|66695857|FG001|Overall Study|Withdrawal by Subject|1|||
23714871|NCT02429258|66329643|FG001|Overall Study|Protocol Violation|1|||
23714872|NCT01586806|66329644|FG000|Overall Study|Protocol Violation|0|||
23714873|NCT01586806|66329645|FG001|Overall Study|Protocol Violation|1|||
23714874|NCT01586806|66329646|FG002|Overall Study|Protocol Violation|0|||
23714875|NCT01586806|66329644|FG000|Overall Study|Withdrawal by Subject|1|||
23714876|NCT01586806|66329645|FG001|Overall Study|Withdrawal by Subject|0|||
23812375|NCT04516759|66695856|FG000|Overall Study|Other|0|||
23812376|NCT04516759|66695857|FG001|Overall Study|Other|1|||
23714877|NCT01586806|66329646|FG002|Overall Study|Withdrawal by Subject|0|||
23714878|NCT01586806|66329644|FG000|Overall Study|Lost to Follow-up|2|||
23714879|NCT01586806|66329645|FG001|Overall Study|Lost to Follow-up|3|||
23714880|NCT01586806|66329646|FG002|Overall Study|Lost to Follow-up|2|||
23714881|NCT01363713|66329647|FG000|Overall Study|Adverse Event|1|||
23714882|NCT01363713|66329647|FG000|Overall Study|Protocol Violation|3|||
23714883|NCT01363713|66329647|FG000|Overall Study|Withdrawal by Subject|2|||
23523513|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
23523514|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
23523515|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
23523516|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
23523517|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
23523518|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
23523519|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
23523520|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
23523521|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
23523522|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
23523523|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
23523524|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
23523525|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
23714884|NCT01318512|66329650|FG000|Maintenance Period (6 Months)|Death|2|||
23523526|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
23523527|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
23714885|NCT01318512|66329650|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
23714886|NCT00980980|66329651|FG000|Overall Study|Withdrawal by Hospital|0|||
23714887|NCT00980980|66329652|FG001|Overall Study|Withdrawal by Hospital|1|||
23714888|NCT00980980|66329653|FG002|Overall Study|Withdrawal by Hospital|0|||
23523528|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
23523529|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
23523530|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
23523531|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
23523532|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
23523533|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
23523534|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
23523535|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
23523536|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
23523537|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
23523538|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
23523539|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
23523540|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
23523541|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
23523542|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
23523543|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
23523544|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
23523545|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
23523546|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
23523547|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
23523548|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
23523549|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
23523550|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
23523551|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
23523552|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
23523553|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
23523554|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
23523555|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
23523556|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
23523557|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
23523558|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
23523559|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
23523560|NCT00127712|65657653|FG000|Overall Study|Adverse Event|3|||
23523561|NCT00127712|65657654|FG001|Overall Study|Adverse Event|0|||
23523562|NCT00127712|65657653|FG000|Overall Study|Lack of GI access to continue|2|||
23523563|NCT00127712|65657654|FG001|Overall Study|Lack of GI access to continue|0|||
23523564|NCT01354496|65657656|FG000|Period 1|Adverse Event|0|||
23523565|NCT01354496|65657657|FG001|Period 1|Adverse Event|0|||
23523566|NCT01354496|65657658|FG002|Period 1|Adverse Event|1|||
23523567|NCT01354496|65657659|FG003|Period 1|Adverse Event|0|||
23523568|NCT01354496|65657660|FG004|Period 1|Adverse Event|0|||
23523569|NCT01354496|65657661|FG005|Period 1|Adverse Event|0|||
23523570|NCT01354496|65657656|FG000|Period 1|Physician Decision|0|||
23523571|NCT01354496|65657657|FG001|Period 1|Physician Decision|0|||
23523572|NCT01354496|65657658|FG002|Period 1|Physician Decision|1|||
23523573|NCT01354496|65657659|FG003|Period 1|Physician Decision|0|||
23523574|NCT01354496|65657660|FG004|Period 1|Physician Decision|0|||
23523575|NCT01354496|65657661|FG005|Period 1|Physician Decision|0|||
23523576|NCT01354496|65657656|FG000|Period 2|Adverse Event|0|||
23523577|NCT01354496|65657657|FG001|Period 2|Adverse Event|0|||
23523578|NCT01354496|65657658|FG002|Period 2|Adverse Event|0|||
23523579|NCT01354496|65657659|FG003|Period 2|Adverse Event|1|||
23523580|NCT01354496|65657660|FG004|Period 2|Adverse Event|0|||
23523581|NCT01354496|65657661|FG005|Period 2|Adverse Event|0|||
23523582|NCT01354496|65657656|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523583|NCT01354496|65657657|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
23523584|NCT01354496|65657658|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23714889|NCT03067129|66329654|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23523585|NCT01354496|65657659|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
23523586|NCT01354496|65657660|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523587|NCT01354496|65657661|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523588|NCT01116232|65657665|FG000|Overall Study|Progressive diease|4|||
23523589|NCT00378703|65657673|FG000|Overall Study|Disease progression|59|||
23523590|NCT00378703|65657674|FG001|Overall Study|Disease progression|43|||
23523591|NCT00378703|65657675|FG002|Overall Study|Disease progression|48|||
23523592|NCT00378703|65657676|FG003|Overall Study|Disease progression|49|||
23523593|NCT00378703|65657673|FG000|Overall Study|Adverse Event|11|||
23523594|NCT00378703|65657674|FG001|Overall Study|Adverse Event|17|||
23523595|NCT00378703|65657675|FG002|Overall Study|Adverse Event|20|||
23523596|NCT00378703|65657676|FG003|Overall Study|Adverse Event|18|||
23523597|NCT00378703|65657673|FG000|Overall Study|Death|2|||
23523598|NCT00378703|65657674|FG001|Overall Study|Death|2|||
23523599|NCT00378703|65657675|FG002|Overall Study|Death|4|||
23523600|NCT00378703|65657676|FG003|Overall Study|Death|3|||
23523601|NCT00378703|65657673|FG000|Overall Study|Withdrawal by Subject|4|||
23523602|NCT00378703|65657674|FG001|Overall Study|Withdrawal by Subject|8|||
23523603|NCT00378703|65657675|FG002|Overall Study|Withdrawal by Subject|5|||
23523604|NCT00378703|65657676|FG003|Overall Study|Withdrawal by Subject|7|||
23523605|NCT00378703|65657673|FG000|Overall Study|Physician Decision|1|||
23523606|NCT00378703|65657674|FG001|Overall Study|Physician Decision|4|||
23523607|NCT00378703|65657675|FG002|Overall Study|Physician Decision|1|||
23523608|NCT00378703|65657676|FG003|Overall Study|Physician Decision|0|||
23523609|NCT00378703|65657673|FG000|Overall Study|Alternative therapy|4|||
23523610|NCT00378703|65657674|FG001|Overall Study|Alternative therapy|2|||
23523611|NCT00378703|65657675|FG002|Overall Study|Alternative therapy|0|||
23523612|NCT00378703|65657676|FG003|Overall Study|Alternative therapy|0|||
23523613|NCT00378703|65657673|FG000|Overall Study|Other complicated disease|0|||
23523614|NCT00378703|65657674|FG001|Overall Study|Other complicated disease|2|||
23523615|NCT00378703|65657675|FG002|Overall Study|Other complicated disease|2|||
23523616|NCT00378703|65657676|FG003|Overall Study|Other complicated disease|0|||
23523617|NCT00378703|65657673|FG000|Overall Study|Symptomatic deterioration|0|||
23523618|NCT00378703|65657674|FG001|Overall Study|Symptomatic deterioration|1|||
23523619|NCT00378703|65657675|FG002|Overall Study|Symptomatic deterioration|0|||
23523620|NCT00378703|65657676|FG003|Overall Study|Symptomatic deterioration|2|||
23523621|NCT00378703|65657673|FG000|Overall Study|Surgery|1|||
23523622|NCT00378703|65657674|FG001|Overall Study|Surgery|0|||
23523623|NCT00378703|65657675|FG002|Overall Study|Surgery|0|||
23523624|NCT00378703|65657676|FG003|Overall Study|Surgery|1|||
23523625|NCT00378703|65657673|FG000|Overall Study|Joint decision of physician and patient|1|||
23523626|NCT00378703|65657674|FG001|Overall Study|Joint decision of physician and patient|0|||
23523627|NCT00378703|65657675|FG002|Overall Study|Joint decision of physician and patient|0|||
23523628|NCT00378703|65657676|FG003|Overall Study|Joint decision of physician and patient|0|||
23523629|NCT00378703|65657673|FG000|Overall Study|Adverse events and progressive disease|0|||
23523630|NCT00378703|65657674|FG001|Overall Study|Adverse events and progressive disease|0|||
23523631|NCT00378703|65657675|FG002|Overall Study|Adverse events and progressive disease|0|||
23523632|NCT00378703|65657676|FG003|Overall Study|Adverse events and progressive disease|1|||
23523633|NCT00378703|65657673|FG000|Overall Study|Relocation|0|||
23523634|NCT00378703|65657674|FG001|Overall Study|Relocation|0|||
23523635|NCT00378703|65657675|FG002|Overall Study|Relocation|1|||
23523636|NCT00378703|65657676|FG003|Overall Study|Relocation|0|||
23523637|NCT00378703|65657673|FG000|Overall Study|Ineligible|4|||
23523638|NCT00378703|65657674|FG001|Overall Study|Ineligible|7|||
23523639|NCT00378703|65657675|FG002|Overall Study|Ineligible|7|||
23523640|NCT00378703|65657676|FG003|Overall Study|Ineligible|7|||
23523641|NCT00378703|65657673|FG000|Overall Study|Never started treatment|1|||
23523642|NCT00378703|65657674|FG001|Overall Study|Never started treatment|4|||
23523643|NCT00378703|65657675|FG002|Overall Study|Never started treatment|0|||
23523644|NCT00378703|65657676|FG003|Overall Study|Never started treatment|0|||
23523645|NCT00378703|65657673|FG000|Overall Study|Other|1|||
23523646|NCT00378703|65657674|FG001|Overall Study|Other|1|||
23523647|NCT00378703|65657675|FG002|Overall Study|Other|2|||
23523648|NCT00378703|65657676|FG003|Overall Study|Other|3|||
23523649|NCT02016625|65657678|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
23523650|NCT02016625|65657679|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
23523651|NCT02016625|65657678|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
23523652|NCT02016625|65657679|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
23523653|NCT02016625|65657678|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
23523654|NCT02016625|65657679|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
23523655|NCT00655564|65657692|FG000|Overall Study|Adverse Event|1|||
23523656|NCT00655564|65657692|FG000|Overall Study|Lost to Follow-up|1|||
23523657|NCT00655564|65657692|FG000|Overall Study|Desired Alternate Therapy|1|||
23523658|NCT00129129|65657693|FG000|Primary Phase|Adverse Event|2|||
23523659|NCT00129129|65657694|FG001|Primary Phase|Adverse Event|1|||
23523660|NCT00129129|65657695|FG002|Primary Phase|Adverse Event|0|||
23523661|NCT00129129|65657696|FG003|Primary Phase|Adverse Event|0|||
23523662|NCT00129129|65657697|FG004|Primary Phase|Adverse Event|0|||
23523663|NCT00129129|65657693|FG000|Primary Phase|Withdrawal by Subject|12|||
23523664|NCT00129129|65657694|FG001|Primary Phase|Withdrawal by Subject|10|||
23523665|NCT00129129|65657695|FG002|Primary Phase|Withdrawal by Subject|0|||
23523666|NCT00129129|65657696|FG003|Primary Phase|Withdrawal by Subject|0|||
23523667|NCT00129129|65657697|FG004|Primary Phase|Withdrawal by Subject|0|||
23523668|NCT00129129|65657693|FG000|Primary Phase|Migration from study area|1|||
23523669|NCT00129129|65657694|FG001|Primary Phase|Migration from study area|3|||
23523670|NCT00129129|65657695|FG002|Primary Phase|Migration from study area|0|||
23416789|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
23416790|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
23416791|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
23416792|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
23416793|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
23416794|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
23416795|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
23416796|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
23416797|NCT00813865|65271277|FG000|Overall Study|Failure to Respond|3|||
23416798|NCT00813865|65271277|FG000|Overall Study|Lost to Follow-up|3|||
23416799|NCT00813865|65271277|FG000|Overall Study|Withdrawal by Subject|1|||
23523671|NCT00129129|65657696|FG003|Primary Phase|Migration from study area|0|||
23523672|NCT00129129|65657697|FG004|Primary Phase|Migration from study area|0|||
23523673|NCT00129129|65657693|FG000|Primary Phase|Lost to Follow-up|8|||
23523674|NCT00129129|65657694|FG001|Primary Phase|Lost to Follow-up|6|||
23523675|NCT00129129|65657695|FG002|Primary Phase|Lost to Follow-up|0|||
23523676|NCT00129129|65657696|FG003|Primary Phase|Lost to Follow-up|0|||
23523677|NCT00129129|65657697|FG004|Primary Phase|Lost to Follow-up|0|||
23416800|NCT00855933|65271278|FG000|Overall Study|Withdrawal by Subject|0|||
23416801|NCT00855933|65271279|FG001|Overall Study|Withdrawal by Subject|1|||
23416802|NCT00920218|65271282|FG000|Overall Study|Serious Adverse Event|2|||
23416803|NCT00920218|65271283|FG001|Overall Study|Serious Adverse Event|0|||
23416804|NCT00920218|65271284|FG002|Overall Study|Serious Adverse Event|2|||
23416805|NCT00920218|65271285|FG003|Overall Study|Serious Adverse Event|1|||
23416806|NCT00920218|65271282|FG000|Overall Study|Withdrawal by Subject|0|||
23416807|NCT00920218|65271283|FG001|Overall Study|Withdrawal by Subject|3|||
23416808|NCT00920218|65271284|FG002|Overall Study|Withdrawal by Subject|2|||
23416809|NCT00920218|65271285|FG003|Overall Study|Withdrawal by Subject|0|||
23416810|NCT00920218|65271282|FG000|Overall Study|Migrated/moved from study area|0|||
23416811|NCT00920218|65271283|FG001|Overall Study|Migrated/moved from study area|0|||
23416812|NCT00920218|65271284|FG002|Overall Study|Migrated/moved from study area|1|||
23416813|NCT00920218|65271285|FG003|Overall Study|Migrated/moved from study area|0|||
23416814|NCT00920218|65271282|FG000|Overall Study|Lost to Follow-up|0|||
23416815|NCT00920218|65271283|FG001|Overall Study|Lost to Follow-up|1|||
23416816|NCT00920218|65271284|FG002|Overall Study|Lost to Follow-up|0|||
23416817|NCT00920218|65271285|FG003|Overall Study|Lost to Follow-up|3|||
23416818|NCT00920218|65271282|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
23416819|NCT00920218|65271283|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
23416820|NCT00920218|65271284|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
23416821|NCT00920218|65271285|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
23416822|NCT00920218|65271282|FG000|Overall Study|Other|0|||
23416823|NCT00920218|65271283|FG001|Overall Study|Other|0|||
23416824|NCT00920218|65271284|FG002|Overall Study|Other|1|||
23416825|NCT00920218|65271285|FG003|Overall Study|Other|0|||
23416826|NCT03213938|65271288|FG000|Overall Study|Lost to Follow-up|4|||
23416827|NCT03213938|65271289|FG001|Overall Study|Lost to Follow-up|3|||
23416828|NCT03213938|65271288|FG000|Overall Study|Lack of Efficacy|1|||
23416829|NCT03213938|65271289|FG001|Overall Study|Lack of Efficacy|0|||
23416830|NCT03213938|65271288|FG000|Overall Study|Decline to participate|5|||
23416831|NCT03213938|65271289|FG001|Overall Study|Decline to participate|4|||
23416832|NCT03213938|65271288|FG000|Overall Study|Without reason|4|||
23416833|NCT03213938|65271289|FG001|Overall Study|Without reason|5|||
23416834|NCT00853242|65271290|FG000|Overall Study|Adverse Event|0|||
23416835|NCT00853242|65271291|FG001|Overall Study|Adverse Event|1|||
23416836|NCT00853242|65271292|FG002|Overall Study|Adverse Event|1|||
23416837|NCT00853242|65271293|FG003|Overall Study|Adverse Event|0|||
23416838|NCT00853242|65271294|FG004|Overall Study|Adverse Event|3|||
23416839|NCT00853242|65271295|FG005|Overall Study|Adverse Event|1|||
23523678|NCT00129129|65657693|FG000|Primary Phase|Other|2|||
23523679|NCT00129129|65657694|FG001|Primary Phase|Other|5|||
23523680|NCT00129129|65657695|FG002|Primary Phase|Other|0|||
23523681|NCT00129129|65657696|FG003|Primary Phase|Other|0|||
23523682|NCT00129129|65657697|FG004|Primary Phase|Other|0|||
23416840|NCT00853242|65271296|FG006|Overall Study|Adverse Event|1|||
23416841|NCT00853242|65271290|FG000|Overall Study|Noncompliant|0|||
23416842|NCT00853242|65271291|FG001|Overall Study|Noncompliant|0|||
23416843|NCT00853242|65271292|FG002|Overall Study|Noncompliant|0|||
23416844|NCT00853242|65271293|FG003|Overall Study|Noncompliant|0|||
23416845|NCT00853242|65271294|FG004|Overall Study|Noncompliant|1|||
23416846|NCT00853242|65271295|FG005|Overall Study|Noncompliant|0|||
23416847|NCT00853242|65271296|FG006|Overall Study|Noncompliant|0|||
23416848|NCT00853242|65271290|FG000|Overall Study|Withdrawal by Subject|1|||
23416849|NCT00853242|65271291|FG001|Overall Study|Withdrawal by Subject|2|||
23523683|NCT00129129|65657693|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
23523684|NCT00129129|65657694|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
23523685|NCT00129129|65657695|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
23523686|NCT00129129|65657696|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
23523687|NCT00129129|65657697|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
23523688|NCT00129129|65657693|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
23523689|NCT00129129|65657694|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
23523690|NCT00129129|65657695|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
23523691|NCT00129129|65657696|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
23523692|NCT00129129|65657697|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
23523693|NCT00129129|65657693|FG000|Fourth Dose Phase|Migration from study area|0|||
23523694|NCT00129129|65657694|FG001|Fourth Dose Phase|Migration from study area|0|||
23523695|NCT00129129|65657695|FG002|Fourth Dose Phase|Migration from study area|0|||
23523696|NCT00129129|65657696|FG003|Fourth Dose Phase|Migration from study area|0|||
23523697|NCT00129129|65657697|FG004|Fourth Dose Phase|Migration from study area|2|||
23523698|NCT00129129|65657693|FG000|Fourth Dose Phase|Other|0|||
23523699|NCT00129129|65657694|FG001|Fourth Dose Phase|Other|0|||
23523700|NCT00129129|65657695|FG002|Fourth Dose Phase|Other|0|||
23523701|NCT00129129|65657696|FG003|Fourth Dose Phase|Other|1|||
23523702|NCT00129129|65657697|FG004|Fourth Dose Phase|Other|1|||
23523703|NCT00129129|65657693|FG000|Fourth Dose Phase|Protocol Violation|0|||
23523704|NCT00129129|65657694|FG001|Fourth Dose Phase|Protocol Violation|0|||
23523705|NCT00129129|65657695|FG002|Fourth Dose Phase|Protocol Violation|0|||
23523706|NCT00129129|65657696|FG003|Fourth Dose Phase|Protocol Violation|1|||
23523707|NCT00129129|65657697|FG004|Fourth Dose Phase|Protocol Violation|0|||
23523708|NCT00805935|65657705|FG000|Overall Study|Stimulation Failure|1|||
23523709|NCT00805935|65657706|FG001|Overall Study|Stimulation Failure|5|||
23523710|NCT00805935|65657707|FG002|Overall Study|Stimulation Failure|2|||
23523711|NCT00805935|65657708|FG003|Overall Study|Stimulation Failure|2|||
23523712|NCT00805935|65657705|FG000|Overall Study|Cycle cancelled|0|||
23523713|NCT00805935|65657706|FG001|Overall Study|Cycle cancelled|0|||
23523714|NCT00805935|65657707|FG002|Overall Study|Cycle cancelled|2|||
23523715|NCT00805935|65657708|FG003|Overall Study|Cycle cancelled|0|||
23523716|NCT00805935|65657705|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
23523717|NCT00805935|65657706|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
23523718|NCT00805935|65657707|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
23523719|NCT00805935|65657708|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
23523720|NCT00805935|65657705|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523721|NCT00805935|65657706|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523722|NCT00805935|65657707|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523723|NCT00805935|65657708|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
23523724|NCT00805935|65657705|FG000|Overall Study|Lost to Follow-up|1|||
23523725|NCT00805935|65657706|FG001|Overall Study|Lost to Follow-up|0|||
23523726|NCT00805935|65657707|FG002|Overall Study|Lost to Follow-up|0|||
23523727|NCT00805935|65657708|FG003|Overall Study|Lost to Follow-up|0|||
23523728|NCT00805935|65657705|FG000|Overall Study|No positive serum pregnancy|8|||
23523729|NCT00805935|65657706|FG001|Overall Study|No positive serum pregnancy|7|||
23523730|NCT00805935|65657707|FG002|Overall Study|No positive serum pregnancy|6|||
23523731|NCT00805935|65657708|FG003|Overall Study|No positive serum pregnancy|5|||
23523732|NCT00805935|65657705|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523733|NCT00805935|65657706|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523734|NCT00805935|65657707|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523735|NCT00805935|65657708|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23523736|NCT00805935|65657705|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
23523737|NCT00805935|65657706|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
23523738|NCT00805935|65657707|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
23523739|NCT00805935|65657708|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
23523740|NCT00805935|65657705|FG000|Overall Study|Biochemical pregnancy|0|||
23523741|NCT00805935|65657706|FG001|Overall Study|Biochemical pregnancy|1|||
23523742|NCT00805935|65657707|FG002|Overall Study|Biochemical pregnancy|0|||
23523743|NCT00805935|65657708|FG003|Overall Study|Biochemical pregnancy|0|||
23523744|NCT00805935|65657705|FG000|Overall Study|Chemical pregnancy|0|||
23523745|NCT00805935|65657706|FG001|Overall Study|Chemical pregnancy|5|||
23523746|NCT00805935|65657707|FG002|Overall Study|Chemical pregnancy|3|||
23523747|NCT00805935|65657708|FG003|Overall Study|Chemical pregnancy|2|||
23812377|NCT01770392|66695858|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
23812378|NCT01212588|66695859|FG000|Overall Study|Physician Decision|0|||
23523748|NCT00805935|65657705|FG000|Overall Study|Ectopic pregnancy|0|||
23523749|NCT00805935|65657706|FG001|Overall Study|Ectopic pregnancy|0|||
23523750|NCT00805935|65657707|FG002|Overall Study|Ectopic pregnancy|1|||
23523751|NCT00805935|65657708|FG003|Overall Study|Ectopic pregnancy|0|||
23523752|NCT00805935|65657705|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523753|NCT00805935|65657706|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
23523754|NCT00805935|65657707|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523755|NCT00805935|65657708|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523756|NCT00136084|65657709|FG000|Overall Study|Death|12|||
23812379|NCT01212588|66695860|FG001|Overall Study|Physician Decision|1|||
23523757|NCT00136084|65657710|FG001|Overall Study|Death|5|||
23523758|NCT00136084|65657709|FG000|Overall Study|Unacceptable toxicity|8|||
23523759|NCT00136084|65657710|FG001|Overall Study|Unacceptable toxicity|11|||
23523760|NCT00136084|65657709|FG000|Overall Study|Relapse|20|||
23523761|NCT00136084|65657710|FG001|Overall Study|Relapse|23|||
23523762|NCT00136084|65657709|FG000|Overall Study|Lost to Follow-up|2|||
23523763|NCT00136084|65657710|FG001|Overall Study|Lost to Follow-up|0|||
23523764|NCT00136084|65657709|FG000|Overall Study|No Response|1|||
23523765|NCT00136084|65657710|FG001|Overall Study|No Response|2|||
23523766|NCT00136084|65657709|FG000|Overall Study|Withdrawal by Subject|5|||
23523767|NCT00136084|65657710|FG001|Overall Study|Withdrawal by Subject|1|||
23523768|NCT00973479|65657711|FG000|Overall Study|Lost to Follow-up|0|||
23523769|NCT00973479|65657712|FG001|Overall Study|Lost to Follow-up|3|||
23523770|NCT00973479|65657711|FG000|Overall Study|Death|2|||
23523771|NCT00973479|65657712|FG001|Overall Study|Death|2|||
23523772|NCT00973479|65657711|FG000|Overall Study|Withdrawal by Subject|15|||
23523773|NCT00973479|65657712|FG001|Overall Study|Withdrawal by Subject|16|||
23523774|NCT00973479|65657711|FG000|Overall Study|Lack of Efficacy|5|||
23523775|NCT00973479|65657712|FG001|Overall Study|Lack of Efficacy|7|||
23523776|NCT00973479|65657711|FG000|Overall Study|Adverse Event|12|||
23523777|NCT00973479|65657712|FG001|Overall Study|Adverse Event|32|||
23523778|NCT00973479|65657711|FG000|Overall Study|Protocol Violation|2|||
23523779|NCT00973479|65657712|FG001|Overall Study|Protocol Violation|2|||
23523780|NCT00973479|65657711|FG000|Overall Study|Other|1|||
23714890|NCT03067129|66329655|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23714891|NCT03067129|66329656|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23714892|NCT03067129|66329657|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
23714893|NCT03067129|66329654|FG000|Overall Study|Withdrawal by Subject|0|||
23714894|NCT03067129|66329655|FG001|Overall Study|Withdrawal by Subject|0|||
23714895|NCT03067129|66329656|FG002|Overall Study|Withdrawal by Subject|1|||
23714896|NCT03067129|66329657|FG003|Overall Study|Withdrawal by Subject|2|||
23714897|NCT03067129|66329654|FG000|Overall Study|Lost to Follow-up|5|||
23714898|NCT03067129|66329655|FG001|Overall Study|Lost to Follow-up|5|||
23714899|NCT03067129|66329656|FG002|Overall Study|Lost to Follow-up|4|||
23714900|NCT03067129|66329657|FG003|Overall Study|Lost to Follow-up|3|||
23523781|NCT00973479|65657712|FG001|Overall Study|Other|7|||
23523782|NCT04200248|65657713|FG000|Overall Study|Personal reasons|0|||
23523783|NCT04200248|65657714|FG001|Overall Study|Personal reasons|0|||
23523784|NCT04200248|65657715|FG002|Overall Study|Personal reasons|1|||
23523785|NCT04200248|65657713|FG000|Overall Study|Discontinued prior to treatment|3|||
23523786|NCT04200248|65657714|FG001|Overall Study|Discontinued prior to treatment|3|||
23523787|NCT04200248|65657715|FG002|Overall Study|Discontinued prior to treatment|2|||
23523788|NCT03080961|65657716|FG000|Overall Study|Withdrawal by Subject|3|||
23523789|NCT01957462|65657720|FG000|Test Period 1|Withdrawal by Subject|1|||
23523790|NCT01957462|65657721|FG001|Test Period 1|Withdrawal by Subject|0|||
23523791|NCT01957462|65657720|FG000|Test Period 1|Adverse Event|1|||
23523792|NCT01957462|65657721|FG001|Test Period 1|Adverse Event|0|||
23523793|NCT01904604|65657722|FG000|Overall Study|Withdrew before receiving dosing|0|||
23523794|NCT01904604|65657723|FG001|Overall Study|Withdrew before receiving dosing|1|||
23523795|NCT01904604|65657724|FG002|Overall Study|Withdrew before receiving dosing|0|||
23523796|NCT01904604|65657722|FG000|Overall Study|Non-compliance|1|||
23523797|NCT01904604|65657723|FG001|Overall Study|Non-compliance|0|||
23523798|NCT01904604|65657724|FG002|Overall Study|Non-compliance|0|||
23523799|NCT01904604|65657722|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
23523800|NCT01904604|65657723|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
23523801|NCT01904604|65657724|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
23523802|NCT01904604|65657722|FG000|Overall Study|Patch site reactions|1|||
23523803|NCT01904604|65657723|FG001|Overall Study|Patch site reactions|1|||
23523804|NCT01904604|65657724|FG002|Overall Study|Patch site reactions|0|||
23523805|NCT01904604|65657722|FG000|Overall Study|Increased syncope|0|||
23523806|NCT01904604|65657723|FG001|Overall Study|Increased syncope|1|||
23523807|NCT01904604|65657724|FG002|Overall Study|Increased syncope|0|||
23523808|NCT01904604|65657722|FG000|Overall Study|Unrelated illness|0|||
23523809|NCT01904604|65657723|FG001|Overall Study|Unrelated illness|1|||
23523810|NCT01904604|65657724|FG002|Overall Study|Unrelated illness|0|||
23523811|NCT01904604|65657722|FG000|Overall Study|Passed Week 52 OFC|1|||
23523812|NCT01904604|65657723|FG001|Overall Study|Passed Week 52 OFC|0|||
23523813|NCT01904604|65657724|FG002|Overall Study|Passed Week 52 OFC|0|||
23523814|NCT01904604|65657722|FG000|Overall Study|Withdrawal by Subject|1|||
23523815|NCT01904604|65657723|FG001|Overall Study|Withdrawal by Subject|2|||
23523816|NCT01904604|65657724|FG002|Overall Study|Withdrawal by Subject|0|||
23523817|NCT01904604|65657722|FG000|Overall Study|Participant Relocated|1|||
23523818|NCT01904604|65657723|FG001|Overall Study|Participant Relocated|1|||
23523819|NCT01904604|65657724|FG002|Overall Study|Participant Relocated|1|||
23523820|NCT01904604|65657722|FG000|Overall Study|Lost to Follow-up|0|||
23523821|NCT01904604|65657723|FG001|Overall Study|Lost to Follow-up|0|||
23523822|NCT01904604|65657724|FG002|Overall Study|Lost to Follow-up|1|||
23523823|NCT02680639|65657725|FG000|Screening Period|Screen Failure|7|||
23714901|NCT01582971|66329658|FG000|Overall Study|Death|2|||
23714902|NCT01582971|66329659|FG001|Overall Study|Death|1|||
23523824|NCT02680639|65657726|FG001|Screening Period|Screen Failure|0|||
23523825|NCT02680639|65657727|FG002|Screening Period|Screen Failure|0|||
23523826|NCT01418209|65657728|FG000|Overall Study|Withdrawal by Subject|1|||
23523827|NCT01418209|65657729|FG001|Overall Study|Withdrawal by Subject|0|||
23523828|NCT01418209|65657730|FG002|Overall Study|Withdrawal by Subject|1|||
23523829|NCT01418209|65657728|FG000|Overall Study|Did not provide hot flash diary data|1|||
23523830|NCT01418209|65657729|FG001|Overall Study|Did not provide hot flash diary data|3|||
23523831|NCT01418209|65657730|FG002|Overall Study|Did not provide hot flash diary data|3|||
23523832|NCT00747435|65657733|FG000|Overall Study|Lost to Follow-up|2|||
23523833|NCT00747435|65657733|FG000|Overall Study|Withdrawal by Subject|3|||
23523834|NCT00747435|65657733|FG000|Overall Study|Still undergoing follow up|1|||
23523835|NCT00449956|65657735|FG000|Overall Study|Adverse Event|7|||
23523836|NCT00449956|65657736|FG001|Overall Study|Adverse Event|1|||
23523837|NCT00449956|65657737|FG002|Overall Study|Adverse Event|6|||
23523838|NCT00449956|65657735|FG000|Overall Study|Lack of Efficacy|0|||
23523839|NCT00449956|65657736|FG001|Overall Study|Lack of Efficacy|0|||
23523840|NCT00449956|65657737|FG002|Overall Study|Lack of Efficacy|1|||
23523841|NCT00449956|65657735|FG000|Overall Study|Protocol Violation|1|||
23523842|NCT00449956|65657736|FG001|Overall Study|Protocol Violation|1|||
23523843|NCT00449956|65657737|FG002|Overall Study|Protocol Violation|1|||
23523844|NCT00449956|65657735|FG000|Overall Study|Withdrawal by Subject|0|||
23523845|NCT00449956|65657736|FG001|Overall Study|Withdrawal by Subject|1|||
23523846|NCT00449956|65657737|FG002|Overall Study|Withdrawal by Subject|0|||
23523847|NCT00449956|65657735|FG000|Overall Study|Physician Decision|2|||
23523848|NCT00449956|65657736|FG001|Overall Study|Physician Decision|1|||
23523849|NCT00449956|65657737|FG002|Overall Study|Physician Decision|1|||
23523850|NCT03239470|65657738|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
23523851|NCT03239470|65657739|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
23523852|NCT02308735|65657742|FG000|Overall Study|Physician Decision|2|||
23523853|NCT02308735|65657743|FG001|Overall Study|Physician Decision|0|||
23523854|NCT02308735|65657744|FG002|Overall Study|Physician Decision|0|||
23523855|NCT02308735|65657745|FG003|Overall Study|Physician Decision|2|||
23523856|NCT01393405|65657746|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
23523857|NCT01393405|65657747|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
23523858|NCT01393405|65657748|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
23523859|NCT01393405|65657746|FG000|Induction Period (week1-16)|Adverse Event|16|||
23523860|NCT01393405|65657747|FG001|Induction Period (week1-16)|Adverse Event|0|||
23523861|NCT01393405|65657748|FG002|Induction Period (week1-16)|Adverse Event|0|||
23523862|NCT01393405|65657746|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
23523863|NCT01393405|65657747|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
23523864|NCT01393405|65657748|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
23523865|NCT01393405|65657746|FG000|Maintenance Period Week|Lack of Efficacy|0|||
23523866|NCT01393405|65657747|FG001|Maintenance Period Week|Lack of Efficacy|22|||
23523867|NCT01393405|65657748|FG002|Maintenance Period Week|Lack of Efficacy|22|||
23523868|NCT01393405|65657746|FG000|Maintenance Period Week|Adverse Event|0|||
23523869|NCT01393405|65657747|FG001|Maintenance Period Week|Adverse Event|5|||
23523870|NCT01393405|65657748|FG002|Maintenance Period Week|Adverse Event|2|||
23523871|NCT01393405|65657746|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
23523872|NCT01393405|65657747|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
23523873|NCT01393405|65657748|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
23523874|NCT01393405|65657746|FG000|Maintenance Period Week|Lost to Follow-up|0|||
23523875|NCT01393405|65657747|FG001|Maintenance Period Week|Lost to Follow-up|1|||
23523876|NCT01393405|65657748|FG002|Maintenance Period Week|Lost to Follow-up|0|||
23523877|NCT01723163|65657749|FG000|Treatment Phase|Withdrawal by Subject|14|||
23523878|NCT01723163|65657750|FG001|Treatment Phase|Withdrawal by Subject|6|||
23523879|NCT01723163|65657749|FG000|Treatment Phase|Withdrawal by PI|5|||
23523880|NCT01723163|65657750|FG001|Treatment Phase|Withdrawal by PI|1|||
23523881|NCT01723163|65657749|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
23523882|NCT01723163|65657750|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
23523883|NCT01723163|65657749|FG000|3-Month Follow-up|Unable to Contact|12|||
23523884|NCT01723163|65657750|FG001|3-Month Follow-up|Unable to Contact|19|||
23523885|NCT01723163|65657749|FG000|6-Month Follow-up|Death|1|||
23523886|NCT01723163|65657750|FG001|6-Month Follow-up|Death|0|||
23714903|NCT01582971|66329658|FG000|Overall Study|Lost to Follow-up|18|||
23523887|NCT01723163|65657749|FG000|6-Month Follow-up|Unable to Contact|17|||
23523888|NCT01723163|65657750|FG001|6-Month Follow-up|Unable to Contact|15|||
23523889|NCT01723163|65657749|FG000|12-Month Follow-up|Death|1|||
23523890|NCT01723163|65657750|FG001|12-Month Follow-up|Death|0|||
23523891|NCT01723163|65657749|FG000|12-Month Follow-up|Unable to Contact|23|||
23523892|NCT01723163|65657750|FG001|12-Month Follow-up|Unable to Contact|28|||
23523893|NCT01554618|65657756|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
23523894|NCT01554618|65657757|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
23523895|NCT01554618|65657756|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
23523896|NCT01554618|65657757|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
23523897|NCT01554618|65657756|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
23523898|NCT01554618|65657757|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
23523899|NCT01554618|65657756|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
23523900|NCT01554618|65657757|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
23523901|NCT01554618|65657756|FG000|Open-Label Extension Period|Physician Decision|0|||
23523902|NCT01554618|65657757|FG001|Open-Label Extension Period|Physician Decision|1|||
23523903|NCT01554618|65657756|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23523904|NCT01554618|65657757|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
23523905|NCT02286193|65657758|FG000|Overall Study|Referred: CRS unable to make contact|62|||
23523906|NCT02286193|65657758|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
23523907|NCT02286193|65657758|FG000|Overall Study|Referred: Declined service|38|||
23523908|NCT02439320|65657759|FG000|Overall Study|Adverse Event|0|||
23523909|NCT02439320|65657760|FG001|Overall Study|Adverse Event|2|||
23523910|NCT02439320|65657761|FG002|Overall Study|Adverse Event|0|||
23523911|NCT02439320|65657759|FG000|Overall Study|Lost to Follow-up|37|||
23523912|NCT02439320|65657760|FG001|Overall Study|Lost to Follow-up|34|||
23523913|NCT02439320|65657761|FG002|Overall Study|Lost to Follow-up|42|||
23523914|NCT02439320|65657759|FG000|Overall Study|Death|0|||
23523915|NCT02439320|65657760|FG001|Overall Study|Death|1|||
23523916|NCT02439320|65657761|FG002|Overall Study|Death|0|||
23523917|NCT02439320|65657759|FG000|Overall Study|Noncompliance with Protocol|10|||
23523918|NCT02439320|65657760|FG001|Overall Study|Noncompliance with Protocol|11|||
23523919|NCT02439320|65657761|FG002|Overall Study|Noncompliance with Protocol|7|||
23523920|NCT02439320|65657759|FG000|Overall Study|Pregnancy|0|||
23523921|NCT02439320|65657760|FG001|Overall Study|Pregnancy|1|||
23523922|NCT02439320|65657761|FG002|Overall Study|Pregnancy|1|||
23523923|NCT02439320|65657759|FG000|Overall Study|Withdrawal by Subject|12|||
23523924|NCT02439320|65657760|FG001|Overall Study|Withdrawal by Subject|16|||
23523925|NCT02439320|65657761|FG002|Overall Study|Withdrawal by Subject|14|||
23523926|NCT02439320|65657759|FG000|Overall Study|Physician Decision|2|||
23523927|NCT02439320|65657760|FG001|Overall Study|Physician Decision|1|||
23523928|NCT02439320|65657761|FG002|Overall Study|Physician Decision|0|||
23523929|NCT02439320|65657759|FG000|Overall Study|Sponsor Request|0|||
23523930|NCT02439320|65657760|FG001|Overall Study|Sponsor Request|2|||
23523931|NCT02439320|65657761|FG002|Overall Study|Sponsor Request|1|||
23523932|NCT02439320|65657759|FG000|Overall Study|Randomization Failure|35|||
23523933|NCT02439320|65657760|FG001|Overall Study|Randomization Failure|46|||
23523934|NCT02439320|65657761|FG002|Overall Study|Randomization Failure|34|||
23523935|NCT01649375|65657762|FG000|Up to Week 16|Adverse Event|2|||
23523936|NCT01649375|65657763|FG001|Up to Week 16|Adverse Event|5|||
23523937|NCT01649375|65657764|FG002|Up to Week 16|Adverse Event|4|||
23523938|NCT01649375|65657765|FG003|Up to Week 16|Adverse Event|0|||
23523939|NCT01649375|65657766|FG004|Up to Week 16|Adverse Event|0|||
23523940|NCT01649375|65657762|FG000|Up to Week 16|Lack of Efficacy|0|||
23523941|NCT01649375|65657763|FG001|Up to Week 16|Lack of Efficacy|0|||
23523942|NCT01649375|65657764|FG002|Up to Week 16|Lack of Efficacy|1|||
23523943|NCT01649375|65657765|FG003|Up to Week 16|Lack of Efficacy|0|||
23523944|NCT01649375|65657766|FG004|Up to Week 16|Lack of Efficacy|0|||
23523945|NCT01649375|65657762|FG000|Up to Week 16|Physician Decision|0|||
23523946|NCT01649375|65657763|FG001|Up to Week 16|Physician Decision|0|||
23523947|NCT01649375|65657764|FG002|Up to Week 16|Physician Decision|1|||
23523948|NCT01649375|65657765|FG003|Up to Week 16|Physician Decision|0|||
23523949|NCT01649375|65657766|FG004|Up to Week 16|Physician Decision|0|||
23523950|NCT01649375|65657762|FG000|Up to Week 16|Withdrawal by Subject|2|||
23523951|NCT01649375|65657763|FG001|Up to Week 16|Withdrawal by Subject|1|||
23523952|NCT01649375|65657764|FG002|Up to Week 16|Withdrawal by Subject|2|||
23523953|NCT01649375|65657765|FG003|Up to Week 16|Withdrawal by Subject|0|||
23523954|NCT01649375|65657766|FG004|Up to Week 16|Withdrawal by Subject|0|||
23523955|NCT01649375|65657762|FG000|Up to Week 16|Death|1|||
23523956|NCT01649375|65657763|FG001|Up to Week 16|Death|0|||
23523957|NCT01649375|65657764|FG002|Up to Week 16|Death|0|||
23812380|NCT01212588|66695859|FG000|Overall Study|Protocol Violation|1|||
23812381|NCT01212588|66695860|FG001|Overall Study|Protocol Violation|1|||
23812382|NCT00655876|66695862|FG000|Overall Study|Protocol Violation|9|||
23812383|NCT00655876|66695863|FG001|Overall Study|Protocol Violation|7|||
23523958|NCT01649375|65657765|FG003|Up to Week 16|Death|0|||
23523959|NCT01649375|65657766|FG004|Up to Week 16|Death|0|||
23523960|NCT01649375|65657762|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
23523961|NCT01649375|65657763|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
23812384|NCT00988442|66695864|FG000|Overall Study|Death|1|||
23523962|NCT01649375|65657764|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
23523963|NCT01649375|65657765|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
23523964|NCT01649375|65657766|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
23523965|NCT01649375|65657762|FG000|Week 16 up to Week 260|Non-compliance|0|||
23523966|NCT01649375|65657763|FG001|Week 16 up to Week 260|Non-compliance|1|||
23523967|NCT01649375|65657764|FG002|Week 16 up to Week 260|Non-compliance|0|||
23523968|NCT01649375|65657765|FG003|Week 16 up to Week 260|Non-compliance|1|||
23812385|NCT00988442|66695865|FG001|Overall Study|Death|2|||
23812386|NCT00988442|66695864|FG000|Overall Study|Lost to Follow-up|0|||
23812387|NCT00988442|66695865|FG001|Overall Study|Lost to Follow-up|1|||
23812388|NCT00988442|66695864|FG000|Overall Study|Early Study Closure|29|||
23812389|NCT00988442|66695865|FG001|Overall Study|Early Study Closure|25|||
23812390|NCT01195103|66695866|FG000|Overall Study|Withdrawal by Subject|1|||
23812391|NCT01195103|66695867|FG001|Overall Study|Withdrawal by Subject|0|||
23812392|NCT01195103|66695868|FG002|Overall Study|Withdrawal by Subject|0|||
23812393|NCT00724048|66695869|FG000|Overall Study|Adverse Event|1|||
23812394|NCT00724048|66695870|FG001|Overall Study|Adverse Event|1|||
23812395|NCT00724048|66695871|FG002|Overall Study|Adverse Event|1|||
23812396|NCT00724048|66695872|FG003|Overall Study|Adverse Event|0|||
23523969|NCT01649375|65657766|FG004|Week 16 up to Week 260|Non-compliance|0|||
23523970|NCT01649375|65657762|FG000|Week 16 up to Week 260|Physician Decision|0|||
23523971|NCT01649375|65657763|FG001|Week 16 up to Week 260|Physician Decision|2|||
23523972|NCT01649375|65657764|FG002|Week 16 up to Week 260|Physician Decision|0|||
23523973|NCT01649375|65657765|FG003|Week 16 up to Week 260|Physician Decision|0|||
23523974|NCT01649375|65657766|FG004|Week 16 up to Week 260|Physician Decision|0|||
23523975|NCT01649375|65657762|FG000|Week 16 up to Week 260|Technical issues|0|||
23523976|NCT01649375|65657763|FG001|Week 16 up to Week 260|Technical issues|1|||
23523977|NCT01649375|65657764|FG002|Week 16 up to Week 260|Technical issues|0|||
23523978|NCT01649375|65657765|FG003|Week 16 up to Week 260|Technical issues|1|||
23523979|NCT01649375|65657766|FG004|Week 16 up to Week 260|Technical issues|0|||
23523980|NCT01649375|65657762|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
23523981|NCT01649375|65657763|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
23523982|NCT01649375|65657764|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
23523983|NCT01649375|65657765|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
23523984|NCT01649375|65657766|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
23523985|NCT01649375|65657762|FG000|Week 16 up to Week 260|Death|1|||
23523986|NCT01649375|65657763|FG001|Week 16 up to Week 260|Death|1|||
23523987|NCT01649375|65657764|FG002|Week 16 up to Week 260|Death|0|||
23523988|NCT01649375|65657765|FG003|Week 16 up to Week 260|Death|0|||
23523989|NCT01649375|65657766|FG004|Week 16 up to Week 260|Death|0|||
23523990|NCT01649375|65657762|FG000|Week 16 up to Week 260|Adverse Event|5|||
23523991|NCT01649375|65657763|FG001|Week 16 up to Week 260|Adverse Event|2|||
23523992|NCT01649375|65657764|FG002|Week 16 up to Week 260|Adverse Event|0|||
23523993|NCT01649375|65657765|FG003|Week 16 up to Week 260|Adverse Event|3|||
23523994|NCT01649375|65657766|FG004|Week 16 up to Week 260|Adverse Event|2|||
23523995|NCT00922766|65657767|FG000|Overall Study|Death|3|||
23523996|NCT00922766|65657767|FG000|Overall Study|Withdrawal by Subject|2|||
23523997|NCT00922766|65657767|FG000|Overall Study|Other|1|||
23523998|NCT00922766|65657767|FG000|Overall Study|Adverse Event|1|||
23523999|NCT00076011|65657768|FG000|Overall Study|Death|1|||
23524000|NCT00076011|65657768|FG000|Overall Study|Adverse Event|10|||
23524001|NCT00076011|65657768|FG000|Overall Study|Lack of Efficacy|25|||
23524002|NCT00076011|65657768|FG000|Overall Study|Withdrawal by Subject|1|||
23524003|NCT00076011|65657768|FG000|Overall Study|Study terminated by sponsor|3|||
23524004|NCT00076011|65657768|FG000|Overall Study|Other|11|||
23524005|NCT00076011|65657768|FG000|Overall Study|Ongoing|1|||
23524006|NCT00806546|65657769|FG000|Overall Study|Enrolled, not treated|35|||
23524007|NCT00806546|65657769|FG000|Overall Study|Lost to Follow-up|32|||
23812397|NCT00724048|66695869|FG000|Overall Study|Lost to Follow-up|0|||
23812398|NCT00724048|66695870|FG001|Overall Study|Lost to Follow-up|1|||
23812399|NCT00724048|66695871|FG002|Overall Study|Lost to Follow-up|0|||
23812400|NCT00724048|66695872|FG003|Overall Study|Lost to Follow-up|0|||
23812401|NCT00724048|66695869|FG000|Overall Study|Withdrawal by Subject|1|||
23812402|NCT00724048|66695870|FG001|Overall Study|Withdrawal by Subject|2|||
23812403|NCT00724048|66695871|FG002|Overall Study|Withdrawal by Subject|1|||
23812404|NCT00724048|66695872|FG003|Overall Study|Withdrawal by Subject|2|||
23812405|NCT00724048|66695869|FG000|Overall Study|Investigator decision|0|||
23812406|NCT00724048|66695870|FG001|Overall Study|Investigator decision|0|||
23812407|NCT00724048|66695871|FG002|Overall Study|Investigator decision|1|||
23812408|NCT00724048|66695872|FG003|Overall Study|Investigator decision|0|||
23812409|NCT00724048|66695869|FG000|Overall Study|Did not tolerate study drug|0|||
23812410|NCT00724048|66695870|FG001|Overall Study|Did not tolerate study drug|0|||
23812411|NCT00724048|66695871|FG002|Overall Study|Did not tolerate study drug|0|||
23524008|NCT00806546|65657769|FG000|Overall Study|Adverse Event|74|||
23524009|NCT00806546|65657769|FG000|Overall Study|Withdrawal by Subject|75|||
23524010|NCT00806546|65657769|FG000|Overall Study|Protocol Violation|49|||
23524011|NCT00806546|65657769|FG000|Overall Study|Various|42|||
23524012|NCT02972632|65657774|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23524013|NCT02972632|65657774|FG000|Overall Study|Lost to Follow-up|4|||
23524014|NCT02972632|65657774|FG000|Overall Study|Voluntary Withdrawal|10|||
23524015|NCT03385239|65657777|FG000|Overall Study|Voluntary Withdrawal|2|||
23524016|NCT03385239|65657778|FG001|Overall Study|Voluntary Withdrawal|3|||
23714904|NCT01582971|66329659|FG001|Overall Study|Lost to Follow-up|21|||
23812412|NCT00724048|66695872|FG003|Overall Study|Did not tolerate study drug|1|||
23812413|NCT00724048|66695869|FG000|Overall Study|Other than specified|1|||
23812414|NCT00724048|66695870|FG001|Overall Study|Other than specified|1|||
23812415|NCT00724048|66695871|FG002|Overall Study|Other than specified|0|||
23812416|NCT00724048|66695872|FG003|Overall Study|Other than specified|0|||
23812417|NCT04268316|66695876|FG000|Overall Study|Withdrawal by Subject|2|||
23812418|NCT04268316|66695877|FG001|Overall Study|Withdrawal by Subject|1|||
23812419|NCT04268316|66695878|FG002|Overall Study|Withdrawal by Subject|0|||
23812420|NCT00780910|66695881|FG000|Overall Study|Adverse Event|2|||
23812421|NCT03222583|66695882|FG000|Overall Study|Withdrawal by Subject|3|||
23812422|NCT03222583|66695883|FG001|Overall Study|Withdrawal by Subject|3|||
23812423|NCT03222583|66695882|FG000|Overall Study|Lost to Follow-up|1|||
23812424|NCT03222583|66695883|FG001|Overall Study|Lost to Follow-up|0|||
23812425|NCT03222583|66695882|FG000|Overall Study|Other|1|||
23812426|NCT03222583|66695883|FG001|Overall Study|Other|3|||
23812427|NCT00003875|66695884|FG000|Overall Study|Screen Failed|1|||
23812428|NCT03283319|66695886|FG000|Overall Study|Lost to Follow-up|5|||
23812429|NCT03283319|66695887|FG001|Overall Study|Lost to Follow-up|4|||
23812430|NCT03283319|66695888|FG002|Overall Study|Lost to Follow-up|5|||
23812431|NCT03283319|66695889|FG003|Overall Study|Lost to Follow-up|5|||
23812432|NCT03283319|66695890|FG004|Overall Study|Lost to Follow-up|4|||
23812433|NCT03283319|66695891|FG005|Overall Study|Lost to Follow-up|3|||
23812434|NCT03283319|66695886|FG000|Overall Study|Withdrawal by Subject|2|||
23812435|NCT03283319|66695887|FG001|Overall Study|Withdrawal by Subject|2|||
23812436|NCT03283319|66695888|FG002|Overall Study|Withdrawal by Subject|2|||
23812437|NCT03283319|66695889|FG003|Overall Study|Withdrawal by Subject|1|||
23812438|NCT03283319|66695890|FG004|Overall Study|Withdrawal by Subject|0|||
23812439|NCT03283319|66695891|FG005|Overall Study|Withdrawal by Subject|1|||
23524017|NCT03385239|65657779|FG002|Overall Study|Voluntary Withdrawal|2|||
23524018|NCT03385239|65657780|FG003|Overall Study|Voluntary Withdrawal|3|||
23812440|NCT03283319|66695886|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
23812441|NCT03283319|66695887|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
23812442|NCT03283319|66695888|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
23812443|NCT03283319|66695889|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
23812444|NCT03283319|66695890|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
23812445|NCT03283319|66695891|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
23812446|NCT00469144|66695892|FG000|Overall Study|Death|0|||
23812447|NCT00469144|66695893|FG001|Overall Study|Death|1|||
23812448|NCT00469144|66695892|FG000|Overall Study|No Response|5|||
23812449|NCT00469144|66695893|FG001|Overall Study|No Response|5|||
23812450|NCT00469144|66695892|FG000|Overall Study|Progressive Disease|1|||
23812451|NCT00469144|66695893|FG001|Overall Study|Progressive Disease|0|||
23812452|NCT00191113|66695894|FG000|Core Study|Withdrawal by Subject|25|||
23812453|NCT00191113|66695895|FG001|Core Study|Withdrawal by Subject|9|||
23812454|NCT00191113|66695894|FG000|Core Study|Protocol Violation|6|||
23812455|NCT00191113|66695895|FG001|Core Study|Protocol Violation|2|||
23812456|NCT00191113|66695894|FG000|Core Study|Lost to Follow-up|3|||
23812457|NCT00191113|66695895|FG001|Core Study|Lost to Follow-up|0|||
23812458|NCT00191113|66695894|FG000|Core Study|Adverse Event|0|||
23812459|NCT00191113|66695895|FG001|Core Study|Adverse Event|2|||
23812460|NCT00191113|66695894|FG000|Core Study|Lack of Efficacy|0|||
23812461|NCT00191113|66695895|FG001|Core Study|Lack of Efficacy|2|||
23812462|NCT00191113|66695894|FG000|Core Study|Death|1|||
23812463|NCT00191113|66695895|FG001|Core Study|Death|0|||
23812464|NCT00923273|66695897|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23416850|NCT00853242|65271292|FG002|Overall Study|Withdrawal by Subject|0|||
23416851|NCT00853242|65271293|FG003|Overall Study|Withdrawal by Subject|4|||
23416852|NCT00853242|65271294|FG004|Overall Study|Withdrawal by Subject|0|||
23416853|NCT00853242|65271295|FG005|Overall Study|Withdrawal by Subject|0|||
23416854|NCT00853242|65271296|FG006|Overall Study|Withdrawal by Subject|2|||
23416855|NCT00853242|65271290|FG000|Overall Study|Other|2|||
23416856|NCT00853242|65271291|FG001|Overall Study|Other|0|||
23416857|NCT00853242|65271292|FG002|Overall Study|Other|2|||
23416858|NCT00853242|65271293|FG003|Overall Study|Other|0|||
23524019|NCT03385239|65657781|FG004|Overall Study|Voluntary Withdrawal|0|||
23524020|NCT03385239|65657777|FG000|Overall Study|Adverse Event|0|||
23812465|NCT00923273|66695898|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23812466|NCT00923273|66695899|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23812467|NCT00923273|66695900|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
23812468|NCT00923273|66695901|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23812469|NCT00923273|66695897|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23812470|NCT00923273|66695898|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23524021|NCT03385239|65657778|FG001|Overall Study|Adverse Event|0|||
23524022|NCT03385239|65657779|FG002|Overall Study|Adverse Event|1|||
23524023|NCT03385239|65657780|FG003|Overall Study|Adverse Event|0|||
23714905|NCT01582971|66329658|FG000|Overall Study|Withdrawal by Subject|4|||
23714906|NCT01582971|66329659|FG001|Overall Study|Withdrawal by Subject|2|||
23714907|NCT01582971|66329658|FG000|Overall Study|Other|15|||
23714908|NCT01582971|66329659|FG001|Overall Study|Other|13|||
23714909|NCT00523341|66329661|FG000|Overall Study|Withdrawal by Subject|399|||
23714910|NCT00523341|66329662|FG001|Overall Study|Withdrawal by Subject|427|||
23714911|NCT00523341|66329661|FG000|Overall Study|Other|181|||
23714912|NCT00523341|66329662|FG001|Overall Study|Other|198|||
23714913|NCT00523341|66329661|FG000|Overall Study|Adverse Event|122|||
23714914|NCT00523341|66329662|FG001|Overall Study|Adverse Event|155|||
23714915|NCT00523341|66329661|FG000|Overall Study|Death|101|||
23714916|NCT00523341|66329662|FG001|Overall Study|Death|110|||
23714917|NCT00523341|66329661|FG000|Overall Study|Lost to Follow-up|73|||
23714918|NCT00523341|66329662|FG001|Overall Study|Lost to Follow-up|61|||
23714919|NCT00523341|66329661|FG000|Overall Study|Non-compliance|20|||
23524024|NCT03385239|65657781|FG004|Overall Study|Adverse Event|0|||
23524025|NCT03385239|65657777|FG000|Overall Study|Other|0|||
23524026|NCT03385239|65657778|FG001|Overall Study|Other|0|||
23524027|NCT03385239|65657779|FG002|Overall Study|Other|0|||
23524028|NCT03385239|65657780|FG003|Overall Study|Other|1|||
23524029|NCT03385239|65657781|FG004|Overall Study|Other|0|||
23524030|NCT02535741|65657784|FG000|Overall Study|Adverse Event|3|||
23524031|NCT02535741|65657784|FG000|Overall Study|Withdrawal by Subject|9|||
23524032|NCT02535741|65657784|FG000|Overall Study|Lost to Follow-up|10|||
23524033|NCT02535741|65657784|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
23714920|NCT00523341|66329662|FG001|Overall Study|Non-compliance|13|||
23714921|NCT00523341|66329661|FG000|Overall Study|Physician Decision|14|||
23714922|NCT00523341|66329662|FG001|Overall Study|Physician Decision|13|||
23714923|NCT00523341|66329661|FG000|Overall Study|Requirement for Alternative Therapy|4|||
23524034|NCT02535741|65657784|FG000|Overall Study|Missing data|6|||
23714924|NCT00523341|66329662|FG001|Overall Study|Requirement for Alternative Therapy|14|||
23714925|NCT00523341|66329661|FG000|Overall Study|Protocol Deviation|6|||
23714926|NCT00523341|66329662|FG001|Overall Study|Protocol Deviation|5|||
23524035|NCT00531232|65657785|FG000|Overall Study|Investigator decision|0|||
23714927|NCT00523341|66329661|FG000|Overall Study|Ineligibility Determined|3|||
23714928|NCT00523341|66329662|FG001|Overall Study|Ineligibility Determined|4|||
23416859|NCT00853242|65271294|FG004|Overall Study|Other|0|||
23524036|NCT00531232|65657786|FG001|Overall Study|Investigator decision|0|||
23524037|NCT00531232|65657787|FG002|Overall Study|Investigator decision|4|||
23524038|NCT00531232|65657785|FG000|Overall Study|Participants refused further treatment|0|||
23714929|NCT00523341|66329661|FG000|Overall Study|Disease Progression|1|||
23714930|NCT00523341|66329662|FG001|Overall Study|Disease Progression|0|||
23714931|NCT02701192|66329663|FG000|Overall Study|Protocol Violation|2|||
23714932|NCT02701192|66329663|FG000|Overall Study|Lost to Follow-up|4|||
23714933|NCT01653158|66329664|FG000|Overall Study|Death|0|||
23714934|NCT01653158|66329665|FG001|Overall Study|Death|0|||
23714935|NCT01653158|66329666|FG002|Overall Study|Death|0|||
23714936|NCT01653158|66329667|FG003|Overall Study|Death|1|||
23812471|NCT00923273|66695899|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23812472|NCT00923273|66695900|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
23812473|NCT00923273|66695901|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23812474|NCT02677714|66695902|FG000|Overall Study|Withdrawal by Subject|2|||
23812475|NCT02677714|66695903|FG001|Overall Study|Withdrawal by Subject|0|||
23812476|NCT00721630|66695904|FG000|Overall Study|Participant found to be ineligible|1|||
23812477|NCT00369655|66695905|FG000|Overall Study|Refusal of further treatment|2|||
23812478|NCT02246439|66695906|FG000|Overall Study|Adverse Event|3|||
23812479|NCT02246439|66695907|FG001|Overall Study|Adverse Event|0|||
23812480|NCT02246439|66695906|FG000|Overall Study|Lost to Follow-up|7|||
23812481|NCT02246439|66695907|FG001|Overall Study|Lost to Follow-up|5|||
23812482|NCT02246439|66695906|FG000|Overall Study|Protocol Violation|0|||
23812483|NCT02246439|66695907|FG001|Overall Study|Protocol Violation|2|||
23812484|NCT02246439|66695906|FG000|Overall Study|Physician Decision|0|||
23812485|NCT02246439|66695907|FG001|Overall Study|Physician Decision|1|||
23812486|NCT02246439|66695906|FG000|Overall Study|Unkonwn|1|||
23812487|NCT02246439|66695907|FG001|Overall Study|Unkonwn|3|||
23812488|NCT02246439|66695906|FG000|Overall Study|Withdrawal by Subject|1|||
23812489|NCT02246439|66695907|FG001|Overall Study|Withdrawal by Subject|0|||
23812490|NCT01189487|66695910|FG000|Overall Study|Lack of Efficacy|2|||
23812491|NCT01189487|66695910|FG000|Overall Study|Adverse Event|1|||
23812492|NCT03511326|66695912|FG000|Overall Study|Withdrawal by Subject|1|||
23812493|NCT01908816|66695916|FG000|Overall Study|Subject's no longer requires study drug|0|||
23812494|NCT01908816|66695917|FG001|Overall Study|Subject's no longer requires study drug|0|||
23812495|NCT01908816|66695918|FG002|Overall Study|Subject's no longer requires study drug|0|||
23812496|NCT01908816|66695919|FG003|Overall Study|Subject's no longer requires study drug|1|||
23812497|NCT01908816|66695916|FG000|Overall Study|Protocol deviation|1|||
23812498|NCT01908816|66695917|FG001|Overall Study|Protocol deviation|2|||
23812499|NCT01908816|66695918|FG002|Overall Study|Protocol deviation|1|||
23812500|NCT01908816|66695919|FG003|Overall Study|Protocol deviation|1|||
23812501|NCT01908816|66695916|FG000|Overall Study|Withdrawal by Subject|0|||
23812502|NCT01908816|66695917|FG001|Overall Study|Withdrawal by Subject|4|||
23812503|NCT01908816|66695918|FG002|Overall Study|Withdrawal by Subject|2|||
23812504|NCT01908816|66695919|FG003|Overall Study|Withdrawal by Subject|2|||
23812505|NCT01908816|66695916|FG000|Overall Study|Lost to Follow-up|3|||
23812506|NCT01908816|66695917|FG001|Overall Study|Lost to Follow-up|5|||
23812507|NCT01908816|66695918|FG002|Overall Study|Lost to Follow-up|4|||
23812508|NCT01908816|66695919|FG003|Overall Study|Lost to Follow-up|2|||
23812509|NCT01908816|66695916|FG000|Overall Study|Death|1|||
23812510|NCT01908816|66695917|FG001|Overall Study|Death|0|||
23812511|NCT01908816|66695918|FG002|Overall Study|Death|7|||
23812512|NCT01908816|66695919|FG003|Overall Study|Death|1|||
23812513|NCT01908816|66695916|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23812514|NCT01908816|66695917|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23812515|NCT01908816|66695918|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23812516|NCT01908816|66695919|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23812517|NCT01908816|66695916|FG000|Overall Study|Early termination|87|||
23812518|NCT01908816|66695917|FG001|Overall Study|Early termination|60|||
23812519|NCT01908816|66695918|FG002|Overall Study|Early termination|43|||
23812520|NCT01908816|66695919|FG003|Overall Study|Early termination|28|||
23812521|NCT03837743|66695920|FG000|Overall Study|Adverse Event|1|||
23812522|NCT03837743|66695920|FG000|Overall Study|Withdrawal by Subject|2|||
23812523|NCT02011386|66695921|FG000|Overall Study|Non-compliance|2|||
23812524|NCT02011386|66695921|FG000|Overall Study|Lack of Efficacy|3|||
23812525|NCT00265395|66695922|FG000|Overall Study|Adverse Event|3|||
23812526|NCT00265395|66695923|FG001|Overall Study|Adverse Event|6|||
23812527|NCT00265395|66695922|FG000|Overall Study|Lost to Follow-up|2|||
23812528|NCT00265395|66695923|FG001|Overall Study|Lost to Follow-up|1|||
23812529|NCT00265395|66695922|FG000|Overall Study|Withdrawal by Subject|1|||
23812530|NCT00265395|66695923|FG001|Overall Study|Withdrawal by Subject|6|||
23812531|NCT00265395|66695922|FG000|Overall Study|Protocol Violation|2|||
23812532|NCT00265395|66695923|FG001|Overall Study|Protocol Violation|2|||
23714937|NCT01653158|66329668|FG004|Overall Study|Death|0|||
23714938|NCT01653158|66329669|FG005|Overall Study|Death|0|||
23714939|NCT01653158|66329670|FG006|Overall Study|Death|0|||
23714940|NCT01653158|66329671|FG007|Overall Study|Death|2|||
23714941|NCT01653158|66329664|FG000|Overall Study|Adverse Event|0|||
23714942|NCT01653158|66329665|FG001|Overall Study|Adverse Event|0|||
23714943|NCT01653158|66329666|FG002|Overall Study|Adverse Event|0|||
23714944|NCT01653158|66329667|FG003|Overall Study|Adverse Event|1|||
23714945|NCT01653158|66329668|FG004|Overall Study|Adverse Event|0|||
23714946|NCT01653158|66329669|FG005|Overall Study|Adverse Event|0|||
23714947|NCT01653158|66329670|FG006|Overall Study|Adverse Event|0|||
23714948|NCT01653158|66329671|FG007|Overall Study|Adverse Event|3|||
23714949|NCT01653158|66329664|FG000|Overall Study|Other|0|||
23714950|NCT01653158|66329665|FG001|Overall Study|Other|0|||
23714951|NCT01653158|66329666|FG002|Overall Study|Other|0|||
23714952|NCT01653158|66329667|FG003|Overall Study|Other|0|||
23714953|NCT01653158|66329668|FG004|Overall Study|Other|0|||
23714954|NCT01653158|66329669|FG005|Overall Study|Other|0|||
23714955|NCT01653158|66329670|FG006|Overall Study|Other|0|||
23714956|NCT01653158|66329671|FG007|Overall Study|Other|1|||
23714957|NCT01653158|66329664|FG000|Overall Study|Progressive disease|0|||
23714958|NCT01653158|66329665|FG001|Overall Study|Progressive disease|0|||
23714959|NCT01653158|66329666|FG002|Overall Study|Progressive disease|0|||
23714960|NCT01653158|66329667|FG003|Overall Study|Progressive disease|0|||
23714961|NCT01653158|66329668|FG004|Overall Study|Progressive disease|1|||
23714962|NCT01653158|66329669|FG005|Overall Study|Progressive disease|1|||
23714963|NCT01653158|66329670|FG006|Overall Study|Progressive disease|2|||
23714964|NCT01653158|66329671|FG007|Overall Study|Progressive disease|9|||
23714965|NCT01653158|66329664|FG000|Overall Study|Withdrawal by Subject|1|||
23714966|NCT01653158|66329665|FG001|Overall Study|Withdrawal by Subject|0|||
23714967|NCT01653158|66329666|FG002|Overall Study|Withdrawal by Subject|0|||
23416860|NCT00853242|65271295|FG005|Overall Study|Other|1|||
23416861|NCT00853242|65271296|FG006|Overall Study|Other|2|||
23416862|NCT00606034|65271301|FG000|Overall Study|incarceration|1|||
23416863|NCT00765037|65271308|FG000|Overall Study|Lost to Follow-up|5|||
23416864|NCT00765037|65271308|FG000|Overall Study|Adverse Event|1|||
23416865|NCT00873041|65271315|FG000|Core Study|Adverse Event|2|||
23416866|NCT00873041|65271316|FG001|Core Study|Adverse Event|3|||
23416867|NCT00873041|65271317|FG002|Core Study|Adverse Event|1|||
23416868|NCT00873041|65271315|FG000|Core Study|Withdrawal by Subject|1|||
23416869|NCT00873041|65271316|FG001|Core Study|Withdrawal by Subject|2|||
23416870|NCT00873041|65271317|FG002|Core Study|Withdrawal by Subject|2|||
23416871|NCT00873041|65271315|FG000|Core Study|Lost to Follow-up|3|||
23524039|NCT00531232|65657786|FG001|Overall Study|Participants refused further treatment|1|||
23524040|NCT00531232|65657787|FG002|Overall Study|Participants refused further treatment|2|||
23524041|NCT00531232|65657785|FG000|Overall Study|Adverse events (AEs)|1|||
23714968|NCT01653158|66329667|FG003|Overall Study|Withdrawal by Subject|0|||
23714969|NCT01653158|66329668|FG004|Overall Study|Withdrawal by Subject|0|||
23714970|NCT01653158|66329669|FG005|Overall Study|Withdrawal by Subject|0|||
23714971|NCT01653158|66329670|FG006|Overall Study|Withdrawal by Subject|0|||
23714972|NCT01653158|66329671|FG007|Overall Study|Withdrawal by Subject|0|||
23714973|NCT01973452|66329672|FG000|Overall Study|Lack of Efficacy|0|||
23714974|NCT01973452|66329673|FG001|Overall Study|Lack of Efficacy|1|||
23416872|NCT00873041|65271316|FG001|Core Study|Lost to Follow-up|1|||
23416873|NCT00873041|65271317|FG002|Core Study|Lost to Follow-up|0|||
23416874|NCT00873041|65271315|FG000|Core Study|Abnormal laboratory value|0|||
23416875|NCT00873041|65271316|FG001|Core Study|Abnormal laboratory value|0|||
23416876|NCT00873041|65271317|FG002|Core Study|Abnormal laboratory value|1|||
23416877|NCT00873041|65271315|FG000|Core Study|Protocol deviation|1|||
23416878|NCT00873041|65271316|FG001|Core Study|Protocol deviation|0|||
23524042|NCT00531232|65657786|FG001|Overall Study|Adverse events (AEs)|2|||
23524043|NCT00531232|65657787|FG002|Overall Study|Adverse events (AEs)|2|||
23416879|NCT00873041|65271317|FG002|Core Study|Protocol deviation|1|||
23524044|NCT00531232|65657785|FG000|Overall Study|Treatment failure|1|||
23524045|NCT00531232|65657786|FG001|Overall Study|Treatment failure|3|||
23524046|NCT00531232|65657787|FG002|Overall Study|Treatment failure|7|||
23524047|NCT00531232|65657785|FG000|Overall Study|Disease recurrence|0|||
23524048|NCT00531232|65657786|FG001|Overall Study|Disease recurrence|0|||
23524049|NCT00531232|65657787|FG002|Overall Study|Disease recurrence|1|||
23524050|NCT00531232|65657785|FG000|Overall Study|Deceased|2|||
23524051|NCT00531232|65657786|FG001|Overall Study|Deceased|2|||
23524052|NCT00531232|65657787|FG002|Overall Study|Deceased|2|||
23714975|NCT01973452|66329672|FG000|Overall Study|Lost to Follow-up|1|||
23714976|NCT01973452|66329673|FG001|Overall Study|Lost to Follow-up|0|||
23714977|NCT01973452|66329672|FG000|Overall Study|Withdrawal by Subject|10|||
23714978|NCT01973452|66329673|FG001|Overall Study|Withdrawal by Subject|9|||
23714979|NCT01973452|66329672|FG000|Overall Study|Ineligible|1|||
23714980|NCT01973452|66329673|FG001|Overall Study|Ineligible|1|||
23714981|NCT01973452|66329672|FG000|Overall Study|Surgery canceled by participant|5|||
23714982|NCT01973452|66329673|FG001|Overall Study|Surgery canceled by participant|3|||
23714983|NCT03814590|66329674|FG000|Overall Study|Adverse Event|0|||
23714984|NCT03814590|66329675|FG001|Overall Study|Adverse Event|0|||
23812533|NCT00265395|66695922|FG000|Overall Study|Lack of Efficacy|0|||
23812534|NCT00265395|66695923|FG001|Overall Study|Lack of Efficacy|1|||
23812535|NCT00265395|66695922|FG000|Overall Study|Administrative|0|||
23812536|NCT00265395|66695923|FG001|Overall Study|Administrative|1|||
23812537|NCT02524730|66695927|FG000|Overall Study|Lost to Follow-up|5|||
23714985|NCT03814590|66329676|FG002|Overall Study|Adverse Event|0|||
23714986|NCT03814590|66329677|FG003|Overall Study|Adverse Event|0|||
23714987|NCT03814590|66329678|FG004|Overall Study|Adverse Event|0|||
23714988|NCT03814590|66329679|FG005|Overall Study|Adverse Event|1|||
23714989|NCT03814590|66329680|FG006|Overall Study|Adverse Event|1|||
23714990|NCT03814590|66329681|FG007|Overall Study|Adverse Event|1|||
23714991|NCT03814590|66329682|FG008|Overall Study|Adverse Event|0|||
23714992|NCT03814590|66329683|FG009|Overall Study|Adverse Event|0|||
23714993|NCT03814590|66329684|FG010|Overall Study|Adverse Event|1|||
23714994|NCT03814590|66329685|FG011|Overall Study|Adverse Event|0|||
23714995|NCT03814590|66329686|FG012|Overall Study|Adverse Event|3|||
23714996|NCT03814590|66329687|FG013|Overall Study|Adverse Event|0|||
23714997|NCT03814590|66329674|FG000|Overall Study|Lost to Follow-up|0|||
23714998|NCT03814590|66329675|FG001|Overall Study|Lost to Follow-up|2|||
23812538|NCT02524730|66695927|FG000|Overall Study|Withdrawal by Subject|18|||
23812539|NCT02524730|66695927|FG000|Overall Study|Death|10|||
23812540|NCT02524730|66695927|FG000|Overall Study|Adverse Event|8|||
23812541|NCT02524730|66695927|FG000|Overall Study|Protocol Violation|1|||
23812542|NCT02524730|66695927|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
23812543|NCT00470067|66695940|FG000|Overall Study|Death|1|||
23812544|NCT00470067|66695940|FG000|Overall Study|Disease Progression|6|||
23812545|NCT03375203|66695941|FG000|Overall Study|Protocol Violation|0|||
23812546|NCT03375203|66695942|FG001|Overall Study|Protocol Violation|0|||
23812547|NCT03375203|66695943|FG002|Overall Study|Protocol Violation|1|||
23812548|NCT03375203|66695944|FG003|Overall Study|Protocol Violation|0|||
23812549|NCT03375203|66695945|FG004|Overall Study|Protocol Violation|0|||
23812550|NCT03375203|66695941|FG000|Overall Study|Adverse Event|2|||
23812551|NCT03375203|66695942|FG001|Overall Study|Adverse Event|3|||
23812552|NCT03375203|66695943|FG002|Overall Study|Adverse Event|0|||
23812553|NCT03375203|66695944|FG003|Overall Study|Adverse Event|2|||
23812554|NCT03375203|66695945|FG004|Overall Study|Adverse Event|2|||
23812555|NCT03375203|66695941|FG000|Overall Study|Withdrawal by Subject|3|||
23812556|NCT03375203|66695942|FG001|Overall Study|Withdrawal by Subject|0|||
23812557|NCT03375203|66695943|FG002|Overall Study|Withdrawal by Subject|1|||
23812558|NCT03375203|66695944|FG003|Overall Study|Withdrawal by Subject|0|||
23812559|NCT03375203|66695945|FG004|Overall Study|Withdrawal by Subject|2|||
23812560|NCT03375203|66695941|FG000|Overall Study|Non-compliance with study drug|1|||
23812561|NCT03375203|66695942|FG001|Overall Study|Non-compliance with study drug|0|||
23812562|NCT03375203|66695943|FG002|Overall Study|Non-compliance with study drug|0|||
23524053|NCT00531232|65657785|FG000|Overall Study|Withdrawal by Subject|0|||
23524054|NCT00531232|65657786|FG001|Overall Study|Withdrawal by Subject|1|||
23524055|NCT00531232|65657787|FG002|Overall Study|Withdrawal by Subject|2|||
23524056|NCT00531232|65657785|FG000|Overall Study|Other|0|||
23524057|NCT00531232|65657786|FG001|Overall Study|Other|0|||
23524058|NCT00531232|65657787|FG002|Overall Study|Other|5|||
23524059|NCT01527292|65657791|FG000|Overall Study|Physician Decision|0|||
23524060|NCT01527292|65657792|FG001|Overall Study|Physician Decision|3|||
23524061|NCT03254134|65657793|FG000|Overall Study|Not eligible patients|599|||
23714999|NCT03814590|66329676|FG002|Overall Study|Lost to Follow-up|1|||
23715000|NCT03814590|66329677|FG003|Overall Study|Lost to Follow-up|0|||
23715001|NCT03814590|66329678|FG004|Overall Study|Lost to Follow-up|1|||
23715002|NCT03814590|66329679|FG005|Overall Study|Lost to Follow-up|1|||
23715003|NCT03814590|66329680|FG006|Overall Study|Lost to Follow-up|1|||
23715004|NCT03814590|66329681|FG007|Overall Study|Lost to Follow-up|1|||
23715005|NCT03814590|66329682|FG008|Overall Study|Lost to Follow-up|0|||
23524062|NCT03254134|65657794|FG001|Overall Study|Not eligible patients|3630|||
23524063|NCT00606892|65657795|FG000|First Intervention|Protocol Violation|1|||
23524064|NCT00606892|65657796|FG001|First Intervention|Protocol Violation|4|||
23524065|NCT00748215|65657798|FG000|Overall Study|Withdrawal by Subject|7|||
23524066|NCT00748215|65657799|FG001|Overall Study|Withdrawal by Subject|7|||
23524067|NCT00748215|65657798|FG000|Overall Study|Treatment change|2|||
23524068|NCT00748215|65657799|FG001|Overall Study|Treatment change|1|||
23524069|NCT00748215|65657798|FG000|Overall Study|Change in patient condition|0|||
23524070|NCT00748215|65657799|FG001|Overall Study|Change in patient condition|3|||
23524071|NCT00748215|65657798|FG000|Overall Study|Non-compliant|0|||
23524072|NCT00748215|65657799|FG001|Overall Study|Non-compliant|2|||
23524073|NCT00748215|65657798|FG000|Overall Study|Adverse Event|0|||
23524074|NCT00748215|65657799|FG001|Overall Study|Adverse Event|5|||
23524075|NCT01446965|65657811|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
23524076|NCT01446965|65657812|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
23524077|NCT01446965|65657811|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
23524078|NCT01446965|65657812|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
23524079|NCT03690388|65657813|FG000|Overall Study|Adverse Event|8|||
23524080|NCT03690388|65657814|FG001|Overall Study|Adverse Event|1|||
23524081|NCT03690388|65657813|FG000|Overall Study|Radiographic Progression|14|||
23524082|NCT03690388|65657814|FG001|Overall Study|Radiographic Progression|29|||
23524083|NCT03690388|65657813|FG000|Overall Study|Clinical deterioration|10|||
23812563|NCT03375203|66695944|FG003|Overall Study|Non-compliance with study drug|0|||
23812564|NCT03375203|66695945|FG004|Overall Study|Non-compliance with study drug|0|||
23812565|NCT03375203|66695941|FG000|Overall Study|Randomized, not treated.|0|||
23812566|NCT03375203|66695942|FG001|Overall Study|Randomized, not treated.|1|||
23524084|NCT03690388|65657814|FG001|Overall Study|Clinical deterioration|6|||
23524085|NCT03690388|65657813|FG000|Overall Study|Withdrawal by Subject|2|||
23715006|NCT03814590|66329683|FG009|Overall Study|Lost to Follow-up|0|||
23715007|NCT03814590|66329684|FG010|Overall Study|Lost to Follow-up|1|||
23715008|NCT03814590|66329685|FG011|Overall Study|Lost to Follow-up|0|||
23715009|NCT03814590|66329686|FG012|Overall Study|Lost to Follow-up|0|||
23715010|NCT03814590|66329687|FG013|Overall Study|Lost to Follow-up|1|||
23715011|NCT03814590|66329674|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715012|NCT03814590|66329675|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715013|NCT03814590|66329676|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715014|NCT03814590|66329677|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715015|NCT03814590|66329678|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715016|NCT03814590|66329679|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715017|NCT03814590|66329680|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715018|NCT03814590|66329681|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715019|NCT03814590|66329682|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715020|NCT03814590|66329683|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
23715021|NCT03814590|66329684|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23812567|NCT03375203|66695943|FG002|Overall Study|Randomized, not treated.|0|||
23812568|NCT03375203|66695944|FG003|Overall Study|Randomized, not treated.|0|||
23524086|NCT03690388|65657814|FG001|Overall Study|Withdrawal by Subject|0|||
23524087|NCT03690388|65657813|FG000|Overall Study|Lack of Efficacy|1|||
23524088|NCT03690388|65657814|FG001|Overall Study|Lack of Efficacy|0|||
23524089|NCT03690388|65657813|FG000|Overall Study|Lost to Follow-up|1|||
23524090|NCT03690388|65657814|FG001|Overall Study|Lost to Follow-up|0|||
23524091|NCT01417481|65657815|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23524092|NCT01417481|65657816|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23524093|NCT02871739|65657817|FG000|Overall Study|Lost to Follow-up|3|||
23524094|NCT02871739|65657818|FG001|Overall Study|Lost to Follow-up|2|||
23524095|NCT02871739|65657819|FG002|Overall Study|Lost to Follow-up|0|||
23524096|NCT02871739|65657820|FG003|Overall Study|Lost to Follow-up|2|||
23524097|NCT01132495|65657821|FG000|Overall Study|Various reasons|40|||
23524098|NCT01132495|65657822|FG001|Overall Study|Various reasons|38|||
23524099|NCT01132495|65657823|FG002|Overall Study|Various reasons|20|||
23524100|NCT01132495|65657824|FG003|Overall Study|Various reasons|12|||
23524101|NCT03595878|65657826|FG000|Overall Study|Death|2|||
23524102|NCT03595878|65657827|FG001|Overall Study|Death|1|||
23524103|NCT03595878|65657828|FG002|Overall Study|Death|0|||
23524104|NCT03595878|65657826|FG000|Overall Study|Disease progression|2|||
23524105|NCT03595878|65657827|FG001|Overall Study|Disease progression|1|||
23524106|NCT03595878|65657828|FG002|Overall Study|Disease progression|2|||
23715022|NCT03814590|66329685|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715023|NCT03814590|66329686|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715024|NCT03814590|66329687|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23715025|NCT03814590|66329674|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715026|NCT03814590|66329675|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715027|NCT03814590|66329676|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715028|NCT03814590|66329677|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715029|NCT03814590|66329678|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715030|NCT03814590|66329679|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
23715031|NCT03814590|66329680|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23715032|NCT03814590|66329681|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
23715033|NCT03814590|66329682|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23715034|NCT03814590|66329683|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
23715035|NCT03814590|66329684|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23715036|NCT03814590|66329685|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23524107|NCT00813358|65657829|FG000|Overall Study|Death|32|||
23524108|NCT00813358|65657829|FG000|Overall Study|Lost to Follow-up|12|||
23524109|NCT00813358|65657829|FG000|Overall Study|other endpoints|5|||
23524110|NCT00813358|65657829|FG000|Overall Study|Withdrawal by Subject|20|||
23524111|NCT00407563|65657832|FG000|Overall Study|Patient continues on treatment|1|||
23524112|NCT00590954|65657836|FG000|Overall Study|Inevaluable|2|||
23524113|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
23524114|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
23524115|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
23524116|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
23524117|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
23524118|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
23524119|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
23715037|NCT03814590|66329686|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23715038|NCT03814590|66329687|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
23715039|NCT03814590|66329674|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715040|NCT03814590|66329675|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715041|NCT03814590|66329676|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715042|NCT03814590|66329677|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715043|NCT03814590|66329678|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715044|NCT03814590|66329679|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715045|NCT03814590|66329680|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715046|NCT03814590|66329681|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23715047|NCT03814590|66329682|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715048|NCT03814590|66329683|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23715049|NCT03814590|66329684|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715050|NCT03814590|66329685|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715051|NCT03814590|66329686|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715052|NCT03814590|66329687|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23715053|NCT03814590|66329674|FG000|Overall Study|UNKNOWN REASON|0|||
23715054|NCT03814590|66329675|FG001|Overall Study|UNKNOWN REASON|0|||
23715055|NCT03814590|66329676|FG002|Overall Study|UNKNOWN REASON|0|||
23715056|NCT03814590|66329677|FG003|Overall Study|UNKNOWN REASON|0|||
23715057|NCT03814590|66329678|FG004|Overall Study|UNKNOWN REASON|0|||
23715058|NCT03814590|66329679|FG005|Overall Study|UNKNOWN REASON|0|||
23715059|NCT03814590|66329680|FG006|Overall Study|UNKNOWN REASON|0|||
23715060|NCT03814590|66329681|FG007|Overall Study|UNKNOWN REASON|1|||
23715061|NCT03814590|66329682|FG008|Overall Study|UNKNOWN REASON|0|||
23715062|NCT03814590|66329683|FG009|Overall Study|UNKNOWN REASON|0|||
23715063|NCT03814590|66329684|FG010|Overall Study|UNKNOWN REASON|0|||
23715064|NCT03814590|66329685|FG011|Overall Study|UNKNOWN REASON|0|||
23812569|NCT03375203|66695945|FG004|Overall Study|Randomized, not treated.|0|||
23812570|NCT02130882|66695948|FG000|Overall Study|Withdrawal by Subject|0|||
23812571|NCT02130882|66695949|FG001|Overall Study|Withdrawal by Subject|1|||
23812572|NCT03393806|66695958|FG000|Overall Study|Physician Decision|1|||
23812573|NCT03393806|66695959|FG001|Overall Study|Physician Decision|0|||
23812574|NCT03310411|66695960|FG000|Period 1|Adverse Event|0|||
23812575|NCT03310411|66695961|FG001|Period 1|Adverse Event|0|||
23812576|NCT03310411|66695962|FG002|Period 1|Adverse Event|0|||
23812577|NCT03310411|66695963|FG003|Period 1|Adverse Event|1|||
23812578|NCT04620135|66695964|FG000|Study Completion|Adverse Event|2|||
23812579|NCT04620135|66695965|FG001|Study Completion|Adverse Event|3|||
23812580|NCT04620135|66695964|FG000|Study Completion|Withdrawal by Subject|2|||
23812581|NCT04620135|66695965|FG001|Study Completion|Withdrawal by Subject|0|||
23812582|NCT00117325|66695966|FG000|Overall Study|Adverse Event|3|||
23812583|NCT00117325|66695967|FG001|Overall Study|Adverse Event|3|||
23812584|NCT00117325|66695966|FG000|Overall Study|Lost to Follow-up|1|||
23812585|NCT00117325|66695967|FG001|Overall Study|Lost to Follow-up|1|||
23812586|NCT00117325|66695966|FG000|Overall Study|Protocol Violation|2|||
23812587|NCT00117325|66695967|FG001|Overall Study|Protocol Violation|3|||
23812588|NCT00117325|66695966|FG000|Overall Study|Withdrawal by Subject|3|||
23812589|NCT00117325|66695967|FG001|Overall Study|Withdrawal by Subject|2|||
23812590|NCT00117325|66695966|FG000|Overall Study|Lack of Efficacy|1|||
23812591|NCT00117325|66695967|FG001|Overall Study|Lack of Efficacy|0|||
23812592|NCT00117325|66695966|FG000|Overall Study|Use of prohibited medicine|1|||
23812593|NCT00117325|66695967|FG001|Overall Study|Use of prohibited medicine|2|||
23812594|NCT00117325|66695966|FG000|Overall Study|Early termination|1|||
23812595|NCT00117325|66695967|FG001|Overall Study|Early termination|1|||
23812596|NCT00117325|66695966|FG000|Overall Study|Admisnitrative|1|||
23812597|NCT00117325|66695967|FG001|Overall Study|Admisnitrative|0|||
23812598|NCT01154816|66695968|FG000|Overall Study|Withdrawal by Subject|1|||
23812599|NCT01154816|66695969|FG001|Overall Study|Withdrawal by Subject|0|||
23812600|NCT01154816|66695970|FG002|Overall Study|Withdrawal by Subject|0|||
23812601|NCT01154816|66695971|FG003|Overall Study|Withdrawal by Subject|1|||
23812602|NCT01154816|66695972|FG004|Overall Study|Withdrawal by Subject|0|||
23812603|NCT01154816|66695973|FG005|Overall Study|Withdrawal by Subject|0|||
23812604|NCT01154816|66695974|FG006|Overall Study|Withdrawal by Subject|0|||
23812605|NCT01154816|66695975|FG007|Overall Study|Withdrawal by Subject|0|||
23715065|NCT03814590|66329686|FG012|Overall Study|UNKNOWN REASON|0|||
23715066|NCT03814590|66329687|FG013|Overall Study|UNKNOWN REASON|0|||
23812606|NCT01154816|66695976|FG008|Overall Study|Withdrawal by Subject|1|||
23524120|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
23524121|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
23715067|NCT01182337|66329690|FG000|Overall Study|Withdrawal by Subject|3|||
23715068|NCT01182337|66329691|FG001|Overall Study|Withdrawal by Subject|1|||
23715069|NCT01182337|66329690|FG000|Overall Study|Lost to Follow-up|0|||
23715070|NCT01182337|66329691|FG001|Overall Study|Lost to Follow-up|1|||
23715071|NCT00488592|66329695|FG000|Overall Study|Withdrawal by Subject|1|||
23715072|NCT00488592|66329695|FG000|Overall Study|Disease progression|1|||
23524122|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
23524123|NCT00380393|65657837|FG000|Month 14|Withdrawal by Subject|9|||
23416880|NCT00873041|65271315|FG000|Extension Study|Adverse Event|1|||
23416881|NCT00873041|65271316|FG001|Extension Study|Adverse Event|0|||
23416882|NCT00873041|65271317|FG002|Extension Study|Adverse Event|1|||
23416883|NCT00873041|65271315|FG000|Extension Study|Administrative reasons|0|||
23416884|NCT00873041|65271316|FG001|Extension Study|Administrative reasons|0|||
23416885|NCT00873041|65271317|FG002|Extension Study|Administrative reasons|1|||
23416886|NCT04731298|65271328|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
23416887|NCT04731298|65271329|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
23416888|NCT02141633|65271335|FG000|Overall Study|Physician Decision|1|||
23416889|NCT02141633|65271336|FG001|Overall Study|Physician Decision|0|||
23416890|NCT00882583|65271338|FG000|Overall Study|Physician Decision|1|||
23416891|NCT00882583|65271339|FG001|Overall Study|Physician Decision|0|||
23416892|NCT00882583|65271338|FG000|Overall Study|Adverse Event|0|||
23416893|NCT00882583|65271339|FG001|Overall Study|Adverse Event|1|||
23416894|NCT03632993|65271340|FG000|Overall Study|Withdrawal by Subject|1|||
23416895|NCT03632993|65271341|FG001|Overall Study|Withdrawal by Subject|0|||
23416896|NCT03632993|65271342|FG002|Overall Study|Withdrawal by Subject|0|||
23416897|NCT03632993|65271343|FG003|Overall Study|Withdrawal by Subject|0|||
23416898|NCT03632993|65271344|FG004|Overall Study|Withdrawal by Subject|0|||
23416899|NCT03632993|65271345|FG005|Overall Study|Withdrawal by Subject|0|||
23416900|NCT03632993|65271346|FG006|Overall Study|Withdrawal by Subject|0|||
23416901|NCT03632993|65271347|FG007|Overall Study|Withdrawal by Subject|0|||
23416902|NCT03632993|65271348|FG008|Overall Study|Withdrawal by Subject|0|||
23416903|NCT03632993|65271349|FG009|Overall Study|Withdrawal by Subject|1|||
23524124|NCT00380393|65657838|FG001|Month 14|Withdrawal by Subject|7|||
23524125|NCT00380393|65657837|FG000|Month 14|Death|1|||
23524126|NCT00380393|65657838|FG001|Month 14|Death|0|||
23524127|NCT00380393|65657837|FG000|Month 14|Lost to Follow-up|0|||
23524128|NCT00380393|65657838|FG001|Month 14|Lost to Follow-up|1|||
23524129|NCT00380393|65657837|FG000|Month 14|Migrated/moved from study area|39|||
23524130|NCT00380393|65657838|FG001|Month 14|Migrated/moved from study area|42|||
23524131|NCT00380393|65657837|FG000|Month 14|Protocol Violation|2|||
23524132|NCT00380393|65657838|FG001|Month 14|Protocol Violation|0|||
23524133|NCT00380393|65657837|FG000|Month 14|Others|6|||
23524134|NCT00380393|65657838|FG001|Month 14|Others|6|||
23524135|NCT01488097|65657839|FG000|Overall Study|Lost to Follow-up|1|||
23524136|NCT01652716|65657842|FG000|Overall Study|Loss of glucose control|1|||
23524137|NCT01652716|65657843|FG001|Overall Study|Loss of glucose control|0|||
23524138|NCT01652716|65657842|FG000|Overall Study|Administrative|0|||
23524139|NCT01652716|65657843|FG001|Overall Study|Administrative|2|||
23524140|NCT01652716|65657842|FG000|Overall Study|Investigator decision|1|||
23524141|NCT01652716|65657843|FG001|Overall Study|Investigator decision|4|||
23524142|NCT01652716|65657842|FG000|Overall Study|Lost to Follow-up|12|||
23524143|NCT01652716|65657843|FG001|Overall Study|Lost to Follow-up|11|||
23524144|NCT01652716|65657842|FG000|Overall Study|Protocol Violation|2|||
23524145|NCT01652716|65657843|FG001|Overall Study|Protocol Violation|1|||
23524146|NCT01652716|65657842|FG000|Overall Study|Adverse Event|7|||
23715073|NCT00488592|66329695|FG000|Overall Study|Enrolled but not treated|1|||
23715074|NCT01194804|66329696|FG000|Overall Study|Withdrawal by Subject|1|||
23715075|NCT00084929|66329697|FG000|Overall Study|ineligible - medical contraindication|1|||
23715076|NCT00084929|66329697|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
23715077|NCT00084929|66329697|FG000|Overall Study|Ineligible - Medical history|6|||
23715078|NCT00084929|66329697|FG000|Overall Study|Withdrawal by Subject|10|||
23715079|NCT00084929|66329697|FG000|Overall Study|Missing/incomplete CTC exam|9|||
23715080|NCT00084929|66329697|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
23715081|NCT02188719|66329698|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23715082|NCT02188719|66329699|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
23715083|NCT02188719|66329700|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23416904|NCT03632993|65271340|FG000|Overall Study|Protocol Non-compliance|0|||
23416905|NCT03632993|65271341|FG001|Overall Study|Protocol Non-compliance|1|||
23416906|NCT03632993|65271342|FG002|Overall Study|Protocol Non-compliance|0|||
23416907|NCT03632993|65271343|FG003|Overall Study|Protocol Non-compliance|0|||
23416908|NCT03632993|65271344|FG004|Overall Study|Protocol Non-compliance|0|||
23416909|NCT03632993|65271345|FG005|Overall Study|Protocol Non-compliance|0|||
23416910|NCT03632993|65271346|FG006|Overall Study|Protocol Non-compliance|0|||
23524147|NCT01652716|65657843|FG001|Overall Study|Adverse Event|10|||
23524148|NCT01652716|65657842|FG000|Overall Study|Withdrawal by Subject|33|||
23524149|NCT01652716|65657843|FG001|Overall Study|Withdrawal by Subject|18|||
23524150|NCT02945410|65657844|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524151|NCT02945410|65657845|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
23524152|NCT02945410|65657846|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524153|NCT02945410|65657847|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524154|NCT02945410|65657848|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524155|NCT02945410|65657849|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524156|NCT02945410|65657844|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
23524157|NCT02945410|65657845|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
23524158|NCT02945410|65657846|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
23524159|NCT02945410|65657847|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
23524160|NCT02945410|65657848|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
23524161|NCT02945410|65657849|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
23524162|NCT02945410|65657844|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524163|NCT02945410|65657845|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524164|NCT02945410|65657846|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
23524165|NCT02945410|65657847|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524166|NCT02945410|65657848|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
23524167|NCT02945410|65657849|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524168|NCT02584504|65657850|FG000|Double-blind Treatment|Participant withdrew consent|0|||
23524169|NCT02584504|65657851|FG001|Double-blind Treatment|Participant withdrew consent|0|||
23524170|NCT02584504|65657852|FG002|Double-blind Treatment|Participant withdrew consent|1|||
23524171|NCT02584504|65657850|FG000|Double-blind Treatment|Adverse Event|0|||
23524172|NCT02584504|65657851|FG001|Double-blind Treatment|Adverse Event|1|||
23524173|NCT02584504|65657852|FG002|Double-blind Treatment|Adverse Event|0|||
23524174|NCT02584504|65657850|FG000|Double-blind Treatment|Family Matter|0|||
23524175|NCT02584504|65657851|FG001|Double-blind Treatment|Family Matter|1|||
23524176|NCT02584504|65657852|FG002|Double-blind Treatment|Family Matter|0|||
23715084|NCT02188719|66329701|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23715085|NCT02709083|66329709|FG000|Overall Study|Original PI left institution|7|||
23715086|NCT02561299|66329714|FG000|Overall Study|Death|2|||
23715087|NCT02561299|66329715|FG001|Overall Study|Death|4|||
23715088|NCT02561299|66329714|FG000|Overall Study|Lost to Follow-up|1|||
23715089|NCT02561299|66329715|FG001|Overall Study|Lost to Follow-up|0|||
23715090|NCT02561299|66329714|FG000|Overall Study|Withdrawal by Subject|2|||
23715091|NCT02561299|66329715|FG001|Overall Study|Withdrawal by Subject|2|||
23715092|NCT01697267|66329718|FG000|Overall Study|Death|3|||
23715093|NCT01697267|66329719|FG001|Overall Study|Death|1|||
23524177|NCT02584504|65657850|FG000|Open-label Treatment|Participant withdrew consent|0|||
23524178|NCT02584504|65657851|FG001|Open-label Treatment|Participant withdrew consent|0|||
23524179|NCT02584504|65657852|FG002|Open-label Treatment|Participant withdrew consent|4|||
23524180|NCT02584504|65657850|FG000|Open-label Treatment|Adverse Event|2|||
23524181|NCT02584504|65657851|FG001|Open-label Treatment|Adverse Event|2|||
23524182|NCT02584504|65657852|FG002|Open-label Treatment|Adverse Event|3|||
23715094|NCT01697267|66329718|FG000|Overall Study|Withdrawal by Subject|5|||
23715095|NCT01697267|66329719|FG001|Overall Study|Withdrawal by Subject|5|||
23715096|NCT01697267|66329718|FG000|Overall Study|Adverse Event|2|||
23524183|NCT02584504|65657850|FG000|Open-label Treatment|Physician Decision|0|||
23524184|NCT02584504|65657851|FG001|Open-label Treatment|Physician Decision|1|||
23524185|NCT02584504|65657852|FG002|Open-label Treatment|Physician Decision|0|||
23524186|NCT02584504|65657850|FG000|Open-label Treatment|Entered but not treated|0|||
23524187|NCT02584504|65657851|FG001|Open-label Treatment|Entered but not treated|1|||
23524188|NCT02584504|65657852|FG002|Open-label Treatment|Entered but not treated|1|||
23524189|NCT00962104|65657858|FG000|Overall Study|Adverse Event|10|||
23524190|NCT00962104|65657859|FG001|Overall Study|Adverse Event|3|||
23524191|NCT00962104|65657858|FG000|Overall Study|Entry Criteria Not Met|1|||
23524192|NCT00962104|65657859|FG001|Overall Study|Entry Criteria Not Met|2|||
23524193|NCT00962104|65657858|FG000|Overall Study|Lack of Efficacy|0|||
23524194|NCT00962104|65657859|FG001|Overall Study|Lack of Efficacy|1|||
23524195|NCT00962104|65657858|FG000|Overall Study|Lost to Follow-up|10|||
23524196|NCT00962104|65657859|FG001|Overall Study|Lost to Follow-up|4|||
23524197|NCT00962104|65657858|FG000|Overall Study|Physician Decision|1|||
23524198|NCT00962104|65657859|FG001|Overall Study|Physician Decision|0|||
23715097|NCT01697267|66329719|FG001|Overall Study|Adverse Event|1|||
23715098|NCT01697267|66329718|FG000|Overall Study|Lost to Follow-up|2|||
23524199|NCT00962104|65657858|FG000|Overall Study|Protocol Violation|6|||
23524200|NCT00962104|65657859|FG001|Overall Study|Protocol Violation|8|||
23524201|NCT00962104|65657858|FG000|Overall Study|Sponsor Decision|0|||
23524202|NCT00962104|65657859|FG001|Overall Study|Sponsor Decision|1|||
23524203|NCT00962104|65657858|FG000|Overall Study|Withdrawal by Subject|10|||
23524204|NCT00962104|65657859|FG001|Overall Study|Withdrawal by Subject|6|||
23524205|NCT00962104|65657858|FG000|Overall Study|Other|2|||
23524206|NCT00962104|65657859|FG001|Overall Study|Other|0|||
23715099|NCT01697267|66329719|FG001|Overall Study|Lost to Follow-up|4|||
23715100|NCT01697267|66329718|FG000|Overall Study|Physician Decision|2|||
23524207|NCT02558790|65657862|FG000|Overall Study|Lost to Follow-up|2|||
23524208|NCT02558790|65657862|FG000|Overall Study|Physician Decision|1|||
23524209|NCT02558790|65657862|FG000|Overall Study|Withdrawal by Subject|1|||
23524210|NCT02558790|65657862|FG000|Overall Study|Screen Fail|3|||
23524211|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23812607|NCT01154816|66695977|FG009|Overall Study|Withdrawal by Subject|3|||
23812608|NCT01154816|66695978|FG010|Overall Study|Withdrawal by Subject|0|||
23416911|NCT03632993|65271347|FG007|Overall Study|Protocol Non-compliance|0|||
23416912|NCT03632993|65271348|FG008|Overall Study|Protocol Non-compliance|0|||
23416913|NCT03632993|65271349|FG009|Overall Study|Protocol Non-compliance|0|||
23416914|NCT03632993|65271340|FG000|Overall Study|Lost to Follow-up|0|||
23416915|NCT03632993|65271341|FG001|Overall Study|Lost to Follow-up|0|||
23416916|NCT03632993|65271342|FG002|Overall Study|Lost to Follow-up|0|||
23416917|NCT03632993|65271343|FG003|Overall Study|Lost to Follow-up|0|||
23416918|NCT03632993|65271344|FG004|Overall Study|Lost to Follow-up|0|||
23416919|NCT03632993|65271345|FG005|Overall Study|Lost to Follow-up|1|||
23416920|NCT03632993|65271346|FG006|Overall Study|Lost to Follow-up|0|||
23416921|NCT03632993|65271347|FG007|Overall Study|Lost to Follow-up|1|||
23416922|NCT03632993|65271348|FG008|Overall Study|Lost to Follow-up|0|||
23416923|NCT03632993|65271349|FG009|Overall Study|Lost to Follow-up|0|||
23416924|NCT03632993|65271340|FG000|Overall Study|Adverse Event|0|||
23416925|NCT03632993|65271341|FG001|Overall Study|Adverse Event|0|||
23416926|NCT03632993|65271342|FG002|Overall Study|Adverse Event|0|||
23416927|NCT03632993|65271343|FG003|Overall Study|Adverse Event|0|||
23416928|NCT03632993|65271344|FG004|Overall Study|Adverse Event|0|||
23416929|NCT03632993|65271345|FG005|Overall Study|Adverse Event|1|||
23416930|NCT03632993|65271346|FG006|Overall Study|Adverse Event|0|||
23416931|NCT03632993|65271347|FG007|Overall Study|Adverse Event|1|||
23416932|NCT03632993|65271348|FG008|Overall Study|Adverse Event|0|||
23416933|NCT03632993|65271349|FG009|Overall Study|Adverse Event|0|||
23416934|NCT04026009|65271350|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23416935|NCT04026009|65271351|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23416936|NCT04026009|65271352|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23416937|NCT04026009|65271353|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23416938|NCT04026009|65271354|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23416939|NCT04026009|65271350|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416940|NCT04026009|65271351|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416941|NCT04026009|65271352|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416942|NCT04026009|65271353|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416943|NCT04026009|65271354|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
23416944|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
23416945|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
23416946|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
23416947|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
23416948|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
23416949|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
23416950|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
23416951|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
23416952|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
23416953|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
23416954|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
23416955|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
23416956|NCT00962741|65271366|FG000|Overall Study|Failed to return|3|||
23416957|NCT00962741|65271366|FG000|Overall Study|Lost to Follow-up|2|||
23416958|NCT00962741|65271366|FG000|Overall Study|Withdrawal by Subject|1|||
23416959|NCT00962741|65271366|FG000|Overall Study|Lack of Efficacy|1|||
23416960|NCT00962741|65271366|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
23416961|NCT01443364|65271370|FG000|Overall Study|Lack of Efficacy|14|||
23416962|NCT01443364|65271370|FG000|Overall Study|Lost to Follow-up|3|||
23416963|NCT01443364|65271370|FG000|Overall Study|Withdrawal by Subject|5|||
23416964|NCT01443364|65271370|FG000|Overall Study|Other Reason|4|||
23416965|NCT01443364|65271370|FG000|Overall Study|SAE, non-fatal|6|||
23416966|NCT01443364|65271370|FG000|Overall Study|AE, non-serious non-fatal|8|||
23416967|NCT01443364|65271370|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23416968|NCT01066104|65271371|FG000|Overall Study|Adverse Event|1|||
23416969|NCT01066104|65271372|FG001|Overall Study|Adverse Event|1|||
23524212|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
23812609|NCT01154816|66695979|FG011|Overall Study|Withdrawal by Subject|0|||
23812610|NCT01154816|66695968|FG000|Overall Study|Progressive Disease|13|||
23812611|NCT01154816|66695969|FG001|Overall Study|Progressive Disease|8|||
23812612|NCT01154816|66695970|FG002|Overall Study|Progressive Disease|9|||
23524213|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
23524214|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
23524215|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
23524216|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
23524217|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
23524218|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
23524219|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
23524220|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
23715101|NCT01697267|66329719|FG001|Overall Study|Physician Decision|4|||
23715102|NCT01295580|66329723|FG000|Overall Study|Protocol Violation|4|||
23715103|NCT01295580|66329724|FG001|Overall Study|Protocol Violation|2|||
23715104|NCT01295580|66329723|FG000|Overall Study|Withdrawal by Subject|1|||
23715105|NCT01295580|66329724|FG001|Overall Study|Withdrawal by Subject|4|||
23715106|NCT01295580|66329723|FG000|Overall Study|Adverse Event|2|||
23715107|NCT01295580|66329724|FG001|Overall Study|Adverse Event|1|||
23715108|NCT01295580|66329723|FG000|Overall Study|Lost to Follow-up|1|||
23715109|NCT01295580|66329724|FG001|Overall Study|Lost to Follow-up|0|||
23715110|NCT01295580|66329723|FG000|Overall Study|Lack of Efficacy|1|||
23715111|NCT01295580|66329724|FG001|Overall Study|Lack of Efficacy|0|||
23715112|NCT01295580|66329723|FG000|Overall Study|Other: inconvenience|1|||
23715113|NCT01295580|66329724|FG001|Overall Study|Other: inconvenience|0|||
23715114|NCT01295580|66329723|FG000|Overall Study|Other: family objection|0|||
23416970|NCT01066104|65271371|FG000|Overall Study|Protocol Violation|1|||
23416971|NCT01066104|65271372|FG001|Overall Study|Protocol Violation|0|||
23416972|NCT01667224|65271373|FG000|Overall Study|Withdrawal by Subject|3|||
23416973|NCT01667224|65271374|FG001|Overall Study|Withdrawal by Subject|1|||
23416974|NCT01667224|65271373|FG000|Overall Study|Protocol Violation|1|||
23416975|NCT01667224|65271374|FG001|Overall Study|Protocol Violation|1|||
23416976|NCT02778555|65271375|FG000|Overall Study|Withdrawal by Subject|55|||
23416977|NCT02778555|65271376|FG001|Overall Study|Withdrawal by Subject|32|||
23416978|NCT02778555|65271377|FG002|Overall Study|Withdrawal by Subject|107|||
23416979|NCT00666588|65271378|FG000|Overall Study|ineligible|2|||
23416980|NCT00666588|65271379|FG001|Overall Study|ineligible|0|||
23715115|NCT01295580|66329724|FG001|Overall Study|Other: family objection|1|||
23715116|NCT03428997|66329725|FG000|Overall Study|Sponsor decision.|1|||
23715117|NCT03428997|66329725|FG000|Overall Study|Withdrawal by Subject|3|||
23715118|NCT03428997|66329725|FG000|Overall Study|Lost to Follow-up|4|||
23715119|NCT04093258|66329726|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
23715120|NCT04093258|66329727|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
23416981|NCT00666588|65271380|FG002|Overall Study|ineligible|0|||
23416982|NCT00666588|65271381|FG003|Overall Study|ineligible|2|||
23416983|NCT00666588|65271378|FG000|Overall Study|inevaluable|2|||
23416984|NCT00666588|65271379|FG001|Overall Study|inevaluable|0|||
23416985|NCT00666588|65271380|FG002|Overall Study|inevaluable|0|||
23416986|NCT00666588|65271381|FG003|Overall Study|inevaluable|0|||
23416987|NCT00733291|65271382|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
23416988|NCT00733291|65271383|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416989|NCT00733291|65271384|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416990|NCT00733291|65271385|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416991|NCT01986231|65271389|FG000|Overall Study|Adverse Event|1|||
23416992|NCT01818258|65271390|FG000|Overall Study|Death|3|||
23416993|NCT01818258|65271391|FG001|Overall Study|Death|0|||
23416994|NCT01818258|65271390|FG000|Overall Study|Withdrawal by Subject|0|||
23416995|NCT01818258|65271391|FG001|Overall Study|Withdrawal by Subject|1|||
23416996|NCT01818258|65271390|FG000|Overall Study|Lost to Follow-up|0|||
23416997|NCT01818258|65271391|FG001|Overall Study|Lost to Follow-up|1|||
23416998|NCT01818258|65271390|FG000|Overall Study|Unable to Travel to Clinic|0|||
23416999|NCT01818258|65271391|FG001|Overall Study|Unable to Travel to Clinic|1|||
23417000|NCT00960011|65271395|FG000|Overall Study|Death|5|||
23417001|NCT00960011|65271396|FG001|Overall Study|Death|0|||
23417002|NCT00960011|65271395|FG000|Overall Study|Lost to Follow-up|6|||
23417003|NCT00960011|65271396|FG001|Overall Study|Lost to Follow-up|2|||
23417004|NCT00431444|65271407|FG000|Overall Study|Protocol Violation|1|||
23417005|NCT00431444|65271408|FG001|Overall Study|Protocol Violation|4|||
23417006|NCT00431444|65271407|FG000|Overall Study|Adverse Event|2|||
23417007|NCT00431444|65271408|FG001|Overall Study|Adverse Event|1|||
23715121|NCT02853032|66329730|FG000|Overall Study|Adverse Event|4|||
23715122|NCT02853032|66329731|FG001|Overall Study|Adverse Event|0|||
23417008|NCT00431444|65271407|FG000|Overall Study|Withdrawal by Subject|1|||
23417009|NCT00431444|65271408|FG001|Overall Study|Withdrawal by Subject|1|||
23417010|NCT00431444|65271407|FG000|Overall Study|Lost to Follow-up|1|||
23417011|NCT00431444|65271408|FG001|Overall Study|Lost to Follow-up|0|||
23417012|NCT00431444|65271407|FG000|Overall Study|Administrative Problems|0|||
23417013|NCT00431444|65271408|FG001|Overall Study|Administrative Problems|1|||
23715123|NCT02853032|66329730|FG000|Overall Study|Withdrawal by Subject|3|||
23417014|NCT04848220|65271409|FG000|Overall Study|Unable to proceed to study procedure|0|||
23524221|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
23524222|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
23524223|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
23524224|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
23524225|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
23524226|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
23524227|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
23524228|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
23524229|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
23524230|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
23524231|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
23524232|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
23524233|NCT00313612|65657865|FG000|Overall Study|Patient never received treatment|0|||
23524234|NCT00313612|65657866|FG001|Overall Study|Patient never received treatment|1|||
23524235|NCT01203072|65657869|FG000|Overall Study|Adverse Event|5|||
23524236|NCT01203072|65657870|FG001|Overall Study|Adverse Event|3|||
23524237|NCT01203072|65657871|FG002|Overall Study|Adverse Event|2|||
23524238|NCT01203072|65657872|FG003|Overall Study|Adverse Event|4|||
23524239|NCT01203072|65657873|FG004|Overall Study|Adverse Event|2|||
23524240|NCT01203072|65657869|FG000|Overall Study|Lack of Efficacy|1|||
23524241|NCT01203072|65657870|FG001|Overall Study|Lack of Efficacy|0|||
23524242|NCT01203072|65657871|FG002|Overall Study|Lack of Efficacy|0|||
23524243|NCT01203072|65657872|FG003|Overall Study|Lack of Efficacy|0|||
23524244|NCT01203072|65657873|FG004|Overall Study|Lack of Efficacy|0|||
23524245|NCT01203072|65657869|FG000|Overall Study|Lost to Follow-up|0|||
23524246|NCT01203072|65657870|FG001|Overall Study|Lost to Follow-up|1|||
23524247|NCT01203072|65657871|FG002|Overall Study|Lost to Follow-up|0|||
23524248|NCT01203072|65657872|FG003|Overall Study|Lost to Follow-up|0|||
23524249|NCT01203072|65657873|FG004|Overall Study|Lost to Follow-up|0|||
23524250|NCT01203072|65657869|FG000|Overall Study|Protocol Violation|2|||
23524251|NCT01203072|65657870|FG001|Overall Study|Protocol Violation|0|||
23524252|NCT01203072|65657871|FG002|Overall Study|Protocol Violation|0|||
23524253|NCT01203072|65657872|FG003|Overall Study|Protocol Violation|0|||
23524254|NCT01203072|65657873|FG004|Overall Study|Protocol Violation|1|||
23524255|NCT01203072|65657869|FG000|Overall Study|Withdrawal by Subject|2|||
23524256|NCT01203072|65657870|FG001|Overall Study|Withdrawal by Subject|2|||
23524257|NCT01203072|65657871|FG002|Overall Study|Withdrawal by Subject|1|||
23524258|NCT01203072|65657872|FG003|Overall Study|Withdrawal by Subject|2|||
23524259|NCT01203072|65657873|FG004|Overall Study|Withdrawal by Subject|3|||
23524260|NCT01072201|65657874|FG000|Overall Study|Lost to Follow-up|0|||
23524261|NCT01072201|65657875|FG001|Overall Study|Lost to Follow-up|1|||
23524262|NCT00439556|65657890|FG000|Overall Study|Patient was taken off study for non-comp|0|||
23524263|NCT00439556|65657891|FG001|Overall Study|Patient was taken off study for non-comp|1|||
23524264|NCT00439556|65657892|FG002|Overall Study|Patient was taken off study for non-comp|0|||
23417015|NCT04848220|65271410|FG001|Overall Study|Unable to proceed to study procedure|1|||
23417016|NCT04848220|65271411|FG002|Overall Study|Unable to proceed to study procedure|0|||
23417017|NCT04848220|65271409|FG000|Overall Study|Fractional flow not significant|0|||
23417018|NCT04848220|65271410|FG001|Overall Study|Fractional flow not significant|1|||
23417019|NCT04848220|65271411|FG002|Overall Study|Fractional flow not significant|0|||
23417020|NCT02545517|65271412|FG000|Overall Study|Death|2|||
23417021|NCT02545517|65271413|FG001|Overall Study|Death|2|||
23417022|NCT02545517|65271414|FG002|Overall Study|Death|1|||
23417023|NCT02545517|65271412|FG000|Overall Study|Lost to Follow-up|14|||
23417024|NCT02545517|65271413|FG001|Overall Study|Lost to Follow-up|13|||
23417025|NCT02545517|65271414|FG002|Overall Study|Lost to Follow-up|17|||
23417026|NCT02545517|65271412|FG000|Overall Study|Protocol Violation|0|||
23417027|NCT02545517|65271413|FG001|Overall Study|Protocol Violation|1|||
23417028|NCT02545517|65271414|FG002|Overall Study|Protocol Violation|1|||
23417029|NCT02545517|65271412|FG000|Overall Study|Withdrawal by Subject|5|||
23417030|NCT02545517|65271413|FG001|Overall Study|Withdrawal by Subject|8|||
23417031|NCT02545517|65271414|FG002|Overall Study|Withdrawal by Subject|9|||
23417032|NCT02545517|65271412|FG000|Overall Study|Administrative reason|5|||
23417033|NCT02545517|65271413|FG001|Overall Study|Administrative reason|6|||
23417034|NCT02545517|65271414|FG002|Overall Study|Administrative reason|10|||
23524265|NCT00449644|65657896|FG000|Overall Study|Adverse Event|0|||
23417035|NCT02545517|65271412|FG000|Overall Study|Other|2|||
23417036|NCT02545517|65271413|FG001|Overall Study|Other|4|||
23417037|NCT02545517|65271414|FG002|Overall Study|Other|3|||
23524266|NCT00449644|65657897|FG001|Overall Study|Adverse Event|0|||
23524267|NCT00449644|65657898|FG002|Overall Study|Adverse Event|3|||
23524268|NCT00449644|65657899|FG003|Overall Study|Adverse Event|5|||
23524269|NCT00449644|65657896|FG000|Overall Study|Death|1|||
23524270|NCT00449644|65657897|FG001|Overall Study|Death|0|||
23524271|NCT00449644|65657898|FG002|Overall Study|Death|6|||
23524272|NCT00449644|65657899|FG003|Overall Study|Death|1|||
23524273|NCT00449644|65657896|FG000|Overall Study|Lost to Follow-up|1|||
23524274|NCT00449644|65657897|FG001|Overall Study|Lost to Follow-up|1|||
23524275|NCT00449644|65657898|FG002|Overall Study|Lost to Follow-up|5|||
23524276|NCT00449644|65657899|FG003|Overall Study|Lost to Follow-up|3|||
23524277|NCT00449644|65657896|FG000|Overall Study|Pregnancy|0|||
23524278|NCT00449644|65657897|FG001|Overall Study|Pregnancy|0|||
23524279|NCT00449644|65657898|FG002|Overall Study|Pregnancy|3|||
23524280|NCT00449644|65657899|FG003|Overall Study|Pregnancy|2|||
23524281|NCT00449644|65657896|FG000|Overall Study|Protocol Violation|4|||
23524282|NCT00449644|65657897|FG001|Overall Study|Protocol Violation|4|||
23524283|NCT00449644|65657898|FG002|Overall Study|Protocol Violation|3|||
23524284|NCT00449644|65657899|FG003|Overall Study|Protocol Violation|7|||
23524285|NCT00449644|65657896|FG000|Overall Study|Withdrawal by Subject|3|||
23524286|NCT00449644|65657897|FG001|Overall Study|Withdrawal by Subject|4|||
23524287|NCT00449644|65657898|FG002|Overall Study|Withdrawal by Subject|6|||
23524288|NCT00449644|65657899|FG003|Overall Study|Withdrawal by Subject|7|||
23524289|NCT00449644|65657896|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23524290|NCT00449644|65657897|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
23524291|NCT00449644|65657898|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
23524292|NCT00449644|65657899|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
23524293|NCT00449644|65657896|FG000|Overall Study|Other|1|||
23524294|NCT00449644|65657897|FG001|Overall Study|Other|4|||
23524295|NCT00449644|65657898|FG002|Overall Study|Other|1|||
23524296|NCT00449644|65657899|FG003|Overall Study|Other|0|||
23524297|NCT00449644|65657896|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
23524298|NCT00449644|65657897|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
23524299|NCT00449644|65657898|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
23524300|NCT00449644|65657899|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
23524301|NCT04536727|65657900|FG000|Overall Study|Lost to Follow-up|1|||
23524302|NCT04536727|65657901|FG001|Overall Study|Lost to Follow-up|1|||
23524303|NCT04536727|65657900|FG000|Overall Study|Death|0|||
23524304|NCT04536727|65657901|FG001|Overall Study|Death|1|||
23524305|NCT02731729|65657902|FG000|Overall Study|Death|2|||
23524306|NCT02731729|65657903|FG001|Overall Study|Death|2|||
23524307|NCT02731729|65657902|FG000|Overall Study|Study terminated by Sponsor|6|||
23524308|NCT02731729|65657903|FG001|Overall Study|Study terminated by Sponsor|6|||
23524309|NCT02731729|65657902|FG000|Overall Study|Withdrawal by Subject|1|||
23524310|NCT02731729|65657903|FG001|Overall Study|Withdrawal by Subject|0|||
23524311|NCT01342510|65657904|FG000|Overall Study|Protocol Violation|12|||
23524312|NCT01342510|65657905|FG001|Overall Study|Protocol Violation|6|||
23524313|NCT01342510|65657906|FG002|Overall Study|Protocol Violation|13|||
23524314|NCT01342510|65657907|FG003|Overall Study|Protocol Violation|11|||
23524315|NCT02196324|65657910|FG000|Overall Study|Withdrawal by Subject|8|||
23524316|NCT02196324|65657911|FG001|Overall Study|Withdrawal by Subject|4|||
23524317|NCT02196324|65657910|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
23524318|NCT02196324|65657911|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
23524319|NCT02196324|65657910|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
23524320|NCT02196324|65657911|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
23524321|NCT02196324|65657910|FG000|Overall Study|Other|1|||
23524322|NCT02196324|65657911|FG001|Overall Study|Other|0|||
23524323|NCT00116831|65657912|FG000|Overall Study|Adverse Event|14|||
23524324|NCT00116831|65657913|FG001|Overall Study|Adverse Event|16|||
23524325|NCT00116831|65657912|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
23524326|NCT00116831|65657913|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
23524327|NCT00116831|65657912|FG000|Overall Study|Lost to Follow-up|8|||
23524328|NCT00116831|65657913|FG001|Overall Study|Lost to Follow-up|6|||
23524329|NCT00116831|65657912|FG000|Overall Study|Protocol Violation|3|||
23524330|NCT00116831|65657913|FG001|Overall Study|Protocol Violation|6|||
23524331|NCT00116831|65657912|FG000|Overall Study|Hypoglycaemic events|1|||
23524332|NCT00116831|65657913|FG001|Overall Study|Hypoglycaemic events|0|||
23524333|NCT00116831|65657912|FG000|Overall Study|Low haemoglobin on screening|1|||
23524334|NCT00116831|65657913|FG001|Overall Study|Low haemoglobin on screening|0|||
23524335|NCT00116831|65657912|FG000|Overall Study|Withdrawn investigational product|1|||
23524336|NCT00116831|65657913|FG001|Overall Study|Withdrawn investigational product|0|||
23524337|NCT00116831|65657912|FG000|Overall Study|Withdrawal by Subject|32|||
23524338|NCT00116831|65657913|FG001|Overall Study|Withdrawal by Subject|32|||
23524339|NCT00116831|65657912|FG000|Overall Study|Insufficient therapeutic effect|0|||
23524340|NCT00116831|65657913|FG001|Overall Study|Insufficient therapeutic effect|1|||
23524341|NCT00116831|65657912|FG000|Overall Study|Missing data for participant|1|||
23524342|NCT00116831|65657913|FG001|Overall Study|Missing data for participant|0|||
23524343|NCT01275066|65657914|FG000|Overall Study|Withdrawal by Subject|0|||
23524344|NCT01275066|65657915|FG001|Overall Study|Withdrawal by Subject|0|||
23524345|NCT01275066|65657916|FG002|Overall Study|Withdrawal by Subject|1|||
23524346|NCT01275066|65657914|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
23524347|NCT01275066|65657915|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
23524348|NCT01275066|65657916|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
23524349|NCT03711162|65657917|FG000|Overall Study|Adverse Event|5|||
23524350|NCT03711162|65657918|FG001|Overall Study|Adverse Event|2|||
23524351|NCT03711162|65657919|FG002|Overall Study|Adverse Event|4|||
23524352|NCT03711162|65657917|FG000|Overall Study|Death|11|||
23524353|NCT03711162|65657918|FG001|Overall Study|Death|7|||
23524354|NCT03711162|65657919|FG002|Overall Study|Death|8|||
23524355|NCT03711162|65657917|FG000|Overall Study|Lost to Follow-up|1|||
23524356|NCT03711162|65657918|FG001|Overall Study|Lost to Follow-up|0|||
23524357|NCT03711162|65657919|FG002|Overall Study|Lost to Follow-up|1|||
23524358|NCT03711162|65657917|FG000|Overall Study|Study Terminated by Sponsor|139|||
23524359|NCT03711162|65657918|FG001|Overall Study|Study Terminated by Sponsor|152|||
23524360|NCT03711162|65657919|FG002|Overall Study|Study Terminated by Sponsor|146|||
23524361|NCT03711162|65657917|FG000|Overall Study|Withdrawal by Subject|17|||
23524362|NCT03711162|65657918|FG001|Overall Study|Withdrawal by Subject|10|||
23524363|NCT03711162|65657919|FG002|Overall Study|Withdrawal by Subject|10|||
23524364|NCT03711162|65657917|FG000|Overall Study|Miscellaneous|1|||
23524365|NCT03711162|65657918|FG001|Overall Study|Miscellaneous|2|||
23524366|NCT03711162|65657919|FG002|Overall Study|Miscellaneous|2|||
23524367|NCT03711162|65657917|FG000|Overall Study|Not Treated|1|||
23524368|NCT03711162|65657918|FG001|Overall Study|Not Treated|0|||
23524369|NCT03711162|65657919|FG002|Overall Study|Not Treated|1|||
23524370|NCT03711162|65657917|FG000|Overall Study|Physician Decision|0|||
23524371|NCT03711162|65657918|FG001|Overall Study|Physician Decision|2|||
23524372|NCT03711162|65657919|FG002|Overall Study|Physician Decision|0|||
23524373|NCT03711162|65657917|FG000|Overall Study|Lack of Efficacy|0|||
23524374|NCT03711162|65657918|FG001|Overall Study|Lack of Efficacy|0|||
23524375|NCT03711162|65657919|FG002|Overall Study|Lack of Efficacy|2|||
23524376|NCT03711162|65657917|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
23524377|NCT03711162|65657918|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
23524378|NCT03711162|65657919|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23524379|NCT03240133|65657920|FG000|Overall Study|Withdrawal by Subject|0|||
23524380|NCT03240133|65657921|FG001|Overall Study|Withdrawal by Subject|1|||
23524381|NCT03240133|65657922|FG002|Overall Study|Withdrawal by Subject|0|||
23524382|NCT03240133|65657920|FG000|Overall Study|Adverse Event|1|||
23524383|NCT03240133|65657921|FG001|Overall Study|Adverse Event|1|||
23524384|NCT03240133|65657922|FG002|Overall Study|Adverse Event|0|||
23524385|NCT03240133|65657920|FG000|Overall Study|Rash|1|||
23524386|NCT03240133|65657921|FG001|Overall Study|Rash|0|||
23524387|NCT03240133|65657922|FG002|Overall Study|Rash|0|||
23524388|NCT03240133|65657920|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
23524389|NCT03240133|65657921|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
23524390|NCT03240133|65657922|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
23524391|NCT03240133|65657920|FG000|Overall Study|Intercurrent illness.|0|||
23812613|NCT01154816|66695971|FG003|Overall Study|Progressive Disease|9|||
23812614|NCT01154816|66695972|FG004|Overall Study|Progressive Disease|8|||
23812615|NCT01154816|66695973|FG005|Overall Study|Progressive Disease|8|||
23812616|NCT01154816|66695974|FG006|Overall Study|Progressive Disease|5|||
23812617|NCT01154816|66695975|FG007|Overall Study|Progressive Disease|6|||
23812618|NCT01154816|66695976|FG008|Overall Study|Progressive Disease|8|||
23812619|NCT01154816|66695977|FG009|Overall Study|Progressive Disease|6|||
23812620|NCT01154816|66695978|FG010|Overall Study|Progressive Disease|10|||
23524392|NCT03240133|65657921|FG001|Overall Study|Intercurrent illness.|1|||
23524393|NCT03240133|65657922|FG002|Overall Study|Intercurrent illness.|0|||
23524394|NCT03240133|65657920|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
23524395|NCT03240133|65657921|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
23524396|NCT03240133|65657922|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
23524397|NCT02321462|65657925|FG000|Overall Study|Withdrawal by Subject|5|||
23524398|NCT02321462|65657926|FG001|Overall Study|Withdrawal by Subject|2|||
23524399|NCT02321462|65657925|FG000|Overall Study|Subject withdrawn before any treatment|1|||
23524400|NCT02321462|65657926|FG001|Overall Study|Subject withdrawn before any treatment|1|||
23524401|NCT00856908|65657927|FG000|Overall Study|Lost to Follow-up|1|||
23524402|NCT00856908|65657928|FG001|Overall Study|Lost to Follow-up|0|||
23812621|NCT01154816|66695979|FG011|Overall Study|Progressive Disease|3|||
23812622|NCT01154816|66695968|FG000|Overall Study|Physician Decision|1|||
23524403|NCT02603432|65657930|FG000|Overall Study|Adverse Event|1|||
23524404|NCT02603432|65657931|FG001|Overall Study|Adverse Event|0|||
23524405|NCT02603432|65657930|FG000|Overall Study|Death|221|||
23812623|NCT01154816|66695969|FG001|Overall Study|Physician Decision|0|||
23812624|NCT01154816|66695970|FG002|Overall Study|Physician Decision|1|||
23524406|NCT02603432|65657931|FG001|Overall Study|Death|242|||
23524407|NCT02603432|65657930|FG000|Overall Study|Lost to Follow-up|3|||
23524408|NCT02603432|65657931|FG001|Overall Study|Lost to Follow-up|9|||
23524409|NCT02603432|65657930|FG000|Overall Study|Progressive Disease|7|||
23524410|NCT02603432|65657931|FG001|Overall Study|Progressive Disease|5|||
23524411|NCT02603432|65657930|FG000|Overall Study|Withdrawal by Subject|12|||
23524412|NCT02603432|65657931|FG001|Overall Study|Withdrawal by Subject|18|||
23812625|NCT01154816|66695971|FG003|Overall Study|Physician Decision|0|||
23524413|NCT02603432|65657930|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
23524414|NCT02603432|65657931|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23524415|NCT02603432|65657930|FG000|Overall Study|Study terminated by sponsor|74|||
23524416|NCT02603432|65657931|FG001|Overall Study|Study terminated by sponsor|75|||
23524417|NCT02603432|65657930|FG000|Overall Study|Other|13|||
23524418|NCT02603432|65657931|FG001|Overall Study|Other|0|||
23524419|NCT04220411|65657932|FG000|Overall Study|Adverse Event|0|||
23524420|NCT04220411|65657933|FG001|Overall Study|Adverse Event|0|||
23524421|NCT04220411|65657934|FG002|Overall Study|Adverse Event|0|||
23524422|NCT04220411|65657935|FG003|Overall Study|Adverse Event|1|||
23524423|NCT02563028|65657936|FG000|Overall Study|Lack of equipment|1|||
23524424|NCT02563028|65657936|FG000|Overall Study|Unable to elicit VEP post induction|1|||
23524425|NCT01339390|65657937|FG000|Overall Study|Death|32|||
23524426|NCT01339390|65657938|FG001|Overall Study|Death|29|||
23524427|NCT01339390|65657937|FG000|Overall Study|Lost to Follow-up|125|||
23524428|NCT01339390|65657938|FG001|Overall Study|Lost to Follow-up|127|||
23524429|NCT02529137|65657941|FG000|Overall Study|Discontinuation for different reasons|8|||
23524430|NCT00907374|65657949|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
23524431|NCT00907374|65657950|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
23524432|NCT02488681|65657955|FG000|Overall Study|Implant unsuccessful|7|||
23524433|NCT01706003|65657964|FG000|Overall Study|Withdrawal by Subject|2|||
23524434|NCT01706003|65657965|FG001|Overall Study|Withdrawal by Subject|0|||
23524435|NCT01706003|65657964|FG000|Overall Study|Not scheduled|3|||
23524436|NCT01706003|65657965|FG001|Overall Study|Not scheduled|0|||
23524437|NCT01706003|65657964|FG000|Overall Study|Lost to Follow-up|6|||
23524438|NCT01706003|65657965|FG001|Overall Study|Lost to Follow-up|4|||
23524439|NCT03338062|65657966|FG000|Overall Study|Alternative Therapy|1|||
23524440|NCT03338062|65657967|FG001|Overall Study|Alternative Therapy|0|||
23524441|NCT04033159|65657968|FG000|Washout Period|Physician Decision|0|||
23524442|NCT04033159|65657969|FG001|Washout Period|Physician Decision|1|||
23524443|NCT04033159|65657970|FG002|Washout Period|Physician Decision|0|||
23524444|NCT04033159|65657968|FG000|Washout Period|Study terminated by Sponsor|0|||
23715124|NCT02853032|66329731|FG001|Overall Study|Withdrawal by Subject|1|||
23715125|NCT02853032|66329730|FG000|Overall Study|Requested to withdraw from all treatment|2|||
23715126|NCT02853032|66329731|FG001|Overall Study|Requested to withdraw from all treatment|2|||
23524445|NCT04033159|65657969|FG001|Washout Period|Study terminated by Sponsor|7|||
23524446|NCT04033159|65657970|FG002|Washout Period|Study terminated by Sponsor|0|||
23524447|NCT04033159|65657968|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
23524448|NCT04033159|65657969|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
23524449|NCT04033159|65657970|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
23524450|NCT03336216|65657971|FG000|Randomization|Not reported|2|||
23524451|NCT03336216|65657972|FG001|Randomization|Not reported|0|||
23524452|NCT03336216|65657973|FG002|Randomization|Not reported|1|||
23524453|NCT03336216|65657974|FG003|Randomization|Not reported|0|||
23524454|NCT03336216|65657971|FG000|Randomization|Other reasons|1|||
23524455|NCT03336216|65657972|FG001|Randomization|Other reasons|1|||
23524456|NCT03336216|65657973|FG002|Randomization|Other reasons|1|||
23524457|NCT03336216|65657974|FG003|Randomization|Other reasons|0|||
23524458|NCT03336216|65657971|FG000|Randomization|Participant no longer meets study criteria|0|||
23524459|NCT03336216|65657972|FG001|Randomization|Participant no longer meets study criteria|2|||
23715127|NCT01315847|66329735|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
23715128|NCT01315847|66329736|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
23812626|NCT01154816|66695972|FG004|Overall Study|Physician Decision|2|||
23524460|NCT03336216|65657973|FG002|Randomization|Participant no longer meets study criteria|4|||
23524461|NCT03336216|65657974|FG003|Randomization|Participant no longer meets study criteria|1|||
23524462|NCT03336216|65657971|FG000|Randomization|Lost to Follow-up|1|||
23524463|NCT03336216|65657972|FG001|Randomization|Lost to Follow-up|0|||
23524464|NCT03336216|65657973|FG002|Randomization|Lost to Follow-up|0|||
23524465|NCT03336216|65657974|FG003|Randomization|Lost to Follow-up|0|||
23524466|NCT03336216|65657971|FG000|Randomization|Participant withdrew consent|9|||
23524467|NCT03336216|65657972|FG001|Randomization|Participant withdrew consent|1|||
23524468|NCT03336216|65657973|FG002|Randomization|Participant withdrew consent|0|||
23715129|NCT01315847|66329735|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
23715130|NCT01315847|66329736|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
23715131|NCT03094832|66329737|FG000|Overall Study|Lost to Follow-up|0|||
23715132|NCT03094832|66329738|FG001|Overall Study|Lost to Follow-up|0|||
23715133|NCT03094832|66329739|FG002|Overall Study|Lost to Follow-up|0|||
23715134|NCT03094832|66329740|FG003|Overall Study|Lost to Follow-up|1|||
23715135|NCT03094832|66329741|FG004|Overall Study|Lost to Follow-up|1|||
23715136|NCT03094832|66329737|FG000|Overall Study|Death|1|||
23715137|NCT03094832|66329738|FG001|Overall Study|Death|0|||
23715138|NCT03094832|66329739|FG002|Overall Study|Death|0|||
23715139|NCT03094832|66329740|FG003|Overall Study|Death|0|||
23812627|NCT01154816|66695973|FG005|Overall Study|Physician Decision|0|||
23417038|NCT01814878|65271415|FG000|Overall Study|Adverse Event|16|||
23715140|NCT03094832|66329741|FG004|Overall Study|Death|0|||
23715141|NCT03094832|66329737|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23715142|NCT03094832|66329738|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23715143|NCT03094832|66329739|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23715144|NCT03094832|66329740|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23715145|NCT03094832|66329741|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23715146|NCT03094832|66329737|FG000|Overall Study|Other|13|||
23715147|NCT03094832|66329738|FG001|Overall Study|Other|20|||
23715148|NCT03094832|66329739|FG002|Overall Study|Other|1|||
23715149|NCT03094832|66329740|FG003|Overall Study|Other|7|||
23715150|NCT03094832|66329741|FG004|Overall Study|Other|1|||
23715151|NCT00830960|66329744|FG000|Overall Study|Death|5|||
23715152|NCT00830960|66329745|FG001|Overall Study|Death|4|||
23715153|NCT00830960|66329746|FG002|Overall Study|Death|3|||
23715154|NCT00830960|66329747|FG003|Overall Study|Death|2|||
23715155|NCT00830960|66329748|FG004|Overall Study|Death|6|||
23524469|NCT03336216|65657974|FG003|Randomization|Participant withdrew consent|0|||
23524470|NCT03336216|65657971|FG000|Randomization|Adverse Event|1|||
23524471|NCT03336216|65657972|FG001|Randomization|Adverse Event|1|||
23524472|NCT03336216|65657973|FG002|Randomization|Adverse Event|0|||
23524473|NCT03336216|65657974|FG003|Randomization|Adverse Event|0|||
23524474|NCT03336216|65657971|FG000|Treatment|Adverse Event|2|||
23524475|NCT03336216|65657972|FG001|Treatment|Adverse Event|3|||
23524476|NCT03336216|65657973|FG002|Treatment|Adverse Event|4|||
23524477|NCT03336216|65657974|FG003|Treatment|Adverse Event|4|||
23524478|NCT03336216|65657971|FG000|Treatment|Participant request to discontinue treatment|2|||
23524479|NCT03336216|65657972|FG001|Treatment|Participant request to discontinue treatment|1|||
23524480|NCT03336216|65657973|FG002|Treatment|Participant request to discontinue treatment|2|||
23524481|NCT03336216|65657974|FG003|Treatment|Participant request to discontinue treatment|2|||
23524482|NCT03336216|65657971|FG000|Treatment|Participant withdrew consent|7|||
23524483|NCT03336216|65657972|FG001|Treatment|Participant withdrew consent|2|||
23524484|NCT03336216|65657973|FG002|Treatment|Participant withdrew consent|3|||
23524485|NCT03336216|65657974|FG003|Treatment|Participant withdrew consent|2|||
23524486|NCT03336216|65657971|FG000|Treatment|Death|2|||
23524487|NCT03336216|65657972|FG001|Treatment|Death|3|||
23524488|NCT03336216|65657973|FG002|Treatment|Death|3|||
23524489|NCT03336216|65657974|FG003|Treatment|Death|4|||
23715156|NCT00830960|66329749|FG005|Overall Study|Death|1|||
23715157|NCT00830960|66329744|FG000|Overall Study|Lost to Follow-up|1|||
23715158|NCT00830960|66329745|FG001|Overall Study|Lost to Follow-up|1|||
23715159|NCT00830960|66329746|FG002|Overall Study|Lost to Follow-up|1|||
23524490|NCT03336216|65657971|FG000|Treatment|Participant no longer meets study criteria|0|||
23524491|NCT03336216|65657972|FG001|Treatment|Participant no longer meets study criteria|1|||
23524492|NCT03336216|65657973|FG002|Treatment|Participant no longer meets study criteria|0|||
23524493|NCT03336216|65657974|FG003|Treatment|Participant no longer meets study criteria|0|||
23715160|NCT00830960|66329747|FG003|Overall Study|Lost to Follow-up|0|||
23715161|NCT00830960|66329748|FG004|Overall Study|Lost to Follow-up|0|||
23715162|NCT00830960|66329749|FG005|Overall Study|Lost to Follow-up|1|||
23524494|NCT03336216|65657971|FG000|Treatment|Other reasons|2|||
23524495|NCT03336216|65657972|FG001|Treatment|Other reasons|0|||
23524496|NCT03336216|65657973|FG002|Treatment|Other reasons|0|||
23524497|NCT03336216|65657974|FG003|Treatment|Other reasons|3|||
23715163|NCT00830960|66329744|FG000|Overall Study|Withdrawal by Subject|19|||
23715164|NCT00830960|66329745|FG001|Overall Study|Withdrawal by Subject|19|||
23524498|NCT03336216|65657971|FG000|Treatment|Disease progression|23|||
23524499|NCT03336216|65657972|FG001|Treatment|Disease progression|34|||
23524500|NCT03336216|65657973|FG002|Treatment|Disease progression|33|||
23524501|NCT03336216|65657974|FG003|Treatment|Disease progression|26|||
23524502|NCT03336216|65657971|FG000|Treatment|Study drug toxicity|0|||
23524503|NCT03336216|65657972|FG001|Treatment|Study drug toxicity|3|||
23524504|NCT03336216|65657973|FG002|Treatment|Study drug toxicity|2|||
23524505|NCT03336216|65657974|FG003|Treatment|Study drug toxicity|0|||
23524506|NCT03336216|65657971|FG000|Treatment|Adverse Event unrelated to study drug|1|||
23524507|NCT03336216|65657972|FG001|Treatment|Adverse Event unrelated to study drug|1|||
23715165|NCT00830960|66329746|FG002|Overall Study|Withdrawal by Subject|18|||
23715166|NCT00830960|66329747|FG003|Overall Study|Withdrawal by Subject|23|||
23715167|NCT00830960|66329748|FG004|Overall Study|Withdrawal by Subject|16|||
23715168|NCT00830960|66329749|FG005|Overall Study|Withdrawal by Subject|21|||
23715169|NCT00830960|66329744|FG000|Overall Study|Sponsor Decision|1|||
23715170|NCT00830960|66329745|FG001|Overall Study|Sponsor Decision|2|||
23715171|NCT00830960|66329746|FG002|Overall Study|Sponsor Decision|3|||
23715172|NCT00830960|66329747|FG003|Overall Study|Sponsor Decision|4|||
23715173|NCT00830960|66329748|FG004|Overall Study|Sponsor Decision|5|||
23715174|NCT00830960|66329749|FG005|Overall Study|Sponsor Decision|7|||
23715175|NCT00830960|66329744|FG000|Overall Study|No study drug received|7|||
23524508|NCT03336216|65657973|FG002|Treatment|Adverse Event unrelated to study drug|1|||
23715176|NCT00830960|66329745|FG001|Overall Study|No study drug received|2|||
23524509|NCT03336216|65657974|FG003|Treatment|Adverse Event unrelated to study drug|0|||
23715177|NCT00830960|66329746|FG002|Overall Study|No study drug received|4|||
23812628|NCT01154816|66695974|FG006|Overall Study|Physician Decision|0|||
23812629|NCT01154816|66695975|FG007|Overall Study|Physician Decision|0|||
23812630|NCT01154816|66695976|FG008|Overall Study|Physician Decision|0|||
23812631|NCT01154816|66695977|FG009|Overall Study|Physician Decision|1|||
23812632|NCT01154816|66695978|FG010|Overall Study|Physician Decision|1|||
23812633|NCT01154816|66695979|FG011|Overall Study|Physician Decision|1|||
23715178|NCT00830960|66329747|FG003|Overall Study|No study drug received|3|||
23715179|NCT00830960|66329748|FG004|Overall Study|No study drug received|5|||
23715180|NCT00830960|66329749|FG005|Overall Study|No study drug received|7|||
23715181|NCT04656418|66329750|FG000|Overall Study|Withdrawal by Subject|1|||
23715182|NCT04656418|66329751|FG001|Overall Study|Withdrawal by Subject|3|||
23715183|NCT03726333|66333345|FG000|Overall Study|Progressive Disease|0|||
23715184|NCT03726333|66333346|FG001|Overall Study|Progressive Disease|0|||
23715185|NCT03726333|66333347|FG002|Overall Study|Progressive Disease|1|||
23715186|NCT03726333|66333348|FG003|Overall Study|Progressive Disease|0|||
23715187|NCT03726333|66333349|FG004|Overall Study|Progressive Disease|0|||
23715188|NCT00475540|66333362|FG000|36 Months|Lost to Follow-up|4|||
23715189|NCT00475540|66333363|FG001|36 Months|Lost to Follow-up|4|||
23715190|NCT00475540|66333362|FG000|36 Months|Death|1|||
23715191|NCT00475540|66333363|FG001|36 Months|Death|2|||
23715192|NCT00475540|66333362|FG000|36 Months|Censored due to reoperation|3|||
23715193|NCT00475540|66333363|FG001|36 Months|Censored due to reoperation|0|||
23715194|NCT01392378|66333364|FG000|Infant Series|Adverse Event|0|||
23715195|NCT01392378|66333365|FG001|Infant Series|Adverse Event|0|||
23715196|NCT01392378|66333366|FG002|Infant Series|Adverse Event|0|||
23715197|NCT01392378|66333367|FG003|Infant Series|Adverse Event|1|||
23715198|NCT01392378|66333368|FG004|Infant Series|Adverse Event|0|||
23715199|NCT01392378|66333364|FG000|Infant Series|Lost to Follow-up|0|||
23715200|NCT01392378|66333365|FG001|Infant Series|Lost to Follow-up|0|||
23715201|NCT01392378|66333366|FG002|Infant Series|Lost to Follow-up|0|||
23715202|NCT01392378|66333367|FG003|Infant Series|Lost to Follow-up|1|||
23715203|NCT01392378|66333368|FG004|Infant Series|Lost to Follow-up|0|||
23715204|NCT01392378|66333364|FG000|Infant Series|Protocol Violation|0|||
23715205|NCT01392378|66333365|FG001|Infant Series|Protocol Violation|1|||
23715206|NCT01392378|66333366|FG002|Infant Series|Protocol Violation|0|||
23715207|NCT01392378|66333367|FG003|Infant Series|Protocol Violation|0|||
23715208|NCT01392378|66333368|FG004|Infant Series|Protocol Violation|0|||
23715209|NCT01392378|66333364|FG000|Infant Series|Withdrawal by Parent|4|||
23715210|NCT01392378|66333365|FG001|Infant Series|Withdrawal by Parent|1|||
23715211|NCT01392378|66333366|FG002|Infant Series|Withdrawal by Parent|0|||
23715212|NCT01392378|66333367|FG003|Infant Series|Withdrawal by Parent|0|||
23715213|NCT01392378|66333368|FG004|Infant Series|Withdrawal by Parent|0|||
23715214|NCT01392378|66333364|FG000|After Infant Series|Lost to Follow-up|0|||
23812634|NCT01154816|66695968|FG000|Overall Study|Adverse Event|5|||
23812635|NCT01154816|66695969|FG001|Overall Study|Adverse Event|2|||
23812636|NCT01154816|66695970|FG002|Overall Study|Adverse Event|0|||
23812637|NCT01154816|66695971|FG003|Overall Study|Adverse Event|0|||
23812638|NCT01154816|66695972|FG004|Overall Study|Adverse Event|0|||
23417039|NCT01814878|65271416|FG001|Overall Study|Adverse Event|5|||
23417040|NCT01814878|65271415|FG000|Overall Study|Withdrawal by Subject|20|||
23417041|NCT01814878|65271416|FG001|Overall Study|Withdrawal by Subject|16|||
23417042|NCT01814878|65271415|FG000|Overall Study|Protocol Violation|5|||
23812639|NCT01154816|66695973|FG005|Overall Study|Adverse Event|0|||
23812640|NCT01154816|66695974|FG006|Overall Study|Adverse Event|1|||
23417043|NCT01814878|65271416|FG001|Overall Study|Protocol Violation|5|||
23524510|NCT03336216|65657971|FG000|Treatment|Disease Recurrence|1|||
23524511|NCT03336216|65657972|FG001|Treatment|Disease Recurrence|0|||
23715215|NCT01392378|66333365|FG001|After Infant Series|Lost to Follow-up|0|||
23715216|NCT01392378|66333366|FG002|After Infant Series|Lost to Follow-up|1|||
23812641|NCT01154816|66695975|FG007|Overall Study|Adverse Event|1|||
23812642|NCT01154816|66695976|FG008|Overall Study|Adverse Event|0|||
23417044|NCT01814878|65271415|FG000|Overall Study|Physician Decision|3|||
23715217|NCT01392378|66333367|FG003|After Infant Series|Lost to Follow-up|0|||
23812643|NCT01154816|66695977|FG009|Overall Study|Adverse Event|0|||
23812644|NCT01154816|66695978|FG010|Overall Study|Adverse Event|0|||
23417045|NCT01814878|65271416|FG001|Overall Study|Physician Decision|1|||
23524512|NCT03336216|65657973|FG002|Treatment|Disease Recurrence|0|||
23715218|NCT01392378|66333368|FG004|After Infant Series|Lost to Follow-up|0|||
23715219|NCT01392378|66333364|FG000|After Infant Series|Withdrawal by Parent|0|||
23715220|NCT01392378|66333365|FG001|After Infant Series|Withdrawal by Parent|1|||
23715221|NCT01392378|66333366|FG002|After Infant Series|Withdrawal by Parent|1|||
23812645|NCT01154816|66695979|FG011|Overall Study|Adverse Event|0|||
23812646|NCT01359969|66695981|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
23524513|NCT03336216|65657974|FG003|Treatment|Disease Recurrence|0|||
23524514|NCT00903617|65657975|FG000|Overall Study|Adverse Event|0|||
23524515|NCT00903617|65657976|FG001|Overall Study|Adverse Event|1|||
23524516|NCT00903617|65657977|FG002|Overall Study|Adverse Event|1|||
23524517|NCT00903617|65657978|FG003|Overall Study|Adverse Event|0|||
23524518|NCT00903617|65657975|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23524519|NCT00903617|65657976|FG001|Overall Study|Protocol-defined stopping criteria|2|||
23524520|NCT00903617|65657977|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23524521|NCT00903617|65657978|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23524522|NCT00903617|65657975|FG000|Overall Study|Lost to Follow-up|2|||
23524523|NCT00903617|65657976|FG001|Overall Study|Lost to Follow-up|0|||
23524524|NCT00903617|65657977|FG002|Overall Study|Lost to Follow-up|1|||
23524525|NCT00903617|65657978|FG003|Overall Study|Lost to Follow-up|1|||
23524526|NCT00903617|65657975|FG000|Overall Study|Withdrawal by Subject|1|||
23524527|NCT00903617|65657976|FG001|Overall Study|Withdrawal by Subject|2|||
23524528|NCT00903617|65657977|FG002|Overall Study|Withdrawal by Subject|3|||
23524529|NCT00903617|65657978|FG003|Overall Study|Withdrawal by Subject|0|||
23524530|NCT00969553|65657979|FG000|Overall Study|Progressive disease (PD)|2|||
23524531|NCT00969553|65657980|FG001|Overall Study|Progressive disease (PD)|2|||
23524532|NCT00969553|65657981|FG002|Overall Study|Progressive disease (PD)|6|||
23524533|NCT00969553|65657982|FG003|Overall Study|Progressive disease (PD)|9|||
23524534|NCT00969553|65657983|FG004|Overall Study|Progressive disease (PD)|2|||
23524535|NCT00969553|65657984|FG005|Overall Study|Progressive disease (PD)|4|||
23524536|NCT00969553|65657985|FG006|Overall Study|Progressive disease (PD)|2|||
23524537|NCT00969553|65657986|FG007|Overall Study|Progressive disease (PD)|12|||
23524538|NCT00969553|65657987|FG008|Overall Study|Progressive disease (PD)|3|||
23524539|NCT00969553|65657979|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524540|NCT00969553|65657980|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
23715222|NCT01392378|66333367|FG003|After Infant Series|Withdrawal by Parent|0|||
23715223|NCT01392378|66333368|FG004|After Infant Series|Withdrawal by Parent|1|||
23715224|NCT01392378|66333364|FG000|Toddler Dose|Lost to Follow-up|0|||
23715225|NCT01392378|66333365|FG001|Toddler Dose|Lost to Follow-up|0|||
23524541|NCT00969553|65657981|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524542|NCT00969553|65657982|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524543|NCT00969553|65657983|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
23524544|NCT00969553|65657984|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
23715226|NCT01392378|66333366|FG002|Toddler Dose|Lost to Follow-up|0|||
23715227|NCT01392378|66333367|FG003|Toddler Dose|Lost to Follow-up|1|||
23715228|NCT01392378|66333368|FG004|Toddler Dose|Lost to Follow-up|0|||
23715229|NCT01392378|66333364|FG000|Toddler Dose|Withdrawal by Parent|0|||
23715230|NCT01392378|66333365|FG001|Toddler Dose|Withdrawal by Parent|1|||
23715231|NCT01392378|66333366|FG002|Toddler Dose|Withdrawal by Parent|0|||
23715232|NCT01392378|66333367|FG003|Toddler Dose|Withdrawal by Parent|1|||
23715233|NCT01392378|66333368|FG004|Toddler Dose|Withdrawal by Parent|1|||
23715234|NCT02921763|66333370|FG000|Overall Study|Adverse Event|4|||
23715235|NCT02921763|66333370|FG000|Overall Study|Lost to Follow-up|4|||
23715236|NCT02921763|66333370|FG000|Overall Study|Lack of Efficacy|3|||
23715237|NCT02921763|66333370|FG000|Overall Study|Protocol Violation|2|||
23715238|NCT02921763|66333370|FG000|Overall Study|Withdrawal by Subject|2|||
23524545|NCT00969553|65657985|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524546|NCT00969553|65657986|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524547|NCT00969553|65657987|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524548|NCT00969553|65657979|FG000|Overall Study|Other Adverse Event|0|||
23524549|NCT00969553|65657980|FG001|Overall Study|Other Adverse Event|0|||
23524550|NCT00969553|65657981|FG002|Overall Study|Other Adverse Event|0|||
23524551|NCT00969553|65657982|FG003|Overall Study|Other Adverse Event|1|||
23524552|NCT00969553|65657983|FG004|Overall Study|Other Adverse Event|0|||
23524553|NCT00969553|65657984|FG005|Overall Study|Other Adverse Event|0|||
23524554|NCT00969553|65657985|FG006|Overall Study|Other Adverse Event|1|||
23524555|NCT00969553|65657986|FG007|Overall Study|Other Adverse Event|0|||
23524556|NCT00969553|65657987|FG008|Overall Study|Other Adverse Event|0|||
23524557|NCT00969553|65657979|FG000|Overall Study|Refused cont. medication|1|||
23524558|NCT00969553|65657980|FG001|Overall Study|Refused cont. medication|1|||
23524559|NCT00969553|65657981|FG002|Overall Study|Refused cont. medication|0|||
23524560|NCT00969553|65657982|FG003|Overall Study|Refused cont. medication|2|||
23715239|NCT02921763|66333370|FG000|Overall Study|Physician Decision|1|||
23524561|NCT00969553|65657983|FG004|Overall Study|Refused cont. medication|0|||
23715240|NCT02921763|66333370|FG000|Overall Study|No data obtained|2|||
23715241|NCT03297216|66333371|FG000|Overall Study|Death|0|||
23715242|NCT03297216|66333372|FG001|Overall Study|Death|1|||
23524562|NCT00969553|65657984|FG005|Overall Study|Refused cont. medication|0|||
23524563|NCT00969553|65657985|FG006|Overall Study|Refused cont. medication|0|||
23524564|NCT00969553|65657986|FG007|Overall Study|Refused cont. medication|1|||
23524565|NCT00969553|65657987|FG008|Overall Study|Refused cont. medication|0|||
23715243|NCT03297216|66333371|FG000|Overall Study|Miscarriage|0|||
23715244|NCT03297216|66333372|FG001|Overall Study|Miscarriage|2|||
23715245|NCT03297216|66333371|FG000|Overall Study|Lost to Follow-up|3|||
23524566|NCT00969553|65657979|FG000|Overall Study|Not specified above|0|||
23524567|NCT00969553|65657980|FG001|Overall Study|Not specified above|0|||
23524568|NCT00969553|65657981|FG002|Overall Study|Not specified above|0|||
23524569|NCT00969553|65657982|FG003|Overall Study|Not specified above|4|||
23524570|NCT00969553|65657983|FG004|Overall Study|Not specified above|0|||
23524571|NCT00969553|65657984|FG005|Overall Study|Not specified above|0|||
23524572|NCT00969553|65657985|FG006|Overall Study|Not specified above|1|||
23524573|NCT00969553|65657986|FG007|Overall Study|Not specified above|1|||
23524574|NCT00969553|65657987|FG008|Overall Study|Not specified above|0|||
23524575|NCT02515942|65657988|FG000|Overall Study|Adverse Event|5|||
23524576|NCT02515942|65657989|FG001|Overall Study|Adverse Event|0|||
23524577|NCT02515942|65657990|FG002|Overall Study|Adverse Event|0|||
23524578|NCT02515942|65657988|FG000|Overall Study|Death|0|||
23524579|NCT02515942|65657989|FG001|Overall Study|Death|0|||
23524580|NCT02515942|65657990|FG002|Overall Study|Death|1|||
23524581|NCT02515942|65657988|FG000|Overall Study|Lack of Efficacy|0|||
23524582|NCT02515942|65657989|FG001|Overall Study|Lack of Efficacy|0|||
23524583|NCT02515942|65657990|FG002|Overall Study|Lack of Efficacy|1|||
23524584|NCT02515942|65657988|FG000|Overall Study|Lost to Follow-up|2|||
23524585|NCT02515942|65657989|FG001|Overall Study|Lost to Follow-up|0|||
23524586|NCT02515942|65657990|FG002|Overall Study|Lost to Follow-up|0|||
23524587|NCT02515942|65657988|FG000|Overall Study|Withdrawal by Subject|0|||
23524588|NCT02515942|65657989|FG001|Overall Study|Withdrawal by Subject|3|||
23524589|NCT02515942|65657990|FG002|Overall Study|Withdrawal by Subject|2|||
23524590|NCT03551210|65657991|FG000|Overall Study|Adverse Event|5|||
23524591|NCT03551210|65657992|FG001|Overall Study|Adverse Event|6|||
23524592|NCT03551210|65657991|FG000|Overall Study|Withdrawal by Subject|1|||
23524593|NCT03551210|65657992|FG001|Overall Study|Withdrawal by Subject|7|||
23524594|NCT03551210|65657991|FG000|Overall Study|Needed in other antibiotic treatment|2|||
23524595|NCT03551210|65657992|FG001|Overall Study|Needed in other antibiotic treatment|5|||
23524596|NCT03551210|65657991|FG000|Overall Study|Lost to Follow-up|1|||
23524597|NCT03551210|65657992|FG001|Overall Study|Lost to Follow-up|1|||
23524598|NCT03551210|65657991|FG000|Overall Study|Absence of visit 4 and 5|1|||
23524599|NCT03551210|65657992|FG001|Overall Study|Absence of visit 4 and 5|0|||
23524600|NCT03551210|65657991|FG000|Overall Study|No drug for dispensing|0|||
23524601|NCT03551210|65657992|FG001|Overall Study|No drug for dispensing|1|||
23524602|NCT03913091|65661553|FG000|Overall Study|Lost to Follow-up|18|||
23524603|NCT03913091|65661554|FG001|Overall Study|Lost to Follow-up|11|||
23524604|NCT03913091|65661553|FG000|Overall Study|Required additional meds/surgery|1|||
23524605|NCT03913091|65661554|FG001|Overall Study|Required additional meds/surgery|2|||
23524606|NCT03913091|65661553|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
23524607|NCT03913091|65661554|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
23524608|NCT01158222|65661555|FG000|Overall Study|Not eligible for intermediate phase|17|||
23524609|NCT02350309|65661556|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524610|NCT02350309|65661557|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524611|NCT02350309|65661558|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
23524612|NCT02350309|65661559|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524613|NCT02350309|65661560|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524614|NCT02350309|65661561|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524615|NCT02350309|65661556|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524616|NCT02350309|65661557|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524617|NCT02350309|65661558|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524618|NCT02350309|65661559|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524619|NCT02350309|65661560|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524620|NCT02350309|65661561|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
23524621|NCT01364428|65661562|FG000|Overall Study|Adverse Event|1|||
23524622|NCT01364428|65661563|FG001|Overall Study|Adverse Event|2|||
23524623|NCT01364428|65661562|FG000|Overall Study|Protocol Violation|2|||
23715246|NCT03297216|66333372|FG001|Overall Study|Lost to Follow-up|2|||
23715247|NCT00643487|66333373|FG000|Overall Study|Technical difficulty|3|||
23715248|NCT02677220|66333382|FG000|Overall Study|Adverse Event|1|||
23524624|NCT01364428|65661563|FG001|Overall Study|Protocol Violation|0|||
23524625|NCT01364428|65661562|FG000|Overall Study|Withdrawal Criteria|14|||
23715249|NCT02887859|66333388|FG000|Overall Study|Ongoing|6|||
23417046|NCT01814878|65271415|FG000|Overall Study|Screening failure (drop-out)|0|||
23524626|NCT01364428|65661563|FG001|Overall Study|Withdrawal Criteria|10|||
23524627|NCT01364428|65661562|FG000|Overall Study|Other|3|||
23524628|NCT01364428|65661563|FG001|Overall Study|Other|3|||
23524629|NCT00508742|65661564|FG000|Period 1: Infant Series|Adverse Event|5|||
23524630|NCT00508742|65661565|FG001|Period 1: Infant Series|Adverse Event|4|||
23715250|NCT02887859|66333388|FG000|Overall Study|Adverse Event|7|||
23524631|NCT00508742|65661564|FG000|Period 1: Infant Series|Protocol Violation|1|||
23524632|NCT00508742|65661565|FG001|Period 1: Infant Series|Protocol Violation|0|||
23524633|NCT00508742|65661564|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
23524634|NCT00508742|65661565|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
23524635|NCT00508742|65661564|FG000|Period 1: Infant Series|Physician Decision|1|||
23524636|NCT00508742|65661565|FG001|Period 1: Infant Series|Physician Decision|0|||
23524637|NCT00508742|65661564|FG000|Period 1: Infant Series|Other|4|||
23524638|NCT00508742|65661565|FG001|Period 1: Infant Series|Other|1|||
23524639|NCT00508742|65661564|FG000|Period 2: After Infant Series|Adverse Event|2|||
23524640|NCT00508742|65661565|FG001|Period 2: After Infant Series|Adverse Event|6|||
23524641|NCT00508742|65661564|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
23524642|NCT00508742|65661565|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
23524643|NCT00508742|65661564|FG000|Period 2: After Infant Series|Protocol Violation|1|||
23524644|NCT00508742|65661565|FG001|Period 2: After Infant Series|Protocol Violation|0|||
23524645|NCT00508742|65661564|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
23524646|NCT00508742|65661565|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
23524647|NCT00508742|65661564|FG000|Period 2: After Infant Series|Failed to Return|1|||
23524648|NCT00508742|65661565|FG001|Period 2: After Infant Series|Failed to Return|0|||
23524649|NCT00508742|65661564|FG000|Period 2: After Infant Series|Other|2|||
23524650|NCT00508742|65661565|FG001|Period 2: After Infant Series|Other|1|||
23524651|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Adverse Event|1|||
23524652|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Adverse Event|0|||
23524653|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
23524654|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
23524655|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
23524656|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
23524657|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Other|5|||
23524658|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Other|4|||
23524659|NCT01236755|65661568|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
23524660|NCT01236755|65661568|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
23524661|NCT01236755|65661568|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
23524662|NCT01236755|65661568|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
23524663|NCT01971346|65661569|FG000|Overall Study|Protocol Violation|3|||
23524664|NCT01971346|65661569|FG000|Overall Study|Lost to Follow-up|2|||
23524665|NCT01971346|65661569|FG000|Overall Study|Withdrawal by Subject|2|||
23524666|NCT01971346|65661569|FG000|Overall Study|Physician Decision|1|||
23524667|NCT03925324|65661570|FG000|Overall Study|Death|1|||
23524668|NCT03925324|65661571|FG001|Overall Study|Death|1|||
23524669|NCT01399593|65661574|FG000|Overall Study|Physician Decision|1|||
23524670|NCT01399593|65661575|FG001|Overall Study|Physician Decision|0|||
23524671|NCT01399593|65661574|FG000|Overall Study|Adverse Event|1|||
23524672|NCT01399593|65661575|FG001|Overall Study|Adverse Event|0|||
23524673|NCT01399593|65661574|FG000|Overall Study|Death|1|||
23524674|NCT01399593|65661575|FG001|Overall Study|Death|1|||
23524675|NCT01399593|65661574|FG000|Overall Study|Transplantectomy|0|||
23524676|NCT01399593|65661575|FG001|Overall Study|Transplantectomy|1|||
23524677|NCT00205712|65661576|FG000|Overall Study|Lost to Follow-up|0|||
23524678|NCT00205712|65661577|FG001|Overall Study|Lost to Follow-up|1|||
23524679|NCT01190254|65661580|FG000|Overall Study|Adverse Event|3|||
23524680|NCT01190254|65661581|FG001|Overall Study|Adverse Event|6|||
23524681|NCT01190254|65661582|FG002|Overall Study|Adverse Event|8|||
23524682|NCT01190254|65661580|FG000|Overall Study|Lack of Efficacy|7|||
23524683|NCT01190254|65661581|FG001|Overall Study|Lack of Efficacy|4|||
23524684|NCT01190254|65661582|FG002|Overall Study|Lack of Efficacy|5|||
23524685|NCT01190254|65661580|FG000|Overall Study|Lost to Follow-up|4|||
23524686|NCT01190254|65661581|FG001|Overall Study|Lost to Follow-up|2|||
23524687|NCT01190254|65661582|FG002|Overall Study|Lost to Follow-up|0|||
23524688|NCT01190254|65661580|FG000|Overall Study|Withdrawal by Subject|4|||
23524689|NCT01190254|65661581|FG001|Overall Study|Withdrawal by Subject|5|||
23524690|NCT01190254|65661582|FG002|Overall Study|Withdrawal by Subject|7|||
23524691|NCT01190254|65661580|FG000|Overall Study|Protocol Violation|2|||
23524692|NCT01190254|65661581|FG001|Overall Study|Protocol Violation|0|||
23524693|NCT01190254|65661582|FG002|Overall Study|Protocol Violation|2|||
23524694|NCT01190254|65661580|FG000|Overall Study|Did not meet protocol eligibility|1|||
23524695|NCT01190254|65661581|FG001|Overall Study|Did not meet protocol eligibility|0|||
23524696|NCT01190254|65661582|FG002|Overall Study|Did not meet protocol eligibility|0|||
23524697|NCT00838201|65661586|FG000|Overall Study|Investigator decision, or other reasons|2|||
23524698|NCT00838201|65661587|FG001|Overall Study|Investigator decision, or other reasons|3|||
23524699|NCT00838201|65661586|FG000|Overall Study|Noncompliance|0|||
23524700|NCT00838201|65661587|FG001|Overall Study|Noncompliance|1|||
23524701|NCT00838201|65661586|FG000|Overall Study|Administrative decision|1|||
23524702|NCT00838201|65661587|FG001|Overall Study|Administrative decision|2|||
23417047|NCT01814878|65271416|FG001|Overall Study|Screening failure (drop-out)|3|||
23417048|NCT01814878|65271415|FG000|Overall Study|Other|2|||
23524703|NCT00838201|65661586|FG000|Overall Study|Disease progression|3|||
23715251|NCT02887859|66333388|FG000|Overall Study|Death|1|||
23715252|NCT02887859|66333388|FG000|Overall Study|Physician Decision|1|||
23715253|NCT00594204|66333390|FG000|Overall Study|Adverse Event|15|||
23715254|NCT00594204|66333391|FG001|Overall Study|Adverse Event|3|||
23715255|NCT00594204|66333390|FG000|Overall Study|Lost to Follow-up|9|||
23715256|NCT00594204|66333391|FG001|Overall Study|Lost to Follow-up|5|||
23715257|NCT00594204|66333390|FG000|Overall Study|Withdrawal by Subject|23|||
23715258|NCT00594204|66333391|FG001|Overall Study|Withdrawal by Subject|29|||
23715259|NCT00594204|66333390|FG000|Overall Study|Other|4|||
23715260|NCT00594204|66333391|FG001|Overall Study|Other|3|||
23715261|NCT00594204|66333390|FG000|Overall Study|Lack of Efficacy|3|||
23715262|NCT00594204|66333391|FG001|Overall Study|Lack of Efficacy|4|||
23715263|NCT00594204|66333390|FG000|Overall Study|Randomized but not treated|4|||
23715264|NCT00594204|66333391|FG001|Overall Study|Randomized but not treated|1|||
23715265|NCT04111107|66333399|FG000|Overall Study|Withdrawal by Subject|6|||
23715266|NCT04111107|66333399|FG000|Overall Study|Declining Health|5|||
23715267|NCT00400712|66333400|FG000|Overall Study|Death|1|||
23715268|NCT00400712|66333401|FG001|Overall Study|Death|0|||
23715269|NCT00400712|66333400|FG000|Overall Study|Withdrawal by Subject|11|||
23715270|NCT00400712|66333401|FG001|Overall Study|Withdrawal by Subject|12|||
23715271|NCT00400712|66333400|FG000|Overall Study|Physician Decision|5|||
23715272|NCT00400712|66333401|FG001|Overall Study|Physician Decision|4|||
23715273|NCT02475850|66333402|FG000|Overall Study|Death|155|||
23715274|NCT02475850|66333403|FG001|Overall Study|Death|141|||
23715275|NCT02475850|66333402|FG000|Overall Study|Lost to Follow-up|217|||
23715276|NCT02475850|66333403|FG001|Overall Study|Lost to Follow-up|188|||
23715277|NCT02475850|66333402|FG000|Overall Study|Withdrawal by Subject|221|||
23715278|NCT02475850|66333403|FG001|Overall Study|Withdrawal by Subject|155|||
23715279|NCT01033487|66333406|FG000|Fourth Intervention Period|Adverse Event|0|||
23715280|NCT01033487|66333407|FG001|Fourth Intervention Period|Adverse Event|0|||
23715281|NCT01033487|66333408|FG002|Fourth Intervention Period|Adverse Event|0|||
23715282|NCT01033487|66333409|FG003|Fourth Intervention Period|Adverse Event|0|||
23715283|NCT01033487|66333410|FG004|Fourth Intervention Period|Adverse Event|0|||
23715284|NCT01033487|66333411|FG005|Fourth Intervention Period|Adverse Event|0|||
23715285|NCT01033487|66333412|FG006|Fourth Intervention Period|Adverse Event|0|||
23715286|NCT01033487|66333413|FG007|Fourth Intervention Period|Adverse Event|0|||
23715287|NCT01033487|66333414|FG008|Fourth Intervention Period|Adverse Event|1|||
23524704|NCT00838201|65661587|FG001|Overall Study|Disease progression|3|||
23524705|NCT00838201|65661586|FG000|Overall Study|Consent withdrawn|16|||
23524706|NCT00838201|65661587|FG001|Overall Study|Consent withdrawn|19|||
23524707|NCT00838201|65661586|FG000|Overall Study|Lost to Follow-up|4|||
23524708|NCT00838201|65661587|FG001|Overall Study|Lost to Follow-up|3|||
23524709|NCT00838201|65661586|FG000|Overall Study|Adverse Event|5|||
23524710|NCT00838201|65661587|FG001|Overall Study|Adverse Event|9|||
23812647|NCT00369317|66695984|FG000|Overall Study|Adverse Event|3|||
23812648|NCT00369317|66695984|FG000|Overall Study|Death|1|||
23812649|NCT00369317|66695984|FG000|Overall Study|Lack of Efficacy|5|||
23812650|NCT00369317|66695984|FG000|Overall Study|Physician Decision|2|||
23812651|NCT00369317|66695984|FG000|Overall Study|Withdrawal by Subject|8|||
23524711|NCT00838201|65661586|FG000|Overall Study|Death|11|||
23524712|NCT00838201|65661587|FG001|Overall Study|Death|13|||
23524713|NCT00842348|65661590|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
23524714|NCT00842348|65661591|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
23524715|NCT00842348|65661590|FG000|Study 729|Disease progression/death|19|||
23524716|NCT00842348|65661591|FG001|Study 729|Disease progression/death|30|||
23524717|NCT00842348|65661590|FG000|Study 729|Adverse Event|1|||
23524718|NCT00842348|65661591|FG001|Study 729|Adverse Event|1|||
23524719|NCT00842348|65661590|FG000|Study 729|Protocol Violation|1|||
23524720|NCT00842348|65661591|FG001|Study 729|Protocol Violation|1|||
23524721|NCT00842348|65661590|FG000|Study 729|Withdrawal by Subject|2|||
23524722|NCT00842348|65661591|FG001|Study 729|Withdrawal by Subject|4|||
23524723|NCT00842348|65661590|FG000|Study 729|Due to Sponsor stopping the study|1|||
23524724|NCT00842348|65661591|FG001|Study 729|Due to Sponsor stopping the study|1|||
23715288|NCT01033487|66333415|FG009|Fourth Intervention Period|Adverse Event|0|||
23524725|NCT00842348|65661590|FG000|Study 729|Due to non-availability of IP|0|||
23715289|NCT00699842|66333416|FG000|Overall Study|Death|0|||
23715290|NCT00699842|66333417|FG001|Overall Study|Death|1|||
23812652|NCT00369317|66695984|FG000|Overall Study|Ineligible|1|||
23812653|NCT00893737|66695985|FG000|Overall Study|Adverse Event|4|||
23812654|NCT00893737|66695985|FG000|Overall Study|Withdrawal by Subject|2|||
23524726|NCT00842348|65661591|FG001|Study 729|Due to non-availability of IP|1|||
23524727|NCT00842348|65661590|FG000|Study 729|Sponsor's decision|1|||
23524728|NCT00842348|65661591|FG001|Study 729|Sponsor's decision|0|||
23524729|NCT00842348|65661590|FG000|Study 729|Surgical resection|1|||
23715291|NCT00699842|66333418|FG002|Overall Study|Death|0|||
23715292|NCT03364335|66333424|FG000|Overall Study|Adverse Event|3|||
23715293|NCT03364335|66333425|FG001|Overall Study|Adverse Event|4|||
23715294|NCT03364335|66333426|FG002|Overall Study|Adverse Event|1|||
23715295|NCT03364335|66333427|FG003|Overall Study|Adverse Event|2|||
23812655|NCT00893737|66695985|FG000|Overall Study|Lost to Follow-up|6|||
23715296|NCT03364335|66333428|FG004|Overall Study|Adverse Event|0|||
23715297|NCT03364335|66333424|FG000|Overall Study|Lost to Follow-up|7|||
23715298|NCT03364335|66333425|FG001|Overall Study|Lost to Follow-up|7|||
23715299|NCT03364335|66333426|FG002|Overall Study|Lost to Follow-up|10|||
23715300|NCT03364335|66333427|FG003|Overall Study|Lost to Follow-up|11|||
23715301|NCT03364335|66333428|FG004|Overall Study|Lost to Follow-up|11|||
23715302|NCT00862121|66333429|FG000|Overall Study|Adverse Event|1|||
23715303|NCT00862121|66333430|FG001|Overall Study|Adverse Event|2|||
23715304|NCT00862121|66333429|FG000|Overall Study|Lack of Efficacy|0|||
23715305|NCT00862121|66333430|FG001|Overall Study|Lack of Efficacy|3|||
23715306|NCT00862121|66333429|FG000|Overall Study|Protocol Violation|0|||
23715307|NCT00862121|66333430|FG001|Overall Study|Protocol Violation|1|||
23715308|NCT00862121|66333429|FG000|Overall Study|Exclusion criterion violation|0|||
23715309|NCT00862121|66333430|FG001|Overall Study|Exclusion criterion violation|1|||
23715310|NCT00862121|66333429|FG000|Overall Study|Incorrect randomisation|0|||
23715311|NCT00862121|66333430|FG001|Overall Study|Incorrect randomisation|1|||
23715312|NCT01413542|66333431|FG000|Overall Study|Physician Decision|1|||
23715313|NCT01413542|66333432|FG001|Overall Study|Physician Decision|0|||
23524730|NCT00842348|65661591|FG001|Study 729|Surgical resection|0|||
23524731|NCT04244786|65661592|FG000|Overall Study|Adverse Event|0|||
23715314|NCT01413542|66333433|FG002|Overall Study|Physician Decision|3|||
23715315|NCT01413542|66333434|FG003|Overall Study|Physician Decision|0|||
23715316|NCT01413542|66333431|FG000|Overall Study|Adverse Event|0|||
23715317|NCT01413542|66333432|FG001|Overall Study|Adverse Event|0|||
23715318|NCT01413542|66333433|FG002|Overall Study|Adverse Event|0|||
23715319|NCT01413542|66333434|FG003|Overall Study|Adverse Event|1|||
23715320|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
23715321|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
23715322|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
23715323|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
23715324|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23715325|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
23715326|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
23715327|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
23715328|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
23715329|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
23715330|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
23715331|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
23715332|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
23715333|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
23715334|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
23715335|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
23715336|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23715337|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23715338|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
23715339|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
23715340|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
23715341|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23715342|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23715343|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23715344|NCT01106625|66333440|FG000|Core Period: Baseline to Week 26|Other|8|||
23715345|NCT01106625|66333441|FG001|Core Period: Baseline to Week 26|Other|7|||
23715346|NCT01106625|66333442|FG002|Core Period: Baseline to Week 26|Other|4|||
23715347|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23715348|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23715349|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
23715350|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23715351|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
23715352|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23715353|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23715354|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23715355|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23715356|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23715357|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23715358|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23715359|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
23715360|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23715361|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23715362|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
23417049|NCT01814878|65271416|FG001|Overall Study|Other|0|||
23812656|NCT03400943|66695990|FG000|Treatment Period 1|Adverse Event|0|||
23812657|NCT03400943|66695991|FG001|Treatment Period 1|Adverse Event|0|||
23812658|NCT03400943|66695992|FG002|Treatment Period 1|Adverse Event|0|||
23812659|NCT03400943|66695993|FG003|Treatment Period 1|Adverse Event|1|||
23812660|NCT03400943|66695990|FG000|Treatment Period 1|Lost to Follow-up|1|||
23812661|NCT03400943|66695991|FG001|Treatment Period 1|Lost to Follow-up|0|||
23812662|NCT03400943|66695992|FG002|Treatment Period 1|Lost to Follow-up|0|||
23715363|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
23812663|NCT03400943|66695993|FG003|Treatment Period 1|Lost to Follow-up|0|||
23812664|NCT03400943|66695990|FG000|Treatment Period 1|Protocol Violation|0|||
23812665|NCT03400943|66695991|FG001|Treatment Period 1|Protocol Violation|1|||
23812666|NCT03400943|66695992|FG002|Treatment Period 1|Protocol Violation|1|||
23812667|NCT03400943|66695993|FG003|Treatment Period 1|Protocol Violation|0|||
23812668|NCT03400943|66695990|FG000|Treatment Period 1|Study terminated by sponsor|2|||
23812669|NCT03400943|66695991|FG001|Treatment Period 1|Study terminated by sponsor|0|||
23812670|NCT03400943|66695992|FG002|Treatment Period 1|Study terminated by sponsor|0|||
23812671|NCT03400943|66695993|FG003|Treatment Period 1|Study terminated by sponsor|1|||
23812672|NCT03400943|66695990|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23812673|NCT03400943|66695991|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23812674|NCT03400943|66695992|FG002|Treatment Period 1|Withdrawal by Subject|3|||
23812675|NCT03400943|66695993|FG003|Treatment Period 1|Withdrawal by Subject|1|||
23812676|NCT03400943|66695990|FG000|Treatment Period 1|Other|2|||
23812677|NCT03400943|66695991|FG001|Treatment Period 1|Other|1|||
23812678|NCT03400943|66695992|FG002|Treatment Period 1|Other|2|||
23812679|NCT03400943|66695993|FG003|Treatment Period 1|Other|2|||
23812680|NCT03400943|66695990|FG000|Post-treatment Period 1|Adverse Event|2|||
23812681|NCT03400943|66695991|FG001|Post-treatment Period 1|Adverse Event|0|||
23524732|NCT04244786|65661593|FG001|Overall Study|Adverse Event|0|||
23715364|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
23715365|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23715366|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23715367|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23715368|NCT01106625|66333440|FG000|Extension Period: Week 26 to Week 52|Other|5|||
23715369|NCT01106625|66333441|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23715370|NCT01106625|66333442|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23715371|NCT01700985|66333443|FG000|Overall Study|Incarcerated|0|||
23715372|NCT01700985|66333444|FG001|Overall Study|Incarcerated|1|||
23715373|NCT01151540|66333448|FG000|Overall Study|Other|2|||
23715374|NCT01151540|66333448|FG000|Overall Study|Adverse event, non-fatal|4|||
23715375|NCT01151540|66333448|FG000|Overall Study|Withdrawal by Subject|7|||
23715376|NCT01681576|66333449|FG000|Period 1|Adverse Event|1|||
23715377|NCT01681576|66333450|FG001|Period 1|Adverse Event|0|||
23715378|NCT01681576|66333449|FG000|Period 1|Protocol Deviation|1|||
23715379|NCT01681576|66333450|FG001|Period 1|Protocol Deviation|0|||
23715380|NCT01681576|66333449|FG000|Period 2|subject/guardian decision|3|||
23715381|NCT01681576|66333450|FG001|Period 2|subject/guardian decision|1|||
23715382|NCT01681576|66333449|FG000|Period 2|Non-compliance with study treatment|1|||
23715383|NCT01681576|66333450|FG001|Period 2|Non-compliance with study treatment|0|||
23715384|NCT01230749|66333454|FG000|Overall Study|Adverse Event|0|||
23715385|NCT01230749|66333455|FG001|Overall Study|Adverse Event|0|||
23715386|NCT01230749|66333456|FG002|Overall Study|Adverse Event|0|||
23715387|NCT01230749|66333457|FG003|Overall Study|Adverse Event|1|||
23715388|NCT01230749|66333454|FG000|Overall Study|Physician Decision|0|||
23715389|NCT01230749|66333455|FG001|Overall Study|Physician Decision|0|||
23715390|NCT01230749|66333456|FG002|Overall Study|Physician Decision|1|||
23715391|NCT01230749|66333457|FG003|Overall Study|Physician Decision|0|||
23715392|NCT01230749|66333454|FG000|Overall Study|Withdrawal by Subject|0|||
23812682|NCT03400943|66695992|FG002|Post-treatment Period 1|Adverse Event|0|||
23812683|NCT03400943|66695993|FG003|Post-treatment Period 1|Adverse Event|0|||
23812684|NCT03400943|66695990|FG000|Post-treatment Period 1|Protocol Violation|1|||
23812685|NCT03400943|66695991|FG001|Post-treatment Period 1|Protocol Violation|0|||
23812686|NCT03400943|66695992|FG002|Post-treatment Period 1|Protocol Violation|0|||
23715393|NCT01230749|66333455|FG001|Overall Study|Withdrawal by Subject|1|||
23812687|NCT03400943|66695993|FG003|Post-treatment Period 1|Protocol Violation|0|||
23524733|NCT04244786|65661594|FG002|Overall Study|Adverse Event|2|||
23715394|NCT01230749|66333456|FG002|Overall Study|Withdrawal by Subject|0|||
23417050|NCT00778375|65271425|FG000|Overall Study|Ineligible|3|||
23715395|NCT01230749|66333457|FG003|Overall Study|Withdrawal by Subject|0|||
23715396|NCT01230749|66333454|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
23715397|NCT01230749|66333455|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23715398|NCT01230749|66333456|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23715399|NCT01230749|66333457|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23715400|NCT02338492|66333458|FG000|Overall Study|Death|32|||
23715401|NCT02338492|66333458|FG000|Overall Study|Adverse Event|3|||
23715402|NCT02338492|66333458|FG000|Overall Study|Lost to Follow-up|4|||
23715403|NCT02338492|66333458|FG000|Overall Study|Reason not captured above|6|||
23524734|NCT04244786|65661592|FG000|Overall Study|Withdrawal by Subject|0|||
23715404|NCT01164865|66333459|FG000|Overall Study|Lost to Follow-up|2|||
23715405|NCT01164865|66333460|FG001|Overall Study|Lost to Follow-up|1|||
23715406|NCT00729326|66333461|FG000|Overall Study|Lost to Follow-up|2|||
23715407|NCT00729326|66333462|FG001|Overall Study|Lost to Follow-up|0|||
23715408|NCT00729326|66333461|FG000|Overall Study|Physician Decision|0|||
23715409|NCT00729326|66333462|FG001|Overall Study|Physician Decision|1|||
23812688|NCT03400943|66695990|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
23812689|NCT03400943|66695991|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
23812690|NCT03400943|66695992|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
23812691|NCT03400943|66695993|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
23812692|NCT03400943|66695990|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
23812693|NCT03400943|66695991|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
23812694|NCT03400943|66695992|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
23812695|NCT03400943|66695993|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
23715410|NCT00729326|66333461|FG000|Overall Study|Protocol Violation|3|||
23715411|NCT00729326|66333462|FG001|Overall Study|Protocol Violation|2|||
23812696|NCT03400943|66695990|FG000|Post-treatment Period 1|Other|2|||
23812697|NCT03400943|66695991|FG001|Post-treatment Period 1|Other|0|||
23812698|NCT03400943|66695992|FG002|Post-treatment Period 1|Other|4|||
23524735|NCT04244786|65661593|FG001|Overall Study|Withdrawal by Subject|0|||
23524736|NCT04244786|65661594|FG002|Overall Study|Withdrawal by Subject|5|||
23524737|NCT00419562|65661595|FG000|Overall Study|Lost to Follow-up|12|||
23715412|NCT00729326|66333461|FG000|Overall Study|Subject Decision|4|||
23715413|NCT00729326|66333462|FG001|Overall Study|Subject Decision|4|||
23715414|NCT00729326|66333461|FG000|Overall Study|Sponsor Decision|1|||
23715415|NCT00729326|66333462|FG001|Overall Study|Sponsor Decision|2|||
23715416|NCT00892957|66333463|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
23715417|NCT00892957|66333464|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
23715418|NCT00892957|66333463|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
23715419|NCT00892957|66333464|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
23715420|NCT00853489|66333465|FG000|Overall Study|Lost to Follow-up|5|||
23715421|NCT00853489|66333466|FG001|Overall Study|Lost to Follow-up|2|||
23715422|NCT00555906|66333467|FG000|Phase 1|Objective Progression or Relapse|3|||
23715423|NCT00555906|66333468|FG001|Phase 1|Objective Progression or Relapse|5|||
23715424|NCT00555906|66333469|FG002|Phase 1|Objective Progression or Relapse|3|||
23715425|NCT00555906|66333470|FG003|Phase 1|Objective Progression or Relapse|1|||
23715426|NCT00555906|66333471|FG004|Phase 1|Objective Progression or Relapse|0|||
23715427|NCT00555906|66333467|FG000|Phase 1|Global Deterioration of Health Status|0|||
23715428|NCT00555906|66333468|FG001|Phase 1|Global Deterioration of Health Status|1|||
23715429|NCT00555906|66333469|FG002|Phase 1|Global Deterioration of Health Status|1|||
23715430|NCT00555906|66333470|FG003|Phase 1|Global Deterioration of Health Status|1|||
23715431|NCT00555906|66333471|FG004|Phase 1|Global Deterioration of Health Status|0|||
23715432|NCT00555906|66333467|FG000|Phase 1|Adverse Event|0|||
23715433|NCT00555906|66333468|FG001|Phase 1|Adverse Event|0|||
23715434|NCT00555906|66333469|FG002|Phase 1|Adverse Event|3|||
23715435|NCT00555906|66333470|FG003|Phase 1|Adverse Event|2|||
23715436|NCT00555906|66333471|FG004|Phase 1|Adverse Event|0|||
23715437|NCT00555906|66333467|FG000|Phase 1|Withdrawal by Subject|0|||
23715438|NCT00555906|66333468|FG001|Phase 1|Withdrawal by Subject|0|||
23715439|NCT00555906|66333469|FG002|Phase 1|Withdrawal by Subject|0|||
23715440|NCT00555906|66333470|FG003|Phase 1|Withdrawal by Subject|1|||
23812699|NCT03400943|66695993|FG003|Post-treatment Period 1|Other|5|||
23812700|NCT03400943|66695990|FG000|Treatment Period 2|Study terminated by sponsor|0|||
23715441|NCT00555906|66333471|FG004|Phase 1|Withdrawal by Subject|0|||
23715442|NCT00555906|66333467|FG000|Phase 2|Adverse Event|0|||
23715443|NCT00555906|66333468|FG001|Phase 2|Adverse Event|0|||
23715444|NCT00555906|66333469|FG002|Phase 2|Adverse Event|0|||
23715445|NCT00555906|66333470|FG003|Phase 2|Adverse Event|0|||
23715446|NCT00555906|66333471|FG004|Phase 2|Adverse Event|4|||
23715447|NCT00555906|66333467|FG000|Phase 2|Global Deterioration of Health Status|0|||
23812701|NCT03400943|66695991|FG001|Treatment Period 2|Study terminated by sponsor|1|||
23812702|NCT03400943|66695992|FG002|Treatment Period 2|Study terminated by sponsor|0|||
23715448|NCT00555906|66333468|FG001|Phase 2|Global Deterioration of Health Status|0|||
23715449|NCT00555906|66333469|FG002|Phase 2|Global Deterioration of Health Status|0|||
23715450|NCT00555906|66333470|FG003|Phase 2|Global Deterioration of Health Status|0|||
23715451|NCT00555906|66333471|FG004|Phase 2|Global Deterioration of Health Status|2|||
23715452|NCT00555906|66333467|FG000|Phase 2|Objective Progression or Relapse|0|||
23715453|NCT00555906|66333468|FG001|Phase 2|Objective Progression or Relapse|0|||
23715454|NCT00555906|66333469|FG002|Phase 2|Objective Progression or Relapse|0|||
23715455|NCT00555906|66333470|FG003|Phase 2|Objective Progression or Relapse|0|||
23715456|NCT00555906|66333471|FG004|Phase 2|Objective Progression or Relapse|16|||
23715457|NCT00555906|66333467|FG000|Phase 2|Withdrawal by Subject|0|||
23715458|NCT00555906|66333468|FG001|Phase 2|Withdrawal by Subject|0|||
23715459|NCT00555906|66333469|FG002|Phase 2|Withdrawal by Subject|0|||
23715460|NCT00555906|66333470|FG003|Phase 2|Withdrawal by Subject|0|||
23715461|NCT00555906|66333471|FG004|Phase 2|Withdrawal by Subject|2|||
23715462|NCT00555906|66333467|FG000|Phase 2|Other|0|||
23715463|NCT00555906|66333468|FG001|Phase 2|Other|0|||
23715464|NCT00555906|66333469|FG002|Phase 2|Other|0|||
23715465|NCT00555906|66333470|FG003|Phase 2|Other|0|||
23715466|NCT00555906|66333471|FG004|Phase 2|Other|6|||
23715467|NCT00555906|66333467|FG000|Phase 2|Randomized but not Treated|0|||
23715468|NCT00555906|66333468|FG001|Phase 2|Randomized but not Treated|0|||
23715469|NCT00555906|66333469|FG002|Phase 2|Randomized but not Treated|0|||
23715470|NCT00555906|66333470|FG003|Phase 2|Randomized but not Treated|0|||
23715471|NCT00555906|66333471|FG004|Phase 2|Randomized but not Treated|2|||
23715472|NCT00668200|66333472|FG000|Overall Study|Withdrawal by Subject|2|||
23715473|NCT00668200|66333472|FG000|Overall Study|Lost to Follow-up|1|||
23715474|NCT00817206|66333473|FG000|Overall Study|Adverse Event|10|||
23715475|NCT00817206|66333474|FG001|Overall Study|Adverse Event|3|||
23715476|NCT00817206|66333473|FG000|Overall Study|Protocol Violation|0|||
23715477|NCT00817206|66333474|FG001|Overall Study|Protocol Violation|2|||
23715478|NCT00817206|66333473|FG000|Overall Study|Lost to Follow-up|0|||
23715479|NCT00817206|66333474|FG001|Overall Study|Lost to Follow-up|1|||
23715480|NCT00817206|66333473|FG000|Overall Study|Death|2|||
23715481|NCT00817206|66333474|FG001|Overall Study|Death|0|||
23715482|NCT00817206|66333473|FG000|Overall Study|Withdrawal by Subject|7|||
23715483|NCT00817206|66333474|FG001|Overall Study|Withdrawal by Subject|3|||
23715484|NCT00817206|66333473|FG000|Overall Study|Physician Decision|2|||
23715485|NCT00817206|66333474|FG001|Overall Study|Physician Decision|0|||
23715486|NCT01120379|66333475|FG000|One Year Timepoint|Withdrawal by Subject|41|||
23715487|NCT01120379|66333475|FG000|One Year Timepoint|Lost to Follow-up|115|||
23715488|NCT01120379|66333475|FG000|One Year Timepoint|Death|108|||
23715489|NCT01120379|66333475|FG000|One Year Timepoint|Physician Decision|9|||
23715490|NCT01120379|66333475|FG000|One Year Timepoint|Any other reason for early termination|5|||
23715491|NCT01120379|66333475|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
23715492|NCT01120379|66333475|FG000|Two Year Timepoint|Lost to Follow-up|87|||
23715493|NCT01120379|66333475|FG000|Two Year Timepoint|Death|123|||
23715494|NCT01120379|66333475|FG000|Two Year Timepoint|Physician Decision|12|||
23715495|NCT01120379|66333475|FG000|Two Year Timepoint|Any other reason for early termination|4|||
23715496|NCT01120379|66333475|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
23715497|NCT01120379|66333475|FG000|Three Year Timepoint|Lost to Follow-up|43|||
23715498|NCT01120379|66333475|FG000|Three Year Timepoint|Death|120|||
23715499|NCT01120379|66333475|FG000|Three Year Timepoint|Physician Decision|9|||
23715500|NCT01120379|66333475|FG000|Three Year Timepoint|Any other reason for early termination|17|||
23715501|NCT01120379|66333475|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
23812703|NCT03400943|66695993|FG003|Treatment Period 2|Study terminated by sponsor|0|||
23812704|NCT03400943|66695990|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23812705|NCT03400943|66695991|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23812706|NCT03400943|66695992|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23812707|NCT03400943|66695993|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23812708|NCT03400943|66695990|FG000|Treatment Period 2|Other|1|||
23715502|NCT01120379|66333475|FG000|Four Year Timepoint|Lost to Follow-up|10|||
23715503|NCT01120379|66333475|FG000|Four Year Timepoint|Death|131|||
23812709|NCT03400943|66695991|FG001|Treatment Period 2|Other|6|||
23715504|NCT01120379|66333475|FG000|Four Year Timepoint|Physician Decision|5|||
23715505|NCT01120379|66333475|FG000|Four Year Timepoint|Any other reason for early termination|217|||
23715506|NCT03655717|66333476|FG000|Overall Study|Withdrawal by Subject|4|||
23524738|NCT00419562|65661596|FG001|Overall Study|Lost to Follow-up|13|||
23715507|NCT03655717|66333477|FG001|Overall Study|Withdrawal by Subject|8|||
23715508|NCT03655717|66333478|FG002|Overall Study|Withdrawal by Subject|1|||
23715509|NCT03655717|66333479|FG003|Overall Study|Withdrawal by Subject|0|||
23715510|NCT03655717|66333480|FG004|Overall Study|Withdrawal by Subject|0|||
23715511|NCT03655717|66333481|FG005|Overall Study|Withdrawal by Subject|1|||
23715512|NCT03655717|66333482|FG006|Overall Study|Withdrawal by Subject|3|||
23715513|NCT03655717|66333483|FG007|Overall Study|Withdrawal by Subject|1|||
23715514|NCT03655717|66333484|FG008|Overall Study|Withdrawal by Subject|2|||
23715515|NCT03655717|66333485|FG009|Overall Study|Withdrawal by Subject|0|||
23715516|NCT03655717|66333486|FG010|Overall Study|Withdrawal by Subject|0|||
23715517|NCT03655717|66333487|FG011|Overall Study|Withdrawal by Subject|1|||
23715518|NCT03655717|66333488|FG012|Overall Study|Withdrawal by Subject|0|||
23715519|NCT03655717|66333489|FG013|Overall Study|Withdrawal by Subject|3|||
23715520|NCT03655717|66333490|FG014|Overall Study|Withdrawal by Subject|0|||
23715521|NCT03655717|66333491|FG015|Overall Study|Withdrawal by Subject|1|||
23715522|NCT03655717|66333492|FG016|Overall Study|Withdrawal by Subject|0|||
23715523|NCT03655717|66333493|FG017|Overall Study|Withdrawal by Subject|0|||
23715524|NCT03655717|66333494|FG018|Overall Study|Withdrawal by Subject|1|||
23715525|NCT03655717|66333495|FG019|Overall Study|Withdrawal by Subject|0|||
23715526|NCT03655717|66333496|FG020|Overall Study|Withdrawal by Subject|0|||
23715527|NCT03655717|66333497|FG021|Overall Study|Withdrawal by Subject|1|||
23417051|NCT00098748|65271426|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
23417052|NCT00098748|65271427|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
23417053|NCT00098748|65271428|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
23417054|NCT00098748|65271426|FG000|Received Study Treatment|Death|2|||
23417055|NCT00098748|65271427|FG001|Received Study Treatment|Death|1|||
23417056|NCT00098748|65271428|FG002|Received Study Treatment|Death|2|||
23417057|NCT00098748|65271426|FG000|Received Study Treatment|Adverse Event|1|||
23417058|NCT00098748|65271427|FG001|Received Study Treatment|Adverse Event|2|||
23417059|NCT00098748|65271428|FG002|Received Study Treatment|Adverse Event|5|||
23417060|NCT00098748|65271426|FG000|Received Study Treatment|Lack of Efficacy|40|||
23417061|NCT00098748|65271427|FG001|Received Study Treatment|Lack of Efficacy|27|||
23417062|NCT00098748|65271428|FG002|Received Study Treatment|Lack of Efficacy|27|||
23417063|NCT00098748|65271426|FG000|Received Study Treatment|Other|2|||
23417064|NCT00098748|65271427|FG001|Received Study Treatment|Other|2|||
23417065|NCT00098748|65271428|FG002|Received Study Treatment|Other|6|||
23417066|NCT00098748|65271426|FG000|Received Study Treatment|Subject defaulted|3|||
23417067|NCT00098748|65271427|FG001|Received Study Treatment|Subject defaulted|4|||
23417068|NCT00098748|65271428|FG002|Received Study Treatment|Subject defaulted|4|||
23417069|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
23417070|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
23417071|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
23417072|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
23715528|NCT03655717|66333498|FG022|Overall Study|Withdrawal by Subject|2|||
23715529|NCT03655717|66333499|FG023|Overall Study|Withdrawal by Subject|1|||
23417073|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
23417074|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
23417075|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
23417076|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
23417077|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
23417078|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
23417079|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
23417080|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
23417081|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
23417082|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
23417083|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
23417084|NCT01519791|65271429|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
23524739|NCT00419562|65661595|FG000|Overall Study|Withdrawal by Subject|20|||
23524740|NCT00419562|65661596|FG001|Overall Study|Withdrawal by Subject|18|||
23524741|NCT00419562|65661595|FG000|Overall Study|Participant Institutionalized|1|||
23524742|NCT00419562|65661596|FG001|Overall Study|Participant Institutionalized|0|||
23524743|NCT01557400|65661597|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
23524744|NCT01557400|65661597|FG000|Overall Study|Adverse Event|3|||
23715530|NCT03655717|66333500|FG024|Overall Study|Withdrawal by Subject|1|||
23715531|NCT03655717|66333501|FG025|Overall Study|Withdrawal by Subject|0|||
23715532|NCT03655717|66333476|FG000|Overall Study|Physician Decision|3|||
23715533|NCT03655717|66333477|FG001|Overall Study|Physician Decision|3|||
23715534|NCT03655717|66333478|FG002|Overall Study|Physician Decision|0|||
23417085|NCT01519791|65271430|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
23417086|NCT01519791|65271429|FG000|Overall Study|Protocol Violation|6|||
23417087|NCT01519791|65271430|FG001|Overall Study|Protocol Violation|19|||
23417088|NCT01519791|65271429|FG000|Overall Study|Other Reason|87|||
23417089|NCT01519791|65271430|FG001|Overall Study|Other Reason|222|||
23417090|NCT01519791|65271429|FG000|Overall Study|subjects randomized in error|2|||
23417091|NCT01519791|65271430|FG001|Overall Study|subjects randomized in error|0|||
23524745|NCT01557400|65661597|FG000|Overall Study|Lost to Follow-up|5|||
23715535|NCT03655717|66333479|FG003|Overall Study|Physician Decision|0|||
23812710|NCT03400943|66695992|FG002|Treatment Period 2|Other|0|||
23812711|NCT03400943|66695993|FG003|Treatment Period 2|Other|0|||
23715536|NCT03655717|66333480|FG004|Overall Study|Physician Decision|0|||
23715537|NCT03655717|66333481|FG005|Overall Study|Physician Decision|0|||
23715538|NCT03655717|66333482|FG006|Overall Study|Physician Decision|0|||
23715539|NCT03655717|66333483|FG007|Overall Study|Physician Decision|0|||
23715540|NCT03655717|66333484|FG008|Overall Study|Physician Decision|0|||
23715541|NCT03655717|66333485|FG009|Overall Study|Physician Decision|1|||
23715542|NCT03655717|66333486|FG010|Overall Study|Physician Decision|0|||
23715543|NCT03655717|66333487|FG011|Overall Study|Physician Decision|0|||
23715544|NCT03655717|66333488|FG012|Overall Study|Physician Decision|0|||
23715545|NCT03655717|66333489|FG013|Overall Study|Physician Decision|0|||
23417092|NCT01519791|65271429|FG000|Overall Study|Lack of Efficacy|16|||
23417093|NCT01519791|65271430|FG001|Overall Study|Lack of Efficacy|20|||
23417094|NCT01519791|65271429|FG000|Overall Study|SAE, non-fatal|6|||
23417095|NCT01519791|65271430|FG001|Overall Study|SAE, non-fatal|22|||
23417096|NCT01519791|65271429|FG000|Overall Study|AE, serious fatal|0|||
23417097|NCT01519791|65271430|FG001|Overall Study|AE, serious fatal|1|||
23417098|NCT01519791|65271429|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
23417099|NCT01519791|65271430|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
23417100|NCT01519791|65271429|FG000|Overall Study|AE, non-serious non-fatal|12|||
23417101|NCT01519791|65271430|FG001|Overall Study|AE, non-serious non-fatal|31|||
23417102|NCT01519791|65271429|FG000|Overall Study|Withdrawal by Subject|15|||
23417103|NCT01519791|65271430|FG001|Overall Study|Withdrawal by Subject|37|||
23417104|NCT01519791|65271429|FG000|Overall Study|Lost to Follow-up|6|||
23417105|NCT01519791|65271430|FG001|Overall Study|Lost to Follow-up|14|||
23417106|NCT04115748|65271438|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
23417107|NCT04115748|65271439|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
23417108|NCT04115748|65271440|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
23417109|NCT04115748|65271441|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
23417110|NCT04115748|65271442|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417111|NCT04115748|65271443|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417112|NCT04115748|65271444|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417113|NCT04115748|65271445|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417114|NCT04115748|65271446|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417115|NCT04115748|65271447|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417116|NCT04115748|65271438|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417117|NCT04115748|65271439|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417118|NCT04115748|65271440|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417119|NCT04115748|65271441|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
23417120|NCT04115748|65271442|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417121|NCT04115748|65271443|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417122|NCT04115748|65271444|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417123|NCT04115748|65271445|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417124|NCT04115748|65271446|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417125|NCT04115748|65271447|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417126|NCT04115748|65271438|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417127|NCT04115748|65271439|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417128|NCT04115748|65271440|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417129|NCT04115748|65271441|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417130|NCT04115748|65271442|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
23417131|NCT04115748|65271443|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
23417132|NCT04115748|65271444|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417133|NCT04115748|65271445|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417134|NCT04115748|65271446|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417135|NCT04115748|65271447|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
23417136|NCT04115748|65271438|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417137|NCT04115748|65271439|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417138|NCT04115748|65271440|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417139|NCT04115748|65271441|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417140|NCT04115748|65271442|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417141|NCT04115748|65271443|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417142|NCT04115748|65271444|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417143|NCT04115748|65271445|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417144|NCT04115748|65271446|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
23417145|NCT04115748|65271447|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417146|NCT01106651|65271452|FG000|Overall Study|Adverse Event|17|||
23715546|NCT03655717|66333490|FG014|Overall Study|Physician Decision|0|||
23715547|NCT03655717|66333491|FG015|Overall Study|Physician Decision|0|||
23715548|NCT03655717|66333492|FG016|Overall Study|Physician Decision|0|||
23715549|NCT03655717|66333493|FG017|Overall Study|Physician Decision|0|||
23715550|NCT03655717|66333494|FG018|Overall Study|Physician Decision|0|||
23715551|NCT03655717|66333495|FG019|Overall Study|Physician Decision|1|||
23715552|NCT03655717|66333496|FG020|Overall Study|Physician Decision|0|||
23417147|NCT01106651|65271453|FG001|Overall Study|Adverse Event|9|||
23417148|NCT01106651|65271454|FG002|Overall Study|Adverse Event|23|||
23417149|NCT01106651|65271452|FG000|Overall Study|Lost to Follow-up|8|||
23417150|NCT01106651|65271453|FG001|Overall Study|Lost to Follow-up|2|||
23417151|NCT01106651|65271454|FG002|Overall Study|Lost to Follow-up|6|||
23417152|NCT01106651|65271452|FG000|Overall Study|Physician Decision|4|||
23417153|NCT01106651|65271453|FG001|Overall Study|Physician Decision|3|||
23417154|NCT01106651|65271454|FG002|Overall Study|Physician Decision|1|||
23417155|NCT01106651|65271452|FG000|Overall Study|Protocol Violation|1|||
23417156|NCT01106651|65271453|FG001|Overall Study|Protocol Violation|2|||
23417157|NCT01106651|65271454|FG002|Overall Study|Protocol Violation|1|||
23417158|NCT01106651|65271452|FG000|Overall Study|Withdrawal by Subject|14|||
23417159|NCT01106651|65271453|FG001|Overall Study|Withdrawal by Subject|7|||
23417160|NCT01106651|65271454|FG002|Overall Study|Withdrawal by Subject|4|||
23417161|NCT01106651|65271452|FG000|Overall Study|Noncompliance with study drug|1|||
23417162|NCT01106651|65271453|FG001|Overall Study|Noncompliance with study drug|0|||
23417163|NCT01106651|65271454|FG002|Overall Study|Noncompliance with study drug|2|||
23417164|NCT01106651|65271452|FG000|Overall Study|Other|34|||
23715553|NCT03655717|66333497|FG021|Overall Study|Physician Decision|0|||
23715554|NCT03655717|66333498|FG022|Overall Study|Physician Decision|0|||
23715555|NCT03655717|66333499|FG023|Overall Study|Physician Decision|1|||
23715556|NCT03655717|66333500|FG024|Overall Study|Physician Decision|0|||
23715557|NCT03655717|66333501|FG025|Overall Study|Physician Decision|0|||
23715558|NCT03655717|66333476|FG000|Overall Study|Lost to Follow-up|3|||
23715559|NCT03655717|66333477|FG001|Overall Study|Lost to Follow-up|1|||
23715560|NCT03655717|66333478|FG002|Overall Study|Lost to Follow-up|0|||
23715561|NCT03655717|66333479|FG003|Overall Study|Lost to Follow-up|1|||
23715562|NCT03655717|66333480|FG004|Overall Study|Lost to Follow-up|0|||
23715563|NCT03655717|66333481|FG005|Overall Study|Lost to Follow-up|1|||
23715564|NCT03655717|66333482|FG006|Overall Study|Lost to Follow-up|0|||
23812712|NCT03400943|66695990|FG000|Follow-up Period|Withdrawal by Subject|1|||
23812713|NCT03400943|66695991|FG001|Follow-up Period|Withdrawal by Subject|0|||
23715565|NCT03655717|66333483|FG007|Overall Study|Lost to Follow-up|0|||
23715566|NCT03655717|66333484|FG008|Overall Study|Lost to Follow-up|0|||
23715567|NCT03655717|66333485|FG009|Overall Study|Lost to Follow-up|0|||
23715568|NCT03655717|66333486|FG010|Overall Study|Lost to Follow-up|0|||
23812714|NCT03400943|66695992|FG002|Follow-up Period|Withdrawal by Subject|0|||
23812715|NCT03400943|66695993|FG003|Follow-up Period|Withdrawal by Subject|0|||
23812716|NCT01070771|66695997|FG000|Overall Study|Adverse Event|2|||
23812717|NCT01070771|66695997|FG000|Overall Study|Protocol Violation|1|||
23812718|NCT03858634|66695998|FG000|Overall Study|Withdrawal by Subject|1|||
23812719|NCT03858634|66695999|FG001|Overall Study|Withdrawal by Subject|0|||
23812720|NCT03858634|66695998|FG000|Overall Study|Adverse Event|1|||
23812721|NCT03858634|66695999|FG001|Overall Study|Adverse Event|0|||
23812722|NCT03858634|66695998|FG000|Overall Study|Lost to Follow-up|0|||
23812723|NCT03858634|66695999|FG001|Overall Study|Lost to Follow-up|1|||
23812724|NCT03858634|66695998|FG000|Overall Study|Other, Not Specified|1|||
23812725|NCT03858634|66695999|FG001|Overall Study|Other, Not Specified|1|||
23812726|NCT00574912|66696000|FG000|Overall Study|Could not place IV lines.|3|||
23812727|NCT00574912|66696000|FG000|Overall Study|scheduling conflicts|3|||
23812728|NCT00574912|66696000|FG000|Overall Study|Physician Decision|2|||
23812729|NCT04280705|66696001|FG000|Overall Study|Enrolled but not treated|4|||
23812730|NCT04280705|66696002|FG001|Overall Study|Enrolled but not treated|10|||
23812731|NCT04280705|66696001|FG000|Overall Study|Physician Decision|1|||
23812732|NCT04280705|66696002|FG001|Overall Study|Physician Decision|0|||
23812733|NCT04280705|66696001|FG000|Overall Study|Withdrawal by Subject|7|||
23812734|NCT04280705|66696002|FG001|Overall Study|Withdrawal by Subject|9|||
23812735|NCT04280705|66696001|FG000|Overall Study|Adverse Event|0|||
23812736|NCT04280705|66696002|FG001|Overall Study|Adverse Event|4|||
23812737|NCT04280705|66696001|FG000|Overall Study|Transferred to another hospital|1|||
23812738|NCT04280705|66696002|FG001|Overall Study|Transferred to another hospital|1|||
23812739|NCT01671332|66696003|FG000|Overall Study|Withdrawal by Subject|1|||
23812740|NCT01671332|66696004|FG001|Overall Study|Withdrawal by Subject|1|||
23715569|NCT03655717|66333487|FG011|Overall Study|Lost to Follow-up|1|||
23715570|NCT03655717|66333488|FG012|Overall Study|Lost to Follow-up|0|||
23715571|NCT03655717|66333489|FG013|Overall Study|Lost to Follow-up|0|||
23812741|NCT02492880|66696005|FG000|Overall Study|Lost to Follow-up|1|||
23417165|NCT01106651|65271453|FG001|Overall Study|Other|31|||
23417166|NCT01106651|65271454|FG002|Overall Study|Other|21|||
23417167|NCT01106651|65271452|FG000|Overall Study|Death|0|||
23417168|NCT01106651|65271453|FG001|Overall Study|Death|3|||
23417169|NCT01106651|65271454|FG002|Overall Study|Death|0|||
23417170|NCT04187144|65271455|FG000|Overall Study|Lost to Follow-up|12|||
23715572|NCT03655717|66333490|FG014|Overall Study|Lost to Follow-up|0|||
23417171|NCT04187144|65271456|FG001|Overall Study|Lost to Follow-up|11|||
23715573|NCT03655717|66333491|FG015|Overall Study|Lost to Follow-up|0|||
23715574|NCT03655717|66333492|FG016|Overall Study|Lost to Follow-up|0|||
23812742|NCT02492880|66696005|FG000|Overall Study|Protocol Violation|1|||
23812743|NCT02447744|66696006|FG000|Overall Study|Withdrawal by Subject|3|||
23812744|NCT02447744|66696007|FG001|Overall Study|Withdrawal by Subject|1|||
23812745|NCT02447744|66696006|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
23812746|NCT02447744|66696007|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
23812747|NCT01523457|66696011|FG000|Overall Study|Withdrawal by Subject|7|||
23812748|NCT01523457|66696012|FG001|Overall Study|Withdrawal by Subject|2|||
23812749|NCT01372774|66696013|FG000|Overall Study|Withdrawal prior to treatment|4|||
23812750|NCT01372774|66696014|FG001|Overall Study|Withdrawal prior to treatment|5|||
23812751|NCT03768726|66696017|FG000|Treatment Phase|Adverse Event|2|||
23812752|NCT03768726|66696018|FG001|Treatment Phase|Adverse Event|2|||
23812753|NCT03768726|66696017|FG000|Treatment Phase|Lost to Follow-up|1|||
23812754|NCT03768726|66696018|FG001|Treatment Phase|Lost to Follow-up|0|||
23812755|NCT03768726|66696017|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
23812756|NCT03768726|66696018|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
23417172|NCT04187144|65271455|FG000|Overall Study|Withdrawal by Subject|20|||
23417173|NCT04187144|65271456|FG001|Overall Study|Withdrawal by Subject|18|||
23524746|NCT01557400|65661597|FG000|Overall Study|Withdrawal by Subject|9|||
23524747|NCT02027844|65661598|FG000|Overall Study|Withdrawal by Subject|3|||
23524748|NCT02027844|65661599|FG001|Overall Study|Withdrawal by Subject|2|||
23524749|NCT02027844|65661600|FG002|Overall Study|Withdrawal by Subject|1|||
23524750|NCT02027844|65661598|FG000|Overall Study|Lost to Follow-up|0|||
23524751|NCT02027844|65661599|FG001|Overall Study|Lost to Follow-up|2|||
23524752|NCT02027844|65661600|FG002|Overall Study|Lost to Follow-up|1|||
23524753|NCT02027844|65661598|FG000|Overall Study|Protocol Violation|0|||
23524754|NCT02027844|65661599|FG001|Overall Study|Protocol Violation|2|||
23524755|NCT02027844|65661600|FG002|Overall Study|Protocol Violation|0|||
23524756|NCT02027844|65661598|FG000|Overall Study|Incomlete data|2|||
23524757|NCT02027844|65661599|FG001|Overall Study|Incomlete data|0|||
23524758|NCT02027844|65661600|FG002|Overall Study|Incomlete data|0|||
23524759|NCT02658890|65661603|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524760|NCT02658890|65661604|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524761|NCT02658890|65661605|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524762|NCT02658890|65661606|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524763|NCT02658890|65661607|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524764|NCT02658890|65661608|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524765|NCT02658890|65661609|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524766|NCT02658890|65661610|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524767|NCT02658890|65661611|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23524768|NCT02658890|65661612|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524769|NCT02658890|65661613|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524770|NCT02658890|65661614|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524771|NCT02658890|65661615|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524772|NCT02658890|65661616|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524773|NCT02658890|65661617|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524774|NCT02658890|65661618|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524775|NCT02658890|65661619|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524776|NCT02658890|65661620|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524777|NCT02658890|65661621|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524778|NCT02658890|65661622|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524779|NCT02658890|65661623|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524780|NCT02658890|65661624|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524781|NCT02658890|65661625|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524782|NCT02658890|65661626|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23417174|NCT04187144|65271455|FG000|Overall Study|Adverse Event|19|||
23417175|NCT04187144|65271456|FG001|Overall Study|Adverse Event|4|||
23417176|NCT04187144|65271455|FG000|Overall Study|Physician Decision|5|||
23417177|NCT04187144|65271456|FG001|Overall Study|Physician Decision|3|||
23417178|NCT04187144|65271455|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
23417179|NCT04187144|65271456|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
23417180|NCT04187144|65271455|FG000|Overall Study|Protocol Deviation|1|||
23417181|NCT04187144|65271456|FG001|Overall Study|Protocol Deviation|4|||
23417182|NCT00281099|65271457|FG000|Overall Study|Death|46|||
23524783|NCT02658890|65661627|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524784|NCT02658890|65661628|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524785|NCT02658890|65661629|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23812757|NCT03768726|66696017|FG000|Treatment Phase|Withdrawal by Subject|3|||
23812758|NCT03768726|66696018|FG001|Treatment Phase|Withdrawal by Subject|1|||
23812759|NCT03768726|66696017|FG000|Follow-Up|Adverse Event|2|||
23524786|NCT02658890|65661603|FG000|Treatment Phase|Adverse Event|0|||
23524787|NCT02658890|65661604|FG001|Treatment Phase|Adverse Event|1|||
23524788|NCT02658890|65661605|FG002|Treatment Phase|Adverse Event|2|||
23524789|NCT02658890|65661606|FG003|Treatment Phase|Adverse Event|2|||
23524790|NCT02658890|65661607|FG004|Treatment Phase|Adverse Event|1|||
23524791|NCT02658890|65661608|FG005|Treatment Phase|Adverse Event|0|||
23524792|NCT02658890|65661609|FG006|Treatment Phase|Adverse Event|0|||
23524793|NCT02658890|65661610|FG007|Treatment Phase|Adverse Event|2|||
23524794|NCT02658890|65661611|FG008|Treatment Phase|Adverse Event|1|||
23524795|NCT02658890|65661612|FG009|Treatment Phase|Adverse Event|2|||
23524796|NCT02658890|65661613|FG010|Treatment Phase|Adverse Event|3|||
23524797|NCT02658890|65661614|FG011|Treatment Phase|Adverse Event|0|||
23524798|NCT02658890|65661615|FG012|Treatment Phase|Adverse Event|1|||
23524799|NCT02658890|65661616|FG013|Treatment Phase|Adverse Event|4|||
23715575|NCT03655717|66333493|FG017|Overall Study|Lost to Follow-up|0|||
23715576|NCT03655717|66333494|FG018|Overall Study|Lost to Follow-up|0|||
23715577|NCT03655717|66333495|FG019|Overall Study|Lost to Follow-up|0|||
23715578|NCT03655717|66333496|FG020|Overall Study|Lost to Follow-up|0|||
23715579|NCT03655717|66333497|FG021|Overall Study|Lost to Follow-up|0|||
23715580|NCT03655717|66333498|FG022|Overall Study|Lost to Follow-up|0|||
23715581|NCT03655717|66333499|FG023|Overall Study|Lost to Follow-up|0|||
23715582|NCT03655717|66333500|FG024|Overall Study|Lost to Follow-up|0|||
23715583|NCT03655717|66333501|FG025|Overall Study|Lost to Follow-up|0|||
23715584|NCT01054976|66333507|FG000|Overall Study|Adverse Event|16|||
23715585|NCT01054976|66333507|FG000|Overall Study|Uncooperative participations to study|7|||
23715586|NCT01054976|66333507|FG000|Overall Study|Withdrawal by Subject|4|||
23715587|NCT01054976|66333507|FG000|Overall Study|Other|8|||
23524800|NCT02658890|65661617|FG014|Treatment Phase|Adverse Event|0|||
23524801|NCT02658890|65661618|FG015|Treatment Phase|Adverse Event|0|||
23524802|NCT02658890|65661619|FG016|Treatment Phase|Adverse Event|0|||
23715588|NCT02802878|66333509|FG000|Overall Study|Withdrawal by Subject|3|||
23715589|NCT02802878|66333510|FG001|Overall Study|Withdrawal by Subject|3|||
23715590|NCT02802878|66333509|FG000|Overall Study|Protocol Violation|1|||
23715591|NCT02802878|66333510|FG001|Overall Study|Protocol Violation|0|||
23524803|NCT02658890|65661620|FG017|Treatment Phase|Adverse Event|0|||
23524804|NCT02658890|65661621|FG018|Treatment Phase|Adverse Event|5|||
23524805|NCT02658890|65661622|FG019|Treatment Phase|Adverse Event|1|||
23715592|NCT03364673|66333511|FG000|Overall Study|Withdrawal by Subject|2|||
23715593|NCT03364673|66333511|FG000|Overall Study|Injury unrelated to study|3|||
23715594|NCT03334396|66333512|FG000|Overall Study|Adverse Event|1|||
23524806|NCT02658890|65661623|FG020|Treatment Phase|Adverse Event|3|||
23524807|NCT02658890|65661624|FG021|Treatment Phase|Adverse Event|0|||
23524808|NCT02658890|65661625|FG022|Treatment Phase|Adverse Event|5|||
23524809|NCT02658890|65661626|FG023|Treatment Phase|Adverse Event|0|||
23524810|NCT02658890|65661627|FG024|Treatment Phase|Adverse Event|0|||
23524811|NCT02658890|65661628|FG025|Treatment Phase|Adverse Event|2|||
23524812|NCT02658890|65661629|FG026|Treatment Phase|Adverse Event|1|||
23524813|NCT02658890|65661603|FG000|Treatment Phase|Death|0|||
23524814|NCT02658890|65661604|FG001|Treatment Phase|Death|0|||
23524815|NCT02658890|65661605|FG002|Treatment Phase|Death|0|||
23524816|NCT02658890|65661606|FG003|Treatment Phase|Death|0|||
23524817|NCT02658890|65661607|FG004|Treatment Phase|Death|0|||
23524818|NCT02658890|65661608|FG005|Treatment Phase|Death|0|||
23524819|NCT02658890|65661609|FG006|Treatment Phase|Death|0|||
23524820|NCT02658890|65661610|FG007|Treatment Phase|Death|0|||
23524821|NCT02658890|65661611|FG008|Treatment Phase|Death|0|||
23524822|NCT02658890|65661612|FG009|Treatment Phase|Death|0|||
23715595|NCT03334396|66333513|FG001|Overall Study|Adverse Event|0|||
23715596|NCT03334396|66333514|FG002|Overall Study|Adverse Event|1|||
23715597|NCT03334396|66333515|FG003|Overall Study|Adverse Event|0|||
23715598|NCT03334396|66333516|FG004|Overall Study|Adverse Event|0|||
23715599|NCT03334396|66333517|FG005|Overall Study|Adverse Event|0|||
23715600|NCT03334396|66333518|FG006|Overall Study|Adverse Event|0|||
23715601|NCT03334396|66333519|FG007|Overall Study|Adverse Event|0|||
23715602|NCT03334396|66333512|FG000|Overall Study|Lack of Efficacy|10|||
23715603|NCT03334396|66333513|FG001|Overall Study|Lack of Efficacy|4|||
23524823|NCT02658890|65661613|FG010|Treatment Phase|Death|0|||
23524824|NCT02658890|65661614|FG011|Treatment Phase|Death|0|||
23524825|NCT02658890|65661615|FG012|Treatment Phase|Death|0|||
23524826|NCT02658890|65661616|FG013|Treatment Phase|Death|0|||
23524827|NCT02658890|65661617|FG014|Treatment Phase|Death|0|||
23524828|NCT02658890|65661618|FG015|Treatment Phase|Death|0|||
23524829|NCT02658890|65661619|FG016|Treatment Phase|Death|0|||
23524830|NCT02658890|65661620|FG017|Treatment Phase|Death|0|||
23524831|NCT02658890|65661621|FG018|Treatment Phase|Death|1|||
23524832|NCT02658890|65661622|FG019|Treatment Phase|Death|0|||
23524833|NCT02658890|65661623|FG020|Treatment Phase|Death|0|||
23524834|NCT02658890|65661624|FG021|Treatment Phase|Death|0|||
23715604|NCT03334396|66333514|FG002|Overall Study|Lack of Efficacy|1|||
23715605|NCT03334396|66333515|FG003|Overall Study|Lack of Efficacy|3|||
23715606|NCT03334396|66333516|FG004|Overall Study|Lack of Efficacy|1|||
23715607|NCT03334396|66333517|FG005|Overall Study|Lack of Efficacy|0|||
23524835|NCT02658890|65661625|FG022|Treatment Phase|Death|0|||
23524836|NCT02658890|65661626|FG023|Treatment Phase|Death|0|||
23524837|NCT02658890|65661627|FG024|Treatment Phase|Death|0|||
23524838|NCT02658890|65661628|FG025|Treatment Phase|Death|0|||
23524839|NCT02658890|65661629|FG026|Treatment Phase|Death|0|||
23524840|NCT02658890|65661603|FG000|Treatment Phase|Lost to Follow-up|0|||
23524841|NCT02658890|65661604|FG001|Treatment Phase|Lost to Follow-up|0|||
23524842|NCT02658890|65661605|FG002|Treatment Phase|Lost to Follow-up|0|||
23524843|NCT02658890|65661606|FG003|Treatment Phase|Lost to Follow-up|0|||
23524844|NCT02658890|65661607|FG004|Treatment Phase|Lost to Follow-up|0|||
23524845|NCT02658890|65661608|FG005|Treatment Phase|Lost to Follow-up|0|||
23524846|NCT02658890|65661609|FG006|Treatment Phase|Lost to Follow-up|1|||
23524847|NCT02658890|65661610|FG007|Treatment Phase|Lost to Follow-up|0|||
23524848|NCT02658890|65661611|FG008|Treatment Phase|Lost to Follow-up|0|||
23524849|NCT02658890|65661612|FG009|Treatment Phase|Lost to Follow-up|0|||
23524850|NCT02658890|65661613|FG010|Treatment Phase|Lost to Follow-up|0|||
23524851|NCT02658890|65661614|FG011|Treatment Phase|Lost to Follow-up|0|||
23524852|NCT02658890|65661615|FG012|Treatment Phase|Lost to Follow-up|0|||
23524853|NCT02658890|65661616|FG013|Treatment Phase|Lost to Follow-up|0|||
23524854|NCT02658890|65661617|FG014|Treatment Phase|Lost to Follow-up|0|||
23524855|NCT02658890|65661618|FG015|Treatment Phase|Lost to Follow-up|0|||
23524856|NCT02658890|65661619|FG016|Treatment Phase|Lost to Follow-up|0|||
23524857|NCT02658890|65661620|FG017|Treatment Phase|Lost to Follow-up|0|||
23524858|NCT02658890|65661621|FG018|Treatment Phase|Lost to Follow-up|0|||
23524859|NCT02658890|65661622|FG019|Treatment Phase|Lost to Follow-up|0|||
23524860|NCT02658890|65661623|FG020|Treatment Phase|Lost to Follow-up|0|||
23524861|NCT02658890|65661624|FG021|Treatment Phase|Lost to Follow-up|0|||
23524862|NCT02658890|65661625|FG022|Treatment Phase|Lost to Follow-up|0|||
23524863|NCT02658890|65661626|FG023|Treatment Phase|Lost to Follow-up|0|||
23524864|NCT02658890|65661627|FG024|Treatment Phase|Lost to Follow-up|0|||
23524865|NCT02658890|65661628|FG025|Treatment Phase|Lost to Follow-up|0|||
23524866|NCT02658890|65661629|FG026|Treatment Phase|Lost to Follow-up|0|||
23524867|NCT02658890|65661603|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
23524868|NCT02658890|65661604|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
23812760|NCT03768726|66696018|FG001|Follow-Up|Adverse Event|2|||
23812761|NCT03768726|66696017|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
23812762|NCT03768726|66696018|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
23812763|NCT03768726|66696017|FG000|Follow-Up|Withdrawal by Subject|2|||
23812764|NCT03768726|66696018|FG001|Follow-Up|Withdrawal by Subject|0|||
23524869|NCT02658890|65661605|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
23524870|NCT02658890|65661606|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
23524871|NCT02658890|65661607|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
23524872|NCT02658890|65661608|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
23524873|NCT02658890|65661609|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
23524874|NCT02658890|65661610|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
23524875|NCT02658890|65661611|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
23524876|NCT02658890|65661612|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
23524877|NCT02658890|65661613|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
23524878|NCT02658890|65661614|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
23524879|NCT02658890|65661615|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
23524880|NCT02658890|65661616|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
23524881|NCT02658890|65661617|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
23524882|NCT02658890|65661618|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
23524883|NCT02658890|65661619|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
23524884|NCT02658890|65661620|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
23524885|NCT02658890|65661621|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
23524886|NCT02658890|65661622|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
23715608|NCT03334396|66333518|FG006|Overall Study|Lack of Efficacy|0|||
23715609|NCT03334396|66333519|FG007|Overall Study|Lack of Efficacy|1|||
23715610|NCT03334396|66333512|FG000|Overall Study|Lost to Follow-up|0|||
23715611|NCT03334396|66333513|FG001|Overall Study|Lost to Follow-up|0|||
23715612|NCT03334396|66333514|FG002|Overall Study|Lost to Follow-up|1|||
23524887|NCT02658890|65661623|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
23524888|NCT02658890|65661624|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
23715613|NCT03334396|66333515|FG003|Overall Study|Lost to Follow-up|0|||
23715614|NCT03334396|66333516|FG004|Overall Study|Lost to Follow-up|0|||
23524889|NCT02658890|65661625|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
23524890|NCT02658890|65661626|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
23524891|NCT02658890|65661627|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
23524892|NCT02658890|65661628|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
23524893|NCT02658890|65661629|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
23524894|NCT02658890|65661603|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
23524895|NCT02658890|65661604|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
23524896|NCT02658890|65661605|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
23524897|NCT02658890|65661606|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
23715615|NCT03334396|66333517|FG005|Overall Study|Lost to Follow-up|0|||
23812765|NCT03768726|66696017|FG000|Follow-Up|Other|1|||
23524898|NCT02658890|65661607|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
23524899|NCT02658890|65661608|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
23524900|NCT02658890|65661609|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
23524901|NCT02658890|65661610|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
23524902|NCT02658890|65661611|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
23524903|NCT02658890|65661612|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
23524904|NCT02658890|65661613|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
23524905|NCT02658890|65661614|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
23524906|NCT02658890|65661615|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
23524907|NCT02658890|65661616|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
23524908|NCT02658890|65661617|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
23524909|NCT02658890|65661618|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
23524910|NCT02658890|65661619|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
23524911|NCT02658890|65661620|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
23524912|NCT02658890|65661621|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
23524913|NCT02658890|65661622|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
23524914|NCT02658890|65661623|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
23524915|NCT02658890|65661624|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
23524916|NCT02658890|65661625|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
23524917|NCT02658890|65661626|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
23524918|NCT02658890|65661627|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
23524919|NCT02658890|65661628|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
23524920|NCT02658890|65661629|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
23524921|NCT02658890|65661603|FG000|Treatment Phase|Other Reasons|0|||
23524922|NCT02658890|65661604|FG001|Treatment Phase|Other Reasons|0|||
23524923|NCT02658890|65661605|FG002|Treatment Phase|Other Reasons|0|||
23524924|NCT02658890|65661606|FG003|Treatment Phase|Other Reasons|0|||
23524925|NCT02658890|65661607|FG004|Treatment Phase|Other Reasons|0|||
23524926|NCT02658890|65661608|FG005|Treatment Phase|Other Reasons|0|||
23524927|NCT02658890|65661609|FG006|Treatment Phase|Other Reasons|1|||
23524928|NCT02658890|65661610|FG007|Treatment Phase|Other Reasons|0|||
23524929|NCT02658890|65661611|FG008|Treatment Phase|Other Reasons|1|||
23524930|NCT02658890|65661612|FG009|Treatment Phase|Other Reasons|0|||
23524931|NCT02658890|65661613|FG010|Treatment Phase|Other Reasons|0|||
23524932|NCT02658890|65661614|FG011|Treatment Phase|Other Reasons|0|||
23524933|NCT02658890|65661615|FG012|Treatment Phase|Other Reasons|0|||
23524934|NCT02658890|65661616|FG013|Treatment Phase|Other Reasons|2|||
23524935|NCT02658890|65661617|FG014|Treatment Phase|Other Reasons|0|||
23524936|NCT02658890|65661618|FG015|Treatment Phase|Other Reasons|0|||
23524937|NCT02658890|65661619|FG016|Treatment Phase|Other Reasons|0|||
23524938|NCT02658890|65661620|FG017|Treatment Phase|Other Reasons|0|||
23524939|NCT02658890|65661621|FG018|Treatment Phase|Other Reasons|1|||
23524940|NCT02658890|65661622|FG019|Treatment Phase|Other Reasons|0|||
23524941|NCT02658890|65661623|FG020|Treatment Phase|Other Reasons|0|||
23524942|NCT02658890|65661624|FG021|Treatment Phase|Other Reasons|0|||
23524943|NCT02658890|65661625|FG022|Treatment Phase|Other Reasons|0|||
23524944|NCT02658890|65661626|FG023|Treatment Phase|Other Reasons|0|||
23524945|NCT02658890|65661627|FG024|Treatment Phase|Other Reasons|1|||
23524946|NCT02658890|65661628|FG025|Treatment Phase|Other Reasons|0|||
23524947|NCT02658890|65661629|FG026|Treatment Phase|Other Reasons|1|||
23524948|NCT02658890|65661603|FG000|Treatment Phase|Progressive Disease|6|||
23524949|NCT02658890|65661604|FG001|Treatment Phase|Progressive Disease|7|||
23524950|NCT02658890|65661605|FG002|Treatment Phase|Progressive Disease|6|||
23524951|NCT02658890|65661606|FG003|Treatment Phase|Progressive Disease|12|||
23524952|NCT02658890|65661607|FG004|Treatment Phase|Progressive Disease|6|||
23524953|NCT02658890|65661608|FG005|Treatment Phase|Progressive Disease|18|||
23524954|NCT02658890|65661609|FG006|Treatment Phase|Progressive Disease|12|||
23524955|NCT02658890|65661610|FG007|Treatment Phase|Progressive Disease|19|||
23524956|NCT02658890|65661611|FG008|Treatment Phase|Progressive Disease|26|||
23524957|NCT02658890|65661612|FG009|Treatment Phase|Progressive Disease|8|||
23524958|NCT02658890|65661613|FG010|Treatment Phase|Progressive Disease|7|||
23524959|NCT02658890|65661614|FG011|Treatment Phase|Progressive Disease|9|||
23524960|NCT02658890|65661615|FG012|Treatment Phase|Progressive Disease|8|||
23524961|NCT02658890|65661616|FG013|Treatment Phase|Progressive Disease|29|||
23524962|NCT02658890|65661617|FG014|Treatment Phase|Progressive Disease|6|||
23524963|NCT02658890|65661618|FG015|Treatment Phase|Progressive Disease|2|||
23524964|NCT02658890|65661619|FG016|Treatment Phase|Progressive Disease|32|||
23524965|NCT02658890|65661620|FG017|Treatment Phase|Progressive Disease|14|||
23524966|NCT02658890|65661621|FG018|Treatment Phase|Progressive Disease|40|||
23524967|NCT02658890|65661622|FG019|Treatment Phase|Progressive Disease|32|||
23524968|NCT02658890|65661623|FG020|Treatment Phase|Progressive Disease|19|||
23524969|NCT02658890|65661624|FG021|Treatment Phase|Progressive Disease|30|||
23524970|NCT02658890|65661625|FG022|Treatment Phase|Progressive Disease|15|||
23524971|NCT02658890|65661626|FG023|Treatment Phase|Progressive Disease|0|||
23524972|NCT02658890|65661627|FG024|Treatment Phase|Progressive Disease|0|||
23715616|NCT03334396|66333518|FG006|Overall Study|Lost to Follow-up|1|||
23524973|NCT02658890|65661628|FG025|Treatment Phase|Progressive Disease|14|||
23524974|NCT02658890|65661629|FG026|Treatment Phase|Progressive Disease|11|||
23524975|NCT02658890|65661603|FG000|Treatment Phase|Study Drug Toxicity|0|||
23524976|NCT02658890|65661604|FG001|Treatment Phase|Study Drug Toxicity|0|||
23524977|NCT02658890|65661605|FG002|Treatment Phase|Study Drug Toxicity|2|||
23524978|NCT02658890|65661606|FG003|Treatment Phase|Study Drug Toxicity|0|||
23524979|NCT02658890|65661607|FG004|Treatment Phase|Study Drug Toxicity|0|||
23524980|NCT02658890|65661608|FG005|Treatment Phase|Study Drug Toxicity|0|||
23524981|NCT02658890|65661609|FG006|Treatment Phase|Study Drug Toxicity|0|||
23524982|NCT02658890|65661610|FG007|Treatment Phase|Study Drug Toxicity|0|||
23524983|NCT02658890|65661611|FG008|Treatment Phase|Study Drug Toxicity|3|||
23524984|NCT02658890|65661612|FG009|Treatment Phase|Study Drug Toxicity|0|||
23524985|NCT02658890|65661613|FG010|Treatment Phase|Study Drug Toxicity|1|||
23524986|NCT02658890|65661614|FG011|Treatment Phase|Study Drug Toxicity|1|||
23524987|NCT02658890|65661615|FG012|Treatment Phase|Study Drug Toxicity|2|||
23524988|NCT02658890|65661616|FG013|Treatment Phase|Study Drug Toxicity|9|||
23524989|NCT02658890|65661617|FG014|Treatment Phase|Study Drug Toxicity|0|||
23524990|NCT02658890|65661618|FG015|Treatment Phase|Study Drug Toxicity|1|||
23524991|NCT02658890|65661619|FG016|Treatment Phase|Study Drug Toxicity|1|||
23524992|NCT02658890|65661620|FG017|Treatment Phase|Study Drug Toxicity|0|||
23524993|NCT02658890|65661621|FG018|Treatment Phase|Study Drug Toxicity|8|||
23524994|NCT02658890|65661622|FG019|Treatment Phase|Study Drug Toxicity|3|||
23524995|NCT02658890|65661623|FG020|Treatment Phase|Study Drug Toxicity|2|||
23524996|NCT02658890|65661624|FG021|Treatment Phase|Study Drug Toxicity|0|||
23524997|NCT02658890|65661625|FG022|Treatment Phase|Study Drug Toxicity|8|||
23524998|NCT02658890|65661626|FG023|Treatment Phase|Study Drug Toxicity|0|||
23524999|NCT02658890|65661627|FG024|Treatment Phase|Study Drug Toxicity|0|||
23525000|NCT02658890|65661628|FG025|Treatment Phase|Study Drug Toxicity|2|||
23525001|NCT02658890|65661629|FG026|Treatment Phase|Study Drug Toxicity|0|||
23525002|NCT02658890|65661603|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525003|NCT02658890|65661604|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525004|NCT02658890|65661605|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525005|NCT02658890|65661606|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525006|NCT02658890|65661607|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525007|NCT02658890|65661608|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525008|NCT02658890|65661609|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525009|NCT02658890|65661610|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525010|NCT02658890|65661611|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525011|NCT02658890|65661612|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525012|NCT02658890|65661613|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525013|NCT02658890|65661614|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525014|NCT02658890|65661615|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525015|NCT02658890|65661616|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525016|NCT02658890|65661617|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525017|NCT02658890|65661618|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525018|NCT02658890|65661619|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525019|NCT02658890|65661620|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525020|NCT02658890|65661621|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525021|NCT02658890|65661622|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525022|NCT02658890|65661623|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525023|NCT02658890|65661624|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525024|NCT02658890|65661625|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525025|NCT02658890|65661626|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525026|NCT02658890|65661627|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525027|NCT02658890|65661628|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525028|NCT02658890|65661629|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525029|NCT02658890|65661603|FG000|Treatment Phase|Withdrawal by Subject|0|||
23525030|NCT02658890|65661604|FG001|Treatment Phase|Withdrawal by Subject|1|||
23525031|NCT02658890|65661605|FG002|Treatment Phase|Withdrawal by Subject|0|||
23525032|NCT02658890|65661606|FG003|Treatment Phase|Withdrawal by Subject|0|||
23525033|NCT02658890|65661607|FG004|Treatment Phase|Withdrawal by Subject|0|||
23525034|NCT02658890|65661608|FG005|Treatment Phase|Withdrawal by Subject|0|||
23525035|NCT02658890|65661609|FG006|Treatment Phase|Withdrawal by Subject|1|||
23525036|NCT02658890|65661610|FG007|Treatment Phase|Withdrawal by Subject|0|||
23525037|NCT02658890|65661611|FG008|Treatment Phase|Withdrawal by Subject|0|||
23525038|NCT02658890|65661612|FG009|Treatment Phase|Withdrawal by Subject|1|||
23525039|NCT02658890|65661613|FG010|Treatment Phase|Withdrawal by Subject|0|||
23715617|NCT03334396|66333519|FG007|Overall Study|Lost to Follow-up|0|||
23812766|NCT03768726|66696018|FG001|Follow-Up|Other|0|||
23812767|NCT01197755|66696019|FG000|Overall Study|Adverse Event|8|||
23812768|NCT01197755|66696020|FG001|Overall Study|Adverse Event|10|||
23812769|NCT01197755|66696021|FG002|Overall Study|Adverse Event|10|||
23812770|NCT01197755|66696019|FG000|Overall Study|Study-specific discontinuation criteria|2|||
23812771|NCT01197755|66696020|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23812772|NCT01197755|66696021|FG002|Overall Study|Study-specific discontinuation criteria|0|||
23812773|NCT01197755|66696019|FG000|Overall Study|Entered the long-term extension study|18|||
23812774|NCT01197755|66696020|FG001|Overall Study|Entered the long-term extension study|21|||
23812775|NCT01197755|66696021|FG002|Overall Study|Entered the long-term extension study|35|||
23812776|NCT01197755|66696019|FG000|Overall Study|Lack of therapeutic response|0|||
23812777|NCT01197755|66696020|FG001|Overall Study|Lack of therapeutic response|7|||
23812778|NCT01197755|66696021|FG002|Overall Study|Lack of therapeutic response|4|||
23812779|NCT01197755|66696019|FG000|Overall Study|Severe non-compliance to the protocol|2|||
23812780|NCT01197755|66696020|FG001|Overall Study|Severe non-compliance to the protocol|1|||
23812781|NCT01197755|66696021|FG002|Overall Study|Severe non-compliance to the protocol|2|||
23812782|NCT01197755|66696019|FG000|Overall Study|Withdrawal by Subject|1|||
23812783|NCT01197755|66696020|FG001|Overall Study|Withdrawal by Subject|0|||
23812784|NCT01197755|66696021|FG002|Overall Study|Withdrawal by Subject|0|||
23812785|NCT01197755|66696019|FG000|Overall Study|Lost to Follow-up|0|||
23812786|NCT01197755|66696020|FG001|Overall Study|Lost to Follow-up|0|||
23812787|NCT01197755|66696021|FG002|Overall Study|Lost to Follow-up|1|||
23812788|NCT01197755|66696019|FG000|Overall Study|eg, change in circumstances|7|||
23812789|NCT01197755|66696020|FG001|Overall Study|eg, change in circumstances|3|||
23812790|NCT01197755|66696021|FG002|Overall Study|eg, change in circumstances|2|||
23812791|NCT00210249|66696032|FG000|Overall Study|Lost to Follow-up|5|||
23812792|NCT00210249|66696032|FG000|Overall Study|Protocol Violation|11|||
23812793|NCT00171301|66696033|FG000|Overall Study|Death|1|||
23812794|NCT00171301|66696034|FG001|Overall Study|Death|2|||
23812795|NCT00171301|66696033|FG000|Overall Study|Adverse Event|1|||
23812796|NCT00171301|66696034|FG001|Overall Study|Adverse Event|2|||
23812797|NCT00171301|66696033|FG000|Overall Study|Lost to Follow-up|6|||
23525040|NCT02658890|65661614|FG011|Treatment Phase|Withdrawal by Subject|0|||
23525041|NCT02658890|65661615|FG012|Treatment Phase|Withdrawal by Subject|1|||
23525042|NCT02658890|65661616|FG013|Treatment Phase|Withdrawal by Subject|3|||
23525043|NCT02658890|65661617|FG014|Treatment Phase|Withdrawal by Subject|0|||
23812798|NCT00171301|66696034|FG001|Overall Study|Lost to Follow-up|2|||
23812799|NCT00171301|66696033|FG000|Overall Study|Protocol Violation|0|||
23812800|NCT00171301|66696034|FG001|Overall Study|Protocol Violation|2|||
23812801|NCT00171301|66696033|FG000|Overall Study|Withdrawal by Subject|0|||
23812802|NCT00171301|66696034|FG001|Overall Study|Withdrawal by Subject|1|||
23812803|NCT01986010|66696041|FG000|Overall Study|Adverse Event|0|||
23812804|NCT01986010|66696042|FG001|Overall Study|Adverse Event|1|||
23812805|NCT01986010|66696043|FG002|Overall Study|Adverse Event|0|||
23812806|NCT01986010|66696044|FG003|Overall Study|Adverse Event|0|||
23812807|NCT01986010|66696045|FG004|Overall Study|Adverse Event|0|||
23812808|NCT01986010|66696046|FG005|Overall Study|Adverse Event|0|||
23812809|NCT01986010|66696047|FG006|Overall Study|Adverse Event|0|||
23812810|NCT01986010|66696048|FG007|Overall Study|Adverse Event|0|||
23812811|NCT01986010|66696049|FG008|Overall Study|Adverse Event|0|||
23812812|NCT01986010|66696050|FG009|Overall Study|Adverse Event|0|||
23812813|NCT01986010|66696051|FG010|Overall Study|Adverse Event|0|||
23812814|NCT01986010|66696052|FG011|Overall Study|Adverse Event|0|||
23812815|NCT01986010|66696053|FG012|Overall Study|Adverse Event|0|||
23812816|NCT01986010|66696054|FG013|Overall Study|Adverse Event|0|||
23812817|NCT01986010|66696055|FG014|Overall Study|Adverse Event|0|||
23812818|NCT01986010|66696056|FG015|Overall Study|Adverse Event|1|||
23812819|NCT01986010|66696057|FG016|Overall Study|Adverse Event|0|||
23812820|NCT01986010|66696041|FG000|Overall Study|Lost to Follow-up|2|||
23812821|NCT01986010|66696042|FG001|Overall Study|Lost to Follow-up|1|||
23812822|NCT01986010|66696043|FG002|Overall Study|Lost to Follow-up|2|||
23812823|NCT01986010|66696044|FG003|Overall Study|Lost to Follow-up|2|||
23812824|NCT01986010|66696045|FG004|Overall Study|Lost to Follow-up|2|||
23812825|NCT01986010|66696046|FG005|Overall Study|Lost to Follow-up|2|||
23812826|NCT01986010|66696047|FG006|Overall Study|Lost to Follow-up|0|||
23417183|NCT00281099|65271458|FG001|Overall Study|Death|57|||
23525044|NCT02658890|65661618|FG015|Treatment Phase|Withdrawal by Subject|0|||
23525045|NCT02658890|65661619|FG016|Treatment Phase|Withdrawal by Subject|1|||
23812827|NCT01986010|66696048|FG007|Overall Study|Lost to Follow-up|0|||
23812828|NCT01986010|66696049|FG008|Overall Study|Lost to Follow-up|4|||
23812829|NCT01986010|66696050|FG009|Overall Study|Lost to Follow-up|2|||
23812830|NCT01986010|66696051|FG010|Overall Study|Lost to Follow-up|0|||
23417184|NCT00281099|65271457|FG000|Overall Study|Lost to Follow-up|10|||
23812831|NCT01986010|66696052|FG011|Overall Study|Lost to Follow-up|1|||
23812832|NCT01986010|66696053|FG012|Overall Study|Lost to Follow-up|1|||
23812833|NCT01986010|66696054|FG013|Overall Study|Lost to Follow-up|1|||
23812834|NCT01986010|66696055|FG014|Overall Study|Lost to Follow-up|2|||
23812835|NCT01986010|66696056|FG015|Overall Study|Lost to Follow-up|0|||
23812836|NCT01986010|66696057|FG016|Overall Study|Lost to Follow-up|0|||
23812837|NCT01986010|66696041|FG000|Overall Study|Physician Decision|0|||
23812838|NCT01986010|66696042|FG001|Overall Study|Physician Decision|0|||
23812839|NCT01986010|66696043|FG002|Overall Study|Physician Decision|0|||
23812840|NCT01986010|66696044|FG003|Overall Study|Physician Decision|0|||
23812841|NCT01986010|66696045|FG004|Overall Study|Physician Decision|0|||
23525046|NCT02658890|65661620|FG017|Treatment Phase|Withdrawal by Subject|0|||
23525047|NCT02658890|65661621|FG018|Treatment Phase|Withdrawal by Subject|4|||
23525048|NCT02658890|65661622|FG019|Treatment Phase|Withdrawal by Subject|3|||
23525049|NCT02658890|65661623|FG020|Treatment Phase|Withdrawal by Subject|0|||
23525050|NCT02658890|65661624|FG021|Treatment Phase|Withdrawal by Subject|4|||
23525051|NCT02658890|65661625|FG022|Treatment Phase|Withdrawal by Subject|1|||
23525052|NCT02658890|65661626|FG023|Treatment Phase|Withdrawal by Subject|1|||
23525053|NCT02658890|65661627|FG024|Treatment Phase|Withdrawal by Subject|0|||
23525054|NCT02658890|65661628|FG025|Treatment Phase|Withdrawal by Subject|0|||
23525055|NCT02658890|65661629|FG026|Treatment Phase|Withdrawal by Subject|0|||
23525056|NCT02268409|65661630|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
23525057|NCT02268409|65661630|FG000|Overall Study|Death|1|||
23525058|NCT02268409|65661630|FG000|Overall Study|Lost to Follow-up|1|||
23525059|NCT02268409|65661630|FG000|Overall Study|Protocol Violation|3|||
23525060|NCT02268409|65661630|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
23525061|NCT02268409|65661630|FG000|Overall Study|Withdrawal by Subject|5|||
23525062|NCT01071512|65661631|FG000|Overall Study|Adverse Event|1|||
23525063|NCT01071512|65661631|FG000|Overall Study|Development of antibodies to drug|2|||
23525064|NCT01071512|65661631|FG000|Overall Study|positive anti-JC virus antibody test|2|||
23525065|NCT01124604|65661632|FG000|Overall Study|Adverse Event|10|||
23812842|NCT01986010|66696046|FG005|Overall Study|Physician Decision|0|||
23812843|NCT01986010|66696047|FG006|Overall Study|Physician Decision|0|||
23812844|NCT01986010|66696048|FG007|Overall Study|Physician Decision|0|||
23812845|NCT01986010|66696049|FG008|Overall Study|Physician Decision|0|||
23812846|NCT01986010|66696050|FG009|Overall Study|Physician Decision|0|||
23525066|NCT01124604|65661633|FG001|Overall Study|Adverse Event|1|||
23525067|NCT01124604|65661632|FG000|Overall Study|Lack of Efficacy|1|||
23525068|NCT01124604|65661633|FG001|Overall Study|Lack of Efficacy|0|||
23525069|NCT01124604|65661632|FG000|Overall Study|Withdrawal by Subject|4|||
23525070|NCT01124604|65661633|FG001|Overall Study|Withdrawal by Subject|0|||
23525071|NCT01124604|65661632|FG000|Overall Study|Disease Progression|0|||
23525072|NCT01124604|65661633|FG001|Overall Study|Disease Progression|1|||
23525073|NCT01537783|65661638|FG000|Overall Study|Lost to Follow-up|11|||
23525074|NCT01537783|65661639|FG001|Overall Study|Lost to Follow-up|2|||
23525075|NCT00850395|65661640|FG000|Overall Study|Death|1|||
23525076|NCT00850395|65661640|FG000|Overall Study|Adverse Event|1|||
23525077|NCT00850395|65661640|FG000|Overall Study|Insufficient clinical response|3|||
23525078|NCT00850395|65661640|FG000|Overall Study|Other|5|||
23525079|NCT01940120|65661642|FG000|Overall Study|Death|40|||
23525080|NCT01940120|65661642|FG000|Overall Study|Withdrawal by Subject|8|||
23525081|NCT00613509|65661643|FG000|Cycle 1|Adverse Event|2|||
23525082|NCT00613509|65661644|FG001|Cycle 1|Adverse Event|1|||
23525083|NCT00613509|65661643|FG000|Cycle 1|Disease Progression|2|||
23525084|NCT00613509|65661644|FG001|Cycle 1|Disease Progression|6|||
23715618|NCT03334396|66333512|FG000|Overall Study|Physician Decision|1|||
23715619|NCT03334396|66333513|FG001|Overall Study|Physician Decision|0|||
23715620|NCT03334396|66333514|FG002|Overall Study|Physician Decision|0|||
23715621|NCT03334396|66333515|FG003|Overall Study|Physician Decision|0|||
23715622|NCT03334396|66333516|FG004|Overall Study|Physician Decision|0|||
23715623|NCT03334396|66333517|FG005|Overall Study|Physician Decision|0|||
23715624|NCT03334396|66333518|FG006|Overall Study|Physician Decision|0|||
23715625|NCT03334396|66333519|FG007|Overall Study|Physician Decision|0|||
23715626|NCT03334396|66333512|FG000|Overall Study|Withdrawal by Subject|10|||
23715627|NCT03334396|66333513|FG001|Overall Study|Withdrawal by Subject|5|||
23715628|NCT03334396|66333514|FG002|Overall Study|Withdrawal by Subject|7|||
23715629|NCT03334396|66333515|FG003|Overall Study|Withdrawal by Subject|2|||
23812847|NCT01986010|66696051|FG010|Overall Study|Physician Decision|0|||
23525085|NCT00613509|65661643|FG000|Cycle 1|Unacceptable Toxicity|1|||
23715630|NCT03334396|66333516|FG004|Overall Study|Withdrawal by Subject|2|||
23812848|NCT01986010|66696052|FG011|Overall Study|Physician Decision|0|||
23812849|NCT01986010|66696053|FG012|Overall Study|Physician Decision|0|||
23525086|NCT00613509|65661644|FG001|Cycle 1|Unacceptable Toxicity|0|||
23525087|NCT00613509|65661643|FG000|Cycle 1|Other administrative reason|0|||
23525088|NCT00613509|65661644|FG001|Cycle 1|Other administrative reason|1|||
23525089|NCT00394212|65661645|FG000|Overall Study|Lost to Follow-up|3|||
23715631|NCT03334396|66333517|FG005|Overall Study|Withdrawal by Subject|1|||
23715632|NCT03334396|66333518|FG006|Overall Study|Withdrawal by Subject|2|||
23715633|NCT03334396|66333519|FG007|Overall Study|Withdrawal by Subject|0|||
23812850|NCT01986010|66696054|FG013|Overall Study|Physician Decision|0|||
23812851|NCT01986010|66696055|FG014|Overall Study|Physician Decision|1|||
23812852|NCT01986010|66696056|FG015|Overall Study|Physician Decision|0|||
23417185|NCT00281099|65271458|FG001|Overall Study|Lost to Follow-up|19|||
23525090|NCT00394212|65661646|FG001|Overall Study|Lost to Follow-up|0|||
23525091|NCT00394212|65661645|FG000|Overall Study|Withdrawal by Subject|4|||
23525092|NCT00394212|65661646|FG001|Overall Study|Withdrawal by Subject|1|||
23525093|NCT00058825|65661647|FG000|Overall Study|Relapse|9|||
23525094|NCT00058825|65661647|FG000|Overall Study|Progressive Disease|5|||
23525095|NCT00058825|65661647|FG000|Overall Study|Graft Failure|5|||
23525096|NCT00058825|65661647|FG000|Overall Study|Death|3|||
23525097|NCT00615056|65661648|FG000|Overall Study|Death|31|||
23525098|NCT00615056|65661649|FG001|Overall Study|Death|31|||
23525099|NCT00615056|65661650|FG002|Overall Study|Death|21|||
23525100|NCT00615056|65661651|FG003|Overall Study|Death|23|||
23715634|NCT03334396|66333512|FG000|Overall Study|Pregnancy|0|||
23715635|NCT03334396|66333513|FG001|Overall Study|Pregnancy|1|||
23715636|NCT03334396|66333514|FG002|Overall Study|Pregnancy|0|||
23715637|NCT03334396|66333515|FG003|Overall Study|Pregnancy|0|||
23715638|NCT03334396|66333516|FG004|Overall Study|Pregnancy|0|||
23715639|NCT03334396|66333517|FG005|Overall Study|Pregnancy|0|||
23715640|NCT03334396|66333518|FG006|Overall Study|Pregnancy|0|||
23715641|NCT03334396|66333519|FG007|Overall Study|Pregnancy|0|||
23715642|NCT03334396|66333512|FG000|Overall Study|Ineligible|0|||
23715643|NCT03334396|66333513|FG001|Overall Study|Ineligible|1|||
23715644|NCT03334396|66333514|FG002|Overall Study|Ineligible|0|||
23715645|NCT03334396|66333515|FG003|Overall Study|Ineligible|0|||
23715646|NCT03334396|66333516|FG004|Overall Study|Ineligible|0|||
23715647|NCT03334396|66333517|FG005|Overall Study|Ineligible|0|||
23715648|NCT03334396|66333518|FG006|Overall Study|Ineligible|0|||
23715649|NCT03334396|66333519|FG007|Overall Study|Ineligible|0|||
23715650|NCT03334396|66333512|FG000|Overall Study|Started New Job|1|||
23715651|NCT03334396|66333513|FG001|Overall Study|Started New Job|0|||
23715652|NCT03334396|66333514|FG002|Overall Study|Started New Job|0|||
23715653|NCT03334396|66333515|FG003|Overall Study|Started New Job|0|||
23715654|NCT03334396|66333516|FG004|Overall Study|Started New Job|0|||
23715655|NCT03334396|66333517|FG005|Overall Study|Started New Job|0|||
23715656|NCT03334396|66333518|FG006|Overall Study|Started New Job|0|||
23715657|NCT03334396|66333519|FG007|Overall Study|Started New Job|0|||
23715658|NCT01529385|66333520|FG000|Overall Study|Lost to Follow-up|2|||
23715659|NCT01529385|66333521|FG001|Overall Study|Lost to Follow-up|1|||
23715660|NCT00574496|66333525|FG000|Overall Study|Withdrawal by Subject|1|||
23715661|NCT04199793|66333531|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
23715662|NCT04199793|66333532|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
23715663|NCT04199793|66333531|FG000|Overall Study|Withdrawal by Subject|1|||
23715664|NCT04199793|66333532|FG001|Overall Study|Withdrawal by Subject|1|||
23715665|NCT01763866|66333533|FG000|Overall Study|Withdrawal by Subject|2|||
23715666|NCT01763866|66333534|FG001|Overall Study|Withdrawal by Subject|1|||
23715667|NCT01763866|66333535|FG002|Overall Study|Withdrawal by Subject|4|||
23715668|NCT01763866|66333536|FG003|Overall Study|Withdrawal by Subject|0|||
23715669|NCT01763866|66333537|FG004|Overall Study|Withdrawal by Subject|0|||
23715670|NCT01763866|66333538|FG005|Overall Study|Withdrawal by Subject|3|||
23715671|NCT01763866|66333539|FG006|Overall Study|Withdrawal by Subject|4|||
23715672|NCT01763866|66333540|FG007|Overall Study|Withdrawal by Subject|0|||
23715673|NCT01763866|66333541|FG008|Overall Study|Withdrawal by Subject|1|||
23715674|NCT01763866|66333542|FG009|Overall Study|Withdrawal by Subject|1|||
23715675|NCT01763866|66333543|FG010|Overall Study|Withdrawal by Subject|2|||
23715676|NCT01763866|66333544|FG011|Overall Study|Withdrawal by Subject|2|||
23715677|NCT01763866|66333545|FG012|Overall Study|Withdrawal by Subject|2|||
23715678|NCT01763866|66333546|FG013|Overall Study|Withdrawal by Subject|0|||
23715679|NCT01763866|66333547|FG014|Overall Study|Withdrawal by Subject|6|||
23715680|NCT01763866|66333548|FG015|Overall Study|Withdrawal by Subject|3|||
23715681|NCT01763866|66333549|FG016|Overall Study|Withdrawal by Subject|0|||
23715682|NCT01763866|66333550|FG017|Overall Study|Withdrawal by Subject|1|||
23715683|NCT01763866|66333551|FG018|Overall Study|Withdrawal by Subject|1|||
23715684|NCT01763866|66333552|FG019|Overall Study|Withdrawal by Subject|1|||
23715685|NCT01763866|66333553|FG020|Overall Study|Withdrawal by Subject|2|||
23715686|NCT01763866|66333554|FG021|Overall Study|Withdrawal by Subject|1|||
23715687|NCT01763866|66333555|FG022|Overall Study|Withdrawal by Subject|2|||
23715688|NCT01763866|66333556|FG023|Overall Study|Withdrawal by Subject|1|||
23715689|NCT01763866|66333533|FG000|Overall Study|Decision by sponsor|0|||
23715690|NCT01763866|66333534|FG001|Overall Study|Decision by sponsor|0|||
23715691|NCT01763866|66333535|FG002|Overall Study|Decision by sponsor|1|||
23715692|NCT01763866|66333536|FG003|Overall Study|Decision by sponsor|0|||
23715693|NCT01763866|66333537|FG004|Overall Study|Decision by sponsor|2|||
23525101|NCT00615056|65661648|FG000|Overall Study|Lost to Follow-up|1|||
23525102|NCT00615056|65661649|FG001|Overall Study|Lost to Follow-up|2|||
23715694|NCT01763866|66333538|FG005|Overall Study|Decision by sponsor|0|||
23715695|NCT01763866|66333539|FG006|Overall Study|Decision by sponsor|2|||
23715696|NCT01763866|66333540|FG007|Overall Study|Decision by sponsor|0|||
23715697|NCT01763866|66333541|FG008|Overall Study|Decision by sponsor|2|||
23525103|NCT00615056|65661650|FG002|Overall Study|Lost to Follow-up|4|||
23715698|NCT01763866|66333542|FG009|Overall Study|Decision by sponsor|0|||
23715699|NCT01763866|66333543|FG010|Overall Study|Decision by sponsor|6|||
23715700|NCT01763866|66333544|FG011|Overall Study|Decision by sponsor|0|||
23715701|NCT01763866|66333545|FG012|Overall Study|Decision by sponsor|1|||
23715702|NCT01763866|66333546|FG013|Overall Study|Decision by sponsor|0|||
23715703|NCT01763866|66333547|FG014|Overall Study|Decision by sponsor|5|||
23715704|NCT01763866|66333548|FG015|Overall Study|Decision by sponsor|0|||
23715705|NCT01763866|66333549|FG016|Overall Study|Decision by sponsor|0|||
23715706|NCT01763866|66333550|FG017|Overall Study|Decision by sponsor|0|||
23715707|NCT01763866|66333551|FG018|Overall Study|Decision by sponsor|4|||
23715708|NCT01763866|66333552|FG019|Overall Study|Decision by sponsor|0|||
23715709|NCT01763866|66333553|FG020|Overall Study|Decision by sponsor|2|||
23715710|NCT01763866|66333554|FG021|Overall Study|Decision by sponsor|0|||
23715711|NCT01763866|66333555|FG022|Overall Study|Decision by sponsor|1|||
23715712|NCT01763866|66333556|FG023|Overall Study|Decision by sponsor|0|||
23715713|NCT01763866|66333533|FG000|Overall Study|Lost to Follow-up|0|||
23715714|NCT01763866|66333534|FG001|Overall Study|Lost to Follow-up|0|||
23715715|NCT01763866|66333535|FG002|Overall Study|Lost to Follow-up|0|||
23715716|NCT01763866|66333536|FG003|Overall Study|Lost to Follow-up|0|||
23715717|NCT01763866|66333537|FG004|Overall Study|Lost to Follow-up|0|||
23715718|NCT01763866|66333538|FG005|Overall Study|Lost to Follow-up|0|||
23715719|NCT01763866|66333539|FG006|Overall Study|Lost to Follow-up|1|||
23715720|NCT01763866|66333540|FG007|Overall Study|Lost to Follow-up|0|||
23715721|NCT01763866|66333541|FG008|Overall Study|Lost to Follow-up|0|||
23715722|NCT01763866|66333542|FG009|Overall Study|Lost to Follow-up|0|||
23715723|NCT01763866|66333543|FG010|Overall Study|Lost to Follow-up|0|||
23715724|NCT01763866|66333544|FG011|Overall Study|Lost to Follow-up|0|||
23715725|NCT01763866|66333545|FG012|Overall Study|Lost to Follow-up|1|||
23715726|NCT01763866|66333546|FG013|Overall Study|Lost to Follow-up|0|||
23715727|NCT01763866|66333547|FG014|Overall Study|Lost to Follow-up|1|||
23715728|NCT01763866|66333548|FG015|Overall Study|Lost to Follow-up|0|||
23715729|NCT01763866|66333549|FG016|Overall Study|Lost to Follow-up|0|||
23715730|NCT01763866|66333550|FG017|Overall Study|Lost to Follow-up|0|||
23715731|NCT01763866|66333551|FG018|Overall Study|Lost to Follow-up|1|||
23715732|NCT01763866|66333552|FG019|Overall Study|Lost to Follow-up|1|||
23715733|NCT01763866|66333553|FG020|Overall Study|Lost to Follow-up|0|||
23715734|NCT01763866|66333554|FG021|Overall Study|Lost to Follow-up|0|||
23715735|NCT01763866|66333555|FG022|Overall Study|Lost to Follow-up|0|||
23715736|NCT01763866|66333556|FG023|Overall Study|Lost to Follow-up|1|||
23715737|NCT01763866|66333533|FG000|Overall Study|Death|0|||
23715738|NCT01763866|66333534|FG001|Overall Study|Death|0|||
23715739|NCT01763866|66333535|FG002|Overall Study|Death|0|||
23715740|NCT01763866|66333536|FG003|Overall Study|Death|0|||
23715741|NCT01763866|66333537|FG004|Overall Study|Death|0|||
23715742|NCT01763866|66333538|FG005|Overall Study|Death|0|||
23715743|NCT01763866|66333539|FG006|Overall Study|Death|0|||
23715744|NCT01763866|66333540|FG007|Overall Study|Death|0|||
23715745|NCT01763866|66333541|FG008|Overall Study|Death|0|||
23715746|NCT01763866|66333542|FG009|Overall Study|Death|0|||
23715747|NCT01763866|66333543|FG010|Overall Study|Death|0|||
23715748|NCT01763866|66333544|FG011|Overall Study|Death|0|||
23715749|NCT01763866|66333545|FG012|Overall Study|Death|0|||
23715750|NCT01763866|66333546|FG013|Overall Study|Death|0|||
23715751|NCT01763866|66333547|FG014|Overall Study|Death|0|||
23715752|NCT01763866|66333548|FG015|Overall Study|Death|0|||
23715753|NCT01763866|66333549|FG016|Overall Study|Death|1|||
23715754|NCT01763866|66333550|FG017|Overall Study|Death|0|||
23715755|NCT01763866|66333551|FG018|Overall Study|Death|0|||
23715756|NCT01763866|66333552|FG019|Overall Study|Death|0|||
23715757|NCT01763866|66333553|FG020|Overall Study|Death|0|||
23715758|NCT01763866|66333554|FG021|Overall Study|Death|0|||
23715759|NCT01763866|66333555|FG022|Overall Study|Death|0|||
23715760|NCT01763866|66333556|FG023|Overall Study|Death|0|||
23715761|NCT01840228|66333557|FG000|Overall Study|Lost to Follow-up|1|||
23715762|NCT01840228|66333558|FG001|Overall Study|Lost to Follow-up|1|||
23715763|NCT00289185|66333565|FG000|Overall Study|Withdrawal by Subject|4|||
23715764|NCT00289185|66333566|FG001|Overall Study|Withdrawal by Subject|8|||
23715765|NCT00289185|66333565|FG000|Overall Study|Lost to Follow-up|23|||
23715766|NCT00289185|66333566|FG001|Overall Study|Lost to Follow-up|17|||
23715767|NCT00289185|66333565|FG000|Overall Study|Death|1|||
23715768|NCT00289185|66333566|FG001|Overall Study|Death|1|||
23715769|NCT00987623|66333567|FG000|Overall Study|Lost to Follow-up|2|||
23715770|NCT00987623|66333568|FG001|Overall Study|Lost to Follow-up|1|||
23715771|NCT00987623|66333567|FG000|Overall Study|Time/job conflict|2|||
23525104|NCT00615056|65661651|FG003|Overall Study|Lost to Follow-up|5|||
23715772|NCT00987623|66333568|FG001|Overall Study|Time/job conflict|0|||
23715773|NCT00987623|66333567|FG000|Overall Study|Discomfort|1|||
23715774|NCT00987623|66333568|FG001|Overall Study|Discomfort|0|||
23715775|NCT00987623|66333567|FG000|Overall Study|Biomicroscopy|0|||
23715776|NCT00987623|66333568|FG001|Overall Study|Biomicroscopy|1|||
23715777|NCT00987623|66333567|FG000|Overall Study|Influenza|0|||
23715778|NCT00987623|66333568|FG001|Overall Study|Influenza|1|||
23715779|NCT02322411|66333569|FG000|Overall Study|Lost to Follow-up|4|||
23715780|NCT02322411|66333570|FG001|Overall Study|Lost to Follow-up|7|||
23715781|NCT02322411|66333569|FG000|Overall Study|Withdrawal by Subject|1|||
23715782|NCT02322411|66333570|FG001|Overall Study|Withdrawal by Subject|0|||
23715783|NCT01995136|66333571|FG000|Overall Study|Change in residence|1|||
23715784|NCT02158091|66333572|FG000|Overall Study|DLT|2|||
23715785|NCT02158091|66333573|FG001|Overall Study|DLT|1|||
23715786|NCT02158091|66333574|FG002|Overall Study|DLT|0|||
23715787|NCT03446651|66333575|FG000|Overall Study|Lost to Follow-up|4|||
23715788|NCT03446651|66333576|FG001|Overall Study|Lost to Follow-up|0|||
23715789|NCT03446651|66333575|FG000|Overall Study|Open Label Participants|5|||
23715790|NCT03446651|66333576|FG001|Overall Study|Open Label Participants|0|||
23715791|NCT00067470|66333577|FG000|Overall Study|Withdrawal by Subject|0|||
23715792|NCT00067470|66333578|FG001|Overall Study|Withdrawal by Subject|1|||
23715793|NCT03519516|66333579|FG000|Overall Study|Adverse Event|0|||
23715794|NCT03519516|66333580|FG001|Overall Study|Adverse Event|1|||
23715795|NCT01175213|66333581|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
23715796|NCT01175213|66333582|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
23715797|NCT01175213|66333581|FG000|IGSC, 10%/rHuPH20|Death|1|||
23715798|NCT01175213|66333582|FG001|IGSC, 10%/rHuPH20|Death|0|||
23715799|NCT01175213|66333581|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
23715800|NCT01175213|66333582|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
23715801|NCT01175213|66333581|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
23715802|NCT01175213|66333582|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
23715803|NCT01175213|66333581|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
23715804|NCT01175213|66333582|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
23715805|NCT01175213|66333581|FG000|Safety Follow-up|Adverse Event|1|||
23715806|NCT01175213|66333582|FG001|Safety Follow-up|Adverse Event|0|||
23715807|NCT00756886|66333591|FG000|Overall Study|Lost to Follow-up|1|||
23715808|NCT00756886|66333592|FG001|Overall Study|Lost to Follow-up|0|||
23715809|NCT00756886|66333591|FG000|Overall Study|Adverse Event|0|||
23715810|NCT00756886|66333592|FG001|Overall Study|Adverse Event|3|||
23715811|NCT00756886|66333591|FG000|Overall Study|Lack of Efficacy|1|||
23715812|NCT00756886|66333592|FG001|Overall Study|Lack of Efficacy|0|||
23715813|NCT00756886|66333591|FG000|Overall Study|Ineligible|9|||
23715814|NCT00756886|66333592|FG001|Overall Study|Ineligible|4|||
23715815|NCT04404010|66333593|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
23715816|NCT04404010|66333594|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
23715817|NCT03115112|66333595|FG000|Overall Study|Adverse Event|5|||
23715818|NCT03115112|66333596|FG001|Overall Study|Adverse Event|1|||
23715819|NCT03115112|66333595|FG000|Overall Study|Withdrawal by Subject|4|||
23715820|NCT03115112|66333596|FG001|Overall Study|Withdrawal by Subject|2|||
23715821|NCT03115112|66333595|FG000|Overall Study|Lost to Follow-up|0|||
23715822|NCT03115112|66333596|FG001|Overall Study|Lost to Follow-up|1|||
23715823|NCT03115112|66333595|FG000|Overall Study|Death|1|||
23715824|NCT03115112|66333596|FG001|Overall Study|Death|0|||
23715825|NCT03115112|66333595|FG000|Overall Study|Pregnancy|1|||
23715826|NCT03115112|66333596|FG001|Overall Study|Pregnancy|0|||
23715827|NCT03115112|66333595|FG000|Overall Study|Site closure|1|||
23715828|NCT03115112|66333596|FG001|Overall Study|Site closure|1|||
23715829|NCT03521193|66333597|FG000|Overall Study|Withdrawal by Subject|8|||
23715830|NCT03521193|66333598|FG001|Overall Study|Withdrawal by Subject|0|||
23715831|NCT03521193|66333597|FG000|Overall Study|non compliant to ASA treatment|8|||
23715832|NCT03521193|66333598|FG001|Overall Study|non compliant to ASA treatment|0|||
23715833|NCT01313208|66333605|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
23715834|NCT01313208|66333606|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
23715835|NCT01313208|66333605|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
23715836|NCT01313208|66333606|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
23715837|NCT01313208|66333605|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
23715838|NCT01313208|66333606|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
23715839|NCT01313208|66333605|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
23715840|NCT01313208|66333606|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
23715841|NCT01313208|66333605|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
23715842|NCT01313208|66333606|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
23715843|NCT01313208|66333605|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
23715844|NCT01313208|66333606|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
23715845|NCT01313208|66333605|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
23715846|NCT01313208|66333606|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
23715847|NCT01313208|66333605|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
23417186|NCT00281099|65271457|FG000|Overall Study|Withdrawal by Subject|65|||
23715848|NCT01313208|66333606|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
23715849|NCT01313208|66333605|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
23715850|NCT01313208|66333606|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
23715851|NCT02218372|66333607|FG000|Overall Study|Adverse Event|1|||
23715852|NCT02218372|66333608|FG001|Overall Study|Adverse Event|1|||
23715853|NCT02218372|66333607|FG000|Overall Study|Miscellaneous|2|||
23715854|NCT02218372|66333608|FG001|Overall Study|Miscellaneous|1|||
23715855|NCT02218372|66333607|FG000|Overall Study|Randomized but did not receive treatment|2|||
23715856|NCT02218372|66333608|FG001|Overall Study|Randomized but did not receive treatment|3|||
23715857|NCT02218372|66333607|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23715858|NCT02218372|66333608|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23715859|NCT01374217|66333609|FG000|Overall Study|Lack of Efficacy|13|||
23715860|NCT05319080|66333610|FG000|Overall Study|Withdrawal by Subject|2|||
23715861|NCT05319080|66333610|FG000|Overall Study|Physician Decision|4|||
23715862|NCT00618449|66333611|FG000|Overall Study|Lost to Follow-up|98|||
23715863|NCT00618449|66333612|FG001|Overall Study|Lost to Follow-up|110|||
23715864|NCT00418379|66333613|FG000|Year 1|Adverse Event|9|||
23715865|NCT00418379|66333614|FG001|Year 1|Adverse Event|15|||
23715866|NCT00418379|66333615|FG002|Year 1|Adverse Event|3|||
23715867|NCT00418379|66333613|FG000|Year 1|Withdrawal by Subject|7|||
23715868|NCT00418379|66333614|FG001|Year 1|Withdrawal by Subject|8|||
23715869|NCT00418379|66333615|FG002|Year 1|Withdrawal by Subject|5|||
23715870|NCT00418379|66333613|FG000|Year 1|Any other reason not above-mentioned|2|||
23715871|NCT00418379|66333614|FG001|Year 1|Any other reason not above-mentioned|5|||
23715872|NCT00418379|66333615|FG002|Year 1|Any other reason not above-mentioned|7|||
23715873|NCT00418379|66333613|FG000|Year 2|Adverse Event|5|||
23715874|NCT00418379|66333614|FG001|Year 2|Adverse Event|2|||
23715875|NCT00418379|66333615|FG002|Year 2|Adverse Event|1|||
23715876|NCT00418379|66333613|FG000|Year 2|Withdrawal by Subject|1|||
23715877|NCT00418379|66333614|FG001|Year 2|Withdrawal by Subject|1|||
23715878|NCT00418379|66333615|FG002|Year 2|Withdrawal by Subject|3|||
23715879|NCT00418379|66333613|FG000|Year 2|Any other reason not above-mentioned|2|||
23715880|NCT00418379|66333614|FG001|Year 2|Any other reason not above-mentioned|1|||
23715881|NCT00418379|66333615|FG002|Year 2|Any other reason not above-mentioned|6|||
23715882|NCT00418379|66333613|FG000|Year 3|Withdrawal by Subject|1|||
23715883|NCT00418379|66333614|FG001|Year 3|Withdrawal by Subject|1|||
23715884|NCT00418379|66333615|FG002|Year 3|Withdrawal by Subject|2|||
23715885|NCT00418379|66333613|FG000|Year 3|Any other reason not above-mentioned|2|||
23715886|NCT00418379|66333614|FG001|Year 3|Any other reason not above-mentioned|1|||
23715887|NCT00418379|66333615|FG002|Year 3|Any other reason not above-mentioned|1|||
23715888|NCT00418379|66333613|FG000|Year 4|Adverse Event|0|||
23715889|NCT00418379|66333614|FG001|Year 4|Adverse Event|1|||
23715890|NCT00418379|66333615|FG002|Year 4|Adverse Event|0|||
23715891|NCT00418379|66333613|FG000|Year 4|Withdrawal by Subject|2|||
23715892|NCT00418379|66333614|FG001|Year 4|Withdrawal by Subject|3|||
23715893|NCT00418379|66333615|FG002|Year 4|Withdrawal by Subject|2|||
23715894|NCT00418379|66333613|FG000|Year 4|Any other reason not above-mentioned|1|||
23715895|NCT00418379|66333614|FG001|Year 4|Any other reason not above-mentioned|1|||
23715896|NCT00418379|66333615|FG002|Year 4|Any other reason not above-mentioned|0|||
23525105|NCT00615056|65661648|FG000|Overall Study|Other|13|||
23525106|NCT00615056|65661649|FG001|Overall Study|Other|15|||
23525107|NCT00615056|65661650|FG002|Overall Study|Other|10|||
23525108|NCT00615056|65661651|FG003|Overall Study|Other|7|||
23525109|NCT00615056|65661648|FG000|Overall Study|Objective progression or relapse|0|||
23525110|NCT00615056|65661649|FG001|Overall Study|Objective progression or relapse|2|||
23525111|NCT00615056|65661650|FG002|Overall Study|Objective progression or relapse|0|||
23525112|NCT00615056|65661651|FG003|Overall Study|Objective progression or relapse|0|||
23525113|NCT00615056|65661648|FG000|Overall Study|Withdrawal by Subject|0|||
23525114|NCT00615056|65661649|FG001|Overall Study|Withdrawal by Subject|1|||
23525115|NCT00615056|65661650|FG002|Overall Study|Withdrawal by Subject|1|||
23525116|NCT00615056|65661651|FG003|Overall Study|Withdrawal by Subject|0|||
23525117|NCT00615056|65661648|FG000|Overall Study|Discontinued by Sponsor|1|||
23525118|NCT00615056|65661649|FG001|Overall Study|Discontinued by Sponsor|0|||
23525119|NCT00615056|65661650|FG002|Overall Study|Discontinued by Sponsor|0|||
23525120|NCT00615056|65661651|FG003|Overall Study|Discontinued by Sponsor|0|||
23525121|NCT00615056|65661648|FG000|Overall Study|Randomized but not treated|3|||
23525122|NCT00615056|65661649|FG001|Overall Study|Randomized but not treated|0|||
23525123|NCT00615056|65661650|FG002|Overall Study|Randomized but not treated|0|||
23525124|NCT00615056|65661651|FG003|Overall Study|Randomized but not treated|0|||
23525125|NCT02155738|65661652|FG000|Overall Study|Missing critical information|1|||
23525126|NCT02155738|65661653|FG001|Overall Study|Missing critical information|0|||
23715897|NCT00418379|66333613|FG000|Year 5|Adverse Event|0|||
23715898|NCT00418379|66333614|FG001|Year 5|Adverse Event|1|||
23715899|NCT00418379|66333615|FG002|Year 5|Adverse Event|0|||
23715900|NCT00418379|66333613|FG000|Year 5|Any other reason not above-mentioned|2|||
23715901|NCT00418379|66333614|FG001|Year 5|Any other reason not above-mentioned|4|||
23715902|NCT00418379|66333615|FG002|Year 5|Any other reason not above-mentioned|3|||
23525127|NCT02155738|65661654|FG002|Overall Study|Missing critical information|0|||
23525128|NCT02155738|65661655|FG003|Overall Study|Missing critical information|1|||
23525129|NCT03149237|65661656|FG000|Overall Study|Withdrawal by Subject|4|||
23715903|NCT04348656|66333616|FG000|Overall Study|Withdrawal by Subject|2|||
23715904|NCT04348656|66333617|FG001|Overall Study|Withdrawal by Subject|0|||
23715905|NCT04348656|66333616|FG000|Overall Study|Lost to Follow-up|11|||
23715906|NCT04348656|66333617|FG001|Overall Study|Lost to Follow-up|6|||
23715907|NCT00664209|66333619|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
23715908|NCT00664209|66333619|FG000|Study Treatment Period|Physician Decision|4|||
23715909|NCT00664209|66333619|FG000|Study Treatment Period|Withdrawal by Subject|2|||
23715910|NCT00779324|66333620|FG000|Overall Study|Lost to Follow-up|2|||
23715911|NCT00779324|66333621|FG001|Overall Study|Lost to Follow-up|1|||
23715912|NCT00779324|66333620|FG000|Overall Study|Withdrawal by Subject|4|||
23715913|NCT00779324|66333621|FG001|Overall Study|Withdrawal by Subject|2|||
23715914|NCT00779324|66333620|FG000|Overall Study|Missed visit|1|||
23715915|NCT00779324|66333621|FG001|Overall Study|Missed visit|1|||
23715916|NCT00868166|66333623|FG000|Overall Study|Death|58|||
23715917|NCT00868166|66333624|FG001|Overall Study|Death|65|||
23715918|NCT00868166|66333623|FG000|Overall Study|Withdrawal by Subject|33|||
23715919|NCT00868166|66333624|FG001|Overall Study|Withdrawal by Subject|25|||
23715920|NCT00868166|66333623|FG000|Overall Study|Protocol Violation|1|||
23715921|NCT00868166|66333624|FG001|Overall Study|Protocol Violation|0|||
23715922|NCT00868166|66333623|FG000|Overall Study|Lost to Follow-up|1|||
23715923|NCT00868166|66333624|FG001|Overall Study|Lost to Follow-up|3|||
23715924|NCT00868166|66333623|FG000|Overall Study|Adverse Event|9|||
23715925|NCT00868166|66333624|FG001|Overall Study|Adverse Event|10|||
23715926|NCT00868166|66333623|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
23715927|NCT00868166|66333624|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
23715928|NCT00868166|66333623|FG000|Overall Study|Non-compliance with IMP|1|||
23715929|NCT00868166|66333624|FG001|Overall Study|Non-compliance with IMP|1|||
23417187|NCT00281099|65271458|FG001|Overall Study|Withdrawal by Subject|70|||
23417188|NCT00281099|65271457|FG000|Overall Study|Physician Decision|79|||
23417189|NCT00281099|65271458|FG001|Overall Study|Physician Decision|72|||
23417190|NCT00281099|65271457|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
23417191|NCT00281099|65271458|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
23417192|NCT00957944|65271460|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
23417193|NCT00957944|65271461|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
23417194|NCT03276026|65271466|FG000|Overall Study|Protocol Violation|1|||
23417195|NCT03276026|65271467|FG001|Overall Study|Protocol Violation|0|||
23417196|NCT02449889|65271468|FG000|Overall Study|Adverse Event|1|||
23417197|NCT02449889|65271469|FG001|Overall Study|Adverse Event|2|||
23417198|NCT02449889|65271470|FG002|Overall Study|Adverse Event|0|||
23417199|NCT02449889|65271468|FG000|Overall Study|Protocol Violation|0|||
23417200|NCT02449889|65271469|FG001|Overall Study|Protocol Violation|4|||
23417201|NCT02449889|65271470|FG002|Overall Study|Protocol Violation|1|||
23417202|NCT00347438|65271471|FG000|Overall Study|Withdrawal by Subject|1|||
23417203|NCT00347438|65271471|FG000|Overall Study|Physician Decision|1|||
23417204|NCT00176488|65271472|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
23417205|NCT01005316|65271473|FG000|Overall Study|Adverse Event|0|||
23417206|NCT01005316|65271474|FG001|Overall Study|Adverse Event|0|||
23417207|NCT01005316|65271475|FG002|Overall Study|Adverse Event|0|||
23417208|NCT01005316|65271476|FG003|Overall Study|Adverse Event|1|||
23417209|NCT01005316|65271473|FG000|Overall Study|Death|20|||
23417210|NCT01005316|65271474|FG001|Overall Study|Death|5|||
23417211|NCT01005316|65271475|FG002|Overall Study|Death|1|||
23417212|NCT01005316|65271476|FG003|Overall Study|Death|15|||
23417213|NCT01005316|65271473|FG000|Overall Study|Study Termination|5|||
23417214|NCT01005316|65271474|FG001|Overall Study|Study Termination|63|||
23417215|NCT01005316|65271475|FG002|Overall Study|Study Termination|9|||
23417216|NCT01005316|65271476|FG003|Overall Study|Study Termination|85|||
23417217|NCT01005316|65271473|FG000|Overall Study|Lost to Follow-up|1|||
23417218|NCT01005316|65271474|FG001|Overall Study|Lost to Follow-up|3|||
23417219|NCT01005316|65271475|FG002|Overall Study|Lost to Follow-up|0|||
23417220|NCT01005316|65271476|FG003|Overall Study|Lost to Follow-up|2|||
23417221|NCT01005316|65271473|FG000|Overall Study|Physician Decision|6|||
23417222|NCT01005316|65271474|FG001|Overall Study|Physician Decision|0|||
23417223|NCT01005316|65271475|FG002|Overall Study|Physician Decision|0|||
23417224|NCT01005316|65271476|FG003|Overall Study|Physician Decision|0|||
23417225|NCT01005316|65271473|FG000|Overall Study|Sponsor Decision|6|||
23417226|NCT01005316|65271474|FG001|Overall Study|Sponsor Decision|3|||
23417227|NCT01005316|65271475|FG002|Overall Study|Sponsor Decision|0|||
23417228|NCT01005316|65271476|FG003|Overall Study|Sponsor Decision|0|||
23417229|NCT01005316|65271473|FG000|Overall Study|Withdrawal by Subject|1|||
23417230|NCT01005316|65271474|FG001|Overall Study|Withdrawal by Subject|1|||
23417231|NCT01005316|65271475|FG002|Overall Study|Withdrawal by Subject|0|||
23715930|NCT01431144|66333625|FG000|Overall Study|Implant mobility and removal|2|||
23417232|NCT01005316|65271476|FG003|Overall Study|Withdrawal by Subject|2|||
23417233|NCT01005316|65271473|FG000|Overall Study|Consented to Another Study|2|||
23417234|NCT01005316|65271474|FG001|Overall Study|Consented to Another Study|0|||
23715931|NCT01431144|66333626|FG001|Overall Study|Implant mobility and removal|0|||
23715932|NCT04603391|66333627|FG000|First Intervention (4 Days)|Adverse Event|1|||
23417235|NCT01005316|65271475|FG002|Overall Study|Consented to Another Study|0|||
23417236|NCT01005316|65271476|FG003|Overall Study|Consented to Another Study|0|||
23417237|NCT01005316|65271473|FG000|Overall Study|Delisted|8|||
23417238|NCT01005316|65271474|FG001|Overall Study|Delisted|0|||
23417239|NCT01005316|65271475|FG002|Overall Study|Delisted|0|||
23417240|NCT01005316|65271476|FG003|Overall Study|Delisted|0|||
23417241|NCT01005316|65271473|FG000|Overall Study|Transferred Care|1|||
23417242|NCT01005316|65271474|FG001|Overall Study|Transferred Care|0|||
23417243|NCT01005316|65271475|FG002|Overall Study|Transferred Care|1|||
23417244|NCT01005316|65271476|FG003|Overall Study|Transferred Care|3|||
23417245|NCT01005316|65271473|FG000|Overall Study|Retransplanted|0|||
23417246|NCT01005316|65271474|FG001|Overall Study|Retransplanted|1|||
23417247|NCT01005316|65271475|FG002|Overall Study|Retransplanted|0|||
23417248|NCT01005316|65271476|FG003|Overall Study|Retransplanted|0|||
23417249|NCT00336284|65271477|FG000|Overall Study|Death|52|||
23417250|NCT00336284|65271478|FG001|Overall Study|Death|26|||
23417251|NCT00336284|65271477|FG000|Overall Study|Lost to Follow-up|82|||
23417252|NCT00336284|65271478|FG001|Overall Study|Lost to Follow-up|61|||
23417253|NCT00336284|65271477|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
23417254|NCT00336284|65271478|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
23417255|NCT00578877|65271479|FG000|Overall Study|Lost to Follow-up|8|||
23417256|NCT00578877|65271480|FG001|Overall Study|Lost to Follow-up|10|||
23417257|NCT00578877|65271479|FG000|Overall Study|early discontinue|61|||
23417258|NCT00578877|65271480|FG001|Overall Study|early discontinue|101|||
23417259|NCT00578877|65271479|FG000|Overall Study|did not provide follow-up data|12|||
23417260|NCT00578877|65271480|FG001|Overall Study|did not provide follow-up data|17|||
23417261|NCT01610713|65271483|FG000|Overall Study|Adverse Event|3|||
23417262|NCT01610713|65271484|FG001|Overall Study|Adverse Event|0|||
23417263|NCT01610713|65271483|FG000|Overall Study|Lack of Efficacy|1|||
23417264|NCT01610713|65271484|FG001|Overall Study|Lack of Efficacy|0|||
23417265|NCT01610713|65271483|FG000|Overall Study|low mood and poor motivation|1|||
23417266|NCT01610713|65271484|FG001|Overall Study|low mood and poor motivation|0|||
23417267|NCT01610713|65271483|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
23417268|NCT01610713|65271484|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
23417269|NCT01610713|65271483|FG000|Overall Study|Lost to Follow-up|0|||
23417270|NCT01610713|65271484|FG001|Overall Study|Lost to Follow-up|1|||
23417271|NCT00616018|65271485|FG000|Overall Study|Protocol Violation|3|||
23417272|NCT03199053|65271492|FG000|ST Period|Withdrawal by Subject|2|||
23417273|NCT03199053|65271493|FG001|ST Period|Withdrawal by Subject|4|||
23417274|NCT03199053|65271494|FG002|ST Period|Withdrawal by Subject|6|||
23417275|NCT03199053|65271492|FG000|ST Period|Withdrawal by parent/guardian|1|||
23417276|NCT03199053|65271493|FG001|ST Period|Withdrawal by parent/guardian|1|||
23417277|NCT03199053|65271494|FG002|ST Period|Withdrawal by parent/guardian|1|||
23417278|NCT03199053|65271492|FG000|ST Period|Lost to Follow-up|2|||
23417279|NCT03199053|65271493|FG001|ST Period|Lost to Follow-up|0|||
23417280|NCT03199053|65271494|FG002|ST Period|Lost to Follow-up|1|||
23417281|NCT03199053|65271492|FG000|LT Period|Withdrawal by Subject|1|||
23417282|NCT03199053|65271493|FG001|LT Period|Withdrawal by Subject|3|||
23417283|NCT03199053|65271494|FG002|LT Period|Withdrawal by Subject|3|||
23417284|NCT03199053|65271492|FG000|LT Period|Withdrawal by parent/guardian|0|||
23417285|NCT03199053|65271493|FG001|LT Period|Withdrawal by parent/guardian|0|||
23417286|NCT03199053|65271494|FG002|LT Period|Withdrawal by parent/guardian|1|||
23417287|NCT03199053|65271492|FG000|LT Period|Lost to Follow-up|0|||
23417288|NCT03199053|65271493|FG001|LT Period|Lost to Follow-up|1|||
23417289|NCT03199053|65271494|FG002|LT Period|Lost to Follow-up|1|||
23417290|NCT03199053|65271492|FG000|LT Period|Miscellaneous|0|||
23417291|NCT03199053|65271493|FG001|LT Period|Miscellaneous|0|||
23417292|NCT03199053|65271494|FG002|LT Period|Miscellaneous|2|||
23417293|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
23417294|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
23417295|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
23417296|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
23417297|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
23417298|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
23417299|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
23417300|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
23417301|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
23417302|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
23417303|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
23417304|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
23417305|NCT00654745|65271495|FG000|Overall Study|Adverse Event|12|||
23417306|NCT00654745|65271495|FG000|Overall Study|Lost to Follow-up|7|||
23417307|NCT00654745|65271495|FG000|Overall Study|Protocol Violation|11|||
23417308|NCT00654745|65271495|FG000|Overall Study|Withdrawal by Subject|10|||
23525130|NCT03149237|65661657|FG001|Overall Study|Withdrawal by Subject|5|||
23417309|NCT00654745|65271495|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
23417310|NCT00396136|65271496|FG000|Overall Study|Death|43|||
23417311|NCT00396136|65271496|FG000|Overall Study|Withdrawal by Subject|59|||
23417312|NCT00396136|65271496|FG000|Overall Study|Lost to Follow-up|15|||
23417313|NCT00396136|65271496|FG000|Overall Study|Study device explanted|8|||
23417314|NCT01127607|65274264|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
23417315|NCT01127607|65274265|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
23417316|NCT01127607|65274264|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
23417317|NCT01127607|65274265|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
23417318|NCT01425359|65274266|FG000|Overall Study|Randomized but Not Treated|2|||
23417319|NCT01425359|65274267|FG001|Overall Study|Randomized but Not Treated|3|||
23812853|NCT01986010|66696057|FG016|Overall Study|Physician Decision|0|||
23812854|NCT01986010|66696041|FG000|Overall Study|Withdrawal by Subject|2|||
23812855|NCT01986010|66696042|FG001|Overall Study|Withdrawal by Subject|2|||
23812856|NCT01986010|66696043|FG002|Overall Study|Withdrawal by Subject|3|||
23417320|NCT01425359|65274266|FG000|Overall Study|Adverse Event|9|||
23417321|NCT01425359|65274267|FG001|Overall Study|Adverse Event|8|||
23417322|NCT01425359|65274266|FG000|Overall Study|Revascularization|0|||
23417323|NCT01425359|65274267|FG001|Overall Study|Revascularization|1|||
23417324|NCT01425359|65274266|FG000|Overall Study|Death|0|||
23417325|NCT01425359|65274267|FG001|Overall Study|Death|1|||
23417326|NCT01425359|65274266|FG000|Overall Study|Unsatisfactory Response|1|||
23417327|NCT01425359|65274267|FG001|Overall Study|Unsatisfactory Response|0|||
23417328|NCT01425359|65274266|FG000|Overall Study|Protocol Violation|1|||
23417329|NCT01425359|65274267|FG001|Overall Study|Protocol Violation|2|||
23417330|NCT01425359|65274266|FG000|Overall Study|Subject Withdrew Consent|1|||
23417331|NCT01425359|65274267|FG001|Overall Study|Subject Withdrew Consent|2|||
23417332|NCT01425359|65274266|FG000|Overall Study|Investigator's Discretion|2|||
23417333|NCT01425359|65274267|FG001|Overall Study|Investigator's Discretion|0|||
23417334|NCT01425359|65274266|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
23417335|NCT01425359|65274267|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
23417336|NCT05935878|65274276|FG000|Overall Study|Death|1|||
23417337|NCT05935878|65274277|FG001|Overall Study|Death|2|||
23417338|NCT05935878|65274276|FG000|Overall Study|Withdrawal by Subject|5|||
23417339|NCT05935878|65274277|FG001|Overall Study|Withdrawal by Subject|5|||
23417340|NCT05935878|65274276|FG000|Overall Study|Revision of implant|1|||
23417341|NCT05935878|65274277|FG001|Overall Study|Revision of implant|1|||
23417342|NCT05935878|65274276|FG000|Overall Study|Mobile bearing dislocation|0|||
23417343|NCT05935878|65274277|FG001|Overall Study|Mobile bearing dislocation|1|||
23417344|NCT02839720|65274278|FG000|Overall Study|Adverse Event|2|||
23417345|NCT02839720|65274278|FG000|Overall Study|Non-compliance|2|||
23417346|NCT02839720|65274278|FG000|Overall Study|Intercurrent Illness|1|||
23417347|NCT02839720|65274278|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
23417348|NCT05289271|65274282|FG000|Overall Study|Mistakenly allocated, untreated|1|||
23417349|NCT05289271|65274283|FG001|Overall Study|Mistakenly allocated, untreated|0|||
23417350|NCT03654040|65274285|FG000|Overall Study|Death|1|||
23417351|NCT03654040|65274286|FG001|Overall Study|Death|0|||
23417352|NCT03654040|65274285|FG000|Overall Study|Withdrawal by Subject|1|||
23417353|NCT03654040|65274286|FG001|Overall Study|Withdrawal by Subject|0|||
23715933|NCT04603391|66333628|FG001|First Intervention (4 Days)|Adverse Event|0|||
23715934|NCT04603391|66333627|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
23715935|NCT04603391|66333628|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
23715936|NCT02133742|66333637|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
23715937|NCT02133742|66333637|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
23715938|NCT02133742|66333637|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
23715939|NCT02133742|66333637|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
23715940|NCT02133742|66333637|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
23715941|NCT04724733|66333640|FG000|Overall Study|Lost to Follow-up|1|||
23715942|NCT04724733|66333641|FG001|Overall Study|Lost to Follow-up|1|||
23715943|NCT04724733|66333642|FG002|Overall Study|Lost to Follow-up|1|||
23715944|NCT03172481|66333643|FG000|Double-blind|Withdrawal by Subject|1|||
23715945|NCT03172481|66333644|FG001|Double-blind|Withdrawal by Subject|0|||
23715946|NCT01317615|66333645|FG000|Overall Study|Disease progression|25|||
23715947|NCT01317615|66333645|FG000|Overall Study|New cancer therapy|5|||
23715948|NCT01317615|66333645|FG000|Overall Study|Death|6|||
23715949|NCT01317615|66333645|FG000|Overall Study|Withdrawal by Subject|5|||
23715950|NCT01317615|66333645|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23812857|NCT01986010|66696044|FG003|Overall Study|Withdrawal by Subject|0|||
23417354|NCT03654040|65274285|FG000|Overall Study|Study terminated by sponsor|8|||
23417355|NCT03654040|65274286|FG001|Overall Study|Study terminated by sponsor|2|||
23715951|NCT01317615|66333645|FG000|Overall Study|Adverse Event|7|||
23715952|NCT05254613|66333646|FG000|Overall Study|Lost to Follow-up|0|||
23715953|NCT05254613|66333647|FG001|Overall Study|Lost to Follow-up|0|||
23812858|NCT01986010|66696045|FG004|Overall Study|Withdrawal by Subject|2|||
23417356|NCT03654040|65274285|FG000|Overall Study|Failure to initiate study therapy|2|||
23417357|NCT03654040|65274286|FG001|Overall Study|Failure to initiate study therapy|0|||
23417358|NCT03654040|65274285|FG000|Overall Study|Transplanted at another center|2|||
23417359|NCT03654040|65274286|FG001|Overall Study|Transplanted at another center|0|||
23417360|NCT03654040|65274285|FG000|Overall Study|Failure to meet eligibility criteria|14|||
23417361|NCT03654040|65274286|FG001|Overall Study|Failure to meet eligibility criteria|2|||
23715954|NCT05254613|66333648|FG002|Overall Study|Lost to Follow-up|1|||
23715955|NCT01769469|66333657|FG000|Overall Study|Consent Withdrawn|5|||
23715956|NCT01769469|66333657|FG000|Overall Study|Moved Out Of Area|3|||
23715957|NCT01769469|66333657|FG000|Overall Study|Lost to Follow-up|17|||
23715958|NCT01769469|66333657|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
23715959|NCT01769469|66333657|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
23715960|NCT02975700|66333658|FG000|Overall Study|Adverse Event|1|||
23715961|NCT02975700|66333658|FG000|Overall Study|Progressive disease|3|||
23715962|NCT02975700|66333658|FG000|Overall Study|Failed screening criteria|2|||
23715963|NCT02690207|66333659|FG000|Overall Study|Lost to Follow-up|48|||
23715964|NCT02690207|66333659|FG000|Overall Study|Withdrawal by Subject|46|||
23417362|NCT03654040|65274285|FG000|Overall Study|No longer transplant candidate|1|||
23417363|NCT03654040|65274286|FG001|Overall Study|No longer transplant candidate|0|||
23417364|NCT03654040|65274285|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
23417365|NCT03654040|65274286|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
23417366|NCT03654040|65274285|FG000|Overall Study|Recipient ineligible|0|||
23417367|NCT03654040|65274286|FG001|Overall Study|Recipient ineligible|2|||
23417368|NCT03654040|65274285|FG000|Overall Study|Received deceased liver|0|||
23417369|NCT03654040|65274286|FG001|Overall Study|Received deceased liver|1|||
23417370|NCT01939002|65274291|FG000|Overall Study|Adverse Event|13|||
23417371|NCT01939002|65274292|FG001|Overall Study|Adverse Event|13|||
23417372|NCT01939002|65274291|FG000|Overall Study|Withdrawal by Subject|5|||
23417373|NCT01939002|65274292|FG001|Overall Study|Withdrawal by Subject|3|||
23417374|NCT01939002|65274291|FG000|Overall Study|Other|1|||
23417375|NCT01939002|65274292|FG001|Overall Study|Other|2|||
23417376|NCT00227344|65274293|FG000|Overall Study|study terminated early|12|||
23417377|NCT00227344|65274294|FG001|Overall Study|study terminated early|5|||
23417378|NCT04123093|65274297|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
23417379|NCT04123093|65274298|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
23417380|NCT04123093|65274297|FG000|Phase 2|Physician Decision|0|||
23525131|NCT02114879|65661658|FG000|Overall Study|Withdrawal by Subject|9|||
23525132|NCT02114879|65661659|FG001|Overall Study|Withdrawal by Subject|5|||
23525133|NCT02114879|65661658|FG000|Overall Study|Death|6|||
23525134|NCT02114879|65661659|FG001|Overall Study|Death|11|||
23525135|NCT02114879|65661658|FG000|Overall Study|Lost to Follow-up|4|||
23525136|NCT02114879|65661659|FG001|Overall Study|Lost to Follow-up|6|||
23525137|NCT02114879|65661658|FG000|Overall Study|Physician Decision|0|||
23525138|NCT02114879|65661659|FG001|Overall Study|Physician Decision|2|||
23525139|NCT01982253|65661662|FG000|Overall Study|Withdrawal by Subject|1|||
23525140|NCT01982253|65661663|FG001|Overall Study|Withdrawal by Subject|0|||
23525141|NCT01982253|65661664|FG002|Overall Study|Withdrawal by Subject|0|||
23525142|NCT01982253|65661662|FG000|Overall Study|Study terminated by sponsor|1|||
23525143|NCT01982253|65661663|FG001|Overall Study|Study terminated by sponsor|4|||
23525144|NCT01982253|65661664|FG002|Overall Study|Study terminated by sponsor|4|||
23525145|NCT04238728|65661665|FG000|Overall Study|Withdrawal by Subject|1|||
23525146|NCT04238728|65661665|FG000|Overall Study|Lost to Follow-up|2|||
23525147|NCT00344773|65661666|FG000|Overall Study|Adverse Event|2|||
23525148|NCT00344773|65661666|FG000|Overall Study|Objective Disease Progression|16|||
23525149|NCT00344773|65661666|FG000|Overall Study|Withdrawal by Subject|1|||
23525150|NCT00344773|65661666|FG000|Overall Study|Not Eligible for the study|2|||
23525151|NCT00913744|65661669|FG000|Overall Study|Adverse Event|2|||
23525152|NCT00913744|65661670|FG001|Overall Study|Adverse Event|0|||
23525153|NCT00913744|65661669|FG000|Overall Study|Withdrawal by Subject|2|||
23525154|NCT00913744|65661670|FG001|Overall Study|Withdrawal by Subject|1|||
23525155|NCT00913744|65661669|FG000|Overall Study|Death|1|||
23525156|NCT00913744|65661670|FG001|Overall Study|Death|0|||
23525157|NCT00082433|65661678|FG000|Overall Study|Adverse Event|12|||
23525158|NCT00082433|65661679|FG001|Overall Study|Adverse Event|17|||
23525159|NCT00082433|65661678|FG000|Overall Study|Death|8|||
23525160|NCT00082433|65661679|FG001|Overall Study|Death|18|||
23525161|NCT00082433|65661678|FG000|Overall Study|Disease Progression/Relapse|270|||
23525162|NCT00082433|65661679|FG001|Overall Study|Disease Progression/Relapse|388|||
23525163|NCT00082433|65661678|FG000|Overall Study|Physician Decision|50|||
23525164|NCT00082433|65661679|FG001|Overall Study|Physician Decision|61|||
23525165|NCT00082433|65661678|FG000|Overall Study|Lost to Follow-up|1|||
23525166|NCT00082433|65661679|FG001|Overall Study|Lost to Follow-up|2|||
23525167|NCT00082433|65661678|FG000|Overall Study|Study Drug Toxicity|179|||
23525168|NCT00082433|65661679|FG001|Overall Study|Study Drug Toxicity|66|||
23715965|NCT02690207|66333659|FG000|Overall Study|Protocol Violation|2|||
23715966|NCT02690207|66333659|FG000|Overall Study|Serious adverse event|110|||
23417381|NCT04123093|65274298|FG001|Phase 2|Physician Decision|1|||
23417382|NCT04123093|65274297|FG000|Phase 2|Withdrawal by Subject|0|||
23417383|NCT04123093|65274298|FG001|Phase 2|Withdrawal by Subject|1|||
23525169|NCT00082433|65661678|FG000|Overall Study|Withdrawal by Subject|55|||
23525170|NCT00082433|65661679|FG001|Overall Study|Withdrawal by Subject|30|||
23525171|NCT00082433|65661678|FG000|Overall Study|Still On Treatment|2|||
23525172|NCT00082433|65661679|FG001|Overall Study|Still On Treatment|1|||
23715967|NCT02690207|66333659|FG000|Overall Study|Non-serious Adverse Event|18|||
23525173|NCT00082433|65661678|FG000|Overall Study|Not Treated|12|||
23525174|NCT00082433|65661679|FG001|Overall Study|Not Treated|11|||
23525175|NCT00082433|65661678|FG000|Overall Study|Ineligible|2|||
23525176|NCT00082433|65661679|FG001|Overall Study|Ineligible|1|||
23525177|NCT00082433|65661678|FG000|Overall Study|Noncompliance|2|||
23525178|NCT00082433|65661679|FG001|Overall Study|Noncompliance|1|||
23525179|NCT00082433|65661678|FG000|Overall Study|New primary cancer|1|||
23525180|NCT00082433|65661679|FG001|Overall Study|New primary cancer|0|||
23525181|NCT00082433|65661678|FG000|Overall Study|Impending surgery|0|||
23525182|NCT00082433|65661679|FG001|Overall Study|Impending surgery|1|||
23525183|NCT03161483|65661685|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525184|NCT03161483|65661686|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
23525185|NCT03161483|65661687|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525186|NCT03161483|65661688|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525187|NCT03161483|65661685|FG000|Treatment Period|Death|1|||
23525188|NCT03161483|65661686|FG001|Treatment Period|Death|0|||
23525189|NCT03161483|65661687|FG002|Treatment Period|Death|0|||
23525190|NCT03161483|65661688|FG003|Treatment Period|Death|0|||
23525191|NCT03161483|65661685|FG000|Treatment Period|Adverse Event|5|||
23525192|NCT03161483|65661686|FG001|Treatment Period|Adverse Event|2|||
23525193|NCT03161483|65661687|FG002|Treatment Period|Adverse Event|1|||
23525194|NCT03161483|65661688|FG003|Treatment Period|Adverse Event|11|||
23525195|NCT03161483|65661685|FG000|Treatment Period|Pregnancy|1|||
23525196|NCT03161483|65661686|FG001|Treatment Period|Pregnancy|0|||
23525197|NCT03161483|65661687|FG002|Treatment Period|Pregnancy|0|||
23525198|NCT03161483|65661688|FG003|Treatment Period|Pregnancy|0|||
23525199|NCT03161483|65661685|FG000|Treatment Period|Lack of Efficacy|0|||
23525200|NCT03161483|65661686|FG001|Treatment Period|Lack of Efficacy|0|||
23525201|NCT03161483|65661687|FG002|Treatment Period|Lack of Efficacy|0|||
23525202|NCT03161483|65661688|FG003|Treatment Period|Lack of Efficacy|1|||
23525203|NCT03161483|65661685|FG000|Treatment Period|Withdrawal by Subject|2|||
23525204|NCT03161483|65661686|FG001|Treatment Period|Withdrawal by Subject|5|||
23525205|NCT03161483|65661687|FG002|Treatment Period|Withdrawal by Subject|2|||
23525206|NCT03161483|65661688|FG003|Treatment Period|Withdrawal by Subject|6|||
23525207|NCT03161483|65661685|FG000|Treatment Period|Lost to Follow-up|0|||
23525208|NCT03161483|65661686|FG001|Treatment Period|Lost to Follow-up|0|||
23525209|NCT03161483|65661687|FG002|Treatment Period|Lost to Follow-up|0|||
23525210|NCT03161483|65661688|FG003|Treatment Period|Lost to Follow-up|1|||
23525211|NCT03161483|65661685|FG000|Treatment Period|Protocol Violation|0|||
23525212|NCT03161483|65661686|FG001|Treatment Period|Protocol Violation|0|||
23525213|NCT03161483|65661687|FG002|Treatment Period|Protocol Violation|0|||
23525214|NCT03161483|65661688|FG003|Treatment Period|Protocol Violation|1|||
23525215|NCT03161483|65661685|FG000|Treatment Period|Other reasons|1|||
23525216|NCT03161483|65661686|FG001|Treatment Period|Other reasons|1|||
23525217|NCT03161483|65661687|FG002|Treatment Period|Other reasons|0|||
23715968|NCT02690207|66333659|FG000|Overall Study|Migrated/moved from study area|5|||
23715969|NCT02690207|66333659|FG000|Overall Study|Suspected HZ Episode|1|||
23525218|NCT03161483|65661688|FG003|Treatment Period|Other reasons|0|||
23525219|NCT03238911|65661689|FG000|Overall Study|Withdrawal by Subject|1|||
23525220|NCT03238911|65661690|FG001|Overall Study|Withdrawal by Subject|2|||
23525221|NCT03238911|65661689|FG000|Overall Study|Lost to Follow-up|2|||
23525222|NCT03238911|65661690|FG001|Overall Study|Lost to Follow-up|1|||
23525223|NCT01428193|65661692|FG000|Overall Study|Physician Decision|1|||
23525224|NCT01428193|65661692|FG000|Overall Study|Elevated screening liver enzymes|1|||
23525225|NCT04145895|65661693|FG000|Overall Study|Physician Decision|2|||
23525226|NCT04145895|65661694|FG001|Overall Study|Physician Decision|0|||
23525227|NCT04145895|65661693|FG000|Overall Study|Withdrawal by Subject|0|||
23525228|NCT04145895|65661694|FG001|Overall Study|Withdrawal by Subject|2|||
23525229|NCT02659020|65661696|FG000|Overall Study|Adverse Event|0|||
23525230|NCT02659020|65661697|FG001|Overall Study|Adverse Event|0|||
23525231|NCT02659020|65661698|FG002|Overall Study|Adverse Event|0|||
23525232|NCT02659020|65661699|FG003|Overall Study|Adverse Event|2|||
23525233|NCT02659020|65661700|FG004|Overall Study|Adverse Event|0|||
23525234|NCT02659020|65661701|FG005|Overall Study|Adverse Event|0|||
23525235|NCT02659020|65661702|FG006|Overall Study|Adverse Event|2|||
23525236|NCT02659020|65661696|FG000|Overall Study|Lost to Follow-up|1|||
23525237|NCT02659020|65661697|FG001|Overall Study|Lost to Follow-up|2|||
23525238|NCT02659020|65661698|FG002|Overall Study|Lost to Follow-up|1|||
23525239|NCT02659020|65661699|FG003|Overall Study|Lost to Follow-up|6|||
23525240|NCT02659020|65661700|FG004|Overall Study|Lost to Follow-up|1|||
23525241|NCT02659020|65661701|FG005|Overall Study|Lost to Follow-up|5|||
23715970|NCT02690207|66333659|FG000|Overall Study|Other reasons for withdrawal|23|||
23525242|NCT02659020|65661702|FG006|Overall Study|Lost to Follow-up|0|||
23525243|NCT02659020|65661696|FG000|Overall Study|Physician Decision|0|||
23525244|NCT02659020|65661697|FG001|Overall Study|Physician Decision|0|||
23525245|NCT02659020|65661698|FG002|Overall Study|Physician Decision|0|||
23525246|NCT02659020|65661699|FG003|Overall Study|Physician Decision|1|||
23525247|NCT02659020|65661700|FG004|Overall Study|Physician Decision|1|||
23525248|NCT02659020|65661701|FG005|Overall Study|Physician Decision|0|||
23525249|NCT02659020|65661702|FG006|Overall Study|Physician Decision|1|||
23525250|NCT02659020|65661696|FG000|Overall Study|Withdrawal by Subject|2|||
23525251|NCT02659020|65661697|FG001|Overall Study|Withdrawal by Subject|1|||
23525252|NCT02659020|65661698|FG002|Overall Study|Withdrawal by Subject|0|||
23525253|NCT02659020|65661699|FG003|Overall Study|Withdrawal by Subject|3|||
23525254|NCT02659020|65661700|FG004|Overall Study|Withdrawal by Subject|3|||
23525255|NCT02659020|65661701|FG005|Overall Study|Withdrawal by Subject|6|||
23525256|NCT02659020|65661702|FG006|Overall Study|Withdrawal by Subject|3|||
23525257|NCT02659020|65661696|FG000|Overall Study|Progressive Disease|0|||
23525258|NCT02659020|65661697|FG001|Overall Study|Progressive Disease|0|||
23525259|NCT02659020|65661698|FG002|Overall Study|Progressive Disease|0|||
23525260|NCT02659020|65661699|FG003|Overall Study|Progressive Disease|4|||
23525261|NCT02659020|65661700|FG004|Overall Study|Progressive Disease|1|||
23525262|NCT02659020|65661701|FG005|Overall Study|Progressive Disease|0|||
23525263|NCT02659020|65661702|FG006|Overall Study|Progressive Disease|2|||
23525264|NCT01859715|65661719|FG000|Overall Study|No 2nd VAS|16|||
23525265|NCT01859715|65661720|FG001|Overall Study|No 2nd VAS|8|||
23525266|NCT01859715|65661721|FG002|Overall Study|No 2nd VAS|23|||
23525267|NCT00006916|65661722|FG000|Overall Study|Device not inserted|4|||
23525268|NCT00006916|65661722|FG000|Overall Study|Complication of device insertion|1|||
23525269|NCT00358527|65661723|FG000|Overall Study|Adverse Event|4|||
23525270|NCT00358527|65661724|FG001|Overall Study|Adverse Event|0|||
23525271|NCT00358527|65661723|FG000|Overall Study|Withdrawal by Subject|1|||
23525272|NCT00358527|65661724|FG001|Overall Study|Withdrawal by Subject|1|||
23525273|NCT00358527|65661723|FG000|Overall Study|Non-compliance with protocol|6|||
23525274|NCT00358527|65661724|FG001|Overall Study|Non-compliance with protocol|1|||
23525275|NCT00358527|65661723|FG000|Overall Study|Administrative|2|||
23525276|NCT00358527|65661724|FG001|Overall Study|Administrative|1|||
23525277|NCT02739269|65661729|FG000|Overall Study|Protocol Violation|5|||
23525278|NCT02739269|65661730|FG001|Overall Study|Protocol Violation|0|||
23715971|NCT01244191|66333660|FG000|Overall Study|Progressive disease|295|||
23715972|NCT01244191|66333661|FG001|Overall Study|Progressive disease|350|||
23715973|NCT01244191|66333660|FG000|Overall Study|Clinical disease progression|54|||
23715974|NCT01244191|66333661|FG001|Overall Study|Clinical disease progression|36|||
23715975|NCT01244191|66333660|FG000|Overall Study|Adverse Event|65|||
23715976|NCT01244191|66333661|FG001|Overall Study|Adverse Event|48|||
23715977|NCT01244191|66333660|FG000|Overall Study|Death|22|||
23715978|NCT01244191|66333661|FG001|Overall Study|Death|29|||
23715979|NCT01244191|66333660|FG000|Overall Study|Lost to Follow-up|0|||
23715980|NCT01244191|66333661|FG001|Overall Study|Lost to Follow-up|2|||
23715981|NCT01244191|66333660|FG000|Overall Study|Protocol Violation|1|||
23715982|NCT01244191|66333661|FG001|Overall Study|Protocol Violation|2|||
23715983|NCT01244191|66333660|FG000|Overall Study|Withdrawal by Subject|31|||
23715984|NCT01244191|66333661|FG001|Overall Study|Withdrawal by Subject|23|||
23715985|NCT01244191|66333660|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
23715986|NCT01244191|66333661|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
23715987|NCT00225147|66333662|FG000|Open-label Phase|Lost to Follow-up|0|||
23715988|NCT00225147|66333663|FG001|Open-label Phase|Lost to Follow-up|0|||
23715989|NCT00225147|66333664|FG002|Open-label Phase|Lost to Follow-up|0|||
23715990|NCT00225147|66333665|FG003|Open-label Phase|Lost to Follow-up|4|||
23715991|NCT00225147|66333662|FG000|Open-label Phase|Withdrawal by Subject|0|||
23715992|NCT00225147|66333663|FG001|Open-label Phase|Withdrawal by Subject|0|||
23525279|NCT02739269|65661729|FG000|Overall Study|Cycle cancellation|2|||
23525280|NCT02739269|65661730|FG001|Overall Study|Cycle cancellation|2|||
23525281|NCT02739269|65661729|FG000|Overall Study|Withdrawal by Subject|0|||
23525282|NCT02739269|65661730|FG001|Overall Study|Withdrawal by Subject|2|||
23525283|NCT00974571|65661731|FG000|Overall Study|Adverse Event|31|||
23525284|NCT00974571|65661732|FG001|Overall Study|Adverse Event|4|||
23715993|NCT00225147|66333664|FG002|Open-label Phase|Withdrawal by Subject|0|||
23715994|NCT00225147|66333665|FG003|Open-label Phase|Withdrawal by Subject|6|||
23715995|NCT00003476|66333666|FG000|Overall Study|Not evaluable|1|||
23715996|NCT03247413|66333671|FG000|Overall Study|Lost to Follow-up|28|||
23525285|NCT00974571|65661733|FG002|Overall Study|Adverse Event|27|||
23525286|NCT00974571|65661731|FG000|Overall Study|Lack of Efficacy|3|||
23525287|NCT00974571|65661732|FG001|Overall Study|Lack of Efficacy|2|||
23525288|NCT00974571|65661733|FG002|Overall Study|Lack of Efficacy|9|||
23715997|NCT02505542|66333672|FG000|Part A: Open-Label Period|Adverse Event|31|||
23715998|NCT02505542|66333673|FG001|Part A: Open-Label Period|Adverse Event|0|||
23715999|NCT02505542|66333674|FG002|Part A: Open-Label Period|Adverse Event|0|||
23716000|NCT02505542|66333675|FG003|Part A: Open-Label Period|Adverse Event|0|||
23716001|NCT02505542|66333672|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
23716002|NCT02505542|66333673|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
23525289|NCT00974571|65661731|FG000|Overall Study|Lost to Follow-up|2|||
23525290|NCT00974571|65661732|FG001|Overall Study|Lost to Follow-up|1|||
23525291|NCT00974571|65661733|FG002|Overall Study|Lost to Follow-up|2|||
23525292|NCT00974571|65661731|FG000|Overall Study|Protocol Violation|13|||
23525293|NCT00974571|65661732|FG001|Overall Study|Protocol Violation|4|||
23716003|NCT02505542|66333674|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
23716004|NCT02505542|66333675|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
23716005|NCT02505542|66333672|FG000|Part A: Open-Label Period|Protocol Violation|1|||
23716006|NCT02505542|66333673|FG001|Part A: Open-Label Period|Protocol Violation|0|||
23716007|NCT02505542|66333674|FG002|Part A: Open-Label Period|Protocol Violation|0|||
23716008|NCT02505542|66333675|FG003|Part A: Open-Label Period|Protocol Violation|0|||
23716009|NCT02505542|66333672|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
23716010|NCT02505542|66333673|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
23716011|NCT02505542|66333674|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
23716012|NCT02505542|66333675|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
23716013|NCT02505542|66333672|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
23716014|NCT02505542|66333673|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
23716015|NCT02505542|66333674|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
23716016|NCT02505542|66333675|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
23716017|NCT02505542|66333672|FG000|Part A: Open-Label Period|New medical history available|1|||
23716018|NCT02505542|66333673|FG001|Part A: Open-Label Period|New medical history available|0|||
23716019|NCT02505542|66333674|FG002|Part A: Open-Label Period|New medical history available|0|||
23716020|NCT02505542|66333675|FG003|Part A: Open-Label Period|New medical history available|0|||
23716021|NCT02505542|66333672|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
23716022|NCT02505542|66333673|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23716023|NCT02505542|66333674|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23716024|NCT02505542|66333675|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23716025|NCT02505542|66333672|FG000|Part A: Open-Label Period|Pregnancy|2|||
23716026|NCT02505542|66333673|FG001|Part A: Open-Label Period|Pregnancy|0|||
23716027|NCT02505542|66333674|FG002|Part A: Open-Label Period|Pregnancy|0|||
23716028|NCT02505542|66333675|FG003|Part A: Open-Label Period|Pregnancy|0|||
23716029|NCT02505542|66333672|FG000|Part A: Open-Label Period|Sponsor directive|1|||
23716030|NCT02505542|66333673|FG001|Part A: Open-Label Period|Sponsor directive|0|||
23716031|NCT02505542|66333674|FG002|Part A: Open-Label Period|Sponsor directive|0|||
23716032|NCT02505542|66333675|FG003|Part A: Open-Label Period|Sponsor directive|0|||
23716033|NCT02505542|66333672|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
23716034|NCT02505542|66333673|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
23716035|NCT02505542|66333674|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
23716036|NCT02505542|66333675|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
23716037|NCT02505542|66333672|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
23716038|NCT02505542|66333673|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23716039|NCT02505542|66333674|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23716040|NCT02505542|66333675|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23716041|NCT02505542|66333672|FG000|Part A: Open-Label Period|Non-compliance|1|||
23716042|NCT02505542|66333673|FG001|Part A: Open-Label Period|Non-compliance|0|||
23716043|NCT02505542|66333674|FG002|Part A: Open-Label Period|Non-compliance|0|||
23716044|NCT02505542|66333675|FG003|Part A: Open-Label Period|Non-compliance|0|||
23716045|NCT02505542|66333672|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
23716046|NCT02505542|66333673|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23716047|NCT02505542|66333674|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23716048|NCT02505542|66333675|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23716049|NCT02505542|66333672|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
23716050|NCT02505542|66333673|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23716051|NCT02505542|66333674|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23716052|NCT02505542|66333675|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23716053|NCT02505542|66333672|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
23716054|NCT02505542|66333673|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23716055|NCT02505542|66333674|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23716056|NCT02505542|66333675|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23716057|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Adverse Event|0|||
23716058|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Adverse Event|0|||
23716059|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Adverse Event|1|||
23716060|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Adverse Event|3|||
23716061|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
23716062|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
23716063|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
23716064|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
23716065|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
23716066|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
23716067|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
23716068|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
23812859|NCT01986010|66696046|FG005|Overall Study|Withdrawal by Subject|4|||
23716069|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
23716070|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
23716071|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
23716072|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
23716073|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
23716074|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
23716075|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
23716076|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
23716077|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
23716078|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
23716079|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
23716080|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
23716081|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
23716082|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
23716083|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
23716084|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
23716085|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Miscalculation|0|||
23716086|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Miscalculation|1|||
23716087|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Miscalculation|0|||
23716088|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Miscalculation|0|||
23716089|NCT02505542|66333672|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23716090|NCT02505542|66333673|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
23716091|NCT02505542|66333674|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23716092|NCT02505542|66333675|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23716093|NCT02702518|66333679|FG000|Overall Study|Lost to Follow-up|3|||
23716094|NCT02702518|66333680|FG001|Overall Study|Lost to Follow-up|4|||
23716095|NCT03371732|66336774|FG000|Overall Study|Withdrawal by Subject|9|||
23716096|NCT03371732|66336775|FG001|Overall Study|Withdrawal by Subject|3|||
23716097|NCT03371732|66336774|FG000|Overall Study|Refusal to continue|3|||
23716098|NCT03371732|66336775|FG001|Overall Study|Refusal to continue|4|||
23716099|NCT01074658|66336777|FG000|Overall Study|No implant attempted|19|||
23716100|NCT01199055|66336780|FG000|Overall Study|Death|0|||
23716101|NCT01199055|66336781|FG001|Overall Study|Death|1|||
23716102|NCT01199055|66336782|FG002|Overall Study|Death|0|||
23716103|NCT01199055|66336780|FG000|Overall Study|Physician Decision|0|||
23716104|NCT01199055|66336781|FG001|Overall Study|Physician Decision|1|||
23716105|NCT01199055|66336782|FG002|Overall Study|Physician Decision|1|||
23716106|NCT01199055|66336780|FG000|Overall Study|Progressive disease|2|||
23716107|NCT01199055|66336781|FG001|Overall Study|Progressive disease|1|||
23716108|NCT01199055|66336782|FG002|Overall Study|Progressive disease|2|||
23716109|NCT01199055|66336780|FG000|Overall Study|Withdrawal by Subject|0|||
23716110|NCT01199055|66336781|FG001|Overall Study|Withdrawal by Subject|0|||
23716111|NCT01199055|66336782|FG002|Overall Study|Withdrawal by Subject|1|||
23716112|NCT01601470|66336784|FG000|Period 2 - LCZ696|Physician Decision|1|||
23716113|NCT03803202|66336785|FG000|Overall Study|Other|0|||
23716114|NCT03803202|66336786|FG001|Overall Study|Other|1|||
23716115|NCT03803202|66336787|FG002|Overall Study|Other|0|||
23716116|NCT03803202|66336788|FG003|Overall Study|Other|0|||
23716117|NCT03803202|66336789|FG004|Overall Study|Other|0|||
23716118|NCT03803202|66336790|FG005|Overall Study|Other|0|||
23716119|NCT03803202|66336791|FG006|Overall Study|Other|0|||
23716120|NCT03803202|66336792|FG007|Overall Study|Other|0|||
23812860|NCT01986010|66696047|FG006|Overall Study|Withdrawal by Subject|0|||
23716121|NCT03803202|66336793|FG008|Overall Study|Other|0|||
23716122|NCT03803202|66336785|FG000|Overall Study|Death|0|||
23716123|NCT03803202|66336786|FG001|Overall Study|Death|0|||
23716124|NCT03803202|66336787|FG002|Overall Study|Death|0|||
23716125|NCT03803202|66336788|FG003|Overall Study|Death|0|||
23716126|NCT03803202|66336789|FG004|Overall Study|Death|0|||
23716127|NCT03803202|66336790|FG005|Overall Study|Death|1|||
23716128|NCT03803202|66336791|FG006|Overall Study|Death|0|||
23716129|NCT03803202|66336792|FG007|Overall Study|Death|0|||
23716130|NCT03803202|66336793|FG008|Overall Study|Death|0|||
23716131|NCT03803202|66336785|FG000|Overall Study|Withdrawal by Subject|0|||
23716132|NCT03803202|66336786|FG001|Overall Study|Withdrawal by Subject|0|||
23716133|NCT03803202|66336787|FG002|Overall Study|Withdrawal by Subject|1|||
23716134|NCT03803202|66336788|FG003|Overall Study|Withdrawal by Subject|0|||
23716135|NCT03803202|66336789|FG004|Overall Study|Withdrawal by Subject|0|||
23716136|NCT03803202|66336790|FG005|Overall Study|Withdrawal by Subject|0|||
23716137|NCT03803202|66336791|FG006|Overall Study|Withdrawal by Subject|0|||
23716138|NCT03803202|66336792|FG007|Overall Study|Withdrawal by Subject|1|||
23716139|NCT03803202|66336793|FG008|Overall Study|Withdrawal by Subject|0|||
23716140|NCT03803202|66336785|FG000|Overall Study|Lost to Follow-up|0|||
23716141|NCT03803202|66336786|FG001|Overall Study|Lost to Follow-up|0|||
23716142|NCT03803202|66336787|FG002|Overall Study|Lost to Follow-up|0|||
23716143|NCT03803202|66336788|FG003|Overall Study|Lost to Follow-up|1|||
23525294|NCT00974571|65661733|FG002|Overall Study|Protocol Violation|18|||
23525295|NCT00974571|65661731|FG000|Overall Study|Withdrawal by Subject|14|||
23525296|NCT00974571|65661732|FG001|Overall Study|Withdrawal by Subject|5|||
23716144|NCT03803202|66336789|FG004|Overall Study|Lost to Follow-up|1|||
23716145|NCT03803202|66336790|FG005|Overall Study|Lost to Follow-up|0|||
23525297|NCT00974571|65661733|FG002|Overall Study|Withdrawal by Subject|16|||
23525298|NCT00974571|65661731|FG000|Overall Study|Patient Moved|1|||
23525299|NCT00974571|65661732|FG001|Overall Study|Patient Moved|0|||
23525300|NCT00974571|65661733|FG002|Overall Study|Patient Moved|1|||
23525301|NCT00974571|65661731|FG000|Overall Study|Other|4|||
23525302|NCT00974571|65661732|FG001|Overall Study|Other|0|||
23525303|NCT00974571|65661733|FG002|Overall Study|Other|10|||
23525304|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
23525305|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
23525306|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23525307|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525308|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525309|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525310|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525311|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525312|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
23525313|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525314|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525315|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525316|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
23525317|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
23525318|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
23525319|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525320|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525321|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525322|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525323|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525324|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
23525325|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525326|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23716146|NCT03803202|66336791|FG006|Overall Study|Lost to Follow-up|1|||
23716147|NCT03803202|66336792|FG007|Overall Study|Lost to Follow-up|0|||
23716148|NCT03803202|66336793|FG008|Overall Study|Lost to Follow-up|0|||
23716149|NCT00676208|66336794|FG000|Overall Study|Lost to Follow-up|0|||
23716150|NCT00676208|66336795|FG001|Overall Study|Lost to Follow-up|2|||
23716151|NCT00676208|66336794|FG000|Overall Study|Incomplete data|2|||
23716152|NCT00676208|66336795|FG001|Overall Study|Incomplete data|4|||
23716153|NCT02293902|66336805|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
23716154|NCT02293902|66336806|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
23716155|NCT02293902|66336807|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
23716156|NCT02293902|66336808|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
23716157|NCT02293902|66336809|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
23716158|NCT02293902|66336805|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
23716159|NCT02293902|66336806|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
23716160|NCT02293902|66336807|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
23716161|NCT02293902|66336808|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
23716162|NCT02293902|66336809|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
23716163|NCT02293902|66336805|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
23716164|NCT02293902|66336806|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23716165|NCT02293902|66336807|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23716166|NCT02293902|66336808|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23716167|NCT02293902|66336809|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23716168|NCT02293902|66336805|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
23716169|NCT02293902|66336806|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
23525327|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525328|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23525329|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23716170|NCT02293902|66336807|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
23716171|NCT02293902|66336808|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
23716172|NCT02293902|66336809|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
23716173|NCT02293902|66336805|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23716174|NCT02293902|66336806|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
23716175|NCT02293902|66336807|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
23716176|NCT02293902|66336808|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23716177|NCT02293902|66336809|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23716178|NCT00282568|66336817|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
23716179|NCT00282568|66336817|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
23716180|NCT00282568|66336817|FG000|Extended Treatment Period|Adverse Event|17|||
23716181|NCT00282568|66336817|FG000|Extended Treatment Period|Non-compliance|4|||
23716182|NCT00282568|66336817|FG000|Extended Treatment Period|Physician Decision|1|||
23716183|NCT00282568|66336817|FG000|Extended Treatment Period|Lost to Follow-up|2|||
23716184|NCT00493974|66336820|FG000|Overall Study|Death|1|||
23716185|NCT00493974|66336821|FG001|Overall Study|Death|2|||
23716186|NCT00493974|66336820|FG000|Overall Study|Withdrawal by Subject|8|||
23716187|NCT00493974|66336821|FG001|Overall Study|Withdrawal by Subject|6|||
23716188|NCT00493974|66336820|FG000|Overall Study|Lost to Follow-up|4|||
23716189|NCT00493974|66336821|FG001|Overall Study|Lost to Follow-up|6|||
23716190|NCT01283997|66336822|FG000|Overall Study|Physician Decision|8|||
23716191|NCT01283997|66336823|FG001|Overall Study|Physician Decision|10|||
23716192|NCT01283997|66336822|FG000|Overall Study|Withdrawal by Subject|3|||
23716193|NCT01283997|66336823|FG001|Overall Study|Withdrawal by Subject|2|||
23716194|NCT01283997|66336822|FG000|Overall Study|Physically unable to continue|0|||
23716195|NCT01283997|66336823|FG001|Overall Study|Physically unable to continue|1|||
23716196|NCT01283997|66336822|FG000|Overall Study|Progressive disease|1|||
23716197|NCT01283997|66336823|FG001|Overall Study|Progressive disease|0|||
23716198|NCT01283997|66336822|FG000|Overall Study|Other|4|||
23716199|NCT01283997|66336823|FG001|Overall Study|Other|4|||
23716200|NCT05631548|66336825|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
23716201|NCT05631548|66336826|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
23716202|NCT03454412|66336840|FG000|Baseline Assesment|Physician Decision|12|||
23716203|NCT02261883|66336841|FG000|Overall Study|Death|3|||
23716204|NCT02261883|66336842|FG001|Overall Study|Death|2|||
23716205|NCT02261883|66336841|FG000|Overall Study|Physician Decision|1|||
23716206|NCT02261883|66336842|FG001|Overall Study|Physician Decision|0|||
23812861|NCT01986010|66696048|FG007|Overall Study|Withdrawal by Subject|0|||
23812862|NCT01986010|66696049|FG008|Overall Study|Withdrawal by Subject|0|||
23525330|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23716207|NCT02261883|66336841|FG000|Overall Study|Protocol Violation|1|||
23716208|NCT02261883|66336842|FG001|Overall Study|Protocol Violation|0|||
23716209|NCT02261883|66336841|FG000|Overall Study|Withdrawal by Subject|0|||
23716210|NCT02261883|66336842|FG001|Overall Study|Withdrawal by Subject|1|||
23716211|NCT02261883|66336841|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
23716212|NCT02261883|66336842|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
23716213|NCT01188096|66336843|FG000|Overall Study|progression of disease|4|||
23716214|NCT01188096|66336843|FG000|Overall Study|Withdrawal by Subject|2|||
23716215|NCT04585451|66336845|FG000|Overall Study|Withdrawal by Subject|26|||
23716216|NCT04585451|66336846|FG001|Overall Study|Withdrawal by Subject|0|||
23716217|NCT00839423|66336855|FG000|Overall Study|Adverse Event|4|||
23716218|NCT00839423|66336856|FG001|Overall Study|Adverse Event|3|||
23716219|NCT00839423|66336857|FG002|Overall Study|Adverse Event|7|||
23716220|NCT00839423|66336858|FG003|Overall Study|Adverse Event|16|||
23716221|NCT00839423|66336855|FG000|Overall Study|Lack of Efficacy|6|||
23716222|NCT00839423|66336856|FG001|Overall Study|Lack of Efficacy|6|||
23716223|NCT00839423|66336857|FG002|Overall Study|Lack of Efficacy|3|||
23716224|NCT00839423|66336858|FG003|Overall Study|Lack of Efficacy|2|||
23417384|NCT01774097|65274301|FG000|Overall Study|Withdrawal by Subject|1|||
23417385|NCT01774097|65274302|FG001|Overall Study|Withdrawal by Subject|1|||
23417386|NCT01774097|65274301|FG000|Overall Study|Adverse Event|1|||
23417387|NCT01774097|65274302|FG001|Overall Study|Adverse Event|1|||
23417388|NCT01535599|65274306|FG000|Overall Study|Adverse Event|6|||
23417389|NCT01535599|65274307|FG001|Overall Study|Adverse Event|15|||
23417390|NCT01535599|65274306|FG000|Overall Study|Lost to Follow-up|3|||
23417391|NCT01535599|65274307|FG001|Overall Study|Lost to Follow-up|4|||
23417392|NCT01535599|65274306|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
23417393|NCT01535599|65274307|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
23417394|NCT01535599|65274306|FG000|Overall Study|Treatment Failure|33|||
23417395|NCT01535599|65274307|FG001|Overall Study|Treatment Failure|66|||
23417396|NCT01535599|65274306|FG000|Overall Study|BL Culture + for Group A Strep|0|||
23417397|NCT01535599|65274307|FG001|Overall Study|BL Culture + for Group A Strep|1|||
23417398|NCT01535599|65274306|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
23417399|NCT01535599|65274307|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
23417400|NCT01535599|65274306|FG000|Overall Study|Randomized in Error|2|||
23417401|NCT01535599|65274307|FG001|Overall Study|Randomized in Error|4|||
23417402|NCT01535599|65274306|FG000|Overall Study|Did not use product|1|||
23417403|NCT01535599|65274307|FG001|Overall Study|Did not use product|0|||
23417404|NCT01535599|65274306|FG000|Overall Study|Other|1|||
23417405|NCT01535599|65274307|FG001|Overall Study|Other|0|||
23417406|NCT01535599|65274306|FG000|Overall Study|Stopped medication|0|||
23417407|NCT01535599|65274307|FG001|Overall Study|Stopped medication|1|||
23417408|NCT01535599|65274306|FG000|Overall Study|Noncompliance|0|||
23417409|NCT01535599|65274307|FG001|Overall Study|Noncompliance|1|||
23525331|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
23525332|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
23525333|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
23525334|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525335|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525336|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525337|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
23716225|NCT00839423|66336855|FG000|Overall Study|Non-compliance|0|||
23716226|NCT00839423|66336856|FG001|Overall Study|Non-compliance|0|||
23417410|NCT01257568|65274308|FG000|Overall Study|Lost to Follow-up|2|||
23417411|NCT01257568|65274308|FG000|Overall Study|Withdrawal by Subject|6|||
23417412|NCT01257568|65274308|FG000|Overall Study|Terminated|1|||
23417413|NCT01257568|65274308|FG000|Overall Study|Component Revision|24|||
23417414|NCT03350256|65274313|FG000|Overall Study|Inclusion/exclusion violation|4|||
23417415|NCT03350256|65274313|FG000|Overall Study|Recommended for other therapies|2|||
23417416|NCT03350256|65274313|FG000|Overall Study|Protocol Violation|3|||
23417417|NCT03350256|65274313|FG000|Overall Study|Non compliance|2|||
23417418|NCT03350256|65274313|FG000|Overall Study|Denial by insurance|1|||
23417419|NCT03350256|65274313|FG000|Overall Study|Adverse Event|2|||
23525338|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23716227|NCT00839423|66336857|FG002|Overall Study|Non-compliance|0|||
23716228|NCT00839423|66336858|FG003|Overall Study|Non-compliance|1|||
23716229|NCT00839423|66336855|FG000|Overall Study|Protocol Violation|0|||
23716230|NCT00839423|66336856|FG001|Overall Study|Protocol Violation|1|||
23716231|NCT00839423|66336857|FG002|Overall Study|Protocol Violation|2|||
23417420|NCT03350256|65274313|FG000|Overall Study|Trial failure|12|||
23417421|NCT03350256|65274313|FG000|Overall Study|Did not proceed to permanent implant|3|||
23417422|NCT03350256|65274313|FG000|Overall Study|Withdrawal by Subject|3|||
23417423|NCT03350256|65274313|FG000|Overall Study|Subject moving out of state|1|||
23417424|NCT03350256|65274313|FG000|Overall Study|Lost to Follow-up|1|||
23417425|NCT03350256|65274313|FG000|Overall Study|Lack of Efficacy|2|||
23417426|NCT03070171|65274314|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
23417427|NCT03070171|65274315|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
23417428|NCT03070171|65274314|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
23417429|NCT03070171|65274315|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
23417430|NCT02019108|65274316|FG000|Overall Study|Lost to Follow-up|5|||
23417431|NCT02019108|65274317|FG001|Overall Study|Lost to Follow-up|7|||
23417432|NCT02461290|65274318|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
23417433|NCT02461290|65274318|FG000|Overall Study|Lost to Follow-up|3|||
23417434|NCT02447250|65274319|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
23417435|NCT02447250|65274319|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
23417436|NCT02447250|65274319|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
23417437|NCT02152371|65274320|FG000|Overall Study|Adverse Event|6|||
23417438|NCT02152371|65274321|FG001|Overall Study|Adverse Event|2|||
23417439|NCT02152371|65274320|FG000|Overall Study|Withdrawal by Subject|3|||
23417440|NCT02152371|65274321|FG001|Overall Study|Withdrawal by Subject|7|||
23417441|NCT02152371|65274320|FG000|Overall Study|Protocol Violation|2|||
23417442|NCT02152371|65274321|FG001|Overall Study|Protocol Violation|3|||
23417443|NCT02152371|65274320|FG000|Overall Study|Lost to Follow-up|1|||
23417444|NCT02152371|65274321|FG001|Overall Study|Lost to Follow-up|0|||
23417445|NCT02152371|65274320|FG000|Overall Study|Lack of Efficacy|0|||
23417446|NCT02152371|65274321|FG001|Overall Study|Lack of Efficacy|1|||
23417447|NCT02152371|65274320|FG000|Overall Study|Physician Decision|0|||
23417448|NCT02152371|65274321|FG001|Overall Study|Physician Decision|2|||
23417449|NCT02152371|65274320|FG000|Overall Study|Reason Not Given|0|||
23417450|NCT02152371|65274321|FG001|Overall Study|Reason Not Given|1|||
23417451|NCT00066222|65274322|FG000|Overall Study|No protocol treatment received|1|||
23417452|NCT02524275|65274323|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
23417453|NCT03037476|65274327|FG000|Overall Study|Lost to Follow-up|63|||
23417454|NCT03037476|65274328|FG001|Overall Study|Lost to Follow-up|46|||
23417455|NCT01369641|65274330|FG000|Overall Study|Withdrawal by Subject|1|||
23417456|NCT03650803|65274338|FG000|Overall Study|Lost to Follow-up|6|||
23417457|NCT01944098|65274339|FG000|Overall Study|Physician Decision|1|||
23417458|NCT01944098|65274340|FG001|Overall Study|Physician Decision|0|||
23417459|NCT02256384|65274341|FG000|Overall Study|Withdrawal by Subject|12|||
23417460|NCT02256384|65274341|FG000|Overall Study|Equipment not capturing data|2|||
23417461|NCT01482169|65274342|FG000|Overall Study|Physician Decision|2|||
23417462|NCT01331837|65274345|FG000|Overall Study|Death|30|||
23417463|NCT01331837|65274346|FG001|Overall Study|Death|34|||
23417464|NCT01331837|65274345|FG000|Overall Study|Lost to Follow-up|3|||
23417465|NCT01331837|65274346|FG001|Overall Study|Lost to Follow-up|1|||
23417466|NCT01331837|65274345|FG000|Overall Study|Info not recorded|10|||
23417467|NCT01331837|65274346|FG001|Overall Study|Info not recorded|16|||
23417468|NCT01331837|65274345|FG000|Overall Study|Withdrawal by Subject|13|||
23417469|NCT01331837|65274346|FG001|Overall Study|Withdrawal by Subject|16|||
23417470|NCT01659996|65274347|FG000|Overall Study|Protocol Violation|3|||
23417471|NCT01659996|65274348|FG001|Overall Study|Protocol Violation|3|||
23417472|NCT01659996|65274349|FG002|Overall Study|Protocol Violation|3|||
23417473|NCT01659996|65274347|FG000|Overall Study|Lost to Follow-up|1|||
23417474|NCT01659996|65274348|FG001|Overall Study|Lost to Follow-up|3|||
23417475|NCT01659996|65274349|FG002|Overall Study|Lost to Follow-up|2|||
23417476|NCT01659996|65274347|FG000|Overall Study|Adverse Event|0|||
23417477|NCT01659996|65274348|FG001|Overall Study|Adverse Event|0|||
23417478|NCT01659996|65274349|FG002|Overall Study|Adverse Event|1|||
23417479|NCT01659996|65274347|FG000|Overall Study|Withdrawal by Subject|4|||
23417480|NCT01659996|65274348|FG001|Overall Study|Withdrawal by Subject|1|||
23417481|NCT01659996|65274349|FG002|Overall Study|Withdrawal by Subject|5|||
23417482|NCT01801436|65274357|FG000|Overall Study|Withdrawal by Subject|3|||
23417483|NCT01801436|65274357|FG000|Overall Study|Adverse Event|2|||
23417484|NCT01801436|65274357|FG000|Overall Study|Progressive disease|4|||
23417485|NCT01545934|65274358|FG000|Overall Study|Withdrawal by Subject|4|||
23417486|NCT01545934|65274359|FG001|Overall Study|Withdrawal by Subject|3|||
23417487|NCT01545934|65274358|FG000|Overall Study|Lost to Follow-up|1|||
23417488|NCT01545934|65274359|FG001|Overall Study|Lost to Follow-up|0|||
23417489|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
23417490|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
23417491|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
23417492|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
23417493|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
23716232|NCT00839423|66336858|FG003|Overall Study|Protocol Violation|0|||
23417494|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
23716233|NCT00839423|66336855|FG000|Overall Study|Withdrawal of consent|4|||
23716234|NCT00839423|66336856|FG001|Overall Study|Withdrawal of consent|0|||
23417495|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
23417496|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
23417497|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
23417498|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
23417499|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
23417500|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
23417501|NCT00433966|65274362|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
23417502|NCT00433966|65274363|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
23417503|NCT00433966|65274364|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
23417504|NCT00433966|65274365|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
23417505|NCT00433966|65274362|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
23417506|NCT00433966|65274363|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
23417507|NCT00433966|65274364|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
23417508|NCT00433966|65274365|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
23417509|NCT01920568|65274366|FG000|Overall Study|Adverse Event|27|||
23417510|NCT01920568|65274367|FG001|Overall Study|Adverse Event|8|||
23417511|NCT01920568|65274366|FG000|Overall Study|Protocol Violation|5|||
23417512|NCT01920568|65274367|FG001|Overall Study|Protocol Violation|3|||
23417513|NCT01920568|65274366|FG000|Overall Study|Lost to Follow-up|2|||
23417514|NCT01920568|65274367|FG001|Overall Study|Lost to Follow-up|2|||
23417515|NCT01920568|65274366|FG000|Overall Study|Physician Decision|13|||
23417516|NCT01920568|65274367|FG001|Overall Study|Physician Decision|4|||
23417517|NCT01920568|65274366|FG000|Overall Study|Withdrawal by Subject|79|||
23417518|NCT01920568|65274367|FG001|Overall Study|Withdrawal by Subject|55|||
23417519|NCT01920568|65274366|FG000|Overall Study|Death due to disease progression|25|||
23716235|NCT00839423|66336857|FG002|Overall Study|Withdrawal of consent|4|||
23417520|NCT01920568|65274367|FG001|Overall Study|Death due to disease progression|12|||
23417521|NCT02324205|65274368|FG000|Overall Study|Withdrawal by Subject|37|||
23417522|NCT04098367|65274369|FG000|Overall Study|Adverse Event|0|||
23417523|NCT04098367|65274370|FG001|Overall Study|Adverse Event|0|||
23417524|NCT04098367|65274371|FG002|Overall Study|Adverse Event|1|||
23417525|NCT04098367|65274369|FG000|Overall Study|Lost to Follow-up|1|||
23417526|NCT04098367|65274370|FG001|Overall Study|Lost to Follow-up|5|||
23417527|NCT04098367|65274371|FG002|Overall Study|Lost to Follow-up|2|||
23417528|NCT04098367|65274369|FG000|Overall Study|Withdrawal by Subject|0|||
23417529|NCT04098367|65274370|FG001|Overall Study|Withdrawal by Subject|0|||
23417530|NCT04098367|65274371|FG002|Overall Study|Withdrawal by Subject|1|||
23417531|NCT04098367|65274369|FG000|Overall Study|Sick . Could not attend visit|1|||
23417532|NCT04098367|65274370|FG001|Overall Study|Sick . Could not attend visit|0|||
23417533|NCT04098367|65274371|FG002|Overall Study|Sick . Could not attend visit|0|||
23417534|NCT00951080|65274374|FG000|Overall Study|Adverse Event|3|||
23417535|NCT00951080|65274375|FG001|Overall Study|Adverse Event|3|||
23417536|NCT00951080|65274374|FG000|Overall Study|Lost to Follow-up|0|||
23417537|NCT00951080|65274375|FG001|Overall Study|Lost to Follow-up|1|||
23417538|NCT00951080|65274374|FG000|Overall Study|Physician Decision|4|||
23417539|NCT00951080|65274375|FG001|Overall Study|Physician Decision|1|||
23417540|NCT00951080|65274374|FG000|Overall Study|Other|19|||
23417541|NCT00951080|65274375|FG001|Overall Study|Other|22|||
23417542|NCT02135029|65274376|FG000|Overall Study|Adverse Event|2|||
23417543|NCT02135029|65274377|FG001|Overall Study|Adverse Event|2|||
23417544|NCT02135029|65274378|FG002|Overall Study|Adverse Event|2|||
23525339|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525340|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525341|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525342|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525343|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525344|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
23525345|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525346|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525347|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525348|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525349|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
23525350|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
23525351|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23525352|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525353|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525354|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525355|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525356|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
23525357|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
23525358|NCT01494610|65661747|FG000|Period 1|Withdrawal by Subject|1|||
23417545|NCT02135029|65274376|FG000|Overall Study|Lost to Follow-up|0|||
23417546|NCT02135029|65274377|FG001|Overall Study|Lost to Follow-up|1|||
23417547|NCT02135029|65274378|FG002|Overall Study|Lost to Follow-up|0|||
23417548|NCT02135029|65274376|FG000|Overall Study|Withdrawal by Subject|2|||
23417549|NCT02135029|65274377|FG001|Overall Study|Withdrawal by Subject|0|||
23417550|NCT02135029|65274378|FG002|Overall Study|Withdrawal by Subject|1|||
23417551|NCT02135029|65274376|FG000|Overall Study|Other|0|||
23417552|NCT02135029|65274377|FG001|Overall Study|Other|1|||
23716236|NCT00839423|66336858|FG003|Overall Study|Withdrawal of consent|1|||
23716237|NCT00839423|66336855|FG000|Overall Study|Lost to Follow-up|1|||
23716238|NCT00839423|66336856|FG001|Overall Study|Lost to Follow-up|0|||
23716239|NCT00839423|66336857|FG002|Overall Study|Lost to Follow-up|1|||
23716240|NCT00839423|66336858|FG003|Overall Study|Lost to Follow-up|0|||
23716241|NCT00839423|66336855|FG000|Overall Study|Administrative or other reasons|3|||
23716242|NCT00839423|66336856|FG001|Overall Study|Administrative or other reasons|0|||
23716243|NCT00839423|66336857|FG002|Overall Study|Administrative or other reasons|1|||
23716244|NCT00839423|66336858|FG003|Overall Study|Administrative or other reasons|0|||
23716245|NCT00178464|66336859|FG000|Overall Study|Withdrawal by Subject|1|||
23525359|NCT01494610|65661748|FG001|Period 1|Withdrawal by Subject|1|||
23417553|NCT02135029|65274378|FG002|Overall Study|Other|0|||
23417554|NCT02135029|65274376|FG000|Overall Study|Death|0|||
23525360|NCT01494610|65661747|FG000|Period 3|Adverse Event|1|||
23525361|NCT01494610|65661748|FG001|Period 3|Adverse Event|0|||
23525362|NCT01494610|65661747|FG000|Period 3|Withdrawal by Subject|1|||
23525363|NCT01494610|65661748|FG001|Period 3|Withdrawal by Subject|0|||
23525364|NCT01494610|65661747|FG000|Period 4|Protocol Violation|1|||
23525365|NCT01494610|65661748|FG001|Period 4|Protocol Violation|0|||
23525366|NCT02404350|65661749|FG000|Overall Study|Adverse Event|2|||
23525367|NCT02404350|65661750|FG001|Overall Study|Adverse Event|2|||
23525368|NCT02404350|65661751|FG002|Overall Study|Adverse Event|3|||
23525369|NCT02404350|65661752|FG003|Overall Study|Adverse Event|9|||
23525370|NCT02404350|65661749|FG000|Overall Study|Lack of Efficacy|3|||
23525371|NCT02404350|65661750|FG001|Overall Study|Lack of Efficacy|1|||
23525372|NCT02404350|65661751|FG002|Overall Study|Lack of Efficacy|0|||
23525373|NCT02404350|65661752|FG003|Overall Study|Lack of Efficacy|3|||
23525374|NCT02404350|65661749|FG000|Overall Study|Lost to Follow-up|2|||
23525375|NCT02404350|65661750|FG001|Overall Study|Lost to Follow-up|0|||
23525376|NCT02404350|65661751|FG002|Overall Study|Lost to Follow-up|0|||
23525377|NCT02404350|65661752|FG003|Overall Study|Lost to Follow-up|1|||
23525378|NCT02404350|65661749|FG000|Overall Study|Physician Decision|1|||
23525379|NCT02404350|65661750|FG001|Overall Study|Physician Decision|0|||
23525380|NCT02404350|65661751|FG002|Overall Study|Physician Decision|0|||
23417555|NCT02135029|65274377|FG001|Overall Study|Death|1|||
23417556|NCT02135029|65274378|FG002|Overall Study|Death|0|||
23417557|NCT00522418|65274379|FG000|Overall Study|Local IRB Consent Violation|5|||
23417558|NCT00522418|65274380|FG001|Overall Study|Local IRB Consent Violation|5|||
23417559|NCT00522418|65274379|FG000|Overall Study|Early Study Termination|46|||
23417560|NCT00522418|65274380|FG001|Overall Study|Early Study Termination|47|||
23417561|NCT00522418|65274379|FG000|Overall Study|Noncompliance|2|||
23525381|NCT02404350|65661752|FG003|Overall Study|Physician Decision|2|||
23525382|NCT02404350|65661749|FG000|Overall Study|Pregnancy|0|||
23525383|NCT02404350|65661750|FG001|Overall Study|Pregnancy|0|||
23525384|NCT02404350|65661751|FG002|Overall Study|Pregnancy|0|||
23525385|NCT02404350|65661752|FG003|Overall Study|Pregnancy|1|||
23525386|NCT02404350|65661749|FG000|Overall Study|Withdrawal by Subject|7|||
23525387|NCT02404350|65661750|FG001|Overall Study|Withdrawal by Subject|3|||
23525388|NCT02404350|65661751|FG002|Overall Study|Withdrawal by Subject|3|||
23525389|NCT02404350|65661752|FG003|Overall Study|Withdrawal by Subject|19|||
23525390|NCT02404350|65661749|FG000|Overall Study|Due to Non-compliance with treatment|0|||
23525391|NCT02404350|65661750|FG001|Overall Study|Due to Non-compliance with treatment|0|||
23525392|NCT02404350|65661751|FG002|Overall Study|Due to Non-compliance with treatment|0|||
23525393|NCT02404350|65661752|FG003|Overall Study|Due to Non-compliance with treatment|1|||
23525394|NCT02404350|65661749|FG000|Overall Study|Due to Technical problems|0|||
23525395|NCT02404350|65661750|FG001|Overall Study|Due to Technical problems|0|||
23525396|NCT02404350|65661751|FG002|Overall Study|Due to Technical problems|0|||
23525397|NCT02404350|65661752|FG003|Overall Study|Due to Technical problems|1|||
23417562|NCT00522418|65274380|FG001|Overall Study|Noncompliance|2|||
23417563|NCT00522418|65274379|FG000|Overall Study|Reason Not Specified|3|||
23417564|NCT00522418|65274380|FG001|Overall Study|Reason Not Specified|1|||
23525398|NCT04371380|65661755|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
23417565|NCT00522418|65274379|FG000|Overall Study|Consent Withdraw|1|||
23417566|NCT00522418|65274380|FG001|Overall Study|Consent Withdraw|2|||
23417567|NCT00522418|65274379|FG000|Overall Study|Lack of Efficacy|0|||
23417568|NCT00522418|65274380|FG001|Overall Study|Lack of Efficacy|1|||
23525399|NCT04371380|65661756|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
23525400|NCT04371380|65661757|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
23525401|NCT02375672|65661769|FG000|Overall Study|remain on follow up|20|||
23716246|NCT00178464|66336859|FG000|Overall Study|Physician Decision|1|||
23417569|NCT00624585|65274382|FG000|Overall Study|Death|3|||
23525402|NCT02457325|65661770|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
23525403|NCT02457325|65661771|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
23525404|NCT00588445|65661772|FG000|Overall Study|Protocol Violation|1|||
23525405|NCT00588445|65661772|FG000|Overall Study|Withdrawal by Subject|3|||
23525406|NCT00588445|65661772|FG000|Overall Study|Disease Progression|1|||
23525407|NCT00588445|65661772|FG000|Overall Study|Not Treated|10|||
23525408|NCT02789176|65661773|FG000|Overall Study|Death|0|||
23525409|NCT02789176|65661774|FG001|Overall Study|Death|0|||
23525410|NCT02789176|65661775|FG002|Overall Study|Death|3|||
23525411|NCT02789176|65661776|FG003|Overall Study|Death|0|||
23525412|NCT02789176|65661773|FG000|Overall Study|Withdrawal by Subject|0|||
23417570|NCT00624585|65274382|FG000|Overall Study|Disease Progression|6|||
23812863|NCT01986010|66696050|FG009|Overall Study|Withdrawal by Subject|0|||
23417571|NCT00624585|65274382|FG000|Overall Study|Adverse Event|3|||
23417572|NCT01703208|65274393|FG000|Overall Study|Death|61|||
23417573|NCT01703208|65274394|FG001|Overall Study|Death|48|||
23417574|NCT01703208|65274393|FG000|Overall Study|Lack of Efficacy|1|||
23417575|NCT01703208|65274394|FG001|Overall Study|Lack of Efficacy|2|||
23417576|NCT01703208|65274393|FG000|Overall Study|Lost to Follow-up|68|||
23417577|NCT01703208|65274394|FG001|Overall Study|Lost to Follow-up|62|||
23417578|NCT01703208|65274393|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23417579|NCT01703208|65274394|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23417580|NCT01703208|65274393|FG000|Overall Study|Excluded Medication|1|||
23417581|NCT01703208|65274394|FG001|Overall Study|Excluded Medication|2|||
23417582|NCT01703208|65274393|FG000|Overall Study|Site Discontinued Study Participation|23|||
23417583|NCT01703208|65274394|FG001|Overall Study|Site Discontinued Study Participation|27|||
23417584|NCT01703208|65274393|FG000|Overall Study|Physician Decision|11|||
23417585|NCT01703208|65274394|FG001|Overall Study|Physician Decision|13|||
23417586|NCT01703208|65274393|FG000|Overall Study|Progressive disease|2|||
23417587|NCT01703208|65274394|FG001|Overall Study|Progressive disease|2|||
23417588|NCT01703208|65274393|FG000|Overall Study|Protocol Violation|1|||
23417589|NCT01703208|65274394|FG001|Overall Study|Protocol Violation|1|||
23417590|NCT01703208|65274393|FG000|Overall Study|Study Terminated by Sponsor|1710|||
23417591|NCT01703208|65274394|FG001|Overall Study|Study Terminated by Sponsor|1716|||
23417592|NCT01703208|65274393|FG000|Overall Study|Withdrawal by Subject|205|||
23417593|NCT01703208|65274394|FG001|Overall Study|Withdrawal by Subject|209|||
23417594|NCT01703208|65274393|FG000|Overall Study|Adverse Event|14|||
23417595|NCT01703208|65274394|FG001|Overall Study|Adverse Event|19|||
23417596|NCT01703208|65274393|FG000|Overall Study|Technical Problems|0|||
23417597|NCT01703208|65274394|FG001|Overall Study|Technical Problems|1|||
23417598|NCT01703208|65274393|FG000|Overall Study|Protocol Deviation|2|||
23417599|NCT01703208|65274394|FG001|Overall Study|Protocol Deviation|0|||
23417600|NCT01685801|65274395|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417601|NCT01685801|65274396|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417602|NCT01685801|65274397|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417603|NCT01685801|65274398|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
23417604|NCT01685801|65274395|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
23417605|NCT01685801|65274396|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
23417606|NCT01685801|65274397|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
23417607|NCT01685801|65274398|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
23417608|NCT00734604|65274399|FG000|Overall Study|Adverse Event|0|||
23417609|NCT00734604|65274400|FG001|Overall Study|Adverse Event|2|||
23417610|NCT00734604|65274401|FG002|Overall Study|Adverse Event|0|||
23417611|NCT00734604|65274402|FG003|Overall Study|Adverse Event|2|||
23417612|NCT00734604|65274403|FG004|Overall Study|Adverse Event|1|||
23417613|NCT00734604|65274404|FG005|Overall Study|Adverse Event|1|||
23525413|NCT02789176|65661774|FG001|Overall Study|Withdrawal by Subject|0|||
23525414|NCT02789176|65661775|FG002|Overall Study|Withdrawal by Subject|1|||
23417614|NCT00734604|65274399|FG000|Overall Study|Serious Adverse Event|1|||
23417615|NCT00734604|65274400|FG001|Overall Study|Serious Adverse Event|0|||
23417616|NCT00734604|65274401|FG002|Overall Study|Serious Adverse Event|1|||
23417617|NCT00734604|65274402|FG003|Overall Study|Serious Adverse Event|2|||
23417618|NCT00734604|65274403|FG004|Overall Study|Serious Adverse Event|0|||
23417619|NCT00734604|65274404|FG005|Overall Study|Serious Adverse Event|1|||
23417620|NCT00734604|65274399|FG000|Overall Study|Lost to Follow-up|1|||
23417621|NCT00734604|65274400|FG001|Overall Study|Lost to Follow-up|2|||
23417622|NCT00734604|65274401|FG002|Overall Study|Lost to Follow-up|2|||
23525415|NCT02789176|65661776|FG003|Overall Study|Withdrawal by Subject|0|||
23417623|NCT00734604|65274402|FG003|Overall Study|Lost to Follow-up|4|||
23417624|NCT00734604|65274403|FG004|Overall Study|Lost to Follow-up|2|||
23417625|NCT00734604|65274404|FG005|Overall Study|Lost to Follow-up|3|||
23417626|NCT00734604|65274399|FG000|Overall Study|Physician Decision|0|||
23417627|NCT00734604|65274400|FG001|Overall Study|Physician Decision|1|||
23417628|NCT00734604|65274401|FG002|Overall Study|Physician Decision|1|||
23417629|NCT00734604|65274402|FG003|Overall Study|Physician Decision|0|||
23417630|NCT00734604|65274403|FG004|Overall Study|Physician Decision|0|||
23417631|NCT00734604|65274404|FG005|Overall Study|Physician Decision|0|||
23417632|NCT00734604|65274399|FG000|Overall Study|Protocol Violation|0|||
23417633|NCT00734604|65274400|FG001|Overall Study|Protocol Violation|2|||
23417634|NCT00734604|65274401|FG002|Overall Study|Protocol Violation|0|||
23417635|NCT00734604|65274402|FG003|Overall Study|Protocol Violation|0|||
23525416|NCT02789176|65661773|FG000|Overall Study|Lost to Follow-up|8|||
23525417|NCT02789176|65661774|FG001|Overall Study|Lost to Follow-up|2|||
23525418|NCT02789176|65661775|FG002|Overall Study|Lost to Follow-up|6|||
23525419|NCT02789176|65661776|FG003|Overall Study|Lost to Follow-up|1|||
23525420|NCT03616912|65661777|FG000|Overall Study|Adverse Event|17|||
23525421|NCT03616912|65661778|FG001|Overall Study|Adverse Event|21|||
23525422|NCT03616912|65661779|FG002|Overall Study|Adverse Event|9|||
23525423|NCT03616912|65661780|FG003|Overall Study|Adverse Event|0|||
23525424|NCT03616912|65661781|FG004|Overall Study|Adverse Event|0|||
23525425|NCT03616912|65661782|FG005|Overall Study|Adverse Event|0|||
23525426|NCT03616912|65661777|FG000|Overall Study|Death|1|||
23525427|NCT03616912|65661778|FG001|Overall Study|Death|1|||
23525428|NCT03616912|65661779|FG002|Overall Study|Death|0|||
23525429|NCT03616912|65661780|FG003|Overall Study|Death|0|||
23525430|NCT03616912|65661781|FG004|Overall Study|Death|0|||
23525431|NCT03616912|65661782|FG005|Overall Study|Death|0|||
23525432|NCT03616912|65661777|FG000|Overall Study|Lack of Efficacy|13|||
23525433|NCT03616912|65661778|FG001|Overall Study|Lack of Efficacy|6|||
23525434|NCT03616912|65661779|FG002|Overall Study|Lack of Efficacy|8|||
23525435|NCT03616912|65661780|FG003|Overall Study|Lack of Efficacy|4|||
23525436|NCT03616912|65661781|FG004|Overall Study|Lack of Efficacy|5|||
23525437|NCT03616912|65661782|FG005|Overall Study|Lack of Efficacy|1|||
23525438|NCT03616912|65661777|FG000|Overall Study|Lost to Follow-up|1|||
23525439|NCT03616912|65661778|FG001|Overall Study|Lost to Follow-up|2|||
23525440|NCT03616912|65661779|FG002|Overall Study|Lost to Follow-up|3|||
23525441|NCT03616912|65661780|FG003|Overall Study|Lost to Follow-up|0|||
23525442|NCT03616912|65661781|FG004|Overall Study|Lost to Follow-up|0|||
23525443|NCT03616912|65661782|FG005|Overall Study|Lost to Follow-up|0|||
23525444|NCT03616912|65661777|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
23525445|NCT03616912|65661778|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
23525446|NCT03616912|65661779|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
23525447|NCT03616912|65661780|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
23525448|NCT03616912|65661781|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
23525449|NCT03616912|65661782|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
23525450|NCT03616912|65661777|FG000|Overall Study|Withdrawal by Subject|12|||
23525451|NCT03616912|65661778|FG001|Overall Study|Withdrawal by Subject|12|||
23525452|NCT03616912|65661779|FG002|Overall Study|Withdrawal by Subject|15|||
23525453|NCT03616912|65661780|FG003|Overall Study|Withdrawal by Subject|2|||
23525454|NCT03616912|65661781|FG004|Overall Study|Withdrawal by Subject|0|||
23525455|NCT03616912|65661782|FG005|Overall Study|Withdrawal by Subject|2|||
23525456|NCT03616912|65661777|FG000|Overall Study|Study Terminated by Sponsor|0|||
23525457|NCT03616912|65661778|FG001|Overall Study|Study Terminated by Sponsor|0|||
23525458|NCT03616912|65661779|FG002|Overall Study|Study Terminated by Sponsor|0|||
23417636|NCT00734604|65274403|FG004|Overall Study|Protocol Violation|1|||
23417637|NCT00734604|65274404|FG005|Overall Study|Protocol Violation|0|||
23417638|NCT00734604|65274399|FG000|Overall Study|Sponsor Decision|1|||
23417639|NCT00734604|65274400|FG001|Overall Study|Sponsor Decision|2|||
23417640|NCT00734604|65274401|FG002|Overall Study|Sponsor Decision|1|||
23417641|NCT00734604|65274402|FG003|Overall Study|Sponsor Decision|0|||
23525459|NCT03616912|65661780|FG003|Overall Study|Study Terminated by Sponsor|10|||
23525460|NCT03616912|65661781|FG004|Overall Study|Study Terminated by Sponsor|9|||
23525461|NCT03616912|65661782|FG005|Overall Study|Study Terminated by Sponsor|11|||
23525462|NCT03616912|65661777|FG000|Overall Study|Protocol Deviation|1|||
23525463|NCT03616912|65661778|FG001|Overall Study|Protocol Deviation|1|||
23525464|NCT03616912|65661779|FG002|Overall Study|Protocol Deviation|0|||
23525465|NCT03616912|65661780|FG003|Overall Study|Protocol Deviation|0|||
23525466|NCT03616912|65661781|FG004|Overall Study|Protocol Deviation|0|||
23525467|NCT03616912|65661782|FG005|Overall Study|Protocol Deviation|0|||
23525468|NCT03616912|65661777|FG000|Overall Study|Pregnancy|1|||
23525469|NCT03616912|65661778|FG001|Overall Study|Pregnancy|0|||
23525470|NCT03616912|65661779|FG002|Overall Study|Pregnancy|4|||
23525471|NCT03616912|65661780|FG003|Overall Study|Pregnancy|0|||
23525472|NCT03616912|65661781|FG004|Overall Study|Pregnancy|0|||
23525473|NCT03616912|65661782|FG005|Overall Study|Pregnancy|0|||
23525474|NCT03616912|65661777|FG000|Overall Study|Protocol Violation|1|||
23525475|NCT03616912|65661778|FG001|Overall Study|Protocol Violation|0|||
23525476|NCT03616912|65661779|FG002|Overall Study|Protocol Violation|2|||
23525477|NCT03616912|65661780|FG003|Overall Study|Protocol Violation|0|||
23525478|NCT03616912|65661781|FG004|Overall Study|Protocol Violation|0|||
23525479|NCT03616912|65661782|FG005|Overall Study|Protocol Violation|0|||
23525480|NCT03616912|65661777|FG000|Overall Study|Physician Decision|2|||
23525481|NCT03616912|65661778|FG001|Overall Study|Physician Decision|0|||
23525482|NCT03616912|65661779|FG002|Overall Study|Physician Decision|0|||
23525483|NCT03616912|65661780|FG003|Overall Study|Physician Decision|0|||
23525484|NCT03616912|65661781|FG004|Overall Study|Physician Decision|1|||
23525485|NCT03616912|65661782|FG005|Overall Study|Physician Decision|0|||
23525486|NCT03616912|65661777|FG000|Overall Study|Randomized But Never Treated|0|||
23525487|NCT03616912|65661778|FG001|Overall Study|Randomized But Never Treated|2|||
23525488|NCT03616912|65661779|FG002|Overall Study|Randomized But Never Treated|0|||
23525489|NCT03616912|65661780|FG003|Overall Study|Randomized But Never Treated|0|||
23525490|NCT03616912|65661781|FG004|Overall Study|Randomized But Never Treated|0|||
23525491|NCT03616912|65661782|FG005|Overall Study|Randomized But Never Treated|0|||
23525492|NCT00578175|65661783|FG000|Overall Study|Adverse Event|0|||
23525493|NCT00578175|65661784|FG001|Overall Study|Adverse Event|1|||
23525494|NCT00578175|65661785|FG002|Overall Study|Adverse Event|1|||
23525495|NCT00578175|65661783|FG000|Overall Study|Other reasons|70|||
23525496|NCT00578175|65661784|FG001|Overall Study|Other reasons|42|||
23525497|NCT00578175|65661785|FG002|Overall Study|Other reasons|23|||
23525498|NCT00749463|65661789|FG000|Overall Study|Adverse Event|0|||
23812864|NCT01986010|66696051|FG010|Overall Study|Withdrawal by Subject|0|||
23812865|NCT01986010|66696052|FG011|Overall Study|Withdrawal by Subject|2|||
23525499|NCT00749463|65661790|FG001|Overall Study|Adverse Event|4|||
23525500|NCT00749463|65661791|FG002|Overall Study|Adverse Event|1|||
23525501|NCT00749463|65661789|FG000|Overall Study|Withdrawal by Subject|1|||
23525502|NCT00749463|65661790|FG001|Overall Study|Withdrawal by Subject|0|||
23525503|NCT00749463|65661791|FG002|Overall Study|Withdrawal by Subject|0|||
23525504|NCT00207142|65661792|FG000|Induction Phase|Adverse Event|9|||
23525505|NCT00207142|65661793|FG001|Induction Phase|Adverse Event|0|||
23525506|NCT00207142|65661794|FG002|Induction Phase|Adverse Event|0|||
23525507|NCT00207142|65661795|FG003|Induction Phase|Adverse Event|0|||
23525508|NCT00207142|65661792|FG000|Induction Phase|Death|1|||
23525509|NCT00207142|65661793|FG001|Induction Phase|Death|0|||
23525510|NCT00207142|65661794|FG002|Induction Phase|Death|0|||
23525511|NCT00207142|65661795|FG003|Induction Phase|Death|0|||
23525512|NCT00207142|65661792|FG000|Induction Phase|Lack of Efficacy|1|||
23525513|NCT00207142|65661793|FG001|Induction Phase|Lack of Efficacy|0|||
23525514|NCT00207142|65661794|FG002|Induction Phase|Lack of Efficacy|0|||
23525515|NCT00207142|65661795|FG003|Induction Phase|Lack of Efficacy|0|||
23525516|NCT00207142|65661792|FG000|Induction Phase|Lost to Follow-up|5|||
23525517|NCT00207142|65661793|FG001|Induction Phase|Lost to Follow-up|0|||
23525518|NCT00207142|65661794|FG002|Induction Phase|Lost to Follow-up|0|||
23525519|NCT00207142|65661795|FG003|Induction Phase|Lost to Follow-up|0|||
23525520|NCT00207142|65661792|FG000|Induction Phase|Physician Decision|2|||
23525521|NCT00207142|65661793|FG001|Induction Phase|Physician Decision|0|||
23525522|NCT00207142|65661794|FG002|Induction Phase|Physician Decision|0|||
23525523|NCT00207142|65661795|FG003|Induction Phase|Physician Decision|0|||
23525524|NCT00207142|65661792|FG000|Induction Phase|Poor/noncompliance|2|||
23525525|NCT00207142|65661793|FG001|Induction Phase|Poor/noncompliance|0|||
23525526|NCT00207142|65661794|FG002|Induction Phase|Poor/noncompliance|0|||
23525527|NCT00207142|65661795|FG003|Induction Phase|Poor/noncompliance|0|||
23525528|NCT00207142|65661792|FG000|Induction Phase|Pregnancy|1|||
23525529|NCT00207142|65661793|FG001|Induction Phase|Pregnancy|0|||
23525530|NCT00207142|65661794|FG002|Induction Phase|Pregnancy|0|||
23525531|NCT00207142|65661795|FG003|Induction Phase|Pregnancy|0|||
23525532|NCT00207142|65661792|FG000|Induction Phase|Subject no longer meets study criteria|3|||
23525533|NCT00207142|65661793|FG001|Induction Phase|Subject no longer meets study criteria|0|||
23525534|NCT00207142|65661794|FG002|Induction Phase|Subject no longer meets study criteria|0|||
23525535|NCT00207142|65661795|FG003|Induction Phase|Subject no longer meets study criteria|0|||
23525536|NCT00207142|65661792|FG000|Induction Phase|Withdrawal by Subject|4|||
23525537|NCT00207142|65661793|FG001|Induction Phase|Withdrawal by Subject|0|||
23525538|NCT00207142|65661794|FG002|Induction Phase|Withdrawal by Subject|0|||
23812866|NCT01986010|66696053|FG012|Overall Study|Withdrawal by Subject|0|||
23525539|NCT00207142|65661795|FG003|Induction Phase|Withdrawal by Subject|0|||
23525540|NCT00207142|65661792|FG000|Induction Phase|Incarceration|1|||
23525541|NCT00207142|65661793|FG001|Induction Phase|Incarceration|0|||
23525542|NCT00207142|65661794|FG002|Induction Phase|Incarceration|0|||
23525543|NCT00207142|65661795|FG003|Induction Phase|Incarceration|0|||
23525544|NCT00207142|65661792|FG000|Induction Phase|Missing lab data|1|||
23525545|NCT00207142|65661793|FG001|Induction Phase|Missing lab data|0|||
23525546|NCT00207142|65661794|FG002|Induction Phase|Missing lab data|0|||
23525547|NCT00207142|65661795|FG003|Induction Phase|Missing lab data|0|||
23525548|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
23525549|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
23525550|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
23525551|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
23525552|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
23525553|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
23525554|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
23525555|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
23525556|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525557|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525558|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
23716247|NCT04577183|66336862|FG000|Overall Study|Death|1|||
23716248|NCT04577183|66336862|FG000|Overall Study|Withdrawal by Subject|3|||
23812867|NCT01986010|66696054|FG013|Overall Study|Withdrawal by Subject|1|||
23812868|NCT01986010|66696055|FG014|Overall Study|Withdrawal by Subject|2|||
23812869|NCT01986010|66696056|FG015|Overall Study|Withdrawal by Subject|0|||
23812870|NCT01986010|66696057|FG016|Overall Study|Withdrawal by Subject|0|||
23812871|NCT01986010|66696041|FG000|Overall Study|Status Not Recorded|2|||
23812872|NCT01986010|66696042|FG001|Overall Study|Status Not Recorded|4|||
23716249|NCT04577183|66336862|FG000|Overall Study|Early termination|2|||
23716250|NCT01184846|66336865|FG000|Overall Study|Adverse Event|2|||
23716251|NCT01184846|66336865|FG000|Overall Study|Insufficient response|1|||
23716252|NCT00600028|66336868|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23716253|NCT00600028|66336869|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23716254|NCT00600028|66336868|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
23716255|NCT00600028|66336869|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
23716256|NCT00600028|66336868|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
23716257|NCT00600028|66336869|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
23716258|NCT00485589|66336870|FG000|Overall Study|Death|2|||
23716259|NCT00485589|66336871|FG001|Overall Study|Death|2|||
23812873|NCT01986010|66696043|FG002|Overall Study|Status Not Recorded|2|||
23812874|NCT01986010|66696044|FG003|Overall Study|Status Not Recorded|0|||
23812875|NCT01986010|66696045|FG004|Overall Study|Status Not Recorded|1|||
23812876|NCT01986010|66696046|FG005|Overall Study|Status Not Recorded|2|||
23812877|NCT01986010|66696047|FG006|Overall Study|Status Not Recorded|0|||
23417642|NCT00734604|65274403|FG004|Overall Study|Sponsor Decision|2|||
23417643|NCT00734604|65274404|FG005|Overall Study|Sponsor Decision|0|||
23417644|NCT00734604|65274399|FG000|Overall Study|Withdrawal by Subject|0|||
23525559|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525560|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
23525561|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
23716260|NCT00485589|66336872|FG002|Overall Study|Death|0|||
23716261|NCT00485589|66336870|FG000|Overall Study|Failure to return|6|||
23812878|NCT01986010|66696048|FG007|Overall Study|Status Not Recorded|0|||
23812879|NCT01986010|66696049|FG008|Overall Study|Status Not Recorded|2|||
23525562|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
23716262|NCT00485589|66336871|FG001|Overall Study|Failure to return|5|||
23716263|NCT00485589|66336872|FG002|Overall Study|Failure to return|1|||
23716264|NCT00485589|66336870|FG000|Overall Study|Protocol Violation|1|||
23716265|NCT00485589|66336871|FG001|Overall Study|Protocol Violation|0|||
23716266|NCT00485589|66336872|FG002|Overall Study|Protocol Violation|0|||
23716267|NCT00485589|66336870|FG000|Overall Study|Violation of selection criteria at entry|0|||
23716268|NCT00485589|66336871|FG001|Overall Study|Violation of selection criteria at entry|3|||
23716269|NCT00485589|66336872|FG002|Overall Study|Violation of selection criteria at entry|1|||
23716270|NCT00485589|66336870|FG000|Overall Study|Administrative/Other|1|||
23716271|NCT00485589|66336871|FG001|Overall Study|Administrative/Other|2|||
23716272|NCT00485589|66336872|FG002|Overall Study|Administrative/Other|1|||
23716273|NCT00485589|66336870|FG000|Overall Study|Insufficient therapeutic response|10|||
23716274|NCT00485589|66336871|FG001|Overall Study|Insufficient therapeutic response|3|||
23716275|NCT00485589|66336872|FG002|Overall Study|Insufficient therapeutic response|1|||
23716276|NCT00485589|66336870|FG000|Overall Study|Refused treatment/did not cooperate|1|||
23716277|NCT00485589|66336871|FG001|Overall Study|Refused treatment/did not cooperate|0|||
23716278|NCT00485589|66336872|FG002|Overall Study|Refused treatment/did not cooperate|2|||
23716279|NCT00485589|66336870|FG000|Overall Study|Withdrawal by Subject|3|||
23716280|NCT00485589|66336871|FG001|Overall Study|Withdrawal by Subject|2|||
23716281|NCT00485589|66336872|FG002|Overall Study|Withdrawal by Subject|2|||
23716282|NCT00485589|66336870|FG000|Overall Study|Adverse Event|3|||
23716283|NCT00485589|66336871|FG001|Overall Study|Adverse Event|3|||
23716284|NCT00485589|66336872|FG002|Overall Study|Adverse Event|10|||
23716285|NCT02207556|66336873|FG000|Overall Study|Physician Decision|1|||
23716286|NCT02207556|66336874|FG001|Overall Study|Physician Decision|0|||
23716287|NCT02207556|66336873|FG000|Overall Study|Withdrawal by Subject|1|||
23716288|NCT02207556|66336874|FG001|Overall Study|Withdrawal by Subject|0|||
23716289|NCT02207556|66336873|FG000|Overall Study|Death|0|||
23716290|NCT02207556|66336874|FG001|Overall Study|Death|5|||
23716291|NCT03196193|66336877|FG000|Overall Study|Adverse Event|1|||
23716292|NCT03196193|66336878|FG001|Overall Study|Adverse Event|0|||
23716293|NCT03196193|66336877|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
23716294|NCT03196193|66336878|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
23716295|NCT01071096|66336881|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
23716296|NCT01071096|66336882|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
23716297|NCT00369967|66336885|FG000|Overall Study|Lost to Follow-up|23|||
23716298|NCT00369967|66336886|FG001|Overall Study|Lost to Follow-up|12|||
23716299|NCT00293423|66336887|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
23716300|NCT00293423|66336888|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
23716301|NCT00293423|66336887|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
23716302|NCT00293423|66336888|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
23716303|NCT00293423|66336887|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
23716304|NCT00293423|66336888|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
23716305|NCT00293423|66336887|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
23716306|NCT00293423|66336888|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
23716307|NCT00293423|66336887|FG000|Surgical Resection|processing error during surgical resection|1|||
23716308|NCT00293423|66336888|FG001|Surgical Resection|processing error during surgical resection|0|||
23716309|NCT00293423|66336887|FG000|Surgical Resection|Withdrawal by Subject|4|||
23716310|NCT00293423|66336888|FG001|Surgical Resection|Withdrawal by Subject|0|||
23716311|NCT00293423|66336887|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
23716312|NCT00293423|66336888|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
23716313|NCT01026389|66336889|FG000|Overall Study|Withdrawal by Subject|1|||
23716314|NCT01026389|66336890|FG001|Overall Study|Withdrawal by Subject|3|||
23716315|NCT01026389|66336889|FG000|Overall Study|change of treatment, patient moved|4|||
23716316|NCT01026389|66336890|FG001|Overall Study|change of treatment, patient moved|2|||
23716317|NCT03627494|66336891|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
23812880|NCT01986010|66696050|FG009|Overall Study|Status Not Recorded|1|||
23417645|NCT00734604|65274400|FG001|Overall Study|Withdrawal by Subject|2|||
23417646|NCT00734604|65274401|FG002|Overall Study|Withdrawal by Subject|0|||
23417647|NCT00734604|65274402|FG003|Overall Study|Withdrawal by Subject|1|||
23417648|NCT00734604|65274403|FG004|Overall Study|Withdrawal by Subject|2|||
23417649|NCT00734604|65274404|FG005|Overall Study|Withdrawal by Subject|1|||
23417650|NCT00734604|65274399|FG000|Overall Study|Lack of Efficacy|0|||
23417651|NCT00734604|65274400|FG001|Overall Study|Lack of Efficacy|1|||
23525563|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
23525564|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
23716318|NCT03627494|66336892|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716319|NCT03627494|66336893|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
23417652|NCT00734604|65274401|FG002|Overall Study|Lack of Efficacy|1|||
23716320|NCT03627494|66336894|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716321|NCT03627494|66336895|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
23525565|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
23525566|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
23525567|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
23525568|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525569|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525570|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
23525571|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525572|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
23525573|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
23812881|NCT01986010|66696051|FG010|Overall Study|Status Not Recorded|7|||
23812882|NCT01986010|66696052|FG011|Overall Study|Status Not Recorded|7|||
23812883|NCT01986010|66696053|FG012|Overall Study|Status Not Recorded|9|||
23417653|NCT00734604|65274402|FG003|Overall Study|Lack of Efficacy|0|||
23417654|NCT00734604|65274403|FG004|Overall Study|Lack of Efficacy|0|||
23417655|NCT00734604|65274404|FG005|Overall Study|Lack of Efficacy|0|||
23417656|NCT05286658|65274405|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
23417657|NCT05286658|65274405|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
23417658|NCT02923830|65274406|FG000|Overall Study|Physician Decision|13|||
23417659|NCT02923830|65274407|FG001|Overall Study|Physician Decision|15|||
23417660|NCT03654404|65274408|FG000|Overall Study|Death|1|||
23417661|NCT03654404|65274408|FG000|Overall Study|Lost to Follow-up|2|||
23417662|NCT03654404|65274408|FG000|Overall Study|Withdrawal by Subject|5|||
23417663|NCT02516098|65274409|FG000|Period 1|Protocol Violation|1|||
23417664|NCT02516098|65274410|FG001|Period 1|Protocol Violation|0|||
23417665|NCT02516098|65274409|FG000|Washout After Period 1|Adverse Event|0|||
23417666|NCT02516098|65274410|FG001|Washout After Period 1|Adverse Event|1|||
23417667|NCT02516098|65274409|FG000|Period 2|Withdrawal by Subject|0|||
23417668|NCT02516098|65274410|FG001|Period 2|Withdrawal by Subject|1|||
23525574|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
23716322|NCT03627494|66336896|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716323|NCT03627494|66336897|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716324|NCT03627494|66336898|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716325|NCT03627494|66336899|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716326|NCT03627494|66336900|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716327|NCT03627494|66336901|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716328|NCT03627494|66336902|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
23716329|NCT03627494|66336891|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716330|NCT03627494|66336892|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716331|NCT03627494|66336893|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716332|NCT03627494|66336894|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716333|NCT03627494|66336895|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716334|NCT03627494|66336896|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716335|NCT03627494|66336897|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716336|NCT03627494|66336898|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
23812884|NCT01986010|66696054|FG013|Overall Study|Status Not Recorded|9|||
23812885|NCT01986010|66696055|FG014|Overall Study|Status Not Recorded|5|||
23812886|NCT01986010|66696056|FG015|Overall Study|Status Not Recorded|10|||
23812887|NCT01986010|66696057|FG016|Overall Study|Status Not Recorded|4|||
23812888|NCT00758680|66696058|FG000|Overall Study|Adverse Event|0|||
23812889|NCT00758680|66696059|FG001|Overall Study|Adverse Event|0|||
23812890|NCT00758680|66696060|FG002|Overall Study|Adverse Event|0|||
23812891|NCT00758680|66696061|FG003|Overall Study|Adverse Event|0|||
23812892|NCT00758680|66696062|FG004|Overall Study|Adverse Event|0|||
23812893|NCT00758680|66696063|FG005|Overall Study|Adverse Event|0|||
23812894|NCT00758680|66696064|FG006|Overall Study|Adverse Event|0|||
23812895|NCT00758680|66696065|FG007|Overall Study|Adverse Event|1|||
23812896|NCT00758680|66696066|FG008|Overall Study|Adverse Event|0|||
23812897|NCT00758680|66696067|FG009|Overall Study|Adverse Event|1|||
23812898|NCT00758680|66696058|FG000|Overall Study|Laboratory Adverse Event|0|||
23812899|NCT00758680|66696059|FG001|Overall Study|Laboratory Adverse Event|0|||
23812900|NCT00758680|66696060|FG002|Overall Study|Laboratory Adverse Event|0|||
23417669|NCT00721578|65274411|FG000|Overall Study|Death|1|||
23417670|NCT00721578|65274412|FG001|Overall Study|Death|1|||
23525575|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
23525576|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Death|0|||
23812901|NCT00758680|66696061|FG003|Overall Study|Laboratory Adverse Event|0|||
23417671|NCT00721578|65274411|FG000|Overall Study|Withdrawal by Subject|1|||
23525577|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Death|0|||
23716337|NCT03627494|66336899|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
23716338|NCT03627494|66336900|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716339|NCT03627494|66336901|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
23812902|NCT00758680|66696062|FG004|Overall Study|Laboratory Adverse Event|0|||
23812903|NCT00758680|66696063|FG005|Overall Study|Laboratory Adverse Event|0|||
23812904|NCT00758680|66696064|FG006|Overall Study|Laboratory Adverse Event|0|||
23812905|NCT00758680|66696065|FG007|Overall Study|Laboratory Adverse Event|0|||
23525578|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Death|0|||
23525579|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Death|1|||
23525580|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23525581|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23716340|NCT03627494|66336902|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
23716341|NCT03627494|66336891|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716342|NCT03627494|66336892|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716343|NCT03627494|66336893|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716344|NCT03627494|66336894|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716345|NCT03627494|66336895|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716346|NCT03627494|66336896|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716347|NCT03627494|66336897|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716348|NCT03627494|66336898|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716349|NCT03627494|66336899|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716350|NCT03627494|66336900|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
23716351|NCT03627494|66336901|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
23716352|NCT03627494|66336902|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
23716353|NCT05425719|66336910|FG000|Overall Study|Lost to Follow-up|4|||
23716354|NCT05425719|66336911|FG001|Overall Study|Lost to Follow-up|0|||
23716355|NCT05425719|66336910|FG000|Overall Study|Withdrew consent|1|||
23716356|NCT05425719|66336911|FG001|Overall Study|Withdrew consent|1|||
23716357|NCT01464788|66336912|FG000|Overall Study|Lost to Follow-up|0|||
23525582|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23525583|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
23525584|NCT04372602|65661810|FG000|Overall Study|Withdrawal by Subject|1|||
23525585|NCT04372602|65661811|FG001|Overall Study|Withdrawal by Subject|1|||
23525586|NCT04372602|65661810|FG000|Overall Study|Adverse Event|0|||
23525587|NCT04372602|65661811|FG001|Overall Study|Adverse Event|1|||
23525588|NCT04372602|65661810|FG000|Overall Study|Transitioned to comfort care|0|||
23525589|NCT04372602|65661811|FG001|Overall Study|Transitioned to comfort care|1|||
23525590|NCT03569371|65661812|FG000|Overall Study|Lack of Efficacy|1|||
23525591|NCT03569371|65661812|FG000|Overall Study|Lost to Follow-up|1|||
23525592|NCT03569371|65661812|FG000|Overall Study|Adverse Event|1|||
23525593|NCT03907683|65661813|FG000|Overall Study|Pregnancy|1|||
23525594|NCT03907683|65661813|FG000|Overall Study|Withdrawal by Subject|1|||
23716358|NCT01464788|66336913|FG001|Overall Study|Lost to Follow-up|1|||
23716359|NCT01464788|66336914|FG002|Overall Study|Lost to Follow-up|0|||
23716360|NCT01464788|66336912|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
23716361|NCT01464788|66336913|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
23716362|NCT01464788|66336914|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
23417672|NCT00721578|65274412|FG001|Overall Study|Withdrawal by Subject|1|||
23716363|NCT01479374|66336916|FG000|Overall Study|Adverse Event|2|||
23716364|NCT01479374|66336917|FG001|Overall Study|Adverse Event|1|||
23716365|NCT01479374|66336918|FG002|Overall Study|Adverse Event|0|||
23417673|NCT00022763|65274413|FG000|Overall Study|Adverse Event|1|||
23417674|NCT00022763|65274414|FG001|Overall Study|Adverse Event|2|||
23417675|NCT00022763|65274413|FG000|Overall Study|Injection Site Reactions|0|||
23417676|NCT00022763|65274414|FG001|Overall Study|Injection Site Reactions|2|||
23417677|NCT00022763|65274413|FG000|Overall Study|Death|0|||
23417678|NCT00022763|65274414|FG001|Overall Study|Death|1|||
23417679|NCT00022763|65274413|FG000|Overall Study|Lost to Follow-up|0|||
23417680|NCT00022763|65274414|FG001|Overall Study|Lost to Follow-up|3|||
23417681|NCT00022763|65274413|FG000|Overall Study|Withdrawal by Subject|4|||
23417682|NCT00022763|65274414|FG001|Overall Study|Withdrawal by Subject|7|||
23417683|NCT00022763|65274413|FG000|Overall Study|Insufficient Therapy|1|||
23417684|NCT00022763|65274414|FG001|Overall Study|Insufficient Therapy|0|||
23417685|NCT00022763|65274413|FG000|Overall Study|Admin|3|||
23417686|NCT00022763|65274414|FG001|Overall Study|Admin|2|||
23417687|NCT00244933|65274418|FG000|Overall Study|Not response evaluable|2|||
23525595|NCT01418937|65661816|FG000|Overall Study|Lost to Follow-up|5|||
23525596|NCT01418937|65661816|FG000|Overall Study|Protocol Violation|1|||
23525597|NCT01418937|65661816|FG000|Overall Study|Pregnancy|1|||
23525598|NCT01418937|65661816|FG000|Overall Study|Withdrawal by Subject|1|||
23716366|NCT01479374|66336916|FG000|Overall Study|Lost to Follow-up|1|||
23716367|NCT01479374|66336917|FG001|Overall Study|Lost to Follow-up|2|||
23716368|NCT01479374|66336918|FG002|Overall Study|Lost to Follow-up|0|||
23716369|NCT01479374|66336916|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
23716370|NCT01479374|66336917|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
23812906|NCT00758680|66696066|FG008|Overall Study|Laboratory Adverse Event|1|||
23417688|NCT02570152|65274419|FG000|Overall Study|Protocol Violation|2|||
23417689|NCT02570152|65274419|FG000|Overall Study|Migrated/moved from study area|13|||
23417690|NCT02954406|65274420|FG000|Overall Study|Adverse Event|0|||
23417691|NCT02954406|65274421|FG001|Overall Study|Adverse Event|1|||
23525599|NCT02244580|65661817|FG000|Overall Study|No cancer tissues available|241|||
23716371|NCT01479374|66336918|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
23716372|NCT01479374|66336916|FG000|Overall Study|Other|0|||
23716373|NCT01479374|66336917|FG001|Overall Study|Other|4|||
23716374|NCT01479374|66336918|FG002|Overall Study|Other|5|||
23716375|NCT00997321|66336919|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
23716376|NCT00997321|66336920|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
23716377|NCT03600714|66336921|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
23716378|NCT00776555|66336922|FG000|Overall Study|Study terminated|3|||
23716379|NCT00776555|66336923|FG001|Overall Study|Study terminated|0|||
23716380|NCT04126031|66336924|FG000|Part A|Withdrawal by Subject|0|||
23716381|NCT04126031|66336925|FG001|Part A|Withdrawal by Subject|0|||
23716382|NCT04126031|66336926|FG002|Part A|Withdrawal by Subject|1|||
23716383|NCT04126031|66336927|FG003|Part A|Withdrawal by Subject|0|||
23716384|NCT04126031|66336928|FG004|Part A|Withdrawal by Subject|0|||
23716385|NCT04126031|66336929|FG005|Part A|Withdrawal by Subject|0|||
23716386|NCT04126031|66336924|FG000|Part A|Other|1|||
23716387|NCT04126031|66336925|FG001|Part A|Other|0|||
23716388|NCT04126031|66336926|FG002|Part A|Other|0|||
23716389|NCT04126031|66336927|FG003|Part A|Other|0|||
23716390|NCT04126031|66336928|FG004|Part A|Other|0|||
23716391|NCT04126031|66336929|FG005|Part A|Other|0|||
23716392|NCT04126031|66336924|FG000|Part B|Adverse Event|0|||
23716393|NCT04126031|66336925|FG001|Part B|Adverse Event|0|||
23716394|NCT04126031|66336926|FG002|Part B|Adverse Event|0|||
23716395|NCT04126031|66336927|FG003|Part B|Adverse Event|0|||
23716396|NCT04126031|66336928|FG004|Part B|Adverse Event|0|||
23716397|NCT04126031|66336929|FG005|Part B|Adverse Event|2|||
23716398|NCT04126031|66336924|FG000|Part B|Pre-existing hypertransaminasemia|0|||
23716399|NCT04126031|66336925|FG001|Part B|Pre-existing hypertransaminasemia|0|||
23716400|NCT04126031|66336926|FG002|Part B|Pre-existing hypertransaminasemia|0|||
23716401|NCT04126031|66336927|FG003|Part B|Pre-existing hypertransaminasemia|0|||
23716402|NCT04126031|66336928|FG004|Part B|Pre-existing hypertransaminasemia|1|||
23716403|NCT04126031|66336929|FG005|Part B|Pre-existing hypertransaminasemia|0|||
23716404|NCT03287245|66336930|FG000|Overall Study|Study terminated by sponsor|3|||
23716405|NCT03287245|66336931|FG001|Overall Study|Study terminated by sponsor|0|||
23716406|NCT03287245|66336932|FG002|Overall Study|Study terminated by sponsor|3|||
23716407|NCT03287245|66336933|FG003|Overall Study|Study terminated by sponsor|1|||
23525600|NCT02476968|65661818|FG000|Overall Study|Other|0|||
23525601|NCT02476968|65661819|FG001|Overall Study|Other|2|||
23525602|NCT02476968|65661820|FG002|Overall Study|Other|0|||
23525603|NCT02476968|65661818|FG000|Overall Study|Lost to Follow-up|10|||
23525604|NCT02476968|65661819|FG001|Overall Study|Lost to Follow-up|0|||
23525605|NCT02476968|65661820|FG002|Overall Study|Lost to Follow-up|1|||
23525606|NCT02476968|65661818|FG000|Overall Study|Death|48|||
23525607|NCT02476968|65661819|FG001|Overall Study|Death|8|||
23525608|NCT02476968|65661820|FG002|Overall Study|Death|1|||
23525609|NCT02476968|65661818|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23525610|NCT02476968|65661819|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23525611|NCT02476968|65661820|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23525612|NCT02476968|65661818|FG000|Overall Study|Patient decision|37|||
23525613|NCT02476968|65661819|FG001|Overall Study|Patient decision|8|||
23525614|NCT02476968|65661820|FG002|Overall Study|Patient decision|0|||
23525615|NCT00414388|65661821|FG000|Overall Study|Adverse Event|1|||
23525616|NCT00245765|65661822|FG000|Overall Study|Adverse Event|1|||
23525617|NCT00245765|65661823|FG001|Overall Study|Adverse Event|1|||
23525618|NCT00245765|65661824|FG002|Overall Study|Adverse Event|0|||
23525619|NCT00245765|65661822|FG000|Overall Study|Lack of Efficacy|14|||
23525620|NCT00245765|65661823|FG001|Overall Study|Lack of Efficacy|7|||
23525621|NCT00245765|65661824|FG002|Overall Study|Lack of Efficacy|0|||
23525622|NCT00245765|65661822|FG000|Overall Study|Lost to Follow-up|1|||
23525623|NCT00245765|65661823|FG001|Overall Study|Lost to Follow-up|2|||
23525624|NCT00245765|65661824|FG002|Overall Study|Lost to Follow-up|0|||
23525625|NCT00245765|65661822|FG000|Overall Study|Withdrawal by Subject|1|||
23525626|NCT00245765|65661823|FG001|Overall Study|Withdrawal by Subject|0|||
23525627|NCT00245765|65661824|FG002|Overall Study|Withdrawal by Subject|3|||
23716408|NCT03287245|66336930|FG000|Overall Study|Adverse Event|1|||
23525628|NCT00245765|65661822|FG000|Overall Study|Other reason|2|||
23525629|NCT00245765|65661823|FG001|Overall Study|Other reason|0|||
23525630|NCT00245765|65661824|FG002|Overall Study|Other reason|1|||
23525631|NCT00245765|65661822|FG000|Overall Study|Other|13|||
23525632|NCT00245765|65661823|FG001|Overall Study|Other|4|||
23525633|NCT00245765|65661824|FG002|Overall Study|Other|4|||
23716409|NCT03287245|66336931|FG001|Overall Study|Adverse Event|0|||
23716410|NCT03287245|66336932|FG002|Overall Study|Adverse Event|0|||
23716411|NCT03287245|66336933|FG003|Overall Study|Adverse Event|0|||
23716412|NCT03287245|66336930|FG000|Overall Study|Withdrawal by Subject|8|||
23716413|NCT03287245|66336931|FG001|Overall Study|Withdrawal by Subject|3|||
23716414|NCT03287245|66336932|FG002|Overall Study|Withdrawal by Subject|3|||
23716415|NCT03287245|66336933|FG003|Overall Study|Withdrawal by Subject|0|||
23716416|NCT03287245|66336930|FG000|Overall Study|Physician Decision|3|||
23525634|NCT00692770|65661828|FG000|Overall Study|Protocol Violation|2|||
23525635|NCT00692770|65661829|FG001|Overall Study|Protocol Violation|7|||
23525636|NCT00692770|65661828|FG000|Overall Study|Withdrawal by Subject|97|||
23716417|NCT03287245|66336931|FG001|Overall Study|Physician Decision|2|||
23716418|NCT03287245|66336932|FG002|Overall Study|Physician Decision|0|||
23716419|NCT03287245|66336933|FG003|Overall Study|Physician Decision|0|||
23525637|NCT00692770|65661829|FG001|Overall Study|Withdrawal by Subject|36|||
23525638|NCT00692770|65661828|FG000|Overall Study|Adverse Event|136|||
23525639|NCT00692770|65661829|FG001|Overall Study|Adverse Event|41|||
23525640|NCT00692770|65661828|FG000|Overall Study|Death|10|||
23525641|NCT00692770|65661829|FG001|Overall Study|Death|5|||
23525642|NCT00692770|65661828|FG000|Overall Study|Lost to Follow-up|7|||
23812907|NCT00758680|66696067|FG009|Overall Study|Laboratory Adverse Event|0|||
23812908|NCT00758680|66696058|FG000|Overall Study|Withdrawal by Subject|0|||
23812909|NCT00758680|66696059|FG001|Overall Study|Withdrawal by Subject|0|||
23812910|NCT00758680|66696060|FG002|Overall Study|Withdrawal by Subject|0|||
23812911|NCT00758680|66696061|FG003|Overall Study|Withdrawal by Subject|0|||
23812912|NCT00758680|66696062|FG004|Overall Study|Withdrawal by Subject|0|||
23812913|NCT00758680|66696063|FG005|Overall Study|Withdrawal by Subject|0|||
23812914|NCT00758680|66696064|FG006|Overall Study|Withdrawal by Subject|1|||
23812915|NCT00758680|66696065|FG007|Overall Study|Withdrawal by Subject|0|||
23812916|NCT00758680|66696066|FG008|Overall Study|Withdrawal by Subject|1|||
23812917|NCT00758680|66696067|FG009|Overall Study|Withdrawal by Subject|0|||
23812918|NCT02455050|66696068|FG000|Treatment Period 1|Lost to Follow-up|1|||
23812919|NCT02455050|66696069|FG001|Treatment Period 1|Lost to Follow-up|1|||
23812920|NCT02455050|66696070|FG002|Treatment Period 1|Lost to Follow-up|1|||
23812921|NCT02455050|66696071|FG003|Treatment Period 1|Lost to Follow-up|2|||
23812922|NCT02455050|66696068|FG000|Treatment Period 2|Lost to Follow-up|1|||
23812923|NCT02455050|66696069|FG001|Treatment Period 2|Lost to Follow-up|0|||
23812924|NCT02455050|66696070|FG002|Treatment Period 2|Lost to Follow-up|2|||
23812925|NCT02455050|66696071|FG003|Treatment Period 2|Lost to Follow-up|1|||
23812926|NCT01437943|66696080|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
23812927|NCT01437943|66696081|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
23812928|NCT01437943|66696080|FG000|Overall Study|Subject expressed pregnancy plans|1|||
23417692|NCT02954406|65274422|FG002|Overall Study|Adverse Event|0|||
23417693|NCT02954406|65274423|FG003|Overall Study|Adverse Event|0|||
23417694|NCT02954406|65274424|FG004|Overall Study|Adverse Event|1|||
23417695|NCT02954406|65274425|FG005|Overall Study|Adverse Event|0|||
23417696|NCT02954406|65274426|FG006|Overall Study|Adverse Event|0|||
23417697|NCT02954406|65274427|FG007|Overall Study|Adverse Event|0|||
23417698|NCT02954406|65274428|FG008|Overall Study|Adverse Event|1|||
23417699|NCT02954406|65274429|FG009|Overall Study|Adverse Event|1|||
23417700|NCT02954406|65274430|FG010|Overall Study|Adverse Event|0|||
23417701|NCT02954406|65274420|FG000|Overall Study|Progressive Disease|3|||
23417702|NCT02954406|65274421|FG001|Overall Study|Progressive Disease|4|||
23417703|NCT02954406|65274422|FG002|Overall Study|Progressive Disease|3|||
23417704|NCT02954406|65274423|FG003|Overall Study|Progressive Disease|4|||
23417705|NCT02954406|65274424|FG004|Overall Study|Progressive Disease|3|||
23417706|NCT02954406|65274425|FG005|Overall Study|Progressive Disease|3|||
23417707|NCT02954406|65274426|FG006|Overall Study|Progressive Disease|2|||
23417708|NCT02954406|65274427|FG007|Overall Study|Progressive Disease|2|||
23417709|NCT02954406|65274428|FG008|Overall Study|Progressive Disease|1|||
23417710|NCT02954406|65274429|FG009|Overall Study|Progressive Disease|1|||
23417711|NCT02954406|65274430|FG010|Overall Study|Progressive Disease|0|||
23417712|NCT02954406|65274420|FG000|Overall Study|Symptomatic Deterioration|0|||
23417713|NCT02954406|65274421|FG001|Overall Study|Symptomatic Deterioration|1|||
23417714|NCT02954406|65274422|FG002|Overall Study|Symptomatic Deterioration|0|||
23417715|NCT02954406|65274423|FG003|Overall Study|Symptomatic Deterioration|0|||
23417716|NCT02954406|65274424|FG004|Overall Study|Symptomatic Deterioration|0|||
23417717|NCT02954406|65274425|FG005|Overall Study|Symptomatic Deterioration|0|||
23417718|NCT02954406|65274426|FG006|Overall Study|Symptomatic Deterioration|0|||
23417719|NCT02954406|65274427|FG007|Overall Study|Symptomatic Deterioration|0|||
23417720|NCT02954406|65274428|FG008|Overall Study|Symptomatic Deterioration|0|||
23417721|NCT02954406|65274429|FG009|Overall Study|Symptomatic Deterioration|0|||
23417722|NCT02954406|65274430|FG010|Overall Study|Symptomatic Deterioration|0|||
23525643|NCT00692770|65661829|FG001|Overall Study|Lost to Follow-up|3|||
23417723|NCT02954406|65274420|FG000|Overall Study|Death|0|||
23417724|NCT02954406|65274421|FG001|Overall Study|Death|0|||
23417725|NCT02954406|65274422|FG002|Overall Study|Death|0|||
23525644|NCT00692770|65661828|FG000|Overall Study|Non-compliant with study medication|11|||
23716420|NCT01890512|66336934|FG000|Overall Study|Physician Decision|1|||
23716421|NCT01890512|66336934|FG000|Overall Study|Withdrawal by Subject|1|||
23716422|NCT01890512|66336934|FG000|Overall Study|Protocol Violation|1|||
23812929|NCT01437943|66696081|FG001|Overall Study|Subject expressed pregnancy plans|0|||
23812930|NCT01437943|66696080|FG000|Overall Study|Adverse Event|2|||
23812931|NCT01437943|66696081|FG001|Overall Study|Adverse Event|0|||
23417726|NCT02954406|65274423|FG003|Overall Study|Death|0|||
23716423|NCT02180217|66336935|FG000|Overall Study|Adverse Event|3|||
23716424|NCT02180217|66336936|FG001|Overall Study|Adverse Event|2|||
23812932|NCT00132028|66696086|FG000|Overall Study|Adverse Event|7|||
23812933|NCT00132028|66696086|FG000|Overall Study|Death|2|||
23716425|NCT02180217|66336937|FG002|Overall Study|Adverse Event|22|||
23716426|NCT02180217|66336935|FG000|Overall Study|Death|1|||
23716427|NCT02180217|66336936|FG001|Overall Study|Death|1|||
23716428|NCT02180217|66336937|FG002|Overall Study|Death|0|||
23716429|NCT02180217|66336935|FG000|Overall Study|Withdrawal by Subject|1|||
23716430|NCT02180217|66336936|FG001|Overall Study|Withdrawal by Subject|1|||
23525645|NCT00692770|65661829|FG001|Overall Study|Non-compliant with study medication|5|||
23525646|NCT00692770|65661828|FG000|Overall Study|Progression by clinical judgment|2|||
23525647|NCT00692770|65661829|FG001|Overall Study|Progression by clinical judgment|3|||
23525648|NCT00692770|65661828|FG000|Overall Study|Physician decision not protocol driven|10|||
23716431|NCT02180217|66336937|FG002|Overall Study|Withdrawal by Subject|4|||
23716432|NCT02180217|66336935|FG000|Overall Study|Subject/Guardian decision|5|||
23525649|NCT00692770|65661829|FG001|Overall Study|Physician decision not protocol driven|14|||
23525650|NCT00692770|65661828|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
23525651|NCT00692770|65661829|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
23525652|NCT00692770|65661828|FG000|Overall Study|Protocol driven decision point|3|||
23525653|NCT00692770|65661829|FG001|Overall Study|Protocol driven decision point|7|||
23716433|NCT02180217|66336936|FG001|Overall Study|Subject/Guardian decision|3|||
23716434|NCT02180217|66336937|FG002|Overall Study|Subject/Guardian decision|6|||
23716435|NCT02180217|66336935|FG000|Overall Study|Physician Decision|1|||
23716436|NCT02180217|66336936|FG001|Overall Study|Physician Decision|1|||
23716437|NCT02180217|66336937|FG002|Overall Study|Physician Decision|6|||
23716438|NCT02180217|66336935|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23716439|NCT02180217|66336936|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23716440|NCT02180217|66336937|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23716441|NCT02022033|66336938|FG000|Overall Study|Physician Decision|1|||
23716442|NCT00426556|66336939|FG000|Phase I - Core Phase|Disease Progression|0|||
23716443|NCT00426556|66336940|FG001|Phase I - Core Phase|Disease Progression|6|||
23716444|NCT00426556|66336941|FG002|Phase I - Core Phase|Disease Progression|2|||
23716445|NCT00426556|66336942|FG003|Phase I - Core Phase|Disease Progression|0|||
23716446|NCT00426556|66336939|FG000|Phase I - Core Phase|Adverse Event|1|||
23716447|NCT00426556|66336940|FG001|Phase I - Core Phase|Adverse Event|3|||
23716448|NCT00426556|66336941|FG002|Phase I - Core Phase|Adverse Event|1|||
23716449|NCT00426556|66336942|FG003|Phase I - Core Phase|Adverse Event|0|||
23716450|NCT00426556|66336939|FG000|Phase I - Core Phase|Death|0|||
23716451|NCT00426556|66336940|FG001|Phase I - Core Phase|Death|1|||
23716452|NCT00426556|66336941|FG002|Phase I - Core Phase|Death|0|||
23716453|NCT00426556|66336942|FG003|Phase I - Core Phase|Death|0|||
23716454|NCT00426556|66336939|FG000|Phase I - Extension Phase|Adverse Event|0|||
23716455|NCT00426556|66336940|FG001|Phase I - Extension Phase|Adverse Event|1|||
23716456|NCT00426556|66336941|FG002|Phase I - Extension Phase|Adverse Event|1|||
23716457|NCT00426556|66336942|FG003|Phase I - Extension Phase|Adverse Event|0|||
23716458|NCT00426556|66336939|FG000|Phase I - Extension Phase|Disease Progression|5|||
23716459|NCT00426556|66336940|FG001|Phase I - Extension Phase|Disease Progression|5|||
23716460|NCT00426556|66336941|FG002|Phase I - Extension Phase|Disease Progression|6|||
23716461|NCT00426556|66336942|FG003|Phase I - Extension Phase|Disease Progression|0|||
23716462|NCT00426556|66336939|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
23716463|NCT00426556|66336940|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
23716464|NCT00426556|66336941|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
23716465|NCT00426556|66336942|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
23716466|NCT00426556|66336939|FG000|Phase II - Core Phase|Disease Progression|0|||
23716467|NCT00426556|66336940|FG001|Phase II - Core Phase|Disease Progression|0|||
23716468|NCT00426556|66336941|FG002|Phase II - Core Phase|Disease Progression|0|||
23716469|NCT00426556|66336942|FG003|Phase II - Core Phase|Disease Progression|16|||
23716470|NCT00426556|66336939|FG000|Phase II - Core Phase|Adverse Event|0|||
23716471|NCT00426556|66336940|FG001|Phase II - Core Phase|Adverse Event|0|||
23716472|NCT00426556|66336941|FG002|Phase II - Core Phase|Adverse Event|0|||
23716473|NCT00426556|66336942|FG003|Phase II - Core Phase|Adverse Event|8|||
23716474|NCT00426556|66336939|FG000|Phase II - Extension Phase|Disease Progression|0|||
23716475|NCT00426556|66336940|FG001|Phase II - Extension Phase|Disease Progression|0|||
23716476|NCT00426556|66336941|FG002|Phase II - Extension Phase|Disease Progression|0|||
23716477|NCT00426556|66336942|FG003|Phase II - Extension Phase|Disease Progression|21|||
23716478|NCT00426556|66336939|FG000|Phase II - Extension Phase|Adverse Event|0|||
23716479|NCT00426556|66336940|FG001|Phase II - Extension Phase|Adverse Event|0|||
23716480|NCT00426556|66336941|FG002|Phase II - Extension Phase|Adverse Event|0|||
23716481|NCT00426556|66336942|FG003|Phase II - Extension Phase|Adverse Event|2|||
23716482|NCT05563714|66336943|FG000|Overall Study|Death|2|||
23716483|NCT05563714|66336944|FG001|Overall Study|Death|2|||
23716484|NCT05563714|66336945|FG002|Overall Study|Death|0|||
23716485|NCT05563714|66336946|FG003|Overall Study|Death|0|||
23716486|NCT05563714|66336943|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
23716487|NCT05563714|66336944|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
23716488|NCT05563714|66336945|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
23525654|NCT00692770|65661828|FG000|Overall Study|Completed all planned assessments|79|||
23525655|NCT00692770|65661829|FG001|Overall Study|Completed all planned assessments|101|||
23525656|NCT00692770|65661828|FG000|Overall Study|Radiological and clinical progression|8|||
23525657|NCT00692770|65661829|FG001|Overall Study|Radiological and clinical progression|8|||
23525658|NCT00692770|65661828|FG000|Overall Study|Clinical endpoint reached|16|||
23525659|NCT00692770|65661829|FG001|Overall Study|Clinical endpoint reached|43|||
23525660|NCT00692770|65661828|FG000|Overall Study|Study terminated by sponsor|2|||
23525661|NCT00692770|65661829|FG001|Overall Study|Study terminated by sponsor|2|||
23525662|NCT00692770|65661828|FG000|Overall Study|Randomized but not treated|3|||
23525663|NCT00692770|65661829|FG001|Overall Study|Randomized but not treated|4|||
23525664|NCT02129803|65661834|FG000|Overall Study|Protocol Violation|4|||
23525665|NCT02129803|65661835|FG001|Overall Study|Protocol Violation|0|||
23525666|NCT02129803|65661834|FG000|Overall Study|Physician Decision|0|||
23525667|NCT02129803|65661835|FG001|Overall Study|Physician Decision|1|||
23525668|NCT02129803|65661834|FG000|Overall Study|Difficulty sleeping|1|||
23525669|NCT02129803|65661835|FG001|Overall Study|Difficulty sleeping|0|||
23525670|NCT02129803|65661834|FG000|Overall Study|Morning headache|0|||
23525671|NCT02129803|65661835|FG001|Overall Study|Morning headache|1|||
23525672|NCT02129803|65661834|FG000|Overall Study|Withdrawal by Subject|1|||
23716489|NCT05563714|66336946|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
23716490|NCT05563714|66336943|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
23716491|NCT05563714|66336944|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
23716492|NCT05563714|66336945|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
23716493|NCT05563714|66336946|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
23716494|NCT05563714|66336943|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23716495|NCT05563714|66336944|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
23716496|NCT05563714|66336945|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23716497|NCT05563714|66336946|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23716498|NCT05563714|66336943|FG000|Overall Study|Lost to Follow-up|22|||
23716499|NCT05563714|66336944|FG001|Overall Study|Lost to Follow-up|19|||
23716500|NCT05563714|66336945|FG002|Overall Study|Lost to Follow-up|0|||
23716501|NCT05563714|66336946|FG003|Overall Study|Lost to Follow-up|0|||
23716502|NCT02248857|66336948|FG000|3 Month|Withdrawal by Subject|9|||
23716503|NCT02248857|66336949|FG001|3 Month|Withdrawal by Subject|3|||
23716504|NCT02248857|66336950|FG002|3 Month|Withdrawal by Subject|4|||
23716505|NCT02248857|66336948|FG000|3 Month|Unable to reach for 3 month|35|||
23716506|NCT02248857|66336949|FG001|3 Month|Unable to reach for 3 month|29|||
23716507|NCT02248857|66336950|FG002|3 Month|Unable to reach for 3 month|26|||
23716508|NCT02248857|66336948|FG000|3 Month|Partially completed, unable to finish|2|||
23716509|NCT02248857|66336949|FG001|3 Month|Partially completed, unable to finish|2|||
23716510|NCT02248857|66336950|FG002|3 Month|Partially completed, unable to finish|1|||
23716511|NCT02248857|66336948|FG000|6 Month|Lost to Follow-up|27|||
23716512|NCT02248857|66336949|FG001|6 Month|Lost to Follow-up|26|||
23716513|NCT02248857|66336950|FG002|6 Month|Lost to Follow-up|15|||
23716514|NCT02248857|66336948|FG000|6 Month|Partially completed, unable to finish|0|||
23716515|NCT02248857|66336949|FG001|6 Month|Partially completed, unable to finish|1|||
23716516|NCT02248857|66336950|FG002|6 Month|Partially completed, unable to finish|0|||
23716517|NCT02248857|66336948|FG000|6 Month|Withdrawal by Subject|0|||
23716518|NCT02248857|66336949|FG001|6 Month|Withdrawal by Subject|2|||
23716519|NCT02248857|66336950|FG002|6 Month|Withdrawal by Subject|2|||
23716520|NCT02248857|66336948|FG000|6 Month|Death|1|||
23716521|NCT02248857|66336949|FG001|6 Month|Death|0|||
23716522|NCT02248857|66336950|FG002|6 Month|Death|0|||
23716523|NCT02614287|66336953|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
23716524|NCT02614287|66336954|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
23716525|NCT02614287|66336953|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
23716526|NCT02614287|66336954|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
23716527|NCT02614287|66336953|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
23716528|NCT02614287|66336954|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
23716529|NCT02614287|66336953|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
23716530|NCT02614287|66336954|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
23716531|NCT02614287|66336953|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
23525673|NCT02129803|65661835|FG001|Overall Study|Withdrawal by Subject|1|||
23525674|NCT02167256|65661843|FG000|Overall Study|Adverse Event|13|||
23525675|NCT02167256|65661844|FG001|Overall Study|Adverse Event|6|||
23525676|NCT02167256|65661843|FG000|Overall Study|Withdrawal by Subject|4|||
23716532|NCT02614287|66336954|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
23716533|NCT02614287|66336953|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
23716534|NCT02614287|66336954|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
23716535|NCT02614287|66336953|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
23716536|NCT02614287|66336954|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
23525677|NCT02167256|65661844|FG001|Overall Study|Withdrawal by Subject|4|||
23525678|NCT02167256|65661843|FG000|Overall Study|non-compliance|3|||
23525679|NCT02167256|65661844|FG001|Overall Study|non-compliance|0|||
23525680|NCT02167256|65661843|FG000|Overall Study|Study partner unable to participate|1|||
23525681|NCT02167256|65661844|FG001|Overall Study|Study partner unable to participate|0|||
23525682|NCT02540954|65661845|FG000|Overall Study|Physician Decision|3|||
23525683|NCT02540954|65661846|FG001|Overall Study|Physician Decision|1|||
23525684|NCT02540954|65661845|FG000|Overall Study|Withdrawal by Subject|6|||
23525685|NCT02540954|65661846|FG001|Overall Study|Withdrawal by Subject|5|||
23525686|NCT02540954|65661845|FG000|Overall Study|Lost to Follow-up|1|||
23525687|NCT02540954|65661846|FG001|Overall Study|Lost to Follow-up|1|||
23525688|NCT02540954|65661845|FG000|Overall Study|Adverse Event|4|||
23525689|NCT02540954|65661846|FG001|Overall Study|Adverse Event|2|||
23525690|NCT02540954|65661845|FG000|Overall Study|Death|0|||
23525691|NCT02540954|65661846|FG001|Overall Study|Death|3|||
23525692|NCT02540954|65661845|FG000|Overall Study|Treatment failure|1|||
23525693|NCT02540954|65661846|FG001|Overall Study|Treatment failure|0|||
23525694|NCT02540954|65661845|FG000|Overall Study|Other reason|4|||
23525695|NCT02540954|65661846|FG001|Overall Study|Other reason|2|||
23525696|NCT00743652|65661849|FG000|Overall Study|Parent/Legal Guardian Request|3|||
23525697|NCT00743652|65661850|FG001|Overall Study|Parent/Legal Guardian Request|2|||
23525698|NCT00743652|65661851|FG002|Overall Study|Parent/Legal Guardian Request|2|||
23525699|NCT00743652|65661852|FG003|Overall Study|Parent/Legal Guardian Request|2|||
23525700|NCT00743652|65661853|FG004|Overall Study|Parent/Legal Guardian Request|0|||
23525701|NCT00743652|65661849|FG000|Overall Study|Adverse Event|3|||
23525702|NCT00743652|65661850|FG001|Overall Study|Adverse Event|0|||
23525703|NCT00743652|65661851|FG002|Overall Study|Adverse Event|0|||
23525704|NCT00743652|65661852|FG003|Overall Study|Adverse Event|0|||
23525705|NCT00743652|65661853|FG004|Overall Study|Adverse Event|0|||
23525706|NCT00743652|65661849|FG000|Overall Study|Death|2|||
23525707|NCT00743652|65661850|FG001|Overall Study|Death|0|||
23525708|NCT00743652|65661851|FG002|Overall Study|Death|0|||
23525709|NCT00743652|65661852|FG003|Overall Study|Death|0|||
23525710|NCT00743652|65661853|FG004|Overall Study|Death|0|||
23525711|NCT00743652|65661849|FG000|Overall Study|Investigator Request|0|||
23525712|NCT00743652|65661850|FG001|Overall Study|Investigator Request|0|||
23525713|NCT00743652|65661851|FG002|Overall Study|Investigator Request|0|||
23525714|NCT00743652|65661852|FG003|Overall Study|Investigator Request|2|||
23525715|NCT00743652|65661853|FG004|Overall Study|Investigator Request|0|||
23525716|NCT00743652|65661849|FG000|Overall Study|Other|1|||
23525717|NCT00743652|65661850|FG001|Overall Study|Other|1|||
23525718|NCT00743652|65661851|FG002|Overall Study|Other|0|||
23525719|NCT00743652|65661852|FG003|Overall Study|Other|0|||
23525720|NCT00743652|65661853|FG004|Overall Study|Other|0|||
23525721|NCT00743652|65661849|FG000|Overall Study|Lost to Follow-up|1|||
23525722|NCT00743652|65661850|FG001|Overall Study|Lost to Follow-up|0|||
23525723|NCT00743652|65661851|FG002|Overall Study|Lost to Follow-up|0|||
23525724|NCT00743652|65661852|FG003|Overall Study|Lost to Follow-up|0|||
23525725|NCT00743652|65661853|FG004|Overall Study|Lost to Follow-up|0|||
23525726|NCT01231581|65661855|FG000|Overall Study|Lost to Follow-up|2|||
23525727|NCT01231581|65661856|FG001|Overall Study|Lost to Follow-up|2|||
23525728|NCT01231581|65661855|FG000|Overall Study|Withdrawal by Subject|6|||
23525729|NCT01231581|65661856|FG001|Overall Study|Withdrawal by Subject|9|||
23525730|NCT01231581|65661855|FG000|Overall Study|Study Closed/Terminated|6|||
23525731|NCT01231581|65661856|FG001|Overall Study|Study Closed/Terminated|5|||
23525732|NCT01231581|65661855|FG000|Overall Study|Death|65|||
23525733|NCT01231581|65661856|FG001|Overall Study|Death|64|||
23525734|NCT01231581|65661855|FG000|Overall Study|Ongoing|1|||
23525735|NCT01231581|65661856|FG001|Overall Study|Ongoing|0|||
23525736|NCT04907032|65661857|FG000|Overall Study|Withdrawal by Subject|7|||
23525737|NCT04907032|65661858|FG001|Overall Study|Withdrawal by Subject|1|||
23525738|NCT02702401|65661859|FG000|Overall Study|Death|242|||
23525739|NCT02702401|65661860|FG001|Overall Study|Death|125|||
23525740|NCT02702401|65661859|FG000|Overall Study|Withdrawal by Subject|15|||
23525741|NCT02702401|65661860|FG001|Overall Study|Withdrawal by Subject|5|||
23525742|NCT02702401|65661859|FG000|Overall Study|Sponsor Decision|19|||
23525743|NCT02702401|65661860|FG001|Overall Study|Sponsor Decision|3|||
23525744|NCT02702401|65661859|FG000|Overall Study|Physician Decision|1|||
23525745|NCT02702401|65661860|FG001|Overall Study|Physician Decision|2|||
23525746|NCT02702401|65661859|FG000|Overall Study|Lost to Follow-up|1|||
23525747|NCT02702401|65661860|FG001|Overall Study|Lost to Follow-up|0|||
23525748|NCT01009099|65661861|FG000|Overall Study|Lost to Follow-up|1|||
23525749|NCT01009099|65661862|FG001|Overall Study|Lost to Follow-up|0|||
23525750|NCT01009099|65661861|FG000|Overall Study|Physician Decision|3|||
23525751|NCT01009099|65661862|FG001|Overall Study|Physician Decision|2|||
23525752|NCT01009099|65661861|FG000|Overall Study|Withdrawal by Subject|1|||
23525753|NCT01009099|65661862|FG001|Overall Study|Withdrawal by Subject|1|||
23525754|NCT01009099|65661861|FG000|Overall Study|Death|0|||
23525755|NCT01009099|65661862|FG001|Overall Study|Death|1|||
23525756|NCT00489853|65661863|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
23525757|NCT00489853|65661864|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
23525758|NCT00489853|65661865|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
23525759|NCT00489853|65661863|FG000|Wash-out Period 1|Adverse Event|0|||
23525760|NCT00489853|65661864|FG001|Wash-out Period 1|Adverse Event|1|||
23525761|NCT00489853|65661865|FG002|Wash-out Period 1|Adverse Event|1|||
23525762|NCT00489853|65661863|FG000|Wash-out Period 1|Protocol Violation|0|||
23525763|NCT00489853|65661864|FG001|Wash-out Period 1|Protocol Violation|1|||
23525764|NCT00489853|65661865|FG002|Wash-out Period 1|Protocol Violation|1|||
23525765|NCT00489853|65661863|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
23525766|NCT00489853|65661864|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
23525767|NCT00489853|65661865|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
23525768|NCT00489853|65661863|FG000|Wash-out Period 2|Adverse Event|1|||
23525769|NCT00489853|65661864|FG001|Wash-out Period 2|Adverse Event|1|||
23525770|NCT00489853|65661865|FG002|Wash-out Period 2|Adverse Event|0|||
23525771|NCT00489853|65661863|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
23525772|NCT00489853|65661864|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
23525773|NCT00489853|65661865|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
23525774|NCT00489853|65661863|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
23525775|NCT00489853|65661864|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
23525776|NCT00489853|65661865|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
23525777|NCT01933048|65661871|FG000|Overall Study|Lost to Follow-up|15|||
23525778|NCT01933048|65661872|FG001|Overall Study|Lost to Follow-up|18|||
23525779|NCT01933048|65661871|FG000|Overall Study|personal reasons|1|||
23525780|NCT01933048|65661872|FG001|Overall Study|personal reasons|1|||
23525781|NCT01933048|65661871|FG000|Overall Study|Protocol Violation|7|||
23525782|NCT01933048|65661872|FG001|Overall Study|Protocol Violation|8|||
23525783|NCT01933048|65661871|FG000|Overall Study|Physician Decision|1|||
23525784|NCT01933048|65661872|FG001|Overall Study|Physician Decision|0|||
23525785|NCT01933048|65661871|FG000|Overall Study|unknown reasons|1|||
23525786|NCT01933048|65661872|FG001|Overall Study|unknown reasons|1|||
23525787|NCT00983580|65661873|FG000|Overall Study|Cancel Prior to treatment|1|||
23525788|NCT00983580|65661874|FG001|Overall Study|Cancel Prior to treatment|3|||
23525789|NCT00983580|65661873|FG000|Overall Study|Protocol Violation|1|||
23525790|NCT00983580|65661874|FG001|Overall Study|Protocol Violation|1|||
23525791|NCT00983580|65661873|FG000|Overall Study|Ineligible|3|||
23525792|NCT00983580|65661874|FG001|Overall Study|Ineligible|0|||
23525793|NCT03026257|65661875|FG000|Overall Study|Adverse Event|3|||
23812934|NCT00132028|66696086|FG000|Overall Study|Lack of Efficacy|11|||
23812935|NCT00132028|66696086|FG000|Overall Study|Withdrawal by Subject|2|||
23812936|NCT00132028|66696086|FG000|Overall Study|not eligible|2|||
23812937|NCT00132028|66696086|FG000|Overall Study|Physician Decision|3|||
23812938|NCT02488330|66696094|FG000|Overall Study|Adverse Event|1|||
23812939|NCT02488330|66696094|FG000|Overall Study|Physician Decision|2|||
23812940|NCT02488330|66696094|FG000|Overall Study|Death|2|||
23812941|NCT02488330|66696094|FG000|Overall Study|Disease Progression|3|||
23812942|NCT02488330|66696094|FG000|Overall Study|Study Termination by Sponsor|4|||
23812943|NCT03861481|66696095|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
23812944|NCT03861481|66696096|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
23525794|NCT03026257|65661876|FG001|Overall Study|Adverse Event|0|||
23525795|NCT03026257|65661877|FG002|Overall Study|Adverse Event|0|||
23525796|NCT03026257|65661878|FG003|Overall Study|Adverse Event|0|||
23525797|NCT03026257|65661879|FG004|Overall Study|Adverse Event|0|||
23812945|NCT03861481|66696095|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
23525798|NCT03026257|65661880|FG005|Overall Study|Adverse Event|0|||
23525799|NCT03026257|65661875|FG000|Overall Study|Lost to Follow-up|1|||
23525800|NCT03026257|65661876|FG001|Overall Study|Lost to Follow-up|0|||
23525801|NCT03026257|65661877|FG002|Overall Study|Lost to Follow-up|0|||
23525802|NCT03026257|65661878|FG003|Overall Study|Lost to Follow-up|0|||
23525803|NCT03026257|65661879|FG004|Overall Study|Lost to Follow-up|0|||
23525804|NCT03026257|65661880|FG005|Overall Study|Lost to Follow-up|0|||
23525805|NCT03026257|65661875|FG000|Overall Study|Protocol Violation|1|||
23525806|NCT03026257|65661876|FG001|Overall Study|Protocol Violation|0|||
23525807|NCT03026257|65661877|FG002|Overall Study|Protocol Violation|0|||
23525808|NCT03026257|65661878|FG003|Overall Study|Protocol Violation|1|||
23525809|NCT03026257|65661879|FG004|Overall Study|Protocol Violation|1|||
23525810|NCT03026257|65661880|FG005|Overall Study|Protocol Violation|0|||
23525811|NCT03026257|65661875|FG000|Overall Study|Withdrawal by Subject|1|||
23525812|NCT03026257|65661876|FG001|Overall Study|Withdrawal by Subject|1|||
23525813|NCT03026257|65661877|FG002|Overall Study|Withdrawal by Subject|0|||
23417727|NCT02954406|65274424|FG004|Overall Study|Death|1|||
23417728|NCT02954406|65274425|FG005|Overall Study|Death|0|||
23417729|NCT02954406|65274426|FG006|Overall Study|Death|0|||
23417730|NCT02954406|65274427|FG007|Overall Study|Death|0|||
23417731|NCT02954406|65274428|FG008|Overall Study|Death|1|||
23417732|NCT02954406|65274429|FG009|Overall Study|Death|1|||
23417733|NCT02954406|65274430|FG010|Overall Study|Death|0|||
23417734|NCT02954406|65274420|FG000|Overall Study|Reason Not Specified|0|||
23417735|NCT02954406|65274421|FG001|Overall Study|Reason Not Specified|0|||
23417736|NCT02954406|65274422|FG002|Overall Study|Reason Not Specified|3|||
23417737|NCT02954406|65274423|FG003|Overall Study|Reason Not Specified|2|||
23417738|NCT02954406|65274424|FG004|Overall Study|Reason Not Specified|2|||
23417739|NCT02954406|65274425|FG005|Overall Study|Reason Not Specified|0|||
23417740|NCT02954406|65274426|FG006|Overall Study|Reason Not Specified|1|||
23417741|NCT02954406|65274427|FG007|Overall Study|Reason Not Specified|0|||
23525814|NCT03026257|65661878|FG003|Overall Study|Withdrawal by Subject|0|||
23525815|NCT03026257|65661879|FG004|Overall Study|Withdrawal by Subject|0|||
23525816|NCT03026257|65661880|FG005|Overall Study|Withdrawal by Subject|0|||
23525817|NCT04365699|65661881|FG000|Overall Study|Death|2|||
23525818|NCT04365699|65661882|FG001|Overall Study|Death|5|||
23525819|NCT04365699|65661883|FG002|Overall Study|Death|15|||
23525820|NCT01640366|65661884|FG000|Overall Study|Withdrawal by Subject|1|||
23525821|NCT01640366|65661884|FG000|Overall Study|Protocol Violation|16|||
23525822|NCT01640366|65661884|FG000|Overall Study|Lost to Follow-up|5|||
23525823|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23525824|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
23525825|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
23525826|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
23525827|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
23525828|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
23525829|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23525830|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
23525831|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23525832|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23525833|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
23525834|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23525835|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
23525836|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
23525837|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
23525838|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
23525839|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
23417742|NCT02954406|65274428|FG008|Overall Study|Reason Not Specified|1|||
23417743|NCT02954406|65274429|FG009|Overall Study|Reason Not Specified|0|||
23525840|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
23525841|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
23525842|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
23525843|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
23417744|NCT02954406|65274430|FG010|Overall Study|Reason Not Specified|0|||
23525844|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
23525845|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
23716537|NCT02614287|66336953|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
23716538|NCT02614287|66336954|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
23525846|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
23525847|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Other|0|||
23525848|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Other|0|||
23525849|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Other|5|||
23525850|NCT01465464|65665304|FG000|Overall Study|Adverse Event|96|||
23525851|NCT01465464|65665305|FG001|Overall Study|Adverse Event|49|||
23525852|NCT01465464|65665304|FG000|Overall Study|Lack of Efficacy|139|||
23525853|NCT01465464|65665305|FG001|Overall Study|Lack of Efficacy|190|||
23525854|NCT01465464|65665304|FG000|Overall Study|Physician Decision|13|||
23525855|NCT01465464|65665305|FG001|Overall Study|Physician Decision|5|||
23525856|NCT01465464|65665304|FG000|Overall Study|Protocol Violation|1|||
23525857|NCT01465464|65665305|FG001|Overall Study|Protocol Violation|1|||
23525858|NCT01465464|65665304|FG000|Overall Study|Withdrawal by Subject|46|||
23525859|NCT01465464|65665305|FG001|Overall Study|Withdrawal by Subject|30|||
23525860|NCT01465464|65665304|FG000|Overall Study|Other|9|||
23525861|NCT01465464|65665305|FG001|Overall Study|Other|3|||
23525862|NCT01465464|65665304|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
23525863|NCT01465464|65665305|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
23525864|NCT00357370|65665306|FG000|Cohort 2|Lack of Efficacy|0|||
23525865|NCT00357370|65665307|FG001|Cohort 2|Lack of Efficacy|2|||
23525866|NCT00357370|65665308|FG002|Cohort 2|Lack of Efficacy|1|||
23525867|NCT00357370|65665306|FG000|Cohort 2|Adverse Event|1|||
23525868|NCT00357370|65665307|FG001|Cohort 2|Adverse Event|1|||
23525869|NCT00357370|65665308|FG002|Cohort 2|Adverse Event|1|||
23525870|NCT00357370|65665306|FG000|Cohort 2|Lost to Follow-up|0|||
23525871|NCT00357370|65665307|FG001|Cohort 2|Lost to Follow-up|1|||
23525872|NCT00357370|65665308|FG002|Cohort 2|Lost to Follow-up|0|||
23525873|NCT00357370|65665306|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
23525874|NCT00357370|65665307|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
23525875|NCT00357370|65665308|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
23525876|NCT00357370|65665306|FG000|Cohort 2|Withdrawal by Subject|0|||
23525877|NCT00357370|65665307|FG001|Cohort 2|Withdrawal by Subject|2|||
23525878|NCT00357370|65665308|FG002|Cohort 2|Withdrawal by Subject|0|||
23525879|NCT00677807|65665309|FG000|Overall Study|Adverse Event|4|||
23525880|NCT00677807|65665310|FG001|Overall Study|Adverse Event|1|||
23525881|NCT00677807|65665311|FG002|Overall Study|Adverse Event|6|||
23525882|NCT00677807|65665309|FG000|Overall Study|Lack of Efficacy|0|||
23525883|NCT00677807|65665310|FG001|Overall Study|Lack of Efficacy|0|||
23525884|NCT00677807|65665311|FG002|Overall Study|Lack of Efficacy|2|||
23525885|NCT00677807|65665309|FG000|Overall Study|Participant no longer needs study drug|0|||
23525886|NCT00677807|65665310|FG001|Overall Study|Participant no longer needs study drug|0|||
23525887|NCT00677807|65665311|FG002|Overall Study|Participant no longer needs study drug|1|||
23525888|NCT00677807|65665309|FG000|Overall Study|Withdrawal by Subject|10|||
23525889|NCT00677807|65665310|FG001|Overall Study|Withdrawal by Subject|3|||
23525890|NCT00677807|65665311|FG002|Overall Study|Withdrawal by Subject|6|||
23525891|NCT00677807|65665309|FG000|Overall Study|Lost to Follow-up|2|||
23525892|NCT00677807|65665310|FG001|Overall Study|Lost to Follow-up|2|||
23525893|NCT00677807|65665311|FG002|Overall Study|Lost to Follow-up|2|||
23525894|NCT00677807|65665309|FG000|Overall Study|Administrative problems|1|||
23525895|NCT00677807|65665310|FG001|Overall Study|Administrative problems|1|||
23525896|NCT00677807|65665311|FG002|Overall Study|Administrative problems|2|||
23525897|NCT00677807|65665309|FG000|Overall Study|Death|0|||
23525898|NCT00677807|65665310|FG001|Overall Study|Death|1|||
23525899|NCT00677807|65665311|FG002|Overall Study|Death|1|||
23525900|NCT00677807|65665309|FG000|Overall Study|Protocol Deviation|1|||
23525901|NCT00677807|65665310|FG001|Overall Study|Protocol Deviation|3|||
23525902|NCT00677807|65665311|FG002|Overall Study|Protocol Deviation|0|||
23716539|NCT02919683|66336955|FG000|Post-Surgery Follow-Up|Death|2|||
23716540|NCT02919683|66336956|FG001|Post-Surgery Follow-Up|Death|2|||
23525903|NCT00794196|65665318|FG000|Overall Study|Lost to Follow-up|5|||
23417745|NCT00557310|65274431|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
23525904|NCT00794196|65665319|FG001|Overall Study|Lost to Follow-up|23|||
23525905|NCT02188485|65665323|FG000|Overall Study|Withdrawal by Subject|2|||
23525906|NCT02188485|65665324|FG001|Overall Study|Withdrawal by Subject|1|||
23716541|NCT02919683|66336955|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
23525907|NCT02188485|65665323|FG000|Overall Study|PI withdrew, lack of capacity|0|||
23716542|NCT02919683|66336956|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
23525908|NCT02188485|65665324|FG001|Overall Study|PI withdrew, lack of capacity|2|||
23525909|NCT03044197|65665327|FG000|Overall Study|Withdrawal by Subject|3|||
23525910|NCT03044197|65665328|FG001|Overall Study|Withdrawal by Subject|1|||
23525911|NCT00405548|65665330|FG000|Overall Study|Cognitive Memory problems on study day|1|||
23525912|NCT00405548|65665331|FG001|Overall Study|Cognitive Memory problems on study day|0|||
23716543|NCT01894477|66336957|FG000|Overall Study|Protocol Violation|0|||
23716544|NCT01894477|66336958|FG001|Overall Study|Protocol Violation|1|||
23716545|NCT01894477|66336957|FG000|Overall Study|protocol changed due SC changed to cord|0|||
23716546|NCT01894477|66336958|FG001|Overall Study|protocol changed due SC changed to cord|1|||
23716547|NCT01879319|66336959|FG000|Overall Study|Withdrawal by Subject|1|||
23716548|NCT01879319|66336960|FG001|Overall Study|Withdrawal by Subject|0|||
23716549|NCT01879319|66336959|FG000|Overall Study|Lost to Follow-up|1|||
23716550|NCT01879319|66336960|FG001|Overall Study|Lost to Follow-up|5|||
23716551|NCT00889681|66336961|FG000|Overall Study|Not meeting qualification Criteria|2|||
23525913|NCT00405548|65665330|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
23525914|NCT00405548|65665331|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
23525915|NCT00405548|65665330|FG000|Overall Study|Unable to self-administer shots|1|||
23525916|NCT00405548|65665331|FG001|Overall Study|Unable to self-administer shots|0|||
23525917|NCT00405548|65665330|FG000|Overall Study|Venous access failed during study day|1|||
23525918|NCT00405548|65665331|FG001|Overall Study|Venous access failed during study day|0|||
23525919|NCT00405548|65665330|FG000|Overall Study|Withdrawal by Subject|1|||
23525920|NCT00405548|65665331|FG001|Overall Study|Withdrawal by Subject|0|||
23525921|NCT01344369|65665340|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23525922|NCT01344369|65665341|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
23525923|NCT01344369|65665340|FG000|Washout of 28 Days|Physician Decision|0|||
23525924|NCT01344369|65665341|FG001|Washout of 28 Days|Physician Decision|1|||
23525925|NCT01344369|65665340|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
23525926|NCT01344369|65665341|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
23417746|NCT00557310|65274431|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
23417747|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
23525927|NCT01709695|65665342|FG000|Overall Study|Withdrawal by Subject|1|||
23525928|NCT01709695|65665343|FG001|Overall Study|Withdrawal by Subject|1|||
23525929|NCT04847674|65665344|FG000|Overall Study|Withdrawal by Subject|0|||
23525930|NCT04847674|65665345|FG001|Overall Study|Withdrawal by Subject|1|||
23525931|NCT04847674|65665346|FG002|Overall Study|Withdrawal by Subject|0|||
23525932|NCT04847674|65665344|FG000|Overall Study|Lost to Follow-up|0|||
23525933|NCT04847674|65665345|FG001|Overall Study|Lost to Follow-up|0|||
23525934|NCT04847674|65665346|FG002|Overall Study|Lost to Follow-up|2|||
23525935|NCT04847674|65665344|FG000|Overall Study|Other than specified|21|||
23525936|NCT04847674|65665345|FG001|Overall Study|Other than specified|20|||
23525937|NCT04847674|65665346|FG002|Overall Study|Other than specified|20|||
23525938|NCT03299842|65665353|FG000|Overall Study|Caregiver withdrew consent|2|||
23525939|NCT03299842|65665353|FG000|Overall Study|Child would not keep the watch on|3|||
23525940|NCT01572038|65665355|FG000|Overall Study|Death|648|||
23525941|NCT01572038|65665355|FG000|Overall Study|Withdrawal by Subject|204|||
23525942|NCT01572038|65665355|FG000|Overall Study|Lost to Follow-up|81|||
23525943|NCT01572038|65665355|FG000|Overall Study|Physician Decision|20|||
23525944|NCT01572038|65665355|FG000|Overall Study|Patient Decision|14|||
23525945|NCT01572038|65665355|FG000|Overall Study|Progressive Disease|8|||
23525946|NCT01572038|65665355|FG000|Overall Study|Site Closed Before Completing Form|6|||
23525947|NCT01572038|65665355|FG000|Overall Study|Enrolled into Another Trial|3|||
23525948|NCT01572038|65665355|FG000|Overall Study|Participated in Another Trial|3|||
23716552|NCT00889681|66336961|FG000|Overall Study|Insurance disapproval|1|||
23716553|NCT00843843|66336962|FG000|Overall Study|Physician Decision|1|||
23716554|NCT00843843|66336963|FG001|Overall Study|Physician Decision|1|||
23716555|NCT00843843|66336962|FG000|Overall Study|Protocol Violation|1|||
23812946|NCT03861481|66696096|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
23812947|NCT03861481|66696095|FG000|Overall Study|Relapse|1|||
23812948|NCT03861481|66696096|FG001|Overall Study|Relapse|0|||
23812949|NCT03861481|66696095|FG000|Overall Study|Withdrawal by Subject|0|||
23812950|NCT03861481|66696096|FG001|Overall Study|Withdrawal by Subject|1|||
23812951|NCT03861481|66696095|FG000|Overall Study|Lack of Efficacy|4|||
23812952|NCT03861481|66696096|FG001|Overall Study|Lack of Efficacy|5|||
23812953|NCT00090363|66696097|FG000|Overall Study|Lost to Follow-up|1|||
23417748|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
23417749|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
23417750|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
23417751|NCT00157196|65274434|FG000|Overall Study|Ongoing at data cut-off|9|||
23417752|NCT02439450|65274435|FG000|Overall Study|Adverse Event|4|||
23417753|NCT02439450|65274436|FG001|Overall Study|Adverse Event|1|||
23417754|NCT02439450|65274437|FG002|Overall Study|Adverse Event|0|||
23525949|NCT01572038|65665355|FG000|Overall Study|Termination by Sponsor|2|||
23525950|NCT01572038|65665355|FG000|Overall Study|Patient Deterioration|1|||
23812954|NCT00090363|66696098|FG001|Overall Study|Lost to Follow-up|2|||
23812955|NCT00090363|66696099|FG002|Overall Study|Lost to Follow-up|1|||
23417755|NCT02439450|65274438|FG003|Overall Study|Adverse Event|0|||
23417756|NCT02439450|65274435|FG000|Overall Study|Withdrawal by Subject|1|||
23417757|NCT02439450|65274436|FG001|Overall Study|Withdrawal by Subject|2|||
23417758|NCT02439450|65274437|FG002|Overall Study|Withdrawal by Subject|0|||
23417759|NCT02439450|65274438|FG003|Overall Study|Withdrawal by Subject|0|||
23417760|NCT02439450|65274435|FG000|Overall Study|Death|3|||
23417761|NCT02439450|65274436|FG001|Overall Study|Death|0|||
23417762|NCT02439450|65274437|FG002|Overall Study|Death|0|||
23417763|NCT02439450|65274438|FG003|Overall Study|Death|1|||
23417764|NCT02439450|65274435|FG000|Overall Study|Progressive Disease|18|||
23417765|NCT02439450|65274436|FG001|Overall Study|Progressive Disease|41|||
23417766|NCT02439450|65274437|FG002|Overall Study|Progressive Disease|2|||
23417767|NCT02439450|65274438|FG003|Overall Study|Progressive Disease|3|||
23417768|NCT03842969|65274439|FG000|Overall Study|Participant declined follow-up visit|0|||
23417769|NCT03842969|65274440|FG001|Overall Study|Participant declined follow-up visit|1|||
23417770|NCT03842969|65274441|FG002|Overall Study|Participant declined follow-up visit|0|||
23417771|NCT03842969|65274439|FG000|Overall Study|Sponsor's decision|12|||
23417772|NCT03842969|65274440|FG001|Overall Study|Sponsor's decision|99|||
23417773|NCT03842969|65274441|FG002|Overall Study|Sponsor's decision|61|||
23417774|NCT03842969|65274439|FG000|Overall Study|Pregnancy|0|||
23417775|NCT03842969|65274440|FG001|Overall Study|Pregnancy|0|||
23417776|NCT03842969|65274441|FG002|Overall Study|Pregnancy|1|||
23417777|NCT03842969|65274439|FG000|Overall Study|Death|1|||
23417778|NCT03842969|65274440|FG001|Overall Study|Death|0|||
23417779|NCT03842969|65274441|FG002|Overall Study|Death|1|||
23417780|NCT03842969|65274439|FG000|Overall Study|Withdrawal by Subject|3|||
23417781|NCT03842969|65274440|FG001|Overall Study|Withdrawal by Subject|30|||
23417782|NCT03842969|65274441|FG002|Overall Study|Withdrawal by Subject|18|||
23417783|NCT03842969|65274439|FG000|Overall Study|Protocol Violation|1|||
23417784|NCT03842969|65274440|FG001|Overall Study|Protocol Violation|1|||
23417785|NCT03842969|65274441|FG002|Overall Study|Protocol Violation|0|||
23417786|NCT03842969|65274439|FG000|Overall Study|Physician Decision|0|||
23417787|NCT03842969|65274440|FG001|Overall Study|Physician Decision|3|||
23417788|NCT03842969|65274441|FG002|Overall Study|Physician Decision|0|||
23417789|NCT03842969|65274439|FG000|Overall Study|Lost to Follow-up|0|||
23417790|NCT03842969|65274440|FG001|Overall Study|Lost to Follow-up|2|||
23417791|NCT03842969|65274441|FG002|Overall Study|Lost to Follow-up|0|||
23417792|NCT03842969|65274439|FG000|Overall Study|Adverse Event|0|||
23417793|NCT03842969|65274440|FG001|Overall Study|Adverse Event|2|||
23417794|NCT03842969|65274441|FG002|Overall Study|Adverse Event|0|||
23417795|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
23417796|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
23417797|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
23417798|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
23417799|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
23417800|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
23417801|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
23417802|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
23417803|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
23417804|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
23417805|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
23417806|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
23417807|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
23417808|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
23417809|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
23417810|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
23417811|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
23417812|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
23525951|NCT01572038|65665355|FG000|Overall Study|Sponsor Decision|1|||
23525952|NCT00637195|65665356|FG000|Overall Study|Lost to Follow-up|1|||
23812956|NCT00090363|66696097|FG000|Overall Study|Withdrawal by Subject|7|||
23812957|NCT00090363|66696098|FG001|Overall Study|Withdrawal by Subject|7|||
23417813|NCT00875485|65274445|FG000|Challenge Dose Epoch|Pregnancy|1|||
23417814|NCT00875485|65274446|FG001|Challenge Dose Epoch|Pregnancy|0|||
23417815|NCT00368836|65274449|FG000|Phase II|Screen Failure|1|||
23417816|NCT00368836|65274449|FG000|Phase II|Withdrawal by Subject|1|||
23417817|NCT00368836|65274449|FG000|Phase II|unable to collect blood and/or breath|17|||
23417818|NCT00368836|65274449|FG000|Phase II|Protocol Violation|2|||
23417819|NCT01779856|65274450|FG000|Overall Study|Withdrawal by Subject|15|||
23417820|NCT01779856|65274450|FG000|Overall Study|Death|3|||
23812958|NCT00090363|66696099|FG002|Overall Study|Withdrawal by Subject|6|||
23417821|NCT01779856|65274450|FG000|Overall Study|Physician Decision|1|||
23417822|NCT01779856|65274450|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
23525953|NCT00637195|65665357|FG001|Overall Study|Lost to Follow-up|0|||
23417823|NCT01779856|65274450|FG000|Overall Study|Delays in scheduling implant|1|||
23417824|NCT01779856|65274450|FG000|Overall Study|Subject ineligible for Implant|2|||
23417825|NCT03905265|65274457|FG000|Overall Study|Withdrawal by Subject|1|||
23417826|NCT03905265|65274458|FG001|Overall Study|Withdrawal by Subject|1|||
23417827|NCT03905265|65274459|FG002|Overall Study|Withdrawal by Subject|0|||
23417828|NCT03905265|65274460|FG003|Overall Study|Withdrawal by Subject|0|||
23417829|NCT01265563|65274461|FG000|Overall Study|Withdrawal by Subject|0|||
23417830|NCT01265563|65274462|FG001|Overall Study|Withdrawal by Subject|1|||
23417831|NCT01265563|65274463|FG002|Overall Study|Withdrawal by Subject|1|||
23417832|NCT01265563|65274464|FG003|Overall Study|Withdrawal by Subject|0|||
23417833|NCT01265563|65274465|FG004|Overall Study|Withdrawal by Subject|2|||
23417834|NCT00695955|65274466|FG000|Cohort 1|Adverse Event|26|||
23417835|NCT00695955|65274466|FG000|Cohort 1|Protocol Violation|2|||
23417836|NCT00695955|65274466|FG000|Cohort 1|Lost to Follow-up|30|||
23417837|NCT00695955|65274466|FG000|Cohort 1|Withdrawal by Subject|25|||
23417838|NCT00695955|65274466|FG000|Cohort 1|Lack of Efficacy|3|||
23417839|NCT00695955|65274466|FG000|Cohort 1|Other|16|||
23417840|NCT00695955|65274466|FG000|Cohort 2|Adverse Event|24|||
23417841|NCT00695955|65274466|FG000|Cohort 2|Protocol Violation|5|||
23417842|NCT00695955|65274466|FG000|Cohort 2|Lost to Follow-up|38|||
23417843|NCT00695955|65274466|FG000|Cohort 2|Withdrawal by Subject|28|||
23417844|NCT00695955|65274466|FG000|Cohort 2|Lack of Efficacy|4|||
23417845|NCT00695955|65274466|FG000|Cohort 2|Other|5|||
23417846|NCT00984165|65274469|FG000|Overall Study|Death on study|2|||
23417847|NCT00984165|65274470|FG001|Overall Study|Death on study|0|||
23417848|NCT00984165|65274471|FG002|Overall Study|Death on study|0|||
23417849|NCT00984165|65274472|FG003|Overall Study|Death on study|0|||
23417850|NCT00984165|65274469|FG000|Overall Study|Disease progression on study|5|||
23417851|NCT00984165|65274470|FG001|Overall Study|Disease progression on study|1|||
23525954|NCT00637195|65665356|FG000|Overall Study|Other|2|||
23525955|NCT00637195|65665357|FG001|Overall Study|Other|0|||
23525956|NCT00637195|65665356|FG000|Overall Study|Withdrawal by Subject|0|||
23525957|NCT00637195|65665357|FG001|Overall Study|Withdrawal by Subject|1|||
23525958|NCT03554291|65665359|FG000|Overall Study|Death|2|||
23525959|NCT03554291|65665360|FG001|Overall Study|Death|1|||
23525960|NCT03554291|65665359|FG000|Overall Study|Lost to Follow-up|1|||
23525961|NCT03554291|65665360|FG001|Overall Study|Lost to Follow-up|0|||
23525962|NCT03554291|65665359|FG000|Overall Study|Withdrawal by Subject|1|||
23525963|NCT03554291|65665360|FG001|Overall Study|Withdrawal by Subject|0|||
23525964|NCT03554291|65665359|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
23525965|NCT03554291|65665360|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
23525966|NCT05091307|65665362|FG000|Overall Study|Death|0|||
23525967|NCT05091307|65665363|FG001|Overall Study|Death|0|||
23525968|NCT05091307|65665364|FG002|Overall Study|Death|1|||
23417852|NCT00984165|65274471|FG002|Overall Study|Disease progression on study|0|||
23417853|NCT00984165|65274472|FG003|Overall Study|Disease progression on study|0|||
23417854|NCT00984165|65274469|FG000|Overall Study|Death of recipient|0|||
23417855|NCT00984165|65274470|FG001|Overall Study|Death of recipient|0|||
23417856|NCT00984165|65274471|FG002|Overall Study|Death of recipient|0|||
23417857|NCT00984165|65274472|FG003|Overall Study|Death of recipient|1|||
23417858|NCT00984165|65274469|FG000|Overall Study|New protocol|0|||
23417859|NCT00984165|65274470|FG001|Overall Study|New protocol|0|||
23417860|NCT00984165|65274471|FG002|Overall Study|New protocol|0|||
23417861|NCT00984165|65274472|FG003|Overall Study|New protocol|1|||
23417862|NCT00984165|65274469|FG000|Overall Study|P+/donor pair removed from protocol|0|||
23812959|NCT00090363|66696097|FG000|Overall Study|Study-specific discontinuation criteria|75|||
23417863|NCT00984165|65274470|FG001|Overall Study|P+/donor pair removed from protocol|0|||
23417864|NCT00984165|65274471|FG002|Overall Study|P+/donor pair removed from protocol|0|||
23417865|NCT00984165|65274472|FG003|Overall Study|P+/donor pair removed from protocol|1|||
23417866|NCT00984165|65274469|FG000|Overall Study|removed with a pair recipient|0|||
23417867|NCT00984165|65274470|FG001|Overall Study|removed with a pair recipient|0|||
23417868|NCT00984165|65274471|FG002|Overall Study|removed with a pair recipient|0|||
23417869|NCT00984165|65274472|FG003|Overall Study|removed with a pair recipient|1|||
23417870|NCT02499900|65274473|FG000|Core Study Period|Other|1|||
23525969|NCT05091307|65665365|FG003|Overall Study|Death|0|||
23525970|NCT05091307|65665362|FG000|Overall Study|Lost to Follow-up|33|||
23417871|NCT02499900|65274474|FG001|Core Study Period|Other|4|||
23525971|NCT05091307|65665363|FG001|Overall Study|Lost to Follow-up|33|||
23525972|NCT05091307|65665364|FG002|Overall Study|Lost to Follow-up|2|||
23417872|NCT02499900|65274473|FG000|Core Study Period|Lost to Follow-up|1|||
23525973|NCT05091307|65665365|FG003|Overall Study|Lost to Follow-up|0|||
23525974|NCT05091307|65665362|FG000|Overall Study|Physician Decision|1|||
23417873|NCT02499900|65274474|FG001|Core Study Period|Lost to Follow-up|2|||
23417874|NCT02499900|65274473|FG000|Core Study Period|Per sponsor request|0|||
23525975|NCT05091307|65665363|FG001|Overall Study|Physician Decision|0|||
23525976|NCT05091307|65665364|FG002|Overall Study|Physician Decision|0|||
23525977|NCT05091307|65665365|FG003|Overall Study|Physician Decision|0|||
23525978|NCT05091307|65665362|FG000|Overall Study|Protocol Violation|1|||
23525979|NCT05091307|65665363|FG001|Overall Study|Protocol Violation|0|||
23525980|NCT05091307|65665364|FG002|Overall Study|Protocol Violation|0|||
23525981|NCT05091307|65665365|FG003|Overall Study|Protocol Violation|0|||
23525982|NCT05091307|65665362|FG000|Overall Study|Withdrawal by Subject|16|||
23525983|NCT05091307|65665363|FG001|Overall Study|Withdrawal by Subject|16|||
23525984|NCT05091307|65665364|FG002|Overall Study|Withdrawal by Subject|0|||
23525985|NCT05091307|65665365|FG003|Overall Study|Withdrawal by Subject|1|||
23525986|NCT05091307|65665362|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
23525987|NCT05091307|65665363|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
23525988|NCT05091307|65665364|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
23525989|NCT05091307|65665365|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
23525990|NCT05091307|65665362|FG000|Overall Study|Initiated Prohibited Medication|1|||
23525991|NCT05091307|65665363|FG001|Overall Study|Initiated Prohibited Medication|0|||
23525992|NCT05091307|65665364|FG002|Overall Study|Initiated Prohibited Medication|0|||
23525993|NCT05091307|65665365|FG003|Overall Study|Initiated Prohibited Medication|0|||
23525994|NCT05091307|65665362|FG000|Overall Study|Other|4|||
23525995|NCT05091307|65665363|FG001|Overall Study|Other|4|||
23525996|NCT05091307|65665364|FG002|Overall Study|Other|0|||
23525997|NCT05091307|65665365|FG003|Overall Study|Other|0|||
23525998|NCT05091307|65665362|FG000|Overall Study|Randomized but not vaccinated|0|||
23525999|NCT05091307|65665363|FG001|Overall Study|Randomized but not vaccinated|2|||
23526000|NCT05091307|65665364|FG002|Overall Study|Randomized but not vaccinated|0|||
23526001|NCT05091307|65665365|FG003|Overall Study|Randomized but not vaccinated|0|||
23526002|NCT00323414|65665368|FG000|Overall Study|Withdrawal by Subject|0|||
23526003|NCT00323414|65665369|FG001|Overall Study|Withdrawal by Subject|1|||
23526004|NCT01907828|65665370|FG000|Overall Study|Exclusion criteria not met|0|||
23526005|NCT01907828|65665371|FG001|Overall Study|Exclusion criteria not met|1|||
23526006|NCT01907828|65665370|FG000|Overall Study|Withdrawal by Subject|3|||
23526007|NCT01907828|65665371|FG001|Overall Study|Withdrawal by Subject|4|||
23526008|NCT01907828|65665370|FG000|Overall Study|Lost to Follow-up|3|||
23526009|NCT01907828|65665371|FG001|Overall Study|Lost to Follow-up|0|||
23526010|NCT01907828|65665370|FG000|Overall Study|Participant refused 24-month follow-up|1|||
23526011|NCT01907828|65665371|FG001|Overall Study|Participant refused 24-month follow-up|0|||
23526012|NCT01907828|65665370|FG000|Overall Study|Participant met exclusion criteria|0|||
23526013|NCT01907828|65665371|FG001|Overall Study|Participant met exclusion criteria|1|||
23526014|NCT02272413|65665374|FG000|Randomized Through Treatment Start|Not treated|3|||
23526015|NCT02272413|65665375|FG001|Randomized Through Treatment Start|Not treated|5|||
23526016|NCT02272413|65665374|FG000|Pre-switch Period|Adverse Event|38|||
23526017|NCT02272413|65665375|FG001|Pre-switch Period|Adverse Event|37|||
23526018|NCT02272413|65665374|FG000|Pre-switch Period|Death|26|||
23526019|NCT02272413|65665375|FG001|Pre-switch Period|Death|26|||
23526020|NCT02272413|65665374|FG000|Pre-switch Period|Withdrawal by Subject|27|||
23526021|NCT02272413|65665375|FG001|Pre-switch Period|Withdrawal by Subject|15|||
23526022|NCT02272413|65665374|FG000|Pre-switch Period|Physician Decision|6|||
23526023|NCT02272413|65665375|FG001|Pre-switch Period|Physician Decision|18|||
23526024|NCT02272413|65665374|FG000|Pre-switch Period|Progressive disease|185|||
23526025|NCT02272413|65665375|FG001|Pre-switch Period|Progressive disease|173|||
23526026|NCT02272413|65665374|FG000|Pre-switch Period|Lost to Follow-up|0|||
23526027|NCT02272413|65665375|FG001|Pre-switch Period|Lost to Follow-up|2|||
23526028|NCT02272413|65665374|FG000|Pre-switch Period|Protocol Violation|1|||
23526029|NCT02272413|65665375|FG001|Pre-switch Period|Protocol Violation|0|||
23526030|NCT02272413|65665374|FG000|Pre-switch Period|Other than listed|10|||
23526031|NCT02272413|65665375|FG001|Pre-switch Period|Other than listed|11|||
23526032|NCT02272413|65665374|FG000|Post-switch Period|Adverse Event|4|||
23526033|NCT02272413|65665375|FG001|Post-switch Period|Adverse Event|4|||
23526034|NCT02272413|65665374|FG000|Post-switch Period|Death|3|||
23526035|NCT02272413|65665375|FG001|Post-switch Period|Death|2|||
23526036|NCT02272413|65665374|FG000|Post-switch Period|Withdrawal by Subject|1|||
23611224|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611225|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611226|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23526037|NCT02272413|65665375|FG001|Post-switch Period|Withdrawal by Subject|2|||
23526038|NCT02272413|65665374|FG000|Post-switch Period|Physician Decision|1|||
23526039|NCT02272413|65665375|FG001|Post-switch Period|Physician Decision|1|||
23526040|NCT02272413|65665374|FG000|Post-switch Period|Progressive disease|21|||
23526041|NCT02272413|65665375|FG001|Post-switch Period|Progressive disease|21|||
23526042|NCT02272413|65665374|FG000|Post-switch Period|Study terminated by sponsor|8|||
23526043|NCT02272413|65665375|FG001|Post-switch Period|Study terminated by sponsor|11|||
23526044|NCT02272413|65665374|FG000|Post-switch Period|Other than listed|4|||
23526045|NCT02272413|65665375|FG001|Post-switch Period|Other than listed|5|||
23526046|NCT01856790|65665378|FG000|Closed Loop Control|Withdrawal by Subject|2|||
23526047|NCT01856790|65665378|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
23526048|NCT02347527|65665381|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
23526049|NCT02347527|65665382|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
23526050|NCT02347527|65665383|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
23526051|NCT02347527|65665384|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
23526052|NCT02347527|65665381|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
23526053|NCT02347527|65665382|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
23526054|NCT02347527|65665383|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
23526055|NCT02347527|65665384|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
23526056|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
23526057|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
23526058|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
23526059|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
23526060|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
23526061|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
23526062|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
23526063|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
23526064|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526065|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
23526066|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526067|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526068|NCT01192152|65665385|FG000|Period 1|left prematurely (while on treatment B)|0|||
23526069|NCT01192152|65665386|FG001|Period 1|left prematurely (while on treatment B)|1|||
23526070|NCT01192152|65665385|FG000|Period 3|family emergency|1|||
23526071|NCT01192152|65665386|FG001|Period 3|family emergency|0|||
23526072|NCT00660348|65665387|FG000|Overall Study|Withdrawal by Subject|1|||
23526073|NCT00660348|65665388|FG001|Overall Study|Withdrawal by Subject|0|||
23526074|NCT00717769|65665390|FG000|Overall Study|Adverse Event|9|||
23526075|NCT00717769|65665391|FG001|Overall Study|Adverse Event|6|||
23526076|NCT00717769|65665392|FG002|Overall Study|Adverse Event|1|||
23526077|NCT00717769|65665390|FG000|Overall Study|Lack of compliance|0|||
23526078|NCT00717769|65665391|FG001|Overall Study|Lack of compliance|2|||
23526079|NCT00717769|65665392|FG002|Overall Study|Lack of compliance|0|||
23526080|NCT00717769|65665390|FG000|Overall Study|Lost to Follow-up|3|||
23526081|NCT00717769|65665391|FG001|Overall Study|Lost to Follow-up|4|||
23526082|NCT00717769|65665392|FG002|Overall Study|Lost to Follow-up|0|||
23526083|NCT00717769|65665390|FG000|Overall Study|Lack of Efficacy|1|||
23526084|NCT00717769|65665391|FG001|Overall Study|Lack of Efficacy|2|||
23526085|NCT00717769|65665392|FG002|Overall Study|Lack of Efficacy|0|||
23526086|NCT00717769|65665390|FG000|Overall Study|Protocol Violation|0|||
23526087|NCT00717769|65665391|FG001|Overall Study|Protocol Violation|2|||
23526088|NCT00717769|65665392|FG002|Overall Study|Protocol Violation|0|||
23526089|NCT00717769|65665390|FG000|Overall Study|Sponsor decision|1|||
23526090|NCT00717769|65665391|FG001|Overall Study|Sponsor decision|0|||
23526091|NCT00717769|65665392|FG002|Overall Study|Sponsor decision|10|||
23526092|NCT00717769|65665390|FG000|Overall Study|Withdrew consent|2|||
23526093|NCT00717769|65665391|FG001|Overall Study|Withdrew consent|2|||
23526094|NCT00717769|65665392|FG002|Overall Study|Withdrew consent|0|||
23526095|NCT01449526|65665393|FG000|Overall Study|Lost to Follow-up|1|||
23526096|NCT01449526|65665394|FG001|Overall Study|Lost to Follow-up|2|||
23526097|NCT01449526|65665393|FG000|Overall Study|Withdrawal by Subject|1|||
23526098|NCT01449526|65665394|FG001|Overall Study|Withdrawal by Subject|1|||
23526099|NCT01449526|65665393|FG000|Overall Study|Symptoms/complaints|0|||
23526100|NCT01449526|65665394|FG001|Overall Study|Symptoms/complaints|1|||
23526101|NCT01449526|65665393|FG000|Overall Study|Lack of Motivation|0|||
23526102|NCT01449526|65665394|FG001|Overall Study|Lack of Motivation|1|||
23526103|NCT01449526|65665393|FG000|Overall Study|Cannot maintain visits|0|||
23526104|NCT01449526|65665394|FG001|Overall Study|Cannot maintain visits|1|||
23526105|NCT03216850|65665405|FG000|Overall Study|Pre-analytical error|6|||
23812960|NCT00090363|66696098|FG001|Overall Study|Study-specific discontinuation criteria|74|||
23812961|NCT00090363|66696099|FG002|Overall Study|Study-specific discontinuation criteria|62|||
23812962|NCT00090363|66696097|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23812963|NCT00090363|66696098|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23526106|NCT03400033|65665406|FG000|Overall Study|Withdrawal by Subject|1|||
23526107|NCT03400033|65665407|FG001|Overall Study|Withdrawal by Subject|2|||
23526108|NCT01434290|65665408|FG000|Overall Study|Protocol Violation|6|||
23526109|NCT01434290|65665409|FG001|Overall Study|Protocol Violation|3|||
23526110|NCT01434290|65665408|FG000|Overall Study|No protocol treatment|2|||
23526111|NCT01434290|65665409|FG001|Overall Study|No protocol treatment|4|||
23812964|NCT00090363|66696099|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23812965|NCT00090363|66696097|FG000|Overall Study|Consent expired|7|||
23526112|NCT00964392|65665410|FG000|Overall Study|Withdrawal by Subject|4|||
23526113|NCT00964392|65665411|FG001|Overall Study|Withdrawal by Subject|6|||
23526114|NCT00964392|65665410|FG000|Overall Study|Lost to Follow-up|4|||
23526115|NCT00964392|65665411|FG001|Overall Study|Lost to Follow-up|10|||
23526116|NCT00964392|65665410|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
23526117|NCT00964392|65665411|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
23526118|NCT00964392|65665410|FG000|Overall Study|Not completed|44|||
23526119|NCT00964392|65665411|FG001|Overall Study|Not completed|168|||
23526120|NCT05074433|65665420|FG000|Overall Study|Adverse Event|0|||
23526121|NCT05074433|65665421|FG001|Overall Study|Adverse Event|2|||
23526122|NCT05074433|65665422|FG002|Overall Study|Adverse Event|0|||
23526123|NCT05074433|65665423|FG003|Overall Study|Adverse Event|1|||
23526124|NCT05074433|65665420|FG000|Overall Study|Sponsor Request|0|||
23526125|NCT05074433|65665421|FG001|Overall Study|Sponsor Request|1|||
23526126|NCT05074433|65665422|FG002|Overall Study|Sponsor Request|1|||
23526127|NCT05074433|65665423|FG003|Overall Study|Sponsor Request|0|||
23526128|NCT05074433|65665420|FG000|Overall Study|Death|1|||
23526129|NCT05074433|65665421|FG001|Overall Study|Death|0|||
23526130|NCT05074433|65665422|FG002|Overall Study|Death|0|||
23526131|NCT05074433|65665423|FG003|Overall Study|Death|0|||
23526132|NCT05074433|65665420|FG000|Overall Study|Lost to Follow-up|0|||
23526133|NCT05074433|65665421|FG001|Overall Study|Lost to Follow-up|0|||
23526134|NCT05074433|65665422|FG002|Overall Study|Lost to Follow-up|2|||
23526135|NCT05074433|65665423|FG003|Overall Study|Lost to Follow-up|0|||
23526136|NCT05074433|65665420|FG000|Overall Study|Subject Decision|8|||
23526137|NCT05074433|65665421|FG001|Overall Study|Subject Decision|6|||
23526138|NCT05074433|65665422|FG002|Overall Study|Subject Decision|4|||
23526139|NCT05074433|65665423|FG003|Overall Study|Subject Decision|5|||
23526140|NCT00594464|65665424|FG000|Overall Study|Withdrawal by Subject|1|||
23526141|NCT00594464|65665424|FG000|Overall Study|Delay in operation|2|||
23526142|NCT01723228|65665425|FG000|Overall Study|Adverse Event|2|||
23526143|NCT01723228|65665426|FG001|Overall Study|Adverse Event|6|||
23526144|NCT01723228|65665425|FG000|Overall Study|Withdrawal by Subject|2|||
23526145|NCT01723228|65665426|FG001|Overall Study|Withdrawal by Subject|1|||
23526146|NCT01723228|65665425|FG000|Overall Study|Protocol Violation|0|||
23526147|NCT01723228|65665426|FG001|Overall Study|Protocol Violation|2|||
23526148|NCT01723228|65665425|FG000|Overall Study|Lost to Follow-up|2|||
23526149|NCT01723228|65665426|FG001|Overall Study|Lost to Follow-up|1|||
23526150|NCT01723228|65665425|FG000|Overall Study|Other|2|||
23526151|NCT01723228|65665426|FG001|Overall Study|Other|1|||
23526152|NCT00578942|65665427|FG000|Overall Study|Lost to Follow-up|1|||
23526153|NCT02126969|65665432|FG000|Overall Study|Withdrawal by Subject|1|||
23526154|NCT02126969|65665433|FG001|Overall Study|Withdrawal by Subject|2|||
23526155|NCT00735371|65665434|FG000|Overall Study|Adverse Event|3|||
23526156|NCT00735371|65665435|FG001|Overall Study|Adverse Event|3|||
23526157|NCT00735371|65665436|FG002|Overall Study|Adverse Event|4|||
23526158|NCT00735371|65665437|FG003|Overall Study|Adverse Event|1|||
23526159|NCT00735371|65665434|FG000|Overall Study|Protocol Violation|2|||
23526160|NCT00735371|65665435|FG001|Overall Study|Protocol Violation|2|||
23526161|NCT00735371|65665436|FG002|Overall Study|Protocol Violation|0|||
23526162|NCT00735371|65665437|FG003|Overall Study|Protocol Violation|3|||
23526163|NCT00735371|65665434|FG000|Overall Study|Withdrawal by Subject|0|||
23526164|NCT00735371|65665435|FG001|Overall Study|Withdrawal by Subject|2|||
23526165|NCT00735371|65665436|FG002|Overall Study|Withdrawal by Subject|2|||
23526166|NCT00735371|65665437|FG003|Overall Study|Withdrawal by Subject|0|||
23526167|NCT00735371|65665434|FG000|Overall Study|Lost to Follow-up|1|||
23526168|NCT00735371|65665435|FG001|Overall Study|Lost to Follow-up|1|||
23526169|NCT00735371|65665436|FG002|Overall Study|Lost to Follow-up|3|||
23526170|NCT00735371|65665437|FG003|Overall Study|Lost to Follow-up|1|||
23526171|NCT00735371|65665434|FG000|Overall Study|Lack of Efficacy|4|||
23526172|NCT00735371|65665435|FG001|Overall Study|Lack of Efficacy|2|||
23526173|NCT00735371|65665436|FG002|Overall Study|Lack of Efficacy|0|||
23526174|NCT00735371|65665437|FG003|Overall Study|Lack of Efficacy|4|||
23526175|NCT00735371|65665434|FG000|Overall Study|Sponsor Decision|3|||
23526176|NCT00735371|65665435|FG001|Overall Study|Sponsor Decision|1|||
23526177|NCT00735371|65665436|FG002|Overall Study|Sponsor Decision|0|||
23526178|NCT00735371|65665437|FG003|Overall Study|Sponsor Decision|1|||
23526179|NCT00735371|65665434|FG000|Overall Study|Protocol Violation|0|||
23526180|NCT00735371|65665435|FG001|Overall Study|Protocol Violation|1|||
23526181|NCT00735371|65665436|FG002|Overall Study|Protocol Violation|2|||
23526182|NCT00735371|65665437|FG003|Overall Study|Protocol Violation|0|||
23526183|NCT00735371|65665434|FG000|Overall Study|Prior Vyvanse Exposure|1|||
23526184|NCT00735371|65665435|FG001|Overall Study|Prior Vyvanse Exposure|1|||
23526185|NCT00735371|65665436|FG002|Overall Study|Prior Vyvanse Exposure|0|||
23526186|NCT00735371|65665437|FG003|Overall Study|Prior Vyvanse Exposure|0|||
23526187|NCT00735371|65665434|FG000|Overall Study|Exclusion criteria|1|||
23526188|NCT00735371|65665435|FG001|Overall Study|Exclusion criteria|0|||
23526189|NCT00735371|65665436|FG002|Overall Study|Exclusion criteria|0|||
23526190|NCT00735371|65665437|FG003|Overall Study|Exclusion criteria|0|||
23611227|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611228|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
23611229|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611230|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611231|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
23526191|NCT02214121|65665438|FG000|Part A|Patient decision|2|||
23526192|NCT02214121|65665439|FG001|Part A|Patient decision|0|||
23526193|NCT02214121|65665440|FG002|Part A|Patient decision|0|||
23526194|NCT02214121|65665438|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
23526195|NCT02214121|65665439|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
23526196|NCT02214121|65665440|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
23526197|NCT02214121|65665438|FG000|Part A|Other|1|||
23611232|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
23611233|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
23611234|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
23611235|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
23611236|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
23611237|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
23611238|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
23611239|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
23611240|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
23611241|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
23611242|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
23611243|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
23611244|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
23611245|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
23611246|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
23526198|NCT02214121|65665439|FG001|Part A|Other|0|||
23526199|NCT02214121|65665440|FG002|Part A|Other|0|||
23526200|NCT02214121|65665438|FG000|Part B|Patient decision|0|||
23526201|NCT02214121|65665439|FG001|Part B|Patient decision|1|||
23526202|NCT02214121|65665440|FG002|Part B|Patient decision|0|||
23526203|NCT02214121|65665438|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
23526204|NCT02214121|65665439|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
23526205|NCT02214121|65665440|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
23526206|NCT02214121|65665438|FG000|Part B|Lost to Follow-up|0|||
23526207|NCT02214121|65665439|FG001|Part B|Lost to Follow-up|0|||
23526208|NCT02214121|65665440|FG002|Part B|Lost to Follow-up|1|||
23526209|NCT01371656|65665451|FG000|Overall Study|Death|7|||
23526210|NCT01371656|65665452|FG001|Overall Study|Death|4|||
23526211|NCT01371656|65665451|FG000|Overall Study|Physician Decision|46|||
23526212|NCT01371656|65665452|FG001|Overall Study|Physician Decision|7|||
23611247|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
23611248|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
23611249|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611250|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611251|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611252|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611253|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611254|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611255|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611256|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611257|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611258|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611259|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611260|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611261|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
23611262|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611263|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611264|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611265|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611266|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611267|NCT01072149|65966713|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23526213|NCT01371656|65665451|FG000|Overall Study|Withdrawal by Subject|7|||
23526214|NCT01371656|65665452|FG001|Overall Study|Withdrawal by Subject|0|||
23526215|NCT01371656|65665451|FG000|Overall Study|Ineligible|4|||
23526216|NCT01371656|65665452|FG001|Overall Study|Ineligible|3|||
23611268|NCT01072149|65966714|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611269|NCT01072149|65966715|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
23526217|NCT04091646|65665453|FG000|Overall Study|Adverse Event|2|||
23611270|NCT01072149|65966716|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23716556|NCT00843843|66336963|FG001|Overall Study|Protocol Violation|1|||
23526218|NCT04091646|65665454|FG001|Overall Study|Adverse Event|1|||
23526219|NCT04091646|65665453|FG000|Overall Study|Lost to Follow-up|6|||
23611271|NCT01072149|65966717|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611272|NCT01072149|65966718|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611273|NCT01072149|65966719|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611274|NCT01072149|65966720|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611275|NCT01072149|65966721|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611276|NCT01072149|65966722|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611277|NCT01072149|65966723|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611278|NCT01072149|65966724|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611279|NCT01072149|65966725|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611280|NCT01072149|65966726|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
23611281|NCT01072149|65966727|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611282|NCT01072149|65966728|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611283|NCT01072149|65966729|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611284|NCT01072149|65966730|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611285|NCT04050722|65966731|FG000|Overall Study|Withdrawal by Subject|1|||
23611286|NCT04050722|65966732|FG001|Overall Study|Withdrawal by Subject|0|||
23611287|NCT00304278|65966733|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
23611288|NCT00304278|65966733|FG000|Overall Study|PT had medical condition preventing TX|1|||
23611289|NCT00476957|65966734|FG000|Overall Study|Lost to Follow-up|176|||
23611290|NCT00476957|65966735|FG001|Overall Study|Lost to Follow-up|193|||
23611291|NCT01131325|65966740|FG000|Overall Study|Adverse Event|1|||
23611292|NCT01131325|65966740|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
23611293|NCT00621842|65966745|FG000|Overall Study|Adverse Event|6|||
23611294|NCT00621842|65966745|FG000|Overall Study|Withdrawal by Subject|7|||
23611295|NCT00621842|65966745|FG000|Overall Study|Protocol Violation|4|||
23611296|NCT00621842|65966745|FG000|Overall Study|Lack of Efficacy|2|||
23611297|NCT03493282|65966747|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
23611298|NCT03493282|65966748|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
23611299|NCT03493282|65966749|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
23611300|NCT03493282|65966747|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
23611301|NCT03493282|65966748|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
23611302|NCT03493282|65966749|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
23526220|NCT04091646|65665454|FG001|Overall Study|Lost to Follow-up|2|||
23526221|NCT04091646|65665453|FG000|Overall Study|Protocol Violation|0|||
23611303|NCT00440037|65966753|FG000|Overall Study|Withdrawal by Subject|6|||
23526222|NCT04091646|65665454|FG001|Overall Study|Protocol Violation|1|||
23526223|NCT04091646|65665453|FG000|Overall Study|Withdrawal by Subject|4|||
23526224|NCT04091646|65665454|FG001|Overall Study|Withdrawal by Subject|1|||
23526225|NCT04091646|65665453|FG000|Overall Study|Participant Incarcerated|1|||
23526226|NCT04091646|65665454|FG001|Overall Study|Participant Incarcerated|0|||
23526227|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
23526228|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
23526229|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
23526230|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
23526231|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
23526232|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
23526233|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
23526234|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
23526235|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
23526236|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
23526237|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Death|4|||
23526238|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Death|0|||
23526239|NCT02382016|65665462|FG000|OL Extension Period|Physician Decision|3|||
23526240|NCT02382016|65665463|FG001|OL Extension Period|Physician Decision|0|||
23526241|NCT02382016|65665462|FG000|OL Extension Period|Death|2|||
23526242|NCT02382016|65665463|FG001|OL Extension Period|Death|0|||
23526243|NCT02382016|65665462|FG000|OL Extension Period|Withdrawal by Subject|1|||
23526244|NCT02382016|65665463|FG001|OL Extension Period|Withdrawal by Subject|0|||
23526245|NCT02703636|65665467|FG000|Overall Study|Adverse Event|14|||
23526246|NCT02703636|65665467|FG000|Overall Study|Study stopped by sponsor|1|||
23526247|NCT02703636|65665467|FG000|Overall Study|Withdrawal by Subject|1|||
23526248|NCT00283439|65665472|FG000|Overall Study|Adverse Event|0|||
23526249|NCT00283439|65665473|FG001|Overall Study|Adverse Event|0|||
23526250|NCT00283439|65665474|FG002|Overall Study|Adverse Event|0|||
23611304|NCT00440037|65966753|FG000|Overall Study|Administrative decision|3|||
23611305|NCT02205476|65966759|FG000|Overall Study|Study termination by Sponsor|7|||
23611306|NCT02205476|65966760|FG001|Overall Study|Study termination by Sponsor|3|||
23526251|NCT00283439|65665475|FG003|Overall Study|Adverse Event|1|||
23526252|NCT00283439|65665472|FG000|Overall Study|Death|0|||
23611307|NCT00308113|65966766|FG000|Overall Study|Protocol closure|0|||
23611308|NCT00308113|65966767|FG001|Overall Study|Protocol closure|0|||
23526253|NCT00283439|65665473|FG001|Overall Study|Death|0|||
23526254|NCT00283439|65665474|FG002|Overall Study|Death|1|||
23526255|NCT00283439|65665475|FG003|Overall Study|Death|0|||
23526256|NCT00283439|65665472|FG000|Overall Study|Disease progression|0|||
23526257|NCT00283439|65665473|FG001|Overall Study|Disease progression|1|||
23526258|NCT00283439|65665474|FG002|Overall Study|Disease progression|0|||
23526259|NCT00283439|65665475|FG003|Overall Study|Disease progression|0|||
23526260|NCT00283439|65665472|FG000|Overall Study|Requirement for alternative therapy|1|||
23526261|NCT00283439|65665473|FG001|Overall Study|Requirement for alternative therapy|2|||
23526262|NCT00283439|65665474|FG002|Overall Study|Requirement for alternative therapy|5|||
23526263|NCT00283439|65665475|FG003|Overall Study|Requirement for alternative therapy|2|||
23526264|NCT00283439|65665472|FG000|Overall Study|Stem cell transplant|6|||
23526265|NCT00283439|65665473|FG001|Overall Study|Stem cell transplant|6|||
23526266|NCT00283439|65665474|FG002|Overall Study|Stem cell transplant|4|||
23526267|NCT00283439|65665475|FG003|Overall Study|Stem cell transplant|3|||
23526268|NCT00283439|65665472|FG000|Overall Study|Treatment discontinued|0|||
23526269|NCT00283439|65665473|FG001|Overall Study|Treatment discontinued|2|||
23526270|NCT00283439|65665474|FG002|Overall Study|Treatment discontinued|1|||
23526271|NCT00283439|65665475|FG003|Overall Study|Treatment discontinued|3|||
23526272|NCT00283439|65665472|FG000|Overall Study|Other|1|||
23526273|NCT00283439|65665473|FG001|Overall Study|Other|0|||
23526274|NCT00283439|65665474|FG002|Overall Study|Other|0|||
23526275|NCT00283439|65665475|FG003|Overall Study|Other|0|||
23526276|NCT00829296|65665476|FG000|Overall Study|Adverse Event|5|||
23526277|NCT00829296|65665477|FG001|Overall Study|Adverse Event|4|||
23526278|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
23526279|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
23526280|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
23526281|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
23526282|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
23526283|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
23526284|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
23526285|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
23526286|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
23526287|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
23526288|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
23526289|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
23526290|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
23611309|NCT00308113|65966768|FG002|Overall Study|Protocol closure|0|||
23611310|NCT00308113|65966769|FG003|Overall Study|Protocol closure|1|||
23611311|NCT01812707|65966772|FG000|Overall Study|Adverse Event|0|||
23611312|NCT01812707|65966773|FG001|Overall Study|Adverse Event|0|||
23611313|NCT01812707|65966774|FG002|Overall Study|Adverse Event|0|||
23611314|NCT01812707|65966775|FG003|Overall Study|Adverse Event|2|||
23611315|NCT01812707|65966772|FG000|Overall Study|Poor compliance to protocol|1|||
23611316|NCT01812707|65966773|FG001|Overall Study|Poor compliance to protocol|0|||
23611317|NCT01812707|65966774|FG002|Overall Study|Poor compliance to protocol|0|||
23611318|NCT01812707|65966775|FG003|Overall Study|Poor compliance to protocol|0|||
23611319|NCT01812707|65966772|FG000|Overall Study|Consent withdrawn by participant|1|||
23611320|NCT01812707|65966773|FG001|Overall Study|Consent withdrawn by participant|0|||
23611321|NCT01812707|65966774|FG002|Overall Study|Consent withdrawn by participant|0|||
23611322|NCT01812707|65966775|FG003|Overall Study|Consent withdrawn by participant|0|||
23611323|NCT00607789|65966776|FG000|Overall Study|Adverse Event|3|||
23611324|NCT00607789|65966777|FG001|Overall Study|Adverse Event|0|||
23611325|NCT00607789|65966776|FG000|Overall Study|Lack of Efficacy|0|||
23611326|NCT00607789|65966777|FG001|Overall Study|Lack of Efficacy|1|||
23611327|NCT00607789|65966776|FG000|Overall Study|Inadequate adherence|3|||
23611328|NCT00607789|65966777|FG001|Overall Study|Inadequate adherence|0|||
23611329|NCT00607789|65966776|FG000|Overall Study|Lost to Follow-up|0|||
23611330|NCT00607789|65966777|FG001|Overall Study|Lost to Follow-up|5|||
23611331|NCT00607789|65966776|FG000|Overall Study|Withdrawal by Subject|1|||
23611332|NCT00607789|65966777|FG001|Overall Study|Withdrawal by Subject|0|||
23611333|NCT01280656|65966779|FG000|Overall Study|Adverse Event|1|||
23812966|NCT00090363|66696098|FG001|Overall Study|Consent expired|10|||
23611334|NCT01280656|65966780|FG001|Overall Study|Adverse Event|14|||
23812967|NCT00090363|66696099|FG002|Overall Study|Consent expired|9|||
23812968|NCT00090363|66696097|FG000|Overall Study|Reasons not specified|2|||
23526291|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
23526292|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
23526293|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
23526294|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
23526295|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
23526296|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Death|0|||
23526297|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Death|0|||
23611335|NCT01280656|65966781|FG002|Overall Study|Adverse Event|13|||
23611336|NCT01280656|65966779|FG000|Overall Study|Lack of Efficacy|1|||
23611337|NCT01280656|65966780|FG001|Overall Study|Lack of Efficacy|22|||
23611338|NCT01280656|65966781|FG002|Overall Study|Lack of Efficacy|38|||
23526298|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Death|1|||
23526299|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Death|0|||
23526300|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Death|0|||
23526301|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Death|0|||
23526302|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Death|0|||
23526303|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Death|0|||
23526304|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Death|0|||
23526305|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
23526306|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
23526307|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
23526308|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526309|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526310|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526311|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526312|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526313|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526314|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
23526315|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
23526316|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
23526317|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526318|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526319|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526320|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526321|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526322|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526323|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
23526324|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
23526325|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
23526326|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
23526327|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
23526328|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
23526329|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
23526330|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
23526331|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
23526332|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
23526333|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
23526334|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
23526335|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
23526336|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
23526337|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
23526338|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
23526339|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
23526340|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
23526341|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
23526342|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
23526343|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
23526344|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526345|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526346|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526347|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526348|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526349|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526350|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526351|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
23526352|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526353|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526354|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526355|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526356|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526357|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526358|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526359|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
23526360|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
23526361|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
23611339|NCT01280656|65966779|FG000|Overall Study|Treatment shortening (RGT)|0|||
23611340|NCT01280656|65966780|FG001|Overall Study|Treatment shortening (RGT)|4|||
23812969|NCT00090363|66696098|FG001|Overall Study|Reasons not specified|1|||
23526362|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
23526363|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
23526364|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
23526365|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
23526366|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
23526367|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
23526368|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Other|0|||
23526369|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Other|1|||
23526370|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Other|0|||
23526371|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Other|0|||
23526372|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Other|0|||
23526373|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Other|0|||
23526374|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Other|0|||
23526375|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Other|0|||
23526376|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Other|0|||
23526377|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
23526378|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
23526379|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
23526380|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
23526381|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
23526382|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
23526383|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
23526384|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
23526385|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
23526386|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
23526387|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
23526388|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
23526389|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
23526390|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
23526391|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
23526392|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
23526393|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
23526394|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
23526395|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526396|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526397|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526398|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526399|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
23526400|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526401|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526402|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526403|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526404|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526405|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526406|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526407|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526408|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526409|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
23526410|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526411|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526412|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526413|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Disease progression|0|||
23526414|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Disease progression|0|||
23526415|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Disease progression|0|||
23526416|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Disease progression|1|||
23526417|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Disease progression|0|||
23526418|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Disease progression|0|||
23526419|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Disease progression|0|||
23526420|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Disease progression|0|||
23526421|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Disease progression|0|||
23526422|NCT00404352|65665478|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526423|NCT00404352|65665479|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526424|NCT00404352|65665480|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526425|NCT00404352|65665481|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526426|NCT00404352|65665482|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526427|NCT00404352|65665483|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526428|NCT00404352|65665484|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
23526429|NCT00404352|65665485|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
23526430|NCT00404352|65665486|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526431|NCT00404352|65665478|FG000|Open Label Extension (up to 36 Months)|Other|0|||
23526432|NCT00404352|65665479|FG001|Open Label Extension (up to 36 Months)|Other|0|||
23526433|NCT00404352|65665480|FG002|Open Label Extension (up to 36 Months)|Other|0|||
23526434|NCT00404352|65665481|FG003|Open Label Extension (up to 36 Months)|Other|0|||
23526435|NCT00404352|65665482|FG004|Open Label Extension (up to 36 Months)|Other|0|||
23526436|NCT00404352|65665483|FG005|Open Label Extension (up to 36 Months)|Other|0|||
23526437|NCT00404352|65665484|FG006|Open Label Extension (up to 36 Months)|Other|0|||
23526438|NCT00404352|65665485|FG007|Open Label Extension (up to 36 Months)|Other|0|||
23526439|NCT00404352|65665486|FG008|Open Label Extension (up to 36 Months)|Other|2|||
23526440|NCT01252290|65665491|FG000|Overall Study|Withdrawal by Subject|1|||
23526441|NCT02385799|65665502|FG000|Overall Study|Lost to Follow-up|1|||
23526442|NCT02385799|65665503|FG001|Overall Study|Lost to Follow-up|2|||
23526443|NCT02385799|65665502|FG000|Overall Study|Adverse Event|4|||
23526444|NCT02385799|65665503|FG001|Overall Study|Adverse Event|2|||
23526445|NCT02385799|65665502|FG000|Overall Study|Withdrawal by Subject|0|||
23526446|NCT02385799|65665503|FG001|Overall Study|Withdrawal by Subject|4|||
23526447|NCT01482767|65665505|FG000|Overall Study|Death|1|||
23526448|NCT01482767|65665506|FG001|Overall Study|Death|1|||
23526449|NCT01482767|65665505|FG000|Overall Study|Withdrawal by Subject|7|||
23526450|NCT01482767|65665506|FG001|Overall Study|Withdrawal by Subject|5|||
23526451|NCT01482767|65665505|FG000|Overall Study|Lost to Follow-up|12|||
23526452|NCT01482767|65665506|FG001|Overall Study|Lost to Follow-up|6|||
23526453|NCT01482767|65665505|FG000|Overall Study|Adverse Event|0|||
23526454|NCT01482767|65665506|FG001|Overall Study|Adverse Event|3|||
23526455|NCT01482767|65665505|FG000|Overall Study|Site closure|22|||
23526456|NCT01482767|65665506|FG001|Overall Study|Site closure|14|||
23526457|NCT01482767|65665505|FG000|Overall Study|Non-adherence to study requirements|4|||
23526458|NCT01482767|65665506|FG001|Overall Study|Non-adherence to study requirements|7|||
23526459|NCT01482767|65665505|FG000|Overall Study|Alternate HCV treatment|7|||
23526460|NCT01482767|65665506|FG001|Overall Study|Alternate HCV treatment|8|||
23526461|NCT01482767|65665505|FG000|Overall Study|Ineligible|0|||
23526462|NCT01482767|65665506|FG001|Overall Study|Ineligible|5|||
23526463|NCT01482767|65665505|FG000|Overall Study|Nurse error|1|||
23526464|NCT01482767|65665506|FG001|Overall Study|Nurse error|0|||
23526465|NCT03829046|65665507|FG000|Overall Study|Withdrawal by Subject|1|||
23526466|NCT03829046|65665508|FG001|Overall Study|Withdrawal by Subject|0|||
23526467|NCT00348556|65665509|FG000|Overall Study|Adverse Event|1|||
23526468|NCT01720069|65665510|FG000|Overall Study|Could not use e-diary correctly|0|||
23526469|NCT01720069|65665511|FG001|Overall Study|Could not use e-diary correctly|1|||
23526470|NCT01720069|65665512|FG002|Overall Study|Could not use e-diary correctly|1|||
23526471|NCT01720069|65665510|FG000|Overall Study|Randomised without baseline values|0|||
23526472|NCT01720069|65665511|FG001|Overall Study|Randomised without baseline values|0|||
23526473|NCT01720069|65665512|FG002|Overall Study|Randomised without baseline values|1|||
23526474|NCT01720069|65665510|FG000|Overall Study|Adverse Event|0|||
23526475|NCT01720069|65665511|FG001|Overall Study|Adverse Event|0|||
23526476|NCT01720069|65665512|FG002|Overall Study|Adverse Event|1|||
23526477|NCT01720069|65665510|FG000|Overall Study|Lack of Efficacy|0|||
23526478|NCT01720069|65665511|FG001|Overall Study|Lack of Efficacy|4|||
23526479|NCT01720069|65665512|FG002|Overall Study|Lack of Efficacy|0|||
23526480|NCT01720069|65665510|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
23526481|NCT01720069|65665511|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
23526482|NCT01720069|65665512|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
23526483|NCT01720069|65665510|FG000|Overall Study|Withdrawal by Subject|0|||
23526484|NCT01720069|65665511|FG001|Overall Study|Withdrawal by Subject|2|||
23526485|NCT01720069|65665512|FG002|Overall Study|Withdrawal by Subject|1|||
23526486|NCT01720069|65665510|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
23526487|NCT01720069|65665511|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
23526488|NCT01720069|65665512|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
23526489|NCT01720069|65665510|FG000|Overall Study|Non-compliance on using e-diary|0|||
23526490|NCT01720069|65665511|FG001|Overall Study|Non-compliance on using e-diary|0|||
23526491|NCT01720069|65665512|FG002|Overall Study|Non-compliance on using e-diary|1|||
23526492|NCT01720069|65665510|FG000|Overall Study|Lost to Follow-up|0|||
23526493|NCT01720069|65665511|FG001|Overall Study|Lost to Follow-up|0|||
23526494|NCT01720069|65665512|FG002|Overall Study|Lost to Follow-up|1|||
23526495|NCT02239536|65665513|FG000|Overall Study|Non-neoplastic polyp|23|||
23526496|NCT02239536|65665514|FG001|Overall Study|Non-neoplastic polyp|17|||
23526497|NCT00116558|65665515|FG000|Overall Study|Death|11|||
23526498|NCT00116558|65665516|FG001|Overall Study|Death|5|||
23526499|NCT00116558|65665517|FG002|Overall Study|Death|3|||
23526500|NCT00116558|65665515|FG000|Overall Study|Withdrawal by Subject|17|||
23526501|NCT00116558|65665516|FG001|Overall Study|Withdrawal by Subject|3|||
23526502|NCT00116558|65665517|FG002|Overall Study|Withdrawal by Subject|12|||
23526503|NCT00116558|65665515|FG000|Overall Study|disease progression|3|||
23526504|NCT00116558|65665516|FG001|Overall Study|disease progression|7|||
23526505|NCT00116558|65665517|FG002|Overall Study|disease progression|18|||
23526506|NCT03090100|65665520|FG000|Overall Study|Adverse Event|9|||
23526507|NCT03090100|65665521|FG001|Overall Study|Adverse Event|11|||
23417875|NCT02499900|65274474|FG001|Core Study Period|Per sponsor request|1|||
23417876|NCT02499900|65274473|FG000|Core Study Period|Pregnancy|1|||
23417877|NCT02499900|65274474|FG001|Core Study Period|Pregnancy|0|||
23417878|NCT02499900|65274473|FG000|Core Study Period|Protocol Violation|3|||
23417879|NCT02499900|65274474|FG001|Core Study Period|Protocol Violation|0|||
23417880|NCT02499900|65274473|FG000|Core Study Period|Withdrawal by Subject|11|||
23417881|NCT02499900|65274474|FG001|Core Study Period|Withdrawal by Subject|10|||
23417882|NCT02499900|65274473|FG000|Core Study Period|Adverse Event|18|||
23417883|NCT02499900|65274474|FG001|Core Study Period|Adverse Event|14|||
23417884|NCT02499900|65274473|FG000|Core Study Period|Death|0|||
23417885|NCT02499900|65274474|FG001|Core Study Period|Death|1|||
23417886|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
23417887|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
23417888|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
23417889|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
23417890|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
23417891|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
23417892|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
23417893|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
23417894|NCT02499900|65274473|FG000|Extension Study Period|Adverse Event|2|||
23417895|NCT02499900|65274474|FG001|Extension Study Period|Adverse Event|4|||
23417896|NCT02499900|65274473|FG000|Extension Study Period|Withdrawal by Subject|5|||
23417897|NCT02499900|65274474|FG001|Extension Study Period|Withdrawal by Subject|2|||
23417898|NCT02499900|65274473|FG000|Extension Study Period|Physician Decision|2|||
23417899|NCT02499900|65274474|FG001|Extension Study Period|Physician Decision|5|||
23417900|NCT02499900|65274473|FG000|Extension Study Period|Pregnancy|1|||
23417901|NCT02499900|65274474|FG001|Extension Study Period|Pregnancy|2|||
23417902|NCT02499900|65274473|FG000|Extension Study Period|Lost to Follow-up|2|||
23417903|NCT02499900|65274474|FG001|Extension Study Period|Lost to Follow-up|5|||
23417904|NCT02499900|65274473|FG000|Extension Study Period|Other|0|||
23417905|NCT02499900|65274474|FG001|Extension Study Period|Other|2|||
23417906|NCT01271712|65274475|FG000|Double Blind Treatment|Death|2|||
23417907|NCT01271712|65274476|FG001|Double Blind Treatment|Death|0|||
23417908|NCT01271712|65274475|FG000|Double Blind Treatment|Lack of Efficacy|1|||
23417909|NCT01271712|65274476|FG001|Double Blind Treatment|Lack of Efficacy|0|||
23417910|NCT01271712|65274475|FG000|Double Blind Treatment|Adverse Event|9|||
23417911|NCT01271712|65274476|FG001|Double Blind Treatment|Adverse Event|4|||
23417912|NCT01271712|65274475|FG000|Double Blind Treatment|Progressive disease|23|||
23417913|NCT01271712|65274476|FG001|Double Blind Treatment|Progressive disease|3|||
23417914|NCT01271712|65274475|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
23417915|NCT01271712|65274476|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
23417916|NCT01271712|65274475|FG000|Double Blind Treatment|Non compliance with study drug|2|||
23417917|NCT01271712|65274476|FG001|Double Blind Treatment|Non compliance with study drug|0|||
23417918|NCT01271712|65274475|FG000|Double Blind Treatment|receive no study drug|1|||
23417919|NCT01271712|65274476|FG001|Double Blind Treatment|receive no study drug|0|||
23417920|NCT01271712|65274475|FG000|Open Label Treatment|Death|6|||
23417921|NCT01271712|65274476|FG001|Open Label Treatment|Death|5|||
23417922|NCT01271712|65274475|FG000|Open Label Treatment|Withdrawal by Subject|6|||
23417923|NCT01271712|65274476|FG001|Open Label Treatment|Withdrawal by Subject|11|||
23417924|NCT01271712|65274475|FG000|Open Label Treatment|Physician Decision|2|||
23417925|NCT01271712|65274476|FG001|Open Label Treatment|Physician Decision|0|||
23417926|NCT01271712|65274475|FG000|Open Label Treatment|Adverse Event|14|||
23417927|NCT01271712|65274476|FG001|Open Label Treatment|Adverse Event|8|||
23417928|NCT01271712|65274475|FG000|Open Label Treatment|Progressive disease|59|||
23417929|NCT01271712|65274476|FG001|Open Label Treatment|Progressive disease|32|||
23417930|NCT01271712|65274475|FG000|Open Label Treatment|transferred to rollover study|1|||
23417931|NCT01271712|65274476|FG001|Open Label Treatment|transferred to rollover study|0|||
23417932|NCT01271712|65274475|FG000|Open Label Treatment|Non-compliance with study drug|1|||
23417933|NCT01271712|65274476|FG001|Open Label Treatment|Non-compliance with study drug|0|||
23417934|NCT01271712|65274475|FG000|Open Label Treatment|Protocol Violation|0|||
23417935|NCT01271712|65274476|FG001|Open Label Treatment|Protocol Violation|1|||
23417936|NCT01271712|65274475|FG000|Open Label Treatment|Switching to other therapy|2|||
23417937|NCT01271712|65274476|FG001|Open Label Treatment|Switching to other therapy|1|||
23417938|NCT01271712|65274475|FG000|Safety Follow-up|Death|11|||
23417939|NCT01271712|65274476|FG001|Safety Follow-up|Death|7|||
23417940|NCT01271712|65274475|FG000|Safety Follow-up|Withdrawal by Subject|4|||
23417941|NCT01271712|65274476|FG001|Safety Follow-up|Withdrawal by Subject|2|||
23417942|NCT01271712|65274475|FG000|Safety Follow-up|Protocol Violation|1|||
23417943|NCT01271712|65274476|FG001|Safety Follow-up|Protocol Violation|1|||
23417944|NCT01271712|65274475|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
23417945|NCT01271712|65274476|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
23417946|NCT01271712|65274475|FG000|Safety Follow-up|No follow-up|1|||
23417947|NCT01271712|65274476|FG001|Safety Follow-up|No follow-up|1|||
23611341|NCT01280656|65966781|FG002|Overall Study|Treatment shortening (RGT)|5|||
23611342|NCT01280656|65966779|FG000|Overall Study|Other|1|||
23611343|NCT01280656|65966780|FG001|Overall Study|Other|7|||
23611344|NCT01280656|65966781|FG002|Overall Study|Other|7|||
23611345|NCT00871494|65966784|FG000|Overall Study|Protocol Violation|5|||
23611346|NCT00871494|65966784|FG000|Overall Study|Lack of Efficacy|4|||
23611347|NCT00871494|65966784|FG000|Overall Study|Adverse Event|4|||
23611348|NCT00871494|65966784|FG000|Overall Study|Lost to Follow-up|1|||
23611349|NCT01695993|65966787|FG000|Overall Study|Lost to Follow-up|2|||
23611350|NCT01695993|65966788|FG001|Overall Study|Lost to Follow-up|1|||
23611351|NCT01695993|65966789|FG002|Overall Study|Lost to Follow-up|3|||
23611352|NCT01695993|65966787|FG000|Overall Study|Withdrawal by Subject|2|||
23611353|NCT01695993|65966788|FG001|Overall Study|Withdrawal by Subject|2|||
23611354|NCT01695993|65966789|FG002|Overall Study|Withdrawal by Subject|2|||
23611355|NCT01695993|65966787|FG000|Overall Study|To ill to continue|1|||
23611356|NCT01695993|65966788|FG001|Overall Study|To ill to continue|2|||
23611357|NCT01695993|65966789|FG002|Overall Study|To ill to continue|0|||
23611358|NCT01695993|65966787|FG000|Overall Study|Changed Medical Facility|0|||
23611359|NCT01695993|65966788|FG001|Overall Study|Changed Medical Facility|0|||
23611360|NCT01695993|65966789|FG002|Overall Study|Changed Medical Facility|1|||
23611361|NCT00794573|65966794|FG000|Overall Study|Death|3|||
23611362|NCT00794573|65966795|FG001|Overall Study|Death|0|||
23611363|NCT00794573|65966794|FG000|Overall Study|Withdrawal by Subject|9|||
23611364|NCT00794573|65966795|FG001|Overall Study|Withdrawal by Subject|12|||
23611365|NCT00794573|65966794|FG000|Overall Study|Lost to Follow-up|26|||
23611366|NCT00794573|65966795|FG001|Overall Study|Lost to Follow-up|33|||
23611367|NCT00422162|65966797|FG000|Overall Study|Adverse Event|11|||
23611368|NCT00422162|65966798|FG001|Overall Study|Adverse Event|9|||
23611369|NCT00422162|65966797|FG000|Overall Study|Lack of Efficacy|4|||
23611370|NCT00422162|65966798|FG001|Overall Study|Lack of Efficacy|10|||
23611371|NCT00422162|65966797|FG000|Overall Study|Withdrawal by Subject|7|||
23611372|NCT00422162|65966798|FG001|Overall Study|Withdrawal by Subject|6|||
23611373|NCT00422162|65966797|FG000|Overall Study|Lost to Follow-up|1|||
23611374|NCT00422162|65966798|FG001|Overall Study|Lost to Follow-up|2|||
23611375|NCT00422162|65966797|FG000|Overall Study|Non-Compliant with Protocol|1|||
23611376|NCT00422162|65966798|FG001|Overall Study|Non-Compliant with Protocol|1|||
23611377|NCT00422162|65966797|FG000|Overall Study|Other|0|||
23611378|NCT00422162|65966798|FG001|Overall Study|Other|1|||
23526508|NCT03090100|65665520|FG000|Overall Study|Pregnancy|1|||
23526509|NCT03090100|65665521|FG001|Overall Study|Pregnancy|1|||
23526510|NCT03090100|65665520|FG000|Overall Study|Lack of Efficacy|2|||
23526511|NCT03090100|65665521|FG001|Overall Study|Lack of Efficacy|7|||
23526512|NCT03090100|65665520|FG000|Overall Study|Lost to Follow-up|2|||
23526513|NCT03090100|65665521|FG001|Overall Study|Lost to Follow-up|2|||
23526514|NCT03090100|65665520|FG000|Overall Study|Withdrawal by Subject|7|||
23526515|NCT03090100|65665521|FG001|Overall Study|Withdrawal by Subject|19|||
23526516|NCT03090100|65665520|FG000|Overall Study|Protocol Violation|2|||
23526517|NCT03090100|65665521|FG001|Overall Study|Protocol Violation|6|||
23526518|NCT03090100|65665520|FG000|Overall Study|Non-compliance|2|||
23526519|NCT03090100|65665521|FG001|Overall Study|Non-compliance|0|||
23526520|NCT03090100|65665520|FG000|Overall Study|Other|2|||
23526521|NCT03090100|65665521|FG001|Overall Study|Other|2|||
23526522|NCT01886833|65665522|FG000|Overall Study|IgA not available from both periods|204|||
23526523|NCT04144166|65665523|FG000|Overall Study|Discharged before study start|1|||
23526524|NCT04144166|65665523|FG000|Overall Study|Pregnancy|1|||
23526525|NCT04144166|65665523|FG000|Overall Study|Nail polish could not be removed from finger|1|||
23526526|NCT01806896|65665529|FG000|Overall Study|Adverse Event|2|||
23526527|NCT01806896|65665530|FG001|Overall Study|Adverse Event|0|||
23526528|NCT01806896|65665529|FG000|Overall Study|Other|1|||
23526529|NCT01806896|65665530|FG001|Overall Study|Other|0|||
23526530|NCT04193176|65665531|FG000|Overall Study|Withdrawal by Subject|6|||
23526531|NCT04193176|65665532|FG001|Overall Study|Withdrawal by Subject|10|||
23526532|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526533|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
23526534|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526535|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526536|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23526537|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23611379|NCT00422162|65966797|FG000|Overall Study|Didn't Receive Treatment|0|||
23611380|NCT00422162|65966798|FG001|Overall Study|Didn't Receive Treatment|1|||
23611381|NCT02465866|65966799|FG000|Period 3|Withdrawal by Subject|0|||
23611382|NCT02465866|65966800|FG001|Period 3|Withdrawal by Subject|1|||
23611383|NCT02465866|65966801|FG002|Period 3|Withdrawal by Subject|0|||
23611384|NCT02465866|65966802|FG003|Period 3|Withdrawal by Subject|0|||
23526538|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
23526539|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23611385|NCT00087516|65966808|FG000|Overall Study|Adverse Event|10|||
23611386|NCT00087516|65966809|FG001|Overall Study|Adverse Event|10|||
23716557|NCT01575899|66336964|FG000|Overall Study|Lost to Follow-up|3|||
23716558|NCT01575899|66336965|FG001|Overall Study|Lost to Follow-up|4|||
23716559|NCT01575899|66336966|FG002|Overall Study|Lost to Follow-up|2|||
23526540|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
23526541|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
23417948|NCT01271712|65274475|FG000|Safety Follow-up|Progressive disease|1|||
23417949|NCT01271712|65274476|FG001|Safety Follow-up|Progressive disease|0|||
23417950|NCT01271712|65274475|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
23417951|NCT01271712|65274476|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
23417952|NCT01044745|65274477|FG000|Overall Study|Ineiligible|2|||
23417953|NCT01089413|65274480|FG000|Overall Study|Lost to Follow-up|1|||
23417954|NCT01089413|65274480|FG000|Overall Study|Progressive Disease|93|||
23417955|NCT01089413|65274480|FG000|Overall Study|Participant Withdrew Consent|1|||
23417956|NCT01089413|65274480|FG000|Overall Study|Unacceptable Toxicity|12|||
23417957|NCT01089413|65274480|FG000|Overall Study|Death|10|||
23417958|NCT01089413|65274480|FG000|Overall Study|Metastasectomy|13|||
23417959|NCT01089413|65274480|FG000|Overall Study|Other|71|||
23417960|NCT03255967|65274481|FG000|Overall Study|Adverse Event|26|||
23417961|NCT03255967|65274482|FG001|Overall Study|Adverse Event|30|||
23417962|NCT03255967|65274481|FG000|Overall Study|Withdrawal by Subject|6|||
23526542|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
23526543|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
23526544|NCT03848845|65665533|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526545|NCT03848845|65665534|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526546|NCT03848845|65665535|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526547|NCT03848845|65665536|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
23526548|NCT02506816|65665543|FG000|Overall Study|Adverse Event|3|||
23526549|NCT03013543|65665544|FG000|Overall Study|Withdrawal by Subject|0|||
23526550|NCT03013543|65665545|FG001|Overall Study|Withdrawal by Subject|2|||
23526551|NCT03013543|65665546|FG002|Overall Study|Withdrawal by Subject|0|||
23526552|NCT03013543|65665547|FG003|Overall Study|Withdrawal by Subject|5|||
23526553|NCT03013543|65665548|FG004|Overall Study|Withdrawal by Subject|6|||
23526554|NCT03013543|65665549|FG005|Overall Study|Withdrawal by Subject|2|||
23526555|NCT03013543|65665550|FG006|Overall Study|Withdrawal by Subject|3|||
23716560|NCT01575899|66336964|FG000|Overall Study|Protocol Violation|2|||
23716561|NCT01575899|66336965|FG001|Overall Study|Protocol Violation|1|||
23417963|NCT03255967|65274482|FG001|Overall Study|Withdrawal by Subject|6|||
23417964|NCT03255967|65274481|FG000|Overall Study|Schedule conflict|6|||
23417965|NCT03255967|65274482|FG001|Overall Study|Schedule conflict|4|||
23417966|NCT03255967|65274481|FG000|Overall Study|POA did not sign consent form|2|||
23417967|NCT03255967|65274482|FG001|Overall Study|POA did not sign consent form|0|||
23526556|NCT03013543|65665551|FG007|Overall Study|Withdrawal by Subject|1|||
23716562|NCT01575899|66336966|FG002|Overall Study|Protocol Violation|0|||
23716563|NCT01205451|66336971|FG000|Overall Study|Lost to Follow-up|1|||
23716564|NCT01205451|66336972|FG001|Overall Study|Lost to Follow-up|1|||
23417968|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Death|5|||
23417969|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Death|0|||
23417970|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Death|0|||
23526557|NCT03013543|65665552|FG008|Overall Study|Withdrawal by Subject|0|||
23526558|NCT03013543|65665553|FG009|Overall Study|Withdrawal by Subject|4|||
23526559|NCT03013543|65665544|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23526560|NCT03013543|65665545|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23526561|NCT03013543|65665546|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23417971|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
23417972|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
23417973|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
23417974|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
23417975|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
23417976|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
23417977|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
23417978|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
23417979|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
23417980|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
23526562|NCT03013543|65665547|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
23526563|NCT03013543|65665548|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
23526564|NCT03013543|65665549|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
23526565|NCT03013543|65665550|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
23526566|NCT03013543|65665551|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
23526567|NCT03013543|65665552|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
23526568|NCT03013543|65665553|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
23526569|NCT03013543|65665544|FG000|Overall Study|Other|0|||
23526570|NCT03013543|65665545|FG001|Overall Study|Other|0|||
23526571|NCT03013543|65665546|FG002|Overall Study|Other|2|||
23611387|NCT00087516|65966810|FG002|Overall Study|Adverse Event|3|||
23611388|NCT00087516|65966811|FG003|Overall Study|Adverse Event|6|||
23611389|NCT00087516|65966808|FG000|Overall Study|Lack of Efficacy|82|||
23611390|NCT00087516|65966809|FG001|Overall Study|Lack of Efficacy|80|||
23611391|NCT00087516|65966810|FG002|Overall Study|Lack of Efficacy|39|||
23611392|NCT00087516|65966811|FG003|Overall Study|Lack of Efficacy|29|||
23611393|NCT00087516|65966808|FG000|Overall Study|Lost to Follow-up|8|||
23611394|NCT00087516|65966809|FG001|Overall Study|Lost to Follow-up|6|||
23611395|NCT00087516|65966810|FG002|Overall Study|Lost to Follow-up|5|||
23526572|NCT03013543|65665547|FG003|Overall Study|Other|0|||
23716565|NCT01205451|66336971|FG000|Overall Study|Withdrawal by Subject|5|||
23526573|NCT03013543|65665548|FG004|Overall Study|Other|2|||
23526574|NCT03013543|65665549|FG005|Overall Study|Other|0|||
23611396|NCT00087516|65966811|FG003|Overall Study|Lost to Follow-up|5|||
23611397|NCT00087516|65966808|FG000|Overall Study|Protocol Violation|4|||
23611398|NCT00087516|65966809|FG001|Overall Study|Protocol Violation|8|||
23611399|NCT00087516|65966810|FG002|Overall Study|Protocol Violation|3|||
23611400|NCT00087516|65966811|FG003|Overall Study|Protocol Violation|6|||
23611401|NCT00087516|65966808|FG000|Overall Study|Withdrawal by Subject|16|||
23611402|NCT00087516|65966809|FG001|Overall Study|Withdrawal by Subject|27|||
23611403|NCT00087516|65966810|FG002|Overall Study|Withdrawal by Subject|11|||
23611404|NCT00087516|65966811|FG003|Overall Study|Withdrawal by Subject|12|||
23611405|NCT00087516|65966808|FG000|Overall Study|Site terminated|0|||
23611406|NCT00087516|65966809|FG001|Overall Study|Site terminated|2|||
23611407|NCT00087516|65966810|FG002|Overall Study|Site terminated|1|||
23611408|NCT00087516|65966811|FG003|Overall Study|Site terminated|0|||
23611409|NCT00087516|65966808|FG000|Overall Study|Protocol specified discontinuation|35|||
23611410|NCT00087516|65966809|FG001|Overall Study|Protocol specified discontinuation|33|||
23716566|NCT01205451|66336972|FG001|Overall Study|Withdrawal by Subject|9|||
23716567|NCT00039741|66336975|FG000|Overall Study|Death|0|||
23716568|NCT00039741|66336976|FG001|Overall Study|Death|1|||
23716569|NCT00039741|66336977|FG002|Overall Study|Death|0|||
23812970|NCT00090363|66696099|FG002|Overall Study|Reasons not specified|1|||
23526575|NCT03013543|65665550|FG006|Overall Study|Other|0|||
23526576|NCT03013543|65665551|FG007|Overall Study|Other|0|||
23526577|NCT03013543|65665552|FG008|Overall Study|Other|1|||
23526578|NCT03013543|65665553|FG009|Overall Study|Other|0|||
23611411|NCT00087516|65966810|FG002|Overall Study|Protocol specified discontinuation|33|||
23611412|NCT00087516|65966811|FG003|Overall Study|Protocol specified discontinuation|26|||
23611413|NCT00087516|65966808|FG000|Overall Study|Patient moved|3|||
23611414|NCT00087516|65966809|FG001|Overall Study|Patient moved|2|||
23716570|NCT00039741|66336978|FG003|Overall Study|Death|0|||
23417981|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
23417982|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
23417983|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
23417984|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
23526579|NCT03013543|65665544|FG000|Overall Study|Adverse Event|0|||
23716571|NCT00039741|66336975|FG000|Overall Study|Lost to Follow-up|3|||
23716572|NCT00039741|66336976|FG001|Overall Study|Lost to Follow-up|1|||
23417985|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
23417986|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
23417987|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
23417988|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
23417989|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
23417990|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
23417991|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
23417992|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
23417993|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
23417994|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
23417995|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
23417996|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
23417997|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
23417998|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
23417999|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
23418000|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
23418001|NCT02576535|65274492|FG000|Overall Study|Withdrawal by Subject|2|||
23418002|NCT00322452|65274493|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23418003|NCT00322452|65274494|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23418004|NCT00322452|65274493|FG000|Overall Study|Lost to Follow-up|5|||
23418005|NCT00322452|65274494|FG001|Overall Study|Lost to Follow-up|2|||
23418006|NCT00322452|65274493|FG000|Overall Study|Withdrawal by Subject|19|||
23418007|NCT00322452|65274494|FG001|Overall Study|Withdrawal by Subject|46|||
23526580|NCT03013543|65665545|FG001|Overall Study|Adverse Event|0|||
23526581|NCT03013543|65665546|FG002|Overall Study|Adverse Event|0|||
23526582|NCT03013543|65665547|FG003|Overall Study|Adverse Event|3|||
23526583|NCT03013543|65665548|FG004|Overall Study|Adverse Event|2|||
23526584|NCT03013543|65665549|FG005|Overall Study|Adverse Event|1|||
23526585|NCT03013543|65665550|FG006|Overall Study|Adverse Event|3|||
23526586|NCT03013543|65665551|FG007|Overall Study|Adverse Event|8|||
23526587|NCT03013543|65665552|FG008|Overall Study|Adverse Event|0|||
23526588|NCT03013543|65665553|FG009|Overall Study|Adverse Event|2|||
23526589|NCT03013543|65665544|FG000|Overall Study|Death|0|||
23526590|NCT03013543|65665545|FG001|Overall Study|Death|0|||
23526591|NCT03013543|65665546|FG002|Overall Study|Death|0|||
23526592|NCT03013543|65665547|FG003|Overall Study|Death|1|||
23526593|NCT03013543|65665548|FG004|Overall Study|Death|0|||
23526594|NCT03013543|65665549|FG005|Overall Study|Death|0|||
23526595|NCT03013543|65665550|FG006|Overall Study|Death|0|||
23526596|NCT03013543|65665551|FG007|Overall Study|Death|0|||
23526597|NCT03013543|65665552|FG008|Overall Study|Death|0|||
23526598|NCT03013543|65665553|FG009|Overall Study|Death|0|||
23526599|NCT03013543|65665544|FG000|Overall Study|Lack of Efficacy|0|||
23526600|NCT03013543|65665545|FG001|Overall Study|Lack of Efficacy|0|||
23526601|NCT03013543|65665546|FG002|Overall Study|Lack of Efficacy|0|||
23526602|NCT03013543|65665547|FG003|Overall Study|Lack of Efficacy|1|||
23526603|NCT03013543|65665548|FG004|Overall Study|Lack of Efficacy|0|||
23526604|NCT03013543|65665549|FG005|Overall Study|Lack of Efficacy|0|||
23526605|NCT03013543|65665550|FG006|Overall Study|Lack of Efficacy|0|||
23526606|NCT03013543|65665551|FG007|Overall Study|Lack of Efficacy|0|||
23526607|NCT03013543|65665552|FG008|Overall Study|Lack of Efficacy|0|||
23526608|NCT03013543|65665553|FG009|Overall Study|Lack of Efficacy|0|||
23526609|NCT03013543|65665544|FG000|Overall Study|Lost to Follow-up|0|||
23526610|NCT03013543|65665545|FG001|Overall Study|Lost to Follow-up|0|||
23526611|NCT03013543|65665546|FG002|Overall Study|Lost to Follow-up|0|||
23526612|NCT03013543|65665547|FG003|Overall Study|Lost to Follow-up|1|||
23526613|NCT03013543|65665548|FG004|Overall Study|Lost to Follow-up|0|||
23526614|NCT03013543|65665549|FG005|Overall Study|Lost to Follow-up|0|||
23526615|NCT03013543|65665550|FG006|Overall Study|Lost to Follow-up|1|||
23526616|NCT03013543|65665551|FG007|Overall Study|Lost to Follow-up|0|||
23526617|NCT03013543|65665552|FG008|Overall Study|Lost to Follow-up|0|||
23526618|NCT03013543|65665553|FG009|Overall Study|Lost to Follow-up|2|||
23526619|NCT03013543|65665544|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23526620|NCT03013543|65665545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23526621|NCT03013543|65665546|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23526622|NCT03013543|65665547|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23526623|NCT03013543|65665548|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23526624|NCT03013543|65665549|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23526625|NCT03013543|65665550|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23526626|NCT03013543|65665551|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23418008|NCT00322452|65274493|FG000|Overall Study|Death|223|||
23418009|NCT00322452|65274494|FG001|Overall Study|Death|227|||
23418010|NCT02199314|65274495|FG000|Overall Study|Withdrawal by Subject|6|||
23526627|NCT03013543|65665552|FG008|Overall Study|Non-Compliance With Study Drug|1|||
23526628|NCT03013543|65665553|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23526629|NCT03013543|65665544|FG000|Overall Study|Physician Decision|0|||
23526630|NCT03013543|65665545|FG001|Overall Study|Physician Decision|0|||
23526631|NCT03013543|65665546|FG002|Overall Study|Physician Decision|0|||
23526632|NCT03013543|65665547|FG003|Overall Study|Physician Decision|0|||
23526633|NCT03013543|65665548|FG004|Overall Study|Physician Decision|1|||
23526634|NCT03013543|65665549|FG005|Overall Study|Physician Decision|0|||
23526635|NCT03013543|65665550|FG006|Overall Study|Physician Decision|0|||
23526636|NCT03013543|65665551|FG007|Overall Study|Physician Decision|0|||
23526637|NCT03013543|65665552|FG008|Overall Study|Physician Decision|0|||
23526638|NCT03013543|65665553|FG009|Overall Study|Physician Decision|0|||
23526639|NCT03013543|65665544|FG000|Overall Study|Protocol Violation|0|||
23526640|NCT03013543|65665545|FG001|Overall Study|Protocol Violation|0|||
23526641|NCT03013543|65665546|FG002|Overall Study|Protocol Violation|0|||
23526642|NCT03013543|65665547|FG003|Overall Study|Protocol Violation|0|||
23526643|NCT03013543|65665548|FG004|Overall Study|Protocol Violation|0|||
23526644|NCT03013543|65665549|FG005|Overall Study|Protocol Violation|0|||
23526645|NCT03013543|65665550|FG006|Overall Study|Protocol Violation|0|||
23526646|NCT03013543|65665551|FG007|Overall Study|Protocol Violation|0|||
23526647|NCT03013543|65665552|FG008|Overall Study|Protocol Violation|0|||
23526648|NCT03013543|65665553|FG009|Overall Study|Protocol Violation|1|||
23526649|NCT00582933|65665554|FG000|Overall Study|Physician Decision|3|||
23526650|NCT00397982|65665560|FG000|Overall Study|Withdrawal by Subject|1|||
23526651|NCT00397982|65665560|FG000|Overall Study|Adverse Event|1|||
23526652|NCT00397982|65665560|FG000|Overall Study|noncompliance|1|||
23526653|NCT00397982|65665560|FG000|Overall Study|Unrelated health issues|1|||
23526654|NCT01541826|65665561|FG000|Overall Study|Lost to Follow-up|2|||
23526655|NCT01541826|65665562|FG001|Overall Study|Lost to Follow-up|3|||
23526656|NCT01541826|65665563|FG002|Overall Study|Lost to Follow-up|0|||
23526657|NCT01541826|65665561|FG000|Overall Study|Withdrawal by Subject|2|||
23526658|NCT01541826|65665562|FG001|Overall Study|Withdrawal by Subject|0|||
23526659|NCT01541826|65665563|FG002|Overall Study|Withdrawal by Subject|0|||
23526660|NCT00297037|65665564|FG000|Overall Study|Withdrawal by Subject|2|||
23526661|NCT00297037|65665565|FG001|Overall Study|Withdrawal by Subject|0|||
23526662|NCT01921829|65665580|FG000|Overall Study|Withdrawal by Subject|0|||
23526663|NCT01921829|65665581|FG001|Overall Study|Withdrawal by Subject|1|||
23526664|NCT00697346|65665588|FG000|Overall Study|Adverse Event|4|||
23526665|NCT00697346|65665589|FG001|Overall Study|Adverse Event|5|||
23526666|NCT00697346|65665590|FG002|Overall Study|Adverse Event|0|||
23526667|NCT00697346|65665588|FG000|Overall Study|Progressive Disease|19|||
23526668|NCT00697346|65665589|FG001|Overall Study|Progressive Disease|18|||
23526669|NCT00697346|65665590|FG002|Overall Study|Progressive Disease|0|||
23526670|NCT00697346|65665588|FG000|Overall Study|Symptomatic Deterioration|0|||
23526671|NCT00697346|65665589|FG001|Overall Study|Symptomatic Deterioration|1|||
23526672|NCT00697346|65665590|FG002|Overall Study|Symptomatic Deterioration|0|||
23526673|NCT00697346|65665588|FG000|Overall Study|Withdrawal by Subject|2|||
23526674|NCT00697346|65665589|FG001|Overall Study|Withdrawal by Subject|2|||
23526675|NCT00697346|65665590|FG002|Overall Study|Withdrawal by Subject|0|||
23526676|NCT00697346|65665588|FG000|Overall Study|Reason not Specified|3|||
23526677|NCT00697346|65665589|FG001|Overall Study|Reason not Specified|0|||
23526678|NCT00697346|65665590|FG002|Overall Study|Reason not Specified|1|||
23526679|NCT00836875|65665592|FG000|Overall Study|Death|3|||
23526680|NCT00836875|65665593|FG001|Overall Study|Death|2|||
23526681|NCT00836875|65665592|FG000|Overall Study|Withdrawal by Subject|0|||
23526682|NCT00836875|65665593|FG001|Overall Study|Withdrawal by Subject|1|||
23526683|NCT04116710|65665594|FG000|Overall Study|Death|4|||
23526684|NCT04116710|65665595|FG001|Overall Study|Death|6|||
23526685|NCT04116710|65665596|FG002|Overall Study|Death|3|||
23526686|NCT04116710|65665597|FG003|Overall Study|Death|1|||
23526687|NCT04116710|65665594|FG000|Overall Study|Withdrawal by Subject|0|||
23526688|NCT04116710|65665595|FG001|Overall Study|Withdrawal by Subject|0|||
23526689|NCT04116710|65665596|FG002|Overall Study|Withdrawal by Subject|0|||
23526690|NCT04116710|65665597|FG003|Overall Study|Withdrawal by Subject|1|||
23611415|NCT00087516|65966810|FG002|Overall Study|Patient moved|1|||
23611416|NCT00087516|65966811|FG003|Overall Study|Patient moved|0|||
23526691|NCT00547703|65665598|FG000|Overall Study|Lost to Follow-up|1|||
23611417|NCT00087516|65966808|FG000|Overall Study|Patient was non-compliant|3|||
23611418|NCT00087516|65966809|FG001|Overall Study|Patient was non-compliant|1|||
23526692|NCT00547703|65665599|FG001|Overall Study|Lost to Follow-up|0|||
23526693|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
23526694|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
23526695|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
23526696|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
23526697|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
23526698|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
23526699|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
23526700|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
23526701|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
23611419|NCT00087516|65966810|FG002|Overall Study|Patient was non-compliant|0|||
23611420|NCT00087516|65966811|FG003|Overall Study|Patient was non-compliant|0|||
23611421|NCT00087516|65966808|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
23611422|NCT00087516|65966809|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
23611423|NCT00087516|65966810|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
23611424|NCT00087516|65966811|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
23526702|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
23526703|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
23526704|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
23526705|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
23526706|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
23526707|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
23526708|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Death|5|||
23526709|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Death|0|||
23526710|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Death|2|||
23526711|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Death|0|||
23526712|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Death|4|||
23526713|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
23526714|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
23526715|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
23526716|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
23526717|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
23526718|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
23526719|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
23526720|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
23526721|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
23526722|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
23526723|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
23526724|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526725|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
23526726|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526727|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526728|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Other|15|||
23526729|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Other|0|||
23526730|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Other|10|||
23526731|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Other|0|||
23526732|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Other|6|||
23526733|NCT01604343|65665602|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
23526734|NCT01604343|65665603|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
23526735|NCT01604343|65665604|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
23526736|NCT01604343|65665605|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
23526737|NCT01604343|65665606|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
23526738|NCT01604343|65665602|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
23526739|NCT01604343|65665603|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
23526740|NCT01604343|65665604|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
23526741|NCT01604343|65665605|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
23526742|NCT01604343|65665606|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
23526743|NCT01604343|65665602|FG000|Week 52 to Week 104|Adverse Event|0|||
23526744|NCT01604343|65665603|FG001|Week 52 to Week 104|Adverse Event|12|||
23526745|NCT01604343|65665604|FG002|Week 52 to Week 104|Adverse Event|26|||
23526746|NCT01604343|65665605|FG003|Week 52 to Week 104|Adverse Event|21|||
23526747|NCT01604343|65665606|FG004|Week 52 to Week 104|Adverse Event|27|||
23526748|NCT01604343|65665602|FG000|Week 52 to Week 104|Death|0|||
23526749|NCT01604343|65665603|FG001|Week 52 to Week 104|Death|4|||
23526750|NCT01604343|65665604|FG002|Week 52 to Week 104|Death|2|||
23526751|NCT01604343|65665605|FG003|Week 52 to Week 104|Death|5|||
23526752|NCT01604343|65665606|FG004|Week 52 to Week 104|Death|0|||
23526753|NCT01604343|65665602|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
23526754|NCT01604343|65665603|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
23526755|NCT01604343|65665604|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
23526756|NCT01604343|65665605|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
23526757|NCT01604343|65665606|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
23526758|NCT01604343|65665602|FG000|Week 52 to Week 104|Physician Decision|0|||
23611425|NCT00087516|65966808|FG000|Overall Study|Other|0|||
23611426|NCT00087516|65966809|FG001|Overall Study|Other|0|||
23526759|NCT01604343|65665603|FG001|Week 52 to Week 104|Physician Decision|1|||
23526760|NCT01604343|65665604|FG002|Week 52 to Week 104|Physician Decision|0|||
23526761|NCT01604343|65665605|FG003|Week 52 to Week 104|Physician Decision|0|||
23526762|NCT01604343|65665606|FG004|Week 52 to Week 104|Physician Decision|2|||
23526763|NCT01604343|65665602|FG000|Week 52 to Week 104|Pregnancy|0|||
23526764|NCT01604343|65665603|FG001|Week 52 to Week 104|Pregnancy|0|||
23526765|NCT01604343|65665604|FG002|Week 52 to Week 104|Pregnancy|1|||
23611427|NCT00087516|65966810|FG002|Overall Study|Other|1|||
23611428|NCT00087516|65966811|FG003|Overall Study|Other|0|||
23611429|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
23611430|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611431|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611432|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23526766|NCT01604343|65665605|FG003|Week 52 to Week 104|Pregnancy|2|||
23526767|NCT01604343|65665606|FG004|Week 52 to Week 104|Pregnancy|1|||
23526768|NCT01604343|65665602|FG000|Week 52 to Week 104|Other|0|||
23526769|NCT01604343|65665603|FG001|Week 52 to Week 104|Other|11|||
23526770|NCT01604343|65665604|FG002|Week 52 to Week 104|Other|11|||
23526771|NCT01604343|65665605|FG003|Week 52 to Week 104|Other|6|||
23526772|NCT01604343|65665606|FG004|Week 52 to Week 104|Other|3|||
23526773|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
23526774|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526775|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
23611433|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611434|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611435|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611436|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611437|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611438|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611439|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611440|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611441|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611442|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611443|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611444|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611445|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611446|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611447|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611448|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611449|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611450|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611451|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611452|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611453|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
23611454|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611455|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
23611456|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611457|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611458|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611459|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611460|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611461|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611462|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23526776|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526777|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526778|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
23526779|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
23526780|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
23526781|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
23526782|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
23526783|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
23526784|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
23526785|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
23526786|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
23526787|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
23526788|NCT03277261|65665607|FG000|Overall Study|Adverse Event|17|||
23526789|NCT03277261|65665608|FG001|Overall Study|Adverse Event|1|||
23526790|NCT03277261|65665607|FG000|Overall Study|Participant Withdrawal of Consent|6|||
23526791|NCT03277261|65665608|FG001|Overall Study|Participant Withdrawal of Consent|15|||
23526792|NCT03277261|65665607|FG000|Overall Study|Investigator / Sponsor Decision|4|||
23526793|NCT03277261|65665608|FG001|Overall Study|Investigator / Sponsor Decision|2|||
23526794|NCT03277261|65665607|FG000|Overall Study|Pregnancy|2|||
23526795|NCT03277261|65665608|FG001|Overall Study|Pregnancy|0|||
23526796|NCT03277261|65665607|FG000|Overall Study|Lost to Follow-up|2|||
23526797|NCT03277261|65665608|FG001|Overall Study|Lost to Follow-up|2|||
23526798|NCT03277261|65665607|FG000|Overall Study|Lack of Efficacy|2|||
23611463|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23526799|NCT03277261|65665608|FG001|Overall Study|Lack of Efficacy|2|||
23526800|NCT03277261|65665607|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
23526801|NCT03277261|65665608|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
23526802|NCT02501096|65665609|FG000|Overall Study|Lost to Follow-up|0|||
23526803|NCT02501096|65665610|FG001|Overall Study|Lost to Follow-up|0|||
23526804|NCT02501096|65665611|FG002|Overall Study|Lost to Follow-up|0|||
23611464|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611465|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611466|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611467|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611468|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611469|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611470|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611471|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611472|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611473|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
23611474|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611475|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611476|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611477|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611478|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611479|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611480|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611481|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611482|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611483|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611484|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611485|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611486|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
23611487|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
23611488|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
23611489|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
23611490|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
23611491|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
23611492|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
23611493|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
23611494|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611495|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611496|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611497|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611498|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23812971|NCT00090363|66696097|FG000|Overall Study|Continuing on study off treatment|14|||
23812972|NCT00090363|66696098|FG001|Overall Study|Continuing on study off treatment|13|||
23812973|NCT00090363|66696099|FG002|Overall Study|Continuing on study off treatment|16|||
23526805|NCT02501096|65665612|FG003|Overall Study|Lost to Follow-up|0|||
23526806|NCT02501096|65665613|FG004|Overall Study|Lost to Follow-up|1|||
23526807|NCT02501096|65665614|FG005|Overall Study|Lost to Follow-up|1|||
23611499|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611500|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611501|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611502|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611503|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611504|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611505|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23716573|NCT00039741|66336977|FG002|Overall Study|Lost to Follow-up|5|||
23716574|NCT00039741|66336978|FG003|Overall Study|Lost to Follow-up|2|||
23526808|NCT02501096|65665615|FG006|Overall Study|Lost to Follow-up|3|||
23526809|NCT02501096|65665616|FG007|Overall Study|Lost to Follow-up|0|||
23526810|NCT02501096|65665617|FG008|Overall Study|Lost to Follow-up|0|||
23526811|NCT02501096|65665609|FG000|Overall Study|Withdrawal by Subject|1|||
23526812|NCT02501096|65665610|FG001|Overall Study|Withdrawal by Subject|0|||
23611506|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23716575|NCT00039741|66336975|FG000|Overall Study|Confounding medical condition|1|||
23716576|NCT00039741|66336976|FG001|Overall Study|Confounding medical condition|0|||
23716577|NCT00039741|66336977|FG002|Overall Study|Confounding medical condition|0|||
23716578|NCT00039741|66336978|FG003|Overall Study|Confounding medical condition|0|||
23812974|NCT01206101|66696100|FG000|Overall Study|Adverse Event|1|||
23526813|NCT02501096|65665611|FG002|Overall Study|Withdrawal by Subject|7|||
23611507|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611508|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611509|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611510|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611511|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611512|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611513|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
23611514|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
23611515|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
23611516|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611517|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611518|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611519|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611520|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611521|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611522|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611523|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611524|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611525|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611526|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611527|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611528|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611529|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611530|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611531|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611532|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
23611533|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611534|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
23611535|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611536|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611537|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611538|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611539|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611540|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611541|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611542|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611543|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611544|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611545|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611546|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611547|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611548|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611549|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611550|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23418011|NCT02199314|65274495|FG000|Overall Study|Physician Decision|10|||
23418012|NCT00633074|65274496|FG000|Overall Study|Adverse Event|1|||
23611551|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611552|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
23611553|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
23611554|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611555|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611556|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611557|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611558|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611559|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611560|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611561|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611562|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611563|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23812975|NCT01206101|66696101|FG001|Overall Study|Adverse Event|0|||
23418013|NCT00633074|65274497|FG001|Overall Study|Adverse Event|0|||
23418014|NCT00328562|65274498|FG000|Overall Study|Disease progression|1|||
23611564|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23812976|NCT01206101|66696100|FG000|Overall Study|Physician Decision|0|||
23418015|NCT03327220|65274499|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
23418016|NCT03327220|65274500|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
23526814|NCT02501096|65665612|FG003|Overall Study|Withdrawal by Subject|13|||
23526815|NCT02501096|65665613|FG004|Overall Study|Withdrawal by Subject|2|||
23526816|NCT02501096|65665614|FG005|Overall Study|Withdrawal by Subject|2|||
23526817|NCT02501096|65665615|FG006|Overall Study|Withdrawal by Subject|2|||
23526818|NCT02501096|65665616|FG007|Overall Study|Withdrawal by Subject|3|||
23526819|NCT02501096|65665617|FG008|Overall Study|Withdrawal by Subject|0|||
23526820|NCT02501096|65665609|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526821|NCT02501096|65665610|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526822|NCT02501096|65665611|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
23526823|NCT02501096|65665612|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
23526824|NCT02501096|65665613|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
23526825|NCT02501096|65665614|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
23611565|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23526826|NCT02501096|65665615|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
23526827|NCT02501096|65665616|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
23526828|NCT02501096|65665617|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526829|NCT02501096|65665609|FG000|Overall Study|Death|1|||
23526830|NCT02501096|65665610|FG001|Overall Study|Death|1|||
23526831|NCT02501096|65665611|FG002|Overall Study|Death|88|||
23526832|NCT02501096|65665612|FG003|Overall Study|Death|74|||
23526833|NCT02501096|65665613|FG004|Overall Study|Death|15|||
23526834|NCT02501096|65665614|FG005|Overall Study|Death|16|||
23526835|NCT02501096|65665615|FG006|Overall Study|Death|15|||
23526836|NCT02501096|65665616|FG007|Overall Study|Death|16|||
23526837|NCT02501096|65665617|FG008|Overall Study|Death|1|||
23526838|NCT03181542|65665618|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
23526839|NCT03181542|65665619|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
23526840|NCT04292730|65665620|FG000|Overall Study|Lost to Follow-up|8|||
23526841|NCT04292730|65665621|FG001|Overall Study|Lost to Follow-up|12|||
23526842|NCT04292730|65665622|FG002|Overall Study|Lost to Follow-up|12|||
23526843|NCT04292730|65665623|FG003|Overall Study|Lost to Follow-up|48|||
23526844|NCT04292730|65665620|FG000|Overall Study|Death|2|||
23526845|NCT04292730|65665621|FG001|Overall Study|Death|2|||
23526846|NCT04292730|65665622|FG002|Overall Study|Death|4|||
23526847|NCT04292730|65665623|FG003|Overall Study|Death|12|||
23526848|NCT04292730|65665620|FG000|Overall Study|Withdrew Consent|2|||
23526849|NCT04292730|65665621|FG001|Overall Study|Withdrew Consent|2|||
23526850|NCT04292730|65665622|FG002|Overall Study|Withdrew Consent|5|||
23526851|NCT04292730|65665623|FG003|Overall Study|Withdrew Consent|6|||
23526852|NCT04292730|65665620|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23526853|NCT04292730|65665621|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23526854|NCT04292730|65665622|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23526855|NCT04292730|65665623|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23526856|NCT04292730|65665620|FG000|Overall Study|Protocol Violation|0|||
23526857|NCT04292730|65665621|FG001|Overall Study|Protocol Violation|0|||
23526858|NCT04292730|65665622|FG002|Overall Study|Protocol Violation|1|||
23526859|NCT04292730|65665623|FG003|Overall Study|Protocol Violation|0|||
23526860|NCT04292730|65665620|FG000|Overall Study|Randomized but not Treated|8|||
23526861|NCT04292730|65665621|FG001|Overall Study|Randomized but not Treated|4|||
23526862|NCT04292730|65665622|FG002|Overall Study|Randomized but not Treated|0|||
23526863|NCT04292730|65665623|FG003|Overall Study|Randomized but not Treated|14|||
23526864|NCT04889625|65665627|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
23526865|NCT04889625|65665628|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
23526866|NCT04889625|65665627|FG000|Period 1|Subject out of window|0|||
23526867|NCT04889625|65665628|FG001|Period 1|Subject out of window|1|||
23526868|NCT04889625|65665627|FG000|Period 1|Wrong add power dispensed|0|||
23526869|NCT04889625|65665628|FG001|Period 1|Wrong add power dispensed|1|||
23526870|NCT04889625|65665627|FG000|Period 1|Discontinued due to fitting guide error|1|||
23611566|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611567|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23812977|NCT01206101|66696101|FG001|Overall Study|Physician Decision|1|||
23526871|NCT04889625|65665628|FG001|Period 1|Discontinued due to fitting guide error|1|||
23526872|NCT04889625|65665627|FG000|Period 2|Test article no longer available|1|||
23526873|NCT04889625|65665628|FG001|Period 2|Test article no longer available|0|||
23526874|NCT04889625|65665627|FG000|Period 2|Incorrect lens dispensed|1|||
23526875|NCT04889625|65665628|FG001|Period 2|Incorrect lens dispensed|0|||
23526876|NCT04889625|65665627|FG000|Period 2|Wrong add power dispensed|0|||
23526877|NCT04889625|65665628|FG001|Period 2|Wrong add power dispensed|1|||
23526878|NCT01574703|65665631|FG000|Overall Study|Adverse Event|0|||
23526879|NCT01574703|65665632|FG001|Overall Study|Adverse Event|2|||
23526880|NCT01574703|65665633|FG002|Overall Study|Adverse Event|1|||
23526881|NCT01574703|65665634|FG003|Overall Study|Adverse Event|1|||
23526882|NCT01574703|65665631|FG000|Overall Study|Protocol Violation|0|||
23526883|NCT01574703|65665632|FG001|Overall Study|Protocol Violation|0|||
23526884|NCT01574703|65665633|FG002|Overall Study|Protocol Violation|0|||
23611568|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611569|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611570|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
23611571|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23526885|NCT01574703|65665634|FG003|Overall Study|Protocol Violation|1|||
23526886|NCT01574703|65665631|FG000|Overall Study|Unspecified Reason|27|||
23526887|NCT01574703|65665632|FG001|Overall Study|Unspecified Reason|15|||
23526888|NCT01574703|65665633|FG002|Overall Study|Unspecified Reason|20|||
23526889|NCT01574703|65665634|FG003|Overall Study|Unspecified Reason|16|||
23526890|NCT01574703|65665631|FG000|Overall Study|Withdrawal by Subject|53|||
23526891|NCT01574703|65665632|FG001|Overall Study|Withdrawal by Subject|52|||
23526892|NCT01574703|65665633|FG002|Overall Study|Withdrawal by Subject|36|||
23526893|NCT01574703|65665634|FG003|Overall Study|Withdrawal by Subject|61|||
23526894|NCT01574703|65665631|FG000|Overall Study|Met Withdrawal Criteria|0|||
23526895|NCT01574703|65665632|FG001|Overall Study|Met Withdrawal Criteria|1|||
23526896|NCT01574703|65665633|FG002|Overall Study|Met Withdrawal Criteria|1|||
23526897|NCT01574703|65665634|FG003|Overall Study|Met Withdrawal Criteria|0|||
23526898|NCT01574703|65665631|FG000|Overall Study|Lost to Follow-up|43|||
23526899|NCT01574703|65665632|FG001|Overall Study|Lost to Follow-up|41|||
23526900|NCT01574703|65665633|FG002|Overall Study|Lost to Follow-up|46|||
23526901|NCT01574703|65665634|FG003|Overall Study|Lost to Follow-up|35|||
23526902|NCT01574703|65665631|FG000|Overall Study|Death|2|||
23526903|NCT01574703|65665632|FG001|Overall Study|Death|1|||
23526904|NCT01574703|65665633|FG002|Overall Study|Death|1|||
23526905|NCT01574703|65665634|FG003|Overall Study|Death|0|||
23582126|NCT02028884|65862334|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
23582127|NCT02028884|65862335|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
23582128|NCT02028884|65862333|FG000|Double-blind Period|Withdrawal by Subject|2|||
23582129|NCT02028884|65862334|FG001|Double-blind Period|Withdrawal by Subject|0|||
23582130|NCT02028884|65862335|FG002|Double-blind Period|Withdrawal by Subject|0|||
23582131|NCT02028884|65862333|FG000|Open-label Extension Period|Adverse Event|3|||
23582132|NCT02028884|65862334|FG001|Open-label Extension Period|Adverse Event|1|||
23582133|NCT02028884|65862335|FG002|Open-label Extension Period|Adverse Event|0|||
23582134|NCT02028884|65862333|FG000|Open-label Extension Period|Lack of Efficacy|3|||
23582135|NCT02028884|65862334|FG001|Open-label Extension Period|Lack of Efficacy|0|||
23582136|NCT02028884|65862335|FG002|Open-label Extension Period|Lack of Efficacy|0|||
23582137|NCT02028884|65862333|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23582138|NCT02028884|65862334|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
23582139|NCT02028884|65862335|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23582140|NCT02028884|65862333|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23582141|NCT02028884|65862334|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
23582142|NCT02028884|65862335|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
23582143|NCT02028884|65862333|FG000|Open-label Extension Period|Switched to another treatment option|3|||
23582144|NCT02028884|65862334|FG001|Open-label Extension Period|Switched to another treatment option|0|||
23582145|NCT02028884|65862335|FG002|Open-label Extension Period|Switched to another treatment option|0|||
23582146|NCT01155869|65862336|FG000|Overall Study|Lost to Follow-up|3|||
23582147|NCT01155869|65862337|FG001|Overall Study|Lost to Follow-up|1|||
23582148|NCT01168401|65862340|FG000|Overall Study|Lost to Follow-up|1|||
23582149|NCT01168401|65862341|FG001|Overall Study|Lost to Follow-up|1|||
23582150|NCT01168401|65862342|FG002|Overall Study|Lost to Follow-up|2|||
23582151|NCT01168401|65862343|FG003|Overall Study|Lost to Follow-up|1|||
23582152|NCT01168401|65862344|FG004|Overall Study|Lost to Follow-up|0|||
23582153|NCT01168401|65862345|FG005|Overall Study|Lost to Follow-up|0|||
23582154|NCT01168401|65862346|FG006|Overall Study|Lost to Follow-up|0|||
23582155|NCT01168401|65862347|FG007|Overall Study|Lost to Follow-up|0|||
23582156|NCT01168401|65862348|FG008|Overall Study|Lost to Follow-up|0|||
23582157|NCT01168401|65862349|FG009|Overall Study|Lost to Follow-up|0|||
23582158|NCT01168401|65862350|FG010|Overall Study|Lost to Follow-up|0|||
23582159|NCT01168401|65862340|FG000|Overall Study|Withdrawal by Subject|0|||
23582160|NCT01168401|65862341|FG001|Overall Study|Withdrawal by Subject|0|||
23582161|NCT01168401|65862342|FG002|Overall Study|Withdrawal by Subject|0|||
23611572|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23582162|NCT01168401|65862343|FG003|Overall Study|Withdrawal by Subject|1|||
23582163|NCT01168401|65862344|FG004|Overall Study|Withdrawal by Subject|0|||
23582164|NCT01168401|65862345|FG005|Overall Study|Withdrawal by Subject|0|||
23582165|NCT01168401|65862346|FG006|Overall Study|Withdrawal by Subject|0|||
23582166|NCT01168401|65862347|FG007|Overall Study|Withdrawal by Subject|0|||
23582167|NCT01168401|65862348|FG008|Overall Study|Withdrawal by Subject|0|||
23582168|NCT01168401|65862349|FG009|Overall Study|Withdrawal by Subject|0|||
23582169|NCT01168401|65862350|FG010|Overall Study|Withdrawal by Subject|0|||
23582170|NCT02223793|65862351|FG000|Overall Study|Lost to Follow-up|10|||
23582171|NCT02223793|65862352|FG001|Overall Study|Lost to Follow-up|1|||
23582172|NCT02223793|65862353|FG002|Overall Study|Lost to Follow-up|2|||
23582173|NCT02223793|65862351|FG000|Overall Study|Withdrawal by Subject|3|||
23611573|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611574|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611575|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611576|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611577|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611578|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611579|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611580|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611581|NCT01587703|65966812|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611582|NCT01587703|65966813|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611583|NCT01587703|65966814|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611584|NCT01587703|65966815|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611585|NCT01587703|65966816|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611586|NCT01587703|65966817|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611587|NCT01587703|65966818|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611588|NCT01587703|65966819|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611589|NCT01587703|65966820|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611590|NCT01587703|65966821|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611591|NCT01587703|65966822|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611592|NCT01587703|65966823|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611593|NCT01587703|65966824|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611594|NCT01587703|65966825|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611595|NCT01587703|65966826|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611596|NCT01587703|65966827|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611597|NCT01587703|65966828|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611598|NCT01587703|65966829|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23716579|NCT00039741|66336975|FG000|Overall Study|Not able to get to clinic|5|||
23526906|NCT01302392|65669173|FG000|Overall Study|Lost to Follow-up|1|||
23526907|NCT01302392|65669174|FG001|Overall Study|Lost to Follow-up|0|||
23526908|NCT01302392|65669173|FG000|Overall Study|Withdrawal by Subject|6|||
23526909|NCT01302392|65669174|FG001|Overall Study|Withdrawal by Subject|1|||
23526910|NCT00579826|65669175|FG000|Overall Study|Withdrawal by Subject|5|||
23526911|NCT00579826|65669176|FG001|Overall Study|Withdrawal by Subject|3|||
23526912|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526913|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
23526914|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
23526915|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
23526916|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526917|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526918|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23716580|NCT00039741|66336976|FG001|Overall Study|Not able to get to clinic|2|||
23716581|NCT00039741|66336977|FG002|Overall Study|Not able to get to clinic|0|||
23716582|NCT00039741|66336978|FG003|Overall Study|Not able to get to clinic|3|||
23716583|NCT00039741|66336975|FG000|Overall Study|Moved|3|||
23716584|NCT00039741|66336976|FG001|Overall Study|Moved|2|||
23716585|NCT00039741|66336977|FG002|Overall Study|Moved|3|||
23716586|NCT00039741|66336978|FG003|Overall Study|Moved|6|||
23716587|NCT00039741|66336975|FG000|Overall Study|Non-compliance with protocol|1|||
23716588|NCT00039741|66336976|FG001|Overall Study|Non-compliance with protocol|0|||
23716589|NCT00039741|66336977|FG002|Overall Study|Non-compliance with protocol|1|||
23716590|NCT00039741|66336978|FG003|Overall Study|Non-compliance with protocol|0|||
23716591|NCT00039741|66336975|FG000|Overall Study|Withdrew consent|0|||
23716592|NCT00039741|66336976|FG001|Overall Study|Withdrew consent|5|||
23716593|NCT00039741|66336977|FG002|Overall Study|Withdrew consent|0|||
23716594|NCT00039741|66336978|FG003|Overall Study|Withdrew consent|1|||
23716595|NCT00039741|66336975|FG000|Overall Study|Missed final visit|2|||
23716596|NCT00039741|66336976|FG001|Overall Study|Missed final visit|1|||
23716597|NCT00039741|66336977|FG002|Overall Study|Missed final visit|2|||
23716598|NCT00039741|66336978|FG003|Overall Study|Missed final visit|2|||
23716599|NCT01578785|66336979|FG000|Overall Study|Withdrawal by Subject|0|||
23716600|NCT01578785|66336980|FG001|Overall Study|Withdrawal by Subject|1|||
23716601|NCT01578785|66336979|FG000|Overall Study|Study terminated by sponsor|59|||
23716602|NCT01578785|66336980|FG001|Overall Study|Study terminated by sponsor|118|||
23716603|NCT03846219|66336981|FG000|Overall Study|Withdrawal by Subject|3|||
23716604|NCT03846219|66336982|FG001|Overall Study|Withdrawal by Subject|2|||
23716605|NCT03846219|66336983|FG002|Overall Study|Withdrawal by Subject|2|||
23716606|NCT03846219|66336981|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
23716607|NCT03846219|66336982|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
23716608|NCT03846219|66336983|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
23716609|NCT03846219|66336981|FG000|Overall Study|Physician Decision|0|||
23716610|NCT03846219|66336982|FG001|Overall Study|Physician Decision|0|||
23526919|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23716611|NCT03846219|66336983|FG002|Overall Study|Physician Decision|2|||
23716612|NCT00205699|66336984|FG000|Overall Study|Lost to Follow-up|1|||
23716613|NCT00205699|66336985|FG001|Overall Study|Lost to Follow-up|3|||
23716614|NCT00205699|66336986|FG002|Overall Study|Lost to Follow-up|5|||
23716615|NCT00205699|66336984|FG000|Overall Study|Adverse Event|1|||
23716616|NCT00205699|66336985|FG001|Overall Study|Adverse Event|0|||
23716617|NCT00205699|66336986|FG002|Overall Study|Adverse Event|0|||
23716618|NCT00205699|66336984|FG000|Overall Study|Withdrawal by Subject|1|||
23716619|NCT00205699|66336985|FG001|Overall Study|Withdrawal by Subject|2|||
23418017|NCT03327220|65274499|FG000|Overall Study|Investigator Decision|2|||
23418018|NCT03327220|65274500|FG001|Overall Study|Investigator Decision|0|||
23526920|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526921|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23812978|NCT01206101|66696100|FG000|Overall Study|Unclassified|1|||
23812979|NCT01206101|66696101|FG001|Overall Study|Unclassified|0|||
23812980|NCT00927394|66696102|FG000|Overall Study|Adverse Event|14|||
23812981|NCT00927394|66696103|FG001|Overall Study|Adverse Event|9|||
23812982|NCT00927394|66696102|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
23812983|NCT00927394|66696103|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
23812984|NCT00927394|66696102|FG000|Overall Study|Withdrawal by Subject|20|||
23812985|NCT00927394|66696103|FG001|Overall Study|Withdrawal by Subject|24|||
23812986|NCT00927394|66696102|FG000|Overall Study|Lost to Follow-up|8|||
23812987|NCT00927394|66696103|FG001|Overall Study|Lost to Follow-up|14|||
23812988|NCT00927394|66696102|FG000|Overall Study|Administrative Problem|1|||
23812989|NCT00927394|66696103|FG001|Overall Study|Administrative Problem|0|||
23812990|NCT00927394|66696102|FG000|Overall Study|Death|1|||
23812991|NCT00927394|66696103|FG001|Overall Study|Death|1|||
23812992|NCT00927394|66696102|FG000|Overall Study|Protocol deviation|16|||
23812993|NCT00927394|66696103|FG001|Overall Study|Protocol deviation|13|||
23812994|NCT00927394|66696102|FG000|Overall Study|Randomized in error|0|||
23812995|NCT00927394|66696103|FG001|Overall Study|Randomized in error|1|||
23812996|NCT04729309|66696104|FG000|Period 1|Subject unable to return for Period 2|3|||
23812997|NCT04729309|66696105|FG001|Period 1|Subject unable to return for Period 2|0|||
23812998|NCT04729309|66696104|FG000|Period 1|Lost to Follow-up|1|||
23812999|NCT04729309|66696105|FG001|Period 1|Lost to Follow-up|0|||
23813000|NCT03327792|66696106|FG000|Overall Study|Adverse Event|4|||
23813001|NCT03327792|66696107|FG001|Overall Study|Adverse Event|0|||
23813002|NCT03327792|66696106|FG000|Overall Study|Family/Personal issues|3|||
23813003|NCT03327792|66696107|FG001|Overall Study|Family/Personal issues|2|||
23813004|NCT03327792|66696106|FG000|Overall Study|Lost to Follow-up|0|||
23813005|NCT03327792|66696107|FG001|Overall Study|Lost to Follow-up|1|||
23813006|NCT00936897|66696108|FG000|Overall Study|Withdrawal by Subject|9|||
23813007|NCT00936897|66696109|FG001|Overall Study|Withdrawal by Subject|19|||
23813008|NCT00936897|66696108|FG000|Overall Study|Adverse Event|4|||
23813009|NCT00936897|66696109|FG001|Overall Study|Adverse Event|13|||
23813010|NCT00936897|66696108|FG000|Overall Study|Other|3|||
23813011|NCT00936897|66696109|FG001|Overall Study|Other|9|||
23813012|NCT00936897|66696108|FG000|Overall Study|Lost to Follow-up|1|||
23813013|NCT00936897|66696109|FG001|Overall Study|Lost to Follow-up|10|||
23813014|NCT00936897|66696108|FG000|Overall Study|Administrative Decision|1|||
23813015|NCT00936897|66696109|FG001|Overall Study|Administrative Decision|2|||
23813016|NCT00936897|66696108|FG000|Overall Study|Protocol Violation|1|||
23813017|NCT00936897|66696109|FG001|Overall Study|Protocol Violation|1|||
23813018|NCT00936897|66696108|FG000|Overall Study|Ineligibility Determined|0|||
23813019|NCT00936897|66696109|FG001|Overall Study|Ineligibility Determined|3|||
23813020|NCT00936897|66696108|FG000|Overall Study|Noncompliance|0|||
23813021|NCT00936897|66696109|FG001|Overall Study|Noncompliance|2|||
23813022|NCT00936897|66696108|FG000|Overall Study|Death|0|||
23813023|NCT00936897|66696109|FG001|Overall Study|Death|1|||
23813024|NCT02836496|66696111|FG000|Overall Study|Adverse Event|2|||
23813025|NCT02836496|66696112|FG001|Overall Study|Adverse Event|1|||
23813026|NCT02836496|66696111|FG000|Overall Study|Withdrawal by Subject|0|||
23813027|NCT02836496|66696112|FG001|Overall Study|Withdrawal by Subject|1|||
23813028|NCT00140426|66696113|FG000|Overall Study|Withdrawal by Subject|0|||
23813029|NCT00140426|66696114|FG001|Overall Study|Withdrawal by Subject|3|||
23813030|NCT00128830|66696115|FG000|Overall Study|Adverse Event|10|||
23813031|NCT00128830|66696115|FG000|Overall Study|Withdrawal by Subject|14|||
23813032|NCT00128830|66696115|FG000|Overall Study|Lost to Follow-up|4|||
23813033|NCT00128830|66696115|FG000|Overall Study|Reached a virologic endpoint|29|||
23813034|NCT00128830|66696115|FG000|Overall Study|Non-compliant|4|||
23813035|NCT00128830|66696115|FG000|Overall Study|Discontinued or ineligible for study|2|||
23813036|NCT00128830|66696115|FG000|Overall Study|Other|9|||
23813037|NCT02143583|66696120|FG000|Overall Study|Withdrawal by Subject|1|||
23813038|NCT02143583|66696121|FG001|Overall Study|Withdrawal by Subject|0|||
23813039|NCT02143583|66696122|FG002|Overall Study|Withdrawal by Subject|1|||
23813040|NCT02143583|66696120|FG000|Overall Study|husband illness|0|||
23813041|NCT02143583|66696121|FG001|Overall Study|husband illness|0|||
23813042|NCT02143583|66696122|FG002|Overall Study|husband illness|1|||
23418019|NCT03327220|65274499|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
23813043|NCT02910063|66696123|FG000|Phase 2|Withdrawal by Subject|3|||
23813044|NCT02910063|66696124|FG001|Phase 2|Withdrawal by Subject|0|||
23813045|NCT02910063|66696125|FG002|Phase 2|Withdrawal by Subject|0|||
23813046|NCT02910063|66696123|FG000|Phase 2|Lost to Follow-up|1|||
23813047|NCT02910063|66696124|FG001|Phase 2|Lost to Follow-up|0|||
23813048|NCT02910063|66696125|FG002|Phase 2|Lost to Follow-up|0|||
23813049|NCT02910063|66696123|FG000|Phase 2|Death|24|||
23813050|NCT02910063|66696124|FG001|Phase 2|Death|0|||
23418020|NCT03327220|65274500|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
23418021|NCT03327220|65274499|FG000|Overall Study|Fungal infection|1|||
23418022|NCT03327220|65274500|FG001|Overall Study|Fungal infection|0|||
23418023|NCT03327220|65274499|FG000|Overall Study|Discharged to Rehabilitation|0|||
23418024|NCT03327220|65274500|FG001|Overall Study|Discharged to Rehabilitation|1|||
23418025|NCT03327220|65274499|FG000|Overall Study|Missing|1|||
23418026|NCT03327220|65274500|FG001|Overall Study|Missing|0|||
23418027|NCT04437511|65274507|FG000|Overall Study|Adverse Event|50|||
23418028|NCT04437511|65274508|FG001|Overall Study|Adverse Event|21|||
23418029|NCT04437511|65274507|FG000|Overall Study|Death|15|||
23418030|NCT04437511|65274508|FG001|Overall Study|Death|10|||
23418031|NCT04437511|65274507|FG000|Overall Study|Lost to Follow-up|11|||
23418032|NCT04437511|65274508|FG001|Overall Study|Lost to Follow-up|11|||
23418033|NCT04437511|65274507|FG000|Overall Study|Physician Decision|19|||
23418034|NCT04437511|65274508|FG001|Overall Study|Physician Decision|10|||
23418035|NCT04437511|65274507|FG000|Overall Study|Progressive Disease|4|||
23418036|NCT04437511|65274508|FG001|Overall Study|Progressive Disease|7|||
23418037|NCT04437511|65274507|FG000|Overall Study|Withdrawal by Subject|111|||
23418038|NCT04437511|65274508|FG001|Overall Study|Withdrawal by Subject|94|||
23418039|NCT04437511|65274507|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
23418040|NCT04437511|65274508|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
23418041|NCT04437511|65274507|FG000|Overall Study|Continuing Study|7|||
23418042|NCT04437511|65274508|FG001|Overall Study|Continuing Study|5|||
23418043|NCT01960998|65274509|FG000|Overall Study|Lost to Follow-up|3|||
23418044|NCT01960998|65274510|FG001|Overall Study|Lost to Follow-up|7|||
23418045|NCT01960998|65274509|FG000|Overall Study|Death|0|||
23418046|NCT01960998|65274510|FG001|Overall Study|Death|1|||
23418047|NCT01960998|65274509|FG000|Overall Study|Withdrawal by Subject|8|||
23418048|NCT01960998|65274510|FG001|Overall Study|Withdrawal by Subject|2|||
23418049|NCT01960998|65274509|FG000|Overall Study|lost computer access|0|||
23418050|NCT01960998|65274510|FG001|Overall Study|lost computer access|1|||
23418051|NCT04493333|65274511|FG000|Overall Study|Withdrawal by Subject|1|||
23418052|NCT04493333|65274512|FG001|Overall Study|Withdrawal by Subject|1|||
23418053|NCT04493333|65274511|FG000|Overall Study|Ineligible|0|||
23418054|NCT04493333|65274512|FG001|Overall Study|Ineligible|1|||
23418055|NCT04493333|65274511|FG000|Overall Study|Noncompliance|2|||
23418056|NCT04493333|65274512|FG001|Overall Study|Noncompliance|1|||
23418057|NCT02534935|65274514|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
23418058|NCT02534935|65274515|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
23418059|NCT02534935|65274516|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
23418060|NCT02534935|65274514|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
23418061|NCT02534935|65274515|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
23418062|NCT02534935|65274516|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
23418063|NCT02534935|65274514|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
23418064|NCT02534935|65274515|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
23418065|NCT02534935|65274516|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
23418066|NCT02534935|65274514|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
23418067|NCT02534935|65274515|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
23418068|NCT02534935|65274516|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
23418069|NCT02534935|65274514|FG000|Stage 1: 24 Months|Adverse Event|0|||
23418070|NCT02534935|65274515|FG001|Stage 1: 24 Months|Adverse Event|2|||
23418071|NCT02534935|65274516|FG002|Stage 1: 24 Months|Adverse Event|0|||
23418072|NCT02534935|65274514|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
23418073|NCT02534935|65274515|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
23418074|NCT02534935|65274516|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
23418075|NCT02534935|65274514|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
23418076|NCT02534935|65274515|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
23418077|NCT02534935|65274516|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
23418078|NCT00564902|65274517|FG000|Overall Study|Withdrawal by Subject|0|||
23418079|NCT00564902|65274518|FG001|Overall Study|Withdrawal by Subject|3|||
23418080|NCT00564902|65274519|FG002|Overall Study|Withdrawal by Subject|4|||
23418081|NCT00564902|65274517|FG000|Overall Study|Death|1|||
23418082|NCT00564902|65274518|FG001|Overall Study|Death|1|||
23418083|NCT00564902|65274519|FG002|Overall Study|Death|0|||
23418084|NCT03576066|65277140|FG000|Overall Study|Noncompliance with study drug|0|||
23526922|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23611599|NCT01587703|65966830|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
23611600|NCT01587703|65966812|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23526923|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23418085|NCT03576066|65277141|FG001|Overall Study|Noncompliance with study drug|1|||
23418086|NCT00978380|65277142|FG000|Overall Study|Protocol Violation|2|||
23418087|NCT00978380|65277142|FG000|Overall Study|Withdrawal criteria|9|||
23418088|NCT00978380|65277142|FG000|Overall Study|Unclassified|8|||
23418089|NCT02359045|65277145|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
23418090|NCT02359045|65277146|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23418091|NCT02359045|65277145|FG000|Overall Study|Lost to Follow-up|1|||
23418092|NCT02359045|65277146|FG001|Overall Study|Lost to Follow-up|1|||
23418093|NCT02359045|65277145|FG000|Overall Study|Adverse Event|0|||
23418094|NCT02359045|65277146|FG001|Overall Study|Adverse Event|1|||
23418095|NCT03344549|65277149|FG000|Overall Study|Withdrawal by Subject|3|||
23418096|NCT03344549|65277150|FG001|Overall Study|Withdrawal by Subject|2|||
23418097|NCT03344549|65277149|FG000|Overall Study|Dialysis|2|||
23418098|NCT03344549|65277150|FG001|Overall Study|Dialysis|0|||
23418099|NCT03344549|65277149|FG000|Overall Study|Cancer|1|||
23418100|NCT03344549|65277150|FG001|Overall Study|Cancer|0|||
23418101|NCT03344549|65277149|FG000|Overall Study|Lack of electronic device|1|||
23418102|NCT03344549|65277150|FG001|Overall Study|Lack of electronic device|0|||
23418103|NCT03344549|65277149|FG000|Overall Study|Transportation difficulty|0|||
23418104|NCT03344549|65277150|FG001|Overall Study|Transportation difficulty|13|||
23418105|NCT00090233|65277151|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
23418106|NCT00090233|65277152|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
23418107|NCT00090233|65277151|FG000|Overall Study|Adverse Event|214|||
23418108|NCT00090233|65277152|FG001|Overall Study|Adverse Event|198|||
23418109|NCT00090233|65277151|FG000|Overall Study|Lost to Follow-up|68|||
23418110|NCT00090233|65277152|FG001|Overall Study|Lost to Follow-up|95|||
23418111|NCT00090233|65277151|FG000|Overall Study|Protocol Violation|960|||
23418112|NCT00090233|65277152|FG001|Overall Study|Protocol Violation|1022|||
23418113|NCT00090233|65277151|FG000|Overall Study|Withdrawal by Subject|182|||
23418114|NCT00090233|65277152|FG001|Overall Study|Withdrawal by Subject|211|||
23418115|NCT00090233|65277151|FG000|Overall Study|Moved|203|||
23418116|NCT00090233|65277152|FG001|Overall Study|Moved|189|||
23418117|NCT00090233|65277151|FG000|Overall Study|Other|1211|||
23418118|NCT00090233|65277152|FG001|Overall Study|Other|1160|||
23418119|NCT00090233|65277151|FG000|Overall Study|Data not available at data cut-off point|1552|||
23418120|NCT00090233|65277152|FG001|Overall Study|Data not available at data cut-off point|1563|||
23418121|NCT02759107|65277160|FG000|Overall Study|Adverse Event|0|||
23418122|NCT02759107|65277161|FG001|Overall Study|Adverse Event|0|||
23418123|NCT02759107|65277162|FG002|Overall Study|Adverse Event|0|||
23418124|NCT02759107|65277163|FG003|Overall Study|Adverse Event|0|||
23418125|NCT02759107|65277164|FG004|Overall Study|Adverse Event|0|||
23418126|NCT02759107|65277165|FG005|Overall Study|Adverse Event|0|||
23418127|NCT02759107|65277166|FG006|Overall Study|Adverse Event|0|||
23418128|NCT02759107|65277167|FG007|Overall Study|Adverse Event|0|||
23418129|NCT02759107|65277168|FG008|Overall Study|Adverse Event|0|||
23418130|NCT02759107|65277169|FG009|Overall Study|Adverse Event|0|||
23418131|NCT02759107|65277170|FG010|Overall Study|Adverse Event|0|||
23418132|NCT02759107|65277171|FG011|Overall Study|Adverse Event|0|||
23418133|NCT02759107|65277172|FG012|Overall Study|Adverse Event|2|||
23418134|NCT02759107|65277173|FG013|Overall Study|Adverse Event|0|||
23418135|NCT02759107|65277174|FG014|Overall Study|Adverse Event|0|||
23418136|NCT02759107|65277175|FG015|Overall Study|Adverse Event|1|||
23418137|NCT02759107|65277176|FG016|Overall Study|Adverse Event|0|||
23418138|NCT02759107|65277177|FG017|Overall Study|Adverse Event|2|||
23418139|NCT02759107|65277160|FG000|Overall Study|Scheduling Conflict|0|||
23418140|NCT02759107|65277161|FG001|Overall Study|Scheduling Conflict|0|||
23418141|NCT02759107|65277162|FG002|Overall Study|Scheduling Conflict|0|||
23418142|NCT02759107|65277163|FG003|Overall Study|Scheduling Conflict|0|||
23418143|NCT02759107|65277164|FG004|Overall Study|Scheduling Conflict|0|||
23418144|NCT02759107|65277165|FG005|Overall Study|Scheduling Conflict|0|||
23418145|NCT02759107|65277166|FG006|Overall Study|Scheduling Conflict|0|||
23418146|NCT02759107|65277167|FG007|Overall Study|Scheduling Conflict|0|||
23418147|NCT02759107|65277168|FG008|Overall Study|Scheduling Conflict|0|||
23418148|NCT02759107|65277169|FG009|Overall Study|Scheduling Conflict|1|||
23418149|NCT02759107|65277170|FG010|Overall Study|Scheduling Conflict|0|||
23418150|NCT02759107|65277171|FG011|Overall Study|Scheduling Conflict|0|||
23418151|NCT02759107|65277172|FG012|Overall Study|Scheduling Conflict|0|||
23418152|NCT02759107|65277173|FG013|Overall Study|Scheduling Conflict|0|||
23418153|NCT02759107|65277174|FG014|Overall Study|Scheduling Conflict|0|||
23418154|NCT02759107|65277175|FG015|Overall Study|Scheduling Conflict|0|||
23418155|NCT02759107|65277176|FG016|Overall Study|Scheduling Conflict|0|||
23418156|NCT02759107|65277177|FG017|Overall Study|Scheduling Conflict|0|||
23418157|NCT00772369|65277184|FG000|Overall Study|Did not return record release form|1|||
23418158|NCT04795167|65277190|FG000|Overall Study|Death|1|||
23418159|NCT04795167|65277191|FG001|Overall Study|Death|18|||
23418160|NCT04795167|65277192|FG002|Overall Study|Death|1|||
23418161|NCT04795167|65277190|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
23526924|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23418162|NCT04795167|65277191|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
23418163|NCT04795167|65277192|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
23418164|NCT00759356|65277194|FG000|Overall Study|Adverse Event|0|||
23418165|NCT00759356|65277195|FG001|Overall Study|Adverse Event|1|||
23418166|NCT00759356|65277194|FG000|Overall Study|Withdrawal by Subject|0|||
23418167|NCT00759356|65277195|FG001|Overall Study|Withdrawal by Subject|2|||
23418168|NCT00759356|65277194|FG000|Overall Study|Subject was unable to return|1|||
23418169|NCT00759356|65277195|FG001|Overall Study|Subject was unable to return|0|||
23418170|NCT01257230|65277198|FG000|Overall Study|Not Treated|0|||
23418171|NCT01257230|65277199|FG001|Overall Study|Not Treated|0|||
23418172|NCT01257230|65277200|FG002|Overall Study|Not Treated|1|||
23418173|NCT01257230|65277198|FG000|Overall Study|Adverse Event|2|||
23526925|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526926|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526927|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526928|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526929|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526930|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526931|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526932|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526933|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526934|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526935|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526936|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611601|NCT01587703|65966813|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611602|NCT01587703|65966814|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611603|NCT01587703|65966815|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611604|NCT01587703|65966816|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611605|NCT01587703|65966817|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611606|NCT01587703|65966818|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23526937|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
23526938|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526939|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611607|NCT01587703|65966819|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611608|NCT01587703|65966820|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611609|NCT01587703|65966821|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611610|NCT01587703|65966822|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611611|NCT01587703|65966823|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611612|NCT01587703|65966824|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611613|NCT01587703|65966825|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611614|NCT01587703|65966826|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611615|NCT01587703|65966827|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611616|NCT01587703|65966828|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611617|NCT01587703|65966829|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
23611618|NCT01587703|65966830|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
23611619|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611620|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611621|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611622|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611623|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611624|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611625|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611626|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611627|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611628|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611629|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611630|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611631|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611632|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611633|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611634|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
23611635|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611636|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611637|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23418174|NCT01257230|65277199|FG001|Overall Study|Adverse Event|0|||
23526940|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526941|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526942|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526943|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526944|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23813051|NCT02910063|66696125|FG002|Phase 2|Death|0|||
23418175|NCT01257230|65277200|FG002|Overall Study|Adverse Event|0|||
23611638|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611639|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611640|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611641|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611642|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611643|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611644|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611645|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611646|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611647|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611648|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611649|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
23611650|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611651|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611652|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
23611653|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611654|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611655|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611656|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611657|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611658|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611659|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611660|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611661|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611662|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611663|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611664|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611665|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611666|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611667|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611668|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
23611669|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
23611670|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
23611671|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
23611672|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
23611673|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
23611674|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611675|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611676|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611677|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611678|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611679|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611680|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611681|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
23813052|NCT02628743|66696129|FG000|Overall Study|Other|3|||
23813053|NCT02628743|66696129|FG000|Overall Study|Withdrawal by Subject|50|||
23813054|NCT02628743|66696129|FG000|Overall Study|Study Terminated by Sponsor|76|||
23813055|NCT02628743|66696129|FG000|Overall Study|Physician Decision|2|||
23813056|NCT04844762|66696131|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813057|NCT04844762|66696132|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813058|NCT04844762|66696133|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
23611682|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611683|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611684|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611685|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611686|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611687|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
23611688|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
23611689|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
23611690|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
23611691|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
23813059|NCT04844762|66696134|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23611692|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
23611693|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611694|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611695|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23813060|NCT04844762|66696135|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813061|NCT04844762|66696136|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813062|NCT04844762|66696131|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23611696|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611697|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611698|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611699|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611700|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611701|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611702|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611703|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611704|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611705|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611706|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
23611707|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611708|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611709|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611710|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611711|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611712|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611713|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611714|NCT02316171|65966831|FG000|Overall Study|difficulties with urinary catheter|1|||
23611715|NCT02316171|65966832|FG001|Overall Study|difficulties with urinary catheter|0|||
23611716|NCT02316171|65966833|FG002|Overall Study|difficulties with urinary catheter|0|||
23611717|NCT02316171|65966834|FG003|Overall Study|difficulties with urinary catheter|0|||
23611718|NCT05287178|65966835|FG000|Overall Study|Lost to Follow-up|2|||
23611719|NCT02389894|65966836|FG000|Overall Study|Death|4|||
23611720|NCT02389894|65966837|FG001|Overall Study|Death|5|||
23611721|NCT02389894|65966838|FG002|Overall Study|Death|3|||
23611722|NCT02389894|65966836|FG000|Overall Study|Withdrawal by Subject|2|||
23611723|NCT02389894|65966837|FG001|Overall Study|Withdrawal by Subject|4|||
23611724|NCT02389894|65966838|FG002|Overall Study|Withdrawal by Subject|5|||
23611725|NCT02389894|65966836|FG000|Overall Study|Lost to Follow-up|2|||
23611726|NCT02389894|65966837|FG001|Overall Study|Lost to Follow-up|1|||
23611727|NCT02389894|65966838|FG002|Overall Study|Lost to Follow-up|1|||
23611728|NCT03686176|65966840|FG000|Overall Study|Procedure cancelled|1|||
23716620|NCT00205699|66336986|FG002|Overall Study|Withdrawal by Subject|1|||
23716621|NCT00205699|66336984|FG000|Overall Study|Lack of Efficacy|0|||
23716622|NCT00205699|66336985|FG001|Overall Study|Lack of Efficacy|1|||
23716623|NCT00205699|66336986|FG002|Overall Study|Lack of Efficacy|0|||
23716624|NCT01116687|66336990|FG000|Overall Study|Withdrawal by Subject|4|||
23716625|NCT02565615|66336991|FG000|Overall Study|Death|0|||
23716626|NCT02565615|66336992|FG001|Overall Study|Death|1|||
23716627|NCT02565615|66336993|FG002|Overall Study|Death|0|||
23716628|NCT02565615|66336994|FG003|Overall Study|Death|0|||
23716629|NCT02565615|66336995|FG004|Overall Study|Death|4|||
23716630|NCT02565615|66336991|FG000|Overall Study|Not willing to participate in study|2|||
23716631|NCT02565615|66336992|FG001|Overall Study|Not willing to participate in study|21|||
23716632|NCT02565615|66336993|FG002|Overall Study|Not willing to participate in study|0|||
23716633|NCT02565615|66336994|FG003|Overall Study|Not willing to participate in study|1|||
23716634|NCT02565615|66336995|FG004|Overall Study|Not willing to participate in study|169|||
23716635|NCT02565615|66336991|FG000|Overall Study|Lost to Follow-up|0|||
23716636|NCT02565615|66336992|FG001|Overall Study|Lost to Follow-up|4|||
23716637|NCT02565615|66336993|FG002|Overall Study|Lost to Follow-up|0|||
23716638|NCT02565615|66336994|FG003|Overall Study|Lost to Follow-up|1|||
23716639|NCT02565615|66336995|FG004|Overall Study|Lost to Follow-up|765|||
23716640|NCT02565615|66336991|FG000|Overall Study|Not meeting eligibility criteria|0|||
23716641|NCT02565615|66336992|FG001|Overall Study|Not meeting eligibility criteria|7|||
23716642|NCT02565615|66336993|FG002|Overall Study|Not meeting eligibility criteria|0|||
23716643|NCT02565615|66336994|FG003|Overall Study|Not meeting eligibility criteria|0|||
23716644|NCT02565615|66336995|FG004|Overall Study|Not meeting eligibility criteria|25|||
23716645|NCT02565615|66336991|FG000|Overall Study|Reason not defined|0|||
23716646|NCT02565615|66336992|FG001|Overall Study|Reason not defined|2|||
23716647|NCT02565615|66336993|FG002|Overall Study|Reason not defined|0|||
23716648|NCT02565615|66336994|FG003|Overall Study|Reason not defined|1|||
23716649|NCT02565615|66336995|FG004|Overall Study|Reason not defined|62|||
23716650|NCT02565615|66336991|FG000|Overall Study|Adverse Event|1|||
23611729|NCT03686176|65966841|FG001|Overall Study|Procedure cancelled|0|||
23611730|NCT03686176|65966842|FG002|Overall Study|Procedure cancelled|0|||
23716651|NCT02565615|66336992|FG001|Overall Study|Adverse Event|1|||
23716652|NCT02565615|66336993|FG002|Overall Study|Adverse Event|0|||
23716653|NCT02565615|66336994|FG003|Overall Study|Adverse Event|0|||
23716654|NCT02565615|66336995|FG004|Overall Study|Adverse Event|9|||
23716655|NCT02565615|66336991|FG000|Overall Study|Untreated|0|||
23716656|NCT02565615|66336992|FG001|Overall Study|Untreated|0|||
23716657|NCT02565615|66336993|FG002|Overall Study|Untreated|0|||
23716658|NCT02565615|66336994|FG003|Overall Study|Untreated|0|||
23716659|NCT02565615|66336995|FG004|Overall Study|Untreated|567|||
23716660|NCT00844285|66336996|FG000|Overall Study|Other|0|||
23716661|NCT00844285|66336997|FG001|Overall Study|Other|1|||
23716662|NCT00844285|66336998|FG002|Overall Study|Other|0|||
23716663|NCT00844285|66336996|FG000|Overall Study|Other than specified|95|||
23526945|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526946|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526947|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526948|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526949|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526950|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526951|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23716664|NCT00844285|66336997|FG001|Overall Study|Other than specified|129|||
23716665|NCT00844285|66336998|FG002|Overall Study|Other than specified|12|||
23716666|NCT00844285|66336996|FG000|Overall Study|Site closure|256|||
23716667|NCT00844285|66336997|FG001|Overall Study|Site closure|450|||
23611731|NCT03686176|65966840|FG000|Overall Study|VR Malfunction|1|||
23611732|NCT03686176|65966841|FG001|Overall Study|VR Malfunction|0|||
23611733|NCT03686176|65966842|FG002|Overall Study|VR Malfunction|0|||
23611734|NCT00670449|65966843|FG000|Overall Study|Adverse Event|6|||
23611735|NCT00670449|65966844|FG001|Overall Study|Adverse Event|2|||
23611736|NCT00670449|65966845|FG002|Overall Study|Adverse Event|8|||
23611737|NCT00670449|65966846|FG003|Overall Study|Adverse Event|5|||
23611738|NCT00670449|65966843|FG000|Overall Study|Protocol Deviation|1|||
23611739|NCT00670449|65966844|FG001|Overall Study|Protocol Deviation|2|||
23611740|NCT00670449|65966845|FG002|Overall Study|Protocol Deviation|0|||
23611741|NCT00670449|65966846|FG003|Overall Study|Protocol Deviation|1|||
23611742|NCT00670449|65966843|FG000|Overall Study|Administrative Problems|0|||
23716668|NCT00844285|66336998|FG002|Overall Study|Site closure|50|||
23716669|NCT00844285|66336996|FG000|Overall Study|Follow-up < 8 years|16|||
23716670|NCT00844285|66336997|FG001|Overall Study|Follow-up < 8 years|23|||
23716671|NCT00844285|66336998|FG002|Overall Study|Follow-up < 8 years|4|||
23716672|NCT00844285|66336996|FG000|Overall Study|Protocol Violation|26|||
23716673|NCT00844285|66336997|FG001|Overall Study|Protocol Violation|28|||
23716674|NCT00844285|66336998|FG002|Overall Study|Protocol Violation|54|||
23716675|NCT00844285|66336996|FG000|Overall Study|Death|22|||
23716676|NCT00844285|66336997|FG001|Overall Study|Death|21|||
23716677|NCT00844285|66336998|FG002|Overall Study|Death|8|||
23418176|NCT01257230|65277198|FG000|Overall Study|Lack of Efficacy|0|||
23716678|NCT00844285|66336996|FG000|Overall Study|Withdrew Consent|344|||
23716679|NCT00844285|66336997|FG001|Overall Study|Withdrew Consent|466|||
23418177|NCT01257230|65277199|FG001|Overall Study|Lack of Efficacy|1|||
23418178|NCT01257230|65277200|FG002|Overall Study|Lack of Efficacy|0|||
23716680|NCT00844285|66336998|FG002|Overall Study|Withdrew Consent|70|||
23716681|NCT00844285|66336996|FG000|Overall Study|Lost to Follow-up|330|||
23418179|NCT01257230|65277198|FG000|Overall Study|Protocol Violation|3|||
23418180|NCT01257230|65277199|FG001|Overall Study|Protocol Violation|0|||
23418181|NCT01257230|65277200|FG002|Overall Study|Protocol Violation|1|||
23418182|NCT01257230|65277198|FG000|Overall Study|Withdrawal by Subject|0|||
23418183|NCT01257230|65277199|FG001|Overall Study|Withdrawal by Subject|4|||
23418184|NCT01257230|65277200|FG002|Overall Study|Withdrawal by Subject|1|||
23418185|NCT01257230|65277198|FG000|Overall Study|Other reason not defined above|1|||
23418186|NCT01257230|65277199|FG001|Overall Study|Other reason not defined above|5|||
23418187|NCT01257230|65277200|FG002|Overall Study|Other reason not defined above|3|||
23418188|NCT00459875|65277201|FG000|Overall Study|Ineligible participant|1|||
23418189|NCT00459875|65277201|FG000|Overall Study|Adverse Event|2|||
23418190|NCT02589665|65277202|FG000|Induction Period|Did not receive drug|0|||
23418191|NCT02589665|65277203|FG001|Induction Period|Did not receive drug|0|||
23418192|NCT02589665|65277204|FG002|Induction Period|Did not receive drug|0|||
23418193|NCT02589665|65277205|FG003|Induction Period|Did not receive drug|1|||
23526952|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611743|NCT00670449|65966844|FG001|Overall Study|Administrative Problems|2|||
23611744|NCT00670449|65966845|FG002|Overall Study|Administrative Problems|0|||
23611745|NCT00670449|65966846|FG003|Overall Study|Administrative Problems|1|||
23611746|NCT00670449|65966843|FG000|Overall Study|Subject Withdrew Consent|0|||
23716682|NCT00844285|66336997|FG001|Overall Study|Lost to Follow-up|486|||
23418194|NCT02589665|65277206|FG004|Induction Period|Did not receive drug|0|||
23418195|NCT02589665|65277207|FG005|Induction Period|Did not receive drug|0|||
23418196|NCT02589665|65277208|FG006|Induction Period|Did not receive drug|0|||
23418197|NCT02589665|65277209|FG007|Induction Period|Did not receive drug|0|||
23716683|NCT00844285|66336998|FG002|Overall Study|Lost to Follow-up|74|||
23716684|NCT01088438|66337005|FG000|Overall Study|Withdrawal by Subject|11|||
23716685|NCT01088438|66337006|FG001|Overall Study|Withdrawal by Subject|6|||
23716686|NCT01088438|66337005|FG000|Overall Study|Lost to Follow-up|18|||
23716687|NCT01088438|66337006|FG001|Overall Study|Lost to Follow-up|30|||
23418198|NCT02589665|65277210|FG008|Induction Period|Did not receive drug|0|||
23716688|NCT02219087|66337007|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
23526953|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526954|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526955|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526956|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526957|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526958|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526959|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526960|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526961|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
23526962|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526963|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526964|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526965|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526966|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526967|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526968|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526969|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526970|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526971|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526972|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526973|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526974|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526975|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526976|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526977|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526978|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526979|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526980|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526981|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526982|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526983|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526984|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
23526985|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
23526986|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
23526987|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
23526988|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526989|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526990|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526991|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526992|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526993|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526994|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526995|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526996|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526997|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526998|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526999|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527000|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527001|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527002|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527003|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527004|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527005|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527006|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527007|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527008|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
23527009|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
23527010|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
23527011|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
23527012|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527013|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527014|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527015|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527016|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527017|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527018|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527019|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527020|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527021|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527022|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527023|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527024|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527025|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527026|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527027|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527028|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527029|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527030|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527031|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527032|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527033|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
23527034|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527035|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
23527036|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527037|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527038|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527039|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527040|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527041|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527042|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527043|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527044|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527045|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527046|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527047|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527048|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527049|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527050|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527051|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527052|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527053|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527054|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527055|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527056|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527057|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527058|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
23527059|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527060|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527061|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527062|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527063|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527064|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527065|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527066|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527067|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527068|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527069|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527070|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527071|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527072|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527073|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527074|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527075|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527076|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527077|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527078|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527079|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527080|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527081|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527082|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527083|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527084|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527085|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527086|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527087|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527088|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23527089|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527090|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527091|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527092|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527093|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527094|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
23527095|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527096|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23527097|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527098|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527099|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527100|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527101|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527102|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527103|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527104|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23716689|NCT02219087|66337008|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
23716690|NCT01167582|66337009|FG000|Overall Study|Lost to Follow-up|0|||
23716691|NCT01167582|66337010|FG001|Overall Study|Lost to Follow-up|1|||
23716692|NCT00599027|66337015|FG000|Overall Study|Withdrawal by Subject|1|||
23716693|NCT00599027|66337016|FG001|Overall Study|Withdrawal by Subject|1|||
23716694|NCT00599027|66337015|FG000|Overall Study|Adverse Event|0|||
23716695|NCT00599027|66337016|FG001|Overall Study|Adverse Event|1|||
23716696|NCT00599027|66337015|FG000|Overall Study|Treatment Failure|0|||
23716697|NCT00599027|66337016|FG001|Overall Study|Treatment Failure|1|||
23527105|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527106|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527107|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23716698|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23716699|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23716700|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
23716701|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
23716702|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23716703|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23716704|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
23716705|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
23716706|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
23716707|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23716708|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23716709|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23716710|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
23813063|NCT04844762|66696132|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23813064|NCT04844762|66696133|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23813065|NCT04844762|66696134|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23527108|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527109|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23716711|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
23716712|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
23716713|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23716714|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23813066|NCT04844762|66696135|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23813067|NCT04844762|66696136|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23527110|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527111|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527112|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527113|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527114|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527115|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527116|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527117|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23527118|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527119|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
23527120|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527121|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527122|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527123|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527124|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527125|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527126|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527127|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527128|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527129|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527130|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527131|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527132|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527133|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527134|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527135|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527136|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527137|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527138|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527139|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527140|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527141|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527142|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
23527143|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527144|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527145|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527146|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527147|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527148|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527149|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527150|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527151|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527152|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527153|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527154|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527155|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527156|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527157|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527158|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527159|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527160|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527161|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527162|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527163|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23527164|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23611747|NCT00670449|65966844|FG001|Overall Study|Subject Withdrew Consent|2|||
23611748|NCT00670449|65966845|FG002|Overall Study|Subject Withdrew Consent|0|||
23611749|NCT00670449|65966846|FG003|Overall Study|Subject Withdrew Consent|1|||
23813068|NCT04844762|66696131|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813069|NCT04844762|66696132|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813070|NCT04844762|66696133|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23813071|NCT04844762|66696134|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
23813072|NCT04844762|66696135|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23527165|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23611750|NCT00670449|65966843|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
23611751|NCT00670449|65966844|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23611752|NCT00670449|65966845|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23611753|NCT00670449|65966846|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23611754|NCT00670449|65966843|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23611755|NCT00670449|65966844|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
23611756|NCT00670449|65966845|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23611757|NCT00670449|65966846|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23611758|NCT00379210|65966847|FG000|Overall Study|Withdrawal by Subject|10|||
23611759|NCT00379210|65966848|FG001|Overall Study|Withdrawal by Subject|7|||
23527166|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
23527167|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23527168|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527169|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527170|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527171|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527172|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527173|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527174|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527175|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527176|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527177|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527178|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527179|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527180|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527181|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527182|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527183|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527184|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527185|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527186|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527187|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527188|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527189|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
23527190|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
23527191|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
23527192|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
23527193|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527194|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527195|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527196|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527197|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527198|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527199|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527200|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527201|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527202|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527203|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527204|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527205|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527206|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
23527207|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527208|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527209|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527210|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527211|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527212|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527213|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527214|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527215|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527216|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527217|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23611760|NCT01375777|65966850|FG000|Overall Study|Withdrawal by Subject|0|||
23611761|NCT01375777|65966851|FG001|Overall Study|Withdrawal by Subject|2|||
23527218|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527219|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527220|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527221|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527222|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527223|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527224|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527225|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23716715|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23716716|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
23716717|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
23716718|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23716719|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23716720|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23716721|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23716722|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
23716723|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
23716724|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23716725|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23716726|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23527226|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527227|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527228|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527229|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527230|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527231|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527232|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527233|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527234|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23716727|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23716728|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
23716729|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23716730|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23716731|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23716732|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23716733|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23716734|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
23716735|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
23716736|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
23716737|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
23716738|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
23716739|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
23716740|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
23716741|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
23716742|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23716743|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23716744|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23716745|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23716746|NCT03444870|66337017|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
23716747|NCT03444870|66337018|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23716748|NCT03444870|66337019|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23716749|NCT03444870|66337020|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23716750|NCT03444870|66337021|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23716751|NCT03444870|66337022|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23716752|NCT03444870|66337017|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23716753|NCT03444870|66337018|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23716754|NCT03444870|66337019|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23716755|NCT03444870|66337020|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23716756|NCT03444870|66337021|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
23716757|NCT03444870|66337022|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
23716758|NCT03444870|66337017|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
23813073|NCT04844762|66696136|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23716759|NCT03444870|66337018|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
23716760|NCT03444870|66337019|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
23716761|NCT03444870|66337020|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
23716762|NCT03444870|66337021|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
23716763|NCT03444870|66337022|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
23716764|NCT03444870|66337017|FG000|Open-Label Extension (OLE) Period|Death|0|||
23716765|NCT03444870|66337018|FG001|Open-Label Extension (OLE) Period|Death|0|||
23716766|NCT03444870|66337019|FG002|Open-Label Extension (OLE) Period|Death|0|||
23716767|NCT03444870|66337020|FG003|Open-Label Extension (OLE) Period|Death|0|||
23716768|NCT03444870|66337021|FG004|Open-Label Extension (OLE) Period|Death|1|||
23716769|NCT03444870|66337022|FG005|Open-Label Extension (OLE) Period|Death|0|||
23716770|NCT03404518|66337023|FG000|Overall Study|Lost to Follow-up|28|||
23716771|NCT03404518|66337024|FG001|Overall Study|Lost to Follow-up|30|||
23716772|NCT03404518|66337023|FG000|Overall Study|Protocol Violation|13|||
23716773|NCT03404518|66337024|FG001|Overall Study|Protocol Violation|6|||
23716774|NCT04900038|66337025|FG000|Overall Study|Adverse Event|1|||
23716775|NCT04900038|66337026|FG001|Overall Study|Adverse Event|0|||
23716776|NCT04900038|66337027|FG002|Overall Study|Adverse Event|1|||
23527235|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527236|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23716777|NCT04900038|66337028|FG003|Overall Study|Adverse Event|1|||
23716778|NCT04900038|66337025|FG000|Overall Study|Withdrawal by Subject|0|||
23716779|NCT04900038|66337026|FG001|Overall Study|Withdrawal by Subject|1|||
23716780|NCT04900038|66337027|FG002|Overall Study|Withdrawal by Subject|0|||
23716781|NCT04900038|66337028|FG003|Overall Study|Withdrawal by Subject|0|||
23716782|NCT04900038|66337025|FG000|Overall Study|Study terminated by sponsor|18|||
23527237|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23716783|NCT04900038|66337026|FG001|Overall Study|Study terminated by sponsor|15|||
23716784|NCT04900038|66337027|FG002|Overall Study|Study terminated by sponsor|17|||
23716785|NCT04900038|66337028|FG003|Overall Study|Study terminated by sponsor|14|||
23716786|NCT04900038|66337025|FG000|Overall Study|Protocol Deviation|1|||
23716787|NCT04900038|66337026|FG001|Overall Study|Protocol Deviation|1|||
23716788|NCT04900038|66337027|FG002|Overall Study|Protocol Deviation|0|||
23716789|NCT04900038|66337028|FG003|Overall Study|Protocol Deviation|0|||
23527238|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527239|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527240|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527241|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527242|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527243|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527244|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527245|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527246|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527247|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527248|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527249|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527250|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527251|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527252|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527253|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527254|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527255|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527256|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527257|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
23527258|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527259|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527260|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23611762|NCT01375777|65966852|FG002|Overall Study|Withdrawal by Subject|1|||
23611763|NCT01375777|65966853|FG003|Overall Study|Withdrawal by Subject|0|||
23611764|NCT01375777|65966854|FG004|Overall Study|Withdrawal by Subject|1|||
23611765|NCT01375777|65966855|FG005|Overall Study|Withdrawal by Subject|1|||
23611766|NCT01375777|65966856|FG006|Overall Study|Withdrawal by Subject|1|||
23716790|NCT04900038|66337025|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
23716791|NCT04900038|66337026|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
23716792|NCT04900038|66337027|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
23716793|NCT04900038|66337028|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
23716794|NCT04900038|66337025|FG000|Overall Study|Lost to Follow-up|0|||
23611767|NCT01375777|65966857|FG007|Overall Study|Withdrawal by Subject|2|||
23611768|NCT01375777|65966858|FG008|Overall Study|Withdrawal by Subject|1|||
23611769|NCT01375777|65966850|FG000|Overall Study|Lost to Follow-up|1|||
23611770|NCT01375777|65966851|FG001|Overall Study|Lost to Follow-up|0|||
23611771|NCT01375777|65966852|FG002|Overall Study|Lost to Follow-up|0|||
23611772|NCT01375777|65966853|FG003|Overall Study|Lost to Follow-up|0|||
23611773|NCT01375777|65966854|FG004|Overall Study|Lost to Follow-up|0|||
23611774|NCT01375777|65966855|FG005|Overall Study|Lost to Follow-up|0|||
23611775|NCT01375777|65966856|FG006|Overall Study|Lost to Follow-up|1|||
23611776|NCT01375777|65966857|FG007|Overall Study|Lost to Follow-up|0|||
23611777|NCT01375777|65966858|FG008|Overall Study|Lost to Follow-up|0|||
23611778|NCT01375777|65966850|FG000|Overall Study|Other|1|||
23611779|NCT01375777|65966851|FG001|Overall Study|Other|1|||
23611780|NCT01375777|65966852|FG002|Overall Study|Other|0|||
23611781|NCT01375777|65966853|FG003|Overall Study|Other|0|||
23611782|NCT01375777|65966854|FG004|Overall Study|Other|0|||
23611783|NCT01375777|65966855|FG005|Overall Study|Other|0|||
23611784|NCT01375777|65966856|FG006|Overall Study|Other|0|||
23611785|NCT01375777|65966857|FG007|Overall Study|Other|0|||
23611786|NCT01375777|65966858|FG008|Overall Study|Other|1|||
23611787|NCT04783389|65966859|FG000|Overall Study|Withdrawal by Subject|2|||
23611788|NCT04783389|65966860|FG001|Overall Study|Withdrawal by Subject|0|||
23611789|NCT04783389|65966861|FG002|Overall Study|Withdrawal by Subject|0|||
23611790|NCT04783389|65966859|FG000|Overall Study|Termination of Study by Sponsor|10|||
23611791|NCT04783389|65966860|FG001|Overall Study|Termination of Study by Sponsor|12|||
23611792|NCT04783389|65966861|FG002|Overall Study|Termination of Study by Sponsor|14|||
23611793|NCT00274287|65966867|FG000|Overall Study|Withdrawal by Subject|1|||
23527261|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527262|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527263|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527264|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527265|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527266|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527267|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527268|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527269|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527270|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527271|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527272|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527273|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527274|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527275|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527276|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527277|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527278|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527279|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527280|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527281|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527282|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
23527283|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527284|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527285|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23611794|NCT00274287|65966867|FG000|Overall Study|subject non-compliance|1|||
23611795|NCT03694210|65966876|FG000|Overall Study|Death|1|||
23611796|NCT03694210|65966876|FG000|Overall Study|Screen Failure|7|||
23611797|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
23611798|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
23611799|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
23611800|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
23611801|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
23611802|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
23611803|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
23611804|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
23611805|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Death|3|||
23611806|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
23611807|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
23611808|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
23611809|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
23716795|NCT04900038|66337026|FG001|Overall Study|Lost to Follow-up|0|||
23611810|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|other|3|||
23611811|NCT04421456|65966878|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
23611812|NCT04421456|65966879|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
23611813|NCT04421456|65966880|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
23611814|NCT04421456|65966878|FG000|Randomized Treatment Period|Adverse Event|0|||
23611815|NCT04421456|65966879|FG001|Randomized Treatment Period|Adverse Event|1|||
23611816|NCT04421456|65966880|FG002|Randomized Treatment Period|Adverse Event|0|||
23611817|NCT04421456|65966878|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
23611818|NCT04421456|65966879|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
23611819|NCT04421456|65966880|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
23611820|NCT04421456|65966878|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
23611821|NCT04421456|65966879|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
23611822|NCT04421456|65966880|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
23611823|NCT04421456|65966878|FG000|Randomized Treatment Period|Participant non-compliance|1|||
23611824|NCT04421456|65966879|FG001|Randomized Treatment Period|Participant non-compliance|1|||
23611825|NCT04421456|65966880|FG002|Randomized Treatment Period|Participant non-compliance|2|||
23611826|NCT04421456|65966878|FG000|Randomized Treatment Period|Other|0|||
23611827|NCT04421456|65966879|FG001|Randomized Treatment Period|Other|1|||
23611828|NCT04421456|65966880|FG002|Randomized Treatment Period|Other|3|||
23716796|NCT04900038|66337027|FG002|Overall Study|Lost to Follow-up|0|||
23716797|NCT04900038|66337028|FG003|Overall Study|Lost to Follow-up|1|||
23716798|NCT00795509|66337031|FG000|Overall Study|Protocol Violation|31|||
23716799|NCT00318565|66337032|FG000|Overall Study|Excluded per protocol|24|||
23527286|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527287|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527288|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527289|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527290|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527291|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527292|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527293|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527294|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527295|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527296|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527297|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527298|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527299|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527300|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527301|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527302|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527303|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527304|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527305|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527306|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527307|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527308|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527309|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527310|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
23527311|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527312|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527313|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527314|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527315|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527316|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527317|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527318|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527319|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527320|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527321|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527322|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23611829|NCT04271254|65966881|FG000|Overall Study|Withdrawal by Subject|3|||
23611830|NCT01123356|65966882|FG000|Overall Study|Adverse Event|2|||
23527323|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527324|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527325|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527326|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527327|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527328|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527329|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527330|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527331|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527332|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527333|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527334|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
23527335|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527336|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527337|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527338|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527339|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527340|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527341|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527342|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527343|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527344|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527345|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527346|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527347|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527348|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527349|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527350|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527351|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527352|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527353|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527354|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527355|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527356|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527357|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527358|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
23527359|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527360|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527361|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527362|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527363|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527364|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527365|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527366|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527367|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527368|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527369|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527370|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527371|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527372|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527373|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527374|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527375|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527376|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527377|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527378|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527379|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23418199|NCT02589665|65277211|FG009|Induction Period|Did not receive drug|0|||
23418200|NCT02589665|65277202|FG000|Induction Period|Adverse Event|3|||
23418201|NCT02589665|65277203|FG001|Induction Period|Adverse Event|0|||
23611831|NCT01123356|65966882|FG000|Overall Study|Lack of Efficacy|4|||
23611832|NCT01123356|65966882|FG000|Overall Study|Withdrawal by Subject|1|||
23611833|NCT04474691|65966883|FG000|Overall Study|Withdrawal by Subject|9|||
23611834|NCT02291861|65966886|FG000|Overall Study|Adverse Event|2|||
23611835|NCT02291861|65966887|FG001|Overall Study|Adverse Event|4|||
23611836|NCT02291861|65966888|FG002|Overall Study|Adverse Event|1|||
23611837|NCT02291861|65966889|FG003|Overall Study|Adverse Event|2|||
23611838|NCT02291861|65966886|FG000|Overall Study|Death|0|||
23611839|NCT02291861|65966887|FG001|Overall Study|Death|0|||
23611840|NCT02291861|65966888|FG002|Overall Study|Death|1|||
23611841|NCT02291861|65966889|FG003|Overall Study|Death|1|||
23611842|NCT02291861|65966886|FG000|Overall Study|Protocol Violation|1|||
23611843|NCT02291861|65966887|FG001|Overall Study|Protocol Violation|0|||
23611844|NCT02291861|65966888|FG002|Overall Study|Protocol Violation|0|||
23611845|NCT02291861|65966889|FG003|Overall Study|Protocol Violation|1|||
23611846|NCT02291861|65966886|FG000|Overall Study|Withdrawal by Subject|1|||
23611847|NCT02291861|65966887|FG001|Overall Study|Withdrawal by Subject|2|||
23611848|NCT02291861|65966888|FG002|Overall Study|Withdrawal by Subject|1|||
23611849|NCT02291861|65966889|FG003|Overall Study|Withdrawal by Subject|4|||
23611850|NCT02291861|65966886|FG000|Overall Study|Noncompliance|1|||
23611851|NCT02291861|65966887|FG001|Overall Study|Noncompliance|1|||
23611852|NCT02291861|65966888|FG002|Overall Study|Noncompliance|2|||
23611853|NCT02291861|65966889|FG003|Overall Study|Noncompliance|1|||
23611854|NCT02291861|65966886|FG000|Overall Study|Lost to Follow-up|2|||
23611855|NCT02291861|65966887|FG001|Overall Study|Lost to Follow-up|1|||
23611856|NCT02291861|65966888|FG002|Overall Study|Lost to Follow-up|4|||
23611857|NCT02291861|65966889|FG003|Overall Study|Lost to Follow-up|0|||
23611858|NCT02291861|65966886|FG000|Overall Study|Other|0|||
23611859|NCT02291861|65966887|FG001|Overall Study|Other|0|||
23611860|NCT02291861|65966888|FG002|Overall Study|Other|0|||
23611861|NCT02291861|65966889|FG003|Overall Study|Other|1|||
23611862|NCT02942771|65966892|FG000|Overall Study|Adverse Event|1|||
23611863|NCT02942771|65966893|FG001|Overall Study|Adverse Event|0|||
23611864|NCT02942771|65966894|FG002|Overall Study|Adverse Event|0|||
23611865|NCT02942771|65966895|FG003|Overall Study|Adverse Event|0|||
23611866|NCT02942771|65966896|FG004|Overall Study|Adverse Event|2|||
23611867|NCT02942771|65966892|FG000|Overall Study|Lost to Follow-up|1|||
23611868|NCT02942771|65966893|FG001|Overall Study|Lost to Follow-up|0|||
23611869|NCT02942771|65966894|FG002|Overall Study|Lost to Follow-up|0|||
23611870|NCT02942771|65966895|FG003|Overall Study|Lost to Follow-up|0|||
23611871|NCT02942771|65966896|FG004|Overall Study|Lost to Follow-up|0|||
23813074|NCT04844762|66696131|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813075|NCT04844762|66696132|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813076|NCT04844762|66696133|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23813077|NCT04844762|66696134|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23611872|NCT02942771|65966892|FG000|Overall Study|Withdrawal by Subject|1|||
23611873|NCT02942771|65966893|FG001|Overall Study|Withdrawal by Subject|0|||
23611874|NCT02942771|65966894|FG002|Overall Study|Withdrawal by Subject|0|||
23611875|NCT02942771|65966895|FG003|Overall Study|Withdrawal by Subject|0|||
23611876|NCT02942771|65966896|FG004|Overall Study|Withdrawal by Subject|2|||
23716800|NCT04511819|66337033|FG000|Overall Study|Non-compliance with study drug|5|||
23716801|NCT04511819|66337034|FG001|Overall Study|Non-compliance with study drug|1|||
23716802|NCT04511819|66337033|FG000|Overall Study|Withdrawal by Subject|0|||
23716803|NCT04511819|66337034|FG001|Overall Study|Withdrawal by Subject|3|||
23716804|NCT04511819|66337033|FG000|Overall Study|Adverse Event|0|||
23716805|NCT04511819|66337034|FG001|Overall Study|Adverse Event|1|||
23716806|NCT04511819|66337033|FG000|Overall Study|Protocol deviation|1|||
23716807|NCT04511819|66337034|FG001|Overall Study|Protocol deviation|0|||
23716808|NCT00363051|66337035|FG000|Overall Study|Adminstrative problems|1|||
23716809|NCT00363051|66337036|FG001|Overall Study|Adminstrative problems|1|||
23716810|NCT00363051|66337035|FG000|Overall Study|Adverse Event|21|||
23716811|NCT00363051|66337036|FG001|Overall Study|Adverse Event|12|||
23716812|NCT00363051|66337035|FG000|Overall Study|New Cancer Therapy|2|||
23716813|NCT00363051|66337036|FG001|Overall Study|New Cancer Therapy|1|||
23716814|NCT00363051|66337035|FG000|Overall Study|Withdrawal by Subject|11|||
23716815|NCT00363051|66337036|FG001|Overall Study|Withdrawal by Subject|3|||
23716816|NCT00363051|66337035|FG000|Overall Study|Lost to Follow-up|0|||
23813078|NCT04844762|66696135|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
23813079|NCT04844762|66696136|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23611877|NCT00848198|65966897|FG000|Overall Study|Incomplete Case Report Forms|15|||
23611878|NCT00472082|65966899|FG000|Overall Study|Study prematurely terminated|5|||
23611879|NCT03672188|65966900|FG000|Overall Study|Withdrawal by Subject|0|||
23611880|NCT03672188|65966901|FG001|Overall Study|Withdrawal by Subject|0|||
23611881|NCT03672188|65966902|FG002|Overall Study|Withdrawal by Subject|0|||
23611882|NCT03672188|65966903|FG003|Overall Study|Withdrawal by Subject|3|||
23611883|NCT03672188|65966904|FG004|Overall Study|Withdrawal by Subject|0|||
23611884|NCT03672188|65966905|FG005|Overall Study|Withdrawal by Subject|0|||
23611885|NCT03672188|65966906|FG006|Overall Study|Withdrawal by Subject|0|||
23716817|NCT00363051|66337036|FG001|Overall Study|Lost to Follow-up|1|||
23716818|NCT00363051|66337035|FG000|Overall Study|Protocol Violation|0|||
23716819|NCT00363051|66337036|FG001|Overall Study|Protocol Violation|2|||
23716820|NCT00363051|66337035|FG000|Overall Study|Death|3|||
23716821|NCT00363051|66337036|FG001|Overall Study|Death|2|||
23716822|NCT03700736|66337037|FG000|Overall Study|Pregnancy|1|||
23716823|NCT03700736|66337038|FG001|Overall Study|Pregnancy|1|||
23716824|NCT03700736|66337037|FG000|Overall Study|Withdrawal by Subject|2|||
23716825|NCT03700736|66337038|FG001|Overall Study|Withdrawal by Subject|6|||
23716826|NCT00168064|66337039|FG000|Overall Study|Adverse Event|26|||
23716827|NCT00168064|66337040|FG001|Overall Study|Adverse Event|22|||
23716828|NCT00168064|66337039|FG000|Overall Study|Withdrawal by Subject|3|||
23716829|NCT00168064|66337040|FG001|Overall Study|Withdrawal by Subject|4|||
23716830|NCT00168064|66337039|FG000|Overall Study|Lack of Efficacy|4|||
23716831|NCT00168064|66337040|FG001|Overall Study|Lack of Efficacy|4|||
23527380|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527381|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527382|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527383|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527384|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527385|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
23527386|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
23527387|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
23527388|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527389|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
23527390|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527391|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527392|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527393|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527394|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527395|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527396|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527397|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527398|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527399|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527400|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527401|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527402|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527403|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527404|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527405|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527406|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527407|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527408|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527409|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527410|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527411|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527412|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527413|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527414|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527415|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527416|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527417|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527418|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527419|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527420|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527421|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527422|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527423|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527424|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527425|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527426|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527427|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611886|NCT03672188|65966907|FG007|Overall Study|Withdrawal by Subject|0|||
23611887|NCT03672188|65966908|FG008|Overall Study|Withdrawal by Subject|0|||
23611888|NCT03672188|65966909|FG009|Overall Study|Withdrawal by Subject|0|||
23716832|NCT00168064|66337039|FG000|Overall Study|Lost to Follow-up|4|||
23716833|NCT00168064|66337040|FG001|Overall Study|Lost to Follow-up|3|||
23716834|NCT00168064|66337039|FG000|Overall Study|Non-compliance|2|||
23716835|NCT00168064|66337040|FG001|Overall Study|Non-compliance|3|||
23716836|NCT00168064|66337039|FG000|Overall Study|Concurrent Illness|4|||
23611889|NCT03672188|65966910|FG010|Overall Study|Withdrawal by Subject|0|||
23611890|NCT03672188|65966911|FG011|Overall Study|Withdrawal by Subject|0|||
23611891|NCT03672188|65966912|FG012|Overall Study|Withdrawal by Subject|0|||
23527428|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527429|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527430|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527431|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527432|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611892|NCT03672188|65966913|FG013|Overall Study|Withdrawal by Subject|0|||
23611893|NCT03672188|65966914|FG014|Overall Study|Withdrawal by Subject|0|||
23611894|NCT03672188|65966900|FG000|Overall Study|Death|0|||
23611895|NCT03672188|65966901|FG001|Overall Study|Death|0|||
23611896|NCT03672188|65966902|FG002|Overall Study|Death|0|||
23611897|NCT03672188|65966903|FG003|Overall Study|Death|0|||
23611898|NCT03672188|65966904|FG004|Overall Study|Death|0|||
23611899|NCT03672188|65966905|FG005|Overall Study|Death|0|||
23611900|NCT03672188|65966906|FG006|Overall Study|Death|0|||
23716837|NCT00168064|66337040|FG001|Overall Study|Concurrent Illness|3|||
23611901|NCT03672188|65966907|FG007|Overall Study|Death|0|||
23611902|NCT03672188|65966908|FG008|Overall Study|Death|0|||
23611903|NCT03672188|65966909|FG009|Overall Study|Death|0|||
23611904|NCT03672188|65966910|FG010|Overall Study|Death|0|||
23611905|NCT03672188|65966911|FG011|Overall Study|Death|0|||
23611906|NCT03672188|65966912|FG012|Overall Study|Death|1|||
23611907|NCT03672188|65966913|FG013|Overall Study|Death|0|||
23527433|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611908|NCT03672188|65966914|FG014|Overall Study|Death|0|||
23611909|NCT03672188|65966900|FG000|Overall Study|Lost to Follow-up|0|||
23611910|NCT03672188|65966901|FG001|Overall Study|Lost to Follow-up|0|||
23611911|NCT03672188|65966902|FG002|Overall Study|Lost to Follow-up|1|||
23611912|NCT03672188|65966903|FG003|Overall Study|Lost to Follow-up|0|||
23611913|NCT03672188|65966904|FG004|Overall Study|Lost to Follow-up|0|||
23611914|NCT03672188|65966905|FG005|Overall Study|Lost to Follow-up|0|||
23611915|NCT03672188|65966906|FG006|Overall Study|Lost to Follow-up|0|||
23611916|NCT03672188|65966907|FG007|Overall Study|Lost to Follow-up|0|||
23611917|NCT03672188|65966908|FG008|Overall Study|Lost to Follow-up|0|||
23611918|NCT03672188|65966909|FG009|Overall Study|Lost to Follow-up|0|||
23611919|NCT03672188|65966910|FG010|Overall Study|Lost to Follow-up|0|||
23611920|NCT03672188|65966911|FG011|Overall Study|Lost to Follow-up|0|||
23611921|NCT03672188|65966912|FG012|Overall Study|Lost to Follow-up|0|||
23527434|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23527435|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527436|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527437|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23527438|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527439|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527440|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527441|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527442|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527443|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527444|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527445|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527446|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527447|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527448|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527449|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527450|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527451|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527452|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527453|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527454|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527455|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527456|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23611922|NCT03672188|65966913|FG013|Overall Study|Lost to Follow-up|0|||
23611923|NCT03672188|65966914|FG014|Overall Study|Lost to Follow-up|0|||
23813080|NCT04844762|66696131|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
23611924|NCT01807234|65966919|FG000|Overall Study|Lost to Follow-up|2|||
23611925|NCT01807234|65966920|FG001|Overall Study|Lost to Follow-up|5|||
23611926|NCT01807234|65966921|FG002|Overall Study|Lost to Follow-up|1|||
23611927|NCT01807234|65966922|FG003|Overall Study|Lost to Follow-up|1|||
23611928|NCT01807234|65966923|FG004|Overall Study|Lost to Follow-up|1|||
23611929|NCT01807234|65966924|FG005|Overall Study|Lost to Follow-up|2|||
23716838|NCT00168064|66337039|FG000|Overall Study|Subject's Best interest|2|||
23716839|NCT00168064|66337040|FG001|Overall Study|Subject's Best interest|2|||
23716840|NCT00168064|66337039|FG000|Overall Study|Various|4|||
23716841|NCT00168064|66337040|FG001|Overall Study|Various|3|||
23716842|NCT01928082|66337041|FG000|Overall Study|Study terminated.|1|||
23716843|NCT01958125|66337042|FG000|Overall Study|Missing diary data|2|||
23716844|NCT01958125|66337043|FG001|Overall Study|Missing diary data|6|||
23716845|NCT01958125|66337042|FG000|Overall Study|No headache attacks|0|||
23716846|NCT01958125|66337043|FG001|Overall Study|No headache attacks|2|||
23716847|NCT00643604|66337046|FG000|Overall Study|Death|1|||
23418202|NCT02589665|65277204|FG002|Induction Period|Adverse Event|2|||
23418203|NCT02589665|65277205|FG003|Induction Period|Adverse Event|2|||
23418204|NCT02589665|65277206|FG004|Induction Period|Adverse Event|0|||
23527457|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527458|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527459|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527460|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23418205|NCT02589665|65277207|FG005|Induction Period|Adverse Event|0|||
23418206|NCT02589665|65277208|FG006|Induction Period|Adverse Event|0|||
23418207|NCT02589665|65277209|FG007|Induction Period|Adverse Event|0|||
23418208|NCT02589665|65277210|FG008|Induction Period|Adverse Event|0|||
23418209|NCT02589665|65277211|FG009|Induction Period|Adverse Event|0|||
23418210|NCT02589665|65277202|FG000|Induction Period|Withdrawal by Subject|0|||
23418211|NCT02589665|65277203|FG001|Induction Period|Withdrawal by Subject|1|||
23418212|NCT02589665|65277204|FG002|Induction Period|Withdrawal by Subject|0|||
23418213|NCT02589665|65277205|FG003|Induction Period|Withdrawal by Subject|1|||
23418214|NCT02589665|65277206|FG004|Induction Period|Withdrawal by Subject|0|||
23418215|NCT02589665|65277207|FG005|Induction Period|Withdrawal by Subject|0|||
23418216|NCT02589665|65277208|FG006|Induction Period|Withdrawal by Subject|0|||
23418217|NCT02589665|65277209|FG007|Induction Period|Withdrawal by Subject|0|||
23418218|NCT02589665|65277210|FG008|Induction Period|Withdrawal by Subject|0|||
23418219|NCT02589665|65277211|FG009|Induction Period|Withdrawal by Subject|0|||
23418220|NCT02589665|65277202|FG000|Induction Period|Protocol Violation|0|||
23418221|NCT02589665|65277203|FG001|Induction Period|Protocol Violation|1|||
23418222|NCT02589665|65277204|FG002|Induction Period|Protocol Violation|0|||
23418223|NCT02589665|65277205|FG003|Induction Period|Protocol Violation|0|||
23418224|NCT02589665|65277206|FG004|Induction Period|Protocol Violation|0|||
23418225|NCT02589665|65277207|FG005|Induction Period|Protocol Violation|0|||
23418226|NCT02589665|65277208|FG006|Induction Period|Protocol Violation|0|||
23418227|NCT02589665|65277209|FG007|Induction Period|Protocol Violation|0|||
23418228|NCT02589665|65277210|FG008|Induction Period|Protocol Violation|0|||
23418229|NCT02589665|65277211|FG009|Induction Period|Protocol Violation|0|||
23418230|NCT02589665|65277202|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418231|NCT02589665|65277203|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418232|NCT02589665|65277204|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418233|NCT02589665|65277205|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418234|NCT02589665|65277206|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
23418235|NCT02589665|65277207|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
23527461|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
23527462|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527463|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527464|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527465|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527466|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527467|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527468|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527469|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23716848|NCT03987919|66337049|FG000|Overall Study|Adverse Event|1|||
23418236|NCT02589665|65277208|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
23418237|NCT02589665|65277209|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418238|NCT02589665|65277210|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418239|NCT02589665|65277211|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418240|NCT02589665|65277202|FG000|Maintenance Period|Withdrawal by Subject|0|||
23418241|NCT02589665|65277203|FG001|Maintenance Period|Withdrawal by Subject|0|||
23418242|NCT02589665|65277204|FG002|Maintenance Period|Withdrawal by Subject|0|||
23418243|NCT02589665|65277205|FG003|Maintenance Period|Withdrawal by Subject|0|||
23716849|NCT03987919|66337050|FG001|Overall Study|Adverse Event|4|||
23418244|NCT02589665|65277206|FG004|Maintenance Period|Withdrawal by Subject|4|||
23527470|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23716850|NCT03987919|66337051|FG002|Overall Study|Adverse Event|1|||
23716851|NCT03987919|66337052|FG003|Overall Study|Adverse Event|3|||
23418245|NCT02589665|65277207|FG005|Maintenance Period|Withdrawal by Subject|2|||
23418246|NCT02589665|65277208|FG006|Maintenance Period|Withdrawal by Subject|4|||
23418247|NCT02589665|65277209|FG007|Maintenance Period|Withdrawal by Subject|0|||
23418248|NCT02589665|65277210|FG008|Maintenance Period|Withdrawal by Subject|0|||
23418249|NCT02589665|65277211|FG009|Maintenance Period|Withdrawal by Subject|0|||
23418250|NCT02589665|65277202|FG000|Maintenance Period|Lack of Efficacy|0|||
23418251|NCT02589665|65277203|FG001|Maintenance Period|Lack of Efficacy|0|||
23527471|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527472|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527473|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527474|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527475|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527476|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527477|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23716852|NCT03987919|66337049|FG000|Overall Study|Death|4|||
23716853|NCT03987919|66337050|FG001|Overall Study|Death|4|||
23527478|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527479|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527480|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527481|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23527482|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23527483|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23527484|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527485|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527486|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527487|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527488|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527489|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527490|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527491|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527492|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527493|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527494|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527495|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527496|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527497|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527498|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527499|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527500|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527501|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527502|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527503|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527504|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527505|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527506|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
23527507|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527508|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527509|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
23527510|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527511|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527512|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527513|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527514|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527515|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527516|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527517|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527518|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527519|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527520|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527521|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527522|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527523|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23716854|NCT03987919|66337051|FG002|Overall Study|Death|4|||
23716855|NCT03987919|66337052|FG003|Overall Study|Death|1|||
23418252|NCT02589665|65277204|FG002|Maintenance Period|Lack of Efficacy|0|||
23611930|NCT01807234|65966919|FG000|Overall Study|Withdrawal by Subject|3|||
23527524|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527525|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527526|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527527|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527528|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527529|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527530|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
23527531|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527532|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527533|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
23527534|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
23611931|NCT01807234|65966920|FG001|Overall Study|Withdrawal by Subject|1|||
23611932|NCT01807234|65966921|FG002|Overall Study|Withdrawal by Subject|1|||
23611933|NCT01807234|65966922|FG003|Overall Study|Withdrawal by Subject|1|||
23611934|NCT01807234|65966923|FG004|Overall Study|Withdrawal by Subject|2|||
23611935|NCT01807234|65966924|FG005|Overall Study|Withdrawal by Subject|1|||
23611936|NCT01807234|65966919|FG000|Overall Study|Lack of Efficacy|0|||
23611937|NCT01807234|65966920|FG001|Overall Study|Lack of Efficacy|0|||
23611938|NCT01807234|65966921|FG002|Overall Study|Lack of Efficacy|0|||
23611939|NCT01807234|65966922|FG003|Overall Study|Lack of Efficacy|0|||
23611940|NCT01807234|65966923|FG004|Overall Study|Lack of Efficacy|1|||
23611941|NCT01807234|65966924|FG005|Overall Study|Lack of Efficacy|1|||
23611942|NCT05203822|65966925|FG000|Overall Study|Adverse Event|1|||
23611943|NCT05203822|65966925|FG000|Overall Study|Withdrawal by Subject|1|||
23611944|NCT03976102|65966926|FG000|Overall Study|Withdrawal by Subject|4|||
23611945|NCT03976102|65966927|FG001|Overall Study|Withdrawal by Subject|4|||
23611946|NCT03976102|65966926|FG000|Overall Study|Adverse Event|2|||
23611947|NCT03976102|65966927|FG001|Overall Study|Adverse Event|4|||
23611948|NCT03976102|65966926|FG000|Overall Study|Not related to Covid-19|9|||
23611949|NCT03976102|65966927|FG001|Overall Study|Not related to Covid-19|13|||
23611950|NCT03976102|65966926|FG000|Overall Study|Lost to Follow-up|0|||
23611951|NCT03976102|65966927|FG001|Overall Study|Lost to Follow-up|2|||
23611952|NCT03976102|65966926|FG000|Overall Study|Death|3|||
23611953|NCT03976102|65966927|FG001|Overall Study|Death|2|||
23611954|NCT03976102|65966926|FG000|Overall Study|Physician Decision|1|||
23611955|NCT03976102|65966927|FG001|Overall Study|Physician Decision|1|||
23611956|NCT01075815|65966928|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
23611957|NCT01075815|65966929|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
23611958|NCT01075815|65966928|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
23611959|NCT01075815|65966929|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
23611960|NCT01075815|65966928|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
23611961|NCT01075815|65966929|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
23813081|NCT04844762|66696132|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
23813082|NCT04844762|66696133|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813083|NCT04844762|66696134|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813084|NCT04844762|66696135|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23527535|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
23527536|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527537|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527538|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527539|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527540|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527541|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527542|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527543|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527544|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527545|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23611962|NCT01714947|65966930|FG000|Part B|Progressive Disease|3|||
23611963|NCT03394508|65966933|FG000|Overall Study|Protocol Violation|0|||
23611964|NCT03394508|65966934|FG001|Overall Study|Protocol Violation|3|||
23716856|NCT03987919|66337049|FG000|Overall Study|Lost to Follow-up|5|||
23611965|NCT03394508|65966933|FG000|Overall Study|Lost to Follow-up|1|||
23716857|NCT03987919|66337050|FG001|Overall Study|Lost to Follow-up|6|||
23716858|NCT03987919|66337051|FG002|Overall Study|Lost to Follow-up|8|||
23716859|NCT03987919|66337052|FG003|Overall Study|Lost to Follow-up|12|||
23716860|NCT03987919|66337049|FG000|Overall Study|Physician Decision|0|||
23716861|NCT03987919|66337050|FG001|Overall Study|Physician Decision|2|||
23716862|NCT03987919|66337051|FG002|Overall Study|Physician Decision|0|||
23611966|NCT03394508|65966934|FG001|Overall Study|Lost to Follow-up|0|||
23611967|NCT00203502|65966938|FG000|Overall Study|Death|1|||
23611968|NCT00942188|65966939|FG000|Overall Study|Adverse Event|0|||
23611969|NCT00942188|65966940|FG001|Overall Study|Adverse Event|3|||
23716863|NCT03987919|66337052|FG003|Overall Study|Physician Decision|4|||
23716864|NCT03987919|66337049|FG000|Overall Study|Pregnancy|1|||
23716865|NCT03987919|66337050|FG001|Overall Study|Pregnancy|0|||
23716866|NCT03987919|66337051|FG002|Overall Study|Pregnancy|1|||
23716867|NCT03987919|66337052|FG003|Overall Study|Pregnancy|1|||
23716868|NCT03987919|66337049|FG000|Overall Study|Protocol Violation|0|||
23716869|NCT03987919|66337050|FG001|Overall Study|Protocol Violation|1|||
23716870|NCT03987919|66337051|FG002|Overall Study|Protocol Violation|0|||
23716871|NCT03987919|66337052|FG003|Overall Study|Protocol Violation|0|||
23716872|NCT03987919|66337049|FG000|Overall Study|Site terminated by Sponsor|0|||
23716873|NCT03987919|66337050|FG001|Overall Study|Site terminated by Sponsor|0|||
23716874|NCT03987919|66337051|FG002|Overall Study|Site terminated by Sponsor|0|||
23716875|NCT03987919|66337052|FG003|Overall Study|Site terminated by Sponsor|1|||
23716876|NCT03987919|66337049|FG000|Overall Study|Withdrawal by Subject|7|||
23611970|NCT00942188|65966941|FG002|Overall Study|Adverse Event|2|||
23527546|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527547|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23611971|NCT00942188|65966942|FG003|Overall Study|Adverse Event|0|||
23611972|NCT00942188|65966939|FG000|Overall Study|Lack of Efficacy|0|||
23611973|NCT00942188|65966940|FG001|Overall Study|Lack of Efficacy|0|||
23716877|NCT03987919|66337050|FG001|Overall Study|Withdrawal by Subject|7|||
23716878|NCT03987919|66337051|FG002|Overall Study|Withdrawal by Subject|8|||
23716879|NCT03987919|66337052|FG003|Overall Study|Withdrawal by Subject|4|||
23716880|NCT03987919|66337049|FG000|Overall Study|Other - as reported by the investigator|1|||
23716881|NCT03987919|66337050|FG001|Overall Study|Other - as reported by the investigator|3|||
23716882|NCT03987919|66337051|FG002|Overall Study|Other - as reported by the investigator|2|||
23716883|NCT03987919|66337052|FG003|Overall Study|Other - as reported by the investigator|0|||
23716884|NCT01989754|66337053|FG000|Overall Study|Withdrawal by Subject|10|||
23716885|NCT01989754|66337054|FG001|Overall Study|Withdrawal by Subject|14|||
23716886|NCT01989754|66337053|FG000|Overall Study|Lost to Follow-up|28|||
23716887|NCT01989754|66337054|FG001|Overall Study|Lost to Follow-up|20|||
23716888|NCT01989754|66337053|FG000|Overall Study|Closed Site|1|||
23716889|NCT01989754|66337054|FG001|Overall Study|Closed Site|1|||
23716890|NCT01830816|66337055|FG000|Overall Study|Progressive Disease|12|||
23716891|NCT01830816|66337056|FG001|Overall Study|Progressive Disease|7|||
23716892|NCT01830816|66337057|FG002|Overall Study|Progressive Disease|7|||
23716893|NCT01830816|66337055|FG000|Overall Study|Adverse Event|3|||
23716894|NCT01830816|66337056|FG001|Overall Study|Adverse Event|4|||
23716895|NCT01830816|66337057|FG002|Overall Study|Adverse Event|0|||
23716896|NCT01830816|66337055|FG000|Overall Study|Study Terminated by Sponsor|1|||
23716897|NCT01830816|66337056|FG001|Overall Study|Study Terminated by Sponsor|1|||
23716898|NCT01830816|66337057|FG002|Overall Study|Study Terminated by Sponsor|0|||
23527548|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527549|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23716899|NCT01830816|66337055|FG000|Overall Study|Withdrawal by Subject|1|||
23716900|NCT01830816|66337056|FG001|Overall Study|Withdrawal by Subject|1|||
23527550|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527551|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527552|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527553|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527554|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
23527555|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527556|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527557|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527558|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527559|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527560|NCT02777125|65669207|FG000|Overall Study|Consent form violation|14|||
23527561|NCT02777125|65669208|FG001|Overall Study|Consent form violation|12|||
23611974|NCT00942188|65966941|FG002|Overall Study|Lack of Efficacy|0|||
23611975|NCT00942188|65966942|FG003|Overall Study|Lack of Efficacy|1|||
23716901|NCT01830816|66337057|FG002|Overall Study|Withdrawal by Subject|0|||
23611976|NCT00942188|65966939|FG000|Overall Study|Protocol Violation|1|||
23611977|NCT00942188|65966940|FG001|Overall Study|Protocol Violation|1|||
23716902|NCT01830816|66337055|FG000|Overall Study|Lost to Follow-up|0|||
23716903|NCT01830816|66337056|FG001|Overall Study|Lost to Follow-up|1|||
23716904|NCT01830816|66337057|FG002|Overall Study|Lost to Follow-up|0|||
23716905|NCT01830816|66337055|FG000|Overall Study|Symptomatic Deterioration|1|||
23716906|NCT01830816|66337056|FG001|Overall Study|Symptomatic Deterioration|0|||
23716907|NCT01830816|66337057|FG002|Overall Study|Symptomatic Deterioration|0|||
23527562|NCT02777125|65669207|FG000|Overall Study|Assent form violation|21|||
23527563|NCT02777125|65669208|FG001|Overall Study|Assent form violation|23|||
23527564|NCT02777125|65669207|FG000|Overall Study|Protocol Violation|8|||
23527565|NCT02777125|65669208|FG001|Overall Study|Protocol Violation|12|||
23527566|NCT04999111|65669209|FG000|Overall Study|Lost to Follow-up|21|||
23527567|NCT04999111|65669210|FG001|Overall Study|Lost to Follow-up|16|||
23527568|NCT04999111|65669211|FG002|Overall Study|Lost to Follow-up|2|||
23527569|NCT04999111|65669212|FG003|Overall Study|Lost to Follow-up|26|||
23527570|NCT04999111|65669213|FG004|Overall Study|Lost to Follow-up|30|||
23527571|NCT04999111|65669214|FG005|Overall Study|Lost to Follow-up|6|||
23527572|NCT04999111|65669209|FG000|Overall Study|Physician Decision|1|||
23527573|NCT04999111|65669210|FG001|Overall Study|Physician Decision|3|||
23527574|NCT04999111|65669211|FG002|Overall Study|Physician Decision|0|||
23527575|NCT04999111|65669212|FG003|Overall Study|Physician Decision|1|||
23527576|NCT04999111|65669213|FG004|Overall Study|Physician Decision|2|||
23527577|NCT04999111|65669214|FG005|Overall Study|Physician Decision|0|||
23527578|NCT04999111|65669209|FG000|Overall Study|Withdrawal by Subject|23|||
23527579|NCT04999111|65669210|FG001|Overall Study|Withdrawal by Subject|29|||
23527580|NCT04999111|65669211|FG002|Overall Study|Withdrawal by Subject|15|||
23527581|NCT04999111|65669212|FG003|Overall Study|Withdrawal by Subject|30|||
23527582|NCT04999111|65669213|FG004|Overall Study|Withdrawal by Subject|35|||
23527583|NCT04999111|65669214|FG005|Overall Study|Withdrawal by Subject|10|||
23527584|NCT04999111|65669209|FG000|Overall Study|Other|6|||
23527585|NCT04999111|65669210|FG001|Overall Study|Other|6|||
23527586|NCT04999111|65669211|FG002|Overall Study|Other|3|||
23527587|NCT04999111|65669212|FG003|Overall Study|Other|8|||
23527588|NCT04999111|65669213|FG004|Overall Study|Other|8|||
23527589|NCT04999111|65669214|FG005|Overall Study|Other|5|||
23527590|NCT04999111|65669209|FG000|Overall Study|Non-compliance with study schedule|1|||
23527591|NCT04999111|65669210|FG001|Overall Study|Non-compliance with study schedule|0|||
23527592|NCT04999111|65669211|FG002|Overall Study|Non-compliance with study schedule|0|||
23527593|NCT04999111|65669212|FG003|Overall Study|Non-compliance with study schedule|1|||
23527594|NCT04999111|65669213|FG004|Overall Study|Non-compliance with study schedule|1|||
23527595|NCT04999111|65669214|FG005|Overall Study|Non-compliance with study schedule|1|||
23527596|NCT04999111|65669209|FG000|Overall Study|Randomized but not vaccinated|1|||
23527597|NCT04999111|65669210|FG001|Overall Study|Randomized but not vaccinated|2|||
23527598|NCT04999111|65669211|FG002|Overall Study|Randomized but not vaccinated|0|||
23527599|NCT04999111|65669212|FG003|Overall Study|Randomized but not vaccinated|3|||
23527600|NCT04999111|65669213|FG004|Overall Study|Randomized but not vaccinated|3|||
23527601|NCT04999111|65669214|FG005|Overall Study|Randomized but not vaccinated|0|||
23527602|NCT04999111|65669209|FG000|Overall Study|Adverse Event|1|||
23527603|NCT04999111|65669210|FG001|Overall Study|Adverse Event|1|||
23527604|NCT04999111|65669211|FG002|Overall Study|Adverse Event|0|||
23527605|NCT04999111|65669212|FG003|Overall Study|Adverse Event|0|||
23527606|NCT04999111|65669213|FG004|Overall Study|Adverse Event|0|||
23527607|NCT04999111|65669214|FG005|Overall Study|Adverse Event|0|||
23527608|NCT04999111|65669209|FG000|Overall Study|Initiated prohibited medication|0|||
23527609|NCT04999111|65669210|FG001|Overall Study|Initiated prohibited medication|0|||
23716908|NCT01830816|66337055|FG000|Overall Study|Reason not Specified|2|||
23716909|NCT01830816|66337056|FG001|Overall Study|Reason not Specified|0|||
23716910|NCT01830816|66337057|FG002|Overall Study|Reason not Specified|0|||
23716911|NCT01359046|66337058|FG000|Overall Study|Did not receive allocated intervention|6|||
23716912|NCT01359046|66337059|FG001|Overall Study|Did not receive allocated intervention|6|||
23716913|NCT01359046|66337058|FG000|Overall Study|Physician Decision|1|||
23716914|NCT01359046|66337059|FG001|Overall Study|Physician Decision|11|||
23716915|NCT02555657|66337060|FG000|Overall Study|Death|274|||
23716916|NCT02555657|66337061|FG001|Overall Study|Death|262|||
23716917|NCT02555657|66337060|FG000|Overall Study|Physician Decision|0|||
23527610|NCT04999111|65669211|FG002|Overall Study|Initiated prohibited medication|0|||
23527611|NCT04999111|65669212|FG003|Overall Study|Initiated prohibited medication|0|||
23527612|NCT04999111|65669213|FG004|Overall Study|Initiated prohibited medication|1|||
23527613|NCT04999111|65669214|FG005|Overall Study|Initiated prohibited medication|0|||
23527614|NCT03027466|65669217|FG000|Overall Study|Opting out of the app|1869|||
23527615|NCT03027466|65669218|FG001|Overall Study|Opting out of the app|1819|||
23527616|NCT03027466|65669219|FG002|Overall Study|Opting out of the app|1743|||
23527617|NCT03027466|65669220|FG003|Overall Study|Opting out of the app|1821|||
23527618|NCT00145509|65669222|FG000|Overall Study|Adverse Event|10|||
23716918|NCT02555657|66337061|FG001|Overall Study|Physician Decision|1|||
23527619|NCT00145509|65669223|FG001|Overall Study|Adverse Event|3|||
23716919|NCT02555657|66337060|FG000|Overall Study|Sponsor Decision|27|||
23527620|NCT00145509|65669222|FG000|Overall Study|Lack of Efficacy|3|||
23716920|NCT02555657|66337061|FG001|Overall Study|Sponsor Decision|15|||
23527621|NCT00145509|65669223|FG001|Overall Study|Lack of Efficacy|1|||
23527622|NCT00145509|65669222|FG000|Overall Study|Lost to Follow-up|5|||
23527623|NCT00145509|65669223|FG001|Overall Study|Lost to Follow-up|9|||
23418253|NCT02589665|65277205|FG003|Maintenance Period|Lack of Efficacy|0|||
23418254|NCT02589665|65277206|FG004|Maintenance Period|Lack of Efficacy|2|||
23418255|NCT02589665|65277207|FG005|Maintenance Period|Lack of Efficacy|1|||
23418256|NCT02589665|65277208|FG006|Maintenance Period|Lack of Efficacy|0|||
23418257|NCT02589665|65277209|FG007|Maintenance Period|Lack of Efficacy|0|||
23418258|NCT02589665|65277210|FG008|Maintenance Period|Lack of Efficacy|0|||
23418259|NCT02589665|65277211|FG009|Maintenance Period|Lack of Efficacy|0|||
23418260|NCT02589665|65277202|FG000|Maintenance Period|Adverse Event|0|||
23418261|NCT02589665|65277203|FG001|Maintenance Period|Adverse Event|0|||
23418262|NCT02589665|65277204|FG002|Maintenance Period|Adverse Event|0|||
23418263|NCT02589665|65277205|FG003|Maintenance Period|Adverse Event|0|||
23418264|NCT02589665|65277206|FG004|Maintenance Period|Adverse Event|0|||
23418265|NCT02589665|65277207|FG005|Maintenance Period|Adverse Event|0|||
23418266|NCT02589665|65277208|FG006|Maintenance Period|Adverse Event|2|||
23418267|NCT02589665|65277209|FG007|Maintenance Period|Adverse Event|0|||
23418268|NCT02589665|65277210|FG008|Maintenance Period|Adverse Event|0|||
23418269|NCT02589665|65277211|FG009|Maintenance Period|Adverse Event|0|||
23418270|NCT02589665|65277202|FG000|Maintenance Period|Lost to Follow-up|0|||
23418271|NCT02589665|65277203|FG001|Maintenance Period|Lost to Follow-up|0|||
23418272|NCT02589665|65277204|FG002|Maintenance Period|Lost to Follow-up|0|||
23418273|NCT02589665|65277205|FG003|Maintenance Period|Lost to Follow-up|0|||
23418274|NCT02589665|65277206|FG004|Maintenance Period|Lost to Follow-up|0|||
23418275|NCT02589665|65277207|FG005|Maintenance Period|Lost to Follow-up|1|||
23418276|NCT02589665|65277208|FG006|Maintenance Period|Lost to Follow-up|0|||
23418277|NCT02589665|65277209|FG007|Maintenance Period|Lost to Follow-up|0|||
23418278|NCT02589665|65277210|FG008|Maintenance Period|Lost to Follow-up|0|||
23418279|NCT02589665|65277211|FG009|Maintenance Period|Lost to Follow-up|0|||
23418280|NCT02589665|65277202|FG000|Maintenance Period|Physician Decision|0|||
23418281|NCT02589665|65277203|FG001|Maintenance Period|Physician Decision|0|||
23418282|NCT02589665|65277204|FG002|Maintenance Period|Physician Decision|0|||
23418283|NCT02589665|65277205|FG003|Maintenance Period|Physician Decision|0|||
23418284|NCT02589665|65277206|FG004|Maintenance Period|Physician Decision|0|||
23418285|NCT02589665|65277207|FG005|Maintenance Period|Physician Decision|1|||
23418286|NCT02589665|65277208|FG006|Maintenance Period|Physician Decision|0|||
23418287|NCT02589665|65277209|FG007|Maintenance Period|Physician Decision|0|||
23418288|NCT02589665|65277210|FG008|Maintenance Period|Physician Decision|0|||
23418289|NCT02589665|65277211|FG009|Maintenance Period|Physician Decision|0|||
23418290|NCT02589665|65277202|FG000|Maintenance Period|Reason Not Collected|0|||
23418291|NCT02589665|65277203|FG001|Maintenance Period|Reason Not Collected|0|||
23418292|NCT02589665|65277204|FG002|Maintenance Period|Reason Not Collected|0|||
23418293|NCT02589665|65277205|FG003|Maintenance Period|Reason Not Collected|0|||
23418294|NCT02589665|65277206|FG004|Maintenance Period|Reason Not Collected|0|||
23418295|NCT02589665|65277207|FG005|Maintenance Period|Reason Not Collected|1|||
23418296|NCT02589665|65277208|FG006|Maintenance Period|Reason Not Collected|1|||
23418297|NCT02589665|65277209|FG007|Maintenance Period|Reason Not Collected|0|||
23418298|NCT02589665|65277210|FG008|Maintenance Period|Reason Not Collected|0|||
23418299|NCT02589665|65277211|FG009|Maintenance Period|Reason Not Collected|0|||
23418300|NCT02589665|65277202|FG000|Induction Extension Period|Adverse Event|0|||
23418301|NCT02589665|65277203|FG001|Induction Extension Period|Adverse Event|0|||
23418302|NCT02589665|65277204|FG002|Induction Extension Period|Adverse Event|0|||
23418303|NCT02589665|65277205|FG003|Induction Extension Period|Adverse Event|0|||
23418304|NCT02589665|65277206|FG004|Induction Extension Period|Adverse Event|0|||
23418305|NCT02589665|65277207|FG005|Induction Extension Period|Adverse Event|0|||
23418306|NCT02589665|65277208|FG006|Induction Extension Period|Adverse Event|0|||
23418307|NCT02589665|65277209|FG007|Induction Extension Period|Adverse Event|0|||
23418308|NCT02589665|65277210|FG008|Induction Extension Period|Adverse Event|4|||
23418309|NCT02589665|65277211|FG009|Induction Extension Period|Adverse Event|0|||
23418310|NCT02589665|65277202|FG000|Induction Extension Period|Lack of Efficacy|0|||
23418311|NCT02589665|65277203|FG001|Induction Extension Period|Lack of Efficacy|0|||
23418312|NCT02589665|65277204|FG002|Induction Extension Period|Lack of Efficacy|0|||
23418313|NCT02589665|65277205|FG003|Induction Extension Period|Lack of Efficacy|0|||
23418314|NCT02589665|65277206|FG004|Induction Extension Period|Lack of Efficacy|0|||
23418315|NCT02589665|65277207|FG005|Induction Extension Period|Lack of Efficacy|0|||
23418316|NCT02589665|65277208|FG006|Induction Extension Period|Lack of Efficacy|0|||
23418317|NCT02589665|65277209|FG007|Induction Extension Period|Lack of Efficacy|0|||
23418318|NCT02589665|65277210|FG008|Induction Extension Period|Lack of Efficacy|3|||
23418319|NCT02589665|65277211|FG009|Induction Extension Period|Lack of Efficacy|0|||
23418320|NCT02589665|65277202|FG000|Induction Extension Period|Withdrawal by Subject|0|||
23418321|NCT02589665|65277203|FG001|Induction Extension Period|Withdrawal by Subject|0|||
23418322|NCT02589665|65277204|FG002|Induction Extension Period|Withdrawal by Subject|0|||
23418323|NCT02589665|65277205|FG003|Induction Extension Period|Withdrawal by Subject|0|||
23418324|NCT02589665|65277206|FG004|Induction Extension Period|Withdrawal by Subject|0|||
23418325|NCT02589665|65277207|FG005|Induction Extension Period|Withdrawal by Subject|0|||
23418326|NCT02589665|65277208|FG006|Induction Extension Period|Withdrawal by Subject|0|||
23527624|NCT00145509|65669222|FG000|Overall Study|Withdrew Consent|2|||
23527625|NCT00145509|65669223|FG001|Overall Study|Withdrew Consent|7|||
23527626|NCT00145509|65669222|FG000|Overall Study|Reason not provided|2|||
23716921|NCT02555657|66337060|FG000|Overall Study|Withdrawal by Subject|11|||
23716922|NCT02555657|66337061|FG001|Overall Study|Withdrawal by Subject|32|||
23716923|NCT00836277|66337062|FG000|Overall Study|Not evaluable for response|6|||
23716924|NCT02716194|66337063|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
23716925|NCT02716194|66337064|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
23716926|NCT02716194|66337065|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
23527627|NCT00145509|65669223|FG001|Overall Study|Reason not provided|1|||
23527628|NCT02296112|65669226|FG000|Overall Study|Disease progression|7|||
23527629|NCT02296112|65669226|FG000|Overall Study|Toxicity|1|||
23527630|NCT02296112|65669226|FG000|Overall Study|Began an alternate therapy|1|||
23527631|NCT01454934|65669227|FG000|Overall Study|Clinical progression|28|||
23527632|NCT01454934|65669228|FG001|Overall Study|Clinical progression|25|||
23527633|NCT01454934|65669227|FG000|Overall Study|Other|6|||
23527634|NCT01454934|65669228|FG001|Overall Study|Other|17|||
23527635|NCT01454934|65669227|FG000|Overall Study|Adverse Event|28|||
23527636|NCT01454934|65669228|FG001|Overall Study|Adverse Event|24|||
23527637|NCT01454934|65669227|FG000|Overall Study|Withdrawn consent|2|||
23527638|NCT01454934|65669228|FG001|Overall Study|Withdrawn consent|5|||
23527639|NCT01454934|65669227|FG000|Overall Study|Withdrawal by Subject|11|||
23527640|NCT01454934|65669228|FG001|Overall Study|Withdrawal by Subject|15|||
23527641|NCT01454934|65669227|FG000|Overall Study|Disease progression|194|||
23527642|NCT01454934|65669228|FG001|Overall Study|Disease progression|181|||
23527643|NCT01454934|65669227|FG000|Overall Study|Lost to Follow-up|0|||
23527644|NCT01454934|65669228|FG001|Overall Study|Lost to Follow-up|1|||
23527645|NCT01454934|65669227|FG000|Overall Study|Not treated|1|||
23527646|NCT01454934|65669228|FG001|Overall Study|Not treated|2|||
23527647|NCT00989833|65669230|FG000|Overall Study|Lost to Follow-up|0|||
23527648|NCT00989833|65669231|FG001|Overall Study|Lost to Follow-up|1|||
23527649|NCT00989833|65669232|FG002|Overall Study|Lost to Follow-up|0|||
23527650|NCT00989833|65669230|FG000|Overall Study|Protocol Violation|1|||
23527651|NCT00989833|65669231|FG001|Overall Study|Protocol Violation|2|||
23527652|NCT00989833|65669232|FG002|Overall Study|Protocol Violation|1|||
23527653|NCT00989833|65669230|FG000|Overall Study|Withdrawal by Subject|0|||
23611978|NCT00942188|65966941|FG002|Overall Study|Protocol Violation|0|||
23611979|NCT00942188|65966942|FG003|Overall Study|Protocol Violation|0|||
23611980|NCT00942188|65966939|FG000|Overall Study|Lost to Follow-up|2|||
23611981|NCT00942188|65966940|FG001|Overall Study|Lost to Follow-up|1|||
23611982|NCT00942188|65966941|FG002|Overall Study|Lost to Follow-up|2|||
23611983|NCT00942188|65966942|FG003|Overall Study|Lost to Follow-up|0|||
23611984|NCT00942188|65966939|FG000|Overall Study|Withdrawal by Subject|1|||
23527654|NCT00989833|65669231|FG001|Overall Study|Withdrawal by Subject|0|||
23527655|NCT00989833|65669232|FG002|Overall Study|Withdrawal by Subject|1|||
23611985|NCT00942188|65966940|FG001|Overall Study|Withdrawal by Subject|3|||
23716927|NCT03833817|66337068|FG000|Overall Study|Withdrawal by Subject|3|||
23716928|NCT03833817|66337069|FG001|Overall Study|Withdrawal by Subject|3|||
23716929|NCT03833817|66337068|FG000|Overall Study|Lost to Follow-up|3|||
23813085|NCT04844762|66696136|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813086|NCT04844762|66696131|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23716930|NCT03833817|66337069|FG001|Overall Study|Lost to Follow-up|3|||
23813087|NCT04844762|66696132|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813088|NCT04844762|66696133|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813089|NCT04844762|66696134|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813090|NCT04844762|66696135|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813091|NCT04844762|66696136|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23716931|NCT02395653|66337070|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
23716932|NCT02395653|66337070|FG000|Overall Study|Consent Withdrawn at Screening|1|||
23716933|NCT02395653|66337070|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
23716934|NCT02395653|66337070|FG000|Overall Study|Investigator Decision at Screening|1|||
23716935|NCT02395653|66337070|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
23716936|NCT02395653|66337070|FG000|Overall Study|Withdrawal by Subject|1|||
23716937|NCT02395653|66337070|FG000|Overall Study|Lost to Follow-up|1|||
23716938|NCT00673894|66337073|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
23716939|NCT00673894|66337074|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
23527656|NCT00989833|65669230|FG000|Overall Study|Incorrectly randomized|1|||
23527657|NCT00989833|65669231|FG001|Overall Study|Incorrectly randomized|0|||
23527658|NCT00989833|65669232|FG002|Overall Study|Incorrectly randomized|0|||
23527659|NCT01147653|65669233|FG000|Year 2|Withdrawal by Subject|2|||
23611986|NCT00942188|65966941|FG002|Overall Study|Withdrawal by Subject|4|||
23611987|NCT00942188|65966942|FG003|Overall Study|Withdrawal by Subject|2|||
23527660|NCT01147653|65669234|FG001|Year 2|Withdrawal by Subject|3|||
23527661|NCT02418468|65669235|FG000|Overall Study|Adverse Event|1|||
23527662|NCT02418468|65669236|FG001|Overall Study|Adverse Event|0|||
23611988|NCT00942188|65966939|FG000|Overall Study|Physician Decision|0|||
23527663|NCT02418468|65669235|FG000|Overall Study|Withdrawal of informed consent|1|||
23527664|NCT02418468|65669236|FG001|Overall Study|Withdrawal of informed consent|1|||
23527665|NCT01466270|65669237|FG000|Overall Study|Withdrawal by Subject|4|||
23527666|NCT01466270|65669238|FG001|Overall Study|Withdrawal by Subject|1|||
23527667|NCT01466270|65669237|FG000|Overall Study|Physician Decision|1|||
23527668|NCT01466270|65669238|FG001|Overall Study|Physician Decision|0|||
23527669|NCT01466270|65669237|FG000|Overall Study|Lost to Follow-up|1|||
23527670|NCT01466270|65669238|FG001|Overall Study|Lost to Follow-up|3|||
23527671|NCT01466270|65669237|FG000|Overall Study|Progression|1|||
23527672|NCT01466270|65669238|FG001|Overall Study|Progression|0|||
23527673|NCT01466270|65669237|FG000|Overall Study|Toxicity|4|||
23527674|NCT01466270|65669238|FG001|Overall Study|Toxicity|1|||
23527675|NCT01466270|65669237|FG000|Overall Study|Multiple|1|||
23527676|NCT01466270|65669238|FG001|Overall Study|Multiple|1|||
23527677|NCT02474199|65669239|FG000|Overall Study|Lost to Follow-up|1|||
23527678|NCT02474199|65669240|FG001|Overall Study|Lost to Follow-up|0|||
23527679|NCT02474199|65669241|FG002|Overall Study|Lost to Follow-up|0|||
23527680|NCT02474199|65669242|FG003|Overall Study|Lost to Follow-up|0|||
23527681|NCT02474199|65669239|FG000|Overall Study|Withdrawal by Subject|1|||
23527682|NCT02474199|65669240|FG001|Overall Study|Withdrawal by Subject|2|||
23527683|NCT02474199|65669241|FG002|Overall Study|Withdrawal by Subject|0|||
23527684|NCT02474199|65669242|FG003|Overall Study|Withdrawal by Subject|1|||
23527685|NCT02474199|65669239|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527686|NCT02474199|65669240|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
23527687|NCT02474199|65669241|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527688|NCT02474199|65669242|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527689|NCT02474199|65669239|FG000|Overall Study|Did not meet eligibility criteria|0|||
23527690|NCT02474199|65669240|FG001|Overall Study|Did not meet eligibility criteria|0|||
23527691|NCT02474199|65669241|FG002|Overall Study|Did not meet eligibility criteria|2|||
23527692|NCT02474199|65669242|FG003|Overall Study|Did not meet eligibility criteria|2|||
23527693|NCT00997503|65669243|FG000|Overall Study|Death|53|||
23527694|NCT00997503|65669243|FG000|Overall Study|Withdrawal by Subject|76|||
23527695|NCT00997503|65669243|FG000|Overall Study|Lost to Follow-up|33|||
23527696|NCT00997503|65669243|FG000|Overall Study|Adverse Event|3|||
23527697|NCT00997503|65669243|FG000|Overall Study|Physician Decision|10|||
23527698|NCT00997503|65669243|FG000|Overall Study|Missed 12-month follow-up|85|||
23527699|NCT00997503|65669243|FG000|Overall Study|Other reason|13|||
23527700|NCT00326612|65669244|FG000|Overall Study|They did not have a seizure requiring tx|129|||
23527701|NCT00326612|65669245|FG001|Overall Study|They did not have a seizure requiring tx|137|||
23527702|NCT00838565|65669246|FG000|Overall Study|Withdrawal by Subject|0|||
23527703|NCT00838565|65669247|FG001|Overall Study|Withdrawal by Subject|0|||
23527704|NCT00838565|65669248|FG002|Overall Study|Withdrawal by Subject|1|||
23527705|NCT00838565|65669249|FG003|Overall Study|Withdrawal by Subject|0|||
23611989|NCT00942188|65966940|FG001|Overall Study|Physician Decision|0|||
23527706|NCT00838565|65669250|FG004|Overall Study|Withdrawal by Subject|0|||
23611990|NCT00942188|65966941|FG002|Overall Study|Physician Decision|1|||
23611991|NCT00942188|65966942|FG003|Overall Study|Physician Decision|0|||
23611992|NCT00942188|65966939|FG000|Overall Study|Sponsor Decision|0|||
23611993|NCT00942188|65966940|FG001|Overall Study|Sponsor Decision|2|||
23611994|NCT00942188|65966941|FG002|Overall Study|Sponsor Decision|0|||
23611995|NCT00942188|65966942|FG003|Overall Study|Sponsor Decision|1|||
23611996|NCT01544309|65966943|FG000|Overall Study|Withdrawal by Subject|12|||
23611997|NCT01544309|65966944|FG001|Overall Study|Withdrawal by Subject|7|||
23611998|NCT01544309|65966943|FG000|Overall Study|Protocol Violation|2|||
23611999|NCT01544309|65966944|FG001|Overall Study|Protocol Violation|1|||
23612000|NCT01544309|65966943|FG000|Overall Study|Physician Decision|4|||
23612001|NCT01544309|65966944|FG001|Overall Study|Physician Decision|1|||
23612002|NCT01544309|65966943|FG000|Overall Study|Not performed pre-dose examination|1|||
23612003|NCT01544309|65966944|FG001|Overall Study|Not performed pre-dose examination|2|||
23612004|NCT01544309|65966943|FG000|Overall Study|Administered prohibit prior medication|1|||
23612005|NCT01544309|65966944|FG001|Overall Study|Administered prohibit prior medication|0|||
23612006|NCT04175392|65966945|FG000|Overall Study|Withdrawal by Subject|3|||
23612007|NCT04175392|65966946|FG001|Overall Study|Withdrawal by Subject|2|||
23612008|NCT03640754|65966947|FG000|Overall Study|Withdrawal by Subject|1|||
23612009|NCT03640754|65966948|FG001|Overall Study|Withdrawal by Subject|0|||
23612010|NCT03640754|65966947|FG000|Overall Study|Lost to Follow-up|0|||
23612011|NCT03640754|65966948|FG001|Overall Study|Lost to Follow-up|1|||
23612012|NCT03740919|65966949|FG000|Lead-in Period|Lost to Follow-up|1|||
23612013|NCT03740919|65966950|FG001|Lead-in Period|Lost to Follow-up|0|||
23612014|NCT03740919|65966951|FG002|Lead-in Period|Lost to Follow-up|0|||
23612015|NCT03740919|65966952|FG003|Lead-in Period|Lost to Follow-up|0|||
23612016|NCT03740919|65966949|FG000|Lead-in Period|Physician Decision|2|||
23612017|NCT03740919|65966950|FG001|Lead-in Period|Physician Decision|0|||
23612018|NCT03740919|65966951|FG002|Lead-in Period|Physician Decision|0|||
23716940|NCT00673894|66337073|FG000|First Intervention 4 Weeks|Adverse Event|1|||
23716941|NCT00673894|66337074|FG001|First Intervention 4 Weeks|Adverse Event|0|||
23418327|NCT02589665|65277209|FG007|Induction Extension Period|Withdrawal by Subject|2|||
23418328|NCT02589665|65277210|FG008|Induction Extension Period|Withdrawal by Subject|3|||
23418329|NCT02589665|65277211|FG009|Induction Extension Period|Withdrawal by Subject|0|||
23418330|NCT02589665|65277202|FG000|Induction Extension Period|Physician Decision|0|||
23418331|NCT02589665|65277203|FG001|Induction Extension Period|Physician Decision|0|||
23418332|NCT02589665|65277204|FG002|Induction Extension Period|Physician Decision|0|||
23418333|NCT02589665|65277205|FG003|Induction Extension Period|Physician Decision|0|||
23418334|NCT02589665|65277206|FG004|Induction Extension Period|Physician Decision|0|||
23418335|NCT02589665|65277207|FG005|Induction Extension Period|Physician Decision|0|||
23418336|NCT02589665|65277208|FG006|Induction Extension Period|Physician Decision|0|||
23418337|NCT02589665|65277209|FG007|Induction Extension Period|Physician Decision|0|||
23418338|NCT02589665|65277210|FG008|Induction Extension Period|Physician Decision|1|||
23418339|NCT02589665|65277211|FG009|Induction Extension Period|Physician Decision|0|||
23418340|NCT02589665|65277202|FG000|Induction Extension Period|Reason Not Collected|0|||
23418341|NCT02589665|65277203|FG001|Induction Extension Period|Reason Not Collected|0|||
23418342|NCT02589665|65277204|FG002|Induction Extension Period|Reason Not Collected|0|||
23418343|NCT02589665|65277205|FG003|Induction Extension Period|Reason Not Collected|0|||
23418344|NCT02589665|65277206|FG004|Induction Extension Period|Reason Not Collected|0|||
23418345|NCT02589665|65277207|FG005|Induction Extension Period|Reason Not Collected|0|||
23418346|NCT02589665|65277208|FG006|Induction Extension Period|Reason Not Collected|0|||
23418347|NCT02589665|65277209|FG007|Induction Extension Period|Reason Not Collected|0|||
23418348|NCT02589665|65277210|FG008|Induction Extension Period|Reason Not Collected|1|||
23418349|NCT02589665|65277211|FG009|Induction Extension Period|Reason Not Collected|0|||
23527707|NCT00838565|65669251|FG005|Overall Study|Withdrawal by Subject|2|||
23527708|NCT00838565|65669246|FG000|Overall Study|Other|0|||
23527709|NCT00838565|65669247|FG001|Overall Study|Other|2|||
23527710|NCT00838565|65669248|FG002|Overall Study|Other|0|||
23527711|NCT00838565|65669249|FG003|Overall Study|Other|0|||
23527712|NCT00838565|65669250|FG004|Overall Study|Other|0|||
23527713|NCT00838565|65669251|FG005|Overall Study|Other|0|||
23527714|NCT00838565|65669246|FG000|Overall Study|Randomized but not Treated|0|||
23527715|NCT00838565|65669247|FG001|Overall Study|Randomized but not Treated|1|||
23527716|NCT00838565|65669248|FG002|Overall Study|Randomized but not Treated|0|||
23527717|NCT00838565|65669249|FG003|Overall Study|Randomized but not Treated|0|||
23527718|NCT00838565|65669250|FG004|Overall Study|Randomized but not Treated|0|||
23527719|NCT00838565|65669251|FG005|Overall Study|Randomized but not Treated|0|||
23527720|NCT01856543|65669252|FG000|Overall Study|Treatment discontinued|6|||
23612019|NCT03740919|65966952|FG003|Lead-in Period|Physician Decision|0|||
23612020|NCT03740919|65966949|FG000|Lead-in Period|Protocol Violation|1|||
23612021|NCT03740919|65966950|FG001|Lead-in Period|Protocol Violation|0|||
23612022|NCT03740919|65966951|FG002|Lead-in Period|Protocol Violation|0|||
23612023|NCT03740919|65966952|FG003|Lead-in Period|Protocol Violation|0|||
23612024|NCT03740919|65966949|FG000|Lead-in Period|Withdrawal by Subject|10|||
23612025|NCT03740919|65966950|FG001|Lead-in Period|Withdrawal by Subject|0|||
23612026|NCT03740919|65966951|FG002|Lead-in Period|Withdrawal by Subject|0|||
23418350|NCT02589665|65277202|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418351|NCT02589665|65277203|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418352|NCT02589665|65277204|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418353|NCT02589665|65277205|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418354|NCT02589665|65277206|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418355|NCT02589665|65277207|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418356|NCT02589665|65277208|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418357|NCT02589665|65277209|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418358|NCT02589665|65277210|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418359|NCT02589665|65277211|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
23418360|NCT02589665|65277202|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
23418361|NCT02589665|65277203|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
23418362|NCT02589665|65277204|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
23418363|NCT02589665|65277205|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
23418364|NCT02589665|65277206|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
23418365|NCT02589665|65277207|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
23418366|NCT02589665|65277208|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
23418367|NCT02589665|65277209|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
23418368|NCT02589665|65277210|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
23418369|NCT02589665|65277211|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
23418370|NCT02589665|65277202|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
23418371|NCT02589665|65277203|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
23418372|NCT02589665|65277204|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
23418373|NCT02589665|65277205|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
23418374|NCT02589665|65277206|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
23418375|NCT02589665|65277207|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
23418376|NCT02589665|65277208|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
23418377|NCT02589665|65277209|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
23418378|NCT02589665|65277210|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
23418379|NCT02589665|65277211|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
23418380|NCT02589665|65277202|FG000|Maintenance Extension Period|Adverse Event|0|||
23418381|NCT02589665|65277203|FG001|Maintenance Extension Period|Adverse Event|0|||
23418382|NCT02589665|65277204|FG002|Maintenance Extension Period|Adverse Event|0|||
23418383|NCT02589665|65277205|FG003|Maintenance Extension Period|Adverse Event|0|||
23418384|NCT02589665|65277206|FG004|Maintenance Extension Period|Adverse Event|0|||
23527721|NCT01856543|65669253|FG001|Overall Study|Treatment discontinued|3|||
23527722|NCT01856543|65669252|FG000|Overall Study|Withdrawn before start|7|||
23527723|NCT01856543|65669253|FG001|Overall Study|Withdrawn before start|3|||
23527724|NCT03029624|65669255|FG000|Overall Study|Adverse Event|1|||
23527725|NCT03029624|65669255|FG000|Overall Study|Withdrawal by Subject|1|||
23527726|NCT03029624|65669255|FG000|Overall Study|Lack of Efficacy|1|||
23527727|NCT03029624|65669255|FG000|Overall Study|MRI need|2|||
23527728|NCT04334460|65669257|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
23813092|NCT04844762|66696131|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813093|NCT04844762|66696132|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813094|NCT04844762|66696133|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23527729|NCT04334460|65669258|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
23527730|NCT04334460|65669257|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
23813095|NCT04844762|66696134|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23418385|NCT02589665|65277207|FG005|Maintenance Extension Period|Adverse Event|0|||
23527731|NCT04334460|65669258|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
23527732|NCT01393743|65669259|FG000|Core Study|Adverse Event|5|||
23527733|NCT01393743|65669260|FG001|Core Study|Adverse Event|9|||
23527734|NCT01393743|65669261|FG002|Core Study|Adverse Event|0|||
23527735|NCT01393743|65669259|FG000|Core Study|Lost to Follow-up|1|||
23527736|NCT01393743|65669260|FG001|Core Study|Lost to Follow-up|1|||
23527737|NCT01393743|65669261|FG002|Core Study|Lost to Follow-up|0|||
23527738|NCT01393743|65669259|FG000|Core Study|Participant's Choice|2|||
23527739|NCT01393743|65669260|FG001|Core Study|Participant's Choice|3|||
23418386|NCT02589665|65277208|FG006|Maintenance Extension Period|Adverse Event|0|||
23418387|NCT02589665|65277209|FG007|Maintenance Extension Period|Adverse Event|0|||
23418388|NCT02589665|65277210|FG008|Maintenance Extension Period|Adverse Event|0|||
23418389|NCT02589665|65277211|FG009|Maintenance Extension Period|Adverse Event|2|||
23418390|NCT02589665|65277202|FG000|Maintenance Extension Period|Non-responder|0|||
23418391|NCT02589665|65277203|FG001|Maintenance Extension Period|Non-responder|0|||
23527740|NCT01393743|65669261|FG002|Core Study|Participant's Choice|0|||
23527741|NCT01393743|65669259|FG000|Core Study|Inadequate therapeutic effect|2|||
23527742|NCT01393743|65669260|FG001|Core Study|Inadequate therapeutic effect|0|||
23527743|NCT01393743|65669261|FG002|Core Study|Inadequate therapeutic effect|0|||
23527744|NCT01393743|65669259|FG000|Extension Phase|Adverse Event|0|||
23527745|NCT01393743|65669260|FG001|Extension Phase|Adverse Event|0|||
23527746|NCT01393743|65669261|FG002|Extension Phase|Adverse Event|12|||
23527747|NCT01393743|65669259|FG000|Extension Phase|Lost to Follow-up|0|||
23527748|NCT01393743|65669260|FG001|Extension Phase|Lost to Follow-up|0|||
23527749|NCT01393743|65669261|FG002|Extension Phase|Lost to Follow-up|2|||
23527750|NCT01393743|65669259|FG000|Extension Phase|Participant choice|0|||
23527751|NCT01393743|65669260|FG001|Extension Phase|Participant choice|0|||
23527752|NCT01393743|65669261|FG002|Extension Phase|Participant choice|16|||
23527753|NCT01393743|65669259|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23527754|NCT01393743|65669260|FG001|Extension Phase|Inadequate therapeutic effect|0|||
23527755|NCT01393743|65669261|FG002|Extension Phase|Inadequate therapeutic effect|7|||
23418392|NCT02589665|65277204|FG002|Maintenance Extension Period|Non-responder|0|||
23418393|NCT02589665|65277205|FG003|Maintenance Extension Period|Non-responder|0|||
23418394|NCT02589665|65277206|FG004|Maintenance Extension Period|Non-responder|0|||
23418395|NCT02589665|65277207|FG005|Maintenance Extension Period|Non-responder|0|||
23418396|NCT02589665|65277208|FG006|Maintenance Extension Period|Non-responder|0|||
23418397|NCT02589665|65277209|FG007|Maintenance Extension Period|Non-responder|0|||
23418398|NCT02589665|65277210|FG008|Maintenance Extension Period|Non-responder|0|||
23418399|NCT02589665|65277211|FG009|Maintenance Extension Period|Non-responder|1|||
23418400|NCT01110330|65277212|FG000|Overall Study|Adverse Event|0|||
23418401|NCT01110330|65277213|FG001|Overall Study|Adverse Event|4|||
23418402|NCT01110330|65277214|FG002|Overall Study|Adverse Event|3|||
23716942|NCT01815580|66337075|FG000|Overall Study|Lost to Follow-up|4|||
23716943|NCT01815580|66337076|FG001|Overall Study|Lost to Follow-up|7|||
23716944|NCT01815580|66337075|FG000|Overall Study|Withdrawal by Subject|3|||
23716945|NCT01815580|66337076|FG001|Overall Study|Withdrawal by Subject|4|||
23716946|NCT01815580|66337075|FG000|Overall Study|Excluded from analysis|5|||
23716947|NCT01815580|66337076|FG001|Overall Study|Excluded from analysis|4|||
23716948|NCT02119026|66340439|FG000|1st-line Treatment|Adverse Event|9|||
23716949|NCT02119026|66340440|FG001|1st-line Treatment|Adverse Event|14|||
23716950|NCT02119026|66340439|FG000|1st-line Treatment|Physician Decision|3|||
23716951|NCT02119026|66340440|FG001|1st-line Treatment|Physician Decision|8|||
23716952|NCT02119026|66340439|FG000|1st-line Treatment|Withdrawal by Subject|4|||
23716953|NCT02119026|66340440|FG001|1st-line Treatment|Withdrawal by Subject|10|||
23716954|NCT02119026|66340439|FG000|1st-line Treatment|Patient condition or compliance|6|||
23716955|NCT02119026|66340440|FG001|1st-line Treatment|Patient condition or compliance|4|||
23716956|NCT02119026|66340439|FG000|1st-line Treatment|Surgery of metastases|2|||
23716957|NCT02119026|66340440|FG001|1st-line Treatment|Surgery of metastases|1|||
23716958|NCT02119026|66340439|FG000|1st-line Treatment|Death|2|||
23418403|NCT01110330|65277212|FG000|Overall Study|Lack of Efficacy|3|||
23418404|NCT01110330|65277213|FG001|Overall Study|Lack of Efficacy|1|||
23418405|NCT01110330|65277214|FG002|Overall Study|Lack of Efficacy|1|||
23418406|NCT01110330|65277212|FG000|Overall Study|Lost to Follow-up|9|||
23418407|NCT01110330|65277213|FG001|Overall Study|Lost to Follow-up|10|||
23527756|NCT01393743|65669259|FG000|Extension Phase|Withdrawal by Subject|0|||
23527757|NCT01393743|65669260|FG001|Extension Phase|Withdrawal by Subject|0|||
23527758|NCT01393743|65669261|FG002|Extension Phase|Withdrawal by Subject|8|||
23418408|NCT01110330|65277214|FG002|Overall Study|Lost to Follow-up|15|||
23418409|NCT01110330|65277212|FG000|Overall Study|Physician Decision|0|||
23527759|NCT01393743|65669259|FG000|Extension Phase|Pregnancy|0|||
23527760|NCT01393743|65669260|FG001|Extension Phase|Pregnancy|0|||
23527761|NCT01393743|65669261|FG002|Extension Phase|Pregnancy|1|||
23716959|NCT02119026|66340440|FG001|1st-line Treatment|Death|1|||
23716960|NCT02119026|66340439|FG000|2nd-line Treatment|Lost to Follow-up|2|||
23716961|NCT02119026|66340440|FG001|2nd-line Treatment|Lost to Follow-up|0|||
23716962|NCT02119026|66340439|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
23716963|NCT02119026|66340440|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
23716964|NCT02119026|66340439|FG000|2nd-line Treatment|Adverse Event|4|||
23716965|NCT02119026|66340440|FG001|2nd-line Treatment|Adverse Event|1|||
23716966|NCT02849626|66340441|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
23716967|NCT02849626|66340442|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
23418410|NCT01110330|65277213|FG001|Overall Study|Physician Decision|1|||
23418411|NCT01110330|65277214|FG002|Overall Study|Physician Decision|0|||
23527762|NCT01393743|65669259|FG000|Extension Phase|Other|0|||
23418412|NCT01110330|65277212|FG000|Overall Study|Protocol Violation|2|||
23418413|NCT01110330|65277213|FG001|Overall Study|Protocol Violation|0|||
23418414|NCT01110330|65277214|FG002|Overall Study|Protocol Violation|4|||
23527763|NCT01393743|65669260|FG001|Extension Phase|Other|0|||
23527764|NCT01393743|65669261|FG002|Extension Phase|Other|14|||
23527765|NCT02920983|65669264|FG000|Dispense 1|Unacceptable Lens Fit|0|||
23527766|NCT02920983|65669265|FG001|Dispense 1|Unacceptable Lens Fit|0|||
23716968|NCT02849626|66340443|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
23716969|NCT02849626|66340444|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
23716970|NCT02849626|66340441|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
23418415|NCT01110330|65277212|FG000|Overall Study|Withdrawal by Subject|0|||
23418416|NCT01110330|65277213|FG001|Overall Study|Withdrawal by Subject|6|||
23418417|NCT01110330|65277214|FG002|Overall Study|Withdrawal by Subject|2|||
23418418|NCT01110330|65277212|FG000|Overall Study|Other|1|||
23418419|NCT01110330|65277213|FG001|Overall Study|Other|1|||
23418420|NCT01110330|65277214|FG002|Overall Study|Other|1|||
23418421|NCT04049266|65277215|FG000|Overall Study|Adverse Event|16|||
23418422|NCT04049266|65277216|FG001|Overall Study|Adverse Event|9|||
23418423|NCT04049266|65277215|FG000|Overall Study|Non-compliance with study drug|0|||
23418424|NCT04049266|65277216|FG001|Overall Study|Non-compliance with study drug|3|||
23418425|NCT04049266|65277215|FG000|Overall Study|Withdrawal by Subject|6|||
23418426|NCT04049266|65277216|FG001|Overall Study|Withdrawal by Subject|10|||
23418427|NCT04049266|65277215|FG000|Overall Study|Lost to Follow-up|2|||
23418428|NCT04049266|65277216|FG001|Overall Study|Lost to Follow-up|2|||
23716971|NCT02849626|66340442|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
23716972|NCT02849626|66340443|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
23716973|NCT02849626|66340444|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
23716974|NCT02849626|66340441|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
23716975|NCT02849626|66340442|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
23716976|NCT02849626|66340443|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
23716977|NCT02849626|66340444|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
23716978|NCT02849626|66340441|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
23716979|NCT02849626|66340442|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
23716980|NCT02849626|66340443|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
23716981|NCT02849626|66340444|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
23716982|NCT02849626|66340441|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
23716983|NCT02849626|66340442|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
23716984|NCT02849626|66340443|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
23716985|NCT02849626|66340444|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
23716986|NCT02849626|66340441|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
23716987|NCT02849626|66340442|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23716988|NCT02849626|66340443|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23716989|NCT02849626|66340444|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23716990|NCT02849626|66340441|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
23716991|NCT02849626|66340442|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
23716992|NCT02849626|66340443|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
23716993|NCT02849626|66340444|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
23716994|NCT02849626|66340441|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
23716995|NCT02849626|66340442|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23716996|NCT02849626|66340443|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23716997|NCT02849626|66340444|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23716998|NCT02849626|66340441|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23716999|NCT02849626|66340442|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23717000|NCT02849626|66340443|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
23717001|NCT02849626|66340444|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23717002|NCT02849626|66340441|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23717003|NCT02849626|66340442|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23717004|NCT02849626|66340443|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
23717005|NCT02849626|66340444|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23717006|NCT02849626|66340441|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
23717007|NCT02849626|66340442|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
23717008|NCT02849626|66340443|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
23717009|NCT02849626|66340444|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
23717010|NCT04154943|66340447|FG000|Overall Study|Study Ongoing|68|||
23717011|NCT04154943|66340447|FG000|Overall Study|Lost to Follow-up|1|||
23717012|NCT04154943|66340447|FG000|Overall Study|Decision by the Investigator|1|||
23717013|NCT04154943|66340447|FG000|Overall Study|Death|5|||
23717014|NCT04154943|66340447|FG000|Overall Study|Withdrawal by Subject|4|||
23717015|NCT01204697|66340448|FG000|Overall Study|Death|26|||
23717016|NCT01204697|66340449|FG001|Overall Study|Death|27|||
23717017|NCT01204697|66340448|FG000|Overall Study|Lost to Follow-up|3|||
23717018|NCT01204697|66340449|FG001|Overall Study|Lost to Follow-up|4|||
23717019|NCT01204697|66340448|FG000|Overall Study|Withdrawal by Subject|2|||
23717020|NCT01204697|66340449|FG001|Overall Study|Withdrawal by Subject|4|||
23717021|NCT01204697|66340448|FG000|Overall Study|Randomized, but not treated|0|||
23717022|NCT01204697|66340449|FG001|Overall Study|Randomized, but not treated|1|||
23717023|NCT03097614|66340451|FG000|Overall Study|Adverse Event|3|||
23717024|NCT02282982|66340452|FG000|Overall Study|Lost to Follow-up|15|||
23717025|NCT02282982|66340452|FG000|Overall Study|Withdrew consent|2|||
23717026|NCT02282982|66340452|FG000|Overall Study|Death|4|||
23418429|NCT04049266|65277215|FG000|Overall Study|Progressive disease|11|||
23717027|NCT02282982|66340452|FG000|Overall Study|Lack of product|156|||
23418430|NCT04049266|65277216|FG001|Overall Study|Progressive disease|2|||
23717028|NCT02282982|66340452|FG000|Overall Study|Palivizumab is ended|11|||
23717029|NCT02282982|66340452|FG000|Overall Study|Other, not specified|18|||
23717030|NCT02273037|66340457|FG000|Overall Study|Lost to Follow-up|1|||
23717031|NCT02273037|66340458|FG001|Overall Study|Lost to Follow-up|0|||
23717032|NCT02273037|66340457|FG000|Overall Study|Delivered before monitoring initiated|1|||
23717033|NCT02273037|66340458|FG001|Overall Study|Delivered before monitoring initiated|3|||
23717034|NCT02273037|66340457|FG000|Overall Study|Breech delivery|2|||
23717035|NCT02273037|66340458|FG001|Overall Study|Breech delivery|3|||
23717036|NCT02273037|66340457|FG000|Overall Study|Multiple delivery|2|||
23717037|NCT02273037|66340458|FG001|Overall Study|Multiple delivery|2|||
23717038|NCT02273037|66340457|FG000|Overall Study|Other complication|2|||
23717039|NCT02273037|66340458|FG001|Overall Study|Other complication|0|||
23717040|NCT00793182|66340463|FG000|Overall Study|Adverse Event|0|||
23717041|NCT00793182|66340464|FG001|Overall Study|Adverse Event|1|||
23717042|NCT00631540|66340467|FG000|Overall Study|Withdrawal by Subject|5|||
23717043|NCT00631540|66340467|FG000|Overall Study|Death|4|||
23717044|NCT00631540|66340467|FG000|Overall Study|Lost to Follow-up|2|||
23717045|NCT00631540|66340467|FG000|Overall Study|Core Lab Data Unavailable|3|||
23717046|NCT04046341|66340468|FG000|Overall Study|Lost to Follow-up|2|||
23717047|NCT04046341|66340468|FG000|Overall Study|Withdrawal by Subject|1|||
23717048|NCT00213980|66340469|FG000|Overall Study|Withdrawal by Subject|3|||
23717049|NCT00213980|66340470|FG001|Overall Study|Withdrawal by Subject|1|||
23717050|NCT00213980|66340469|FG000|Overall Study|Adverse Event|1|||
23717051|NCT00213980|66340470|FG001|Overall Study|Adverse Event|1|||
23717052|NCT00213980|66340469|FG000|Overall Study|Disease progression|0|||
23717053|NCT00213980|66340470|FG001|Overall Study|Disease progression|2|||
23717054|NCT00213980|66340469|FG000|Overall Study|Developed ovarian cancer|1|||
23717055|NCT00213980|66340470|FG001|Overall Study|Developed ovarian cancer|0|||
23717056|NCT00213980|66340469|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
23717057|NCT00213980|66340470|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
23717058|NCT00881361|66340483|FG000|Overall Study|Terminated prior to surgery|27|||
23717059|NCT00881361|66340484|FG001|Overall Study|Terminated prior to surgery|7|||
23717060|NCT00881361|66340485|FG002|Overall Study|Terminated prior to surgery|0|||
23717061|NCT00881361|66340483|FG000|Overall Study|Ineligible|17|||
23717062|NCT00881361|66340484|FG001|Overall Study|Ineligible|2|||
23717063|NCT00881361|66340485|FG002|Overall Study|Ineligible|2|||
23717064|NCT00862654|66340486|FG000|Overall Study|Lack of Efficacy|1|||
23717065|NCT00862654|66340487|FG001|Overall Study|Lack of Efficacy|0|||
23717066|NCT00862654|66340488|FG002|Overall Study|Lack of Efficacy|1|||
23717067|NCT00862654|66340489|FG003|Overall Study|Lack of Efficacy|0|||
23717068|NCT00862654|66340486|FG000|Overall Study|Lost to Follow-up|1|||
23717069|NCT00862654|66340487|FG001|Overall Study|Lost to Follow-up|2|||
23717070|NCT00862654|66340488|FG002|Overall Study|Lost to Follow-up|1|||
23717071|NCT00862654|66340489|FG003|Overall Study|Lost to Follow-up|3|||
23717072|NCT00862654|66340486|FG000|Overall Study|Adverse Event|0|||
23717073|NCT00862654|66340487|FG001|Overall Study|Adverse Event|1|||
23717074|NCT00862654|66340488|FG002|Overall Study|Adverse Event|1|||
23717075|NCT00862654|66340489|FG003|Overall Study|Adverse Event|0|||
23717076|NCT00862654|66340486|FG000|Overall Study|Pregnancy|1|||
23717077|NCT00862654|66340487|FG001|Overall Study|Pregnancy|1|||
23717078|NCT00862654|66340488|FG002|Overall Study|Pregnancy|0|||
23717079|NCT00862654|66340489|FG003|Overall Study|Pregnancy|0|||
23717080|NCT00862654|66340486|FG000|Overall Study|Withdrawal by Subject|2|||
23717081|NCT00862654|66340487|FG001|Overall Study|Withdrawal by Subject|2|||
23717082|NCT00862654|66340488|FG002|Overall Study|Withdrawal by Subject|2|||
23717083|NCT00862654|66340489|FG003|Overall Study|Withdrawal by Subject|3|||
23717084|NCT00862654|66340486|FG000|Overall Study|Subject mistake|0|||
23717085|NCT00862654|66340487|FG001|Overall Study|Subject mistake|1|||
23717086|NCT00862654|66340488|FG002|Overall Study|Subject mistake|0|||
23527767|NCT02920983|65669266|FG002|Dispense 1|Unacceptable Lens Fit|0|||
23717087|NCT00862654|66340489|FG003|Overall Study|Subject mistake|0|||
23717088|NCT00862654|66340486|FG000|Overall Study|Familly constraint|0|||
23717089|NCT00862654|66340487|FG001|Overall Study|Familly constraint|1|||
23717090|NCT00862654|66340488|FG002|Overall Study|Familly constraint|0|||
23717091|NCT00862654|66340489|FG003|Overall Study|Familly constraint|0|||
23717092|NCT00862654|66340486|FG000|Overall Study|Never used study drugs|1|||
23717093|NCT00862654|66340487|FG001|Overall Study|Never used study drugs|0|||
23717094|NCT00862654|66340488|FG002|Overall Study|Never used study drugs|0|||
23717095|NCT00862654|66340489|FG003|Overall Study|Never used study drugs|0|||
23717096|NCT00862654|66340486|FG000|Overall Study|Included after end of inclusions|0|||
23717097|NCT00862654|66340487|FG001|Overall Study|Included after end of inclusions|0|||
23717098|NCT00862654|66340488|FG002|Overall Study|Included after end of inclusions|1|||
23717099|NCT00862654|66340489|FG003|Overall Study|Included after end of inclusions|0|||
23717100|NCT02247401|66340494|FG000|Overall Study|Adverse Event|1|||
23717101|NCT02247401|66340495|FG001|Overall Study|Adverse Event|0|||
23527768|NCT02920983|65669267|FG003|Dispense 1|Unacceptable Lens Fit|0|||
23717102|NCT02247401|66340496|FG002|Overall Study|Adverse Event|0|||
23717103|NCT02247401|66340494|FG000|Overall Study|Withdrawal by Subject|4|||
23717104|NCT02247401|66340495|FG001|Overall Study|Withdrawal by Subject|1|||
23717105|NCT02247401|66340496|FG002|Overall Study|Withdrawal by Subject|1|||
23717106|NCT02247401|66340494|FG000|Overall Study|Lost to Follow-up|1|||
23717107|NCT02247401|66340495|FG001|Overall Study|Lost to Follow-up|1|||
23418431|NCT04049266|65277215|FG000|Overall Study|Physician Decision|1|||
23418432|NCT04049266|65277216|FG001|Overall Study|Physician Decision|0|||
23418433|NCT04049266|65277215|FG000|Overall Study|Patient moved out of state|1|||
23418434|NCT04049266|65277216|FG001|Overall Study|Patient moved out of state|0|||
23717108|NCT02247401|66340496|FG002|Overall Study|Lost to Follow-up|1|||
23717109|NCT03495453|66340499|FG000|Overall Study|Withdrawal by Subject|0|||
23813096|NCT04844762|66696135|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23813097|NCT04844762|66696136|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23813098|NCT04844762|66696131|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
23813099|NCT04844762|66696132|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813100|NCT04844762|66696133|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813101|NCT04844762|66696134|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813102|NCT04844762|66696135|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23813103|NCT04844762|66696136|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23418435|NCT04085458|65277217|FG000|Overall Study|Other|1|||
23418436|NCT04085458|65277217|FG000|Overall Study|Withdrawal by Subject|2|||
23418437|NCT04085458|65277217|FG000|Overall Study|Adverse Event|2|||
23418438|NCT02141399|65277222|FG000|Overall Study|Adverse Event|158|||
23418439|NCT02141399|65277222|FG000|Overall Study|Lack of Efficacy|62|||
23418440|NCT02141399|65277222|FG000|Overall Study|Lost to Follow-up|151|||
23717110|NCT03495453|66340500|FG001|Overall Study|Withdrawal by Subject|1|||
23717111|NCT02674685|66340505|FG000|Overall Study|Withdrawal by Subject|4|||
23717112|NCT02585999|66340506|FG000|Overall Study|Lost to Follow-up|1|||
23717113|NCT02585999|66340506|FG000|Overall Study|Protocol Violation|1|||
23717114|NCT02494778|66340510|FG000|Overall Study|Death|3|||
23717115|NCT02494778|66340510|FG000|Overall Study|Other|173|||
23717116|NCT02494778|66340510|FG000|Overall Study|Lack of Efficacy|4|||
23418441|NCT02141399|65277222|FG000|Overall Study|Non-compliance with study drug|18|||
23418442|NCT02141399|65277222|FG000|Overall Study|Other|45|||
23418443|NCT02141399|65277222|FG000|Overall Study|Physician Decision|17|||
23418444|NCT02141399|65277222|FG000|Overall Study|Pregnancy|3|||
23527769|NCT02920983|65669268|FG004|Dispense 1|Unacceptable Lens Fit|1|||
23527770|NCT02920983|65669269|FG005|Dispense 1|Unacceptable Lens Fit|0|||
23527771|NCT02920983|65669264|FG000|Dispense 2|Unscceptable lens fit|1|||
23527772|NCT02920983|65669265|FG001|Dispense 2|Unscceptable lens fit|0|||
23527773|NCT02920983|65669266|FG002|Dispense 2|Unscceptable lens fit|0|||
23527774|NCT02920983|65669267|FG003|Dispense 2|Unscceptable lens fit|0|||
23527775|NCT02920983|65669268|FG004|Dispense 2|Unscceptable lens fit|1|||
23527776|NCT02920983|65669269|FG005|Dispense 2|Unscceptable lens fit|0|||
23527777|NCT02920983|65669264|FG000|Dispense 3|Unacceptable Lens Fit|1|||
23527778|NCT02920983|65669265|FG001|Dispense 3|Unacceptable Lens Fit|1|||
23527779|NCT02920983|65669266|FG002|Dispense 3|Unacceptable Lens Fit|0|||
23527780|NCT02920983|65669267|FG003|Dispense 3|Unacceptable Lens Fit|0|||
23527781|NCT02920983|65669268|FG004|Dispense 3|Unacceptable Lens Fit|1|||
23527782|NCT02920983|65669269|FG005|Dispense 3|Unacceptable Lens Fit|0|||
23527783|NCT01256593|65669270|FG000|Overall Study|Protocol Violation|26|||
23527784|NCT01256593|65669270|FG000|Overall Study|No Drug Administration Information|2|||
23527785|NCT01256593|65669270|FG000|Overall Study|No Visit After Treatment|186|||
23527786|NCT00855309|65669273|FG000|Overall Study|patient never recieved drug|1|||
23527787|NCT00855309|65669274|FG001|Overall Study|patient never recieved drug|0|||
23527788|NCT02932904|65669282|FG000|Overall Study|Reason not Specified|1|||
23527789|NCT02932904|65669283|FG001|Overall Study|Reason not Specified|0|||
23527790|NCT02932904|65669284|FG002|Overall Study|Reason not Specified|2|||
23527791|NCT02932904|65669285|FG003|Overall Study|Reason not Specified|2|||
23527792|NCT02932904|65669282|FG000|Overall Study|Noncompliance with Study Drug|2|||
23527793|NCT02932904|65669283|FG001|Overall Study|Noncompliance with Study Drug|3|||
23527794|NCT02932904|65669284|FG002|Overall Study|Noncompliance with Study Drug|3|||
23527795|NCT02932904|65669285|FG003|Overall Study|Noncompliance with Study Drug|4|||
23527796|NCT02932904|65669282|FG000|Overall Study|Pregnancy|0|||
23527797|NCT02932904|65669283|FG001|Overall Study|Pregnancy|1|||
23527798|NCT02932904|65669284|FG002|Overall Study|Pregnancy|1|||
23717117|NCT02494778|66340510|FG000|Overall Study|Adverse Event|18|||
23717118|NCT02494778|66340510|FG000|Overall Study|Withdrawal by Subject|20|||
23813104|NCT04844762|66696131|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23527799|NCT02932904|65669285|FG003|Overall Study|Pregnancy|0|||
23527800|NCT02932904|65669282|FG000|Overall Study|Study Termination|0|||
23527801|NCT02932904|65669283|FG001|Overall Study|Study Termination|1|||
23527802|NCT02932904|65669284|FG002|Overall Study|Study Termination|0|||
23527803|NCT02932904|65669285|FG003|Overall Study|Study Termination|0|||
23717119|NCT02494778|66340510|FG000|Overall Study|Lost to Follow-up|2|||
23717120|NCT02494778|66340510|FG000|Overall Study|Noncompliant with study drug admin.|1|||
23418445|NCT02141399|65277222|FG000|Overall Study|Protocol Violation|38|||
23418446|NCT02141399|65277222|FG000|Overall Study|Withdrawal by Subject|238|||
23527804|NCT02932904|65669282|FG000|Overall Study|Voluntary Withdrawal|2|||
23717121|NCT00818207|66340511|FG000|Overall Study|Adverse Event|6|||
23717122|NCT00818207|66340512|FG001|Overall Study|Adverse Event|0|||
23717123|NCT00818207|66340511|FG000|Overall Study|Lost to Follow-up|160|||
23717124|NCT00818207|66340512|FG001|Overall Study|Lost to Follow-up|146|||
23717125|NCT00818207|66340511|FG000|Overall Study|Multiple reasons|11|||
23717126|NCT00818207|66340512|FG001|Overall Study|Multiple reasons|12|||
23527805|NCT02932904|65669283|FG001|Overall Study|Voluntary Withdrawal|1|||
23527806|NCT02932904|65669284|FG002|Overall Study|Voluntary Withdrawal|4|||
23527807|NCT02932904|65669285|FG003|Overall Study|Voluntary Withdrawal|2|||
23527808|NCT02932904|65669282|FG000|Overall Study|Lost to Follow-up|5|||
23527809|NCT02932904|65669283|FG001|Overall Study|Lost to Follow-up|3|||
23527810|NCT02932904|65669284|FG002|Overall Study|Lost to Follow-up|6|||
23527811|NCT02932904|65669285|FG003|Overall Study|Lost to Follow-up|0|||
23527812|NCT02932904|65669282|FG000|Overall Study|Significant Protocol Deviation|2|||
23527813|NCT02932904|65669283|FG001|Overall Study|Significant Protocol Deviation|3|||
23527814|NCT02932904|65669284|FG002|Overall Study|Significant Protocol Deviation|6|||
23527815|NCT02932904|65669285|FG003|Overall Study|Significant Protocol Deviation|1|||
23527816|NCT02932904|65669282|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23527817|NCT02932904|65669283|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
23527818|NCT02932904|65669284|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23527819|NCT02932904|65669285|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
23527820|NCT02932904|65669282|FG000|Overall Study|Randomized But Not Treated|1|||
23527821|NCT02932904|65669283|FG001|Overall Study|Randomized But Not Treated|1|||
23527822|NCT02932904|65669284|FG002|Overall Study|Randomized But Not Treated|0|||
23527823|NCT02932904|65669285|FG003|Overall Study|Randomized But Not Treated|2|||
23527824|NCT01600586|65669286|FG000|Overall Study|Physician Decision|3|||
23527825|NCT01600586|65669287|FG001|Overall Study|Physician Decision|3|||
23527826|NCT00360334|65669289|FG000|Overall Study|Adverse Event|7|||
23527827|NCT00360334|65669290|FG001|Overall Study|Adverse Event|4|||
23527828|NCT00360334|65669289|FG000|Overall Study|Protocol Violation|1|||
23527829|NCT00360334|65669290|FG001|Overall Study|Protocol Violation|1|||
23527830|NCT00360334|65669289|FG000|Overall Study|Physician Decision|2|||
23527831|NCT00360334|65669290|FG001|Overall Study|Physician Decision|3|||
23527832|NCT00360334|65669289|FG000|Overall Study|Lack of Efficacy|0|||
23527833|NCT00360334|65669290|FG001|Overall Study|Lack of Efficacy|1|||
23527834|NCT00360334|65669289|FG000|Overall Study|Entry criterion not met|1|||
23527835|NCT00360334|65669290|FG001|Overall Study|Entry criterion not met|2|||
23527836|NCT00360334|65669289|FG000|Overall Study|Subject decision|8|||
23527837|NCT00360334|65669290|FG001|Overall Study|Subject decision|2|||
23527838|NCT01524770|65669291|FG000|First Intervention|Withdrawal by Subject|1|||
23527839|NCT01524770|65669292|FG001|First Intervention|Withdrawal by Subject|0|||
23527840|NCT01524770|65669291|FG000|First Intervention|Adverse Event|1|||
23527841|NCT01524770|65669292|FG001|First Intervention|Adverse Event|1|||
23527842|NCT01524770|65669291|FG000|First Intervention|Protocol Violation|1|||
23527843|NCT01524770|65669292|FG001|First Intervention|Protocol Violation|0|||
23527844|NCT00670228|65669295|FG000|Overall Study|Adverse Event|1|||
23527845|NCT00670228|65669296|FG001|Overall Study|Adverse Event|0|||
23527846|NCT00670228|65669295|FG000|Overall Study|Death or MACE|0|||
23527847|NCT00670228|65669296|FG001|Overall Study|Death or MACE|1|||
23527848|NCT00670228|65669295|FG000|Overall Study|Not treated|2|||
23717127|NCT00818207|66340511|FG000|Overall Study|Withdrawal by Subject|42|||
23717128|NCT00818207|66340512|FG001|Overall Study|Withdrawal by Subject|104|||
23717129|NCT00818207|66340511|FG000|Overall Study|Death|3|||
23717130|NCT00818207|66340512|FG001|Overall Study|Death|5|||
23717131|NCT01686958|66340513|FG000|Overall Study|Withdrawal by Subject|1|||
23717132|NCT04209530|66340514|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
23717133|NCT04209530|66340515|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
23717134|NCT04209530|66340514|FG000|Overall Study|Withdrawal by Subject|0|||
23717135|NCT04209530|66340515|FG001|Overall Study|Withdrawal by Subject|1|||
23717136|NCT02483078|66340517|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
23717137|NCT02483078|66340518|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
23717138|NCT02483078|66340517|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
23717139|NCT02483078|66340518|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
23527849|NCT00670228|65669296|FG001|Overall Study|Not treated|2|||
23527850|NCT00670228|65669295|FG000|Overall Study|Not meeting the selection criteria|2|||
23527851|NCT00670228|65669296|FG001|Overall Study|Not meeting the selection criteria|0|||
23527852|NCT02849548|65669297|FG000|Overall Study|Lost to Follow-up|1|||
23717140|NCT02483078|66340517|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23717141|NCT02483078|66340518|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
23527853|NCT02849548|65669298|FG001|Overall Study|Lost to Follow-up|2|||
23527854|NCT02849548|65669297|FG000|Overall Study|Protocol Violation|1|||
23527855|NCT02849548|65669298|FG001|Overall Study|Protocol Violation|0|||
23527856|NCT00779675|65669299|FG000|Treatment Period|Adverse Event|87|||
23527857|NCT00779675|65669299|FG000|Treatment Period|Treatment Failure|80|||
23813105|NCT04844762|66696132|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23717142|NCT02483078|66340517|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
23813106|NCT04844762|66696133|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23527858|NCT00779675|65669299|FG000|Treatment Period|Transferred to Another Study|38|||
23527859|NCT00779675|65669299|FG000|Treatment Period|Lost to Follow-up|23|||
23527860|NCT00779675|65669299|FG000|Treatment Period|Withdrawal by Subject|46|||
23527861|NCT00779675|65669299|FG000|Treatment Period|Protocol Violation|54|||
23527862|NCT00779675|65669299|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
23527863|NCT00779675|65669299|FG000|Treatment Period|Administrative|3|||
23527864|NCT00779675|65669299|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
23527865|NCT00779675|65669299|FG000|Extended Treatment Period|Protocol Violation|13|||
23527866|NCT00779675|65669299|FG000|Extended Treatment Period|Adverse Event|6|||
23612027|NCT03740919|65966952|FG003|Lead-in Period|Withdrawal by Subject|0|||
23612028|NCT03740919|65966949|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
23612029|NCT03740919|65966950|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612030|NCT03740919|65966951|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612031|NCT03740919|65966952|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612032|NCT03740919|65966949|FG000|Lead-in Period|Study Task Too Burdensome|1|||
23612033|NCT03740919|65966950|FG001|Lead-in Period|Study Task Too Burdensome|0|||
23612034|NCT03740919|65966951|FG002|Lead-in Period|Study Task Too Burdensome|0|||
23612035|NCT03740919|65966952|FG003|Lead-in Period|Study Task Too Burdensome|0|||
23612036|NCT03740919|65966949|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
23612037|NCT03740919|65966950|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612038|NCT03740919|65966951|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612039|NCT03740919|65966952|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612040|NCT03740919|65966949|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
23612041|NCT03740919|65966950|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612042|NCT03740919|65966951|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612043|NCT03740919|65966952|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612044|NCT03740919|65966949|FG000|Treatment Period|Adverse Event|0|||
23612045|NCT03740919|65966950|FG001|Treatment Period|Adverse Event|0|||
23612046|NCT03740919|65966951|FG002|Treatment Period|Adverse Event|2|||
23612047|NCT03740919|65966952|FG003|Treatment Period|Adverse Event|0|||
23612048|NCT03740919|65966949|FG000|Treatment Period|Protocol Violation|0|||
23612049|NCT03740919|65966950|FG001|Treatment Period|Protocol Violation|1|||
23612050|NCT03740919|65966951|FG002|Treatment Period|Protocol Violation|0|||
23612051|NCT03740919|65966952|FG003|Treatment Period|Protocol Violation|0|||
23612052|NCT03740919|65966949|FG000|Treatment Period|Withdrawal by Subject|0|||
23612053|NCT03740919|65966950|FG001|Treatment Period|Withdrawal by Subject|7|||
23612054|NCT03740919|65966951|FG002|Treatment Period|Withdrawal by Subject|6|||
23612055|NCT03740919|65966952|FG003|Treatment Period|Withdrawal by Subject|2|||
23612056|NCT03740919|65966949|FG000|Treatment Period|Terminated by Sponsor|0|||
23612057|NCT03740919|65966950|FG001|Treatment Period|Terminated by Sponsor|1|||
23612058|NCT03740919|65966951|FG002|Treatment Period|Terminated by Sponsor|0|||
23612059|NCT03740919|65966952|FG003|Treatment Period|Terminated by Sponsor|0|||
23612060|NCT03740919|65966949|FG000|Treatment Period|Issue with Insulin Pump|0|||
23612061|NCT03740919|65966950|FG001|Treatment Period|Issue with Insulin Pump|1|||
23612062|NCT03740919|65966951|FG002|Treatment Period|Issue with Insulin Pump|0|||
23612063|NCT03740919|65966952|FG003|Treatment Period|Issue with Insulin Pump|0|||
23612064|NCT03740919|65966949|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
23612065|NCT03740919|65966950|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
23527867|NCT00779675|65669299|FG000|Extended Treatment Period|Treatment Failure|11|||
23527868|NCT00779675|65669299|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
23527869|NCT00779675|65669299|FG000|Extended Treatment Period|Lost to Follow-up|6|||
23527870|NCT02547129|65669300|FG000|Overall Study|Difficulty with ongoing infection|1|||
23612066|NCT03740919|65966951|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
23612067|NCT03740919|65966952|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
23612068|NCT03740919|65966949|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
23612069|NCT03740919|65966950|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
23612070|NCT03740919|65966951|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
23612071|NCT03740919|65966952|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
23813107|NCT04844762|66696134|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813108|NCT04844762|66696135|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23813109|NCT04844762|66696136|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23527871|NCT02547129|65669301|FG001|Overall Study|Difficulty with ongoing infection|0|||
23527872|NCT02052739|65669302|FG000|Overall Study|Withdrew due to Adverse Event|3|||
23527873|NCT02052739|65669303|FG001|Overall Study|Withdrew due to Adverse Event|0|||
23612072|NCT03740919|65966949|FG000|Treatment Period|Not Completing Diary|0|||
23612073|NCT03740919|65966950|FG001|Treatment Period|Not Completing Diary|0|||
23612074|NCT03740919|65966951|FG002|Treatment Period|Not Completing Diary|1|||
23612075|NCT03740919|65966952|FG003|Treatment Period|Not Completing Diary|0|||
23612076|NCT03740919|65966949|FG000|Treatment Period|Insulin Painful to Participant|0|||
23813110|NCT04844762|66696131|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23813111|NCT04844762|66696132|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
23813112|NCT04844762|66696133|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23813113|NCT04844762|66696134|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23813114|NCT04844762|66696135|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23813115|NCT04844762|66696136|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23527874|NCT02052739|65669302|FG000|Overall Study|Participant Died|2|||
23527875|NCT02052739|65669303|FG001|Overall Study|Participant Died|1|||
23527876|NCT04187196|65669304|FG000|Overall Study|Screen Failure|2|||
23527877|NCT04187196|65669305|FG001|Overall Study|Screen Failure|0|||
23527878|NCT00805766|65669306|FG000|Screening Period|Adverse Event|1|||
23527879|NCT00805766|65669306|FG000|Screening Period|Lack of Efficacy|2|||
23527880|NCT00805766|65669306|FG000|Screening Period|Pregnancy|1|||
23527881|NCT00805766|65669306|FG000|Screening Period|Responder|2|||
23527882|NCT00805766|65669306|FG000|Increased Dose Period|Adverse Event|4|||
23527883|NCT00805766|65669306|FG000|Increased Dose Period|Lack of Efficacy|7|||
23527884|NCT00805766|65669306|FG000|Increased Dose Period|Pregnancy|1|||
23527885|NCT00805766|65669306|FG000|Increased Dose Period|Withdrawal by Subject|1|||
23527886|NCT03102918|65669308|FG000|Overall Study|Protocol Violation|1|||
23527887|NCT03102918|65669309|FG001|Overall Study|Protocol Violation|0|||
23813116|NCT04844762|66696131|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23527888|NCT00159588|65669310|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
23527889|NCT00159588|65669311|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
23527890|NCT00159588|65669312|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
23527891|NCT01888497|65669313|FG000|Washout Period 1|Withdrawal by Subject|0|||
23813117|NCT04844762|66696132|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23813118|NCT04844762|66696133|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23813119|NCT04844762|66696134|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
23813120|NCT04844762|66696135|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23813121|NCT04844762|66696136|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23813122|NCT00394524|66699257|FG000|Overall Study|Protocol Violation|2|||
23813123|NCT00394524|66699258|FG001|Overall Study|Protocol Violation|3|||
23813124|NCT00394524|66699257|FG000|Overall Study|Death|1|||
23527892|NCT01888497|65669314|FG001|Washout Period 1|Withdrawal by Subject|0|||
23612077|NCT03740919|65966950|FG001|Treatment Period|Insulin Painful to Participant|0|||
23612078|NCT03740919|65966951|FG002|Treatment Period|Insulin Painful to Participant|1|||
23612079|NCT03740919|65966952|FG003|Treatment Period|Insulin Painful to Participant|0|||
23612080|NCT00609245|65966954|FG000|Overall Study|Adverse Event|1|||
23612081|NCT03696342|65966955|FG000|Overall Study|Lost to Follow-up|1|||
23612082|NCT03696342|65966956|FG001|Overall Study|Lost to Follow-up|0|||
23612083|NCT01021683|65966957|FG000|Overall Study|Lack of Efficacy|12|||
23612084|NCT01021683|65966957|FG000|Overall Study|Recovery of neutrophil count|51|||
23612085|NCT01021683|65966957|FG000|Overall Study|Other|8|||
23612086|NCT02014402|65966958|FG000|Overall Study|Adverse Event|1|||
23612087|NCT02014402|65966959|FG001|Overall Study|Adverse Event|0|||
23612088|NCT02014402|65966960|FG002|Overall Study|Adverse Event|0|||
23612089|NCT02014402|65966961|FG003|Overall Study|Adverse Event|0|||
23612090|NCT02014402|65966958|FG000|Overall Study|Withdrawal by Subject|1|||
23612091|NCT02014402|65966959|FG001|Overall Study|Withdrawal by Subject|2|||
23612092|NCT02014402|65966960|FG002|Overall Study|Withdrawal by Subject|2|||
23612093|NCT02014402|65966961|FG003|Overall Study|Withdrawal by Subject|1|||
23612094|NCT02014402|65966958|FG000|Overall Study|Subject did not have transportation|0|||
23612095|NCT02014402|65966959|FG001|Overall Study|Subject did not have transportation|1|||
23612096|NCT02014402|65966960|FG002|Overall Study|Subject did not have transportation|0|||
23612097|NCT02014402|65966961|FG003|Overall Study|Subject did not have transportation|0|||
23612098|NCT02014402|65966958|FG000|Overall Study|Lost to Follow-up|0|||
23612099|NCT02014402|65966959|FG001|Overall Study|Lost to Follow-up|0|||
23612100|NCT02014402|65966960|FG002|Overall Study|Lost to Follow-up|1|||
23612101|NCT02014402|65966961|FG003|Overall Study|Lost to Follow-up|2|||
23612102|NCT02097056|65966962|FG000|Overall Study|Protocol Violation|2|||
23612103|NCT02097056|65966962|FG000|Overall Study|Withdrawal by Subject|15|||
23612104|NCT02097056|65966962|FG000|Overall Study|Lost to Follow-up|2|||
23612105|NCT02097056|65966962|FG000|Overall Study|Adverse Event|37|||
23813125|NCT00394524|66699258|FG001|Overall Study|Death|0|||
23813126|NCT00394524|66699257|FG000|Overall Study|Withdrawal by Subject|0|||
23527893|NCT01888497|65669315|FG002|Washout Period 1|Withdrawal by Subject|1|||
23527894|NCT01888497|65669316|FG003|Washout Period 1|Withdrawal by Subject|1|||
23527895|NCT01888497|65669313|FG000|Washout Period 2|Adverse Event|0|||
23527896|NCT01888497|65669314|FG001|Washout Period 2|Adverse Event|0|||
23527897|NCT01888497|65669315|FG002|Washout Period 2|Adverse Event|0|||
23612106|NCT02097056|65966962|FG000|Overall Study|Other|2|||
23612107|NCT03906240|65966966|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
23612108|NCT03906240|65966967|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
23612109|NCT03906240|65966966|FG000|Overall Study|Lost to Follow-up|1|||
23612110|NCT03906240|65966967|FG001|Overall Study|Lost to Follow-up|0|||
23717143|NCT02483078|66340518|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
23717144|NCT02483078|66340517|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
23717145|NCT02483078|66340518|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
23717146|NCT02483078|66340517|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
23717147|NCT02483078|66340518|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
23717148|NCT01419080|66340520|FG000|Overall Study|Withdrawal by Subject|75|||
23717149|NCT01419080|66340520|FG000|Overall Study|Death|30|||
23717150|NCT01419080|66340520|FG000|Overall Study|Lost to Follow-up|23|||
23717151|NCT01419080|66340520|FG000|Overall Study|Too Ill|3|||
23717152|NCT02034552|66340530|FG000|Overall Study|Never treated|3|||
23717153|NCT02034552|66340531|FG001|Overall Study|Never treated|2|||
23717154|NCT02034552|66340532|FG002|Overall Study|Never treated|0|||
23612111|NCT03906240|65966966|FG000|Overall Study|Withdrawal by Subject|0|||
23612112|NCT03906240|65966967|FG001|Overall Study|Withdrawal by Subject|1|||
23612113|NCT01922102|65966968|FG000|Overall Study|Withdrawal by Subject|7|||
23612114|NCT01922102|65966969|FG001|Overall Study|Withdrawal by Subject|3|||
23612115|NCT01922102|65966970|FG002|Overall Study|Withdrawal by Subject|7|||
23612116|NCT01922102|65966968|FG000|Overall Study|Physician Decision|0|||
23612117|NCT01922102|65966969|FG001|Overall Study|Physician Decision|2|||
23612118|NCT01922102|65966970|FG002|Overall Study|Physician Decision|1|||
23612119|NCT01922102|65966968|FG000|Overall Study|Adverse Event|1|||
23612120|NCT01922102|65966969|FG001|Overall Study|Adverse Event|2|||
23612121|NCT01922102|65966970|FG002|Overall Study|Adverse Event|0|||
23612122|NCT01922102|65966968|FG000|Overall Study|Lost to Follow-up|1|||
23612123|NCT01922102|65966969|FG001|Overall Study|Lost to Follow-up|0|||
23612124|NCT01922102|65966970|FG002|Overall Study|Lost to Follow-up|0|||
23612125|NCT01922102|65966968|FG000|Overall Study|Administrative problems|0|||
23612126|NCT01922102|65966969|FG001|Overall Study|Administrative problems|2|||
23612127|NCT01922102|65966970|FG002|Overall Study|Administrative problems|0|||
23612128|NCT00409006|65966971|FG000|Overall Study|Death|15|||
23612129|NCT00409006|65966972|FG001|Overall Study|Death|6|||
23612130|NCT00409006|65966971|FG000|Overall Study|Lost to Follow-up|1|||
23612131|NCT00409006|65966972|FG001|Overall Study|Lost to Follow-up|2|||
23612132|NCT00409006|65966971|FG000|Overall Study|Withdrawal by Subject|3|||
23612133|NCT00409006|65966972|FG001|Overall Study|Withdrawal by Subject|2|||
23612134|NCT00409006|65966971|FG000|Overall Study|Physician Decision|1|||
23612135|NCT00409006|65966972|FG001|Overall Study|Physician Decision|2|||
23612136|NCT04908800|65966976|FG000|Overall Study|Adverse Event|0|||
23612137|NCT04908800|65966977|FG001|Overall Study|Adverse Event|0|||
23612138|NCT04908800|65966978|FG002|Overall Study|Adverse Event|0|||
23612139|NCT04908800|65966979|FG003|Overall Study|Adverse Event|0|||
23612140|NCT04908800|65966980|FG004|Overall Study|Adverse Event|0|||
23612141|NCT04908800|65966981|FG005|Overall Study|Adverse Event|0|||
23612142|NCT04908800|65966982|FG006|Overall Study|Adverse Event|0|||
23612143|NCT04908800|65966983|FG007|Overall Study|Adverse Event|0|||
23612144|NCT04908800|65966984|FG008|Overall Study|Adverse Event|0|||
23612145|NCT04908800|65966985|FG009|Overall Study|Adverse Event|0|||
23612146|NCT04908800|65966986|FG010|Overall Study|Adverse Event|1|||
23612147|NCT04908800|65966987|FG011|Overall Study|Adverse Event|0|||
23612148|NCT04908800|65966988|FG012|Overall Study|Adverse Event|0|||
23612149|NCT01804140|65966997|FG000|Overall Study|No sampling or biopsy procedures done|114|||
23612150|NCT01180400|65966998|FG000|Overall Study|Withdrawal by Subject|5|||
23612151|NCT01180400|65966999|FG001|Overall Study|Withdrawal by Subject|6|||
23612152|NCT01180400|65966998|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23612153|NCT01180400|65966999|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23612154|NCT01180400|65966998|FG000|Overall Study|Adverse Event|12|||
23612155|NCT01180400|65966999|FG001|Overall Study|Adverse Event|10|||
23612156|NCT01180400|65966998|FG000|Overall Study|Severe non-compliance to protocol|1|||
23612157|NCT01180400|65966999|FG001|Overall Study|Severe non-compliance to protocol|2|||
23612158|NCT01180400|65966998|FG000|Overall Study|Condition under investigation worsened|2|||
23612159|NCT01180400|65966999|FG001|Overall Study|Condition under investigation worsened|1|||
23612160|NCT01180400|65966998|FG000|Overall Study|Lack of Efficacy|2|||
23612161|NCT01180400|65966999|FG001|Overall Study|Lack of Efficacy|0|||
23612162|NCT01180400|65966998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23612163|NCT01180400|65966999|FG001|Overall Study|Study-specific withdrawal criteria|2|||
23612164|NCT01180400|65966998|FG000|Overall Study|Lost to Follow-up|2|||
23717155|NCT02034552|66340530|FG000|Overall Study|Radiological progression|3|||
23612165|NCT01180400|65966999|FG001|Overall Study|Lost to Follow-up|3|||
23612166|NCT01180400|65966998|FG000|Overall Study|Other|0|||
23612167|NCT01180400|65966999|FG001|Overall Study|Other|1|||
23612168|NCT01322347|65967000|FG000|Overall Study|Adverse Event|7|||
23612169|NCT01322347|65967001|FG001|Overall Study|Adverse Event|2|||
23612170|NCT01322347|65967000|FG000|Overall Study|Death|5|||
23612171|NCT01322347|65967001|FG001|Overall Study|Death|3|||
23612172|NCT01322347|65967000|FG000|Overall Study|Physician Decision|2|||
23717156|NCT02034552|66340531|FG001|Overall Study|Radiological progression|5|||
23612173|NCT01322347|65967001|FG001|Overall Study|Physician Decision|1|||
23612174|NCT01322347|65967000|FG000|Overall Study|Protocol Violation|5|||
23612175|NCT01322347|65967001|FG001|Overall Study|Protocol Violation|2|||
23717157|NCT02034552|66340532|FG002|Overall Study|Radiological progression|4|||
23717158|NCT02034552|66340530|FG000|Overall Study|AE not assoc. with disease progression|1|||
23717159|NCT02034552|66340531|FG001|Overall Study|AE not assoc. with disease progression|4|||
23717160|NCT02034552|66340532|FG002|Overall Study|AE not assoc. with disease progression|2|||
23717161|NCT02034552|66340530|FG000|Overall Study|AE associated with disease progression|0|||
23717162|NCT02034552|66340531|FG001|Overall Study|AE associated with disease progression|1|||
23717163|NCT02034552|66340532|FG002|Overall Study|AE associated with disease progression|0|||
23717164|NCT02034552|66340530|FG000|Overall Study|Withdrawal by Subject|2|||
23717165|NCT02034552|66340531|FG001|Overall Study|Withdrawal by Subject|1|||
23717166|NCT02034552|66340532|FG002|Overall Study|Withdrawal by Subject|1|||
23717167|NCT02034552|66340530|FG000|Overall Study|Non-compliance with study drug|0|||
23717168|NCT02034552|66340531|FG001|Overall Study|Non-compliance with study drug|0|||
23717169|NCT02034552|66340532|FG002|Overall Study|Non-compliance with study drug|1|||
23717170|NCT02034552|66340530|FG000|Overall Study|Clinical progression|5|||
23717171|NCT02034552|66340531|FG001|Overall Study|Clinical progression|7|||
23717172|NCT02034552|66340532|FG002|Overall Study|Clinical progression|9|||
23717173|NCT01245764|66340533|FG000|Study Phase A|Other|3|||
23717174|NCT01245764|66340534|FG001|Study Phase A|Other|2|||
23717175|NCT01245764|66340535|FG002|Study Phase A|Other|3|||
23717176|NCT01245764|66340536|FG003|Study Phase A|Other|1|||
23717177|NCT01245764|66340533|FG000|Study Phase A|Protocol Violation|6|||
23717178|NCT01245764|66340534|FG001|Study Phase A|Protocol Violation|3|||
23717179|NCT01245764|66340535|FG002|Study Phase A|Protocol Violation|2|||
23527898|NCT01888497|65669316|FG003|Washout Period 2|Adverse Event|1|||
23527899|NCT01888497|65669313|FG000|Washout Period 2|Withdrawal by Subject|0|||
23527900|NCT01888497|65669314|FG001|Washout Period 2|Withdrawal by Subject|0|||
23527901|NCT01888497|65669315|FG002|Washout Period 2|Withdrawal by Subject|0|||
23527902|NCT01888497|65669316|FG003|Washout Period 2|Withdrawal by Subject|1|||
23527903|NCT00994448|65669317|FG000|Overall Study|Adverse Event|1|||
23527904|NCT00994448|65669318|FG001|Overall Study|Adverse Event|0|||
23527905|NCT00994448|65669317|FG000|Overall Study|Lost to Follow-up|5|||
23527906|NCT00994448|65669318|FG001|Overall Study|Lost to Follow-up|1|||
23527907|NCT00994448|65669317|FG000|Overall Study|Withdrawal by Subject|1|||
23527908|NCT00994448|65669318|FG001|Overall Study|Withdrawal by Subject|1|||
23527909|NCT00994448|65669317|FG000|Overall Study|Physician Decision|1|||
23527910|NCT00994448|65669318|FG001|Overall Study|Physician Decision|0|||
23717180|NCT01245764|66340536|FG003|Study Phase A|Protocol Violation|2|||
23717181|NCT01245764|66340533|FG000|Study Phase A|Lost to Follow-up|0|||
23717182|NCT01245764|66340534|FG001|Study Phase A|Lost to Follow-up|0|||
23717183|NCT01245764|66340535|FG002|Study Phase A|Lost to Follow-up|5|||
23813127|NCT00394524|66699258|FG001|Overall Study|Withdrawal by Subject|1|||
23813128|NCT03822832|66699259|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
23813129|NCT03822832|66699260|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
23527911|NCT03851016|65669326|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23527912|NCT03851016|65669327|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
23527913|NCT01440322|65669334|FG000|Overall Study|Discomfort|2|||
23527914|NCT01440322|65669335|FG001|Overall Study|Discomfort|0|||
23527915|NCT01440322|65669334|FG000|Overall Study|Biomicroscopy|1|||
23527916|NCT01440322|65669335|FG001|Overall Study|Biomicroscopy|0|||
23527917|NCT01440322|65669334|FG000|Overall Study|Symptoms and Problems|1|||
23527918|NCT01440322|65669335|FG001|Overall Study|Symptoms and Problems|0|||
23527919|NCT01440322|65669334|FG000|Overall Study|Unacceptable Subjective Vision|1|||
23527920|NCT01440322|65669335|FG001|Overall Study|Unacceptable Subjective Vision|0|||
23527921|NCT01440322|65669334|FG000|Overall Study|Other Product Related|1|||
23527922|NCT01440322|65669335|FG001|Overall Study|Other Product Related|0|||
23527923|NCT01440322|65669334|FG000|Overall Study|Unrelated Medical Problem|0|||
23527924|NCT01440322|65669335|FG001|Overall Study|Unrelated Medical Problem|1|||
23527925|NCT01440322|65669334|FG000|Overall Study|Other Non-Product Related|1|||
23527926|NCT01440322|65669335|FG001|Overall Study|Other Non-Product Related|0|||
23527927|NCT02433834|65669336|FG000|Overall Study|Protocol-specified criteria|7|||
23527928|NCT02433834|65669336|FG000|Overall Study|Protocol Violation|3|||
23527929|NCT02433834|65669336|FG000|Overall Study|Lost to Follow-up|6|||
23527930|NCT02433834|65669336|FG000|Overall Study|Withdrawal by Subject|14|||
23527931|NCT02433834|65669336|FG000|Overall Study|Adverse Event|6|||
23527932|NCT02433834|65669336|FG000|Overall Study|Physician Decision|1|||
23527933|NCT01849588|65669337|FG000|Overall Study|Lack of Efficacy|3|||
23527934|NCT00539838|65669338|FG000|Overall Study|Fail to return|2|||
23527935|NCT00539838|65669339|FG001|Overall Study|Fail to return|0|||
23527936|NCT00539838|65669340|FG002|Overall Study|Fail to return|0|||
23612176|NCT01322347|65967000|FG000|Overall Study|Withdrawal by Subject|1|||
23717184|NCT01245764|66340536|FG003|Study Phase A|Lost to Follow-up|0|||
23717185|NCT00405652|66340537|FG000|Overall Study|Adverse Event|4|||
23717186|NCT01957787|66340538|FG000|Overall Study|Death|18|||
23717187|NCT01957787|66340538|FG000|Overall Study|Lost to Follow-up|3|||
23527937|NCT00539838|65669338|FG000|Overall Study|Withdrawal by Subject|0|||
23813130|NCT03822832|66699259|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
23813131|NCT03822832|66699260|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
23813132|NCT03822832|66699259|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
23813133|NCT03822832|66699260|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
23813134|NCT03822832|66699259|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
23813135|NCT03822832|66699260|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
23813136|NCT03822832|66699259|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
23813137|NCT03822832|66699260|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
23813138|NCT03822832|66699259|FG000|Re-allocation|Not re-allocated to open label period|2|||
23813139|NCT03822832|66699260|FG001|Re-allocation|Not re-allocated to open label period|6|||
23813140|NCT03822832|66699259|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
23813141|NCT03822832|66699260|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
23527938|NCT00539838|65669339|FG001|Overall Study|Withdrawal by Subject|4|||
23527939|NCT00539838|65669340|FG002|Overall Study|Withdrawal by Subject|0|||
23527940|NCT00539838|65669338|FG000|Overall Study|Death|0|||
23527941|NCT00539838|65669339|FG001|Overall Study|Death|2|||
23527942|NCT00539838|65669340|FG002|Overall Study|Death|0|||
23527943|NCT00539838|65669338|FG000|Overall Study|Did not cooperate|1|||
23612177|NCT01322347|65967001|FG001|Overall Study|Withdrawal by Subject|4|||
23612178|NCT01322347|65967000|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
23612179|NCT01322347|65967001|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
23612180|NCT01322347|65967000|FG000|Overall Study|blood transfusion|5|||
23612181|NCT01322347|65967001|FG001|Overall Study|blood transfusion|5|||
23612182|NCT01322347|65967000|FG000|Overall Study|sponsor decision|1|||
23717188|NCT01957787|66340538|FG000|Overall Study|Withdrawal by Subject|3|||
23717189|NCT01957787|66340538|FG000|Overall Study|Entered Hospice or Similar Program|2|||
23717190|NCT01957787|66340538|FG000|Overall Study|Index Tumor(s) Resected|2|||
23717191|NCT01957787|66340538|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
23717192|NCT01957787|66340538|FG000|Overall Study|Local therapy, not cryoablation|6|||
23717193|NCT00792701|66340539|FG000|Overall Study|Adverse Event|0|||
23717194|NCT00792701|66340540|FG001|Overall Study|Adverse Event|22|||
23527944|NCT00539838|65669339|FG001|Overall Study|Did not cooperate|0|||
23527945|NCT00539838|65669340|FG002|Overall Study|Did not cooperate|1|||
23527946|NCT00539838|65669338|FG000|Overall Study|Administrative|4|||
23612183|NCT01322347|65967001|FG001|Overall Study|sponsor decision|3|||
23612184|NCT01322347|65967000|FG000|Overall Study|ineligible|6|||
23612185|NCT01322347|65967001|FG001|Overall Study|ineligible|3|||
23612186|NCT01322347|65967000|FG000|Overall Study|kidney transplant|3|||
23612187|NCT01322347|65967001|FG001|Overall Study|kidney transplant|1|||
23612188|NCT01322347|65967000|FG000|Overall Study|study drug withheld > 12 wks|0|||
23612189|NCT01322347|65967001|FG001|Overall Study|study drug withheld > 12 wks|1|||
23612190|NCT01322347|65967000|FG000|Overall Study|moved/changed dialysis|2|||
23612191|NCT01322347|65967001|FG001|Overall Study|moved/changed dialysis|4|||
23612192|NCT00476151|65967004|FG000|Overall Study|Adverse Event|0|||
23612193|NCT00476151|65967005|FG001|Overall Study|Adverse Event|2|||
23612194|NCT00476151|65967004|FG000|Overall Study|Protocol Violation|1|||
23612195|NCT00476151|65967005|FG001|Overall Study|Protocol Violation|3|||
23612196|NCT00476151|65967004|FG000|Overall Study|Withdrawal by Subject|2|||
23612197|NCT00476151|65967005|FG001|Overall Study|Withdrawal by Subject|0|||
23612198|NCT00476151|65967004|FG000|Overall Study|Physician Decision|0|||
23612199|NCT00476151|65967005|FG001|Overall Study|Physician Decision|2|||
23612200|NCT00748098|65967006|FG000|First Treatment Intervention Period|Adverse Event|1|||
23612201|NCT00748098|65967007|FG001|First Treatment Intervention Period|Adverse Event|1|||
23612202|NCT00748098|65967006|FG000|First Treatment Intervention Period|Protocol Violation|1|||
23612203|NCT00748098|65967007|FG001|First Treatment Intervention Period|Protocol Violation|0|||
23612204|NCT00748098|65967006|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
23612205|NCT00748098|65967007|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
23612206|NCT00748098|65967006|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
23612207|NCT00748098|65967007|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
23612208|NCT00748098|65967006|FG000|First Taper Period|Protocol Violation|1|||
23612209|NCT00748098|65967007|FG001|First Taper Period|Protocol Violation|0|||
23717195|NCT00792701|66340539|FG000|Overall Study|Ineligible|1|||
23813142|NCT03822832|66699259|FG000|Period 2 - Open Label Period|Adverse Event|0|||
23527947|NCT00539838|65669339|FG001|Overall Study|Administrative|0|||
23527948|NCT00539838|65669340|FG002|Overall Study|Administrative|8|||
23527949|NCT00086580|65669341|FG000|Treatment Period|Disease progression|9|||
23612210|NCT00748098|65967006|FG000|First Taper Period|Withdrawal by Subject|2|||
23717196|NCT00792701|66340540|FG001|Overall Study|Ineligible|3|||
23527950|NCT00086580|65669342|FG001|Treatment Period|Disease progression|8|||
23527951|NCT00086580|65669341|FG000|Treatment Period|Unable to comply with protocol|3|||
23612211|NCT00748098|65967007|FG001|First Taper Period|Withdrawal by Subject|0|||
23612212|NCT00748098|65967006|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
23717197|NCT00792701|66340539|FG000|Overall Study|Withdrawal by Subject|1|||
23717198|NCT00792701|66340540|FG001|Overall Study|Withdrawal by Subject|19|||
23813143|NCT03822832|66699260|FG001|Period 2 - Open Label Period|Adverse Event|3|||
23527952|NCT00086580|65669342|FG001|Treatment Period|Unable to comply with protocol|1|||
23527953|NCT00086580|65669341|FG000|Treatment Period|Withdrawal by Subject|7|||
23527954|NCT00086580|65669342|FG001|Treatment Period|Withdrawal by Subject|8|||
23527955|NCT00086580|65669341|FG000|Treatment Period|Physician Decision|13|||
23527956|NCT00086580|65669342|FG001|Treatment Period|Physician Decision|7|||
23527957|NCT00086580|65669341|FG000|Treatment Period|AE - not treatment related|7|||
23527958|NCT00086580|65669342|FG001|Treatment Period|AE - not treatment related|7|||
23527959|NCT00086580|65669341|FG000|Treatment Period|Toxicity - treatment related|15|||
23527960|NCT00086580|65669342|FG001|Treatment Period|Toxicity - treatment related|15|||
23527961|NCT00086580|65669341|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
23527962|NCT00086580|65669342|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
23612213|NCT00748098|65967007|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
23612214|NCT00748098|65967006|FG000|1-Week Washout Period|Adverse Event|0|||
23612215|NCT00748098|65967007|FG001|1-Week Washout Period|Adverse Event|1|||
23612216|NCT00748098|65967006|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
23612217|NCT00748098|65967007|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
23612218|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Adverse Event|4|||
23612219|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Adverse Event|1|||
23612220|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
23612221|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
23612222|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
23612223|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
23612224|NCT01199302|65967008|FG000|Overall Study|Adverse Event|1|||
23612225|NCT01199302|65967009|FG001|Overall Study|Adverse Event|1|||
23612226|NCT01199302|65967010|FG002|Overall Study|Adverse Event|2|||
23612227|NCT01199302|65967011|FG003|Overall Study|Adverse Event|0|||
23612228|NCT01199302|65967008|FG000|Overall Study|Withdrawal by Subject|2|||
23612229|NCT01199302|65967009|FG001|Overall Study|Withdrawal by Subject|2|||
23612230|NCT01199302|65967010|FG002|Overall Study|Withdrawal by Subject|3|||
23612231|NCT01199302|65967011|FG003|Overall Study|Withdrawal by Subject|0|||
23612232|NCT01199302|65967008|FG000|Overall Study|Disease Progression|3|||
23612233|NCT01199302|65967009|FG001|Overall Study|Disease Progression|4|||
23612234|NCT01199302|65967010|FG002|Overall Study|Disease Progression|4|||
23612235|NCT01199302|65967011|FG003|Overall Study|Disease Progression|2|||
23612236|NCT01199302|65967008|FG000|Overall Study|Study Termination|13|||
23612237|NCT01199302|65967009|FG001|Overall Study|Study Termination|8|||
23612238|NCT01199302|65967010|FG002|Overall Study|Study Termination|11|||
23612239|NCT01199302|65967011|FG003|Overall Study|Study Termination|9|||
23612240|NCT01199302|65967008|FG000|Overall Study|Lost to Follow-up|0|||
23813144|NCT04431726|66699262|FG000|Overall Study|Ongoing in the Study|55|||
23813145|NCT02140411|66699263|FG000|Overall Study|Adverse Event|1|||
23813146|NCT03283761|66699264|FG000|Study Treatment|Patient Non-Compliance|1|||
23813147|NCT03283761|66699264|FG000|Study Treatment|Alternative Cancer Therapy|7|||
23813148|NCT03283761|66699264|FG000|Study Treatment|Disease progression|21|||
23813149|NCT03283761|66699264|FG000|Study Treatment|Adverse Event|3|||
23813150|NCT03283761|66699264|FG000|Study Treatment|Withdrawal by Subject|4|||
23813151|NCT03283761|66699264|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
23813152|NCT03283761|66699264|FG000|Study Treatment|Symptomatic Deterioration|1|||
23717199|NCT00792701|66340539|FG000|Overall Study|Not protocol specified|17|||
23717200|NCT00792701|66340540|FG001|Overall Study|Not protocol specified|0|||
23717201|NCT03986190|66340543|FG000|Overall Study|Withdrawal by Subject|12|||
23717202|NCT03986190|66340544|FG001|Overall Study|Withdrawal by Subject|0|||
23717203|NCT03495817|66340545|FG000|26 Week Open Label|Adverse Event|3|||
23717204|NCT03495817|66340545|FG000|26 Week Open Label|Withdrawal by Subject|4|||
23717205|NCT03495817|66340545|FG000|26 Week Open Label|Lost to Follow-up|1|||
23717206|NCT03495817|66340545|FG000|26 Week Extension|Lost to Follow-up|2|||
23717207|NCT02999100|66340548|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
23717208|NCT02999100|66340549|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
23717209|NCT02999100|66340550|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
23717210|NCT02999100|66340551|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
23717211|NCT02999100|66340552|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
23717212|NCT02999100|66340553|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
23717213|NCT02999100|66340548|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23717214|NCT02999100|66340549|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23813153|NCT03283761|66699264|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
23527963|NCT00086580|65669341|FG000|Treatment Period|Death|5|||
23527964|NCT00086580|65669342|FG001|Treatment Period|Death|7|||
23527965|NCT00086580|65669341|FG000|Treatment Period|Other|5|||
23527966|NCT00086580|65669342|FG001|Treatment Period|Other|3|||
23527967|NCT00086580|65669341|FG000|Follow-up Period|Disease progression|72|||
23612241|NCT01199302|65967009|FG001|Overall Study|Lost to Follow-up|1|||
23612242|NCT01199302|65967010|FG002|Overall Study|Lost to Follow-up|0|||
23612243|NCT01199302|65967011|FG003|Overall Study|Lost to Follow-up|0|||
23527968|NCT00086580|65669342|FG001|Follow-up Period|Disease progression|99|||
23717215|NCT02999100|66340550|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23717216|NCT02999100|66340551|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23717217|NCT02999100|66340552|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23717218|NCT02999100|66340553|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
23717219|NCT02999100|66340548|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23717220|NCT02999100|66340549|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23717221|NCT02999100|66340550|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
23717222|NCT02999100|66340551|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23717223|NCT02999100|66340552|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23717224|NCT02999100|66340553|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23717225|NCT04031404|66340554|FG000|Baseline|Lost to Follow-up|0|||
23717226|NCT04031404|66340555|FG001|Baseline|Lost to Follow-up|1|||
23717227|NCT04031404|66340554|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
23717228|NCT04031404|66340555|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
23717229|NCT04031404|66340554|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
23717230|NCT04031404|66340555|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
23717231|NCT04031404|66340554|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
23717232|NCT04031404|66340555|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
23717233|NCT04031404|66340554|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
23717234|NCT04031404|66340555|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
23717235|NCT02227849|66340556|FG000|Overall Study|Adverse Event|4|||
23717236|NCT02227849|66340556|FG000|Overall Study|Physician Decision|1|||
23717237|NCT02227849|66340556|FG000|Overall Study|Withdrawal by Subject|3|||
23717238|NCT02017899|66340559|FG000|Overall Study|Withdrawal by Subject|0|||
23717239|NCT02017899|66340560|FG001|Overall Study|Withdrawal by Subject|0|||
23717240|NCT02017899|66340561|FG002|Overall Study|Withdrawal by Subject|0|||
23717241|NCT02017899|66340562|FG003|Overall Study|Withdrawal by Subject|1|||
23717242|NCT02017899|66340563|FG004|Overall Study|Withdrawal by Subject|1|||
23717243|NCT02017899|66340564|FG005|Overall Study|Withdrawal by Subject|0|||
23717244|NCT02447458|66340565|FG000|Overall Study|Other|0|||
23717245|NCT02447458|66340566|FG001|Overall Study|Other|0|||
23717246|NCT02447458|66340567|FG002|Overall Study|Other|1|||
23717247|NCT02447458|66340568|FG003|Overall Study|Other|0|||
23717248|NCT02447458|66340569|FG004|Overall Study|Other|0|||
23717249|NCT02447458|66340570|FG005|Overall Study|Other|0|||
23717250|NCT02671461|66340578|FG000|Treatment|Adverse Event|0|||
23717251|NCT02671461|66340579|FG001|Treatment|Adverse Event|0|||
23527969|NCT00086580|65669341|FG000|Follow-up Period|Unable to comply with protocol|5|||
23527970|NCT00086580|65669342|FG001|Follow-up Period|Unable to comply with protocol|0|||
23527971|NCT00086580|65669341|FG000|Follow-up Period|Withdrawal by Subject|6|||
23717252|NCT02671461|66340580|FG002|Treatment|Adverse Event|1|||
23717253|NCT02671461|66340578|FG000|Treatment|Administrative Reason by Sponsor|1|||
23717254|NCT02671461|66340579|FG001|Treatment|Administrative Reason by Sponsor|3|||
23717255|NCT02671461|66340580|FG002|Treatment|Administrative Reason by Sponsor|4|||
23717256|NCT02671461|66340578|FG000|Treatment|Randomized, not treated|1|||
23527972|NCT00086580|65669342|FG001|Follow-up Period|Withdrawal by Subject|6|||
23527973|NCT00086580|65669341|FG000|Follow-up Period|Physician Decision|0|||
23717257|NCT02671461|66340579|FG001|Treatment|Randomized, not treated|0|||
23527974|NCT00086580|65669342|FG001|Follow-up Period|Physician Decision|1|||
23527975|NCT00086580|65669341|FG000|Follow-up Period|AE - not related|1|||
23527976|NCT00086580|65669342|FG001|Follow-up Period|AE - not related|0|||
23527977|NCT00086580|65669341|FG000|Follow-up Period|Death|13|||
23527978|NCT00086580|65669342|FG001|Follow-up Period|Death|7|||
23527979|NCT00086580|65669341|FG000|Follow-up Period|Other|7|||
23527980|NCT00086580|65669342|FG001|Follow-up Period|Other|6|||
23527981|NCT00086580|65669341|FG000|Observation Period|Unable to comply with protocol|1|||
23527982|NCT00086580|65669342|FG001|Observation Period|Unable to comply with protocol|1|||
23527983|NCT00086580|65669341|FG000|Observation Period|Withdrawal by Subject|4|||
23527984|NCT00086580|65669342|FG001|Observation Period|Withdrawal by Subject|2|||
23527985|NCT00086580|65669341|FG000|Observation Period|Death|33|||
23527986|NCT00086580|65669342|FG001|Observation Period|Death|55|||
23527987|NCT00086580|65669341|FG000|Observation Period|Other|8|||
23527988|NCT00086580|65669342|FG001|Observation Period|Other|7|||
23527989|NCT00430092|65669346|FG000|Overall Study|Adverse Event|0|||
23527990|NCT00430092|65669347|FG001|Overall Study|Adverse Event|0|||
23527991|NCT00430092|65669348|FG002|Overall Study|Adverse Event|1|||
23527992|NCT00430092|65669346|FG000|Overall Study|Lack of Efficacy|5|||
23527993|NCT00430092|65669347|FG001|Overall Study|Lack of Efficacy|2|||
23527994|NCT00430092|65669348|FG002|Overall Study|Lack of Efficacy|54|||
23527995|NCT00430092|65669346|FG000|Overall Study|Lost to Follow-up|1|||
23527996|NCT00430092|65669347|FG001|Overall Study|Lost to Follow-up|0|||
23527997|NCT00430092|65669348|FG002|Overall Study|Lost to Follow-up|0|||
23527998|NCT00430092|65669346|FG000|Overall Study|Protocol Violation|0|||
23418447|NCT02141399|65277222|FG000|Overall Study|Failure to meet eligibility criteria|14|||
23418448|NCT01205061|65277223|FG000|Overall Study|Adverse Event|4|||
23418449|NCT01205061|65277223|FG000|Overall Study|Withdrawal by Subject|11|||
23418450|NCT01205061|65277223|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
23418451|NCT01205061|65277223|FG000|Overall Study|Lost to Follow-up|9|||
23418452|NCT01205061|65277223|FG000|Overall Study|Other|1|||
23418453|NCT02013206|65277224|FG000|Overall Study|Progressive disease (PD)|14|||
23418454|NCT02013206|65277225|FG001|Overall Study|Progressive disease (PD)|17|||
23418455|NCT02013206|65277224|FG000|Overall Study|Symptomatic deterioration|3|||
23418456|NCT02013206|65277225|FG001|Overall Study|Symptomatic deterioration|1|||
23418457|NCT02013206|65277224|FG000|Overall Study|Adverse Event|1|||
23418458|NCT02013206|65277225|FG001|Overall Study|Adverse Event|0|||
23527999|NCT00430092|65669347|FG001|Overall Study|Protocol Violation|1|||
23528000|NCT00430092|65669348|FG002|Overall Study|Protocol Violation|1|||
23528001|NCT00430092|65669346|FG000|Overall Study|Withdrawal by Subject|0|||
23528002|NCT00430092|65669347|FG001|Overall Study|Withdrawal by Subject|1|||
23528003|NCT00430092|65669348|FG002|Overall Study|Withdrawal by Subject|1|||
23528004|NCT01541930|65669349|FG000|Overall Study|Withdrawal by Subject|1|||
23528005|NCT00529386|65669350|FG000|Overall Study|Lost to Follow-up|1|||
23528006|NCT03670810|65669351|FG000|Main Study|Adverse Event|37|||
23528007|NCT03670810|65669352|FG001|Main Study|Adverse Event|38|||
23528008|NCT03670810|65669353|FG002|Main Study|Adverse Event|3|||
23528009|NCT03670810|65669354|FG003|Main Study|Adverse Event|4|||
23528010|NCT03670810|65669355|FG004|Main Study|Adverse Event|4|||
23528011|NCT03670810|65669356|FG005|Main Study|Adverse Event|5|||
23528012|NCT03670810|65669357|FG006|Main Study|Adverse Event|0|||
23528013|NCT03670810|65669358|FG007|Main Study|Adverse Event|0|||
23528014|NCT03670810|65669359|FG008|Main Study|Adverse Event|0|||
23528015|NCT03670810|65669351|FG000|Main Study|Lack of Efficacy|8|||
23528016|NCT03670810|65669352|FG001|Main Study|Lack of Efficacy|9|||
23528017|NCT03670810|65669353|FG002|Main Study|Lack of Efficacy|3|||
23528018|NCT03670810|65669354|FG003|Main Study|Lack of Efficacy|4|||
23528019|NCT03670810|65669355|FG004|Main Study|Lack of Efficacy|0|||
23528020|NCT03670810|65669356|FG005|Main Study|Lack of Efficacy|0|||
23528021|NCT03670810|65669357|FG006|Main Study|Lack of Efficacy|0|||
23528022|NCT03670810|65669358|FG007|Main Study|Lack of Efficacy|0|||
23528023|NCT03670810|65669359|FG008|Main Study|Lack of Efficacy|0|||
23528024|NCT03670810|65669351|FG000|Main Study|Lost to Follow-up|9|||
23528025|NCT03670810|65669352|FG001|Main Study|Lost to Follow-up|7|||
23528026|NCT03670810|65669353|FG002|Main Study|Lost to Follow-up|4|||
23528027|NCT03670810|65669354|FG003|Main Study|Lost to Follow-up|6|||
23528028|NCT03670810|65669355|FG004|Main Study|Lost to Follow-up|1|||
23528029|NCT03670810|65669356|FG005|Main Study|Lost to Follow-up|0|||
23528030|NCT03670810|65669357|FG006|Main Study|Lost to Follow-up|0|||
23528031|NCT03670810|65669358|FG007|Main Study|Lost to Follow-up|0|||
23528032|NCT03670810|65669359|FG008|Main Study|Lost to Follow-up|0|||
23528033|NCT03670810|65669351|FG000|Main Study|Non-compliance with Study Drug|0|||
23528034|NCT03670810|65669352|FG001|Main Study|Non-compliance with Study Drug|2|||
23528035|NCT03670810|65669353|FG002|Main Study|Non-compliance with Study Drug|3|||
23528036|NCT03670810|65669354|FG003|Main Study|Non-compliance with Study Drug|0|||
23528037|NCT03670810|65669355|FG004|Main Study|Non-compliance with Study Drug|0|||
23528038|NCT03670810|65669356|FG005|Main Study|Non-compliance with Study Drug|0|||
23528039|NCT03670810|65669357|FG006|Main Study|Non-compliance with Study Drug|0|||
23717258|NCT02671461|66340580|FG002|Treatment|Randomized, not treated|0|||
23717259|NCT02671461|66340578|FG000|Follow-up|Withdrawal by Subject|1|||
23717260|NCT02671461|66340579|FG001|Follow-up|Withdrawal by Subject|0|||
23418459|NCT02013206|65277224|FG000|Overall Study|Patient refusal|2|||
23418460|NCT02013206|65277225|FG001|Overall Study|Patient refusal|0|||
23528040|NCT03670810|65669358|FG007|Main Study|Non-compliance with Study Drug|1|||
23528041|NCT03670810|65669359|FG008|Main Study|Non-compliance with Study Drug|0|||
23528042|NCT03670810|65669351|FG000|Main Study|Physician Decision|3|||
23528043|NCT03670810|65669352|FG001|Main Study|Physician Decision|0|||
23528044|NCT03670810|65669353|FG002|Main Study|Physician Decision|1|||
23528045|NCT03670810|65669354|FG003|Main Study|Physician Decision|0|||
23528046|NCT03670810|65669355|FG004|Main Study|Physician Decision|0|||
23528047|NCT03670810|65669356|FG005|Main Study|Physician Decision|0|||
23528048|NCT03670810|65669357|FG006|Main Study|Physician Decision|1|||
23528049|NCT03670810|65669358|FG007|Main Study|Physician Decision|1|||
23528050|NCT03670810|65669359|FG008|Main Study|Physician Decision|0|||
23528051|NCT03670810|65669351|FG000|Main Study|Pregnancy|1|||
23528052|NCT03670810|65669352|FG001|Main Study|Pregnancy|2|||
23528053|NCT03670810|65669353|FG002|Main Study|Pregnancy|0|||
23528054|NCT03670810|65669354|FG003|Main Study|Pregnancy|0|||
23418461|NCT02013206|65277224|FG000|Overall Study|Patient non-compliance|1|||
23528055|NCT03670810|65669355|FG004|Main Study|Pregnancy|0|||
23528056|NCT03670810|65669356|FG005|Main Study|Pregnancy|0|||
23528057|NCT03670810|65669357|FG006|Main Study|Pregnancy|0|||
23528058|NCT03670810|65669358|FG007|Main Study|Pregnancy|0|||
23528059|NCT03670810|65669359|FG008|Main Study|Pregnancy|0|||
23528060|NCT03670810|65669351|FG000|Main Study|Protocol Deviation|2|||
23528061|NCT03670810|65669352|FG001|Main Study|Protocol Deviation|12|||
23418462|NCT02013206|65277225|FG001|Overall Study|Patient non-compliance|0|||
23418463|NCT02013206|65277224|FG000|Overall Study|Death|1|||
23418464|NCT02013206|65277225|FG001|Overall Study|Death|2|||
23418465|NCT02013206|65277224|FG000|Overall Study|Other reasons off treatment|5|||
23418466|NCT02013206|65277225|FG001|Overall Study|Other reasons off treatment|2|||
23418467|NCT02438384|65277226|FG000|Overall Study|Lost to Follow-up|8|||
23418468|NCT02438384|65277227|FG001|Overall Study|Lost to Follow-up|6|||
23418469|NCT02438384|65277228|FG002|Overall Study|Lost to Follow-up|4|||
23418470|NCT03781323|65277243|FG000|Overall Study|Withdrawal by Subject|1|||
23418471|NCT01082874|65277244|FG000|Overall Study|Lost to Follow-up|10|||
23418472|NCT01082874|65277245|FG001|Overall Study|Lost to Follow-up|10|||
23418473|NCT01082874|65277246|FG002|Overall Study|Lost to Follow-up|6|||
23418474|NCT01082874|65277247|FG003|Overall Study|Lost to Follow-up|10|||
23418475|NCT01082874|65277244|FG000|Overall Study|Withdrawal by Subject|1|||
23418476|NCT01082874|65277245|FG001|Overall Study|Withdrawal by Subject|2|||
23418477|NCT01082874|65277246|FG002|Overall Study|Withdrawal by Subject|5|||
23418478|NCT01082874|65277247|FG003|Overall Study|Withdrawal by Subject|3|||
23418479|NCT01988662|65277250|FG000|Overall Study|Subject/guardian decision|1|||
23418480|NCT01988662|65277251|FG001|Overall Study|Subject/guardian decision|1|||
23418481|NCT01988662|65277250|FG000|Overall Study|Adverse Event|3|||
23418482|NCT01988662|65277251|FG001|Overall Study|Adverse Event|1|||
23418483|NCT01229254|65277252|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
23418484|NCT01229254|65277253|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
23418485|NCT01229254|65277254|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
23418486|NCT01229254|65277252|FG000|Overall Study|Adverse Event|4|||
23418487|NCT01229254|65277253|FG001|Overall Study|Adverse Event|5|||
23418488|NCT01229254|65277254|FG002|Overall Study|Adverse Event|3|||
23418489|NCT01229254|65277252|FG000|Overall Study|Lost to Follow-up|3|||
23418490|NCT01229254|65277253|FG001|Overall Study|Lost to Follow-up|0|||
23418491|NCT01229254|65277254|FG002|Overall Study|Lost to Follow-up|1|||
23418492|NCT01229254|65277252|FG000|Overall Study|Physician Decision|0|||
23418493|NCT01229254|65277253|FG001|Overall Study|Physician Decision|3|||
23418494|NCT01229254|65277254|FG002|Overall Study|Physician Decision|0|||
23418495|NCT01229254|65277252|FG000|Overall Study|Protocol Violation|4|||
23418496|NCT01229254|65277253|FG001|Overall Study|Protocol Violation|6|||
23418497|NCT01229254|65277254|FG002|Overall Study|Protocol Violation|5|||
23418498|NCT01229254|65277252|FG000|Overall Study|Withdrawal by Subject|1|||
23418499|NCT01229254|65277253|FG001|Overall Study|Withdrawal by Subject|0|||
23418500|NCT01229254|65277254|FG002|Overall Study|Withdrawal by Subject|1|||
23418501|NCT01229254|65277252|FG000|Overall Study|Non-compliance with Study Drug|0|||
23418502|NCT01229254|65277253|FG001|Overall Study|Non-compliance with Study Drug|1|||
23418503|NCT01229254|65277254|FG002|Overall Study|Non-compliance with Study Drug|1|||
23418504|NCT02487654|65277255|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
23418505|NCT02487654|65277256|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
23418506|NCT02487654|65277255|FG000|Overall Study|Withdrawal by Subject|3|||
23418507|NCT02487654|65277256|FG001|Overall Study|Withdrawal by Subject|7|||
23418508|NCT01035463|65277257|FG000|Overall Study|Adverse Event|0|||
23418509|NCT01035463|65277258|FG001|Overall Study|Adverse Event|0|||
23418510|NCT01035463|65277259|FG002|Overall Study|Adverse Event|4|||
23418511|NCT01035463|65277260|FG003|Overall Study|Adverse Event|1|||
23418512|NCT01035463|65277261|FG004|Overall Study|Adverse Event|5|||
23418513|NCT01035463|65277262|FG005|Overall Study|Adverse Event|7|||
23418514|NCT01035463|65277257|FG000|Overall Study|Withdrawal by Subject|0|||
23418515|NCT01035463|65277258|FG001|Overall Study|Withdrawal by Subject|2|||
23418516|NCT01035463|65277259|FG002|Overall Study|Withdrawal by Subject|1|||
23418517|NCT01035463|65277260|FG003|Overall Study|Withdrawal by Subject|0|||
23418518|NCT01035463|65277261|FG004|Overall Study|Withdrawal by Subject|1|||
23418519|NCT01035463|65277262|FG005|Overall Study|Withdrawal by Subject|4|||
23418520|NCT01035463|65277257|FG000|Overall Study|Disease progression|0|||
23418521|NCT01035463|65277258|FG001|Overall Study|Disease progression|0|||
23418522|NCT01035463|65277259|FG002|Overall Study|Disease progression|0|||
23418523|NCT01035463|65277260|FG003|Overall Study|Disease progression|0|||
23418524|NCT01035463|65277261|FG004|Overall Study|Disease progression|0|||
23418525|NCT01035463|65277262|FG005|Overall Study|Disease progression|3|||
23418526|NCT01035463|65277257|FG000|Overall Study|Other Malignancy|0|||
23418527|NCT01035463|65277258|FG001|Overall Study|Other Malignancy|0|||
23418528|NCT01035463|65277259|FG002|Overall Study|Other Malignancy|0|||
23418529|NCT01035463|65277260|FG003|Overall Study|Other Malignancy|0|||
23418530|NCT01035463|65277261|FG004|Overall Study|Other Malignancy|0|||
23418531|NCT01035463|65277262|FG005|Overall Study|Other Malignancy|2|||
23418532|NCT01035463|65277257|FG000|Overall Study|Other|0|||
23418533|NCT01035463|65277258|FG001|Overall Study|Other|0|||
23418534|NCT01035463|65277259|FG002|Overall Study|Other|0|||
23418535|NCT01035463|65277260|FG003|Overall Study|Other|1|||
23418536|NCT01035463|65277261|FG004|Overall Study|Other|0|||
23418537|NCT01035463|65277262|FG005|Overall Study|Other|2|||
23418538|NCT02585830|65277264|FG000|Overall Study|Withdrawal by Subject|3|||
23418539|NCT05312632|65277265|FG000|Overall Study|Adverse Event|12|||
23528062|NCT03670810|65669353|FG002|Main Study|Protocol Deviation|8|||
23528063|NCT03670810|65669354|FG003|Main Study|Protocol Deviation|4|||
23528064|NCT03670810|65669355|FG004|Main Study|Protocol Deviation|0|||
23528065|NCT03670810|65669356|FG005|Main Study|Protocol Deviation|0|||
23528066|NCT03670810|65669357|FG006|Main Study|Protocol Deviation|0|||
23528067|NCT03670810|65669358|FG007|Main Study|Protocol Deviation|0|||
23528068|NCT03670810|65669359|FG008|Main Study|Protocol Deviation|0|||
23528069|NCT03670810|65669351|FG000|Main Study|Withdrawal by Subject|21|||
23528070|NCT03670810|65669352|FG001|Main Study|Withdrawal by Subject|21|||
23528071|NCT03670810|65669353|FG002|Main Study|Withdrawal by Subject|8|||
23528072|NCT03670810|65669354|FG003|Main Study|Withdrawal by Subject|9|||
23528073|NCT03670810|65669355|FG004|Main Study|Withdrawal by Subject|5|||
23528074|NCT03670810|65669356|FG005|Main Study|Withdrawal by Subject|2|||
23528075|NCT03670810|65669357|FG006|Main Study|Withdrawal by Subject|1|||
23528076|NCT03670810|65669358|FG007|Main Study|Withdrawal by Subject|1|||
23528077|NCT03670810|65669359|FG008|Main Study|Withdrawal by Subject|0|||
23528078|NCT03670810|65669351|FG000|Main Study|Participant did not want to take the three other treatments|1|||
23528079|NCT03670810|65669352|FG001|Main Study|Participant did not want to take the three other treatments|0|||
23528080|NCT03670810|65669353|FG002|Main Study|Participant did not want to take the three other treatments|0|||
23528081|NCT03670810|65669354|FG003|Main Study|Participant did not want to take the three other treatments|0|||
23528082|NCT03670810|65669355|FG004|Main Study|Participant did not want to take the three other treatments|0|||
23528083|NCT03670810|65669356|FG005|Main Study|Participant did not want to take the three other treatments|0|||
23528084|NCT03670810|65669357|FG006|Main Study|Participant did not want to take the three other treatments|0|||
23528085|NCT03670810|65669358|FG007|Main Study|Participant did not want to take the three other treatments|0|||
23528086|NCT03670810|65669359|FG008|Main Study|Participant did not want to take the three other treatments|0|||
23528087|NCT03670810|65669351|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528088|NCT03670810|65669352|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
23528089|NCT03670810|65669353|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528090|NCT03670810|65669354|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528091|NCT03670810|65669355|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528092|NCT03670810|65669356|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528093|NCT03670810|65669357|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528094|NCT03670810|65669358|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528095|NCT03670810|65669359|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528096|NCT03670810|65669351|FG000|Main Study|Travel and Coronavirus issues|0|||
23528097|NCT03670810|65669352|FG001|Main Study|Travel and Coronavirus issues|0|||
23528098|NCT03670810|65669353|FG002|Main Study|Travel and Coronavirus issues|0|||
23528099|NCT03670810|65669354|FG003|Main Study|Travel and Coronavirus issues|1|||
23528100|NCT03670810|65669355|FG004|Main Study|Travel and Coronavirus issues|0|||
23528101|NCT03670810|65669356|FG005|Main Study|Travel and Coronavirus issues|0|||
23528102|NCT03670810|65669357|FG006|Main Study|Travel and Coronavirus issues|0|||
23528103|NCT03670810|65669358|FG007|Main Study|Travel and Coronavirus issues|0|||
23528104|NCT03670810|65669359|FG008|Main Study|Travel and Coronavirus issues|0|||
23528105|NCT03670810|65669351|FG000|Open Label Extension|Protocol Deviation|0|||
23528106|NCT03670810|65669352|FG001|Open Label Extension|Protocol Deviation|0|||
23528107|NCT03670810|65669353|FG002|Open Label Extension|Protocol Deviation|0|||
23528108|NCT03670810|65669354|FG003|Open Label Extension|Protocol Deviation|0|||
23528109|NCT03670810|65669355|FG004|Open Label Extension|Protocol Deviation|0|||
23528110|NCT03670810|65669356|FG005|Open Label Extension|Protocol Deviation|0|||
23528111|NCT03670810|65669357|FG006|Open Label Extension|Protocol Deviation|0|||
23528112|NCT03670810|65669358|FG007|Open Label Extension|Protocol Deviation|0|||
23528113|NCT03670810|65669359|FG008|Open Label Extension|Protocol Deviation|5|||
23528114|NCT03670810|65669351|FG000|Open Label Extension|Death|0|||
23528115|NCT03670810|65669352|FG001|Open Label Extension|Death|0|||
23528116|NCT03670810|65669353|FG002|Open Label Extension|Death|0|||
23528117|NCT03670810|65669354|FG003|Open Label Extension|Death|0|||
23528118|NCT03670810|65669355|FG004|Open Label Extension|Death|0|||
23528119|NCT03670810|65669356|FG005|Open Label Extension|Death|0|||
23528120|NCT03670810|65669357|FG006|Open Label Extension|Death|0|||
23528121|NCT03670810|65669358|FG007|Open Label Extension|Death|0|||
23528122|NCT03670810|65669359|FG008|Open Label Extension|Death|1|||
23528123|NCT03670810|65669351|FG000|Open Label Extension|COVID-19|0|||
23528124|NCT03670810|65669352|FG001|Open Label Extension|COVID-19|0|||
23528125|NCT03670810|65669353|FG002|Open Label Extension|COVID-19|0|||
23528126|NCT03670810|65669354|FG003|Open Label Extension|COVID-19|0|||
23528127|NCT03670810|65669355|FG004|Open Label Extension|COVID-19|0|||
23528128|NCT03670810|65669356|FG005|Open Label Extension|COVID-19|0|||
23528129|NCT03670810|65669357|FG006|Open Label Extension|COVID-19|0|||
23528130|NCT03670810|65669358|FG007|Open Label Extension|COVID-19|0|||
23528131|NCT03670810|65669359|FG008|Open Label Extension|COVID-19|1|||
23528132|NCT03670810|65669351|FG000|Open Label Extension|Lack of Efficacy|0|||
23528133|NCT03670810|65669352|FG001|Open Label Extension|Lack of Efficacy|0|||
23418540|NCT05312632|65277265|FG000|Overall Study|Withdrawal by Subject|10|||
23418541|NCT05312632|65277265|FG000|Overall Study|Lack of Efficacy|4|||
23418542|NCT05312632|65277265|FG000|Overall Study|Non-compliance with study procedures|9|||
23418543|NCT05312632|65277265|FG000|Overall Study|Other|4|||
23418544|NCT02901054|65277266|FG000|Overall Study|Physician Decision|1|||
23418545|NCT02901054|65277266|FG000|Overall Study|Withdrawal by Subject|3|||
23418546|NCT00294645|65277267|FG000|Overall Study|Death|10|||
23418547|NCT00294645|65277268|FG001|Overall Study|Death|18|||
23418548|NCT00294645|65277267|FG000|Overall Study|Lost to Follow-up|1|||
23418549|NCT00294645|65277268|FG001|Overall Study|Lost to Follow-up|10|||
23418550|NCT00294645|65277267|FG000|Overall Study|Withdrawal by Subject|18|||
23418551|NCT00294645|65277268|FG001|Overall Study|Withdrawal by Subject|34|||
23418552|NCT00294645|65277267|FG000|Overall Study|Physician Decision|15|||
23418553|NCT00294645|65277268|FG001|Overall Study|Physician Decision|20|||
23418554|NCT00294645|65277267|FG000|Overall Study|Other|4|||
23418555|NCT00294645|65277268|FG001|Overall Study|Other|10|||
23418556|NCT00541866|65277269|FG000|Overall Study|Adverse Event|3|||
23418557|NCT00541866|65277270|FG001|Overall Study|Adverse Event|0|||
23418558|NCT00541866|65277271|FG002|Overall Study|Adverse Event|0|||
23418559|NCT00541866|65277272|FG003|Overall Study|Adverse Event|0|||
23418560|NCT00541866|65277273|FG004|Overall Study|Adverse Event|0|||
23418561|NCT00541866|65277269|FG000|Overall Study|Death|1|||
23418562|NCT00541866|65277270|FG001|Overall Study|Death|0|||
23418563|NCT00541866|65277271|FG002|Overall Study|Death|0|||
23418564|NCT00541866|65277272|FG003|Overall Study|Death|0|||
23418565|NCT00541866|65277273|FG004|Overall Study|Death|0|||
23418566|NCT00541866|65277269|FG000|Overall Study|Lack of Efficacy|19|||
23418567|NCT00541866|65277270|FG001|Overall Study|Lack of Efficacy|15|||
23418568|NCT00541866|65277271|FG002|Overall Study|Lack of Efficacy|10|||
23813154|NCT03283761|66699264|FG000|Follow up|Lost to Follow-up|1|||
23813155|NCT03283761|66699264|FG000|Follow up|Symptomatic Deterioration|1|||
23813156|NCT03283761|66699264|FG000|Follow up|Death|29|||
23813157|NCT03283761|66699264|FG000|Follow up|study terminated|4|||
23813158|NCT03283761|66699264|FG000|Follow up|Primary Investigator Withdrawal|1|||
23813159|NCT03283761|66699264|FG000|Follow up|Switched to alternative therapy|1|||
23813160|NCT03283761|66699264|FG000|Follow up|Subject is now in Hospice|1|||
23813161|NCT01502410|66699265|FG000|Overall Study|Adverse Event|1|||
23813162|NCT01502410|66699266|FG001|Overall Study|Adverse Event|2|||
23813163|NCT01502410|66699267|FG002|Overall Study|Adverse Event|0|||
23813164|NCT01502410|66699268|FG003|Overall Study|Adverse Event|0|||
23813165|NCT01502410|66699265|FG000|Overall Study|Lack of Efficacy|7|||
23813166|NCT01502410|66699266|FG001|Overall Study|Lack of Efficacy|7|||
23813167|NCT01502410|66699267|FG002|Overall Study|Lack of Efficacy|0|||
23813168|NCT01502410|66699268|FG003|Overall Study|Lack of Efficacy|0|||
23813169|NCT01502410|66699265|FG000|Overall Study|Physician Decision|0|||
23813170|NCT01502410|66699266|FG001|Overall Study|Physician Decision|1|||
23813171|NCT01502410|66699267|FG002|Overall Study|Physician Decision|0|||
23813172|NCT01502410|66699268|FG003|Overall Study|Physician Decision|0|||
23813173|NCT01502410|66699265|FG000|Overall Study|Withdrawal by Subject|2|||
23813174|NCT01502410|66699266|FG001|Overall Study|Withdrawal by Subject|0|||
23813175|NCT01502410|66699267|FG002|Overall Study|Withdrawal by Subject|0|||
23813176|NCT01502410|66699268|FG003|Overall Study|Withdrawal by Subject|0|||
23813177|NCT00896480|66699269|FG000|Overall Study|Disease progression/recurrence|21|||
23813178|NCT02085135|66699270|FG000|Overall Study|Adverse Event|4|||
23813179|NCT02085135|66699271|FG001|Overall Study|Adverse Event|7|||
23813180|NCT02085135|66699270|FG000|Overall Study|Lost to Follow-up|2|||
23813181|NCT02085135|66699271|FG001|Overall Study|Lost to Follow-up|2|||
23813182|NCT02085135|66699270|FG000|Overall Study|Withdrawal by Subject|3|||
23813183|NCT02085135|66699271|FG001|Overall Study|Withdrawal by Subject|0|||
23813184|NCT02085135|66699270|FG000|Overall Study|Lack of Efficacy|2|||
23813185|NCT02085135|66699271|FG001|Overall Study|Lack of Efficacy|0|||
23418569|NCT00541866|65277272|FG003|Overall Study|Lack of Efficacy|12|||
23418570|NCT00541866|65277273|FG004|Overall Study|Lack of Efficacy|14|||
23418571|NCT00541866|65277269|FG000|Overall Study|Not Reported or Other|11|||
23813186|NCT00950963|66699274|FG000|Overall Study|Lost to Follow-up|29|||
23418572|NCT00541866|65277270|FG001|Overall Study|Not Reported or Other|3|||
23418573|NCT00541866|65277271|FG002|Overall Study|Not Reported or Other|3|||
23418574|NCT00541866|65277272|FG003|Overall Study|Not Reported or Other|3|||
23418575|NCT00541866|65277273|FG004|Overall Study|Not Reported or Other|1|||
23418576|NCT00541866|65277269|FG000|Overall Study|Physician Decision|0|||
23418577|NCT00541866|65277270|FG001|Overall Study|Physician Decision|0|||
23418578|NCT00541866|65277271|FG002|Overall Study|Physician Decision|2|||
23418579|NCT00541866|65277272|FG003|Overall Study|Physician Decision|1|||
23418580|NCT00541866|65277273|FG004|Overall Study|Physician Decision|0|||
23813187|NCT00950963|66699275|FG001|Overall Study|Lost to Follow-up|24|||
23813188|NCT00077857|66699276|FG000|Overall Study|Adverse Event|30|||
23813189|NCT00077857|66699277|FG001|Overall Study|Adverse Event|32|||
23813190|NCT00077857|66699276|FG000|Overall Study|Death|7|||
23813191|NCT00077857|66699277|FG001|Overall Study|Death|3|||
23813192|NCT00077857|66699276|FG000|Overall Study|Insufficient therapeutic response|112|||
23813193|NCT00077857|66699277|FG001|Overall Study|Insufficient therapeutic response|128|||
23813194|NCT00077857|66699276|FG000|Overall Study|Violation of selection criteria at entry|3|||
23813195|NCT00077857|66699277|FG001|Overall Study|Violation of selection criteria at entry|1|||
23813196|NCT00077857|66699276|FG000|Overall Study|Other protocol violation|0|||
23813197|NCT00077857|66699277|FG001|Overall Study|Other protocol violation|1|||
23813198|NCT00077857|66699276|FG000|Overall Study|Refused treatment|29|||
23813199|NCT00077857|66699277|FG001|Overall Study|Refused treatment|21|||
23813200|NCT00077857|66699276|FG000|Overall Study|Failure to return|5|||
23813201|NCT00077857|66699277|FG001|Overall Study|Failure to return|5|||
23813202|NCT00077857|66699276|FG000|Overall Study|Other|15|||
23813203|NCT00077857|66699277|FG001|Overall Study|Other|13|||
23813204|NCT00144781|66699278|FG000|Overall Study|Adverse Event|0|||
23813205|NCT00144781|66699279|FG001|Overall Study|Adverse Event|1|||
23813206|NCT00144781|66699280|FG002|Overall Study|Adverse Event|0|||
23813207|NCT00144781|66699281|FG003|Overall Study|Adverse Event|0|||
23813208|NCT00144781|66699278|FG000|Overall Study|Non-compliant|0|||
23813209|NCT00144781|66699279|FG001|Overall Study|Non-compliant|1|||
23813210|NCT00144781|66699280|FG002|Overall Study|Non-compliant|0|||
23813211|NCT00144781|66699281|FG003|Overall Study|Non-compliant|0|||
23418581|NCT01126268|65277275|FG000|Overall Study|Adverse Event|1|||
23418582|NCT04195438|65277276|FG000|Overall Study|Withdrawal by Subject|1|||
23418583|NCT00313313|65277278|FG000|Overall Study|Lack of Efficacy|14|||
23418584|NCT00313313|65277279|FG001|Overall Study|Lack of Efficacy|9|||
23418585|NCT00313313|65277280|FG002|Overall Study|Lack of Efficacy|20|||
23418586|NCT00313313|65277278|FG000|Overall Study|Withdrawal of consent by subject|18|||
23717261|NCT02671461|66340580|FG002|Follow-up|Withdrawal by Subject|0|||
23717262|NCT02671461|66340578|FG000|Follow-up|Lost to Follow-up|0|||
23717263|NCT02671461|66340579|FG001|Follow-up|Lost to Follow-up|0|||
23717264|NCT02671461|66340580|FG002|Follow-up|Lost to Follow-up|1|||
23717265|NCT02671461|66340578|FG000|Follow-up|Administrative Reason by Sponsor|0|||
23717266|NCT02671461|66340579|FG001|Follow-up|Administrative Reason by Sponsor|1|||
23717267|NCT02671461|66340580|FG002|Follow-up|Administrative Reason by Sponsor|0|||
23717268|NCT02420223|66340581|FG000|Overall Study|Adverse Event|1|||
23717269|NCT02420223|66340582|FG001|Overall Study|Adverse Event|0|||
23717270|NCT02420223|66340581|FG000|Overall Study|Physician Decision|0|||
23717271|NCT02420223|66340582|FG001|Overall Study|Physician Decision|2|||
23717272|NCT05101486|66340583|FG000|Overall Study|Death|1|||
23717273|NCT05101486|66340584|FG001|Overall Study|Death|0|||
23717274|NCT05101486|66340585|FG002|Overall Study|Death|1|||
23717275|NCT05101486|66340583|FG000|Overall Study|Lost to Follow-up|12|||
23717276|NCT05101486|66340584|FG001|Overall Study|Lost to Follow-up|8|||
23717277|NCT05101486|66340585|FG002|Overall Study|Lost to Follow-up|17|||
23717278|NCT05101486|66340583|FG000|Overall Study|Physician Decision|1|||
23717279|NCT05101486|66340584|FG001|Overall Study|Physician Decision|0|||
23717280|NCT05101486|66340585|FG002|Overall Study|Physician Decision|0|||
23717281|NCT05101486|66340583|FG000|Overall Study|Protocol Violation|0|||
23717282|NCT05101486|66340584|FG001|Overall Study|Protocol Violation|0|||
23717283|NCT05101486|66340585|FG002|Overall Study|Protocol Violation|1|||
23717284|NCT05101486|66340583|FG000|Overall Study|Withdrawal by Subject|5|||
23717285|NCT05101486|66340584|FG001|Overall Study|Withdrawal by Subject|2|||
23717286|NCT05101486|66340585|FG002|Overall Study|Withdrawal by Subject|4|||
23717287|NCT05101486|66340583|FG000|Overall Study|Randomized but not vaccinated|1|||
23717288|NCT05101486|66340584|FG001|Overall Study|Randomized but not vaccinated|1|||
23717289|NCT05101486|66340585|FG002|Overall Study|Randomized but not vaccinated|1|||
23717290|NCT02591238|66340586|FG000|Overall Study|Pregnancy|1|||
23717291|NCT02591238|66340587|FG001|Overall Study|Pregnancy|0|||
23717292|NCT02591238|66340588|FG002|Overall Study|Pregnancy|0|||
23717293|NCT02591238|66340589|FG003|Overall Study|Pregnancy|0|||
23717294|NCT02591238|66340586|FG000|Overall Study|Withdrawal by Subject|0|||
23717295|NCT02591238|66340587|FG001|Overall Study|Withdrawal by Subject|0|||
23717296|NCT02591238|66340588|FG002|Overall Study|Withdrawal by Subject|0|||
23717297|NCT02591238|66340589|FG003|Overall Study|Withdrawal by Subject|1|||
23418587|NCT00313313|65277279|FG001|Overall Study|Withdrawal of consent by subject|17|||
23418588|NCT00313313|65277280|FG002|Overall Study|Withdrawal of consent by subject|31|||
23418589|NCT00313313|65277278|FG000|Overall Study|Lost to Follow-up|10|||
23418590|NCT00313313|65277279|FG001|Overall Study|Lost to Follow-up|7|||
23717298|NCT02591238|66340586|FG000|Overall Study|influenza|0|||
23717299|NCT02591238|66340587|FG001|Overall Study|influenza|0|||
23717300|NCT02591238|66340588|FG002|Overall Study|influenza|0|||
23717301|NCT02591238|66340589|FG003|Overall Study|influenza|1|||
23717302|NCT02591238|66340586|FG000|Overall Study|personal circumstances|0|||
23717303|NCT02591238|66340587|FG001|Overall Study|personal circumstances|0|||
23717304|NCT02591238|66340588|FG002|Overall Study|personal circumstances|0|||
23717305|NCT02591238|66340589|FG003|Overall Study|personal circumstances|1|||
23813212|NCT01383135|66699284|FG000|Overall Study|Not Scanned / Imaged|1|||
23813213|NCT01383135|66699285|FG001|Overall Study|Not Scanned / Imaged|0|||
23813214|NCT01383135|66699286|FG002|Overall Study|Not Scanned / Imaged|1|||
23813215|NCT01383135|66699287|FG003|Overall Study|Not Scanned / Imaged|0|||
23813216|NCT02679235|66699288|FG000|Overall Study|Withdrawal by Subject|3|||
23418591|NCT00313313|65277280|FG002|Overall Study|Lost to Follow-up|9|||
23418592|NCT00313313|65277278|FG000|Overall Study|Adverse Event|15|||
23418593|NCT00313313|65277279|FG001|Overall Study|Adverse Event|16|||
23418594|NCT00313313|65277280|FG002|Overall Study|Adverse Event|12|||
23418595|NCT00313313|65277278|FG000|Overall Study|Physician Decision|2|||
23418596|NCT00313313|65277279|FG001|Overall Study|Physician Decision|6|||
23418597|NCT00313313|65277280|FG002|Overall Study|Physician Decision|4|||
23418598|NCT00313313|65277278|FG000|Overall Study|Poor/Noncompliance|3|||
23418599|NCT00313313|65277279|FG001|Overall Study|Poor/Noncompliance|6|||
23418600|NCT00313313|65277280|FG002|Overall Study|Poor/Noncompliance|2|||
23418601|NCT00313313|65277278|FG000|Overall Study|Pregnancy|1|||
23418602|NCT00313313|65277279|FG001|Overall Study|Pregnancy|2|||
23418603|NCT00313313|65277280|FG002|Overall Study|Pregnancy|0|||
23418604|NCT00313313|65277278|FG000|Overall Study|Death|0|||
23418605|NCT00313313|65277279|FG001|Overall Study|Death|0|||
23418606|NCT00313313|65277280|FG002|Overall Study|Death|2|||
23418607|NCT00313313|65277278|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23418608|NCT00313313|65277279|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
23418609|NCT00313313|65277280|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
23418610|NCT01471028|65277281|FG000|VTI-208|Adverse Event|39|||
23528134|NCT03670810|65669353|FG002|Open Label Extension|Lack of Efficacy|0|||
23528135|NCT03670810|65669354|FG003|Open Label Extension|Lack of Efficacy|0|||
23528136|NCT03670810|65669355|FG004|Open Label Extension|Lack of Efficacy|0|||
23528137|NCT03670810|65669356|FG005|Open Label Extension|Lack of Efficacy|0|||
23528138|NCT03670810|65669357|FG006|Open Label Extension|Lack of Efficacy|0|||
23528139|NCT03670810|65669358|FG007|Open Label Extension|Lack of Efficacy|0|||
23528140|NCT03670810|65669359|FG008|Open Label Extension|Lack of Efficacy|39|||
23528141|NCT03670810|65669351|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
23418611|NCT01471028|65277282|FG001|VTI-208|Adverse Event|41|||
23418612|NCT01471028|65277281|FG000|VTI-208|Withdrawal by Subject|0|||
23418613|NCT01471028|65277282|FG001|VTI-208|Withdrawal by Subject|2|||
23418614|NCT01471028|65277281|FG000|VTI-208|Lost to Follow-up|1|||
23418615|NCT01471028|65277282|FG001|VTI-208|Lost to Follow-up|1|||
23418616|NCT01471028|65277281|FG000|VTI-208E|Death|7|||
23528142|NCT03670810|65669352|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
23528143|NCT03670810|65669353|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
23528144|NCT03670810|65669354|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
23528145|NCT03670810|65669355|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
23528146|NCT03670810|65669356|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
23528147|NCT03670810|65669357|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
23528148|NCT03670810|65669358|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
23528149|NCT03670810|65669359|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
23528150|NCT03670810|65669351|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528151|NCT03670810|65669352|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528152|NCT03670810|65669353|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528153|NCT03670810|65669354|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528154|NCT03670810|65669355|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528155|NCT03670810|65669356|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528156|NCT03670810|65669357|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528157|NCT03670810|65669358|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528158|NCT03670810|65669359|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
23528159|NCT03670810|65669351|FG000|Open Label Extension|Withdrawal by Subject|0|||
23528160|NCT03670810|65669352|FG001|Open Label Extension|Withdrawal by Subject|0|||
23528161|NCT03670810|65669353|FG002|Open Label Extension|Withdrawal by Subject|0|||
23528162|NCT03670810|65669354|FG003|Open Label Extension|Withdrawal by Subject|0|||
23528163|NCT03670810|65669355|FG004|Open Label Extension|Withdrawal by Subject|0|||
23528164|NCT03670810|65669356|FG005|Open Label Extension|Withdrawal by Subject|0|||
23528165|NCT03670810|65669357|FG006|Open Label Extension|Withdrawal by Subject|0|||
23528166|NCT03670810|65669358|FG007|Open Label Extension|Withdrawal by Subject|0|||
23528167|NCT03670810|65669359|FG008|Open Label Extension|Withdrawal by Subject|46|||
23528168|NCT03670810|65669351|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528169|NCT03670810|65669352|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23813217|NCT02679235|66699288|FG000|Overall Study|Adverse Event|1|||
23528170|NCT03670810|65669353|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528171|NCT03670810|65669354|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23418617|NCT01471028|65277282|FG001|VTI-208E|Death|10|||
23418618|NCT01471028|65277281|FG000|VTI-208E|Withdrawal by Subject|1|||
23418619|NCT01471028|65277282|FG001|VTI-208E|Withdrawal by Subject|0|||
23418620|NCT01471028|65277281|FG000|VTI-208E|Lost to Follow-up|0|||
23418621|NCT01471028|65277282|FG001|VTI-208E|Lost to Follow-up|2|||
23528172|NCT03670810|65669355|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528173|NCT03670810|65669356|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528174|NCT03670810|65669357|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528175|NCT03670810|65669358|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528176|NCT03670810|65669359|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
23528177|NCT03670810|65669351|FG000|Open Label Extension|Physician Decision|0|||
23528178|NCT03670810|65669352|FG001|Open Label Extension|Physician Decision|0|||
23612244|NCT01199302|65967008|FG000|Overall Study|Other|1|||
23612245|NCT01199302|65967009|FG001|Overall Study|Other|0|||
23612246|NCT01199302|65967010|FG002|Overall Study|Other|0|||
23612247|NCT01199302|65967011|FG003|Overall Study|Other|0|||
23612248|NCT03839355|65967012|FG000|Overall Study|Withdrawal by Subject|1|||
23612249|NCT03839355|65967013|FG001|Overall Study|Withdrawal by Subject|0|||
23612250|NCT03861078|65969573|FG000|Overall Study|COVID-19 shut down|4|||
23612251|NCT03861078|65969573|FG000|Overall Study|Lost to Follow-up|1|||
23612252|NCT03861078|65969573|FG000|Overall Study|Protocol Violation|2|||
23612253|NCT03861078|65969573|FG000|Overall Study|lack of venous access|1|||
23612254|NCT00312845|65969574|FG000|Overall Study|Adverse Event|19|||
23612255|NCT00312845|65969575|FG001|Overall Study|Adverse Event|5|||
23612256|NCT00312845|65969574|FG000|Overall Study|Death|2|||
23612257|NCT00312845|65969575|FG001|Overall Study|Death|2|||
23612258|NCT00312845|65969574|FG000|Overall Study|Withdrawal by Subject|14|||
23612259|NCT00312845|65969575|FG001|Overall Study|Withdrawal by Subject|6|||
23612260|NCT00312845|65969574|FG000|Overall Study|Disease Progression|56|||
23612261|NCT00312845|65969575|FG001|Overall Study|Disease Progression|77|||
23612262|NCT00312845|65969574|FG000|Overall Study|Lost to Follow-up|2|||
23612263|NCT00312845|65969575|FG001|Overall Study|Lost to Follow-up|0|||
23612264|NCT00312845|65969574|FG000|Overall Study|Other|6|||
23612265|NCT00312845|65969575|FG001|Overall Study|Other|5|||
23612266|NCT02473913|65969576|FG000|Overall Study|Lost to Follow-up|3|||
23612267|NCT02473913|65969577|FG001|Overall Study|Lost to Follow-up|3|||
23612268|NCT01919489|65969579|FG000|Overall Study|Rejected the need of injections|4|||
23612269|NCT01919489|65969580|FG001|Overall Study|Rejected the need of injections|7|||
23612270|NCT01919489|65969579|FG000|Overall Study|Adverse Event|10|||
23612271|NCT01919489|65969580|FG001|Overall Study|Adverse Event|0|||
23612272|NCT01919489|65969579|FG000|Overall Study|Hospital readmission|2|||
23612273|NCT01919489|65969580|FG001|Overall Study|Hospital readmission|9|||
23612274|NCT01919489|65969579|FG000|Overall Study|Death|2|||
23612275|NCT01919489|65969580|FG001|Overall Study|Death|1|||
23612276|NCT01919489|65969579|FG000|Overall Study|Lost to Follow-up|38|||
23612277|NCT01919489|65969580|FG001|Overall Study|Lost to Follow-up|27|||
23612278|NCT02722278|65969581|FG000|Overall Study|Withdrawal by Subject|5|||
23612279|NCT02722278|65969582|FG001|Overall Study|Withdrawal by Subject|3|||
23528179|NCT03670810|65669353|FG002|Open Label Extension|Physician Decision|0|||
23528180|NCT03670810|65669354|FG003|Open Label Extension|Physician Decision|0|||
23612280|NCT02722278|65969581|FG000|Overall Study|Adverse Event|4|||
23528181|NCT03670810|65669355|FG004|Open Label Extension|Physician Decision|0|||
23528182|NCT03670810|65669356|FG005|Open Label Extension|Physician Decision|0|||
23528183|NCT03670810|65669357|FG006|Open Label Extension|Physician Decision|0|||
23612281|NCT02722278|65969582|FG001|Overall Study|Adverse Event|1|||
23612282|NCT02722278|65969581|FG000|Overall Study|Lost to Follow-up|2|||
23717306|NCT02591238|66340586|FG000|Overall Study|personal circumstances|0|||
23717307|NCT02591238|66340587|FG001|Overall Study|personal circumstances|1|||
23717308|NCT02591238|66340588|FG002|Overall Study|personal circumstances|0|||
23717309|NCT02591238|66340589|FG003|Overall Study|personal circumstances|0|||
23528184|NCT03670810|65669358|FG007|Open Label Extension|Physician Decision|0|||
23528185|NCT03670810|65669359|FG008|Open Label Extension|Physician Decision|2|||
23528186|NCT03670810|65669351|FG000|Open Label Extension|Non-compliance with study drug|0|||
23528187|NCT03670810|65669352|FG001|Open Label Extension|Non-compliance with study drug|0|||
23528188|NCT03670810|65669353|FG002|Open Label Extension|Non-compliance with study drug|0|||
23528189|NCT03670810|65669354|FG003|Open Label Extension|Non-compliance with study drug|0|||
23528190|NCT03670810|65669355|FG004|Open Label Extension|Non-compliance with study drug|0|||
23612283|NCT02722278|65969582|FG001|Overall Study|Lost to Follow-up|0|||
23717310|NCT04142216|66340590|FG000|Overall Study|Hospitalization|0|||
23528191|NCT03670810|65669356|FG005|Open Label Extension|Non-compliance with study drug|0|||
23528192|NCT03670810|65669357|FG006|Open Label Extension|Non-compliance with study drug|0|||
23528193|NCT03670810|65669358|FG007|Open Label Extension|Non-compliance with study drug|0|||
23612284|NCT02722278|65969581|FG000|Overall Study|Protocol Violation|1|||
23612285|NCT02722278|65969582|FG001|Overall Study|Protocol Violation|0|||
23612286|NCT02722278|65969581|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
23612287|NCT02722278|65969582|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
23612288|NCT02722278|65969581|FG000|Overall Study|Subject declined after tx assignment|0|||
23612289|NCT02722278|65969582|FG001|Overall Study|Subject declined after tx assignment|1|||
23717311|NCT04142216|66340591|FG001|Overall Study|Hospitalization|2|||
23717312|NCT04142216|66340590|FG000|Overall Study|Death|3|||
23717313|NCT04142216|66340591|FG001|Overall Study|Death|1|||
23813218|NCT03323437|66699289|FG000|Overall Study|Withdrawal by Subject|0|||
23813219|NCT03323437|66699290|FG001|Overall Study|Withdrawal by Subject|4|||
23813220|NCT01517373|66699293|FG000|Run-in Period|Death|1|||
23813221|NCT01517373|66699294|FG001|Run-in Period|Death|0|||
23528194|NCT03670810|65669359|FG008|Open Label Extension|Non-compliance with study drug|5|||
23528195|NCT03670810|65669351|FG000|Open Label Extension|Pregnancy|0|||
23528196|NCT03670810|65669352|FG001|Open Label Extension|Pregnancy|0|||
23528197|NCT03670810|65669353|FG002|Open Label Extension|Pregnancy|0|||
23528198|NCT03670810|65669354|FG003|Open Label Extension|Pregnancy|0|||
23528199|NCT03670810|65669355|FG004|Open Label Extension|Pregnancy|0|||
23528200|NCT03670810|65669356|FG005|Open Label Extension|Pregnancy|0|||
23528201|NCT03670810|65669357|FG006|Open Label Extension|Pregnancy|0|||
23528202|NCT03670810|65669358|FG007|Open Label Extension|Pregnancy|0|||
23528203|NCT03670810|65669359|FG008|Open Label Extension|Pregnancy|3|||
23528204|NCT03670810|65669351|FG000|Open Label Extension|Adverse Event|0|||
23528205|NCT03670810|65669352|FG001|Open Label Extension|Adverse Event|0|||
23528206|NCT03670810|65669353|FG002|Open Label Extension|Adverse Event|0|||
23528207|NCT03670810|65669354|FG003|Open Label Extension|Adverse Event|0|||
23528208|NCT03670810|65669355|FG004|Open Label Extension|Adverse Event|0|||
23528209|NCT03670810|65669356|FG005|Open Label Extension|Adverse Event|0|||
23528210|NCT03670810|65669357|FG006|Open Label Extension|Adverse Event|0|||
23528211|NCT03670810|65669358|FG007|Open Label Extension|Adverse Event|0|||
23528212|NCT03670810|65669359|FG008|Open Label Extension|Adverse Event|24|||
23528213|NCT03670810|65669351|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
23528214|NCT03670810|65669352|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
23528215|NCT03670810|65669353|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
23528216|NCT03670810|65669354|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
23528217|NCT03670810|65669355|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
23528218|NCT03670810|65669356|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
23528219|NCT03670810|65669357|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
23528220|NCT03670810|65669358|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
23528221|NCT03670810|65669359|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
23528222|NCT03670810|65669351|FG000|Open Label Extension|Lost to Follow-up|0|||
23528223|NCT03670810|65669352|FG001|Open Label Extension|Lost to Follow-up|0|||
23528224|NCT03670810|65669353|FG002|Open Label Extension|Lost to Follow-up|0|||
23528225|NCT03670810|65669354|FG003|Open Label Extension|Lost to Follow-up|0|||
23528226|NCT03670810|65669355|FG004|Open Label Extension|Lost to Follow-up|0|||
23528227|NCT03670810|65669356|FG005|Open Label Extension|Lost to Follow-up|0|||
23717314|NCT04142216|66340590|FG000|Overall Study|Referral to another hemodialysis unit|3|||
23717315|NCT04142216|66340591|FG001|Overall Study|Referral to another hemodialysis unit|2|||
23717316|NCT04142216|66340590|FG000|Overall Study|Use of clove|0|||
23717317|NCT04142216|66340591|FG001|Overall Study|Use of clove|1|||
23717318|NCT01626989|66340592|FG000|Screening Period|Screen Failure|15|||
23717319|NCT01626989|66340593|FG001|Screening Period|Screen Failure|0|||
23717320|NCT01626989|66340594|FG002|Screening Period|Screen Failure|0|||
23717321|NCT01626989|66340592|FG000|Screening Period|Withdrawal by Subject|2|||
23717322|NCT01626989|66340593|FG001|Screening Period|Withdrawal by Subject|0|||
23717323|NCT01626989|66340594|FG002|Screening Period|Withdrawal by Subject|0|||
23717324|NCT04096326|66340595|FG000|Overall Study|Withdrawal by Subject|0|||
23528228|NCT03670810|65669357|FG006|Open Label Extension|Lost to Follow-up|0|||
23528229|NCT03670810|65669358|FG007|Open Label Extension|Lost to Follow-up|0|||
23528230|NCT03670810|65669359|FG008|Open Label Extension|Lost to Follow-up|23|||
23528231|NCT02356783|65669360|FG000|Overall Study|Lost to Follow-up|1|||
23528232|NCT02356783|65669361|FG001|Overall Study|Lost to Follow-up|3|||
23528233|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
23528234|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
23528235|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
23528236|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
23528237|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23582174|NCT02223793|65862352|FG001|Overall Study|Withdrawal by Subject|2|||
23717325|NCT04096326|66340596|FG001|Overall Study|Withdrawal by Subject|0|||
23813222|NCT01517373|66699295|FG002|Run-in Period|Death|0|||
23528238|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
23528239|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23528240|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23528241|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
23813223|NCT01517373|66699296|FG003|Run-in Period|Death|0|||
23813224|NCT01517373|66699297|FG004|Run-in Period|Death|0|||
23813225|NCT01517373|66699298|FG005|Run-in Period|Death|0|||
23813226|NCT01517373|66699293|FG000|Run-in Period|Adverse Event|5|||
23813227|NCT01517373|66699294|FG001|Run-in Period|Adverse Event|0|||
23528242|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
23528243|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
23528244|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
23528245|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
23528246|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528247|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528248|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528249|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
23528250|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
23528251|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
23528252|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
23528253|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528254|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
23528255|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528256|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528257|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528258|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
23528259|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528260|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528261|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528262|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
23528263|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528264|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528265|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
23528266|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
23528267|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
23528268|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
23528269|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528270|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
23528271|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528272|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528273|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
23528274|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
23528275|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
23528276|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
23528277|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
23528278|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
23528279|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
23528280|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
23528289|NCT03139916|65669369|FG000|Overall Study|Withdrawal by Subject|2|||
23528290|NCT03139916|65669369|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
23528291|NCT02552316|65669370|FG000|Overall Study|Withdrawal by Subject|1|||
23528292|NCT02552316|65669370|FG000|Overall Study|Withdrawal due to non-compliance|1|||
23528293|NCT03548584|65669375|FG000|Overall Study|Lost to Follow-up|0|||
23813228|NCT01517373|66699295|FG002|Run-in Period|Adverse Event|0|||
23813229|NCT01517373|66699296|FG003|Run-in Period|Adverse Event|0|||
23813230|NCT01517373|66699297|FG004|Run-in Period|Adverse Event|0|||
23612290|NCT02722278|65969581|FG000|Overall Study|Site closure not study related|0|||
23612291|NCT02722278|65969582|FG001|Overall Study|Site closure not study related|1|||
23612292|NCT00755716|65969585|FG000|Overall Study|Adverse Event|1|||
23612293|NCT00755716|65969586|FG001|Overall Study|Adverse Event|4|||
23612294|NCT00755716|65969587|FG002|Overall Study|Adverse Event|1|||
23612295|NCT00755716|65969585|FG000|Overall Study|Lack of Efficacy|2|||
23612296|NCT00755716|65969586|FG001|Overall Study|Lack of Efficacy|0|||
23612297|NCT00755716|65969587|FG002|Overall Study|Lack of Efficacy|0|||
23612298|NCT00755716|65969585|FG000|Overall Study|Lost to Follow-up|5|||
23612299|NCT00755716|65969586|FG001|Overall Study|Lost to Follow-up|3|||
23612300|NCT00755716|65969587|FG002|Overall Study|Lost to Follow-up|1|||
23612301|NCT00755716|65969585|FG000|Overall Study|work schedule issues|0|||
23612302|NCT00755716|65969586|FG001|Overall Study|work schedule issues|1|||
23612303|NCT00755716|65969587|FG002|Overall Study|work schedule issues|1|||
23612304|NCT00451906|65969588|FG000|Overall Study|Adverse Event|515|||
23612305|NCT00451906|65969588|FG000|Overall Study|Lost to Follow-up|31|||
23612306|NCT00451906|65969588|FG000|Overall Study|Withdrawal by Subject|111|||
23612307|NCT00451906|65969588|FG000|Overall Study|Protocol Violation|21|||
23612308|NCT00451906|65969588|FG000|Overall Study|Progressive disease|1328|||
23612309|NCT00451906|65969588|FG000|Overall Study|Termination of the study|108|||
23612310|NCT00451906|65969588|FG000|Overall Study|Other Reasons|121|||
23612311|NCT00451906|65969588|FG000|Overall Study|Did not complete final visit|4|||
23612312|NCT01061775|65969589|FG000|Overall Study|Physician Decision|2|||
23612313|NCT01061775|65969589|FG000|Overall Study|Lost to Follow-up|1|||
23717326|NCT04096326|66340597|FG002|Overall Study|Withdrawal by Subject|0|||
23528294|NCT03548584|65669376|FG001|Overall Study|Lost to Follow-up|0|||
23528295|NCT03548584|65669377|FG002|Overall Study|Lost to Follow-up|1|||
23528296|NCT03548584|65669375|FG000|Overall Study|Adverse Event|1|||
23528297|NCT03548584|65669376|FG001|Overall Study|Adverse Event|11|||
23528298|NCT03548584|65669377|FG002|Overall Study|Adverse Event|5|||
23528299|NCT03548584|65669375|FG000|Overall Study|Site Terminated by Sponsor|1|||
23528300|NCT03548584|65669376|FG001|Overall Study|Site Terminated by Sponsor|3|||
23528301|NCT03548584|65669377|FG002|Overall Study|Site Terminated by Sponsor|2|||
23528302|NCT03548584|65669375|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
23528303|NCT03548584|65669376|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
23528304|NCT03548584|65669377|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
23528305|NCT03548584|65669375|FG000|Overall Study|Lack of Efficacy|0|||
23528306|NCT03548584|65669376|FG001|Overall Study|Lack of Efficacy|1|||
23528307|NCT03548584|65669377|FG002|Overall Study|Lack of Efficacy|0|||
23528308|NCT03548584|65669375|FG000|Overall Study|Non-compliance with Study Drug|0|||
23528309|NCT03548584|65669376|FG001|Overall Study|Non-compliance with Study Drug|1|||
23528310|NCT03548584|65669377|FG002|Overall Study|Non-compliance with Study Drug|0|||
23528311|NCT03548584|65669375|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
23528312|NCT03548584|65669376|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
23528313|NCT03548584|65669377|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
23528314|NCT00353366|65669378|FG000|Overall Study|Adverse Event|8|||
23528315|NCT00353366|65669378|FG000|Overall Study|Protocol Violation|12|||
23528316|NCT00353366|65669378|FG000|Overall Study|Withdrawal by Subject|12|||
23528317|NCT00353366|65669378|FG000|Overall Study|Lost to Follow-up|92|||
23528318|NCT00353366|65669378|FG000|Overall Study|Other|19|||
23528319|NCT00101101|65669386|FG000|Overall Study|never received vaccine|20|||
23528320|NCT03350503|65669387|FG000|Overall Study|Adverse Event|5|||
23528321|NCT03350503|65669387|FG000|Overall Study|Withdrawal by Subject|5|||
23528322|NCT03350503|65669387|FG000|Overall Study|Continuation impossible due to move|4|||
23528323|NCT03350503|65669387|FG000|Overall Study|Physician Decision|3|||
23528324|NCT01454726|65669390|FG000|Overall Study|Withdrawal by Subject|0|||
23528325|NCT01454726|65669391|FG001|Overall Study|Withdrawal by Subject|1|||
23528326|NCT02821962|65669392|FG000|Overall Study|Lost to Follow-up|2|||
23528327|NCT02821962|65669393|FG001|Overall Study|Lost to Follow-up|0|||
23528328|NCT00094653|65669394|FG000|Overall Study|Death|306|||
23528329|NCT00094653|65669395|FG001|Overall Study|Death|100|||
23528330|NCT00094653|65669396|FG002|Overall Study|Death|119|||
23528331|NCT00094653|65669394|FG000|Overall Study|Subject Withdrew Consent|10|||
23528332|NCT00094653|65669395|FG001|Overall Study|Subject Withdrew Consent|2|||
23528333|NCT00094653|65669396|FG002|Overall Study|Subject Withdrew Consent|3|||
23528334|NCT00094653|65669394|FG000|Overall Study|Other|2|||
23528335|NCT00094653|65669395|FG001|Overall Study|Other|2|||
23528336|NCT00094653|65669396|FG002|Overall Study|Other|2|||
23528337|NCT00094653|65669394|FG000|Overall Study|Lost to Follow-up|3|||
23528338|NCT00094653|65669395|FG001|Overall Study|Lost to Follow-up|2|||
23528339|NCT00094653|65669396|FG002|Overall Study|Lost to Follow-up|1|||
23528340|NCT00094653|65669394|FG000|Overall Study|Protocol Violation|0|||
23612314|NCT02632747|65969592|FG000|Wash-out Period|Adverse Event|1|||
23528341|NCT00094653|65669395|FG001|Overall Study|Protocol Violation|0|||
23528342|NCT00094653|65669396|FG002|Overall Study|Protocol Violation|1|||
23612315|NCT02632747|65969593|FG001|Wash-out Period|Adverse Event|0|||
23612316|NCT01393964|65969597|FG000|Overall Study|Disease Progression|4|||
23528343|NCT00192075|65669397|FG000|Overall Study|Disease Progression|23|||
23528344|NCT00192075|65669398|FG001|Overall Study|Disease Progression|6|||
23528345|NCT00192075|65669397|FG000|Overall Study|Adverse Event|1|||
23528346|NCT00192075|65669398|FG001|Overall Study|Adverse Event|3|||
23528347|NCT00192075|65669397|FG000|Overall Study|Death|0|||
23528348|NCT00192075|65669398|FG001|Overall Study|Death|1|||
23528349|NCT00192075|65669397|FG000|Overall Study|Lack of Efficacy|0|||
23717327|NCT04096326|66340598|FG003|Overall Study|Withdrawal by Subject|0|||
23717328|NCT04096326|66340599|FG004|Overall Study|Withdrawal by Subject|0|||
23717329|NCT04096326|66340600|FG005|Overall Study|Withdrawal by Subject|0|||
23717330|NCT04096326|66340601|FG006|Overall Study|Withdrawal by Subject|1|||
23717331|NCT04096326|66340602|FG007|Overall Study|Withdrawal by Subject|0|||
23717332|NCT04096326|66340603|FG008|Overall Study|Withdrawal by Subject|0|||
23717333|NCT04096326|66340604|FG009|Overall Study|Withdrawal by Subject|0|||
23418622|NCT00191724|65277287|FG000|Overall Study|Adverse Event|0|||
23418623|NCT00191724|65277288|FG001|Overall Study|Adverse Event|0|||
23418624|NCT00191724|65277289|FG002|Overall Study|Adverse Event|1|||
23528350|NCT00192075|65669398|FG001|Overall Study|Lack of Efficacy|0|||
23528351|NCT00192075|65669397|FG000|Overall Study|Physician Decision|3|||
23528352|NCT00192075|65669398|FG001|Overall Study|Physician Decision|0|||
23528353|NCT00192075|65669397|FG000|Overall Study|Withdrawal by Subject|5|||
23528354|NCT00192075|65669398|FG001|Overall Study|Withdrawal by Subject|5|||
23528355|NCT00192075|65669397|FG000|Overall Study|Patient Non-Compliance|0|||
23528356|NCT00192075|65669398|FG001|Overall Study|Patient Non-Compliance|1|||
23528357|NCT00192075|65669397|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
23528358|NCT00192075|65669398|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
23528359|NCT00192075|65669397|FG000|Overall Study|Other|5|||
23528360|NCT00192075|65669398|FG001|Overall Study|Other|2|||
23528361|NCT02223767|65669399|FG000|Overall Study|Withdrawal by Subject|4|||
23528362|NCT02223767|65669400|FG001|Overall Study|Withdrawal by Subject|4|||
23528363|NCT00235989|65669405|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528364|NCT00235989|65669406|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528365|NCT00235989|65669407|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528366|NCT00235989|65669408|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528367|NCT00235989|65669409|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528368|NCT00235989|65669410|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
23528369|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
23528370|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
23528371|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
23528372|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
23528373|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
23418625|NCT00191724|65277290|FG003|Overall Study|Adverse Event|0|||
23418626|NCT00191724|65277291|FG004|Overall Study|Adverse Event|0|||
23418627|NCT00191724|65277287|FG000|Overall Study|Lost to Follow-up|1|||
23418628|NCT00191724|65277288|FG001|Overall Study|Lost to Follow-up|1|||
23418629|NCT00191724|65277289|FG002|Overall Study|Lost to Follow-up|0|||
23418630|NCT00191724|65277290|FG003|Overall Study|Lost to Follow-up|2|||
23418631|NCT00191724|65277291|FG004|Overall Study|Lost to Follow-up|3|||
23418632|NCT00191724|65277287|FG000|Overall Study|Withdrawal by Subject|0|||
23418633|NCT00191724|65277288|FG001|Overall Study|Withdrawal by Subject|0|||
23418634|NCT00191724|65277289|FG002|Overall Study|Withdrawal by Subject|0|||
23418635|NCT00191724|65277290|FG003|Overall Study|Withdrawal by Subject|1|||
23418636|NCT00191724|65277291|FG004|Overall Study|Withdrawal by Subject|0|||
23418637|NCT03215758|65277294|FG000|Overall Study|Technical Problems|1|||
23418638|NCT03215758|65277295|FG001|Overall Study|Technical Problems|0|||
23418639|NCT03215758|65277294|FG000|Overall Study|Protocol deviation|0|||
23418640|NCT03215758|65277295|FG001|Overall Study|Protocol deviation|1|||
23528374|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
23528375|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
23528376|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528377|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
23528378|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23717334|NCT04096326|66340595|FG000|Overall Study|Lost to Follow-up|0|||
23717335|NCT04096326|66340596|FG001|Overall Study|Lost to Follow-up|1|||
23528379|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528380|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528381|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418641|NCT03215758|65277294|FG000|Overall Study|Physician Decision|0|||
23418642|NCT03215758|65277295|FG001|Overall Study|Physician Decision|1|||
23418643|NCT03215758|65277294|FG000|Overall Study|Death|0|||
23717336|NCT04096326|66340597|FG002|Overall Study|Lost to Follow-up|0|||
23717337|NCT04096326|66340598|FG003|Overall Study|Lost to Follow-up|0|||
23717338|NCT04096326|66340599|FG004|Overall Study|Lost to Follow-up|0|||
23717339|NCT04096326|66340600|FG005|Overall Study|Lost to Follow-up|0|||
23717340|NCT04096326|66340601|FG006|Overall Study|Lost to Follow-up|0|||
23717341|NCT04096326|66340602|FG007|Overall Study|Lost to Follow-up|0|||
23717342|NCT04096326|66340603|FG008|Overall Study|Lost to Follow-up|0|||
23717343|NCT04096326|66340604|FG009|Overall Study|Lost to Follow-up|0|||
23717344|NCT04096326|66340595|FG000|Overall Study|COVID-19-related reasons|0|||
23717345|NCT04096326|66340596|FG001|Overall Study|COVID-19-related reasons|0|||
23717346|NCT04096326|66340597|FG002|Overall Study|COVID-19-related reasons|0|||
23717347|NCT04096326|66340598|FG003|Overall Study|COVID-19-related reasons|0|||
23717348|NCT04096326|66340599|FG004|Overall Study|COVID-19-related reasons|1|||
23717349|NCT04096326|66340600|FG005|Overall Study|COVID-19-related reasons|5|||
23717350|NCT04096326|66340601|FG006|Overall Study|COVID-19-related reasons|0|||
23717351|NCT04096326|66340602|FG007|Overall Study|COVID-19-related reasons|0|||
23717352|NCT04096326|66340603|FG008|Overall Study|COVID-19-related reasons|0|||
23717353|NCT04096326|66340604|FG009|Overall Study|COVID-19-related reasons|0|||
23717354|NCT00871377|66340605|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23717355|NCT00871377|66340606|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23717356|NCT00871377|66340607|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
23717357|NCT00871377|66340608|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23717358|NCT00871377|66340609|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23717359|NCT00871377|66340610|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23717360|NCT00871377|66340605|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23717361|NCT00871377|66340606|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23717362|NCT00871377|66340607|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23717363|NCT00871377|66340608|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23717364|NCT00871377|66340609|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23717365|NCT00871377|66340610|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
23717366|NCT00871377|66340605|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
23717367|NCT00871377|66340606|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717368|NCT00871377|66340607|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717369|NCT00871377|66340608|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717370|NCT00871377|66340609|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717371|NCT00871377|66340610|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717372|NCT00871377|66340605|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717373|NCT00871377|66340606|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717374|NCT00871377|66340607|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717375|NCT00871377|66340608|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717376|NCT00871377|66340609|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
23717377|NCT00871377|66340610|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
23717378|NCT00871377|66340605|FG000|Third Intervention (10 Weeks)|Death|0|||
23717379|NCT00871377|66340606|FG001|Third Intervention (10 Weeks)|Death|0|||
23717380|NCT00871377|66340607|FG002|Third Intervention (10 Weeks)|Death|0|||
23717381|NCT00871377|66340608|FG003|Third Intervention (10 Weeks)|Death|1|||
23612317|NCT01393964|65969598|FG001|Overall Study|Disease Progression|3|||
23418644|NCT03215758|65277295|FG001|Overall Study|Death|1|||
23418645|NCT03215758|65277294|FG000|Overall Study|Adverse Event|1|||
23418646|NCT03215758|65277295|FG001|Overall Study|Adverse Event|2|||
23418647|NCT03215758|65277294|FG000|Overall Study|Subject/Guardian Decision|3|||
23418648|NCT03215758|65277295|FG001|Overall Study|Subject/Guardian Decision|3|||
23418649|NCT02095873|65277296|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23418650|NCT02095873|65277297|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23418651|NCT02095873|65277296|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23418652|NCT02095873|65277297|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23418653|NCT02095873|65277296|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
23418654|NCT02095873|65277297|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
23418655|NCT00713349|65277298|FG000|Overall Study|Protocol Violation|1|||
23418656|NCT00724854|65277300|FG000|Overall Study|Lack of Efficacy|187|||
23418657|NCT00724854|65277301|FG001|Overall Study|Lack of Efficacy|13|||
23418658|NCT00724854|65277300|FG000|Overall Study|Lost to Follow-up|87|||
23418659|NCT00724854|65277301|FG001|Overall Study|Lost to Follow-up|10|||
23418660|NCT00724854|65277300|FG000|Overall Study|Adverse Event|62|||
23418661|NCT00724854|65277301|FG001|Overall Study|Adverse Event|4|||
23418662|NCT00724854|65277300|FG000|Overall Study|Other|42|||
23418663|NCT00724854|65277301|FG001|Overall Study|Other|3|||
23418664|NCT00724854|65277300|FG000|Overall Study|Death|11|||
23418665|NCT00724854|65277301|FG001|Overall Study|Death|0|||
23418666|NCT00724854|65277300|FG000|Overall Study|Change of treatment|7|||
23418667|NCT00724854|65277301|FG001|Overall Study|Change of treatment|0|||
23418668|NCT00724854|65277300|FG000|Overall Study|Withdrawal by Subject|5|||
23418669|NCT00724854|65277301|FG001|Overall Study|Withdrawal by Subject|0|||
23418670|NCT00724854|65277300|FG000|Overall Study|Adverse event + lack of efficacy|2|||
23418671|NCT00724854|65277301|FG001|Overall Study|Adverse event + lack of efficacy|1|||
23418672|NCT01560637|65277302|FG000|Overall Study|Adverse Event|63|||
23418673|NCT01560637|65277302|FG000|Overall Study|Death|69|||
23418674|NCT01560637|65277302|FG000|Overall Study|Lost to Follow-up|8|||
23418675|NCT01560637|65277302|FG000|Overall Study|Protocol Violation|8|||
23418676|NCT01560637|65277302|FG000|Overall Study|Withdrawal by Subject|24|||
23418677|NCT01560637|65277302|FG000|Overall Study|Progressive Disease|20|||
23418678|NCT01560637|65277302|FG000|Overall Study|Other Reason Not Specified|6|||
23418679|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
23418680|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
23418681|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
23418682|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
23418683|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23418684|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23418685|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23418686|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23418687|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
23418688|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
23418689|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
23418690|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
23418691|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
23418692|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
23418693|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
23418694|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
23418695|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
23418696|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418697|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418698|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418699|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23717382|NCT00871377|66340609|FG004|Third Intervention (10 Weeks)|Death|0|||
23717383|NCT00871377|66340610|FG005|Third Intervention (10 Weeks)|Death|0|||
23717384|NCT00563368|66340614|FG000|Overall Study|Lost to Follow-up|14|||
23717385|NCT00563368|66340615|FG001|Overall Study|Lost to Follow-up|14|||
23717386|NCT00563368|66340616|FG002|Overall Study|Lost to Follow-up|12|||
23717387|NCT00563368|66340617|FG003|Overall Study|Lost to Follow-up|6|||
23717388|NCT00563368|66340618|FG004|Overall Study|Lost to Follow-up|9|||
23717389|NCT00563368|66340619|FG005|Overall Study|Lost to Follow-up|8|||
23717390|NCT00563368|66340620|FG006|Overall Study|Lost to Follow-up|9|||
23418700|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418701|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418702|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418703|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23717391|NCT00563368|66340614|FG000|Overall Study|Adverse Event|3|||
23717392|NCT00563368|66340615|FG001|Overall Study|Adverse Event|4|||
23418704|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418705|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418706|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418707|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418708|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418709|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
23717393|NCT00563368|66340616|FG002|Overall Study|Adverse Event|5|||
23717394|NCT00563368|66340617|FG003|Overall Study|Adverse Event|9|||
23717395|NCT00563368|66340618|FG004|Overall Study|Adverse Event|6|||
23717396|NCT00563368|66340619|FG005|Overall Study|Adverse Event|10|||
23717397|NCT00563368|66340620|FG006|Overall Study|Adverse Event|17|||
23717398|NCT00563368|66340614|FG000|Overall Study|Withdrawal by Subject|11|||
23717399|NCT00563368|66340615|FG001|Overall Study|Withdrawal by Subject|6|||
23717400|NCT00563368|66340616|FG002|Overall Study|Withdrawal by Subject|5|||
23717401|NCT00563368|66340617|FG003|Overall Study|Withdrawal by Subject|7|||
23717402|NCT00563368|66340618|FG004|Overall Study|Withdrawal by Subject|8|||
23717403|NCT00563368|66340619|FG005|Overall Study|Withdrawal by Subject|5|||
23717404|NCT00563368|66340620|FG006|Overall Study|Withdrawal by Subject|4|||
23717405|NCT00563368|66340614|FG000|Overall Study|protocol non-compliance|1|||
23717406|NCT00563368|66340615|FG001|Overall Study|protocol non-compliance|1|||
23717407|NCT00563368|66340616|FG002|Overall Study|protocol non-compliance|2|||
23717408|NCT00563368|66340617|FG003|Overall Study|protocol non-compliance|1|||
23717409|NCT00563368|66340618|FG004|Overall Study|protocol non-compliance|0|||
23717410|NCT00563368|66340619|FG005|Overall Study|protocol non-compliance|1|||
23717411|NCT00563368|66340620|FG006|Overall Study|protocol non-compliance|3|||
23717412|NCT00563368|66340614|FG000|Overall Study|Pregnancy|1|||
23717413|NCT00563368|66340615|FG001|Overall Study|Pregnancy|0|||
23717414|NCT00563368|66340616|FG002|Overall Study|Pregnancy|1|||
23717415|NCT00563368|66340617|FG003|Overall Study|Pregnancy|2|||
23717416|NCT00563368|66340618|FG004|Overall Study|Pregnancy|1|||
23717417|NCT00563368|66340619|FG005|Overall Study|Pregnancy|2|||
23717418|NCT00563368|66340620|FG006|Overall Study|Pregnancy|0|||
23717419|NCT00563368|66340614|FG000|Overall Study|requirement for restricted medication|0|||
23717420|NCT00563368|66340615|FG001|Overall Study|requirement for restricted medication|0|||
23418710|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
23717421|NCT00563368|66340616|FG002|Overall Study|requirement for restricted medication|2|||
23717422|NCT00563368|66340617|FG003|Overall Study|requirement for restricted medication|0|||
23717423|NCT00563368|66340618|FG004|Overall Study|requirement for restricted medication|0|||
23717424|NCT00563368|66340619|FG005|Overall Study|requirement for restricted medication|0|||
23717425|NCT00563368|66340620|FG006|Overall Study|requirement for restricted medication|0|||
23813231|NCT01517373|66699298|FG005|Run-in Period|Adverse Event|0|||
23813232|NCT01517373|66699293|FG000|Run-in Period|Did not meet eligibility criteria|34|||
23813233|NCT01517373|66699294|FG001|Run-in Period|Did not meet eligibility criteria|0|||
23813234|NCT01517373|66699295|FG002|Run-in Period|Did not meet eligibility criteria|0|||
23813235|NCT01517373|66699296|FG003|Run-in Period|Did not meet eligibility criteria|0|||
23418711|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
23418712|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
23418713|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
23418714|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
23418715|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
23418716|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
23418717|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
23418718|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
23528382|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418719|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
23418720|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
23418721|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
23528383|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418722|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
23418723|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
23418724|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
23528384|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
23528385|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
23528386|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
23528387|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
23528388|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
23528389|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
23528390|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
23528391|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
23528392|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
23717426|NCT00563368|66340614|FG000|Overall Study|Other|5|||
23717427|NCT00563368|66340615|FG001|Overall Study|Other|5|||
23717428|NCT00563368|66340616|FG002|Overall Study|Other|3|||
23717429|NCT00563368|66340617|FG003|Overall Study|Other|4|||
23717430|NCT00563368|66340618|FG004|Overall Study|Other|4|||
23717431|NCT00563368|66340619|FG005|Overall Study|Other|4|||
23717432|NCT00563368|66340620|FG006|Overall Study|Other|0|||
23813236|NCT01517373|66699297|FG004|Run-in Period|Did not meet eligibility criteria|0|||
23418725|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
23418726|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
23612318|NCT01393964|65969599|FG002|Overall Study|Disease Progression|5|||
23612319|NCT01393964|65969597|FG000|Overall Study|Study drug toxicity|1|||
23612320|NCT01393964|65969598|FG001|Overall Study|Study drug toxicity|0|||
23612321|NCT01393964|65969599|FG002|Overall Study|Study drug toxicity|0|||
23612322|NCT01393964|65969597|FG000|Overall Study|Withdrawal by Subject|0|||
23612323|NCT01393964|65969598|FG001|Overall Study|Withdrawal by Subject|0|||
23612324|NCT01393964|65969599|FG002|Overall Study|Withdrawal by Subject|1|||
23612325|NCT01393964|65969597|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23612326|NCT01393964|65969598|FG001|Overall Study|Adverse event unrelated to study drug|3|||
23612327|NCT01393964|65969599|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23612328|NCT01393964|65969597|FG000|Overall Study|Subject request stop study treatment|0|||
23612329|NCT01393964|65969598|FG001|Overall Study|Subject request stop study treatment|1|||
23612330|NCT01393964|65969599|FG002|Overall Study|Subject request stop study treatment|0|||
23612331|NCT01393964|65969597|FG000|Overall Study|Subject decided to move to transplant|1|||
23612332|NCT01393964|65969598|FG001|Overall Study|Subject decided to move to transplant|0|||
23528393|NCT04587193|65669411|FG000|Overall Study|Screen failure after consent|3|||
23528394|NCT04587193|65669412|FG001|Overall Study|Screen failure after consent|0|||
23528395|NCT04587193|65669411|FG000|Overall Study|Device broke during study|3|||
23528396|NCT04587193|65669412|FG001|Overall Study|Device broke during study|2|||
23528397|NCT01344447|65669413|FG000|Overall Study|Adverse Event|1|||
23528398|NCT01344447|65669413|FG000|Overall Study|Protocol Violation|1|||
23528399|NCT01344447|65669413|FG000|Overall Study|Withdrawal by Subject|1|||
23528400|NCT01344447|65669413|FG000|Overall Study|The contrast was not seen|1|||
23528401|NCT01344447|65669413|FG000|Overall Study|Physician Decision|1|||
23528402|NCT01344447|65669413|FG000|Overall Study|MRA unsuccessful|1|||
23528403|NCT01344447|65669413|FG000|Overall Study|Bolus tracking failed|1|||
23528404|NCT01344447|65669413|FG000|Overall Study|Error of power injector|1|||
23528405|NCT00096044|65669414|FG000|Overall Study|Withdrawal by Subject|9|||
23528406|NCT00096044|65669414|FG000|Overall Study|Adverse Event|21|||
23528407|NCT00096044|65669414|FG000|Overall Study|Disease Progression|4|||
23528408|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
23528409|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
23528410|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Graft loss|1|||
23528411|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Graft loss|2|||
23528412|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Death|5|||
23528413|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Death|3|||
23528414|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
23528415|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
23528416|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
23528417|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
23528418|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
23528419|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
23528420|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
23528421|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
23528422|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
23528423|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
23528424|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
23528425|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
23528426|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Death|1|||
23528427|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Death|2|||
23528428|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
23528429|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
23528430|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
23528431|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
23528432|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
23528433|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
23528434|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
23528435|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
23528436|NCT00799617|65669417|FG000|Main Testosterone Trial|Randomized in error|1|||
23528437|NCT00799617|65669418|FG001|Main Testosterone Trial|Randomized in error|1|||
23528438|NCT00799617|65669417|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
23528439|NCT00799617|65669418|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
23528440|NCT00799617|65669417|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
23528441|NCT00799617|65669418|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
23528442|NCT00799617|65669417|FG000|Sexual Funtion Trial|No Baseline Data|4|||
23528443|NCT00799617|65669418|FG001|Sexual Funtion Trial|No Baseline Data|7|||
23528444|NCT00799617|65669417|FG000|Physical Function Trial|Lost to Follow-up|6|||
23612333|NCT01393964|65969599|FG002|Overall Study|Subject decided to move to transplant|0|||
23612334|NCT01393964|65969597|FG000|Overall Study|Subject switched to commercial supply|1|||
23612335|NCT01393964|65969598|FG001|Overall Study|Subject switched to commercial supply|0|||
23612336|NCT01393964|65969599|FG002|Overall Study|Subject switched to commercial supply|2|||
23612337|NCT01393964|65969597|FG000|Overall Study|Subject plateaued in terms of effect|1|||
23612338|NCT01393964|65969598|FG001|Overall Study|Subject plateaued in terms of effect|0|||
23612339|NCT01393964|65969599|FG002|Overall Study|Subject plateaued in terms of effect|0|||
23612340|NCT01393964|65969597|FG000|Overall Study|Investigator removed subject from study|0|||
23612341|NCT01393964|65969598|FG001|Overall Study|Investigator removed subject from study|1|||
23612342|NCT01393964|65969599|FG002|Overall Study|Investigator removed subject from study|0|||
23612343|NCT01393964|65969597|FG000|Overall Study|Subject converted to roll-over study|0|||
23612344|NCT01393964|65969598|FG001|Overall Study|Subject converted to roll-over study|1|||
23612345|NCT01393964|65969599|FG002|Overall Study|Subject converted to roll-over study|0|||
23612346|NCT01393964|65969597|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
23612347|NCT01393964|65969598|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
23612348|NCT01393964|65969599|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
23612349|NCT00538629|65969600|FG000|Overall Study|At subject's request|1|||
23612350|NCT00538629|65969600|FG000|Overall Study|Adverse Event|2|||
23612351|NCT00538629|65969600|FG000|Overall Study|Lack of Efficacy|12|||
23612352|NCT00538629|65969600|FG000|Overall Study|Lost to Follow-up|6|||
23612353|NCT00538629|65969600|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
23612354|NCT02522299|65969606|FG000|Overall Study|Adverse Event|2|||
23612355|NCT02522299|65969607|FG001|Overall Study|Adverse Event|0|||
23612356|NCT02522299|65969606|FG000|Overall Study|Physician Decision|0|||
23612357|NCT02522299|65969607|FG001|Overall Study|Physician Decision|1|||
23612358|NCT02522299|65969606|FG000|Overall Study|Withdrawal by Subject|2|||
23612359|NCT02522299|65969607|FG001|Overall Study|Withdrawal by Subject|0|||
23612360|NCT02069379|65969608|FG000|Baseline Measurements|Lost to Follow-up|1|||
23612361|NCT02069379|65969609|FG001|Baseline Measurements|Lost to Follow-up|0|||
23612362|NCT02069379|65969610|FG002|Baseline Measurements|Lost to Follow-up|0|||
23612363|NCT02069379|65969611|FG003|Baseline Measurements|Lost to Follow-up|0|||
23612364|NCT02069379|65969608|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
23612365|NCT02069379|65969609|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
23612366|NCT02069379|65969610|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
23612367|NCT02069379|65969611|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
23612368|NCT02069379|65969608|FG000|First Treatment Arm|Lost to Follow-up|0|||
23612369|NCT02069379|65969609|FG001|First Treatment Arm|Lost to Follow-up|1|||
23612370|NCT02069379|65969610|FG002|First Treatment Arm|Lost to Follow-up|1|||
23528445|NCT00799617|65669418|FG001|Physical Function Trial|Lost to Follow-up|11|||
23528446|NCT00799617|65669417|FG000|Vitality Trial|Lost to Follow-up|7|||
23528447|NCT00799617|65669418|FG001|Vitality Trial|Lost to Follow-up|22|||
23528448|NCT00799617|65669417|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
23528449|NCT00799617|65669418|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
23528450|NCT00799617|65669417|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
23528451|NCT00799617|65669418|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
23528452|NCT00799617|65669417|FG000|Bone Trial|Month 12 scan not available|6|||
23528453|NCT00799617|65669418|FG001|Bone Trial|Month 12 scan not available|16|||
23528454|NCT00799617|65669417|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
23528455|NCT00799617|65669418|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
23528456|NCT00799617|65669417|FG000|Anemia Trial|Withdrawal by Subject|3|||
23528457|NCT00799617|65669418|FG001|Anemia Trial|Withdrawal by Subject|3|||
23528458|NCT01073865|65669423|FG000|Overall Study|Reasons other than below|19|||
23528459|NCT01073865|65669424|FG001|Overall Study|Reasons other than below|31|||
23528460|NCT01073865|65669423|FG000|Overall Study|Lost to Follow-up|1|||
23528461|NCT01073865|65669424|FG001|Overall Study|Lost to Follow-up|1|||
23528462|NCT01073865|65669423|FG000|Overall Study|Death|3|||
23528463|NCT01073865|65669424|FG001|Overall Study|Death|2|||
23528464|NCT01073865|65669423|FG000|Overall Study|Withdrawal by Subject|5|||
23528465|NCT01073865|65669424|FG001|Overall Study|Withdrawal by Subject|5|||
23528466|NCT02342704|65669425|FG000|Overall Study|Physician Decision|0|||
23528467|NCT02342704|65669426|FG001|Overall Study|Physician Decision|3|||
23528468|NCT02342704|65669425|FG000|Overall Study|Sponsor Termination|49|||
23528469|NCT02342704|65669426|FG001|Overall Study|Sponsor Termination|43|||
23528470|NCT02342704|65669425|FG000|Overall Study|Other|0|||
23528471|NCT02342704|65669426|FG001|Overall Study|Other|1|||
23528472|NCT02342704|65669425|FG000|Overall Study|Withdrawal by Subject|1|||
23528473|NCT02342704|65669426|FG001|Overall Study|Withdrawal by Subject|0|||
23528474|NCT02342704|65669425|FG000|Overall Study|Lost to Follow-up|2|||
23528475|NCT02342704|65669426|FG001|Overall Study|Lost to Follow-up|1|||
23612371|NCT02069379|65969611|FG003|First Treatment Arm|Lost to Follow-up|0|||
23612372|NCT02069379|65969608|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23528476|NCT02342704|65669425|FG000|Overall Study|Adverse Event|1|||
23528477|NCT02342704|65669426|FG001|Overall Study|Adverse Event|3|||
23528478|NCT03568942|65669427|FG000|Overall Study|Family emergency|1|||
23528479|NCT03568942|65669427|FG000|Overall Study|Lost to Follow-up|1|||
23528480|NCT01466192|65669428|FG000|Overall Study|Physician Decision|1|||
23528481|NCT01466192|65669428|FG000|Overall Study|Withdrawal by Subject|3|||
23528482|NCT01944059|65669429|FG000|Overall Study|Lost to Follow-up|1|||
23528483|NCT01944059|65669429|FG000|Overall Study|Physician Decision|3|||
23528484|NCT01944059|65669429|FG000|Overall Study|Withdrawal by Subject|1|||
23528485|NCT01944059|65669429|FG000|Overall Study|Adverse Event|2|||
23528486|NCT02256891|65669430|FG000|Overall Study|Death|0|||
23528487|NCT02256891|65669431|FG001|Overall Study|Death|2|||
23528488|NCT02256891|65669430|FG000|Overall Study|Lost to Follow-up|0|||
23528489|NCT02256891|65669431|FG001|Overall Study|Lost to Follow-up|3|||
23528490|NCT02256891|65669430|FG000|Overall Study|Physician Decision|7|||
23528491|NCT02256891|65669431|FG001|Overall Study|Physician Decision|3|||
23528492|NCT02256891|65669430|FG000|Overall Study|Screen Fail|5|||
23528493|NCT02256891|65669431|FG001|Overall Study|Screen Fail|4|||
23528494|NCT02256891|65669430|FG000|Overall Study|Equipment Malfunction|0|||
23528495|NCT02256891|65669431|FG001|Overall Study|Equipment Malfunction|1|||
23528496|NCT00701129|65669432|FG000|Overall Study|Death|2|||
23528497|NCT03467425|65669433|FG000|Overall Study|Adverse Event|9|||
23528498|NCT03467425|65669434|FG001|Overall Study|Adverse Event|9|||
23528499|NCT03467425|65669433|FG000|Overall Study|Lack of Efficacy|3|||
23717433|NCT02120157|66340623|FG000|Overall Study|Death|8|||
23717434|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
23717435|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
23717436|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
23717437|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
23717438|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
23717439|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
23717440|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
23717441|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
23717442|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
23717443|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
23717444|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
23717445|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
23717446|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
23717447|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
23717448|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
23717449|NCT01412060|66340624|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
23717450|NCT01412060|66340625|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
23717451|NCT01412060|66340626|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
23717452|NCT01412060|66340624|FG000|Period Between RIP and SP|Adverse Event|4|||
23717453|NCT01412060|66340625|FG001|Period Between RIP and SP|Adverse Event|0|||
23717454|NCT01412060|66340626|FG002|Period Between RIP and SP|Adverse Event|0|||
23717455|NCT01412060|66340624|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
23717456|NCT01412060|66340625|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
23717457|NCT01412060|66340626|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
23717458|NCT01412060|66340624|FG000|Period Between RIP and SP|Protocol Violation|2|||
23717459|NCT01412060|66340625|FG001|Period Between RIP and SP|Protocol Violation|0|||
23717460|NCT01412060|66340626|FG002|Period Between RIP and SP|Protocol Violation|0|||
23528500|NCT03467425|65669434|FG001|Overall Study|Lack of Efficacy|1|||
23528501|NCT03467425|65669433|FG000|Overall Study|Protocol Violation|0|||
23528502|NCT03467425|65669434|FG001|Overall Study|Protocol Violation|1|||
23528503|NCT03467425|65669433|FG000|Overall Study|Lost to Follow-up|18|||
23528504|NCT03467425|65669434|FG001|Overall Study|Lost to Follow-up|25|||
23528505|NCT03467425|65669433|FG000|Overall Study|Physician Decision|2|||
23528506|NCT03467425|65669434|FG001|Overall Study|Physician Decision|1|||
23528507|NCT03467425|65669433|FG000|Overall Study|Withdrawal by Subject|15|||
23717461|NCT01412060|66340624|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
23717462|NCT01412060|66340625|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
23717463|NCT01412060|66340626|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
23717464|NCT01412060|66340624|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
23528508|NCT03467425|65669434|FG001|Overall Study|Withdrawal by Subject|17|||
23528509|NCT01387607|65669435|FG000|Overall Study|Adverse Event|23|||
23528510|NCT01387607|65669436|FG001|Overall Study|Adverse Event|11|||
23528511|NCT01387607|65669435|FG000|Overall Study|Lack of Efficacy|8|||
23528512|NCT01387607|65669436|FG001|Overall Study|Lack of Efficacy|6|||
23528513|NCT01387607|65669435|FG000|Overall Study|Lost to Follow-up|2|||
23528514|NCT01387607|65669436|FG001|Overall Study|Lost to Follow-up|1|||
23528515|NCT01387607|65669435|FG000|Overall Study|No longer meets eligibility criteria|0|||
23528516|NCT01387607|65669436|FG001|Overall Study|No longer meets eligibility criteria|1|||
23528517|NCT01387607|65669435|FG000|Overall Study|Protocol Violation|1|||
23528518|NCT01387607|65669436|FG001|Overall Study|Protocol Violation|5|||
23528519|NCT01387607|65669435|FG000|Overall Study|Withdrawal by Subject|13|||
23528520|NCT01387607|65669436|FG001|Overall Study|Withdrawal by Subject|14|||
23528521|NCT01387607|65669435|FG000|Overall Study|Other|1|||
23528522|NCT01387607|65669436|FG001|Overall Study|Other|1|||
23528523|NCT01387607|65669435|FG000|Overall Study|Randomized, not treated|3|||
23528524|NCT01387607|65669436|FG001|Overall Study|Randomized, not treated|6|||
23528525|NCT00715793|65669437|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
23528526|NCT00715793|65669438|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
23528527|NCT00715793|65669437|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
23528528|NCT00715793|65669438|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
23528529|NCT00308711|65669439|FG000|Overall Study|Withdrawal by Subject|1|||
23528530|NCT00308711|65669440|FG001|Overall Study|Withdrawal by Subject|0|||
23528531|NCT00308711|65669441|FG002|Overall Study|Withdrawal by Subject|1|||
23528532|NCT00308711|65669439|FG000|Overall Study|Protocol Violation|0|||
23528533|NCT00308711|65669440|FG001|Overall Study|Protocol Violation|1|||
23528534|NCT00308711|65669441|FG002|Overall Study|Protocol Violation|1|||
23528535|NCT00308711|65669439|FG000|Overall Study|Lost to Follow-up|0|||
23528536|NCT00308711|65669440|FG001|Overall Study|Lost to Follow-up|1|||
23528537|NCT00308711|65669441|FG002|Overall Study|Lost to Follow-up|0|||
23528538|NCT00308711|65669439|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
23528539|NCT00308711|65669440|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
23528540|NCT00308711|65669441|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
23528541|NCT00308711|65669439|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
23612373|NCT02069379|65969609|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23612374|NCT02069379|65969610|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23612375|NCT02069379|65969611|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23612376|NCT02069379|65969608|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
23612377|NCT02069379|65969609|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
23612378|NCT02069379|65969610|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
23612379|NCT02069379|65969611|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
23612380|NCT02069379|65969608|FG000|Second Treatment Arm|Lost to Follow-up|0|||
23612381|NCT02069379|65969609|FG001|Second Treatment Arm|Lost to Follow-up|0|||
23612382|NCT02069379|65969610|FG002|Second Treatment Arm|Lost to Follow-up|1|||
23612383|NCT02069379|65969611|FG003|Second Treatment Arm|Lost to Follow-up|0|||
23612384|NCT03409276|65969612|FG000|Overall Study|Withdrawal by Subject|0|||
23612385|NCT03409276|65969613|FG001|Overall Study|Withdrawal by Subject|0|||
23612386|NCT03409276|65969614|FG002|Overall Study|Withdrawal by Subject|0|||
23612387|NCT03409276|65969615|FG003|Overall Study|Withdrawal by Subject|0|||
23612388|NCT03409276|65969616|FG004|Overall Study|Withdrawal by Subject|1|||
23612389|NCT03409276|65969612|FG000|Overall Study|Lost to Follow-up|0|||
23612390|NCT03409276|65969613|FG001|Overall Study|Lost to Follow-up|0|||
23612391|NCT03409276|65969614|FG002|Overall Study|Lost to Follow-up|0|||
23612392|NCT03409276|65969615|FG003|Overall Study|Lost to Follow-up|2|||
23612393|NCT03409276|65969616|FG004|Overall Study|Lost to Follow-up|2|||
23717465|NCT01412060|66340625|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
23717466|NCT01412060|66340626|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
23528542|NCT00308711|65669440|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
23528543|NCT00308711|65669441|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
23528544|NCT00025883|65669442|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
23528545|NCT00025883|65669442|FG000|Overall Study|no baseline data|1|||
23528546|NCT00025883|65669442|FG000|Overall Study|Death|1|||
23528547|NCT00025883|65669442|FG000|Overall Study|Adverse Event|1|||
23528548|NCT00025883|65669442|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
23528549|NCT00600756|65669445|FG000|Analysis After 6 Months|Adverse Event|43|||
23528550|NCT00600756|65669446|FG001|Analysis After 6 Months|Adverse Event|33|||
23612394|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
23612395|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
23612396|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
23612397|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
23612398|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
23612399|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
23612400|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
23612401|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
23612402|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
23612403|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
23612404|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
23612405|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
23612406|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
23612407|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
23612408|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
23528551|NCT00600756|65669445|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
23528552|NCT00600756|65669446|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
23528553|NCT00600756|65669445|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
23528554|NCT00600756|65669446|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
23528555|NCT00600756|65669445|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
23528556|NCT00600756|65669446|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
23612409|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
23612410|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
23612411|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
23612412|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
23612413|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
23717467|NCT01412060|66340624|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
23528557|NCT00600756|65669445|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
23528558|NCT00600756|65669446|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
23612414|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
23717468|NCT01412060|66340625|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
23717469|NCT01412060|66340626|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
23528559|NCT00600756|65669445|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
23528560|NCT00600756|65669446|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
23528561|NCT00600756|65669445|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
23528562|NCT00600756|65669446|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
23528563|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
23528564|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
23528565|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
23528566|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
23528567|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
23528568|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
23528569|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
23528570|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
23528571|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
23528572|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
23528573|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
23528574|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
23528575|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
23528576|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
23528577|NCT01559311|65669447|FG000|Overall Study|Protocol Violation|0|||
23528578|NCT01559311|65669448|FG001|Overall Study|Protocol Violation|0|||
23528579|NCT01559311|65669449|FG002|Overall Study|Protocol Violation|2|||
23528580|NCT01559311|65669447|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
23528581|NCT01559311|65669448|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
23528582|NCT01559311|65669449|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
23528583|NCT01559311|65669447|FG000|Overall Study|Withdrawal by Subject|2|||
23528584|NCT01559311|65669448|FG001|Overall Study|Withdrawal by Subject|1|||
23528585|NCT01559311|65669449|FG002|Overall Study|Withdrawal by Subject|0|||
23528586|NCT01559311|65669447|FG000|Overall Study|Death|0|||
23528587|NCT01559311|65669448|FG001|Overall Study|Death|2|||
23528588|NCT01559311|65669449|FG002|Overall Study|Death|3|||
23528589|NCT01559311|65669447|FG000|Overall Study|Lost to Follow-up|0|||
23528590|NCT01559311|65669448|FG001|Overall Study|Lost to Follow-up|3|||
23528591|NCT01559311|65669449|FG002|Overall Study|Lost to Follow-up|2|||
23528592|NCT01559311|65669447|FG000|Overall Study|Adverse Event|0|||
23528593|NCT01559311|65669448|FG001|Overall Study|Adverse Event|0|||
23528594|NCT01559311|65669449|FG002|Overall Study|Adverse Event|1|||
23528595|NCT01247090|65669450|FG000|Overall Study|Physician Decision|1|||
23528596|NCT01247090|65669451|FG001|Overall Study|Physician Decision|0|||
23528597|NCT01247090|65669452|FG002|Overall Study|Physician Decision|0|||
23528598|NCT01247090|65669450|FG000|Overall Study|Withdrawal by Subject|0|||
23528599|NCT01247090|65669451|FG001|Overall Study|Withdrawal by Subject|1|||
23528600|NCT01247090|65669452|FG002|Overall Study|Withdrawal by Subject|0|||
23528601|NCT02448875|65669453|FG000|Overall Study|Adverse Event|2|||
23528602|NCT02448875|65669454|FG001|Overall Study|Adverse Event|1|||
23528603|NCT02448875|65669455|FG002|Overall Study|Adverse Event|0|||
23528604|NCT02448875|65669453|FG000|Overall Study|Lost to Follow-up|1|||
23528605|NCT02448875|65669454|FG001|Overall Study|Lost to Follow-up|0|||
23528606|NCT02448875|65669455|FG002|Overall Study|Lost to Follow-up|0|||
23528607|NCT02448875|65669453|FG000|Overall Study|Investigator Decision|3|||
23528608|NCT02448875|65669454|FG001|Overall Study|Investigator Decision|0|||
23528609|NCT02448875|65669455|FG002|Overall Study|Investigator Decision|1|||
23528610|NCT02448875|65669453|FG000|Overall Study|Withdrawal by Subject|1|||
23528611|NCT02448875|65669454|FG001|Overall Study|Withdrawal by Subject|0|||
23528612|NCT02448875|65669455|FG002|Overall Study|Withdrawal by Subject|0|||
23528613|NCT00958776|65669456|FG000|Overall Study|Adverse Event|0|||
23528614|NCT00958776|65669457|FG001|Overall Study|Adverse Event|1|||
23528615|NCT00958776|65669456|FG000|Overall Study|Physician Decision|1|||
23528616|NCT00958776|65669457|FG001|Overall Study|Physician Decision|0|||
23528617|NCT00958776|65669456|FG000|Overall Study|Lost to Follow-up|2|||
23528618|NCT00958776|65669457|FG001|Overall Study|Lost to Follow-up|6|||
23528619|NCT00958776|65669456|FG000|Overall Study|Withdrawal by Subject|7|||
23528620|NCT00958776|65669457|FG001|Overall Study|Withdrawal by Subject|16|||
23528621|NCT00958776|65669456|FG000|Overall Study|Protocol Violation|1|||
23528622|NCT00958776|65669457|FG001|Overall Study|Protocol Violation|1|||
23528623|NCT00958776|65669456|FG000|Overall Study|Death|2|||
23528624|NCT00958776|65669457|FG001|Overall Study|Death|1|||
23528625|NCT00958776|65669456|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
23528626|NCT00958776|65669457|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
23528627|NCT00958776|65669456|FG000|Overall Study|Missing|1|||
23528628|NCT00958776|65669457|FG001|Overall Study|Missing|1|||
23528629|NCT00262067|65669459|FG000|Overall Study|Death|190|||
23528630|NCT00262067|65669460|FG001|Overall Study|Death|89|||
23528631|NCT00262067|65669461|FG002|Overall Study|Death|186|||
23528632|NCT00262067|65669462|FG003|Overall Study|Death|99|||
23717470|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
23717471|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
23717472|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
23717473|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
23717474|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
23528633|NCT00262067|65669459|FG000|Overall Study|Lost to Follow-up|5|||
23717475|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
23528634|NCT00262067|65669460|FG001|Overall Study|Lost to Follow-up|4|||
23528635|NCT00262067|65669461|FG002|Overall Study|Lost to Follow-up|7|||
23528636|NCT00262067|65669462|FG003|Overall Study|Lost to Follow-up|5|||
23528637|NCT00262067|65669459|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
23528638|NCT00262067|65669460|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
23528639|NCT00262067|65669461|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
23528640|NCT00262067|65669462|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
23717476|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
23813237|NCT01517373|66699298|FG005|Run-in Period|Did not meet eligibility criteria|0|||
23528641|NCT00262067|65669459|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
23528642|NCT00262067|65669460|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
23528643|NCT00262067|65669461|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
23528644|NCT00262067|65669462|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
23528645|NCT01828034|65669465|FG000|Overall Study|Withdrawal by Subject|0|||
23528646|NCT01828034|65669466|FG001|Overall Study|Withdrawal by Subject|0|||
23528647|NCT01828034|65669467|FG002|Overall Study|Withdrawal by Subject|0|||
23528648|NCT01828034|65669468|FG003|Overall Study|Withdrawal by Subject|1|||
23528649|NCT00500370|65669469|FG000|Overall Study|Adverse Event|9|||
23528650|NCT00500370|65669470|FG001|Overall Study|Adverse Event|3|||
23528651|NCT00500370|65669469|FG000|Overall Study|Lost to Follow-up|10|||
23528652|NCT00500370|65669470|FG001|Overall Study|Lost to Follow-up|10|||
23528653|NCT00500370|65669469|FG000|Overall Study|Protocol Violation|2|||
23528654|NCT00500370|65669470|FG001|Overall Study|Protocol Violation|4|||
23528655|NCT00500370|65669469|FG000|Overall Study|Sponsor Decision|2|||
23528656|NCT00500370|65669470|FG001|Overall Study|Sponsor Decision|0|||
23528657|NCT00500370|65669469|FG000|Overall Study|Subject Decision|10|||
23528658|NCT00500370|65669470|FG001|Overall Study|Subject Decision|17|||
23528659|NCT02410811|65669473|FG000|Overall Study|Withdrawal by Subject|0|||
23528660|NCT02410811|65669474|FG001|Overall Study|Withdrawal by Subject|0|||
23528661|NCT02410811|65669475|FG002|Overall Study|Withdrawal by Subject|1|||
23528662|NCT02410811|65669476|FG003|Overall Study|Withdrawal by Subject|0|||
23528663|NCT01440946|65669477|FG000|Overall Study|Lost to Follow-up|1|||
23528664|NCT01440946|65669478|FG001|Overall Study|Lost to Follow-up|1|||
23528665|NCT01440946|65669477|FG000|Overall Study|Physician Decision|1|||
23528666|NCT01440946|65669478|FG001|Overall Study|Physician Decision|0|||
23528667|NCT02553421|65669487|FG000|Overall Study|Lost to Follow-up|21|||
23528668|NCT02553421|65669488|FG001|Overall Study|Lost to Follow-up|1|||
23528669|NCT02553421|65669487|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
23528670|NCT02553421|65669488|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
23528671|NCT02553421|65669487|FG000|Overall Study|Improper Device Placement|3|||
23528672|NCT02553421|65669488|FG001|Overall Study|Improper Device Placement|0|||
23528673|NCT00337103|65669489|FG000|Overall Study|Progressive Disease|414|||
23528674|NCT00337103|65669490|FG001|Overall Study|Progressive Disease|410|||
23528675|NCT00337103|65669489|FG000|Overall Study|Adverse Event|45|||
23528676|NCT00337103|65669490|FG001|Overall Study|Adverse Event|59|||
23528677|NCT00337103|65669489|FG000|Overall Study|Subject Choice|34|||
23528678|NCT00337103|65669490|FG001|Overall Study|Subject Choice|27|||
23528679|NCT00337103|65669489|FG000|Overall Study|Clinical Progression|27|||
23528680|NCT00337103|65669490|FG001|Overall Study|Clinical Progression|24|||
23717477|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
23528681|NCT00337103|65669489|FG000|Overall Study|Physician Decision|15|||
23528682|NCT00337103|65669490|FG001|Overall Study|Physician Decision|14|||
23528683|NCT00337103|65669489|FG000|Overall Study|Withdrawal by Subject|8|||
23528684|NCT00337103|65669490|FG001|Overall Study|Withdrawal by Subject|5|||
23528685|NCT00337103|65669489|FG000|Overall Study|Other|5|||
23528686|NCT00337103|65669490|FG001|Overall Study|Other|6|||
23528687|NCT00337103|65669489|FG000|Overall Study|Entry Criteria Not Met|4|||
23528688|NCT00337103|65669490|FG001|Overall Study|Entry Criteria Not Met|1|||
23528689|NCT00337103|65669489|FG000|Overall Study|Lost to Follow-up|1|||
23528690|NCT00337103|65669490|FG001|Overall Study|Lost to Follow-up|2|||
23528691|NCT00337103|65669489|FG000|Overall Study|Death|1|||
23528692|NCT00337103|65669490|FG001|Overall Study|Death|0|||
23528693|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
23528694|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
23528695|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
23528696|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
23528697|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
23528698|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
23528699|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
23717478|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
23717479|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
23717480|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
23717481|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
23717482|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
23717483|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
23717484|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
23717485|NCT01412060|66340624|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
23717486|NCT01412060|66340625|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
23717487|NCT01412060|66340626|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
23717488|NCT01412060|66340624|FG000|Period Between SP and DBP|Protocol Violation|2|||
23717489|NCT01412060|66340625|FG001|Period Between SP and DBP|Protocol Violation|0|||
23717490|NCT01412060|66340626|FG002|Period Between SP and DBP|Protocol Violation|0|||
23717491|NCT01412060|66340624|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
23717492|NCT01412060|66340625|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
23717493|NCT01412060|66340626|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
23717494|NCT01412060|66340624|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
23717495|NCT01412060|66340625|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
23717496|NCT01412060|66340626|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
23717497|NCT01412060|66340624|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
23717498|NCT01412060|66340625|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
23717499|NCT01412060|66340626|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
23717500|NCT01412060|66340624|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
23717501|NCT01412060|66340625|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
23717502|NCT01412060|66340626|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
23717503|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
23717504|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
23717505|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
23717506|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
23717507|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
23717508|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
23717509|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
23717510|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
23717511|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
23717512|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
23717513|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
23717514|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
23717515|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
23717516|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
23717517|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
23717518|NCT01412060|66340624|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
23813238|NCT01517373|66699293|FG000|Run-in Period|Lost to Follow-up|1|||
23813239|NCT01517373|66699294|FG001|Run-in Period|Lost to Follow-up|0|||
23813240|NCT01517373|66699295|FG002|Run-in Period|Lost to Follow-up|0|||
23813241|NCT01517373|66699296|FG003|Run-in Period|Lost to Follow-up|0|||
23813242|NCT01517373|66699297|FG004|Run-in Period|Lost to Follow-up|0|||
23813243|NCT01517373|66699298|FG005|Run-in Period|Lost to Follow-up|0|||
23813244|NCT01517373|66699293|FG000|Run-in Period|Withdrawal by Subject|12|||
23813245|NCT01517373|66699294|FG001|Run-in Period|Withdrawal by Subject|0|||
23813246|NCT01517373|66699295|FG002|Run-in Period|Withdrawal by Subject|0|||
23813247|NCT01517373|66699296|FG003|Run-in Period|Withdrawal by Subject|0|||
23813248|NCT01517373|66699297|FG004|Run-in Period|Withdrawal by Subject|0|||
23813249|NCT01517373|66699298|FG005|Run-in Period|Withdrawal by Subject|0|||
23813250|NCT01517373|66699293|FG000|Run-in Period|Sponsor Decision|3|||
23813251|NCT01517373|66699294|FG001|Run-in Period|Sponsor Decision|0|||
23813252|NCT01517373|66699295|FG002|Run-in Period|Sponsor Decision|0|||
23813253|NCT01517373|66699296|FG003|Run-in Period|Sponsor Decision|0|||
23813254|NCT01517373|66699297|FG004|Run-in Period|Sponsor Decision|0|||
23813255|NCT01517373|66699298|FG005|Run-in Period|Sponsor Decision|0|||
23813256|NCT01517373|66699293|FG000|Run-in Period|Other|1|||
23813257|NCT01517373|66699294|FG001|Run-in Period|Other|0|||
23528700|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
23528701|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
23717519|NCT01412060|66340625|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
23813258|NCT01517373|66699295|FG002|Run-in Period|Other|0|||
23813259|NCT01517373|66699296|FG003|Run-in Period|Other|0|||
23813260|NCT01517373|66699297|FG004|Run-in Period|Other|0|||
23813261|NCT01517373|66699298|FG005|Run-in Period|Other|0|||
23528702|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
23528703|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
23528704|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
23528705|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
23528706|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
23528707|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
23528708|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
23528709|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
23528710|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
23528711|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
23528712|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
23528713|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
23528714|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
23528715|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
23528716|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
23528717|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
23528718|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
23528719|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
23528720|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
23528721|NCT04542070|65669491|FG000|Maintenance + Extension Period|Adverse Event|10|||
23528722|NCT04542070|65669492|FG001|Maintenance + Extension Period|Adverse Event|2|||
23528723|NCT04542070|65669493|FG002|Maintenance + Extension Period|Adverse Event|0|||
23528724|NCT04542070|65669494|FG003|Maintenance + Extension Period|Adverse Event|0|||
23528725|NCT04542070|65669491|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
23528726|NCT04542070|65669492|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
23528727|NCT04542070|65669493|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
23528728|NCT04542070|65669494|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
23528729|NCT04542070|65669491|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
23528730|NCT04542070|65669492|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
23528731|NCT04542070|65669493|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
23528732|NCT04542070|65669494|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
23528733|NCT04542070|65669491|FG000|Maintenance + Extension Period|Physician Decision|1|||
23528734|NCT04542070|65669492|FG001|Maintenance + Extension Period|Physician Decision|1|||
23528735|NCT04542070|65669493|FG002|Maintenance + Extension Period|Physician Decision|0|||
23528736|NCT04542070|65669494|FG003|Maintenance + Extension Period|Physician Decision|0|||
23528737|NCT04542070|65669491|FG000|Maintenance + Extension Period|Protocol Violation|2|||
23528738|NCT04542070|65669492|FG001|Maintenance + Extension Period|Protocol Violation|5|||
23528739|NCT04542070|65669493|FG002|Maintenance + Extension Period|Protocol Violation|0|||
23528740|NCT04542070|65669494|FG003|Maintenance + Extension Period|Protocol Violation|0|||
23528741|NCT04542070|65669491|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
23528742|NCT04542070|65669492|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
23528743|NCT04542070|65669493|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
23528744|NCT04542070|65669494|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
23528745|NCT04542070|65669491|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
23418727|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
23418728|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
23418729|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
23418730|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
23418731|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
23418732|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
23418733|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
23528746|NCT04542070|65669492|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
23528747|NCT04542070|65669493|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
23717520|NCT01412060|66340626|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
23717521|NCT00304915|66340627|FG000|Overall Study|Lost to Follow-up|11|||
23717522|NCT00304915|66340628|FG001|Overall Study|Lost to Follow-up|11|||
23717523|NCT00304915|66340627|FG000|Overall Study|Death|4|||
23813262|NCT01517373|66699293|FG000|Treatment Period|Adverse Event|0|||
23813263|NCT01517373|66699294|FG001|Treatment Period|Adverse Event|0|||
23418734|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
23418735|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
23528748|NCT04542070|65669494|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
23528749|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528750|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528751|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528752|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
23717524|NCT00304915|66340628|FG001|Overall Study|Death|5|||
23717525|NCT00304915|66340627|FG000|Overall Study|Withdrawal by Subject|3|||
23717526|NCT00304915|66340628|FG001|Overall Study|Withdrawal by Subject|0|||
23717527|NCT01419015|66340631|FG000|Overall Study|Death|2|||
23717528|NCT02713789|66340632|FG000|Overall Study|Lost to Follow-up|0|||
23717529|NCT02713789|66340633|FG001|Overall Study|Lost to Follow-up|1|||
23717530|NCT02713789|66340634|FG002|Overall Study|Lost to Follow-up|1|||
23717531|NCT03341923|66340635|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
23717532|NCT03341923|66340636|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
23717533|NCT03505749|66340637|FG000|Overall Study|Lost to Follow-up|7|||
23717534|NCT03505749|66340638|FG001|Overall Study|Lost to Follow-up|11|||
23717535|NCT03505749|66340637|FG000|Overall Study|Withdrawal by Subject|6|||
23717536|NCT03505749|66340638|FG001|Overall Study|Withdrawal by Subject|0|||
23717537|NCT03505749|66340637|FG000|Overall Study|Discharged from treatment|3|||
23717538|NCT03505749|66340638|FG001|Overall Study|Discharged from treatment|6|||
23717539|NCT03101514|66340639|FG000|Overall Study|Withdrawal by Subject|4|||
23717540|NCT03101514|66340639|FG000|Overall Study|Protocol Violation|2|||
23717541|NCT03101514|66340639|FG000|Overall Study|patient's information was incomplete|1|||
23528753|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23528754|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23717542|NCT03219567|66340640|FG000|Overall Study|Withdrawal by Subject|0|||
23717543|NCT03219567|66340641|FG001|Overall Study|Withdrawal by Subject|1|||
23717544|NCT02287402|66340642|FG000|Treatment Period|Adverse Event|17|||
23717545|NCT02287402|66340642|FG000|Treatment Period|Voluntary Withdrawal|10|||
23717546|NCT02287402|66340642|FG000|Follow-up|Lost to Follow-up|1|||
23717547|NCT02287402|66340642|FG000|Follow-up|Voluntary Withdrawal|2|||
23717548|NCT01819506|66340643|FG000|Overall Study|Physician Decision|5|||
23528755|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23717549|NCT01819506|66340644|FG001|Overall Study|Physician Decision|2|||
23717550|NCT01819506|66340643|FG000|Overall Study|Withdrawal by Subject|3|||
23717551|NCT01819506|66340644|FG001|Overall Study|Withdrawal by Subject|3|||
23717552|NCT01670656|66340645|FG000|Overall Study|Non-compliance with study drug|0|||
23717553|NCT01670656|66340646|FG001|Overall Study|Non-compliance with study drug|0|||
23813264|NCT01517373|66699295|FG002|Treatment Period|Adverse Event|0|||
23813265|NCT01517373|66699296|FG003|Treatment Period|Adverse Event|0|||
23813266|NCT01517373|66699297|FG004|Treatment Period|Adverse Event|0|||
23813267|NCT01517373|66699298|FG005|Treatment Period|Adverse Event|2|||
23813268|NCT01517373|66699293|FG000|Treatment Period|Lost to Follow-up|0|||
23813269|NCT01517373|66699294|FG001|Treatment Period|Lost to Follow-up|0|||
23813270|NCT01517373|66699295|FG002|Treatment Period|Lost to Follow-up|1|||
23813271|NCT01517373|66699296|FG003|Treatment Period|Lost to Follow-up|1|||
23813272|NCT01517373|66699297|FG004|Treatment Period|Lost to Follow-up|0|||
23813273|NCT01517373|66699298|FG005|Treatment Period|Lost to Follow-up|0|||
23813274|NCT01517373|66699293|FG000|Treatment Period|Withdrawal by Subject|0|||
23813275|NCT01517373|66699294|FG001|Treatment Period|Withdrawal by Subject|3|||
23813276|NCT01517373|66699295|FG002|Treatment Period|Withdrawal by Subject|2|||
23813277|NCT01517373|66699296|FG003|Treatment Period|Withdrawal by Subject|2|||
23813278|NCT01517373|66699297|FG004|Treatment Period|Withdrawal by Subject|2|||
23813279|NCT01517373|66699298|FG005|Treatment Period|Withdrawal by Subject|3|||
23813280|NCT01517373|66699293|FG000|Treatment Period|Other|0|||
23813281|NCT01517373|66699294|FG001|Treatment Period|Other|0|||
23813282|NCT01517373|66699295|FG002|Treatment Period|Other|0|||
23813283|NCT01517373|66699296|FG003|Treatment Period|Other|0|||
23813284|NCT01517373|66699297|FG004|Treatment Period|Other|1|||
23813285|NCT01517373|66699298|FG005|Treatment Period|Other|0|||
23813286|NCT01517373|66699293|FG000|Treatment Period|Protocol Violation|0|||
23813287|NCT01517373|66699294|FG001|Treatment Period|Protocol Violation|0|||
23813288|NCT01517373|66699295|FG002|Treatment Period|Protocol Violation|0|||
23813289|NCT01517373|66699296|FG003|Treatment Period|Protocol Violation|0|||
23813290|NCT01517373|66699297|FG004|Treatment Period|Protocol Violation|1|||
23813291|NCT01517373|66699298|FG005|Treatment Period|Protocol Violation|0|||
23813292|NCT01517373|66699293|FG000|Treatment Period|Lack of Efficacy|0|||
23813293|NCT01517373|66699294|FG001|Treatment Period|Lack of Efficacy|1|||
23813294|NCT01517373|66699295|FG002|Treatment Period|Lack of Efficacy|1|||
23813295|NCT01517373|66699296|FG003|Treatment Period|Lack of Efficacy|3|||
23813296|NCT01517373|66699297|FG004|Treatment Period|Lack of Efficacy|2|||
23813297|NCT01517373|66699298|FG005|Treatment Period|Lack of Efficacy|0|||
23813298|NCT01517373|66699293|FG000|Treatment Period|Medication error without AEs|0|||
23813299|NCT01517373|66699294|FG001|Treatment Period|Medication error without AEs|0|||
23528756|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
23717554|NCT01670656|66340647|FG002|Overall Study|Non-compliance with study drug|3|||
23717555|NCT01670656|66340648|FG003|Overall Study|Non-compliance with study drug|0|||
23717556|NCT01670656|66340649|FG004|Overall Study|Non-compliance with study drug|1|||
23717557|NCT01670656|66340645|FG000|Overall Study|Pregnancy|0|||
23717558|NCT01670656|66340646|FG001|Overall Study|Pregnancy|0|||
23717559|NCT01670656|66340647|FG002|Overall Study|Pregnancy|0|||
23717560|NCT01670656|66340648|FG003|Overall Study|Pregnancy|0|||
23528757|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528758|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528759|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528760|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
23528761|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528762|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528763|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528764|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
23528765|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528766|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528767|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528768|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
23528769|NCT00218543|65669497|FG000|Overall Study|Lost to Follow-up|8|||
23418736|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
23418737|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
23418738|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
23418739|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
23418740|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23418741|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
23418742|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
23418743|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418744|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418745|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418746|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418747|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418748|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418749|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418750|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418751|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418752|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418753|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418754|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
23418755|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
23418756|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
23418757|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
23418758|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418759|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418760|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418761|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418762|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418763|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418764|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418765|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418766|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418767|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418768|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418769|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418770|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418771|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528770|NCT00218543|65669497|FG000|Overall Study|relocated|1|||
23528771|NCT00218543|65669497|FG000|Overall Study|Withdrawal by Subject|1|||
23528772|NCT00218543|65669497|FG000|Overall Study|Physician Decision|3|||
23528773|NCT00218543|65669497|FG000|Overall Study|Adverse Event|2|||
23528774|NCT00427635|65669502|FG000|Treatment Phase|Withdrawal by Subject|1|||
23528775|NCT00427635|65669503|FG001|Treatment Phase|Withdrawal by Subject|0|||
23528776|NCT00427635|65669502|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
23528777|NCT00427635|65669503|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
23528778|NCT01755416|65669504|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
23528779|NCT01755416|65669505|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
23528780|NCT01589822|65669509|FG000|Overall Study|Withdrawal by Subject|1|||
23528781|NCT01589822|65669510|FG001|Overall Study|Withdrawal by Subject|2|||
23717561|NCT01670656|66340649|FG004|Overall Study|Pregnancy|1|||
23418772|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
23528782|NCT01589822|65669511|FG002|Overall Study|Withdrawal by Subject|0|||
23528783|NCT01589822|65669509|FG000|Overall Study|Death|1|||
23528784|NCT01589822|65669510|FG001|Overall Study|Death|0|||
23528785|NCT01589822|65669511|FG002|Overall Study|Death|0|||
23528786|NCT01589822|65669509|FG000|Overall Study|Missed 90 day visit|2|||
23528787|NCT01589822|65669510|FG001|Overall Study|Missed 90 day visit|1|||
23717562|NCT01670656|66340645|FG000|Overall Study|Withdrawal by Subject|1|||
23418773|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418774|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418775|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418776|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418777|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418778|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528788|NCT01589822|65669511|FG002|Overall Study|Missed 90 day visit|1|||
23418779|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418780|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418781|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418782|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528789|NCT00581776|65669512|FG000|Overall Study|Disease progression or no response|3|||
23528790|NCT01632891|65669513|FG000|Overall Study|Lost to Follow-up|0|||
23528791|NCT01632891|65669514|FG001|Overall Study|Lost to Follow-up|1|||
23528792|NCT01632891|65669513|FG000|Overall Study|Withdrawal by Subject|1|||
23528793|NCT01632891|65669514|FG001|Overall Study|Withdrawal by Subject|0|||
23528794|NCT00376168|65669515|FG000|Overall Study|Adverse Event|1|||
23418783|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418784|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418785|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418786|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418787|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418788|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418789|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
23418790|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
23418791|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418792|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
23418793|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418794|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418795|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
23418796|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418797|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418798|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
23418799|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418800|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418801|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418802|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418803|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418804|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418805|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418806|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418807|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418808|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418809|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418810|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418811|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418812|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418813|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23418814|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418815|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418816|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418817|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418818|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23528795|NCT00376168|65669516|FG001|Overall Study|Adverse Event|1|||
23528796|NCT00376168|65669515|FG000|Overall Study|Pregnancy|1|||
23418819|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418820|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418821|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418822|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418823|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418824|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418825|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418826|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418827|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23528797|NCT00376168|65669516|FG001|Overall Study|Pregnancy|0|||
23528798|NCT02075320|65669517|FG000|Overall Study|Withdrawal by Subject|2|||
23528799|NCT00684424|65669521|FG000|Overall Study|Adverse Event|1|||
23528800|NCT00684424|65669521|FG000|Overall Study|Lost to Follow-up|2|||
23528801|NCT00684424|65669521|FG000|Overall Study|Other|2|||
23528802|NCT02774681|65669524|FG000|Treatment on Study|Progressive Disease|7|||
23528803|NCT02774681|65669524|FG000|Follow-Up for 3 Years|Death|11|||
23528804|NCT02774681|65669524|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
23528805|NCT01120210|65669525|FG000|MAIN INFUSION|Adverse Event|1|||
23528806|NCT01120210|65669526|FG001|MAIN INFUSION|Adverse Event|0|||
23528807|NCT01120210|65669525|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
23528808|NCT01120210|65669526|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
23418828|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
23418829|NCT04225676|65277318|FG000|Overall Study|Physician Decision|1|||
23418830|NCT04225676|65277318|FG000|Overall Study|Lack of Efficacy|1|||
23418831|NCT04225676|65277318|FG000|Overall Study|Study terminated by sponsor|3|||
23418832|NCT00349921|65277320|FG000|First Spinal Injection|Physician Decision|1|||
23418833|NCT00349921|65277321|FG001|First Spinal Injection|Physician Decision|0|||
23418834|NCT00349921|65277322|FG002|First Spinal Injection|Physician Decision|0|||
23418835|NCT00349921|65277323|FG003|First Spinal Injection|Physician Decision|0|||
23418836|NCT00349921|65277320|FG000|First Spinal Injection|Adverse Event|0|||
23418837|NCT00349921|65277321|FG001|First Spinal Injection|Adverse Event|0|||
23418838|NCT00349921|65277322|FG002|First Spinal Injection|Adverse Event|1|||
23418839|NCT00349921|65277323|FG003|First Spinal Injection|Adverse Event|0|||
23418840|NCT00473668|65277324|FG000|Overall Study|Withdrawal by Subject|0|||
23418841|NCT00473668|65277325|FG001|Overall Study|Withdrawal by Subject|2|||
23418842|NCT00473668|65277326|FG002|Overall Study|Withdrawal by Subject|0|||
23418843|NCT00473668|65277324|FG000|Overall Study|Migrated/moved from study area|3|||
23418844|NCT00473668|65277325|FG001|Overall Study|Migrated/moved from study area|2|||
23418845|NCT00473668|65277326|FG002|Overall Study|Migrated/moved from study area|0|||
23418846|NCT00473668|65277324|FG000|Overall Study|Lost to Follow-up|0|||
23418847|NCT00473668|65277325|FG001|Overall Study|Lost to Follow-up|4|||
23418848|NCT00473668|65277326|FG002|Overall Study|Lost to Follow-up|6|||
23418849|NCT00473668|65277324|FG000|Overall Study|Other|2|||
23418850|NCT00473668|65277325|FG001|Overall Study|Other|3|||
23418851|NCT00473668|65277326|FG002|Overall Study|Other|4|||
23418852|NCT01534260|65277333|FG000|Overall Study|Adverse Event|1|||
23418853|NCT01534260|65277334|FG001|Overall Study|Adverse Event|8|||
23418854|NCT01534260|65277333|FG000|Overall Study|Death|2|||
23418855|NCT01534260|65277334|FG001|Overall Study|Death|0|||
23418856|NCT01534260|65277333|FG000|Overall Study|Lack of Efficacy|1|||
23418857|NCT01534260|65277334|FG001|Overall Study|Lack of Efficacy|1|||
23418858|NCT01534260|65277333|FG000|Overall Study|Withdrawal by Subject|1|||
23418859|NCT01534260|65277334|FG001|Overall Study|Withdrawal by Subject|3|||
23418860|NCT01534260|65277333|FG000|Overall Study|Disease Progression|8|||
23418861|NCT01534260|65277334|FG001|Overall Study|Disease Progression|6|||
23418862|NCT01534260|65277333|FG000|Overall Study|Physician Decision|3|||
23418863|NCT01534260|65277334|FG001|Overall Study|Physician Decision|1|||
23418864|NCT01534260|65277333|FG000|Overall Study|No treatment, per protocol|0|||
23528809|NCT04568122|65672702|FG000|Overall Study|Lost to Follow-up|48|||
23528810|NCT04568122|65672703|FG001|Overall Study|Lost to Follow-up|44|||
23528811|NCT04568122|65672704|FG002|Overall Study|Lost to Follow-up|4|||
23528812|NCT04568122|65672705|FG003|Overall Study|Lost to Follow-up|0|||
23528813|NCT04568122|65672706|FG004|Overall Study|Lost to Follow-up|0|||
23528814|NCT04206293|65672707|FG000|Overall Study|Consent withdrawal|1|||
23528815|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
23528816|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
23528817|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
23528818|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
23528819|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
23528820|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
23717563|NCT01670656|66340646|FG001|Overall Study|Withdrawal by Subject|1|||
23717564|NCT01670656|66340647|FG002|Overall Study|Withdrawal by Subject|0|||
23418865|NCT01534260|65277334|FG001|Overall Study|No treatment, per protocol|1|||
23418866|NCT01451931|65277337|FG000|Overall Study|Lost to Follow-up|17|||
23418867|NCT01451931|65277338|FG001|Overall Study|Lost to Follow-up|36|||
23418868|NCT01451931|65277339|FG002|Overall Study|Lost to Follow-up|21|||
23717565|NCT01670656|66340648|FG003|Overall Study|Withdrawal by Subject|0|||
23418869|NCT01451931|65277337|FG000|Overall Study|Withdrawal by Subject|16|||
23418870|NCT01451931|65277338|FG001|Overall Study|Withdrawal by Subject|22|||
23418871|NCT01451931|65277339|FG002|Overall Study|Withdrawal by Subject|22|||
23418872|NCT05791565|65277341|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
23418873|NCT05791565|65277342|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
23418874|NCT04686084|65277343|FG000|Overall Study|Lost to Follow-up|1|||
23528821|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
23528822|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
23528823|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
23528824|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
23528825|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
23717566|NCT01670656|66340649|FG004|Overall Study|Withdrawal by Subject|0|||
23528826|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
23528827|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
23528828|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
23528829|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
23528830|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
23528831|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
23528832|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
23528833|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
23528834|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
23528835|NCT04033003|65672721|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
23528836|NCT04033003|65672722|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
23528837|NCT04033003|65672721|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
23528838|NCT04033003|65672722|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
23528839|NCT04033003|65672721|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
23528840|NCT04033003|65672722|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
23528841|NCT02399085|65672724|FG000|Overall Study|Adverse Event|16|||
23528842|NCT02399085|65672724|FG000|Overall Study|Death|2|||
23528843|NCT02399085|65672724|FG000|Overall Study|Withdrawal by Subject|8|||
23612415|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
23612416|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
23612417|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
23612418|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
23612419|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
23612420|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
23612421|NCT01975701|65969625|FG000|Overall Study|Lost to Follow-up|1|||
23612422|NCT01975701|65969625|FG000|Overall Study|Death|23|||
23612423|NCT01975701|65969625|FG000|Overall Study|Physician Decision|1|||
23612424|NCT03209492|65969626|FG000|Overall Study|Case Report Forms Uncollected|5|||
23717567|NCT01670656|66340645|FG000|Overall Study|Non-compliance with protocol|0|||
23717568|NCT01670656|66340646|FG001|Overall Study|Non-compliance with protocol|3|||
23717569|NCT01670656|66340647|FG002|Overall Study|Non-compliance with protocol|1|||
23717570|NCT01670656|66340648|FG003|Overall Study|Non-compliance with protocol|1|||
23717571|NCT01670656|66340649|FG004|Overall Study|Non-compliance with protocol|2|||
23717572|NCT01670656|66340645|FG000|Overall Study|Adverse Event|2|||
23717573|NCT01670656|66340646|FG001|Overall Study|Adverse Event|2|||
23717574|NCT01670656|66340647|FG002|Overall Study|Adverse Event|2|||
23717575|NCT01670656|66340648|FG003|Overall Study|Adverse Event|3|||
23528844|NCT02399085|65672724|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
23528845|NCT02399085|65672724|FG000|Overall Study|Physician Decision|5|||
23528846|NCT03450707|65672727|FG000|Overall Study|Outside enrollment window|4|||
23528847|NCT03450707|65672728|FG001|Overall Study|Outside enrollment window|1|||
23528848|NCT03450707|65672727|FG000|Overall Study|Death|1|||
23528849|NCT03450707|65672728|FG001|Overall Study|Death|0|||
23528850|NCT03450707|65672727|FG000|Overall Study|Indication for thiamine|1|||
23528851|NCT03450707|65672728|FG001|Overall Study|Indication for thiamine|1|||
23528852|NCT03450707|65672727|FG000|Overall Study|Evidence of traumatic brain injury|1|||
23717576|NCT01670656|66340649|FG004|Overall Study|Adverse Event|3|||
23717577|NCT01670656|66340645|FG000|Overall Study|Subject withdrew consent|0|||
23717578|NCT01670656|66340646|FG001|Overall Study|Subject withdrew consent|1|||
23717579|NCT01670656|66340647|FG002|Overall Study|Subject withdrew consent|2|||
23717580|NCT01670656|66340648|FG003|Overall Study|Subject withdrew consent|1|||
23717581|NCT01670656|66340649|FG004|Overall Study|Subject withdrew consent|1|||
23717582|NCT01670656|66340645|FG000|Overall Study|Lost to Follow-up|0|||
23717583|NCT01670656|66340646|FG001|Overall Study|Lost to Follow-up|0|||
23717584|NCT01670656|66340647|FG002|Overall Study|Lost to Follow-up|0|||
23717585|NCT01670656|66340648|FG003|Overall Study|Lost to Follow-up|0|||
23717586|NCT01670656|66340649|FG004|Overall Study|Lost to Follow-up|3|||
23717587|NCT01670656|66340645|FG000|Overall Study|Subject moved|0|||
23717588|NCT01670656|66340646|FG001|Overall Study|Subject moved|0|||
23717589|NCT01670656|66340647|FG002|Overall Study|Subject moved|0|||
23528853|NCT03450707|65672728|FG001|Overall Study|Evidence of traumatic brain injury|0|||
23612425|NCT01090076|65969627|FG000|Overall Study|Death|1|||
23612426|NCT01090076|65969628|FG001|Overall Study|Death|1|||
23612427|NCT01090076|65969627|FG000|Overall Study|Withdrawal by Subject|0|||
23612428|NCT01090076|65969628|FG001|Overall Study|Withdrawal by Subject|1|||
23612429|NCT05265247|65969629|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
23717590|NCT01670656|66340648|FG003|Overall Study|Subject moved|1|||
23528854|NCT03450707|65672727|FG000|Overall Study|Following commands|0|||
23528855|NCT03450707|65672728|FG001|Overall Study|Following commands|3|||
23528856|NCT03450707|65672727|FG000|Overall Study|Lactate < 3.5|0|||
23612430|NCT05265247|65969630|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
23717591|NCT01670656|66340649|FG004|Overall Study|Subject moved|0|||
23717592|NCT02007954|66340650|FG000|Overall Study|Received liver transplant|3|||
23717593|NCT02007954|66340650|FG000|Overall Study|Switch in treatment modality|2|||
23717594|NCT02007954|66340650|FG000|Overall Study|Disease progression and unrelated AE|1|||
23717595|NCT02007954|66340650|FG000|Overall Study|Death|1|||
23717596|NCT01610076|66340652|FG000|Overall Study|Technical issue with video|0|||
23717597|NCT01610076|66340653|FG001|Overall Study|Technical issue with video|1|||
23717598|NCT01610076|66340652|FG000|Overall Study|Lost to Follow-up|3|||
23717599|NCT01610076|66340653|FG001|Overall Study|Lost to Follow-up|4|||
23717600|NCT00479557|66340660|FG000|Overall Study|Death|0|||
23717601|NCT00479557|66340661|FG001|Overall Study|Death|0|||
23717602|NCT00479557|66340662|FG002|Overall Study|Death|0|||
23717603|NCT00479557|66340663|FG003|Overall Study|Death|0|||
23717604|NCT00479557|66340664|FG004|Overall Study|Death|0|||
23813300|NCT01517373|66699295|FG002|Treatment Period|Medication error without AEs|2|||
23813301|NCT01517373|66699296|FG003|Treatment Period|Medication error without AEs|1|||
23813302|NCT01517373|66699297|FG004|Treatment Period|Medication error without AEs|0|||
23813303|NCT01517373|66699298|FG005|Treatment Period|Medication error without AEs|2|||
23528857|NCT03450707|65672728|FG001|Overall Study|Lactate < 3.5|2|||
23528858|NCT03450707|65672727|FG000|Overall Study|Rearrest with ECMO|0|||
23528859|NCT03450707|65672728|FG001|Overall Study|Rearrest with ECMO|1|||
23528860|NCT03450707|65672727|FG000|Overall Study|Indication for thiamine + head CT results|0|||
23528861|NCT03450707|65672728|FG001|Overall Study|Indication for thiamine + head CT results|1|||
23528862|NCT03450707|65672727|FG000|Overall Study|Family/patient goals of care|0|||
23528863|NCT03450707|65672728|FG001|Overall Study|Family/patient goals of care|1|||
23528864|NCT02603809|65672729|FG000|Overall Study|Withdrawal by Subject|4|||
23528865|NCT02603809|65672730|FG001|Overall Study|Withdrawal by Subject|1|||
23528866|NCT02603809|65672731|FG002|Overall Study|Withdrawal by Subject|2|||
23528867|NCT02603809|65672732|FG003|Overall Study|Withdrawal by Subject|3|||
23528868|NCT02603809|65672733|FG004|Overall Study|Withdrawal by Subject|3|||
23528869|NCT02603809|65672734|FG005|Overall Study|Withdrawal by Subject|4|||
23528870|NCT02603809|65672729|FG000|Overall Study|Lost to Follow-up|2|||
23528871|NCT02603809|65672730|FG001|Overall Study|Lost to Follow-up|3|||
23528872|NCT02603809|65672731|FG002|Overall Study|Lost to Follow-up|1|||
23528873|NCT02603809|65672732|FG003|Overall Study|Lost to Follow-up|4|||
23528874|NCT02603809|65672733|FG004|Overall Study|Lost to Follow-up|2|||
23528875|NCT02603809|65672734|FG005|Overall Study|Lost to Follow-up|2|||
23528876|NCT02603809|65672729|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
23528877|NCT02603809|65672730|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
23528878|NCT02603809|65672731|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
23528879|NCT02603809|65672732|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
23528880|NCT02603809|65672733|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
23528881|NCT02603809|65672734|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
23528882|NCT02603809|65672729|FG000|Overall Study|Physician Decision|0|||
23528883|NCT02603809|65672730|FG001|Overall Study|Physician Decision|0|||
23528884|NCT02603809|65672731|FG002|Overall Study|Physician Decision|0|||
23528885|NCT02603809|65672732|FG003|Overall Study|Physician Decision|1|||
23528886|NCT02603809|65672733|FG004|Overall Study|Physician Decision|2|||
23528887|NCT02603809|65672734|FG005|Overall Study|Physician Decision|1|||
23528888|NCT02603809|65672729|FG000|Overall Study|Adverse Event|3|||
23528889|NCT02603809|65672730|FG001|Overall Study|Adverse Event|0|||
23528890|NCT02603809|65672731|FG002|Overall Study|Adverse Event|2|||
23528891|NCT02603809|65672732|FG003|Overall Study|Adverse Event|2|||
23528892|NCT02603809|65672733|FG004|Overall Study|Adverse Event|1|||
23528893|NCT02603809|65672734|FG005|Overall Study|Adverse Event|1|||
23528894|NCT02603809|65672729|FG000|Overall Study|Lack of Efficacy|0|||
23528895|NCT02603809|65672730|FG001|Overall Study|Lack of Efficacy|1|||
23528896|NCT02603809|65672731|FG002|Overall Study|Lack of Efficacy|0|||
23528897|NCT02603809|65672732|FG003|Overall Study|Lack of Efficacy|0|||
23528898|NCT02603809|65672733|FG004|Overall Study|Lack of Efficacy|0|||
23528899|NCT02603809|65672734|FG005|Overall Study|Lack of Efficacy|1|||
23528900|NCT02357576|65672738|FG000|Treatment Period|Withdrawal by Subject|0|||
23528901|NCT02357576|65672739|FG001|Treatment Period|Withdrawal by Subject|1|||
23528902|NCT02357576|65672738|FG000|Treatment Period|Physician Decision|0|||
23528903|NCT02357576|65672739|FG001|Treatment Period|Physician Decision|1|||
23813304|NCT01329549|66699299|FG000|Overall Study|Withdrawal by Subject|1|||
23813305|NCT01329549|66699299|FG000|Overall Study|Adverse Event|1|||
23528904|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
23528905|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
23528906|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
23528907|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
23528908|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
23528909|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
23528910|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
23528911|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
23717605|NCT00479557|66340665|FG005|Overall Study|Death|1|||
23717606|NCT00479557|66340666|FG006|Overall Study|Death|0|||
23717607|NCT00479557|66340660|FG000|Overall Study|Lack of Efficacy|1|||
23528912|NCT02722928|65672740|FG000|Overall Study|Standard CT was not as required per prot|5|||
23528913|NCT02722928|65672741|FG001|Overall Study|Standard CT was not as required per prot|13|||
23528914|NCT02722928|65672740|FG000|Overall Study|Required Intraoperative MRI|5|||
23528915|NCT02722928|65672741|FG001|Overall Study|Required Intraoperative MRI|7|||
23528916|NCT00502697|65672742|FG000|Overall Study|Withdrawal by Subject|3|||
23528917|NCT00502697|65672743|FG001|Overall Study|Withdrawal by Subject|1|||
23528918|NCT00502697|65672742|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
23528919|NCT00502697|65672743|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
23528920|NCT00502697|65672742|FG000|Overall Study|found not to meet eligibility criteria|3|||
23528921|NCT00502697|65672743|FG001|Overall Study|found not to meet eligibility criteria|4|||
23528922|NCT00502697|65672742|FG000|Overall Study|did not meet assignment criteria|4|||
23528923|NCT00502697|65672743|FG001|Overall Study|did not meet assignment criteria|2|||
23528924|NCT02203591|65672744|FG000|Overall Study|Did not meet treatment day baseline|147|||
23528925|NCT02203591|65672745|FG001|Overall Study|Did not meet treatment day baseline|141|||
23528926|NCT02203591|65672746|FG002|Overall Study|Did not meet treatment day baseline|150|||
23528927|NCT02203591|65672747|FG003|Overall Study|Did not meet treatment day baseline|45|||
23528928|NCT02203591|65672748|FG004|Overall Study|Did not meet treatment day baseline|33|||
23528929|NCT02203591|65672749|FG005|Overall Study|Did not meet treatment day baseline|35|||
23528930|NCT02203591|65672750|FG006|Overall Study|Did not meet treatment day baseline|29|||
23528931|NCT02203591|65672751|FG007|Overall Study|Did not meet treatment day baseline|12|||
23528932|NCT02203591|65672744|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
23528933|NCT02203591|65672745|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
23528934|NCT02203591|65672746|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
23528935|NCT02203591|65672747|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
23528936|NCT02203591|65672748|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
23528937|NCT02203591|65672749|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
23528938|NCT02203591|65672750|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
23528939|NCT02203591|65672751|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
23528940|NCT00596011|65672752|FG000|Overall Study|Withdrawal by Subject|2|||
23528941|NCT00596011|65672753|FG001|Overall Study|Withdrawal by Subject|3|||
23528942|NCT00596011|65672752|FG000|Overall Study|Adverse Event|11|||
23528943|NCT00596011|65672753|FG001|Overall Study|Adverse Event|7|||
23528944|NCT02624284|65672755|FG000|Overall Study|Withdrawal by Subject|3|||
23528945|NCT02624284|65672756|FG001|Overall Study|Withdrawal by Subject|6|||
23528946|NCT02624284|65672757|FG002|Overall Study|Withdrawal by Subject|3|||
23528947|NCT02624284|65672755|FG000|Overall Study|Protocol Violation|9|||
23528948|NCT02624284|65672756|FG001|Overall Study|Protocol Violation|10|||
23528949|NCT02624284|65672757|FG002|Overall Study|Protocol Violation|7|||
23528950|NCT02624284|65672755|FG000|Overall Study|Revealed exclusionary condition|2|||
23528951|NCT02624284|65672756|FG001|Overall Study|Revealed exclusionary condition|2|||
23528952|NCT02624284|65672757|FG002|Overall Study|Revealed exclusionary condition|0|||
23528953|NCT02624284|65672755|FG000|Overall Study|Adverse Event|0|||
23528954|NCT02624284|65672756|FG001|Overall Study|Adverse Event|0|||
23528955|NCT02624284|65672757|FG002|Overall Study|Adverse Event|1|||
23528956|NCT01481116|65672758|FG000|Overall Study|Adverse Event|26|||
23528957|NCT01481116|65672759|FG001|Overall Study|Adverse Event|26|||
23528958|NCT01481116|65672760|FG002|Overall Study|Adverse Event|42|||
23528959|NCT01481116|65672758|FG000|Overall Study|Major Protocol Deviation|3|||
23528960|NCT01481116|65672759|FG001|Overall Study|Major Protocol Deviation|7|||
23528961|NCT01481116|65672760|FG002|Overall Study|Major Protocol Deviation|1|||
23528962|NCT01481116|65672758|FG000|Overall Study|Lost to Follow-up|8|||
23528963|NCT01481116|65672759|FG001|Overall Study|Lost to Follow-up|12|||
23528964|NCT01481116|65672760|FG002|Overall Study|Lost to Follow-up|11|||
23528965|NCT01481116|65672758|FG000|Overall Study|Withdrawal by Subject|37|||
23528966|NCT01481116|65672759|FG001|Overall Study|Withdrawal by Subject|33|||
23528967|NCT01481116|65672760|FG002|Overall Study|Withdrawal by Subject|37|||
23528968|NCT01481116|65672758|FG000|Overall Study|Study Termination|730|||
23528969|NCT01481116|65672759|FG001|Overall Study|Study Termination|729|||
23528970|NCT01481116|65672760|FG002|Overall Study|Study Termination|713|||
23528971|NCT01481116|65672758|FG000|Overall Study|Pregnancy|0|||
23528972|NCT01481116|65672759|FG001|Overall Study|Pregnancy|0|||
23528973|NCT01481116|65672760|FG002|Overall Study|Pregnancy|1|||
23528974|NCT01481116|65672758|FG000|Overall Study|Lack of Efficacy|3|||
23528975|NCT01481116|65672759|FG001|Overall Study|Lack of Efficacy|3|||
23528976|NCT01481116|65672760|FG002|Overall Study|Lack of Efficacy|1|||
23528977|NCT01481116|65672758|FG000|Overall Study|Contraindications|1|||
23528978|NCT01481116|65672759|FG001|Overall Study|Contraindications|1|||
23528979|NCT01481116|65672760|FG002|Overall Study|Contraindications|0|||
23528980|NCT01481116|65672758|FG000|Overall Study|Other|1|||
23528981|NCT01481116|65672759|FG001|Overall Study|Other|1|||
23528982|NCT01481116|65672760|FG002|Overall Study|Other|0|||
23528983|NCT01481116|65672758|FG000|Overall Study|Participant Started Taking Glipizide|1|||
23528984|NCT01481116|65672759|FG001|Overall Study|Participant Started Taking Glipizide|0|||
23528985|NCT01481116|65672760|FG002|Overall Study|Participant Started Taking Glipizide|0|||
23717608|NCT00479557|66340661|FG001|Overall Study|Lack of Efficacy|0|||
23717609|NCT00479557|66340662|FG002|Overall Study|Lack of Efficacy|0|||
23717610|NCT00479557|66340663|FG003|Overall Study|Lack of Efficacy|0|||
23717611|NCT00479557|66340664|FG004|Overall Study|Lack of Efficacy|0|||
23528986|NCT01481116|65672758|FG000|Overall Study|Participant Moved Out of Area|2|||
23528987|NCT01481116|65672759|FG001|Overall Study|Participant Moved Out of Area|0|||
23528988|NCT01481116|65672760|FG002|Overall Study|Participant Moved Out of Area|1|||
23528989|NCT01481116|65672758|FG000|Overall Study|Participant Moved Out of Country|1|||
23717612|NCT00479557|66340665|FG005|Overall Study|Lack of Efficacy|0|||
23717613|NCT00479557|66340666|FG006|Overall Study|Lack of Efficacy|0|||
23717614|NCT00479557|66340660|FG000|Overall Study|Lost to Follow-up|0|||
23717615|NCT00479557|66340661|FG001|Overall Study|Lost to Follow-up|2|||
23717616|NCT00479557|66340662|FG002|Overall Study|Lost to Follow-up|0|||
23717617|NCT00479557|66340663|FG003|Overall Study|Lost to Follow-up|2|||
23717618|NCT00479557|66340664|FG004|Overall Study|Lost to Follow-up|0|||
23717619|NCT00479557|66340665|FG005|Overall Study|Lost to Follow-up|0|||
23717620|NCT00479557|66340666|FG006|Overall Study|Lost to Follow-up|0|||
23717621|NCT00479557|66340660|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23717622|NCT00479557|66340661|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23717623|NCT00479557|66340662|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
23717624|NCT00479557|66340663|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
23717625|NCT00479557|66340664|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23717626|NCT00479557|66340665|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23717627|NCT00479557|66340666|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23717628|NCT00479557|66340660|FG000|Overall Study|AE not related to Study Drug|1|||
23717629|NCT00479557|66340661|FG001|Overall Study|AE not related to Study Drug|3|||
23717630|NCT00479557|66340662|FG002|Overall Study|AE not related to Study Drug|0|||
23717631|NCT00479557|66340663|FG003|Overall Study|AE not related to Study Drug|0|||
23717632|NCT00479557|66340664|FG004|Overall Study|AE not related to Study Drug|2|||
23717633|NCT00479557|66340665|FG005|Overall Study|AE not related to Study Drug|2|||
23717634|NCT00479557|66340666|FG006|Overall Study|AE not related to Study Drug|1|||
23717635|NCT00479557|66340660|FG000|Overall Study|Caregiver Request|2|||
23717636|NCT00479557|66340661|FG001|Overall Study|Caregiver Request|2|||
23717637|NCT00479557|66340662|FG002|Overall Study|Caregiver Request|2|||
23717638|NCT00479557|66340663|FG003|Overall Study|Caregiver Request|0|||
23717639|NCT00479557|66340664|FG004|Overall Study|Caregiver Request|1|||
23717640|NCT00479557|66340665|FG005|Overall Study|Caregiver Request|2|||
23717641|NCT00479557|66340666|FG006|Overall Study|Caregiver Request|0|||
23717642|NCT00479557|66340660|FG000|Overall Study|Investigator Request|0|||
23528990|NCT01481116|65672759|FG001|Overall Study|Participant Moved Out of Country|0|||
23528991|NCT01481116|65672760|FG002|Overall Study|Participant Moved Out of Country|1|||
23528992|NCT01481116|65672758|FG000|Overall Study|Investigator Decision|3|||
23528993|NCT01481116|65672759|FG001|Overall Study|Investigator Decision|2|||
23528994|NCT01481116|65672760|FG002|Overall Study|Investigator Decision|1|||
23528995|NCT01481116|65672758|FG000|Overall Study|Sponsor Decision|0|||
23528996|NCT01481116|65672759|FG001|Overall Study|Sponsor Decision|1|||
23528997|NCT01481116|65672760|FG002|Overall Study|Sponsor Decision|3|||
23528998|NCT01481116|65672758|FG000|Overall Study|Non-Compliant With Study Drug|0|||
23528999|NCT01481116|65672759|FG001|Overall Study|Non-Compliant With Study Drug|1|||
23529000|NCT01481116|65672760|FG002|Overall Study|Non-Compliant With Study Drug|1|||
23529001|NCT01481116|65672758|FG000|Overall Study|Investigator's Discretion|2|||
23529002|NCT01481116|65672759|FG001|Overall Study|Investigator's Discretion|0|||
23529003|NCT01481116|65672760|FG002|Overall Study|Investigator's Discretion|0|||
23529004|NCT01481116|65672758|FG000|Overall Study|Death|2|||
23529005|NCT01481116|65672759|FG001|Overall Study|Death|1|||
23717643|NCT00479557|66340661|FG001|Overall Study|Investigator Request|0|||
23717644|NCT00479557|66340662|FG002|Overall Study|Investigator Request|1|||
23717645|NCT00479557|66340663|FG003|Overall Study|Investigator Request|0|||
23717646|NCT00479557|66340664|FG004|Overall Study|Investigator Request|0|||
23717647|NCT00479557|66340665|FG005|Overall Study|Investigator Request|0|||
23717648|NCT00479557|66340666|FG006|Overall Study|Investigator Request|0|||
23717649|NCT00479557|66340660|FG000|Overall Study|Subject Request|3|||
23529006|NCT01481116|65672760|FG002|Overall Study|Death|0|||
23529007|NCT01481116|65672758|FG000|Overall Study|Hypoglycemic Event|4|||
23529008|NCT01481116|65672759|FG001|Overall Study|Hypoglycemic Event|0|||
23529009|NCT01481116|65672760|FG002|Overall Study|Hypoglycemic Event|0|||
23529010|NCT02751983|65672761|FG000|Treatment|Stopped ACT, but Remained in study|2|||
23529011|NCT02751983|65672762|FG001|Treatment|Stopped ACT, but Remained in study|0|||
23529012|NCT02751983|65672761|FG000|Treatment|Discharged prior to beginning ACT|2|||
23717650|NCT00479557|66340661|FG001|Overall Study|Subject Request|0|||
23717651|NCT00479557|66340662|FG002|Overall Study|Subject Request|1|||
23717652|NCT00479557|66340663|FG003|Overall Study|Subject Request|1|||
23529013|NCT02751983|65672762|FG001|Treatment|Discharged prior to beginning ACT|0|||
23529014|NCT02751983|65672761|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
23529015|NCT02751983|65672762|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
23717653|NCT00479557|66340664|FG004|Overall Study|Subject Request|1|||
23717654|NCT00479557|66340665|FG005|Overall Study|Subject Request|4|||
23717655|NCT00479557|66340666|FG006|Overall Study|Subject Request|1|||
23717656|NCT00479557|66340660|FG000|Overall Study|Other|2|||
23717657|NCT00479557|66340661|FG001|Overall Study|Other|3|||
23717658|NCT00479557|66340662|FG002|Overall Study|Other|1|||
23717659|NCT00479557|66340663|FG003|Overall Study|Other|0|||
23529016|NCT02751983|65672761|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
23529017|NCT02751983|65672762|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
23529018|NCT02751983|65672761|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
23529019|NCT02751983|65672762|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
23529020|NCT04765358|65672763|FG000|Overall Study|Withdrawal by Subject|1|||
23529021|NCT00586469|65672770|FG000|Overall Study|Adverse Event|0|||
23529022|NCT00586469|65672771|FG001|Overall Study|Adverse Event|1|||
23529023|NCT00057746|65672774|FG000|Overall Study|Withdrawal by Subject|0|||
23529024|NCT00057746|65672775|FG001|Overall Study|Withdrawal by Subject|0|||
23529025|NCT00057746|65672776|FG002|Overall Study|Withdrawal by Subject|1|||
23529026|NCT02510794|65672779|FG000|Overall Study|Adverse Event|0|||
23529027|NCT02510794|65672780|FG001|Overall Study|Adverse Event|1|||
23717660|NCT00479557|66340664|FG004|Overall Study|Other|0|||
23717661|NCT00479557|66340665|FG005|Overall Study|Other|3|||
23529028|NCT02510794|65672781|FG002|Overall Study|Adverse Event|0|||
23529029|NCT02510794|65672782|FG003|Overall Study|Adverse Event|0|||
23717662|NCT00479557|66340666|FG006|Overall Study|Other|0|||
23717663|NCT01203787|66340667|FG000|Overall Study|Death|12|||
23717664|NCT01203787|66340668|FG001|Overall Study|Death|10|||
23717665|NCT01203787|66340667|FG000|Overall Study|Withdrawal by Subject|6|||
23717666|NCT01203787|66340668|FG001|Overall Study|Withdrawal by Subject|2|||
23717667|NCT01203787|66340667|FG000|Overall Study|Lost to Follow-up|2|||
23717668|NCT01203787|66340668|FG001|Overall Study|Lost to Follow-up|0|||
23717669|NCT01203787|66340667|FG000|Overall Study|Adverse Event|11|||
23717670|NCT01203787|66340668|FG001|Overall Study|Adverse Event|15|||
23717671|NCT02146248|66340669|FG000|Overall Study|Withdrawal by Subject|2|||
23717672|NCT02616185|66340670|FG000|Overall Study|Death|0|||
23717673|NCT02616185|66340671|FG001|Overall Study|Death|0|||
23717674|NCT02616185|66340672|FG002|Overall Study|Death|0|||
23717675|NCT02616185|66340673|FG003|Overall Study|Death|1|||
23717676|NCT02616185|66340674|FG004|Overall Study|Death|2|||
23717677|NCT02616185|66340675|FG005|Overall Study|Death|0|||
23717678|NCT02616185|66340676|FG006|Overall Study|Death|0|||
23717679|NCT02616185|66340677|FG007|Overall Study|Death|2|||
23717680|NCT02616185|66340678|FG008|Overall Study|Death|1|||
23717681|NCT02616185|66340670|FG000|Overall Study|Study terminated by sponsor|0|||
23717682|NCT02616185|66340671|FG001|Overall Study|Study terminated by sponsor|0|||
23717683|NCT02616185|66340672|FG002|Overall Study|Study terminated by sponsor|1|||
23717684|NCT02616185|66340673|FG003|Overall Study|Study terminated by sponsor|0|||
23717685|NCT02616185|66340674|FG004|Overall Study|Study terminated by sponsor|0|||
23717686|NCT02616185|66340675|FG005|Overall Study|Study terminated by sponsor|0|||
23717687|NCT02616185|66340676|FG006|Overall Study|Study terminated by sponsor|5|||
23717688|NCT02616185|66340677|FG007|Overall Study|Study terminated by sponsor|2|||
23717689|NCT02616185|66340678|FG008|Overall Study|Study terminated by sponsor|0|||
23717690|NCT02616185|66340670|FG000|Overall Study|Participant refused further follow-up|1|||
23717691|NCT02616185|66340671|FG001|Overall Study|Participant refused further follow-up|1|||
23717692|NCT02616185|66340672|FG002|Overall Study|Participant refused further follow-up|2|||
23717693|NCT02616185|66340673|FG003|Overall Study|Participant refused further follow-up|3|||
23717694|NCT02616185|66340674|FG004|Overall Study|Participant refused further follow-up|4|||
23717695|NCT02616185|66340675|FG005|Overall Study|Participant refused further follow-up|0|||
23717696|NCT02616185|66340676|FG006|Overall Study|Participant refused further follow-up|3|||
23717697|NCT02616185|66340677|FG007|Overall Study|Participant refused further follow-up|4|||
23717698|NCT02616185|66340678|FG008|Overall Study|Participant refused further follow-up|3|||
23717699|NCT02616185|66340670|FG000|Overall Study|Not reported|0|||
23717700|NCT02616185|66340671|FG001|Overall Study|Not reported|0|||
23717701|NCT02616185|66340672|FG002|Overall Study|Not reported|0|||
23717702|NCT02616185|66340673|FG003|Overall Study|Not reported|1|||
23717703|NCT02616185|66340674|FG004|Overall Study|Not reported|3|||
23717704|NCT02616185|66340675|FG005|Overall Study|Not reported|1|||
23717705|NCT02616185|66340676|FG006|Overall Study|Not reported|0|||
23717706|NCT02616185|66340677|FG007|Overall Study|Not reported|5|||
23717707|NCT02616185|66340678|FG008|Overall Study|Not reported|2|||
23717708|NCT00971425|66340681|FG000|Overall Study|Adverse Event|1|||
23717709|NCT00971425|66340682|FG001|Overall Study|Adverse Event|1|||
23717710|NCT00971425|66340681|FG000|Overall Study|Withdrawal by Subject|0|||
23717711|NCT00971425|66340682|FG001|Overall Study|Withdrawal by Subject|1|||
23813306|NCT04645966|66699300|FG000|Vaccination Phase|Adverse Event|1|||
23418875|NCT02743949|65277344|FG000|Overall Study|Adverse Event|0|||
23529030|NCT02510794|65672779|FG000|Overall Study|Death|1|||
23529031|NCT02510794|65672780|FG001|Overall Study|Death|2|||
23529032|NCT02510794|65672781|FG002|Overall Study|Death|1|||
23717712|NCT00719953|66340687|FG000|Overall Study|Adverse Event|4|||
23717713|NCT00615914|66340693|FG000|Overall Study|Adverse Event|274|||
23717714|NCT00615914|66340693|FG000|Overall Study|Death|20|||
23717715|NCT00615914|66340693|FG000|Overall Study|Lack of Efficacy|59|||
23717716|NCT00615914|66340693|FG000|Overall Study|Lost to Follow-up|187|||
23717717|NCT00615914|66340693|FG000|Overall Study|Withdrawal by Subject|16|||
23717718|NCT00615914|66340693|FG000|Overall Study|Physician Decision|4|||
23717719|NCT00615914|66340693|FG000|Overall Study|No data was collected.|65|||
23717720|NCT00615914|66340693|FG000|Overall Study|No treatment|2|||
23717721|NCT00615914|66340693|FG000|Overall Study|Irregularly enrolled patients|10|||
23717722|NCT01117012|66340694|FG000|Overall Study|Adverse Event|0|||
23717723|NCT01117012|66340695|FG001|Overall Study|Adverse Event|1|||
23717724|NCT01117012|66340694|FG000|Overall Study|Death|1|||
23717725|NCT01117012|66340695|FG001|Overall Study|Death|1|||
23717726|NCT01117012|66340694|FG000|Overall Study|Withdrawal by Subject|3|||
23717727|NCT01117012|66340695|FG001|Overall Study|Withdrawal by Subject|0|||
23717728|NCT01117012|66340694|FG000|Overall Study|Undefined|4|||
23717729|NCT01117012|66340695|FG001|Overall Study|Undefined|3|||
23717730|NCT02871401|66340698|FG000|Overall Study|Adverse Event|1|||
23717731|NCT02871401|66340699|FG001|Overall Study|Adverse Event|0|||
23717732|NCT00691093|66340700|FG000|Overall Study|Adverse Event|1|||
23717733|NCT00691093|66340700|FG000|Overall Study|Lost to Follow-up|1|||
23717734|NCT00691093|66340700|FG000|Overall Study|Lack of Efficacy|1|||
23717735|NCT00691093|66340700|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
23717736|NCT02758613|66340705|FG000|Treatment|Physician and Sponsor Decision|1|||
23717737|NCT02758613|66340706|FG001|Treatment|Physician and Sponsor Decision|0|||
23717738|NCT02758613|66340707|FG002|Treatment|Physician and Sponsor Decision|0|||
23717739|NCT02758613|66340708|FG003|Treatment|Physician and Sponsor Decision|0|||
23717740|NCT02758613|66340705|FG000|Treatment|Withdrawal by Subject|1|||
23717741|NCT02758613|66340706|FG001|Treatment|Withdrawal by Subject|0|||
23717742|NCT02758613|66340707|FG002|Treatment|Withdrawal by Subject|1|||
23717743|NCT02758613|66340708|FG003|Treatment|Withdrawal by Subject|0|||
23717744|NCT00630812|66340709|FG000|Randomisation to First Dose|Adverse Event|1|||
23717745|NCT00630812|66340710|FG001|Randomisation to First Dose|Adverse Event|1|||
23717746|NCT00630812|66340709|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
23717747|NCT00630812|66340710|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
23717748|NCT00630812|66340709|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
23717749|NCT00630812|66340710|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
23717750|NCT00630812|66340709|FG000|Randomisation to First Dose|Protocol Violation|4|||
23717751|NCT00630812|66340710|FG001|Randomisation to First Dose|Protocol Violation|1|||
23717752|NCT00630812|66340709|FG000|Double Blind Treatment Period|Adverse Event|13|||
23717753|NCT00630812|66340710|FG001|Double Blind Treatment Period|Adverse Event|5|||
23717754|NCT00630812|66340709|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
23717755|NCT00630812|66340710|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23717756|NCT00630812|66340709|FG000|Double Blind Treatment Period|Physician Decision|2|||
23717757|NCT00630812|66340710|FG001|Double Blind Treatment Period|Physician Decision|1|||
23717758|NCT00630812|66340709|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23717759|NCT00630812|66340710|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23717760|NCT00630812|66340709|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
23717761|NCT00630812|66340710|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
23717762|NCT00630812|66340709|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
23717763|NCT00630812|66340710|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
23717764|NCT00630812|66340709|FG000|Double Blind Treatment Period|Non-compliance|0|||
23717765|NCT00630812|66340710|FG001|Double Blind Treatment Period|Non-compliance|1|||
23717766|NCT04325906|66340711|FG000|Overall Study|Withdrawal by Subject|2|||
23717767|NCT04325906|66340712|FG001|Overall Study|Withdrawal by Subject|0|||
23717768|NCT03517449|66340713|FG000|Overall Study|Death|184|||
23717769|NCT03517449|66340714|FG001|Overall Study|Death|236|||
23717770|NCT03517449|66340713|FG000|Overall Study|Lost to Follow-up|0|||
23717771|NCT03517449|66340714|FG001|Overall Study|Lost to Follow-up|2|||
23813307|NCT04645966|66699301|FG001|Vaccination Phase|Adverse Event|0|||
23813308|NCT04645966|66699302|FG002|Vaccination Phase|Adverse Event|0|||
23813309|NCT04645966|66699303|FG003|Vaccination Phase|Adverse Event|0|||
23813310|NCT04645966|66699304|FG004|Vaccination Phase|Adverse Event|0|||
23813311|NCT04645966|66699305|FG005|Vaccination Phase|Adverse Event|0|||
23717772|NCT03517449|66340713|FG000|Overall Study|Withdrawal by Subject|7|||
23717773|NCT03517449|66340714|FG001|Overall Study|Withdrawal by Subject|26|||
23717774|NCT03517449|66340713|FG000|Overall Study|Participants Ongoing|220|||
23717775|NCT03517449|66340714|FG001|Overall Study|Participants Ongoing|152|||
23813312|NCT04645966|66699306|FG006|Vaccination Phase|Adverse Event|1|||
23717776|NCT00108953|66340715|FG000|Follow-up|Death|18|||
23717777|NCT00108953|66340716|FG001|Follow-up|Death|26|||
23717778|NCT00108953|66340715|FG000|Follow-up|Lost to Follow-up|1|||
23717779|NCT00108953|66340716|FG001|Follow-up|Lost to Follow-up|1|||
23717780|NCT00108953|66340715|FG000|Follow-up|Study terminated by sponsor|10|||
23813313|NCT04645966|66699307|FG007|Vaccination Phase|Adverse Event|0|||
23813314|NCT04645966|66699308|FG008|Vaccination Phase|Adverse Event|0|||
23529033|NCT02510794|65672782|FG003|Overall Study|Death|1|||
23529034|NCT02510794|65672779|FG000|Overall Study|Lack of Efficacy|3|||
23529035|NCT02510794|65672780|FG001|Overall Study|Lack of Efficacy|1|||
23529036|NCT02510794|65672781|FG002|Overall Study|Lack of Efficacy|1|||
23529037|NCT02510794|65672782|FG003|Overall Study|Lack of Efficacy|0|||
23529038|NCT02510794|65672779|FG000|Overall Study|Participant moved out of the area|0|||
23529039|NCT02510794|65672780|FG001|Overall Study|Participant moved out of the area|0|||
23529040|NCT02510794|65672781|FG002|Overall Study|Participant moved out of the area|0|||
23529041|NCT02510794|65672782|FG003|Overall Study|Participant moved out of the area|1|||
23529042|NCT02510794|65672779|FG000|Overall Study|Physician Decision|3|||
23529043|NCT02510794|65672780|FG001|Overall Study|Physician Decision|0|||
23529044|NCT02510794|65672781|FG002|Overall Study|Physician Decision|0|||
23529045|NCT02510794|65672782|FG003|Overall Study|Physician Decision|0|||
23529046|NCT02510794|65672779|FG000|Overall Study|Protocol Violation|0|||
23529047|NCT02510794|65672780|FG001|Overall Study|Protocol Violation|0|||
23529048|NCT02510794|65672781|FG002|Overall Study|Protocol Violation|1|||
23529049|NCT02510794|65672782|FG003|Overall Study|Protocol Violation|0|||
23529050|NCT02510794|65672779|FG000|Overall Study|Withdrawal by Subject|1|||
23529051|NCT02510794|65672780|FG001|Overall Study|Withdrawal by Subject|2|||
23529052|NCT02510794|65672781|FG002|Overall Study|Withdrawal by Subject|4|||
23529053|NCT02510794|65672782|FG003|Overall Study|Withdrawal by Subject|3|||
23529054|NCT03643562|65672783|FG000|Overall Study|Adverse Event|1|||
23529055|NCT03643562|65672784|FG001|Overall Study|Adverse Event|0|||
23529056|NCT03643562|65672783|FG000|Overall Study|Lack of Efficacy|0|||
23529057|NCT03643562|65672784|FG001|Overall Study|Lack of Efficacy|1|||
23529058|NCT03643562|65672783|FG000|Overall Study|Physician Decision|0|||
23529059|NCT03643562|65672784|FG001|Overall Study|Physician Decision|1|||
23529060|NCT03643562|65672783|FG000|Overall Study|Study Terminated by Sponsor|2|||
23529061|NCT03643562|65672784|FG001|Overall Study|Study Terminated by Sponsor|10|||
23529062|NCT03643562|65672783|FG000|Overall Study|Withdrawal by Subject|2|||
23529063|NCT03643562|65672784|FG001|Overall Study|Withdrawal by Subject|2|||
23529064|NCT03643562|65672783|FG000|Overall Study|Other than specified|3|||
23529065|NCT03643562|65672784|FG001|Overall Study|Other than specified|2|||
23529066|NCT01469065|65672787|FG000|Overall Study|Lack of Efficacy|0|||
23529067|NCT01469065|65672788|FG001|Overall Study|Lack of Efficacy|0|||
23529068|NCT01469065|65672789|FG002|Overall Study|Lack of Efficacy|0|||
23529069|NCT01469065|65672790|FG003|Overall Study|Lack of Efficacy|0|||
23529070|NCT01469065|65672791|FG004|Overall Study|Lack of Efficacy|1|||
23529071|NCT01469065|65672787|FG000|Overall Study|Other|0|||
23529072|NCT01469065|65672788|FG001|Overall Study|Other|1|||
23529073|NCT01469065|65672789|FG002|Overall Study|Other|0|||
23529074|NCT01469065|65672790|FG003|Overall Study|Other|0|||
23529075|NCT01469065|65672791|FG004|Overall Study|Other|0|||
23529076|NCT03491150|65672795|FG000|Overall Study|Adverse Event|1|||
23529077|NCT03491150|65672796|FG001|Overall Study|Adverse Event|0|||
23529078|NCT03491150|65672795|FG000|Overall Study|Study Terminated by Sponsor|74|||
23529079|NCT03491150|65672796|FG001|Overall Study|Study Terminated by Sponsor|70|||
23529080|NCT03491150|65672795|FG000|Overall Study|Other|0|||
23529081|NCT03491150|65672796|FG001|Overall Study|Other|1|||
23529082|NCT03491150|65672795|FG000|Overall Study|Withdrawal by Subject|1|||
23529083|NCT03491150|65672796|FG001|Overall Study|Withdrawal by Subject|2|||
23529084|NCT00595582|65672797|FG000|Overall Study|Pilot study that PI terminated|2|||
23529085|NCT00595582|65672797|FG000|Overall Study|Lost to Follow-up|1|||
23529086|NCT00595582|65672797|FG000|Overall Study|Adverse Event|2|||
23529087|NCT00595582|65672797|FG000|Overall Study|Physician Decision|5|||
23529088|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
23529089|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
23529090|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
23529091|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
23529092|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
23529093|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
23529094|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
23529095|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
23529096|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
23529097|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
23529098|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
23529099|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
23529100|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
23529101|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
23529102|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
23529103|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
23529104|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
23529105|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
23529106|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
23529107|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
23529108|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Other|3|||
23529109|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Other|0|||
23529110|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Other|2|||
23529111|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Other|2|||
23717781|NCT00108953|66340716|FG001|Follow-up|Study terminated by sponsor|6|||
23717782|NCT01381718|66340717|FG000|Overall Study|Withdrawal by Subject|2|||
23717783|NCT01381718|66340718|FG001|Overall Study|Withdrawal by Subject|5|||
23717784|NCT01381718|66340717|FG000|Overall Study|Lost to Follow-up|3|||
23717785|NCT01381718|66340718|FG001|Overall Study|Lost to Follow-up|5|||
23717786|NCT01381718|66340717|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
23717787|NCT01381718|66340718|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
23717788|NCT02260648|66340719|FG000|Overall Study|Adverse Event|3|||
23717789|NCT02260648|66340720|FG001|Overall Study|Adverse Event|0|||
23717790|NCT02260648|66340721|FG002|Overall Study|Adverse Event|1|||
23717791|NCT02260648|66340719|FG000|Overall Study|Withdrawal by Subject|1|||
23717792|NCT02260648|66340720|FG001|Overall Study|Withdrawal by Subject|1|||
23529112|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Other|7|||
23529113|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529114|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529115|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529116|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
23529117|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529118|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529119|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529120|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529121|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529122|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
23529123|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
23529124|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
23529125|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
23529126|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
23529127|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
23529128|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
23529129|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
23529130|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
23529131|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
23529132|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
23529133|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
23529134|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
23529135|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
23529136|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
23529137|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
23529138|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Other|2|||
23529139|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Other|1|||
23529140|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Other|2|||
23529141|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Other|8|||
23529142|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Other|7|||
23529143|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529144|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
23529145|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529146|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529147|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529148|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
23529149|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529150|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529151|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529152|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529153|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
23529154|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
23529155|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
23529156|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
23529157|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
23529158|NCT00213148|65672798|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23529159|NCT00213148|65672799|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
23529160|NCT00213148|65672800|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23529161|NCT00213148|65672801|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23717793|NCT02260648|66340721|FG002|Overall Study|Withdrawal by Subject|0|||
23529162|NCT00213148|65672802|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
23529163|NCT00213148|65672798|FG000|Cycle 3 (1 Month)|Other|0|||
23529164|NCT00213148|65672799|FG001|Cycle 3 (1 Month)|Other|0|||
23717794|NCT02260648|66340719|FG000|Overall Study|Protocol Violation|1|||
23529165|NCT00213148|65672800|FG002|Cycle 3 (1 Month)|Other|1|||
23529166|NCT00213148|65672801|FG003|Cycle 3 (1 Month)|Other|1|||
23529167|NCT00213148|65672802|FG004|Cycle 3 (1 Month)|Other|0|||
23529168|NCT04476030|65672803|FG000|Overall Study|Withdrawal by Subject|20|||
23529169|NCT04476030|65672804|FG001|Overall Study|Withdrawal by Subject|16|||
23529170|NCT04476030|65672803|FG000|Overall Study|Adverse Event|10|||
23529171|NCT04476030|65672804|FG001|Overall Study|Adverse Event|11|||
23529172|NCT04476030|65672803|FG000|Overall Study|Lost to Follow-up|7|||
23529173|NCT04476030|65672804|FG001|Overall Study|Lost to Follow-up|4|||
23529174|NCT04476030|65672803|FG000|Overall Study|Physician Decision|1|||
23529175|NCT04476030|65672804|FG001|Overall Study|Physician Decision|1|||
23529176|NCT04476030|65672803|FG000|Overall Study|Protocol Deviation|2|||
23529177|NCT04476030|65672804|FG001|Overall Study|Protocol Deviation|0|||
23529178|NCT04476030|65672803|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
23529179|NCT04476030|65672804|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
23529180|NCT04476030|65672803|FG000|Overall Study|Randomized but not Dosed|2|||
23529181|NCT04476030|65672804|FG001|Overall Study|Randomized but not Dosed|8|||
23529182|NCT01467076|65672805|FG000|Overall Study|Lost to Follow-up|1|||
23529183|NCT01467076|65672806|FG001|Overall Study|Lost to Follow-up|0|||
23529184|NCT01467076|65672807|FG002|Overall Study|Lost to Follow-up|0|||
23529185|NCT00111228|65672808|FG000|Overall Study|Withdrawal by Subject|5|||
23529186|NCT00111228|65672809|FG001|Overall Study|Withdrawal by Subject|1|||
23529187|NCT00111228|65672810|FG002|Overall Study|Withdrawal by Subject|0|||
23529188|NCT01565291|65672811|FG000|Overall Study|Withdrawal by Subject|1|||
23529189|NCT01565291|65672812|FG001|Overall Study|Withdrawal by Subject|0|||
23529190|NCT00423891|65672813|FG000|Enrolled|Withdrawal by Subject|0|||
23529191|NCT00423891|65672814|FG001|Enrolled|Withdrawal by Subject|0|||
23529192|NCT00423891|65672815|FG002|Enrolled|Withdrawal by Subject|1|||
23529193|NCT00423891|65672813|FG000|Enrolled|Lost to Follow-up|0|||
23529194|NCT00423891|65672814|FG001|Enrolled|Lost to Follow-up|0|||
23529195|NCT00423891|65672815|FG002|Enrolled|Lost to Follow-up|1|||
23529196|NCT00423891|65672813|FG000|Enrolled|No longer met criteria|11|||
23529197|NCT00423891|65672814|FG001|Enrolled|No longer met criteria|2|||
23529198|NCT00423891|65672815|FG002|Enrolled|No longer met criteria|1|||
23529199|NCT00423891|65672813|FG000|Treatment|Withdrawal by Subject|1|||
23529200|NCT00423891|65672814|FG001|Treatment|Withdrawal by Subject|0|||
23529201|NCT00423891|65672815|FG002|Treatment|Withdrawal by Subject|0|||
23529202|NCT00423891|65672813|FG000|Treatment|Lost to Follow-up|1|||
23529203|NCT00423891|65672814|FG001|Treatment|Lost to Follow-up|0|||
23529204|NCT00423891|65672815|FG002|Treatment|Lost to Follow-up|0|||
23529205|NCT00423891|65672813|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
23529206|NCT00423891|65672814|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
23529207|NCT00423891|65672815|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
23529208|NCT00423891|65672813|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
23529209|NCT00423891|65672814|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
23529210|NCT00423891|65672815|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
23529211|NCT04074317|65672816|FG000|Third Period|Withdrawal by Subject|0|||
23529212|NCT04074317|65672817|FG001|Third Period|Withdrawal by Subject|0|||
23529213|NCT04074317|65672818|FG002|Third Period|Withdrawal by Subject|0|||
23529214|NCT04074317|65672819|FG003|Third Period|Withdrawal by Subject|1|||
23529215|NCT04074317|65672820|FG004|Third Period|Withdrawal by Subject|0|||
23529216|NCT04074317|65672821|FG005|Third Period|Withdrawal by Subject|0|||
23529217|NCT01077960|65672822|FG000|Overall Study|Adverse Event|6|||
23529218|NCT01077960|65672822|FG000|Overall Study|Protocol Violation|3|||
23529219|NCT01077960|65672822|FG000|Overall Study|Lost to Follow-up|5|||
23529220|NCT01077960|65672822|FG000|Overall Study|Subject decision|1|||
23529221|NCT01077960|65672822|FG000|Overall Study|Reason unspecified|1|||
23529222|NCT02118428|65672823|FG000|Overall Study|Physician Decision|0|||
23529223|NCT02118428|65672824|FG001|Overall Study|Physician Decision|1|||
23529224|NCT02118428|65672825|FG002|Overall Study|Physician Decision|0|||
23529225|NCT02118428|65672823|FG000|Overall Study|Withdrawal by Subject|2|||
23529226|NCT02118428|65672824|FG001|Overall Study|Withdrawal by Subject|2|||
23529227|NCT02118428|65672825|FG002|Overall Study|Withdrawal by Subject|0|||
23529228|NCT02118428|65672823|FG000|Overall Study|Death|7|||
23529229|NCT02118428|65672824|FG001|Overall Study|Death|5|||
23529230|NCT02118428|65672825|FG002|Overall Study|Death|0|||
23529231|NCT02118428|65672823|FG000|Overall Study|Lost to Follow-up|3|||
23418876|NCT02743949|65277345|FG001|Overall Study|Adverse Event|0|||
23529232|NCT02118428|65672824|FG001|Overall Study|Lost to Follow-up|1|||
23529233|NCT02118428|65672825|FG002|Overall Study|Lost to Follow-up|0|||
23717795|NCT02260648|66340720|FG001|Overall Study|Protocol Violation|0|||
23529234|NCT02118428|65672823|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
23529235|NCT02118428|65672824|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
23418877|NCT02743949|65277346|FG002|Overall Study|Adverse Event|2|||
23529236|NCT02118428|65672825|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
23529237|NCT00354172|65672826|FG000|Overall Study|Did not receive transplant|1|||
23529238|NCT00403273|65672827|FG000|Overall Study|Lost to Follow-up|3|||
23529239|NCT00403273|65672828|FG001|Overall Study|Lost to Follow-up|2|||
23529240|NCT00403273|65672827|FG000|Overall Study|Physician Decision|0|||
23529241|NCT00403273|65672828|FG001|Overall Study|Physician Decision|1|||
23529242|NCT00403273|65672827|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
23529243|NCT00403273|65672828|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
23529244|NCT01574352|65672831|FG000|Overall Study|Withdrawal by Subject|6|||
23529245|NCT01574352|65672832|FG001|Overall Study|Withdrawal by Subject|13|||
23717796|NCT02260648|66340721|FG002|Overall Study|Protocol Violation|0|||
23813315|NCT04645966|66699300|FG000|Vaccination Phase|Death|0|||
23813316|NCT04645966|66699301|FG001|Vaccination Phase|Death|0|||
23813317|NCT04645966|66699302|FG002|Vaccination Phase|Death|0|||
23813318|NCT04645966|66699303|FG003|Vaccination Phase|Death|0|||
23813319|NCT04645966|66699304|FG004|Vaccination Phase|Death|0|||
23813320|NCT04645966|66699305|FG005|Vaccination Phase|Death|1|||
23813321|NCT04645966|66699306|FG006|Vaccination Phase|Death|0|||
23813322|NCT04645966|66699307|FG007|Vaccination Phase|Death|0|||
23813323|NCT04645966|66699308|FG008|Vaccination Phase|Death|0|||
23813324|NCT04645966|66699300|FG000|Vaccination Phase|Protocol Violation|0|||
23813325|NCT04645966|66699301|FG001|Vaccination Phase|Protocol Violation|0|||
23813326|NCT04645966|66699302|FG002|Vaccination Phase|Protocol Violation|0|||
23813327|NCT04645966|66699303|FG003|Vaccination Phase|Protocol Violation|0|||
23813328|NCT04645966|66699304|FG004|Vaccination Phase|Protocol Violation|1|||
23813329|NCT04645966|66699305|FG005|Vaccination Phase|Protocol Violation|0|||
23813330|NCT04645966|66699306|FG006|Vaccination Phase|Protocol Violation|0|||
23813331|NCT04645966|66699307|FG007|Vaccination Phase|Protocol Violation|0|||
23813332|NCT04645966|66699308|FG008|Vaccination Phase|Protocol Violation|0|||
23813333|NCT04645966|66699300|FG000|Vaccination Phase|Study terminated by sponsor|0|||
23813334|NCT04645966|66699301|FG001|Vaccination Phase|Study terminated by sponsor|0|||
23813335|NCT04645966|66699302|FG002|Vaccination Phase|Study terminated by sponsor|14|||
23813336|NCT04645966|66699303|FG003|Vaccination Phase|Study terminated by sponsor|15|||
23813337|NCT04645966|66699304|FG004|Vaccination Phase|Study terminated by sponsor|47|||
23813338|NCT04645966|66699305|FG005|Vaccination Phase|Study terminated by sponsor|43|||
23813339|NCT04645966|66699306|FG006|Vaccination Phase|Study terminated by sponsor|29|||
23813340|NCT04645966|66699307|FG007|Vaccination Phase|Study terminated by sponsor|29|||
23813341|NCT04645966|66699308|FG008|Vaccination Phase|Study terminated by sponsor|12|||
23813342|NCT04645966|66699300|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
23813343|NCT04645966|66699301|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
23813344|NCT04645966|66699302|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
23813345|NCT04645966|66699303|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
23813346|NCT04645966|66699304|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
23813347|NCT04645966|66699305|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
23813348|NCT04645966|66699306|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
23813349|NCT04645966|66699307|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
23813350|NCT04645966|66699308|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
23813351|NCT04645966|66699300|FG000|Vaccination Phase|Other|0|||
23813352|NCT04645966|66699301|FG001|Vaccination Phase|Other|0|||
23813353|NCT04645966|66699302|FG002|Vaccination Phase|Other|0|||
23813354|NCT04645966|66699303|FG003|Vaccination Phase|Other|0|||
23813355|NCT04645966|66699304|FG004|Vaccination Phase|Other|0|||
23813356|NCT04645966|66699305|FG005|Vaccination Phase|Other|2|||
23813357|NCT04645966|66699306|FG006|Vaccination Phase|Other|0|||
23813358|NCT04645966|66699307|FG007|Vaccination Phase|Other|0|||
23813359|NCT04645966|66699308|FG008|Vaccination Phase|Other|0|||
23813360|NCT04645966|66699300|FG000|Vaccination Phase|Lost to Follow-up|0|||
23813361|NCT04645966|66699301|FG001|Vaccination Phase|Lost to Follow-up|0|||
23813362|NCT04645966|66699302|FG002|Vaccination Phase|Lost to Follow-up|0|||
23813363|NCT04645966|66699303|FG003|Vaccination Phase|Lost to Follow-up|0|||
23813364|NCT04645966|66699304|FG004|Vaccination Phase|Lost to Follow-up|0|||
23813365|NCT04645966|66699305|FG005|Vaccination Phase|Lost to Follow-up|0|||
23813366|NCT04645966|66699306|FG006|Vaccination Phase|Lost to Follow-up|0|||
23813367|NCT04645966|66699307|FG007|Vaccination Phase|Lost to Follow-up|1|||
23813368|NCT04645966|66699308|FG008|Vaccination Phase|Lost to Follow-up|0|||
23813369|NCT04645966|66699300|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
23813370|NCT04645966|66699301|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
23813371|NCT04645966|66699302|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
23813372|NCT04645966|66699303|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
23813373|NCT04645966|66699304|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
23813374|NCT04645966|66699305|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
23813375|NCT04645966|66699306|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
23813376|NCT04645966|66699307|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
23813377|NCT04645966|66699308|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
23813378|NCT04645966|66699300|FG000|Follow-up Phase|Lost to Follow-up|0|||
23813379|NCT04645966|66699301|FG001|Follow-up Phase|Lost to Follow-up|0|||
23813380|NCT04645966|66699302|FG002|Follow-up Phase|Lost to Follow-up|0|||
23813381|NCT04645966|66699303|FG003|Follow-up Phase|Lost to Follow-up|0|||
23813382|NCT04645966|66699304|FG004|Follow-up Phase|Lost to Follow-up|0|||
23813383|NCT04645966|66699305|FG005|Follow-up Phase|Lost to Follow-up|0|||
23813384|NCT04645966|66699306|FG006|Follow-up Phase|Lost to Follow-up|0|||
23813385|NCT04645966|66699307|FG007|Follow-up Phase|Lost to Follow-up|1|||
23813386|NCT04645966|66699308|FG008|Follow-up Phase|Lost to Follow-up|0|||
23813387|NCT04594707|66699309|FG000|Overall Study|Adverse Event|0|||
23813388|NCT04594707|66699310|FG001|Overall Study|Adverse Event|0|||
23813389|NCT04594707|66699311|FG002|Overall Study|Adverse Event|1|||
23529246|NCT01574352|65672831|FG000|Overall Study|Injury in non-camp related sport|1|||
23529247|NCT01574352|65672832|FG001|Overall Study|Injury in non-camp related sport|0|||
23529248|NCT00720941|65672835|FG000|Overall Study|Death|334|||
23529249|NCT00720941|65672836|FG001|Overall Study|Death|335|||
23529250|NCT00720941|65672835|FG000|Overall Study|Protocol Violation|0|||
23529251|NCT00720941|65672836|FG001|Overall Study|Protocol Violation|2|||
23529252|NCT00720941|65672835|FG000|Overall Study|Lost to Follow-up|17|||
23529253|NCT00720941|65672836|FG001|Overall Study|Lost to Follow-up|15|||
23529254|NCT00720941|65672835|FG000|Overall Study|Physician Decision|1|||
23529255|NCT00720941|65672836|FG001|Overall Study|Physician Decision|5|||
23529256|NCT00720941|65672835|FG000|Overall Study|Withdrawal by Subject|27|||
23529257|NCT00720941|65672836|FG001|Overall Study|Withdrawal by Subject|35|||
23529258|NCT00720941|65672835|FG000|Overall Study|Ongoing|34|||
23529259|NCT00720941|65672836|FG001|Overall Study|Ongoing|23|||
23529260|NCT00834912|65672841|FG000|Treatment Period 1|Adverse Event|0|||
23529261|NCT00834912|65672842|FG001|Treatment Period 1|Adverse Event|1|||
23529262|NCT00834912|65672843|FG002|Treatment Period 1|Adverse Event|0|||
23529263|NCT00834912|65672844|FG003|Treatment Period 1|Adverse Event|1|||
23529264|NCT00834912|65672845|FG004|Treatment Period 1|Adverse Event|0|||
23529265|NCT00834912|65672846|FG005|Treatment Period 1|Adverse Event|0|||
23529266|NCT00834912|65672841|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23529267|NCT00834912|65672842|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23529268|NCT00834912|65672843|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23529269|NCT00834912|65672844|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23529270|NCT00834912|65672845|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23529271|NCT00834912|65672846|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23529272|NCT04382911|65672847|FG000|Overall Study|unable to be imaged prior to surgery|2|||
23529273|NCT02023151|65672848|FG000|Overall Study|Lost to Follow-up|4|||
23529274|NCT00910715|65672851|FG000|Overall Study|Lost to Follow-up|22|||
23529275|NCT00910715|65672852|FG001|Overall Study|Lost to Follow-up|26|||
23529276|NCT00910715|65672853|FG002|Overall Study|Lost to Follow-up|0|||
23529277|NCT01207778|65672854|FG000|Overall Study|Lost to Follow-up|0|||
23529278|NCT01207778|65672855|FG001|Overall Study|Lost to Follow-up|3|||
23529279|NCT01207778|65672856|FG002|Overall Study|Lost to Follow-up|3|||
23529280|NCT02042924|65672857|FG000|Overall Study|Early Death|1|||
23529281|NCT01864291|65672858|FG000|Overall Study|need for revision surgery|2|||
23529282|NCT02404311|65672861|FG000|Part A: Month 0-18|Death|2|||
23529283|NCT02404311|65672862|FG001|Part A: Month 0-18|Death|0|||
23529284|NCT02404311|65672863|FG002|Part A: Month 0-18|Death|0|||
23529285|NCT02404311|65672864|FG003|Part A: Month 0-18|Death|0|||
23529286|NCT02404311|65672865|FG004|Part A: Month 0-18|Death|0|||
23529287|NCT02404311|65672861|FG000|Part A: Month 0-18|Physician Decision|1|||
23529288|NCT02404311|65672862|FG001|Part A: Month 0-18|Physician Decision|0|||
23529289|NCT02404311|65672863|FG002|Part A: Month 0-18|Physician Decision|0|||
23529290|NCT02404311|65672864|FG003|Part A: Month 0-18|Physician Decision|0|||
23529291|NCT02404311|65672865|FG004|Part A: Month 0-18|Physician Decision|0|||
23529292|NCT02404311|65672861|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
23529293|NCT02404311|65672862|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
23529294|NCT02404311|65672863|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
23529295|NCT02404311|65672864|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
23529296|NCT02404311|65672865|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
23529297|NCT02404311|65672861|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
23529298|NCT02404311|65672862|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
23529299|NCT02404311|65672863|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
23529300|NCT02404311|65672864|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
23529301|NCT02404311|65672865|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
23529302|NCT02404311|65672861|FG000|Part A: Month 0-18|HIV Infection|6|||
23529303|NCT02404311|65672862|FG001|Part A: Month 0-18|HIV Infection|2|||
23529304|NCT02404311|65672863|FG002|Part A: Month 0-18|HIV Infection|0|||
23529305|NCT02404311|65672864|FG003|Part A: Month 0-18|HIV Infection|0|||
23529306|NCT02404311|65672865|FG004|Part A: Month 0-18|HIV Infection|0|||
23529307|NCT02404311|65672861|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
23529308|NCT02404311|65672862|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
23529309|NCT02404311|65672863|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
23529310|NCT02404311|65672864|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
23529311|NCT02404311|65672865|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
23529312|NCT01552772|65672866|FG000|Overall Study|Lost to Follow-up|2|||
23529313|NCT01552772|65672866|FG000|Overall Study|Adverse Event|1|||
23529314|NCT01552772|65672866|FG000|Overall Study|Protocol Deviation|1|||
23529315|NCT02318693|65672867|FG000|Overall Study|Protocol Violation|0|||
23529316|NCT02318693|65672868|FG001|Overall Study|Protocol Violation|1|||
23529317|NCT00259857|65672869|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
23529318|NCT00259857|65672870|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
23529319|NCT00259857|65672869|FG000|24 Months Treatment|Lost to Follow-up|0|||
23529320|NCT00259857|65672870|FG001|24 Months Treatment|Lost to Follow-up|3|||
23529321|NCT00577122|65672871|FG000|Overall Study|Adverse Event|0|||
23529322|NCT00577122|65672872|FG001|Overall Study|Adverse Event|2|||
23529323|NCT00577122|65672871|FG000|Overall Study|Progression, relapse during active trt|6|||
23529324|NCT00577122|65672872|FG001|Overall Study|Progression, relapse during active trt|8|||
23529325|NCT00577122|65672871|FG000|Overall Study|Prog, refract disease during active trt|8|||
23529326|NCT00577122|65672872|FG001|Overall Study|Prog, refract disease during active trt|5|||
23529327|NCT00577122|65672871|FG000|Overall Study|Alternative Therapy|0|||
23529328|NCT00577122|65672872|FG001|Overall Study|Alternative Therapy|1|||
23529329|NCT01176292|65672873|FG000|Overall Study|Lost to Follow-up|2|||
23529330|NCT01176292|65672874|FG001|Overall Study|Lost to Follow-up|4|||
23529331|NCT01176292|65672873|FG000|Overall Study|Adverse Event|1|||
23529332|NCT01176292|65672874|FG001|Overall Study|Adverse Event|1|||
23529333|NCT01176292|65672873|FG000|Overall Study|Physician Decision|0|||
23529334|NCT01176292|65672874|FG001|Overall Study|Physician Decision|2|||
23529335|NCT01176292|65672873|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
23529336|NCT01176292|65672874|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
23529337|NCT00004412|65672875|FG000|Randomized Period|Moved to Crossover Period|3|||
23529338|NCT00004412|65672876|FG001|Randomized Period|Moved to Crossover Period|0|||
23529339|NCT00004412|65672877|FG002|Randomized Period|Moved to Crossover Period|0|||
23529340|NCT00436748|65672878|FG000|Overall Study|Ineligibility Determined|1|||
23529341|NCT00436748|65672879|FG001|Overall Study|Ineligibility Determined|1|||
23529342|NCT00436748|65672878|FG000|Overall Study|Adverse Event|0|||
23529343|NCT00436748|65672879|FG001|Overall Study|Adverse Event|2|||
23529344|NCT00436748|65672878|FG000|Overall Study|Consent Withdrawn|1|||
23529345|NCT00436748|65672879|FG001|Overall Study|Consent Withdrawn|4|||
23529346|NCT00436748|65672878|FG000|Overall Study|Administrative Decision|1|||
23529347|NCT00436748|65672879|FG001|Overall Study|Administrative Decision|0|||
23529348|NCT00436748|65672878|FG000|Overall Study|Lost to Follow-up|0|||
23529349|NCT00436748|65672879|FG001|Overall Study|Lost to Follow-up|1|||
23529350|NCT00436748|65672878|FG000|Overall Study|Protocol-specified Criteria|5|||
23529351|NCT00436748|65672879|FG001|Overall Study|Protocol-specified Criteria|4|||
23529352|NCT00436748|65672878|FG000|Overall Study|Other|3|||
23529353|NCT00436748|65672879|FG001|Overall Study|Other|0|||
23529354|NCT01577758|65672882|FG000|Dose Escalation Phase|Adverse Event|0|||
23529355|NCT01577758|65672883|FG001|Dose Escalation Phase|Adverse Event|0|||
23529356|NCT01577758|65672884|FG002|Dose Escalation Phase|Adverse Event|0|||
23529357|NCT01577758|65672885|FG003|Dose Escalation Phase|Adverse Event|0|||
23529358|NCT01577758|65672886|FG004|Dose Escalation Phase|Adverse Event|0|||
23529359|NCT01577758|65672887|FG005|Dose Escalation Phase|Adverse Event|2|||
23529360|NCT01577758|65672888|FG006|Dose Escalation Phase|Adverse Event|1|||
23529361|NCT01577758|65672889|FG007|Dose Escalation Phase|Adverse Event|0|||
23529362|NCT01577758|65672882|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529363|NCT01577758|65672883|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529364|NCT01577758|65672884|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529365|NCT01577758|65672885|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529366|NCT01577758|65672886|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529367|NCT01577758|65672887|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529368|NCT01577758|65672888|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529369|NCT01577758|65672889|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529370|NCT01577758|65672882|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23529371|NCT01577758|65672883|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23529372|NCT01577758|65672884|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23529373|NCT01577758|65672885|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23529374|NCT01577758|65672886|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23529375|NCT01577758|65672887|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
23529376|NCT01577758|65672888|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
23529377|NCT01577758|65672889|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
23529378|NCT01577758|65672882|FG000|Dose Escalation Phase|Progression Disease|2|||
23529379|NCT01577758|65672883|FG001|Dose Escalation Phase|Progression Disease|2|||
23529380|NCT01577758|65672884|FG002|Dose Escalation Phase|Progression Disease|1|||
23529381|NCT01577758|65672885|FG003|Dose Escalation Phase|Progression Disease|2|||
23529382|NCT01577758|65672886|FG004|Dose Escalation Phase|Progression Disease|5|||
23529383|NCT01577758|65672887|FG005|Dose Escalation Phase|Progression Disease|0|||
23529384|NCT01577758|65672888|FG006|Dose Escalation Phase|Progression Disease|0|||
23529385|NCT01577758|65672889|FG007|Dose Escalation Phase|Progression Disease|0|||
23529386|NCT01577758|65672882|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529387|NCT01577758|65672883|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529388|NCT01577758|65672884|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529389|NCT01577758|65672885|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529390|NCT01577758|65672886|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529391|NCT01577758|65672887|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529392|NCT01577758|65672888|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529393|NCT01577758|65672889|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
23529394|NCT01577758|65672882|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529395|NCT01577758|65672883|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529396|NCT01577758|65672884|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529397|NCT01577758|65672885|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529398|NCT01577758|65672886|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
23717797|NCT02260648|66340719|FG000|Overall Study|Discontinue Due to Study Termination|13|||
23717798|NCT02260648|66340720|FG001|Overall Study|Discontinue Due to Study Termination|12|||
23529399|NCT01577758|65672887|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529400|NCT01577758|65672888|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529401|NCT01577758|65672889|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
23529402|NCT01577758|65672882|FG000|mCRC Expansion Phase|Progression Disease|0|||
23529403|NCT01577758|65672883|FG001|mCRC Expansion Phase|Progression Disease|0|||
23529404|NCT01577758|65672884|FG002|mCRC Expansion Phase|Progression Disease|0|||
23529405|NCT01577758|65672885|FG003|mCRC Expansion Phase|Progression Disease|0|||
23529406|NCT01577758|65672886|FG004|mCRC Expansion Phase|Progression Disease|0|||
23529407|NCT01577758|65672887|FG005|mCRC Expansion Phase|Progression Disease|0|||
23529408|NCT01577758|65672888|FG006|mCRC Expansion Phase|Progression Disease|0|||
23529409|NCT01577758|65672889|FG007|mCRC Expansion Phase|Progression Disease|19|||
23529410|NCT01785602|65672890|FG000|Overall Study|Withdrawal by Subject|2|||
23529411|NCT01785602|65672891|FG001|Overall Study|Withdrawal by Subject|0|||
23529412|NCT01785602|65672890|FG000|Overall Study|Lost to Follow-up|1|||
23529413|NCT01785602|65672891|FG001|Overall Study|Lost to Follow-up|1|||
23529414|NCT01785602|65672890|FG000|Overall Study|Adverse Event|3|||
23529415|NCT01785602|65672891|FG001|Overall Study|Adverse Event|5|||
23529416|NCT01785602|65672890|FG000|Overall Study|Administrative problems|7|||
23529417|NCT01785602|65672891|FG001|Overall Study|Administrative problems|3|||
23529418|NCT02434770|65672892|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
23813390|NCT04594707|66699309|FG000|Overall Study|Death|0|||
23813391|NCT04594707|66699310|FG001|Overall Study|Death|2|||
23813392|NCT04594707|66699311|FG002|Overall Study|Death|2|||
23813393|NCT04594707|66699309|FG000|Overall Study|Lung Transplant|0|||
23813394|NCT04594707|66699310|FG001|Overall Study|Lung Transplant|0|||
23813395|NCT04594707|66699311|FG002|Overall Study|Lung Transplant|1|||
23813396|NCT04594707|66699309|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
23813397|NCT04594707|66699310|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
23813398|NCT04594707|66699311|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
23813399|NCT04594707|66699309|FG000|Overall Study|Study Terminated By Sponsor|19|||
23813400|NCT04594707|66699310|FG001|Overall Study|Study Terminated By Sponsor|47|||
23813401|NCT04594707|66699311|FG002|Overall Study|Study Terminated By Sponsor|41|||
23813402|NCT04594707|66699309|FG000|Overall Study|Withdrawal by Subject|1|||
23813403|NCT04594707|66699310|FG001|Overall Study|Withdrawal by Subject|0|||
23813404|NCT04594707|66699311|FG002|Overall Study|Withdrawal by Subject|2|||
23813405|NCT00777036|66699312|FG000|On Treatment|Reason Not Specified|4|||
23813406|NCT00777036|66699313|FG001|On Treatment|Reason Not Specified|7|||
23813407|NCT00777036|66699314|FG002|On Treatment|Reason Not Specified|12|||
23813408|NCT00777036|66699312|FG000|On Treatment|Failure to Meet Study Criteria|0|||
23813409|NCT00777036|66699313|FG001|On Treatment|Failure to Meet Study Criteria|1|||
23813410|NCT00777036|66699314|FG002|On Treatment|Failure to Meet Study Criteria|0|||
23813411|NCT00777036|66699312|FG000|On Treatment|Non-compliance with Study Drug|1|||
23813412|NCT00777036|66699313|FG001|On Treatment|Non-compliance with Study Drug|0|||
23813413|NCT00777036|66699314|FG002|On Treatment|Non-compliance with Study Drug|0|||
23813414|NCT00777036|66699312|FG000|On Treatment|Maximum Clinical Benefit|2|||
23813415|NCT00777036|66699313|FG001|On Treatment|Maximum Clinical Benefit|0|||
23418878|NCT02743949|65277344|FG000|Overall Study|Significant Protocol Deviation|2|||
23418879|NCT02743949|65277345|FG001|Overall Study|Significant Protocol Deviation|0|||
23813416|NCT00777036|66699314|FG002|On Treatment|Maximum Clinical Benefit|1|||
23813417|NCT00777036|66699312|FG000|On Treatment|Withdrawal by Subject|3|||
23813418|NCT00777036|66699313|FG001|On Treatment|Withdrawal by Subject|2|||
23813419|NCT00777036|66699314|FG002|On Treatment|Withdrawal by Subject|3|||
23813420|NCT00777036|66699312|FG000|On Treatment|Death|0|||
23813421|NCT00777036|66699313|FG001|On Treatment|Death|2|||
23813422|NCT00777036|66699314|FG002|On Treatment|Death|0|||
23813423|NCT00777036|66699312|FG000|On Treatment|Study Drug Toxicity|0|||
23813424|NCT00777036|66699313|FG001|On Treatment|Study Drug Toxicity|0|||
23418880|NCT02743949|65277346|FG002|Overall Study|Significant Protocol Deviation|1|||
23418881|NCT02743949|65277344|FG000|Overall Study|Voluntary Withdrawal|2|||
23418882|NCT02743949|65277345|FG001|Overall Study|Voluntary Withdrawal|1|||
23418883|NCT02743949|65277346|FG002|Overall Study|Voluntary Withdrawal|0|||
23418884|NCT02109432|65277347|FG000|Overall Study|Withdrawal by Subject|1|||
23418885|NCT04027049|65277348|FG000|Overall Study|Withdrawn by family|1|||
23529419|NCT02434770|65672893|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
23529420|NCT02434770|65672894|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
23813425|NCT00777036|66699314|FG002|On Treatment|Study Drug Toxicity|1|||
23813426|NCT00777036|66699312|FG000|On Treatment|Progressive Disease|5|||
23813427|NCT00777036|66699313|FG001|On Treatment|Progressive Disease|4|||
23813428|NCT00777036|66699314|FG002|On Treatment|Progressive Disease|6|||
23813429|NCT00777036|66699312|FG000|Follow-Up|Lost to Follow-up|1|||
23813430|NCT00777036|66699313|FG001|Follow-Up|Lost to Follow-up|0|||
23340852|NCT01936181|64992873|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
23529421|NCT02434770|65672892|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
23529422|NCT02434770|65672893|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
23813431|NCT00777036|66699314|FG002|Follow-Up|Lost to Follow-up|0|||
23813432|NCT00777036|66699312|FG000|Follow-Up|Reason Not Specified|2|||
23813433|NCT00777036|66699313|FG001|Follow-Up|Reason Not Specified|0|||
23418886|NCT04027049|65277349|FG001|Overall Study|Withdrawn by family|0|||
23418887|NCT04027049|65277348|FG000|Overall Study|Participant safety|1|||
23418888|NCT04027049|65277349|FG001|Overall Study|Participant safety|0|||
23418889|NCT03645421|65277350|FG000|Overall Study|Adverse Event|0|||
23418890|NCT03645421|65277351|FG001|Overall Study|Adverse Event|0|||
23418891|NCT03645421|65277352|FG002|Overall Study|Adverse Event|4|||
23418892|NCT03645421|65277353|FG003|Overall Study|Adverse Event|1|||
23418893|NCT03645421|65277350|FG000|Overall Study|Withdrawal by patient|0|||
23418894|NCT03645421|65277351|FG001|Overall Study|Withdrawal by patient|0|||
23717799|NCT02260648|66340721|FG002|Overall Study|Discontinue Due to Study Termination|7|||
23717800|NCT00098020|66340722|FG000|Overall Study|Adverse Event|2|||
23717801|NCT00098020|66340722|FG000|Overall Study|Lost to Follow-up|1|||
23717802|NCT00098020|66340722|FG000|Overall Study|elevated liver enzymes|1|||
23717803|NCT00098020|66340722|FG000|Overall Study|Low urine PCR|1|||
23717804|NCT00098020|66340722|FG000|Overall Study|Low epidermal growth factor receptor|1|||
23717805|NCT00174785|66340725|FG000|Overall Study|Adverse Event|293|||
23717806|NCT00174785|66340726|FG001|Overall Study|Adverse Event|191|||
23717807|NCT00174785|66340725|FG000|Overall Study|Protocol Violation|14|||
23717808|NCT00174785|66340726|FG001|Overall Study|Protocol Violation|14|||
23717809|NCT00174785|66340725|FG000|Overall Study|Withdrawal by Subject|173|||
23717810|NCT00174785|66340726|FG001|Overall Study|Withdrawal by Subject|175|||
23717811|NCT00174785|66340725|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
23717812|NCT00174785|66340726|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
23717813|NCT00174785|66340725|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
23717814|NCT00174785|66340726|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
23717815|NCT00174785|66340725|FG000|Overall Study|Other prohibited medication|5|||
23813434|NCT00777036|66699314|FG002|Follow-Up|Reason Not Specified|0|||
23418895|NCT03645421|65277352|FG002|Overall Study|Withdrawal by patient|0|||
23813435|NCT00777036|66699312|FG000|Follow-Up|Withdrawal by Subject|1|||
23418896|NCT03645421|65277353|FG003|Overall Study|Withdrawal by patient|3|||
23418897|NCT03645421|65277350|FG000|Overall Study|Study specific withdrawal criteria|0|||
23418898|NCT03645421|65277351|FG001|Overall Study|Study specific withdrawal criteria|0|||
23418899|NCT03645421|65277352|FG002|Overall Study|Study specific withdrawal criteria|1|||
23418900|NCT03645421|65277353|FG003|Overall Study|Study specific withdrawal criteria|0|||
23418901|NCT01631747|65277357|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
23418902|NCT01631747|65277358|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
23418903|NCT01631747|65277357|FG000|Live Birth|Pregnancy Termination|1|||
23418904|NCT01631747|65277358|FG001|Live Birth|Pregnancy Termination|0|||
23418905|NCT01631747|65277357|FG000|Live Birth|MIscarriage|2|||
23418906|NCT01631747|65277358|FG001|Live Birth|MIscarriage|0|||
23418907|NCT01631747|65277357|FG000|Live Birth|Stillbirth|1|||
23418908|NCT01631747|65277358|FG001|Live Birth|Stillbirth|1|||
23418909|NCT01631747|65277357|FG000|One Year Infant Outcomes|Patient Refused|13|||
23418910|NCT01631747|65277358|FG001|One Year Infant Outcomes|Patient Refused|9|||
23529423|NCT02434770|65672894|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
23529424|NCT02434770|65672892|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
23529425|NCT02434770|65672893|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
23813436|NCT00777036|66699313|FG001|Follow-Up|Withdrawal by Subject|0|||
23418911|NCT03727646|65277361|FG000|Overall Study|Adverse Event|1|||
23418912|NCT03727646|65277362|FG001|Overall Study|Adverse Event|0|||
23418913|NCT02513485|65277377|FG000|Overall Study|Adverse Event|1|||
23418914|NCT02513485|65277378|FG001|Overall Study|Adverse Event|0|||
23418915|NCT02379221|65277379|FG000|Overall Study|Lost to Follow-up|1|||
23418916|NCT01296711|65277382|FG000|Overall Study|Adverse Event|3|||
23418917|NCT01296711|65277383|FG001|Overall Study|Adverse Event|1|||
23418918|NCT01296711|65277384|FG002|Overall Study|Adverse Event|4|||
23418919|NCT01296711|65277385|FG003|Overall Study|Adverse Event|3|||
23418920|NCT01296711|65277386|FG004|Overall Study|Adverse Event|1|||
23418921|NCT01296711|65277387|FG005|Overall Study|Adverse Event|6|||
23418922|NCT01296711|65277388|FG006|Overall Study|Adverse Event|11|||
23418923|NCT01296711|65277389|FG007|Overall Study|Adverse Event|3|||
23418924|NCT01296711|65277382|FG000|Overall Study|Lack of Efficacy|1|||
23418925|NCT01296711|65277383|FG001|Overall Study|Lack of Efficacy|4|||
23418926|NCT01296711|65277384|FG002|Overall Study|Lack of Efficacy|1|||
23418927|NCT01296711|65277385|FG003|Overall Study|Lack of Efficacy|1|||
23418928|NCT01296711|65277386|FG004|Overall Study|Lack of Efficacy|1|||
23418929|NCT01296711|65277387|FG005|Overall Study|Lack of Efficacy|0|||
23813437|NCT00777036|66699314|FG002|Follow-Up|Withdrawal by Subject|4|||
23418930|NCT01296711|65277388|FG006|Overall Study|Lack of Efficacy|2|||
23418931|NCT01296711|65277389|FG007|Overall Study|Lack of Efficacy|3|||
23418932|NCT01296711|65277382|FG000|Overall Study|Lost to Follow-up|0|||
23418933|NCT01296711|65277383|FG001|Overall Study|Lost to Follow-up|0|||
23418934|NCT01296711|65277384|FG002|Overall Study|Lost to Follow-up|1|||
23717816|NCT00174785|66340726|FG001|Overall Study|Other prohibited medication|3|||
23418935|NCT01296711|65277385|FG003|Overall Study|Lost to Follow-up|1|||
23418936|NCT01296711|65277386|FG004|Overall Study|Lost to Follow-up|2|||
23418937|NCT01296711|65277387|FG005|Overall Study|Lost to Follow-up|0|||
23418938|NCT01296711|65277388|FG006|Overall Study|Lost to Follow-up|4|||
23418939|NCT01296711|65277389|FG007|Overall Study|Lost to Follow-up|2|||
23813438|NCT00777036|66699312|FG000|Follow-Up|Death|1|||
23418940|NCT01296711|65277382|FG000|Overall Study|Protocol Violation|0|||
23418941|NCT01296711|65277383|FG001|Overall Study|Protocol Violation|0|||
23418942|NCT01296711|65277384|FG002|Overall Study|Protocol Violation|0|||
23418943|NCT01296711|65277385|FG003|Overall Study|Protocol Violation|1|||
23418944|NCT01296711|65277386|FG004|Overall Study|Protocol Violation|1|||
23418945|NCT01296711|65277387|FG005|Overall Study|Protocol Violation|0|||
23418946|NCT01296711|65277388|FG006|Overall Study|Protocol Violation|0|||
23418947|NCT01296711|65277389|FG007|Overall Study|Protocol Violation|0|||
23418948|NCT01296711|65277382|FG000|Overall Study|Withdrawal by Subject|4|||
23418949|NCT01296711|65277383|FG001|Overall Study|Withdrawal by Subject|2|||
23418950|NCT01296711|65277384|FG002|Overall Study|Withdrawal by Subject|2|||
23418951|NCT01296711|65277385|FG003|Overall Study|Withdrawal by Subject|1|||
23418952|NCT01296711|65277386|FG004|Overall Study|Withdrawal by Subject|1|||
23418953|NCT01296711|65277387|FG005|Overall Study|Withdrawal by Subject|1|||
23418954|NCT01296711|65277388|FG006|Overall Study|Withdrawal by Subject|2|||
23418955|NCT01296711|65277389|FG007|Overall Study|Withdrawal by Subject|1|||
23418956|NCT01296711|65277382|FG000|Overall Study|Study termination|8|||
23418957|NCT01296711|65277383|FG001|Overall Study|Study termination|1|||
23418958|NCT01296711|65277384|FG002|Overall Study|Study termination|5|||
23418959|NCT01296711|65277385|FG003|Overall Study|Study termination|4|||
23418960|NCT01296711|65277386|FG004|Overall Study|Study termination|4|||
23418961|NCT01296711|65277387|FG005|Overall Study|Study termination|4|||
23418962|NCT01296711|65277388|FG006|Overall Study|Study termination|8|||
23418963|NCT01296711|65277389|FG007|Overall Study|Study termination|10|||
23418964|NCT01296711|65277382|FG000|Overall Study|Continued elevated liver enzymes|0|||
23418965|NCT01296711|65277383|FG001|Overall Study|Continued elevated liver enzymes|0|||
23418966|NCT01296711|65277384|FG002|Overall Study|Continued elevated liver enzymes|0|||
23418967|NCT01296711|65277385|FG003|Overall Study|Continued elevated liver enzymes|1|||
23418968|NCT01296711|65277386|FG004|Overall Study|Continued elevated liver enzymes|0|||
23418969|NCT01296711|65277387|FG005|Overall Study|Continued elevated liver enzymes|0|||
23418970|NCT01296711|65277388|FG006|Overall Study|Continued elevated liver enzymes|0|||
23418971|NCT01296711|65277389|FG007|Overall Study|Continued elevated liver enzymes|0|||
23418972|NCT01296711|65277382|FG000|Overall Study|Methotrexate discontinued|0|||
23418973|NCT01296711|65277383|FG001|Overall Study|Methotrexate discontinued|0|||
23418974|NCT01296711|65277384|FG002|Overall Study|Methotrexate discontinued|0|||
23418975|NCT01296711|65277385|FG003|Overall Study|Methotrexate discontinued|1|||
23418976|NCT01296711|65277386|FG004|Overall Study|Methotrexate discontinued|0|||
23418977|NCT01296711|65277387|FG005|Overall Study|Methotrexate discontinued|0|||
23418978|NCT01296711|65277388|FG006|Overall Study|Methotrexate discontinued|0|||
23418979|NCT01296711|65277389|FG007|Overall Study|Methotrexate discontinued|0|||
23418980|NCT01296711|65277382|FG000|Overall Study|Investigator discretion|0|||
23418981|NCT01296711|65277383|FG001|Overall Study|Investigator discretion|0|||
23418982|NCT01296711|65277384|FG002|Overall Study|Investigator discretion|0|||
23418983|NCT01296711|65277385|FG003|Overall Study|Investigator discretion|0|||
23418984|NCT01296711|65277386|FG004|Overall Study|Investigator discretion|0|||
23418985|NCT01296711|65277387|FG005|Overall Study|Investigator discretion|0|||
23418986|NCT01296711|65277388|FG006|Overall Study|Investigator discretion|1|||
23418987|NCT01296711|65277389|FG007|Overall Study|Investigator discretion|0|||
23418988|NCT01296711|65277382|FG000|Overall Study|Other|0|||
23418989|NCT01296711|65277383|FG001|Overall Study|Other|0|||
23418990|NCT01296711|65277384|FG002|Overall Study|Other|0|||
23418991|NCT01296711|65277385|FG003|Overall Study|Other|0|||
23418992|NCT01296711|65277386|FG004|Overall Study|Other|0|||
23418993|NCT01296711|65277387|FG005|Overall Study|Other|0|||
23418994|NCT01296711|65277388|FG006|Overall Study|Other|1|||
23418995|NCT01296711|65277389|FG007|Overall Study|Other|0|||
23418996|NCT01296711|65277382|FG000|Overall Study|Required restricted steroid injections|0|||
23418997|NCT01296711|65277383|FG001|Overall Study|Required restricted steroid injections|0|||
23418998|NCT01296711|65277384|FG002|Overall Study|Required restricted steroid injections|0|||
23418999|NCT01296711|65277385|FG003|Overall Study|Required restricted steroid injections|0|||
23419000|NCT01296711|65277386|FG004|Overall Study|Required restricted steroid injections|0|||
23419001|NCT01296711|65277387|FG005|Overall Study|Required restricted steroid injections|0|||
23419002|NCT01296711|65277388|FG006|Overall Study|Required restricted steroid injections|1|||
23529426|NCT02434770|65672894|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
23529427|NCT02434770|65672892|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
23419003|NCT01296711|65277389|FG007|Overall Study|Required restricted steroid injections|0|||
23419004|NCT01296711|65277382|FG000|Overall Study|Ongoing missed appointments|0|||
23419005|NCT01296711|65277383|FG001|Overall Study|Ongoing missed appointments|0|||
23419006|NCT01296711|65277384|FG002|Overall Study|Ongoing missed appointments|0|||
23419007|NCT01296711|65277385|FG003|Overall Study|Ongoing missed appointments|0|||
23419008|NCT01296711|65277386|FG004|Overall Study|Ongoing missed appointments|0|||
23419009|NCT01296711|65277387|FG005|Overall Study|Ongoing missed appointments|0|||
23419010|NCT01296711|65277388|FG006|Overall Study|Ongoing missed appointments|1|||
23419011|NCT01296711|65277389|FG007|Overall Study|Ongoing missed appointments|0|||
23419012|NCT01296711|65277382|FG000|Overall Study|Failure to comply with visits|0|||
23419013|NCT01296711|65277383|FG001|Overall Study|Failure to comply with visits|0|||
23419014|NCT01296711|65277384|FG002|Overall Study|Failure to comply with visits|0|||
23419015|NCT01296711|65277385|FG003|Overall Study|Failure to comply with visits|0|||
23419016|NCT01296711|65277386|FG004|Overall Study|Failure to comply with visits|0|||
23419017|NCT01296711|65277387|FG005|Overall Study|Failure to comply with visits|0|||
23419018|NCT01296711|65277388|FG006|Overall Study|Failure to comply with visits|0|||
23419019|NCT01296711|65277389|FG007|Overall Study|Failure to comply with visits|1|||
23419020|NCT01296711|65277382|FG000|Overall Study|Patient decision due to transport|0|||
23419021|NCT01296711|65277383|FG001|Overall Study|Patient decision due to transport|0|||
23717817|NCT00174785|66340725|FG000|Overall Study|Family request|6|||
23419022|NCT01296711|65277384|FG002|Overall Study|Patient decision due to transport|0|||
23419023|NCT01296711|65277385|FG003|Overall Study|Patient decision due to transport|0|||
23419024|NCT01296711|65277386|FG004|Overall Study|Patient decision due to transport|0|||
23419025|NCT01296711|65277387|FG005|Overall Study|Patient decision due to transport|0|||
23419026|NCT01296711|65277388|FG006|Overall Study|Patient decision due to transport|0|||
23419027|NCT01296711|65277389|FG007|Overall Study|Patient decision due to transport|1|||
23419028|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Death|1|||
23419029|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Death|1|||
23419030|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Death|0|||
23419031|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Death|0|||
23419032|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Death|1|||
23419033|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Death|0|||
23419034|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Death|0|||
23419035|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Death|0|||
23419036|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Death|0|||
23419037|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Death|0|||
23419038|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
23419039|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
23419040|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
23419041|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419042|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
23419043|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419044|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
23717818|NCT00174785|66340726|FG001|Overall Study|Family request|8|||
23717819|NCT00174785|66340725|FG000|Overall Study|Not pre-specified/Not coded|56|||
23717820|NCT00174785|66340726|FG001|Overall Study|Not pre-specified/Not coded|70|||
23717821|NCT00506948|66340727|FG000|Overall Study|Death|4|||
23717822|NCT00506948|66340727|FG000|Overall Study|Adverse Event|5|||
23717823|NCT00506948|66340727|FG000|Overall Study|Physician Decision|1|||
23717824|NCT02270684|66340728|FG000|Overall Study|Lost to Follow-up|0|||
23717825|NCT02270684|66340729|FG001|Overall Study|Lost to Follow-up|3|||
23717826|NCT02270684|66340728|FG000|Overall Study|Study terminated|1|||
23717827|NCT02270684|66340729|FG001|Overall Study|Study terminated|0|||
23717828|NCT00194025|66340732|FG000|Overall Study|Adverse Event|1|||
23717829|NCT00194025|66340732|FG000|Overall Study|non-adherence with study medication|4|||
23717830|NCT02586077|66344294|FG000|Overall Study|Withdrawal by Subject|1|||
23717831|NCT02586077|66344294|FG000|Overall Study|Physician Decision|4|||
23717832|NCT02586077|66344294|FG000|Overall Study|Lost to Follow-up|3|||
23717833|NCT00424294|66344295|FG000|Overall Study|Adverse Event|4|||
23717834|NCT00424294|66344296|FG001|Overall Study|Adverse Event|10|||
23717835|NCT00424294|66344295|FG000|Overall Study|Lack of Efficacy|2|||
23717836|NCT00424294|66344296|FG001|Overall Study|Lack of Efficacy|1|||
23717837|NCT00424294|66344295|FG000|Overall Study|Withdrawal by Subject|1|||
23717838|NCT00424294|66344296|FG001|Overall Study|Withdrawal by Subject|2|||
23717839|NCT00424294|66344295|FG000|Overall Study|Other|0|||
23717840|NCT00424294|66344296|FG001|Overall Study|Other|2|||
23717841|NCT00424294|66344295|FG000|Overall Study|Randomized but not Treated|1|||
23717842|NCT00424294|66344296|FG001|Overall Study|Randomized but not Treated|0|||
23717843|NCT02917629|66344303|FG000|Overall Study|Withdrawal by Subject|0|||
23717844|NCT02917629|66344304|FG001|Overall Study|Withdrawal by Subject|1|||
23717845|NCT00753688|66344305|FG000|Overall Study|Death|102|||
23717846|NCT00753688|66344306|FG001|Overall Study|Death|203|||
23717847|NCT00753688|66344305|FG000|Overall Study|Missing|4|||
23419045|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419046|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
23717848|NCT00753688|66344306|FG001|Overall Study|Missing|9|||
23717849|NCT00753688|66344305|FG000|Overall Study|Participant Withdrew Consent|2|||
23419047|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419048|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419049|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23717850|NCT00753688|66344306|FG001|Overall Study|Participant Withdrew Consent|2|||
23717851|NCT00753688|66344305|FG000|Overall Study|Ongoing - in Follow-up|15|||
23717852|NCT00753688|66344306|FG001|Overall Study|Ongoing - in Follow-up|31|||
23717853|NCT00753688|66344305|FG000|Overall Study|Adverse Event|0|||
23717854|NCT00753688|66344306|FG001|Overall Study|Adverse Event|1|||
23717855|NCT03205982|66344308|FG000|Overall Study|Lost to Follow-up|20|||
23717856|NCT03205982|66344309|FG001|Overall Study|Lost to Follow-up|19|||
23717857|NCT03205982|66344308|FG000|Overall Study|Withdrawal by Subject|4|||
23717858|NCT03205982|66344309|FG001|Overall Study|Withdrawal by Subject|3|||
23717859|NCT03205982|66344308|FG000|Overall Study|Withdrawal by PI|0|||
23717860|NCT03205982|66344309|FG001|Overall Study|Withdrawal by PI|1|||
23717861|NCT01975246|66344310|FG000|Overall Study|Adverse Event|2|||
23717862|NCT01975246|66344311|FG001|Overall Study|Adverse Event|1|||
23717863|NCT01975246|66344310|FG000|Overall Study|Lack of Efficacy|1|||
23717864|NCT01975246|66344311|FG001|Overall Study|Lack of Efficacy|0|||
23717865|NCT01975246|66344310|FG000|Overall Study|Protocol Violation|1|||
23717866|NCT01975246|66344311|FG001|Overall Study|Protocol Violation|0|||
23717867|NCT01975246|66344310|FG000|Overall Study|Other than stated|0|||
23717868|NCT01975246|66344311|FG001|Overall Study|Other than stated|1|||
23717869|NCT00089479|66344312|FG000|Overall Study|Death|108|||
23717870|NCT00089479|66344313|FG001|Overall Study|Death|75|||
23717871|NCT00089479|66344312|FG000|Overall Study|Withdrawal by Subject|86|||
23717872|NCT00089479|66344313|FG001|Overall Study|Withdrawal by Subject|107|||
23717873|NCT00089479|66344312|FG000|Overall Study|Lost to Follow-up|137|||
23717874|NCT00089479|66344313|FG001|Overall Study|Lost to Follow-up|107|||
23717875|NCT02378883|66344318|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
23717876|NCT02378883|66344318|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
23717877|NCT02378883|66344318|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
23717878|NCT02378883|66344318|FG000|30 Day Follow-Up|Physician Decision|2|||
23717879|NCT02378883|66344318|FG000|30 Day Follow-Up|Missed Visit|2|||
23717880|NCT02378883|66344318|FG000|30 Day Follow-Up|Death|1|||
23717881|NCT02378883|66344318|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
23717882|NCT02378883|66344318|FG000|12 Months Follow-Up|Death|2|||
23717883|NCT01296698|66344323|FG000|Overall Study|Adverse Event|1|||
23717884|NCT01296698|66344324|FG001|Overall Study|Adverse Event|0|||
23717885|NCT01296698|66344323|FG000|Overall Study|Death|1|||
23717886|NCT01296698|66344324|FG001|Overall Study|Death|0|||
23717887|NCT01296698|66344323|FG000|Overall Study|Lost to Follow-up|19|||
23717888|NCT01296698|66344324|FG001|Overall Study|Lost to Follow-up|1|||
23717889|NCT01296698|66344323|FG000|Overall Study|Withdrawal by Subject|12|||
23717890|NCT01296698|66344324|FG001|Overall Study|Withdrawal by Subject|0|||
23717891|NCT01296698|66344323|FG000|Overall Study|Difficulty Contacting Subject|2|||
23717892|NCT01296698|66344324|FG001|Overall Study|Difficulty Contacting Subject|0|||
23717893|NCT01296698|66344323|FG000|Overall Study|Study Terminated by Sponsor|209|||
23717894|NCT01296698|66344324|FG001|Overall Study|Study Terminated by Sponsor|12|||
23717895|NCT01079195|66344325|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
23717896|NCT01079195|66344325|FG000|Overall Study|No Documentation Available|437|||
23717897|NCT01079195|66344325|FG000|Overall Study|Adverse Event|157|||
23717898|NCT01079195|66344325|FG000|Overall Study|Reason Unknown|39|||
23717899|NCT01079195|66344325|FG000|Overall Study|Withdrawal by Subject|18|||
23813439|NCT00777036|66699313|FG001|Follow-Up|Death|8|||
23813440|NCT00777036|66699314|FG002|Follow-Up|Death|0|||
23813441|NCT00620555|66699315|FG000|Overall Study|Adverse Event|4|||
23813442|NCT00620555|66699315|FG000|Overall Study|Protocol Violation|2|||
23813443|NCT00620555|66699315|FG000|Overall Study|Lack of Efficacy|12|||
23813444|NCT00620555|66699315|FG000|Overall Study|Withdrawal by Subject|1|||
23813445|NCT00620555|66699315|FG000|Overall Study|Choice of other treatment|1|||
23813446|NCT00620555|66699315|FG000|Overall Study|Visit failure against planned|1|||
23813447|NCT01248013|66699316|FG000|Overall Study|Withdrawal by Subject|14|||
23813448|NCT00849186|66699317|FG000|Overall Study|Adverse Event|2|||
23813449|NCT00849186|66699317|FG000|Overall Study|Withdrawal by Subject|1|||
23813450|NCT00849186|66699317|FG000|Overall Study|not treated|6|||
23813451|NCT00849186|66699317|FG000|Overall Study|Other|1|||
23529428|NCT02434770|65672893|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
23529429|NCT02434770|65672894|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
23529430|NCT02434770|65672892|FG000|Week 1 to Week 18|Death|1|||
23529431|NCT02434770|65672893|FG001|Week 1 to Week 18|Death|0|||
23529432|NCT02434770|65672894|FG002|Week 1 to Week 18|Death|0|||
23529433|NCT02434770|65672892|FG000|Week 18 to Week|Lost to Follow-up|2|||
23529434|NCT02434770|65672893|FG001|Week 18 to Week|Lost to Follow-up|2|||
23529435|NCT02434770|65672894|FG002|Week 18 to Week|Lost to Follow-up|1|||
23717900|NCT01079195|66344325|FG000|Overall Study|Financial Reasons|15|||
23717901|NCT01079195|66344325|FG000|Overall Study|Lack of Effectiveness|12|||
23717902|NCT01079195|66344325|FG000|Overall Study|Physician Decision|4|||
23717903|NCT01079195|66344325|FG000|Overall Study|Improved Status of Participant|4|||
23813452|NCT04392583|66699318|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
23813453|NCT02397408|66699322|FG000|Overall Study|Physician Decision|4|||
23717904|NCT01079195|66344325|FG000|Overall Study|No Follow-up Documentation Available|4|||
23529436|NCT02434770|65672892|FG000|Week 18 to Week|Withdrawal by Subject|0|||
23717905|NCT01079195|66344325|FG000|Overall Study|Non-compliance|2|||
23717906|NCT01280266|66344328|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
23717907|NCT01280266|66344329|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
23717908|NCT01280266|66344328|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
23529437|NCT02434770|65672893|FG001|Week 18 to Week|Withdrawal by Subject|0|||
23529438|NCT02434770|65672894|FG002|Week 18 to Week|Withdrawal by Subject|2|||
23717909|NCT01280266|66344329|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
23717910|NCT00377429|66344331|FG000|Overall Study|Withdrawal by Subject|5|||
23717911|NCT00377429|66344331|FG000|Overall Study|Adverse Event|8|||
23717912|NCT00377429|66344331|FG000|Overall Study|Physician Decision|1|||
23717913|NCT00377429|66344331|FG000|Overall Study|Patient non-compliance|1|||
23717914|NCT04929613|66344334|FG000|Overall Study|Withdrawal by Subject|12|||
23717915|NCT01354431|66344335|FG000|Pre-Treatment Period|Not reported|1|||
23717916|NCT01354431|66344336|FG001|Pre-Treatment Period|Not reported|0|||
23717917|NCT01354431|66344337|FG002|Pre-Treatment Period|Not reported|0|||
23340853|NCT01936181|64992870|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
23717918|NCT01354431|66344335|FG000|Treatment Period|Disease Progression|50|||
23717919|NCT01354431|66344336|FG001|Treatment Period|Disease Progression|40|||
23717920|NCT01354431|66344337|FG002|Treatment Period|Disease Progression|44|||
23717921|NCT01354431|66344335|FG000|Treatment Period|Study Drug Toxicity|5|||
23717922|NCT01354431|66344336|FG001|Treatment Period|Study Drug Toxicity|8|||
23717923|NCT01354431|66344337|FG002|Treatment Period|Study Drug Toxicity|4|||
23717924|NCT01354431|66344335|FG000|Treatment Period|Death|0|||
23717925|NCT01354431|66344336|FG001|Treatment Period|Death|1|||
23717926|NCT01354431|66344337|FG002|Treatment Period|Death|0|||
23717927|NCT01354431|66344335|FG000|Treatment Period|AE unrelated to study drug|1|||
23717928|NCT01354431|66344336|FG001|Treatment Period|AE unrelated to study drug|2|||
23717929|NCT01354431|66344337|FG002|Treatment Period|AE unrelated to study drug|5|||
23717930|NCT01354431|66344335|FG000|Treatment Period|Participant request to discontinue|2|||
23717931|NCT01354431|66344336|FG001|Treatment Period|Participant request to discontinue|2|||
23717932|NCT01354431|66344337|FG002|Treatment Period|Participant request to discontinue|1|||
23717933|NCT01354431|66344335|FG000|Treatment Period|Participant withdrew consent|0|||
23717934|NCT01354431|66344336|FG001|Treatment Period|Participant withdrew consent|1|||
23717935|NCT01354431|66344337|FG002|Treatment Period|Participant withdrew consent|0|||
23717936|NCT01354431|66344335|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
23717937|NCT01354431|66344336|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
23717938|NCT01354431|66344337|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
23717939|NCT01293006|66344338|FG000|Period 2|Lost to Follow-up|1|||
23717940|NCT01293006|66344339|FG001|Period 2|Lost to Follow-up|0|||
23717941|NCT01293006|66344340|FG002|Period 2|Lost to Follow-up|0|||
23717942|NCT01293006|66344341|FG003|Period 2|Lost to Follow-up|0|||
23717943|NCT01595438|66344342|FG000|Overall Study|Lost to Follow-up|20|||
23717944|NCT01595438|66344343|FG001|Overall Study|Lost to Follow-up|20|||
23717945|NCT01595438|66344342|FG000|Overall Study|Withdrawal by Subject|12|||
23717946|NCT01595438|66344343|FG001|Overall Study|Withdrawal by Subject|12|||
23717947|NCT01595438|66344342|FG000|Overall Study|Other Eligibility criteria|11|||
23717948|NCT01595438|66344343|FG001|Overall Study|Other Eligibility criteria|9|||
23717949|NCT01337167|66344344|FG000|Infant Series|Adverse Event|1|||
23717950|NCT01337167|66344345|FG001|Infant Series|Adverse Event|1|||
23717951|NCT01337167|66344344|FG000|Infant Series|Death|1|||
23717952|NCT01337167|66344345|FG001|Infant Series|Death|1|||
23717953|NCT01337167|66344344|FG000|Infant Series|Lost to Follow-up|13|||
23717954|NCT01337167|66344345|FG001|Infant Series|Lost to Follow-up|7|||
23717955|NCT01337167|66344344|FG000|Infant Series|Non-compliance with study drug|2|||
23717956|NCT01337167|66344345|FG001|Infant Series|Non-compliance with study drug|1|||
23717957|NCT01337167|66344344|FG000|Infant Series|Physician Decision|3|||
23717958|NCT01337167|66344345|FG001|Infant Series|Physician Decision|1|||
23717959|NCT01337167|66344344|FG000|Infant Series|Protocol Violation|22|||
23717960|NCT01337167|66344345|FG001|Infant Series|Protocol Violation|9|||
23717961|NCT01337167|66344344|FG000|Infant Series|Withdrawal by Subject|15|||
23717962|NCT01337167|66344345|FG001|Infant Series|Withdrawal by Subject|4|||
23717963|NCT01337167|66344344|FG000|Infant Series|Randomized but not vaccinated|5|||
23419050|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419051|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419052|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
23419053|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419054|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23717964|NCT01337167|66344345|FG001|Infant Series|Randomized but not vaccinated|3|||
23717965|NCT01337167|66344344|FG000|Interim Period|Lost to Follow-up|51|||
23717966|NCT01337167|66344345|FG001|Interim Period|Lost to Follow-up|23|||
23717967|NCT01337167|66344344|FG000|Interim Period|Non-compliance with study drug|1|||
23717968|NCT01337167|66344345|FG001|Interim Period|Non-compliance with study drug|0|||
23717969|NCT01337167|66344344|FG000|Interim Period|Physician Decision|6|||
23419055|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419056|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419057|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23529439|NCT02434770|65672892|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
23717970|NCT01337167|66344345|FG001|Interim Period|Physician Decision|3|||
23717971|NCT01337167|66344344|FG000|Interim Period|Protocol Violation|5|||
23717972|NCT01337167|66344345|FG001|Interim Period|Protocol Violation|3|||
23717973|NCT01337167|66344344|FG000|Interim Period|Withdrawal by Subject|18|||
23717974|NCT01337167|66344345|FG001|Interim Period|Withdrawal by Subject|10|||
23717975|NCT01337167|66344344|FG000|Interim Period|Other protocol criterion not met|0|||
23717976|NCT01337167|66344345|FG001|Interim Period|Other protocol criterion not met|1|||
23717977|NCT01337167|66344344|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
23717978|NCT01337167|66344345|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
23717979|NCT01337167|66344344|FG000|Toddler Vaccinations|Protocol Violation|0|||
23717980|NCT01337167|66344345|FG001|Toddler Vaccinations|Protocol Violation|1|||
23717981|NCT01337167|66344344|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
23717982|NCT01337167|66344345|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
23717983|NCT03199638|66344346|FG000|Overall Study|inability to drink glutamine during regularly|0|||
23717984|NCT03199638|66344347|FG001|Overall Study|inability to drink glutamine during regularly|2|||
23717985|NCT00936117|66344348|FG000|Overall Study|Adverse Event|7|||
23717986|NCT00936117|66344348|FG000|Overall Study|Unable to continue oral medication|3|||
23717987|NCT00603733|66344351|FG000|Active Phase ITT|Adverse Event|8|||
23717988|NCT00603733|66344352|FG001|Active Phase ITT|Adverse Event|7|||
23717989|NCT00603733|66344351|FG000|Active Phase ITT|Withdrawal by Subject|0|||
23717990|NCT00603733|66344352|FG001|Active Phase ITT|Withdrawal by Subject|3|||
23717991|NCT00603733|66344351|FG000|Active Phase ITT|Lost to Follow-up|0|||
23717992|NCT00603733|66344352|FG001|Active Phase ITT|Lost to Follow-up|1|||
23717993|NCT00603733|66344351|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
23717994|NCT00603733|66344352|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
23529440|NCT02434770|65672893|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
23529441|NCT02434770|65672894|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
23529442|NCT00670800|65672895|FG000|Overall Study|2 controls were insulin resistant|0|||
23529443|NCT00670800|65672896|FG001|Overall Study|2 controls were insulin resistant|2|||
23529444|NCT01802775|65672901|FG000|Overall Study|Death|0|||
23529445|NCT01802775|65672902|FG001|Overall Study|Death|3|||
23529446|NCT01802775|65672901|FG000|Overall Study|Reason not provided|0|||
23529447|NCT01802775|65672902|FG001|Overall Study|Reason not provided|1|||
23529448|NCT01802775|65672901|FG000|Overall Study|Physician Decision|1|||
23529449|NCT01802775|65672902|FG001|Overall Study|Physician Decision|0|||
23529450|NCT01802775|65672901|FG000|Overall Study|Adverse Event|1|||
23529451|NCT01802775|65672902|FG001|Overall Study|Adverse Event|1|||
23529452|NCT01802775|65672901|FG000|Overall Study|Withdrawal by Subject|3|||
23529453|NCT01802775|65672902|FG001|Overall Study|Withdrawal by Subject|5|||
23529454|NCT01802775|65672901|FG000|Overall Study|Lost to Follow-up|1|||
23529455|NCT01802775|65672902|FG001|Overall Study|Lost to Follow-up|2|||
23717995|NCT00603733|66344351|FG000|Active Phase ITT|Lack of Efficacy|1|||
23717996|NCT00603733|66344352|FG001|Active Phase ITT|Lack of Efficacy|2|||
23717997|NCT00603733|66344351|FG000|Active Phase ITT|Subject moved, site closed|1|||
23717998|NCT00603733|66344352|FG001|Active Phase ITT|Subject moved, site closed|1|||
23717999|NCT00603733|66344351|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
23718000|NCT00603733|66344352|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
23718001|NCT00603733|66344351|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
23718002|NCT00603733|66344352|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
23718003|NCT00603733|66344351|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
23718004|NCT00603733|66344352|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
23718005|NCT00603733|66344351|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
23718006|NCT00603733|66344352|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
23718007|NCT00603733|66344351|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
23718008|NCT00603733|66344352|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
23718009|NCT00603733|66344351|FG000|Maintenance Phase ITT|Adverse Event|3|||
23718010|NCT00603733|66344352|FG001|Maintenance Phase ITT|Adverse Event|6|||
23718011|NCT00603733|66344351|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
23718012|NCT00603733|66344352|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
23419058|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
23419059|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419060|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419061|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419062|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419063|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419064|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23718013|NCT00603733|66344351|FG000|Maintenance Phase ITT|Protocol Violation|1|||
23718014|NCT00603733|66344352|FG001|Maintenance Phase ITT|Protocol Violation|1|||
23718015|NCT00603733|66344351|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
23718016|NCT00603733|66344352|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
23718017|NCT00603733|66344351|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
23718018|NCT00603733|66344352|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
23529456|NCT01762943|65672903|FG000|Overall Study|Physician Decision|1|||
23529457|NCT01762943|65672904|FG001|Overall Study|Physician Decision|1|||
23529458|NCT01762943|65672903|FG000|Overall Study|Protocol Violation|1|||
23718019|NCT00603733|66344351|FG000|Maintenance Phase ITT|Physician Decision|0|||
23718020|NCT00603733|66344352|FG001|Maintenance Phase ITT|Physician Decision|1|||
23529459|NCT01762943|65672904|FG001|Overall Study|Protocol Violation|0|||
23419065|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23529460|NCT01762943|65672903|FG000|Overall Study|Withdrawal by Subject|2|||
23529461|NCT01762943|65672904|FG001|Overall Study|Withdrawal by Subject|1|||
23529462|NCT01434823|65672907|FG000|Overall Study|Incomplete data in medical record|4|||
23529463|NCT01434823|65672908|FG001|Overall Study|Incomplete data in medical record|7|||
23529464|NCT01916304|65672909|FG000|Overall Study|Screening failure|17|||
23529465|NCT01420081|65672910|FG000|Overall Study|Death|1|||
23529466|NCT01420081|65672911|FG001|Overall Study|Death|0|||
23529467|NCT01420081|65672912|FG002|Overall Study|Death|8|||
23529468|NCT01420081|65672913|FG003|Overall Study|Death|0|||
23529469|NCT01420081|65672914|FG004|Overall Study|Death|7|||
23529470|NCT01420081|65672915|FG005|Overall Study|Death|12|||
23529471|NCT01420081|65672916|FG006|Overall Study|Death|0|||
23529472|NCT01420081|65672917|FG007|Overall Study|Death|1|||
23529473|NCT01420081|65672918|FG008|Overall Study|Death|1|||
23529474|NCT01420081|65672910|FG000|Overall Study|Lost to Follow-up|0|||
23529475|NCT01420081|65672911|FG001|Overall Study|Lost to Follow-up|0|||
23529476|NCT01420081|65672912|FG002|Overall Study|Lost to Follow-up|0|||
23529477|NCT01420081|65672913|FG003|Overall Study|Lost to Follow-up|0|||
23529478|NCT01420081|65672914|FG004|Overall Study|Lost to Follow-up|1|||
23718021|NCT00603733|66344351|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
23718022|NCT00603733|66344352|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
23718023|NCT00990249|66344353|FG000|Overall Study|Disease Progression|8|||
23718024|NCT00990249|66344353|FG000|Overall Study|Non-Compliance|1|||
23718025|NCT00990249|66344353|FG000|Overall Study|Death|2|||
23718026|NCT00990249|66344353|FG000|Overall Study|Not treated|2|||
23718027|NCT04247815|66344354|FG000|Overall Study|Adverse Event|1|||
23718028|NCT04247815|66344355|FG001|Overall Study|Adverse Event|0|||
23718029|NCT04247815|66344354|FG000|Overall Study|Withdrawal by Subject|1|||
23718030|NCT04247815|66344355|FG001|Overall Study|Withdrawal by Subject|0|||
23718031|NCT04247815|66344354|FG000|Overall Study|Protocol Violation|0|||
23419066|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419067|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419068|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
23419069|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419070|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419071|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
23419072|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
23419073|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419074|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419075|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419076|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419077|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419078|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
23419079|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419080|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419081|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
23419082|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419083|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419084|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419085|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419086|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419087|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419088|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
23419089|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419090|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419091|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419092|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
23419093|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419094|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419095|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419096|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419097|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419098|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
23419099|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23718032|NCT04247815|66344355|FG001|Overall Study|Protocol Violation|1|||
23529479|NCT01420081|65672915|FG005|Overall Study|Lost to Follow-up|1|||
23529480|NCT01420081|65672916|FG006|Overall Study|Lost to Follow-up|0|||
23529481|NCT01420081|65672917|FG007|Overall Study|Lost to Follow-up|0|||
23529482|NCT01420081|65672918|FG008|Overall Study|Lost to Follow-up|0|||
23529483|NCT01420081|65672910|FG000|Overall Study|Study Terminated by Sponsor|2|||
23718033|NCT00187889|66344356|FG000|Overall Study|Withdrawal by Subject|6|||
23718034|NCT00187889|66344357|FG001|Overall Study|Withdrawal by Subject|4|||
23718035|NCT01548417|66344358|FG000|Overall Study|Withdrawal by Subject|0|||
23718036|NCT01548417|66344359|FG001|Overall Study|Withdrawal by Subject|2|||
23718037|NCT01170702|66344360|FG000|Overall Study|Exclusion criteria met after consent|1|||
23718038|NCT01170702|66344361|FG001|Overall Study|Exclusion criteria met after consent|2|||
23718039|NCT01170702|66344362|FG002|Overall Study|Exclusion criteria met after consent|0|||
23718040|NCT01170702|66344363|FG003|Overall Study|Exclusion criteria met after consent|2|||
23718041|NCT00196196|66344365|FG000|Overall Study|Withdrawal by Subject|2|||
23718042|NCT00196196|66344365|FG000|Overall Study|Did not have required condition (hydroce|5|||
23718043|NCT03485222|66344366|FG000|Overall Study|Death|0|||
23718044|NCT03485222|66344367|FG001|Overall Study|Death|1|||
23718045|NCT03485222|66344366|FG000|Overall Study|Lost to Follow-up|2|||
23718046|NCT03485222|66344367|FG001|Overall Study|Lost to Follow-up|1|||
23718047|NCT05200455|66344368|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
23718048|NCT00290589|66344369|FG000|Overall Study|Lost to Follow-up|2|||
23718049|NCT00290589|66344370|FG001|Overall Study|Lost to Follow-up|2|||
23718050|NCT00351819|66344371|FG000|Overall Study|Lost to Follow-up|4|||
23718051|NCT00351819|66344372|FG001|Overall Study|Lost to Follow-up|4|||
23718052|NCT00351819|66344371|FG000|Overall Study|Withdrawal by Subject|0|||
23718053|NCT00351819|66344372|FG001|Overall Study|Withdrawal by Subject|4|||
23718054|NCT00351819|66344371|FG000|Overall Study|Elevated PSA|1|||
23718055|NCT00351819|66344372|FG001|Overall Study|Elevated PSA|1|||
23718056|NCT00351819|66344371|FG000|Overall Study|Traumatic ankle fracture|1|||
23718057|NCT00351819|66344372|FG001|Overall Study|Traumatic ankle fracture|0|||
23718058|NCT00351819|66344371|FG000|Overall Study|Unprofessional behavior|1|||
23718059|NCT00351819|66344372|FG001|Overall Study|Unprofessional behavior|0|||
23718060|NCT00351819|66344371|FG000|Overall Study|Non-compliance|0|||
23718061|NCT00351819|66344372|FG001|Overall Study|Non-compliance|1|||
23718062|NCT00351819|66344371|FG000|Overall Study|Incarcerated|0|||
23718063|NCT00351819|66344372|FG001|Overall Study|Incarcerated|1|||
23718064|NCT00351819|66344371|FG000|Overall Study|Enrolled in another trial|0|||
23718065|NCT00351819|66344372|FG001|Overall Study|Enrolled in another trial|1|||
23718066|NCT00441103|66344374|FG000|Overall Study|Adverse Event|2|||
23718067|NCT00441103|66344375|FG001|Overall Study|Adverse Event|1|||
23718068|NCT00441103|66344374|FG000|Overall Study|Death|1|||
23718069|NCT00441103|66344375|FG001|Overall Study|Death|0|||
23718070|NCT00441103|66344374|FG000|Overall Study|Disease Progression|2|||
23718071|NCT00441103|66344375|FG001|Overall Study|Disease Progression|0|||
23718072|NCT00441103|66344374|FG000|Overall Study|Lost to Follow-up|1|||
23718073|NCT00441103|66344375|FG001|Overall Study|Lost to Follow-up|0|||
23718074|NCT00441103|66344374|FG000|Overall Study|Protocol Violation|1|||
23718075|NCT00441103|66344375|FG001|Overall Study|Protocol Violation|0|||
23718076|NCT00441103|66344374|FG000|Overall Study|Participant unable to use Rebiject II|1|||
23718077|NCT00441103|66344375|FG001|Overall Study|Participant unable to use Rebiject II|0|||
23718078|NCT00441103|66344374|FG000|Overall Study|Participant refused MRI|1|||
23718079|NCT00441103|66344375|FG001|Overall Study|Participant refused MRI|0|||
23718080|NCT00441103|66344374|FG000|Overall Study|Inclusion criteria absent|1|||
23718081|NCT00441103|66344375|FG001|Overall Study|Inclusion criteria absent|0|||
23718082|NCT00441103|66344374|FG000|Overall Study|Non-compliant|0|||
23718083|NCT00441103|66344375|FG001|Overall Study|Non-compliant|1|||
23718084|NCT00441103|66344374|FG000|Overall Study|Participant decided to withdraw|1|||
23718085|NCT00441103|66344375|FG001|Overall Study|Participant decided to withdraw|0|||
23718086|NCT00441103|66344374|FG000|Overall Study|Participant's reason|0|||
23718087|NCT00441103|66344375|FG001|Overall Study|Participant's reason|1|||
23718088|NCT00441103|66344374|FG000|Overall Study|Participant decided to stop|0|||
23718089|NCT00441103|66344375|FG001|Overall Study|Participant decided to stop|1|||
23718090|NCT02293993|66344376|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
23718091|NCT02293993|66344377|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
23718092|NCT02293993|66344378|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
23718093|NCT02293993|66344379|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
23718094|NCT02293993|66344376|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
23718095|NCT02293993|66344377|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
23718096|NCT02293993|66344378|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
23718097|NCT02293993|66344379|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
23419100|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23529484|NCT01420081|65672911|FG001|Overall Study|Study Terminated by Sponsor|1|||
23718098|NCT02293993|66344376|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23718099|NCT02293993|66344377|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23718100|NCT02293993|66344378|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
23718101|NCT02293993|66344379|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23718102|NCT02293993|66344376|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
23718103|NCT02293993|66344377|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
23718104|NCT02293993|66344378|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
23718105|NCT02293993|66344379|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
23718106|NCT02293993|66344376|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23718107|NCT02293993|66344377|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
23718108|NCT02293993|66344378|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23718109|NCT02293993|66344379|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23718110|NCT00992186|66344389|FG000|Overall Study|Withdrawal by Subject|2|||
23718111|NCT00992186|66344389|FG000|Overall Study|Protocol Violation|1|||
23718112|NCT00992186|66344389|FG000|Overall Study|Physician Decision|1|||
23718113|NCT00992186|66344389|FG000|Overall Study|Adverse Event|9|||
23718114|NCT00992186|66344389|FG000|Overall Study|Progressive Disease|30|||
23718115|NCT00992186|66344389|FG000|Overall Study|Refusal To Receive Study Agent|3|||
23718116|NCT01677624|66344390|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
23718117|NCT02156804|66344392|FG000|Overall Study|Withdrawal by Subject|1|||
23718118|NCT01231607|66344393|FG000|Overall Study|Adverse Event|0|||
23718119|NCT01231607|66344394|FG001|Overall Study|Adverse Event|8|||
23718120|NCT01231607|66344395|FG002|Overall Study|Adverse Event|4|||
23718121|NCT01231607|66344396|FG003|Overall Study|Adverse Event|4|||
23718122|NCT01231607|66344397|FG004|Overall Study|Adverse Event|5|||
23718123|NCT01231607|66344393|FG000|Overall Study|Lost to Follow-up|13|||
23718124|NCT01231607|66344394|FG001|Overall Study|Lost to Follow-up|11|||
23718125|NCT01231607|66344395|FG002|Overall Study|Lost to Follow-up|10|||
23718126|NCT01231607|66344396|FG003|Overall Study|Lost to Follow-up|10|||
23718127|NCT01231607|66344397|FG004|Overall Study|Lost to Follow-up|4|||
23718128|NCT01231607|66344393|FG000|Overall Study|Physician Decision|4|||
23718129|NCT01231607|66344394|FG001|Overall Study|Physician Decision|4|||
23718130|NCT01231607|66344395|FG002|Overall Study|Physician Decision|3|||
23718131|NCT01231607|66344396|FG003|Overall Study|Physician Decision|5|||
23718132|NCT01231607|66344397|FG004|Overall Study|Physician Decision|4|||
23718133|NCT01231607|66344393|FG000|Overall Study|Protocol Violation|3|||
23718134|NCT01231607|66344394|FG001|Overall Study|Protocol Violation|2|||
23718135|NCT01231607|66344395|FG002|Overall Study|Protocol Violation|0|||
23718136|NCT01231607|66344396|FG003|Overall Study|Protocol Violation|2|||
23718137|NCT01231607|66344397|FG004|Overall Study|Protocol Violation|2|||
23718138|NCT01231607|66344393|FG000|Overall Study|Withdrawal by Subject|9|||
23718139|NCT01231607|66344394|FG001|Overall Study|Withdrawal by Subject|9|||
23718140|NCT01231607|66344395|FG002|Overall Study|Withdrawal by Subject|14|||
23718141|NCT01231607|66344396|FG003|Overall Study|Withdrawal by Subject|17|||
23718142|NCT01231607|66344397|FG004|Overall Study|Withdrawal by Subject|9|||
23718143|NCT01207388|66344400|FG000|Overall Study|Death|67|||
23718144|NCT01207388|66344400|FG000|Overall Study|Withdrawal by Subject|1|||
23718145|NCT02759861|66344401|FG000|Overall Study|Death|1|||
23718146|NCT00618995|66344402|FG000|Period 1|Adverse Event|0|||
23718147|NCT00618995|66344403|FG001|Period 1|Adverse Event|0|||
23718148|NCT00618995|66344404|FG002|Period 1|Adverse Event|1|||
23718149|NCT00618995|66344405|FG003|Period 1|Adverse Event|0|||
23718150|NCT00618995|66344402|FG000|Period 1|Protocol Violation|0|||
23718151|NCT00618995|66344403|FG001|Period 1|Protocol Violation|1|||
23718152|NCT00618995|66344404|FG002|Period 1|Protocol Violation|1|||
23718153|NCT00618995|66344405|FG003|Period 1|Protocol Violation|0|||
23718154|NCT00618995|66344402|FG000|Period 2|Protocol Violation|0|||
23718155|NCT00618995|66344403|FG001|Period 2|Protocol Violation|0|||
23718156|NCT00618995|66344404|FG002|Period 2|Protocol Violation|1|||
23718157|NCT00618995|66344405|FG003|Period 2|Protocol Violation|0|||
23718158|NCT00618995|66344402|FG000|Period 4|Adverse Event|1|||
23718159|NCT00618995|66344403|FG001|Period 4|Adverse Event|0|||
23718160|NCT00618995|66344404|FG002|Period 4|Adverse Event|0|||
23718161|NCT00618995|66344405|FG003|Period 4|Adverse Event|0|||
23718162|NCT00118911|66344406|FG000|Overall Study|Withdrawal by Subject|2|||
23718163|NCT00118911|66344407|FG001|Overall Study|Withdrawal by Subject|5|||
23718164|NCT02513771|66344408|FG000|Overall Study|Lost to Follow-up|1|||
23813454|NCT02397408|66699322|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
23813455|NCT04159935|66699325|FG000|Overall Study|Study terminated due to COVID-19|1|||
23718165|NCT02513771|66344409|FG001|Overall Study|Lost to Follow-up|1|||
23718166|NCT02513771|66344408|FG000|Overall Study|Not being able to get to clinic|1|||
23718167|NCT02513771|66344409|FG001|Overall Study|Not being able to get to clinic|0|||
23718168|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
23718169|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
23718170|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
23718171|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
23718172|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
23718173|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
23718174|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
23718175|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
23718176|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
23718177|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
23718178|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
23718179|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
23718180|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23718181|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
23718182|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23718183|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23718184|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
23718185|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
23718186|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
23718187|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
23718188|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
23718189|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
23718190|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
23718191|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
23718192|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
23718193|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
23718194|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
23718195|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
23718196|NCT00476996|66344410|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
23718197|NCT00476996|66344411|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
23718198|NCT00476996|66344412|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
23718199|NCT00476996|66344413|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
23718200|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23718201|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23718202|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23718203|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
23718204|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
23718205|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
23718206|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
23718207|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
23718208|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Death|0|||
23718209|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Death|0|||
23718210|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Death|0|||
23718211|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Death|7|||
23718212|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23718213|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23718214|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23718215|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
23718216|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23718217|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23718218|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23718219|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
23718220|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23718221|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23718222|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23529485|NCT01420081|65672912|FG002|Overall Study|Study Terminated by Sponsor|1|||
23529486|NCT01420081|65672913|FG003|Overall Study|Study Terminated by Sponsor|3|||
23529487|NCT01420081|65672914|FG004|Overall Study|Study Terminated by Sponsor|11|||
23529488|NCT01420081|65672915|FG005|Overall Study|Study Terminated by Sponsor|7|||
23529489|NCT01420081|65672916|FG006|Overall Study|Study Terminated by Sponsor|3|||
23529490|NCT01420081|65672917|FG007|Overall Study|Study Terminated by Sponsor|2|||
23529491|NCT01420081|65672918|FG008|Overall Study|Study Terminated by Sponsor|2|||
23529492|NCT01420081|65672910|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
23529493|NCT01420081|65672911|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
23529494|NCT01420081|65672912|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
23529495|NCT01420081|65672913|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
23718223|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
23813456|NCT04159935|66699326|FG001|Overall Study|Study terminated due to COVID-19|3|||
23453583|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
23529496|NCT01420081|65672914|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
23529497|NCT01420081|65672915|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
23718224|NCT00476996|66344410|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
23813457|NCT01199471|66699327|FG000|Overall Study|Protocol Violation|4|||
23529498|NCT01420081|65672916|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
23529499|NCT01420081|65672917|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
23529500|NCT01420081|65672918|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
23529501|NCT01420081|65672910|FG000|Overall Study|Other Reasons|0|||
23529502|NCT01420081|65672911|FG001|Overall Study|Other Reasons|0|||
23529503|NCT01420081|65672912|FG002|Overall Study|Other Reasons|1|||
23529504|NCT01420081|65672913|FG003|Overall Study|Other Reasons|0|||
23529505|NCT01420081|65672914|FG004|Overall Study|Other Reasons|0|||
23529506|NCT01420081|65672915|FG005|Overall Study|Other Reasons|0|||
23529507|NCT01420081|65672916|FG006|Overall Study|Other Reasons|0|||
23529508|NCT01420081|65672917|FG007|Overall Study|Other Reasons|0|||
23529509|NCT01420081|65672918|FG008|Overall Study|Other Reasons|0|||
23529510|NCT02586012|65672919|FG000|Overall Study|Withdrawal by Subject|1|||
23529511|NCT02586012|65672920|FG001|Overall Study|Withdrawal by Subject|1|||
23529512|NCT02586012|65672921|FG002|Overall Study|Withdrawal by Subject|0|||
23529513|NCT02586012|65672922|FG003|Overall Study|Withdrawal by Subject|1|||
23529514|NCT02586012|65672923|FG004|Overall Study|Withdrawal by Subject|0|||
23529515|NCT02586012|65672924|FG005|Overall Study|Withdrawal by Subject|2|||
23529516|NCT02586012|65672919|FG000|Overall Study|Protocol Violation|0|||
23529517|NCT02586012|65672920|FG001|Overall Study|Protocol Violation|0|||
23529518|NCT02586012|65672921|FG002|Overall Study|Protocol Violation|0|||
23529519|NCT02586012|65672922|FG003|Overall Study|Protocol Violation|0|||
23529520|NCT02586012|65672923|FG004|Overall Study|Protocol Violation|0|||
23529521|NCT02586012|65672924|FG005|Overall Study|Protocol Violation|1|||
23529522|NCT02586012|65672919|FG000|Overall Study|study terminated|0|||
23529523|NCT02586012|65672920|FG001|Overall Study|study terminated|2|||
23529524|NCT02586012|65672921|FG002|Overall Study|study terminated|1|||
23529525|NCT02586012|65672922|FG003|Overall Study|study terminated|1|||
23529526|NCT02586012|65672923|FG004|Overall Study|study terminated|1|||
23718225|NCT00476996|66344411|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
23718226|NCT00476996|66344412|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
23718227|NCT00476996|66344413|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
23718228|NCT02384395|66344414|FG000|Overall Study|Physician Decision|4|||
23718229|NCT02384395|66344414|FG000|Overall Study|Withdrawal by Subject|3|||
23718230|NCT02384395|66344414|FG000|Overall Study|Lost to Follow-up|3|||
23718231|NCT03310580|66344415|FG000|Overall Study|Adverse Event|0|||
23718232|NCT03310580|66344416|FG001|Overall Study|Adverse Event|1|||
23718233|NCT03310580|66344417|FG002|Overall Study|Adverse Event|0|||
23718234|NCT00617656|66344425|FG000|Overall Study|Inclusion error|4|||
23718235|NCT00617656|66344426|FG001|Overall Study|Inclusion error|4|||
23718236|NCT00617656|66344427|FG002|Overall Study|Inclusion error|0|||
23718237|NCT00617656|66344428|FG003|Overall Study|Inclusion error|0|||
23718238|NCT00617656|66344425|FG000|Overall Study|Missing data|44|||
23718239|NCT00617656|66344426|FG001|Overall Study|Missing data|30|||
23718240|NCT00617656|66344427|FG002|Overall Study|Missing data|13|||
23718241|NCT00617656|66344428|FG003|Overall Study|Missing data|6|||
23718242|NCT00617656|66344425|FG000|Overall Study|Withdrawal by Subject|0|||
23718243|NCT00617656|66344426|FG001|Overall Study|Withdrawal by Subject|2|||
23718244|NCT00617656|66344427|FG002|Overall Study|Withdrawal by Subject|0|||
23718245|NCT00617656|66344428|FG003|Overall Study|Withdrawal by Subject|0|||
23718246|NCT00085917|66344434|FG000|Overall Study|Adverse Event|4|||
23718247|NCT00085917|66344435|FG001|Overall Study|Adverse Event|3|||
23718248|NCT03084718|66344436|FG000|Overall Study|Withdrawal by Subject|4|||
23718249|NCT03084718|66344437|FG001|Overall Study|Withdrawal by Subject|3|||
23718250|NCT03084718|66344438|FG002|Overall Study|Withdrawal by Subject|4|||
23718251|NCT03084718|66344439|FG003|Overall Study|Withdrawal by Subject|0|||
23718252|NCT03084718|66344440|FG004|Overall Study|Withdrawal by Subject|0|||
23718253|NCT03084718|66344436|FG000|Overall Study|Physician Decision|1|||
23718254|NCT03084718|66344437|FG001|Overall Study|Physician Decision|0|||
23718255|NCT03084718|66344438|FG002|Overall Study|Physician Decision|0|||
23718256|NCT03084718|66344439|FG003|Overall Study|Physician Decision|0|||
23718257|NCT03084718|66344440|FG004|Overall Study|Physician Decision|0|||
23718258|NCT03084718|66344436|FG000|Overall Study|Adverse Event|3|||
23419101|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23529527|NCT02586012|65672924|FG005|Overall Study|study terminated|0|||
23718259|NCT03084718|66344437|FG001|Overall Study|Adverse Event|5|||
23718260|NCT03084718|66344438|FG002|Overall Study|Adverse Event|5|||
23718261|NCT03084718|66344439|FG003|Overall Study|Adverse Event|8|||
23718262|NCT03084718|66344440|FG004|Overall Study|Adverse Event|2|||
23718263|NCT03084718|66344436|FG000|Overall Study|Lack of Efficacy|2|||
23718264|NCT03084718|66344437|FG001|Overall Study|Lack of Efficacy|0|||
23718265|NCT03084718|66344438|FG002|Overall Study|Lack of Efficacy|1|||
23529528|NCT02365636|65672925|FG000|Overall Study|Adverse Event|3|||
23529529|NCT02365636|65672926|FG001|Overall Study|Adverse Event|3|||
23529530|NCT02365636|65672927|FG002|Overall Study|Adverse Event|2|||
23529531|NCT02365636|65672925|FG000|Overall Study|Protocol Violation|1|||
23718266|NCT03084718|66344439|FG003|Overall Study|Lack of Efficacy|4|||
23718267|NCT03084718|66344440|FG004|Overall Study|Lack of Efficacy|0|||
23718268|NCT03084718|66344436|FG000|Overall Study|Lost to Follow-up|0|||
23718269|NCT03084718|66344437|FG001|Overall Study|Lost to Follow-up|1|||
23718270|NCT03084718|66344438|FG002|Overall Study|Lost to Follow-up|0|||
23718271|NCT03084718|66344439|FG003|Overall Study|Lost to Follow-up|0|||
23718272|NCT03084718|66344440|FG004|Overall Study|Lost to Follow-up|2|||
23718273|NCT03084718|66344436|FG000|Overall Study|Protocol Violation|0|||
23718274|NCT03084718|66344437|FG001|Overall Study|Protocol Violation|0|||
23718275|NCT03084718|66344438|FG002|Overall Study|Protocol Violation|1|||
23718276|NCT03084718|66344439|FG003|Overall Study|Protocol Violation|0|||
23718277|NCT03084718|66344440|FG004|Overall Study|Protocol Violation|0|||
23718278|NCT03084718|66344436|FG000|Overall Study|Death|0|||
23718279|NCT03084718|66344437|FG001|Overall Study|Death|1|||
23718280|NCT03084718|66344438|FG002|Overall Study|Death|0|||
23718281|NCT03084718|66344439|FG003|Overall Study|Death|0|||
23718282|NCT03084718|66344440|FG004|Overall Study|Death|0|||
23718283|NCT03084718|66344436|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
23718284|NCT03084718|66344437|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
23718285|NCT03084718|66344438|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
23718286|NCT03084718|66344439|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
23718287|NCT03084718|66344440|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
23718288|NCT00842361|66344441|FG000|Overall Study|Protocol Violation|1|||
23718289|NCT00842361|66344442|FG001|Overall Study|Protocol Violation|0|||
23718290|NCT00842361|66344441|FG000|Overall Study|Unclassified|0|||
23718291|NCT00842361|66344442|FG001|Overall Study|Unclassified|2|||
23718292|NCT02029638|66344443|FG000|Overall Study|Death|0|||
23718293|NCT02029638|66344444|FG001|Overall Study|Death|0|||
23718294|NCT02029638|66344445|FG002|Overall Study|Death|1|||
23718295|NCT02029638|66344443|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
23718296|NCT02029638|66344444|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
23718297|NCT02029638|66344445|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
23718298|NCT01332019|66344446|FG000|Overall Study|Was Not Dosed|1|||
23718299|NCT01332019|66344447|FG001|Overall Study|Was Not Dosed|0|||
23718300|NCT01332019|66344446|FG000|Overall Study|Other|16|||
23718301|NCT01332019|66344447|FG001|Overall Study|Other|18|||
23718302|NCT01332019|66344446|FG000|Overall Study|Death|2|||
23718303|NCT01332019|66344447|FG001|Overall Study|Death|1|||
23718304|NCT01332019|66344446|FG000|Overall Study|Physician Decision|4|||
23718305|NCT01332019|66344447|FG001|Overall Study|Physician Decision|3|||
23718306|NCT01332019|66344446|FG000|Overall Study|Withdrawal by Subject|73|||
23718307|NCT01332019|66344447|FG001|Overall Study|Withdrawal by Subject|71|||
23718308|NCT01332019|66344446|FG000|Overall Study|Lost to Follow-up|4|||
23718309|NCT01332019|66344447|FG001|Overall Study|Lost to Follow-up|7|||
23718310|NCT01332019|66344446|FG000|Overall Study|Adverse Event|13|||
23718311|NCT01332019|66344447|FG001|Overall Study|Adverse Event|22|||
23612431|NCT05265247|65969629|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
23612432|NCT05265247|65969630|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
23612433|NCT05265247|65969629|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
23612434|NCT05265247|65969630|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
23612435|NCT01654289|65969631|FG000|Overall Study|Withdrawal by Subject|10|||
23718312|NCT01406652|66344451|FG000|Overall Study|Lost-to-follow-up|3|||
23718313|NCT01406652|66344452|FG001|Overall Study|Lost-to-follow-up|4|||
23718314|NCT01406652|66344451|FG000|Overall Study|Withdrawal by Subject|2|||
23612436|NCT01654289|65969632|FG001|Overall Study|Withdrawal by Subject|8|||
23612437|NCT01654289|65969633|FG002|Overall Study|Withdrawal by Subject|5|||
23612438|NCT01654289|65969631|FG000|Overall Study|Withdrew from intervention only|17|||
23612439|NCT01654289|65969632|FG001|Overall Study|Withdrew from intervention only|20|||
23612440|NCT01654289|65969633|FG002|Overall Study|Withdrew from intervention only|0|||
23718315|NCT01406652|66344452|FG001|Overall Study|Withdrawal by Subject|2|||
23718316|NCT01406652|66344451|FG000|Overall Study|Insufficient follow-up|5|||
23718317|NCT01406652|66344452|FG001|Overall Study|Insufficient follow-up|4|||
23718318|NCT01406652|66344451|FG000|Overall Study|Infection not sure|10|||
23718319|NCT01406652|66344452|FG001|Overall Study|Infection not sure|10|||
23718320|NCT01082367|66344458|FG000|Double-blind Period|Administrative problems|0|||
23718321|NCT01082367|66344459|FG001|Double-blind Period|Administrative problems|1|||
23718322|NCT01082367|66344458|FG000|Double-blind Period|Lack of Efficacy|5|||
23718323|NCT01082367|66344459|FG001|Double-blind Period|Lack of Efficacy|11|||
23718324|NCT01082367|66344458|FG000|Double-blind Period|Adverse Event|0|||
23718325|NCT01082367|66344459|FG001|Double-blind Period|Adverse Event|1|||
23718326|NCT01082367|66344458|FG000|Follow-up (F-U) Period|Administrative problems|1|||
23718327|NCT01082367|66344459|FG001|Follow-up (F-U) Period|Administrative problems|0|||
23612441|NCT02379078|65969634|FG000|Overall Study|Lost to Follow-up|33|||
23612442|NCT02379078|65969635|FG001|Overall Study|Lost to Follow-up|30|||
23419102|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
23419103|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419104|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419105|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419106|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419107|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419108|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
23419109|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419110|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419111|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
23419112|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
23419113|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419114|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419115|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419116|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419117|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23453584|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
23718328|NCT01082367|66344458|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
23718329|NCT01082367|66344459|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
23718330|NCT01082367|66344458|FG000|Follow-up (F-U) Period|Adverse Event|0|||
23813458|NCT01199471|66699327|FG000|Overall Study|Withdrawal by Subject|1|||
23813459|NCT01199471|66699327|FG000|Overall Study|Physician Decision|1|||
23718331|NCT01082367|66344459|FG001|Follow-up (F-U) Period|Adverse Event|1|||
23718332|NCT05109702|66344460|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
23718333|NCT05109702|66344461|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
23718334|NCT05109702|66344462|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
23718335|NCT05109702|66344460|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
23718336|NCT05109702|66344461|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
23718337|NCT05109702|66344462|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
23718338|NCT05109702|66344460|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
23718339|NCT05109702|66344461|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
23718340|NCT05109702|66344462|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
23718341|NCT05109702|66344460|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
23718342|NCT05109702|66344461|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
23718343|NCT05109702|66344462|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
23718344|NCT05109702|66344460|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
23718345|NCT05109702|66344461|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
23718346|NCT05109702|66344462|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
23718347|NCT01646398|66344463|FG000|Overall Study|Withdrawal by Subject|1|||
23813460|NCT03052127|66699329|FG000|Overall Study|Withdrawal by Subject|0|||
23813461|NCT03052127|66699330|FG001|Overall Study|Withdrawal by Subject|0|||
23813462|NCT03052127|66699331|FG002|Overall Study|Withdrawal by Subject|0|||
23813463|NCT03052127|66699332|FG003|Overall Study|Withdrawal by Subject|0|||
23813464|NCT03052127|66699333|FG004|Overall Study|Withdrawal by Subject|0|||
23813465|NCT03052127|66699334|FG005|Overall Study|Withdrawal by Subject|0|||
23813466|NCT03052127|66699335|FG006|Overall Study|Withdrawal by Subject|0|||
23813467|NCT03052127|66699336|FG007|Overall Study|Withdrawal by Subject|1|||
23813468|NCT03052127|66699337|FG008|Overall Study|Withdrawal by Subject|1|||
23813469|NCT03052127|66699338|FG009|Overall Study|Withdrawal by Subject|1|||
23813470|NCT03052127|66699339|FG010|Overall Study|Withdrawal by Subject|0|||
23813471|NCT03052127|66699340|FG011|Overall Study|Withdrawal by Subject|0|||
23813472|NCT03052127|66699329|FG000|Overall Study|Discontinuation by Sponsor|0|||
23813473|NCT03052127|66699330|FG001|Overall Study|Discontinuation by Sponsor|0|||
23813474|NCT03052127|66699331|FG002|Overall Study|Discontinuation by Sponsor|0|||
23813475|NCT03052127|66699332|FG003|Overall Study|Discontinuation by Sponsor|0|||
23813476|NCT03052127|66699333|FG004|Overall Study|Discontinuation by Sponsor|0|||
23813477|NCT03052127|66699334|FG005|Overall Study|Discontinuation by Sponsor|0|||
23813478|NCT03052127|66699335|FG006|Overall Study|Discontinuation by Sponsor|0|||
23813479|NCT03052127|66699336|FG007|Overall Study|Discontinuation by Sponsor|0|||
23813480|NCT03052127|66699337|FG008|Overall Study|Discontinuation by Sponsor|4|||
23813481|NCT03052127|66699338|FG009|Overall Study|Discontinuation by Sponsor|2|||
23813482|NCT03052127|66699339|FG010|Overall Study|Discontinuation by Sponsor|5|||
23718348|NCT01646398|66344464|FG001|Overall Study|Withdrawal by Subject|0|||
23718349|NCT01410799|66344465|FG000|Overall Study|PI decision|13|||
23813483|NCT03052127|66699340|FG011|Overall Study|Discontinuation by Sponsor|13|||
23419118|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419119|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419120|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419121|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419122|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419123|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419124|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419125|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419126|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419127|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419128|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419129|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419130|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419131|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419132|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419133|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419134|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419135|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419136|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419137|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419138|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
23419139|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
23419140|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
23419141|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
23718350|NCT02379390|66344469|FG000|Overall Study|Adverse Event|1|||
23718351|NCT02379390|66344470|FG001|Overall Study|Adverse Event|1|||
23718352|NCT02379390|66344469|FG000|Overall Study|Investigator's decision|1|||
23718353|NCT02379390|66344470|FG001|Overall Study|Investigator's decision|0|||
23718354|NCT02379390|66344469|FG000|Overall Study|Study Termination|0|||
23718355|NCT02379390|66344470|FG001|Overall Study|Study Termination|1|||
23718356|NCT02267278|66344471|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
23718357|NCT02267278|66344471|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
23718358|NCT02267278|66344471|FG000|Overall Study|Developed new cancer diagnoses|2|||
23718359|NCT02267278|66344471|FG000|Overall Study|prescribed prohibited medication|1|||
23718360|NCT04354155|66344475|FG000|Overall Study|Withdrawal by Subject|1|||
23718361|NCT04354155|66344475|FG000|Overall Study|Did not meet criteria for study intervention|1|||
23718362|NCT03595384|66344478|FG000|Overall Study|Other time commitments|8|||
23718363|NCT03595384|66344478|FG000|Overall Study|Changes to session time|7|||
23718364|NCT03595384|66344478|FG000|Overall Study|Relocation out of country|1|||
23718365|NCT03372603|66344479|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
23718366|NCT03372603|66344480|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
23718367|NCT03372603|66344479|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
23718368|NCT03372603|66344480|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
23718369|NCT04449276|66344484|FG000|Overall Study|Adverse Event|1|||
23718370|NCT04449276|66344485|FG001|Overall Study|Adverse Event|2|||
23718371|NCT04449276|66344486|FG002|Overall Study|Adverse Event|0|||
23718372|NCT04449276|66344487|FG003|Overall Study|Adverse Event|0|||
23718373|NCT04449276|66344488|FG004|Overall Study|Adverse Event|2|||
23718374|NCT04449276|66344489|FG005|Overall Study|Adverse Event|0|||
23718375|NCT04449276|66344490|FG006|Overall Study|Adverse Event|0|||
23718376|NCT04449276|66344491|FG007|Overall Study|Adverse Event|1|||
23718377|NCT04449276|66344484|FG000|Overall Study|Withdrawal by Subject|2|||
23718378|NCT04449276|66344485|FG001|Overall Study|Withdrawal by Subject|0|||
23813484|NCT03052127|66699329|FG000|Overall Study|Inability to comply with trial requirements|0|||
23529532|NCT02365636|65672926|FG001|Overall Study|Protocol Violation|4|||
23612443|NCT02379078|65969634|FG000|Overall Study|Withdrawal by Subject|6|||
23718379|NCT04449276|66344486|FG002|Overall Study|Withdrawal by Subject|0|||
23718380|NCT04449276|66344487|FG003|Overall Study|Withdrawal by Subject|1|||
23718381|NCT04449276|66344488|FG004|Overall Study|Withdrawal by Subject|0|||
23813485|NCT03052127|66699330|FG001|Overall Study|Inability to comply with trial requirements|0|||
23718382|NCT04449276|66344489|FG005|Overall Study|Withdrawal by Subject|0|||
23718383|NCT04449276|66344490|FG006|Overall Study|Withdrawal by Subject|0|||
23718384|NCT04449276|66344491|FG007|Overall Study|Withdrawal by Subject|0|||
23718385|NCT04449276|66344484|FG000|Overall Study|Other|0|||
23718386|NCT04449276|66344485|FG001|Overall Study|Other|2|||
23718387|NCT04449276|66344486|FG002|Overall Study|Other|3|||
23718388|NCT04449276|66344487|FG003|Overall Study|Other|2|||
23718389|NCT04449276|66344488|FG004|Overall Study|Other|0|||
23718390|NCT04449276|66344489|FG005|Overall Study|Other|0|||
23718391|NCT04449276|66344490|FG006|Overall Study|Other|0|||
23813486|NCT03052127|66699331|FG002|Overall Study|Inability to comply with trial requirements|1|||
23813487|NCT03052127|66699332|FG003|Overall Study|Inability to comply with trial requirements|0|||
23419142|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
23419143|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419144|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419145|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419146|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419147|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419148|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419149|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419150|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419151|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
23419152|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
23419153|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23813488|NCT03052127|66699333|FG004|Overall Study|Inability to comply with trial requirements|0|||
23813489|NCT03052127|66699334|FG005|Overall Study|Inability to comply with trial requirements|0|||
23813490|NCT03052127|66699335|FG006|Overall Study|Inability to comply with trial requirements|0|||
23813491|NCT03052127|66699336|FG007|Overall Study|Inability to comply with trial requirements|0|||
23419154|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419155|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419156|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419157|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23529533|NCT02365636|65672927|FG002|Overall Study|Protocol Violation|0|||
23529534|NCT02365636|65672925|FG000|Overall Study|Lost to Follow-up|0|||
23612444|NCT02379078|65969635|FG001|Overall Study|Withdrawal by Subject|5|||
23612445|NCT02542293|65969636|FG000|Overall Study|Death|367|||
23612446|NCT02542293|65969637|FG001|Overall Study|Death|377|||
23612447|NCT02542293|65969636|FG000|Overall Study|Withdrawal by Subject|8|||
23612448|NCT02542293|65969637|FG001|Overall Study|Withdrawal by Subject|19|||
23612449|NCT03529942|65969638|FG000|Overall Study|Withdrawal by Subject|13|||
23612450|NCT03529942|65969638|FG000|Overall Study|Physician Decision|1|||
23612451|NCT03529942|65969638|FG000|Overall Study|Lost to Follow-up|7|||
23612452|NCT03529942|65969638|FG000|Overall Study|Needle inserted but no drug administered|1|||
23612453|NCT03529942|65969638|FG000|Overall Study|Personal reasons|1|||
23612454|NCT00278395|65969639|FG000|Overall Study|Adverse Event|2|||
23612455|NCT00278395|65969639|FG000|Overall Study|Nonevaluable|1|||
23612456|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612457|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612458|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612459|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
23612460|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612461|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612462|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612463|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612464|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
23612465|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
23612466|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612467|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612468|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612469|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612470|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
23813492|NCT03052127|66699337|FG008|Overall Study|Inability to comply with trial requirements|0|||
23813493|NCT03052127|66699338|FG009|Overall Study|Inability to comply with trial requirements|0|||
23612471|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612472|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612473|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23718392|NCT04449276|66344491|FG007|Overall Study|Other|1|||
23718393|NCT01824693|66344492|FG000|Overall Study|Death|0|||
23419158|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419159|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419160|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419161|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419162|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419163|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419164|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419165|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419166|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419167|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419168|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419169|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23529535|NCT02365636|65672926|FG001|Overall Study|Lost to Follow-up|0|||
23529536|NCT02365636|65672927|FG002|Overall Study|Lost to Follow-up|1|||
23529537|NCT02365636|65672925|FG000|Overall Study|Other|2|||
23529538|NCT02365636|65672926|FG001|Overall Study|Other|0|||
23529539|NCT02365636|65672927|FG002|Overall Study|Other|0|||
23529540|NCT00279708|65672928|FG000|Overall Study|Withdrawal by Subject|2|||
23529541|NCT00279708|65672929|FG001|Overall Study|Withdrawal by Subject|3|||
23529542|NCT00279708|65672928|FG000|Overall Study|Adverse Event|1|||
23529543|NCT00279708|65672929|FG001|Overall Study|Adverse Event|1|||
23529544|NCT00261716|65672932|FG000|Overall Study|Withdrawal by Subject|6|||
23529545|NCT00261716|65672933|FG001|Overall Study|Withdrawal by Subject|8|||
23529546|NCT00261716|65672932|FG000|Overall Study|Lost to Follow-up|0|||
23529547|NCT00261716|65672933|FG001|Overall Study|Lost to Follow-up|2|||
23529548|NCT02554656|65672937|FG000|Overall Study|Protocol Violation|3|||
23529549|NCT02643251|65672938|FG000|Overall Study|Adverse Event|3|||
23529550|NCT02643251|65672939|FG001|Overall Study|Adverse Event|1|||
23529551|NCT02643251|65672938|FG000|Overall Study|Withdrawal by Subject|2|||
23529552|NCT02643251|65672939|FG001|Overall Study|Withdrawal by Subject|0|||
23529553|NCT02643251|65672938|FG000|Overall Study|Lost to Follow-up|4|||
23529554|NCT02643251|65672939|FG001|Overall Study|Lost to Follow-up|1|||
23529555|NCT02643251|65672938|FG000|Overall Study|Protocol Violation|1|||
23529556|NCT02643251|65672939|FG001|Overall Study|Protocol Violation|0|||
23529557|NCT02643251|65672938|FG000|Overall Study|PI Decision to terminate patient|1|||
23529558|NCT02643251|65672939|FG001|Overall Study|PI Decision to terminate patient|0|||
23529559|NCT01485861|65672940|FG000|Phase Ib|Death|1|||
23529560|NCT01485861|65672941|FG001|Phase Ib|Death|0|||
23529561|NCT01485861|65672942|FG002|Phase Ib|Death|0|||
23529562|NCT01485861|65672943|FG003|Phase Ib|Death|0|||
23529563|NCT01485861|65672944|FG004|Phase Ib|Death|0|||
23718394|NCT01824693|66344493|FG001|Overall Study|Death|1|||
23718395|NCT01824693|66344494|FG002|Overall Study|Death|0|||
23718396|NCT01824693|66344492|FG000|Overall Study|Physician Decision|1|||
23529564|NCT01485861|65672945|FG005|Phase Ib|Death|0|||
23529565|NCT01485861|65672940|FG000|Phase Ib|Physician Decision|1|||
23529566|NCT01485861|65672941|FG001|Phase Ib|Physician Decision|1|||
23529567|NCT01485861|65672942|FG002|Phase Ib|Physician Decision|0|||
23529568|NCT01485861|65672943|FG003|Phase Ib|Physician Decision|0|||
23529569|NCT01485861|65672944|FG004|Phase Ib|Physician Decision|0|||
23529570|NCT01485861|65672945|FG005|Phase Ib|Physician Decision|0|||
23529571|NCT01485861|65672940|FG000|Phase Ib|Adverse Event|0|||
23529572|NCT01485861|65672941|FG001|Phase Ib|Adverse Event|4|||
23529573|NCT01485861|65672942|FG002|Phase Ib|Adverse Event|0|||
23529574|NCT01485861|65672943|FG003|Phase Ib|Adverse Event|0|||
23529575|NCT01485861|65672944|FG004|Phase Ib|Adverse Event|0|||
23529576|NCT01485861|65672945|FG005|Phase Ib|Adverse Event|0|||
23529577|NCT01485861|65672940|FG000|Phase Ib|Progression of disease|5|||
23529578|NCT01485861|65672941|FG001|Phase Ib|Progression of disease|0|||
23529579|NCT01485861|65672942|FG002|Phase Ib|Progression of disease|0|||
23529580|NCT01485861|65672943|FG003|Phase Ib|Progression of disease|0|||
23529581|NCT01485861|65672944|FG004|Phase Ib|Progression of disease|0|||
23529582|NCT01485861|65672945|FG005|Phase Ib|Progression of disease|0|||
23529583|NCT01485861|65672940|FG000|Phase Ib|Other|3|||
23529584|NCT01485861|65672941|FG001|Phase Ib|Other|0|||
23529585|NCT01485861|65672942|FG002|Phase Ib|Other|0|||
23529586|NCT01485861|65672943|FG003|Phase Ib|Other|0|||
23529587|NCT01485861|65672944|FG004|Phase Ib|Other|0|||
23529588|NCT01485861|65672945|FG005|Phase Ib|Other|0|||
23529589|NCT01485861|65672940|FG000|Phase Ib|Withdrawal by Subject|4|||
23529590|NCT01485861|65672941|FG001|Phase Ib|Withdrawal by Subject|1|||
23718397|NCT01824693|66344493|FG001|Overall Study|Physician Decision|1|||
23718398|NCT01824693|66344494|FG002|Overall Study|Physician Decision|1|||
23529591|NCT01485861|65672942|FG002|Phase Ib|Withdrawal by Subject|0|||
23529592|NCT01485861|65672943|FG003|Phase Ib|Withdrawal by Subject|0|||
23529593|NCT01485861|65672944|FG004|Phase Ib|Withdrawal by Subject|0|||
23529594|NCT01485861|65672945|FG005|Phase Ib|Withdrawal by Subject|0|||
23718399|NCT01824693|66344492|FG000|Overall Study|Withdrawal by Subject|0|||
23718400|NCT01824693|66344493|FG001|Overall Study|Withdrawal by Subject|0|||
23718401|NCT01824693|66344494|FG002|Overall Study|Withdrawal by Subject|1|||
23718402|NCT01824693|66344492|FG000|Overall Study|Progressive Disease|0|||
23718403|NCT01824693|66344493|FG001|Overall Study|Progressive Disease|5|||
23718404|NCT01824693|66344494|FG002|Overall Study|Progressive Disease|0|||
23718405|NCT01824693|66344492|FG000|Overall Study|Ineligible|0|||
23718406|NCT01824693|66344493|FG001|Overall Study|Ineligible|0|||
23718407|NCT01824693|66344494|FG002|Overall Study|Ineligible|3|||
23718408|NCT01824693|66344492|FG000|Overall Study|No Transplant Planned|0|||
23419170|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23718409|NCT01824693|66344493|FG001|Overall Study|No Transplant Planned|0|||
23718410|NCT01824693|66344494|FG002|Overall Study|No Transplant Planned|10|||
23718411|NCT00120289|66344496|FG000|Overall Study|Death|96|||
23718412|NCT00120289|66344497|FG001|Overall Study|Death|82|||
23718413|NCT00120289|66344496|FG000|Overall Study|Lost to Follow-up|11|||
23718414|NCT00120289|66344497|FG001|Overall Study|Lost to Follow-up|14|||
23718415|NCT00120289|66344496|FG000|Overall Study|Withdrawal by Subject|14|||
23718416|NCT00120289|66344497|FG001|Overall Study|Withdrawal by Subject|13|||
23718417|NCT01342952|66344500|FG000|Overall Study|Adverse Event|0|||
23718418|NCT01342952|66344501|FG001|Overall Study|Adverse Event|5|||
23718419|NCT01342952|66344502|FG002|Overall Study|Adverse Event|1|||
23718420|NCT01342952|66344503|FG003|Overall Study|Adverse Event|0|||
23718421|NCT01342952|66344500|FG000|Overall Study|Lost to Follow-up|0|||
23718422|NCT01342952|66344501|FG001|Overall Study|Lost to Follow-up|2|||
23718423|NCT01342952|66344502|FG002|Overall Study|Lost to Follow-up|0|||
23718424|NCT01342952|66344503|FG003|Overall Study|Lost to Follow-up|0|||
23718425|NCT01342952|66344500|FG000|Overall Study|Withdrawal by Subject|1|||
23718426|NCT01342952|66344501|FG001|Overall Study|Withdrawal by Subject|1|||
23718427|NCT01342952|66344502|FG002|Overall Study|Withdrawal by Subject|0|||
23718428|NCT01342952|66344503|FG003|Overall Study|Withdrawal by Subject|0|||
23718429|NCT01342952|66344500|FG000|Overall Study|Physician Decision|3|||
23718430|NCT01342952|66344501|FG001|Overall Study|Physician Decision|3|||
23718431|NCT01342952|66344502|FG002|Overall Study|Physician Decision|1|||
23718432|NCT01342952|66344503|FG003|Overall Study|Physician Decision|0|||
23718433|NCT01185704|66344504|FG000|Overall Study|Randomized but not treated|3|||
23718434|NCT01185704|66344505|FG001|Overall Study|Randomized but not treated|3|||
23718435|NCT01185704|66344504|FG000|Overall Study|Lack of ovarian response|5|||
23718436|NCT01185704|66344505|FG001|Overall Study|Lack of ovarian response|1|||
23718437|NCT01185704|66344504|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
23718438|NCT01185704|66344505|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23419171|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419172|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419173|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419174|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419175|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419176|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419177|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419178|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419179|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419180|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419181|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419182|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
23419183|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419184|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419185|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419186|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23718439|NCT01185704|66344504|FG000|Overall Study|Ectopic pregnancy|0|||
23718440|NCT01185704|66344505|FG001|Overall Study|Ectopic pregnancy|1|||
23718441|NCT00109772|66344506|FG000|Double-blind Treatment|Adverse Event|14|||
23718442|NCT00109772|66344507|FG001|Double-blind Treatment|Adverse Event|5|||
23718443|NCT00109772|66344506|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23718444|NCT00109772|66344507|FG001|Double-blind Treatment|Lack of Efficacy|0|||
23718445|NCT00109772|66344506|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
23718446|NCT00109772|66344507|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
23718447|NCT00109772|66344506|FG000|Double-blind Treatment|Lost to Follow-up|2|||
23718448|NCT00109772|66344507|FG001|Double-blind Treatment|Lost to Follow-up|3|||
23718449|NCT00109772|66344506|FG000|Double-blind Treatment|Protocol Violation|0|||
23718450|NCT00109772|66344507|FG001|Double-blind Treatment|Protocol Violation|1|||
23718451|NCT00109772|66344506|FG000|Double-blind Treatment|Other|0|||
23718452|NCT00109772|66344507|FG001|Double-blind Treatment|Other|4|||
23718453|NCT00109772|66344506|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
23718454|NCT00109772|66344507|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
23718455|NCT00109772|66344506|FG000|Open-label Extension|Adverse Event|10|||
23718456|NCT00109772|66344507|FG001|Open-label Extension|Adverse Event|19|||
23718457|NCT00109772|66344506|FG000|Open-label Extension|Lack of Efficacy|19|||
23718458|NCT00109772|66344507|FG001|Open-label Extension|Lack of Efficacy|11|||
23718459|NCT00109772|66344506|FG000|Open-label Extension|Withdrawal by Subject|9|||
23718460|NCT00109772|66344507|FG001|Open-label Extension|Withdrawal by Subject|6|||
23718461|NCT00109772|66344506|FG000|Open-label Extension|Lost to Follow-up|1|||
23718462|NCT00109772|66344507|FG001|Open-label Extension|Lost to Follow-up|0|||
23718463|NCT00109772|66344506|FG000|Open-label Extension|Death|0|||
23813494|NCT03052127|66699339|FG010|Overall Study|Inability to comply with trial requirements|0|||
23813495|NCT03052127|66699340|FG011|Overall Study|Inability to comply with trial requirements|0|||
23813496|NCT03052127|66699329|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23813497|NCT03052127|66699330|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813498|NCT03052127|66699331|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813499|NCT03052127|66699332|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813500|NCT03052127|66699333|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23813501|NCT03052127|66699334|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23813502|NCT03052127|66699335|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23813503|NCT03052127|66699336|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813504|NCT03052127|66699337|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813505|NCT03052127|66699338|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813506|NCT03052127|66699339|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813507|NCT03052127|66699340|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23813508|NCT00510289|66699341|FG000|Overall Study|Withdrawal by Subject|7|||
23813509|NCT00510289|66699341|FG000|Overall Study|Refused bone marrow biopsy|2|||
23813510|NCT00510289|66699341|FG000|Overall Study|Lost to Follow-up|1|||
23813511|NCT00510289|66699341|FG000|Overall Study|Progressed prior to starting drug|2|||
23813512|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
23813513|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
23813514|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
23529595|NCT01485861|65672940|FG000|Phase II|Death|0|||
23529596|NCT01485861|65672941|FG001|Phase II|Death|0|||
23529597|NCT01485861|65672942|FG002|Phase II|Death|67|||
23529598|NCT01485861|65672943|FG003|Phase II|Death|71|||
23529599|NCT01485861|65672944|FG004|Phase II|Death|68|||
23529600|NCT01485861|65672945|FG005|Phase II|Death|0|||
23529601|NCT01485861|65672940|FG000|Phase II|Progression of Disease|0|||
23529602|NCT01485861|65672941|FG001|Phase II|Progression of Disease|0|||
23529603|NCT01485861|65672942|FG002|Phase II|Progression of Disease|1|||
23529604|NCT01485861|65672943|FG003|Phase II|Progression of Disease|0|||
23529605|NCT01485861|65672944|FG004|Phase II|Progression of Disease|0|||
23529606|NCT01485861|65672945|FG005|Phase II|Progression of Disease|0|||
23529607|NCT01485861|65672940|FG000|Phase II|Other|0|||
23529608|NCT01485861|65672941|FG001|Phase II|Other|0|||
23529609|NCT01485861|65672942|FG002|Phase II|Other|0|||
23529610|NCT01485861|65672943|FG003|Phase II|Other|1|||
23529611|NCT01485861|65672944|FG004|Phase II|Other|0|||
23529612|NCT01485861|65672945|FG005|Phase II|Other|0|||
23529613|NCT01485861|65672940|FG000|Phase II|Withdrawal by Subject|0|||
23529614|NCT01485861|65672941|FG001|Phase II|Withdrawal by Subject|0|||
23529615|NCT01485861|65672942|FG002|Phase II|Withdrawal by Subject|6|||
23529616|NCT01485861|65672943|FG003|Phase II|Withdrawal by Subject|3|||
23529617|NCT01485861|65672944|FG004|Phase II|Withdrawal by Subject|4|||
23529618|NCT01485861|65672945|FG005|Phase II|Withdrawal by Subject|0|||
23529619|NCT01485861|65672940|FG000|Phase II|Lost to Follow-up|0|||
23529620|NCT01485861|65672941|FG001|Phase II|Lost to Follow-up|0|||
23529621|NCT01485861|65672942|FG002|Phase II|Lost to Follow-up|2|||
23529622|NCT01485861|65672943|FG003|Phase II|Lost to Follow-up|3|||
23529623|NCT01485861|65672944|FG004|Phase II|Lost to Follow-up|5|||
23529624|NCT01485861|65672945|FG005|Phase II|Lost to Follow-up|0|||
23529625|NCT01485861|65672940|FG000|Phase II|Study Ended|0|||
23529626|NCT01485861|65672941|FG001|Phase II|Study Ended|0|||
23718464|NCT00109772|66344507|FG001|Open-label Extension|Death|1|||
23718465|NCT00109772|66344506|FG000|Open-label Extension|Protocol Violation|2|||
23718466|NCT00109772|66344507|FG001|Open-label Extension|Protocol Violation|2|||
23718467|NCT00109772|66344506|FG000|Open-label Extension|Other|4|||
23718468|NCT00109772|66344507|FG001|Open-label Extension|Other|10|||
23718469|NCT02767856|66344511|FG000|Overall Study|Lost to Follow-up|9|||
23529627|NCT01485861|65672942|FG002|Phase II|Study Ended|7|||
23529628|NCT01485861|65672943|FG003|Phase II|Study Ended|8|||
23529629|NCT01485861|65672944|FG004|Phase II|Study Ended|6|||
23612474|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612475|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612476|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
23612477|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
23612478|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612479|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612480|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612481|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612482|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
23612483|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
23612484|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612485|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612486|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
23612487|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
23612488|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
23612489|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
23612490|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
23718470|NCT02767856|66344512|FG001|Overall Study|Lost to Follow-up|1|||
23718471|NCT02767856|66344511|FG000|Overall Study|Withdrawal by Subject|2|||
23718472|NCT02767856|66344512|FG001|Overall Study|Withdrawal by Subject|1|||
23813515|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
23813516|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
23813517|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
23718473|NCT01360762|66344513|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
23718474|NCT01360762|66344513|FG000|Main Study Period (12-month Treatment)|Death|5|||
23718475|NCT01360762|66344513|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
23718476|NCT01360762|66344513|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
23718477|NCT01360762|66344513|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
23718478|NCT01360762|66344513|FG000|Whole Study Period|Lost to Follow-up|10|||
23718479|NCT01360762|66344513|FG000|Whole Study Period|Death|7|||
23718480|NCT01360762|66344513|FG000|Whole Study Period|Patient relapsed|18|||
23718481|NCT01360762|66344513|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
23718482|NCT00131664|66344514|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
23718483|NCT00131664|66344515|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
23718484|NCT00131664|66344516|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
23718485|NCT00131664|66344517|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
23718486|NCT00131664|66344518|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
23718487|NCT00131664|66344519|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
23718488|NCT00131664|66344514|FG000|First Period (First 6 Months)|Death|0|||
23718489|NCT00131664|66344515|FG001|First Period (First 6 Months)|Death|1|||
23718490|NCT00131664|66344516|FG002|First Period (First 6 Months)|Death|0|||
23718491|NCT00131664|66344517|FG003|First Period (First 6 Months)|Death|0|||
23718492|NCT00131664|66344518|FG004|First Period (First 6 Months)|Death|0|||
23718493|NCT00131664|66344519|FG005|First Period (First 6 Months)|Death|0|||
23718494|NCT00131664|66344514|FG000|First Period (First 6 Months)|Protocol Violation|2|||
23718495|NCT00131664|66344515|FG001|First Period (First 6 Months)|Protocol Violation|2|||
23718496|NCT00131664|66344516|FG002|First Period (First 6 Months)|Protocol Violation|1|||
23718497|NCT00131664|66344517|FG003|First Period (First 6 Months)|Protocol Violation|0|||
23718498|NCT00131664|66344518|FG004|First Period (First 6 Months)|Protocol Violation|0|||
23718499|NCT00131664|66344519|FG005|First Period (First 6 Months)|Protocol Violation|0|||
23718500|NCT00131664|66344514|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
23718501|NCT00131664|66344515|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
23718502|NCT00131664|66344516|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
23718503|NCT00131664|66344517|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
23718504|NCT00131664|66344518|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
23718505|NCT00131664|66344519|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
23718506|NCT00131664|66344514|FG000|First Period (First 6 Months)|Adverse Event|9|||
23529630|NCT01485861|65672945|FG005|Phase II|Study Ended|0|||
23529631|NCT01485861|65672940|FG000|Safety Phase|Death|0|||
23529632|NCT01485861|65672941|FG001|Safety Phase|Death|0|||
23529633|NCT01485861|65672942|FG002|Safety Phase|Death|0|||
23529634|NCT01485861|65672943|FG003|Safety Phase|Death|0|||
23529635|NCT01485861|65672944|FG004|Safety Phase|Death|0|||
23529636|NCT01485861|65672945|FG005|Safety Phase|Death|2|||
23529637|NCT01485861|65672940|FG000|Safety Phase|Adverse Event|0|||
23529638|NCT01485861|65672941|FG001|Safety Phase|Adverse Event|0|||
23529639|NCT01485861|65672942|FG002|Safety Phase|Adverse Event|0|||
23529640|NCT01485861|65672943|FG003|Safety Phase|Adverse Event|0|||
23718507|NCT00131664|66344515|FG001|First Period (First 6 Months)|Adverse Event|4|||
23718508|NCT00131664|66344516|FG002|First Period (First 6 Months)|Adverse Event|5|||
23718509|NCT00131664|66344517|FG003|First Period (First 6 Months)|Adverse Event|0|||
23718510|NCT00131664|66344518|FG004|First Period (First 6 Months)|Adverse Event|0|||
23718511|NCT00131664|66344519|FG005|First Period (First 6 Months)|Adverse Event|0|||
23718512|NCT00131664|66344514|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
23529641|NCT01485861|65672944|FG004|Safety Phase|Adverse Event|0|||
23529642|NCT01485861|65672945|FG005|Safety Phase|Adverse Event|1|||
23529643|NCT01485861|65672940|FG000|Safety Phase|Other|0|||
23529644|NCT01485861|65672941|FG001|Safety Phase|Other|0|||
23529645|NCT01485861|65672942|FG002|Safety Phase|Other|0|||
23529646|NCT01485861|65672943|FG003|Safety Phase|Other|0|||
23529647|NCT01485861|65672944|FG004|Safety Phase|Other|0|||
23529648|NCT01485861|65672945|FG005|Safety Phase|Other|5|||
23529649|NCT01485861|65672940|FG000|Safety Phase|Progression of Disease|0|||
23529650|NCT01485861|65672941|FG001|Safety Phase|Progression of Disease|0|||
23529651|NCT01485861|65672942|FG002|Safety Phase|Progression of Disease|0|||
23529652|NCT01485861|65672943|FG003|Safety Phase|Progression of Disease|0|||
23529653|NCT01485861|65672944|FG004|Safety Phase|Progression of Disease|0|||
23529654|NCT01485861|65672945|FG005|Safety Phase|Progression of Disease|9|||
23529655|NCT01485861|65672940|FG000|Safety Phase|Withdrawal by Subject|0|||
23529656|NCT01485861|65672941|FG001|Safety Phase|Withdrawal by Subject|0|||
23612491|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
23612492|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
23612493|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
23612494|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
23612495|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
23612496|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
23529657|NCT01485861|65672942|FG002|Safety Phase|Withdrawal by Subject|0|||
23529658|NCT01485861|65672943|FG003|Safety Phase|Withdrawal by Subject|0|||
23529659|NCT01485861|65672944|FG004|Safety Phase|Withdrawal by Subject|0|||
23529660|NCT01485861|65672945|FG005|Safety Phase|Withdrawal by Subject|6|||
23529661|NCT01485861|65672940|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
23529662|NCT01485861|65672941|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
23529663|NCT01485861|65672942|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
23612497|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
23529664|NCT01485861|65672943|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
23612498|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612499|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
23612500|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
23612501|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
23612502|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612503|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612504|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
23612505|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612506|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
23612507|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
23612508|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612509|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612510|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
23612511|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
23612512|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
23612513|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
23612514|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
23612515|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
23612516|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
23612517|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612518|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
23612519|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
23612520|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612521|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612522|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Death|0|||
23612523|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Death|0|||
23718513|NCT00131664|66344515|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
23718514|NCT00131664|66344516|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23718515|NCT00131664|66344517|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23529665|NCT01485861|65672944|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
23718516|NCT00131664|66344518|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23718517|NCT00131664|66344519|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23718518|NCT00131664|66344514|FG000|First Period (First 6 Months)|Administrative reasons|2|||
23718519|NCT00131664|66344515|FG001|First Period (First 6 Months)|Administrative reasons|0|||
23718520|NCT00131664|66344516|FG002|First Period (First 6 Months)|Administrative reasons|5|||
23718521|NCT00131664|66344517|FG003|First Period (First 6 Months)|Administrative reasons|0|||
23718522|NCT00131664|66344518|FG004|First Period (First 6 Months)|Administrative reasons|0|||
23718523|NCT00131664|66344519|FG005|First Period (First 6 Months)|Administrative reasons|0|||
23718524|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
23718525|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
23718526|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
23718527|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
23718528|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
23718529|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
23718530|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
23718531|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
23718532|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
23718533|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
23718534|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
23718535|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
23718536|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
23718537|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23718538|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23718539|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23718540|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23718541|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23718542|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
23718543|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
23718544|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
23529666|NCT01485861|65672945|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
23529667|NCT00678691|65672947|FG000|Overall Study|Adverse Event|6|||
23529668|NCT00678691|65672948|FG001|Overall Study|Adverse Event|4|||
23529669|NCT02107703|65672949|FG000|Overall Study|Withdrawal by Subject|46|||
23529670|NCT02107703|65672950|FG001|Overall Study|Withdrawal by Subject|21|||
23529671|NCT02107703|65672949|FG000|Overall Study|Lost to Follow-up|20|||
23529672|NCT02107703|65672950|FG001|Overall Study|Lost to Follow-up|9|||
23529673|NCT02107703|65672949|FG000|Overall Study|On study treatment/follow up|48|||
23529674|NCT02107703|65672950|FG001|Overall Study|On study treatment/follow up|5|||
23529675|NCT03878134|65672951|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
23529676|NCT01800903|65672952|FG000|Second Test Period|unable to catheterise|1|||
23529677|NCT01800903|65672953|FG001|Second Test Period|unable to catheterise|0|||
23529678|NCT01800903|65672954|FG002|Second Test Period|unable to catheterise|0|||
23529679|NCT01800903|65672955|FG003|Second Test Period|unable to catheterise|0|||
23529680|NCT01800903|65672956|FG004|Second Test Period|unable to catheterise|0|||
23529681|NCT01800903|65672957|FG005|Second Test Period|unable to catheterise|0|||
23529682|NCT00749775|65672964|FG000|Overall Study|Protocol Violation|24|||
23529683|NCT00749775|65672964|FG000|Overall Study|Lost to Follow-up|36|||
23529684|NCT00749775|65672964|FG000|Overall Study|No visit after first day of treatment|44|||
23529685|NCT00749775|65672964|FG000|Overall Study|No drug administration|3|||
23529686|NCT02059148|65672975|FG000|Treatment 1|Protocol Violation|0|||
23529687|NCT02059148|65672976|FG001|Treatment 1|Protocol Violation|0|||
23529688|NCT02059148|65672977|FG002|Treatment 1|Protocol Violation|0|||
23529689|NCT02059148|65672978|FG003|Treatment 1|Protocol Violation|0|||
23529690|NCT02059148|65672979|FG004|Treatment 1|Protocol Violation|0|||
23529691|NCT02059148|65672980|FG005|Treatment 1|Protocol Violation|1|||
23529692|NCT02181556|65672981|FG000|Overall Study|Withdrawal by Subject|1|||
23529693|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
23529694|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
23529695|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
23529696|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
23529697|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
23529698|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529699|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529700|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529701|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
23529702|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
23718545|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
23718546|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
23718547|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
23718548|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23718549|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23718550|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23718551|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
23718552|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23718553|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23718554|NCT00131664|66344514|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
23718555|NCT00131664|66344515|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
23718556|NCT00131664|66344516|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
23718557|NCT00131664|66344517|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
23718558|NCT00131664|66344518|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
23718559|NCT00131664|66344519|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
23718560|NCT00166517|66344520|FG000|Overall Study|Lost to Follow-up|1|||
23718561|NCT00166517|66344521|FG001|Overall Study|Lost to Follow-up|0|||
23718562|NCT00166517|66344520|FG000|Overall Study|Protocol Violation|4|||
23718563|NCT00166517|66344521|FG001|Overall Study|Protocol Violation|1|||
23718564|NCT00166517|66344520|FG000|Overall Study|Withdrawal by Subject|0|||
23718565|NCT00166517|66344521|FG001|Overall Study|Withdrawal by Subject|1|||
23718566|NCT02031432|66344522|FG000|Overall Study|Protocol Violation|1|||
23718567|NCT02031432|66344522|FG000|Overall Study|Lack of Efficacy|5|||
23718568|NCT02031432|66344522|FG000|Overall Study|Cancer Progression|2|||
23718569|NCT02031432|66344522|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
23718570|NCT02031432|66344522|FG000|Overall Study|Adverse Event|8|||
23718571|NCT02031432|66344522|FG000|Overall Study|Withdrawal by Subject|5|||
23718572|NCT02031432|66344522|FG000|Overall Study|Lost to Follow-up|1|||
23718573|NCT02031432|66344522|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
23718574|NCT02031432|66344522|FG000|Overall Study|Death|10|||
23718575|NCT04671342|66344523|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
23529703|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
23529704|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
23718576|NCT04671342|66344523|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
23529705|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
23529706|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
23718577|NCT04671342|66344523|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
23718578|NCT04671342|66344523|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
23718579|NCT04671342|66344523|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
23718580|NCT04671342|66344523|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
23718581|NCT00949910|66344530|FG000|Overall Study|Progressive Disease|3750|||
23718582|NCT00949910|66344530|FG000|Overall Study|Symptomatic Deterioration|1088|||
23718583|NCT00949910|66344530|FG000|Overall Study|Lost to Follow-up|100|||
23718584|NCT00949910|66344530|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
23718585|NCT00949910|66344530|FG000|Overall Study|Participant Refusal|390|||
23718586|NCT00949910|66344530|FG000|Overall Study|Death Due to Malignant Disease|456|||
23718587|NCT00949910|66344530|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
23718588|NCT00949910|66344530|FG000|Overall Study|Death Due to Adverse Event|115|||
23718589|NCT00949910|66344530|FG000|Overall Study|Death Due to Toxicity|3|||
23718590|NCT00949910|66344530|FG000|Overall Study|Death from Unknown Cause|5|||
23718591|NCT00949910|66344530|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
23718592|NCT00949910|66344530|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
23718593|NCT00949910|66344530|FG000|Overall Study|Switched to Commercial Treatment|4|||
23813518|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
23813519|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
23813520|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
23813521|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
23813522|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Death|1|||
23813523|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Death|0|||
23813524|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Death|0|||
23813525|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Death|0|||
23813526|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Death|0|||
23813527|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23813528|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23813529|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
23813530|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23813531|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23813532|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
23813533|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
23813534|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23813535|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
23813536|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
23813537|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
23813538|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23813539|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
23813540|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23813541|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
23813542|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
23813543|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
23813544|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
23813545|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
23813546|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23813547|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23813548|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23813549|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23813550|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23813551|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23813552|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Other|4|||
23813553|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Other|4|||
23813554|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Other|3|||
23813555|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Other|1|||
23813556|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Other|0|||
23813557|NCT01081834|66699342|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
23813558|NCT01081834|66699343|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
23813559|NCT01081834|66699344|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23813560|NCT01081834|66699345|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23813561|NCT01081834|66699346|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23813562|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23529707|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
23453585|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
23529708|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
23529709|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
23529710|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
23529711|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
23529712|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
23529713|NCT02047110|65672982|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529714|NCT02047110|65672983|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
23529715|NCT02047110|65672984|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529716|NCT02047110|65672985|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529717|NCT02047110|65672982|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
23529718|NCT02047110|65672983|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
23612524|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Death|0|||
23813563|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23813564|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23813565|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23813566|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23813567|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Death|1|||
23813568|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Death|0|||
23813569|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23813570|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Death|0|||
23813571|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Death|0|||
23813572|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
23813573|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
23813574|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23813575|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23813576|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23813577|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23813578|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23813579|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23813580|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23813581|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23813582|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23813583|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
23813584|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23813585|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23813586|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23813587|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23813588|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23813589|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23813590|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23813591|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23813592|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23813593|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
23813594|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23813595|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23529719|NCT02047110|65672984|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
23612525|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Death|0|||
23612526|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Death|1|||
23612527|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Death|4|||
23612528|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612529|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612530|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612531|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612532|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
23612533|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
23718594|NCT00949910|66344530|FG000|Overall Study|Violation of Eligibility|23|||
23718595|NCT00949910|66344530|FG000|Overall Study|Logistical Reasons|13|||
23718596|NCT00949910|66344530|FG000|Overall Study|Non-Compliance|10|||
23718597|NCT00949910|66344530|FG000|Overall Study|Prolonged Dosing Interruption|4|||
23718598|NCT00949910|66344530|FG000|Overall Study|Adverse Event|83|||
23813596|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23612534|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612535|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612536|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612537|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612538|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
23612539|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612540|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612541|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612542|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612543|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612544|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
23612545|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
23612546|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612547|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612548|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612549|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612550|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
23612551|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
23612552|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612553|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612554|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612555|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612556|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
23612557|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
23612558|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612559|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612560|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612561|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612562|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
23718599|NCT00949910|66344530|FG000|Overall Study|Serious Adverse Event|6|||
23718600|NCT00949910|66344530|FG000|Overall Study|Physician/Participant Decision|7|||
23718601|NCT00949910|66344530|FG000|Overall Study|Other|4|||
23718602|NCT00949910|66344530|FG000|Overall Study|No Data|9|||
23718603|NCT03805971|66344531|FG000|Overall Study|Withdrawal by Subject|1|||
23718604|NCT03805971|66344531|FG000|Overall Study|Protocol Violation|2|||
23718605|NCT00628758|66344532|FG000|Overall Study|Adverse Event|2|||
23718606|NCT00628758|66344533|FG001|Overall Study|Adverse Event|3|||
23718607|NCT00628758|66344532|FG000|Overall Study|Withdrawal by Subject|6|||
23718608|NCT00628758|66344533|FG001|Overall Study|Withdrawal by Subject|3|||
23813597|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Other|4|||
23718609|NCT00628758|66344532|FG000|Overall Study|Death|1|||
23718610|NCT00628758|66344533|FG001|Overall Study|Death|0|||
23718611|NCT00628758|66344532|FG000|Overall Study|Protocol Violation|5|||
23718612|NCT00628758|66344533|FG001|Overall Study|Protocol Violation|1|||
23718613|NCT00628758|66344532|FG000|Overall Study|Lost to Follow-up|25|||
23718614|NCT00628758|66344533|FG001|Overall Study|Lost to Follow-up|31|||
23718615|NCT00628758|66344532|FG000|Overall Study|Pregnancy|2|||
23718616|NCT00628758|66344533|FG001|Overall Study|Pregnancy|2|||
23718617|NCT00628758|66344532|FG000|Overall Study|Investigator Moved|3|||
23718618|NCT00628758|66344533|FG001|Overall Study|Investigator Moved|0|||
23419187|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419188|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419189|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
23419190|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419191|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419192|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
23419193|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419194|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419195|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419196|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419197|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419198|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
23419199|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419200|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419201|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419202|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
23419203|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419204|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419205|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419206|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419207|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419208|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
23419209|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419210|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
23419211|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419212|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
23419213|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419214|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419215|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419216|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419217|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419218|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Other|5|||
23419219|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Other|1|||
23419220|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Other|0|||
23419221|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Other|3|||
23419222|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Other|0|||
23419223|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Other|0|||
23419224|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Other|0|||
23419225|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Other|0|||
23419226|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Other|0|||
23419227|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Other|0|||
23419228|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419229|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419230|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419231|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419232|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
23419233|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419234|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419235|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419236|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419237|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419238|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Death|0|||
23419239|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Death|0|||
23419240|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Death|0|||
23419241|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Death|0|||
23419242|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Death|0|||
23419243|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Death|1|||
23419244|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Death|0|||
23419245|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Death|1|||
23419246|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Death|1|||
23419247|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Death|1|||
23419248|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419249|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23612563|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
23419250|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419251|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419252|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23529720|NCT02047110|65672985|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
23529721|NCT02047110|65672982|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
23529722|NCT02047110|65672983|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
23529723|NCT02047110|65672984|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
23529724|NCT02047110|65672985|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
23529725|NCT02047110|65672982|FG000|Escape Treatment Period|Adverse Event|1|||
23529726|NCT02047110|65672983|FG001|Escape Treatment Period|Adverse Event|2|||
23529727|NCT02047110|65672984|FG002|Escape Treatment Period|Adverse Event|2|||
23529728|NCT02047110|65672985|FG003|Escape Treatment Period|Adverse Event|0|||
23529729|NCT02047110|65672982|FG000|Escape Treatment Period|Other than specified|1|||
23529730|NCT02047110|65672983|FG001|Escape Treatment Period|Other than specified|2|||
23529731|NCT02047110|65672984|FG002|Escape Treatment Period|Other than specified|0|||
23529732|NCT02047110|65672985|FG003|Escape Treatment Period|Other than specified|1|||
23529733|NCT02047110|65672982|FG000|OLE Treatment Period|Other than specified|0|||
23529734|NCT02047110|65672983|FG001|OLE Treatment Period|Other than specified|0|||
23529735|NCT02047110|65672984|FG002|OLE Treatment Period|Other than specified|1|||
23529736|NCT02047110|65672985|FG003|OLE Treatment Period|Other than specified|0|||
23529737|NCT00463060|65672986|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
23529738|NCT00463060|65672986|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
23529739|NCT02852265|65672987|FG000|3-month Follow-up|Lost to Follow-up|1|||
23529740|NCT02852265|65672988|FG001|3-month Follow-up|Lost to Follow-up|1|||
23529741|NCT00302003|65672989|FG000|Overall Study|Lack of Efficacy|62|||
23813598|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23813599|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23813600|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Other|0|||
23813601|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Other|0|||
23813602|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
23419253|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
23419254|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419255|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419256|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419257|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23529742|NCT00302003|65672989|FG000|Overall Study|Lost to Follow-up|1|||
23529743|NCT00302003|65672989|FG000|Overall Study|Physician Decision|2|||
23529744|NCT00302003|65672989|FG000|Overall Study|Withdrawal by Subject|5|||
23718619|NCT00628758|66344532|FG000|Overall Study|Treatment Failure|0|||
23718620|NCT00628758|66344533|FG001|Overall Study|Treatment Failure|2|||
23718621|NCT00453180|66344535|FG000|Overall Study|Lost to Follow-up|2|||
23718622|NCT00453180|66344536|FG001|Overall Study|Lost to Follow-up|1|||
23718623|NCT00453180|66344535|FG000|Overall Study|Adverse Event|1|||
23718624|NCT00453180|66344536|FG001|Overall Study|Adverse Event|2|||
23718625|NCT03728140|66344537|FG000|Overall Study|Abnormal embryo transfer operation|10|||
23718626|NCT03728140|66344538|FG001|Overall Study|Abnormal embryo transfer operation|7|||
23718627|NCT02678312|66344539|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
23718628|NCT02678312|66344540|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23813603|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
23813604|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23813605|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23813606|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23529745|NCT00302003|65672989|FG000|Overall Study|Ineligible|9|||
23529746|NCT00302003|65672989|FG000|Overall Study|Protocol Violation|1|||
23529747|NCT01069289|65672990|FG000|Overall Study|Withdrawal by Subject|15|||
23529748|NCT01069289|65672991|FG001|Overall Study|Withdrawal by Subject|26|||
23529749|NCT01069289|65672990|FG000|Overall Study|Adverse Event|21|||
23529750|NCT01069289|65672991|FG001|Overall Study|Adverse Event|28|||
23529751|NCT01069289|65672990|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23529752|NCT01069289|65672991|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23529753|NCT01069289|65672990|FG000|Overall Study|Severe non-compliance to protocol|3|||
23529754|NCT01069289|65672991|FG001|Overall Study|Severe non-compliance to protocol|2|||
23529755|NCT01069289|65672990|FG000|Overall Study|Due to deteriorating health condition|1|||
23529756|NCT01069289|65672991|FG001|Overall Study|Due to deteriorating health condition|0|||
23529757|NCT01782313|65672992|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
23529758|NCT01782313|65672992|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
23529759|NCT01782313|65672992|FG000|Treated Cycle 3|Progressive Disease|21|||
23718629|NCT02678312|66344541|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23718630|NCT02678312|66344542|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23718631|NCT02678312|66344543|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23529760|NCT01782313|65672992|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
23529761|NCT01782313|65672992|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
23529762|NCT01782313|65672992|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
23529763|NCT01782313|65672992|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
23529764|NCT01782313|65672992|FG000|Survival Follow up|Lost to Follow-up|1|||
23718632|NCT02678312|66344539|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
23718633|NCT02678312|66344540|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23718634|NCT02678312|66344541|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23718635|NCT02678312|66344542|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23718636|NCT02678312|66344543|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23718637|NCT02678312|66344539|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
23718638|NCT02678312|66344540|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23718639|NCT02678312|66344541|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23718640|NCT02678312|66344542|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23718641|NCT02678312|66344543|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23718642|NCT02678312|66344539|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
23718643|NCT02678312|66344540|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
23718644|NCT02678312|66344541|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
23718645|NCT02678312|66344542|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
23718646|NCT02678312|66344543|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
23419258|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419259|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419260|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419261|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419262|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419263|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419264|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419265|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419266|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
23529765|NCT01140477|65672993|FG000|Overall Study|Lost to Follow-up|4|||
23529766|NCT01140477|65672994|FG001|Overall Study|Lost to Follow-up|0|||
23529767|NCT01140477|65672993|FG000|Overall Study|Withdrawal by Subject|1|||
23529768|NCT01140477|65672994|FG001|Overall Study|Withdrawal by Subject|4|||
23529769|NCT01140477|65672993|FG000|Overall Study|Surgical complication preventing implant|2|||
23529770|NCT01140477|65672994|FG001|Overall Study|Surgical complication preventing implant|0|||
23529771|NCT01140477|65672993|FG000|Overall Study|Death|1|||
23529772|NCT01140477|65672994|FG001|Overall Study|Death|1|||
23529773|NCT01140477|65672993|FG000|Overall Study|Subject explanted|0|||
23529774|NCT01140477|65672994|FG001|Overall Study|Subject explanted|1|||
23529775|NCT00480636|65673005|FG000|Overall Study|Death|12|||
23529776|NCT00480636|65673005|FG000|Overall Study|Lost to Follow-up|4|||
23529777|NCT00480636|65673005|FG000|Overall Study|Other|2|||
23529778|NCT00480636|65673005|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
23529779|NCT00110812|65673010|FG000|Main Study|Death|0|||
23529780|NCT00110812|65673011|FG001|Main Study|Death|0|||
23529781|NCT00110812|65673012|FG002|Main Study|Death|2|||
23529782|NCT00110812|65673010|FG000|Main Study|Withdrawal by Subject|0|||
23529783|NCT00110812|65673011|FG001|Main Study|Withdrawal by Subject|0|||
23529784|NCT00110812|65673012|FG002|Main Study|Withdrawal by Subject|1|||
23529785|NCT00110812|65673010|FG000|Main Study|Lost to Follow-up|8|||
23529786|NCT00110812|65673011|FG001|Main Study|Lost to Follow-up|11|||
23529787|NCT00110812|65673012|FG002|Main Study|Lost to Follow-up|10|||
23529788|NCT00110812|65673010|FG000|Extended Follow-up|Death|1|||
23529789|NCT00110812|65673011|FG001|Extended Follow-up|Death|0|||
23529790|NCT00110812|65673012|FG002|Extended Follow-up|Death|3|||
23529791|NCT00110812|65673010|FG000|Extended Follow-up|Withdrawal by Subject|0|||
23529792|NCT00110812|65673011|FG001|Extended Follow-up|Withdrawal by Subject|1|||
23529793|NCT00110812|65673012|FG002|Extended Follow-up|Withdrawal by Subject|0|||
23529794|NCT00110812|65673010|FG000|Extended Follow-up|Lost to Follow-up|1|||
23529795|NCT00110812|65673011|FG001|Extended Follow-up|Lost to Follow-up|3|||
23529796|NCT00110812|65673012|FG002|Extended Follow-up|Lost to Follow-up|1|||
23529797|NCT01239368|65673013|FG000|Overall Study|Principal investigator discretion|1|||
23529798|NCT01239368|65673014|FG001|Overall Study|Principal investigator discretion|0|||
23529799|NCT01239368|65673015|FG002|Overall Study|Principal investigator discretion|0|||
23529800|NCT01239368|65673016|FG003|Overall Study|Principal investigator discretion|0|||
23529801|NCT01239368|65673017|FG004|Overall Study|Principal investigator discretion|1|||
23529802|NCT01239368|65673018|FG005|Overall Study|Principal investigator discretion|2|||
23529803|NCT01239368|65673019|FG006|Overall Study|Principal investigator discretion|0|||
23529804|NCT01239368|65673020|FG007|Overall Study|Principal investigator discretion|0|||
23529805|NCT01239368|65673021|FG008|Overall Study|Principal investigator discretion|0|||
23529806|NCT01239368|65673022|FG009|Overall Study|Principal investigator discretion|1|||
23718647|NCT02678312|66344539|FG000|Part 2 Double Blind Epoch|Death|0|||
23612564|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Other|0|||
23612565|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Other|0|||
23612566|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Other|0|||
23612567|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Other|0|||
23612568|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Other|3|||
23612569|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Other|3|||
23612570|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612571|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612572|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612573|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612574|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
23612575|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
23612576|NCT04839289|65969646|FG000|Overall Study|Withdrawal by Subject|1|||
23612577|NCT04839289|65969647|FG001|Overall Study|Withdrawal by Subject|0|||
23612578|NCT01774929|65969648|FG000|Overall Study|Adverse Event|3|||
23612579|NCT04879823|65969651|FG000|Overall Study|Physician Decision|3|||
23612580|NCT04879823|65969652|FG001|Overall Study|Physician Decision|1|||
23612581|NCT04879823|65969651|FG000|Overall Study|Protocol Violation|2|||
23612582|NCT04879823|65969652|FG001|Overall Study|Protocol Violation|3|||
23612583|NCT04879823|65969651|FG000|Overall Study|Lost to Follow-up|43|||
23612584|NCT04879823|65969652|FG001|Overall Study|Lost to Follow-up|35|||
23612585|NCT02879448|65969653|FG000|Overall Study|No implant attempt|17|||
23612586|NCT02879448|65969654|FG001|Overall Study|No implant attempt|28|||
23612587|NCT02879448|65969653|FG000|Overall Study|Withdrawal by Subject|20|||
23612588|NCT02879448|65969654|FG001|Overall Study|Withdrawal by Subject|46|||
23612589|NCT02879448|65969653|FG000|Overall Study|Death|63|||
23612590|NCT02879448|65969654|FG001|Overall Study|Death|85|||
23612591|NCT02879448|65969653|FG000|Overall Study|Lost to Follow-up|3|||
23612592|NCT02879448|65969654|FG001|Overall Study|Lost to Follow-up|4|||
23612593|NCT02879448|65969653|FG000|Overall Study|Missing visit|34|||
23612594|NCT02879448|65969654|FG001|Overall Study|Missing visit|39|||
23612595|NCT02879448|65969653|FG000|Overall Study|Pending evaluation|1|||
23612596|NCT02879448|65969654|FG001|Overall Study|Pending evaluation|0|||
23612597|NCT03481725|65969655|FG000|Overall Study|Withdrawal by Subject|1|||
23612598|NCT03481725|65969656|FG001|Overall Study|Withdrawal by Subject|0|||
23612599|NCT04620733|65969657|FG000|Overall Study|Adverse Event|4|||
23612600|NCT04620733|65969658|FG001|Overall Study|Adverse Event|3|||
23612601|NCT04620733|65969657|FG000|Overall Study|Withdrawal by Subject|2|||
23612602|NCT04620733|65969658|FG001|Overall Study|Withdrawal by Subject|5|||
23612603|NCT04620733|65969657|FG000|Overall Study|Lost to Follow-up|1|||
23612604|NCT04620733|65969658|FG001|Overall Study|Lost to Follow-up|1|||
23612605|NCT04620733|65969657|FG000|Overall Study|Protocol Deviation|1|||
23612606|NCT04620733|65969658|FG001|Overall Study|Protocol Deviation|1|||
23612607|NCT04620733|65969657|FG000|Overall Study|Reason Not Specified|0|||
23612608|NCT04620733|65969658|FG001|Overall Study|Reason Not Specified|1|||
23612609|NCT02105688|65969660|FG000|Part A: Double-Blind|Adverse Event|1|||
23612610|NCT02105688|65969661|FG001|Part A: Double-Blind|Adverse Event|0|||
23612611|NCT02105688|65969660|FG000|Part A: Double-Blind|Death|0|||
23612612|NCT02105688|65969661|FG001|Part A: Double-Blind|Death|1|||
23718648|NCT02678312|66344540|FG001|Part 2 Double Blind Epoch|Death|0|||
23529807|NCT01239368|65673013|FG000|Overall Study|Disease progression on study|1|||
23529808|NCT01239368|65673014|FG001|Overall Study|Disease progression on study|1|||
23529809|NCT01239368|65673015|FG002|Overall Study|Disease progression on study|1|||
23529810|NCT01239368|65673016|FG003|Overall Study|Disease progression on study|1|||
23529811|NCT01239368|65673017|FG004|Overall Study|Disease progression on study|4|||
23529812|NCT01239368|65673018|FG005|Overall Study|Disease progression on study|2|||
23529813|NCT01239368|65673019|FG006|Overall Study|Disease progression on study|5|||
23529814|NCT01239368|65673020|FG007|Overall Study|Disease progression on study|0|||
23529815|NCT01239368|65673021|FG008|Overall Study|Disease progression on study|0|||
23529816|NCT01239368|65673022|FG009|Overall Study|Disease progression on study|2|||
23529817|NCT01239368|65673013|FG000|Overall Study|Refused further treatment|0|||
23529818|NCT01239368|65673014|FG001|Overall Study|Refused further treatment|0|||
23529819|NCT01239368|65673015|FG002|Overall Study|Refused further treatment|0|||
23529820|NCT01239368|65673016|FG003|Overall Study|Refused further treatment|0|||
23529821|NCT01239368|65673017|FG004|Overall Study|Refused further treatment|0|||
23529822|NCT01239368|65673018|FG005|Overall Study|Refused further treatment|0|||
23529823|NCT01239368|65673019|FG006|Overall Study|Refused further treatment|0|||
23612613|NCT02105688|65969660|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
23612614|NCT02105688|65969661|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
23612615|NCT02105688|65969660|FG000|Part A: Double-Blind|Physician Decision|0|||
23718649|NCT02678312|66344541|FG002|Part 2 Double Blind Epoch|Death|0|||
23718650|NCT02678312|66344542|FG003|Part 2 Double Blind Epoch|Death|8|||
23612616|NCT02105688|65969661|FG001|Part A: Double-Blind|Physician Decision|1|||
23612617|NCT02105688|65969660|FG000|Part A: Double-Blind|Status Unknown|0|||
23612618|NCT02105688|65969661|FG001|Part A: Double-Blind|Status Unknown|2|||
23718651|NCT02678312|66344543|FG004|Part 2 Double Blind Epoch|Death|12|||
23529824|NCT01239368|65673020|FG007|Overall Study|Refused further treatment|0|||
23529825|NCT01239368|65673021|FG008|Overall Study|Refused further treatment|0|||
23529826|NCT01239368|65673022|FG009|Overall Study|Refused further treatment|1|||
23529827|NCT01239368|65673013|FG000|Overall Study|Death|0|||
23529828|NCT01239368|65673014|FG001|Overall Study|Death|0|||
23529829|NCT01239368|65673015|FG002|Overall Study|Death|0|||
23529830|NCT01239368|65673016|FG003|Overall Study|Death|0|||
23529831|NCT01239368|65673017|FG004|Overall Study|Death|0|||
23529832|NCT01239368|65673018|FG005|Overall Study|Death|0|||
23529833|NCT01239368|65673019|FG006|Overall Study|Death|1|||
23529834|NCT01239368|65673020|FG007|Overall Study|Death|0|||
23529835|NCT01239368|65673021|FG008|Overall Study|Death|0|||
23529836|NCT01239368|65673022|FG009|Overall Study|Death|0|||
23529837|NCT01232296|65673030|FG000|Overall Study|Adverse Event|24|||
23529838|NCT01232296|65673031|FG001|Overall Study|Adverse Event|12|||
23529839|NCT01232296|65673030|FG000|Overall Study|Physician Decision|1|||
23529840|NCT01232296|65673031|FG001|Overall Study|Physician Decision|1|||
23529841|NCT01232296|65673030|FG000|Overall Study|Progressive disease|43|||
23529842|NCT01232296|65673031|FG001|Overall Study|Progressive disease|61|||
23529843|NCT01232296|65673030|FG000|Overall Study|Study terminated by sponsor|0|||
23529844|NCT01232296|65673031|FG001|Overall Study|Study terminated by sponsor|1|||
23529845|NCT01232296|65673030|FG000|Overall Study|Technical problems|3|||
23529846|NCT01232296|65673031|FG001|Overall Study|Technical problems|0|||
23529847|NCT01232296|65673030|FG000|Overall Study|Subject/guardian decision|10|||
23529848|NCT01232296|65673031|FG001|Overall Study|Subject/guardian decision|2|||
23529849|NCT01232296|65673030|FG000|Overall Study|Death|1|||
23529850|NCT01232296|65673031|FG001|Overall Study|Death|6|||
23529851|NCT02412631|65673032|FG000|Overall Study|Adverse Event|1|||
23529852|NCT02412631|65673033|FG001|Overall Study|Adverse Event|2|||
23529853|NCT02412631|65673032|FG000|Overall Study|Lost to Follow-up|5|||
23529854|NCT02412631|65673033|FG001|Overall Study|Lost to Follow-up|9|||
23529855|NCT02412631|65673032|FG000|Overall Study|Withdrawal by Subject|9|||
23529856|NCT02412631|65673033|FG001|Overall Study|Withdrawal by Subject|3|||
23529857|NCT02412631|65673032|FG000|Overall Study|Early stop by FDA|5|||
23529858|NCT02412631|65673033|FG001|Overall Study|Early stop by FDA|2|||
23529859|NCT02412631|65673032|FG000|Overall Study|Unspecified reason|6|||
23529860|NCT02412631|65673033|FG001|Overall Study|Unspecified reason|8|||
23529861|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
23529862|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529863|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529864|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529865|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
23529866|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529867|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529868|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529869|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
23529870|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529871|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529872|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529873|NCT01502644|65673034|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
23529874|NCT01502644|65673035|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
23529875|NCT01502644|65673036|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
23529876|NCT01502644|65673037|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
23529877|NCT01502644|65673034|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
23529878|NCT01502644|65673035|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
23529879|NCT01502644|65673036|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
23529880|NCT01502644|65673037|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
23529881|NCT01433263|65673041|FG000|Overall Study|Adverse Event|3|||
23529882|NCT01433263|65673042|FG001|Overall Study|Adverse Event|1|||
23529883|NCT01433263|65673041|FG000|Overall Study|Death|5|||
23529884|NCT01433263|65673042|FG001|Overall Study|Death|3|||
23529885|NCT01433263|65673041|FG000|Overall Study|Lost to Follow-up|0|||
23529886|NCT01433263|65673042|FG001|Overall Study|Lost to Follow-up|1|||
23529887|NCT01433263|65673041|FG000|Overall Study|Protocol Deviation|1|||
23529888|NCT01433263|65673042|FG001|Overall Study|Protocol Deviation|0|||
23529889|NCT01433263|65673041|FG000|Overall Study|Withdrawal by Subject|10|||
23529890|NCT01433263|65673042|FG001|Overall Study|Withdrawal by Subject|7|||
23529891|NCT01848990|65673043|FG000|Overall Study|Adverse Event|6|||
23529892|NCT01848990|65673044|FG001|Overall Study|Adverse Event|2|||
23529893|NCT01848990|65673045|FG002|Overall Study|Adverse Event|0|||
23529894|NCT01848990|65673043|FG000|Overall Study|Lost to Follow-up|6|||
23529895|NCT01848990|65673044|FG001|Overall Study|Lost to Follow-up|2|||
23529896|NCT01848990|65673045|FG002|Overall Study|Lost to Follow-up|2|||
23529897|NCT01848990|65673043|FG000|Overall Study|Protocol Violation|1|||
23529898|NCT01848990|65673044|FG001|Overall Study|Protocol Violation|1|||
23529899|NCT01848990|65673045|FG002|Overall Study|Protocol Violation|0|||
23529900|NCT01848990|65673043|FG000|Overall Study|Withdrawal by Subject|29|||
23529901|NCT01848990|65673044|FG001|Overall Study|Withdrawal by Subject|10|||
23529902|NCT01848990|65673045|FG002|Overall Study|Withdrawal by Subject|11|||
23529903|NCT01848990|65673043|FG000|Overall Study|Physician Decision|1|||
23529904|NCT01848990|65673044|FG001|Overall Study|Physician Decision|1|||
23529905|NCT01848990|65673045|FG002|Overall Study|Physician Decision|0|||
23529906|NCT01848990|65673043|FG000|Overall Study|Non Compliance|1|||
23529907|NCT01848990|65673044|FG001|Overall Study|Non Compliance|0|||
23529908|NCT01848990|65673045|FG002|Overall Study|Non Compliance|0|||
23529909|NCT01848990|65673043|FG000|Overall Study|Death|1|||
23529910|NCT01848990|65673044|FG001|Overall Study|Death|0|||
23529911|NCT01848990|65673045|FG002|Overall Study|Death|1|||
23813607|NCT01081834|66699342|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23529912|NCT01848990|65673043|FG000|Overall Study|Other|1|||
23529913|NCT01848990|65673044|FG001|Overall Study|Other|4|||
23529914|NCT01848990|65673045|FG002|Overall Study|Other|2|||
23529915|NCT01533246|65673051|FG000|Overall Study|Adverse Event|1|||
23529916|NCT01533246|65673051|FG000|Overall Study|Withdrawal by Subject|1|||
23529917|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Adverse Event|2|||
23529918|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Adverse Event|3|||
23529919|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Adverse Event|4|||
23529920|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Adverse Event|4|||
23529921|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
23529922|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
23529923|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
23529924|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
23529925|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
23529926|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
23529927|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
23529928|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23529929|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
23529930|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
23529931|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
23529932|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
23529933|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
23529934|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
23529935|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
23529936|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
23529937|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
23529938|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
23529939|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
23529940|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
23529941|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529942|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529943|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529944|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
23529945|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529946|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529947|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529948|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
23529949|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529950|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529951|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529952|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
23529953|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23529954|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23529955|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
23529956|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
23529957|NCT01712984|65676007|FG000|Overall Study|Adverse Event|0|||
23529958|NCT01712984|65676008|FG001|Overall Study|Adverse Event|0|||
23529959|NCT01712984|65676009|FG002|Overall Study|Adverse Event|1|||
23529960|NCT01712984|65676007|FG000|Overall Study|Protocol Violation|2|||
23529961|NCT01712984|65676008|FG001|Overall Study|Protocol Violation|0|||
23529962|NCT01712984|65676009|FG002|Overall Study|Protocol Violation|1|||
23612619|NCT02105688|65969660|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
23813608|NCT01081834|66699343|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23529963|NCT01712984|65676007|FG000|Overall Study|Lost to Follow-up|8|||
23529964|NCT01712984|65676008|FG001|Overall Study|Lost to Follow-up|10|||
23529965|NCT01712984|65676009|FG002|Overall Study|Lost to Follow-up|1|||
23529966|NCT01712984|65676007|FG000|Overall Study|Withdrawal by Subject|6|||
23529967|NCT01712984|65676008|FG001|Overall Study|Withdrawal by Subject|6|||
23612620|NCT02105688|65969661|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
23529968|NCT01712984|65676009|FG002|Overall Study|Withdrawal by Subject|7|||
23529969|NCT01438541|65676010|FG000|Overall Study|Physician Decision|1|||
23529970|NCT01438541|65676010|FG000|Overall Study|Withdrawal by Subject|1|||
23529971|NCT01438541|65676010|FG000|Overall Study|discharge from the hospital|5|||
23529972|NCT02517905|65676011|FG000|Overall Study|Lost to Follow-up|4|||
23529973|NCT02517905|65676012|FG001|Overall Study|Lost to Follow-up|0|||
23529974|NCT02517905|65676011|FG000|Overall Study|Withdrawal by Subject|4|||
23529975|NCT02517905|65676012|FG001|Overall Study|Withdrawal by Subject|0|||
23529976|NCT02517905|65676011|FG000|Overall Study|Screen failure|2|||
23529977|NCT02517905|65676012|FG001|Overall Study|Screen failure|2|||
23529978|NCT02487394|65676015|FG000|Phase 1|Withdrawal by Subject|0|||
23529979|NCT02487394|65676016|FG001|Phase 1|Withdrawal by Subject|1|||
23529980|NCT00393939|65676019|FG000|Overall Study|Protocol Violation|1|||
23529981|NCT00393939|65676020|FG001|Overall Study|Protocol Violation|1|||
23529982|NCT00393939|65676019|FG000|Overall Study|Lost to Follow-up|2|||
23529983|NCT00393939|65676020|FG001|Overall Study|Lost to Follow-up|4|||
23529984|NCT00393939|65676019|FG000|Overall Study|Death|10|||
23529985|NCT00393939|65676020|FG001|Overall Study|Death|4|||
23529986|NCT00393939|65676019|FG000|Overall Study|Sponsor|5|||
23529987|NCT00393939|65676020|FG001|Overall Study|Sponsor|13|||
23529988|NCT00393939|65676019|FG000|Overall Study|Objective progression or relapse|239|||
23529989|NCT00393939|65676020|FG001|Overall Study|Objective progression or relapse|223|||
23529990|NCT00393939|65676019|FG000|Overall Study|Withdrawal by Subject|2|||
23529991|NCT00393939|65676020|FG001|Overall Study|Withdrawal by Subject|7|||
23529992|NCT00393939|65676019|FG000|Overall Study|Other|37|||
23529993|NCT00393939|65676020|FG001|Overall Study|Other|45|||
23529994|NCT05044234|65676021|FG000|Overall Study|Lost to Follow-up|2|||
23529995|NCT05044234|65676022|FG001|Overall Study|Lost to Follow-up|1|||
23529996|NCT05044234|65676023|FG002|Overall Study|Lost to Follow-up|1|||
23529997|NCT05044234|65676024|FG003|Overall Study|Lost to Follow-up|2|||
23529998|NCT05044234|65676021|FG000|Overall Study|Withdrawal by Subject|6|||
23529999|NCT05044234|65676022|FG001|Overall Study|Withdrawal by Subject|4|||
23530000|NCT05044234|65676023|FG002|Overall Study|Withdrawal by Subject|5|||
23530001|NCT05044234|65676024|FG003|Overall Study|Withdrawal by Subject|8|||
23530002|NCT05044234|65676021|FG000|Overall Study|Study terminated by Sponsor|21|||
23530003|NCT05044234|65676022|FG001|Overall Study|Study terminated by Sponsor|21|||
23530004|NCT05044234|65676023|FG002|Overall Study|Study terminated by Sponsor|20|||
23530005|NCT05044234|65676024|FG003|Overall Study|Study terminated by Sponsor|14|||
23530006|NCT05044234|65676021|FG000|Overall Study|Other, not specified|0|||
23530007|NCT05044234|65676022|FG001|Overall Study|Other, not specified|0|||
23530008|NCT05044234|65676023|FG002|Overall Study|Other, not specified|1|||
23530009|NCT05044234|65676024|FG003|Overall Study|Other, not specified|2|||
23612621|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Death|2|||
23612622|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Death|1|||
23612623|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
23612624|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
23612625|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
23612626|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
23612627|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Physician Decision|3|||
23612628|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Physician Decision|1|||
23612629|NCT01234675|65969662|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
23612630|NCT01234675|65969663|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23612631|NCT01234675|65969662|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23612632|NCT01234675|65969663|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23612633|NCT01332318|65969664|FG000|Overall Study|Adverse Event|0|||
23612634|NCT01332318|65969665|FG001|Overall Study|Adverse Event|3|||
23612635|NCT01332318|65969666|FG002|Overall Study|Adverse Event|0|||
23530010|NCT05044234|65676021|FG000|Overall Study|Delayed data entry|0|||
23530011|NCT05044234|65676022|FG001|Overall Study|Delayed data entry|0|||
23530012|NCT05044234|65676023|FG002|Overall Study|Delayed data entry|0|||
23530013|NCT05044234|65676024|FG003|Overall Study|Delayed data entry|1|||
23530014|NCT00004031|65676025|FG000|Overall Study|Adverse Event|5|||
23530015|NCT00004031|65676026|FG001|Overall Study|Adverse Event|0|||
23530016|NCT00004031|65676025|FG000|Overall Study|Refusal unrelated to adverse events|2|||
23530017|NCT00004031|65676026|FG001|Overall Study|Refusal unrelated to adverse events|11|||
23530018|NCT00004031|65676025|FG000|Overall Study|Progression/relapse|9|||
23530019|NCT00004031|65676026|FG001|Overall Study|Progression/relapse|4|||
23530020|NCT00004031|65676025|FG000|Overall Study|Death|3|||
23530021|NCT00004031|65676026|FG001|Overall Study|Death|1|||
23530022|NCT00004031|65676025|FG000|Overall Study|Other- not protocol specified|3|||
23530023|NCT00004031|65676026|FG001|Overall Study|Other- not protocol specified|3|||
23612636|NCT01332318|65969667|FG003|Overall Study|Adverse Event|0|||
23612637|NCT01332318|65969664|FG000|Overall Study|Withdrawal by Subject|1|||
23612638|NCT01332318|65969665|FG001|Overall Study|Withdrawal by Subject|1|||
23530024|NCT00004031|65676025|FG000|Overall Study|Reason under review|3|||
23530025|NCT00004031|65676026|FG001|Overall Study|Reason under review|2|||
23718652|NCT02678312|66344539|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
23718653|NCT02678312|66344540|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
23419267|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419268|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419269|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23530026|NCT03277846|65676028|FG000|Overall Study|Inpatient stay too brief|12|||
23530027|NCT03277846|65676029|FG001|Overall Study|Inpatient stay too brief|11|||
23530028|NCT01603875|65676038|FG000|Overall Study|Preexisting rabies antibody|3|||
23530029|NCT01603875|65676039|FG001|Overall Study|Preexisting rabies antibody|4|||
23530030|NCT01603875|65676040|FG002|Overall Study|Preexisting rabies antibody|3|||
23530031|NCT01603875|65676038|FG000|Overall Study|Lost to Follow-up|4|||
23530032|NCT01603875|65676039|FG001|Overall Study|Lost to Follow-up|3|||
23530033|NCT01603875|65676040|FG002|Overall Study|Lost to Follow-up|6|||
23530034|NCT01603875|65676038|FG000|Overall Study|Protocol Violation|0|||
23530035|NCT01603875|65676039|FG001|Overall Study|Protocol Violation|1|||
23530036|NCT01603875|65676040|FG002|Overall Study|Protocol Violation|0|||
23530037|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
23530038|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
23530039|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
23530040|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
23530041|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
23530042|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
23530043|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
23530044|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
23419270|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419271|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419272|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419273|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
23419274|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
23419275|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
23419276|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
23419277|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
23419278|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419279|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419280|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419281|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419282|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23530045|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
23530046|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
23530047|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
23530048|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
23530049|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
23530050|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
23530051|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
23530052|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
23530053|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
23530054|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
23530055|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
23530056|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
23530057|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
23530058|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
23530059|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
23530060|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
23530061|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
23530062|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
23530063|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
23530064|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
23530065|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
23530066|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
23612639|NCT01332318|65969666|FG002|Overall Study|Withdrawal by Subject|0|||
23612640|NCT01332318|65969667|FG003|Overall Study|Withdrawal by Subject|1|||
23612641|NCT01332318|65969664|FG000|Overall Study|Protocol Violation|1|||
23612642|NCT01332318|65969665|FG001|Overall Study|Protocol Violation|0|||
23612643|NCT01332318|65969666|FG002|Overall Study|Protocol Violation|1|||
23718654|NCT02678312|66344541|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
23530067|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
23530068|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
23530069|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
23530070|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
23530071|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
23530072|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
23530073|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
23530074|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
23530075|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
23530076|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
23530077|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
23530078|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
23530079|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
23530080|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
23612644|NCT01332318|65969667|FG003|Overall Study|Protocol Violation|1|||
23612645|NCT03449979|65969668|FG000|Overall Study|Technical difficulty|0|||
23612646|NCT03449979|65969669|FG001|Overall Study|Technical difficulty|0|||
23612647|NCT03449979|65969670|FG002|Overall Study|Technical difficulty|0|||
23612648|NCT03449979|65969671|FG003|Overall Study|Technical difficulty|1|||
23612649|NCT02854436|65969676|FG000|Overall Study|Adverse Event|1|||
23612650|NCT02854436|65969676|FG000|Overall Study|Death|208|||
23612651|NCT02854436|65969676|FG000|Overall Study|Lost to Follow-up|5|||
23612652|NCT02854436|65969676|FG000|Overall Study|Withdrawal by Subject|24|||
23612653|NCT02854436|65969676|FG000|Overall Study|Other|45|||
23612654|NCT02854436|65969676|FG000|Overall Study|Physician Decision|6|||
23612655|NCT00080119|65969677|FG000|Overall Study|Discontinued because of study closure|0|||
23612656|NCT00080119|65969678|FG001|Overall Study|Discontinued because of study closure|0|||
23612657|NCT00080119|65969679|FG002|Overall Study|Discontinued because of study closure|130|||
23612658|NCT00080119|65969680|FG003|Overall Study|Discontinued because of study closure|141|||
23612659|NCT00080119|65969677|FG000|Overall Study|Unable to get to clinic|24|||
23612660|NCT00080119|65969678|FG001|Overall Study|Unable to get to clinic|24|||
23612661|NCT00080119|65969679|FG002|Overall Study|Unable to get to clinic|7|||
23612662|NCT00080119|65969680|FG003|Overall Study|Unable to get to clinic|1|||
23612663|NCT00080119|65969677|FG000|Overall Study|Consent withdrawn|13|||
23612664|NCT00080119|65969678|FG001|Overall Study|Consent withdrawn|17|||
23612665|NCT00080119|65969679|FG002|Overall Study|Consent withdrawn|4|||
23612666|NCT00080119|65969680|FG003|Overall Study|Consent withdrawn|6|||
23612667|NCT00080119|65969677|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
23612668|NCT00080119|65969678|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
23612669|NCT00080119|65969679|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
23612670|NCT00080119|65969680|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
23612671|NCT00080119|65969677|FG000|Overall Study|Lost to Follow-up|16|||
23612672|NCT00080119|65969678|FG001|Overall Study|Lost to Follow-up|19|||
23612673|NCT00080119|65969679|FG002|Overall Study|Lost to Follow-up|19|||
23612674|NCT00080119|65969680|FG003|Overall Study|Lost to Follow-up|14|||
23612675|NCT02092285|65969684|FG000|Induction Phase|Adverse Event|7|||
23612676|NCT02092285|65969684|FG000|Induction Phase|Physician Decision|4|||
23612677|NCT02092285|65969684|FG000|Induction Phase|Pregnancy|1|||
23612678|NCT02092285|65969684|FG000|Induction Phase|Relapse/Recurrence|7|||
23612679|NCT02092285|65969684|FG000|Induction Phase|Withdrawal by Subject|2|||
23612680|NCT02092285|65969684|FG000|Induction Phase|Lack of Efficacy|14|||
23612681|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
23612682|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
23612683|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
23813609|NCT01081834|66699344|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23718655|NCT02678312|66344542|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
23718656|NCT02678312|66344543|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
23718657|NCT02678312|66344539|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23718658|NCT02678312|66344540|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23718659|NCT02678312|66344541|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23718660|NCT02678312|66344542|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23718661|NCT02678312|66344543|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
23718662|NCT02678312|66344539|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23718663|NCT02678312|66344540|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23718664|NCT02678312|66344541|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23718665|NCT02678312|66344542|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
23718666|NCT02678312|66344543|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
23718667|NCT02148211|66344547|FG000|Overall Study|Lost to Follow-up|352|||
23718668|NCT02966353|66344550|FG000|Overall Study|Withdrawal by Subject|7|||
23718669|NCT02966353|66344550|FG000|Overall Study|Adverse Event|4|||
23718670|NCT02966353|66344550|FG000|Overall Study|Death|4|||
23718671|NCT02966353|66344550|FG000|Overall Study|Physician Decision|3|||
23813610|NCT01081834|66699345|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23813611|NCT01081834|66699346|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23813612|NCT03825341|66699349|FG000|Overall Study|Withdrawal by Subject|0|||
23813613|NCT03825341|66699350|FG001|Overall Study|Withdrawal by Subject|1|||
23813614|NCT01857271|66699351|FG000|Overall Study|Lost to Follow-up|1|||
23813615|NCT01524679|66699352|FG000|Overall Study|Lost to Follow-up|1|||
23813616|NCT01524679|66699353|FG001|Overall Study|Lost to Follow-up|4|||
23813617|NCT01524679|66699352|FG000|Overall Study|Withdrawal by Subject|4|||
23813618|NCT01524679|66699353|FG001|Overall Study|Withdrawal by Subject|4|||
23813619|NCT01524679|66699352|FG000|Overall Study|Adverse Event|9|||
23813620|NCT01524679|66699353|FG001|Overall Study|Adverse Event|0|||
23813621|NCT01524679|66699352|FG000|Overall Study|Protocol Violation|1|||
23813622|NCT01524679|66699353|FG001|Overall Study|Protocol Violation|0|||
23813623|NCT01524679|66699352|FG000|Overall Study|Lack of Efficacy|2|||
23813624|NCT01524679|66699353|FG001|Overall Study|Lack of Efficacy|0|||
23813625|NCT01524679|66699352|FG000|Overall Study|e.g.wish for children, relocation|6|||
23813626|NCT01524679|66699353|FG001|Overall Study|e.g.wish for children, relocation|1|||
23813627|NCT02458287|66699356|FG000|Overall Study|Adverse Event|0|||
23813628|NCT02458287|66699357|FG001|Overall Study|Adverse Event|0|||
23813629|NCT02458287|66699358|FG002|Overall Study|Adverse Event|0|||
23813630|NCT02458287|66699359|FG003|Overall Study|Adverse Event|1|||
23813631|NCT02458287|66699356|FG000|Overall Study|Lost to Follow-up|0|||
23813632|NCT02458287|66699357|FG001|Overall Study|Lost to Follow-up|1|||
23813633|NCT02458287|66699358|FG002|Overall Study|Lost to Follow-up|1|||
23813634|NCT02458287|66699359|FG003|Overall Study|Lost to Follow-up|0|||
23813635|NCT02458287|66699356|FG000|Overall Study|Protocol Violation|0|||
23813636|NCT02458287|66699357|FG001|Overall Study|Protocol Violation|1|||
23813637|NCT02458287|66699358|FG002|Overall Study|Protocol Violation|0|||
23813638|NCT02458287|66699359|FG003|Overall Study|Protocol Violation|0|||
23813639|NCT02458287|66699356|FG000|Overall Study|Withdrawal by Subject|0|||
23813640|NCT02458287|66699357|FG001|Overall Study|Withdrawal by Subject|2|||
23813641|NCT02458287|66699358|FG002|Overall Study|Withdrawal by Subject|2|||
23718672|NCT02966353|66344550|FG000|Overall Study|Progressive disease|2|||
23718673|NCT02966353|66344550|FG000|Overall Study|Protocol deviation|2|||
23813642|NCT02458287|66699359|FG003|Overall Study|Withdrawal by Subject|1|||
23813643|NCT02458287|66699356|FG000|Overall Study|Relocated Out of State|0|||
23813644|NCT02458287|66699357|FG001|Overall Study|Relocated Out of State|0|||
23813645|NCT02458287|66699358|FG002|Overall Study|Relocated Out of State|0|||
23813646|NCT02458287|66699359|FG003|Overall Study|Relocated Out of State|1|||
23718674|NCT00270998|66344551|FG000|3 Month Follow-up|Adverse Event|1|||
23813647|NCT02325518|66699369|FG000|Overall Study|Adverse Event|4|||
23813648|NCT02325518|66699370|FG001|Overall Study|Adverse Event|1|||
23813649|NCT02325518|66699369|FG000|Overall Study|Physician Decision|0|||
23813650|NCT02325518|66699370|FG001|Overall Study|Physician Decision|1|||
23813651|NCT02325518|66699369|FG000|Overall Study|Withdrawal by Subject|0|||
23813652|NCT02325518|66699370|FG001|Overall Study|Withdrawal by Subject|1|||
23813653|NCT03753763|66699373|FG000|Overall Study|Adverse Event|2|||
23813654|NCT03753763|66699374|FG001|Overall Study|Adverse Event|0|||
23813655|NCT03753763|66699373|FG000|Overall Study|Withdrawal by Subject|3|||
23813656|NCT03753763|66699374|FG001|Overall Study|Withdrawal by Subject|1|||
23813657|NCT03753763|66699373|FG000|Overall Study|clinical deterioration|1|||
23813658|NCT03753763|66699374|FG001|Overall Study|clinical deterioration|0|||
23813659|NCT01292226|66699375|FG000|Overall Study|Adverse Event|5|||
23813660|NCT01292226|66699375|FG000|Overall Study|Death|1|||
23813661|NCT01292226|66699375|FG000|Overall Study|Graft loss|1|||
23813662|NCT01292226|66699375|FG000|Overall Study|Protocol Violation|3|||
23813663|NCT01292226|66699375|FG000|Overall Study|Withdrawal by Subject|1|||
23813664|NCT01292226|66699375|FG000|Overall Study|Other|2|||
23813665|NCT01104792|66699376|FG000|Overall Study|Adverse Event|77|||
23813666|NCT01104792|66699376|FG000|Overall Study|Insufficient Therapeutic Response|22|||
23813667|NCT01104792|66699376|FG000|Overall Study|Protocol Violation|45|||
23813668|NCT01104792|66699376|FG000|Overall Study|Withdrawal of Consent|179|||
23813669|NCT01104792|66699376|FG000|Overall Study|Lost to Follow-up|43|||
23813670|NCT01104792|66699376|FG000|Overall Study|Reasons Not Specified|27|||
23813671|NCT01104792|66699376|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
23813672|NCT02994940|66699377|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
23813673|NCT02994940|66699378|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
23813674|NCT02994940|66699377|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
23813675|NCT02994940|66699378|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
23813676|NCT02994940|66699377|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
23813677|NCT02994940|66699378|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
23813678|NCT02712333|66699379|FG000|First Period|Withdrawal by Subject|3|||
23813679|NCT02712333|66699380|FG001|First Period|Withdrawal by Subject|2|||
23813680|NCT01955083|66699381|FG000|Overall Study|Lost to Follow-up|1|||
23813681|NCT01955083|66699382|FG001|Overall Study|Lost to Follow-up|1|||
23813682|NCT04933968|66699384|FG000|Overall Study|Adverse Event|0|||
23813683|NCT04933968|66699385|FG001|Overall Study|Adverse Event|0|||
23813684|NCT04933968|66699386|FG002|Overall Study|Adverse Event|1|||
23813685|NCT04933968|66699387|FG003|Overall Study|Adverse Event|1|||
23813686|NCT04933968|66699388|FG004|Overall Study|Adverse Event|0|||
23813687|NCT04933968|66699389|FG005|Overall Study|Adverse Event|0|||
23813688|NCT04933968|66699384|FG000|Overall Study|Lost to Follow-up|1|||
23813689|NCT04933968|66699385|FG001|Overall Study|Lost to Follow-up|0|||
23813690|NCT04933968|66699386|FG002|Overall Study|Lost to Follow-up|1|||
23813691|NCT04933968|66699387|FG003|Overall Study|Lost to Follow-up|0|||
23813692|NCT04933968|66699388|FG004|Overall Study|Lost to Follow-up|0|||
23813693|NCT04933968|66699389|FG005|Overall Study|Lost to Follow-up|0|||
23813694|NCT04933968|66699384|FG000|Overall Study|Randomized not treated|1|||
23813695|NCT04933968|66699385|FG001|Overall Study|Randomized not treated|0|||
23813696|NCT04933968|66699386|FG002|Overall Study|Randomized not treated|0|||
23813697|NCT04933968|66699387|FG003|Overall Study|Randomized not treated|0|||
23813698|NCT04933968|66699388|FG004|Overall Study|Randomized not treated|0|||
23813699|NCT04933968|66699389|FG005|Overall Study|Randomized not treated|0|||
23813700|NCT04933968|66699384|FG000|Overall Study|Sponsor terminated study|0|||
23813701|NCT04933968|66699385|FG001|Overall Study|Sponsor terminated study|0|||
23813702|NCT04933968|66699386|FG002|Overall Study|Sponsor terminated study|0|||
23813703|NCT04933968|66699387|FG003|Overall Study|Sponsor terminated study|1|||
23813704|NCT04933968|66699388|FG004|Overall Study|Sponsor terminated study|2|||
23813705|NCT04933968|66699389|FG005|Overall Study|Sponsor terminated study|0|||
23813706|NCT04933968|66699384|FG000|Overall Study|Other|0|||
23813707|NCT04933968|66699385|FG001|Overall Study|Other|0|||
23813708|NCT04933968|66699386|FG002|Overall Study|Other|0|||
23813709|NCT04933968|66699387|FG003|Overall Study|Other|1|||
23813710|NCT04933968|66699388|FG004|Overall Study|Other|0|||
23813711|NCT04933968|66699389|FG005|Overall Study|Other|0|||
23813712|NCT04933968|66699384|FG000|Overall Study|Missing|1|||
23813713|NCT04933968|66699385|FG001|Overall Study|Missing|3|||
23718675|NCT00270998|66344552|FG001|3 Month Follow-up|Adverse Event|0|||
23718676|NCT00270998|66344553|FG002|3 Month Follow-up|Adverse Event|0|||
23718677|NCT00270998|66344551|FG000|3 Month Follow-up|Lack of Efficacy|1|||
23718678|NCT00270998|66344552|FG001|3 Month Follow-up|Lack of Efficacy|2|||
23718679|NCT00270998|66344553|FG002|3 Month Follow-up|Lack of Efficacy|1|||
23718680|NCT00270998|66344551|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
23718681|NCT00270998|66344552|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
23718682|NCT00270998|66344553|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
23718683|NCT00270998|66344551|FG000|3 Month Follow-up|Pessary did not fit|12|||
23718684|NCT00270998|66344552|FG001|3 Month Follow-up|Pessary did not fit|0|||
23718685|NCT00270998|66344553|FG002|3 Month Follow-up|Pessary did not fit|0|||
23718686|NCT00270998|66344551|FG000|3 Month Follow-up|Personal/family health|1|||
23718687|NCT00270998|66344552|FG001|3 Month Follow-up|Personal/family health|1|||
23718688|NCT00270998|66344553|FG002|3 Month Follow-up|Personal/family health|0|||
23718689|NCT00270998|66344551|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
23718690|NCT00270998|66344552|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
23718691|NCT00270998|66344553|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
23718692|NCT00270998|66344551|FG000|12 Month Follow-up|Lack of Efficacy|5|||
23718693|NCT00270998|66344552|FG001|12 Month Follow-up|Lack of Efficacy|4|||
23718694|NCT00270998|66344553|FG002|12 Month Follow-up|Lack of Efficacy|3|||
23718695|NCT00270998|66344551|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
23718696|NCT00270998|66344552|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
23718697|NCT00270998|66344553|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
23718698|NCT00270998|66344551|FG000|12 Month Follow-up|Pessary did not fit|1|||
23718699|NCT00270998|66344552|FG001|12 Month Follow-up|Pessary did not fit|0|||
23718700|NCT00270998|66344553|FG002|12 Month Follow-up|Pessary did not fit|0|||
23718701|NCT00270998|66344551|FG000|12 Month Follow-up|Personal/family health|0|||
23718702|NCT00270998|66344552|FG001|12 Month Follow-up|Personal/family health|5|||
23718703|NCT00270998|66344553|FG002|12 Month Follow-up|Personal/family health|1|||
23718704|NCT00270998|66344551|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
23718705|NCT00270998|66344552|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
23718706|NCT00270998|66344553|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
23718707|NCT01617655|66344555|FG000|Overall Study|Adverse Event|2|||
23718708|NCT01617655|66344556|FG001|Overall Study|Adverse Event|3|||
23530081|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
23530082|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
23530083|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
23530084|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
23530085|NCT02884089|65676055|FG000|Period 1|Dosing error|2|||
23530086|NCT02884089|65676056|FG001|Period 1|Dosing error|2|||
23530087|NCT02884089|65676057|FG002|Period 1|Dosing error|0|||
23530088|NCT02884089|65676058|FG003|Period 1|Dosing error|0|||
23530089|NCT02884089|65676055|FG000|Washout Period 1|Lost to Follow-up|0|||
23530090|NCT02884089|65676056|FG001|Washout Period 1|Lost to Follow-up|1|||
23530091|NCT02884089|65676057|FG002|Washout Period 1|Lost to Follow-up|0|||
23530092|NCT02884089|65676058|FG003|Washout Period 1|Lost to Follow-up|1|||
23530093|NCT02884089|65676055|FG000|Washout Period 1|Withdrawal by Subject|0|||
23530094|NCT02884089|65676056|FG001|Washout Period 1|Withdrawal by Subject|1|||
23530095|NCT02884089|65676057|FG002|Washout Period 1|Withdrawal by Subject|0|||
23530096|NCT02884089|65676058|FG003|Washout Period 1|Withdrawal by Subject|0|||
23530097|NCT02884089|65676055|FG000|Period 2|Adverse Event|1|||
23530098|NCT02884089|65676056|FG001|Period 2|Adverse Event|0|||
23530099|NCT02884089|65676057|FG002|Period 2|Adverse Event|0|||
23530100|NCT02884089|65676058|FG003|Period 2|Adverse Event|0|||
23530101|NCT02884089|65676055|FG000|Period 3|Withdrawal by Subject|0|||
23530102|NCT02884089|65676056|FG001|Period 3|Withdrawal by Subject|0|||
23530103|NCT02884089|65676057|FG002|Period 3|Withdrawal by Subject|1|||
23530104|NCT02884089|65676058|FG003|Period 3|Withdrawal by Subject|0|||
23530105|NCT02884089|65676055|FG000|Washout Period 3|Withdrawal by Subject|0|||
23530106|NCT02884089|65676056|FG001|Washout Period 3|Withdrawal by Subject|0|||
23612684|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
23612685|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
23612686|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
23612687|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
23612688|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
23612689|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
23612690|NCT00561678|65969686|FG000|Overall Study|Withdrawal by Subject|4|||
23718709|NCT01617655|66344555|FG000|Overall Study|Poor compliance to protocol|1|||
23718710|NCT01617655|66344556|FG001|Overall Study|Poor compliance to protocol|4|||
23718711|NCT01617655|66344555|FG000|Overall Study|Participants moved|0|||
23718712|NCT01617655|66344556|FG001|Overall Study|Participants moved|4|||
23718713|NCT01617655|66344555|FG000|Overall Study|Consent withdrawn by participant|1|||
23718714|NCT01617655|66344556|FG001|Overall Study|Consent withdrawn by participant|1|||
23718715|NCT01617655|66344555|FG000|Overall Study|Last visit outside protocol visit window|1|||
23612691|NCT00561678|65969687|FG001|Overall Study|Withdrawal by Subject|3|||
23612692|NCT00561678|65969686|FG000|Overall Study|surgery cancelled|1|||
23612693|NCT00561678|65969687|FG001|Overall Study|surgery cancelled|1|||
23612694|NCT00561678|65969686|FG000|Overall Study|surgery rescheduled to different site|2|||
23612695|NCT00561678|65969687|FG001|Overall Study|surgery rescheduled to different site|2|||
23612696|NCT00561678|65969686|FG000|Overall Study|anesthesia provider refusal|1|||
23612697|NCT00561678|65969687|FG001|Overall Study|anesthesia provider refusal|0|||
23612698|NCT00587171|65969688|FG000|Overall Study|Lost to Follow-up|1|||
23612699|NCT00587171|65969689|FG001|Overall Study|Lost to Follow-up|1|||
23612700|NCT01525875|65969690|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
23612701|NCT01525875|65969691|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
23612702|NCT01525875|65969690|FG000|Open-label Period|Lost to Follow-up|0|||
23612703|NCT01525875|65969691|FG001|Open-label Period|Lost to Follow-up|2|||
23612704|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
23612705|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Death|1|||
23612706|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
23612707|NCT03023878|65969692|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
23612708|NCT03023878|65969692|FG000|Treatment Period|Disease Progression|1|||
23612709|NCT03023878|65969692|FG000|Treatment Period|Withdrawal by Subject|1|||
23612710|NCT03023878|65969692|FG000|Treatment Period|Adverse Event|1|||
23530107|NCT02884089|65676057|FG002|Washout Period 3|Withdrawal by Subject|1|||
23612711|NCT03023878|65969692|FG000|Long Term Follow-Up Period|Death|2|||
23612712|NCT03214198|65969693|FG000|Overall Study|Case Report Forms Uncollected|18|||
23612713|NCT03214198|65969693|FG000|Overall Study|Protocol Deviation|18|||
23612714|NCT00700999|65969694|FG000|Overall Study|Lost to Follow-up|7|||
23612715|NCT00700999|65969695|FG001|Overall Study|Lost to Follow-up|7|||
23530108|NCT02884089|65676058|FG003|Washout Period 3|Withdrawal by Subject|0|||
23530109|NCT02884089|65676055|FG000|Washout Period 3|Lost to Follow-up|0|||
23530110|NCT02884089|65676056|FG001|Washout Period 3|Lost to Follow-up|0|||
23530111|NCT02884089|65676057|FG002|Washout Period 3|Lost to Follow-up|0|||
23718716|NCT01617655|66344556|FG001|Overall Study|Last visit outside protocol visit window|10|||
23718717|NCT01617655|66344555|FG000|Overall Study|Site closure|3|||
23718718|NCT01617655|66344556|FG001|Overall Study|Site closure|5|||
23718719|NCT01617655|66344555|FG000|Overall Study|Other than specified above|1|||
23718720|NCT01617655|66344556|FG001|Overall Study|Other than specified above|2|||
23718721|NCT01576406|66344560|FG000|Overall Study|Lost to Follow-up|1|||
23718722|NCT01576406|66344561|FG001|Overall Study|Lost to Follow-up|2|||
23718723|NCT01576406|66344562|FG002|Overall Study|Lost to Follow-up|0|||
23718724|NCT01576406|66344563|FG003|Overall Study|Lost to Follow-up|0|||
23718725|NCT01576406|66344564|FG004|Overall Study|Lost to Follow-up|0|||
23718726|NCT01576406|66344565|FG005|Overall Study|Lost to Follow-up|0|||
23718727|NCT01576406|66344560|FG000|Overall Study|Death|3|||
23718728|NCT01576406|66344561|FG001|Overall Study|Death|4|||
23718729|NCT01576406|66344562|FG002|Overall Study|Death|8|||
23718730|NCT01576406|66344563|FG003|Overall Study|Death|5|||
23718731|NCT01576406|66344564|FG004|Overall Study|Death|7|||
23718732|NCT01576406|66344565|FG005|Overall Study|Death|9|||
23718733|NCT01576406|66344560|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23718734|NCT01576406|66344561|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23718735|NCT01576406|66344562|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
23718736|NCT01576406|66344563|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
23718737|NCT01576406|66344564|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23718738|NCT01576406|66344565|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23718739|NCT01576406|66344560|FG000|Overall Study|Withdrawal the consent|2|||
23718740|NCT01576406|66344561|FG001|Overall Study|Withdrawal the consent|2|||
23718741|NCT01576406|66344562|FG002|Overall Study|Withdrawal the consent|5|||
23718742|NCT01576406|66344563|FG003|Overall Study|Withdrawal the consent|1|||
23718743|NCT01576406|66344564|FG004|Overall Study|Withdrawal the consent|1|||
23718744|NCT01576406|66344565|FG005|Overall Study|Withdrawal the consent|3|||
23718745|NCT01576406|66344560|FG000|Overall Study|Other|0|||
23718746|NCT01576406|66344561|FG001|Overall Study|Other|0|||
23718747|NCT01576406|66344562|FG002|Overall Study|Other|2|||
23718748|NCT01576406|66344563|FG003|Overall Study|Other|2|||
23718749|NCT01576406|66344564|FG004|Overall Study|Other|0|||
23718750|NCT01576406|66344565|FG005|Overall Study|Other|0|||
23718751|NCT04685499|66344570|FG000|Overall Study|Study Terminated Early|1|||
23718752|NCT02137837|66344573|FG000|Overall Study|Adverse Event|0|||
23718753|NCT02137837|66344574|FG001|Overall Study|Adverse Event|2|||
23718754|NCT02137837|66344575|FG002|Overall Study|Adverse Event|1|||
23718755|NCT02137837|66344573|FG000|Overall Study|Refusal unrelated to adverse event|2|||
23718756|NCT02137837|66344574|FG001|Overall Study|Refusal unrelated to adverse event|2|||
23718757|NCT02137837|66344575|FG002|Overall Study|Refusal unrelated to adverse event|1|||
23718758|NCT02137837|66344573|FG000|Overall Study|Progression/relapse|9|||
23718759|NCT02137837|66344574|FG001|Overall Study|Progression/relapse|7|||
23718760|NCT02137837|66344575|FG002|Overall Study|Progression/relapse|7|||
23718761|NCT02137837|66344573|FG000|Overall Study|Not protocol specified|2|||
23718762|NCT02137837|66344574|FG001|Overall Study|Not protocol specified|1|||
23718763|NCT02137837|66344575|FG002|Overall Study|Not protocol specified|3|||
23718764|NCT04507776|66344576|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
23718765|NCT02580240|66348372|FG000|Overall Study|Physician Decision|2|||
23718766|NCT02580240|66348373|FG001|Overall Study|Physician Decision|0|||
23718767|NCT00880763|66348374|FG000|Extension Period (Part 2)|Adverse Event|0|||
23718768|NCT00880763|66348375|FG001|Extension Period (Part 2)|Adverse Event|0|||
23718769|NCT00880763|66348376|FG002|Extension Period (Part 2)|Adverse Event|1|||
23718770|NCT00880763|66348377|FG003|Extension Period (Part 2)|Adverse Event|1|||
23718771|NCT00880763|66348374|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
23718772|NCT00880763|66348375|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
23718773|NCT00880763|66348376|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
23718774|NCT00880763|66348377|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
23718775|NCT00880763|66348374|FG000|Extension Period (Part 2)|Physician Decision|0|||
23530112|NCT02884089|65676058|FG003|Washout Period 3|Lost to Follow-up|1|||
23530113|NCT02884089|65676055|FG000|Period 4|Withdrawal by Subject|0|||
23718776|NCT00880763|66348375|FG001|Extension Period (Part 2)|Physician Decision|1|||
23718777|NCT00880763|66348376|FG002|Extension Period (Part 2)|Physician Decision|1|||
23718778|NCT00880763|66348377|FG003|Extension Period (Part 2)|Physician Decision|0|||
23718779|NCT00880763|66348374|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
23813714|NCT04933968|66699386|FG002|Overall Study|Missing|2|||
23813715|NCT04933968|66699387|FG003|Overall Study|Missing|1|||
23718780|NCT00880763|66348375|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
23718781|NCT00880763|66348376|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
23718782|NCT00880763|66348377|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
23718783|NCT00879437|66348378|FG000|Overall Study|Protocol Violation|0|||
23718784|NCT00879437|66348379|FG001|Overall Study|Protocol Violation|1|||
23718785|NCT00879437|66348378|FG000|Overall Study|Death|1|||
23718786|NCT00879437|66348379|FG001|Overall Study|Death|0|||
23718787|NCT01235728|66348384|FG000|Overall Study|Protocol Violation|0|||
23813716|NCT04933968|66699388|FG004|Overall Study|Missing|1|||
23419283|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23419284|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419285|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
23419286|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
23419287|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
23419288|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419289|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419290|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419291|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419292|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419293|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419294|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419295|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419296|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419297|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419298|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419299|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419300|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419301|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419302|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419303|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419304|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419305|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419306|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419307|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
23419308|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419309|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419310|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419311|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419312|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419313|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419314|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419315|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419316|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
23419317|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
23419318|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419319|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419320|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23718788|NCT01235728|66348385|FG001|Overall Study|Protocol Violation|0|||
23718789|NCT01235728|66348386|FG002|Overall Study|Protocol Violation|0|||
23718790|NCT01235728|66348387|FG003|Overall Study|Protocol Violation|1|||
23419321|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419322|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419323|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419324|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419325|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419326|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419327|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419328|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419329|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419330|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419331|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419332|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23530114|NCT02884089|65676056|FG001|Period 4|Withdrawal by Subject|1|||
23718791|NCT01235728|66348388|FG004|Overall Study|Protocol Violation|0|||
23718792|NCT01235728|66348389|FG005|Overall Study|Protocol Violation|0|||
23419333|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23718793|NCT01235728|66348390|FG006|Overall Study|Protocol Violation|0|||
23718794|NCT01235728|66348391|FG007|Overall Study|Protocol Violation|0|||
23718795|NCT01641991|66348392|FG000|Overall Study|Physician Decision|0|||
23530115|NCT02884089|65676057|FG002|Period 4|Withdrawal by Subject|0|||
23530116|NCT02884089|65676058|FG003|Period 4|Withdrawal by Subject|0|||
23530117|NCT02884089|65676055|FG000|Period 4|Lost to Follow-up|1|||
23530118|NCT02884089|65676056|FG001|Period 4|Lost to Follow-up|0|||
23419334|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419335|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
23419336|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23718796|NCT01641991|66348393|FG001|Overall Study|Physician Decision|1|||
23718797|NCT01641991|66348394|FG002|Overall Study|Physician Decision|7|||
23718798|NCT01641991|66348395|FG003|Overall Study|Physician Decision|5|||
23419337|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419338|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530119|NCT02884089|65676057|FG002|Period 4|Lost to Follow-up|0|||
23530120|NCT02884089|65676058|FG003|Period 4|Lost to Follow-up|0|||
23530121|NCT02884089|65676055|FG000|Follow-up Visit|Withdrawal by Subject|1|||
23530122|NCT02884089|65676056|FG001|Follow-up Visit|Withdrawal by Subject|0|||
23530123|NCT02884089|65676057|FG002|Follow-up Visit|Withdrawal by Subject|0|||
23530124|NCT02884089|65676058|FG003|Follow-up Visit|Withdrawal by Subject|1|||
23530125|NCT03921411|65676071|FG000|Overall Study|Withdrawal by Subject|1|||
23530126|NCT03921411|65676071|FG000|Overall Study|Protocol Deviation|2|||
23530127|NCT03921411|65676071|FG000|Overall Study|Enrolled, but never treated|2|||
23530128|NCT01227512|65676072|FG000|Overall Study|Physician Decision|6|||
23530129|NCT01227512|65676073|FG001|Overall Study|Physician Decision|6|||
23530130|NCT01227512|65676072|FG000|Overall Study|Adverse Event|4|||
23530131|NCT01227512|65676073|FG001|Overall Study|Adverse Event|3|||
23530132|NCT01227512|65676072|FG000|Overall Study|Withdrawal by Subject|3|||
23530133|NCT01227512|65676073|FG001|Overall Study|Withdrawal by Subject|0|||
23530134|NCT01227512|65676072|FG000|Overall Study|Participant met withdrawal criteria|0|||
23530135|NCT01227512|65676073|FG001|Overall Study|Participant met withdrawal criteria|1|||
23530136|NCT03325166|65676074|FG000|Overall Study|Adverse Event|1|||
23530137|NCT00699972|65676077|FG000|Overall Study|Adverse Event|7|||
23530138|NCT00699972|65676078|FG001|Overall Study|Adverse Event|9|||
23530139|NCT00699972|65676079|FG002|Overall Study|Adverse Event|24|||
23718799|NCT01641991|66348392|FG000|Overall Study|Withdrawal by Subject|4|||
23718800|NCT01641991|66348393|FG001|Overall Study|Withdrawal by Subject|2|||
23718801|NCT01641991|66348394|FG002|Overall Study|Withdrawal by Subject|1|||
23718802|NCT01641991|66348395|FG003|Overall Study|Withdrawal by Subject|5|||
23718803|NCT01641991|66348392|FG000|Overall Study|Adverse Event|2|||
23718804|NCT01641991|66348393|FG001|Overall Study|Adverse Event|1|||
23718805|NCT01641991|66348394|FG002|Overall Study|Adverse Event|2|||
23718806|NCT01641991|66348395|FG003|Overall Study|Adverse Event|1|||
23718807|NCT01641991|66348392|FG000|Overall Study|Lost to Follow-up|0|||
23718808|NCT01641991|66348393|FG001|Overall Study|Lost to Follow-up|2|||
23718809|NCT01641991|66348394|FG002|Overall Study|Lost to Follow-up|3|||
23718810|NCT01641991|66348395|FG003|Overall Study|Lost to Follow-up|1|||
23718811|NCT01641991|66348392|FG000|Overall Study|Protocol Violation|1|||
23718812|NCT01641991|66348393|FG001|Overall Study|Protocol Violation|1|||
23718813|NCT01641991|66348394|FG002|Overall Study|Protocol Violation|3|||
23718814|NCT01641991|66348395|FG003|Overall Study|Protocol Violation|0|||
23718815|NCT01641991|66348392|FG000|Overall Study|Pregnancy|0|||
23718816|NCT01641991|66348393|FG001|Overall Study|Pregnancy|0|||
23718817|NCT01641991|66348394|FG002|Overall Study|Pregnancy|1|||
23718818|NCT01641991|66348395|FG003|Overall Study|Pregnancy|0|||
23453586|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
23453587|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
23453588|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453589|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453590|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453591|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453592|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
23453593|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453594|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
23453595|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453596|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
23453597|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453598|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453599|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453600|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453601|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453602|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23530140|NCT00699972|65676077|FG000|Overall Study|Lost to Follow-up|0|||
23530141|NCT00699972|65676078|FG001|Overall Study|Lost to Follow-up|2|||
23530142|NCT00699972|65676079|FG002|Overall Study|Lost to Follow-up|0|||
23530143|NCT00699972|65676077|FG000|Overall Study|Withdrawal by Subject|3|||
23530144|NCT00699972|65676078|FG001|Overall Study|Withdrawal by Subject|7|||
23530145|NCT00699972|65676079|FG002|Overall Study|Withdrawal by Subject|4|||
23530146|NCT00699972|65676077|FG000|Overall Study|Lack of Efficacy|2|||
23530147|NCT00699972|65676078|FG001|Overall Study|Lack of Efficacy|0|||
23530148|NCT00699972|65676079|FG002|Overall Study|Lack of Efficacy|2|||
23530149|NCT00699972|65676077|FG000|Overall Study|Administrative/Other|3|||
23530150|NCT00699972|65676078|FG001|Overall Study|Administrative/Other|1|||
23612716|NCT00700999|65969694|FG000|Overall Study|Excluded - did not meet study criteria|0|||
23612717|NCT00700999|65969695|FG001|Overall Study|Excluded - did not meet study criteria|1|||
23612718|NCT00700999|65969694|FG000|Overall Study|Withdrawal by Subject|8|||
23612719|NCT00700999|65969695|FG001|Overall Study|Withdrawal by Subject|1|||
23612720|NCT00784277|65969696|FG000|IR Treatment|Adverse Event|4|||
23612721|NCT00784277|65969697|FG001|IR Treatment|Adverse Event|8|||
23612722|NCT00784277|65969698|FG002|IR Treatment|Adverse Event|19|||
23612723|NCT00784277|65969699|FG003|IR Treatment|Adverse Event|35|||
23612724|NCT00784277|65969700|FG004|IR Treatment|Adverse Event|0|||
23612725|NCT00784277|65969701|FG005|IR Treatment|Adverse Event|0|||
23612726|NCT00784277|65969702|FG006|IR Treatment|Adverse Event|0|||
23612727|NCT00784277|65969696|FG000|IR Treatment|Lack of Efficacy|4|||
23612728|NCT00784277|65969697|FG001|IR Treatment|Lack of Efficacy|4|||
23612729|NCT00784277|65969698|FG002|IR Treatment|Lack of Efficacy|1|||
23612730|NCT00784277|65969699|FG003|IR Treatment|Lack of Efficacy|0|||
23612731|NCT00784277|65969700|FG004|IR Treatment|Lack of Efficacy|0|||
23612732|NCT00784277|65969701|FG005|IR Treatment|Lack of Efficacy|0|||
23612733|NCT00784277|65969702|FG006|IR Treatment|Lack of Efficacy|0|||
23612734|NCT00784277|65969696|FG000|IR Treatment|Lost to Follow-up|1|||
23718819|NCT01641991|66348392|FG000|Overall Study|no longer eligible|2|||
23718820|NCT01641991|66348393|FG001|Overall Study|no longer eligible|1|||
23718821|NCT01641991|66348394|FG002|Overall Study|no longer eligible|0|||
23718822|NCT01641991|66348395|FG003|Overall Study|no longer eligible|4|||
23718823|NCT02151682|66348398|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23718824|NCT02151682|66348399|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
23718825|NCT02151682|66348400|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23718826|NCT02151682|66348401|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23718827|NCT02151682|66348402|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23718828|NCT02151682|66348403|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23718829|NCT02151682|66348398|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23718830|NCT02151682|66348399|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
23718831|NCT02151682|66348400|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23718832|NCT02151682|66348401|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23718833|NCT02151682|66348402|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23718834|NCT02151682|66348403|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23718835|NCT02151682|66348398|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23718836|NCT02151682|66348399|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
23718837|NCT02151682|66348400|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23718838|NCT02151682|66348401|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23718839|NCT02151682|66348402|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23718840|NCT02151682|66348403|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23718841|NCT02151682|66348398|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
23718842|NCT02151682|66348399|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
23718843|NCT02151682|66348400|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23718844|NCT02151682|66348401|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23718845|NCT02151682|66348402|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23718846|NCT02151682|66348403|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23718847|NCT02151682|66348398|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
23718848|NCT02151682|66348399|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23718849|NCT02151682|66348400|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23718850|NCT02151682|66348401|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23718851|NCT02151682|66348402|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23813717|NCT04933968|66699389|FG005|Overall Study|Missing|0|||
23530151|NCT00699972|65676079|FG002|Overall Study|Administrative/Other|4|||
23530152|NCT00699972|65676077|FG000|Overall Study|Randomized, Not Treated|1|||
23530153|NCT00699972|65676078|FG001|Overall Study|Randomized, Not Treated|0|||
23530154|NCT00699972|65676079|FG002|Overall Study|Randomized, Not Treated|1|||
23612735|NCT00784277|65969697|FG001|IR Treatment|Lost to Follow-up|0|||
23813718|NCT01593696|66699390|FG000|Dose Escalation|Progressive Disease|2|||
23530155|NCT00640510|65676080|FG000|Overall Study|Lack of Efficacy|0|||
23612736|NCT00784277|65969698|FG002|IR Treatment|Lost to Follow-up|1|||
23813719|NCT01593696|66699391|FG001|Dose Escalation|Progressive Disease|0|||
23612737|NCT00784277|65969699|FG003|IR Treatment|Lost to Follow-up|0|||
23612738|NCT00784277|65969700|FG004|IR Treatment|Lost to Follow-up|0|||
23612739|NCT00784277|65969701|FG005|IR Treatment|Lost to Follow-up|0|||
23612740|NCT00784277|65969702|FG006|IR Treatment|Lost to Follow-up|0|||
23612741|NCT00784277|65969696|FG000|IR Treatment|Withdrawal by Subject|5|||
23612742|NCT00784277|65969697|FG001|IR Treatment|Withdrawal by Subject|1|||
23612743|NCT00784277|65969698|FG002|IR Treatment|Withdrawal by Subject|4|||
23612744|NCT00784277|65969699|FG003|IR Treatment|Withdrawal by Subject|6|||
23612745|NCT00784277|65969700|FG004|IR Treatment|Withdrawal by Subject|0|||
23612746|NCT00784277|65969701|FG005|IR Treatment|Withdrawal by Subject|0|||
23612747|NCT00784277|65969702|FG006|IR Treatment|Withdrawal by Subject|0|||
23612748|NCT00784277|65969696|FG000|IR Treatment|Resolution Of Pain|0|||
23612749|NCT00784277|65969697|FG001|IR Treatment|Resolution Of Pain|1|||
23612750|NCT00784277|65969698|FG002|IR Treatment|Resolution Of Pain|0|||
23612751|NCT00784277|65969699|FG003|IR Treatment|Resolution Of Pain|0|||
23612752|NCT00784277|65969700|FG004|IR Treatment|Resolution Of Pain|0|||
23612753|NCT00784277|65969701|FG005|IR Treatment|Resolution Of Pain|0|||
23612754|NCT00784277|65969702|FG006|IR Treatment|Resolution Of Pain|0|||
23612755|NCT00784277|65969696|FG000|IR Treatment|Other|2|||
23612756|NCT00784277|65969697|FG001|IR Treatment|Other|3|||
23612757|NCT00784277|65969698|FG002|IR Treatment|Other|3|||
23813720|NCT01593696|66699392|FG002|Dose Escalation|Progressive Disease|0|||
23813721|NCT01593696|66699393|FG003|Dose Escalation|Progressive Disease|0|||
23612758|NCT00784277|65969699|FG003|IR Treatment|Other|2|||
23612759|NCT00784277|65969700|FG004|IR Treatment|Other|0|||
23612760|NCT00784277|65969701|FG005|IR Treatment|Other|0|||
23612761|NCT00784277|65969702|FG006|IR Treatment|Other|0|||
23612762|NCT00784277|65969696|FG000|ER Treatment|Adverse Event|0|||
23530156|NCT00640510|65676081|FG001|Overall Study|Lack of Efficacy|1|||
23530157|NCT00640510|65676080|FG000|Overall Study|Protocol Violation|1|||
23530158|NCT00640510|65676081|FG001|Overall Study|Protocol Violation|0|||
23530159|NCT00640510|65676080|FG000|Overall Study|Physician Decision|0|||
23530160|NCT00640510|65676081|FG001|Overall Study|Physician Decision|1|||
23530161|NCT00298831|65676082|FG000|Overall Study|Adverse Event|1|||
23530162|NCT00298831|65676082|FG000|Overall Study|Lost to Follow-up|3|||
23530163|NCT00298831|65676082|FG000|Overall Study|Withdrawal by Subject|1|||
23530164|NCT00298831|65676082|FG000|Overall Study|Participants did not receive treatment|27|||
23530165|NCT00689481|65676083|FG000|Overall Study|Adverse Event|7|||
23813722|NCT01593696|66699390|FG000|Dose Expansion|Fungal infection|0|||
23813723|NCT01593696|66699391|FG001|Dose Expansion|Fungal infection|0|||
23813724|NCT01593696|66699392|FG002|Dose Expansion|Fungal infection|1|||
23813725|NCT01593696|66699393|FG003|Dose Expansion|Fungal infection|0|||
23419339|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530166|NCT00689481|65676084|FG001|Overall Study|Adverse Event|1|||
23530167|NCT00689481|65676083|FG000|Overall Study|Lost to Follow-up|4|||
23530168|NCT00689481|65676084|FG001|Overall Study|Lost to Follow-up|3|||
23530169|NCT00689481|65676083|FG000|Overall Study|Lack of Efficacy|4|||
23530170|NCT00689481|65676084|FG001|Overall Study|Lack of Efficacy|3|||
23530171|NCT00689481|65676083|FG000|Overall Study|Non-compliance with study treatment|1|||
23530172|NCT00689481|65676084|FG001|Overall Study|Non-compliance with study treatment|1|||
23530173|NCT00689481|65676083|FG000|Overall Study|Withdrawal by Subject|8|||
23612763|NCT00784277|65969697|FG001|ER Treatment|Adverse Event|0|||
23612764|NCT00784277|65969698|FG002|ER Treatment|Adverse Event|0|||
23612765|NCT00784277|65969699|FG003|ER Treatment|Adverse Event|0|||
23612766|NCT00784277|65969700|FG004|ER Treatment|Adverse Event|1|||
23612767|NCT00784277|65969701|FG005|ER Treatment|Adverse Event|7|||
23612768|NCT00784277|65969702|FG006|ER Treatment|Adverse Event|7|||
23612769|NCT00784277|65969696|FG000|ER Treatment|Lack of Efficacy|0|||
23612770|NCT00784277|65969697|FG001|ER Treatment|Lack of Efficacy|0|||
23612771|NCT00784277|65969698|FG002|ER Treatment|Lack of Efficacy|0|||
23612772|NCT00784277|65969699|FG003|ER Treatment|Lack of Efficacy|0|||
23612773|NCT00784277|65969700|FG004|ER Treatment|Lack of Efficacy|3|||
23612774|NCT00784277|65969701|FG005|ER Treatment|Lack of Efficacy|4|||
23612775|NCT00784277|65969702|FG006|ER Treatment|Lack of Efficacy|0|||
23612776|NCT00784277|65969696|FG000|ER Treatment|Lost to Follow-up|0|||
23718852|NCT02151682|66348403|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23718853|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23718854|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23718855|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
23718856|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23718857|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23718858|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23813726|NCT03981419|66699394|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
23612777|NCT00784277|65969697|FG001|ER Treatment|Lost to Follow-up|0|||
23612778|NCT00784277|65969698|FG002|ER Treatment|Lost to Follow-up|0|||
23612779|NCT00784277|65969699|FG003|ER Treatment|Lost to Follow-up|0|||
23612780|NCT00784277|65969700|FG004|ER Treatment|Lost to Follow-up|0|||
23612781|NCT00784277|65969701|FG005|ER Treatment|Lost to Follow-up|2|||
23612782|NCT00784277|65969702|FG006|ER Treatment|Lost to Follow-up|0|||
23718859|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
23718860|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
23530174|NCT00689481|65676084|FG001|Overall Study|Withdrawal by Subject|4|||
23530175|NCT00689481|65676083|FG000|Overall Study|Excluded medication started during study|0|||
23530176|NCT00689481|65676084|FG001|Overall Study|Excluded medication started during study|1|||
23530177|NCT00689481|65676083|FG000|Overall Study|Subject early term, left on vacation|0|||
23530178|NCT00689481|65676084|FG001|Overall Study|Subject early term, left on vacation|1|||
23530179|NCT00515827|65676085|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
23530180|NCT00515827|65676086|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
23530181|NCT00515827|65676085|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
23530182|NCT00515827|65676086|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
23530183|NCT02043015|65676087|FG000|Overall Study|Lost to Follow-up|4|||
23530184|NCT02043015|65676087|FG000|Overall Study|Withdrawal by Subject|4|||
23530185|NCT02043015|65676087|FG000|Overall Study|Removed once target enrollment reached|15|||
23530186|NCT02043015|65676087|FG000|Overall Study|Participant moved away from study city|4|||
23530187|NCT02043015|65676087|FG000|Overall Study|Incarceration|1|||
23530188|NCT03742141|65676088|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
23530189|NCT02806726|65676089|FG000|Overall Study|Lost to Follow-up|1|||
23530190|NCT03191903|65676090|FG000|Overall Study|Withdrawal by Subject|6|||
23530191|NCT03191903|65676091|FG001|Overall Study|Withdrawal by Subject|5|||
23530192|NCT03191903|65676092|FG002|Overall Study|Withdrawal by Subject|4|||
23530193|NCT03191903|65676090|FG000|Overall Study|Adverse Event|1|||
23530194|NCT03191903|65676091|FG001|Overall Study|Adverse Event|0|||
23530195|NCT03191903|65676092|FG002|Overall Study|Adverse Event|0|||
23530196|NCT00418691|65676094|FG000|Overall Study|Lost to Follow-up|1|||
23530197|NCT00418691|65676095|FG001|Overall Study|Lost to Follow-up|2|||
23530198|NCT00418691|65676096|FG002|Overall Study|Lost to Follow-up|3|||
23530199|NCT00418691|65676094|FG000|Overall Study|Started new medication voiding entry|0|||
23530200|NCT00418691|65676095|FG001|Overall Study|Started new medication voiding entry|0|||
23530201|NCT00418691|65676096|FG002|Overall Study|Started new medication voiding entry|1|||
23530202|NCT00418691|65676094|FG000|Overall Study|Progressive Disease|1|||
23530203|NCT00418691|65676095|FG001|Overall Study|Progressive Disease|0|||
23530204|NCT00418691|65676096|FG002|Overall Study|Progressive Disease|1|||
23530205|NCT01777997|65676097|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
23530206|NCT01777997|65676097|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
23530207|NCT01777997|65676097|FG000|Weeks 48 to 72/96 on ART|Death|1|||
23530208|NCT01777997|65676097|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
23530209|NCT02948842|65676101|FG000|Overall Study|Withdrawal by Subject|4|||
23530210|NCT00519649|65676102|FG000|Overall Study|Withdrawal by Subject|1|||
23530211|NCT01205165|65676105|FG000|Overall Study|Lost to Follow-up|2|||
23530212|NCT01633944|65676106|FG000|Open-label Titration Phase|Adverse Event|109|||
23530213|NCT01633944|65676107|FG001|Open-label Titration Phase|Adverse Event|0|||
23530214|NCT01633944|65676108|FG002|Open-label Titration Phase|Adverse Event|0|||
23530215|NCT01633944|65676106|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
23530216|NCT01633944|65676107|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
23530217|NCT01633944|65676108|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
23530218|NCT01633944|65676106|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
23530219|NCT01633944|65676107|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
23530220|NCT01633944|65676108|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
23530221|NCT01633944|65676106|FG000|Open-label Titration Phase|Protocol Violation|24|||
23530222|NCT01633944|65676107|FG001|Open-label Titration Phase|Protocol Violation|0|||
23530223|NCT01633944|65676108|FG002|Open-label Titration Phase|Protocol Violation|0|||
23530224|NCT01633944|65676106|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
23718861|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
23718862|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
23718863|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
23718864|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
23718865|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23718866|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23419340|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530225|NCT01633944|65676107|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
23530226|NCT01633944|65676108|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
23530227|NCT01633944|65676106|FG000|Open-label Titration Phase|Other|68|||
23530228|NCT01633944|65676107|FG001|Open-label Titration Phase|Other|0|||
23530229|NCT01633944|65676108|FG002|Open-label Titration Phase|Other|0|||
23530230|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23530231|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Adverse Event|13|||
23530232|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Adverse Event|7|||
23530233|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23530234|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
23530235|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
23530236|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23530237|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23530238|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
23530239|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23530240|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
23530241|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
23530242|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23530243|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
23530244|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
23530245|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
23530246|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
23530247|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
23530248|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
23530249|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
23530250|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
23530251|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Other|0|||
23530252|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Other|7|||
23530253|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Other|0|||
23530254|NCT00774995|65676109|FG000|Overall Study|Protocol Violation|0|||
23530255|NCT00774995|65676110|FG001|Overall Study|Protocol Violation|0|||
23530256|NCT00774995|65676111|FG002|Overall Study|Protocol Violation|1|||
23530257|NCT00774995|65676112|FG003|Overall Study|Protocol Violation|0|||
23530258|NCT00953329|65676113|FG000|Overall Study|Lack of Efficacy|1|||
23530259|NCT02908529|65676114|FG000|Overall Study|Lost to Follow-up|0|||
23530260|NCT02908529|65676115|FG001|Overall Study|Lost to Follow-up|2|||
23530261|NCT01337297|65676119|FG000|Overall Study|They entered to single anodal tDCS|4|||
23530262|NCT01337297|65676120|FG001|Overall Study|They entered to single anodal tDCS|3|||
23530263|NCT01337297|65676119|FG000|Overall Study|Lost to Follow-up|1|||
23813727|NCT03981419|66699395|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
23813728|NCT00638027|66699397|FG000|Overall Study|Adverse Event|0|||
23813729|NCT00638027|66699398|FG001|Overall Study|Adverse Event|2|||
23813730|NCT02087189|66699407|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
23813731|NCT00478426|66699408|FG000|Overall Study|Withdrawal by Subject|1|||
23813732|NCT01119508|66699411|FG000|Overall Study|Adverse Event|56|||
23813733|NCT01119508|66699411|FG000|Overall Study|Withdrawal by Subject|2|||
23813734|NCT01119508|66699411|FG000|Overall Study|Died before tumor response evaluation|1|||
23813735|NCT03421730|66699414|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813736|NCT03421730|66699415|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
23813737|NCT03421730|66699416|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813738|NCT03421730|66699417|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813739|NCT03421730|66699418|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813740|NCT03421730|66699419|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813741|NCT03421730|66699420|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813742|NCT03421730|66699421|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813743|NCT03421730|66699422|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813744|NCT03421730|66699423|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813745|NCT03421730|66699424|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813746|NCT03421730|66699425|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23813747|NCT03421730|66699414|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813748|NCT03421730|66699415|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813749|NCT03421730|66699416|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813750|NCT03421730|66699417|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813751|NCT03421730|66699418|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
23813752|NCT03421730|66699419|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813753|NCT03421730|66699420|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23530264|NCT01337297|65676120|FG001|Overall Study|Lost to Follow-up|3|||
23530265|NCT02316717|65676129|FG000|Overall Study|Adverse Event|2|||
23530266|NCT02316717|65676130|FG001|Overall Study|Adverse Event|2|||
23530267|NCT02316717|65676131|FG002|Overall Study|Adverse Event|0|||
23530268|NCT02316717|65676129|FG000|Overall Study|Lost to Follow-up|1|||
23530269|NCT02316717|65676130|FG001|Overall Study|Lost to Follow-up|2|||
23530270|NCT02316717|65676131|FG002|Overall Study|Lost to Follow-up|1|||
23530271|NCT02316717|65676129|FG000|Overall Study|Non compliance|3|||
23530272|NCT02316717|65676130|FG001|Overall Study|Non compliance|1|||
23530273|NCT02316717|65676131|FG002|Overall Study|Non compliance|0|||
23530274|NCT02316717|65676129|FG000|Overall Study|Protocol Violation|2|||
23813754|NCT03421730|66699421|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813755|NCT03421730|66699422|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813756|NCT03421730|66699423|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813757|NCT03421730|66699424|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813758|NCT03421730|66699425|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23813759|NCT01934335|66699426|FG000|Overall Study|Withdrawal by Subject|1|||
23813760|NCT01934335|66699427|FG001|Overall Study|Withdrawal by Subject|1|||
23813761|NCT03084367|66699431|FG000|Overall Study|Lost to Follow-up|32|||
23813762|NCT03084367|66699431|FG000|Overall Study|Withdrawal by Subject|4|||
23813763|NCT03084367|66699431|FG000|Overall Study|Other|1|||
23813764|NCT01001988|66699432|FG000|Overall Study|Protocol Violation|84|||
23813765|NCT01001988|66699432|FG000|Overall Study|Withdrawal by Subject|18|||
23813766|NCT01001988|66699432|FG000|Overall Study|Lost to Follow-up|15|||
23813767|NCT00213135|66699433|FG000|Overall Study|Adverse Event|9|||
23813768|NCT00213135|66699434|FG001|Overall Study|Adverse Event|5|||
23813769|NCT00213135|66699435|FG002|Overall Study|Adverse Event|5|||
23813770|NCT00213135|66699433|FG000|Overall Study|Lost to Follow-up|11|||
23813771|NCT00213135|66699434|FG001|Overall Study|Lost to Follow-up|8|||
23813772|NCT00213135|66699435|FG002|Overall Study|Lost to Follow-up|4|||
23813773|NCT00213135|66699433|FG000|Overall Study|Protocol Violation|4|||
23813774|NCT00213135|66699434|FG001|Overall Study|Protocol Violation|4|||
23813775|NCT00213135|66699435|FG002|Overall Study|Protocol Violation|10|||
23813776|NCT00213135|66699433|FG000|Overall Study|Death|1|||
23813777|NCT00213135|66699434|FG001|Overall Study|Death|1|||
23718867|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
23718868|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
23718869|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23718870|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23718871|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23718872|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23718873|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
23718874|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23718875|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23718876|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23718877|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23813778|NCT00213135|66699435|FG002|Overall Study|Death|2|||
23813779|NCT00213135|66699433|FG000|Overall Study|Disease progression|4|||
23813780|NCT00213135|66699434|FG001|Overall Study|Disease progression|5|||
23813781|NCT00213135|66699435|FG002|Overall Study|Disease progression|21|||
23813782|NCT00213135|66699433|FG000|Overall Study|Other|21|||
23813783|NCT00213135|66699434|FG001|Overall Study|Other|12|||
23813784|NCT00213135|66699435|FG002|Overall Study|Other|15|||
23813785|NCT02377427|66699436|FG000|Part A (Up to Week 20)|Physician Decision|1|||
23813786|NCT02377427|66699437|FG001|Part A (Up to Week 20)|Physician Decision|0|||
23813787|NCT02377427|66699438|FG002|Part A (Up to Week 20)|Physician Decision|0|||
23813788|NCT02377427|66699439|FG003|Part A (Up to Week 20)|Physician Decision|0|||
23813789|NCT02377427|66699440|FG004|Part A (Up to Week 20)|Physician Decision|0|||
23813790|NCT02377427|66699436|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
23813791|NCT02377427|66699437|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23813792|NCT02377427|66699438|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23530275|NCT02316717|65676130|FG001|Overall Study|Protocol Violation|0|||
23530276|NCT02316717|65676131|FG002|Overall Study|Protocol Violation|0|||
23530277|NCT02316717|65676129|FG000|Overall Study|Withdrawal by Subject|2|||
23530278|NCT02316717|65676130|FG001|Overall Study|Withdrawal by Subject|1|||
23530279|NCT02316717|65676131|FG002|Overall Study|Withdrawal by Subject|1|||
23530280|NCT02316717|65676129|FG000|Overall Study|Death|0|||
23530281|NCT02316717|65676130|FG001|Overall Study|Death|0|||
23530282|NCT02316717|65676131|FG002|Overall Study|Death|1|||
23530283|NCT02316717|65676129|FG000|Overall Study|Physician Decision|0|||
23530284|NCT02316717|65676130|FG001|Overall Study|Physician Decision|1|||
23530285|NCT02316717|65676131|FG002|Overall Study|Physician Decision|0|||
23530286|NCT02316717|65676129|FG000|Overall Study|TBC|1|||
23530287|NCT02316717|65676130|FG001|Overall Study|TBC|0|||
23530288|NCT02316717|65676131|FG002|Overall Study|TBC|0|||
23530289|NCT02797262|65676132|FG000|Overall Study|Withdrawal by Subject|5|||
23718878|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23813793|NCT02377427|66699439|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23813794|NCT02377427|66699440|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23813795|NCT02377427|66699436|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
23813796|NCT02377427|66699437|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23813797|NCT02377427|66699438|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23530290|NCT02797262|65676133|FG001|Overall Study|Withdrawal by Subject|1|||
23530291|NCT02797262|65676132|FG000|Overall Study|Lost to Follow-up|10|||
23530292|NCT02797262|65676133|FG001|Overall Study|Lost to Follow-up|7|||
23813798|NCT02377427|66699439|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23813799|NCT02377427|66699440|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23813800|NCT02377427|66699436|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23813801|NCT02377427|66699437|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23813802|NCT02377427|66699438|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
23813803|NCT02377427|66699439|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23813804|NCT02377427|66699440|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23530293|NCT02797262|65676132|FG000|Overall Study|Death|1|||
23530294|NCT02797262|65676133|FG001|Overall Study|Death|2|||
23530295|NCT02797262|65676132|FG000|Overall Study|Adverse Event|1|||
23530296|NCT02797262|65676133|FG001|Overall Study|Adverse Event|0|||
23530297|NCT02797262|65676132|FG000|Overall Study|COVID-19|2|||
23530298|NCT02797262|65676133|FG001|Overall Study|COVID-19|1|||
23530299|NCT02797262|65676132|FG000|Overall Study|Out-of-country|1|||
23530300|NCT02797262|65676133|FG001|Overall Study|Out-of-country|0|||
23530301|NCT00931307|65676134|FG000|Overall Study|Lack of Efficacy|12|||
23530302|NCT00931307|65676134|FG000|Overall Study|Biomicroscopy|1|||
23530303|NCT02177266|65676142|FG000|Overall Study|Adverse Event|0|||
23530304|NCT02177266|65676143|FG001|Overall Study|Adverse Event|1|||
23530305|NCT02177266|65676142|FG000|Overall Study|Withdrawal by Subject|1|||
23530306|NCT02177266|65676143|FG001|Overall Study|Withdrawal by Subject|0|||
23530307|NCT01914666|65676146|FG000|Treatment Period|Lack of Efficacy|0|||
23530308|NCT01914666|65676147|FG001|Treatment Period|Lack of Efficacy|0|||
23530309|NCT01914666|65676148|FG002|Treatment Period|Lack of Efficacy|2|||
23530310|NCT01914666|65676146|FG000|Treatment Period|Adverse Event|10|||
23530311|NCT01914666|65676147|FG001|Treatment Period|Adverse Event|4|||
23530312|NCT01914666|65676148|FG002|Treatment Period|Adverse Event|2|||
23530313|NCT01914666|65676146|FG000|Treatment Period|Withdrawal by Subject|3|||
23530314|NCT01914666|65676147|FG001|Treatment Period|Withdrawal by Subject|2|||
23530315|NCT01914666|65676148|FG002|Treatment Period|Withdrawal by Subject|2|||
23530316|NCT01914666|65676146|FG000|Treatment Period|Physician Decision|0|||
23530317|NCT01914666|65676147|FG001|Treatment Period|Physician Decision|0|||
23530318|NCT01914666|65676148|FG002|Treatment Period|Physician Decision|2|||
23530319|NCT03773757|65676149|FG000|Overall Study|Withdrawal by Subject|2|||
23530320|NCT03773757|65676150|FG001|Overall Study|Withdrawal by Subject|4|||
23530321|NCT00727714|65676151|FG000|Overall Study|Lost to Follow-up|2|||
23530322|NCT03228680|65676154|FG000|Overall Study|Adverse Event|13|||
23530323|NCT03228680|65676155|FG001|Overall Study|Adverse Event|18|||
23530324|NCT03228680|65676154|FG000|Overall Study|Randomization failure|0|||
23530325|NCT03228680|65676155|FG001|Overall Study|Randomization failure|1|||
23530326|NCT03228680|65676154|FG000|Overall Study|Withdrawal by Subject|1|||
23530327|NCT03228680|65676155|FG001|Overall Study|Withdrawal by Subject|0|||
23530328|NCT03228680|65676154|FG000|Overall Study|Other|9|||
23530329|NCT03228680|65676155|FG001|Overall Study|Other|16|||
23530330|NCT01430585|65676156|FG000|Overall Study|Death|1|||
23530331|NCT01430585|65676156|FG000|Overall Study|Objective Progression or Relapse|3|||
23530332|NCT01430585|65676156|FG000|Overall Study|Study Terminated by Sponsor|3|||
23530333|NCT01430585|65676156|FG000|Overall Study|Other|7|||
23530334|NCT03571516|65676172|FG000|Overall Study|Severe diarrhea|1|||
23530335|NCT03571516|65676173|FG001|Overall Study|Severe diarrhea|0|||
23530336|NCT03571516|65676172|FG000|Overall Study|Withdrawal by Subject|0|||
23530337|NCT03571516|65676173|FG001|Overall Study|Withdrawal by Subject|1|||
23530338|NCT01988571|65676179|FG000|Overall Study|Death|3|||
23530339|NCT01988571|65676180|FG001|Overall Study|Death|1|||
23530340|NCT01988571|65676179|FG000|Overall Study|Physician Decision|2|||
23530341|NCT01988571|65676180|FG001|Overall Study|Physician Decision|1|||
23530342|NCT01988571|65676179|FG000|Overall Study|Lost to Follow-up|3|||
23530343|NCT01988571|65676180|FG001|Overall Study|Lost to Follow-up|0|||
23530344|NCT01988571|65676179|FG000|Overall Study|Withdrawal by Subject|31|||
23530345|NCT01988571|65676180|FG001|Overall Study|Withdrawal by Subject|33|||
23530346|NCT02708680|65676181|FG000|Overall Study|Withdrawal by Subject|4|||
23530347|NCT02708680|65676182|FG001|Overall Study|Withdrawal by Subject|12|||
23530348|NCT02708680|65676183|FG002|Overall Study|Withdrawal by Subject|12|||
23530349|NCT02708680|65676181|FG000|Overall Study|Death|4|||
23530350|NCT02708680|65676182|FG001|Overall Study|Death|19|||
23530351|NCT02708680|65676183|FG002|Overall Study|Death|21|||
23530352|NCT02708680|65676181|FG000|Overall Study|Lost to Follow-up|0|||
23530353|NCT02708680|65676182|FG001|Overall Study|Lost to Follow-up|3|||
23530354|NCT02708680|65676183|FG002|Overall Study|Lost to Follow-up|3|||
23530355|NCT02708680|65676181|FG000|Overall Study|Study Terminated By Sponsor|0|||
23530356|NCT02708680|65676182|FG001|Overall Study|Study Terminated By Sponsor|5|||
23530357|NCT02708680|65676183|FG002|Overall Study|Study Terminated By Sponsor|4|||
23530358|NCT02708680|65676181|FG000|Overall Study|Other than Specified|0|||
23530359|NCT02708680|65676182|FG001|Overall Study|Other than Specified|0|||
23530360|NCT02708680|65676183|FG002|Overall Study|Other than Specified|1|||
23530361|NCT02708680|65676181|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
23612783|NCT00784277|65969696|FG000|ER Treatment|Withdrawal by Subject|0|||
23612784|NCT00784277|65969697|FG001|ER Treatment|Withdrawal by Subject|0|||
23612785|NCT00784277|65969698|FG002|ER Treatment|Withdrawal by Subject|0|||
23612786|NCT00784277|65969699|FG003|ER Treatment|Withdrawal by Subject|0|||
23612787|NCT00784277|65969700|FG004|ER Treatment|Withdrawal by Subject|2|||
23612788|NCT00784277|65969701|FG005|ER Treatment|Withdrawal by Subject|5|||
23612789|NCT00784277|65969702|FG006|ER Treatment|Withdrawal by Subject|3|||
23612790|NCT00784277|65969696|FG000|ER Treatment|Study Medication Non-Compliant|0|||
23612791|NCT00784277|65969697|FG001|ER Treatment|Study Medication Non-Compliant|0|||
23612792|NCT00784277|65969698|FG002|ER Treatment|Study Medication Non-Compliant|0|||
23612793|NCT00784277|65969699|FG003|ER Treatment|Study Medication Non-Compliant|0|||
23612794|NCT00784277|65969700|FG004|ER Treatment|Study Medication Non-Compliant|2|||
23612795|NCT00784277|65969701|FG005|ER Treatment|Study Medication Non-Compliant|3|||
23612796|NCT00784277|65969702|FG006|ER Treatment|Study Medication Non-Compliant|3|||
23612797|NCT00784277|65969696|FG000|ER Treatment|Other|0|||
23530362|NCT02708680|65676182|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
23530363|NCT02708680|65676183|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
23530364|NCT01956110|65676184|FG000|Overall Study|Protocol Violation|25|||
23530365|NCT01956110|65676185|FG001|Overall Study|Protocol Violation|11|||
23530366|NCT01956110|65676184|FG000|Overall Study|Adverse Event|9|||
23612798|NCT00784277|65969697|FG001|ER Treatment|Other|0|||
23612799|NCT00784277|65969698|FG002|ER Treatment|Other|0|||
23612800|NCT00784277|65969699|FG003|ER Treatment|Other|0|||
23612801|NCT00784277|65969700|FG004|ER Treatment|Other|1|||
23612802|NCT00784277|65969701|FG005|ER Treatment|Other|3|||
23612803|NCT00784277|65969702|FG006|ER Treatment|Other|2|||
23612804|NCT03873714|65969703|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
23612805|NCT02097420|65969706|FG000|Overall Study|Death|6|||
23612806|NCT02097420|65969706|FG000|Overall Study|Valve explanted|13|||
23612807|NCT02097420|65969706|FG000|Overall Study|Other Reason|1|||
23612808|NCT01864200|65969713|FG000|Overall Study|Lost to Follow-up|1|||
23612809|NCT01864200|65969714|FG001|Overall Study|Lost to Follow-up|3|||
23530367|NCT01956110|65676185|FG001|Overall Study|Adverse Event|10|||
23530368|NCT01956110|65676184|FG000|Overall Study|Personal reasons|1|||
23530369|NCT01956110|65676185|FG001|Overall Study|Personal reasons|1|||
23530370|NCT00785486|65676187|FG000|Midazolam Alone|Withdrawal by Subject|1|||
23530371|NCT02932891|65676188|FG000|Overall Study|Lost to Follow-up|2|||
23530372|NCT02932891|65676188|FG000|Overall Study|HPA Suppress|2|||
23530373|NCT01539226|65676189|FG000|Overall Study|Withdrawal by Subject|24|||
23530374|NCT01539226|65676190|FG001|Overall Study|Withdrawal by Subject|54|||
23530375|NCT01539226|65676189|FG000|Overall Study|Lost to Follow-up|20|||
23530376|NCT01539226|65676190|FG001|Overall Study|Lost to Follow-up|54|||
23530377|NCT01539226|65676189|FG000|Overall Study|Death|1|||
23530378|NCT01539226|65676190|FG001|Overall Study|Death|2|||
23530379|NCT01539226|65676189|FG000|Overall Study|Adverse Event|2|||
23530380|NCT01539226|65676190|FG001|Overall Study|Adverse Event|0|||
23530381|NCT01539226|65676189|FG000|Overall Study|Pregnancy|13|||
23530382|NCT01539226|65676190|FG001|Overall Study|Pregnancy|29|||
23530383|NCT01539226|65676189|FG000|Overall Study|inappropriate enrollment|0|||
23530384|NCT01539226|65676190|FG001|Overall Study|inappropriate enrollment|1|||
23530385|NCT01539226|65676189|FG000|Overall Study|Multiple Reasons|3|||
23530386|NCT01539226|65676190|FG001|Overall Study|Multiple Reasons|1|||
23530387|NCT01539226|65676189|FG000|Overall Study|not HIV seroconversion-related|93|||
23530388|NCT01539226|65676190|FG001|Overall Study|not HIV seroconversion-related|176|||
23530389|NCT01539226|65676189|FG000|Overall Study|HIV seroconversion-related|55|||
23530390|NCT01539226|65676190|FG001|Overall Study|HIV seroconversion-related|80|||
23530391|NCT01539226|65676189|FG000|Overall Study|Non-compliance|6|||
23530392|NCT01539226|65676190|FG001|Overall Study|Non-compliance|8|||
23530393|NCT01143090|65676196|FG000|Overall Study|Lack of Efficacy|2|||
23530394|NCT01143090|65676196|FG000|Overall Study|Adverse Event|17|||
23530395|NCT01143090|65676196|FG000|Overall Study|Lost to Follow-up|9|||
23530396|NCT01143090|65676196|FG000|Overall Study|Protocol Violation|2|||
23612810|NCT01864200|65969713|FG000|Overall Study|Protocol Violation|1|||
23612811|NCT01864200|65969714|FG001|Overall Study|Protocol Violation|0|||
23612812|NCT01064856|65969722|FG000|Double-blind (DB) Period|Adverse Event|1|||
23612813|NCT01064856|65969723|FG001|Double-blind (DB) Period|Adverse Event|0|||
23530397|NCT01143090|65676196|FG000|Overall Study|Withdrawal by Subject|18|||
23530398|NCT01143090|65676196|FG000|Overall Study|Non-compliance with study drug|1|||
23530399|NCT01143090|65676196|FG000|Overall Study|Failure to meet eligibility criteria|1|||
23530400|NCT01143090|65676196|FG000|Overall Study|Administrative|1|||
23530401|NCT03192150|65676199|FG000|Overall Study|Adverse Event|14|||
23530402|NCT03192150|65676200|FG001|Overall Study|Adverse Event|12|||
23530403|NCT03192150|65676199|FG000|Overall Study|Lack of Efficacy|23|||
23530404|NCT03192150|65676200|FG001|Overall Study|Lack of Efficacy|30|||
23612814|NCT01064856|65969724|FG002|Double-blind (DB) Period|Adverse Event|0|||
23612815|NCT01064856|65969725|FG003|Double-blind (DB) Period|Adverse Event|0|||
23612816|NCT01064856|65969722|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
23612817|NCT01064856|65969723|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23612818|NCT01064856|65969724|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23530405|NCT03192150|65676199|FG000|Overall Study|Lost to Follow-up|1|||
23612819|NCT01064856|65969725|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23612820|NCT01064856|65969722|FG000|Open-label (OL) Period|Adverse Event|0|||
23530406|NCT03192150|65676200|FG001|Overall Study|Lost to Follow-up|1|||
23612821|NCT01064856|65969723|FG001|Open-label (OL) Period|Adverse Event|0|||
23612822|NCT01064856|65969724|FG002|Open-label (OL) Period|Adverse Event|12|||
23612823|NCT01064856|65969725|FG003|Open-label (OL) Period|Adverse Event|6|||
23612824|NCT01064856|65969722|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
23612825|NCT01064856|65969723|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
23612826|NCT01064856|65969724|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
23612827|NCT01064856|65969725|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
23612828|NCT01064856|65969722|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
23612829|NCT01064856|65969723|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
23612830|NCT01064856|65969724|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
23612831|NCT01064856|65969725|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
23612832|NCT01064856|65969722|FG000|Open-label (OL) Period|Other|0|||
23612833|NCT01064856|65969723|FG001|Open-label (OL) Period|Other|0|||
23612834|NCT01064856|65969724|FG002|Open-label (OL) Period|Other|7|||
23612835|NCT01064856|65969725|FG003|Open-label (OL) Period|Other|7|||
23612836|NCT03034772|65969726|FG000|Overall Study|Adverse Event|0|||
23612837|NCT03034772|65969727|FG001|Overall Study|Adverse Event|1|||
23612838|NCT03034772|65969726|FG000|Overall Study|Withdrawal by Subject|0|||
23612839|NCT03034772|65969727|FG001|Overall Study|Withdrawal by Subject|1|||
23612840|NCT01320683|65969728|FG000|Overall Study|Positive antibody response|1|||
23612841|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
23612842|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
23612843|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
23612844|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
23612845|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
23530407|NCT03192150|65676199|FG000|Overall Study|Withdrawal by Subject|4|||
23530408|NCT03192150|65676200|FG001|Overall Study|Withdrawal by Subject|2|||
23530409|NCT03192150|65676199|FG000|Overall Study|Protocol Violation|5|||
23530410|NCT03192150|65676200|FG001|Overall Study|Protocol Violation|2|||
23530411|NCT03192150|65676199|FG000|Overall Study|Surgery Canceled|6|||
23530412|NCT03192150|65676200|FG001|Overall Study|Surgery Canceled|2|||
23530413|NCT03192150|65676199|FG000|Overall Study|Other-Various Administrative Reasons|2|||
23530414|NCT03192150|65676200|FG001|Overall Study|Other-Various Administrative Reasons|5|||
23530415|NCT04152447|65676213|FG000|Overall Study|Lost to Follow-up|1|||
23530416|NCT04152447|65676214|FG001|Overall Study|Lost to Follow-up|0|||
23530417|NCT04152447|65676213|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
23530418|NCT04152447|65676214|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
23530419|NCT04152447|65676213|FG000|Overall Study|Withdrawal by Subject|0|||
23530420|NCT04152447|65676214|FG001|Overall Study|Withdrawal by Subject|1|||
23530421|NCT04152447|65676213|FG000|Overall Study|Found ineligible after enrolling|1|||
23530422|NCT04152447|65676214|FG001|Overall Study|Found ineligible after enrolling|1|||
23530423|NCT04152447|65676213|FG000|Overall Study|Did not receive VR headset in time.|0|||
23530424|NCT04152447|65676214|FG001|Overall Study|Did not receive VR headset in time.|2|||
23612846|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
23612847|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
23612848|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
23612849|NCT01863368|65969732|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
23612850|NCT01863368|65969733|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
23612851|NCT01863368|65969732|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
23612852|NCT01863368|65969733|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
23612853|NCT01721759|65969734|FG000|Treatment Period|Disease Progression|85|||
23612854|NCT01721759|65969734|FG000|Treatment Period|Study drug toxicity|14|||
23612855|NCT01721759|65969734|FG000|Treatment Period|Death|1|||
23612856|NCT01721759|65969734|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
23612857|NCT01721759|65969734|FG000|Treatment Period|Participant request to withdraw|3|||
23530425|NCT04380857|65676215|FG000|Overall Study|Lost to Follow-up|3|||
23530426|NCT04380857|65676216|FG001|Overall Study|Lost to Follow-up|3|||
23530427|NCT00183872|65676220|FG000|Overall Study|Death|3|||
23612858|NCT01721759|65969734|FG000|Treatment Period|Other Reasons|3|||
23612859|NCT01721759|65969734|FG000|End of Study Period|Participant Withdrew Consent|5|||
23612860|NCT01721759|65969734|FG000|End of Study Period|Death|101|||
23612861|NCT01721759|65969734|FG000|End of Study Period|Lost to Follow-up|1|||
23612862|NCT01721759|65969734|FG000|End of Study Period|Other Reasons|10|||
23612863|NCT03341312|65969735|FG000|Period 1|Withdrawal by Subject|0|||
23612864|NCT03341312|65969736|FG001|Period 1|Withdrawal by Subject|1|||
23612865|NCT03341312|65969737|FG002|Period 1|Withdrawal by Subject|0|||
23612866|NCT03341312|65969738|FG003|Period 1|Withdrawal by Subject|0|||
23612867|NCT02516202|65969739|FG000|Overall Study|Withdrawal by Subject|1|||
23612868|NCT02516202|65969740|FG001|Overall Study|Withdrawal by Subject|0|||
23612869|NCT02516202|65969741|FG002|Overall Study|Withdrawal by Subject|1|||
23612870|NCT02516202|65969739|FG000|Overall Study|Lost to Follow-up|1|||
23612871|NCT02516202|65969740|FG001|Overall Study|Lost to Follow-up|1|||
23612872|NCT02516202|65969741|FG002|Overall Study|Lost to Follow-up|1|||
23612873|NCT02516202|65969739|FG000|Overall Study|Stopped Follow-up|0|||
23612874|NCT02516202|65969740|FG001|Overall Study|Stopped Follow-up|0|||
23612875|NCT02516202|65969741|FG002|Overall Study|Stopped Follow-up|1|||
23612876|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
23813805|NCT00658021|66699443|FG000|28-Week Treatment Period|Adverse Event|3|||
23813806|NCT00658021|66699444|FG001|28-Week Treatment Period|Adverse Event|1|||
23813807|NCT00658021|66699445|FG002|28-Week Treatment Period|Adverse Event|0|||
23813808|NCT00658021|66699443|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
23813809|NCT00658021|66699444|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
23813810|NCT00658021|66699445|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
23813811|NCT00658021|66699443|FG000|28-Week Treatment Period|Protocol Violation|0|||
23813812|NCT00658021|66699444|FG001|28-Week Treatment Period|Protocol Violation|2|||
23530428|NCT00183872|65676220|FG000|Overall Study|Adverse Event|9|||
23530429|NCT00183872|65676220|FG000|Overall Study|Withdrawal by Subject|2|||
23530430|NCT00183872|65676220|FG000|Overall Study|Drug delayed more than 28 days|2|||
23530431|NCT01400841|65676221|FG000|Initial Study Phase (6 Months)|Death|1|||
23813813|NCT00658021|66699445|FG002|28-Week Treatment Period|Protocol Violation|1|||
23813814|NCT00658021|66699443|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
23813815|NCT00658021|66699444|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
23530432|NCT01400841|65676221|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
23530433|NCT00706966|65676222|FG000|Overall Study|Adverse Event|1|||
23530434|NCT00705575|65676225|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23530435|NCT00705575|65676226|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23530436|NCT00705575|65676225|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23612877|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
23612878|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
23612879|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
23612880|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
23612881|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
23612882|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
23612883|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23612884|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
23612885|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
23612886|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
23612887|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
23612888|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
23718879|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
23718880|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23530437|NCT00705575|65676226|FG001|Overall Study|Abnormal test procedure result(s)|12|||
23530438|NCT00705575|65676225|FG000|Overall Study|Adverse Event|11|||
23612889|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
23718881|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23718882|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23718883|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23718884|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23718885|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
23718886|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23718887|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23813816|NCT00658021|66699445|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
23813817|NCT00658021|66699443|FG000|28-Week Treatment Period|Physician Decision|1|||
23813818|NCT00658021|66699444|FG001|28-Week Treatment Period|Physician Decision|2|||
23530439|NCT00705575|65676226|FG001|Overall Study|Adverse Event|15|||
23612890|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
23530440|NCT00705575|65676225|FG000|Overall Study|Lost to Follow-up|3|||
23612891|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
23612892|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
23718888|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23718889|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
23718890|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
23718891|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
23718892|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
23718893|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
23718894|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
23718895|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
23718896|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
23718897|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
23718898|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
23718899|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
23718900|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
23718901|NCT02151682|66348398|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23419341|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419342|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419343|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419344|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530441|NCT00705575|65676226|FG001|Overall Study|Lost to Follow-up|4|||
23530442|NCT00705575|65676225|FG000|Overall Study|Protocol Violation|2|||
23530443|NCT00705575|65676226|FG001|Overall Study|Protocol Violation|2|||
23530444|NCT00705575|65676225|FG000|Overall Study|Withdrawal by Subject|5|||
23530445|NCT00705575|65676226|FG001|Overall Study|Withdrawal by Subject|10|||
23530446|NCT01687166|65676234|FG000|Overall Study|Attempt subject|2|||
23530447|NCT01687166|65676235|FG001|Overall Study|Attempt subject|3|||
23530448|NCT01687166|65676236|FG002|Overall Study|Attempt subject|2|||
23530449|NCT01687166|65676237|FG003|Overall Study|Attempt subject|0|||
23530450|NCT01687166|65676234|FG000|Overall Study|Did not meet eligibility criteria|4|||
23530451|NCT01687166|65676235|FG001|Overall Study|Did not meet eligibility criteria|6|||
23530452|NCT01687166|65676236|FG002|Overall Study|Did not meet eligibility criteria|1|||
23530453|NCT01687166|65676237|FG003|Overall Study|Did not meet eligibility criteria|1|||
23530454|NCT01687166|65676234|FG000|Overall Study|Adverse Event|2|||
23530455|NCT01687166|65676235|FG001|Overall Study|Adverse Event|1|||
23530456|NCT01687166|65676236|FG002|Overall Study|Adverse Event|0|||
23530457|NCT01687166|65676237|FG003|Overall Study|Adverse Event|0|||
23530458|NCT01687166|65676234|FG000|Overall Study|Physician Decision|3|||
23530459|NCT01687166|65676235|FG001|Overall Study|Physician Decision|2|||
23530460|NCT01687166|65676236|FG002|Overall Study|Physician Decision|1|||
23530461|NCT01687166|65676237|FG003|Overall Study|Physician Decision|0|||
23530462|NCT01687166|65676234|FG000|Overall Study|Withdrawal by Subject|11|||
23530463|NCT01687166|65676235|FG001|Overall Study|Withdrawal by Subject|4|||
23530464|NCT01687166|65676236|FG002|Overall Study|Withdrawal by Subject|3|||
23530465|NCT01687166|65676237|FG003|Overall Study|Withdrawal by Subject|0|||
23612893|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
23612894|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
23612895|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
23612896|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
23612897|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
23612898|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
23530466|NCT01687166|65676234|FG000|Overall Study|Lost to Follow-up|2|||
23530467|NCT01687166|65676235|FG001|Overall Study|Lost to Follow-up|5|||
23530468|NCT01687166|65676236|FG002|Overall Study|Lost to Follow-up|1|||
23530469|NCT01687166|65676237|FG003|Overall Study|Lost to Follow-up|0|||
23530470|NCT01687166|65676234|FG000|Overall Study|Equipment/Device Availability|0|||
23530471|NCT01687166|65676235|FG001|Overall Study|Equipment/Device Availability|1|||
23530472|NCT01687166|65676236|FG002|Overall Study|Equipment/Device Availability|0|||
23530473|NCT01687166|65676237|FG003|Overall Study|Equipment/Device Availability|0|||
23612899|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
23612900|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
23612901|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
23612902|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
23612903|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
23530474|NCT01687166|65676234|FG000|Overall Study|Death|1|||
23530475|NCT01687166|65676235|FG001|Overall Study|Death|1|||
23530476|NCT01687166|65676236|FG002|Overall Study|Death|0|||
23718902|NCT02151682|66348399|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23530477|NCT01687166|65676237|FG003|Overall Study|Death|0|||
23530478|NCT01687166|65676234|FG000|Overall Study|Protocol Violation|1|||
23530479|NCT01687166|65676235|FG001|Overall Study|Protocol Violation|1|||
23419345|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
23419346|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
23718903|NCT02151682|66348400|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
23718904|NCT02151682|66348401|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23718905|NCT02151682|66348402|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23718906|NCT02151682|66348403|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23718907|NCT02151682|66348398|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23718908|NCT02151682|66348399|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23718909|NCT02151682|66348400|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23718910|NCT02151682|66348401|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23718911|NCT02151682|66348402|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23718912|NCT02151682|66348403|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
23718913|NCT02151682|66348398|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23718914|NCT02151682|66348399|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23718915|NCT02151682|66348400|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23718916|NCT02151682|66348401|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23718917|NCT02151682|66348402|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23718918|NCT02151682|66348403|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
23718919|NCT02151682|66348398|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23718920|NCT02151682|66348399|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23718921|NCT02151682|66348400|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23718922|NCT02151682|66348401|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23718923|NCT02151682|66348402|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23718924|NCT02151682|66348403|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
23718925|NCT02151682|66348398|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23718926|NCT02151682|66348399|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23718927|NCT02151682|66348400|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23718928|NCT02151682|66348401|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23718929|NCT02151682|66348402|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23718930|NCT02151682|66348403|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
23718931|NCT05567393|66348404|FG000|Overall Study|Voluntary Withdrawal|0|||
23718932|NCT05567393|66348405|FG001|Overall Study|Voluntary Withdrawal|0|||
23718933|NCT05567393|66348406|FG002|Overall Study|Voluntary Withdrawal|0|||
23718934|NCT05567393|66348407|FG003|Overall Study|Voluntary Withdrawal|0|||
23718935|NCT05567393|66348408|FG004|Overall Study|Voluntary Withdrawal|0|||
23718936|NCT05567393|66348409|FG005|Overall Study|Voluntary Withdrawal|0|||
23718937|NCT05567393|66348410|FG006|Overall Study|Voluntary Withdrawal|0|||
23718938|NCT05567393|66348411|FG007|Overall Study|Voluntary Withdrawal|0|||
23718939|NCT05567393|66348412|FG008|Overall Study|Voluntary Withdrawal|0|||
23718940|NCT05567393|66348413|FG009|Overall Study|Voluntary Withdrawal|0|||
23718941|NCT05567393|66348414|FG010|Overall Study|Voluntary Withdrawal|0|||
23718942|NCT05567393|66348415|FG011|Overall Study|Voluntary Withdrawal|0|||
23419347|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419348|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23718943|NCT05567393|66348416|FG012|Overall Study|Voluntary Withdrawal|0|||
23718944|NCT05567393|66348417|FG013|Overall Study|Voluntary Withdrawal|1|||
23718945|NCT05567393|66348418|FG014|Overall Study|Voluntary Withdrawal|0|||
23718946|NCT05567393|66348419|FG015|Overall Study|Voluntary Withdrawal|0|||
23718947|NCT05567393|66348420|FG016|Overall Study|Voluntary Withdrawal|0|||
23718948|NCT05567393|66348421|FG017|Overall Study|Voluntary Withdrawal|0|||
23718949|NCT03479216|66348422|FG000|Overall Study|Withdrawal by Subject|3|||
23718950|NCT03479216|66348423|FG001|Overall Study|Withdrawal by Subject|2|||
23718951|NCT03479216|66348422|FG000|Overall Study|Physician Decision|2|||
23718952|NCT03479216|66348423|FG001|Overall Study|Physician Decision|3|||
23718953|NCT01747811|66348424|FG000|Overall Study|Lack of Efficacy|2|||
23718954|NCT01747811|66348425|FG001|Overall Study|Lack of Efficacy|4|||
23718955|NCT00903370|66348438|FG000|Overall Study|Death|13|||
23718956|NCT00903370|66348439|FG001|Overall Study|Death|10|||
23718957|NCT00903370|66348438|FG000|Overall Study|Withdrawal by Subject|9|||
23718958|NCT00903370|66348439|FG001|Overall Study|Withdrawal by Subject|6|||
23718959|NCT00903370|66348438|FG000|Overall Study|Lost to Follow-up|6|||
23718960|NCT00903370|66348439|FG001|Overall Study|Lost to Follow-up|8|||
23718961|NCT01162304|66348440|FG000|Overall Study|Beck scale to high|11|||
23718962|NCT03820726|66348443|FG000|Overall Study|Other than listed|23|||
23718963|NCT03820726|66348443|FG000|Overall Study|Withdrawal by Subject|37|||
23718964|NCT03820726|66348443|FG000|Overall Study|Lost to Follow-up|3|||
23718965|NCT03820726|66348443|FG000|Overall Study|Protocol deviation|1|||
23718966|NCT03820726|66348443|FG000|Overall Study|Adverse Event|146|||
23718967|NCT03820726|66348443|FG000|Overall Study|Not treated|1|||
23718968|NCT01103778|66348446|FG000|Overall Study|Lost to Follow-up|1|||
23718969|NCT01103778|66348446|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
23718970|NCT01103778|66348446|FG000|Overall Study|Screen failure|1|||
23718971|NCT02527148|66348449|FG000|Overall Study|Did not receive study intervention|1|||
23718972|NCT02527148|66348450|FG001|Overall Study|Did not receive study intervention|0|||
23718973|NCT03447821|66348451|FG000|Overall Study|Withdrawal by Subject|1|||
23718974|NCT03447821|66348452|FG001|Overall Study|Withdrawal by Subject|1|||
23718975|NCT03447821|66348453|FG002|Overall Study|Withdrawal by Subject|0|||
23718976|NCT03447821|66348451|FG000|Overall Study|Lost to Follow-up|0|||
23718977|NCT03447821|66348452|FG001|Overall Study|Lost to Follow-up|0|||
23718978|NCT03447821|66348453|FG002|Overall Study|Lost to Follow-up|1|||
23718979|NCT01924299|66348454|FG000|Period 2|Withdrawal by Subject|1|||
23718980|NCT01924299|66348455|FG001|Period 2|Withdrawal by Subject|0|||
23718981|NCT01924299|66348454|FG000|Period 2|Adverse Event|0|||
23718982|NCT01924299|66348455|FG001|Period 2|Adverse Event|1|||
23718983|NCT02141217|66348456|FG000|Overall Study|Adverse Event|1|||
23813819|NCT00658021|66699445|FG002|28-Week Treatment Period|Physician Decision|1|||
23813820|NCT00658021|66699443|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23813821|NCT00658021|66699444|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23813822|NCT00658021|66699445|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23813823|NCT00658021|66699443|FG000|28-Week Treatment Period|Loss of glucose control|1|||
23813824|NCT00658021|66699444|FG001|28-Week Treatment Period|Loss of glucose control|1|||
23813825|NCT00658021|66699445|FG002|28-Week Treatment Period|Loss of glucose control|10|||
23813826|NCT00658021|66699443|FG000|28-Week Treatment Period|Other|2|||
23813827|NCT00658021|66699444|FG001|28-Week Treatment Period|Other|3|||
23813828|NCT00658021|66699445|FG002|28-Week Treatment Period|Other|1|||
23813829|NCT00658021|66699443|FG000|28-Week Treatment Period|Did not receive treatment|2|||
23419349|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419350|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23530480|NCT01687166|65676236|FG002|Overall Study|Protocol Violation|1|||
23530481|NCT01687166|65676237|FG003|Overall Study|Protocol Violation|0|||
23530482|NCT01687166|65676234|FG000|Overall Study|Subject moved out of state|0|||
23419351|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23530483|NCT01687166|65676235|FG001|Overall Study|Subject moved out of state|1|||
23530484|NCT01687166|65676236|FG002|Overall Study|Subject moved out of state|0|||
23530485|NCT01687166|65676237|FG003|Overall Study|Subject moved out of state|0|||
23530486|NCT01687166|65676234|FG000|Overall Study|Patient unable to be compliant|1|||
23419352|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419353|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
23419354|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419355|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419356|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
23419357|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419358|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419359|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419360|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419361|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419362|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419363|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23530487|NCT01687166|65676235|FG001|Overall Study|Patient unable to be compliant|0|||
23530488|NCT01687166|65676236|FG002|Overall Study|Patient unable to be compliant|0|||
23530489|NCT01687166|65676237|FG003|Overall Study|Patient unable to be compliant|0|||
23718984|NCT02141217|66348457|FG001|Overall Study|Adverse Event|2|||
23718985|NCT02141217|66348456|FG000|Overall Study|Protocol Violation|1|||
23530490|NCT01687166|65676234|FG000|Overall Study|Physician choice to use different device|1|||
23718986|NCT02141217|66348457|FG001|Overall Study|Protocol Violation|4|||
23718987|NCT02141217|66348456|FG000|Overall Study|Withdrawal by Subject|6|||
23718988|NCT02141217|66348457|FG001|Overall Study|Withdrawal by Subject|0|||
23813830|NCT00658021|66699444|FG001|28-Week Treatment Period|Did not receive treatment|0|||
23530491|NCT01687166|65676235|FG001|Overall Study|Physician choice to use different device|2|||
23530492|NCT01687166|65676236|FG002|Overall Study|Physician choice to use different device|4|||
23530493|NCT01687166|65676237|FG003|Overall Study|Physician choice to use different device|0|||
23530494|NCT01687166|65676234|FG000|Overall Study|Insurance|0|||
23530495|NCT01687166|65676235|FG001|Overall Study|Insurance|0|||
23530496|NCT01687166|65676236|FG002|Overall Study|Insurance|1|||
23530497|NCT01687166|65676237|FG003|Overall Study|Insurance|1|||
23530498|NCT03144180|65676238|FG000|Overall Study|STAT Delivery|1|||
23530499|NCT03144180|65676239|FG001|Overall Study|STAT Delivery|1|||
23718989|NCT02141217|66348456|FG000|Overall Study|Lost to Follow-up|1|||
23718990|NCT02141217|66348457|FG001|Overall Study|Lost to Follow-up|1|||
23530500|NCT03144180|65676238|FG000|Overall Study|Provider forgot to fill out forms|1|||
23530501|NCT03144180|65676239|FG001|Overall Study|Provider forgot to fill out forms|3|||
23530502|NCT03144180|65676238|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
23530503|NCT03144180|65676239|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
23530504|NCT03144180|65676238|FG000|Overall Study|Scrub tech removed tube cap|0|||
23612904|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
23718991|NCT02141217|66348456|FG000|Overall Study|Physician Decision|1|||
23718992|NCT02141217|66348457|FG001|Overall Study|Physician Decision|0|||
23718993|NCT02141217|66348456|FG000|Overall Study|Surgical Intervention|1|||
23718994|NCT02141217|66348457|FG001|Overall Study|Surgical Intervention|1|||
23718995|NCT00851253|66348458|FG000|Overall Study|Disease Progression|1|||
23419364|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419365|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419366|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419367|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
23530505|NCT03144180|65676239|FG001|Overall Study|Scrub tech removed tube cap|1|||
23718996|NCT00851253|66348459|FG001|Overall Study|Disease Progression|0|||
23718997|NCT02566109|66348462|FG000|Overall Study|Withdrawal by Subject|1|||
23718998|NCT03657810|66348463|FG000|Overall Study|Adverse Event|0|||
23530506|NCT04960228|65676240|FG000|Overall Study|Withdrawal by Subject|216|||
23718999|NCT03657810|66348464|FG001|Overall Study|Adverse Event|1|||
23419368|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419369|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419370|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419371|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419372|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419373|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419374|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419375|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419376|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
23419377|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
23419378|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419379|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419380|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419381|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419382|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419383|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419384|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23530507|NCT04960228|65676241|FG001|Overall Study|Withdrawal by Subject|35|||
23530508|NCT04960228|65676240|FG000|Overall Study|Failed attention check|69|||
23530509|NCT04960228|65676241|FG001|Overall Study|Failed attention check|148|||
23530510|NCT04960228|65676240|FG000|Overall Study|Flagged for response quality by Dynata|3|||
23530511|NCT04960228|65676241|FG001|Overall Study|Flagged for response quality by Dynata|3|||
23530512|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
23530513|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
23530514|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
23530515|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
23530516|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
23530517|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
23530518|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
23530519|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
23530520|NCT01866709|65676252|FG000|Overall Study|Adverse Event|1|||
23530521|NCT01866709|65676253|FG001|Overall Study|Adverse Event|0|||
23530522|NCT00782210|65676254|FG000|Overall Study|Adverse Event|21|||
23530523|NCT00782210|65676255|FG001|Overall Study|Adverse Event|17|||
23530524|NCT00782210|65676256|FG002|Overall Study|Adverse Event|16|||
23530525|NCT00782210|65676254|FG000|Overall Study|Lost to Follow-up|2|||
23530526|NCT00782210|65676255|FG001|Overall Study|Lost to Follow-up|1|||
23530527|NCT00782210|65676256|FG002|Overall Study|Lost to Follow-up|2|||
23530528|NCT00782210|65676254|FG000|Overall Study|Withdrawal by Subject|11|||
23612905|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
23612906|NCT02164578|65969744|FG000|Treatment Period|Withdrawal by Subject|3|||
23612907|NCT02164578|65969745|FG001|Treatment Period|Withdrawal by Subject|3|||
23612908|NCT02164578|65969744|FG000|Treatment Period|Adverse Event|13|||
23612909|NCT02164578|65969745|FG001|Treatment Period|Adverse Event|6|||
23612910|NCT02164578|65969744|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
23419385|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
23530529|NCT00782210|65676255|FG001|Overall Study|Withdrawal by Subject|8|||
23530530|NCT00782210|65676256|FG002|Overall Study|Withdrawal by Subject|11|||
23530531|NCT00782210|65676254|FG000|Overall Study|Non compliance with protocol|0|||
23530532|NCT00782210|65676255|FG001|Overall Study|Non compliance with protocol|3|||
23530533|NCT00782210|65676256|FG002|Overall Study|Non compliance with protocol|2|||
23530534|NCT00782210|65676254|FG000|Overall Study|Lack of Efficacy|13|||
23530535|NCT00782210|65676255|FG001|Overall Study|Lack of Efficacy|4|||
23530536|NCT00782210|65676256|FG002|Overall Study|Lack of Efficacy|1|||
23530537|NCT00782210|65676254|FG000|Overall Study|Other reason not described above|3|||
23530538|NCT00782210|65676255|FG001|Overall Study|Other reason not described above|2|||
23530539|NCT00782210|65676256|FG002|Overall Study|Other reason not described above|3|||
23530540|NCT01109316|65676257|FG000|Study Period 1|Adverse Event|0|||
23530541|NCT01109316|65676258|FG001|Study Period 1|Adverse Event|0|||
23530542|NCT01109316|65676259|FG002|Study Period 1|Adverse Event|1|||
23530543|NCT01109316|65676260|FG003|Study Period 1|Adverse Event|0|||
23530544|NCT01109316|65676261|FG004|Study Period 1|Adverse Event|0|||
23530545|NCT01109316|65676262|FG005|Study Period 1|Adverse Event|0|||
23530546|NCT01109316|65676257|FG000|Study Period 1|Lost to Follow-up|0|||
23612911|NCT02164578|65969745|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
23530547|NCT01109316|65676258|FG001|Study Period 1|Lost to Follow-up|0|||
23530548|NCT01109316|65676259|FG002|Study Period 1|Lost to Follow-up|1|||
23530549|NCT01109316|65676260|FG003|Study Period 1|Lost to Follow-up|1|||
23530550|NCT01109316|65676261|FG004|Study Period 1|Lost to Follow-up|0|||
23612912|NCT02164578|65969744|FG000|Treatment Period|Protocol Violation|0|||
23530551|NCT01109316|65676262|FG005|Study Period 1|Lost to Follow-up|0|||
23612913|NCT02164578|65969745|FG001|Treatment Period|Protocol Violation|2|||
23612914|NCT02164578|65969744|FG000|Extension Period|Withdrawal by Subject|2|||
23530552|NCT01109316|65676257|FG000|Study Period 1|Withdrawal by Subject|0|||
23530553|NCT01109316|65676258|FG001|Study Period 1|Withdrawal by Subject|0|||
23530554|NCT01109316|65676259|FG002|Study Period 1|Withdrawal by Subject|1|||
23530555|NCT01109316|65676260|FG003|Study Period 1|Withdrawal by Subject|0|||
23530556|NCT01109316|65676261|FG004|Study Period 1|Withdrawal by Subject|2|||
23530557|NCT01109316|65676262|FG005|Study Period 1|Withdrawal by Subject|0|||
23530558|NCT01109316|65676257|FG000|Study Period 1|Sponsor Decision|0|||
23530559|NCT01109316|65676258|FG001|Study Period 1|Sponsor Decision|0|||
23530560|NCT01109316|65676259|FG002|Study Period 1|Sponsor Decision|0|||
23530561|NCT01109316|65676260|FG003|Study Period 1|Sponsor Decision|0|||
23530562|NCT01109316|65676261|FG004|Study Period 1|Sponsor Decision|0|||
23530563|NCT01109316|65676262|FG005|Study Period 1|Sponsor Decision|2|||
23530564|NCT01109316|65676257|FG000|Study Period 2|Entry Criteria Not Met|0|||
23530565|NCT01109316|65676258|FG001|Study Period 2|Entry Criteria Not Met|1|||
23530566|NCT01109316|65676259|FG002|Study Period 2|Entry Criteria Not Met|0|||
23530567|NCT01109316|65676260|FG003|Study Period 2|Entry Criteria Not Met|0|||
23530568|NCT01109316|65676261|FG004|Study Period 2|Entry Criteria Not Met|0|||
23530569|NCT01109316|65676262|FG005|Study Period 2|Entry Criteria Not Met|0|||
23530570|NCT01109316|65676257|FG000|Study Period 2|Physician Decision|0|||
23530571|NCT01109316|65676258|FG001|Study Period 2|Physician Decision|0|||
23530572|NCT01109316|65676259|FG002|Study Period 2|Physician Decision|0|||
23530573|NCT01109316|65676260|FG003|Study Period 2|Physician Decision|1|||
23530574|NCT01109316|65676261|FG004|Study Period 2|Physician Decision|0|||
23530575|NCT01109316|65676262|FG005|Study Period 2|Physician Decision|0|||
23530576|NCT01109316|65676257|FG000|Study Period 2|Protocol Violation|1|||
23530577|NCT01109316|65676258|FG001|Study Period 2|Protocol Violation|0|||
23530578|NCT01109316|65676259|FG002|Study Period 2|Protocol Violation|0|||
23530579|NCT01109316|65676260|FG003|Study Period 2|Protocol Violation|0|||
23530580|NCT01109316|65676261|FG004|Study Period 2|Protocol Violation|0|||
23530581|NCT01109316|65676262|FG005|Study Period 2|Protocol Violation|0|||
23530582|NCT01109316|65676257|FG000|Study Period 2|Withdrawal by Subject|0|||
23530583|NCT01109316|65676258|FG001|Study Period 2|Withdrawal by Subject|0|||
23530584|NCT01109316|65676259|FG002|Study Period 2|Withdrawal by Subject|1|||
23530585|NCT01109316|65676260|FG003|Study Period 2|Withdrawal by Subject|0|||
23530586|NCT01109316|65676261|FG004|Study Period 2|Withdrawal by Subject|0|||
23530587|NCT01109316|65676262|FG005|Study Period 2|Withdrawal by Subject|1|||
23530588|NCT01109316|65676257|FG000|Study Period 3|Lost to Follow-up|0|||
23530589|NCT01109316|65676258|FG001|Study Period 3|Lost to Follow-up|0|||
23530590|NCT01109316|65676259|FG002|Study Period 3|Lost to Follow-up|0|||
23530591|NCT01109316|65676260|FG003|Study Period 3|Lost to Follow-up|0|||
23530592|NCT01109316|65676261|FG004|Study Period 3|Lost to Follow-up|1|||
23530593|NCT01109316|65676262|FG005|Study Period 3|Lost to Follow-up|0|||
23530594|NCT01109316|65676257|FG000|Study Period 3|Withdrawal by Subject|1|||
23530595|NCT01109316|65676258|FG001|Study Period 3|Withdrawal by Subject|0|||
23530596|NCT01109316|65676259|FG002|Study Period 3|Withdrawal by Subject|0|||
23530597|NCT01109316|65676260|FG003|Study Period 3|Withdrawal by Subject|0|||
23530598|NCT01109316|65676261|FG004|Study Period 3|Withdrawal by Subject|1|||
23530599|NCT01109316|65676262|FG005|Study Period 3|Withdrawal by Subject|0|||
23530600|NCT01020019|65676266|FG000|Overall Study|Lost to Follow-up|21|||
23530601|NCT01020019|65676267|FG001|Overall Study|Lost to Follow-up|18|||
23530602|NCT01020019|65676266|FG000|Overall Study|Adverse Event|1|||
23719000|NCT03657810|66348465|FG002|Overall Study|Adverse Event|0|||
23719001|NCT03657810|66348463|FG000|Overall Study|Lack of Efficacy|4|||
23719002|NCT03657810|66348464|FG001|Overall Study|Lack of Efficacy|1|||
23719003|NCT03657810|66348465|FG002|Overall Study|Lack of Efficacy|3|||
23719004|NCT03657810|66348463|FG000|Overall Study|Protocol Violation|1|||
23719005|NCT03657810|66348464|FG001|Overall Study|Protocol Violation|0|||
23719006|NCT03657810|66348465|FG002|Overall Study|Protocol Violation|0|||
23719007|NCT03657810|66348463|FG000|Overall Study|Lost to Follow-up|0|||
23719008|NCT03657810|66348464|FG001|Overall Study|Lost to Follow-up|1|||
23719009|NCT03657810|66348465|FG002|Overall Study|Lost to Follow-up|0|||
23719010|NCT03657810|66348463|FG000|Overall Study|Not provided|0|||
23719011|NCT03657810|66348464|FG001|Overall Study|Not provided|1|||
23719012|NCT03657810|66348465|FG002|Overall Study|Not provided|0|||
23719013|NCT00669032|66348466|FG000|Overall Study|Lost to Follow-up|6|||
23530603|NCT01020019|65676267|FG001|Overall Study|Adverse Event|5|||
23530604|NCT01020019|65676266|FG000|Overall Study|not interested in treatment|4|||
23530605|NCT01020019|65676267|FG001|Overall Study|not interested in treatment|4|||
23530606|NCT01020019|65676266|FG000|Overall Study|moving|0|||
23530607|NCT01020019|65676267|FG001|Overall Study|moving|2|||
23530608|NCT01639040|65676271|FG000|Overall Study|Adverse Event|1|||
23530609|NCT01639040|65676272|FG001|Overall Study|Adverse Event|0|||
23530610|NCT03019627|65676273|FG000|Overall Study|Adverse Event|8|||
23530611|NCT03019627|65676274|FG001|Overall Study|Adverse Event|0|||
23530612|NCT03019627|65676273|FG000|Overall Study|Unrelated to adverse event|1|||
23530613|NCT03019627|65676274|FG001|Overall Study|Unrelated to adverse event|3|||
23530614|NCT03019627|65676273|FG000|Overall Study|Lost to Follow-up|2|||
23719014|NCT00669032|66348467|FG001|Overall Study|Lost to Follow-up|5|||
23719015|NCT00669032|66348466|FG000|Overall Study|Lack of Efficacy|8|||
23719016|NCT00669032|66348467|FG001|Overall Study|Lack of Efficacy|19|||
23719017|NCT00669032|66348466|FG000|Overall Study|Withdrawal by Subject|12|||
23719018|NCT00669032|66348467|FG001|Overall Study|Withdrawal by Subject|13|||
23719019|NCT00669032|66348466|FG000|Overall Study|Adverse Event|12|||
23719020|NCT00669032|66348467|FG001|Overall Study|Adverse Event|16|||
23719021|NCT00669032|66348466|FG000|Overall Study|Physician Decision|1|||
23719022|NCT00669032|66348467|FG001|Overall Study|Physician Decision|1|||
23719023|NCT00669032|66348466|FG000|Overall Study|No fulfilment of the selection criteria|5|||
23719024|NCT00669032|66348467|FG001|Overall Study|No fulfilment of the selection criteria|5|||
23719025|NCT04179786|66348470|FG000|Overall Study|Withdrawal by Subject|8|||
23719026|NCT00804843|66348471|FG000|Overall Study|Protocol Violation|1|||
23719027|NCT00804843|66348472|FG001|Overall Study|Protocol Violation|0|||
23719028|NCT00804843|66348471|FG000|Overall Study|Adverse Event|8|||
23719029|NCT00804843|66348472|FG001|Overall Study|Adverse Event|5|||
23719030|NCT00804843|66348471|FG000|Overall Study|Withdrawal by Subject|1|||
23719031|NCT00804843|66348472|FG001|Overall Study|Withdrawal by Subject|2|||
23719032|NCT01957709|66348473|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
23719033|NCT00605722|66348474|FG000|Overall Study|Adverse Event|6|||
23719034|NCT00605722|66348474|FG000|Overall Study|Insufficient therapeutic response|44|||
23719035|NCT00605722|66348474|FG000|Overall Study|Failure to return|1|||
23719036|NCT04095442|66348476|FG000|Overall Study|Lost to Follow-up|0|||
23719037|NCT04095442|66348477|FG001|Overall Study|Lost to Follow-up|1|||
23719038|NCT04095442|66348476|FG000|Overall Study|Screen failure|1|||
23719039|NCT04095442|66348477|FG001|Overall Study|Screen failure|0|||
23530615|NCT03019627|65676274|FG001|Overall Study|Lost to Follow-up|1|||
23530616|NCT03019627|65676273|FG000|Overall Study|not compliance|2|||
23530617|NCT03019627|65676274|FG001|Overall Study|not compliance|2|||
23530618|NCT03019627|65676273|FG000|Overall Study|Other|2|||
23530619|NCT03019627|65676274|FG001|Overall Study|Other|2|||
23530620|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
23530621|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
23530622|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
23530623|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
23530624|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
23530625|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
23530626|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
23530627|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
23530628|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
23530629|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
23530630|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
23530631|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
23530632|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
23530633|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
23530634|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
23530635|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
23530636|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
23530637|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
23530638|NCT00280566|65676277|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
23530639|NCT00280566|65676278|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
23530640|NCT00280566|65676279|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
23530641|NCT00280566|65676277|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
23530642|NCT00280566|65676278|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
23530643|NCT00280566|65676279|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
23530644|NCT00280566|65676277|FG000|Period 2 Double Blind|Adverse Event|0|||
23530645|NCT00280566|65676278|FG001|Period 2 Double Blind|Adverse Event|11|||
23530646|NCT00280566|65676279|FG002|Period 2 Double Blind|Adverse Event|15|||
23530647|NCT00280566|65676277|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
23719040|NCT00014911|66348481|FG000|Overall Study|Adverse Event|1|||
23719041|NCT00014911|66348481|FG000|Overall Study|Lost to Follow-up|1|||
23719042|NCT00014911|66348481|FG000|Overall Study|Withdrawal by Subject|6|||
23719043|NCT00014911|66348481|FG000|Overall Study|Unknown Reasons|2|||
23530648|NCT00280566|65676278|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
23530649|NCT00280566|65676279|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
23530650|NCT00280566|65676277|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
23530651|NCT00280566|65676278|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
23530652|NCT00280566|65676279|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
23530653|NCT00280566|65676277|FG000|Period 2 Double Blind|miscellaneous|0|||
23530654|NCT00280566|65676278|FG001|Period 2 Double Blind|miscellaneous|10|||
23530655|NCT00280566|65676279|FG002|Period 2 Double Blind|miscellaneous|5|||
23612915|NCT02164578|65969745|FG001|Extension Period|Withdrawal by Subject|0|||
23612916|NCT02164578|65969744|FG000|Extension Period|Adverse Event|4|||
23719044|NCT00014911|66348481|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
23719045|NCT01677507|66348482|FG000|Initial Assignment|Adverse Event|0|||
23719046|NCT01677507|66348483|FG001|Initial Assignment|Adverse Event|1|||
23530656|NCT02940691|65676280|FG000|Overall Study|Lost to Follow-up|5|||
23530657|NCT02940691|65676280|FG000|Overall Study|Incarceration|1|||
23530658|NCT00622635|65676287|FG000|Treatment Period 1|Adverse Event|0|||
23530659|NCT00622635|65676288|FG001|Treatment Period 1|Adverse Event|0|||
23530660|NCT00622635|65676289|FG002|Treatment Period 1|Adverse Event|1|||
23530661|NCT00622635|65676290|FG003|Treatment Period 1|Adverse Event|0|||
23530662|NCT00622635|65676291|FG004|Treatment Period 1|Adverse Event|0|||
23530663|NCT00622635|65676292|FG005|Treatment Period 1|Adverse Event|0|||
23530664|NCT00622635|65676287|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23530665|NCT00622635|65676288|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23530666|NCT00622635|65676289|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23530667|NCT00622635|65676290|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23612917|NCT02164578|65969745|FG001|Extension Period|Adverse Event|0|||
23419386|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
23419387|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419388|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Other|0|||
23419389|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Other|0|||
23419390|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Other|0|||
23419391|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Other|0|||
23419392|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Other|0|||
23419393|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Other|0|||
23419394|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Other|0|||
23419395|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Other|1|||
23419396|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Other|0|||
23419397|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Other|0|||
23419398|NCT00503776|65277400|FG000|Overall Study|Withdrawal by Subject|1|||
23419399|NCT00503776|65277401|FG001|Overall Study|Withdrawal by Subject|0|||
23419400|NCT00503776|65277402|FG002|Overall Study|Withdrawal by Subject|1|||
23419401|NCT00503776|65277403|FG003|Overall Study|Withdrawal by Subject|1|||
23719047|NCT01677507|66348482|FG000|Initial Assignment|Protocol Violation|0|||
23719048|NCT01677507|66348483|FG001|Initial Assignment|Protocol Violation|1|||
23719049|NCT01677507|66348482|FG000|Second Assigment|Withdrawal by Subject|2|||
23719050|NCT01677507|66348483|FG001|Second Assigment|Withdrawal by Subject|2|||
23719051|NCT01677507|66348482|FG000|Second Assigment|Adverse Event|1|||
23719052|NCT01677507|66348483|FG001|Second Assigment|Adverse Event|3|||
23719053|NCT01167153|66348484|FG000|Overall Study|Non-effective therapy|1|||
23719054|NCT01167153|66348485|FG001|Overall Study|Non-effective therapy|4|||
23719055|NCT01167153|66348484|FG000|Overall Study|AE including clinical laboratory AE|2|||
23719056|NCT01167153|66348485|FG001|Overall Study|AE including clinical laboratory AE|8|||
23719057|NCT01167153|66348484|FG000|Overall Study|Hypotension|1|||
23719058|NCT01167153|66348485|FG001|Overall Study|Hypotension|0|||
23719059|NCT01167153|66348484|FG000|Overall Study|Lost to Follow-up|7|||
23719060|NCT01167153|66348485|FG001|Overall Study|Lost to Follow-up|9|||
23719061|NCT01167153|66348484|FG000|Overall Study|Non-compliance to concomitant medication|0|||
23719062|NCT01167153|66348485|FG001|Overall Study|Non-compliance to concomitant medication|2|||
23719063|NCT01167153|66348484|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
23719064|NCT01167153|66348485|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
23719065|NCT01167153|66348484|FG000|Overall Study|Withdrawal consent|1|||
23719066|NCT01167153|66348485|FG001|Overall Study|Withdrawal consent|1|||
23719067|NCT01167153|66348484|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
23719068|NCT01167153|66348485|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
23719069|NCT01181778|66348492|FG000|Overall Study|Physician Decision|48|||
23719070|NCT04377672|66348493|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
23719071|NCT00141037|66348494|FG000|Overall Study|Physician Decision|1|||
23719072|NCT00141037|66348495|FG001|Overall Study|Physician Decision|2|||
23719073|NCT00141037|66348494|FG000|Overall Study|Lost to Follow-up|3|||
23719074|NCT00141037|66348495|FG001|Overall Study|Lost to Follow-up|1|||
23719075|NCT00141037|66348494|FG000|Overall Study|Protocol Violation|0|||
23719076|NCT00141037|66348495|FG001|Overall Study|Protocol Violation|2|||
23719077|NCT00141037|66348494|FG000|Overall Study|Withdrawal by Subject|2|||
23719078|NCT00141037|66348495|FG001|Overall Study|Withdrawal by Subject|1|||
23719079|NCT00141037|66348494|FG000|Overall Study|Other|0|||
23419402|NCT00503776|65277400|FG000|Overall Study|Physician Decision|0|||
23419403|NCT00503776|65277401|FG001|Overall Study|Physician Decision|0|||
23530668|NCT00622635|65676291|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23719080|NCT00141037|66348495|FG001|Overall Study|Other|1|||
23719081|NCT00141037|66348494|FG000|Overall Study|Moved from area|1|||
23719082|NCT00141037|66348495|FG001|Overall Study|Moved from area|7|||
23719083|NCT00141037|66348494|FG000|Overall Study|Graft Failure|3|||
23813831|NCT00658021|66699445|FG002|28-Week Treatment Period|Did not receive treatment|0|||
23419404|NCT00503776|65277402|FG002|Overall Study|Physician Decision|1|||
23419405|NCT00503776|65277403|FG003|Overall Study|Physician Decision|1|||
23719084|NCT00141037|66348495|FG001|Overall Study|Graft Failure|4|||
23719085|NCT03365947|66348500|FG000|Overall Study|Lost to Follow-up|0|||
23813832|NCT00658021|66699443|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
23419406|NCT01200407|65277414|FG000|Overall Study|Lost to Follow-up|56|||
23719086|NCT03365947|66348501|FG001|Overall Study|Lost to Follow-up|0|||
23719087|NCT03365947|66348502|FG002|Overall Study|Lost to Follow-up|0|||
23719088|NCT03365947|66348503|FG003|Overall Study|Lost to Follow-up|0|||
23719089|NCT03365947|66348504|FG004|Overall Study|Lost to Follow-up|0|||
23719090|NCT03365947|66348505|FG005|Overall Study|Lost to Follow-up|1|||
23719091|NCT03365947|66348506|FG006|Overall Study|Lost to Follow-up|0|||
23719092|NCT03365947|66348507|FG007|Overall Study|Lost to Follow-up|0|||
23719093|NCT03365947|66348508|FG008|Overall Study|Lost to Follow-up|0|||
23719094|NCT03365947|66348509|FG009|Overall Study|Lost to Follow-up|0|||
23719095|NCT03365947|66348510|FG010|Overall Study|Lost to Follow-up|0|||
23719096|NCT03365947|66348511|FG011|Overall Study|Lost to Follow-up|0|||
23719097|NCT03365947|66348512|FG012|Overall Study|Lost to Follow-up|0|||
23719098|NCT03365947|66348513|FG013|Overall Study|Lost to Follow-up|0|||
23719099|NCT03365947|66348514|FG014|Overall Study|Lost to Follow-up|0|||
23719100|NCT03365947|66348515|FG015|Overall Study|Lost to Follow-up|0|||
23719101|NCT03365947|66348516|FG016|Overall Study|Lost to Follow-up|0|||
23719102|NCT03365947|66348517|FG017|Overall Study|Lost to Follow-up|0|||
23719103|NCT03365947|66348518|FG018|Overall Study|Lost to Follow-up|0|||
23719104|NCT02146833|66348519|FG000|Overall Study|Death|10|||
23719105|NCT02146833|66348519|FG000|Overall Study|No longer consented to study treatment|1|||
23719106|NCT02939599|66348522|FG000|Overall Study|Adverse Event|1|||
23719107|NCT02939599|66348523|FG001|Overall Study|Adverse Event|0|||
23719108|NCT02939599|66348522|FG000|Overall Study|Study Terminated By Sponsor|2|||
23719109|NCT02939599|66348523|FG001|Overall Study|Study Terminated By Sponsor|2|||
23719110|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
23719111|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
23719112|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
23719113|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
23719114|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
23719115|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23719116|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23719117|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23719118|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
23719119|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23719120|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23719121|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23719122|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23719123|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
23719124|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23719125|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23719126|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23719127|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23719128|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
23719129|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23719130|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23719131|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23612918|NCT02164578|65969744|FG000|Extension Period|Expiry of study medication|1|||
23612919|NCT02164578|65969745|FG001|Extension Period|Expiry of study medication|0|||
23612920|NCT02164578|65969744|FG000|Extension Period|Protocol Violation|0|||
23612921|NCT02164578|65969745|FG001|Extension Period|Protocol Violation|1|||
23612922|NCT01018992|65969746|FG000|Overall Study|Adverse Event|8|||
23612923|NCT01018992|65969747|FG001|Overall Study|Adverse Event|3|||
23612924|NCT01018992|65969746|FG000|Overall Study|Withdrawal by Subject|3|||
23612925|NCT01018992|65969747|FG001|Overall Study|Withdrawal by Subject|8|||
23612926|NCT01018992|65969746|FG000|Overall Study|Protocol Violation|0|||
23719132|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23719133|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
23719134|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23719135|NCT00856986|66348524|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
23530669|NCT00622635|65676292|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23530670|NCT00622635|65676287|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530671|NCT00622635|65676288|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530672|NCT00622635|65676289|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530673|NCT00622635|65676290|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530674|NCT00622635|65676291|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
23530675|NCT00622635|65676292|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530676|NCT00622635|65676287|FG000|Treatment Period 2|Adverse Event|1|||
23612927|NCT01018992|65969747|FG001|Overall Study|Protocol Violation|4|||
23612928|NCT01018992|65969746|FG000|Overall Study|Lost to Follow-up|5|||
23612929|NCT01018992|65969747|FG001|Overall Study|Lost to Follow-up|1|||
23719136|NCT00856986|66348525|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
23719137|NCT00856986|66348526|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
23719138|NCT00856986|66348527|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
23719139|NCT00856986|66348528|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
23719140|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
23719141|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
23719142|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
23719143|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
23719144|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
23719145|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
23719146|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
23719147|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
23719148|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
23719149|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
23719150|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
23719151|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23719152|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
23719153|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23719154|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23719155|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
23719156|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
23719157|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
23719158|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
23719159|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
23719160|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
23719161|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
23719162|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23719163|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23719164|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23719165|NCT00856986|66348524|FG000|Main Period, Weeks 0-26|Unclassified|7|||
23719166|NCT00856986|66348525|FG001|Main Period, Weeks 0-26|Unclassified|6|||
23719167|NCT00856986|66348526|FG002|Main Period, Weeks 0-26|Unclassified|7|||
23719168|NCT00856986|66348527|FG003|Main Period, Weeks 0-26|Unclassified|0|||
23719169|NCT00856986|66348528|FG004|Main Period, Weeks 0-26|Unclassified|0|||
23719170|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
23719171|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
23719172|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
23719173|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
23719174|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
23719175|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
23719176|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
23719177|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
23719178|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
23530677|NCT00622635|65676288|FG001|Treatment Period 2|Adverse Event|0|||
23530678|NCT00622635|65676289|FG002|Treatment Period 2|Adverse Event|0|||
23530679|NCT00622635|65676290|FG003|Treatment Period 2|Adverse Event|0|||
23719179|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
23719180|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
23719181|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23719182|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
23719183|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23719184|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23719185|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23719186|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
23719187|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
23719188|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23719189|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23719190|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
23719191|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
23719192|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
23719193|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
23719194|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
23719195|NCT00856986|66348524|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
23719196|NCT00856986|66348525|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
23719197|NCT00856986|66348526|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
23719198|NCT00856986|66348527|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
23719199|NCT00856986|66348528|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
23530680|NCT00622635|65676291|FG004|Treatment Period 2|Adverse Event|0|||
23719200|NCT04209400|66348529|FG000|Overall Study|Withdrawal by Subject|0|||
23719201|NCT04209400|66348530|FG001|Overall Study|Withdrawal by Subject|1|||
23719202|NCT04295356|66348531|FG000|Overall Study|Physician Decision|1|||
23719203|NCT04295356|66348532|FG001|Overall Study|Physician Decision|0|||
23530681|NCT00622635|65676292|FG005|Treatment Period 2|Adverse Event|0|||
23530682|NCT00622635|65676287|FG000|Treatment Period 3|Adverse Event|0|||
23719204|NCT04295356|66348531|FG000|Overall Study|Lost to Follow-up|0|||
23719205|NCT04295356|66348532|FG001|Overall Study|Lost to Follow-up|3|||
23719206|NCT04295356|66348531|FG000|Overall Study|Protocol Violation|0|||
23719207|NCT04295356|66348532|FG001|Overall Study|Protocol Violation|1|||
23719208|NCT02168803|66348533|FG000|Overall Study|Lost to Follow-up|1|||
23719209|NCT02168803|66348534|FG001|Overall Study|Lost to Follow-up|0|||
23719210|NCT02168803|66348535|FG002|Overall Study|Lost to Follow-up|1|||
23719211|NCT02168803|66348533|FG000|Overall Study|Withdrawal by Subject|1|||
23719212|NCT02168803|66348534|FG001|Overall Study|Withdrawal by Subject|1|||
23719213|NCT02168803|66348535|FG002|Overall Study|Withdrawal by Subject|2|||
23719214|NCT02168803|66348533|FG000|Overall Study|Physician Decision|0|||
23719215|NCT02168803|66348534|FG001|Overall Study|Physician Decision|1|||
23719216|NCT02168803|66348535|FG002|Overall Study|Physician Decision|0|||
23719217|NCT02168803|66348533|FG000|Overall Study|Adverse Event|0|||
23719218|NCT02168803|66348534|FG001|Overall Study|Adverse Event|1|||
23719219|NCT02168803|66348535|FG002|Overall Study|Adverse Event|1|||
23719220|NCT02168803|66348533|FG000|Overall Study|Death|0|||
23719221|NCT02168803|66348534|FG001|Overall Study|Death|0|||
23719222|NCT02168803|66348535|FG002|Overall Study|Death|1|||
23719223|NCT02168803|66348533|FG000|Overall Study|Sponsor Decision|0|||
23719224|NCT02168803|66348534|FG001|Overall Study|Sponsor Decision|0|||
23719225|NCT02168803|66348535|FG002|Overall Study|Sponsor Decision|1|||
23719226|NCT02472795|66348538|FG000|Overall Study|Adverse Event|0|||
23719227|NCT02472795|66348539|FG001|Overall Study|Adverse Event|1|||
23719228|NCT02472795|66348540|FG002|Overall Study|Adverse Event|0|||
23719229|NCT02472795|66348541|FG003|Overall Study|Adverse Event|0|||
23719230|NCT02472795|66348542|FG004|Overall Study|Adverse Event|2|||
23530683|NCT00622635|65676288|FG001|Treatment Period 3|Adverse Event|0|||
23530684|NCT00622635|65676289|FG002|Treatment Period 3|Adverse Event|0|||
23530685|NCT00622635|65676290|FG003|Treatment Period 3|Adverse Event|2|||
23530686|NCT00622635|65676291|FG004|Treatment Period 3|Adverse Event|0|||
23530687|NCT00622635|65676292|FG005|Treatment Period 3|Adverse Event|0|||
23530688|NCT00622635|65676287|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23530689|NCT00622635|65676288|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23530690|NCT00622635|65676289|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23530691|NCT00622635|65676290|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23530692|NCT00622635|65676291|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23530693|NCT00622635|65676292|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23530694|NCT01183975|65676293|FG000|Overall Study|Lost to Follow-up|73|||
23530695|NCT03149328|65676296|FG000|Overall Study|Withdrawal by Subject|30|||
23530696|NCT03149328|65676297|FG001|Overall Study|Withdrawal by Subject|26|||
23530697|NCT03149328|65676296|FG000|Overall Study|Changed Dialysis Modality|18|||
23530698|NCT03149328|65676297|FG001|Overall Study|Changed Dialysis Modality|1|||
23530699|NCT03149328|65676296|FG000|Overall Study|Transplant|9|||
23530700|NCT03149328|65676297|FG001|Overall Study|Transplant|1|||
23530701|NCT03149328|65676296|FG000|Overall Study|Lost to Follow-up|25|||
23530702|NCT03149328|65676297|FG001|Overall Study|Lost to Follow-up|16|||
23530703|NCT03149328|65676296|FG000|Overall Study|Left Study Site|1|||
23530704|NCT03149328|65676297|FG001|Overall Study|Left Study Site|2|||
23530705|NCT03149328|65676296|FG000|Overall Study|Language Barrier|1|||
23530706|NCT03149328|65676297|FG001|Overall Study|Language Barrier|0|||
23530707|NCT00437034|65676298|FG000|Overall Study|Adverse Event|1|||
23530708|NCT00437034|65676298|FG000|Overall Study|Disease progression during treatment|5|||
23530709|NCT03591575|65676299|FG000|Overall Study|Adverse Event|2|||
23530710|NCT03591575|65676300|FG001|Overall Study|Adverse Event|0|||
23530711|NCT03591575|65676299|FG000|Overall Study|Withdrawal by Subject|4|||
23530712|NCT03591575|65676300|FG001|Overall Study|Withdrawal by Subject|1|||
23719231|NCT02472795|66348538|FG000|Overall Study|Withdrawal by Subject|0|||
23719232|NCT02472795|66348539|FG001|Overall Study|Withdrawal by Subject|0|||
23719233|NCT02472795|66348540|FG002|Overall Study|Withdrawal by Subject|0|||
23719234|NCT02472795|66348541|FG003|Overall Study|Withdrawal by Subject|0|||
23419407|NCT01200407|65277414|FG000|Overall Study|Adverse Event|3|||
23530713|NCT01660711|65679904|FG000|Overall Study|Adverse Event|7|||
23530714|NCT01660711|65679904|FG000|Overall Study|Withdrawal by Subject|1|||
23530715|NCT01585766|65679905|FG000|Overall Study|Withdrawal by Subject|0|||
23530716|NCT01585766|65679906|FG001|Overall Study|Withdrawal by Subject|1|||
23530717|NCT01585766|65679907|FG002|Overall Study|Withdrawal by Subject|1|||
23530718|NCT01585766|65679908|FG003|Overall Study|Withdrawal by Subject|0|||
23530719|NCT01585766|65679909|FG004|Overall Study|Withdrawal by Subject|0|||
23530720|NCT01585766|65679910|FG005|Overall Study|Withdrawal by Subject|0|||
23612930|NCT02305797|65969748|FG000|Overall Study|Adverse Event|11|||
23530721|NCT01585766|65679905|FG000|Overall Study|Death|0|||
23530722|NCT01585766|65679906|FG001|Overall Study|Death|1|||
23530723|NCT01585766|65679907|FG002|Overall Study|Death|0|||
23719235|NCT02472795|66348542|FG004|Overall Study|Withdrawal by Subject|1|||
23719236|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
23719237|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
23719238|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
23719239|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
23719240|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
23719241|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
23719242|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Death|1|||
23719243|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Death|3|||
23719244|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
23719245|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
23719246|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
23719247|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
23719248|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
23719249|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
23813833|NCT00658021|66699444|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
23612931|NCT02305797|65969749|FG001|Overall Study|Adverse Event|2|||
23612932|NCT02305797|65969748|FG000|Overall Study|Withdrawal by Subject|9|||
23612933|NCT02305797|65969749|FG001|Overall Study|Withdrawal by Subject|10|||
23612934|NCT02305797|65969748|FG000|Overall Study|Lack of Efficacy|6|||
23813834|NCT00658021|66699445|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
23530724|NCT01585766|65679908|FG003|Overall Study|Death|0|||
23530725|NCT01585766|65679909|FG004|Overall Study|Death|0|||
23530726|NCT01585766|65679910|FG005|Overall Study|Death|0|||
23530727|NCT01585766|65679905|FG000|Overall Study|Physician Decision|0|||
23530728|NCT01585766|65679906|FG001|Overall Study|Physician Decision|0|||
23530729|NCT01585766|65679907|FG002|Overall Study|Physician Decision|1|||
23530730|NCT01585766|65679908|FG003|Overall Study|Physician Decision|0|||
23530731|NCT01585766|65679909|FG004|Overall Study|Physician Decision|0|||
23530732|NCT01585766|65679910|FG005|Overall Study|Physician Decision|0|||
23530733|NCT00978731|65679911|FG000|Overall Study|Death|4|||
23530734|NCT00978731|65679912|FG001|Overall Study|Death|1|||
23530735|NCT00978731|65679913|FG002|Overall Study|Death|1|||
23530736|NCT00978731|65679914|FG003|Overall Study|Death|0|||
23530737|NCT00978731|65679911|FG000|Overall Study|Lost to Follow-up|0|||
23530738|NCT00978731|65679912|FG001|Overall Study|Lost to Follow-up|0|||
23530739|NCT00978731|65679913|FG002|Overall Study|Lost to Follow-up|0|||
23530740|NCT00978731|65679914|FG003|Overall Study|Lost to Follow-up|1|||
23612935|NCT02305797|65969749|FG001|Overall Study|Lack of Efficacy|0|||
23813835|NCT00658021|66699443|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
23813836|NCT00658021|66699444|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
23813837|NCT00658021|66699445|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
23813838|NCT02185053|66699446|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
23813839|NCT02185053|66699447|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
23813840|NCT02185053|66699448|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
23813841|NCT02185053|66699446|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
23813842|NCT02185053|66699447|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23813843|NCT02185053|66699448|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23813844|NCT02185053|66699446|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
23813845|NCT02185053|66699447|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
23813846|NCT02185053|66699448|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
23813847|NCT02185053|66699446|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
23813848|NCT02185053|66699447|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
23813849|NCT02185053|66699448|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
23813850|NCT02185053|66699446|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23813851|NCT02185053|66699447|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
23813852|NCT02185053|66699448|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23813853|NCT02185053|66699446|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
23813854|NCT02185053|66699447|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
23813855|NCT02185053|66699448|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
23813856|NCT02185053|66699446|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
23813857|NCT02185053|66699447|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
23813858|NCT02185053|66699448|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
23813859|NCT02185053|66699446|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
23813860|NCT02185053|66699447|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
23813861|NCT02185053|66699448|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
23813862|NCT02549027|66699449|FG000|Washout After Period 4|Withdrawal by Subject|0|||
23530741|NCT00978731|65679911|FG000|Overall Study|Adverse Event|5|||
23530742|NCT00978731|65679912|FG001|Overall Study|Adverse Event|2|||
23612936|NCT02305797|65969748|FG000|Overall Study|Lost to Follow-up|5|||
23530743|NCT00978731|65679913|FG002|Overall Study|Adverse Event|0|||
23530744|NCT00978731|65679914|FG003|Overall Study|Adverse Event|0|||
23530745|NCT00978731|65679911|FG000|Overall Study|Participant's request|1|||
23530746|NCT00978731|65679912|FG001|Overall Study|Participant's request|0|||
23530747|NCT00978731|65679913|FG002|Overall Study|Participant's request|0|||
23612937|NCT02305797|65969749|FG001|Overall Study|Lost to Follow-up|11|||
23813863|NCT02549027|66699450|FG001|Washout After Period 4|Withdrawal by Subject|1|||
23813864|NCT02549027|66699451|FG002|Washout After Period 4|Withdrawal by Subject|1|||
23813865|NCT02549027|66699452|FG003|Washout After Period 4|Withdrawal by Subject|1|||
23813866|NCT02549027|66699453|FG004|Washout After Period 4|Withdrawal by Subject|0|||
23813867|NCT02549027|66699454|FG005|Washout After Period 4|Withdrawal by Subject|0|||
23813868|NCT02549027|66699449|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23813869|NCT02549027|66699450|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23813870|NCT02549027|66699451|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23612938|NCT02305797|65969748|FG000|Overall Study|Pregnancy|0|||
23612939|NCT02305797|65969749|FG001|Overall Study|Pregnancy|2|||
23612940|NCT02305797|65969748|FG000|Overall Study|Noncompliance|14|||
23612941|NCT02305797|65969749|FG001|Overall Study|Noncompliance|12|||
23612942|NCT02305797|65969748|FG000|Overall Study|Reason not collected|0|||
23612943|NCT02305797|65969749|FG001|Overall Study|Reason not collected|1|||
23612944|NCT00331799|65969750|FG000|Overall Study|Withdrawal by Subject|2|||
23612945|NCT00331799|65969750|FG000|Overall Study|Sedation|1|||
23612946|NCT00910871|65969751|FG000|Overall Study|Adverse Event|5|||
23612947|NCT00910871|65969751|FG000|Overall Study|Death|12|||
23612948|NCT00910871|65969751|FG000|Overall Study|Lost to Follow-up|8|||
23612949|NCT00910871|65969751|FG000|Overall Study|Protocol Violation|11|||
23612950|NCT00910871|65969751|FG000|Overall Study|Withdrawal by Subject|12|||
23612951|NCT00910871|65969751|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
23612952|NCT00910871|65969751|FG000|Overall Study|Undefined|1|||
23612953|NCT03651271|65969752|FG000|Overall Study|Death|4|||
23612954|NCT03651271|65969753|FG001|Overall Study|Death|37|||
23612955|NCT03651271|65969754|FG002|Overall Study|Death|0|||
23612956|NCT03651271|65969755|FG003|Overall Study|Death|2|||
23612957|NCT03651271|65969756|FG004|Overall Study|Death|6|||
23612958|NCT03651271|65969752|FG000|Overall Study|Lost to Follow-up|1|||
23612959|NCT03651271|65969753|FG001|Overall Study|Lost to Follow-up|5|||
23612960|NCT03651271|65969754|FG002|Overall Study|Lost to Follow-up|0|||
23612961|NCT03651271|65969755|FG003|Overall Study|Lost to Follow-up|1|||
23612962|NCT03651271|65969756|FG004|Overall Study|Lost to Follow-up|0|||
23612963|NCT03651271|65969752|FG000|Overall Study|Physician Decision|0|||
23612964|NCT03651271|65969753|FG001|Overall Study|Physician Decision|2|||
23612965|NCT03651271|65969754|FG002|Overall Study|Physician Decision|0|||
23612966|NCT03651271|65969755|FG003|Overall Study|Physician Decision|0|||
23813871|NCT02549027|66699452|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23813872|NCT02549027|66699453|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
23813873|NCT02549027|66699454|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23813874|NCT00867503|66699459|FG000|Overall Study|Withdrawal by Subject|1|||
23813875|NCT01646138|66699469|FG000|Overall Study|Lost to Follow-up|0|||
23813876|NCT01646138|66699470|FG001|Overall Study|Lost to Follow-up|0|||
23813877|NCT01646138|66699471|FG002|Overall Study|Lost to Follow-up|0|||
23813878|NCT01646138|66699472|FG003|Overall Study|Lost to Follow-up|0|||
23813879|NCT01646138|66699473|FG004|Overall Study|Lost to Follow-up|2|||
23813880|NCT01275430|66699474|FG000|Overall Study|Adverse Event|1|||
23813881|NCT01275430|66699474|FG000|Overall Study|No Contrast Injection|6|||
23813882|NCT01275430|66699474|FG000|Overall Study|Device Malfunction|1|||
23813883|NCT01275430|66699474|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
23813884|NCT00858143|66699497|FG000|Overall Study|Adverse Event|16|||
23813885|NCT00858143|66699497|FG000|Overall Study|Lack of Efficacy|4|||
23813886|NCT00858143|66699497|FG000|Overall Study|Death|7|||
23813887|NCT00858143|66699497|FG000|Overall Study|Other|23|||
23813888|NCT02011113|66699500|FG000|Overall Study|Adverse Event|4|||
23813889|NCT02011113|66699500|FG000|Overall Study|Disease Progression (DP)|16|||
23813890|NCT02011113|66699500|FG000|Overall Study|Death|1|||
23813891|NCT02011113|66699500|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
23813892|NCT02011113|66699500|FG000|Overall Study|Investigator's judgement- DP|3|||
23813893|NCT02011113|66699500|FG000|Overall Study|Study terminated by sponsor|11|||
23813894|NCT02885181|66699501|FG000|Overall Study|Investigator's Discretion|0|||
23813895|NCT02885181|66699502|FG001|Overall Study|Investigator's Discretion|1|||
23612967|NCT03651271|65969756|FG004|Overall Study|Physician Decision|0|||
23813896|NCT02885181|66699503|FG002|Overall Study|Investigator's Discretion|0|||
23813897|NCT02885181|66699504|FG003|Overall Study|Investigator's Discretion|1|||
23813898|NCT02885181|66699501|FG000|Overall Study|Adverse Event|0|||
23813899|NCT02885181|66699502|FG001|Overall Study|Adverse Event|0|||
23813900|NCT02885181|66699503|FG002|Overall Study|Adverse Event|0|||
23813901|NCT02885181|66699504|FG003|Overall Study|Adverse Event|1|||
23813902|NCT02885181|66699501|FG000|Overall Study|Withdrawal by Subject|0|||
23813903|NCT02885181|66699502|FG001|Overall Study|Withdrawal by Subject|0|||
23612968|NCT03651271|65969752|FG000|Overall Study|Withdrawal by Subject|1|||
23612969|NCT03651271|65969753|FG001|Overall Study|Withdrawal by Subject|15|||
23813904|NCT02885181|66699503|FG002|Overall Study|Withdrawal by Subject|0|||
23813905|NCT02885181|66699504|FG003|Overall Study|Withdrawal by Subject|1|||
23612970|NCT03651271|65969754|FG002|Overall Study|Withdrawal by Subject|0|||
23612971|NCT03651271|65969755|FG003|Overall Study|Withdrawal by Subject|0|||
23612972|NCT03651271|65969756|FG004|Overall Study|Withdrawal by Subject|1|||
23813906|NCT02006693|66699505|FG000|Overall Study|No Reason Specified|6|||
23813907|NCT02006693|66699506|FG001|Overall Study|No Reason Specified|8|||
23813908|NCT02006693|66699505|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
23813909|NCT02006693|66699506|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
23813910|NCT02006693|66699505|FG000|Overall Study|XEN Implant Explantation|0|||
23813911|NCT02006693|66699506|FG001|Overall Study|XEN Implant Explantation|1|||
23813912|NCT02006693|66699505|FG000|Overall Study|Death|2|||
23813913|NCT02006693|66699506|FG001|Overall Study|Death|2|||
23813914|NCT02006693|66699505|FG000|Overall Study|Lost to Follow-up|4|||
23813915|NCT02006693|66699506|FG001|Overall Study|Lost to Follow-up|1|||
23813916|NCT02006693|66699505|FG000|Overall Study|Patient Decision|4|||
23813917|NCT02006693|66699506|FG001|Overall Study|Patient Decision|0|||
23813918|NCT02132637|66699507|FG000|Study Period 1|Withdrawal by Subject|0|||
23813919|NCT02132637|66699508|FG001|Study Period 1|Withdrawal by Subject|4|||
23813920|NCT02132637|66699507|FG000|Study Period 1|Physician Decision|1|||
23813921|NCT02132637|66699508|FG001|Study Period 1|Physician Decision|0|||
23813922|NCT02132637|66699507|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
23813923|NCT02132637|66699508|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
23813924|NCT02132637|66699507|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
23813925|NCT02132637|66699508|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
23813926|NCT03560986|66699511|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
23813927|NCT03560986|66699512|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
23813928|NCT03560986|66699511|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23813929|NCT03560986|66699512|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23813930|NCT03560986|66699511|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
23813931|NCT03560986|66699512|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
23813932|NCT03560986|66699511|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
23813933|NCT03560986|66699512|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
23813934|NCT03560986|66699511|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
23612973|NCT03651271|65969752|FG000|Overall Study|Patient medically unable to continue|0|||
23612974|NCT03651271|65969753|FG001|Overall Study|Patient medically unable to continue|0|||
23612975|NCT03651271|65969754|FG002|Overall Study|Patient medically unable to continue|0|||
23612976|NCT03651271|65969755|FG003|Overall Study|Patient medically unable to continue|1|||
23612977|NCT03651271|65969756|FG004|Overall Study|Patient medically unable to continue|0|||
23612978|NCT00841321|65969758|FG000|Overall Study|Lost to Follow-up|1|||
23612979|NCT00841321|65969759|FG001|Overall Study|Lost to Follow-up|1|||
23612980|NCT00841321|65969758|FG000|Overall Study|Adverse Event|0|||
23612981|NCT00841321|65969759|FG001|Overall Study|Adverse Event|2|||
23612982|NCT01799993|65969760|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
23612983|NCT01799993|65969761|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
23612984|NCT01799993|65969760|FG000|Overall Study|Death|61|||
23612985|NCT01799993|65969761|FG001|Overall Study|Death|45|||
23612986|NCT01799993|65969760|FG000|Overall Study|Withdrawal by Subject|23|||
23612987|NCT01799993|65969761|FG001|Overall Study|Withdrawal by Subject|24|||
23719250|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
23719251|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
23719252|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
23719253|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
23719254|NCT02553317|66348556|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
23719255|NCT02553317|66348557|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
23719256|NCT02224638|66348558|FG000|Overall Study|Adverse Event|1|||
23719257|NCT02224638|66348559|FG001|Overall Study|Adverse Event|1|||
23719258|NCT01179347|66348560|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
23719259|NCT01179347|66348561|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
23719260|NCT01179347|66348560|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
23719261|NCT01179347|66348561|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
23719262|NCT01179347|66348560|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
23719263|NCT01179347|66348561|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23719264|NCT01179347|66348560|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
23813935|NCT03560986|66699512|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
23813936|NCT03560986|66699511|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
23813937|NCT03560986|66699512|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
23813938|NCT03560986|66699511|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
23813939|NCT03560986|66699512|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
23813940|NCT01214915|66699513|FG000|Overall Study|Adverse Event|8|||
23813941|NCT01214915|66699513|FG000|Overall Study|Lack of Efficacy|3|||
23813942|NCT03397771|66699514|FG000|Overall Study|2 erroneously randomized, never treated|3|||
23612988|NCT01799993|65969760|FG000|Overall Study|Lost to Follow-up|5|||
23612989|NCT01799993|65969761|FG001|Overall Study|Lost to Follow-up|8|||
23612990|NCT01799993|65969760|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
23612991|NCT01799993|65969761|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
23612992|NCT01799993|65969760|FG000|Overall Study|Protocol driven decision point|0|||
23612993|NCT01799993|65969761|FG001|Overall Study|Protocol driven decision point|3|||
23612994|NCT01799993|65969760|FG000|Overall Study|Protocol Violation|1|||
23612995|NCT01799993|65969761|FG001|Overall Study|Protocol Violation|1|||
23612996|NCT01799993|65969760|FG000|Overall Study|Deterioration of general conditions|2|||
23612997|NCT01799993|65969761|FG001|Overall Study|Deterioration of general conditions|0|||
23612998|NCT01799993|65969760|FG000|Overall Study|Screen failure|0|||
23612999|NCT01799993|65969761|FG001|Overall Study|Screen failure|1|||
23613000|NCT01799993|65969760|FG000|Overall Study|Adverse Event|1|||
23613001|NCT01799993|65969761|FG001|Overall Study|Adverse Event|0|||
23613002|NCT01799993|65969760|FG000|Overall Study|Lack of Efficacy|1|||
23613003|NCT01799993|65969761|FG001|Overall Study|Lack of Efficacy|0|||
23613004|NCT01799993|65969760|FG000|Overall Study|Recovery|0|||
23613005|NCT01799993|65969761|FG001|Overall Study|Recovery|1|||
23613006|NCT01799993|65969760|FG000|Overall Study|Logistical difficulties|1|||
23613007|NCT01799993|65969761|FG001|Overall Study|Logistical difficulties|0|||
23613008|NCT01799993|65969760|FG000|Overall Study|Protocol deviation|1|||
23613009|NCT01799993|65969761|FG001|Overall Study|Protocol deviation|0|||
23613010|NCT01799993|65969760|FG000|Overall Study|Non-compliance with medical device|1|||
23613011|NCT01799993|65969761|FG001|Overall Study|Non-compliance with medical device|0|||
23613012|NCT01799993|65969760|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23613013|NCT01799993|65969761|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23613014|NCT01799993|65969760|FG000|Overall Study|Other|1|||
23613015|NCT01799993|65969761|FG001|Overall Study|Other|0|||
23719265|NCT01179347|66348561|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
23719266|NCT01179347|66348560|FG000|Double-blind Period (12 Weeks)|Other|2|||
23719267|NCT01179347|66348561|FG001|Double-blind Period (12 Weeks)|Other|4|||
23719268|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
23719269|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
23719270|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
23719271|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
23719272|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
23719273|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
23719274|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
23719275|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
23719276|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
23719277|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
23719278|NCT01179347|66348560|FG000|Open-label Period (12 Weeks)|Other|7|||
23719279|NCT01179347|66348561|FG001|Open-label Period (12 Weeks)|Other|4|||
23813943|NCT03397771|66699515|FG001|Overall Study|2 erroneously randomized, never treated|1|||
23813944|NCT03397771|66699514|FG000|Overall Study|Withdrawal by Subject|1|||
23813945|NCT03397771|66699515|FG001|Overall Study|Withdrawal by Subject|3|||
23813946|NCT03397771|66699514|FG000|Overall Study|Protocol Violation|2|||
23813947|NCT03397771|66699515|FG001|Overall Study|Protocol Violation|2|||
23813948|NCT03397771|66699514|FG000|Overall Study|Adverse Event|2|||
23719280|NCT02581982|66348566|FG000|Overall Study|Lack of Efficacy|12|||
23719281|NCT02581982|66348566|FG000|Overall Study|Adverse Event|3|||
23719282|NCT02581982|66348566|FG000|Overall Study|Physician Decision|1|||
23530748|NCT00978731|65679914|FG003|Overall Study|Participant's request|0|||
23530749|NCT00978731|65679911|FG000|Overall Study|Administrative reason|3|||
23530750|NCT00978731|65679912|FG001|Overall Study|Administrative reason|3|||
23530751|NCT00978731|65679913|FG002|Overall Study|Administrative reason|1|||
23530752|NCT00978731|65679914|FG003|Overall Study|Administrative reason|0|||
23530753|NCT00978731|65679911|FG000|Overall Study|Deterioration without progression|0|||
23530754|NCT00978731|65679912|FG001|Overall Study|Deterioration without progression|1|||
23530755|NCT00978731|65679913|FG002|Overall Study|Deterioration without progression|0|||
23613016|NCT01799993|65969760|FG000|Overall Study|Subject didn't return for follow-up|0|||
23613017|NCT01799993|65969761|FG001|Overall Study|Subject didn't return for follow-up|1|||
23719283|NCT00970268|66348567|FG000|Overall Study|Withdrawal by Subject|12|||
23719284|NCT00970268|66348568|FG001|Overall Study|Withdrawal by Subject|19|||
23719285|NCT00970268|66348567|FG000|Overall Study|Adverse Event|15|||
23719286|NCT00970268|66348568|FG001|Overall Study|Adverse Event|12|||
23719287|NCT00970268|66348567|FG000|Overall Study|Lack of Efficacy|3|||
23813949|NCT03397771|66699515|FG001|Overall Study|Adverse Event|1|||
23813950|NCT00289536|66699520|FG000|Period 3|Lost to Follow-up|0|||
23613018|NCT01074229|65969762|FG000|Overall Study|Lost to Follow-up|1|||
23813951|NCT00289536|66699521|FG001|Period 3|Lost to Follow-up|0|||
23613019|NCT01074229|65969763|FG001|Overall Study|Lost to Follow-up|0|||
23613020|NCT01074229|65969764|FG002|Overall Study|Lost to Follow-up|0|||
23613021|NCT01074229|65969762|FG000|Overall Study|Change to open surgical procedure|1|||
23719288|NCT00970268|66348568|FG001|Overall Study|Lack of Efficacy|6|||
23719289|NCT00970268|66348567|FG000|Overall Study|Protocol Violation|4|||
23719290|NCT00970268|66348568|FG001|Overall Study|Protocol Violation|7|||
23613022|NCT01074229|65969763|FG001|Overall Study|Change to open surgical procedure|3|||
23719291|NCT00970268|66348567|FG000|Overall Study|Other Reason|3|||
23719292|NCT00970268|66348568|FG001|Overall Study|Other Reason|1|||
23719293|NCT00970268|66348567|FG000|Overall Study|COPD Exacerbation|4|||
23719294|NCT00970268|66348568|FG001|Overall Study|COPD Exacerbation|2|||
23719295|NCT00970268|66348567|FG000|Overall Study|Lost to Follow-up|1|||
23719296|NCT00970268|66348568|FG001|Overall Study|Lost to Follow-up|2|||
23719297|NCT00970268|66348567|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
23719298|NCT00970268|66348568|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23719299|NCT02810951|66348571|FG000|Overall Study|Adverse Event|1|||
23719300|NCT02924688|66348572|FG000|Overall Study|Adverse Event|9|||
23719301|NCT02924688|66348573|FG001|Overall Study|Adverse Event|3|||
23719302|NCT02924688|66348574|FG002|Overall Study|Adverse Event|2|||
23719303|NCT02924688|66348575|FG003|Overall Study|Adverse Event|2|||
23719304|NCT02924688|66348576|FG004|Overall Study|Adverse Event|3|||
23719305|NCT02924688|66348577|FG005|Overall Study|Adverse Event|2|||
23719306|NCT02924688|66348572|FG000|Overall Study|Lack of Efficacy|2|||
23719307|NCT02924688|66348573|FG001|Overall Study|Lack of Efficacy|3|||
23719308|NCT02924688|66348574|FG002|Overall Study|Lack of Efficacy|4|||
23719309|NCT02924688|66348575|FG003|Overall Study|Lack of Efficacy|2|||
23719310|NCT02924688|66348576|FG004|Overall Study|Lack of Efficacy|1|||
23719311|NCT02924688|66348577|FG005|Overall Study|Lack of Efficacy|1|||
23719312|NCT02924688|66348572|FG000|Overall Study|Protocol Violation|3|||
23719313|NCT02924688|66348573|FG001|Overall Study|Protocol Violation|7|||
23719314|NCT02924688|66348574|FG002|Overall Study|Protocol Violation|5|||
23719315|NCT02924688|66348575|FG003|Overall Study|Protocol Violation|6|||
23719316|NCT02924688|66348576|FG004|Overall Study|Protocol Violation|2|||
23719317|NCT02924688|66348577|FG005|Overall Study|Protocol Violation|2|||
23719318|NCT02924688|66348572|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
23719319|NCT02924688|66348573|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
23719320|NCT02924688|66348574|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
23719321|NCT02924688|66348575|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
23719322|NCT02924688|66348576|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
23719323|NCT02924688|66348577|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
23530756|NCT00978731|65679914|FG003|Overall Study|Deterioration without progression|0|||
23530757|NCT00978731|65679911|FG000|Overall Study|Disease progression/relapse|5|||
23530758|NCT00978731|65679912|FG001|Overall Study|Disease progression/relapse|4|||
23530759|NCT00978731|65679913|FG002|Overall Study|Disease progression/relapse|2|||
23530760|NCT00978731|65679914|FG003|Overall Study|Disease progression/relapse|2|||
23530761|NCT00978731|65679911|FG000|Overall Study|Study closure|3|||
23530762|NCT00978731|65679912|FG001|Overall Study|Study closure|4|||
23530763|NCT00978731|65679913|FG002|Overall Study|Study closure|1|||
23530764|NCT00978731|65679914|FG003|Overall Study|Study closure|1|||
23530765|NCT00978731|65679911|FG000|Overall Study|No response|1|||
23530766|NCT00978731|65679912|FG001|Overall Study|No response|0|||
23530767|NCT00978731|65679913|FG002|Overall Study|No response|0|||
23530768|NCT00978731|65679914|FG003|Overall Study|No response|0|||
23530769|NCT02759120|65679915|FG000|Overall Study|Death|34|||
23530770|NCT02759120|65679916|FG001|Overall Study|Death|36|||
23530771|NCT02759120|65679915|FG000|Overall Study|Lost to Follow-up|4|||
23530772|NCT02759120|65679916|FG001|Overall Study|Lost to Follow-up|7|||
23530773|NCT02759120|65679915|FG000|Overall Study|Physician Decision|3|||
23530774|NCT02759120|65679916|FG001|Overall Study|Physician Decision|0|||
23530775|NCT02759120|65679915|FG000|Overall Study|Withdrawal by Subject|28|||
23530776|NCT02759120|65679916|FG001|Overall Study|Withdrawal by Subject|15|||
23530777|NCT02759120|65679915|FG000|Overall Study|Moved out of area|3|||
23530778|NCT02759120|65679916|FG001|Overall Study|Moved out of area|4|||
23530779|NCT02759120|65679915|FG000|Overall Study|Lung transplant|3|||
23530780|NCT02759120|65679916|FG001|Overall Study|Lung transplant|5|||
23530781|NCT02759120|65679915|FG000|Overall Study|Other reason not completed|10|||
23530782|NCT02759120|65679916|FG001|Overall Study|Other reason not completed|12|||
23530783|NCT00578565|65679917|FG000|Overall Study|Adverse Event|3|||
23530784|NCT01610791|65679918|FG000|Overall Study|Lost to Follow-up|7|||
23530785|NCT01610791|65679918|FG000|Overall Study|Adverse Event|6|||
23530786|NCT01610791|65679918|FG000|Overall Study|Physician Decision|1|||
23530787|NCT01610791|65679918|FG000|Overall Study|Adverse event and Investigator decision|1|||
23530788|NCT01610791|65679918|FG000|Overall Study|Death|1|||
23530789|NCT01610791|65679918|FG000|Overall Study|Not determined|5|||
23530790|NCT01987427|65679919|FG000|Overall Study|Adverse Event|4|||
23530791|NCT01987427|65679920|FG001|Overall Study|Adverse Event|2|||
23530792|NCT01987427|65679921|FG002|Overall Study|Adverse Event|8|||
23719324|NCT02924688|66348572|FG000|Overall Study|Lost to Follow-up|2|||
23530793|NCT01987427|65679919|FG000|Overall Study|Lost to Follow-up|6|||
23530794|NCT01987427|65679920|FG001|Overall Study|Lost to Follow-up|6|||
23530795|NCT01987427|65679921|FG002|Overall Study|Lost to Follow-up|9|||
23719325|NCT02924688|66348573|FG001|Overall Study|Lost to Follow-up|4|||
23719326|NCT02924688|66348574|FG002|Overall Study|Lost to Follow-up|2|||
23719327|NCT02924688|66348575|FG003|Overall Study|Lost to Follow-up|4|||
23719328|NCT02924688|66348576|FG004|Overall Study|Lost to Follow-up|2|||
23530796|NCT01987427|65679919|FG000|Overall Study|Withdrawal by Subject|2|||
23719329|NCT02924688|66348577|FG005|Overall Study|Lost to Follow-up|4|||
23719330|NCT02924688|66348572|FG000|Overall Study|Physician Decision|2|||
23719331|NCT02924688|66348573|FG001|Overall Study|Physician Decision|1|||
23719332|NCT02924688|66348574|FG002|Overall Study|Physician Decision|0|||
23719333|NCT02924688|66348575|FG003|Overall Study|Physician Decision|1|||
23719334|NCT02924688|66348576|FG004|Overall Study|Physician Decision|1|||
23719335|NCT02924688|66348577|FG005|Overall Study|Physician Decision|1|||
23719336|NCT02924688|66348572|FG000|Overall Study|Withdrawal by Subject|14|||
23719337|NCT02924688|66348573|FG001|Overall Study|Withdrawal by Subject|13|||
23719338|NCT02924688|66348574|FG002|Overall Study|Withdrawal by Subject|9|||
23719339|NCT02924688|66348575|FG003|Overall Study|Withdrawal by Subject|12|||
23719340|NCT02924688|66348576|FG004|Overall Study|Withdrawal by Subject|13|||
23719341|NCT02924688|66348577|FG005|Overall Study|Withdrawal by Subject|14|||
23719342|NCT00436982|66348578|FG000|Overall Study|Withdrawal by Subject|3|||
23719343|NCT00436982|66348579|FG001|Overall Study|Withdrawal by Subject|1|||
23719344|NCT00436982|66348578|FG000|Overall Study|Did not receive allocated intervention|0|||
23719345|NCT00436982|66348579|FG001|Overall Study|Did not receive allocated intervention|1|||
23813952|NCT00289536|66699522|FG002|Period 3|Lost to Follow-up|1|||
23813953|NCT04669691|66699523|FG000|Overall Study|Death|0|||
23813954|NCT04669691|66699524|FG001|Overall Study|Death|1|||
23813955|NCT04669691|66699525|FG002|Overall Study|Death|0|||
23813956|NCT04669691|66699526|FG003|Overall Study|Death|0|||
23813957|NCT04669691|66699527|FG004|Overall Study|Death|0|||
23813958|NCT04669691|66699528|FG005|Overall Study|Death|0|||
23813959|NCT00090610|66699529|FG000|Overall Study|Withdrawal by Subject|1|||
23813960|NCT00090610|66699530|FG001|Overall Study|Withdrawal by Subject|1|||
23813961|NCT00619112|66699531|FG000|Overall Study|Adverse Event|1|||
23813962|NCT00619112|66699532|FG001|Overall Study|Adverse Event|2|||
23813963|NCT02116608|66699539|FG000|Overall Study|Lost to Follow-up|0|||
23813964|NCT02116608|66699540|FG001|Overall Study|Lost to Follow-up|0|||
23530797|NCT01987427|65679920|FG001|Overall Study|Withdrawal by Subject|1|||
23613023|NCT01074229|65969764|FG002|Overall Study|Change to open surgical procedure|4|||
23613024|NCT01358175|65969765|FG000|Overall Study|Death|1|||
23719346|NCT00436982|66348578|FG000|Overall Study|no RSA data|1|||
23530798|NCT01987427|65679921|FG002|Overall Study|Withdrawal by Subject|3|||
23530799|NCT01987427|65679919|FG000|Overall Study|Lack of Efficacy|1|||
23530800|NCT01987427|65679920|FG001|Overall Study|Lack of Efficacy|0|||
23530801|NCT01987427|65679921|FG002|Overall Study|Lack of Efficacy|0|||
23530802|NCT01987427|65679919|FG000|Overall Study|Other|1|||
23530803|NCT01987427|65679920|FG001|Overall Study|Other|1|||
23530804|NCT01987427|65679921|FG002|Overall Study|Other|0|||
23530805|NCT04251533|65679924|FG000|Overall Study|Progressive disease|33|||
23530806|NCT04251533|65679925|FG001|Overall Study|Progressive disease|29|||
23530807|NCT04251533|65679926|FG002|Overall Study|Progressive disease|22|||
23530808|NCT04251533|65679924|FG000|Overall Study|Death|5|||
23530809|NCT04251533|65679925|FG001|Overall Study|Death|1|||
23530810|NCT04251533|65679926|FG002|Overall Study|Death|3|||
23530811|NCT04251533|65679924|FG000|Overall Study|Physician Decision|3|||
23530812|NCT04251533|65679925|FG001|Overall Study|Physician Decision|2|||
23530813|NCT04251533|65679926|FG002|Overall Study|Physician Decision|4|||
23530814|NCT04251533|65679924|FG000|Overall Study|Participant decision|1|||
23530815|NCT04251533|65679925|FG001|Overall Study|Participant decision|3|||
23530816|NCT04251533|65679926|FG002|Overall Study|Participant decision|1|||
23530817|NCT04251533|65679924|FG000|Overall Study|Adverse Event|2|||
23530818|NCT04251533|65679925|FG001|Overall Study|Adverse Event|1|||
23530819|NCT04251533|65679926|FG002|Overall Study|Adverse Event|1|||
23530820|NCT00333229|65679931|FG000|Overall Study|Lack of Efficacy|0|||
23530821|NCT00333229|65679932|FG001|Overall Study|Lack of Efficacy|1|||
23530822|NCT01701258|65679935|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
23530823|NCT01701258|65679936|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
23530824|NCT01701258|65679937|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
23530825|NCT01701258|65679938|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
23530826|NCT01701258|65679939|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
23719347|NCT00436982|66348579|FG001|Overall Study|no RSA data|2|||
23530827|NCT01701258|65679940|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
23719348|NCT04721977|66348580|FG000|Overall Study|Death|15|||
23719349|NCT04721977|66348580|FG000|Overall Study|Ongoing|51|||
23719350|NCT00179517|66348583|FG000|Overall Study|Withdrawal by Subject|2|||
23719351|NCT00179517|66348584|FG001|Overall Study|Withdrawal by Subject|1|||
23813965|NCT02116608|66699541|FG002|Overall Study|Lost to Follow-up|1|||
23613025|NCT01358175|65969766|FG001|Overall Study|Death|0|||
23813966|NCT02116608|66699539|FG000|Overall Study|Physician Decision|0|||
23419408|NCT01200407|65277414|FG000|Overall Study|Withdrawal by Subject|4|||
23530828|NCT01701258|65679941|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
23530829|NCT01701258|65679942|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
23530830|NCT01701258|65679943|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
23530831|NCT01701258|65679944|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
23530832|NCT01701258|65679945|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
23530833|NCT01701258|65679946|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
23530834|NCT01701258|65679947|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
23530835|NCT01701258|65679935|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
23719352|NCT02475395|66348593|FG000|Overall Study|Protocol Violation|30|||
23719353|NCT02475395|66348594|FG001|Overall Study|Protocol Violation|3|||
23719354|NCT00525785|66348595|FG000|Overall Study|Withdrawal by Subject|1|||
23719355|NCT00525785|66348595|FG000|Overall Study|Lack of Efficacy|1|||
23719356|NCT00525785|66348595|FG000|Overall Study|Physician Decision|1|||
23719357|NCT01610206|66348606|FG000|Overall Study|Adverse Event|10|||
23719358|NCT01610206|66348607|FG001|Overall Study|Adverse Event|30|||
23719359|NCT02016898|66348608|FG000|Overall Study|Death|1|||
23719360|NCT02016898|66348609|FG001|Overall Study|Death|1|||
23719361|NCT02016898|66348608|FG000|Overall Study|Lost to Follow-up|4|||
23719362|NCT02016898|66348609|FG001|Overall Study|Lost to Follow-up|4|||
23719363|NCT00871572|66348611|FG000|Overall Study|Adverse Event|0|||
23719364|NCT00871572|66348612|FG001|Overall Study|Adverse Event|2|||
23719365|NCT00871572|66348613|FG002|Overall Study|Adverse Event|0|||
23719366|NCT00871572|66348614|FG003|Overall Study|Adverse Event|3|||
23719367|NCT00871572|66348611|FG000|Overall Study|Investigator Decision|0|||
23719368|NCT00871572|66348612|FG001|Overall Study|Investigator Decision|1|||
23719369|NCT00871572|66348613|FG002|Overall Study|Investigator Decision|0|||
23719370|NCT00871572|66348614|FG003|Overall Study|Investigator Decision|1|||
23719371|NCT00871572|66348611|FG000|Overall Study|Lost to Follow-up|0|||
23719372|NCT00871572|66348612|FG001|Overall Study|Lost to Follow-up|1|||
23719373|NCT00871572|66348613|FG002|Overall Study|Lost to Follow-up|0|||
23719374|NCT00871572|66348614|FG003|Overall Study|Lost to Follow-up|1|||
23719375|NCT00871572|66348611|FG000|Overall Study|Protocol Violation|0|||
23719376|NCT00871572|66348612|FG001|Overall Study|Protocol Violation|0|||
23719377|NCT00871572|66348613|FG002|Overall Study|Protocol Violation|1|||
23719378|NCT00871572|66348614|FG003|Overall Study|Protocol Violation|1|||
23719379|NCT00871572|66348611|FG000|Overall Study|Sponsor Decision|1|||
23719380|NCT00871572|66348612|FG001|Overall Study|Sponsor Decision|0|||
23719381|NCT00871572|66348613|FG002|Overall Study|Sponsor Decision|0|||
23719382|NCT00871572|66348614|FG003|Overall Study|Sponsor Decision|0|||
23719383|NCT00871572|66348611|FG000|Overall Study|Withdrawal by Subject|1|||
23719384|NCT00871572|66348612|FG001|Overall Study|Withdrawal by Subject|2|||
23719385|NCT00871572|66348613|FG002|Overall Study|Withdrawal by Subject|3|||
23719386|NCT00871572|66348614|FG003|Overall Study|Withdrawal by Subject|1|||
23719387|NCT02394808|66348617|FG000|Period 1|Unsatisfactory lens fitting|0|||
23719388|NCT02394808|66348618|FG001|Period 1|Unsatisfactory lens fitting|1|||
23719389|NCT02394808|66348617|FG000|Period 2|Lost to Follow-up|1|||
23719390|NCT02394808|66348618|FG001|Period 2|Lost to Follow-up|0|||
23719391|NCT03625141|66348622|FG000|Overall Study|Adverse Event|0|||
23719392|NCT03625141|66348623|FG001|Overall Study|Adverse Event|2|||
23719393|NCT03625141|66348622|FG000|Overall Study|Study Terminated By Sponsor|1|||
23719394|NCT03625141|66348623|FG001|Overall Study|Study Terminated By Sponsor|13|||
23719395|NCT03625141|66348622|FG000|Overall Study|Withdrawal by Subject|3|||
23719396|NCT03625141|66348623|FG001|Overall Study|Withdrawal by Subject|0|||
23719397|NCT03625141|66348622|FG000|Overall Study|Withdrawal Of Consent|0|||
23719398|NCT03625141|66348623|FG001|Overall Study|Withdrawal Of Consent|1|||
23719399|NCT03625141|66348622|FG000|Overall Study|Death|11|||
23719400|NCT03625141|66348623|FG001|Overall Study|Death|47|||
23719401|NCT03625141|66348622|FG000|Overall Study|Progressive Disease|0|||
23419409|NCT01200407|65277414|FG000|Overall Study|Other|19|||
23419410|NCT01239381|65277415|FG000|Overall Study|Protocol Violation|1|||
23419411|NCT01239381|65277415|FG000|Overall Study|Withdrawal by Subject|1|||
23419412|NCT01340625|65277416|FG000|First Intervention|Adverse Event|1|||
23419413|NCT01340625|65277417|FG001|First Intervention|Adverse Event|0|||
23419414|NCT01340625|65277416|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
23613026|NCT01358175|65969767|FG002|Overall Study|Death|1|||
23719402|NCT03625141|66348623|FG001|Overall Study|Progressive Disease|2|||
23719403|NCT02174861|66348635|FG000|Overall Study|Decision by sponsor|8|||
23719404|NCT02174861|66348635|FG000|Overall Study|Withdrawal by Subject|124|||
23719405|NCT02174861|66348635|FG000|Overall Study|Lost to Follow-up|26|||
23613027|NCT01358175|65969765|FG000|Overall Study|Withdrawal by Subject|9|||
23719406|NCT02807844|66348636|FG000|Overall Study|Physician Decision|0|||
23419415|NCT01340625|65277417|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
23419416|NCT02080481|65277418|FG000|Overall Study|Never received a block.|1|||
23719407|NCT02807844|66348637|FG001|Overall Study|Physician Decision|0|||
23719408|NCT02807844|66348638|FG002|Overall Study|Physician Decision|0|||
23719409|NCT02807844|66348639|FG003|Overall Study|Physician Decision|0|||
23813967|NCT02116608|66699540|FG001|Overall Study|Physician Decision|1|||
23813968|NCT02116608|66699541|FG002|Overall Study|Physician Decision|0|||
23813969|NCT02116608|66699539|FG000|Overall Study|Death|0|||
23813970|NCT02116608|66699540|FG001|Overall Study|Death|1|||
23813971|NCT02116608|66699541|FG002|Overall Study|Death|0|||
23813972|NCT01330459|66699546|FG000|Overall Study|Physician Decision|0|||
23813973|NCT01330459|66699547|FG001|Overall Study|Physician Decision|2|||
23813974|NCT01032018|66699549|FG000|Overall Study|Lost to Follow-up|6|||
23813975|NCT01032018|66699550|FG001|Overall Study|Lost to Follow-up|5|||
23813976|NCT01032018|66699549|FG000|Overall Study|Death|0|||
23813977|NCT01032018|66699550|FG001|Overall Study|Death|1|||
23813978|NCT02040779|66699551|FG000|Overall Study|Adverse Event|1|||
23813979|NCT02040779|66699552|FG001|Overall Study|Adverse Event|0|||
23813980|NCT02040779|66699553|FG002|Overall Study|Adverse Event|0|||
23813981|NCT02040779|66699551|FG000|Overall Study|Withdrawal by Subject|4|||
23813982|NCT02040779|66699552|FG001|Overall Study|Withdrawal by Subject|1|||
23813983|NCT02040779|66699553|FG002|Overall Study|Withdrawal by Subject|3|||
23813984|NCT02040779|66699551|FG000|Overall Study|Non-compliance|0|||
23813985|NCT02040779|66699552|FG001|Overall Study|Non-compliance|1|||
23813986|NCT02040779|66699553|FG002|Overall Study|Non-compliance|0|||
23813987|NCT02040779|66699551|FG000|Overall Study|Protocol Violation|2|||
23813988|NCT02040779|66699552|FG001|Overall Study|Protocol Violation|1|||
23813989|NCT02040779|66699553|FG002|Overall Study|Protocol Violation|0|||
23813990|NCT02040779|66699551|FG000|Overall Study|Lost to Follow-up|1|||
23719410|NCT02807844|66348640|FG004|Overall Study|Physician Decision|0|||
23719411|NCT02807844|66348641|FG005|Overall Study|Physician Decision|0|||
23719412|NCT02807844|66348642|FG006|Overall Study|Physician Decision|3|||
23719413|NCT02807844|66348643|FG007|Overall Study|Physician Decision|0|||
23719414|NCT02807844|66348644|FG008|Overall Study|Physician Decision|1|||
23719415|NCT02807844|66348645|FG009|Overall Study|Physician Decision|2|||
23719416|NCT02807844|66348636|FG000|Overall Study|Death|0|||
23719417|NCT02807844|66348637|FG001|Overall Study|Death|0|||
23719418|NCT02807844|66348638|FG002|Overall Study|Death|2|||
23719419|NCT02807844|66348639|FG003|Overall Study|Death|4|||
23719420|NCT02807844|66348640|FG004|Overall Study|Death|1|||
23719421|NCT02807844|66348641|FG005|Overall Study|Death|2|||
23719422|NCT02807844|66348642|FG006|Overall Study|Death|1|||
23813991|NCT02040779|66699552|FG001|Overall Study|Lost to Follow-up|2|||
23813992|NCT02040779|66699553|FG002|Overall Study|Lost to Follow-up|1|||
23813993|NCT02040779|66699551|FG000|Overall Study|Lack of Efficacy|4|||
23419417|NCT02080481|65277419|FG001|Overall Study|Never received a block.|0|||
23719423|NCT02807844|66348643|FG007|Overall Study|Death|2|||
23813994|NCT02040779|66699552|FG001|Overall Study|Lack of Efficacy|2|||
23813995|NCT02040779|66699553|FG002|Overall Study|Lack of Efficacy|0|||
23813996|NCT02283294|66699555|FG000|Overall Study|Lost to Follow-up|1|||
23813997|NCT02283294|66699556|FG001|Overall Study|Lost to Follow-up|1|||
23813998|NCT02283294|66699555|FG000|Overall Study|Withdrawal by Subject|1|||
23813999|NCT02283294|66699556|FG001|Overall Study|Withdrawal by Subject|6|||
23719424|NCT02807844|66348644|FG008|Overall Study|Death|0|||
23719425|NCT02807844|66348645|FG009|Overall Study|Death|1|||
23719426|NCT02807844|66348636|FG000|Overall Study|Withdrawal by Subject|0|||
23719427|NCT02807844|66348637|FG001|Overall Study|Withdrawal by Subject|0|||
23814000|NCT02283294|66699555|FG000|Overall Study|Protocol Violation|1|||
23814001|NCT02283294|66699556|FG001|Overall Study|Protocol Violation|0|||
23530836|NCT01701258|65679936|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
23719428|NCT02807844|66348638|FG002|Overall Study|Withdrawal by Subject|2|||
23719429|NCT02807844|66348639|FG003|Overall Study|Withdrawal by Subject|1|||
23719430|NCT02807844|66348640|FG004|Overall Study|Withdrawal by Subject|1|||
23719431|NCT02807844|66348641|FG005|Overall Study|Withdrawal by Subject|0|||
23719432|NCT02807844|66348642|FG006|Overall Study|Withdrawal by Subject|1|||
23719433|NCT02807844|66348643|FG007|Overall Study|Withdrawal by Subject|0|||
23719434|NCT02807844|66348644|FG008|Overall Study|Withdrawal by Subject|0|||
23719435|NCT02807844|66348645|FG009|Overall Study|Withdrawal by Subject|0|||
23719436|NCT02807844|66348636|FG000|Overall Study|Progressive disease|5|||
23719437|NCT02807844|66348637|FG001|Overall Study|Progressive disease|12|||
23814002|NCT02283294|66699555|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
23814003|NCT02283294|66699556|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
23814004|NCT02968849|66699557|FG000|Overall Study|Death|8|||
23814005|NCT02968849|66699558|FG001|Overall Study|Death|10|||
23814006|NCT02968849|66699557|FG000|Overall Study|Lost to Follow-up|31|||
23814007|NCT02968849|66699558|FG001|Overall Study|Lost to Follow-up|29|||
23814008|NCT02968849|66699557|FG000|Overall Study|Withdrawal by Subject|73|||
23814009|NCT02968849|66699558|FG001|Overall Study|Withdrawal by Subject|64|||
23814010|NCT02968849|66699557|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
23814011|NCT02968849|66699558|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
23814012|NCT02968849|66699557|FG000|Overall Study|Physician Decision|6|||
23814013|NCT02968849|66699558|FG001|Overall Study|Physician Decision|9|||
23814014|NCT02968849|66699557|FG000|Overall Study|Other|16|||
23814015|NCT02968849|66699558|FG001|Overall Study|Other|10|||
23814016|NCT03190330|66699561|FG000|Overall Study|Adverse Event|2|||
23814017|NCT03190330|66699561|FG000|Overall Study|Death|10|||
23814018|NCT03190330|66699561|FG000|Overall Study|Lost to Follow-up|1|||
23814019|NCT03190330|66699561|FG000|Overall Study|Withdrawal by Subject|6|||
23814020|NCT03190330|66699561|FG000|Overall Study|Progressive Disease|1|||
23814021|NCT02517463|66699562|FG000|Overall Study|Lost to Follow-up|5|||
23814022|NCT02517463|66699563|FG001|Overall Study|Lost to Follow-up|2|||
23814023|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
23814024|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
23814025|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
23814026|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
23814027|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23814028|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23814029|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23814030|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
23814031|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23814032|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23814033|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23814034|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
23814035|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
23814036|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
23814037|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
23814038|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
23814039|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23814040|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23814041|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23814042|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
23814043|NCT00593736|66699564|FG000|Screening Period and Placebo Run-in|Various|0|||
23814044|NCT00593736|66699565|FG001|Screening Period and Placebo Run-in|Various|0|||
23814045|NCT00593736|66699566|FG002|Screening Period and Placebo Run-in|Various|0|||
23814046|NCT00593736|66699567|FG003|Screening Period and Placebo Run-in|Various|25|||
23814047|NCT00593736|66699564|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
23814048|NCT00593736|66699565|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
23814049|NCT00593736|66699566|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
23814050|NCT00593736|66699567|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
23814051|NCT00593736|66699564|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
23814052|NCT00593736|66699565|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
23814053|NCT00593736|66699566|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
23814054|NCT00593736|66699567|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
23814055|NCT00593736|66699564|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
23814056|NCT00593736|66699565|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
23814057|NCT00593736|66699566|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
23814058|NCT00593736|66699567|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
23814059|NCT00593736|66699564|FG000|Treatment Period and Placebo Run-out|Various|1|||
23530837|NCT01701258|65679937|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
23719438|NCT02807844|66348638|FG002|Overall Study|Progressive disease|8|||
23719439|NCT02807844|66348639|FG003|Overall Study|Progressive disease|8|||
23719440|NCT02807844|66348640|FG004|Overall Study|Progressive disease|3|||
23719441|NCT02807844|66348641|FG005|Overall Study|Progressive disease|8|||
23719442|NCT02807844|66348642|FG006|Overall Study|Progressive disease|14|||
23719443|NCT02807844|66348643|FG007|Overall Study|Progressive disease|17|||
23719444|NCT02807844|66348644|FG008|Overall Study|Progressive disease|19|||
23719445|NCT02807844|66348645|FG009|Overall Study|Progressive disease|15|||
23719446|NCT02807844|66348636|FG000|Overall Study|Adverse Event|1|||
23719447|NCT02807844|66348637|FG001|Overall Study|Adverse Event|0|||
23719448|NCT02807844|66348638|FG002|Overall Study|Adverse Event|0|||
23719449|NCT02807844|66348639|FG003|Overall Study|Adverse Event|0|||
23719450|NCT02807844|66348640|FG004|Overall Study|Adverse Event|1|||
23719451|NCT02807844|66348641|FG005|Overall Study|Adverse Event|1|||
23719452|NCT02807844|66348642|FG006|Overall Study|Adverse Event|1|||
23719453|NCT02807844|66348643|FG007|Overall Study|Adverse Event|1|||
23719454|NCT02807844|66348644|FG008|Overall Study|Adverse Event|1|||
23719455|NCT02807844|66348645|FG009|Overall Study|Adverse Event|2|||
23719456|NCT00637377|66348651|FG000|Overall Study|Adverse Event|2|||
23719457|NCT00637377|66348652|FG001|Overall Study|Adverse Event|6|||
23719458|NCT00637377|66348653|FG002|Overall Study|Adverse Event|8|||
23719459|NCT00637377|66348654|FG003|Overall Study|Adverse Event|9|||
23719460|NCT00637377|66348651|FG000|Overall Study|Death|1|||
23719461|NCT00637377|66348652|FG001|Overall Study|Death|3|||
23613028|NCT01358175|65969766|FG001|Overall Study|Withdrawal by Subject|5|||
23719462|NCT00637377|66348653|FG002|Overall Study|Death|2|||
23719463|NCT00637377|66348654|FG003|Overall Study|Death|1|||
23719464|NCT00637377|66348651|FG000|Overall Study|Lack of Efficacy|0|||
23719465|NCT00637377|66348652|FG001|Overall Study|Lack of Efficacy|0|||
23719466|NCT00637377|66348653|FG002|Overall Study|Lack of Efficacy|1|||
23719467|NCT00637377|66348654|FG003|Overall Study|Lack of Efficacy|1|||
23613029|NCT01358175|65969767|FG002|Overall Study|Withdrawal by Subject|10|||
23613030|NCT01358175|65969765|FG000|Overall Study|Technical issues|0|||
23719468|NCT00637377|66348651|FG000|Overall Study|Lost to Follow-up|4|||
23613031|NCT01358175|65969766|FG001|Overall Study|Technical issues|1|||
23719469|NCT00637377|66348652|FG001|Overall Study|Lost to Follow-up|1|||
23719470|NCT00637377|66348653|FG002|Overall Study|Lost to Follow-up|2|||
23719471|NCT00637377|66348654|FG003|Overall Study|Lost to Follow-up|2|||
23719472|NCT00637377|66348651|FG000|Overall Study|Protocol Violation|2|||
23719473|NCT00637377|66348652|FG001|Overall Study|Protocol Violation|1|||
23719474|NCT00637377|66348653|FG002|Overall Study|Protocol Violation|1|||
23719475|NCT00637377|66348654|FG003|Overall Study|Protocol Violation|0|||
23719476|NCT00637377|66348651|FG000|Overall Study|Withdrawal by Subject|11|||
23719477|NCT00637377|66348652|FG001|Overall Study|Withdrawal by Subject|15|||
23719478|NCT00637377|66348653|FG002|Overall Study|Withdrawal by Subject|13|||
23719479|NCT00637377|66348654|FG003|Overall Study|Withdrawal by Subject|11|||
23719480|NCT00637377|66348651|FG000|Overall Study|Other (no further information available)|7|||
23719481|NCT00637377|66348652|FG001|Overall Study|Other (no further information available)|6|||
23719482|NCT00637377|66348653|FG002|Overall Study|Other (no further information available)|10|||
23719483|NCT00637377|66348654|FG003|Overall Study|Other (no further information available)|5|||
23719484|NCT01688635|66348655|FG000|Washout 1|Withdrawal by Subject|1|||
23719485|NCT01688635|66348656|FG001|Washout 1|Withdrawal by Subject|0|||
23719486|NCT01688635|66348655|FG000|Washout 1|Adverse Event|0|||
23719487|NCT01688635|66348656|FG001|Washout 1|Adverse Event|1|||
23719488|NCT01688635|66348655|FG000|Washout 1|Physician Decision|0|||
23719489|NCT01688635|66348656|FG001|Washout 1|Physician Decision|1|||
23719490|NCT01688635|66348655|FG000|Washout 2|Physician Decision|1|||
23719491|NCT01688635|66348656|FG001|Washout 2|Physician Decision|0|||
23719492|NCT01688635|66348655|FG000|Washout 2|Withdrawal by Subject|1|||
23719493|NCT01688635|66348656|FG001|Washout 2|Withdrawal by Subject|0|||
23814060|NCT00593736|66699565|FG001|Treatment Period and Placebo Run-out|Various|1|||
23814061|NCT00593736|66699566|FG002|Treatment Period and Placebo Run-out|Various|1|||
23814062|NCT00593736|66699567|FG003|Treatment Period and Placebo Run-out|Various|0|||
23814063|NCT03262038|66699578|FG000|Overall Study|Withdrawal by Subject|0|||
23814064|NCT03262038|66699579|FG001|Overall Study|Withdrawal by Subject|1|||
23814065|NCT04740814|66699582|FG000|Overall Study|Adverse Event|3|||
23814066|NCT04740814|66699582|FG000|Overall Study|Protocol Violation|2|||
23814067|NCT04740814|66699582|FG000|Overall Study|Lost to Follow-up|2|||
23814068|NCT04740814|66699582|FG000|Overall Study|Withdrawal by Subject|3|||
23814069|NCT01664130|66699585|FG000|Overall Study|competing secondary disease|2|||
23814070|NCT02365558|66699596|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
23814071|NCT02365558|66699597|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
23814072|NCT02365558|66699596|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
23814073|NCT02365558|66699597|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
23814074|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
23814075|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
23814076|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
23814077|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
23814078|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
23814079|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
23814080|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
23814081|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
23814082|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
23814083|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
23814084|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
23814085|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
23814086|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
23814087|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
23814088|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
23814089|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
23814090|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
23814091|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
23814092|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
23814093|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
23814094|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
23814095|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
23814096|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
23814097|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
23814098|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
23814099|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
23814100|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
23814101|NCT02552212|66699598|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
23814102|NCT02552212|66699599|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
23530838|NCT01701258|65679938|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
23719494|NCT01688635|66348655|FG000|Washout 2|Sponsor Decision|1|||
23719495|NCT01688635|66348656|FG001|Washout 2|Sponsor Decision|2|||
23719496|NCT01688635|66348655|FG000|Washout 3|Withdrawal by Subject|1|||
23719497|NCT01688635|66348656|FG001|Washout 3|Withdrawal by Subject|0|||
23719498|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
23530839|NCT01701258|65679939|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
23530840|NCT01701258|65679940|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
23814103|NCT02552212|66699600|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
23814104|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
23814105|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
23814106|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
23530841|NCT01701258|65679941|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
23530842|NCT01701258|65679942|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
23530843|NCT01701258|65679943|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
23530844|NCT01701258|65679944|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
23719499|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
23719500|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
23719501|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
23719502|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
23719503|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
23719504|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
23719505|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
23719506|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
23719507|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
23719508|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
23719509|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
23719510|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
23719511|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
23719512|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
23719513|NCT03814005|66348657|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
23719514|NCT03814005|66348658|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
23719515|NCT03814005|66348659|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
23719516|NCT00062647|66348660|FG000|Overall Study|Death|2|||
23719517|NCT00062647|66348661|FG001|Overall Study|Death|2|||
23719518|NCT00062647|66348660|FG000|Overall Study|Adverse Event|1|||
23719519|NCT00062647|66348661|FG001|Overall Study|Adverse Event|1|||
23719520|NCT00062647|66348660|FG000|Overall Study|Withdrawal by Subject|2|||
23719521|NCT00062647|66348661|FG001|Overall Study|Withdrawal by Subject|1|||
23719522|NCT00062647|66348660|FG000|Overall Study|Protocol Violation|1|||
23719523|NCT00062647|66348661|FG001|Overall Study|Protocol Violation|0|||
23719524|NCT00062647|66348660|FG000|Overall Study|Lost to Follow-up|1|||
23719525|NCT00062647|66348661|FG001|Overall Study|Lost to Follow-up|2|||
23814107|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
23814108|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
23814109|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
23814110|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
23814111|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
23814112|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
23814113|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
23814114|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
23814115|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
23814116|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
23814117|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
23814118|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
23814119|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
23814120|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
23814121|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
23814122|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
23613032|NCT01358175|65969767|FG002|Overall Study|Technical issues|0|||
23719526|NCT00062647|66348660|FG000|Overall Study|Failed continuation criteria|4|||
23719527|NCT00062647|66348661|FG001|Overall Study|Failed continuation criteria|2|||
23719528|NCT00062647|66348660|FG000|Overall Study|Other|4|||
23814123|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
23814124|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
23814125|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
23814126|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
23814127|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
23814128|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
23814129|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
23814130|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
23814131|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
23530845|NCT01701258|65679945|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
23530846|NCT01701258|65679946|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
23613033|NCT01358175|65969765|FG000|Overall Study|Pregnancy|0|||
23613034|NCT01358175|65969766|FG001|Overall Study|Pregnancy|1|||
23419418|NCT03194568|65280244|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
23419419|NCT00072293|65280245|FG000|Overall Study|Lost to Follow-up|1|||
23419420|NCT00072293|65280246|FG001|Overall Study|Lost to Follow-up|1|||
23419421|NCT00072293|65280245|FG000|Overall Study|Withdrawal by Subject|0|||
23419422|NCT00072293|65280246|FG001|Overall Study|Withdrawal by Subject|1|||
23419423|NCT04417218|65280249|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
23419424|NCT04417218|65280250|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
23419425|NCT03136497|65280251|FG000|Overall Study|Screen Failure|1|||
23419426|NCT03136497|65280252|FG001|Overall Study|Screen Failure|0|||
23419427|NCT03136497|65280253|FG002|Overall Study|Screen Failure|0|||
23419428|NCT02867813|65280256|FG000|Overall Study|Withdrawal by Subject|57|||
23419429|NCT02867813|65280257|FG001|Overall Study|Withdrawal by Subject|56|||
23419430|NCT02867813|65280256|FG000|Overall Study|Decision by Sponsor|7|||
23419431|NCT02867813|65280257|FG001|Overall Study|Decision by Sponsor|7|||
23814132|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
23530847|NCT01701258|65679947|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
23530848|NCT01701258|65679935|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
23530849|NCT01701258|65679936|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
23530850|NCT01701258|65679937|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
23530851|NCT01701258|65679938|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
23530852|NCT01701258|65679939|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
23530853|NCT01701258|65679940|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
23530854|NCT01701258|65679941|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
23530855|NCT01701258|65679942|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
23530856|NCT01701258|65679943|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
23530857|NCT01701258|65679944|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
23530858|NCT01701258|65679945|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
23530859|NCT01701258|65679946|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
23530860|NCT01701258|65679947|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
23530861|NCT01701258|65679935|FG000|Assessment and Scheduling|Investigator Terminated|2|||
23530862|NCT01701258|65679936|FG001|Assessment and Scheduling|Investigator Terminated|0|||
23530863|NCT01701258|65679937|FG002|Assessment and Scheduling|Investigator Terminated|0|||
23530864|NCT01701258|65679938|FG003|Assessment and Scheduling|Investigator Terminated|0|||
23530865|NCT01701258|65679939|FG004|Assessment and Scheduling|Investigator Terminated|0|||
23530866|NCT01701258|65679940|FG005|Assessment and Scheduling|Investigator Terminated|0|||
23530867|NCT01701258|65679941|FG006|Assessment and Scheduling|Investigator Terminated|0|||
23530868|NCT01701258|65679942|FG007|Assessment and Scheduling|Investigator Terminated|0|||
23530869|NCT01701258|65679943|FG008|Assessment and Scheduling|Investigator Terminated|0|||
23530870|NCT01701258|65679944|FG009|Assessment and Scheduling|Investigator Terminated|0|||
23530871|NCT01701258|65679945|FG010|Assessment and Scheduling|Investigator Terminated|0|||
23530872|NCT01701258|65679946|FG011|Assessment and Scheduling|Investigator Terminated|0|||
23530873|NCT01701258|65679947|FG012|Assessment and Scheduling|Investigator Terminated|0|||
23530874|NCT02310672|65679948|FG000|Overall Study|Death|1|||
23530875|NCT02310672|65679948|FG000|Overall Study|Lost to Follow-up|1|||
23530876|NCT02310672|65679948|FG000|Overall Study|Withdrawal by Subject|1|||
23530877|NCT02310672|65679948|FG000|Overall Study|Sponsor's decision|12|||
23530878|NCT00293384|65679949|FG000|Overall Study|Non-compliance|2|||
23530879|NCT00293384|65679949|FG000|Overall Study|Missed dosage/study drug|1|||
23530880|NCT00293384|65679949|FG000|Overall Study|Ineligible|2|||
23530881|NCT01516879|65679952|FG000|Overall Study|Withdrawal by Subject|9|||
23530882|NCT01516879|65679953|FG001|Overall Study|Withdrawal by Subject|11|||
23530883|NCT01516879|65679952|FG000|Overall Study|Death|0|||
23530884|NCT01516879|65679953|FG001|Overall Study|Death|2|||
23530885|NCT01516879|65679952|FG000|Overall Study|Lost to Follow-up|2|||
23530886|NCT01516879|65679953|FG001|Overall Study|Lost to Follow-up|11|||
23530887|NCT01516879|65679952|FG000|Overall Study|Other|5|||
23530888|NCT01516879|65679953|FG001|Overall Study|Other|10|||
23530889|NCT04399161|65679954|FG000|Overall Study|Withdrawal by Subject|1|||
23530890|NCT04399161|65679955|FG001|Overall Study|Withdrawal by Subject|0|||
23530891|NCT04399161|65679956|FG002|Overall Study|Withdrawal by Subject|2|||
23530892|NCT04399161|65679954|FG000|Overall Study|Protocol Violation|1|||
23530893|NCT04399161|65679955|FG001|Overall Study|Protocol Violation|2|||
23530894|NCT04399161|65679956|FG002|Overall Study|Protocol Violation|0|||
23530895|NCT00678561|65679957|FG000|Overall Study|Adverse Event|0|||
23530896|NCT00678561|65679958|FG001|Overall Study|Adverse Event|1|||
23530897|NCT00678561|65679959|FG002|Overall Study|Adverse Event|1|||
23530898|NCT00678561|65679960|FG003|Overall Study|Adverse Event|0|||
23530899|NCT00678561|65679961|FG004|Overall Study|Adverse Event|1|||
23530900|NCT00678561|65679962|FG005|Overall Study|Adverse Event|0|||
23530901|NCT00678561|65679963|FG006|Overall Study|Adverse Event|0|||
23530902|NCT00678561|65679964|FG007|Overall Study|Adverse Event|0|||
23530903|NCT00678561|65679957|FG000|Overall Study|Protocol Violation|0|||
23419432|NCT02867813|65280256|FG000|Overall Study|Lost to Follow-up|91|||
23419433|NCT02867813|65280257|FG001|Overall Study|Lost to Follow-up|78|||
23419434|NCT02867813|65280256|FG000|Overall Study|Missing|2|||
23613035|NCT01358175|65969767|FG002|Overall Study|Pregnancy|0|||
23613036|NCT01358175|65969765|FG000|Overall Study|Physician Decision|1|||
23613037|NCT01358175|65969766|FG001|Overall Study|Physician Decision|0|||
23613038|NCT01358175|65969767|FG002|Overall Study|Physician Decision|0|||
23613039|NCT01358175|65969765|FG000|Overall Study|Non Compliance with Study Treatment|0|||
23613040|NCT01358175|65969766|FG001|Overall Study|Non Compliance with Study Treatment|1|||
23613041|NCT01358175|65969767|FG002|Overall Study|Non Compliance with Study Treatment|1|||
23613042|NCT01358175|65969765|FG000|Overall Study|Lost to Follow-up|1|||
23613043|NCT01358175|65969766|FG001|Overall Study|Lost to Follow-up|1|||
23613044|NCT01358175|65969767|FG002|Overall Study|Lost to Follow-up|3|||
23613045|NCT01358175|65969765|FG000|Overall Study|Lack of Efficacy|3|||
23613046|NCT01358175|65969766|FG001|Overall Study|Lack of Efficacy|8|||
23613047|NCT01358175|65969767|FG002|Overall Study|Lack of Efficacy|6|||
23613048|NCT01358175|65969765|FG000|Overall Study|Adverse Event|6|||
23613049|NCT01358175|65969766|FG001|Overall Study|Adverse Event|11|||
23613050|NCT01358175|65969767|FG002|Overall Study|Adverse Event|11|||
23613051|NCT00248794|65969768|FG000|Overall Study|Lost to Follow-up|6|||
23613052|NCT00248794|65969769|FG001|Overall Study|Lost to Follow-up|8|||
23613053|NCT00248794|65969770|FG002|Overall Study|Lost to Follow-up|3|||
23613054|NCT01767376|65969771|FG000|Overall Study|Lost to Follow-up|3|||
23613055|NCT01767376|65969772|FG001|Overall Study|Lost to Follow-up|2|||
23530904|NCT00678561|65679958|FG001|Overall Study|Protocol Violation|0|||
23530905|NCT00678561|65679959|FG002|Overall Study|Protocol Violation|0|||
23530906|NCT00678561|65679960|FG003|Overall Study|Protocol Violation|0|||
23530907|NCT00678561|65679961|FG004|Overall Study|Protocol Violation|1|||
23530908|NCT00678561|65679962|FG005|Overall Study|Protocol Violation|1|||
23530909|NCT00678561|65679963|FG006|Overall Study|Protocol Violation|0|||
23530910|NCT00678561|65679964|FG007|Overall Study|Protocol Violation|0|||
23530911|NCT00678561|65679957|FG000|Overall Study|Withdrawal by Subject|0|||
23530912|NCT00678561|65679958|FG001|Overall Study|Withdrawal by Subject|0|||
23530913|NCT00678561|65679959|FG002|Overall Study|Withdrawal by Subject|0|||
23530914|NCT00678561|65679960|FG003|Overall Study|Withdrawal by Subject|0|||
23530915|NCT00678561|65679961|FG004|Overall Study|Withdrawal by Subject|0|||
23530916|NCT00678561|65679962|FG005|Overall Study|Withdrawal by Subject|0|||
23613056|NCT01767376|65969773|FG002|Overall Study|Lost to Follow-up|0|||
23613057|NCT01767376|65969771|FG000|Overall Study|Withdrawal by Subject|1|||
23419435|NCT02867813|65280257|FG001|Overall Study|Missing|1|||
23613058|NCT01767376|65969772|FG001|Overall Study|Withdrawal by Subject|1|||
23613059|NCT01767376|65969773|FG002|Overall Study|Withdrawal by Subject|0|||
23613060|NCT03018288|65969781|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
23814133|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
23419436|NCT02867813|65280256|FG000|Overall Study|Death|294|||
23419437|NCT02867813|65280257|FG001|Overall Study|Death|268|||
23419438|NCT01007435|65280260|FG000|Overall Study|Adverse Event|16|||
23419439|NCT01007435|65280261|FG001|Overall Study|Adverse Event|25|||
23419440|NCT01007435|65280262|FG002|Overall Study|Adverse Event|47|||
23419441|NCT01007435|65280263|FG003|Overall Study|Adverse Event|31|||
23419442|NCT01007435|65280260|FG000|Overall Study|Death|2|||
23419443|NCT01007435|65280261|FG001|Overall Study|Death|4|||
23419444|NCT01007435|65280262|FG002|Overall Study|Death|2|||
23419445|NCT01007435|65280263|FG003|Overall Study|Death|1|||
23419446|NCT01007435|65280260|FG000|Overall Study|Insufficient Therapeutic Response|21|||
23419447|NCT01007435|65280261|FG001|Overall Study|Insufficient Therapeutic Response|7|||
23419448|NCT01007435|65280262|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23419449|NCT01007435|65280263|FG003|Overall Study|Insufficient Therapeutic Response|9|||
23419450|NCT01007435|65280260|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
23419451|NCT01007435|65280261|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
23419452|NCT01007435|65280262|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
23419453|NCT01007435|65280263|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
23419454|NCT01007435|65280260|FG000|Overall Study|Other Protocol Violation|2|||
23419455|NCT01007435|65280261|FG001|Overall Study|Other Protocol Violation|0|||
23419456|NCT01007435|65280262|FG002|Overall Study|Other Protocol Violation|1|||
23419457|NCT01007435|65280263|FG003|Overall Study|Other Protocol Violation|0|||
23613061|NCT03018288|65969782|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
23613062|NCT03018288|65969783|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
23613063|NCT03018288|65969784|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
23613064|NCT03018288|65969781|FG000|Overall Study|Participant withdrew consent.|0|||
23613065|NCT03018288|65969782|FG001|Overall Study|Participant withdrew consent.|0|||
23419458|NCT01007435|65280260|FG000|Overall Study|Refused Treatment|13|||
23419459|NCT01007435|65280261|FG001|Overall Study|Refused Treatment|13|||
23419460|NCT01007435|65280262|FG002|Overall Study|Refused Treatment|5|||
23419461|NCT01007435|65280263|FG003|Overall Study|Refused Treatment|8|||
23530917|NCT00678561|65679963|FG006|Overall Study|Withdrawal by Subject|0|||
23530918|NCT00678561|65679964|FG007|Overall Study|Withdrawal by Subject|1|||
23530919|NCT00424372|65679965|FG000|Overall Study|Death|1|||
23530920|NCT00424372|65679965|FG000|Overall Study|Adverse Event|18|||
23530921|NCT00424372|65679965|FG000|Overall Study|Lack of Efficacy|6|||
23530922|NCT00424372|65679965|FG000|Overall Study|Withdrawal by Subject|4|||
23530923|NCT00424372|65679965|FG000|Overall Study|Protocol Violation|1|||
23530924|NCT00424372|65679965|FG000|Overall Study|Health deterioration|1|||
23530925|NCT01857063|65679966|FG000|Period 1 (7 Days)|Adverse Event|0|||
23530926|NCT01857063|65679967|FG001|Period 1 (7 Days)|Adverse Event|1|||
23530927|NCT01857063|65679966|FG000|Period 1 (7 Days)|Physician Decision|1|||
23530928|NCT01857063|65679967|FG001|Period 1 (7 Days)|Physician Decision|0|||
23530929|NCT01857063|65679966|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
23530930|NCT01857063|65679967|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
23530931|NCT01857063|65679966|FG000|Period 2 (7 Days)|Adverse Event|2|||
23530932|NCT01857063|65679967|FG001|Period 2 (7 Days)|Adverse Event|1|||
23530933|NCT01857063|65679966|FG000|Period 2 (7 Days)|Physician Decision|1|||
23530934|NCT01857063|65679967|FG001|Period 2 (7 Days)|Physician Decision|1|||
23530935|NCT01857063|65679966|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
23530936|NCT01857063|65679967|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
23530937|NCT04280783|65679968|FG000|Overall Study|Family issues unrelated to the study.|1|||
23530938|NCT04280783|65679969|FG001|Overall Study|Family issues unrelated to the study.|0|||
23530939|NCT04280783|65679968|FG000|Overall Study|Withdrawal by Subject|0|||
23530940|NCT04280783|65679969|FG001|Overall Study|Withdrawal by Subject|1|||
23530941|NCT04208412|65679970|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
23530942|NCT04208412|65679971|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
23530943|NCT04208412|65679970|FG000|Overall Study|Withdrawal by Subject|1|||
23530944|NCT04208412|65679971|FG001|Overall Study|Withdrawal by Subject|0|||
23530945|NCT04208412|65679970|FG000|Overall Study|Lost to Follow-up|0|||
23530946|NCT04208412|65679971|FG001|Overall Study|Lost to Follow-up|1|||
23530947|NCT01470469|65679974|FG000|Overall Study|Withdrawal by Subject|4|||
23530948|NCT01470469|65679975|FG001|Overall Study|Withdrawal by Subject|6|||
23530949|NCT01470469|65679974|FG000|Overall Study|Lack of Efficacy|1|||
23530950|NCT01470469|65679975|FG001|Overall Study|Lack of Efficacy|7|||
23530951|NCT01470469|65679974|FG000|Overall Study|Adverse Event|0|||
23530952|NCT01470469|65679975|FG001|Overall Study|Adverse Event|7|||
23530953|NCT01470469|65679974|FG000|Overall Study|Lost to Follow-up|2|||
23530954|NCT01470469|65679975|FG001|Overall Study|Lost to Follow-up|2|||
23530955|NCT01470469|65679974|FG000|Overall Study|Protocol Violation|1|||
23530956|NCT01470469|65679975|FG001|Overall Study|Protocol Violation|1|||
23530957|NCT01470469|65679974|FG000|Overall Study|Other|2|||
23530958|NCT01470469|65679975|FG001|Overall Study|Other|1|||
23530959|NCT02469610|65679976|FG000|Overall Study|Death|1|||
23530960|NCT02469610|65679977|FG001|Overall Study|Death|0|||
23530961|NCT02469610|65679976|FG000|Overall Study|Lost to Follow-up|1|||
23530962|NCT02469610|65679977|FG001|Overall Study|Lost to Follow-up|0|||
23530963|NCT02469610|65679976|FG000|Overall Study|exclusion criteria|2|||
23530964|NCT02469610|65679977|FG001|Overall Study|exclusion criteria|1|||
23530965|NCT00724451|65679980|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
23530966|NCT00724451|65679980|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
23530967|NCT00724451|65679980|FG000|Overall Study|Not Eligible for Treatment|431|||
23530968|NCT00724451|65679980|FG000|Overall Study|Participant Refused Treatment|89|||
23530969|NCT00724451|65679980|FG000|Overall Study|Never Started Treatment|89|||
23530970|NCT00724451|65679980|FG000|Overall Study|Unknown; No Data Sources Available|9|||
23530971|NCT00724451|65679980|FG000|Overall Study|Physician Decision|116|||
23530972|NCT00724451|65679980|FG000|Overall Study|Withdrawal by Subject|45|||
23530973|NCT00724451|65679980|FG000|Overall Study|Investigator + Participant Decision|13|||
23530974|NCT04258839|65679986|FG000|Overall Study|Adverse Event|2|||
23530975|NCT04258839|65679987|FG001|Overall Study|Adverse Event|4|||
23530976|NCT04258839|65679986|FG000|Overall Study|Lack of Efficacy|0|||
23530977|NCT04258839|65679987|FG001|Overall Study|Lack of Efficacy|2|||
23530978|NCT04258839|65679986|FG000|Overall Study|Lost to Follow-up|2|||
23530979|NCT04258839|65679987|FG001|Overall Study|Lost to Follow-up|0|||
23530980|NCT04258839|65679986|FG000|Overall Study|Withdrawal by Subject|1|||
23530981|NCT04258839|65679987|FG001|Overall Study|Withdrawal by Subject|2|||
23530982|NCT04258839|65679986|FG000|Overall Study|Withdrawal by Caregiver|5|||
23530983|NCT04258839|65679987|FG001|Overall Study|Withdrawal by Caregiver|6|||
23530984|NCT04258839|65679986|FG000|Overall Study|Reason not Specified|0|||
23530985|NCT04258839|65679987|FG001|Overall Study|Reason not Specified|1|||
23530986|NCT00654628|65679988|FG000|6-week Active Treatment Period|Adverse Event|9|||
23530987|NCT00654628|65679988|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
23530988|NCT00654628|65679988|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
23530989|NCT00654628|65679988|FG000|6-week Active Treatment Period|Out of window period|1|||
23530990|NCT00654628|65679988|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
23530991|NCT00654628|65679988|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
23530992|NCT01632800|65679989|FG000|Overall Study|Subject did not fit in apparatus|1|||
23530993|NCT02907359|65679991|FG000|Overall Study|Death|234|||
23530994|NCT02907359|65679992|FG001|Overall Study|Death|117|||
23530995|NCT02907359|65679991|FG000|Overall Study|Withdrawal by Subject|6|||
23530996|NCT02907359|65679992|FG001|Overall Study|Withdrawal by Subject|11|||
23613066|NCT03018288|65969783|FG002|Overall Study|Participant withdrew consent.|1|||
23613067|NCT03018288|65969784|FG003|Overall Study|Participant withdrew consent.|0|||
23613068|NCT03018288|65969781|FG000|Overall Study|Switched to alternative treatment.|0|||
23613069|NCT03018288|65969782|FG001|Overall Study|Switched to alternative treatment.|0|||
23613070|NCT03018288|65969783|FG002|Overall Study|Switched to alternative treatment.|1|||
23613071|NCT03018288|65969784|FG003|Overall Study|Switched to alternative treatment.|0|||
23613072|NCT03018288|65969781|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613073|NCT03018288|65969782|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613074|NCT03018288|65969783|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
23613075|NCT03018288|65969784|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613076|NCT03018288|65969781|FG000|Overall Study|Screen failures|0|||
23530997|NCT02907359|65679991|FG000|Overall Study|Lost to Follow-up|1|||
23530998|NCT02907359|65679992|FG001|Overall Study|Lost to Follow-up|0|||
23530999|NCT00179647|65679993|FG000|Overall Study|Adverse Event|294|||
23531000|NCT00179647|65679993|FG000|Overall Study|Lack of Efficacy|478|||
23531001|NCT00179647|65679993|FG000|Overall Study|Withdrawal by Subject|83|||
23531002|NCT00179647|65679993|FG000|Overall Study|Lost to Follow-up|4|||
23531003|NCT00179647|65679993|FG000|Overall Study|Death|94|||
23531004|NCT00179647|65679993|FG000|Overall Study|Other|960|||
23531005|NCT04013191|65679996|FG000|Overall Study|Adverse Event|1|||
23531006|NCT04013191|65679997|FG001|Overall Study|Adverse Event|0|||
23531007|NCT01641367|65679998|FG000|Cohorts|Death|18|||
23531008|NCT01641367|65679999|FG001|Cohorts|Death|1|||
23531009|NCT01641367|65680000|FG002|Cohorts|Death|2|||
23531010|NCT01641367|65680001|FG003|Cohorts|Death|0|||
23531011|NCT01641367|65680002|FG004|Cohorts|Death|1|||
23613077|NCT03018288|65969782|FG001|Overall Study|Screen failures|0|||
23613078|NCT03018288|65969783|FG002|Overall Study|Screen failures|0|||
23613079|NCT03018288|65969784|FG003|Overall Study|Screen failures|51|||
23613080|NCT03018288|65969781|FG000|Overall Study|Chose treatment outside of UNC|0|||
23613081|NCT03018288|65969782|FG001|Overall Study|Chose treatment outside of UNC|0|||
23613082|NCT03018288|65969783|FG002|Overall Study|Chose treatment outside of UNC|0|||
23613083|NCT03018288|65969784|FG003|Overall Study|Chose treatment outside of UNC|1|||
23613084|NCT03018288|65969781|FG000|Overall Study|Unable to comply with protocol requirements|1|||
23613085|NCT03018288|65969782|FG001|Overall Study|Unable to comply with protocol requirements|1|||
23613086|NCT03018288|65969783|FG002|Overall Study|Unable to comply with protocol requirements|0|||
23613087|NCT03018288|65969784|FG003|Overall Study|Unable to comply with protocol requirements|1|||
23613088|NCT03018288|65969781|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
23613089|NCT03018288|65969782|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
23613090|NCT03018288|65969783|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
23613091|NCT03018288|65969784|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
23613092|NCT03018288|65969781|FG000|Overall Study|Physician Decision|0|||
23613093|NCT03018288|65969782|FG001|Overall Study|Physician Decision|0|||
23613094|NCT03018288|65969783|FG002|Overall Study|Physician Decision|0|||
23613095|NCT03018288|65969784|FG003|Overall Study|Physician Decision|1|||
23613096|NCT00914732|65969787|FG000|Overall Study|Lost to Follow-up|6|||
23613097|NCT00914732|65969788|FG001|Overall Study|Lost to Follow-up|7|||
23613098|NCT00914732|65969789|FG002|Overall Study|Lost to Follow-up|9|||
23613099|NCT00914732|65969787|FG000|Overall Study|Withdrawal by Subject|3|||
23613100|NCT00914732|65969788|FG001|Overall Study|Withdrawal by Subject|0|||
23613101|NCT00914732|65969789|FG002|Overall Study|Withdrawal by Subject|2|||
23613102|NCT00914732|65969787|FG000|Overall Study|Adverse Event|1|||
23613103|NCT00914732|65969788|FG001|Overall Study|Adverse Event|0|||
23613104|NCT00914732|65969789|FG002|Overall Study|Adverse Event|0|||
23613105|NCT00443820|65969790|FG000|Overall Study|Adverse Event|1|||
23613106|NCT00443820|65969791|FG001|Overall Study|Adverse Event|1|||
23613107|NCT00443820|65969792|FG002|Overall Study|Adverse Event|0|||
23613108|NCT00443820|65969793|FG003|Overall Study|Adverse Event|0|||
23613109|NCT00443820|65969790|FG000|Overall Study|Lack of Efficacy|3|||
23613110|NCT00443820|65969791|FG001|Overall Study|Lack of Efficacy|2|||
23613111|NCT00443820|65969792|FG002|Overall Study|Lack of Efficacy|1|||
23613112|NCT00443820|65969793|FG003|Overall Study|Lack of Efficacy|1|||
23531012|NCT01641367|65680003|FG005|Cohorts|Death|1|||
23531013|NCT01641367|65680004|FG006|Cohorts|Death|0|||
23531014|NCT01641367|65680005|FG007|Cohorts|Death|0|||
23613113|NCT00443820|65969790|FG000|Overall Study|Protocol Violation|2|||
23613114|NCT00443820|65969791|FG001|Overall Study|Protocol Violation|1|||
23613115|NCT00443820|65969792|FG002|Overall Study|Protocol Violation|2|||
23531015|NCT01641367|65679998|FG000|Cohorts|Lost to Follow-up|16|||
23613116|NCT00443820|65969793|FG003|Overall Study|Protocol Violation|1|||
23613117|NCT00443820|65969790|FG000|Overall Study|Withdrawal by Subject|6|||
23419462|NCT01007435|65280260|FG000|Overall Study|Failure to Return|5|||
23531016|NCT01641367|65679999|FG001|Cohorts|Lost to Follow-up|0|||
23531017|NCT01641367|65680000|FG002|Cohorts|Lost to Follow-up|2|||
23531018|NCT01641367|65680001|FG003|Cohorts|Lost to Follow-up|0|||
23613118|NCT00443820|65969791|FG001|Overall Study|Withdrawal by Subject|7|||
23613119|NCT00443820|65969792|FG002|Overall Study|Withdrawal by Subject|8|||
23613120|NCT00443820|65969793|FG003|Overall Study|Withdrawal by Subject|9|||
23613121|NCT00443820|65969790|FG000|Overall Study|Lost to Follow-up|9|||
23613122|NCT00443820|65969791|FG001|Overall Study|Lost to Follow-up|8|||
23613123|NCT00443820|65969792|FG002|Overall Study|Lost to Follow-up|6|||
23613124|NCT00443820|65969793|FG003|Overall Study|Lost to Follow-up|5|||
23613125|NCT00443820|65969790|FG000|Overall Study|Administrative problems|0|||
23613126|NCT00443820|65969791|FG001|Overall Study|Administrative problems|0|||
23613127|NCT00443820|65969792|FG002|Overall Study|Administrative problems|0|||
23613128|NCT00443820|65969793|FG003|Overall Study|Administrative problems|1|||
23613129|NCT00443820|65969790|FG000|Overall Study|Death|0|||
23613130|NCT00443820|65969791|FG001|Overall Study|Death|0|||
23613131|NCT00443820|65969792|FG002|Overall Study|Death|1|||
23613132|NCT00443820|65969793|FG003|Overall Study|Death|0|||
23613133|NCT03219216|65969796|FG000|Overall Study|Lost to Follow-up|0|||
23613134|NCT03219216|65969797|FG001|Overall Study|Lost to Follow-up|1|||
23613135|NCT02577315|65969798|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23613136|NCT02577315|65969799|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23613137|NCT00988429|65969800|FG000|Overall Study|Adverse Event|9|||
23613138|NCT00988429|65969801|FG001|Overall Study|Adverse Event|21|||
23613139|NCT00988429|65969802|FG002|Overall Study|Adverse Event|45|||
23613140|NCT00988429|65969800|FG000|Overall Study|Lack of Efficacy|0|||
23613141|NCT00988429|65969801|FG001|Overall Study|Lack of Efficacy|0|||
23613142|NCT00988429|65969802|FG002|Overall Study|Lack of Efficacy|1|||
23613143|NCT00988429|65969800|FG000|Overall Study|Non-Compliance with Study Drug|5|||
23613144|NCT00988429|65969801|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23613145|NCT00988429|65969802|FG002|Overall Study|Non-Compliance with Study Drug|3|||
23613146|NCT00988429|65969800|FG000|Overall Study|Physician Decision|1|||
23613147|NCT00988429|65969801|FG001|Overall Study|Physician Decision|0|||
23613148|NCT00988429|65969802|FG002|Overall Study|Physician Decision|3|||
23613149|NCT00988429|65969800|FG000|Overall Study|Pregnancy|2|||
23613150|NCT00988429|65969801|FG001|Overall Study|Pregnancy|1|||
23613151|NCT00988429|65969802|FG002|Overall Study|Pregnancy|0|||
23613152|NCT00988429|65969800|FG000|Overall Study|Protocol Violation|4|||
23613153|NCT00988429|65969801|FG001|Overall Study|Protocol Violation|3|||
23613154|NCT00988429|65969802|FG002|Overall Study|Protocol Violation|3|||
23613155|NCT00988429|65969800|FG000|Overall Study|Withdrawal by Subject|7|||
23613156|NCT00988429|65969801|FG001|Overall Study|Withdrawal by Subject|7|||
23613157|NCT00988429|65969802|FG002|Overall Study|Withdrawal by Subject|12|||
23613158|NCT00988429|65969800|FG000|Overall Study|Administrative Reasons|1|||
23613159|NCT00988429|65969801|FG001|Overall Study|Administrative Reasons|2|||
23613160|NCT00988429|65969802|FG002|Overall Study|Administrative Reasons|1|||
23613161|NCT00988429|65969800|FG000|Overall Study|other reasons|8|||
23613162|NCT00988429|65969801|FG001|Overall Study|other reasons|8|||
23613163|NCT00988429|65969802|FG002|Overall Study|other reasons|1|||
23613164|NCT01524887|65969803|FG000|Overall Study|Withdrawal by Subject|6|||
23613165|NCT01524887|65969804|FG001|Overall Study|Withdrawal by Subject|2|||
23613166|NCT01524887|65969805|FG002|Overall Study|Withdrawal by Subject|3|||
23613167|NCT01524887|65969803|FG000|Overall Study|Adverse Event|5|||
23613168|NCT01524887|65969804|FG001|Overall Study|Adverse Event|1|||
23613169|NCT01524887|65969805|FG002|Overall Study|Adverse Event|1|||
23613170|NCT01524887|65969803|FG000|Overall Study|Protocol Violation|0|||
23613171|NCT01524887|65969804|FG001|Overall Study|Protocol Violation|0|||
23613172|NCT01524887|65969805|FG002|Overall Study|Protocol Violation|1|||
23613173|NCT01524887|65969803|FG000|Overall Study|Study termination|73|||
23613174|NCT01524887|65969804|FG001|Overall Study|Study termination|87|||
23613175|NCT01524887|65969805|FG002|Overall Study|Study termination|79|||
23613176|NCT01524887|65969803|FG000|Overall Study|Withdrawal by Caregiver|0|||
23613177|NCT01524887|65969804|FG001|Overall Study|Withdrawal by Caregiver|0|||
23613178|NCT01524887|65969805|FG002|Overall Study|Withdrawal by Caregiver|2|||
23613179|NCT01524887|65969803|FG000|Overall Study|Use of prohibited medication|1|||
23613180|NCT01524887|65969804|FG001|Overall Study|Use of prohibited medication|0|||
23613181|NCT01524887|65969805|FG002|Overall Study|Use of prohibited medication|0|||
23613182|NCT01876823|65969806|FG000|Overall Study|Withdrawal by Subject|5|||
23613183|NCT01876823|65969806|FG000|Overall Study|Physician Decision|2|||
23613184|NCT01876823|65969806|FG000|Overall Study|Patients moved|2|||
23613185|NCT00447499|65969809|FG000|Overall Study|Adverse Event|1|||
23613186|NCT00447499|65969809|FG000|Overall Study|Patient Decision|4|||
23613187|NCT00447499|65969809|FG000|Overall Study|Sponsor Decision|1|||
23613188|NCT00447499|65969809|FG000|Overall Study|Physician Decision|1|||
23613189|NCT02489799|65969810|FG000|Overall Study|Lost to Follow-up|4|||
23613190|NCT02489799|65969811|FG001|Overall Study|Lost to Follow-up|1|||
23613191|NCT02489799|65969810|FG000|Overall Study|Failure to Maintain Eligibility|4|||
23613192|NCT02489799|65969811|FG001|Overall Study|Failure to Maintain Eligibility|6|||
23613193|NCT02489799|65969810|FG000|Overall Study|Withdrawal by Subject|1|||
23613194|NCT02489799|65969811|FG001|Overall Study|Withdrawal by Subject|1|||
23613195|NCT02489799|65969810|FG000|Overall Study|Death|0|||
23613196|NCT02489799|65969811|FG001|Overall Study|Death|1|||
23719529|NCT00062647|66348661|FG001|Overall Study|Other|4|||
23719530|NCT00062647|66348660|FG000|Overall Study|Never received study treatment|1|||
23719531|NCT00062647|66348661|FG001|Overall Study|Never received study treatment|1|||
23719532|NCT00050960|66348663|FG000|Overall Study|Progressive Disease|137|||
23719533|NCT00050960|66348664|FG001|Overall Study|Progressive Disease|93|||
23719534|NCT00050960|66348663|FG000|Overall Study|Stable Disease|19|||
23719535|NCT00050960|66348664|FG001|Overall Study|Stable Disease|48|||
23719536|NCT00050960|66348663|FG000|Overall Study|Partial Response|14|||
23719537|NCT00050960|66348664|FG001|Overall Study|Partial Response|19|||
23719538|NCT00050960|66348663|FG000|Overall Study|Complete Response|0|||
23719539|NCT00050960|66348664|FG001|Overall Study|Complete Response|2|||
23719540|NCT00050960|66348663|FG000|Overall Study|Adverse Event|62|||
23719541|NCT00050960|66348664|FG001|Overall Study|Adverse Event|61|||
23719542|NCT00050960|66348663|FG000|Overall Study|Lost to Follow-up|0|||
23719543|NCT00050960|66348664|FG001|Overall Study|Lost to Follow-up|1|||
23719544|NCT00050960|66348663|FG000|Overall Study|Withdrawal by Subject|23|||
23719545|NCT00050960|66348664|FG001|Overall Study|Withdrawal by Subject|18|||
23719546|NCT00050960|66348663|FG000|Overall Study|Administrative|31|||
23719547|NCT00050960|66348664|FG001|Overall Study|Administrative|46|||
23719548|NCT00050960|66348663|FG000|Overall Study|Non-compliance|3|||
23719549|NCT00050960|66348664|FG001|Overall Study|Non-compliance|1|||
23719550|NCT00050960|66348663|FG000|Overall Study|Death|13|||
23719551|NCT00050960|66348664|FG001|Overall Study|Death|15|||
23719552|NCT03271307|66348665|FG000|Overall Study|Lost to Follow-up|0|||
23719553|NCT03271307|66348666|FG001|Overall Study|Lost to Follow-up|0|||
23719554|NCT03271307|66348667|FG002|Overall Study|Lost to Follow-up|0|||
23719555|NCT03271307|66348668|FG003|Overall Study|Lost to Follow-up|28|||
23719556|NCT03271307|66348669|FG004|Overall Study|Lost to Follow-up|91|||
23719557|NCT01828099|66348670|FG000|Overall Study|Adverse Event|15|||
23719558|NCT01828099|66348671|FG001|Overall Study|Adverse Event|18|||
23719559|NCT01828099|66348670|FG000|Overall Study|Death|9|||
23719560|NCT01828099|66348671|FG001|Overall Study|Death|11|||
23719561|NCT01828099|66348670|FG000|Overall Study|Lost to Follow-up|2|||
23719562|NCT01828099|66348671|FG001|Overall Study|Lost to Follow-up|0|||
23719563|NCT01828099|66348670|FG000|Overall Study|Non-compliance with study treatment|2|||
23719564|NCT01828099|66348671|FG001|Overall Study|Non-compliance with study treatment|0|||
23719565|NCT01828099|66348670|FG000|Overall Study|Physician Decision|7|||
23719566|NCT01828099|66348671|FG001|Overall Study|Physician Decision|11|||
23719567|NCT01828099|66348670|FG000|Overall Study|Progressive disease|51|||
23719568|NCT01828099|66348671|FG001|Overall Study|Progressive disease|94|||
23419463|NCT01007435|65280261|FG001|Overall Study|Failure to Return|4|||
23419464|NCT01007435|65280262|FG002|Overall Study|Failure to Return|3|||
23419465|NCT01007435|65280263|FG003|Overall Study|Failure to Return|6|||
23419466|NCT01007435|65280260|FG000|Overall Study|Reason not Specified|1|||
23419467|NCT01007435|65280261|FG001|Overall Study|Reason not Specified|1|||
23419468|NCT01007435|65280262|FG002|Overall Study|Reason not Specified|2|||
23419469|NCT01007435|65280263|FG003|Overall Study|Reason not Specified|1|||
23419470|NCT00549900|65280264|FG000|Overall Study|Adverse Event|1|||
23419471|NCT01421303|65280265|FG000|Overall Study|Lost to Follow-up|13|||
23419472|NCT01421303|65280265|FG000|Overall Study|Non compliance with study procedure|1|||
23419473|NCT01421303|65280265|FG000|Overall Study|Other|7|||
23419474|NCT01421303|65280265|FG000|Overall Study|Withdrawal by Subject|1|||
23419475|NCT03457142|65280266|FG000|Overall Study|Death|1|||
23419476|NCT02403817|65280267|FG000|Overall Study|Withdrawal by Subject|5|||
23419477|NCT02403817|65280268|FG001|Overall Study|Withdrawal by Subject|0|||
23419478|NCT01579565|65280269|FG000|Randomized|Adverse Event|1|||
23419479|NCT01579565|65280270|FG001|Randomized|Adverse Event|3|||
23419480|NCT01579565|65280269|FG000|Randomized|Withdrawal by Subject|3|||
23419481|NCT01579565|65280270|FG001|Randomized|Withdrawal by Subject|0|||
23419482|NCT01579565|65280269|FG000|Randomized|inadequate preoperative pupil dilation|0|||
23419483|NCT01579565|65280270|FG001|Randomized|inadequate preoperative pupil dilation|1|||
23419484|NCT01579565|65280269|FG000|Randomized|prohibited preoperative eating|1|||
23419485|NCT01579565|65280270|FG001|Randomized|prohibited preoperative eating|0|||
23419486|NCT01579565|65280269|FG000|Randomized|prohibited preoperative medication|0|||
23419487|NCT01579565|65280270|FG001|Randomized|prohibited preoperative medication|1|||
23419488|NCT01579565|65280269|FG000|Treated|Physician Decision|0|||
23419489|NCT01579565|65280270|FG001|Treated|Physician Decision|1|||
23419490|NCT01579565|65280269|FG000|Treated|Lost to Follow-up|2|||
23419491|NCT01579565|65280270|FG001|Treated|Lost to Follow-up|1|||
23419492|NCT01579565|65280269|FG000|Treated|declined to return for final visit|0|||
23419493|NCT01579565|65280270|FG001|Treated|declined to return for final visit|1|||
23419494|NCT00778258|65280271|FG000|Overall Study|Adverse Event|1|||
23419495|NCT00778258|65280272|FG001|Overall Study|Adverse Event|0|||
23419496|NCT00778258|65280273|FG002|Overall Study|Adverse Event|0|||
23419497|NCT00778258|65280274|FG003|Overall Study|Adverse Event|0|||
23419498|NCT00778258|65280275|FG004|Overall Study|Adverse Event|0|||
23419499|NCT00778258|65280276|FG005|Overall Study|Adverse Event|1|||
23419500|NCT00778258|65280277|FG006|Overall Study|Adverse Event|0|||
23419501|NCT00778258|65280278|FG007|Overall Study|Adverse Event|0|||
23419502|NCT00778258|65280279|FG008|Overall Study|Adverse Event|0|||
23419503|NCT00778258|65280271|FG000|Overall Study|Lost to Follow-up|0|||
23419504|NCT00778258|65280272|FG001|Overall Study|Lost to Follow-up|0|||
23419505|NCT00778258|65280273|FG002|Overall Study|Lost to Follow-up|2|||
23419506|NCT00778258|65280274|FG003|Overall Study|Lost to Follow-up|0|||
23419507|NCT00778258|65280275|FG004|Overall Study|Lost to Follow-up|0|||
23419508|NCT00778258|65280276|FG005|Overall Study|Lost to Follow-up|3|||
23419509|NCT00778258|65280277|FG006|Overall Study|Lost to Follow-up|2|||
23419510|NCT00778258|65280278|FG007|Overall Study|Lost to Follow-up|2|||
23419511|NCT00778258|65280279|FG008|Overall Study|Lost to Follow-up|0|||
23419512|NCT00778258|65280271|FG000|Overall Study|Withdrawal by Subject|6|||
23419513|NCT00778258|65280272|FG001|Overall Study|Withdrawal by Subject|2|||
23419514|NCT00778258|65280273|FG002|Overall Study|Withdrawal by Subject|8|||
23419515|NCT00778258|65280274|FG003|Overall Study|Withdrawal by Subject|2|||
23419516|NCT00778258|65280275|FG004|Overall Study|Withdrawal by Subject|0|||
23419517|NCT00778258|65280276|FG005|Overall Study|Withdrawal by Subject|6|||
23419518|NCT00778258|65280277|FG006|Overall Study|Withdrawal by Subject|12|||
23419519|NCT00778258|65280278|FG007|Overall Study|Withdrawal by Subject|12|||
23419520|NCT00778258|65280279|FG008|Overall Study|Withdrawal by Subject|4|||
23419521|NCT00778258|65280271|FG000|Overall Study|New Contraindication|0|||
23419522|NCT00778258|65280272|FG001|Overall Study|New Contraindication|0|||
23419523|NCT00778258|65280273|FG002|Overall Study|New Contraindication|0|||
23419524|NCT00778258|65280274|FG003|Overall Study|New Contraindication|0|||
23419525|NCT00778258|65280275|FG004|Overall Study|New Contraindication|0|||
23419526|NCT00778258|65280276|FG005|Overall Study|New Contraindication|0|||
23419527|NCT00778258|65280277|FG006|Overall Study|New Contraindication|0|||
23419528|NCT00778258|65280278|FG007|Overall Study|New Contraindication|1|||
23419529|NCT00778258|65280279|FG008|Overall Study|New Contraindication|0|||
23419530|NCT00778258|65280271|FG000|Overall Study|Non-compliance|0|||
23419531|NCT00778258|65280272|FG001|Overall Study|Non-compliance|0|||
23419532|NCT00778258|65280273|FG002|Overall Study|Non-compliance|0|||
23419533|NCT00778258|65280274|FG003|Overall Study|Non-compliance|1|||
23531019|NCT01641367|65680002|FG004|Cohorts|Lost to Follow-up|2|||
23531020|NCT01641367|65680003|FG005|Cohorts|Lost to Follow-up|0|||
23419534|NCT00778258|65280275|FG004|Overall Study|Non-compliance|0|||
23419535|NCT00778258|65280276|FG005|Overall Study|Non-compliance|0|||
23419536|NCT00778258|65280277|FG006|Overall Study|Non-compliance|0|||
23419537|NCT00778258|65280278|FG007|Overall Study|Non-compliance|0|||
23419538|NCT00778258|65280279|FG008|Overall Study|Non-compliance|0|||
23531021|NCT01641367|65680004|FG006|Cohorts|Lost to Follow-up|0|||
23419539|NCT00778258|65280271|FG000|Overall Study|Other|0|||
23419540|NCT00778258|65280272|FG001|Overall Study|Other|0|||
23419541|NCT00778258|65280273|FG002|Overall Study|Other|0|||
23419542|NCT00778258|65280274|FG003|Overall Study|Other|0|||
23419543|NCT00778258|65280275|FG004|Overall Study|Other|0|||
23419544|NCT00778258|65280276|FG005|Overall Study|Other|0|||
23419545|NCT00778258|65280277|FG006|Overall Study|Other|1|||
23419546|NCT00778258|65280278|FG007|Overall Study|Other|0|||
23531022|NCT01641367|65680005|FG007|Cohorts|Lost to Follow-up|0|||
23531023|NCT01641367|65679998|FG000|Randomized Adherence Intervention|Death|0|||
23531024|NCT01641367|65679999|FG001|Randomized Adherence Intervention|Death|0|||
23531025|NCT01641367|65680000|FG002|Randomized Adherence Intervention|Death|0|||
23531026|NCT01641367|65680001|FG003|Randomized Adherence Intervention|Death|0|||
23531027|NCT01641367|65680002|FG004|Randomized Adherence Intervention|Death|0|||
23531028|NCT01641367|65680003|FG005|Randomized Adherence Intervention|Death|0|||
23531029|NCT01641367|65680004|FG006|Randomized Adherence Intervention|Death|11|||
23531030|NCT01641367|65680005|FG007|Randomized Adherence Intervention|Death|12|||
23531031|NCT01641367|65679998|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531032|NCT01641367|65679999|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531033|NCT01641367|65680000|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531034|NCT01641367|65680001|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531035|NCT01641367|65680002|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531036|NCT01641367|65680003|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531037|NCT01641367|65680004|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
23531038|NCT01641367|65680005|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
23531039|NCT02696096|65680006|FG000|Overall Study|ruled out at screening|1|||
23531040|NCT02696096|65680006|FG000|Overall Study|did not attend second fMRI|1|||
23531041|NCT01986829|65680007|FG000|Overall Study|Death|1|||
23531042|NCT03364049|65680008|FG000|Overall Study|Death|6|||
23419547|NCT00778258|65280279|FG008|Overall Study|Other|0|||
23419548|NCT00096226|65280282|FG000|Overall Study|Ineligible|2|||
23419549|NCT00096226|65280282|FG000|Overall Study|Protocol treatment not started|1|||
23419550|NCT03172325|65280285|FG000|Overall Study|Adverse Event|2|||
23419551|NCT03172325|65280286|FG001|Overall Study|Adverse Event|3|||
23419552|NCT03172325|65280285|FG000|Overall Study|Positive PPD|1|||
23419553|NCT03172325|65280286|FG001|Overall Study|Positive PPD|0|||
23419554|NCT03172325|65280285|FG000|Overall Study|Poor Compliance|1|||
23419555|NCT03172325|65280286|FG001|Overall Study|Poor Compliance|1|||
23419556|NCT02557100|65280290|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
23419557|NCT02557100|65280291|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
23419558|NCT02557100|65280292|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
23419559|NCT02557100|65280290|FG000|Single Blind Treatment Period|Death|0|||
23419560|NCT02557100|65280291|FG001|Single Blind Treatment Period|Death|1|||
23419561|NCT02557100|65280292|FG002|Single Blind Treatment Period|Death|0|||
23419562|NCT02557100|65280290|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
23419563|NCT02557100|65280291|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
23419564|NCT02557100|65280292|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
23419565|NCT02557100|65280290|FG000|Single Blind Treatment Period|Adverse Event|0|||
23419566|NCT02557100|65280291|FG001|Single Blind Treatment Period|Adverse Event|1|||
23419567|NCT02557100|65280292|FG002|Single Blind Treatment Period|Adverse Event|0|||
23419568|NCT02557100|65280290|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
23419569|NCT02557100|65280291|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
23419570|NCT02557100|65280292|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
23419571|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Other Reasons|0|||
23419572|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Other Reasons|0|||
23419573|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Other Reasons|1|||
23419574|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
23419575|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
23419576|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
23419577|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
23419578|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
23419579|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
23419580|NCT00923975|65280295|FG000|Overall Study|Did not meet inclusion criteria|1|||
23419581|NCT03319953|65280296|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
23531043|NCT03364049|65680009|FG001|Overall Study|Death|4|||
23419582|NCT03319953|65280297|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23419583|NCT03319953|65280298|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23531044|NCT03364049|65680010|FG002|Overall Study|Death|5|||
23531045|NCT03364049|65680011|FG003|Overall Study|Death|14|||
23582175|NCT02223793|65862353|FG002|Overall Study|Withdrawal by Subject|3|||
23419584|NCT03319953|65280299|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23419585|NCT03319953|65280296|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
23419586|NCT03319953|65280297|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
23419587|NCT03319953|65280298|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
23419588|NCT03319953|65280299|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
23419589|NCT00519376|65280302|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419590|NCT00519376|65280303|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419591|NCT00519376|65280304|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419592|NCT00519376|65280305|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419593|NCT00519376|65280306|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419594|NCT00519376|65280307|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419595|NCT00519376|65280308|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419596|NCT00519376|65280309|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419597|NCT00519376|65280310|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419598|NCT00519376|65280311|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419599|NCT00519376|65280312|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419600|NCT00519376|65280313|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419601|NCT00519376|65280314|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
23419602|NCT00519376|65280315|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419603|NCT00519376|65280316|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419604|NCT00519376|65280317|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419605|NCT00519376|65280302|FG000|Treatment Period 4|Lost to Follow-up|0|||
23419606|NCT00519376|65280303|FG001|Treatment Period 4|Lost to Follow-up|0|||
23419607|NCT00519376|65280304|FG002|Treatment Period 4|Lost to Follow-up|1|||
23419608|NCT00519376|65280305|FG003|Treatment Period 4|Lost to Follow-up|0|||
23419609|NCT00519376|65280306|FG004|Treatment Period 4|Lost to Follow-up|0|||
23419610|NCT00519376|65280307|FG005|Treatment Period 4|Lost to Follow-up|0|||
23419611|NCT00519376|65280308|FG006|Treatment Period 4|Lost to Follow-up|0|||
23419612|NCT00519376|65280309|FG007|Treatment Period 4|Lost to Follow-up|0|||
23419613|NCT00519376|65280310|FG008|Treatment Period 4|Lost to Follow-up|0|||
23419614|NCT00519376|65280311|FG009|Treatment Period 4|Lost to Follow-up|0|||
23419615|NCT00519376|65280312|FG010|Treatment Period 4|Lost to Follow-up|0|||
23419616|NCT00519376|65280313|FG011|Treatment Period 4|Lost to Follow-up|0|||
23419617|NCT00519376|65280314|FG012|Treatment Period 4|Lost to Follow-up|0|||
23419618|NCT00519376|65280315|FG013|Treatment Period 4|Lost to Follow-up|0|||
23419619|NCT00519376|65280316|FG014|Treatment Period 4|Lost to Follow-up|0|||
23419620|NCT00519376|65280317|FG015|Treatment Period 4|Lost to Follow-up|0|||
23419621|NCT03315793|65280318|FG000|Overall Study|Adverse Event|4|||
23419622|NCT03315793|65280319|FG001|Overall Study|Adverse Event|2|||
23419623|NCT03315793|65280318|FG000|Overall Study|Protocol Deviation|1|||
23419624|NCT03315793|65280319|FG001|Overall Study|Protocol Deviation|0|||
23419625|NCT03315793|65280318|FG000|Overall Study|Difficult for regular visit|0|||
23419626|NCT03315793|65280319|FG001|Overall Study|Difficult for regular visit|1|||
23419627|NCT00064259|65280324|FG000|Overall Study|Adverse Event|1|||
23419628|NCT00064259|65280325|FG001|Overall Study|Adverse Event|0|||
23419629|NCT00064259|65280326|FG002|Overall Study|Adverse Event|0|||
23419630|NCT00064259|65280327|FG003|Overall Study|Adverse Event|1|||
23419631|NCT01118520|65280334|FG000|Overall Study|AAA repair|9|||
23419632|NCT01118520|65280335|FG001|Overall Study|AAA repair|7|||
23419633|NCT01118520|65280336|FG002|Overall Study|AAA repair|9|||
23419634|NCT01118520|65280334|FG000|Overall Study|Adverse Event|3|||
23419635|NCT01118520|65280335|FG001|Overall Study|Adverse Event|3|||
23419636|NCT01118520|65280336|FG002|Overall Study|Adverse Event|3|||
23419637|NCT01118520|65280334|FG000|Overall Study|Withdrawal by Subject|8|||
23419638|NCT01118520|65280335|FG001|Overall Study|Withdrawal by Subject|13|||
23419639|NCT01118520|65280336|FG002|Overall Study|Withdrawal by Subject|8|||
23419640|NCT00676520|65280339|FG000|Overall Study|Withdrawal by Subject|163|||
23419641|NCT00676520|65280339|FG000|Overall Study|Lost to Follow-up|162|||
23419642|NCT00676520|65280339|FG000|Overall Study|Death|159|||
23419643|NCT00676520|65280339|FG000|Overall Study|Physician Decision|20|||
23419644|NCT00676520|65280339|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
23419645|NCT00676520|65280339|FG000|Overall Study|Other Reason|18|||
23419646|NCT01566149|65280340|FG000|Overall Study|Adverse Event|0|||
23419647|NCT01566149|65280341|FG001|Overall Study|Adverse Event|1|||
23419648|NCT01566149|65280340|FG000|Overall Study|Non-compliance with study medication|2|||
23419649|NCT01566149|65280341|FG001|Overall Study|Non-compliance with study medication|0|||
23719569|NCT01828099|66348670|FG000|Overall Study|Protocol Violation|1|||
23814134|NCT02552212|66699598|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
23419650|NCT01566149|65280340|FG000|Overall Study|Protocol Violation|0|||
23419651|NCT01566149|65280341|FG001|Overall Study|Protocol Violation|1|||
23419652|NCT01566149|65280340|FG000|Overall Study|Withdrawal by Subject|1|||
23419653|NCT01566149|65280341|FG001|Overall Study|Withdrawal by Subject|0|||
23419654|NCT02099344|65280344|FG000|Overall Study|Physician Decision|1|||
23419655|NCT02099344|65280345|FG001|Overall Study|Physician Decision|0|||
23419656|NCT01159171|65280346|FG000|Overall Study|Adverse Event|11|||
23419657|NCT01159171|65280346|FG000|Overall Study|Progression of Disease|28|||
23419658|NCT01159171|65280346|FG000|Overall Study|Protocol Violation|1|||
23419659|NCT01159171|65280346|FG000|Overall Study|Need for Surgery|5|||
23419660|NCT01159171|65280346|FG000|Overall Study|Medical Decision|4|||
23419661|NCT01159171|65280346|FG000|Overall Study|Death|1|||
23419662|NCT01691885|65280349|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
23419663|NCT01691885|65280350|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
23419664|NCT01691885|65280349|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
23419665|NCT01691885|65280350|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
23419666|NCT01166373|65280353|FG000|Overall Study|Lost to Follow-up|3|||
23419667|NCT01166373|65280354|FG001|Overall Study|Lost to Follow-up|2|||
23419668|NCT01166373|65280355|FG002|Overall Study|Lost to Follow-up|2|||
23419669|NCT01166373|65280356|FG003|Overall Study|Lost to Follow-up|2|||
23419670|NCT01166373|65280353|FG000|Overall Study|Withdrawal by Subject|1|||
23419671|NCT01166373|65280354|FG001|Overall Study|Withdrawal by Subject|2|||
23419672|NCT01166373|65280355|FG002|Overall Study|Withdrawal by Subject|2|||
23419673|NCT01166373|65280356|FG003|Overall Study|Withdrawal by Subject|3|||
23419674|NCT01166373|65280353|FG000|Overall Study|Physician Decision|1|||
23419675|NCT01166373|65280354|FG001|Overall Study|Physician Decision|0|||
23419676|NCT01166373|65280355|FG002|Overall Study|Physician Decision|0|||
23419677|NCT01166373|65280356|FG003|Overall Study|Physician Decision|0|||
23419678|NCT00559845|65280357|FG000|Overall Study|Withdrew Consent|1|||
23419679|NCT00559845|65280357|FG000|Overall Study|Disease Progression|1|||
23419680|NCT00559845|65280357|FG000|Overall Study|Adverse Event|3|||
23419681|NCT00559845|65280357|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
23419682|NCT00559845|65280357|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
23419683|NCT04065074|65280358|FG000|Overall Study|Adverse Event|1|||
23419684|NCT04065074|65280358|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
23419685|NCT00090142|65280362|FG000|Treatment Period I|Lost to Follow-up|1|||
23419686|NCT00090142|65280363|FG001|Treatment Period I|Lost to Follow-up|2|||
23419687|NCT00090142|65280362|FG000|Treatment Period I|Protocol Violation|2|||
23419688|NCT00090142|65280363|FG001|Treatment Period I|Protocol Violation|0|||
23419689|NCT00090142|65280362|FG000|Treatment Period I|Withdrawal by Subject|2|||
23419690|NCT00090142|65280363|FG001|Treatment Period I|Withdrawal by Subject|0|||
23419691|NCT00090142|65280362|FG000|Treatment Period I|Other|0|||
23419692|NCT00090142|65280363|FG001|Treatment Period I|Other|1|||
23419693|NCT00090142|65280362|FG000|Treatment Period II|Other|1|||
23419694|NCT00090142|65280363|FG001|Treatment Period II|Other|0|||
23419695|NCT04600076|65280372|FG000|Overall Study|Lost to Follow-up|3|||
23419696|NCT00948857|65280373|FG000|Overall Study|Lost to Follow-up|1|||
23419697|NCT00948857|65280374|FG001|Overall Study|Lost to Follow-up|0|||
23419698|NCT00790647|65280376|FG000|Overall Study|Adverse Event|1|||
23419699|NCT03116828|65280377|FG000|Overall Study|Adverse Event|1|||
23419700|NCT03116828|65280378|FG001|Overall Study|Adverse Event|10|||
23419701|NCT03116828|65280377|FG000|Overall Study|Withdrawal by Subject|4|||
23419702|NCT03116828|65280378|FG001|Overall Study|Withdrawal by Subject|8|||
23419703|NCT03116828|65280377|FG000|Overall Study|OTHER|3|||
23419704|NCT03116828|65280378|FG001|Overall Study|OTHER|3|||
23419705|NCT01177553|65280381|FG000|Overall Study|babies not yet 6 months of age|1|||
23419706|NCT01177553|65280382|FG001|Overall Study|babies not yet 6 months of age|0|||
23419707|NCT01734395|65280383|FG000|Overall Study|Other|65|||
23419708|NCT01734395|65280383|FG000|Overall Study|Lost to Follow-up|287|||
23419709|NCT01734395|65280383|FG000|Overall Study|Lack of Efficacy|5|||
23419710|NCT01734395|65280383|FG000|Overall Study|Adverse Event|40|||
23419711|NCT01734395|65280383|FG000|Overall Study|Withdrawal by Subject|10|||
23419712|NCT01734395|65280383|FG000|Overall Study|Missing the reasons for not completed|3|||
23419713|NCT02247011|65280386|FG000|Overall Study|Poor quality of radiological results|125|||
23419714|NCT02509052|65280387|FG000|Overall Study|Non compliance|0|||
23419715|NCT02509052|65280388|FG001|Overall Study|Non compliance|0|||
23419716|NCT02509052|65280389|FG002|Overall Study|Non compliance|1|||
23419717|NCT02039219|65280390|FG000|Treatment|Withdrawal by Subject|1|||
23419718|NCT02039219|65280391|FG001|Treatment|Withdrawal by Subject|0|||
23419719|NCT02039219|65280390|FG000|Treatment|Adverse Event|0|||
23419720|NCT02039219|65280391|FG001|Treatment|Adverse Event|1|||
23419721|NCT02039219|65280390|FG000|Treatment|Physician Decision|1|||
23419722|NCT02039219|65280391|FG001|Treatment|Physician Decision|0|||
23419723|NCT02039219|65280390|FG000|Treatment|Lost to Follow-up|0|||
23613197|NCT02959866|65969812|FG000|Overall Study|Withdrawal by Subject|1|||
23419724|NCT02039219|65280391|FG001|Treatment|Lost to Follow-up|1|||
23419725|NCT02039219|65280390|FG000|Treatment|Protocol Violation|1|||
23419726|NCT02039219|65280391|FG001|Treatment|Protocol Violation|0|||
23419727|NCT02039219|65280390|FG000|Treatment|Death|1|||
23419728|NCT02039219|65280391|FG001|Treatment|Death|0|||
23419729|NCT02039219|65280390|FG000|Follow up|Adverse Event|0|||
23419730|NCT02039219|65280391|FG001|Follow up|Adverse Event|1|||
23419731|NCT00570037|65280392|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
23419732|NCT00570037|65280393|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
23419733|NCT00737711|65280394|FG000|Overall Study|Adverse Event|2|||
23419734|NCT00737711|65280394|FG000|Overall Study|Death|8|||
23419735|NCT00737711|65280394|FG000|Overall Study|Failure to return|4|||
23419736|NCT00737711|65280394|FG000|Overall Study|Protocol Violation|1|||
23419737|NCT00737711|65280394|FG000|Overall Study|Withdrawal by Subject|5|||
23419738|NCT00737711|65280394|FG000|Overall Study|Blood transfusion|6|||
23419739|NCT00737711|65280394|FG000|Overall Study|Other|5|||
23419740|NCT00404755|65280395|FG000|Phase I (Bupropion)|Adverse Event|3|||
23419741|NCT00404755|65280395|FG000|Phase I (Bupropion)|Other|1|||
23419742|NCT00404755|65280395|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
23419743|NCT03359785|65280399|FG000|Overall Study|Protocol Violation|0|||
23419744|NCT03359785|65280400|FG001|Overall Study|Protocol Violation|1|||
23419745|NCT03359785|65280401|FG002|Overall Study|Protocol Violation|0|||
23419746|NCT03359785|65280402|FG003|Overall Study|Protocol Violation|0|||
23419747|NCT03359785|65280399|FG000|Overall Study|Early study termination due to study pause|0|||
23419748|NCT03359785|65280400|FG001|Overall Study|Early study termination due to study pause|0|||
23419749|NCT03359785|65280401|FG002|Overall Study|Early study termination due to study pause|2|||
23419750|NCT03359785|65280402|FG003|Overall Study|Early study termination due to study pause|0|||
23419751|NCT03359785|65280399|FG000|Overall Study|Withdrawal by Subject|2|||
23419752|NCT03359785|65280400|FG001|Overall Study|Withdrawal by Subject|2|||
23419753|NCT03359785|65280401|FG002|Overall Study|Withdrawal by Subject|0|||
23419754|NCT03359785|65280402|FG003|Overall Study|Withdrawal by Subject|0|||
23814135|NCT02552212|66699599|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
23419755|NCT03555981|65280405|FG000|Overall Study|Lost to Follow-up|0|||
23419756|NCT03555981|65280406|FG001|Overall Study|Lost to Follow-up|2|||
23419757|NCT01626118|65280407|FG000|Overall Study|Lack of Efficacy|1|||
23419758|NCT01626118|65280408|FG001|Overall Study|Lack of Efficacy|0|||
23419759|NCT01626118|65280409|FG002|Overall Study|Lack of Efficacy|1|||
23419760|NCT01626118|65280410|FG003|Overall Study|Lack of Efficacy|3|||
23419761|NCT01626118|65280407|FG000|Overall Study|Lost to Follow-up|1|||
23419762|NCT01626118|65280408|FG001|Overall Study|Lost to Follow-up|0|||
23419763|NCT01626118|65280409|FG002|Overall Study|Lost to Follow-up|0|||
23419764|NCT01626118|65280410|FG003|Overall Study|Lost to Follow-up|0|||
23419765|NCT01626118|65280407|FG000|Overall Study|Adverse Event|0|||
23419766|NCT01626118|65280408|FG001|Overall Study|Adverse Event|1|||
23419767|NCT01626118|65280409|FG002|Overall Study|Adverse Event|1|||
23419768|NCT01626118|65280410|FG003|Overall Study|Adverse Event|0|||
23419769|NCT01626118|65280407|FG000|Overall Study|Investigator Decision|0|||
23419770|NCT01626118|65280408|FG001|Overall Study|Investigator Decision|1|||
23531046|NCT03364049|65680008|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23582176|NCT02223793|65862351|FG000|Overall Study|Moved/studycenter unable to participate|4|||
23814136|NCT02552212|66699600|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
23814137|NCT01147107|66703110|FG000|Overall Study|Lack of Efficacy|5|||
23814138|NCT01147107|66703111|FG001|Overall Study|Lack of Efficacy|0|||
23419771|NCT01626118|65280409|FG002|Overall Study|Investigator Decision|0|||
23419772|NCT01626118|65280410|FG003|Overall Study|Investigator Decision|0|||
23419773|NCT00394251|65280412|FG000|Overall Study|Adverse Event|7|||
23419774|NCT00394251|65280413|FG001|Overall Study|Adverse Event|5|||
23419775|NCT00394251|65280412|FG000|Overall Study|Unacceptable Toxicity|20|||
23419776|NCT00394251|65280413|FG001|Overall Study|Unacceptable Toxicity|18|||
23419777|NCT00394251|65280412|FG000|Overall Study|Physician Decision|1|||
23419778|NCT00394251|65280413|FG001|Overall Study|Physician Decision|1|||
23419779|NCT00394251|65280412|FG000|Overall Study|Protocol Violation|0|||
23419780|NCT00394251|65280413|FG001|Overall Study|Protocol Violation|1|||
23419781|NCT00394251|65280412|FG000|Overall Study|Withdrawal by Subject|7|||
23419782|NCT00394251|65280413|FG001|Overall Study|Withdrawal by Subject|11|||
23419783|NCT00394251|65280412|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
23419784|NCT00394251|65280413|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
23419785|NCT00283803|65280422|FG000|Overall Study|Physician Decision|9|||
23419786|NCT00283803|65280422|FG000|Overall Study|Withdrawal by Subject|4|||
23419787|NCT05260073|65280423|FG000|Overall Study|Physician Decision|1|||
23419788|NCT05260073|65280423|FG000|Overall Study|Withdrawal by Subject|6|||
23419789|NCT05260073|65280423|FG000|Overall Study|Lost to Follow-up|14|||
23419790|NCT03299881|65280428|FG000|Overall Study|Study Termination|17|||
23419791|NCT03299881|65280429|FG001|Overall Study|Study Termination|13|||
23419792|NCT01345591|65280430|FG000|Overall Study|Lost to Follow-up|1|||
23419793|NCT01921218|65280437|FG000|Overall Study|Death|2|||
23419794|NCT01921218|65280438|FG001|Overall Study|Death|1|||
23419795|NCT01921218|65280437|FG000|Overall Study|Withdrawal by Subject|0|||
23419796|NCT01921218|65280438|FG001|Overall Study|Withdrawal by Subject|2|||
23419797|NCT01921218|65280437|FG000|Overall Study|Kidney transplant|1|||
23419798|NCT01921218|65280438|FG001|Overall Study|Kidney transplant|1|||
23419799|NCT04173260|65280439|FG000|Overall Study|Early termination|4|||
23419800|NCT03596047|65280442|FG000|Overall Study|Withdrawal by Subject|7|||
23419801|NCT03596047|65280443|FG001|Overall Study|Withdrawal by Subject|4|||
23419802|NCT03596047|65280442|FG000|Overall Study|Lost to Follow-up|0|||
23419803|NCT03596047|65280443|FG001|Overall Study|Lost to Follow-up|2|||
23419804|NCT03389555|65280444|FG000|Overall Study|Protocol Violation|1|||
23419805|NCT03389555|65280445|FG001|Overall Study|Protocol Violation|3|||
23419806|NCT03389555|65280444|FG000|Overall Study|Death|1|||
23419807|NCT03389555|65280445|FG001|Overall Study|Death|0|||
23531047|NCT03364049|65680009|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
23531048|NCT03364049|65680010|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23531049|NCT03364049|65680011|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23531050|NCT03364049|65680008|FG000|Overall Study|Withdrawal by Subject|0|||
23531051|NCT03364049|65680009|FG001|Overall Study|Withdrawal by Subject|1|||
23531052|NCT03364049|65680010|FG002|Overall Study|Withdrawal by Subject|1|||
23531053|NCT03364049|65680011|FG003|Overall Study|Withdrawal by Subject|1|||
23531054|NCT00813124|65680012|FG000|Overall Study|Death|2|||
23531055|NCT00813124|65680012|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
23531056|NCT00813124|65680012|FG000|Overall Study|Withdrawal by Subject|1|||
23531057|NCT00414661|65680017|FG000|Overall Study|Death|2|||
23531058|NCT00414661|65680018|FG001|Overall Study|Death|5|||
23531059|NCT00414661|65680019|FG002|Overall Study|Death|0|||
23531060|NCT00414661|65680020|FG003|Overall Study|Death|0|||
23531061|NCT00414661|65680017|FG000|Overall Study|Lost to Follow-up|1|||
23531062|NCT00414661|65680018|FG001|Overall Study|Lost to Follow-up|4|||
23531063|NCT00414661|65680019|FG002|Overall Study|Lost to Follow-up|0|||
23531064|NCT00414661|65680020|FG003|Overall Study|Lost to Follow-up|1|||
23531065|NCT00414661|65680017|FG000|Overall Study|Withdrawal by Subject|5|||
23531066|NCT00414661|65680018|FG001|Overall Study|Withdrawal by Subject|2|||
23531067|NCT00414661|65680019|FG002|Overall Study|Withdrawal by Subject|2|||
23531068|NCT00414661|65680020|FG003|Overall Study|Withdrawal by Subject|2|||
23531069|NCT00414661|65680017|FG000|Overall Study|Other|6|||
23531070|NCT00414661|65680018|FG001|Overall Study|Other|3|||
23531071|NCT00414661|65680019|FG002|Overall Study|Other|0|||
23531072|NCT00414661|65680020|FG003|Overall Study|Other|0|||
23531073|NCT00482391|65680021|FG000|Overall Study|Withdrawal by Subject|1|||
23531074|NCT00482391|65680021|FG000|Overall Study|Adverse Event|1|||
23531075|NCT00482391|65680021|FG000|Overall Study|Death|1|||
23531076|NCT00700011|65680022|FG000|Overall Study|Death|0|||
23531077|NCT00700011|65680023|FG001|Overall Study|Death|1|||
23531078|NCT05009251|65680026|FG000|Overall Study|Protocol Violation|100|||
23531079|NCT05009251|65680027|FG001|Overall Study|Protocol Violation|105|||
23531080|NCT05009251|65680028|FG002|Overall Study|Protocol Violation|119|||
23531081|NCT05009251|65680029|FG003|Overall Study|Protocol Violation|120|||
23531082|NCT05009251|65680030|FG004|Overall Study|Protocol Violation|119|||
23531083|NCT05009251|65680026|FG000|Overall Study|Death|25|||
23531084|NCT05009251|65680027|FG001|Overall Study|Death|22|||
23531085|NCT05009251|65680028|FG002|Overall Study|Death|24|||
23531086|NCT05009251|65680029|FG003|Overall Study|Death|19|||
23531087|NCT05009251|65680030|FG004|Overall Study|Death|15|||
23531088|NCT03354429|65680048|FG000|Overall Study|Withdrawal by Subject|8|||
23531089|NCT03354429|65680049|FG001|Overall Study|Withdrawal by Subject|7|||
23531090|NCT03354429|65680048|FG000|Overall Study|Lost to Follow-up|1|||
23531091|NCT03354429|65680049|FG001|Overall Study|Lost to Follow-up|0|||
23531092|NCT02579616|65680050|FG000|Overall Study|Participants did not receive treatment|3|||
23531093|NCT00499603|65680053|FG000|Overall Study|Adverse Event|0|||
23719570|NCT01828099|66348671|FG001|Overall Study|Protocol Violation|0|||
23719571|NCT01828099|66348670|FG000|Overall Study|Subject/guardian decision|7|||
23719572|NCT01828099|66348671|FG001|Overall Study|Subject/guardian decision|23|||
23719573|NCT03034057|66348672|FG000|Overall Study|Withdrawal by Subject|10|||
23719574|NCT03034057|66348672|FG000|Overall Study|Protocol Violation|1|||
23719575|NCT03034057|66348672|FG000|Overall Study|Not defined|2|||
23719576|NCT03034057|66348672|FG000|Overall Study|Lost to Follow-up|19|||
23719577|NCT03034057|66348672|FG000|Overall Study|Adverse Event|22|||
23719578|NCT03034057|66348672|FG000|Overall Study|Medication error without associated AE|1|||
23719579|NCT01993615|66348673|FG000|Overall Study|Death|1|||
23719580|NCT01993615|66348674|FG001|Overall Study|Death|0|||
23719581|NCT00425113|66348675|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
23719582|NCT00425113|66348676|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
23613198|NCT01655498|65969813|FG000|Overall Study|Unrelated health issue|2|||
23613199|NCT01655498|65969813|FG000|Overall Study|Protocol Violation|2|||
23719583|NCT00425113|66348675|FG000|Overall Study|diagnosis of abdominal TB|0|||
23531094|NCT00499603|65680054|FG001|Overall Study|Adverse Event|1|||
23531095|NCT01786629|65680055|FG000|Overall Study|Lack of Efficacy|0|||
23613200|NCT01655498|65969813|FG000|Overall Study|Withdrawal by Subject|1|||
23613201|NCT00839306|65969821|FG000|Overall Study|Adverse Event|3|||
23719584|NCT00425113|66348676|FG001|Overall Study|diagnosis of abdominal TB|1|||
23719585|NCT00425113|66348675|FG000|Overall Study|missing study drug more than 14 days|0|||
23531096|NCT01786629|65680056|FG001|Overall Study|Lack of Efficacy|4|||
23531097|NCT01786629|65680055|FG000|Overall Study|Adverse Event|0|||
23531098|NCT01786629|65680056|FG001|Overall Study|Adverse Event|1|||
23531099|NCT00451282|65680057|FG000|Overall Study|Lost to Follow-up|6|||
23531100|NCT00451282|65680058|FG001|Overall Study|Lost to Follow-up|5|||
23531101|NCT00952341|65680059|FG000|Cycle 1|Adverse Event|4|||
23531102|NCT00952341|65680060|FG001|Cycle 1|Adverse Event|1|||
23531103|NCT00952341|65680059|FG000|Cycle 1|Withdrawal by Subject|3|||
23613202|NCT00839306|65969822|FG001|Overall Study|Adverse Event|5|||
23613203|NCT00839306|65969821|FG000|Overall Study|Lost to Follow-up|6|||
23613204|NCT00839306|65969822|FG001|Overall Study|Lost to Follow-up|9|||
23613205|NCT00839306|65969821|FG000|Overall Study|Withdrawal by Subject|5|||
23613206|NCT00839306|65969822|FG001|Overall Study|Withdrawal by Subject|7|||
23613207|NCT00839306|65969821|FG000|Overall Study|Lack of Efficacy|5|||
23613208|NCT00839306|65969822|FG001|Overall Study|Lack of Efficacy|4|||
23613209|NCT00839306|65969821|FG000|Overall Study|Other|6|||
23613210|NCT00839306|65969822|FG001|Overall Study|Other|18|||
23613211|NCT01636258|65969823|FG000|Overall Study|Lost to Follow-up|1|||
23531104|NCT00952341|65680060|FG001|Cycle 1|Withdrawal by Subject|8|||
23531105|NCT00952341|65680059|FG000|Cycle 1|Protocol Violation|2|||
23531106|NCT00952341|65680060|FG001|Cycle 1|Protocol Violation|1|||
23531107|NCT00952341|65680059|FG000|Cycle 1|Lost to Follow-up|11|||
23531108|NCT00952341|65680060|FG001|Cycle 1|Lost to Follow-up|2|||
23531109|NCT00952341|65680059|FG000|Cycle 1|Physician Decision|0|||
23531110|NCT00952341|65680060|FG001|Cycle 1|Physician Decision|1|||
23531111|NCT00952341|65680059|FG000|Cycle 2|Withdrawal by Subject|1|||
23531112|NCT00952341|65680060|FG001|Cycle 2|Withdrawal by Subject|1|||
23531113|NCT00952341|65680059|FG000|Cycle 2|Protocol Violation|1|||
23531114|NCT00952341|65680060|FG001|Cycle 2|Protocol Violation|0|||
23531115|NCT00952341|65680059|FG000|Cycle 2|Lost to Follow-up|6|||
23531116|NCT00952341|65680060|FG001|Cycle 2|Lost to Follow-up|9|||
23531117|NCT00952341|65680059|FG000|Cycle 2|Physician Decision|1|||
23531118|NCT00952341|65680060|FG001|Cycle 2|Physician Decision|1|||
23531119|NCT00952341|65680059|FG000|Cycle 2|Progressive Disease|0|||
23531120|NCT00952341|65680060|FG001|Cycle 2|Progressive Disease|1|||
23531121|NCT04055116|65680061|FG000|First Intervention|Physician Decision|2|||
23613212|NCT01636258|65969824|FG001|Overall Study|Lost to Follow-up|0|||
23613213|NCT01786551|65969825|FG000|Overall Study|Participant withdrew consent|2|||
23613214|NCT05072795|65969826|FG000|Overall Study|Lost to Follow-up|5|||
23613215|NCT01350102|65969827|FG000|Overall Study|Adverse Event|0|||
23613216|NCT01350102|65969828|FG001|Overall Study|Adverse Event|0|||
23613217|NCT01350102|65969829|FG002|Overall Study|Adverse Event|1|||
23613218|NCT01350102|65969830|FG003|Overall Study|Adverse Event|0|||
23613219|NCT03386344|65969831|FG000|Overall Study|Adverse Event|6|||
23613220|NCT03386344|65969832|FG001|Overall Study|Adverse Event|3|||
23613221|NCT03386344|65969833|FG002|Overall Study|Adverse Event|1|||
23613222|NCT03386344|65969831|FG000|Overall Study|Poor Compliance to Protocol|0|||
23613223|NCT03386344|65969832|FG001|Overall Study|Poor Compliance to Protocol|1|||
23613224|NCT03386344|65969833|FG002|Overall Study|Poor Compliance to Protocol|0|||
23613225|NCT03386344|65969831|FG000|Overall Study|Study Terminated by Sponsor|101|||
23613226|NCT03386344|65969832|FG001|Overall Study|Study Terminated by Sponsor|102|||
23613227|NCT03386344|65969833|FG002|Overall Study|Study Terminated by Sponsor|106|||
23613228|NCT03386344|65969831|FG000|Overall Study|Lost to Follow-up|3|||
23613229|NCT03386344|65969832|FG001|Overall Study|Lost to Follow-up|2|||
23613230|NCT03386344|65969833|FG002|Overall Study|Lost to Follow-up|1|||
23613231|NCT03386344|65969831|FG000|Overall Study|At the Participant's own Request|7|||
23613232|NCT03386344|65969832|FG001|Overall Study|At the Participant's own Request|7|||
23613233|NCT03386344|65969833|FG002|Overall Study|At the Participant's own Request|8|||
23613234|NCT03386344|65969831|FG000|Overall Study|Reason not Specified|0|||
23613235|NCT03386344|65969832|FG001|Overall Study|Reason not Specified|1|||
23613236|NCT03386344|65969833|FG002|Overall Study|Reason not Specified|0|||
23613237|NCT04361617|65969834|FG000|Overall Study|Withdrawal by Subject|0|||
23613238|NCT04361617|65969835|FG001|Overall Study|Withdrawal by Subject|1|||
23613239|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
23419808|NCT03245736|65280446|FG000|Overall Study|Adverse Event|1|||
23419809|NCT03245736|65280446|FG000|Overall Study|Progressive Disease|4|||
23419810|NCT02685748|65280447|FG000|Overall Study|Withdrawal by Subject|3|||
23419811|NCT02685748|65280448|FG001|Overall Study|Withdrawal by Subject|2|||
23419812|NCT00252694|65280449|FG000|Overall Study|Withdrawal by Subject|83|||
23419813|NCT00252694|65280450|FG001|Overall Study|Withdrawal by Subject|91|||
23419814|NCT00252694|65280449|FG000|Overall Study|Death|36|||
23419815|NCT00252694|65280450|FG001|Overall Study|Death|34|||
23419816|NCT00252694|65280449|FG000|Overall Study|Mostly Lost to Follow Up|8|||
23419817|NCT00252694|65280450|FG001|Overall Study|Mostly Lost to Follow Up|13|||
23419818|NCT00252694|65280449|FG000|Overall Study|Patient Moving|17|||
23419819|NCT00252694|65280450|FG001|Overall Study|Patient Moving|16|||
23531122|NCT04055116|65680062|FG001|First Intervention|Physician Decision|7|||
23531123|NCT02953821|65680063|FG000|Overall Study|Adverse Event|0|||
23531124|NCT02953821|65680064|FG001|Overall Study|Adverse Event|4|||
23531125|NCT02953821|65680063|FG000|Overall Study|Death|1|||
23613240|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
23613241|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
23613242|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
23613243|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
23613244|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
23531126|NCT02953821|65680064|FG001|Overall Study|Death|0|||
23531127|NCT02953821|65680063|FG000|Overall Study|Progressive Disease|5|||
23613245|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
23613246|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Death|0|||
23613247|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Death|1|||
23613248|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Death|0|||
23613249|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Death|0|||
23613250|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Death|0|||
23613251|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Death|0|||
23613252|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Death|0|||
23613253|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
23613254|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613255|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613256|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613257|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613258|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613259|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613260|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613261|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
23613262|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613263|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613264|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613265|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613266|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613267|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Other|1|||
23613268|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Other|0|||
23613269|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Other|0|||
23814139|NCT01147107|66703110|FG000|Overall Study|Withdrawal by Subject|1|||
23814140|NCT01147107|66703111|FG001|Overall Study|Withdrawal by Subject|1|||
23531128|NCT02953821|65680064|FG001|Overall Study|Progressive Disease|1|||
23531129|NCT02953821|65680063|FG000|Overall Study|Lost to Follow-up|2|||
23531130|NCT02953821|65680064|FG001|Overall Study|Lost to Follow-up|0|||
23531131|NCT02953821|65680063|FG000|Overall Study|Physician Decision|1|||
23531132|NCT02953821|65680064|FG001|Overall Study|Physician Decision|1|||
23531133|NCT02953821|65680063|FG000|Overall Study|Withdrawal by Subject|3|||
23531134|NCT02953821|65680064|FG001|Overall Study|Withdrawal by Subject|3|||
23531135|NCT02953821|65680063|FG000|Overall Study|Change of address|0|||
23531136|NCT02953821|65680064|FG001|Overall Study|Change of address|1|||
23531137|NCT02953821|65680063|FG000|Overall Study|Lack of Efficacy|1|||
23531138|NCT02953821|65680064|FG001|Overall Study|Lack of Efficacy|0|||
23531139|NCT02953821|65680063|FG000|Overall Study|Out of state for indeterminate time|0|||
23531140|NCT02953821|65680064|FG001|Overall Study|Out of state for indeterminate time|1|||
23531141|NCT02953821|65680063|FG000|Overall Study|No improvement|0|||
23531142|NCT02953821|65680064|FG001|Overall Study|No improvement|1|||
23531143|NCT02953821|65680063|FG000|Overall Study|Refused follow-up visit|2|||
23531144|NCT02953821|65680064|FG001|Overall Study|Refused follow-up visit|1|||
23531145|NCT03795922|65680069|FG000|Overall Study|Adverse Event|2|||
23531146|NCT03795922|65680070|FG001|Overall Study|Adverse Event|1|||
23531147|NCT03795922|65680069|FG000|Overall Study|Withdrawal by Subject|5|||
23531148|NCT03795922|65680070|FG001|Overall Study|Withdrawal by Subject|13|||
23613270|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Other|0|||
23613271|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Other|0|||
23814141|NCT02952898|66703112|FG000|Overall Study|Withdrawal by Subject|10|||
23814142|NCT02952898|66703113|FG001|Overall Study|Withdrawal by Subject|8|||
23814143|NCT02952898|66703114|FG002|Overall Study|Withdrawal by Subject|8|||
23531149|NCT03795922|65680069|FG000|Overall Study|Lost to Follow-up|2|||
23814144|NCT02952898|66703112|FG000|Overall Study|Adverse Event|8|||
23814145|NCT02952898|66703113|FG001|Overall Study|Adverse Event|8|||
23814146|NCT02952898|66703114|FG002|Overall Study|Adverse Event|3|||
23814147|NCT02952898|66703112|FG000|Overall Study|Lost to Follow-up|3|||
23814148|NCT02952898|66703113|FG001|Overall Study|Lost to Follow-up|2|||
23814149|NCT02952898|66703114|FG002|Overall Study|Lost to Follow-up|2|||
23719586|NCT00425113|66348676|FG001|Overall Study|missing study drug more than 14 days|1|||
23719587|NCT00425113|66348675|FG000|Overall Study|Withdrawal by Subject|1|||
23719588|NCT00425113|66348676|FG001|Overall Study|Withdrawal by Subject|0|||
23719589|NCT01188538|66348677|FG000|Overall Study|Lost to Follow-up|0|||
23719590|NCT01188538|66348678|FG001|Overall Study|Lost to Follow-up|1|||
23719591|NCT01270958|66348679|FG000|Overall Study|Lost to Follow-up|2|||
23613272|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Other|0|||
23613273|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Other|0|||
23613274|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
23613275|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
23719592|NCT01270958|66348679|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
23531150|NCT03795922|65680070|FG001|Overall Study|Lost to Follow-up|3|||
23531151|NCT03795922|65680069|FG000|Overall Study|Pregnancy|0|||
23531152|NCT03795922|65680070|FG001|Overall Study|Pregnancy|1|||
23719593|NCT01181102|66348680|FG000|Overall Study|Adverse Event|28|||
23719594|NCT01181102|66348681|FG001|Overall Study|Adverse Event|26|||
23719595|NCT01181102|66348680|FG000|Overall Study|Lack of Efficacy|3|||
23719596|NCT01181102|66348681|FG001|Overall Study|Lack of Efficacy|1|||
23719597|NCT01181102|66348680|FG000|Overall Study|Lost to Follow-up|2|||
23719598|NCT01181102|66348681|FG001|Overall Study|Lost to Follow-up|0|||
23719599|NCT01181102|66348680|FG000|Overall Study|Physician Decision|3|||
23719600|NCT01181102|66348681|FG001|Overall Study|Physician Decision|1|||
23719601|NCT01181102|66348680|FG000|Overall Study|Protocol Violation|5|||
23719602|NCT01181102|66348681|FG001|Overall Study|Protocol Violation|6|||
23531153|NCT03795922|65680069|FG000|Overall Study|Physician Decision|1|||
23719603|NCT01181102|66348680|FG000|Overall Study|Withdrawal by Subject|10|||
23531154|NCT03795922|65680070|FG001|Overall Study|Physician Decision|2|||
23719604|NCT01181102|66348681|FG001|Overall Study|Withdrawal by Subject|12|||
23814150|NCT02952898|66703112|FG000|Overall Study|Non-compliance with study drug|1|||
23719605|NCT02394795|66348682|FG000|Overall Study|Adverse Event|92|||
23719606|NCT02394795|66348683|FG001|Overall Study|Adverse Event|70|||
23719607|NCT02394795|66348682|FG000|Overall Study|Lost to Follow-up|0|||
23719608|NCT02394795|66348683|FG001|Overall Study|Lost to Follow-up|1|||
23719609|NCT02394795|66348682|FG000|Overall Study|Withdrawal by Subject|17|||
23719610|NCT02394795|66348683|FG001|Overall Study|Withdrawal by Subject|26|||
23719611|NCT02394795|66348682|FG000|Overall Study|Lack of Efficacy|181|||
23719612|NCT02394795|66348683|FG001|Overall Study|Lack of Efficacy|211|||
23719613|NCT02394795|66348682|FG000|Overall Study|Death|4|||
23719614|NCT02394795|66348683|FG001|Overall Study|Death|5|||
23719615|NCT02394795|66348682|FG000|Overall Study|Physician Decision|109|||
23719616|NCT02394795|66348683|FG001|Overall Study|Physician Decision|93|||
23719617|NCT03654755|66348684|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
23719618|NCT03654755|66348685|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
23719619|NCT03654755|66348686|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
23719620|NCT03654755|66348684|FG000|Overall Study|Withdrawal by Subject|2|||
23719621|NCT03654755|66348685|FG001|Overall Study|Withdrawal by Subject|4|||
23719622|NCT03654755|66348686|FG002|Overall Study|Withdrawal by Subject|8|||
23719623|NCT03654755|66348684|FG000|Overall Study|Lost to Follow-up|1|||
23719624|NCT03654755|66348685|FG001|Overall Study|Lost to Follow-up|3|||
23719625|NCT03654755|66348686|FG002|Overall Study|Lost to Follow-up|7|||
23719626|NCT03654755|66348684|FG000|Overall Study|Physician Decision|0|||
23719627|NCT03654755|66348685|FG001|Overall Study|Physician Decision|1|||
23719628|NCT03654755|66348686|FG002|Overall Study|Physician Decision|0|||
23719629|NCT03654755|66348684|FG000|Overall Study|Adverse Event|0|||
23719630|NCT03654755|66348685|FG001|Overall Study|Adverse Event|0|||
23719631|NCT03654755|66348686|FG002|Overall Study|Adverse Event|4|||
23719632|NCT03654755|66348684|FG000|Overall Study|Lack of Efficacy|0|||
23719633|NCT03654755|66348685|FG001|Overall Study|Lack of Efficacy|0|||
23719634|NCT03654755|66348686|FG002|Overall Study|Lack of Efficacy|1|||
23719635|NCT02528253|66348687|FG000|Overall Study|Adverse Event|3|||
23719636|NCT02528253|66348688|FG001|Overall Study|Adverse Event|4|||
23719637|NCT02528253|66348689|FG002|Overall Study|Adverse Event|4|||
23719638|NCT02528253|66348690|FG003|Overall Study|Adverse Event|8|||
23719639|NCT02528253|66348691|FG004|Overall Study|Adverse Event|18|||
23719640|NCT02528253|66348687|FG000|Overall Study|Death|2|||
23719641|NCT02528253|66348688|FG001|Overall Study|Death|2|||
23719642|NCT02528253|66348689|FG002|Overall Study|Death|1|||
23719643|NCT02528253|66348690|FG003|Overall Study|Death|0|||
23719644|NCT02528253|66348691|FG004|Overall Study|Death|1|||
23719645|NCT02528253|66348687|FG000|Overall Study|Insufficient clinical response|7|||
23719646|NCT02528253|66348688|FG001|Overall Study|Insufficient clinical response|10|||
23719647|NCT02528253|66348689|FG002|Overall Study|Insufficient clinical response|13|||
23719648|NCT02528253|66348690|FG003|Overall Study|Insufficient clinical response|12|||
23719649|NCT02528253|66348691|FG004|Overall Study|Insufficient clinical response|16|||
23719650|NCT02528253|66348687|FG000|Overall Study|Lost to Follow-up|16|||
23719651|NCT02528253|66348688|FG001|Overall Study|Lost to Follow-up|9|||
23719652|NCT02528253|66348689|FG002|Overall Study|Lost to Follow-up|31|||
23719653|NCT02528253|66348690|FG003|Overall Study|Lost to Follow-up|16|||
23719654|NCT02528253|66348691|FG004|Overall Study|Lost to Follow-up|34|||
23719655|NCT02528253|66348687|FG000|Overall Study|Other|21|||
23719656|NCT02528253|66348688|FG001|Overall Study|Other|22|||
23719657|NCT02528253|66348689|FG002|Overall Study|Other|58|||
23719658|NCT02528253|66348690|FG003|Overall Study|Other|52|||
23719659|NCT02528253|66348691|FG004|Overall Study|Other|76|||
23719660|NCT02528253|66348687|FG000|Overall Study|Withdrawal by Subject|25|||
23719661|NCT02528253|66348688|FG001|Overall Study|Withdrawal by Subject|20|||
23719662|NCT02528253|66348689|FG002|Overall Study|Withdrawal by Subject|29|||
23719663|NCT02528253|66348690|FG003|Overall Study|Withdrawal by Subject|48|||
23719664|NCT02528253|66348691|FG004|Overall Study|Withdrawal by Subject|73|||
23719665|NCT02528253|66348687|FG000|Overall Study|Protocol Violation|1|||
23719666|NCT02528253|66348688|FG001|Overall Study|Protocol Violation|2|||
23719667|NCT02528253|66348689|FG002|Overall Study|Protocol Violation|4|||
23719668|NCT02528253|66348690|FG003|Overall Study|Protocol Violation|0|||
23719669|NCT02528253|66348691|FG004|Overall Study|Protocol Violation|4|||
23719670|NCT02528253|66348687|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
23814151|NCT02952898|66703113|FG001|Overall Study|Non-compliance with study drug|1|||
23719671|NCT02528253|66348688|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
23719672|NCT02528253|66348689|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
23719673|NCT02528253|66348690|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
23719674|NCT02528253|66348691|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
23719675|NCT01135017|66348692|FG000|Overall Study|Adverse Event|3|||
23719676|NCT01135017|66348693|FG001|Overall Study|Adverse Event|8|||
23719677|NCT01135017|66348692|FG000|Overall Study|Other than above|3|||
23814152|NCT02952898|66703114|FG002|Overall Study|Non-compliance with study drug|2|||
23719678|NCT01135017|66348693|FG001|Overall Study|Other than above|4|||
23719679|NCT03750240|66348696|FG000|Overall Study|Technical Difficulties|2|||
23719680|NCT02727660|66348699|FG000|Overall Study|Lack of Efficacy|40|||
23719681|NCT02727660|66348700|FG001|Overall Study|Lack of Efficacy|40|||
23719682|NCT02727660|66348701|FG002|Overall Study|Lack of Efficacy|70|||
23719683|NCT02727660|66348699|FG000|Overall Study|Adverse Event|28|||
23719684|NCT02727660|66348700|FG001|Overall Study|Adverse Event|21|||
23719685|NCT02727660|66348701|FG002|Overall Study|Adverse Event|32|||
23719686|NCT02727660|66348699|FG000|Overall Study|Withdrawal by Subject|26|||
23719687|NCT02727660|66348700|FG001|Overall Study|Withdrawal by Subject|25|||
23719688|NCT02727660|66348701|FG002|Overall Study|Withdrawal by Subject|30|||
23719689|NCT02727660|66348699|FG000|Overall Study|Physician Decision|3|||
23719690|NCT02727660|66348700|FG001|Overall Study|Physician Decision|8|||
23719691|NCT02727660|66348701|FG002|Overall Study|Physician Decision|14|||
23719692|NCT02727660|66348699|FG000|Overall Study|Lost to Follow-up|5|||
23719693|NCT02727660|66348700|FG001|Overall Study|Lost to Follow-up|9|||
23419820|NCT01751906|65280451|FG000|Overall Study|Lost to Follow-up|151|||
23419821|NCT01751906|65280452|FG001|Overall Study|Lost to Follow-up|68|||
23419822|NCT01751906|65280451|FG000|Overall Study|Withdrawal by Subject|22|||
23419823|NCT01751906|65280452|FG001|Overall Study|Withdrawal by Subject|18|||
23419824|NCT01751906|65280451|FG000|Overall Study|Physician Decision|5|||
23419825|NCT01751906|65280452|FG001|Overall Study|Physician Decision|2|||
23419826|NCT01751906|65280451|FG000|Overall Study|Death|84|||
23419827|NCT01751906|65280452|FG001|Overall Study|Death|43|||
23419828|NCT01751906|65280451|FG000|Overall Study|Denied on premises for follow-up by law|1|||
23419829|NCT01751906|65280452|FG001|Overall Study|Denied on premises for follow-up by law|0|||
23419830|NCT01892436|65280453|FG000|Overall Study|Withdrawal by Subject|8|||
23419831|NCT01892436|65280454|FG001|Overall Study|Withdrawal by Subject|15|||
23419832|NCT01892436|65280455|FG002|Overall Study|Withdrawal by Subject|4|||
23419833|NCT01892436|65280456|FG003|Overall Study|Withdrawal by Subject|4|||
23419834|NCT01892436|65280453|FG000|Overall Study|Death|1|||
23419835|NCT01892436|65280454|FG001|Overall Study|Death|1|||
23419836|NCT01892436|65280455|FG002|Overall Study|Death|0|||
23419837|NCT01892436|65280456|FG003|Overall Study|Death|0|||
23419838|NCT01892436|65280453|FG000|Overall Study|Physician Decision|2|||
23419839|NCT01892436|65280454|FG001|Overall Study|Physician Decision|1|||
23419840|NCT01892436|65280455|FG002|Overall Study|Physician Decision|0|||
23419841|NCT01892436|65280456|FG003|Overall Study|Physician Decision|1|||
23419842|NCT01892436|65280453|FG000|Overall Study|Pregnancy|0|||
23419843|NCT01892436|65280454|FG001|Overall Study|Pregnancy|2|||
23419844|NCT01892436|65280455|FG002|Overall Study|Pregnancy|1|||
23419845|NCT01892436|65280456|FG003|Overall Study|Pregnancy|0|||
23419846|NCT01892436|65280453|FG000|Overall Study|Technical problems|2|||
23419847|NCT01892436|65280454|FG001|Overall Study|Technical problems|1|||
23419848|NCT01892436|65280455|FG002|Overall Study|Technical problems|1|||
23419849|NCT01892436|65280456|FG003|Overall Study|Technical problems|1|||
23419850|NCT01892436|65280453|FG000|Overall Study|Lack of Efficacy|1|||
23419851|NCT01892436|65280454|FG001|Overall Study|Lack of Efficacy|2|||
23419852|NCT01892436|65280455|FG002|Overall Study|Lack of Efficacy|2|||
23419853|NCT01892436|65280456|FG003|Overall Study|Lack of Efficacy|2|||
23419854|NCT01892436|65280453|FG000|Overall Study|Lost to Follow-up|1|||
23419855|NCT01892436|65280454|FG001|Overall Study|Lost to Follow-up|1|||
23419856|NCT01892436|65280455|FG002|Overall Study|Lost to Follow-up|1|||
23419857|NCT01892436|65280456|FG003|Overall Study|Lost to Follow-up|3|||
23419858|NCT01892436|65280453|FG000|Overall Study|non-compliance with treatment|1|||
23419859|NCT01892436|65280454|FG001|Overall Study|non-compliance with treatment|0|||
23419860|NCT01892436|65280455|FG002|Overall Study|non-compliance with treatment|0|||
23419861|NCT01892436|65280456|FG003|Overall Study|non-compliance with treatment|0|||
23419862|NCT01892436|65280453|FG000|Overall Study|Adverse Event|7|||
23419863|NCT01892436|65280454|FG001|Overall Study|Adverse Event|6|||
23419864|NCT01892436|65280455|FG002|Overall Study|Adverse Event|2|||
23419865|NCT01892436|65280456|FG003|Overall Study|Adverse Event|3|||
23419866|NCT01330628|65280457|FG000|Overall Study|Death|2|||
23419867|NCT01330628|65280458|FG001|Overall Study|Death|3|||
23419868|NCT01330628|65280457|FG000|Overall Study|Lost to Follow-up|5|||
23419869|NCT01330628|65280458|FG001|Overall Study|Lost to Follow-up|6|||
23719694|NCT02727660|66348701|FG002|Overall Study|Lost to Follow-up|8|||
23719695|NCT02727660|66348699|FG000|Overall Study|Protocol Violation|7|||
23419870|NCT01330628|65280457|FG000|Overall Study|Adverse Event|44|||
23419871|NCT01330628|65280458|FG001|Overall Study|Adverse Event|25|||
23719696|NCT02727660|66348700|FG001|Overall Study|Protocol Violation|5|||
23419872|NCT01330628|65280457|FG000|Overall Study|Withdrawn|18|||
23419873|NCT01330628|65280458|FG001|Overall Study|Withdrawn|6|||
23419874|NCT01330628|65280457|FG000|Overall Study|Didn't receive study treatment|1|||
23419875|NCT01330628|65280458|FG001|Overall Study|Didn't receive study treatment|0|||
23719697|NCT02727660|66348701|FG002|Overall Study|Protocol Violation|5|||
23419876|NCT03362502|65280459|FG000|Overall Study|Death|0|||
23419877|NCT03362502|65280460|FG001|Overall Study|Death|0|||
23419878|NCT03362502|65280461|FG002|Overall Study|Death|1|||
23419879|NCT04649359|65280462|FG000|Overall Study|Withdrawal by Subject|7|||
23419880|NCT04649359|65280463|FG001|Overall Study|Withdrawal by Subject|7|||
23419881|NCT04649359|65280462|FG000|Overall Study|Death|41|||
23814153|NCT04713553|66703117|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
23419882|NCT04649359|65280463|FG001|Overall Study|Death|26|||
23719698|NCT02727660|66348699|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
23719699|NCT02727660|66348700|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
23719700|NCT02727660|66348701|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
23719701|NCT02727660|66348699|FG000|Overall Study|Administrative Reasons|2|||
23719702|NCT02727660|66348700|FG001|Overall Study|Administrative Reasons|3|||
23719703|NCT02727660|66348701|FG002|Overall Study|Administrative Reasons|4|||
23719704|NCT00004732|66348702|FG000|Overall Study|Withdrawal by Subject|36|||
23719705|NCT00004732|66348703|FG001|Overall Study|Withdrawal by Subject|64|||
23719706|NCT00004732|66348702|FG000|Overall Study|Lost to Follow-up|33|||
23719707|NCT00004732|66348703|FG001|Overall Study|Lost to Follow-up|47|||
23719708|NCT01369849|66348704|FG000|Overall Study|Ineligible prior to treatment|0|||
23719709|NCT01369849|66348705|FG001|Overall Study|Ineligible prior to treatment|0|||
23719710|NCT01369849|66348706|FG002|Overall Study|Ineligible prior to treatment|1|||
23719711|NCT01369849|66348704|FG000|Overall Study|Ineligible after receiving treatment|0|||
23719712|NCT01369849|66348705|FG001|Overall Study|Ineligible after receiving treatment|1|||
23419883|NCT04649359|65280462|FG000|Overall Study|Ongoing in the study|75|||
23419884|NCT04649359|65280463|FG001|Overall Study|Ongoing in the study|31|||
23419885|NCT01972308|65280464|FG000|Overall Study|Withdrawal by Subject|0|||
23419886|NCT01972308|65280465|FG001|Overall Study|Withdrawal by Subject|1|||
23419887|NCT01972308|65280464|FG000|Overall Study|Lost to Follow-up|4|||
23419888|NCT01972308|65280465|FG001|Overall Study|Lost to Follow-up|6|||
23419889|NCT01972308|65280464|FG000|Overall Study|Death|4|||
23419890|NCT01972308|65280465|FG001|Overall Study|Death|1|||
23419891|NCT00365105|65280466|FG000|Overall Study|Protocol Violation|5|||
23419892|NCT00365105|65280467|FG001|Overall Study|Protocol Violation|8|||
23419893|NCT01549886|65280471|FG000|Overall Study|Sponsor's decision|2|||
23419894|NCT01549886|65280472|FG001|Overall Study|Sponsor's decision|3|||
23419895|NCT00688324|65280473|FG000|Overall Study|Withdrawal by Subject|2|||
23419896|NCT00688324|65280473|FG000|Overall Study|Physician Decision|5|||
23419897|NCT00688324|65280473|FG000|Overall Study|Lost to Follow-up|1|||
23419898|NCT00420004|65280482|FG000|Overall Study|Adverse Event|4|||
23419899|NCT00420004|65280483|FG001|Overall Study|Adverse Event|1|||
23419900|NCT00420004|65280484|FG002|Overall Study|Adverse Event|1|||
23419901|NCT00420004|65280482|FG000|Overall Study|Lack of Efficacy|5|||
23419902|NCT00420004|65280483|FG001|Overall Study|Lack of Efficacy|4|||
23419903|NCT00420004|65280484|FG002|Overall Study|Lack of Efficacy|1|||
23419904|NCT00420004|65280482|FG000|Overall Study|Lost to Follow-up|31|||
23419905|NCT00420004|65280483|FG001|Overall Study|Lost to Follow-up|12|||
23419906|NCT00420004|65280484|FG002|Overall Study|Lost to Follow-up|10|||
23419907|NCT00420004|65280482|FG000|Overall Study|Entry Criteria Not Met|0|||
23419908|NCT00420004|65280483|FG001|Overall Study|Entry Criteria Not Met|1|||
23419909|NCT00420004|65280484|FG002|Overall Study|Entry Criteria Not Met|0|||
23419910|NCT00420004|65280482|FG000|Overall Study|Physician Decision|14|||
23419911|NCT00420004|65280483|FG001|Overall Study|Physician Decision|4|||
23419912|NCT00420004|65280484|FG002|Overall Study|Physician Decision|2|||
23419913|NCT00420004|65280482|FG000|Overall Study|Protocol Violation|5|||
23419914|NCT00420004|65280483|FG001|Overall Study|Protocol Violation|4|||
23419915|NCT00420004|65280484|FG002|Overall Study|Protocol Violation|3|||
23419916|NCT00420004|65280482|FG000|Overall Study|Withdrawal by Subject|67|||
23419917|NCT00420004|65280483|FG001|Overall Study|Withdrawal by Subject|42|||
23419918|NCT00420004|65280484|FG002|Overall Study|Withdrawal by Subject|14|||
23419919|NCT00420004|65280482|FG000|Overall Study|Sponsor Decision|3|||
23419920|NCT00420004|65280483|FG001|Overall Study|Sponsor Decision|3|||
23419921|NCT00420004|65280484|FG002|Overall Study|Sponsor Decision|1|||
23419922|NCT02752958|65280485|FG000|Overall Study|Adverse Event|3|||
23419923|NCT02752958|65280485|FG000|Overall Study|Lost to Follow-up|1|||
23419924|NCT02752958|65280485|FG000|Overall Study|Protocol Violation|1|||
23419925|NCT02752958|65280485|FG000|Overall Study|Withdrawal by Subject|2|||
23419926|NCT02752958|65280485|FG000|Overall Study|Other (Reason not specified)|2|||
23719713|NCT01369849|66348706|FG002|Overall Study|Ineligible after receiving treatment|0|||
23719714|NCT02228564|66348711|FG000|Overall Study|Withdrawal by Subject|10|||
23719715|NCT02228564|66348711|FG000|Overall Study|Death|11|||
23719716|NCT02228564|66348711|FG000|Overall Study|Physician Decision|5|||
23719717|NCT02228564|66348711|FG000|Overall Study|Lost to Follow-up|17|||
23719718|NCT02228564|66348711|FG000|Overall Study|Other|6|||
23719719|NCT01018511|66348713|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
23419927|NCT01380535|65280488|FG000|Overall Study|Adverse Event|3|||
23419928|NCT01380535|65280489|FG001|Overall Study|Adverse Event|3|||
23419929|NCT01380535|65280488|FG000|Overall Study|Death|3|||
23419930|NCT01380535|65280489|FG001|Overall Study|Death|0|||
23419931|NCT01380535|65280488|FG000|Overall Study|Study site closed|0|||
23419932|NCT01380535|65280489|FG001|Overall Study|Study site closed|5|||
23419933|NCT01380535|65280488|FG000|Overall Study|Withdrawal by Subject|1|||
23419934|NCT01380535|65280489|FG001|Overall Study|Withdrawal by Subject|2|||
23419935|NCT01380535|65280488|FG000|Overall Study|Protocol Violation|0|||
23419936|NCT01380535|65280489|FG001|Overall Study|Protocol Violation|2|||
23419937|NCT01380535|65280488|FG000|Overall Study|Lack of Efficacy|0|||
23419938|NCT01380535|65280489|FG001|Overall Study|Lack of Efficacy|3|||
23719720|NCT01018511|66348714|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
23719721|NCT01018511|66348715|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
23719722|NCT01018511|66348716|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
23719723|NCT01018511|66348713|FG000|Overall Study|Adverse Event|5|||
23719724|NCT01018511|66348714|FG001|Overall Study|Adverse Event|9|||
23719725|NCT01018511|66348715|FG002|Overall Study|Adverse Event|13|||
23719726|NCT01018511|66348716|FG003|Overall Study|Adverse Event|10|||
23419939|NCT01032291|65280490|FG000|Safety Lead-in|Adverse Event|1|||
23419940|NCT01032291|65280491|FG001|Safety Lead-in|Adverse Event|0|||
23419941|NCT01032291|65280492|FG002|Safety Lead-in|Adverse Event|0|||
23419942|NCT01032291|65280490|FG000|Safety Lead-in|Death|1|||
23719727|NCT01018511|66348713|FG000|Overall Study|Lack of Efficacy|4|||
23719728|NCT01018511|66348714|FG001|Overall Study|Lack of Efficacy|1|||
23719729|NCT01018511|66348715|FG002|Overall Study|Lack of Efficacy|1|||
23719730|NCT01018511|66348716|FG003|Overall Study|Lack of Efficacy|2|||
23719731|NCT01018511|66348713|FG000|Overall Study|Withdrawal by Subject|6|||
23719732|NCT01018511|66348714|FG001|Overall Study|Withdrawal by Subject|5|||
23719733|NCT01018511|66348715|FG002|Overall Study|Withdrawal by Subject|11|||
23719734|NCT01018511|66348716|FG003|Overall Study|Withdrawal by Subject|9|||
23719735|NCT01018511|66348713|FG000|Overall Study|Lost to Follow-up|0|||
23719736|NCT01018511|66348714|FG001|Overall Study|Lost to Follow-up|0|||
23719737|NCT01018511|66348715|FG002|Overall Study|Lost to Follow-up|1|||
23719738|NCT01018511|66348716|FG003|Overall Study|Lost to Follow-up|0|||
23419943|NCT01032291|65280491|FG001|Safety Lead-in|Death|0|||
23419944|NCT01032291|65280492|FG002|Safety Lead-in|Death|0|||
23419945|NCT01032291|65280490|FG000|Proof of Concept|Adverse Event|0|||
23419946|NCT01032291|65280491|FG001|Proof of Concept|Adverse Event|5|||
23419947|NCT01032291|65280492|FG002|Proof of Concept|Adverse Event|1|||
23419948|NCT01032291|65280490|FG000|Proof of Concept|Death|0|||
23419949|NCT01032291|65280491|FG001|Proof of Concept|Death|1|||
23419950|NCT01032291|65280492|FG002|Proof of Concept|Death|2|||
23419951|NCT01032291|65280490|FG000|Proof of Concept|Lack of Efficacy|0|||
23419952|NCT01032291|65280491|FG001|Proof of Concept|Lack of Efficacy|1|||
23419953|NCT01032291|65280492|FG002|Proof of Concept|Lack of Efficacy|0|||
23419954|NCT01032291|65280490|FG000|Proof of Concept|Never Received Study Drug|0|||
23419955|NCT01032291|65280491|FG001|Proof of Concept|Never Received Study Drug|1|||
23419956|NCT01032291|65280492|FG002|Proof of Concept|Never Received Study Drug|0|||
23419957|NCT02442310|65280497|FG000|Overall Study|Adverse Event|2|||
23419958|NCT02442310|65280497|FG000|Overall Study|Withdrawal by Subject|1|||
23419959|NCT03054350|65280499|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
23419960|NCT03054350|65280500|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
23419961|NCT03054350|65280501|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
23419962|NCT03054350|65280502|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
23419963|NCT03054350|65280503|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
23419964|NCT03054350|65280504|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
23419965|NCT03054350|65280499|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419966|NCT03054350|65280500|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419967|NCT03054350|65280501|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
23419968|NCT03054350|65280502|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419969|NCT03054350|65280503|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419970|NCT03054350|65280504|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419971|NCT03054350|65280499|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
23419972|NCT03054350|65280500|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419973|NCT03054350|65280501|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419974|NCT03054350|65280502|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
23719739|NCT01018511|66348713|FG000|Overall Study|Protocol Violation|5|||
23719740|NCT01018511|66348714|FG001|Overall Study|Protocol Violation|8|||
23719741|NCT01018511|66348715|FG002|Overall Study|Protocol Violation|7|||
23719742|NCT01018511|66348716|FG003|Overall Study|Protocol Violation|9|||
23719743|NCT01018511|66348713|FG000|Overall Study|Miscellaneous|0|||
23719744|NCT01018511|66348714|FG001|Overall Study|Miscellaneous|2|||
23719745|NCT01018511|66348715|FG002|Overall Study|Miscellaneous|0|||
23719746|NCT01018511|66348716|FG003|Overall Study|Miscellaneous|0|||
23719747|NCT02667457|66348724|FG000|Overall Study|Withdrawal by Subject|1|||
23719748|NCT02667457|66348725|FG001|Overall Study|Withdrawal by Subject|0|||
23719749|NCT02667457|66348724|FG000|Overall Study|Other Reason|0|||
23719750|NCT02667457|66348725|FG001|Overall Study|Other Reason|2|||
23719751|NCT01459068|66352383|FG000|Overall Study|Withdrawal by Subject|8|||
23719752|NCT01459068|66352384|FG001|Overall Study|Withdrawal by Subject|18|||
23419975|NCT03054350|65280503|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23531155|NCT03795922|65680069|FG000|Overall Study|Protocol Violation|0|||
23719753|NCT01459068|66352383|FG000|Overall Study|Lost to Follow-up|31|||
23719754|NCT01459068|66352384|FG001|Overall Study|Lost to Follow-up|15|||
23719755|NCT01459068|66352383|FG000|Overall Study|Death|0|||
23719756|NCT01459068|66352384|FG001|Overall Study|Death|1|||
23719757|NCT03549429|66352388|FG000|Overall Study|Protocol Violation|5|||
23719758|NCT03549429|66352389|FG001|Overall Study|Protocol Violation|3|||
23719759|NCT00781963|66352390|FG000|Overall Study|Death|3|||
23613276|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613277|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23719760|NCT00781963|66352391|FG001|Overall Study|Death|0|||
23719761|NCT00781963|66352390|FG000|Overall Study|Lost to Follow-up|2|||
23719762|NCT00781963|66352391|FG001|Overall Study|Lost to Follow-up|1|||
23719763|NCT00781963|66352390|FG000|Overall Study|Withdrawal by Subject|3|||
23719764|NCT00781963|66352391|FG001|Overall Study|Withdrawal by Subject|1|||
23719765|NCT00781963|66352390|FG000|Overall Study|Refused follow-up|9|||
23719766|NCT00781963|66352391|FG001|Overall Study|Refused follow-up|0|||
23719767|NCT01532570|66352392|FG000|Overall Study|Lack of Efficacy|1|||
23719768|NCT01532570|66352393|FG001|Overall Study|Lack of Efficacy|0|||
23613278|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613279|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613280|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613281|NCT04585815|65973054|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613282|NCT04585815|65973055|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
23613283|NCT04585815|65973056|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613284|NCT04585815|65973057|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613285|NCT04585815|65973058|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613286|NCT04585815|65973059|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613287|NCT04585815|65973060|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613288|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
23613289|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
23613290|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
23613291|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
23613292|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
23613293|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
23613294|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
23613295|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Death|0|||
23613296|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Death|0|||
23613297|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Death|0|||
23613298|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Death|1|||
23613299|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Death|0|||
23613300|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Death|0|||
23613301|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Death|0|||
23613302|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613303|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613304|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613305|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
23613306|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613307|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
23613308|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613309|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613310|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613311|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613312|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
23613313|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613314|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613315|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613316|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613317|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613318|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613319|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613320|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613321|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613322|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
23613323|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
23613324|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
23613325|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
23613326|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
23613327|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
23719769|NCT01532570|66352394|FG002|Overall Study|Lack of Efficacy|0|||
23719770|NCT01532570|66352395|FG003|Overall Study|Lack of Efficacy|0|||
23719771|NCT01532570|66352392|FG000|Overall Study|Withdrawal by Subject|0|||
23613328|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
23613329|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
23719772|NCT01532570|66352393|FG001|Overall Study|Withdrawal by Subject|1|||
23719773|NCT01532570|66352394|FG002|Overall Study|Withdrawal by Subject|0|||
23719774|NCT01532570|66352395|FG003|Overall Study|Withdrawal by Subject|0|||
23814154|NCT04713553|66703118|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
23814155|NCT04713553|66703119|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
23814156|NCT04713553|66703120|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
23814157|NCT04713553|66703121|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
23814158|NCT04713553|66703122|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
23814159|NCT04713553|66703123|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
23814160|NCT04713553|66703117|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23814161|NCT04713553|66703118|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23814162|NCT04713553|66703119|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23814163|NCT04713553|66703120|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
23814164|NCT04713553|66703121|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23531156|NCT03795922|65680070|FG001|Overall Study|Protocol Violation|1|||
23531157|NCT03795922|65680069|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
23531158|NCT03795922|65680070|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
23531159|NCT03337724|65680074|FG000|Overall Study|Reason not Specified|12|||
23531160|NCT03337724|65680075|FG001|Overall Study|Reason not Specified|21|||
23531161|NCT03337724|65680076|FG002|Overall Study|Reason not Specified|9|||
23531162|NCT03337724|65680077|FG003|Overall Study|Reason not Specified|9|||
23531163|NCT03337724|65680078|FG004|Overall Study|Reason not Specified|29|||
23531164|NCT03337724|65680074|FG000|Overall Study|Withdrawal by Subject|13|||
23531165|NCT03337724|65680075|FG001|Overall Study|Withdrawal by Subject|15|||
23531166|NCT03337724|65680076|FG002|Overall Study|Withdrawal by Subject|4|||
23531167|NCT03337724|65680077|FG003|Overall Study|Withdrawal by Subject|15|||
23531168|NCT03337724|65680078|FG004|Overall Study|Withdrawal by Subject|6|||
23531169|NCT03337724|65680074|FG000|Overall Study|Protocol Deviation|0|||
23531170|NCT03337724|65680075|FG001|Overall Study|Protocol Deviation|1|||
23531171|NCT03337724|65680076|FG002|Overall Study|Protocol Deviation|1|||
23531172|NCT03337724|65680077|FG003|Overall Study|Protocol Deviation|1|||
23531173|NCT03337724|65680078|FG004|Overall Study|Protocol Deviation|0|||
23531174|NCT03337724|65680074|FG000|Overall Study|Adverse Event|1|||
23531175|NCT03337724|65680075|FG001|Overall Study|Adverse Event|1|||
23531176|NCT03337724|65680076|FG002|Overall Study|Adverse Event|0|||
23531177|NCT03337724|65680077|FG003|Overall Study|Adverse Event|1|||
23531178|NCT03337724|65680078|FG004|Overall Study|Adverse Event|0|||
23531179|NCT03337724|65680074|FG000|Overall Study|Death|40|||
23531180|NCT03337724|65680075|FG001|Overall Study|Death|89|||
23531181|NCT03337724|65680076|FG002|Overall Study|Death|43|||
23719775|NCT03559192|66352398|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
23719776|NCT03559192|66352399|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
23719777|NCT03559192|66352400|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
23719778|NCT03559192|66352398|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
23719779|NCT03559192|66352399|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
23719780|NCT03559192|66352400|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
23719781|NCT03559192|66352398|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
23719782|NCT03559192|66352399|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
23719783|NCT03559192|66352400|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
23719784|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
23719785|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
23719786|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
23719787|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
23719788|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
23719789|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
23719790|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
23719791|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
23719792|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
23719793|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
23719794|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
23719795|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
23719796|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
23719797|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
23719798|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
23814165|NCT04713553|66703122|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23531182|NCT03337724|65680077|FG003|Overall Study|Death|76|||
23531183|NCT03337724|65680078|FG004|Overall Study|Death|50|||
23531184|NCT03337724|65680074|FG000|Overall Study|Lost to Follow-up|5|||
23531185|NCT03337724|65680075|FG001|Overall Study|Lost to Follow-up|5|||
23613330|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
23613331|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
23613332|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
23531186|NCT03337724|65680076|FG002|Overall Study|Lost to Follow-up|4|||
23531187|NCT03337724|65680077|FG003|Overall Study|Lost to Follow-up|7|||
23531188|NCT03337724|65680078|FG004|Overall Study|Lost to Follow-up|4|||
23531189|NCT03337724|65680074|FG000|Overall Study|Physician Decision|16|||
23531190|NCT03337724|65680075|FG001|Overall Study|Physician Decision|34|||
23531191|NCT03337724|65680076|FG002|Overall Study|Physician Decision|14|||
23531192|NCT03337724|65680077|FG003|Overall Study|Physician Decision|34|||
23531193|NCT03337724|65680078|FG004|Overall Study|Physician Decision|13|||
23531194|NCT03337724|65680074|FG000|Overall Study|Progressive Disease|0|||
23531195|NCT03337724|65680075|FG001|Overall Study|Progressive Disease|2|||
23531196|NCT03337724|65680076|FG002|Overall Study|Progressive Disease|1|||
23531197|NCT03337724|65680077|FG003|Overall Study|Progressive Disease|2|||
23531198|NCT03337724|65680078|FG004|Overall Study|Progressive Disease|0|||
23531199|NCT03337724|65680074|FG000|Overall Study|Symptomatic Deterioration|0|||
23531200|NCT03337724|65680075|FG001|Overall Study|Symptomatic Deterioration|0|||
23531201|NCT03337724|65680076|FG002|Overall Study|Symptomatic Deterioration|0|||
23613333|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
23613334|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
23613335|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
23613336|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
23613337|NCT04585815|65973054|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613338|NCT04585815|65973055|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613339|NCT04585815|65973056|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613340|NCT04585815|65973057|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613341|NCT04585815|65973058|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
23613342|NCT04585815|65973059|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
23613343|NCT04585815|65973060|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
23613344|NCT04585815|65973054|FG000|Sub-study B- Follow-up Phase|Death|0|||
23613345|NCT04585815|65973055|FG001|Sub-study B- Follow-up Phase|Death|0|||
23613346|NCT04585815|65973056|FG002|Sub-study B- Follow-up Phase|Death|1|||
23613347|NCT04585815|65973057|FG003|Sub-study B- Follow-up Phase|Death|3|||
23613348|NCT04585815|65973058|FG004|Sub-study B- Follow-up Phase|Death|0|||
23613349|NCT04585815|65973059|FG005|Sub-study B- Follow-up Phase|Death|0|||
23613350|NCT04585815|65973060|FG006|Sub-study B- Follow-up Phase|Death|1|||
23613351|NCT00730925|65973063|FG000|Overall Study|Progressive Disease|21|||
23613352|NCT00730925|65973063|FG000|Overall Study|Dose reducing Event|2|||
23613353|NCT00730925|65973063|FG000|Overall Study|Other Averse Event|7|||
23613354|NCT00730925|65973063|FG000|Overall Study|Protocol Violation|1|||
23613355|NCT00730925|65973063|FG000|Overall Study|Withdrawal by Subject|1|||
23613356|NCT00730925|65973063|FG000|Overall Study|Switch to combination therapy|8|||
23613357|NCT00730925|65973063|FG000|Overall Study|Other|1|||
23613358|NCT00402298|65973064|FG000|Overall Study|Withdrawal by Subject|1|||
23613359|NCT00402298|65973065|FG001|Overall Study|Withdrawal by Subject|0|||
23613360|NCT02339506|65973066|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
23613361|NCT02339506|65973067|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
23719799|NCT03559192|66352398|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
23719800|NCT03559192|66352399|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
23719801|NCT03559192|66352400|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
23719802|NCT02514772|66352401|FG000|Overall Study|Adverse Event|1|||
23719803|NCT02514772|66352402|FG001|Overall Study|Adverse Event|0|||
23719804|NCT02514772|66352401|FG000|Overall Study|Death|0|||
23719805|NCT02514772|66352402|FG001|Overall Study|Death|1|||
23719806|NCT02514772|66352401|FG000|Overall Study|Withdrawal by Subject|2|||
23719807|NCT02514772|66352402|FG001|Overall Study|Withdrawal by Subject|1|||
23719808|NCT01125293|66352403|FG000|Overall Study|Disease Progression|1|||
23719809|NCT01125293|66352404|FG001|Overall Study|Disease Progression|3|||
23719810|NCT01125293|66352405|FG002|Overall Study|Disease Progression|4|||
23719811|NCT01125293|66352406|FG003|Overall Study|Disease Progression|3|||
23719812|NCT01125293|66352407|FG004|Overall Study|Disease Progression|5|||
23719813|NCT01125293|66352408|FG005|Overall Study|Disease Progression|12|||
23719814|NCT01125293|66352403|FG000|Overall Study|Adverse Event|1|||
23719815|NCT01125293|66352404|FG001|Overall Study|Adverse Event|0|||
23719816|NCT01125293|66352405|FG002|Overall Study|Adverse Event|0|||
23719817|NCT01125293|66352406|FG003|Overall Study|Adverse Event|0|||
23613362|NCT02339506|65973066|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
23613363|NCT02339506|65973067|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
23531202|NCT03337724|65680077|FG003|Overall Study|Symptomatic Deterioration|1|||
23531203|NCT03337724|65680078|FG004|Overall Study|Symptomatic Deterioration|0|||
23531204|NCT04497987|65680079|FG000|Overall Study|Adverse Event|1|||
23719818|NCT01125293|66352407|FG004|Overall Study|Adverse Event|2|||
23719819|NCT01125293|66352408|FG005|Overall Study|Adverse Event|8|||
23719820|NCT01125293|66352403|FG000|Overall Study|Symptomatic Deterioration|1|||
23531205|NCT04497987|65680080|FG001|Overall Study|Adverse Event|0|||
23613364|NCT00170950|65973068|FG000|Overall Study|Death|236|||
23613365|NCT00170950|65973069|FG001|Overall Study|Death|274|||
23613366|NCT00170950|65973068|FG000|Overall Study|Withdrawal by Subject|496|||
23613367|NCT00170950|65973069|FG001|Overall Study|Withdrawal by Subject|498|||
23613368|NCT00170950|65973068|FG000|Overall Study|Lost to Follow-up|134|||
23613369|NCT00170950|65973069|FG001|Overall Study|Lost to Follow-up|115|||
23531206|NCT04497987|65680079|FG000|Overall Study|Death|21|||
23531207|NCT04497987|65680080|FG001|Overall Study|Death|13|||
23531208|NCT04497987|65680079|FG000|Overall Study|Lost to Follow-up|19|||
23531209|NCT04497987|65680080|FG001|Overall Study|Lost to Follow-up|17|||
23531210|NCT04497987|65680079|FG000|Overall Study|Other - as reported by the investigator|22|||
23531211|NCT04497987|65680080|FG001|Overall Study|Other - as reported by the investigator|16|||
23531212|NCT04497987|65680079|FG000|Overall Study|Physician Decision|1|||
23531213|NCT04497987|65680080|FG001|Overall Study|Physician Decision|0|||
23531214|NCT04497987|65680079|FG000|Overall Study|Withdrawal by Subject|35|||
23531215|NCT04497987|65680080|FG001|Overall Study|Withdrawal by Subject|21|||
23531216|NCT00770120|65680085|FG000|Overall Study|Progression|31|||
23531217|NCT00770120|65680085|FG000|Overall Study|Adverse Event|11|||
23531218|NCT00770120|65680085|FG000|Overall Study|Not Protocol Specified|11|||
23531219|NCT00770120|65680085|FG000|Overall Study|Death|3|||
23531220|NCT00770120|65680085|FG000|Overall Study|Withdrawal by Subject|2|||
23531221|NCT00770120|65680085|FG000|Overall Study|Ineligible|1|||
23531222|NCT00770120|65680085|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
23531223|NCT00770120|65680085|FG000|Overall Study|Reason under Review|1|||
23531224|NCT04382612|65680098|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
23531225|NCT00006184|65680099|FG000|Overall Study|Death|1|||
23531226|NCT00006184|65680100|FG001|Overall Study|Death|0|||
23531227|NCT02644967|65680101|FG000|Overall Study|Death|26|||
23531228|NCT02644967|65680101|FG000|Overall Study|Physician Decision|1|||
23531229|NCT02644967|65680101|FG000|Overall Study|Withdrawal by Subject|2|||
23531230|NCT02644967|65680101|FG000|Overall Study|Protocol Violation|1|||
23531231|NCT02644967|65680101|FG000|Overall Study|Progressive Disease|1|||
23531232|NCT02644967|65680101|FG000|Overall Study|Study Terminated by Sponsor|4|||
23531233|NCT00080223|65680106|FG000|Overall Study|Adverse Event|23|||
23531234|NCT00080223|65680106|FG000|Overall Study|Death|21|||
23531235|NCT00080223|65680106|FG000|Overall Study|Withdrawal by Subject|13|||
23531236|NCT00080223|65680106|FG000|Overall Study|Lung Transplantation|9|||
23531237|NCT00080223|65680106|FG000|Overall Study|Non-compliance With Study Treatment|7|||
23531238|NCT00080223|65680106|FG000|Overall Study|Participant unwilling to continue|2|||
23531239|NCT00080223|65680106|FG000|Overall Study|Physician Decision|1|||
23531240|NCT02127307|65680109|FG000|Overall Study|Protocol Violation|36|||
23531241|NCT02127307|65680109|FG000|Overall Study|Lost to Follow-up|2|||
23531242|NCT02127307|65680109|FG000|Overall Study|Death|101|||
23531243|NCT02127307|65680109|FG000|Overall Study|Other than specified above|169|||
23531244|NCT00691210|65680112|FG000|Overall Study|Progression of Disease|0|||
23531245|NCT00691210|65680113|FG001|Overall Study|Progression of Disease|0|||
23531246|NCT00691210|65680114|FG002|Overall Study|Progression of Disease|0|||
23531247|NCT00691210|65680115|FG003|Overall Study|Progression of Disease|2|||
23531248|NCT00691210|65680116|FG004|Overall Study|Progression of Disease|0|||
23531249|NCT00691210|65680117|FG005|Overall Study|Progression of Disease|0|||
23531250|NCT00691210|65680118|FG006|Overall Study|Progression of Disease|0|||
23531251|NCT00691210|65680119|FG007|Overall Study|Progression of Disease|0|||
23531252|NCT00691210|65680112|FG000|Overall Study|Lack of Efficacy|0|||
23531253|NCT00691210|65680113|FG001|Overall Study|Lack of Efficacy|0|||
23531254|NCT00691210|65680114|FG002|Overall Study|Lack of Efficacy|0|||
23531255|NCT00691210|65680115|FG003|Overall Study|Lack of Efficacy|1|||
23531256|NCT00691210|65680116|FG004|Overall Study|Lack of Efficacy|0|||
23531257|NCT00691210|65680117|FG005|Overall Study|Lack of Efficacy|1|||
23531258|NCT00691210|65680118|FG006|Overall Study|Lack of Efficacy|0|||
23531259|NCT00691210|65680119|FG007|Overall Study|Lack of Efficacy|0|||
23531260|NCT00797667|65680121|FG000|Overall Study|Lack of Efficacy|0|||
23531261|NCT00797667|65680122|FG001|Overall Study|Lack of Efficacy|1|||
23531262|NCT00797667|65680123|FG002|Overall Study|Lack of Efficacy|0|||
23531263|NCT00797667|65680121|FG000|Overall Study|Lost to Follow-up|8|||
23613370|NCT00170950|65973068|FG000|Overall Study|Missing|2|||
23613371|NCT00170950|65973069|FG001|Overall Study|Missing|1|||
23613372|NCT00170950|65973068|FG000|Overall Study|Termination Data Not Recorded|17|||
23613373|NCT00170950|65973069|FG001|Overall Study|Termination Data Not Recorded|22|||
23531264|NCT00797667|65680122|FG001|Overall Study|Lost to Follow-up|12|||
23613374|NCT02446912|65973070|FG000|Overall Study|Adverse Event|3|||
23613375|NCT02446912|65973071|FG001|Overall Study|Adverse Event|13|||
23531265|NCT00797667|65680123|FG002|Overall Study|Lost to Follow-up|2|||
23531266|NCT00797667|65680121|FG000|Overall Study|Physician Decision|3|||
23531267|NCT00797667|65680122|FG001|Overall Study|Physician Decision|1|||
23531268|NCT00797667|65680123|FG002|Overall Study|Physician Decision|0|||
23531269|NCT00797667|65680121|FG000|Overall Study|Pregnancy|2|||
23531270|NCT00797667|65680122|FG001|Overall Study|Pregnancy|0|||
23531271|NCT00797667|65680123|FG002|Overall Study|Pregnancy|0|||
23531272|NCT00797667|65680121|FG000|Overall Study|Protocol Violation|2|||
23531273|NCT00797667|65680122|FG001|Overall Study|Protocol Violation|7|||
23531274|NCT00797667|65680123|FG002|Overall Study|Protocol Violation|0|||
23531275|NCT00797667|65680121|FG000|Overall Study|Study Terminated by Sponsor|217|||
23531276|NCT00797667|65680122|FG001|Overall Study|Study Terminated by Sponsor|216|||
23531277|NCT00797667|65680123|FG002|Overall Study|Study Terminated by Sponsor|115|||
23531278|NCT00797667|65680121|FG000|Overall Study|Withdrawal by Subject|9|||
23719821|NCT01125293|66352404|FG001|Overall Study|Symptomatic Deterioration|0|||
23719822|NCT01125293|66352405|FG002|Overall Study|Symptomatic Deterioration|0|||
23719823|NCT01125293|66352406|FG003|Overall Study|Symptomatic Deterioration|0|||
23719824|NCT01125293|66352407|FG004|Overall Study|Symptomatic Deterioration|0|||
23719825|NCT01125293|66352408|FG005|Overall Study|Symptomatic Deterioration|0|||
23719826|NCT01125293|66352403|FG000|Overall Study|Death|0|||
23719827|NCT01125293|66352404|FG001|Overall Study|Death|0|||
23719828|NCT01125293|66352405|FG002|Overall Study|Death|0|||
23719829|NCT01125293|66352406|FG003|Overall Study|Death|0|||
23719830|NCT01125293|66352407|FG004|Overall Study|Death|1|||
23719831|NCT01125293|66352408|FG005|Overall Study|Death|0|||
23719832|NCT01125293|66352403|FG000|Overall Study|Withdrawal by Subject|0|||
23719833|NCT01125293|66352404|FG001|Overall Study|Withdrawal by Subject|0|||
23719834|NCT01125293|66352405|FG002|Overall Study|Withdrawal by Subject|0|||
23719835|NCT01125293|66352406|FG003|Overall Study|Withdrawal by Subject|0|||
23719836|NCT01125293|66352407|FG004|Overall Study|Withdrawal by Subject|2|||
23719837|NCT01125293|66352408|FG005|Overall Study|Withdrawal by Subject|1|||
23719838|NCT01125293|66352403|FG000|Overall Study|Physician Decision|0|||
23719839|NCT01125293|66352404|FG001|Overall Study|Physician Decision|0|||
23719840|NCT01125293|66352405|FG002|Overall Study|Physician Decision|0|||
23719841|NCT01125293|66352406|FG003|Overall Study|Physician Decision|0|||
23719842|NCT01125293|66352407|FG004|Overall Study|Physician Decision|0|||
23719843|NCT01125293|66352408|FG005|Overall Study|Physician Decision|2|||
23719844|NCT00973622|66352415|FG000|Overall Study|did not attend MRI|14|||
23719845|NCT00973622|66352416|FG001|Overall Study|did not attend MRI|3|||
23719846|NCT00973622|66352415|FG000|Overall Study|did not pass MRI screen|6|||
23719847|NCT00973622|66352416|FG001|Overall Study|did not pass MRI screen|0|||
23719848|NCT00973622|66352415|FG000|Overall Study|did not complete rTMS sessions|11|||
23719849|NCT00973622|66352416|FG001|Overall Study|did not complete rTMS sessions|2|||
23719850|NCT02700919|66352417|FG000|Overall Study|Physician Decision|1|||
23531279|NCT00797667|65680122|FG001|Overall Study|Withdrawal by Subject|14|||
23531280|NCT00797667|65680123|FG002|Overall Study|Withdrawal by Subject|2|||
23531281|NCT00797667|65680121|FG000|Overall Study|Adverse Event|19|||
23531282|NCT00797667|65680122|FG001|Overall Study|Adverse Event|8|||
23531283|NCT00797667|65680123|FG002|Overall Study|Adverse Event|8|||
23531284|NCT04545515|65680124|FG000|Overall Study|Adverse Event|1|||
23531285|NCT04545515|65680124|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
23531286|NCT04545515|65680124|FG000|Overall Study|Commercial drug is available for participant|7|||
23719851|NCT02700919|66352418|FG001|Overall Study|Physician Decision|0|||
23719852|NCT02700919|66352419|FG002|Overall Study|Physician Decision|0|||
23719853|NCT02700919|66352417|FG000|Overall Study|Protocol Violation|1|||
23719854|NCT02700919|66352418|FG001|Overall Study|Protocol Violation|0|||
23719855|NCT02700919|66352419|FG002|Overall Study|Protocol Violation|0|||
23719856|NCT02700919|66352417|FG000|Overall Study|Adverse Event|1|||
23719857|NCT02700919|66352418|FG001|Overall Study|Adverse Event|3|||
23719858|NCT02700919|66352419|FG002|Overall Study|Adverse Event|1|||
23719859|NCT02700919|66352417|FG000|Overall Study|Withdrawal by Subject|5|||
23719860|NCT02700919|66352418|FG001|Overall Study|Withdrawal by Subject|8|||
23719861|NCT02700919|66352419|FG002|Overall Study|Withdrawal by Subject|2|||
23719862|NCT02700919|66352417|FG000|Overall Study|Lost to Follow-up|2|||
23719863|NCT02700919|66352418|FG001|Overall Study|Lost to Follow-up|0|||
23719864|NCT02700919|66352419|FG002|Overall Study|Lost to Follow-up|0|||
23719865|NCT02700919|66352417|FG000|Overall Study|Other|2|||
23719866|NCT02700919|66352418|FG001|Overall Study|Other|1|||
23719867|NCT02700919|66352419|FG002|Overall Study|Other|1|||
23531287|NCT02212730|65680127|FG000|Overall Study|Tumor not of the required cell histology|1|||
23531288|NCT02212730|65680128|FG001|Overall Study|Tumor not of the required cell histology|0|||
23531289|NCT02212730|65680127|FG000|Overall Study|Withdrawal by Subject|1|||
23719868|NCT00732641|66352420|FG000|Overall Study|Relapse or Progressive Disease|65|||
23719869|NCT00732641|66352421|FG001|Overall Study|Relapse or Progressive Disease|101|||
23719870|NCT00732641|66352420|FG000|Overall Study|Serious Adverse Events|12|||
23531290|NCT02212730|65680128|FG001|Overall Study|Withdrawal by Subject|0|||
23719871|NCT00732641|66352421|FG001|Overall Study|Serious Adverse Events|3|||
23719872|NCT00732641|66352420|FG000|Overall Study|Physician Decision|6|||
23531291|NCT02212730|65680127|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
23719873|NCT00732641|66352421|FG001|Overall Study|Physician Decision|0|||
23719874|NCT00732641|66352420|FG000|Overall Study|Withdrawal by Subject|4|||
23719875|NCT00732641|66352421|FG001|Overall Study|Withdrawal by Subject|2|||
23719876|NCT00732641|66352420|FG000|Overall Study|Unable to Complete|1|||
23719877|NCT00732641|66352421|FG001|Overall Study|Unable to Complete|1|||
23719878|NCT00732641|66352420|FG000|Overall Study|Other|18|||
23719879|NCT00732641|66352421|FG001|Overall Study|Other|5|||
23719880|NCT03483116|66352422|FG000|Overall Study|Adverse Event|0|||
23719881|NCT03483116|66352423|FG001|Overall Study|Adverse Event|1|||
23719882|NCT03483116|66352424|FG002|Overall Study|Adverse Event|0|||
23719883|NCT03483116|66352425|FG003|Overall Study|Adverse Event|1|||
23719884|NCT03483116|66352422|FG000|Overall Study|Protocol Violation|1|||
23531292|NCT02212730|65680128|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
23531293|NCT04709575|65680129|FG000|Overall Study|Withdrawal by Subject|6|||
23531294|NCT04709575|65680130|FG001|Overall Study|Withdrawal by Subject|2|||
23531295|NCT04709575|65680129|FG000|Overall Study|Lost to Follow-up|2|||
23531296|NCT04709575|65680130|FG001|Overall Study|Lost to Follow-up|2|||
23531297|NCT04709575|65680129|FG000|Overall Study|Adverse Event|1|||
23531298|NCT04709575|65680130|FG001|Overall Study|Adverse Event|0|||
23531299|NCT04709575|65680129|FG000|Overall Study|Protocol Violation|1|||
23531300|NCT04709575|65680130|FG001|Overall Study|Protocol Violation|1|||
23531301|NCT04879745|65680131|FG000|Overall Study|Lost to Follow-up|4|||
23531302|NCT04879745|65680132|FG001|Overall Study|Lost to Follow-up|1|||
23531303|NCT01957475|65680133|FG000|Test Period 1|Withdrawal by Subject|1|||
23531304|NCT01957475|65680134|FG001|Test Period 1|Withdrawal by Subject|0|||
23531305|NCT01957475|65680133|FG000|Test Period 1|Other|1|||
23531306|NCT01957475|65680134|FG001|Test Period 1|Other|0|||
23531307|NCT01957475|65680133|FG000|Test Period 1|Lack of Efficacy|0|||
23531308|NCT01957475|65680134|FG001|Test Period 1|Lack of Efficacy|1|||
23531309|NCT01957475|65680133|FG000|Test Period 2|Adverse Event|1|||
23531310|NCT01957475|65680134|FG001|Test Period 2|Adverse Event|0|||
23531311|NCT02148003|65680135|FG000|Overall Study|Failed inclusion criteria|1|||
23531312|NCT02148003|65680136|FG001|Overall Study|Failed inclusion criteria|0|||
23531313|NCT02148003|65680135|FG000|Overall Study|Met exclusion criteria|0|||
23531314|NCT02148003|65680136|FG001|Overall Study|Met exclusion criteria|1|||
23531315|NCT02148003|65680135|FG000|Overall Study|Withdrawal by Subject|0|||
23613376|NCT02446912|65973072|FG002|Overall Study|Adverse Event|5|||
23613377|NCT02446912|65973070|FG000|Overall Study|Condition under investigation worsened|0|||
23613378|NCT02446912|65973071|FG001|Overall Study|Condition under investigation worsened|1|||
23613379|NCT02446912|65973072|FG002|Overall Study|Condition under investigation worsened|1|||
23719885|NCT03483116|66352423|FG001|Overall Study|Protocol Violation|0|||
23719886|NCT03483116|66352424|FG002|Overall Study|Protocol Violation|0|||
23719887|NCT03483116|66352425|FG003|Overall Study|Protocol Violation|7|||
23719888|NCT03483116|66352422|FG000|Overall Study|Lost to Follow-up|9|||
23719889|NCT03483116|66352423|FG001|Overall Study|Lost to Follow-up|4|||
23719890|NCT03483116|66352424|FG002|Overall Study|Lost to Follow-up|9|||
23719891|NCT03483116|66352425|FG003|Overall Study|Lost to Follow-up|5|||
23719892|NCT03483116|66352422|FG000|Overall Study|Death|1|||
23719893|NCT03483116|66352423|FG001|Overall Study|Death|0|||
23719894|NCT03483116|66352424|FG002|Overall Study|Death|2|||
23719895|NCT03483116|66352425|FG003|Overall Study|Death|1|||
23719896|NCT03483116|66352422|FG000|Overall Study|Withdrawal by Subject|14|||
23719897|NCT03483116|66352423|FG001|Overall Study|Withdrawal by Subject|16|||
23719898|NCT03483116|66352424|FG002|Overall Study|Withdrawal by Subject|14|||
23719899|NCT03483116|66352425|FG003|Overall Study|Withdrawal by Subject|16|||
23719900|NCT03483116|66352422|FG000|Overall Study|Unknown other reason|3|||
23719901|NCT03483116|66352423|FG001|Overall Study|Unknown other reason|2|||
23719902|NCT03483116|66352424|FG002|Overall Study|Unknown other reason|1|||
23719903|NCT03483116|66352425|FG003|Overall Study|Unknown other reason|1|||
23719904|NCT01544478|66352426|FG000|Overall Study|Adverse Event|1|||
23719905|NCT01544478|66352426|FG000|Overall Study|Death|1|||
23719906|NCT01544478|66352426|FG000|Overall Study|Lost to Follow-up|48|||
23719907|NCT01544478|66352426|FG000|Overall Study|Physician Decision|15|||
23814166|NCT04713553|66703123|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23531316|NCT02148003|65680136|FG001|Overall Study|Withdrawal by Subject|1|||
23613380|NCT02446912|65973070|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23613381|NCT02446912|65973071|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23814167|NCT04713553|66703117|FG000|Primary Study (2 Months)|Other|1|||
23719908|NCT01544478|66352426|FG000|Overall Study|Pregnancy|1|||
23719909|NCT01544478|66352426|FG000|Overall Study|Withdrawal by Subject|52|||
23719910|NCT02896192|66352429|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
23719911|NCT02896192|66352429|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
23719912|NCT02896192|66352429|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
23719913|NCT01213264|66352431|FG000|Overall Study|Adverse Event|1|||
23719914|NCT01213264|66352432|FG001|Overall Study|Adverse Event|0|||
23531317|NCT00355238|65680137|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23531318|NCT00355238|65680138|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23531319|NCT00355238|65680139|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23531320|NCT00355238|65680140|FG003|Overall Study|Adverse event unrelated to study drug|1|||
23719915|NCT01213264|66352433|FG002|Overall Study|Adverse Event|0|||
23719916|NCT01213264|66352431|FG000|Overall Study|Lost to Follow-up|1|||
23719917|NCT01213264|66352432|FG001|Overall Study|Lost to Follow-up|2|||
23719918|NCT01213264|66352433|FG002|Overall Study|Lost to Follow-up|6|||
23719919|NCT01425749|66352434|FG000|Overall Study|progression of melanoma|0|||
23719920|NCT01425749|66352435|FG001|Overall Study|progression of melanoma|1|||
23719921|NCT00345540|66352437|FG000|Overall Study|Withdrawal by Subject|1|||
23719922|NCT01947894|66352438|FG000|Overall Study|Other|3|||
23719923|NCT01947894|66352439|FG001|Overall Study|Other|4|||
23719924|NCT01947894|66352440|FG002|Overall Study|Other|3|||
23719925|NCT01947894|66352438|FG000|Overall Study|Withdrawal by Subject|12|||
23814168|NCT04713553|66703118|FG001|Primary Study (2 Months)|Other|2|||
23531321|NCT00355238|65680137|FG000|Overall Study|Death|1|||
23531322|NCT00355238|65680138|FG001|Overall Study|Death|0|||
23814169|NCT04713553|66703119|FG002|Primary Study (2 Months)|Other|0|||
23814170|NCT04713553|66703120|FG003|Primary Study (2 Months)|Other|0|||
23531323|NCT00355238|65680139|FG002|Overall Study|Death|0|||
23531324|NCT00355238|65680140|FG003|Overall Study|Death|0|||
23531325|NCT00355238|65680137|FG000|Overall Study|Disease progression|37|||
23531326|NCT00355238|65680138|FG001|Overall Study|Disease progression|36|||
23531327|NCT00355238|65680139|FG002|Overall Study|Disease progression|16|||
23531328|NCT00355238|65680140|FG003|Overall Study|Disease progression|11|||
23719926|NCT01947894|66352439|FG001|Overall Study|Withdrawal by Subject|4|||
23814171|NCT04713553|66703121|FG004|Primary Study (2 Months)|Other|1|||
23814172|NCT04713553|66703122|FG005|Primary Study (2 Months)|Other|0|||
23814173|NCT04713553|66703123|FG006|Primary Study (2 Months)|Other|0|||
23814174|NCT04713553|66703117|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
23814175|NCT04713553|66703118|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
23814176|NCT04713553|66703119|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
23814177|NCT04713553|66703120|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
23814178|NCT04713553|66703121|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
23814179|NCT04713553|66703122|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
23814180|NCT04713553|66703123|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
23814181|NCT04713553|66703117|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814182|NCT04713553|66703118|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814183|NCT04713553|66703119|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
23814184|NCT04713553|66703120|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814185|NCT04713553|66703121|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814186|NCT04713553|66703122|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814187|NCT04713553|66703123|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
23814188|NCT04495283|66703128|FG000|Overall Study|Physician Decision|0|||
23814189|NCT04495283|66703129|FG001|Overall Study|Physician Decision|0|||
23814190|NCT04495283|66703130|FG002|Overall Study|Physician Decision|1|||
23814191|NCT04495283|66703128|FG000|Overall Study|Withdrawal by Subject|0|||
23814192|NCT04495283|66703129|FG001|Overall Study|Withdrawal by Subject|1|||
23814193|NCT04495283|66703130|FG002|Overall Study|Withdrawal by Subject|1|||
23814194|NCT04495283|66703128|FG000|Overall Study|Other|1|||
23814195|NCT04495283|66703129|FG001|Overall Study|Other|0|||
23814196|NCT04495283|66703130|FG002|Overall Study|Other|1|||
23814197|NCT00976911|66703134|FG000|Overall Study|Withdrawal by Subject|4|||
23814198|NCT00976911|66703135|FG001|Overall Study|Withdrawal by Subject|6|||
23814199|NCT00976911|66703134|FG000|Overall Study|Death|138|||
23814200|NCT00976911|66703135|FG001|Overall Study|Death|126|||
23814201|NCT00976911|66703134|FG000|Overall Study|Adverse Event|0|||
23814202|NCT00976911|66703135|FG001|Overall Study|Adverse Event|1|||
23814203|NCT00976911|66703134|FG000|Overall Study|Protocol Violation|2|||
23531329|NCT00355238|65680137|FG000|Overall Study|Study drug toxicity|11|||
23531330|NCT00355238|65680138|FG001|Overall Study|Study drug toxicity|7|||
23531331|NCT00355238|65680139|FG002|Overall Study|Study drug toxicity|5|||
23531332|NCT00355238|65680140|FG003|Overall Study|Study drug toxicity|2|||
23531333|NCT00355238|65680137|FG000|Overall Study|Participant withdrew consent|3|||
23531334|NCT00355238|65680138|FG001|Overall Study|Participant withdrew consent|1|||
23531335|NCT00355238|65680139|FG002|Overall Study|Participant withdrew consent|0|||
23531336|NCT00355238|65680140|FG003|Overall Study|Participant withdrew consent|0|||
23531337|NCT00355238|65680137|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23531338|NCT00355238|65680138|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23531339|NCT00355238|65680139|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23531340|NCT00355238|65680140|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23531341|NCT02755831|65680151|FG000|Overall Study|Lost to Follow-up|3|||
23719927|NCT01947894|66352440|FG002|Overall Study|Withdrawal by Subject|1|||
23719928|NCT01947894|66352438|FG000|Overall Study|Death|12|||
23814204|NCT00976911|66703135|FG001|Overall Study|Protocol Violation|0|||
23814205|NCT00976911|66703134|FG000|Overall Study|Other|8|||
23814206|NCT00976911|66703135|FG001|Overall Study|Other|9|||
23814207|NCT00976911|66703134|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
23814208|NCT00976911|66703135|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
23814209|NCT00678886|66703142|FG000|Overall Study|Withdrawal by Subject|0|||
23531342|NCT02755831|65680152|FG001|Overall Study|Lost to Follow-up|3|||
23531343|NCT03912233|65680153|FG000|Overall Study|Adverse Event|1|||
23531344|NCT03912233|65680154|FG001|Overall Study|Adverse Event|0|||
23531345|NCT03912233|65680155|FG002|Overall Study|Adverse Event|0|||
23531346|NCT03912233|65680156|FG003|Overall Study|Adverse Event|0|||
23531347|NCT03912233|65680157|FG004|Overall Study|Adverse Event|0|||
23531348|NCT03912233|65680158|FG005|Overall Study|Adverse Event|0|||
23531349|NCT03912233|65680153|FG000|Overall Study|Physician Decision|1|||
23531350|NCT03912233|65680154|FG001|Overall Study|Physician Decision|0|||
23531351|NCT03912233|65680155|FG002|Overall Study|Physician Decision|0|||
23531352|NCT03912233|65680156|FG003|Overall Study|Physician Decision|0|||
23719929|NCT01947894|66352439|FG001|Overall Study|Death|1|||
23719930|NCT01947894|66352440|FG002|Overall Study|Death|0|||
23719931|NCT01947894|66352438|FG000|Overall Study|Physician Decision|2|||
23719932|NCT01947894|66352439|FG001|Overall Study|Physician Decision|0|||
23719933|NCT01947894|66352440|FG002|Overall Study|Physician Decision|0|||
23719934|NCT01947894|66352438|FG000|Overall Study|Adverse Event|5|||
23719935|NCT01947894|66352439|FG001|Overall Study|Adverse Event|1|||
23719936|NCT01947894|66352440|FG002|Overall Study|Adverse Event|0|||
23531353|NCT03912233|65680157|FG004|Overall Study|Physician Decision|0|||
23531354|NCT03912233|65680158|FG005|Overall Study|Physician Decision|0|||
23531355|NCT03912233|65680153|FG000|Overall Study|Other|0|||
23531356|NCT03912233|65680154|FG001|Overall Study|Other|0|||
23531357|NCT03912233|65680155|FG002|Overall Study|Other|0|||
23531358|NCT03912233|65680156|FG003|Overall Study|Other|0|||
23531359|NCT03912233|65680157|FG004|Overall Study|Other|7|||
23531360|NCT03912233|65680158|FG005|Overall Study|Other|12|||
23531361|NCT03246958|65680159|FG000|Overall Study|Withdrawal by Subject|0|||
23531362|NCT03246958|65680160|FG001|Overall Study|Withdrawal by Subject|1|||
23531363|NCT03246958|65680161|FG002|Overall Study|Withdrawal by Subject|0|||
23531364|NCT03246958|65680162|FG003|Overall Study|Withdrawal by Subject|0|||
23531365|NCT03246958|65680163|FG004|Overall Study|Withdrawal by Subject|0|||
23531366|NCT03246958|65680164|FG005|Overall Study|Withdrawal by Subject|1|||
23531367|NCT03246958|65680165|FG006|Overall Study|Withdrawal by Subject|0|||
23531368|NCT03246958|65680159|FG000|Overall Study|Progression|13|||
23531369|NCT03246958|65680160|FG001|Overall Study|Progression|9|||
23719937|NCT01947894|66352438|FG000|Overall Study|Switched to other growth hormone brand|53|||
23531370|NCT03246958|65680161|FG002|Overall Study|Progression|3|||
23531371|NCT03246958|65680162|FG003|Overall Study|Progression|2|||
23531372|NCT03246958|65680163|FG004|Overall Study|Progression|1|||
23531373|NCT03246958|65680164|FG005|Overall Study|Progression|2|||
23719938|NCT01947894|66352439|FG001|Overall Study|Switched to other growth hormone brand|8|||
23719939|NCT01947894|66352440|FG002|Overall Study|Switched to other growth hormone brand|23|||
23719940|NCT00636441|66352441|FG000|Overall Study|Adverse Event|0|||
23719941|NCT00636441|66352442|FG001|Overall Study|Adverse Event|1|||
23719942|NCT00636441|66352443|FG002|Overall Study|Adverse Event|1|||
23719943|NCT00636441|66352444|FG003|Overall Study|Adverse Event|0|||
23719944|NCT00636441|66352445|FG004|Overall Study|Adverse Event|0|||
23719945|NCT00636441|66352446|FG005|Overall Study|Adverse Event|1|||
23719946|NCT00636441|66352447|FG006|Overall Study|Adverse Event|0|||
23719947|NCT00636441|66352441|FG000|Overall Study|Late, ineligible|0|||
23719948|NCT00636441|66352442|FG001|Overall Study|Late, ineligible|0|||
23531374|NCT03246958|65680165|FG006|Overall Study|Progression|1|||
23531375|NCT03246958|65680159|FG000|Overall Study|Adverse Event|2|||
23531376|NCT03246958|65680160|FG001|Overall Study|Adverse Event|2|||
23531377|NCT03246958|65680161|FG002|Overall Study|Adverse Event|0|||
23531378|NCT03246958|65680162|FG003|Overall Study|Adverse Event|1|||
23531379|NCT03246958|65680163|FG004|Overall Study|Adverse Event|1|||
23531380|NCT03246958|65680164|FG005|Overall Study|Adverse Event|0|||
23531381|NCT03246958|65680165|FG006|Overall Study|Adverse Event|2|||
23531382|NCT03246958|65680159|FG000|Overall Study|Death|0|||
23531383|NCT03246958|65680160|FG001|Overall Study|Death|1|||
23531384|NCT03246958|65680161|FG002|Overall Study|Death|0|||
23531385|NCT03246958|65680162|FG003|Overall Study|Death|0|||
23531386|NCT03246958|65680163|FG004|Overall Study|Death|0|||
23531387|NCT03246958|65680164|FG005|Overall Study|Death|0|||
23531388|NCT03246958|65680165|FG006|Overall Study|Death|0|||
23719949|NCT00636441|66352443|FG002|Overall Study|Late, ineligible|0|||
23719950|NCT00636441|66352444|FG003|Overall Study|Late, ineligible|0|||
23531389|NCT03246958|65680159|FG000|Overall Study|Physician Decision|0|||
23531390|NCT03246958|65680160|FG001|Overall Study|Physician Decision|0|||
23531391|NCT03246958|65680161|FG002|Overall Study|Physician Decision|0|||
23531392|NCT03246958|65680162|FG003|Overall Study|Physician Decision|1|||
23531393|NCT03246958|65680163|FG004|Overall Study|Physician Decision|0|||
23531394|NCT03246958|65680164|FG005|Overall Study|Physician Decision|0|||
23719951|NCT00636441|66352445|FG004|Overall Study|Late, ineligible|0|||
23719952|NCT00636441|66352446|FG005|Overall Study|Late, ineligible|0|||
23531395|NCT03246958|65680165|FG006|Overall Study|Physician Decision|0|||
23531396|NCT03246958|65680159|FG000|Overall Study|Never start treatment|1|||
23531397|NCT03246958|65680160|FG001|Overall Study|Never start treatment|0|||
23719953|NCT00636441|66352447|FG006|Overall Study|Late, ineligible|1|||
23719954|NCT00636441|66352441|FG000|Overall Study|Screen Failure|0|||
23531398|NCT03246958|65680161|FG002|Overall Study|Never start treatment|0|||
23531399|NCT03246958|65680162|FG003|Overall Study|Never start treatment|0|||
23531400|NCT03246958|65680163|FG004|Overall Study|Never start treatment|0|||
23531401|NCT03246958|65680164|FG005|Overall Study|Never start treatment|0|||
23531402|NCT03246958|65680165|FG006|Overall Study|Never start treatment|0|||
23531403|NCT03246958|65680159|FG000|Overall Study|Over enrollment|0|||
23719955|NCT00636441|66352442|FG001|Overall Study|Screen Failure|0|||
23719956|NCT00636441|66352443|FG002|Overall Study|Screen Failure|0|||
23719957|NCT00636441|66352444|FG003|Overall Study|Screen Failure|0|||
23719958|NCT00636441|66352445|FG004|Overall Study|Screen Failure|0|||
23531404|NCT03246958|65680160|FG001|Overall Study|Over enrollment|2|||
23719959|NCT00636441|66352446|FG005|Overall Study|Screen Failure|0|||
23719960|NCT00636441|66352447|FG006|Overall Study|Screen Failure|17|||
23719961|NCT00802867|66352448|FG000|Overall Study|Lost to Follow-up|6|||
23719962|NCT00802867|66352448|FG000|Overall Study|Protocol Violation|6|||
23719963|NCT00802867|66352448|FG000|Overall Study|Withdrawal by Subject|1|||
23719964|NCT03215667|66352449|FG000|Overall Study|Physician Decision|4|||
23719965|NCT02910583|66352450|FG000|Overall Study|Withdrawal by Subject|6|||
23719966|NCT02910583|66352451|FG001|Overall Study|Withdrawal by Subject|7|||
23719967|NCT02910583|66352450|FG000|Overall Study|Other, Not Specified|1|||
23719968|NCT02910583|66352451|FG001|Overall Study|Other, Not Specified|0|||
23719969|NCT04019795|66352452|FG000|Overall Study|Withdrawal by Subject|1|||
23719970|NCT04019795|66352453|FG001|Overall Study|Withdrawal by Subject|2|||
23719971|NCT04019795|66352454|FG002|Overall Study|Withdrawal by Subject|2|||
23719972|NCT04019795|66352455|FG003|Overall Study|Withdrawal by Subject|1|||
23719973|NCT04019795|66352452|FG000|Overall Study|Lost to Follow-up|0|||
23719974|NCT04019795|66352453|FG001|Overall Study|Lost to Follow-up|1|||
23719975|NCT04019795|66352454|FG002|Overall Study|Lost to Follow-up|1|||
23719976|NCT04019795|66352455|FG003|Overall Study|Lost to Follow-up|2|||
23719977|NCT04019795|66352452|FG000|Overall Study|Treatment non-compliance|3|||
23719978|NCT04019795|66352453|FG001|Overall Study|Treatment non-compliance|1|||
23719979|NCT04019795|66352454|FG002|Overall Study|Treatment non-compliance|2|||
23719980|NCT04019795|66352455|FG003|Overall Study|Treatment non-compliance|0|||
23719981|NCT04019795|66352452|FG000|Overall Study|Physician Decision|0|||
23719982|NCT04019795|66352453|FG001|Overall Study|Physician Decision|0|||
23719983|NCT04019795|66352454|FG002|Overall Study|Physician Decision|1|||
23719984|NCT04019795|66352455|FG003|Overall Study|Physician Decision|0|||
23719985|NCT04019795|66352452|FG000|Overall Study|Adverse Event|1|||
23719986|NCT04019795|66352453|FG001|Overall Study|Adverse Event|0|||
23719987|NCT04019795|66352454|FG002|Overall Study|Adverse Event|0|||
23719988|NCT04019795|66352455|FG003|Overall Study|Adverse Event|0|||
23719989|NCT01225172|66352457|FG000|Overall Study|Subject decision to stop|1|||
23719990|NCT01225172|66352458|FG001|Overall Study|Subject decision to stop|0|||
23719991|NCT01225172|66352457|FG000|Overall Study|Subject request to discontinue treatment|3|||
23719992|NCT01225172|66352458|FG001|Overall Study|Subject request to discontinue treatment|1|||
23719993|NCT01225172|66352457|FG000|Overall Study|Subject no longer meets study criteria|1|||
23719994|NCT01225172|66352458|FG001|Overall Study|Subject no longer meets study criteria|0|||
23719995|NCT01225172|66352457|FG000|Overall Study|Withdrawal by Subject|1|||
23719996|NCT01225172|66352458|FG001|Overall Study|Withdrawal by Subject|0|||
23719997|NCT01453998|66352459|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
23719998|NCT01453998|66352460|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
23719999|NCT01453998|66352461|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
23720000|NCT01838590|66352463|FG000|Overall Study|Lack of Efficacy|12|||
23720001|NCT01838590|66352464|FG001|Overall Study|Lack of Efficacy|4|||
23720002|NCT01838590|66352463|FG000|Overall Study|Lost to Follow-up|0|||
23720003|NCT01838590|66352464|FG001|Overall Study|Lost to Follow-up|1|||
23531405|NCT03246958|65680161|FG002|Overall Study|Over enrollment|0|||
23720004|NCT00924729|66352473|FG000|Overall Study|insufficient volume for analysis|1|||
23720005|NCT00924729|66352474|FG001|Overall Study|insufficient volume for analysis|0|||
23720006|NCT00924729|66352473|FG000|Overall Study|Protocol Violation|1|||
23531406|NCT03246958|65680162|FG003|Overall Study|Over enrollment|0|||
23720007|NCT00924729|66352474|FG001|Overall Study|Protocol Violation|0|||
23720008|NCT00065442|66352476|FG000|Overall Study|Lost to Follow-up|1|||
23720009|NCT00065442|66352477|FG001|Overall Study|Lost to Follow-up|1|||
23720010|NCT00065442|66352476|FG000|Overall Study|Death|121|||
23720011|NCT00065442|66352477|FG001|Overall Study|Death|210|||
23720012|NCT00065442|66352476|FG000|Overall Study|Withdrawal by Subject|3|||
23720013|NCT00065442|66352477|FG001|Overall Study|Withdrawal by Subject|9|||
23720014|NCT00796003|66352478|FG000|Overall Study|Disease Progression|2|||
23720015|NCT00796003|66352479|FG001|Overall Study|Disease Progression|13|||
23720016|NCT00796003|66352478|FG000|Overall Study|Adverse Event|1|||
23720017|NCT00796003|66352479|FG001|Overall Study|Adverse Event|7|||
23720018|NCT00796003|66352478|FG000|Overall Study|Specified organ function not met|0|||
23720019|NCT00796003|66352479|FG001|Overall Study|Specified organ function not met|1|||
23720020|NCT00796003|66352478|FG000|Overall Study|Physician Decision|0|||
23720021|NCT00796003|66352479|FG001|Overall Study|Physician Decision|4|||
23720022|NCT00796003|66352478|FG000|Overall Study|Withdrawal by Subject|0|||
23720023|NCT00796003|66352479|FG001|Overall Study|Withdrawal by Subject|1|||
23720024|NCT00796003|66352478|FG000|Overall Study|Other|0|||
23720025|NCT00796003|66352479|FG001|Overall Study|Other|1|||
23419976|NCT03054350|65280504|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419977|NCT03054350|65280499|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419978|NCT03054350|65280500|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419979|NCT03054350|65280501|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
23419980|NCT03054350|65280502|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419981|NCT03054350|65280503|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419982|NCT03054350|65280504|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419983|NCT03746600|65280505|FG000|Overall Study|Withdrawal by Subject|3|||
23419984|NCT03746600|65280506|FG001|Overall Study|Withdrawal by Subject|3|||
23419985|NCT03746600|65280505|FG000|Overall Study|dismissed from study|1|||
23419986|NCT03746600|65280506|FG001|Overall Study|dismissed from study|0|||
23720026|NCT00796003|66352478|FG000|Overall Study|Participants Not treated|0|||
23814210|NCT00678886|66703143|FG001|Overall Study|Withdrawal by Subject|0|||
23814211|NCT00678886|66703144|FG002|Overall Study|Withdrawal by Subject|4|||
23814212|NCT00678886|66703145|FG003|Overall Study|Withdrawal by Subject|6|||
23814213|NCT00678886|66703142|FG000|Overall Study|Physician Decision|0|||
23814214|NCT00678886|66703143|FG001|Overall Study|Physician Decision|0|||
23814215|NCT00678886|66703144|FG002|Overall Study|Physician Decision|1|||
23814216|NCT00678886|66703145|FG003|Overall Study|Physician Decision|1|||
23814217|NCT00678886|66703142|FG000|Overall Study|Lost to Follow-up|0|||
23814218|NCT00678886|66703143|FG001|Overall Study|Lost to Follow-up|0|||
23814219|NCT00678886|66703144|FG002|Overall Study|Lost to Follow-up|3|||
23814220|NCT00678886|66703145|FG003|Overall Study|Lost to Follow-up|2|||
23814221|NCT00678886|66703142|FG000|Overall Study|Other|0|||
23814222|NCT00678886|66703143|FG001|Overall Study|Other|0|||
23814223|NCT00678886|66703144|FG002|Overall Study|Other|1|||
23814224|NCT00678886|66703145|FG003|Overall Study|Other|0|||
23814225|NCT00565617|66703146|FG000|Overall Study|Withdrawal by Subject|1|||
23814226|NCT03786718|66703147|FG000|Overall Study|Lost to Follow-up|3|||
23814227|NCT03786718|66703147|FG000|Overall Study|Withdrawal by Subject|1|||
23814228|NCT03786718|66703147|FG000|Overall Study|Did not use the intervention|2|||
23814229|NCT03786718|66703147|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
23814230|NCT02992418|66703151|FG000|Overall Study|Withdrawal by Subject|11|||
23814231|NCT02992418|66703152|FG001|Overall Study|Withdrawal by Subject|12|||
23814232|NCT02992418|66703151|FG000|Overall Study|Non-compliance with the protocol|308|||
23814233|NCT02992418|66703152|FG001|Overall Study|Non-compliance with the protocol|308|||
23814234|NCT02992418|66703151|FG000|Overall Study|Lost to Follow-up|27|||
23814235|NCT02992418|66703152|FG001|Overall Study|Lost to Follow-up|22|||
23814236|NCT04283500|66703153|FG000|Overall Study|Lost to Follow-up|8|||
23814237|NCT04283500|66703153|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
23814238|NCT00642278|66703154|FG000|Overall Study|Adverse Event|2|||
23814239|NCT00642278|66703155|FG001|Overall Study|Adverse Event|1|||
23814240|NCT00642278|66703156|FG002|Overall Study|Adverse Event|3|||
23814241|NCT00642278|66703157|FG003|Overall Study|Adverse Event|1|||
23814242|NCT00642278|66703158|FG004|Overall Study|Adverse Event|2|||
23814243|NCT00642278|66703159|FG005|Overall Study|Adverse Event|2|||
23814244|NCT00642278|66703160|FG006|Overall Study|Adverse Event|0|||
23814245|NCT00642278|66703154|FG000|Overall Study|Lack of Efficacy|0|||
23814246|NCT00642278|66703155|FG001|Overall Study|Lack of Efficacy|1|||
23814247|NCT00642278|66703156|FG002|Overall Study|Lack of Efficacy|0|||
23814248|NCT00642278|66703157|FG003|Overall Study|Lack of Efficacy|0|||
23814249|NCT00642278|66703158|FG004|Overall Study|Lack of Efficacy|0|||
23814250|NCT00642278|66703159|FG005|Overall Study|Lack of Efficacy|0|||
23814251|NCT00642278|66703160|FG006|Overall Study|Lack of Efficacy|0|||
23814252|NCT00642278|66703154|FG000|Overall Study|Lost to Follow-up|5|||
23531407|NCT03246958|65680163|FG004|Overall Study|Over enrollment|0|||
23720027|NCT00796003|66352479|FG001|Overall Study|Participants Not treated|2|||
23720028|NCT00387348|66352480|FG000|Overall Study|Death|1|||
23720029|NCT00387348|66352481|FG001|Overall Study|Death|1|||
23814253|NCT00642278|66703155|FG001|Overall Study|Lost to Follow-up|1|||
23814254|NCT00642278|66703156|FG002|Overall Study|Lost to Follow-up|0|||
23814255|NCT00642278|66703157|FG003|Overall Study|Lost to Follow-up|1|||
23814256|NCT00642278|66703158|FG004|Overall Study|Lost to Follow-up|0|||
23814257|NCT00642278|66703159|FG005|Overall Study|Lost to Follow-up|1|||
23814258|NCT00642278|66703160|FG006|Overall Study|Lost to Follow-up|1|||
23814259|NCT00642278|66703154|FG000|Overall Study|Physician Decision|0|||
23814260|NCT00642278|66703155|FG001|Overall Study|Physician Decision|0|||
23814261|NCT00642278|66703156|FG002|Overall Study|Physician Decision|0|||
23814262|NCT00642278|66703157|FG003|Overall Study|Physician Decision|1|||
23720030|NCT00387348|66352482|FG002|Overall Study|Death|0|||
23720031|NCT00387348|66352480|FG000|Overall Study|Physician Decision|1|||
23720032|NCT00387348|66352481|FG001|Overall Study|Physician Decision|0|||
23720033|NCT00387348|66352482|FG002|Overall Study|Physician Decision|1|||
23419987|NCT03746600|65280505|FG000|Overall Study|Lost to Follow-up|1|||
23419988|NCT03746600|65280506|FG001|Overall Study|Lost to Follow-up|0|||
23419989|NCT01846663|65280511|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
23419990|NCT01846663|65280512|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
23419991|NCT01846663|65280511|FG000|Overall Study|Withdrawal by Subject|1|||
23419992|NCT01846663|65280512|FG001|Overall Study|Withdrawal by Subject|0|||
23419993|NCT01846663|65280511|FG000|Overall Study|Adverse Event|1|||
23419994|NCT01846663|65280512|FG001|Overall Study|Adverse Event|2|||
23419995|NCT04239222|65280513|FG000|Baseline|Withdrawal by Subject|0|||
23419996|NCT04239222|65280514|FG001|Baseline|Withdrawal by Subject|0|||
23419997|NCT04239222|65280515|FG002|Baseline|Withdrawal by Subject|1|||
23419998|NCT04239222|65280516|FG003|Baseline|Withdrawal by Subject|1|||
23419999|NCT04239222|65280513|FG000|First Foot Assignment|Withdrawal by Subject|0|||
23420000|NCT04239222|65280514|FG001|First Foot Assignment|Withdrawal by Subject|0|||
23420001|NCT04239222|65280515|FG002|First Foot Assignment|Withdrawal by Subject|1|||
23420002|NCT04239222|65280516|FG003|First Foot Assignment|Withdrawal by Subject|0|||
23420003|NCT04239222|65280513|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420004|NCT04239222|65280514|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420005|NCT04239222|65280515|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
23420006|NCT04239222|65280516|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420007|NCT03960580|65280520|FG000|Overall Study|Adverse Event|2|||
23420008|NCT03960580|65280521|FG001|Overall Study|Adverse Event|1|||
23420009|NCT03960580|65280522|FG002|Overall Study|Adverse Event|1|||
23420010|NCT03960580|65280520|FG000|Overall Study|Lost to Follow-up|1|||
23531408|NCT03246958|65680164|FG005|Overall Study|Over enrollment|0|||
23531409|NCT03246958|65680165|FG006|Overall Study|Over enrollment|0|||
23720034|NCT00387348|66352480|FG000|Overall Study|Withdrawal by Subject|0|||
23720035|NCT00387348|66352481|FG001|Overall Study|Withdrawal by Subject|2|||
23720036|NCT00387348|66352482|FG002|Overall Study|Withdrawal by Subject|2|||
23720037|NCT00387348|66352480|FG000|Overall Study|Adverse Event|1|||
23720038|NCT00387348|66352481|FG001|Overall Study|Adverse Event|0|||
23720039|NCT00387348|66352482|FG002|Overall Study|Adverse Event|1|||
23720040|NCT01357980|66352490|FG000|Overall Study|Lack of Efficacy|0|||
23720041|NCT01357980|66352491|FG001|Overall Study|Lack of Efficacy|1|||
23720042|NCT01357980|66352492|FG002|Overall Study|Lack of Efficacy|0|||
23720043|NCT01357980|66352493|FG003|Overall Study|Lack of Efficacy|0|||
23720044|NCT01357980|66352490|FG000|Overall Study|Consent withdrawn|0|||
23720045|NCT01357980|66352491|FG001|Overall Study|Consent withdrawn|0|||
23720046|NCT01357980|66352492|FG002|Overall Study|Consent withdrawn|1|||
23720047|NCT01357980|66352493|FG003|Overall Study|Consent withdrawn|0|||
23720048|NCT03434418|66352496|FG000|Overall Study|Disease Progression|11|||
23720049|NCT03434418|66352496|FG000|Overall Study|Adverse Event|2|||
23720050|NCT03434418|66352496|FG000|Overall Study|Physician Decision|1|||
23720051|NCT03434418|66352496|FG000|Overall Study|Decline in Performance Status (PS)|1|||
23720052|NCT03841526|66352500|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
23720053|NCT03841526|66352501|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23720054|NCT03841526|66352502|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23720055|NCT03841526|66352503|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
23720056|NCT03841526|66352504|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23720057|NCT03841526|66352505|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23720058|NCT03841526|66352500|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
23720059|NCT03841526|66352501|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
23720060|NCT03841526|66352502|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
23720061|NCT03841526|66352503|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
23720062|NCT03841526|66352504|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
23720063|NCT03841526|66352505|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
23720064|NCT03841526|66352500|FG000|Outpatient Phase Treatment|Physician Decision|0|||
23720065|NCT03841526|66352501|FG001|Outpatient Phase Treatment|Physician Decision|1|||
23720066|NCT03841526|66352502|FG002|Outpatient Phase Treatment|Physician Decision|0|||
23720067|NCT03841526|66352503|FG003|Outpatient Phase Treatment|Physician Decision|0|||
23720068|NCT03841526|66352504|FG004|Outpatient Phase Treatment|Physician Decision|0|||
23720069|NCT03841526|66352505|FG005|Outpatient Phase Treatment|Physician Decision|0|||
23720070|NCT03841526|66352500|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23720071|NCT03841526|66352501|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23814263|NCT00642278|66703158|FG004|Overall Study|Physician Decision|0|||
23814264|NCT00642278|66703159|FG005|Overall Study|Physician Decision|0|||
23420011|NCT03960580|65280521|FG001|Overall Study|Lost to Follow-up|0|||
23420012|NCT03960580|65280522|FG002|Overall Study|Lost to Follow-up|0|||
23420013|NCT03960580|65280520|FG000|Overall Study|Lack of Efficacy|2|||
23420014|NCT03960580|65280521|FG001|Overall Study|Lack of Efficacy|1|||
23720072|NCT03841526|66352502|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
23720073|NCT03841526|66352503|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23720074|NCT03841526|66352504|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23720075|NCT03841526|66352505|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
23720076|NCT00865189|66352508|FG000|Overall Study|Other|1|||
23720077|NCT00865189|66352509|FG001|Overall Study|Other|2|||
23720078|NCT00865189|66352508|FG000|Overall Study|Death|4|||
23720079|NCT00865189|66352509|FG001|Overall Study|Death|11|||
23720080|NCT00865189|66352508|FG000|Overall Study|Lost to Follow-up|6|||
23720081|NCT00865189|66352509|FG001|Overall Study|Lost to Follow-up|6|||
23720082|NCT00865189|66352508|FG000|Overall Study|Withdrawal by Subject|1|||
23720083|NCT00865189|66352509|FG001|Overall Study|Withdrawal by Subject|0|||
23720084|NCT00091026|66352510|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
23720085|NCT00091026|66352511|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
23720086|NCT00091026|66352510|FG000|Overall Study|Patient withdrew and never received trea|0|||
23720087|NCT00091026|66352511|FG001|Overall Study|Patient withdrew and never received trea|2|||
23720088|NCT00091026|66352510|FG000|Overall Study|Unknown-never received treatment|0|||
23720089|NCT00091026|66352511|FG001|Overall Study|Unknown-never received treatment|1|||
23720090|NCT00326417|66352512|FG000|Overall Study|Withdrawal by Subject|0|||
23720091|NCT00326417|66352513|FG001|Overall Study|Withdrawal by Subject|0|||
23720092|NCT00326417|66352514|FG002|Overall Study|Withdrawal by Subject|1|||
23720093|NCT00326417|66352515|FG003|Overall Study|Withdrawal by Subject|0|||
23720094|NCT00326417|66352512|FG000|Overall Study|Arm Closed|7|||
23720095|NCT00326417|66352513|FG001|Overall Study|Arm Closed|0|||
23720096|NCT00326417|66352514|FG002|Overall Study|Arm Closed|0|||
23720097|NCT00326417|66352515|FG003|Overall Study|Arm Closed|3|||
23720098|NCT00326417|66352512|FG000|Overall Study|Death|7|||
23720099|NCT00326417|66352513|FG001|Overall Study|Death|0|||
23420015|NCT03960580|65280522|FG002|Overall Study|Lack of Efficacy|0|||
23420016|NCT03960580|65280520|FG000|Overall Study|Protocol Violation|0|||
23420017|NCT03960580|65280521|FG001|Overall Study|Protocol Violation|0|||
23420018|NCT03960580|65280522|FG002|Overall Study|Protocol Violation|1|||
23420019|NCT03960580|65280520|FG000|Overall Study|Withdrawal by Subject|1|||
23420020|NCT03960580|65280521|FG001|Overall Study|Withdrawal by Subject|1|||
23420021|NCT03960580|65280522|FG002|Overall Study|Withdrawal by Subject|1|||
23420022|NCT03960580|65280520|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
23420023|NCT03960580|65280521|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
23420024|NCT03960580|65280522|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
23420025|NCT05426031|65280524|FG000|Overall Study|Circulatory Arrest|3|||
23420026|NCT05426031|65280525|FG001|Overall Study|Circulatory Arrest|2|||
23420027|NCT04621240|65280526|FG000|Overall Study|Withdrawal by Subject|36|||
23420028|NCT00543803|65280527|FG000|Overall Study|Adverse Event|14|||
23420029|NCT00543803|65280527|FG000|Overall Study|Lack of Efficacy|22|||
23420030|NCT00543803|65280527|FG000|Overall Study|Lost to Follow-up|20|||
23420031|NCT00543803|65280527|FG000|Overall Study|Other|86|||
23420032|NCT00132691|65280528|FG000|Overall Study|Lost to Follow-up|5|||
23420033|NCT00132691|65280529|FG001|Overall Study|Lost to Follow-up|8|||
23420034|NCT00132691|65280528|FG000|Overall Study|Missed 2-year visit|4|||
23420035|NCT00132691|65280529|FG001|Overall Study|Missed 2-year visit|4|||
23420036|NCT00132691|65280528|FG000|Overall Study|Death|2|||
23420037|NCT00132691|65280529|FG001|Overall Study|Death|0|||
23814265|NCT00642278|66703160|FG006|Overall Study|Physician Decision|0|||
23814266|NCT00642278|66703154|FG000|Overall Study|Protocol Violation|0|||
23814267|NCT00642278|66703155|FG001|Overall Study|Protocol Violation|0|||
23814268|NCT00642278|66703156|FG002|Overall Study|Protocol Violation|1|||
23814269|NCT00642278|66703157|FG003|Overall Study|Protocol Violation|1|||
23814270|NCT00642278|66703158|FG004|Overall Study|Protocol Violation|0|||
23814271|NCT00642278|66703159|FG005|Overall Study|Protocol Violation|1|||
23814272|NCT00642278|66703160|FG006|Overall Study|Protocol Violation|2|||
23814273|NCT00642278|66703154|FG000|Overall Study|Withdrawal by Subject|1|||
23814274|NCT00642278|66703155|FG001|Overall Study|Withdrawal by Subject|1|||
23814275|NCT00642278|66703156|FG002|Overall Study|Withdrawal by Subject|1|||
23531410|NCT01797536|65680168|FG000|Overall Study|Adverse Event|0|||
23531411|NCT01797536|65680169|FG001|Overall Study|Adverse Event|1|||
23531412|NCT01797536|65680170|FG002|Overall Study|Adverse Event|0|||
23720100|NCT00326417|66352514|FG002|Overall Study|Death|0|||
23420038|NCT01973387|65280530|FG000|Overall Study|Adverse Event|14|||
23531413|NCT01797536|65680171|FG003|Overall Study|Adverse Event|0|||
23814276|NCT00642278|66703157|FG003|Overall Study|Withdrawal by Subject|3|||
23420039|NCT01973387|65280531|FG001|Overall Study|Adverse Event|4|||
23420040|NCT01973387|65280530|FG000|Overall Study|Withdrawal by Subject|7|||
23531414|NCT00546715|65680178|FG000|Overall Study|Withdrawal by Subject|0|||
23814277|NCT00642278|66703158|FG004|Overall Study|Withdrawal by Subject|6|||
23531415|NCT00546715|65680179|FG001|Overall Study|Withdrawal by Subject|1|||
23420041|NCT01973387|65280531|FG001|Overall Study|Withdrawal by Subject|4|||
23420042|NCT01973387|65280530|FG000|Overall Study|Study terminated by sponsor|63|||
23420043|NCT01973387|65280531|FG001|Overall Study|Study terminated by sponsor|0|||
23420044|NCT01973387|65280530|FG000|Overall Study|Progressive disease or relapse|16|||
23420045|NCT01973387|65280531|FG001|Overall Study|Progressive disease or relapse|5|||
23420046|NCT01973387|65280530|FG000|Overall Study|Death|4|||
23420047|NCT01973387|65280531|FG001|Overall Study|Death|3|||
23420048|NCT01973387|65280530|FG000|Overall Study|Randomized, not treated|2|||
23420049|NCT01973387|65280531|FG001|Overall Study|Randomized, not treated|2|||
23420050|NCT00642174|65283734|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
23420051|NCT00642174|65283735|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
23420052|NCT01498575|65283738|FG000|Overall Sample|Withdrawal by Subject|60|||
23420053|NCT01498575|65283739|FG001|Overall Sample|Withdrawal by Subject|14|||
23420054|NCT01498575|65283738|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
23420055|NCT01498575|65283739|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
23420056|NCT01498575|65283738|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
23420057|NCT01498575|65283739|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
23420058|NCT01466660|65283742|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
23420059|NCT01466660|65283743|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
23420060|NCT01466660|65283742|FG000|Overall Study|Worsening of underlying cancer disease|5|||
23420061|NCT01466660|65283743|FG001|Overall Study|Worsening of underlying cancer disease|2|||
23420062|NCT01466660|65283742|FG000|Overall Study|Other adverse event|19|||
23420063|NCT01466660|65283743|FG001|Overall Study|Other adverse event|18|||
23420064|NCT01466660|65283742|FG000|Overall Study|Protocol Violation|2|||
23420065|NCT01466660|65283743|FG001|Overall Study|Protocol Violation|1|||
23420066|NCT01466660|65283742|FG000|Overall Study|Refused continuation of trial medication|4|||
23420067|NCT01466660|65283743|FG001|Overall Study|Refused continuation of trial medication|3|||
23420068|NCT01466660|65283742|FG000|Overall Study|Other reason not defined above|10|||
23420069|NCT01466660|65283743|FG001|Overall Study|Other reason not defined above|8|||
23420070|NCT03100539|65283744|FG000|Overall Study|Lost to Follow-up|60|||
23420071|NCT03100539|65283745|FG001|Overall Study|Lost to Follow-up|54|||
23420072|NCT03100539|65283746|FG002|Overall Study|Lost to Follow-up|17|||
23420073|NCT03100539|65283744|FG000|Overall Study|Uncollected|8|||
23420074|NCT03100539|65283745|FG001|Overall Study|Uncollected|8|||
23420075|NCT03100539|65283746|FG002|Overall Study|Uncollected|0|||
23420076|NCT03100539|65283744|FG000|Overall Study|Ally Health|0|||
23420077|NCT03100539|65283745|FG001|Overall Study|Ally Health|0|||
23420078|NCT03100539|65283746|FG002|Overall Study|Ally Health|3|||
23420079|NCT03100539|65283744|FG000|Overall Study|Disinterest|0|||
23420080|NCT03100539|65283745|FG001|Overall Study|Disinterest|0|||
23420081|NCT03100539|65283746|FG002|Overall Study|Disinterest|22|||
23420082|NCT03100539|65283744|FG000|Overall Study|Veteran Health|0|||
23420083|NCT03100539|65283745|FG001|Overall Study|Veteran Health|0|||
23420084|NCT03100539|65283746|FG002|Overall Study|Veteran Health|8|||
23420085|NCT03100539|65283744|FG000|Overall Study|Moved|0|||
23420086|NCT03100539|65283745|FG001|Overall Study|Moved|0|||
23420087|NCT03100539|65283746|FG002|Overall Study|Moved|1|||
23420088|NCT03100539|65283744|FG000|Overall Study|Scheduling Conflicts|0|||
23420089|NCT03100539|65283745|FG001|Overall Study|Scheduling Conflicts|0|||
23420090|NCT03100539|65283746|FG002|Overall Study|Scheduling Conflicts|12|||
23420091|NCT03816176|65283747|FG000|Overall Study|Miscellaneous|5|||
23420092|NCT03816176|65283747|FG000|Overall Study|Lack of Efficacy|4|||
23420093|NCT03816176|65283747|FG000|Overall Study|Adverse Event|3|||
23420094|NCT03730961|65283748|FG000|Overall Study|Adverse Event|0|||
23420095|NCT03730961|65283749|FG001|Overall Study|Adverse Event|1|||
23420096|NCT00075725|65283755|FG000|Overall Study|Adverse Event|6|||
23420097|NCT00075725|65283756|FG001|Overall Study|Adverse Event|6|||
23420098|NCT00075725|65283757|FG002|Overall Study|Adverse Event|20|||
23420099|NCT00075725|65283758|FG003|Overall Study|Adverse Event|8|||
23420100|NCT00075725|65283759|FG004|Overall Study|Adverse Event|4|||
23420101|NCT00075725|65283760|FG005|Overall Study|Adverse Event|38|||
23420102|NCT00075725|65283761|FG006|Overall Study|Adverse Event|3|||
23420103|NCT00075725|65283762|FG007|Overall Study|Adverse Event|51|||
23420104|NCT00075725|65283763|FG008|Overall Study|Adverse Event|15|||
23420105|NCT00075725|65283764|FG009|Overall Study|Adverse Event|4|||
23420106|NCT00075725|65283765|FG010|Overall Study|Adverse Event|2|||
23420107|NCT00075725|65283766|FG011|Overall Study|Adverse Event|2|||
23420108|NCT00075725|65283755|FG000|Overall Study|Death|3|||
23420109|NCT00075725|65283756|FG001|Overall Study|Death|5|||
23420110|NCT00075725|65283757|FG002|Overall Study|Death|10|||
23420111|NCT00075725|65283758|FG003|Overall Study|Death|2|||
23420112|NCT00075725|65283759|FG004|Overall Study|Death|3|||
23720101|NCT00326417|66352515|FG003|Overall Study|Death|0|||
23420113|NCT00075725|65283760|FG005|Overall Study|Death|25|||
23420114|NCT00075725|65283761|FG006|Overall Study|Death|4|||
23420115|NCT00075725|65283762|FG007|Overall Study|Death|22|||
23420116|NCT00075725|65283763|FG008|Overall Study|Death|14|||
23420117|NCT00075725|65283764|FG009|Overall Study|Death|4|||
23420118|NCT00075725|65283765|FG010|Overall Study|Death|3|||
23420119|NCT00075725|65283766|FG011|Overall Study|Death|0|||
23420120|NCT00075725|65283755|FG000|Overall Study|Lost to Follow-up|1|||
23420121|NCT00075725|65283756|FG001|Overall Study|Lost to Follow-up|1|||
23420122|NCT00075725|65283757|FG002|Overall Study|Lost to Follow-up|4|||
23420123|NCT00075725|65283758|FG003|Overall Study|Lost to Follow-up|1|||
23420124|NCT00075725|65283759|FG004|Overall Study|Lost to Follow-up|0|||
23420125|NCT00075725|65283760|FG005|Overall Study|Lost to Follow-up|13|||
23531416|NCT00546715|65680180|FG002|Overall Study|Withdrawal by Subject|0|||
23531417|NCT00546715|65680181|FG003|Overall Study|Withdrawal by Subject|0|||
23613382|NCT02446912|65973072|FG002|Overall Study|Study-specific withdrawal criteria|0|||
23613383|NCT02446912|65973070|FG000|Overall Study|Lack of Efficacy|1|||
23531418|NCT02287896|65680184|FG000|Second Injection Visit|Withdrawal by Subject|0|||
23531419|NCT02287896|65680185|FG001|Second Injection Visit|Withdrawal by Subject|1|||
23531420|NCT01631474|65680186|FG000|Overall Study|Lost to Follow-up|8|||
23531421|NCT01631474|65680187|FG001|Overall Study|Lost to Follow-up|5|||
23531422|NCT01631474|65680188|FG002|Overall Study|Lost to Follow-up|7|||
23531423|NCT01631474|65680189|FG003|Overall Study|Lost to Follow-up|5|||
23531424|NCT01631474|65680190|FG004|Overall Study|Lost to Follow-up|5|||
23531425|NCT01631474|65680186|FG000|Overall Study|Withdrawal by Subject|4|||
23531426|NCT01631474|65680187|FG001|Overall Study|Withdrawal by Subject|4|||
23531427|NCT01631474|65680188|FG002|Overall Study|Withdrawal by Subject|2|||
23531428|NCT01631474|65680189|FG003|Overall Study|Withdrawal by Subject|6|||
23531429|NCT01631474|65680190|FG004|Overall Study|Withdrawal by Subject|5|||
23531430|NCT01631474|65680186|FG000|Overall Study|Lack of Efficacy|2|||
23531431|NCT01631474|65680187|FG001|Overall Study|Lack of Efficacy|2|||
23531432|NCT01631474|65680188|FG002|Overall Study|Lack of Efficacy|0|||
23531433|NCT01631474|65680189|FG003|Overall Study|Lack of Efficacy|0|||
23531434|NCT01631474|65680190|FG004|Overall Study|Lack of Efficacy|2|||
23531435|NCT01631474|65680186|FG000|Overall Study|Noncompliance with Study Drug|0|||
23531436|NCT01631474|65680187|FG001|Overall Study|Noncompliance with Study Drug|0|||
23531437|NCT01631474|65680188|FG002|Overall Study|Noncompliance with Study Drug|0|||
23531438|NCT01631474|65680189|FG003|Overall Study|Noncompliance with Study Drug|0|||
23531439|NCT01631474|65680190|FG004|Overall Study|Noncompliance with Study Drug|1|||
23531440|NCT01631474|65680186|FG000|Overall Study|Adverse Event|0|||
23613384|NCT02446912|65973071|FG001|Overall Study|Lack of Efficacy|4|||
23613385|NCT02446912|65973072|FG002|Overall Study|Lack of Efficacy|7|||
23613386|NCT02446912|65973070|FG000|Overall Study|Lost to Follow-up|0|||
23613387|NCT02446912|65973071|FG001|Overall Study|Lost to Follow-up|0|||
23613388|NCT02446912|65973072|FG002|Overall Study|Lost to Follow-up|2|||
23613389|NCT02446912|65973070|FG000|Overall Study|Severe non-compliance to protocol|1|||
23613390|NCT02446912|65973071|FG001|Overall Study|Severe non-compliance to protocol|0|||
23613391|NCT02446912|65973072|FG002|Overall Study|Severe non-compliance to protocol|1|||
23613392|NCT02446912|65973070|FG000|Overall Study|Withdrawal by Subject|10|||
23613393|NCT02446912|65973071|FG001|Overall Study|Withdrawal by Subject|15|||
23613394|NCT02446912|65973072|FG002|Overall Study|Withdrawal by Subject|15|||
23613395|NCT02446912|65973070|FG000|Overall Study|Miscellaneous|2|||
23531441|NCT01631474|65680187|FG001|Overall Study|Adverse Event|1|||
23531442|NCT01631474|65680188|FG002|Overall Study|Adverse Event|0|||
23531443|NCT01631474|65680189|FG003|Overall Study|Adverse Event|0|||
23613396|NCT02446912|65973071|FG001|Overall Study|Miscellaneous|2|||
23613397|NCT02446912|65973072|FG002|Overall Study|Miscellaneous|4|||
23613398|NCT03614923|65973073|FG000|Overall Study|Withdrawal by Subject|2|||
23613399|NCT03614923|65973074|FG001|Overall Study|Withdrawal by Subject|1|||
23613400|NCT03614923|65973075|FG002|Overall Study|Withdrawal by Subject|1|||
23613401|NCT03614923|65973073|FG000|Overall Study|Adverse Event|0|||
23613402|NCT03614923|65973074|FG001|Overall Study|Adverse Event|2|||
23613403|NCT03614923|65973075|FG002|Overall Study|Adverse Event|1|||
23613404|NCT03614923|65973073|FG000|Overall Study|Lost to Follow-up|1|||
23613405|NCT03614923|65973074|FG001|Overall Study|Lost to Follow-up|0|||
23613406|NCT03614923|65973075|FG002|Overall Study|Lost to Follow-up|1|||
23613407|NCT03614923|65973073|FG000|Overall Study|Lack of Efficacy|2|||
23613408|NCT03614923|65973074|FG001|Overall Study|Lack of Efficacy|0|||
23613409|NCT03614923|65973075|FG002|Overall Study|Lack of Efficacy|1|||
23531444|NCT01631474|65680190|FG004|Overall Study|Adverse Event|0|||
23613410|NCT03614923|65973073|FG000|Overall Study|Non-compliance|0|||
23613411|NCT03614923|65973074|FG001|Overall Study|Non-compliance|1|||
23613412|NCT03614923|65973075|FG002|Overall Study|Non-compliance|0|||
23613413|NCT03614923|65973073|FG000|Overall Study|Other|0|||
23420126|NCT00075725|65283761|FG006|Overall Study|Lost to Follow-up|2|||
23613414|NCT03614923|65973074|FG001|Overall Study|Other|1|||
23613415|NCT03614923|65973075|FG002|Overall Study|Other|1|||
23531445|NCT03235024|65680191|FG000|Overall Study|Adverse Event|2|||
23531446|NCT03235024|65680192|FG001|Overall Study|Adverse Event|2|||
23531447|NCT03235024|65680191|FG000|Overall Study|Death|1|||
23531448|NCT03235024|65680192|FG001|Overall Study|Death|0|||
23531449|NCT03235024|65680191|FG000|Overall Study|Lost to Follow-up|2|||
23531450|NCT03235024|65680192|FG001|Overall Study|Lost to Follow-up|5|||
23613416|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
23613417|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
23613418|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
23613419|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
23613420|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
23613421|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
23613422|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Other|3|||
23613423|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Other|0|||
23613424|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Other|0|||
23613425|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
23613426|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
23613427|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
23613428|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
23613429|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
23613430|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
23613431|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
23613432|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
23613433|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
23613434|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Other|0|||
23613435|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Other|1|||
23613436|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Other|0|||
23613437|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
23613438|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
23613439|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
23613440|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
23613441|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
23613442|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
23613443|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
23613444|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
23613445|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
23613446|NCT03169530|65973082|FG000|Overall Study|Study ended by NIH|15|||
23613447|NCT03169530|65973083|FG001|Overall Study|Study ended by NIH|17|||
23613448|NCT03997409|65973084|FG000|Overall Study|Protocol Violation|1|||
23613449|NCT03997409|65973085|FG001|Overall Study|Protocol Violation|1|||
23613450|NCT03997409|65973086|FG002|Overall Study|Protocol Violation|0|||
23613451|NCT03997409|65973084|FG000|Overall Study|Withdrawal by Subject|3|||
23613452|NCT03997409|65973085|FG001|Overall Study|Withdrawal by Subject|0|||
23613453|NCT03997409|65973086|FG002|Overall Study|Withdrawal by Subject|0|||
23613454|NCT03997409|65973084|FG000|Overall Study|Lost to Follow-up|0|||
23613455|NCT03997409|65973085|FG001|Overall Study|Lost to Follow-up|0|||
23613456|NCT03997409|65973086|FG002|Overall Study|Lost to Follow-up|1|||
23613457|NCT01304940|65973087|FG000|Overall Study|not meet symptom severity requirement|3|||
23613458|NCT01304940|65973088|FG001|Overall Study|not meet symptom severity requirement|0|||
23613459|NCT02812706|65973089|FG000|Phase 1|Adverse Event|0|||
23613460|NCT02812706|65973090|FG001|Phase 1|Adverse Event|2|||
23613461|NCT02812706|65973091|FG002|Phase 1|Adverse Event|0|||
23613462|NCT02812706|65973089|FG000|Phase 1|Progressive disease|3|||
23613463|NCT02812706|65973090|FG001|Phase 1|Progressive disease|3|||
23613464|NCT02812706|65973091|FG002|Phase 1|Progressive disease|0|||
23613465|NCT02812706|65973089|FG000|Phase 2|Adverse Event|0|||
23613466|NCT02812706|65973090|FG001|Phase 2|Adverse Event|0|||
23613467|NCT02812706|65973091|FG002|Phase 2|Adverse Event|2|||
23613468|NCT02812706|65973089|FG000|Phase 2|Progressive disease|0|||
23613469|NCT02812706|65973090|FG001|Phase 2|Progressive disease|0|||
23613470|NCT02812706|65973091|FG002|Phase 2|Progressive disease|22|||
23613471|NCT02812706|65973089|FG000|Phase 2|Other-Unspecified|0|||
23613472|NCT02812706|65973090|FG001|Phase 2|Other-Unspecified|0|||
23613473|NCT02812706|65973091|FG002|Phase 2|Other-Unspecified|4|||
23613474|NCT04380688|65973095|FG000|Overall Study|Death|2|||
23613475|NCT04380688|65973096|FG001|Overall Study|Death|2|||
23613476|NCT04380688|65973095|FG000|Overall Study|Lost to Follow-up|2|||
23613477|NCT04380688|65973096|FG001|Overall Study|Lost to Follow-up|4|||
23613478|NCT04380688|65973095|FG000|Overall Study|Withdrawal by Subject|3|||
23613479|NCT04380688|65973096|FG001|Overall Study|Withdrawal by Subject|3|||
23613480|NCT01877720|65973097|FG000|Overall Study|Adverse Event|1|||
23613481|NCT01877720|65973098|FG001|Overall Study|Adverse Event|0|||
23613482|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
23613483|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
23613484|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
23613485|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613486|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613487|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613488|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
23613489|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
23613490|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
23613491|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613492|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613493|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613494|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613495|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
23613496|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613497|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613498|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613499|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613500|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613501|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
23613502|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613503|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613504|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613505|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613506|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613507|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613508|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
23613509|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613510|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613511|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613512|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613513|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
23613514|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
23613515|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613516|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613517|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613518|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
23613519|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
23613520|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
23613521|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23531451|NCT03235024|65680191|FG000|Overall Study|Protocol Violation|1|||
23531452|NCT03235024|65680192|FG001|Overall Study|Protocol Violation|0|||
23531453|NCT03235024|65680191|FG000|Overall Study|Withdrawal by Subject|0|||
23531454|NCT03235024|65680192|FG001|Overall Study|Withdrawal by Subject|3|||
23531455|NCT01256710|65680198|FG000|Overall Study|Death|449|||
23531456|NCT01256710|65680198|FG000|Overall Study|System Explant|67|||
23531457|NCT01256710|65680198|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
23531458|NCT01256710|65680198|FG000|Overall Study|Lost to Follow-up|67|||
23531459|NCT01256710|65680198|FG000|Overall Study|Withdrawal by Subject|29|||
23531460|NCT01256710|65680198|FG000|Overall Study|Physician Decision|9|||
23531461|NCT01256710|65680198|FG000|Overall Study|Subject Noncompliance|2|||
23531462|NCT01256710|65680198|FG000|Overall Study|Study Terminated by Sponsor|273|||
23531463|NCT01451424|65680199|FG000|Overall Study|Withdrawal by Subject|1|||
23531464|NCT01451424|65680200|FG001|Overall Study|Withdrawal by Subject|1|||
23531465|NCT01451424|65680201|FG002|Overall Study|Withdrawal by Subject|0|||
23531466|NCT01451424|65680202|FG003|Overall Study|Withdrawal by Subject|2|||
23531467|NCT01451424|65680199|FG000|Overall Study|Lost to Follow-up|0|||
23531468|NCT01451424|65680200|FG001|Overall Study|Lost to Follow-up|1|||
23531469|NCT01451424|65680201|FG002|Overall Study|Lost to Follow-up|0|||
23531470|NCT01451424|65680202|FG003|Overall Study|Lost to Follow-up|1|||
23531471|NCT01451424|65680199|FG000|Overall Study|Physician Decision|0|||
23531472|NCT01451424|65680200|FG001|Overall Study|Physician Decision|0|||
23531473|NCT01451424|65680201|FG002|Overall Study|Physician Decision|1|||
23531474|NCT01451424|65680202|FG003|Overall Study|Physician Decision|1|||
23531475|NCT01451424|65680199|FG000|Overall Study|Adverse Event|0|||
23531476|NCT01451424|65680200|FG001|Overall Study|Adverse Event|0|||
23531477|NCT01451424|65680201|FG002|Overall Study|Adverse Event|0|||
23531478|NCT01451424|65680202|FG003|Overall Study|Adverse Event|1|||
23613522|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23613523|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23636601|NCT01498887|66052944|FG000|Overall Study|Abnormal result from test procedure|1|||
23531479|NCT03945981|65680211|FG000|Overall Study|Lost to Follow-up|12|||
23531480|NCT03945981|65680211|FG000|Overall Study|Physician Decision|4|||
23531481|NCT03945981|65680211|FG000|Overall Study|Withdrawal by Subject|6|||
23531482|NCT03945981|65680211|FG000|Overall Study|Protocol Violation|1|||
23531483|NCT00574405|65680212|FG000|Overall Study|Withdrawal by Subject|3|||
23531484|NCT00574405|65680213|FG001|Overall Study|Withdrawal by Subject|2|||
23531485|NCT00240071|65680214|FG000|Overall Study|Withdrawal by Subject|3|||
23531486|NCT02460224|65680215|FG000|Overall Study|Adverse Event|0|||
23531487|NCT02460224|65680216|FG001|Overall Study|Adverse Event|0|||
23531488|NCT02460224|65680217|FG002|Overall Study|Adverse Event|0|||
23531489|NCT02460224|65680218|FG003|Overall Study|Adverse Event|0|||
23531490|NCT02460224|65680219|FG004|Overall Study|Adverse Event|0|||
23720102|NCT00376246|66352516|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
23531491|NCT02460224|65680220|FG005|Overall Study|Adverse Event|0|||
23531492|NCT02460224|65680221|FG006|Overall Study|Adverse Event|1|||
23531493|NCT02460224|65680222|FG007|Overall Study|Adverse Event|0|||
23531494|NCT02460224|65680223|FG008|Overall Study|Adverse Event|0|||
23531495|NCT02460224|65680224|FG009|Overall Study|Adverse Event|0|||
23531496|NCT02460224|65680225|FG010|Overall Study|Adverse Event|0|||
23531497|NCT02460224|65680226|FG011|Overall Study|Adverse Event|0|||
23531498|NCT02460224|65680227|FG012|Overall Study|Adverse Event|1|||
23531499|NCT02460224|65680228|FG013|Overall Study|Adverse Event|0|||
23531500|NCT02460224|65680229|FG014|Overall Study|Adverse Event|0|||
23531501|NCT02460224|65680230|FG015|Overall Study|Adverse Event|0|||
23531502|NCT02460224|65680231|FG016|Overall Study|Adverse Event|1|||
23531503|NCT02460224|65680232|FG017|Overall Study|Adverse Event|0|||
23531504|NCT02460224|65680233|FG018|Overall Study|Adverse Event|1|||
23531505|NCT02460224|65680234|FG019|Overall Study|Adverse Event|0|||
23613524|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
23613525|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
23613526|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
23613527|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613528|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613529|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613530|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Adverse Event|0|||
23613531|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Adverse Event|0|||
23613532|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Adverse Event|0|||
23613533|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Adverse Event|2|||
23613534|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Adverse Event|0|||
23613535|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Adverse Event|0|||
23613536|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613537|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613538|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613539|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
23613540|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
23720103|NCT00376246|66352517|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
23720104|NCT00376246|66352516|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23720105|NCT00376246|66352517|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
23720106|NCT00376246|66352516|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23720107|NCT00376246|66352517|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23720108|NCT01624506|66352518|FG000|Overall Study|Lost to Follow-up|29|||
23720109|NCT01624506|66352519|FG001|Overall Study|Lost to Follow-up|15|||
23720110|NCT01624506|66352518|FG000|Overall Study|Withdrawal by Subject|9|||
23720111|NCT01624506|66352519|FG001|Overall Study|Withdrawal by Subject|2|||
23720112|NCT01624506|66352518|FG000|Overall Study|Death|1|||
23720113|NCT01624506|66352519|FG001|Overall Study|Death|0|||
23720114|NCT01624506|66352518|FG000|Overall Study|LINX explants|23|||
23720115|NCT01624506|66352519|FG001|Overall Study|LINX explants|0|||
23720116|NCT01624506|66352518|FG000|Overall Study|Adverse Event|3|||
23720117|NCT01624506|66352519|FG001|Overall Study|Adverse Event|0|||
23720118|NCT01444898|66352520|FG000|Overall Study|Withdrawal by Subject|1|||
23720119|NCT03039738|66352524|FG000|Overall Study|Incomplete data sets|54|||
23720120|NCT03039738|66352525|FG001|Overall Study|Incomplete data sets|0|||
23720121|NCT01068717|66352526|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
23720122|NCT01068717|66352527|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23720123|NCT01068717|66352528|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23720124|NCT01068717|66352529|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23720125|NCT02501902|66352530|FG000|Overall Study|Subject Refused Further Follow-up|0|||
23720126|NCT02501902|66352531|FG001|Overall Study|Subject Refused Further Follow-up|0|||
23720127|NCT02501902|66352532|FG002|Overall Study|Subject Refused Further Follow-up|0|||
23531506|NCT02460224|65680235|FG020|Overall Study|Adverse Event|1|||
23531507|NCT02460224|65680236|FG021|Overall Study|Adverse Event|1|||
23531508|NCT02460224|65680237|FG022|Overall Study|Adverse Event|1|||
23531509|NCT02460224|65680238|FG023|Overall Study|Adverse Event|0|||
23531510|NCT02460224|65680239|FG024|Overall Study|Adverse Event|0|||
23531511|NCT02460224|65680240|FG025|Overall Study|Adverse Event|0|||
23531512|NCT02460224|65680241|FG026|Overall Study|Adverse Event|11|||
23613541|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
23531513|NCT02460224|65680242|FG027|Overall Study|Adverse Event|1|||
23814278|NCT00642278|66703159|FG005|Overall Study|Withdrawal by Subject|2|||
23613542|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Pregnancy|0|||
23613543|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Pregnancy|0|||
23613544|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Pregnancy|0|||
23613545|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Pregnancy|1|||
23613546|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Pregnancy|0|||
23613547|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Pregnancy|0|||
23613548|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613549|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613550|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613551|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
23613552|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613553|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613554|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613555|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613556|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613557|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23814279|NCT00642278|66703160|FG006|Overall Study|Withdrawal by Subject|2|||
23814280|NCT00642278|66703154|FG000|Overall Study|Noncompliance with study drug regimen|0|||
23814281|NCT00642278|66703155|FG001|Overall Study|Noncompliance with study drug regimen|0|||
23531514|NCT02460224|65680243|FG028|Overall Study|Adverse Event|6|||
23531515|NCT02460224|65680215|FG000|Overall Study|Death|0|||
23531516|NCT02460224|65680216|FG001|Overall Study|Death|0|||
23531517|NCT02460224|65680217|FG002|Overall Study|Death|0|||
23531518|NCT02460224|65680218|FG003|Overall Study|Death|0|||
23531519|NCT02460224|65680219|FG004|Overall Study|Death|0|||
23531520|NCT02460224|65680220|FG005|Overall Study|Death|2|||
23531521|NCT02460224|65680221|FG006|Overall Study|Death|1|||
23531522|NCT02460224|65680222|FG007|Overall Study|Death|0|||
23531523|NCT02460224|65680223|FG008|Overall Study|Death|0|||
23531524|NCT02460224|65680224|FG009|Overall Study|Death|1|||
23531525|NCT02460224|65680225|FG010|Overall Study|Death|0|||
23531526|NCT02460224|65680226|FG011|Overall Study|Death|0|||
23531527|NCT02460224|65680227|FG012|Overall Study|Death|0|||
23531528|NCT02460224|65680228|FG013|Overall Study|Death|1|||
23613558|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
23613559|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613560|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613561|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613562|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613563|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613564|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
23613565|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613566|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613567|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613568|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613569|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613570|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
23613571|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613572|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613573|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613574|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613575|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23814282|NCT00642278|66703156|FG002|Overall Study|Noncompliance with study drug regimen|0|||
23613576|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
23613577|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613578|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613579|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613580|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613581|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23814283|NCT00642278|66703157|FG003|Overall Study|Noncompliance with study drug regimen|1|||
23531529|NCT02460224|65680229|FG014|Overall Study|Death|0|||
23531530|NCT02460224|65680230|FG015|Overall Study|Death|0|||
23531531|NCT02460224|65680231|FG016|Overall Study|Death|2|||
23531532|NCT02460224|65680232|FG017|Overall Study|Death|1|||
23531533|NCT02460224|65680233|FG018|Overall Study|Death|0|||
23613582|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
23613583|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613584|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613585|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613586|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613587|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613588|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
23613589|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613590|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613591|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613592|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613593|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613594|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
23613595|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613596|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613597|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613598|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613599|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613600|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613601|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
23613602|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613603|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613604|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613605|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613606|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613607|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
23613608|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613609|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613610|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613611|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613612|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613613|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
23613614|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613615|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613616|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613617|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613618|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613619|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
23613620|NCT01770509|65973105|FG000|Overall Study|Injury|0|||
23613621|NCT01770509|65973106|FG001|Overall Study|Injury|1|||
23613622|NCT01770509|65973105|FG000|Overall Study|Lost to Follow-up|1|||
23613623|NCT01770509|65973106|FG001|Overall Study|Lost to Follow-up|2|||
23613624|NCT00108355|65973107|FG000|Overall Study|Peritonitis at index paracentesis|1|||
23531534|NCT02460224|65680234|FG019|Overall Study|Death|2|||
23531535|NCT02460224|65680235|FG020|Overall Study|Death|0|||
23531536|NCT02460224|65680236|FG021|Overall Study|Death|0|||
23531537|NCT02460224|65680237|FG022|Overall Study|Death|0|||
23531538|NCT02460224|65680238|FG023|Overall Study|Death|0|||
23531539|NCT02460224|65680239|FG024|Overall Study|Death|1|||
23531540|NCT02460224|65680240|FG025|Overall Study|Death|1|||
23531541|NCT02460224|65680241|FG026|Overall Study|Death|5|||
23531542|NCT02460224|65680242|FG027|Overall Study|Death|0|||
23613625|NCT00108355|65973108|FG001|Overall Study|Peritonitis at index paracentesis|1|||
23613626|NCT00108355|65973107|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
23613627|NCT00108355|65973108|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
23613628|NCT01540474|65973114|FG000|Vaccination Period|Lost to Follow-up|0|||
23531543|NCT02460224|65680243|FG028|Overall Study|Death|1|||
23531544|NCT02460224|65680215|FG000|Overall Study|Lost to Follow-up|0|||
23531545|NCT02460224|65680216|FG001|Overall Study|Lost to Follow-up|0|||
23613629|NCT01540474|65973115|FG001|Vaccination Period|Lost to Follow-up|1|||
23531546|NCT02460224|65680217|FG002|Overall Study|Lost to Follow-up|0|||
23531547|NCT02460224|65680218|FG003|Overall Study|Lost to Follow-up|0|||
23531548|NCT02460224|65680219|FG004|Overall Study|Lost to Follow-up|0|||
23531549|NCT02460224|65680220|FG005|Overall Study|Lost to Follow-up|0|||
23531550|NCT02460224|65680221|FG006|Overall Study|Lost to Follow-up|0|||
23531551|NCT02460224|65680222|FG007|Overall Study|Lost to Follow-up|0|||
23531552|NCT02460224|65680223|FG008|Overall Study|Lost to Follow-up|0|||
23531553|NCT02460224|65680224|FG009|Overall Study|Lost to Follow-up|0|||
23531554|NCT02460224|65680225|FG010|Overall Study|Lost to Follow-up|0|||
23531555|NCT02460224|65680226|FG011|Overall Study|Lost to Follow-up|0|||
23531556|NCT02460224|65680227|FG012|Overall Study|Lost to Follow-up|0|||
23531557|NCT02460224|65680228|FG013|Overall Study|Lost to Follow-up|0|||
23531558|NCT02460224|65680229|FG014|Overall Study|Lost to Follow-up|0|||
23531559|NCT02460224|65680230|FG015|Overall Study|Lost to Follow-up|0|||
23531560|NCT02460224|65680231|FG016|Overall Study|Lost to Follow-up|0|||
23531561|NCT02460224|65680232|FG017|Overall Study|Lost to Follow-up|0|||
23531562|NCT02460224|65680233|FG018|Overall Study|Lost to Follow-up|0|||
23531563|NCT02460224|65680234|FG019|Overall Study|Lost to Follow-up|0|||
23531564|NCT02460224|65680235|FG020|Overall Study|Lost to Follow-up|0|||
23531565|NCT02460224|65680236|FG021|Overall Study|Lost to Follow-up|0|||
23531566|NCT02460224|65680237|FG022|Overall Study|Lost to Follow-up|1|||
23531567|NCT02460224|65680238|FG023|Overall Study|Lost to Follow-up|0|||
23531568|NCT02460224|65680239|FG024|Overall Study|Lost to Follow-up|0|||
23531569|NCT02460224|65680240|FG025|Overall Study|Lost to Follow-up|0|||
23531570|NCT02460224|65680241|FG026|Overall Study|Lost to Follow-up|0|||
23531571|NCT02460224|65680242|FG027|Overall Study|Lost to Follow-up|0|||
23531572|NCT02460224|65680243|FG028|Overall Study|Lost to Follow-up|0|||
23531573|NCT02460224|65680215|FG000|Overall Study|Physician Decision|0|||
23531574|NCT02460224|65680216|FG001|Overall Study|Physician Decision|1|||
23531575|NCT02460224|65680217|FG002|Overall Study|Physician Decision|0|||
23531576|NCT02460224|65680218|FG003|Overall Study|Physician Decision|0|||
23531577|NCT02460224|65680219|FG004|Overall Study|Physician Decision|1|||
23531578|NCT02460224|65680220|FG005|Overall Study|Physician Decision|0|||
23531579|NCT02460224|65680221|FG006|Overall Study|Physician Decision|0|||
23531580|NCT02460224|65680222|FG007|Overall Study|Physician Decision|1|||
23531581|NCT02460224|65680223|FG008|Overall Study|Physician Decision|0|||
23531582|NCT02460224|65680224|FG009|Overall Study|Physician Decision|0|||
23531583|NCT02460224|65680225|FG010|Overall Study|Physician Decision|0|||
23531584|NCT02460224|65680226|FG011|Overall Study|Physician Decision|1|||
23531585|NCT02460224|65680227|FG012|Overall Study|Physician Decision|0|||
23531586|NCT02460224|65680228|FG013|Overall Study|Physician Decision|1|||
23531587|NCT02460224|65680229|FG014|Overall Study|Physician Decision|0|||
23531588|NCT02460224|65680230|FG015|Overall Study|Physician Decision|0|||
23531589|NCT02460224|65680231|FG016|Overall Study|Physician Decision|2|||
23531590|NCT02460224|65680232|FG017|Overall Study|Physician Decision|1|||
23531591|NCT02460224|65680233|FG018|Overall Study|Physician Decision|1|||
23531592|NCT02460224|65680234|FG019|Overall Study|Physician Decision|2|||
23531593|NCT02460224|65680235|FG020|Overall Study|Physician Decision|1|||
23531594|NCT02460224|65680236|FG021|Overall Study|Physician Decision|1|||
23531595|NCT02460224|65680237|FG022|Overall Study|Physician Decision|0|||
23531596|NCT02460224|65680238|FG023|Overall Study|Physician Decision|0|||
23531597|NCT02460224|65680239|FG024|Overall Study|Physician Decision|1|||
23531598|NCT02460224|65680240|FG025|Overall Study|Physician Decision|0|||
23531599|NCT02460224|65680241|FG026|Overall Study|Physician Decision|14|||
23531600|NCT02460224|65680242|FG027|Overall Study|Physician Decision|1|||
23531601|NCT02460224|65680243|FG028|Overall Study|Physician Decision|6|||
23531602|NCT02460224|65680215|FG000|Overall Study|Progressive disease|15|||
23531603|NCT02460224|65680216|FG001|Overall Study|Progressive disease|11|||
23531604|NCT02460224|65680217|FG002|Overall Study|Progressive disease|5|||
23531605|NCT02460224|65680218|FG003|Overall Study|Progressive disease|6|||
23531606|NCT02460224|65680219|FG004|Overall Study|Progressive disease|3|||
23531607|NCT02460224|65680220|FG005|Overall Study|Progressive disease|26|||
23531608|NCT02460224|65680221|FG006|Overall Study|Progressive disease|28|||
23531609|NCT02460224|65680222|FG007|Overall Study|Progressive disease|4|||
23531610|NCT02460224|65680223|FG008|Overall Study|Progressive disease|5|||
23531611|NCT02460224|65680224|FG009|Overall Study|Progressive disease|9|||
23531612|NCT02460224|65680225|FG010|Overall Study|Progressive disease|5|||
23531613|NCT02460224|65680226|FG011|Overall Study|Progressive disease|4|||
23531614|NCT02460224|65680227|FG012|Overall Study|Progressive disease|5|||
23531615|NCT02460224|65680228|FG013|Overall Study|Progressive disease|4|||
23531616|NCT02460224|65680229|FG014|Overall Study|Progressive disease|5|||
23531617|NCT02460224|65680230|FG015|Overall Study|Progressive disease|5|||
23531618|NCT02460224|65680231|FG016|Overall Study|Progressive disease|15|||
23531619|NCT02460224|65680232|FG017|Overall Study|Progressive disease|3|||
23531620|NCT02460224|65680233|FG018|Overall Study|Progressive disease|8|||
23531621|NCT02460224|65680234|FG019|Overall Study|Progressive disease|3|||
23613630|NCT01540474|65973116|FG002|Vaccination Period|Lost to Follow-up|0|||
23531622|NCT02460224|65680235|FG020|Overall Study|Progressive disease|4|||
23531623|NCT02460224|65680236|FG021|Overall Study|Progressive disease|9|||
23531624|NCT02460224|65680237|FG022|Overall Study|Progressive disease|4|||
23531625|NCT02460224|65680238|FG023|Overall Study|Progressive disease|11|||
23531626|NCT02460224|65680239|FG024|Overall Study|Progressive disease|4|||
23531627|NCT02460224|65680240|FG025|Overall Study|Progressive disease|5|||
23720128|NCT02501902|66352533|FG003|Overall Study|Subject Refused Further Follow-up|0|||
23814284|NCT00642278|66703158|FG004|Overall Study|Noncompliance with study drug regimen|0|||
23814285|NCT00642278|66703159|FG005|Overall Study|Noncompliance with study drug regimen|0|||
23814286|NCT00642278|66703160|FG006|Overall Study|Noncompliance with study drug regimen|0|||
23531628|NCT02460224|65680241|FG026|Overall Study|Progressive disease|85|||
23531629|NCT02460224|65680242|FG027|Overall Study|Progressive disease|17|||
23531630|NCT02460224|65680243|FG028|Overall Study|Progressive disease|77|||
23531631|NCT02460224|65680215|FG000|Overall Study|Subject/guardian decision|2|||
23531632|NCT02460224|65680216|FG001|Overall Study|Subject/guardian decision|0|||
23531633|NCT02460224|65680217|FG002|Overall Study|Subject/guardian decision|1|||
23531634|NCT02460224|65680218|FG003|Overall Study|Subject/guardian decision|0|||
23531635|NCT02460224|65680219|FG004|Overall Study|Subject/guardian decision|2|||
23531636|NCT02460224|65680220|FG005|Overall Study|Subject/guardian decision|2|||
23531637|NCT02460224|65680221|FG006|Overall Study|Subject/guardian decision|0|||
23531638|NCT02460224|65680222|FG007|Overall Study|Subject/guardian decision|0|||
23531639|NCT02460224|65680223|FG008|Overall Study|Subject/guardian decision|1|||
23531640|NCT02460224|65680224|FG009|Overall Study|Subject/guardian decision|1|||
23531641|NCT02460224|65680225|FG010|Overall Study|Subject/guardian decision|0|||
23531642|NCT02460224|65680226|FG011|Overall Study|Subject/guardian decision|1|||
23531643|NCT02460224|65680227|FG012|Overall Study|Subject/guardian decision|0|||
23531644|NCT02460224|65680228|FG013|Overall Study|Subject/guardian decision|0|||
23531645|NCT02460224|65680229|FG014|Overall Study|Subject/guardian decision|0|||
23531646|NCT02460224|65680230|FG015|Overall Study|Subject/guardian decision|1|||
23531647|NCT02460224|65680231|FG016|Overall Study|Subject/guardian decision|0|||
23531648|NCT02460224|65680232|FG017|Overall Study|Subject/guardian decision|1|||
23531649|NCT02460224|65680233|FG018|Overall Study|Subject/guardian decision|2|||
23531650|NCT02460224|65680234|FG019|Overall Study|Subject/guardian decision|0|||
23531651|NCT02460224|65680235|FG020|Overall Study|Subject/guardian decision|0|||
23531652|NCT02460224|65680236|FG021|Overall Study|Subject/guardian decision|1|||
23531653|NCT02460224|65680237|FG022|Overall Study|Subject/guardian decision|0|||
23531654|NCT02460224|65680238|FG023|Overall Study|Subject/guardian decision|0|||
23531655|NCT02460224|65680239|FG024|Overall Study|Subject/guardian decision|0|||
23531656|NCT02460224|65680240|FG025|Overall Study|Subject/guardian decision|0|||
23531657|NCT02460224|65680241|FG026|Overall Study|Subject/guardian decision|6|||
23531658|NCT02460224|65680242|FG027|Overall Study|Subject/guardian decision|2|||
23531659|NCT02460224|65680243|FG028|Overall Study|Subject/guardian decision|3|||
23531660|NCT01800916|65680244|FG000|Test Period 1 (1 Week)|Convex product user|0|||
23531661|NCT01800916|65680245|FG001|Test Period 1 (1 Week)|Convex product user|0|||
23531662|NCT01800916|65680246|FG002|Test Period 1 (1 Week)|Convex product user|0|||
23531663|NCT01800916|65680247|FG003|Test Period 1 (1 Week)|Convex product user|1|||
23531664|NCT01800916|65680248|FG004|Test Period 1 (1 Week)|Convex product user|0|||
23531665|NCT01800916|65680249|FG005|Test Period 1 (1 Week)|Convex product user|0|||
23531666|NCT01800916|65680250|FG006|Test Period 1 (1 Week)|Convex product user|0|||
23531667|NCT01800916|65680251|FG007|Test Period 1 (1 Week)|Convex product user|0|||
23531668|NCT01800916|65680252|FG008|Test Period 1 (1 Week)|Convex product user|0|||
23531669|NCT01800916|65680244|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
23531670|NCT01800916|65680245|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
23531671|NCT01800916|65680246|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
23531672|NCT01800916|65680247|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
23531673|NCT01800916|65680248|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
23531674|NCT01800916|65680249|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
23531675|NCT01800916|65680250|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
23531676|NCT01800916|65680251|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
23531677|NCT01800916|65680252|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
23531678|NCT04171414|65680253|FG000|Overall Study|Death|1|||
23531679|NCT04171414|65680253|FG000|Overall Study|Withdrawal by Subject|1|||
23531680|NCT01158924|65680256|FG000|Overall Study|Withdrawal by Subject|1|||
23531681|NCT01158924|65680257|FG001|Overall Study|Withdrawal by Subject|2|||
23531682|NCT01158924|65680256|FG000|Overall Study|Lost to Follow-up|0|||
23531683|NCT01158924|65680257|FG001|Overall Study|Lost to Follow-up|1|||
23720129|NCT02501902|66352534|FG004|Overall Study|Subject Refused Further Follow-up|0|||
23814287|NCT00642278|66703154|FG000|Overall Study|Other|2|||
23814288|NCT00642278|66703155|FG001|Overall Study|Other|1|||
23814289|NCT00642278|66703156|FG002|Overall Study|Other|0|||
23814290|NCT00642278|66703157|FG003|Overall Study|Other|1|||
23814291|NCT00642278|66703158|FG004|Overall Study|Other|0|||
23814292|NCT00642278|66703159|FG005|Overall Study|Other|1|||
23814293|NCT00642278|66703160|FG006|Overall Study|Other|0|||
23814294|NCT00537303|66703161|FG000|Overall Study|Adverse Event|1|||
23814295|NCT00537303|66703162|FG001|Overall Study|Adverse Event|4|||
23814296|NCT00537303|66703161|FG000|Overall Study|Lack of Efficacy|6|||
23531684|NCT01898793|65680265|FG000|Overall Study|Death|2|||
23531685|NCT01898793|65680266|FG001|Overall Study|Death|1|||
23531686|NCT01898793|65680267|FG002|Overall Study|Death|4|||
23531687|NCT01898793|65680268|FG003|Overall Study|Death|0|||
23720130|NCT02501902|66352535|FG005|Overall Study|Subject Refused Further Follow-up|0|||
23420127|NCT00075725|65283762|FG007|Overall Study|Lost to Follow-up|4|||
23420128|NCT00075725|65283763|FG008|Overall Study|Lost to Follow-up|1|||
23420129|NCT00075725|65283764|FG009|Overall Study|Lost to Follow-up|0|||
23420130|NCT00075725|65283765|FG010|Overall Study|Lost to Follow-up|0|||
23420131|NCT00075725|65283766|FG011|Overall Study|Lost to Follow-up|0|||
23420132|NCT00075725|65283755|FG000|Overall Study|Physician Decision|2|||
23420133|NCT00075725|65283756|FG001|Overall Study|Physician Decision|6|||
23420134|NCT00075725|65283757|FG002|Overall Study|Physician Decision|5|||
23420135|NCT00075725|65283758|FG003|Overall Study|Physician Decision|8|||
23420136|NCT00075725|65283759|FG004|Overall Study|Physician Decision|4|||
23420137|NCT00075725|65283760|FG005|Overall Study|Physician Decision|19|||
23613631|NCT01540474|65973117|FG003|Vaccination Period|Lost to Follow-up|0|||
23613632|NCT02206607|65973118|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
23613633|NCT02206607|65973119|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
23613634|NCT02206607|65973120|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
23613635|NCT02206607|65973121|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
23613636|NCT02206607|65973122|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
23613637|NCT02206607|65973118|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
23613638|NCT02206607|65973119|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
23613639|NCT02206607|65973120|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
23613640|NCT02206607|65973121|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
23613641|NCT02206607|65973122|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
23613642|NCT03960437|65973123|FG000|Overall Study|Removed by PI|4|||
23613643|NCT03960437|65973123|FG000|Overall Study|Lost to Follow-up|2|||
23613644|NCT03960437|65973123|FG000|Overall Study|Withdrawal by Subject|1|||
23613645|NCT03960437|65973123|FG000|Overall Study|Death|2|||
23613646|NCT05431543|65973132|FG000|Overall Study|Medical History|1|||
23613647|NCT05431543|65973133|FG001|Overall Study|Medical History|0|||
23613648|NCT05431543|65973134|FG002|Overall Study|Medical History|0|||
23613649|NCT04049578|65973157|FG000|Overall Study|Physician Decision|1|||
23613650|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
23613651|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
23613652|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
23613653|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
23613654|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
23613655|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
23613656|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
23613657|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
23814297|NCT00537303|66703162|FG001|Overall Study|Lack of Efficacy|7|||
23814298|NCT00537303|66703161|FG000|Overall Study|Protocol Violation|8|||
23814299|NCT00537303|66703162|FG001|Overall Study|Protocol Violation|4|||
23814300|NCT00537303|66703161|FG000|Overall Study|Withdrawal criteria|3|||
23814301|NCT00537303|66703162|FG001|Overall Study|Withdrawal criteria|3|||
23814302|NCT00537303|66703161|FG000|Overall Study|Unclassified|8|||
23814303|NCT00537303|66703162|FG001|Overall Study|Unclassified|7|||
23814304|NCT01735955|66703163|FG000|Overall Study|Administrative problems|1|||
23814305|NCT01735955|66703163|FG000|Overall Study|Patient/guardian decision|1|||
23814306|NCT01735955|66703163|FG000|Overall Study|Patient withdrew consent|2|||
23814307|NCT01735955|66703163|FG000|Overall Study|Physician Decision|4|||
23531688|NCT01898793|65680269|FG004|Overall Study|Death|0|||
23531689|NCT01898793|65680270|FG005|Overall Study|Death|0|||
23613658|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
23613659|NCT01365546|65973163|FG000|Overall Study|Withdrawal by Subject|1|||
23613660|NCT01365546|65973163|FG000|Overall Study|Screen failure|9|||
23613661|NCT01365546|65973163|FG000|Overall Study|Study termination|1|||
23613662|NCT01148017|65973164|FG000|Overall Study|Withdrawal by Subject|31|||
23613663|NCT01148017|65973165|FG001|Overall Study|Withdrawal by Subject|14|||
23613664|NCT01148017|65973166|FG002|Overall Study|Withdrawal by Subject|0|||
23613665|NCT01148017|65973167|FG003|Overall Study|Withdrawal by Subject|0|||
23613666|NCT01148017|65973164|FG000|Overall Study|Lost to Follow-up|23|||
23613667|NCT01148017|65973165|FG001|Overall Study|Lost to Follow-up|10|||
23613668|NCT01148017|65973166|FG002|Overall Study|Lost to Follow-up|0|||
23613669|NCT01148017|65973167|FG003|Overall Study|Lost to Follow-up|0|||
23613670|NCT01148017|65973164|FG000|Overall Study|Inappropriate enrollment|1|||
23613671|NCT01148017|65973165|FG001|Overall Study|Inappropriate enrollment|0|||
23613672|NCT01148017|65973166|FG002|Overall Study|Inappropriate enrollment|0|||
23613673|NCT01148017|65973167|FG003|Overall Study|Inappropriate enrollment|0|||
23814308|NCT01735955|66703163|FG000|Overall Study|Disease progression|24|||
23720131|NCT02501902|66352536|FG006|Overall Study|Subject Refused Further Follow-up|0|||
23720132|NCT02501902|66352537|FG007|Overall Study|Subject Refused Further Follow-up|1|||
23720133|NCT02501902|66352530|FG000|Overall Study|Study Terminated by Sponsor|0|||
23720134|NCT02501902|66352531|FG001|Overall Study|Study Terminated by Sponsor|3|||
23720135|NCT02501902|66352532|FG002|Overall Study|Study Terminated by Sponsor|0|||
23720136|NCT02501902|66352533|FG003|Overall Study|Study Terminated by Sponsor|1|||
23720137|NCT02501902|66352534|FG004|Overall Study|Study Terminated by Sponsor|1|||
23720138|NCT02501902|66352535|FG005|Overall Study|Study Terminated by Sponsor|0|||
23814309|NCT01735955|66703163|FG000|Overall Study|Adverse Event|5|||
23420138|NCT00075725|65283761|FG006|Overall Study|Physician Decision|3|||
23420139|NCT00075725|65283762|FG007|Overall Study|Physician Decision|17|||
23420140|NCT00075725|65283763|FG008|Overall Study|Physician Decision|5|||
23420141|NCT00075725|65283764|FG009|Overall Study|Physician Decision|0|||
23420142|NCT00075725|65283765|FG010|Overall Study|Physician Decision|1|||
23420143|NCT00075725|65283766|FG011|Overall Study|Physician Decision|0|||
23420144|NCT00075725|65283755|FG000|Overall Study|Pregnancy|0|||
23420145|NCT00075725|65283756|FG001|Overall Study|Pregnancy|0|||
23420146|NCT00075725|65283757|FG002|Overall Study|Pregnancy|0|||
23420147|NCT00075725|65283758|FG003|Overall Study|Pregnancy|0|||
23420148|NCT00075725|65283759|FG004|Overall Study|Pregnancy|0|||
23420149|NCT00075725|65283760|FG005|Overall Study|Pregnancy|1|||
23420150|NCT00075725|65283761|FG006|Overall Study|Pregnancy|0|||
23420151|NCT00075725|65283762|FG007|Overall Study|Pregnancy|1|||
23420152|NCT00075725|65283763|FG008|Overall Study|Pregnancy|0|||
23420153|NCT00075725|65283764|FG009|Overall Study|Pregnancy|0|||
23420154|NCT00075725|65283765|FG010|Overall Study|Pregnancy|0|||
23420155|NCT00075725|65283766|FG011|Overall Study|Pregnancy|0|||
23420156|NCT00075725|65283755|FG000|Overall Study|Protocol Violation|1|||
23420157|NCT00075725|65283756|FG001|Overall Study|Protocol Violation|1|||
23420158|NCT00075725|65283757|FG002|Overall Study|Protocol Violation|0|||
23420159|NCT00075725|65283758|FG003|Overall Study|Protocol Violation|3|||
23420160|NCT00075725|65283759|FG004|Overall Study|Protocol Violation|3|||
23420161|NCT00075725|65283760|FG005|Overall Study|Protocol Violation|2|||
23420162|NCT00075725|65283761|FG006|Overall Study|Protocol Violation|1|||
23420163|NCT00075725|65283762|FG007|Overall Study|Protocol Violation|2|||
23420164|NCT00075725|65283763|FG008|Overall Study|Protocol Violation|3|||
23420165|NCT00075725|65283764|FG009|Overall Study|Protocol Violation|0|||
23420166|NCT00075725|65283765|FG010|Overall Study|Protocol Violation|0|||
23420167|NCT00075725|65283766|FG011|Overall Study|Protocol Violation|1|||
23613674|NCT01148017|65973164|FG000|Overall Study|Administrative reason|22|||
23613675|NCT01148017|65973165|FG001|Overall Study|Administrative reason|9|||
23613676|NCT01148017|65973166|FG002|Overall Study|Administrative reason|0|||
23613677|NCT01148017|65973167|FG003|Overall Study|Administrative reason|0|||
23613678|NCT01148017|65973164|FG000|Overall Study|Unable to classify|3|||
23613679|NCT01148017|65973165|FG001|Overall Study|Unable to classify|1|||
23613680|NCT01148017|65973166|FG002|Overall Study|Unable to classify|0|||
23613681|NCT01148017|65973167|FG003|Overall Study|Unable to classify|0|||
23613682|NCT01469819|65973171|FG000|Overall Study|Withdrawal by Subject|1|||
23613683|NCT01469819|65973171|FG000|Overall Study|Did not meet inclusionary criteria|2|||
23613684|NCT01469819|65973171|FG000|Overall Study|Could not swallow SmartPill|2|||
23613685|NCT01469819|65973171|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
23613686|NCT01446042|65973172|FG000|Overall Study|Withdrawal by Subject|12|||
23613687|NCT01446042|65973173|FG001|Overall Study|Withdrawal by Subject|2|||
23613688|NCT01446042|65973174|FG002|Overall Study|Withdrawal by Subject|4|||
23613689|NCT01446042|65973172|FG000|Overall Study|Adverse Event|1|||
23613690|NCT01446042|65973173|FG001|Overall Study|Adverse Event|0|||
23613691|NCT01446042|65973174|FG002|Overall Study|Adverse Event|4|||
23613692|NCT01446042|65973172|FG000|Overall Study|Lost to Follow-up|5|||
23613693|NCT01446042|65973173|FG001|Overall Study|Lost to Follow-up|0|||
23613694|NCT01446042|65973174|FG002|Overall Study|Lost to Follow-up|0|||
23613695|NCT01446042|65973172|FG000|Overall Study|Other reasons|2|||
23613696|NCT01446042|65973173|FG001|Overall Study|Other reasons|1|||
23613697|NCT01446042|65973174|FG002|Overall Study|Other reasons|1|||
23613698|NCT00376259|65973176|FG000|Overall Study|Sponsor request - study termination|21|||
23613699|NCT00376259|65973177|FG001|Overall Study|Sponsor request - study termination|21|||
23420168|NCT00075725|65283755|FG000|Overall Study|Withdrawal by Subject|12|||
23420169|NCT00075725|65283756|FG001|Overall Study|Withdrawal by Subject|3|||
23420170|NCT00075725|65283757|FG002|Overall Study|Withdrawal by Subject|6|||
23420171|NCT00075725|65283758|FG003|Overall Study|Withdrawal by Subject|10|||
23613700|NCT00376259|65973176|FG000|Overall Study|Patient request|1|||
23420172|NCT00075725|65283759|FG004|Overall Study|Withdrawal by Subject|6|||
23420173|NCT00075725|65283760|FG005|Overall Study|Withdrawal by Subject|27|||
23420174|NCT00075725|65283761|FG006|Overall Study|Withdrawal by Subject|7|||
23420175|NCT00075725|65283762|FG007|Overall Study|Withdrawal by Subject|31|||
23420176|NCT00075725|65283763|FG008|Overall Study|Withdrawal by Subject|10|||
23420177|NCT00075725|65283764|FG009|Overall Study|Withdrawal by Subject|2|||
23420178|NCT00075725|65283765|FG010|Overall Study|Withdrawal by Subject|0|||
23420179|NCT00075725|65283766|FG011|Overall Study|Withdrawal by Subject|0|||
23420180|NCT00075725|65283755|FG000|Overall Study|Disease Progression, all other reasons|17|||
23420181|NCT00075725|65283756|FG001|Overall Study|Disease Progression, all other reasons|5|||
23420182|NCT00075725|65283757|FG002|Overall Study|Disease Progression, all other reasons|33|||
23420183|NCT00075725|65283758|FG003|Overall Study|Disease Progression, all other reasons|6|||
23420184|NCT00075725|65283759|FG004|Overall Study|Disease Progression, all other reasons|21|||
23420185|NCT00075725|65283760|FG005|Overall Study|Disease Progression, all other reasons|59|||
23420186|NCT00075725|65283761|FG006|Overall Study|Disease Progression, all other reasons|20|||
23420187|NCT00075725|65283762|FG007|Overall Study|Disease Progression, all other reasons|46|||
23420188|NCT00075725|65283763|FG008|Overall Study|Disease Progression, all other reasons|21|||
23420189|NCT00075725|65283764|FG009|Overall Study|Disease Progression, all other reasons|4|||
23420190|NCT00075725|65283765|FG010|Overall Study|Disease Progression, all other reasons|0|||
23420191|NCT00075725|65283766|FG011|Overall Study|Disease Progression, all other reasons|5|||
23420192|NCT00075725|65283755|FG000|Overall Study|Patient off treatment|0|||
23420193|NCT00075725|65283756|FG001|Overall Study|Patient off treatment|0|||
23420194|NCT00075725|65283757|FG002|Overall Study|Patient off treatment|1|||
23420195|NCT00075725|65283758|FG003|Overall Study|Patient off treatment|2|||
23420196|NCT00075725|65283759|FG004|Overall Study|Patient off treatment|1|||
23420197|NCT00075725|65283760|FG005|Overall Study|Patient off treatment|0|||
23420198|NCT00075725|65283761|FG006|Overall Study|Patient off treatment|0|||
23420199|NCT00075725|65283762|FG007|Overall Study|Patient off treatment|2|||
23420200|NCT00075725|65283763|FG008|Overall Study|Patient off treatment|1|||
23420201|NCT00075725|65283764|FG009|Overall Study|Patient off treatment|0|||
23420202|NCT00075725|65283765|FG010|Overall Study|Patient off treatment|0|||
23420203|NCT00075725|65283766|FG011|Overall Study|Patient off treatment|0|||
23420204|NCT00075725|65283755|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
23420205|NCT00075725|65283756|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
23420206|NCT00075725|65283757|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
23420207|NCT00075725|65283758|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
23420208|NCT00075725|65283759|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
23420209|NCT00075725|65283760|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
23420210|NCT00075725|65283761|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
23420211|NCT00075725|65283762|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
23420212|NCT00075725|65283763|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
23420213|NCT00075725|65283764|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
23420214|NCT00075725|65283765|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
23420215|NCT00075725|65283766|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
23420216|NCT00075725|65283755|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
23420217|NCT00075725|65283756|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
23420218|NCT00075725|65283757|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
23420219|NCT00075725|65283758|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
23420220|NCT00075725|65283759|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
23420221|NCT00075725|65283760|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
23420222|NCT00075725|65283761|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
23420223|NCT00075725|65283762|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
23420224|NCT00075725|65283763|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
23420225|NCT00075725|65283764|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
23531690|NCT01898793|65680271|FG006|Overall Study|Death|0|||
23531691|NCT05091528|65680276|FG000|Overall Study|Study Termination by Sponsor|0|||
23531692|NCT05091528|65680277|FG001|Overall Study|Study Termination by Sponsor|1|||
23531693|NCT05091528|65680278|FG002|Overall Study|Study Termination by Sponsor|0|||
23531694|NCT05091528|65680279|FG003|Overall Study|Study Termination by Sponsor|1|||
23531695|NCT02388997|65680280|FG000|Overall Study|Adverse Event|1|||
23531696|NCT02388997|65680281|FG001|Overall Study|Adverse Event|2|||
23531697|NCT02388997|65680280|FG000|Overall Study|Withdrawal by Subject|2|||
23720139|NCT02501902|66352536|FG006|Overall Study|Study Terminated by Sponsor|2|||
23420226|NCT00075725|65283765|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
23420227|NCT00075725|65283766|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
23420228|NCT00075725|65283755|FG000|Overall Study|Pt non compliant with therapy|2|||
23420229|NCT00075725|65283756|FG001|Overall Study|Pt non compliant with therapy|1|||
23420230|NCT00075725|65283757|FG002|Overall Study|Pt non compliant with therapy|1|||
23420231|NCT00075725|65283758|FG003|Overall Study|Pt non compliant with therapy|0|||
23420232|NCT00075725|65283759|FG004|Overall Study|Pt non compliant with therapy|2|||
23531698|NCT02388997|65680281|FG001|Overall Study|Withdrawal by Subject|1|||
23613701|NCT00376259|65973177|FG001|Overall Study|Patient request|0|||
23613702|NCT04617847|65973178|FG000|Overall Study|Withdrawal by Subject|1|||
23613703|NCT04617847|65973179|FG001|Overall Study|Withdrawal by Subject|0|||
23613704|NCT04617847|65973178|FG000|Overall Study|Adverse Event|0|||
23613705|NCT04617847|65973179|FG001|Overall Study|Adverse Event|2|||
23613706|NCT04617847|65973178|FG000|Overall Study|Death|0|||
23613707|NCT04617847|65973179|FG001|Overall Study|Death|1|||
23613708|NCT04617847|65973178|FG000|Overall Study|Termination of Study by Sponsor|2|||
23613709|NCT04617847|65973179|FG001|Overall Study|Termination of Study by Sponsor|21|||
23613710|NCT04468633|65973180|FG000|Overall Study|Withdrawal by Subject|4|||
23613711|NCT04468633|65973181|FG001|Overall Study|Withdrawal by Subject|0|||
23613712|NCT00139659|65973183|FG000|Overall Study|Adverse Event|12|||
23613713|NCT00139659|65973184|FG001|Overall Study|Adverse Event|1|||
23613714|NCT00139659|65973183|FG000|Overall Study|Lack of Efficacy|1|||
23613715|NCT00139659|65973184|FG001|Overall Study|Lack of Efficacy|1|||
23613716|NCT00139659|65973183|FG000|Overall Study|Lost to Follow-up|7|||
23613717|NCT00139659|65973184|FG001|Overall Study|Lost to Follow-up|3|||
23613718|NCT00139659|65973183|FG000|Overall Study|Reason not Specified|6|||
23613719|NCT00139659|65973184|FG001|Overall Study|Reason not Specified|3|||
23720140|NCT02501902|66352537|FG007|Overall Study|Study Terminated by Sponsor|4|||
23720141|NCT02501902|66352530|FG000|Overall Study|Death|3|||
23720142|NCT02501902|66352531|FG001|Overall Study|Death|4|||
23720143|NCT02501902|66352532|FG002|Overall Study|Death|4|||
23720144|NCT02501902|66352533|FG003|Overall Study|Death|10|||
23720145|NCT02501902|66352534|FG004|Overall Study|Death|10|||
23720146|NCT02501902|66352535|FG005|Overall Study|Death|11|||
23720147|NCT02501902|66352536|FG006|Overall Study|Death|7|||
23720148|NCT02501902|66352537|FG007|Overall Study|Death|15|||
23720149|NCT01807949|66352538|FG000|Overall Study|Adverse Event|1|||
23720150|NCT01807949|66352539|FG001|Overall Study|Adverse Event|2|||
23720151|NCT01807949|66352540|FG002|Overall Study|Adverse Event|2|||
23720152|NCT01807949|66352538|FG000|Overall Study|Withdrawal by Subject|1|||
23720153|NCT01807949|66352539|FG001|Overall Study|Withdrawal by Subject|2|||
23720154|NCT01807949|66352540|FG002|Overall Study|Withdrawal by Subject|2|||
23720155|NCT01807949|66352538|FG000|Overall Study|Non-Compliance|0|||
23720156|NCT01807949|66352539|FG001|Overall Study|Non-Compliance|0|||
23720157|NCT01807949|66352540|FG002|Overall Study|Non-Compliance|1|||
23720158|NCT01807949|66352538|FG000|Overall Study|Undefined|0|||
23720159|NCT01807949|66352539|FG001|Overall Study|Undefined|1|||
23720160|NCT01807949|66352540|FG002|Overall Study|Undefined|2|||
23720161|NCT01807949|66352538|FG000|Overall Study|Randomized But Not Treated|0|||
23720162|NCT01807949|66352539|FG001|Overall Study|Randomized But Not Treated|2|||
23720163|NCT01807949|66352540|FG002|Overall Study|Randomized But Not Treated|2|||
23720164|NCT01494987|66352541|FG000|Overall Study|Adverse Event|6|||
23720165|NCT01494987|66352542|FG001|Overall Study|Adverse Event|5|||
23720166|NCT01494987|66352541|FG000|Overall Study|Hyperglycemia|6|||
23720167|NCT01494987|66352542|FG001|Overall Study|Hyperglycemia|4|||
23720168|NCT01494987|66352541|FG000|Overall Study|Investigator's Discretion|1|||
23720169|NCT01494987|66352542|FG001|Overall Study|Investigator's Discretion|2|||
23814310|NCT00049530|66703164|FG000|Overall Study|Lack of Efficacy|25|||
23613720|NCT00139659|65973183|FG000|Overall Study|Withdrawal by Subject|14|||
23613721|NCT00139659|65973184|FG001|Overall Study|Withdrawal by Subject|10|||
23613722|NCT03512288|65973185|FG000|Overall Study|Adverse Event|1|||
23613723|NCT03512288|65973186|FG001|Overall Study|Adverse Event|0|||
23613724|NCT03512288|65973185|FG000|Overall Study|Lost to Follow-up|12|||
23613725|NCT03512288|65973186|FG001|Overall Study|Lost to Follow-up|15|||
23613726|NCT03512288|65973185|FG000|Overall Study|Physician Decision|0|||
23613727|NCT03512288|65973186|FG001|Overall Study|Physician Decision|2|||
23613728|NCT03512288|65973185|FG000|Overall Study|Protocol Violation|6|||
23613729|NCT03512288|65973186|FG001|Overall Study|Protocol Violation|4|||
23720170|NCT01494987|66352541|FG000|Overall Study|Lost to Follow-up|1|||
23720171|NCT01494987|66352542|FG001|Overall Study|Lost to Follow-up|1|||
23720172|NCT01494987|66352541|FG000|Overall Study|Protocol Violation|3|||
23720173|NCT01494987|66352542|FG001|Overall Study|Protocol Violation|3|||
23720174|NCT01494987|66352541|FG000|Overall Study|Subject Non-Compliance|9|||
23420233|NCT00075725|65283760|FG005|Overall Study|Pt non compliant with therapy|14|||
23613730|NCT03512288|65973185|FG000|Overall Study|Medication error without associated adverse event|1|||
23613731|NCT03512288|65973186|FG001|Overall Study|Medication error without associated adverse event|0|||
23720175|NCT01494987|66352542|FG001|Overall Study|Subject Non-Compliance|10|||
23720176|NCT01494987|66352541|FG000|Overall Study|Subject Withdrew Consent|2|||
23613732|NCT03512288|65973185|FG000|Overall Study|No longer met eligibility criteria|5|||
23613733|NCT03512288|65973186|FG001|Overall Study|No longer met eligibility criteria|2|||
23613734|NCT03512288|65973185|FG000|Overall Study|Withdrawal by parent/guardian|14|||
23613735|NCT03512288|65973186|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23720177|NCT01494987|66352542|FG001|Overall Study|Subject Withdrew Consent|3|||
23720178|NCT00966693|66352543|FG000|Overall Study|Adverse Event|0|||
23720179|NCT00966693|66352544|FG001|Overall Study|Adverse Event|0|||
23720180|NCT00966693|66352545|FG002|Overall Study|Adverse Event|1|||
23720181|NCT00966693|66352546|FG003|Overall Study|Adverse Event|2|||
23720182|NCT00966693|66352543|FG000|Overall Study|Death|0|||
23720183|NCT00966693|66352544|FG001|Overall Study|Death|0|||
23720184|NCT00966693|66352545|FG002|Overall Study|Death|1|||
23720185|NCT00966693|66352546|FG003|Overall Study|Death|0|||
23720186|NCT00966693|66352543|FG000|Overall Study|Withdrawal by Subject|1|||
23720187|NCT00966693|66352544|FG001|Overall Study|Withdrawal by Subject|0|||
23720188|NCT00966693|66352545|FG002|Overall Study|Withdrawal by Subject|0|||
23720189|NCT00966693|66352546|FG003|Overall Study|Withdrawal by Subject|5|||
23720190|NCT00966693|66352543|FG000|Overall Study|Disease Progression|0|||
23720191|NCT00966693|66352544|FG001|Overall Study|Disease Progression|0|||
23720192|NCT00966693|66352545|FG002|Overall Study|Disease Progression|1|||
23720193|NCT00966693|66352546|FG003|Overall Study|Disease Progression|16|||
23720194|NCT02685995|66352548|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
23720195|NCT02685995|66352549|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
23720196|NCT01797445|66352550|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
23720197|NCT01797445|66352551|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
23720198|NCT01797445|66352550|FG000|Double-Blind Phase|Adverse Event|3|||
23720199|NCT01797445|66352551|FG001|Double-Blind Phase|Adverse Event|0|||
23720200|NCT01797445|66352550|FG000|Double-Blind Phase|Death|5|||
23420234|NCT00075725|65283761|FG006|Overall Study|Pt non compliant with therapy|2|||
23720201|NCT01797445|66352551|FG001|Double-Blind Phase|Death|4|||
23720202|NCT01797445|66352550|FG000|Double-Blind Phase|Pregnancy|0|||
23720203|NCT01797445|66352551|FG001|Double-Blind Phase|Pregnancy|1|||
23720204|NCT01797445|66352550|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23720205|NCT01797445|66352551|FG001|Double-Blind Phase|Lack of Efficacy|2|||
23720206|NCT01797445|66352550|FG000|Double-Blind Phase|Investigator's Discretion|15|||
23720207|NCT01797445|66352551|FG001|Double-Blind Phase|Investigator's Discretion|17|||
23720208|NCT01797445|66352550|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
23720209|NCT01797445|66352551|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
23720210|NCT01797445|66352550|FG000|Double-Blind Phase|Protocol Violation|0|||
23720211|NCT01797445|66352551|FG001|Double-Blind Phase|Protocol Violation|1|||
23720212|NCT01797445|66352550|FG000|Double-Blind Phase|Withdrew Consent|20|||
23720213|NCT01797445|66352551|FG001|Double-Blind Phase|Withdrew Consent|35|||
23720214|NCT01797445|66352550|FG000|Double-Blind Phase|Lost to Follow-up|34|||
23720215|NCT01797445|66352551|FG001|Double-Blind Phase|Lost to Follow-up|26|||
23720216|NCT01797445|66352550|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
23720217|NCT01797445|66352551|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23420235|NCT00075725|65283762|FG007|Overall Study|Pt non compliant with therapy|5|||
23420236|NCT00075725|65283763|FG008|Overall Study|Pt non compliant with therapy|3|||
23531699|NCT02388997|65680280|FG000|Overall Study|Lung function exclusion criteria|0|||
23531700|NCT02388997|65680281|FG001|Overall Study|Lung function exclusion criteria|2|||
23531701|NCT02388997|65680280|FG000|Overall Study|Tested positive for virus during run-in|0|||
23531702|NCT02388997|65680281|FG001|Overall Study|Tested positive for virus during run-in|1|||
23531703|NCT00325234|65680282|FG000|Overall Study|Adverse Event|10|||
23531704|NCT00325234|65680283|FG001|Overall Study|Adverse Event|7|||
23531705|NCT00325234|65680282|FG000|Overall Study|Death due to Study Disease|1|||
23531706|NCT00325234|65680283|FG001|Overall Study|Death due to Study Disease|0|||
23531707|NCT00325234|65680282|FG000|Overall Study|Entry Criteria Not Met|1|||
23531708|NCT00325234|65680283|FG001|Overall Study|Entry Criteria Not Met|2|||
23531709|NCT00325234|65680282|FG000|Overall Study|Subject Decision|6|||
23531710|NCT00325234|65680283|FG001|Overall Study|Subject Decision|8|||
23531711|NCT00325234|65680282|FG000|Overall Study|Physician Decision|17|||
23531712|NCT00325234|65680283|FG001|Overall Study|Physician Decision|12|||
23531713|NCT00325234|65680282|FG000|Overall Study|Progressive Disease|34|||
23531714|NCT00325234|65680283|FG001|Overall Study|Progressive Disease|37|||
23531715|NCT03240575|65680284|FG000|Overall Study|Adverse Event|0|||
23531716|NCT03240575|65680285|FG001|Overall Study|Adverse Event|2|||
23613736|NCT03512288|65973185|FG000|Overall Study|Other|1|||
23720218|NCT02198651|66352552|FG000|Lead-in Period|Withdrew consent|13|||
23720219|NCT02198651|66352553|FG001|Lead-in Period|Withdrew consent|0|||
23720220|NCT02198651|66352554|FG002|Lead-in Period|Withdrew consent|0|||
23814311|NCT00049530|66703164|FG000|Overall Study|Adverse Event|2|||
23531717|NCT03240575|65680286|FG002|Overall Study|Adverse Event|0|||
23814312|NCT00049530|66703164|FG000|Overall Study|Death|1|||
23420237|NCT00075725|65283764|FG009|Overall Study|Pt non compliant with therapy|0|||
23531718|NCT03240575|65680287|FG003|Overall Study|Adverse Event|1|||
23531719|NCT03240575|65680284|FG000|Overall Study|Withdrawal by Subject|2|||
23613737|NCT03512288|65973186|FG001|Overall Study|Other|1|||
23720221|NCT02198651|66352555|FG003|Lead-in Period|Withdrew consent|0|||
23613738|NCT03512288|65973185|FG000|Overall Study|Randomized but not treated|1|||
23720222|NCT02198651|66352556|FG004|Lead-in Period|Withdrew consent|0|||
23720223|NCT02198651|66352552|FG000|Lead-in Period|Adverse Event|2|||
23720224|NCT02198651|66352553|FG001|Lead-in Period|Adverse Event|0|||
23531720|NCT03240575|65680285|FG001|Overall Study|Withdrawal by Subject|11|||
23531721|NCT03240575|65680286|FG002|Overall Study|Withdrawal by Subject|0|||
23531722|NCT03240575|65680287|FG003|Overall Study|Withdrawal by Subject|1|||
23531723|NCT03240575|65680284|FG000|Overall Study|Other|0|||
23531724|NCT03240575|65680285|FG001|Overall Study|Other|1|||
23720225|NCT02198651|66352554|FG002|Lead-in Period|Adverse Event|0|||
23720226|NCT02198651|66352555|FG003|Lead-in Period|Adverse Event|0|||
23720227|NCT02198651|66352556|FG004|Lead-in Period|Adverse Event|0|||
23720228|NCT02198651|66352552|FG000|Lead-in Period|Other, not specified|22|||
23720229|NCT02198651|66352553|FG001|Lead-in Period|Other, not specified|0|||
23720230|NCT02198651|66352554|FG002|Lead-in Period|Other, not specified|0|||
23720231|NCT02198651|66352555|FG003|Lead-in Period|Other, not specified|0|||
23720232|NCT02198651|66352556|FG004|Lead-in Period|Other, not specified|0|||
23720233|NCT02198651|66352552|FG000|Double-blind Period|Withdrew consent|0|||
23720234|NCT02198651|66352553|FG001|Double-blind Period|Withdrew consent|4|||
23720235|NCT02198651|66352554|FG002|Double-blind Period|Withdrew consent|0|||
23720236|NCT02198651|66352555|FG003|Double-blind Period|Withdrew consent|0|||
23720237|NCT02198651|66352556|FG004|Double-blind Period|Withdrew consent|0|||
23720238|NCT02198651|66352552|FG000|Double-blind Period|Adverse Event|0|||
23720239|NCT02198651|66352553|FG001|Double-blind Period|Adverse Event|1|||
23720240|NCT02198651|66352554|FG002|Double-blind Period|Adverse Event|0|||
23720241|NCT02198651|66352555|FG003|Double-blind Period|Adverse Event|0|||
23720242|NCT02198651|66352556|FG004|Double-blind Period|Adverse Event|0|||
23720243|NCT02198651|66352552|FG000|Double-blind Period|Other, not specified|0|||
23720244|NCT02198651|66352553|FG001|Double-blind Period|Other, not specified|4|||
23720245|NCT02198651|66352554|FG002|Double-blind Period|Other, not specified|1|||
23720246|NCT02198651|66352555|FG003|Double-blind Period|Other, not specified|0|||
23720247|NCT02198651|66352556|FG004|Double-blind Period|Other, not specified|0|||
23720248|NCT02198651|66352552|FG000|Open-label Rescue Period|Withdrew consent|0|||
23720249|NCT02198651|66352553|FG001|Open-label Rescue Period|Withdrew consent|0|||
23720250|NCT02198651|66352554|FG002|Open-label Rescue Period|Withdrew consent|0|||
23720251|NCT02198651|66352555|FG003|Open-label Rescue Period|Withdrew consent|2|||
23720252|NCT02198651|66352556|FG004|Open-label Rescue Period|Withdrew consent|0|||
23720253|NCT02198651|66352552|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23720254|NCT02198651|66352553|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23720255|NCT02198651|66352554|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23720256|NCT02198651|66352555|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
23720257|NCT02198651|66352556|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23720258|NCT00965146|66352557|FG000|Overall Study|Death|7|||
23720259|NCT00965146|66352557|FG000|Overall Study|Lost to Follow-up|22|||
23720260|NCT00965146|66352557|FG000|Overall Study|Withdrawal by Subject|17|||
23720261|NCT00965146|66352557|FG000|Overall Study|Unable to return|1|||
23720262|NCT00965146|66352557|FG000|Overall Study|Unwilling to return|11|||
23720263|NCT00965146|66352557|FG000|Overall Study|Intercurrent illness|1|||
23720264|NCT00965146|66352557|FG000|Overall Study|Revision / Removal of Study Implant|6|||
23720265|NCT00965146|66352557|FG000|Overall Study|Overall Study Termination|145|||
23720266|NCT02670915|66352559|FG000|Overall Study|Withdrawal by Subject|0|||
23720267|NCT02670915|66352560|FG001|Overall Study|Withdrawal by Subject|1|||
23720268|NCT02670915|66352561|FG002|Overall Study|Withdrawal by Subject|4|||
23720269|NCT02670915|66352559|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23720270|NCT02670915|66352560|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23720271|NCT02670915|66352561|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23531725|NCT03240575|65680286|FG002|Overall Study|Other|0|||
23531726|NCT03240575|65680287|FG003|Overall Study|Other|0|||
23531727|NCT00548808|65680288|FG000|Overall Study|Lost to Follow-up|9|||
23531728|NCT00548808|65680289|FG001|Overall Study|Lost to Follow-up|3|||
23531729|NCT00548808|65680288|FG000|Overall Study|Protocol Violation|8|||
23531730|NCT00548808|65680289|FG001|Overall Study|Protocol Violation|8|||
23720272|NCT02670915|66352559|FG000|Overall Study|Unclassified|0|||
23531731|NCT00548808|65680288|FG000|Overall Study|Withdrawal by Subject|8|||
23531732|NCT00548808|65680289|FG001|Overall Study|Withdrawal by Subject|4|||
23720273|NCT02670915|66352560|FG001|Overall Study|Unclassified|3|||
23720274|NCT02670915|66352561|FG002|Overall Study|Unclassified|0|||
23720275|NCT01061567|66352562|FG000|Overall Study|Adverse Event|32|||
23720276|NCT01061567|66352562|FG000|Overall Study|Death|2|||
23720277|NCT01061567|66352562|FG000|Overall Study|Lack of Efficacy|3|||
23720278|NCT01061567|66352562|FG000|Overall Study|Lost to Follow-up|24|||
23531733|NCT00548808|65680288|FG000|Overall Study|Physician Decision|6|||
23531734|NCT00548808|65680289|FG001|Overall Study|Physician Decision|3|||
23531735|NCT00548808|65680288|FG000|Overall Study|Adverse Event|4|||
23531736|NCT00548808|65680289|FG001|Overall Study|Adverse Event|5|||
23531737|NCT00548808|65680288|FG000|Overall Study|Death|2|||
23531738|NCT00548808|65680289|FG001|Overall Study|Death|0|||
23531739|NCT00548808|65680288|FG000|Overall Study|Entry Criteria Not Met|2|||
23531740|NCT00548808|65680289|FG001|Overall Study|Entry Criteria Not Met|2|||
23531741|NCT00548808|65680288|FG000|Overall Study|Lack of Efficacy|2|||
23531742|NCT00548808|65680289|FG001|Overall Study|Lack of Efficacy|0|||
23531743|NCT00548808|65680288|FG000|Overall Study|Sponsor Decision|1|||
23531744|NCT00548808|65680289|FG001|Overall Study|Sponsor Decision|1|||
23531745|NCT00646204|65680290|FG000|Overall Study|Adverse Event|3|||
23531746|NCT00646204|65680291|FG001|Overall Study|Adverse Event|0|||
23531747|NCT00646204|65680290|FG000|Overall Study|Withdrawal by Subject|1|||
23531748|NCT00646204|65680291|FG001|Overall Study|Withdrawal by Subject|0|||
23531749|NCT02178475|65680292|FG000|Overall Study|Withdrawal by Subject|7|||
23531750|NCT02178475|65680292|FG000|Overall Study|Lost to Follow-up|10|||
23531751|NCT02178475|65680292|FG000|Overall Study|Death|13|||
23531752|NCT02178475|65680292|FG000|Overall Study|Protocol-specified Criteria|99|||
23531753|NCT01448850|65680295|FG000|Overall Study|Death|3|||
23531754|NCT01448850|65680296|FG001|Overall Study|Death|6|||
23531755|NCT01448850|65680295|FG000|Overall Study|Withdrawal by Subject|13|||
23531756|NCT01448850|65680296|FG001|Overall Study|Withdrawal by Subject|21|||
23531757|NCT01448850|65680295|FG000|Overall Study|Lost to Follow-up|3|||
23531758|NCT01448850|65680296|FG001|Overall Study|Lost to Follow-up|1|||
23531759|NCT01448850|65680295|FG000|Overall Study|Other|15|||
23531760|NCT01448850|65680296|FG001|Overall Study|Other|12|||
23531761|NCT02778204|65683085|FG000|Overall Study|Adverse Event|1|||
23531762|NCT02778204|65683086|FG001|Overall Study|Adverse Event|0|||
23720279|NCT01061567|66352562|FG000|Overall Study|Protocol Violation|1|||
23720280|NCT01061567|66352562|FG000|Overall Study|Withdrawal by Subject|11|||
23720281|NCT01061567|66352562|FG000|Overall Study|Other reason than stated above|3|||
23720282|NCT00719862|66352563|FG000|Overall Study|Adverse Event|1|||
23720283|NCT00719862|66352564|FG001|Overall Study|Adverse Event|2|||
23720284|NCT00719862|66352563|FG000|Overall Study|Lack of Efficacy|3|||
23720285|NCT00719862|66352564|FG001|Overall Study|Lack of Efficacy|0|||
23720286|NCT00719862|66352563|FG000|Overall Study|Non-Compliance|1|||
23720287|NCT00719862|66352564|FG001|Overall Study|Non-Compliance|0|||
23720288|NCT00719862|66352563|FG000|Overall Study|Withdrawal by Subject|1|||
23720289|NCT00719862|66352564|FG001|Overall Study|Withdrawal by Subject|0|||
23720290|NCT00719862|66352563|FG000|Overall Study|Lost to Follow-up|0|||
23720291|NCT00719862|66352564|FG001|Overall Study|Lost to Follow-up|1|||
23720292|NCT00719862|66352563|FG000|Overall Study|Other|2|||
23720293|NCT00719862|66352564|FG001|Overall Study|Other|3|||
23720294|NCT04024462|66352566|FG000|Overall Study|Withdrawal by Subject|6|||
23720295|NCT04024462|66352567|FG001|Overall Study|Withdrawal by Subject|7|||
23720296|NCT04024462|66352566|FG000|Overall Study|Progressive Disease|0|||
23720297|NCT04024462|66352567|FG001|Overall Study|Progressive Disease|1|||
23720298|NCT04024462|66352566|FG000|Overall Study|Adverse Event|0|||
23720299|NCT04024462|66352567|FG001|Overall Study|Adverse Event|1|||
23720300|NCT04024462|66352566|FG000|Overall Study|Death|0|||
23720301|NCT04024462|66352567|FG001|Overall Study|Death|1|||
23720302|NCT04024462|66352566|FG000|Overall Study|Lost to Follow-up|1|||
23720303|NCT04024462|66352567|FG001|Overall Study|Lost to Follow-up|0|||
23720304|NCT04024462|66352566|FG000|Overall Study|Ongoing in the Study|94|||
23720305|NCT04024462|66352567|FG001|Overall Study|Ongoing in the Study|89|||
23720306|NCT02126670|66352568|FG000|Overall Study|Withdrawal by Subject|1|||
23720307|NCT02126670|66352569|FG001|Overall Study|Withdrawal by Subject|0|||
23720308|NCT02126670|66352570|FG002|Overall Study|Withdrawal by Subject|0|||
23720309|NCT02126670|66352571|FG003|Overall Study|Withdrawal by Subject|1|||
23720310|NCT02177175|66352579|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
23420238|NCT00075725|65283765|FG010|Overall Study|Pt non compliant with therapy|0|||
23531763|NCT02778204|65683087|FG002|Overall Study|Adverse Event|0|||
23531764|NCT02778204|65683088|FG003|Overall Study|Adverse Event|0|||
23531765|NCT02778204|65683085|FG000|Overall Study|Withdrawal by Subject|0|||
23531766|NCT02778204|65683086|FG001|Overall Study|Withdrawal by Subject|0|||
23531767|NCT02778204|65683087|FG002|Overall Study|Withdrawal by Subject|1|||
23531768|NCT02778204|65683088|FG003|Overall Study|Withdrawal by Subject|2|||
23531769|NCT02778204|65683085|FG000|Overall Study|Lost to Follow-up|1|||
23531770|NCT02778204|65683086|FG001|Overall Study|Lost to Follow-up|0|||
23531771|NCT02778204|65683087|FG002|Overall Study|Lost to Follow-up|2|||
23720311|NCT02177175|66352580|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
23720312|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
23720313|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
23531772|NCT02778204|65683088|FG003|Overall Study|Lost to Follow-up|1|||
23531773|NCT02778204|65683085|FG000|Overall Study|Protocol Violation|0|||
23720314|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
23531774|NCT02778204|65683086|FG001|Overall Study|Protocol Violation|0|||
23531775|NCT02778204|65683087|FG002|Overall Study|Protocol Violation|1|||
23531776|NCT02778204|65683088|FG003|Overall Study|Protocol Violation|0|||
23531777|NCT02778204|65683085|FG000|Overall Study|Eligibility Violation|0|||
23531778|NCT02778204|65683086|FG001|Overall Study|Eligibility Violation|0|||
23531779|NCT02778204|65683087|FG002|Overall Study|Eligibility Violation|0|||
23531780|NCT02778204|65683088|FG003|Overall Study|Eligibility Violation|1|||
23531781|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Death|0|||
23531782|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Death|1|||
23531783|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
23531784|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
23531785|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
23531786|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
23531787|NCT02460198|65683093|FG000|Overall Study|Adverse Event|1|||
23531788|NCT02460198|65683094|FG001|Overall Study|Adverse Event|3|||
23531789|NCT02460198|65683093|FG000|Overall Study|Death|36|||
23531790|NCT02460198|65683094|FG001|Overall Study|Death|28|||
23531791|NCT02460198|65683093|FG000|Overall Study|Lost to Follow-up|1|||
23531792|NCT02460198|65683094|FG001|Overall Study|Lost to Follow-up|1|||
23531793|NCT02460198|65683093|FG000|Overall Study|Transferred to Extension Study|15|||
23531794|NCT02460198|65683094|FG001|Overall Study|Transferred to Extension Study|15|||
23531795|NCT02460198|65683093|FG000|Overall Study|Withdrawal by Subject|2|||
23531796|NCT02460198|65683094|FG001|Overall Study|Withdrawal by Subject|4|||
23531797|NCT02460198|65683093|FG000|Overall Study|Site Terminated By Sponsor|0|||
23613739|NCT03512288|65973186|FG001|Overall Study|Randomized but not treated|1|||
23613740|NCT01648699|65973191|FG000|Overall Study|Death|1|||
23613741|NCT01648699|65973191|FG000|Overall Study|Lost to Follow-up|2|||
23613742|NCT01648699|65973191|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
23613743|NCT01753323|65973196|FG000|Overall Study|Lack of Efficacy|0|||
23613744|NCT01753323|65973197|FG001|Overall Study|Lack of Efficacy|0|||
23613745|NCT01753323|65973198|FG002|Overall Study|Lack of Efficacy|8|||
23613746|NCT01753323|65973196|FG000|Overall Study|Protocol deviation|1|||
23613747|NCT01753323|65973197|FG001|Overall Study|Protocol deviation|0|||
23613748|NCT01753323|65973198|FG002|Overall Study|Protocol deviation|0|||
23613749|NCT01753323|65973196|FG000|Overall Study|Adverse Event|0|||
23720315|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23720316|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
23720317|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
23720318|NCT00996593|66352581|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
23720319|NCT00996593|66352581|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
23720320|NCT00996593|66352581|FG000|Long-Term Follow-Up|Site Closed|1|||
23720321|NCT00422903|66352590|FG000|Overall Study|Disease Progression|3|||
23720322|NCT00422903|66352591|FG001|Overall Study|Disease Progression|1|||
23720323|NCT00422903|66352590|FG000|Overall Study|Adverse Event|0|||
23720324|NCT00422903|66352591|FG001|Overall Study|Adverse Event|2|||
23720325|NCT00422903|66352590|FG000|Overall Study|Informed Consent Withdrawn|1|||
23814313|NCT00049530|66703164|FG000|Overall Study|symptomatic deterioration|1|||
23814314|NCT00049530|66703164|FG000|Overall Study|ineligible|3|||
23720326|NCT00422903|66352591|FG001|Overall Study|Informed Consent Withdrawn|2|||
23420239|NCT00075725|65283766|FG011|Overall Study|Pt non compliant with therapy|0|||
23720327|NCT03911869|66352592|FG000|Safety Lead-in Phase|Death|7|||
23720328|NCT03911869|66352593|FG001|Safety Lead-in Phase|Death|0|||
23720329|NCT03911869|66352594|FG002|Safety Lead-in Phase|Death|0|||
23720330|NCT03911869|66352592|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
23814315|NCT01687478|66703165|FG000|Overall Study|Adverse Event|3|||
23814316|NCT01687478|66703166|FG001|Overall Study|Adverse Event|10|||
23814317|NCT01687478|66703165|FG000|Overall Study|Lost to Follow-up|1|||
23814318|NCT01687478|66703166|FG001|Overall Study|Lost to Follow-up|3|||
23814319|NCT01687478|66703165|FG000|Overall Study|Protocol Violation|0|||
23814320|NCT01687478|66703166|FG001|Overall Study|Protocol Violation|2|||
23814321|NCT01687478|66703165|FG000|Overall Study|Withdrawal by Subject|21|||
23814322|NCT01687478|66703166|FG001|Overall Study|Withdrawal by Subject|19|||
23814323|NCT01687478|66703165|FG000|Overall Study|Physician Decision|1|||
23814324|NCT01687478|66703166|FG001|Overall Study|Physician Decision|3|||
23814325|NCT01687478|66703165|FG000|Overall Study|Entry Criteria Not Met|6|||
23531798|NCT02460198|65683094|FG001|Overall Study|Site Terminated By Sponsor|1|||
23420240|NCT00075725|65283755|FG000|Overall Study|Pt age out of range for treatment|0|||
23531799|NCT02460198|65683093|FG000|Overall Study|Did Not Continue on Extension Study|6|||
23531800|NCT02460198|65683094|FG001|Overall Study|Did Not Continue on Extension Study|11|||
23531801|NCT03135522|65683098|FG000|Overall Study|Adverse Event|1|||
23613750|NCT01753323|65973197|FG001|Overall Study|Adverse Event|0|||
23613751|NCT01753323|65973198|FG002|Overall Study|Adverse Event|1|||
23720331|NCT03911869|66352593|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
23814326|NCT01687478|66703166|FG001|Overall Study|Entry Criteria Not Met|2|||
23531802|NCT03135522|65683099|FG001|Overall Study|Adverse Event|0|||
23531803|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Adverse Event|9|||
23613752|NCT02023099|65973201|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
23814327|NCT01823835|66703167|FG000|Overall Study|Adverse Event|0|||
23720332|NCT03911869|66352594|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
23720333|NCT03911869|66352592|FG000|Safety Lead-in Phase|Other|1|||
23720334|NCT03911869|66352593|FG001|Safety Lead-in Phase|Other|0|||
23720335|NCT03911869|66352594|FG002|Safety Lead-in Phase|Other|0|||
23720336|NCT03911869|66352592|FG000|Phase 2|Death|0|||
23720337|NCT03911869|66352593|FG001|Phase 2|Death|3|||
23720338|NCT03911869|66352594|FG002|Phase 2|Death|0|||
23720339|NCT00505752|66352595|FG000|Overall Study|Adverse Event|1|||
23720340|NCT00505752|66352596|FG001|Overall Study|Adverse Event|0|||
23720341|NCT00505752|66352597|FG002|Overall Study|Adverse Event|1|||
23720342|NCT00505752|66352598|FG003|Overall Study|Adverse Event|0|||
23720343|NCT00505752|66352595|FG000|Overall Study|Lost to Follow-up|1|||
23720344|NCT00505752|66352596|FG001|Overall Study|Lost to Follow-up|0|||
23720345|NCT00505752|66352597|FG002|Overall Study|Lost to Follow-up|0|||
23720346|NCT00505752|66352598|FG003|Overall Study|Lost to Follow-up|0|||
23720347|NCT00505752|66352595|FG000|Overall Study|Lack of ovarian response|1|||
23720348|NCT00505752|66352596|FG001|Overall Study|Lack of ovarian response|3|||
23720349|NCT00505752|66352597|FG002|Overall Study|Lack of ovarian response|0|||
23720350|NCT00505752|66352598|FG003|Overall Study|Lack of ovarian response|0|||
23720351|NCT00505752|66352595|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23720352|NCT00505752|66352596|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23720353|NCT00505752|66352597|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23720354|NCT00505752|66352598|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23720355|NCT00505752|66352595|FG000|Overall Study|No oocytes retrieved|0|||
23720356|NCT00505752|66352596|FG001|Overall Study|No oocytes retrieved|2|||
23720357|NCT00505752|66352597|FG002|Overall Study|No oocytes retrieved|0|||
23720358|NCT00505752|66352598|FG003|Overall Study|No oocytes retrieved|1|||
23720359|NCT00505752|66352595|FG000|Overall Study|No Fertilization|1|||
23720360|NCT00505752|66352596|FG001|Overall Study|No Fertilization|1|||
23720361|NCT00505752|66352597|FG002|Overall Study|No Fertilization|2|||
23720362|NCT00505752|66352598|FG003|Overall Study|No Fertilization|1|||
23720363|NCT00505752|66352595|FG000|Overall Study|All embryos/blastocysts discarded|0|||
23814328|NCT01823835|66703168|FG001|Overall Study|Adverse Event|0|||
23613753|NCT02023099|65973202|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
23613754|NCT02023099|65973203|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
23814329|NCT01823835|66703169|FG002|Overall Study|Adverse Event|0|||
23814330|NCT01823835|66703170|FG003|Overall Study|Adverse Event|0|||
23814331|NCT01823835|66703171|FG004|Overall Study|Adverse Event|1|||
23814332|NCT01823835|66703172|FG005|Overall Study|Adverse Event|0|||
23814333|NCT01823835|66703173|FG006|Overall Study|Adverse Event|1|||
23814334|NCT01823835|66703174|FG007|Overall Study|Adverse Event|0|||
23814335|NCT01823835|66703175|FG008|Overall Study|Adverse Event|0|||
23814336|NCT01823835|66703176|FG009|Overall Study|Adverse Event|0|||
23814337|NCT01823835|66703177|FG010|Overall Study|Adverse Event|1|||
23814338|NCT01823835|66703178|FG011|Overall Study|Adverse Event|2|||
23814339|NCT01823835|66703179|FG012|Overall Study|Adverse Event|0|||
23814340|NCT01823835|66703180|FG013|Overall Study|Adverse Event|0|||
23814341|NCT01823835|66703181|FG014|Overall Study|Adverse Event|0|||
23814342|NCT01823835|66703167|FG000|Overall Study|Physician Decision|0|||
23814343|NCT01823835|66703168|FG001|Overall Study|Physician Decision|0|||
23814344|NCT01823835|66703169|FG002|Overall Study|Physician Decision|0|||
23814345|NCT01823835|66703170|FG003|Overall Study|Physician Decision|0|||
23814346|NCT01823835|66703171|FG004|Overall Study|Physician Decision|0|||
23814347|NCT01823835|66703172|FG005|Overall Study|Physician Decision|0|||
23814348|NCT01823835|66703173|FG006|Overall Study|Physician Decision|0|||
23814349|NCT01823835|66703174|FG007|Overall Study|Physician Decision|0|||
23814350|NCT01823835|66703175|FG008|Overall Study|Physician Decision|0|||
23814351|NCT01823835|66703176|FG009|Overall Study|Physician Decision|0|||
23814352|NCT01823835|66703177|FG010|Overall Study|Physician Decision|0|||
23814353|NCT01823835|66703178|FG011|Overall Study|Physician Decision|2|||
23814354|NCT01823835|66703179|FG012|Overall Study|Physician Decision|0|||
23814355|NCT01823835|66703180|FG013|Overall Study|Physician Decision|0|||
23814356|NCT01823835|66703181|FG014|Overall Study|Physician Decision|0|||
23814357|NCT01823835|66703167|FG000|Overall Study|Progressive Disease|3|||
23814358|NCT01823835|66703168|FG001|Overall Study|Progressive Disease|4|||
23720364|NCT00505752|66352596|FG001|Overall Study|All embryos/blastocysts discarded|0|||
23720365|NCT00505752|66352597|FG002|Overall Study|All embryos/blastocysts discarded|1|||
23720366|NCT00505752|66352598|FG003|Overall Study|All embryos/blastocysts discarded|1|||
23720367|NCT00505752|66352595|FG000|Overall Study|Other|1|||
23613755|NCT02023099|65973201|FG000|Overall Study|Withdrawn Consent|3|||
23613756|NCT02023099|65973202|FG001|Overall Study|Withdrawn Consent|0|||
23613757|NCT02023099|65973203|FG002|Overall Study|Withdrawn Consent|1|||
23613758|NCT02023099|65973201|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
23613759|NCT02023099|65973202|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
23613760|NCT02023099|65973203|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
23613761|NCT02188784|65973204|FG000|Overall Study|Death|3|||
23613762|NCT02188784|65973205|FG001|Overall Study|Death|1|||
23613763|NCT02188784|65973204|FG000|Overall Study|Lost to Follow-up|1|||
23720368|NCT00505752|66352596|FG001|Overall Study|Other|2|||
23720369|NCT00505752|66352597|FG002|Overall Study|Other|1|||
23720370|NCT00505752|66352598|FG003|Overall Study|Other|2|||
23720371|NCT03094611|66352599|FG000|Overall Study|Lack of Efficacy|1|||
23720372|NCT03094611|66352599|FG000|Overall Study|Stem Cell Transplant|1|||
23720373|NCT00994162|66352600|FG000|Overall Study|Withdrawal by Subject|1|||
23720374|NCT00994162|66352600|FG000|Overall Study|Lost to Follow-up|2|||
23720375|NCT00994162|66352600|FG000|Overall Study|Product Complaint|1|||
23720376|NCT00994162|66352600|FG000|Overall Study|Poor Compliance|5|||
23720377|NCT00994162|66352600|FG000|Overall Study|Lack of Response|3|||
23720378|NCT00994162|66352600|FG000|Overall Study|Discharged from Hospital|4|||
23720379|NCT00994162|66352600|FG000|Overall Study|Death|2|||
23720380|NCT00994162|66352600|FG000|Overall Study|Care Transferred to Another Physician|2|||
23720381|NCT00994162|66352600|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
23720382|NCT00994162|66352600|FG000|Overall Study|Physician Decision|2|||
23720383|NCT00994162|66352600|FG000|Overall Study|Surrounding Wound Erythematous|1|||
23814359|NCT01823835|66703169|FG002|Overall Study|Progressive Disease|3|||
23613764|NCT02188784|65973205|FG001|Overall Study|Lost to Follow-up|0|||
23720384|NCT00994162|66352600|FG000|Overall Study|Machine Losing Vaccum|1|||
23814360|NCT01823835|66703170|FG003|Overall Study|Progressive Disease|6|||
23720385|NCT00994162|66352600|FG000|Overall Study|Patient Lived Too Far Away|1|||
23720386|NCT00994162|66352600|FG000|Overall Study|Above Knee Amputation|1|||
23814361|NCT01823835|66703171|FG004|Overall Study|Progressive Disease|4|||
23814362|NCT01823835|66703172|FG005|Overall Study|Progressive Disease|6|||
23814363|NCT01823835|66703173|FG006|Overall Study|Progressive Disease|5|||
23814364|NCT01823835|66703174|FG007|Overall Study|Progressive Disease|3|||
23814365|NCT01823835|66703175|FG008|Overall Study|Progressive Disease|3|||
23613765|NCT02188784|65973204|FG000|Overall Study|Withdrawal by Subject|3|||
23613766|NCT02188784|65973205|FG001|Overall Study|Withdrawal by Subject|9|||
23814366|NCT01823835|66703176|FG009|Overall Study|Progressive Disease|18|||
23814367|NCT01823835|66703177|FG010|Overall Study|Progressive Disease|8|||
23720387|NCT00994162|66352600|FG000|Overall Study|Reason Not Reported By Site|1|||
23720388|NCT00877006|66352601|FG000|Treatment Period|Death|2|||
23720389|NCT00877006|66352602|FG001|Treatment Period|Death|1|||
23720390|NCT00877006|66352601|FG000|Treatment Period|Adverse Event|10|||
23720391|NCT00877006|66352602|FG001|Treatment Period|Adverse Event|3|||
23720392|NCT00877006|66352601|FG000|Treatment Period|Withdrawal by Subject|2|||
23720393|NCT00877006|66352602|FG001|Treatment Period|Withdrawal by Subject|3|||
23720394|NCT00877006|66352601|FG000|Treatment Period|Protocol Violation|1|||
23720395|NCT00877006|66352602|FG001|Treatment Period|Protocol Violation|0|||
23720396|NCT00877006|66352601|FG000|Treatment Period|Lost to Follow-up|0|||
23720397|NCT00877006|66352602|FG001|Treatment Period|Lost to Follow-up|1|||
23720398|NCT00877006|66352601|FG000|Treatment Period|Disease Progression|1|||
23720399|NCT00877006|66352602|FG001|Treatment Period|Disease Progression|2|||
23720400|NCT00877006|66352601|FG000|Treatment Period|Started New Treatment Regimen|2|||
23720401|NCT00877006|66352602|FG001|Treatment Period|Started New Treatment Regimen|5|||
23720402|NCT00877006|66352601|FG000|Treatment Period|Other|4|||
23720403|NCT00877006|66352602|FG001|Treatment Period|Other|4|||
23720404|NCT00877006|66352601|FG000|Treatment Period|Randomized but Not Treated|3|||
23720405|NCT00877006|66352602|FG001|Treatment Period|Randomized but Not Treated|8|||
23720406|NCT00877006|66352601|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
23720407|NCT00877006|66352602|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
23814368|NCT01823835|66703178|FG011|Overall Study|Progressive Disease|46|||
23814369|NCT01823835|66703179|FG012|Overall Study|Progressive Disease|18|||
23814370|NCT01823835|66703180|FG013|Overall Study|Progressive Disease|4|||
23814371|NCT01823835|66703181|FG014|Overall Study|Progressive Disease|6|||
23420241|NCT00075725|65283756|FG001|Overall Study|Pt age out of range for treatment|1|||
23814372|NCT01823835|66703167|FG000|Overall Study|Study Termination|0|||
23420242|NCT00075725|65283757|FG002|Overall Study|Pt age out of range for treatment|0|||
23420243|NCT00075725|65283758|FG003|Overall Study|Pt age out of range for treatment|0|||
23420244|NCT00075725|65283759|FG004|Overall Study|Pt age out of range for treatment|0|||
23420245|NCT00075725|65283760|FG005|Overall Study|Pt age out of range for treatment|1|||
23420246|NCT00075725|65283761|FG006|Overall Study|Pt age out of range for treatment|0|||
23420247|NCT00075725|65283762|FG007|Overall Study|Pt age out of range for treatment|1|||
23420248|NCT00075725|65283763|FG008|Overall Study|Pt age out of range for treatment|0|||
23420249|NCT00075725|65283764|FG009|Overall Study|Pt age out of range for treatment|0|||
23420250|NCT00075725|65283765|FG010|Overall Study|Pt age out of range for treatment|0|||
23420251|NCT00075725|65283766|FG011|Overall Study|Pt age out of range for treatment|0|||
23420252|NCT00075725|65283755|FG000|Overall Study|Insurance issues|0|||
23420253|NCT00075725|65283756|FG001|Overall Study|Insurance issues|1|||
23420254|NCT00075725|65283757|FG002|Overall Study|Insurance issues|0|||
23420255|NCT00075725|65283758|FG003|Overall Study|Insurance issues|1|||
23420256|NCT00075725|65283759|FG004|Overall Study|Insurance issues|1|||
23420257|NCT00075725|65283760|FG005|Overall Study|Insurance issues|1|||
23420258|NCT00075725|65283761|FG006|Overall Study|Insurance issues|0|||
23420259|NCT00075725|65283762|FG007|Overall Study|Insurance issues|1|||
23814373|NCT01823835|66703168|FG001|Overall Study|Study Termination|0|||
23814374|NCT01823835|66703169|FG002|Overall Study|Study Termination|0|||
23814375|NCT01823835|66703170|FG003|Overall Study|Study Termination|0|||
23814376|NCT01823835|66703171|FG004|Overall Study|Study Termination|1|||
23814377|NCT01823835|66703172|FG005|Overall Study|Study Termination|0|||
23814378|NCT01823835|66703173|FG006|Overall Study|Study Termination|0|||
23814379|NCT01823835|66703174|FG007|Overall Study|Study Termination|0|||
23814380|NCT01823835|66703175|FG008|Overall Study|Study Termination|0|||
23814381|NCT01823835|66703176|FG009|Overall Study|Study Termination|0|||
23814382|NCT01823835|66703177|FG010|Overall Study|Study Termination|0|||
23814383|NCT01823835|66703178|FG011|Overall Study|Study Termination|1|||
23814384|NCT01823835|66703179|FG012|Overall Study|Study Termination|0|||
23814385|NCT01823835|66703180|FG013|Overall Study|Study Termination|0|||
23420260|NCT00075725|65283763|FG008|Overall Study|Insurance issues|0|||
23531804|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Adverse Event|2|||
23531805|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
23720408|NCT00877006|66352601|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
23720409|NCT00877006|66352602|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
23720410|NCT00877006|66352601|FG000|Long-Term Follow-up Period|Death|26|||
23720411|NCT00877006|66352602|FG001|Long-Term Follow-up Period|Death|18|||
23814386|NCT01823835|66703181|FG014|Overall Study|Study Termination|0|||
23420261|NCT00075725|65283764|FG009|Overall Study|Insurance issues|0|||
23420262|NCT00075725|65283765|FG010|Overall Study|Insurance issues|0|||
23420263|NCT00075725|65283766|FG011|Overall Study|Insurance issues|0|||
23420264|NCT00075725|65283755|FG000|Overall Study|MRD positive after extended ind|0|||
23420265|NCT00075725|65283756|FG001|Overall Study|MRD positive after extended ind|1|||
23814387|NCT01823835|66703167|FG000|Overall Study|Withdrawal by Subject|0|||
23814388|NCT01823835|66703168|FG001|Overall Study|Withdrawal by Subject|0|||
23814389|NCT01823835|66703169|FG002|Overall Study|Withdrawal by Subject|1|||
23814390|NCT01823835|66703170|FG003|Overall Study|Withdrawal by Subject|0|||
23814391|NCT01823835|66703171|FG004|Overall Study|Withdrawal by Subject|0|||
23814392|NCT01823835|66703172|FG005|Overall Study|Withdrawal by Subject|0|||
23613767|NCT02188784|65973204|FG000|Overall Study|Physician Decision|2|||
23420266|NCT00075725|65283757|FG002|Overall Study|MRD positive after extended ind|1|||
23420267|NCT00075725|65283758|FG003|Overall Study|MRD positive after extended ind|0|||
23420268|NCT00075725|65283759|FG004|Overall Study|MRD positive after extended ind|1|||
23420269|NCT00075725|65283760|FG005|Overall Study|MRD positive after extended ind|2|||
23420270|NCT00075725|65283761|FG006|Overall Study|MRD positive after extended ind|0|||
23420271|NCT00075725|65283762|FG007|Overall Study|MRD positive after extended ind|1|||
23420272|NCT00075725|65283763|FG008|Overall Study|MRD positive after extended ind|0|||
23420273|NCT00075725|65283764|FG009|Overall Study|MRD positive after extended ind|0|||
23420274|NCT00075725|65283765|FG010|Overall Study|MRD positive after extended ind|0|||
23420275|NCT00075725|65283766|FG011|Overall Study|MRD positive after extended ind|0|||
23420276|NCT00075725|65283755|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
23420277|NCT00075725|65283756|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
23420278|NCT00075725|65283757|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
23420279|NCT00075725|65283758|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
23420280|NCT00075725|65283759|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
23420281|NCT00075725|65283760|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
23420282|NCT00075725|65283761|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
23420283|NCT00075725|65283762|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
23420284|NCT00075725|65283763|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
23420285|NCT00075725|65283764|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
23420286|NCT00075725|65283765|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
23420287|NCT00075725|65283766|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
23420288|NCT00075725|65283755|FG000|Overall Study|Inevaluable|1|||
23420289|NCT00075725|65283756|FG001|Overall Study|Inevaluable|1|||
23420290|NCT00075725|65283757|FG002|Overall Study|Inevaluable|4|||
23814393|NCT01823835|66703173|FG006|Overall Study|Withdrawal by Subject|0|||
23420291|NCT00075725|65283758|FG003|Overall Study|Inevaluable|2|||
23420292|NCT00075725|65283759|FG004|Overall Study|Inevaluable|2|||
23420293|NCT00075725|65283760|FG005|Overall Study|Inevaluable|9|||
23420294|NCT00075725|65283761|FG006|Overall Study|Inevaluable|1|||
23420295|NCT00075725|65283762|FG007|Overall Study|Inevaluable|11|||
23420296|NCT00075725|65283763|FG008|Overall Study|Inevaluable|2|||
23420297|NCT00075725|65283764|FG009|Overall Study|Inevaluable|0|||
23420298|NCT00075725|65283765|FG010|Overall Study|Inevaluable|1|||
23420299|NCT00075725|65283766|FG011|Overall Study|Inevaluable|0|||
23420300|NCT00075725|65283755|FG000|Overall Study|Other|4|||
23613768|NCT02188784|65973205|FG001|Overall Study|Physician Decision|3|||
23613769|NCT05274906|65973207|FG000|Overall Study|Withdrawal by Subject|2|||
23613770|NCT05274906|65973208|FG001|Overall Study|Withdrawal by Subject|1|||
23613771|NCT03761849|65973209|FG000|Overall Study|transferred to OpenLabelExtension|35|||
23613772|NCT03761849|65973210|FG001|Overall Study|transferred to OpenLabelExtension|34|||
23613773|NCT03761849|65973211|FG002|Overall Study|transferred to OpenLabelExtension|36|||
23613774|NCT03761849|65973212|FG003|Overall Study|transferred to OpenLabelExtension|0|||
23613775|NCT03761849|65973213|FG004|Overall Study|transferred to OpenLabelExtension|0|||
23613776|NCT03761849|65973214|FG005|Overall Study|transferred to OpenLabelExtension|0|||
23613777|NCT03761849|65973209|FG000|Overall Study|Adverse Event|1|||
23613778|NCT03761849|65973210|FG001|Overall Study|Adverse Event|0|||
23613779|NCT03761849|65973211|FG002|Overall Study|Adverse Event|0|||
23613780|NCT03761849|65973212|FG003|Overall Study|Adverse Event|0|||
23613781|NCT03761849|65973213|FG004|Overall Study|Adverse Event|2|||
23613782|NCT03761849|65973214|FG005|Overall Study|Adverse Event|3|||
23613783|NCT03761849|65973209|FG000|Overall Study|Withdrawal by Subject|0|||
23613784|NCT03761849|65973210|FG001|Overall Study|Withdrawal by Subject|0|||
23613785|NCT03761849|65973211|FG002|Overall Study|Withdrawal by Subject|0|||
23613786|NCT03761849|65973212|FG003|Overall Study|Withdrawal by Subject|41|||
23613787|NCT03761849|65973213|FG004|Overall Study|Withdrawal by Subject|43|||
23613788|NCT03761849|65973214|FG005|Overall Study|Withdrawal by Subject|35|||
23613789|NCT03761849|65973209|FG000|Overall Study|Lost to Follow-up|0|||
23613790|NCT03761849|65973210|FG001|Overall Study|Lost to Follow-up|1|||
23613791|NCT03761849|65973211|FG002|Overall Study|Lost to Follow-up|0|||
23613792|NCT03761849|65973212|FG003|Overall Study|Lost to Follow-up|2|||
23613793|NCT03761849|65973213|FG004|Overall Study|Lost to Follow-up|4|||
23613794|NCT03761849|65973214|FG005|Overall Study|Lost to Follow-up|5|||
23720412|NCT00877006|66352601|FG000|Long-Term Follow-up Period|Other|7|||
23720413|NCT00877006|66352602|FG001|Long-Term Follow-up Period|Other|9|||
23420301|NCT00075725|65283756|FG001|Overall Study|Other|2|||
23814394|NCT01823835|66703174|FG007|Overall Study|Withdrawal by Subject|0|||
23420302|NCT00075725|65283757|FG002|Overall Study|Other|1|||
23420303|NCT00075725|65283758|FG003|Overall Study|Other|1|||
23420304|NCT00075725|65283759|FG004|Overall Study|Other|1|||
23420305|NCT00075725|65283760|FG005|Overall Study|Other|4|||
23613795|NCT03761849|65973209|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
23613796|NCT03761849|65973210|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
23420306|NCT00075725|65283761|FG006|Overall Study|Other|2|||
23420307|NCT00075725|65283762|FG007|Overall Study|Other|9|||
23420308|NCT00075725|65283763|FG008|Overall Study|Other|2|||
23420309|NCT00075725|65283764|FG009|Overall Study|Other|1|||
23420310|NCT00075725|65283765|FG010|Overall Study|Other|0|||
23420311|NCT00075725|65283766|FG011|Overall Study|Other|3|||
23420312|NCT00075725|65283755|FG000|Overall Study|Pt trying to find a BM donor|0|||
23720414|NCT03371251|66352605|FG000|Overall Study|Withdrawal by Subject|1|||
23720415|NCT03371251|66352606|FG001|Overall Study|Withdrawal by Subject|0|||
23720416|NCT03371251|66352607|FG002|Overall Study|Withdrawal by Subject|1|||
23720417|NCT03371251|66352608|FG003|Overall Study|Withdrawal by Subject|0|||
23720418|NCT03371251|66352609|FG004|Overall Study|Withdrawal by Subject|2|||
23720419|NCT03371251|66352610|FG005|Overall Study|Withdrawal by Subject|2|||
23720420|NCT03371251|66352605|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
23720421|NCT03371251|66352606|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23720422|NCT03371251|66352607|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23720423|NCT03371251|66352608|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23720424|NCT03371251|66352609|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
23720425|NCT03371251|66352610|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
23420313|NCT00075725|65283756|FG001|Overall Study|Pt trying to find a BM donor|1|||
23720426|NCT03371251|66352605|FG000|Overall Study|Adverse Event|0|||
23420314|NCT00075725|65283757|FG002|Overall Study|Pt trying to find a BM donor|0|||
23814395|NCT01823835|66703175|FG008|Overall Study|Withdrawal by Subject|0|||
23814396|NCT01823835|66703176|FG009|Overall Study|Withdrawal by Subject|1|||
23420315|NCT00075725|65283758|FG003|Overall Study|Pt trying to find a BM donor|0|||
23420316|NCT00075725|65283759|FG004|Overall Study|Pt trying to find a BM donor|0|||
23420317|NCT00075725|65283760|FG005|Overall Study|Pt trying to find a BM donor|0|||
23420318|NCT00075725|65283761|FG006|Overall Study|Pt trying to find a BM donor|0|||
23720427|NCT03371251|66352606|FG001|Overall Study|Adverse Event|0|||
23720428|NCT03371251|66352607|FG002|Overall Study|Adverse Event|0|||
23720429|NCT03371251|66352608|FG003|Overall Study|Adverse Event|0|||
23720430|NCT03371251|66352609|FG004|Overall Study|Adverse Event|1|||
23720431|NCT03371251|66352610|FG005|Overall Study|Adverse Event|0|||
23720432|NCT03371251|66352605|FG000|Overall Study|Decision by Sponsor|0|||
23720433|NCT03371251|66352606|FG001|Overall Study|Decision by Sponsor|0|||
23720434|NCT03371251|66352607|FG002|Overall Study|Decision by Sponsor|0|||
23720435|NCT03371251|66352608|FG003|Overall Study|Decision by Sponsor|0|||
23720436|NCT03371251|66352609|FG004|Overall Study|Decision by Sponsor|2|||
23720437|NCT03371251|66352610|FG005|Overall Study|Decision by Sponsor|0|||
23720438|NCT05441540|66352617|FG000|Overall Study|Withdrawal by Subject|2|||
23420319|NCT00075725|65283762|FG007|Overall Study|Pt trying to find a BM donor|0|||
23420320|NCT00075725|65283763|FG008|Overall Study|Pt trying to find a BM donor|0|||
23420321|NCT00075725|65283764|FG009|Overall Study|Pt trying to find a BM donor|0|||
23420322|NCT00075725|65283765|FG010|Overall Study|Pt trying to find a BM donor|0|||
23420323|NCT00075725|65283766|FG011|Overall Study|Pt trying to find a BM donor|0|||
23420324|NCT00075725|65283755|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
23420325|NCT00075725|65283756|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
23420326|NCT00075725|65283757|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
23420327|NCT00075725|65283758|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
23420328|NCT00075725|65283759|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
23420329|NCT00075725|65283760|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
23420330|NCT00075725|65283761|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
23420331|NCT00075725|65283762|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
23420332|NCT00075725|65283763|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
23420333|NCT00075725|65283764|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
23814397|NCT01823835|66703177|FG010|Overall Study|Withdrawal by Subject|1|||
23814398|NCT01823835|66703178|FG011|Overall Study|Withdrawal by Subject|2|||
23814399|NCT01823835|66703179|FG012|Overall Study|Withdrawal by Subject|1|||
23420334|NCT00075725|65283765|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
23420335|NCT00075725|65283766|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
23420336|NCT00075725|65283755|FG000|Overall Study|Unsuccessful institutional transfer|0|||
23420337|NCT00075725|65283756|FG001|Overall Study|Unsuccessful institutional transfer|0|||
23420338|NCT00075725|65283757|FG002|Overall Study|Unsuccessful institutional transfer|2|||
23814400|NCT01823835|66703180|FG013|Overall Study|Withdrawal by Subject|0|||
23814401|NCT01823835|66703181|FG014|Overall Study|Withdrawal by Subject|0|||
23814402|NCT00851318|66703187|FG000|Overall Study|Withdrawal by Subject|7|||
23814403|NCT00851318|66703188|FG001|Overall Study|Withdrawal by Subject|1|||
23420339|NCT00075725|65283758|FG003|Overall Study|Unsuccessful institutional transfer|0|||
23420340|NCT00075725|65283759|FG004|Overall Study|Unsuccessful institutional transfer|0|||
23420341|NCT00075725|65283760|FG005|Overall Study|Unsuccessful institutional transfer|0|||
23420342|NCT00075725|65283761|FG006|Overall Study|Unsuccessful institutional transfer|0|||
23720439|NCT02899377|66352620|FG000|Overall Study|Adverse Event|1|||
23720440|NCT02899377|66352621|FG001|Overall Study|Adverse Event|0|||
23720441|NCT00391807|66352624|FG000|Overall Study|Did not receive study medication|23|||
23720442|NCT00391807|66352624|FG000|Overall Study|Adverse Event|177|||
23720443|NCT00391807|66352624|FG000|Overall Study|Pregnancy|25|||
23720444|NCT00391807|66352624|FG000|Overall Study|Lost to Follow-up|227|||
23720445|NCT00391807|66352624|FG000|Overall Study|Withdrawal by Subject|147|||
23720446|NCT00391807|66352624|FG000|Overall Study|Protocol Violation|20|||
23720447|NCT00391807|66352624|FG000|Overall Study|Various|96|||
23720448|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
23720449|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
23720450|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
23720451|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
23814404|NCT00851318|66703189|FG002|Overall Study|Withdrawal by Subject|5|||
23814405|NCT00851318|66703190|FG003|Overall Study|Withdrawal by Subject|3|||
23814406|NCT00851318|66703187|FG000|Overall Study|Adverse Event|13|||
23420343|NCT00075725|65283762|FG007|Overall Study|Unsuccessful institutional transfer|0|||
23420344|NCT00075725|65283763|FG008|Overall Study|Unsuccessful institutional transfer|0|||
23420345|NCT00075725|65283764|FG009|Overall Study|Unsuccessful institutional transfer|1|||
23420346|NCT00075725|65283765|FG010|Overall Study|Unsuccessful institutional transfer|0|||
23420347|NCT00075725|65283766|FG011|Overall Study|Unsuccessful institutional transfer|0|||
23420348|NCT00075725|65283755|FG000|Overall Study|specimen(s) not submitted|0|||
23420349|NCT00075725|65283756|FG001|Overall Study|specimen(s) not submitted|0|||
23420350|NCT00075725|65283757|FG002|Overall Study|specimen(s) not submitted|2|||
23420351|NCT00075725|65283758|FG003|Overall Study|specimen(s) not submitted|0|||
23420352|NCT00075725|65283759|FG004|Overall Study|specimen(s) not submitted|0|||
23420353|NCT00075725|65283760|FG005|Overall Study|specimen(s) not submitted|0|||
23420354|NCT00075725|65283761|FG006|Overall Study|specimen(s) not submitted|0|||
23420355|NCT00075725|65283762|FG007|Overall Study|specimen(s) not submitted|0|||
23420356|NCT00075725|65283763|FG008|Overall Study|specimen(s) not submitted|0|||
23420357|NCT00075725|65283764|FG009|Overall Study|specimen(s) not submitted|0|||
23420358|NCT00075725|65283765|FG010|Overall Study|specimen(s) not submitted|0|||
23420359|NCT00075725|65283766|FG011|Overall Study|specimen(s) not submitted|0|||
23420360|NCT00075725|65283755|FG000|Overall Study|Pt went to transplant|0|||
23720452|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
23720453|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23720454|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
23720455|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23814407|NCT00851318|66703188|FG001|Overall Study|Adverse Event|2|||
23814408|NCT00851318|66703189|FG002|Overall Study|Adverse Event|9|||
23814409|NCT00851318|66703190|FG003|Overall Study|Adverse Event|12|||
23814410|NCT00851318|66703187|FG000|Overall Study|Pregnancy|0|||
23814411|NCT00851318|66703188|FG001|Overall Study|Pregnancy|0|||
23814412|NCT00851318|66703189|FG002|Overall Study|Pregnancy|1|||
23814413|NCT00851318|66703190|FG003|Overall Study|Pregnancy|1|||
23814414|NCT00851318|66703187|FG000|Overall Study|Lack of Efficacy|8|||
23814415|NCT00851318|66703188|FG001|Overall Study|Lack of Efficacy|2|||
23814416|NCT00851318|66703189|FG002|Overall Study|Lack of Efficacy|4|||
23814417|NCT00851318|66703190|FG003|Overall Study|Lack of Efficacy|2|||
23814418|NCT00851318|66703187|FG000|Overall Study|Non-compliance with Study Procedures|2|||
23814419|NCT00851318|66703188|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23814420|NCT00851318|66703189|FG002|Overall Study|Non-compliance with Study Procedures|1|||
23814421|NCT00851318|66703190|FG003|Overall Study|Non-compliance with Study Procedures|0|||
23814422|NCT00851318|66703187|FG000|Overall Study|Physician Decision|0|||
23814423|NCT00851318|66703188|FG001|Overall Study|Physician Decision|0|||
23814424|NCT00851318|66703189|FG002|Overall Study|Physician Decision|1|||
23814425|NCT00851318|66703190|FG003|Overall Study|Physician Decision|1|||
23814426|NCT03866902|66703191|FG000|Overall Study|Lost to Follow-up|98|||
23814427|NCT03866902|66703192|FG001|Overall Study|Lost to Follow-up|82|||
23814428|NCT03866902|66703191|FG000|Overall Study|Pregnancy|18|||
23420361|NCT00075725|65283756|FG001|Overall Study|Pt went to transplant|0|||
23420362|NCT00075725|65283757|FG002|Overall Study|Pt went to transplant|0|||
23420363|NCT00075725|65283758|FG003|Overall Study|Pt went to transplant|1|||
23420364|NCT00075725|65283759|FG004|Overall Study|Pt went to transplant|0|||
23531806|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
23531807|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
23531808|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
23531809|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Physician Decision|1|||
23814429|NCT03866902|66703192|FG001|Overall Study|Pregnancy|24|||
23814430|NCT00940316|66703193|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
23814431|NCT00940316|66703194|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
23814432|NCT00940316|66703195|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
23814433|NCT00940316|66703193|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
23814434|NCT00940316|66703194|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
23814435|NCT00940316|66703195|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
23531810|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Physician Decision|1|||
23531811|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Pregnancy|2|||
23531812|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Pregnancy|0|||
23531813|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
23531814|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
23531815|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Technical problems|1|||
23531816|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Technical problems|0|||
23613797|NCT03761849|65973211|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
23613798|NCT03761849|65973212|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
23613799|NCT03761849|65973213|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
23613800|NCT03761849|65973214|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
23613801|NCT03761849|65973209|FG000|Overall Study|Physician Decision|0|||
23613802|NCT03761849|65973210|FG001|Overall Study|Physician Decision|0|||
23720456|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23720457|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
23613803|NCT03761849|65973211|FG002|Overall Study|Physician Decision|0|||
23613804|NCT03761849|65973212|FG003|Overall Study|Physician Decision|1|||
23613805|NCT03761849|65973213|FG004|Overall Study|Physician Decision|4|||
23613806|NCT03761849|65973214|FG005|Overall Study|Physician Decision|4|||
23613807|NCT03761849|65973209|FG000|Overall Study|Death|0|||
23720458|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23720459|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23720460|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23720461|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
23720462|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23720463|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
23720464|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
23720465|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
23720466|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
23720467|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
23720468|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
23720469|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23720470|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
23720471|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23720472|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23531817|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
23531818|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
23531819|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
23531820|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
23531821|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
23531822|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
23531823|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
23531824|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
23531825|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
23531826|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
23531827|NCT03394391|65683102|FG000|Overall Study|Lost to Follow-up|1|||
23531828|NCT03394391|65683103|FG001|Overall Study|Lost to Follow-up|2|||
23531829|NCT04439240|65683104|FG000|Overall Study|Ineligible|2|||
23531830|NCT04439240|65683104|FG000|Overall Study|Never started treatment|2|||
23531831|NCT04439240|65683104|FG000|Overall Study|Adverse Event|12|||
23531832|NCT04439240|65683104|FG000|Overall Study|Death|2|||
23531833|NCT04439240|65683104|FG000|Overall Study|Disease progression|25|||
23531834|NCT04439240|65683104|FG000|Overall Study|Other diseases|2|||
23531835|NCT04439240|65683104|FG000|Overall Study|Withdrawal by Subject|3|||
23531836|NCT04439240|65683104|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
23531837|NCT04439240|65683104|FG000|Overall Study|Symptomatic decline|1|||
23531838|NCT04439240|65683104|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
23531839|NCT04439240|65683104|FG000|Overall Study|Clinical progression|1|||
23531840|NCT00503685|65683105|FG000|Overall Study|Adverse Event|0|||
23531841|NCT00503685|65683106|FG001|Overall Study|Adverse Event|0|||
23531842|NCT00503685|65683107|FG002|Overall Study|Adverse Event|2|||
23531843|NCT00503685|65683105|FG000|Overall Study|Withdrawal by Subject|0|||
23531844|NCT00503685|65683106|FG001|Overall Study|Withdrawal by Subject|1|||
23531845|NCT00503685|65683107|FG002|Overall Study|Withdrawal by Subject|0|||
23531846|NCT00503685|65683105|FG000|Overall Study|Protocol Violation|0|||
23613808|NCT03761849|65973210|FG001|Overall Study|Death|0|||
23613809|NCT03761849|65973211|FG002|Overall Study|Death|0|||
23613810|NCT03761849|65973212|FG003|Overall Study|Death|1|||
23613811|NCT03761849|65973213|FG004|Overall Study|Death|1|||
23613812|NCT03761849|65973214|FG005|Overall Study|Death|3|||
23613813|NCT03761849|65973209|FG000|Overall Study|Protocol Violation|0|||
23613814|NCT03761849|65973210|FG001|Overall Study|Protocol Violation|0|||
23613815|NCT03761849|65973211|FG002|Overall Study|Protocol Violation|0|||
23613816|NCT03761849|65973212|FG003|Overall Study|Protocol Violation|2|||
23613817|NCT03761849|65973213|FG004|Overall Study|Protocol Violation|2|||
23613818|NCT03761849|65973214|FG005|Overall Study|Protocol Violation|1|||
23613819|NCT03761849|65973209|FG000|Overall Study|Participant could not come to site|0|||
23613820|NCT03761849|65973210|FG001|Overall Study|Participant could not come to site|0|||
23613821|NCT03761849|65973211|FG002|Overall Study|Participant could not come to site|0|||
23613822|NCT03761849|65973212|FG003|Overall Study|Participant could not come to site|0|||
23613823|NCT03761849|65973213|FG004|Overall Study|Participant could not come to site|1|||
23613824|NCT03761849|65973214|FG005|Overall Study|Participant could not come to site|0|||
23613825|NCT03761849|65973209|FG000|Overall Study|SF- safety Finding|0|||
23613826|NCT03761849|65973210|FG001|Overall Study|SF- safety Finding|0|||
23613827|NCT03761849|65973211|FG002|Overall Study|SF- safety Finding|0|||
23613828|NCT03761849|65973212|FG003|Overall Study|SF- safety Finding|0|||
23613829|NCT03761849|65973213|FG004|Overall Study|SF- safety Finding|0|||
23613830|NCT03761849|65973214|FG005|Overall Study|SF- safety Finding|1|||
23531847|NCT00503685|65683106|FG001|Overall Study|Protocol Violation|1|||
23531848|NCT00503685|65683107|FG002|Overall Study|Protocol Violation|0|||
23531849|NCT00503685|65683105|FG000|Overall Study|Eligibility Criteria Not Met|0|||
23531850|NCT00503685|65683106|FG001|Overall Study|Eligibility Criteria Not Met|1|||
23531851|NCT00503685|65683107|FG002|Overall Study|Eligibility Criteria Not Met|0|||
23531852|NCT04524403|65683109|FG000|Overall Study|Withdrawal by Subject|10|||
23531853|NCT04524403|65683110|FG001|Overall Study|Withdrawal by Subject|3|||
23531854|NCT04524403|65683111|FG002|Overall Study|Withdrawal by Subject|8|||
23613831|NCT03761849|65973209|FG000|Overall Study|Patient did not attend visit|0|||
23613832|NCT03761849|65973210|FG001|Overall Study|Patient did not attend visit|0|||
23531855|NCT04524403|65683109|FG000|Overall Study|Lost to Follow-up|3|||
23613833|NCT03761849|65973211|FG002|Overall Study|Patient did not attend visit|0|||
23613834|NCT03761849|65973212|FG003|Overall Study|Patient did not attend visit|0|||
23613835|NCT03761849|65973213|FG004|Overall Study|Patient did not attend visit|0|||
23613836|NCT03761849|65973214|FG005|Overall Study|Patient did not attend visit|1|||
23613837|NCT01113541|65973215|FG000|Overall Study|Withdrawal by Subject|1|||
23613838|NCT01113541|65973215|FG000|Overall Study|Protocol Violation|1|||
23613839|NCT01113541|65973215|FG000|Overall Study|Study Terminated by Sponsor|7|||
23613840|NCT01113541|65973215|FG000|Overall Study|Adverse Event|4|||
23613841|NCT03050372|65973216|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
23613842|NCT03050372|65973217|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
23613843|NCT03050372|65973216|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
23613844|NCT03050372|65973217|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
23613845|NCT04295499|65973218|FG000|Overall Study|moving out of state|1|||
23613846|NCT04295499|65973219|FG001|Overall Study|moving out of state|0|||
23613847|NCT04295499|65973218|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
23613848|NCT04295499|65973219|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
23613849|NCT02005484|65973220|FG000|Overall Study|Death|1|||
23613850|NCT02005484|65973220|FG000|Overall Study|Disease progression|1|||
23613851|NCT02005484|65973220|FG000|Overall Study|Changed to a Different Study|1|||
23613852|NCT02005484|65973220|FG000|Overall Study|Sponsor decision|1|||
23613853|NCT00525915|65973221|FG000|Overall Study|Non-Compliance|0|||
23613854|NCT00525915|65973222|FG001|Overall Study|Non-Compliance|1|||
23613855|NCT00525915|65973221|FG000|Overall Study|Disease Progression|5|||
23613856|NCT00525915|65973222|FG001|Overall Study|Disease Progression|6|||
23814436|NCT00940316|66703193|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
23814437|NCT00940316|66703194|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
23814438|NCT00940316|66703195|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
23814439|NCT00940316|66703193|FG000|Treated After Cycle 5|Adverse Event|0|||
23613857|NCT00525915|65973221|FG000|Overall Study|Withdrawal by Subject|1|||
23613858|NCT00525915|65973222|FG001|Overall Study|Withdrawal by Subject|0|||
23613859|NCT00525915|65973221|FG000|Overall Study|Refused Surgery|1|||
23613860|NCT00525915|65973222|FG001|Overall Study|Refused Surgery|2|||
23613861|NCT00525915|65973221|FG000|Overall Study|Unrelated illness|1|||
23613862|NCT00525915|65973222|FG001|Overall Study|Unrelated illness|0|||
23613863|NCT00762502|65973231|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
23613864|NCT00762502|65973232|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
23613865|NCT00762502|65973233|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
23613866|NCT00762502|65973231|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
23613867|NCT00762502|65973232|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
23613868|NCT00762502|65973233|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
23613869|NCT00762502|65973231|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
23613870|NCT00762502|65973232|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
23613871|NCT00762502|65973233|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
23613872|NCT02525744|65973236|FG000|Period 1|Physician Decision|0|||
23613873|NCT02525744|65973237|FG001|Period 1|Physician Decision|0|||
23613874|NCT02525744|65973238|FG002|Period 1|Physician Decision|1|||
23613875|NCT02525744|65973239|FG003|Period 1|Physician Decision|0|||
23613876|NCT02525744|65973236|FG000|Period 3|Adverse Event|0|||
23613877|NCT02525744|65973237|FG001|Period 3|Adverse Event|1|||
23613878|NCT02525744|65973238|FG002|Period 3|Adverse Event|0|||
23613879|NCT02525744|65973239|FG003|Period 3|Adverse Event|0|||
23613880|NCT02525744|65973236|FG000|Period 4|Withdrawal by Subject|1|||
23613881|NCT02525744|65973237|FG001|Period 4|Withdrawal by Subject|0|||
23613882|NCT02525744|65973238|FG002|Period 4|Withdrawal by Subject|0|||
23613883|NCT02525744|65973239|FG003|Period 4|Withdrawal by Subject|0|||
23613884|NCT02525744|65973236|FG000|Period 5|Physician Decision|1|||
23613885|NCT02525744|65973237|FG001|Period 5|Physician Decision|0|||
23613886|NCT02525744|65973238|FG002|Period 5|Physician Decision|0|||
23613887|NCT02525744|65973239|FG003|Period 5|Physician Decision|0|||
23613888|NCT03613454|65973240|FG000|Overall Study|Protocol Violation|1|||
23613889|NCT03613454|65973241|FG001|Overall Study|Protocol Violation|0|||
23613890|NCT03613454|65973240|FG000|Overall Study|Protocol Violation|0|||
23613891|NCT03613454|65973241|FG001|Overall Study|Protocol Violation|1|||
23613892|NCT01066897|65973246|FG000|Overall Study|Withdrawal by Subject|1|||
23613893|NCT01066897|65973247|FG001|Overall Study|Withdrawal by Subject|0|||
23613894|NCT01066897|65973246|FG000|Overall Study|stopped study after developing the flu.|1|||
23613895|NCT01066897|65973247|FG001|Overall Study|stopped study after developing the flu.|0|||
23613896|NCT00580047|65973249|FG000|Overall Study|Lost to Follow-up|1|||
23613897|NCT00580047|65973250|FG001|Overall Study|Lost to Follow-up|1|||
23613898|NCT00580047|65973251|FG002|Overall Study|Lost to Follow-up|0|||
23613899|NCT00580047|65973249|FG000|Overall Study|Withdrawal by Subject|1|||
23613900|NCT00580047|65973250|FG001|Overall Study|Withdrawal by Subject|1|||
23613901|NCT00580047|65973251|FG002|Overall Study|Withdrawal by Subject|2|||
23613902|NCT00580047|65973249|FG000|Overall Study|Withdrawal by Subject|1|||
23613903|NCT00580047|65973250|FG001|Overall Study|Withdrawal by Subject|0|||
23613904|NCT00580047|65973251|FG002|Overall Study|Withdrawal by Subject|0|||
23613905|NCT02543294|65973252|FG000|Overall Study|Lost to Follow-up|3|||
23613906|NCT02543294|65973252|FG000|Overall Study|Physician Decision|2|||
23613907|NCT02543294|65973252|FG000|Overall Study|Withdrawal by Subject|7|||
23613908|NCT02820298|65973254|FG000|Overall Study|Withdrawal by Subject|0|||
23613909|NCT02820298|65973255|FG001|Overall Study|Withdrawal by Subject|1|||
23613910|NCT02820298|65973254|FG000|Overall Study|Physician Decision|1|||
23613911|NCT02820298|65973255|FG001|Overall Study|Physician Decision|0|||
23613912|NCT02820298|65973254|FG000|Overall Study|Protocol Violation|0|||
23613913|NCT02820298|65973255|FG001|Overall Study|Protocol Violation|1|||
23613914|NCT00296504|65973256|FG000|Interim Analysis|Withdrawal by Subject|8|||
23613915|NCT00296504|65973257|FG001|Interim Analysis|Withdrawal by Subject|0|||
23613916|NCT00296504|65973258|FG002|Interim Analysis|Withdrawal by Subject|12|||
23613917|NCT00296504|65973259|FG003|Interim Analysis|Withdrawal by Subject|0|||
23613918|NCT00296504|65973260|FG004|Interim Analysis|Withdrawal by Subject|5|||
23613919|NCT00296504|65973261|FG005|Interim Analysis|Withdrawal by Subject|5|||
23613920|NCT00296504|65973262|FG006|Interim Analysis|Withdrawal by Subject|9|||
23613921|NCT00296504|65973263|FG007|Interim Analysis|Withdrawal by Subject|3|||
23613922|NCT00296504|65973264|FG008|Interim Analysis|Withdrawal by Subject|0|||
23613923|NCT00296504|65973256|FG000|Interim Analysis|Lost to Follow-up|13|||
23613924|NCT00296504|65973257|FG001|Interim Analysis|Lost to Follow-up|3|||
23613925|NCT00296504|65973258|FG002|Interim Analysis|Lost to Follow-up|26|||
23613926|NCT00296504|65973259|FG003|Interim Analysis|Lost to Follow-up|8|||
23613927|NCT00296504|65973260|FG004|Interim Analysis|Lost to Follow-up|14|||
23613928|NCT00296504|65973261|FG005|Interim Analysis|Lost to Follow-up|4|||
23613929|NCT00296504|65973262|FG006|Interim Analysis|Lost to Follow-up|11|||
23613930|NCT00296504|65973263|FG007|Interim Analysis|Lost to Follow-up|4|||
23613931|NCT00296504|65973264|FG008|Interim Analysis|Lost to Follow-up|0|||
23613932|NCT00296504|65973256|FG000|Interim Analysis|Clinical Progression|1|||
23613933|NCT00296504|65973257|FG001|Interim Analysis|Clinical Progression|0|||
23613934|NCT00296504|65973258|FG002|Interim Analysis|Clinical Progression|1|||
23613935|NCT00296504|65973259|FG003|Interim Analysis|Clinical Progression|1|||
23613936|NCT00296504|65973260|FG004|Interim Analysis|Clinical Progression|0|||
23613937|NCT00296504|65973261|FG005|Interim Analysis|Clinical Progression|2|||
23613938|NCT00296504|65973262|FG006|Interim Analysis|Clinical Progression|1|||
23613939|NCT00296504|65973263|FG007|Interim Analysis|Clinical Progression|2|||
23613940|NCT00296504|65973264|FG008|Interim Analysis|Clinical Progression|0|||
23613941|NCT00296504|65973256|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
23613942|NCT00296504|65973257|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
23613943|NCT00296504|65973258|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
23720473|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Other|1|||
23720474|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Other|0|||
23531856|NCT04524403|65683110|FG001|Overall Study|Lost to Follow-up|4|||
23531857|NCT04524403|65683111|FG002|Overall Study|Lost to Follow-up|3|||
23531858|NCT04524403|65683109|FG000|Overall Study|Adverse Event|3|||
23531859|NCT04524403|65683110|FG001|Overall Study|Adverse Event|1|||
23531860|NCT04524403|65683111|FG002|Overall Study|Adverse Event|4|||
23531861|NCT04524403|65683109|FG000|Overall Study|Non-compliant with study drug|1|||
23531862|NCT04524403|65683110|FG001|Overall Study|Non-compliant with study drug|2|||
23531863|NCT04524403|65683111|FG002|Overall Study|Non-compliant with study drug|3|||
23531864|NCT04524403|65683109|FG000|Overall Study|Moved|0|||
23531865|NCT04524403|65683110|FG001|Overall Study|Moved|1|||
23531866|NCT04524403|65683111|FG002|Overall Study|Moved|0|||
23531867|NCT02472756|65683112|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
23531868|NCT02472756|65683112|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
23531869|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
23531870|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
23531871|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
23531872|NCT03120013|65683115|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23531873|NCT03120013|65683116|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23531874|NCT00528528|65683134|FG000|Overall Study|Lost to Follow-up|0|||
23531875|NCT00528528|65683135|FG001|Overall Study|Lost to Follow-up|0|||
23531876|NCT00528528|65683136|FG002|Overall Study|Lost to Follow-up|1|||
23531877|NCT00528528|65683137|FG003|Overall Study|Lost to Follow-up|1|||
23531878|NCT00528528|65683134|FG000|Overall Study|Ineligible to continue the trial|0|||
23531879|NCT00528528|65683135|FG001|Overall Study|Ineligible to continue the trial|0|||
23531880|NCT00528528|65683136|FG002|Overall Study|Ineligible to continue the trial|0|||
23531881|NCT00528528|65683137|FG003|Overall Study|Ineligible to continue the trial|1|||
23531882|NCT00528528|65683134|FG000|Overall Study|Other|0|||
23613944|NCT00296504|65973259|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
23613945|NCT00296504|65973260|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
23613946|NCT00296504|65973261|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
23613947|NCT00296504|65973262|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
23613948|NCT00296504|65973263|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
23613949|NCT00296504|65973264|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
23720475|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Other|0|||
23720476|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Other|0|||
23531883|NCT00528528|65683135|FG001|Overall Study|Other|1|||
23531884|NCT00528528|65683136|FG002|Overall Study|Other|0|||
23531885|NCT00528528|65683137|FG003|Overall Study|Other|0|||
23531886|NCT00528528|65683134|FG000|Overall Study|Withdrawal by Subject|3|||
23531887|NCT00528528|65683135|FG001|Overall Study|Withdrawal by Subject|2|||
23531888|NCT00528528|65683136|FG002|Overall Study|Withdrawal by Subject|1|||
23531889|NCT00528528|65683137|FG003|Overall Study|Withdrawal by Subject|1|||
23531890|NCT00528528|65683134|FG000|Overall Study|Ongoing participant|0|||
23531891|NCT00528528|65683135|FG001|Overall Study|Ongoing participant|0|||
23531892|NCT00528528|65683136|FG002|Overall Study|Ongoing participant|1|||
23531893|NCT00528528|65683137|FG003|Overall Study|Ongoing participant|0|||
23531894|NCT00775437|65683140|FG000|Overall Study|Loss of efficacy|2|||
23531895|NCT00775437|65683140|FG000|Overall Study|Withdrawal by Subject|3|||
23531896|NCT00775437|65683140|FG000|Overall Study|Lost to Follow-up|1|||
23531897|NCT01000051|65683141|FG000|Overall Study|Withdrawal by Subject|1|||
23531898|NCT01000051|65683142|FG001|Overall Study|Withdrawal by Subject|1|||
23531899|NCT01000051|65683141|FG000|Overall Study|Disease Progression|1|||
23531900|NCT01000051|65683142|FG001|Overall Study|Disease Progression|0|||
23531901|NCT01000051|65683141|FG000|Overall Study|Serious noncompliance|1|||
23531902|NCT01000051|65683142|FG001|Overall Study|Serious noncompliance|0|||
23531903|NCT03852316|65683143|FG000|Overall Study|Protocol Violation|1|||
23531904|NCT03852316|65683143|FG000|Overall Study|Withdrawal by Subject|2|||
23531905|NCT03852316|65683143|FG000|Overall Study|Enrolled but Device not Utilized|1|||
23531906|NCT00079274|65683144|FG000|Overall Study|Withdrawal by Subject|111|||
23531907|NCT00079274|65683145|FG001|Overall Study|Withdrawal by Subject|10|||
23531908|NCT00079274|65683146|FG002|Overall Study|Withdrawal by Subject|12|||
23531909|NCT00079274|65683147|FG003|Overall Study|Withdrawal by Subject|163|||
23531910|NCT00079274|65683148|FG004|Overall Study|Withdrawal by Subject|7|||
23531911|NCT00079274|65683149|FG005|Overall Study|Withdrawal by Subject|8|||
23531912|NCT00079274|65683150|FG006|Overall Study|Withdrawal by Subject|0|||
23531913|NCT00079274|65683144|FG000|Overall Study|Adverse Event|130|||
23531914|NCT00079274|65683145|FG001|Overall Study|Adverse Event|8|||
23531915|NCT00079274|65683146|FG002|Overall Study|Adverse Event|8|||
23531916|NCT00079274|65683147|FG003|Overall Study|Adverse Event|184|||
23531917|NCT00079274|65683148|FG004|Overall Study|Adverse Event|7|||
23531918|NCT00079274|65683149|FG005|Overall Study|Adverse Event|8|||
23531919|NCT00079274|65683150|FG006|Overall Study|Adverse Event|0|||
23531920|NCT00079274|65683144|FG000|Overall Study|Recurrence|21|||
23531921|NCT00079274|65683145|FG001|Overall Study|Recurrence|0|||
23531922|NCT00079274|65683146|FG002|Overall Study|Recurrence|1|||
23531923|NCT00079274|65683147|FG003|Overall Study|Recurrence|15|||
23531924|NCT00079274|65683148|FG004|Overall Study|Recurrence|0|||
23531925|NCT00079274|65683149|FG005|Overall Study|Recurrence|2|||
23531926|NCT00079274|65683150|FG006|Overall Study|Recurrence|0|||
23531927|NCT00079274|65683144|FG000|Overall Study|Alternate Treatment|6|||
23531928|NCT00079274|65683145|FG001|Overall Study|Alternate Treatment|1|||
23531929|NCT00079274|65683146|FG002|Overall Study|Alternate Treatment|0|||
23531930|NCT00079274|65683147|FG003|Overall Study|Alternate Treatment|3|||
23531931|NCT00079274|65683148|FG004|Overall Study|Alternate Treatment|0|||
23531932|NCT00079274|65683149|FG005|Overall Study|Alternate Treatment|0|||
23531933|NCT00079274|65683150|FG006|Overall Study|Alternate Treatment|0|||
23531934|NCT00079274|65683144|FG000|Overall Study|Other Medical Problems|6|||
23531935|NCT00079274|65683145|FG001|Overall Study|Other Medical Problems|1|||
23531936|NCT00079274|65683146|FG002|Overall Study|Other Medical Problems|0|||
23531937|NCT00079274|65683147|FG003|Overall Study|Other Medical Problems|7|||
23531938|NCT00079274|65683148|FG004|Overall Study|Other Medical Problems|0|||
23531939|NCT00079274|65683149|FG005|Overall Study|Other Medical Problems|0|||
23531940|NCT00079274|65683150|FG006|Overall Study|Other Medical Problems|0|||
23531941|NCT00079274|65683144|FG000|Overall Study|Death|4|||
23531942|NCT00079274|65683145|FG001|Overall Study|Death|0|||
23720477|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Other|1|||
23720478|NCT02980692|66352625|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
23782239|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23531943|NCT00079274|65683146|FG002|Overall Study|Death|1|||
23531944|NCT00079274|65683147|FG003|Overall Study|Death|15|||
23531945|NCT00079274|65683148|FG004|Overall Study|Death|0|||
23531946|NCT00079274|65683149|FG005|Overall Study|Death|0|||
23531947|NCT00079274|65683150|FG006|Overall Study|Death|0|||
23531948|NCT00079274|65683144|FG000|Overall Study|Cytogenetic resistance|0|||
23531949|NCT00079274|65683145|FG001|Overall Study|Cytogenetic resistance|0|||
23531950|NCT00079274|65683146|FG002|Overall Study|Cytogenetic resistance|0|||
23531951|NCT00079274|65683147|FG003|Overall Study|Cytogenetic resistance|2|||
23531952|NCT00079274|65683148|FG004|Overall Study|Cytogenetic resistance|0|||
23531953|NCT00079274|65683149|FG005|Overall Study|Cytogenetic resistance|0|||
23531954|NCT00079274|65683150|FG006|Overall Study|Cytogenetic resistance|0|||
23531955|NCT00079274|65683144|FG000|Overall Study|Other|43|||
23531956|NCT00079274|65683145|FG001|Overall Study|Other|7|||
23531957|NCT00079274|65683146|FG002|Overall Study|Other|5|||
23531958|NCT00079274|65683147|FG003|Overall Study|Other|55|||
23531959|NCT00079274|65683148|FG004|Overall Study|Other|1|||
23531960|NCT00079274|65683149|FG005|Overall Study|Other|2|||
23531961|NCT00079274|65683150|FG006|Overall Study|Other|0|||
23531962|NCT02919670|65683152|FG000|Overall Study|Only 17 participants met compliance|43|||
23531963|NCT02919670|65683153|FG001|Overall Study|Only 17 participants met compliance|39|||
23531964|NCT02489981|65683158|FG000|Overall Study|Adverse Event|21|||
23531965|NCT02489981|65683158|FG000|Overall Study|Insufficient effectiveness|16|||
23531966|NCT02489981|65683158|FG000|Overall Study|Improved|31|||
23531967|NCT02489981|65683158|FG000|Overall Study|Lost to Follow-up|31|||
23531968|NCT02489981|65683158|FG000|Overall Study|Other than listed|28|||
23531969|NCT02141516|65683159|FG000|Overall Study|Adverse Event|0|||
23531970|NCT02141516|65683160|FG001|Overall Study|Adverse Event|1|||
23531971|NCT02141516|65683161|FG002|Overall Study|Adverse Event|0|||
23531972|NCT02141516|65683159|FG000|Overall Study|Lost to Follow-up|0|||
23531973|NCT02141516|65683160|FG001|Overall Study|Lost to Follow-up|1|||
23531974|NCT02141516|65683161|FG002|Overall Study|Lost to Follow-up|0|||
23531975|NCT02141516|65683159|FG000|Overall Study|Other|0|||
23531976|NCT02141516|65683160|FG001|Overall Study|Other|3|||
23531977|NCT02141516|65683161|FG002|Overall Study|Other|0|||
23531978|NCT02556710|65683163|FG000|Overall Study|Surgical treatment|3|||
23531979|NCT02556710|65683164|FG001|Overall Study|Surgical treatment|0|||
23531980|NCT02556710|65683163|FG000|Overall Study|Required proscribed pain medication|2|||
23531981|NCT02556710|65683164|FG001|Overall Study|Required proscribed pain medication|1|||
23531982|NCT02556710|65683163|FG000|Overall Study|Lack of Efficacy|1|||
23531983|NCT02556710|65683164|FG001|Overall Study|Lack of Efficacy|0|||
23531984|NCT02556710|65683163|FG000|Overall Study|Worsening osteoarthritis|1|||
23531985|NCT02556710|65683164|FG001|Overall Study|Worsening osteoarthritis|0|||
23531986|NCT02556710|65683163|FG000|Overall Study|Moved out of state|1|||
23531987|NCT02556710|65683164|FG001|Overall Study|Moved out of state|0|||
23531988|NCT02556710|65683163|FG000|Overall Study|Missing reason|3|||
23531989|NCT02556710|65683164|FG001|Overall Study|Missing reason|1|||
23531990|NCT02556710|65683163|FG000|Overall Study|Pain as lack of efficacy|0|||
23531991|NCT02556710|65683164|FG001|Overall Study|Pain as lack of efficacy|4|||
23531992|NCT02376166|65683166|FG000|Overall Study|Adverse Event|1|||
23531993|NCT02376166|65683166|FG000|Overall Study|Discontinued metformin early|2|||
23531994|NCT02442830|65683171|FG000|Overall Study|Technical Failure|0|||
23531995|NCT02442830|65683172|FG001|Overall Study|Technical Failure|1|||
23720479|NCT02980692|66352626|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
23720480|NCT02980692|66352627|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
23720481|NCT02980692|66352628|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
23720482|NCT02980692|66352629|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
23720483|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Adverse Event|0|||
23720484|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Adverse Event|0|||
23720485|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Adverse Event|0|||
23720486|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Adverse Event|1|||
23720487|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Adverse Event|1|||
23720488|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23720489|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
23720490|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
23720491|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23782240|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23531996|NCT01700179|65683175|FG000|Overall Study|Physician Decision|2|||
23531997|NCT02388737|65683176|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
23531998|NCT02388737|65683177|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
23531999|NCT02388737|65683178|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
23532000|NCT02388737|65683176|FG000|Overall Study|Major Protocol Deviation|18|||
23532001|NCT02388737|65683177|FG001|Overall Study|Major Protocol Deviation|25|||
23532002|NCT02388737|65683178|FG002|Overall Study|Major Protocol Deviation|22|||
23532003|NCT02388737|65683176|FG000|Overall Study|Lost to Follow-up|5|||
23532004|NCT02388737|65683177|FG001|Overall Study|Lost to Follow-up|1|||
23532005|NCT02388737|65683178|FG002|Overall Study|Lost to Follow-up|4|||
23532006|NCT02388737|65683176|FG000|Overall Study|Voluntary Withdrawal|10|||
23532007|NCT02388737|65683177|FG001|Overall Study|Voluntary Withdrawal|18|||
23532008|NCT02388737|65683178|FG002|Overall Study|Voluntary Withdrawal|17|||
23532009|NCT02388737|65683176|FG000|Overall Study|Lack of Efficacy|3|||
23532010|NCT02388737|65683177|FG001|Overall Study|Lack of Efficacy|0|||
23532011|NCT02388737|65683178|FG002|Overall Study|Lack of Efficacy|3|||
23532012|NCT02388737|65683176|FG000|Overall Study|Reason Not Specified|5|||
23532013|NCT02388737|65683177|FG001|Overall Study|Reason Not Specified|5|||
23532014|NCT02388737|65683178|FG002|Overall Study|Reason Not Specified|4|||
23532015|NCT03417141|65683179|FG000|Overall Study|Withdrawal by Subject|1|||
23532016|NCT03417141|65683179|FG000|Overall Study|Protocol Violation|3|||
23532017|NCT00458484|65683180|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
23613950|NCT00296504|65973256|FG000|Interim Analysis|Adverse Event|0|||
23613951|NCT00296504|65973257|FG001|Interim Analysis|Adverse Event|0|||
23613952|NCT00296504|65973258|FG002|Interim Analysis|Adverse Event|13|||
23613953|NCT00296504|65973259|FG003|Interim Analysis|Adverse Event|4|||
23720492|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23720493|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
23720494|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
23720495|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
23720496|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
23720497|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
23720498|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Pregnancy|0|||
23720499|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Pregnancy|0|||
23720500|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Pregnancy|1|||
23720501|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Pregnancy|1|||
23720502|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Pregnancy|0|||
23720503|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
23720504|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23720505|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
23720506|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23720507|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23720508|NCT02980692|66352625|FG000|Double-blind Follow-up Period|Other|0|||
23720509|NCT02980692|66352626|FG001|Double-blind Follow-up Period|Other|0|||
23720510|NCT02980692|66352627|FG002|Double-blind Follow-up Period|Other|1|||
23720511|NCT02980692|66352628|FG003|Double-blind Follow-up Period|Other|1|||
23720512|NCT02980692|66352629|FG004|Double-blind Follow-up Period|Other|3|||
23720513|NCT04992546|66352630|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23720514|NCT04992546|66352630|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
23720515|NCT04992546|66352630|FG000|Open-Label Treatment Period|Adverse Event|3|||
23720516|NCT04992546|66352630|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
23720517|NCT01148693|66352631|FG000|Overall Study|Attempts for cannulation were failed|13|||
23720518|NCT01148693|66352632|FG001|Overall Study|Attempts for cannulation were failed|10|||
23720519|NCT03363919|66352633|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
23720520|NCT03363919|66352634|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
23720521|NCT03363919|66352633|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
23720522|NCT03363919|66352634|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
23720523|NCT01061736|66352637|FG000|Overall Study|Dose regimen not selected|0|||
23720524|NCT01061736|66352638|FG001|Overall Study|Dose regimen not selected|0|||
23720525|NCT01061736|66352639|FG002|Overall Study|Dose regimen not selected|0|||
23720526|NCT01061736|66352640|FG003|Overall Study|Dose regimen not selected|0|||
23720527|NCT01061736|66352641|FG004|Overall Study|Dose regimen not selected|0|||
23720528|NCT01061736|66352642|FG005|Overall Study|Dose regimen not selected|0|||
23720529|NCT01061736|66352643|FG006|Overall Study|Dose regimen not selected|79|||
23720530|NCT01061736|66352644|FG007|Overall Study|Dose regimen not selected|0|||
23720531|NCT01061736|66352645|FG008|Overall Study|Dose regimen not selected|0|||
23720532|NCT01061736|66352646|FG009|Overall Study|Dose regimen not selected|0|||
23720533|NCT01061736|66352637|FG000|Overall Study|Adverse Event|13|||
23720534|NCT01061736|66352638|FG001|Overall Study|Adverse Event|1|||
23720535|NCT01061736|66352639|FG002|Overall Study|Adverse Event|3|||
23720536|NCT01061736|66352640|FG003|Overall Study|Adverse Event|2|||
23720537|NCT01061736|66352641|FG004|Overall Study|Adverse Event|4|||
23720538|NCT01061736|66352642|FG005|Overall Study|Adverse Event|1|||
23720539|NCT01061736|66352643|FG006|Overall Study|Adverse Event|4|||
23720540|NCT01061736|66352644|FG007|Overall Study|Adverse Event|63|||
23720541|NCT01061736|66352645|FG008|Overall Study|Adverse Event|67|||
23720542|NCT01061736|66352646|FG009|Overall Study|Adverse Event|34|||
23720543|NCT01061736|66352637|FG000|Overall Study|Lack of Efficacy|0|||
23720544|NCT01061736|66352638|FG001|Overall Study|Lack of Efficacy|2|||
23720545|NCT01061736|66352639|FG002|Overall Study|Lack of Efficacy|1|||
23720546|NCT01061736|66352640|FG003|Overall Study|Lack of Efficacy|1|||
23720547|NCT01061736|66352641|FG004|Overall Study|Lack of Efficacy|1|||
23720548|NCT01061736|66352642|FG005|Overall Study|Lack of Efficacy|2|||
23720549|NCT01061736|66352643|FG006|Overall Study|Lack of Efficacy|1|||
23720550|NCT01061736|66352644|FG007|Overall Study|Lack of Efficacy|9|||
23613954|NCT00296504|65973260|FG004|Interim Analysis|Adverse Event|6|||
23720551|NCT01061736|66352645|FG008|Overall Study|Lack of Efficacy|9|||
23720552|NCT01061736|66352646|FG009|Overall Study|Lack of Efficacy|10|||
23720553|NCT01061736|66352637|FG000|Overall Study|Poor compliance to protocol|0|||
23720554|NCT01061736|66352638|FG001|Overall Study|Poor compliance to protocol|0|||
23720555|NCT01061736|66352639|FG002|Overall Study|Poor compliance to protocol|0|||
23720556|NCT01061736|66352640|FG003|Overall Study|Poor compliance to protocol|0|||
23613955|NCT00296504|65973261|FG005|Interim Analysis|Adverse Event|3|||
23613956|NCT00296504|65973262|FG006|Interim Analysis|Adverse Event|4|||
23613957|NCT00296504|65973263|FG007|Interim Analysis|Adverse Event|5|||
23720557|NCT01061736|66352641|FG004|Overall Study|Poor compliance to protocol|0|||
23720558|NCT01061736|66352642|FG005|Overall Study|Poor compliance to protocol|0|||
23720559|NCT01061736|66352643|FG006|Overall Study|Poor compliance to protocol|0|||
23720560|NCT01061736|66352644|FG007|Overall Study|Poor compliance to protocol|2|||
23720561|NCT01061736|66352645|FG008|Overall Study|Poor compliance to protocol|5|||
23720562|NCT01061736|66352646|FG009|Overall Study|Poor compliance to protocol|9|||
23720563|NCT01061736|66352637|FG000|Overall Study|Not treated|0|||
23720564|NCT01061736|66352638|FG001|Overall Study|Not treated|0|||
23720565|NCT01061736|66352639|FG002|Overall Study|Not treated|0|||
23720566|NCT01061736|66352640|FG003|Overall Study|Not treated|0|||
23720567|NCT01061736|66352641|FG004|Overall Study|Not treated|1|||
23720568|NCT01061736|66352642|FG005|Overall Study|Not treated|0|||
23720569|NCT01061736|66352643|FG006|Overall Study|Not treated|0|||
23720570|NCT01061736|66352644|FG007|Overall Study|Not treated|2|||
23720571|NCT01061736|66352645|FG008|Overall Study|Not treated|1|||
23720572|NCT01061736|66352646|FG009|Overall Study|Not treated|0|||
23720573|NCT01061736|66352637|FG000|Overall Study|Other than specified above|0|||
23720574|NCT01061736|66352638|FG001|Overall Study|Other than specified above|1|||
23720575|NCT01061736|66352639|FG002|Overall Study|Other than specified above|2|||
23720576|NCT01061736|66352640|FG003|Overall Study|Other than specified above|0|||
23720577|NCT01061736|66352641|FG004|Overall Study|Other than specified above|1|||
23720578|NCT01061736|66352642|FG005|Overall Study|Other than specified above|0|||
23720579|NCT01061736|66352643|FG006|Overall Study|Other than specified above|0|||
23720580|NCT01061736|66352644|FG007|Overall Study|Other than specified above|18|||
23720581|NCT01061736|66352645|FG008|Overall Study|Other than specified above|15|||
23720582|NCT01061736|66352646|FG009|Overall Study|Other than specified above|21|||
23720583|NCT00105560|66352651|FG000|Overall Study|Lost to Follow-up|1|||
23720584|NCT03258593|66352656|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
23720585|NCT03258593|66352657|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
23720586|NCT03258593|66352658|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
23720587|NCT03258593|66352659|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
23720588|NCT03258593|66352656|FG000|Run-In Maintenance Phase|Disease progression|3|||
23720589|NCT03258593|66352657|FG001|Run-In Maintenance Phase|Disease progression|0|||
23720590|NCT03258593|66352658|FG002|Run-In Maintenance Phase|Disease progression|0|||
23720591|NCT03258593|66352659|FG003|Run-In Maintenance Phase|Disease progression|0|||
23720592|NCT03258593|66352656|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23720593|NCT03258593|66352657|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
23720594|NCT03258593|66352658|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23720595|NCT03258593|66352659|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23720596|NCT03258593|66352656|FG000|Expansion Maintenance Phase|Physician Decision|0|||
23720597|NCT03258593|66352657|FG001|Expansion Maintenance Phase|Physician Decision|1|||
23720598|NCT03258593|66352658|FG002|Expansion Maintenance Phase|Physician Decision|0|||
23720599|NCT03258593|66352659|FG003|Expansion Maintenance Phase|Physician Decision|0|||
23720600|NCT01451398|66352662|FG000|Overall Study|Adverse Event|7|||
23720601|NCT01451398|66352663|FG001|Overall Study|Adverse Event|9|||
23720602|NCT01451398|66352662|FG000|Overall Study|Protocol Violation|1|||
23720603|NCT01451398|66352663|FG001|Overall Study|Protocol Violation|2|||
23720604|NCT01451398|66352662|FG000|Overall Study|Physician Decision|1|||
23720605|NCT01451398|66352663|FG001|Overall Study|Physician Decision|1|||
23720606|NCT01451398|66352662|FG000|Overall Study|Withdrawal by Subject|10|||
23720607|NCT01451398|66352663|FG001|Overall Study|Withdrawal by Subject|14|||
23720608|NCT01451398|66352662|FG000|Overall Study|Lost to Follow-up|6|||
23720609|NCT01451398|66352663|FG001|Overall Study|Lost to Follow-up|4|||
23720610|NCT01451398|66352662|FG000|Overall Study|Non-compliance with study drug|1|||
23720611|NCT01451398|66352663|FG001|Overall Study|Non-compliance with study drug|3|||
23720612|NCT01451398|66352662|FG000|Overall Study|Non-compliance with protocol|1|||
23720613|NCT01451398|66352663|FG001|Overall Study|Non-compliance with protocol|1|||
23720614|NCT01451398|66352662|FG000|Overall Study|Moved out of country|0|||
23720615|NCT01451398|66352663|FG001|Overall Study|Moved out of country|1|||
23720616|NCT01451398|66352662|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
23720617|NCT01451398|66352663|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
23720618|NCT01451398|66352662|FG000|Overall Study|Lack of Efficacy|0|||
23720619|NCT01451398|66352663|FG001|Overall Study|Lack of Efficacy|1|||
23720620|NCT03097029|66352671|FG000|Overall Study|Withdrawal by Subject|1|||
23720621|NCT01925612|66352674|FG000|Overall Study|Progressive Disease|1|||
23720622|NCT01925612|66352675|FG001|Overall Study|Progressive Disease|1|||
23720623|NCT01925612|66352676|FG002|Overall Study|Progressive Disease|1|||
23720624|NCT01925612|66352677|FG003|Overall Study|Progressive Disease|0|||
23720625|NCT01925612|66352678|FG004|Overall Study|Progressive Disease|0|||
23720626|NCT01925612|66352674|FG000|Overall Study|Adverse Event|3|||
23720627|NCT01925612|66352675|FG001|Overall Study|Adverse Event|3|||
23720628|NCT01925612|66352676|FG002|Overall Study|Adverse Event|0|||
23720629|NCT01925612|66352677|FG003|Overall Study|Adverse Event|1|||
23720630|NCT01925612|66352678|FG004|Overall Study|Adverse Event|2|||
23720631|NCT03032510|66352684|FG000|Overall Study|Adverse Event|5|||
23720632|NCT03032510|66352685|FG001|Overall Study|Adverse Event|2|||
23720633|NCT03032510|66352684|FG000|Overall Study|Lost to Follow-up|8|||
23720634|NCT03032510|66352685|FG001|Overall Study|Lost to Follow-up|7|||
23720635|NCT03032510|66352684|FG000|Overall Study|Withdrawal by Subject|8|||
23720636|NCT03032510|66352685|FG001|Overall Study|Withdrawal by Subject|7|||
23720637|NCT03032510|66352684|FG000|Overall Study|Subject noncompliance|4|||
23720638|NCT03032510|66352685|FG001|Overall Study|Subject noncompliance|2|||
23720639|NCT03032510|66352684|FG000|Overall Study|Physician Decision|2|||
23720640|NCT03032510|66352685|FG001|Overall Study|Physician Decision|0|||
23720641|NCT01019252|66352688|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
23720642|NCT01019252|66352689|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
23532018|NCT00458484|65683181|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
23532019|NCT00458484|65683182|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
23532020|NCT00458484|65683183|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
23532021|NCT00458484|65683184|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
23532022|NCT00458484|65683185|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
23532023|NCT00458484|65683186|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
23532024|NCT03306264|65683187|FG000|Overall Study|Death|33|||
23532025|NCT03306264|65683188|FG001|Overall Study|Death|25|||
23532026|NCT03306264|65683189|FG002|Overall Study|Death|34|||
23532027|NCT03306264|65683190|FG003|Overall Study|Death|34|||
23532028|NCT03306264|65683187|FG000|Overall Study|Complete Consent Withdrawal|4|||
23532029|NCT03306264|65683188|FG001|Overall Study|Complete Consent Withdrawal|4|||
23532030|NCT03306264|65683189|FG002|Overall Study|Complete Consent Withdrawal|1|||
23532031|NCT03306264|65683190|FG003|Overall Study|Complete Consent Withdrawal|8|||
23532032|NCT03306264|65683187|FG000|Overall Study|Lost to Follow-up|1|||
23532033|NCT03306264|65683188|FG001|Overall Study|Lost to Follow-up|0|||
23532034|NCT03306264|65683189|FG002|Overall Study|Lost to Follow-up|1|||
23532035|NCT03306264|65683190|FG003|Overall Study|Lost to Follow-up|0|||
23532036|NCT03306264|65683187|FG000|Overall Study|Rollover to ASTX727-06|10|||
23532037|NCT03306264|65683188|FG001|Overall Study|Rollover to ASTX727-06|18|||
23532038|NCT03306264|65683189|FG002|Overall Study|Rollover to ASTX727-06|4|||
23532039|NCT03306264|65683190|FG003|Overall Study|Rollover to ASTX727-06|2|||
23532040|NCT03306264|65683187|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
23532041|NCT03306264|65683188|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
23532042|NCT03306264|65683189|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
23532043|NCT03306264|65683190|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
23532044|NCT02985736|65683191|FG000|Overall Study|Lost to Follow-up|3|||
23532045|NCT00667342|65683193|FG000|Overall Study|Protocol Violation|1|||
23532046|NCT00667342|65683194|FG001|Overall Study|Protocol Violation|0|||
23532047|NCT00667342|65683195|FG002|Overall Study|Protocol Violation|0|||
23532048|NCT00667342|65683193|FG000|Overall Study|Withdrawal by Subject|1|||
23532049|NCT00667342|65683194|FG001|Overall Study|Withdrawal by Subject|0|||
23532050|NCT00667342|65683195|FG002|Overall Study|Withdrawal by Subject|0|||
23532051|NCT00667342|65683193|FG000|Overall Study|Physician Decision|3|||
23532052|NCT00667342|65683194|FG001|Overall Study|Physician Decision|0|||
23532053|NCT00667342|65683195|FG002|Overall Study|Physician Decision|0|||
23532054|NCT00667342|65683193|FG000|Overall Study|Relapse or tumor progression|9|||
23532055|NCT00667342|65683194|FG001|Overall Study|Relapse or tumor progression|0|||
23532056|NCT00667342|65683195|FG002|Overall Study|Relapse or tumor progression|7|||
23532057|NCT00667342|65683193|FG000|Overall Study|Adverse Event|0|||
23532058|NCT00667342|65683194|FG001|Overall Study|Adverse Event|0|||
23532059|NCT00667342|65683195|FG002|Overall Study|Adverse Event|1|||
23532060|NCT00667342|65683193|FG000|Overall Study|Ineligible|0|||
23532061|NCT00667342|65683194|FG001|Overall Study|Ineligible|0|||
23532062|NCT00667342|65683195|FG002|Overall Study|Ineligible|1|||
23532063|NCT00550836|65683197|FG000|Overall Study|Withdrawal by Subject|3|||
23532064|NCT00550836|65683198|FG001|Overall Study|Withdrawal by Subject|9|||
23532065|NCT01545817|65683199|FG000|Pazopanib|Disease progression|51|||
23532066|NCT01545817|65683200|FG001|Pazopanib|Disease progression|0|||
23532067|NCT01545817|65683199|FG000|Pazopanib|Adverse Event|19|||
23532068|NCT01545817|65683200|FG001|Pazopanib|Adverse Event|0|||
23532069|NCT01545817|65683199|FG000|Pazopanib|Other reason|4|||
23532070|NCT01545817|65683200|FG001|Pazopanib|Other reason|0|||
23532071|NCT01545817|65683199|FG000|Everolimus|Other reason|0|||
23532072|NCT01545817|65683200|FG001|Everolimus|Other reason|7|||
23532073|NCT01545817|65683199|FG000|Everolimus|Disease progression|0|||
23532074|NCT01545817|65683200|FG001|Everolimus|Disease progression|25|||
23720643|NCT01019252|66352688|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
23532075|NCT01545817|65683199|FG000|Everolimus|Adverse Event|0|||
23532076|NCT01545817|65683200|FG001|Everolimus|Adverse Event|6|||
23532077|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
23720644|NCT01019252|66352689|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
23720645|NCT01019252|66352688|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
23720646|NCT01019252|66352689|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
23720647|NCT01019252|66352688|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
23720648|NCT01019252|66352689|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
23720649|NCT03326869|66352690|FG000|Overall Study|Study data has been lost to natural disa|1|||
23720650|NCT03326869|66352691|FG001|Overall Study|Study data has been lost to natural disa|1|||
23720651|NCT00961116|66352694|FG000|Washout Period of 7 Days|Adverse Event|1|||
23720652|NCT00961116|66352695|FG001|Washout Period of 7 Days|Adverse Event|1|||
23720653|NCT00961116|66352694|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23720654|NCT00961116|66352695|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23720655|NCT00961116|66352694|FG000|Washout Period of 7 Days|Protocol Violation|0|||
23720656|NCT00961116|66352695|FG001|Washout Period of 7 Days|Protocol Violation|1|||
23720657|NCT01255306|66355717|FG000|Overall Study|Physician Decision|1|||
23720658|NCT01255306|66355718|FG001|Overall Study|Physician Decision|1|||
23720659|NCT02337686|66355724|FG000|Overall Study|Adverse Event|1|||
23720660|NCT00089999|66355725|FG000|Overall Study|Adverse Event|4|||
23720661|NCT00089999|66355726|FG001|Overall Study|Adverse Event|7|||
23720662|NCT00089999|66355725|FG000|Overall Study|Withdrawal by Subject|0|||
23720663|NCT00089999|66355726|FG001|Overall Study|Withdrawal by Subject|4|||
23720664|NCT00089999|66355725|FG000|Overall Study|Lost to Follow-up|2|||
23720665|NCT00089999|66355726|FG001|Overall Study|Lost to Follow-up|1|||
23720666|NCT00089999|66355725|FG000|Overall Study|Radiological Progression of Cancer|52|||
23720667|NCT00089999|66355726|FG001|Overall Study|Radiological Progression of Cancer|44|||
23720668|NCT00089999|66355725|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
23720669|NCT00089999|66355726|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
23720670|NCT00089999|66355725|FG000|Overall Study|Death|3|||
23720671|NCT00089999|66355726|FG001|Overall Study|Death|3|||
23720672|NCT00089999|66355725|FG000|Overall Study|Poor General Condition|1|||
23720673|NCT00089999|66355726|FG001|Overall Study|Poor General Condition|0|||
23720674|NCT00089999|66355725|FG000|Overall Study|Clinical Progression|1|||
23720675|NCT00089999|66355726|FG001|Overall Study|Clinical Progression|2|||
23720676|NCT00089999|66355725|FG000|Overall Study|Physician Decision|2|||
23720677|NCT00089999|66355726|FG001|Overall Study|Physician Decision|2|||
23720678|NCT00089999|66355725|FG000|Overall Study|Patient Underwent Surgery|2|||
23720679|NCT00089999|66355726|FG001|Overall Study|Patient Underwent Surgery|0|||
23720680|NCT00089999|66355725|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
23720681|NCT00089999|66355726|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
23720682|NCT01072448|66355727|FG000|Overall Study|Adverse Event|9|||
23720683|NCT01072448|66355728|FG001|Overall Study|Adverse Event|10|||
23720684|NCT01072448|66355727|FG000|Overall Study|Subject withdrew consent|4|||
23720685|NCT01072448|66355728|FG001|Overall Study|Subject withdrew consent|9|||
23720686|NCT01072448|66355727|FG000|Overall Study|Protocol deviation|3|||
23720687|NCT01072448|66355728|FG001|Overall Study|Protocol deviation|4|||
23720688|NCT01072448|66355727|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23720689|NCT01072448|66355728|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23720690|NCT01072448|66355727|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23720691|NCT01072448|66355728|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23720692|NCT01072448|66355727|FG000|Overall Study|Lost to Follow-up|1|||
23720693|NCT01072448|66355728|FG001|Overall Study|Lost to Follow-up|1|||
23720694|NCT01072448|66355727|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23720695|NCT01072448|66355728|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23720696|NCT01072448|66355727|FG000|Overall Study|Death|0|||
23720697|NCT01072448|66355728|FG001|Overall Study|Death|2|||
23720698|NCT01896856|66355729|FG000|Overall Study|Transportation issues / Non-compliance|0|||
23720699|NCT01896856|66355730|FG001|Overall Study|Transportation issues / Non-compliance|0|||
23720700|NCT01896856|66355731|FG002|Overall Study|Transportation issues / Non-compliance|1|||
23720701|NCT01896856|66355732|FG003|Overall Study|Transportation issues / Non-compliance|0|||
23720702|NCT01896856|66355733|FG004|Overall Study|Transportation issues / Non-compliance|0|||
23720703|NCT01896856|66355734|FG005|Overall Study|Transportation issues / Non-compliance|0|||
23720704|NCT03819218|66355743|FG000|Overall Study|Protocol Violation|1|||
23720705|NCT02571972|66355744|FG000|Overall Study|Protocol Violation|2|||
23720706|NCT02571972|66355744|FG000|Overall Study|Withdrawal by Subject|2|||
23720707|NCT02186561|66355745|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
23720708|NCT02186561|66355745|FG000|Enrollment|Enrollment Cap Reached|5|||
23720709|NCT02186561|66355745|FG000|Enrollment|Insurance Denial|2|||
23720710|NCT02186561|66355745|FG000|Enrollment|Withdrawal by Subject|2|||
23720711|NCT02186561|66355745|FG000|Enrollment|Investigator Withdrew Consent|1|||
23720712|NCT02186561|66355745|FG000|30-Day Post Index Procedure Visit|Death|1|||
23720713|NCT02186561|66355745|FG000|1- Year Post Index Procedure Visit|Death|1|||
23720714|NCT02186561|66355745|FG000|1- Year Post Index Procedure Visit|Missed|1|||
23720715|NCT04605159|66355751|FG000|Overall Study|Adverse Event|6|||
23720716|NCT04605159|66355752|FG001|Overall Study|Adverse Event|3|||
23720717|NCT04605159|66355753|FG002|Overall Study|Adverse Event|21|||
23532078|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
23720718|NCT04605159|66355754|FG003|Overall Study|Adverse Event|4|||
23720719|NCT04605159|66355751|FG000|Overall Study|Lost to Follow-up|74|||
23720720|NCT04605159|66355752|FG001|Overall Study|Lost to Follow-up|45|||
23720721|NCT04605159|66355753|FG002|Overall Study|Lost to Follow-up|119|||
23720722|NCT04605159|66355754|FG003|Overall Study|Lost to Follow-up|80|||
23720723|NCT04605159|66355751|FG000|Overall Study|Protocol Violation|4|||
23720724|NCT04605159|66355752|FG001|Overall Study|Protocol Violation|5|||
23720725|NCT04605159|66355753|FG002|Overall Study|Protocol Violation|2|||
23720726|NCT04605159|66355754|FG003|Overall Study|Protocol Violation|0|||
23720727|NCT04605159|66355751|FG000|Overall Study|Withdrawal by Subject|66|||
23720728|NCT04605159|66355752|FG001|Overall Study|Withdrawal by Subject|37|||
23720729|NCT04605159|66355753|FG002|Overall Study|Withdrawal by Subject|68|||
23720730|NCT04605159|66355754|FG003|Overall Study|Withdrawal by Subject|50|||
23720731|NCT04605159|66355751|FG000|Overall Study|Migrated / moved from the study area|32|||
23720732|NCT04605159|66355752|FG001|Overall Study|Migrated / moved from the study area|22|||
23720733|NCT04605159|66355753|FG002|Overall Study|Migrated / moved from the study area|41|||
23720734|NCT04605159|66355754|FG003|Overall Study|Migrated / moved from the study area|21|||
23814440|NCT00940316|66703194|FG001|Treated After Cycle 5|Adverse Event|0|||
23814441|NCT00940316|66703195|FG002|Treated After Cycle 5|Adverse Event|1|||
23814442|NCT00940316|66703193|FG000|Treated After Cycle 5|Progressive disease|0|||
23814443|NCT00940316|66703194|FG001|Treated After Cycle 5|Progressive disease|1|||
23814444|NCT00940316|66703195|FG002|Treated After Cycle 5|Progressive disease|0|||
23814445|NCT00928707|66703196|FG000|Overall Study|Protocol Violation|1|||
23814446|NCT00928707|66703197|FG001|Overall Study|Protocol Violation|0|||
23814447|NCT01724489|66703198|FG000|Overall Study|Adverse Event|8|||
23814448|NCT01724489|66703199|FG001|Overall Study|Adverse Event|3|||
23420365|NCT00075725|65283760|FG005|Overall Study|Pt went to transplant|1|||
23420366|NCT00075725|65283761|FG006|Overall Study|Pt went to transplant|0|||
23420367|NCT00075725|65283762|FG007|Overall Study|Pt went to transplant|0|||
23420368|NCT00075725|65283763|FG008|Overall Study|Pt went to transplant|0|||
23814449|NCT01724489|66703198|FG000|Overall Study|Surgery, medication|1|||
23720735|NCT04605159|66355751|FG000|Overall Study|Other|1|||
23720736|NCT04605159|66355752|FG001|Overall Study|Other|2|||
23720737|NCT04605159|66355753|FG002|Overall Study|Other|7|||
23720738|NCT04605159|66355754|FG003|Overall Study|Other|3|||
23814450|NCT01724489|66703199|FG001|Overall Study|Surgery, medication|1|||
23814451|NCT01724489|66703198|FG000|Overall Study|Lost to Follow-up|1|||
23814452|NCT01724489|66703199|FG001|Overall Study|Lost to Follow-up|2|||
23420369|NCT00075725|65283764|FG009|Overall Study|Pt went to transplant|0|||
23420370|NCT00075725|65283765|FG010|Overall Study|Pt went to transplant|0|||
23420371|NCT00075725|65283766|FG011|Overall Study|Pt went to transplant|0|||
23420372|NCT00075725|65283755|FG000|Overall Study|Pt received additional steroids|0|||
23814453|NCT01724489|66703198|FG000|Overall Study|Withdrawal by Subject|6|||
23814454|NCT01724489|66703199|FG001|Overall Study|Withdrawal by Subject|6|||
23532079|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
23814455|NCT02564211|66703200|FG000|Overall Study|Adverse Event|4|||
23814456|NCT02752906|66703203|FG000|Overall Study|Protocol Violation|2|||
23720739|NCT02023112|66355755|FG000|Overall Study|Withdrawal by Subject|2|||
23720740|NCT02023112|66355756|FG001|Overall Study|Withdrawal by Subject|1|||
23720741|NCT02806947|66355761|FG000|Overall Study|Withdrawal by Subject|5|||
23720742|NCT02806947|66355762|FG001|Overall Study|Withdrawal by Subject|1|||
23720743|NCT00884221|66355764|FG000|Overall Study|Withdrawal by Subject|0|||
23720744|NCT00884221|66355765|FG001|Overall Study|Withdrawal by Subject|3|||
23720745|NCT00884221|66355764|FG000|Overall Study|Adverse Event|6|||
23720746|NCT00884221|66355765|FG001|Overall Study|Adverse Event|3|||
23720747|NCT00884221|66355764|FG000|Overall Study|Protocol Violation|16|||
23720748|NCT00884221|66355765|FG001|Overall Study|Protocol Violation|13|||
23720749|NCT00884221|66355764|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
23720750|NCT00884221|66355765|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
23720751|NCT01814826|66355766|FG000|Overall Study|Other|3|||
23720752|NCT01814826|66355767|FG001|Overall Study|Other|5|||
23720753|NCT01814826|66355768|FG002|Overall Study|Other|0|||
23720754|NCT01814826|66355766|FG000|Overall Study|Death|29|||
23720755|NCT01814826|66355767|FG001|Overall Study|Death|24|||
23720756|NCT01814826|66355768|FG002|Overall Study|Death|3|||
23720757|NCT00653328|66355769|FG000|Overall Study|Withdrawal by Subject|1|||
23720758|NCT00653328|66355769|FG000|Overall Study|Adverse Event|2|||
23720759|NCT00653328|66355769|FG000|Overall Study|Disease progression|10|||
23720760|NCT00653328|66355769|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
23720761|NCT05742841|66355770|FG000|Overall Study|Withdrawal by Subject|1|||
23720762|NCT05742841|66355770|FG000|Overall Study|Lost to Follow-up|1|||
23720763|NCT00764946|66355771|FG000|Overall Study|Lack of Efficacy|1|||
23720764|NCT00764946|66355772|FG001|Overall Study|Lack of Efficacy|0|||
23720765|NCT00764946|66355773|FG002|Overall Study|Lack of Efficacy|0|||
23720766|NCT00764946|66355771|FG000|Overall Study|Lost to Follow-up|3|||
23720767|NCT00764946|66355772|FG001|Overall Study|Lost to Follow-up|4|||
23720768|NCT00764946|66355773|FG002|Overall Study|Lost to Follow-up|0|||
23720769|NCT00764946|66355771|FG000|Overall Study|Physician Decision|2|||
23720770|NCT00764946|66355772|FG001|Overall Study|Physician Decision|4|||
23720771|NCT00764946|66355773|FG002|Overall Study|Physician Decision|0|||
23720772|NCT00764946|66355771|FG000|Overall Study|Adverse Event|3|||
23720773|NCT00764946|66355772|FG001|Overall Study|Adverse Event|2|||
23720774|NCT00764946|66355773|FG002|Overall Study|Adverse Event|1|||
23720775|NCT00764946|66355771|FG000|Overall Study|Withdrawal by Subject|3|||
23720776|NCT00764946|66355772|FG001|Overall Study|Withdrawal by Subject|6|||
23720777|NCT00764946|66355773|FG002|Overall Study|Withdrawal by Subject|2|||
23720778|NCT00764946|66355771|FG000|Overall Study|Never Treated|1|||
23720779|NCT00764946|66355772|FG001|Overall Study|Never Treated|1|||
23720780|NCT00764946|66355773|FG002|Overall Study|Never Treated|1|||
23720781|NCT00260429|66355774|FG000|Overall Study|failure to follow appointments|1|||
23720782|NCT00260429|66355775|FG001|Overall Study|failure to follow appointments|0|||
23720783|NCT00260429|66355774|FG000|Overall Study|scheduled hand surgery|1|||
23720784|NCT00260429|66355775|FG001|Overall Study|scheduled hand surgery|0|||
23720785|NCT01253187|66355786|FG000|Period 2|Withdrawal by Subject|0|||
23720786|NCT01253187|66355787|FG001|Period 2|Withdrawal by Subject|0|||
23720787|NCT01253187|66355788|FG002|Period 2|Withdrawal by Subject|0|||
23814457|NCT02752906|66703204|FG001|Overall Study|Protocol Violation|1|||
23814458|NCT02752906|66703203|FG000|Overall Study|Withdrawal by Subject|2|||
23814459|NCT02752906|66703204|FG001|Overall Study|Withdrawal by Subject|2|||
23814460|NCT02752906|66703203|FG000|Overall Study|Lost to Follow-up|3|||
23814461|NCT02752906|66703204|FG001|Overall Study|Lost to Follow-up|2|||
23814462|NCT03146962|66703209|FG000|Overall Study|Lost to Follow-up|1|||
23720788|NCT01253187|66355789|FG003|Period 2|Withdrawal by Subject|0|||
23720789|NCT01253187|66355790|FG004|Period 2|Withdrawal by Subject|1|||
23720790|NCT01253187|66355791|FG005|Period 2|Withdrawal by Subject|0|||
23720791|NCT01253187|66355786|FG000|Period 3|Pregnancy|1|||
23720792|NCT01253187|66355787|FG001|Period 3|Pregnancy|0|||
23720793|NCT01253187|66355788|FG002|Period 3|Pregnancy|0|||
23720794|NCT01253187|66355789|FG003|Period 3|Pregnancy|0|||
23814463|NCT03146962|66703210|FG001|Overall Study|Lost to Follow-up|1|||
23720795|NCT01253187|66355790|FG004|Period 3|Pregnancy|0|||
23720796|NCT01253187|66355791|FG005|Period 3|Pregnancy|0|||
23720797|NCT01253187|66355786|FG000|Period 3|difficulty with blood sampling|0|||
23720798|NCT01253187|66355787|FG001|Period 3|difficulty with blood sampling|1|||
23720799|NCT01253187|66355788|FG002|Period 3|difficulty with blood sampling|0|||
23720800|NCT01253187|66355789|FG003|Period 3|difficulty with blood sampling|0|||
23720801|NCT01253187|66355790|FG004|Period 3|difficulty with blood sampling|0|||
23720802|NCT01253187|66355791|FG005|Period 3|difficulty with blood sampling|0|||
23720803|NCT01253187|66355786|FG000|Period 3|non-compliance|0|||
23720804|NCT01253187|66355787|FG001|Period 3|non-compliance|0|||
23720805|NCT01253187|66355788|FG002|Period 3|non-compliance|0|||
23720806|NCT01253187|66355789|FG003|Period 3|non-compliance|0|||
23720807|NCT01253187|66355790|FG004|Period 3|non-compliance|1|||
23720808|NCT01253187|66355791|FG005|Period 3|non-compliance|0|||
23720809|NCT00340834|66355793|FG000|Core Phase of Study|Adverse Event|26|||
23720810|NCT00340834|66355794|FG001|Core Phase of Study|Adverse Event|9|||
23720811|NCT00340834|66355795|FG002|Core Phase of Study|Adverse Event|9|||
23720812|NCT00340834|66355796|FG003|Core Phase of Study|Adverse Event|0|||
23720813|NCT00340834|66355797|FG004|Core Phase of Study|Adverse Event|0|||
23720814|NCT00340834|66355793|FG000|Core Phase of Study|Withdrawal by Subject|11|||
23720815|NCT00340834|66355794|FG001|Core Phase of Study|Withdrawal by Subject|9|||
23720816|NCT00340834|66355795|FG002|Core Phase of Study|Withdrawal by Subject|16|||
23720817|NCT00340834|66355796|FG003|Core Phase of Study|Withdrawal by Subject|0|||
23814464|NCT03146962|66703211|FG002|Overall Study|Lost to Follow-up|0|||
23814465|NCT03146962|66703212|FG003|Overall Study|Lost to Follow-up|0|||
23720818|NCT00340834|66355797|FG004|Core Phase of Study|Withdrawal by Subject|0|||
23720819|NCT00340834|66355793|FG000|Core Phase of Study|Administrative Problems|6|||
23720820|NCT00340834|66355794|FG001|Core Phase of Study|Administrative Problems|2|||
23720821|NCT00340834|66355795|FG002|Core Phase of Study|Administrative Problems|7|||
23720822|NCT00340834|66355796|FG003|Core Phase of Study|Administrative Problems|0|||
23720823|NCT00340834|66355797|FG004|Core Phase of Study|Administrative Problems|0|||
23814466|NCT03146962|66703213|FG004|Overall Study|Lost to Follow-up|0|||
23814467|NCT03146962|66703214|FG005|Overall Study|Lost to Follow-up|0|||
23814468|NCT03146962|66703215|FG006|Overall Study|Lost to Follow-up|0|||
23814469|NCT03146962|66703216|FG007|Overall Study|Lost to Follow-up|0|||
23814470|NCT03146962|66703217|FG008|Overall Study|Lost to Follow-up|0|||
23814471|NCT03146962|66703218|FG009|Overall Study|Lost to Follow-up|0|||
23814472|NCT03146962|66703209|FG000|Overall Study|Adverse Event|0|||
23814473|NCT03146962|66703210|FG001|Overall Study|Adverse Event|3|||
23814474|NCT03146962|66703211|FG002|Overall Study|Adverse Event|0|||
23814475|NCT03146962|66703212|FG003|Overall Study|Adverse Event|0|||
23814476|NCT03146962|66703213|FG004|Overall Study|Adverse Event|0|||
23814477|NCT03146962|66703214|FG005|Overall Study|Adverse Event|0|||
23814478|NCT03146962|66703215|FG006|Overall Study|Adverse Event|0|||
23814479|NCT03146962|66703216|FG007|Overall Study|Adverse Event|1|||
23814480|NCT03146962|66703217|FG008|Overall Study|Adverse Event|0|||
23814481|NCT03146962|66703218|FG009|Overall Study|Adverse Event|0|||
23814482|NCT03146962|66703209|FG000|Overall Study|Withdrawal by Subject|0|||
23814483|NCT03146962|66703210|FG001|Overall Study|Withdrawal by Subject|0|||
23814484|NCT03146962|66703211|FG002|Overall Study|Withdrawal by Subject|0|||
23814485|NCT03146962|66703212|FG003|Overall Study|Withdrawal by Subject|0|||
23814486|NCT03146962|66703213|FG004|Overall Study|Withdrawal by Subject|1|||
23814487|NCT03146962|66703214|FG005|Overall Study|Withdrawal by Subject|0|||
23814488|NCT03146962|66703215|FG006|Overall Study|Withdrawal by Subject|0|||
23814489|NCT03146962|66703216|FG007|Overall Study|Withdrawal by Subject|0|||
23814490|NCT03146962|66703217|FG008|Overall Study|Withdrawal by Subject|0|||
23814491|NCT03146962|66703218|FG009|Overall Study|Withdrawal by Subject|0|||
23814492|NCT03146962|66703209|FG000|Overall Study|Death|0|||
23814493|NCT03146962|66703210|FG001|Overall Study|Death|1|||
23814494|NCT03146962|66703211|FG002|Overall Study|Death|0|||
23814495|NCT03146962|66703212|FG003|Overall Study|Death|0|||
23814496|NCT03146962|66703213|FG004|Overall Study|Death|0|||
23814497|NCT03146962|66703214|FG005|Overall Study|Death|0|||
23814498|NCT03146962|66703215|FG006|Overall Study|Death|0|||
23720824|NCT00340834|66355793|FG000|Core Phase of Study|Lack of Efficacy|3|||
23720825|NCT00340834|66355794|FG001|Core Phase of Study|Lack of Efficacy|3|||
23720826|NCT00340834|66355795|FG002|Core Phase of Study|Lack of Efficacy|7|||
23720827|NCT00340834|66355796|FG003|Core Phase of Study|Lack of Efficacy|0|||
23720828|NCT00340834|66355797|FG004|Core Phase of Study|Lack of Efficacy|0|||
23720829|NCT00340834|66355793|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
23814499|NCT03146962|66703216|FG007|Overall Study|Death|0|||
23814500|NCT03146962|66703217|FG008|Overall Study|Death|0|||
23814501|NCT03146962|66703218|FG009|Overall Study|Death|0|||
23814502|NCT03146962|66703209|FG000|Overall Study|COVID Precautions|1|||
23814503|NCT03146962|66703210|FG001|Overall Study|COVID Precautions|0|||
23814504|NCT03146962|66703211|FG002|Overall Study|COVID Precautions|0|||
23720830|NCT00340834|66355794|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
23814505|NCT03146962|66703212|FG003|Overall Study|COVID Precautions|0|||
23814506|NCT03146962|66703213|FG004|Overall Study|COVID Precautions|0|||
23720831|NCT00340834|66355795|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
23720832|NCT00340834|66355796|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
23720833|NCT00340834|66355797|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
23720834|NCT00340834|66355793|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
23720835|NCT00340834|66355794|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
23720836|NCT00340834|66355795|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
23420373|NCT00075725|65283756|FG001|Overall Study|Pt received additional steroids|0|||
23420374|NCT00075725|65283757|FG002|Overall Study|Pt received additional steroids|0|||
23420375|NCT00075725|65283758|FG003|Overall Study|Pt received additional steroids|1|||
23420376|NCT00075725|65283759|FG004|Overall Study|Pt received additional steroids|0|||
23420377|NCT00075725|65283760|FG005|Overall Study|Pt received additional steroids|0|||
23420378|NCT00075725|65283761|FG006|Overall Study|Pt received additional steroids|0|||
23420379|NCT00075725|65283762|FG007|Overall Study|Pt received additional steroids|0|||
23420380|NCT00075725|65283763|FG008|Overall Study|Pt received additional steroids|0|||
23420381|NCT00075725|65283764|FG009|Overall Study|Pt received additional steroids|0|||
23420382|NCT00075725|65283765|FG010|Overall Study|Pt received additional steroids|0|||
23420383|NCT00075725|65283766|FG011|Overall Study|Pt received additional steroids|0|||
23420384|NCT00075725|65283755|FG000|Overall Study|Pt relocated|0|||
23420385|NCT00075725|65283756|FG001|Overall Study|Pt relocated|0|||
23420386|NCT00075725|65283757|FG002|Overall Study|Pt relocated|0|||
23420387|NCT00075725|65283758|FG003|Overall Study|Pt relocated|2|||
23420388|NCT00075725|65283759|FG004|Overall Study|Pt relocated|0|||
23420389|NCT00075725|65283760|FG005|Overall Study|Pt relocated|1|||
23420390|NCT00075725|65283761|FG006|Overall Study|Pt relocated|1|||
23420391|NCT00075725|65283762|FG007|Overall Study|Pt relocated|2|||
23420392|NCT00075725|65283763|FG008|Overall Study|Pt relocated|1|||
23420393|NCT00075725|65283764|FG009|Overall Study|Pt relocated|0|||
23420394|NCT00075725|65283765|FG010|Overall Study|Pt relocated|0|||
23420395|NCT00075725|65283766|FG011|Overall Study|Pt relocated|0|||
23420396|NCT00075725|65283755|FG000|Overall Study|Institution Terminated|0|||
23420397|NCT00075725|65283756|FG001|Overall Study|Institution Terminated|0|||
23420398|NCT00075725|65283757|FG002|Overall Study|Institution Terminated|0|||
23420399|NCT00075725|65283758|FG003|Overall Study|Institution Terminated|0|||
23420400|NCT00075725|65283759|FG004|Overall Study|Institution Terminated|1|||
23420401|NCT00075725|65283760|FG005|Overall Study|Institution Terminated|0|||
23420402|NCT00075725|65283761|FG006|Overall Study|Institution Terminated|0|||
23420403|NCT00075725|65283762|FG007|Overall Study|Institution Terminated|3|||
23420404|NCT00075725|65283763|FG008|Overall Study|Institution Terminated|0|||
23420405|NCT00075725|65283764|FG009|Overall Study|Institution Terminated|0|||
23420406|NCT00075725|65283765|FG010|Overall Study|Institution Terminated|0|||
23420407|NCT00075725|65283766|FG011|Overall Study|Institution Terminated|0|||
23420408|NCT00075725|65283755|FG000|Overall Study|Study Closure|1|||
23420409|NCT00075725|65283756|FG001|Overall Study|Study Closure|0|||
23420410|NCT00075725|65283757|FG002|Overall Study|Study Closure|0|||
23420411|NCT00075725|65283758|FG003|Overall Study|Study Closure|0|||
23420412|NCT00075725|65283759|FG004|Overall Study|Study Closure|1|||
23420413|NCT00075725|65283760|FG005|Overall Study|Study Closure|3|||
23420414|NCT00075725|65283761|FG006|Overall Study|Study Closure|0|||
23420415|NCT00075725|65283762|FG007|Overall Study|Study Closure|1|||
23420416|NCT00075725|65283763|FG008|Overall Study|Study Closure|0|||
23420417|NCT00075725|65283764|FG009|Overall Study|Study Closure|0|||
23420418|NCT00075725|65283765|FG010|Overall Study|Study Closure|0|||
23420419|NCT00075725|65283766|FG011|Overall Study|Study Closure|0|||
23420420|NCT00075725|65283755|FG000|Overall Study|Other complications|0|||
23420421|NCT00075725|65283756|FG001|Overall Study|Other complications|0|||
23420422|NCT00075725|65283757|FG002|Overall Study|Other complications|0|||
23420423|NCT00075725|65283758|FG003|Overall Study|Other complications|0|||
23420424|NCT00075725|65283759|FG004|Overall Study|Other complications|0|||
23720837|NCT00340834|66355796|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
23420425|NCT00075725|65283760|FG005|Overall Study|Other complications|1|||
23420426|NCT00075725|65283761|FG006|Overall Study|Other complications|0|||
23420427|NCT00075725|65283762|FG007|Overall Study|Other complications|0|||
23420428|NCT00075725|65283763|FG008|Overall Study|Other complications|0|||
23420429|NCT00075725|65283764|FG009|Overall Study|Other complications|0|||
23420430|NCT00075725|65283765|FG010|Overall Study|Other complications|0|||
23420431|NCT00075725|65283766|FG011|Overall Study|Other complications|0|||
23420432|NCT00075725|65283755|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
23420433|NCT00075725|65283756|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
23420434|NCT00075725|65283757|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
23532080|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
23532081|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
23420435|NCT00075725|65283758|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
23420436|NCT00075725|65283759|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
23420437|NCT00075725|65283760|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
23420438|NCT00075725|65283761|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
23420439|NCT00075725|65283762|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
23420440|NCT00075725|65283763|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
23720838|NCT00340834|66355797|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
23720839|NCT00340834|66355793|FG000|Core Phase of Study|Lost to Follow-up|1|||
23720840|NCT00340834|66355794|FG001|Core Phase of Study|Lost to Follow-up|1|||
23720841|NCT00340834|66355795|FG002|Core Phase of Study|Lost to Follow-up|4|||
23720842|NCT00340834|66355796|FG003|Core Phase of Study|Lost to Follow-up|0|||
23720843|NCT00340834|66355797|FG004|Core Phase of Study|Lost to Follow-up|0|||
23720844|NCT00340834|66355793|FG000|Core Phase of Study|Death|2|||
23420441|NCT00075725|65283764|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
23420442|NCT00075725|65283765|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
23420443|NCT00075725|65283766|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
23420444|NCT00075725|65283755|FG000|Overall Study|Pt incarcerated|0|||
23420445|NCT00075725|65283756|FG001|Overall Study|Pt incarcerated|0|||
23420446|NCT00075725|65283757|FG002|Overall Study|Pt incarcerated|0|||
23420447|NCT00075725|65283758|FG003|Overall Study|Pt incarcerated|0|||
23420448|NCT00075725|65283759|FG004|Overall Study|Pt incarcerated|0|||
23420449|NCT00075725|65283760|FG005|Overall Study|Pt incarcerated|0|||
23420450|NCT00075725|65283761|FG006|Overall Study|Pt incarcerated|0|||
23420451|NCT00075725|65283762|FG007|Overall Study|Pt incarcerated|1|||
23420452|NCT00075725|65283763|FG008|Overall Study|Pt incarcerated|0|||
23420453|NCT00075725|65283764|FG009|Overall Study|Pt incarcerated|0|||
23420454|NCT00075725|65283765|FG010|Overall Study|Pt incarcerated|0|||
23420455|NCT00075725|65283766|FG011|Overall Study|Pt incarcerated|0|||
23420456|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
23420457|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
23420458|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420459|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
23420460|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
23420461|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420462|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
23420463|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420464|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420465|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420466|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420467|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
23420468|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420469|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420470|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420471|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23720845|NCT00340834|66355794|FG001|Core Phase of Study|Death|0|||
23720846|NCT00340834|66355795|FG002|Core Phase of Study|Death|0|||
23720847|NCT00340834|66355796|FG003|Core Phase of Study|Death|0|||
23720848|NCT00340834|66355797|FG004|Core Phase of Study|Death|0|||
23720849|NCT00340834|66355793|FG000|Core Phase of Study|Protocol Violation|0|||
23720850|NCT00340834|66355794|FG001|Core Phase of Study|Protocol Violation|0|||
23720851|NCT00340834|66355795|FG002|Core Phase of Study|Protocol Violation|2|||
23720852|NCT00340834|66355796|FG003|Core Phase of Study|Protocol Violation|0|||
23420472|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420473|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420474|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420475|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420476|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420477|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23720853|NCT00340834|66355797|FG004|Core Phase of Study|Protocol Violation|0|||
23720854|NCT00340834|66355793|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
23720855|NCT00340834|66355794|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
23420478|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420479|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420480|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420481|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420482|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420483|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23613958|NCT00296504|65973264|FG008|Interim Analysis|Adverse Event|0|||
23613959|NCT00296504|65973256|FG000|Interim Analysis|Protocol Violation|0|||
23613960|NCT00296504|65973257|FG001|Interim Analysis|Protocol Violation|0|||
23720856|NCT00340834|66355795|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
23814507|NCT03146962|66703214|FG005|Overall Study|COVID Precautions|0|||
23720857|NCT00340834|66355796|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
23420484|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420485|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420486|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420487|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420488|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420489|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420490|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420491|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420492|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420493|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420494|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
23420495|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420496|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420497|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420498|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420499|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420500|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420501|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420502|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23720858|NCT00340834|66355797|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
23720859|NCT00340834|66355793|FG000|Extension Phase of Study|Subject withdrew consent|26|||
23720860|NCT00340834|66355794|FG001|Extension Phase of Study|Subject withdrew consent|31|||
23720861|NCT00340834|66355795|FG002|Extension Phase of Study|Subject withdrew consent|0|||
23720862|NCT00340834|66355796|FG003|Extension Phase of Study|Subject withdrew consent|12|||
23720863|NCT00340834|66355797|FG004|Extension Phase of Study|Subject withdrew consent|15|||
23720864|NCT00340834|66355793|FG000|Extension Phase of Study|Adverse Event|21|||
23720865|NCT00340834|66355794|FG001|Extension Phase of Study|Adverse Event|22|||
23720866|NCT00340834|66355795|FG002|Extension Phase of Study|Adverse Event|0|||
23720867|NCT00340834|66355796|FG003|Extension Phase of Study|Adverse Event|19|||
23420503|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420504|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420505|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420506|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420507|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420508|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420509|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420510|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420511|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420512|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
23420513|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420514|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420515|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420516|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420517|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420518|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420519|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420520|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420521|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420522|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23532082|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
23532083|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
23532084|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
23532085|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
23532086|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
23532087|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
23532088|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
23532089|NCT03252522|65683201|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
23532090|NCT03252522|65683202|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
23532091|NCT03252522|65683203|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
23532092|NCT03252522|65683201|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
23532093|NCT03252522|65683202|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
23532094|NCT03252522|65683203|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
23532095|NCT03252522|65683201|FG000|Phase 2: Open Label|Adverse Event|0|||
23532096|NCT03252522|65683202|FG001|Phase 2: Open Label|Adverse Event|0|||
23532097|NCT03252522|65683203|FG002|Phase 2: Open Label|Adverse Event|2|||
23720868|NCT00340834|66355797|FG004|Extension Phase of Study|Adverse Event|7|||
23720869|NCT00340834|66355793|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
23420523|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420524|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420525|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420526|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420527|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420528|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420529|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420530|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420531|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420532|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420533|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420534|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420535|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420536|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420537|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23720870|NCT00340834|66355794|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
23720871|NCT00340834|66355795|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
23720872|NCT00340834|66355796|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
23420538|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
23420539|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420540|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420541|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420542|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420543|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420544|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420545|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420546|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420547|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420548|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420549|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
23420550|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420551|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
23420552|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420553|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420554|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420555|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420556|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420557|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420558|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420559|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420560|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420561|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420562|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420563|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420564|NCT01271010|65283785|FG000|Overall Study|Reason not specified|11|||
23420565|NCT01271010|65283785|FG000|Overall Study|Start of new CLL therapy|1|||
23420566|NCT01271010|65283785|FG000|Overall Study|Protocol Violation|1|||
23420567|NCT01271010|65283785|FG000|Overall Study|Death|2|||
23420568|NCT01271010|65283785|FG000|Overall Study|Progression and relapse of disease|1|||
23420569|NCT01271010|65283785|FG000|Overall Study|Withdrawal by Subject|18|||
23420570|NCT01271010|65283785|FG000|Overall Study|Disease progression|27|||
23420571|NCT02927925|65283786|FG000|Overall Study|Death|16|||
23420572|NCT02927925|65283786|FG000|Overall Study|Physician Decision|1|||
23420573|NCT02927925|65283786|FG000|Overall Study|Withdrawal by Subject|11|||
23420574|NCT02927925|65283786|FG000|Overall Study|Other|3|||
23420575|NCT02927925|65283786|FG000|Overall Study|Disease progression at clinical cutoff|1|||
23420576|NCT03703817|65283787|FG000|Overall Study|Not meeting eligibility criteria|7|||
23814508|NCT03146962|66703215|FG006|Overall Study|COVID Precautions|0|||
23814509|NCT03146962|66703216|FG007|Overall Study|COVID Precautions|0|||
23814510|NCT03146962|66703217|FG008|Overall Study|COVID Precautions|0|||
23420577|NCT03703817|65283788|FG001|Overall Study|Not meeting eligibility criteria|4|||
23420578|NCT00585221|65283789|FG000|Overall Study|Protocol Violation|8|||
23420579|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
23420580|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
23420581|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
23420582|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
23420583|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
23420584|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
23420585|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
23420586|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
23420587|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
23814511|NCT03146962|66703218|FG009|Overall Study|COVID Precautions|0|||
23814512|NCT03146962|66703209|FG000|Overall Study|Physician Decision|0|||
23814513|NCT03146962|66703210|FG001|Overall Study|Physician Decision|0|||
23814514|NCT03146962|66703211|FG002|Overall Study|Physician Decision|0|||
23814515|NCT03146962|66703212|FG003|Overall Study|Physician Decision|0|||
23814516|NCT03146962|66703213|FG004|Overall Study|Physician Decision|0|||
23814517|NCT03146962|66703214|FG005|Overall Study|Physician Decision|0|||
23814518|NCT03146962|66703215|FG006|Overall Study|Physician Decision|0|||
23814519|NCT03146962|66703216|FG007|Overall Study|Physician Decision|0|||
23814520|NCT03146962|66703217|FG008|Overall Study|Physician Decision|0|||
23720873|NCT00340834|66355797|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
23720874|NCT00340834|66355793|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
23814521|NCT03146962|66703218|FG009|Overall Study|Physician Decision|1|||
23814522|NCT03146962|66703209|FG000|Overall Study|Started New Treatment|0|||
23814523|NCT03146962|66703210|FG001|Overall Study|Started New Treatment|1|||
23814524|NCT03146962|66703211|FG002|Overall Study|Started New Treatment|0|||
23814525|NCT03146962|66703212|FG003|Overall Study|Started New Treatment|0|||
23814526|NCT03146962|66703213|FG004|Overall Study|Started New Treatment|0|||
23814527|NCT03146962|66703214|FG005|Overall Study|Started New Treatment|0|||
23814528|NCT03146962|66703215|FG006|Overall Study|Started New Treatment|0|||
23420588|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
23420589|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
23420590|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
23420591|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
23420592|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
23420593|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
23420594|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
23420595|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
23420596|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
23420597|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
23420598|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
23420599|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
23532098|NCT03252522|65683201|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
23532099|NCT03252522|65683202|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
23532100|NCT03252522|65683203|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
23532101|NCT00927927|65683206|FG000|Overall Study|Withdrawal by Subject|0|||
23532102|NCT00927927|65683207|FG001|Overall Study|Withdrawal by Subject|0|||
23532103|NCT00927927|65683208|FG002|Overall Study|Withdrawal by Subject|0|||
23532104|NCT00927927|65683209|FG003|Overall Study|Withdrawal by Subject|0|||
23532105|NCT00927927|65683210|FG004|Overall Study|Withdrawal by Subject|0|||
23532106|NCT00927927|65683211|FG005|Overall Study|Withdrawal by Subject|0|||
23532107|NCT00927927|65683212|FG006|Overall Study|Withdrawal by Subject|0|||
23720875|NCT00340834|66355794|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
23720876|NCT00340834|66355795|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
23720877|NCT00340834|66355796|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
23720878|NCT00340834|66355797|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
23720879|NCT00340834|66355793|FG000|Extension Phase of Study|Lost to Follow-up|1|||
23720880|NCT00340834|66355794|FG001|Extension Phase of Study|Lost to Follow-up|1|||
23720881|NCT00340834|66355795|FG002|Extension Phase of Study|Lost to Follow-up|0|||
23720882|NCT00340834|66355796|FG003|Extension Phase of Study|Lost to Follow-up|2|||
23720883|NCT00340834|66355797|FG004|Extension Phase of Study|Lost to Follow-up|3|||
23720884|NCT00340834|66355793|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
23720885|NCT00340834|66355794|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
23814529|NCT03146962|66703216|FG007|Overall Study|Started New Treatment|0|||
23814530|NCT03146962|66703217|FG008|Overall Study|Started New Treatment|0|||
23814531|NCT03146962|66703218|FG009|Overall Study|Started New Treatment|0|||
23532108|NCT00927927|65683213|FG007|Overall Study|Withdrawal by Subject|2|||
23532109|NCT00927927|65683214|FG008|Overall Study|Withdrawal by Subject|0|||
23532110|NCT00927927|65683215|FG009|Overall Study|Withdrawal by Subject|0|||
23720886|NCT00340834|66355795|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
23814532|NCT03709823|66703232|FG000|Overall Study|Adverse Event|0|||
23814533|NCT03709823|66703233|FG001|Overall Study|Adverse Event|0|||
23720887|NCT00340834|66355796|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
23720888|NCT00340834|66355797|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
23720889|NCT00340834|66355793|FG000|Extension Phase of Study|Administrative problems|3|||
23720890|NCT00340834|66355794|FG001|Extension Phase of Study|Administrative problems|0|||
23720891|NCT00340834|66355795|FG002|Extension Phase of Study|Administrative problems|0|||
23720892|NCT00340834|66355796|FG003|Extension Phase of Study|Administrative problems|1|||
23720893|NCT00340834|66355797|FG004|Extension Phase of Study|Administrative problems|1|||
23720894|NCT00340834|66355793|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23720895|NCT00340834|66355794|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
23720896|NCT00340834|66355795|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23720897|NCT00340834|66355796|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23720898|NCT00340834|66355797|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
23720899|NCT00340834|66355793|FG000|Extension Phase of Study|Protocol Violation|3|||
23720900|NCT00340834|66355794|FG001|Extension Phase of Study|Protocol Violation|0|||
23720901|NCT00340834|66355795|FG002|Extension Phase of Study|Protocol Violation|0|||
23720902|NCT00340834|66355796|FG003|Extension Phase of Study|Protocol Violation|0|||
23720903|NCT00340834|66355797|FG004|Extension Phase of Study|Protocol Violation|0|||
23720904|NCT00340834|66355793|FG000|Extension Phase of Study|Death|0|||
23720905|NCT00340834|66355794|FG001|Extension Phase of Study|Death|0|||
23720906|NCT00340834|66355795|FG002|Extension Phase of Study|Death|0|||
23720907|NCT00340834|66355796|FG003|Extension Phase of Study|Death|0|||
23720908|NCT00340834|66355797|FG004|Extension Phase of Study|Death|1|||
23720909|NCT00646113|66355799|FG000|Overall Study|Lost to Follow-up|5|||
23720910|NCT00646113|66355799|FG000|Overall Study|Adverse Event|3|||
23720911|NCT01504971|66355800|FG000|Overall Study|Physician Decision|13|||
23720912|NCT00587301|66355802|FG000|Overall Study|Screen Failure|9|||
23720913|NCT00587301|66355802|FG000|Overall Study|Lost to Follow-up|22|||
23720914|NCT00587301|66355802|FG000|Overall Study|Withdrawal by Subject|7|||
23720915|NCT00587301|66355802|FG000|Overall Study|Protocol Violation|7|||
23720916|NCT00830115|66355803|FG000|Overall Study|Adverse Event|2|||
23720917|NCT00830115|66355803|FG000|Overall Study|Improvement/recovery|1|||
23720918|NCT00888615|66355804|FG000|Overall Study|No treatment|2|||
23720919|NCT03351478|66355805|FG000|Overall Study|At the subject's own request|11|||
23720920|NCT03351478|66355806|FG001|Overall Study|At the subject's own request|12|||
23720921|NCT03351478|66355807|FG002|Overall Study|At the subject's own request|5|||
23720922|NCT03351478|66355805|FG000|Overall Study|Adverse Event|1|||
23720923|NCT03351478|66355806|FG001|Overall Study|Adverse Event|2|||
23720924|NCT03351478|66355807|FG002|Overall Study|Adverse Event|1|||
23720925|NCT03351478|66355805|FG000|Overall Study|Poor compliance to protocol|1|||
23720926|NCT03351478|66355806|FG001|Overall Study|Poor compliance to protocol|0|||
23720927|NCT03351478|66355807|FG002|Overall Study|Poor compliance to protocol|0|||
23720928|NCT03351478|66355805|FG000|Overall Study|Reason not Specified|1|||
23720929|NCT03351478|66355806|FG001|Overall Study|Reason not Specified|3|||
23720930|NCT03351478|66355807|FG002|Overall Study|Reason not Specified|0|||
23720931|NCT03351478|66355805|FG000|Overall Study|Lost to Follow-up|0|||
23720932|NCT03351478|66355806|FG001|Overall Study|Lost to Follow-up|0|||
23720933|NCT03351478|66355807|FG002|Overall Study|Lost to Follow-up|1|||
23720934|NCT00861380|66355810|FG000|Overall Study|Withdrawal Information not recorded|8427|||
23720935|NCT00861380|66355811|FG001|Overall Study|Withdrawal Information not recorded|9112|||
23720936|NCT00861380|66355812|FG002|Overall Study|Withdrawal Information not recorded|8872|||
23720937|NCT00861380|66355813|FG003|Overall Study|Withdrawal Information not recorded|3689|||
23720938|NCT00861380|66355814|FG004|Overall Study|Withdrawal Information not recorded|1812|||
23720939|NCT00861380|66355815|FG005|Overall Study|Withdrawal Information not recorded|6249|||
23720940|NCT00861380|66355816|FG006|Overall Study|Withdrawal Information not recorded|3020|||
23720941|NCT02079519|66355820|FG000|Overall Study|Disease Progression|9|||
23720942|NCT02079519|66355820|FG000|Overall Study|Adverse Event|1|||
23720943|NCT00438464|66355821|FG000|Overall Study|Terminated Early|14|||
23720944|NCT00438464|66355822|FG001|Overall Study|Terminated Early|5|||
23720945|NCT00438464|66355821|FG000|Overall Study|Incomplete data submission|0|||
23720946|NCT00438464|66355822|FG001|Overall Study|Incomplete data submission|2|||
23720947|NCT01153841|66355823|FG000|Overall Study|Adverse Event|1|||
23720948|NCT01153841|66355824|FG001|Overall Study|Adverse Event|0|||
23720949|NCT01153841|66355823|FG000|Overall Study|Withdrawal by Subject|1|||
23720950|NCT01153841|66355824|FG001|Overall Study|Withdrawal by Subject|0|||
23720951|NCT01153841|66355823|FG000|Overall Study|Protocol Violation|2|||
23720952|NCT01153841|66355824|FG001|Overall Study|Protocol Violation|0|||
23720953|NCT01153841|66355823|FG000|Overall Study|Lost to Follow-up|2|||
23720954|NCT01153841|66355824|FG001|Overall Study|Lost to Follow-up|0|||
23720955|NCT01705587|66355825|FG000|Overall Study|Withdrawal by Subject|0|||
23720956|NCT01705587|66355826|FG001|Overall Study|Withdrawal by Subject|1|||
23720957|NCT00305604|66355831|FG000|Overall Study|Adverse Event|6|||
23720958|NCT00305604|66355832|FG001|Overall Study|Adverse Event|3|||
23720959|NCT00305604|66355831|FG000|Overall Study|Lack of Efficacy|11|||
23720960|NCT00305604|66355832|FG001|Overall Study|Lack of Efficacy|18|||
23720961|NCT00305604|66355831|FG000|Overall Study|Lost to Follow-up|0|||
23720962|NCT00305604|66355832|FG001|Overall Study|Lost to Follow-up|4|||
23720963|NCT00305604|66355831|FG000|Overall Study|Protocol Violation|2|||
23720964|NCT00305604|66355832|FG001|Overall Study|Protocol Violation|1|||
23720965|NCT00305604|66355831|FG000|Overall Study|Withdrawal by Subject|12|||
23720966|NCT00305604|66355832|FG001|Overall Study|Withdrawal by Subject|21|||
23720967|NCT00305604|66355831|FG000|Overall Study|Patient moved|1|||
23720968|NCT00305604|66355832|FG001|Overall Study|Patient moved|0|||
23720969|NCT02088541|66355833|FG000|Overall Study|Adverse Event|3|||
23720970|NCT02088541|66355834|FG001|Overall Study|Adverse Event|0|||
23720971|NCT02088541|66355835|FG002|Overall Study|Adverse Event|3|||
23720972|NCT02088541|66355836|FG003|Overall Study|Adverse Event|3|||
23720973|NCT02088541|66355837|FG004|Overall Study|Adverse Event|0|||
23720974|NCT02088541|66355833|FG000|Overall Study|Death|51|||
23720975|NCT02088541|66355834|FG001|Overall Study|Death|21|||
23720976|NCT02088541|66355835|FG002|Overall Study|Death|85|||
23720977|NCT02088541|66355836|FG003|Overall Study|Death|28|||
23720978|NCT02088541|66355837|FG004|Overall Study|Death|38|||
23720979|NCT02088541|66355833|FG000|Overall Study|Lost to Follow-up|2|||
23720980|NCT02088541|66355834|FG001|Overall Study|Lost to Follow-up|0|||
23720981|NCT02088541|66355835|FG002|Overall Study|Lost to Follow-up|1|||
23720982|NCT02088541|66355836|FG003|Overall Study|Lost to Follow-up|0|||
23720983|NCT02088541|66355837|FG004|Overall Study|Lost to Follow-up|0|||
23720984|NCT02088541|66355833|FG000|Overall Study|Physician Decision|2|||
23613961|NCT00296504|65973258|FG002|Interim Analysis|Protocol Violation|2|||
23613962|NCT00296504|65973259|FG003|Interim Analysis|Protocol Violation|0|||
23613963|NCT00296504|65973260|FG004|Interim Analysis|Protocol Violation|1|||
23720985|NCT02088541|66355834|FG001|Overall Study|Physician Decision|1|||
23720986|NCT02088541|66355835|FG002|Overall Study|Physician Decision|2|||
23720987|NCT02088541|66355836|FG003|Overall Study|Physician Decision|0|||
23720988|NCT02088541|66355837|FG004|Overall Study|Physician Decision|2|||
23720989|NCT02088541|66355833|FG000|Overall Study|Disease progression|7|||
23720990|NCT02088541|66355834|FG001|Overall Study|Disease progression|1|||
23720991|NCT02088541|66355835|FG002|Overall Study|Disease progression|2|||
23720992|NCT02088541|66355836|FG003|Overall Study|Disease progression|3|||
23720993|NCT02088541|66355837|FG004|Overall Study|Disease progression|1|||
23613964|NCT00296504|65973261|FG005|Interim Analysis|Protocol Violation|0|||
23613965|NCT00296504|65973262|FG006|Interim Analysis|Protocol Violation|0|||
23613966|NCT00296504|65973263|FG007|Interim Analysis|Protocol Violation|1|||
23613967|NCT00296504|65973264|FG008|Interim Analysis|Protocol Violation|0|||
23613968|NCT00296504|65973256|FG000|Interim Analysis|Insufficient CD4 Response|0|||
23613969|NCT00296504|65973257|FG001|Interim Analysis|Insufficient CD4 Response|0|||
23613970|NCT00296504|65973258|FG002|Interim Analysis|Insufficient CD4 Response|0|||
23613971|NCT00296504|65973259|FG003|Interim Analysis|Insufficient CD4 Response|0|||
23613972|NCT00296504|65973260|FG004|Interim Analysis|Insufficient CD4 Response|1|||
23613973|NCT00296504|65973261|FG005|Interim Analysis|Insufficient CD4 Response|1|||
23613974|NCT00296504|65973262|FG006|Interim Analysis|Insufficient CD4 Response|0|||
23613975|NCT00296504|65973263|FG007|Interim Analysis|Insufficient CD4 Response|0|||
23613976|NCT00296504|65973264|FG008|Interim Analysis|Insufficient CD4 Response|0|||
23613977|NCT00296504|65973256|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
23613978|NCT00296504|65973257|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
23613979|NCT00296504|65973258|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
23613980|NCT00296504|65973259|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
23613981|NCT00296504|65973260|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
23613982|NCT00296504|65973261|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
23613983|NCT00296504|65973262|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
23613984|NCT00296504|65973263|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
23613985|NCT00296504|65973264|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
23613986|NCT00296504|65973256|FG000|Interim Analysis|Pregnancy|4|||
23613987|NCT00296504|65973257|FG001|Interim Analysis|Pregnancy|1|||
23613988|NCT00296504|65973258|FG002|Interim Analysis|Pregnancy|4|||
23613989|NCT00296504|65973259|FG003|Interim Analysis|Pregnancy|2|||
23613990|NCT00296504|65973260|FG004|Interim Analysis|Pregnancy|0|||
23720994|NCT02088541|66355833|FG000|Overall Study|Study terminated by sponsor|1|||
23720995|NCT02088541|66355834|FG001|Overall Study|Study terminated by sponsor|1|||
23720996|NCT02088541|66355835|FG002|Overall Study|Study terminated by sponsor|12|||
23720997|NCT02088541|66355836|FG003|Overall Study|Study terminated by sponsor|2|||
23720998|NCT02088541|66355837|FG004|Overall Study|Study terminated by sponsor|6|||
23720999|NCT02088541|66355833|FG000|Overall Study|Withdrawal by Subject|3|||
23721000|NCT02088541|66355834|FG001|Overall Study|Withdrawal by Subject|2|||
23721001|NCT02088541|66355835|FG002|Overall Study|Withdrawal by Subject|9|||
23613991|NCT00296504|65973261|FG005|Interim Analysis|Pregnancy|1|||
23613992|NCT00296504|65973262|FG006|Interim Analysis|Pregnancy|1|||
23613993|NCT00296504|65973263|FG007|Interim Analysis|Pregnancy|1|||
23613994|NCT00296504|65973264|FG008|Interim Analysis|Pregnancy|0|||
23613995|NCT00296504|65973256|FG000|Interim Analysis|Death|1|||
23721002|NCT02088541|66355836|FG003|Overall Study|Withdrawal by Subject|7|||
23721003|NCT02088541|66355837|FG004|Overall Study|Withdrawal by Subject|10|||
23721004|NCT02088541|66355833|FG000|Overall Study|Other|2|||
23721005|NCT02088541|66355834|FG001|Overall Study|Other|1|||
23721006|NCT02088541|66355835|FG002|Overall Study|Other|3|||
23721007|NCT02088541|66355836|FG003|Overall Study|Other|1|||
23721008|NCT02088541|66355837|FG004|Overall Study|Other|1|||
23721009|NCT01946412|66355838|FG000|Overall Study|Adverse Event|1|||
23721010|NCT01946412|66355838|FG000|Overall Study|Non-Compliance|1|||
23613996|NCT00296504|65973257|FG001|Interim Analysis|Death|0|||
23613997|NCT00296504|65973258|FG002|Interim Analysis|Death|3|||
23613998|NCT00296504|65973259|FG003|Interim Analysis|Death|0|||
23613999|NCT00296504|65973260|FG004|Interim Analysis|Death|0|||
23814534|NCT03709823|66703234|FG002|Overall Study|Adverse Event|1|||
23814535|NCT03709823|66703235|FG003|Overall Study|Adverse Event|0|||
23814536|NCT03709823|66703236|FG004|Overall Study|Adverse Event|0|||
23814537|NCT03709823|66703237|FG005|Overall Study|Adverse Event|0|||
23814538|NCT03709823|66703232|FG000|Overall Study|Lost to Follow-up|2|||
23420600|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
23420601|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
23420602|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
23420603|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
23420604|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
23420605|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
23420606|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
23420607|NCT00350870|65283803|FG000|Overall Study|Withdrawal by Subject|21|||
23420608|NCT00350870|65283804|FG001|Overall Study|Withdrawal by Subject|17|||
23420609|NCT00350870|65283805|FG002|Overall Study|Withdrawal by Subject|15|||
23420610|NCT00350870|65283806|FG003|Overall Study|Withdrawal by Subject|14|||
23420611|NCT00350870|65283803|FG000|Overall Study|Physician Decision|1|||
23420612|NCT00350870|65283804|FG001|Overall Study|Physician Decision|0|||
23420613|NCT00350870|65283805|FG002|Overall Study|Physician Decision|1|||
23420614|NCT00350870|65283806|FG003|Overall Study|Physician Decision|1|||
23420615|NCT02242435|65283807|FG000|Overall Study|Lost to Follow-up|3|||
23420616|NCT02242435|65283808|FG001|Overall Study|Lost to Follow-up|4|||
23614000|NCT00296504|65973261|FG005|Interim Analysis|Death|0|||
23614001|NCT00296504|65973262|FG006|Interim Analysis|Death|0|||
23614002|NCT00296504|65973263|FG007|Interim Analysis|Death|0|||
23614003|NCT00296504|65973264|FG008|Interim Analysis|Death|0|||
23614004|NCT00296504|65973256|FG000|Interim Analysis|Participant Non-compliant|0|||
23614005|NCT00296504|65973257|FG001|Interim Analysis|Participant Non-compliant|1|||
23721011|NCT01946412|66355838|FG000|Overall Study|Continued with commercial Kalydeco|2|||
23721012|NCT01946412|66355838|FG000|Overall Study|Difficulty in swallowing|1|||
23721013|NCT01090102|66355839|FG000|First 12 Weeks|Withdrawal by Subject|1|||
23721014|NCT01090102|66355840|FG001|First 12 Weeks|Withdrawal by Subject|1|||
23721015|NCT01090102|66355839|FG000|First 12 Weeks|Adverse Event|2|||
23721016|NCT01090102|66355840|FG001|First 12 Weeks|Adverse Event|0|||
23721017|NCT01090102|66355839|FG000|First 12 Weeks|Death|1|||
23721018|NCT01090102|66355840|FG001|First 12 Weeks|Death|1|||
23721019|NCT01090102|66355839|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
23721020|NCT01090102|66355840|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
23721021|NCT00047008|66355841|FG000|Overall Study|Withdrawn consent|2|||
23721022|NCT00047008|66355842|FG001|Overall Study|Withdrawn consent|3|||
23721023|NCT00047008|66355841|FG000|Overall Study|Ineligible|9|||
23721024|NCT00047008|66355842|FG001|Overall Study|Ineligible|8|||
23721025|NCT02633046|66355843|FG000|Overall Study|Adverse Event|8|||
23721026|NCT02633046|66355843|FG000|Overall Study|Physician Decision|7|||
23721027|NCT02633046|66355843|FG000|Overall Study|Withdrawal by Subject|8|||
23721028|NCT02633046|66355843|FG000|Overall Study|Increased proteinuria|2|||
23721029|NCT02633046|66355843|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
23721030|NCT02633046|66355843|FG000|Overall Study|Mutual decision patient and physician|1|||
23721031|NCT03024255|66355844|FG000|Overall Study|Adverse Event|1|||
23721032|NCT03024255|66355845|FG001|Overall Study|Adverse Event|4|||
23721033|NCT03024255|66355846|FG002|Overall Study|Adverse Event|8|||
23721034|NCT03024255|66355847|FG003|Overall Study|Adverse Event|0|||
23721035|NCT03024255|66355844|FG000|Overall Study|Withdrawal by Subject|3|||
23721036|NCT03024255|66355845|FG001|Overall Study|Withdrawal by Subject|1|||
23721037|NCT03024255|66355846|FG002|Overall Study|Withdrawal by Subject|0|||
23721038|NCT03024255|66355847|FG003|Overall Study|Withdrawal by Subject|3|||
23721039|NCT03024255|66355844|FG000|Overall Study|Protocol Violation|0|||
23721040|NCT03024255|66355845|FG001|Overall Study|Protocol Violation|0|||
23721041|NCT03024255|66355846|FG002|Overall Study|Protocol Violation|2|||
23721042|NCT03024255|66355847|FG003|Overall Study|Protocol Violation|0|||
23420617|NCT02242435|65283807|FG000|Overall Study|Adverse Event|3|||
23420618|NCT02242435|65283808|FG001|Overall Study|Adverse Event|2|||
23420619|NCT02242435|65283807|FG000|Overall Study|Withdrawal by Subject|13|||
23614006|NCT00296504|65973258|FG002|Interim Analysis|Participant Non-compliant|2|||
23614007|NCT00296504|65973259|FG003|Interim Analysis|Participant Non-compliant|1|||
23721043|NCT03024255|66355844|FG000|Overall Study|Lost to Follow-up|1|||
23721044|NCT03024255|66355845|FG001|Overall Study|Lost to Follow-up|2|||
23420620|NCT02242435|65283808|FG001|Overall Study|Withdrawal by Subject|8|||
23721045|NCT03024255|66355846|FG002|Overall Study|Lost to Follow-up|1|||
23721046|NCT03024255|66355847|FG003|Overall Study|Lost to Follow-up|1|||
23721047|NCT03024255|66355844|FG000|Overall Study|Lack of Efficacy|1|||
23721048|NCT03024255|66355845|FG001|Overall Study|Lack of Efficacy|0|||
23721049|NCT03024255|66355846|FG002|Overall Study|Lack of Efficacy|0|||
23721050|NCT03024255|66355847|FG003|Overall Study|Lack of Efficacy|0|||
23721051|NCT03024255|66355844|FG000|Overall Study|Protocol Noncompliance|1|||
23721052|NCT03024255|66355845|FG001|Overall Study|Protocol Noncompliance|1|||
23721053|NCT03024255|66355846|FG002|Overall Study|Protocol Noncompliance|0|||
23721054|NCT03024255|66355847|FG003|Overall Study|Protocol Noncompliance|1|||
23721055|NCT03395223|66355855|FG000|Overall Study|Lost to Follow-up|3|||
23721056|NCT03395223|66355855|FG000|Overall Study|Other|1|||
23721057|NCT04857892|66355856|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
23721058|NCT04857892|66355857|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23721059|NCT04857892|66355858|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23721060|NCT04857892|66355859|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23721061|NCT04857892|66355860|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23721062|NCT04857892|66355856|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
23721063|NCT04857892|66355857|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
23721064|NCT04857892|66355858|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
23721065|NCT04857892|66355859|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
23721066|NCT04857892|66355860|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
23721067|NCT04857892|66355856|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23721068|NCT04857892|66355857|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23721069|NCT04857892|66355858|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23721070|NCT04857892|66355859|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23721071|NCT04857892|66355860|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
23721072|NCT04294095|66355861|FG000|Overall Study|Adverse Event|1|||
23721073|NCT04294095|66355862|FG001|Overall Study|Adverse Event|0|||
23721074|NCT00023712|66355863|FG000|Overall Study|Not platinum sensitive|1|||
23721075|NCT00023712|66355864|FG001|Overall Study|Not platinum sensitive|0|||
23721076|NCT00023712|66355863|FG000|Overall Study|Never treated|1|||
23721077|NCT00023712|66355864|FG001|Overall Study|Never treated|1|||
23721078|NCT00282867|66355865|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
23721079|NCT00282867|66355866|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
23721080|NCT00282867|66355867|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
23721081|NCT04681729|66355868|FG000|Overall Study|Lack of Efficacy|2|||
23721082|NCT04681729|66355869|FG001|Overall Study|Lack of Efficacy|2|||
23721083|NCT04681729|66355868|FG000|Overall Study|Withdrawal by Subject|8|||
23721084|NCT04681729|66355869|FG001|Overall Study|Withdrawal by Subject|9|||
23721085|NCT01455415|66355870|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
23721086|NCT01455415|66355871|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
23721087|NCT01455415|66355870|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
23721088|NCT01455415|66355871|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
23721089|NCT01455415|66355870|FG000|Period 1|Drug Error not Associated to AE|0|||
23420621|NCT02242435|65283807|FG000|Overall Study|Death|0|||
23420622|NCT02242435|65283808|FG001|Overall Study|Death|1|||
23420623|NCT02242435|65283807|FG000|Overall Study|Protocol Violation|1|||
23420624|NCT02242435|65283808|FG001|Overall Study|Protocol Violation|0|||
23420625|NCT02242435|65283807|FG000|Overall Study|Physician Decision|0|||
23532111|NCT00927927|65683216|FG010|Overall Study|Withdrawal by Subject|0|||
23532112|NCT00927927|65683217|FG011|Overall Study|Withdrawal by Subject|2|||
23532113|NCT00927927|65683218|FG012|Overall Study|Withdrawal by Subject|0|||
23532114|NCT00927927|65683219|FG013|Overall Study|Withdrawal by Subject|0|||
23532115|NCT00927927|65683220|FG014|Overall Study|Withdrawal by Subject|0|||
23532116|NCT02331446|65683221|FG000|Overall Study|Lost to Follow-up|2|||
23532117|NCT02331446|65683222|FG001|Overall Study|Lost to Follow-up|1|||
23532118|NCT02331446|65683223|FG002|Overall Study|Lost to Follow-up|0|||
23532119|NCT02331446|65683224|FG003|Overall Study|Lost to Follow-up|1|||
23532120|NCT02331446|65683221|FG000|Overall Study|Personal Problem|2|||
23532121|NCT02331446|65683222|FG001|Overall Study|Personal Problem|0|||
23532122|NCT02331446|65683223|FG002|Overall Study|Personal Problem|0|||
23532123|NCT02331446|65683224|FG003|Overall Study|Personal Problem|0|||
23532124|NCT02331446|65683221|FG000|Overall Study|Disease|0|||
23532125|NCT02331446|65683222|FG001|Overall Study|Disease|2|||
23532126|NCT02331446|65683223|FG002|Overall Study|Disease|2|||
23532127|NCT02331446|65683224|FG003|Overall Study|Disease|1|||
23532128|NCT02331446|65683221|FG000|Overall Study|Physician Decision|0|||
23721090|NCT01455415|66355871|FG001|Period 1|Drug Error not Associated to AE|1|||
23721091|NCT01455415|66355870|FG000|Period 1|AE Not Related to Study Drug|2|||
23420626|NCT02242435|65283808|FG001|Overall Study|Physician Decision|1|||
23532129|NCT02331446|65683222|FG001|Overall Study|Physician Decision|1|||
23532130|NCT02331446|65683223|FG002|Overall Study|Physician Decision|0|||
23420627|NCT05807464|65283809|FG000|Overall Study|Adverse Event|1|||
23532131|NCT02331446|65683224|FG003|Overall Study|Physician Decision|1|||
23420628|NCT03466099|65283815|FG000|Overall Study|Adverse Event|1|||
23420629|NCT03466099|65283816|FG001|Overall Study|Adverse Event|1|||
23420630|NCT03466099|65283817|FG002|Overall Study|Adverse Event|1|||
23420631|NCT03466099|65283815|FG000|Overall Study|Withdrawal by Subject|2|||
23420632|NCT03466099|65283816|FG001|Overall Study|Withdrawal by Subject|3|||
23420633|NCT03466099|65283817|FG002|Overall Study|Withdrawal by Subject|1|||
23420634|NCT03466099|65283815|FG000|Overall Study|Use of rescue medication|8|||
23420635|NCT03466099|65283816|FG001|Overall Study|Use of rescue medication|9|||
23420636|NCT03466099|65283817|FG002|Overall Study|Use of rescue medication|13|||
23420637|NCT03466099|65283815|FG000|Overall Study|Rescued without meeting criteria|4|||
23420638|NCT03466099|65283816|FG001|Overall Study|Rescued without meeting criteria|1|||
23420639|NCT03466099|65283817|FG002|Overall Study|Rescued without meeting criteria|1|||
23420640|NCT03466099|65283815|FG000|Overall Study|Subject compliance|2|||
23420641|NCT03466099|65283816|FG001|Overall Study|Subject compliance|0|||
23420642|NCT03466099|65283817|FG002|Overall Study|Subject compliance|0|||
23420643|NCT03466099|65283815|FG000|Overall Study|Worsening disease|0|||
23420644|NCT03466099|65283816|FG001|Overall Study|Worsening disease|0|||
23420645|NCT03466099|65283817|FG002|Overall Study|Worsening disease|1|||
23420646|NCT03260894|65283818|FG000|Overall Study|Death|6|||
23420647|NCT03260894|65283819|FG001|Overall Study|Death|8|||
23420648|NCT03260894|65283818|FG000|Overall Study|Withdrawal by Subject|4|||
23420649|NCT03260894|65283819|FG001|Overall Study|Withdrawal by Subject|11|||
23420650|NCT03260894|65283818|FG000|Overall Study|On-going at clinical cut off date|36|||
23420651|NCT03260894|65283819|FG001|Overall Study|On-going at clinical cut off date|31|||
23420652|NCT01774253|65283827|FG000|Overall Study|Lack of Efficacy|4|||
23420653|NCT01774253|65283827|FG000|Overall Study|Physician Decision|2|||
23420654|NCT01774253|65283827|FG000|Overall Study|Withdrawal by Subject|2|||
23420655|NCT01774253|65283827|FG000|Overall Study|Death|1|||
23420656|NCT05593913|65283828|FG000|Overall Study|Insufficient image quality|39|||
23420657|NCT03764631|65283835|FG000|Overall Study|Personal Reasons|3|||
23420658|NCT03764631|65283836|FG001|Overall Study|Personal Reasons|2|||
23420659|NCT03764631|65283835|FG000|Overall Study|Switching Therapy|3|||
23420660|NCT03764631|65283836|FG001|Overall Study|Switching Therapy|3|||
23420661|NCT03764631|65283835|FG000|Overall Study|Adverse Event|0|||
23420662|NCT03764631|65283836|FG001|Overall Study|Adverse Event|1|||
23420663|NCT03764631|65283835|FG000|Overall Study|Lost to Follow-up|33|||
23420664|NCT03764631|65283836|FG001|Overall Study|Lost to Follow-up|41|||
23420665|NCT03764631|65283835|FG000|Overall Study|No data as study site was closed|2|||
23420666|NCT03764631|65283836|FG001|Overall Study|No data as study site was closed|6|||
23420667|NCT00027378|65283847|FG000|Overall Study|Physician Decision|0|||
23420668|NCT00027378|65283848|FG001|Overall Study|Physician Decision|3|||
23420669|NCT05599451|65283856|FG000|Overall Study|Not randomized|11|||
23420670|NCT05599451|65283857|FG001|Overall Study|Not randomized|0|||
23420671|NCT05599451|65283858|FG002|Overall Study|Not randomized|0|||
23420672|NCT05599451|65283859|FG003|Overall Study|Not randomized|0|||
23420673|NCT05599451|65283860|FG004|Overall Study|Not randomized|0|||
23420674|NCT05599451|65283856|FG000|Overall Study|Physician Decision|0|||
23420675|NCT05599451|65283857|FG001|Overall Study|Physician Decision|0|||
23420676|NCT05599451|65283858|FG002|Overall Study|Physician Decision|0|||
23420677|NCT05599451|65283859|FG003|Overall Study|Physician Decision|1|||
23420678|NCT05599451|65283860|FG004|Overall Study|Physician Decision|0|||
23721092|NCT01455415|66355871|FG001|Period 1|AE Not Related to Study Drug|6|||
23420679|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Adverse Event|76|||
23420680|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Adverse Event|0|||
23721093|NCT01455415|66355870|FG000|Period 1|Withdrawal by Subject|4|||
23721094|NCT01455415|66355871|FG001|Period 1|Withdrawal by Subject|5|||
23721095|NCT01455415|66355870|FG000|Period 1|Unspecified Reason|1|||
23721096|NCT01455415|66355871|FG001|Period 1|Unspecified Reason|1|||
23721097|NCT01455415|66355870|FG000|Period 1|Protocol Violation|0|||
23721098|NCT01455415|66355871|FG001|Period 1|Protocol Violation|2|||
23721099|NCT01455415|66355870|FG000|Washout|AE Related to Study Drug|2|||
23721100|NCT01455415|66355871|FG001|Washout|AE Related to Study Drug|0|||
23721101|NCT01455415|66355870|FG000|Washout|Lost to Follow-up|1|||
23721102|NCT01455415|66355871|FG001|Washout|Lost to Follow-up|0|||
23721103|NCT01455415|66355870|FG000|Washout|Drug Error not Associated to AE|2|||
23721104|NCT01455415|66355871|FG001|Washout|Drug Error not Associated to AE|1|||
23721105|NCT01455415|66355870|FG000|Washout|AE Not Related to Study Drug|2|||
23420681|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Adverse Event|0|||
23721106|NCT01455415|66355871|FG001|Washout|AE Not Related to Study Drug|3|||
23721107|NCT01455415|66355870|FG000|Washout|Unspecified Reason|1|||
23420682|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Death|3|||
23420683|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Death|0|||
23420684|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Death|0|||
23420685|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
23420686|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
23420687|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
23721108|NCT01455415|66355871|FG001|Washout|Unspecified Reason|2|||
23721109|NCT01455415|66355870|FG000|Washout|Protocol Violation|0|||
23721110|NCT01455415|66355871|FG001|Washout|Protocol Violation|1|||
23420688|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Physician Decision|9|||
23420689|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Physician Decision|0|||
23420690|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Physician Decision|0|||
23420691|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
23420692|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
23420693|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
23420694|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Disease progression|45|||
23420695|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Disease progression|0|||
23420696|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Disease progression|0|||
23420697|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
23420698|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
23420699|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
23721111|NCT01455415|66355870|FG000|Period 2|AE Related to Study Drug|1|||
23721112|NCT01455415|66355871|FG001|Period 2|AE Related to Study Drug|2|||
23420700|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
23420701|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
23420702|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
23420703|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
23420704|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
23420705|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
23420706|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
23420707|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
23420708|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
23420709|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
23420710|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
23420711|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
23420712|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
23420713|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
23420714|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
23420715|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
23420716|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
23420717|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
23420718|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
23420719|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
23420720|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
23420721|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
23420722|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
23420723|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
23420724|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Promotor request|1|||
23420725|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Promotor request|0|||
23420726|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Promotor request|0|||
23420727|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
23420728|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
23420729|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
23532132|NCT02331446|65683221|FG000|Overall Study|Lost before baseline analysis|0|||
23532133|NCT02331446|65683222|FG001|Overall Study|Lost before baseline analysis|1|||
23532134|NCT02331446|65683223|FG002|Overall Study|Lost before baseline analysis|1|||
23532135|NCT02331446|65683224|FG003|Overall Study|Lost before baseline analysis|0|||
23532136|NCT01096784|65683225|FG000|Overall Study|Withdrawal by Subject|2|||
23532137|NCT01096784|65683226|FG001|Overall Study|Withdrawal by Subject|1|||
23532138|NCT01096784|65683225|FG000|Overall Study|Adverse Event|11|||
23532139|NCT01096784|65683226|FG001|Overall Study|Adverse Event|9|||
23532140|NCT01096784|65683225|FG000|Overall Study|Protocol Deviation|2|||
23532141|NCT01096784|65683226|FG001|Overall Study|Protocol Deviation|2|||
23532142|NCT01096784|65683225|FG000|Overall Study|Administrative Decision|0|||
23532143|NCT01096784|65683226|FG001|Overall Study|Administrative Decision|1|||
23721113|NCT01455415|66355870|FG000|Period 2|Lost to Follow-up|2|||
23721114|NCT01455415|66355871|FG001|Period 2|Lost to Follow-up|1|||
23721115|NCT01455415|66355870|FG000|Period 2|AE Not Related to Study Drug|2|||
23721116|NCT01455415|66355871|FG001|Period 2|AE Not Related to Study Drug|1|||
23721117|NCT01455415|66355870|FG000|Period 2|Lack of Efficacy|2|||
23721118|NCT01455415|66355871|FG001|Period 2|Lack of Efficacy|0|||
23420730|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
23420731|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
23532144|NCT01096784|65683225|FG000|Overall Study|Other Unspecified|0|||
23532145|NCT01096784|65683226|FG001|Overall Study|Other Unspecified|1|||
23532146|NCT02488629|65683229|FG000|Overall Study|Lack of Efficacy|3|||
23532147|NCT02488629|65683230|FG001|Overall Study|Lack of Efficacy|1|||
23532148|NCT02488629|65683231|FG002|Overall Study|Lack of Efficacy|0|||
23814539|NCT03709823|66703233|FG001|Overall Study|Lost to Follow-up|2|||
23814540|NCT03709823|66703234|FG002|Overall Study|Lost to Follow-up|2|||
23814541|NCT03709823|66703235|FG003|Overall Study|Lost to Follow-up|1|||
23814542|NCT03709823|66703236|FG004|Overall Study|Lost to Follow-up|1|||
23814543|NCT03709823|66703237|FG005|Overall Study|Lost to Follow-up|0|||
23814544|NCT03709823|66703232|FG000|Overall Study|Withdrawal by Subject|1|||
23814545|NCT03709823|66703233|FG001|Overall Study|Withdrawal by Subject|3|||
23814546|NCT03709823|66703234|FG002|Overall Study|Withdrawal by Subject|0|||
23814547|NCT03709823|66703235|FG003|Overall Study|Withdrawal by Subject|0|||
23814548|NCT03709823|66703236|FG004|Overall Study|Withdrawal by Subject|0|||
23814549|NCT03709823|66703237|FG005|Overall Study|Withdrawal by Subject|0|||
23814550|NCT03709823|66703232|FG000|Overall Study|Other, Not Specified|0|||
23814551|NCT03709823|66703233|FG001|Overall Study|Other, Not Specified|0|||
23814552|NCT03709823|66703234|FG002|Overall Study|Other, Not Specified|0|||
23814553|NCT03709823|66703235|FG003|Overall Study|Other, Not Specified|1|||
23532149|NCT02488629|65683232|FG003|Overall Study|Lack of Efficacy|0|||
23532150|NCT02488629|65683229|FG000|Overall Study|Withdrawal by Subject|0|||
23532151|NCT02488629|65683230|FG001|Overall Study|Withdrawal by Subject|1|||
23532152|NCT02488629|65683231|FG002|Overall Study|Withdrawal by Subject|0|||
23532153|NCT02488629|65683232|FG003|Overall Study|Withdrawal by Subject|0|||
23532154|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
23532155|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
23532156|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
23721119|NCT01455415|66355870|FG000|Period 2|Withdrawal by Subject|2|||
23721120|NCT01455415|66355871|FG001|Period 2|Withdrawal by Subject|3|||
23721121|NCT01455415|66355870|FG000|Period 2|Unspecified Reason|2|||
23721122|NCT01455415|66355871|FG001|Period 2|Unspecified Reason|3|||
23721123|NCT01455415|66355870|FG000|Period 2|Protocol Violation|2|||
23721124|NCT01455415|66355871|FG001|Period 2|Protocol Violation|0|||
23721125|NCT01455415|66355870|FG000|Follow-up|AE Related to Study Drug|0|||
23721126|NCT01455415|66355871|FG001|Follow-up|AE Related to Study Drug|1|||
23721127|NCT01455415|66355870|FG000|Follow-up|Lack of Efficacy|0|||
23721128|NCT01455415|66355871|FG001|Follow-up|Lack of Efficacy|1|||
23721129|NCT01455415|66355870|FG000|Follow-up|Withdrawal by Subject|2|||
23721130|NCT01455415|66355871|FG001|Follow-up|Withdrawal by Subject|0|||
23721131|NCT01455415|66355870|FG000|Follow-up|Unspecified Reason|1|||
23721132|NCT01455415|66355871|FG001|Follow-up|Unspecified Reason|0|||
23721133|NCT01779648|66355872|FG000|Overall Study|Protocol Violation|1|||
23721134|NCT01779648|66355873|FG001|Overall Study|Protocol Violation|0|||
23721135|NCT02661464|66355876|FG000|Overall Study|Lost to Follow-up|28|||
23721136|NCT02661464|66355877|FG001|Overall Study|Lost to Follow-up|0|||
23721137|NCT02661464|66355878|FG002|Overall Study|Lost to Follow-up|0|||
23721138|NCT02661464|66355879|FG003|Overall Study|Lost to Follow-up|0|||
23721139|NCT02661464|66355876|FG000|Overall Study|Withdrawal by Subject|3|||
23721140|NCT02661464|66355877|FG001|Overall Study|Withdrawal by Subject|1|||
23721141|NCT02661464|66355878|FG002|Overall Study|Withdrawal by Subject|0|||
23721142|NCT02661464|66355879|FG003|Overall Study|Withdrawal by Subject|0|||
23721143|NCT02661464|66355876|FG000|Overall Study|Participants terminated prematurely|288|||
23721144|NCT02661464|66355877|FG001|Overall Study|Participants terminated prematurely|52|||
23721145|NCT02661464|66355878|FG002|Overall Study|Participants terminated prematurely|1|||
23721146|NCT02661464|66355879|FG003|Overall Study|Participants terminated prematurely|1|||
23721147|NCT02661464|66355876|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
23721148|NCT02661464|66355877|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
23721149|NCT02661464|66355878|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
23721150|NCT02661464|66355879|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
23721151|NCT00912340|66355880|FG000|Overall Study|Adverse Event|2|||
23721152|NCT00912340|66355881|FG001|Overall Study|Adverse Event|4|||
23721153|NCT00912340|66355882|FG002|Overall Study|Adverse Event|0|||
23721154|NCT00912340|66355880|FG000|Overall Study|Protocol revised to remove arm|0|||
23721155|NCT00912340|66355881|FG001|Overall Study|Protocol revised to remove arm|0|||
23721156|NCT00912340|66355882|FG002|Overall Study|Protocol revised to remove arm|4|||
23814554|NCT03709823|66703236|FG004|Overall Study|Other, Not Specified|0|||
23814555|NCT03709823|66703237|FG005|Overall Study|Other, Not Specified|0|||
23532157|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Death|1|||
23532158|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
23532159|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
23721157|NCT00807014|66355884|FG000|Overall Study|Participant Considered Disease Cured|13|||
23721158|NCT00807014|66355885|FG001|Overall Study|Participant Considered Disease Cured|2|||
23814556|NCT02293863|66703238|FG000|Overall Study|Death|4|||
23814557|NCT02293863|66703239|FG001|Overall Study|Death|6|||
23814558|NCT02293863|66703240|FG002|Overall Study|Death|4|||
23814559|NCT02293863|66703238|FG000|Overall Study|Lost to Follow-up|2|||
23814560|NCT02293863|66703239|FG001|Overall Study|Lost to Follow-up|2|||
23814561|NCT02293863|66703240|FG002|Overall Study|Lost to Follow-up|2|||
23814562|NCT02293863|66703238|FG000|Overall Study|Withdrawal by Subject|3|||
23532160|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
23532161|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Treatment failure|1|||
23532162|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
23532163|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
23814563|NCT02293863|66703239|FG001|Overall Study|Withdrawal by Subject|3|||
23814564|NCT02293863|66703240|FG002|Overall Study|Withdrawal by Subject|1|||
23814565|NCT02293863|66703238|FG000|Overall Study|Reason Not Specified|0|||
23814566|NCT02293863|66703239|FG001|Overall Study|Reason Not Specified|2|||
23814567|NCT02293863|66703240|FG002|Overall Study|Reason Not Specified|2|||
23814568|NCT04497948|66703245|FG000|Overall Study|Death|2|||
23532164|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Death|1|||
23532165|NCT02840877|65683235|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
23532166|NCT02840877|65683235|FG000|6 Months to 18 Months|Treatment failure|7|||
23532167|NCT02840877|65683235|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
23532168|NCT02840877|65683235|FG000|6 Months to 18 Months|Moved/transferred out|6|||
23532169|NCT02840877|65683235|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
23532170|NCT02840877|65683235|FG000|6 Months to 18 Months|Death|4|||
23532171|NCT02840877|65683235|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
23532172|NCT02840877|65683235|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
23532173|NCT02840877|65683235|FG000|6 Months to 18 Months|Still in study.|14|||
23532174|NCT04177108|65683236|FG000|Overall Study|Withdrawal by Subject|4|||
23532175|NCT04177108|65683237|FG001|Overall Study|Withdrawal by Subject|8|||
23532176|NCT04177108|65683238|FG002|Overall Study|Withdrawal by Subject|9|||
23532177|NCT04177108|65683239|FG003|Overall Study|Withdrawal by Subject|11|||
23532178|NCT04177108|65683240|FG004|Overall Study|Withdrawal by Subject|13|||
23532179|NCT04177108|65683236|FG000|Overall Study|Physician Decision|23|||
23532180|NCT04177108|65683237|FG001|Overall Study|Physician Decision|15|||
23532181|NCT04177108|65683238|FG002|Overall Study|Physician Decision|18|||
23532182|NCT04177108|65683239|FG003|Overall Study|Physician Decision|29|||
23532183|NCT04177108|65683240|FG004|Overall Study|Physician Decision|23|||
23532184|NCT04177108|65683236|FG000|Overall Study|Reason Not Specified|0|||
23532185|NCT04177108|65683237|FG001|Overall Study|Reason Not Specified|1|||
23532186|NCT04177108|65683238|FG002|Overall Study|Reason Not Specified|0|||
23532187|NCT04177108|65683239|FG003|Overall Study|Reason Not Specified|0|||
23532188|NCT04177108|65683240|FG004|Overall Study|Reason Not Specified|2|||
23532189|NCT04177108|65683236|FG000|Overall Study|Lost to Follow-up|0|||
23532190|NCT04177108|65683237|FG001|Overall Study|Lost to Follow-up|0|||
23532191|NCT04177108|65683238|FG002|Overall Study|Lost to Follow-up|1|||
23532192|NCT04177108|65683239|FG003|Overall Study|Lost to Follow-up|1|||
23532193|NCT04177108|65683240|FG004|Overall Study|Lost to Follow-up|1|||
23532194|NCT04177108|65683236|FG000|Overall Study|Death|16|||
23532195|NCT04177108|65683237|FG001|Overall Study|Death|19|||
23532196|NCT04177108|65683238|FG002|Overall Study|Death|13|||
23532197|NCT04177108|65683239|FG003|Overall Study|Death|17|||
23532198|NCT04177108|65683240|FG004|Overall Study|Death|18|||
23532199|NCT02896400|65683243|FG000|1 Month Follow-up|Lost to Follow-up|7|||
23532200|NCT02896400|65683244|FG001|1 Month Follow-up|Lost to Follow-up|7|||
23532201|NCT02896400|65683245|FG002|1 Month Follow-up|Lost to Follow-up|5|||
23532202|NCT02896400|65683246|FG003|1 Month Follow-up|Lost to Follow-up|8|||
23614008|NCT00296504|65973260|FG004|Interim Analysis|Participant Non-compliant|1|||
23614009|NCT00296504|65973261|FG005|Interim Analysis|Participant Non-compliant|3|||
23614010|NCT00296504|65973262|FG006|Interim Analysis|Participant Non-compliant|6|||
23614011|NCT00296504|65973263|FG007|Interim Analysis|Participant Non-compliant|2|||
23614012|NCT00296504|65973264|FG008|Interim Analysis|Participant Non-compliant|0|||
23614013|NCT00296504|65973256|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614014|NCT00296504|65973257|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614015|NCT00296504|65973258|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
23614016|NCT00296504|65973259|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614017|NCT00296504|65973260|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614018|NCT00296504|65973261|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
23614019|NCT00296504|65973262|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23532203|NCT02896400|65683247|FG004|1 Month Follow-up|Lost to Follow-up|9|||
23532204|NCT02896400|65683248|FG005|1 Month Follow-up|Lost to Follow-up|6|||
23532205|NCT02896400|65683249|FG006|1 Month Follow-up|Lost to Follow-up|5|||
23532206|NCT02896400|65683250|FG007|1 Month Follow-up|Lost to Follow-up|6|||
23532207|NCT02896400|65683251|FG008|1 Month Follow-up|Lost to Follow-up|4|||
23532208|NCT02896400|65683252|FG009|1 Month Follow-up|Lost to Follow-up|7|||
23532209|NCT02896400|65683253|FG010|1 Month Follow-up|Lost to Follow-up|5|||
23614020|NCT00296504|65973263|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614021|NCT00296504|65973264|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23814569|NCT00985712|66703248|FG000|Overall Study|Adverse Event|0|||
23814570|NCT00985712|66703249|FG001|Overall Study|Adverse Event|1|||
23814571|NCT00985712|66703248|FG000|Overall Study|Lost to Follow-up|2|||
23814572|NCT00985712|66703249|FG001|Overall Study|Lost to Follow-up|2|||
23814573|NCT00985712|66703248|FG000|Overall Study|Protocol Violation|0|||
23614022|NCT00296504|65973256|FG000|Interim Analysis|To Simplify Treatment|0|||
23614023|NCT00296504|65973257|FG001|Interim Analysis|To Simplify Treatment|0|||
23614024|NCT00296504|65973258|FG002|Interim Analysis|To Simplify Treatment|1|||
23614025|NCT00296504|65973259|FG003|Interim Analysis|To Simplify Treatment|0|||
23614026|NCT00296504|65973260|FG004|Interim Analysis|To Simplify Treatment|0|||
23614027|NCT00296504|65973261|FG005|Interim Analysis|To Simplify Treatment|0|||
23614028|NCT00296504|65973262|FG006|Interim Analysis|To Simplify Treatment|2|||
23614029|NCT00296504|65973263|FG007|Interim Analysis|To Simplify Treatment|0|||
23614030|NCT00296504|65973264|FG008|Interim Analysis|To Simplify Treatment|0|||
23721159|NCT00807014|66355884|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
23721160|NCT00807014|66355885|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
23721161|NCT00807014|66355884|FG000|Overall Study|Protocol Violation|2|||
23721162|NCT00807014|66355885|FG001|Overall Study|Protocol Violation|8|||
23721163|NCT00807014|66355884|FG000|Overall Study|Adverse Event|0|||
23721164|NCT00807014|66355885|FG001|Overall Study|Adverse Event|2|||
23721165|NCT00807014|66355884|FG000|Overall Study|Lost to Follow-up|9|||
23721166|NCT00807014|66355885|FG001|Overall Study|Lost to Follow-up|7|||
23814574|NCT00985712|66703249|FG001|Overall Study|Protocol Violation|1|||
23814575|NCT00985712|66703248|FG000|Overall Study|Withdrawal by Subject|4|||
23814576|NCT00985712|66703249|FG001|Overall Study|Withdrawal by Subject|1|||
23814577|NCT00985712|66703248|FG000|Overall Study|Sponsor decision|0|||
23814578|NCT00985712|66703249|FG001|Overall Study|Sponsor decision|2|||
23814579|NCT01004003|66703250|FG000|Overall Study|Progressive disease|2|||
23814580|NCT01004003|66703251|FG001|Overall Study|Progressive disease|1|||
23814581|NCT01004003|66703252|FG002|Overall Study|Progressive disease|1|||
23814582|NCT01004003|66703253|FG003|Overall Study|Progressive disease|0|||
23814583|NCT01004003|66703254|FG004|Overall Study|Progressive disease|2|||
23814584|NCT01004003|66703255|FG005|Overall Study|Progressive disease|1|||
23814585|NCT01004003|66703256|FG006|Overall Study|Progressive disease|1|||
23814586|NCT01004003|66703257|FG007|Overall Study|Progressive disease|39|||
23814587|NCT01004003|66703258|FG008|Overall Study|Progressive disease|22|||
23814588|NCT01004003|66703250|FG000|Overall Study|Adverse Event|4|||
23814589|NCT01004003|66703251|FG001|Overall Study|Adverse Event|2|||
23814590|NCT01004003|66703252|FG002|Overall Study|Adverse Event|3|||
23814591|NCT01004003|66703253|FG003|Overall Study|Adverse Event|3|||
23814592|NCT01004003|66703254|FG004|Overall Study|Adverse Event|2|||
23814593|NCT01004003|66703255|FG005|Overall Study|Adverse Event|2|||
23814594|NCT01004003|66703256|FG006|Overall Study|Adverse Event|7|||
23814595|NCT01004003|66703257|FG007|Overall Study|Adverse Event|21|||
23814596|NCT01004003|66703258|FG008|Overall Study|Adverse Event|6|||
23814597|NCT01004003|66703250|FG000|Overall Study|Refused to continue taking trial med.|0|||
23814598|NCT01004003|66703251|FG001|Overall Study|Refused to continue taking trial med.|0|||
23420732|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
23532210|NCT02896400|65683254|FG011|1 Month Follow-up|Lost to Follow-up|5|||
23532211|NCT02896400|65683255|FG012|1 Month Follow-up|Lost to Follow-up|3|||
23532212|NCT02896400|65683256|FG013|1 Month Follow-up|Lost to Follow-up|4|||
23532213|NCT02896400|65683257|FG014|1 Month Follow-up|Lost to Follow-up|1|||
23532214|NCT02896400|65683258|FG015|1 Month Follow-up|Lost to Follow-up|2|||
23532215|NCT02896400|65683243|FG000|1 Month Follow-up|Death|0|||
23532216|NCT02896400|65683244|FG001|1 Month Follow-up|Death|0|||
23532217|NCT02896400|65683245|FG002|1 Month Follow-up|Death|0|||
23532218|NCT02896400|65683246|FG003|1 Month Follow-up|Death|0|||
23532219|NCT02896400|65683247|FG004|1 Month Follow-up|Death|0|||
23532220|NCT02896400|65683248|FG005|1 Month Follow-up|Death|0|||
23532221|NCT02896400|65683249|FG006|1 Month Follow-up|Death|0|||
23532222|NCT02896400|65683250|FG007|1 Month Follow-up|Death|0|||
23532223|NCT02896400|65683251|FG008|1 Month Follow-up|Death|0|||
23532224|NCT02896400|65683252|FG009|1 Month Follow-up|Death|0|||
23532225|NCT02896400|65683253|FG010|1 Month Follow-up|Death|0|||
23532226|NCT02896400|65683254|FG011|1 Month Follow-up|Death|0|||
23532227|NCT02896400|65683255|FG012|1 Month Follow-up|Death|0|||
23532228|NCT02896400|65683256|FG013|1 Month Follow-up|Death|0|||
23532229|NCT02896400|65683257|FG014|1 Month Follow-up|Death|0|||
23614031|NCT00296504|65973256|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614032|NCT00296504|65973257|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
23721167|NCT00807014|66355884|FG000|Overall Study|Recovery|1|||
23814599|NCT01004003|66703252|FG002|Overall Study|Refused to continue taking trial med.|0|||
23814600|NCT01004003|66703253|FG003|Overall Study|Refused to continue taking trial med.|0|||
23532230|NCT02896400|65683258|FG015|1 Month Follow-up|Death|1|||
23532231|NCT02896400|65683243|FG000|3 Month Follow-up|Lost to Follow-up|6|||
23532232|NCT02896400|65683244|FG001|3 Month Follow-up|Lost to Follow-up|3|||
23532233|NCT02896400|65683245|FG002|3 Month Follow-up|Lost to Follow-up|6|||
23532234|NCT02896400|65683246|FG003|3 Month Follow-up|Lost to Follow-up|11|||
23532235|NCT02896400|65683247|FG004|3 Month Follow-up|Lost to Follow-up|12|||
23532236|NCT02896400|65683248|FG005|3 Month Follow-up|Lost to Follow-up|6|||
23814601|NCT01004003|66703254|FG004|Overall Study|Refused to continue taking trial med.|0|||
23814602|NCT01004003|66703255|FG005|Overall Study|Refused to continue taking trial med.|0|||
23814603|NCT01004003|66703256|FG006|Overall Study|Refused to continue taking trial med.|0|||
23721168|NCT00807014|66355885|FG001|Overall Study|Recovery|0|||
23721169|NCT00807014|66355884|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
23721170|NCT00807014|66355885|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
23721171|NCT03587584|66355886|FG000|Overall Study|SOC deviations|4|||
23721172|NCT03587584|66355887|FG001|Overall Study|SOC deviations|6|||
23721173|NCT03587584|66355886|FG000|Overall Study|Incomplete data|0|||
23721174|NCT03587584|66355887|FG001|Overall Study|Incomplete data|3|||
23721175|NCT01467661|66355890|FG000|Overall Study|Adverse Event|16|||
23721176|NCT01467661|66355890|FG000|Overall Study|Withdrawal by Subject|1|||
23721177|NCT01467661|66355890|FG000|Overall Study|Lack of Efficacy|3|||
23721178|NCT01467661|66355890|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
23721179|NCT03276572|66355899|FG000|Overall Study|In follow-up|0|||
23721180|NCT03276572|66355900|FG001|Overall Study|In follow-up|0|||
23721181|NCT03276572|66355901|FG002|Overall Study|In follow-up|0|||
23721182|NCT03276572|66355902|FG003|Overall Study|In follow-up|0|||
23721183|NCT03276572|66355903|FG004|Overall Study|In follow-up|0|||
23721184|NCT03276572|66355904|FG005|Overall Study|In follow-up|1|||
23614033|NCT00296504|65973258|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
23614034|NCT00296504|65973259|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614035|NCT00296504|65973260|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614036|NCT00296504|65973261|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614037|NCT00296504|65973262|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
23814604|NCT01004003|66703257|FG007|Overall Study|Refused to continue taking trial med.|0|||
23814605|NCT01004003|66703258|FG008|Overall Study|Refused to continue taking trial med.|2|||
23814606|NCT01004003|66703250|FG000|Overall Study|Other|0|||
23814607|NCT01004003|66703251|FG001|Overall Study|Other|0|||
23814608|NCT01004003|66703252|FG002|Overall Study|Other|0|||
23614038|NCT00296504|65973263|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614039|NCT00296504|65973264|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614040|NCT00296504|65973256|FG000|Interim Analysis|Participant Moved|1|||
23614041|NCT00296504|65973257|FG001|Interim Analysis|Participant Moved|0|||
23614042|NCT00296504|65973258|FG002|Interim Analysis|Participant Moved|1|||
23614043|NCT00296504|65973259|FG003|Interim Analysis|Participant Moved|0|||
23614044|NCT00296504|65973260|FG004|Interim Analysis|Participant Moved|0|||
23614045|NCT00296504|65973261|FG005|Interim Analysis|Participant Moved|1|||
23614046|NCT00296504|65973262|FG006|Interim Analysis|Participant Moved|1|||
23614047|NCT00296504|65973263|FG007|Interim Analysis|Participant Moved|0|||
23614048|NCT00296504|65973264|FG008|Interim Analysis|Participant Moved|0|||
23614049|NCT00296504|65973256|FG000|Interim Analysis|Participant Was Incarcerated|2|||
23614050|NCT00296504|65973257|FG001|Interim Analysis|Participant Was Incarcerated|0|||
23614051|NCT00296504|65973258|FG002|Interim Analysis|Participant Was Incarcerated|1|||
23614052|NCT00296504|65973259|FG003|Interim Analysis|Participant Was Incarcerated|0|||
23614053|NCT00296504|65973260|FG004|Interim Analysis|Participant Was Incarcerated|0|||
23614054|NCT00296504|65973261|FG005|Interim Analysis|Participant Was Incarcerated|0|||
23614055|NCT00296504|65973262|FG006|Interim Analysis|Participant Was Incarcerated|0|||
23614056|NCT00296504|65973263|FG007|Interim Analysis|Participant Was Incarcerated|0|||
23614057|NCT00296504|65973264|FG008|Interim Analysis|Participant Was Incarcerated|0|||
23614058|NCT00296504|65973256|FG000|Interim Analysis|Resistance to FPV|0|||
23614059|NCT00296504|65973257|FG001|Interim Analysis|Resistance to FPV|0|||
23614060|NCT00296504|65973258|FG002|Interim Analysis|Resistance to FPV|1|||
23614061|NCT00296504|65973259|FG003|Interim Analysis|Resistance to FPV|0|||
23614062|NCT00296504|65973260|FG004|Interim Analysis|Resistance to FPV|0|||
23614063|NCT00296504|65973261|FG005|Interim Analysis|Resistance to FPV|0|||
23614064|NCT00296504|65973262|FG006|Interim Analysis|Resistance to FPV|0|||
23614065|NCT00296504|65973263|FG007|Interim Analysis|Resistance to FPV|0|||
23614066|NCT00296504|65973264|FG008|Interim Analysis|Resistance to FPV|0|||
23614067|NCT00296504|65973256|FG000|Interim Analysis|Physician Decision|0|||
23614068|NCT00296504|65973257|FG001|Interim Analysis|Physician Decision|0|||
23614069|NCT00296504|65973258|FG002|Interim Analysis|Physician Decision|1|||
23614070|NCT00296504|65973259|FG003|Interim Analysis|Physician Decision|0|||
23614071|NCT00296504|65973260|FG004|Interim Analysis|Physician Decision|0|||
23614072|NCT00296504|65973261|FG005|Interim Analysis|Physician Decision|0|||
23614073|NCT00296504|65973262|FG006|Interim Analysis|Physician Decision|0|||
23721185|NCT03276572|66355905|FG006|Overall Study|In follow-up|1|||
23814609|NCT01004003|66703253|FG003|Overall Study|Other|0|||
23814610|NCT01004003|66703254|FG004|Overall Study|Other|0|||
23614074|NCT00296504|65973263|FG007|Interim Analysis|Physician Decision|0|||
23614075|NCT00296504|65973264|FG008|Interim Analysis|Physician Decision|0|||
23614076|NCT00296504|65973256|FG000|Interim Analysis|Principle Investigator Discretion|2|||
23614077|NCT00296504|65973257|FG001|Interim Analysis|Principle Investigator Discretion|0|||
23614078|NCT00296504|65973258|FG002|Interim Analysis|Principle Investigator Discretion|1|||
23721186|NCT03276572|66355899|FG000|Overall Study|Lost to Follow-up|0|||
23814611|NCT01004003|66703255|FG005|Overall Study|Other|1|||
23814612|NCT01004003|66703256|FG006|Overall Study|Other|0|||
23814613|NCT01004003|66703257|FG007|Overall Study|Other|0|||
23532237|NCT02896400|65683249|FG006|3 Month Follow-up|Lost to Follow-up|4|||
23532238|NCT02896400|65683250|FG007|3 Month Follow-up|Lost to Follow-up|3|||
23532239|NCT02896400|65683251|FG008|3 Month Follow-up|Lost to Follow-up|6|||
23532240|NCT02896400|65683252|FG009|3 Month Follow-up|Lost to Follow-up|5|||
23814614|NCT01004003|66703258|FG008|Overall Study|Other|0|||
23814615|NCT03559400|66703259|FG000|Overall Study|Lost to Follow-up|9|||
23814616|NCT03559400|66703260|FG001|Overall Study|Lost to Follow-up|7|||
23814617|NCT03559400|66703259|FG000|Overall Study|Death|0|||
23814618|NCT03559400|66703260|FG001|Overall Study|Death|2|||
23814619|NCT01377987|66703263|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
23814620|NCT01377987|66703264|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23814621|NCT00792935|66703265|FG000|Overall Study|Adverse Event|2|||
23814622|NCT00792935|66703266|FG001|Overall Study|Adverse Event|1|||
23814623|NCT00792935|66703265|FG000|Overall Study|Lost to Follow-up|0|||
23420733|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Death|3|||
23420734|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Death|0|||
23420735|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Death|0|||
23420736|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
23420737|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
23420738|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
23420739|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
23420740|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
23420741|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
23420742|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Diseases progression|91|||
23532241|NCT02896400|65683253|FG010|3 Month Follow-up|Lost to Follow-up|6|||
23532242|NCT02896400|65683254|FG011|3 Month Follow-up|Lost to Follow-up|6|||
23532243|NCT02896400|65683255|FG012|3 Month Follow-up|Lost to Follow-up|3|||
23532244|NCT02896400|65683256|FG013|3 Month Follow-up|Lost to Follow-up|5|||
23532245|NCT02896400|65683257|FG014|3 Month Follow-up|Lost to Follow-up|3|||
23532246|NCT02896400|65683258|FG015|3 Month Follow-up|Lost to Follow-up|2|||
23532247|NCT02896400|65683243|FG000|3 Month Follow-up|Death|0|||
23532248|NCT02896400|65683244|FG001|3 Month Follow-up|Death|0|||
23420743|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Diseases progression|0|||
23532249|NCT02896400|65683245|FG002|3 Month Follow-up|Death|0|||
23532250|NCT02896400|65683246|FG003|3 Month Follow-up|Death|0|||
23532251|NCT02896400|65683247|FG004|3 Month Follow-up|Death|0|||
23532252|NCT02896400|65683248|FG005|3 Month Follow-up|Death|0|||
23532253|NCT02896400|65683249|FG006|3 Month Follow-up|Death|0|||
23532254|NCT02896400|65683250|FG007|3 Month Follow-up|Death|0|||
23532255|NCT02896400|65683251|FG008|3 Month Follow-up|Death|0|||
23532256|NCT02896400|65683252|FG009|3 Month Follow-up|Death|0|||
23532257|NCT02896400|65683253|FG010|3 Month Follow-up|Death|0|||
23532258|NCT02896400|65683254|FG011|3 Month Follow-up|Death|0|||
23532259|NCT02896400|65683255|FG012|3 Month Follow-up|Death|0|||
23532260|NCT02896400|65683256|FG013|3 Month Follow-up|Death|1|||
23532261|NCT02896400|65683257|FG014|3 Month Follow-up|Death|1|||
23532262|NCT02896400|65683258|FG015|3 Month Follow-up|Death|0|||
23420744|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Diseases progression|0|||
23420745|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Adverse Event|70|||
23420746|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Adverse Event|0|||
23532263|NCT02896400|65683243|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532264|NCT02896400|65683244|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532265|NCT02896400|65683245|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532266|NCT02896400|65683246|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532267|NCT02896400|65683247|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532268|NCT02896400|65683248|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532269|NCT02896400|65683249|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
23532270|NCT02896400|65683250|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
23532271|NCT02896400|65683251|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532272|NCT02896400|65683252|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532273|NCT02896400|65683253|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532274|NCT02896400|65683254|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23814624|NCT00792935|66703266|FG001|Overall Study|Lost to Follow-up|1|||
23420747|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Adverse Event|0|||
23532275|NCT02896400|65683255|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532276|NCT02896400|65683256|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532277|NCT02896400|65683257|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
23532278|NCT02896400|65683258|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532279|NCT02896400|65683243|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
23532280|NCT02896400|65683244|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532281|NCT02896400|65683245|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
23532282|NCT02896400|65683246|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
23721187|NCT03276572|66355900|FG001|Overall Study|Lost to Follow-up|0|||
23814625|NCT00792935|66703265|FG000|Overall Study|Protocol Violation|2|||
23420748|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Physician Decision|9|||
23420749|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Physician Decision|0|||
23420750|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Physician Decision|0|||
23420751|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
23420752|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
23721188|NCT03276572|66355901|FG002|Overall Study|Lost to Follow-up|0|||
23721189|NCT03276572|66355902|FG003|Overall Study|Lost to Follow-up|0|||
23721190|NCT03276572|66355903|FG004|Overall Study|Lost to Follow-up|0|||
23721191|NCT03276572|66355904|FG005|Overall Study|Lost to Follow-up|0|||
23721192|NCT03276572|66355905|FG006|Overall Study|Lost to Follow-up|1|||
23721193|NCT03136484|66355906|FG000|Overall Study|Withdrawal by Subject|19|||
23721194|NCT03136484|66355907|FG001|Overall Study|Withdrawal by Subject|14|||
23721195|NCT03136484|66355906|FG000|Overall Study|Lost to Follow-up|7|||
23721196|NCT03136484|66355907|FG001|Overall Study|Lost to Follow-up|8|||
23721197|NCT03136484|66355906|FG000|Overall Study|Death|1|||
23721198|NCT03136484|66355907|FG001|Overall Study|Death|0|||
23721199|NCT01602549|66355908|FG000|Overall Study|Protocol Violation|0|||
23721200|NCT01602549|66355909|FG001|Overall Study|Protocol Violation|1|||
23721201|NCT01602549|66355908|FG000|Overall Study|Withdrawal by Subject|1|||
23721202|NCT01602549|66355909|FG001|Overall Study|Withdrawal by Subject|0|||
23721203|NCT03549117|66355910|FG000|Overall Study|Withdrawal by Subject|1|||
23721204|NCT03549117|66355911|FG001|Overall Study|Withdrawal by Subject|0|||
23721205|NCT02150213|66355914|FG000|Overall Study|Lost to Follow-up|1|||
23721206|NCT02150213|66355914|FG000|Overall Study|Withdrawal by Subject|1|||
23721207|NCT00239356|66355916|FG000|Overall Study|Lack of Efficacy|1|||
23420753|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
23420754|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
23721208|NCT00239356|66355917|FG001|Overall Study|Lack of Efficacy|0|||
23420755|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
23420756|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
23420757|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
23420758|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
23420759|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
23420760|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Not compliant|1|||
23420761|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Not compliant|0|||
23420762|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Not compliant|0|||
23420763|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
23420764|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
23420765|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
23420766|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Adverse Event|0|||
23420767|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Adverse Event|2|||
23420768|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Adverse Event|0|||
23420769|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Death|0|||
23420770|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Death|10|||
23420771|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Death|8|||
23420772|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Physician Decision|0|||
23420773|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Physician Decision|0|||
23420774|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Physician Decision|4|||
23420775|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
23420776|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
23420777|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
23420778|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Moved to another town|0|||
23420779|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Moved to another town|1|||
23420780|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Moved to another town|0|||
23420781|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Disease progression|0|||
23420782|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Disease progression|0|||
23420783|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Disease progression|3|||
23721209|NCT00239356|66355916|FG000|Overall Study|Adverse Event|6|||
23420784|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
23721210|NCT00239356|66355917|FG001|Overall Study|Adverse Event|0|||
23721211|NCT00239356|66355916|FG000|Overall Study|Withdrawal by Subject|15|||
23721212|NCT00239356|66355917|FG001|Overall Study|Withdrawal by Subject|6|||
23721213|NCT00239356|66355916|FG000|Overall Study|Lost to Follow-up|3|||
23420785|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
23420786|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
23420787|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
23420788|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
23420789|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
23420790|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
23420791|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
23420792|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
23420793|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
23420794|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
23420795|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
23420796|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
23532283|NCT02896400|65683247|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
23532284|NCT02896400|65683248|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532285|NCT02896400|65683249|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532286|NCT02896400|65683250|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
23532287|NCT02896400|65683251|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
23532288|NCT02896400|65683252|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532289|NCT02896400|65683253|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
23420797|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
23420798|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
23420799|NCT05032690|65283865|FG000|Period 1|Adverse Event|0|||
23420800|NCT05032690|65283866|FG001|Period 1|Adverse Event|1|||
23420801|NCT05032690|65283867|FG002|Period 1|Adverse Event|0|||
23420802|NCT05032690|65283868|FG003|Period 1|Adverse Event|0|||
23420803|NCT05032690|65283865|FG000|Period 1|Withdrawal by Subject|1|||
23420804|NCT05032690|65283866|FG001|Period 1|Withdrawal by Subject|0|||
23420805|NCT05032690|65283867|FG002|Period 1|Withdrawal by Subject|0|||
23420806|NCT05032690|65283868|FG003|Period 1|Withdrawal by Subject|0|||
23420807|NCT05032690|65283865|FG000|Period 1|No longer meets eligibility criteria|0|||
23420808|NCT05032690|65283866|FG001|Period 1|No longer meets eligibility criteria|1|||
23420809|NCT05032690|65283867|FG002|Period 1|No longer meets eligibility criteria|0|||
23420810|NCT05032690|65283868|FG003|Period 1|No longer meets eligibility criteria|0|||
23420811|NCT05032690|65283865|FG000|Period 2|Adverse Event|1|||
23420812|NCT05032690|65283866|FG001|Period 2|Adverse Event|0|||
23420813|NCT05032690|65283867|FG002|Period 2|Adverse Event|0|||
23420814|NCT05032690|65283868|FG003|Period 2|Adverse Event|0|||
23420815|NCT05032690|65283865|FG000|Period 2|Withdrawal by Subject|0|||
23420816|NCT05032690|65283866|FG001|Period 2|Withdrawal by Subject|1|||
23420817|NCT05032690|65283867|FG002|Period 2|Withdrawal by Subject|0|||
23420818|NCT05032690|65283868|FG003|Period 2|Withdrawal by Subject|0|||
23420819|NCT05032690|65283865|FG000|Period 2|No longer meets eligibility criteria|0|||
23420820|NCT05032690|65283866|FG001|Period 2|No longer meets eligibility criteria|1|||
23420821|NCT05032690|65283867|FG002|Period 2|No longer meets eligibility criteria|0|||
23420822|NCT05032690|65283868|FG003|Period 2|No longer meets eligibility criteria|0|||
23420823|NCT05032690|65283865|FG000|Period 3|Adverse Event|0|||
23420824|NCT05032690|65283866|FG001|Period 3|Adverse Event|1|||
23420825|NCT05032690|65283867|FG002|Period 3|Adverse Event|0|||
23420826|NCT05032690|65283868|FG003|Period 3|Adverse Event|0|||
23420827|NCT01574157|65283874|FG000|Overall Study|Withdrawal by Subject|4|||
23420828|NCT01574157|65283875|FG001|Overall Study|Withdrawal by Subject|5|||
23420829|NCT01574157|65283874|FG000|Overall Study|Lost to Follow-up|0|||
23420830|NCT01574157|65283875|FG001|Overall Study|Lost to Follow-up|3|||
23420831|NCT04043234|65283878|FG000|Overall Study|Lost to Follow-up|1|||
23420832|NCT04043234|65283878|FG000|Overall Study|Withdrawal by Subject|1|||
23420833|NCT01289353|65283890|FG000|Overall Study|Lost to Follow-up|2|||
23420834|NCT00712725|65283895|FG000|Overall Study|Adverse Event|1|||
23420835|NCT00712725|65283896|FG001|Overall Study|Adverse Event|0|||
23420836|NCT00712725|65283897|FG002|Overall Study|Adverse Event|0|||
23420837|NCT00712725|65283898|FG003|Overall Study|Adverse Event|1|||
23420838|NCT00712725|65283899|FG004|Overall Study|Adverse Event|0|||
23420839|NCT00712725|65283900|FG005|Overall Study|Adverse Event|0|||
23420840|NCT00712725|65283901|FG006|Overall Study|Adverse Event|0|||
23420841|NCT00712725|65283902|FG007|Overall Study|Adverse Event|0|||
23420842|NCT00712725|65283895|FG000|Overall Study|Lost to Follow-up|3|||
23420843|NCT00712725|65283896|FG001|Overall Study|Lost to Follow-up|2|||
23420844|NCT00712725|65283897|FG002|Overall Study|Lost to Follow-up|1|||
23420845|NCT00712725|65283898|FG003|Overall Study|Lost to Follow-up|1|||
23420846|NCT00712725|65283899|FG004|Overall Study|Lost to Follow-up|2|||
23420847|NCT00712725|65283900|FG005|Overall Study|Lost to Follow-up|2|||
23420848|NCT00712725|65283901|FG006|Overall Study|Lost to Follow-up|3|||
23420849|NCT00712725|65283902|FG007|Overall Study|Lost to Follow-up|1|||
23420850|NCT00712725|65283895|FG000|Overall Study|Physician Decision|2|||
23420851|NCT00712725|65283896|FG001|Overall Study|Physician Decision|0|||
23420852|NCT00712725|65283897|FG002|Overall Study|Physician Decision|0|||
23420853|NCT00712725|65283898|FG003|Overall Study|Physician Decision|0|||
23420854|NCT00712725|65283899|FG004|Overall Study|Physician Decision|1|||
23420855|NCT00712725|65283900|FG005|Overall Study|Physician Decision|0|||
23420856|NCT00712725|65283901|FG006|Overall Study|Physician Decision|2|||
23420857|NCT00712725|65283902|FG007|Overall Study|Physician Decision|0|||
23420858|NCT00712725|65283895|FG000|Overall Study|Pregnancy|0|||
23420859|NCT00712725|65283896|FG001|Overall Study|Pregnancy|1|||
23420860|NCT00712725|65283897|FG002|Overall Study|Pregnancy|0|||
23420861|NCT00712725|65283898|FG003|Overall Study|Pregnancy|0|||
23420862|NCT00712725|65283899|FG004|Overall Study|Pregnancy|1|||
23420863|NCT00712725|65283900|FG005|Overall Study|Pregnancy|0|||
23420864|NCT00712725|65283901|FG006|Overall Study|Pregnancy|2|||
23420865|NCT00712725|65283902|FG007|Overall Study|Pregnancy|0|||
23420866|NCT00712725|65283895|FG000|Overall Study|Protocol Violation|2|||
23420867|NCT00712725|65283896|FG001|Overall Study|Protocol Violation|0|||
23420868|NCT00712725|65283897|FG002|Overall Study|Protocol Violation|1|||
23420869|NCT00712725|65283898|FG003|Overall Study|Protocol Violation|3|||
23420870|NCT00712725|65283899|FG004|Overall Study|Protocol Violation|2|||
23420871|NCT00712725|65283900|FG005|Overall Study|Protocol Violation|0|||
23420872|NCT00712725|65283901|FG006|Overall Study|Protocol Violation|1|||
23420873|NCT00712725|65283902|FG007|Overall Study|Protocol Violation|1|||
23420874|NCT00712725|65283895|FG000|Overall Study|Withdrawal by Subject|2|||
23420875|NCT00712725|65283896|FG001|Overall Study|Withdrawal by Subject|1|||
23420876|NCT00712725|65283897|FG002|Overall Study|Withdrawal by Subject|1|||
23420877|NCT00712725|65283898|FG003|Overall Study|Withdrawal by Subject|2|||
23420878|NCT00712725|65283899|FG004|Overall Study|Withdrawal by Subject|1|||
23420879|NCT00712725|65283900|FG005|Overall Study|Withdrawal by Subject|1|||
23420880|NCT00712725|65283901|FG006|Overall Study|Withdrawal by Subject|1|||
23420881|NCT00712725|65283902|FG007|Overall Study|Withdrawal by Subject|2|||
23420882|NCT00712725|65283895|FG000|Overall Study|Lack of Qualifying Event|16|||
23420883|NCT00712725|65283896|FG001|Overall Study|Lack of Qualifying Event|2|||
23420884|NCT00712725|65283897|FG002|Overall Study|Lack of Qualifying Event|6|||
23420885|NCT00712725|65283898|FG003|Overall Study|Lack of Qualifying Event|8|||
23420886|NCT00712725|65283899|FG004|Overall Study|Lack of Qualifying Event|11|||
23420887|NCT00712725|65283900|FG005|Overall Study|Lack of Qualifying Event|13|||
23420888|NCT00712725|65283901|FG006|Overall Study|Lack of Qualifying Event|11|||
23420889|NCT00712725|65283902|FG007|Overall Study|Lack of Qualifying Event|6|||
23420890|NCT00712725|65283895|FG000|Overall Study|Protocol Specified Criteria|3|||
23420891|NCT00712725|65283896|FG001|Overall Study|Protocol Specified Criteria|0|||
23420892|NCT00712725|65283897|FG002|Overall Study|Protocol Specified Criteria|1|||
23420893|NCT00712725|65283898|FG003|Overall Study|Protocol Specified Criteria|2|||
23420894|NCT00712725|65283899|FG004|Overall Study|Protocol Specified Criteria|1|||
23420895|NCT00712725|65283900|FG005|Overall Study|Protocol Specified Criteria|0|||
23420896|NCT00712725|65283901|FG006|Overall Study|Protocol Specified Criteria|2|||
23420897|NCT00712725|65283902|FG007|Overall Study|Protocol Specified Criteria|1|||
23420898|NCT04752566|65283903|FG000|Overall Study|Protocol Violation|0|||
23420899|NCT04752566|65283904|FG001|Overall Study|Protocol Violation|1|||
23420900|NCT04752566|65283903|FG000|Overall Study|Death|1|||
23420901|NCT04752566|65283904|FG001|Overall Study|Death|0|||
23420902|NCT04752566|65283903|FG000|Overall Study|Adverse Event|1|||
23420903|NCT04752566|65283904|FG001|Overall Study|Adverse Event|0|||
23420904|NCT04752566|65283903|FG000|Overall Study|Withdrawal by Subject|2|||
23420905|NCT04752566|65283904|FG001|Overall Study|Withdrawal by Subject|0|||
23420906|NCT04752566|65283903|FG000|Overall Study|Physician Decision|1|||
23420907|NCT04752566|65283904|FG001|Overall Study|Physician Decision|1|||
23420908|NCT01865812|65283905|FG000|Primary Treatment Phase|Adverse Event|2|||
23420909|NCT01865812|65283906|FG001|Primary Treatment Phase|Adverse Event|0|||
23420910|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
23420911|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
23420912|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Pruritus|0|||
23420913|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Pruritus|3|||
23420914|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
23420915|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
23420916|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
23420917|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
23420918|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
23420919|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
23420920|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Death|0|||
23420921|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Death|0|||
23420922|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23420923|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23420924|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
23420925|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
23420926|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
23420927|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
23420928|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
23420929|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
23420930|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
23420931|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
23420932|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
23420933|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
23420934|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
23420935|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
23420936|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
23420937|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
23420938|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
23420939|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
23420940|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
23420941|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
23420942|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
23420943|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
23420944|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
23420945|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
23420946|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
23420947|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
23420948|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
23420949|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
23420950|NCT01327053|65283913|FG000|Overall Study|Adverse Event|23|||
23420951|NCT01327053|65283914|FG001|Overall Study|Adverse Event|57|||
23420952|NCT01327053|65283913|FG000|Overall Study|Patient/guardian decision|11|||
23420953|NCT01327053|65283914|FG001|Overall Study|Patient/guardian decision|35|||
23420954|NCT01327053|65283913|FG000|Overall Study|Physician Decision|10|||
23420955|NCT01327053|65283914|FG001|Overall Study|Physician Decision|14|||
23420956|NCT01327053|65283913|FG000|Overall Study|Death|1|||
23420957|NCT01327053|65283914|FG001|Overall Study|Death|5|||
23420958|NCT01327053|65283913|FG000|Overall Study|Lost to Follow-up|2|||
23420959|NCT01327053|65283914|FG001|Overall Study|Lost to Follow-up|4|||
23420960|NCT01327053|65283913|FG000|Overall Study|Non-compliance with study treatment|0|||
23420961|NCT01327053|65283914|FG001|Overall Study|Non-compliance with study treatment|5|||
23420962|NCT01327053|65283913|FG000|Overall Study|Study terminated by Sponsor|1|||
23420963|NCT01327053|65283914|FG001|Overall Study|Study terminated by Sponsor|3|||
23420964|NCT01327053|65283913|FG000|Overall Study|Progressive disease|31|||
23420965|NCT01327053|65283914|FG001|Overall Study|Progressive disease|26|||
23420966|NCT01327053|65283913|FG000|Overall Study|Protocol Violation|0|||
23420967|NCT01327053|65283914|FG001|Overall Study|Protocol Violation|1|||
23420968|NCT01327053|65283913|FG000|Overall Study|Untreated|0|||
23420969|NCT01327053|65283914|FG001|Overall Study|Untreated|1|||
23420970|NCT00842153|65283915|FG000|Overall Study|Adverse Event|0|||
23420971|NCT00842153|65283916|FG001|Overall Study|Adverse Event|1|||
23420972|NCT00842153|65283915|FG000|Overall Study|Lost to Follow-up|1|||
23420973|NCT00842153|65283916|FG001|Overall Study|Lost to Follow-up|2|||
23420974|NCT04484649|65283919|FG000|Overall Study|Lost to Follow-up|2|||
23420975|NCT04484649|65283920|FG001|Overall Study|Lost to Follow-up|1|||
23420976|NCT04484649|65283919|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
23420977|NCT04484649|65283920|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
23420978|NCT03195660|65283923|FG000|Overall Study|The study was terminated|2|||
23420979|NCT03425006|65283924|FG000|Overall Study|Withdrawal by Subject|1|||
23420980|NCT03425006|65283924|FG000|Overall Study|Physician Decision|1|||
23420981|NCT03425006|65283924|FG000|Overall Study|Death|1|||
23420982|NCT00837265|65283925|FG000|Pilot Phase|Withdrawal by Subject|0|||
23420983|NCT00837265|65283926|FG001|Pilot Phase|Withdrawal by Subject|2|||
23420984|NCT00837265|65283927|FG002|Pilot Phase|Withdrawal by Subject|3|||
23420985|NCT00837265|65283928|FG003|Pilot Phase|Withdrawal by Subject|2|||
23420986|NCT00837265|65283929|FG004|Pilot Phase|Withdrawal by Subject|0|||
23420987|NCT00837265|65283930|FG005|Pilot Phase|Withdrawal by Subject|0|||
23721214|NCT00239356|66355917|FG001|Overall Study|Lost to Follow-up|0|||
23721215|NCT00239356|66355916|FG000|Overall Study|poor/non-compliance|2|||
23420988|NCT00837265|65283931|FG006|Pilot Phase|Withdrawal by Subject|0|||
23420989|NCT00837265|65283925|FG000|Pilot Phase|Decision of the investigator|2|||
23420990|NCT00837265|65283926|FG001|Pilot Phase|Decision of the investigator|1|||
23420991|NCT00837265|65283927|FG002|Pilot Phase|Decision of the investigator|0|||
23420992|NCT00837265|65283928|FG003|Pilot Phase|Decision of the investigator|0|||
23420993|NCT00837265|65283929|FG004|Pilot Phase|Decision of the investigator|0|||
23721216|NCT00239356|66355917|FG001|Overall Study|poor/non-compliance|0|||
23420994|NCT00837265|65283930|FG005|Pilot Phase|Decision of the investigator|0|||
23420995|NCT00837265|65283931|FG006|Pilot Phase|Decision of the investigator|0|||
23420996|NCT00837265|65283925|FG000|Pilot Phase|Adverse Event|1|||
23721217|NCT00239356|66355916|FG000|Overall Study|Pregnancy|1|||
23721218|NCT00239356|66355917|FG001|Overall Study|Pregnancy|0|||
23420997|NCT00837265|65283926|FG001|Pilot Phase|Adverse Event|0|||
23420998|NCT00837265|65283927|FG002|Pilot Phase|Adverse Event|0|||
23420999|NCT00837265|65283928|FG003|Pilot Phase|Adverse Event|0|||
23421000|NCT00837265|65283929|FG004|Pilot Phase|Adverse Event|0|||
23421001|NCT00837265|65283930|FG005|Pilot Phase|Adverse Event|0|||
23421002|NCT00837265|65283931|FG006|Pilot Phase|Adverse Event|0|||
23421003|NCT00837265|65283925|FG000|Pilot Phase|Disease progression|0|||
23421004|NCT00837265|65283926|FG001|Pilot Phase|Disease progression|0|||
23421005|NCT00837265|65283927|FG002|Pilot Phase|Disease progression|0|||
23421006|NCT00837265|65283928|FG003|Pilot Phase|Disease progression|1|||
23421007|NCT00837265|65283929|FG004|Pilot Phase|Disease progression|0|||
23421008|NCT00837265|65283930|FG005|Pilot Phase|Disease progression|0|||
23421009|NCT00837265|65283931|FG006|Pilot Phase|Disease progression|0|||
23421010|NCT00837265|65283925|FG000|Pilot Phase|Participant left the city|0|||
23421011|NCT00837265|65283926|FG001|Pilot Phase|Participant left the city|0|||
23421012|NCT00837265|65283927|FG002|Pilot Phase|Participant left the city|0|||
23421013|NCT00837265|65283928|FG003|Pilot Phase|Participant left the city|1|||
23421014|NCT00837265|65283929|FG004|Pilot Phase|Participant left the city|0|||
23421015|NCT00837265|65283930|FG005|Pilot Phase|Participant left the city|0|||
23421016|NCT00837265|65283931|FG006|Pilot Phase|Participant left the city|0|||
23421017|NCT00837265|65283925|FG000|Main Phase|Withdrawal by Subject|0|||
23421018|NCT00837265|65283926|FG001|Main Phase|Withdrawal by Subject|0|||
23421019|NCT00837265|65283927|FG002|Main Phase|Withdrawal by Subject|0|||
23421020|NCT00837265|65283928|FG003|Main Phase|Withdrawal by Subject|0|||
23421021|NCT00837265|65283929|FG004|Main Phase|Withdrawal by Subject|4|||
23421022|NCT00837265|65283930|FG005|Main Phase|Withdrawal by Subject|2|||
23421023|NCT00837265|65283931|FG006|Main Phase|Withdrawal by Subject|1|||
23421024|NCT00837265|65283925|FG000|Main Phase|Decision of the investigator|0|||
23421025|NCT00837265|65283926|FG001|Main Phase|Decision of the investigator|0|||
23421026|NCT00837265|65283927|FG002|Main Phase|Decision of the investigator|0|||
23421027|NCT00837265|65283928|FG003|Main Phase|Decision of the investigator|0|||
23421028|NCT00837265|65283929|FG004|Main Phase|Decision of the investigator|0|||
23421029|NCT00837265|65283930|FG005|Main Phase|Decision of the investigator|2|||
23421030|NCT00837265|65283931|FG006|Main Phase|Decision of the investigator|1|||
23421031|NCT00837265|65283925|FG000|Main Phase|Adverse Event|0|||
23421032|NCT00837265|65283926|FG001|Main Phase|Adverse Event|0|||
23421033|NCT00837265|65283927|FG002|Main Phase|Adverse Event|0|||
23421034|NCT00837265|65283928|FG003|Main Phase|Adverse Event|0|||
23421035|NCT00837265|65283929|FG004|Main Phase|Adverse Event|0|||
23421036|NCT00837265|65283930|FG005|Main Phase|Adverse Event|1|||
23421037|NCT00837265|65283931|FG006|Main Phase|Adverse Event|0|||
23421038|NCT00837265|65283925|FG000|Main Phase|Death|0|||
23421039|NCT00837265|65283926|FG001|Main Phase|Death|0|||
23421040|NCT00837265|65283927|FG002|Main Phase|Death|0|||
23421041|NCT00837265|65283928|FG003|Main Phase|Death|0|||
23421042|NCT00837265|65283929|FG004|Main Phase|Death|2|||
23421043|NCT00837265|65283930|FG005|Main Phase|Death|0|||
23421044|NCT00837265|65283931|FG006|Main Phase|Death|1|||
23421045|NCT00837265|65283925|FG000|Main Phase|Lost to Follow-up|0|||
23421046|NCT00837265|65283926|FG001|Main Phase|Lost to Follow-up|0|||
23421047|NCT00837265|65283927|FG002|Main Phase|Lost to Follow-up|0|||
23421048|NCT00837265|65283928|FG003|Main Phase|Lost to Follow-up|0|||
23421049|NCT00837265|65283929|FG004|Main Phase|Lost to Follow-up|1|||
23421050|NCT00837265|65283930|FG005|Main Phase|Lost to Follow-up|0|||
23421051|NCT00837265|65283931|FG006|Main Phase|Lost to Follow-up|0|||
23421052|NCT00837265|65283925|FG000|Main Phase|Principal investigator resignation|0|||
23421053|NCT00837265|65283926|FG001|Main Phase|Principal investigator resignation|0|||
23421054|NCT00837265|65283927|FG002|Main Phase|Principal investigator resignation|0|||
23421055|NCT00837265|65283928|FG003|Main Phase|Principal investigator resignation|0|||
23614079|NCT00296504|65973259|FG003|Interim Analysis|Principle Investigator Discretion|1|||
23421056|NCT00837265|65283929|FG004|Main Phase|Principal investigator resignation|2|||
23421057|NCT00837265|65283930|FG005|Main Phase|Principal investigator resignation|0|||
23421058|NCT00837265|65283931|FG006|Main Phase|Principal investigator resignation|0|||
23421059|NCT00837265|65283925|FG000|Main Phase|Participant's personal reason|0|||
23421060|NCT00837265|65283926|FG001|Main Phase|Participant's personal reason|0|||
23421061|NCT00837265|65283927|FG002|Main Phase|Participant's personal reason|0|||
23421062|NCT00837265|65283928|FG003|Main Phase|Participant's personal reason|0|||
23421063|NCT00837265|65283929|FG004|Main Phase|Participant's personal reason|1|||
23421064|NCT00837265|65283930|FG005|Main Phase|Participant's personal reason|0|||
23421065|NCT00837265|65283931|FG006|Main Phase|Participant's personal reason|0|||
23421066|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Physician Decision|1|||
23421067|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Physician Decision|0|||
23421068|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Physician Decision|0|||
23421069|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
23421070|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
23421071|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
23421072|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
23421073|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
23421074|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
23421075|NCT00385944|65283932|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
23421076|NCT00385944|65283933|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
23421077|NCT00385944|65283934|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
23421078|NCT02358031|65283935|FG000|Overall Study|Death|253|||
23421079|NCT02358031|65283936|FG001|Overall Study|Death|237|||
23421080|NCT02358031|65283937|FG002|Overall Study|Death|266|||
23421081|NCT02358031|65283935|FG000|Overall Study|Lost to Follow-up|1|||
23421082|NCT02358031|65283936|FG001|Overall Study|Lost to Follow-up|1|||
23421083|NCT02358031|65283937|FG002|Overall Study|Lost to Follow-up|0|||
23421084|NCT02358031|65283935|FG000|Overall Study|Withdrawal by Subject|19|||
23421085|NCT02358031|65283936|FG001|Overall Study|Withdrawal by Subject|14|||
23421086|NCT02358031|65283937|FG002|Overall Study|Withdrawal by Subject|18|||
23421087|NCT02358031|65283935|FG000|Overall Study|Sponsor Decision|26|||
23421088|NCT02358031|65283936|FG001|Overall Study|Sponsor Decision|28|||
23421089|NCT02358031|65283937|FG002|Overall Study|Sponsor Decision|16|||
23421090|NCT02750345|65283938|FG000|Intervention 1|Adverse Event|0|||
23421091|NCT02750345|65283939|FG001|Intervention 1|Adverse Event|0|||
23421092|NCT02750345|65283940|FG002|Intervention 1|Adverse Event|0|||
23421093|NCT02750345|65283941|FG003|Intervention 1|Adverse Event|0|||
23421094|NCT02750345|65283942|FG004|Intervention 1|Adverse Event|1|||
23421095|NCT02750345|65283943|FG005|Intervention 1|Adverse Event|0|||
23421096|NCT00812006|65283946|FG000|Overall Study|Lost to Follow-up|0|||
23421097|NCT00812006|65283947|FG001|Overall Study|Lost to Follow-up|0|||
23421098|NCT00812006|65283948|FG002|Overall Study|Lost to Follow-up|2|||
23421099|NCT00812006|65283946|FG000|Overall Study|Physician Decision|0|||
23421100|NCT00812006|65283947|FG001|Overall Study|Physician Decision|0|||
23421101|NCT00812006|65283948|FG002|Overall Study|Physician Decision|1|||
23421102|NCT00812006|65283946|FG000|Overall Study|Withdrawal by Subject|2|||
23421103|NCT00812006|65283947|FG001|Overall Study|Withdrawal by Subject|1|||
23421104|NCT00812006|65283948|FG002|Overall Study|Withdrawal by Subject|1|||
23421105|NCT00812006|65283946|FG000|Overall Study|Lack of Qualifying Event|4|||
23421106|NCT00812006|65283947|FG001|Overall Study|Lack of Qualifying Event|2|||
23421107|NCT00812006|65283948|FG002|Overall Study|Lack of Qualifying Event|2|||
23421108|NCT01062841|65283949|FG000|Overall Study|Indwelling Device Removed|41|||
23421109|NCT01062841|65283950|FG001|Overall Study|Indwelling Device Removed|48|||
23421110|NCT01062841|65283949|FG000|Overall Study|Death|3|||
23421111|NCT01062841|65283950|FG001|Overall Study|Death|5|||
23421112|NCT01062841|65283949|FG000|Overall Study|Withdrawal by Subject|2|||
23421113|NCT01062841|65283950|FG001|Overall Study|Withdrawal by Subject|0|||
23421114|NCT01062841|65283949|FG000|Overall Study|Withdrawal by Study|3|||
23421115|NCT01062841|65283950|FG001|Overall Study|Withdrawal by Study|0|||
23421116|NCT02300558|65283951|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
23421117|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
23421118|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
23421119|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
23421120|NCT01457014|65283952|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
23421121|NCT01457014|65283953|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421122|NCT01457014|65283954|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421123|NCT01457014|65283955|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421124|NCT01457014|65283952|FG000|First Night|Withdrawal by Subject|3|||
23421125|NCT01457014|65283953|FG001|First Night|Withdrawal by Subject|0|||
23421126|NCT01457014|65283954|FG002|First Night|Withdrawal by Subject|0|||
23421127|NCT01457014|65283955|FG003|First Night|Withdrawal by Subject|0|||
23421128|NCT01145352|65283956|FG000|Overall Study|Found to have been registered twice|6|||
23421129|NCT01145352|65283956|FG000|Overall Study|Treated before marketing approval|4|||
23421130|NCT01145352|65283956|FG000|Overall Study|Syringe formulation was used|1|||
23421131|NCT02509039|65283957|FG000|Overall Study|Adverse Event|0|||
23421132|NCT02509039|65283958|FG001|Overall Study|Adverse Event|1|||
23421133|NCT02509039|65283959|FG002|Overall Study|Adverse Event|1|||
23421134|NCT02509039|65283960|FG003|Overall Study|Adverse Event|1|||
23421135|NCT02509039|65283957|FG000|Overall Study|Withdrawal by Subject|0|||
23421136|NCT02509039|65283958|FG001|Overall Study|Withdrawal by Subject|0|||
23421137|NCT02509039|65283959|FG002|Overall Study|Withdrawal by Subject|1|||
23421138|NCT02509039|65283960|FG003|Overall Study|Withdrawal by Subject|0|||
23421139|NCT02509039|65283957|FG000|Overall Study|Progressive disease|2|||
23421140|NCT02509039|65283958|FG001|Overall Study|Progressive disease|2|||
23421141|NCT02509039|65283959|FG002|Overall Study|Progressive disease|1|||
23421142|NCT02509039|65283960|FG003|Overall Study|Progressive disease|5|||
23421143|NCT02509039|65283957|FG000|Overall Study|Study terminated by Sponsor|1|||
23421144|NCT02509039|65283958|FG001|Overall Study|Study terminated by Sponsor|0|||
23421145|NCT02509039|65283959|FG002|Overall Study|Study terminated by Sponsor|0|||
23421146|NCT02509039|65283960|FG003|Overall Study|Study terminated by Sponsor|0|||
23421147|NCT00503581|65283961|FG000|Overall Study|Study closed|3|||
23532290|NCT02896400|65683254|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
23721219|NCT00239356|66355916|FG000|Overall Study|Administrative reason|0|||
23721220|NCT00239356|66355917|FG001|Overall Study|Administrative reason|1|||
23721221|NCT00239356|66355916|FG000|Overall Study|Drug available on market|11|||
23721222|NCT00239356|66355917|FG001|Overall Study|Drug available on market|2|||
23721223|NCT02460978|66355918|FG000|Overall Study|Adverse Event|17|||
23721224|NCT02460978|66355919|FG001|Overall Study|Adverse Event|11|||
23721225|NCT02460978|66355920|FG002|Overall Study|Adverse Event|11|||
23721226|NCT02460978|66355918|FG000|Overall Study|Withdrawal by Subject|5|||
23721227|NCT02460978|66355919|FG001|Overall Study|Withdrawal by Subject|5|||
23721228|NCT02460978|66355920|FG002|Overall Study|Withdrawal by Subject|14|||
23614080|NCT00296504|65973260|FG004|Interim Analysis|Principle Investigator Discretion|0|||
23614081|NCT00296504|65973261|FG005|Interim Analysis|Principle Investigator Discretion|0|||
23614082|NCT00296504|65973262|FG006|Interim Analysis|Principle Investigator Discretion|0|||
23614083|NCT00296504|65973263|FG007|Interim Analysis|Principle Investigator Discretion|0|||
23614084|NCT00296504|65973264|FG008|Interim Analysis|Principle Investigator Discretion|0|||
23614085|NCT00296504|65973256|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
23614086|NCT00296504|65973257|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
23614087|NCT00296504|65973258|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
23614088|NCT00296504|65973259|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
23614089|NCT00296504|65973260|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
23614090|NCT00296504|65973261|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
23721229|NCT02460978|66355918|FG000|Overall Study|Lost to Follow-up|2|||
23721230|NCT02460978|66355919|FG001|Overall Study|Lost to Follow-up|3|||
23721231|NCT02460978|66355920|FG002|Overall Study|Lost to Follow-up|1|||
23721232|NCT02460978|66355918|FG000|Overall Study|Protocol Violation|1|||
23721233|NCT02460978|66355919|FG001|Overall Study|Protocol Violation|1|||
23721234|NCT02460978|66355920|FG002|Overall Study|Protocol Violation|1|||
23721235|NCT02460978|66355918|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
23532291|NCT02896400|65683255|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532292|NCT02896400|65683256|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532293|NCT02896400|65683257|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532294|NCT02896400|65683258|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
23532295|NCT05204134|65683263|FG000|Overall Study|Withdrawal by Subject|3|||
23532296|NCT05204134|65683263|FG000|Overall Study|Physician Decision|1|||
23532297|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
23532298|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
23532299|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
23532300|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
23532301|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
23532302|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
23532303|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
23532304|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
23532305|NCT01852292|65683266|FG000|Overall Study|Untreated - did not receive study drug|3|||
23532306|NCT01852292|65683267|FG001|Overall Study|Untreated - did not receive study drug|1|||
23532307|NCT01852292|65683266|FG000|Overall Study|Death|9|||
23532308|NCT01852292|65683267|FG001|Overall Study|Death|8|||
23532309|NCT01852292|65683266|FG000|Overall Study|Patient/guardian decision|8|||
23532310|NCT01852292|65683267|FG001|Overall Study|Patient/guardian decision|4|||
23532311|NCT01852292|65683266|FG000|Overall Study|Adverse Event|8|||
23532312|NCT01852292|65683267|FG001|Overall Study|Adverse Event|11|||
23532313|NCT01852292|65683266|FG000|Overall Study|Physician Decision|6|||
23532314|NCT01852292|65683267|FG001|Overall Study|Physician Decision|2|||
23532315|NCT01852292|65683266|FG000|Overall Study|Protocol Violation|2|||
23532316|NCT01852292|65683267|FG001|Overall Study|Protocol Violation|0|||
23532317|NCT01852292|65683266|FG000|Overall Study|Non-compliance with study treatment|1|||
23532318|NCT01852292|65683267|FG001|Overall Study|Non-compliance with study treatment|0|||
23532319|NCT01852292|65683266|FG000|Overall Study|Study terminated by Sponsor|0|||
23532320|NCT01852292|65683267|FG001|Overall Study|Study terminated by Sponsor|1|||
23532321|NCT01852292|65683266|FG000|Overall Study|Progressive disease|42|||
23532322|NCT01852292|65683267|FG001|Overall Study|Progressive disease|52|||
23532323|NCT03592641|65683268|FG000|Overall Study|Withdrawal by Subject|1|||
23532324|NCT00512096|65683272|FG000|Overall Study|Adverse Event|2|||
23532325|NCT00512096|65683272|FG000|Overall Study|Withdrawal by Subject|2|||
23532326|NCT00512096|65683272|FG000|Overall Study|Lack of Efficacy|3|||
23614091|NCT00296504|65973262|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
23721236|NCT02460978|66355919|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
23721237|NCT02460978|66355920|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
23721238|NCT02460978|66355918|FG000|Overall Study|Pregnancy|0|||
23721239|NCT02460978|66355919|FG001|Overall Study|Pregnancy|0|||
23721240|NCT02460978|66355920|FG002|Overall Study|Pregnancy|2|||
23721241|NCT00510068|66355921|FG000|Double-blind Period|Disease progression|98|||
23532327|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
23532328|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532329|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532330|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532331|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532332|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532333|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532334|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532335|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532336|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532337|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
23532338|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532339|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
23532340|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
23532341|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532342|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532343|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532344|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
23532345|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
23532346|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532347|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
23532348|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532349|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
23532350|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532351|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
23532352|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532353|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
23532354|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532355|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
23532356|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532357|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532358|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
23532359|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532360|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532361|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532362|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532363|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
23532364|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
23532365|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
23532366|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
23532367|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
23532368|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
23532369|NCT01632579|65683279|FG000|Washout Period|Adverse Event|1|||
23532370|NCT01632579|65683280|FG001|Washout Period|Adverse Event|0|||
23532371|NCT01632579|65683281|FG002|Washout Period|Adverse Event|0|||
23532372|NCT01632579|65683282|FG003|Washout Period|Adverse Event|0|||
23532373|NCT01632579|65683283|FG004|Washout Period|Adverse Event|0|||
23532374|NCT01632579|65683284|FG005|Washout Period|Adverse Event|0|||
23532375|NCT01632579|65683285|FG006|Washout Period|Adverse Event|0|||
23532376|NCT01632579|65683286|FG007|Washout Period|Adverse Event|0|||
23532377|NCT01632579|65683287|FG008|Washout Period|Adverse Event|0|||
23532378|NCT01632579|65683279|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
23532379|NCT01632579|65683280|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
23532380|NCT01632579|65683281|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
23532381|NCT01632579|65683282|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
23532382|NCT01632579|65683283|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
23532383|NCT01632579|65683284|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
23532384|NCT01632579|65683285|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
23532385|NCT01632579|65683286|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
23532386|NCT01632579|65683287|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
23532387|NCT00654381|65683288|FG000|1st Stage|Adverse Event|3|||
23614092|NCT00296504|65973263|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
23721242|NCT00510068|66355922|FG001|Double-blind Period|Disease progression|169|||
23814626|NCT00792935|66703266|FG001|Overall Study|Protocol Violation|0|||
23532388|NCT00654381|65683289|FG001|1st Stage|Adverse Event|3|||
23532389|NCT00654381|65683290|FG002|1st Stage|Adverse Event|3|||
23532390|NCT00654381|65683291|FG003|1st Stage|Adverse Event|3|||
23532391|NCT00654381|65683292|FG004|1st Stage|Adverse Event|2|||
23532392|NCT00654381|65683293|FG005|1st Stage|Adverse Event|1|||
23532393|NCT00654381|65683288|FG000|1st Stage|Withdrawal by Subject|0|||
23532394|NCT00654381|65683289|FG001|1st Stage|Withdrawal by Subject|0|||
23532395|NCT00654381|65683290|FG002|1st Stage|Withdrawal by Subject|0|||
23532396|NCT00654381|65683291|FG003|1st Stage|Withdrawal by Subject|1|||
23532397|NCT00654381|65683292|FG004|1st Stage|Withdrawal by Subject|0|||
23532398|NCT00654381|65683293|FG005|1st Stage|Withdrawal by Subject|1|||
23532399|NCT00654381|65683288|FG000|1st Stage|Investigator's decision|0|||
23532400|NCT00654381|65683289|FG001|1st Stage|Investigator's decision|0|||
23532401|NCT00654381|65683290|FG002|1st Stage|Investigator's decision|0|||
23532402|NCT00654381|65683291|FG003|1st Stage|Investigator's decision|1|||
23532403|NCT00654381|65683292|FG004|1st Stage|Investigator's decision|0|||
23532404|NCT00654381|65683293|FG005|1st Stage|Investigator's decision|0|||
23532405|NCT00654381|65683288|FG000|2nd Stage|Adverse Event|2|||
23532406|NCT00654381|65683289|FG001|2nd Stage|Adverse Event|0|||
23532407|NCT00654381|65683290|FG002|2nd Stage|Adverse Event|2|||
23532408|NCT00654381|65683291|FG003|2nd Stage|Adverse Event|3|||
23721243|NCT00510068|66355921|FG000|Double-blind Period|Final primary analysis|52|||
23721244|NCT00510068|66355922|FG001|Double-blind Period|Final primary analysis|18|||
23721245|NCT00510068|66355921|FG000|Double-blind Period|Adverse Event|37|||
23721246|NCT00510068|66355922|FG001|Double-blind Period|Adverse Event|7|||
23532409|NCT00654381|65683292|FG004|2nd Stage|Adverse Event|7|||
23532410|NCT00654381|65683293|FG005|2nd Stage|Adverse Event|2|||
23532411|NCT00654381|65683288|FG000|2nd Stage|Withdrawal by Subject|0|||
23532412|NCT00654381|65683289|FG001|2nd Stage|Withdrawal by Subject|0|||
23532413|NCT00654381|65683290|FG002|2nd Stage|Withdrawal by Subject|0|||
23532414|NCT00654381|65683291|FG003|2nd Stage|Withdrawal by Subject|0|||
23532415|NCT00654381|65683292|FG004|2nd Stage|Withdrawal by Subject|1|||
23532416|NCT00654381|65683293|FG005|2nd Stage|Withdrawal by Subject|1|||
23532417|NCT00654381|65683288|FG000|2nd Stage|Investigator's decision|0|||
23532418|NCT00654381|65683289|FG001|2nd Stage|Investigator's decision|0|||
23532419|NCT00654381|65683290|FG002|2nd Stage|Investigator's decision|1|||
23532420|NCT00654381|65683291|FG003|2nd Stage|Investigator's decision|1|||
23532421|NCT00654381|65683292|FG004|2nd Stage|Investigator's decision|0|||
23532422|NCT00654381|65683293|FG005|2nd Stage|Investigator's decision|0|||
23532423|NCT00654381|65683288|FG000|Extension Stage|Adverse Event|1|||
23532424|NCT00654381|65683289|FG001|Extension Stage|Adverse Event|2|||
23532425|NCT00654381|65683290|FG002|Extension Stage|Adverse Event|9|||
23532426|NCT00654381|65683291|FG003|Extension Stage|Adverse Event|7|||
23721247|NCT00510068|66355921|FG000|Double-blind Period|Withdrawal by Subject|8|||
23721248|NCT00510068|66355922|FG001|Double-blind Period|Withdrawal by Subject|6|||
23721249|NCT00510068|66355921|FG000|Double-blind Period|Death|4|||
23721250|NCT00510068|66355922|FG001|Double-blind Period|Death|3|||
23721251|NCT00510068|66355921|FG000|Double-blind Period|Abnormal test result (s)|1|||
23721252|NCT00510068|66355922|FG001|Double-blind Period|Abnormal test result (s)|0|||
23721253|NCT00510068|66355921|FG000|Double-blind Period|Lost to Follow-up|1|||
23721254|NCT00510068|66355922|FG001|Double-blind Period|Lost to Follow-up|0|||
23721255|NCT00510068|66355921|FG000|Double-blind Period|Protocol Violation|6|||
23721256|NCT00510068|66355922|FG001|Double-blind Period|Protocol Violation|0|||
23721257|NCT00510068|66355921|FG000|Open-label Period|Disease Progression|124|||
23721258|NCT00510068|66355922|FG001|Open-label Period|Disease Progression|0|||
23532427|NCT00654381|65683292|FG004|Extension Stage|Adverse Event|1|||
23532428|NCT00654381|65683293|FG005|Extension Stage|Adverse Event|1|||
23532429|NCT00654381|65683288|FG000|Extension Stage|Protocol Violation|0|||
23532430|NCT00654381|65683289|FG001|Extension Stage|Protocol Violation|0|||
23532431|NCT00654381|65683290|FG002|Extension Stage|Protocol Violation|0|||
23532432|NCT00654381|65683291|FG003|Extension Stage|Protocol Violation|1|||
23532433|NCT00654381|65683292|FG004|Extension Stage|Protocol Violation|0|||
23532434|NCT00654381|65683293|FG005|Extension Stage|Protocol Violation|0|||
23532435|NCT00654381|65683288|FG000|Extension Stage|Lack of Efficacy|0|||
23532436|NCT00654381|65683289|FG001|Extension Stage|Lack of Efficacy|0|||
23532437|NCT00654381|65683290|FG002|Extension Stage|Lack of Efficacy|1|||
23532438|NCT00654381|65683291|FG003|Extension Stage|Lack of Efficacy|0|||
23532439|NCT00654381|65683292|FG004|Extension Stage|Lack of Efficacy|0|||
23532440|NCT00654381|65683293|FG005|Extension Stage|Lack of Efficacy|0|||
23532441|NCT00654381|65683288|FG000|Extension Stage|Withdrawal by Subject|0|||
23532442|NCT00654381|65683289|FG001|Extension Stage|Withdrawal by Subject|0|||
23614093|NCT00296504|65973264|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
23814627|NCT00792935|66703265|FG000|Overall Study|Withdrawal by Subject|0|||
23532443|NCT00654381|65683290|FG002|Extension Stage|Withdrawal by Subject|1|||
23532444|NCT00654381|65683291|FG003|Extension Stage|Withdrawal by Subject|1|||
23532445|NCT00654381|65683292|FG004|Extension Stage|Withdrawal by Subject|1|||
23532446|NCT00654381|65683293|FG005|Extension Stage|Withdrawal by Subject|1|||
23532447|NCT00654381|65683288|FG000|Extension Stage|Closure of the trial site|0|||
23532448|NCT00654381|65683289|FG001|Extension Stage|Closure of the trial site|0|||
23532449|NCT00654381|65683290|FG002|Extension Stage|Closure of the trial site|0|||
23532450|NCT00654381|65683291|FG003|Extension Stage|Closure of the trial site|0|||
23721259|NCT00510068|66355921|FG000|Open-label Period|Adverse Event|46|||
23721260|NCT00510068|66355922|FG001|Open-label Period|Adverse Event|0|||
23614094|NCT00296504|65973256|FG000|Interim Analysis|Non-adherence|2|||
23614095|NCT00296504|65973257|FG001|Interim Analysis|Non-adherence|0|||
23614096|NCT00296504|65973258|FG002|Interim Analysis|Non-adherence|0|||
23614097|NCT00296504|65973259|FG003|Interim Analysis|Non-adherence|0|||
23614098|NCT00296504|65973260|FG004|Interim Analysis|Non-adherence|1|||
23614099|NCT00296504|65973261|FG005|Interim Analysis|Non-adherence|0|||
23614100|NCT00296504|65973262|FG006|Interim Analysis|Non-adherence|0|||
23614101|NCT00296504|65973263|FG007|Interim Analysis|Non-adherence|1|||
23614102|NCT00296504|65973264|FG008|Interim Analysis|Non-adherence|0|||
23614103|NCT00296504|65973256|FG000|Interim Analysis|Site Closing|1|||
23614104|NCT00296504|65973257|FG001|Interim Analysis|Site Closing|0|||
23614105|NCT00296504|65973258|FG002|Interim Analysis|Site Closing|0|||
23614106|NCT00296504|65973259|FG003|Interim Analysis|Site Closing|0|||
23614107|NCT00296504|65973260|FG004|Interim Analysis|Site Closing|0|||
23614108|NCT00296504|65973261|FG005|Interim Analysis|Site Closing|1|||
23614109|NCT00296504|65973262|FG006|Interim Analysis|Site Closing|2|||
23614110|NCT00296504|65973263|FG007|Interim Analysis|Site Closing|0|||
23814628|NCT00792935|66703266|FG001|Overall Study|Withdrawal by Subject|1|||
23814629|NCT00326963|66703267|FG000|Overall Study|Adverse Event|2|||
23814630|NCT00326963|66703267|FG000|Overall Study|Injection site reaction|1|||
23814631|NCT00326963|66703267|FG000|Overall Study|Death|1|||
23814632|NCT00326963|66703267|FG000|Overall Study|Failure to return|10|||
23814633|NCT00326963|66703267|FG000|Overall Study|Withdrawal by Subject|10|||
23814634|NCT00326963|66703267|FG000|Overall Study|Refused treatment / did not cooperate|5|||
23421148|NCT00503581|65283962|FG001|Overall Study|Study closed|4|||
23421149|NCT00503581|65283963|FG002|Overall Study|Study closed|2|||
23614111|NCT00296504|65973264|FG008|Interim Analysis|Site Closing|0|||
23614112|NCT00296504|65973256|FG000|Interim Analysis|Lack of Personnel at Site|1|||
23614113|NCT00296504|65973257|FG001|Interim Analysis|Lack of Personnel at Site|0|||
23614114|NCT00296504|65973258|FG002|Interim Analysis|Lack of Personnel at Site|0|||
23614115|NCT00296504|65973259|FG003|Interim Analysis|Lack of Personnel at Site|0|||
23614116|NCT00296504|65973260|FG004|Interim Analysis|Lack of Personnel at Site|0|||
23614117|NCT00296504|65973261|FG005|Interim Analysis|Lack of Personnel at Site|0|||
23614118|NCT00296504|65973262|FG006|Interim Analysis|Lack of Personnel at Site|0|||
23614119|NCT00296504|65973263|FG007|Interim Analysis|Lack of Personnel at Site|0|||
23614120|NCT00296504|65973264|FG008|Interim Analysis|Lack of Personnel at Site|0|||
23614121|NCT00296504|65973256|FG000|Interim Analysis|Missed Schedule Date|1|||
23614122|NCT00296504|65973257|FG001|Interim Analysis|Missed Schedule Date|0|||
23614123|NCT00296504|65973258|FG002|Interim Analysis|Missed Schedule Date|0|||
23614124|NCT00296504|65973259|FG003|Interim Analysis|Missed Schedule Date|0|||
23614125|NCT00296504|65973260|FG004|Interim Analysis|Missed Schedule Date|0|||
23614126|NCT00296504|65973261|FG005|Interim Analysis|Missed Schedule Date|0|||
23614127|NCT00296504|65973262|FG006|Interim Analysis|Missed Schedule Date|0|||
23614128|NCT00296504|65973263|FG007|Interim Analysis|Missed Schedule Date|0|||
23614129|NCT00296504|65973264|FG008|Interim Analysis|Missed Schedule Date|0|||
23614130|NCT00296504|65973256|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
23614131|NCT00296504|65973257|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
23614132|NCT00296504|65973258|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
23614133|NCT00296504|65973259|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
23614134|NCT00296504|65973260|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
23614135|NCT00296504|65973261|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
23614136|NCT00296504|65973262|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
23614137|NCT00296504|65973263|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
23614138|NCT00296504|65973264|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
23614139|NCT00296504|65973256|FG000|Interim Analysis|Participant Stopped|0|||
23614140|NCT00296504|65973257|FG001|Interim Analysis|Participant Stopped|0|||
23614141|NCT00296504|65973258|FG002|Interim Analysis|Participant Stopped|0|||
23614142|NCT00296504|65973259|FG003|Interim Analysis|Participant Stopped|0|||
23614143|NCT00296504|65973260|FG004|Interim Analysis|Participant Stopped|1|||
23614144|NCT00296504|65973261|FG005|Interim Analysis|Participant Stopped|0|||
23814635|NCT00326963|66703267|FG000|Overall Study|Violation of selection criteria at entry|2|||
23614145|NCT00296504|65973262|FG006|Interim Analysis|Participant Stopped|0|||
23614146|NCT00296504|65973263|FG007|Interim Analysis|Participant Stopped|0|||
23614147|NCT00296504|65973264|FG008|Interim Analysis|Participant Stopped|0|||
23614148|NCT00296504|65973256|FG000|Interim Analysis|Physician and Participant Decision|0|||
23614149|NCT00296504|65973257|FG001|Interim Analysis|Physician and Participant Decision|0|||
23614150|NCT00296504|65973258|FG002|Interim Analysis|Physician and Participant Decision|0|||
23614151|NCT00296504|65973259|FG003|Interim Analysis|Physician and Participant Decision|0|||
23614152|NCT00296504|65973260|FG004|Interim Analysis|Physician and Participant Decision|0|||
23614153|NCT00296504|65973261|FG005|Interim Analysis|Physician and Participant Decision|1|||
23614154|NCT00296504|65973262|FG006|Interim Analysis|Physician and Participant Decision|0|||
23614155|NCT00296504|65973263|FG007|Interim Analysis|Physician and Participant Decision|0|||
23814636|NCT00326963|66703267|FG000|Overall Study|Other protocol violation|1|||
23814637|NCT00326963|66703267|FG000|Overall Study|Administrative / other|1|||
23614156|NCT00296504|65973264|FG008|Interim Analysis|Physician and Participant Decision|0|||
23614157|NCT00296504|65973256|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
23614158|NCT00296504|65973257|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
23532451|NCT00654381|65683292|FG004|Extension Stage|Closure of the trial site|1|||
23532452|NCT00654381|65683293|FG005|Extension Stage|Closure of the trial site|1|||
23532453|NCT03096782|65683294|FG000|Overall Study|Death|1|||
23532454|NCT03096782|65683294|FG000|Overall Study|Participant Relapsed|1|||
23532455|NCT00414050|65683295|FG000|Overall Study|Adverse Event|1|||
23532456|NCT00414050|65683296|FG001|Overall Study|Adverse Event|1|||
23532457|NCT00414050|65683297|FG002|Overall Study|Adverse Event|1|||
23532458|NCT00414050|65683298|FG003|Overall Study|Adverse Event|1|||
23532459|NCT00414050|65683295|FG000|Overall Study|Lost to Follow-up|2|||
23532460|NCT00414050|65683296|FG001|Overall Study|Lost to Follow-up|2|||
23532461|NCT00414050|65683297|FG002|Overall Study|Lost to Follow-up|1|||
23532462|NCT00414050|65683298|FG003|Overall Study|Lost to Follow-up|1|||
23532463|NCT00414050|65683295|FG000|Overall Study|Withdrawal by Subject|5|||
23532464|NCT00414050|65683296|FG001|Overall Study|Withdrawal by Subject|3|||
23532465|NCT00414050|65683297|FG002|Overall Study|Withdrawal by Subject|2|||
23532466|NCT00414050|65683298|FG003|Overall Study|Withdrawal by Subject|4|||
23532467|NCT00414050|65683295|FG000|Overall Study|Subject discontinued for other reason|1|||
23532468|NCT00414050|65683296|FG001|Overall Study|Subject discontinued for other reason|2|||
23532469|NCT00414050|65683297|FG002|Overall Study|Subject discontinued for other reason|2|||
23532470|NCT00414050|65683298|FG003|Overall Study|Subject discontinued for other reason|1|||
23532471|NCT00414050|65683295|FG000|Overall Study|Subject Moved|0|||
23532472|NCT00414050|65683296|FG001|Overall Study|Subject Moved|0|||
23532473|NCT00414050|65683297|FG002|Overall Study|Subject Moved|0|||
23532474|NCT00414050|65683298|FG003|Overall Study|Subject Moved|1|||
23532475|NCT03256552|65683301|FG000|Overall Study|Protocol Violation|1|||
23532476|NCT03256552|65683301|FG000|Overall Study|Physician Decision|1|||
23532477|NCT03256552|65683301|FG000|Overall Study|Adverse Event|1|||
23532478|NCT03256552|65683301|FG000|Overall Study|Withdrawal by Subject|2|||
23532479|NCT04537806|65683312|FG000|Overall Study|Randomized but not treated|1|||
23532480|NCT04537806|65683313|FG001|Overall Study|Randomized but not treated|0|||
23532481|NCT04537806|65683312|FG000|Overall Study|Adverse Event|1|||
23532482|NCT04537806|65683313|FG001|Overall Study|Adverse Event|1|||
23532483|NCT00587587|65683314|FG000|Overall Study|Lost to Follow-up|6|||
23532484|NCT00587587|65683315|FG001|Overall Study|Lost to Follow-up|1|||
23721261|NCT00510068|66355921|FG000|Open-label Period|Withdrawal by Subject|21|||
23721262|NCT00510068|66355922|FG001|Open-label Period|Withdrawal by Subject|0|||
23721263|NCT00510068|66355921|FG000|Open-label Period|Administrative problems|17|||
23721264|NCT00510068|66355922|FG001|Open-label Period|Administrative problems|0|||
23721265|NCT00510068|66355921|FG000|Open-label Period|Death|7|||
23721266|NCT00510068|66355922|FG001|Open-label Period|Death|0|||
23721267|NCT00510068|66355921|FG000|Open-label Period|New cancer therapy|7|||
23721268|NCT00510068|66355922|FG001|Open-label Period|New cancer therapy|0|||
23721269|NCT00510068|66355921|FG000|Open-label Period|Protocol Violation|2|||
23721270|NCT00510068|66355922|FG001|Open-label Period|Protocol Violation|0|||
23721271|NCT00510068|66355921|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
23721272|NCT00510068|66355922|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
23614159|NCT00296504|65973258|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
23614160|NCT00296504|65973259|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
23614161|NCT00296504|65973260|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
23614162|NCT00296504|65973261|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
23614163|NCT00296504|65973262|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
23721273|NCT04839393|66355924|FG000|Overall Study|Adverse Event|0|||
23721274|NCT04839393|66355925|FG001|Overall Study|Adverse Event|0|||
23421150|NCT01646645|65283964|FG000|Overall Study|No Treated|1|||
23532485|NCT00413413|65683319|FG000|Single-Blind|Adverse Event|0|||
23532486|NCT00413413|65683320|FG001|Single-Blind|Adverse Event|9|||
23532487|NCT00413413|65683321|FG002|Single-Blind|Adverse Event|0|||
23532488|NCT00413413|65683319|FG000|Single-Blind|Lack of Efficacy|0|||
23532489|NCT00413413|65683320|FG001|Single-Blind|Lack of Efficacy|5|||
23532490|NCT00413413|65683321|FG002|Single-Blind|Lack of Efficacy|0|||
23532491|NCT00413413|65683319|FG000|Single-Blind|Subject no longer requires study drug|0|||
23532492|NCT00413413|65683320|FG001|Single-Blind|Subject no longer requires study drug|151|||
23532493|NCT00413413|65683321|FG002|Single-Blind|Subject no longer requires study drug|0|||
23532494|NCT00413413|65683319|FG000|Single-Blind|Protocol Violation|0|||
23532495|NCT00413413|65683320|FG001|Single-Blind|Protocol Violation|16|||
23532496|NCT00413413|65683321|FG002|Single-Blind|Protocol Violation|0|||
23532497|NCT00413413|65683319|FG000|Single-Blind|Withdrawal by Subject|0|||
23532498|NCT00413413|65683320|FG001|Single-Blind|Withdrawal by Subject|27|||
23421151|NCT01646645|65283964|FG000|Overall Study|Inevaluable Donor|29|||
23532499|NCT00413413|65683321|FG002|Single-Blind|Withdrawal by Subject|0|||
23721275|NCT04839393|66355926|FG002|Overall Study|Adverse Event|2|||
23721276|NCT04839393|66355924|FG000|Overall Study|Withdrawal by participant|0|||
23721277|NCT04839393|66355925|FG001|Overall Study|Withdrawal by participant|0|||
23532500|NCT00413413|65683319|FG000|Single-Blind|Lost to Follow-up|0|||
23532501|NCT00413413|65683320|FG001|Single-Blind|Lost to Follow-up|8|||
23532502|NCT00413413|65683321|FG002|Single-Blind|Lost to Follow-up|0|||
23532503|NCT00413413|65683319|FG000|Double-Blind|Adverse Event|6|||
23532504|NCT00413413|65683320|FG001|Double-Blind|Adverse Event|0|||
23532505|NCT00413413|65683321|FG002|Double-Blind|Adverse Event|5|||
23532506|NCT00413413|65683319|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
23532507|NCT00413413|65683320|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
23532508|NCT00413413|65683321|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
23532509|NCT00413413|65683319|FG000|Double-Blind|Protocol deviation|1|||
23532510|NCT00413413|65683320|FG001|Double-Blind|Protocol deviation|2|||
23532511|NCT00413413|65683321|FG002|Double-Blind|Protocol deviation|1|||
23532512|NCT00413413|65683319|FG000|Double-Blind|Subject withdrew consent|4|||
23532513|NCT00413413|65683320|FG001|Double-Blind|Subject withdrew consent|6|||
23721278|NCT04839393|66355926|FG002|Overall Study|Withdrawal by participant|1|||
23721279|NCT00033371|66355927|FG000|Overall Study|Adverse Event|1|||
23721280|NCT00033371|66355928|FG001|Overall Study|Adverse Event|5|||
23721281|NCT00033371|66355927|FG000|Overall Study|Lost to Follow-up|2|||
23532514|NCT00413413|65683321|FG002|Double-Blind|Subject withdrew consent|9|||
23532515|NCT00413413|65683319|FG000|Double-Blind|Lost to Follow-up|3|||
23532516|NCT00413413|65683320|FG001|Double-Blind|Lost to Follow-up|4|||
23532517|NCT00413413|65683321|FG002|Double-Blind|Lost to Follow-up|2|||
23721282|NCT00033371|66355928|FG001|Overall Study|Lost to Follow-up|1|||
23721283|NCT00033371|66355927|FG000|Overall Study|Withdrawal by Subject|3|||
23721284|NCT00033371|66355928|FG001|Overall Study|Withdrawal by Subject|3|||
23721285|NCT00033371|66355927|FG000|Overall Study|Disease Progression|0|||
23721286|NCT00033371|66355928|FG001|Overall Study|Disease Progression|1|||
23814638|NCT04581369|66703268|FG000|Overall Study|Death|7|||
23814639|NCT04581369|66703269|FG001|Overall Study|Death|6|||
23814640|NCT04581369|66703270|FG002|Overall Study|Death|0|||
23721287|NCT00709124|66355930|FG000|Overall Study|Death|3|||
23721288|NCT00709124|66355931|FG001|Overall Study|Death|1|||
23721289|NCT00709124|66355930|FG000|Overall Study|encephalopathy; can't do assessment|1|||
23721290|NCT00709124|66355931|FG001|Overall Study|encephalopathy; can't do assessment|0|||
23721291|NCT00571688|66355932|FG000|Overall Study|Lost to Follow-up|3|||
23721292|NCT00571688|66355933|FG001|Overall Study|Lost to Follow-up|6|||
23721293|NCT00571688|66355932|FG000|Overall Study|subject did not tolerate Consta|1|||
23721294|NCT00571688|66355933|FG001|Overall Study|subject did not tolerate Consta|0|||
23721295|NCT00571688|66355932|FG000|Overall Study|subject moved out of the area|1|||
23721296|NCT00571688|66355933|FG001|Overall Study|subject moved out of the area|0|||
23721297|NCT01732107|66355936|FG000|Overall Study|Adverse Event|2|||
23814641|NCT04581369|66703268|FG000|Overall Study|Lost to Follow-up|7|||
23814642|NCT04581369|66703269|FG001|Overall Study|Lost to Follow-up|3|||
23814643|NCT04581369|66703270|FG002|Overall Study|Lost to Follow-up|0|||
23814644|NCT04581369|66703268|FG000|Overall Study|liver transplant|2|||
23814645|NCT04581369|66703269|FG001|Overall Study|liver transplant|2|||
23814646|NCT04581369|66703270|FG002|Overall Study|liver transplant|0|||
23814647|NCT04581369|66703268|FG000|Overall Study|transitioned to hospice care|0|||
23814648|NCT04581369|66703269|FG001|Overall Study|transitioned to hospice care|5|||
23814649|NCT04581369|66703270|FG002|Overall Study|transitioned to hospice care|0|||
23814650|NCT00609518|66703273|FG000|Overall Study|Death from Study Disease|32|||
23814651|NCT00609518|66703274|FG001|Overall Study|Death from Study Disease|32|||
23814652|NCT00609518|66703273|FG000|Overall Study|Withdrawal by Subject|5|||
23814653|NCT00609518|66703274|FG001|Overall Study|Withdrawal by Subject|3|||
23814654|NCT00609518|66703273|FG000|Overall Study|Lost to Follow-up|3|||
23814655|NCT00609518|66703274|FG001|Overall Study|Lost to Follow-up|0|||
23814656|NCT00609518|66703273|FG000|Overall Study|Physician Decision|1|||
23814657|NCT00609518|66703274|FG001|Overall Study|Physician Decision|3|||
23814658|NCT00609518|66703273|FG000|Overall Study|Death from Adverse Event|2|||
23814659|NCT00609518|66703274|FG001|Overall Study|Death from Adverse Event|2|||
23814660|NCT01140503|66703275|FG000|Overall Study|Withdrawal by Subject|1|||
23532518|NCT00773097|65683322|FG000|Overall Study|Withdrawal by Subject|1|||
23614164|NCT00296504|65973263|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
23721298|NCT01732107|66355936|FG000|Overall Study|Disease Progression|8|||
23721299|NCT01732107|66355936|FG000|Overall Study|Physician Decision|1|||
23721300|NCT01732107|66355936|FG000|Overall Study|Withdrawal by Subject|2|||
23721301|NCT01742078|66355938|FG000|Overall Study|Withdrawal by Subject|0|||
23721302|NCT01742078|66355939|FG001|Overall Study|Withdrawal by Subject|0|||
23814661|NCT02092467|66703280|FG000|Overall Study|Death|49|||
23814662|NCT02092467|66703281|FG001|Overall Study|Death|66|||
23814663|NCT02092467|66703282|FG002|Overall Study|Death|38|||
23814664|NCT02092467|66703280|FG000|Overall Study|Lost to Follow-up|38|||
23814665|NCT02092467|66703281|FG001|Overall Study|Lost to Follow-up|35|||
23814666|NCT02092467|66703282|FG002|Overall Study|Lost to Follow-up|40|||
23814667|NCT02092467|66703280|FG000|Overall Study|Global Deterioration of Health Status|1|||
23814668|NCT02092467|66703281|FG001|Overall Study|Global Deterioration of Health Status|0|||
23721303|NCT01742078|66355940|FG002|Overall Study|Withdrawal by Subject|0|||
23721304|NCT01742078|66355941|FG003|Overall Study|Withdrawal by Subject|1|||
23721305|NCT01742078|66355942|FG004|Overall Study|Withdrawal by Subject|0|||
23721306|NCT01742078|66355943|FG005|Overall Study|Withdrawal by Subject|0|||
23721307|NCT01742078|66355944|FG006|Overall Study|Withdrawal by Subject|0|||
23721308|NCT01742078|66355945|FG007|Overall Study|Withdrawal by Subject|0|||
23721309|NCT01742078|66355946|FG008|Overall Study|Withdrawal by Subject|0|||
23721310|NCT03339401|66355952|FG000|Overall Study|Death|2|||
23721311|NCT03339401|66355953|FG001|Overall Study|Death|1|||
23721312|NCT03339401|66355952|FG000|Overall Study|Withdrawal by Subject|2|||
23721313|NCT03339401|66355953|FG001|Overall Study|Withdrawal by Subject|0|||
23721314|NCT03339401|66355952|FG000|Overall Study|Study terminated|4|||
23721315|NCT03339401|66355953|FG001|Overall Study|Study terminated|3|||
23721316|NCT03339401|66355952|FG000|Overall Study|Investigator Decision|1|||
23721317|NCT03339401|66355953|FG001|Overall Study|Investigator Decision|0|||
23721318|NCT01998880|66355957|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
23721319|NCT01998880|66355958|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
23721320|NCT01998880|66355957|FG000|Overall Study|Disease Progression|1|||
23721321|NCT01998880|66355958|FG001|Overall Study|Disease Progression|8|||
23721322|NCT01998880|66355957|FG000|Overall Study|Withdrew Consent|2|||
23721323|NCT01998880|66355958|FG001|Overall Study|Withdrew Consent|1|||
23814669|NCT02092467|66703282|FG002|Overall Study|Global Deterioration of Health Status|0|||
23814670|NCT02092467|66703280|FG000|Overall Study|Other|32|||
23814671|NCT02092467|66703281|FG001|Overall Study|Other|30|||
23814672|NCT02092467|66703282|FG002|Overall Study|Other|24|||
23814673|NCT02092467|66703280|FG000|Overall Study|Withdrawal by Subject|282|||
23814674|NCT02092467|66703281|FG001|Overall Study|Withdrawal by Subject|327|||
23814675|NCT02092467|66703282|FG002|Overall Study|Withdrawal by Subject|289|||
23814676|NCT02092467|66703280|FG000|Overall Study|Randomized but not treated|2|||
23814677|NCT02092467|66703281|FG001|Overall Study|Randomized but not treated|1|||
23814678|NCT02092467|66703282|FG002|Overall Study|Randomized but not treated|7|||
23814679|NCT01898650|66703287|FG000|Overall Study|the subject would not lie still for imaging|1|||
23814680|NCT04555720|66703292|FG000|Overall Study|Lost to Follow-up|2|||
23814681|NCT04555720|66703293|FG001|Overall Study|Lost to Follow-up|0|||
23814682|NCT04555720|66703294|FG002|Overall Study|Lost to Follow-up|0|||
23814683|NCT04555720|66703295|FG003|Overall Study|Lost to Follow-up|0|||
23814684|NCT04555720|66703292|FG000|Overall Study|Withdrawal by Subject|4|||
23814685|NCT04555720|66703293|FG001|Overall Study|Withdrawal by Subject|6|||
23814686|NCT04555720|66703294|FG002|Overall Study|Withdrawal by Subject|0|||
23814687|NCT04555720|66703295|FG003|Overall Study|Withdrawal by Subject|0|||
23814688|NCT02049450|66703303|FG000|Overall Study|Adverse Event|2|||
23814689|NCT02049450|66703303|FG000|Overall Study|Withdrawal by Subject|1|||
23814690|NCT02049450|66703303|FG000|Overall Study|Patients/guardian decision|1|||
23814691|NCT00912912|66703306|FG000|Overall Study|Withdrawal by Subject|1|||
23814692|NCT00912912|66703306|FG000|Overall Study|Disease Progression|3|||
23814693|NCT02728843|66703307|FG000|Overall Study|Adverse Event|0|||
23814694|NCT02728843|66703308|FG001|Overall Study|Adverse Event|2|||
23814695|NCT02728843|66703309|FG002|Overall Study|Adverse Event|3|||
23814696|NCT02728843|66703310|FG003|Overall Study|Adverse Event|1|||
23814697|NCT02728843|66703311|FG004|Overall Study|Adverse Event|2|||
23814698|NCT02728843|66703307|FG000|Overall Study|Lack of Efficacy|0|||
23814699|NCT02728843|66703308|FG001|Overall Study|Lack of Efficacy|1|||
23814700|NCT02728843|66703309|FG002|Overall Study|Lack of Efficacy|1|||
23814701|NCT02728843|66703310|FG003|Overall Study|Lack of Efficacy|0|||
23814702|NCT02728843|66703311|FG004|Overall Study|Lack of Efficacy|0|||
23814703|NCT02728843|66703307|FG000|Overall Study|Protocol Violation|2|||
23814704|NCT02728843|66703308|FG001|Overall Study|Protocol Violation|0|||
23814705|NCT02728843|66703309|FG002|Overall Study|Protocol Violation|4|||
23814706|NCT02728843|66703310|FG003|Overall Study|Protocol Violation|2|||
23814707|NCT02728843|66703311|FG004|Overall Study|Protocol Violation|2|||
23814708|NCT02728843|66703307|FG000|Overall Study|Withdrawal by Subject|1|||
23814709|NCT02728843|66703308|FG001|Overall Study|Withdrawal by Subject|0|||
23721324|NCT01998880|66355957|FG000|Overall Study|Death|3|||
23721325|NCT01998880|66355958|FG001|Overall Study|Death|6|||
23721326|NCT01998880|66355957|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23721327|NCT01998880|66355958|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23721328|NCT01998880|66355957|FG000|Overall Study|Administrative/Other|1|||
23721329|NCT01998880|66355958|FG001|Overall Study|Administrative/Other|1|||
23721330|NCT01998880|66355957|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
23814710|NCT02728843|66703309|FG002|Overall Study|Withdrawal by Subject|0|||
23814711|NCT02728843|66703310|FG003|Overall Study|Withdrawal by Subject|1|||
23814712|NCT02728843|66703311|FG004|Overall Study|Withdrawal by Subject|0|||
23814713|NCT02728843|66703307|FG000|Overall Study|Use of rescue medication|0|||
23814714|NCT02728843|66703308|FG001|Overall Study|Use of rescue medication|2|||
23814715|NCT02728843|66703309|FG002|Overall Study|Use of rescue medication|0|||
23814716|NCT02728843|66703310|FG003|Overall Study|Use of rescue medication|2|||
23814717|NCT02728843|66703311|FG004|Overall Study|Use of rescue medication|1|||
23532519|NCT00773097|65683322|FG000|Overall Study|Physician Decision|6|||
23721331|NCT01998880|66355958|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23721332|NCT01998880|66355957|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23721333|NCT01998880|66355958|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23721334|NCT01998880|66355957|FG000|Overall Study|Did Not Receive Treatment|3|||
23721335|NCT01998880|66355958|FG001|Overall Study|Did Not Receive Treatment|2|||
23721336|NCT02091921|66355963|FG000|Overall Study|Adverse Event|3|||
23721337|NCT01142193|66355964|FG000|Overall Study|Adverse Event|12|||
23721338|NCT01142193|66355965|FG001|Overall Study|Adverse Event|4|||
23721339|NCT01142193|66355964|FG000|Overall Study|Lack of Efficacy|2|||
23721340|NCT01142193|66355965|FG001|Overall Study|Lack of Efficacy|1|||
23721341|NCT01142193|66355964|FG000|Overall Study|Physician Decision|1|||
23721342|NCT01142193|66355965|FG001|Overall Study|Physician Decision|1|||
23721343|NCT01142193|66355964|FG000|Overall Study|Withdrawal by Subject|4|||
23721344|NCT01142193|66355965|FG001|Overall Study|Withdrawal by Subject|3|||
23721345|NCT01142193|66355964|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
23721346|NCT01142193|66355965|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
23721347|NCT01142193|66355964|FG000|Overall Study|Other|1|||
23532520|NCT01465802|65683323|FG000|Overall Study|Study terminated by sponsor|1|||
23532521|NCT01465802|65683324|FG001|Overall Study|Study terminated by sponsor|0|||
23532522|NCT01465802|65683325|FG002|Overall Study|Study terminated by sponsor|0|||
23532523|NCT01465802|65683326|FG003|Overall Study|Study terminated by sponsor|1|||
23532524|NCT01465802|65683327|FG004|Overall Study|Study terminated by sponsor|7|||
23532525|NCT01465802|65683323|FG000|Overall Study|Withdrawal by Subject|7|||
23532526|NCT01465802|65683324|FG001|Overall Study|Withdrawal by Subject|7|||
23532527|NCT01465802|65683325|FG002|Overall Study|Withdrawal by Subject|0|||
23532528|NCT01465802|65683326|FG003|Overall Study|Withdrawal by Subject|8|||
23721348|NCT01142193|66355965|FG001|Overall Study|Other|2|||
23721349|NCT01438307|66355975|FG000|Overall Study|Death|1|||
23721350|NCT01438307|66355976|FG001|Overall Study|Death|1|||
23721351|NCT02064205|66355977|FG000|Overall Study|Withdrawal by Subject|1|||
23721352|NCT03168555|66355978|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
23721353|NCT03168555|66355978|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
23721354|NCT03168555|66355978|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
23721355|NCT03168555|66355978|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
23721356|NCT01522443|66355979|FG000|Overall Study|No longer receiving clinical benefit|36|||
23721357|NCT01522443|66355980|FG001|Overall Study|No longer receiving clinical benefit|28|||
23721358|NCT01522443|66355979|FG000|Overall Study|Adverse Event|10|||
23532529|NCT01465802|65683327|FG004|Overall Study|Withdrawal by Subject|1|||
23721359|NCT01522443|66355980|FG001|Overall Study|Adverse Event|15|||
23721360|NCT01522443|66355979|FG000|Overall Study|Withdrawal by Subject|5|||
23721361|NCT01522443|66355980|FG001|Overall Study|Withdrawal by Subject|8|||
23814718|NCT00554606|66703312|FG000|Overall Study|Adverse Event|3|||
23814719|NCT00554606|66703312|FG000|Overall Study|Abnormal laboratory values|1|||
23532530|NCT01465802|65683323|FG000|Overall Study|Lost to Follow-up|1|||
23532531|NCT01465802|65683324|FG001|Overall Study|Lost to Follow-up|1|||
23532532|NCT01465802|65683325|FG002|Overall Study|Lost to Follow-up|0|||
23532533|NCT01465802|65683326|FG003|Overall Study|Lost to Follow-up|0|||
23532534|NCT01465802|65683327|FG004|Overall Study|Lost to Follow-up|0|||
23532535|NCT01465802|65683323|FG000|Overall Study|Reason not specified|9|||
23532536|NCT01465802|65683324|FG001|Overall Study|Reason not specified|4|||
23532537|NCT01465802|65683325|FG002|Overall Study|Reason not specified|0|||
23532538|NCT01465802|65683326|FG003|Overall Study|Reason not specified|10|||
23532539|NCT01465802|65683327|FG004|Overall Study|Reason not specified|2|||
23532540|NCT01465802|65683323|FG000|Overall Study|Death|15|||
23532541|NCT01465802|65683324|FG001|Overall Study|Death|12|||
23532542|NCT01465802|65683325|FG002|Overall Study|Death|0|||
23532543|NCT01465802|65683326|FG003|Overall Study|Death|10|||
23532544|NCT01465802|65683327|FG004|Overall Study|Death|2|||
23532545|NCT02477020|65683328|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
23532546|NCT02477020|65683329|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23532547|NCT02477020|65683328|FG000|Overall Study|Voluntary Withdrawal|7|||
23532548|NCT02477020|65683329|FG001|Overall Study|Voluntary Withdrawal|16|||
23532549|NCT02477020|65683328|FG000|Overall Study|Reason not Specified|3|||
23532550|NCT02477020|65683329|FG001|Overall Study|Reason not Specified|1|||
23532551|NCT02477020|65683328|FG000|Overall Study|Lack of Efficacy|14|||
23421152|NCT03224507|65283965|FG000|Overall Study|Death|3|||
23532552|NCT02477020|65683329|FG001|Overall Study|Lack of Efficacy|5|||
23532553|NCT04115358|65683330|FG000|Overall Study|exfoliation|0|||
23532554|NCT04115358|65683331|FG001|Overall Study|exfoliation|0|||
23532555|NCT04115358|65683332|FG002|Overall Study|exfoliation|1|||
23532556|NCT00326911|65683336|FG000|Overall Study|Hospitalization prior to treatment|0|||
23721362|NCT01522443|66355979|FG000|Overall Study|No study treatment given|1|||
23721363|NCT01522443|66355980|FG001|Overall Study|No study treatment given|1|||
23532557|NCT00326911|65683337|FG001|Overall Study|Hospitalization prior to treatment|1|||
23532558|NCT00326911|65683336|FG000|Overall Study|Physician decision prior to treatment|1|||
23532559|NCT00326911|65683337|FG001|Overall Study|Physician decision prior to treatment|0|||
23532560|NCT00326911|65683336|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
23532561|NCT00326911|65683337|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
23532562|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
23532563|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532564|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532565|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532566|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532567|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532568|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532569|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
23532570|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532571|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532572|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532573|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532574|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532575|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532576|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
23532577|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532578|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532579|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532580|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532581|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532582|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532583|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
23532584|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532585|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532586|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532587|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532588|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23721364|NCT01522443|66355979|FG000|Overall Study|Other|1|||
23721365|NCT01522443|66355980|FG001|Overall Study|Other|3|||
23721366|NCT03210220|66355981|FG000|Overall Study|Physician Decision|1|||
23721367|NCT03210220|66355982|FG001|Overall Study|Physician Decision|0|||
23721368|NCT02062398|66355983|FG000|Overall Study|Implant removal|1|||
23721369|NCT01263093|66355985|FG000|Washout|Physician Decision|1|||
23721370|NCT01263093|66355986|FG001|Washout|Physician Decision|0|||
23721371|NCT01263093|66355985|FG000|Period 2|Adverse Event|1|||
23721372|NCT01263093|66355986|FG001|Period 2|Adverse Event|0|||
23721373|NCT03148756|66355987|FG000|Overall Study|Study Terminated|0|||
23721374|NCT03148756|66355988|FG001|Overall Study|Study Terminated|1|||
23721375|NCT01601704|66355991|FG000|Overall Study|Randomized but not dispensed study med|1|||
23721376|NCT01601704|66355992|FG001|Overall Study|Randomized but not dispensed study med|4|||
23721377|NCT02873208|66355993|FG000|Overall Study|Withdrawal by Subject|36|||
23721378|NCT02873208|66355993|FG000|Overall Study|Lost to Follow-up|22|||
23721379|NCT02873208|66355993|FG000|Overall Study|Adverse Event|15|||
23721380|NCT02873208|66355993|FG000|Overall Study|Non-compliance with study drug|12|||
23721381|NCT02873208|66355993|FG000|Overall Study|Protocol Violation|8|||
23721382|NCT02873208|66355993|FG000|Overall Study|Pregnancy|2|||
23721383|NCT02873208|66355993|FG000|Overall Study|Incarceration|1|||
23721384|NCT02873208|66355993|FG000|Overall Study|Lack of Efficacy|1|||
23721385|NCT02873208|66355993|FG000|Overall Study|Physician Decision|1|||
23721386|NCT05159362|66355994|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
23721387|NCT05159362|66355995|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
23721388|NCT05159362|66355996|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
23721389|NCT00418717|66355997|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
23721390|NCT00418717|66355997|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
23721391|NCT01437267|66359031|FG000|Overall Study|Withdrawal by Subject|0|||
23721392|NCT01437267|66359032|FG001|Overall Study|Withdrawal by Subject|0|||
23721393|NCT01437267|66359033|FG002|Overall Study|Withdrawal by Subject|0|||
23721394|NCT01437267|66359034|FG003|Overall Study|Withdrawal by Subject|1|||
23721395|NCT01437267|66359035|FG004|Overall Study|Withdrawal by Subject|0|||
23721396|NCT01437267|66359036|FG005|Overall Study|Withdrawal by Subject|0|||
23721397|NCT01437267|66359031|FG000|Overall Study|Protocol Violation|0|||
23721398|NCT01437267|66359032|FG001|Overall Study|Protocol Violation|1|||
23721399|NCT01437267|66359033|FG002|Overall Study|Protocol Violation|0|||
23721400|NCT01437267|66359034|FG003|Overall Study|Protocol Violation|0|||
23721401|NCT01437267|66359035|FG004|Overall Study|Protocol Violation|0|||
23721402|NCT01437267|66359036|FG005|Overall Study|Protocol Violation|0|||
23721403|NCT02905825|66359037|FG000|Overall Study|Protocol Violation|11|||
23721404|NCT02905825|66359037|FG000|Overall Study|Device Malfunction|1|||
23721405|NCT00435994|66359038|FG000|Overall Study|Lost to Follow-up|7|||
23721406|NCT00435994|66359039|FG001|Overall Study|Lost to Follow-up|0|||
23721407|NCT00435994|66359040|FG002|Overall Study|Lost to Follow-up|0|||
23721408|NCT02290340|66359041|FG000|Overall Study|Lost to Follow-up|0|||
23721409|NCT02290340|66359042|FG001|Overall Study|Lost to Follow-up|0|||
23721410|NCT02290340|66359043|FG002|Overall Study|Lost to Follow-up|0|||
23721411|NCT02290340|66359044|FG003|Overall Study|Lost to Follow-up|1|||
23721412|NCT02290340|66359041|FG000|Overall Study|Withdrawal by Subject|1|||
23721413|NCT02290340|66359042|FG001|Overall Study|Withdrawal by Subject|0|||
23614165|NCT00296504|65973264|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
23614166|NCT00296504|65973256|FG000|Interim Analysis|Study Ended|0|||
23614167|NCT00296504|65973257|FG001|Interim Analysis|Study Ended|0|||
23614168|NCT00296504|65973258|FG002|Interim Analysis|Study Ended|0|||
23614169|NCT00296504|65973259|FG003|Interim Analysis|Study Ended|0|||
23614170|NCT00296504|65973260|FG004|Interim Analysis|Study Ended|0|||
23614171|NCT00296504|65973261|FG005|Interim Analysis|Study Ended|0|||
23614172|NCT00296504|65973262|FG006|Interim Analysis|Study Ended|1|||
23614173|NCT00296504|65973263|FG007|Interim Analysis|Study Ended|0|||
23614174|NCT00296504|65973264|FG008|Interim Analysis|Study Ended|0|||
23614175|NCT00296504|65973256|FG000|Interim Analysis|Participant Needed Interferon|0|||
23614176|NCT00296504|65973257|FG001|Interim Analysis|Participant Needed Interferon|0|||
23614177|NCT00296504|65973258|FG002|Interim Analysis|Participant Needed Interferon|0|||
23614178|NCT00296504|65973259|FG003|Interim Analysis|Participant Needed Interferon|0|||
23614179|NCT00296504|65973260|FG004|Interim Analysis|Participant Needed Interferon|0|||
23614180|NCT00296504|65973261|FG005|Interim Analysis|Participant Needed Interferon|0|||
23614181|NCT00296504|65973262|FG006|Interim Analysis|Participant Needed Interferon|0|||
23614182|NCT00296504|65973263|FG007|Interim Analysis|Participant Needed Interferon|1|||
23721414|NCT02290340|66359043|FG002|Overall Study|Withdrawal by Subject|0|||
23721415|NCT02290340|66359044|FG003|Overall Study|Withdrawal by Subject|0|||
23721416|NCT02290340|66359041|FG000|Overall Study|Other|1|||
23721417|NCT02290340|66359042|FG001|Overall Study|Other|0|||
23721418|NCT02290340|66359043|FG002|Overall Study|Other|0|||
23721419|NCT02290340|66359044|FG003|Overall Study|Other|1|||
23721420|NCT00617591|66359047|FG000|Overall Study|Withdrew consent during Induction|4|||
23721421|NCT00617591|66359047|FG000|Overall Study|Withdrew consent during Maintenance|6|||
23721422|NCT00728936|66359053|FG000|Overall Study|Withdrawal by Subject|0|||
23721423|NCT00728936|66359054|FG001|Overall Study|Withdrawal by Subject|0|||
23721424|NCT00728936|66359055|FG002|Overall Study|Withdrawal by Subject|0|||
23721425|NCT00728936|66359056|FG003|Overall Study|Withdrawal by Subject|0|||
23721426|NCT00728936|66359057|FG004|Overall Study|Withdrawal by Subject|0|||
23614183|NCT00296504|65973264|FG008|Interim Analysis|Participant Needed Interferon|0|||
23614184|NCT00296504|65973256|FG000|Interim Analysis|Ongoing|32|||
23614185|NCT00296504|65973257|FG001|Interim Analysis|Ongoing|12|||
23614186|NCT00296504|65973258|FG002|Interim Analysis|Ongoing|16|||
23721427|NCT00728936|66359058|FG005|Overall Study|Withdrawal by Subject|1|||
23721428|NCT00728936|66359059|FG006|Overall Study|Withdrawal by Subject|0|||
23721429|NCT02574481|66359062|FG000|Overall Study|Withdrawal by Subject|29|||
23721430|NCT02574481|66359063|FG001|Overall Study|Withdrawal by Subject|15|||
23721431|NCT02574481|66359064|FG002|Overall Study|Withdrawal by Subject|4|||
23721432|NCT02574481|66359065|FG003|Overall Study|Withdrawal by Subject|1|||
23721433|NCT02574481|66359062|FG000|Overall Study|Adverse Event|5|||
23721434|NCT02574481|66359063|FG001|Overall Study|Adverse Event|1|||
23721435|NCT02574481|66359064|FG002|Overall Study|Adverse Event|1|||
23721436|NCT02574481|66359065|FG003|Overall Study|Adverse Event|0|||
23721437|NCT02574481|66359062|FG000|Overall Study|Visit Missed|15|||
23721438|NCT02574481|66359063|FG001|Overall Study|Visit Missed|7|||
23721439|NCT02574481|66359064|FG002|Overall Study|Visit Missed|5|||
23721440|NCT02574481|66359065|FG003|Overall Study|Visit Missed|0|||
23721441|NCT02574481|66359062|FG000|Overall Study|Other|7|||
23721442|NCT02574481|66359063|FG001|Overall Study|Other|2|||
23721443|NCT02574481|66359064|FG002|Overall Study|Other|0|||
23721444|NCT02574481|66359065|FG003|Overall Study|Other|0|||
23721445|NCT02574481|66359062|FG000|Overall Study|Death|48|||
23721446|NCT02574481|66359063|FG001|Overall Study|Death|26|||
23721447|NCT02574481|66359064|FG002|Overall Study|Death|12|||
23721448|NCT02574481|66359065|FG003|Overall Study|Death|4|||
23721449|NCT02574481|66359062|FG000|Overall Study|Physician Decision|5|||
23721450|NCT02574481|66359063|FG001|Overall Study|Physician Decision|2|||
23721451|NCT02574481|66359064|FG002|Overall Study|Physician Decision|0|||
23721452|NCT02574481|66359065|FG003|Overall Study|Physician Decision|0|||
23721453|NCT02574481|66359062|FG000|Overall Study|Lost to Follow-up|5|||
23721454|NCT02574481|66359063|FG001|Overall Study|Lost to Follow-up|1|||
23814720|NCT00554606|66703312|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
23814721|NCT00554606|66703312|FG000|Overall Study|Subject withdrew consent|2|||
23814722|NCT00554606|66703312|FG000|Overall Study|Lost to Follow-up|2|||
23814723|NCT00554606|66703312|FG000|Overall Study|Administrative problems|60|||
23814724|NCT00554606|66703312|FG000|Overall Study|Death|1|||
23814725|NCT00554606|66703312|FG000|Overall Study|Protocol deviation|2|||
23814726|NCT05819203|66703313|FG000|Overall Study|Protocol Violation|1|||
23814727|NCT05819203|66703314|FG001|Overall Study|Protocol Violation|2|||
23814728|NCT05819203|66703313|FG000|Overall Study|Withdrawal by Subject|1|||
23814729|NCT05819203|66703314|FG001|Overall Study|Withdrawal by Subject|0|||
23814730|NCT01400919|66703317|FG000|Overall Study|Withdrawal by Subject|4|||
23814731|NCT01400919|66703317|FG000|Overall Study|Lost to Follow-up|2|||
23814732|NCT01400919|66703317|FG000|Overall Study|Missed visit|2|||
23814733|NCT00509366|66703324|FG000|Overall Study|Not Treated (Screen Failure)|1|||
23814734|NCT00509366|66703325|FG001|Overall Study|Not Treated (Screen Failure)|1|||
23814735|NCT00509366|66703326|FG002|Overall Study|Not Treated (Screen Failure)|1|||
23814736|NCT00509366|66703327|FG003|Overall Study|Not Treated (Screen Failure)|0|||
23814737|NCT00509366|66703328|FG004|Overall Study|Not Treated (Screen Failure)|0|||
23814738|NCT00509795|66703329|FG000|Overall Study|Adverse Event|4|||
23814739|NCT00509795|66703330|FG001|Overall Study|Adverse Event|3|||
23814740|NCT00509795|66703331|FG002|Overall Study|Adverse Event|5|||
23814741|NCT00509795|66703332|FG003|Overall Study|Adverse Event|4|||
23814742|NCT00509795|66703329|FG000|Overall Study|Death|3|||
23814743|NCT00509795|66703330|FG001|Overall Study|Death|1|||
23814744|NCT00509795|66703331|FG002|Overall Study|Death|2|||
23814745|NCT00509795|66703332|FG003|Overall Study|Death|7|||
23814746|NCT00509795|66703329|FG000|Overall Study|Lack of Efficacy|0|||
23814747|NCT00509795|66703330|FG001|Overall Study|Lack of Efficacy|0|||
23814748|NCT00509795|66703331|FG002|Overall Study|Lack of Efficacy|2|||
23814749|NCT00509795|66703332|FG003|Overall Study|Lack of Efficacy|2|||
23814750|NCT00509795|66703329|FG000|Overall Study|Lost to Follow-up|1|||
23814751|NCT00509795|66703330|FG001|Overall Study|Lost to Follow-up|2|||
23814752|NCT00509795|66703331|FG002|Overall Study|Lost to Follow-up|4|||
23814753|NCT00509795|66703332|FG003|Overall Study|Lost to Follow-up|4|||
23614187|NCT00296504|65973259|FG003|Interim Analysis|Ongoing|22|||
23614188|NCT00296504|65973260|FG004|Interim Analysis|Ongoing|0|||
23614189|NCT00296504|65973261|FG005|Interim Analysis|Ongoing|0|||
23614190|NCT00296504|65973262|FG006|Interim Analysis|Ongoing|30|||
23614191|NCT00296504|65973263|FG007|Interim Analysis|Ongoing|1|||
23614192|NCT00296504|65973264|FG008|Interim Analysis|Ongoing|0|||
23721455|NCT02574481|66359064|FG002|Overall Study|Lost to Follow-up|3|||
23721456|NCT02574481|66359065|FG003|Overall Study|Lost to Follow-up|0|||
23721457|NCT04114539|66359066|FG000|Overall Study|Adverse Event|14|||
23721458|NCT04114539|66359066|FG000|Overall Study|Lost to Follow-up|2|||
23721459|NCT04114539|66359066|FG000|Overall Study|Non-compliance with Protocol|2|||
23721460|NCT04114539|66359066|FG000|Overall Study|Non-compliance with Study Drug|1|||
23814754|NCT00509795|66703329|FG000|Overall Study|OTHER|1|||
23814755|NCT00509795|66703330|FG001|Overall Study|OTHER|0|||
23814756|NCT00509795|66703331|FG002|Overall Study|OTHER|4|||
23814757|NCT00509795|66703332|FG003|Overall Study|OTHER|1|||
23814758|NCT00509795|66703329|FG000|Overall Study|Protocol Violation|3|||
23814759|NCT00509795|66703330|FG001|Overall Study|Protocol Violation|0|||
23814760|NCT00509795|66703331|FG002|Overall Study|Protocol Violation|3|||
23721461|NCT04114539|66359066|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
23721462|NCT04114539|66359066|FG000|Overall Study|Withdrew consent|10|||
23721463|NCT04114539|66359066|FG000|Overall Study|Others not specified|5|||
23721464|NCT04114539|66359066|FG000|Overall Study|Investigator Decision|2|||
23721465|NCT00701103|66359069|FG000|Overall Study|Adverse Event|0|||
23721466|NCT00701103|66359070|FG001|Overall Study|Adverse Event|0|||
23721467|NCT00701103|66359071|FG002|Overall Study|Adverse Event|1|||
23721468|NCT00701103|66359072|FG003|Overall Study|Adverse Event|1|||
23721469|NCT00701103|66359073|FG004|Overall Study|Adverse Event|0|||
23721470|NCT00701103|66359074|FG005|Overall Study|Adverse Event|1|||
23721471|NCT00701103|66359075|FG006|Overall Study|Adverse Event|1|||
23721472|NCT00701103|66359076|FG007|Overall Study|Adverse Event|0|||
23721473|NCT00701103|66359077|FG008|Overall Study|Adverse Event|0|||
23721474|NCT00701103|66359078|FG009|Overall Study|Adverse Event|2|||
23721475|NCT00701103|66359079|FG010|Overall Study|Adverse Event|0|||
23721476|NCT00701103|66359069|FG000|Overall Study|Progressive Disease|5|||
23721477|NCT00701103|66359070|FG001|Overall Study|Progressive Disease|2|||
23721478|NCT00701103|66359071|FG002|Overall Study|Progressive Disease|6|||
23721479|NCT00701103|66359072|FG003|Overall Study|Progressive Disease|5|||
23721480|NCT00701103|66359073|FG004|Overall Study|Progressive Disease|6|||
23721481|NCT00701103|66359074|FG005|Overall Study|Progressive Disease|5|||
23721482|NCT00701103|66359075|FG006|Overall Study|Progressive Disease|7|||
23721483|NCT00701103|66359076|FG007|Overall Study|Progressive Disease|7|||
23721484|NCT00701103|66359077|FG008|Overall Study|Progressive Disease|8|||
23721485|NCT00701103|66359078|FG009|Overall Study|Progressive Disease|8|||
23721486|NCT00701103|66359079|FG010|Overall Study|Progressive Disease|11|||
23721487|NCT00701103|66359069|FG000|Overall Study|Withdrawal by Subject|0|||
23721488|NCT00701103|66359070|FG001|Overall Study|Withdrawal by Subject|1|||
23721489|NCT00701103|66359071|FG002|Overall Study|Withdrawal by Subject|1|||
23721490|NCT00701103|66359072|FG003|Overall Study|Withdrawal by Subject|0|||
23721491|NCT00701103|66359073|FG004|Overall Study|Withdrawal by Subject|0|||
23721492|NCT00701103|66359074|FG005|Overall Study|Withdrawal by Subject|0|||
23721493|NCT00701103|66359075|FG006|Overall Study|Withdrawal by Subject|0|||
23721494|NCT00701103|66359076|FG007|Overall Study|Withdrawal by Subject|0|||
23721495|NCT00701103|66359077|FG008|Overall Study|Withdrawal by Subject|0|||
23721496|NCT00701103|66359078|FG009|Overall Study|Withdrawal by Subject|0|||
23721497|NCT00701103|66359079|FG010|Overall Study|Withdrawal by Subject|0|||
23721498|NCT00701103|66359069|FG000|Overall Study|Other|0|||
23721499|NCT00701103|66359070|FG001|Overall Study|Other|0|||
23721500|NCT00701103|66359071|FG002|Overall Study|Other|0|||
23721501|NCT00701103|66359072|FG003|Overall Study|Other|0|||
23721502|NCT00701103|66359073|FG004|Overall Study|Other|0|||
23721503|NCT00701103|66359074|FG005|Overall Study|Other|0|||
23721504|NCT00701103|66359075|FG006|Overall Study|Other|0|||
23721505|NCT00701103|66359076|FG007|Overall Study|Other|0|||
23721506|NCT00701103|66359077|FG008|Overall Study|Other|1|||
23721507|NCT00701103|66359078|FG009|Overall Study|Other|1|||
23721508|NCT00701103|66359079|FG010|Overall Study|Other|0|||
23721509|NCT01998399|66359080|FG000|Overall Study|Lost to Follow-up|1|||
23721510|NCT01998399|66359081|FG001|Overall Study|Lost to Follow-up|3|||
23721511|NCT01998399|66359080|FG000|Overall Study|Death|4|||
23721512|NCT01998399|66359081|FG001|Overall Study|Death|2|||
23721513|NCT01998399|66359080|FG000|Overall Study|Study stopped before dosing completed|3|||
23721514|NCT01998399|66359081|FG001|Overall Study|Study stopped before dosing completed|3|||
23421153|NCT03224507|65283966|FG001|Overall Study|Death|0|||
23421154|NCT03224507|65283965|FG000|Overall Study|Lack of Efficacy|6|||
23421155|NCT03224507|65283966|FG001|Overall Study|Lack of Efficacy|0|||
23421156|NCT03224507|65283965|FG000|Overall Study|Withdrawal by Subject|6|||
23421157|NCT03224507|65283966|FG001|Overall Study|Withdrawal by Subject|0|||
23721515|NCT01998399|66359080|FG000|Overall Study|Withdrawal by Subject|0|||
23721516|NCT01998399|66359081|FG001|Overall Study|Withdrawal by Subject|1|||
23721517|NCT02306161|66359082|FG000|Overall Study|Death|1|||
23721518|NCT02306161|66359083|FG001|Overall Study|Death|3|||
23721519|NCT02306161|66359082|FG000|Overall Study|Lack of Efficacy|20|||
23721520|NCT02306161|66359083|FG001|Overall Study|Lack of Efficacy|43|||
23721521|NCT02306161|66359082|FG000|Overall Study|Physician Decision|30|||
23721522|NCT02306161|66359083|FG001|Overall Study|Physician Decision|18|||
23814761|NCT00509795|66703332|FG003|Overall Study|Protocol Violation|1|||
23421158|NCT04240457|65283967|FG000|Overall Study|Lost to Follow-up|5|||
23421159|NCT04240457|65283968|FG001|Overall Study|Lost to Follow-up|1|||
23421160|NCT05275010|65283969|FG000|Overall Study|Reason Not Specified|4|||
23532589|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532590|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
23532591|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532592|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532593|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532594|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532595|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532596|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532597|NCT01479621|65683340|FG000|Treatment Period|Adverse Event|0|||
23532598|NCT01479621|65683341|FG001|Treatment Period|Adverse Event|0|||
23532599|NCT01479621|65683342|FG002|Treatment Period|Adverse Event|0|||
23532600|NCT01479621|65683343|FG003|Treatment Period|Adverse Event|0|||
23532601|NCT01479621|65683344|FG004|Treatment Period|Adverse Event|1|||
23614193|NCT00296504|65973256|FG000|Final Analysis|Withdrawal by Subject|0|||
23614194|NCT00296504|65973257|FG001|Final Analysis|Withdrawal by Subject|0|||
23721523|NCT02306161|66359082|FG000|Overall Study|Withdrawal by Subject|4|||
23532602|NCT01479621|65683345|FG005|Treatment Period|Adverse Event|2|||
23721524|NCT02306161|66359083|FG001|Overall Study|Withdrawal by Subject|0|||
23721525|NCT02306161|66359082|FG000|Overall Study|Ineligible|9|||
23721526|NCT02306161|66359083|FG001|Overall Study|Ineligible|5|||
23721527|NCT00323310|66359084|FG000|Overall Study|Withdrawal by Subject|1|||
23721528|NCT00323310|66359084|FG000|Overall Study|a parent refused blood draw|1|||
23721529|NCT00323310|66359084|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
23721530|NCT02988219|66359085|FG000|Overall Study|Lack of Efficacy|1|||
23614195|NCT00296504|65973258|FG002|Final Analysis|Withdrawal by Subject|0|||
23721531|NCT02988219|66359086|FG001|Overall Study|Lack of Efficacy|1|||
23721532|NCT02988219|66359085|FG000|Overall Study|Withdrawal by Subject|0|||
23721533|NCT02988219|66359086|FG001|Overall Study|Withdrawal by Subject|2|||
23721534|NCT01373918|66359087|FG000|Overall Study|Physician Decision|0|||
23721535|NCT01373918|66359088|FG001|Overall Study|Physician Decision|1|||
23721536|NCT03170258|66359089|FG000|Overall Study|Physician Decision|4|||
23721537|NCT03170258|66359090|FG001|Overall Study|Physician Decision|0|||
23721538|NCT03170258|66359089|FG000|Overall Study|Equipment issues|1|||
23721539|NCT03170258|66359090|FG001|Overall Study|Equipment issues|0|||
23721540|NCT03170258|66359089|FG000|Overall Study|Medication|1|||
23721541|NCT03170258|66359090|FG001|Overall Study|Medication|0|||
23721542|NCT03170258|66359089|FG000|Overall Study|Sleep issues|1|||
23721543|NCT03170258|66359090|FG001|Overall Study|Sleep issues|0|||
23721544|NCT04186663|66359098|FG000|Overall Study|Lost to Follow-up|1|||
23721545|NCT04186663|66359098|FG000|Overall Study|Unable to complete blood draw|3|||
23721546|NCT00651313|66359099|FG000|Overall Study|Adverse Event|0|||
23721547|NCT00651313|66359100|FG001|Overall Study|Adverse Event|1|||
23721548|NCT00651313|66359099|FG000|Overall Study|Withdrawal by Subject|3|||
23721549|NCT00651313|66359100|FG001|Overall Study|Withdrawal by Subject|1|||
23721550|NCT00651313|66359099|FG000|Overall Study|Lost to Follow-up|1|||
23721551|NCT00651313|66359100|FG001|Overall Study|Lost to Follow-up|1|||
23421161|NCT05275010|65283970|FG001|Overall Study|Reason Not Specified|1|||
23421162|NCT05275010|65283969|FG000|Overall Study|Withdrawal by Subject|1|||
23421163|NCT05275010|65283970|FG001|Overall Study|Withdrawal by Subject|0|||
23421164|NCT05275010|65283969|FG000|Overall Study|Lost to Follow-up|0|||
23421165|NCT05275010|65283970|FG001|Overall Study|Lost to Follow-up|1|||
23421166|NCT00782171|65283971|FG000|Overall Study|Lost to Follow-up|2|||
23421167|NCT00782171|65283972|FG001|Overall Study|Lost to Follow-up|2|||
23421168|NCT00782171|65283971|FG000|Overall Study|Withdrawal by Subject|2|||
23421169|NCT00782171|65283972|FG001|Overall Study|Withdrawal by Subject|1|||
23421170|NCT00782171|65283971|FG000|Overall Study|complications|3|||
23421171|NCT00782171|65283972|FG001|Overall Study|complications|1|||
23421172|NCT00782171|65283971|FG000|Overall Study|others|7|||
23421173|NCT00782171|65283972|FG001|Overall Study|others|9|||
23421174|NCT00782171|65283971|FG000|Overall Study|not eligible|8|||
23421175|NCT00782171|65283972|FG001|Overall Study|not eligible|6|||
23421176|NCT04096820|65283973|FG000|Overall Study|Did not return for intervention|2|||
23421177|NCT04096820|65283973|FG000|Overall Study|Death|1|||
23421178|NCT00884039|65283975|FG000|Overall Study|Withdrawal by Subject|0|||
23421179|NCT00884039|65283976|FG001|Overall Study|Withdrawal by Subject|1|||
23421180|NCT00884039|65283975|FG000|Overall Study|Lack of Efficacy|2|||
23421181|NCT00884039|65283976|FG001|Overall Study|Lack of Efficacy|0|||
23421182|NCT00096174|65283977|FG000|Overall Study|Lack of Efficacy|9|||
23421183|NCT00096174|65283977|FG000|Overall Study|Adverse Event|15|||
23421184|NCT00096174|65283977|FG000|Overall Study|Death|6|||
23421185|NCT00096174|65283977|FG000|Overall Study|Withdrawal by Subject|15|||
23421186|NCT00096174|65283977|FG000|Overall Study|Not started protocol therapy|3|||
23421187|NCT00096174|65283977|FG000|Overall Study|Ineligible|6|||
23421188|NCT00096174|65283977|FG000|Overall Study|other reason|8|||
23421189|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
23421190|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421191|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421192|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421193|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
23421194|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
23421195|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
23421196|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
23421197|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
23421198|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
23421199|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
23421200|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
23421201|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
23421202|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
23421203|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
23421204|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
23532603|NCT01479621|65683346|FG006|Treatment Period|Adverse Event|2|||
23421205|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23421206|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
23532604|NCT01479621|65683340|FG000|Treatment Period|Withdrawal by Subject|0|||
23532605|NCT01479621|65683341|FG001|Treatment Period|Withdrawal by Subject|4|||
23721552|NCT00651313|66359099|FG000|Overall Study|Adminstrative Discontinuation|2|||
23421207|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23532606|NCT01479621|65683342|FG002|Treatment Period|Withdrawal by Subject|2|||
23721553|NCT00651313|66359100|FG001|Overall Study|Adminstrative Discontinuation|3|||
23721554|NCT00810810|66359103|FG000|Overall Study|Withdrawal by Subject|0|||
23721555|NCT00810810|66359104|FG001|Overall Study|Withdrawal by Subject|8|||
23721556|NCT00810810|66359105|FG002|Overall Study|Withdrawal by Subject|10|||
23721557|NCT00810810|66359106|FG003|Overall Study|Withdrawal by Subject|8|||
23721558|NCT00810810|66359103|FG000|Overall Study|Physician Decision|0|||
23721559|NCT00810810|66359104|FG001|Overall Study|Physician Decision|3|||
23721560|NCT00810810|66359105|FG002|Overall Study|Physician Decision|1|||
23721561|NCT00810810|66359106|FG003|Overall Study|Physician Decision|5|||
23721562|NCT01938001|66359107|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
23721563|NCT01938001|66359108|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
23721564|NCT01938001|66359107|FG000|Pre-Treatment|Death|1|||
23721565|NCT01938001|66359108|FG001|Pre-Treatment|Death|0|||
23721566|NCT01938001|66359107|FG000|Treatment|Death|2|||
23721567|NCT01938001|66359108|FG001|Treatment|Death|0|||
23721568|NCT01938001|66359107|FG000|Treatment|Adverse Event|14|||
23721569|NCT01938001|66359108|FG001|Treatment|Adverse Event|8|||
23721570|NCT01938001|66359107|FG000|Treatment|Progressive Disease|21|||
23721571|NCT01938001|66359108|FG001|Treatment|Progressive Disease|54|||
23721572|NCT01938001|66359107|FG000|Treatment|Withdrawal by Subject|13|||
23721573|NCT01938001|66359108|FG001|Treatment|Withdrawal by Subject|7|||
23721574|NCT01938001|66359107|FG000|Treatment|Other reasons|2|||
23532607|NCT01479621|65683343|FG003|Treatment Period|Withdrawal by Subject|2|||
23532608|NCT01479621|65683344|FG004|Treatment Period|Withdrawal by Subject|5|||
23532609|NCT01479621|65683345|FG005|Treatment Period|Withdrawal by Subject|5|||
23532610|NCT01479621|65683346|FG006|Treatment Period|Withdrawal by Subject|1|||
23532611|NCT01479621|65683340|FG000|Treatment Period|Physician Decision|0|||
23721575|NCT01938001|66359108|FG001|Treatment|Other reasons|1|||
23721576|NCT00517413|66359113|FG000|Overall Study|Adverse Event|7|||
23721577|NCT00517413|66359113|FG000|Overall Study|Death|13|||
23721578|NCT00517413|66359113|FG000|Overall Study|Protocol Violation|15|||
23721579|NCT00517413|66359113|FG000|Overall Study|Withdrawal by Subject|2|||
23721580|NCT00517413|66359113|FG000|Overall Study|Failure to return|1|||
23721581|NCT00517413|66359113|FG000|Overall Study|Other-Reasons|23|||
23721582|NCT03332303|66359114|FG000|Overall Study|Participant did not dose|1|||
23721583|NCT03332303|66359115|FG001|Overall Study|Participant did not dose|2|||
23721584|NCT03332303|66359116|FG002|Overall Study|Participant did not dose|0|||
23721585|NCT03332303|66359114|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
23721586|NCT03332303|66359115|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
23532612|NCT01479621|65683341|FG001|Treatment Period|Physician Decision|0|||
23532613|NCT01479621|65683342|FG002|Treatment Period|Physician Decision|0|||
23532614|NCT01479621|65683343|FG003|Treatment Period|Physician Decision|0|||
23532615|NCT01479621|65683344|FG004|Treatment Period|Physician Decision|1|||
23532616|NCT01479621|65683345|FG005|Treatment Period|Physician Decision|1|||
23614196|NCT00296504|65973259|FG003|Final Analysis|Withdrawal by Subject|0|||
23532617|NCT01479621|65683346|FG006|Treatment Period|Physician Decision|0|||
23532618|NCT01479621|65683340|FG000|Treatment Period|Non-compliance to study drug|0|||
23532619|NCT01479621|65683341|FG001|Treatment Period|Non-compliance to study drug|1|||
23532620|NCT01479621|65683342|FG002|Treatment Period|Non-compliance to study drug|0|||
23532621|NCT01479621|65683343|FG003|Treatment Period|Non-compliance to study drug|0|||
23532622|NCT01479621|65683344|FG004|Treatment Period|Non-compliance to study drug|0|||
23532623|NCT01479621|65683345|FG005|Treatment Period|Non-compliance to study drug|0|||
23532624|NCT01479621|65683346|FG006|Treatment Period|Non-compliance to study drug|1|||
23532625|NCT01479621|65683340|FG000|Treatment Period|Protocol Violation|0|||
23532626|NCT01479621|65683341|FG001|Treatment Period|Protocol Violation|9|||
23532627|NCT01479621|65683342|FG002|Treatment Period|Protocol Violation|6|||
23532628|NCT01479621|65683343|FG003|Treatment Period|Protocol Violation|5|||
23532629|NCT01479621|65683344|FG004|Treatment Period|Protocol Violation|2|||
23532630|NCT01479621|65683345|FG005|Treatment Period|Protocol Violation|10|||
23532631|NCT01479621|65683346|FG006|Treatment Period|Protocol Violation|6|||
23532632|NCT01479621|65683340|FG000|Treatment Period|Pregnancy|0|||
23532633|NCT01479621|65683341|FG001|Treatment Period|Pregnancy|0|||
23532634|NCT01479621|65683342|FG002|Treatment Period|Pregnancy|2|||
23532635|NCT01479621|65683343|FG003|Treatment Period|Pregnancy|0|||
23532636|NCT01479621|65683344|FG004|Treatment Period|Pregnancy|0|||
23532637|NCT01479621|65683345|FG005|Treatment Period|Pregnancy|0|||
23532638|NCT01479621|65683346|FG006|Treatment Period|Pregnancy|0|||
23532639|NCT01479621|65683340|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
23721587|NCT03332303|66359116|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
23721588|NCT03332303|66359114|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
23721589|NCT03332303|66359115|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
23721590|NCT03332303|66359116|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
23721591|NCT03332303|66359114|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
23721592|NCT03332303|66359115|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
23721593|NCT03332303|66359116|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
23721594|NCT03332303|66359114|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
23721595|NCT03332303|66359115|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
23721596|NCT03332303|66359116|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
23532640|NCT01479621|65683341|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
23721597|NCT03332303|66359114|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
23721598|NCT03332303|66359115|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
23721599|NCT03332303|66359116|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
23721600|NCT03332303|66359114|FG000|Overall Study|Participant had a significant protocol deviation|0|||
23721601|NCT03332303|66359115|FG001|Overall Study|Participant had a significant protocol deviation|1|||
23721602|NCT03332303|66359116|FG002|Overall Study|Participant had a significant protocol deviation|0|||
23721603|NCT01149343|66359117|FG000|Overall Study|Withdrawal by Subject|1|||
23721604|NCT01149343|66359118|FG001|Overall Study|Withdrawal by Subject|1|||
23721605|NCT01149343|66359119|FG002|Overall Study|Withdrawal by Subject|1|||
23721606|NCT01149343|66359120|FG003|Overall Study|Withdrawal by Subject|5|||
23721607|NCT01149343|66359117|FG000|Overall Study|Death|10|||
23721608|NCT01149343|66359118|FG001|Overall Study|Death|13|||
23721609|NCT01149343|66359119|FG002|Overall Study|Death|18|||
23721610|NCT01149343|66359120|FG003|Overall Study|Death|18|||
23721611|NCT01149343|66359117|FG000|Overall Study|Lost to Follow-up|1|||
23721612|NCT01149343|66359118|FG001|Overall Study|Lost to Follow-up|0|||
23421208|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23421209|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
23421210|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
23421211|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
23421212|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
23421213|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23614197|NCT00296504|65973260|FG004|Final Analysis|Withdrawal by Subject|0|||
23421214|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23421215|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
23421216|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23532641|NCT01479621|65683342|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
23532642|NCT01479621|65683343|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532643|NCT01479621|65683344|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532644|NCT01479621|65683345|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532645|NCT01479621|65683346|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
23532646|NCT01479621|65683340|FG000|Treatment Period|Lost to Follow-up|0|||
23532647|NCT01479621|65683341|FG001|Treatment Period|Lost to Follow-up|0|||
23532648|NCT01479621|65683342|FG002|Treatment Period|Lost to Follow-up|1|||
23532649|NCT01479621|65683343|FG003|Treatment Period|Lost to Follow-up|0|||
23532650|NCT01479621|65683344|FG004|Treatment Period|Lost to Follow-up|2|||
23532651|NCT01479621|65683345|FG005|Treatment Period|Lost to Follow-up|2|||
23532652|NCT01479621|65683346|FG006|Treatment Period|Lost to Follow-up|1|||
23532653|NCT01479621|65683340|FG000|Treatment Period|Met stopping criteria|0|||
23532654|NCT01479621|65683341|FG001|Treatment Period|Met stopping criteria|8|||
23532655|NCT01479621|65683342|FG002|Treatment Period|Met stopping criteria|7|||
23532656|NCT01479621|65683343|FG003|Treatment Period|Met stopping criteria|4|||
23532657|NCT01479621|65683344|FG004|Treatment Period|Met stopping criteria|9|||
23532658|NCT01479621|65683345|FG005|Treatment Period|Met stopping criteria|20|||
23532659|NCT01479621|65683346|FG006|Treatment Period|Met stopping criteria|6|||
23532660|NCT03265119|65683349|FG000|Overall Study|Adverse Event|2|||
23532661|NCT03265119|65683350|FG001|Overall Study|Adverse Event|1|||
23532662|NCT03265119|65683349|FG000|Overall Study|Lack of Efficacy|3|||
23614198|NCT00296504|65973261|FG005|Final Analysis|Withdrawal by Subject|0|||
23421217|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
23421218|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
23421219|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
23421220|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
23421221|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
23421222|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
23421223|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
23421224|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
23421225|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
23421226|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
23421227|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
23421228|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
23421229|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
23421230|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
23421231|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
23421232|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
23421233|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23532663|NCT03265119|65683350|FG001|Overall Study|Lack of Efficacy|0|||
23532664|NCT03265119|65683349|FG000|Overall Study|Protocol Violation|1|||
23532665|NCT03265119|65683350|FG001|Overall Study|Protocol Violation|2|||
23721613|NCT01149343|66359119|FG002|Overall Study|Lost to Follow-up|0|||
23721614|NCT01149343|66359120|FG003|Overall Study|Lost to Follow-up|1|||
23721615|NCT01149343|66359117|FG000|Overall Study|Other|8|||
23721616|NCT01149343|66359118|FG001|Overall Study|Other|10|||
23721617|NCT01149343|66359119|FG002|Overall Study|Other|2|||
23532666|NCT03265119|65683349|FG000|Overall Study|Withdrawal by Subject|2|||
23532667|NCT03265119|65683350|FG001|Overall Study|Withdrawal by Subject|4|||
23614199|NCT00296504|65973262|FG006|Final Analysis|Withdrawal by Subject|0|||
23614200|NCT00296504|65973263|FG007|Final Analysis|Withdrawal by Subject|0|||
23614201|NCT00296504|65973264|FG008|Final Analysis|Withdrawal by Subject|1|||
23614202|NCT00296504|65973256|FG000|Final Analysis|Lost to Follow-up|0|||
23614203|NCT00296504|65973257|FG001|Final Analysis|Lost to Follow-up|0|||
23614204|NCT00296504|65973258|FG002|Final Analysis|Lost to Follow-up|0|||
23614205|NCT00296504|65973259|FG003|Final Analysis|Lost to Follow-up|0|||
23614206|NCT00296504|65973260|FG004|Final Analysis|Lost to Follow-up|0|||
23614207|NCT00296504|65973261|FG005|Final Analysis|Lost to Follow-up|0|||
23614208|NCT00296504|65973262|FG006|Final Analysis|Lost to Follow-up|0|||
23614209|NCT00296504|65973263|FG007|Final Analysis|Lost to Follow-up|0|||
23614210|NCT00296504|65973264|FG008|Final Analysis|Lost to Follow-up|5|||
23614211|NCT00296504|65973256|FG000|Final Analysis|Insufficient Viral Load Response|0|||
23614212|NCT00296504|65973257|FG001|Final Analysis|Insufficient Viral Load Response|0|||
23614213|NCT00296504|65973258|FG002|Final Analysis|Insufficient Viral Load Response|0|||
23814762|NCT00509795|66703329|FG000|Overall Study|Withdrawal by Subject|10|||
23814763|NCT00509795|66703330|FG001|Overall Study|Withdrawal by Subject|5|||
23814764|NCT00509795|66703331|FG002|Overall Study|Withdrawal by Subject|7|||
23814765|NCT00509795|66703332|FG003|Overall Study|Withdrawal by Subject|8|||
23814766|NCT03371459|66703335|FG000|Washout|Lost to Follow-up|0|||
23814767|NCT03371459|66703336|FG001|Washout|Lost to Follow-up|1|||
23814768|NCT00351533|66703341|FG000|Overall Study|Extubated before first BAL|1|||
23814769|NCT00351533|66703342|FG001|Overall Study|Extubated before first BAL|0|||
23814770|NCT00351533|66703341|FG000|Overall Study|Lost to Follow-up|1|||
23814771|NCT00351533|66703342|FG001|Overall Study|Lost to Follow-up|3|||
23814772|NCT00351533|66703341|FG000|Overall Study|Physician Decision|0|||
23814773|NCT00351533|66703342|FG001|Overall Study|Physician Decision|1|||
23814774|NCT00351533|66703341|FG000|Overall Study|Withdrawal by Subject|0|||
23814775|NCT00351533|66703342|FG001|Overall Study|Withdrawal by Subject|1|||
23814776|NCT03200912|66703351|FG000|Overall Study|Adverse Event|3|||
23814777|NCT03200912|66703352|FG001|Overall Study|Adverse Event|0|||
23814778|NCT03200912|66703353|FG002|Overall Study|Adverse Event|0|||
23814779|NCT03200912|66703351|FG000|Overall Study|Withdrawal by Subject|1|||
23814780|NCT03200912|66703352|FG001|Overall Study|Withdrawal by Subject|2|||
23814781|NCT03200912|66703353|FG002|Overall Study|Withdrawal by Subject|4|||
23814782|NCT03200912|66703351|FG000|Overall Study|Non-compliance with study drug|0|||
23814783|NCT03200912|66703352|FG001|Overall Study|Non-compliance with study drug|1|||
23814784|NCT03200912|66703353|FG002|Overall Study|Non-compliance with study drug|0|||
23814785|NCT00416884|66703355|FG000|Overall Study|Study terminated due to low accrual|1|||
23814786|NCT01468818|66703356|FG000|Overall Study|Death during treatment|2|||
23814787|NCT04502212|66703357|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
23532668|NCT03265119|65683349|FG000|Overall Study|Lost to Follow-up|1|||
23532669|NCT03265119|65683350|FG001|Overall Study|Lost to Follow-up|0|||
23532670|NCT03265119|65683349|FG000|Overall Study|Lack of Compliance|1|||
23532671|NCT03265119|65683350|FG001|Overall Study|Lack of Compliance|0|||
23532672|NCT02130765|65683351|FG000|Overall Study|Did not receive treatment|4|||
23532673|NCT02130765|65683352|FG001|Overall Study|Did not receive treatment|0|||
23532674|NCT02130765|65683353|FG002|Overall Study|Did not receive treatment|0|||
23532675|NCT02130765|65683354|FG003|Overall Study|Did not receive treatment|0|||
23532676|NCT01234467|65683355|FG000|Overall Study|Adverse Event|3|||
23614214|NCT00296504|65973259|FG003|Final Analysis|Insufficient Viral Load Response|0|||
23614215|NCT00296504|65973260|FG004|Final Analysis|Insufficient Viral Load Response|0|||
23614216|NCT00296504|65973261|FG005|Final Analysis|Insufficient Viral Load Response|0|||
23614217|NCT00296504|65973262|FG006|Final Analysis|Insufficient Viral Load Response|0|||
23814788|NCT04502212|66703357|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
23814789|NCT04305587|66703358|FG000|Overall Study|Withdrawal by Subject|0|||
23532677|NCT01234467|65683355|FG000|Overall Study|Death|2|||
23532678|NCT01234467|65683355|FG000|Overall Study|Withdrawal by Subject|2|||
23532679|NCT01234467|65683355|FG000|Overall Study|Disease Progression|2|||
23532680|NCT01234467|65683355|FG000|Overall Study|Clinical deterioration|1|||
23532681|NCT01234467|65683355|FG000|Overall Study|Physician Decision|1|||
23532682|NCT01234467|65683355|FG000|Overall Study|Other complicating disease (stroke)|1|||
23814790|NCT04305587|66703359|FG001|Overall Study|Withdrawal by Subject|0|||
23814791|NCT04305587|66703360|FG002|Overall Study|Withdrawal by Subject|0|||
23814792|NCT04305587|66703361|FG003|Overall Study|Withdrawal by Subject|1|||
23814793|NCT04305587|66703362|FG004|Overall Study|Withdrawal by Subject|0|||
23532683|NCT00767676|65683358|FG000|Overall Study|Investigator error|54|||
23532684|NCT04122443|65683359|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
23532685|NCT04122443|65683360|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
23614218|NCT00296504|65973263|FG007|Final Analysis|Insufficient Viral Load Response|0|||
23614219|NCT00296504|65973264|FG008|Final Analysis|Insufficient Viral Load Response|6|||
23614220|NCT00296504|65973256|FG000|Final Analysis|Adverse Event|0|||
23532686|NCT04122443|65683361|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
23532687|NCT04122443|65683359|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
23532688|NCT04122443|65683360|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
23532689|NCT04122443|65683361|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
23532690|NCT00826267|65683362|FG000|Overall Study|Other Adverse Event|1|||
23532691|NCT00826267|65683363|FG001|Overall Study|Other Adverse Event|0|||
23532692|NCT00826267|65683364|FG002|Overall Study|Other Adverse Event|0|||
23532693|NCT02871375|65683365|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
23532694|NCT02871375|65683366|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
23532695|NCT01714310|65683367|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
23532696|NCT01714310|65683368|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
23532697|NCT01714310|65683369|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
23532698|NCT01714310|65683367|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
23532699|NCT01714310|65683368|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
23532700|NCT01714310|65683369|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
23532701|NCT01714310|65683367|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
23532702|NCT01714310|65683368|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
23532703|NCT01714310|65683369|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
23532704|NCT01714310|65683367|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
23532705|NCT01714310|65683368|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
23532706|NCT01714310|65683369|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
23532707|NCT02880371|65683372|FG000|Phase 1b|Lost to Follow-up|1|||
23421234|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23421235|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
23421236|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23421237|NCT00489424|65283990|FG000|Overall Study|Adverse Event|3|||
23421238|NCT00489424|65283991|FG001|Overall Study|Adverse Event|3|||
23421239|NCT00489424|65283992|FG002|Overall Study|Adverse Event|4|||
23421240|NCT00489424|65283990|FG000|Overall Study|Lack of Efficacy|1|||
23421241|NCT00489424|65283991|FG001|Overall Study|Lack of Efficacy|0|||
23421242|NCT00489424|65283992|FG002|Overall Study|Lack of Efficacy|0|||
23421243|NCT00489424|65283990|FG000|Overall Study|Administrative problems|0|||
23421244|NCT00489424|65283991|FG001|Overall Study|Administrative problems|2|||
23421245|NCT00489424|65283992|FG002|Overall Study|Administrative problems|1|||
23421246|NCT02310230|65283993|FG000|Overall Study|Physician Decision|1|||
23421247|NCT02310230|65283994|FG001|Overall Study|Physician Decision|3|||
23421248|NCT02310230|65283993|FG000|Overall Study|monitor baseline taken after induction|2|||
23421249|NCT02310230|65283994|FG001|Overall Study|monitor baseline taken after induction|7|||
23421250|NCT02310230|65283993|FG000|Overall Study|Poor signal quality|5|||
23421251|NCT02310230|65283994|FG001|Overall Study|Poor signal quality|8|||
23421252|NCT02310230|65283993|FG000|Overall Study|Case cancelled|1|||
23421253|NCT02310230|65283994|FG001|Overall Study|Case cancelled|0|||
23421254|NCT02220855|65283995|FG000|Overall Study|Adverse Event|8|||
23421255|NCT02220855|65283995|FG000|Overall Study|Disease Progression|5|||
23421256|NCT02220855|65283995|FG000|Overall Study|Withdrawal by Subject|1|||
23421257|NCT01468207|65283996|FG000|Treatment Period 1|Adverse Event|1|||
23421258|NCT01468207|65283997|FG001|Treatment Period 1|Adverse Event|0|||
23421259|NCT01468207|65283998|FG002|Treatment Period 1|Adverse Event|0|||
23421260|NCT01468207|65283999|FG003|Treatment Period 1|Adverse Event|0|||
23421261|NCT01468207|65284000|FG004|Treatment Period 1|Adverse Event|0|||
23421262|NCT01468207|65284001|FG005|Treatment Period 1|Adverse Event|0|||
23421263|NCT01468207|65283996|FG000|Treatment Period 1|Protocol Violation|1|||
23421264|NCT01468207|65283997|FG001|Treatment Period 1|Protocol Violation|1|||
23421265|NCT01468207|65283998|FG002|Treatment Period 1|Protocol Violation|0|||
23421266|NCT01468207|65283999|FG003|Treatment Period 1|Protocol Violation|0|||
23421267|NCT01468207|65284000|FG004|Treatment Period 1|Protocol Violation|0|||
23421268|NCT01468207|65284001|FG005|Treatment Period 1|Protocol Violation|0|||
23421269|NCT01468207|65283996|FG000|Treatment Period 1|Withdrawal by Subject|5|||
23421270|NCT01468207|65283997|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23421271|NCT01468207|65283998|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23421272|NCT01468207|65283999|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23421273|NCT01468207|65284000|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23421274|NCT01468207|65284001|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23421275|NCT01468207|65283996|FG000|Treatment Period 1|Lost to Follow-up|2|||
23532708|NCT02880371|65683373|FG001|Phase 1b|Lost to Follow-up|0|||
23532709|NCT02880371|65683374|FG002|Phase 1b|Lost to Follow-up|0|||
23421276|NCT01468207|65283997|FG001|Treatment Period 1|Lost to Follow-up|1|||
23421277|NCT01468207|65283998|FG002|Treatment Period 1|Lost to Follow-up|0|||
23421278|NCT01468207|65283999|FG003|Treatment Period 1|Lost to Follow-up|0|||
23421279|NCT01468207|65284000|FG004|Treatment Period 1|Lost to Follow-up|0|||
23421280|NCT01468207|65284001|FG005|Treatment Period 1|Lost to Follow-up|0|||
23421281|NCT01468207|65283996|FG000|Treatment Period 1|Other|0|||
23421282|NCT01468207|65283997|FG001|Treatment Period 1|Other|2|||
23421283|NCT01468207|65283998|FG002|Treatment Period 1|Other|0|||
23614221|NCT00296504|65973257|FG001|Final Analysis|Adverse Event|0|||
23614222|NCT00296504|65973258|FG002|Final Analysis|Adverse Event|0|||
23614223|NCT00296504|65973259|FG003|Final Analysis|Adverse Event|0|||
23614224|NCT00296504|65973260|FG004|Final Analysis|Adverse Event|0|||
23614225|NCT00296504|65973261|FG005|Final Analysis|Adverse Event|0|||
23614226|NCT00296504|65973262|FG006|Final Analysis|Adverse Event|0|||
23532710|NCT02880371|65683375|FG003|Phase 1b|Lost to Follow-up|0|||
23532711|NCT02880371|65683376|FG004|Phase 1b|Lost to Follow-up|0|||
23532712|NCT02880371|65683377|FG005|Phase 1b|Lost to Follow-up|0|||
23532713|NCT02880371|65683378|FG006|Phase 1b|Lost to Follow-up|0|||
23532714|NCT02880371|65683379|FG007|Phase 1b|Lost to Follow-up|0|||
23532715|NCT02880371|65683372|FG000|Phase 1b|Participants terminated by Sponsor|1|||
23532716|NCT02880371|65683373|FG001|Phase 1b|Participants terminated by Sponsor|0|||
23532717|NCT02880371|65683374|FG002|Phase 1b|Participants terminated by Sponsor|0|||
23532718|NCT02880371|65683375|FG003|Phase 1b|Participants terminated by Sponsor|0|||
23532719|NCT02880371|65683376|FG004|Phase 1b|Participants terminated by Sponsor|0|||
23532720|NCT02880371|65683377|FG005|Phase 1b|Participants terminated by Sponsor|0|||
23532721|NCT02880371|65683378|FG006|Phase 1b|Participants terminated by Sponsor|0|||
23532722|NCT02880371|65683379|FG007|Phase 1b|Participants terminated by Sponsor|0|||
23532723|NCT02880371|65683372|FG000|Phase 1b|Withdrawal by Subject|0|||
23532724|NCT02880371|65683373|FG001|Phase 1b|Withdrawal by Subject|0|||
23532725|NCT02880371|65683374|FG002|Phase 1b|Withdrawal by Subject|1|||
23532726|NCT02880371|65683375|FG003|Phase 1b|Withdrawal by Subject|0|||
23532727|NCT02880371|65683376|FG004|Phase 1b|Withdrawal by Subject|0|||
23532728|NCT02880371|65683377|FG005|Phase 1b|Withdrawal by Subject|0|||
23532729|NCT02880371|65683378|FG006|Phase 1b|Withdrawal by Subject|0|||
23532730|NCT02880371|65683379|FG007|Phase 1b|Withdrawal by Subject|0|||
23532731|NCT02880371|65683372|FG000|Phase 1b|Death|4|||
23532732|NCT02880371|65683373|FG001|Phase 1b|Death|6|||
23532733|NCT02880371|65683374|FG002|Phase 1b|Death|5|||
23614227|NCT00296504|65973263|FG007|Final Analysis|Adverse Event|0|||
23814794|NCT04305587|66703363|FG005|Overall Study|Withdrawal by Subject|0|||
23814795|NCT04305587|66703364|FG006|Overall Study|Withdrawal by Subject|0|||
23814796|NCT04305587|66703365|FG007|Overall Study|Withdrawal by Subject|0|||
23814797|NCT04305587|66703366|FG008|Overall Study|Withdrawal by Subject|0|||
23814798|NCT02099682|66703367|FG000|Overall Study|Data Not Available|51|||
23532734|NCT02880371|65683375|FG003|Phase 1b|Death|1|||
23532735|NCT02880371|65683376|FG004|Phase 1b|Death|0|||
23532736|NCT02880371|65683377|FG005|Phase 1b|Death|0|||
23532737|NCT02880371|65683378|FG006|Phase 1b|Death|0|||
23532738|NCT02880371|65683379|FG007|Phase 1b|Death|0|||
23532739|NCT02880371|65683372|FG000|Phase 1b|Enrolled but not Treated|0|||
23532740|NCT02880371|65683373|FG001|Phase 1b|Enrolled but not Treated|1|||
23532741|NCT02880371|65683374|FG002|Phase 1b|Enrolled but not Treated|0|||
23532742|NCT02880371|65683375|FG003|Phase 1b|Enrolled but not Treated|0|||
23814799|NCT02099682|66703367|FG000|Overall Study|Lost to Follow-up|31|||
23814800|NCT02099682|66703367|FG000|Overall Study|Other|29|||
23814801|NCT01683838|66703368|FG000|Overall Study|Adverse Event|12|||
23532743|NCT02880371|65683376|FG004|Phase 1b|Enrolled but not Treated|0|||
23532744|NCT02880371|65683377|FG005|Phase 1b|Enrolled but not Treated|0|||
23532745|NCT02880371|65683378|FG006|Phase 1b|Enrolled but not Treated|0|||
23614228|NCT00296504|65973264|FG008|Final Analysis|Adverse Event|2|||
23614229|NCT00296504|65973256|FG000|Final Analysis|Pregnancy|0|||
23814802|NCT01683838|66703369|FG001|Overall Study|Adverse Event|2|||
23814803|NCT01683838|66703368|FG000|Overall Study|Protocol Violation|3|||
23814804|NCT01683838|66703369|FG001|Overall Study|Protocol Violation|1|||
23814805|NCT01683838|66703368|FG000|Overall Study|Withdrawal by Subject|6|||
23814806|NCT01683838|66703369|FG001|Overall Study|Withdrawal by Subject|5|||
23814807|NCT01683838|66703368|FG000|Overall Study|Lost to Follow-up|1|||
23814808|NCT01683838|66703369|FG001|Overall Study|Lost to Follow-up|1|||
23814809|NCT01683838|66703368|FG000|Overall Study|Other|4|||
23814810|NCT01683838|66703369|FG001|Overall Study|Other|3|||
23814811|NCT03151811|66703370|FG000|Overall Study|Randomized But Not Treated|18|||
23814812|NCT03151811|66703371|FG001|Overall Study|Randomized But Not Treated|3|||
23421284|NCT01468207|65283999|FG003|Treatment Period 1|Other|0|||
23532746|NCT02880371|65683379|FG007|Phase 1b|Enrolled but not Treated|0|||
23814813|NCT03151811|66703370|FG000|Overall Study|Progressive Disease|130|||
23814814|NCT03151811|66703371|FG001|Overall Study|Progressive Disease|170|||
23814815|NCT03151811|66703370|FG000|Overall Study|Adverse Event|49|||
23532747|NCT02880371|65683372|FG000|Phase 2|Enrolled but not Treated|0|||
23532748|NCT02880371|65683373|FG001|Phase 2|Enrolled but not Treated|0|||
23532749|NCT02880371|65683374|FG002|Phase 2|Enrolled but not Treated|0|||
23532750|NCT02880371|65683375|FG003|Phase 2|Enrolled but not Treated|0|||
23532751|NCT02880371|65683376|FG004|Phase 2|Enrolled but not Treated|0|||
23532752|NCT02880371|65683377|FG005|Phase 2|Enrolled but not Treated|1|||
23532753|NCT02880371|65683378|FG006|Phase 2|Enrolled but not Treated|1|||
23614230|NCT00296504|65973257|FG001|Final Analysis|Pregnancy|0|||
23614231|NCT00296504|65973258|FG002|Final Analysis|Pregnancy|0|||
23814816|NCT03151811|66703371|FG001|Overall Study|Adverse Event|40|||
23421285|NCT01468207|65284000|FG004|Treatment Period 1|Other|0|||
23614232|NCT00296504|65973259|FG003|Final Analysis|Pregnancy|0|||
23814817|NCT03151811|66703370|FG000|Overall Study|Lack of Efficacy|6|||
23532754|NCT02880371|65683379|FG007|Phase 2|Enrolled but not Treated|0|||
23532755|NCT02880371|65683372|FG000|Phase 2|Other|0|||
23532756|NCT02880371|65683373|FG001|Phase 2|Other|0|||
23532757|NCT02880371|65683374|FG002|Phase 2|Other|0|||
23532758|NCT02880371|65683375|FG003|Phase 2|Other|0|||
23532759|NCT02880371|65683376|FG004|Phase 2|Other|0|||
23532760|NCT02880371|65683377|FG005|Phase 2|Other|1|||
23532761|NCT02880371|65683378|FG006|Phase 2|Other|2|||
23532762|NCT02880371|65683379|FG007|Phase 2|Other|1|||
23532763|NCT02880371|65683372|FG000|Phase 2|Participants terminated by Sponsor|0|||
23532764|NCT02880371|65683373|FG001|Phase 2|Participants terminated by Sponsor|0|||
23532765|NCT02880371|65683374|FG002|Phase 2|Participants terminated by Sponsor|0|||
23532766|NCT02880371|65683375|FG003|Phase 2|Participants terminated by Sponsor|0|||
23532767|NCT02880371|65683376|FG004|Phase 2|Participants terminated by Sponsor|1|||
23532768|NCT02880371|65683377|FG005|Phase 2|Participants terminated by Sponsor|6|||
23532769|NCT02880371|65683378|FG006|Phase 2|Participants terminated by Sponsor|1|||
23532770|NCT02880371|65683379|FG007|Phase 2|Participants terminated by Sponsor|5|||
23532771|NCT02880371|65683372|FG000|Phase 2|Death|0|||
23532772|NCT02880371|65683373|FG001|Phase 2|Death|0|||
23532773|NCT02880371|65683374|FG002|Phase 2|Death|0|||
23532774|NCT02880371|65683375|FG003|Phase 2|Death|0|||
23532775|NCT02880371|65683376|FG004|Phase 2|Death|1|||
23532776|NCT02880371|65683377|FG005|Phase 2|Death|10|||
23532777|NCT02880371|65683378|FG006|Phase 2|Death|20|||
23532778|NCT02880371|65683379|FG007|Phase 2|Death|5|||
23532779|NCT02880371|65683372|FG000|Phase 2|Lost to Follow-up|0|||
23532780|NCT02880371|65683373|FG001|Phase 2|Lost to Follow-up|0|||
23532781|NCT02880371|65683374|FG002|Phase 2|Lost to Follow-up|0|||
23532782|NCT02880371|65683375|FG003|Phase 2|Lost to Follow-up|0|||
23532783|NCT02880371|65683376|FG004|Phase 2|Lost to Follow-up|0|||
23532784|NCT02880371|65683377|FG005|Phase 2|Lost to Follow-up|0|||
23532785|NCT02880371|65683378|FG006|Phase 2|Lost to Follow-up|3|||
23532786|NCT02880371|65683379|FG007|Phase 2|Lost to Follow-up|0|||
23532787|NCT02880371|65683372|FG000|Phase 2|Withdrawal by Subject|0|||
23532788|NCT02880371|65683373|FG001|Phase 2|Withdrawal by Subject|0|||
23532789|NCT02880371|65683374|FG002|Phase 2|Withdrawal by Subject|0|||
23532790|NCT02880371|65683375|FG003|Phase 2|Withdrawal by Subject|0|||
23532791|NCT02880371|65683376|FG004|Phase 2|Withdrawal by Subject|0|||
23532792|NCT02880371|65683377|FG005|Phase 2|Withdrawal by Subject|1|||
23532793|NCT02880371|65683378|FG006|Phase 2|Withdrawal by Subject|1|||
23532794|NCT02880371|65683379|FG007|Phase 2|Withdrawal by Subject|0|||
23532795|NCT02880371|65683372|FG000|Phase 2|End of Study page not completed by error|0|||
23532796|NCT02880371|65683373|FG001|Phase 2|End of Study page not completed by error|0|||
23614233|NCT00296504|65973260|FG004|Final Analysis|Pregnancy|0|||
23614234|NCT00296504|65973261|FG005|Final Analysis|Pregnancy|0|||
23614235|NCT00296504|65973262|FG006|Final Analysis|Pregnancy|0|||
23614236|NCT00296504|65973263|FG007|Final Analysis|Pregnancy|0|||
23614237|NCT00296504|65973264|FG008|Final Analysis|Pregnancy|4|||
23614238|NCT00296504|65973256|FG000|Final Analysis|Tuberculosis|0|||
23614239|NCT00296504|65973257|FG001|Final Analysis|Tuberculosis|0|||
23814818|NCT03151811|66703371|FG001|Overall Study|Lack of Efficacy|8|||
23814819|NCT03151811|66703370|FG000|Overall Study|Physician Decision|21|||
23614240|NCT00296504|65973258|FG002|Final Analysis|Tuberculosis|0|||
23614241|NCT00296504|65973259|FG003|Final Analysis|Tuberculosis|0|||
23614242|NCT00296504|65973260|FG004|Final Analysis|Tuberculosis|0|||
23614243|NCT00296504|65973261|FG005|Final Analysis|Tuberculosis|0|||
23614244|NCT00296504|65973262|FG006|Final Analysis|Tuberculosis|0|||
23614245|NCT00296504|65973263|FG007|Final Analysis|Tuberculosis|0|||
23614246|NCT00296504|65973264|FG008|Final Analysis|Tuberculosis|1|||
23614247|NCT00296504|65973256|FG000|Final Analysis|Participant Moved to Another Country|0|||
23614248|NCT00296504|65973257|FG001|Final Analysis|Participant Moved to Another Country|0|||
23614249|NCT00296504|65973258|FG002|Final Analysis|Participant Moved to Another Country|0|||
23614250|NCT00296504|65973259|FG003|Final Analysis|Participant Moved to Another Country|0|||
23614251|NCT00296504|65973260|FG004|Final Analysis|Participant Moved to Another Country|0|||
23614252|NCT00296504|65973261|FG005|Final Analysis|Participant Moved to Another Country|0|||
23814820|NCT03151811|66703371|FG001|Overall Study|Physician Decision|9|||
23532797|NCT02880371|65683374|FG002|Phase 2|End of Study page not completed by error|0|||
23532798|NCT02880371|65683375|FG003|Phase 2|End of Study page not completed by error|0|||
23532799|NCT02880371|65683376|FG004|Phase 2|End of Study page not completed by error|0|||
23614253|NCT00296504|65973262|FG006|Final Analysis|Participant Moved to Another Country|0|||
23614254|NCT00296504|65973263|FG007|Final Analysis|Participant Moved to Another Country|0|||
23614255|NCT00296504|65973264|FG008|Final Analysis|Participant Moved to Another Country|1|||
23614256|NCT00296504|65973256|FG000|Final Analysis|Poor Adherence|0|||
23614257|NCT00296504|65973257|FG001|Final Analysis|Poor Adherence|0|||
23814821|NCT03151811|66703370|FG000|Overall Study|Withdrawal by Subject|17|||
23532800|NCT02880371|65683377|FG005|Phase 2|End of Study page not completed by error|1|||
23532801|NCT02880371|65683378|FG006|Phase 2|End of Study page not completed by error|0|||
23532802|NCT02880371|65683379|FG007|Phase 2|End of Study page not completed by error|0|||
23532803|NCT00850200|65683382|FG000|Overall Study|Physician Decision|2|||
23532804|NCT00850200|65683382|FG000|Overall Study|Did not recieve treatment|2|||
23532805|NCT00850200|65683382|FG000|Overall Study|Withdrawal by Subject|1|||
23532806|NCT02143843|65683385|FG000|Overall Study|Adverse Event|8|||
23532807|NCT02143843|65683385|FG000|Overall Study|Lack of Efficacy|2|||
23532808|NCT02143843|65683385|FG000|Overall Study|Withdrawal by Subject|2|||
23532809|NCT00714259|65683386|FG000|Overall Study|Death|2|||
23532810|NCT00853658|65686408|FG000|Overall Study|Death|713|||
23532811|NCT00853658|65686409|FG001|Overall Study|Death|768|||
23532812|NCT00853658|65686410|FG002|Overall Study|Death|753|||
23532813|NCT00853658|65686408|FG000|Overall Study|Lost to Follow-up|11|||
23532814|NCT00853658|65686409|FG001|Overall Study|Lost to Follow-up|6|||
23532815|NCT00853658|65686410|FG002|Overall Study|Lost to Follow-up|11|||
23532816|NCT00853658|65686408|FG000|Overall Study|H.A. Request|26|||
23532817|NCT00853658|65686409|FG001|Overall Study|H.A. Request|23|||
23532818|NCT00853658|65686410|FG002|Overall Study|H.A. Request|19|||
23532819|NCT00853658|65686408|FG000|Overall Study|IRB request|0|||
23532820|NCT00853658|65686409|FG001|Overall Study|IRB request|0|||
23532821|NCT00853658|65686410|FG002|Overall Study|IRB request|2|||
23532822|NCT00853658|65686408|FG000|Overall Study|Vital Status known (alive) at study end|2|||
23532823|NCT00853658|65686409|FG001|Overall Study|Vital Status known (alive) at study end|3|||
23532824|NCT00853658|65686410|FG002|Overall Study|Vital Status known (alive) at study end|3|||
23532825|NCT00853658|65686408|FG000|Overall Study|Vital Status unknown at study end|1|||
23532826|NCT00853658|65686409|FG001|Overall Study|Vital Status unknown at study end|1|||
23532827|NCT00853658|65686410|FG002|Overall Study|Vital Status unknown at study end|0|||
23532828|NCT00853658|65686408|FG000|Overall Study|Vital Status at study end N/A|8|||
23532829|NCT00853658|65686409|FG001|Overall Study|Vital Status at study end N/A|10|||
23532830|NCT00853658|65686410|FG002|Overall Study|Vital Status at study end N/A|10|||
23532831|NCT00853658|65686408|FG000|Overall Study|Patient's request|21|||
23532832|NCT00853658|65686409|FG001|Overall Study|Patient's request|17|||
23532833|NCT00853658|65686410|FG002|Overall Study|Patient's request|11|||
23532834|NCT00853658|65686408|FG000|Overall Study|Missing study completion information|5|||
23532835|NCT00853658|65686409|FG001|Overall Study|Missing study completion information|4|||
23532836|NCT00853658|65686410|FG002|Overall Study|Missing study completion information|6|||
23532837|NCT00941733|65686411|FG000|Overall Study|Death|24|||
23532838|NCT00941733|65686412|FG001|Overall Study|Death|10|||
23532839|NCT00941733|65686411|FG000|Overall Study|Withdrawal by Subject|14|||
23532840|NCT00941733|65686412|FG001|Overall Study|Withdrawal by Subject|6|||
23532841|NCT00941733|65686411|FG000|Overall Study|Adverse Event|20|||
23532842|NCT00941733|65686412|FG001|Overall Study|Adverse Event|4|||
23532843|NCT00941733|65686411|FG000|Overall Study|Lost to Follow-up|1|||
23532844|NCT00941733|65686412|FG001|Overall Study|Lost to Follow-up|2|||
23532845|NCT00941733|65686411|FG000|Overall Study|Protocol Violation|15|||
23532846|NCT00941733|65686412|FG001|Overall Study|Protocol Violation|6|||
23532847|NCT01375049|65686416|FG000|Overall Study|Adverse Event|2|||
23532848|NCT01375049|65686416|FG000|Overall Study|Lost to Follow-up|1|||
23532849|NCT01375049|65686416|FG000|Overall Study|Withdrawal by Subject|2|||
23532850|NCT01375049|65686416|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
23532851|NCT01126541|65686417|FG000|Overall Study|Adverse Event|0|||
23532852|NCT01126541|65686418|FG001|Overall Study|Adverse Event|2|||
23532853|NCT01126541|65686419|FG002|Overall Study|Adverse Event|4|||
23532854|NCT01126541|65686417|FG000|Overall Study|Death|0|||
23532855|NCT01126541|65686418|FG001|Overall Study|Death|1|||
23532856|NCT01126541|65686419|FG002|Overall Study|Death|0|||
23532857|NCT01126541|65686417|FG000|Overall Study|Lack of Efficacy|6|||
23532858|NCT01126541|65686418|FG001|Overall Study|Lack of Efficacy|1|||
23532859|NCT01126541|65686419|FG002|Overall Study|Lack of Efficacy|11|||
23532860|NCT01126541|65686417|FG000|Overall Study|Lost to Follow-up|1|||
23814822|NCT03151811|66703371|FG001|Overall Study|Withdrawal by Subject|7|||
23814823|NCT03151811|66703370|FG000|Overall Study|Lost to Follow-up|0|||
23532861|NCT01126541|65686418|FG001|Overall Study|Lost to Follow-up|2|||
23532862|NCT01126541|65686419|FG002|Overall Study|Lost to Follow-up|2|||
23532863|NCT01126541|65686417|FG000|Overall Study|Withdrawal by Subject|2|||
23814824|NCT03151811|66703371|FG001|Overall Study|Lost to Follow-up|1|||
23532864|NCT01126541|65686418|FG001|Overall Study|Withdrawal by Subject|5|||
23532865|NCT01126541|65686419|FG002|Overall Study|Withdrawal by Subject|6|||
23532866|NCT01126541|65686417|FG000|Overall Study|Protocol Violation|0|||
23532867|NCT01126541|65686418|FG001|Overall Study|Protocol Violation|0|||
23532868|NCT01126541|65686419|FG002|Overall Study|Protocol Violation|1|||
23532869|NCT01126541|65686417|FG000|Overall Study|Administrative reason or other|1|||
23814825|NCT03151811|66703370|FG000|Overall Study|Study Terminated by Sponsor|5|||
23814826|NCT03151811|66703371|FG001|Overall Study|Study Terminated by Sponsor|11|||
23532870|NCT01126541|65686418|FG001|Overall Study|Administrative reason or other|1|||
23532871|NCT01126541|65686419|FG002|Overall Study|Administrative reason or other|2|||
23532872|NCT01410110|65686420|FG000|Overall Study|Withdrawal by Subject|4|||
23532873|NCT01410110|65686421|FG001|Overall Study|Withdrawal by Subject|2|||
23532874|NCT00679341|65686424|FG000|Overall Study|Disease progression|42|||
23532875|NCT00679341|65686425|FG001|Overall Study|Disease progression|36|||
23814827|NCT03489109|66703372|FG000|Overall Study|Lost to Follow-up|1|||
23532876|NCT00679341|65686424|FG000|Overall Study|Adverse Event|5|||
23532877|NCT00679341|65686425|FG001|Overall Study|Adverse Event|6|||
23532878|NCT00679341|65686424|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
23532879|NCT00679341|65686425|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
23532880|NCT00679341|65686424|FG000|Overall Study|Death|1|||
23532881|NCT00679341|65686425|FG001|Overall Study|Death|1|||
23532882|NCT00679341|65686424|FG000|Overall Study|Other|1|||
23532883|NCT00679341|65686425|FG001|Overall Study|Other|0|||
23532884|NCT00679341|65686424|FG000|Overall Study|Physician Decision|1|||
23532885|NCT00679341|65686425|FG001|Overall Study|Physician Decision|0|||
23532886|NCT00679341|65686424|FG000|Overall Study|Not treated|0|||
23532887|NCT00679341|65686425|FG001|Overall Study|Not treated|2|||
23532888|NCT00679341|65686424|FG000|Overall Study|Physician/patient decision to withdraw|0|||
23532889|NCT00679341|65686425|FG001|Overall Study|Physician/patient decision to withdraw|6|||
23532890|NCT02103478|65686426|FG000|Overall Study|Adverse Event|0|||
23532891|NCT02103478|65686427|FG001|Overall Study|Adverse Event|0|||
23532892|NCT02103478|65686428|FG002|Overall Study|Adverse Event|1|||
23532893|NCT02103478|65686429|FG003|Overall Study|Adverse Event|1|||
23532894|NCT02103478|65686430|FG004|Overall Study|Adverse Event|2|||
23532895|NCT02103478|65686431|FG005|Overall Study|Adverse Event|1|||
23532896|NCT02103478|65686432|FG006|Overall Study|Adverse Event|0|||
23532897|NCT02103478|65686433|FG007|Overall Study|Adverse Event|0|||
23532898|NCT02103478|65686434|FG008|Overall Study|Adverse Event|0|||
23532899|NCT02103478|65686426|FG000|Overall Study|Death|2|||
23532900|NCT02103478|65686427|FG001|Overall Study|Death|2|||
23532901|NCT02103478|65686428|FG002|Overall Study|Death|1|||
23532902|NCT02103478|65686429|FG003|Overall Study|Death|1|||
23532903|NCT02103478|65686430|FG004|Overall Study|Death|5|||
23532904|NCT02103478|65686431|FG005|Overall Study|Death|15|||
23532905|NCT02103478|65686432|FG006|Overall Study|Death|14|||
23532906|NCT02103478|65686433|FG007|Overall Study|Death|10|||
23532907|NCT02103478|65686434|FG008|Overall Study|Death|11|||
23532908|NCT02103478|65686426|FG000|Overall Study|Progressive Disease|2|||
23532909|NCT02103478|65686427|FG001|Overall Study|Progressive Disease|1|||
23532910|NCT02103478|65686428|FG002|Overall Study|Progressive Disease|2|||
23532911|NCT02103478|65686429|FG003|Overall Study|Progressive Disease|0|||
23532912|NCT02103478|65686430|FG004|Overall Study|Progressive Disease|9|||
23532913|NCT02103478|65686431|FG005|Overall Study|Progressive Disease|1|||
23532914|NCT02103478|65686432|FG006|Overall Study|Progressive Disease|2|||
23532915|NCT02103478|65686433|FG007|Overall Study|Progressive Disease|0|||
23532916|NCT02103478|65686434|FG008|Overall Study|Progressive Disease|1|||
23532917|NCT02103478|65686426|FG000|Overall Study|Withdrawal by Subject|2|||
23532918|NCT02103478|65686427|FG001|Overall Study|Withdrawal by Subject|0|||
23532919|NCT02103478|65686428|FG002|Overall Study|Withdrawal by Subject|0|||
23532920|NCT02103478|65686429|FG003|Overall Study|Withdrawal by Subject|4|||
23532921|NCT02103478|65686430|FG004|Overall Study|Withdrawal by Subject|0|||
23532922|NCT02103478|65686431|FG005|Overall Study|Withdrawal by Subject|0|||
23532923|NCT02103478|65686432|FG006|Overall Study|Withdrawal by Subject|1|||
23532924|NCT02103478|65686433|FG007|Overall Study|Withdrawal by Subject|1|||
23532925|NCT02103478|65686434|FG008|Overall Study|Withdrawal by Subject|0|||
23532926|NCT02103478|65686426|FG000|Overall Study|Lost to Follow-up|0|||
23532927|NCT02103478|65686427|FG001|Overall Study|Lost to Follow-up|0|||
23532928|NCT02103478|65686428|FG002|Overall Study|Lost to Follow-up|0|||
23532929|NCT02103478|65686429|FG003|Overall Study|Lost to Follow-up|0|||
23532930|NCT02103478|65686430|FG004|Overall Study|Lost to Follow-up|0|||
23532931|NCT02103478|65686431|FG005|Overall Study|Lost to Follow-up|0|||
23532932|NCT02103478|65686432|FG006|Overall Study|Lost to Follow-up|0|||
23532933|NCT02103478|65686433|FG007|Overall Study|Lost to Follow-up|1|||
23532934|NCT02103478|65686434|FG008|Overall Study|Lost to Follow-up|0|||
23532935|NCT02103478|65686426|FG000|Overall Study|Other|1|||
23532936|NCT02103478|65686427|FG001|Overall Study|Other|3|||
23532937|NCT02103478|65686428|FG002|Overall Study|Other|2|||
23532938|NCT02103478|65686429|FG003|Overall Study|Other|0|||
23532939|NCT02103478|65686430|FG004|Overall Study|Other|3|||
23532940|NCT02103478|65686431|FG005|Overall Study|Other|8|||
23532941|NCT02103478|65686432|FG006|Overall Study|Other|8|||
23532942|NCT02103478|65686433|FG007|Overall Study|Other|4|||
23532943|NCT02103478|65686434|FG008|Overall Study|Other|2|||
23532944|NCT02583256|65686437|FG000|Overall Study|Withdrawal by Subject|0|||
23532945|NCT02583256|65686438|FG001|Overall Study|Withdrawal by Subject|1|||
23532946|NCT02583256|65686439|FG002|Overall Study|Withdrawal by Subject|1|||
23532947|NCT02583256|65686440|FG003|Overall Study|Withdrawal by Subject|0|||
23532948|NCT02583256|65686437|FG000|Overall Study|Lost to Follow-up|1|||
23532949|NCT02583256|65686438|FG001|Overall Study|Lost to Follow-up|1|||
23532950|NCT02583256|65686439|FG002|Overall Study|Lost to Follow-up|0|||
23532951|NCT02583256|65686440|FG003|Overall Study|Lost to Follow-up|1|||
23532952|NCT02583256|65686437|FG000|Overall Study|Administrative/Other|2|||
23532953|NCT02583256|65686438|FG001|Overall Study|Administrative/Other|0|||
23532954|NCT02583256|65686439|FG002|Overall Study|Administrative/Other|1|||
23532955|NCT02583256|65686440|FG003|Overall Study|Administrative/Other|2|||
23532956|NCT00440271|65686441|FG000|Overall Study|Protocol Violation|1|||
23532957|NCT00440271|65686442|FG001|Overall Study|Protocol Violation|1|||
23532958|NCT00440271|65686441|FG000|Overall Study|Adverse Event|0|||
23532959|NCT00440271|65686442|FG001|Overall Study|Adverse Event|1|||
23532960|NCT00440271|65686441|FG000|Overall Study|Lost to Follow-up|1|||
23532961|NCT00440271|65686442|FG001|Overall Study|Lost to Follow-up|0|||
23532962|NCT00440271|65686441|FG000|Overall Study|Withdrawal by Subject|0|||
23532963|NCT00440271|65686442|FG001|Overall Study|Withdrawal by Subject|2|||
23532964|NCT00440271|65686441|FG000|Overall Study|Lack of Efficacy|0|||
23532965|NCT00440271|65686442|FG001|Overall Study|Lack of Efficacy|1|||
23532966|NCT00440271|65686441|FG000|Overall Study|Due to closure of trial|8|||
23532967|NCT00440271|65686442|FG001|Overall Study|Due to closure of trial|10|||
23532968|NCT00440271|65686441|FG000|Overall Study|Other|2|||
23532969|NCT00440271|65686442|FG001|Overall Study|Other|0|||
23532970|NCT00833924|65686444|FG000|Overall Study|Death|21|||
23532971|NCT00833924|65686444|FG000|Overall Study|Conversion|2|||
23532972|NCT00833924|65686444|FG000|Overall Study|Lost to Follow-up|2|||
23532973|NCT00833924|65686444|FG000|Overall Study|Withdrawal by Subject|13|||
23532974|NCT00833924|65686444|FG000|Overall Study|In study follow-up|71|||
23532975|NCT02247349|65686445|FG000|Overall Study|Disease Progression|7|||
23532976|NCT02247349|65686446|FG001|Overall Study|Disease Progression|4|||
23532977|NCT02247349|65686447|FG002|Overall Study|Disease Progression|26|||
23532978|NCT02247349|65686448|FG003|Overall Study|Disease Progression|31|||
23532979|NCT02247349|65686449|FG004|Overall Study|Disease Progression|16|||
23532980|NCT02247349|65686450|FG005|Overall Study|Disease Progression|6|||
23532981|NCT02247349|65686445|FG000|Overall Study|Study drug toxicity|0|||
23532982|NCT02247349|65686446|FG001|Overall Study|Study drug toxicity|1|||
23532983|NCT02247349|65686447|FG002|Overall Study|Study drug toxicity|1|||
23532984|NCT02247349|65686448|FG003|Overall Study|Study drug toxicity|1|||
23532985|NCT02247349|65686449|FG004|Overall Study|Study drug toxicity|2|||
23532986|NCT02247349|65686450|FG005|Overall Study|Study drug toxicity|2|||
23532987|NCT02247349|65686445|FG000|Overall Study|Death|0|||
23532988|NCT02247349|65686446|FG001|Overall Study|Death|0|||
23532989|NCT02247349|65686447|FG002|Overall Study|Death|0|||
23532990|NCT02247349|65686448|FG003|Overall Study|Death|1|||
23532991|NCT02247349|65686449|FG004|Overall Study|Death|0|||
23532992|NCT02247349|65686450|FG005|Overall Study|Death|0|||
23532993|NCT02247349|65686445|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23532994|NCT02247349|65686446|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23532995|NCT02247349|65686447|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23532996|NCT02247349|65686448|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
23532997|NCT02247349|65686449|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
23532998|NCT02247349|65686450|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
23532999|NCT02247349|65686445|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23533000|NCT02247349|65686446|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23533001|NCT02247349|65686447|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23533002|NCT02247349|65686448|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23533003|NCT02247349|65686449|FG004|Overall Study|Participant request to discontinue study treatment|1|||
23533004|NCT02247349|65686450|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23533005|NCT02247349|65686445|FG000|Overall Study|Withdrawal by Subject|0|||
23533006|NCT02247349|65686446|FG001|Overall Study|Withdrawal by Subject|1|||
23533007|NCT02247349|65686447|FG002|Overall Study|Withdrawal by Subject|0|||
23533008|NCT02247349|65686448|FG003|Overall Study|Withdrawal by Subject|0|||
23533009|NCT02247349|65686449|FG004|Overall Study|Withdrawal by Subject|0|||
23533010|NCT02247349|65686450|FG005|Overall Study|Withdrawal by Subject|0|||
23533011|NCT02247349|65686445|FG000|Overall Study|Administrative reason by sponsor|0|||
23533012|NCT02247349|65686446|FG001|Overall Study|Administrative reason by sponsor|0|||
23533013|NCT02247349|65686447|FG002|Overall Study|Administrative reason by sponsor|0|||
23533014|NCT02247349|65686448|FG003|Overall Study|Administrative reason by sponsor|0|||
23533015|NCT02247349|65686449|FG004|Overall Study|Administrative reason by sponsor|1|||
23533016|NCT02247349|65686450|FG005|Overall Study|Administrative reason by sponsor|0|||
23533017|NCT02247349|65686445|FG000|Overall Study|Other reasons|0|||
23533018|NCT02247349|65686446|FG001|Overall Study|Other reasons|0|||
23533019|NCT02247349|65686447|FG002|Overall Study|Other reasons|1|||
23533020|NCT02247349|65686448|FG003|Overall Study|Other reasons|0|||
23533021|NCT02247349|65686449|FG004|Overall Study|Other reasons|0|||
23533022|NCT02247349|65686450|FG005|Overall Study|Other reasons|0|||
23533023|NCT03304379|65686457|FG000|Overall Study|Protocol Violation|8|||
23814828|NCT03489109|66703373|FG001|Overall Study|Lost to Follow-up|2|||
23814829|NCT02113189|66703374|FG000|Overall Study|Lost to follow up|2|||
23814830|NCT02113189|66703375|FG001|Overall Study|Lost to follow up|1|||
23533024|NCT03304379|65686458|FG001|Overall Study|Protocol Violation|10|||
23533025|NCT03304379|65686459|FG002|Overall Study|Protocol Violation|5|||
23533026|NCT03304379|65686460|FG003|Overall Study|Protocol Violation|0|||
23533027|NCT03304379|65686461|FG004|Overall Study|Protocol Violation|2|||
23533028|NCT03304379|65686457|FG000|Overall Study|Adverse Event|4|||
23533029|NCT03304379|65686458|FG001|Overall Study|Adverse Event|20|||
23533030|NCT03304379|65686459|FG002|Overall Study|Adverse Event|17|||
23533031|NCT03304379|65686460|FG003|Overall Study|Adverse Event|1|||
23533032|NCT03304379|65686461|FG004|Overall Study|Adverse Event|0|||
23533033|NCT03304379|65686457|FG000|Overall Study|Lack of Efficacy|17|||
23533034|NCT03304379|65686458|FG001|Overall Study|Lack of Efficacy|16|||
23533035|NCT03304379|65686459|FG002|Overall Study|Lack of Efficacy|20|||
23533036|NCT03304379|65686460|FG003|Overall Study|Lack of Efficacy|0|||
23533037|NCT03304379|65686461|FG004|Overall Study|Lack of Efficacy|0|||
23533038|NCT03304379|65686457|FG000|Overall Study|Physician Decision|6|||
23533039|NCT03304379|65686458|FG001|Overall Study|Physician Decision|10|||
23533040|NCT03304379|65686459|FG002|Overall Study|Physician Decision|6|||
23533041|NCT03304379|65686460|FG003|Overall Study|Physician Decision|9|||
23533042|NCT03304379|65686461|FG004|Overall Study|Physician Decision|10|||
23533043|NCT03304379|65686457|FG000|Overall Study|Withdrawal by Subject|26|||
23533044|NCT03304379|65686458|FG001|Overall Study|Withdrawal by Subject|58|||
23533045|NCT03304379|65686459|FG002|Overall Study|Withdrawal by Subject|66|||
23533046|NCT03304379|65686460|FG003|Overall Study|Withdrawal by Subject|3|||
23533047|NCT03304379|65686461|FG004|Overall Study|Withdrawal by Subject|5|||
23533048|NCT03304379|65686457|FG000|Overall Study|Lost to Follow-up|8|||
23533049|NCT03304379|65686458|FG001|Overall Study|Lost to Follow-up|24|||
23533050|NCT03304379|65686459|FG002|Overall Study|Lost to Follow-up|35|||
23533051|NCT03304379|65686460|FG003|Overall Study|Lost to Follow-up|4|||
23533052|NCT03304379|65686461|FG004|Overall Study|Lost to Follow-up|0|||
23533053|NCT03304379|65686457|FG000|Overall Study|Death|1|||
23533054|NCT03304379|65686458|FG001|Overall Study|Death|2|||
23533055|NCT03304379|65686459|FG002|Overall Study|Death|0|||
23533056|NCT03304379|65686460|FG003|Overall Study|Death|0|||
23533057|NCT03304379|65686461|FG004|Overall Study|Death|0|||
23533058|NCT03304379|65686457|FG000|Overall Study|Other|0|||
23533059|NCT03304379|65686458|FG001|Overall Study|Other|1|||
23533060|NCT03304379|65686459|FG002|Overall Study|Other|0|||
23533061|NCT03304379|65686460|FG003|Overall Study|Other|0|||
23533062|NCT03304379|65686461|FG004|Overall Study|Other|0|||
23533063|NCT00938431|65686470|FG000|Overall Study|Adverse Event|5|||
23533064|NCT00938431|65686471|FG001|Overall Study|Adverse Event|8|||
23533065|NCT00938431|65686472|FG002|Overall Study|Adverse Event|6|||
23533066|NCT00938431|65686470|FG000|Overall Study|Lack of Efficacy|0|||
23533067|NCT00938431|65686471|FG001|Overall Study|Lack of Efficacy|1|||
23533068|NCT00938431|65686472|FG002|Overall Study|Lack of Efficacy|0|||
23533069|NCT00938431|65686470|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
23533070|NCT00938431|65686471|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
23533071|NCT00938431|65686472|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
23533072|NCT00938431|65686470|FG000|Overall Study|Dosing compliance issue|0|||
23533073|NCT00938431|65686471|FG001|Overall Study|Dosing compliance issue|0|||
23533074|NCT00938431|65686472|FG002|Overall Study|Dosing compliance issue|1|||
23533075|NCT00938431|65686470|FG000|Overall Study|Reached maximum dose early|0|||
23533076|NCT00938431|65686471|FG001|Overall Study|Reached maximum dose early|0|||
23533077|NCT00938431|65686472|FG002|Overall Study|Reached maximum dose early|1|||
23533078|NCT03146650|65686479|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
23533079|NCT03146650|65686479|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
23533080|NCT03146650|65686479|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
23533081|NCT03146650|65686479|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
23533082|NCT03146650|65686479|FG000|2 Year Follow-up|Death|11|||
23533083|NCT03146650|65686479|FG000|2 Year Follow-up|Still in follow-up|7|||
23533084|NCT03146650|65686479|FG000|2 Year Follow-up|Lost to Follow-up|1|||
23533085|NCT00958880|65686488|FG000|Overall Study|Lost to Follow-up|2|||
23533086|NCT00958880|65686489|FG001|Overall Study|Lost to Follow-up|2|||
23533087|NCT02520531|65686492|FG000|Overall Study|Revision of study device components|2|||
23814831|NCT02113189|66703376|FG002|Overall Study|Lost to follow up|3|||
23814832|NCT01320150|66703377|FG000|Overall Study|Protocol Violation|15|||
23814833|NCT01320150|66703377|FG000|Overall Study|Withdrawal by Subject|5|||
23533088|NCT02520531|65686493|FG001|Overall Study|Revision of study device components|2|||
23533089|NCT02520531|65686492|FG000|Overall Study|Death|1|||
23533090|NCT02520531|65686493|FG001|Overall Study|Death|2|||
23533091|NCT02520531|65686492|FG000|Overall Study|Lost to Follow-up|1|||
23533092|NCT02520531|65686493|FG001|Overall Study|Lost to Follow-up|1|||
23533093|NCT02520531|65686492|FG000|Overall Study|Meet exclusion criterion|0|||
23533094|NCT02520531|65686493|FG001|Overall Study|Meet exclusion criterion|1|||
23533095|NCT02520531|65686492|FG000|Overall Study|Withdrawal by Subject|1|||
23533096|NCT02520531|65686493|FG001|Overall Study|Withdrawal by Subject|0|||
23533097|NCT02520531|65686492|FG000|Overall Study|Not study device|1|||
23814834|NCT01320150|66703377|FG000|Overall Study|Death|2|||
23533098|NCT02520531|65686493|FG001|Overall Study|Not study device|0|||
23533099|NCT01709318|65686496|FG000|Overall Study|Adverse Event|3|||
23533100|NCT01709318|65686497|FG001|Overall Study|Adverse Event|4|||
23533101|NCT01709318|65686498|FG002|Overall Study|Adverse Event|2|||
23533102|NCT01709318|65686499|FG003|Overall Study|Adverse Event|2|||
23533103|NCT01709318|65686500|FG004|Overall Study|Adverse Event|0|||
23533104|NCT01709318|65686501|FG005|Overall Study|Adverse Event|1|||
23533105|NCT01709318|65686502|FG006|Overall Study|Adverse Event|2|||
23533106|NCT01709318|65686496|FG000|Overall Study|Lost to Follow-up|2|||
23533107|NCT01709318|65686497|FG001|Overall Study|Lost to Follow-up|0|||
23533108|NCT01709318|65686498|FG002|Overall Study|Lost to Follow-up|0|||
23533109|NCT01709318|65686499|FG003|Overall Study|Lost to Follow-up|0|||
23533110|NCT01709318|65686500|FG004|Overall Study|Lost to Follow-up|1|||
23533111|NCT01709318|65686501|FG005|Overall Study|Lost to Follow-up|1|||
23533112|NCT01709318|65686502|FG006|Overall Study|Lost to Follow-up|1|||
23533113|NCT01709318|65686496|FG000|Overall Study|Non-compliance with Study Drug|0|||
23533114|NCT01709318|65686497|FG001|Overall Study|Non-compliance with Study Drug|2|||
23533115|NCT01709318|65686498|FG002|Overall Study|Non-compliance with Study Drug|1|||
23533116|NCT01709318|65686499|FG003|Overall Study|Non-compliance with Study Drug|1|||
23533117|NCT01709318|65686500|FG004|Overall Study|Non-compliance with Study Drug|0|||
23533118|NCT01709318|65686501|FG005|Overall Study|Non-compliance with Study Drug|0|||
23533119|NCT01709318|65686502|FG006|Overall Study|Non-compliance with Study Drug|2|||
23533120|NCT01709318|65686496|FG000|Overall Study|Physician Decision|0|||
23533121|NCT01709318|65686497|FG001|Overall Study|Physician Decision|0|||
23533122|NCT01709318|65686498|FG002|Overall Study|Physician Decision|0|||
23533123|NCT01709318|65686499|FG003|Overall Study|Physician Decision|0|||
23533124|NCT01709318|65686500|FG004|Overall Study|Physician Decision|0|||
23533125|NCT01709318|65686501|FG005|Overall Study|Physician Decision|0|||
23533126|NCT01709318|65686502|FG006|Overall Study|Physician Decision|1|||
23533127|NCT01709318|65686496|FG000|Overall Study|Pregnancy|0|||
23533128|NCT01709318|65686497|FG001|Overall Study|Pregnancy|0|||
23533129|NCT01709318|65686498|FG002|Overall Study|Pregnancy|0|||
23533130|NCT01709318|65686499|FG003|Overall Study|Pregnancy|0|||
23533131|NCT01709318|65686500|FG004|Overall Study|Pregnancy|1|||
23533132|NCT01709318|65686501|FG005|Overall Study|Pregnancy|0|||
23533133|NCT01709318|65686502|FG006|Overall Study|Pregnancy|0|||
23533134|NCT01709318|65686496|FG000|Overall Study|Protocol Violation|0|||
23533135|NCT01709318|65686497|FG001|Overall Study|Protocol Violation|0|||
23533136|NCT01709318|65686498|FG002|Overall Study|Protocol Violation|0|||
23533137|NCT01709318|65686499|FG003|Overall Study|Protocol Violation|0|||
23533138|NCT01709318|65686500|FG004|Overall Study|Protocol Violation|2|||
23533139|NCT01709318|65686501|FG005|Overall Study|Protocol Violation|0|||
23533140|NCT01709318|65686502|FG006|Overall Study|Protocol Violation|1|||
23533141|NCT01709318|65686496|FG000|Overall Study|Technical Problems|1|||
23533142|NCT01709318|65686497|FG001|Overall Study|Technical Problems|0|||
23533143|NCT01709318|65686498|FG002|Overall Study|Technical Problems|0|||
23533144|NCT01709318|65686499|FG003|Overall Study|Technical Problems|0|||
23533145|NCT01709318|65686500|FG004|Overall Study|Technical Problems|0|||
23533146|NCT01709318|65686501|FG005|Overall Study|Technical Problems|0|||
23533147|NCT01709318|65686502|FG006|Overall Study|Technical Problems|0|||
23533148|NCT01709318|65686496|FG000|Overall Study|Withdrawal by Subject|3|||
23533149|NCT01709318|65686497|FG001|Overall Study|Withdrawal by Subject|0|||
23533150|NCT01709318|65686498|FG002|Overall Study|Withdrawal by Subject|3|||
23533151|NCT01709318|65686499|FG003|Overall Study|Withdrawal by Subject|3|||
23533152|NCT01709318|65686500|FG004|Overall Study|Withdrawal by Subject|0|||
23533153|NCT01709318|65686501|FG005|Overall Study|Withdrawal by Subject|2|||
23533154|NCT01709318|65686502|FG006|Overall Study|Withdrawal by Subject|4|||
23533155|NCT01709318|65686496|FG000|Overall Study|Other Protocol Specified Criteria|0|||
23533156|NCT01709318|65686497|FG001|Overall Study|Other Protocol Specified Criteria|1|||
23533157|NCT01709318|65686498|FG002|Overall Study|Other Protocol Specified Criteria|0|||
23533158|NCT01709318|65686499|FG003|Overall Study|Other Protocol Specified Criteria|0|||
23533159|NCT01709318|65686500|FG004|Overall Study|Other Protocol Specified Criteria|0|||
23533160|NCT01709318|65686501|FG005|Overall Study|Other Protocol Specified Criteria|0|||
23533161|NCT01709318|65686502|FG006|Overall Study|Other Protocol Specified Criteria|0|||
23533162|NCT04532112|65686503|FG000|Overall Study|Adverse Event|3|||
23533163|NCT04532112|65686504|FG001|Overall Study|Adverse Event|0|||
23533164|NCT01114516|65686505|FG000|Overall Study|Lost to Follow-up|2|||
23533165|NCT01114516|65686506|FG001|Overall Study|Lost to Follow-up|1|||
23533166|NCT00559962|65686509|FG000|Overall Study|Adverse Event|1|||
23533167|NCT00559962|65686510|FG001|Overall Study|Adverse Event|7|||
23533168|NCT00559962|65686511|FG002|Overall Study|Adverse Event|8|||
23533169|NCT00559962|65686512|FG003|Overall Study|Adverse Event|5|||
23533170|NCT00559962|65686513|FG004|Overall Study|Adverse Event|11|||
23533171|NCT00559962|65686514|FG005|Overall Study|Adverse Event|4|||
23814835|NCT01320150|66703377|FG000|Overall Study|Lost to Follow-up|44|||
23533172|NCT00559962|65686515|FG006|Overall Study|Adverse Event|4|||
23533173|NCT00559962|65686516|FG007|Overall Study|Adverse Event|2|||
23533174|NCT00559962|65686509|FG000|Overall Study|Lost to Follow-up|0|||
23533175|NCT00559962|65686510|FG001|Overall Study|Lost to Follow-up|1|||
23533176|NCT00559962|65686511|FG002|Overall Study|Lost to Follow-up|0|||
23533177|NCT00559962|65686512|FG003|Overall Study|Lost to Follow-up|0|||
23533178|NCT00559962|65686513|FG004|Overall Study|Lost to Follow-up|0|||
23533179|NCT00559962|65686514|FG005|Overall Study|Lost to Follow-up|0|||
23533180|NCT00559962|65686515|FG006|Overall Study|Lost to Follow-up|0|||
23533181|NCT00559962|65686516|FG007|Overall Study|Lost to Follow-up|0|||
23533182|NCT00559962|65686509|FG000|Overall Study|Withdrawal by Subject|1|||
23533183|NCT00559962|65686510|FG001|Overall Study|Withdrawal by Subject|1|||
23614258|NCT00296504|65973258|FG002|Final Analysis|Poor Adherence|0|||
23614259|NCT00296504|65973259|FG003|Final Analysis|Poor Adherence|0|||
23614260|NCT00296504|65973260|FG004|Final Analysis|Poor Adherence|0|||
23614261|NCT00296504|65973261|FG005|Final Analysis|Poor Adherence|0|||
23614262|NCT00296504|65973262|FG006|Final Analysis|Poor Adherence|0|||
23614263|NCT00296504|65973263|FG007|Final Analysis|Poor Adherence|0|||
23614264|NCT00296504|65973264|FG008|Final Analysis|Poor Adherence|1|||
23614265|NCT02374476|65973271|FG000|VT Induced Ablation|Screening Failures|36|||
23614266|NCT02374476|65973272|FG001|VT Induced Ablation|Screening Failures|0|||
23614267|NCT02374476|65973273|FG002|VT Induced Ablation|Screening Failures|0|||
23614268|NCT02374476|65973271|FG000|Arm Assignment|Withdrawal by Subject|0|||
23614269|NCT02374476|65973272|FG001|Arm Assignment|Withdrawal by Subject|0|||
23614270|NCT02374476|65973273|FG002|Arm Assignment|Withdrawal by Subject|1|||
23614271|NCT00316589|65973278|FG000|Overall Study|Withdrawal by Subject|0|||
23614272|NCT00316589|65973279|FG001|Overall Study|Withdrawal by Subject|5|||
23614273|NCT00316589|65973280|FG002|Overall Study|Withdrawal by Subject|0|||
23614274|NCT00316589|65973281|FG003|Overall Study|Withdrawal by Subject|1|||
23614275|NCT00316589|65973278|FG000|Overall Study|Subject unwilling/unable to comply|0|||
23614276|NCT00316589|65973279|FG001|Overall Study|Subject unwilling/unable to comply|6|||
23614277|NCT00316589|65973280|FG002|Overall Study|Subject unwilling/unable to comply|0|||
23614278|NCT00316589|65973281|FG003|Overall Study|Subject unwilling/unable to comply|2|||
23614279|NCT00316589|65973278|FG000|Overall Study|Adverse Event|1|||
23614280|NCT00316589|65973279|FG001|Overall Study|Adverse Event|0|||
23614281|NCT00316589|65973280|FG002|Overall Study|Adverse Event|0|||
23614282|NCT00316589|65973281|FG003|Overall Study|Adverse Event|1|||
23614283|NCT00316589|65973278|FG000|Overall Study|Physician Decision|0|||
23614284|NCT00316589|65973279|FG001|Overall Study|Physician Decision|1|||
23614285|NCT00316589|65973280|FG002|Overall Study|Physician Decision|0|||
23614286|NCT00316589|65973281|FG003|Overall Study|Physician Decision|0|||
23614287|NCT00316589|65973278|FG000|Overall Study|Other reason|0|||
23614288|NCT00316589|65973279|FG001|Overall Study|Other reason|12|||
23614289|NCT00316589|65973280|FG002|Overall Study|Other reason|1|||
23614290|NCT00316589|65973281|FG003|Overall Study|Other reason|1|||
23614291|NCT02798861|65973284|FG000|Overall Study|Lost to Follow-up|22|||
23614292|NCT02798861|65973284|FG000|Overall Study|Withdrawal by Subject|1|||
23614293|NCT00938041|65973288|FG000|Overall Study|Lost to Follow-up|6|||
23614294|NCT00938041|65973288|FG000|Overall Study|Received Alternative Therapy|1|||
23614295|NCT00938041|65973288|FG000|Overall Study|Progressive Disease|5|||
23614296|NCT00938041|65973288|FG000|Overall Study|Death|12|||
23614297|NCT00938041|65973288|FG000|Overall Study|Adrenal Insufficiency|3|||
23614298|NCT01078571|65973289|FG000|Overall Study|Adverse Event|36|||
23614299|NCT01078571|65973289|FG000|Overall Study|Lack of effectiveness|36|||
23614300|NCT01078571|65973289|FG000|Overall Study|Reason not reported|21|||
23614301|NCT01078571|65973289|FG000|Overall Study|Withdrawal by Subject|12|||
23614302|NCT01078571|65973289|FG000|Overall Study|Lost to Follow-up|8|||
23614303|NCT01078571|65973289|FG000|Overall Study|Protocol Violation|2|||
23614304|NCT01133678|65973290|FG000|Overall Study|Death|1|||
23614305|NCT01133678|65973291|FG001|Overall Study|Death|1|||
23614306|NCT01270347|65973292|FG000|Core Phase|Adverse Event|1|||
23614307|NCT01270347|65973293|FG001|Core Phase|Adverse Event|6|||
23614308|NCT01270347|65973292|FG000|Core Phase|Withdrawal by Subject|1|||
23614309|NCT01270347|65973293|FG001|Core Phase|Withdrawal by Subject|2|||
23614310|NCT01270347|65973292|FG000|Core Phase|Lost to Follow-up|0|||
23614311|NCT01270347|65973293|FG001|Core Phase|Lost to Follow-up|1|||
23614312|NCT01270347|65973292|FG000|Core Phase|Miscellaneous|8|||
23614313|NCT01270347|65973293|FG001|Core Phase|Miscellaneous|14|||
23614314|NCT01270347|65973292|FG000|Extension Phase|Adverse Event|1|||
23614315|NCT01270347|65973293|FG001|Extension Phase|Adverse Event|3|||
23614316|NCT01270347|65973292|FG000|Extension Phase|Withdrawal by Subject|3|||
23614317|NCT01270347|65973293|FG001|Extension Phase|Withdrawal by Subject|4|||
23614318|NCT01270347|65973292|FG000|Extension Phase|Miscellaneous|2|||
23614319|NCT01270347|65973293|FG001|Extension Phase|Miscellaneous|2|||
23614320|NCT01038128|65973294|FG000|Overall Study|Lack of Efficacy|1|||
23614321|NCT01038128|65973294|FG000|Overall Study|Lost to Follow-up|1|||
23614322|NCT01038128|65973294|FG000|Overall Study|Withdrawal by Subject|2|||
23614323|NCT00821093|65973298|FG000|Overall Study|Adverse Event|20|||
23614324|NCT00821093|65973299|FG001|Overall Study|Adverse Event|12|||
23614325|NCT00821093|65973298|FG000|Overall Study|Withdrawal by Subject|9|||
23614326|NCT00821093|65973299|FG001|Overall Study|Withdrawal by Subject|13|||
23614327|NCT00821093|65973298|FG000|Overall Study|Lost to Follow-up|9|||
23614328|NCT00821093|65973299|FG001|Overall Study|Lost to Follow-up|3|||
23614329|NCT00821093|65973298|FG000|Overall Study|Protocol deviation|3|||
23614330|NCT00821093|65973299|FG001|Overall Study|Protocol deviation|6|||
23614331|NCT00821093|65973298|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23614332|NCT00821093|65973299|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23614333|NCT00821093|65973298|FG000|Overall Study|Lack of Efficacy|2|||
23614334|NCT00821093|65973299|FG001|Overall Study|Lack of Efficacy|2|||
23614335|NCT00821093|65973298|FG000|Overall Study|Death|2|||
23614336|NCT00821093|65973299|FG001|Overall Study|Death|1|||
23533184|NCT00559962|65686511|FG002|Overall Study|Withdrawal by Subject|2|||
23533185|NCT00559962|65686512|FG003|Overall Study|Withdrawal by Subject|0|||
23533186|NCT00559962|65686513|FG004|Overall Study|Withdrawal by Subject|3|||
23533187|NCT00559962|65686514|FG005|Overall Study|Withdrawal by Subject|1|||
23533188|NCT00559962|65686515|FG006|Overall Study|Withdrawal by Subject|0|||
23533189|NCT00559962|65686516|FG007|Overall Study|Withdrawal by Subject|2|||
23533190|NCT00559962|65686509|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23533191|NCT00559962|65686510|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
23533192|NCT00559962|65686511|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
23533193|NCT00559962|65686512|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
23533194|NCT00559962|65686513|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
23533195|NCT00559962|65686514|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
23533196|NCT00559962|65686515|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
23533197|NCT00559962|65686516|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
23533198|NCT00720876|65686519|FG000|Overall Study|found to be ineligible after starting tx|2|||
23533199|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533200|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533201|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533202|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533203|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
23533204|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533205|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
23533206|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533207|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533208|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533209|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
23533210|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533211|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533212|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
23533213|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
23533214|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533215|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533216|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533217|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533218|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
23533219|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533220|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533221|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533222|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533223|NCT00718042|65686520|FG000|Donor Follow-up|Lost to Follow-up|13|||
23533224|NCT00718042|65686521|FG001|Donor Follow-up|Lost to Follow-up|0|||
23533225|NCT00718042|65686522|FG002|Donor Follow-up|Lost to Follow-up|0|||
23721618|NCT01149343|66359120|FG003|Overall Study|Other|14|||
23721619|NCT01149343|66359117|FG000|Overall Study|Sponsor study termination|0|||
23721620|NCT01149343|66359118|FG001|Overall Study|Sponsor study termination|0|||
23721621|NCT01149343|66359119|FG002|Overall Study|Sponsor study termination|0|||
23721622|NCT01149343|66359120|FG003|Overall Study|Sponsor study termination|2|||
23721623|NCT01149343|66359117|FG000|Overall Study|Recurrence / Progressive disease|0|||
23721624|NCT01149343|66359118|FG001|Overall Study|Recurrence / Progressive disease|0|||
23721625|NCT01149343|66359119|FG002|Overall Study|Recurrence / Progressive disease|1|||
23533226|NCT00718042|65686523|FG003|Donor Follow-up|Lost to Follow-up|0|||
23533227|NCT00718042|65686524|FG004|Donor Follow-up|Lost to Follow-up|19|||
23533228|NCT00718042|65686525|FG005|Donor Follow-up|Lost to Follow-up|0|||
23533229|NCT01933932|65686530|FG000|Overall Study|Death|173|||
23533230|NCT01933932|65686531|FG001|Overall Study|Death|163|||
23533231|NCT01933932|65686530|FG000|Overall Study|Withdrawal by Subject|11|||
23533232|NCT01933932|65686531|FG001|Overall Study|Withdrawal by Subject|14|||
23533233|NCT01933932|65686530|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23533234|NCT01933932|65686531|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23533235|NCT00589108|65686536|FG000|Overall Study|Lost to Follow-up|1|||
23533236|NCT00589108|65686537|FG001|Overall Study|Lost to Follow-up|1|||
23533237|NCT00589108|65686538|FG002|Overall Study|Lost to Follow-up|1|||
23533238|NCT00589108|65686536|FG000|Overall Study|Death|3|||
23533239|NCT00589108|65686537|FG001|Overall Study|Death|3|||
23533240|NCT00589108|65686538|FG002|Overall Study|Death|4|||
23533241|NCT01461096|65686539|FG000|Overall Study|Death|3|||
23533242|NCT01461096|65686540|FG001|Overall Study|Death|6|||
23533243|NCT01461096|65686539|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23533244|NCT01461096|65686540|FG001|Overall Study|Severe debilitation, unable to continue|1|||
23721626|NCT01149343|66359120|FG003|Overall Study|Recurrence / Progressive disease|0|||
23721627|NCT02067533|66359121|FG000|Overall Study|Lost to Follow-up|4|||
23721628|NCT02067533|66359122|FG001|Overall Study|Lost to Follow-up|2|||
23721629|NCT02843178|66359125|FG000|Overall Study|Lost to Follow-up|8|||
23533245|NCT01461096|65686539|FG000|Overall Study|Subj not able to get to clinic|15|||
23533246|NCT01461096|65686540|FG001|Overall Study|Subj not able to get to clinic|13|||
23533247|NCT01461096|65686539|FG000|Overall Study|Site is closing|27|||
23533248|NCT01461096|65686540|FG001|Overall Study|Site is closing|30|||
23533249|NCT01461096|65686539|FG000|Overall Study|Withdrawal by Subject|5|||
23533250|NCT01461096|65686540|FG001|Overall Study|Withdrawal by Subject|3|||
23533251|NCT01461096|65686539|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
23533252|NCT01461096|65686540|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
23533253|NCT01461096|65686539|FG000|Overall Study|Lost to Follow-up|8|||
23533254|NCT01461096|65686540|FG001|Overall Study|Lost to Follow-up|4|||
23533255|NCT00098839|65686544|FG000|Overall Study|Adverse Event|5|||
23533256|NCT00098839|65686545|FG001|Overall Study|Adverse Event|2|||
23533257|NCT00098839|65686544|FG000|Overall Study|Death|1|||
23533258|NCT00098839|65686545|FG001|Overall Study|Death|2|||
23533259|NCT00098839|65686544|FG000|Overall Study|Physician Decision|4|||
23533260|NCT00098839|65686545|FG001|Overall Study|Physician Decision|14|||
23533261|NCT00098839|65686544|FG000|Overall Study|Withdrawal by Subject|1|||
23533262|NCT00098839|65686545|FG001|Overall Study|Withdrawal by Subject|0|||
23533263|NCT00098839|65686544|FG000|Overall Study|Refusal of further protocol therapy|3|||
23533264|NCT00098839|65686545|FG001|Overall Study|Refusal of further protocol therapy|1|||
23533265|NCT00098839|65686544|FG000|Overall Study|Relapse|6|||
23533266|NCT00098839|65686545|FG001|Overall Study|Relapse|3|||
23533267|NCT00098839|65686544|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
23533268|NCT00098839|65686545|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
23533269|NCT00098839|65686544|FG000|Overall Study|Ineligible|2|||
23533270|NCT00098839|65686545|FG001|Overall Study|Ineligible|0|||
23533271|NCT03511560|65686546|FG000|Overall Study|Death|0|||
23533272|NCT03511560|65686547|FG001|Overall Study|Death|1|||
23533273|NCT03511560|65686546|FG000|Overall Study|Adverse Event|0|||
23533274|NCT03511560|65686547|FG001|Overall Study|Adverse Event|2|||
23533275|NCT03511560|65686546|FG000|Overall Study|Transplant cancelled|0|||
23533276|NCT03511560|65686547|FG001|Overall Study|Transplant cancelled|1|||
23533277|NCT03511560|65686546|FG000|Overall Study|Patient switched to another drug|1|||
23533278|NCT03511560|65686547|FG001|Overall Study|Patient switched to another drug|0|||
23721630|NCT02843178|66359126|FG001|Overall Study|Lost to Follow-up|8|||
23721631|NCT02843178|66359127|FG002|Overall Study|Lost to Follow-up|6|||
23533279|NCT00436280|65686548|FG000|Period 1: Induction|Adverse Event|8|||
23533280|NCT00436280|65686548|FG000|Period 1: Induction|Progressive Disease|12|||
23533281|NCT00436280|65686548|FG000|Period 1: Induction|Stable Disease|6|||
23533282|NCT00436280|65686548|FG000|Period 1: Induction|Withdrawal by Subject|1|||
23533283|NCT00436280|65686548|FG000|Period 1: Induction|Death|1|||
23533284|NCT00436280|65686548|FG000|Period 2: Consolidation|Adverse Event|1|||
23533285|NCT00436280|65686548|FG000|Period 2: Consolidation|Progressive Disease|10|||
23533286|NCT00436280|65686548|FG000|Period 2: Consolidation|Stable Disease|1|||
23533287|NCT00436280|65686548|FG000|Period 2: Consolidation|Physician Decision|2|||
23533288|NCT00436280|65686548|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
23533289|NCT00436280|65686548|FG000|Period 2: Consolidation|Death|1|||
23533290|NCT00436280|65686548|FG000|Period 3: Maintenance|Adverse Event|6|||
23533291|NCT00436280|65686548|FG000|Period 3: Maintenance|Progressive Disease|12|||
23533292|NCT00727194|65686550|FG000|Screening Period|Low QMG scores|0|||
23533293|NCT00727194|65686551|FG001|Screening Period|Low QMG scores|0|||
23533294|NCT00727194|65686552|FG002|Screening Period|Low QMG scores|6|||
23533295|NCT00727194|65686550|FG000|Screening Period|Lacked AChR antibodies|0|||
23533296|NCT00727194|65686551|FG001|Screening Period|Lacked AChR antibodies|0|||
23533297|NCT00727194|65686552|FG002|Screening Period|Lacked AChR antibodies|5|||
23533298|NCT00727194|65686550|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
23533299|NCT00727194|65686551|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
23533300|NCT00727194|65686552|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
23533301|NCT00727194|65686550|FG000|Screening Period|Severe infections|0|||
23721632|NCT02843178|66359128|FG003|Overall Study|Lost to Follow-up|3|||
23533302|NCT00727194|65686551|FG001|Screening Period|Severe infections|0|||
23721633|NCT02843178|66359125|FG000|Overall Study|Withdrawal by Subject|0|||
23721634|NCT02843178|66359126|FG001|Overall Study|Withdrawal by Subject|0|||
23721635|NCT02843178|66359127|FG002|Overall Study|Withdrawal by Subject|1|||
23533303|NCT00727194|65686552|FG002|Screening Period|Severe infections|2|||
23533304|NCT00727194|65686550|FG000|Screening Period|History of thymoma|0|||
23533305|NCT00727194|65686551|FG001|Screening Period|History of thymoma|0|||
23533306|NCT00727194|65686552|FG002|Screening Period|History of thymoma|1|||
23533307|NCT00727194|65686550|FG000|Treatment Period 2|Lack of Efficacy|0|||
23533308|NCT00727194|65686551|FG001|Treatment Period 2|Lack of Efficacy|1|||
23533309|NCT00727194|65686552|FG002|Treatment Period 2|Lack of Efficacy|0|||
23533310|NCT03085927|65686553|FG000|Overall Study|Withdrawal by Subject|1|||
23533311|NCT03085927|65686554|FG001|Overall Study|Withdrawal by Subject|4|||
23533312|NCT03085927|65686553|FG000|Overall Study|Lost to Follow-up|3|||
23721636|NCT02843178|66359128|FG003|Overall Study|Withdrawal by Subject|1|||
23721637|NCT01590212|66359129|FG000|Overall Study|Withdrawal by Subject|2|||
23814836|NCT01783548|66703378|FG000|Overall Study|Adverse Event|8|||
23533313|NCT03085927|65686554|FG001|Overall Study|Lost to Follow-up|1|||
23533314|NCT03085927|65686553|FG000|Overall Study|Death|1|||
23533315|NCT03085927|65686554|FG001|Overall Study|Death|0|||
23533316|NCT03085927|65686553|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
23533317|NCT03085927|65686554|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
23533318|NCT03085927|65686553|FG000|Overall Study|Dyad Became Ineligible|0|||
23533319|NCT03085927|65686554|FG001|Overall Study|Dyad Became Ineligible|1|||
23533320|NCT02711800|65686565|FG000|Overall Study|Lost to Follow-up|1|||
23533321|NCT02711800|65686565|FG000|Overall Study|Withdrawal by Subject|1|||
23533322|NCT01978184|65686566|FG000|Overall Study|Progressive disease|5|||
23533323|NCT01978184|65686567|FG001|Overall Study|Progressive disease|5|||
23533324|NCT01978184|65686566|FG000|Overall Study|Other than PDA|2|||
23533325|NCT01978184|65686567|FG001|Overall Study|Other than PDA|2|||
23533326|NCT01978184|65686566|FG000|Overall Study|Physician Decision|0|||
23533327|NCT01978184|65686567|FG001|Overall Study|Physician Decision|3|||
23533328|NCT01978184|65686566|FG000|Overall Study|Noncompliance|1|||
23614337|NCT00821093|65973298|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23614338|NCT00821093|65973299|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23614339|NCT00821093|65973298|FG000|Overall Study|Administrative problems|1|||
23614340|NCT00821093|65973299|FG001|Overall Study|Administrative problems|2|||
23614341|NCT03320941|65973300|FG000|Overall Study|subject/guardian decision|0|||
23614342|NCT03320941|65973301|FG001|Overall Study|subject/guardian decision|0|||
23614343|NCT03320941|65973302|FG002|Overall Study|subject/guardian decision|0|||
23614344|NCT03320941|65973303|FG003|Overall Study|subject/guardian decision|1|||
23614345|NCT03320941|65973304|FG004|Overall Study|subject/guardian decision|0|||
23614346|NCT00417989|65973309|FG000|Overall Study|Withdrawal by Subject|13|||
23614347|NCT00417989|65973310|FG001|Overall Study|Withdrawal by Subject|13|||
23614348|NCT00417989|65973309|FG000|Overall Study|Lost to Follow-up|1|||
23614349|NCT00417989|65973310|FG001|Overall Study|Lost to Follow-up|6|||
23614350|NCT00417989|65973309|FG000|Overall Study|Protocol Violation|1|||
23614351|NCT00417989|65973310|FG001|Overall Study|Protocol Violation|0|||
23614352|NCT00417989|65973309|FG000|Overall Study|Death|0|||
23614353|NCT00417989|65973310|FG001|Overall Study|Death|1|||
23614354|NCT00417989|65973309|FG000|Overall Study|Physician Decision|5|||
23614355|NCT00417989|65973310|FG001|Overall Study|Physician Decision|2|||
23614356|NCT04267393|65973313|FG000|Randomization|Adverse Event|1|||
23614357|NCT04267393|65973314|FG001|Randomization|Adverse Event|0|||
23614358|NCT04267393|65973315|FG002|Randomization|Adverse Event|0|||
23614359|NCT04267393|65973313|FG000|Randomization|Administrative Reasons by Sponsor|0|||
23614360|NCT04267393|65973314|FG001|Randomization|Administrative Reasons by Sponsor|1|||
23614361|NCT04267393|65973315|FG002|Randomization|Administrative Reasons by Sponsor|0|||
23614362|NCT04267393|65973313|FG000|Treatment Period|Adverse Event|0|||
23614363|NCT04267393|65973314|FG001|Treatment Period|Adverse Event|2|||
23614364|NCT04267393|65973315|FG002|Treatment Period|Adverse Event|3|||
23614365|NCT04267393|65973313|FG000|Treatment Period|Participant Withdrew Consent|0|||
23614366|NCT04267393|65973314|FG001|Treatment Period|Participant Withdrew Consent|0|||
23614367|NCT04267393|65973315|FG002|Treatment Period|Participant Withdrew Consent|1|||
23614368|NCT04267393|65973313|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
23614369|NCT04267393|65973314|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
23614370|NCT04267393|65973315|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
23614371|NCT00857311|65973317|FG000|Overall Study|Lost to Follow-up|1|||
23614372|NCT00857311|65973318|FG001|Overall Study|Lost to Follow-up|0|||
23614373|NCT00857311|65973319|FG002|Overall Study|Lost to Follow-up|0|||
23614374|NCT00857311|65973320|FG003|Overall Study|Lost to Follow-up|0|||
23614375|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
23614376|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23614377|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
23614378|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
23614379|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
23614380|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
23614381|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
23614382|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
23614383|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
23614384|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23614385|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23614386|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23533329|NCT01978184|65686567|FG001|Overall Study|Noncompliance|2|||
23533330|NCT01978184|65686566|FG000|Overall Study|Death|1|||
23533331|NCT01978184|65686567|FG001|Overall Study|Death|0|||
23533332|NCT01978184|65686566|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
23614387|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
23614388|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
23614389|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
23533333|NCT01978184|65686567|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
23614390|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
23614391|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
23614392|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
23614393|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
23614394|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
23614395|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
23614396|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
23614397|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
23614398|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
23614399|NCT01294358|65973324|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614400|NCT01294358|65973325|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
23614401|NCT01294358|65973326|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614402|NCT01294358|65973327|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614403|NCT01294358|65973328|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614404|NCT01294358|65973324|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614405|NCT01294358|65973325|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614406|NCT01294358|65973326|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
23614407|NCT01294358|65973327|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23721638|NCT01590212|66359130|FG001|Overall Study|Withdrawal by Subject|2|||
23721639|NCT01590212|66359131|FG002|Overall Study|Withdrawal by Subject|2|||
23721640|NCT01590212|66359129|FG000|Overall Study|Lost to Follow-up|1|||
23721641|NCT01590212|66359130|FG001|Overall Study|Lost to Follow-up|2|||
23721642|NCT01590212|66359131|FG002|Overall Study|Lost to Follow-up|3|||
23721643|NCT00557323|66359132|FG000|Overall Study|Death|3|||
23721644|NCT00557323|66359132|FG000|Overall Study|Withdrawal by Subject|2|||
23721645|NCT00557323|66359132|FG000|Overall Study|Administrative change|2|||
23721646|NCT00291499|66359133|FG000|Overall Study|Adverse Event|3|||
23721647|NCT00291499|66359134|FG001|Overall Study|Adverse Event|8|||
23721648|NCT00291499|66359133|FG000|Overall Study|Change to other therapy|2|||
23721649|NCT00291499|66359134|FG001|Overall Study|Change to other therapy|1|||
23721650|NCT00291499|66359133|FG000|Overall Study|Intercurrent illness|1|||
23721651|NCT00291499|66359134|FG001|Overall Study|Intercurrent illness|0|||
23721652|NCT00291499|66359133|FG000|Overall Study|Protocol Violation|2|||
23614408|NCT01294358|65973328|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614409|NCT01294358|65973324|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614410|NCT01294358|65973325|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614411|NCT01294358|65973326|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614412|NCT01294358|65973327|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
23614413|NCT01294358|65973328|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614414|NCT01294358|65973324|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614415|NCT01294358|65973325|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614416|NCT01294358|65973326|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614417|NCT01294358|65973327|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614418|NCT01294358|65973328|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
23614419|NCT00191984|65973333|FG000|Overall Study|Disease Progression|21|||
23614420|NCT00191984|65973333|FG000|Overall Study|Adverse Event|4|||
23614421|NCT00191984|65973333|FG000|Overall Study|Death|2|||
23614422|NCT00191984|65973333|FG000|Overall Study|Entry Criteria Exclusion|1|||
23614423|NCT00191984|65973333|FG000|Overall Study|Withdrawal by Subject|7|||
23614424|NCT00191984|65973333|FG000|Overall Study|Physician Decision|4|||
23614425|NCT00005908|65973334|FG000|Overall Study|Withdrawal by Subject|1|||
23614426|NCT00005908|65973335|FG001|Overall Study|Withdrawal by Subject|0|||
23614427|NCT02152995|65973336|FG000|Overall Study|Withdrawal by Subject|1|||
23721653|NCT00291499|66359134|FG001|Overall Study|Protocol Violation|2|||
23721654|NCT00291499|66359133|FG000|Overall Study|Other reasons|1|||
23721655|NCT00291499|66359134|FG001|Overall Study|Other reasons|4|||
23721656|NCT00064077|66359140|FG000|Overall Study|Improper prior treatment|1|||
23721657|NCT00064077|66359141|FG001|Overall Study|Improper prior treatment|0|||
23721658|NCT00064077|66359142|FG002|Overall Study|Improper prior treatment|0|||
23721659|NCT00064077|66359143|FG003|Overall Study|Improper prior treatment|0|||
23721660|NCT00064077|66359140|FG000|Overall Study|Poor risk|2|||
23721661|NCT00064077|66359141|FG001|Overall Study|Poor risk|0|||
23721662|NCT00064077|66359142|FG002|Overall Study|Poor risk|1|||
23721663|NCT00064077|66359143|FG003|Overall Study|Poor risk|1|||
23614428|NCT02152995|65973337|FG001|Overall Study|Withdrawal by Subject|0|||
23614429|NCT01631825|65973338|FG000|Overall Study|Adverse Event|42|||
23721664|NCT00064077|66359140|FG000|Overall Study|Pathology|10|||
23721665|NCT00064077|66359141|FG001|Overall Study|Pathology|7|||
23721666|NCT00064077|66359142|FG002|Overall Study|Pathology|3|||
23721667|NCT00064077|66359143|FG003|Overall Study|Pathology|4|||
23721668|NCT00064077|66359140|FG000|Overall Study|No surgery|0|||
23721669|NCT00064077|66359141|FG001|Overall Study|No surgery|0|||
23721670|NCT00064077|66359142|FG002|Overall Study|No surgery|1|||
23721671|NCT00064077|66359143|FG003|Overall Study|No surgery|0|||
23721672|NCT00064077|66359140|FG000|Overall Study|No tumor|0|||
23533334|NCT00723606|65686568|FG000|Overall Study|Adverse Event|2|||
23533335|NCT00723606|65686569|FG001|Overall Study|Adverse Event|5|||
23721673|NCT00064077|66359141|FG001|Overall Study|No tumor|0|||
23721674|NCT00064077|66359142|FG002|Overall Study|No tumor|1|||
23721675|NCT00064077|66359143|FG003|Overall Study|No tumor|0|||
23721676|NCT00064077|66359140|FG000|Overall Study|Other reasons|2|||
23721677|NCT00064077|66359141|FG001|Overall Study|Other reasons|2|||
23721678|NCT00064077|66359142|FG002|Overall Study|Other reasons|1|||
23721679|NCT00064077|66359143|FG003|Overall Study|Other reasons|2|||
23721680|NCT00656084|66359144|FG000|Overall Study|Adverse Event|4|||
23721681|NCT00656084|66359144|FG000|Overall Study|Withdrawal by Subject|1|||
23721682|NCT00656084|66359144|FG000|Overall Study|Patient Request|1|||
23721683|NCT00656084|66359144|FG000|Overall Study|Investigator Request|1|||
23721684|NCT00718523|66359147|FG000|Overall Study|Withdrawal by Subject|5|||
23721685|NCT00718523|66359148|FG001|Overall Study|Withdrawal by Subject|7|||
23721686|NCT00718523|66359147|FG000|Overall Study|Death|13|||
23721687|NCT00718523|66359148|FG001|Overall Study|Death|17|||
23721688|NCT00659126|66359149|FG000|Overall Study|Adverse Event|2|||
23721689|NCT00659126|66359150|FG001|Overall Study|Adverse Event|2|||
23721690|NCT00659126|66359149|FG000|Overall Study|Screen failure|1|||
23721691|NCT00659126|66359150|FG001|Overall Study|Screen failure|1|||
23721692|NCT00659126|66359149|FG000|Overall Study|Technical problems with MRI|0|||
23721693|NCT00659126|66359150|FG001|Overall Study|Technical problems with MRI|1|||
23721694|NCT04397796|66359152|FG000|Overall Study|Death|3|||
23721695|NCT04397796|66359153|FG001|Overall Study|Death|1|||
23721696|NCT03673956|66359154|FG000|Overall Study|Lost to Follow-up|1|||
23721697|NCT03673956|66359155|FG001|Overall Study|Lost to Follow-up|0|||
23721698|NCT03673956|66359156|FG002|Overall Study|Lost to Follow-up|0|||
23721699|NCT03673956|66359157|FG003|Overall Study|Lost to Follow-up|0|||
23721700|NCT03673956|66359154|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
23721701|NCT03673956|66359155|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23721702|NCT03673956|66359156|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23721703|NCT03673956|66359157|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23721704|NCT01803711|66359158|FG000|Overall Study|Adverse Event|1|||
23721705|NCT01803711|66359159|FG001|Overall Study|Adverse Event|1|||
23721706|NCT03228394|66359160|FG000|Overall Study|Lost to Follow-up|0|||
23721707|NCT03228394|66359161|FG001|Overall Study|Lost to Follow-up|0|||
23721708|NCT03228394|66359162|FG002|Overall Study|Lost to Follow-up|1|||
23721709|NCT03228394|66359163|FG003|Overall Study|Lost to Follow-up|1|||
23721710|NCT03228394|66359164|FG004|Overall Study|Lost to Follow-up|0|||
23721711|NCT03228394|66359165|FG005|Overall Study|Lost to Follow-up|0|||
23721712|NCT03228394|66359166|FG006|Overall Study|Lost to Follow-up|2|||
23721713|NCT03228394|66359167|FG007|Overall Study|Lost to Follow-up|0|||
23721714|NCT03228394|66359160|FG000|Overall Study|Withdrawal by Subject|0|||
23721715|NCT03228394|66359161|FG001|Overall Study|Withdrawal by Subject|0|||
23721716|NCT03228394|66359162|FG002|Overall Study|Withdrawal by Subject|1|||
23721717|NCT03228394|66359163|FG003|Overall Study|Withdrawal by Subject|0|||
23721718|NCT03228394|66359164|FG004|Overall Study|Withdrawal by Subject|0|||
23721719|NCT03228394|66359165|FG005|Overall Study|Withdrawal by Subject|0|||
23721720|NCT03228394|66359166|FG006|Overall Study|Withdrawal by Subject|1|||
23721721|NCT03228394|66359167|FG007|Overall Study|Withdrawal by Subject|3|||
23721722|NCT03228394|66359160|FG000|Overall Study|Protocol Violation|0|||
23721723|NCT03228394|66359161|FG001|Overall Study|Protocol Violation|0|||
23721724|NCT03228394|66359162|FG002|Overall Study|Protocol Violation|0|||
23721725|NCT03228394|66359163|FG003|Overall Study|Protocol Violation|1|||
23721726|NCT03228394|66359164|FG004|Overall Study|Protocol Violation|0|||
23721727|NCT03228394|66359165|FG005|Overall Study|Protocol Violation|0|||
23721728|NCT03228394|66359166|FG006|Overall Study|Protocol Violation|0|||
23721729|NCT03228394|66359167|FG007|Overall Study|Protocol Violation|0|||
23721730|NCT03228394|66359160|FG000|Overall Study|Physician Decision|0|||
23721731|NCT03228394|66359161|FG001|Overall Study|Physician Decision|0|||
23721732|NCT03228394|66359162|FG002|Overall Study|Physician Decision|0|||
23721733|NCT03228394|66359163|FG003|Overall Study|Physician Decision|0|||
23721734|NCT03228394|66359164|FG004|Overall Study|Physician Decision|0|||
23721735|NCT03228394|66359165|FG005|Overall Study|Physician Decision|0|||
23721736|NCT03228394|66359166|FG006|Overall Study|Physician Decision|1|||
23721737|NCT03228394|66359167|FG007|Overall Study|Physician Decision|0|||
23721738|NCT03228394|66359160|FG000|Overall Study|Noncompliance|0|||
23721739|NCT03228394|66359161|FG001|Overall Study|Noncompliance|0|||
23721740|NCT03228394|66359162|FG002|Overall Study|Noncompliance|0|||
23721741|NCT03228394|66359163|FG003|Overall Study|Noncompliance|0|||
23721742|NCT03228394|66359164|FG004|Overall Study|Noncompliance|0|||
23721743|NCT03228394|66359165|FG005|Overall Study|Noncompliance|0|||
23721744|NCT03228394|66359166|FG006|Overall Study|Noncompliance|1|||
23721745|NCT03228394|66359167|FG007|Overall Study|Noncompliance|0|||
23721746|NCT00510484|66359170|FG000|Wash-out Period|Adverse Event|0|||
23721747|NCT00510484|66359171|FG001|Wash-out Period|Adverse Event|1|||
23721748|NCT01015820|66359173|FG000|Overall Study|Suboptimal measurements|1|||
23721749|NCT01015820|66359174|FG001|Overall Study|Suboptimal measurements|0|||
23721750|NCT01306032|66359177|FG000|First Intervention|Adverse Event|1|||
23721751|NCT01306032|66359178|FG001|First Intervention|Adverse Event|0|||
23721752|NCT01306032|66359179|FG002|First Intervention|Adverse Event|1|||
23721753|NCT01306032|66359180|FG003|First Intervention|Adverse Event|0|||
23721754|NCT01306032|66359181|FG004|First Intervention|Adverse Event|0|||
23721755|NCT01306032|66359182|FG005|First Intervention|Adverse Event|1|||
23721756|NCT01306032|66359177|FG000|First Intervention|Withdrawal by Subject|0|||
23721757|NCT01306032|66359178|FG001|First Intervention|Withdrawal by Subject|2|||
23721758|NCT01306032|66359179|FG002|First Intervention|Withdrawal by Subject|0|||
23721759|NCT01306032|66359180|FG003|First Intervention|Withdrawal by Subject|1|||
23721760|NCT01306032|66359181|FG004|First Intervention|Withdrawal by Subject|0|||
23721761|NCT01306032|66359182|FG005|First Intervention|Withdrawal by Subject|0|||
23721762|NCT01306032|66359177|FG000|First Intervention|Death|0|||
23721763|NCT01306032|66359178|FG001|First Intervention|Death|0|||
23721764|NCT01306032|66359179|FG002|First Intervention|Death|1|||
23814837|NCT01783548|66703379|FG001|Overall Study|Adverse Event|4|||
23814838|NCT01783548|66703378|FG000|Overall Study|Withdrawal by Subject|11|||
23721765|NCT01306032|66359180|FG003|First Intervention|Death|0|||
23721766|NCT01306032|66359181|FG004|First Intervention|Death|0|||
23814839|NCT01783548|66703379|FG001|Overall Study|Withdrawal by Subject|8|||
23814840|NCT01783548|66703378|FG000|Overall Study|Non-compliance|4|||
23814841|NCT01783548|66703379|FG001|Overall Study|Non-compliance|0|||
23814842|NCT01783548|66703378|FG000|Overall Study|Protocol Violation|2|||
23814843|NCT01783548|66703379|FG001|Overall Study|Protocol Violation|2|||
23814844|NCT01783548|66703378|FG000|Overall Study|Lost to Follow-up|8|||
23814845|NCT01783548|66703379|FG001|Overall Study|Lost to Follow-up|3|||
23814846|NCT01783548|66703378|FG000|Overall Study|Lack of Efficacy|1|||
23814847|NCT01783548|66703379|FG001|Overall Study|Lack of Efficacy|1|||
23814848|NCT01635218|66703380|FG000|Overall Study|Lost to Follow-up|3|||
23814849|NCT01635218|66703381|FG001|Overall Study|Lost to Follow-up|7|||
23814850|NCT01635218|66703382|FG002|Overall Study|Lost to Follow-up|6|||
23421286|NCT01468207|65284001|FG005|Treatment Period 1|Other|0|||
23421287|NCT01468207|65283996|FG000|Treatment Period 2|Adverse Event|0|||
23421288|NCT01468207|65283997|FG001|Treatment Period 2|Adverse Event|0|||
23421289|NCT01468207|65283998|FG002|Treatment Period 2|Adverse Event|6|||
23421290|NCT01468207|65283999|FG003|Treatment Period 2|Adverse Event|1|||
23421291|NCT01468207|65284000|FG004|Treatment Period 2|Adverse Event|2|||
23421292|NCT01468207|65284001|FG005|Treatment Period 2|Adverse Event|1|||
23421293|NCT01468207|65283996|FG000|Treatment Period 2|Lack of Efficacy|0|||
23421294|NCT01468207|65283997|FG001|Treatment Period 2|Lack of Efficacy|0|||
23421295|NCT01468207|65283998|FG002|Treatment Period 2|Lack of Efficacy|1|||
23421296|NCT01468207|65283999|FG003|Treatment Period 2|Lack of Efficacy|1|||
23421297|NCT01468207|65284000|FG004|Treatment Period 2|Lack of Efficacy|0|||
23421298|NCT01468207|65284001|FG005|Treatment Period 2|Lack of Efficacy|2|||
23421299|NCT01468207|65283996|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23421300|NCT01468207|65283997|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23421301|NCT01468207|65283998|FG002|Treatment Period 2|Withdrawal by Subject|5|||
23421302|NCT01468207|65283999|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23421303|NCT01468207|65284000|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23421304|NCT01468207|65284001|FG005|Treatment Period 2|Withdrawal by Subject|2|||
23421305|NCT01468207|65283996|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
23421306|NCT01468207|65283997|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
23421307|NCT01468207|65283998|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
23421308|NCT01468207|65283999|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
23421309|NCT01468207|65284000|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
23421310|NCT01468207|65284001|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
23421311|NCT01468207|65283996|FG000|Treatment Period 2|Lost to Follow-up|0|||
23721767|NCT01306032|66359182|FG005|First Intervention|Death|0|||
23721768|NCT01306032|66359177|FG000|First Intervention|Ineligible|0|||
23721769|NCT01306032|66359178|FG001|First Intervention|Ineligible|0|||
23721770|NCT01306032|66359179|FG002|First Intervention|Ineligible|0|||
23721771|NCT01306032|66359180|FG003|First Intervention|Ineligible|0|||
23721772|NCT01306032|66359181|FG004|First Intervention|Ineligible|0|||
23814851|NCT00922272|66703385|FG000|Open-label Phase|Adverse Event|5|||
23814852|NCT00922272|66703386|FG001|Open-label Phase|Adverse Event|0|||
23814853|NCT00922272|66703385|FG000|Open-label Phase|Protocol Violation|1|||
23814854|NCT00922272|66703386|FG001|Open-label Phase|Protocol Violation|0|||
23814855|NCT00922272|66703385|FG000|Open-label Phase|Withdrawal by Subject|11|||
23421312|NCT01468207|65283997|FG001|Treatment Period 2|Lost to Follow-up|0|||
23421313|NCT01468207|65283998|FG002|Treatment Period 2|Lost to Follow-up|5|||
23421314|NCT01468207|65283999|FG003|Treatment Period 2|Lost to Follow-up|1|||
23421315|NCT01468207|65284000|FG004|Treatment Period 2|Lost to Follow-up|0|||
23421316|NCT01468207|65284001|FG005|Treatment Period 2|Lost to Follow-up|0|||
23421317|NCT01468207|65283996|FG000|Treatment Period 2|Other|0|||
23421318|NCT01468207|65283997|FG001|Treatment Period 2|Other|0|||
23421319|NCT01468207|65283998|FG002|Treatment Period 2|Other|5|||
23421320|NCT01468207|65283999|FG003|Treatment Period 2|Other|1|||
23421321|NCT01468207|65284000|FG004|Treatment Period 2|Other|1|||
23421322|NCT01468207|65284001|FG005|Treatment Period 2|Other|2|||
23721773|NCT01306032|66359182|FG005|First Intervention|Ineligible|1|||
23721774|NCT01306032|66359177|FG000|First Intervention|Progressive disease|0|||
23721775|NCT01306032|66359178|FG001|First Intervention|Progressive disease|0|||
23721776|NCT01306032|66359179|FG002|First Intervention|Progressive disease|0|||
23721777|NCT01306032|66359180|FG003|First Intervention|Progressive disease|0|||
23421323|NCT01804582|65284007|FG000|Overall Study|Lost to Follow-up|47|||
23421324|NCT01804582|65284008|FG001|Overall Study|Lost to Follow-up|56|||
23421325|NCT01804582|65284007|FG000|Overall Study|Physician Decision|2|||
23421326|NCT01804582|65284008|FG001|Overall Study|Physician Decision|0|||
23421327|NCT02185014|65284011|FG000|Overall Study|Adverse Event|18|||
23421328|NCT02185014|65284011|FG000|Overall Study|Withdrew Consent|8|||
23421329|NCT02185014|65284011|FG000|Overall Study|Lost to Follow-up|4|||
23421330|NCT02185014|65284011|FG000|Overall Study|Lack of Efficacy|14|||
23421331|NCT02185014|65284011|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
23421332|NCT02185014|65284011|FG000|Overall Study|Subject Noncompliance|1|||
23533336|NCT00723606|65686568|FG000|Overall Study|Other|2|||
23533337|NCT00723606|65686569|FG001|Overall Study|Other|0|||
23533338|NCT00723606|65686568|FG000|Overall Study|Withdrawal by Subject|0|||
23533339|NCT00723606|65686569|FG001|Overall Study|Withdrawal by Subject|2|||
23533340|NCT03614793|65686570|FG000|Overall Study|Lost to Follow-up|1|||
23533341|NCT03614793|65686571|FG001|Overall Study|Lost to Follow-up|2|||
23533342|NCT03614793|65686570|FG000|Overall Study|Lack of Efficacy|0|||
23533343|NCT03614793|65686571|FG001|Overall Study|Lack of Efficacy|5|||
23533344|NCT03614793|65686570|FG000|Overall Study|Withdrawal by Subject|0|||
23533345|NCT03614793|65686571|FG001|Overall Study|Withdrawal by Subject|1|||
23533346|NCT03614793|65686570|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
23533347|NCT03614793|65686571|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
23533348|NCT02649972|65686572|FG000|Overall Study|Not treated|1|||
23533349|NCT04360824|65686575|FG000|Overall Study|Withdrawal by Subject|2|||
23533350|NCT04360824|65686576|FG001|Overall Study|Withdrawal by Subject|1|||
23533351|NCT04360824|65686575|FG000|Overall Study|Did not receive assigned treatment|1|||
23533352|NCT04360824|65686576|FG001|Overall Study|Did not receive assigned treatment|3|||
23533353|NCT03351049|65686577|FG000|Overall Study|Withdrawal|26|||
23533354|NCT03351049|65686578|FG001|Overall Study|Withdrawal|22|||
23533355|NCT02504866|65686579|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
23533356|NCT02504866|65686580|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
23533357|NCT02504866|65686581|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
23533358|NCT02465528|65686582|FG000|Overall Study|Progressive disease|0|||
23533359|NCT02465528|65686583|FG001|Overall Study|Progressive disease|2|||
23533360|NCT02465528|65686584|FG002|Overall Study|Progressive disease|9|||
23533361|NCT02465528|65686585|FG003|Overall Study|Progressive disease|4|||
23533362|NCT02465528|65686582|FG000|Overall Study|Study terminated by sponsor|1|||
23533363|NCT02465528|65686583|FG001|Overall Study|Study terminated by sponsor|2|||
23533364|NCT02465528|65686584|FG002|Overall Study|Study terminated by sponsor|0|||
23533365|NCT02465528|65686585|FG003|Overall Study|Study terminated by sponsor|0|||
23533366|NCT02465528|65686582|FG000|Overall Study|Withdrawal by Subject|0|||
23533367|NCT02465528|65686583|FG001|Overall Study|Withdrawal by Subject|0|||
23614430|NCT01631825|65973338|FG000|Overall Study|Lack of Efficacy|7|||
23614431|NCT01631825|65973338|FG000|Overall Study|Withdrawal by Subject|9|||
23614432|NCT01631825|65973338|FG000|Overall Study|Protocol Violation|4|||
23614433|NCT01631825|65973338|FG000|Overall Study|Discontinuation criteria|1|||
23614434|NCT01631825|65973338|FG000|Overall Study|Physician Decision|2|||
23614435|NCT00215943|65973339|FG000|Overall Study|Disease Progression|3|||
23614436|NCT00215943|65973340|FG001|Overall Study|Disease Progression|5|||
23614437|NCT00215943|65973339|FG000|Overall Study|Alternate therapy|0|||
23614438|NCT00215943|65973340|FG001|Overall Study|Alternate therapy|1|||
23614439|NCT00215943|65973339|FG000|Overall Study|Adverse Event|3|||
23421333|NCT02185014|65284011|FG000|Overall Study|Other|4|||
23533368|NCT02465528|65686584|FG002|Overall Study|Withdrawal by Subject|2|||
23533369|NCT02465528|65686585|FG003|Overall Study|Withdrawal by Subject|0|||
23533370|NCT02465528|65686582|FG000|Overall Study|Adverse Event|0|||
23533371|NCT02465528|65686583|FG001|Overall Study|Adverse Event|0|||
23533372|NCT02465528|65686584|FG002|Overall Study|Adverse Event|0|||
23533373|NCT02465528|65686585|FG003|Overall Study|Adverse Event|1|||
23533374|NCT02465528|65686582|FG000|Overall Study|Physician Decision|0|||
23614440|NCT00215943|65973340|FG001|Overall Study|Adverse Event|6|||
23614441|NCT00215943|65973339|FG000|Overall Study|Other disease|0|||
23721778|NCT01306032|66359181|FG004|First Intervention|Progressive disease|2|||
23721779|NCT01306032|66359182|FG005|First Intervention|Progressive disease|0|||
23421334|NCT02118766|65284012|FG000|Overall Study|Adverse Event|7|||
23421335|NCT02118766|65284013|FG001|Overall Study|Adverse Event|2|||
23421336|NCT02118766|65284012|FG000|Overall Study|Withdrawal by Subject|3|||
23533375|NCT02465528|65686583|FG001|Overall Study|Physician Decision|0|||
23533376|NCT02465528|65686584|FG002|Overall Study|Physician Decision|1|||
23533377|NCT02465528|65686585|FG003|Overall Study|Physician Decision|0|||
23533378|NCT03194646|65686590|FG000|Overall Study|Adverse Event|24|||
23533379|NCT03194646|65686591|FG001|Overall Study|Adverse Event|25|||
23533380|NCT03194646|65686592|FG002|Overall Study|Adverse Event|14|||
23533381|NCT03194646|65686593|FG003|Overall Study|Adverse Event|17|||
23533382|NCT03194646|65686590|FG000|Overall Study|Lack of Efficacy|4|||
23533383|NCT03194646|65686591|FG001|Overall Study|Lack of Efficacy|2|||
23533384|NCT03194646|65686592|FG002|Overall Study|Lack of Efficacy|2|||
23533385|NCT03194646|65686593|FG003|Overall Study|Lack of Efficacy|12|||
23533386|NCT03194646|65686590|FG000|Overall Study|Lost to Follow-up|30|||
23533387|NCT03194646|65686591|FG001|Overall Study|Lost to Follow-up|22|||
23533388|NCT03194646|65686592|FG002|Overall Study|Lost to Follow-up|12|||
23533389|NCT03194646|65686593|FG003|Overall Study|Lost to Follow-up|35|||
23533390|NCT03194646|65686590|FG000|Overall Study|Non-compliance with study drug|4|||
23533391|NCT03194646|65686591|FG001|Overall Study|Non-compliance with study drug|0|||
23533392|NCT03194646|65686592|FG002|Overall Study|Non-compliance with study drug|1|||
23533393|NCT03194646|65686593|FG003|Overall Study|Non-compliance with study drug|1|||
23533394|NCT03194646|65686590|FG000|Overall Study|Other|89|||
23533395|NCT03194646|65686591|FG001|Overall Study|Other|68|||
23533396|NCT03194646|65686592|FG002|Overall Study|Other|34|||
23533397|NCT03194646|65686593|FG003|Overall Study|Other|31|||
23533398|NCT03194646|65686590|FG000|Overall Study|Physician Decision|7|||
23533399|NCT03194646|65686591|FG001|Overall Study|Physician Decision|9|||
23533400|NCT03194646|65686592|FG002|Overall Study|Physician Decision|5|||
23533401|NCT03194646|65686593|FG003|Overall Study|Physician Decision|4|||
23533402|NCT03194646|65686590|FG000|Overall Study|Pregnancy|4|||
23533403|NCT03194646|65686591|FG001|Overall Study|Pregnancy|5|||
23533404|NCT03194646|65686592|FG002|Overall Study|Pregnancy|1|||
23533405|NCT03194646|65686593|FG003|Overall Study|Pregnancy|2|||
23533406|NCT03194646|65686590|FG000|Overall Study|Protocol Violation|4|||
23533407|NCT03194646|65686591|FG001|Overall Study|Protocol Violation|2|||
23533408|NCT03194646|65686592|FG002|Overall Study|Protocol Violation|1|||
23533409|NCT03194646|65686593|FG003|Overall Study|Protocol Violation|1|||
23533410|NCT03194646|65686590|FG000|Overall Study|Site terminated by sponsor|0|||
23533411|NCT03194646|65686591|FG001|Overall Study|Site terminated by sponsor|0|||
23533412|NCT03194646|65686592|FG002|Overall Study|Site terminated by sponsor|2|||
23533413|NCT03194646|65686593|FG003|Overall Study|Site terminated by sponsor|0|||
23533414|NCT03194646|65686590|FG000|Overall Study|Study terminated by sponsor|62|||
23614442|NCT00215943|65973340|FG001|Overall Study|Other disease|1|||
23614443|NCT00215943|65973339|FG000|Overall Study|Other complications|3|||
23721780|NCT01306032|66359177|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
23721781|NCT01306032|66359178|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
23721782|NCT01306032|66359179|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
23614444|NCT00215943|65973340|FG001|Overall Study|Other complications|1|||
23614445|NCT00267956|65973341|FG000|Controlled Period|Adverse Event|4|||
23614446|NCT00267956|65973342|FG001|Controlled Period|Adverse Event|1|||
23533415|NCT03194646|65686591|FG001|Overall Study|Study terminated by sponsor|61|||
23533416|NCT03194646|65686592|FG002|Overall Study|Study terminated by sponsor|30|||
23533417|NCT03194646|65686593|FG003|Overall Study|Study terminated by sponsor|34|||
23614447|NCT00267956|65973343|FG002|Controlled Period|Adverse Event|0|||
23614448|NCT00267956|65973344|FG003|Controlled Period|Adverse Event|0|||
23614449|NCT00267956|65973341|FG000|Controlled Period|Lack of Efficacy|4|||
23614450|NCT00267956|65973342|FG001|Controlled Period|Lack of Efficacy|2|||
23614451|NCT00267956|65973343|FG002|Controlled Period|Lack of Efficacy|0|||
23614452|NCT00267956|65973344|FG003|Controlled Period|Lack of Efficacy|0|||
23614453|NCT00267956|65973341|FG000|Controlled Period|Lost to Follow-up|2|||
23614454|NCT00267956|65973342|FG001|Controlled Period|Lost to Follow-up|0|||
23614455|NCT00267956|65973343|FG002|Controlled Period|Lost to Follow-up|0|||
23614456|NCT00267956|65973344|FG003|Controlled Period|Lost to Follow-up|0|||
23614457|NCT00267956|65973341|FG000|Controlled Period|Withdrew consent|3|||
23614458|NCT00267956|65973342|FG001|Controlled Period|Withdrew consent|1|||
23614459|NCT00267956|65973343|FG002|Controlled Period|Withdrew consent|0|||
23614460|NCT00267956|65973344|FG003|Controlled Period|Withdrew consent|0|||
23614461|NCT00267956|65973341|FG000|After Controlled Period|Adverse Event|0|||
23721783|NCT01306032|66359180|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
23721784|NCT01306032|66359181|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
23533418|NCT03194646|65686590|FG000|Overall Study|Withdrawal by Subject|75|||
23533419|NCT03194646|65686591|FG001|Overall Study|Withdrawal by Subject|74|||
23533420|NCT03194646|65686592|FG002|Overall Study|Withdrawal by Subject|36|||
23533421|NCT03194646|65686593|FG003|Overall Study|Withdrawal by Subject|131|||
23533422|NCT03194646|65686590|FG000|Overall Study|Missing|1|||
23614462|NCT00267956|65973342|FG001|After Controlled Period|Adverse Event|0|||
23614463|NCT00267956|65973343|FG002|After Controlled Period|Adverse Event|2|||
23614464|NCT00267956|65973344|FG003|After Controlled Period|Adverse Event|1|||
23614465|NCT00267956|65973341|FG000|After Controlled Period|Lack of Efficacy|0|||
23721785|NCT01306032|66359182|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
23533423|NCT03194646|65686591|FG001|Overall Study|Missing|0|||
23533424|NCT03194646|65686592|FG002|Overall Study|Missing|1|||
23533425|NCT03194646|65686593|FG003|Overall Study|Missing|12|||
23533426|NCT01976845|65686595|FG000|Overall Study|Physician Decision|8|||
23533427|NCT01976845|65686596|FG001|Overall Study|Physician Decision|8|||
23533428|NCT01976845|65686597|FG002|Overall Study|Physician Decision|3|||
23614466|NCT00267956|65973342|FG001|After Controlled Period|Lack of Efficacy|0|||
23614467|NCT00267956|65973343|FG002|After Controlled Period|Lack of Efficacy|1|||
23614468|NCT00267956|65973344|FG003|After Controlled Period|Lack of Efficacy|1|||
23614469|NCT00267956|65973341|FG000|After Controlled Period|Lost to Follow-up|0|||
23614470|NCT00267956|65973342|FG001|After Controlled Period|Lost to Follow-up|0|||
23614471|NCT00267956|65973343|FG002|After Controlled Period|Lost to Follow-up|1|||
23614472|NCT00267956|65973344|FG003|After Controlled Period|Lost to Follow-up|0|||
23614473|NCT00267956|65973341|FG000|After Controlled Period|Withdrew consent|0|||
23614474|NCT00267956|65973342|FG001|After Controlled Period|Withdrew consent|0|||
23614475|NCT00267956|65973343|FG002|After Controlled Period|Withdrew consent|1|||
23614476|NCT00267956|65973344|FG003|After Controlled Period|Withdrew consent|0|||
23614477|NCT01263223|65973349|FG000|Period 2|Withdrawal by Subject|0|||
23614478|NCT01263223|65973350|FG001|Period 2|Withdrawal by Subject|1|||
23614479|NCT01263223|65973349|FG000|7-day Follow-up|Withdrawal by Subject|0|||
23614480|NCT01263223|65973350|FG001|7-day Follow-up|Withdrawal by Subject|1|||
23614481|NCT01263223|65973349|FG000|7-day Follow-up|Lost to Follow-up|1|||
23614482|NCT01263223|65973350|FG001|7-day Follow-up|Lost to Follow-up|0|||
23614483|NCT03444155|65973351|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
23614484|NCT03444155|65973352|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
23614485|NCT04543942|65973360|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
23614486|NCT04543942|65973361|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
23614487|NCT04543942|65973360|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
23614488|NCT04543942|65973361|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
23614489|NCT00276016|65973362|FG000|Intervention 1|Withdrawal by Subject|0|||
23614490|NCT00276016|65973363|FG001|Intervention 1|Withdrawal by Subject|1|||
23614491|NCT00276016|65973364|FG002|Intervention 1|Withdrawal by Subject|0|||
23614492|NCT00276016|65973365|FG003|Intervention 1|Withdrawal by Subject|0|||
23614493|NCT00276016|65973366|FG004|Intervention 1|Withdrawal by Subject|0|||
23614494|NCT00276016|65973367|FG005|Intervention 1|Withdrawal by Subject|0|||
23614495|NCT01283971|65973369|FG000|Overall Study|Adverse Event|3|||
23614496|NCT01283971|65973370|FG001|Overall Study|Adverse Event|5|||
23614497|NCT01283971|65973369|FG000|Overall Study|Insufficient therapeutic responses|3|||
23614498|NCT01283971|65973370|FG001|Overall Study|Insufficient therapeutic responses|3|||
23614499|NCT01283971|65973369|FG000|Overall Study|Protocol Violation|5|||
23614500|NCT01283971|65973370|FG001|Overall Study|Protocol Violation|1|||
23614501|NCT01283971|65973369|FG000|Overall Study|Refused treatment|3|||
23614502|NCT01283971|65973370|FG001|Overall Study|Refused treatment|1|||
23614503|NCT01283971|65973369|FG000|Overall Study|Failure to return|0|||
23614504|NCT01283971|65973370|FG001|Overall Study|Failure to return|1|||
23614505|NCT01283971|65973369|FG000|Overall Study|Administrative reasons|1|||
23614506|NCT01283971|65973370|FG001|Overall Study|Administrative reasons|1|||
23614507|NCT03441789|65973371|FG000|Overall Study|Withdrawal by Subject|1|||
23614508|NCT03441789|65973372|FG001|Overall Study|Withdrawal by Subject|1|||
23614509|NCT03441789|65973371|FG000|Overall Study|Adverse Event|0|||
23614510|NCT03441789|65973372|FG001|Overall Study|Adverse Event|1|||
23614511|NCT03441789|65973371|FG000|Overall Study|Protocol Violation|0|||
23614512|NCT03441789|65973372|FG001|Overall Study|Protocol Violation|1|||
23614513|NCT03441789|65973371|FG000|Overall Study|Lost to Follow-up|0|||
23614514|NCT03441789|65973372|FG001|Overall Study|Lost to Follow-up|1|||
23533429|NCT01706250|65686603|FG000|Overall Study|Lost to Follow-up|2|||
23533430|NCT02052466|65686616|FG000|Overall Study|Withdrawal by Subject|1|||
23533431|NCT02052466|65686616|FG000|Overall Study|Acromial fracture|1|||
23533432|NCT03746522|65686617|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
23533433|NCT03746522|65686618|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
23533434|NCT03746522|65686619|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
23533435|NCT03746522|65686617|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
23533436|NCT03746522|65686618|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
23533437|NCT03746522|65686619|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
23533438|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
23533439|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
23533440|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
23533441|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
23533442|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
23614515|NCT01622088|65973377|FG000|Overall Study|Adverse Event|20|||
23614516|NCT01622088|65973377|FG000|Overall Study|Lost to Follow-up|1|||
23614517|NCT01622088|65973377|FG000|Overall Study|Withdrawal by Subject|20|||
23614518|NCT01622088|65973377|FG000|Overall Study|Investigator Decision|1|||
23614519|NCT01622088|65973377|FG000|Overall Study|Death|53|||
23614520|NCT01622088|65973377|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
23614521|NCT02849509|65973388|FG000|Overall Study|Worsening of disease under study|1|||
23614522|NCT02849509|65973389|FG001|Overall Study|Worsening of disease under study|1|||
23614523|NCT02849509|65973390|FG002|Overall Study|Worsening of disease under study|1|||
23533443|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
23614524|NCT02849509|65973388|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23814856|NCT00922272|66703386|FG001|Open-label Phase|Withdrawal by Subject|0|||
23814857|NCT00922272|66703385|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
23814858|NCT00922272|66703386|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
23814859|NCT00922272|66703385|FG000|Open-label Phase|Withdrawal criteria met|5|||
23814860|NCT00922272|66703386|FG001|Open-label Phase|Withdrawal criteria met|0|||
23814861|NCT00922272|66703385|FG000|Double-blind Phase|Adverse Event|1|||
23814862|NCT00922272|66703386|FG001|Double-blind Phase|Adverse Event|1|||
23814863|NCT00922272|66703385|FG000|Double-blind Phase|Withdrawal by Subject|1|||
23814864|NCT00922272|66703386|FG001|Double-blind Phase|Withdrawal by Subject|1|||
23814865|NCT00922272|66703385|FG000|Double-blind Phase|Lost to Follow-up|2|||
23814866|NCT00922272|66703386|FG001|Double-blind Phase|Lost to Follow-up|1|||
23814867|NCT00922272|66703385|FG000|Double-blind Phase|Withdrawal criteria met|1|||
23814868|NCT00922272|66703386|FG001|Double-blind Phase|Withdrawal criteria met|1|||
23814869|NCT00922272|66703385|FG000|Double-blind Phase|Noncompliance|1|||
23814870|NCT00922272|66703386|FG001|Double-blind Phase|Noncompliance|1|||
23814871|NCT00922272|66703385|FG000|Double-blind Phase|Positive urine drug screen|1|||
23533444|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
23533445|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
23533446|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
23533447|NCT00456092|65686620|FG000|Extension Phase|Grade 2 or Greater AE|2|||
23614525|NCT02849509|65973389|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23614526|NCT02849509|65973390|FG002|Overall Study|Worsening of other pre-existing disease|2|||
23614527|NCT02849509|65973388|FG000|Overall Study|Other adverse event|36|||
23614528|NCT02849509|65973389|FG001|Overall Study|Other adverse event|41|||
23614529|NCT02849509|65973390|FG002|Overall Study|Other adverse event|8|||
23614530|NCT02849509|65973388|FG000|Overall Study|Withdrawal by Subject|6|||
23614531|NCT02849509|65973389|FG001|Overall Study|Withdrawal by Subject|17|||
23614532|NCT02849509|65973390|FG002|Overall Study|Withdrawal by Subject|12|||
23614533|NCT02849509|65973388|FG000|Overall Study|Lost to Follow-up|27|||
23614534|NCT02849509|65973389|FG001|Overall Study|Lost to Follow-up|67|||
23614535|NCT02849509|65973390|FG002|Overall Study|Lost to Follow-up|36|||
23614536|NCT02849509|65973388|FG000|Overall Study|Other, reason not specified|14|||
23614537|NCT02849509|65973389|FG001|Overall Study|Other, reason not specified|29|||
23614538|NCT02849509|65973390|FG002|Overall Study|Other, reason not specified|25|||
23614539|NCT02849509|65973388|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
23614540|NCT02849509|65973389|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
23614541|NCT02849509|65973390|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
23614542|NCT01848483|65973391|FG000|Overall Study|Death|2|||
23533448|NCT00456092|65686621|FG001|Extension Phase|Grade 2 or Greater AE|2|||
23533449|NCT00456092|65686622|FG002|Extension Phase|Grade 2 or Greater AE|0|||
23533450|NCT00456092|65686623|FG003|Extension Phase|Grade 2 or Greater AE|0|||
23533451|NCT00456092|65686624|FG004|Extension Phase|Grade 2 or Greater AE|2|||
23533452|NCT00456092|65686620|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
23533453|NCT00456092|65686621|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533454|NCT00456092|65686622|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533455|NCT00456092|65686623|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533456|NCT00456092|65686624|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
23533457|NCT00456092|65686620|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
23533458|NCT00456092|65686621|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
23533459|NCT00456092|65686622|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
23533460|NCT00456092|65686623|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
23533461|NCT00456092|65686624|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
23533462|NCT00456092|65686620|FG000|Extension Phase|Withdrew Consent|2|||
23533463|NCT00456092|65686621|FG001|Extension Phase|Withdrew Consent|0|||
23533464|NCT00456092|65686622|FG002|Extension Phase|Withdrew Consent|0|||
23533465|NCT00456092|65686623|FG003|Extension Phase|Withdrew Consent|0|||
23533466|NCT00456092|65686624|FG004|Extension Phase|Withdrew Consent|0|||
23533467|NCT00456092|65686620|FG000|Extension Phase|Lost to Follow-up|1|||
23533468|NCT00456092|65686621|FG001|Extension Phase|Lost to Follow-up|1|||
23614543|NCT01848483|65973392|FG001|Overall Study|Death|1|||
23614544|NCT01848483|65973391|FG000|Overall Study|Lost to Follow-up|6|||
23614545|NCT01848483|65973392|FG001|Overall Study|Lost to Follow-up|8|||
23614546|NCT01848483|65973391|FG000|Overall Study|Withdrawal by Subject|1|||
23614547|NCT01848483|65973392|FG001|Overall Study|Withdrawal by Subject|0|||
23814872|NCT00922272|66703386|FG001|Double-blind Phase|Positive urine drug screen|1|||
23814873|NCT00205803|66703389|FG000|Infant Series|Lost to Follow-up|10|||
23814874|NCT00205803|66703390|FG001|Infant Series|Lost to Follow-up|4|||
23814875|NCT00205803|66703389|FG000|Infant Series|Withdrawal by Subject|2|||
23533469|NCT00456092|65686622|FG002|Extension Phase|Lost to Follow-up|0|||
23614548|NCT01848483|65973391|FG000|Overall Study|Incarceration|2|||
23614549|NCT01848483|65973392|FG001|Overall Study|Incarceration|2|||
23533470|NCT00456092|65686623|FG003|Extension Phase|Lost to Follow-up|0|||
23533471|NCT00456092|65686624|FG004|Extension Phase|Lost to Follow-up|1|||
23614550|NCT01348763|65973393|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
23614551|NCT01348763|65973393|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
23614552|NCT00547300|65973395|FG000|Overall Study|Study was Administratively Terminated|25|||
23614553|NCT00547300|65973396|FG001|Overall Study|Study was Administratively Terminated|24|||
23614554|NCT00547300|65973395|FG000|Overall Study|Did not Meet Entry Criteria|0|||
23614555|NCT00547300|65973396|FG001|Overall Study|Did not Meet Entry Criteria|2|||
23614556|NCT04203199|65973397|FG000|First Intervention Period|Lost to Follow-up|0|||
23614557|NCT04203199|65973398|FG001|First Intervention Period|Lost to Follow-up|1|||
23614558|NCT04203199|65973397|FG000|Second Intervention Period|Medication change|1|||
23614559|NCT04203199|65973398|FG001|Second Intervention Period|Medication change|0|||
23614560|NCT01014013|65973399|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
23614561|NCT01014013|65973400|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
23614562|NCT01014013|65973399|FG000|Overall Study|Clinical adverse experience|4|||
23614563|NCT01014013|65973400|FG001|Overall Study|Clinical adverse experience|2|||
23614564|NCT01014013|65973399|FG000|Overall Study|Laboratory adverse experience|1|||
23614565|NCT01014013|65973400|FG001|Overall Study|Laboratory adverse experience|1|||
23614566|NCT01014013|65973399|FG000|Overall Study|Protocol Violation|1|||
23614567|NCT01014013|65973400|FG001|Overall Study|Protocol Violation|3|||
23614568|NCT01014013|65973399|FG000|Overall Study|Withdrawal by Subject|7|||
23614569|NCT01014013|65973400|FG001|Overall Study|Withdrawal by Subject|4|||
23614570|NCT01014013|65973399|FG000|Overall Study|Clinical/microbiologic failure|1|||
23614571|NCT01014013|65973400|FG001|Overall Study|Clinical/microbiologic failure|2|||
23614572|NCT01014013|65973399|FG000|Overall Study|Pathogen culture = no growth|26|||
23614573|NCT01014013|65973400|FG001|Overall Study|Pathogen culture = no growth|34|||
23614574|NCT01014013|65973399|FG000|Overall Study|Negative urine culture|2|||
23614575|NCT01014013|65973400|FG001|Overall Study|Negative urine culture|0|||
23614576|NCT01014013|65973399|FG000|Overall Study|Pathogen resistant|7|||
23614577|NCT01014013|65973400|FG001|Overall Study|Pathogen resistant|4|||
23614578|NCT01014013|65973399|FG000|Overall Study|Physician Decision|0|||
23614579|NCT01014013|65973400|FG001|Overall Study|Physician Decision|1|||
23614580|NCT01014013|65973399|FG000|Overall Study|Another antibiotic therapy required|0|||
23614581|NCT01014013|65973400|FG001|Overall Study|Another antibiotic therapy required|1|||
23614582|NCT01014013|65973399|FG000|Overall Study|Appendectomy|1|||
23614583|NCT01014013|65973400|FG001|Overall Study|Appendectomy|0|||
23614584|NCT01014013|65973399|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
23614585|NCT01014013|65973400|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
23614586|NCT00676663|65973401|FG000|Overall Study|Death|43|||
23614587|NCT00676663|65973402|FG001|Overall Study|Death|27|||
23614588|NCT00676663|65973401|FG000|Overall Study|Withdrew Consent|1|||
23614589|NCT00676663|65973402|FG001|Overall Study|Withdrew Consent|8|||
23614590|NCT00676663|65973401|FG000|Overall Study|Lost to Follow-up|1|||
23614591|NCT00676663|65973402|FG001|Overall Study|Lost to Follow-up|3|||
23614592|NCT00714688|65973403|FG000|Overall Study|Lack of Efficacy|14|||
23614593|NCT00714688|65973404|FG001|Overall Study|Lack of Efficacy|1|||
23614594|NCT00714688|65973405|FG002|Overall Study|Lack of Efficacy|4|||
23614595|NCT00714688|65973403|FG000|Overall Study|Withdrawal by Subject|4|||
23614596|NCT00714688|65973404|FG001|Overall Study|Withdrawal by Subject|3|||
23614597|NCT00714688|65973405|FG002|Overall Study|Withdrawal by Subject|3|||
23614598|NCT00714688|65973403|FG000|Overall Study|Lost to Follow-up|5|||
23614599|NCT00714688|65973404|FG001|Overall Study|Lost to Follow-up|2|||
23614600|NCT00714688|65973405|FG002|Overall Study|Lost to Follow-up|0|||
23614601|NCT00714688|65973403|FG000|Overall Study|Adverse Event|2|||
23614602|NCT00714688|65973404|FG001|Overall Study|Adverse Event|15|||
23614603|NCT00714688|65973405|FG002|Overall Study|Adverse Event|19|||
23614604|NCT00714688|65973403|FG000|Overall Study|Subject Non-compliant|3|||
23614605|NCT00714688|65973404|FG001|Overall Study|Subject Non-compliant|5|||
23614606|NCT00714688|65973405|FG002|Overall Study|Subject Non-compliant|5|||
23614607|NCT00714688|65973403|FG000|Overall Study|Ineligible to Continue the Study|0|||
23614608|NCT00714688|65973404|FG001|Overall Study|Ineligible to Continue the Study|1|||
23614609|NCT00714688|65973405|FG002|Overall Study|Ineligible to Continue the Study|1|||
23614610|NCT00714688|65973403|FG000|Overall Study|Sponsor's Decision|0|||
23614611|NCT00714688|65973404|FG001|Overall Study|Sponsor's Decision|2|||
23614612|NCT00714688|65973405|FG002|Overall Study|Sponsor's Decision|0|||
23614613|NCT00714688|65973403|FG000|Overall Study|Other|1|||
23614614|NCT00714688|65973404|FG001|Overall Study|Other|6|||
23614615|NCT00714688|65973405|FG002|Overall Study|Other|5|||
23614616|NCT01755598|65973411|FG000|Overall Study|Other|109|||
23614617|NCT01755598|65973412|FG001|Overall Study|Other|109|||
23614618|NCT01755598|65973411|FG000|Overall Study|Lost to Follow-up|32|||
23614619|NCT01755598|65973412|FG001|Overall Study|Lost to Follow-up|43|||
23614620|NCT01755598|65973411|FG000|Overall Study|Migrated/moved from study area|76|||
23614621|NCT01755598|65973412|FG001|Overall Study|Migrated/moved from study area|65|||
23614622|NCT01755598|65973411|FG000|Overall Study|Withdrawal by Subject|22|||
23614623|NCT01755598|65973412|FG001|Overall Study|Withdrawal by Subject|31|||
23614624|NCT01755598|65973411|FG000|Overall Study|Protocol Violation|7|||
23614625|NCT01755598|65973412|FG001|Overall Study|Protocol Violation|7|||
23614626|NCT01755598|65973411|FG000|Overall Study|Adverse Event|19|||
23614627|NCT01755598|65973412|FG001|Overall Study|Adverse Event|28|||
23614628|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23614629|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
23614630|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
23614631|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
23614632|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
23614633|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
23614634|NCT03530345|65976241|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
23614635|NCT03530345|65976242|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
23614636|NCT01586910|65976243|FG000|Overall Study|Death|4|||
23614637|NCT01586910|65976244|FG001|Overall Study|Death|4|||
23614638|NCT01586910|65976243|FG000|Overall Study|Withdrawal by Subject|6|||
23614639|NCT01586910|65976244|FG001|Overall Study|Withdrawal by Subject|43|||
23614640|NCT01586910|65976243|FG000|Overall Study|Physician withdrew Subject|5|||
23614641|NCT01586910|65976244|FG001|Overall Study|Physician withdrew Subject|24|||
23614642|NCT03751280|65976245|FG000|Overall Study|Adverse Event|0|||
23614643|NCT03751280|65976246|FG001|Overall Study|Adverse Event|1|||
23614644|NCT03751280|65976245|FG000|Overall Study|Lost to Follow-up|3|||
23614645|NCT03751280|65976246|FG001|Overall Study|Lost to Follow-up|5|||
23614646|NCT03751280|65976245|FG000|Overall Study|Physician Decision|0|||
23614647|NCT03751280|65976246|FG001|Overall Study|Physician Decision|2|||
23614648|NCT03751280|65976245|FG000|Overall Study|Protocol Violation|0|||
23614649|NCT03751280|65976246|FG001|Overall Study|Protocol Violation|2|||
23614650|NCT03751280|65976245|FG000|Overall Study|Withdrawal by Subject|5|||
23614651|NCT03751280|65976246|FG001|Overall Study|Withdrawal by Subject|2|||
23614652|NCT03802513|65976247|FG000|Overall Study|Lost to Follow-up|1|||
23614653|NCT03332589|65976248|FG000|Overall Study|Lack of Efficacy|2|||
23614654|NCT03332589|65976249|FG001|Overall Study|Lack of Efficacy|0|||
23614655|NCT03332589|65976250|FG002|Overall Study|Lack of Efficacy|0|||
23614656|NCT03332589|65976248|FG000|Overall Study|Adverse Event|1|||
23533472|NCT00456092|65686620|FG000|Extension Phase|Other|2|||
23533473|NCT00456092|65686621|FG001|Extension Phase|Other|0|||
23533474|NCT00456092|65686622|FG002|Extension Phase|Other|0|||
23533475|NCT00456092|65686623|FG003|Extension Phase|Other|1|||
23533476|NCT00456092|65686624|FG004|Extension Phase|Other|1|||
23533477|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
23614657|NCT03332589|65976249|FG001|Overall Study|Adverse Event|0|||
23533478|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
23533479|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
23533480|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
23533481|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
23533482|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
23614658|NCT03332589|65976250|FG002|Overall Study|Adverse Event|0|||
23721786|NCT01306032|66359177|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
23721787|NCT01306032|66359178|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
23721788|NCT01306032|66359179|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
23721789|NCT01306032|66359180|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
23721790|NCT01306032|66359181|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
23721791|NCT01306032|66359182|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
23721792|NCT00094835|66359186|FG000|Overall Study|Physician Decision|1|||
23721793|NCT00094835|66359187|FG001|Overall Study|Physician Decision|0|||
23721794|NCT00094835|66359188|FG002|Overall Study|Physician Decision|0|||
23721795|NCT00094835|66359189|FG003|Overall Study|Physician Decision|0|||
23721796|NCT00094835|66359190|FG004|Overall Study|Physician Decision|0|||
23721797|NCT00094835|66359191|FG005|Overall Study|Physician Decision|1|||
23814876|NCT00205803|66703390|FG001|Infant Series|Withdrawal by Subject|5|||
23533483|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
23533484|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23614659|NCT03332589|65976248|FG000|Overall Study|Death|1|||
23614660|NCT03332589|65976249|FG001|Overall Study|Death|0|||
23614661|NCT03332589|65976250|FG002|Overall Study|Death|0|||
23614662|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
23614663|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
23721798|NCT00094835|66359192|FG006|Overall Study|Physician Decision|0|||
23721799|NCT00094835|66359186|FG000|Overall Study|Withdrawal by Subject|0|||
23814877|NCT00205803|66703389|FG000|Infant Series|Physician Decision|3|||
23533485|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23533486|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23721800|NCT00094835|66359187|FG001|Overall Study|Withdrawal by Subject|0|||
23721801|NCT00094835|66359188|FG002|Overall Study|Withdrawal by Subject|0|||
23721802|NCT00094835|66359189|FG003|Overall Study|Withdrawal by Subject|0|||
23721803|NCT00094835|66359190|FG004|Overall Study|Withdrawal by Subject|0|||
23721804|NCT00094835|66359191|FG005|Overall Study|Withdrawal by Subject|0|||
23721805|NCT00094835|66359192|FG006|Overall Study|Withdrawal by Subject|1|||
23721806|NCT00094835|66359186|FG000|Overall Study|Lost to Follow-up|0|||
23721807|NCT00094835|66359187|FG001|Overall Study|Lost to Follow-up|0|||
23721808|NCT00094835|66359188|FG002|Overall Study|Lost to Follow-up|0|||
23721809|NCT00094835|66359189|FG003|Overall Study|Lost to Follow-up|0|||
23721810|NCT00094835|66359190|FG004|Overall Study|Lost to Follow-up|1|||
23721811|NCT00094835|66359191|FG005|Overall Study|Lost to Follow-up|0|||
23721812|NCT00094835|66359192|FG006|Overall Study|Lost to Follow-up|0|||
23721813|NCT00094835|66359186|FG000|Overall Study|Death|1|||
23421337|NCT02118766|65284013|FG001|Overall Study|Withdrawal by Subject|6|||
23421338|NCT02118766|65284012|FG000|Overall Study|Lost to Follow-up|5|||
23421339|NCT02118766|65284013|FG001|Overall Study|Lost to Follow-up|4|||
23421340|NCT02118766|65284012|FG000|Overall Study|Withdrawal by parent/guardian|12|||
23421341|NCT02118766|65284013|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23421342|NCT02118766|65284012|FG000|Overall Study|Other|3|||
23421343|NCT02118766|65284013|FG001|Overall Study|Other|1|||
23421344|NCT02182440|65284014|FG000|Overall Study|Adverse Event|0|||
23421345|NCT02182440|65284015|FG001|Overall Study|Adverse Event|1|||
23421346|NCT02182440|65284016|FG002|Overall Study|Adverse Event|0|||
23721814|NCT00094835|66359187|FG001|Overall Study|Death|0|||
23721815|NCT00094835|66359188|FG002|Overall Study|Death|0|||
23721816|NCT00094835|66359189|FG003|Overall Study|Death|0|||
23721817|NCT00094835|66359190|FG004|Overall Study|Death|1|||
23721818|NCT00094835|66359191|FG005|Overall Study|Death|0|||
23721819|NCT00094835|66359192|FG006|Overall Study|Death|0|||
23721820|NCT00094835|66359186|FG000|Overall Study|Non-compliance|1|||
23721821|NCT00094835|66359187|FG001|Overall Study|Non-compliance|2|||
23721822|NCT00094835|66359188|FG002|Overall Study|Non-compliance|2|||
23721823|NCT00094835|66359189|FG003|Overall Study|Non-compliance|0|||
23721824|NCT00094835|66359190|FG004|Overall Study|Non-compliance|2|||
23721825|NCT00094835|66359191|FG005|Overall Study|Non-compliance|2|||
23721826|NCT00094835|66359192|FG006|Overall Study|Non-compliance|1|||
23721827|NCT00094835|66359186|FG000|Overall Study|Other|1|||
23721828|NCT00094835|66359187|FG001|Overall Study|Other|1|||
23721829|NCT00094835|66359188|FG002|Overall Study|Other|1|||
23721830|NCT00094835|66359189|FG003|Overall Study|Other|1|||
23721831|NCT00094835|66359190|FG004|Overall Study|Other|0|||
23421347|NCT02182440|65284017|FG003|Overall Study|Adverse Event|0|||
23721832|NCT00094835|66359191|FG005|Overall Study|Other|0|||
23721833|NCT00094835|66359192|FG006|Overall Study|Other|0|||
23721834|NCT00443846|66359193|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
23721835|NCT00443846|66359194|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
23721836|NCT00443846|66359193|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
23721837|NCT00443846|66359194|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
23721838|NCT00443846|66359193|FG000|Overall Study|Adverse Event|0|||
23721839|NCT00443846|66359194|FG001|Overall Study|Adverse Event|1|||
23721840|NCT00443846|66359193|FG000|Overall Study|Personal reason|8|||
23721841|NCT00443846|66359194|FG001|Overall Study|Personal reason|3|||
23721842|NCT00443846|66359193|FG000|Overall Study|Lost to Follow-up|1|||
23721843|NCT00443846|66359194|FG001|Overall Study|Lost to Follow-up|2|||
23814878|NCT00205803|66703390|FG001|Infant Series|Physician Decision|1|||
23814879|NCT00205803|66703389|FG000|Infant Series|Protocol Violation|1|||
23814880|NCT00205803|66703390|FG001|Infant Series|Protocol Violation|0|||
23814881|NCT00205803|66703389|FG000|Infant Series|Lost Kaiser coverage|0|||
23814882|NCT00205803|66703390|FG001|Infant Series|Lost Kaiser coverage|1|||
23814883|NCT00205803|66703389|FG000|Infant Series|Non-compliant|1|||
23814884|NCT00205803|66703390|FG001|Infant Series|Non-compliant|0|||
23814885|NCT00205803|66703389|FG000|Infant Series|Sponsor request|1|||
23814886|NCT00205803|66703390|FG001|Infant Series|Sponsor request|0|||
23814887|NCT00205803|66703389|FG000|After Infant Series|Adverse Event|1|||
23814888|NCT00205803|66703390|FG001|After Infant Series|Adverse Event|1|||
23814889|NCT00205803|66703389|FG000|After Infant Series|Protocol Violation|1|||
23721844|NCT03725293|66359197|FG000|Overall Study|Physician Decision|9|||
23721845|NCT03725293|66359198|FG001|Overall Study|Physician Decision|6|||
23721846|NCT03725293|66359197|FG000|Overall Study|alternative vascular access needs|1|||
23721847|NCT03725293|66359198|FG001|Overall Study|alternative vascular access needs|2|||
23721848|NCT03725293|66359197|FG000|Overall Study|venous anatomy screen failures|2|||
23421348|NCT02182440|65284014|FG000|Overall Study|Death|31|||
23421349|NCT02182440|65284015|FG001|Overall Study|Death|8|||
23421350|NCT02182440|65284016|FG002|Overall Study|Death|5|||
23721849|NCT03725293|66359198|FG001|Overall Study|venous anatomy screen failures|1|||
23721850|NCT02759562|66359199|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
23721851|NCT02759562|66359200|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
23721852|NCT02759562|66359199|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
23721853|NCT02759562|66359200|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
23721854|NCT01742091|66359201|FG000|Overall Study|Adverse Event|0|||
23721855|NCT01742091|66359202|FG001|Overall Study|Adverse Event|0|||
23721856|NCT01742091|66359203|FG002|Overall Study|Adverse Event|0|||
23721857|NCT01742091|66359204|FG003|Overall Study|Adverse Event|0|||
23721858|NCT01742091|66359205|FG004|Overall Study|Adverse Event|1|||
23721859|NCT01742091|66359206|FG005|Overall Study|Adverse Event|0|||
23721860|NCT01742091|66359201|FG000|Overall Study|Physician Decision|0|||
23721861|NCT01742091|66359202|FG001|Overall Study|Physician Decision|0|||
23721862|NCT01742091|66359203|FG002|Overall Study|Physician Decision|0|||
23721863|NCT01742091|66359204|FG003|Overall Study|Physician Decision|0|||
23721864|NCT01742091|66359205|FG004|Overall Study|Physician Decision|0|||
23721865|NCT01742091|66359206|FG005|Overall Study|Physician Decision|1|||
23721866|NCT01742091|66359201|FG000|Overall Study|Withdrawal by Subject|0|||
23721867|NCT01742091|66359202|FG001|Overall Study|Withdrawal by Subject|0|||
23721868|NCT01742091|66359203|FG002|Overall Study|Withdrawal by Subject|0|||
23721869|NCT01742091|66359204|FG003|Overall Study|Withdrawal by Subject|1|||
23721870|NCT01742091|66359205|FG004|Overall Study|Withdrawal by Subject|0|||
23721871|NCT01742091|66359206|FG005|Overall Study|Withdrawal by Subject|0|||
23721872|NCT01742091|66359201|FG000|Overall Study|Lost to Follow-up|0|||
23721873|NCT01742091|66359202|FG001|Overall Study|Lost to Follow-up|0|||
23533487|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
23533488|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533489|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23721874|NCT01742091|66359203|FG002|Overall Study|Lost to Follow-up|0|||
23721875|NCT01742091|66359204|FG003|Overall Study|Lost to Follow-up|0|||
23721876|NCT01742091|66359205|FG004|Overall Study|Lost to Follow-up|0|||
23721877|NCT01742091|66359206|FG005|Overall Study|Lost to Follow-up|1|||
23721878|NCT00050622|66359210|FG000|Overall Study|Adverse Event|1|||
23421351|NCT02182440|65284017|FG003|Overall Study|Death|16|||
23421352|NCT02182440|65284014|FG000|Overall Study|Protocol Violation|0|||
23421353|NCT02182440|65284015|FG001|Overall Study|Protocol Violation|1|||
23421354|NCT02182440|65284016|FG002|Overall Study|Protocol Violation|0|||
23421355|NCT02182440|65284017|FG003|Overall Study|Protocol Violation|0|||
23421356|NCT02182440|65284014|FG000|Overall Study|Physician Decision|1|||
23421357|NCT02182440|65284015|FG001|Overall Study|Physician Decision|0|||
23421358|NCT02182440|65284016|FG002|Overall Study|Physician Decision|0|||
23421359|NCT02182440|65284017|FG003|Overall Study|Physician Decision|0|||
23421360|NCT02182440|65284014|FG000|Overall Study|Withdrawal by Subject|1|||
23421361|NCT02182440|65284015|FG001|Overall Study|Withdrawal by Subject|1|||
23421362|NCT02182440|65284016|FG002|Overall Study|Withdrawal by Subject|3|||
23421363|NCT02182440|65284017|FG003|Overall Study|Withdrawal by Subject|4|||
23721879|NCT01827319|66359213|FG000|Overall Study|Lost to Follow-up|3|||
23721880|NCT01927068|66359214|FG000|Overall Study|Death|37|||
23721881|NCT01927068|66359215|FG001|Overall Study|Death|3|||
23721882|NCT01927068|66359214|FG000|Overall Study|Withdrawal by Subject|50|||
23721883|NCT01927068|66359215|FG001|Overall Study|Withdrawal by Subject|3|||
23721884|NCT01927068|66359214|FG000|Overall Study|Lost to Follow-up|10|||
23814890|NCT00205803|66703390|FG001|After Infant Series|Protocol Violation|1|||
23814891|NCT00205803|66703389|FG000|After Infant Series|Lost to Follow-up|2|||
23814892|NCT00205803|66703390|FG001|After Infant Series|Lost to Follow-up|1|||
23814893|NCT00205803|66703389|FG000|After Infant Series|Physician Decision|3|||
23814894|NCT00205803|66703390|FG001|After Infant Series|Physician Decision|2|||
23814895|NCT00205803|66703389|FG000|After Infant Series|Withdrawal by Subject|1|||
23814896|NCT00205803|66703390|FG001|After Infant Series|Withdrawal by Subject|4|||
23421364|NCT02182440|65284014|FG000|Overall Study|different, e.g adm other hospital|12|||
23421365|NCT02182440|65284015|FG001|Overall Study|different, e.g adm other hospital|3|||
23421366|NCT02182440|65284016|FG002|Overall Study|different, e.g adm other hospital|3|||
23421367|NCT02182440|65284017|FG003|Overall Study|different, e.g adm other hospital|10|||
23721885|NCT01927068|66359215|FG001|Overall Study|Lost to Follow-up|2|||
23721886|NCT01927068|66359214|FG000|Overall Study|Physician Decision|9|||
23421368|NCT00907803|65284018|FG000|Overall Study|Withdrawal of consent - long commute|1|||
23421369|NCT00907803|65284019|FG001|Overall Study|Withdrawal of consent - long commute|0|||
23421370|NCT00907803|65284020|FG002|Overall Study|Withdrawal of consent - long commute|0|||
23721887|NCT01927068|66359215|FG001|Overall Study|Physician Decision|0|||
23721888|NCT01927068|66359214|FG000|Overall Study|Missed last follow-up visit|2|||
23421371|NCT00907803|65284018|FG000|Overall Study|Adverse Event|2|||
23533490|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533491|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533492|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533493|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
23533494|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
23533495|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533496|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533497|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533498|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
23533499|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
23533500|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533501|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533502|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533503|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
23533504|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
23533505|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533506|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533507|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533508|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
23533509|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
23533510|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533511|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533512|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533513|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23533514|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23533515|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533516|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533517|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Other|1|||
23533518|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Other|0|||
23533519|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Other|1|||
23533520|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Other|0|||
23533521|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Other|0|||
23533522|NCT01863446|65686625|FG000|Overall Study|Withdrawal by Subject|1|||
23533523|NCT01863446|65686626|FG001|Overall Study|Withdrawal by Subject|0|||
23533524|NCT01863446|65686627|FG002|Overall Study|Withdrawal by Subject|1|||
23533525|NCT01863446|65686628|FG003|Overall Study|Withdrawal by Subject|2|||
23533526|NCT01863446|65686625|FG000|Overall Study|Physician Decision|0|||
23721889|NCT01927068|66359215|FG001|Overall Study|Missed last follow-up visit|0|||
23721890|NCT00801892|66359217|FG000|Main Study Period|Withdrawal by Subject|0|||
23721891|NCT00801892|66359218|FG001|Main Study Period|Withdrawal by Subject|1|||
23721892|NCT00801892|66359217|FG000|Sham Crossover Period|Lost to Follow-up|0|||
23721893|NCT00801892|66359218|FG001|Sham Crossover Period|Lost to Follow-up|2|||
23721894|NCT01400139|66359220|FG000|HYD Core Study|Adverse Event|210|||
23421372|NCT00907803|65284019|FG001|Overall Study|Adverse Event|0|||
23421373|NCT00907803|65284020|FG002|Overall Study|Adverse Event|0|||
23421374|NCT00907803|65284018|FG000|Overall Study|Withdrawal by Subject|0|||
23421375|NCT00907803|65284019|FG001|Overall Study|Withdrawal by Subject|1|||
23421376|NCT00907803|65284020|FG002|Overall Study|Withdrawal by Subject|0|||
23421377|NCT00907803|65284018|FG000|Overall Study|Lost to Follow-up|0|||
23421378|NCT00907803|65284019|FG001|Overall Study|Lost to Follow-up|1|||
23421379|NCT00907803|65284020|FG002|Overall Study|Lost to Follow-up|0|||
23421380|NCT00907803|65284018|FG000|Overall Study|Protocol Violation|0|||
23421381|NCT00907803|65284019|FG001|Overall Study|Protocol Violation|1|||
23421382|NCT00907803|65284020|FG002|Overall Study|Protocol Violation|0|||
23421383|NCT03280303|65284027|FG000|Overall Study|Death|505|||
23421384|NCT03280303|65284027|FG000|Overall Study|Study terminated by sponsor|383|||
23421385|NCT03280303|65284027|FG000|Overall Study|Other|148|||
23721895|NCT01400139|66359220|FG000|HYD Core Study|Lack of Efficacy|59|||
23721896|NCT01400139|66359220|FG000|HYD Core Study|Withdrawal by Subject|114|||
23721897|NCT01400139|66359220|FG000|HYD Core Study|Lost to Follow-up|39|||
23533527|NCT01863446|65686626|FG001|Overall Study|Physician Decision|0|||
23533528|NCT01863446|65686627|FG002|Overall Study|Physician Decision|1|||
23533529|NCT01863446|65686628|FG003|Overall Study|Physician Decision|0|||
23421386|NCT03280303|65284027|FG000|Overall Study|No longer willing to participate in study|101|||
23421387|NCT03280303|65284027|FG000|Overall Study|Lost to follow up|39|||
23421388|NCT03280303|65284027|FG000|Overall Study|Adverse Event|20|||
23533530|NCT00779766|65686629|FG000|Month 24|Serious Adverse Event|2|||
23533531|NCT00779766|65686630|FG001|Month 24|Serious Adverse Event|3|||
23721898|NCT01400139|66359220|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
23721899|NCT01400139|66359220|FG000|HYD Core Study|Administrative|56|||
23721900|NCT01400139|66359220|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
23421389|NCT00457821|65288150|FG000|Part 2|Withdrawal by Subject|0|||
23421390|NCT00457821|65288151|FG001|Part 2|Withdrawal by Subject|0|||
23421391|NCT00457821|65288152|FG002|Part 2|Withdrawal by Subject|0|||
23421392|NCT00457821|65288153|FG003|Part 2|Withdrawal by Subject|0|||
23721901|NCT01400139|66359220|FG000|HYD Extension Period|Adverse Event|8|||
23721902|NCT01400139|66359220|FG000|HYD Extension Period|Withdrawal by Subject|5|||
23421393|NCT00457821|65288154|FG004|Part 2|Withdrawal by Subject|0|||
23421394|NCT00457821|65288155|FG005|Part 2|Withdrawal by Subject|0|||
23421395|NCT00457821|65288156|FG006|Part 2|Withdrawal by Subject|0|||
23421396|NCT00457821|65288157|FG007|Part 2|Withdrawal by Subject|1|||
23421397|NCT00496483|65288159|FG000|Overall Study|Not dosed|9|||
23421398|NCT00496483|65288159|FG000|Overall Study|Adverse Event|2|||
23421399|NCT00496483|65288159|FG000|Overall Study|Lack of Efficacy|1|||
23421400|NCT02578680|65288160|FG000|Overall Study|Death|329|||
23421401|NCT02578680|65288161|FG001|Overall Study|Death|181|||
23421402|NCT02578680|65288160|FG000|Overall Study|Lost to Follow-up|3|||
23421403|NCT02578680|65288161|FG001|Overall Study|Lost to Follow-up|1|||
23421404|NCT02578680|65288160|FG000|Overall Study|Physician Decision|0|||
23421405|NCT02578680|65288161|FG001|Overall Study|Physician Decision|1|||
23421406|NCT02578680|65288160|FG000|Overall Study|Protocol Violation|1|||
23421407|NCT02578680|65288161|FG001|Overall Study|Protocol Violation|1|||
23421408|NCT02578680|65288160|FG000|Overall Study|Sponsor Decision|64|||
23421409|NCT02578680|65288161|FG001|Overall Study|Sponsor Decision|13|||
23421410|NCT02578680|65288160|FG000|Overall Study|Withdrawal by Subject|13|||
23421411|NCT02578680|65288161|FG001|Overall Study|Withdrawal by Subject|9|||
23421412|NCT02370537|65288162|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
23421413|NCT02370537|65288163|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
23421414|NCT02370537|65288164|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
23421415|NCT02370537|65288162|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
23421416|NCT02370537|65288163|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
23421417|NCT02370537|65288164|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
23421418|NCT02370537|65288162|FG000|Part B|Not randomised to receive treatment|1|||
23421419|NCT02370537|65288163|FG001|Part B|Not randomised to receive treatment|2|||
23421420|NCT02370537|65288164|FG002|Part B|Not randomised to receive treatment|259|||
23421421|NCT02370537|65288162|FG000|Part B|Withdrawal by Subject|0|||
23421422|NCT02370537|65288163|FG001|Part B|Withdrawal by Subject|1|||
23421423|NCT02370537|65288164|FG002|Part B|Withdrawal by Subject|0|||
23421424|NCT04508751|65288165|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
23421425|NCT04508751|65288166|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
23421426|NCT04508751|65288167|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
23421427|NCT04677660|65288168|FG000|Overall Study|Lost to Follow-up|0|||
23421428|NCT04677660|65288169|FG001|Overall Study|Lost to Follow-up|2|||
23421429|NCT04677660|65288168|FG000|Overall Study|Withdrawal by Subject|0|||
23421430|NCT04677660|65288169|FG001|Overall Study|Withdrawal by Subject|1|||
23421431|NCT04677660|65288168|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
23421432|NCT04677660|65288169|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
23421433|NCT01146652|65288173|FG000|Overall Study|Adverse Event|506|||
23421434|NCT01146652|65288174|FG001|Overall Study|Adverse Event|15|||
23421435|NCT01146652|65288173|FG000|Overall Study|Lack of Efficacy|91|||
23421436|NCT01146652|65288174|FG001|Overall Study|Lack of Efficacy|7|||
23421437|NCT01146652|65288173|FG000|Overall Study|Poor compliance to protocol|38|||
23421438|NCT01146652|65288174|FG001|Overall Study|Poor compliance to protocol|1|||
23533532|NCT00779766|65686629|FG000|Month 24|Adverse Event|3|||
23533533|NCT00779766|65686630|FG001|Month 24|Adverse Event|3|||
23533534|NCT00779766|65686629|FG000|Month 24|Protocol Violation|3|||
23533535|NCT00779766|65686630|FG001|Month 24|Protocol Violation|1|||
23721903|NCT01400139|66359220|FG000|HYD Extension Period|Administrative|10|||
23421439|NCT01146652|65288173|FG000|Overall Study|Other unspecified reasons|314|||
23421440|NCT01146652|65288174|FG001|Overall Study|Other unspecified reasons|22|||
23421441|NCT01146652|65288173|FG000|Overall Study|Enrolled but not treated|2|||
23421442|NCT01146652|65288174|FG001|Overall Study|Enrolled but not treated|0|||
23421443|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
23721904|NCT00555568|66359221|FG000|Overall Study|Lost to Follow-up|26|||
23421444|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
23421445|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
23721905|NCT00555568|66359222|FG001|Overall Study|Lost to Follow-up|16|||
23421446|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
23421447|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
23421448|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
23421449|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
23421450|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
23533536|NCT00779766|65686629|FG000|Month 24|Withdrawal by Subject|159|||
23721906|NCT00555568|66359223|FG002|Overall Study|Lost to Follow-up|16|||
23721907|NCT01153893|66359224|FG000|Overall Study|Adverse Event|1|||
23533537|NCT00779766|65686630|FG001|Month 24|Withdrawal by Subject|127|||
23533538|NCT00779766|65686629|FG000|Month 24|Migrated/moved from study area|138|||
23533539|NCT00779766|65686630|FG001|Month 24|Migrated/moved from study area|162|||
23533540|NCT00779766|65686629|FG000|Month 24|Lost to Follow-up|9|||
23721908|NCT01153893|66359225|FG001|Overall Study|Adverse Event|0|||
23721909|NCT00696436|66359226|FG000|Overall Study|Adverse Event|7|||
23721910|NCT00696436|66359227|FG001|Overall Study|Adverse Event|9|||
23721911|NCT00696436|66359228|FG002|Overall Study|Adverse Event|8|||
23721912|NCT00696436|66359229|FG003|Overall Study|Adverse Event|6|||
23721913|NCT00696436|66359230|FG004|Overall Study|Adverse Event|4|||
23533541|NCT00779766|65686630|FG001|Month 24|Lost to Follow-up|9|||
23533542|NCT00779766|65686629|FG000|Month 24|Other|18|||
23533543|NCT00779766|65686630|FG001|Month 24|Other|27|||
23533544|NCT00779766|65686629|FG000|Month 48|Withdrawal by Subject|68|||
23721914|NCT00696436|66359226|FG000|Overall Study|Protocol Violation|3|||
23721915|NCT00696436|66359227|FG001|Overall Study|Protocol Violation|2|||
23721916|NCT00696436|66359228|FG002|Overall Study|Protocol Violation|2|||
23721917|NCT00696436|66359229|FG003|Overall Study|Protocol Violation|0|||
23721918|NCT00696436|66359230|FG004|Overall Study|Protocol Violation|1|||
23721919|NCT00696436|66359226|FG000|Overall Study|Lost to Follow-up|1|||
23721920|NCT00696436|66359227|FG001|Overall Study|Lost to Follow-up|6|||
23721921|NCT00696436|66359228|FG002|Overall Study|Lost to Follow-up|2|||
23721922|NCT00696436|66359229|FG003|Overall Study|Lost to Follow-up|4|||
23721923|NCT00696436|66359230|FG004|Overall Study|Lost to Follow-up|3|||
23721924|NCT00696436|66359226|FG000|Overall Study|Withdrawal by Subject|4|||
23721925|NCT00696436|66359227|FG001|Overall Study|Withdrawal by Subject|11|||
23721926|NCT00696436|66359228|FG002|Overall Study|Withdrawal by Subject|5|||
23721927|NCT00696436|66359229|FG003|Overall Study|Withdrawal by Subject|7|||
23721928|NCT00696436|66359230|FG004|Overall Study|Withdrawal by Subject|1|||
23721929|NCT00696436|66359226|FG000|Overall Study|Lack of Efficacy|3|||
23721930|NCT00696436|66359227|FG001|Overall Study|Lack of Efficacy|1|||
23721931|NCT00696436|66359228|FG002|Overall Study|Lack of Efficacy|5|||
23721932|NCT00696436|66359229|FG003|Overall Study|Lack of Efficacy|2|||
23721933|NCT00696436|66359230|FG004|Overall Study|Lack of Efficacy|4|||
23721934|NCT00696436|66359226|FG000|Overall Study|Participant Unavailability|2|||
23721935|NCT00696436|66359227|FG001|Overall Study|Participant Unavailability|0|||
23721936|NCT00696436|66359228|FG002|Overall Study|Participant Unavailability|2|||
23721937|NCT00696436|66359229|FG003|Overall Study|Participant Unavailability|1|||
23721938|NCT00696436|66359230|FG004|Overall Study|Participant Unavailability|0|||
23721939|NCT00696436|66359226|FG000|Overall Study|Administrative Error|2|||
23721940|NCT00696436|66359227|FG001|Overall Study|Administrative Error|0|||
23721941|NCT00696436|66359228|FG002|Overall Study|Administrative Error|2|||
23721942|NCT00696436|66359229|FG003|Overall Study|Administrative Error|0|||
23721943|NCT00696436|66359230|FG004|Overall Study|Administrative Error|0|||
23721944|NCT00696436|66359226|FG000|Overall Study|Participant Non-compliance|0|||
23421451|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
23421452|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
23421453|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
23421454|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
23421455|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
23421456|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
23421457|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
23421458|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
23421459|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
23421460|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
23421461|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
23421462|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
23533545|NCT00779766|65686630|FG001|Month 48|Withdrawal by Subject|63|||
23533546|NCT00779766|65686629|FG000|Month 48|Migrated/moved from study area|76|||
23721945|NCT00696436|66359227|FG001|Overall Study|Participant Non-compliance|0|||
23721946|NCT00696436|66359228|FG002|Overall Study|Participant Non-compliance|1|||
23721947|NCT00696436|66359229|FG003|Overall Study|Participant Non-compliance|2|||
23721948|NCT00696436|66359230|FG004|Overall Study|Participant Non-compliance|0|||
23721949|NCT00696436|66359226|FG000|Overall Study|Administrative Decision|1|||
23721950|NCT00696436|66359227|FG001|Overall Study|Administrative Decision|0|||
23721951|NCT00696436|66359228|FG002|Overall Study|Administrative Decision|0|||
23721952|NCT00696436|66359229|FG003|Overall Study|Administrative Decision|0|||
23721953|NCT00696436|66359230|FG004|Overall Study|Administrative Decision|0|||
23721954|NCT00696436|66359226|FG000|Overall Study|Missing|0|||
23533547|NCT00779766|65686630|FG001|Month 48|Migrated/moved from study area|75|||
23721955|NCT00696436|66359227|FG001|Overall Study|Missing|1|||
23721956|NCT00696436|66359228|FG002|Overall Study|Missing|1|||
23721957|NCT00696436|66359229|FG003|Overall Study|Missing|0|||
23721958|NCT00696436|66359230|FG004|Overall Study|Missing|0|||
23721959|NCT01000025|66359231|FG000|Overall Study|Adverse Event|43|||
23533548|NCT00779766|65686629|FG000|Month 48|Lost to Follow-up|29|||
23533549|NCT00779766|65686630|FG001|Month 48|Lost to Follow-up|30|||
23533550|NCT00779766|65686629|FG000|Month 48|Other|1|||
23533551|NCT00779766|65686630|FG001|Month 48|Other|0|||
23721960|NCT01000025|66359232|FG001|Overall Study|Adverse Event|2|||
23721961|NCT01000025|66359231|FG000|Overall Study|Withdrawal by Subject|13|||
23421463|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
23421464|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
23421465|NCT00006164|65288182|FG000|Overall Study|Withdrew or lost to follow-up|70|||
23421466|NCT00006164|65288183|FG001|Overall Study|Withdrew or lost to follow-up|81|||
23421467|NCT00171925|65288184|FG000|Overall Study|Adverse Event|10|||
23421468|NCT00171925|65288185|FG001|Overall Study|Adverse Event|6|||
23421469|NCT00171925|65288184|FG000|Overall Study|Protocol Violation|1|||
23421470|NCT00171925|65288185|FG001|Overall Study|Protocol Violation|1|||
23421471|NCT00171925|65288184|FG000|Overall Study|Withdrawal by Subject|6|||
23421472|NCT00171925|65288185|FG001|Overall Study|Withdrawal by Subject|9|||
23421473|NCT00171925|65288184|FG000|Overall Study|Lost to Follow-up|2|||
23421474|NCT00171925|65288185|FG001|Overall Study|Lost to Follow-up|2|||
23421475|NCT00171925|65288184|FG000|Overall Study|Administrative problems|10|||
23421476|NCT00171925|65288185|FG001|Overall Study|Administrative problems|11|||
23421477|NCT00171925|65288184|FG000|Overall Study|Death|1|||
23421478|NCT00171925|65288185|FG001|Overall Study|Death|2|||
23421479|NCT02186652|65288186|FG000|Overall Study|Lost to Follow-up|2|||
23421480|NCT02186652|65288187|FG001|Overall Study|Lost to Follow-up|0|||
23421481|NCT01170065|65288188|FG000|Overall Study|Adverse Event|17|||
23421482|NCT01170065|65288189|FG001|Overall Study|Adverse Event|50|||
23421483|NCT01170065|65288190|FG002|Overall Study|Adverse Event|10|||
23421484|NCT01170065|65288188|FG000|Overall Study|Lost to Follow-up|1|||
23421485|NCT01170065|65288189|FG001|Overall Study|Lost to Follow-up|4|||
23421486|NCT01170065|65288190|FG002|Overall Study|Lost to Follow-up|1|||
23421487|NCT01170065|65288188|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
23421488|NCT01170065|65288189|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
23421489|NCT01170065|65288190|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
23421490|NCT01170065|65288188|FG000|Overall Study|Reason other than specified|3|||
23421491|NCT01170065|65288189|FG001|Overall Study|Reason other than specified|8|||
23421492|NCT01170065|65288190|FG002|Overall Study|Reason other than specified|3|||
23421493|NCT01170065|65288188|FG000|Overall Study|Ongoing after planned observation time|5|||
23421494|NCT01170065|65288189|FG001|Overall Study|Ongoing after planned observation time|26|||
23421495|NCT01170065|65288190|FG002|Overall Study|Ongoing after planned observation time|10|||
23421496|NCT00896363|65288191|FG000|Overall Study|Adverse Event|3|||
23421497|NCT00896363|65288192|FG001|Overall Study|Adverse Event|4|||
23421498|NCT00896363|65288193|FG002|Overall Study|Adverse Event|2|||
23421499|NCT00896363|65288191|FG000|Overall Study|Lack of Efficacy|0|||
23421500|NCT00896363|65288192|FG001|Overall Study|Lack of Efficacy|2|||
23421501|NCT00896363|65288193|FG002|Overall Study|Lack of Efficacy|1|||
23421502|NCT00896363|65288191|FG000|Overall Study|Withdrawal by Subject|3|||
23421503|NCT00896363|65288192|FG001|Overall Study|Withdrawal by Subject|5|||
23421504|NCT00896363|65288193|FG002|Overall Study|Withdrawal by Subject|5|||
23421505|NCT02780856|65288196|FG000|Overall Study|Lost to Follow-up|1|||
23421506|NCT01080768|65288197|FG000|Overall Study|Protocol Deviation|2|||
23421507|NCT01080768|65288198|FG001|Overall Study|Protocol Deviation|1|||
23421508|NCT03483038|65288200|FG000|Overall Study|Subjects still in follow-up|18|||
23421509|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421510|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421511|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421512|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421513|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421514|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421515|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421516|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421517|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23533552|NCT00779766|65686629|FG000|Month 72|Withdrawal by Subject|55|||
23721962|NCT01000025|66359232|FG001|Overall Study|Withdrawal by Subject|8|||
23721963|NCT01000025|66359231|FG000|Overall Study|Death|23|||
23421518|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421519|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421520|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421521|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421522|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421523|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
23421524|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23533553|NCT00779766|65686630|FG001|Month 72|Withdrawal by Subject|71|||
23533554|NCT00779766|65686629|FG000|Month 72|Migrated/moved from study area|124|||
23421525|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421526|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421527|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421528|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421529|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421530|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421531|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421532|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421533|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421534|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421535|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
23421536|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421537|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23533555|NCT00779766|65686630|FG001|Month 72|Migrated/moved from study area|109|||
23533556|NCT00779766|65686629|FG000|Month 72|Lost to Follow-up|6|||
23533557|NCT00779766|65686630|FG001|Month 72|Lost to Follow-up|8|||
23533558|NCT00779766|65686629|FG000|Month 72|Other|0|||
23533559|NCT00779766|65686630|FG001|Month 72|Other|1|||
23533560|NCT04068181|65686647|FG000|Overall Study|Withdrawal by Subject|2|||
23533561|NCT04068181|65686648|FG001|Overall Study|Withdrawal by Subject|0|||
23533562|NCT04068181|65686649|FG002|Overall Study|Withdrawal by Subject|0|||
23533563|NCT04068181|65686650|FG003|Overall Study|Withdrawal by Subject|0|||
23533564|NCT04068181|65686647|FG000|Overall Study|Lost to Follow-up|1|||
23533565|NCT04068181|65686648|FG001|Overall Study|Lost to Follow-up|0|||
23533566|NCT04068181|65686649|FG002|Overall Study|Lost to Follow-up|0|||
23721964|NCT01000025|66359232|FG001|Overall Study|Death|13|||
23721965|NCT01000025|66359231|FG000|Overall Study|Lack of Efficacy|363|||
23721966|NCT01000025|66359232|FG001|Overall Study|Lack of Efficacy|208|||
23721967|NCT01000025|66359231|FG000|Overall Study|Intercurrent Illness|26|||
23721968|NCT01000025|66359232|FG001|Overall Study|Intercurrent Illness|7|||
23721969|NCT00606177|66359233|FG000|Overall Study|Adverse Event|9|||
23721970|NCT00606177|66359234|FG001|Overall Study|Adverse Event|5|||
23721971|NCT00606177|66359233|FG000|Overall Study|Lack of Efficacy|3|||
23721972|NCT00606177|66359234|FG001|Overall Study|Lack of Efficacy|7|||
23721973|NCT00606177|66359233|FG000|Overall Study|Physician Decision|1|||
23721974|NCT00606177|66359234|FG001|Overall Study|Physician Decision|0|||
23721975|NCT00606177|66359233|FG000|Overall Study|Protocol Violation|1|||
23721976|NCT00606177|66359234|FG001|Overall Study|Protocol Violation|4|||
23721977|NCT00606177|66359233|FG000|Overall Study|Withdrawal by Subject|5|||
23721978|NCT00606177|66359234|FG001|Overall Study|Withdrawal by Subject|6|||
23721979|NCT00606177|66359233|FG000|Overall Study|Progression to depressive phase|6|||
23721980|NCT00606177|66359234|FG001|Overall Study|Progression to depressive phase|1|||
23721981|NCT00606177|66359233|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
23721982|NCT00606177|66359234|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
23721983|NCT00606177|66359233|FG000|Overall Study|Change of residence or other commitments|1|||
23721984|NCT00606177|66359234|FG001|Overall Study|Change of residence or other commitments|1|||
23721985|NCT00967226|66359235|FG000|Overall Study|Adverse Event|0|||
23721986|NCT00967226|66359236|FG001|Overall Study|Adverse Event|5|||
23721987|NCT00967226|66359235|FG000|Overall Study|Protocol Violation|2|||
23721988|NCT00967226|66359236|FG001|Overall Study|Protocol Violation|0|||
23721989|NCT00967226|66359235|FG000|Overall Study|Physician Decision|0|||
23721990|NCT00967226|66359236|FG001|Overall Study|Physician Decision|1|||
23721991|NCT00249795|66359237|FG000|Overall Study|Not treated|16|||
23721992|NCT00249795|66359238|FG001|Overall Study|Not treated|14|||
23721993|NCT00249795|66359237|FG000|Overall Study|Symptomatic hypotension|127|||
23721994|NCT00249795|66359238|FG001|Overall Study|Symptomatic hypotension|64|||
23721995|NCT00249795|66359237|FG000|Overall Study|Other Serious Adverse Event|84|||
23721996|NCT00249795|66359238|FG001|Overall Study|Other Serious Adverse Event|93|||
23721997|NCT00249795|66359237|FG000|Overall Study|Qualifying condition not present|26|||
23721998|NCT00249795|66359238|FG001|Overall Study|Qualifying condition not present|29|||
23721999|NCT00249795|66359237|FG000|Overall Study|Withdrawal by Subject|678|||
23722000|NCT00249795|66359238|FG001|Overall Study|Withdrawal by Subject|742|||
23722001|NCT00249795|66359237|FG000|Overall Study|Thromboembolic / outcome event|39|||
23722002|NCT00249795|66359238|FG001|Overall Study|Thromboembolic / outcome event|45|||
23722003|NCT00249795|66359237|FG000|Overall Study|Oral anticoagulant required|2|||
23722004|NCT00249795|66359238|FG001|Overall Study|Oral anticoagulant required|0|||
23722005|NCT00249795|66359237|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
23533567|NCT04068181|65686650|FG003|Overall Study|Lost to Follow-up|0|||
23722006|NCT00249795|66359238|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
23722007|NCT00249795|66359237|FG000|Overall Study|Non-compliance|71|||
23533568|NCT04068181|65686647|FG000|Overall Study|Death|8|||
23722008|NCT00249795|66359238|FG001|Overall Study|Non-compliance|69|||
23722009|NCT00249795|66359237|FG000|Overall Study|Study drug intolerance|3|||
23722010|NCT00249795|66359238|FG001|Overall Study|Study drug intolerance|3|||
23614664|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
23614665|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
23614666|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Death|0|||
23614667|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Death|0|||
23614668|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Death|1|||
23722011|NCT00249795|66359237|FG000|Overall Study|Other adverse events (non-serious)|188|||
23722012|NCT00249795|66359238|FG001|Overall Study|Other adverse events (non-serious)|159|||
23722013|NCT00249795|66359237|FG000|Overall Study|Physician withdrew consent|71|||
23722014|NCT00249795|66359238|FG001|Overall Study|Physician withdrew consent|63|||
23722015|NCT00249795|66359237|FG000|Overall Study|Surgery / procedure|4|||
23722016|NCT00249795|66359238|FG001|Overall Study|Surgery / procedure|5|||
23722017|NCT00249795|66359237|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
23722018|NCT00249795|66359238|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
23722019|NCT00249795|66359237|FG000|Overall Study|Lightheadedness / dizziness|15|||
23722020|NCT00249795|66359238|FG001|Overall Study|Lightheadedness / dizziness|11|||
23722021|NCT00249795|66359237|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
23722022|NCT00249795|66359238|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
23722023|NCT00249795|66359237|FG000|Overall Study|Other contraindicated medication|1|||
23722024|NCT00249795|66359238|FG001|Overall Study|Other contraindicated medication|1|||
23722025|NCT00249795|66359237|FG000|Overall Study|Event related to cardiac condition|17|||
23722026|NCT00249795|66359238|FG001|Overall Study|Event related to cardiac condition|16|||
23722027|NCT00249795|66359237|FG000|Overall Study|Patient not wish to continue after May08|4|||
23722028|NCT00249795|66359238|FG001|Overall Study|Patient not wish to continue after May08|6|||
23722029|NCT00249795|66359237|FG000|Overall Study|Site not agree to continue after May08|1|||
23722030|NCT00249795|66359238|FG001|Overall Study|Site not agree to continue after May08|1|||
23722031|NCT00249795|66359237|FG000|Overall Study|Lost to Follow-up|0|||
23722032|NCT00249795|66359238|FG001|Overall Study|Lost to Follow-up|2|||
23722033|NCT00249795|66359237|FG000|Overall Study|Missing|0|||
23722034|NCT00249795|66359238|FG001|Overall Study|Missing|1|||
23722035|NCT05552859|66359239|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
23722036|NCT05552859|66359240|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
23722037|NCT01040845|66359241|FG000|Overall Study|Withdrawal by Subject|1|||
23722038|NCT01040845|66359242|FG001|Overall Study|Withdrawal by Subject|1|||
23722039|NCT01040845|66359241|FG000|Overall Study|Physician Decision|1|||
23722040|NCT01040845|66359242|FG001|Overall Study|Physician Decision|0|||
23722041|NCT00927758|66359247|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23722042|NCT00927758|66359248|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23722043|NCT00927758|66359249|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23722044|NCT00927758|66359250|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
23722045|NCT00927758|66359251|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23722046|NCT00927758|66359252|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
23722047|NCT00927758|66359247|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23722048|NCT00927758|66359248|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23722049|NCT00927758|66359249|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23722050|NCT00927758|66359250|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23722051|NCT00927758|66359251|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23722052|NCT00927758|66359252|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23722053|NCT01809197|66359253|FG000|Overall Study|Lost to Follow-up|4|||
23722054|NCT01809197|66359254|FG001|Overall Study|Lost to Follow-up|2|||
23722055|NCT01809197|66359253|FG000|Overall Study|Adverse Event|2|||
23722056|NCT01809197|66359254|FG001|Overall Study|Adverse Event|3|||
23614669|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Death|0|||
23614670|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
23722057|NCT01809197|66359253|FG000|Overall Study|Failed slit lamp exam|1|||
23722058|NCT01809197|66359254|FG001|Overall Study|Failed slit lamp exam|0|||
23722059|NCT01809197|66359253|FG000|Overall Study|Non-Compliance|1|||
23722060|NCT01809197|66359254|FG001|Overall Study|Non-Compliance|1|||
23722061|NCT01809197|66359253|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
23421538|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23722062|NCT01809197|66359254|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
23614671|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
23722063|NCT01809197|66359253|FG000|Overall Study|Withdrawal by Subject|1|||
23722064|NCT01809197|66359254|FG001|Overall Study|Withdrawal by Subject|1|||
23722065|NCT01809197|66359253|FG000|Overall Study|Product not available|0|||
23722066|NCT01809197|66359254|FG001|Overall Study|Product not available|1|||
23722067|NCT02517268|66359259|FG000|Overall Study|Withdrawal by Subject|1|||
23533569|NCT04068181|65686648|FG001|Overall Study|Death|8|||
23614672|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
23614673|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
23722068|NCT02517268|66359260|FG001|Overall Study|Withdrawal by Subject|0|||
23722069|NCT03488238|66359264|FG000|Overall Study|Equipment malfunction|1|||
23722070|NCT03488238|66359264|FG000|Overall Study|Adverse Event|1|||
23722071|NCT03057951|66359265|FG000|Overall Study|Adverse Event|553|||
23722072|NCT03057951|66359266|FG001|Overall Study|Adverse Event|575|||
23722073|NCT03057951|66359265|FG000|Overall Study|Protocol Violation|30|||
23722074|NCT03057951|66359266|FG001|Overall Study|Protocol Violation|24|||
23722075|NCT03057951|66359265|FG000|Overall Study|Lost to Follow-up|6|||
23722076|NCT03057951|66359266|FG001|Overall Study|Lost to Follow-up|16|||
23722077|NCT03057951|66359265|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
23722078|NCT03057951|66359266|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
23722079|NCT03057951|66359265|FG000|Overall Study|Study drug stopped, reason missing|6|||
23722080|NCT03057951|66359266|FG001|Overall Study|Study drug stopped, reason missing|1|||
23722081|NCT03057951|66359265|FG000|Overall Study|Medical advice|6|||
23722082|NCT03057951|66359266|FG001|Overall Study|Medical advice|2|||
23722083|NCT03057951|66359265|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
23614674|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23614675|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23614676|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23614677|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23614678|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
23614679|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614680|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614681|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614682|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
23614683|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
23614684|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
23614685|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
23614686|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
23614687|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614688|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614689|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614690|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Other|2|||
23614691|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Other|0|||
23614692|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Other|0|||
23614693|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Other|0|||
23614694|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
23614695|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
23614696|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
23614697|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
23614698|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
23614699|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
23614700|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
23614701|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
23614702|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
23614703|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
23722084|NCT03057951|66359266|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
23722085|NCT03057951|66359265|FG000|Overall Study|Investigator decision|2|||
23722086|NCT03057951|66359266|FG001|Overall Study|Investigator decision|0|||
23722087|NCT03057951|66359265|FG000|Overall Study|Patient decision|5|||
23722088|NCT03057951|66359266|FG001|Overall Study|Patient decision|2|||
23533570|NCT04068181|65686649|FG002|Overall Study|Death|4|||
23533571|NCT04068181|65686650|FG003|Overall Study|Death|2|||
23533572|NCT04068181|65686647|FG000|Overall Study|Continuing Study|16|||
23533573|NCT04068181|65686648|FG001|Overall Study|Continuing Study|7|||
23533574|NCT04068181|65686649|FG002|Overall Study|Continuing Study|11|||
23533575|NCT04068181|65686650|FG003|Overall Study|Continuing Study|13|||
23533576|NCT02707640|65686653|FG000|Overall Study|Adverse Event|4|||
23533577|NCT02707640|65686654|FG001|Overall Study|Adverse Event|2|||
23533578|NCT02707640|65686653|FG000|Overall Study|Death|1|||
23533579|NCT02707640|65686654|FG001|Overall Study|Death|2|||
23614704|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
23614705|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23614706|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
23722089|NCT03057951|66359265|FG000|Overall Study|Not attending study visits|3|||
23722090|NCT03057951|66359266|FG001|Overall Study|Not attending study visits|0|||
23722091|NCT03057951|66359265|FG000|Overall Study|Patient moved away|3|||
23722092|NCT03057951|66359266|FG001|Overall Study|Patient moved away|4|||
23722093|NCT03057951|66359265|FG000|Overall Study|Other reason than stated above|23|||
23533580|NCT02707640|65686653|FG000|Overall Study|Physician Decision|2|||
23533581|NCT02707640|65686654|FG001|Overall Study|Physician Decision|0|||
23533582|NCT02707640|65686653|FG000|Overall Study|Withdrawal by Subject|0|||
23614707|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
23533583|NCT02707640|65686654|FG001|Overall Study|Withdrawal by Subject|1|||
23722094|NCT03057951|66359266|FG001|Overall Study|Other reason than stated above|29|||
23722095|NCT03057951|66359265|FG000|Overall Study|Not treated|2|||
23722096|NCT03057951|66359266|FG001|Overall Study|Not treated|1|||
23722097|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
23722098|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
23722099|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
23722100|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
23722101|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
23722102|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
23722103|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
23533584|NCT02707640|65686653|FG000|Overall Study|Participant's Personal Decision|1|||
23533585|NCT02707640|65686654|FG001|Overall Study|Participant's Personal Decision|2|||
23533586|NCT02707640|65686653|FG000|Overall Study|Sponsor Discretion|1|||
23533587|NCT02707640|65686654|FG001|Overall Study|Sponsor Discretion|0|||
23533588|NCT02039427|65686655|FG000|Overall Study|Duration of surgery > 3h|1|||
23533589|NCT02039427|65686656|FG001|Overall Study|Duration of surgery > 3h|1|||
23533590|NCT02039427|65686657|FG002|Overall Study|Duration of surgery > 3h|0|||
23533591|NCT02039427|65686658|FG003|Overall Study|Duration of surgery > 3h|0|||
23533592|NCT02039427|65686655|FG000|Overall Study|Withdrawal on concent|0|||
23614708|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
23722104|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
23722105|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722106|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722107|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722108|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722109|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722110|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23722111|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
23722112|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
23722113|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
23722114|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
23722115|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
23722116|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
23722117|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
23722118|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
23722119|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23722120|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23722121|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23614709|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
23614710|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Death|0|||
23614711|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Death|0|||
23614712|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Death|1|||
23614713|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Death|1|||
23614714|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
23614715|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
23614716|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
23614717|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
23614718|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
23614719|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
23614720|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
23614721|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
23614722|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23722122|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23722123|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23722124|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23722125|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
23722126|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23722127|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23722128|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23722129|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23722130|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23722131|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23421539|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421540|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23533593|NCT02039427|65686656|FG001|Overall Study|Withdrawal on concent|0|||
23614723|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23722132|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
23722133|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23533594|NCT02039427|65686657|FG002|Overall Study|Withdrawal on concent|0|||
23533595|NCT02039427|65686658|FG003|Overall Study|Withdrawal on concent|1|||
23533596|NCT02039427|65686655|FG000|Overall Study|Cancellation of surgery|0|||
23722134|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23722135|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23722136|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23722137|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23722138|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23722139|NCT02120352|66359268|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
23722140|NCT02120352|66359269|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
23722141|NCT02120352|66359270|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
23722142|NCT02120352|66359271|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
23722143|NCT02120352|66359272|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
23722144|NCT02120352|66359273|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
23722145|NCT02120352|66359274|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
23722146|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23722147|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
23722148|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
23722149|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
23722150|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23722151|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23722152|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23722153|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23722154|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
23722155|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23722156|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
23722157|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23722158|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23722159|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23722160|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23814897|NCT00205803|66703389|FG000|After Infant Series|Other|10|||
23722161|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
23722162|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
23722163|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23722164|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23722165|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23722166|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23722167|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23722168|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23722169|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
23722170|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
23722171|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23722172|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23722173|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23722174|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722175|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722176|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722177|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
23722178|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722179|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722180|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23722181|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23722182|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
23722183|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
23722184|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
23722185|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23722186|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23722187|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23722188|NCT02120352|66359268|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722189|NCT02120352|66359269|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
23722190|NCT02120352|66359270|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722191|NCT02120352|66359271|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722192|NCT02120352|66359272|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722193|NCT02120352|66359273|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722194|NCT02120352|66359274|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23722195|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23722196|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
23722197|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
23722198|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23722199|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
23722200|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
23722201|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23722202|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722203|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722204|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722205|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722206|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
23722207|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722208|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23722209|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23722210|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
23722211|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
23722212|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23722213|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
23722214|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23722215|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23722216|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23722217|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
23533597|NCT02039427|65686656|FG001|Overall Study|Cancellation of surgery|0|||
23533598|NCT02039427|65686657|FG002|Overall Study|Cancellation of surgery|1|||
23533599|NCT02039427|65686658|FG003|Overall Study|Cancellation of surgery|0|||
23533600|NCT02039427|65686655|FG000|Overall Study|Loss of follow - up|1|||
23533601|NCT02039427|65686656|FG001|Overall Study|Loss of follow - up|0|||
23533602|NCT02039427|65686657|FG002|Overall Study|Loss of follow - up|2|||
23614724|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23614725|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
23614726|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Other|1|||
23614727|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Other|0|||
23722218|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
23722219|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23722220|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
23722221|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23614728|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Other|1|||
23614729|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Other|0|||
23614730|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
23614731|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614732|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614733|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614734|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614735|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614736|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614737|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
23614738|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
23614739|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
23614740|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
23533603|NCT02039427|65686658|FG003|Overall Study|Loss of follow - up|4|||
23533604|NCT02039427|65686655|FG000|Overall Study|Steroid Use|1|||
23533605|NCT02039427|65686656|FG001|Overall Study|Steroid Use|0|||
23533606|NCT02039427|65686657|FG002|Overall Study|Steroid Use|0|||
23533607|NCT02039427|65686658|FG003|Overall Study|Steroid Use|0|||
23533608|NCT00382733|65686659|FG000|Overall Study|Withdrawal by Subject|0|||
23533609|NCT00382733|65686660|FG001|Overall Study|Withdrawal by Subject|1|||
23533610|NCT00382733|65686661|FG002|Overall Study|Withdrawal by Subject|0|||
23614741|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
23614742|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
23722222|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23722223|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23722224|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
23722225|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
23722226|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23722227|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
23722228|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23722229|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23722230|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23722231|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
23722232|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
23722233|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23722234|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23722235|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23722236|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23722237|NCT02120352|66359268|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
23722238|NCT02120352|66359269|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
23722239|NCT02120352|66359270|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
23722240|NCT02120352|66359271|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
23814898|NCT00205803|66703390|FG001|After Infant Series|Other|4|||
23814899|NCT00205803|66703389|FG000|Toddler Dose|Lost to Follow-up|2|||
23814900|NCT00205803|66703390|FG001|Toddler Dose|Lost to Follow-up|3|||
23814901|NCT02853370|66703391|FG000|Overall Study|Physician Decision|1|||
23814902|NCT02853370|66703391|FG000|Overall Study|Lack of Efficacy|2|||
23814903|NCT02853370|66703391|FG000|Overall Study|Death|1|||
23814904|NCT02853370|66703391|FG000|Overall Study|Adverse Event|4|||
23814905|NCT02853370|66703391|FG000|Overall Study|Withdrawal by Subject|3|||
23814906|NCT03186781|66703392|FG000|Overall Study|Lost to Follow-up|0|||
23814907|NCT03186781|66703393|FG001|Overall Study|Lost to Follow-up|0|||
23814908|NCT03186781|66703394|FG002|Overall Study|Lost to Follow-up|1|||
23814909|NCT03186781|66703395|FG003|Overall Study|Lost to Follow-up|0|||
23814910|NCT03186781|66703396|FG004|Overall Study|Lost to Follow-up|1|||
23814911|NCT03186781|66703397|FG005|Overall Study|Lost to Follow-up|0|||
23814912|NCT03186781|66703392|FG000|Overall Study|Moved from Area|0|||
23814913|NCT03186781|66703393|FG001|Overall Study|Moved from Area|0|||
23814914|NCT03186781|66703394|FG002|Overall Study|Moved from Area|0|||
23814915|NCT03186781|66703395|FG003|Overall Study|Moved from Area|0|||
23814916|NCT03186781|66703396|FG004|Overall Study|Moved from Area|1|||
23814917|NCT03186781|66703397|FG005|Overall Study|Moved from Area|0|||
23814918|NCT03186781|66703392|FG000|Overall Study|Withdrawal by Subject|0|||
23814919|NCT03186781|66703393|FG001|Overall Study|Withdrawal by Subject|0|||
23814920|NCT03186781|66703394|FG002|Overall Study|Withdrawal by Subject|0|||
23814921|NCT03186781|66703395|FG003|Overall Study|Withdrawal by Subject|0|||
23814922|NCT03186781|66703396|FG004|Overall Study|Withdrawal by Subject|1|||
23814923|NCT03186781|66703397|FG005|Overall Study|Withdrawal by Subject|0|||
23814924|NCT01161407|66703398|FG000|Overall Study|Protocol Violation|3|||
23814925|NCT01161407|66703399|FG001|Overall Study|Protocol Violation|1|||
23814926|NCT02521376|66703400|FG000|Overall Study|Enrolled, But Not Treated|1|||
23814927|NCT02521376|66703401|FG001|Overall Study|Enrolled, But Not Treated|0|||
23814928|NCT02521376|66703402|FG002|Overall Study|Enrolled, But Not Treated|0|||
23814929|NCT02521376|66703403|FG003|Overall Study|Enrolled, But Not Treated|0|||
23814930|NCT03665441|66703404|FG000|Overall Study|survival follow up ongoing|23|||
23814931|NCT03665441|66703405|FG001|Overall Study|survival follow up ongoing|0|||
23814932|NCT03665441|66703404|FG000|Overall Study|Patients ongoing on treatment|9|||
23814933|NCT03665441|66703405|FG001|Overall Study|Patients ongoing on treatment|6|||
23814934|NCT03665441|66703404|FG000|Overall Study|Randomized but not treated|7|||
23814935|NCT03665441|66703405|FG001|Overall Study|Randomized but not treated|11|||
23814936|NCT02933255|66703409|FG000|Overall Study|Discontinued due to study closure.|1|||
23814937|NCT02933255|66703410|FG001|Overall Study|Discontinued due to study closure.|0|||
23814938|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Death|89|||
23814939|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Death|193|||
23814940|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Death|198|||
23814941|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
23814942|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
23814943|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
23814944|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
23722241|NCT02120352|66359272|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
23814945|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
23814946|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
23814947|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
23814948|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
23421541|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421542|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421543|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421544|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421545|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421546|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421547|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421548|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421549|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421550|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421551|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421552|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421553|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
23421554|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421555|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421556|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421557|NCT00969761|65288203|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421558|NCT00969761|65288204|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421559|NCT00969761|65288205|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
23421560|NCT00969761|65288206|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421561|NCT00969761|65288207|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421562|NCT00969761|65288208|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421563|NCT00969761|65288209|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421564|NCT00969761|65288210|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
23421565|NCT00969761|65288211|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
23421566|NCT00969761|65288212|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421567|NCT00969761|65288213|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421568|NCT00969761|65288214|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421569|NCT00969761|65288203|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421570|NCT00969761|65288204|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421571|NCT00969761|65288205|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421572|NCT00969761|65288206|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
23421573|NCT00969761|65288207|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
23421574|NCT00969761|65288208|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421575|NCT00969761|65288209|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421576|NCT00969761|65288210|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421577|NCT00969761|65288211|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
23421578|NCT00969761|65288212|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421579|NCT00969761|65288213|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421580|NCT00969761|65288214|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421581|NCT03158012|65288215|FG000|Overall Study|Withdrawal by Subject|0|||
23421582|NCT03158012|65288216|FG001|Overall Study|Withdrawal by Subject|1|||
23421583|NCT02785458|65288217|FG000|1 Month|Withdrawal by Subject|2|||
23421584|NCT02785458|65288218|FG001|1 Month|Withdrawal by Subject|1|||
23421585|NCT02785458|65288217|FG000|1 Month|Lost to Follow-up|38|||
23421586|NCT02785458|65288218|FG001|1 Month|Lost to Follow-up|31|||
23421587|NCT02785458|65288217|FG000|1 Month|Deemed Ineligible|1|||
23421588|NCT02785458|65288218|FG001|1 Month|Deemed Ineligible|0|||
23421589|NCT02785458|65288217|FG000|1 Month|Completed Evaluation by Baseline|42|||
23421590|NCT02785458|65288218|FG001|1 Month|Completed Evaluation by Baseline|39|||
23421591|NCT02785458|65288217|FG000|1 Month|Partial Interview|0|||
23421592|NCT02785458|65288218|FG001|1 Month|Partial Interview|4|||
23421593|NCT02785458|65288217|FG000|3 Months|Withdrawal by Subject|3|||
23421594|NCT02785458|65288218|FG001|3 Months|Withdrawal by Subject|1|||
23421595|NCT02785458|65288217|FG000|3 Months|Lost to Follow-up|25|||
23421596|NCT02785458|65288218|FG001|3 Months|Lost to Follow-up|21|||
23421597|NCT02785458|65288217|FG000|3 Months|Completed Evaluation at 1 Month|100|||
23421598|NCT02785458|65288218|FG001|3 Months|Completed Evaluation at 1 Month|89|||
23421599|NCT05463952|65288222|FG000|Treatment|Progressive disease|4|||
23421600|NCT05463952|65288222|FG000|Treatment|Ongoing|2|||
23421601|NCT00744978|65288223|FG000|Period 1|Lost to Follow-up|1|||
23421602|NCT00744978|65288224|FG001|Period 1|Lost to Follow-up|0|||
23421603|NCT00744978|65288223|FG000|Period 1|Withdrawal by Subject|0|||
23814949|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
23421604|NCT00744978|65288224|FG001|Period 1|Withdrawal by Subject|2|||
23421605|NCT00744978|65288223|FG000|Period 1|Other|0|||
23421606|NCT00744978|65288224|FG001|Period 1|Other|2|||
23421607|NCT00744978|65288223|FG000|Period 1|Adverse Event|4|||
23421608|NCT00744978|65288224|FG001|Period 1|Adverse Event|0|||
23421609|NCT00744978|65288223|FG000|Period 1|Randomized but not Treated|1|||
23421610|NCT00744978|65288224|FG001|Period 1|Randomized but not Treated|1|||
23421611|NCT00744978|65288223|FG000|Period 2|Adverse Event|0|||
23421612|NCT00744978|65288224|FG001|Period 2|Adverse Event|1|||
23421613|NCT01904149|65288225|FG000|Overall Study|Adverse Event|3|||
23421614|NCT01904149|65288226|FG001|Overall Study|Adverse Event|4|||
23421615|NCT01904149|65288227|FG002|Overall Study|Adverse Event|0|||
23421616|NCT01904149|65288228|FG003|Overall Study|Adverse Event|1|||
23421617|NCT01904149|65288229|FG004|Overall Study|Adverse Event|1|||
23421618|NCT01904149|65288230|FG005|Overall Study|Adverse Event|2|||
23421619|NCT01904149|65288225|FG000|Overall Study|Lack of Efficacy|0|||
23421620|NCT01904149|65288226|FG001|Overall Study|Lack of Efficacy|3|||
23421621|NCT01904149|65288227|FG002|Overall Study|Lack of Efficacy|1|||
23421622|NCT01904149|65288228|FG003|Overall Study|Lack of Efficacy|3|||
23421623|NCT01904149|65288229|FG004|Overall Study|Lack of Efficacy|3|||
23421624|NCT01904149|65288230|FG005|Overall Study|Lack of Efficacy|1|||
23421625|NCT01904149|65288225|FG000|Overall Study|Withdrawal by Subject|1|||
23421626|NCT01904149|65288226|FG001|Overall Study|Withdrawal by Subject|3|||
23421627|NCT01904149|65288227|FG002|Overall Study|Withdrawal by Subject|1|||
23421628|NCT01904149|65288228|FG003|Overall Study|Withdrawal by Subject|0|||
23421629|NCT01904149|65288229|FG004|Overall Study|Withdrawal by Subject|1|||
23421630|NCT01904149|65288230|FG005|Overall Study|Withdrawal by Subject|0|||
23421631|NCT01904149|65288225|FG000|Overall Study|Protocol Violation|0|||
23421632|NCT01904149|65288226|FG001|Overall Study|Protocol Violation|1|||
23421633|NCT01904149|65288227|FG002|Overall Study|Protocol Violation|0|||
23421634|NCT01904149|65288228|FG003|Overall Study|Protocol Violation|0|||
23421635|NCT01904149|65288229|FG004|Overall Study|Protocol Violation|0|||
23421636|NCT01904149|65288230|FG005|Overall Study|Protocol Violation|0|||
23421637|NCT01904149|65288225|FG000|Overall Study|non compliance with study drug|1|||
23421638|NCT01904149|65288226|FG001|Overall Study|non compliance with study drug|0|||
23421639|NCT01904149|65288227|FG002|Overall Study|non compliance with study drug|0|||
23421640|NCT01904149|65288228|FG003|Overall Study|non compliance with study drug|0|||
23421641|NCT01904149|65288229|FG004|Overall Study|non compliance with study drug|0|||
23421642|NCT01904149|65288230|FG005|Overall Study|non compliance with study drug|0|||
23421643|NCT01824823|65288232|FG000|Overall Study|Lack of Efficacy|1|||
23421644|NCT01824823|65288233|FG001|Overall Study|Lack of Efficacy|1|||
23421645|NCT01824823|65288232|FG000|Overall Study|Off-treatment reason not submitted|1|||
23533611|NCT00382733|65686662|FG003|Overall Study|Withdrawal by Subject|0|||
23533612|NCT00382733|65686663|FG004|Overall Study|Withdrawal by Subject|0|||
23533613|NCT01328002|65686664|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
23421646|NCT01824823|65288233|FG001|Overall Study|Off-treatment reason not submitted|0|||
23421647|NCT01133405|65288234|FG000|Period 1|Withdrawal by Subject|0|||
23421648|NCT01133405|65288235|FG001|Period 1|Withdrawal by Subject|1|||
23421649|NCT01133405|65288236|FG002|Period 1|Withdrawal by Subject|0|||
23421650|NCT01133405|65288237|FG003|Period 1|Withdrawal by Subject|1|||
23421651|NCT01133405|65288238|FG004|Period 1|Withdrawal by Subject|0|||
23421652|NCT01133405|65288239|FG005|Period 1|Withdrawal by Subject|1|||
23421653|NCT01133405|65288240|FG006|Period 1|Withdrawal by Subject|0|||
23421654|NCT01133405|65288241|FG007|Period 1|Withdrawal by Subject|0|||
23421655|NCT01133405|65288242|FG008|Period 1|Withdrawal by Subject|0|||
23421656|NCT01133405|65288243|FG009|Period 1|Withdrawal by Subject|0|||
23421657|NCT01133405|65288234|FG000|Period 1|Physician Decision|0|||
23421658|NCT01133405|65288235|FG001|Period 1|Physician Decision|0|||
23421659|NCT01133405|65288236|FG002|Period 1|Physician Decision|0|||
23421660|NCT01133405|65288237|FG003|Period 1|Physician Decision|1|||
23421661|NCT01133405|65288238|FG004|Period 1|Physician Decision|0|||
23421662|NCT01133405|65288239|FG005|Period 1|Physician Decision|0|||
23614743|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23421663|NCT01133405|65288240|FG006|Period 1|Physician Decision|0|||
23421664|NCT01133405|65288241|FG007|Period 1|Physician Decision|0|||
23421665|NCT01133405|65288242|FG008|Period 1|Physician Decision|0|||
23421666|NCT01133405|65288243|FG009|Period 1|Physician Decision|0|||
23421667|NCT01133405|65288234|FG000|Period 1|Discontinued after randomization|1|||
23421668|NCT01133405|65288235|FG001|Period 1|Discontinued after randomization|0|||
23421669|NCT01133405|65288236|FG002|Period 1|Discontinued after randomization|0|||
23421670|NCT01133405|65288237|FG003|Period 1|Discontinued after randomization|0|||
23421671|NCT01133405|65288238|FG004|Period 1|Discontinued after randomization|0|||
23421672|NCT01133405|65288239|FG005|Period 1|Discontinued after randomization|0|||
23421673|NCT01133405|65288240|FG006|Period 1|Discontinued after randomization|1|||
23421674|NCT01133405|65288241|FG007|Period 1|Discontinued after randomization|0|||
23421675|NCT01133405|65288242|FG008|Period 1|Discontinued after randomization|0|||
23421676|NCT01133405|65288243|FG009|Period 1|Discontinued after randomization|0|||
23421677|NCT01133405|65288234|FG000|Period 1|Received drug only in period 2|0|||
23421678|NCT01133405|65288235|FG001|Period 1|Received drug only in period 2|1|||
23421679|NCT01133405|65288236|FG002|Period 1|Received drug only in period 2|0|||
23421680|NCT01133405|65288237|FG003|Period 1|Received drug only in period 2|2|||
23421681|NCT01133405|65288238|FG004|Period 1|Received drug only in period 2|0|||
23614744|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23421682|NCT01133405|65288239|FG005|Period 1|Received drug only in period 2|1|||
23421683|NCT01133405|65288240|FG006|Period 1|Received drug only in period 2|0|||
23421684|NCT01133405|65288241|FG007|Period 1|Received drug only in period 2|0|||
23614745|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614746|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614747|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614748|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614749|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614750|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614751|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614752|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614753|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614754|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614755|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614756|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614757|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
23614758|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614759|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614760|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614761|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614762|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
23614763|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614764|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614765|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614766|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614767|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614768|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614769|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614770|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614771|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614772|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23421685|NCT01133405|65288242|FG008|Period 1|Received drug only in period 2|0|||
23421686|NCT01133405|65288243|FG009|Period 1|Received drug only in period 2|0|||
23421687|NCT01133405|65288234|FG000|Period 1|Received drug only in period 3|0|||
23421688|NCT01133405|65288235|FG001|Period 1|Received drug only in period 3|1|||
23421689|NCT01133405|65288236|FG002|Period 1|Received drug only in period 3|1|||
23421690|NCT01133405|65288237|FG003|Period 1|Received drug only in period 3|0|||
23421691|NCT01133405|65288238|FG004|Period 1|Received drug only in period 3|0|||
23614773|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23614774|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614775|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614776|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614777|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614778|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23421692|NCT01133405|65288239|FG005|Period 1|Received drug only in period 3|0|||
23614779|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614780|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614781|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23614782|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614783|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23614784|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23421693|NCT01133405|65288240|FG006|Period 1|Received drug only in period 3|0|||
23421694|NCT01133405|65288241|FG007|Period 1|Received drug only in period 3|0|||
23421695|NCT01133405|65288242|FG008|Period 1|Received drug only in period 3|0|||
23421696|NCT01133405|65288243|FG009|Period 1|Received drug only in period 3|0|||
23421697|NCT01133405|65288234|FG000|Period 2|Adverse Event|0|||
23421698|NCT01133405|65288235|FG001|Period 2|Adverse Event|0|||
23421699|NCT01133405|65288236|FG002|Period 2|Adverse Event|1|||
23421700|NCT01133405|65288237|FG003|Period 2|Adverse Event|0|||
23421701|NCT01133405|65288238|FG004|Period 2|Adverse Event|0|||
23421702|NCT01133405|65288239|FG005|Period 2|Adverse Event|0|||
23421703|NCT01133405|65288240|FG006|Period 2|Adverse Event|0|||
23421704|NCT01133405|65288241|FG007|Period 2|Adverse Event|0|||
23421705|NCT01133405|65288242|FG008|Period 2|Adverse Event|0|||
23421706|NCT01133405|65288243|FG009|Period 2|Adverse Event|0|||
23421707|NCT01133405|65288234|FG000|Period 2|Withdrawal by Subject|0|||
23421708|NCT01133405|65288235|FG001|Period 2|Withdrawal by Subject|0|||
23421709|NCT01133405|65288236|FG002|Period 2|Withdrawal by Subject|0|||
23421710|NCT01133405|65288237|FG003|Period 2|Withdrawal by Subject|1|||
23421711|NCT01133405|65288238|FG004|Period 2|Withdrawal by Subject|0|||
23421712|NCT01133405|65288239|FG005|Period 2|Withdrawal by Subject|1|||
23421713|NCT01133405|65288240|FG006|Period 2|Withdrawal by Subject|0|||
23421714|NCT01133405|65288241|FG007|Period 2|Withdrawal by Subject|0|||
23421715|NCT01133405|65288242|FG008|Period 2|Withdrawal by Subject|0|||
23421716|NCT01133405|65288243|FG009|Period 2|Withdrawal by Subject|0|||
23421717|NCT01133405|65288234|FG000|Period 2|Entry Criteria Not Met|0|||
23421718|NCT01133405|65288235|FG001|Period 2|Entry Criteria Not Met|1|||
23421719|NCT01133405|65288236|FG002|Period 2|Entry Criteria Not Met|0|||
23421720|NCT01133405|65288237|FG003|Period 2|Entry Criteria Not Met|0|||
23421721|NCT01133405|65288238|FG004|Period 2|Entry Criteria Not Met|0|||
23421722|NCT01133405|65288239|FG005|Period 2|Entry Criteria Not Met|0|||
23421723|NCT01133405|65288240|FG006|Period 2|Entry Criteria Not Met|0|||
23421724|NCT01133405|65288241|FG007|Period 2|Entry Criteria Not Met|0|||
23421725|NCT01133405|65288242|FG008|Period 2|Entry Criteria Not Met|0|||
23421726|NCT01133405|65288243|FG009|Period 2|Entry Criteria Not Met|0|||
23421727|NCT01133405|65288234|FG000|Period 2|Physician Decision|0|||
23421728|NCT01133405|65288235|FG001|Period 2|Physician Decision|0|||
23421729|NCT01133405|65288236|FG002|Period 2|Physician Decision|0|||
23421730|NCT01133405|65288237|FG003|Period 2|Physician Decision|0|||
23421731|NCT01133405|65288238|FG004|Period 2|Physician Decision|0|||
23421732|NCT01133405|65288239|FG005|Period 2|Physician Decision|1|||
23421733|NCT01133405|65288240|FG006|Period 2|Physician Decision|0|||
23421734|NCT01133405|65288241|FG007|Period 2|Physician Decision|0|||
23421735|NCT01133405|65288242|FG008|Period 2|Physician Decision|0|||
23421736|NCT01133405|65288243|FG009|Period 2|Physician Decision|0|||
23421737|NCT01874275|65288250|FG000|Overall Study|Lost to Follow-up|1|||
23421738|NCT01874275|65288251|FG001|Overall Study|Lost to Follow-up|0|||
23421739|NCT01238835|65288252|FG000|Overall Study|Death|124|||
23421740|NCT01238835|65288252|FG000|Overall Study|Withdrawal by Subject|9|||
23421741|NCT01238835|65288252|FG000|Overall Study|Lost to Follow-up|1|||
23421742|NCT01238835|65288252|FG000|Overall Study|Site early discontinuation|2|||
23421743|NCT03028480|65288258|FG000|Overall Study|No revisit after the first prescription date|2|||
23421744|NCT03028480|65288258|FG000|Overall Study|Did not use the drug|1|||
23421745|NCT03028480|65288258|FG000|Overall Study|Violation of the enrollment deadline|10|||
23421746|NCT03028480|65288258|FG000|Overall Study|Case report forms were not collected|21|||
23421747|NCT02649218|65288259|FG000|Overall Study|Adverse Event|8|||
23421748|NCT02649218|65288259|FG000|Overall Study|Lack of Efficacy|8|||
23421749|NCT02649218|65288259|FG000|Overall Study|Pregnancy|3|||
23421750|NCT02649218|65288259|FG000|Overall Study|Protocol Violation|3|||
23421751|NCT02649218|65288259|FG000|Overall Study|Physician Decision|1|||
23421752|NCT02649218|65288259|FG000|Overall Study|Withdrawal by Subject|2|||
23614785|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23421753|NCT00937404|65288268|FG000|Overall Study|Protocol Violation|1|||
23614786|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23421754|NCT00937404|65288268|FG000|Overall Study|Withdrawal by Subject|1|||
23614787|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23421755|NCT00068250|65288269|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
23421756|NCT00068250|65288270|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
23421757|NCT00068250|65288271|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
23421758|NCT00068250|65288272|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
23421759|NCT03640052|65288273|FG000|Overall Study|Lost to Follow-up|0|||
23421760|NCT03640052|65288274|FG001|Overall Study|Lost to Follow-up|1|||
23421761|NCT03640052|65288275|FG002|Overall Study|Lost to Follow-up|0|||
23421762|NCT03640052|65288276|FG003|Overall Study|Lost to Follow-up|0|||
23421763|NCT03640052|65288277|FG004|Overall Study|Lost to Follow-up|0|||
23421764|NCT00596154|65288278|FG000|Overall Study|Not Evaluable|2|||
23421765|NCT03298984|65288279|FG000|Overall Study|Physician Decision|1|||
23421766|NCT03298984|65288280|FG001|Overall Study|Physician Decision|0|||
23421767|NCT03298984|65288281|FG002|Overall Study|Physician Decision|0|||
23421768|NCT03298984|65288282|FG003|Overall Study|Physician Decision|6|||
23421769|NCT03298984|65288279|FG000|Overall Study|Lack of Efficacy|0|||
23421770|NCT03298984|65288280|FG001|Overall Study|Lack of Efficacy|1|||
23421771|NCT03298984|65288281|FG002|Overall Study|Lack of Efficacy|1|||
23421772|NCT03298984|65288282|FG003|Overall Study|Lack of Efficacy|4|||
23421773|NCT03298984|65288279|FG000|Overall Study|Relapsed disease (following remission)|0|||
23421774|NCT03298984|65288280|FG001|Overall Study|Relapsed disease (following remission)|0|||
23421775|NCT03298984|65288281|FG002|Overall Study|Relapsed disease (following remission)|1|||
23421776|NCT03298984|65288282|FG003|Overall Study|Relapsed disease (following remission)|1|||
23421777|NCT03298984|65288279|FG000|Overall Study|Adverse Event|0|||
23421778|NCT03298984|65288280|FG001|Overall Study|Adverse Event|0|||
23421779|NCT03298984|65288281|FG002|Overall Study|Adverse Event|0|||
23421780|NCT03298984|65288282|FG003|Overall Study|Adverse Event|1|||
23421781|NCT03298984|65288279|FG000|Overall Study|Death|0|||
23421782|NCT03298984|65288280|FG001|Overall Study|Death|0|||
23421783|NCT03298984|65288281|FG002|Overall Study|Death|0|||
23421784|NCT03298984|65288282|FG003|Overall Study|Death|2|||
23421785|NCT03298984|65288279|FG000|Overall Study|Insurance Company Decision|0|||
23421786|NCT03298984|65288280|FG001|Overall Study|Insurance Company Decision|0|||
23421787|NCT03298984|65288281|FG002|Overall Study|Insurance Company Decision|0|||
23421788|NCT03298984|65288282|FG003|Overall Study|Insurance Company Decision|1|||
23421789|NCT04941807|65288283|FG000|Overall Study|Lost to Follow-up|1|||
23722242|NCT02120352|66359273|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
23722243|NCT02120352|66359274|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
23722244|NCT02120352|66359268|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722245|NCT02120352|66359269|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722246|NCT02120352|66359270|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722247|NCT02120352|66359271|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722248|NCT02120352|66359272|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722249|NCT02120352|66359273|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23722250|NCT02120352|66359274|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
23722251|NCT01002742|66359275|FG000|Overall Study|Determined to be ineligible|0|||
23722252|NCT01002742|66359276|FG001|Overall Study|Determined to be ineligible|1|||
23722253|NCT03628599|66359277|FG000|Overall Study|Adverse Event|0|||
23722254|NCT03628599|66359278|FG001|Overall Study|Adverse Event|1|||
23722255|NCT04581863|66359279|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
23722256|NCT04581863|66359280|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
23722257|NCT00425100|66359281|FG000|Overall Study|Adverse Event|36|||
23722258|NCT00425100|66359281|FG000|Overall Study|Lack of Efficacy|4|||
23722259|NCT00425100|66359281|FG000|Overall Study|Lost to Follow-up|2|||
23722260|NCT00425100|66359281|FG000|Overall Study|Protocol Violation|4|||
23722261|NCT00425100|66359281|FG000|Overall Study|Withdrawal by Subject|7|||
23722262|NCT01170221|66359282|FG000|Overall Study|Lost to Follow-up|22|||
23722263|NCT01170221|66359283|FG001|Overall Study|Lost to Follow-up|21|||
23722264|NCT01170221|66359282|FG000|Overall Study|Withdrawal by Subject|9|||
23722265|NCT01170221|66359283|FG001|Overall Study|Withdrawal by Subject|7|||
23722266|NCT01170221|66359282|FG000|Overall Study|Subject completed only screening and LFU|1|||
23722267|NCT01170221|66359283|FG001|Overall Study|Subject completed only screening and LFU|0|||
23722268|NCT01170221|66359282|FG000|Overall Study|Randomized but not treated|1|||
23722269|NCT01170221|66359283|FG001|Overall Study|Randomized but not treated|0|||
23722270|NCT02650895|66359288|FG000|Overall Study|Withdrawal by Subject|0|||
23722271|NCT02650895|66359289|FG001|Overall Study|Withdrawal by Subject|1|||
23722272|NCT02650895|66359290|FG002|Overall Study|Withdrawal by Subject|0|||
23722273|NCT02650895|66359291|FG003|Overall Study|Withdrawal by Subject|0|||
23722274|NCT02650895|66359292|FG004|Overall Study|Withdrawal by Subject|0|||
23722275|NCT02650895|66359293|FG005|Overall Study|Withdrawal by Subject|0|||
23722276|NCT03407170|66359296|FG000|Overall Study|Adverse Event|1|||
23722277|NCT00814307|66359297|FG000|Overall Study|Randomized but not treated|1|||
23722278|NCT00814307|66359298|FG001|Overall Study|Randomized but not treated|0|||
23722279|NCT00814307|66359299|FG002|Overall Study|Randomized but not treated|0|||
23722280|NCT00814307|66359300|FG003|Overall Study|Randomized but not treated|0|||
23722281|NCT00814307|66359297|FG000|Overall Study|Adverse Event|3|||
23722282|NCT00814307|66359298|FG001|Overall Study|Adverse Event|9|||
23722283|NCT00814307|66359299|FG002|Overall Study|Adverse Event|3|||
23722284|NCT00814307|66359300|FG003|Overall Study|Adverse Event|2|||
23421790|NCT04941807|65288284|FG001|Overall Study|Lost to Follow-up|1|||
23421791|NCT02596958|65288297|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
23421792|NCT02596958|65288297|FG000|Overall Study|Cancer Progression|441|||
23421793|NCT02596958|65288297|FG000|Overall Study|Death From Cancer|112|||
23421794|NCT02596958|65288297|FG000|Overall Study|Death From Other Cause|33|||
23421795|NCT02596958|65288297|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
23421796|NCT02596958|65288297|FG000|Overall Study|Administrative Reasons/Other|231|||
23421797|NCT02596958|65288297|FG000|Overall Study|Lost to Follow-up|33|||
23421798|NCT02596958|65288297|FG000|Overall Study|Missing|32|||
23421799|NCT02596958|65288297|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
23421800|NCT03920293|65288300|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
23421801|NCT03920293|65288301|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
23814950|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
23814951|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
23814952|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
23814953|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
23814954|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
23814955|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
23814956|NCT02031458|66703411|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
23533614|NCT01328002|65686665|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
23533615|NCT01328002|65686664|FG000|Open-Label Period|Adverse Event|8|||
23533616|NCT01328002|65686665|FG001|Open-Label Period|Adverse Event|0|||
23814957|NCT02031458|66703412|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
23814958|NCT02031458|66703413|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
23814959|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Death|36|||
23814960|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Death|87|||
23814961|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Death|100|||
23814962|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
23814963|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
23421802|NCT03920293|65288300|FG000|Randomized-Controlled Period|Physician Decision|1|||
23533617|NCT01328002|65686664|FG000|Open-Label Period|Lack of Efficacy|3|||
23533618|NCT01328002|65686665|FG001|Open-Label Period|Lack of Efficacy|0|||
23533619|NCT01328002|65686664|FG000|Open-Label Period|Protocol Violation|2|||
23533620|NCT01328002|65686665|FG001|Open-Label Period|Protocol Violation|0|||
23533621|NCT01328002|65686664|FG000|Open-Label Period|Withdrawal by Subject|9|||
23533622|NCT01328002|65686665|FG001|Open-Label Period|Withdrawal by Subject|0|||
23533623|NCT01328002|65686664|FG000|Open-Label Period|Lost to Follow-up|6|||
23533624|NCT01328002|65686665|FG001|Open-Label Period|Lost to Follow-up|0|||
23533625|NCT01328002|65686664|FG000|Open-Label Period|Other Reason|2|||
23533626|NCT01328002|65686665|FG001|Open-Label Period|Other Reason|0|||
23533627|NCT01328002|65686664|FG000|Double-Blind Period|Adverse Event|1|||
23533628|NCT01328002|65686665|FG001|Double-Blind Period|Adverse Event|0|||
23533629|NCT01328002|65686664|FG000|Double-Blind Period|Lack of Efficacy|1|||
23533630|NCT01328002|65686665|FG001|Double-Blind Period|Lack of Efficacy|0|||
23533631|NCT02652624|65686668|FG000|Randomized Phase|Pregnancy|3|||
23533632|NCT02652624|65686669|FG001|Randomized Phase|Pregnancy|1|||
23533633|NCT02652624|65686668|FG000|Randomized Phase|Investigator's Discretion|0|||
23533634|NCT02652624|65686669|FG001|Randomized Phase|Investigator's Discretion|2|||
23533635|NCT02652624|65686668|FG000|Randomized Phase|Death|0|||
23533636|NCT02652624|65686669|FG001|Randomized Phase|Death|1|||
23533637|NCT02652624|65686668|FG000|Randomized Phase|Lost to Follow-up|0|||
23533638|NCT02652624|65686669|FG001|Randomized Phase|Lost to Follow-up|1|||
23533639|NCT02652624|65686668|FG000|Extension Phase|Lost to Follow-up|3|||
23533640|NCT02652624|65686669|FG001|Extension Phase|Lost to Follow-up|1|||
23533641|NCT02652624|65686668|FG000|Extension Phase|Pregnancy|1|||
23533642|NCT02652624|65686669|FG001|Extension Phase|Pregnancy|1|||
23533643|NCT02652624|65686668|FG000|Extension Phase|Adverse Event|0|||
23533644|NCT02652624|65686669|FG001|Extension Phase|Adverse Event|1|||
23533645|NCT02652624|65686668|FG000|Extension Phase|Withdrew Consent|0|||
23533646|NCT02652624|65686669|FG001|Extension Phase|Withdrew Consent|1|||
23533647|NCT01067352|65686670|FG000|Overall Study|Withdrawal by Subject|1|||
23533648|NCT01067352|65686671|FG001|Overall Study|Withdrawal by Subject|2|||
23533649|NCT01067352|65686672|FG002|Overall Study|Withdrawal by Subject|1|||
23533650|NCT01067352|65686670|FG000|Overall Study|Physician Decision|0|||
23533651|NCT01067352|65686671|FG001|Overall Study|Physician Decision|1|||
23533652|NCT01067352|65686672|FG002|Overall Study|Physician Decision|0|||
23421803|NCT03920293|65288301|FG001|Randomized-Controlled Period|Physician Decision|2|||
23533653|NCT00298896|65686673|FG000|Overall Study|Death|3|||
23533654|NCT00298896|65686673|FG000|Overall Study|Physician Decision|2|||
23533655|NCT00298896|65686673|FG000|Overall Study|Intercurrent Illness|1|||
23533656|NCT00298896|65686673|FG000|Overall Study|Disease Progression|41|||
23533657|NCT00298896|65686673|FG000|Overall Study|Withdrawal by Subject|2|||
23533658|NCT00298896|65686673|FG000|Overall Study|Assigned to treatment in error|1|||
23814964|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
23533659|NCT00281840|65686674|FG000|Overall Study|Adverse Event|12|||
23533660|NCT00281840|65686674|FG000|Overall Study|Physician Decision|6|||
23533661|NCT00281840|65686674|FG000|Overall Study|Withdrawal by Subject|3|||
23533662|NCT00281840|65686674|FG000|Overall Study|Disease Progression|2|||
23533663|NCT00281840|65686674|FG000|Overall Study|exceed maximum delay in treatment|1|||
23533664|NCT00281840|65686674|FG000|Overall Study|Complicating Disease|1|||
23533665|NCT03075644|65686675|FG000|Overall Study|Withdrawal by Subject|1|||
23533666|NCT03075644|65686676|FG001|Overall Study|Withdrawal by Subject|1|||
23533667|NCT01209624|65686681|FG000|Overall Study|Death|2|||
23533668|NCT01209624|65686681|FG000|Overall Study|Adverse Event|13|||
23533669|NCT01209624|65686681|FG000|Overall Study|Lack of Efficacy|17|||
23533670|NCT01209624|65686681|FG000|Overall Study|Lost to Follow-up|290|||
23533671|NCT01209624|65686681|FG000|Overall Study|Other|4|||
23533672|NCT00179413|65686682|FG000|Overall Study|Adverse Event|38|||
23533673|NCT00179413|65686683|FG001|Overall Study|Adverse Event|20|||
23533674|NCT00179413|65686682|FG000|Overall Study|Withdrawal by Subject|87|||
23533675|NCT00179413|65686683|FG001|Overall Study|Withdrawal by Subject|95|||
23533676|NCT02082522|65686686|FG000|Overall Study|Sponsor termination|5|||
23533677|NCT02082522|65686687|FG001|Overall Study|Sponsor termination|3|||
23533678|NCT02082522|65686686|FG000|Overall Study|Withdrawal by Subject|2|||
23533679|NCT02082522|65686687|FG001|Overall Study|Withdrawal by Subject|4|||
23533680|NCT02082522|65686686|FG000|Overall Study|Death|1|||
23533681|NCT02082522|65686687|FG001|Overall Study|Death|0|||
23533682|NCT02082522|65686686|FG000|Overall Study|Lost to Follow-up|1|||
23533683|NCT02082522|65686687|FG001|Overall Study|Lost to Follow-up|0|||
23533684|NCT02082522|65686686|FG000|Overall Study|Physician Decision|3|||
23533685|NCT02082522|65686687|FG001|Overall Study|Physician Decision|1|||
23533686|NCT02082522|65686686|FG000|Overall Study|Disease progression|2|||
23533687|NCT02082522|65686687|FG001|Overall Study|Disease progression|2|||
23533688|NCT02082522|65686686|FG000|Overall Study|Chemotherapy change|1|||
23814965|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Physician Decision|0|||
23814966|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Physician Decision|1|||
23814967|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Physician Decision|0|||
23814968|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
23814969|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
23814970|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
23614788|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23614789|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614790|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614791|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23614792|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
23614793|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23533689|NCT02082522|65686687|FG001|Overall Study|Chemotherapy change|3|||
23533690|NCT01306617|65686688|FG000|Overall Study|Adverse Event|1|||
23533691|NCT01306617|65686689|FG001|Overall Study|Adverse Event|0|||
23533692|NCT01306617|65686690|FG002|Overall Study|Adverse Event|0|||
23533693|NCT01306617|65686688|FG000|Overall Study|Virologic Failure|0|||
23533694|NCT01306617|65686689|FG001|Overall Study|Virologic Failure|0|||
23533695|NCT01306617|65686690|FG002|Overall Study|Virologic Failure|5|||
23533696|NCT01306617|65686688|FG000|Overall Study|Non-compliance|0|||
23533697|NCT01306617|65686689|FG001|Overall Study|Non-compliance|1|||
23533698|NCT01306617|65686690|FG002|Overall Study|Non-compliance|0|||
23533699|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533700|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
23533701|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533702|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533703|NCT03049813|65686691|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
23533704|NCT03049813|65686692|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
23722285|NCT00814307|66359297|FG000|Overall Study|Lack of Efficacy|1|||
23722286|NCT00814307|66359298|FG001|Overall Study|Lack of Efficacy|1|||
23533705|NCT03049813|65686693|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
23533706|NCT03049813|65686694|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
23533707|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533708|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
23533709|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533710|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533711|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
23533712|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
23533713|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
23533714|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
23614794|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23722287|NCT00814307|66359299|FG002|Overall Study|Lack of Efficacy|3|||
23722288|NCT00814307|66359300|FG003|Overall Study|Lack of Efficacy|4|||
23722289|NCT00814307|66359297|FG000|Overall Study|Other|1|||
23722290|NCT00814307|66359298|FG001|Overall Study|Other|2|||
23722291|NCT00814307|66359299|FG002|Overall Study|Other|0|||
23722292|NCT00814307|66359300|FG003|Overall Study|Other|1|||
23722293|NCT00814307|66359297|FG000|Overall Study|Protocol Violation|2|||
23533715|NCT01340976|65686695|FG000|Overall Study|Physician Decision|2|||
23533716|NCT01340976|65686696|FG001|Overall Study|Physician Decision|0|||
23533717|NCT01340976|65686697|FG002|Overall Study|Physician Decision|1|||
23533718|NCT01340976|65686698|FG003|Overall Study|Physician Decision|1|||
23533719|NCT01340976|65686699|FG004|Overall Study|Physician Decision|1|||
23533720|NCT01340976|65686700|FG005|Overall Study|Physician Decision|0|||
23533721|NCT01340976|65686695|FG000|Overall Study|Death|0|||
23533722|NCT01340976|65686696|FG001|Overall Study|Death|1|||
23533723|NCT01340976|65686697|FG002|Overall Study|Death|0|||
23533724|NCT01340976|65686698|FG003|Overall Study|Death|0|||
23533725|NCT01340976|65686699|FG004|Overall Study|Death|0|||
23533726|NCT01340976|65686700|FG005|Overall Study|Death|0|||
23533727|NCT01340976|65686695|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
23533728|NCT01340976|65686696|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533729|NCT01340976|65686697|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533730|NCT01340976|65686698|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533731|NCT01340976|65686699|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533732|NCT01340976|65686700|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533733|NCT01340976|65686695|FG000|Overall Study|Withdrawal by Subject|0|||
23533734|NCT01340976|65686696|FG001|Overall Study|Withdrawal by Subject|0|||
23533735|NCT01340976|65686697|FG002|Overall Study|Withdrawal by Subject|0|||
23533736|NCT01340976|65686698|FG003|Overall Study|Withdrawal by Subject|1|||
23533737|NCT01340976|65686699|FG004|Overall Study|Withdrawal by Subject|1|||
23533738|NCT01340976|65686700|FG005|Overall Study|Withdrawal by Subject|0|||
23533739|NCT01340976|65686695|FG000|Overall Study|Other anemia treatment|1|||
23533740|NCT01340976|65686696|FG001|Overall Study|Other anemia treatment|0|||
23533741|NCT01340976|65686697|FG002|Overall Study|Other anemia treatment|2|||
23533742|NCT01340976|65686698|FG003|Overall Study|Other anemia treatment|1|||
23533743|NCT01340976|65686699|FG004|Overall Study|Other anemia treatment|0|||
23533744|NCT01340976|65686700|FG005|Overall Study|Other anemia treatment|1|||
23533745|NCT01340976|65686695|FG000|Overall Study|Adverse Event|0|||
23533746|NCT01340976|65686696|FG001|Overall Study|Adverse Event|1|||
23533747|NCT01340976|65686697|FG002|Overall Study|Adverse Event|0|||
23533748|NCT01340976|65686698|FG003|Overall Study|Adverse Event|0|||
23533749|NCT01340976|65686699|FG004|Overall Study|Adverse Event|0|||
23533750|NCT01340976|65686700|FG005|Overall Study|Adverse Event|0|||
23533751|NCT01282216|65686701|FG000|Overall Study|Graft failure|0|||
23533752|NCT01282216|65686702|FG001|Overall Study|Graft failure|0|||
23533753|NCT01282216|65686703|FG002|Overall Study|Graft failure|3|||
23533754|NCT01282216|65686704|FG003|Overall Study|Graft failure|2|||
23533755|NCT01282216|65686701|FG000|Overall Study|Physician Decision|0|||
23533756|NCT01282216|65686702|FG001|Overall Study|Physician Decision|0|||
23533757|NCT01282216|65686703|FG002|Overall Study|Physician Decision|11|||
23533758|NCT01282216|65686704|FG003|Overall Study|Physician Decision|0|||
23533759|NCT01282216|65686701|FG000|Overall Study|Relapse|0|||
23533760|NCT01282216|65686702|FG001|Overall Study|Relapse|0|||
23533761|NCT01282216|65686703|FG002|Overall Study|Relapse|17|||
23533762|NCT01282216|65686704|FG003|Overall Study|Relapse|6|||
23533763|NCT01282216|65686701|FG000|Overall Study|Death|0|||
23533764|NCT01282216|65686702|FG001|Overall Study|Death|0|||
23533765|NCT01282216|65686703|FG002|Overall Study|Death|2|||
23533766|NCT01282216|65686704|FG003|Overall Study|Death|0|||
23533767|NCT01707004|65686705|FG000|Overall Study|Physician Decision|3|||
23533768|NCT02550652|65686708|FG000|Overall Study|Death|1|||
23533769|NCT02550652|65686709|FG001|Overall Study|Death|4|||
23533770|NCT02550652|65686708|FG000|Overall Study|Lack of Efficacy|1|||
23533771|NCT02550652|65686709|FG001|Overall Study|Lack of Efficacy|0|||
23533772|NCT02550652|65686708|FG000|Overall Study|Withdrawal by Subject|4|||
23533773|NCT02550652|65686709|FG001|Overall Study|Withdrawal by Subject|7|||
23533774|NCT02550652|65686708|FG000|Overall Study|Post Trial Access|1|||
23533775|NCT02550652|65686709|FG001|Overall Study|Post Trial Access|0|||
23533776|NCT02550652|65686708|FG000|Overall Study|Lost to Follow-up|1|||
23533777|NCT02550652|65686709|FG001|Overall Study|Lost to Follow-up|3|||
23533778|NCT02550652|65686708|FG000|Overall Study|Physician Decision|0|||
23533779|NCT02550652|65686709|FG001|Overall Study|Physician Decision|2|||
23533780|NCT02550652|65686708|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
23533781|NCT02550652|65686709|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
23533782|NCT00048724|65686710|FG000|Overall Study|Adverse Event|53|||
23533783|NCT00048724|65686711|FG001|Overall Study|Adverse Event|12|||
23533784|NCT00048724|65686710|FG000|Overall Study|Withdrawal by Subject|34|||
23533785|NCT00048724|65686711|FG001|Overall Study|Withdrawal by Subject|54|||
23533786|NCT00048724|65686710|FG000|Overall Study|Lost to Follow-up|5|||
23533787|NCT00048724|65686711|FG001|Overall Study|Lost to Follow-up|5|||
23533788|NCT00048724|65686710|FG000|Overall Study|Protocol-defined Clinical Event|17|||
23533789|NCT00048724|65686711|FG001|Overall Study|Protocol-defined Clinical Event|32|||
23533790|NCT00048724|65686710|FG000|Overall Study|Noncompliance With Protocol|4|||
23533791|NCT00048724|65686711|FG001|Overall Study|Noncompliance With Protocol|12|||
23533792|NCT00048724|65686710|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
23614795|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
23614796|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614797|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614798|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614799|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614800|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614801|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614802|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
23614803|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614804|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614805|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614806|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614807|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
23614808|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614809|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
23614810|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614811|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614812|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614813|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614814|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614815|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614816|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614817|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614818|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614819|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614820|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614821|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614822|NCT00930644|65976277|FG000|Overall Study|Withdrawal by Subject|4|||
23614823|NCT00930644|65976277|FG000|Overall Study|Physician Decision|2|||
23614824|NCT00930644|65976277|FG000|Overall Study|Death|1|||
23614825|NCT00930644|65976277|FG000|Overall Study|Adverse Event|16|||
23614826|NCT00449033|65976278|FG000|Treatment Period|Adverse Event|117|||
23614827|NCT00449033|65976279|FG001|Treatment Period|Adverse Event|83|||
23614828|NCT00449033|65976278|FG000|Treatment Period|Death|21|||
23614829|NCT00449033|65976279|FG001|Treatment Period|Death|12|||
23614830|NCT00449033|65976278|FG000|Treatment Period|Lost to Follow-up|0|||
23614831|NCT00449033|65976279|FG001|Treatment Period|Lost to Follow-up|2|||
23614832|NCT00449033|65976278|FG000|Treatment Period|Physician Decision|4|||
23614833|NCT00449033|65976279|FG001|Treatment Period|Physician Decision|5|||
23614834|NCT00449033|65976278|FG000|Treatment Period|Protocol Violation|8|||
23614835|NCT00449033|65976279|FG001|Treatment Period|Protocol Violation|7|||
23614836|NCT00449033|65976278|FG000|Treatment Period|Disease Progression|231|||
23614837|NCT00449033|65976279|FG001|Treatment Period|Disease Progression|288|||
23614838|NCT00449033|65976278|FG000|Treatment Period|Consent Withdrawn|36|||
23614839|NCT00449033|65976279|FG001|Treatment Period|Consent Withdrawn|20|||
23614840|NCT00449033|65976278|FG000|Treatment Period|Amended Protocol Criteria|22|||
23614841|NCT00449033|65976279|FG001|Treatment Period|Amended Protocol Criteria|18|||
23614842|NCT00449033|65976278|FG000|Treatment Period|Non-compliance|7|||
23614843|NCT00449033|65976279|FG001|Treatment Period|Non-compliance|8|||
23614844|NCT00449033|65976278|FG000|Treatment Period|Second Malignancy|0|||
23614845|NCT00449033|65976279|FG001|Treatment Period|Second Malignancy|1|||
23614846|NCT00449033|65976278|FG000|Treatment Period|Reason Missing|0|||
23614847|NCT00449033|65976279|FG001|Treatment Period|Reason Missing|4|||
23614848|NCT00449033|65976278|FG000|Treatment Period|Treatment Ongoing|6|||
23614849|NCT00449033|65976279|FG001|Treatment Period|Treatment Ongoing|4|||
23614850|NCT00449033|65976278|FG000|Follow-up Period|Death|299|||
23614851|NCT00449033|65976279|FG001|Follow-up Period|Death|311|||
23614852|NCT00449033|65976278|FG000|Follow-up Period|Lost to Follow-up|6|||
23614853|NCT00449033|65976279|FG001|Follow-up Period|Lost to Follow-up|10|||
23614854|NCT00449033|65976278|FG000|Follow-up Period|Reason Missing|120|||
23614855|NCT00449033|65976279|FG001|Follow-up Period|Reason Missing|113|||
23614856|NCT00788671|65976280|FG000|Overall Study|Death|2|||
23614857|NCT00788671|65976280|FG000|Overall Study|Unable to biopsy|1|||
23614858|NCT00788671|65976280|FG000|Overall Study|Withdrawal by Subject|4|||
23614859|NCT00788671|65976280|FG000|Overall Study|IUD expulsed|1|||
23614860|NCT00788671|65976280|FG000|Overall Study|Lost to follow up|2|||
23614861|NCT01951105|65976281|FG000|Overall Study|Adverse Event|0|||
23614862|NCT01951105|65976282|FG001|Overall Study|Adverse Event|5|||
23614863|NCT01951105|65976283|FG002|Overall Study|Adverse Event|0|||
23614864|NCT01951105|65976281|FG000|Overall Study|Lost to Follow-up|0|||
23614865|NCT01951105|65976282|FG001|Overall Study|Lost to Follow-up|1|||
23614866|NCT01951105|65976283|FG002|Overall Study|Lost to Follow-up|0|||
23614867|NCT01951105|65976281|FG000|Overall Study|Protocol Violation|1|||
23614868|NCT01951105|65976282|FG001|Overall Study|Protocol Violation|1|||
23533793|NCT00048724|65686711|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
23533794|NCT00048724|65686710|FG000|Overall Study|Administrative|1|||
23533795|NCT00048724|65686711|FG001|Overall Study|Administrative|1|||
23533796|NCT00773175|65686712|FG000|Overall Study|Adverse Event|2|||
23533797|NCT00773175|65686713|FG001|Overall Study|Adverse Event|0|||
23533798|NCT00773175|65686712|FG000|Overall Study|Consent Withdrawn|0|||
23533799|NCT00773175|65686713|FG001|Overall Study|Consent Withdrawn|2|||
23582177|NCT02223793|65862352|FG001|Overall Study|Moved/studycenter unable to participate|6|||
23582178|NCT02223793|65862353|FG002|Overall Study|Moved/studycenter unable to participate|8|||
23582179|NCT02219490|65862354|FG000|Overall Study|Adverse Event|24|||
23421804|NCT03920293|65288300|FG000|Randomized-Controlled Period|Adverse Event|0|||
23421805|NCT03920293|65288301|FG001|Randomized-Controlled Period|Adverse Event|2|||
23421806|NCT03920293|65288300|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
23421807|NCT03920293|65288301|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
23421808|NCT03920293|65288300|FG000|Randomized-Controlled Period|Death|2|||
23421809|NCT03920293|65288301|FG001|Randomized-Controlled Period|Death|0|||
23421810|NCT03920293|65288300|FG000|Randomized-Controlled Period|Protocol Violation|1|||
23421811|NCT03920293|65288301|FG001|Randomized-Controlled Period|Protocol Violation|0|||
23421812|NCT03920293|65288300|FG000|Randomized-Controlled Period|Noncompliance|1|||
23421813|NCT03920293|65288301|FG001|Randomized-Controlled Period|Noncompliance|0|||
23421814|NCT03920293|65288300|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
23421815|NCT03920293|65288301|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
23421816|NCT03920293|65288300|FG000|Open- Label Extension Period|Death|3|||
23421817|NCT03920293|65288301|FG001|Open- Label Extension Period|Death|3|||
23421818|NCT03920293|65288300|FG000|Open- Label Extension Period|Physician Decision|5|||
23421819|NCT03920293|65288301|FG001|Open- Label Extension Period|Physician Decision|3|||
23421820|NCT03920293|65288300|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
23421821|NCT03920293|65288301|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
23421822|NCT02374814|65288302|FG000|Overall Study|Lost to Follow-up|1|||
23421823|NCT02374814|65288303|FG001|Overall Study|Lost to Follow-up|1|||
23421824|NCT02374814|65288304|FG002|Overall Study|Lost to Follow-up|0|||
23421825|NCT02374814|65288305|FG003|Overall Study|Lost to Follow-up|1|||
23421826|NCT02374814|65288306|FG004|Overall Study|Lost to Follow-up|0|||
23421827|NCT02374814|65288307|FG005|Overall Study|Lost to Follow-up|0|||
23421828|NCT02374814|65288302|FG000|Overall Study|Withdrawal by Subject|0|||
23582180|NCT02219490|65862354|FG000|Overall Study|Withdrew consent|96|||
23582181|NCT02219490|65862354|FG000|Overall Study|Lost to Follow-up|126|||
23582182|NCT02219490|65862354|FG000|Overall Study|COVID-19 infection|2|||
23614869|NCT01951105|65976283|FG002|Overall Study|Protocol Violation|1|||
23421829|NCT02374814|65288303|FG001|Overall Study|Withdrawal by Subject|0|||
23421830|NCT02374814|65288304|FG002|Overall Study|Withdrawal by Subject|1|||
23421831|NCT02374814|65288305|FG003|Overall Study|Withdrawal by Subject|1|||
23421832|NCT02374814|65288306|FG004|Overall Study|Withdrawal by Subject|0|||
23421833|NCT02374814|65288307|FG005|Overall Study|Withdrawal by Subject|0|||
23421834|NCT05659719|65288308|FG000|Overall Study|At sponsor's request|0|||
23421835|NCT05659719|65288309|FG001|Overall Study|At sponsor's request|0|||
23421836|NCT05659719|65288310|FG002|Overall Study|At sponsor's request|0|||
23421837|NCT05659719|65288311|FG003|Overall Study|At sponsor's request|95|||
23421838|NCT05659719|65288308|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421839|NCT05659719|65288309|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421840|NCT05659719|65288310|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421841|NCT05659719|65288311|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
23421842|NCT05659719|65288308|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
23421843|NCT05659719|65288309|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
23421844|NCT05659719|65288310|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
23421845|NCT05659719|65288311|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
23421846|NCT05659719|65288308|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421847|NCT05659719|65288309|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421848|NCT05659719|65288310|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421849|NCT05659719|65288311|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
23421850|NCT05659719|65288308|FG000|Overall Study|Lost to Follow-up|0|||
23421851|NCT05659719|65288309|FG001|Overall Study|Lost to Follow-up|0|||
23421852|NCT05659719|65288310|FG002|Overall Study|Lost to Follow-up|0|||
23421853|NCT05659719|65288311|FG003|Overall Study|Lost to Follow-up|2|||
23421854|NCT05659719|65288308|FG000|Overall Study|Moved to another observational study|0|||
23421855|NCT05659719|65288309|FG001|Overall Study|Moved to another observational study|0|||
23421856|NCT05659719|65288310|FG002|Overall Study|Moved to another observational study|0|||
23722294|NCT00814307|66359298|FG001|Overall Study|Protocol Violation|8|||
23421857|NCT05659719|65288311|FG003|Overall Study|Moved to another observational study|1|||
23421858|NCT05659719|65288308|FG000|Overall Study|The child was enrolled in an interventional study|0|||
23421859|NCT05659719|65288309|FG001|Overall Study|The child was enrolled in an interventional study|0|||
23421860|NCT05659719|65288310|FG002|Overall Study|The child was enrolled in an interventional study|0|||
23421861|NCT05659719|65288311|FG003|Overall Study|The child was enrolled in an interventional study|55|||
23421862|NCT05659719|65288308|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421863|NCT05659719|65288309|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421864|NCT05659719|65288310|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421865|NCT05659719|65288311|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
23421866|NCT05659719|65288308|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421867|NCT05659719|65288309|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421868|NCT05659719|65288310|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421869|NCT05659719|65288311|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
23421870|NCT00470093|65288312|FG000|Overall Study|Adverse Event|2|||
23421871|NCT05438602|65288315|FG000|Treatment (15 Days)|Adverse Event|2|||
23421872|NCT05438602|65288316|FG001|Treatment (15 Days)|Adverse Event|1|||
23421873|NCT05438602|65288317|FG002|Treatment (15 Days)|Adverse Event|3|||
23421874|NCT05438602|65288315|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
23421875|NCT05438602|65288316|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
23533800|NCT03769116|65689242|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
23533801|NCT03769116|65689243|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
23533802|NCT03769116|65689242|FG000|Part 3 - Open Label|Physician Decision|1|||
23533803|NCT03769116|65689243|FG001|Part 3 - Open Label|Physician Decision|0|||
23533804|NCT03769116|65689242|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
23533805|NCT03769116|65689243|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
23722295|NCT00814307|66359299|FG002|Overall Study|Protocol Violation|1|||
23421876|NCT05438602|65288317|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
23421877|NCT05438602|65288315|FG000|Treatment (15 Days)|Other|0|||
23421878|NCT05438602|65288316|FG001|Treatment (15 Days)|Other|0|||
23421879|NCT05438602|65288317|FG002|Treatment (15 Days)|Other|1|||
23421880|NCT05438602|65288315|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
23421881|NCT05438602|65288316|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
23421882|NCT05438602|65288317|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
23421883|NCT05438602|65288315|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
23421884|NCT05438602|65288316|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
23421885|NCT05438602|65288317|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
23421886|NCT05438602|65288315|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
23421887|NCT05438602|65288316|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
23421888|NCT05438602|65288317|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
23421889|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
23421890|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
23421891|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
23421892|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
23421893|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
23421894|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
23421895|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
23421896|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
23421897|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
23421898|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
23421899|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
23421900|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
23421901|NCT00996281|65288328|FG000|Overall Study|Adverse Event|75|||
23421902|NCT00996281|65288329|FG001|Overall Study|Adverse Event|37|||
23421903|NCT00996281|65288328|FG000|Overall Study|Major Protocol Deviation|6|||
23421904|NCT00996281|65288329|FG001|Overall Study|Major Protocol Deviation|7|||
23421905|NCT00996281|65288328|FG000|Overall Study|Lost to Follow-up|14|||
23421906|NCT00996281|65288329|FG001|Overall Study|Lost to Follow-up|16|||
23421907|NCT00996281|65288328|FG000|Overall Study|Withdrawal by Subject|31|||
23421908|NCT00996281|65288329|FG001|Overall Study|Withdrawal by Subject|20|||
23421909|NCT00996281|65288328|FG000|Overall Study|Lack of Efficacy|0|||
23421910|NCT00996281|65288329|FG001|Overall Study|Lack of Efficacy|2|||
23421911|NCT00996281|65288328|FG000|Overall Study|Other|5|||
23421912|NCT00996281|65288329|FG001|Overall Study|Other|7|||
23421913|NCT00835640|65288330|FG000|Second Intervention|Protocol Violation|1|||
23421914|NCT00835640|65288331|FG001|Second Intervention|Protocol Violation|0|||
23421915|NCT00223808|65288335|FG000|Overall Study|<5 hrs therapy before discharge|3|||
23421916|NCT00223808|65288336|FG001|Overall Study|<5 hrs therapy before discharge|5|||
23421917|NCT00223808|65288337|FG002|Overall Study|<5 hrs therapy before discharge|5|||
23421918|NCT02999477|65288338|FG000|Overall Study|found ineligible after first dose|0|||
23421919|NCT02999477|65288339|FG001|Overall Study|found ineligible after first dose|1|||
23421920|NCT02999477|65288338|FG000|Overall Study|Withdrawal by Subject|1|||
23421921|NCT02999477|65288339|FG001|Overall Study|Withdrawal by Subject|1|||
23421922|NCT00515294|65288342|FG000|Overall Study|Lost to Follow-up|3|||
23421923|NCT00515294|65288343|FG001|Overall Study|Lost to Follow-up|2|||
23421924|NCT00515294|65288344|FG002|Overall Study|Lost to Follow-up|3|||
23421925|NCT00515294|65288345|FG003|Overall Study|Lost to Follow-up|1|||
23421926|NCT00515294|65288342|FG000|Overall Study|Driver simulator problems|1|||
23421927|NCT00515294|65288343|FG001|Overall Study|Driver simulator problems|1|||
23421928|NCT00515294|65288344|FG002|Overall Study|Driver simulator problems|1|||
23421929|NCT00515294|65288345|FG003|Overall Study|Driver simulator problems|3|||
23421930|NCT00515294|65288342|FG000|Overall Study|Caffeine amount inaccurate|5|||
23421931|NCT00515294|65288343|FG001|Overall Study|Caffeine amount inaccurate|0|||
23533828|NCT04101526|65689263|FG000|Overall Study|Did not complete all sleep diary entries|0|||
23722296|NCT00814307|66359300|FG003|Overall Study|Protocol Violation|1|||
23421932|NCT00515294|65288344|FG002|Overall Study|Caffeine amount inaccurate|7|||
23421933|NCT00515294|65288345|FG003|Overall Study|Caffeine amount inaccurate|0|||
23421934|NCT03176472|65288346|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
23421935|NCT03176472|65288347|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
23421936|NCT03176472|65288346|FG000|Double Blind Treatment Period|Adverse Event|0|||
23421937|NCT03176472|65288347|FG001|Double Blind Treatment Period|Adverse Event|5|||
23421938|NCT03176472|65288346|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
23421939|NCT03176472|65288347|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23421940|NCT03176472|65288346|FG000|Double Blind Treatment Period|Physician Decision|0|||
23421941|NCT03176472|65288347|FG001|Double Blind Treatment Period|Physician Decision|1|||
23421942|NCT03176472|65288346|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23421943|NCT03176472|65288347|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23421944|NCT03176472|65288346|FG000|Double Blind Treatment Period|Not Provided|1|||
23421945|NCT03176472|65288347|FG001|Double Blind Treatment Period|Not Provided|0|||
23421946|NCT03176472|65288346|FG000|Open Label Extension|Withdrawal by Subject|3|||
23421947|NCT03176472|65288347|FG001|Open Label Extension|Withdrawal by Subject|4|||
23421948|NCT03176472|65288346|FG000|Open Label Extension|Adverse Event|2|||
23421949|NCT03176472|65288347|FG001|Open Label Extension|Adverse Event|4|||
23421950|NCT03176472|65288346|FG000|Open Label Extension|Lost to Follow-up|1|||
23421951|NCT03176472|65288347|FG001|Open Label Extension|Lost to Follow-up|2|||
23421952|NCT03176472|65288346|FG000|Open Label Extension|Protocol Violation|0|||
23421953|NCT03176472|65288347|FG001|Open Label Extension|Protocol Violation|1|||
23421954|NCT03176472|65288346|FG000|Open Label Extension|Not Provided|2|||
23421955|NCT03176472|65288347|FG001|Open Label Extension|Not Provided|1|||
23421956|NCT04753658|65288349|FG000|Overall Study|Progressive disease|7|||
23421957|NCT04753658|65288349|FG000|Overall Study|Other|7|||
23421958|NCT04753658|65288349|FG000|Overall Study|Adverse Event|1|||
23421959|NCT01328535|65288350|FG000|Overall Study|Ineligible|1|||
23421960|NCT00613925|65288351|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
23421961|NCT00613925|65288352|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
23421962|NCT02088073|65288355|FG000|Acute Phase|Withdrawal by Subject|5|||
23421963|NCT02088073|65288356|FG001|Acute Phase|Withdrawal by Subject|0|||
23421964|NCT02088073|65288357|FG002|Acute Phase|Withdrawal by Subject|0|||
23421965|NCT02088073|65288358|FG003|Acute Phase|Withdrawal by Subject|0|||
23421966|NCT02088073|65288359|FG004|Acute Phase|Withdrawal by Subject|0|||
23421967|NCT02088073|65288355|FG000|Acute Phase|Hyperkalemia|2|||
23421968|NCT02088073|65288356|FG001|Acute Phase|Hyperkalemia|0|||
23421969|NCT02088073|65288357|FG002|Acute Phase|Hyperkalemia|0|||
23421970|NCT02088073|65288358|FG003|Acute Phase|Hyperkalemia|0|||
23421971|NCT02088073|65288359|FG004|Acute Phase|Hyperkalemia|0|||
23421972|NCT02088073|65288355|FG000|Maintanance Phase|Withdrawal by Subject|0|||
23421973|NCT02088073|65288356|FG001|Maintanance Phase|Withdrawal by Subject|2|||
23421974|NCT02088073|65288357|FG002|Maintanance Phase|Withdrawal by Subject|0|||
23421975|NCT02088073|65288358|FG003|Maintanance Phase|Withdrawal by Subject|0|||
23421976|NCT02088073|65288359|FG004|Maintanance Phase|Withdrawal by Subject|0|||
23421977|NCT02088073|65288355|FG000|Maintanance Phase|Adverse Event|0|||
23421978|NCT02088073|65288356|FG001|Maintanance Phase|Adverse Event|0|||
23421979|NCT02088073|65288357|FG002|Maintanance Phase|Adverse Event|3|||
23421980|NCT02088073|65288358|FG003|Maintanance Phase|Adverse Event|0|||
23421981|NCT02088073|65288359|FG004|Maintanance Phase|Adverse Event|1|||
23421982|NCT02088073|65288355|FG000|Maintanance Phase|Physician Decision|0|||
23421983|NCT02088073|65288356|FG001|Maintanance Phase|Physician Decision|0|||
23421984|NCT02088073|65288357|FG002|Maintanance Phase|Physician Decision|0|||
23421985|NCT02088073|65288358|FG003|Maintanance Phase|Physician Decision|0|||
23421986|NCT02088073|65288359|FG004|Maintanance Phase|Physician Decision|1|||
23421987|NCT02088073|65288355|FG000|Maintanance Phase|Sponsor's decision|0|||
23421988|NCT02088073|65288356|FG001|Maintanance Phase|Sponsor's decision|2|||
23421989|NCT02088073|65288357|FG002|Maintanance Phase|Sponsor's decision|0|||
23421990|NCT02088073|65288358|FG003|Maintanance Phase|Sponsor's decision|2|||
23421991|NCT02088073|65288359|FG004|Maintanance Phase|Sponsor's decision|1|||
23421992|NCT02088073|65288355|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
23421993|NCT02088073|65288356|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
23421994|NCT02088073|65288357|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
23421995|NCT02088073|65288358|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
23421996|NCT02088073|65288359|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
23421997|NCT02088073|65288355|FG000|Maintanance Phase|Miscellaneous|0|||
23421998|NCT02088073|65288356|FG001|Maintanance Phase|Miscellaneous|2|||
23421999|NCT02088073|65288357|FG002|Maintanance Phase|Miscellaneous|1|||
23422000|NCT02088073|65288358|FG003|Maintanance Phase|Miscellaneous|2|||
23422001|NCT02088073|65288359|FG004|Maintanance Phase|Miscellaneous|1|||
23422002|NCT02088073|65288355|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
23422003|NCT02088073|65288356|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
23533829|NCT04101526|65689264|FG001|Overall Study|Did not complete all sleep diary entries|1|||
23422004|NCT02088073|65288357|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
23422005|NCT02088073|65288358|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
23422006|NCT02088073|65288359|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
23422007|NCT02088073|65288355|FG000|Maintanance Phase|Subject compliance|0|||
23422008|NCT02088073|65288356|FG001|Maintanance Phase|Subject compliance|1|||
23422009|NCT02088073|65288357|FG002|Maintanance Phase|Subject compliance|0|||
23422010|NCT02088073|65288358|FG003|Maintanance Phase|Subject compliance|0|||
23422011|NCT02088073|65288359|FG004|Maintanance Phase|Subject compliance|0|||
23422012|NCT02701777|65288361|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
23422013|NCT02701777|65288362|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
23422014|NCT02701777|65288363|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
23422015|NCT02701777|65288364|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
23422016|NCT02701777|65288361|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
23422017|NCT02701777|65288362|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
23422018|NCT02701777|65288363|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
23422019|NCT02701777|65288364|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
23422020|NCT03894969|65288365|FG000|Overall Study|Adverse Event|0|||
23722297|NCT00814307|66359297|FG000|Overall Study|Withdrawal by Subject|4|||
23722298|NCT00814307|66359298|FG001|Overall Study|Withdrawal by Subject|6|||
23722299|NCT00814307|66359299|FG002|Overall Study|Withdrawal by Subject|0|||
23722300|NCT00814307|66359300|FG003|Overall Study|Withdrawal by Subject|2|||
23722301|NCT00814307|66359297|FG000|Overall Study|Death|0|||
23722302|NCT00814307|66359298|FG001|Overall Study|Death|1|||
23422021|NCT03894969|65288366|FG001|Overall Study|Adverse Event|2|||
23422022|NCT03894969|65288367|FG002|Overall Study|Adverse Event|0|||
23422023|NCT03894969|65288368|FG003|Overall Study|Adverse Event|1|||
23722303|NCT00814307|66359299|FG002|Overall Study|Death|0|||
23722304|NCT00814307|66359300|FG003|Overall Study|Death|0|||
23722305|NCT04702984|66359301|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
23722306|NCT01297309|66359302|FG000|Overall Study|Eligibility failure|2|||
23422024|NCT03894969|65288369|FG004|Overall Study|Adverse Event|2|||
23422025|NCT03894969|65288365|FG000|Overall Study|Lost to Follow-up|3|||
23422026|NCT03894969|65288366|FG001|Overall Study|Lost to Follow-up|1|||
23422027|NCT03894969|65288367|FG002|Overall Study|Lost to Follow-up|1|||
23422028|NCT03894969|65288368|FG003|Overall Study|Lost to Follow-up|0|||
23422029|NCT03894969|65288369|FG004|Overall Study|Lost to Follow-up|0|||
23422030|NCT03894969|65288365|FG000|Overall Study|Withdrawal by Subject|2|||
23422031|NCT03894969|65288366|FG001|Overall Study|Withdrawal by Subject|1|||
23422032|NCT03894969|65288367|FG002|Overall Study|Withdrawal by Subject|3|||
23422033|NCT03894969|65288368|FG003|Overall Study|Withdrawal by Subject|4|||
23533830|NCT02944578|65689265|FG000|Overall Study|Physician Decision|1|||
23533831|NCT02944578|65689266|FG001|Overall Study|Physician Decision|0|||
23722307|NCT01297309|66359302|FG000|Overall Study|Screen failure|2|||
23722308|NCT01297309|66359302|FG000|Overall Study|Withdrawal by Subject|5|||
23722309|NCT01297309|66359302|FG000|Overall Study|Adverse Event|1|||
23422034|NCT03894969|65288369|FG004|Overall Study|Withdrawal by Subject|8|||
23422035|NCT03894969|65288365|FG000|Overall Study|Other|0|||
23422036|NCT03894969|65288366|FG001|Overall Study|Other|0|||
23422037|NCT03894969|65288367|FG002|Overall Study|Other|0|||
23422038|NCT03894969|65288368|FG003|Overall Study|Other|0|||
23422039|NCT03894969|65288369|FG004|Overall Study|Other|3|||
23422040|NCT03894969|65288365|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422041|NCT03894969|65288366|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422042|NCT03894969|65288367|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422043|NCT03894969|65288368|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
23422044|NCT03894969|65288369|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
23422045|NCT03894969|65288365|FG000|Overall Study|Solicited Adverse Event|0|||
23422046|NCT03894969|65288366|FG001|Overall Study|Solicited Adverse Event|1|||
23422047|NCT03894969|65288367|FG002|Overall Study|Solicited Adverse Event|0|||
23422048|NCT03894969|65288368|FG003|Overall Study|Solicited Adverse Event|0|||
23422049|NCT03894969|65288369|FG004|Overall Study|Solicited Adverse Event|0|||
23422050|NCT02240368|65288374|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
23422051|NCT02240368|65288375|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
23422052|NCT02240368|65288376|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
23422053|NCT02240368|65288374|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
23422054|NCT02240368|65288375|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
23422055|NCT02240368|65288376|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
23422056|NCT02298179|65288377|FG000|Overall Study|Lost to Follow-up|0|||
23422057|NCT02298179|65288378|FG001|Overall Study|Lost to Follow-up|0|||
23422058|NCT02298179|65288379|FG002|Overall Study|Lost to Follow-up|1|||
23422059|NCT02298179|65288380|FG003|Overall Study|Lost to Follow-up|0|||
23422060|NCT02298179|65288381|FG004|Overall Study|Lost to Follow-up|0|||
23422061|NCT02298179|65288382|FG005|Overall Study|Lost to Follow-up|0|||
23422062|NCT02298179|65288383|FG006|Overall Study|Lost to Follow-up|0|||
23422063|NCT02298179|65288384|FG007|Overall Study|Lost to Follow-up|1|||
23422064|NCT02298179|65288385|FG008|Overall Study|Lost to Follow-up|0|||
23422065|NCT02298179|65288386|FG009|Overall Study|Lost to Follow-up|0|||
23422066|NCT02298179|65288387|FG010|Overall Study|Lost to Follow-up|0|||
23422067|NCT02298179|65288388|FG011|Overall Study|Lost to Follow-up|0|||
23422068|NCT02403635|65288400|FG000|Overall Study|Not eligible|9|||
23422069|NCT03895086|65288406|FG000|Overall Study|Early termination study|1|||
23422070|NCT03895086|65288407|FG001|Overall Study|Early termination study|0|||
23422071|NCT04606199|65288408|FG000|Overall Study|Withdrawal by Subject|2|||
23422072|NCT01323270|65288411|FG000|Overall Study|Withdrawal by Subject|19|||
23422073|NCT01323270|65288412|FG001|Overall Study|Withdrawal by Subject|10|||
23422074|NCT01323270|65288411|FG000|Overall Study|Protocol Violation|9|||
23422075|NCT01323270|65288412|FG001|Overall Study|Protocol Violation|7|||
23422076|NCT01323270|65288411|FG000|Overall Study|Lost to Follow-up|4|||
23422077|NCT01323270|65288412|FG001|Overall Study|Lost to Follow-up|6|||
23422078|NCT01323270|65288411|FG000|Overall Study|Adverse Event|8|||
23422079|NCT01323270|65288412|FG001|Overall Study|Adverse Event|0|||
23722310|NCT01297309|66359302|FG000|Overall Study|Investigator Decision|2|||
23722311|NCT01297309|66359302|FG000|Overall Study|Death|1|||
23722312|NCT01297309|66359302|FG000|Overall Study|Participant not entering extensionperiod|1|||
23722313|NCT00389441|66359303|FG000|Overall Study|Adverse Event|7|||
23722314|NCT00389441|66359303|FG000|Overall Study|Death|4|||
23722315|NCT00389441|66359303|FG000|Overall Study|Lost to Follow-up|2|||
23722316|NCT00389441|66359303|FG000|Overall Study|Withdrawal by Subject|4|||
23722317|NCT00389441|66359303|FG000|Overall Study|Physician Decision|1|||
23722318|NCT00389441|66359303|FG000|Overall Study|Protocol Violation|1|||
23722319|NCT00389441|66359303|FG000|Overall Study|Global deterioration of health status|4|||
23722320|NCT00389441|66359303|FG000|Overall Study|Objective progression or relapse|26|||
23722321|NCT00389441|66359303|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
23722322|NCT00389441|66359303|FG000|Overall Study|Clinical progression|1|||
23722323|NCT02983799|66359312|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
23722324|NCT02983799|66359313|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
23722325|NCT02983799|66359314|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
23722326|NCT02983799|66359315|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
23722327|NCT02983799|66359316|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
23722328|NCT02983799|66359312|FG000|Overall Study|Death|20|||
23722329|NCT02983799|66359313|FG001|Overall Study|Death|5|||
23722330|NCT02983799|66359314|FG002|Overall Study|Death|23|||
23722331|NCT02983799|66359315|FG003|Overall Study|Death|47|||
23722332|NCT02983799|66359316|FG004|Overall Study|Death|7|||
23722333|NCT02983799|66359312|FG000|Overall Study|Withdrawal by Subject|1|||
23722334|NCT02983799|66359313|FG001|Overall Study|Withdrawal by Subject|0|||
23422080|NCT01323270|65288411|FG000|Overall Study|Other|0|||
23422081|NCT01323270|65288412|FG001|Overall Study|Other|3|||
23422082|NCT01323270|65288411|FG000|Overall Study|Physician Decision|0|||
23422083|NCT01323270|65288412|FG001|Overall Study|Physician Decision|2|||
23422084|NCT01323270|65288411|FG000|Overall Study|Not eligible|1|||
23422085|NCT01323270|65288412|FG001|Overall Study|Not eligible|1|||
23422086|NCT01323270|65288411|FG000|Overall Study|Death|1|||
23422087|NCT01323270|65288412|FG001|Overall Study|Death|0|||
23422088|NCT01323270|65288411|FG000|Overall Study|Randomized, but not vaccinated|1|||
23422089|NCT01323270|65288412|FG001|Overall Study|Randomized, but not vaccinated|0|||
23422090|NCT03762616|65288413|FG000|Overall Study|Protocol Violation|2|||
23422091|NCT00246025|65288414|FG000|Overall Study|Adverse Event|7|||
23422092|NCT00246025|65288415|FG001|Overall Study|Adverse Event|9|||
23422093|NCT00246025|65288416|FG002|Overall Study|Adverse Event|9|||
23422094|NCT00246025|65288417|FG003|Overall Study|Adverse Event|10|||
23422095|NCT00246025|65288414|FG000|Overall Study|Withdrawal by Subject|3|||
23422096|NCT00246025|65288415|FG001|Overall Study|Withdrawal by Subject|0|||
23422097|NCT00246025|65288416|FG002|Overall Study|Withdrawal by Subject|1|||
23422098|NCT00246025|65288417|FG003|Overall Study|Withdrawal by Subject|2|||
23422099|NCT00246025|65288414|FG000|Overall Study|unsuitable medical history was found|0|||
23422100|NCT00246025|65288415|FG001|Overall Study|unsuitable medical history was found|0|||
23422101|NCT00246025|65288416|FG002|Overall Study|unsuitable medical history was found|0|||
23422102|NCT00246025|65288417|FG003|Overall Study|unsuitable medical history was found|1|||
23422103|NCT02754141|65288418|FG000|Overall Study|Disease progression|11|||
23422104|NCT02754141|65288419|FG001|Overall Study|Disease progression|7|||
23422105|NCT02754141|65288420|FG002|Overall Study|Disease progression|8|||
23422106|NCT02754141|65288421|FG003|Overall Study|Disease progression|5|||
23422107|NCT02754141|65288422|FG004|Overall Study|Disease progression|7|||
23422108|NCT02754141|65288423|FG005|Overall Study|Disease progression|7|||
23422109|NCT02754141|65288424|FG006|Overall Study|Disease progression|7|||
23422110|NCT02754141|65288425|FG007|Overall Study|Disease progression|6|||
23422111|NCT02754141|65288426|FG008|Overall Study|Disease progression|11|||
23422112|NCT02754141|65288427|FG009|Overall Study|Disease progression|16|||
23422113|NCT02754141|65288428|FG010|Overall Study|Disease progression|18|||
23422114|NCT02754141|65288429|FG011|Overall Study|Disease progression|13|||
23422115|NCT02754141|65288430|FG012|Overall Study|Disease progression|10|||
23422116|NCT02754141|65288431|FG013|Overall Study|Disease progression|12|||
23422117|NCT02754141|65288432|FG014|Overall Study|Disease progression|12|||
23422118|NCT02754141|65288433|FG015|Overall Study|Disease progression|14|||
23422119|NCT02754141|65288434|FG016|Overall Study|Disease progression|0|||
23422120|NCT02754141|65288435|FG017|Overall Study|Disease progression|1|||
23422121|NCT02754141|65288418|FG000|Overall Study|Study drug toxicity|1|||
23422122|NCT02754141|65288419|FG001|Overall Study|Study drug toxicity|1|||
23422123|NCT02754141|65288420|FG002|Overall Study|Study drug toxicity|0|||
23422124|NCT02754141|65288421|FG003|Overall Study|Study drug toxicity|0|||
23422125|NCT02754141|65288422|FG004|Overall Study|Study drug toxicity|0|||
23422126|NCT02754141|65288423|FG005|Overall Study|Study drug toxicity|0|||
23422127|NCT02754141|65288424|FG006|Overall Study|Study drug toxicity|0|||
23422128|NCT02754141|65288425|FG007|Overall Study|Study drug toxicity|0|||
23422129|NCT02754141|65288426|FG008|Overall Study|Study drug toxicity|0|||
23422130|NCT02754141|65288427|FG009|Overall Study|Study drug toxicity|0|||
23422131|NCT02754141|65288428|FG010|Overall Study|Study drug toxicity|2|||
23422132|NCT02754141|65288429|FG011|Overall Study|Study drug toxicity|1|||
23422133|NCT02754141|65288430|FG012|Overall Study|Study drug toxicity|1|||
23422134|NCT02754141|65288431|FG013|Overall Study|Study drug toxicity|0|||
23422135|NCT02754141|65288432|FG014|Overall Study|Study drug toxicity|0|||
23422136|NCT02754141|65288433|FG015|Overall Study|Study drug toxicity|0|||
23422137|NCT02754141|65288434|FG016|Overall Study|Study drug toxicity|0|||
23422138|NCT02754141|65288435|FG017|Overall Study|Study drug toxicity|0|||
23422139|NCT02754141|65288418|FG000|Overall Study|AE unrelated to study drug|1|||
23422140|NCT02754141|65288419|FG001|Overall Study|AE unrelated to study drug|1|||
23422141|NCT02754141|65288420|FG002|Overall Study|AE unrelated to study drug|0|||
23422142|NCT02754141|65288421|FG003|Overall Study|AE unrelated to study drug|1|||
23422143|NCT02754141|65288422|FG004|Overall Study|AE unrelated to study drug|3|||
23422144|NCT02754141|65288423|FG005|Overall Study|AE unrelated to study drug|2|||
23422145|NCT02754141|65288424|FG006|Overall Study|AE unrelated to study drug|1|||
23422146|NCT02754141|65288425|FG007|Overall Study|AE unrelated to study drug|0|||
23422147|NCT02754141|65288426|FG008|Overall Study|AE unrelated to study drug|0|||
23422148|NCT02754141|65288427|FG009|Overall Study|AE unrelated to study drug|0|||
23422149|NCT02754141|65288428|FG010|Overall Study|AE unrelated to study drug|0|||
23422150|NCT02754141|65288429|FG011|Overall Study|AE unrelated to study drug|0|||
23422151|NCT02754141|65288430|FG012|Overall Study|AE unrelated to study drug|0|||
23422152|NCT02754141|65288431|FG013|Overall Study|AE unrelated to study drug|0|||
23422153|NCT02754141|65288432|FG014|Overall Study|AE unrelated to study drug|0|||
23422154|NCT02754141|65288433|FG015|Overall Study|AE unrelated to study drug|0|||
23422155|NCT02754141|65288434|FG016|Overall Study|AE unrelated to study drug|0|||
23422156|NCT02754141|65288435|FG017|Overall Study|AE unrelated to study drug|0|||
23422157|NCT02754141|65288418|FG000|Overall Study|Request to discontinue|0|||
23422158|NCT02754141|65288419|FG001|Overall Study|Request to discontinue|0|||
23422159|NCT02754141|65288420|FG002|Overall Study|Request to discontinue|0|||
23422160|NCT02754141|65288421|FG003|Overall Study|Request to discontinue|0|||
23422161|NCT02754141|65288422|FG004|Overall Study|Request to discontinue|0|||
23422162|NCT02754141|65288423|FG005|Overall Study|Request to discontinue|0|||
23422163|NCT02754141|65288424|FG006|Overall Study|Request to discontinue|0|||
23422164|NCT02754141|65288425|FG007|Overall Study|Request to discontinue|0|||
23422165|NCT02754141|65288426|FG008|Overall Study|Request to discontinue|1|||
23422166|NCT02754141|65288427|FG009|Overall Study|Request to discontinue|0|||
23422167|NCT02754141|65288428|FG010|Overall Study|Request to discontinue|0|||
23422168|NCT02754141|65288429|FG011|Overall Study|Request to discontinue|0|||
23422169|NCT02754141|65288430|FG012|Overall Study|Request to discontinue|0|||
23422170|NCT02754141|65288431|FG013|Overall Study|Request to discontinue|1|||
23422171|NCT02754141|65288432|FG014|Overall Study|Request to discontinue|1|||
23422172|NCT02754141|65288433|FG015|Overall Study|Request to discontinue|0|||
23422173|NCT02754141|65288434|FG016|Overall Study|Request to discontinue|0|||
23422174|NCT02754141|65288435|FG017|Overall Study|Request to discontinue|0|||
23422175|NCT02754141|65288418|FG000|Overall Study|Withdrew consent|0|||
23422176|NCT02754141|65288419|FG001|Overall Study|Withdrew consent|0|||
23422177|NCT02754141|65288420|FG002|Overall Study|Withdrew consent|0|||
23422178|NCT02754141|65288421|FG003|Overall Study|Withdrew consent|0|||
23422179|NCT02754141|65288422|FG004|Overall Study|Withdrew consent|0|||
23422180|NCT02754141|65288423|FG005|Overall Study|Withdrew consent|0|||
23422181|NCT02754141|65288424|FG006|Overall Study|Withdrew consent|0|||
23422182|NCT02754141|65288425|FG007|Overall Study|Withdrew consent|0|||
23422183|NCT02754141|65288426|FG008|Overall Study|Withdrew consent|0|||
23422184|NCT02754141|65288427|FG009|Overall Study|Withdrew consent|1|||
23422185|NCT02754141|65288428|FG010|Overall Study|Withdrew consent|0|||
23422186|NCT02754141|65288429|FG011|Overall Study|Withdrew consent|0|||
23422187|NCT02754141|65288430|FG012|Overall Study|Withdrew consent|0|||
23422188|NCT02754141|65288431|FG013|Overall Study|Withdrew consent|0|||
23422189|NCT02754141|65288432|FG014|Overall Study|Withdrew consent|0|||
23422190|NCT02754141|65288433|FG015|Overall Study|Withdrew consent|0|||
23422191|NCT02754141|65288434|FG016|Overall Study|Withdrew consent|0|||
23422192|NCT02754141|65288435|FG017|Overall Study|Withdrew consent|0|||
23422193|NCT02754141|65288418|FG000|Overall Study|Maximum clinical benefit|0|||
23533852|NCT01023659|65689279|FG000|Overall Study|Lost to Follow-up|73|||
23533853|NCT01023659|65689280|FG001|Overall Study|Lost to Follow-up|228|||
23533854|NCT01023659|65689281|FG002|Overall Study|Lost to Follow-up|99|||
23533855|NCT00501540|65689283|FG000|Overall Study|Death|5|||
23533856|NCT01175382|65689284|FG000|Overall Study|Lost to Follow-up|4|||
23533857|NCT01175382|65689285|FG001|Overall Study|Lost to Follow-up|3|||
23533858|NCT01175382|65689286|FG002|Overall Study|Lost to Follow-up|1|||
23533859|NCT01175382|65689284|FG000|Overall Study|Physician Decision|0|||
23533860|NCT01175382|65689285|FG001|Overall Study|Physician Decision|1|||
23533861|NCT01175382|65689286|FG002|Overall Study|Physician Decision|0|||
23533862|NCT01175382|65689284|FG000|Overall Study|Withdrawal by Subject|0|||
23533863|NCT01175382|65689285|FG001|Overall Study|Withdrawal by Subject|0|||
23533864|NCT01175382|65689286|FG002|Overall Study|Withdrawal by Subject|1|||
23533865|NCT01175382|65689284|FG000|Overall Study|No longer having problem|1|||
23533866|NCT01175382|65689285|FG001|Overall Study|No longer having problem|0|||
23533867|NCT01175382|65689286|FG002|Overall Study|No longer having problem|1|||
23533868|NCT01175382|65689284|FG000|Overall Study|Unable/unwilling to attend visits|3|||
23533869|NCT01175382|65689285|FG001|Overall Study|Unable/unwilling to attend visits|1|||
23533870|NCT01175382|65689286|FG002|Overall Study|Unable/unwilling to attend visits|2|||
23533871|NCT01175382|65689284|FG000|Overall Study|Unwilling to follow protocol|0|||
23533872|NCT01175382|65689285|FG001|Overall Study|Unwilling to follow protocol|1|||
23533873|NCT01175382|65689286|FG002|Overall Study|Unwilling to follow protocol|0|||
23533874|NCT01175382|65689284|FG000|Overall Study|Unable to tolerate study meds|0|||
23533875|NCT01175382|65689285|FG001|Overall Study|Unable to tolerate study meds|1|||
23422194|NCT02754141|65288419|FG001|Overall Study|Maximum clinical benefit|0|||
23422195|NCT02754141|65288420|FG002|Overall Study|Maximum clinical benefit|0|||
23422196|NCT02754141|65288421|FG003|Overall Study|Maximum clinical benefit|1|||
23422197|NCT02754141|65288422|FG004|Overall Study|Maximum clinical benefit|0|||
23422198|NCT02754141|65288423|FG005|Overall Study|Maximum clinical benefit|0|||
23422199|NCT02754141|65288424|FG006|Overall Study|Maximum clinical benefit|0|||
23533876|NCT01175382|65689286|FG002|Overall Study|Unable to tolerate study meds|1|||
23533877|NCT01824303|65689287|FG000|Randomized Study|Withdrawal by Subject|1|||
23533878|NCT01824303|65689288|FG001|Randomized Study|Withdrawal by Subject|1|||
23533879|NCT01824303|65689287|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
23533880|NCT01824303|65689288|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
23814971|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
23814972|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
23814973|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
23814974|NCT02031458|66703411|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
23814975|NCT02031458|66703412|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
23533887|NCT01034397|65689294|FG000|Overall Study|Lack of compliance|0|||
23533888|NCT01034397|65689295|FG001|Overall Study|Lack of compliance|1|||
23533889|NCT01034397|65689294|FG000|Overall Study|Lack of Efficacy|3|||
23533890|NCT01034397|65689295|FG001|Overall Study|Lack of Efficacy|0|||
23533891|NCT01034397|65689294|FG000|Overall Study|Adverse Event|4|||
23533892|NCT01034397|65689295|FG001|Overall Study|Adverse Event|0|||
23533893|NCT01034397|65689294|FG000|Overall Study|Other|0|||
23533894|NCT01034397|65689295|FG001|Overall Study|Other|1|||
23533895|NCT01600040|65689296|FG000|Overall Study|Withdrawal by Subject|1|||
23533896|NCT00575588|65689299|FG000|Overall Study|Adverse Event|11|||
23814976|NCT02031458|66703413|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
23814977|NCT02031458|66703411|FG000|Baseline to May 8, 2015|On Treatment|43|||
23533897|NCT00575588|65689300|FG001|Overall Study|Adverse Event|13|||
23533898|NCT00575588|65689299|FG000|Overall Study|Withdrawal by Subject|27|||
23533899|NCT00575588|65689300|FG001|Overall Study|Withdrawal by Subject|31|||
23533900|NCT00575588|65689299|FG000|Overall Study|Lost to Follow-up|1|||
23533901|NCT00575588|65689300|FG001|Overall Study|Lost to Follow-up|3|||
23533902|NCT00575588|65689299|FG000|Overall Study|Death|4|||
23814978|NCT02031458|66703412|FG001|Baseline to May 8, 2015|On Treatment|81|||
23814979|NCT02031458|66703413|FG002|Baseline to May 8, 2015|On Treatment|73|||
23814980|NCT02031458|66703411|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
23814981|NCT02031458|66703412|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
23814982|NCT02031458|66703413|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
23533903|NCT00575588|65689300|FG001|Overall Study|Death|2|||
23533904|NCT00575588|65689299|FG000|Overall Study|Incorrect enrollment|8|||
23533905|NCT00575588|65689300|FG001|Overall Study|Incorrect enrollment|4|||
23533906|NCT00575588|65689299|FG000|Overall Study|Study specific discontinuation criteria|203|||
23533907|NCT00575588|65689300|FG001|Overall Study|Study specific discontinuation criteria|218|||
23422200|NCT02754141|65288425|FG007|Overall Study|Maximum clinical benefit|0|||
23533908|NCT00575588|65689299|FG000|Overall Study|Severe non-compliance to protocol|5|||
23533909|NCT00575588|65689300|FG001|Overall Study|Severe non-compliance to protocol|7|||
23533910|NCT00575588|65689299|FG000|Overall Study|Safety reasons|2|||
23422201|NCT02754141|65288426|FG008|Overall Study|Maximum clinical benefit|0|||
23422202|NCT02754141|65288427|FG009|Overall Study|Maximum clinical benefit|0|||
23422203|NCT02754141|65288428|FG010|Overall Study|Maximum clinical benefit|0|||
23422204|NCT02754141|65288429|FG011|Overall Study|Maximum clinical benefit|0|||
23422205|NCT02754141|65288430|FG012|Overall Study|Maximum clinical benefit|0|||
23422206|NCT02754141|65288431|FG013|Overall Study|Maximum clinical benefit|0|||
23422207|NCT02754141|65288432|FG014|Overall Study|Maximum clinical benefit|0|||
23422208|NCT02754141|65288433|FG015|Overall Study|Maximum clinical benefit|0|||
23422209|NCT02754141|65288434|FG016|Overall Study|Maximum clinical benefit|0|||
23422210|NCT02754141|65288435|FG017|Overall Study|Maximum clinical benefit|0|||
23422211|NCT02754141|65288418|FG000|Overall Study|No longer meets study criteria|0|||
23422212|NCT02754141|65288419|FG001|Overall Study|No longer meets study criteria|0|||
23422213|NCT02754141|65288420|FG002|Overall Study|No longer meets study criteria|0|||
23422214|NCT02754141|65288421|FG003|Overall Study|No longer meets study criteria|1|||
23422215|NCT02754141|65288422|FG004|Overall Study|No longer meets study criteria|0|||
23422216|NCT02754141|65288423|FG005|Overall Study|No longer meets study criteria|0|||
23422217|NCT02754141|65288424|FG006|Overall Study|No longer meets study criteria|0|||
23422218|NCT02754141|65288425|FG007|Overall Study|No longer meets study criteria|0|||
23422219|NCT02754141|65288426|FG008|Overall Study|No longer meets study criteria|0|||
23422220|NCT02754141|65288427|FG009|Overall Study|No longer meets study criteria|0|||
23422221|NCT02754141|65288428|FG010|Overall Study|No longer meets study criteria|0|||
23422222|NCT02754141|65288429|FG011|Overall Study|No longer meets study criteria|0|||
23533911|NCT00575588|65689300|FG001|Overall Study|Safety reasons|1|||
23533912|NCT00575588|65689299|FG000|Overall Study|Elevated triglyceride|1|||
23533913|NCT00575588|65689300|FG001|Overall Study|Elevated triglyceride|0|||
23533914|NCT00575588|65689299|FG000|Overall Study|Patient moved|1|||
23533915|NCT00575588|65689300|FG001|Overall Study|Patient moved|3|||
23533916|NCT00575588|65689299|FG000|Overall Study|Impossible to determine HbA1c|0|||
23533917|NCT00575588|65689300|FG001|Overall Study|Impossible to determine HbA1c|1|||
23533921|NCT04304001|65689305|FG000|Overall Study|Lost to Follow-up|13|||
23533922|NCT04304001|65689306|FG001|Overall Study|Lost to Follow-up|9|||
23533923|NCT04776148|65689307|FG000|Overall Study|Death|172|||
23533924|NCT04776148|65689308|FG001|Overall Study|Death|188|||
23533925|NCT04776148|65689307|FG000|Overall Study|Lost to Follow-up|0|||
23533926|NCT04776148|65689308|FG001|Overall Study|Lost to Follow-up|1|||
23533927|NCT04776148|65689307|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23533928|NCT04776148|65689308|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23533929|NCT04776148|65689307|FG000|Overall Study|Withdrawal by Subject|2|||
23533930|NCT04776148|65689308|FG001|Overall Study|Withdrawal by Subject|4|||
23533931|NCT04776148|65689307|FG000|Overall Study|Ongoing in Study|67|||
23533932|NCT04776148|65689308|FG001|Overall Study|Ongoing in Study|45|||
23533933|NCT03064126|65689309|FG000|Overall Study|Death|40|||
23533934|NCT03064126|65689310|FG001|Overall Study|Death|16|||
23533935|NCT03064126|65689311|FG002|Overall Study|Death|4|||
23533936|NCT03064126|65689312|FG003|Overall Study|Death|2|||
23533937|NCT03064126|65689309|FG000|Overall Study|Withdrawal by Subject|17|||
23533938|NCT03064126|65689310|FG001|Overall Study|Withdrawal by Subject|9|||
23533939|NCT03064126|65689311|FG002|Overall Study|Withdrawal by Subject|0|||
23533940|NCT03064126|65689312|FG003|Overall Study|Withdrawal by Subject|2|||
23533941|NCT03064126|65689309|FG000|Overall Study|Lost to Follow-up|7|||
23533942|NCT03064126|65689310|FG001|Overall Study|Lost to Follow-up|3|||
23722335|NCT02983799|66359314|FG002|Overall Study|Withdrawal by Subject|3|||
23722336|NCT02983799|66359315|FG003|Overall Study|Withdrawal by Subject|4|||
23722337|NCT02983799|66359316|FG004|Overall Study|Withdrawal by Subject|1|||
23722338|NCT02983799|66359312|FG000|Overall Study|Protocol Violation|0|||
23722339|NCT02983799|66359313|FG001|Overall Study|Protocol Violation|1|||
23722340|NCT02983799|66359314|FG002|Overall Study|Protocol Violation|0|||
23722341|NCT02983799|66359315|FG003|Overall Study|Protocol Violation|0|||
23722342|NCT02983799|66359316|FG004|Overall Study|Protocol Violation|1|||
23722343|NCT02983799|66359312|FG000|Overall Study|Lost to Follow-up|1|||
23722344|NCT02983799|66359313|FG001|Overall Study|Lost to Follow-up|0|||
23722345|NCT02983799|66359314|FG002|Overall Study|Lost to Follow-up|1|||
23722346|NCT02983799|66359315|FG003|Overall Study|Lost to Follow-up|0|||
23722347|NCT02983799|66359316|FG004|Overall Study|Lost to Follow-up|0|||
23722348|NCT03209362|66359325|FG000|Overall Study|Adverse Event|0|||
23722349|NCT03209362|66359326|FG001|Overall Study|Adverse Event|1|||
23722350|NCT03209362|66359325|FG000|Overall Study|Lost to Follow-up|0|||
23722351|NCT03209362|66359326|FG001|Overall Study|Lost to Follow-up|1|||
23722352|NCT03209362|66359325|FG000|Overall Study|Withdrawal by Subject|2|||
23533943|NCT03064126|65689311|FG002|Overall Study|Lost to Follow-up|0|||
23533944|NCT03064126|65689312|FG003|Overall Study|Lost to Follow-up|0|||
23533945|NCT03064126|65689309|FG000|Overall Study|Adverse Event|2|||
23533946|NCT03064126|65689310|FG001|Overall Study|Adverse Event|0|||
23533947|NCT03064126|65689311|FG002|Overall Study|Adverse Event|0|||
23533948|NCT03064126|65689312|FG003|Overall Study|Adverse Event|0|||
23533949|NCT03064126|65689309|FG000|Overall Study|Physician Decision|3|||
23533950|NCT03064126|65689310|FG001|Overall Study|Physician Decision|0|||
23722353|NCT03209362|66359326|FG001|Overall Study|Withdrawal by Subject|0|||
23722354|NCT03209362|66359325|FG000|Overall Study|Other|0|||
23722355|NCT03209362|66359326|FG001|Overall Study|Other|1|||
23614870|NCT01951105|65976281|FG000|Overall Study|Withdrawal by Subject|0|||
23614871|NCT01951105|65976282|FG001|Overall Study|Withdrawal by Subject|3|||
23614872|NCT01951105|65976283|FG002|Overall Study|Withdrawal by Subject|1|||
23614873|NCT02762500|65976285|FG000|Overall Study|Lack of Efficacy|1|||
23614874|NCT02762500|65976286|FG001|Overall Study|Lack of Efficacy|0|||
23614875|NCT02762500|65976285|FG000|Overall Study|Withdrawal by Subject|1|||
23614876|NCT02762500|65976286|FG001|Overall Study|Withdrawal by Subject|1|||
23614877|NCT02762500|65976285|FG000|Overall Study|Adverse Event|0|||
23614878|NCT02762500|65976286|FG001|Overall Study|Adverse Event|2|||
23614879|NCT03647709|65976287|FG000|Overall Study|Lost to Follow-up|5|||
23614880|NCT03647709|65976287|FG000|Overall Study|Physician Decision|6|||
23614881|NCT03647709|65976287|FG000|Overall Study|Withdrawal by Subject|3|||
23614882|NCT02246647|65976288|FG000|Overall Study|Withdrawal by Subject|1|||
23614883|NCT02246647|65976289|FG001|Overall Study|Withdrawal by Subject|1|||
23614884|NCT02121808|65976292|FG000|Overall Study|Technical problem|3|||
23614885|NCT04736602|65976293|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
23614886|NCT04736602|65976293|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
23614887|NCT01124916|65976294|FG000|Overall Study|Lost to Follow-up|3|||
23614888|NCT01124916|65976295|FG001|Overall Study|Lost to Follow-up|2|||
23614889|NCT04385849|65976296|FG000|Overall Study|Lost to Follow-up|1|||
23614890|NCT04385849|65976297|FG001|Overall Study|Lost to Follow-up|0|||
23614891|NCT02101554|65976298|FG000|Overall Study|Protocol Violation|0|||
23614892|NCT02101554|65976299|FG001|Overall Study|Protocol Violation|1|||
23614893|NCT02101554|65976300|FG002|Overall Study|Protocol Violation|0|||
23614894|NCT02101554|65976298|FG000|Overall Study|Insufficient Clinical Response|0|||
23614895|NCT02101554|65976299|FG001|Overall Study|Insufficient Clinical Response|2|||
23614896|NCT02101554|65976300|FG002|Overall Study|Insufficient Clinical Response|0|||
23614897|NCT02101554|65976298|FG000|Overall Study|Adverse Event|2|||
23614898|NCT02101554|65976299|FG001|Overall Study|Adverse Event|1|||
23614899|NCT02101554|65976300|FG002|Overall Study|Adverse Event|1|||
23614900|NCT02101554|65976298|FG000|Overall Study|Lost to Follow-up|0|||
23614901|NCT02101554|65976299|FG001|Overall Study|Lost to Follow-up|1|||
23614902|NCT02101554|65976300|FG002|Overall Study|Lost to Follow-up|0|||
23614903|NCT02101554|65976298|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
23614904|NCT02101554|65976299|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
23614905|NCT02101554|65976300|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
23533951|NCT03064126|65689311|FG002|Overall Study|Physician Decision|0|||
23533952|NCT03064126|65689312|FG003|Overall Study|Physician Decision|0|||
23614906|NCT01816165|65976302|FG000|Overall Study|Adverse Event|1|||
23614907|NCT01816165|65976303|FG001|Overall Study|Adverse Event|0|||
23614908|NCT01816165|65976304|FG002|Overall Study|Adverse Event|0|||
23614909|NCT01816165|65976305|FG003|Overall Study|Adverse Event|0|||
23614910|NCT04088500|65976311|FG000|Overall Study|Reason unknown|1|||
23614911|NCT04088500|65976311|FG000|Overall Study|Participant withdrew consent|1|||
23614912|NCT04088500|65976311|FG000|Overall Study|Disease progression|3|||
23614913|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
23614914|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
23614915|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
23614916|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Other|1|||
23614917|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Other|0|||
23614918|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Other|0|||
23614919|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Physician Decision|3|||
23614920|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Physician Decision|0|||
23614921|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Physician Decision|0|||
23614922|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
23614923|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
23614924|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
23614925|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
23614926|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
23614927|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
23614928|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Adverse Event|18|||
23614929|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Adverse Event|0|||
23614930|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Adverse Event|0|||
23614931|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
23533953|NCT03064126|65689309|FG000|Overall Study|Other reason for early termination|3|||
23533954|NCT03064126|65689310|FG001|Overall Study|Other reason for early termination|2|||
23533955|NCT03064126|65689311|FG002|Overall Study|Other reason for early termination|0|||
23533956|NCT03064126|65689312|FG003|Overall Study|Other reason for early termination|0|||
23533957|NCT03064126|65689309|FG000|Overall Study|Missed Visit|3|||
23533958|NCT03064126|65689310|FG001|Overall Study|Missed Visit|1|||
23533959|NCT03064126|65689311|FG002|Overall Study|Missed Visit|0|||
23533960|NCT03064126|65689312|FG003|Overall Study|Missed Visit|0|||
23614932|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
23614933|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
23614934|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
23614935|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
23614936|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
23614937|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
23614938|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
23614939|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
23533967|NCT03586999|65689315|FG000|Overall Study|Lack of Efficacy|2|||
23533968|NCT04096560|65689316|FG000|Overall Study|Reason not Specified|1|||
23533969|NCT04096560|65689317|FG001|Overall Study|Reason not Specified|0|||
23814983|NCT04709835|66703414|FG000|Overall Study|Withdrawal by Subject|0|||
23814984|NCT04709835|66703415|FG001|Overall Study|Withdrawal by Subject|1|||
23814985|NCT04709835|66703416|FG002|Overall Study|Withdrawal by Subject|0|||
23814986|NCT02036775|66703417|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23814987|NCT02036775|66703418|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23814988|NCT02036775|66703419|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23814989|NCT02036775|66703420|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23814990|NCT02036775|66703421|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23814991|NCT02036775|66703422|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
23814992|NCT01087489|66703423|FG000|Overall Study|enrolled in another VA study|0|||
23814993|NCT01087489|66703424|FG001|Overall Study|enrolled in another VA study|1|||
23814994|NCT01087489|66703423|FG000|Overall Study|Death|0|||
23814995|NCT01087489|66703424|FG001|Overall Study|Death|1|||
23814996|NCT01087489|66703423|FG000|Overall Study|unable to survey by telephone|0|||
23814997|NCT01087489|66703424|FG001|Overall Study|unable to survey by telephone|1|||
23422223|NCT02754141|65288430|FG012|Overall Study|No longer meets study criteria|0|||
23422224|NCT02754141|65288431|FG013|Overall Study|No longer meets study criteria|0|||
23422225|NCT02754141|65288432|FG014|Overall Study|No longer meets study criteria|0|||
23422226|NCT02754141|65288433|FG015|Overall Study|No longer meets study criteria|0|||
23422227|NCT02754141|65288434|FG016|Overall Study|No longer meets study criteria|0|||
23422228|NCT02754141|65288435|FG017|Overall Study|No longer meets study criteria|0|||
23422229|NCT02754141|65288418|FG000|Overall Study|Other reasons|0|||
23422230|NCT02754141|65288419|FG001|Overall Study|Other reasons|0|||
23422231|NCT02754141|65288420|FG002|Overall Study|Other reasons|0|||
23422232|NCT02754141|65288421|FG003|Overall Study|Other reasons|0|||
23422233|NCT02754141|65288422|FG004|Overall Study|Other reasons|0|||
23422234|NCT02754141|65288423|FG005|Overall Study|Other reasons|0|||
23422235|NCT02754141|65288424|FG006|Overall Study|Other reasons|0|||
23422236|NCT02754141|65288425|FG007|Overall Study|Other reasons|1|||
23422237|NCT02754141|65288426|FG008|Overall Study|Other reasons|0|||
23422238|NCT02754141|65288427|FG009|Overall Study|Other reasons|0|||
23422239|NCT02754141|65288428|FG010|Overall Study|Other reasons|0|||
23422240|NCT02754141|65288429|FG011|Overall Study|Other reasons|0|||
23422241|NCT02754141|65288430|FG012|Overall Study|Other reasons|2|||
23422242|NCT02754141|65288431|FG013|Overall Study|Other reasons|0|||
23422243|NCT02754141|65288432|FG014|Overall Study|Other reasons|0|||
23422244|NCT02754141|65288433|FG015|Overall Study|Other reasons|0|||
23422245|NCT02754141|65288434|FG016|Overall Study|Other reasons|0|||
23422246|NCT02754141|65288435|FG017|Overall Study|Other reasons|0|||
23422247|NCT02754141|65288418|FG000|Overall Study|Completed treatment as per protocol|0|||
23422248|NCT02754141|65288419|FG001|Overall Study|Completed treatment as per protocol|1|||
23422249|NCT02754141|65288420|FG002|Overall Study|Completed treatment as per protocol|0|||
23422250|NCT02754141|65288421|FG003|Overall Study|Completed treatment as per protocol|0|||
23422251|NCT02754141|65288422|FG004|Overall Study|Completed treatment as per protocol|0|||
23422252|NCT02754141|65288423|FG005|Overall Study|Completed treatment as per protocol|0|||
23422253|NCT02754141|65288424|FG006|Overall Study|Completed treatment as per protocol|0|||
23422254|NCT02754141|65288425|FG007|Overall Study|Completed treatment as per protocol|0|||
23422255|NCT02754141|65288426|FG008|Overall Study|Completed treatment as per protocol|0|||
23422256|NCT02754141|65288427|FG009|Overall Study|Completed treatment as per protocol|0|||
23814998|NCT00307437|66703427|FG000|Controlled Period|Adverse Event|7|||
23422257|NCT02754141|65288428|FG010|Overall Study|Completed treatment as per protocol|0|||
23422258|NCT02754141|65288429|FG011|Overall Study|Completed treatment as per protocol|0|||
23422259|NCT02754141|65288430|FG012|Overall Study|Completed treatment as per protocol|1|||
23814999|NCT00307437|66703428|FG001|Controlled Period|Adverse Event|2|||
23815000|NCT00307437|66703429|FG002|Controlled Period|Adverse Event|5|||
23815001|NCT00307437|66703430|FG003|Controlled Period|Adverse Event|0|||
23815002|NCT00307437|66703431|FG004|Controlled Period|Adverse Event|0|||
23815003|NCT00307437|66703432|FG005|Controlled Period|Adverse Event|0|||
23815004|NCT00307437|66703433|FG006|Controlled Period|Adverse Event|0|||
23815005|NCT00307437|66703427|FG000|Controlled Period|Death|0|||
23815006|NCT00307437|66703428|FG001|Controlled Period|Death|0|||
23815007|NCT00307437|66703429|FG002|Controlled Period|Death|1|||
23815008|NCT00307437|66703430|FG003|Controlled Period|Death|0|||
23815009|NCT00307437|66703431|FG004|Controlled Period|Death|0|||
23815010|NCT00307437|66703432|FG005|Controlled Period|Death|0|||
23815011|NCT00307437|66703433|FG006|Controlled Period|Death|0|||
23815012|NCT00307437|66703427|FG000|Controlled Period|Lack of Efficacy|2|||
23722356|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
23815013|NCT00307437|66703428|FG001|Controlled Period|Lack of Efficacy|0|||
23815014|NCT00307437|66703429|FG002|Controlled Period|Lack of Efficacy|0|||
23815015|NCT00307437|66703430|FG003|Controlled Period|Lack of Efficacy|0|||
23815016|NCT00307437|66703431|FG004|Controlled Period|Lack of Efficacy|0|||
23815017|NCT00307437|66703432|FG005|Controlled Period|Lack of Efficacy|0|||
23815018|NCT00307437|66703433|FG006|Controlled Period|Lack of Efficacy|0|||
23815019|NCT00307437|66703427|FG000|Controlled Period|Lost to Follow-up|2|||
23815020|NCT00307437|66703428|FG001|Controlled Period|Lost to Follow-up|3|||
23815021|NCT00307437|66703429|FG002|Controlled Period|Lost to Follow-up|0|||
23815022|NCT00307437|66703430|FG003|Controlled Period|Lost to Follow-up|0|||
23815023|NCT00307437|66703431|FG004|Controlled Period|Lost to Follow-up|0|||
23815024|NCT00307437|66703432|FG005|Controlled Period|Lost to Follow-up|0|||
23815025|NCT00307437|66703433|FG006|Controlled Period|Lost to Follow-up|0|||
23815026|NCT00307437|66703427|FG000|Controlled Period|Other|5|||
23815027|NCT00307437|66703428|FG001|Controlled Period|Other|1|||
23815028|NCT00307437|66703429|FG002|Controlled Period|Other|3|||
23815029|NCT00307437|66703430|FG003|Controlled Period|Other|0|||
23815030|NCT00307437|66703431|FG004|Controlled Period|Other|0|||
23815031|NCT00307437|66703432|FG005|Controlled Period|Other|0|||
23815032|NCT00307437|66703433|FG006|Controlled Period|Other|0|||
23815033|NCT00307437|66703427|FG000|After Controlled Period|Adverse Event|0|||
23815034|NCT00307437|66703428|FG001|After Controlled Period|Adverse Event|0|||
23422260|NCT02754141|65288431|FG013|Overall Study|Completed treatment as per protocol|0|||
23722357|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
23722358|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
23722359|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
23722360|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
23722361|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23722362|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23722363|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23722364|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23722365|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
23722366|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
23722367|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23722368|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23722369|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23722370|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23722371|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
23722372|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23722373|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
23722374|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23722375|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23722376|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23722377|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23722378|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23722379|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
23722380|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
23722381|NCT01457924|66359327|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
23722382|NCT01457924|66359328|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
23722383|NCT01457924|66359329|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
23722384|NCT01457924|66359330|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
23815035|NCT00307437|66703429|FG002|After Controlled Period|Adverse Event|0|||
23815036|NCT00307437|66703430|FG003|After Controlled Period|Adverse Event|18|||
23815037|NCT00307437|66703431|FG004|After Controlled Period|Adverse Event|16|||
23815038|NCT00307437|66703432|FG005|After Controlled Period|Adverse Event|31|||
23815039|NCT00307437|66703433|FG006|After Controlled Period|Adverse Event|40|||
23815040|NCT00307437|66703427|FG000|After Controlled Period|Death|0|||
23422261|NCT02754141|65288432|FG014|Overall Study|Completed treatment as per protocol|0|||
23815041|NCT00307437|66703428|FG001|After Controlled Period|Death|0|||
23815042|NCT00307437|66703429|FG002|After Controlled Period|Death|0|||
23815043|NCT00307437|66703430|FG003|After Controlled Period|Death|3|||
23815044|NCT00307437|66703431|FG004|After Controlled Period|Death|1|||
23815045|NCT00307437|66703432|FG005|After Controlled Period|Death|1|||
23815046|NCT00307437|66703433|FG006|After Controlled Period|Death|3|||
23815047|NCT00307437|66703427|FG000|After Controlled Period|Lack of Efficacy|0|||
23815048|NCT00307437|66703428|FG001|After Controlled Period|Lack of Efficacy|0|||
23815049|NCT00307437|66703429|FG002|After Controlled Period|Lack of Efficacy|0|||
23815050|NCT00307437|66703430|FG003|After Controlled Period|Lack of Efficacy|15|||
23815051|NCT00307437|66703431|FG004|After Controlled Period|Lack of Efficacy|17|||
23815052|NCT00307437|66703432|FG005|After Controlled Period|Lack of Efficacy|37|||
23815053|NCT00307437|66703433|FG006|After Controlled Period|Lack of Efficacy|24|||
23815054|NCT00307437|66703427|FG000|After Controlled Period|Lost to Follow-up|0|||
23815055|NCT00307437|66703428|FG001|After Controlled Period|Lost to Follow-up|0|||
23815056|NCT00307437|66703429|FG002|After Controlled Period|Lost to Follow-up|0|||
23815057|NCT00307437|66703430|FG003|After Controlled Period|Lost to Follow-up|7|||
23815058|NCT00307437|66703431|FG004|After Controlled Period|Lost to Follow-up|12|||
23815059|NCT00307437|66703432|FG005|After Controlled Period|Lost to Follow-up|13|||
23815060|NCT00307437|66703433|FG006|After Controlled Period|Lost to Follow-up|18|||
23815061|NCT00307437|66703427|FG000|After Controlled Period|Other|0|||
23815062|NCT00307437|66703428|FG001|After Controlled Period|Other|0|||
23815063|NCT00307437|66703429|FG002|After Controlled Period|Other|0|||
23815064|NCT00307437|66703430|FG003|After Controlled Period|Other|15|||
23815065|NCT00307437|66703431|FG004|After Controlled Period|Other|9|||
23815066|NCT00307437|66703432|FG005|After Controlled Period|Other|40|||
23815067|NCT00307437|66703433|FG006|After Controlled Period|Other|28|||
23815068|NCT02903030|66703434|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23815069|NCT02903030|66703435|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23815070|NCT02932306|66703436|FG000|Overall Study|Withdrawal by Subject|16|||
23815071|NCT02932306|66703437|FG001|Overall Study|Withdrawal by Subject|25|||
23815072|NCT02932306|66703436|FG000|Overall Study|Adverse Event|3|||
23815073|NCT02932306|66703437|FG001|Overall Study|Adverse Event|0|||
23815074|NCT02932306|66703436|FG000|Overall Study|Pregnancy|2|||
23815075|NCT02932306|66703437|FG001|Overall Study|Pregnancy|0|||
23815076|NCT02932306|66703436|FG000|Overall Study|Protocol Violation|1|||
23815077|NCT02932306|66703437|FG001|Overall Study|Protocol Violation|1|||
23815078|NCT02932306|66703436|FG000|Overall Study|Noncompliance with Study Drug|1|||
23815079|NCT02932306|66703437|FG001|Overall Study|Noncompliance with Study Drug|1|||
23815080|NCT02932306|66703436|FG000|Overall Study|Lost to Follow-up|36|||
23815081|NCT02932306|66703437|FG001|Overall Study|Lost to Follow-up|40|||
23815082|NCT02932306|66703436|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
23815083|NCT02932306|66703437|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
23815084|NCT02932306|66703436|FG000|Overall Study|Lack of Efficacy|0|||
23815085|NCT02932306|66703437|FG001|Overall Study|Lack of Efficacy|2|||
23422262|NCT02754141|65288433|FG015|Overall Study|Completed treatment as per protocol|0|||
23422263|NCT02754141|65288434|FG016|Overall Study|Completed treatment as per protocol|0|||
23533970|NCT04096560|65689318|FG002|Overall Study|Reason not Specified|0|||
23533971|NCT04096560|65689319|FG003|Overall Study|Reason not Specified|0|||
23533972|NCT04096560|65689320|FG004|Overall Study|Reason not Specified|1|||
23533973|NCT04096560|65689321|FG005|Overall Study|Reason not Specified|1|||
23533974|NCT04096560|65689322|FG006|Overall Study|Reason not Specified|1|||
23533975|NCT04096560|65689323|FG007|Overall Study|Reason not Specified|0|||
23533976|NCT04096560|65689316|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533977|NCT04096560|65689317|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533978|NCT04096560|65689318|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533979|NCT04096560|65689319|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533980|NCT04096560|65689320|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533981|NCT04096560|65689321|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
23533982|NCT04096560|65689322|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
23533983|NCT04096560|65689323|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533984|NCT04096560|65689316|FG000|Overall Study|Study Terminated by Sponsor|0|||
23815086|NCT02932306|66703436|FG000|Overall Study|Worsening condition|2|||
23815087|NCT02932306|66703437|FG001|Overall Study|Worsening condition|0|||
23815088|NCT02932306|66703436|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
23815089|NCT02932306|66703437|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
23815090|NCT01243775|66703438|FG000|Overall Study|Withdrawal by Subject|2|||
23815091|NCT00987389|66703444|FG000|Overall Study|Ineligible|0|||
23815092|NCT00987389|66703445|FG001|Overall Study|Ineligible|3|||
23815093|NCT00987389|66703446|FG002|Overall Study|Ineligible|0|||
23815094|NCT00987389|66703447|FG003|Overall Study|Ineligible|0|||
23533985|NCT04096560|65689317|FG001|Overall Study|Study Terminated by Sponsor|0|||
23533986|NCT04096560|65689318|FG002|Overall Study|Study Terminated by Sponsor|0|||
23815095|NCT00987389|66703444|FG000|Overall Study|Lost to Follow-up|4|||
23815096|NCT00987389|66703445|FG001|Overall Study|Lost to Follow-up|1|||
23533987|NCT04096560|65689319|FG003|Overall Study|Study Terminated by Sponsor|5|||
23533988|NCT04096560|65689320|FG004|Overall Study|Study Terminated by Sponsor|6|||
23533989|NCT04096560|65689321|FG005|Overall Study|Study Terminated by Sponsor|4|||
23533990|NCT04096560|65689322|FG006|Overall Study|Study Terminated by Sponsor|6|||
23533991|NCT04096560|65689323|FG007|Overall Study|Study Terminated by Sponsor|1|||
23533992|NCT04096560|65689316|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533993|NCT04096560|65689317|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533994|NCT04096560|65689318|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533995|NCT04096560|65689319|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533996|NCT04096560|65689320|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533997|NCT04096560|65689321|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533998|NCT04096560|65689322|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533999|NCT04096560|65689323|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
23534000|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
23534001|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
23534002|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
23534003|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
23534004|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
23534005|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
23534006|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
23534007|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
23534008|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
23534009|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
23534010|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
23534011|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
23534012|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
23534013|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
23534014|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
23534015|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
23534016|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
23534017|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
23534018|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
23534019|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
23534020|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
23534021|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
23722385|NCT01457924|66359331|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
23815097|NCT00987389|66703446|FG002|Overall Study|Lost to Follow-up|3|||
23815098|NCT00987389|66703447|FG003|Overall Study|Lost to Follow-up|1|||
23815099|NCT00987389|66703444|FG000|Overall Study|Withdrawal by Subject|4|||
23815100|NCT00987389|66703445|FG001|Overall Study|Withdrawal by Subject|3|||
23815101|NCT00987389|66703446|FG002|Overall Study|Withdrawal by Subject|2|||
23614940|NCT03030599|65976312|FG000|Stable Dose|Protocol deviation|3|||
23614941|NCT03030599|65976313|FG001|Stable Dose|Protocol deviation|0|||
23614942|NCT03030599|65976314|FG002|Stable Dose|Protocol deviation|0|||
23614943|NCT03030599|65976312|FG000|Stable Dose|Adverse Event|1|||
23614944|NCT03030599|65976313|FG001|Stable Dose|Adverse Event|0|||
23614945|NCT03030599|65976314|FG002|Stable Dose|Adverse Event|0|||
23614946|NCT03030599|65976312|FG000|Stable Dose|Lost to Follow-up|1|||
23614947|NCT03030599|65976313|FG001|Stable Dose|Lost to Follow-up|0|||
23614948|NCT03030599|65976314|FG002|Stable Dose|Lost to Follow-up|0|||
23614949|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
23614950|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
23614951|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
23614952|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
23614953|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
23614954|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
23614955|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
23614956|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
23614957|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
23614958|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
23340854|NCT01936181|64992871|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
23722386|NCT01457924|66359327|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
23722387|NCT01457924|66359328|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
23722388|NCT01457924|66359329|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
23815102|NCT00987389|66703447|FG003|Overall Study|Withdrawal by Subject|1|||
23815103|NCT00987389|66703444|FG000|Overall Study|Withdrawn from Treatment|0|||
23815104|NCT00987389|66703445|FG001|Overall Study|Withdrawn from Treatment|1|||
23815105|NCT00987389|66703446|FG002|Overall Study|Withdrawn from Treatment|0|||
23815106|NCT00987389|66703447|FG003|Overall Study|Withdrawn from Treatment|0|||
23815107|NCT00987389|66703444|FG000|Overall Study|Multiple different reasons|1|||
23815108|NCT00987389|66703445|FG001|Overall Study|Multiple different reasons|0|||
23815109|NCT00987389|66703446|FG002|Overall Study|Multiple different reasons|3|||
23815110|NCT00987389|66703447|FG003|Overall Study|Multiple different reasons|1|||
23815111|NCT01341782|66703483|FG000|Overall Study|Adverse Event|1|||
23815112|NCT01341782|66703484|FG001|Overall Study|Adverse Event|1|||
23815113|NCT01341782|66703483|FG000|Overall Study|Withdrawal by Subject|6|||
23815114|NCT01341782|66703484|FG001|Overall Study|Withdrawal by Subject|5|||
23815115|NCT01341782|66703483|FG000|Overall Study|Missed 3 consecutive doses|0|||
23815116|NCT01341782|66703484|FG001|Overall Study|Missed 3 consecutive doses|4|||
23815117|NCT01341782|66703483|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
23815118|NCT01341782|66703484|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
23815119|NCT01341782|66703483|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
23722389|NCT01457924|66359330|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
23722390|NCT01457924|66359331|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
23722391|NCT01457924|66359327|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
23722392|NCT01457924|66359328|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
23722393|NCT01457924|66359329|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
23722394|NCT01457924|66359330|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
23722395|NCT01457924|66359331|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
23815120|NCT01341782|66703484|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
23815121|NCT01341782|66703483|FG000|Overall Study|Other|5|||
23815122|NCT01341782|66703484|FG001|Overall Study|Other|0|||
23815123|NCT00969540|66703486|FG000|Overall Study|Lost to Follow-up|1|||
23815124|NCT00969540|66703487|FG001|Overall Study|Lost to Follow-up|1|||
23815125|NCT04007991|66703488|FG000|Overall Study|Withdrawal by Subject|1|||
23815126|NCT04007991|66703489|FG001|Overall Study|Withdrawal by Subject|1|||
23815127|NCT04007991|66703488|FG000|Overall Study|Physician Decision|1|||
23815128|NCT04007991|66703489|FG001|Overall Study|Physician Decision|1|||
23815129|NCT04007991|66703488|FG000|Overall Study|Non-compliance with Study Drug|0|||
23815130|NCT04007991|66703489|FG001|Overall Study|Non-compliance with Study Drug|1|||
23815131|NCT04007991|66703488|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
23815132|NCT04007991|66703489|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
23815133|NCT04007991|66703488|FG000|Overall Study|Adverse event, non-fatal|5|||
23815134|NCT04007991|66703489|FG001|Overall Study|Adverse event, non-fatal|0|||
23815135|NCT04007991|66703488|FG000|Overall Study|Lost to Follow-up|2|||
23614959|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
23722396|NCT01457924|66359327|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23722397|NCT01457924|66359328|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23815136|NCT04007991|66703489|FG001|Overall Study|Lost to Follow-up|1|||
23815137|NCT01085201|66703490|FG000|Overall Study|Scheduling conflict|1|||
23815138|NCT01085201|66703491|FG001|Overall Study|Scheduling conflict|0|||
23815139|NCT01085201|66703492|FG002|Overall Study|Scheduling conflict|1|||
23815140|NCT01085201|66703493|FG003|Overall Study|Scheduling conflict|0|||
23815141|NCT01085201|66703494|FG004|Overall Study|Scheduling conflict|0|||
23815142|NCT01085201|66703490|FG000|Overall Study|Unknown- no study drug|2|||
23815143|NCT01085201|66703491|FG001|Overall Study|Unknown- no study drug|0|||
23815144|NCT01085201|66703492|FG002|Overall Study|Unknown- no study drug|0|||
23815145|NCT01085201|66703493|FG003|Overall Study|Unknown- no study drug|0|||
23815146|NCT01085201|66703494|FG004|Overall Study|Unknown- no study drug|0|||
23815147|NCT01085201|66703490|FG000|Overall Study|Fond ineligible after consent|0|||
23815148|NCT01085201|66703491|FG001|Overall Study|Fond ineligible after consent|1|||
23815149|NCT01085201|66703492|FG002|Overall Study|Fond ineligible after consent|1|||
23815150|NCT01085201|66703493|FG003|Overall Study|Fond ineligible after consent|0|||
23815151|NCT01085201|66703494|FG004|Overall Study|Fond ineligible after consent|0|||
23815152|NCT00174954|66703496|FG000|Overall Study|Adverse Event|2|||
23815153|NCT00174954|66703496|FG000|Overall Study|No tophi found in MRI|1|||
23815154|NCT00174954|66703496|FG000|Overall Study|Physician Decision|1|||
23815155|NCT00252239|66703499|FG000|Overall Study|Withdrawal by Subject|1|||
23815156|NCT00252239|66703500|FG001|Overall Study|Withdrawal by Subject|0|||
23815157|NCT00252239|66703501|FG002|Overall Study|Withdrawal by Subject|0|||
23815158|NCT00252239|66703502|FG003|Overall Study|Withdrawal by Subject|1|||
23815159|NCT00252239|66703499|FG000|Overall Study|Lost to Follow-up|0|||
23815160|NCT00252239|66703500|FG001|Overall Study|Lost to Follow-up|0|||
23815161|NCT00252239|66703501|FG002|Overall Study|Lost to Follow-up|2|||
23815162|NCT00252239|66703502|FG003|Overall Study|Lost to Follow-up|0|||
23815163|NCT00681590|66703503|FG000|Overall Study|Withdrawal by Subject|2|||
23815164|NCT00681590|66703504|FG001|Overall Study|Withdrawal by Subject|12|||
23815165|NCT01221363|66708138|FG000|Overall Study|Pregnancy|1|||
23815166|NCT01221363|66708139|FG001|Overall Study|Pregnancy|0|||
23815167|NCT01221363|66708138|FG000|Overall Study|Withdrawal by Subject|11|||
23815168|NCT01221363|66708139|FG001|Overall Study|Withdrawal by Subject|5|||
23815169|NCT00699283|66708142|FG000|Overall Study|Lack of Efficacy|15|||
23815170|NCT00699283|66708143|FG001|Overall Study|Lack of Efficacy|5|||
23815171|NCT00699283|66708142|FG000|Overall Study|Lost to Follow-up|2|||
23815172|NCT00699283|66708143|FG001|Overall Study|Lost to Follow-up|0|||
23815173|NCT00699283|66708142|FG000|Overall Study|Withdrawal by Subject|1|||
23815174|NCT00699283|66708143|FG001|Overall Study|Withdrawal by Subject|0|||
23815175|NCT00699283|66708142|FG000|Overall Study|Other Reason|5|||
23815176|NCT00699283|66708143|FG001|Overall Study|Other Reason|1|||
23815177|NCT00699283|66708142|FG000|Overall Study|SAE, non-fatal|1|||
23815178|NCT00699283|66708143|FG001|Overall Study|SAE, non-fatal|1|||
23815179|NCT00699283|66708142|FG000|Overall Study|AE, non-serious non-fatal|8|||
23815180|NCT00699283|66708143|FG001|Overall Study|AE, non-serious non-fatal|1|||
23722398|NCT01457924|66359329|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23722399|NCT01457924|66359330|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
23722400|NCT01457924|66359331|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23722401|NCT01457924|66359327|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
23722402|NCT01457924|66359328|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
23722403|NCT01457924|66359329|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
23722404|NCT01457924|66359330|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
23722405|NCT01457924|66359331|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
23722406|NCT01457924|66359327|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
23722407|NCT01457924|66359328|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23722408|NCT01457924|66359329|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
23722409|NCT01457924|66359330|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23722410|NCT01457924|66359331|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23722411|NCT01457924|66359327|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
23722412|NCT01457924|66359328|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
23722413|NCT01457924|66359329|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
23722414|NCT01457924|66359330|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
23722415|NCT01457924|66359331|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
23722416|NCT01457924|66359327|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23722417|NCT01457924|66359328|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
23722418|NCT01457924|66359329|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23722419|NCT01457924|66359330|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
23722420|NCT01457924|66359331|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23722421|NCT00830804|66359336|FG000|Overall Study|Lost to Follow-up|4|||
23722422|NCT00830804|66359336|FG000|Overall Study|Death|1|||
23722423|NCT00830804|66359336|FG000|Overall Study|Unable to get to clinic|7|||
23722424|NCT00830804|66359336|FG000|Overall Study|Consent withdrawn|2|||
23722425|NCT00830804|66359336|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23722426|NCT01563107|66359337|FG000|Overall Study|Physician Decision|0|||
23722427|NCT01563107|66359338|FG001|Overall Study|Physician Decision|1|||
23722428|NCT01563107|66359339|FG002|Overall Study|Physician Decision|1|||
23722429|NCT01563107|66359340|FG003|Overall Study|Physician Decision|3|||
23722430|NCT01563107|66359337|FG000|Overall Study|Withdrawal by Subject|1|||
23722431|NCT01563107|66359338|FG001|Overall Study|Withdrawal by Subject|2|||
23722432|NCT01563107|66359339|FG002|Overall Study|Withdrawal by Subject|1|||
23722433|NCT01563107|66359340|FG003|Overall Study|Withdrawal by Subject|2|||
23722434|NCT00520299|66359341|FG000|Overall Study|Withdrawal by Subject|0|||
23722435|NCT00520299|66359342|FG001|Overall Study|Withdrawal by Subject|0|||
23722436|NCT00520299|66359343|FG002|Overall Study|Withdrawal by Subject|2|||
23722437|NCT00520299|66359341|FG000|Overall Study|Progressive disease|0|||
23722438|NCT00520299|66359342|FG001|Overall Study|Progressive disease|3|||
23722439|NCT00520299|66359343|FG002|Overall Study|Progressive disease|4|||
23722440|NCT00431496|66359344|FG000|Overall Study|Adverse Event|3|||
23722441|NCT00431496|66359344|FG000|Overall Study|Lost to Follow-up|1|||
23722442|NCT00431496|66359344|FG000|Overall Study|Withdrawal by Subject|2|||
23722443|NCT00431496|66359344|FG000|Overall Study|Protocol-specified criteria|5|||
23722444|NCT01878097|66359347|FG000|Baseline|Surveys not fully completed|2497|||
23815181|NCT00699283|66708142|FG000|Overall Study|AE of unknown type|1|||
23815182|NCT00699283|66708143|FG001|Overall Study|AE of unknown type|0|||
23815183|NCT03477903|66708144|FG000|Overall Study|Study Terminated by Sponsor|1|||
23815184|NCT01844856|66708151|FG000|Overall Study|Lost to Follow-up|15|||
23815185|NCT01844856|66708152|FG001|Overall Study|Lost to Follow-up|3|||
23815186|NCT01844856|66708151|FG000|Overall Study|Adverse Event|3|||
23815187|NCT01844856|66708152|FG001|Overall Study|Adverse Event|6|||
23815188|NCT01844856|66708151|FG000|Overall Study|Withdrawal by Subject|3|||
23815189|NCT01844856|66708152|FG001|Overall Study|Withdrawal by Subject|2|||
23815190|NCT01844856|66708151|FG000|Overall Study|Noncompliance|2|||
23815191|NCT01844856|66708152|FG001|Overall Study|Noncompliance|3|||
23815192|NCT01844856|66708151|FG000|Overall Study|Enterococcus Resistant|0|||
23815193|NCT01844856|66708152|FG001|Overall Study|Enterococcus Resistant|1|||
23815194|NCT01844856|66708151|FG000|Overall Study|Inadvertently Not Scheduled|1|||
23815195|NCT01844856|66708152|FG001|Overall Study|Inadvertently Not Scheduled|0|||
23815196|NCT01844856|66708151|FG000|Overall Study|Randomized but was a Screen Failure|0|||
23815197|NCT01844856|66708152|FG001|Overall Study|Randomized but was a Screen Failure|1|||
23815198|NCT04590040|66708155|FG000|Treatment Period|Lost to Follow-up|2|||
23815199|NCT04590040|66708156|FG001|Treatment Period|Lost to Follow-up|5|||
23815200|NCT04590040|66708157|FG002|Treatment Period|Lost to Follow-up|0|||
23815201|NCT04590040|66708155|FG000|Treatment Period|Physician Decision|0|||
23815202|NCT04590040|66708156|FG001|Treatment Period|Physician Decision|0|||
23815203|NCT04590040|66708157|FG002|Treatment Period|Physician Decision|2|||
23815204|NCT04715932|66708158|FG000|Overall Study|Lost to Follow-up|1|||
23815205|NCT04715932|66708159|FG001|Overall Study|Lost to Follow-up|0|||
23815206|NCT01438996|66708160|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
23815207|NCT01438996|66708161|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
23815208|NCT01438996|66708162|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
23815209|NCT03968978|66708163|FG000|Overall Study|Adverse Event|1|||
23815210|NCT03968978|66708164|FG001|Overall Study|Adverse Event|0|||
23815211|NCT00206323|66708165|FG000|Overall Study|Lack of Efficacy|4|||
23815212|NCT00206323|66708166|FG001|Overall Study|Lack of Efficacy|1|||
23815213|NCT00206323|66708165|FG000|Overall Study|Adverse Event|1|||
23815214|NCT00206323|66708166|FG001|Overall Study|Adverse Event|1|||
23815215|NCT00206323|66708165|FG000|Overall Study|Lost to Follow-up|1|||
23815216|NCT00206323|66708166|FG001|Overall Study|Lost to Follow-up|1|||
23815217|NCT04485039|66708167|FG000|TPOXX Only|Adverse Event|2|||
23815218|NCT04485039|66708167|FG000|TPOXX Only|Physician Decision|1|||
23815219|NCT04485039|66708167|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
23815220|NCT04485039|66708167|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
23815221|NCT03210714|66708168|FG000|Overall Study|Adverse Event|6|||
23815222|NCT03210714|66708168|FG000|Overall Study|Physician Decision|1|||
23815223|NCT03210714|66708168|FG000|Overall Study|Progressive disease|11|||
23815224|NCT03210714|66708168|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
23815225|NCT01293539|66708173|FG000|Overall Study|Physician Decision|1|||
23815226|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23815227|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23815228|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
23815229|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23815230|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23815231|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
23815232|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23815233|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23815234|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23422264|NCT02754141|65288435|FG017|Overall Study|Completed treatment as per protocol|0|||
23815235|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23815236|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23815237|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23815238|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23815239|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
23815240|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
23815241|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23815242|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815243|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815244|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815245|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815246|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
23815247|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
23815248|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
23815249|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23815250|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23815251|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23815252|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23815253|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
23815254|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23815255|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23815256|NCT03713619|66708176|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
23815257|NCT03713619|66708177|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
23815258|NCT03713619|66708178|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23815259|NCT03713619|66708179|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23815260|NCT03713619|66708180|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23815261|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
23815262|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
23815263|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
23422265|NCT02754141|65288418|FG000|Overall Study|Not completing monotherapy|0|||
23422266|NCT02754141|65288419|FG001|Overall Study|Not completing monotherapy|0|||
23422267|NCT02754141|65288420|FG002|Overall Study|Not completing monotherapy|0|||
23422268|NCT02754141|65288421|FG003|Overall Study|Not completing monotherapy|0|||
23422269|NCT02754141|65288422|FG004|Overall Study|Not completing monotherapy|0|||
23422270|NCT02754141|65288423|FG005|Overall Study|Not completing monotherapy|0|||
23422271|NCT02754141|65288424|FG006|Overall Study|Not completing monotherapy|0|||
23422272|NCT02754141|65288425|FG007|Overall Study|Not completing monotherapy|0|||
23422273|NCT02754141|65288426|FG008|Overall Study|Not completing monotherapy|0|||
23422274|NCT02754141|65288427|FG009|Overall Study|Not completing monotherapy|0|||
23422275|NCT02754141|65288428|FG010|Overall Study|Not completing monotherapy|0|||
23422276|NCT02754141|65288429|FG011|Overall Study|Not completing monotherapy|0|||
23422277|NCT02754141|65288430|FG012|Overall Study|Not completing monotherapy|0|||
23422278|NCT02754141|65288431|FG013|Overall Study|Not completing monotherapy|1|||
23422279|NCT02754141|65288432|FG014|Overall Study|Not completing monotherapy|0|||
23422280|NCT02754141|65288433|FG015|Overall Study|Not completing monotherapy|0|||
23422281|NCT02754141|65288434|FG016|Overall Study|Not completing monotherapy|0|||
23614960|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
23614961|NCT03030599|65976312|FG000|Open-label Extension|Adverse Event|3|||
23614962|NCT03030599|65976313|FG001|Open-label Extension|Adverse Event|0|||
23614963|NCT03030599|65976314|FG002|Open-label Extension|Adverse Event|0|||
23614964|NCT03030599|65976312|FG000|Open-label Extension|Lost to Follow-up|2|||
23614965|NCT03030599|65976313|FG001|Open-label Extension|Lost to Follow-up|0|||
23614966|NCT03030599|65976314|FG002|Open-label Extension|Lost to Follow-up|0|||
23614967|NCT03030599|65976312|FG000|Open-label Extension|Lack of Efficacy|1|||
23614968|NCT03030599|65976313|FG001|Open-label Extension|Lack of Efficacy|0|||
23614969|NCT03030599|65976314|FG002|Open-label Extension|Lack of Efficacy|0|||
23614970|NCT03030599|65976312|FG000|Open-label Extension|Other Reason|1|||
23614971|NCT03030599|65976313|FG001|Open-label Extension|Other Reason|0|||
23614972|NCT03030599|65976314|FG002|Open-label Extension|Other Reason|0|||
23614973|NCT00070707|65976315|FG000|Overall Study|Adverse Event|1|||
23614974|NCT00070707|65976316|FG001|Overall Study|Adverse Event|2|||
23614975|NCT00070707|65976315|FG000|Overall Study|Lack of Efficacy|4|||
23614976|NCT00070707|65976316|FG001|Overall Study|Lack of Efficacy|1|||
23614977|NCT00070707|65976315|FG000|Overall Study|Protocol Violation|8|||
23614978|NCT00070707|65976316|FG001|Overall Study|Protocol Violation|4|||
23614979|NCT00070707|65976315|FG000|Overall Study|Unrelated to Study Medication|1|||
23614980|NCT00070707|65976316|FG001|Overall Study|Unrelated to Study Medication|0|||
23614981|NCT01182285|65976317|FG000|First Intervention Week 1-10|Disease progression|1|||
23614982|NCT01182285|65976318|FG001|First Intervention Week 1-10|Disease progression|0|||
23614983|NCT01182285|65976319|FG002|First Intervention Week 1-10|Disease progression|0|||
23614984|NCT01182285|65976317|FG000|First Intervention Week 1-10|Adverse Event|1|||
23614985|NCT01182285|65976318|FG001|First Intervention Week 1-10|Adverse Event|0|||
23614986|NCT01182285|65976319|FG002|First Intervention Week 1-10|Adverse Event|0|||
23614987|NCT01182285|65976317|FG000|First Intervention Week 1-10|Non-compliance|1|||
23614988|NCT01182285|65976318|FG001|First Intervention Week 1-10|Non-compliance|0|||
23614989|NCT01182285|65976319|FG002|First Intervention Week 1-10|Non-compliance|0|||
23614990|NCT01182285|65976317|FG000|Third Intervention Week 11-52|Disease Progression|0|||
23614991|NCT01182285|65976318|FG001|Third Intervention Week 11-52|Disease Progression|0|||
23614992|NCT01182285|65976319|FG002|Third Intervention Week 11-52|Disease Progression|6|||
23614993|NCT01182285|65976317|FG000|Third Intervention Week 11-52|Other|0|||
23614994|NCT01182285|65976318|FG001|Third Intervention Week 11-52|Other|0|||
23722445|NCT01878097|66359348|FG001|Baseline|Surveys not fully completed|1800|||
23722446|NCT01878097|66359347|FG000|Implementation Year 1|Surveys not fully completed|3202|||
23722447|NCT01878097|66359348|FG001|Implementation Year 1|Surveys not fully completed|2549|||
23614995|NCT01182285|65976319|FG002|Third Intervention Week 11-52|Other|2|||
23614996|NCT01544153|65976320|FG000|Overall Study|Under 18|0|||
23614997|NCT01544153|65976321|FG001|Overall Study|Under 18|1|||
23614998|NCT01544153|65976322|FG002|Overall Study|Under 18|0|||
23614999|NCT01544153|65976323|FG003|Overall Study|Under 18|0|||
23615000|NCT01544153|65976320|FG000|Overall Study|Non-smoker|0|||
23615001|NCT01544153|65976321|FG001|Overall Study|Non-smoker|0|||
23615002|NCT01544153|65976322|FG002|Overall Study|Non-smoker|1|||
23615003|NCT01544153|65976323|FG003|Overall Study|Non-smoker|0|||
23615004|NCT02176018|65976326|FG000|Overall Study|Adverse Event|0|||
23615005|NCT02176018|65976327|FG001|Overall Study|Adverse Event|2|||
23615006|NCT02176018|65976326|FG000|Overall Study|Lost to Follow-up|3|||
23615007|NCT02176018|65976327|FG001|Overall Study|Lost to Follow-up|1|||
23615008|NCT02176018|65976326|FG000|Overall Study|Protocol Violation|1|||
23615009|NCT02176018|65976327|FG001|Overall Study|Protocol Violation|1|||
23615010|NCT02176018|65976326|FG000|Overall Study|Withdrawal by Subject|1|||
23615011|NCT02176018|65976327|FG001|Overall Study|Withdrawal by Subject|2|||
23615012|NCT02282917|65976328|FG000|Overall Study|Withdrawal by Subject|1|||
23615013|NCT02282917|65976328|FG000|Overall Study|Screen Failure/Not Eligible|1|||
23615014|NCT01268488|65976329|FG000|Overall Study|Adverse Event|3|||
23615015|NCT01268488|65976329|FG000|Overall Study|Physician Decision|2|||
23615016|NCT02499835|65976331|FG000|Overall Study|Withdrawal by Subject|1|||
23615017|NCT02499835|65976332|FG001|Overall Study|Withdrawal by Subject|0|||
23615018|NCT02499835|65976333|FG002|Overall Study|Withdrawal by Subject|0|||
23615019|NCT02499835|65976334|FG003|Overall Study|Withdrawal by Subject|1|||
23615020|NCT02499835|65976331|FG000|Overall Study|Physician Decision|0|||
23615021|NCT02499835|65976332|FG001|Overall Study|Physician Decision|3|||
23615022|NCT02499835|65976333|FG002|Overall Study|Physician Decision|18|||
23615023|NCT02499835|65976334|FG003|Overall Study|Physician Decision|7|||
23615024|NCT02499835|65976331|FG000|Overall Study|Adverse Event|0|||
23615025|NCT02499835|65976332|FG001|Overall Study|Adverse Event|0|||
23615026|NCT02499835|65976333|FG002|Overall Study|Adverse Event|0|||
23615027|NCT02499835|65976334|FG003|Overall Study|Adverse Event|1|||
23615028|NCT02499835|65976331|FG000|Overall Study|Disease progression|2|||
23615029|NCT02499835|65976332|FG001|Overall Study|Disease progression|1|||
23615030|NCT02499835|65976333|FG002|Overall Study|Disease progression|0|||
23615031|NCT02499835|65976334|FG003|Overall Study|Disease progression|7|||
23615032|NCT01745380|65976335|FG000|Overall Study|Lost to Follow-up|1|||
23615033|NCT01745380|65976336|FG001|Overall Study|Lost to Follow-up|0|||
23615034|NCT01745380|65976335|FG000|Overall Study|Lack of Efficacy|0|||
23615035|NCT01745380|65976336|FG001|Overall Study|Lack of Efficacy|1|||
23615036|NCT04288778|65976337|FG000|Overall Study|Withdrawal by Subject|2|||
23615037|NCT04288778|65976337|FG000|Overall Study|Adverse Event|5|||
23615038|NCT04288778|65976337|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23615039|NCT04288778|65976337|FG000|Overall Study|Other|1|||
23615040|NCT04288778|65976337|FG000|Overall Study|Started but not treated|2|||
23615041|NCT03356145|65976339|FG000|Overall Study|Withdrawal by Subject|2|||
23615042|NCT03356145|65976340|FG001|Overall Study|Withdrawal by Subject|1|||
23615043|NCT03356145|65976339|FG000|Overall Study|Did not meet inclusion criteria|1|||
23615044|NCT03356145|65976340|FG001|Overall Study|Did not meet inclusion criteria|0|||
23615045|NCT03120949|65976341|FG000|Overall Study|randomized in error|1|||
23615046|NCT03120949|65976342|FG001|Overall Study|randomized in error|0|||
23615047|NCT03120949|65976341|FG000|Overall Study|Death|13|||
23615048|NCT03120949|65976342|FG001|Overall Study|Death|13|||
23615049|NCT03120949|65976341|FG000|Overall Study|Lost to Follow-up|23|||
23615050|NCT03120949|65976342|FG001|Overall Study|Lost to Follow-up|13|||
23615051|NCT03120949|65976341|FG000|Overall Study|Withdrawal by Subject|139|||
23615052|NCT03120949|65976342|FG001|Overall Study|Withdrawal by Subject|124|||
23615053|NCT03120949|65976341|FG000|Overall Study|Covid-19|43|||
23615054|NCT03120949|65976342|FG001|Overall Study|Covid-19|34|||
23815264|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
23815265|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
23815266|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23815267|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815268|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815269|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23815270|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815271|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
23815272|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
23815273|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
23534297|NCT03946670|65689367|FG000|Overall Study|Progressive Disease|26|||
23534298|NCT03946670|65689368|FG001|Overall Study|Progressive Disease|23|||
23534299|NCT03946670|65689367|FG000|Overall Study|Adverse Event|7|||
23534300|NCT03946670|65689368|FG001|Overall Study|Adverse Event|9|||
23534301|NCT03946670|65689367|FG000|Overall Study|Death|5|||
23534302|NCT03946670|65689368|FG001|Overall Study|Death|6|||
23534303|NCT03946670|65689367|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
23534304|NCT03946670|65689368|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
23815274|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
23815275|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
23815276|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
23534305|NCT03946670|65689367|FG000|Overall Study|Subject Decision|4|||
23534306|NCT03946670|65689368|FG001|Overall Study|Subject Decision|4|||
23815277|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
23534307|NCT03946670|65689367|FG000|Overall Study|Physician Decision|3|||
23534308|NCT03946670|65689368|FG001|Overall Study|Physician Decision|3|||
23534309|NCT03946670|65689367|FG000|Overall Study|New Therapy for Study Indication|1|||
23534310|NCT03946670|65689368|FG001|Overall Study|New Therapy for Study Indication|0|||
23534311|NCT03946670|65689367|FG000|Overall Study|Not treated|1|||
23534312|NCT03946670|65689368|FG001|Overall Study|Not treated|1|||
23534334|NCT02048813|65689376|FG000|Overall Study|Still on treatment|279|||
23534335|NCT02048813|65689377|FG001|Overall Study|Still on treatment|0|||
23534336|NCT02048813|65689376|FG000|Overall Study|Adverse Event|40|||
23534337|NCT02048813|65689377|FG001|Overall Study|Adverse Event|38|||
23534338|NCT02048813|65689376|FG000|Overall Study|Disease progression|13|||
23534339|NCT02048813|65689377|FG001|Overall Study|Disease progression|3|||
23534340|NCT02048813|65689376|FG000|Overall Study|Withdrawal by Subject|7|||
23534341|NCT02048813|65689377|FG001|Overall Study|Withdrawal by Subject|8|||
23534342|NCT02048813|65689376|FG000|Overall Study|Death|2|||
23534343|NCT02048813|65689377|FG001|Overall Study|Death|1|||
23534344|NCT02048813|65689376|FG000|Overall Study|Complication|2|||
23534345|NCT02048813|65689377|FG001|Overall Study|Complication|2|||
23534346|NCT02048813|65689376|FG000|Overall Study|Non-protocol therapy|0|||
23534347|NCT02048813|65689377|FG001|Overall Study|Non-protocol therapy|1|||
23534348|NCT02048813|65689376|FG000|Overall Study|Second primary cancer|2|||
23534349|NCT02048813|65689377|FG001|Overall Study|Second primary cancer|0|||
23534350|NCT02048813|65689376|FG000|Overall Study|Insurance|2|||
23534351|NCT02048813|65689377|FG001|Overall Study|Insurance|0|||
23534352|NCT02048813|65689376|FG000|Overall Study|Wound infection/healing|2|||
23534353|NCT02048813|65689377|FG001|Overall Study|Wound infection/healing|0|||
23534354|NCT02048813|65689376|FG000|Overall Study|Missed appointment|3|||
23534355|NCT02048813|65689377|FG001|Overall Study|Missed appointment|0|||
23534356|NCT02048813|65689376|FG000|Overall Study|Never started treatment|2|||
23534357|NCT02048813|65689377|FG001|Overall Study|Never started treatment|17|||
23534358|NCT03296696|65689378|FG000|Overall Study|Started Other Antitumor Therapy|1|||
23534359|NCT03296696|65689379|FG001|Overall Study|Started Other Antitumor Therapy|2|||
23534360|NCT03296696|65689380|FG002|Overall Study|Started Other Antitumor Therapy|1|||
23534361|NCT03296696|65689381|FG003|Overall Study|Started Other Antitumor Therapy|2|||
23534362|NCT03296696|65689382|FG004|Overall Study|Started Other Antitumor Therapy|1|||
23534363|NCT03296696|65689383|FG005|Overall Study|Started Other Antitumor Therapy|1|||
23534364|NCT03296696|65689384|FG006|Overall Study|Started Other Antitumor Therapy|2|||
23534365|NCT03296696|65689385|FG007|Overall Study|Started Other Antitumor Therapy|3|||
23534366|NCT03296696|65689386|FG008|Overall Study|Started Other Antitumor Therapy|1|||
23534367|NCT03296696|65689387|FG009|Overall Study|Started Other Antitumor Therapy|0|||
23534368|NCT03296696|65689378|FG000|Overall Study|Death|0|||
23534369|NCT03296696|65689379|FG001|Overall Study|Death|1|||
23534370|NCT03296696|65689380|FG002|Overall Study|Death|1|||
23534371|NCT03296696|65689381|FG003|Overall Study|Death|2|||
23534372|NCT03296696|65689382|FG004|Overall Study|Death|2|||
23534373|NCT03296696|65689383|FG005|Overall Study|Death|3|||
23534374|NCT03296696|65689384|FG006|Overall Study|Death|1|||
23534375|NCT03296696|65689385|FG007|Overall Study|Death|2|||
23534376|NCT03296696|65689386|FG008|Overall Study|Death|0|||
23534377|NCT03296696|65689387|FG009|Overall Study|Death|0|||
23534378|NCT03296696|65689378|FG000|Overall Study|Withdrawal by Subject|0|||
23534379|NCT03296696|65689379|FG001|Overall Study|Withdrawal by Subject|0|||
23534380|NCT03296696|65689380|FG002|Overall Study|Withdrawal by Subject|1|||
23534381|NCT03296696|65689381|FG003|Overall Study|Withdrawal by Subject|0|||
23534382|NCT03296696|65689382|FG004|Overall Study|Withdrawal by Subject|1|||
23615055|NCT03120949|65976341|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
23615056|NCT03120949|65976342|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
23615057|NCT03120949|65976341|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
23615058|NCT03120949|65976342|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
23615059|NCT03120949|65976341|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
23615060|NCT03120949|65976342|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
23615061|NCT03120949|65976341|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
23615062|NCT03120949|65976342|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
23615063|NCT03120949|65976341|FG000|Overall Study|Site was closed|2|||
23615064|NCT03120949|65976342|FG001|Overall Study|Site was closed|3|||
23615065|NCT03120949|65976341|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
23615066|NCT03120949|65976342|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
23615067|NCT03120949|65976341|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
23615068|NCT03120949|65976342|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
23615069|NCT03120949|65976341|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
23615070|NCT03120949|65976342|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
23615071|NCT03120949|65976341|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
23615072|NCT03120949|65976342|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
23615073|NCT03120949|65976341|FG000|Overall Study|Other: Adverse Event|0|||
23615074|NCT03120949|65976342|FG001|Overall Study|Other: Adverse Event|1|||
23615075|NCT03120949|65976341|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
23815278|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
23815279|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
23815280|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
23534383|NCT03296696|65689383|FG005|Overall Study|Withdrawal by Subject|0|||
23534384|NCT03296696|65689384|FG006|Overall Study|Withdrawal by Subject|0|||
23534385|NCT03296696|65689385|FG007|Overall Study|Withdrawal by Subject|0|||
23534386|NCT03296696|65689386|FG008|Overall Study|Withdrawal by Subject|0|||
23534387|NCT03296696|65689387|FG009|Overall Study|Withdrawal by Subject|1|||
23534388|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
23534389|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
23534390|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
23534391|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534392|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534393|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534394|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534395|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534396|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
23534397|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23615076|NCT03120949|65976342|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
23615077|NCT03120949|65976341|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
23615078|NCT03120949|65976342|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
23615079|NCT03120949|65976341|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
23615080|NCT03120949|65976342|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
23615081|NCT03120949|65976341|FG000|Overall Study|Personal Reasons|0|||
23615082|NCT03120949|65976342|FG001|Overall Study|Personal Reasons|1|||
23615083|NCT03120949|65976341|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
23615084|NCT03120949|65976342|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
23615085|NCT03120949|65976341|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
23615086|NCT03120949|65976342|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
23615087|NCT03120949|65976341|FG000|Overall Study|Compliance With Medication|0|||
23615088|NCT03120949|65976342|FG001|Overall Study|Compliance With Medication|1|||
23615089|NCT03120949|65976341|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
23636602|NCT01498887|66052945|FG001|Overall Study|Abnormal result from test procedure|1|||
23636603|NCT01498887|66052944|FG000|Overall Study|Abnormal laboratory value|2|||
23815281|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
23815282|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
23815283|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23815284|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
23534398|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534399|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534400|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534401|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534402|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534403|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
23534404|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
23534405|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534406|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534407|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534408|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534409|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
23534410|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534411|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534412|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534413|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534414|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534415|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534416|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534417|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
23534418|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534419|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534420|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534421|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534422|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534423|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534424|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534425|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534426|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
23534427|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534428|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534429|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534430|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534431|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534432|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534433|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534434|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534435|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534436|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
23534437|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534438|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534439|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534440|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534441|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
23534442|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534443|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
23534444|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534445|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534446|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534447|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23636604|NCT01498887|66052945|FG001|Overall Study|Abnormal laboratory value|2|||
23534448|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534449|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534450|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
23534451|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534452|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
23534453|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534454|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534455|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534456|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23636605|NCT01498887|66052944|FG000|Overall Study|Adverse Event|4|||
23636606|NCT01498887|66052945|FG001|Overall Study|Adverse Event|1|||
23636607|NCT01827046|66052946|FG000|Overall Study|Lost to Follow-up|1|||
23815285|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
23534457|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534458|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534459|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534460|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534461|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534462|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
23534463|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534464|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534465|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534466|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534467|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534468|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534469|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
23534470|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534471|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23615090|NCT03120949|65976342|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
23615091|NCT03120949|65976341|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
23615092|NCT03120949|65976342|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
23615093|NCT03120949|65976341|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
23615094|NCT03120949|65976342|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
23615095|NCT01679613|65976343|FG000|Overall Study|other than stated above|0|||
23615096|NCT01679613|65976344|FG001|Overall Study|other than stated above|1|||
23615097|NCT01679613|65976345|FG002|Overall Study|other than stated above|2|||
23615098|NCT01679613|65976346|FG003|Overall Study|other than stated above|2|||
23615099|NCT04564027|65976347|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
23615100|NCT04564027|65976348|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
23615101|NCT04564027|65976349|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
23615102|NCT04564027|65976350|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
23615103|NCT01808144|65976353|FG000|Overall Study|Death|1|||
23615104|NCT01808144|65976354|FG001|Overall Study|Death|0|||
23615105|NCT01808144|65976353|FG000|Overall Study|Withdrawal by Subject|16|||
23615106|NCT01808144|65976354|FG001|Overall Study|Withdrawal by Subject|23|||
23615107|NCT01808144|65976353|FG000|Overall Study|Lost to Follow-up|6|||
23615108|NCT01808144|65976354|FG001|Overall Study|Lost to Follow-up|3|||
23615109|NCT01808144|65976353|FG000|Overall Study|Protocol Violation|6|||
23615110|NCT01808144|65976354|FG001|Overall Study|Protocol Violation|6|||
23615111|NCT01808144|65976353|FG000|Overall Study|Gout flare|0|||
23615112|NCT01808144|65976354|FG001|Overall Study|Gout flare|1|||
23615113|NCT01808144|65976353|FG000|Overall Study|Adverse Event|11|||
23615114|NCT01808144|65976354|FG001|Overall Study|Adverse Event|15|||
23615115|NCT00006436|65976355|FG000|Overall Study|Refused further treatment|2|||
23615116|NCT00006436|65976355|FG000|Overall Study|Declined to participate (before treatment started)|1|||
23615117|NCT01536795|65976356|FG000|Overall Study|Lost to Follow-up|0|||
23615118|NCT01536795|65976357|FG001|Overall Study|Lost to Follow-up|2|||
23615119|NCT01536795|65976356|FG000|Overall Study|Lack of Efficacy|1|||
23615120|NCT01536795|65976357|FG001|Overall Study|Lack of Efficacy|0|||
23615121|NCT00527514|65976358|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
23615122|NCT00527514|65976358|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
23422282|NCT02754141|65288435|FG017|Overall Study|Not completing monotherapy|0|||
23422283|NCT02526524|65288436|FG000|Overall Study|Withdrawal by Subject|3|||
23534472|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534473|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
23534474|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
23534475|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
23534476|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534477|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534478|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534479|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
23615123|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
23615124|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
23615125|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
23615126|NCT00527514|65976358|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
23615127|NCT00527514|65976358|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
23615128|NCT00265096|65976359|FG000|Overall Study|Adverse Event|14|||
23615129|NCT00265096|65976360|FG001|Overall Study|Adverse Event|18|||
23615130|NCT00265096|65976361|FG002|Overall Study|Adverse Event|18|||
23534480|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534481|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
23534482|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
23534483|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534484|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534485|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
23534486|NCT04456699|65689395|FG000|Overall Study|Death|48|||
23534487|NCT04456699|65689396|FG001|Overall Study|Death|50|||
23534488|NCT04456699|65689397|FG002|Overall Study|Death|52|||
23534489|NCT04456699|65689395|FG000|Overall Study|Physician Decision|0|||
23534490|NCT04456699|65689396|FG001|Overall Study|Physician Decision|0|||
23534491|NCT04456699|65689397|FG002|Overall Study|Physician Decision|2|||
23615131|NCT00265096|65976359|FG000|Overall Study|Lost to Follow-up|2|||
23615132|NCT00265096|65976360|FG001|Overall Study|Lost to Follow-up|5|||
23815286|NCT03713619|66708176|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23815287|NCT03713619|66708177|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23815288|NCT03713619|66708178|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23815289|NCT03713619|66708179|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23815290|NCT03713619|66708180|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23815291|NCT03172494|66708181|FG000|Overall Study|Adverse Event|5|||
23815292|NCT03172494|66708182|FG001|Overall Study|Adverse Event|1|||
23815293|NCT03172494|66708183|FG002|Overall Study|Adverse Event|15|||
23815294|NCT03172494|66708181|FG000|Overall Study|Protocol Violation|3|||
23815295|NCT03172494|66708182|FG001|Overall Study|Protocol Violation|2|||
23815296|NCT03172494|66708183|FG002|Overall Study|Protocol Violation|1|||
23815297|NCT03172494|66708181|FG000|Overall Study|Lack of Efficacy|0|||
23815298|NCT03172494|66708182|FG001|Overall Study|Lack of Efficacy|0|||
23815299|NCT03172494|66708183|FG002|Overall Study|Lack of Efficacy|4|||
23815300|NCT03172494|66708181|FG000|Overall Study|Pregnancy|0|||
23815301|NCT03172494|66708182|FG001|Overall Study|Pregnancy|1|||
23815302|NCT03172494|66708183|FG002|Overall Study|Pregnancy|0|||
23815303|NCT03172494|66708181|FG000|Overall Study|Withdrawal by Subject|10|||
23815304|NCT03172494|66708182|FG001|Overall Study|Withdrawal by Subject|8|||
23815305|NCT03172494|66708183|FG002|Overall Study|Withdrawal by Subject|8|||
23815306|NCT03172494|66708181|FG000|Overall Study|Severe hypoglycaemic episode|0|||
23815307|NCT03172494|66708182|FG001|Overall Study|Severe hypoglycaemic episode|0|||
23815308|NCT03172494|66708183|FG002|Overall Study|Severe hypoglycaemic episode|1|||
23815309|NCT03172494|66708181|FG000|Overall Study|Non-compliance towards treatment|2|||
23815310|NCT03172494|66708182|FG001|Overall Study|Non-compliance towards treatment|0|||
23815311|NCT03172494|66708183|FG002|Overall Study|Non-compliance towards treatment|0|||
23815312|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
23815313|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
23815314|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
23815315|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23815316|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23815317|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
23815318|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23815319|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23815320|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23815321|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23815322|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23815323|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23815324|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23534492|NCT04456699|65689395|FG000|Overall Study|Sponsor Decision|55|||
23615133|NCT00265096|65976361|FG002|Overall Study|Lost to Follow-up|3|||
23615134|NCT00265096|65976359|FG000|Overall Study|Death|0|||
23534493|NCT04456699|65689396|FG001|Overall Study|Sponsor Decision|61|||
23722448|NCT01878097|66359347|FG000|Implementation Year 2|Surveys not fully completed|3281|||
23722449|NCT01878097|66359348|FG001|Implementation Year 2|Surveys not fully completed|2841|||
23722450|NCT01878097|66359347|FG000|Implementation Year 3|Surveys not fully completed|3494|||
23722451|NCT01878097|66359348|FG001|Implementation Year 3|Surveys not fully completed|2980|||
23722452|NCT01878097|66359347|FG000|Implementation Year 4|Surveys not fully completed|3604|||
23722453|NCT01878097|66359348|FG001|Implementation Year 4|Surveys not fully completed|3007|||
23722454|NCT03446612|66362829|FG000|Overall Study|Protocol defined stopping criteria|0|||
23722455|NCT03446612|66362830|FG001|Overall Study|Protocol defined stopping criteria|1|||
23815325|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23815326|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23815327|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
23815328|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23815329|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
23815330|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23815331|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23815332|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23815333|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815334|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23815335|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815336|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23815337|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23815338|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23815339|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
23815340|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23815341|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23815342|NCT03713632|66708184|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
23815343|NCT03713632|66708185|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23815344|NCT03713632|66708186|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23815345|NCT03713632|66708187|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23815346|NCT03713632|66708188|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23815347|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
23815348|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
23815349|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
23815350|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
23815351|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
23815352|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
23815353|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
23815354|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
23815355|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
23815356|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
23815357|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
23815358|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
23815359|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
23815360|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
23815361|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
23815362|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
23815363|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
23815364|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23815365|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
23815366|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23815367|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23815368|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23815369|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23815370|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23722456|NCT03175562|66362833|FG000|Overall Study|Adverse Event|1|||
23815371|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23815372|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
23815373|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23722457|NCT03175562|66362833|FG000|Overall Study|Lost to Follow-up|3|||
23722458|NCT03175562|66362833|FG000|Overall Study|Withdrawal by Subject|7|||
23722459|NCT03175562|66362833|FG000|Overall Study|Other (Not Specified)|5|||
23722460|NCT01599806|66362834|FG000|Overall Study|Lost to Follow-up|20|||
23722461|NCT01599806|66362835|FG001|Overall Study|Lost to Follow-up|20|||
23722462|NCT01599806|66362834|FG000|Overall Study|Withdrawal by Subject|12|||
23722463|NCT01599806|66362835|FG001|Overall Study|Withdrawal by Subject|12|||
23722464|NCT01599806|66362834|FG000|Overall Study|Other Eligibility criteria|11|||
23722465|NCT01599806|66362835|FG001|Overall Study|Other Eligibility criteria|9|||
23722466|NCT00415519|66362837|FG000|Overall Study|Adverse Event|1|||
23722467|NCT00415519|66362838|FG001|Overall Study|Adverse Event|0|||
23722468|NCT00415519|66362837|FG000|Overall Study|Withdrawal by Subject|2|||
23722469|NCT00415519|66362838|FG001|Overall Study|Withdrawal by Subject|0|||
23722470|NCT00415519|66362837|FG000|Overall Study|Patient's convenience|1|||
23815374|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23815375|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23815376|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23815377|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Death|0|||
23815378|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Death|1|||
23815379|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Death|0|||
23815380|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Death|0|||
23815381|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Death|0|||
23815382|NCT03713632|66708184|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815383|NCT03713632|66708185|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23815384|NCT03713632|66708186|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815385|NCT03713632|66708187|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815386|NCT03713632|66708188|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23815387|NCT05014412|66708189|FG000|Overall Study|Death|11|||
23815388|NCT05014412|66708190|FG001|Overall Study|Death|7|||
23815389|NCT05014412|66708191|FG002|Overall Study|Death|4|||
23815390|NCT05014412|66708192|FG003|Overall Study|Death|7|||
23815391|NCT05014412|66708189|FG000|Overall Study|Withdrawal by Subject|1|||
23815392|NCT05014412|66708190|FG001|Overall Study|Withdrawal by Subject|1|||
23815393|NCT05014412|66708191|FG002|Overall Study|Withdrawal by Subject|1|||
23815394|NCT05014412|66708192|FG003|Overall Study|Withdrawal by Subject|2|||
23815395|NCT05014412|66708189|FG000|Overall Study|Ongoing|21|||
23815396|NCT05014412|66708190|FG001|Overall Study|Ongoing|4|||
23815397|NCT05014412|66708191|FG002|Overall Study|Ongoing|6|||
23815398|NCT05014412|66708192|FG003|Overall Study|Ongoing|20|||
23815399|NCT04345601|66708195|FG000|Overall Study|Death|0|||
23815400|NCT04345601|66708196|FG001|Overall Study|Death|3|||
23815401|NCT04345601|66708197|FG002|Overall Study|Death|2|||
23815402|NCT04345601|66708195|FG000|Overall Study|Lost to Follow-up|0|||
23815403|NCT04345601|66708196|FG001|Overall Study|Lost to Follow-up|0|||
23815404|NCT04345601|66708197|FG002|Overall Study|Lost to Follow-up|2|||
23815405|NCT02283983|66708198|FG000|Overall Study|Inclusion criteria not met|0|||
23815406|NCT02283983|66708199|FG001|Overall Study|Inclusion criteria not met|1|||
23815407|NCT02283983|66708198|FG000|Overall Study|Withdrawal by Subject|4|||
23815408|NCT02283983|66708199|FG001|Overall Study|Withdrawal by Subject|2|||
23815409|NCT02283983|66708198|FG000|Overall Study|Protocol Violation|0|||
23815410|NCT02283983|66708199|FG001|Overall Study|Protocol Violation|4|||
23815411|NCT02283983|66708198|FG000|Overall Study|Physician Decision|2|||
23815412|NCT02283983|66708199|FG001|Overall Study|Physician Decision|4|||
23815413|NCT02283983|66708198|FG000|Overall Study|Death|1|||
23815414|NCT02283983|66708199|FG001|Overall Study|Death|0|||
23815415|NCT02283983|66708198|FG000|Overall Study|Adverse Event|1|||
23815416|NCT02283983|66708199|FG001|Overall Study|Adverse Event|0|||
23815417|NCT02283983|66708198|FG000|Overall Study|Lost to Follow-up|9|||
23815418|NCT02283983|66708199|FG001|Overall Study|Lost to Follow-up|8|||
23815419|NCT02283983|66708198|FG000|Overall Study|Relapse|1|||
23815420|NCT02283983|66708199|FG001|Overall Study|Relapse|0|||
23815421|NCT01685840|66708200|FG000|Overall Study|Death|77|||
23815422|NCT01685840|66708201|FG001|Overall Study|Death|66|||
23815423|NCT01685840|66708200|FG000|Overall Study|Lost to Follow-up|27|||
23815424|NCT01685840|66708201|FG001|Overall Study|Lost to Follow-up|25|||
23815425|NCT01685840|66708200|FG000|Overall Study|Physician Decision|3|||
23722471|NCT00415519|66362838|FG001|Overall Study|Patient's convenience|0|||
23722472|NCT02384993|66362839|FG000|Overall Study|Adverse Event|0|||
23722473|NCT02384993|66362840|FG001|Overall Study|Adverse Event|1|||
23722474|NCT03934541|66362842|FG000|Overall Study|Study Terminated by Sponsor|0|||
23815426|NCT01685840|66708201|FG001|Overall Study|Physician Decision|7|||
23815427|NCT01685840|66708200|FG000|Overall Study|Withdrawal by Subject|14|||
23815428|NCT01685840|66708201|FG001|Overall Study|Withdrawal by Subject|17|||
23815429|NCT01685840|66708200|FG000|Overall Study|Futility|197|||
23815430|NCT01685840|66708201|FG001|Overall Study|Futility|200|||
23815431|NCT01685840|66708200|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
23815432|NCT01685840|66708201|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
23815433|NCT03853148|66708202|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
23422284|NCT02526524|65288437|FG001|Overall Study|Withdrawal by Subject|3|||
23422285|NCT02526524|65288438|FG002|Overall Study|Withdrawal by Subject|6|||
23422286|NCT02526524|65288439|FG003|Overall Study|Withdrawal by Subject|1|||
23422287|NCT02526524|65288440|FG004|Overall Study|Withdrawal by Subject|9|||
23422288|NCT02526524|65288441|FG005|Overall Study|Withdrawal by Subject|5|||
23422289|NCT02526524|65288436|FG000|Overall Study|Adverse Event|3|||
23422290|NCT02526524|65288437|FG001|Overall Study|Adverse Event|2|||
23422291|NCT02526524|65288438|FG002|Overall Study|Adverse Event|4|||
23422292|NCT02526524|65288439|FG003|Overall Study|Adverse Event|2|||
23422293|NCT02526524|65288440|FG004|Overall Study|Adverse Event|6|||
23422294|NCT02526524|65288441|FG005|Overall Study|Adverse Event|8|||
23422295|NCT02526524|65288436|FG000|Overall Study|Lost to Follow-up|2|||
23422296|NCT02526524|65288437|FG001|Overall Study|Lost to Follow-up|3|||
23722475|NCT03934541|66362843|FG001|Overall Study|Study Terminated by Sponsor|1|||
23722476|NCT03934541|66362844|FG002|Overall Study|Study Terminated by Sponsor|0|||
23722477|NCT03934541|66362845|FG003|Overall Study|Study Terminated by Sponsor|0|||
23722478|NCT00981747|66362846|FG000|Losartan|Withdrawal by Subject|1|||
23722479|NCT00981747|66362846|FG000|Losartan|Death|1|||
23722480|NCT00981747|66362846|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
23722481|NCT02670928|66362847|FG000|Overall Study|Adverse Event|3|||
23422297|NCT02526524|65288438|FG002|Overall Study|Lost to Follow-up|8|||
23422298|NCT02526524|65288439|FG003|Overall Study|Lost to Follow-up|1|||
23422299|NCT02526524|65288440|FG004|Overall Study|Lost to Follow-up|2|||
23422300|NCT02526524|65288441|FG005|Overall Study|Lost to Follow-up|5|||
23422301|NCT02526524|65288436|FG000|Overall Study|Protocol Violation|3|||
23422302|NCT02526524|65288437|FG001|Overall Study|Protocol Violation|1|||
23422303|NCT02526524|65288438|FG002|Overall Study|Protocol Violation|5|||
23422304|NCT02526524|65288439|FG003|Overall Study|Protocol Violation|3|||
23422305|NCT02526524|65288440|FG004|Overall Study|Protocol Violation|4|||
23422306|NCT02526524|65288441|FG005|Overall Study|Protocol Violation|3|||
23422307|NCT02526524|65288436|FG000|Overall Study|Loss of Glucose Control|0|||
23422308|NCT02526524|65288437|FG001|Overall Study|Loss of Glucose Control|0|||
23422309|NCT02526524|65288438|FG002|Overall Study|Loss of Glucose Control|3|||
23422310|NCT02526524|65288439|FG003|Overall Study|Loss of Glucose Control|0|||
23422311|NCT02526524|65288440|FG004|Overall Study|Loss of Glucose Control|2|||
23422312|NCT02526524|65288441|FG005|Overall Study|Loss of Glucose Control|0|||
23422313|NCT02526524|65288436|FG000|Overall Study|Physician Decision|0|||
23422314|NCT02526524|65288437|FG001|Overall Study|Physician Decision|0|||
23422315|NCT02526524|65288438|FG002|Overall Study|Physician Decision|0|||
23422316|NCT02526524|65288439|FG003|Overall Study|Physician Decision|0|||
23422317|NCT02526524|65288440|FG004|Overall Study|Physician Decision|1|||
23422318|NCT02526524|65288441|FG005|Overall Study|Physician Decision|0|||
23422319|NCT02526524|65288436|FG000|Overall Study|Sponsor Decision|1|||
23422320|NCT02526524|65288437|FG001|Overall Study|Sponsor Decision|0|||
23422321|NCT02526524|65288438|FG002|Overall Study|Sponsor Decision|0|||
23422322|NCT02526524|65288439|FG003|Overall Study|Sponsor Decision|0|||
23722482|NCT02670928|66362848|FG001|Overall Study|Adverse Event|1|||
23422323|NCT02526524|65288440|FG004|Overall Study|Sponsor Decision|0|||
23422324|NCT02526524|65288441|FG005|Overall Study|Sponsor Decision|0|||
23422325|NCT01598753|65288442|FG000|Overall Study|Adverse Event|1|||
23422326|NCT01598753|65288443|FG001|Overall Study|Adverse Event|9|||
23422327|NCT01598753|65288444|FG002|Overall Study|Adverse Event|1|||
23722483|NCT02670928|66362847|FG000|Overall Study|Withdrawal by Subject|4|||
23422328|NCT01598753|65288445|FG003|Overall Study|Adverse Event|7|||
23422329|NCT01598753|65288442|FG000|Overall Study|Lost to Follow-up|4|||
23422330|NCT01598753|65288443|FG001|Overall Study|Lost to Follow-up|3|||
23422331|NCT01598753|65288444|FG002|Overall Study|Lost to Follow-up|7|||
23422332|NCT01598753|65288445|FG003|Overall Study|Lost to Follow-up|5|||
23422333|NCT01598753|65288442|FG000|Overall Study|Physician Decision|0|||
23422334|NCT01598753|65288443|FG001|Overall Study|Physician Decision|1|||
23422335|NCT01598753|65288444|FG002|Overall Study|Physician Decision|0|||
23422336|NCT01598753|65288445|FG003|Overall Study|Physician Decision|2|||
23422337|NCT01598753|65288442|FG000|Overall Study|Withdrawal by Subject|7|||
23422338|NCT01598753|65288443|FG001|Overall Study|Withdrawal by Subject|2|||
23422339|NCT01598753|65288444|FG002|Overall Study|Withdrawal by Subject|0|||
23422340|NCT01598753|65288445|FG003|Overall Study|Withdrawal by Subject|1|||
23422341|NCT01349322|65288454|FG000|Overall Study|Protocol Violation|45|||
23422342|NCT01349322|65288455|FG001|Overall Study|Protocol Violation|47|||
23422343|NCT00322023|65288456|FG000|Overall Study|various|0|||
23422344|NCT00322023|65288457|FG001|Overall Study|various|2|||
23422345|NCT00322023|65288458|FG002|Overall Study|various|6|||
23422346|NCT03334851|65288459|FG000|Overall Study|Other|0|||
23422347|NCT03334851|65288460|FG001|Overall Study|Other|0|||
23422348|NCT03334851|65288461|FG002|Overall Study|Other|0|||
23422349|NCT03334851|65288462|FG003|Overall Study|Other|0|||
23422350|NCT03334851|65288463|FG004|Overall Study|Other|0|||
23422351|NCT03334851|65288464|FG005|Overall Study|Other|0|||
23422352|NCT03334851|65288465|FG006|Overall Study|Other|0|||
23422353|NCT03334851|65288466|FG007|Overall Study|Other|1|||
23615135|NCT00265096|65976360|FG001|Overall Study|Death|1|||
23615136|NCT00265096|65976361|FG002|Overall Study|Death|2|||
23815434|NCT03853148|66708203|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
23815435|NCT03853148|66708204|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
23815436|NCT03853148|66708205|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
23815437|NCT01716715|66708206|FG000|Overall Study|Never Treated|2|||
23815438|NCT01716715|66708207|FG001|Overall Study|Never Treated|4|||
23815439|NCT04428333|66708208|FG000|Overall Study|Physician Decision|5|||
23815440|NCT04428333|66708209|FG001|Overall Study|Physician Decision|6|||
23815441|NCT04428333|66708208|FG000|Overall Study|Withdrawal by Subject|1|||
23815442|NCT04428333|66708209|FG001|Overall Study|Withdrawal by Subject|3|||
23422354|NCT03334851|65288467|FG008|Overall Study|Other|0|||
23422355|NCT03334851|65288468|FG009|Overall Study|Other|0|||
23422356|NCT03334851|65288469|FG010|Overall Study|Other|0|||
23422357|NCT03334851|65288470|FG011|Overall Study|Other|0|||
23422358|NCT03334851|65288471|FG012|Overall Study|Other|0|||
23422359|NCT03334851|65288459|FG000|Overall Study|Adverse Event|0|||
23422360|NCT03334851|65288460|FG001|Overall Study|Adverse Event|0|||
23422361|NCT03334851|65288461|FG002|Overall Study|Adverse Event|0|||
23422362|NCT03334851|65288462|FG003|Overall Study|Adverse Event|0|||
23422363|NCT03334851|65288463|FG004|Overall Study|Adverse Event|0|||
23422364|NCT03334851|65288464|FG005|Overall Study|Adverse Event|0|||
23422365|NCT03334851|65288465|FG006|Overall Study|Adverse Event|0|||
23422366|NCT03334851|65288466|FG007|Overall Study|Adverse Event|1|||
23422367|NCT03334851|65288467|FG008|Overall Study|Adverse Event|0|||
23615137|NCT00265096|65976359|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23815443|NCT04428333|66708208|FG000|Overall Study|Study Terminated By Sponsor|14|||
23815444|NCT04428333|66708209|FG001|Overall Study|Study Terminated By Sponsor|16|||
23422368|NCT03334851|65288468|FG009|Overall Study|Adverse Event|0|||
23422369|NCT03334851|65288469|FG010|Overall Study|Adverse Event|0|||
23422370|NCT03334851|65288470|FG011|Overall Study|Adverse Event|0|||
23422371|NCT03334851|65288471|FG012|Overall Study|Adverse Event|0|||
23422372|NCT03334851|65288459|FG000|Overall Study|Withdrawal by Subject|0|||
23422373|NCT03334851|65288460|FG001|Overall Study|Withdrawal by Subject|0|||
23422374|NCT03334851|65288461|FG002|Overall Study|Withdrawal by Subject|0|||
23422375|NCT03334851|65288462|FG003|Overall Study|Withdrawal by Subject|0|||
23422376|NCT03334851|65288463|FG004|Overall Study|Withdrawal by Subject|0|||
23422377|NCT03334851|65288464|FG005|Overall Study|Withdrawal by Subject|0|||
23615138|NCT00265096|65976360|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23422378|NCT03334851|65288465|FG006|Overall Study|Withdrawal by Subject|0|||
23422379|NCT03334851|65288466|FG007|Overall Study|Withdrawal by Subject|0|||
23422380|NCT03334851|65288467|FG008|Overall Study|Withdrawal by Subject|0|||
23422381|NCT03334851|65288468|FG009|Overall Study|Withdrawal by Subject|0|||
23422382|NCT03334851|65288469|FG010|Overall Study|Withdrawal by Subject|1|||
23422383|NCT03334851|65288470|FG011|Overall Study|Withdrawal by Subject|0|||
23422384|NCT03334851|65288471|FG012|Overall Study|Withdrawal by Subject|1|||
23422385|NCT03334851|65288459|FG000|Overall Study|Lost to Follow-up|0|||
23422386|NCT03334851|65288460|FG001|Overall Study|Lost to Follow-up|0|||
23422387|NCT03334851|65288461|FG002|Overall Study|Lost to Follow-up|0|||
23422388|NCT03334851|65288462|FG003|Overall Study|Lost to Follow-up|0|||
23422389|NCT03334851|65288463|FG004|Overall Study|Lost to Follow-up|0|||
23422390|NCT03334851|65288464|FG005|Overall Study|Lost to Follow-up|0|||
23422391|NCT03334851|65288465|FG006|Overall Study|Lost to Follow-up|0|||
23422392|NCT03334851|65288466|FG007|Overall Study|Lost to Follow-up|0|||
23422393|NCT03334851|65288467|FG008|Overall Study|Lost to Follow-up|0|||
23422394|NCT03334851|65288468|FG009|Overall Study|Lost to Follow-up|0|||
23422395|NCT03334851|65288469|FG010|Overall Study|Lost to Follow-up|2|||
23422396|NCT03334851|65288470|FG011|Overall Study|Lost to Follow-up|1|||
23422397|NCT03334851|65288471|FG012|Overall Study|Lost to Follow-up|0|||
23422398|NCT03500172|65288472|FG000|Period 1: Baseline Randomization|Death|0|||
23422399|NCT03500172|65288473|FG001|Period 1: Baseline Randomization|Death|0|||
23422400|NCT03500172|65288474|FG002|Period 1: Baseline Randomization|Death|0|||
23422401|NCT03500172|65288475|FG003|Period 1: Baseline Randomization|Death|0|||
23422402|NCT03500172|65288476|FG004|Period 1: Baseline Randomization|Death|0|||
23422403|NCT03500172|65288477|FG005|Period 1: Baseline Randomization|Death|0|||
23422404|NCT03500172|65288478|FG006|Period 1: Baseline Randomization|Death|0|||
23422405|NCT03500172|65288479|FG007|Period 1: Baseline Randomization|Death|0|||
23422406|NCT03500172|65288480|FG008|Period 1: Baseline Randomization|Death|0|||
23422407|NCT03500172|65288481|FG009|Period 1: Baseline Randomization|Death|2|||
23422408|NCT03500172|65288482|FG010|Period 1: Baseline Randomization|Death|0|||
23422409|NCT03500172|65288472|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
23422410|NCT03500172|65288473|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
23422411|NCT03500172|65288474|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
23422412|NCT03500172|65288475|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
23422413|NCT03500172|65288476|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
23422414|NCT03500172|65288477|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
23422415|NCT03500172|65288478|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
23422416|NCT03500172|65288479|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
23422417|NCT03500172|65288480|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
23422418|NCT03500172|65288481|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
23815445|NCT03317834|66708210|FG000|Overall Study|Death|2|||
23815446|NCT03317834|66708210|FG000|Overall Study|Device Revision|5|||
23815447|NCT03317834|66708210|FG000|Overall Study|Withdrawal by Subject|13|||
23815448|NCT03317834|66708210|FG000|Overall Study|Lost to Follow-up|13|||
23815449|NCT04628793|66708211|FG000|Overall Study|Study terminated by sponsor|0|||
23815450|NCT04628793|66708212|FG001|Overall Study|Study terminated by sponsor|0|||
23815451|NCT04628793|66708213|FG002|Overall Study|Study terminated by sponsor|8|||
23815452|NCT04628793|66708211|FG000|Overall Study|Withdrawal by Subject|2|||
23815453|NCT04628793|66708212|FG001|Overall Study|Withdrawal by Subject|3|||
23422419|NCT03500172|65288482|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
23422420|NCT03500172|65288472|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
23422421|NCT03500172|65288473|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
23422422|NCT03500172|65288474|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
23422423|NCT03500172|65288475|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
23422424|NCT03500172|65288476|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
23534494|NCT04456699|65689397|FG002|Overall Study|Sponsor Decision|50|||
23534495|NCT04456699|65689395|FG000|Overall Study|Withdrawal by Subject|8|||
23534496|NCT04456699|65689396|FG001|Overall Study|Withdrawal by Subject|4|||
23534497|NCT04456699|65689397|FG002|Overall Study|Withdrawal by Subject|5|||
23534498|NCT03199469|65689400|FG000|Overall Study|Randomized, not treated|0|||
23534499|NCT03199469|65689401|FG001|Overall Study|Randomized, not treated|3|||
23815454|NCT04628793|66708213|FG002|Overall Study|Withdrawal by Subject|0|||
23815455|NCT04628793|66708211|FG000|Overall Study|Lost to Follow-up|0|||
23422425|NCT03500172|65288477|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
23422426|NCT03500172|65288478|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
23422427|NCT03500172|65288479|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
23422428|NCT03500172|65288480|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
23422429|NCT03500172|65288481|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
23422430|NCT03500172|65288482|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
23534500|NCT03199469|65689400|FG000|Overall Study|Withdrawal by Subject|1|||
23815456|NCT04628793|66708212|FG001|Overall Study|Lost to Follow-up|1|||
23422431|NCT03500172|65288472|FG000|Period 2: Re-Randomization|Death|0|||
23636608|NCT01827046|66052947|FG001|Overall Study|Lost to Follow-up|5|||
23422432|NCT03500172|65288473|FG001|Period 2: Re-Randomization|Death|0|||
23422433|NCT03500172|65288474|FG002|Period 2: Re-Randomization|Death|0|||
23422434|NCT03500172|65288475|FG003|Period 2: Re-Randomization|Death|4|||
23422435|NCT03500172|65288476|FG004|Period 2: Re-Randomization|Death|2|||
23422436|NCT03500172|65288477|FG005|Period 2: Re-Randomization|Death|0|||
23422437|NCT03500172|65288478|FG006|Period 2: Re-Randomization|Death|5|||
23422438|NCT03500172|65288479|FG007|Period 2: Re-Randomization|Death|2|||
23422439|NCT03500172|65288480|FG008|Period 2: Re-Randomization|Death|0|||
23422440|NCT03500172|65288481|FG009|Period 2: Re-Randomization|Death|0|||
23422441|NCT03500172|65288482|FG010|Period 2: Re-Randomization|Death|0|||
23422442|NCT01474772|65288490|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
23422443|NCT01474772|65288491|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
23422444|NCT01474772|65288490|FG000|Period 1|AE not Related to Study Drug|1|||
23422445|NCT01474772|65288491|FG001|Period 1|AE not Related to Study Drug|0|||
23422446|NCT01474772|65288490|FG000|Period 1|Withdrawal by Subject|3|||
23422447|NCT01474772|65288491|FG001|Period 1|Withdrawal by Subject|1|||
23422448|NCT01474772|65288490|FG000|Period 1|Lost to Follow-up|1|||
23422449|NCT01474772|65288491|FG001|Period 1|Lost to Follow-up|0|||
23422450|NCT01474772|65288490|FG000|Period 1|Reason not Specified|1|||
23422451|NCT01474772|65288491|FG001|Period 1|Reason not Specified|1|||
23422452|NCT01474772|65288490|FG000|Washout|AE not Related to Study Drug|2|||
23422453|NCT01474772|65288491|FG001|Washout|AE not Related to Study Drug|0|||
23422454|NCT01474772|65288490|FG000|Washout|Withdrawal by Subject|1|||
23422455|NCT01474772|65288491|FG001|Washout|Withdrawal by Subject|0|||
23422456|NCT01474772|65288490|FG000|Washout|Lost to Follow-up|0|||
23422457|NCT01474772|65288491|FG001|Washout|Lost to Follow-up|1|||
23422458|NCT01474772|65288490|FG000|Washout|Reason not Specified|0|||
23422459|NCT01474772|65288491|FG001|Washout|Reason not Specified|1|||
23422460|NCT01474772|65288490|FG000|Period 2|Death|0|||
23422461|NCT01474772|65288491|FG001|Period 2|Death|1|||
23422462|NCT01474772|65288490|FG000|Period 2|AE Related to Study Drug|0|||
23422463|NCT01474772|65288491|FG001|Period 2|AE Related to Study Drug|1|||
23422464|NCT01474772|65288490|FG000|Period 2|AE not Related to Study Drug|4|||
23422465|NCT01474772|65288491|FG001|Period 2|AE not Related to Study Drug|1|||
23422466|NCT01474772|65288490|FG000|Period 2|Lack of Efficacy|1|||
23422467|NCT01474772|65288491|FG001|Period 2|Lack of Efficacy|0|||
23422468|NCT01474772|65288490|FG000|Period 2|Withdrawal by Subject|3|||
23422469|NCT01474772|65288491|FG001|Period 2|Withdrawal by Subject|4|||
23422470|NCT01474772|65288490|FG000|Period 2|Lost to Follow-up|1|||
23422471|NCT01474772|65288491|FG001|Period 2|Lost to Follow-up|1|||
23422472|NCT01474772|65288490|FG000|Period 2|Reason not Specified|0|||
23422473|NCT01474772|65288491|FG001|Period 2|Reason not Specified|2|||
23422474|NCT01474772|65288490|FG000|Follow-up|AE not Related to Study Drug|0|||
23422475|NCT01474772|65288491|FG001|Follow-up|AE not Related to Study Drug|1|||
23422476|NCT01510145|65288492|FG000|Overall Study|Adverse Event|6|||
23422477|NCT01510145|65288492|FG000|Overall Study|Lost to Follow-up|5|||
23422478|NCT01510145|65288492|FG000|Overall Study|Withdrawal by Subject|6|||
23422479|NCT01510145|65288492|FG000|Overall Study|Relative reported subject withdrew|1|||
23422480|NCT00683917|65288493|FG000|Overall Study|Study prematurely terminated|10|||
23422481|NCT04126564|65288496|FG000|Overall Study|Withdrawal by Subject|0|||
23422482|NCT04126564|65288497|FG001|Overall Study|Withdrawal by Subject|2|||
23422483|NCT04126564|65288496|FG000|Overall Study|Lost to Follow-up|0|||
23422484|NCT04126564|65288497|FG001|Overall Study|Lost to Follow-up|1|||
23422485|NCT03784846|65288506|FG000|Pre-COVID Study|Lost to Follow-up|3|||
23422486|NCT03784846|65288507|FG001|Pre-COVID Study|Lost to Follow-up|3|||
23422487|NCT03784846|65288508|FG002|Pre-COVID Study|Lost to Follow-up|2|||
23422488|NCT03784846|65288506|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
23422489|NCT03784846|65288507|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
23422490|NCT03784846|65288508|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
23534501|NCT03199469|65689401|FG001|Overall Study|Withdrawal by Subject|0|||
23815457|NCT04628793|66708213|FG002|Overall Study|Lost to Follow-up|0|||
23815458|NCT01145508|66708216|FG000|Overall Study|Adverse Event|1|||
23815459|NCT01145508|66708217|FG001|Overall Study|Adverse Event|0|||
23815460|NCT01145508|66708216|FG000|Overall Study|Death|1|||
23815461|NCT01145508|66708217|FG001|Overall Study|Death|0|||
23815462|NCT01145508|66708216|FG000|Overall Study|Physician Decision|2|||
23815463|NCT01145508|66708217|FG001|Overall Study|Physician Decision|1|||
23815464|NCT01145508|66708216|FG000|Overall Study|Never started treatment|1|||
23422491|NCT03784846|65288506|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
23422492|NCT03784846|65288507|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
23422493|NCT03784846|65288508|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
23422494|NCT03784846|65288506|FG000|Post-COVID Study|Lost to Follow-up|3|||
23422495|NCT03784846|65288507|FG001|Post-COVID Study|Lost to Follow-up|5|||
23422496|NCT03784846|65288508|FG002|Post-COVID Study|Lost to Follow-up|1|||
23422497|NCT03784846|65288506|FG000|Post-COVID Study|Withdrawal by Subject|1|||
23422498|NCT03784846|65288507|FG001|Post-COVID Study|Withdrawal by Subject|2|||
23422499|NCT03784846|65288508|FG002|Post-COVID Study|Withdrawal by Subject|0|||
23422500|NCT03831880|65288509|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
23534502|NCT03199469|65689400|FG000|Overall Study|Death|1|||
23534503|NCT03199469|65689401|FG001|Overall Study|Death|3|||
23534504|NCT03199469|65689400|FG000|Overall Study|Ongoing|5|||
23815465|NCT01145508|66708217|FG001|Overall Study|Never started treatment|1|||
23534505|NCT03199469|65689401|FG001|Overall Study|Ongoing|14|||
23534518|NCT02684006|65689408|FG000|Overall Study|Ongoing|31|||
23534519|NCT02684006|65689409|FG001|Overall Study|Ongoing|10|||
23534520|NCT02684006|65689408|FG000|Overall Study|Other|7|||
23534521|NCT02684006|65689409|FG001|Overall Study|Other|6|||
23534522|NCT02684006|65689408|FG000|Overall Study|Protocol Violation|2|||
23815466|NCT00103610|66708218|FG000|Overall Study|Entered Rescue Procedure|10|||
23815467|NCT00103610|66708219|FG001|Overall Study|Entered Rescue Procedure|52|||
23815468|NCT00103610|66708218|FG000|Overall Study|Death|16|||
23815469|NCT00103610|66708219|FG001|Overall Study|Death|12|||
23815470|NCT00103610|66708218|FG000|Overall Study|Elective Withdrawal|4|||
23615139|NCT00265096|65976361|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23615140|NCT00265096|65976359|FG000|Overall Study|Other|11|||
23615141|NCT00265096|65976360|FG001|Overall Study|Other|19|||
23615142|NCT00265096|65976361|FG002|Overall Study|Other|10|||
23615143|NCT00665392|65976364|FG000|Overall Study|not treated|1|||
23615144|NCT00647699|65976366|FG000|Overall Study|Lost to Follow-up|5|||
23615145|NCT00647699|65976367|FG001|Overall Study|Lost to Follow-up|4|||
23615146|NCT00647699|65976366|FG000|Overall Study|Withdrawal by Subject|3|||
23615147|NCT00647699|65976367|FG001|Overall Study|Withdrawal by Subject|8|||
23615148|NCT03899259|65976368|FG000|Overall Study|Adverse Event|5|||
23615149|NCT03899259|65976369|FG001|Overall Study|Adverse Event|4|||
23615150|NCT03899259|65976370|FG002|Overall Study|Adverse Event|6|||
23615151|NCT03899259|65976368|FG000|Overall Study|Lack of Efficacy|5|||
23615152|NCT03899259|65976369|FG001|Overall Study|Lack of Efficacy|0|||
23615153|NCT03899259|65976370|FG002|Overall Study|Lack of Efficacy|2|||
23615154|NCT03899259|65976368|FG000|Overall Study|Pregnancy|3|||
23615155|NCT03899259|65976369|FG001|Overall Study|Pregnancy|0|||
23615156|NCT03899259|65976370|FG002|Overall Study|Pregnancy|1|||
23615157|NCT03899259|65976368|FG000|Overall Study|Physician Decision|0|||
23615158|NCT03899259|65976369|FG001|Overall Study|Physician Decision|1|||
23615159|NCT03899259|65976370|FG002|Overall Study|Physician Decision|0|||
23615160|NCT03899259|65976368|FG000|Overall Study|Protocol Deviation|1|||
23615161|NCT03899259|65976369|FG001|Overall Study|Protocol Deviation|1|||
23615162|NCT03899259|65976370|FG002|Overall Study|Protocol Deviation|1|||
23615163|NCT03899259|65976368|FG000|Overall Study|Withdrawal by Subject|8|||
23615164|NCT03899259|65976369|FG001|Overall Study|Withdrawal by Subject|10|||
23615165|NCT03899259|65976370|FG002|Overall Study|Withdrawal by Subject|12|||
23615166|NCT03899259|65976368|FG000|Overall Study|Lost to Follow-up|5|||
23615167|NCT03899259|65976369|FG001|Overall Study|Lost to Follow-up|6|||
23615168|NCT03899259|65976370|FG002|Overall Study|Lost to Follow-up|2|||
23615169|NCT03899259|65976368|FG000|Overall Study|Lack of Adherence|1|||
23615170|NCT03899259|65976369|FG001|Overall Study|Lack of Adherence|0|||
23615171|NCT03899259|65976370|FG002|Overall Study|Lack of Adherence|0|||
23615172|NCT03899259|65976368|FG000|Overall Study|Screen Failure|1|||
23615173|NCT03899259|65976369|FG001|Overall Study|Screen Failure|0|||
23615174|NCT03899259|65976370|FG002|Overall Study|Screen Failure|0|||
23534523|NCT02684006|65689409|FG001|Overall Study|Protocol Violation|1|||
23534524|NCT02684006|65689408|FG000|Overall Study|Non-compliance with study drug|1|||
23615175|NCT03899259|65976368|FG000|Overall Study|Ongoing Study Participation|127|||
23615176|NCT03899259|65976369|FG001|Overall Study|Ongoing Study Participation|134|||
23615177|NCT03899259|65976370|FG002|Overall Study|Ongoing Study Participation|210|||
23615178|NCT04748445|65976377|FG000|Overall Study|No longer met eligibility criteria|12|||
23815471|NCT00103610|66708219|FG001|Overall Study|Elective Withdrawal|0|||
23534525|NCT02684006|65689409|FG001|Overall Study|Non-compliance with study drug|1|||
23534526|NCT02684006|65689408|FG000|Overall Study|No longer meets eligibility criteria|6|||
23534527|NCT02684006|65689409|FG001|Overall Study|No longer meets eligibility criteria|2|||
23534528|NCT02684006|65689408|FG000|Overall Study|Lost to Follow-up|0|||
23534529|NCT02684006|65689409|FG001|Overall Study|Lost to Follow-up|1|||
23615179|NCT04748445|65976377|FG000|Overall Study|Other|36|||
23615180|NCT04748445|65976377|FG000|Overall Study|Withdrawal by Subject|553|||
23615181|NCT04748445|65976377|FG000|Overall Study|Lost to Follow-up|30|||
23815472|NCT00103610|66708218|FG000|Overall Study|Lost to Follow-up|3|||
23534530|NCT02684006|65689408|FG000|Overall Study|Death|24|||
23534531|NCT02684006|65689409|FG001|Overall Study|Death|22|||
23534532|NCT02684006|65689408|FG000|Overall Study|Global deterioration of health status|18|||
23534533|NCT02684006|65689409|FG001|Overall Study|Global deterioration of health status|20|||
23534534|NCT02684006|65689408|FG000|Overall Study|Physician Decision|14|||
23534535|NCT02684006|65689409|FG001|Overall Study|Physician Decision|9|||
23534536|NCT02684006|65689408|FG000|Overall Study|Adverse Event|74|||
23534537|NCT02684006|65689409|FG001|Overall Study|Adverse Event|65|||
23534538|NCT02684006|65689408|FG000|Overall Study|Withdrawal by Subject|29|||
23534539|NCT02684006|65689409|FG001|Overall Study|Withdrawal by Subject|41|||
23534540|NCT02684006|65689408|FG000|Overall Study|Progressive disease|236|||
23534541|NCT02684006|65689409|FG001|Overall Study|Progressive disease|266|||
23534542|NCT00937547|65689410|FG000|Overall Study|misdiagnosis|1|||
23534543|NCT00937547|65689411|FG001|Overall Study|misdiagnosis|6|||
23534544|NCT00937547|65689412|FG002|Overall Study|misdiagnosis|7|||
23534545|NCT05061446|65689421|FG000|Overall Study|Adverse Event|2|||
23534546|NCT05061446|65689422|FG001|Overall Study|Adverse Event|0|||
23534547|NCT05061446|65689423|FG002|Overall Study|Adverse Event|0|||
23534548|NCT05061446|65689421|FG000|Overall Study|Participant no longer available due to personal reason|0|||
23534549|NCT05061446|65689422|FG001|Overall Study|Participant no longer available due to personal reason|1|||
23534550|NCT05061446|65689423|FG002|Overall Study|Participant no longer available due to personal reason|0|||
23534551|NCT03975647|65689424|FG000|Overall Study|Death|71|||
23534552|NCT03975647|65689425|FG001|Overall Study|Death|63|||
23534553|NCT03975647|65689424|FG000|Overall Study|Lost to Follow-up|2|||
23534554|NCT03975647|65689425|FG001|Overall Study|Lost to Follow-up|2|||
23534555|NCT03975647|65689424|FG000|Overall Study|Subject withdrawal of consent|7|||
23534556|NCT03975647|65689425|FG001|Overall Study|Subject withdrawal of consent|11|||
23534557|NCT04111497|65689426|FG000|Overall Study|relapse of primary disease|1|||
23534558|NCT04111497|65689426|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
23534564|NCT03880578|65689428|FG000|Overall Study|Withdrawal by Subject|0|||
23534565|NCT03880578|65689429|FG001|Overall Study|Withdrawal by Subject|3|||
23534566|NCT03880578|65689430|FG002|Overall Study|Withdrawal by Subject|1|||
23534567|NCT03880578|65689428|FG000|Overall Study|Death|0|||
23534568|NCT03880578|65689429|FG001|Overall Study|Death|1|||
23534569|NCT03880578|65689430|FG002|Overall Study|Death|0|||
23534570|NCT04537715|65689431|FG000|Overall Study|Death|3|||
23534571|NCT04537715|65689432|FG001|Overall Study|Death|1|||
23534572|NCT04537715|65689431|FG000|Overall Study|Withdrawal by Subject|3|||
23534573|NCT04537715|65689432|FG001|Overall Study|Withdrawal by Subject|1|||
23534574|NCT04537715|65689431|FG000|Overall Study|Other|4|||
23534575|NCT04537715|65689432|FG001|Overall Study|Other|3|||
23534576|NCT04537715|65689431|FG000|Overall Study|Progressive disease|1|||
23534577|NCT04537715|65689432|FG001|Overall Study|Progressive disease|0|||
23534582|NCT01886872|65689435|FG000|Overall Study|Ineligible|7|||
23534583|NCT01886872|65689436|FG001|Overall Study|Ineligible|4|||
23534584|NCT01886872|65689437|FG002|Overall Study|Ineligible|12|||
23534585|NCT03056690|65689438|FG000|Overall Study|Adverse Event|3|||
23534586|NCT03056690|65689439|FG001|Overall Study|Adverse Event|2|||
23534587|NCT03056690|65689438|FG000|Overall Study|Lack of Efficacy|1|||
23615182|NCT00002540|65976378|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
23615183|NCT00002540|65976379|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
23615184|NCT00002540|65976378|FG000|Overall Study|Died Before Randomization|2|||
23615185|NCT00002540|65976379|FG001|Overall Study|Died Before Randomization|6|||
23534588|NCT03056690|65689439|FG001|Overall Study|Lack of Efficacy|2|||
23534589|NCT03056690|65689438|FG000|Overall Study|Lost to Follow-up|3|||
23534590|NCT03056690|65689439|FG001|Overall Study|Lost to Follow-up|2|||
23615186|NCT00002540|65976378|FG000|Overall Study|Died Before ASU (Control)|202|||
23534591|NCT03056690|65689438|FG000|Overall Study|Protocol Violation|2|||
23534592|NCT03056690|65689439|FG001|Overall Study|Protocol Violation|2|||
23534593|NCT03056690|65689438|FG000|Overall Study|Withdrawal by Subject|3|||
23534594|NCT03056690|65689439|FG001|Overall Study|Withdrawal by Subject|6|||
23534595|NCT03056690|65689438|FG000|Overall Study|Non-compliance with Study Drug|1|||
23534596|NCT03056690|65689439|FG001|Overall Study|Non-compliance with Study Drug|0|||
23615187|NCT00002540|65976379|FG001|Overall Study|Died Before ASU (Control)|0|||
23815473|NCT00103610|66708219|FG001|Overall Study|Lost to Follow-up|1|||
23534597|NCT03056690|65689438|FG000|Overall Study|Miscellaneous|1|||
23534598|NCT03056690|65689439|FG001|Overall Study|Miscellaneous|2|||
23534599|NCT03837899|65689448|FG000|Overall Study|Death|6|||
23534600|NCT03837899|65689449|FG001|Overall Study|Death|8|||
23534601|NCT03837899|65689450|FG002|Overall Study|Death|3|||
23534602|NCT03837899|65689451|FG003|Overall Study|Death|7|||
23534603|NCT03837899|65689452|FG004|Overall Study|Death|8|||
23534604|NCT03837899|65689453|FG005|Overall Study|Death|7|||
23722484|NCT02670928|66362848|FG001|Overall Study|Withdrawal by Subject|0|||
23722485|NCT02670928|66362847|FG000|Overall Study|Lost to Follow-up|1|||
23722486|NCT02670928|66362848|FG001|Overall Study|Lost to Follow-up|0|||
23722487|NCT02670928|66362847|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
23722488|NCT02670928|66362848|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
23534605|NCT03837899|65689448|FG000|Overall Study|Moved to post-trial access program|0|||
23534606|NCT03837899|65689449|FG001|Overall Study|Moved to post-trial access program|1|||
23534607|NCT03837899|65689450|FG002|Overall Study|Moved to post-trial access program|0|||
23534608|NCT03837899|65689451|FG003|Overall Study|Moved to post-trial access program|0|||
23534609|NCT03837899|65689452|FG004|Overall Study|Moved to post-trial access program|0|||
23534610|NCT03837899|65689453|FG005|Overall Study|Moved to post-trial access program|0|||
23534611|NCT03837899|65689448|FG000|Overall Study|Other|0|||
23534612|NCT03837899|65689449|FG001|Overall Study|Other|0|||
23534613|NCT03837899|65689450|FG002|Overall Study|Other|0|||
23534614|NCT03837899|65689451|FG003|Overall Study|Other|0|||
23534615|NCT03837899|65689452|FG004|Overall Study|Other|0|||
23534616|NCT03837899|65689453|FG005|Overall Study|Other|2|||
23534617|NCT03837899|65689448|FG000|Overall Study|Lost to Follow-up|0|||
23534618|NCT03837899|65689449|FG001|Overall Study|Lost to Follow-up|1|||
23534619|NCT03837899|65689450|FG002|Overall Study|Lost to Follow-up|0|||
23534620|NCT03837899|65689451|FG003|Overall Study|Lost to Follow-up|0|||
23534621|NCT03837899|65689452|FG004|Overall Study|Lost to Follow-up|0|||
23534622|NCT03837899|65689453|FG005|Overall Study|Lost to Follow-up|0|||
23534623|NCT03837899|65689448|FG000|Overall Study|Withdrawal by Subject|0|||
23534624|NCT03837899|65689449|FG001|Overall Study|Withdrawal by Subject|0|||
23534625|NCT03837899|65689450|FG002|Overall Study|Withdrawal by Subject|0|||
23534626|NCT03837899|65689451|FG003|Overall Study|Withdrawal by Subject|1|||
23534627|NCT03837899|65689452|FG004|Overall Study|Withdrawal by Subject|0|||
23534628|NCT03837899|65689453|FG005|Overall Study|Withdrawal by Subject|0|||
23534629|NCT03837899|65689448|FG000|Overall Study|Study specific discontinuation criteria|0|||
23534630|NCT03837899|65689449|FG001|Overall Study|Study specific discontinuation criteria|1|||
23534631|NCT03837899|65689450|FG002|Overall Study|Study specific discontinuation criteria|0|||
23534632|NCT03837899|65689451|FG003|Overall Study|Study specific discontinuation criteria|0|||
23534633|NCT03837899|65689452|FG004|Overall Study|Study specific discontinuation criteria|3|||
23534634|NCT03837899|65689453|FG005|Overall Study|Study specific discontinuation criteria|1|||
23534635|NCT01856192|65689454|FG000|Overall Study|Adverse Event|12|||
23534636|NCT01856192|65689455|FG001|Overall Study|Adverse Event|4|||
23534637|NCT01856192|65689454|FG000|Overall Study|Alternative therapy|0|||
23615188|NCT00002540|65976378|FG000|Overall Study|Refused ASU (Control)|597|||
23722489|NCT01313039|66362849|FG000|Overall Study|Physician Decision|1|||
23722490|NCT01313039|66362849|FG000|Overall Study|Adverse Event|1|||
23722491|NCT00045630|66362851|FG000|Overall Study|Adverse Event|1|||
23722492|NCT00045630|66362851|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23722493|NCT00045630|66362851|FG000|Overall Study|Progression/relapse|1|||
23722494|NCT00045630|66362851|FG000|Overall Study|Death|1|||
23722495|NCT00045630|66362851|FG000|Overall Study|Ineligible|2|||
23722496|NCT01313078|66362855|FG000|Overall Study|Death|1|||
23722497|NCT01313078|66362855|FG000|Overall Study|Discontinued study drug|1|||
23722498|NCT01313078|66362855|FG000|Overall Study|Withdrawal by Subject|1|||
23722499|NCT02910219|66362860|FG000|Overall Study|Withdrawal by Subject|1|||
23722500|NCT02910219|66362861|FG001|Overall Study|Withdrawal by Subject|1|||
23722501|NCT01369225|66362865|FG000|Overall Study|Withdrawal by Subject|1|||
23722502|NCT01369225|66362866|FG001|Overall Study|Withdrawal by Subject|0|||
23722503|NCT01369225|66362867|FG002|Overall Study|Withdrawal by Subject|2|||
23722504|NCT01369225|66362868|FG003|Overall Study|Withdrawal by Subject|1|||
23534638|NCT01856192|65689455|FG001|Overall Study|Alternative therapy|3|||
23534639|NCT01856192|65689454|FG000|Overall Study|Death|3|||
23722505|NCT01369225|66362869|FG004|Overall Study|Withdrawal by Subject|0|||
23722506|NCT01369225|66362870|FG005|Overall Study|Withdrawal by Subject|0|||
23722507|NCT01369225|66362865|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
23722508|NCT01369225|66362866|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
23534640|NCT01856192|65689455|FG001|Overall Study|Death|5|||
23534641|NCT01856192|65689454|FG000|Overall Study|Lack of Efficacy|0|||
23534642|NCT01856192|65689455|FG001|Overall Study|Lack of Efficacy|5|||
23534643|NCT01856192|65689454|FG000|Overall Study|Withdrawal by Subject|1|||
23534644|NCT01856192|65689455|FG001|Overall Study|Withdrawal by Subject|1|||
23534645|NCT01856192|65689454|FG000|Overall Study|Other diseases|1|||
23534646|NCT01856192|65689455|FG001|Overall Study|Other diseases|0|||
23534647|NCT01856192|65689454|FG000|Overall Study|Never started treatment|7|||
23534648|NCT01856192|65689455|FG001|Overall Study|Never started treatment|5|||
23534649|NCT01856192|65689454|FG000|Overall Study|Path ineligible|20|||
23815474|NCT00103610|66708218|FG000|Overall Study|Adverse Event|2|||
23815475|NCT00103610|66708219|FG001|Overall Study|Adverse Event|2|||
23815476|NCT00103610|66708218|FG000|Overall Study|Other|2|||
23815477|NCT00103610|66708219|FG001|Overall Study|Other|7|||
23815478|NCT00103610|66708218|FG000|Overall Study|Failed mobilization|1|||
23815479|NCT00103610|66708219|FG001|Overall Study|Failed mobilization|5|||
23815480|NCT00103610|66708218|FG000|Overall Study|Noncompliance|0|||
23815481|NCT00103610|66708219|FG001|Overall Study|Noncompliance|1|||
23534650|NCT01856192|65689455|FG001|Overall Study|Path ineligible|34|||
23534651|NCT01856192|65689454|FG000|Overall Study|Non-path ineligible|2|||
23534652|NCT01856192|65689455|FG001|Overall Study|Non-path ineligible|2|||
23534653|NCT01856192|65689454|FG000|Overall Study|Physician Decision|1|||
23534654|NCT01856192|65689455|FG001|Overall Study|Physician Decision|1|||
23534655|NCT01856192|65689454|FG000|Overall Study|Suspicion of progressive disease|1|||
23534656|NCT01856192|65689455|FG001|Overall Study|Suspicion of progressive disease|0|||
23534657|NCT01856192|65689454|FG000|Overall Study|Non-compliance|1|||
23534658|NCT01856192|65689455|FG001|Overall Study|Non-compliance|0|||
23534659|NCT02003209|65689456|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
23534660|NCT02003209|65689457|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
23534661|NCT03433456|65689458|FG000|Overall Study|Death|1|||
23534662|NCT03433456|65689459|FG001|Overall Study|Death|1|||
23534663|NCT03433456|65689458|FG000|Overall Study|Lost to Follow-up|14|||
23534664|NCT03433456|65689459|FG001|Overall Study|Lost to Follow-up|11|||
23534665|NCT03433456|65689458|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
23534666|NCT03433456|65689459|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
23815482|NCT00371397|66708220|FG000|Session 1|Withdrawal by Subject|1|||
23422501|NCT03831880|65288510|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
23815483|NCT00371397|66708221|FG001|Session 1|Withdrawal by Subject|0|||
23534705|NCT04346615|65690464|FG000|Overall Study|Lost to Follow-up|0|||
23534706|NCT04346615|65690465|FG001|Overall Study|Lost to Follow-up|2|||
23534707|NCT04346615|65690464|FG000|Overall Study|Withdrawal by Subject|1|||
23534708|NCT04346615|65690465|FG001|Overall Study|Withdrawal by Subject|0|||
23534709|NCT04346615|65690464|FG000|Overall Study|Death|5|||
23534710|NCT04346615|65690465|FG001|Overall Study|Death|1|||
23534711|NCT04346615|65690464|FG000|Overall Study|Other|0|||
23534712|NCT04346615|65690465|FG001|Overall Study|Other|2|||
23534713|NCT04346615|65690464|FG000|Overall Study|Randomized not treated|1|||
23534714|NCT04346615|65690465|FG001|Overall Study|Randomized not treated|0|||
23534715|NCT01818336|65690466|FG000|Overall Study|Declined retest visit|0|||
23534716|NCT01818336|65690467|FG001|Overall Study|Declined retest visit|11|||
23534717|NCT01818336|65690466|FG000|Overall Study|Lost to Follow-up|0|||
23534718|NCT01818336|65690467|FG001|Overall Study|Lost to Follow-up|1|||
23534719|NCT03455855|65690470|FG000|Overall Study|Lost to Follow-up|4|||
23534720|NCT03455855|65690471|FG001|Overall Study|Lost to Follow-up|2|||
23534733|NCT02453594|65690474|FG000|Overall Study|Protocol Violation|0|||
23534734|NCT02453594|65690475|FG001|Overall Study|Protocol Violation|0|||
23534735|NCT02453594|65690476|FG002|Overall Study|Protocol Violation|1|||
23534736|NCT02453594|65690474|FG000|Overall Study|Cohort Was Closed|17|||
23534737|NCT02453594|65690475|FG001|Overall Study|Cohort Was Closed|21|||
23534738|NCT02453594|65690476|FG002|Overall Study|Cohort Was Closed|14|||
23534739|NCT02453594|65690474|FG000|Overall Study|Death|20|||
23722509|NCT01369225|66362867|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
23534740|NCT02453594|65690475|FG001|Overall Study|Death|24|||
23534741|NCT02453594|65690476|FG002|Overall Study|Death|16|||
23534742|NCT02453594|65690474|FG000|Overall Study|Lost to Follow-up|6|||
23722510|NCT01369225|66362868|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
23534743|NCT02453594|65690475|FG001|Overall Study|Lost to Follow-up|14|||
23534744|NCT02453594|65690476|FG002|Overall Study|Lost to Follow-up|2|||
23534745|NCT02453594|65690474|FG000|Overall Study|Physician Decision|2|||
23534746|NCT02453594|65690475|FG001|Overall Study|Physician Decision|4|||
23534747|NCT02453594|65690476|FG002|Overall Study|Physician Decision|0|||
23534748|NCT02453594|65690474|FG000|Overall Study|Site Terminated by Sponsor|1|||
23534749|NCT02453594|65690475|FG001|Overall Study|Site Terminated by Sponsor|0|||
23534750|NCT02453594|65690476|FG002|Overall Study|Site Terminated by Sponsor|1|||
23534751|NCT02453594|65690474|FG000|Overall Study|Transitioned to Extension Study|16|||
23534752|NCT02453594|65690475|FG001|Overall Study|Transitioned to Extension Study|9|||
23615189|NCT00002540|65976379|FG001|Overall Study|Refused ASU (Control)|0|||
23615190|NCT00002540|65976378|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
23615191|NCT00002540|65976379|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
23615192|NCT02507297|65976380|FG000|Overall Study|Withdrawal by Subject|1|||
23615193|NCT02507297|65976381|FG001|Overall Study|Withdrawal by Subject|0|||
23615194|NCT02507297|65976380|FG000|Overall Study|Lost to Follow-up|0|||
23534753|NCT02453594|65690476|FG002|Overall Study|Transitioned to Extension Study|16|||
23534754|NCT02453594|65690474|FG000|Overall Study|Withdrawal by Subject|7|||
23534755|NCT02453594|65690475|FG001|Overall Study|Withdrawal by Subject|9|||
23534756|NCT02453594|65690476|FG002|Overall Study|Withdrawal by Subject|11|||
23534761|NCT03986944|65690481|FG000|Overall Study|Adverse Event|1|||
23534762|NCT03986944|65690482|FG001|Overall Study|Adverse Event|2|||
23534763|NCT03986944|65690483|FG002|Overall Study|Adverse Event|3|||
23534764|NCT03986944|65690481|FG000|Overall Study|Protocol Violation|0|||
23534765|NCT03986944|65690482|FG001|Overall Study|Protocol Violation|1|||
23534766|NCT03986944|65690483|FG002|Overall Study|Protocol Violation|1|||
23534767|NCT03986944|65690481|FG000|Overall Study|Withdrawal by Subject|3|||
23534768|NCT03986944|65690482|FG001|Overall Study|Withdrawal by Subject|5|||
23534769|NCT03986944|65690483|FG002|Overall Study|Withdrawal by Subject|5|||
23534770|NCT03986944|65690481|FG000|Overall Study|Study termination|10|||
23534771|NCT03986944|65690482|FG001|Overall Study|Study termination|10|||
23534772|NCT03986944|65690483|FG002|Overall Study|Study termination|10|||
23534773|NCT03986944|65690481|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
23534774|NCT03986944|65690482|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
23534775|NCT03986944|65690483|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
23534776|NCT03986944|65690481|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
23534777|NCT03986944|65690482|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
23534778|NCT03986944|65690483|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
23534779|NCT02844816|65690484|FG000|Overall Study|No protocol treatment received|5|||
23534780|NCT02844816|65690485|FG001|Overall Study|No protocol treatment received|1|||
23534781|NCT02844816|65690484|FG000|Overall Study|Ineligible|22|||
23534782|NCT02844816|65690485|FG001|Overall Study|Ineligible|15|||
23534783|NCT02844816|65690484|FG000|Overall Study|Participant refusal|5|||
23534784|NCT02844816|65690485|FG001|Overall Study|Participant refusal|5|||
23534785|NCT02844816|65690484|FG000|Overall Study|Adverse Event|5|||
23534786|NCT02844816|65690485|FG001|Overall Study|Adverse Event|4|||
23534787|NCT02844816|65690484|FG000|Overall Study|Death|0|||
23534788|NCT02844816|65690485|FG001|Overall Study|Death|1|||
23534789|NCT02844816|65690484|FG000|Overall Study|Disease progression/recurrence|50|||
23534790|NCT02844816|65690485|FG001|Overall Study|Disease progression/recurrence|24|||
23534791|NCT02844816|65690484|FG000|Overall Study|Physician Decision|1|||
23534792|NCT02844816|65690485|FG001|Overall Study|Physician Decision|1|||
23534793|NCT04983901|65690486|FG000|Overall Study|Death|1|||
23534794|NCT04983901|65690487|FG001|Overall Study|Death|4|||
23534795|NCT04983901|65690486|FG000|Overall Study|Lost to Follow-up|3|||
23534796|NCT04983901|65690487|FG001|Overall Study|Lost to Follow-up|0|||
23534797|NCT04983901|65690486|FG000|Overall Study|Protocol Violation|1|||
23534798|NCT04983901|65690487|FG001|Overall Study|Protocol Violation|0|||
23534799|NCT04983901|65690486|FG000|Overall Study|Withdrawal by Subject|1|||
23534800|NCT04983901|65690487|FG001|Overall Study|Withdrawal by Subject|2|||
23534807|NCT04085523|65690492|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534808|NCT04085523|65690493|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534809|NCT04085523|65690494|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534810|NCT04085523|65690495|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534811|NCT04085523|65690496|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534812|NCT04085523|65690497|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
23615195|NCT02507297|65976381|FG001|Overall Study|Lost to Follow-up|1|||
23615196|NCT02963922|65976382|FG000|Overall Study|Adverse Event|15|||
23615197|NCT02963922|65976383|FG001|Overall Study|Adverse Event|6|||
23615198|NCT02963922|65976382|FG000|Overall Study|Protocol deviation|6|||
23615199|NCT02963922|65976383|FG001|Overall Study|Protocol deviation|6|||
23615200|NCT02963922|65976382|FG000|Overall Study|Lack of Efficacy|1|||
23615201|NCT02963922|65976383|FG001|Overall Study|Lack of Efficacy|1|||
23615202|NCT02963922|65976382|FG000|Overall Study|Lost to Follow-up|2|||
23615203|NCT02963922|65976383|FG001|Overall Study|Lost to Follow-up|3|||
23615204|NCT02963922|65976382|FG000|Overall Study|Other|8|||
23615205|NCT02963922|65976383|FG001|Overall Study|Other|14|||
23615206|NCT01780584|65976384|FG000|Overall Study|Death|1|||
23615207|NCT01780584|65976385|FG001|Overall Study|Death|0|||
23615208|NCT01780584|65976386|FG002|Overall Study|Death|1|||
23615209|NCT01780584|65976384|FG000|Overall Study|Adverse Event|0|||
23615210|NCT01780584|65976385|FG001|Overall Study|Adverse Event|1|||
23615211|NCT01780584|65976386|FG002|Overall Study|Adverse Event|0|||
23615212|NCT01780584|65976384|FG000|Overall Study|Protocol Violation|0|||
23615213|NCT01780584|65976385|FG001|Overall Study|Protocol Violation|0|||
23615214|NCT01780584|65976386|FG002|Overall Study|Protocol Violation|1|||
23615215|NCT01196741|65976387|FG000|Overall Study|Disease progression|34|||
23615216|NCT01196741|65976388|FG001|Overall Study|Disease progression|14|||
23615217|NCT01196741|65976387|FG000|Overall Study|Adverse Event|10|||
23615218|NCT01196741|65976388|FG001|Overall Study|Adverse Event|6|||
23615219|NCT01196741|65976387|FG000|Overall Study|Serious Adverse Event|3|||
23615220|NCT01196741|65976388|FG001|Overall Study|Serious Adverse Event|1|||
23615221|NCT01196741|65976387|FG000|Overall Study|Dose limiting Adverse Event|2|||
23615222|NCT01196741|65976388|FG001|Overall Study|Dose limiting Adverse Event|1|||
23615223|NCT01196741|65976387|FG000|Overall Study|Withdrawal by Subject|3|||
23615224|NCT01196741|65976388|FG001|Overall Study|Withdrawal by Subject|0|||
23615225|NCT01196741|65976387|FG000|Overall Study|Other reason|3|||
23615226|NCT01196741|65976388|FG001|Overall Study|Other reason|3|||
23615227|NCT01196741|65976387|FG000|Overall Study|Other|3|||
23615228|NCT01196741|65976388|FG001|Overall Study|Other|2|||
23615229|NCT01196741|65976387|FG000|Overall Study|Protocol Violation|2|||
23615230|NCT01196741|65976388|FG001|Overall Study|Protocol Violation|1|||
23615231|NCT01023022|65976392|FG000|Overall Study|Death|5|||
23615232|NCT01023022|65976392|FG000|Overall Study|Lost to Follow-up|7|||
23615233|NCT01023022|65976392|FG000|Overall Study|due to technical issues|2|||
23615234|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
23615235|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
23615236|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
23615237|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
23615238|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
23615239|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
23615240|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
23615241|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
23815484|NCT00371397|66708222|FG002|Session 1|Withdrawal by Subject|0|||
23815485|NCT00371397|66708223|FG003|Session 1|Withdrawal by Subject|0|||
23815486|NCT00371397|66708224|FG004|Session 1|Withdrawal by Subject|0|||
23615242|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
23615243|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
23615244|NCT05066230|65976399|FG000|After Week 48|Adverse Event|1|||
23615245|NCT05066230|65976400|FG001|After Week 48|Adverse Event|0|||
23615246|NCT05066230|65976399|FG000|After Week 48|Non-compliance with study schedule|1|||
23615247|NCT05066230|65976400|FG001|After Week 48|Non-compliance with study schedule|0|||
23615248|NCT05066230|65976399|FG000|After Week 48|Withdrawal by Subject|0|||
23615249|NCT05066230|65976400|FG001|After Week 48|Withdrawal by Subject|1|||
23615250|NCT05066230|65976399|FG000|After Week 48|Lost to Follow-up|3|||
23615251|NCT05066230|65976400|FG001|After Week 48|Lost to Follow-up|3|||
23815487|NCT00371397|66708225|FG005|Session 1|Withdrawal by Subject|0|||
23615252|NCT05066230|65976399|FG000|After Week 48|Sponsor Request|115|||
23615253|NCT05066230|65976400|FG001|After Week 48|Sponsor Request|111|||
23615254|NCT00050167|65976405|FG000|Overall Study|not eligible not invasive|1|||
23615255|NCT00050167|65976406|FG001|Overall Study|not eligible not invasive|1|||
23615256|NCT04435522|65976407|FG000|Overall Study|Withdrawal by Subject|2|||
23615257|NCT02267746|65976408|FG000|Overall Study|Adverse Event|0|||
23815488|NCT00371397|66708226|FG006|Session 1|Withdrawal by Subject|0|||
23615258|NCT02267746|65976409|FG001|Overall Study|Adverse Event|2|||
23615259|NCT02267746|65976410|FG002|Overall Study|Adverse Event|1|||
23615260|NCT02267746|65976408|FG000|Overall Study|Protocol Violation|8|||
23615261|NCT02267746|65976409|FG001|Overall Study|Protocol Violation|7|||
23615262|NCT02267746|65976410|FG002|Overall Study|Protocol Violation|3|||
23615263|NCT02267746|65976408|FG000|Overall Study|Lack of Efficacy|11|||
23534819|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
23534820|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
23534821|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
23422502|NCT03831880|65288509|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
23422503|NCT03831880|65288510|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
23422504|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
23422505|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
23422506|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
23422507|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
23422508|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
23422509|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
23422510|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
23422511|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
23422512|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
23422513|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
23422514|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Other|4|||
23422515|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Other|0|||
23422516|NCT01352741|65288514|FG000|Double-blind Comparative Period|Protocol Violation|2|||
23422517|NCT01352741|65288515|FG001|Double-blind Comparative Period|Protocol Violation|0|||
23422518|NCT01352741|65288514|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
23422519|NCT01352741|65288515|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
23534822|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
23534823|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
23534824|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
23534825|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
23534826|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
23534827|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
23534828|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
23534829|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
23534830|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
23534831|NCT00983814|65690522|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
23534832|NCT00983814|65690523|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
23534833|NCT00983814|65690524|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
23534834|NCT01110239|65690525|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
23534835|NCT01110239|65690526|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
23534836|NCT01110239|65690527|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
23615264|NCT02267746|65976409|FG001|Overall Study|Lack of Efficacy|11|||
23815489|NCT00371397|66708227|FG007|Session 1|Withdrawal by Subject|1|||
23815490|NCT00371397|66708228|FG008|Session 1|Withdrawal by Subject|0|||
23534837|NCT01110239|65690528|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
23615265|NCT02267746|65976410|FG002|Overall Study|Lack of Efficacy|15|||
23615266|NCT02267746|65976408|FG000|Overall Study|Protocol Violation|1|||
23422520|NCT01352741|65288514|FG000|Double-blind Comparative Period|Adverse Event|16|||
23422521|NCT01352741|65288515|FG001|Double-blind Comparative Period|Adverse Event|17|||
23422522|NCT01352741|65288514|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
23422523|NCT01352741|65288515|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
23422524|NCT01352741|65288514|FG000|Double-blind Comparative Period|Death|0|||
23422525|NCT01352741|65288515|FG001|Double-blind Comparative Period|Death|1|||
23422526|NCT01352741|65288514|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
23422527|NCT01352741|65288515|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
23422528|NCT01352741|65288514|FG000|Double-blind Comparative Period|Other|1|||
23422529|NCT01352741|65288515|FG001|Double-blind Comparative Period|Other|2|||
23422530|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
23422531|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
23422532|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
23422533|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
23422534|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
23422535|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
23422536|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
23422537|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
23422538|NCT01713283|65288525|FG000|Overall Study|Lack of Efficacy|10|||
23422539|NCT01713283|65288526|FG001|Overall Study|Lack of Efficacy|2|||
23422540|NCT01713283|65288525|FG000|Overall Study|Lost to Follow-up|1|||
23422541|NCT01713283|65288526|FG001|Overall Study|Lost to Follow-up|1|||
23422542|NCT04422561|65288527|FG000|Overall Study|Lost to Follow-up|25|||
23534838|NCT01110239|65690525|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
23534839|NCT01110239|65690526|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
23534840|NCT01110239|65690527|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
23534841|NCT01110239|65690528|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
23815491|NCT00371397|66708229|FG009|Session 1|Withdrawal by Subject|0|||
23815492|NCT00371397|66708230|FG010|Session 1|Withdrawal by Subject|0|||
23815493|NCT00371397|66708231|FG011|Session 1|Withdrawal by Subject|0|||
23815494|NCT03610516|66708232|FG000|Treatment Epoch|Adverse Event|3|||
23815495|NCT03610516|66708233|FG001|Treatment Epoch|Adverse Event|1|||
23815496|NCT03610516|66708232|FG000|Treatment Epoch|Death|1|||
23815497|NCT03610516|66708233|FG001|Treatment Epoch|Death|0|||
23815498|NCT03610516|66708232|FG000|Treatment Epoch|Lack of Efficacy|0|||
23422543|NCT04422561|65288528|FG001|Overall Study|Lost to Follow-up|11|||
23534856|NCT03484819|65690543|FG000|Overall Study|Death|2|||
23615267|NCT02267746|65976409|FG001|Overall Study|Protocol Violation|2|||
23722511|NCT01369225|66362869|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
23722512|NCT01369225|66362870|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
23722513|NCT01369225|66362865|FG000|Overall Study|Other|1|||
23722514|NCT01369225|66362866|FG001|Overall Study|Other|0|||
23722515|NCT01369225|66362867|FG002|Overall Study|Other|0|||
23722516|NCT01369225|66362868|FG003|Overall Study|Other|0|||
23722517|NCT01369225|66362869|FG004|Overall Study|Other|1|||
23722518|NCT01369225|66362870|FG005|Overall Study|Other|0|||
23722519|NCT01369225|66362865|FG000|Overall Study|Adverse Event|0|||
23722520|NCT01369225|66362866|FG001|Overall Study|Adverse Event|0|||
23722521|NCT01369225|66362867|FG002|Overall Study|Adverse Event|0|||
23722522|NCT01369225|66362868|FG003|Overall Study|Adverse Event|1|||
23722523|NCT01369225|66362869|FG004|Overall Study|Adverse Event|1|||
23815499|NCT03610516|66708233|FG001|Treatment Epoch|Lack of Efficacy|1|||
23815500|NCT03610516|66708232|FG000|Treatment Epoch|No longer requires treatment|1|||
23422544|NCT00129701|65288532|FG000|Overall Study|Withdrawal by Subject|33|||
23422545|NCT01069861|65288533|FG000|Overall Study|Death|1|||
23534857|NCT03484819|65690543|FG000|Overall Study|Adverse Event|2|||
23534858|NCT03484819|65690543|FG000|Overall Study|Physician Decision|1|||
23534859|NCT03484819|65690543|FG000|Overall Study|Withdrawal by Subject|2|||
23534860|NCT03484819|65690543|FG000|Overall Study|Disease Progression|4|||
23534861|NCT03484819|65690543|FG000|Overall Study|Complicating Condition|1|||
23722524|NCT01369225|66362870|FG005|Overall Study|Adverse Event|0|||
23722525|NCT04285853|66362873|FG000|Overall Study|Withdrawal by Subject|1|||
23815501|NCT03610516|66708233|FG001|Treatment Epoch|No longer requires treatment|0|||
23422546|NCT01069861|65288533|FG000|Overall Study|Adverse Event|1|||
23422547|NCT01069861|65288533|FG000|Overall Study|Did not meet entrance criteria|1|||
23422548|NCT00149994|65288534|FG000|Overall Study|Administrative problems:|1|||
23422549|NCT00149994|65288535|FG001|Overall Study|Administrative problems:|0|||
23422550|NCT00149994|65288534|FG000|Overall Study|Protocol Violation|0|||
23422551|NCT00149994|65288535|FG001|Overall Study|Protocol Violation|1|||
23422552|NCT01994863|65288538|FG000|Period 1|Adverse Event|4|||
23422553|NCT01994863|65288539|FG001|Period 1|Adverse Event|0|||
23422554|NCT01994863|65288538|FG000|Period 1|Withdrawal by Subject|1|||
23422555|NCT01994863|65288539|FG001|Period 1|Withdrawal by Subject|0|||
23422556|NCT01994863|65288538|FG000|Period 1|Trial stopped by sponsor|1|||
23422557|NCT01994863|65288539|FG001|Period 1|Trial stopped by sponsor|3|||
23422558|NCT01994863|65288538|FG000|Period 1|Lack of Efficacy|1|||
23422559|NCT01994863|65288539|FG001|Period 1|Lack of Efficacy|0|||
23422560|NCT01994863|65288538|FG000|Period 2|Adverse Event|0|||
23422561|NCT01994863|65288539|FG001|Period 2|Adverse Event|1|||
23422562|NCT01994863|65288538|FG000|Period 2|Lack of Efficacy|0|||
23422563|NCT01994863|65288539|FG001|Period 2|Lack of Efficacy|2|||
23422564|NCT01994863|65288538|FG000|Period 2|Withdrawal by Subject|1|||
23422565|NCT01994863|65288539|FG001|Period 2|Withdrawal by Subject|1|||
23422566|NCT01396265|65288542|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
23422567|NCT04979897|65288547|FG000|Overall Study|Death|1|||
23422568|NCT04979897|65288548|FG001|Overall Study|Death|8|||
23422569|NCT04979897|65288547|FG000|Overall Study|Lost to Follow-up|111|||
23422570|NCT04979897|65288548|FG001|Overall Study|Lost to Follow-up|56|||
23422571|NCT04979897|65288547|FG000|Overall Study|Withdrawal by Subject|7|||
23422572|NCT04979897|65288548|FG001|Overall Study|Withdrawal by Subject|2|||
23422573|NCT03834506|65292362|FG000|Overall Study|Death|336|||
23422574|NCT03834506|65292363|FG001|Overall Study|Death|326|||
23422575|NCT03834506|65292362|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23422576|NCT03834506|65292363|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23615268|NCT02267746|65976410|FG002|Overall Study|Protocol Violation|1|||
23615269|NCT02267746|65976408|FG000|Overall Study|Miscellaneous|1|||
23615270|NCT02267746|65976409|FG001|Overall Study|Miscellaneous|0|||
23615271|NCT02267746|65976410|FG002|Overall Study|Miscellaneous|1|||
23615272|NCT00443755|65976418|FG000|Overall Study|Withdrawal by Subject|2|||
23615273|NCT00443755|65976419|FG001|Overall Study|Withdrawal by Subject|1|||
23422577|NCT03834506|65292362|FG000|Overall Study|Withdrawal by Subject|10|||
23422578|NCT03834506|65292363|FG001|Overall Study|Withdrawal by Subject|8|||
23422579|NCT03834506|65292362|FG000|Overall Study|Sponsor decision|165|||
23422580|NCT03834506|65292363|FG001|Overall Study|Sponsor decision|178|||
23422581|NCT03834506|65292362|FG000|Overall Study|Physician Decision|3|||
23422582|NCT03834506|65292363|FG001|Overall Study|Physician Decision|1|||
23422583|NCT03834506|65292362|FG000|Overall Study|Lost to Follow-up|0|||
23422584|NCT03834506|65292363|FG001|Overall Study|Lost to Follow-up|1|||
23422585|NCT02334683|65292374|FG000|First 12 Week Period|Lost to Follow-up|1|||
23422586|NCT02334683|65292375|FG001|First 12 Week Period|Lost to Follow-up|0|||
23422587|NCT02334683|65292374|FG000|Second 12 Week Period|Adverse Event|0|||
23422588|NCT02334683|65292375|FG001|Second 12 Week Period|Adverse Event|1|||
23422589|NCT01778049|65292376|FG000|Open Label Treatment Period|Adverse Event|5|||
23422590|NCT01778049|65292377|FG001|Open Label Treatment Period|Adverse Event|15|||
23422591|NCT01778049|65292378|FG002|Open Label Treatment Period|Adverse Event|0|||
23422592|NCT01778049|65292379|FG003|Open Label Treatment Period|Adverse Event|0|||
23422593|NCT01778049|65292380|FG004|Open Label Treatment Period|Adverse Event|0|||
23422594|NCT01778049|65292381|FG005|Open Label Treatment Period|Adverse Event|0|||
23422595|NCT01778049|65292376|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
23422596|NCT01778049|65292377|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
23422597|NCT01778049|65292378|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
23422598|NCT01778049|65292379|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
23422599|NCT01778049|65292380|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
23422600|NCT01778049|65292381|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
23422601|NCT01778049|65292376|FG000|Open Label Treatment Period|Protocol Violation|5|||
23422602|NCT01778049|65292377|FG001|Open Label Treatment Period|Protocol Violation|5|||
23422603|NCT01778049|65292378|FG002|Open Label Treatment Period|Protocol Violation|0|||
23722526|NCT04285853|66362874|FG001|Overall Study|Withdrawal by Subject|0|||
23722527|NCT04285853|66362873|FG000|Overall Study|Lost to Follow-up|9|||
23722528|NCT04285853|66362874|FG001|Overall Study|Lost to Follow-up|5|||
23722529|NCT01855945|66362876|FG000|Overall Study|Adverse Event|0|||
23722530|NCT01855945|66362877|FG001|Overall Study|Adverse Event|0|||
23722531|NCT01855945|66362878|FG002|Overall Study|Adverse Event|0|||
23722532|NCT01855945|66362879|FG003|Overall Study|Adverse Event|0|||
23722533|NCT01855945|66362880|FG004|Overall Study|Adverse Event|0|||
23722534|NCT01855945|66362881|FG005|Overall Study|Adverse Event|0|||
23722535|NCT01855945|66362882|FG006|Overall Study|Adverse Event|1|||
23815502|NCT03610516|66708232|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
23815503|NCT03610516|66708233|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
23815504|NCT03610516|66708232|FG000|Treatment Epoch|Physician Decision|8|||
23815505|NCT03610516|66708233|FG001|Treatment Epoch|Physician Decision|5|||
23815506|NCT03610516|66708232|FG000|Treatment Epoch|Protocol Deviation|1|||
23815507|NCT03610516|66708233|FG001|Treatment Epoch|Protocol Deviation|0|||
23815508|NCT03610516|66708232|FG000|Treatment Epoch|Withdrawal by Subject|3|||
23815509|NCT03610516|66708233|FG001|Treatment Epoch|Withdrawal by Subject|1|||
23815510|NCT03610516|66708232|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
23815511|NCT03610516|66708233|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
23815512|NCT03610516|66708232|FG000|Post-Treatment Follow-up|Death|1|||
23815513|NCT03610516|66708233|FG001|Post-Treatment Follow-up|Death|0|||
23815514|NCT00951496|66708234|FG000|Overall Study|Did not initiate study treatment|10|||
23815515|NCT00951496|66708235|FG001|Overall Study|Did not initiate study treatment|8|||
23815516|NCT00951496|66708236|FG002|Overall Study|Did not initiate study treatment|13|||
23815517|NCT03783039|66708246|FG000|Overall Study|Death|2|||
23815518|NCT03783039|66708247|FG001|Overall Study|Death|1|||
23815519|NCT02752087|66708248|FG000|Washout|Physician Decision|1|||
23815520|NCT02752087|66708249|FG001|Washout|Physician Decision|0|||
23815521|NCT01753297|66708250|FG000|Overall Study|Lost to Follow-up|7|||
23815522|NCT01753297|66708251|FG001|Overall Study|Lost to Follow-up|2|||
23815523|NCT01753297|66708250|FG000|Overall Study|Withdrawal by Subject|26|||
23815524|NCT01753297|66708251|FG001|Overall Study|Withdrawal by Subject|23|||
23815525|NCT01753297|66708250|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
23815526|NCT01753297|66708251|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
23815527|NCT01753297|66708250|FG000|Overall Study|Death|0|||
23815528|NCT01753297|66708251|FG001|Overall Study|Death|2|||
23815529|NCT01753297|66708250|FG000|Overall Study|Did not attend end of study visit|7|||
23815530|NCT01753297|66708251|FG001|Overall Study|Did not attend end of study visit|8|||
23815531|NCT02704403|66708252|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
23815532|NCT02704403|66708253|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
23815533|NCT02704403|66708252|FG000|Overall Study|Administrative reasons by sponsor|1251|||
23815534|NCT02704403|66708253|FG001|Overall Study|Administrative reasons by sponsor|616|||
23815535|NCT02704403|66708252|FG000|Overall Study|Death|4|||
23815536|NCT02704403|66708253|FG001|Overall Study|Death|3|||
23815537|NCT02704403|66708252|FG000|Overall Study|Endpoint event|52|||
23722536|NCT01855945|66362883|FG007|Overall Study|Adverse Event|0|||
23422604|NCT01778049|65292379|FG003|Open Label Treatment Period|Protocol Violation|0|||
23815538|NCT02704403|66708253|FG001|Overall Study|Endpoint event|24|||
23422605|NCT01778049|65292380|FG004|Open Label Treatment Period|Protocol Violation|0|||
23422606|NCT01778049|65292381|FG005|Open Label Treatment Period|Protocol Violation|0|||
23422607|NCT01778049|65292376|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
23422608|NCT01778049|65292377|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
23422609|NCT01778049|65292378|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
23422610|NCT01778049|65292379|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
23422611|NCT01778049|65292380|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
23422612|NCT01778049|65292381|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
23422613|NCT01778049|65292376|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
23422614|NCT01778049|65292377|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
23422615|NCT01778049|65292378|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
23422616|NCT01778049|65292379|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
23422617|NCT01778049|65292380|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
23422618|NCT01778049|65292381|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
23422619|NCT01778049|65292376|FG000|Open Label Treatment Period|Not treated|2|||
23422620|NCT01778049|65292377|FG001|Open Label Treatment Period|Not treated|1|||
23422621|NCT01778049|65292378|FG002|Open Label Treatment Period|Not treated|0|||
23422622|NCT01778049|65292379|FG003|Open Label Treatment Period|Not treated|0|||
23422623|NCT01778049|65292380|FG004|Open Label Treatment Period|Not treated|0|||
23422624|NCT01778049|65292381|FG005|Open Label Treatment Period|Not treated|0|||
23422625|NCT01778049|65292376|FG000|Open Label Treatment Period|Other reason not defined above|77|||
23422626|NCT01778049|65292377|FG001|Open Label Treatment Period|Other reason not defined above|94|||
23422627|NCT01778049|65292378|FG002|Open Label Treatment Period|Other reason not defined above|0|||
23422628|NCT01778049|65292379|FG003|Open Label Treatment Period|Other reason not defined above|0|||
23422629|NCT01778049|65292380|FG004|Open Label Treatment Period|Other reason not defined above|0|||
23422630|NCT01778049|65292381|FG005|Open Label Treatment Period|Other reason not defined above|0|||
23422631|NCT01778049|65292376|FG000|Double Blind Treatment Period|Adverse Event|0|||
23422632|NCT01778049|65292377|FG001|Double Blind Treatment Period|Adverse Event|0|||
23422633|NCT01778049|65292378|FG002|Double Blind Treatment Period|Adverse Event|4|||
23422634|NCT01778049|65292379|FG003|Double Blind Treatment Period|Adverse Event|5|||
23422635|NCT01778049|65292380|FG004|Double Blind Treatment Period|Adverse Event|3|||
23422636|NCT01778049|65292381|FG005|Double Blind Treatment Period|Adverse Event|2|||
23422637|NCT01778049|65292376|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
23422638|NCT01778049|65292377|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23422639|NCT01778049|65292378|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23422640|NCT01778049|65292379|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23422641|NCT01778049|65292380|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23422642|NCT01778049|65292381|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
23422643|NCT01778049|65292376|FG000|Double Blind Treatment Period|Protocol Violation|0|||
23422644|NCT01778049|65292377|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23422645|NCT01778049|65292378|FG002|Double Blind Treatment Period|Protocol Violation|2|||
23422646|NCT01778049|65292379|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23422647|NCT01778049|65292380|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23422648|NCT01778049|65292381|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23422649|NCT01778049|65292376|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
23422650|NCT01778049|65292377|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23422651|NCT01778049|65292378|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
23422652|NCT01778049|65292379|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
23422653|NCT01778049|65292380|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
23422654|NCT01778049|65292381|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
23422655|NCT01778049|65292376|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
23815539|NCT02704403|66708252|FG000|Overall Study|Lost to Follow-up|22|||
23815540|NCT02704403|66708253|FG001|Overall Study|Lost to Follow-up|11|||
23422656|NCT01778049|65292377|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
23422657|NCT01778049|65292378|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
23422658|NCT01778049|65292379|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
23422659|NCT01778049|65292380|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23422660|NCT01778049|65292381|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
23422661|NCT01778049|65292376|FG000|Double Blind Treatment Period|Not treated|0|||
23422662|NCT01778049|65292377|FG001|Double Blind Treatment Period|Not treated|0|||
23422663|NCT01778049|65292378|FG002|Double Blind Treatment Period|Not treated|0|||
23422664|NCT01778049|65292379|FG003|Double Blind Treatment Period|Not treated|2|||
23722537|NCT01855945|66362884|FG008|Overall Study|Adverse Event|0|||
23722538|NCT01855945|66362885|FG009|Overall Study|Adverse Event|0|||
23422665|NCT01778049|65292380|FG004|Double Blind Treatment Period|Not treated|2|||
23422666|NCT01778049|65292381|FG005|Double Blind Treatment Period|Not treated|0|||
23422667|NCT01778049|65292376|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
23422668|NCT01778049|65292377|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
23422669|NCT01778049|65292378|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
23422670|NCT01778049|65292379|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
23422671|NCT01778049|65292380|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
23422672|NCT01778049|65292381|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
23422673|NCT02098369|65292382|FG000|Overall Study|Withdrawal by Subject|1|||
23422674|NCT02098369|65292383|FG001|Overall Study|Withdrawal by Subject|5|||
23422675|NCT02098369|65292384|FG002|Overall Study|Withdrawal by Subject|0|||
23422676|NCT02098369|65292382|FG000|Overall Study|Lost to Follow-up|5|||
23422677|NCT02098369|65292383|FG001|Overall Study|Lost to Follow-up|1|||
23422678|NCT02098369|65292384|FG002|Overall Study|Lost to Follow-up|3|||
23722539|NCT01855945|66362886|FG010|Overall Study|Adverse Event|0|||
23422679|NCT02098369|65292382|FG000|Overall Study|Death|1|||
23422680|NCT02098369|65292383|FG001|Overall Study|Death|1|||
23422681|NCT02098369|65292384|FG002|Overall Study|Death|1|||
23722540|NCT01855945|66362887|FG011|Overall Study|Adverse Event|0|||
23422682|NCT02098369|65292382|FG000|Overall Study|Other|0|||
23815541|NCT02704403|66708252|FG000|Overall Study|Protocol Violation|15|||
23815542|NCT02704403|66708253|FG001|Overall Study|Protocol Violation|15|||
23815543|NCT02704403|66708252|FG000|Overall Study|Adverse Event|2|||
23815544|NCT02704403|66708253|FG001|Overall Study|Adverse Event|0|||
23815545|NCT02704403|66708252|FG000|Overall Study|Withdrawal by Subject|85|||
23815546|NCT02704403|66708253|FG001|Overall Study|Withdrawal by Subject|45|||
23815547|NCT02704403|66708252|FG000|Overall Study|Investigator decision|1|||
23815548|NCT02704403|66708253|FG001|Overall Study|Investigator decision|1|||
23815549|NCT02704403|66708252|FG000|Overall Study|Follow-up not possible|1|||
23815550|NCT02704403|66708253|FG001|Overall Study|Follow-up not possible|2|||
23815551|NCT00229723|66708257|FG000|Concomitant Phase|Adverse Event|4|||
23615274|NCT04908488|65976420|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23615275|NCT04908488|65976421|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23615276|NCT04908488|65976420|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
23615277|NCT04908488|65976421|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
23615278|NCT00919061|65976422|FG000|Overall Study|Adverse Event|1|||
23615279|NCT00919061|65976422|FG000|Overall Study|Withdrawal by Subject|1|||
23615280|NCT03048058|65976425|FG000|Overall Study|Lost to Follow-up|4|||
23615281|NCT03048058|65976426|FG001|Overall Study|Lost to Follow-up|0|||
23615282|NCT03048058|65976425|FG000|Overall Study|Withdrawal by Subject|0|||
23615283|NCT03048058|65976426|FG001|Overall Study|Withdrawal by Subject|4|||
23615284|NCT01129011|65976427|FG000|Overall Study|Adverse Event|20|||
23615285|NCT01129011|65976428|FG001|Overall Study|Adverse Event|30|||
23615286|NCT01129011|65976427|FG000|Overall Study|Withdrawal by Subject|24|||
23615287|NCT01129011|65976428|FG001|Overall Study|Withdrawal by Subject|8|||
23615288|NCT01129011|65976427|FG000|Overall Study|Lost to Follow-up|6|||
23615289|NCT01129011|65976428|FG001|Overall Study|Lost to Follow-up|7|||
23615290|NCT01129011|65976427|FG000|Overall Study|Duodenal Ulcer|2|||
23615291|NCT01129011|65976428|FG001|Overall Study|Duodenal Ulcer|8|||
23615292|NCT01129011|65976427|FG000|Overall Study|misc|7|||
23615293|NCT01129011|65976428|FG001|Overall Study|misc|4|||
23815552|NCT00229723|66708258|FG001|Concomitant Phase|Adverse Event|2|||
23815553|NCT00229723|66708259|FG002|Concomitant Phase|Adverse Event|5|||
23815554|NCT00229723|66708260|FG003|Concomitant Phase|Adverse Event|2|||
23815555|NCT00229723|66708261|FG004|Concomitant Phase|Adverse Event|0|||
23815556|NCT00229723|66708262|FG005|Concomitant Phase|Adverse Event|1|||
23615294|NCT01636778|65976429|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
23722541|NCT01855945|66362876|FG000|Overall Study|Death|0|||
23815557|NCT00229723|66708263|FG006|Concomitant Phase|Adverse Event|2|||
23815558|NCT00229723|66708257|FG000|Concomitant Phase|Objective disease progression|0|||
23815559|NCT00229723|66708258|FG001|Concomitant Phase|Objective disease progression|0|||
23534946|NCT03120624|65690556|FG000|Overall Study|Withdrawal by Subject|0|||
23534947|NCT03120624|65690557|FG001|Overall Study|Withdrawal by Subject|1|||
23534948|NCT03120624|65690558|FG002|Overall Study|Withdrawal by Subject|0|||
23534949|NCT03120624|65690559|FG003|Overall Study|Withdrawal by Subject|0|||
23534950|NCT03120624|65690560|FG004|Overall Study|Withdrawal by Subject|0|||
23534951|NCT03120624|65690561|FG005|Overall Study|Withdrawal by Subject|0|||
23534952|NCT03120624|65690562|FG006|Overall Study|Withdrawal by Subject|0|||
23534953|NCT03120624|65690563|FG007|Overall Study|Withdrawal by Subject|0|||
23534963|NCT01950390|65690874|FG000|Overall Study|Never started treatment|3|||
23534964|NCT01950390|65690875|FG001|Overall Study|Never started treatment|2|||
23534965|NCT01950390|65690874|FG000|Overall Study|Disease progression|45|||
23534966|NCT01950390|65690875|FG001|Overall Study|Disease progression|52|||
23534967|NCT01950390|65690874|FG000|Overall Study|Adverse Event|22|||
23534968|NCT01950390|65690875|FG001|Overall Study|Adverse Event|16|||
23534969|NCT01950390|65690874|FG000|Overall Study|Death|5|||
23534970|NCT01950390|65690875|FG001|Overall Study|Death|3|||
23534971|NCT01950390|65690874|FG000|Overall Study|Withdrawal by Subject|5|||
23534972|NCT01950390|65690875|FG001|Overall Study|Withdrawal by Subject|1|||
23534973|NCT01950390|65690874|FG000|Overall Study|Alternative therapy|0|||
23534974|NCT01950390|65690875|FG001|Overall Study|Alternative therapy|3|||
23534975|NCT01950390|65690874|FG000|Overall Study|Complicating disease|1|||
23534976|NCT01950390|65690875|FG001|Overall Study|Complicating disease|0|||
23534977|NCT01950390|65690874|FG000|Overall Study|On treatment|1|||
23534978|NCT01950390|65690875|FG001|Overall Study|On treatment|0|||
23534979|NCT01950390|65690874|FG000|Overall Study|Symptomatic deterioration|2|||
23534980|NCT01950390|65690875|FG001|Overall Study|Symptomatic deterioration|1|||
23534981|NCT01950390|65690874|FG000|Overall Study|Physician Decision|0|||
23534982|NCT01950390|65690875|FG001|Overall Study|Physician Decision|4|||
23534983|NCT01950390|65690874|FG000|Overall Study|Lack of clinical benefit|0|||
23534984|NCT01950390|65690875|FG001|Overall Study|Lack of clinical benefit|1|||
23534985|NCT01950390|65690874|FG000|Overall Study|Maintained PR and moved to observation only|0|||
23534986|NCT01950390|65690875|FG001|Overall Study|Maintained PR and moved to observation only|1|||
23534987|NCT03984188|65690882|FG000|Overall Study|Death|2|||
23534988|NCT03984188|65690883|FG001|Overall Study|Death|4|||
23534989|NCT03984188|65690882|FG000|Overall Study|Physician Decision|0|||
23534990|NCT03984188|65690883|FG001|Overall Study|Physician Decision|2|||
23534991|NCT03984188|65690882|FG000|Overall Study|Lost to Follow-up|3|||
23534992|NCT03984188|65690883|FG001|Overall Study|Lost to Follow-up|2|||
23534993|NCT03984188|65690882|FG000|Overall Study|Withdrawal by Subject|6|||
23534994|NCT03984188|65690883|FG001|Overall Study|Withdrawal by Subject|0|||
23722542|NCT01855945|66362877|FG001|Overall Study|Death|0|||
23815560|NCT00229723|66708259|FG002|Concomitant Phase|Objective disease progression|0|||
23815561|NCT00229723|66708260|FG003|Concomitant Phase|Objective disease progression|0|||
23422683|NCT02098369|65292383|FG001|Overall Study|Other|2|||
23422684|NCT02098369|65292384|FG002|Overall Study|Other|1|||
23422685|NCT02136680|65292385|FG000|Overall Study|No Longer Interested|1|||
23422686|NCT02136680|65292386|FG001|Overall Study|No Longer Interested|1|||
23422687|NCT02136680|65292385|FG000|Overall Study|No longer receiving care at clinic|3|||
23422688|NCT02136680|65292386|FG001|Overall Study|No longer receiving care at clinic|5|||
23422689|NCT02136680|65292385|FG000|Overall Study|Moved away|5|||
23422690|NCT02136680|65292386|FG001|Overall Study|Moved away|4|||
23422691|NCT02136680|65292385|FG000|Overall Study|Unable to schedule|17|||
23422692|NCT02136680|65292386|FG001|Overall Study|Unable to schedule|16|||
23422693|NCT02136680|65292385|FG000|Overall Study|Study ended before interview due|6|||
23422694|NCT02136680|65292386|FG001|Overall Study|Study ended before interview due|3|||
23422695|NCT04706273|65292391|FG000|Overall Study|Withdrawal by Subject|27|||
23422696|NCT04706273|65292391|FG000|Overall Study|Physician Decision|1|||
23422697|NCT04706273|65292391|FG000|Overall Study|Lost to Follow-up|42|||
23422698|NCT04706273|65292391|FG000|Overall Study|Death|85|||
23422699|NCT04706273|65292391|FG000|Overall Study|Amputation that removes study device|2|||
23422700|NCT04706273|65292391|FG000|Overall Study|Surgical bypass|3|||
23422701|NCT04706273|65292391|FG000|Overall Study|Changing hospital|23|||
23422702|NCT04706273|65292391|FG000|Overall Study|Unable to attend hospital|2|||
23422703|NCT01730339|65292393|FG000|Overall Study|Withdrawal by Subject|3|||
23422704|NCT01730339|65292394|FG001|Overall Study|Withdrawal by Subject|2|||
23422705|NCT01730339|65292393|FG000|Overall Study|Lost to Follow-up|1|||
23422706|NCT01730339|65292394|FG001|Overall Study|Lost to Follow-up|1|||
23422707|NCT01730339|65292393|FG000|Overall Study|Un-specified|1|||
23422708|NCT01730339|65292394|FG001|Overall Study|Un-specified|0|||
23422709|NCT01133275|65292396|FG000|Overall Study|Withdrawal by Subject|1|||
23422710|NCT01133275|65292396|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
23422711|NCT01390779|65292401|FG000|Overall Study|Physician Decision|1|||
23422712|NCT00006046|65292405|FG000|Overall Study|Adverse Event|3|||
23422713|NCT00006046|65292406|FG001|Overall Study|Adverse Event|0|||
23422714|NCT00006046|65292407|FG002|Overall Study|Adverse Event|0|||
23422715|NCT00006046|65292408|FG003|Overall Study|Adverse Event|0|||
23422716|NCT00006046|65292409|FG004|Overall Study|Adverse Event|0|||
23422717|NCT00006046|65292405|FG000|Overall Study|Disease Progression|2|||
23422718|NCT00006046|65292406|FG001|Overall Study|Disease Progression|0|||
23422719|NCT00006046|65292407|FG002|Overall Study|Disease Progression|0|||
23422720|NCT00006046|65292408|FG003|Overall Study|Disease Progression|0|||
23422721|NCT00006046|65292409|FG004|Overall Study|Disease Progression|0|||
23422722|NCT02046226|65292410|FG000|Overall Study|Lost to Follow-up|7|||
23422723|NCT01071200|65292412|FG000|Overall Study|Lack of ovarian response|1|||
23422724|NCT01071200|65292413|FG001|Overall Study|Lack of ovarian response|1|||
23422725|NCT01071200|65292412|FG000|Overall Study|No fertilization|4|||
23422726|NCT01071200|65292413|FG001|Overall Study|No fertilization|0|||
23422727|NCT01071200|65292412|FG000|Overall Study|No oocytes retrieved|1|||
23422728|NCT01071200|65292413|FG001|Overall Study|No oocytes retrieved|1|||
23422729|NCT01071200|65292412|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
23422730|NCT01071200|65292413|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
23422731|NCT01071200|65292412|FG000|Overall Study|No viable embryos|0|||
23422732|NCT01071200|65292413|FG001|Overall Study|No viable embryos|1|||
23422733|NCT03754582|65292416|FG000|Treatment Phase|Adverse Event|0|||
23422734|NCT03754582|65292417|FG001|Treatment Phase|Adverse Event|1|||
23422735|NCT03754582|65292418|FG002|Treatment Phase|Adverse Event|0|||
23422736|NCT03754582|65292416|FG000|Follow-up Phase|Other|0|||
23422737|NCT03754582|65292417|FG001|Follow-up Phase|Other|0|||
23422738|NCT03754582|65292418|FG002|Follow-up Phase|Other|1|||
23422739|NCT00693017|65292420|FG000|Overall Study|Sponsor Decision|2|||
23422740|NCT00693017|65292421|FG001|Overall Study|Sponsor Decision|1|||
23422741|NCT00693017|65292420|FG000|Overall Study|Death|0|||
23422742|NCT00693017|65292421|FG001|Overall Study|Death|1|||
23422743|NCT00435162|65292428|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
23422744|NCT00435162|65292429|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
23422745|NCT00435162|65292430|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
23422746|NCT00435162|65292431|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
23422747|NCT00435162|65292432|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
23422748|NCT00435162|65292433|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
23422749|NCT00241631|65292435|FG000|Run in (2 Weeks)|Physician Decision|3|||
23422750|NCT00241631|65292436|FG001|Run in (2 Weeks)|Physician Decision|3|||
23615295|NCT01636778|65976430|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
23615296|NCT01636778|65976431|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
23615297|NCT01636778|65976429|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
23615298|NCT01636778|65976430|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
23615299|NCT01636778|65976431|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
23615300|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
23615301|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
23615302|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
23615303|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
23722543|NCT01855945|66362878|FG002|Overall Study|Death|0|||
23722544|NCT01855945|66362879|FG003|Overall Study|Death|0|||
23722545|NCT01855945|66362880|FG004|Overall Study|Death|0|||
23722546|NCT01855945|66362881|FG005|Overall Study|Death|0|||
23722547|NCT01855945|66362882|FG006|Overall Study|Death|2|||
23722548|NCT01855945|66362883|FG007|Overall Study|Death|0|||
23722549|NCT01855945|66362884|FG008|Overall Study|Death|0|||
23722550|NCT01855945|66362885|FG009|Overall Study|Death|0|||
23722551|NCT01855945|66362886|FG010|Overall Study|Death|0|||
23722552|NCT01855945|66362887|FG011|Overall Study|Death|0|||
23722553|NCT01855945|66362876|FG000|Overall Study|Lost to Follow-up|11|||
23722554|NCT01855945|66362877|FG001|Overall Study|Lost to Follow-up|10|||
23722555|NCT01855945|66362878|FG002|Overall Study|Lost to Follow-up|7|||
23722556|NCT01855945|66362879|FG003|Overall Study|Lost to Follow-up|3|||
23722557|NCT01855945|66362880|FG004|Overall Study|Lost to Follow-up|0|||
23722558|NCT01855945|66362881|FG005|Overall Study|Lost to Follow-up|3|||
23722559|NCT01855945|66362882|FG006|Overall Study|Lost to Follow-up|4|||
23722560|NCT01855945|66362883|FG007|Overall Study|Lost to Follow-up|7|||
23722561|NCT01855945|66362884|FG008|Overall Study|Lost to Follow-up|2|||
23722562|NCT01855945|66362885|FG009|Overall Study|Lost to Follow-up|0|||
23722563|NCT01855945|66362886|FG010|Overall Study|Lost to Follow-up|0|||
23722564|NCT01855945|66362887|FG011|Overall Study|Lost to Follow-up|2|||
23722565|NCT01855945|66362876|FG000|Overall Study|Other - Unclassified|1|||
23722566|NCT01855945|66362877|FG001|Overall Study|Other - Unclassified|1|||
23722567|NCT01855945|66362878|FG002|Overall Study|Other - Unclassified|1|||
23722568|NCT01855945|66362879|FG003|Overall Study|Other - Unclassified|0|||
23722569|NCT01855945|66362880|FG004|Overall Study|Other - Unclassified|0|||
23722570|NCT01855945|66362881|FG005|Overall Study|Other - Unclassified|0|||
23722571|NCT01855945|66362882|FG006|Overall Study|Other - Unclassified|2|||
23722572|NCT01855945|66362883|FG007|Overall Study|Other - Unclassified|1|||
23722573|NCT01855945|66362884|FG008|Overall Study|Other - Unclassified|0|||
23722574|NCT01855945|66362885|FG009|Overall Study|Other - Unclassified|0|||
23722575|NCT01855945|66362886|FG010|Overall Study|Other - Unclassified|1|||
23722576|NCT01855945|66362887|FG011|Overall Study|Other - Unclassified|0|||
23722577|NCT01855945|66362876|FG000|Overall Study|Withdrawal by Subject|4|||
23722578|NCT01855945|66362877|FG001|Overall Study|Withdrawal by Subject|0|||
23722579|NCT01855945|66362878|FG002|Overall Study|Withdrawal by Subject|4|||
23722580|NCT01855945|66362879|FG003|Overall Study|Withdrawal by Subject|1|||
23722581|NCT01855945|66362880|FG004|Overall Study|Withdrawal by Subject|1|||
23722582|NCT01855945|66362881|FG005|Overall Study|Withdrawal by Subject|0|||
23722583|NCT01855945|66362882|FG006|Overall Study|Withdrawal by Subject|1|||
23722584|NCT01855945|66362883|FG007|Overall Study|Withdrawal by Subject|0|||
23722585|NCT01855945|66362884|FG008|Overall Study|Withdrawal by Subject|0|||
23722586|NCT01855945|66362885|FG009|Overall Study|Withdrawal by Subject|2|||
23722587|NCT01855945|66362886|FG010|Overall Study|Withdrawal by Subject|4|||
23722588|NCT01855945|66362887|FG011|Overall Study|Withdrawal by Subject|1|||
23422751|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|sore throat|1|||
23722589|NCT00361218|66362891|FG000|Overall Study|Lost to Follow-up|11|||
23722590|NCT00361218|66362891|FG000|Overall Study|Personal Reasons|7|||
23722591|NCT00361218|66362891|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
23722592|NCT00880607|66362899|FG000|Overall Study|Physician Decision|2|||
23722593|NCT00880607|66362900|FG001|Overall Study|Physician Decision|2|||
23722594|NCT00880607|66362899|FG000|Overall Study|Protocol Violation|2|||
23722595|NCT00880607|66362900|FG001|Overall Study|Protocol Violation|1|||
23722596|NCT00880607|66362899|FG000|Overall Study|surgery did not extend past L1 level|3|||
23722597|NCT00880607|66362900|FG001|Overall Study|surgery did not extend past L1 level|0|||
23722598|NCT02057068|66362901|FG000|Overall Study|Withdrawal by Subject|2|||
23582183|NCT02219490|65862354|FG000|Overall Study|COVID-19 logistical restrictions|33|||
23582184|NCT02219490|65862354|FG000|Overall Study|Other, not specified|57|||
23582185|NCT05824351|65862355|FG000|Overall Study|Adverse Event|6|||
23582186|NCT01740557|65862356|FG000|Overall Study|Ineligible|1|||
23582187|NCT01740557|65862356|FG000|Overall Study|Screen failure|1|||
23582188|NCT01123161|65862360|FG000|Overall Study|Lost to Follow-up|1|||
23582189|NCT01123161|65862361|FG001|Overall Study|Lost to Follow-up|0|||
23582190|NCT01123161|65862360|FG000|Overall Study|Withdrawal by Subject|1|||
23582191|NCT01123161|65862361|FG001|Overall Study|Withdrawal by Subject|0|||
23615304|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
23615305|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
23615306|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
23615307|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
23615308|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
23615309|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Other|0|||
23615310|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Other|0|||
23615311|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Other|1|||
23615312|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
23615313|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
23615314|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
23615315|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
23815562|NCT00229723|66708261|FG004|Concomitant Phase|Objective disease progression|0|||
23615316|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
23615317|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
23615318|NCT02359552|65976432|FG000|Overall Study|Lost to Follow-up|3|||
23615319|NCT02359552|65976433|FG001|Overall Study|Lost to Follow-up|4|||
23615320|NCT04150250|65976434|FG000|Overall Study|Lost to Follow-up|0|||
23815563|NCT00229723|66708262|FG005|Concomitant Phase|Objective disease progression|0|||
23815564|NCT00229723|66708263|FG006|Concomitant Phase|Objective disease progression|0|||
23815565|NCT00229723|66708257|FG000|Concomitant Phase|Clinical progression|0|||
23815566|NCT00229723|66708258|FG001|Concomitant Phase|Clinical progression|0|||
23815567|NCT00229723|66708259|FG002|Concomitant Phase|Clinical progression|0|||
23815568|NCT00229723|66708260|FG003|Concomitant Phase|Clinical progression|0|||
23815569|NCT00229723|66708261|FG004|Concomitant Phase|Clinical progression|0|||
23815570|NCT00229723|66708262|FG005|Concomitant Phase|Clinical progression|0|||
23815571|NCT00229723|66708263|FG006|Concomitant Phase|Clinical progression|1|||
23815572|NCT00229723|66708257|FG000|Concomitant Phase|Lost to Follow-up|0|||
23815573|NCT00229723|66708258|FG001|Concomitant Phase|Lost to Follow-up|0|||
23815574|NCT00229723|66708259|FG002|Concomitant Phase|Lost to Follow-up|0|||
23815575|NCT00229723|66708260|FG003|Concomitant Phase|Lost to Follow-up|0|||
23815576|NCT00229723|66708261|FG004|Concomitant Phase|Lost to Follow-up|1|||
23815577|NCT00229723|66708262|FG005|Concomitant Phase|Lost to Follow-up|0|||
23815578|NCT00229723|66708263|FG006|Concomitant Phase|Lost to Follow-up|0|||
23815579|NCT00229723|66708257|FG000|Concomitant Phase|Informed consent withdrawn|3|||
23815580|NCT00229723|66708258|FG001|Concomitant Phase|Informed consent withdrawn|2|||
23815581|NCT00229723|66708259|FG002|Concomitant Phase|Informed consent withdrawn|0|||
23815582|NCT00229723|66708260|FG003|Concomitant Phase|Informed consent withdrawn|2|||
23815583|NCT00229723|66708261|FG004|Concomitant Phase|Informed consent withdrawn|0|||
23815584|NCT00229723|66708262|FG005|Concomitant Phase|Informed consent withdrawn|0|||
23815585|NCT00229723|66708263|FG006|Concomitant Phase|Informed consent withdrawn|0|||
23815586|NCT00229723|66708257|FG000|Concomitant Phase|Severe non-compliance|0|||
23815587|NCT00229723|66708258|FG001|Concomitant Phase|Severe non-compliance|1|||
23815588|NCT00229723|66708259|FG002|Concomitant Phase|Severe non-compliance|0|||
23815589|NCT00229723|66708260|FG003|Concomitant Phase|Severe non-compliance|0|||
23815590|NCT00229723|66708261|FG004|Concomitant Phase|Severe non-compliance|1|||
23815591|NCT00229723|66708262|FG005|Concomitant Phase|Severe non-compliance|0|||
23815592|NCT00229723|66708263|FG006|Concomitant Phase|Severe non-compliance|0|||
23815593|NCT00229723|66708257|FG000|Concomitant Phase|Other|3|||
23815594|NCT00229723|66708258|FG001|Concomitant Phase|Other|0|||
23815595|NCT00229723|66708259|FG002|Concomitant Phase|Other|1|||
23815596|NCT00229723|66708260|FG003|Concomitant Phase|Other|1|||
23815597|NCT00229723|66708261|FG004|Concomitant Phase|Other|0|||
23815598|NCT00229723|66708262|FG005|Concomitant Phase|Other|2|||
23815599|NCT00229723|66708263|FG006|Concomitant Phase|Other|0|||
23815600|NCT00229723|66708257|FG000|Maintenance Phase|Adverse Event|7|||
23815601|NCT00229723|66708258|FG001|Maintenance Phase|Adverse Event|2|||
23582192|NCT02929108|65862367|FG000|Overall Study|Hospice patient death|100|||
23582193|NCT02929108|65862368|FG001|Overall Study|Hospice patient death|64|||
23582194|NCT02929108|65862369|FG002|Overall Study|Hospice patient death|28|||
23582195|NCT02929108|65862370|FG003|Overall Study|Hospice patient death|46|||
23582196|NCT02929108|65862371|FG004|Overall Study|Hospice patient death|55|||
23722599|NCT02057068|66362902|FG001|Overall Study|Withdrawal by Subject|2|||
23722600|NCT02057068|66362901|FG000|Overall Study|Caregiver (CG) Health|0|||
23722601|NCT02057068|66362902|FG001|Overall Study|Caregiver (CG) Health|2|||
23722602|NCT02057068|66362901|FG000|Overall Study|Carepartner (CP) Health|4|||
23722603|NCT02057068|66362902|FG001|Overall Study|Carepartner (CP) Health|2|||
23722604|NCT02057068|66362901|FG000|Overall Study|Lost to Follow-up|2|||
23722605|NCT02057068|66362902|FG001|Overall Study|Lost to Follow-up|2|||
23722606|NCT01194869|66362903|FG000|Overall Study|Disease Progression|2|||
23722607|NCT01194869|66362903|FG000|Overall Study|Toxicity|2|||
23722608|NCT01810380|66362904|FG000|Overall Study|Randomised not treated|2|||
23722609|NCT01810380|66362905|FG001|Overall Study|Randomised not treated|1|||
23722610|NCT01810380|66362906|FG002|Overall Study|Randomised not treated|1|||
23722611|NCT01810380|66362904|FG000|Overall Study|Adverse Event|11|||
23722612|NCT01810380|66362905|FG001|Overall Study|Adverse Event|14|||
23722613|NCT01810380|66362906|FG002|Overall Study|Adverse Event|4|||
23722614|NCT01810380|66362904|FG000|Overall Study|Lack of Efficacy|24|||
23722615|NCT01810380|66362905|FG001|Overall Study|Lack of Efficacy|10|||
23722616|NCT01810380|66362906|FG002|Overall Study|Lack of Efficacy|11|||
23722617|NCT01810380|66362904|FG000|Overall Study|Protocol Violation|1|||
23722618|NCT01810380|66362905|FG001|Overall Study|Protocol Violation|0|||
23722619|NCT01810380|66362906|FG002|Overall Study|Protocol Violation|1|||
23722620|NCT01810380|66362904|FG000|Overall Study|Withdrawal by Subject|6|||
23722621|NCT01810380|66362905|FG001|Overall Study|Withdrawal by Subject|0|||
23722622|NCT01810380|66362906|FG002|Overall Study|Withdrawal by Subject|6|||
23722623|NCT01810380|66362904|FG000|Overall Study|Administrative or other reasons|11|||
23722624|NCT01810380|66362905|FG001|Overall Study|Administrative or other reasons|13|||
23722625|NCT01810380|66362906|FG002|Overall Study|Administrative or other reasons|9|||
23722626|NCT01655069|66362907|FG000|Overall Study|Physician Decision|0|||
23722627|NCT01655069|66362908|FG001|Overall Study|Physician Decision|0|||
23722628|NCT01655069|66362909|FG002|Overall Study|Physician Decision|0|||
23722629|NCT01655069|66362910|FG003|Overall Study|Physician Decision|1|||
23722630|NCT01655069|66362907|FG000|Overall Study|Adverse Event|6|||
23722631|NCT01655069|66362908|FG001|Overall Study|Adverse Event|7|||
23722632|NCT01655069|66362909|FG002|Overall Study|Adverse Event|2|||
23722633|NCT01655069|66362910|FG003|Overall Study|Adverse Event|3|||
23722634|NCT01655069|66362907|FG000|Overall Study|Lack of Efficacy|0|||
23722635|NCT01655069|66362908|FG001|Overall Study|Lack of Efficacy|1|||
23722636|NCT01655069|66362909|FG002|Overall Study|Lack of Efficacy|0|||
23722637|NCT01655069|66362910|FG003|Overall Study|Lack of Efficacy|0|||
23722638|NCT01655069|66362907|FG000|Overall Study|No Treatment Needed|0|||
23722639|NCT01655069|66362908|FG001|Overall Study|No Treatment Needed|1|||
23722640|NCT01655069|66362909|FG002|Overall Study|No Treatment Needed|0|||
23722641|NCT01655069|66362910|FG003|Overall Study|No Treatment Needed|0|||
23722642|NCT01655069|66362907|FG000|Overall Study|Withdrawal by Subject|2|||
23722643|NCT01655069|66362908|FG001|Overall Study|Withdrawal by Subject|3|||
23722644|NCT01655069|66362909|FG002|Overall Study|Withdrawal by Subject|0|||
23722645|NCT01655069|66362910|FG003|Overall Study|Withdrawal by Subject|0|||
23722646|NCT04038385|66362911|FG000|Overall Study|Completed baseline assessment only|7|||
23722647|NCT04038385|66362912|FG001|Overall Study|Completed baseline assessment only|4|||
23722648|NCT04038385|66362911|FG000|Overall Study|Moved out of area|4|||
23722649|NCT04038385|66362912|FG001|Overall Study|Moved out of area|2|||
23722650|NCT04038385|66362911|FG000|Overall Study|Discontinued study involvement|6|||
23722651|NCT04038385|66362912|FG001|Overall Study|Discontinued study involvement|1|||
23722652|NCT01711541|66362931|FG000|Overall Study|Cancel prior to treatment|0|||
23722653|NCT01711541|66362932|FG001|Overall Study|Cancel prior to treatment|0|||
23722654|NCT01711541|66362933|FG002|Overall Study|Cancel prior to treatment|0|||
23722655|NCT01711541|66362934|FG003|Overall Study|Cancel prior to treatment|1|||
23722656|NCT01711541|66362935|FG004|Overall Study|Cancel prior to treatment|0|||
23722657|NCT01711541|66362931|FG000|Overall Study|Ineligible|0|||
23722658|NCT01711541|66362932|FG001|Overall Study|Ineligible|1|||
23722659|NCT01711541|66362933|FG002|Overall Study|Ineligible|0|||
23722660|NCT01711541|66362934|FG003|Overall Study|Ineligible|0|||
23722661|NCT01711541|66362935|FG004|Overall Study|Ineligible|0|||
23615321|NCT04150250|65976435|FG001|Overall Study|Lost to Follow-up|2|||
23722662|NCT00562640|66362936|FG000|Overall Study|Death|0|||
23722663|NCT00562640|66362937|FG001|Overall Study|Death|1|||
23722664|NCT00562640|66362938|FG002|Overall Study|Death|1|||
23722665|NCT00562640|66362939|FG003|Overall Study|Death|0|||
23722666|NCT01335698|66362941|FG000|Treatment Stage 1|Lack of Efficacy|3|||
23722667|NCT01335698|66362942|FG001|Treatment Stage 1|Lack of Efficacy|1|||
23722668|NCT01335698|66362943|FG002|Treatment Stage 1|Lack of Efficacy|3|||
23615322|NCT00981578|65976436|FG000|Overall Study|Death|1|||
23722669|NCT01335698|66362944|FG003|Treatment Stage 1|Lack of Efficacy|3|||
23722670|NCT01335698|66362945|FG004|Treatment Stage 1|Lack of Efficacy|1|||
23722671|NCT01335698|66362941|FG000|Treatment Stage 1|Adverse Event|1|||
23722672|NCT01335698|66362942|FG001|Treatment Stage 1|Adverse Event|2|||
23722673|NCT01335698|66362943|FG002|Treatment Stage 1|Adverse Event|2|||
23722674|NCT01335698|66362944|FG003|Treatment Stage 1|Adverse Event|1|||
23722675|NCT01335698|66362945|FG004|Treatment Stage 1|Adverse Event|1|||
23815602|NCT00229723|66708259|FG002|Maintenance Phase|Adverse Event|1|||
23815603|NCT00229723|66708260|FG003|Maintenance Phase|Adverse Event|4|||
23815604|NCT00229723|66708261|FG004|Maintenance Phase|Adverse Event|7|||
23815605|NCT00229723|66708262|FG005|Maintenance Phase|Adverse Event|5|||
23815606|NCT00229723|66708263|FG006|Maintenance Phase|Adverse Event|2|||
23815607|NCT00229723|66708257|FG000|Maintenance Phase|Objective disease progression|5|||
23815608|NCT00229723|66708258|FG001|Maintenance Phase|Objective disease progression|5|||
23815609|NCT00229723|66708259|FG002|Maintenance Phase|Objective disease progression|3|||
23815610|NCT00229723|66708260|FG003|Maintenance Phase|Objective disease progression|6|||
23815611|NCT00229723|66708261|FG004|Maintenance Phase|Objective disease progression|2|||
23815612|NCT00229723|66708262|FG005|Maintenance Phase|Objective disease progression|9|||
23815613|NCT00229723|66708263|FG006|Maintenance Phase|Objective disease progression|5|||
23815614|NCT00229723|66708257|FG000|Maintenance Phase|Clinical progression|4|||
23815615|NCT00229723|66708258|FG001|Maintenance Phase|Clinical progression|1|||
23815616|NCT00229723|66708259|FG002|Maintenance Phase|Clinical progression|2|||
23722676|NCT01335698|66362941|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
23722677|NCT01335698|66362942|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
23722678|NCT01335698|66362943|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
23722679|NCT01335698|66362944|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
23722680|NCT01335698|66362945|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
23722681|NCT01335698|66362941|FG000|Treatment Stage 1|Lost to Follow-up|1|||
23722682|NCT01335698|66362942|FG001|Treatment Stage 1|Lost to Follow-up|1|||
23722683|NCT01335698|66362943|FG002|Treatment Stage 1|Lost to Follow-up|0|||
23722684|NCT01335698|66362944|FG003|Treatment Stage 1|Lost to Follow-up|0|||
23722685|NCT01335698|66362945|FG004|Treatment Stage 1|Lost to Follow-up|0|||
23722686|NCT01335698|66362941|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
23722687|NCT01335698|66362942|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
23722688|NCT01335698|66362943|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
23722689|NCT01335698|66362944|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
23722690|NCT01335698|66362945|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
23722691|NCT01335698|66362941|FG000|Treatment Stage 1|No longer meets study criteria|1|||
23722692|NCT01335698|66362942|FG001|Treatment Stage 1|No longer meets study criteria|1|||
23722693|NCT01335698|66362943|FG002|Treatment Stage 1|No longer meets study criteria|0|||
23722694|NCT01335698|66362944|FG003|Treatment Stage 1|No longer meets study criteria|1|||
23722695|NCT01335698|66362945|FG004|Treatment Stage 1|No longer meets study criteria|0|||
23722696|NCT01335698|66362941|FG000|Treatment Stage 1|Other|1|||
23722697|NCT01335698|66362942|FG001|Treatment Stage 1|Other|0|||
23722698|NCT01335698|66362943|FG002|Treatment Stage 1|Other|0|||
23722699|NCT01335698|66362944|FG003|Treatment Stage 1|Other|1|||
23722700|NCT01335698|66362945|FG004|Treatment Stage 1|Other|0|||
23722701|NCT01335698|66362941|FG000|Treatment Stage 2|Lack of Efficacy|2|||
23722702|NCT01335698|66362942|FG001|Treatment Stage 2|Lack of Efficacy|1|||
23722703|NCT01335698|66362943|FG002|Treatment Stage 2|Lack of Efficacy|3|||
23722704|NCT01335698|66362944|FG003|Treatment Stage 2|Lack of Efficacy|1|||
23722705|NCT01335698|66362945|FG004|Treatment Stage 2|Lack of Efficacy|0|||
23722706|NCT01335698|66362941|FG000|Treatment Stage 2|Adverse Event|2|||
23722707|NCT01335698|66362942|FG001|Treatment Stage 2|Adverse Event|0|||
23722708|NCT01335698|66362943|FG002|Treatment Stage 2|Adverse Event|0|||
23722709|NCT01335698|66362944|FG003|Treatment Stage 2|Adverse Event|3|||
23722710|NCT01335698|66362945|FG004|Treatment Stage 2|Adverse Event|0|||
23722711|NCT01335698|66362941|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
23722712|NCT01335698|66362942|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
23722713|NCT01335698|66362943|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
23722714|NCT01335698|66362944|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
23722715|NCT01335698|66362945|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
23722716|NCT01335698|66362941|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
23722717|NCT01335698|66362942|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
23722718|NCT01335698|66362943|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
23722719|NCT01335698|66362944|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
23722720|NCT01335698|66362945|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
23722721|NCT01335698|66362941|FG000|Treatment Stage 2|Lost to Follow-up|1|||
23722722|NCT01335698|66362942|FG001|Treatment Stage 2|Lost to Follow-up|0|||
23722723|NCT01335698|66362943|FG002|Treatment Stage 2|Lost to Follow-up|0|||
23722724|NCT01335698|66362944|FG003|Treatment Stage 2|Lost to Follow-up|0|||
23722725|NCT01335698|66362945|FG004|Treatment Stage 2|Lost to Follow-up|0|||
23722726|NCT01335698|66362941|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
23722727|NCT01335698|66362942|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
23722728|NCT01335698|66362943|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
23722729|NCT01335698|66362944|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
23722730|NCT01335698|66362945|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
23722731|NCT01335698|66362941|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
23722732|NCT01335698|66362942|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
23722733|NCT01335698|66362943|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
23422752|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|sore throat|0|||
23422753|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
23422754|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
23422755|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
23422756|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
23422757|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
23422758|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
23422759|NCT02460783|65292460|FG000|Overall Study|Withdrawal by Subject|1|||
23422760|NCT02460783|65292461|FG001|Overall Study|Withdrawal by Subject|3|||
23422761|NCT02460783|65292460|FG000|Overall Study|Lost to Follow-up|1|||
23422762|NCT02460783|65292461|FG001|Overall Study|Lost to Follow-up|1|||
23422763|NCT03263923|65292462|FG000|Overall Study|Withdrawal by Subject|10|||
23422764|NCT03263923|65292463|FG001|Overall Study|Withdrawal by Subject|8|||
23422765|NCT03263923|65292462|FG000|Overall Study|Lost to Follow-up|15|||
23422766|NCT03263923|65292463|FG001|Overall Study|Lost to Follow-up|13|||
23422767|NCT03351114|65292468|FG000|Overall Study|Withdrawal by Subject|1|||
23422768|NCT01187446|65292469|FG000|Overall Study|Patient started non-protocol therapy|0|||
23722734|NCT01335698|66362944|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
23722735|NCT01335698|66362945|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
23722736|NCT01335698|66362941|FG000|Treatment Stage 2|Switched to another formulation|1|||
23722737|NCT01335698|66362942|FG001|Treatment Stage 2|Switched to another formulation|1|||
23422769|NCT01187446|65292470|FG001|Overall Study|Patient started non-protocol therapy|1|||
23422770|NCT00445848|65292474|FG000|Overall Study|Adverse Event|14|||
23422771|NCT00445848|65292474|FG000|Overall Study|Withdrawal by Subject|4|||
23422772|NCT00445848|65292474|FG000|Overall Study|Progression|62|||
23422773|NCT00445848|65292474|FG000|Overall Study|Other-Not protocol specified|5|||
23422774|NCT02692040|65292475|FG000|Overall Study|Protocol Violation|0|||
23422775|NCT02692040|65292476|FG001|Overall Study|Protocol Violation|0|||
23422776|NCT02692040|65292477|FG002|Overall Study|Protocol Violation|0|||
23422777|NCT02692040|65292478|FG003|Overall Study|Protocol Violation|0|||
23422778|NCT02692040|65292479|FG004|Overall Study|Protocol Violation|0|||
23422779|NCT02692040|65292480|FG005|Overall Study|Protocol Violation|0|||
23422780|NCT02692040|65292481|FG006|Overall Study|Protocol Violation|0|||
23422781|NCT02692040|65292482|FG007|Overall Study|Protocol Violation|0|||
23422782|NCT02692040|65292483|FG008|Overall Study|Protocol Violation|0|||
23422783|NCT02692040|65292484|FG009|Overall Study|Protocol Violation|0|||
23422784|NCT02692040|65292485|FG010|Overall Study|Protocol Violation|0|||
23422785|NCT02692040|65292486|FG011|Overall Study|Protocol Violation|0|||
23422786|NCT02692040|65292487|FG012|Overall Study|Protocol Violation|1|||
23422787|NCT02692040|65292488|FG013|Overall Study|Protocol Violation|0|||
23422788|NCT02692040|65292489|FG014|Overall Study|Protocol Violation|0|||
23422789|NCT02692040|65292490|FG015|Overall Study|Protocol Violation|0|||
23722738|NCT01335698|66362943|FG002|Treatment Stage 2|Switched to another formulation|0|||
23422790|NCT02692040|65292491|FG016|Overall Study|Protocol Violation|0|||
23422791|NCT02692040|65292475|FG000|Overall Study|Adverse Event|0|||
23422792|NCT02692040|65292476|FG001|Overall Study|Adverse Event|0|||
23422793|NCT02692040|65292477|FG002|Overall Study|Adverse Event|0|||
23422794|NCT02692040|65292478|FG003|Overall Study|Adverse Event|0|||
23422795|NCT02692040|65292479|FG004|Overall Study|Adverse Event|0|||
23422796|NCT02692040|65292480|FG005|Overall Study|Adverse Event|0|||
23422797|NCT02692040|65292481|FG006|Overall Study|Adverse Event|0|||
23422798|NCT02692040|65292482|FG007|Overall Study|Adverse Event|0|||
23422799|NCT02692040|65292483|FG008|Overall Study|Adverse Event|0|||
23422800|NCT02692040|65292484|FG009|Overall Study|Adverse Event|0|||
23422801|NCT02692040|65292485|FG010|Overall Study|Adverse Event|0|||
23422802|NCT02692040|65292486|FG011|Overall Study|Adverse Event|0|||
23422803|NCT02692040|65292487|FG012|Overall Study|Adverse Event|0|||
23422804|NCT02692040|65292488|FG013|Overall Study|Adverse Event|3|||
23422805|NCT02692040|65292489|FG014|Overall Study|Adverse Event|1|||
23422806|NCT02692040|65292490|FG015|Overall Study|Adverse Event|1|||
23422807|NCT02692040|65292491|FG016|Overall Study|Adverse Event|0|||
23422808|NCT03372460|65292492|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
23422809|NCT03372460|65292493|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
23422810|NCT02226562|65292498|FG000|Overall Study|Lost to Follow-up|0|||
23422811|NCT02226562|65292499|FG001|Overall Study|Lost to Follow-up|1|||
23422812|NCT03773133|65292502|FG000|Overall Study|Screen Failure|8|||
23422813|NCT02264665|65292503|FG000|Overall Study|Other|0|||
23422814|NCT02264665|65292504|FG001|Overall Study|Other|0|||
23722739|NCT01335698|66362944|FG003|Treatment Stage 2|Switched to another formulation|0|||
23422815|NCT02264665|65292505|FG002|Overall Study|Other|3|||
23422816|NCT02264665|65292506|FG003|Overall Study|Other|0|||
23422817|NCT02264665|65292507|FG004|Overall Study|Other|0|||
23422818|NCT02264665|65292508|FG005|Overall Study|Other|0|||
23422819|NCT02264665|65292509|FG006|Overall Study|Other|0|||
23422820|NCT02264665|65292503|FG000|Overall Study|Death|9|||
23422821|NCT02264665|65292504|FG001|Overall Study|Death|8|||
23422822|NCT02264665|65292505|FG002|Overall Study|Death|13|||
23422823|NCT02264665|65292506|FG003|Overall Study|Death|5|||
23422824|NCT02264665|65292507|FG004|Overall Study|Death|0|||
23422825|NCT02264665|65292508|FG005|Overall Study|Death|0|||
23422826|NCT02264665|65292509|FG006|Overall Study|Death|1|||
23422827|NCT02264665|65292503|FG000|Overall Study|Lost to Follow-up|1|||
23422828|NCT02264665|65292504|FG001|Overall Study|Lost to Follow-up|0|||
23422829|NCT02264665|65292505|FG002|Overall Study|Lost to Follow-up|2|||
23422830|NCT02264665|65292506|FG003|Overall Study|Lost to Follow-up|1|||
23422831|NCT02264665|65292507|FG004|Overall Study|Lost to Follow-up|0|||
23422832|NCT02264665|65292508|FG005|Overall Study|Lost to Follow-up|0|||
23722740|NCT01335698|66362945|FG004|Treatment Stage 2|Switched to another formulation|0|||
23722741|NCT01449955|66362950|FG000|Overall Study|Withdrawal by Subject|1|||
23722742|NCT01449955|66362951|FG001|Overall Study|Withdrawal by Subject|2|||
23722743|NCT01981109|66362952|FG000|Overall Study|Death|36|||
23722744|NCT01981109|66362952|FG000|Overall Study|Withdrawal by Subject|40|||
23722745|NCT01981109|66362952|FG000|Overall Study|Lost to Follow-up|9|||
23722746|NCT01981109|66362952|FG000|Overall Study|No Discontinuation Documentation|37|||
23722747|NCT01981109|66362952|FG000|Overall Study|Study Termination|100|||
23422833|NCT02264665|65292509|FG006|Overall Study|Lost to Follow-up|0|||
23422834|NCT02264665|65292503|FG000|Overall Study|Participant decision|0|||
23422835|NCT02264665|65292504|FG001|Overall Study|Participant decision|0|||
23422836|NCT02264665|65292505|FG002|Overall Study|Participant decision|0|||
23422837|NCT02264665|65292506|FG003|Overall Study|Participant decision|1|||
23422838|NCT02264665|65292507|FG004|Overall Study|Participant decision|0|||
23422839|NCT02264665|65292508|FG005|Overall Study|Participant decision|0|||
23422840|NCT02264665|65292509|FG006|Overall Study|Participant decision|0|||
23422841|NCT02264665|65292503|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
23422842|NCT02264665|65292504|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422843|NCT02264665|65292505|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422844|NCT02264665|65292506|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422845|NCT02264665|65292507|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422846|NCT02264665|65292508|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422847|NCT02264665|65292509|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422848|NCT02264665|65292503|FG000|Overall Study|Data Missing|0|||
23422849|NCT02264665|65292504|FG001|Overall Study|Data Missing|0|||
23422850|NCT02264665|65292505|FG002|Overall Study|Data Missing|1|||
23422851|NCT02264665|65292506|FG003|Overall Study|Data Missing|0|||
23722748|NCT01981109|66362952|FG000|Overall Study|No data available|2|||
23722749|NCT04362813|66362953|FG000|Overall Study|Death|12|||
23722750|NCT04362813|66362954|FG001|Overall Study|Death|16|||
23722751|NCT04362813|66362953|FG000|Overall Study|Withdrawal by Subject|3|||
23722752|NCT04362813|66362954|FG001|Overall Study|Withdrawal by Subject|1|||
23722753|NCT04362813|66362953|FG000|Overall Study|Protocol Violation|0|||
23722754|NCT04362813|66362954|FG001|Overall Study|Protocol Violation|3|||
23722755|NCT04362813|66362953|FG000|Overall Study|Lost to Follow-up|1|||
23722756|NCT04362813|66362954|FG001|Overall Study|Lost to Follow-up|1|||
23722757|NCT04362813|66362953|FG000|Overall Study|Enrolled but did not receive treatment|2|||
23722758|NCT04362813|66362954|FG001|Overall Study|Enrolled but did not receive treatment|4|||
23722759|NCT01281189|66362957|FG000|Overall Study|Adverse Event|7|||
23722760|NCT01281189|66362958|FG001|Overall Study|Adverse Event|9|||
23722761|NCT01281189|66362957|FG000|Overall Study|Lost to Follow-up|6|||
23722762|NCT01281189|66362958|FG001|Overall Study|Lost to Follow-up|4|||
23722763|NCT01281189|66362957|FG000|Overall Study|Withdrawal by Subject|21|||
23722764|NCT01281189|66362958|FG001|Overall Study|Withdrawal by Subject|24|||
23722765|NCT01281189|66362957|FG000|Overall Study|Physician Decision|2|||
23722766|NCT01281189|66362958|FG001|Overall Study|Physician Decision|3|||
23722767|NCT01281189|66362957|FG000|Overall Study|Death|103|||
23722768|NCT01281189|66362958|FG001|Overall Study|Death|91|||
23722769|NCT01281189|66362957|FG000|Overall Study|Other|8|||
23722770|NCT01281189|66362958|FG001|Overall Study|Other|12|||
23815617|NCT00229723|66708260|FG003|Maintenance Phase|Clinical progression|2|||
23815618|NCT00229723|66708261|FG004|Maintenance Phase|Clinical progression|1|||
23815619|NCT00229723|66708262|FG005|Maintenance Phase|Clinical progression|1|||
23815620|NCT00229723|66708263|FG006|Maintenance Phase|Clinical progression|1|||
23422852|NCT02264665|65292507|FG004|Overall Study|Data Missing|0|||
23422853|NCT02264665|65292508|FG005|Overall Study|Data Missing|0|||
23422854|NCT02264665|65292509|FG006|Overall Study|Data Missing|0|||
23422855|NCT03272828|65292510|FG000|Overall Study|Lost to Follow-up|7|||
23422856|NCT03272828|65292511|FG001|Overall Study|Lost to Follow-up|7|||
23722771|NCT03862495|66362959|FG000|Overall Study|Lost to Follow-up|37|||
23722772|NCT03862495|66362960|FG001|Overall Study|Lost to Follow-up|35|||
23722773|NCT01376245|66362961|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
23722774|NCT01376245|66362962|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23722775|NCT01376245|66362963|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23422857|NCT03272828|65292510|FG000|Overall Study|Withdrawal by Subject|2|||
23722776|NCT01376245|66362964|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23722777|NCT01376245|66362965|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23422858|NCT03272828|65292511|FG001|Overall Study|Withdrawal by Subject|0|||
23422859|NCT03272828|65292510|FG000|Overall Study|Deceased|1|||
23422860|NCT03272828|65292511|FG001|Overall Study|Deceased|1|||
23422861|NCT03272828|65292510|FG000|Overall Study|Failed implant|1|||
23422862|NCT03272828|65292511|FG001|Overall Study|Failed implant|2|||
23422863|NCT00075946|65292512|FG000|Overall Study|Path ineligible: undetermined histology|0|||
23422864|NCT00075946|65292513|FG001|Overall Study|Path ineligible: undetermined histology|0|||
23422865|NCT00075946|65292514|FG002|Overall Study|Path ineligible: undetermined histology|0|||
23422866|NCT00075946|65292515|FG003|Overall Study|Path ineligible: undetermined histology|0|||
23422867|NCT00075946|65292516|FG004|Overall Study|Path ineligible: undetermined histology|6|||
23422868|NCT00075946|65292512|FG000|Overall Study|Did not achieve response after induction|0|||
23422869|NCT00075946|65292513|FG001|Overall Study|Did not achieve response after induction|0|||
23422870|NCT00075946|65292514|FG002|Overall Study|Did not achieve response after induction|0|||
23422871|NCT00075946|65292515|FG003|Overall Study|Did not achieve response after induction|0|||
23422872|NCT00075946|65292516|FG004|Overall Study|Did not achieve response after induction|182|||
23422873|NCT00075946|65292512|FG000|Overall Study|Incorrectly randomized (no response)|5|||
23422874|NCT00075946|65292513|FG001|Overall Study|Incorrectly randomized (no response)|5|||
23422875|NCT00075946|65292514|FG002|Overall Study|Incorrectly randomized (no response)|5|||
23422876|NCT00075946|65292515|FG003|Overall Study|Incorrectly randomized (no response)|1|||
23422877|NCT00075946|65292516|FG004|Overall Study|Incorrectly randomized (no response)|0|||
23422878|NCT00075946|65292512|FG000|Overall Study|Adverse Event|2|||
23422879|NCT00075946|65292513|FG001|Overall Study|Adverse Event|10|||
23422880|NCT00075946|65292514|FG002|Overall Study|Adverse Event|0|||
23422881|NCT00075946|65292515|FG003|Overall Study|Adverse Event|2|||
23422882|NCT00075946|65292516|FG004|Overall Study|Adverse Event|0|||
23422883|NCT00075946|65292512|FG000|Overall Study|Death|0|||
23422884|NCT00075946|65292513|FG001|Overall Study|Death|1|||
23422885|NCT00075946|65292514|FG002|Overall Study|Death|0|||
23422886|NCT00075946|65292515|FG003|Overall Study|Death|0|||
23422887|NCT00075946|65292516|FG004|Overall Study|Death|0|||
23422888|NCT00075946|65292512|FG000|Overall Study|Withdrawal by Subject|23|||
23422889|NCT00075946|65292513|FG001|Overall Study|Withdrawal by Subject|58|||
23422890|NCT00075946|65292514|FG002|Overall Study|Withdrawal by Subject|4|||
23422891|NCT00075946|65292515|FG003|Overall Study|Withdrawal by Subject|9|||
23422892|NCT00075946|65292516|FG004|Overall Study|Withdrawal by Subject|0|||
23422893|NCT00075946|65292512|FG000|Overall Study|Alternative therapy|16|||
23422894|NCT00075946|65292513|FG001|Overall Study|Alternative therapy|2|||
23422895|NCT00075946|65292514|FG002|Overall Study|Alternative therapy|5|||
23422896|NCT00075946|65292515|FG003|Overall Study|Alternative therapy|0|||
23422897|NCT00075946|65292516|FG004|Overall Study|Alternative therapy|0|||
23615323|NCT00981578|65976436|FG000|Overall Study|Withdrawal by Subject|2|||
23615324|NCT00443599|65976437|FG000|Overall Study|Physician Decision|2|||
23615325|NCT00443599|65976438|FG001|Overall Study|Physician Decision|1|||
23615326|NCT00443599|65976437|FG000|Overall Study|Death|1|||
23615327|NCT00443599|65976438|FG001|Overall Study|Death|1|||
23615328|NCT00443599|65976437|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
23615329|NCT00443599|65976438|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
23615330|NCT03087851|65976439|FG000|Overall Study|Withdraw on medical grounds|0|||
23615331|NCT03087851|65976440|FG001|Overall Study|Withdraw on medical grounds|1|||
23615332|NCT03087851|65976441|FG002|Overall Study|Withdraw on medical grounds|2|||
23615333|NCT02877680|65976442|FG000|Overall Study|Lost to Follow-up|1|||
23615334|NCT02877680|65976443|FG001|Overall Study|Lost to Follow-up|1|||
23615335|NCT01323309|65976444|FG000|Overall Study|Death|9|||
23615336|NCT01323309|65976445|FG001|Overall Study|Death|15|||
23615337|NCT01323309|65976446|FG002|Overall Study|Death|5|||
23615338|NCT01323309|65976444|FG000|Overall Study|Lost to Follow-up|11|||
23615339|NCT01323309|65976445|FG001|Overall Study|Lost to Follow-up|14|||
23615340|NCT01323309|65976446|FG002|Overall Study|Lost to Follow-up|24|||
23615341|NCT01323309|65976444|FG000|Overall Study|Withdrawal by Subject|14|||
23615342|NCT01323309|65976445|FG001|Overall Study|Withdrawal by Subject|14|||
23615343|NCT01323309|65976446|FG002|Overall Study|Withdrawal by Subject|18|||
23615344|NCT01323309|65976444|FG000|Overall Study|Disease progression|5|||
23615345|NCT01323309|65976445|FG001|Overall Study|Disease progression|11|||
23615346|NCT01323309|65976446|FG002|Overall Study|Disease progression|4|||
23422898|NCT00075946|65292512|FG000|Overall Study|Other complicating disease|7|||
23422899|NCT00075946|65292513|FG001|Overall Study|Other complicating disease|13|||
23422900|NCT00075946|65292514|FG002|Overall Study|Other complicating disease|1|||
23615347|NCT03749616|65976451|FG000|Overall Study|Lost to Follow-up|4|||
23615348|NCT03749616|65976452|FG001|Overall Study|Lost to Follow-up|7|||
23615349|NCT03749616|65976451|FG000|Overall Study|Screen Failure|1|||
23615350|NCT03749616|65976452|FG001|Overall Study|Screen Failure|1|||
23422901|NCT00075946|65292515|FG003|Overall Study|Other complicating disease|4|||
23615351|NCT03749616|65976451|FG000|Overall Study|Withdrawal by Subject|2|||
23615352|NCT03749616|65976452|FG001|Overall Study|Withdrawal by Subject|0|||
23615353|NCT04372186|65976453|FG000|Overall Study|Death|24|||
23615354|NCT04372186|65976454|FG001|Overall Study|Death|11|||
23615355|NCT04372186|65976453|FG000|Overall Study|Transferred to a different facility for care|0|||
23615356|NCT04372186|65976454|FG001|Overall Study|Transferred to a different facility for care|2|||
23615357|NCT03151551|65976455|FG000|Open-Label Treatment Period|Adverse Event|0|||
23615358|NCT03151551|65976456|FG001|Open-Label Treatment Period|Adverse Event|2|||
23615359|NCT03151551|65976455|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
23615360|NCT03151551|65976456|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23615361|NCT03151551|65976455|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
23615362|NCT03151551|65976456|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
23615363|NCT03151551|65976455|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
23615364|NCT03151551|65976456|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
23615365|NCT03151551|65976455|FG000|Open-Label Treatment Period|Physician Decision|3|||
23615366|NCT03151551|65976456|FG001|Open-Label Treatment Period|Physician Decision|0|||
23615367|NCT03151551|65976455|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
23422902|NCT00075946|65292516|FG004|Overall Study|Other complicating disease|0|||
23615368|NCT03151551|65976456|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
23615369|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
23615370|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
23615371|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23615372|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23615373|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
23615374|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
23615375|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
23615376|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
23615377|NCT00702520|65976458|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23615378|NCT00702520|65976459|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
23615379|NCT00702520|65976460|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23615380|NCT00702520|65976461|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23615381|NCT00702520|65976458|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
23615382|NCT00702520|65976459|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
23615383|NCT00702520|65976460|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
23615384|NCT00702520|65976461|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
23615385|NCT00702520|65976458|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
23615386|NCT00702520|65976459|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
23615387|NCT00702520|65976460|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
23535031|NCT04086472|65693384|FG000|Overall Study|Lost to Follow-up|1|||
23535032|NCT04086472|65693385|FG001|Overall Study|Lost to Follow-up|0|||
23535033|NCT04086472|65693386|FG002|Overall Study|Lost to Follow-up|0|||
23535034|NCT04086472|65693387|FG003|Overall Study|Lost to Follow-up|0|||
23535035|NCT04086472|65693388|FG004|Overall Study|Lost to Follow-up|1|||
23535036|NCT04086472|65693384|FG000|Overall Study|Physician Decision|0|||
23535037|NCT04086472|65693385|FG001|Overall Study|Physician Decision|1|||
23535038|NCT04086472|65693386|FG002|Overall Study|Physician Decision|1|||
23535039|NCT04086472|65693387|FG003|Overall Study|Physician Decision|0|||
23535040|NCT04086472|65693388|FG004|Overall Study|Physician Decision|0|||
23535041|NCT04086472|65693384|FG000|Overall Study|Withdrawal by Subject|1|||
23535042|NCT04086472|65693385|FG001|Overall Study|Withdrawal by Subject|1|||
23535043|NCT04086472|65693386|FG002|Overall Study|Withdrawal by Subject|1|||
23615388|NCT00702520|65976461|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
23615389|NCT04088136|65976464|FG000|Overall Study|Withdrawal by Subject|5|||
23615390|NCT04088136|65976465|FG001|Overall Study|Withdrawal by Subject|0|||
23615391|NCT04088136|65976464|FG000|Overall Study|Lack of Efficacy|0|||
23615392|NCT04088136|65976465|FG001|Overall Study|Lack of Efficacy|1|||
23615393|NCT03029234|65976466|FG000|Overall Study|Sponsor Decision|1|||
23615394|NCT03029234|65976466|FG000|Overall Study|Withdrawal by Subject|5|||
23615395|NCT03029234|65976466|FG000|Overall Study|Death|91|||
23615396|NCT03029234|65976466|FG000|Overall Study|Lost to Follow-up|2|||
23615397|NCT00734851|65976470|FG000|Overall Study|Withdrawal by Subject|2|||
23615398|NCT00734851|65976470|FG000|Overall Study|Lost to Follow-up|1|||
23615399|NCT00734851|65976470|FG000|Overall Study|Physician Decision|18|||
23615400|NCT03972137|65976475|FG000|Overall Study|Lost to Follow-up|2|||
23615401|NCT03972137|65976475|FG000|Overall Study|Withdrawal by Subject|4|||
23615402|NCT03575572|65976476|FG000|Overall Study|Withdrawal by Subject|2|||
23615403|NCT03575572|65976476|FG000|Overall Study|Physician Decision|2|||
23615404|NCT00228813|65976477|FG000|Overall Study|Death|4|||
23615405|NCT01527500|65976478|FG000|Part A|Administrative|11|||
23615406|NCT01527500|65976479|FG001|Part A|Administrative|7|||
23615407|NCT01527500|65976478|FG000|Part A|Adverse Event|4|||
23615408|NCT01527500|65976479|FG001|Part A|Adverse Event|2|||
23615409|NCT01527500|65976478|FG000|Part A|Death|4|||
23615410|NCT01527500|65976479|FG001|Part A|Death|1|||
23615411|NCT01527500|65976478|FG000|Part A|Lost to Follow-up|0|||
23615412|NCT01527500|65976479|FG001|Part A|Lost to Follow-up|1|||
23615413|NCT01527500|65976478|FG000|Part A|Protocol Deviation|9|||
23615414|NCT01527500|65976479|FG001|Part A|Protocol Deviation|2|||
23422903|NCT00075946|65292512|FG000|Overall Study|No response to retreatment|23|||
23615415|NCT01527500|65976478|FG000|Part A|Withdrawal by Subject|2|||
23615416|NCT01527500|65976479|FG001|Part A|Withdrawal by Subject|0|||
23615417|NCT01527500|65976478|FG000|Part B|Adverse Event|1|||
23535044|NCT04086472|65693387|FG003|Overall Study|Withdrawal by Subject|0|||
23615418|NCT01527500|65976479|FG001|Part B|Adverse Event|0|||
23615419|NCT01678898|65976480|FG000|PB-102-F01|Adverse Event|0|||
23615420|NCT01678898|65976481|FG001|PB-102-F01|Adverse Event|1|||
23615421|NCT01678898|65976482|FG002|PB-102-F01|Adverse Event|0|||
23615422|NCT01678898|65976480|FG000|PB-102-F01|Physician Decision|0|||
23615423|NCT01678898|65976481|FG001|PB-102-F01|Physician Decision|1|||
23615424|NCT01678898|65976482|FG002|PB-102-F01|Physician Decision|0|||
23615425|NCT00464737|65976485|FG000|Overall Study|Adverse Event|12|||
23615426|NCT00464737|65976486|FG001|Overall Study|Adverse Event|17|||
23615427|NCT00464737|65976487|FG002|Overall Study|Adverse Event|33|||
23615428|NCT00464737|65976485|FG000|Overall Study|Lack of Efficacy|7|||
23615429|NCT00464737|65976486|FG001|Overall Study|Lack of Efficacy|7|||
23615430|NCT00464737|65976487|FG002|Overall Study|Lack of Efficacy|4|||
23615431|NCT00464737|65976485|FG000|Overall Study|Withdrawal by Subject|5|||
23615432|NCT00464737|65976486|FG001|Overall Study|Withdrawal by Subject|3|||
23615433|NCT00464737|65976487|FG002|Overall Study|Withdrawal by Subject|5|||
23615434|NCT00464737|65976485|FG000|Overall Study|Protocol Violation|1|||
23615435|NCT00464737|65976486|FG001|Overall Study|Protocol Violation|1|||
23615436|NCT00464737|65976487|FG002|Overall Study|Protocol Violation|5|||
23615437|NCT00464737|65976485|FG000|Overall Study|Non-compliance|0|||
23615438|NCT00464737|65976486|FG001|Overall Study|Non-compliance|1|||
23615439|NCT00464737|65976487|FG002|Overall Study|Non-compliance|1|||
23615440|NCT00464737|65976485|FG000|Overall Study|Lost to Follow-up|5|||
23615441|NCT00464737|65976486|FG001|Overall Study|Lost to Follow-up|2|||
23615442|NCT00464737|65976487|FG002|Overall Study|Lost to Follow-up|5|||
23615443|NCT00464737|65976485|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
23615444|NCT00464737|65976486|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
23615445|NCT00464737|65976487|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
23615446|NCT00464737|65976485|FG000|Overall Study|Other: Subject left town; family illness|1|||
23615447|NCT00464737|65976486|FG001|Overall Study|Other: Subject left town; family illness|0|||
23422904|NCT00075946|65292513|FG001|Overall Study|No response to retreatment|0|||
23422905|NCT00075946|65292514|FG002|Overall Study|No response to retreatment|2|||
23422906|NCT00075946|65292515|FG003|Overall Study|No response to retreatment|0|||
23422907|NCT00075946|65292516|FG004|Overall Study|No response to retreatment|0|||
23535045|NCT04086472|65693388|FG004|Overall Study|Withdrawal by Subject|0|||
23535046|NCT04086472|65693384|FG000|Overall Study|Various reasons|2|||
23535047|NCT04086472|65693385|FG001|Overall Study|Various reasons|0|||
23615448|NCT00464737|65976487|FG002|Overall Study|Other: Subject left town; family illness|0|||
23722778|NCT01376245|66362961|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
23722779|NCT01376245|66362962|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23535048|NCT04086472|65693386|FG002|Overall Study|Various reasons|0|||
23535049|NCT04086472|65693387|FG003|Overall Study|Various reasons|3|||
23535050|NCT04086472|65693388|FG004|Overall Study|Various reasons|1|||
23535051|NCT00132769|65693389|FG000|Overall Study|Withdrawal by Subject|1|||
23535052|NCT00132769|65693390|FG001|Overall Study|Withdrawal by Subject|3|||
23535053|NCT00132769|65693389|FG000|Overall Study|Lack of Efficacy|7|||
23535054|NCT00132769|65693390|FG001|Overall Study|Lack of Efficacy|6|||
23535055|NCT00132769|65693389|FG000|Overall Study|Adverse Event|2|||
23535056|NCT00132769|65693390|FG001|Overall Study|Adverse Event|1|||
23535057|NCT00132769|65693389|FG000|Overall Study|Protocol Violation|1|||
23535058|NCT00132769|65693390|FG001|Overall Study|Protocol Violation|1|||
23535059|NCT01743092|65693391|FG000|Overall Study|Lost to Follow-up|14|||
23535060|NCT01743092|65693392|FG001|Overall Study|Lost to Follow-up|15|||
23535061|NCT01430130|65693393|FG000|Overall Study|Lost to Follow-up|1|||
23535062|NCT01430130|65693393|FG000|Overall Study|Infection on Control Side of Incision|1|||
23535063|NCT01575561|65693415|FG000|Overall Study|Adverse Event|9|||
23535064|NCT01575561|65693415|FG000|Overall Study|Lack of Efficacy|8|||
23535065|NCT01575561|65693415|FG000|Overall Study|Lost to Follow-up|6|||
23535066|NCT01575561|65693415|FG000|Overall Study|Protocol Violation|4|||
23535067|NCT01575561|65693415|FG000|Overall Study|Withdrawal by Subject|11|||
23535068|NCT01575561|65693415|FG000|Overall Study|administration|1|||
23535069|NCT00781326|65693416|FG000|Phase I|Adverse Event|1|||
23535070|NCT00781326|65693416|FG000|Phase I|Withdrawal by Subject|1|||
23535071|NCT00781326|65693416|FG000|Phase I|Physician Decision|2|||
23535072|NCT02383758|65693417|FG000|Overall Study|Withdrawal by Subject|0|||
23615449|NCT00464737|65976485|FG000|Overall Study|Other: Study demands too great|0|||
23615450|NCT00464737|65976486|FG001|Overall Study|Other: Study demands too great|1|||
23615451|NCT00464737|65976487|FG002|Overall Study|Other: Study demands too great|0|||
23615452|NCT00464737|65976485|FG000|Overall Study|Other: Personal family reasons|0|||
23615453|NCT00464737|65976486|FG001|Overall Study|Other: Personal family reasons|0|||
23615454|NCT00464737|65976487|FG002|Overall Study|Other: Personal family reasons|1|||
23615455|NCT00464737|65976485|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
23615456|NCT00464737|65976486|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
23615457|NCT00464737|65976487|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
23615458|NCT05153499|65976499|FG000|Overall Study|Withdrawal by Subject|1|||
23615459|NCT05153499|65976500|FG001|Overall Study|Withdrawal by Subject|0|||
23615460|NCT05153499|65976499|FG000|Overall Study|Clinical Hold|1|||
23615461|NCT05153499|65976500|FG001|Overall Study|Clinical Hold|0|||
23615462|NCT05153499|65976499|FG000|Overall Study|Study Termination|6|||
23615463|NCT05153499|65976500|FG001|Overall Study|Study Termination|5|||
23615464|NCT01374971|65976504|FG000|Overall Study|Withdrawal by Subject|1|||
23615465|NCT01502371|65979353|FG000|Overall Study|Withdrawal by Subject|1|||
23615466|NCT01502371|65979354|FG001|Overall Study|Withdrawal by Subject|2|||
23615467|NCT01502371|65979355|FG002|Overall Study|Withdrawal by Subject|1|||
23615468|NCT01502371|65979356|FG003|Overall Study|Withdrawal by Subject|1|||
23615469|NCT01502371|65979357|FG004|Overall Study|Withdrawal by Subject|1|||
23615470|NCT01502371|65979353|FG000|Overall Study|Adverse Event|2|||
23615471|NCT01502371|65979354|FG001|Overall Study|Adverse Event|1|||
23615472|NCT01502371|65979355|FG002|Overall Study|Adverse Event|0|||
23615473|NCT01502371|65979356|FG003|Overall Study|Adverse Event|4|||
23615474|NCT01502371|65979357|FG004|Overall Study|Adverse Event|3|||
23615475|NCT01502371|65979353|FG000|Overall Study|Treatment Failure|22|||
23615476|NCT01502371|65979354|FG001|Overall Study|Treatment Failure|20|||
23615477|NCT01502371|65979355|FG002|Overall Study|Treatment Failure|12|||
23615478|NCT01502371|65979356|FG003|Overall Study|Treatment Failure|19|||
23615479|NCT01502371|65979357|FG004|Overall Study|Treatment Failure|30|||
23615480|NCT01502371|65979353|FG000|Overall Study|Lack of Efficacy|3|||
23615481|NCT01502371|65979354|FG001|Overall Study|Lack of Efficacy|3|||
23615482|NCT01502371|65979355|FG002|Overall Study|Lack of Efficacy|2|||
23615483|NCT01502371|65979356|FG003|Overall Study|Lack of Efficacy|2|||
23615484|NCT01502371|65979357|FG004|Overall Study|Lack of Efficacy|4|||
23615485|NCT01502371|65979353|FG000|Overall Study|Physician Decision|3|||
23615486|NCT01502371|65979354|FG001|Overall Study|Physician Decision|0|||
23615487|NCT01502371|65979355|FG002|Overall Study|Physician Decision|0|||
23615488|NCT01502371|65979356|FG003|Overall Study|Physician Decision|0|||
23615489|NCT01502371|65979357|FG004|Overall Study|Physician Decision|1|||
23615490|NCT01502371|65979353|FG000|Overall Study|Noncompliance with Study Drug|0|||
23615491|NCT01502371|65979354|FG001|Overall Study|Noncompliance with Study Drug|0|||
23615492|NCT01502371|65979355|FG002|Overall Study|Noncompliance with Study Drug|1|||
23615493|NCT01502371|65979356|FG003|Overall Study|Noncompliance with Study Drug|2|||
23615494|NCT01502371|65979357|FG004|Overall Study|Noncompliance with Study Drug|1|||
23615495|NCT01502371|65979353|FG000|Overall Study|Technical Problems|1|||
23615496|NCT01502371|65979354|FG001|Overall Study|Technical Problems|0|||
23615497|NCT01502371|65979355|FG002|Overall Study|Technical Problems|2|||
23615498|NCT01502371|65979356|FG003|Overall Study|Technical Problems|4|||
23615499|NCT01502371|65979357|FG004|Overall Study|Technical Problems|1|||
23615500|NCT01502371|65979353|FG000|Overall Study|Protocol Violation|9|||
23615501|NCT01502371|65979354|FG001|Overall Study|Protocol Violation|5|||
23615502|NCT01502371|65979355|FG002|Overall Study|Protocol Violation|6|||
23615503|NCT01502371|65979356|FG003|Overall Study|Protocol Violation|5|||
23422908|NCT00075946|65292512|FG000|Overall Study|Time to progression less than 6 months|15|||
23615504|NCT01502371|65979357|FG004|Overall Study|Protocol Violation|10|||
23615505|NCT01502371|65979353|FG000|Overall Study|Excluded Medication|0|||
23615506|NCT01502371|65979354|FG001|Overall Study|Excluded Medication|1|||
23615507|NCT01502371|65979355|FG002|Overall Study|Excluded Medication|1|||
23615508|NCT01502371|65979356|FG003|Overall Study|Excluded Medication|0|||
23615509|NCT01502371|65979357|FG004|Overall Study|Excluded Medication|1|||
23615510|NCT00640042|65979358|FG000|Enrollment|Did not receive study drug|83|||
23615511|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Adverse Event|0|||
23615512|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Adverse Event|0|||
23615513|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Adverse Event|0|||
23615514|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Adverse Event|5|||
23615515|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Adverse Event|0|||
23615516|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Death|0|||
23615517|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Death|0|||
23615518|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Death|0|||
23615519|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Death|1|||
23615520|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Death|0|||
23615521|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Disease Progression|1|||
23615522|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Disease Progression|1|||
23615523|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Disease Progression|0|||
23615524|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Disease Progression|10|||
23615525|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Disease Progression|1|||
23615526|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Other|0|||
23615527|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Other|0|||
23615528|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Other|0|||
23615529|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Other|1|||
23615530|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Other|0|||
23615531|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Adverse Event|0|||
23615532|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Adverse Event|0|||
23615533|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Adverse Event|0|||
23615534|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Adverse Event|1|||
23615535|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Adverse Event|0|||
23615536|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Death|0|||
23615537|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Death|0|||
23615538|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Death|0|||
23615539|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Death|1|||
23615540|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Death|1|||
23615541|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Disease Progression|0|||
23615542|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Disease Progression|2|||
23615543|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Disease Progression|2|||
23615544|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Disease Progression|17|||
23615545|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Disease Progression|1|||
23615546|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615547|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615548|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615549|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
23615550|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615551|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Other|1|||
23615552|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Other|0|||
23722780|NCT01376245|66362963|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23722781|NCT01376245|66362964|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23722782|NCT01376245|66362965|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23615553|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Other|0|||
23615554|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Other|3|||
23615555|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Other|0|||
23615556|NCT01924806|65979364|FG000|Overall Study|Physician Decision|2|||
23615557|NCT01924806|65979365|FG001|Overall Study|Physician Decision|1|||
23615558|NCT01498445|65979372|FG000|Overall Study|Lack of Efficacy|0|||
23615559|NCT01498445|65979373|FG001|Overall Study|Lack of Efficacy|0|||
23615560|NCT01498445|65979374|FG002|Overall Study|Lack of Efficacy|1|||
23615561|NCT01498445|65979375|FG003|Overall Study|Lack of Efficacy|2|||
23615562|NCT01498445|65979376|FG004|Overall Study|Lack of Efficacy|0|||
23615563|NCT01498445|65979377|FG005|Overall Study|Lack of Efficacy|0|||
23615564|NCT01498445|65979372|FG000|Overall Study|Screen Failure|0|||
23615565|NCT01498445|65979373|FG001|Overall Study|Screen Failure|0|||
23615566|NCT01498445|65979374|FG002|Overall Study|Screen Failure|0|||
23615567|NCT01498445|65979375|FG003|Overall Study|Screen Failure|0|||
23815621|NCT00229723|66708257|FG000|Maintenance Phase|Lost to Follow-up|0|||
23535073|NCT02383758|65693418|FG001|Overall Study|Withdrawal by Subject|2|||
23535074|NCT02742103|65693419|FG000|Overall Study|Protocol Violation|1|||
23535075|NCT02742103|65693420|FG001|Overall Study|Protocol Violation|0|||
23535076|NCT02742103|65693419|FG000|Overall Study|Death|2|||
23535077|NCT02742103|65693420|FG001|Overall Study|Death|2|||
23535078|NCT02742103|65693419|FG000|Overall Study|Adverse Event|1|||
23535079|NCT02742103|65693420|FG001|Overall Study|Adverse Event|0|||
23535080|NCT02742103|65693419|FG000|Overall Study|Moved to another town|0|||
23535081|NCT02742103|65693420|FG001|Overall Study|Moved to another town|1|||
23815622|NCT00229723|66708258|FG001|Maintenance Phase|Lost to Follow-up|1|||
23815623|NCT00229723|66708259|FG002|Maintenance Phase|Lost to Follow-up|2|||
23815624|NCT00229723|66708260|FG003|Maintenance Phase|Lost to Follow-up|2|||
23815625|NCT00229723|66708261|FG004|Maintenance Phase|Lost to Follow-up|0|||
23815626|NCT00229723|66708262|FG005|Maintenance Phase|Lost to Follow-up|0|||
23815627|NCT00229723|66708263|FG006|Maintenance Phase|Lost to Follow-up|1|||
23535082|NCT02742103|65693419|FG000|Overall Study|Withdrawal by Subject|5|||
23535083|NCT02742103|65693420|FG001|Overall Study|Withdrawal by Subject|2|||
23535084|NCT00807092|65693421|FG000|Overall Study|Adverse Event|0|||
23535085|NCT00807092|65693422|FG001|Overall Study|Adverse Event|1|||
23535086|NCT00807092|65693421|FG000|Overall Study|Protocol Violation|0|||
23535087|NCT00807092|65693422|FG001|Overall Study|Protocol Violation|2|||
23535088|NCT00807092|65693421|FG000|Overall Study|Withdrawal by Subject|1|||
23535089|NCT00807092|65693422|FG001|Overall Study|Withdrawal by Subject|0|||
23535090|NCT00807092|65693421|FG000|Overall Study|CGMS data collection failed|0|||
23535091|NCT00807092|65693422|FG001|Overall Study|CGMS data collection failed|1|||
23535092|NCT04452344|65693423|FG000|Overall Study|Withdrawal by Subject|3|||
23535093|NCT04452344|65693424|FG001|Overall Study|Withdrawal by Subject|6|||
23535094|NCT04452344|65693423|FG000|Overall Study|Adverse Event|1|||
23535095|NCT04452344|65693424|FG001|Overall Study|Adverse Event|2|||
23535096|NCT04452344|65693423|FG000|Overall Study|Lost to Follow-up|2|||
23535097|NCT04452344|65693424|FG001|Overall Study|Lost to Follow-up|2|||
23535098|NCT04452344|65693423|FG000|Overall Study|No Post-Op Visit|6|||
23535099|NCT04452344|65693424|FG001|Overall Study|No Post-Op Visit|7|||
23535100|NCT00298038|65693425|FG000|Overall Study|Lost to Follow-up|0|||
23535101|NCT00298038|65693426|FG001|Overall Study|Lost to Follow-up|1|||
23535102|NCT00298038|65693425|FG000|Overall Study|Liver Transplant|0|||
23535103|NCT00298038|65693426|FG001|Overall Study|Liver Transplant|1|||
23535104|NCT00298038|65693425|FG000|Overall Study|Protocol Violation|1|||
23535105|NCT00298038|65693426|FG001|Overall Study|Protocol Violation|3|||
23535106|NCT00298038|65693425|FG000|Overall Study|Death|6|||
23535107|NCT00298038|65693426|FG001|Overall Study|Death|3|||
23535108|NCT00298038|65693425|FG000|Overall Study|Withdrawal by Subject|6|||
23535109|NCT00298038|65693426|FG001|Overall Study|Withdrawal by Subject|9|||
23535110|NCT00298038|65693425|FG000|Overall Study|Adverse Event|8|||
23535111|NCT00298038|65693426|FG001|Overall Study|Adverse Event|7|||
23535112|NCT00298038|65693425|FG000|Overall Study|Breakthrough overt HE episode|28|||
23535113|NCT00298038|65693426|FG001|Overall Study|Breakthrough overt HE episode|69|||
23535114|NCT00298038|65693425|FG000|Overall Study|Noncompliance|1|||
23535115|NCT00298038|65693426|FG001|Overall Study|Noncompliance|0|||
23535116|NCT00298038|65693425|FG000|Overall Study|Cocaine Abuse|1|||
23535117|NCT00298038|65693426|FG001|Overall Study|Cocaine Abuse|0|||
23535118|NCT00298038|65693425|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
23535119|NCT00298038|65693426|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
23535120|NCT02266381|65693431|FG000|Overall Study|Physician Decision|3|||
23535121|NCT02266381|65693432|FG001|Overall Study|Physician Decision|5|||
23535122|NCT02266381|65693433|FG002|Overall Study|Physician Decision|4|||
23535123|NCT03698773|65693434|FG000|Overall Study|Lost to Follow-up|2|||
23535124|NCT03698773|65693435|FG001|Overall Study|Lost to Follow-up|1|||
23815628|NCT00229723|66708257|FG000|Maintenance Phase|Informed consent withdrawn|1|||
23815629|NCT00229723|66708258|FG001|Maintenance Phase|Informed consent withdrawn|0|||
23815630|NCT00229723|66708259|FG002|Maintenance Phase|Informed consent withdrawn|0|||
23815631|NCT00229723|66708260|FG003|Maintenance Phase|Informed consent withdrawn|1|||
23815632|NCT00229723|66708261|FG004|Maintenance Phase|Informed consent withdrawn|1|||
23815633|NCT00229723|66708262|FG005|Maintenance Phase|Informed consent withdrawn|1|||
23815634|NCT00229723|66708263|FG006|Maintenance Phase|Informed consent withdrawn|0|||
23815635|NCT00229723|66708257|FG000|Maintenance Phase|Severe non-compliance|3|||
23535125|NCT01049919|65693441|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
23535126|NCT01049919|65693442|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
23535127|NCT01049919|65693441|FG000|Overall Study|Withdrawal by Subject|5|||
23535128|NCT01049919|65693442|FG001|Overall Study|Withdrawal by Subject|0|||
23535129|NCT01049919|65693441|FG000|Overall Study|Lost to Follow-up|6|||
23535130|NCT01049919|65693442|FG001|Overall Study|Lost to Follow-up|1|||
23535131|NCT01049919|65693441|FG000|Overall Study|Physician Decision|2|||
23535132|NCT01049919|65693442|FG001|Overall Study|Physician Decision|0|||
23615568|NCT01498445|65979376|FG004|Overall Study|Screen Failure|1|||
23535133|NCT01049919|65693441|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
23535134|NCT01049919|65693442|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
23535135|NCT01049919|65693441|FG000|Overall Study|Early study termination by sponsor.|2|||
23535136|NCT01049919|65693442|FG001|Overall Study|Early study termination by sponsor.|0|||
23535137|NCT01040871|65693443|FG000|Overall Study|Adverse Event|6|||
23535138|NCT01040871|65693444|FG001|Overall Study|Adverse Event|2|||
23535139|NCT01040871|65693443|FG000|Overall Study|Withdrawal by Subject|2|||
23535140|NCT01040871|65693444|FG001|Overall Study|Withdrawal by Subject|0|||
23535141|NCT01040871|65693443|FG000|Overall Study|Death|1|||
23535142|NCT01040871|65693444|FG001|Overall Study|Death|3|||
23535143|NCT01040871|65693443|FG000|Overall Study|Lack of Efficacy|1|||
23535144|NCT01040871|65693444|FG001|Overall Study|Lack of Efficacy|1|||
23535145|NCT01040871|65693443|FG000|Overall Study|drug supply issue|1|||
23535146|NCT01040871|65693444|FG001|Overall Study|drug supply issue|0|||
23535147|NCT01040871|65693443|FG000|Overall Study|Randomized and Not Treated|2|||
23535148|NCT01040871|65693444|FG001|Overall Study|Randomized and Not Treated|1|||
23535149|NCT01649856|65693445|FG000|Overall Study|Withdrawal by Subject|14|||
23535150|NCT01649856|65693446|FG001|Overall Study|Withdrawal by Subject|14|||
23535151|NCT01649856|65693445|FG000|Overall Study|Protocol Violation|4|||
23535152|NCT01649856|65693446|FG001|Overall Study|Protocol Violation|4|||
23535153|NCT01649856|65693445|FG000|Overall Study|Treatment Failure|1|||
23535154|NCT01649856|65693446|FG001|Overall Study|Treatment Failure|1|||
23535155|NCT01649856|65693445|FG000|Overall Study|Death|69|||
23535156|NCT01649856|65693446|FG001|Overall Study|Death|34|||
23535157|NCT01649856|65693445|FG000|Overall Study|Stable or Progressed Disease|5|||
23535158|NCT01649856|65693446|FG001|Overall Study|Stable or Progressed Disease|3|||
23535159|NCT01649856|65693445|FG000|Overall Study|Lost to Follow-up|20|||
23535160|NCT01649856|65693446|FG001|Overall Study|Lost to Follow-up|16|||
23535161|NCT01649856|65693445|FG000|Overall Study|Lack of Compliance|6|||
23535162|NCT01649856|65693446|FG001|Overall Study|Lack of Compliance|1|||
23535163|NCT01649856|65693445|FG000|Overall Study|Other|20|||
23535164|NCT01649856|65693446|FG001|Overall Study|Other|5|||
23535165|NCT00306592|65693447|FG000|Overall Study|Adverse Event|8|||
23535166|NCT00306592|65693448|FG001|Overall Study|Adverse Event|15|||
23535167|NCT00306592|65693447|FG000|Overall Study|Lost to Follow-up|1|||
23535168|NCT00306592|65693448|FG001|Overall Study|Lost to Follow-up|0|||
23535169|NCT00306592|65693447|FG000|Overall Study|Noncompliance|0|||
23535170|NCT00306592|65693448|FG001|Overall Study|Noncompliance|2|||
23535171|NCT00306592|65693447|FG000|Overall Study|Persistent Antibodies|6|||
23535172|NCT00306592|65693448|FG001|Overall Study|Persistent Antibodies|3|||
23535173|NCT00306592|65693447|FG000|Overall Study|Voluntary|10|||
23535174|NCT00306592|65693448|FG001|Overall Study|Voluntary|6|||
23535175|NCT00306592|65693447|FG000|Overall Study|Other|5|||
23535176|NCT00306592|65693448|FG001|Overall Study|Other|10|||
23535177|NCT00306592|65693447|FG000|Overall Study|Other|1|||
23535178|NCT00306592|65693448|FG001|Overall Study|Other|2|||
23535179|NCT00306592|65693447|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
23535180|NCT00306592|65693448|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
23535181|NCT03509948|65693449|FG000|Overall Study|Protocol Violation|0|||
23535182|NCT03509948|65693450|FG001|Overall Study|Protocol Violation|1|||
23535183|NCT00912405|65693451|FG000|Overall Study|Lost to Follow-up|5|||
23535184|NCT00530023|65693453|FG000|Overall Study|Withdrawal by Subject|0|||
23535185|NCT00530023|65693454|FG001|Overall Study|Withdrawal by Subject|1|||
23535186|NCT00774787|65693455|FG000|Overall Study|Lost to Follow-up|1|||
23535187|NCT00965848|65693459|FG000|Overall Study|Protocol Violation|3|||
23535188|NCT00965848|65693460|FG001|Overall Study|Protocol Violation|0|||
23535189|NCT00965848|65693461|FG002|Overall Study|Protocol Violation|1|||
23535190|NCT00965848|65693459|FG000|Overall Study|Death|11|||
23535191|NCT00965848|65693460|FG001|Overall Study|Death|1|||
23535192|NCT00965848|65693461|FG002|Overall Study|Death|5|||
23535193|NCT00965848|65693459|FG000|Overall Study|Lost to Follow-up|0|||
23535194|NCT00965848|65693460|FG001|Overall Study|Lost to Follow-up|0|||
23535195|NCT00965848|65693461|FG002|Overall Study|Lost to Follow-up|1|||
23535196|NCT00965848|65693459|FG000|Overall Study|Withdrawal by Subject|1|||
23535197|NCT00965848|65693460|FG001|Overall Study|Withdrawal by Subject|0|||
23535198|NCT00965848|65693461|FG002|Overall Study|Withdrawal by Subject|0|||
23535199|NCT00965848|65693459|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
23535200|NCT00965848|65693460|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
23535201|NCT00965848|65693461|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
23535202|NCT00965848|65693459|FG000|Overall Study|Not Clinically Evaluable|7|||
23535203|NCT00965848|65693460|FG001|Overall Study|Not Clinically Evaluable|1|||
23535204|NCT00965848|65693461|FG002|Overall Study|Not Clinically Evaluable|1|||
23535205|NCT00965848|65693459|FG000|Overall Study|Other|5|||
23535206|NCT00965848|65693460|FG001|Overall Study|Other|0|||
23535207|NCT00965848|65693461|FG002|Overall Study|Other|1|||
23535208|NCT01038778|65693462|FG000|Overall Study|Withdrawal by Subject|0|||
23535209|NCT01038778|65693463|FG001|Overall Study|Withdrawal by Subject|2|||
23535210|NCT01038778|65693464|FG002|Overall Study|Withdrawal by Subject|3|||
23815636|NCT00229723|66708258|FG001|Maintenance Phase|Severe non-compliance|1|||
23815637|NCT00229723|66708259|FG002|Maintenance Phase|Severe non-compliance|0|||
23815638|NCT00229723|66708260|FG003|Maintenance Phase|Severe non-compliance|0|||
23815639|NCT00229723|66708261|FG004|Maintenance Phase|Severe non-compliance|1|||
23815640|NCT00229723|66708262|FG005|Maintenance Phase|Severe non-compliance|0|||
23815641|NCT00229723|66708263|FG006|Maintenance Phase|Severe non-compliance|0|||
23815642|NCT00229723|66708257|FG000|Maintenance Phase|Other|5|||
23815643|NCT00229723|66708258|FG001|Maintenance Phase|Other|4|||
23815644|NCT00229723|66708259|FG002|Maintenance Phase|Other|1|||
23815645|NCT00229723|66708260|FG003|Maintenance Phase|Other|2|||
23815646|NCT00229723|66708261|FG004|Maintenance Phase|Other|3|||
23815647|NCT00229723|66708262|FG005|Maintenance Phase|Other|3|||
23815648|NCT00229723|66708263|FG006|Maintenance Phase|Other|1|||
23815649|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815650|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23815651|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815652|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815653|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815654|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23815655|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23815656|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815657|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815658|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815659|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815660|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815661|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815662|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815663|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815664|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815665|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815666|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815667|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815668|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815669|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815670|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815671|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815672|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815673|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23815674|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815675|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
23815676|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815677|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815678|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815679|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815680|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815681|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815682|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23535211|NCT01276327|65693465|FG000|Overall Study|Adverse Event|1|||
23535212|NCT01276327|65693466|FG001|Overall Study|Adverse Event|3|||
23535213|NCT01276327|65693465|FG000|Overall Study|Withdrawal by Subject|1|||
23535214|NCT01276327|65693466|FG001|Overall Study|Withdrawal by Subject|0|||
23535215|NCT04709237|65693468|FG000|Overall Study|Lost to Follow-up|1|||
23535216|NCT04709237|65693469|FG001|Overall Study|Lost to Follow-up|0|||
23535217|NCT04709237|65693470|FG002|Overall Study|Lost to Follow-up|0|||
23535218|NCT01208233|65693473|FG000|Overall Study|Adverse Event|0|||
23535219|NCT01208233|65693474|FG001|Overall Study|Adverse Event|1|||
23535220|NCT01208233|65693475|FG002|Overall Study|Adverse Event|2|||
23535221|NCT01208233|65693476|FG003|Overall Study|Adverse Event|0|||
23535222|NCT01208233|65693477|FG004|Overall Study|Adverse Event|3|||
23535223|NCT01208233|65693478|FG005|Overall Study|Adverse Event|5|||
23535224|NCT01208233|65693473|FG000|Overall Study|Death|0|||
23535225|NCT01208233|65693474|FG001|Overall Study|Death|0|||
23535226|NCT01208233|65693475|FG002|Overall Study|Death|0|||
23535227|NCT01208233|65693476|FG003|Overall Study|Death|0|||
23535228|NCT01208233|65693477|FG004|Overall Study|Death|3|||
23535229|NCT01208233|65693478|FG005|Overall Study|Death|5|||
23535230|NCT01208233|65693473|FG000|Overall Study|Did not meet entrance criteria|2|||
23535231|NCT01208233|65693474|FG001|Overall Study|Did not meet entrance criteria|1|||
23535232|NCT01208233|65693475|FG002|Overall Study|Did not meet entrance criteria|1|||
23535233|NCT01208233|65693476|FG003|Overall Study|Did not meet entrance criteria|0|||
23535234|NCT01208233|65693477|FG004|Overall Study|Did not meet entrance criteria|1|||
23535235|NCT01208233|65693478|FG005|Overall Study|Did not meet entrance criteria|0|||
23422909|NCT00075946|65292513|FG001|Overall Study|Time to progression less than 6 months|30|||
23422910|NCT00075946|65292514|FG002|Overall Study|Time to progression less than 6 months|8|||
23422911|NCT00075946|65292515|FG003|Overall Study|Time to progression less than 6 months|3|||
23422912|NCT00075946|65292516|FG004|Overall Study|Time to progression less than 6 months|0|||
23422913|NCT00075946|65292512|FG000|Overall Study|Other|57|||
23422914|NCT00075946|65292513|FG001|Overall Study|Other|32|||
23422915|NCT00075946|65292514|FG002|Overall Study|Other|3|||
23722783|NCT01376245|66362961|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
23535236|NCT01208233|65693473|FG000|Overall Study|Medication error without adverse event|0|||
23535237|NCT01208233|65693474|FG001|Overall Study|Medication error without adverse event|0|||
23535238|NCT01208233|65693475|FG002|Overall Study|Medication error without adverse event|0|||
23535239|NCT01208233|65693476|FG003|Overall Study|Medication error without adverse event|0|||
23535240|NCT01208233|65693477|FG004|Overall Study|Medication error without adverse event|0|||
23535241|NCT01208233|65693478|FG005|Overall Study|Medication error without adverse event|1|||
23535242|NCT01208233|65693473|FG000|Overall Study|Study terminated by sponsor|0|||
23535243|NCT01208233|65693474|FG001|Overall Study|Study terminated by sponsor|0|||
23535244|NCT01208233|65693475|FG002|Overall Study|Study terminated by sponsor|0|||
23535245|NCT01208233|65693476|FG003|Overall Study|Study terminated by sponsor|0|||
23535246|NCT01208233|65693477|FG004|Overall Study|Study terminated by sponsor|10|||
23535247|NCT01208233|65693478|FG005|Overall Study|Study terminated by sponsor|7|||
23535248|NCT01208233|65693473|FG000|Overall Study|Protocol Violation|0|||
23535249|NCT01208233|65693474|FG001|Overall Study|Protocol Violation|0|||
23535250|NCT01208233|65693475|FG002|Overall Study|Protocol Violation|0|||
23535251|NCT01208233|65693476|FG003|Overall Study|Protocol Violation|0|||
23535252|NCT01208233|65693477|FG004|Overall Study|Protocol Violation|3|||
23535253|NCT01208233|65693478|FG005|Overall Study|Protocol Violation|0|||
23535254|NCT01208233|65693473|FG000|Overall Study|Other|2|||
23535255|NCT01208233|65693474|FG001|Overall Study|Other|1|||
23535256|NCT01208233|65693475|FG002|Overall Study|Other|0|||
23535257|NCT01208233|65693476|FG003|Overall Study|Other|0|||
23535258|NCT01208233|65693477|FG004|Overall Study|Other|0|||
23535259|NCT01208233|65693478|FG005|Overall Study|Other|1|||
23535260|NCT01208233|65693473|FG000|Overall Study|Withdrawal by Subject|1|||
23535261|NCT01208233|65693474|FG001|Overall Study|Withdrawal by Subject|0|||
23535262|NCT01208233|65693475|FG002|Overall Study|Withdrawal by Subject|1|||
23535263|NCT01208233|65693476|FG003|Overall Study|Withdrawal by Subject|1|||
23535264|NCT01208233|65693477|FG004|Overall Study|Withdrawal by Subject|4|||
23535265|NCT01208233|65693478|FG005|Overall Study|Withdrawal by Subject|2|||
23535266|NCT01181895|65693479|FG000|Overall Study|Adverse Event|3|||
23535267|NCT01181895|65693480|FG001|Overall Study|Adverse Event|1|||
23535268|NCT01181895|65693481|FG002|Overall Study|Adverse Event|1|||
23535269|NCT01181895|65693479|FG000|Overall Study|Lack of Efficacy|8|||
23722784|NCT01376245|66362962|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23722785|NCT01376245|66362963|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23722786|NCT01376245|66362964|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23722787|NCT01376245|66362965|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23422916|NCT00075946|65292515|FG003|Overall Study|Other|11|||
23422917|NCT00075946|65292516|FG004|Overall Study|Other|0|||
23422918|NCT02150057|65292517|FG000|Overall Study|Lost to Follow-up|6|||
23422919|NCT02150057|65292518|FG001|Overall Study|Lost to Follow-up|4|||
23422920|NCT03733028|65292520|FG000|Overall Study|Study was stopped by PI|1|||
23422921|NCT03733028|65292521|FG001|Overall Study|Study was stopped by PI|2|||
23422922|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
23422923|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
23422924|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Death|1|||
23422925|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Death|0|||
23422926|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
23422927|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
23535270|NCT01181895|65693480|FG001|Overall Study|Lack of Efficacy|9|||
23535271|NCT01181895|65693481|FG002|Overall Study|Lack of Efficacy|9|||
23535272|NCT01181895|65693479|FG000|Overall Study|Protocol Violation|2|||
23535273|NCT01181895|65693480|FG001|Overall Study|Protocol Violation|1|||
23535274|NCT01181895|65693481|FG002|Overall Study|Protocol Violation|0|||
23535275|NCT01181895|65693479|FG000|Overall Study|Lost to Follow-up|0|||
23722788|NCT01376245|66362961|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
23722789|NCT01376245|66362962|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23722790|NCT01376245|66362963|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23722791|NCT01376245|66362964|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23722792|NCT01376245|66362965|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23535276|NCT01181895|65693480|FG001|Overall Study|Lost to Follow-up|1|||
23535277|NCT01181895|65693481|FG002|Overall Study|Lost to Follow-up|2|||
23535278|NCT01181895|65693479|FG000|Overall Study|Investigator Discretion|1|||
23422928|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
23422929|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
23535279|NCT01181895|65693480|FG001|Overall Study|Investigator Discretion|2|||
23535280|NCT01181895|65693481|FG002|Overall Study|Investigator Discretion|1|||
23535281|NCT01181895|65693479|FG000|Overall Study|Withdrawal by Subject|3|||
23535282|NCT01181895|65693480|FG001|Overall Study|Withdrawal by Subject|0|||
23535283|NCT01181895|65693481|FG002|Overall Study|Withdrawal by Subject|5|||
23535284|NCT03766009|65693482|FG000|Usual Care|Death|0|||
23535285|NCT03766009|65693483|FG001|Usual Care|Death|0|||
23535286|NCT03766009|65693484|FG002|Usual Care|Death|0|||
23535287|NCT03766009|65693485|FG003|Usual Care|Death|1|||
23535288|NCT03766009|65693486|FG004|Usual Care|Death|0|||
23535289|NCT03766009|65693487|FG005|Usual Care|Death|0|||
23535290|NCT03766009|65693482|FG000|Usual Care|Lost to Follow-up|0|||
23535291|NCT03766009|65693483|FG001|Usual Care|Lost to Follow-up|0|||
23535292|NCT03766009|65693484|FG002|Usual Care|Lost to Follow-up|0|||
23535293|NCT03766009|65693485|FG003|Usual Care|Lost to Follow-up|1|||
23535294|NCT03766009|65693486|FG004|Usual Care|Lost to Follow-up|0|||
23535295|NCT03766009|65693487|FG005|Usual Care|Lost to Follow-up|0|||
23535296|NCT03766009|65693482|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535297|NCT03766009|65693483|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535298|NCT03766009|65693484|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
23535299|NCT03766009|65693485|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535300|NCT03766009|65693486|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
23535301|NCT03766009|65693487|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535302|NCT03766009|65693482|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535303|NCT03766009|65693483|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
23535304|NCT03766009|65693484|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535305|NCT03766009|65693485|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
23535306|NCT03766009|65693486|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535307|NCT03766009|65693487|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535308|NCT03766009|65693482|FG000|Usual Care|No treatment or declined surgery|0|||
23535309|NCT03766009|65693483|FG001|Usual Care|No treatment or declined surgery|0|||
23535310|NCT03766009|65693484|FG002|Usual Care|No treatment or declined surgery|0|||
23722793|NCT01376245|66362961|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
23722794|NCT01376245|66362962|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23722795|NCT01376245|66362963|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23722796|NCT01376245|66362964|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23722797|NCT01376245|66362965|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23722798|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23722799|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
23722800|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
23722801|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
23722802|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
23722803|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23722804|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
23722805|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
23535311|NCT03766009|65693485|FG003|Usual Care|No treatment or declined surgery|2|||
23535312|NCT03766009|65693486|FG004|Usual Care|No treatment or declined surgery|0|||
23722806|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
23722807|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
23535313|NCT03766009|65693487|FG005|Usual Care|No treatment or declined surgery|0|||
23535314|NCT03766009|65693482|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
23535315|NCT03766009|65693483|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
23535316|NCT03766009|65693484|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
23535317|NCT03766009|65693485|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
23535318|NCT03766009|65693486|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
23535319|NCT03766009|65693487|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
23535320|NCT03766009|65693482|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23422930|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
23422931|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
23422932|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
23422933|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
23422934|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
23422935|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
23422936|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
23422937|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
23422938|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
23422939|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
23422940|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
23422941|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
23422942|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
23422943|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
23422944|NCT03610581|65292525|FG000|Overall Study|Study terminated by sponsor|2|||
23535321|NCT03766009|65693483|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
23535322|NCT03766009|65693484|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535323|NCT03766009|65693485|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535324|NCT03766009|65693486|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535325|NCT03766009|65693487|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535326|NCT03766009|65693482|FG000|Usual Care|Ineligible|0|||
23535327|NCT03766009|65693483|FG001|Usual Care|Ineligible|1|||
23535328|NCT03766009|65693484|FG002|Usual Care|Ineligible|0|||
23535329|NCT03766009|65693485|FG003|Usual Care|Ineligible|0|||
23535330|NCT03766009|65693486|FG004|Usual Care|Ineligible|0|||
23535331|NCT03766009|65693487|FG005|Usual Care|Ineligible|0|||
23722808|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23422945|NCT03610581|65292526|FG001|Overall Study|Study terminated by sponsor|0|||
23422946|NCT03610581|65292525|FG000|Overall Study|Other|0|||
23422947|NCT03610581|65292526|FG001|Overall Study|Other|1|||
23422948|NCT03610581|65292525|FG000|Overall Study|Withdrawal by Subject|1|||
23422949|NCT03610581|65292526|FG001|Overall Study|Withdrawal by Subject|0|||
23422950|NCT00758264|65292528|FG000|Active Phase|Withdrawal by Subject|0|||
23422951|NCT00758264|65292529|FG001|Active Phase|Withdrawal by Subject|0|||
23422952|NCT00758264|65292530|FG002|Active Phase|Withdrawal by Subject|1|||
23422953|NCT00758264|65292528|FG000|Active Phase|Lost to Follow-up|1|||
23422954|NCT00758264|65292529|FG001|Active Phase|Lost to Follow-up|0|||
23722809|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23722810|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23722811|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23722812|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
23722813|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23722814|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
23422955|NCT00758264|65292530|FG002|Active Phase|Lost to Follow-up|0|||
23422956|NCT00758264|65292528|FG000|Active Phase|Other|0|||
23422957|NCT00758264|65292529|FG001|Active Phase|Other|0|||
23422958|NCT00758264|65292530|FG002|Active Phase|Other|4|||
23422959|NCT04209114|65292531|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
23422960|NCT04209114|65292532|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
23422961|NCT04209114|65292533|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
23422962|NCT04209114|65292531|FG000|Pre-Treatment Phase|Other reasons|0|||
23422963|NCT04209114|65292532|FG001|Pre-Treatment Phase|Other reasons|0|||
23422964|NCT04209114|65292533|FG002|Pre-Treatment Phase|Other reasons|1|||
23422965|NCT04209114|65292531|FG000|Pre-Treatment Phase|Death|0|||
23422966|NCT04209114|65292532|FG001|Pre-Treatment Phase|Death|0|||
23422967|NCT04209114|65292533|FG002|Pre-Treatment Phase|Death|1|||
23422968|NCT04209114|65292531|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
23422969|NCT04209114|65292532|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
23722815|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
23422970|NCT04209114|65292533|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
23422971|NCT04209114|65292531|FG000|Treatment Phase|Other reasons|5|||
23422972|NCT04209114|65292532|FG001|Treatment Phase|Other reasons|3|||
23422973|NCT04209114|65292533|FG002|Treatment Phase|Other reasons|0|||
23422974|NCT04209114|65292531|FG000|Treatment Phase|Lost to Follow-up|1|||
23422975|NCT04209114|65292532|FG001|Treatment Phase|Lost to Follow-up|0|||
23422976|NCT04209114|65292533|FG002|Treatment Phase|Lost to Follow-up|0|||
23422977|NCT04209114|65292531|FG000|Treatment Phase|Participant withdrew consent|1|||
23422978|NCT04209114|65292532|FG001|Treatment Phase|Participant withdrew consent|0|||
23422979|NCT04209114|65292533|FG002|Treatment Phase|Participant withdrew consent|0|||
23422980|NCT04209114|65292531|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
23422981|NCT04209114|65292532|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
23422982|NCT04209114|65292533|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
23422983|NCT04209114|65292531|FG000|Treatment Phase|Death|4|||
23422984|NCT04209114|65292532|FG001|Treatment Phase|Death|1|||
23422985|NCT04209114|65292533|FG002|Treatment Phase|Death|0|||
23815683|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23422986|NCT04209114|65292531|FG000|Treatment Phase|Study drug toxicity|4|||
23422987|NCT04209114|65292532|FG001|Treatment Phase|Study drug toxicity|6|||
23422988|NCT04209114|65292533|FG002|Treatment Phase|Study drug toxicity|0|||
23422989|NCT04209114|65292531|FG000|Treatment Phase|Disease progression|6|||
23422990|NCT04209114|65292532|FG001|Treatment Phase|Disease progression|9|||
23422991|NCT04209114|65292533|FG002|Treatment Phase|Disease progression|0|||
23422992|NCT02434354|65292536|FG000|Overall Study|screen fail|3|||
23422993|NCT02974855|65292537|FG000|Overall Study|Adverse Event|0|||
23422994|NCT02974855|65292538|FG001|Overall Study|Adverse Event|1|||
23422995|NCT02974855|65292539|FG002|Overall Study|Adverse Event|0|||
23422996|NCT02974855|65292540|FG003|Overall Study|Adverse Event|1|||
23422997|NCT03946124|65292543|FG000|Overall Study|Withdrawal by Subject|19|||
23422998|NCT01945216|65292544|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
23422999|NCT01945216|65292544|FG000|Overall Study|Protocol Violation|42|||
23423000|NCT01945216|65292544|FG000|Overall Study|CRF not assured by investigators|5|||
23423001|NCT00931723|65292545|FG000|Overall Study|Withdrawal by Subject|11|||
23423002|NCT00931723|65292546|FG001|Overall Study|Withdrawal by Subject|13|||
23423003|NCT00931723|65292545|FG000|Overall Study|Adverse Event|6|||
23423004|NCT00931723|65292546|FG001|Overall Study|Adverse Event|13|||
23815684|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815685|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23423005|NCT00931723|65292545|FG000|Overall Study|Lithium found in blood|0|||
23423006|NCT00931723|65292546|FG001|Overall Study|Lithium found in blood|1|||
23423007|NCT00931723|65292545|FG000|Overall Study|Condition under investigation worsened|1|||
23423008|NCT00931723|65292546|FG001|Overall Study|Condition under investigation worsened|2|||
23423009|NCT00931723|65292545|FG000|Overall Study|Lost to Follow-up|1|||
23423010|NCT00931723|65292546|FG001|Overall Study|Lost to Follow-up|2|||
23423011|NCT00931723|65292545|FG000|Overall Study|Study-specific discontinuation criteria|1|||
23423012|NCT00931723|65292546|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23423013|NCT00931723|65292545|FG000|Overall Study|Severe non-compliance to protocol|2|||
23423014|NCT00931723|65292546|FG001|Overall Study|Severe non-compliance to protocol|0|||
23423015|NCT00931723|65292545|FG000|Overall Study|Safety reasons|0|||
23423016|NCT00931723|65292546|FG001|Overall Study|Safety reasons|1|||
23423017|NCT00931723|65292545|FG000|Overall Study|Took prohibited concomitant medication|0|||
23423018|NCT00931723|65292546|FG001|Overall Study|Took prohibited concomitant medication|1|||
23423019|NCT00931723|65292545|FG000|Overall Study|Lack or insufficient theraputic response|2|||
23423020|NCT00931723|65292546|FG001|Overall Study|Lack or insufficient theraputic response|5|||
23423021|NCT00931723|65292545|FG000|Overall Study|Sponsor decision|1|||
23423022|NCT00931723|65292546|FG001|Overall Study|Sponsor decision|0|||
23423023|NCT00931723|65292545|FG000|Overall Study|Late hospital discharge|1|||
23423024|NCT00931723|65292546|FG001|Overall Study|Late hospital discharge|0|||
23423025|NCT02763254|65292562|FG000|Overall Study|Adverse Event|1|||
23423026|NCT02826421|65292563|FG000|Overall Study|Adverse Event|1|||
23535332|NCT03766009|65693482|FG000|Usual Care|Other: Staff turnover|0|||
23535333|NCT03766009|65693483|FG001|Usual Care|Other: Staff turnover|0|||
23423027|NCT02826421|65292564|FG001|Overall Study|Adverse Event|0|||
23423028|NCT02826421|65292565|FG002|Overall Study|Adverse Event|0|||
23423029|NCT02826421|65292566|FG003|Overall Study|Adverse Event|1|||
23423030|NCT02826421|65292563|FG000|Overall Study|Withdrawal by Subject|1|||
23423031|NCT02826421|65292564|FG001|Overall Study|Withdrawal by Subject|3|||
23423032|NCT02826421|65292565|FG002|Overall Study|Withdrawal by Subject|1|||
23423033|NCT02826421|65292566|FG003|Overall Study|Withdrawal by Subject|1|||
23423034|NCT02826421|65292563|FG000|Overall Study|Reason not given|1|||
23423035|NCT02826421|65292564|FG001|Overall Study|Reason not given|0|||
23423036|NCT02826421|65292565|FG002|Overall Study|Reason not given|1|||
23423037|NCT02826421|65292566|FG003|Overall Study|Reason not given|0|||
23423038|NCT03510468|65292571|FG000|Overall Study|Lost to Follow-up|1|||
23423039|NCT03510468|65292571|FG000|Overall Study|Adverse Event|5|||
23423040|NCT03510468|65292571|FG000|Overall Study|Physician Decision|1|||
23423041|NCT03510468|65292571|FG000|Overall Study|non-compliant with treatment|2|||
23423042|NCT03510468|65292571|FG000|Overall Study|Missed visit|1|||
23423043|NCT00076336|65292572|FG000|Overall Study|Death|13|||
23423044|NCT00076336|65292573|FG001|Overall Study|Death|17|||
23423045|NCT00076336|65292572|FG000|Overall Study|Adverse Event|4|||
23423046|NCT00076336|65292573|FG001|Overall Study|Adverse Event|4|||
23423047|NCT00076336|65292572|FG000|Overall Study|Lost to Follow-up|4|||
23423048|NCT00076336|65292573|FG001|Overall Study|Lost to Follow-up|4|||
23423049|NCT00076336|65292572|FG000|Overall Study|Non-Compliance|2|||
23423050|NCT00076336|65292573|FG001|Overall Study|Non-Compliance|0|||
23423051|NCT00076336|65292572|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
23423052|NCT00076336|65292573|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
23423053|NCT00076336|65292572|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
23423054|NCT00076336|65292573|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
23423055|NCT00076336|65292572|FG000|Overall Study|Liver Transplantation|3|||
23423056|NCT00076336|65292573|FG001|Overall Study|Liver Transplantation|3|||
23423057|NCT00076336|65292572|FG000|Overall Study|Virologic Breakthrough|14|||
23423058|NCT00076336|65292573|FG001|Overall Study|Virologic Breakthrough|16|||
23423059|NCT00076336|65292572|FG000|Overall Study|Treatment failure|4|||
23423060|NCT00076336|65292573|FG001|Overall Study|Treatment failure|5|||
23423061|NCT02312219|65292576|FG000|Overall Study|Withdrawal by Subject|1|||
23423062|NCT02312219|65292577|FG001|Overall Study|Withdrawal by Subject|2|||
23423063|NCT02312219|65292576|FG000|Overall Study|could not schedule imaging in time|0|||
23423064|NCT02312219|65292577|FG001|Overall Study|could not schedule imaging in time|2|||
23423065|NCT02312219|65292576|FG000|Overall Study|Other|0|||
23423066|NCT02312219|65292577|FG001|Overall Study|Other|1|||
23423067|NCT02312219|65292576|FG000|Overall Study|Not randomized. Ineligible|0|||
23423068|NCT02312219|65292577|FG001|Overall Study|Not randomized. Ineligible|1|||
23423069|NCT03777917|65292578|FG000|Overall Study|Withdrawal by Subject|1|||
23423070|NCT03777917|65292579|FG001|Overall Study|Withdrawal by Subject|0|||
23423071|NCT03777917|65292578|FG000|Overall Study|Physician Decision|1|||
23423072|NCT03777917|65292579|FG001|Overall Study|Physician Decision|0|||
23423073|NCT03777917|65292578|FG000|Overall Study|Lost to Follow-up|6|||
23423074|NCT03777917|65292579|FG001|Overall Study|Lost to Follow-up|2|||
23423075|NCT03777917|65292578|FG000|Overall Study|Other|1|||
23423076|NCT03777917|65292579|FG001|Overall Study|Other|0|||
23423077|NCT04569136|65292581|FG000|Overall Study|Lost to Follow-up|2|||
23423078|NCT04569136|65292582|FG001|Overall Study|Lost to Follow-up|0|||
23423079|NCT04569136|65292583|FG002|Overall Study|Lost to Follow-up|1|||
23423080|NCT02233738|65292584|FG000|Overall Study|Lost to Follow-up|5|||
23423081|NCT02233738|65292585|FG001|Overall Study|Lost to Follow-up|12|||
23423082|NCT02233738|65292584|FG000|Overall Study|Death|0|||
23423083|NCT02233738|65292585|FG001|Overall Study|Death|1|||
23423084|NCT02233738|65292584|FG000|Overall Study|Withdrawal by Subject|0|||
23423085|NCT02233738|65292585|FG001|Overall Study|Withdrawal by Subject|1|||
23423086|NCT02233738|65292584|FG000|Overall Study|Did not return after Baseline|3|||
23423087|NCT02233738|65292585|FG001|Overall Study|Did not return after Baseline|2|||
23423088|NCT01453946|65292586|FG000|Overall Study|Did not receive drug for the taper phase|1|||
23423089|NCT01453946|65292586|FG000|Overall Study|Protocol Violation|2|||
23423090|NCT01453946|65292586|FG000|Overall Study|Lack of Efficacy|3|||
23423091|NCT01453946|65292586|FG000|Overall Study|Adverse Event|3|||
23423092|NCT01779869|65292587|FG000|Overall Study|Physician Decision|2|||
23722816|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
23722817|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23722818|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23722819|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23722820|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23722821|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23722822|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23722823|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23722824|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
23722825|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23722826|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
23722827|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
23722828|NCT01376245|66362961|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23722829|NCT01376245|66362962|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
23815686|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23423093|NCT00608023|65292591|FG000|Overall Study|Withdrawal by Subject|8|||
23423094|NCT00608023|65292592|FG001|Overall Study|Withdrawal by Subject|10|||
23423095|NCT00608023|65292593|FG002|Overall Study|Withdrawal by Subject|7|||
23423096|NCT00608023|65292591|FG000|Overall Study|Adverse Event|1|||
23423097|NCT00608023|65292592|FG001|Overall Study|Adverse Event|4|||
23423098|NCT00608023|65292593|FG002|Overall Study|Adverse Event|5|||
23423099|NCT00608023|65292591|FG000|Overall Study|Lost to Follow-up|2|||
23423100|NCT00608023|65292592|FG001|Overall Study|Lost to Follow-up|2|||
23423101|NCT00608023|65292593|FG002|Overall Study|Lost to Follow-up|1|||
23423102|NCT00608023|65292591|FG000|Overall Study|Protocol Violation|1|||
23722830|NCT01376245|66362963|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23722831|NCT01376245|66362964|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
23722832|NCT01376245|66362965|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
23722833|NCT03947255|66362966|FG000|Overall Study|Study Closure by Sponsor|2|||
23722834|NCT03947255|66362967|FG001|Overall Study|Study Closure by Sponsor|2|||
23722835|NCT03947255|66362966|FG000|Overall Study|Withdrawal by Subject|2|||
23722836|NCT03947255|66362967|FG001|Overall Study|Withdrawal by Subject|2|||
23722837|NCT03947255|66362966|FG000|Overall Study|Lost to Follow-up|2|||
23722838|NCT03947255|66362967|FG001|Overall Study|Lost to Follow-up|0|||
23722839|NCT03947255|66362966|FG000|Overall Study|Death|0|||
23722840|NCT03947255|66362967|FG001|Overall Study|Death|2|||
23722841|NCT01143714|66362968|FG000|Overall Study|Adverse Event|4|||
23722842|NCT01143714|66362969|FG001|Overall Study|Adverse Event|2|||
23722843|NCT01143714|66362968|FG000|Overall Study|Withdrawal by Subject|1|||
23722844|NCT01143714|66362969|FG001|Overall Study|Withdrawal by Subject|0|||
23722845|NCT01143714|66362968|FG000|Overall Study|Subject non-compliance|0|||
23722846|NCT01143714|66362969|FG001|Overall Study|Subject non-compliance|1|||
23722847|NCT01143714|66362968|FG000|Overall Study|wound closed = deemed healed|1|||
23722848|NCT01143714|66362969|FG001|Overall Study|wound closed = deemed healed|0|||
23722849|NCT01143714|66362968|FG000|Overall Study|wound size increased|1|||
23722850|NCT01143714|66362969|FG001|Overall Study|wound size increased|0|||
23722851|NCT01250756|66362972|FG000|Infant Series|Withdrawal by Subject|4|||
23722852|NCT01250756|66362973|FG001|Infant Series|Withdrawal by Subject|5|||
23722853|NCT01250756|66362972|FG000|Infant Series|Randomized, Not Vaccinated|2|||
23722854|NCT01250756|66362973|FG001|Infant Series|Randomized, Not Vaccinated|2|||
23722855|NCT01250756|66362972|FG000|Infant Series|Other|22|||
23423103|NCT00608023|65292592|FG001|Overall Study|Protocol Violation|3|||
23423104|NCT00608023|65292593|FG002|Overall Study|Protocol Violation|1|||
23423105|NCT00608023|65292591|FG000|Overall Study|Unknown reason|0|||
23423106|NCT00608023|65292592|FG001|Overall Study|Unknown reason|3|||
23423107|NCT00608023|65292593|FG002|Overall Study|Unknown reason|0|||
23423108|NCT02210221|65292594|FG000|Overall Study|Lack of Efficacy|7|||
23423109|NCT02210221|65292594|FG000|Overall Study|Withdrawal by Subject|43|||
23423110|NCT02981407|65292597|FG000|Overall Study|Withdrawal by Subject|2|||
23423111|NCT02981407|65292598|FG001|Overall Study|Withdrawal by Subject|0|||
23423112|NCT01338610|65292601|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
23423113|NCT01338610|65292602|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
23535334|NCT03766009|65693484|FG002|Usual Care|Other: Staff turnover|0|||
23535335|NCT03766009|65693485|FG003|Usual Care|Other: Staff turnover|0|||
23535336|NCT03766009|65693486|FG004|Usual Care|Other: Staff turnover|0|||
23535337|NCT03766009|65693487|FG005|Usual Care|Other: Staff turnover|2|||
23535338|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
23535339|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
23535340|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
23535341|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
23535342|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
23535343|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
23535344|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
23535345|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
23535346|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
23535347|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
23535348|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
23535349|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
23535350|NCT00403546|65693488|FG000|Screening Phase|Screening Failure|22|||
23535351|NCT00403546|65693489|FG001|Screening Phase|Screening Failure|0|||
23535352|NCT00403546|65693490|FG002|Screening Phase|Screening Failure|0|||
23535353|NCT00403546|65693488|FG000|Screening Phase|Adverse Event|1|||
23535354|NCT00403546|65693489|FG001|Screening Phase|Adverse Event|0|||
23535355|NCT00403546|65693490|FG002|Screening Phase|Adverse Event|0|||
23535356|NCT00403546|65693488|FG000|Screening Phase|Terminated Prior to Randomization|5|||
23535357|NCT00403546|65693489|FG001|Screening Phase|Terminated Prior to Randomization|0|||
23535358|NCT00403546|65693490|FG002|Screening Phase|Terminated Prior to Randomization|0|||
23535359|NCT00403546|65693488|FG000|Randomized Trial|Early Terminations|0|||
23535360|NCT00403546|65693489|FG001|Randomized Trial|Early Terminations|17|||
23535361|NCT00403546|65693490|FG002|Randomized Trial|Early Terminations|16|||
23423114|NCT01338610|65292603|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
23535362|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
23722856|NCT01250756|66362973|FG001|Infant Series|Other|0|||
23423115|NCT01338610|65292601|FG000|Overall Study|Protocol Violation|1|||
23423116|NCT01338610|65292602|FG001|Overall Study|Protocol Violation|0|||
23423117|NCT01338610|65292603|FG002|Overall Study|Protocol Violation|1|||
23535363|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535364|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535365|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535366|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
23535367|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
23535368|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
23535369|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
23535370|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535371|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535372|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535373|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
23535374|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535375|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535376|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
23535377|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535378|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535379|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535380|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
23535381|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535382|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535383|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
23535384|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535385|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535386|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
23535387|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
23535388|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
23535389|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
23535390|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
23535391|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
23535392|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
23535393|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
23535394|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
23535395|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
23535396|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
23535397|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
23535398|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535399|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535400|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535401|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
23535402|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
23535403|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
23535404|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
23535405|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
23535406|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
23535407|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
23535408|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
23535409|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
23535410|NCT00796861|65693496|FG000|Overall Study|Withdrawal by Subject|2|||
23535411|NCT00796861|65693496|FG000|Overall Study|Death|2|||
23535412|NCT00377676|65693498|FG000|Overall Study|Adverse Event|498|||
23535413|NCT00377676|65693499|FG001|Overall Study|Adverse Event|107|||
23535414|NCT00377676|65693498|FG000|Overall Study|Protocol Violation|33|||
23535415|NCT00377676|65693499|FG001|Overall Study|Protocol Violation|27|||
23535416|NCT00377676|65693498|FG000|Overall Study|Death|5|||
23535417|NCT00377676|65693499|FG001|Overall Study|Death|2|||
23535418|NCT00377676|65693498|FG000|Overall Study|Withdrawal by Subject|187|||
23535419|NCT00377676|65693499|FG001|Overall Study|Withdrawal by Subject|72|||
23535420|NCT00377676|65693498|FG000|Overall Study|Lost to Follow-up|120|||
23535421|NCT00377676|65693499|FG001|Overall Study|Lost to Follow-up|56|||
23535422|NCT00377676|65693498|FG000|Overall Study|Other|118|||
23535423|NCT00377676|65693499|FG001|Overall Study|Other|58|||
23535424|NCT00991302|65693502|FG000|Overall Study|Death|0|||
23535425|NCT00991302|65693503|FG001|Overall Study|Death|1|||
23535426|NCT00991302|65693502|FG000|Overall Study|Lost to Follow-up|14|||
23535427|NCT00991302|65693503|FG001|Overall Study|Lost to Follow-up|12|||
23535428|NCT03525834|65693507|FG000|Overall Study|Progressive disease|1|||
23535429|NCT02097134|65693508|FG000|Overall Study|Physician Decision|4|||
23535430|NCT02097134|65693508|FG000|Overall Study|Non-Protocol Therapy|1|||
23535431|NCT02097134|65693508|FG000|Overall Study|Progressive Disease|3|||
23535432|NCT02097134|65693508|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
23535433|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535434|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
23535435|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23615569|NCT01498445|65979377|FG005|Overall Study|Screen Failure|1|||
23615570|NCT01072396|65979380|FG000|Period One|Adverse Event|1|||
23615571|NCT01072396|65979381|FG001|Period One|Adverse Event|1|||
23615572|NCT01072396|65979380|FG000|Period One|Protocol Violation|2|||
23615573|NCT01072396|65979381|FG001|Period One|Protocol Violation|1|||
23615574|NCT01072396|65979380|FG000|Period One|Withdrawal by Subject|2|||
23615575|NCT01072396|65979381|FG001|Period One|Withdrawal by Subject|0|||
23615576|NCT01072396|65979380|FG000|Washout Period|Missing termination information|0|||
23615577|NCT01072396|65979381|FG001|Washout Period|Missing termination information|1|||
23615578|NCT01072396|65979380|FG000|Period Two|Adverse Event|0|||
23615579|NCT01072396|65979381|FG001|Period Two|Adverse Event|3|||
23615580|NCT01072396|65979380|FG000|Period Two|Lost to Follow-up|1|||
23615581|NCT01072396|65979381|FG001|Period Two|Lost to Follow-up|0|||
23615582|NCT00837096|65979385|FG000|Overall Study|Physician Decision|1|||
23615583|NCT00837096|65979386|FG001|Overall Study|Physician Decision|1|||
23615584|NCT00837096|65979385|FG000|Overall Study|Not reported|9|||
23615585|NCT00837096|65979386|FG001|Overall Study|Not reported|8|||
23615586|NCT00711555|65979389|FG000|Overall Study|Adverse Event|3|||
23615587|NCT04374253|65979393|FG000|Overall Study|Adverse Event|0|||
23615588|NCT04374253|65979394|FG001|Overall Study|Adverse Event|26|||
23615589|NCT04374253|65979395|FG002|Overall Study|Adverse Event|2|||
23615590|NCT04374253|65979396|FG003|Overall Study|Adverse Event|12|||
23615591|NCT04374253|65979393|FG000|Overall Study|Study terminated by sponsor|13|||
23615592|NCT04374253|65979394|FG001|Overall Study|Study terminated by sponsor|593|||
23615593|NCT04374253|65979395|FG002|Overall Study|Study terminated by sponsor|21|||
23615594|NCT04374253|65979396|FG003|Overall Study|Study terminated by sponsor|567|||
23615595|NCT04374253|65979393|FG000|Overall Study|Withdrawal by Subject|0|||
23615596|NCT04374253|65979394|FG001|Overall Study|Withdrawal by Subject|55|||
23615597|NCT04374253|65979395|FG002|Overall Study|Withdrawal by Subject|3|||
23615598|NCT04374253|65979396|FG003|Overall Study|Withdrawal by Subject|40|||
23615599|NCT04374253|65979393|FG000|Overall Study|Physician Decision|1|||
23615600|NCT04374253|65979394|FG001|Overall Study|Physician Decision|10|||
23615601|NCT04374253|65979395|FG002|Overall Study|Physician Decision|1|||
23615602|NCT04374253|65979396|FG003|Overall Study|Physician Decision|10|||
23615603|NCT04374253|65979393|FG000|Overall Study|Protocol Violation|0|||
23615604|NCT04374253|65979394|FG001|Overall Study|Protocol Violation|0|||
23615605|NCT04374253|65979395|FG002|Overall Study|Protocol Violation|0|||
23615606|NCT04374253|65979396|FG003|Overall Study|Protocol Violation|2|||
23615607|NCT04374253|65979393|FG000|Overall Study|Death|0|||
23615608|NCT04374253|65979394|FG001|Overall Study|Death|3|||
23615609|NCT04374253|65979395|FG002|Overall Study|Death|1|||
23615610|NCT04374253|65979396|FG003|Overall Study|Death|1|||
23615611|NCT04374253|65979393|FG000|Overall Study|Lack of Efficacy|0|||
23615612|NCT04374253|65979394|FG001|Overall Study|Lack of Efficacy|0|||
23722857|NCT01250756|66362972|FG000|After Infant Series|Adverse Event|5|||
23615613|NCT04374253|65979395|FG002|Overall Study|Lack of Efficacy|0|||
23615614|NCT04374253|65979396|FG003|Overall Study|Lack of Efficacy|1|||
23615615|NCT04374253|65979393|FG000|Overall Study|Lost to Follow-up|1|||
23615616|NCT04374253|65979394|FG001|Overall Study|Lost to Follow-up|1|||
23615617|NCT04374253|65979395|FG002|Overall Study|Lost to Follow-up|0|||
23615618|NCT04374253|65979396|FG003|Overall Study|Lost to Follow-up|2|||
23615619|NCT04374253|65979393|FG000|Overall Study|Reason Not Specified|0|||
23615620|NCT04374253|65979394|FG001|Overall Study|Reason Not Specified|8|||
23615621|NCT04374253|65979395|FG002|Overall Study|Reason Not Specified|0|||
23615622|NCT04374253|65979396|FG003|Overall Study|Reason Not Specified|8|||
23615623|NCT00460577|65979398|FG000|Overall Study|Protocol Violation|2|||
23615624|NCT00460577|65979399|FG001|Overall Study|Protocol Violation|6|||
23615625|NCT01898442|65979404|FG000|Overall Study|Hemolysis/technical problems|1|||
23615626|NCT01898442|65979405|FG001|Overall Study|Hemolysis/technical problems|2|||
23615627|NCT01898442|65979406|FG002|Overall Study|Hemolysis/technical problems|2|||
23615628|NCT01898442|65979404|FG000|Overall Study|Patient vomited pills|0|||
23615629|NCT01898442|65979405|FG001|Overall Study|Patient vomited pills|0|||
23722858|NCT01250756|66362973|FG001|After Infant Series|Adverse Event|2|||
23615630|NCT01898442|65979406|FG002|Overall Study|Patient vomited pills|1|||
23615631|NCT01313299|65979410|FG000|Overall Study|Adverse Event|3|||
23615632|NCT01313299|65979411|FG001|Overall Study|Adverse Event|1|||
23615633|NCT01313299|65979412|FG002|Overall Study|Adverse Event|1|||
23615634|NCT01313299|65979410|FG000|Overall Study|Lost to Follow-up|1|||
23615635|NCT01313299|65979411|FG001|Overall Study|Lost to Follow-up|0|||
23615636|NCT01313299|65979412|FG002|Overall Study|Lost to Follow-up|0|||
23615637|NCT01313299|65979410|FG000|Overall Study|Protocol Violation|2|||
23615638|NCT01313299|65979411|FG001|Overall Study|Protocol Violation|0|||
23615639|NCT01313299|65979412|FG002|Overall Study|Protocol Violation|0|||
23615640|NCT01313299|65979410|FG000|Overall Study|Withdrawal by Subject|1|||
23615641|NCT01313299|65979411|FG001|Overall Study|Withdrawal by Subject|0|||
23615642|NCT01313299|65979412|FG002|Overall Study|Withdrawal by Subject|2|||
23423118|NCT01338610|65292601|FG000|Overall Study|Adverse Event|3|||
23423119|NCT01338610|65292602|FG001|Overall Study|Adverse Event|0|||
23615643|NCT01313299|65979410|FG000|Overall Study|Family reason and moved out of state|0|||
23615644|NCT01313299|65979411|FG001|Overall Study|Family reason and moved out of state|2|||
23423120|NCT01338610|65292603|FG002|Overall Study|Adverse Event|0|||
23423121|NCT00413920|65292604|FG000|Overall Study|Adverse Event|9|||
23423122|NCT00413920|65292605|FG001|Overall Study|Adverse Event|11|||
23615645|NCT01313299|65979412|FG002|Overall Study|Family reason and moved out of state|0|||
23722859|NCT01250756|66362972|FG000|After Infant Series|Withdrawal by Subject|4|||
23722860|NCT01250756|66362973|FG001|After Infant Series|Withdrawal by Subject|1|||
23722861|NCT01250756|66362972|FG000|After Infant Series|Other|2|||
23535436|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535437|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535438|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535439|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23535440|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
23535441|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23535442|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535443|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535444|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535445|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
23722862|NCT01250756|66362973|FG001|After Infant Series|Other|1|||
23722863|NCT01250756|66362972|FG000|Toddler Dose|Adverse Event|0|||
23722864|NCT01250756|66362973|FG001|Toddler Dose|Adverse Event|1|||
23722865|NCT01250756|66362972|FG000|After Toddler Dose|Adverse Event|0|||
23722866|NCT01250756|66362973|FG001|After Toddler Dose|Adverse Event|1|||
23722867|NCT02944513|66362976|FG000|Overall Study|Withdrawal by Subject|4|||
23535446|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535447|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23722868|NCT02944513|66362977|FG001|Overall Study|Withdrawal by Subject|1|||
23722869|NCT03943446|66362978|FG000|Overall Study|Lost to Follow-up|0|||
23722870|NCT03943446|66362979|FG001|Overall Study|Lost to Follow-up|0|||
23722871|NCT03943446|66362980|FG002|Overall Study|Lost to Follow-up|1|||
23722872|NCT03943446|66362978|FG000|Overall Study|Withdrawal by Subject|1|||
23722873|NCT03943446|66362979|FG001|Overall Study|Withdrawal by Subject|1|||
23722874|NCT03943446|66362980|FG002|Overall Study|Withdrawal by Subject|2|||
23722875|NCT03943446|66362978|FG000|Overall Study|Study Terminated by Sponsor|1|||
23722876|NCT03943446|66362979|FG001|Overall Study|Study Terminated by Sponsor|2|||
23722877|NCT03943446|66362980|FG002|Overall Study|Study Terminated by Sponsor|1|||
23722878|NCT03943446|66362978|FG000|Overall Study|Reason not Specified|5|||
23722879|NCT03943446|66362979|FG001|Overall Study|Reason not Specified|1|||
23722880|NCT03943446|66362980|FG002|Overall Study|Reason not Specified|3|||
23722881|NCT01042938|66362981|FG000|Overall Study|Withdrawal by Subject|1|||
23722882|NCT01042938|66362982|FG001|Overall Study|Withdrawal by Subject|1|||
23722883|NCT01042938|66362981|FG000|Overall Study|Protocol Violation|1|||
23722884|NCT01042938|66362982|FG001|Overall Study|Protocol Violation|1|||
23722885|NCT01042938|66362981|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
23722886|NCT01042938|66362982|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
23722887|NCT01357889|66362983|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
23722888|NCT01357889|66362984|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
23722889|NCT01357889|66362983|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
23722890|NCT01357889|66362984|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
23722891|NCT01357889|66362983|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
23722892|NCT01357889|66362984|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
23722893|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
23722894|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
23722895|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
23722896|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
23722897|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
23722898|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
23722899|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
23722900|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
23722901|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
23722902|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
23722903|NCT01357889|66362983|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
23722904|NCT01357889|66362984|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
23722905|NCT01357889|66362983|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
23722906|NCT01357889|66362984|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
23722907|NCT01357889|66362983|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
23722908|NCT01357889|66362984|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
23722909|NCT01357889|66362983|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
23722910|NCT01357889|66362984|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
23722911|NCT01357889|66362983|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
23722912|NCT01357889|66362984|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
23722913|NCT04583969|66362989|FG000|Overall Study|Death|31|||
23722914|NCT04583969|66362990|FG001|Overall Study|Death|38|||
23722915|NCT04583969|66362989|FG000|Overall Study|Lost to Follow-up|16|||
23722916|NCT04583969|66362990|FG001|Overall Study|Lost to Follow-up|13|||
23722917|NCT04583969|66362989|FG000|Overall Study|Protocol Violation|1|||
23722918|NCT04583969|66362990|FG001|Overall Study|Protocol Violation|0|||
23535448|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535449|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23722919|NCT04583969|66362989|FG000|Overall Study|Withdrawal by Subject|3|||
23535450|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23722920|NCT04583969|66362990|FG001|Overall Study|Withdrawal by Subject|3|||
23722921|NCT04583969|66362989|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
23722922|NCT04583969|66362990|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
23722923|NCT04583969|66362989|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
23722924|NCT04583969|66362990|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
23722925|NCT04583969|66362989|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
23815687|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815688|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23722926|NCT04583969|66362990|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
23722927|NCT04583969|66362989|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
23423123|NCT00413920|65292604|FG000|Overall Study|Lack of Efficacy|11|||
23423124|NCT00413920|65292605|FG001|Overall Study|Lack of Efficacy|9|||
23423125|NCT00413920|65292604|FG000|Overall Study|Death|3|||
23423126|NCT00413920|65292605|FG001|Overall Study|Death|5|||
23423127|NCT00413920|65292604|FG000|Overall Study|Graft Loss|5|||
23423128|NCT00413920|65292605|FG001|Overall Study|Graft Loss|3|||
23423129|NCT02573246|65292606|FG000|Overall Study|Lost to Follow-up|2|||
23423130|NCT02573246|65292607|FG001|Overall Study|Lost to Follow-up|0|||
23423131|NCT02573246|65292608|FG002|Overall Study|Lost to Follow-up|0|||
23423132|NCT02573246|65292609|FG003|Overall Study|Lost to Follow-up|0|||
23423133|NCT02573246|65292610|FG004|Overall Study|Lost to Follow-up|1|||
23423134|NCT02573246|65292606|FG000|Overall Study|Withdrawal by Subject|0|||
23535451|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535452|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
23535453|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23535454|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535455|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535456|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535457|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535458|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535459|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535460|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
23535461|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535462|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535463|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23722928|NCT04583969|66362990|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
23722929|NCT04583969|66362989|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
23815689|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815690|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815691|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815692|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815693|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815694|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815695|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815696|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815697|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815698|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23815699|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
23815700|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
23423135|NCT02573246|65292607|FG001|Overall Study|Withdrawal by Subject|0|||
23722930|NCT04583969|66362990|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
23722931|NCT00379236|66362991|FG000|Double-blind|Adverse Event|11|||
23722932|NCT00379236|66362992|FG001|Double-blind|Adverse Event|6|||
23722933|NCT00379236|66362993|FG002|Double-blind|Adverse Event|0|||
23722934|NCT00379236|66362991|FG000|Double-blind|Protocol Violation|3|||
23722935|NCT00379236|66362992|FG001|Double-blind|Protocol Violation|3|||
23722936|NCT00379236|66362993|FG002|Double-blind|Protocol Violation|0|||
23722937|NCT00379236|66362991|FG000|Double-blind|Withdrawal by Subject|12|||
23722938|NCT00379236|66362992|FG001|Double-blind|Withdrawal by Subject|13|||
23722939|NCT00379236|66362993|FG002|Double-blind|Withdrawal by Subject|0|||
23722940|NCT00379236|66362991|FG000|Double-blind|Lost to Follow-up|4|||
23722941|NCT00379236|66362992|FG001|Double-blind|Lost to Follow-up|3|||
23722942|NCT00379236|66362993|FG002|Double-blind|Lost to Follow-up|0|||
23722943|NCT00379236|66362991|FG000|Double-blind|Use of exclusionary medication|1|||
23722944|NCT00379236|66362992|FG001|Double-blind|Use of exclusionary medication|2|||
23722945|NCT00379236|66362993|FG002|Double-blind|Use of exclusionary medication|0|||
23722946|NCT00379236|66362991|FG000|Double-blind|Other|3|||
23722947|NCT00379236|66362992|FG001|Double-blind|Other|7|||
23722948|NCT00379236|66362993|FG002|Double-blind|Other|0|||
23722949|NCT00379236|66362991|FG000|Double-blind|Data could not be retrieved|2|||
23722950|NCT00379236|66362992|FG001|Double-blind|Data could not be retrieved|2|||
23423136|NCT02573246|65292608|FG002|Overall Study|Withdrawal by Subject|0|||
23423137|NCT02573246|65292609|FG003|Overall Study|Withdrawal by Subject|0|||
23423138|NCT02573246|65292610|FG004|Overall Study|Withdrawal by Subject|1|||
23423139|NCT02573246|65292606|FG000|Overall Study|Physician Decision|1|||
23722951|NCT00379236|66362993|FG002|Double-blind|Data could not be retrieved|0|||
23722952|NCT00379236|66362991|FG000|Open-label Extension|Adverse Event|0|||
23722953|NCT00379236|66362992|FG001|Open-label Extension|Adverse Event|0|||
23722954|NCT00379236|66362993|FG002|Open-label Extension|Adverse Event|13|||
23423140|NCT02573246|65292607|FG001|Overall Study|Physician Decision|1|||
23423141|NCT02573246|65292608|FG002|Overall Study|Physician Decision|3|||
23423142|NCT02573246|65292609|FG003|Overall Study|Physician Decision|2|||
23423143|NCT02573246|65292610|FG004|Overall Study|Physician Decision|2|||
23423144|NCT04493684|65292613|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423145|NCT04493684|65292614|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423146|NCT04493684|65292615|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423147|NCT04493684|65292616|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423148|NCT04493684|65292617|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423149|NCT04493684|65292618|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423150|NCT04493684|65292619|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423151|NCT04493684|65292620|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423152|NCT04493684|65292621|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423153|NCT04493684|65292622|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423154|NCT04493684|65292623|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423155|NCT04493684|65292624|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423156|NCT04493684|65292625|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423157|NCT04493684|65292626|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423158|NCT04493684|65292627|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423159|NCT04493684|65292628|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423160|NCT04493684|65292629|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423161|NCT04493684|65292613|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
23423162|NCT04493684|65292614|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23535464|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23423163|NCT04493684|65292615|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423164|NCT04493684|65292616|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423165|NCT04493684|65292617|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423166|NCT04493684|65292618|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423167|NCT04493684|65292619|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423168|NCT04493684|65292620|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423169|NCT04493684|65292621|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423170|NCT04493684|65292622|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423171|NCT04493684|65292623|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423172|NCT04493684|65292624|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423173|NCT04493684|65292625|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423174|NCT04493684|65292626|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423175|NCT04493684|65292627|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423176|NCT04493684|65292628|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423177|NCT04493684|65292629|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423178|NCT04493684|65292613|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423179|NCT04493684|65292614|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423180|NCT04493684|65292615|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423181|NCT04493684|65292616|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423182|NCT04493684|65292617|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423183|NCT04493684|65292618|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423184|NCT04493684|65292619|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
23423185|NCT04493684|65292620|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423186|NCT04493684|65292621|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423187|NCT04493684|65292622|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423188|NCT04493684|65292623|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423189|NCT04493684|65292624|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423190|NCT04493684|65292625|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423191|NCT04493684|65292626|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423192|NCT04493684|65292627|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423193|NCT04493684|65292628|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423194|NCT04493684|65292629|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423195|NCT04493684|65292613|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
23423196|NCT04493684|65292614|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423197|NCT04493684|65292615|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423198|NCT04493684|65292616|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423199|NCT04493684|65292617|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23535465|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23535466|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
23722955|NCT00379236|66362991|FG000|Open-label Extension|Protocol Violation|0|||
23423200|NCT04493684|65292618|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423201|NCT04493684|65292619|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423202|NCT04493684|65292620|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423203|NCT04493684|65292621|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423204|NCT04493684|65292622|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423205|NCT04493684|65292623|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423206|NCT04493684|65292624|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423207|NCT04493684|65292625|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423208|NCT04493684|65292626|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423209|NCT04493684|65292627|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423210|NCT04493684|65292628|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423211|NCT04493684|65292629|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423212|NCT04493684|65292613|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423213|NCT04493684|65292614|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423214|NCT04493684|65292615|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423215|NCT04493684|65292616|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423216|NCT04493684|65292617|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423217|NCT04493684|65292618|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
23423218|NCT04493684|65292619|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423219|NCT04493684|65292620|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423220|NCT04493684|65292621|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423221|NCT04493684|65292622|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423222|NCT04493684|65292623|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423223|NCT04493684|65292624|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423224|NCT04493684|65292625|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423225|NCT04493684|65292626|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423226|NCT04493684|65292627|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423227|NCT04493684|65292628|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423228|NCT04493684|65292629|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423229|NCT04493684|65292613|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423230|NCT04493684|65292614|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423231|NCT04493684|65292615|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423232|NCT04493684|65292616|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423233|NCT04493684|65292617|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423234|NCT04493684|65292618|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423235|NCT04493684|65292619|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423236|NCT04493684|65292620|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423237|NCT04493684|65292621|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423238|NCT04493684|65292622|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423239|NCT04493684|65292623|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423240|NCT04493684|65292624|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
23423241|NCT04493684|65292625|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423242|NCT04493684|65292626|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423243|NCT04493684|65292627|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423244|NCT04493684|65292628|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423245|NCT04493684|65292629|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423246|NCT04493684|65292613|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423247|NCT04493684|65292614|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423248|NCT04493684|65292615|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423249|NCT04493684|65292616|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423250|NCT04493684|65292617|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423251|NCT04493684|65292618|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423252|NCT04493684|65292619|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423253|NCT04493684|65292620|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23535467|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23535468|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
23535469|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535470|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535471|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535472|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
23535473|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535474|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23582197|NCT02929108|65862372|FG005|Overall Study|Hospice patient death|28|||
23535475|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535476|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535477|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535478|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
23535479|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535480|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535481|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535482|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535483|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535484|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
23535485|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
23535486|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
23535487|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535488|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535489|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535490|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
23535491|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
23535492|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
23535493|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
23535494|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
23535495|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
23535496|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
23535497|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
23535498|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
23535499|NCT02057757|65693516|FG000|Overall Study|Withdrawal by Subject|3|||
23535500|NCT02057757|65693517|FG001|Overall Study|Withdrawal by Subject|5|||
23535501|NCT02057757|65693516|FG000|Overall Study|Death|2|||
23535502|NCT02057757|65693517|FG001|Overall Study|Death|0|||
23535503|NCT02057757|65693516|FG000|Overall Study|Lost to Follow-up|8|||
23535504|NCT02057757|65693517|FG001|Overall Study|Lost to Follow-up|3|||
23535505|NCT02057757|65693516|FG000|Overall Study|Non-compliance|1|||
23535506|NCT02057757|65693517|FG001|Overall Study|Non-compliance|0|||
23535507|NCT01940705|65693518|FG000|Overall Study|Lost to Follow-up|1|||
23535508|NCT01940705|65693519|FG001|Overall Study|Lost to Follow-up|3|||
23535509|NCT01940705|65693520|FG002|Overall Study|Lost to Follow-up|2|||
23535510|NCT01940705|65693521|FG003|Overall Study|Lost to Follow-up|2|||
23535511|NCT01940705|65693518|FG000|Overall Study|Withdrawal by Subject|2|||
23535512|NCT01940705|65693519|FG001|Overall Study|Withdrawal by Subject|2|||
23535513|NCT01940705|65693520|FG002|Overall Study|Withdrawal by Subject|3|||
23535514|NCT01940705|65693521|FG003|Overall Study|Withdrawal by Subject|2|||
23615646|NCT01313299|65979410|FG000|Overall Study|Lack of subject compliance|0|||
23615647|NCT01313299|65979411|FG001|Overall Study|Lack of subject compliance|0|||
23615648|NCT01313299|65979412|FG002|Overall Study|Lack of subject compliance|1|||
23535515|NCT01940705|65693518|FG000|Overall Study|Intervention not given|0|||
23615649|NCT01762345|65979413|FG000|Overall Study|Adverse Event|5|||
23615650|NCT01762345|65979413|FG000|Overall Study|Protocol Violation|2|||
23615651|NCT03334747|65979414|FG000|Treatment Phase|Technical problems|0|||
23615652|NCT03334747|65979415|FG001|Treatment Phase|Technical problems|0|||
23615653|NCT03334747|65979416|FG002|Treatment Phase|Technical problems|0|||
23615654|NCT03334747|65979417|FG003|Treatment Phase|Technical problems|0|||
23615655|NCT03334747|65979418|FG004|Treatment Phase|Technical problems|1|||
23615656|NCT03334747|65979419|FG005|Treatment Phase|Technical problems|0|||
23615657|NCT03334747|65979420|FG006|Treatment Phase|Technical problems|0|||
23615658|NCT03334747|65979421|FG007|Treatment Phase|Technical problems|0|||
23615659|NCT03334747|65979422|FG008|Treatment Phase|Technical problems|0|||
23615660|NCT03334747|65979414|FG000|Treatment Phase|Subject/guardian decision|1|||
23615661|NCT03334747|65979415|FG001|Treatment Phase|Subject/guardian decision|0|||
23615662|NCT03334747|65979416|FG002|Treatment Phase|Subject/guardian decision|0|||
23535516|NCT01940705|65693519|FG001|Overall Study|Intervention not given|3|||
23615663|NCT03334747|65979417|FG003|Treatment Phase|Subject/guardian decision|0|||
23615664|NCT03334747|65979418|FG004|Treatment Phase|Subject/guardian decision|0|||
23615665|NCT03334747|65979419|FG005|Treatment Phase|Subject/guardian decision|1|||
23615666|NCT03334747|65979420|FG006|Treatment Phase|Subject/guardian decision|0|||
23615667|NCT03334747|65979421|FG007|Treatment Phase|Subject/guardian decision|0|||
23615668|NCT03334747|65979422|FG008|Treatment Phase|Subject/guardian decision|0|||
23615669|NCT03334747|65979414|FG000|Follow-Up Phase|Subject/guardian decision|0|||
23615670|NCT03334747|65979415|FG001|Follow-Up Phase|Subject/guardian decision|0|||
23615671|NCT03334747|65979416|FG002|Follow-Up Phase|Subject/guardian decision|0|||
23615672|NCT03334747|65979417|FG003|Follow-Up Phase|Subject/guardian decision|0|||
23615673|NCT03334747|65979418|FG004|Follow-Up Phase|Subject/guardian decision|0|||
23615674|NCT03334747|65979419|FG005|Follow-Up Phase|Subject/guardian decision|0|||
23615675|NCT03334747|65979420|FG006|Follow-Up Phase|Subject/guardian decision|1|||
23615676|NCT03334747|65979421|FG007|Follow-Up Phase|Subject/guardian decision|0|||
23615677|NCT03334747|65979422|FG008|Follow-Up Phase|Subject/guardian decision|1|||
23722956|NCT00379236|66362992|FG001|Open-label Extension|Protocol Violation|0|||
23423254|NCT04493684|65292621|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23615678|NCT01951261|65979423|FG000|Overall Study|Death|1|||
23615679|NCT01951261|65979424|FG001|Overall Study|Death|0|||
23615680|NCT01951261|65979423|FG000|Overall Study|Lost to Follow-up|4|||
23615681|NCT01951261|65979424|FG001|Overall Study|Lost to Follow-up|3|||
23615682|NCT01951261|65979423|FG000|Overall Study|Protocol Violation|4|||
23615683|NCT01951261|65979424|FG001|Overall Study|Protocol Violation|3|||
23615684|NCT01482819|65979425|FG000|Overall Study|Lost to Follow-up|2|||
23615685|NCT00884793|65979426|FG000|Overall Study|Withdrawal by Subject|1|||
23615686|NCT00147745|65979430|FG000|Overall Study|Withdrawal by Subject|1|||
23615687|NCT00147745|65979431|FG001|Overall Study|Withdrawal by Subject|0|||
23615688|NCT00147745|65979432|FG002|Overall Study|Withdrawal by Subject|0|||
23615689|NCT02409732|65979433|FG000|Overall Study|Withdrawal by Subject|4|||
23615690|NCT02409732|65979433|FG000|Overall Study|Lost to Follow-up|2|||
23615691|NCT01012999|65979434|FG000|Overall Study|Protocol Violation|1|||
23615692|NCT04523571|65979437|FG000|Received 2 Doses|Withdrawal by Subject|0|||
23615693|NCT04523571|65979438|FG001|Received 2 Doses|Withdrawal by Subject|0|||
23615694|NCT04523571|65979439|FG002|Received 2 Doses|Withdrawal by Subject|0|||
23615695|NCT04523571|65979440|FG003|Received 2 Doses|Withdrawal by Subject|1|||
23615696|NCT04523571|65979441|FG004|Received 2 Doses|Withdrawal by Subject|1|||
23615697|NCT04523571|65979442|FG005|Received 2 Doses|Withdrawal by Subject|0|||
23615698|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
23615699|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615700|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
23615701|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615702|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615703|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615704|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615705|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615706|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615707|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615708|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615709|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
23615710|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615711|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615712|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615713|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
23615714|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
23423255|NCT04493684|65292622|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423256|NCT04493684|65292623|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423257|NCT04493684|65292624|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423258|NCT04493684|65292625|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423259|NCT04493684|65292626|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423260|NCT04493684|65292627|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423261|NCT04493684|65292628|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
23423262|NCT04493684|65292629|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423263|NCT04493684|65292613|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423264|NCT04493684|65292614|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423265|NCT04493684|65292615|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23615715|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615716|NCT04089332|65979443|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
23615717|NCT04089332|65979443|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
23615718|NCT04089332|65979443|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
23722957|NCT00379236|66362993|FG002|Open-label Extension|Protocol Violation|7|||
23423266|NCT04493684|65292616|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23615719|NCT01190449|65979444|FG000|Overall Study|Ineligible|0|||
23615720|NCT01190449|65979445|FG001|Overall Study|Ineligible|4|||
23615721|NCT05294328|65979446|FG000|Overall Study|Adverse Event|1|||
23615722|NCT05294328|65979447|FG001|Overall Study|Adverse Event|0|||
23615723|NCT05294328|65979448|FG002|Overall Study|Adverse Event|0|||
23423267|NCT04493684|65292617|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423268|NCT04493684|65292618|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423269|NCT04493684|65292619|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423270|NCT04493684|65292620|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423271|NCT04493684|65292621|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423272|NCT04493684|65292622|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423273|NCT04493684|65292623|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423274|NCT04493684|65292624|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423275|NCT04493684|65292625|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423276|NCT04493684|65292626|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423277|NCT04493684|65292627|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423278|NCT04493684|65292628|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
23423279|NCT04493684|65292629|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423280|NCT01866423|65292630|FG000|Overall Study|Lack of Efficacy|3|||
23423281|NCT01866423|65292630|FG000|Overall Study|Sponsor Decision|1|||
23423282|NCT00790868|65292631|FG000|Overall Study|Withdrawal by Subject|4|||
23535517|NCT01940705|65693520|FG002|Overall Study|Intervention not given|3|||
23535518|NCT01940705|65693521|FG003|Overall Study|Intervention not given|0|||
23535519|NCT01940705|65693518|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
23535520|NCT01940705|65693519|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
23615724|NCT05294328|65979446|FG000|Overall Study|Physician Decision|1|||
23615725|NCT05294328|65979447|FG001|Overall Study|Physician Decision|1|||
23615726|NCT05294328|65979448|FG002|Overall Study|Physician Decision|0|||
23615727|NCT05294328|65979446|FG000|Overall Study|Withdrawal by Subject|0|||
23615728|NCT05294328|65979447|FG001|Overall Study|Withdrawal by Subject|2|||
23615729|NCT05294328|65979448|FG002|Overall Study|Withdrawal by Subject|1|||
23615730|NCT05294328|65979446|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
23615731|NCT05294328|65979447|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
23615732|NCT05294328|65979448|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
23615733|NCT02679079|65979449|FG000|Overall Study|Adverse Event|2|||
23615734|NCT02679079|65979450|FG001|Overall Study|Adverse Event|0|||
23615735|NCT02679079|65979451|FG002|Overall Study|Adverse Event|2|||
23615736|NCT02679079|65979449|FG000|Overall Study|Protocol Violation|0|||
23615737|NCT02679079|65979450|FG001|Overall Study|Protocol Violation|1|||
23615738|NCT02679079|65979451|FG002|Overall Study|Protocol Violation|0|||
23615739|NCT02679079|65979449|FG000|Overall Study|Withdrawal by Subject|2|||
23615740|NCT02679079|65979450|FG001|Overall Study|Withdrawal by Subject|1|||
23615741|NCT02679079|65979451|FG002|Overall Study|Withdrawal by Subject|0|||
23615742|NCT00130728|65979452|FG000|Overall Study|Death|258|||
23615743|NCT00130728|65979453|FG001|Overall Study|Death|258|||
23615744|NCT00130728|65979452|FG000|Overall Study|Lost to Follow-up|4|||
23615745|NCT00130728|65979453|FG001|Overall Study|Lost to Follow-up|0|||
23615746|NCT00130728|65979452|FG000|Overall Study|Withdrawal by Subject|0|||
23615747|NCT00130728|65979453|FG001|Overall Study|Withdrawal by Subject|2|||
23535521|NCT01940705|65693520|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
23535522|NCT01940705|65693521|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
23535523|NCT00563797|65693522|FG000|Overall Study|Lost to Follow-up|7|||
23535524|NCT00563797|65693523|FG001|Overall Study|Lost to Follow-up|2|||
23535525|NCT02496884|65693528|FG000|Overall Study|Counted twice as enrolled|2|||
23535526|NCT02496884|65693529|FG001|Overall Study|Counted twice as enrolled|0|||
23535527|NCT02496884|65693530|FG002|Overall Study|Counted twice as enrolled|0|||
23535528|NCT02496884|65693531|FG003|Overall Study|Counted twice as enrolled|0|||
23535529|NCT02496884|65693528|FG000|Overall Study|Withdrawal by Subject|0|||
23535530|NCT02496884|65693529|FG001|Overall Study|Withdrawal by Subject|3|||
23535531|NCT02496884|65693530|FG002|Overall Study|Withdrawal by Subject|0|||
23535532|NCT02496884|65693531|FG003|Overall Study|Withdrawal by Subject|0|||
23535533|NCT02047604|65693532|FG000|Overall Study|Withdrawal by Subject|0|||
23535534|NCT02047604|65693533|FG001|Overall Study|Withdrawal by Subject|0|||
23535535|NCT02047604|65693534|FG002|Overall Study|Withdrawal by Subject|0|||
23615748|NCT01257698|65979469|FG000|Overall Study|Protocol Violation|4|||
23615749|NCT01257698|65979470|FG001|Overall Study|Protocol Violation|0|||
23615750|NCT02515097|65979477|FG000|Overall Study|Lost to Follow-up|4|||
23615751|NCT02515097|65979478|FG001|Overall Study|Lost to Follow-up|2|||
23615752|NCT02515097|65979477|FG000|Overall Study|Withdrawal by Subject|1|||
23615753|NCT02515097|65979478|FG001|Overall Study|Withdrawal by Subject|3|||
23615754|NCT02515097|65979477|FG000|Overall Study|Adverse Event|2|||
23615755|NCT02515097|65979478|FG001|Overall Study|Adverse Event|1|||
23423283|NCT00790868|65292632|FG001|Overall Study|Withdrawal by Subject|5|||
23535536|NCT02047604|65693535|FG003|Overall Study|Withdrawal by Subject|0|||
23615756|NCT03049306|65979479|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
23615757|NCT03049306|65979480|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
23615758|NCT01485991|65979481|FG000|Overall Study|Adverse Event|0|||
23615759|NCT01485991|65979482|FG001|Overall Study|Adverse Event|4|||
23615760|NCT01485991|65979481|FG000|Overall Study|Lost to Follow-up|13|||
23615761|NCT01485991|65979482|FG001|Overall Study|Lost to Follow-up|10|||
23615762|NCT01485991|65979481|FG000|Overall Study|Withdrawal by Subject|13|||
23615763|NCT01485991|65979482|FG001|Overall Study|Withdrawal by Subject|20|||
23615764|NCT01485991|65979481|FG000|Overall Study|randomized but not treated|6|||
23615765|NCT01485991|65979482|FG001|Overall Study|randomized but not treated|2|||
23615766|NCT01032200|65979493|FG000|Overall Study|Death|1|||
23615767|NCT01032200|65979494|FG001|Overall Study|Death|1|||
23615768|NCT01032200|65979493|FG000|Overall Study|Withdrawal by Subject|1|||
23615769|NCT01032200|65979494|FG001|Overall Study|Withdrawal by Subject|3|||
23615770|NCT01032200|65979493|FG000|Overall Study|Toxicity|0|||
23615771|NCT01032200|65979494|FG001|Overall Study|Toxicity|2|||
23615772|NCT01032200|65979493|FG000|Overall Study|Progression|1|||
23615773|NCT01032200|65979494|FG001|Overall Study|Progression|0|||
23615774|NCT01032200|65979493|FG000|Overall Study|Multiple|1|||
23615775|NCT01032200|65979494|FG001|Overall Study|Multiple|1|||
23615776|NCT02161185|65979495|FG000|Treatment Phase|Administrative/Other|7|||
23615777|NCT00562484|65979498|FG000|Overall Study|Adverse Event|6|||
23615778|NCT00562484|65979499|FG001|Overall Study|Adverse Event|1|||
23615779|NCT00562484|65979498|FG000|Overall Study|Protocol Violation|11|||
23615780|NCT00562484|65979499|FG001|Overall Study|Protocol Violation|2|||
23615781|NCT00562484|65979498|FG000|Overall Study|Withdrawal by Subject|12|||
23615782|NCT00562484|65979499|FG001|Overall Study|Withdrawal by Subject|9|||
23615783|NCT00562484|65979498|FG000|Overall Study|Moved away from the study area|20|||
23615784|NCT00562484|65979499|FG001|Overall Study|Moved away from the study area|9|||
23615785|NCT00562484|65979498|FG000|Overall Study|Lost to Follow-up|132|||
23615786|NCT00562484|65979499|FG001|Overall Study|Lost to Follow-up|71|||
23615787|NCT00562484|65979498|FG000|Overall Study|Reason not provided or not specified|25|||
23615788|NCT00562484|65979499|FG001|Overall Study|Reason not provided or not specified|12|||
23615789|NCT01107912|65979500|FG000|Period 1|Adverse Event|0|||
23615790|NCT01107912|65979501|FG001|Period 1|Adverse Event|0|||
23615791|NCT01107912|65979502|FG002|Period 1|Adverse Event|0|||
23615792|NCT01107912|65979503|FG003|Period 1|Adverse Event|0|||
23615793|NCT01107912|65979504|FG004|Period 1|Adverse Event|2|||
23615794|NCT01107912|65979505|FG005|Period 1|Adverse Event|0|||
23615795|NCT01107912|65979500|FG000|Period 1|Physician Decision|0|||
23615796|NCT01107912|65979501|FG001|Period 1|Physician Decision|0|||
23615797|NCT01107912|65979502|FG002|Period 1|Physician Decision|0|||
23615798|NCT01107912|65979503|FG003|Period 1|Physician Decision|0|||
23615799|NCT01107912|65979504|FG004|Period 1|Physician Decision|1|||
23615800|NCT01107912|65979505|FG005|Period 1|Physician Decision|0|||
23615801|NCT01107912|65979500|FG000|Period 1|Withdrawal by Subject|1|||
23615802|NCT01107912|65979501|FG001|Period 1|Withdrawal by Subject|0|||
23615803|NCT01107912|65979502|FG002|Period 1|Withdrawal by Subject|0|||
23615804|NCT01107912|65979503|FG003|Period 1|Withdrawal by Subject|0|||
23615805|NCT01107912|65979504|FG004|Period 1|Withdrawal by Subject|0|||
23615806|NCT01107912|65979505|FG005|Period 1|Withdrawal by Subject|0|||
23615807|NCT01107912|65979500|FG000|Period 2|Physician Decision|0|||
23535537|NCT02047604|65693536|FG004|Overall Study|Withdrawal by Subject|1|||
23535538|NCT02047604|65693537|FG005|Overall Study|Withdrawal by Subject|1|||
23535539|NCT03285646|65693538|FG000|Overall Study|Adverse Event|1|||
23535540|NCT03285646|65693539|FG001|Overall Study|Adverse Event|0|||
23535541|NCT03285646|65693538|FG000|Overall Study|Withdrawal by Subject|10|||
23535542|NCT03285646|65693539|FG001|Overall Study|Withdrawal by Subject|2|||
23535543|NCT03285646|65693538|FG000|Overall Study|Lost to Follow-up|2|||
23535544|NCT03285646|65693539|FG001|Overall Study|Lost to Follow-up|1|||
23535545|NCT03285646|65693538|FG000|Overall Study|Investigator/Sponsor Decision|0|||
23535546|NCT03285646|65693539|FG001|Overall Study|Investigator/Sponsor Decision|1|||
23535547|NCT01175824|65693540|FG000|Overall Study|Adverse Event|2|||
23535548|NCT01175824|65693541|FG001|Overall Study|Adverse Event|1|||
23535549|NCT01175824|65693540|FG000|Overall Study|Lack of Efficacy|2|||
23535550|NCT01175824|65693541|FG001|Overall Study|Lack of Efficacy|0|||
23535551|NCT01175824|65693540|FG000|Overall Study|Lost to Follow-up|0|||
23535552|NCT01175824|65693541|FG001|Overall Study|Lost to Follow-up|1|||
23535553|NCT01175824|65693540|FG000|Overall Study|Physician Decision|0|||
23615808|NCT01107912|65979501|FG001|Period 2|Physician Decision|0|||
23615809|NCT01107912|65979502|FG002|Period 2|Physician Decision|1|||
23615810|NCT01107912|65979503|FG003|Period 2|Physician Decision|0|||
23615811|NCT01107912|65979504|FG004|Period 2|Physician Decision|0|||
23615812|NCT01107912|65979505|FG005|Period 2|Physician Decision|0|||
23615813|NCT01107912|65979500|FG000|Period 3|Adverse Event|0|||
23615814|NCT01107912|65979501|FG001|Period 3|Adverse Event|1|||
23535554|NCT01175824|65693541|FG001|Overall Study|Physician Decision|4|||
23535555|NCT01175824|65693540|FG000|Overall Study|Protocol Violation|2|||
23535556|NCT01175824|65693541|FG001|Overall Study|Protocol Violation|5|||
23535557|NCT01175824|65693540|FG000|Overall Study|Withdrawal by Subject|3|||
23615815|NCT01107912|65979502|FG002|Period 3|Adverse Event|1|||
23615816|NCT01107912|65979503|FG003|Period 3|Adverse Event|0|||
23615817|NCT01107912|65979504|FG004|Period 3|Adverse Event|0|||
23615818|NCT01107912|65979505|FG005|Period 3|Adverse Event|0|||
23615819|NCT01107912|65979500|FG000|Period 3|Withdrawal by Subject|0|||
23615820|NCT01107912|65979501|FG001|Period 3|Withdrawal by Subject|0|||
23615821|NCT01107912|65979502|FG002|Period 3|Withdrawal by Subject|0|||
23615822|NCT01107912|65979503|FG003|Period 3|Withdrawal by Subject|1|||
23615823|NCT01107912|65979504|FG004|Period 3|Withdrawal by Subject|0|||
23615824|NCT01107912|65979505|FG005|Period 3|Withdrawal by Subject|0|||
23615825|NCT02065895|65979507|FG000|Overall Study|Protocol Violation|1|||
23615826|NCT02065895|65979508|FG001|Overall Study|Protocol Violation|0|||
23615827|NCT02065895|65979509|FG002|Overall Study|Protocol Violation|0|||
23615828|NCT02065895|65979510|FG003|Overall Study|Protocol Violation|1|||
23615829|NCT02065895|65979511|FG004|Overall Study|Protocol Violation|0|||
23615830|NCT02065895|65979512|FG005|Overall Study|Protocol Violation|0|||
23615831|NCT02065895|65979507|FG000|Overall Study|Scheduling conflicts|0|||
23615832|NCT02065895|65979508|FG001|Overall Study|Scheduling conflicts|1|||
23615833|NCT02065895|65979509|FG002|Overall Study|Scheduling conflicts|0|||
23615834|NCT02065895|65979510|FG003|Overall Study|Scheduling conflicts|0|||
23615835|NCT02065895|65979511|FG004|Overall Study|Scheduling conflicts|0|||
23615836|NCT02065895|65979512|FG005|Overall Study|Scheduling conflicts|0|||
23615837|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
23615838|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
23615839|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
23615840|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
23615841|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
23615842|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
23615843|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
23615844|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
23615845|NCT02213458|65979524|FG000|Overall Study|Refused re-consent|6|||
23615846|NCT02213458|65979525|FG001|Overall Study|Refused re-consent|0|||
23615847|NCT02213458|65979524|FG000|Overall Study|Lost to Follow-up|2|||
23615848|NCT02213458|65979525|FG001|Overall Study|Lost to Follow-up|2|||
23615849|NCT02213458|65979524|FG000|Overall Study|Withdrawal by Subject|26|||
23722958|NCT00379236|66362991|FG000|Open-label Extension|Withdrawal by Subject|0|||
23722959|NCT00379236|66362992|FG001|Open-label Extension|Withdrawal by Subject|0|||
23722960|NCT00379236|66362993|FG002|Open-label Extension|Withdrawal by Subject|13|||
23535558|NCT01175824|65693541|FG001|Overall Study|Withdrawal by Subject|7|||
23535559|NCT01175824|65693540|FG000|Overall Study|Sponsor Decision|1|||
23535560|NCT01175824|65693541|FG001|Overall Study|Sponsor Decision|0|||
23722961|NCT00379236|66362991|FG000|Open-label Extension|Lost to Follow-up|0|||
23722962|NCT00379236|66362992|FG001|Open-label Extension|Lost to Follow-up|0|||
23535561|NCT01175824|65693540|FG000|Overall Study|Entry Criteria Not Met|6|||
23535562|NCT01175824|65693541|FG001|Overall Study|Entry Criteria Not Met|4|||
23535563|NCT01332149|65693544|FG000|Overall Study|Adverse Event|11|||
23535564|NCT01332149|65693545|FG001|Overall Study|Adverse Event|9|||
23535565|NCT01332149|65693544|FG000|Overall Study|Other unspecified|5|||
23535566|NCT01332149|65693545|FG001|Overall Study|Other unspecified|7|||
23535567|NCT01332149|65693544|FG000|Overall Study|Protocol Violation|1|||
23535568|NCT01332149|65693545|FG001|Overall Study|Protocol Violation|3|||
23535569|NCT01332149|65693544|FG000|Overall Study|Withdrawal by Subject|4|||
23535570|NCT01332149|65693545|FG001|Overall Study|Withdrawal by Subject|5|||
23535571|NCT01332149|65693544|FG000|Overall Study|Lost to Follow-up|1|||
23535572|NCT01332149|65693545|FG001|Overall Study|Lost to Follow-up|1|||
23535573|NCT01332149|65693544|FG000|Overall Study|Insufficient clinical response|4|||
23535574|NCT01332149|65693545|FG001|Overall Study|Insufficient clinical response|7|||
23535575|NCT01332149|65693544|FG000|Overall Study|Did not meet entrance criteria|3|||
23535576|NCT01332149|65693545|FG001|Overall Study|Did not meet entrance criteria|4|||
23535577|NCT01332149|65693544|FG000|Overall Study|Randomized but not treated|1|||
23535578|NCT01332149|65693545|FG001|Overall Study|Randomized but not treated|2|||
23722963|NCT00379236|66362993|FG002|Open-label Extension|Lost to Follow-up|12|||
23722964|NCT00379236|66362991|FG000|Open-label Extension|Use of exclusionary medication|0|||
23722965|NCT00379236|66362992|FG001|Open-label Extension|Use of exclusionary medication|0|||
23722966|NCT00379236|66362993|FG002|Open-label Extension|Use of exclusionary medication|3|||
23722967|NCT00379236|66362991|FG000|Open-label Extension|Other|0|||
23722968|NCT00379236|66362992|FG001|Open-label Extension|Other|0|||
23722969|NCT00379236|66362993|FG002|Open-label Extension|Other|7|||
23815701|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
23815702|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
23535579|NCT03219333|65693546|FG000|Overall Study|Withdrawal by Subject|9|||
23535580|NCT03219333|65693547|FG001|Overall Study|Withdrawal by Subject|4|||
23535581|NCT03219333|65693546|FG000|Overall Study|Lost to Follow-up|1|||
23535582|NCT03219333|65693547|FG001|Overall Study|Lost to Follow-up|1|||
23535583|NCT03219333|65693546|FG000|Overall Study|Death|104|||
23722970|NCT02254551|66362998|FG000|Dose Escalation|Physician Decision|1|||
23722971|NCT02254551|66362998|FG000|Dose Escalation|Dose-limiting toxicity|2|||
23722972|NCT00209170|66363004|FG000|Overall Study|Adverse Event|0|||
23722973|NCT00209170|66363005|FG001|Overall Study|Adverse Event|1|||
23722974|NCT00209170|66363004|FG000|Overall Study|Withdrawal by Subject|2|||
23722975|NCT00209170|66363005|FG001|Overall Study|Withdrawal by Subject|1|||
23722976|NCT00209170|66363004|FG000|Overall Study|Lack of Efficacy|0|||
23722977|NCT00209170|66363005|FG001|Overall Study|Lack of Efficacy|1|||
23722978|NCT00367432|66363007|FG000|First Period (16 Weeks)|Adverse Event|6|||
23722979|NCT00367432|66363008|FG001|First Period (16 Weeks)|Adverse Event|0|||
23722980|NCT00367432|66363007|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
23815703|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
23815704|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
23615850|NCT02213458|65979525|FG001|Overall Study|Withdrawal by Subject|8|||
23615851|NCT00850993|65979526|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
23615852|NCT00850993|65979527|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
23615853|NCT00850993|65979528|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
23615854|NCT00850993|65979529|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
23615855|NCT03302559|65979533|FG000|Overall Study|Adverse Event|2|||
23615856|NCT03302559|65979533|FG000|Overall Study|Lost to Follow-up|1|||
23615857|NCT03302559|65979533|FG000|Overall Study|Withdrew Consent|3|||
23615858|NCT01870999|65979542|FG000|Overall Study|Adverse Event|0|||
23615859|NCT01870999|65979543|FG001|Overall Study|Adverse Event|4|||
23615860|NCT01870999|65979544|FG002|Overall Study|Adverse Event|1|||
23615861|NCT01870999|65979542|FG000|Overall Study|Subject met withdrawal criteria|3|||
23615862|NCT01870999|65979543|FG001|Overall Study|Subject met withdrawal criteria|2|||
23615863|NCT01870999|65979544|FG002|Overall Study|Subject met withdrawal criteria|0|||
23615864|NCT01870999|65979542|FG000|Overall Study|Subject withdrawn by Investigator|1|||
23615865|NCT01870999|65979543|FG001|Overall Study|Subject withdrawn by Investigator|0|||
23615866|NCT01870999|65979544|FG002|Overall Study|Subject withdrawn by Investigator|0|||
23615867|NCT01870999|65979542|FG000|Overall Study|Withdrawal by Subject|0|||
23615868|NCT01870999|65979543|FG001|Overall Study|Withdrawal by Subject|2|||
23615869|NCT01870999|65979544|FG002|Overall Study|Withdrawal by Subject|5|||
23615870|NCT01870999|65979542|FG000|Overall Study|Protocol Violation|0|||
23615871|NCT01870999|65979543|FG001|Overall Study|Protocol Violation|0|||
23815705|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
23815706|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
23815707|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
23535584|NCT03219333|65693547|FG001|Overall Study|Death|72|||
23535585|NCT03219333|65693546|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
23535586|NCT03219333|65693547|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
23535587|NCT03219333|65693546|FG000|Overall Study|Other|2|||
23535588|NCT03219333|65693547|FG001|Overall Study|Other|2|||
23535589|NCT00612313|65693548|FG000|Overall Study|Withdrawal by Subject|6|||
23815708|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
23815709|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
23815710|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
23815711|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
23815712|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
23815713|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
23815714|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
23815715|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
23815716|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
23815717|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
23815718|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
23535590|NCT00612313|65693549|FG001|Overall Study|Withdrawal by Subject|9|||
23535591|NCT00612313|65693548|FG000|Overall Study|Lost to Follow-up|11|||
23535592|NCT00612313|65693549|FG001|Overall Study|Lost to Follow-up|4|||
23535593|NCT02752048|65693552|FG000|Overall Study|Withdrawal by Subject|0|||
23535594|NCT02752048|65693553|FG001|Overall Study|Withdrawal by Subject|0|||
23535595|NCT02752048|65693554|FG002|Overall Study|Withdrawal by Subject|3|||
23535596|NCT01975389|65693555|FG000|Overall Study|Adverse Event|10|||
23535597|NCT01975389|65693556|FG001|Overall Study|Adverse Event|6|||
23535598|NCT01975389|65693555|FG000|Overall Study|Death|61|||
23815719|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
23815720|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
23815721|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
23815722|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
23535599|NCT01975389|65693556|FG001|Overall Study|Death|54|||
23535600|NCT01975389|65693555|FG000|Overall Study|Lost to Follow-up|81|||
23535601|NCT01975389|65693556|FG001|Overall Study|Lost to Follow-up|86|||
23615872|NCT01870999|65979544|FG002|Overall Study|Protocol Violation|1|||
23615873|NCT00382408|65979545|FG000|Overall Study|Did not meet protocol requirement|3|||
23535602|NCT01975389|65693555|FG000|Overall Study|Withdrawal by Subject|90|||
23615874|NCT00382408|65979546|FG001|Overall Study|Did not meet protocol requirement|3|||
23615875|NCT00382408|65979545|FG000|Overall Study|Protocol Violation|2|||
23615876|NCT00382408|65979546|FG001|Overall Study|Protocol Violation|2|||
23615877|NCT00382408|65979545|FG000|Overall Study|Physician Decision|1|||
23615878|NCT00382408|65979546|FG001|Overall Study|Physician Decision|0|||
23615879|NCT00382408|65979545|FG000|Overall Study|Withdrawal by Subject|17|||
23615880|NCT00382408|65979546|FG001|Overall Study|Withdrawal by Subject|6|||
23615881|NCT00382408|65979545|FG000|Overall Study|Pregnancy|2|||
23615882|NCT00382408|65979546|FG001|Overall Study|Pregnancy|0|||
23615883|NCT00382408|65979545|FG000|Overall Study|Lost to Follow-up|19|||
23615884|NCT00382408|65979546|FG001|Overall Study|Lost to Follow-up|8|||
23615885|NCT00382408|65979545|FG000|Overall Study|Other|100|||
23615886|NCT00382408|65979546|FG001|Overall Study|Other|35|||
23615887|NCT02864342|65979550|FG000|Overall Study|Eligibility Criteria Deviation|2|||
23615888|NCT02864342|65979551|FG001|Overall Study|Eligibility Criteria Deviation|3|||
23615889|NCT02864342|65979550|FG000|Overall Study|Withdrawal by Subject|4|||
23535603|NCT01975389|65693556|FG001|Overall Study|Withdrawal by Subject|76|||
23535604|NCT01975389|65693555|FG000|Overall Study|Other|6|||
23535605|NCT01975389|65693556|FG001|Overall Study|Other|9|||
23535606|NCT01975389|65693555|FG000|Overall Study|Randomized, not treated|4|||
23535607|NCT01975389|65693556|FG001|Overall Study|Randomized, not treated|5|||
23535608|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535609|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535610|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
23535611|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535612|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535613|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
23535614|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535615|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
23535616|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
23535617|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
23535618|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23535619|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
23535620|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23535621|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23535622|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
23535623|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535624|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535625|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535626|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535627|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535628|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535629|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23535630|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535631|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23535632|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535633|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535634|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
23535635|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535636|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535637|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535638|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535639|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535640|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535641|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535642|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535643|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535644|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535645|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535646|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535647|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23615890|NCT02864342|65979551|FG001|Overall Study|Withdrawal by Subject|2|||
23615891|NCT02864342|65979550|FG000|Overall Study|Device Technology Issue|6|||
23615892|NCT02864342|65979551|FG001|Overall Study|Device Technology Issue|7|||
23615893|NCT02864342|65979550|FG000|Overall Study|Death|0|||
23615894|NCT02864342|65979551|FG001|Overall Study|Death|1|||
23615895|NCT02864342|65979550|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
23615896|NCT02864342|65979551|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
23615897|NCT02864342|65979550|FG000|Overall Study|Lost to Follow-up|1|||
23615898|NCT02864342|65979551|FG001|Overall Study|Lost to Follow-up|5|||
23615899|NCT02864342|65979550|FG000|Overall Study|Lost Device|1|||
23615900|NCT02864342|65979551|FG001|Overall Study|Lost Device|0|||
23615901|NCT02864342|65979550|FG000|Overall Study|Adverse Event|1|||
23615902|NCT02864342|65979551|FG001|Overall Study|Adverse Event|0|||
23615903|NCT03233204|65979552|FG000|Overall Study|Adverse Event|1|||
23615904|NCT03233204|65979552|FG000|Overall Study|Death|1|||
23615905|NCT03233204|65979552|FG000|Overall Study|Withdrawal by Subject|1|||
23615906|NCT03233204|65979552|FG000|Overall Study|Progressive Disease|3|||
23615907|NCT00759681|65979554|FG000|Overall Study|Death|2|||
23615908|NCT00759681|65979555|FG001|Overall Study|Death|5|||
23615909|NCT00759681|65979554|FG000|Overall Study|Lost to Follow-up|8|||
23615910|NCT00759681|65979555|FG001|Overall Study|Lost to Follow-up|5|||
23722981|NCT00367432|66363008|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
23722982|NCT00367432|66363007|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
23815723|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
23815724|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
23815725|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815726|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815727|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815728|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815729|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815730|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815731|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23535648|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
23535649|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535650|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535651|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535652|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535653|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535654|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535655|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535656|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535657|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23535658|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535659|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
23722983|NCT00367432|66363008|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
23722984|NCT00367432|66363007|FG000|First Period (16 Weeks)|Other Reason|2|||
23535660|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23535661|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535662|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535663|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535664|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535665|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535666|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535667|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535668|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535669|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
23535670|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535671|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535672|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535673|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535674|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
23535675|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535676|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23615911|NCT01572493|65979559|FG000|Overall Study|Physician Decision|1|||
23615912|NCT01572493|65979560|FG001|Overall Study|Physician Decision|0|||
23615913|NCT01572493|65979561|FG002|Overall Study|Physician Decision|0|||
23615914|NCT01572493|65979562|FG003|Overall Study|Physician Decision|0|||
23615915|NCT01572493|65979563|FG004|Overall Study|Physician Decision|0|||
23615916|NCT01572493|65979564|FG005|Overall Study|Physician Decision|0|||
23722985|NCT00367432|66363008|FG001|First Period (16 Weeks)|Other Reason|0|||
23722986|NCT00367432|66363007|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
23722987|NCT00367432|66363008|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
23722988|NCT00367432|66363007|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
23423284|NCT00790868|65292631|FG000|Overall Study|Lost to Follow-up|2|||
23615917|NCT01572493|65979565|FG006|Overall Study|Physician Decision|0|||
23615918|NCT01572493|65979566|FG007|Overall Study|Physician Decision|0|||
23615919|NCT01572493|65979567|FG008|Overall Study|Physician Decision|0|||
23615920|NCT01572493|65979559|FG000|Overall Study|Switched to alternative treatment|0|||
23615921|NCT01572493|65979560|FG001|Overall Study|Switched to alternative treatment|1|||
23615922|NCT01572493|65979561|FG002|Overall Study|Switched to alternative treatment|2|||
23615923|NCT01572493|65979562|FG003|Overall Study|Switched to alternative treatment|1|||
23615924|NCT01572493|65979563|FG004|Overall Study|Switched to alternative treatment|2|||
23615925|NCT01572493|65979564|FG005|Overall Study|Switched to alternative treatment|0|||
23535677|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23535678|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535679|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535680|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535681|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535682|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535683|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23615926|NCT01572493|65979565|FG006|Overall Study|Switched to alternative treatment|2|||
23615927|NCT01572493|65979566|FG007|Overall Study|Switched to alternative treatment|0|||
23615928|NCT01572493|65979567|FG008|Overall Study|Switched to alternative treatment|2|||
23615929|NCT01572493|65979559|FG000|Overall Study|Death|0|||
23615930|NCT01572493|65979560|FG001|Overall Study|Death|0|||
23615931|NCT01572493|65979561|FG002|Overall Study|Death|0|||
23615932|NCT01572493|65979562|FG003|Overall Study|Death|1|||
23615933|NCT01572493|65979563|FG004|Overall Study|Death|0|||
23615934|NCT01572493|65979564|FG005|Overall Study|Death|1|||
23615935|NCT01572493|65979565|FG006|Overall Study|Death|0|||
23615936|NCT01572493|65979566|FG007|Overall Study|Death|0|||
23615937|NCT01572493|65979567|FG008|Overall Study|Death|0|||
23615938|NCT01572493|65979559|FG000|Overall Study|Adverse Event|0|||
23615939|NCT01572493|65979560|FG001|Overall Study|Adverse Event|0|||
23615940|NCT01572493|65979561|FG002|Overall Study|Adverse Event|0|||
23615941|NCT01572493|65979562|FG003|Overall Study|Adverse Event|0|||
23615942|NCT01572493|65979563|FG004|Overall Study|Adverse Event|0|||
23615943|NCT01572493|65979564|FG005|Overall Study|Adverse Event|0|||
23615944|NCT01572493|65979565|FG006|Overall Study|Adverse Event|1|||
23615945|NCT01572493|65979566|FG007|Overall Study|Adverse Event|0|||
23615946|NCT01572493|65979567|FG008|Overall Study|Adverse Event|0|||
23615947|NCT02965599|65979568|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
23615948|NCT02965599|65979569|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
23615949|NCT02706834|65979570|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23615950|NCT02706834|65979571|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23615951|NCT02706834|65979572|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23615952|NCT02706834|65979573|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23615953|NCT02706834|65979574|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23615954|NCT02706834|65979575|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23615955|NCT02706834|65979576|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
23615956|NCT02706834|65979577|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
23615957|NCT02706834|65979578|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
23615958|NCT02706834|65979579|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
23615959|NCT02706834|65979580|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
23615960|NCT02706834|65979570|FG000|Overall Study|Lost to Follow-up|0|||
23615961|NCT02706834|65979571|FG001|Overall Study|Lost to Follow-up|0|||
23615962|NCT02706834|65979572|FG002|Overall Study|Lost to Follow-up|1|||
23615963|NCT02706834|65979573|FG003|Overall Study|Lost to Follow-up|0|||
23615964|NCT02706834|65979574|FG004|Overall Study|Lost to Follow-up|0|||
23615965|NCT02706834|65979575|FG005|Overall Study|Lost to Follow-up|0|||
23615966|NCT02706834|65979576|FG006|Overall Study|Lost to Follow-up|0|||
23615967|NCT02706834|65979577|FG007|Overall Study|Lost to Follow-up|0|||
23615968|NCT02706834|65979578|FG008|Overall Study|Lost to Follow-up|0|||
23615969|NCT02706834|65979579|FG009|Overall Study|Lost to Follow-up|0|||
23615970|NCT02706834|65979580|FG010|Overall Study|Lost to Follow-up|0|||
23615971|NCT02706834|65979570|FG000|Overall Study|Voluntary Withdrawal|1|||
23615972|NCT02706834|65979571|FG001|Overall Study|Voluntary Withdrawal|0|||
23615973|NCT02706834|65979572|FG002|Overall Study|Voluntary Withdrawal|0|||
23615974|NCT02706834|65979573|FG003|Overall Study|Voluntary Withdrawal|0|||
23615975|NCT02706834|65979574|FG004|Overall Study|Voluntary Withdrawal|0|||
23615976|NCT02706834|65979575|FG005|Overall Study|Voluntary Withdrawal|0|||
23615977|NCT02706834|65979576|FG006|Overall Study|Voluntary Withdrawal|0|||
23615978|NCT02706834|65979577|FG007|Overall Study|Voluntary Withdrawal|0|||
23615979|NCT02706834|65979578|FG008|Overall Study|Voluntary Withdrawal|0|||
23615980|NCT02706834|65979579|FG009|Overall Study|Voluntary Withdrawal|1|||
23615981|NCT02706834|65979580|FG010|Overall Study|Voluntary Withdrawal|0|||
23615982|NCT02706834|65979570|FG000|Overall Study|Other Reason Not Specified|1|||
23615983|NCT02706834|65979571|FG001|Overall Study|Other Reason Not Specified|0|||
23615984|NCT02706834|65979572|FG002|Overall Study|Other Reason Not Specified|0|||
23615985|NCT02706834|65979573|FG003|Overall Study|Other Reason Not Specified|0|||
23615986|NCT02706834|65979574|FG004|Overall Study|Other Reason Not Specified|1|||
23615987|NCT02706834|65979575|FG005|Overall Study|Other Reason Not Specified|0|||
23615988|NCT02706834|65979576|FG006|Overall Study|Other Reason Not Specified|0|||
23615989|NCT02706834|65979577|FG007|Overall Study|Other Reason Not Specified|0|||
23615990|NCT02706834|65979578|FG008|Overall Study|Other Reason Not Specified|0|||
23615991|NCT02706834|65979579|FG009|Overall Study|Other Reason Not Specified|0|||
23615992|NCT02706834|65979580|FG010|Overall Study|Other Reason Not Specified|0|||
23615993|NCT01177228|65979581|FG000|Overall Study|Positive tuberculosis test|0|||
23615994|NCT01177228|65979582|FG001|Overall Study|Positive tuberculosis test|1|||
23615995|NCT01177228|65979583|FG002|Overall Study|Positive tuberculosis test|0|||
23615996|NCT01177228|65979584|FG003|Overall Study|Positive tuberculosis test|0|||
23615997|NCT01177228|65979581|FG000|Overall Study|Worsening disease activity|1|||
23615998|NCT01177228|65979582|FG001|Overall Study|Worsening disease activity|0|||
23615999|NCT01177228|65979583|FG002|Overall Study|Worsening disease activity|0|||
23616000|NCT01177228|65979584|FG003|Overall Study|Worsening disease activity|0|||
23616001|NCT01177228|65979581|FG000|Overall Study|Withdrawal by Subject|0|||
23616002|NCT01177228|65979582|FG001|Overall Study|Withdrawal by Subject|1|||
23616003|NCT01177228|65979583|FG002|Overall Study|Withdrawal by Subject|0|||
23722989|NCT00367432|66363008|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
23722990|NCT00367432|66363007|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
23722991|NCT00367432|66363008|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
23722992|NCT00367432|66363007|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
23722993|NCT00367432|66363008|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
23722994|NCT00367432|66363007|FG000|Second Period (up to 54 Months)|Other Reason|6|||
23722995|NCT00367432|66363008|FG001|Second Period (up to 54 Months)|Other Reason|2|||
23722996|NCT03287869|66363009|FG000|Overall Study|Adverse Event|14|||
23722997|NCT03287869|66363010|FG001|Overall Study|Adverse Event|12|||
23722998|NCT03287869|66363009|FG000|Overall Study|Lack of Efficacy|1|||
23722999|NCT03287869|66363010|FG001|Overall Study|Lack of Efficacy|0|||
23723000|NCT03287869|66363009|FG000|Overall Study|Lost to Follow-up|13|||
23723001|NCT03287869|66363010|FG001|Overall Study|Lost to Follow-up|19|||
23723002|NCT03287869|66363009|FG000|Overall Study|Non-Compliance With Study Drug|5|||
23723003|NCT03287869|66363010|FG001|Overall Study|Non-Compliance With Study Drug|9|||
23723004|NCT03287869|66363009|FG000|Overall Study|Progressive Disease|1|||
23723005|NCT03287869|66363010|FG001|Overall Study|Progressive Disease|0|||
23723006|NCT03287869|66363009|FG000|Overall Study|Protocol Deviation|2|||
23723007|NCT03287869|66363010|FG001|Overall Study|Protocol Deviation|1|||
23723008|NCT03287869|66363009|FG000|Overall Study|Withdrawal by Subject|36|||
23723009|NCT03287869|66363010|FG001|Overall Study|Withdrawal by Subject|43|||
23723010|NCT03287869|66363009|FG000|Overall Study|Early Closure of the Site|0|||
23535684|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535685|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
23535686|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
23535687|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
23535688|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
23535689|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
23535690|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
23723011|NCT03287869|66363010|FG001|Overall Study|Early Closure of the Site|1|||
23723012|NCT03287869|66363009|FG000|Overall Study|Physician Decision|5|||
23723013|NCT03287869|66363010|FG001|Overall Study|Physician Decision|5|||
23423285|NCT00790868|65292632|FG001|Overall Study|Lost to Follow-up|12|||
23423286|NCT02214225|65292633|FG000|Overall Study|Lost to Follow-up|46|||
23423287|NCT02214225|65292634|FG001|Overall Study|Lost to Follow-up|18|||
23423288|NCT02214225|65292635|FG002|Overall Study|Lost to Follow-up|18|||
23423289|NCT02214225|65292633|FG000|Overall Study|Withdrawal by Subject|2|||
23423290|NCT02214225|65292634|FG001|Overall Study|Withdrawal by Subject|0|||
23423291|NCT02214225|65292635|FG002|Overall Study|Withdrawal by Subject|2|||
23423292|NCT02214225|65292633|FG000|Overall Study|Death|5|||
23423293|NCT02214225|65292634|FG001|Overall Study|Death|0|||
23423294|NCT02214225|65292635|FG002|Overall Study|Death|1|||
23423295|NCT02214225|65292633|FG000|Overall Study|randomized in error, not vaccinated|2|||
23616004|NCT01177228|65979584|FG003|Overall Study|Withdrawal by Subject|0|||
23723014|NCT03287869|66363009|FG000|Overall Study|Reason not Specified|6|||
23723015|NCT03287869|66363010|FG001|Overall Study|Reason not Specified|3|||
23723016|NCT01851863|66363016|FG000|Overall Study|Did not receive study medication|2|||
23723017|NCT01851863|66363017|FG001|Overall Study|Did not receive study medication|5|||
23723018|NCT01851863|66363018|FG002|Overall Study|Did not receive study medication|3|||
23423296|NCT02214225|65292634|FG001|Overall Study|randomized in error, not vaccinated|1|||
23423297|NCT02214225|65292635|FG002|Overall Study|randomized in error, not vaccinated|1|||
23423298|NCT00098722|65292636|FG000|Double Blind Phase|Adverse Event|7|||
23423299|NCT00098722|65292637|FG001|Double Blind Phase|Adverse Event|7|||
23616005|NCT00274846|65979592|FG000|Overall Study|Did not receive adequate NK cells|1|||
23616006|NCT02391116|65979593|FG000|Treatment|Withdrawal by Subject|1|||
23423300|NCT00098722|65292638|FG002|Double Blind Phase|Adverse Event|3|||
23423301|NCT00098722|65292639|FG003|Double Blind Phase|Adverse Event|0|||
23423302|NCT00098722|65292640|FG004|Double Blind Phase|Adverse Event|0|||
23423303|NCT00098722|65292641|FG005|Double Blind Phase|Adverse Event|0|||
23423304|NCT00098722|65292642|FG006|Double Blind Phase|Adverse Event|0|||
23423305|NCT00098722|65292636|FG000|Double Blind Phase|Death|2|||
23423306|NCT00098722|65292637|FG001|Double Blind Phase|Death|5|||
23423307|NCT00098722|65292638|FG002|Double Blind Phase|Death|0|||
23423308|NCT00098722|65292639|FG003|Double Blind Phase|Death|0|||
23423309|NCT00098722|65292640|FG004|Double Blind Phase|Death|0|||
23423310|NCT00098722|65292641|FG005|Double Blind Phase|Death|0|||
23423311|NCT00098722|65292642|FG006|Double Blind Phase|Death|0|||
23423312|NCT00098722|65292636|FG000|Double Blind Phase|Lack of Efficacy|21|||
23423313|NCT00098722|65292637|FG001|Double Blind Phase|Lack of Efficacy|23|||
23423314|NCT00098722|65292638|FG002|Double Blind Phase|Lack of Efficacy|15|||
23423315|NCT00098722|65292639|FG003|Double Blind Phase|Lack of Efficacy|0|||
23423316|NCT00098722|65292640|FG004|Double Blind Phase|Lack of Efficacy|0|||
23423317|NCT00098722|65292641|FG005|Double Blind Phase|Lack of Efficacy|0|||
23423318|NCT00098722|65292642|FG006|Double Blind Phase|Lack of Efficacy|0|||
23423319|NCT00098722|65292636|FG000|Double Blind Phase|Participant defaulted|16|||
23423320|NCT00098722|65292637|FG001|Double Blind Phase|Participant defaulted|11|||
23423321|NCT00098722|65292638|FG002|Double Blind Phase|Participant defaulted|9|||
23423322|NCT00098722|65292639|FG003|Double Blind Phase|Participant defaulted|0|||
23423323|NCT00098722|65292640|FG004|Double Blind Phase|Participant defaulted|0|||
23423324|NCT00098722|65292641|FG005|Double Blind Phase|Participant defaulted|0|||
23423325|NCT00098722|65292642|FG006|Double Blind Phase|Participant defaulted|0|||
23423326|NCT00098722|65292636|FG000|Double Blind Phase|Pregnancy|1|||
23423327|NCT00098722|65292637|FG001|Double Blind Phase|Pregnancy|0|||
23423328|NCT00098722|65292638|FG002|Double Blind Phase|Pregnancy|0|||
23423329|NCT00098722|65292639|FG003|Double Blind Phase|Pregnancy|0|||
23423330|NCT00098722|65292640|FG004|Double Blind Phase|Pregnancy|0|||
23423331|NCT00098722|65292641|FG005|Double Blind Phase|Pregnancy|0|||
23423332|NCT00098722|65292642|FG006|Double Blind Phase|Pregnancy|0|||
23423333|NCT00098722|65292636|FG000|Double Blind Phase|Randomized, not treated|4|||
23423334|NCT00098722|65292637|FG001|Double Blind Phase|Randomized, not treated|3|||
23423335|NCT00098722|65292638|FG002|Double Blind Phase|Randomized, not treated|3|||
23423336|NCT00098722|65292639|FG003|Double Blind Phase|Randomized, not treated|0|||
23423337|NCT00098722|65292640|FG004|Double Blind Phase|Randomized, not treated|0|||
23423338|NCT00098722|65292641|FG005|Double Blind Phase|Randomized, not treated|0|||
23535691|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
23535692|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535693|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
23535694|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535695|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535696|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535697|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
23535698|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535699|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
23535700|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535701|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535702|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535703|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535704|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535705|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535706|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535707|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535708|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535709|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535710|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23423339|NCT00098722|65292642|FG006|Double Blind Phase|Randomized, not treated|0|||
23423340|NCT00098722|65292636|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
23423341|NCT00098722|65292637|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
23423342|NCT00098722|65292638|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
23423343|NCT00098722|65292639|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
23423344|NCT00098722|65292640|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
23423345|NCT00098722|65292641|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
23423346|NCT00098722|65292642|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
23723019|NCT01851863|66363019|FG003|Overall Study|Did not receive study medication|0|||
23423347|NCT00098722|65292636|FG000|Double Blind Phase|Other|7|||
23423348|NCT00098722|65292637|FG001|Double Blind Phase|Other|8|||
23423349|NCT00098722|65292638|FG002|Double Blind Phase|Other|7|||
23423350|NCT00098722|65292639|FG003|Double Blind Phase|Other|0|||
23535711|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535712|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535713|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
23535714|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535715|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535716|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535717|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535718|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535719|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535720|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
23535721|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535722|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535723|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535724|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535725|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535726|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
23535727|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
23535728|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535729|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535730|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535731|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535732|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
23535733|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535734|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23815732|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23535735|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
23535736|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23723020|NCT01851863|66363016|FG000|Overall Study|Lost to Follow-up|3|||
23723021|NCT01851863|66363017|FG001|Overall Study|Lost to Follow-up|4|||
23723022|NCT01851863|66363018|FG002|Overall Study|Lost to Follow-up|2|||
23723023|NCT01851863|66363019|FG003|Overall Study|Lost to Follow-up|3|||
23723024|NCT00469209|66363020|FG000|Overall Study|Adverse Event|1|||
23723025|NCT00469209|66363021|FG001|Overall Study|Adverse Event|0|||
23723026|NCT00469209|66363022|FG002|Overall Study|Adverse Event|1|||
23723027|NCT03934203|66363023|FG000|Overall Study|Adverse Event|0|||
23723028|NCT03934203|66363024|FG001|Overall Study|Adverse Event|0|||
23723029|NCT03934203|66363025|FG002|Overall Study|Adverse Event|1|||
23723030|NCT03934203|66363026|FG003|Overall Study|Adverse Event|0|||
23723031|NCT03934203|66363027|FG004|Overall Study|Adverse Event|1|||
23723032|NCT03934203|66363028|FG005|Overall Study|Adverse Event|0|||
23723033|NCT03934203|66363029|FG006|Overall Study|Adverse Event|2|||
23723034|NCT03934203|66363030|FG007|Overall Study|Adverse Event|0|||
23723035|NCT03934203|66363031|FG008|Overall Study|Adverse Event|0|||
23723036|NCT03934203|66363032|FG009|Overall Study|Adverse Event|0|||
23723037|NCT03934203|66363033|FG010|Overall Study|Adverse Event|0|||
23815733|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23535737|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535738|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535739|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535740|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535741|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535742|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
23535743|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535744|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535745|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535746|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535747|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535748|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535749|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535750|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23616007|NCT02391116|65979593|FG000|Treatment|Protocol Violation|1|||
23723038|NCT03934203|66363034|FG011|Overall Study|Adverse Event|0|||
23723039|NCT03934203|66363035|FG012|Overall Study|Adverse Event|0|||
23723040|NCT03934203|66363036|FG013|Overall Study|Adverse Event|1|||
23723041|NCT03934203|66363037|FG014|Overall Study|Adverse Event|0|||
23723042|NCT00132314|66363041|FG000|Overall Study|Lost to Follow-up|70|||
23815734|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23723043|NCT00132314|66363042|FG001|Overall Study|Lost to Follow-up|62|||
23616008|NCT02391116|65979593|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
23616009|NCT02391116|65979593|FG000|Treatment|AE with Clinical PD|3|||
23616010|NCT02391116|65979593|FG000|Safety Follow-up|Adverse Event|1|||
23616011|NCT02391116|65979593|FG000|Safety Follow-up|Withdrawal by Subject|4|||
23616012|NCT02391116|65979593|FG000|Safety Follow-up|Switching to Other Therapy|4|||
23616013|NCT02391116|65979593|FG000|Safety Follow-up|No Follow Up|1|||
23616014|NCT02391116|65979593|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
23616015|NCT02391116|65979593|FG000|Active Follow-up|Withdrawal by Subject|1|||
23616016|NCT02391116|65979593|FG000|Active Follow-up|Switching to Other Therapy|2|||
23616017|NCT02391116|65979593|FG000|Survival Follow-up|Withdrawal by Subject|3|||
23723044|NCT00132314|66363041|FG000|Overall Study|Lacked SSN|1|||
23815735|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23616018|NCT02391116|65979593|FG000|Survival Follow-up|Switching to Other Therapy|1|||
23616019|NCT00515112|65979597|FG000|Overall Study|Death|0|||
23616020|NCT00515112|65979598|FG001|Overall Study|Death|1|||
23535751|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535752|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535753|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23535754|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23535755|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535756|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535757|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535758|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535759|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535760|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535761|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535762|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
23535763|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535764|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535765|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535766|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23535767|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23535768|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
23535769|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535770|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
23535771|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535772|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535773|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535774|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
23535775|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535776|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
23535777|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535778|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535779|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535780|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535781|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535782|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535783|NCT01573624|65693557|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535784|NCT01573624|65693558|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535785|NCT01573624|65693559|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535786|NCT01573624|65693560|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535787|NCT01573624|65693561|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
23535788|NCT01573624|65693562|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
23535789|NCT01573624|65693563|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535790|NCT01573624|65693557|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
23535791|NCT01573624|65693558|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535792|NCT01573624|65693559|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23616021|NCT00515112|65979597|FG000|Overall Study|The study was terminated|3|||
23616022|NCT00515112|65979598|FG001|Overall Study|The study was terminated|2|||
23616023|NCT02068352|65979599|FG000|Overall Study|Lost to Follow-up|0|||
23616024|NCT02068352|65979600|FG001|Overall Study|Lost to Follow-up|2|||
23616025|NCT02068352|65979601|FG002|Overall Study|Lost to Follow-up|0|||
23616026|NCT02068352|65979599|FG000|Overall Study|Adverse Event|4|||
23815736|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23535793|NCT01573624|65693560|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535794|NCT01573624|65693561|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535795|NCT01573624|65693562|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535796|NCT01573624|65693563|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535797|NCT04448561|65693564|FG000|Overall Study|Noncompliance|1|||
23535798|NCT04448561|65693565|FG001|Overall Study|Noncompliance|0|||
23535799|NCT00304070|65693566|FG000|Overall Study|Death|0|||
23535800|NCT00304070|65693567|FG001|Overall Study|Death|0|||
23535801|NCT00304070|65693568|FG002|Overall Study|Death|3|||
23535802|NCT00304070|65693566|FG000|Overall Study|Lost to Follow-up|0|||
23535803|NCT00304070|65693567|FG001|Overall Study|Lost to Follow-up|0|||
23535804|NCT00304070|65693568|FG002|Overall Study|Lost to Follow-up|1|||
23535805|NCT00304070|65693566|FG000|Overall Study|Physician Decision|0|||
23535806|NCT00304070|65693567|FG001|Overall Study|Physician Decision|0|||
23535807|NCT00304070|65693568|FG002|Overall Study|Physician Decision|3|||
23535808|NCT00304070|65693566|FG000|Overall Study|Withdrawal by Subject|0|||
23535809|NCT00304070|65693567|FG001|Overall Study|Withdrawal by Subject|0|||
23535810|NCT00304070|65693568|FG002|Overall Study|Withdrawal by Subject|1|||
23535811|NCT00304070|65693566|FG000|Overall Study|Progressive Disease|3|||
23535812|NCT00304070|65693567|FG001|Overall Study|Progressive Disease|7|||
23535813|NCT00304070|65693568|FG002|Overall Study|Progressive Disease|4|||
23535814|NCT01101841|65693577|FG000|Overall Study|Adverse Event|15|||
23535815|NCT01101841|65693578|FG001|Overall Study|Adverse Event|15|||
23535816|NCT01101841|65693577|FG000|Overall Study|Lost to Follow-up|9|||
23535817|NCT01101841|65693578|FG001|Overall Study|Lost to Follow-up|3|||
23535818|NCT01101841|65693577|FG000|Overall Study|Withdrawal by Subject|21|||
23535819|NCT01101841|65693578|FG001|Overall Study|Withdrawal by Subject|40|||
23535820|NCT01101841|65693577|FG000|Overall Study|Protocol Violation|1|||
23535821|NCT01101841|65693578|FG001|Overall Study|Protocol Violation|1|||
23535822|NCT01101841|65693577|FG000|Overall Study|Physician Decision|0|||
23535823|NCT01101841|65693578|FG001|Overall Study|Physician Decision|2|||
23535824|NCT01101841|65693577|FG000|Overall Study|Lack of Efficacy|0|||
23535825|NCT01101841|65693578|FG001|Overall Study|Lack of Efficacy|2|||
23535826|NCT01101841|65693577|FG000|Overall Study|Other|0|||
23535827|NCT01101841|65693578|FG001|Overall Study|Other|1|||
23535828|NCT01101841|65693577|FG000|Overall Study|Suicidality Tracking Scale|3|||
23535829|NCT01101841|65693578|FG001|Overall Study|Suicidality Tracking Scale|1|||
23535830|NCT01101841|65693577|FG000|Overall Study|Eligibility Criteria|1|||
23535831|NCT01101841|65693578|FG001|Overall Study|Eligibility Criteria|2|||
23535832|NCT03100825|65693579|FG000|Overall Study|Participant/Guardian Decision|7|||
23535833|NCT03100825|65693579|FG000|Overall Study|Physician Decision|1|||
23535834|NCT00428610|65693580|FG000|Overall Study|Death Due to Adverse Event|3|||
23535835|NCT00428610|65693581|FG001|Overall Study|Death Due to Adverse Event|0|||
23535836|NCT00428610|65693582|FG002|Overall Study|Death Due to Adverse Event|5|||
23535837|NCT00428610|65693580|FG000|Overall Study|Death Due to Progressive Disease|0|||
23535838|NCT00428610|65693581|FG001|Overall Study|Death Due to Progressive Disease|0|||
23535839|NCT00428610|65693582|FG002|Overall Study|Death Due to Progressive Disease|2|||
23535840|NCT00428610|65693580|FG000|Overall Study|Adverse Event|2|||
23535841|NCT00428610|65693581|FG001|Overall Study|Adverse Event|3|||
23535842|NCT00428610|65693582|FG002|Overall Study|Adverse Event|2|||
23535843|NCT00428610|65693580|FG000|Overall Study|Investigator Decision|2|||
23535844|NCT00428610|65693581|FG001|Overall Study|Investigator Decision|1|||
23535845|NCT00428610|65693582|FG002|Overall Study|Investigator Decision|1|||
23535846|NCT00428610|65693580|FG000|Overall Study|Progressive Disease|42|||
23535847|NCT00428610|65693581|FG001|Overall Study|Progressive Disease|14|||
23535848|NCT00428610|65693582|FG002|Overall Study|Progressive Disease|22|||
23535849|NCT00428610|65693580|FG000|Overall Study|Withdrawal by Subject|4|||
23535850|NCT00428610|65693581|FG001|Overall Study|Withdrawal by Subject|0|||
23535851|NCT00428610|65693582|FG002|Overall Study|Withdrawal by Subject|0|||
23535852|NCT03662750|65693583|FG000|Overall Study|Withdrawal by Subject|1|||
23535853|NCT04442737|65693586|FG000|Overall Study|Lost to Follow-up|1|||
23535854|NCT04442737|65693587|FG001|Overall Study|Lost to Follow-up|3|||
23535855|NCT04442737|65693586|FG000|Overall Study|Withdrawal by Subject|3|||
23535856|NCT04442737|65693587|FG001|Overall Study|Withdrawal by Subject|2|||
23535857|NCT04442737|65693586|FG000|Overall Study|Adverse Event|3|||
23535858|NCT04442737|65693587|FG001|Overall Study|Adverse Event|2|||
23535859|NCT04442737|65693586|FG000|Overall Study|Death|0|||
23616027|NCT02068352|65979600|FG001|Overall Study|Adverse Event|2|||
23535860|NCT04442737|65693587|FG001|Overall Study|Death|1|||
23535861|NCT04442737|65693586|FG000|Overall Study|Protocol Violation|0|||
23535862|NCT04442737|65693587|FG001|Overall Study|Protocol Violation|2|||
23535863|NCT04442737|65693586|FG000|Overall Study|Other|1|||
23535864|NCT04442737|65693587|FG001|Overall Study|Other|1|||
23535865|NCT02337829|65693588|FG000|Overall Study|Death|0|||
23535866|NCT02337829|65693589|FG001|Overall Study|Death|1|||
23535867|NCT02337829|65693590|FG002|Overall Study|Death|0|||
23535868|NCT02337829|65693591|FG003|Overall Study|Death|0|||
23535869|NCT02337829|65693588|FG000|Overall Study|Study terminated by sponsor|12|||
23616028|NCT02068352|65979601|FG002|Overall Study|Adverse Event|7|||
23535870|NCT02337829|65693589|FG001|Overall Study|Study terminated by sponsor|10|||
23535871|NCT02337829|65693590|FG002|Overall Study|Study terminated by sponsor|5|||
23535872|NCT02337829|65693591|FG003|Overall Study|Study terminated by sponsor|6|||
23535873|NCT02337829|65693588|FG000|Overall Study|discontinued for other reasons|6|||
23535874|NCT02337829|65693589|FG001|Overall Study|discontinued for other reasons|3|||
23535875|NCT02337829|65693590|FG002|Overall Study|discontinued for other reasons|1|||
23535876|NCT02337829|65693591|FG003|Overall Study|discontinued for other reasons|4|||
23535877|NCT00120042|65693594|FG000|Overall Study|all completed protocl|0|||
23535878|NCT00120042|65693595|FG001|Overall Study|all completed protocl|0|||
23535879|NCT00120042|65693596|FG002|Overall Study|all completed protocl|0|||
23535880|NCT02566759|65693597|FG000|All Parts|Withdrawal by Subject|0|||
23535881|NCT02566759|65693598|FG001|All Parts|Withdrawal by Subject|1|||
23535882|NCT02566759|65693599|FG002|All Parts|Withdrawal by Subject|0|||
23535883|NCT02566759|65693600|FG003|All Parts|Withdrawal by Subject|0|||
23535884|NCT02566759|65693601|FG004|All Parts|Withdrawal by Subject|0|||
23535885|NCT02566759|65693602|FG005|All Parts|Withdrawal by Subject|0|||
23535886|NCT02566759|65693603|FG006|All Parts|Withdrawal by Subject|0|||
23535887|NCT02566759|65693604|FG007|All Parts|Withdrawal by Subject|0|||
23535888|NCT02566759|65693605|FG008|All Parts|Withdrawal by Subject|0|||
23535889|NCT02566759|65693606|FG009|All Parts|Withdrawal by Subject|0|||
23535890|NCT02566759|65693607|FG010|All Parts|Withdrawal by Subject|0|||
23535891|NCT02566759|65693608|FG011|All Parts|Withdrawal by Subject|0|||
23535892|NCT02566759|65693609|FG012|All Parts|Withdrawal by Subject|0|||
23535893|NCT02566759|65693610|FG013|All Parts|Withdrawal by Subject|0|||
23535894|NCT02566759|65693611|FG014|All Parts|Withdrawal by Subject|0|||
23535895|NCT02566759|65693612|FG015|All Parts|Withdrawal by Subject|0|||
23535896|NCT02566759|65693613|FG016|All Parts|Withdrawal by Subject|0|||
23535897|NCT02566759|65693597|FG000|All Parts|Adverse Event|0|||
23535898|NCT02566759|65693598|FG001|All Parts|Adverse Event|0|||
23535899|NCT02566759|65693599|FG002|All Parts|Adverse Event|0|||
23535900|NCT02566759|65693600|FG003|All Parts|Adverse Event|0|||
23535901|NCT02566759|65693601|FG004|All Parts|Adverse Event|0|||
23535902|NCT02566759|65693602|FG005|All Parts|Adverse Event|0|||
23535903|NCT02566759|65693603|FG006|All Parts|Adverse Event|0|||
23535904|NCT02566759|65693604|FG007|All Parts|Adverse Event|0|||
23535905|NCT02566759|65693605|FG008|All Parts|Adverse Event|0|||
23535906|NCT02566759|65693606|FG009|All Parts|Adverse Event|0|||
23535907|NCT02566759|65693607|FG010|All Parts|Adverse Event|0|||
23535908|NCT02566759|65693608|FG011|All Parts|Adverse Event|0|||
23535909|NCT02566759|65693609|FG012|All Parts|Adverse Event|1|||
23535910|NCT02566759|65693610|FG013|All Parts|Adverse Event|3|||
23535911|NCT02566759|65693611|FG014|All Parts|Adverse Event|0|||
23535912|NCT02566759|65693612|FG015|All Parts|Adverse Event|0|||
23535913|NCT02566759|65693613|FG016|All Parts|Adverse Event|0|||
23535914|NCT02566759|65693597|FG000|All Parts|Other|0|||
23535915|NCT02566759|65693598|FG001|All Parts|Other|0|||
23535916|NCT02566759|65693599|FG002|All Parts|Other|0|||
23535917|NCT02566759|65693600|FG003|All Parts|Other|0|||
23535918|NCT02566759|65693601|FG004|All Parts|Other|0|||
23535919|NCT02566759|65693602|FG005|All Parts|Other|0|||
23535920|NCT02566759|65693603|FG006|All Parts|Other|0|||
23535921|NCT02566759|65693604|FG007|All Parts|Other|0|||
23535922|NCT02566759|65693605|FG008|All Parts|Other|0|||
23535923|NCT02566759|65693606|FG009|All Parts|Other|0|||
23535924|NCT02566759|65693607|FG010|All Parts|Other|0|||
23535925|NCT02566759|65693608|FG011|All Parts|Other|0|||
23535926|NCT02566759|65693609|FG012|All Parts|Other|0|||
23535927|NCT02566759|65693610|FG013|All Parts|Other|2|||
23535928|NCT02566759|65693611|FG014|All Parts|Other|0|||
23535929|NCT02566759|65693612|FG015|All Parts|Other|0|||
23535930|NCT02566759|65693613|FG016|All Parts|Other|0|||
23535931|NCT02566759|65693597|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535932|NCT02566759|65693598|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535933|NCT02566759|65693599|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535934|NCT02566759|65693600|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535935|NCT02566759|65693601|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535936|NCT02566759|65693602|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535937|NCT02566759|65693603|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535938|NCT02566759|65693604|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535939|NCT02566759|65693605|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535940|NCT02566759|65693606|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535941|NCT02566759|65693607|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535942|NCT02566759|65693608|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535943|NCT02566759|65693609|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535944|NCT02566759|65693610|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535945|NCT02566759|65693611|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535946|NCT02566759|65693612|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535947|NCT02566759|65693613|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
23535948|NCT02984020|65693621|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
23535949|NCT02984020|65693621|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
23535950|NCT02984020|65693621|FG000|Overall Study|Other significant protocol violation|2|||
23535951|NCT04327934|65693624|FG000|Overall Study|Did not qualify|7|||
23535952|NCT04327934|65693625|FG001|Overall Study|Did not qualify|4|||
23535953|NCT04327934|65693624|FG000|Overall Study|Physician Decision|0|||
23535954|NCT04327934|65693625|FG001|Overall Study|Physician Decision|1|||
23535955|NCT01565993|65693630|FG000|Overall Study|Physician Decision|0|||
23535956|NCT01565993|65693631|FG001|Overall Study|Physician Decision|3|||
23535957|NCT02473445|65693632|FG000|Overall Study|Withdrawal by Subject|2|||
23535958|NCT02473445|65693632|FG000|Overall Study|Sponsor Decision|20|||
23535959|NCT01083433|65693634|FG000|Overall Study|Lost to Follow-up|2|||
23535960|NCT01083433|65693635|FG001|Overall Study|Lost to Follow-up|1|||
23535961|NCT01083433|65693636|FG002|Overall Study|Lost to Follow-up|1|||
23535962|NCT01083433|65693634|FG000|Overall Study|Withdrawal by Subject|0|||
23535963|NCT01083433|65693635|FG001|Overall Study|Withdrawal by Subject|5|||
23535964|NCT01083433|65693636|FG002|Overall Study|Withdrawal by Subject|3|||
23535965|NCT01083433|65693634|FG000|Overall Study|Pregnancy|0|||
23535966|NCT01083433|65693635|FG001|Overall Study|Pregnancy|0|||
23535967|NCT01083433|65693636|FG002|Overall Study|Pregnancy|1|||
23535968|NCT04369469|65693637|FG000|Overall Study|Lost to Follow-up|2|||
23535969|NCT04369469|65693638|FG001|Overall Study|Lost to Follow-up|4|||
23535970|NCT04369469|65693637|FG000|Overall Study|Physician Decision|2|||
23535971|NCT04369469|65693638|FG001|Overall Study|Physician Decision|1|||
23535972|NCT04369469|65693637|FG000|Overall Study|Withdrawal by Subject|2|||
23535973|NCT04369469|65693638|FG001|Overall Study|Withdrawal by Subject|3|||
23535974|NCT04369469|65693637|FG000|Overall Study|Adverse Event|1|||
23535975|NCT04369469|65693638|FG001|Overall Study|Adverse Event|0|||
23535976|NCT04369469|65693637|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
23535977|NCT04369469|65693638|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
23535978|NCT04369469|65693637|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
23535979|NCT04369469|65693638|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
23535980|NCT04369469|65693637|FG000|Overall Study|Unable to Provide Consent|0|||
23535981|NCT04369469|65693638|FG001|Overall Study|Unable to Provide Consent|1|||
23535982|NCT03459196|65693642|FG000|Overall Study|Subject didn't receive study catheter|2|||
23535983|NCT03495908|65693643|FG000|Overall Study|Withdrawal by Subject|3|||
23535984|NCT03495908|65693644|FG001|Overall Study|Withdrawal by Subject|1|||
23535985|NCT03495908|65693643|FG000|Overall Study|Lost to Follow-up|1|||
23535986|NCT03495908|65693644|FG001|Overall Study|Lost to Follow-up|4|||
23535987|NCT03495908|65693643|FG000|Overall Study|Adverse Event|0|||
23535988|NCT03495908|65693644|FG001|Overall Study|Adverse Event|2|||
23535989|NCT03495908|65693643|FG000|Overall Study|Death|1|||
23535990|NCT03495908|65693644|FG001|Overall Study|Death|0|||
23535991|NCT03495908|65693643|FG000|Overall Study|Physician Decision|5|||
23535992|NCT03495908|65693644|FG001|Overall Study|Physician Decision|4|||
23535993|NCT03495908|65693643|FG000|Overall Study|No documented reason|0|||
23535994|NCT03495908|65693644|FG001|Overall Study|No documented reason|2|||
23535995|NCT01110915|65693645|FG000|Overall Study|Death|2|||
23535996|NCT01110915|65693646|FG001|Overall Study|Death|1|||
23535997|NCT01110915|65693645|FG000|Overall Study|Lost to Follow-up|1|||
23535998|NCT01110915|65693646|FG001|Overall Study|Lost to Follow-up|0|||
23535999|NCT01110915|65693645|FG000|Overall Study|Withdrawal by Subject|7|||
23636609|NCT01827046|66052946|FG000|Overall Study|Withdrawal by Subject|0|||
23815737|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23536000|NCT01110915|65693646|FG001|Overall Study|Withdrawal by Subject|1|||
23536001|NCT02838420|65693651|FG000|Overall Study|Ongoing in Study|113|||
23536002|NCT02838420|65693652|FG001|Overall Study|Ongoing in Study|45|||
23536003|NCT02838420|65693651|FG000|Overall Study|Lost to Follow-up|1|||
23536004|NCT02838420|65693652|FG001|Overall Study|Lost to Follow-up|0|||
23536005|NCT02838420|65693651|FG000|Overall Study|Withdrawal by Subject|3|||
23536006|NCT02838420|65693652|FG001|Overall Study|Withdrawal by Subject|4|||
23536007|NCT02838420|65693651|FG000|Overall Study|Death|8|||
23536008|NCT02838420|65693652|FG001|Overall Study|Death|13|||
23536009|NCT00061048|65693653|FG000|Overall Study|Adverse Event|2|||
23536010|NCT00061048|65693653|FG000|Overall Study|disease progression|20|||
23536011|NCT01752933|65693654|FG000|Treatment|Disease Progression|3|||
23536012|NCT01752933|65693655|FG001|Treatment|Disease Progression|29|||
23536013|NCT01752933|65693654|FG000|Treatment|Withdrawal by Subject|0|||
23536014|NCT01752933|65693655|FG001|Treatment|Withdrawal by Subject|5|||
23536015|NCT01752933|65693654|FG000|Treatment|Adverse Event|1|||
23536016|NCT01752933|65693655|FG001|Treatment|Adverse Event|4|||
23536017|NCT01752933|65693654|FG000|Treatment|Physician Decision|0|||
23536018|NCT01752933|65693655|FG001|Treatment|Physician Decision|3|||
23536019|NCT01752933|65693654|FG000|Treatment|Death|0|||
23536020|NCT01752933|65693655|FG001|Treatment|Death|2|||
23536021|NCT01752933|65693654|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
23536022|NCT01752933|65693655|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
23536023|NCT01752933|65693654|FG000|Treatment|Patient noncompliant|0|||
23636610|NCT01827046|66052947|FG001|Overall Study|Withdrawal by Subject|4|||
23723045|NCT00132314|66363042|FG001|Overall Study|Lacked SSN|3|||
23723046|NCT00132314|66363041|FG000|Overall Study|Refused intervention at baseline|2|||
23723047|NCT00132314|66363042|FG001|Overall Study|Refused intervention at baseline|7|||
23423351|NCT00098722|65292640|FG004|Double Blind Phase|Other|0|||
23423352|NCT00098722|65292641|FG005|Double Blind Phase|Other|0|||
23723048|NCT00565812|66363043|FG000|Overall Study|Death|2|||
23723049|NCT00565812|66363044|FG001|Overall Study|Death|1|||
23723050|NCT00565812|66363045|FG002|Overall Study|Death|3|||
23723051|NCT00565812|66363043|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
23723052|NCT00565812|66363044|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
23723053|NCT00565812|66363045|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
23723054|NCT00565812|66363043|FG000|Overall Study|Lost to Follow-up|10|||
23723055|NCT00565812|66363044|FG001|Overall Study|Lost to Follow-up|8|||
23723056|NCT00565812|66363045|FG002|Overall Study|Lost to Follow-up|8|||
23723057|NCT00565812|66363043|FG000|Overall Study|Withdrawal by Subject|58|||
23723058|NCT00565812|66363044|FG001|Overall Study|Withdrawal by Subject|47|||
23723059|NCT00565812|66363045|FG002|Overall Study|Withdrawal by Subject|48|||
23723060|NCT00565812|66363043|FG000|Overall Study|Work Schedule|5|||
23723061|NCT00565812|66363044|FG001|Overall Study|Work Schedule|3|||
23723062|NCT00565812|66363045|FG002|Overall Study|Work Schedule|1|||
23723063|NCT00565812|66363043|FG000|Overall Study|Protocol Violation|2|||
23723064|NCT00565812|66363044|FG001|Overall Study|Protocol Violation|6|||
23723065|NCT00565812|66363045|FG002|Overall Study|Protocol Violation|4|||
23723066|NCT00565812|66363043|FG000|Overall Study|Adverse Event|41|||
23723067|NCT00565812|66363044|FG001|Overall Study|Adverse Event|54|||
23815738|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23423353|NCT00098722|65292642|FG006|Double Blind Phase|Other|0|||
23423354|NCT00098722|65292636|FG000|Open Label Phase|Adverse Event|0|||
23423355|NCT00098722|65292637|FG001|Open Label Phase|Adverse Event|0|||
23423356|NCT00098722|65292638|FG002|Open Label Phase|Adverse Event|0|||
23423357|NCT00098722|65292639|FG003|Open Label Phase|Adverse Event|5|||
23423358|NCT00098722|65292640|FG004|Open Label Phase|Adverse Event|0|||
23536024|NCT01752933|65693655|FG001|Treatment|Patient noncompliant|1|||
23536025|NCT01752933|65693654|FG000|Treatment|Patient unable to travel to appointments|0|||
23536026|NCT01752933|65693655|FG001|Treatment|Patient unable to travel to appointments|1|||
23536027|NCT01752933|65693654|FG000|Overall Study and Follow-up|Death|4|||
23536028|NCT01752933|65693655|FG001|Overall Study and Follow-up|Death|34|||
23536029|NCT01752933|65693654|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
23536030|NCT01752933|65693655|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
23536031|NCT01752933|65693654|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
23423359|NCT00098722|65292641|FG005|Open Label Phase|Adverse Event|0|||
23536032|NCT01752933|65693655|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
23536033|NCT01752933|65693654|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
23536034|NCT01752933|65693655|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
23536035|NCT01581593|65693657|FG000|Overall Study|Withdrawal by Subject|1|||
23536036|NCT01302964|65693658|FG000|Overall Study|Adverse Event|1|||
23536037|NCT01302964|65693659|FG001|Overall Study|Adverse Event|0|||
23536038|NCT01850004|65693660|FG000|Overall Study|Poor/Non-compliance|1|||
23536039|NCT01850004|65693660|FG000|Overall Study|Participant Withdrew Consent|9|||
23536040|NCT01850004|65693660|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
23536041|NCT01850004|65693660|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23536042|NCT01850004|65693660|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
23536043|NCT01850004|65693660|FG000|Overall Study|Other Reasons|2|||
23536044|NCT01850004|65693660|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
23536045|NCT01850004|65693660|FG000|Overall Study|Maximum Clinical Benefit|4|||
23536046|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Adverse Event|3|||
23536047|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Adverse Event|2|||
23536048|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Adverse Event|0|||
23536049|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Adverse Event|0|||
23536050|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Adverse Event|0|||
23536051|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Adverse Event|0|||
23536052|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Adverse Event|0|||
23536053|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
23536054|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
23536055|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536056|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536057|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536058|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23723068|NCT00565812|66363045|FG002|Overall Study|Adverse Event|40|||
23723069|NCT00565812|66363043|FG000|Overall Study|Jury Duty|1|||
23723070|NCT00565812|66363044|FG001|Overall Study|Jury Duty|0|||
23723071|NCT00565812|66363045|FG002|Overall Study|Jury Duty|0|||
23723072|NCT00565812|66363043|FG000|Overall Study|Relocated Out of Area|5|||
23723073|NCT00565812|66363044|FG001|Overall Study|Relocated Out of Area|8|||
23423360|NCT00098722|65292642|FG006|Open Label Phase|Adverse Event|0|||
23723074|NCT00565812|66363045|FG002|Overall Study|Relocated Out of Area|9|||
23723075|NCT00565812|66363043|FG000|Overall Study|Sponsor Decision|1|||
23723076|NCT00565812|66363044|FG001|Overall Study|Sponsor Decision|5|||
23723077|NCT00565812|66363045|FG002|Overall Study|Sponsor Decision|1|||
23723078|NCT00565812|66363043|FG000|Overall Study|Domestic Reasons|7|||
23723079|NCT00565812|66363044|FG001|Overall Study|Domestic Reasons|1|||
23723080|NCT00565812|66363045|FG002|Overall Study|Domestic Reasons|3|||
23723081|NCT00565812|66363043|FG000|Overall Study|Research Site Closure|6|||
23723082|NCT00565812|66363044|FG001|Overall Study|Research Site Closure|1|||
23423361|NCT00098722|65292636|FG000|Open Label Phase|Death|0|||
23423362|NCT00098722|65292637|FG001|Open Label Phase|Death|0|||
23423363|NCT00098722|65292638|FG002|Open Label Phase|Death|0|||
23423364|NCT00098722|65292639|FG003|Open Label Phase|Death|2|||
23423365|NCT00098722|65292640|FG004|Open Label Phase|Death|0|||
23423366|NCT00098722|65292641|FG005|Open Label Phase|Death|0|||
23423367|NCT00098722|65292642|FG006|Open Label Phase|Death|0|||
23423368|NCT00098722|65292636|FG000|Open Label Phase|Lack of Efficacy|0|||
23423369|NCT00098722|65292637|FG001|Open Label Phase|Lack of Efficacy|0|||
23423370|NCT00098722|65292638|FG002|Open Label Phase|Lack of Efficacy|0|||
23423371|NCT00098722|65292639|FG003|Open Label Phase|Lack of Efficacy|8|||
23423372|NCT00098722|65292640|FG004|Open Label Phase|Lack of Efficacy|0|||
23423373|NCT00098722|65292641|FG005|Open Label Phase|Lack of Efficacy|0|||
23423374|NCT00098722|65292642|FG006|Open Label Phase|Lack of Efficacy|0|||
23423375|NCT00098722|65292636|FG000|Open Label Phase|Pregnancy|0|||
23423376|NCT00098722|65292637|FG001|Open Label Phase|Pregnancy|0|||
23423377|NCT00098722|65292638|FG002|Open Label Phase|Pregnancy|0|||
23423378|NCT00098722|65292639|FG003|Open Label Phase|Pregnancy|1|||
23423379|NCT00098722|65292640|FG004|Open Label Phase|Pregnancy|0|||
23423380|NCT00098722|65292641|FG005|Open Label Phase|Pregnancy|0|||
23423381|NCT00098722|65292642|FG006|Open Label Phase|Pregnancy|0|||
23423382|NCT00098722|65292636|FG000|Open Label Phase|Participant defaulted|0|||
23423383|NCT00098722|65292637|FG001|Open Label Phase|Participant defaulted|0|||
23423384|NCT00098722|65292638|FG002|Open Label Phase|Participant defaulted|0|||
23423385|NCT00098722|65292639|FG003|Open Label Phase|Participant defaulted|18|||
23423386|NCT00098722|65292640|FG004|Open Label Phase|Participant defaulted|0|||
23423387|NCT00098722|65292641|FG005|Open Label Phase|Participant defaulted|0|||
23423388|NCT00098722|65292642|FG006|Open Label Phase|Participant defaulted|0|||
23423389|NCT00098722|65292636|FG000|Open Label Phase|Ongoing at cut-off date|0|||
23423390|NCT00098722|65292637|FG001|Open Label Phase|Ongoing at cut-off date|0|||
23423391|NCT00098722|65292638|FG002|Open Label Phase|Ongoing at cut-off date|0|||
23423392|NCT00098722|65292639|FG003|Open Label Phase|Ongoing at cut-off date|220|||
23423393|NCT00098722|65292640|FG004|Open Label Phase|Ongoing at cut-off date|50|||
23423394|NCT00098722|65292641|FG005|Open Label Phase|Ongoing at cut-off date|0|||
23423395|NCT00098722|65292642|FG006|Open Label Phase|Ongoing at cut-off date|0|||
23423396|NCT00098722|65292636|FG000|Open Label Phase|Other|0|||
23423397|NCT00098722|65292637|FG001|Open Label Phase|Other|0|||
23423398|NCT00098722|65292638|FG002|Open Label Phase|Other|0|||
23423399|NCT00098722|65292639|FG003|Open Label Phase|Other|18|||
23423400|NCT00098722|65292640|FG004|Open Label Phase|Other|0|||
23423401|NCT00098722|65292641|FG005|Open Label Phase|Other|0|||
23423402|NCT00098722|65292642|FG006|Open Label Phase|Other|0|||
23423403|NCT00098722|65292636|FG000|Observation Phase|Death|0|||
23423404|NCT00098722|65292637|FG001|Observation Phase|Death|0|||
23423405|NCT00098722|65292638|FG002|Observation Phase|Death|0|||
23423406|NCT00098722|65292639|FG003|Observation Phase|Death|0|||
23423407|NCT00098722|65292640|FG004|Observation Phase|Death|0|||
23815739|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23423408|NCT00098722|65292641|FG005|Observation Phase|Death|5|||
23536059|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536060|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Physician Decision|1|||
23536061|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Physician Decision|0|||
23536062|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Physician Decision|0|||
23536063|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Physician Decision|0|||
23536064|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Physician Decision|0|||
23536065|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Physician Decision|0|||
23536066|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Physician Decision|0|||
23536067|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
23536068|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
23536069|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536070|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23723083|NCT00565812|66363045|FG002|Overall Study|Research Site Closure|8|||
23723084|NCT00565812|66363043|FG000|Overall Study|Surgical Intervention|0|||
23815740|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23423409|NCT00098722|65292642|FG006|Observation Phase|Death|3|||
23423410|NCT00098722|65292636|FG000|Observation Phase|Lack of Efficacy|0|||
23423411|NCT00098722|65292637|FG001|Observation Phase|Lack of Efficacy|0|||
23423412|NCT00098722|65292638|FG002|Observation Phase|Lack of Efficacy|0|||
23423413|NCT00098722|65292639|FG003|Observation Phase|Lack of Efficacy|0|||
23423414|NCT00098722|65292640|FG004|Observation Phase|Lack of Efficacy|0|||
23423415|NCT00098722|65292641|FG005|Observation Phase|Lack of Efficacy|2|||
23423416|NCT00098722|65292642|FG006|Observation Phase|Lack of Efficacy|0|||
23536071|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536072|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536073|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536074|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536075|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
23536076|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
23423417|NCT00098722|65292636|FG000|Observation Phase|Participant defaulted|0|||
23423418|NCT00098722|65292637|FG001|Observation Phase|Participant defaulted|0|||
23423419|NCT00098722|65292638|FG002|Observation Phase|Participant defaulted|0|||
23423420|NCT00098722|65292639|FG003|Observation Phase|Participant defaulted|0|||
23423421|NCT00098722|65292640|FG004|Observation Phase|Participant defaulted|0|||
23423422|NCT00098722|65292641|FG005|Observation Phase|Participant defaulted|17|||
23423423|NCT00098722|65292642|FG006|Observation Phase|Participant defaulted|4|||
23423424|NCT00098722|65292636|FG000|Observation Phase|Other|0|||
23423425|NCT00098722|65292637|FG001|Observation Phase|Other|0|||
23423426|NCT00098722|65292638|FG002|Observation Phase|Other|0|||
23423427|NCT00098722|65292639|FG003|Observation Phase|Other|0|||
23423428|NCT00098722|65292640|FG004|Observation Phase|Other|0|||
23423429|NCT00098722|65292641|FG005|Observation Phase|Other|21|||
23423430|NCT00098722|65292642|FG006|Observation Phase|Other|10|||
23423431|NCT02435680|65292645|FG000|Overall Study|Physician Decision|3|||
23423432|NCT02435680|65292646|FG001|Overall Study|Physician Decision|0|||
23423433|NCT02435680|65292647|FG002|Overall Study|Physician Decision|0|||
23423434|NCT02435680|65292645|FG000|Overall Study|subject / guardian decision|0|||
23423435|NCT02435680|65292646|FG001|Overall Study|subject / guardian decision|3|||
23423436|NCT02435680|65292647|FG002|Overall Study|subject / guardian decision|2|||
23423437|NCT02435680|65292645|FG000|Overall Study|Adverse Event|8|||
23423438|NCT02435680|65292646|FG001|Overall Study|Adverse Event|3|||
23423439|NCT02435680|65292647|FG002|Overall Study|Adverse Event|2|||
23536077|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536078|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536079|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536080|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536081|NCT02265705|65693661|FG000|Rescue Period|Withdrawal by Subject|0|||
23536082|NCT02265705|65693662|FG001|Rescue Period|Withdrawal by Subject|0|||
23536083|NCT02265705|65693663|FG002|Rescue Period|Withdrawal by Subject|1|||
23536084|NCT02265705|65693664|FG003|Rescue Period|Withdrawal by Subject|0|||
23536085|NCT02265705|65693665|FG004|Rescue Period|Withdrawal by Subject|0|||
23536086|NCT02265705|65693666|FG005|Rescue Period|Withdrawal by Subject|0|||
23536087|NCT02265705|65693667|FG006|Rescue Period|Withdrawal by Subject|0|||
23536088|NCT02265705|65693661|FG000|Rescue Period|Death|0|||
23536089|NCT02265705|65693662|FG001|Rescue Period|Death|0|||
23536090|NCT02265705|65693663|FG002|Rescue Period|Death|1|||
23536091|NCT02265705|65693664|FG003|Rescue Period|Death|0|||
23536092|NCT02265705|65693665|FG004|Rescue Period|Death|0|||
23536093|NCT02265705|65693666|FG005|Rescue Period|Death|0|||
23536094|NCT02265705|65693667|FG006|Rescue Period|Death|0|||
23536095|NCT02265705|65693661|FG000|Rescue Period|Lack of Efficacy|0|||
23536096|NCT02265705|65693662|FG001|Rescue Period|Lack of Efficacy|0|||
23536097|NCT02265705|65693663|FG002|Rescue Period|Lack of Efficacy|1|||
23536098|NCT02265705|65693664|FG003|Rescue Period|Lack of Efficacy|0|||
23536099|NCT02265705|65693665|FG004|Rescue Period|Lack of Efficacy|0|||
23536100|NCT02265705|65693666|FG005|Rescue Period|Lack of Efficacy|0|||
23536101|NCT02265705|65693667|FG006|Rescue Period|Lack of Efficacy|0|||
23536102|NCT02265705|65693661|FG000|Open Label Period|Adverse Event|0|||
23536103|NCT02265705|65693662|FG001|Open Label Period|Adverse Event|0|||
23536104|NCT02265705|65693663|FG002|Open Label Period|Adverse Event|0|||
23536105|NCT02265705|65693664|FG003|Open Label Period|Adverse Event|2|||
23536106|NCT02265705|65693665|FG004|Open Label Period|Adverse Event|2|||
23536107|NCT02265705|65693666|FG005|Open Label Period|Adverse Event|0|||
23536108|NCT02265705|65693667|FG006|Open Label Period|Adverse Event|0|||
23536109|NCT02265705|65693661|FG000|Open Label Period|Physician Decision|0|||
23536110|NCT02265705|65693662|FG001|Open Label Period|Physician Decision|0|||
23536111|NCT02265705|65693663|FG002|Open Label Period|Physician Decision|0|||
23536112|NCT02265705|65693664|FG003|Open Label Period|Physician Decision|0|||
23536113|NCT02265705|65693665|FG004|Open Label Period|Physician Decision|1|||
23536114|NCT02265705|65693666|FG005|Open Label Period|Physician Decision|0|||
23536115|NCT02265705|65693667|FG006|Open Label Period|Physician Decision|0|||
23536116|NCT02265705|65693661|FG000|Open Label Period|Withdrawal by Subject|0|||
23536117|NCT02265705|65693662|FG001|Open Label Period|Withdrawal by Subject|0|||
23536118|NCT02265705|65693663|FG002|Open Label Period|Withdrawal by Subject|0|||
23423440|NCT02435680|65292645|FG000|Overall Study|progressive disease|10|||
23423441|NCT02435680|65292646|FG001|Overall Study|progressive disease|7|||
23423442|NCT02435680|65292647|FG002|Overall Study|progressive disease|11|||
23423443|NCT02435680|65292645|FG000|Overall Study|not treated|0|||
23536119|NCT02265705|65693664|FG003|Open Label Period|Withdrawal by Subject|0|||
23536120|NCT02265705|65693665|FG004|Open Label Period|Withdrawal by Subject|2|||
23815741|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815742|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815743|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815744|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815745|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815746|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815747|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815748|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23815749|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815750|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815751|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815752|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815753|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23536121|NCT02265705|65693666|FG005|Open Label Period|Withdrawal by Subject|0|||
23536122|NCT02265705|65693667|FG006|Open Label Period|Withdrawal by Subject|0|||
23536123|NCT02265705|65693661|FG000|Follow-up Period|Sponsor Decision|0|||
23723085|NCT00565812|66363044|FG001|Overall Study|Surgical Intervention|1|||
23723086|NCT00565812|66363045|FG002|Overall Study|Surgical Intervention|2|||
23723087|NCT00565812|66363043|FG000|Overall Study|Low Compliance|1|||
23536124|NCT02265705|65693662|FG001|Follow-up Period|Sponsor Decision|0|||
23536125|NCT02265705|65693663|FG002|Follow-up Period|Sponsor Decision|0|||
23536126|NCT02265705|65693664|FG003|Follow-up Period|Sponsor Decision|0|||
23536127|NCT02265705|65693665|FG004|Follow-up Period|Sponsor Decision|0|||
23536128|NCT02265705|65693666|FG005|Follow-up Period|Sponsor Decision|1|||
23536129|NCT02265705|65693667|FG006|Follow-up Period|Sponsor Decision|6|||
23536130|NCT02265705|65693661|FG000|Follow-up Period|Adverse Event|0|||
23536131|NCT02265705|65693662|FG001|Follow-up Period|Adverse Event|0|||
23536132|NCT02265705|65693663|FG002|Follow-up Period|Adverse Event|0|||
23536133|NCT02265705|65693664|FG003|Follow-up Period|Adverse Event|0|||
23536134|NCT02265705|65693665|FG004|Follow-up Period|Adverse Event|0|||
23536135|NCT02265705|65693666|FG005|Follow-up Period|Adverse Event|0|||
23536136|NCT02265705|65693667|FG006|Follow-up Period|Adverse Event|3|||
23536137|NCT02265705|65693661|FG000|Follow-up Period|Physician Decision|0|||
23536138|NCT02265705|65693662|FG001|Follow-up Period|Physician Decision|0|||
23536139|NCT02265705|65693663|FG002|Follow-up Period|Physician Decision|0|||
23536140|NCT02265705|65693664|FG003|Follow-up Period|Physician Decision|0|||
23536141|NCT02265705|65693665|FG004|Follow-up Period|Physician Decision|0|||
23536142|NCT02265705|65693666|FG005|Follow-up Period|Physician Decision|0|||
23536143|NCT02265705|65693667|FG006|Follow-up Period|Physician Decision|1|||
23536144|NCT02265705|65693661|FG000|Follow-up Period|Withdrawal by Subject|0|||
23536145|NCT02265705|65693662|FG001|Follow-up Period|Withdrawal by Subject|0|||
23536146|NCT02265705|65693663|FG002|Follow-up Period|Withdrawal by Subject|0|||
23536147|NCT02265705|65693664|FG003|Follow-up Period|Withdrawal by Subject|0|||
23536148|NCT02265705|65693665|FG004|Follow-up Period|Withdrawal by Subject|0|||
23536149|NCT02265705|65693666|FG005|Follow-up Period|Withdrawal by Subject|0|||
23536150|NCT02265705|65693667|FG006|Follow-up Period|Withdrawal by Subject|1|||
23536151|NCT01599650|65693668|FG000|Overall Study|Administrative issue|1|||
23616029|NCT02068352|65979599|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
23636611|NCT01072630|66052948|FG000|Overall Study|Adverse Event|11|||
23536152|NCT01599650|65693669|FG001|Overall Study|Administrative issue|0|||
23536153|NCT01599650|65693670|FG002|Overall Study|Administrative issue|1|||
23536154|NCT01599650|65693668|FG000|Overall Study|Physician Decision|2|||
23536155|NCT01599650|65693669|FG001|Overall Study|Physician Decision|0|||
23536156|NCT01599650|65693670|FG002|Overall Study|Physician Decision|7|||
23536157|NCT01599650|65693668|FG000|Overall Study|Protocol Violation|0|||
23536158|NCT01599650|65693669|FG001|Overall Study|Protocol Violation|3|||
23536159|NCT01599650|65693670|FG002|Overall Study|Protocol Violation|0|||
23536160|NCT01599650|65693668|FG000|Overall Study|Death|2|||
23536161|NCT01599650|65693669|FG001|Overall Study|Death|1|||
23636612|NCT01072630|66052949|FG001|Overall Study|Adverse Event|19|||
23636613|NCT01072630|66052950|FG002|Overall Study|Adverse Event|2|||
23636614|NCT01072630|66052948|FG000|Overall Study|Lack of Efficacy|10|||
23636615|NCT01072630|66052949|FG001|Overall Study|Lack of Efficacy|10|||
23636616|NCT01072630|66052950|FG002|Overall Study|Lack of Efficacy|1|||
23636617|NCT01072630|66052948|FG000|Overall Study|Withdrawal by Subject|8|||
23636618|NCT01072630|66052949|FG001|Overall Study|Withdrawal by Subject|7|||
23636619|NCT01072630|66052950|FG002|Overall Study|Withdrawal by Subject|2|||
23636620|NCT01072630|66052948|FG000|Overall Study|Protocol Violation|10|||
23636621|NCT01072630|66052949|FG001|Overall Study|Protocol Violation|8|||
23636622|NCT01072630|66052950|FG002|Overall Study|Protocol Violation|4|||
23636623|NCT01072630|66052948|FG000|Overall Study|Lost to Follow-up|11|||
23636624|NCT01072630|66052949|FG001|Overall Study|Lost to Follow-up|11|||
23636625|NCT01072630|66052950|FG002|Overall Study|Lost to Follow-up|1|||
23636626|NCT01072630|66052948|FG000|Overall Study|Noncompliance with study medication|1|||
23723088|NCT00565812|66363044|FG001|Overall Study|Low Compliance|0|||
23723089|NCT00565812|66363045|FG002|Overall Study|Low Compliance|1|||
23723090|NCT00565812|66363043|FG000|Overall Study|Follow-up Visit Not Completed|2|||
23723091|NCT00565812|66363044|FG001|Overall Study|Follow-up Visit Not Completed|0|||
23536162|NCT01599650|65693670|FG002|Overall Study|Death|2|||
23536163|NCT01599650|65693668|FG000|Overall Study|Lost to Follow-up|3|||
23536164|NCT01599650|65693669|FG001|Overall Study|Lost to Follow-up|3|||
23536165|NCT01599650|65693670|FG002|Overall Study|Lost to Follow-up|3|||
23536166|NCT01599650|65693668|FG000|Overall Study|Withdrawal by Subject|11|||
23536167|NCT01599650|65693669|FG001|Overall Study|Withdrawal by Subject|11|||
23536168|NCT01599650|65693670|FG002|Overall Study|Withdrawal by Subject|10|||
23536169|NCT01599650|65693668|FG000|Overall Study|Adverse Event|3|||
23536170|NCT01599650|65693669|FG001|Overall Study|Adverse Event|8|||
23536171|NCT01599650|65693670|FG002|Overall Study|Adverse Event|4|||
23536172|NCT04496258|65697411|FG000|Overall Study|Withdrawal by Subject|2|||
23536173|NCT04496258|65697412|FG001|Overall Study|Withdrawal by Subject|1|||
23536174|NCT00162136|65697413|FG000|Overall Study|Adverse Event|1|||
23536175|NCT00162136|65697413|FG000|Overall Study|Death|1|||
23536176|NCT00162136|65697413|FG000|Overall Study|Disease Progression/Relapse|23|||
23536177|NCT00162136|65697413|FG000|Overall Study|Investigator Request|5|||
23536178|NCT00162136|65697413|FG000|Overall Study|Study Drug Toxicity|4|||
23536179|NCT00162136|65697413|FG000|Overall Study|Withdrawal by Subject|1|||
23536180|NCT03003676|65697414|FG000|Overall Study|Lack of Efficacy|5|||
23536181|NCT03003676|65697415|FG001|Overall Study|Lack of Efficacy|7|||
23536182|NCT03003676|65697414|FG000|Overall Study|Withdrawal by Subject|0|||
23536183|NCT03003676|65697415|FG001|Overall Study|Withdrawal by Subject|1|||
23536184|NCT03003676|65697414|FG000|Overall Study|Hepatitis B infection|1|||
23723092|NCT00565812|66363045|FG002|Overall Study|Follow-up Visit Not Completed|1|||
23723093|NCT00565812|66363043|FG000|Overall Study|Physician Decision|2|||
23723094|NCT00565812|66363044|FG001|Overall Study|Physician Decision|0|||
23723095|NCT00565812|66363045|FG002|Overall Study|Physician Decision|0|||
23723096|NCT00268463|66363049|FG000|Overall Study|study terminated due to low accrual|10|||
23723097|NCT00268463|66363050|FG001|Overall Study|study terminated due to low accrual|12|||
23723098|NCT04018612|66363051|FG000|Overall Study|Withdrawal by Subject|1|||
23723099|NCT04018612|66363052|FG001|Overall Study|Withdrawal by Subject|0|||
23723100|NCT04018612|66363053|FG002|Overall Study|Withdrawal by Subject|1|||
23723101|NCT02427100|66363054|FG000|Overall Study|Lost to Follow-up|0|||
23723102|NCT02427100|66363055|FG001|Overall Study|Lost to Follow-up|2|||
23723103|NCT00724815|66363056|FG000|Overall Study|Randomized, not treated|31|||
23723104|NCT00724815|66363057|FG001|Overall Study|Randomized, not treated|30|||
23723105|NCT00724815|66363056|FG000|Overall Study|Adverse Event|5|||
23723106|NCT00724815|66363057|FG001|Overall Study|Adverse Event|3|||
23723107|NCT00724815|66363056|FG000|Overall Study|Lost to Follow-up|4|||
23723108|NCT00724815|66363057|FG001|Overall Study|Lost to Follow-up|1|||
23723109|NCT00724815|66363056|FG000|Overall Study|Other Various|3|||
23723110|NCT00724815|66363057|FG001|Overall Study|Other Various|5|||
23723111|NCT02142504|66363058|FG000|Overall Study|Protocol Violation|2|||
23723112|NCT02142504|66363059|FG001|Overall Study|Protocol Violation|1|||
23723113|NCT02142504|66363060|FG002|Overall Study|Protocol Violation|2|||
23723114|NCT02142504|66363058|FG000|Overall Study|Adverse Event|2|||
23723115|NCT02142504|66363059|FG001|Overall Study|Adverse Event|3|||
23723116|NCT02142504|66363060|FG002|Overall Study|Adverse Event|4|||
23723117|NCT02142504|66363058|FG000|Overall Study|Lost to Follow-up|12|||
23723118|NCT02142504|66363059|FG001|Overall Study|Lost to Follow-up|19|||
23723119|NCT02142504|66363060|FG002|Overall Study|Lost to Follow-up|17|||
23723120|NCT02142504|66363058|FG000|Overall Study|Withdrawal by Subject|7|||
23723121|NCT02142504|66363059|FG001|Overall Study|Withdrawal by Subject|9|||
23723122|NCT02142504|66363060|FG002|Overall Study|Withdrawal by Subject|11|||
23723123|NCT02142504|66363058|FG000|Overall Study|Pregnancy|4|||
23723124|NCT02142504|66363059|FG001|Overall Study|Pregnancy|4|||
23723125|NCT02142504|66363060|FG002|Overall Study|Pregnancy|2|||
23536185|NCT03003676|65697415|FG001|Overall Study|Hepatitis B infection|0|||
23536186|NCT00129259|65697416|FG000|Overall Study|Lost to Follow-up|1|||
23536187|NCT00129259|65697417|FG001|Overall Study|Lost to Follow-up|1|||
23536188|NCT00129259|65697416|FG000|Overall Study|Withdrawal by Subject|2|||
23616030|NCT02068352|65979600|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
23723126|NCT02142504|66363058|FG000|Overall Study|Physician Decision|0|||
23723127|NCT02142504|66363059|FG001|Overall Study|Physician Decision|1|||
23723128|NCT02142504|66363060|FG002|Overall Study|Physician Decision|3|||
23723129|NCT02142504|66363058|FG000|Overall Study|Reason Not Specified|4|||
23723130|NCT02142504|66363059|FG001|Overall Study|Reason Not Specified|5|||
23723131|NCT02142504|66363060|FG002|Overall Study|Reason Not Specified|4|||
23723132|NCT01432457|66363061|FG000|Overall Study|Adverse Event|7|||
23723133|NCT01432457|66363062|FG001|Overall Study|Adverse Event|10|||
23536189|NCT00129259|65697417|FG001|Overall Study|Withdrawal by Subject|1|||
23723134|NCT01432457|66363063|FG002|Overall Study|Adverse Event|16|||
23723135|NCT01432457|66363061|FG000|Overall Study|Lack of Efficacy|2|||
23723136|NCT01432457|66363062|FG001|Overall Study|Lack of Efficacy|1|||
23536190|NCT00129259|65697416|FG000|Overall Study|Only available minimal phone assessments|0|||
23536191|NCT00129259|65697417|FG001|Overall Study|Only available minimal phone assessments|1|||
23536192|NCT01723904|65697420|FG000|Overall Study|Noncompliant|3|||
23536193|NCT01723904|65697420|FG000|Overall Study|Adverse Event|5|||
23536194|NCT01723904|65697420|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
23536195|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
23536196|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536197|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536198|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536199|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536200|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536201|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536202|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536203|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536204|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536205|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536206|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536207|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536208|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536209|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
23536210|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536211|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536212|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536213|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536214|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536215|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536216|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536217|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536218|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536219|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536220|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536221|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536222|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
23536223|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536224|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536225|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536226|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536227|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536228|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536229|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536230|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536231|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536232|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536233|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536234|NCT04640311|65697426|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
23536235|NCT04640311|65697427|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
23536236|NCT04640311|65697428|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
23536237|NCT04640311|65697429|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536238|NCT04640311|65697430|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536239|NCT04640311|65697431|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536240|NCT04640311|65697432|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536241|NCT04640311|65697433|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536242|NCT04640311|65697434|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536243|NCT04640311|65697435|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536244|NCT04640311|65697436|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536245|NCT04640311|65697437|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536246|NCT04640311|65697438|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536247|NCT04640311|65697426|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536248|NCT04640311|65697427|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536249|NCT04640311|65697428|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
23536250|NCT04640311|65697429|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536251|NCT04640311|65697430|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536252|NCT04640311|65697431|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536253|NCT04640311|65697432|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536254|NCT04640311|65697433|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536255|NCT04640311|65697434|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536256|NCT04640311|65697435|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536257|NCT04640311|65697436|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536258|NCT04640311|65697437|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536259|NCT04640311|65697438|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536260|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536261|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536262|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536263|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
23536264|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536265|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536266|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
23536267|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536268|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536269|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536270|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536271|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536272|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536273|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536274|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536275|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536276|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536277|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536278|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
23536279|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536280|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536281|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
23536282|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536283|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536284|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536285|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536286|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536287|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536288|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536289|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536290|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536291|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536292|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
23536293|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536294|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536295|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536296|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
23536297|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536298|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536299|NCT04640311|65697426|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536300|NCT04640311|65697427|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536301|NCT04640311|65697428|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536302|NCT04640311|65697429|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536303|NCT04640311|65697430|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536304|NCT04640311|65697431|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536305|NCT04640311|65697432|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536306|NCT04640311|65697433|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23723137|NCT01432457|66363063|FG002|Overall Study|Lack of Efficacy|1|||
23536307|NCT04640311|65697434|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536308|NCT04640311|65697435|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536309|NCT04640311|65697436|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536310|NCT04640311|65697437|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
23536311|NCT04640311|65697438|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536312|NCT01416805|65697444|FG000|Overall Study|Lost to Follow-up|4|||
23536313|NCT01416805|65697445|FG001|Overall Study|Lost to Follow-up|4|||
23536314|NCT00211081|65697446|FG000|Overall Study|Withdrawal by Subject|2|||
23536315|NCT01336738|65697447|FG000|Overall Study|Adverse Event|0|||
23536316|NCT01336738|65697448|FG001|Overall Study|Adverse Event|3|||
23536317|NCT01336738|65697449|FG002|Overall Study|Adverse Event|2|||
23536318|NCT01336738|65697450|FG003|Overall Study|Adverse Event|1|||
23536319|NCT01336738|65697451|FG004|Overall Study|Adverse Event|3|||
23536320|NCT01336738|65697447|FG000|Overall Study|Lost to Follow-up|2|||
23536321|NCT01336738|65697448|FG001|Overall Study|Lost to Follow-up|1|||
23536322|NCT01336738|65697449|FG002|Overall Study|Lost to Follow-up|2|||
23536323|NCT01336738|65697450|FG003|Overall Study|Lost to Follow-up|2|||
23536324|NCT01336738|65697451|FG004|Overall Study|Lost to Follow-up|2|||
23536325|NCT01336738|65697447|FG000|Overall Study|Did not meet entrance criteria|0|||
23536326|NCT01336738|65697448|FG001|Overall Study|Did not meet entrance criteria|1|||
23536327|NCT01336738|65697449|FG002|Overall Study|Did not meet entrance criteria|0|||
23536328|NCT01336738|65697450|FG003|Overall Study|Did not meet entrance criteria|0|||
23536329|NCT01336738|65697451|FG004|Overall Study|Did not meet entrance criteria|0|||
23536330|NCT01336738|65697447|FG000|Overall Study|Protocol Violation|0|||
23536331|NCT01336738|65697448|FG001|Overall Study|Protocol Violation|1|||
23536332|NCT01336738|65697449|FG002|Overall Study|Protocol Violation|0|||
23536333|NCT01336738|65697450|FG003|Overall Study|Protocol Violation|0|||
23536334|NCT01336738|65697451|FG004|Overall Study|Protocol Violation|0|||
23536335|NCT01336738|65697447|FG000|Overall Study|Withdrawal by Subject|2|||
23536336|NCT01336738|65697448|FG001|Overall Study|Withdrawal by Subject|0|||
23536337|NCT01336738|65697449|FG002|Overall Study|Withdrawal by Subject|2|||
23536338|NCT01336738|65697450|FG003|Overall Study|Withdrawal by Subject|1|||
23536339|NCT01336738|65697451|FG004|Overall Study|Withdrawal by Subject|1|||
23536340|NCT01336738|65697447|FG000|Overall Study|Other|3|||
23536341|NCT01336738|65697448|FG001|Overall Study|Other|3|||
23536342|NCT01336738|65697449|FG002|Overall Study|Other|2|||
23536343|NCT01336738|65697450|FG003|Overall Study|Other|3|||
23536344|NCT01336738|65697451|FG004|Overall Study|Other|4|||
23536345|NCT02370888|65697452|FG000|Overall Study|disease progression|2|||
23536346|NCT02370888|65697452|FG000|Overall Study|did not meet chimerism criteria|6|||
23536347|NCT05789875|65697458|FG000|Overall Study|Lost to Follow-up|6|||
23536348|NCT00534352|65697462|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
23536349|NCT00534352|65697462|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
23536350|NCT00534352|65697462|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
23536351|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
23536352|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
23536353|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
23536354|NCT03323099|65697463|FG000|Overall Study|Withdrawal by Subject|6|||
23536355|NCT03323099|65697464|FG001|Overall Study|Withdrawal by Subject|12|||
23536356|NCT03323099|65697463|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
23536357|NCT03323099|65697464|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
23536358|NCT01994395|65697468|FG000|Overall Study|Withdrawal by Subject|1|||
23536359|NCT01994395|65697469|FG001|Overall Study|Withdrawal by Subject|2|||
23536360|NCT01802411|65697471|FG000|Overall Study|Death|2|||
23536361|NCT01802411|65697472|FG001|Overall Study|Death|1|||
23536362|NCT01802411|65697471|FG000|Overall Study|Adverse Event|2|||
23536363|NCT01802411|65697472|FG001|Overall Study|Adverse Event|7|||
23536364|NCT01802411|65697471|FG000|Overall Study|Lack of Efficacy|8|||
23536365|NCT01802411|65697472|FG001|Overall Study|Lack of Efficacy|10|||
23536366|NCT01802411|65697471|FG000|Overall Study|Withdrawal by Subject|0|||
23536367|NCT01802411|65697472|FG001|Overall Study|Withdrawal by Subject|2|||
23536368|NCT01802411|65697471|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
23536369|NCT01802411|65697472|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
23723138|NCT01432457|66363061|FG000|Overall Study|Lost to Follow-up|11|||
23723139|NCT01432457|66363062|FG001|Overall Study|Lost to Follow-up|15|||
23536370|NCT01802411|65697471|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
23536371|NCT01802411|65697472|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
23536372|NCT01802411|65697471|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
23536373|NCT01802411|65697472|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
23536374|NCT02720484|65697473|FG000|Treatment on Study|Adverse Event|1|||
23723140|NCT01432457|66363063|FG002|Overall Study|Lost to Follow-up|20|||
23536375|NCT02720484|65697473|FG000|Treatment on Study|Withdrawal by Subject|1|||
23536376|NCT02720484|65697473|FG000|Treatment on Study|Progressive Disease|4|||
23536377|NCT02720484|65697473|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
23723141|NCT01432457|66363061|FG000|Overall Study|Protocol Violation|3|||
23723142|NCT01432457|66363062|FG001|Overall Study|Protocol Violation|2|||
23536378|NCT02720484|65697473|FG000|Follow Up for 2 Years|Death|3|||
23536379|NCT02720484|65697473|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
23536380|NCT02673697|65697476|FG000|Overall Study|Adverse Event|2|||
23536381|NCT02673697|65697477|FG001|Overall Study|Adverse Event|0|||
23536382|NCT02673697|65697476|FG000|Overall Study|Death|32|||
23536383|NCT02673697|65697477|FG001|Overall Study|Death|24|||
23536384|NCT02673697|65697476|FG000|Overall Study|Lost to Follow-up|5|||
23536385|NCT02673697|65697477|FG001|Overall Study|Lost to Follow-up|2|||
23536386|NCT02673697|65697476|FG000|Overall Study|Physician Decision|2|||
23536387|NCT02673697|65697477|FG001|Overall Study|Physician Decision|1|||
23536388|NCT02673697|65697476|FG000|Overall Study|Withdrawal by Subject|10|||
23536389|NCT02673697|65697477|FG001|Overall Study|Withdrawal by Subject|7|||
23536390|NCT02673697|65697476|FG000|Overall Study|Change subj medical status|1|||
23536391|NCT02673697|65697477|FG001|Overall Study|Change subj medical status|2|||
23536392|NCT02673697|65697476|FG000|Overall Study|Explant|10|||
23536393|NCT02673697|65697477|FG001|Overall Study|Explant|5|||
23536394|NCT02673697|65697476|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
23536395|NCT02673697|65697477|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
23536396|NCT02647359|65697478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
23536397|NCT02647359|65697479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
23536398|NCT02647359|65697478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
23536399|NCT02647359|65697479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
23536400|NCT02647359|65697478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
23536401|NCT02647359|65697479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
23536402|NCT02647359|65697478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
23536403|NCT02647359|65697479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
23536404|NCT02647359|65697478|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
23536405|NCT02647359|65697479|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
23536406|NCT02647359|65697478|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
23536407|NCT02647359|65697479|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
23536408|NCT03160703|65697484|FG000|Overall Study|Withdrawal by Subject|0|||
23536409|NCT03160703|65697485|FG001|Overall Study|Withdrawal by Subject|0|||
23536410|NCT03160703|65697486|FG002|Overall Study|Withdrawal by Subject|0|||
23536411|NCT03160703|65697487|FG003|Overall Study|Withdrawal by Subject|1|||
23536412|NCT01826825|65697491|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
23536413|NCT01826825|65697492|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
23536414|NCT00812929|65697493|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
23536415|NCT00812929|65697494|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
23536416|NCT00812929|65697495|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
23536417|NCT00812929|65697496|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
23536418|NCT00812929|65697497|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
23536419|NCT00812929|65697498|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
23536420|NCT00812929|65697499|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
23536421|NCT00812929|65697500|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
23536422|NCT00812929|65697501|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
23536423|NCT00812929|65697502|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
23536424|NCT00812929|65697493|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
23536425|NCT00812929|65697494|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
23536426|NCT00812929|65697495|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
23536427|NCT00812929|65697496|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
23536428|NCT00812929|65697497|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
23536429|NCT00812929|65697498|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
23536430|NCT00812929|65697499|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
23536431|NCT00812929|65697500|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
23536432|NCT00812929|65697501|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
23536433|NCT00812929|65697502|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
23536434|NCT00812929|65697493|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
23536435|NCT00812929|65697494|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
23536436|NCT00812929|65697495|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
23536437|NCT00812929|65697496|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
23536438|NCT00812929|65697497|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
23536439|NCT00812929|65697498|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
23536440|NCT00812929|65697499|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
23536441|NCT00812929|65697500|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
23536442|NCT00812929|65697501|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
23536443|NCT00812929|65697502|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
23536444|NCT03003520|65697509|FG000|Overall Study|Adverse Event|9|||
23536445|NCT03003520|65697510|FG001|Overall Study|Adverse Event|0|||
23536446|NCT03003520|65697509|FG000|Overall Study|Death|1|||
23536447|NCT03003520|65697510|FG001|Overall Study|Death|0|||
23723143|NCT01432457|66363063|FG002|Overall Study|Protocol Violation|6|||
23536448|NCT03003520|65697509|FG000|Overall Study|Other reasons|4|||
23536449|NCT03003520|65697510|FG001|Overall Study|Other reasons|0|||
23536450|NCT03003520|65697509|FG000|Overall Study|Withdrawal by Subject|6|||
23536451|NCT03003520|65697510|FG001|Overall Study|Withdrawal by Subject|0|||
23536452|NCT03003520|65697509|FG000|Overall Study|Progressive disease|9|||
23536453|NCT03003520|65697510|FG001|Overall Study|Progressive disease|1|||
23536454|NCT01529645|65697512|FG000|Overall Study|Lost to Follow-up|0|||
23536455|NCT01529645|65697513|FG001|Overall Study|Lost to Follow-up|1|||
23536456|NCT01529645|65697514|FG002|Overall Study|Lost to Follow-up|1|||
23536457|NCT01529645|65697515|FG003|Overall Study|Lost to Follow-up|1|||
23536458|NCT01529645|65697516|FG004|Overall Study|Lost to Follow-up|1|||
23536459|NCT01529645|65697517|FG005|Overall Study|Lost to Follow-up|0|||
23536460|NCT01529645|65697518|FG006|Overall Study|Lost to Follow-up|2|||
23536461|NCT01529645|65697519|FG007|Overall Study|Lost to Follow-up|0|||
23536462|NCT01529645|65697520|FG008|Overall Study|Lost to Follow-up|1|||
23536463|NCT01529645|65697521|FG009|Overall Study|Lost to Follow-up|0|||
23536464|NCT01529645|65697512|FG000|Overall Study|SAE - Premature contractions|0|||
23536465|NCT01529645|65697513|FG001|Overall Study|SAE - Premature contractions|0|||
23536466|NCT01529645|65697514|FG002|Overall Study|SAE - Premature contractions|1|||
23536467|NCT01529645|65697515|FG003|Overall Study|SAE - Premature contractions|0|||
23536468|NCT01529645|65697516|FG004|Overall Study|SAE - Premature contractions|0|||
23536469|NCT01529645|65697517|FG005|Overall Study|SAE - Premature contractions|0|||
23536470|NCT01529645|65697518|FG006|Overall Study|SAE - Premature contractions|0|||
23536471|NCT01529645|65697519|FG007|Overall Study|SAE - Premature contractions|0|||
23536472|NCT01529645|65697520|FG008|Overall Study|SAE - Premature contractions|0|||
23536473|NCT01529645|65697521|FG009|Overall Study|SAE - Premature contractions|0|||
23536474|NCT01529645|65697512|FG000|Overall Study|Withdrawal by Subject|2|||
23536475|NCT01529645|65697513|FG001|Overall Study|Withdrawal by Subject|0|||
23536476|NCT01529645|65697514|FG002|Overall Study|Withdrawal by Subject|0|||
23536477|NCT01529645|65697515|FG003|Overall Study|Withdrawal by Subject|1|||
23536478|NCT01529645|65697516|FG004|Overall Study|Withdrawal by Subject|1|||
23536479|NCT01529645|65697517|FG005|Overall Study|Withdrawal by Subject|1|||
23536480|NCT01529645|65697518|FG006|Overall Study|Withdrawal by Subject|0|||
23536481|NCT01529645|65697519|FG007|Overall Study|Withdrawal by Subject|0|||
23536482|NCT01529645|65697520|FG008|Overall Study|Withdrawal by Subject|0|||
23536483|NCT01529645|65697521|FG009|Overall Study|Withdrawal by Subject|0|||
23723144|NCT01432457|66363061|FG000|Overall Study|Withdrawal by Subject|6|||
23723145|NCT01432457|66363062|FG001|Overall Study|Withdrawal by Subject|11|||
23536484|NCT03586869|65697522|FG000|Overall Study|Progressive Disease|3|||
23536485|NCT00087568|65697525|FG000|Overall Study|Adverse Event|4|||
23536486|NCT00087568|65697526|FG001|Overall Study|Adverse Event|0|||
23536487|NCT00087568|65697525|FG000|Overall Study|Withdrawal by Subject|1|||
23536488|NCT00087568|65697526|FG001|Overall Study|Withdrawal by Subject|1|||
23536489|NCT00087568|65697525|FG000|Overall Study|Lost to Follow-up|1|||
23536490|NCT00087568|65697526|FG001|Overall Study|Lost to Follow-up|0|||
23536491|NCT00087568|65697525|FG000|Overall Study|Lack of Efficacy|24|||
23536492|NCT00087568|65697526|FG001|Overall Study|Lack of Efficacy|1|||
23536493|NCT00718718|65697527|FG000|Prior to Week 12|Adverse Event|0|||
23536494|NCT00718718|65697528|FG001|Prior to Week 12|Adverse Event|0|||
23536495|NCT00718718|65697529|FG002|Prior to Week 12|Adverse Event|0|||
23536496|NCT00718718|65697530|FG003|Prior to Week 12|Adverse Event|0|||
23536497|NCT00718718|65697531|FG004|Prior to Week 12|Adverse Event|0|||
23536498|NCT00718718|65697532|FG005|Prior to Week 12|Adverse Event|0|||
23536499|NCT00718718|65697533|FG006|Prior to Week 12|Adverse Event|0|||
23536500|NCT00718718|65697534|FG007|Prior to Week 12|Adverse Event|1|||
23536501|NCT00718718|65697535|FG008|Prior to Week 12|Adverse Event|1|||
23536502|NCT00718718|65697536|FG009|Prior to Week 12|Adverse Event|0|||
23536503|NCT00718718|65697527|FG000|Prior to Week 12|Withdrawal by Subject|0|||
23536504|NCT00718718|65697528|FG001|Prior to Week 12|Withdrawal by Subject|0|||
23536505|NCT00718718|65697529|FG002|Prior to Week 12|Withdrawal by Subject|0|||
23536506|NCT00718718|65697530|FG003|Prior to Week 12|Withdrawal by Subject|0|||
23723146|NCT01432457|66363063|FG002|Overall Study|Withdrawal by Subject|9|||
23723147|NCT01432457|66363061|FG000|Overall Study|Reasons not defined|2|||
23723148|NCT01432457|66363062|FG001|Overall Study|Reasons not defined|3|||
23536507|NCT00718718|65697531|FG004|Prior to Week 12|Withdrawal by Subject|3|||
23536508|NCT00718718|65697532|FG005|Prior to Week 12|Withdrawal by Subject|0|||
23536509|NCT00718718|65697533|FG006|Prior to Week 12|Withdrawal by Subject|1|||
23536510|NCT00718718|65697534|FG007|Prior to Week 12|Withdrawal by Subject|1|||
23536511|NCT00718718|65697535|FG008|Prior to Week 12|Withdrawal by Subject|1|||
23536512|NCT00718718|65697536|FG009|Prior to Week 12|Withdrawal by Subject|0|||
23536513|NCT00718718|65697527|FG000|Prior to Week 12|Other|1|||
23536514|NCT00718718|65697528|FG001|Prior to Week 12|Other|0|||
23723149|NCT01432457|66363063|FG002|Overall Study|Reasons not defined|4|||
23536515|NCT00718718|65697529|FG002|Prior to Week 12|Other|1|||
23536516|NCT00718718|65697530|FG003|Prior to Week 12|Other|0|||
23536517|NCT00718718|65697531|FG004|Prior to Week 12|Other|0|||
23536518|NCT00718718|65697532|FG005|Prior to Week 12|Other|0|||
23536519|NCT00718718|65697533|FG006|Prior to Week 12|Other|0|||
23723150|NCT01432457|66363061|FG000|Overall Study|Did not take study drug|6|||
23723151|NCT01432457|66363062|FG001|Overall Study|Did not take study drug|6|||
23536520|NCT00718718|65697534|FG007|Prior to Week 12|Other|0|||
23536521|NCT00718718|65697535|FG008|Prior to Week 12|Other|0|||
23536522|NCT00718718|65697536|FG009|Prior to Week 12|Other|0|||
23536523|NCT00718718|65697527|FG000|Week 12 to End of Study|Adverse Event|0|||
23536524|NCT00718718|65697528|FG001|Week 12 to End of Study|Adverse Event|0|||
23536525|NCT00718718|65697529|FG002|Week 12 to End of Study|Adverse Event|0|||
23536526|NCT00718718|65697530|FG003|Week 12 to End of Study|Adverse Event|0|||
23536527|NCT00718718|65697531|FG004|Week 12 to End of Study|Adverse Event|0|||
23536528|NCT00718718|65697532|FG005|Week 12 to End of Study|Adverse Event|0|||
23536529|NCT00718718|65697533|FG006|Week 12 to End of Study|Adverse Event|0|||
23536530|NCT00718718|65697534|FG007|Week 12 to End of Study|Adverse Event|1|||
23536531|NCT00718718|65697535|FG008|Week 12 to End of Study|Adverse Event|0|||
23536532|NCT00718718|65697536|FG009|Week 12 to End of Study|Adverse Event|0|||
23536533|NCT00718718|65697527|FG000|Week 12 to End of Study|Death|0|||
23536534|NCT00718718|65697528|FG001|Week 12 to End of Study|Death|0|||
23536535|NCT00718718|65697529|FG002|Week 12 to End of Study|Death|0|||
23536536|NCT00718718|65697530|FG003|Week 12 to End of Study|Death|0|||
23536537|NCT00718718|65697531|FG004|Week 12 to End of Study|Death|0|||
23536538|NCT00718718|65697532|FG005|Week 12 to End of Study|Death|1|||
23536539|NCT00718718|65697533|FG006|Week 12 to End of Study|Death|0|||
23536540|NCT00718718|65697534|FG007|Week 12 to End of Study|Death|0|||
23536541|NCT00718718|65697535|FG008|Week 12 to End of Study|Death|0|||
23536542|NCT00718718|65697536|FG009|Week 12 to End of Study|Death|0|||
23536543|NCT00718718|65697527|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
23536544|NCT00718718|65697528|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
23536545|NCT00718718|65697529|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
23536546|NCT00718718|65697530|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
23536547|NCT00718718|65697531|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
23536548|NCT00718718|65697532|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
23536549|NCT00718718|65697533|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
23536550|NCT00718718|65697534|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
23536551|NCT00718718|65697535|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
23536552|NCT00718718|65697536|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
23536553|NCT00718718|65697527|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
23536554|NCT00718718|65697528|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
23536555|NCT00718718|65697529|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
23536556|NCT00718718|65697530|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
23536557|NCT00718718|65697531|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
23536558|NCT00718718|65697532|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
23536559|NCT00718718|65697533|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
23536560|NCT00718718|65697534|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
23536561|NCT00718718|65697535|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
23536562|NCT00718718|65697536|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
23536563|NCT00718718|65697527|FG000|Week 12 to End of Study|Other|0|||
23536564|NCT00718718|65697528|FG001|Week 12 to End of Study|Other|1|||
23616031|NCT02068352|65979601|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
23616032|NCT02068352|65979599|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
23616033|NCT02068352|65979600|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
23616034|NCT02068352|65979601|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
23616035|NCT02068352|65979599|FG000|Overall Study|Protocol Deviation|0|||
23616036|NCT02068352|65979600|FG001|Overall Study|Protocol Deviation|0|||
23616037|NCT02068352|65979601|FG002|Overall Study|Protocol Deviation|1|||
23616038|NCT01345188|65979603|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
23616039|NCT01345188|65979603|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
23616040|NCT02029521|65979606|FG000|Overall Study|Protocol Violation|1|||
23616041|NCT02029521|65979607|FG001|Overall Study|Protocol Violation|0|||
23616042|NCT02029521|65979606|FG000|Overall Study|Withdrawal by Subject|1|||
23616043|NCT02029521|65979607|FG001|Overall Study|Withdrawal by Subject|1|||
23616044|NCT01106586|65979610|FG000|Overall Study|Adverse Event|9|||
23616045|NCT01106586|65979611|FG001|Overall Study|Adverse Event|15|||
23616046|NCT01106586|65979610|FG000|Overall Study|Death|1|||
23723152|NCT01432457|66363063|FG002|Overall Study|Did not take study drug|3|||
23536565|NCT00718718|65697529|FG002|Week 12 to End of Study|Other|0|||
23536566|NCT00718718|65697530|FG003|Week 12 to End of Study|Other|1|||
23536567|NCT00718718|65697531|FG004|Week 12 to End of Study|Other|0|||
23536568|NCT00718718|65697532|FG005|Week 12 to End of Study|Other|0|||
23536569|NCT00718718|65697533|FG006|Week 12 to End of Study|Other|1|||
23536570|NCT00718718|65697534|FG007|Week 12 to End of Study|Other|0|||
23536571|NCT00718718|65697535|FG008|Week 12 to End of Study|Other|0|||
23536572|NCT00718718|65697536|FG009|Week 12 to End of Study|Other|0|||
23536573|NCT01933334|65697537|FG000|Overall Study|Adverse Event|5|||
23536574|NCT01933334|65697538|FG001|Overall Study|Adverse Event|1|||
23723153|NCT01202760|66363066|FG000|Overall Study|Entry Criteria Not Met|0|||
23616047|NCT01106586|65979611|FG001|Overall Study|Death|3|||
23616048|NCT01106586|65979610|FG000|Overall Study|Pregnancy|2|||
23616049|NCT01106586|65979611|FG001|Overall Study|Pregnancy|2|||
23616050|NCT01106586|65979610|FG000|Overall Study|Lack of Efficacy|1|||
23616051|NCT01106586|65979611|FG001|Overall Study|Lack of Efficacy|0|||
23616052|NCT01106586|65979610|FG000|Overall Study|Investigator's Discretion|5|||
23616053|NCT01106586|65979611|FG001|Overall Study|Investigator's Discretion|8|||
23616054|NCT01106586|65979610|FG000|Overall Study|Withdrew Consent|18|||
23616055|NCT01106586|65979611|FG001|Overall Study|Withdrew Consent|30|||
23616056|NCT01106586|65979610|FG000|Overall Study|Lost to Follow-up|24|||
23616057|NCT01106586|65979611|FG001|Overall Study|Lost to Follow-up|20|||
23616058|NCT01106586|65979610|FG000|Overall Study|Participant Noncompliance|12|||
23616059|NCT01106586|65979611|FG001|Overall Study|Participant Noncompliance|10|||
23616060|NCT01106586|65979610|FG000|Overall Study|Protocol Violation|1|||
23616061|NCT01106586|65979611|FG001|Overall Study|Protocol Violation|0|||
23616062|NCT01106586|65979610|FG000|Overall Study|Participant Transferred to Another Study|212|||
23616063|NCT01106586|65979611|FG001|Overall Study|Participant Transferred to Another Study|197|||
23616064|NCT02056873|65979623|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
23616065|NCT01601821|65979624|FG000|Overall Study|Death|2|||
23616066|NCT01601821|65979625|FG001|Overall Study|Death|5|||
23616067|NCT01601821|65979624|FG000|Overall Study|Protocol Violation|2|||
23616068|NCT01601821|65979625|FG001|Overall Study|Protocol Violation|2|||
23616069|NCT01601821|65979624|FG000|Overall Study|Lost to Follow-up|6|||
23616070|NCT01601821|65979625|FG001|Overall Study|Lost to Follow-up|14|||
23616071|NCT01601821|65979624|FG000|Overall Study|Withdrawal by Subject|1|||
23616072|NCT01601821|65979625|FG001|Overall Study|Withdrawal by Subject|0|||
23616073|NCT01601821|65979624|FG000|Overall Study|Graft Loss|6|||
23616074|NCT01601821|65979625|FG001|Overall Study|Graft Loss|6|||
23616075|NCT01601821|65979624|FG000|Overall Study|Study Events|7|||
23616076|NCT01601821|65979625|FG001|Overall Study|Study Events|1|||
23616077|NCT01601821|65979624|FG000|Overall Study|Other|5|||
23616078|NCT01601821|65979625|FG001|Overall Study|Other|1|||
23616079|NCT00645099|65979628|FG000|Overall Study|Lack of Efficacy|15|||
23616080|NCT00645099|65979629|FG001|Overall Study|Lack of Efficacy|6|||
23616081|NCT00645099|65979628|FG000|Overall Study|Withdrawal by Subject|30|||
23616082|NCT00645099|65979629|FG001|Overall Study|Withdrawal by Subject|22|||
23616083|NCT00645099|65979628|FG000|Overall Study|Lost to Follow-up|6|||
23616084|NCT00645099|65979629|FG001|Overall Study|Lost to Follow-up|4|||
23616085|NCT00645099|65979628|FG000|Overall Study|Adverse Event|11|||
23616086|NCT00645099|65979629|FG001|Overall Study|Adverse Event|5|||
23616087|NCT00645099|65979628|FG000|Overall Study|Other|9|||
23616088|NCT00645099|65979629|FG001|Overall Study|Other|5|||
23616089|NCT03340766|65979630|FG000|Overall Study|Withdrawal by Subject|2|||
23616090|NCT03340766|65979631|FG001|Overall Study|Withdrawal by Subject|1|||
23616091|NCT03340766|65979632|FG002|Overall Study|Withdrawal by Subject|3|||
23616092|NCT03340766|65979630|FG000|Overall Study|Lost to Follow-up|0|||
23616093|NCT03340766|65979631|FG001|Overall Study|Lost to Follow-up|0|||
23616094|NCT03340766|65979632|FG002|Overall Study|Lost to Follow-up|1|||
23616095|NCT03340766|65979630|FG000|Overall Study|Death|6|||
23616096|NCT03340766|65979631|FG001|Overall Study|Death|7|||
23616097|NCT03340766|65979632|FG002|Overall Study|Death|4|||
23616098|NCT00145496|65979633|FG000|Overall Study|Adverse Event|42|||
23616099|NCT00145496|65979634|FG001|Overall Study|Adverse Event|30|||
23616100|NCT00145496|65979633|FG000|Overall Study|Lack of Efficacy|12|||
23616101|NCT00145496|65979634|FG001|Overall Study|Lack of Efficacy|7|||
23616102|NCT00145496|65979633|FG000|Overall Study|Withdrawal by Subject|32|||
23616103|NCT00145496|65979634|FG001|Overall Study|Withdrawal by Subject|26|||
23616104|NCT00145496|65979633|FG000|Overall Study|Lost to Follow-up|12|||
23616105|NCT00145496|65979634|FG001|Overall Study|Lost to Follow-up|5|||
23616106|NCT00145496|65979633|FG000|Overall Study|Other|25|||
23616107|NCT00145496|65979634|FG001|Overall Study|Other|13|||
23616108|NCT00511147|65979639|FG000|Overall Study|Withdrawal by Subject|1|||
23616109|NCT00511147|65979639|FG000|Overall Study|Disease progression|5|||
23616110|NCT00511147|65979639|FG000|Overall Study|Required platelet transfusion|1|||
23616111|NCT00348283|65979640|FG000|Induction|Adverse Event|0|||
23616112|NCT00348283|65979641|FG001|Induction|Adverse Event|2|||
23616113|NCT00348283|65979640|FG000|Induction|Protocol Violation|0|||
23616114|NCT00348283|65979641|FG001|Induction|Protocol Violation|4|||
23616115|NCT00348283|65979640|FG000|Double Blind|Adverse Event|2|||
23616116|NCT00348283|65979641|FG001|Double Blind|Adverse Event|5|||
23616117|NCT00348283|65979640|FG000|Double Blind|Withdrawal by Subject|1|||
23616118|NCT00348283|65979641|FG001|Double Blind|Withdrawal by Subject|1|||
23616119|NCT00348283|65979640|FG000|Double Blind|Protocol Violation|0|||
23616120|NCT00348283|65979641|FG001|Double Blind|Protocol Violation|1|||
23616121|NCT00348283|65979640|FG000|Double Blind|Lack of Efficacy|2|||
23616122|NCT00348283|65979641|FG001|Double Blind|Lack of Efficacy|2|||
23616123|NCT00348283|65979640|FG000|Double Blind|Pregnancy|0|||
23616124|NCT00348283|65979641|FG001|Double Blind|Pregnancy|1|||
23616125|NCT00348283|65979640|FG000|Open Label|Adverse Event|0|||
23616126|NCT00348283|65979641|FG001|Open Label|Adverse Event|8|||
23616127|NCT00348283|65979640|FG000|Open Label|Withdrawal by Subject|0|||
23616128|NCT00348283|65979641|FG001|Open Label|Withdrawal by Subject|4|||
23616129|NCT00348283|65979640|FG000|Open Label|Lost to Follow-up|0|||
23616130|NCT00348283|65979641|FG001|Open Label|Lost to Follow-up|1|||
23616131|NCT00348283|65979640|FG000|Open Label|Lack of Efficacy|0|||
23616132|NCT00348283|65979641|FG001|Open Label|Lack of Efficacy|13|||
23616133|NCT00348283|65979640|FG000|Open Label|Administrative reasons|0|||
23616134|NCT00348283|65979641|FG001|Open Label|Administrative reasons|5|||
23616135|NCT00348283|65979640|FG000|Open Label|Subject moved to the United States|0|||
23616136|NCT00348283|65979641|FG001|Open Label|Subject moved to the United States|1|||
23616137|NCT00348283|65979640|FG000|Open Label|Pregnancy|0|||
23616138|NCT00348283|65979641|FG001|Open Label|Pregnancy|1|||
23616139|NCT00348283|65979640|FG000|Open Label|Sponsor decision|0|||
23616140|NCT00348283|65979641|FG001|Open Label|Sponsor decision|1|||
23616141|NCT04393779|65979642|FG000|Overall Study|Death|1|||
23616142|NCT04393779|65979642|FG000|Overall Study|Device reintervention or explant|4|||
23616143|NCT04369664|65979646|FG000|Overall Study|Physician Decision|1|||
23616144|NCT04369664|65979647|FG001|Overall Study|Physician Decision|0|||
23616145|NCT00495612|65979649|FG000|Overall Study|Lost to Follow-up|1|||
23616146|NCT00495612|65979650|FG001|Overall Study|Lost to Follow-up|0|||
23616147|NCT00495612|65979649|FG000|Overall Study|Subject's Decision to Withdraw|3|||
23616148|NCT00495612|65979650|FG001|Overall Study|Subject's Decision to Withdraw|0|||
23616149|NCT02567227|65979655|FG000|9 Weeks|Adverse Event|5|||
23616150|NCT02567227|65979656|FG001|9 Weeks|Adverse Event|5|||
23616151|NCT02567227|65979655|FG000|9 Weeks|Withdrawal by Subject|18|||
23616152|NCT02567227|65979656|FG001|9 Weeks|Withdrawal by Subject|8|||
23616153|NCT02567227|65979655|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
23536575|NCT01933334|65697537|FG000|Overall Study|Withdrawal by Subject|0|||
23536576|NCT01933334|65697538|FG001|Overall Study|Withdrawal by Subject|1|||
23536577|NCT02348489|65697539|FG000|Overall Study|Death|336|||
23536578|NCT02348489|65697540|FG001|Overall Study|Death|335|||
23536579|NCT02348489|65697539|FG000|Overall Study|Withdrawal by Subject|14|||
23536580|NCT02348489|65697540|FG001|Overall Study|Withdrawal by Subject|27|||
23536581|NCT02348489|65697539|FG000|Overall Study|Lost to Follow-up|3|||
23536582|NCT02348489|65697540|FG001|Overall Study|Lost to Follow-up|5|||
23536583|NCT02822794|65697544|FG000|Overall Study|Withdrew Consent|1|||
23536584|NCT02822794|65697545|FG001|Overall Study|Withdrew Consent|0|||
23536585|NCT01412424|65697550|FG000|Core Treatment Period|Treatment Failure|24|||
23536586|NCT01412424|65697550|FG000|Core Treatment Period|Adverse Event|21|||
23536587|NCT01412424|65697550|FG000|Core Treatment Period|Patient Request|5|||
23536588|NCT01412424|65697550|FG000|Core Treatment Period|Lost to Follow-up|2|||
23536589|NCT01412424|65697550|FG000|Core Treatment Period|Sponsor Request|1|||
23536590|NCT01412424|65697550|FG000|Extension Treatment Period|Adverse Event|2|||
23536591|NCT01412424|65697550|FG000|Extension Treatment Period|Treatment Failure|2|||
23536592|NCT01412424|65697550|FG000|Extension Treatment Period|Patient Request|2|||
23536593|NCT00097591|65697551|FG000|Overall Study|Withdrawal of consent|342|||
23536594|NCT00097591|65697552|FG001|Overall Study|Withdrawal of consent|323|||
23536595|NCT00097591|65697551|FG000|Overall Study|Less than 6 months on study drug|9|||
23536596|NCT00097591|65697552|FG001|Overall Study|Less than 6 months on study drug|7|||
23536597|NCT00097591|65697551|FG000|Overall Study|Unable to attend termination visit|53|||
23536598|NCT00097591|65697552|FG001|Overall Study|Unable to attend termination visit|51|||
23536599|NCT00097591|65697551|FG000|Overall Study|Lost to follow up|6|||
23536600|NCT00097591|65697552|FG001|Overall Study|Lost to follow up|10|||
23536601|NCT00097591|65697551|FG000|Overall Study|Other|0|||
23536602|NCT00097591|65697552|FG001|Overall Study|Other|3|||
23536603|NCT02334748|65697553|FG000|Overall Study|Adverse Event|1|||
23536604|NCT02334748|65697553|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
23536605|NCT02334748|65697553|FG000|Overall Study|Patient no longer required study drug|2|||
23536606|NCT02334748|65697553|FG000|Overall Study|Lack of Efficacy|4|||
23536607|NCT00403455|65697554|FG000|Overall Study|Withdrawal by Subject|1|||
23536608|NCT02610192|65697555|FG000|Overall Study|Received other treatment|8|||
23536609|NCT02610192|65697555|FG000|Overall Study|Physician Decision|1|||
23536610|NCT03779841|65697556|FG000|Randomized Population|Did Not Receive Treatment|3|||
23536611|NCT03779841|65697557|FG001|Randomized Population|Did Not Receive Treatment|1|||
23536612|NCT03779841|65697558|FG002|Randomized Population|Did Not Receive Treatment|0|||
23536613|NCT03779841|65697556|FG000|Treated (Safety) Population|Adverse Event|1|||
23536614|NCT03779841|65697557|FG001|Treated (Safety) Population|Adverse Event|1|||
23536615|NCT03779841|65697558|FG002|Treated (Safety) Population|Adverse Event|0|||
23536616|NCT03779841|65697556|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
23536617|NCT03779841|65697557|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
23536618|NCT03779841|65697558|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
23536619|NCT03779841|65697556|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
23536620|NCT03779841|65697557|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
23616154|NCT02567227|65979656|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
23616155|NCT02567227|65979655|FG000|6 Month|Death|2|||
23616156|NCT02567227|65979656|FG001|6 Month|Death|0|||
23616157|NCT02567227|65979655|FG000|6 Month|Lost to Follow-up|43|||
23616158|NCT02567227|65979656|FG001|6 Month|Lost to Follow-up|40|||
23616159|NCT02567227|65979655|FG000|12 Months|Lost to Follow-up|31|||
23616160|NCT02567227|65979656|FG001|12 Months|Lost to Follow-up|32|||
23616161|NCT02567227|65979655|FG000|12 Months|Death|0|||
23616162|NCT02567227|65979656|FG001|12 Months|Death|2|||
23616163|NCT04054193|65979657|FG000|Cycle 1|Physician Decision|1|||
23616164|NCT04054193|65979657|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
23616165|NCT04054193|65979657|FG000|Cycle 1|Allocated but not treated|3|||
23616166|NCT04054193|65979657|FG000|Cycles 2-3|Physician Decision|2|||
23616167|NCT04054193|65979657|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
23616168|NCT04054193|65979657|FG000|Cycles 2-3|Various reasons|17|||
23616169|NCT02273180|65979660|FG000|Overall Study|Adverse Event|2|||
23616170|NCT02273180|65979661|FG001|Overall Study|Adverse Event|2|||
23616171|NCT02273180|65979660|FG000|Overall Study|Lack of Efficacy|1|||
23616172|NCT02273180|65979661|FG001|Overall Study|Lack of Efficacy|0|||
23616173|NCT02273180|65979660|FG000|Overall Study|Protocol Violation|1|||
23616174|NCT02273180|65979661|FG001|Overall Study|Protocol Violation|7|||
23616175|NCT02273180|65979660|FG000|Overall Study|Randomized but not treated|1|||
23616176|NCT02273180|65979661|FG001|Overall Study|Randomized but not treated|0|||
23616177|NCT02273180|65979660|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
23616178|NCT02273180|65979661|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
23536621|NCT03779841|65697558|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
23536622|NCT03779841|65697556|FG000|Treated (Safety) Population|Death|1|||
23536623|NCT03779841|65697557|FG001|Treated (Safety) Population|Death|0|||
23536624|NCT03779841|65697558|FG002|Treated (Safety) Population|Death|2|||
23536625|NCT03403634|65697559|FG000|Overall Study|Disease progression|3|||
23536626|NCT03403634|65697559|FG000|Overall Study|Did not meet eligibility criteria|4|||
23536627|NCT00767000|65697560|FG000|54-week Study|Adverse Event|4|||
23536628|NCT00767000|65697561|FG001|54-week Study|Adverse Event|6|||
23536629|NCT00767000|65697562|FG002|54-week Study|Adverse Event|6|||
23536630|NCT00767000|65697563|FG003|54-week Study|Adverse Event|8|||
23536631|NCT00767000|65697564|FG004|54-week Study|Adverse Event|4|||
23536632|NCT00767000|65697560|FG000|54-week Study|Creaninine/creatinine clearance|2|||
23536633|NCT00767000|65697561|FG001|54-week Study|Creaninine/creatinine clearance|1|||
23536634|NCT00767000|65697562|FG002|54-week Study|Creaninine/creatinine clearance|2|||
23536635|NCT00767000|65697563|FG003|54-week Study|Creaninine/creatinine clearance|2|||
23536636|NCT00767000|65697564|FG004|54-week Study|Creaninine/creatinine clearance|4|||
23536637|NCT00767000|65697560|FG000|54-week Study|Hyperglycemia|0|||
23536638|NCT00767000|65697561|FG001|54-week Study|Hyperglycemia|0|||
23536639|NCT00767000|65697562|FG002|54-week Study|Hyperglycemia|1|||
23536640|NCT00767000|65697563|FG003|54-week Study|Hyperglycemia|0|||
23536641|NCT00767000|65697564|FG004|54-week Study|Hyperglycemia|1|||
23536642|NCT00767000|65697560|FG000|54-week Study|Hypoglycemia|0|||
23536643|NCT00767000|65697561|FG001|54-week Study|Hypoglycemia|1|||
23536644|NCT00767000|65697562|FG002|54-week Study|Hypoglycemia|0|||
23536645|NCT00767000|65697563|FG003|54-week Study|Hypoglycemia|0|||
23536646|NCT00767000|65697564|FG004|54-week Study|Hypoglycemia|0|||
23536647|NCT00767000|65697560|FG000|54-week Study|Interruption of study medication|0|||
23536648|NCT00767000|65697561|FG001|54-week Study|Interruption of study medication|0|||
23536649|NCT00767000|65697562|FG002|54-week Study|Interruption of study medication|1|||
23616179|NCT02273180|65979660|FG000|Overall Study|Other than specified above|21|||
23616180|NCT02273180|65979661|FG001|Overall Study|Other than specified above|10|||
23616181|NCT02085408|65979664|FG000|Step 1: Induction|Disease Progression|19|||
23616182|NCT02085408|65979665|FG001|Step 1: Induction|Disease Progression|19|||
23616183|NCT02085408|65979664|FG000|Step 1: Induction|Adverse Event|18|||
23616184|NCT02085408|65979665|FG001|Step 1: Induction|Adverse Event|17|||
23616185|NCT02085408|65979664|FG000|Step 1: Induction|Death|33|||
23616186|NCT02085408|65979665|FG001|Step 1: Induction|Death|30|||
23723154|NCT01202760|66363067|FG001|Overall Study|Entry Criteria Not Met|3|||
23723155|NCT01202760|66363068|FG002|Overall Study|Entry Criteria Not Met|1|||
23723156|NCT01202760|66363066|FG000|Overall Study|Adverse Event|11|||
23723157|NCT01202760|66363067|FG001|Overall Study|Adverse Event|9|||
23723158|NCT01202760|66363068|FG002|Overall Study|Adverse Event|10|||
23723159|NCT01202760|66363066|FG000|Overall Study|Death|2|||
23536650|NCT00767000|65697563|FG003|54-week Study|Interruption of study medication|0|||
23536651|NCT00767000|65697564|FG004|54-week Study|Interruption of study medication|0|||
23536652|NCT00767000|65697560|FG000|54-week Study|Lack of Efficacy|2|||
23616187|NCT02085408|65979664|FG000|Step 1: Induction|Withdrawal by Subject|16|||
23723160|NCT01202760|66363067|FG001|Overall Study|Death|1|||
23536653|NCT00767000|65697561|FG001|54-week Study|Lack of Efficacy|0|||
23536654|NCT00767000|65697562|FG002|54-week Study|Lack of Efficacy|1|||
23616188|NCT02085408|65979665|FG001|Step 1: Induction|Withdrawal by Subject|8|||
23616189|NCT02085408|65979664|FG000|Step 1: Induction|Alternative Therapy|15|||
23616190|NCT02085408|65979665|FG001|Step 1: Induction|Alternative Therapy|19|||
23616191|NCT02085408|65979664|FG000|Step 1: Induction|Complicating Disease|2|||
23616192|NCT02085408|65979665|FG001|Step 1: Induction|Complicating Disease|3|||
23616193|NCT02085408|65979664|FG000|Step 1: Induction|Other|27|||
23616194|NCT02085408|65979665|FG001|Step 1: Induction|Other|39|||
23723161|NCT01202760|66363068|FG002|Overall Study|Death|0|||
23723162|NCT01202760|66363066|FG000|Overall Study|Lack of Efficacy|6|||
23723163|NCT01202760|66363067|FG001|Overall Study|Lack of Efficacy|8|||
23723164|NCT01202760|66363068|FG002|Overall Study|Lack of Efficacy|7|||
23723165|NCT01202760|66363066|FG000|Overall Study|Lost to Follow-up|0|||
23616195|NCT02085408|65979664|FG000|Step 1: Induction|Never started treatment|6|||
23536655|NCT00767000|65697563|FG003|54-week Study|Lack of Efficacy|0|||
23536656|NCT00767000|65697564|FG004|54-week Study|Lack of Efficacy|5|||
23536657|NCT00767000|65697560|FG000|54-week Study|Lost to Follow-up|4|||
23536658|NCT00767000|65697561|FG001|54-week Study|Lost to Follow-up|0|||
23536659|NCT00767000|65697562|FG002|54-week Study|Lost to Follow-up|1|||
23536660|NCT00767000|65697563|FG003|54-week Study|Lost to Follow-up|4|||
23536661|NCT00767000|65697564|FG004|54-week Study|Lost to Follow-up|2|||
23536662|NCT00767000|65697560|FG000|54-week Study|Physician Decision|4|||
23536663|NCT00767000|65697561|FG001|54-week Study|Physician Decision|0|||
23536664|NCT00767000|65697562|FG002|54-week Study|Physician Decision|1|||
23536665|NCT00767000|65697563|FG003|54-week Study|Physician Decision|1|||
23536666|NCT00767000|65697564|FG004|54-week Study|Physician Decision|1|||
23536667|NCT00767000|65697560|FG000|54-week Study|Progressive disease|0|||
23536668|NCT00767000|65697561|FG001|54-week Study|Progressive disease|0|||
23536669|NCT00767000|65697562|FG002|54-week Study|Progressive disease|1|||
23536670|NCT00767000|65697563|FG003|54-week Study|Progressive disease|0|||
23536671|NCT00767000|65697564|FG004|54-week Study|Progressive disease|0|||
23536672|NCT00767000|65697560|FG000|54-week Study|Protocol Violation|0|||
23536673|NCT00767000|65697561|FG001|54-week Study|Protocol Violation|0|||
23536674|NCT00767000|65697562|FG002|54-week Study|Protocol Violation|1|||
23536675|NCT00767000|65697563|FG003|54-week Study|Protocol Violation|2|||
23536676|NCT00767000|65697564|FG004|54-week Study|Protocol Violation|0|||
23536677|NCT00767000|65697560|FG000|54-week Study|Withdrawal by Subject|2|||
23536678|NCT00767000|65697561|FG001|54-week Study|Withdrawal by Subject|3|||
23536679|NCT00767000|65697562|FG002|54-week Study|Withdrawal by Subject|5|||
23536680|NCT00767000|65697563|FG003|54-week Study|Withdrawal by Subject|11|||
23536681|NCT00767000|65697564|FG004|54-week Study|Withdrawal by Subject|13|||
23536682|NCT00767000|65697560|FG000|54-week Study|Study terminated by sponsor|90|||
23536683|NCT00767000|65697561|FG001|54-week Study|Study terminated by sponsor|102|||
23536684|NCT00767000|65697562|FG002|54-week Study|Study terminated by sponsor|89|||
23536685|NCT00767000|65697563|FG003|54-week Study|Study terminated by sponsor|196|||
23536686|NCT00767000|65697564|FG004|54-week Study|Study terminated by sponsor|194|||
23536687|NCT00767000|65697560|FG000|54-week Study|Reason not reported|0|||
23536688|NCT00767000|65697561|FG001|54-week Study|Reason not reported|0|||
23536689|NCT00767000|65697562|FG002|54-week Study|Reason not reported|0|||
23536690|NCT00767000|65697563|FG003|54-week Study|Reason not reported|1|||
23536691|NCT00767000|65697564|FG004|54-week Study|Reason not reported|0|||
23536692|NCT00767000|65697560|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
23536693|NCT00767000|65697561|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
23536694|NCT00767000|65697562|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
23536695|NCT00767000|65697563|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
23536696|NCT00767000|65697564|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
23536697|NCT04382326|65697565|FG000|Overall Study|Adverse Event, not serious|1|||
23536698|NCT04382326|65697566|FG001|Overall Study|Adverse Event, not serious|2|||
23536699|NCT04382326|65697565|FG000|Overall Study|Other|1|||
23536700|NCT04382326|65697566|FG001|Overall Study|Other|0|||
23536701|NCT04382326|65697565|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
23536702|NCT04382326|65697566|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
23536703|NCT04382326|65697565|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
23536704|NCT04382326|65697566|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
23536705|NCT04382326|65697565|FG000|Overall Study|Protocol Violation|29|||
23536706|NCT04382326|65697566|FG001|Overall Study|Protocol Violation|23|||
23536707|NCT04382326|65697565|FG000|Overall Study|Physician Decision|0|||
23536708|NCT04382326|65697566|FG001|Overall Study|Physician Decision|1|||
23536709|NCT04382326|65697565|FG000|Overall Study|Lost to Follow-up|48|||
23536710|NCT04382326|65697566|FG001|Overall Study|Lost to Follow-up|63|||
23536711|NCT04382326|65697565|FG000|Overall Study|Adverse Event, non-fatal|1|||
23616196|NCT02085408|65979665|FG001|Step 1: Induction|Never started treatment|4|||
23616197|NCT02085408|65979664|FG000|Step 2: Consolidation|Disease Progression|5|||
23616198|NCT02085408|65979665|FG001|Step 2: Consolidation|Disease Progression|20|||
23723166|NCT01202760|66363067|FG001|Overall Study|Lost to Follow-up|2|||
23536712|NCT04382326|65697566|FG001|Overall Study|Adverse Event, non-fatal|1|||
23536713|NCT02738775|65697568|FG000|Overall Study|Withdrawal by Subject|0|||
23536714|NCT02738775|65697569|FG001|Overall Study|Withdrawal by Subject|1|||
23536715|NCT02738775|65697570|FG002|Overall Study|Withdrawal by Subject|0|||
23536716|NCT02738775|65697571|FG003|Overall Study|Withdrawal by Subject|0|||
23723167|NCT01202760|66363068|FG002|Overall Study|Lost to Follow-up|1|||
23723168|NCT01202760|66363066|FG000|Overall Study|Parent / Caregiver Decision|0|||
23536717|NCT02738775|65697572|FG004|Overall Study|Withdrawal by Subject|0|||
23536718|NCT02738775|65697573|FG005|Overall Study|Withdrawal by Subject|0|||
23536719|NCT02738775|65697568|FG000|Overall Study|Adverse Event|0|||
23536720|NCT02738775|65697569|FG001|Overall Study|Adverse Event|0|||
23536721|NCT02738775|65697570|FG002|Overall Study|Adverse Event|0|||
23616199|NCT02085408|65979664|FG000|Step 2: Consolidation|Adverse Event|9|||
23616200|NCT02085408|65979665|FG001|Step 2: Consolidation|Adverse Event|8|||
23616201|NCT02085408|65979664|FG000|Step 2: Consolidation|Death|4|||
23616202|NCT02085408|65979665|FG001|Step 2: Consolidation|Death|3|||
23616203|NCT02085408|65979664|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
23616204|NCT02085408|65979665|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
23616205|NCT02085408|65979664|FG000|Step 2: Consolidation|Alternative Therapy|9|||
23616206|NCT02085408|65979665|FG001|Step 2: Consolidation|Alternative Therapy|3|||
23616207|NCT02085408|65979664|FG000|Step 2: Consolidation|Complicating Disease|0|||
23616208|NCT02085408|65979665|FG001|Step 2: Consolidation|Complicating Disease|2|||
23616209|NCT02085408|65979664|FG000|Step 2: Consolidation|Other|6|||
23616210|NCT02085408|65979665|FG001|Step 2: Consolidation|Other|6|||
23616211|NCT02085408|65979664|FG000|Step 2: Consolidation|Never started treatment|4|||
23616212|NCT02085408|65979665|FG001|Step 2: Consolidation|Never started treatment|3|||
23616213|NCT02085408|65979664|FG000|Step 3: Maintenance|Disease Progression|13|||
23616214|NCT02085408|65979665|FG001|Step 3: Maintenance|Disease Progression|11|||
23616215|NCT02085408|65979664|FG000|Step 3: Maintenance|Adverse Event|2|||
23616216|NCT02085408|65979665|FG001|Step 3: Maintenance|Adverse Event|4|||
23723169|NCT01202760|66363067|FG001|Overall Study|Parent / Caregiver Decision|1|||
23723170|NCT01202760|66363068|FG002|Overall Study|Parent / Caregiver Decision|0|||
23723171|NCT01202760|66363066|FG000|Overall Study|Withdrawal by Subject|17|||
23723172|NCT01202760|66363067|FG001|Overall Study|Withdrawal by Subject|18|||
23723173|NCT01202760|66363068|FG002|Overall Study|Withdrawal by Subject|14|||
23723174|NCT01202760|66363066|FG000|Overall Study|Physician Decision|0|||
23723175|NCT01202760|66363067|FG001|Overall Study|Physician Decision|1|||
23723176|NCT01202760|66363068|FG002|Overall Study|Physician Decision|0|||
23723177|NCT01202760|66363066|FG000|Overall Study|Protocol Violation|7|||
23723178|NCT01202760|66363067|FG001|Overall Study|Protocol Violation|5|||
23723179|NCT01202760|66363068|FG002|Overall Study|Protocol Violation|2|||
23723180|NCT01202760|66363066|FG000|Overall Study|Sponsor Decision|4|||
23723181|NCT01202760|66363067|FG001|Overall Study|Sponsor Decision|4|||
23723182|NCT01202760|66363068|FG002|Overall Study|Sponsor Decision|0|||
23723183|NCT00640146|66363069|FG000|Overall Study|Adverse Event|2|||
23723184|NCT00640146|66363070|FG001|Overall Study|Adverse Event|0|||
23723185|NCT00640146|66363069|FG000|Overall Study|Lost to Follow-up|0|||
23723186|NCT00640146|66363070|FG001|Overall Study|Lost to Follow-up|1|||
23723187|NCT00640146|66363069|FG000|Overall Study|Lack of Efficacy|0|||
23723188|NCT00640146|66363070|FG001|Overall Study|Lack of Efficacy|1|||
23723189|NCT00640146|66363069|FG000|Overall Study|Withdrawal by Subject|1|||
23723190|NCT00640146|66363070|FG001|Overall Study|Withdrawal by Subject|1|||
23723191|NCT00640146|66363069|FG000|Overall Study|Randomized but not treated|1|||
23723192|NCT00640146|66363070|FG001|Overall Study|Randomized but not treated|3|||
23723193|NCT01176240|66363071|FG000|Study 306A|Lack of Efficacy|2|||
23723194|NCT01176240|66363072|FG001|Study 306A|Lack of Efficacy|1|||
23723195|NCT01176240|66363071|FG000|Study 306A|Protocol Violation|0|||
23723196|NCT01176240|66363072|FG001|Study 306A|Protocol Violation|1|||
23723197|NCT01176240|66363071|FG000|Study 306A|Withdrawal by Subject|0|||
23723198|NCT01176240|66363072|FG001|Study 306A|Withdrawal by Subject|1|||
23723199|NCT01176240|66363071|FG000|Study 306A|Stop due to diverse problems|1|||
23723200|NCT01176240|66363072|FG001|Study 306A|Stop due to diverse problems|0|||
23723201|NCT01176240|66363071|FG000|Study 306B|Lack of Efficacy|5|||
23723202|NCT01176240|66363072|FG001|Study 306B|Lack of Efficacy|3|||
23723203|NCT01176240|66363071|FG000|Study 306B|Adverse Event|10|||
23723204|NCT01176240|66363072|FG001|Study 306B|Adverse Event|5|||
23723205|NCT01176240|66363071|FG000|Study 306B|Protocol Violation|2|||
23723206|NCT01176240|66363072|FG001|Study 306B|Protocol Violation|3|||
23723207|NCT01176240|66363071|FG000|Study 306B|Withdrawal by Subject|4|||
23723208|NCT01176240|66363072|FG001|Study 306B|Withdrawal by Subject|1|||
23723209|NCT01176240|66363071|FG000|Study 306B|Physician Decision|2|||
23723210|NCT01176240|66363072|FG001|Study 306B|Physician Decision|1|||
23723211|NCT01176240|66363071|FG000|Study 306B|Supine Hypertension|1|||
23723212|NCT01176240|66363072|FG001|Study 306B|Supine Hypertension|2|||
23723213|NCT01176240|66363071|FG000|Study 306B|Lost to Follow-up|0|||
23723214|NCT01176240|66363072|FG001|Study 306B|Lost to Follow-up|1|||
23723215|NCT01176240|66363071|FG000|Study 306B|withdrew prior to dosing|2|||
23723216|NCT01176240|66363072|FG001|Study 306B|withdrew prior to dosing|1|||
23723217|NCT00092677|66363073|FG000|Overall Study|Lost to Follow-up|0|||
23723218|NCT00092677|66363074|FG001|Overall Study|Lost to Follow-up|2|||
23723219|NCT00092677|66363073|FG000|Overall Study|Adminstrative|5|||
23723220|NCT00092677|66363074|FG001|Overall Study|Adminstrative|9|||
23723221|NCT03146403|66363081|FG000|Overall Study|Withdrawal by Subject|0|||
23723222|NCT03146403|66363082|FG001|Overall Study|Withdrawal by Subject|3|||
23723223|NCT03146403|66363081|FG000|Overall Study|Lost to Follow-up|2|||
23723224|NCT03146403|66363082|FG001|Overall Study|Lost to Follow-up|0|||
23723225|NCT01484561|66363083|FG000|Overall Study|Lack of Efficacy|3|||
23723226|NCT01484561|66363084|FG001|Overall Study|Lack of Efficacy|1|||
23723227|NCT01484561|66363083|FG000|Overall Study|Lost to Follow-up|1|||
23723228|NCT01484561|66363084|FG001|Overall Study|Lost to Follow-up|0|||
23723229|NCT01484561|66363083|FG000|Overall Study|Withdrawal by Subject|3|||
23723230|NCT01484561|66363084|FG001|Overall Study|Withdrawal by Subject|0|||
23536722|NCT02738775|65697571|FG003|Overall Study|Adverse Event|1|||
23536723|NCT02738775|65697572|FG004|Overall Study|Adverse Event|0|||
23536724|NCT02738775|65697573|FG005|Overall Study|Adverse Event|0|||
23536725|NCT02738775|65697568|FG000|Overall Study|Pregnancy|0|||
23723231|NCT01484561|66363083|FG000|Overall Study|Other|1|||
23723232|NCT01484561|66363084|FG001|Overall Study|Other|1|||
23723233|NCT01484561|66363083|FG000|Overall Study|Adverse Event|1|||
23723234|NCT01484561|66363084|FG001|Overall Study|Adverse Event|4|||
23723235|NCT01192204|66363089|FG000|Overall Study|could not keep recall appointments|1|||
23723236|NCT01192204|66363090|FG001|Overall Study|could not keep recall appointments|0|||
23723237|NCT02773368|66363093|FG000|Overall Study|Lost to Follow-up|4|||
23723238|NCT02773368|66363094|FG001|Overall Study|Lost to Follow-up|1|||
23723239|NCT02773368|66363093|FG000|Overall Study|Withdrawal by Subject|5|||
23723240|NCT02773368|66363094|FG001|Overall Study|Withdrawal by Subject|1|||
23723241|NCT02773368|66363093|FG000|Overall Study|Unclassified|1|||
23723242|NCT02773368|66363094|FG001|Overall Study|Unclassified|1|||
23723243|NCT02773368|66363093|FG000|Overall Study|Missing|0|||
23723244|NCT02773368|66363094|FG001|Overall Study|Missing|1|||
23723245|NCT05406440|66363095|FG000|Overall Study|Lost to Follow-up|0|||
23723246|NCT05406440|66363096|FG001|Overall Study|Lost to Follow-up|0|||
23723247|NCT05406440|66363097|FG002|Overall Study|Lost to Follow-up|0|||
23723248|NCT05406440|66363098|FG003|Overall Study|Lost to Follow-up|0|||
23536726|NCT02738775|65697569|FG001|Overall Study|Pregnancy|1|||
23536727|NCT02738775|65697570|FG002|Overall Study|Pregnancy|0|||
23536728|NCT02738775|65697571|FG003|Overall Study|Pregnancy|0|||
23536729|NCT02738775|65697572|FG004|Overall Study|Pregnancy|0|||
23536730|NCT02738775|65697573|FG005|Overall Study|Pregnancy|0|||
23536731|NCT02738775|65697568|FG000|Overall Study|Missing|0|||
23536732|NCT02738775|65697569|FG001|Overall Study|Missing|0|||
23536733|NCT02738775|65697570|FG002|Overall Study|Missing|0|||
23536734|NCT02738775|65697571|FG003|Overall Study|Missing|0|||
23536735|NCT02738775|65697572|FG004|Overall Study|Missing|0|||
23536736|NCT02738775|65697573|FG005|Overall Study|Missing|1|||
23536737|NCT01312467|65697574|FG000|Overall Study|Adverse Event|4|||
23536738|NCT01312467|65697574|FG000|Overall Study|Lost to Follow-up|1|||
23536739|NCT01312467|65697574|FG000|Overall Study|Withdrawal by Subject|2|||
23536740|NCT01312467|65697574|FG000|Overall Study|Deported to country of origin|1|||
23536741|NCT01312467|65697574|FG000|Overall Study|Another medical condition|1|||
23536742|NCT01312467|65697574|FG000|Overall Study|Ineligible|4|||
23536743|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
23536744|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
23536745|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
23536746|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
23536747|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
23536748|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
23536749|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
23536750|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
23536751|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
23536752|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
23536753|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
23536754|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
23536755|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
23536756|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
23536757|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
23536758|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
23536759|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
23536760|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
23536761|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
23536762|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
23536763|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
23536764|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
23536765|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
23536766|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
23536767|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
23723249|NCT05406440|66363099|FG004|Overall Study|Lost to Follow-up|2|||
23723250|NCT05406440|66363100|FG005|Overall Study|Lost to Follow-up|0|||
23723251|NCT05406440|66363101|FG006|Overall Study|Lost to Follow-up|0|||
23723252|NCT05406440|66363095|FG000|Overall Study|Physician Decision|0|||
23723253|NCT05406440|66363096|FG001|Overall Study|Physician Decision|0|||
23536768|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
23536769|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
23723254|NCT05406440|66363097|FG002|Overall Study|Physician Decision|0|||
23723255|NCT05406440|66363098|FG003|Overall Study|Physician Decision|0|||
23723256|NCT05406440|66363099|FG004|Overall Study|Physician Decision|1|||
23723257|NCT05406440|66363100|FG005|Overall Study|Physician Decision|0|||
23723258|NCT05406440|66363101|FG006|Overall Study|Physician Decision|0|||
23723259|NCT05406440|66363095|FG000|Overall Study|Withdrawal by Subject|0|||
23723260|NCT05406440|66363096|FG001|Overall Study|Withdrawal by Subject|0|||
23723261|NCT05406440|66363097|FG002|Overall Study|Withdrawal by Subject|0|||
23723262|NCT05406440|66363098|FG003|Overall Study|Withdrawal by Subject|0|||
23723263|NCT05406440|66363099|FG004|Overall Study|Withdrawal by Subject|0|||
23723264|NCT05406440|66363100|FG005|Overall Study|Withdrawal by Subject|2|||
23723265|NCT05406440|66363101|FG006|Overall Study|Withdrawal by Subject|0|||
23723266|NCT01922739|66363102|FG000|Titration/Adjustment Period|Adverse Event|3|||
23723267|NCT01922739|66363102|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
23723268|NCT01922739|66363102|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
23723269|NCT01922739|66363102|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
23723270|NCT01922739|66363102|FG000|Open-label Treatment Period|Adverse Event|6|||
23723271|NCT01922739|66363102|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
23723272|NCT01922739|66363102|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
23723273|NCT01922739|66363102|FG000|Open-label Treatment Period|Protocol Violation|5|||
23723274|NCT01922739|66363102|FG000|Open-label Treatment Period|Pregnancy|1|||
23723275|NCT01922739|66363102|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
23723276|NCT01922739|66363102|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
23723277|NCT01922739|66363102|FG000|Open-label Treatment Period|Physician Decision|1|||
23723278|NCT01922739|66363102|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
23723279|NCT01181141|66363104|FG000|Overall Study|Adverse Event|2|||
23723280|NCT01181141|66363105|FG001|Overall Study|Adverse Event|1|||
23723281|NCT01181141|66363104|FG000|Overall Study|Lack of Efficacy|1|||
23723282|NCT01181141|66363105|FG001|Overall Study|Lack of Efficacy|0|||
23536770|NCT00499369|65697578|FG000|Overall Study|Adverse Event|2|||
23536771|NCT00499369|65697579|FG001|Overall Study|Adverse Event|2|||
23536772|NCT00499369|65697580|FG002|Overall Study|Adverse Event|3|||
23536773|NCT00499369|65697581|FG003|Overall Study|Adverse Event|1|||
23536774|NCT00499369|65697582|FG004|Overall Study|Adverse Event|2|||
23536775|NCT00499369|65697578|FG000|Overall Study|Withdrawal by Subject|0|||
23536776|NCT00499369|65697579|FG001|Overall Study|Withdrawal by Subject|1|||
23536777|NCT00499369|65697580|FG002|Overall Study|Withdrawal by Subject|1|||
23536778|NCT00499369|65697581|FG003|Overall Study|Withdrawal by Subject|0|||
23536779|NCT00499369|65697582|FG004|Overall Study|Withdrawal by Subject|0|||
23536780|NCT00499369|65697578|FG000|Overall Study|Progression|10|||
23536781|NCT00499369|65697579|FG001|Overall Study|Progression|12|||
23536782|NCT00499369|65697580|FG002|Overall Study|Progression|9|||
23536783|NCT00499369|65697581|FG003|Overall Study|Progression|6|||
23536784|NCT00499369|65697582|FG004|Overall Study|Progression|10|||
23536785|NCT00499369|65697578|FG000|Overall Study|Death|0|||
23536786|NCT00499369|65697579|FG001|Overall Study|Death|1|||
23536787|NCT00499369|65697580|FG002|Overall Study|Death|0|||
23536788|NCT00499369|65697581|FG003|Overall Study|Death|0|||
23536789|NCT00499369|65697582|FG004|Overall Study|Death|0|||
23536790|NCT00499369|65697578|FG000|Overall Study|Not protocol specified|2|||
23536791|NCT00499369|65697579|FG001|Overall Study|Not protocol specified|0|||
23536792|NCT00499369|65697580|FG002|Overall Study|Not protocol specified|3|||
23536793|NCT00499369|65697581|FG003|Overall Study|Not protocol specified|1|||
23536794|NCT00499369|65697582|FG004|Overall Study|Not protocol specified|0|||
23536795|NCT00499369|65697578|FG000|Overall Study|Ineligible|2|||
23536796|NCT00499369|65697579|FG001|Overall Study|Ineligible|2|||
23536797|NCT00499369|65697580|FG002|Overall Study|Ineligible|1|||
23536798|NCT00499369|65697581|FG003|Overall Study|Ineligible|1|||
23536799|NCT00499369|65697582|FG004|Overall Study|Ineligible|0|||
23536800|NCT04919499|65697583|FG000|Overall Study|Adverse Event|0|||
23536801|NCT04919499|65697584|FG001|Overall Study|Adverse Event|0|||
23536802|NCT04919499|65697585|FG002|Overall Study|Adverse Event|0|||
23536803|NCT04919499|65697586|FG003|Overall Study|Adverse Event|0|||
23536804|NCT04919499|65697587|FG004|Overall Study|Adverse Event|2|||
23536805|NCT04919499|65697583|FG000|Overall Study|Not treated|0|||
23536806|NCT04919499|65697584|FG001|Overall Study|Not treated|0|||
23536807|NCT04919499|65697585|FG002|Overall Study|Not treated|0|||
23536808|NCT04919499|65697586|FG003|Overall Study|Not treated|1|||
23536809|NCT04919499|65697587|FG004|Overall Study|Not treated|0|||
23536810|NCT03465540|65697588|FG000|Overall Study|Withdrawal by Subject|0|||
23536811|NCT03465540|65697589|FG001|Overall Study|Withdrawal by Subject|0|||
23536812|NCT03465540|65697590|FG002|Overall Study|Withdrawal by Subject|1|||
23536813|NCT03465540|65697591|FG003|Overall Study|Withdrawal by Subject|1|||
23536814|NCT03465540|65697592|FG004|Overall Study|Withdrawal by Subject|1|||
23536815|NCT03465540|65697593|FG005|Overall Study|Withdrawal by Subject|0|||
23536816|NCT03465540|65697588|FG000|Overall Study|Lost to Follow-up|0|||
23536817|NCT03465540|65697589|FG001|Overall Study|Lost to Follow-up|1|||
23536818|NCT03465540|65697590|FG002|Overall Study|Lost to Follow-up|0|||
23536819|NCT03465540|65697591|FG003|Overall Study|Lost to Follow-up|0|||
23536820|NCT03465540|65697592|FG004|Overall Study|Lost to Follow-up|1|||
23536821|NCT03465540|65697593|FG005|Overall Study|Lost to Follow-up|0|||
23536822|NCT03465540|65697588|FG000|Overall Study|Death|1|||
23536823|NCT03465540|65697589|FG001|Overall Study|Death|1|||
23536824|NCT03465540|65697590|FG002|Overall Study|Death|0|||
23536825|NCT03465540|65697591|FG003|Overall Study|Death|2|||
23536826|NCT03465540|65697592|FG004|Overall Study|Death|0|||
23536827|NCT03465540|65697593|FG005|Overall Study|Death|2|||
23536828|NCT03465540|65697588|FG000|Overall Study|Protocol specified criteria|0|||
23536829|NCT03465540|65697589|FG001|Overall Study|Protocol specified criteria|2|||
23536830|NCT03465540|65697590|FG002|Overall Study|Protocol specified criteria|2|||
23536831|NCT03465540|65697591|FG003|Overall Study|Protocol specified criteria|0|||
23536832|NCT03465540|65697592|FG004|Overall Study|Protocol specified criteria|2|||
23536833|NCT03465540|65697593|FG005|Overall Study|Protocol specified criteria|0|||
23536834|NCT01229436|65697600|FG000|Overall Study|Withdrawal by Subject|2|||
23536835|NCT01229436|65697600|FG000|Overall Study|Lost to Follow-up|3|||
23536836|NCT01431508|65697601|FG000|Overall Study|Lack of Efficacy|1|||
23536837|NCT01431508|65697601|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
23536838|NCT01243944|65697603|FG000|Overall Study|Adverse Event|15|||
23536839|NCT01243944|65697604|FG001|Overall Study|Adverse Event|13|||
23536840|NCT01243944|65697603|FG000|Overall Study|Lost to Follow-up|2|||
23536841|NCT01243944|65697604|FG001|Overall Study|Lost to Follow-up|1|||
23536842|NCT01243944|65697603|FG000|Overall Study|Physician Decision|2|||
23536843|NCT01243944|65697604|FG001|Overall Study|Physician Decision|7|||
23536844|NCT01243944|65697603|FG000|Overall Study|Disease progression|12|||
23536845|NCT01243944|65697604|FG001|Overall Study|Disease progression|11|||
23536846|NCT01243944|65697603|FG000|Overall Study|Protocol deviation|1|||
23536847|NCT01243944|65697604|FG001|Overall Study|Protocol deviation|1|||
23536848|NCT01243944|65697603|FG000|Overall Study|Participant decision|10|||
23536849|NCT01243944|65697604|FG001|Overall Study|Participant decision|15|||
23536850|NCT01243944|65697603|FG000|Overall Study|Death|2|||
23536851|NCT01243944|65697604|FG001|Overall Study|Death|3|||
23536852|NCT01243944|65697603|FG000|Overall Study|Non-compliance with study treatment|1|||
23536853|NCT01243944|65697604|FG001|Overall Study|Non-compliance with study treatment|0|||
23536854|NCT04028388|65697605|FG000|Overall Study|Evaluations missing|3|||
23536855|NCT04028388|65697606|FG001|Overall Study|Evaluations missing|6|||
23536856|NCT04028388|65697605|FG000|Overall Study|Not started|2|||
23536857|NCT04028388|65697606|FG001|Overall Study|Not started|0|||
23536858|NCT01033747|65697607|FG000|Overall Study|Adverse Event|9|||
23536859|NCT01033747|65697608|FG001|Overall Study|Adverse Event|4|||
23536860|NCT01033747|65697607|FG000|Overall Study|Abnormal Laboratory Value|1|||
23536861|NCT01033747|65697608|FG001|Overall Study|Abnormal Laboratory Value|0|||
23536862|NCT01033747|65697607|FG000|Overall Study|Abnormal test procedure|0|||
23536863|NCT01033747|65697608|FG001|Overall Study|Abnormal test procedure|1|||
23536864|NCT01033747|65697607|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
23536865|NCT01033747|65697608|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23536866|NCT01033747|65697607|FG000|Overall Study|Protocol Violation|1|||
23536867|NCT01033747|65697608|FG001|Overall Study|Protocol Violation|0|||
23536868|NCT01033747|65697607|FG000|Overall Study|Withdrawal by Subject|9|||
23536869|NCT01033747|65697608|FG001|Overall Study|Withdrawal by Subject|6|||
23536870|NCT01033747|65697607|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
23536871|NCT01033747|65697608|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
23536872|NCT01033747|65697607|FG000|Overall Study|Stopped at end of Extension 1|2|||
23536873|NCT01033747|65697608|FG001|Overall Study|Stopped at end of Extension 1|0|||
23536874|NCT04796610|65697616|FG000|Overall Study|Withdrawal by Subject|1|||
23536875|NCT04796610|65697617|FG001|Overall Study|Withdrawal by Subject|0|||
23536876|NCT04796610|65697618|FG002|Overall Study|Withdrawal by Subject|0|||
23536877|NCT04796610|65697619|FG003|Overall Study|Withdrawal by Subject|0|||
23536878|NCT04796610|65697616|FG000|Overall Study|Lost to Follow-up|2|||
23536879|NCT04796610|65697617|FG001|Overall Study|Lost to Follow-up|0|||
23536880|NCT04796610|65697618|FG002|Overall Study|Lost to Follow-up|1|||
23536881|NCT04796610|65697619|FG003|Overall Study|Lost to Follow-up|1|||
23536882|NCT01075321|65697628|FG000|Overall Study|Withdrawal by Subject|0|||
23536883|NCT01075321|65697629|FG001|Overall Study|Withdrawal by Subject|0|||
23536884|NCT01075321|65697630|FG002|Overall Study|Withdrawal by Subject|1|||
23536885|NCT01075321|65697631|FG003|Overall Study|Withdrawal by Subject|1|||
23536886|NCT01075321|65697628|FG000|Overall Study|Protocol Violation|0|||
23536887|NCT01075321|65697629|FG001|Overall Study|Protocol Violation|0|||
23536888|NCT01075321|65697630|FG002|Overall Study|Protocol Violation|1|||
23536889|NCT01075321|65697631|FG003|Overall Study|Protocol Violation|0|||
23536890|NCT01075321|65697628|FG000|Overall Study|Treatment Incomplete due to progression|1|||
23536891|NCT01075321|65697629|FG001|Overall Study|Treatment Incomplete due to progression|0|||
23536892|NCT01075321|65697630|FG002|Overall Study|Treatment Incomplete due to progression|0|||
23536893|NCT01075321|65697631|FG003|Overall Study|Treatment Incomplete due to progression|0|||
23536894|NCT01075321|65697628|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
23536895|NCT01075321|65697629|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
23536896|NCT01075321|65697630|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
23536897|NCT01075321|65697631|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
23723283|NCT01181141|66363104|FG000|Overall Study|Lost to Follow-up|1|||
23723284|NCT01181141|66363105|FG001|Overall Study|Lost to Follow-up|1|||
23723285|NCT01181141|66363104|FG000|Overall Study|Physician Decision|2|||
23723286|NCT01181141|66363105|FG001|Overall Study|Physician Decision|0|||
23723287|NCT01181141|66363104|FG000|Overall Study|Protocol Violation|3|||
23723288|NCT01181141|66363105|FG001|Overall Study|Protocol Violation|1|||
23723289|NCT01181141|66363104|FG000|Overall Study|Withdrawal by Subject|3|||
23723290|NCT01181141|66363105|FG001|Overall Study|Withdrawal by Subject|1|||
23723291|NCT01517412|66363112|FG000|Overall Study|Adverse Event|10|||
23723292|NCT01517412|66363113|FG001|Overall Study|Adverse Event|11|||
23723293|NCT01517412|66363112|FG000|Overall Study|Lack of Efficacy|10|||
23723294|NCT01517412|66363113|FG001|Overall Study|Lack of Efficacy|5|||
23723295|NCT01517412|66363112|FG000|Overall Study|Poor compliance to protocol|8|||
23723296|NCT01517412|66363113|FG001|Overall Study|Poor compliance to protocol|3|||
23723297|NCT01517412|66363112|FG000|Overall Study|Other than specified above|8|||
23723298|NCT01517412|66363113|FG001|Overall Study|Other than specified above|5|||
23723299|NCT01906476|66363116|FG000|Overall Study|Lost to Follow-up|17|||
23723300|NCT01906476|66363117|FG001|Overall Study|Lost to Follow-up|16|||
23723301|NCT00254163|66363118|FG000|Overall Study|Adverse Event|29|||
23723302|NCT00254163|66363119|FG001|Overall Study|Adverse Event|26|||
23723303|NCT00254163|66363118|FG000|Overall Study|Patient request/withdrew consent|6|||
23723304|NCT00254163|66363119|FG001|Overall Study|Patient request/withdrew consent|4|||
23723305|NCT00254163|66363118|FG000|Overall Study|Investigator request|1|||
23723306|NCT00254163|66363119|FG001|Overall Study|Investigator request|3|||
23723307|NCT00254163|66363118|FG000|Overall Study|Failed entry|1|||
23723308|NCT00254163|66363119|FG001|Overall Study|Failed entry|3|||
23723309|NCT00254163|66363118|FG000|Overall Study|Progressive disease|0|||
23723310|NCT00254163|66363119|FG001|Overall Study|Progressive disease|1|||
23423444|NCT02435680|65292646|FG001|Overall Study|not treated|0|||
23423445|NCT02435680|65292647|FG002|Overall Study|not treated|1|||
23536898|NCT02091167|65697632|FG000|Overall Study|Lost to Follow-up|0|||
23536899|NCT02091167|65697633|FG001|Overall Study|Lost to Follow-up|2|||
23536900|NCT02252081|65697641|FG000|Overall Study|Withdrawal by Subject|2|||
23536901|NCT02252081|65697642|FG001|Overall Study|Withdrawal by Subject|1|||
23536902|NCT02252081|65697641|FG000|Overall Study|Adverse Event|4|||
23536903|NCT02252081|65697642|FG001|Overall Study|Adverse Event|1|||
23536904|NCT02252081|65697641|FG000|Overall Study|non compliance & others|0|||
23536905|NCT02252081|65697642|FG001|Overall Study|non compliance & others|2|||
23536906|NCT03042312|65697650|FG000|Overall Study|Administrative Reason|1|||
23536907|NCT03042312|65697651|FG001|Overall Study|Administrative Reason|1|||
23536908|NCT03042312|65697650|FG000|Overall Study|Adverse Event|0|||
23536909|NCT03042312|65697651|FG001|Overall Study|Adverse Event|1|||
23536910|NCT03042312|65697650|FG000|Overall Study|Lost to Follow-up|1|||
23536911|NCT03042312|65697651|FG001|Overall Study|Lost to Follow-up|3|||
23536912|NCT03042312|65697650|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
23536913|NCT03042312|65697651|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
23536914|NCT03042312|65697650|FG000|Overall Study|Withdrawal by Subject|4|||
23536915|NCT03042312|65697651|FG001|Overall Study|Withdrawal by Subject|5|||
23536916|NCT00699699|65697652|FG000|Overall Study|Adverse Event|36|||
23536917|NCT00699699|65697652|FG000|Overall Study|Individual different reasons|21|||
23536918|NCT01532687|65697654|FG000|Overall Study|Death|2|||
23536919|NCT01532687|65697655|FG001|Overall Study|Death|0|||
23536920|NCT01532687|65697654|FG000|Overall Study|Adverse Event|6|||
23536921|NCT01532687|65697655|FG001|Overall Study|Adverse Event|1|||
23536922|NCT01532687|65697654|FG000|Overall Study|Withdrawal by Subject|1|||
23536923|NCT01532687|65697655|FG001|Overall Study|Withdrawal by Subject|0|||
23536924|NCT01532687|65697654|FG000|Overall Study|Physician Decision|2|||
23536925|NCT01532687|65697655|FG001|Overall Study|Physician Decision|1|||
23536926|NCT01532687|65697654|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
23536927|NCT01532687|65697655|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
23536928|NCT02886572|65697658|FG000|Overall Study|Death|8|||
23536929|NCT02984995|65697659|FG000|Overall Study|Required stem cell transplant|13|||
23536930|NCT02984995|65697660|FG001|Overall Study|Required stem cell transplant|2|||
23723311|NCT00254163|66363118|FG000|Overall Study|Death|0|||
23723312|NCT00254163|66363119|FG001|Overall Study|Death|1|||
23723313|NCT00254163|66363118|FG000|Overall Study|Other|8|||
23423446|NCT01596335|65292662|FG000|Overall Study|exacerbation of primary disease|5|||
23536931|NCT02984995|65697659|FG000|Overall Study|Progressive disease|11|||
23536932|NCT02984995|65697660|FG001|Overall Study|Progressive disease|1|||
23723314|NCT00254163|66363119|FG001|Overall Study|Other|8|||
23723315|NCT01146951|66363120|FG000|Overall Study|Adverse Event|4|||
23536933|NCT02984995|65697659|FG000|Overall Study|Adverse Event|1|||
23723316|NCT01146951|66363121|FG001|Overall Study|Adverse Event|1|||
23723317|NCT01316939|66363123|FG000|Overall Study|Study closed/terminated|26|||
23423447|NCT01596335|65292663|FG001|Overall Study|exacerbation of primary disease|9|||
23723318|NCT01316939|66363124|FG001|Overall Study|Study closed/terminated|25|||
23723319|NCT01316939|66363125|FG002|Overall Study|Study closed/terminated|23|||
23423448|NCT03362931|65292664|FG000|Overall Study|Adverse Event|1|||
23536934|NCT02984995|65697660|FG001|Overall Study|Adverse Event|0|||
23536935|NCT04121962|65697661|FG000|Overall Study|Lost to Follow-up|42|||
23536936|NCT04121962|65697662|FG001|Overall Study|Lost to Follow-up|39|||
23536937|NCT05070897|65697665|FG000|Overall Study|Protocol Violation|123|||
23536938|NCT05070897|65697666|FG001|Overall Study|Protocol Violation|68|||
23536939|NCT01018264|65697667|FG000|Overall Study|Withdrawal by Subject|1|||
23536940|NCT01018264|65697668|FG001|Overall Study|Withdrawal by Subject|0|||
23536941|NCT01018264|65697667|FG000|Overall Study|Lost to Follow-up|0|||
23536942|NCT01018264|65697668|FG001|Overall Study|Lost to Follow-up|1|||
23536943|NCT03930745|65697674|FG000|Overall Study|Lost to Follow-up|10|||
23536944|NCT03930745|65697675|FG001|Overall Study|Lost to Follow-up|5|||
23536945|NCT03930745|65697674|FG000|Overall Study|Withdrawal by Subject|1|||
23536946|NCT03930745|65697675|FG001|Overall Study|Withdrawal by Subject|2|||
23536947|NCT03930745|65697674|FG000|Overall Study|Protocol Violation|2|||
23536948|NCT03930745|65697675|FG001|Overall Study|Protocol Violation|2|||
23536949|NCT03930745|65697674|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
23536950|NCT03930745|65697675|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
23536951|NCT03930745|65697674|FG000|Overall Study|Adverse Event|0|||
23536952|NCT03930745|65697675|FG001|Overall Study|Adverse Event|1|||
23536953|NCT03930745|65697674|FG000|Overall Study|Pregnancy|0|||
23536954|NCT03930745|65697675|FG001|Overall Study|Pregnancy|1|||
23536955|NCT00533949|65697676|FG000|Overall Study|Protocol Violation|12|||
23536956|NCT00533949|65697677|FG001|Overall Study|Protocol Violation|12|||
23536957|NCT00533949|65697678|FG002|Overall Study|Protocol Violation|9|||
23536958|NCT00533949|65697679|FG003|Overall Study|Protocol Violation|9|||
23536959|NCT00533949|65697676|FG000|Overall Study|Withdrawal by Subject|3|||
23536960|NCT00533949|65697677|FG001|Overall Study|Withdrawal by Subject|2|||
23536961|NCT00533949|65697678|FG002|Overall Study|Withdrawal by Subject|1|||
23536962|NCT00533949|65697679|FG003|Overall Study|Withdrawal by Subject|1|||
23536963|NCT03952039|65697680|FG000|Overall Study|Adverse Event|22|||
23536964|NCT03952039|65697681|FG001|Overall Study|Adverse Event|8|||
23536965|NCT03952039|65697680|FG000|Overall Study|Withdrawal by Participant|17|||
23536966|NCT03952039|65697681|FG001|Overall Study|Withdrawal by Participant|12|||
23536967|NCT03952039|65697680|FG000|Overall Study|Death|13|||
23536968|NCT03952039|65697681|FG001|Overall Study|Death|6|||
23536969|NCT03952039|65697680|FG000|Overall Study|Lack of Efficacy|12|||
23536970|NCT03952039|65697681|FG001|Overall Study|Lack of Efficacy|2|||
23536971|NCT03952039|65697680|FG000|Overall Study|Physician Decision|9|||
23536972|NCT03952039|65697681|FG001|Overall Study|Physician Decision|3|||
23536973|NCT03952039|65697680|FG000|Overall Study|Progressive Disease|6|||
23536974|NCT03952039|65697681|FG001|Overall Study|Progressive Disease|4|||
23723320|NCT01316939|66363123|FG000|Overall Study|Lack of Efficacy|24|||
23423449|NCT03362931|65292664|FG000|Overall Study|Death|2|||
23536975|NCT03952039|65697680|FG000|Overall Study|Other Reasons|12|||
23536976|NCT03952039|65697681|FG001|Overall Study|Other Reasons|4|||
23536977|NCT00274716|65697686|FG000|Phase A|Other non-reported reason|4|||
23536978|NCT00274716|65697687|FG001|Phase A|Other non-reported reason|2|||
23536979|NCT00274716|65697688|FG002|Phase A|Other non-reported reason|1|||
23536980|NCT00274716|65697689|FG003|Phase A|Other non-reported reason|2|||
23536981|NCT00274716|65697690|FG004|Phase A|Other non-reported reason|0|||
23536982|NCT00274716|65697691|FG005|Phase A|Other non-reported reason|1|||
23536983|NCT00274716|65697686|FG000|Phase A|Participant moved|0|||
23536984|NCT00274716|65697687|FG001|Phase A|Participant moved|0|||
23536985|NCT00274716|65697688|FG002|Phase A|Participant moved|1|||
23536986|NCT00274716|65697689|FG003|Phase A|Participant moved|0|||
23536987|NCT00274716|65697690|FG004|Phase A|Participant moved|0|||
23536988|NCT00274716|65697691|FG005|Phase A|Participant moved|1|||
23536989|NCT00274716|65697686|FG000|Phase A|Site Terminated|0|||
23536990|NCT00274716|65697687|FG001|Phase A|Site Terminated|0|||
23536991|NCT00274716|65697688|FG002|Phase A|Site Terminated|0|||
23536992|NCT00274716|65697689|FG003|Phase A|Site Terminated|1|||
23536993|NCT00274716|65697690|FG004|Phase A|Site Terminated|0|||
23536994|NCT00274716|65697691|FG005|Phase A|Site Terminated|0|||
23536995|NCT00274716|65697686|FG000|Phase A|Protocol Violation|1|||
23536996|NCT00274716|65697687|FG001|Phase A|Protocol Violation|0|||
23536997|NCT00274716|65697688|FG002|Phase A|Protocol Violation|0|||
23536998|NCT00274716|65697689|FG003|Phase A|Protocol Violation|1|||
23536999|NCT00274716|65697690|FG004|Phase A|Protocol Violation|0|||
23537000|NCT00274716|65697691|FG005|Phase A|Protocol Violation|0|||
23537001|NCT00274716|65697686|FG000|Phase A|Met criteria for discontinuation|1|||
23537002|NCT00274716|65697687|FG001|Phase A|Met criteria for discontinuation|1|||
23537003|NCT00274716|65697688|FG002|Phase A|Met criteria for discontinuation|0|||
23537004|NCT00274716|65697689|FG003|Phase A|Met criteria for discontinuation|0|||
23537005|NCT00274716|65697690|FG004|Phase A|Met criteria for discontinuation|0|||
23723321|NCT01316939|66363124|FG001|Overall Study|Lack of Efficacy|25|||
23423450|NCT01819129|65292669|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
23537006|NCT00274716|65697691|FG005|Phase A|Met criteria for discontinuation|0|||
23537007|NCT00274716|65697686|FG000|Phase A|Withdrawal by Subject|2|||
23537008|NCT00274716|65697687|FG001|Phase A|Withdrawal by Subject|2|||
23537009|NCT00274716|65697688|FG002|Phase A|Withdrawal by Subject|1|||
23537010|NCT00274716|65697689|FG003|Phase A|Withdrawal by Subject|3|||
23423451|NCT01819129|65292670|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
23423452|NCT01819129|65292669|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
23537011|NCT00274716|65697690|FG004|Phase A|Withdrawal by Subject|0|||
23537012|NCT00274716|65697691|FG005|Phase A|Withdrawal by Subject|1|||
23537013|NCT00274716|65697686|FG000|Phase A|Adverse Event|2|||
23537014|NCT00274716|65697687|FG001|Phase A|Adverse Event|3|||
23537015|NCT00274716|65697688|FG002|Phase A|Adverse Event|3|||
23537016|NCT00274716|65697689|FG003|Phase A|Adverse Event|0|||
23537017|NCT00274716|65697690|FG004|Phase A|Adverse Event|2|||
23537018|NCT00274716|65697691|FG005|Phase A|Adverse Event|0|||
23537019|NCT00274716|65697686|FG000|Phase A|Completed but did not enter Phase B|1|||
23537020|NCT00274716|65697687|FG001|Phase A|Completed but did not enter Phase B|2|||
23537021|NCT00274716|65697688|FG002|Phase A|Completed but did not enter Phase B|2|||
23537022|NCT00274716|65697689|FG003|Phase A|Completed but did not enter Phase B|2|||
23537023|NCT00274716|65697690|FG004|Phase A|Completed but did not enter Phase B|1|||
23537024|NCT00274716|65697691|FG005|Phase A|Completed but did not enter Phase B|1|||
23537025|NCT00274716|65697686|FG000|Phase B|Adverse Event|0|||
23537026|NCT00274716|65697687|FG001|Phase B|Adverse Event|0|||
23537027|NCT00274716|65697688|FG002|Phase B|Adverse Event|2|||
23537028|NCT00274716|65697689|FG003|Phase B|Adverse Event|0|||
23537029|NCT00274716|65697690|FG004|Phase B|Adverse Event|0|||
23537030|NCT00274716|65697691|FG005|Phase B|Adverse Event|1|||
23537031|NCT00274716|65697686|FG000|Phase B|Protocol Violation|0|||
23423453|NCT01819129|65292670|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
23423454|NCT01819129|65292669|FG000|Overall Study|Other, Subject moved out of the country|0|||
23423455|NCT01819129|65292670|FG001|Overall Study|Other, Subject moved out of the country|1|||
23423456|NCT01819129|65292669|FG000|Overall Study|Withdrawal by Subject|15|||
23423457|NCT01819129|65292670|FG001|Overall Study|Withdrawal by Subject|15|||
23423458|NCT01819129|65292669|FG000|Overall Study|Lost to Follow-up|5|||
23423459|NCT01819129|65292670|FG001|Overall Study|Lost to Follow-up|2|||
23423460|NCT01819129|65292669|FG000|Overall Study|Lack of Efficacy|0|||
23423461|NCT01819129|65292670|FG001|Overall Study|Lack of Efficacy|1|||
23423462|NCT01819129|65292669|FG000|Overall Study|Adverse Event|1|||
23423463|NCT01819129|65292670|FG001|Overall Study|Adverse Event|4|||
23423464|NCT01819129|65292669|FG000|Overall Study|Death|1|||
23423465|NCT01819129|65292670|FG001|Overall Study|Death|1|||
23423466|NCT01819129|65292669|FG000|Overall Study|Withdrawal Criteria|20|||
23423467|NCT01819129|65292670|FG001|Overall Study|Withdrawal Criteria|15|||
23423468|NCT02791191|65292671|FG000|Overall Study|Adverse Event|2|||
23423469|NCT02791191|65292672|FG001|Overall Study|Adverse Event|4|||
23423470|NCT02791191|65292673|FG002|Overall Study|Adverse Event|5|||
23423471|NCT02791191|65292671|FG000|Overall Study|Lack of Efficacy|0|||
23423472|NCT02791191|65292672|FG001|Overall Study|Lack of Efficacy|1|||
23423473|NCT02791191|65292673|FG002|Overall Study|Lack of Efficacy|0|||
23423474|NCT02791191|65292671|FG000|Overall Study|Study Drug Non-Compliance|0|||
23423475|NCT02791191|65292672|FG001|Overall Study|Study Drug Non-Compliance|2|||
23423476|NCT02791191|65292673|FG002|Overall Study|Study Drug Non-Compliance|0|||
23537032|NCT00274716|65697687|FG001|Phase B|Protocol Violation|2|||
23537033|NCT00274716|65697688|FG002|Phase B|Protocol Violation|0|||
23537034|NCT00274716|65697689|FG003|Phase B|Protocol Violation|0|||
23537035|NCT00274716|65697690|FG004|Phase B|Protocol Violation|0|||
23537036|NCT00274716|65697691|FG005|Phase B|Protocol Violation|0|||
23537037|NCT00274716|65697686|FG000|Phase B|Withdrawal by Subject|0|||
23537038|NCT00274716|65697687|FG001|Phase B|Withdrawal by Subject|1|||
23537039|NCT00274716|65697688|FG002|Phase B|Withdrawal by Subject|0|||
23537040|NCT00274716|65697689|FG003|Phase B|Withdrawal by Subject|0|||
23537041|NCT00274716|65697690|FG004|Phase B|Withdrawal by Subject|0|||
23423477|NCT02791191|65292671|FG000|Overall Study|Site Closed by Sponsor|1|||
23423478|NCT02791191|65292672|FG001|Overall Study|Site Closed by Sponsor|1|||
23537042|NCT00274716|65697691|FG005|Phase B|Withdrawal by Subject|0|||
23537043|NCT00274716|65697686|FG000|Phase B|Participant moved|1|||
23537044|NCT00274716|65697687|FG001|Phase B|Participant moved|0|||
23537045|NCT00274716|65697688|FG002|Phase B|Participant moved|0|||
23537046|NCT00274716|65697689|FG003|Phase B|Participant moved|0|||
23537047|NCT00274716|65697690|FG004|Phase B|Participant moved|0|||
23423479|NCT02791191|65292673|FG002|Overall Study|Site Closed by Sponsor|3|||
23423480|NCT02791191|65292671|FG000|Overall Study|Progressive Disease|1|||
23423481|NCT02791191|65292672|FG001|Overall Study|Progressive Disease|0|||
23423482|NCT02791191|65292673|FG002|Overall Study|Progressive Disease|0|||
23423483|NCT02791191|65292671|FG000|Overall Study|Study Terminated by Sponsor|29|||
23537048|NCT00274716|65697691|FG005|Phase B|Participant moved|0|||
23537049|NCT00274716|65697686|FG000|Phase B|Other non-reported reason|0|||
23537050|NCT00274716|65697687|FG001|Phase B|Other non-reported reason|0|||
23537051|NCT00274716|65697688|FG002|Phase B|Other non-reported reason|1|||
23537052|NCT00274716|65697689|FG003|Phase B|Other non-reported reason|1|||
23537053|NCT00274716|65697690|FG004|Phase B|Other non-reported reason|0|||
23537054|NCT00274716|65697691|FG005|Phase B|Other non-reported reason|0|||
23537055|NCT00274716|65697686|FG000|Phase B|Lost to Follow-up|0|||
23537056|NCT00274716|65697687|FG001|Phase B|Lost to Follow-up|1|||
23423484|NCT02791191|65292672|FG001|Overall Study|Study Terminated by Sponsor|101|||
23423485|NCT02791191|65292673|FG002|Overall Study|Study Terminated by Sponsor|109|||
23423486|NCT02791191|65292671|FG000|Overall Study|Withdrawal by Subject|3|||
23423487|NCT02791191|65292672|FG001|Overall Study|Withdrawal by Subject|1|||
23423488|NCT02791191|65292673|FG002|Overall Study|Withdrawal by Subject|3|||
23423489|NCT02791191|65292671|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
23423490|NCT02791191|65292672|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
23423491|NCT02791191|65292673|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
23423492|NCT03440918|65292674|FG000|Overall Study|Protocol Violation|0|||
23423493|NCT03440918|65292675|FG001|Overall Study|Protocol Violation|16|||
23537057|NCT00274716|65697688|FG002|Phase B|Lost to Follow-up|0|||
23423494|NCT01952665|65292676|FG000|Overall Study|Physician Decision|3|||
23423495|NCT01952665|65292677|FG001|Overall Study|Physician Decision|2|||
23423496|NCT01952665|65292676|FG000|Overall Study|Lost to Follow-up|1|||
23423497|NCT01952665|65292677|FG001|Overall Study|Lost to Follow-up|2|||
23423498|NCT01952665|65292676|FG000|Overall Study|Adverse Event|2|||
23423499|NCT01952665|65292677|FG001|Overall Study|Adverse Event|1|||
23423500|NCT01952665|65292676|FG000|Overall Study|Protocol Violation|0|||
23423501|NCT01952665|65292677|FG001|Overall Study|Protocol Violation|1|||
23423502|NCT01728077|65292678|FG000|Overall Study|Lack of Efficacy|3|||
23423503|NCT01728077|65292679|FG001|Overall Study|Lack of Efficacy|1|||
23423504|NCT01728077|65292678|FG000|Overall Study|Lost to Follow-up|1|||
23423505|NCT01728077|65292679|FG001|Overall Study|Lost to Follow-up|0|||
23423506|NCT01728077|65292678|FG000|Overall Study|Subject choice|2|||
23423507|NCT01728077|65292679|FG001|Overall Study|Subject choice|3|||
23423508|NCT01728077|65292678|FG000|Overall Study|Death|0|||
23423509|NCT01728077|65292679|FG001|Overall Study|Death|1|||
23423510|NCT01728077|65292678|FG000|Overall Study|Patient moving|1|||
23423511|NCT01728077|65292679|FG001|Overall Study|Patient moving|0|||
23423512|NCT01728077|65292678|FG000|Overall Study|Non compliance|1|||
23423513|NCT01728077|65292679|FG001|Overall Study|Non compliance|0|||
23423514|NCT01571284|65292681|FG000|Overall Study|Participant's decision|84|||
23423515|NCT01571284|65292681|FG000|Overall Study|Lost to Follow-up|3|||
23423516|NCT01571284|65292681|FG000|Overall Study|Enrolled but not treated|2|||
23423517|NCT01571284|65292681|FG000|Overall Study|Other than specified above|80|||
23423518|NCT03060512|65292682|FG000|Overall Study|Adverse Event|4|||
23423519|NCT03060512|65292683|FG001|Overall Study|Adverse Event|6|||
23423520|NCT03060512|65292682|FG000|Overall Study|Lost to Follow-up|1|||
23423521|NCT03060512|65292683|FG001|Overall Study|Lost to Follow-up|1|||
23537058|NCT00274716|65697689|FG003|Phase B|Lost to Follow-up|0|||
23537059|NCT00274716|65697690|FG004|Phase B|Lost to Follow-up|0|||
23537060|NCT00274716|65697691|FG005|Phase B|Lost to Follow-up|0|||
23537061|NCT00110266|65697692|FG000|Overall Study|Adverse Event|27|||
23537062|NCT00110266|65697692|FG000|Overall Study|Abnormal laboratory value|15|||
23537063|NCT00110266|65697692|FG000|Overall Study|Withdrawal by Subject|16|||
23537064|NCT00110266|65697692|FG000|Overall Study|Death|17|||
23537065|NCT00110266|65697692|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23537066|NCT00110266|65697692|FG000|Overall Study|Participant condition no longer requires study drug|1|||
23537067|NCT02167035|65697694|FG000|Overall Study|Adverse Event|2|||
23537068|NCT02167035|65697695|FG001|Overall Study|Adverse Event|2|||
23537069|NCT02167035|65697694|FG000|Overall Study|Lost to Follow-up|3|||
23537070|NCT02167035|65697695|FG001|Overall Study|Lost to Follow-up|3|||
23537071|NCT02167035|65697694|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
23537072|NCT02167035|65697695|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
23537073|NCT04317586|65697696|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
23537074|NCT04317586|65697696|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
23537075|NCT02486406|65697697|FG000|Overall Study|Withdrew consent|1|||
23537076|NCT02486406|65697698|FG001|Overall Study|Withdrew consent|0|||
23537077|NCT02486406|65697699|FG002|Overall Study|Withdrew consent|0|||
23537078|NCT02486406|65697700|FG003|Overall Study|Withdrew consent|1|||
23537079|NCT02486406|65697697|FG000|Overall Study|Lost to Follow-up|1|||
23537080|NCT02486406|65697698|FG001|Overall Study|Lost to Follow-up|3|||
23537081|NCT02486406|65697699|FG002|Overall Study|Lost to Follow-up|1|||
23537082|NCT02486406|65697700|FG003|Overall Study|Lost to Follow-up|3|||
23537083|NCT02486406|65697697|FG000|Overall Study|Other, not specified|0|||
23537084|NCT02486406|65697698|FG001|Overall Study|Other, not specified|0|||
23537085|NCT02486406|65697699|FG002|Overall Study|Other, not specified|1|||
23537086|NCT02486406|65697700|FG003|Overall Study|Other, not specified|0|||
23537087|NCT01168999|65697701|FG000|Overall Study|Lost to Follow-up|2|||
23537088|NCT01168999|65697702|FG001|Overall Study|Lost to Follow-up|1|||
23537089|NCT01168999|65697703|FG002|Overall Study|Lost to Follow-up|0|||
23423522|NCT03060512|65292682|FG000|Overall Study|Withdrawal by Subject|1|||
23423523|NCT03060512|65292683|FG001|Overall Study|Withdrawal by Subject|0|||
23423524|NCT03060512|65292682|FG000|Overall Study|Non-compliance with study medication|1|||
23423525|NCT03060512|65292683|FG001|Overall Study|Non-compliance with study medication|2|||
23423526|NCT03770728|65296172|FG000|Overall Study|Adverse Event|1|||
23423527|NCT03770728|65296173|FG001|Overall Study|Adverse Event|0|||
23423528|NCT03770728|65296174|FG002|Overall Study|Adverse Event|1|||
23537090|NCT01168999|65697704|FG003|Overall Study|Lost to Follow-up|0|||
23537091|NCT00844545|65697705|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
23537092|NCT00844545|65697705|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
23537093|NCT00844545|65697705|FG000|Extension Treatment Period|Adverse Event|2|||
23537094|NCT00844545|65697705|FG000|Post Treatment Period|Withdrawal by Subject|1|||
23537095|NCT04661033|65697706|FG000|Overall Study|Adverse Event|0|||
23537096|NCT04661033|65697707|FG001|Overall Study|Adverse Event|0|||
23537097|NCT04661033|65697708|FG002|Overall Study|Adverse Event|1|||
23537098|NCT04661033|65697709|FG003|Overall Study|Adverse Event|0|||
23537099|NCT04661033|65697706|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
23537100|NCT04661033|65697707|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537101|NCT04661033|65697708|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537102|NCT04661033|65697709|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537103|NCT04661033|65697706|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
23537104|NCT04661033|65697707|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
23537105|NCT04661033|65697708|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
23537106|NCT04661033|65697709|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
23537107|NCT04661033|65697706|FG000|Overall Study|Early discontinuation as per PI|1|||
23537108|NCT04661033|65697707|FG001|Overall Study|Early discontinuation as per PI|0|||
23537109|NCT04661033|65697708|FG002|Overall Study|Early discontinuation as per PI|0|||
23537110|NCT04661033|65697709|FG003|Overall Study|Early discontinuation as per PI|0|||
23537111|NCT04982029|65697710|FG000|Overall Study|Lost to Follow-up|2|||
23537112|NCT04982029|65697711|FG001|Overall Study|Lost to Follow-up|3|||
23537113|NCT00441337|65697718|FG000|Overall Study|Disease Progression|6|||
23537114|NCT00441337|65697719|FG001|Overall Study|Disease Progression|6|||
23537115|NCT00441337|65697720|FG002|Overall Study|Disease Progression|4|||
23537116|NCT00441337|65697721|FG003|Overall Study|Disease Progression|18|||
23537117|NCT00441337|65697718|FG000|Overall Study|Lost to Follow-up|0|||
23537118|NCT00441337|65697719|FG001|Overall Study|Lost to Follow-up|0|||
23537119|NCT00441337|65697720|FG002|Overall Study|Lost to Follow-up|0|||
23537120|NCT00441337|65697721|FG003|Overall Study|Lost to Follow-up|1|||
23537121|NCT00441337|65697718|FG000|Overall Study|Sponsor Decision|0|||
23537122|NCT00441337|65697719|FG001|Overall Study|Sponsor Decision|0|||
23537123|NCT00441337|65697720|FG002|Overall Study|Sponsor Decision|1|||
23537124|NCT00441337|65697721|FG003|Overall Study|Sponsor Decision|2|||
23537125|NCT00441337|65697718|FG000|Overall Study|Did not meet inclusion criteria|0|||
23537126|NCT00441337|65697719|FG001|Overall Study|Did not meet inclusion criteria|0|||
23537127|NCT00441337|65697720|FG002|Overall Study|Did not meet inclusion criteria|1|||
23537128|NCT00441337|65697721|FG003|Overall Study|Did not meet inclusion criteria|0|||
23537129|NCT00733824|65697722|FG000|Phase I|Withdrawal by Subject|1|||
23537130|NCT00733824|65697723|FG001|Phase I|Withdrawal by Subject|0|||
23537131|NCT00733824|65697724|FG002|Phase I|Withdrawal by Subject|0|||
23537132|NCT00733824|65697725|FG003|Phase I|Withdrawal by Subject|0|||
23537133|NCT00733824|65697726|FG004|Phase I|Withdrawal by Subject|0|||
23537134|NCT00320216|65697727|FG000|Overall Study|Adverse Event|0|||
23537135|NCT00320216|65697728|FG001|Overall Study|Adverse Event|6|||
23537136|NCT00320216|65697729|FG002|Overall Study|Adverse Event|0|||
23537137|NCT00320216|65697730|FG003|Overall Study|Adverse Event|2|||
23537138|NCT00320216|65697731|FG004|Overall Study|Adverse Event|2|||
23537139|NCT00320216|65697727|FG000|Overall Study|Lack of Efficacy|6|||
23537140|NCT00320216|65697728|FG001|Overall Study|Lack of Efficacy|2|||
23537141|NCT00320216|65697729|FG002|Overall Study|Lack of Efficacy|1|||
23537142|NCT00320216|65697730|FG003|Overall Study|Lack of Efficacy|0|||
23537143|NCT00320216|65697731|FG004|Overall Study|Lack of Efficacy|1|||
23537144|NCT00320216|65697727|FG000|Overall Study|Lost to Follow-up|3|||
23537145|NCT00320216|65697728|FG001|Overall Study|Lost to Follow-up|0|||
23723322|NCT01316939|66363125|FG002|Overall Study|Lack of Efficacy|25|||
23723323|NCT01316939|66363123|FG000|Overall Study|Adverse Event|9|||
23723324|NCT01316939|66363124|FG001|Overall Study|Adverse Event|12|||
23723325|NCT01316939|66363125|FG002|Overall Study|Adverse Event|11|||
23723326|NCT01316939|66363123|FG000|Overall Study|Withdrawal by Subject|1|||
23723327|NCT01316939|66363124|FG001|Overall Study|Withdrawal by Subject|3|||
23723328|NCT01316939|66363125|FG002|Overall Study|Withdrawal by Subject|6|||
23723329|NCT01316939|66363123|FG000|Overall Study|Physician Decision|2|||
23723330|NCT01316939|66363124|FG001|Overall Study|Physician Decision|2|||
23723331|NCT01316939|66363125|FG002|Overall Study|Physician Decision|1|||
23723332|NCT01316939|66363123|FG000|Overall Study|Lost to Follow-up|0|||
23537146|NCT00320216|65697729|FG002|Overall Study|Lost to Follow-up|0|||
23537147|NCT00320216|65697730|FG003|Overall Study|Lost to Follow-up|0|||
23537148|NCT00320216|65697731|FG004|Overall Study|Lost to Follow-up|0|||
23537149|NCT00320216|65697727|FG000|Overall Study|Other|7|||
23537150|NCT00320216|65697728|FG001|Overall Study|Other|2|||
23537151|NCT00320216|65697729|FG002|Overall Study|Other|5|||
23537152|NCT00320216|65697730|FG003|Overall Study|Other|1|||
23537153|NCT00320216|65697731|FG004|Overall Study|Other|3|||
23723333|NCT01316939|66363124|FG001|Overall Study|Lost to Follow-up|0|||
23537154|NCT01344057|65697735|FG000|Overall Study|Premature Withdrawal|1|||
23723334|NCT01316939|66363125|FG002|Overall Study|Lost to Follow-up|2|||
23723335|NCT01316939|66363123|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
23723336|NCT01316939|66363124|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
23723337|NCT01316939|66363125|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
23723338|NCT01316939|66363123|FG000|Overall Study|Protocol Violation|0|||
23723339|NCT01316939|66363124|FG001|Overall Study|Protocol Violation|1|||
23723340|NCT01316939|66363125|FG002|Overall Study|Protocol Violation|0|||
23723341|NCT05263921|66363132|FG000|Overall Study|Other: family emergency.|0|||
23723342|NCT05263921|66363133|FG001|Overall Study|Other: family emergency.|0|||
23723343|NCT05263921|66363134|FG002|Overall Study|Other: family emergency.|1|||
23723344|NCT05263921|66363135|FG003|Overall Study|Other: family emergency.|0|||
23723345|NCT02563925|66365976|FG000|Overall Study|Withdrawal by Subject|2|||
23723346|NCT03970824|66365977|FG000|Overall Study|Withdrawal by Subject|1|||
23723347|NCT03970824|66365978|FG001|Overall Study|Withdrawal by Subject|1|||
23723348|NCT03970824|66365979|FG002|Overall Study|Withdrawal by Subject|3|||
23723349|NCT03970824|66365977|FG000|Overall Study|Lost to Follow-up|0|||
23723350|NCT03970824|66365978|FG001|Overall Study|Lost to Follow-up|2|||
23723351|NCT03970824|66365979|FG002|Overall Study|Lost to Follow-up|1|||
23723352|NCT03970824|66365977|FG000|Overall Study|Adverse Event|1|||
23723353|NCT03970824|66365978|FG001|Overall Study|Adverse Event|0|||
23723354|NCT03970824|66365979|FG002|Overall Study|Adverse Event|0|||
23723355|NCT01293084|66365980|FG000|Overall Study|Physician Decision|3|||
23723356|NCT01293084|66365980|FG000|Overall Study|Withdrawal by Subject|2|||
23723357|NCT02709109|66365994|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
23723358|NCT02709109|66365995|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
23723359|NCT02709109|66365996|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
23723360|NCT02709109|66365997|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
23723361|NCT02709109|66365994|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23723362|NCT02709109|66365995|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
23723363|NCT02709109|66365996|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23723364|NCT02709109|66365997|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23723365|NCT02709109|66365994|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
23723366|NCT02709109|66365995|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23723367|NCT02709109|66365996|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23723368|NCT02709109|66365997|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23723369|NCT02709109|66365994|FG000|Washout Period (28 Days)|Other|2|||
23723370|NCT02709109|66365995|FG001|Washout Period (28 Days)|Other|2|||
23723371|NCT02709109|66365996|FG002|Washout Period (28 Days)|Other|3|||
23723372|NCT02709109|66365997|FG003|Washout Period (28 Days)|Other|0|||
23723373|NCT02709109|66365994|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
23723374|NCT02709109|66365995|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
23723375|NCT02709109|66365996|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
23537155|NCT03251924|65697736|FG000|Overall Study|Disease Progression|6|||
23537156|NCT03251924|65697737|FG001|Overall Study|Disease Progression|6|||
23537157|NCT03251924|65697738|FG002|Overall Study|Disease Progression|7|||
23537158|NCT03251924|65697739|FG003|Overall Study|Disease Progression|8|||
23537159|NCT03251924|65697740|FG004|Overall Study|Disease Progression|8|||
23537160|NCT03251924|65697741|FG005|Overall Study|Disease Progression|7|||
23537161|NCT03251924|65697742|FG006|Overall Study|Disease Progression|6|||
23537162|NCT03251924|65697743|FG007|Overall Study|Disease Progression|10|||
23723376|NCT02709109|66365997|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
23723377|NCT02709109|66365994|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
23723378|NCT02709109|66365995|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
23537163|NCT03251924|65697744|FG008|Overall Study|Disease Progression|6|||
23537164|NCT03251924|65697736|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23537165|NCT03251924|65697737|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23537166|NCT03251924|65697738|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23537167|NCT03251924|65697739|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
23723379|NCT02709109|66365996|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
23723380|NCT02709109|66365997|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
23723381|NCT02709109|66365994|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23723382|NCT02709109|66365995|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23723383|NCT02709109|66365996|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
23723384|NCT02709109|66365997|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23723385|NCT02709109|66365994|FG000|Treatment Period 2 (28 Days)|Other|0|||
23723386|NCT02709109|66365995|FG001|Treatment Period 2 (28 Days)|Other|0|||
23723387|NCT02709109|66365996|FG002|Treatment Period 2 (28 Days)|Other|1|||
23723388|NCT02709109|66365997|FG003|Treatment Period 2 (28 Days)|Other|0|||
23723389|NCT01302691|66365998|FG000|Overall Study|Adverse Event|2|||
23723390|NCT01302691|66365999|FG001|Overall Study|Adverse Event|0|||
23537168|NCT03251924|65697740|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
23723391|NCT01302691|66365998|FG000|Overall Study|Death|0|||
23723392|NCT01302691|66365999|FG001|Overall Study|Death|1|||
23537169|NCT03251924|65697741|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
23537170|NCT03251924|65697742|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
23537171|NCT03251924|65697743|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
23537172|NCT03251924|65697744|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
23537173|NCT03251924|65697736|FG000|Overall Study|Death|0|||
23537174|NCT03251924|65697737|FG001|Overall Study|Death|1|||
23537175|NCT03251924|65697738|FG002|Overall Study|Death|0|||
23537176|NCT03251924|65697739|FG003|Overall Study|Death|1|||
23537177|NCT03251924|65697740|FG004|Overall Study|Death|1|||
23537178|NCT03251924|65697741|FG005|Overall Study|Death|1|||
23537179|NCT03251924|65697742|FG006|Overall Study|Death|0|||
23537180|NCT03251924|65697743|FG007|Overall Study|Death|0|||
23537181|NCT03251924|65697744|FG008|Overall Study|Death|0|||
23537182|NCT03251924|65697736|FG000|Overall Study|Study Drug Toxicity|0|||
23537183|NCT03251924|65697737|FG001|Overall Study|Study Drug Toxicity|0|||
23537184|NCT03251924|65697738|FG002|Overall Study|Study Drug Toxicity|0|||
23537185|NCT03251924|65697739|FG003|Overall Study|Study Drug Toxicity|1|||
23537186|NCT03251924|65697740|FG004|Overall Study|Study Drug Toxicity|0|||
23537187|NCT03251924|65697741|FG005|Overall Study|Study Drug Toxicity|0|||
23537188|NCT03251924|65697742|FG006|Overall Study|Study Drug Toxicity|0|||
23537189|NCT03251924|65697743|FG007|Overall Study|Study Drug Toxicity|0|||
23537190|NCT03251924|65697744|FG008|Overall Study|Study Drug Toxicity|1|||
23537191|NCT03251924|65697736|FG000|Overall Study|Other Reasons|0|||
23537192|NCT03251924|65697737|FG001|Overall Study|Other Reasons|0|||
23537193|NCT03251924|65697738|FG002|Overall Study|Other Reasons|0|||
23537194|NCT03251924|65697739|FG003|Overall Study|Other Reasons|0|||
23537195|NCT03251924|65697740|FG004|Overall Study|Other Reasons|0|||
23537196|NCT03251924|65697741|FG005|Overall Study|Other Reasons|0|||
23537197|NCT03251924|65697742|FG006|Overall Study|Other Reasons|0|||
23537198|NCT03251924|65697743|FG007|Overall Study|Other Reasons|0|||
23537199|NCT03251924|65697744|FG008|Overall Study|Other Reasons|1|||
23537200|NCT03251924|65697736|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23537201|NCT03251924|65697737|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23537202|NCT03251924|65697738|FG002|Overall Study|Participant request to discontinue study treatment|0|||
23537203|NCT03251924|65697739|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23537204|NCT03251924|65697740|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23537205|NCT03251924|65697741|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23537206|NCT03251924|65697742|FG006|Overall Study|Participant request to discontinue study treatment|0|||
23537207|NCT03251924|65697743|FG007|Overall Study|Participant request to discontinue study treatment|1|||
23537208|NCT03251924|65697744|FG008|Overall Study|Participant request to discontinue study treatment|0|||
23537209|NCT01827904|65697745|FG000|Main Study|Withdrawal by Subject|1|||
23537210|NCT01827904|65697746|FG001|Main Study|Withdrawal by Subject|0|||
23537211|NCT01827904|65697747|FG002|Main Study|Withdrawal by Subject|0|||
23537212|NCT01827904|65697745|FG000|Main Study|Adverse Event|1|||
23537213|NCT01827904|65697746|FG001|Main Study|Adverse Event|0|||
23537214|NCT01827904|65697747|FG002|Main Study|Adverse Event|0|||
23537215|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
23537216|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
23537217|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
23537218|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
23537219|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
23537220|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
23537221|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
23537222|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
23537223|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
23537224|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
23537225|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
23537226|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
23537227|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
23537228|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
23537229|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
23537230|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
23537231|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
23537232|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
23537233|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
23537234|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
23537235|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
23537236|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Physician Decision|1|||
23537237|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Physician Decision|0|||
23537238|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Physician Decision|0|||
23537239|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
23537240|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
23537241|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
23537242|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
23537243|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
23537244|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
23537245|NCT00827372|65697748|FG000|Overall Study|Adverse Event|5|||
23537246|NCT00827372|65697748|FG000|Overall Study|Lack of Efficacy|3|||
23537247|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
23537248|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537249|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537250|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537251|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537252|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537253|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
23537254|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537255|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537256|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537257|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537258|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537259|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
23537260|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537261|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537262|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537263|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23723393|NCT01302691|66365998|FG000|Overall Study|Lost to Follow-up|1|||
23723394|NCT01302691|66365999|FG001|Overall Study|Lost to Follow-up|0|||
23723395|NCT01302691|66365998|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
23723396|NCT01302691|66365999|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
23815754|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
23815755|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
23815756|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815757|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815758|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
23815759|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815760|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815761|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815762|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23723397|NCT01302691|66365998|FG000|Overall Study|Physician Decision|0|||
23723398|NCT01302691|66365999|FG001|Overall Study|Physician Decision|1|||
23723399|NCT01302691|66365998|FG000|Overall Study|Protocol Violation|1|||
23723400|NCT01302691|66365999|FG001|Overall Study|Protocol Violation|0|||
23723401|NCT01634113|66366000|FG000|Overall Study|Not treated|0|||
23723402|NCT01634113|66366001|FG001|Overall Study|Not treated|0|||
23723403|NCT01634113|66366002|FG002|Overall Study|Not treated|1|||
23723404|NCT03000686|66366011|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23815763|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815764|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815765|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815766|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815767|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815768|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815769|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815770|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815771|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815772|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815773|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23815774|NCT02393248|66708276|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815775|NCT02393248|66708277|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815776|NCT02393248|66708278|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815777|NCT02393248|66708279|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815778|NCT02393248|66708280|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815779|NCT02393248|66708281|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815780|NCT02393248|66708282|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
23815781|NCT02393248|66708283|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23723405|NCT03000686|66366012|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
23723406|NCT03000686|66366013|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23723407|NCT03000686|66366014|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23723408|NCT02197897|66366015|FG000|Overall Study|not eligible|1|||
23723409|NCT04968353|66366017|FG000|Overall Study|Non-compliance|1|||
23815782|NCT02393248|66708284|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815783|NCT02393248|66708285|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815784|NCT02393248|66708286|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815785|NCT02393248|66708287|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815786|NCT02393248|66708288|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815787|NCT02393248|66708289|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815788|NCT02393248|66708290|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815789|NCT02393248|66708291|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815790|NCT02393248|66708292|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815791|NCT02393248|66708293|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815792|NCT02393248|66708294|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815793|NCT02393248|66708295|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815794|NCT02393248|66708296|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815795|NCT02393248|66708297|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23537264|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537265|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
23537266|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537267|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537268|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537269|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537270|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23723410|NCT04968353|66366018|FG001|Overall Study|Non-compliance|0|||
23723411|NCT04968353|66366019|FG002|Overall Study|Non-compliance|2|||
23723412|NCT04968353|66366020|FG003|Overall Study|Non-compliance|0|||
23723413|NCT00968708|66366023|FG000|Overall Study|Adverse Event|169|||
23723414|NCT00968708|66366024|FG001|Overall Study|Adverse Event|150|||
23723415|NCT00968708|66366023|FG000|Overall Study|Major Protocol Deviation|0|||
23723416|NCT00968708|66366024|FG001|Overall Study|Major Protocol Deviation|1|||
23723417|NCT00968708|66366023|FG000|Overall Study|Lost to Follow-up|19|||
23723418|NCT00968708|66366024|FG001|Overall Study|Lost to Follow-up|11|||
23723419|NCT00968708|66366023|FG000|Overall Study|Voluntary Withdrawal|104|||
23723420|NCT00968708|66366024|FG001|Overall Study|Voluntary Withdrawal|101|||
23723421|NCT00968708|66366023|FG000|Overall Study|Investigator Discretion|0|||
23723422|NCT00968708|66366024|FG001|Overall Study|Investigator Discretion|1|||
23723423|NCT00968708|66366023|FG000|Overall Study|Other|26|||
23723424|NCT00968708|66366024|FG001|Overall Study|Other|34|||
23723425|NCT01989572|66366030|FG000|Overall Study|Lack of Efficacy|35|||
23723426|NCT01989572|66366031|FG001|Overall Study|Lack of Efficacy|48|||
23723427|NCT01989572|66366032|FG002|Overall Study|Lack of Efficacy|48|||
23723428|NCT01989572|66366033|FG003|Overall Study|Lack of Efficacy|43|||
23723429|NCT01989572|66366034|FG004|Overall Study|Lack of Efficacy|71|||
23723430|NCT01989572|66366035|FG005|Overall Study|Lack of Efficacy|79|||
23723431|NCT01989572|66366030|FG000|Overall Study|Adverse Event|2|||
23723432|NCT01989572|66366031|FG001|Overall Study|Adverse Event|1|||
23723433|NCT01989572|66366032|FG002|Overall Study|Adverse Event|3|||
23723434|NCT01989572|66366033|FG003|Overall Study|Adverse Event|0|||
23723435|NCT01989572|66366034|FG004|Overall Study|Adverse Event|3|||
23723436|NCT01989572|66366035|FG005|Overall Study|Adverse Event|0|||
23723437|NCT01989572|66366030|FG000|Overall Study|Death|0|||
23723438|NCT01989572|66366031|FG001|Overall Study|Death|0|||
23723439|NCT01989572|66366032|FG002|Overall Study|Death|0|||
23723440|NCT01989572|66366033|FG003|Overall Study|Death|0|||
23723441|NCT01989572|66366034|FG004|Overall Study|Death|1|||
23723442|NCT01989572|66366035|FG005|Overall Study|Death|0|||
23723443|NCT01989572|66366030|FG000|Overall Study|Withdrawal by Subject|4|||
23723444|NCT01989572|66366031|FG001|Overall Study|Withdrawal by Subject|1|||
23723445|NCT01989572|66366032|FG002|Overall Study|Withdrawal by Subject|5|||
23723446|NCT01989572|66366033|FG003|Overall Study|Withdrawal by Subject|1|||
23723447|NCT01989572|66366034|FG004|Overall Study|Withdrawal by Subject|12|||
23723448|NCT01989572|66366035|FG005|Overall Study|Withdrawal by Subject|4|||
23537271|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
23723449|NCT01989572|66366030|FG000|Overall Study|complicating disease|1|||
23723450|NCT01989572|66366031|FG001|Overall Study|complicating disease|1|||
23723451|NCT01989572|66366032|FG002|Overall Study|complicating disease|2|||
23723452|NCT01989572|66366033|FG003|Overall Study|complicating disease|0|||
23723453|NCT01989572|66366034|FG004|Overall Study|complicating disease|1|||
23723454|NCT01989572|66366035|FG005|Overall Study|complicating disease|0|||
23723455|NCT01989572|66366030|FG000|Overall Study|error|2|||
23723456|NCT01989572|66366031|FG001|Overall Study|error|1|||
23723457|NCT01989572|66366032|FG002|Overall Study|error|1|||
23815796|NCT02393248|66708298|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815797|NCT02393248|66708299|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815798|NCT02393248|66708300|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23815799|NCT02393248|66708276|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23537272|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537273|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537274|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537275|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537276|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537277|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
23537278|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23616217|NCT02085408|65979664|FG000|Step 3: Maintenance|Death|1|||
23616218|NCT02085408|65979665|FG001|Step 3: Maintenance|Death|2|||
23616219|NCT02085408|65979664|FG000|Step 3: Maintenance|Alternative Therapy|1|||
23616220|NCT02085408|65979665|FG001|Step 3: Maintenance|Alternative Therapy|1|||
23616221|NCT02085408|65979664|FG000|Step 3: Maintenance|Complicating Disease|0|||
23616222|NCT02085408|65979665|FG001|Step 3: Maintenance|Complicating Disease|1|||
23616223|NCT02085408|65979664|FG000|Step 3: Maintenance|Other|3|||
23616224|NCT02085408|65979665|FG001|Step 3: Maintenance|Other|2|||
23616225|NCT02085408|65979664|FG000|Step 3: Maintenance|Never started treatment|5|||
23616226|NCT02085408|65979665|FG001|Step 3: Maintenance|Never started treatment|1|||
23616227|NCT01514864|65982270|FG000|Overall Study|Disease progression|7|||
23616228|NCT01514864|65982271|FG001|Overall Study|Disease progression|5|||
23616229|NCT01514864|65982270|FG000|Overall Study|Study drug toxicity|2|||
23616230|NCT01514864|65982271|FG001|Overall Study|Study drug toxicity|0|||
23616231|NCT01882088|65982272|FG000|Overall Study|Intolerance of esophageal manometry|1|||
23616232|NCT01882088|65982272|FG000|Overall Study|no possibility to place the catheter|1|||
23616233|NCT01882088|65982272|FG000|Overall Study|Protocol Violation|1|||
23616234|NCT01882088|65982272|FG000|Overall Study|inadequate pH-impedance tracings|2|||
23616235|NCT03282799|65982274|FG000|Overall Study|Pregnancy|1|||
23616236|NCT03282799|65982275|FG001|Overall Study|Pregnancy|0|||
23616237|NCT03282799|65982274|FG000|Overall Study|Physician Decision|1|||
23616238|NCT03282799|65982275|FG001|Overall Study|Physician Decision|0|||
23616239|NCT05041439|65982276|FG000|Overall Study|Withdrawal by Subject|1|||
23616240|NCT05041439|65982277|FG001|Overall Study|Withdrawal by Subject|1|||
23616241|NCT05041439|65982276|FG000|Overall Study|Death|1|||
23616242|NCT05041439|65982277|FG001|Overall Study|Death|0|||
23616243|NCT01136733|65982278|FG000|Phase 1b|Adverse Event|0|||
23616244|NCT01136733|65982279|FG001|Phase 1b|Adverse Event|3|||
23616245|NCT01136733|65982280|FG002|Phase 1b|Adverse Event|1|||
23616246|NCT01136733|65982281|FG003|Phase 1b|Adverse Event|0|||
23616247|NCT01136733|65982282|FG004|Phase 1b|Adverse Event|0|||
23616248|NCT01136733|65982283|FG005|Phase 1b|Adverse Event|0|||
23815800|NCT02393248|66708277|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815801|NCT02393248|66708278|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23616249|NCT01136733|65982284|FG006|Phase 1b|Adverse Event|0|||
23616250|NCT01136733|65982278|FG000|Phase 1b|Participant Choice|0|||
23616251|NCT01136733|65982279|FG001|Phase 1b|Participant Choice|0|||
23616252|NCT01136733|65982280|FG002|Phase 1b|Participant Choice|1|||
23616253|NCT01136733|65982281|FG003|Phase 1b|Participant Choice|0|||
23616254|NCT01136733|65982282|FG004|Phase 1b|Participant Choice|0|||
23616255|NCT01136733|65982283|FG005|Phase 1b|Participant Choice|0|||
23616256|NCT01136733|65982284|FG006|Phase 1b|Participant Choice|0|||
23616257|NCT01136733|65982278|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
23616258|NCT01136733|65982279|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
23616259|NCT01136733|65982280|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
23616260|NCT01136733|65982281|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
23616261|NCT01136733|65982282|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
23616262|NCT01136733|65982283|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
23616263|NCT01136733|65982284|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
23616264|NCT01136733|65982278|FG000|Phase 1b|Clinical Progression|1|||
23616265|NCT01136733|65982279|FG001|Phase 1b|Clinical Progression|1|||
23616266|NCT01136733|65982280|FG002|Phase 1b|Clinical Progression|0|||
23616267|NCT01136733|65982281|FG003|Phase 1b|Clinical Progression|0|||
23537279|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537280|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537281|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23616268|NCT01136733|65982282|FG004|Phase 1b|Clinical Progression|0|||
23616269|NCT01136733|65982283|FG005|Phase 1b|Clinical Progression|0|||
23616270|NCT01136733|65982284|FG006|Phase 1b|Clinical Progression|0|||
23616271|NCT01136733|65982278|FG000|Phase 2|Disease Progression|0|||
23616272|NCT01136733|65982279|FG001|Phase 2|Disease Progression|0|||
23616273|NCT01136733|65982280|FG002|Phase 2|Disease Progression|0|||
23616274|NCT01136733|65982281|FG003|Phase 2|Disease Progression|0|||
23616275|NCT01136733|65982282|FG004|Phase 2|Disease Progression|30|||
23616276|NCT01136733|65982283|FG005|Phase 2|Disease Progression|32|||
23537282|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537283|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Other|6|||
23537284|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Other|0|||
23537285|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Other|0|||
23723458|NCT01989572|66366033|FG003|Overall Study|error|1|||
23723459|NCT01989572|66366034|FG004|Overall Study|error|1|||
23723460|NCT01989572|66366035|FG005|Overall Study|error|1|||
23723461|NCT01989572|66366030|FG000|Overall Study|maximum dose reached|0|||
23723462|NCT01989572|66366031|FG001|Overall Study|maximum dose reached|1|||
23723463|NCT01989572|66366032|FG002|Overall Study|maximum dose reached|0|||
23723464|NCT01989572|66366033|FG003|Overall Study|maximum dose reached|0|||
23815802|NCT02393248|66708279|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815803|NCT02393248|66708280|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815804|NCT02393248|66708281|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815805|NCT02393248|66708282|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815806|NCT02393248|66708283|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815807|NCT02393248|66708284|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815808|NCT02393248|66708285|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815809|NCT02393248|66708286|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815810|NCT02393248|66708287|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
23815811|NCT02393248|66708288|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
23815812|NCT02393248|66708289|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
23815813|NCT02393248|66708290|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
23815814|NCT02393248|66708291|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815815|NCT02393248|66708292|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815816|NCT02393248|66708293|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815817|NCT02393248|66708294|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815818|NCT02393248|66708295|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23537286|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Other|0|||
23537287|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Other|0|||
23537288|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Other|0|||
23537289|NCT02139644|65697751|FG000|Treatment Period|Adverse Event|0|||
23537290|NCT02139644|65697752|FG001|Treatment Period|Adverse Event|0|||
23815819|NCT02393248|66708296|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815820|NCT02393248|66708297|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815821|NCT02393248|66708298|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23537291|NCT02139644|65697753|FG002|Treatment Period|Adverse Event|3|||
23537292|NCT02139644|65697754|FG003|Treatment Period|Adverse Event|2|||
23537293|NCT02139644|65697755|FG004|Treatment Period|Adverse Event|1|||
23537294|NCT02139644|65697756|FG005|Treatment Period|Adverse Event|6|||
23537295|NCT02139644|65697751|FG000|Treatment Period|Withdrawal by Subject|0|||
23616277|NCT01136733|65982284|FG006|Phase 2|Disease Progression|38|||
23723465|NCT01989572|66366034|FG004|Overall Study|maximum dose reached|1|||
23723466|NCT01989572|66366035|FG005|Overall Study|maximum dose reached|0|||
23723467|NCT01989572|66366030|FG000|Overall Study|unknown/not specify|3|||
23723468|NCT01989572|66366031|FG001|Overall Study|unknown/not specify|4|||
23723469|NCT01989572|66366032|FG002|Overall Study|unknown/not specify|1|||
23723470|NCT01989572|66366033|FG003|Overall Study|unknown/not specify|3|||
23723471|NCT01989572|66366034|FG004|Overall Study|unknown/not specify|3|||
23723472|NCT01989572|66366035|FG005|Overall Study|unknown/not specify|5|||
23723473|NCT01989572|66366030|FG000|Overall Study|not start protocol therapy|5|||
23723474|NCT01989572|66366031|FG001|Overall Study|not start protocol therapy|1|||
23723475|NCT01989572|66366032|FG002|Overall Study|not start protocol therapy|2|||
23723476|NCT01989572|66366033|FG003|Overall Study|not start protocol therapy|3|||
23723477|NCT01989572|66366034|FG004|Overall Study|not start protocol therapy|4|||
23723478|NCT01989572|66366035|FG005|Overall Study|not start protocol therapy|18|||
23723479|NCT01989572|66366030|FG000|Overall Study|alternative therapy|3|||
23723480|NCT01989572|66366031|FG001|Overall Study|alternative therapy|0|||
23723481|NCT01989572|66366032|FG002|Overall Study|alternative therapy|0|||
23723482|NCT01989572|66366033|FG003|Overall Study|alternative therapy|0|||
23723483|NCT01989572|66366034|FG004|Overall Study|alternative therapy|1|||
23723484|NCT01989572|66366035|FG005|Overall Study|alternative therapy|3|||
23723485|NCT00608842|66366037|FG000|Overall Study|Participant's Request|0|||
23723486|NCT00608842|66366038|FG001|Overall Study|Participant's Request|1|||
23723487|NCT00608842|66366039|FG002|Overall Study|Participant's Request|2|||
23815822|NCT02393248|66708299|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815823|NCT02393248|66708300|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23815824|NCT02393248|66708276|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23537296|NCT02139644|65697752|FG001|Treatment Period|Withdrawal by Subject|0|||
23537297|NCT02139644|65697753|FG002|Treatment Period|Withdrawal by Subject|2|||
23723488|NCT00608842|66366040|FG003|Overall Study|Participant's Request|1|||
23723489|NCT00608842|66366037|FG000|Overall Study|Lost to Follow-up|1|||
23723490|NCT00608842|66366038|FG001|Overall Study|Lost to Follow-up|0|||
23723491|NCT00608842|66366039|FG002|Overall Study|Lost to Follow-up|0|||
23723492|NCT00608842|66366040|FG003|Overall Study|Lost to Follow-up|0|||
23723493|NCT01024920|66366043|FG000|Overall Study|Progressive disease|47|||
23723494|NCT01024920|66366044|FG001|Overall Study|Progressive disease|25|||
23723495|NCT01024920|66366043|FG000|Overall Study|Adverse Event|8|||
23723496|NCT01024920|66366044|FG001|Overall Study|Adverse Event|4|||
23723497|NCT01024920|66366043|FG000|Overall Study|Lost to Follow-up|0|||
23723498|NCT01024920|66366044|FG001|Overall Study|Lost to Follow-up|1|||
23537298|NCT02139644|65697754|FG003|Treatment Period|Withdrawal by Subject|2|||
23723499|NCT01024920|66366043|FG000|Overall Study|Patient refusal to continue|4|||
23723500|NCT01024920|66366044|FG001|Overall Study|Patient refusal to continue|0|||
23723501|NCT01024920|66366043|FG000|Overall Study|Other than listed|5|||
23723502|NCT01024920|66366044|FG001|Overall Study|Other than listed|1|||
23723503|NCT01024920|66366043|FG000|Overall Study|Not treated|3|||
23723504|NCT01024920|66366044|FG001|Overall Study|Not treated|0|||
23723505|NCT01024920|66366043|FG000|Overall Study|Protocol Violation|0|||
23723506|NCT01024920|66366044|FG001|Overall Study|Protocol Violation|1|||
23723507|NCT00439725|66366045|FG000|Treatment Period|Withdrawal by Subject|22|||
23723508|NCT00439725|66366046|FG001|Treatment Period|Withdrawal by Subject|19|||
23723509|NCT00439725|66366045|FG000|Treatment Period|Study terminated by sponsor|156|||
23723510|NCT00439725|66366046|FG001|Treatment Period|Study terminated by sponsor|148|||
23723511|NCT00439725|66366045|FG000|Treatment Period|Site closed by investigator|1|||
23723512|NCT00439725|66366046|FG001|Treatment Period|Site closed by investigator|2|||
23723513|NCT00439725|66366045|FG000|Treatment Period|Adverse Event|39|||
23723514|NCT00439725|66366046|FG001|Treatment Period|Adverse Event|18|||
23723515|NCT00439725|66366045|FG000|Treatment Period|Physician Decision|1|||
23723516|NCT00439725|66366046|FG001|Treatment Period|Physician Decision|1|||
23723517|NCT00439725|66366045|FG000|Treatment Period|Protocol Violation|2|||
23723518|NCT00439725|66366046|FG001|Treatment Period|Protocol Violation|1|||
23723519|NCT00439725|66366045|FG000|Treatment Period|Clinical endpoint reached|6|||
23723520|NCT00439725|66366046|FG001|Treatment Period|Clinical endpoint reached|50|||
23723521|NCT00439725|66366045|FG000|Treatment Period|Technical problems|1|||
23723522|NCT00439725|66366046|FG001|Treatment Period|Technical problems|0|||
23723523|NCT00439725|66366045|FG000|Treatment Period|Lost to Follow-up|1|||
23723524|NCT00439725|66366046|FG001|Treatment Period|Lost to Follow-up|1|||
23723525|NCT00439725|66366045|FG000|Treatment Period|Participant convenience|1|||
23723526|NCT00439725|66366046|FG001|Treatment Period|Participant convenience|0|||
23723527|NCT00439725|66366045|FG000|Treatment Period|Protocol driven decision point|1|||
23723528|NCT00439725|66366046|FG001|Treatment Period|Protocol driven decision point|1|||
23723529|NCT00439725|66366045|FG000|Treatment Period|Death|1|||
23723530|NCT00439725|66366046|FG001|Treatment Period|Death|1|||
23723531|NCT00439725|66366045|FG000|Treatment Period|Participant did not receive treatment|4|||
23723532|NCT00439725|66366046|FG001|Treatment Period|Participant did not receive treatment|4|||
23723533|NCT00439725|66366045|FG000|Observational Period|Withdrawal by Subject|2|||
23723534|NCT00439725|66366046|FG001|Observational Period|Withdrawal by Subject|2|||
23723535|NCT00439725|66366045|FG000|Observational Period|Lost to Follow-up|0|||
23723536|NCT00439725|66366046|FG001|Observational Period|Lost to Follow-up|1|||
23723537|NCT00439725|66366045|FG000|Observational Period|Death|0|||
23723538|NCT00439725|66366046|FG001|Observational Period|Death|2|||
23723539|NCT00439725|66366045|FG000|Observational Period|Study termination by sponsor|1|||
23723540|NCT00439725|66366046|FG001|Observational Period|Study termination by sponsor|1|||
23723541|NCT00439725|66366045|FG000|Observational Period|Clinical endpoint reached|3|||
23723542|NCT00439725|66366046|FG001|Observational Period|Clinical endpoint reached|1|||
23723543|NCT00439725|66366045|FG000|Observational Period|Technical problems|1|||
23723544|NCT00439725|66366046|FG001|Observational Period|Technical problems|0|||
23723545|NCT00439725|66366045|FG000|Observational Period|Participant convenience|1|||
23723546|NCT00439725|66366046|FG001|Observational Period|Participant convenience|0|||
23723547|NCT01390038|66366049|FG000|Overall Study|Death|1|||
23723548|NCT01390038|66366049|FG000|Overall Study|Lost to Follow-up|1|||
23723549|NCT01390038|66366049|FG000|Overall Study|Withdrawal by Subject|4|||
23723550|NCT01390038|66366049|FG000|Overall Study|Simpliciti System Removal|2|||
23723551|NCT00719537|66366051|FG000|Overall Study|Withdrawal by Subject|1|||
23723552|NCT00719537|66366052|FG001|Overall Study|Withdrawal by Subject|0|||
23723553|NCT00719537|66366051|FG000|Overall Study|Lost to Follow-up|0|||
23723554|NCT00719537|66366052|FG001|Overall Study|Lost to Follow-up|1|||
23723555|NCT01587274|66366058|FG000|Overall Study|Lost to Follow-up|4|||
23723556|NCT01587274|66366059|FG001|Overall Study|Lost to Follow-up|5|||
23723557|NCT01587274|66366060|FG002|Overall Study|Lost to Follow-up|3|||
23723558|NCT00416312|66366061|FG000|Overall Study|tumors not visible on imaging|2|||
23723559|NCT01570309|66366064|FG000|Overall Study|Withdrawal by Subject|3|||
23723560|NCT01570309|66366065|FG001|Overall Study|Withdrawal by Subject|3|||
23723561|NCT00937326|66366070|FG000|Overall Study|Adverse Event|0|||
23723562|NCT00937326|66366071|FG001|Overall Study|Adverse Event|3|||
23723563|NCT00937326|66366072|FG002|Overall Study|Adverse Event|1|||
23537299|NCT02139644|65697755|FG004|Treatment Period|Withdrawal by Subject|3|||
23723564|NCT00937326|66366073|FG003|Overall Study|Adverse Event|1|||
23723565|NCT00937326|66366074|FG004|Overall Study|Adverse Event|2|||
23723566|NCT00937326|66366070|FG000|Overall Study|Death|0|||
23723567|NCT00937326|66366071|FG001|Overall Study|Death|0|||
23423529|NCT03770728|65296175|FG003|Overall Study|Adverse Event|0|||
23423530|NCT03770728|65296172|FG000|Overall Study|Poor compliance to protocol|0|||
23423531|NCT03770728|65296173|FG001|Overall Study|Poor compliance to protocol|0|||
23423532|NCT03770728|65296174|FG002|Overall Study|Poor compliance to protocol|1|||
23423533|NCT03770728|65296175|FG003|Overall Study|Poor compliance to protocol|0|||
23423534|NCT03770728|65296172|FG000|Overall Study|Withdrawal by Subject|13|||
23723568|NCT00937326|66366072|FG002|Overall Study|Death|1|||
23723569|NCT00937326|66366073|FG003|Overall Study|Death|0|||
23423535|NCT03770728|65296173|FG001|Overall Study|Withdrawal by Subject|8|||
23423536|NCT03770728|65296174|FG002|Overall Study|Withdrawal by Subject|9|||
23423537|NCT03770728|65296175|FG003|Overall Study|Withdrawal by Subject|13|||
23423538|NCT03770728|65296172|FG000|Overall Study|Other than specified|24|||
23423539|NCT03770728|65296173|FG001|Overall Study|Other than specified|23|||
23723570|NCT00937326|66366074|FG004|Overall Study|Death|0|||
23723571|NCT00937326|66366070|FG000|Overall Study|Withdrawal by Subject|3|||
23723572|NCT00937326|66366071|FG001|Overall Study|Withdrawal by Subject|4|||
23723573|NCT00937326|66366072|FG002|Overall Study|Withdrawal by Subject|1|||
23815825|NCT02393248|66708277|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23423540|NCT03770728|65296174|FG002|Overall Study|Other than specified|21|||
23423541|NCT03770728|65296175|FG003|Overall Study|Other than specified|22|||
23423542|NCT03664674|65296178|FG000|Overall Study|Adverse Event|1|||
23423543|NCT03664674|65296179|FG001|Overall Study|Adverse Event|1|||
23423544|NCT03664674|65296178|FG000|Overall Study|Physician Decision|0|||
23423545|NCT03664674|65296179|FG001|Overall Study|Physician Decision|1|||
23423546|NCT03664674|65296178|FG000|Overall Study|Withdrawal by Subject|2|||
23423547|NCT03664674|65296179|FG001|Overall Study|Withdrawal by Subject|0|||
23423548|NCT01566695|65296180|FG000|Overall Study|Lack of Efficacy|18|||
23423549|NCT01566695|65296181|FG001|Overall Study|Lack of Efficacy|45|||
23423550|NCT01566695|65296180|FG000|Overall Study|Adverse Event|28|||
23423551|NCT01566695|65296181|FG001|Overall Study|Adverse Event|27|||
23423552|NCT01566695|65296180|FG000|Overall Study|Death|20|||
23423553|NCT01566695|65296181|FG001|Overall Study|Death|8|||
23423554|NCT01566695|65296180|FG000|Overall Study|Withdrawal by Subject|14|||
23423555|NCT01566695|65296181|FG001|Overall Study|Withdrawal by Subject|7|||
23423556|NCT01566695|65296180|FG000|Overall Study|Progressive Disease|11|||
23423557|NCT01566695|65296181|FG001|Overall Study|Progressive Disease|6|||
23423558|NCT01566695|65296180|FG000|Overall Study|Miscellaneous|4|||
23423559|NCT01566695|65296181|FG001|Overall Study|Miscellaneous|6|||
23423560|NCT01799239|65296184|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
23423561|NCT01799239|65296185|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
23423562|NCT01799239|65296184|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
23423563|NCT01799239|65296185|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
23423564|NCT01799239|65296184|FG000|Period 1 (7 Days)|Protocol Violation|0|||
23423565|NCT01799239|65296185|FG001|Period 1 (7 Days)|Protocol Violation|1|||
23723574|NCT00937326|66366073|FG003|Overall Study|Withdrawal by Subject|4|||
23723575|NCT00937326|66366074|FG004|Overall Study|Withdrawal by Subject|3|||
23723576|NCT00937326|66366070|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23723577|NCT00937326|66366071|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23723578|NCT00937326|66366072|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
23723579|NCT00937326|66366073|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23723580|NCT00937326|66366074|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23723581|NCT00813917|66366075|FG000|Overall Study|Adverse Event|0|||
23723582|NCT00813917|66366076|FG001|Overall Study|Adverse Event|1|||
23815826|NCT02393248|66708278|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815827|NCT02393248|66708279|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815828|NCT02393248|66708280|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815829|NCT02393248|66708281|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815830|NCT02393248|66708282|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815831|NCT02393248|66708283|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815832|NCT02393248|66708284|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815833|NCT02393248|66708285|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815834|NCT02393248|66708286|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
23815835|NCT02393248|66708287|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
23815836|NCT02393248|66708288|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23423566|NCT01799239|65296184|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
23423567|NCT01799239|65296185|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
23423568|NCT01799239|65296184|FG000|Period 2 (7 Days)|Protocol Violation|1|||
23423569|NCT01799239|65296185|FG001|Period 2 (7 Days)|Protocol Violation|0|||
23423570|NCT03392883|65296188|FG000|Overall Study|Lost to Follow-up|122|||
23423571|NCT03392883|65296189|FG001|Overall Study|Lost to Follow-up|13|||
23423572|NCT03392883|65296190|FG002|Overall Study|Lost to Follow-up|9|||
23423573|NCT03392883|65296188|FG000|Overall Study|Death|4|||
23423574|NCT03392883|65296189|FG001|Overall Study|Death|0|||
23423575|NCT03392883|65296190|FG002|Overall Study|Death|0|||
23423576|NCT03392883|65296188|FG000|Overall Study|Lack of Efficacy|29|||
23423577|NCT03392883|65296189|FG001|Overall Study|Lack of Efficacy|0|||
23423578|NCT03392883|65296190|FG002|Overall Study|Lack of Efficacy|0|||
23423579|NCT03392883|65296188|FG000|Overall Study|Withdrawal by Subject|180|||
23815837|NCT02393248|66708289|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815838|NCT02393248|66708290|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815839|NCT02393248|66708291|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815840|NCT02393248|66708292|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815841|NCT02393248|66708293|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815842|NCT02393248|66708294|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815843|NCT02393248|66708295|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815844|NCT02393248|66708296|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815845|NCT02393248|66708297|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815846|NCT02393248|66708298|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815847|NCT02393248|66708299|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815848|NCT02393248|66708300|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23815849|NCT02393248|66708276|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
23815850|NCT02393248|66708277|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
23815851|NCT02393248|66708278|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
23815852|NCT02393248|66708279|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
23815853|NCT02393248|66708280|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
23815854|NCT02393248|66708281|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
23815855|NCT02393248|66708282|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
23815856|NCT02393248|66708283|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
23815857|NCT02393248|66708284|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
23815858|NCT02393248|66708285|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
23423580|NCT03392883|65296189|FG001|Overall Study|Withdrawal by Subject|0|||
23423581|NCT03392883|65296190|FG002|Overall Study|Withdrawal by Subject|0|||
23423582|NCT03392883|65296188|FG000|Overall Study|Adverse Event|1|||
23423583|NCT03392883|65296189|FG001|Overall Study|Adverse Event|0|||
23723583|NCT00813917|66366075|FG000|Overall Study|Withdrawal by Subject|3|||
23723584|NCT00813917|66366076|FG001|Overall Study|Withdrawal by Subject|4|||
23723585|NCT00813917|66366075|FG000|Overall Study|Lost to Follow-up|3|||
23723586|NCT00813917|66366076|FG001|Overall Study|Lost to Follow-up|1|||
23723587|NCT03379376|66366077|FG000|Overall Study|Lost to Follow-up|2|||
23723588|NCT03379376|66366077|FG000|Overall Study|Did not wish to complete follow up|1|||
23723589|NCT03379376|66366077|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
23723590|NCT03379376|66366077|FG000|Overall Study|Death|1|||
23423584|NCT03392883|65296190|FG002|Overall Study|Adverse Event|0|||
23423585|NCT00866047|65296191|FG000|Treatment Period|Progressive disease|13|||
23423586|NCT00866047|65296191|FG000|Treatment Period|Adverse Event|16|||
23423587|NCT00866047|65296191|FG000|Treatment Period|Physician Decision|14|||
23423588|NCT00866047|65296191|FG000|Treatment Period|Withdrawal by Subject|5|||
23537300|NCT02139644|65697756|FG005|Treatment Period|Withdrawal by Subject|2|||
23537301|NCT02139644|65697751|FG000|Treatment Period|Non-compliance|0|||
23423589|NCT00866047|65296191|FG000|Follow-up Period|Lost to Follow-up|5|||
23423590|NCT00934947|65296192|FG000|Overall Study|Adverse Event|0|||
23423591|NCT00934947|65296193|FG001|Overall Study|Adverse Event|2|||
23423592|NCT02323204|65296194|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
23423593|NCT02323204|65296195|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
23423594|NCT02323204|65296196|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
23423595|NCT02323204|65296197|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
23537302|NCT02139644|65697752|FG001|Treatment Period|Non-compliance|0|||
23537303|NCT02139644|65697753|FG002|Treatment Period|Non-compliance|0|||
23537304|NCT02139644|65697754|FG003|Treatment Period|Non-compliance|1|||
23537305|NCT02139644|65697755|FG004|Treatment Period|Non-compliance|0|||
23537306|NCT02139644|65697756|FG005|Treatment Period|Non-compliance|0|||
23815859|NCT02393248|66708286|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
23815860|NCT02393248|66708287|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
23815861|NCT02393248|66708288|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
23815862|NCT02393248|66708289|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
23423596|NCT02323204|65296194|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
23423597|NCT02323204|65296195|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
23423598|NCT02323204|65296196|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
23423599|NCT02323204|65296197|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
23423600|NCT02323204|65296194|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
23423601|NCT02323204|65296195|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
23423602|NCT02323204|65296196|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
23423603|NCT02323204|65296197|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
23537307|NCT02139644|65697751|FG000|Treatment Period|Protocol Violation|0|||
23537308|NCT02139644|65697752|FG001|Treatment Period|Protocol Violation|0|||
23616278|NCT01136733|65982278|FG000|Phase 2|Adverse Event|0|||
23537309|NCT02139644|65697753|FG002|Treatment Period|Protocol Violation|0|||
23537310|NCT02139644|65697754|FG003|Treatment Period|Protocol Violation|1|||
23537311|NCT02139644|65697755|FG004|Treatment Period|Protocol Violation|1|||
23537312|NCT02139644|65697756|FG005|Treatment Period|Protocol Violation|1|||
23537313|NCT02139644|65697751|FG000|Treatment Period|Disease progression|0|||
23537314|NCT02139644|65697752|FG001|Treatment Period|Disease progression|0|||
23423604|NCT02323204|65296194|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
23423605|NCT02323204|65296195|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
23423606|NCT02323204|65296196|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
23423607|NCT02323204|65296197|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
23423608|NCT02323204|65296194|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
23423609|NCT02323204|65296195|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
23423610|NCT02323204|65296196|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
23423611|NCT02323204|65296197|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
23423612|NCT02323204|65296194|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
23423613|NCT02323204|65296195|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
23423614|NCT02323204|65296196|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
23423615|NCT02323204|65296197|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
23423616|NCT02323204|65296194|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423617|NCT02323204|65296195|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
23423618|NCT02323204|65296196|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423619|NCT02323204|65296197|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
23423620|NCT02323204|65296194|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
23423621|NCT02323204|65296195|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
23423622|NCT02323204|65296196|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
23423623|NCT02323204|65296197|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
23423624|NCT02323204|65296194|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423625|NCT02323204|65296195|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423626|NCT02323204|65296196|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
23423627|NCT02323204|65296197|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
23423628|NCT04612842|65296198|FG000|Overall Study|Lost to Follow-up|20|||
23423629|NCT04612842|65296199|FG001|Overall Study|Lost to Follow-up|11|||
23423630|NCT04612842|65296198|FG000|Overall Study|Withdrawal by Subject|26|||
23423631|NCT04612842|65296199|FG001|Overall Study|Withdrawal by Subject|15|||
23423632|NCT04612842|65296198|FG000|Overall Study|Death|2|||
23423633|NCT04612842|65296199|FG001|Overall Study|Death|2|||
23423634|NCT01081301|65296200|FG000|Overall Study|Bereaved|3|||
23537315|NCT02139644|65697753|FG002|Treatment Period|Disease progression|0|||
23537316|NCT02139644|65697754|FG003|Treatment Period|Disease progression|1|||
23537317|NCT02139644|65697755|FG004|Treatment Period|Disease progression|1|||
23537318|NCT02139644|65697756|FG005|Treatment Period|Disease progression|2|||
23537319|NCT02139644|65697751|FG000|Treatment Period|Lost to Follow-up|0|||
23537320|NCT02139644|65697752|FG001|Treatment Period|Lost to Follow-up|0|||
23537321|NCT02139644|65697753|FG002|Treatment Period|Lost to Follow-up|1|||
23537322|NCT02139644|65697754|FG003|Treatment Period|Lost to Follow-up|1|||
23537323|NCT02139644|65697755|FG004|Treatment Period|Lost to Follow-up|1|||
23537324|NCT02139644|65697756|FG005|Treatment Period|Lost to Follow-up|1|||
23537325|NCT02139644|65697751|FG000|Treatment Period|Lack of Efficacy|0|||
23537326|NCT02139644|65697752|FG001|Treatment Period|Lack of Efficacy|0|||
23537327|NCT02139644|65697753|FG002|Treatment Period|Lack of Efficacy|1|||
23537328|NCT02139644|65697754|FG003|Treatment Period|Lack of Efficacy|0|||
23537329|NCT02139644|65697755|FG004|Treatment Period|Lack of Efficacy|1|||
23537330|NCT02139644|65697756|FG005|Treatment Period|Lack of Efficacy|4|||
23723591|NCT00212758|66366078|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
23723592|NCT00212758|66366079|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
23723593|NCT00212758|66366078|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
23723594|NCT00212758|66366079|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
23723595|NCT02911519|66366090|FG000|Overall Study|Lost to Follow-up|2|||
23723596|NCT02911519|66366091|FG001|Overall Study|Lost to Follow-up|2|||
23723597|NCT02911519|66366090|FG000|Overall Study|Death|0|||
23723598|NCT02911519|66366091|FG001|Overall Study|Death|2|||
23723599|NCT01001234|66366096|FG000|Overall Study|Withdrawal by Subject|2|||
23723600|NCT01001234|66366097|FG001|Overall Study|Withdrawal by Subject|0|||
23537331|NCT02139644|65697751|FG000|Treatment Period|Other|0|||
23723601|NCT01001234|66366098|FG002|Overall Study|Withdrawal by Subject|3|||
23723602|NCT01001234|66366099|FG003|Overall Study|Withdrawal by Subject|0|||
23423635|NCT01081301|65296200|FG000|Overall Study|Too busy|5|||
23537332|NCT02139644|65697752|FG001|Treatment Period|Other|3|||
23537333|NCT02139644|65697753|FG002|Treatment Period|Other|1|||
23537334|NCT02139644|65697754|FG003|Treatment Period|Other|1|||
23537335|NCT02139644|65697755|FG004|Treatment Period|Other|0|||
23537336|NCT02139644|65697756|FG005|Treatment Period|Other|1|||
23537337|NCT02564471|65697757|FG000|Overall Study|Adverse Event|1|||
23537338|NCT02564471|65697758|FG001|Overall Study|Adverse Event|0|||
23537339|NCT02564471|65697759|FG002|Overall Study|Adverse Event|0|||
23537340|NCT02564471|65697760|FG003|Overall Study|Adverse Event|0|||
23537341|NCT02564471|65697757|FG000|Overall Study|Withdrawal by Subject|2|||
23537342|NCT02564471|65697758|FG001|Overall Study|Withdrawal by Subject|1|||
23537343|NCT02564471|65697759|FG002|Overall Study|Withdrawal by Subject|3|||
23537344|NCT02564471|65697760|FG003|Overall Study|Withdrawal by Subject|0|||
23537345|NCT02564471|65697757|FG000|Overall Study|Lost to Follow-up|0|||
23537346|NCT02564471|65697758|FG001|Overall Study|Lost to Follow-up|2|||
23537347|NCT02564471|65697759|FG002|Overall Study|Lost to Follow-up|0|||
23537348|NCT02564471|65697760|FG003|Overall Study|Lost to Follow-up|0|||
23537349|NCT01310413|65697761|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
23537350|NCT01310413|65697762|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
23537351|NCT01310413|65697763|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
23815863|NCT02393248|66708290|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
23815864|NCT02393248|66708291|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
23815865|NCT02393248|66708292|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
23815866|NCT02393248|66708293|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
23815867|NCT02393248|66708294|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
23815868|NCT02393248|66708295|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
23815869|NCT02393248|66708296|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
23815870|NCT02393248|66708297|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
23815871|NCT02393248|66708298|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
23815872|NCT02393248|66708299|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
23815873|NCT02393248|66708300|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
23537352|NCT01310413|65697764|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
23537353|NCT01310413|65697765|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
23537354|NCT01310413|65697766|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
23537355|NCT01310413|65697767|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
23537356|NCT01310413|65697761|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
23537357|NCT01310413|65697762|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
23537358|NCT01310413|65697763|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
23537359|NCT01310413|65697764|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
23537360|NCT01310413|65697765|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
23537361|NCT01310413|65697766|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
23537362|NCT01310413|65697767|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
23537363|NCT01310413|65697761|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
23537364|NCT01310413|65697762|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
23537365|NCT01310413|65697763|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
23537366|NCT01310413|65697764|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
23537367|NCT01310413|65697765|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
23537368|NCT01310413|65697766|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
23537369|NCT01310413|65697767|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
23537370|NCT01310413|65697761|FG000|Day 0 to Day 385|Other|1|||
23537371|NCT01310413|65697762|FG001|Day 0 to Day 385|Other|0|||
23537372|NCT01310413|65697763|FG002|Day 0 to Day 385|Other|3|||
23537373|NCT01310413|65697764|FG003|Day 0 to Day 385|Other|0|||
23537374|NCT01310413|65697765|FG004|Day 0 to Day 385|Other|0|||
23537375|NCT01310413|65697766|FG005|Day 0 to Day 385|Other|0|||
23537376|NCT01310413|65697767|FG006|Day 0 to Day 385|Other|0|||
23537377|NCT01310413|65697761|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537378|NCT01310413|65697762|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537379|NCT01310413|65697763|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537380|NCT01310413|65697764|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537381|NCT01310413|65697765|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537382|NCT01310413|65697766|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537383|NCT01310413|65697767|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
23537384|NCT01310413|65697761|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
23537385|NCT01310413|65697762|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
23537386|NCT01310413|65697763|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
23537387|NCT01310413|65697764|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
23537388|NCT01310413|65697765|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
23537389|NCT01310413|65697766|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
23537390|NCT01310413|65697767|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
23815874|NCT02393248|66708276|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537391|NCT01968434|65697768|FG000|Overall Study|Lost to Follow-up|3|||
23537392|NCT01968434|65697769|FG001|Overall Study|Lost to Follow-up|6|||
23537393|NCT00633984|65697791|FG000|Overall Study|Lost to Follow-up|0|||
23537394|NCT00633984|65697792|FG001|Overall Study|Lost to Follow-up|6|||
23537395|NCT00633984|65697791|FG000|Overall Study|Withdrawal by Subject|8|||
23537396|NCT00633984|65697792|FG001|Overall Study|Withdrawal by Subject|7|||
23537397|NCT00633984|65697791|FG000|Overall Study|Hospitalized|1|||
23537398|NCT00633984|65697792|FG001|Overall Study|Hospitalized|0|||
23537399|NCT02970968|65697798|FG000|Overall Study|Withdrawal by Subject|3|||
23537400|NCT02970968|65697799|FG001|Overall Study|Withdrawal by Subject|3|||
23537401|NCT02970968|65697798|FG000|Overall Study|Adverse Event|1|||
23537402|NCT02970968|65697799|FG001|Overall Study|Adverse Event|2|||
23537403|NCT02970968|65697798|FG000|Overall Study|Lost to Follow-up|1|||
23537404|NCT02970968|65697799|FG001|Overall Study|Lost to Follow-up|1|||
23537405|NCT02970968|65697798|FG000|Overall Study|Non-Compliance|0|||
23537406|NCT02970968|65697799|FG001|Overall Study|Non-Compliance|1|||
23537407|NCT03285477|65697800|FG000|Treatment and Response Assessment Period|Death|1|||
23537408|NCT03285477|65697801|FG001|Treatment and Response Assessment Period|Death|0|||
23537409|NCT03285477|65697800|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
23537410|NCT03285477|65697801|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
23537411|NCT03285477|65697800|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
23537412|NCT03285477|65697801|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
23537413|NCT03285477|65697800|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
23537414|NCT03285477|65697801|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
23537415|NCT03285477|65697800|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
23537416|NCT03285477|65697801|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
23537417|NCT01816139|65697806|FG000|Overall Study|Adverse Event|6|||
23537418|NCT01816139|65697807|FG001|Overall Study|Adverse Event|8|||
23537419|NCT01816139|65697806|FG000|Overall Study|Lack of Efficacy|1|||
23537420|NCT01816139|65697807|FG001|Overall Study|Lack of Efficacy|2|||
23537421|NCT01816139|65697806|FG000|Overall Study|Lost to Follow-up|5|||
23537422|NCT01816139|65697807|FG001|Overall Study|Lost to Follow-up|3|||
23537423|NCT01816139|65697806|FG000|Overall Study|Withdrew Consent|6|||
23537424|NCT01816139|65697807|FG001|Overall Study|Withdrew Consent|4|||
23537425|NCT01816139|65697806|FG000|Overall Study|Protocol Violation|6|||
23537426|NCT01816139|65697807|FG001|Overall Study|Protocol Violation|3|||
23537427|NCT01816139|65697806|FG000|Overall Study|Reason not Specified|4|||
23537428|NCT01816139|65697807|FG001|Overall Study|Reason not Specified|2|||
23537429|NCT03864614|65701977|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
23537430|NCT03864614|65701978|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
23537431|NCT03864614|65701979|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
23537432|NCT03864614|65701980|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
23537433|NCT03864614|65701977|FG000|Overall Study|Withdrawal by Subject|72|||
23537434|NCT03864614|65701978|FG001|Overall Study|Withdrawal by Subject|100|||
23537435|NCT03864614|65701979|FG002|Overall Study|Withdrawal by Subject|1|||
23537436|NCT03864614|65701980|FG003|Overall Study|Withdrawal by Subject|21|||
23537437|NCT03864614|65701977|FG000|Overall Study|Lost to Follow-up|45|||
23537438|NCT03864614|65701978|FG001|Overall Study|Lost to Follow-up|54|||
23537439|NCT03864614|65701979|FG002|Overall Study|Lost to Follow-up|0|||
23537440|NCT03864614|65701980|FG003|Overall Study|Lost to Follow-up|9|||
23537441|NCT03864614|65701977|FG000|Overall Study|Adverse Event|42|||
23537442|NCT03864614|65701978|FG001|Overall Study|Adverse Event|30|||
23537443|NCT03864614|65701979|FG002|Overall Study|Adverse Event|1|||
23537444|NCT03864614|65701980|FG003|Overall Study|Adverse Event|9|||
23537445|NCT03864614|65701977|FG000|Overall Study|Protocol Deviation|6|||
23537446|NCT03864614|65701978|FG001|Overall Study|Protocol Deviation|26|||
23537447|NCT03864614|65701979|FG002|Overall Study|Protocol Deviation|0|||
23537448|NCT03864614|65701980|FG003|Overall Study|Protocol Deviation|1|||
23537449|NCT03864614|65701977|FG000|Overall Study|Physician Decision|7|||
23537450|NCT03864614|65701978|FG001|Overall Study|Physician Decision|10|||
23537451|NCT03864614|65701979|FG002|Overall Study|Physician Decision|1|||
23537452|NCT03864614|65701980|FG003|Overall Study|Physician Decision|5|||
23537453|NCT03864614|65701977|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
23537454|NCT03864614|65701978|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
23537455|NCT03864614|65701979|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
23537456|NCT03864614|65701980|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
23537457|NCT03864614|65701977|FG000|Overall Study|Sponsor Decision|1|||
23537458|NCT03864614|65701978|FG001|Overall Study|Sponsor Decision|2|||
23537459|NCT03864614|65701979|FG002|Overall Study|Sponsor Decision|0|||
23537460|NCT03864614|65701980|FG003|Overall Study|Sponsor Decision|0|||
23537461|NCT03864614|65701977|FG000|Overall Study|Pregnancy|0|||
23537462|NCT03864614|65701978|FG001|Overall Study|Pregnancy|1|||
23723603|NCT01001234|66366100|FG004|Overall Study|Withdrawal by Subject|0|||
23723604|NCT01001234|66366096|FG000|Overall Study|Protocol Violation|34|||
23723605|NCT01001234|66366097|FG001|Overall Study|Protocol Violation|3|||
23723606|NCT01001234|66366098|FG002|Overall Study|Protocol Violation|19|||
23537463|NCT03864614|65701979|FG002|Overall Study|Pregnancy|0|||
23537464|NCT03864614|65701980|FG003|Overall Study|Pregnancy|0|||
23537465|NCT03864614|65701977|FG000|Overall Study|Other|7|||
23537466|NCT03864614|65701978|FG001|Overall Study|Other|9|||
23537467|NCT03864614|65701979|FG002|Overall Study|Other|1|||
23815875|NCT02393248|66708277|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537468|NCT03864614|65701980|FG003|Overall Study|Other|4|||
23723607|NCT01001234|66366099|FG003|Overall Study|Protocol Violation|18|||
23537469|NCT03864614|65701977|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537470|NCT03864614|65701978|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537471|NCT03864614|65701979|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537472|NCT03864614|65701980|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
23537473|NCT01696032|65701981|FG000|Overall Study|Withdrawal by Subject|0|||
23537474|NCT01696032|65701982|FG001|Overall Study|Withdrawal by Subject|0|||
23537475|NCT01696032|65701983|FG002|Overall Study|Withdrawal by Subject|1|||
23537476|NCT01696032|65701984|FG003|Overall Study|Withdrawal by Subject|2|||
23723608|NCT01001234|66366100|FG004|Overall Study|Protocol Violation|0|||
23723609|NCT01001234|66366096|FG000|Overall Study|Lost to Follow-up|0|||
23723610|NCT01001234|66366097|FG001|Overall Study|Lost to Follow-up|0|||
23723611|NCT01001234|66366098|FG002|Overall Study|Lost to Follow-up|1|||
23723612|NCT01001234|66366099|FG003|Overall Study|Lost to Follow-up|2|||
23723613|NCT01001234|66366100|FG004|Overall Study|Lost to Follow-up|0|||
23723614|NCT01001234|66366096|FG000|Overall Study|Physician Decision|1|||
23723615|NCT01001234|66366097|FG001|Overall Study|Physician Decision|0|||
23723616|NCT01001234|66366098|FG002|Overall Study|Physician Decision|0|||
23723617|NCT01001234|66366099|FG003|Overall Study|Physician Decision|0|||
23723618|NCT01001234|66366100|FG004|Overall Study|Physician Decision|0|||
23723619|NCT01001234|66366096|FG000|Overall Study|Not Treated: Adverse Event|1|||
23723620|NCT01001234|66366097|FG001|Overall Study|Not Treated: Adverse Event|0|||
23723621|NCT01001234|66366098|FG002|Overall Study|Not Treated: Adverse Event|0|||
23723622|NCT01001234|66366099|FG003|Overall Study|Not Treated: Adverse Event|0|||
23723623|NCT01001234|66366100|FG004|Overall Study|Not Treated: Adverse Event|0|||
23723624|NCT01001234|66366096|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
23723625|NCT01001234|66366097|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
23723626|NCT01001234|66366098|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
23723627|NCT01001234|66366099|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
23723628|NCT01001234|66366100|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
23723629|NCT01001234|66366096|FG000|Overall Study|Not Treated: Protocol Violation|3|||
23723630|NCT01001234|66366097|FG001|Overall Study|Not Treated: Protocol Violation|0|||
23723631|NCT01001234|66366098|FG002|Overall Study|Not Treated: Protocol Violation|0|||
23723632|NCT01001234|66366099|FG003|Overall Study|Not Treated: Protocol Violation|0|||
23723633|NCT01001234|66366100|FG004|Overall Study|Not Treated: Protocol Violation|0|||
23723634|NCT01001234|66366096|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
23723635|NCT01001234|66366097|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
23723636|NCT01001234|66366098|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
23723637|NCT01001234|66366099|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
23723638|NCT01001234|66366100|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
23723639|NCT01001234|66366096|FG000|Overall Study|Not Treated: Pregnancy|3|||
23723640|NCT01001234|66366097|FG001|Overall Study|Not Treated: Pregnancy|0|||
23723641|NCT01001234|66366098|FG002|Overall Study|Not Treated: Pregnancy|0|||
23723642|NCT01001234|66366099|FG003|Overall Study|Not Treated: Pregnancy|0|||
23723643|NCT01001234|66366100|FG004|Overall Study|Not Treated: Pregnancy|0|||
23723644|NCT01001234|66366096|FG000|Overall Study|Not Treated: Physician Decision|37|||
23723645|NCT01001234|66366097|FG001|Overall Study|Not Treated: Physician Decision|4|||
23723646|NCT01001234|66366098|FG002|Overall Study|Not Treated: Physician Decision|0|||
23723647|NCT01001234|66366099|FG003|Overall Study|Not Treated: Physician Decision|0|||
23723648|NCT01001234|66366100|FG004|Overall Study|Not Treated: Physician Decision|0|||
23723649|NCT01001234|66366096|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
23723650|NCT01001234|66366097|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
23723651|NCT01001234|66366098|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23723652|NCT01001234|66366099|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23723653|NCT01001234|66366100|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23723654|NCT00762268|66366102|FG000|Overall Study|Withdrawal by Subject|3|||
23723655|NCT00762268|66366103|FG001|Overall Study|Withdrawal by Subject|3|||
23723656|NCT02693691|66366106|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
23723657|NCT02693691|66366106|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
23723658|NCT02693691|66366106|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
23723659|NCT02693691|66366106|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
23723660|NCT02693691|66366106|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
23423636|NCT01081301|65296200|FG000|Overall Study|Patient too ill|2|||
23537477|NCT01696032|65701981|FG000|Overall Study|Death|14|||
23723661|NCT02693691|66366106|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
23723662|NCT02693691|66366106|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
23723663|NCT00571519|66366107|FG000|Overall Study|Subject withdrew consent|0|||
23423637|NCT01081301|65296200|FG000|Overall Study|Lost to Follow-up|4|||
23537478|NCT01696032|65701982|FG001|Overall Study|Death|4|||
23537479|NCT01696032|65701983|FG002|Overall Study|Death|43|||
23537480|NCT01696032|65701984|FG003|Overall Study|Death|18|||
23723664|NCT00571519|66366108|FG001|Overall Study|Subject withdrew consent|1|||
23723665|NCT00571519|66366109|FG002|Overall Study|Subject withdrew consent|0|||
23723666|NCT00571519|66366110|FG003|Overall Study|Subject withdrew consent|2|||
23815876|NCT02393248|66708278|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815877|NCT02393248|66708279|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815878|NCT02393248|66708280|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537481|NCT01696032|65701981|FG000|Overall Study|Lost to Follow-up|0|||
23537482|NCT01696032|65701982|FG001|Overall Study|Lost to Follow-up|1|||
23815879|NCT02393248|66708281|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815880|NCT02393248|66708282|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815881|NCT02393248|66708283|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537483|NCT01696032|65701983|FG002|Overall Study|Lost to Follow-up|0|||
23537484|NCT01696032|65701984|FG003|Overall Study|Lost to Follow-up|0|||
23537485|NCT01696032|65701981|FG000|Overall Study|Database lock|0|||
23537486|NCT01696032|65701982|FG001|Overall Study|Database lock|1|||
23537487|NCT01696032|65701983|FG002|Overall Study|Database lock|7|||
23616279|NCT01136733|65982279|FG001|Phase 2|Adverse Event|0|||
23616280|NCT01136733|65982280|FG002|Phase 2|Adverse Event|0|||
23616281|NCT01136733|65982281|FG003|Phase 2|Adverse Event|0|||
23616282|NCT01136733|65982282|FG004|Phase 2|Adverse Event|11|||
23616283|NCT01136733|65982283|FG005|Phase 2|Adverse Event|13|||
23616284|NCT01136733|65982284|FG006|Phase 2|Adverse Event|5|||
23616285|NCT01136733|65982278|FG000|Phase 2|Participant Choice|0|||
23616286|NCT01136733|65982279|FG001|Phase 2|Participant Choice|0|||
23616287|NCT01136733|65982280|FG002|Phase 2|Participant Choice|0|||
23616288|NCT01136733|65982281|FG003|Phase 2|Participant Choice|0|||
23616289|NCT01136733|65982282|FG004|Phase 2|Participant Choice|3|||
23616290|NCT01136733|65982283|FG005|Phase 2|Participant Choice|0|||
23616291|NCT01136733|65982284|FG006|Phase 2|Participant Choice|1|||
23616292|NCT01136733|65982278|FG000|Phase 2|Administrative-Withdrew Consent|0|||
23616293|NCT01136733|65982279|FG001|Phase 2|Administrative-Withdrew Consent|0|||
23616294|NCT01136733|65982280|FG002|Phase 2|Administrative-Withdrew Consent|0|||
23616295|NCT01136733|65982281|FG003|Phase 2|Administrative-Withdrew Consent|0|||
23616296|NCT01136733|65982282|FG004|Phase 2|Administrative-Withdrew Consent|1|||
23616297|NCT01136733|65982283|FG005|Phase 2|Administrative-Withdrew Consent|0|||
23616298|NCT01136733|65982284|FG006|Phase 2|Administrative-Withdrew Consent|0|||
23616299|NCT01136733|65982278|FG000|Phase 2|Other|0|||
23616300|NCT01136733|65982279|FG001|Phase 2|Other|0|||
23616301|NCT01136733|65982280|FG002|Phase 2|Other|0|||
23616302|NCT01136733|65982281|FG003|Phase 2|Other|0|||
23616303|NCT01136733|65982282|FG004|Phase 2|Other|6|||
23616304|NCT01136733|65982283|FG005|Phase 2|Other|7|||
23616305|NCT01136733|65982284|FG006|Phase 2|Other|6|||
23616306|NCT02498418|65982285|FG000|Overall Study|Lack of Efficacy|0|||
23616307|NCT02498418|65982286|FG001|Overall Study|Lack of Efficacy|0|||
23616308|NCT02498418|65982287|FG002|Overall Study|Lack of Efficacy|1|||
23616309|NCT02498418|65982285|FG000|Overall Study|Withdrawal by Subject|2|||
23616310|NCT02498418|65982286|FG001|Overall Study|Withdrawal by Subject|0|||
23616311|NCT02498418|65982287|FG002|Overall Study|Withdrawal by Subject|3|||
23616312|NCT02498418|65982285|FG000|Overall Study|Lost to Follow-up|0|||
23616313|NCT02498418|65982286|FG001|Overall Study|Lost to Follow-up|1|||
23616314|NCT02498418|65982287|FG002|Overall Study|Lost to Follow-up|1|||
23616315|NCT02498418|65982285|FG000|Overall Study|Participant taken prohibited medication|0|||
23616316|NCT02498418|65982286|FG001|Overall Study|Participant taken prohibited medication|1|||
23616317|NCT02498418|65982287|FG002|Overall Study|Participant taken prohibited medication|1|||
23616318|NCT00092456|65982291|FG000|Overall Study|Adverse Event|0|||
23616319|NCT00092456|65982292|FG001|Overall Study|Adverse Event|0|||
23616320|NCT00092456|65982293|FG002|Overall Study|Adverse Event|1|||
23616321|NCT00092456|65982294|FG003|Overall Study|Adverse Event|1|||
23616322|NCT00092456|65982291|FG000|Overall Study|Lost to Follow-up|2|||
23616323|NCT00092456|65982292|FG001|Overall Study|Lost to Follow-up|2|||
23616324|NCT00092456|65982293|FG002|Overall Study|Lost to Follow-up|1|||
23616325|NCT00092456|65982294|FG003|Overall Study|Lost to Follow-up|2|||
23616326|NCT00092456|65982291|FG000|Overall Study|Protocol Violation|5|||
23616327|NCT00092456|65982292|FG001|Overall Study|Protocol Violation|7|||
23616328|NCT00092456|65982293|FG002|Overall Study|Protocol Violation|8|||
23616329|NCT00092456|65982294|FG003|Overall Study|Protocol Violation|6|||
23815882|NCT02393248|66708284|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537488|NCT01696032|65701984|FG003|Overall Study|Database lock|2|||
23537489|NCT01260922|65701985|FG000|First Intervention|Withdrawal by Subject|0|||
23616330|NCT00092456|65982291|FG000|Overall Study|Withdrawal by Subject|13|||
23616331|NCT00092456|65982292|FG001|Overall Study|Withdrawal by Subject|5|||
23616332|NCT00092456|65982293|FG002|Overall Study|Withdrawal by Subject|16|||
23616333|NCT00092456|65982294|FG003|Overall Study|Withdrawal by Subject|6|||
23616334|NCT00092456|65982291|FG000|Overall Study|Moved|1|||
23616335|NCT00092456|65982292|FG001|Overall Study|Moved|1|||
23616336|NCT00092456|65982293|FG002|Overall Study|Moved|0|||
23616337|NCT00092456|65982294|FG003|Overall Study|Moved|1|||
23616338|NCT00092456|65982291|FG000|Overall Study|Other|4|||
23616339|NCT00092456|65982292|FG001|Overall Study|Other|2|||
23616340|NCT00092456|65982293|FG002|Overall Study|Other|3|||
23616341|NCT00092456|65982294|FG003|Overall Study|Other|0|||
23723667|NCT00571519|66366111|FG004|Overall Study|Subject withdrew consent|1|||
23723668|NCT00571519|66366112|FG005|Overall Study|Subject withdrew consent|1|||
23723669|NCT00571519|66366113|FG006|Overall Study|Subject withdrew consent|2|||
23723670|NCT00571519|66366107|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23723671|NCT00571519|66366108|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23723672|NCT00571519|66366109|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23723673|NCT00571519|66366110|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23723674|NCT00571519|66366111|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23723675|NCT00571519|66366112|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23723676|NCT00571519|66366113|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23723677|NCT00571519|66366107|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723678|NCT00571519|66366108|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
23723679|NCT00571519|66366109|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723680|NCT00571519|66366110|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723681|NCT00571519|66366111|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723682|NCT00571519|66366112|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723683|NCT00571519|66366113|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
23723684|NCT00571519|66366107|FG000|Overall Study|Termination of study by Sponsor|2|||
23723685|NCT00571519|66366108|FG001|Overall Study|Termination of study by Sponsor|7|||
23723686|NCT00571519|66366109|FG002|Overall Study|Termination of study by Sponsor|10|||
23723687|NCT00571519|66366110|FG003|Overall Study|Termination of study by Sponsor|24|||
23723688|NCT00571519|66366111|FG004|Overall Study|Termination of study by Sponsor|8|||
23723689|NCT00571519|66366112|FG005|Overall Study|Termination of study by Sponsor|9|||
23723690|NCT00571519|66366113|FG006|Overall Study|Termination of study by Sponsor|22|||
23723691|NCT00571519|66366107|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723692|NCT00571519|66366108|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723693|NCT00571519|66366109|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
23723694|NCT00571519|66366110|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723695|NCT00571519|66366111|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723696|NCT00571519|66366112|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723697|NCT00571519|66366113|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23723698|NCT03039569|66366120|FG000|Overall Study|Lost to Follow-up|5|||
23723699|NCT03039569|66366121|FG001|Overall Study|Lost to Follow-up|4|||
23723700|NCT02096042|66366122|FG000|Overall Study|Disease Progression|1|||
23537490|NCT01260922|65701986|FG001|First Intervention|Withdrawal by Subject|1|||
23537491|NCT01260922|65701985|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
23537492|NCT01260922|65701986|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
23537493|NCT01260922|65701985|FG000|Second Intervention|Emesis|0|||
23537494|NCT01260922|65701986|FG001|Second Intervention|Emesis|2|||
23537495|NCT01751568|65701987|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
23537496|NCT01751568|65701988|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
23537497|NCT01751568|65701989|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
23537498|NCT01578551|65701992|FG000|Overall Study|Adverse Event|1|||
23723701|NCT02096042|66366123|FG001|Overall Study|Disease Progression|0|||
23723702|NCT02096042|66366124|FG002|Overall Study|Disease Progression|0|||
23723703|NCT03619837|66366125|FG000|Screening|received organs from HCV-negative donors|47|||
23723704|NCT03619837|66366125|FG000|Screening|died on the wait-list|2|||
23723705|NCT03619837|66366125|FG000|Screening|remained on the wait list|40|||
23723706|NCT03619837|66366125|FG000|Screening|didn't meet eligibility criteria|3|||
23723707|NCT03619837|66366125|FG000|Screening|withdrew consent|2|||
23723708|NCT03619837|66366125|FG000|Screening|never listed for HCV-viremic donor|1|||
23723709|NCT03619837|66366125|FG000|Screening|developed exclusion criteria|2|||
23723710|NCT03619837|66366125|FG000|Screening|excluded by the investigator due to non-compliance|1|||
23723711|NCT02725268|66366127|FG000|Overall Study|Death|58|||
23537499|NCT01578551|65701993|FG001|Overall Study|Adverse Event|0|||
23537500|NCT00459134|65701995|FG000|Overall Study|Physician Decision|1|||
23537501|NCT00459134|65701996|FG001|Overall Study|Physician Decision|1|||
23537502|NCT00459134|65701995|FG000|Overall Study|Withdrawal by Subject|8|||
23537503|NCT00459134|65701996|FG001|Overall Study|Withdrawal by Subject|7|||
23537504|NCT00459134|65701995|FG000|Overall Study|Lost to Follow-up|6|||
23537505|NCT00459134|65701996|FG001|Overall Study|Lost to Follow-up|7|||
23537506|NCT00459134|65701995|FG000|Overall Study|Surgery|1|||
23537507|NCT00459134|65701996|FG001|Overall Study|Surgery|2|||
23537508|NCT00459134|65701995|FG000|Overall Study|Toxicity|4|||
23537509|NCT00459134|65701996|FG001|Overall Study|Toxicity|5|||
23537510|NCT00459134|65701995|FG000|Overall Study|Progression|1|||
23537511|NCT00459134|65701996|FG001|Overall Study|Progression|0|||
23537512|NCT00459134|65701995|FG000|Overall Study|Multiple Reasons|2|||
23537513|NCT00459134|65701996|FG001|Overall Study|Multiple Reasons|3|||
23537514|NCT00142909|65701997|FG000|Randomization|Various Reasons|7|||
23537515|NCT00142909|65701998|FG001|Randomization|Various Reasons|10|||
23723712|NCT02725268|66366128|FG001|Overall Study|Death|59|||
23537516|NCT00142909|65701997|FG000|Medications Begin|Protocol Violation|2|||
23537517|NCT00142909|65701998|FG001|Medications Begin|Protocol Violation|0|||
23537518|NCT00142909|65701997|FG000|Medications Begin|Withdrawal by Subject|5|||
23537519|NCT00142909|65701998|FG001|Medications Begin|Withdrawal by Subject|3|||
23537520|NCT00142909|65701997|FG000|Medications Begin|Withdrawal by Subject|2|||
23537521|NCT00142909|65701998|FG001|Medications Begin|Withdrawal by Subject|0|||
23537522|NCT04666441|65702000|FG000|Overall Study|Lost to Follow-up|1|||
23537523|NCT04666441|65702001|FG001|Overall Study|Lost to Follow-up|4|||
23537524|NCT04666441|65702002|FG002|Overall Study|Lost to Follow-up|1|||
23537525|NCT04666441|65702003|FG003|Overall Study|Lost to Follow-up|3|||
23537526|NCT04666441|65702004|FG004|Overall Study|Lost to Follow-up|0|||
23537527|NCT04666441|65702005|FG005|Overall Study|Lost to Follow-up|2|||
23537528|NCT04666441|65702006|FG006|Overall Study|Lost to Follow-up|2|||
23537529|NCT04666441|65702007|FG007|Overall Study|Lost to Follow-up|2|||
23537530|NCT04666441|65702000|FG000|Overall Study|Subject Decision|1|||
23537531|NCT04666441|65702001|FG001|Overall Study|Subject Decision|1|||
23537532|NCT04666441|65702002|FG002|Overall Study|Subject Decision|3|||
23537533|NCT04666441|65702003|FG003|Overall Study|Subject Decision|1|||
23537534|NCT04666441|65702004|FG004|Overall Study|Subject Decision|0|||
23537535|NCT04666441|65702005|FG005|Overall Study|Subject Decision|1|||
23537536|NCT04666441|65702006|FG006|Overall Study|Subject Decision|3|||
23537537|NCT04666441|65702007|FG007|Overall Study|Subject Decision|2|||
23537538|NCT02158039|65702008|FG000|Overall Study|Withdrawal by Subject|1|||
23537539|NCT02158039|65702008|FG000|Overall Study|Screen Failure|9|||
23537540|NCT05008055|65702009|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
23537541|NCT05008055|65702010|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
23537542|NCT05008055|65702011|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
23537543|NCT03832192|65702015|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
23537544|NCT03832192|65702016|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
23723713|NCT02725268|66366129|FG002|Overall Study|Death|30|||
23723714|NCT02725268|66366130|FG003|Overall Study|Death|16|||
23723715|NCT02725268|66366127|FG000|Overall Study|Lost to Follow-up|4|||
23723716|NCT02725268|66366128|FG001|Overall Study|Lost to Follow-up|3|||
23723717|NCT02725268|66366129|FG002|Overall Study|Lost to Follow-up|0|||
23723718|NCT02725268|66366130|FG003|Overall Study|Lost to Follow-up|1|||
23723719|NCT02725268|66366127|FG000|Overall Study|Site Terminated by Sponsor|0|||
23723720|NCT02725268|66366128|FG001|Overall Study|Site Terminated by Sponsor|1|||
23723721|NCT02725268|66366129|FG002|Overall Study|Site Terminated by Sponsor|0|||
23723722|NCT02725268|66366130|FG003|Overall Study|Site Terminated by Sponsor|0|||
23723723|NCT02725268|66366127|FG000|Overall Study|Withdrawal by Subject|8|||
23723724|NCT02725268|66366128|FG001|Overall Study|Withdrawal by Subject|6|||
23723725|NCT02725268|66366129|FG002|Overall Study|Withdrawal by Subject|8|||
23723726|NCT02725268|66366130|FG003|Overall Study|Withdrawal by Subject|1|||
23723727|NCT02725268|66366127|FG000|Overall Study|Reason not Specified|2|||
23723728|NCT02725268|66366128|FG001|Overall Study|Reason not Specified|1|||
23723729|NCT02725268|66366129|FG002|Overall Study|Reason not Specified|0|||
23723730|NCT02725268|66366130|FG003|Overall Study|Reason not Specified|0|||
23723731|NCT04685538|66366133|FG000|Overall Study|Adverse Event|0|||
23723732|NCT04685538|66366134|FG001|Overall Study|Adverse Event|1|||
23723733|NCT04685538|66366133|FG000|Overall Study|Lost to Follow-up|0|||
23723734|NCT04685538|66366134|FG001|Overall Study|Lost to Follow-up|2|||
23723735|NCT02768103|66366135|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
23723736|NCT00412113|66366136|FG000|Overall Study|Adverse Event|11|||
23723737|NCT00412113|66366137|FG001|Overall Study|Adverse Event|15|||
23723738|NCT00412113|66366136|FG000|Overall Study|did not receive treatment|1|||
23723739|NCT00412113|66366137|FG001|Overall Study|did not receive treatment|0|||
23723740|NCT01102140|66366140|FG000|Overall Study|Lost to Follow-up|1|||
23723741|NCT01102140|66366141|FG001|Overall Study|Lost to Follow-up|0|||
23723742|NCT01102140|66366140|FG000|Overall Study|Investigator terminated study|2|||
23723743|NCT01102140|66366141|FG001|Overall Study|Investigator terminated study|2|||
23537545|NCT01079234|65702017|FG000|Main: Week 0 to 26|Adverse Event|5|||
23537546|NCT01079234|65702018|FG001|Main: Week 0 to 26|Adverse Event|4|||
23537547|NCT01079234|65702019|FG002|Main: Week 0 to 26|Adverse Event|1|||
23537548|NCT01079234|65702020|FG003|Main: Week 0 to 26|Adverse Event|0|||
23537549|NCT01079234|65702017|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
23723744|NCT02260388|66366146|FG000|Overall Study|Lost to Follow-up|2|||
23723745|NCT02260388|66366147|FG001|Overall Study|Lost to Follow-up|8|||
23723746|NCT02260388|66366148|FG002|Overall Study|Lost to Follow-up|3|||
23723747|NCT02260388|66366149|FG003|Overall Study|Lost to Follow-up|4|||
23723748|NCT00499460|66366150|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
23723749|NCT00499460|66366151|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
23723750|NCT00499460|66366150|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
23723751|NCT00499460|66366151|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
23537550|NCT01079234|65702018|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
23723752|NCT00499460|66366150|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
23723753|NCT00499460|66366151|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
23723754|NCT00424346|66366160|FG000|Core Study|Adverse Event|5|||
23723755|NCT00424346|66366161|FG001|Core Study|Adverse Event|3|||
23723756|NCT00424346|66366162|FG002|Core Study|Adverse Event|1|||
23723757|NCT00424346|66366163|FG003|Core Study|Adverse Event|1|||
23723758|NCT00424346|66366160|FG000|Core Study|Abnormal Laboratory Values|0|||
23723759|NCT00424346|66366161|FG001|Core Study|Abnormal Laboratory Values|1|||
23723760|NCT00424346|66366162|FG002|Core Study|Abnormal Laboratory Values|0|||
23723761|NCT00424346|66366163|FG003|Core Study|Abnormal Laboratory Values|0|||
23723762|NCT00424346|66366160|FG000|Core Study|Lack of Efficacy|1|||
23723763|NCT00424346|66366161|FG001|Core Study|Lack of Efficacy|3|||
23723764|NCT00424346|66366162|FG002|Core Study|Lack of Efficacy|0|||
23723765|NCT00424346|66366163|FG003|Core Study|Lack of Efficacy|4|||
23723766|NCT00424346|66366160|FG000|Core Study|Withdrawal by Subject|1|||
23723767|NCT00424346|66366161|FG001|Core Study|Withdrawal by Subject|0|||
23723768|NCT00424346|66366162|FG002|Core Study|Withdrawal by Subject|0|||
23723769|NCT00424346|66366163|FG003|Core Study|Withdrawal by Subject|2|||
23723770|NCT00424346|66366160|FG000|Core Study|Lost to Follow-up|1|||
23723771|NCT00424346|66366161|FG001|Core Study|Lost to Follow-up|1|||
23723772|NCT00424346|66366162|FG002|Core Study|Lost to Follow-up|0|||
23723773|NCT00424346|66366163|FG003|Core Study|Lost to Follow-up|0|||
23723774|NCT00424346|66366160|FG000|Core Study|Administrative Problems|1|||
23723775|NCT00424346|66366161|FG001|Core Study|Administrative Problems|0|||
23423638|NCT05427539|65296201|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23423639|NCT05427539|65296202|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23423640|NCT05427539|65296201|FG000|Period 1|Withdrawal by Subject|1|||
23423641|NCT05427539|65296202|FG001|Period 1|Withdrawal by Subject|0|||
23423642|NCT00681564|65296203|FG000|Overall Study|Lost to Follow-up|6|||
23423643|NCT00681564|65296204|FG001|Overall Study|Lost to Follow-up|6|||
23423644|NCT00681564|65296203|FG000|Overall Study|Withdrawal by Subject|0|||
23423645|NCT00681564|65296204|FG001|Overall Study|Withdrawal by Subject|1|||
23423646|NCT00681564|65296203|FG000|Overall Study|Death|0|||
23423647|NCT00681564|65296204|FG001|Overall Study|Death|1|||
23423648|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
23423649|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
23423650|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
23423651|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
23423652|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
23423653|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
23423654|NCT01224821|65296205|FG000|Long-Term Follow-Up|Death|2|||
23423655|NCT01224821|65296205|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
23423656|NCT00794365|65296206|FG000|Overall Study|Lost to Follow-up|38|||
23423657|NCT00794365|65296206|FG000|Overall Study|Other|17|||
23423658|NCT00794365|65296206|FG000|Overall Study|Poor Compliance|11|||
23423659|NCT00794365|65296206|FG000|Overall Study|Adverse Event|10|||
23537551|NCT01079234|65702019|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
23537552|NCT01079234|65702020|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
23423660|NCT00794365|65296206|FG000|Overall Study|Lack of Efficacy|3|||
23423661|NCT01688921|65296209|FG000|Overall Study|Lost to Follow-up|7|||
23423662|NCT01688921|65296210|FG001|Overall Study|Lost to Follow-up|13|||
23423663|NCT01688921|65296209|FG000|Overall Study|Physician Decision|6|||
23423664|NCT01688921|65296210|FG001|Overall Study|Physician Decision|1|||
23423665|NCT01688921|65296209|FG000|Overall Study|Protocol Violation|0|||
23423666|NCT01688921|65296210|FG001|Overall Study|Protocol Violation|1|||
23423667|NCT01688921|65296209|FG000|Overall Study|informed consent|3|||
23537553|NCT01079234|65702017|FG000|Main: Week 0 to 26|Protocol Violation|6|||
23537554|NCT01079234|65702018|FG001|Main: Week 0 to 26|Protocol Violation|2|||
23723776|NCT00424346|66366162|FG002|Core Study|Administrative Problems|1|||
23723777|NCT00424346|66366163|FG003|Core Study|Administrative Problems|0|||
23723778|NCT00424346|66366160|FG000|Core Study|Protocol Violation|0|||
23423668|NCT01688921|65296210|FG001|Overall Study|informed consent|0|||
23423669|NCT01149486|65296211|FG000|First Intervention|Adverse Event|0|||
23423670|NCT01149486|65296212|FG001|First Intervention|Adverse Event|1|||
23423671|NCT00367744|65296216|FG000|Overall Study|Lost to Follow-up|4|||
23723779|NCT00424346|66366161|FG001|Core Study|Protocol Violation|0|||
23423672|NCT00367744|65296217|FG001|Overall Study|Lost to Follow-up|5|||
23537555|NCT01079234|65702019|FG002|Main: Week 0 to 26|Protocol Violation|4|||
23537556|NCT01079234|65702020|FG003|Main: Week 0 to 26|Protocol Violation|0|||
23537557|NCT01079234|65702017|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
23537558|NCT01079234|65702018|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
23723780|NCT00424346|66366162|FG002|Core Study|Protocol Violation|2|||
23423673|NCT00521599|65296218|FG000|Overall Study|Adverse Event|5|||
23423674|NCT00521599|65296219|FG001|Overall Study|Adverse Event|7|||
23423675|NCT00521599|65296220|FG002|Overall Study|Adverse Event|6|||
23423676|NCT00521599|65296218|FG000|Overall Study|Treatment Failure|8|||
23423677|NCT00521599|65296219|FG001|Overall Study|Treatment Failure|9|||
23723781|NCT00424346|66366163|FG003|Core Study|Protocol Violation|0|||
23423678|NCT00521599|65296220|FG002|Overall Study|Treatment Failure|22|||
23423679|NCT00521599|65296218|FG000|Overall Study|Lost to Follow-up|2|||
23423680|NCT00521599|65296219|FG001|Overall Study|Lost to Follow-up|1|||
23423681|NCT00521599|65296220|FG002|Overall Study|Lost to Follow-up|2|||
23423682|NCT00521599|65296218|FG000|Overall Study|Withdrawal by Subject|3|||
23423683|NCT00521599|65296219|FG001|Overall Study|Withdrawal by Subject|5|||
23423684|NCT00521599|65296220|FG002|Overall Study|Withdrawal by Subject|1|||
23423685|NCT00521599|65296218|FG000|Overall Study|Withdrawal by subject treatment related|3|||
23423686|NCT00521599|65296219|FG001|Overall Study|Withdrawal by subject treatment related|1|||
23423687|NCT00521599|65296220|FG002|Overall Study|Withdrawal by subject treatment related|2|||
23423688|NCT00521599|65296218|FG000|Overall Study|Protocol Violation|2|||
23423689|NCT00521599|65296219|FG001|Overall Study|Protocol Violation|4|||
23423690|NCT00521599|65296220|FG002|Overall Study|Protocol Violation|2|||
23423691|NCT00521599|65296218|FG000|Overall Study|Did not meet protocol eligibility|2|||
23423692|NCT00521599|65296219|FG001|Overall Study|Did not meet protocol eligibility|2|||
23423693|NCT00521599|65296220|FG002|Overall Study|Did not meet protocol eligibility|1|||
23423694|NCT00293709|65296221|FG000|Overall Study|Other|47|||
23423695|NCT02370641|65296232|FG000|Overall Study|dropped study|4|||
23423696|NCT02370641|65296233|FG001|Overall Study|dropped study|2|||
23423697|NCT00983515|65296236|FG000|Ritonavir Alone|liver panel out of range|6|||
23423698|NCT00983515|65296236|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
23423699|NCT02387164|65296237|FG000|Overall Study|Lost to Follow-up|2|||
23423700|NCT02387164|65296238|FG001|Overall Study|Lost to Follow-up|0|||
23423701|NCT02387164|65296237|FG000|Overall Study|Diagnosed|1|||
23423702|NCT02387164|65296238|FG001|Overall Study|Diagnosed|2|||
23423703|NCT02891681|65296239|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
23423704|NCT02891681|65296240|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
23423705|NCT02891681|65296241|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
23423706|NCT02891681|65296239|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
23423707|NCT02891681|65296240|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
23423708|NCT02891681|65296241|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
23423709|NCT02891681|65296239|FG000|Overall Study|Taken off study after first imaging appointment|1|||
23423710|NCT02891681|65296240|FG001|Overall Study|Taken off study after first imaging appointment|0|||
23423711|NCT02891681|65296241|FG002|Overall Study|Taken off study after first imaging appointment|0|||
23423712|NCT03220581|65296242|FG000|Overall Study|Withdrawal by Subject|0|||
23423713|NCT03220581|65296243|FG001|Overall Study|Withdrawal by Subject|1|||
23423714|NCT03220581|65296242|FG000|Overall Study|Lost to Follow-up|3|||
23423715|NCT03220581|65296243|FG001|Overall Study|Lost to Follow-up|6|||
23423716|NCT04346108|65296248|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
23423717|NCT04346108|65296249|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
23423718|NCT04346108|65296250|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
23423719|NCT04346108|65296248|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
23423720|NCT04346108|65296249|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
23423721|NCT04346108|65296250|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
23423722|NCT01456195|65296253|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23423723|NCT01456195|65296254|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
23423724|NCT01456195|65296255|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23423725|NCT01456195|65296253|FG000|Overall Study|Lost to Follow-up|3|||
23423726|NCT01456195|65296254|FG001|Overall Study|Lost to Follow-up|1|||
23537559|NCT01079234|65702019|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
23537560|NCT01079234|65702020|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
23537561|NCT01079234|65702017|FG000|Main: Week 0 to 26|Unclassified|7|||
23537562|NCT01079234|65702018|FG001|Main: Week 0 to 26|Unclassified|13|||
23537563|NCT01079234|65702019|FG002|Main: Week 0 to 26|Unclassified|4|||
23537564|NCT01079234|65702020|FG003|Main: Week 0 to 26|Unclassified|0|||
23537565|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Adverse Event|0|||
23537566|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Adverse Event|0|||
23537567|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Adverse Event|1|||
23537568|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Adverse Event|0|||
23537569|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537570|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537571|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537572|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
23537573|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
23537574|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
23537575|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
23537576|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
23423727|NCT01456195|65296255|FG002|Overall Study|Lost to Follow-up|3|||
23423728|NCT01456195|65296253|FG000|Overall Study|Voluntary Withdrawal|5|||
23423729|NCT01456195|65296254|FG001|Overall Study|Voluntary Withdrawal|3|||
23423730|NCT01456195|65296255|FG002|Overall Study|Voluntary Withdrawal|7|||
23423731|NCT01456195|65296253|FG000|Overall Study|Lack of Efficacy|0|||
23423732|NCT01456195|65296254|FG001|Overall Study|Lack of Efficacy|1|||
23423733|NCT01456195|65296255|FG002|Overall Study|Lack of Efficacy|0|||
23423734|NCT01456195|65296253|FG000|Overall Study|Other Reasons|2|||
23423735|NCT01456195|65296254|FG001|Overall Study|Other Reasons|1|||
23423736|NCT01456195|65296255|FG002|Overall Study|Other Reasons|3|||
23423737|NCT03095027|65296256|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
23423738|NCT03095027|65296257|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
23423739|NCT03553498|65296259|FG000|Overall Study|Missing primary outcome|1|||
23423740|NCT03553498|65296260|FG001|Overall Study|Missing primary outcome|2|||
23423741|NCT02969590|65296261|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
23423742|NCT02969590|65296262|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
23423743|NCT02969590|65296263|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
23423744|NCT02928029|65296264|FG000|Overall Study|Withdrawal by Subject|0|||
23423745|NCT02928029|65296265|FG001|Overall Study|Withdrawal by Subject|1|||
23423746|NCT02928029|65296264|FG000|Overall Study|Radiological progression|1|||
23423747|NCT02928029|65296265|FG001|Overall Study|Radiological progression|0|||
23423748|NCT02928029|65296264|FG000|Overall Study|Clinical progression|1|||
23423749|NCT02928029|65296265|FG001|Overall Study|Clinical progression|2|||
23423750|NCT02928029|65296264|FG000|Overall Study|AE not related to clinical progression|1|||
23423751|NCT02928029|65296265|FG001|Overall Study|AE not related to clinical progression|1|||
23423752|NCT02635347|65296266|FG000|Overall Study|Failed screening|20|||
23423753|NCT02635347|65296267|FG001|Overall Study|Failed screening|7|||
23423754|NCT03305419|65296268|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423755|NCT03305419|65296269|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
23423756|NCT03305419|65296270|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423757|NCT03305419|65296271|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423758|NCT03305419|65296272|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423759|NCT03305419|65296273|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423760|NCT03305419|65296274|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423761|NCT03305419|65296275|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423762|NCT03305419|65296268|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
23423763|NCT03305419|65296269|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423764|NCT03305419|65296270|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423765|NCT03305419|65296271|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423766|NCT03305419|65296272|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423767|NCT03305419|65296273|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423768|NCT03305419|65296274|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423769|NCT03305419|65296275|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423770|NCT03305419|65296268|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
23423771|NCT03305419|65296269|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423772|NCT03305419|65296270|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423773|NCT03305419|65296271|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423774|NCT03305419|65296272|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423775|NCT03305419|65296273|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423776|NCT03305419|65296274|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423777|NCT03305419|65296275|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423778|NCT03305419|65296268|FG000|Part B (14 Days)|Adverse Event|0|||
23423779|NCT03305419|65296269|FG001|Part B (14 Days)|Adverse Event|0|||
23423780|NCT03305419|65296270|FG002|Part B (14 Days)|Adverse Event|0|||
23423781|NCT03305419|65296271|FG003|Part B (14 Days)|Adverse Event|0|||
23423782|NCT03305419|65296272|FG004|Part B (14 Days)|Adverse Event|1|||
23423783|NCT03305419|65296273|FG005|Part B (14 Days)|Adverse Event|2|||
23423784|NCT03305419|65296274|FG006|Part B (14 Days)|Adverse Event|4|||
23423785|NCT03305419|65296275|FG007|Part B (14 Days)|Adverse Event|0|||
23423786|NCT03305419|65296268|FG000|Part B (14 Days)|Physician Decision|0|||
23423787|NCT03305419|65296269|FG001|Part B (14 Days)|Physician Decision|0|||
23423788|NCT03305419|65296270|FG002|Part B (14 Days)|Physician Decision|0|||
23423789|NCT03305419|65296271|FG003|Part B (14 Days)|Physician Decision|0|||
23423790|NCT03305419|65296272|FG004|Part B (14 Days)|Physician Decision|2|||
23423791|NCT03305419|65296273|FG005|Part B (14 Days)|Physician Decision|8|||
23423792|NCT03305419|65296274|FG006|Part B (14 Days)|Physician Decision|1|||
23423793|NCT03305419|65296275|FG007|Part B (14 Days)|Physician Decision|0|||
23423794|NCT01342965|65296276|FG000|Overall Study|Death|58|||
23423795|NCT01342965|65296277|FG001|Overall Study|Death|57|||
23423796|NCT01342965|65296276|FG000|Overall Study|Lost to Follow-up|5|||
23423797|NCT01342965|65296277|FG001|Overall Study|Lost to Follow-up|3|||
23423798|NCT01342965|65296276|FG000|Overall Study|Other Reasons- Unspecified|44|||
23423799|NCT01342965|65296277|FG001|Overall Study|Other Reasons- Unspecified|38|||
23423800|NCT01342965|65296276|FG000|Overall Study|Withdrawal by Subject|2|||
23423801|NCT01342965|65296277|FG001|Overall Study|Withdrawal by Subject|9|||
23423802|NCT04863248|65296278|FG000|Overall Study|Sponsor Terminated|4|||
23423803|NCT04863248|65296279|FG001|Overall Study|Sponsor Terminated|1|||
23423804|NCT04863248|65296278|FG000|Overall Study|Death|0|||
23423805|NCT04863248|65296279|FG001|Overall Study|Death|1|||
23423806|NCT04863248|65296278|FG000|Overall Study|Withdrawal by Subject|0|||
23423807|NCT04863248|65296279|FG001|Overall Study|Withdrawal by Subject|1|||
23423808|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
23423809|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
23423810|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
23423811|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
23423812|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
23423813|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23423814|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
23423815|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
23423816|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
23423817|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
23423818|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Other|1|||
23423819|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Other|1|||
23423820|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
23423821|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
23423822|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
23423823|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
23423824|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
23423825|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
23423826|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
23423827|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
23423828|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
23423829|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
23423830|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
23423831|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
23423832|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Other|1|||
23423833|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Other|2|||
23423834|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
23423835|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
23423836|NCT00847665|65296286|FG000|Overall Study|Withdrawal by Subject|1|||
23423837|NCT00847665|65296287|FG001|Overall Study|Withdrawal by Subject|0|||
23423838|NCT01367704|65296288|FG000|Overall Study|Lost to Follow-up|47|||
23423839|NCT01367704|65296289|FG001|Overall Study|Lost to Follow-up|161|||
23423840|NCT00511433|65296291|FG000|Overall Study|Adverse Event|5|||
23423841|NCT00511433|65296292|FG001|Overall Study|Adverse Event|0|||
23423842|NCT00511433|65296291|FG000|Overall Study|Other Reason|1|||
23423843|NCT00511433|65296292|FG001|Overall Study|Other Reason|1|||
23423844|NCT01218100|65296295|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423845|NCT01218100|65296296|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423846|NCT01218100|65296297|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423847|NCT01218100|65296298|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
23423848|NCT01218100|65296295|FG000|Overall Study|Adverse Event|4|||
23423849|NCT01218100|65296296|FG001|Overall Study|Adverse Event|6|||
23423850|NCT01218100|65296297|FG002|Overall Study|Adverse Event|6|||
23423851|NCT01218100|65296298|FG003|Overall Study|Adverse Event|7|||
23423852|NCT01218100|65296295|FG000|Overall Study|Lack of Efficacy|9|||
23423853|NCT01218100|65296296|FG001|Overall Study|Lack of Efficacy|6|||
23423854|NCT01218100|65296297|FG002|Overall Study|Lack of Efficacy|5|||
23423855|NCT01218100|65296298|FG003|Overall Study|Lack of Efficacy|12|||
23423856|NCT01218100|65296295|FG000|Overall Study|Protocol Violation|0|||
23423857|NCT01218100|65296296|FG001|Overall Study|Protocol Violation|0|||
23423858|NCT01218100|65296297|FG002|Overall Study|Protocol Violation|1|||
23423859|NCT01218100|65296298|FG003|Overall Study|Protocol Violation|1|||
23423860|NCT01218100|65296295|FG000|Overall Study|Withdrawal by Subject|5|||
23423861|NCT01218100|65296296|FG001|Overall Study|Withdrawal by Subject|2|||
23423862|NCT01218100|65296297|FG002|Overall Study|Withdrawal by Subject|6|||
23423863|NCT01218100|65296298|FG003|Overall Study|Withdrawal by Subject|7|||
23423864|NCT01218100|65296295|FG000|Overall Study|Lost to Follow-up|3|||
23423865|NCT01218100|65296296|FG001|Overall Study|Lost to Follow-up|8|||
23423866|NCT01218100|65296297|FG002|Overall Study|Lost to Follow-up|2|||
23423867|NCT01218100|65296298|FG003|Overall Study|Lost to Follow-up|1|||
23423868|NCT01218100|65296295|FG000|Overall Study|Other Reason|2|||
23616342|NCT00246129|65982295|FG000|Overall Study|Lost to Follow-up|1|||
23723782|NCT00424346|66366160|FG000|Extension Phase|Adverse Event|0|||
23423869|NCT01218100|65296296|FG001|Overall Study|Other Reason|2|||
23423870|NCT01218100|65296297|FG002|Overall Study|Other Reason|6|||
23423871|NCT01218100|65296298|FG003|Overall Study|Other Reason|4|||
23423872|NCT01089023|65296299|FG000|Overall Study|Lost to Follow-up|3|||
23423873|NCT01089023|65296299|FG000|Overall Study|Adverse Event|1|||
23423874|NCT01089023|65296299|FG000|Overall Study|Withdrawal by Subject|1|||
23423875|NCT01089023|65296299|FG000|Overall Study|Protocol Violation|1|||
23423876|NCT01089023|65296299|FG000|Overall Study|Lack of Efficacy|1|||
23537577|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
23537578|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
23537579|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
23537580|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
23537581|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Unclassified|0|||
23537582|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Unclassified|0|||
23537583|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Unclassified|4|||
23537584|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Unclassified|7|||
23723783|NCT00424346|66366161|FG001|Extension Phase|Adverse Event|9|||
23723784|NCT00424346|66366162|FG002|Extension Phase|Adverse Event|5|||
23723785|NCT00424346|66366163|FG003|Extension Phase|Adverse Event|4|||
23723786|NCT00424346|66366160|FG000|Extension Phase|Lack of Efficacy|0|||
23723787|NCT00424346|66366161|FG001|Extension Phase|Lack of Efficacy|16|||
23723788|NCT00424346|66366162|FG002|Extension Phase|Lack of Efficacy|14|||
23723789|NCT00424346|66366163|FG003|Extension Phase|Lack of Efficacy|11|||
23723790|NCT00424346|66366160|FG000|Extension Phase|Withdrawal by Subject|0|||
23723791|NCT00424346|66366161|FG001|Extension Phase|Withdrawal by Subject|5|||
23723792|NCT00424346|66366162|FG002|Extension Phase|Withdrawal by Subject|3|||
23723793|NCT00424346|66366163|FG003|Extension Phase|Withdrawal by Subject|4|||
23723794|NCT00424346|66366160|FG000|Extension Phase|Lost to Follow-up|0|||
23723795|NCT00424346|66366161|FG001|Extension Phase|Lost to Follow-up|2|||
23723796|NCT00424346|66366162|FG002|Extension Phase|Lost to Follow-up|0|||
23723797|NCT00424346|66366163|FG003|Extension Phase|Lost to Follow-up|0|||
23723798|NCT00424346|66366160|FG000|Extension Phase|Administrative Problems|0|||
23723799|NCT00424346|66366161|FG001|Extension Phase|Administrative Problems|69|||
23723800|NCT00424346|66366162|FG002|Extension Phase|Administrative Problems|32|||
23723801|NCT00424346|66366163|FG003|Extension Phase|Administrative Problems|35|||
23723802|NCT00424346|66366160|FG000|Extension Phase|Death|0|||
23723803|NCT00424346|66366161|FG001|Extension Phase|Death|0|||
23723804|NCT00424346|66366162|FG002|Extension Phase|Death|0|||
23723805|NCT00424346|66366163|FG003|Extension Phase|Death|1|||
23723806|NCT00424346|66366160|FG000|Extension Phase|Protocol Violation|0|||
23723807|NCT00424346|66366161|FG001|Extension Phase|Protocol Violation|1|||
23723808|NCT00424346|66366162|FG002|Extension Phase|Protocol Violation|1|||
23723809|NCT00424346|66366163|FG003|Extension Phase|Protocol Violation|0|||
23723810|NCT01248364|66366164|FG000|Overall Study|Adverse Event|0|||
23723811|NCT01248364|66366165|FG001|Overall Study|Adverse Event|1|||
23723812|NCT01248364|66366166|FG002|Overall Study|Adverse Event|0|||
23723813|NCT01248364|66366167|FG003|Overall Study|Adverse Event|0|||
23723814|NCT01997281|66366168|FG000|Overall Study|Withdrawal by Subject|1|||
23723815|NCT01997281|66366169|FG001|Overall Study|Withdrawal by Subject|0|||
23723816|NCT00804986|66366172|FG000|Overall Study|Adverse Event|0|||
23723817|NCT00804986|66366173|FG001|Overall Study|Adverse Event|1|||
23723818|NCT00804986|66366174|FG002|Overall Study|Adverse Event|2|||
23723819|NCT00804986|66366175|FG003|Overall Study|Adverse Event|1|||
23723820|NCT00804986|66366176|FG004|Overall Study|Adverse Event|3|||
23723821|NCT00804986|66366177|FG005|Overall Study|Adverse Event|0|||
23723822|NCT00804986|66366172|FG000|Overall Study|Lack of Efficacy|0|||
23723823|NCT00804986|66366173|FG001|Overall Study|Lack of Efficacy|0|||
23723824|NCT00804986|66366174|FG002|Overall Study|Lack of Efficacy|0|||
23723825|NCT00804986|66366175|FG003|Overall Study|Lack of Efficacy|1|||
23723826|NCT00804986|66366176|FG004|Overall Study|Lack of Efficacy|0|||
23723827|NCT00804986|66366177|FG005|Overall Study|Lack of Efficacy|3|||
23723828|NCT00804986|66366172|FG000|Overall Study|Lost to Follow-up|0|||
23723829|NCT00804986|66366173|FG001|Overall Study|Lost to Follow-up|0|||
23723830|NCT00804986|66366174|FG002|Overall Study|Lost to Follow-up|0|||
23723831|NCT00804986|66366175|FG003|Overall Study|Lost to Follow-up|1|||
23723832|NCT00804986|66366176|FG004|Overall Study|Lost to Follow-up|1|||
23723833|NCT00804986|66366177|FG005|Overall Study|Lost to Follow-up|3|||
23723834|NCT00804986|66366172|FG000|Overall Study|Protocol Violation|0|||
23723835|NCT00804986|66366173|FG001|Overall Study|Protocol Violation|1|||
23723836|NCT00804986|66366174|FG002|Overall Study|Protocol Violation|0|||
23723837|NCT00804986|66366175|FG003|Overall Study|Protocol Violation|1|||
23723838|NCT00804986|66366176|FG004|Overall Study|Protocol Violation|0|||
23723839|NCT00804986|66366177|FG005|Overall Study|Protocol Violation|0|||
23723840|NCT00804986|66366172|FG000|Overall Study|Withdrawal by Subject|0|||
23723841|NCT00804986|66366173|FG001|Overall Study|Withdrawal by Subject|3|||
23723842|NCT00804986|66366174|FG002|Overall Study|Withdrawal by Subject|0|||
23723843|NCT00804986|66366175|FG003|Overall Study|Withdrawal by Subject|3|||
23537585|NCT00818441|65702023|FG000|Overall Study|Death|69|||
23537586|NCT00818441|65702024|FG001|Overall Study|Death|26|||
23723844|NCT00804986|66366176|FG004|Overall Study|Withdrawal by Subject|5|||
23723845|NCT00804986|66366177|FG005|Overall Study|Withdrawal by Subject|3|||
23723846|NCT00804986|66366172|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23723847|NCT00804986|66366173|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
23723848|NCT00804986|66366174|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
23723849|NCT00804986|66366175|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
23723850|NCT00804986|66366176|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
23423877|NCT01135914|65296300|FG000|Overall Study|Withdrawal by Subject|1|||
23423878|NCT01135914|65296301|FG001|Overall Study|Withdrawal by Subject|3|||
23423879|NCT01135914|65296302|FG002|Overall Study|Withdrawal by Subject|6|||
23423880|NCT01135914|65296300|FG000|Overall Study|Lost to Follow-up|1|||
23423881|NCT01135914|65296301|FG001|Overall Study|Lost to Follow-up|0|||
23423882|NCT01135914|65296302|FG002|Overall Study|Lost to Follow-up|1|||
23423883|NCT01135914|65296300|FG000|Overall Study|Protocol Violation|0|||
23423884|NCT01135914|65296301|FG001|Overall Study|Protocol Violation|0|||
23815883|NCT02393248|66708285|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23537587|NCT00818441|65702023|FG000|Overall Study|Other|5|||
23423885|NCT01135914|65296302|FG002|Overall Study|Protocol Violation|3|||
23423886|NCT01135914|65296300|FG000|Overall Study|Lack of Efficacy|2|||
23423887|NCT01135914|65296301|FG001|Overall Study|Lack of Efficacy|1|||
23423888|NCT01135914|65296302|FG002|Overall Study|Lack of Efficacy|10|||
23423889|NCT01135914|65296300|FG000|Overall Study|Adverse Event|0|||
23537588|NCT00818441|65702024|FG001|Overall Study|Other|0|||
23537589|NCT00818441|65702023|FG000|Overall Study|Lost to Follow-up|2|||
23537590|NCT00818441|65702024|FG001|Overall Study|Lost to Follow-up|1|||
23537591|NCT00818441|65702023|FG000|Overall Study|Withdrawal by Subject|2|||
23537592|NCT00818441|65702024|FG001|Overall Study|Withdrawal by Subject|0|||
23815884|NCT02393248|66708286|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815885|NCT02393248|66708287|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
23815886|NCT02393248|66708288|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815887|NCT02393248|66708289|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
23815888|NCT02393248|66708290|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23423890|NCT01135914|65296301|FG001|Overall Study|Adverse Event|1|||
23423891|NCT01135914|65296302|FG002|Overall Study|Adverse Event|2|||
23423892|NCT03622112|65296303|FG000|Overall Study|Withdrawal by Subject|6|||
23423893|NCT03622112|65296304|FG001|Overall Study|Withdrawal by Subject|2|||
23423894|NCT03622112|65296305|FG002|Overall Study|Withdrawal by Subject|4|||
23423895|NCT03622112|65296306|FG003|Overall Study|Withdrawal by Subject|2|||
23423896|NCT03622112|65296307|FG004|Overall Study|Withdrawal by Subject|1|||
23423897|NCT03622112|65296308|FG005|Overall Study|Withdrawal by Subject|2|||
23423898|NCT03622112|65296309|FG006|Overall Study|Withdrawal by Subject|2|||
23423899|NCT03622112|65296303|FG000|Overall Study|Death|0|||
23423900|NCT03622112|65296304|FG001|Overall Study|Death|0|||
23537593|NCT00818441|65702023|FG000|Overall Study|Adverse Event|0|||
23537594|NCT00818441|65702024|FG001|Overall Study|Adverse Event|1|||
23537595|NCT00818441|65702023|FG000|Overall Study|Study terminated by sponsor|11|||
23537596|NCT00818441|65702024|FG001|Overall Study|Study terminated by sponsor|2|||
23537597|NCT01700946|65702025|FG000|Overall Study|Lost to Follow-up|1|||
23537598|NCT01700946|65702026|FG001|Overall Study|Lost to Follow-up|0|||
23537599|NCT01700946|65702025|FG000|Overall Study|Physician Decision|7|||
23537600|NCT01700946|65702026|FG001|Overall Study|Physician Decision|12|||
23537601|NCT01700946|65702025|FG000|Overall Study|Withdrawal by Subject|0|||
23423901|NCT03622112|65296305|FG002|Overall Study|Death|0|||
23537602|NCT01700946|65702026|FG001|Overall Study|Withdrawal by Subject|2|||
23537603|NCT01700946|65702025|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
23423902|NCT03622112|65296306|FG003|Overall Study|Death|1|||
23423903|NCT03622112|65296307|FG004|Overall Study|Death|0|||
23423904|NCT03622112|65296308|FG005|Overall Study|Death|0|||
23423905|NCT03622112|65296309|FG006|Overall Study|Death|0|||
23537604|NCT01700946|65702026|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
23723851|NCT00804986|66366177|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
23423906|NCT03622112|65296303|FG000|Overall Study|Lost to Follow-up|1|||
23423907|NCT03622112|65296304|FG001|Overall Study|Lost to Follow-up|1|||
23423908|NCT03622112|65296305|FG002|Overall Study|Lost to Follow-up|0|||
23423909|NCT03622112|65296306|FG003|Overall Study|Lost to Follow-up|0|||
23723852|NCT00804986|66366172|FG000|Overall Study|Sponsor Decision|0|||
23723853|NCT00804986|66366173|FG001|Overall Study|Sponsor Decision|1|||
23723854|NCT00804986|66366174|FG002|Overall Study|Sponsor Decision|0|||
23423910|NCT03622112|65296307|FG004|Overall Study|Lost to Follow-up|0|||
23423911|NCT03622112|65296308|FG005|Overall Study|Lost to Follow-up|0|||
23423912|NCT03622112|65296309|FG006|Overall Study|Lost to Follow-up|0|||
23423913|NCT03622112|65296303|FG000|Overall Study|Study-specific withdrawal criteria|10|||
23537605|NCT01700946|65702025|FG000|Overall Study|Relapse|2|||
23537606|NCT01700946|65702026|FG001|Overall Study|Relapse|1|||
23537607|NCT01700946|65702025|FG000|Overall Study|Unacceptable toxicity|1|||
23537608|NCT01700946|65702026|FG001|Overall Study|Unacceptable toxicity|0|||
23537609|NCT04067141|65702027|FG000|First Intervention|Withdrawal by Subject|0|||
23537610|NCT04067141|65702028|FG001|First Intervention|Withdrawal by Subject|1|||
23537611|NCT04067141|65702027|FG000|Second Intervention|Adverse Event|0|||
23537612|NCT04067141|65702028|FG001|Second Intervention|Adverse Event|2|||
23537613|NCT04934670|65702037|FG000|Overall Study|Death|4|||
23537614|NCT04934670|65702038|FG001|Overall Study|Death|0|||
23537615|NCT04934670|65702037|FG000|Overall Study|Lost to Follow-up|1|||
23537616|NCT04934670|65702038|FG001|Overall Study|Lost to Follow-up|4|||
23537617|NCT01611259|65702041|FG000|Overall Study|Physician Decision|1|||
23537618|NCT01611259|65702041|FG000|Overall Study|Lack of Efficacy|2|||
23537619|NCT01611259|65702041|FG000|Overall Study|Adverse Event|4|||
23537620|NCT01611259|65702041|FG000|Overall Study|Withdrawal by Subject|7|||
23537621|NCT01663636|65702042|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
23537622|NCT01663636|65702043|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
23537623|NCT00226941|65702045|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
23537624|NCT00226941|65702046|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
23537625|NCT00226941|65702047|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
23537626|NCT00226941|65702048|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
23537627|NCT00226941|65702045|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537628|NCT00226941|65702046|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537629|NCT00226941|65702047|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537630|NCT00226941|65702048|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
23537631|NCT01263873|65702049|FG000|Overall Study|One provider unable to complete numbers|1|||
23537632|NCT01263873|65702050|FG001|Overall Study|One provider unable to complete numbers|1|||
23537633|NCT00555438|65702053|FG000|10 Days Post-operative|Death|4|||
23537634|NCT00555438|65702053|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
23537635|NCT00499889|65702054|FG000|Overall Study|Infection prior to treatment|1|||
23537636|NCT02573324|65702055|FG000|Overall Study|Withdrawal by Subject|26|||
23537637|NCT02573324|65702056|FG001|Overall Study|Withdrawal by Subject|23|||
23537638|NCT02573324|65702057|FG002|Overall Study|Withdrawal by Subject|3|||
23537639|NCT02573324|65702055|FG000|Overall Study|Lost to Follow-up|4|||
23537640|NCT02573324|65702056|FG001|Overall Study|Lost to Follow-up|5|||
23537641|NCT02573324|65702057|FG002|Overall Study|Lost to Follow-up|0|||
23537642|NCT02573324|65702055|FG000|Overall Study|Study Terminated by Sponsor|107|||
23537643|NCT02573324|65702056|FG001|Overall Study|Study Terminated by Sponsor|89|||
23537644|NCT02573324|65702057|FG002|Overall Study|Study Terminated by Sponsor|2|||
23537645|NCT02573324|65702055|FG000|Overall Study|Death|182|||
23537646|NCT02573324|65702056|FG001|Overall Study|Death|200|||
23537647|NCT02573324|65702057|FG002|Overall Study|Death|1|||
23616343|NCT00246129|65982296|FG001|Overall Study|Lost to Follow-up|0|||
23723855|NCT00804986|66366175|FG003|Overall Study|Sponsor Decision|0|||
23723856|NCT00804986|66366176|FG004|Overall Study|Sponsor Decision|0|||
23723857|NCT00804986|66366177|FG005|Overall Study|Sponsor Decision|0|||
23723858|NCT00804986|66366172|FG000|Overall Study|Physician Decision|1|||
23723859|NCT00804986|66366173|FG001|Overall Study|Physician Decision|0|||
23723860|NCT00804986|66366174|FG002|Overall Study|Physician Decision|0|||
23723861|NCT00804986|66366175|FG003|Overall Study|Physician Decision|0|||
23723862|NCT00804986|66366176|FG004|Overall Study|Physician Decision|0|||
23723863|NCT00804986|66366177|FG005|Overall Study|Physician Decision|0|||
23723864|NCT00614991|66366178|FG000|Overall Study|Adverse Event|3|||
23723865|NCT00614991|66366179|FG001|Overall Study|Adverse Event|3|||
23723866|NCT00614991|66366180|FG002|Overall Study|Adverse Event|0|||
23723867|NCT00614991|66366181|FG003|Overall Study|Adverse Event|0|||
23723868|NCT00614991|66366182|FG004|Overall Study|Adverse Event|1|||
23723869|NCT00614991|66366183|FG005|Overall Study|Adverse Event|0|||
23723870|NCT00105183|66366184|FG000|Overall Study|Death|19|||
23723871|NCT00105183|66366185|FG001|Overall Study|Death|13|||
23723872|NCT00105183|66366186|FG002|Overall Study|Death|15|||
23423914|NCT03622112|65296304|FG001|Overall Study|Study-specific withdrawal criteria|8|||
23423915|NCT03622112|65296305|FG002|Overall Study|Study-specific withdrawal criteria|7|||
23537648|NCT02573324|65702055|FG000|Overall Study|Other, Not Specified|20|||
23537649|NCT02573324|65702056|FG001|Overall Study|Other, Not Specified|27|||
23537650|NCT02573324|65702057|FG002|Overall Study|Other, Not Specified|0|||
23537651|NCT02573324|65702055|FG000|Overall Study|Unknown Reason|2|||
23537652|NCT02573324|65702056|FG001|Overall Study|Unknown Reason|0|||
23723873|NCT00105183|66366184|FG000|Overall Study|Withdrawal by Subject|1|||
23723874|NCT00105183|66366185|FG001|Overall Study|Withdrawal by Subject|1|||
23723875|NCT00105183|66366186|FG002|Overall Study|Withdrawal by Subject|4|||
23723876|NCT00105183|66366184|FG000|Overall Study|Physician Decision|1|||
23723877|NCT00105183|66366185|FG001|Overall Study|Physician Decision|2|||
23723878|NCT00105183|66366186|FG002|Overall Study|Physician Decision|3|||
23723879|NCT00105183|66366184|FG000|Overall Study|Lost to Follow-up|0|||
23723880|NCT00105183|66366185|FG001|Overall Study|Lost to Follow-up|1|||
23723881|NCT00105183|66366186|FG002|Overall Study|Lost to Follow-up|1|||
23723882|NCT00105183|66366184|FG000|Overall Study|Other reason|1|||
23723883|NCT00105183|66366185|FG001|Overall Study|Other reason|2|||
23723884|NCT00105183|66366186|FG002|Overall Study|Other reason|0|||
23723885|NCT03457636|66366192|FG000|Overall Study|Lost to Follow-up|2|||
23723886|NCT00841672|66366193|FG000|Overall Study|Adverse Event|7|||
23723887|NCT00841672|66366194|FG001|Overall Study|Adverse Event|16|||
23723888|NCT00841672|66366193|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23723889|NCT00841672|66366194|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23723890|NCT00841672|66366193|FG000|Overall Study|Subject withdrew consent|2|||
23723891|NCT00841672|66366194|FG001|Overall Study|Subject withdrew consent|4|||
23723892|NCT00841672|66366193|FG000|Overall Study|Lost to Follow-up|1|||
23723893|NCT00841672|66366194|FG001|Overall Study|Lost to Follow-up|1|||
23723894|NCT00841672|66366193|FG000|Overall Study|Administrative problems|9|||
23537653|NCT02573324|65702057|FG002|Overall Study|Unknown Reason|0|||
23537654|NCT00723801|65702058|FG000|Overall Study|Lost to Follow-up|1|||
23537655|NCT00723801|65702059|FG001|Overall Study|Lost to Follow-up|2|||
23537656|NCT00723801|65702058|FG000|Overall Study|Protocol Violation|2|||
23537657|NCT00723801|65702059|FG001|Overall Study|Protocol Violation|1|||
23537658|NCT00503841|65702061|FG000|Overall Study|All screen failures|44|||
23537659|NCT00861341|65702064|FG000|Overall Study|Withdrawal by Subject|2|||
23537660|NCT01358981|65702065|FG000|Period 1|Withdrawal by Subject|0|||
23537661|NCT01358981|65702066|FG001|Period 1|Withdrawal by Subject|0|||
23723895|NCT00841672|66366194|FG001|Overall Study|Administrative problems|9|||
23723896|NCT00841672|66366193|FG000|Overall Study|Misrandomized|1|||
23723897|NCT00841672|66366194|FG001|Overall Study|Misrandomized|0|||
23723898|NCT00841672|66366193|FG000|Overall Study|Protocol Deviation|0|||
23723899|NCT00841672|66366194|FG001|Overall Study|Protocol Deviation|1|||
23723900|NCT00224003|66366200|FG000|Overall Study|Adverse Event|1|||
23723901|NCT00224003|66366200|FG000|Overall Study|Protocol Violation|2|||
23723902|NCT00224003|66366200|FG000|Overall Study|Withdrawal by Subject|1|||
23723903|NCT00224003|66366200|FG000|Overall Study|unk|3|||
23723904|NCT00114218|66366201|FG000|Overall Study|Wrong Cell Type|2|||
23723905|NCT00114218|66366201|FG000|Overall Study|Wrong Primary|1|||
23723906|NCT00114218|66366201|FG000|Overall Study|Never Treated|1|||
23723907|NCT01105936|66366202|FG000|Period 1|Adverse Event|0|||
23723908|NCT01105936|66366203|FG001|Period 1|Adverse Event|0|||
23723909|NCT01105936|66366204|FG002|Period 1|Adverse Event|0|||
23723910|NCT01105936|66366205|FG003|Period 1|Adverse Event|1|||
23723911|NCT01105936|66366202|FG000|Period 2|Adverse Event|1|||
23723912|NCT01105936|66366203|FG001|Period 2|Adverse Event|0|||
23723913|NCT01105936|66366204|FG002|Period 2|Adverse Event|0|||
23723914|NCT01105936|66366205|FG003|Period 2|Adverse Event|0|||
23723915|NCT01105936|66366202|FG000|Period 3|Protocol Violation|0|||
23723916|NCT01105936|66366203|FG001|Period 3|Protocol Violation|2|||
23723917|NCT01105936|66366204|FG002|Period 3|Protocol Violation|0|||
23723918|NCT01105936|66366205|FG003|Period 3|Protocol Violation|0|||
23723919|NCT01855425|66366206|FG000|Overall Study|Physician Decision|20|||
23723920|NCT00845845|66366207|FG000|Overall Study|Lost to Follow-up|0|||
23723921|NCT00845845|66366208|FG001|Overall Study|Lost to Follow-up|4|||
23723922|NCT03235726|66366210|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723923|NCT03235726|66366211|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723924|NCT03235726|66366212|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723925|NCT03235726|66366213|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723926|NCT03235726|66366214|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
23723927|NCT03235726|66366215|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723928|NCT03235726|66366216|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723929|NCT03235726|66366217|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23537662|NCT01358981|65702067|FG002|Period 1|Withdrawal by Subject|0|||
23537663|NCT01358981|65702068|FG003|Period 1|Withdrawal by Subject|1|||
23616344|NCT00246129|65982295|FG000|Overall Study|Death|2|||
23723930|NCT03235726|66366218|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723931|NCT03235726|66366219|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23723932|NCT03235726|66366210|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23537664|NCT01358981|65702069|FG004|Period 1|Withdrawal by Subject|0|||
23537665|NCT01358981|65702070|FG005|Period 1|Withdrawal by Subject|0|||
23723933|NCT03235726|66366211|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723934|NCT03235726|66366212|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723935|NCT03235726|66366213|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723936|NCT03235726|66366214|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
23723937|NCT03235726|66366215|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723938|NCT03235726|66366216|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723939|NCT03235726|66366217|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723940|NCT03235726|66366218|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723941|NCT03235726|66366219|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23723942|NCT02204410|66366220|FG000|Overall Study|Lost to Follow-up|5|||
23723943|NCT02204410|66366220|FG000|Overall Study|Physician Decision|2|||
23723944|NCT02204410|66366220|FG000|Overall Study|Protocol Violation|1|||
23723945|NCT02204410|66366220|FG000|Overall Study|Withdrawal by Subject|3|||
23723946|NCT02699125|66366237|FG000|Placebo|Lost to Follow-up|2|||
23723947|NCT02699125|66366238|FG001|Placebo|Lost to Follow-up|0|||
23723948|NCT02699125|66366237|FG000|Placebo|Protocol Violation|1|||
23723949|NCT02699125|66366238|FG001|Placebo|Protocol Violation|0|||
23723950|NCT02699125|66366237|FG000|Placebo|Withdrawal by Subject|0|||
23723951|NCT02699125|66366238|FG001|Placebo|Withdrawal by Subject|4|||
23723952|NCT02699125|66366237|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
23723953|NCT02699125|66366238|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
23723954|NCT00251589|66366245|FG000|Overall Study|Adverse Event|5|||
23723955|NCT00251589|66366246|FG001|Overall Study|Adverse Event|1|||
23723956|NCT00251589|66366247|FG002|Overall Study|Adverse Event|2|||
23723957|NCT00251589|66366248|FG003|Overall Study|Adverse Event|1|||
23723958|NCT00251589|66366245|FG000|Overall Study|Withdrawal by Subject|1|||
23723959|NCT00251589|66366246|FG001|Overall Study|Withdrawal by Subject|1|||
23723960|NCT00251589|66366247|FG002|Overall Study|Withdrawal by Subject|0|||
23723961|NCT00251589|66366248|FG003|Overall Study|Withdrawal by Subject|0|||
23723962|NCT00251589|66366245|FG000|Overall Study|Discontinued due to progressive disease|9|||
23723963|NCT00251589|66366246|FG001|Overall Study|Discontinued due to progressive disease|1|||
23723964|NCT00251589|66366247|FG002|Overall Study|Discontinued due to progressive disease|0|||
23723965|NCT00251589|66366248|FG003|Overall Study|Discontinued due to progressive disease|1|||
23723966|NCT00407550|66366249|FG000|Overall Study|Adverse Event|0|||
23723967|NCT00407550|66366250|FG001|Overall Study|Adverse Event|1|||
23723968|NCT00407550|66366249|FG000|Overall Study|Withdrawal by Subject|0|||
23723969|NCT00407550|66366250|FG001|Overall Study|Withdrawal by Subject|2|||
23723970|NCT00407550|66366249|FG000|Overall Study|Death|1|||
23723971|NCT00407550|66366250|FG001|Overall Study|Death|0|||
23723972|NCT00407550|66366249|FG000|Overall Study|Insurance or Other medical condition|2|||
23723973|NCT00407550|66366250|FG001|Overall Study|Insurance or Other medical condition|1|||
23723974|NCT01709708|66366251|FG000|Overall Study|Protocol Violation|1|||
23723975|NCT01709708|66366252|FG001|Overall Study|Protocol Violation|2|||
23723976|NCT00441480|66366254|FG000|Overall Study|Protocol Violation|1|||
23723977|NCT00441480|66366255|FG001|Overall Study|Protocol Violation|1|||
23723978|NCT00441480|66366254|FG000|Overall Study|Withdrawal by Subject|2|||
23723979|NCT00441480|66366255|FG001|Overall Study|Withdrawal by Subject|3|||
23723980|NCT03077243|66366259|FG000|Overall Study|Death|1|||
23723981|NCT03077243|66366260|FG001|Overall Study|Death|2|||
23723982|NCT03077243|66366261|FG002|Overall Study|Death|0|||
23723983|NCT03077243|66366262|FG003|Overall Study|Death|0|||
23723984|NCT03077243|66366259|FG000|Overall Study|Withdrawal by Subject|1|||
23723985|NCT03077243|66366260|FG001|Overall Study|Withdrawal by Subject|3|||
23723986|NCT03077243|66366261|FG002|Overall Study|Withdrawal by Subject|0|||
23723987|NCT03077243|66366262|FG003|Overall Study|Withdrawal by Subject|0|||
23723988|NCT03077243|66366259|FG000|Overall Study|Physician Decision|1|||
23723989|NCT03077243|66366260|FG001|Overall Study|Physician Decision|0|||
23723990|NCT03077243|66366261|FG002|Overall Study|Physician Decision|0|||
23723991|NCT03077243|66366262|FG003|Overall Study|Physician Decision|0|||
23723992|NCT03077243|66366259|FG000|Overall Study|Research at two study sites terminated early|0|||
23723993|NCT03077243|66366260|FG001|Overall Study|Research at two study sites terminated early|0|||
23723994|NCT03077243|66366261|FG002|Overall Study|Research at two study sites terminated early|0|||
23723995|NCT03077243|66366262|FG003|Overall Study|Research at two study sites terminated early|69|||
23723996|NCT02999191|66366263|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
23723997|NCT02999191|66366264|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
23723998|NCT02999191|66366265|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
23723999|NCT01527110|66366266|FG000|Overall Study|Adverse Event|1|||
23724000|NCT04423757|66366268|FG000|Overall Study|Adverse Event|2|||
23724001|NCT04423757|66366269|FG001|Overall Study|Adverse Event|0|||
23724002|NCT04423757|66366268|FG000|Overall Study|Not treated|1|||
23724003|NCT04423757|66366269|FG001|Overall Study|Not treated|1|||
23724004|NCT00712933|66366270|FG000|Overall Study|Adverse Event|69|||
23724005|NCT00712933|66366270|FG000|Overall Study|Lack of Efficacy|6|||
23423916|NCT03622112|65296306|FG003|Overall Study|Study-specific withdrawal criteria|6|||
23724006|NCT00712933|66366270|FG000|Overall Study|Lost to Follow-up|22|||
23724007|NCT00712933|66366270|FG000|Overall Study|Non-compliance with study drug|13|||
23724008|NCT00712933|66366270|FG000|Overall Study|Other Pregnancy|37|||
23724009|NCT00712933|66366270|FG000|Overall Study|Sponsor decision|14|||
23724010|NCT00712933|66366270|FG000|Overall Study|Withdrew consent|4|||
23724011|NCT00712933|66366270|FG000|Overall Study|Hip replacement surgery|1|||
23724012|NCT00712933|66366270|FG000|Overall Study|Involved in Clinical research|3|||
23724013|NCT00712933|66366270|FG000|Overall Study|Participant hospitalized|1|||
23724014|NCT00712933|66366270|FG000|Overall Study|Participant travelled overseas|2|||
23724015|NCT00712933|66366270|FG000|Overall Study|Death of patient|1|||
23724016|NCT00712933|66366270|FG000|Overall Study|Other Physician decision|1|||
23724017|NCT00712933|66366270|FG000|Overall Study|Not committed to contraception|1|||
23724018|NCT00712933|66366270|FG000|Overall Study|Participant received medication|1|||
23724019|NCT00712933|66366270|FG000|Overall Study|Physician Decision|36|||
23724020|NCT00712933|66366270|FG000|Overall Study|Protocol Violation|4|||
23724021|NCT00712933|66366270|FG000|Overall Study|Withdrawal by Subject|151|||
23724022|NCT02420795|66366276|FG000|Overall Study|Withdrawal by Subject|1|||
23537666|NCT01358981|65702071|FG006|Period 1|Withdrawal by Subject|0|||
23537667|NCT04223856|65702072|FG000|Overall Study|Progressive disease|153|||
23537668|NCT04223856|65702073|FG001|Overall Study|Progressive disease|73|||
23537669|NCT04223856|65702072|FG000|Overall Study|Adverse Event|97|||
23537670|NCT04223856|65702073|FG001|Overall Study|Adverse Event|62|||
23537671|NCT04223856|65702072|FG000|Overall Study|Physician Decision|9|||
23724023|NCT02420795|66366277|FG001|Overall Study|Withdrawal by Subject|0|||
23724024|NCT02420795|66366278|FG002|Overall Study|Withdrawal by Subject|0|||
23724025|NCT02420795|66366276|FG000|Overall Study|Adverse Event|1|||
23724026|NCT02420795|66366277|FG001|Overall Study|Adverse Event|0|||
23724027|NCT02420795|66366278|FG002|Overall Study|Adverse Event|0|||
23724028|NCT02420795|66366276|FG000|Overall Study|Progressive disease|2|||
23724029|NCT02420795|66366277|FG001|Overall Study|Progressive disease|2|||
23724030|NCT02420795|66366278|FG002|Overall Study|Progressive disease|4|||
23724031|NCT02420795|66366276|FG000|Overall Study|Death|0|||
23724032|NCT02420795|66366277|FG001|Overall Study|Death|0|||
23724033|NCT02420795|66366278|FG002|Overall Study|Death|1|||
23724034|NCT01263444|66366279|FG000|Overall Study|Adverse Event|8|||
23724035|NCT01263444|66366279|FG000|Overall Study|Withdrawal by Subject|1|||
23724036|NCT01263444|66366279|FG000|Overall Study|Protocol Violation|1|||
23724037|NCT03382262|66366280|FG000|Overall Study|Physician Decision|0|||
23724038|NCT03382262|66366281|FG001|Overall Study|Physician Decision|0|||
23724039|NCT03382262|66366282|FG002|Overall Study|Physician Decision|1|||
23724040|NCT03382262|66366283|FG003|Overall Study|Physician Decision|0|||
23724041|NCT03382262|66366280|FG000|Overall Study|Withdrawal by Subject|0|||
23724042|NCT03382262|66366281|FG001|Overall Study|Withdrawal by Subject|0|||
23724043|NCT03382262|66366282|FG002|Overall Study|Withdrawal by Subject|0|||
23724044|NCT03382262|66366283|FG003|Overall Study|Withdrawal by Subject|1|||
23724045|NCT01119963|66366284|FG000|Overall Study|Lost to Follow-up|1|||
23724046|NCT01119963|66366285|FG001|Overall Study|Lost to Follow-up|1|||
23724047|NCT03693404|66366287|FG000|Overall Study|Withdrawal by Subject|1|||
23724048|NCT03693404|66366288|FG001|Overall Study|Withdrawal by Subject|0|||
23724049|NCT03693404|66366287|FG000|Overall Study|Lost to Follow-up|0|||
23724050|NCT03693404|66366288|FG001|Overall Study|Lost to Follow-up|5|||
23724051|NCT03693404|66366287|FG000|Overall Study|Excluded from Analysis|0|||
23724052|NCT03693404|66366288|FG001|Overall Study|Excluded from Analysis|1|||
23724053|NCT00318370|66366289|FG000|Period 1|Lack of Efficacy|5|||
23724054|NCT00318370|66366290|FG001|Period 1|Lack of Efficacy|0|||
23724055|NCT00318370|66366291|FG002|Period 1|Lack of Efficacy|0|||
23724056|NCT00318370|66366289|FG000|Period 1|Physician Decision|1|||
23724057|NCT00318370|66366290|FG001|Period 1|Physician Decision|0|||
23724058|NCT00318370|66366291|FG002|Period 1|Physician Decision|0|||
23724059|NCT00318370|66366289|FG000|Period 1|Withdrawal by Subject|1|||
23724060|NCT00318370|66366290|FG001|Period 1|Withdrawal by Subject|0|||
23724061|NCT00318370|66366291|FG002|Period 1|Withdrawal by Subject|0|||
23724062|NCT00318370|66366289|FG000|Period 2|Adverse Event|0|||
23724063|NCT00318370|66366290|FG001|Period 2|Adverse Event|3|||
23724064|NCT00318370|66366291|FG002|Period 2|Adverse Event|0|||
23724065|NCT00318370|66366289|FG000|Period 2|Lack of Efficacy|0|||
23724066|NCT00318370|66366290|FG001|Period 2|Lack of Efficacy|5|||
23724067|NCT00318370|66366291|FG002|Period 2|Lack of Efficacy|0|||
23724068|NCT00318370|66366289|FG000|Period 2|Physician Decision|0|||
23724069|NCT00318370|66366290|FG001|Period 2|Physician Decision|1|||
23724070|NCT00318370|66366291|FG002|Period 2|Physician Decision|0|||
23724071|NCT00318370|66366289|FG000|Period 2|Withdrawal by Subject|0|||
23724072|NCT00318370|66366290|FG001|Period 2|Withdrawal by Subject|1|||
23724073|NCT00318370|66366291|FG002|Period 2|Withdrawal by Subject|0|||
23724074|NCT00318370|66366289|FG000|Period 2|Other|0|||
23724075|NCT00318370|66366290|FG001|Period 2|Other|1|||
23724076|NCT00318370|66366291|FG002|Period 2|Other|0|||
23724077|NCT00318370|66366289|FG000|Period 3|Adverse Event|0|||
23724078|NCT00318370|66366290|FG001|Period 3|Adverse Event|0|||
23724079|NCT00318370|66366291|FG002|Period 3|Adverse Event|1|||
23724080|NCT00318370|66366289|FG000|Period 3|Lack of Efficacy|0|||
23724081|NCT00318370|66366290|FG001|Period 3|Lack of Efficacy|0|||
23537672|NCT04223856|65702073|FG001|Overall Study|Physician Decision|28|||
23724082|NCT00318370|66366291|FG002|Period 3|Lack of Efficacy|24|||
23724083|NCT00318370|66366289|FG000|Period 3|Death|0|||
23537673|NCT04223856|65702072|FG000|Overall Study|Withdrawal by Subject|22|||
23537674|NCT04223856|65702073|FG001|Overall Study|Withdrawal by Subject|24|||
23537675|NCT04223856|65702072|FG000|Overall Study|Other|7|||
23537676|NCT04223856|65702073|FG001|Overall Study|Other|2|||
23724084|NCT00318370|66366290|FG001|Period 3|Death|0|||
23724085|NCT00318370|66366291|FG002|Period 3|Death|1|||
23537677|NCT04223856|65702072|FG000|Overall Study|Randomized but not treated|2|||
23724086|NCT00318370|66366289|FG000|Period 3|Physician Decision|0|||
23724087|NCT00318370|66366290|FG001|Period 3|Physician Decision|0|||
23724088|NCT00318370|66366291|FG002|Period 3|Physician Decision|1|||
23724089|NCT00318370|66366289|FG000|Period 3|Withdrawal by Subject|0|||
23724090|NCT00318370|66366290|FG001|Period 3|Withdrawal by Subject|0|||
23724091|NCT00318370|66366291|FG002|Period 3|Withdrawal by Subject|3|||
23724092|NCT00318370|66366289|FG000|Period 3|Other|0|||
23724093|NCT00318370|66366290|FG001|Period 3|Other|0|||
23724094|NCT00318370|66366291|FG002|Period 3|Other|3|||
23724095|NCT02255760|66366292|FG000|Overall Study|Lost to Follow-up|0|||
23724096|NCT02255760|66366293|FG001|Overall Study|Lost to Follow-up|1|||
23724097|NCT02255760|66366294|FG002|Overall Study|Lost to Follow-up|0|||
23724098|NCT02255760|66366295|FG003|Overall Study|Lost to Follow-up|0|||
23724099|NCT02255760|66366296|FG004|Overall Study|Lost to Follow-up|0|||
23724100|NCT02925312|66366299|FG000|Overall Study|Lost to Follow-up|25|||
23724101|NCT02925312|66366300|FG001|Overall Study|Lost to Follow-up|0|||
23724102|NCT02925312|66366299|FG000|Overall Study|Adverse Event|2|||
23724103|NCT02925312|66366300|FG001|Overall Study|Adverse Event|0|||
23724104|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
23724105|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
23724106|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
23724107|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
23724108|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
23724109|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
23724110|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
23724111|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
23724112|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
23724113|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
23724114|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
23724115|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
23724116|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
23724117|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
23724118|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
23724119|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
23724120|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
23724121|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
23724122|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
23724123|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
23724124|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
23724125|NCT01001572|66370364|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
23724126|NCT01001572|66370365|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
23724127|NCT01001572|66370366|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
23724128|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23724129|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
23724130|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
23724131|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23724132|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
23724133|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
23724134|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
23724135|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
23724136|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
23724137|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23724138|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23724139|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
23724140|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
23724141|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
23724142|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
23724143|NCT01001572|66370364|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23724144|NCT01001572|66370365|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23724145|NCT01001572|66370366|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23724146|NCT00423592|66370369|FG000|Overall Study|Adverse Event (through Week 12)|2|||
23724147|NCT00423592|66370369|FG000|Overall Study|Adverse Event (post Week 12)|5|||
23724148|NCT03004976|66370370|FG000|Overall Study|Lost to Follow-up|7|||
23724149|NCT03004976|66370371|FG001|Overall Study|Lost to Follow-up|5|||
23724150|NCT03004976|66370370|FG000|Overall Study|Physician Decision|1|||
23724151|NCT03004976|66370371|FG001|Overall Study|Physician Decision|0|||
23724152|NCT03004976|66370370|FG000|Overall Study|Withdrawal by Subject|1|||
23724153|NCT03004976|66370371|FG001|Overall Study|Withdrawal by Subject|0|||
23724154|NCT03004976|66370370|FG000|Overall Study|Death|4|||
23724155|NCT03004976|66370371|FG001|Overall Study|Death|1|||
23724156|NCT00383708|66370376|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
23724157|NCT00383708|66370376|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
23724158|NCT00383708|66370376|FG000|Run-in Period|Protocol Violation|4|||
23724159|NCT00383708|66370376|FG000|Run-in Period|Adverse Event|2|||
23724160|NCT00383708|66370376|FG000|Run-in Period|Claustrophobia|1|||
23724161|NCT00383708|66370376|FG000|Co-administration Period|Adverse Event|5|||
23724162|NCT03363165|66370377|FG000|3-month Follow-up|Death|0|||
23724163|NCT03363165|66370378|FG001|3-month Follow-up|Death|1|||
23724164|NCT03363165|66370377|FG000|6-month Follow-up|Death|0|||
23724165|NCT03363165|66370378|FG001|6-month Follow-up|Death|1|||
23724166|NCT03363165|66370377|FG000|6-month Follow-up|Withdrawal by Subject|1|||
23724167|NCT03363165|66370378|FG001|6-month Follow-up|Withdrawal by Subject|1|||
23724168|NCT03363165|66370377|FG000|12-month Follow-up|Death|1|||
23724169|NCT03363165|66370378|FG001|12-month Follow-up|Death|1|||
23724170|NCT03363165|66370377|FG000|12-month Follow-up|Withdrawal by Subject|1|||
23724171|NCT03363165|66370378|FG001|12-month Follow-up|Withdrawal by Subject|1|||
23724172|NCT02920450|66370382|FG000|Overall Study|Death|1|||
23724173|NCT02920450|66370383|FG001|Overall Study|Death|0|||
23724174|NCT02920450|66370384|FG002|Overall Study|Death|0|||
23724175|NCT02920450|66370385|FG003|Overall Study|Death|0|||
23724176|NCT02920450|66370382|FG000|Overall Study|Withdrawal by Subject|1|||
23724177|NCT02920450|66370383|FG001|Overall Study|Withdrawal by Subject|0|||
23724178|NCT02920450|66370384|FG002|Overall Study|Withdrawal by Subject|0|||
23724179|NCT02920450|66370385|FG003|Overall Study|Withdrawal by Subject|0|||
23724180|NCT01843205|66370386|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
23724181|NCT01843205|66370387|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
23724182|NCT00953225|66370388|FG000|Overall Study|Withdrawal by Subject|2|||
23724183|NCT00953225|66370389|FG001|Overall Study|Withdrawal by Subject|0|||
23724184|NCT02266004|66370393|FG000|Overall Study|unrelated adverse event|1|||
23724185|NCT02266004|66370393|FG000|Overall Study|Physician Decision|1|||
23724186|NCT01095666|66370396|FG000|Overall Study|Lack of Efficacy|0|||
23724187|NCT01095666|66370397|FG001|Overall Study|Lack of Efficacy|0|||
23724188|NCT01095666|66370398|FG002|Overall Study|Lack of Efficacy|1|||
23724189|NCT01095666|66370396|FG000|Overall Study|Adverse Event|2|||
23724190|NCT01095666|66370397|FG001|Overall Study|Adverse Event|1|||
23724191|NCT01095666|66370398|FG002|Overall Study|Adverse Event|3|||
23724192|NCT01095666|66370396|FG000|Overall Study|Lost to Follow-up|2|||
23724193|NCT01095666|66370397|FG001|Overall Study|Lost to Follow-up|2|||
23724194|NCT01095666|66370398|FG002|Overall Study|Lost to Follow-up|0|||
23724195|NCT01095666|66370396|FG000|Overall Study|Withdrawal by Subject|6|||
23724196|NCT01095666|66370397|FG001|Overall Study|Withdrawal by Subject|6|||
23724197|NCT01095666|66370398|FG002|Overall Study|Withdrawal by Subject|1|||
23724198|NCT01095666|66370396|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
23724199|NCT01095666|66370397|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
23724200|NCT01095666|66370398|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
23724201|NCT01415908|66370402|FG000|Overall Study|Withdrawal by Subject|1|||
23724202|NCT01415908|66370403|FG001|Overall Study|Withdrawal by Subject|0|||
23724203|NCT01749800|66370406|FG000|Overall Study|not meeting inclusion criteria|3|||
23724204|NCT01749800|66370407|FG001|Overall Study|not meeting inclusion criteria|0|||
23724205|NCT01749800|66370408|FG002|Overall Study|not meeting inclusion criteria|0|||
23724206|NCT01749800|66370406|FG000|Overall Study|Withdrawal by Subject|0|||
23724207|NCT01749800|66370407|FG001|Overall Study|Withdrawal by Subject|1|||
23724208|NCT01749800|66370408|FG002|Overall Study|Withdrawal by Subject|0|||
23724209|NCT02820038|66370413|FG000|Overall Study|Lost to Follow-up|7|||
23724210|NCT02820038|66370414|FG001|Overall Study|Lost to Follow-up|11|||
23724211|NCT02820038|66370415|FG002|Overall Study|Lost to Follow-up|2|||
23724212|NCT02820038|66370416|FG003|Overall Study|Lost to Follow-up|9|||
23724213|NCT02820038|66370413|FG000|Overall Study|Withdrawal by Subject|3|||
23724214|NCT02820038|66370414|FG001|Overall Study|Withdrawal by Subject|14|||
23724215|NCT02820038|66370415|FG002|Overall Study|Withdrawal by Subject|3|||
23537678|NCT04223856|65702073|FG001|Overall Study|Randomized but not treated|11|||
23724216|NCT02820038|66370416|FG003|Overall Study|Withdrawal by Subject|13|||
23724217|NCT02017704|66370421|FG000|Overall Study|Withdrawal by Subject|2|||
23724218|NCT02017704|66370422|FG001|Overall Study|Withdrawal by Subject|0|||
23724219|NCT04153929|66370423|FG000|Overall Study|Other than listed|2|||
23724220|NCT04153929|66370424|FG001|Overall Study|Other than listed|2|||
23724221|NCT04153929|66370425|FG002|Overall Study|Other than listed|0|||
23724222|NCT04153929|66370426|FG003|Overall Study|Other than listed|1|||
23724223|NCT04153929|66370427|FG004|Overall Study|Other than listed|0|||
23724224|NCT04153929|66370428|FG005|Overall Study|Other than listed|2|||
23724225|NCT04153929|66370429|FG006|Overall Study|Other than listed|2|||
23724226|NCT04153929|66370430|FG007|Overall Study|Other than listed|1|||
23724227|NCT04153929|66370423|FG000|Overall Study|Lost to Follow-up|2|||
23724228|NCT04153929|66370424|FG001|Overall Study|Lost to Follow-up|1|||
23724229|NCT04153929|66370425|FG002|Overall Study|Lost to Follow-up|0|||
23724230|NCT04153929|66370426|FG003|Overall Study|Lost to Follow-up|1|||
23724231|NCT04153929|66370427|FG004|Overall Study|Lost to Follow-up|1|||
23724232|NCT04153929|66370428|FG005|Overall Study|Lost to Follow-up|0|||
23815889|NCT02393248|66708291|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815890|NCT02393248|66708292|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815891|NCT02393248|66708293|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815892|NCT02393248|66708294|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815893|NCT02393248|66708295|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815894|NCT02393248|66708296|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815895|NCT02393248|66708297|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815896|NCT02393248|66708298|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815897|NCT02393248|66708299|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815898|NCT02393248|66708300|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23815899|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23724233|NCT04153929|66370429|FG006|Overall Study|Lost to Follow-up|0|||
23815900|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815901|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815902|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815903|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815904|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815905|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815906|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815907|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815908|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815909|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815910|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815911|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815912|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815913|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815914|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23423917|NCT03622112|65296307|FG004|Overall Study|Study-specific withdrawal criteria|4|||
23423918|NCT03622112|65296308|FG005|Overall Study|Study-specific withdrawal criteria|18|||
23423919|NCT03622112|65296309|FG006|Overall Study|Study-specific withdrawal criteria|4|||
23423920|NCT03622112|65296303|FG000|Overall Study|Protocol Violation|2|||
23423921|NCT03622112|65296304|FG001|Overall Study|Protocol Violation|0|||
23423922|NCT03622112|65296305|FG002|Overall Study|Protocol Violation|1|||
23537679|NCT04223856|65702072|FG000|Overall Study|On-treatment|144|||
23537680|NCT04223856|65702073|FG001|Overall Study|On-treatment|0|||
23537681|NCT03286140|65702074|FG000|Overall Study|Withdrawal by Subject|10|||
23537682|NCT03286140|65702075|FG001|Overall Study|Withdrawal by Subject|5|||
23537683|NCT03286140|65702074|FG000|Overall Study|Lost to Follow-up|5|||
23537684|NCT03286140|65702075|FG001|Overall Study|Lost to Follow-up|10|||
23537685|NCT03286140|65702074|FG000|Overall Study|Failure to comply|0|||
23537686|NCT03286140|65702075|FG001|Overall Study|Failure to comply|1|||
23537687|NCT04079933|65702078|FG000|Overall Study|Withdrawal by Subject|3|||
23537688|NCT04079933|65702079|FG001|Overall Study|Withdrawal by Subject|4|||
23537689|NCT04079933|65702078|FG000|Overall Study|Lost to Follow-up|0|||
23616345|NCT00246129|65982296|FG001|Overall Study|Death|1|||
23616346|NCT00246129|65982295|FG000|Overall Study|suffered primary non-function|1|||
23724234|NCT04153929|66370430|FG007|Overall Study|Lost to Follow-up|0|||
23724235|NCT04153929|66370423|FG000|Overall Study|Withdrawal by Subject|3|||
23724236|NCT04153929|66370424|FG001|Overall Study|Withdrawal by Subject|1|||
23724237|NCT04153929|66370425|FG002|Overall Study|Withdrawal by Subject|0|||
23724238|NCT04153929|66370426|FG003|Overall Study|Withdrawal by Subject|3|||
23724239|NCT04153929|66370427|FG004|Overall Study|Withdrawal by Subject|1|||
23724240|NCT04153929|66370428|FG005|Overall Study|Withdrawal by Subject|0|||
23724241|NCT04153929|66370429|FG006|Overall Study|Withdrawal by Subject|1|||
23616347|NCT00246129|65982296|FG001|Overall Study|suffered primary non-function|0|||
23616348|NCT00246129|65982295|FG000|Overall Study|grafts failed|3|||
23616349|NCT00246129|65982296|FG001|Overall Study|grafts failed|1|||
23616350|NCT01047306|65982298|FG000|Overall Study|Withdrawal by Subject|2|||
23616351|NCT01047306|65982299|FG001|Overall Study|Withdrawal by Subject|0|||
23616352|NCT01047306|65982298|FG000|Overall Study|Lost to Follow-up|1|||
23616353|NCT01047306|65982299|FG001|Overall Study|Lost to Follow-up|0|||
23616354|NCT01838499|65982301|FG000|Overall Study|Protocol Violation|0|||
23616355|NCT01838499|65982302|FG001|Overall Study|Protocol Violation|1|||
23724242|NCT04153929|66370430|FG007|Overall Study|Withdrawal by Subject|0|||
23815915|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23537690|NCT04079933|65702079|FG001|Overall Study|Lost to Follow-up|1|||
23537691|NCT04394351|65702088|FG000|Part A (16 Weeks)|Adverse Event|1|||
23724243|NCT04153929|66370423|FG000|Overall Study|Protocol Violation|0|||
23724244|NCT04153929|66370424|FG001|Overall Study|Protocol Violation|0|||
23423923|NCT03622112|65296306|FG003|Overall Study|Protocol Violation|1|||
23616356|NCT01838499|65982301|FG000|Overall Study|Lost to Follow-up|2|||
23616357|NCT01838499|65982302|FG001|Overall Study|Lost to Follow-up|4|||
23724245|NCT04153929|66370425|FG002|Overall Study|Protocol Violation|0|||
23724246|NCT04153929|66370426|FG003|Overall Study|Protocol Violation|0|||
23724247|NCT04153929|66370427|FG004|Overall Study|Protocol Violation|0|||
23724248|NCT04153929|66370428|FG005|Overall Study|Protocol Violation|0|||
23724249|NCT04153929|66370429|FG006|Overall Study|Protocol Violation|1|||
23724250|NCT04153929|66370430|FG007|Overall Study|Protocol Violation|2|||
23724251|NCT04153929|66370423|FG000|Overall Study|Adverse Event|3|||
23724252|NCT04153929|66370424|FG001|Overall Study|Adverse Event|5|||
23724253|NCT04153929|66370425|FG002|Overall Study|Adverse Event|5|||
23724254|NCT04153929|66370426|FG003|Overall Study|Adverse Event|11|||
23724255|NCT04153929|66370427|FG004|Overall Study|Adverse Event|15|||
23724256|NCT04153929|66370428|FG005|Overall Study|Adverse Event|4|||
23724257|NCT04153929|66370429|FG006|Overall Study|Adverse Event|8|||
23724258|NCT04153929|66370430|FG007|Overall Study|Adverse Event|2|||
23724259|NCT04153929|66370423|FG000|Overall Study|Not treated|1|||
23724260|NCT04153929|66370424|FG001|Overall Study|Not treated|0|||
23724261|NCT04153929|66370425|FG002|Overall Study|Not treated|0|||
23815916|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815917|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23815918|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23537692|NCT04394351|65702089|FG001|Part A (16 Weeks)|Adverse Event|0|||
23537693|NCT04394351|65702090|FG002|Part A (16 Weeks)|Adverse Event|0|||
23537694|NCT04394351|65702091|FG003|Part A (16 Weeks)|Adverse Event|0|||
23537695|NCT04394351|65702092|FG004|Part A (16 Weeks)|Adverse Event|0|||
23537696|NCT04394351|65702093|FG005|Part A (16 Weeks)|Adverse Event|0|||
23537697|NCT04394351|65702094|FG006|Part A (16 Weeks)|Adverse Event|0|||
23537698|NCT04394351|65702095|FG007|Part A (16 Weeks)|Adverse Event|0|||
23537699|NCT04394351|65702088|FG000|Part A (16 Weeks)|Physician Decision|0|||
23537700|NCT04394351|65702089|FG001|Part A (16 Weeks)|Physician Decision|1|||
23537701|NCT04394351|65702090|FG002|Part A (16 Weeks)|Physician Decision|0|||
23537702|NCT04394351|65702091|FG003|Part A (16 Weeks)|Physician Decision|0|||
23537703|NCT04394351|65702092|FG004|Part A (16 Weeks)|Physician Decision|0|||
23537704|NCT04394351|65702093|FG005|Part A (16 Weeks)|Physician Decision|0|||
23537705|NCT04394351|65702094|FG006|Part A (16 Weeks)|Physician Decision|0|||
23537706|NCT04394351|65702095|FG007|Part A (16 Weeks)|Physician Decision|0|||
23537707|NCT04394351|65702088|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537708|NCT04394351|65702089|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
23815919|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
23815920|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23815921|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815922|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23815923|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23815924|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Death|0|||
23423924|NCT03622112|65296307|FG004|Overall Study|Protocol Violation|0|||
23423925|NCT03622112|65296308|FG005|Overall Study|Protocol Violation|0|||
23423926|NCT03622112|65296309|FG006|Overall Study|Protocol Violation|0|||
23423927|NCT03622112|65296303|FG000|Overall Study|Adverse Event|6|||
23423928|NCT03622112|65296304|FG001|Overall Study|Adverse Event|8|||
23423929|NCT03622112|65296305|FG002|Overall Study|Adverse Event|4|||
23423930|NCT03622112|65296306|FG003|Overall Study|Adverse Event|11|||
23423931|NCT03622112|65296307|FG004|Overall Study|Adverse Event|4|||
23423932|NCT03622112|65296308|FG005|Overall Study|Adverse Event|20|||
23423933|NCT03622112|65296309|FG006|Overall Study|Adverse Event|2|||
23423934|NCT03622112|65296303|FG000|Overall Study|Reason not specified|0|||
23423935|NCT03622112|65296304|FG001|Overall Study|Reason not specified|1|||
23423936|NCT03622112|65296305|FG002|Overall Study|Reason not specified|0|||
23423937|NCT03622112|65296306|FG003|Overall Study|Reason not specified|1|||
23423938|NCT03622112|65296307|FG004|Overall Study|Reason not specified|1|||
23423939|NCT03622112|65296308|FG005|Overall Study|Reason not specified|2|||
23423940|NCT03622112|65296309|FG006|Overall Study|Reason not specified|1|||
23423941|NCT01886690|65296310|FG000|Overall Study|Protocol Violation|0|||
23423942|NCT01886690|65296311|FG001|Overall Study|Protocol Violation|1|||
23423943|NCT01886690|65296310|FG000|Overall Study|Personal Reasons|0|||
23423944|NCT01886690|65296311|FG001|Overall Study|Personal Reasons|1|||
23537709|NCT04394351|65702090|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
23724262|NCT04153929|66370426|FG003|Overall Study|Not treated|0|||
23724263|NCT04153929|66370427|FG004|Overall Study|Not treated|0|||
23537710|NCT04394351|65702091|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537711|NCT04394351|65702092|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
23724264|NCT04153929|66370428|FG005|Overall Study|Not treated|0|||
23724265|NCT04153929|66370429|FG006|Overall Study|Not treated|1|||
23724266|NCT04153929|66370430|FG007|Overall Study|Not treated|0|||
23815925|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Death|0|||
23815926|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Death|0|||
23423945|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
23423946|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
23423947|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
23724267|NCT00688545|66370431|FG000|Overall Study|Lost to Follow-up|1|||
23537712|NCT04394351|65702093|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
23724268|NCT00688545|66370432|FG001|Overall Study|Lost to Follow-up|4|||
23724269|NCT00688545|66370431|FG000|Overall Study|Insurance/cost of drug|0|||
23724270|NCT00688545|66370432|FG001|Overall Study|Insurance/cost of drug|1|||
23537713|NCT04394351|65702094|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537714|NCT04394351|65702095|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537715|NCT04394351|65702088|FG000|Part B (36 Weeks)|Adverse Event|0|||
23537716|NCT04394351|65702089|FG001|Part B (36 Weeks)|Adverse Event|0|||
23537717|NCT04394351|65702090|FG002|Part B (36 Weeks)|Adverse Event|0|||
23537718|NCT04394351|65702091|FG003|Part B (36 Weeks)|Adverse Event|0|||
23537719|NCT04394351|65702092|FG004|Part B (36 Weeks)|Adverse Event|0|||
23537720|NCT04394351|65702093|FG005|Part B (36 Weeks)|Adverse Event|0|||
23537721|NCT04394351|65702094|FG006|Part B (36 Weeks)|Adverse Event|1|||
23537722|NCT04394351|65702095|FG007|Part B (36 Weeks)|Adverse Event|0|||
23537723|NCT04798586|65702096|FG000|Overall Study|Death|2|||
23537724|NCT02461589|65702107|FG000|Overall Study|Withdrawal by Subject|5|||
23537725|NCT02461589|65702108|FG001|Overall Study|Withdrawal by Subject|1|||
23537726|NCT02461589|65702109|FG002|Overall Study|Withdrawal by Subject|3|||
23537727|NCT02461589|65702110|FG003|Overall Study|Withdrawal by Subject|2|||
23537728|NCT02461589|65702111|FG004|Overall Study|Withdrawal by Subject|1|||
23537729|NCT02461589|65702112|FG005|Overall Study|Withdrawal by Subject|2|||
23537730|NCT02461589|65702113|FG006|Overall Study|Withdrawal by Subject|1|||
23537731|NCT02461589|65702114|FG007|Overall Study|Withdrawal by Subject|3|||
23537732|NCT02461589|65702115|FG008|Overall Study|Withdrawal by Subject|3|||
23537733|NCT02461589|65702116|FG009|Overall Study|Withdrawal by Subject|1|||
23537734|NCT02461589|65702107|FG000|Overall Study|Lost to Follow-up|0|||
23537735|NCT02461589|65702108|FG001|Overall Study|Lost to Follow-up|0|||
23537736|NCT02461589|65702109|FG002|Overall Study|Lost to Follow-up|2|||
23537737|NCT02461589|65702110|FG003|Overall Study|Lost to Follow-up|3|||
23537738|NCT02461589|65702111|FG004|Overall Study|Lost to Follow-up|1|||
23537739|NCT02461589|65702112|FG005|Overall Study|Lost to Follow-up|1|||
23537740|NCT02461589|65702113|FG006|Overall Study|Lost to Follow-up|3|||
23537741|NCT02461589|65702114|FG007|Overall Study|Lost to Follow-up|1|||
23537742|NCT02461589|65702115|FG008|Overall Study|Lost to Follow-up|3|||
23537743|NCT02461589|65702116|FG009|Overall Study|Lost to Follow-up|1|||
23537744|NCT02461589|65702107|FG000|Overall Study|Death|0|||
23537745|NCT02461589|65702108|FG001|Overall Study|Death|0|||
23537746|NCT02461589|65702109|FG002|Overall Study|Death|0|||
23537747|NCT02461589|65702110|FG003|Overall Study|Death|0|||
23537748|NCT02461589|65702111|FG004|Overall Study|Death|0|||
23537749|NCT02461589|65702112|FG005|Overall Study|Death|0|||
23537750|NCT02461589|65702113|FG006|Overall Study|Death|0|||
23537751|NCT02461589|65702114|FG007|Overall Study|Death|1|||
23537752|NCT02461589|65702115|FG008|Overall Study|Death|0|||
23537753|NCT02461589|65702116|FG009|Overall Study|Death|0|||
23537754|NCT02461589|65702107|FG000|Overall Study|Unclassified|0|||
23537755|NCT02461589|65702108|FG001|Overall Study|Unclassified|0|||
23537756|NCT02461589|65702109|FG002|Overall Study|Unclassified|0|||
23616358|NCT01838499|65982301|FG000|Overall Study|Lack of Efficacy|1|||
23724271|NCT00688545|66370431|FG000|Overall Study|Withdrawal by Subject|2|||
23724272|NCT00688545|66370432|FG001|Overall Study|Withdrawal by Subject|3|||
23724273|NCT00688545|66370431|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
23724274|NCT00688545|66370432|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
23724275|NCT01849562|66370438|FG000|Overall Study|Lost to Follow-up|1|||
23724276|NCT01849562|66370439|FG001|Overall Study|Lost to Follow-up|0|||
23724277|NCT01849562|66370440|FG002|Overall Study|Lost to Follow-up|0|||
23724278|NCT01849562|66370438|FG000|Overall Study|Non-compliance with Study Drug|1|||
23724279|NCT01849562|66370439|FG001|Overall Study|Non-compliance with Study Drug|0|||
23724280|NCT01849562|66370440|FG002|Overall Study|Non-compliance with Study Drug|0|||
23724281|NCT02116361|66370441|FG000|Overall Study|Pregnancy|0|||
23724282|NCT02116361|66370442|FG001|Overall Study|Pregnancy|0|||
23724283|NCT02116361|66370443|FG002|Overall Study|Pregnancy|0|||
23815927|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Death|0|||
23815928|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Death|0|||
23815929|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Death|0|||
23815930|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Death|0|||
23537757|NCT02461589|65702110|FG003|Overall Study|Unclassified|0|||
23537758|NCT02461589|65702111|FG004|Overall Study|Unclassified|0|||
23537759|NCT02461589|65702112|FG005|Overall Study|Unclassified|0|||
23537760|NCT02461589|65702113|FG006|Overall Study|Unclassified|1|||
23724284|NCT02116361|66370444|FG003|Overall Study|Pregnancy|1|||
23724285|NCT02116361|66370441|FG000|Overall Study|Protocol Violation|1|||
23815931|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Death|0|||
23423948|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
23537761|NCT02461589|65702114|FG007|Overall Study|Unclassified|0|||
23537762|NCT02461589|65702115|FG008|Overall Study|Unclassified|0|||
23537763|NCT02461589|65702116|FG009|Overall Study|Unclassified|2|||
23537764|NCT02461589|65702107|FG000|Overall Study|Missing follow-up information|1|||
23537765|NCT02461589|65702108|FG001|Overall Study|Missing follow-up information|1|||
23537766|NCT02461589|65702109|FG002|Overall Study|Missing follow-up information|0|||
23537767|NCT02461589|65702110|FG003|Overall Study|Missing follow-up information|0|||
23537768|NCT02461589|65702111|FG004|Overall Study|Missing follow-up information|0|||
23537769|NCT02461589|65702112|FG005|Overall Study|Missing follow-up information|0|||
23537770|NCT02461589|65702113|FG006|Overall Study|Missing follow-up information|1|||
23537771|NCT02461589|65702114|FG007|Overall Study|Missing follow-up information|0|||
23537772|NCT02461589|65702115|FG008|Overall Study|Missing follow-up information|0|||
23537773|NCT02461589|65702116|FG009|Overall Study|Missing follow-up information|0|||
23537774|NCT02461589|65702107|FG000|Overall Study|Withdrawal from trial before exposure|0|||
23537775|NCT02461589|65702108|FG001|Overall Study|Withdrawal from trial before exposure|0|||
23537776|NCT02461589|65702109|FG002|Overall Study|Withdrawal from trial before exposure|0|||
23537777|NCT02461589|65702110|FG003|Overall Study|Withdrawal from trial before exposure|0|||
23537778|NCT02461589|65702111|FG004|Overall Study|Withdrawal from trial before exposure|0|||
23537779|NCT02461589|65702112|FG005|Overall Study|Withdrawal from trial before exposure|0|||
23537780|NCT02461589|65702113|FG006|Overall Study|Withdrawal from trial before exposure|0|||
23537781|NCT02461589|65702114|FG007|Overall Study|Withdrawal from trial before exposure|0|||
23537782|NCT02461589|65702115|FG008|Overall Study|Withdrawal from trial before exposure|0|||
23537783|NCT02461589|65702116|FG009|Overall Study|Withdrawal from trial before exposure|1|||
23537784|NCT02788175|65702118|FG000|Overall Study|Protocol Violation|3|||
23537785|NCT02788175|65702118|FG000|Overall Study|Withdrawal by Subject|4|||
23537786|NCT02788175|65702118|FG000|Overall Study|Ineligible prior to study agent|6|||
23537787|NCT01513291|65702119|FG000|Treatment Period|Adverse Event|8|||
23537788|NCT01513291|65702120|FG001|Treatment Period|Adverse Event|4|||
23537789|NCT01513291|65702121|FG002|Treatment Period|Adverse Event|0|||
23537790|NCT01513291|65702122|FG003|Treatment Period|Adverse Event|0|||
23537791|NCT01513291|65702123|FG004|Treatment Period|Adverse Event|0|||
23537792|NCT01513291|65702119|FG000|Treatment Period|Lack of Efficacy|3|||
23724286|NCT02116361|66370442|FG001|Overall Study|Protocol Violation|0|||
23815932|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Death|0|||
23815933|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Death|0|||
23815934|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Death|0|||
23815935|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Death|0|||
23815936|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Death|0|||
23815937|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Death|0|||
23724287|NCT02116361|66370443|FG002|Overall Study|Protocol Violation|0|||
23724288|NCT02116361|66370444|FG003|Overall Study|Protocol Violation|2|||
23724289|NCT02116361|66370441|FG000|Overall Study|Physician Decision|2|||
23724290|NCT02116361|66370442|FG001|Overall Study|Physician Decision|3|||
23724291|NCT02116361|66370443|FG002|Overall Study|Physician Decision|0|||
23724292|NCT02116361|66370444|FG003|Overall Study|Physician Decision|0|||
23724293|NCT02116361|66370441|FG000|Overall Study|Adverse Event|1|||
23724294|NCT02116361|66370442|FG001|Overall Study|Adverse Event|0|||
23724295|NCT02116361|66370443|FG002|Overall Study|Adverse Event|0|||
23724296|NCT02116361|66370444|FG003|Overall Study|Adverse Event|3|||
23724297|NCT02116361|66370441|FG000|Overall Study|Other Reasons|3|||
23724298|NCT02116361|66370442|FG001|Overall Study|Other Reasons|3|||
23724299|NCT02116361|66370443|FG002|Overall Study|Other Reasons|3|||
23724300|NCT02116361|66370444|FG003|Overall Study|Other Reasons|3|||
23724301|NCT02116361|66370441|FG000|Overall Study|Lack of Efficacy|5|||
23724302|NCT02116361|66370442|FG001|Overall Study|Lack of Efficacy|7|||
23815938|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Death|0|||
23423949|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
23423950|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
23423951|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
23423952|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
23423953|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
23423954|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
23423955|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
23423956|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
23423957|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
23423958|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
23423959|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
23423960|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
23423961|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
23423962|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
23423963|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
23423964|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
23423965|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
23423966|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
23423967|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
23423968|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
23423969|NCT01340937|65296320|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
23537793|NCT01513291|65702120|FG001|Treatment Period|Lack of Efficacy|0|||
23537794|NCT01513291|65702121|FG002|Treatment Period|Lack of Efficacy|0|||
23537795|NCT01513291|65702122|FG003|Treatment Period|Lack of Efficacy|0|||
23537796|NCT01513291|65702123|FG004|Treatment Period|Lack of Efficacy|0|||
23537797|NCT01513291|65702119|FG000|Treatment Period|Lost to Follow-up|2|||
23537798|NCT01513291|65702120|FG001|Treatment Period|Lost to Follow-up|3|||
23537799|NCT01513291|65702121|FG002|Treatment Period|Lost to Follow-up|0|||
23537800|NCT01513291|65702122|FG003|Treatment Period|Lost to Follow-up|0|||
23537801|NCT01513291|65702123|FG004|Treatment Period|Lost to Follow-up|0|||
23537802|NCT01513291|65702119|FG000|Treatment Period|Physician Decision|1|||
23537803|NCT01513291|65702120|FG001|Treatment Period|Physician Decision|0|||
23537804|NCT01513291|65702121|FG002|Treatment Period|Physician Decision|0|||
23537805|NCT01513291|65702122|FG003|Treatment Period|Physician Decision|0|||
23537806|NCT01513291|65702123|FG004|Treatment Period|Physician Decision|0|||
23537807|NCT01513291|65702119|FG000|Treatment Period|Protocol Violation|1|||
23537808|NCT01513291|65702120|FG001|Treatment Period|Protocol Violation|2|||
23537809|NCT01513291|65702121|FG002|Treatment Period|Protocol Violation|0|||
23537810|NCT01513291|65702122|FG003|Treatment Period|Protocol Violation|0|||
23537811|NCT01513291|65702123|FG004|Treatment Period|Protocol Violation|0|||
23537812|NCT01513291|65702119|FG000|Treatment Period|Withdrawal by Subject|8|||
23537813|NCT01513291|65702120|FG001|Treatment Period|Withdrawal by Subject|5|||
23537814|NCT01513291|65702121|FG002|Treatment Period|Withdrawal by Subject|0|||
23537815|NCT01513291|65702122|FG003|Treatment Period|Withdrawal by Subject|0|||
23537816|NCT01513291|65702123|FG004|Treatment Period|Withdrawal by Subject|0|||
23537817|NCT01513291|65702119|FG000|Treatment Period|Randomized not treated|0|||
23537818|NCT01513291|65702120|FG001|Treatment Period|Randomized not treated|2|||
23537819|NCT01513291|65702121|FG002|Treatment Period|Randomized not treated|0|||
23537820|NCT01513291|65702122|FG003|Treatment Period|Randomized not treated|0|||
23537821|NCT01513291|65702123|FG004|Treatment Period|Randomized not treated|0|||
23537822|NCT01513291|65702119|FG000|Run-out Period|Lost to Follow-up|0|||
23537823|NCT01513291|65702120|FG001|Run-out Period|Lost to Follow-up|0|||
23724303|NCT02116361|66370443|FG002|Overall Study|Lack of Efficacy|4|||
23724304|NCT02116361|66370444|FG003|Overall Study|Lack of Efficacy|3|||
23724305|NCT02116361|66370441|FG000|Overall Study|Lost to Follow-up|4|||
23724306|NCT02116361|66370442|FG001|Overall Study|Lost to Follow-up|5|||
23537824|NCT01513291|65702121|FG002|Run-out Period|Lost to Follow-up|0|||
23537825|NCT01513291|65702122|FG003|Run-out Period|Lost to Follow-up|1|||
23537826|NCT01513291|65702123|FG004|Run-out Period|Lost to Follow-up|0|||
23537827|NCT01513291|65702119|FG000|Run-out Period|Withdrawal by Subject|0|||
23537828|NCT01513291|65702120|FG001|Run-out Period|Withdrawal by Subject|0|||
23537829|NCT01513291|65702121|FG002|Run-out Period|Withdrawal by Subject|0|||
23537830|NCT01513291|65702122|FG003|Run-out Period|Withdrawal by Subject|1|||
23537831|NCT01513291|65702123|FG004|Run-out Period|Withdrawal by Subject|0|||
23537832|NCT02838017|65702131|FG000|Overall Study|Lost to Follow-up|14|||
23537833|NCT02838017|65702132|FG001|Overall Study|Lost to Follow-up|11|||
23537834|NCT02863354|65702137|FG000|Year 1|Lost to Follow-up|1|||
23537835|NCT02863354|65702138|FG001|Year 1|Lost to Follow-up|1|||
23537836|NCT02863354|65702137|FG000|Year 1|Withdrawal by Subject|3|||
23537837|NCT02863354|65702138|FG001|Year 1|Withdrawal by Subject|0|||
23537838|NCT02863354|65702137|FG000|Year 1|Death|0|||
23537839|NCT02863354|65702138|FG001|Year 1|Death|1|||
23724307|NCT02116361|66370443|FG002|Overall Study|Lost to Follow-up|7|||
23724308|NCT02116361|66370444|FG003|Overall Study|Lost to Follow-up|5|||
23724309|NCT02116361|66370441|FG000|Overall Study|Personal Reasons|6|||
23537840|NCT02863354|65702137|FG000|Year 2|Lost to Follow-up|2|||
23537841|NCT02863354|65702138|FG001|Year 2|Lost to Follow-up|2|||
23537842|NCT01163682|65702139|FG000|Overall Study|Lost to Follow-up|6|||
23537843|NCT01163682|65702140|FG001|Overall Study|Lost to Follow-up|9|||
23537844|NCT02096835|65702141|FG000|Overall Study|Withdrawal by Subject|1|||
23537845|NCT02096835|65702142|FG001|Overall Study|Withdrawal by Subject|0|||
23537846|NCT02096835|65702143|FG002|Overall Study|Withdrawal by Subject|0|||
23537847|NCT02096835|65702141|FG000|Overall Study|converted to open procedures|1|||
23537848|NCT02096835|65702142|FG001|Overall Study|converted to open procedures|0|||
23537849|NCT02096835|65702143|FG002|Overall Study|converted to open procedures|0|||
23537850|NCT02096835|65702141|FG000|Overall Study|Lost to Follow-up|1|||
23537851|NCT02096835|65702142|FG001|Overall Study|Lost to Follow-up|0|||
23537852|NCT02096835|65702143|FG002|Overall Study|Lost to Follow-up|1|||
23537853|NCT02565381|65702144|FG000|Overall Study|Lost to Follow-up|1|||
23537854|NCT02565381|65702145|FG001|Overall Study|Lost to Follow-up|0|||
23537855|NCT02565381|65702146|FG002|Overall Study|Lost to Follow-up|1|||
23537856|NCT01775137|65702147|FG000|Overall Study|Death|1|||
23537857|NCT01775137|65702147|FG000|Overall Study|Protocol deviation|2|||
23537858|NCT01775137|65702147|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23537859|NCT01775137|65702147|FG000|Overall Study|Adverse Event|1|||
23537860|NCT01775137|65702147|FG000|Overall Study|Withdrawal by participants|5|||
23537861|NCT02443298|65702151|FG000|Overall Study|Adverse Event|3|||
23537862|NCT02443298|65702152|FG001|Overall Study|Adverse Event|3|||
23724310|NCT02116361|66370442|FG001|Overall Study|Personal Reasons|6|||
23724311|NCT02116361|66370443|FG002|Overall Study|Personal Reasons|4|||
23537863|NCT02443298|65702151|FG000|Overall Study|Withdrawal by Subject|1|||
23537864|NCT02443298|65702152|FG001|Overall Study|Withdrawal by Subject|2|||
23537865|NCT01312961|65702155|FG000|Overall Study|Adverse Event|3|||
23537866|NCT01312961|65702156|FG001|Overall Study|Adverse Event|3|||
23537867|NCT01312961|65702155|FG000|Overall Study|Lack of Efficacy|11|||
23537868|NCT01312961|65702156|FG001|Overall Study|Lack of Efficacy|1|||
23537869|NCT01312961|65702155|FG000|Overall Study|Poor compliance to protocol|1|||
23537870|NCT01312961|65702156|FG001|Overall Study|Poor compliance to protocol|0|||
23537871|NCT01312961|65702155|FG000|Overall Study|Other than specified above|2|||
23537872|NCT01312961|65702156|FG001|Overall Study|Other than specified above|3|||
23537873|NCT01858194|65702165|FG000|Overall Study|Total Artificial Heart Implant|0|||
23537874|NCT01858194|65702166|FG001|Overall Study|Total Artificial Heart Implant|1|||
23537875|NCT01858194|65702165|FG000|Overall Study|Lost to Follow-up|0|||
23537876|NCT01858194|65702166|FG001|Overall Study|Lost to Follow-up|1|||
23537877|NCT02660359|65702173|FG000|Overall Study|Protocol Deviation|0|||
23537878|NCT02660359|65702174|FG001|Overall Study|Protocol Deviation|0|||
23537879|NCT02660359|65702175|FG002|Overall Study|Protocol Deviation|1|||
23537880|NCT02660359|65702173|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
23537881|NCT02660359|65702174|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
23537882|NCT02660359|65702175|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
23537883|NCT02660359|65702173|FG000|Overall Study|Lack of Efficacy|1|||
23537884|NCT02660359|65702174|FG001|Overall Study|Lack of Efficacy|1|||
23537885|NCT02660359|65702175|FG002|Overall Study|Lack of Efficacy|1|||
23537886|NCT02660359|65702173|FG000|Overall Study|Adverse Event|0|||
23537887|NCT02660359|65702174|FG001|Overall Study|Adverse Event|1|||
23537888|NCT02660359|65702175|FG002|Overall Study|Adverse Event|0|||
23537889|NCT02660359|65702173|FG000|Overall Study|Other|2|||
23537890|NCT02660359|65702174|FG001|Overall Study|Other|1|||
23537891|NCT02660359|65702175|FG002|Overall Study|Other|3|||
23537892|NCT02660359|65702173|FG000|Overall Study|Withdrawal by Subject|7|||
23537893|NCT02660359|65702174|FG001|Overall Study|Withdrawal by Subject|5|||
23537894|NCT02660359|65702175|FG002|Overall Study|Withdrawal by Subject|8|||
23537895|NCT02660359|65702173|FG000|Overall Study|Lost to Follow-up|3|||
23537896|NCT02660359|65702174|FG001|Overall Study|Lost to Follow-up|3|||
23537897|NCT02660359|65702175|FG002|Overall Study|Lost to Follow-up|0|||
23537898|NCT01813019|65702176|FG000|Overall Study|Adverse Event|0|||
23537899|NCT01813019|65702177|FG001|Overall Study|Adverse Event|3|||
23537900|NCT01813019|65702176|FG000|Overall Study|Withdrawal by Subject|3|||
23537901|NCT01813019|65702177|FG001|Overall Study|Withdrawal by Subject|2|||
23537902|NCT01813019|65702176|FG000|Overall Study|administrative problems|2|||
23537903|NCT01813019|65702177|FG001|Overall Study|administrative problems|0|||
23537904|NCT01813019|65702176|FG000|Overall Study|Protocol Deviation|2|||
23537905|NCT01813019|65702177|FG001|Overall Study|Protocol Deviation|1|||
23537906|NCT02019719|65702182|FG000|Overall Study|Adverse Event|1|||
23537907|NCT02019719|65702183|FG001|Overall Study|Adverse Event|0|||
23537908|NCT02019719|65702184|FG002|Overall Study|Adverse Event|0|||
23724312|NCT02116361|66370444|FG003|Overall Study|Personal Reasons|9|||
23724313|NCT02116361|66370441|FG000|Overall Study|Investigator Decision - Relapse|9|||
23724314|NCT02116361|66370442|FG001|Overall Study|Investigator Decision - Relapse|7|||
23724315|NCT02116361|66370443|FG002|Overall Study|Investigator Decision - Relapse|8|||
23724316|NCT02116361|66370444|FG003|Overall Study|Investigator Decision - Relapse|5|||
23724317|NCT00607919|66370445|FG000|Acute Phase|Adverse Event|9|||
23537909|NCT02019719|65702185|FG003|Overall Study|Adverse Event|1|||
23537910|NCT02019719|65702186|FG004|Overall Study|Adverse Event|1|||
23537911|NCT02019719|65702182|FG000|Overall Study|Protocol Violation|1|||
23537912|NCT02019719|65702183|FG001|Overall Study|Protocol Violation|1|||
23537913|NCT02019719|65702184|FG002|Overall Study|Protocol Violation|0|||
23537914|NCT02019719|65702185|FG003|Overall Study|Protocol Violation|0|||
23537915|NCT02019719|65702186|FG004|Overall Study|Protocol Violation|0|||
23537916|NCT02019719|65702182|FG000|Overall Study|Protocol defined stopping criteria|2|||
23537917|NCT02019719|65702183|FG001|Overall Study|Protocol defined stopping criteria|0|||
23724318|NCT00607919|66370446|FG001|Acute Phase|Adverse Event|2|||
23724319|NCT00607919|66370445|FG000|Acute Phase|Entry Criteria Not Met|1|||
23724320|NCT00607919|66370446|FG001|Acute Phase|Entry Criteria Not Met|1|||
23537918|NCT02019719|65702184|FG002|Overall Study|Protocol defined stopping criteria|0|||
23537919|NCT02019719|65702185|FG003|Overall Study|Protocol defined stopping criteria|1|||
23537920|NCT02019719|65702186|FG004|Overall Study|Protocol defined stopping criteria|1|||
23537921|NCT02019719|65702182|FG000|Overall Study|Physician Decision|2|||
23537922|NCT02019719|65702183|FG001|Overall Study|Physician Decision|0|||
23537923|NCT02019719|65702184|FG002|Overall Study|Physician Decision|0|||
23537924|NCT02019719|65702185|FG003|Overall Study|Physician Decision|0|||
23537925|NCT02019719|65702186|FG004|Overall Study|Physician Decision|0|||
23537926|NCT04354831|65702191|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
23537927|NCT04354831|65702192|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
23537928|NCT00096941|65702195|FG000|Overall Study|disease progression|3|||
23537929|NCT04027686|65702196|FG000|Overall Study|Lost to Follow-up|2|||
23537930|NCT04027686|65702197|FG001|Overall Study|Lost to Follow-up|0|||
23537931|NCT04027686|65702196|FG000|Overall Study|Withdrawal by Subject|0|||
23537932|NCT04027686|65702197|FG001|Overall Study|Withdrawal by Subject|1|||
23537933|NCT03653429|65702198|FG000|Overall Study|Physician Decision|4|||
23537934|NCT03653429|65702199|FG001|Overall Study|Physician Decision|10|||
23537935|NCT00194012|65702200|FG000|Randomized Phase|Lack of Efficacy|8|||
23537936|NCT00194012|65702201|FG001|Randomized Phase|Lack of Efficacy|18|||
23537937|NCT00194012|65702200|FG000|Randomized Phase|Study nonadherence|2|||
23537938|NCT00194012|65702201|FG001|Randomized Phase|Study nonadherence|1|||
23537939|NCT00194012|65702200|FG000|Randomized Phase|Withdrawal by Subject|3|||
23537940|NCT00194012|65702201|FG001|Randomized Phase|Withdrawal by Subject|3|||
23537941|NCT00194012|65702200|FG000|Randomized Phase|Adverse Event|2|||
23537942|NCT00194012|65702201|FG001|Randomized Phase|Adverse Event|1|||
23537943|NCT00194012|65702200|FG000|Randomized Phase|Participant reported having a rash|1|||
23537944|NCT00194012|65702201|FG001|Randomized Phase|Participant reported having a rash|0|||
23537945|NCT00194012|65702200|FG000|Randomized Phase|Emesis and enuresis|0|||
23537946|NCT00194012|65702201|FG001|Randomized Phase|Emesis and enuresis|1|||
23537947|NCT00194012|65702200|FG000|Randomized Phase|Oral/nasal twitching|0|||
23537948|NCT00194012|65702201|FG001|Randomized Phase|Oral/nasal twitching|1|||
23537949|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Weight Gain|1|||
23537950|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Weight Gain|0|||
23537951|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
23537952|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
23537953|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
23537954|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
23537955|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
23537956|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
23537957|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Adverse Event|41|||
23537958|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Adverse Event|24|||
23537959|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
23537960|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
23537961|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
23537962|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
23724321|NCT00607919|66370445|FG000|Acute Phase|Lack of Efficacy|1|||
23724322|NCT00607919|66370446|FG001|Acute Phase|Lack of Efficacy|2|||
23724323|NCT00607919|66370445|FG000|Acute Phase|Lost to Follow-up|9|||
23724324|NCT00607919|66370446|FG001|Acute Phase|Lost to Follow-up|3|||
23724325|NCT00607919|66370445|FG000|Acute Phase|Parent/Caregiver Decision|6|||
23724326|NCT00607919|66370446|FG001|Acute Phase|Parent/Caregiver Decision|4|||
23537963|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Physician Decision|0|||
23537964|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Physician Decision|6|||
23537965|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
23537966|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
23537967|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
23537968|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
23537969|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
23537970|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
23537971|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
23537972|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
23537973|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
23537974|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
23537975|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
23537976|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
23537977|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
23537978|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
23537979|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
23537980|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
23537981|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
23537982|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
23537983|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
23537984|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
23537985|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
23537986|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
23537987|NCT01896895|65702204|FG000|Double-blind MP|Physician Decision|0|||
23537988|NCT01896895|65702205|FG001|Double-blind MP|Physician Decision|0|||
23537989|NCT01896895|65702206|FG002|Double-blind MP|Physician Decision|1|||
23537990|NCT01896895|65702207|FG003|Double-blind MP|Physician Decision|0|||
23537991|NCT01896895|65702204|FG000|Double-blind MP|Withdrawal by Subject|0|||
23537992|NCT01896895|65702205|FG001|Double-blind MP|Withdrawal by Subject|2|||
23537993|NCT01896895|65702206|FG002|Double-blind MP|Withdrawal by Subject|1|||
23724327|NCT00607919|66370445|FG000|Acute Phase|Protocol Violation|5|||
23423970|NCT01340937|65296321|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
23616359|NCT01838499|65982302|FG001|Overall Study|Lack of Efficacy|2|||
23724328|NCT00607919|66370446|FG001|Acute Phase|Protocol Violation|1|||
23537994|NCT01896895|65702207|FG003|Double-blind MP|Withdrawal by Subject|0|||
23537995|NCT01896895|65702204|FG000|Double-blind MP|Lost to Follow-up|1|||
23537996|NCT01896895|65702205|FG001|Double-blind MP|Lost to Follow-up|0|||
23537997|NCT01896895|65702206|FG002|Double-blind MP|Lost to Follow-up|1|||
23537998|NCT01896895|65702207|FG003|Double-blind MP|Lost to Follow-up|0|||
23537999|NCT01607905|65702208|FG000|Overall Study|Withdrawal by participant|7|||
23538000|NCT01607905|65702209|FG001|Overall Study|Withdrawal by participant|2|||
23538001|NCT01607905|65702210|FG002|Overall Study|Withdrawal by participant|4|||
23538002|NCT01607905|65702211|FG003|Overall Study|Withdrawal by participant|6|||
23538003|NCT01607905|65702212|FG004|Overall Study|Withdrawal by participant|0|||
23538004|NCT01607905|65702213|FG005|Overall Study|Withdrawal by participant|4|||
23538005|NCT01607905|65702214|FG006|Overall Study|Withdrawal by participant|12|||
23538006|NCT01607905|65702208|FG000|Overall Study|Incidence or severity of AEs|5|||
23538007|NCT01607905|65702209|FG001|Overall Study|Incidence or severity of AEs|1|||
23538008|NCT01607905|65702210|FG002|Overall Study|Incidence or severity of AEs|1|||
23538009|NCT01607905|65702211|FG003|Overall Study|Incidence or severity of AEs|3|||
23538010|NCT01607905|65702212|FG004|Overall Study|Incidence or severity of AEs|0|||
23538011|NCT01607905|65702213|FG005|Overall Study|Incidence or severity of AEs|2|||
23538012|NCT01607905|65702214|FG006|Overall Study|Incidence or severity of AEs|8|||
23724329|NCT00607919|66370445|FG000|Acute Phase|Withdrawal by Subject|3|||
23724330|NCT00607919|66370446|FG001|Acute Phase|Withdrawal by Subject|3|||
23724331|NCT00607919|66370445|FG000|Open-Label Phase|Adverse Event|1|||
23724332|NCT00607919|66370446|FG001|Open-Label Phase|Adverse Event|5|||
23724333|NCT00607919|66370445|FG000|Open-Label Phase|Lost to Follow-up|4|||
23724334|NCT00607919|66370446|FG001|Open-Label Phase|Lost to Follow-up|1|||
23724335|NCT00607919|66370445|FG000|Open-Label Phase|Protocol Violation|2|||
23724336|NCT00607919|66370446|FG001|Open-Label Phase|Protocol Violation|2|||
23724337|NCT00607919|66370445|FG000|Open-Label Phase|Withdrawal by Subject|2|||
23724338|NCT00607919|66370446|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23724339|NCT00607919|66370445|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
23724340|NCT00607919|66370446|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
23724341|NCT01112982|66370451|FG000|Overall Study|Withdrawal by Subject|1|||
23724342|NCT01112982|66370451|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
23724343|NCT00910728|66370454|FG000|Overall Study|Lack of Efficacy|2|||
23724344|NCT00910728|66370455|FG001|Overall Study|Lack of Efficacy|3|||
23724345|NCT00910728|66370456|FG002|Overall Study|Lack of Efficacy|1|||
23724346|NCT00910728|66370457|FG003|Overall Study|Lack of Efficacy|2|||
23724347|NCT00910728|66370458|FG004|Overall Study|Lack of Efficacy|1|||
23724348|NCT00910728|66370459|FG005|Overall Study|Lack of Efficacy|0|||
23724349|NCT00910728|66370460|FG006|Overall Study|Lack of Efficacy|2|||
23724350|NCT00910728|66370461|FG007|Overall Study|Lack of Efficacy|2|||
23724351|NCT00910728|66370462|FG008|Overall Study|Lack of Efficacy|2|||
23724352|NCT00910728|66370454|FG000|Overall Study|Withdrawal by Subject|0|||
23724353|NCT00910728|66370455|FG001|Overall Study|Withdrawal by Subject|0|||
23724354|NCT00910728|66370456|FG002|Overall Study|Withdrawal by Subject|0|||
23724355|NCT00910728|66370457|FG003|Overall Study|Withdrawal by Subject|0|||
23724356|NCT00910728|66370458|FG004|Overall Study|Withdrawal by Subject|3|||
23724357|NCT00910728|66370459|FG005|Overall Study|Withdrawal by Subject|1|||
23724358|NCT00910728|66370460|FG006|Overall Study|Withdrawal by Subject|2|||
23724359|NCT00910728|66370461|FG007|Overall Study|Withdrawal by Subject|0|||
23724360|NCT00910728|66370462|FG008|Overall Study|Withdrawal by Subject|0|||
23724361|NCT00910728|66370454|FG000|Overall Study|(not specified)|2|||
23724362|NCT00910728|66370455|FG001|Overall Study|(not specified)|0|||
23724363|NCT00910728|66370456|FG002|Overall Study|(not specified)|1|||
23724364|NCT00910728|66370457|FG003|Overall Study|(not specified)|0|||
23724365|NCT00910728|66370458|FG004|Overall Study|(not specified)|1|||
23724366|NCT00910728|66370459|FG005|Overall Study|(not specified)|0|||
23724367|NCT00910728|66370460|FG006|Overall Study|(not specified)|0|||
23724368|NCT00910728|66370461|FG007|Overall Study|(not specified)|0|||
23724369|NCT00910728|66370462|FG008|Overall Study|(not specified)|0|||
23815939|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Death|1|||
23423971|NCT01340937|65296322|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
23538013|NCT01607905|65702208|FG000|Overall Study|Disease progression|44|||
23538014|NCT01607905|65702209|FG001|Overall Study|Disease progression|16|||
23724370|NCT00910728|66370454|FG000|Overall Study|Adverse Event|2|||
23724371|NCT00910728|66370455|FG001|Overall Study|Adverse Event|0|||
23724372|NCT00910728|66370456|FG002|Overall Study|Adverse Event|1|||
23724373|NCT00910728|66370457|FG003|Overall Study|Adverse Event|1|||
23724374|NCT00910728|66370458|FG004|Overall Study|Adverse Event|0|||
23724375|NCT00910728|66370459|FG005|Overall Study|Adverse Event|0|||
23724376|NCT00910728|66370460|FG006|Overall Study|Adverse Event|2|||
23724377|NCT00910728|66370461|FG007|Overall Study|Adverse Event|1|||
23724378|NCT00910728|66370462|FG008|Overall Study|Adverse Event|1|||
23724379|NCT02455388|66370463|FG000|Overall Study|Protocol Violation|1|||
23724380|NCT02455388|66370464|FG001|Overall Study|Protocol Violation|0|||
23724381|NCT02455388|66370465|FG002|Overall Study|Protocol Violation|4|||
23724382|NCT02455388|66370463|FG000|Overall Study|Withdrawal by Subject|0|||
23724383|NCT02455388|66370464|FG001|Overall Study|Withdrawal by Subject|0|||
23724384|NCT02455388|66370465|FG002|Overall Study|Withdrawal by Subject|7|||
23724385|NCT02443805|66370466|FG000|Overall Study|Adverse Event|100|||
23724386|NCT02443805|66370467|FG001|Overall Study|Adverse Event|18|||
23724387|NCT02443805|66370466|FG000|Overall Study|Withdrawal by Subject|73|||
23724388|NCT02443805|66370467|FG001|Overall Study|Withdrawal by Subject|74|||
23724389|NCT02443805|66370466|FG000|Overall Study|Lost to Follow-up|19|||
23724390|NCT02443805|66370467|FG001|Overall Study|Lost to Follow-up|14|||
23724391|NCT02443805|66370466|FG000|Overall Study|Pregnancy|6|||
23724392|NCT02443805|66370467|FG001|Overall Study|Pregnancy|5|||
23724393|NCT02443805|66370466|FG000|Overall Study|Protocol Violation|2|||
23724394|NCT02443805|66370467|FG001|Overall Study|Protocol Violation|4|||
23724395|NCT02443805|66370466|FG000|Overall Study|Lack of Efficacy|1|||
23724396|NCT02443805|66370467|FG001|Overall Study|Lack of Efficacy|1|||
23724397|NCT02443805|66370466|FG000|Overall Study|Non-compliance with study drug|6|||
23724398|NCT02443805|66370467|FG001|Overall Study|Non-compliance with study drug|4|||
23724399|NCT02443805|66370466|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23724400|NCT02443805|66370467|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23724401|NCT02443805|66370466|FG000|Overall Study|Any other reason not above-mentioned|3|||
23724402|NCT02443805|66370467|FG001|Overall Study|Any other reason not above-mentioned|2|||
23724403|NCT01448707|66370470|FG000|Overall Study|Adverse Event|3|||
23724404|NCT01448707|66370471|FG001|Overall Study|Adverse Event|1|||
23724405|NCT01448707|66370470|FG000|Overall Study|Lost to Follow-up|2|||
23724406|NCT01448707|66370471|FG001|Overall Study|Lost to Follow-up|6|||
23724407|NCT01448707|66370470|FG000|Overall Study|Withdrawal by Subject|6|||
23724408|NCT01448707|66370471|FG001|Overall Study|Withdrawal by Subject|7|||
23724409|NCT01448707|66370470|FG000|Overall Study|Other|7|||
23724410|NCT01448707|66370471|FG001|Overall Study|Other|4|||
23724411|NCT01156532|66370472|FG000|Overall Study|Family Reasons|1|||
23724412|NCT01156532|66370472|FG000|Overall Study|Lost to Follow-up|1|||
23724413|NCT00044213|66370473|FG000|Overall Study|Withdrawal by Subject|50|||
23724414|NCT00044213|66370474|FG001|Overall Study|Withdrawal by Subject|65|||
23724415|NCT00044213|66370475|FG002|Overall Study|Withdrawal by Subject|91|||
23724416|NCT00044213|66370476|FG003|Overall Study|Withdrawal by Subject|83|||
23815940|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Death|7|||
23616360|NCT01838499|65982301|FG000|Overall Study|Adverse Event|2|||
23724417|NCT00044213|66370473|FG000|Overall Study|Death|42|||
23724418|NCT00044213|66370474|FG001|Overall Study|Death|42|||
23724419|NCT00044213|66370475|FG002|Overall Study|Death|42|||
23724420|NCT00044213|66370476|FG003|Overall Study|Death|49|||
23724421|NCT00044213|66370473|FG000|Overall Study|Lost to Follow-up|8|||
23724422|NCT00044213|66370474|FG001|Overall Study|Lost to Follow-up|5|||
23423972|NCT01340937|65296323|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
23423973|NCT01340937|65296320|FG000|Period 1: Infant Series|Adverse Event|0|||
23423974|NCT01340937|65296321|FG001|Period 1: Infant Series|Adverse Event|1|||
23423975|NCT01340937|65296322|FG002|Period 1: Infant Series|Adverse Event|4|||
23423976|NCT01340937|65296323|FG003|Period 1: Infant Series|Adverse Event|0|||
23423977|NCT01340937|65296320|FG000|Period 1: Infant Series|Death|2|||
23423978|NCT01340937|65296321|FG001|Period 1: Infant Series|Death|0|||
23423979|NCT01340937|65296322|FG002|Period 1: Infant Series|Death|2|||
23423980|NCT01340937|65296323|FG003|Period 1: Infant Series|Death|0|||
23423981|NCT01340937|65296320|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
23423982|NCT01340937|65296321|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
23423983|NCT01340937|65296322|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
23423984|NCT01340937|65296323|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
23423985|NCT01340937|65296320|FG000|Period 1: Infant Series|Physician Decision|2|||
23423986|NCT01340937|65296321|FG001|Period 1: Infant Series|Physician Decision|3|||
23423987|NCT01340937|65296322|FG002|Period 1: Infant Series|Physician Decision|1|||
23423988|NCT01340937|65296323|FG003|Period 1: Infant Series|Physician Decision|0|||
23423989|NCT01340937|65296320|FG000|Period 1: Infant Series|Protocol Violation|1|||
23423990|NCT01340937|65296321|FG001|Period 1: Infant Series|Protocol Violation|4|||
23423991|NCT01340937|65296322|FG002|Period 1: Infant Series|Protocol Violation|4|||
23423992|NCT01340937|65296323|FG003|Period 1: Infant Series|Protocol Violation|3|||
23423993|NCT01340937|65296320|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
23423994|NCT01340937|65296321|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
23423995|NCT01340937|65296322|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
23423996|NCT01340937|65296323|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
23538015|NCT01607905|65702210|FG002|Overall Study|Disease progression|15|||
23538016|NCT01607905|65702211|FG003|Overall Study|Disease progression|11|||
23538017|NCT01607905|65702212|FG004|Overall Study|Disease progression|6|||
23538018|NCT01607905|65702213|FG005|Overall Study|Disease progression|7|||
23538019|NCT01607905|65702214|FG006|Overall Study|Disease progression|21|||
23538020|NCT01607905|65702208|FG000|Overall Study|Non-compliance with study procedures|0|||
23616361|NCT01838499|65982302|FG001|Overall Study|Adverse Event|1|||
23616362|NCT01838499|65982301|FG000|Overall Study|Withdrawal by Subject|19|||
23538021|NCT01607905|65702209|FG001|Overall Study|Non-compliance with study procedures|0|||
23616363|NCT01838499|65982302|FG001|Overall Study|Withdrawal by Subject|9|||
23616364|NCT05740371|65982303|FG000|Overall Study|Death|1|||
23616365|NCT00774306|65982304|FG000|Overall Study|Adverse Event|3|||
23616366|NCT00774306|65982305|FG001|Overall Study|Adverse Event|0|||
23616367|NCT00774306|65982306|FG002|Overall Study|Adverse Event|0|||
23616368|NCT00774306|65982307|FG003|Overall Study|Adverse Event|0|||
23616369|NCT00774306|65982304|FG000|Overall Study|Protocol Violation|2|||
23616370|NCT00774306|65982305|FG001|Overall Study|Protocol Violation|0|||
23616371|NCT00774306|65982306|FG002|Overall Study|Protocol Violation|3|||
23616372|NCT00774306|65982307|FG003|Overall Study|Protocol Violation|0|||
23724423|NCT00044213|66370475|FG002|Overall Study|Lost to Follow-up|5|||
23423997|NCT01340937|65296320|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
23538022|NCT01607905|65702210|FG002|Overall Study|Non-compliance with study procedures|0|||
23538023|NCT01607905|65702211|FG003|Overall Study|Non-compliance with study procedures|0|||
23538024|NCT01607905|65702212|FG004|Overall Study|Non-compliance with study procedures|0|||
23538025|NCT01607905|65702213|FG005|Overall Study|Non-compliance with study procedures|0|||
23538026|NCT01607905|65702214|FG006|Overall Study|Non-compliance with study procedures|1|||
23538027|NCT01607905|65702208|FG000|Overall Study|Death|1|||
23538028|NCT01607905|65702209|FG001|Overall Study|Death|1|||
23538029|NCT01607905|65702210|FG002|Overall Study|Death|1|||
23538030|NCT01607905|65702211|FG003|Overall Study|Death|1|||
23538031|NCT01607905|65702212|FG004|Overall Study|Death|0|||
23538032|NCT01607905|65702213|FG005|Overall Study|Death|0|||
23538033|NCT01607905|65702214|FG006|Overall Study|Death|3|||
23538034|NCT01607905|65702208|FG000|Overall Study|Other treatments become available|1|||
23538035|NCT01607905|65702209|FG001|Overall Study|Other treatments become available|0|||
23538036|NCT01607905|65702210|FG002|Overall Study|Other treatments become available|0|||
23538037|NCT01607905|65702211|FG003|Overall Study|Other treatments become available|0|||
23616373|NCT00774306|65982304|FG000|Overall Study|Withdrawal by Subject|6|||
23616374|NCT00774306|65982305|FG001|Overall Study|Withdrawal by Subject|1|||
23616375|NCT00774306|65982306|FG002|Overall Study|Withdrawal by Subject|1|||
23423998|NCT01340937|65296321|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
23423999|NCT01340937|65296322|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
23538038|NCT01607905|65702212|FG004|Overall Study|Other treatments become available|0|||
23538039|NCT01607905|65702213|FG005|Overall Study|Other treatments become available|0|||
23538040|NCT01607905|65702214|FG006|Overall Study|Other treatments become available|1|||
23616376|NCT00774306|65982307|FG003|Overall Study|Withdrawal by Subject|0|||
23538041|NCT01607905|65702208|FG000|Overall Study|Investigator discretion|0|||
23424000|NCT01340937|65296323|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
23424001|NCT01340937|65296320|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
23538042|NCT01607905|65702209|FG001|Overall Study|Investigator discretion|0|||
23538043|NCT01607905|65702210|FG002|Overall Study|Investigator discretion|0|||
23538044|NCT01607905|65702211|FG003|Overall Study|Investigator discretion|0|||
23538045|NCT01607905|65702212|FG004|Overall Study|Investigator discretion|0|||
23538046|NCT01607905|65702213|FG005|Overall Study|Investigator discretion|1|||
23538047|NCT01607905|65702214|FG006|Overall Study|Investigator discretion|0|||
23538048|NCT01607905|65702208|FG000|Overall Study|Other|1|||
23538049|NCT01607905|65702209|FG001|Overall Study|Other|0|||
23538050|NCT01607905|65702210|FG002|Overall Study|Other|0|||
23538051|NCT01607905|65702211|FG003|Overall Study|Other|0|||
23538052|NCT01607905|65702212|FG004|Overall Study|Other|0|||
23538053|NCT01607905|65702213|FG005|Overall Study|Other|0|||
23538054|NCT01607905|65702214|FG006|Overall Study|Other|1|||
23538055|NCT01607905|65702208|FG000|Overall Study|Randomized but not treated|1|||
23538056|NCT01607905|65702209|FG001|Overall Study|Randomized but not treated|0|||
23538057|NCT01607905|65702210|FG002|Overall Study|Randomized but not treated|0|||
23538058|NCT01607905|65702211|FG003|Overall Study|Randomized but not treated|0|||
23538059|NCT01607905|65702212|FG004|Overall Study|Randomized but not treated|1|||
23538060|NCT01607905|65702213|FG005|Overall Study|Randomized but not treated|1|||
23538061|NCT01607905|65702214|FG006|Overall Study|Randomized but not treated|0|||
23538062|NCT01003249|65702222|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538063|NCT01003249|65702223|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538064|NCT01003249|65702222|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
23538065|NCT01003249|65702223|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
23538066|NCT01003249|65702222|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23538067|NCT01003249|65702223|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538068|NCT01003249|65702222|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
23538069|NCT01003249|65702223|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
23538070|NCT03238001|65702234|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
23538071|NCT03238001|65702234|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
23538072|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
23538073|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
23538074|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
23538075|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
23538076|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
23538077|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
23538078|NCT01694706|65702237|FG000|Overall Study|Adverse Event|0|||
23538079|NCT01694706|65702238|FG001|Overall Study|Adverse Event|1|||
23538080|NCT01694706|65702239|FG002|Overall Study|Adverse Event|0|||
23538081|NCT01694706|65702237|FG000|Overall Study|other reason not defined above|1|||
23538082|NCT01694706|65702238|FG001|Overall Study|other reason not defined above|0|||
23538083|NCT01694706|65702239|FG002|Overall Study|other reason not defined above|0|||
23538084|NCT01458171|65702240|FG000|Overall Study|Adverse Event|1|||
23538085|NCT00766415|65702243|FG000|Overall Study|Withdrawal by Subject|0|||
23538086|NCT00766415|65702244|FG001|Overall Study|Withdrawal by Subject|1|||
23538087|NCT02805257|65702245|FG000|Overall Study|Lost to Follow-up|7|||
23538088|NCT02805257|65702246|FG001|Overall Study|Lost to Follow-up|6|||
23538089|NCT02805257|65702245|FG000|Overall Study|Death|0|||
23538090|NCT02805257|65702246|FG001|Overall Study|Death|1|||
23538091|NCT01465334|65702247|FG000|Overall Study|Disease Progression|1|||
23538092|NCT01465334|65702248|FG001|Overall Study|Disease Progression|0|||
23538093|NCT01465334|65702247|FG000|Overall Study|Adverse Event|1|||
23538094|NCT01465334|65702248|FG001|Overall Study|Adverse Event|0|||
23538095|NCT01465334|65702247|FG000|Overall Study|Richter's transformation|0|||
23538096|NCT01465334|65702248|FG001|Overall Study|Richter's transformation|3|||
23538097|NCT01465334|65702247|FG000|Overall Study|Refractory Disease|0|||
23538098|NCT01465334|65702248|FG001|Overall Study|Refractory Disease|3|||
23538099|NCT03766646|65702256|FG000|Overall Study|Withdrawal by Subject|1|||
23538100|NCT03766646|65702257|FG001|Overall Study|Withdrawal by Subject|0|||
23538101|NCT03766646|65702256|FG000|Overall Study|Protocol Violation|0|||
23538102|NCT03766646|65702257|FG001|Overall Study|Protocol Violation|3|||
23538103|NCT04788147|65702258|FG000|Overall Study|Screen Failure|3|||
23538104|NCT04788147|65702259|FG001|Overall Study|Screen Failure|10|||
23538105|NCT04788147|65702258|FG000|Overall Study|Incomplete RMRS image session|2|||
23538106|NCT04788147|65702259|FG001|Overall Study|Incomplete RMRS image session|0|||
23538107|NCT01677195|65702260|FG000|Overall Study|Lost to Follow-up|14|||
23538108|NCT01677195|65702261|FG001|Overall Study|Lost to Follow-up|22|||
23538109|NCT01677195|65702262|FG002|Overall Study|Lost to Follow-up|22|||
23538110|NCT01677195|65702260|FG000|Overall Study|Withdrawal by Subject|1|||
23538111|NCT01677195|65702261|FG001|Overall Study|Withdrawal by Subject|0|||
23538112|NCT01677195|65702262|FG002|Overall Study|Withdrawal by Subject|1|||
23538113|NCT01677195|65702260|FG000|Overall Study|Adverse Event|6|||
23538114|NCT01677195|65702261|FG001|Overall Study|Adverse Event|4|||
23538115|NCT01677195|65702262|FG002|Overall Study|Adverse Event|1|||
23538116|NCT01677195|65702260|FG000|Overall Study|Physician Decision|1|||
23538117|NCT01677195|65702261|FG001|Overall Study|Physician Decision|2|||
23724424|NCT00044213|66370476|FG003|Overall Study|Lost to Follow-up|4|||
23538118|NCT01677195|65702262|FG002|Overall Study|Physician Decision|2|||
23724425|NCT04731922|66370490|FG000|Overall Study|Adverse Event|0|||
23724426|NCT04731922|66370491|FG001|Overall Study|Adverse Event|0|||
23724427|NCT04731922|66370492|FG002|Overall Study|Adverse Event|0|||
23724428|NCT04731922|66370493|FG003|Overall Study|Adverse Event|0|||
23724429|NCT04731922|66370494|FG004|Overall Study|Adverse Event|0|||
23724430|NCT04731922|66370495|FG005|Overall Study|Adverse Event|0|||
23724431|NCT04731922|66370496|FG006|Overall Study|Adverse Event|0|||
23724432|NCT04731922|66370497|FG007|Overall Study|Adverse Event|0|||
23724433|NCT04731922|66370498|FG008|Overall Study|Adverse Event|0|||
23724434|NCT04731922|66370499|FG009|Overall Study|Adverse Event|0|||
23724435|NCT04731922|66370500|FG010|Overall Study|Adverse Event|1|||
23724436|NCT04731922|66370501|FG011|Overall Study|Adverse Event|0|||
23724437|NCT04731922|66370502|FG012|Overall Study|Adverse Event|0|||
23724438|NCT04731922|66370503|FG013|Overall Study|Adverse Event|0|||
23724439|NCT04731922|66370504|FG014|Overall Study|Adverse Event|0|||
23815941|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Death|5|||
23815942|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Death|5|||
23815943|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Death|3|||
23815944|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Death|7|||
23815945|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Death|5|||
23815946|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Death|6|||
23815947|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Death|3|||
23815948|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Death|0|||
23815949|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815950|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23424002|NCT01340937|65296321|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
23424003|NCT01340937|65296322|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
23424004|NCT01340937|65296323|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
23424005|NCT01340937|65296320|FG000|Period 2: Interim Period|Adverse Event|1|||
23424006|NCT01340937|65296321|FG001|Period 2: Interim Period|Adverse Event|0|||
23424007|NCT01340937|65296322|FG002|Period 2: Interim Period|Adverse Event|1|||
23424008|NCT01340937|65296323|FG003|Period 2: Interim Period|Adverse Event|0|||
23538119|NCT01677195|65702260|FG000|Overall Study|Pregnancy|0|||
23616377|NCT00774306|65982304|FG000|Overall Study|Lost to Follow-up|6|||
23616378|NCT00774306|65982305|FG001|Overall Study|Lost to Follow-up|0|||
23616379|NCT00774306|65982306|FG002|Overall Study|Lost to Follow-up|4|||
23724440|NCT04731922|66370505|FG015|Overall Study|Adverse Event|0|||
23424009|NCT01340937|65296320|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
23424010|NCT01340937|65296321|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
23424011|NCT01340937|65296322|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
23424012|NCT01340937|65296323|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
23424013|NCT01340937|65296320|FG000|Period 2: Interim Period|Physician Decision|0|||
23424014|NCT01340937|65296321|FG001|Period 2: Interim Period|Physician Decision|1|||
23424015|NCT01340937|65296322|FG002|Period 2: Interim Period|Physician Decision|1|||
23424016|NCT01340937|65296323|FG003|Period 2: Interim Period|Physician Decision|0|||
23424017|NCT01340937|65296320|FG000|Period 2: Interim Period|Protocol Violation|5|||
23424018|NCT01340937|65296321|FG001|Period 2: Interim Period|Protocol Violation|3|||
23538120|NCT01677195|65702261|FG001|Overall Study|Pregnancy|1|||
23538121|NCT01677195|65702262|FG002|Overall Study|Pregnancy|0|||
23538122|NCT01677195|65702260|FG000|Overall Study|Protocol Violation|7|||
23538123|NCT01677195|65702261|FG001|Overall Study|Protocol Violation|3|||
23538124|NCT01677195|65702262|FG002|Overall Study|Protocol Violation|4|||
23538125|NCT03823651|65702263|FG000|Overall Study|Death|5|||
23538126|NCT03823651|65702264|FG001|Overall Study|Death|0|||
23538127|NCT03823651|65702263|FG000|Overall Study|Physician Decision|1|||
23616380|NCT00774306|65982307|FG003|Overall Study|Lost to Follow-up|5|||
23616381|NCT00774306|65982304|FG000|Overall Study|Death|1|||
23815951|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815952|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23538128|NCT03823651|65702264|FG001|Overall Study|Physician Decision|0|||
23538129|NCT03823651|65702263|FG000|Overall Study|Caregiver to patient who died|0|||
23538130|NCT03823651|65702264|FG001|Overall Study|Caregiver to patient who died|5|||
23538131|NCT03823651|65702263|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
23815953|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815954|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23724441|NCT04731922|66370506|FG016|Overall Study|Adverse Event|0|||
23815955|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815956|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815957|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23724442|NCT04731922|66370490|FG000|Overall Study|Lost to Follow-up|0|||
23724443|NCT04731922|66370491|FG001|Overall Study|Lost to Follow-up|0|||
23724444|NCT04731922|66370492|FG002|Overall Study|Lost to Follow-up|0|||
23724445|NCT04731922|66370493|FG003|Overall Study|Lost to Follow-up|1|||
23424019|NCT01340937|65296322|FG002|Period 2: Interim Period|Protocol Violation|6|||
23424020|NCT01340937|65296323|FG003|Period 2: Interim Period|Protocol Violation|3|||
23424021|NCT01340937|65296320|FG000|Period 2: Interim Period|Technical problems|4|||
23424022|NCT01340937|65296321|FG001|Period 2: Interim Period|Technical problems|4|||
23424023|NCT01340937|65296322|FG002|Period 2: Interim Period|Technical problems|6|||
23424024|NCT01340937|65296323|FG003|Period 2: Interim Period|Technical problems|3|||
23538132|NCT03823651|65702264|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
23538133|NCT02664038|65702269|FG000|13 Week|Lost to Follow-up|7|||
23538134|NCT02664038|65702270|FG001|13 Week|Lost to Follow-up|14|||
23538135|NCT02664038|65702269|FG000|13 Week|Withdrawal by Subject|1|||
23538136|NCT02664038|65702270|FG001|13 Week|Withdrawal by Subject|0|||
23538137|NCT02664038|65702269|FG000|26 Week|Lost to Follow-up|5|||
23724446|NCT04731922|66370494|FG004|Overall Study|Lost to Follow-up|0|||
23724447|NCT04731922|66370495|FG005|Overall Study|Lost to Follow-up|1|||
23724448|NCT04731922|66370496|FG006|Overall Study|Lost to Follow-up|0|||
23724449|NCT04731922|66370497|FG007|Overall Study|Lost to Follow-up|0|||
23724450|NCT04731922|66370498|FG008|Overall Study|Lost to Follow-up|0|||
23724451|NCT04731922|66370499|FG009|Overall Study|Lost to Follow-up|0|||
23724452|NCT04731922|66370500|FG010|Overall Study|Lost to Follow-up|0|||
23724453|NCT04731922|66370501|FG011|Overall Study|Lost to Follow-up|0|||
23724454|NCT04731922|66370502|FG012|Overall Study|Lost to Follow-up|0|||
23724455|NCT04731922|66370503|FG013|Overall Study|Lost to Follow-up|0|||
23724456|NCT04731922|66370504|FG014|Overall Study|Lost to Follow-up|0|||
23724457|NCT04731922|66370505|FG015|Overall Study|Lost to Follow-up|0|||
23724458|NCT04731922|66370506|FG016|Overall Study|Lost to Follow-up|0|||
23724459|NCT04731922|66370490|FG000|Overall Study|Withdrawal by Subject|1|||
23724460|NCT04731922|66370491|FG001|Overall Study|Withdrawal by Subject|0|||
23724461|NCT04731922|66370492|FG002|Overall Study|Withdrawal by Subject|0|||
23724462|NCT04731922|66370493|FG003|Overall Study|Withdrawal by Subject|0|||
23724463|NCT04731922|66370494|FG004|Overall Study|Withdrawal by Subject|1|||
23724464|NCT04731922|66370495|FG005|Overall Study|Withdrawal by Subject|0|||
23724465|NCT04731922|66370496|FG006|Overall Study|Withdrawal by Subject|1|||
23724466|NCT04731922|66370497|FG007|Overall Study|Withdrawal by Subject|0|||
23724467|NCT04731922|66370498|FG008|Overall Study|Withdrawal by Subject|0|||
23724468|NCT04731922|66370499|FG009|Overall Study|Withdrawal by Subject|0|||
23724469|NCT04731922|66370500|FG010|Overall Study|Withdrawal by Subject|0|||
23724470|NCT04731922|66370501|FG011|Overall Study|Withdrawal by Subject|0|||
23724471|NCT04731922|66370502|FG012|Overall Study|Withdrawal by Subject|0|||
23724472|NCT04731922|66370503|FG013|Overall Study|Withdrawal by Subject|1|||
23724473|NCT04731922|66370504|FG014|Overall Study|Withdrawal by Subject|0|||
23724474|NCT04731922|66370505|FG015|Overall Study|Withdrawal by Subject|0|||
23724475|NCT04731922|66370506|FG016|Overall Study|Withdrawal by Subject|0|||
23724476|NCT04731922|66370490|FG000|Overall Study|Other|0|||
23724477|NCT04731922|66370491|FG001|Overall Study|Other|0|||
23724478|NCT04731922|66370492|FG002|Overall Study|Other|0|||
23724479|NCT04731922|66370493|FG003|Overall Study|Other|0|||
23724480|NCT04731922|66370494|FG004|Overall Study|Other|0|||
23724481|NCT04731922|66370495|FG005|Overall Study|Other|0|||
23724482|NCT04731922|66370496|FG006|Overall Study|Other|1|||
23724483|NCT04731922|66370497|FG007|Overall Study|Other|0|||
23724484|NCT04731922|66370498|FG008|Overall Study|Other|0|||
23724485|NCT04731922|66370499|FG009|Overall Study|Other|0|||
23724486|NCT04731922|66370500|FG010|Overall Study|Other|0|||
23724487|NCT04731922|66370501|FG011|Overall Study|Other|0|||
23724488|NCT04731922|66370502|FG012|Overall Study|Other|0|||
23724489|NCT04731922|66370503|FG013|Overall Study|Other|0|||
23724490|NCT04731922|66370504|FG014|Overall Study|Other|0|||
23724491|NCT04731922|66370505|FG015|Overall Study|Other|0|||
23724492|NCT04731922|66370506|FG016|Overall Study|Other|0|||
23724493|NCT04498468|66370507|FG000|Overall Study|Lost to Follow-up|3|||
23724494|NCT01041404|66370510|FG000|Overall Study|Adverse Event|45|||
23724495|NCT01041404|66370511|FG001|Overall Study|Adverse Event|35|||
23724496|NCT01041404|66370510|FG000|Overall Study|Lack of Efficacy|200|||
23724497|NCT01041404|66370511|FG001|Overall Study|Lack of Efficacy|210|||
23724498|NCT01041404|66370510|FG000|Overall Study|Violation of Selection Criteria|0|||
23724499|NCT01041404|66370511|FG001|Overall Study|Violation of Selection Criteria|1|||
23724500|NCT01041404|66370510|FG000|Overall Study|Protocol Violation|4|||
23724501|NCT01041404|66370511|FG001|Overall Study|Protocol Violation|0|||
23724502|NCT01041404|66370510|FG000|Overall Study|Withdrawal by Subject|29|||
23724503|NCT01041404|66370511|FG001|Overall Study|Withdrawal by Subject|23|||
23724504|NCT01041404|66370510|FG000|Overall Study|Failure to Return|1|||
23724505|NCT01041404|66370511|FG001|Overall Study|Failure to Return|2|||
23724506|NCT01041404|66370510|FG000|Overall Study|Other|11|||
23724507|NCT01041404|66370511|FG001|Overall Study|Other|23|||
23724508|NCT00291187|66370512|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
23724509|NCT00291187|66370513|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
23724510|NCT00291187|66370514|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
23724511|NCT00291187|66370515|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
23724512|NCT02023268|66370518|FG000|Overall Study|Lack of Efficacy|0|||
23538138|NCT02664038|65702270|FG001|26 Week|Lost to Follow-up|4|||
23538139|NCT05077267|65702271|FG000|Treatment Period|Lost to Follow-up|0|||
23538140|NCT05077267|65702272|FG001|Treatment Period|Lost to Follow-up|1|||
23538141|NCT05077267|65702273|FG002|Treatment Period|Lost to Follow-up|0|||
23538142|NCT05077267|65702271|FG000|Treatment Period|Withdrawal by Subject|0|||
23538143|NCT05077267|65702272|FG001|Treatment Period|Withdrawal by Subject|1|||
23538144|NCT05077267|65702273|FG002|Treatment Period|Withdrawal by Subject|0|||
23815958|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815959|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815960|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815961|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815962|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815963|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815964|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815965|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815966|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815967|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815968|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23815969|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815970|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815971|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815972|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
23724513|NCT02023268|66370519|FG001|Overall Study|Lack of Efficacy|1|||
23724514|NCT02023268|66370518|FG000|Overall Study|Adverse Event|0|||
23724515|NCT02023268|66370519|FG001|Overall Study|Adverse Event|2|||
23724516|NCT02023268|66370518|FG000|Overall Study|Withdrawal by Subject|0|||
23724517|NCT02023268|66370519|FG001|Overall Study|Withdrawal by Subject|1|||
23724518|NCT00524043|66370521|FG000|Overall Study|Lack of Efficacy|15|||
23724519|NCT00524043|66370522|FG001|Overall Study|Lack of Efficacy|13|||
23724520|NCT00524043|66370523|FG002|Overall Study|Lack of Efficacy|14|||
23724521|NCT00524043|66370521|FG000|Overall Study|Withdrawal by Subject|5|||
23724522|NCT00524043|66370522|FG001|Overall Study|Withdrawal by Subject|7|||
23724523|NCT00524043|66370523|FG002|Overall Study|Withdrawal by Subject|7|||
23724524|NCT00524043|66370521|FG000|Overall Study|Adverse Event|5|||
23815973|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23815974|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Disease Progression|0|||
23815975|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Disease Progression|0|||
23815976|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Disease Progression|0|||
23815977|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Disease Progression|0|||
23815978|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Disease Progression|0|||
23815979|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Disease Progression|0|||
23815980|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Disease Progression|0|||
23815981|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Disease Progression|0|||
23815982|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Disease Progression|0|||
23815983|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Disease Progression|0|||
23815984|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Disease Progression|0|||
23815985|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Disease Progression|0|||
23815986|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Disease Progression|0|||
23815987|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Disease Progression|0|||
23815988|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Disease Progression|0|||
23815989|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Disease Progression|0|||
23815990|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Disease Progression|0|||
23815991|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Disease Progression|0|||
23815992|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Disease Progression|0|||
23815993|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Disease Progression|0|||
23815994|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Disease Progression|2|||
23724525|NCT00524043|66370522|FG001|Overall Study|Adverse Event|2|||
23724526|NCT00524043|66370523|FG002|Overall Study|Adverse Event|7|||
23724527|NCT00524043|66370521|FG000|Overall Study|Lost to Follow-up|3|||
23724528|NCT00524043|66370522|FG001|Overall Study|Lost to Follow-up|5|||
23815995|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Disease Progression|1|||
23815996|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Disease Progression|0|||
23815997|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Disease Progression|0|||
23538145|NCT05077267|65702271|FG000|Follow-up Period|Lost to Follow-up|0|||
23538146|NCT05077267|65702272|FG001|Follow-up Period|Lost to Follow-up|5|||
23538147|NCT05077267|65702273|FG002|Follow-up Period|Lost to Follow-up|7|||
23724529|NCT00524043|66370523|FG002|Overall Study|Lost to Follow-up|3|||
23724530|NCT00524043|66370521|FG000|Overall Study|Various (eg, incarceration)|2|||
23724531|NCT00524043|66370522|FG001|Overall Study|Various (eg, incarceration)|1|||
23724532|NCT00524043|66370523|FG002|Overall Study|Various (eg, incarceration)|0|||
23724533|NCT00425945|66370524|FG000|Overall Study|Concern about Supplement|2|||
23724534|NCT00425945|66370525|FG001|Overall Study|Concern about Supplement|0|||
23724535|NCT00425945|66370524|FG000|Overall Study|Inconvenience|0|||
23724536|NCT00425945|66370525|FG001|Overall Study|Inconvenience|2|||
23724537|NCT00425945|66370524|FG000|Overall Study|Lost to Follow-up|0|||
23724538|NCT00425945|66370525|FG001|Overall Study|Lost to Follow-up|2|||
23724539|NCT00425945|66370524|FG000|Overall Study|Began hypertension medication|1|||
23724540|NCT00425945|66370525|FG001|Overall Study|Began hypertension medication|0|||
23724541|NCT00425945|66370524|FG000|Overall Study|Began cancer treatments|1|||
23724542|NCT00425945|66370525|FG001|Overall Study|Began cancer treatments|0|||
23724543|NCT00425945|66370524|FG000|Overall Study|Moved from area|0|||
23724544|NCT00425945|66370525|FG001|Overall Study|Moved from area|1|||
23724545|NCT02583711|66370526|FG000|Overall Study|Withdrawal by Subject|0|||
23724546|NCT02583711|66370527|FG001|Overall Study|Withdrawal by Subject|10|||
23724547|NCT02583711|66370528|FG002|Overall Study|Withdrawal by Subject|0|||
23724548|NCT04268303|66370529|FG000|Overall Study|Lost to Follow-up|1|||
23724549|NCT04268303|66370530|FG001|Overall Study|Lost to Follow-up|1|||
23724550|NCT04268303|66370531|FG002|Overall Study|Lost to Follow-up|2|||
23724551|NCT04268303|66370529|FG000|Overall Study|Withdrawal by Subject|0|||
23724552|NCT04268303|66370530|FG001|Overall Study|Withdrawal by Subject|1|||
23724553|NCT04268303|66370531|FG002|Overall Study|Withdrawal by Subject|1|||
23724554|NCT04268303|66370529|FG000|Overall Study|Adverse Event|2|||
23724555|NCT04268303|66370530|FG001|Overall Study|Adverse Event|0|||
23724556|NCT04268303|66370531|FG002|Overall Study|Adverse Event|0|||
23724557|NCT00606294|66370532|FG000|Overall Study|Withdrawal by Subject|36|||
23724558|NCT00606294|66370533|FG001|Overall Study|Withdrawal by Subject|0|||
23815998|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Disease Progression|0|||
23815999|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816000|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816001|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816002|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816003|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816004|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816005|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816006|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816007|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816008|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816009|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816010|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816011|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816012|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816013|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816014|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816015|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816016|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816017|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816018|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816019|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
23424025|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
23538148|NCT05077267|65702271|FG000|Follow-up Period|Withdrawal by Subject|0|||
23538149|NCT05077267|65702272|FG001|Follow-up Period|Withdrawal by Subject|2|||
23724567|NCT00355134|66370538|FG000|Core Phase|Withdrawal by Subject|35|||
23724568|NCT00355134|66370539|FG001|Core Phase|Withdrawal by Subject|24|||
23724569|NCT00355134|66370540|FG002|Core Phase|Withdrawal by Subject|35|||
23724570|NCT00355134|66370541|FG003|Core Phase|Withdrawal by Subject|0|||
23724571|NCT00355134|66370542|FG004|Core Phase|Withdrawal by Subject|0|||
23724572|NCT00355134|66370538|FG000|Core Phase|Adverse Event|28|||
23724573|NCT00355134|66370539|FG001|Core Phase|Adverse Event|22|||
23816020|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
23724574|NCT00355134|66370540|FG002|Core Phase|Adverse Event|16|||
23424026|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
23538150|NCT05077267|65702273|FG002|Follow-up Period|Withdrawal by Subject|5|||
23816021|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
23724575|NCT00355134|66370541|FG003|Core Phase|Adverse Event|0|||
23724576|NCT00355134|66370542|FG004|Core Phase|Adverse Event|0|||
23724577|NCT00355134|66370538|FG000|Core Phase|Lost to Follow-up|17|||
23724578|NCT00355134|66370539|FG001|Core Phase|Lost to Follow-up|13|||
23724579|NCT00355134|66370540|FG002|Core Phase|Lost to Follow-up|21|||
23724580|NCT00355134|66370541|FG003|Core Phase|Lost to Follow-up|0|||
23724581|NCT00355134|66370542|FG004|Core Phase|Lost to Follow-up|0|||
23724582|NCT00355134|66370538|FG000|Core Phase|Abnormal laboratory value(s)|19|||
23724583|NCT00355134|66370539|FG001|Core Phase|Abnormal laboratory value(s)|14|||
23724584|NCT00355134|66370540|FG002|Core Phase|Abnormal laboratory value(s)|2|||
23724585|NCT00355134|66370541|FG003|Core Phase|Abnormal laboratory value(s)|0|||
23724586|NCT00355134|66370542|FG004|Core Phase|Abnormal laboratory value(s)|0|||
23724587|NCT00355134|66370538|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
23724588|NCT00355134|66370539|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
23724589|NCT00355134|66370540|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
23724590|NCT00355134|66370541|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
23724591|NCT00355134|66370542|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
23724592|NCT00355134|66370538|FG000|Core Phase|Administrative problems|5|||
23724593|NCT00355134|66370539|FG001|Core Phase|Administrative problems|3|||
23724594|NCT00355134|66370540|FG002|Core Phase|Administrative problems|5|||
23724595|NCT00355134|66370541|FG003|Core Phase|Administrative problems|0|||
23724596|NCT00355134|66370542|FG004|Core Phase|Administrative problems|0|||
23724597|NCT00355134|66370538|FG000|Core Phase|Protocol Violation|3|||
23724598|NCT00355134|66370539|FG001|Core Phase|Protocol Violation|2|||
23724599|NCT00355134|66370540|FG002|Core Phase|Protocol Violation|2|||
23724600|NCT00355134|66370541|FG003|Core Phase|Protocol Violation|0|||
23724601|NCT00355134|66370542|FG004|Core Phase|Protocol Violation|0|||
23724602|NCT00355134|66370538|FG000|Core Phase|Abnormal test procedure result(s)|1|||
23724603|NCT00355134|66370539|FG001|Core Phase|Abnormal test procedure result(s)|2|||
23724604|NCT00355134|66370540|FG002|Core Phase|Abnormal test procedure result(s)|1|||
23724605|NCT00355134|66370541|FG003|Core Phase|Abnormal test procedure result(s)|0|||
23724606|NCT00355134|66370542|FG004|Core Phase|Abnormal test procedure result(s)|0|||
23724607|NCT00355134|66370538|FG000|Core Phase|Condition no longer requires study drug|1|||
23724608|NCT00355134|66370539|FG001|Core Phase|Condition no longer requires study drug|0|||
23724609|NCT00355134|66370540|FG002|Core Phase|Condition no longer requires study drug|1|||
23724610|NCT00355134|66370541|FG003|Core Phase|Condition no longer requires study drug|0|||
23724611|NCT00355134|66370542|FG004|Core Phase|Condition no longer requires study drug|0|||
23724612|NCT00355134|66370538|FG000|Extension Phase|Withdrawal by Subject|7|||
23724613|NCT00355134|66370539|FG001|Extension Phase|Withdrawal by Subject|11|||
23724614|NCT00355134|66370540|FG002|Extension Phase|Withdrawal by Subject|0|||
23724615|NCT00355134|66370541|FG003|Extension Phase|Withdrawal by Subject|7|||
23724616|NCT00355134|66370542|FG004|Extension Phase|Withdrawal by Subject|5|||
23724617|NCT00355134|66370538|FG000|Extension Phase|Adverse Event|13|||
23724618|NCT00355134|66370539|FG001|Extension Phase|Adverse Event|9|||
23724619|NCT00355134|66370540|FG002|Extension Phase|Adverse Event|0|||
23724620|NCT00355134|66370541|FG003|Extension Phase|Adverse Event|3|||
23724621|NCT00355134|66370542|FG004|Extension Phase|Adverse Event|5|||
23724622|NCT00355134|66370538|FG000|Extension Phase|Lost to Follow-up|2|||
23724623|NCT00355134|66370539|FG001|Extension Phase|Lost to Follow-up|6|||
23724624|NCT00355134|66370540|FG002|Extension Phase|Lost to Follow-up|0|||
23724625|NCT00355134|66370541|FG003|Extension Phase|Lost to Follow-up|2|||
23724626|NCT00355134|66370542|FG004|Extension Phase|Lost to Follow-up|4|||
23724627|NCT00355134|66370538|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
23724628|NCT00355134|66370539|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
23724629|NCT00355134|66370540|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
23724630|NCT00355134|66370541|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
23724631|NCT00355134|66370542|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
23724632|NCT00355134|66370538|FG000|Extension Phase|Administrative problems|2|||
23724633|NCT00355134|66370539|FG001|Extension Phase|Administrative problems|4|||
23724634|NCT00355134|66370540|FG002|Extension Phase|Administrative problems|0|||
23724635|NCT00355134|66370541|FG003|Extension Phase|Administrative problems|1|||
23724636|NCT00355134|66370542|FG004|Extension Phase|Administrative problems|1|||
23724637|NCT00355134|66370538|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
23724638|NCT00355134|66370539|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
23724639|NCT00355134|66370540|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23724640|NCT00355134|66370541|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
23724641|NCT00355134|66370542|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
23724642|NCT00355134|66370538|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
23724643|NCT00355134|66370539|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
23724644|NCT00355134|66370540|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
23724645|NCT00355134|66370541|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
23724646|NCT00355134|66370542|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
23724647|NCT00355134|66370538|FG000|Extension Phase|Protocol Violation|0|||
23724648|NCT00355134|66370539|FG001|Extension Phase|Protocol Violation|0|||
23724649|NCT00355134|66370540|FG002|Extension Phase|Protocol Violation|0|||
23724650|NCT00355134|66370541|FG003|Extension Phase|Protocol Violation|1|||
23724651|NCT00355134|66370542|FG004|Extension Phase|Protocol Violation|0|||
23724652|NCT02578992|66370546|FG000|Overall Study|equipment not available or malfunction|3|||
23724653|NCT02578992|66370547|FG001|Overall Study|equipment not available or malfunction|3|||
23724654|NCT00701441|66370549|FG000|Overall Study|failure in cpap compliance|0|||
23724655|NCT00701441|66370550|FG001|Overall Study|failure in cpap compliance|4|||
23724656|NCT00293241|66370551|FG000|Overall Study|Lost to Follow-up|9|||
23724657|NCT00293241|66370552|FG001|Overall Study|Lost to Follow-up|16|||
23724658|NCT00293241|66370551|FG000|Overall Study|Physician Decision|23|||
23724659|NCT00293241|66370552|FG001|Overall Study|Physician Decision|17|||
23724660|NCT00293241|66370551|FG000|Overall Study|Withdrawal by Subject|4|||
23724661|NCT00293241|66370552|FG001|Overall Study|Withdrawal by Subject|8|||
23724662|NCT00527072|66370555|FG000|Overall Study|Adverse Event|13|||
23724663|NCT00527072|66370555|FG000|Overall Study|Lack of Efficacy|11|||
23724664|NCT00527072|66370555|FG000|Overall Study|Lost to Follow-up|3|||
23724665|NCT00527072|66370555|FG000|Overall Study|Protocol Violation|2|||
23724666|NCT00527072|66370555|FG000|Overall Study|Withdrawal by Subject|7|||
23724667|NCT00429572|66370564|FG000|Overall Study|Disease progression|1|||
23724668|NCT01822223|66370565|FG000|Overall Study|Death|0|||
23724669|NCT01822223|66370566|FG001|Overall Study|Death|1|||
23724670|NCT00481988|66370567|FG000|Overall Study|Withdrawal by Subject|1|||
23724671|NCT00481988|66370568|FG001|Overall Study|Withdrawal by Subject|1|||
23724672|NCT00753623|66370573|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
23724673|NCT00753623|66370574|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
23724674|NCT00753623|66370573|FG000|Phase I (14 Days)|Physician Decision|1|||
23724675|NCT00753623|66370574|FG001|Phase I (14 Days)|Physician Decision|2|||
23724676|NCT00753623|66370573|FG000|Phase I (14 Days)|Adverse Event|0|||
23724677|NCT00753623|66370574|FG001|Phase I (14 Days)|Adverse Event|1|||
23724678|NCT00753623|66370573|FG000|Washout (7 Days)|Physician Decision|1|||
23724679|NCT00753623|66370574|FG001|Washout (7 Days)|Physician Decision|0|||
23724680|NCT00753623|66370573|FG000|Phase II (14 Days)|Physician Decision|0|||
23724681|NCT00753623|66370574|FG001|Phase II (14 Days)|Physician Decision|1|||
23724682|NCT03892707|66370575|FG000|Overall Study|Screen failure|6|||
23724683|NCT03892707|66370576|FG001|Overall Study|Screen failure|0|||
23724684|NCT03892707|66370575|FG000|Overall Study|Pain resolution|0|||
23724685|NCT03892707|66370576|FG001|Overall Study|Pain resolution|4|||
23724686|NCT03892707|66370575|FG000|Overall Study|Withdrawal by Subject|0|||
23724687|NCT03892707|66370576|FG001|Overall Study|Withdrawal by Subject|1|||
23724688|NCT03892707|66370575|FG000|Overall Study|Other (long business trip)|0|||
23724689|NCT03892707|66370576|FG001|Overall Study|Other (long business trip)|1|||
23724690|NCT03682055|66370578|FG000|Overall Study|Lack of Efficacy|1|||
23724691|NCT03682055|66370579|FG001|Overall Study|Lack of Efficacy|2|||
23724692|NCT03682055|66370580|FG002|Overall Study|Lack of Efficacy|1|||
23724693|NCT03682055|66370581|FG003|Overall Study|Lack of Efficacy|2|||
23724694|NCT03682055|66370582|FG004|Overall Study|Lack of Efficacy|1|||
23724695|NCT03682055|66370583|FG005|Overall Study|Lack of Efficacy|3|||
23816022|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
23816023|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
23724696|NCT03682055|66370578|FG000|Overall Study|Withdrawal by Subject|0|||
23724697|NCT03682055|66370579|FG001|Overall Study|Withdrawal by Subject|0|||
23724698|NCT03682055|66370580|FG002|Overall Study|Withdrawal by Subject|0|||
23724699|NCT03682055|66370581|FG003|Overall Study|Withdrawal by Subject|0|||
23724700|NCT03682055|66370582|FG004|Overall Study|Withdrawal by Subject|0|||
23724701|NCT03682055|66370583|FG005|Overall Study|Withdrawal by Subject|1|||
23724702|NCT03682055|66370578|FG000|Overall Study|Termination of Study by Sponsor|0|||
23724703|NCT03682055|66370579|FG001|Overall Study|Termination of Study by Sponsor|0|||
23724704|NCT03682055|66370580|FG002|Overall Study|Termination of Study by Sponsor|0|||
23724705|NCT03682055|66370581|FG003|Overall Study|Termination of Study by Sponsor|0|||
23724706|NCT03682055|66370582|FG004|Overall Study|Termination of Study by Sponsor|0|||
23724707|NCT03682055|66370583|FG005|Overall Study|Termination of Study by Sponsor|3|||
23724708|NCT03984812|66370585|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724709|NCT03984812|66370586|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724710|NCT03984812|66370587|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
23724711|NCT03984812|66370588|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724712|NCT03984812|66370589|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724713|NCT03984812|66370590|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724714|NCT03984812|66370591|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23816024|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816025|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23724715|NCT03984812|66370592|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724716|NCT03984812|66370593|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724717|NCT03984812|66370594|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724718|NCT03984812|66370595|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23724719|NCT00611767|66370596|FG000|Overall Study|Withdrawal by Subject|4|||
23724720|NCT00611767|66370597|FG001|Overall Study|Withdrawal by Subject|1|||
23724721|NCT00611767|66370596|FG000|Overall Study|Thiopental not available|3|||
23724722|NCT00611767|66370597|FG001|Overall Study|Thiopental not available|0|||
23724723|NCT00611767|66370596|FG000|Overall Study|didn't like the medication|1|||
23724724|NCT00611767|66370597|FG001|Overall Study|didn't like the medication|1|||
23724725|NCT00611767|66370596|FG000|Overall Study|Physician Decision|1|||
23724726|NCT00611767|66370597|FG001|Overall Study|Physician Decision|0|||
23724727|NCT02671760|66370598|FG000|Overall Study|Lost to Follow-up|0|||
23724728|NCT02671760|66370599|FG001|Overall Study|Lost to Follow-up|1|||
23724729|NCT02671760|66370600|FG002|Overall Study|Lost to Follow-up|0|||
23724730|NCT03907969|66370601|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
23724731|NCT03907969|66370602|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
23724732|NCT03907969|66370603|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
23724733|NCT03907969|66370604|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
23724734|NCT03907969|66370605|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
23724735|NCT03907969|66370606|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
23724736|NCT03907969|66370607|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
23724737|NCT03907969|66370608|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
23724738|NCT03907969|66370609|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
23724739|NCT03907969|66370610|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
23724740|NCT03907969|66370611|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
23724741|NCT03907969|66370601|FG000|Monotherapy Part A|Progressive Disease|0|||
23724742|NCT03907969|66370602|FG001|Monotherapy Part A|Progressive Disease|1|||
23724743|NCT03907969|66370603|FG002|Monotherapy Part A|Progressive Disease|0|||
23724744|NCT03907969|66370604|FG003|Monotherapy Part A|Progressive Disease|0|||
23724745|NCT03907969|66370605|FG004|Monotherapy Part A|Progressive Disease|0|||
23724746|NCT03907969|66370606|FG005|Monotherapy Part A|Progressive Disease|1|||
23724747|NCT03907969|66370607|FG006|Monotherapy Part A|Progressive Disease|2|||
23724748|NCT03907969|66370608|FG007|Monotherapy Part A|Progressive Disease|0|||
23724749|NCT03907969|66370609|FG008|Monotherapy Part A|Progressive Disease|0|||
23724750|NCT03907969|66370610|FG009|Monotherapy Part A|Progressive Disease|0|||
23724751|NCT03907969|66370611|FG010|Monotherapy Part A|Progressive Disease|0|||
23724752|NCT03907969|66370601|FG000|Monotherapy Part A|Death|0|||
23724753|NCT03907969|66370602|FG001|Monotherapy Part A|Death|0|||
23724754|NCT03907969|66370603|FG002|Monotherapy Part A|Death|1|||
23724755|NCT03907969|66370604|FG003|Monotherapy Part A|Death|1|||
23724756|NCT03907969|66370605|FG004|Monotherapy Part A|Death|0|||
23724757|NCT03907969|66370606|FG005|Monotherapy Part A|Death|1|||
23724758|NCT03907969|66370607|FG006|Monotherapy Part A|Death|0|||
23724759|NCT03907969|66370608|FG007|Monotherapy Part A|Death|0|||
23724760|NCT03907969|66370609|FG008|Monotherapy Part A|Death|0|||
23724761|NCT03907969|66370610|FG009|Monotherapy Part A|Death|0|||
23724762|NCT03907969|66370611|FG010|Monotherapy Part A|Death|0|||
23724763|NCT03907969|66370601|FG000|Combination Therapy Part A|Adverse Event|0|||
23724764|NCT03907969|66370602|FG001|Combination Therapy Part A|Adverse Event|0|||
23724765|NCT03907969|66370603|FG002|Combination Therapy Part A|Adverse Event|0|||
23724766|NCT03907969|66370604|FG003|Combination Therapy Part A|Adverse Event|0|||
23724767|NCT03907969|66370605|FG004|Combination Therapy Part A|Adverse Event|0|||
23724768|NCT03907969|66370606|FG005|Combination Therapy Part A|Adverse Event|0|||
23724769|NCT03907969|66370607|FG006|Combination Therapy Part A|Adverse Event|0|||
23724770|NCT03907969|66370608|FG007|Combination Therapy Part A|Adverse Event|0|||
23724771|NCT03907969|66370609|FG008|Combination Therapy Part A|Adverse Event|0|||
23724772|NCT03907969|66370610|FG009|Combination Therapy Part A|Adverse Event|1|||
23724773|NCT03907969|66370611|FG010|Combination Therapy Part A|Adverse Event|1|||
23724774|NCT03907969|66370601|FG000|Combination Therapy Part A|Progressive disease|0|||
23724775|NCT03907969|66370602|FG001|Combination Therapy Part A|Progressive disease|0|||
23724776|NCT03907969|66370603|FG002|Combination Therapy Part A|Progressive disease|0|||
23724777|NCT03907969|66370604|FG003|Combination Therapy Part A|Progressive disease|0|||
23724778|NCT03907969|66370605|FG004|Combination Therapy Part A|Progressive disease|0|||
23724779|NCT03907969|66370606|FG005|Combination Therapy Part A|Progressive disease|0|||
23724780|NCT03907969|66370607|FG006|Combination Therapy Part A|Progressive disease|0|||
23724781|NCT03907969|66370608|FG007|Combination Therapy Part A|Progressive disease|1|||
23724782|NCT03907969|66370609|FG008|Combination Therapy Part A|Progressive disease|0|||
23724783|NCT03907969|66370610|FG009|Combination Therapy Part A|Progressive disease|2|||
23724784|NCT03907969|66370611|FG010|Combination Therapy Part A|Progressive disease|3|||
23424027|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
23424028|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
23724785|NCT03907969|66370601|FG000|Combination Therapy Part A|Death|0|||
23724786|NCT03907969|66370602|FG001|Combination Therapy Part A|Death|0|||
23724787|NCT03907969|66370603|FG002|Combination Therapy Part A|Death|0|||
23724788|NCT03907969|66370604|FG003|Combination Therapy Part A|Death|0|||
23724789|NCT03907969|66370605|FG004|Combination Therapy Part A|Death|0|||
23724790|NCT03907969|66370606|FG005|Combination Therapy Part A|Death|0|||
23724791|NCT03907969|66370607|FG006|Combination Therapy Part A|Death|0|||
23724792|NCT03907969|66370608|FG007|Combination Therapy Part A|Death|0|||
23724793|NCT03907969|66370609|FG008|Combination Therapy Part A|Death|1|||
23724794|NCT03907969|66370610|FG009|Combination Therapy Part A|Death|0|||
23724795|NCT03907969|66370611|FG010|Combination Therapy Part A|Death|1|||
23724796|NCT03907969|66370601|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
23724797|NCT03907969|66370602|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
23724798|NCT03907969|66370603|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
23538151|NCT05077267|65702271|FG000|Follow-up Period|Study terminated by sponsor|0|||
23538152|NCT05077267|65702272|FG001|Follow-up Period|Study terminated by sponsor|27|||
23538153|NCT05077267|65702273|FG002|Follow-up Period|Study terminated by sponsor|23|||
23538154|NCT05077267|65702271|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
23538155|NCT05077267|65702272|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
23538156|NCT05077267|65702273|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
23724799|NCT03907969|66370604|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
23724800|NCT03907969|66370605|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
23724801|NCT03907969|66370606|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
23724802|NCT03907969|66370607|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
23724803|NCT03907969|66370608|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
23724804|NCT03907969|66370609|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
23538157|NCT05077267|65702271|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
23538158|NCT05077267|65702272|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
23538159|NCT05077267|65702273|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
23538160|NCT02992899|65702274|FG000|Overall Study|Withdrawal by Subject|1|||
23724805|NCT03907969|66370610|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
23724806|NCT03907969|66370611|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
23724807|NCT03907969|66370601|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
23724808|NCT03907969|66370602|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
23724809|NCT03907969|66370603|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
23724810|NCT03907969|66370604|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
23724811|NCT03907969|66370605|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
23724812|NCT03907969|66370606|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
23724813|NCT03907969|66370607|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
23724814|NCT03907969|66370608|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
23724815|NCT03907969|66370609|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
23724816|NCT03907969|66370610|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
23724817|NCT03907969|66370611|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
23724818|NCT03907969|66370601|FG000|Combination Therapy Part A|Physician Decision|0|||
23724819|NCT03907969|66370602|FG001|Combination Therapy Part A|Physician Decision|0|||
23724820|NCT03907969|66370603|FG002|Combination Therapy Part A|Physician Decision|0|||
23724821|NCT03907969|66370604|FG003|Combination Therapy Part A|Physician Decision|0|||
23724822|NCT03907969|66370605|FG004|Combination Therapy Part A|Physician Decision|0|||
23724823|NCT03907969|66370606|FG005|Combination Therapy Part A|Physician Decision|0|||
23724824|NCT03907969|66370607|FG006|Combination Therapy Part A|Physician Decision|0|||
23724825|NCT03907969|66370608|FG007|Combination Therapy Part A|Physician Decision|1|||
23724826|NCT03907969|66370609|FG008|Combination Therapy Part A|Physician Decision|0|||
23724827|NCT03907969|66370610|FG009|Combination Therapy Part A|Physician Decision|0|||
23724828|NCT03907969|66370611|FG010|Combination Therapy Part A|Physician Decision|1|||
23724829|NCT01802515|66370614|FG000|Overall Study|Withdrawal by Subject|3|||
23724830|NCT01802515|66370615|FG001|Overall Study|Withdrawal by Subject|0|||
23724831|NCT01802515|66370616|FG002|Overall Study|Withdrawal by Subject|0|||
23724832|NCT01804842|66370617|FG000|Overall Study|Adverse Event|1|||
23724833|NCT01804842|66370618|FG001|Overall Study|Adverse Event|1|||
23724834|NCT01804842|66370619|FG002|Overall Study|Adverse Event|0|||
23724835|NCT01804842|66370617|FG000|Overall Study|Lost to Follow-up|1|||
23724836|NCT01804842|66370618|FG001|Overall Study|Lost to Follow-up|0|||
23724837|NCT01804842|66370619|FG002|Overall Study|Lost to Follow-up|0|||
23724838|NCT01804842|66370617|FG000|Overall Study|Non-Compliance|1|||
23724839|NCT01804842|66370618|FG001|Overall Study|Non-Compliance|1|||
23724840|NCT01804842|66370619|FG002|Overall Study|Non-Compliance|0|||
23724841|NCT01804842|66370617|FG000|Overall Study|Personal Reason|0|||
23724842|NCT01804842|66370618|FG001|Overall Study|Personal Reason|0|||
23724843|NCT01804842|66370619|FG002|Overall Study|Personal Reason|1|||
23816026|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816027|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816028|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816029|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816030|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816031|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23538161|NCT02992899|65702275|FG001|Overall Study|Withdrawal by Subject|0|||
23616382|NCT00774306|65982305|FG001|Overall Study|Death|1|||
23724844|NCT03991936|66370622|FG000|Overall Study|Lost to Follow-up|1|||
23724845|NCT03991936|66370623|FG001|Overall Study|Lost to Follow-up|1|||
23724846|NCT03991936|66370624|FG002|Overall Study|Lost to Follow-up|1|||
23724847|NCT03991936|66370625|FG003|Overall Study|Lost to Follow-up|1|||
23724848|NCT03991936|66370626|FG004|Overall Study|Lost to Follow-up|1|||
23724849|NCT01352845|66370628|FG000|Overall Study|Lost to Follow-up|313|||
23724850|NCT01352845|66370629|FG001|Overall Study|Lost to Follow-up|92|||
23724851|NCT01352845|66370628|FG000|Overall Study|No Longer Willing to Participate|205|||
23724852|NCT01352845|66370629|FG001|Overall Study|No Longer Willing to Participate|58|||
23724853|NCT01352845|66370628|FG000|Overall Study|Withdrawal by Subject|48|||
23424029|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
23424030|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
23724854|NCT01352845|66370629|FG001|Overall Study|Withdrawal by Subject|16|||
23724855|NCT01352845|66370628|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
23424031|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
23538162|NCT02992899|65702274|FG000|Overall Study|Lost to Follow-up|1|||
23724856|NCT01352845|66370629|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
23424032|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
23424033|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23424034|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23538163|NCT02992899|65702275|FG001|Overall Study|Lost to Follow-up|3|||
23538164|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
23538165|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
23538166|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
23538167|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
23538168|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
23538169|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
23538170|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Death|1|||
23538171|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Death|0|||
23538172|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Other|4|||
23538173|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Other|0|||
23538174|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
23538175|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
23538176|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
23538177|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
23538178|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
23538179|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
23538180|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
23538181|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
23538182|NCT02209324|65702278|FG000|Overall Study|Adverse Event|2|||
23538183|NCT02209324|65702278|FG000|Overall Study|Lack of Efficacy|1|||
23538184|NCT02209324|65702278|FG000|Overall Study|Lost to Follow-up|1|||
23538185|NCT02209324|65702278|FG000|Overall Study|Physician Decision|3|||
23538186|NCT02209324|65702278|FG000|Overall Study|Protocol Violation|14|||
23538187|NCT02209324|65702278|FG000|Overall Study|Withdrawal by Subject|8|||
23538188|NCT02209324|65702278|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
23538189|NCT02209324|65702278|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
23538190|NCT02209324|65702278|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
23538191|NCT01427712|65702279|FG000|Overall Study|Transfer to a different hospital|2|||
23538192|NCT01427712|65702279|FG000|Overall Study|Lost to Follow-up|1|||
23538193|NCT01427712|65702279|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
23538194|NCT01427712|65702279|FG000|Overall Study|Failure to visit|1|||
23538195|NCT00600821|65702280|FG000|Overall Study|Death|45|||
23538196|NCT00600821|65702281|FG001|Overall Study|Death|46|||
23538197|NCT00600821|65702280|FG000|Overall Study|Lost to Follow-up|2|||
23538198|NCT00600821|65702281|FG001|Overall Study|Lost to Follow-up|2|||
23538199|NCT00600821|65702280|FG000|Overall Study|Withdrawal by Subject|1|||
23538200|NCT00600821|65702281|FG001|Overall Study|Withdrawal by Subject|1|||
23538201|NCT00600821|65702280|FG000|Overall Study|Terminated by sponsor|8|||
23538202|NCT00600821|65702281|FG001|Overall Study|Terminated by sponsor|6|||
23538203|NCT00600821|65702280|FG000|Overall Study|Objective progression or relapse|0|||
23538204|NCT00600821|65702281|FG001|Overall Study|Objective progression or relapse|1|||
23538205|NCT00600821|65702280|FG000|Overall Study|Randomized but not treated|0|||
23538206|NCT00600821|65702281|FG001|Overall Study|Randomized but not treated|1|||
23538207|NCT00600821|65702280|FG000|Overall Study|Other|2|||
23538208|NCT00600821|65702281|FG001|Overall Study|Other|3|||
23538209|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
23538210|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
23538211|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
23538212|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
23538213|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
23538214|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
23424035|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23538215|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
23538216|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
23538217|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
23538218|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
23538219|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
23538220|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
23538221|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
23538222|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
23538223|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
23538224|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
23538225|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
23538226|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
23538227|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
23538228|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
23538229|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
23538230|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
23538231|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
23538232|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
23538233|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
23538234|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
23538235|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
23538236|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
23538237|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
23538238|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
23538239|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
23538240|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
23538241|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
23538242|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
23538243|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
23538244|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
23538245|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
23538246|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
23538247|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
23538248|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
23538249|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
23538250|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
23538251|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
23538252|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
23538253|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
23538254|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
23538255|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
23538256|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
23424036|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
23424037|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
23424038|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
23424039|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
23538257|NCT02170727|65702286|FG000|Overall Study|Lost to Follow-up|1|||
23538258|NCT02170727|65702287|FG001|Overall Study|Lost to Follow-up|0|||
23538259|NCT02170727|65702286|FG000|Overall Study|Withdrawal by Subject|2|||
23538260|NCT02170727|65702287|FG001|Overall Study|Withdrawal by Subject|0|||
23538261|NCT02663128|65702290|FG000|Period 2|Physician Decision|0|||
23538262|NCT02663128|65702291|FG001|Period 2|Physician Decision|0|||
23538263|NCT02663128|65702292|FG002|Period 2|Physician Decision|0|||
23538264|NCT02663128|65702293|FG003|Period 2|Physician Decision|0|||
23724857|NCT01352845|66370628|FG000|Overall Study|Pregnancy|27|||
23724858|NCT01352845|66370629|FG001|Overall Study|Pregnancy|7|||
23724859|NCT01352845|66370628|FG000|Overall Study|Adverse Event|22|||
23724860|NCT01352845|66370629|FG001|Overall Study|Adverse Event|6|||
23724861|NCT01352845|66370628|FG000|Overall Study|Other|17|||
23724862|NCT01352845|66370629|FG001|Overall Study|Other|7|||
23724863|NCT01352845|66370628|FG000|Overall Study|Protocol Violation|12|||
23724864|NCT01352845|66370629|FG001|Overall Study|Protocol Violation|6|||
23724865|NCT01352845|66370628|FG000|Overall Study|Death|3|||
23724866|NCT01352845|66370629|FG001|Overall Study|Death|0|||
23724867|NCT04445688|66370638|FG000|Washout (One Week)|Adverse Event|2|||
23724868|NCT04445688|66370638|FG000|Washout (One Week)|Withdrawal by Subject|1|||
23538265|NCT02663128|65702294|FG004|Period 2|Physician Decision|1|||
23538266|NCT02663128|65702295|FG005|Period 2|Physician Decision|0|||
23538267|NCT01519518|65702302|FG000|Overall Study|Consent not available|7|||
23538268|NCT01519518|65702303|FG001|Overall Study|Consent not available|10|||
23538269|NCT00844194|65702304|FG000|Overall Study|Adverse Event|17|||
23538270|NCT00844194|65702305|FG001|Overall Study|Adverse Event|5|||
23538271|NCT00844194|65702304|FG000|Overall Study|Protocol Violation|1|||
23538272|NCT00844194|65702305|FG001|Overall Study|Protocol Violation|1|||
23538273|NCT00844194|65702304|FG000|Overall Study|Lost to Follow-up|1|||
23538274|NCT00844194|65702305|FG001|Overall Study|Lost to Follow-up|1|||
23538275|NCT00844194|65702304|FG000|Overall Study|Withdrawal by Subject|2|||
23538276|NCT00844194|65702305|FG001|Overall Study|Withdrawal by Subject|1|||
23724869|NCT02076334|66370641|FG000|Overall Study|Protocol Violation|1|||
23724870|NCT02076334|66370642|FG001|Overall Study|Protocol Violation|0|||
23724871|NCT02076334|66370643|FG002|Overall Study|Protocol Violation|0|||
23538277|NCT00844194|65702304|FG000|Overall Study|Lack of Efficacy|3|||
23538278|NCT00844194|65702305|FG001|Overall Study|Lack of Efficacy|0|||
23724872|NCT02076334|66370644|FG003|Overall Study|Protocol Violation|0|||
23724873|NCT02076334|66370641|FG000|Overall Study|Lost to Follow-up|0|||
23724874|NCT02076334|66370642|FG001|Overall Study|Lost to Follow-up|1|||
23724875|NCT02076334|66370643|FG002|Overall Study|Lost to Follow-up|1|||
23538279|NCT00844194|65702304|FG000|Overall Study|Other reason (not specified)|1|||
23538280|NCT00844194|65702305|FG001|Overall Study|Other reason (not specified)|0|||
23538281|NCT00779246|65702307|FG000|Overall Study|Missing sufficient data for analysis|33|||
23538282|NCT00779246|65702308|FG001|Overall Study|Missing sufficient data for analysis|53|||
23538283|NCT02758236|65702309|FG000|Overall Study|Investigator discretion|43|||
23538284|NCT00968617|65702310|FG000|Overall Study|Study terminated by sponsor|6|||
23538285|NCT01959581|65702311|FG000|Overall Study|Lost to Follow-up|5|||
23538286|NCT04632940|65702312|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
23538287|NCT04632940|65702313|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
23538288|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
23538289|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
23538290|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
23538291|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
23538292|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
23538293|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
23538294|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
23538295|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
23538296|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
23538297|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
23538298|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Other than specified|0|||
23538299|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Other than specified|1|||
23538300|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
23538301|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
23538302|NCT00334815|65702316|FG000|Overall Study|Adverse Event|3|||
23538303|NCT00334815|65702317|FG001|Overall Study|Adverse Event|2|||
23538304|NCT00334815|65702316|FG000|Overall Study|Death|0|||
23538305|NCT00334815|65702317|FG001|Overall Study|Death|2|||
23538306|NCT00334815|65702316|FG000|Overall Study|Progression|1|||
23538307|NCT00334815|65702317|FG001|Overall Study|Progression|0|||
23616383|NCT00774306|65982306|FG002|Overall Study|Death|0|||
23724876|NCT02076334|66370644|FG003|Overall Study|Lost to Follow-up|0|||
23724877|NCT02076334|66370641|FG000|Overall Study|muscle soreness|0|||
23724878|NCT02076334|66370642|FG001|Overall Study|muscle soreness|0|||
23724879|NCT02076334|66370643|FG002|Overall Study|muscle soreness|0|||
23724880|NCT02076334|66370644|FG003|Overall Study|muscle soreness|1|||
23724881|NCT01300767|66370645|FG000|Overall Study|Discomfort|2|||
23724882|NCT01300767|66370645|FG000|Overall Study|Biomicroscopy|1|||
23724883|NCT01300767|66370645|FG000|Overall Study|Unacceptable fit|1|||
23724884|NCT02007252|66370648|FG000|Overall Study|Administrative problems|3|||
23724885|NCT02007252|66370649|FG001|Overall Study|Administrative problems|7|||
23724886|NCT02007252|66370648|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23724887|NCT02007252|66370649|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23724888|NCT02007252|66370648|FG000|Overall Study|Adverse Event|7|||
23724889|NCT02007252|66370649|FG001|Overall Study|Adverse Event|4|||
23724890|NCT00322387|66370650|FG000|Treatment Period|Adverse Event|0|||
23724891|NCT00322387|66370651|FG001|Treatment Period|Adverse Event|1|||
23724892|NCT00322387|66370650|FG000|Follow-up Period|Final assessment not done|1|||
23724893|NCT00322387|66370651|FG001|Follow-up Period|Final assessment not done|3|||
23724894|NCT00322387|66370650|FG000|Follow-up Period|Death|1|||
23724895|NCT00322387|66370651|FG001|Follow-up Period|Death|0|||
23724896|NCT04134728|66370652|FG000|Overall Study|Adverse Event|3|||
23724897|NCT04134728|66370653|FG001|Overall Study|Adverse Event|2|||
23724898|NCT04134728|66370654|FG002|Overall Study|Adverse Event|9|||
23724899|NCT04134728|66370655|FG003|Overall Study|Adverse Event|0|||
23724900|NCT04134728|66370656|FG004|Overall Study|Adverse Event|0|||
23724901|NCT04134728|66370657|FG005|Overall Study|Adverse Event|0|||
23724902|NCT04134728|66370652|FG000|Overall Study|Lack of Efficacy|3|||
23724903|NCT04134728|66370653|FG001|Overall Study|Lack of Efficacy|3|||
23816032|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816033|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23538308|NCT00334815|65702316|FG000|Overall Study|ineligible|1|||
23724904|NCT04134728|66370654|FG002|Overall Study|Lack of Efficacy|1|||
23724905|NCT04134728|66370655|FG003|Overall Study|Lack of Efficacy|2|||
23724906|NCT04134728|66370656|FG004|Overall Study|Lack of Efficacy|0|||
23724907|NCT04134728|66370657|FG005|Overall Study|Lack of Efficacy|0|||
23616384|NCT00774306|65982307|FG003|Overall Study|Death|0|||
23538309|NCT00334815|65702317|FG001|Overall Study|ineligible|1|||
23538310|NCT00334815|65702316|FG000|Overall Study|patient refused treatment|0|||
23538311|NCT00334815|65702317|FG001|Overall Study|patient refused treatment|1|||
23538312|NCT00334815|65702316|FG000|Overall Study|Physician Decision|2|||
23538313|NCT00334815|65702317|FG001|Overall Study|Physician Decision|4|||
23724908|NCT04134728|66370652|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
23724909|NCT04134728|66370653|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23538314|NCT01148810|65702318|FG000|Overall Study|Adverse Event|0|||
23538315|NCT01148810|65702319|FG001|Overall Study|Adverse Event|2|||
23538316|NCT01148810|65702318|FG000|Overall Study|Lack of Efficacy|0|||
23538317|NCT01148810|65702319|FG001|Overall Study|Lack of Efficacy|1|||
23538318|NCT01148810|65702318|FG000|Overall Study|Withdrawal by Subject|0|||
23538319|NCT01148810|65702319|FG001|Overall Study|Withdrawal by Subject|2|||
23538320|NCT01148810|65702318|FG000|Overall Study|Protocol Violation|1|||
23538321|NCT01148810|65702319|FG001|Overall Study|Protocol Violation|0|||
23538322|NCT01732835|65702320|FG000|6-month Primary Endpoint|Did not receive device|19|||
23538323|NCT01732835|65702320|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
23538324|NCT01732835|65702320|FG000|6-month Primary Endpoint|Adverse Event|3|||
23538325|NCT01732835|65702320|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
23538326|NCT01732835|65702320|FG000|2-year Extended Follow-up|Adverse Event|3|||
23538327|NCT01732835|65702320|FG000|2-year Extended Follow-up|Death|1|||
23538328|NCT03099382|65702325|FG000|Overall Study|Protocol Violation|2|||
23538329|NCT03099382|65702326|FG001|Overall Study|Protocol Violation|3|||
23538330|NCT00829621|65702327|FG000|Overall Study|Death|1|||
23538331|NCT00829621|65702328|FG001|Overall Study|Death|0|||
23538332|NCT00829621|65702327|FG000|Overall Study|Lost to Follow-up|3|||
23538333|NCT00829621|65702328|FG001|Overall Study|Lost to Follow-up|4|||
23538334|NCT01513317|65702329|FG000|Overall Study|Withdrawal by Subject|15|||
23724910|NCT04134728|66370654|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
23724911|NCT04134728|66370655|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23724912|NCT04134728|66370656|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23724913|NCT04134728|66370657|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23424040|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
23424041|NCT00867087|65296324|FG000|Overall Study|Other|1|||
23424042|NCT00867087|65296324|FG000|Overall Study|Withdrawal by Subject|4|||
23424043|NCT00867087|65296324|FG000|Overall Study|Death|37|||
23424044|NCT01559259|65296327|FG000|Overall Study|Withdrawal by Subject|0|||
23424045|NCT01559259|65296328|FG001|Overall Study|Withdrawal by Subject|0|||
23424046|NCT01559259|65296329|FG002|Overall Study|Withdrawal by Subject|0|||
23424047|NCT01559259|65296330|FG003|Overall Study|Withdrawal by Subject|1|||
23424048|NCT01559259|65296331|FG004|Overall Study|Withdrawal by Subject|0|||
23424049|NCT01559259|65296327|FG000|Overall Study|Adverse Event|0|||
23424050|NCT01559259|65296328|FG001|Overall Study|Adverse Event|1|||
23424051|NCT01559259|65296329|FG002|Overall Study|Adverse Event|1|||
23424052|NCT01559259|65296330|FG003|Overall Study|Adverse Event|0|||
23424053|NCT01559259|65296331|FG004|Overall Study|Adverse Event|0|||
23424054|NCT02437305|65296334|FG000|Overall Study|Lost to Follow-up|18|||
23424055|NCT02437305|65296335|FG001|Overall Study|Lost to Follow-up|12|||
23424056|NCT00856206|65296336|FG000|Overall Study|Protocol Violation|6|||
23424057|NCT00856206|65296337|FG001|Overall Study|Protocol Violation|18|||
23424058|NCT00856206|65296336|FG000|Overall Study|Adverse Event|10|||
23424059|NCT00856206|65296337|FG001|Overall Study|Adverse Event|46|||
23424060|NCT00856206|65296336|FG000|Overall Study|Lack of Efficacy|1|||
23424061|NCT00856206|65296337|FG001|Overall Study|Lack of Efficacy|2|||
23424062|NCT00856206|65296336|FG000|Overall Study|Withdrawal by Subject|15|||
23424063|NCT00856206|65296337|FG001|Overall Study|Withdrawal by Subject|36|||
23424064|NCT00856206|65296336|FG000|Overall Study|Lost to Follow-up|13|||
23424065|NCT00856206|65296337|FG001|Overall Study|Lost to Follow-up|39|||
23424066|NCT00856206|65296336|FG000|Overall Study|Death|2|||
23424067|NCT00856206|65296337|FG001|Overall Study|Death|2|||
23424068|NCT00856206|65296336|FG000|Overall Study|Decision by the Sponsor|4|||
23424069|NCT00856206|65296337|FG001|Overall Study|Decision by the Sponsor|8|||
23424070|NCT00856206|65296336|FG000|Overall Study|Other than specified above|3|||
23424071|NCT00856206|65296337|FG001|Overall Study|Other than specified above|10|||
23424072|NCT00624819|65296338|FG000|Follow-up Period: Year 4|Parents decision|0|||
23424073|NCT00624819|65296339|FG001|Follow-up Period: Year 4|Parents decision|0|||
23424074|NCT00624819|65296340|FG002|Follow-up Period: Year 4|Parents decision|1|||
23424075|NCT00624819|65296341|FG003|Follow-up Period: Year 4|Parents decision|0|||
23424076|NCT00624819|65296338|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
23538335|NCT01513317|65702330|FG001|Overall Study|Withdrawal by Subject|4|||
23538336|NCT01513317|65702329|FG000|Overall Study|Death|1|||
23538337|NCT01513317|65702330|FG001|Overall Study|Death|1|||
23424077|NCT00624819|65296339|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
23424078|NCT00624819|65296340|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
23424079|NCT00624819|65296341|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
23538338|NCT01513317|65702329|FG000|Overall Study|Study terminated by sponsor|18|||
23538339|NCT01513317|65702330|FG001|Overall Study|Study terminated by sponsor|18|||
23424080|NCT01665430|65296342|FG000|Overall Study|Adverse Event|1|||
23424081|NCT01665430|65296342|FG000|Overall Study|Withdrawal by Subject|6|||
23424082|NCT01665430|65296342|FG000|Overall Study|Other Unspecified|2|||
23424083|NCT01156389|65296343|FG000|Overall Study|Elevated liver enzymes|4|||
23538340|NCT01513317|65702329|FG000|Overall Study|Other|0|||
23538341|NCT01513317|65702330|FG001|Overall Study|Other|1|||
23538342|NCT02104557|65702331|FG000|Overall Study|Adverse Event|24|||
23538343|NCT02104557|65702331|FG000|Overall Study|Lost to Follow-up|34|||
23538344|NCT02104557|65702331|FG000|Overall Study|Violated the usage and dosage|14|||
23538345|NCT02104557|65702331|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
23538346|NCT02104557|65702331|FG000|Overall Study|Administered Sayana prior to the contract|1|||
23538347|NCT02104557|65702331|FG000|Overall Study|Other|17|||
23424084|NCT01156389|65296344|FG001|Overall Study|Elevated liver enzymes|0|||
23424085|NCT01156389|65296343|FG000|Overall Study|Vomiting|0|||
23424086|NCT01156389|65296344|FG001|Overall Study|Vomiting|1|||
23538348|NCT02104557|65702331|FG000|Overall Study|Change to other contraception methods|5|||
23538349|NCT02104557|65702331|FG000|Overall Study|Discontinuation due to no pain|1|||
23538350|NCT02104557|65702331|FG000|Overall Study|Withdrawal consent|2|||
23538351|NCT02104557|65702331|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
23538352|NCT02104557|65702331|FG000|Overall Study|Discontinuation of contraception|9|||
23538353|NCT04558346|65702332|FG000|Overall Study|Withdrawal by Subject|2|||
23538354|NCT04558346|65702333|FG001|Overall Study|Withdrawal by Subject|0|||
23538355|NCT04558346|65702332|FG000|Overall Study|Lost to Follow-up|0|||
23538356|NCT04558346|65702333|FG001|Overall Study|Lost to Follow-up|1|||
23538357|NCT04558346|65702332|FG000|Overall Study|Adverse Event|0|||
23538358|NCT04558346|65702333|FG001|Overall Study|Adverse Event|1|||
23538359|NCT03268811|65702334|FG000|Overall Study|Adverse Event|0|||
23538360|NCT03268811|65702335|FG001|Overall Study|Adverse Event|1|||
23538361|NCT03603964|65702337|FG000|Overall Study|Death|9|||
23538362|NCT03603964|65702337|FG000|Overall Study|Withdrawal by participant|7|||
23538363|NCT03603964|65702337|FG000|Overall Study|Study terminated by Sponsor|19|||
23538364|NCT02041429|65702338|FG000|Overall Study|Progressive Disease|2|||
23538365|NCT02041429|65702339|FG001|Overall Study|Progressive Disease|2|||
23538366|NCT02041429|65702340|FG002|Overall Study|Progressive Disease|3|||
23538367|NCT02041429|65702341|FG003|Overall Study|Progressive Disease|2|||
23538368|NCT02041429|65702338|FG000|Overall Study|Toxicity|0|||
23538369|NCT02041429|65702339|FG001|Overall Study|Toxicity|1|||
23538370|NCT02041429|65702340|FG002|Overall Study|Toxicity|4|||
23538371|NCT02041429|65702341|FG003|Overall Study|Toxicity|2|||
23538372|NCT02041429|65702338|FG000|Overall Study|Withdrawal by Subject|0|||
23538373|NCT02041429|65702339|FG001|Overall Study|Withdrawal by Subject|1|||
23538374|NCT02041429|65702340|FG002|Overall Study|Withdrawal by Subject|0|||
23538375|NCT02041429|65702341|FG003|Overall Study|Withdrawal by Subject|0|||
23538376|NCT02041429|65702338|FG000|Overall Study|On Maintenance Therapy|1|||
23538377|NCT02041429|65702339|FG001|Overall Study|On Maintenance Therapy|0|||
23538378|NCT02041429|65702340|FG002|Overall Study|On Maintenance Therapy|0|||
23538379|NCT02041429|65702341|FG003|Overall Study|On Maintenance Therapy|2|||
23538380|NCT00690755|65705750|FG000|Overall Study|Physician Decision|2|||
23538381|NCT00690755|65705751|FG001|Overall Study|Physician Decision|0|||
23538382|NCT00690755|65705752|FG002|Overall Study|Physician Decision|46|||
23538383|NCT00690755|65705753|FG003|Overall Study|Physician Decision|5|||
23538384|NCT00690755|65705754|FG004|Overall Study|Physician Decision|0|||
23538385|NCT00690755|65705755|FG005|Overall Study|Physician Decision|4|||
23538386|NCT00690755|65705756|FG006|Overall Study|Physician Decision|0|||
23538387|NCT04713748|65705757|FG000|Overall Study|Not enough kits allocated|35|||
23538388|NCT00022516|65705758|FG000|Overall Study|Adverse Event|0|||
23538389|NCT00022516|65705759|FG001|Overall Study|Adverse Event|59|||
23538390|NCT00022516|65705758|FG000|Overall Study|Lack of Efficacy|0|||
23538391|NCT00022516|65705759|FG001|Overall Study|Lack of Efficacy|27|||
23538392|NCT00022516|65705758|FG000|Overall Study|Physician Decision|0|||
23538393|NCT00022516|65705759|FG001|Overall Study|Physician Decision|1|||
23538394|NCT00022516|65705758|FG000|Overall Study|Protocol Violation|1|||
23538395|NCT00022516|65705759|FG001|Overall Study|Protocol Violation|3|||
23538396|NCT00022516|65705758|FG000|Overall Study|Withdrawal by Subject|2|||
23538397|NCT00022516|65705759|FG001|Overall Study|Withdrawal by Subject|113|||
23538398|NCT00022516|65705758|FG000|Overall Study|Incomplete documentation|0|||
23538399|NCT00022516|65705759|FG001|Overall Study|Incomplete documentation|27|||
23724914|NCT04134728|66370652|FG000|Overall Study|Protocol Deviation|0|||
23724915|NCT04134728|66370653|FG001|Overall Study|Protocol Deviation|0|||
23816034|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23424087|NCT00837876|65296345|FG000|Overall Study|Death|2|||
23424088|NCT00837876|65296345|FG000|Overall Study|Adverse Event|7|||
23424089|NCT00837876|65296345|FG000|Overall Study|Physician Decision|1|||
23424090|NCT00837876|65296345|FG000|Overall Study|Withdrawal by Subject|3|||
23538400|NCT00614939|65705763|FG000|Overall Study|Withdrawal by Subject|10|||
23538401|NCT00614939|65705764|FG001|Overall Study|Withdrawal by Subject|17|||
23538402|NCT00614939|65705763|FG000|Overall Study|Study specific discontinuation criteris|13|||
23538403|NCT00614939|65705764|FG001|Overall Study|Study specific discontinuation criteris|16|||
23538404|NCT00614939|65705763|FG000|Overall Study|Adverse Event|2|||
23538405|NCT00614939|65705764|FG001|Overall Study|Adverse Event|5|||
23538406|NCT00614939|65705763|FG000|Overall Study|Incorrect enrollment|1|||
23538407|NCT00614939|65705764|FG001|Overall Study|Incorrect enrollment|2|||
23538408|NCT00614939|65705763|FG000|Overall Study|Death|4|||
23538409|NCT00614939|65705764|FG001|Overall Study|Death|3|||
23538410|NCT00614939|65705763|FG000|Overall Study|Poor/non-compliance|4|||
23538411|NCT00614939|65705764|FG001|Overall Study|Poor/non-compliance|0|||
23538412|NCT00614939|65705763|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
23538413|NCT00614939|65705764|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
23538414|NCT01993719|65705772|FG000|First Drug Administration|Not treated|1|||
23538415|NCT01993719|65705773|FG001|First Drug Administration|Not treated|0|||
23538416|NCT01993719|65705774|FG002|First Drug Administration|Not treated|0|||
23538417|NCT01993719|65705775|FG003|First Drug Administration|Not treated|0|||
23538418|NCT01993719|65705776|FG004|First Drug Administration|Not treated|0|||
23538419|NCT00153101|65705777|FG000|Overall Study|Lost to Follow-up|14|||
23724916|NCT04134728|66370654|FG002|Overall Study|Protocol Deviation|1|||
23724917|NCT04134728|66370655|FG003|Overall Study|Protocol Deviation|0|||
23724918|NCT04134728|66370656|FG004|Overall Study|Protocol Deviation|0|||
23724919|NCT04134728|66370657|FG005|Overall Study|Protocol Deviation|0|||
23724920|NCT04134728|66370652|FG000|Overall Study|Informed Consent Withdrawn|3|||
23724921|NCT04134728|66370653|FG001|Overall Study|Informed Consent Withdrawn|6|||
23724922|NCT04134728|66370654|FG002|Overall Study|Informed Consent Withdrawn|8|||
23724923|NCT04134728|66370655|FG003|Overall Study|Informed Consent Withdrawn|1|||
23724924|NCT04134728|66370656|FG004|Overall Study|Informed Consent Withdrawn|1|||
23724925|NCT04134728|66370657|FG005|Overall Study|Informed Consent Withdrawn|0|||
23724926|NCT04134728|66370652|FG000|Overall Study|Physician Decision|2|||
23724927|NCT04134728|66370653|FG001|Overall Study|Physician Decision|0|||
23724928|NCT04134728|66370654|FG002|Overall Study|Physician Decision|0|||
23724929|NCT04134728|66370655|FG003|Overall Study|Physician Decision|0|||
23724930|NCT04134728|66370656|FG004|Overall Study|Physician Decision|0|||
23724931|NCT04134728|66370657|FG005|Overall Study|Physician Decision|0|||
23724932|NCT04134728|66370652|FG000|Overall Study|Lost to Follow-up|1|||
23724933|NCT04134728|66370653|FG001|Overall Study|Lost to Follow-up|2|||
23724934|NCT04134728|66370654|FG002|Overall Study|Lost to Follow-up|1|||
23724935|NCT04134728|66370655|FG003|Overall Study|Lost to Follow-up|0|||
23724936|NCT04134728|66370656|FG004|Overall Study|Lost to Follow-up|0|||
23724937|NCT04134728|66370657|FG005|Overall Study|Lost to Follow-up|1|||
23724938|NCT04134728|66370652|FG000|Overall Study|Investigator Site Closed|0|||
23724939|NCT04134728|66370653|FG001|Overall Study|Investigator Site Closed|1|||
23724940|NCT04134728|66370654|FG002|Overall Study|Investigator Site Closed|1|||
23724941|NCT04134728|66370655|FG003|Overall Study|Investigator Site Closed|0|||
23816035|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816036|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816037|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816038|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816039|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816040|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23538420|NCT00153101|65705778|FG001|Overall Study|Lost to Follow-up|14|||
23538421|NCT00153101|65705779|FG002|Overall Study|Lost to Follow-up|12|||
23538422|NCT00153101|65705780|FG003|Overall Study|Lost to Follow-up|5|||
23538423|NCT00153101|65705781|FG004|Overall Study|Lost to Follow-up|5|||
23538424|NCT00153101|65705777|FG000|Overall Study|Withdrawal by Subject|3|||
23538425|NCT00153101|65705778|FG001|Overall Study|Withdrawal by Subject|4|||
23538426|NCT00153101|65705779|FG002|Overall Study|Withdrawal by Subject|3|||
23538427|NCT00153101|65705780|FG003|Overall Study|Withdrawal by Subject|3|||
23538428|NCT00153101|65705781|FG004|Overall Study|Withdrawal by Subject|5|||
23538429|NCT02293005|65705785|FG000|Overall Study|Adverse Event|2|||
23538430|NCT02293005|65705785|FG000|Overall Study|Death|4|||
23538431|NCT02293005|65705785|FG000|Overall Study|Lost to Follow-up|1|||
23538432|NCT02293005|65705785|FG000|Overall Study|Withdrawal by Subject|2|||
23538433|NCT02293005|65705785|FG000|Overall Study|Progression|17|||
23538434|NCT03231371|65705786|FG000|Overall Study|Withdrawal by Subject|1|||
23538435|NCT03231371|65705786|FG000|Overall Study|chose or were ineligible to have MRI|12|||
23538436|NCT02732847|65705787|FG000|Overall Study|some filled early|42|||
23538437|NCT02732847|65705788|FG001|Overall Study|some filled early|42|||
23538438|NCT01252251|65705789|FG000|Overall Study|Withdrawal by Subject|1|||
23538439|NCT02530619|65705790|FG000|Registered for Study|Withdrawal by Subject|2|||
23724942|NCT04134728|66370656|FG004|Overall Study|Investigator Site Closed|0|||
23724943|NCT04134728|66370657|FG005|Overall Study|Investigator Site Closed|0|||
23724944|NCT00770224|66370658|FG000|Step 1: Induction|Adverse Event|3|||
23724945|NCT00770224|66370659|FG001|Step 1: Induction|Adverse Event|0|||
23724946|NCT00770224|66370658|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
23724947|NCT00770224|66370659|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
23724948|NCT00770224|66370658|FG000|Step 1: Induction|Other reason not protocol specified|2|||
23724949|NCT00770224|66370659|FG001|Step 1: Induction|Other reason not protocol specified|0|||
23724950|NCT00770224|66370658|FG000|Step 1: Induction|Ineligible|2|||
23724951|NCT00770224|66370659|FG001|Step 1: Induction|Ineligible|0|||
23724952|NCT00770224|66370658|FG000|Step 1: Induction|No protocol treatment given|1|||
23538440|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
23724953|NCT00770224|66370659|FG001|Step 1: Induction|No protocol treatment given|0|||
23724954|NCT00770224|66370658|FG000|Step 2: Maintenance|Adverse Event|0|||
23724955|NCT00770224|66370659|FG001|Step 2: Maintenance|Adverse Event|10|||
23724956|NCT00770224|66370658|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
23724957|NCT00770224|66370659|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
23724958|NCT00770224|66370658|FG000|Step 2: Maintenance|Progression/relapse|0|||
23724959|NCT00770224|66370659|FG001|Step 2: Maintenance|Progression/relapse|1|||
23724960|NCT00770224|66370658|FG000|Step 2: Maintenance|Death|0|||
23724961|NCT00770224|66370659|FG001|Step 2: Maintenance|Death|2|||
23724962|NCT00770224|66370658|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
23724963|NCT00770224|66370659|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
23724964|NCT00770224|66370658|FG000|Step 2: Maintenance|Ineligible|0|||
23724965|NCT00770224|66370659|FG001|Step 2: Maintenance|Ineligible|2|||
23724966|NCT02033850|66370660|FG000|Overall Study|Death|1|||
23724967|NCT02033850|66370661|FG001|Overall Study|Death|0|||
23724968|NCT02033850|66370660|FG000|Overall Study|unrelated medical reason|1|||
23724969|NCT02033850|66370661|FG001|Overall Study|unrelated medical reason|1|||
23724970|NCT00255034|66370662|FG000|Overall Study|Withdrawal by Subject|15|||
23724971|NCT00255034|66370663|FG001|Overall Study|Withdrawal by Subject|38|||
23724972|NCT01902173|66370664|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
23724973|NCT01902173|66370665|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23724974|NCT01902173|66370666|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23724975|NCT01902173|66370667|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23724976|NCT01902173|66370668|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23724977|NCT01902173|66370669|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23724978|NCT01902173|66370664|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
23724979|NCT01902173|66370665|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23724980|NCT01902173|66370666|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23724981|NCT01902173|66370667|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23724982|NCT01902173|66370668|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23724983|NCT01902173|66370669|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23724984|NCT01902173|66370664|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23724985|NCT01902173|66370665|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
23724986|NCT01902173|66370666|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23724987|NCT01902173|66370667|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23724988|NCT01902173|66370668|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23724989|NCT01902173|66370669|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23724990|NCT01902173|66370664|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23724991|NCT01902173|66370665|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
23724992|NCT01902173|66370666|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23724993|NCT01902173|66370667|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23724994|NCT01902173|66370668|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23724995|NCT01902173|66370669|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23724996|NCT01902173|66370664|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23724997|NCT01902173|66370665|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
23724998|NCT01902173|66370666|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23724999|NCT01902173|66370667|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23725000|NCT01902173|66370668|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23725001|NCT01902173|66370669|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23725002|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23725003|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23725004|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
23725005|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23725006|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23725007|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23725008|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23725009|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23725010|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
23725011|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23725012|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23725013|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23725014|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23725015|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23725016|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23725017|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
23725018|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23725019|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23816041|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816042|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23725020|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23725021|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23725022|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23725023|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
23725024|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23725025|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23725026|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23725027|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23725028|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23725029|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23725030|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
23725031|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23725032|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23725033|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23725034|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23725035|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23725036|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
23725037|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23725038|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23725039|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23725040|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23725041|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23725042|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23725043|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
23725044|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23725045|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23725046|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23725047|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23538441|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
23538442|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
23816043|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816044|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
23538443|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
23538444|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Death|4|||
23538445|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
23725048|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23725049|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
23725050|NCT01902173|66370664|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23725051|NCT01902173|66370665|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23725052|NCT01902173|66370666|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23725053|NCT01902173|66370667|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23725054|NCT01902173|66370668|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23725055|NCT01902173|66370669|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
23725056|NCT06048705|66370670|FG000|Overall Study|Physician Decision|1|||
23843092|NCT01738503|66805582|FG001|Treatment Period|Withdrawal by Subject|1|||
23538446|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
23538447|NCT03574389|65705791|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
23538448|NCT03574389|65705792|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
23538449|NCT03574389|65705793|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
23538450|NCT03574389|65705794|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
23538451|NCT03574389|65705795|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
23538452|NCT03574389|65705796|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
23538453|NCT03574389|65705797|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
23538454|NCT03574389|65705791|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
23538455|NCT03574389|65705792|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
23538456|NCT03574389|65705793|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
23538457|NCT03574389|65705794|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
23538458|NCT03574389|65705795|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538459|NCT03574389|65705796|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538460|NCT03574389|65705797|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538461|NCT03574389|65705791|FG000|Vaccination Period|Other|6|||
23538462|NCT03574389|65705792|FG001|Vaccination Period|Other|0|||
23725057|NCT06048705|66370671|FG001|Overall Study|Physician Decision|0|||
23725058|NCT06048705|66370672|FG002|Overall Study|Physician Decision|0|||
23725059|NCT06048705|66370670|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
23538463|NCT03574389|65705793|FG002|Vaccination Period|Other|0|||
23725060|NCT06048705|66370671|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
23538464|NCT03574389|65705794|FG003|Vaccination Period|Other|0|||
23538465|NCT03574389|65705795|FG004|Vaccination Period|Other|0|||
23538466|NCT03574389|65705796|FG005|Vaccination Period|Other|0|||
23538467|NCT03574389|65705797|FG006|Vaccination Period|Other|0|||
23538468|NCT03574389|65705791|FG000|Vaccination Period|Adverse Event|0|||
23538469|NCT03574389|65705792|FG001|Vaccination Period|Adverse Event|1|||
23538470|NCT03574389|65705793|FG002|Vaccination Period|Adverse Event|0|||
23538471|NCT03574389|65705794|FG003|Vaccination Period|Adverse Event|0|||
23725061|NCT06048705|66370672|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
23725062|NCT06048705|66370670|FG000|Overall Study|Death prior to lymphodepletion|0|||
23725063|NCT06048705|66370671|FG001|Overall Study|Death prior to lymphodepletion|0|||
23725064|NCT06048705|66370672|FG002|Overall Study|Death prior to lymphodepletion|1|||
23725065|NCT00928512|66370673|FG000|Overall Study|Adverse Event|4|||
23616385|NCT02350127|65982308|FG000|4-Month Assessment|Withdrawal by Subject|10|||
23616386|NCT02350127|65982309|FG001|4-Month Assessment|Withdrawal by Subject|9|||
23616387|NCT02350127|65982308|FG000|4-Month Assessment|Death|1|||
23616388|NCT02350127|65982309|FG001|4-Month Assessment|Death|0|||
23616389|NCT02350127|65982308|FG000|8-Month Assessment|Death|1|||
23616390|NCT02350127|65982309|FG001|8-Month Assessment|Death|1|||
23616391|NCT02350127|65982308|FG000|8-Month Assessment|Withdrawal by Subject|5|||
23616392|NCT02350127|65982309|FG001|8-Month Assessment|Withdrawal by Subject|8|||
23616393|NCT03360071|65982312|FG000|Overall Study|Lost to Follow-up|1|||
23616394|NCT03360071|65982313|FG001|Overall Study|Lost to Follow-up|0|||
23616395|NCT05109117|65982319|FG000|Overall Study|Lost to Follow-up|1|||
23616396|NCT05109117|65982319|FG000|Overall Study|Discontinued for non-compliance|1|||
23725066|NCT00928512|66370674|FG001|Overall Study|Adverse Event|3|||
23725067|NCT00928512|66370675|FG002|Overall Study|Adverse Event|2|||
23538472|NCT03574389|65705795|FG004|Vaccination Period|Adverse Event|0|||
23538473|NCT03574389|65705796|FG005|Vaccination Period|Adverse Event|0|||
23538474|NCT03574389|65705797|FG006|Vaccination Period|Adverse Event|0|||
23538475|NCT03574389|65705791|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
23538476|NCT03574389|65705792|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
23538477|NCT03574389|65705793|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
23538478|NCT03574389|65705794|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
23538479|NCT03574389|65705795|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
23538480|NCT03574389|65705796|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
23538481|NCT03574389|65705797|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
23538482|NCT03394924|65705798|FG000|Overall Study|Adverse Event|0|||
23616397|NCT00244751|65982321|FG000|Overall Study|Adverse Event|7|||
23616398|NCT00244751|65982322|FG001|Overall Study|Adverse Event|7|||
23725068|NCT00928512|66370676|FG003|Overall Study|Adverse Event|8|||
23725069|NCT00928512|66370677|FG004|Overall Study|Adverse Event|6|||
23725070|NCT00928512|66370673|FG000|Overall Study|Lack of Efficacy|2|||
23725071|NCT00928512|66370674|FG001|Overall Study|Lack of Efficacy|0|||
23725072|NCT00928512|66370675|FG002|Overall Study|Lack of Efficacy|4|||
23424091|NCT00837876|65296345|FG000|Overall Study|disease progression|24|||
23424092|NCT03349645|65296347|FG000|Overall Study|Sponsor Terminated Study|75|||
23424093|NCT03349645|65296347|FG000|Overall Study|Withdrawal by Subject|4|||
23424094|NCT03349645|65296347|FG000|Overall Study|Protocol Violation|1|||
23424095|NCT03349645|65296347|FG000|Overall Study|Other|2|||
23424096|NCT02078102|65296350|FG000|Overall Study|Adverse Event|1|||
23424097|NCT02078102|65296351|FG001|Overall Study|Adverse Event|0|||
23424098|NCT02078102|65296350|FG000|Overall Study|Withdrawal by Subject|1|||
23424099|NCT02078102|65296351|FG001|Overall Study|Withdrawal by Subject|0|||
23424100|NCT02078102|65296350|FG000|Overall Study|Physician Decision|0|||
23424101|NCT02078102|65296351|FG001|Overall Study|Physician Decision|1|||
23424102|NCT00541099|65296352|FG000|Overall Study|Ineligible|3|||
23424103|NCT00405964|65296357|FG000|Overall Study|Treatment Failure|17|||
23424104|NCT00405964|65296358|FG001|Overall Study|Treatment Failure|45|||
23424105|NCT00405964|65296357|FG000|Overall Study|Adverse Event|7|||
23424106|NCT00405964|65296358|FG001|Overall Study|Adverse Event|16|||
23424107|NCT00405964|65296357|FG000|Overall Study|Lost to Follow-up|5|||
23424108|NCT00405964|65296358|FG001|Overall Study|Lost to Follow-up|5|||
23424109|NCT00405964|65296357|FG000|Overall Study|Withdrawal by Subject|19|||
23843093|NCT01738503|66805583|FG002|Treatment Period|Withdrawal by Subject|0|||
23424110|NCT00405964|65296358|FG001|Overall Study|Withdrawal by Subject|23|||
23424111|NCT00405964|65296357|FG000|Overall Study|Protocol Violation|11|||
23538483|NCT03394924|65705799|FG001|Overall Study|Adverse Event|5|||
23538484|NCT03394924|65705800|FG002|Overall Study|Adverse Event|0|||
23538485|NCT03394924|65705798|FG000|Overall Study|Withdrawal by Subject|2|||
23424112|NCT00405964|65296358|FG001|Overall Study|Protocol Violation|6|||
23424113|NCT00468676|65296359|FG000|Overall Study|Lost to Follow-up|14|||
23424114|NCT00468676|65296360|FG001|Overall Study|Lost to Follow-up|11|||
23424115|NCT00468676|65296359|FG000|Overall Study|Death|2|||
23424116|NCT00468676|65296360|FG001|Overall Study|Death|1|||
23424117|NCT03141788|65296361|FG000|Overall Study|Lost to Follow-up|1|||
23424118|NCT03141788|65296361|FG000|Overall Study|Protocol Violation|3|||
23424119|NCT03141788|65296361|FG000|Overall Study|Withdrawal by Subject|4|||
23424120|NCT03372551|65296367|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
23424121|NCT03372551|65296368|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
23424122|NCT03089944|65296369|FG000|Overall Study|Lost to Follow-up|8|||
23424123|NCT03089944|65296369|FG000|Overall Study|Withdrew Consent|2|||
23424124|NCT03089944|65296369|FG000|Overall Study|Adverse Event|1|||
23424125|NCT03089944|65296369|FG000|Overall Study|Other|1|||
23424126|NCT01643850|65296370|FG000|Overall Study|Withdrawal by Subject|0|||
23424127|NCT01643850|65296371|FG001|Overall Study|Withdrawal by Subject|0|||
23424128|NCT01643850|65296372|FG002|Overall Study|Withdrawal by Subject|0|||
23424129|NCT01643850|65296373|FG003|Overall Study|Withdrawal by Subject|0|||
23424130|NCT01643850|65296374|FG004|Overall Study|Withdrawal by Subject|1|||
23424131|NCT01643850|65296375|FG005|Overall Study|Withdrawal by Subject|0|||
23424132|NCT01643850|65296376|FG006|Overall Study|Withdrawal by Subject|0|||
23424133|NCT01643850|65296377|FG007|Overall Study|Withdrawal by Subject|0|||
23424134|NCT01643850|65296378|FG008|Overall Study|Withdrawal by Subject|0|||
23538486|NCT03394924|65705799|FG001|Overall Study|Withdrawal by Subject|0|||
23538487|NCT03394924|65705800|FG002|Overall Study|Withdrawal by Subject|0|||
23424135|NCT01643850|65296370|FG000|Overall Study|Lost to Follow-up|0|||
23424136|NCT01643850|65296371|FG001|Overall Study|Lost to Follow-up|0|||
23424137|NCT01643850|65296372|FG002|Overall Study|Lost to Follow-up|0|||
23424138|NCT01643850|65296373|FG003|Overall Study|Lost to Follow-up|0|||
23424139|NCT01643850|65296374|FG004|Overall Study|Lost to Follow-up|0|||
23424140|NCT01643850|65296375|FG005|Overall Study|Lost to Follow-up|0|||
23424141|NCT01643850|65296376|FG006|Overall Study|Lost to Follow-up|1|||
23424142|NCT01643850|65296377|FG007|Overall Study|Lost to Follow-up|0|||
23424143|NCT01643850|65296378|FG008|Overall Study|Lost to Follow-up|1|||
23538488|NCT03394924|65705798|FG000|Overall Study|Lost to Follow-up|0|||
23538489|NCT03394924|65705799|FG001|Overall Study|Lost to Follow-up|1|||
23538490|NCT03394924|65705800|FG002|Overall Study|Lost to Follow-up|0|||
23538491|NCT03394924|65705798|FG000|Overall Study|Did not meet all inclusion criteria|1|||
23538492|NCT03394924|65705799|FG001|Overall Study|Did not meet all inclusion criteria|0|||
23538493|NCT03394924|65705800|FG002|Overall Study|Did not meet all inclusion criteria|0|||
23538494|NCT00646958|65705801|FG000|Overall Study|Lack of Efficacy|1|||
23538495|NCT00646958|65705802|FG001|Overall Study|Lack of Efficacy|0|||
23538496|NCT00646958|65705803|FG002|Overall Study|Lack of Efficacy|0|||
23725073|NCT00928512|66370676|FG003|Overall Study|Lack of Efficacy|7|||
23725074|NCT00928512|66370677|FG004|Overall Study|Lack of Efficacy|3|||
23725075|NCT00928512|66370673|FG000|Overall Study|Protocol Violation|0|||
23725076|NCT00928512|66370674|FG001|Overall Study|Protocol Violation|1|||
23725077|NCT00928512|66370675|FG002|Overall Study|Protocol Violation|0|||
23725078|NCT00928512|66370676|FG003|Overall Study|Protocol Violation|1|||
23725079|NCT00928512|66370677|FG004|Overall Study|Protocol Violation|3|||
23725080|NCT00928512|66370673|FG000|Overall Study|Withdrawal by Subject|3|||
23725081|NCT00928512|66370674|FG001|Overall Study|Withdrawal by Subject|0|||
23538497|NCT00646958|65705801|FG000|Overall Study|Adverse Event|4|||
23538498|NCT00646958|65705802|FG001|Overall Study|Adverse Event|0|||
23538499|NCT00646958|65705803|FG002|Overall Study|Adverse Event|0|||
23538500|NCT00646958|65705801|FG000|Overall Study|Lost to Follow-up|1|||
23538501|NCT00646958|65705802|FG001|Overall Study|Lost to Follow-up|5|||
23538502|NCT00646958|65705803|FG002|Overall Study|Lost to Follow-up|7|||
23538503|NCT00646958|65705801|FG000|Overall Study|Protocol Violation|1|||
23725082|NCT00928512|66370675|FG002|Overall Study|Withdrawal by Subject|3|||
23725083|NCT00928512|66370676|FG003|Overall Study|Withdrawal by Subject|4|||
23725084|NCT00928512|66370677|FG004|Overall Study|Withdrawal by Subject|0|||
23424144|NCT01643850|65296370|FG000|Overall Study|Adverse Event|0|||
23424145|NCT01643850|65296371|FG001|Overall Study|Adverse Event|0|||
23538504|NCT00646958|65705802|FG001|Overall Study|Protocol Violation|1|||
23538505|NCT00646958|65705803|FG002|Overall Study|Protocol Violation|0|||
23538506|NCT00646958|65705801|FG000|Overall Study|Abnormal screening lab tests|1|||
23725085|NCT00928512|66370673|FG000|Overall Study|Lost to Follow-up|1|||
23725086|NCT00928512|66370674|FG001|Overall Study|Lost to Follow-up|1|||
23424146|NCT01643850|65296372|FG002|Overall Study|Adverse Event|0|||
23538507|NCT00646958|65705802|FG001|Overall Study|Abnormal screening lab tests|1|||
23538508|NCT00646958|65705803|FG002|Overall Study|Abnormal screening lab tests|0|||
23424147|NCT01643850|65296373|FG003|Overall Study|Adverse Event|0|||
23424148|NCT01643850|65296374|FG004|Overall Study|Adverse Event|1|||
23424149|NCT01643850|65296375|FG005|Overall Study|Adverse Event|0|||
23538509|NCT00646958|65705801|FG000|Overall Study|Withdrawal by Subject|1|||
23725087|NCT00928512|66370675|FG002|Overall Study|Lost to Follow-up|2|||
23725088|NCT00928512|66370676|FG003|Overall Study|Lost to Follow-up|1|||
23538510|NCT00646958|65705802|FG001|Overall Study|Withdrawal by Subject|2|||
23538511|NCT00646958|65705803|FG002|Overall Study|Withdrawal by Subject|0|||
23538512|NCT00646958|65705801|FG000|Overall Study|Did not receive study drug|2|||
23538513|NCT00646958|65705802|FG001|Overall Study|Did not receive study drug|0|||
23538514|NCT00646958|65705803|FG002|Overall Study|Did not receive study drug|2|||
23538515|NCT02200042|65705804|FG000|Overall Study|Withdrawal by Subject|0|||
23538516|NCT02200042|65705805|FG001|Overall Study|Withdrawal by Subject|1|||
23538517|NCT02338362|65705808|FG000|Overall Study|Withdrawal by Subject|1|||
23538518|NCT02338362|65705809|FG001|Overall Study|Withdrawal by Subject|1|||
23538519|NCT00616967|65705812|FG000|Overall Study|Withdrawal by Subject|0|||
23538520|NCT00616967|65705813|FG001|Overall Study|Withdrawal by Subject|0|||
23538521|NCT00616967|65705814|FG002|Overall Study|Withdrawal by Subject|1|||
23538522|NCT02819726|65705815|FG000|Part A (All Participants)|Lost to Follow-up|0|||
23538523|NCT02819726|65705816|FG001|Part A (All Participants)|Lost to Follow-up|1|||
23538524|NCT02819726|65705817|FG002|Part A (All Participants)|Lost to Follow-up|0|||
23538525|NCT02819726|65705818|FG003|Part A (All Participants)|Lost to Follow-up|0|||
23538526|NCT02819726|65705815|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
23538527|NCT02819726|65705816|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
23538528|NCT02819726|65705817|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
23538529|NCT02819726|65705818|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
23538530|NCT02819726|65705815|FG000|Part A (All Participants)|Protocol non-compliance|3|||
23538531|NCT02819726|65705816|FG001|Part A (All Participants)|Protocol non-compliance|4|||
23538532|NCT02819726|65705817|FG002|Part A (All Participants)|Protocol non-compliance|5|||
23538533|NCT02819726|65705818|FG003|Part A (All Participants)|Protocol non-compliance|0|||
23538534|NCT02819726|65705815|FG000|Part B (All Participants)|Lost to Follow-up|1|||
23816045|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816046|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816047|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23816048|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23424150|NCT01643850|65296376|FG006|Overall Study|Adverse Event|0|||
23538535|NCT02819726|65705816|FG001|Part B (All Participants)|Lost to Follow-up|1|||
23538536|NCT02819726|65705817|FG002|Part B (All Participants)|Lost to Follow-up|2|||
23538537|NCT02819726|65705818|FG003|Part B (All Participants)|Lost to Follow-up|2|||
23538538|NCT02819726|65705815|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
23538539|NCT02819726|65705816|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
23725089|NCT00928512|66370677|FG004|Overall Study|Lost to Follow-up|3|||
23538540|NCT02819726|65705817|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
23538541|NCT02819726|65705818|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
23538542|NCT02819726|65705815|FG000|Part B (All Participants)|Protocol non-compliance|0|||
23538543|NCT02819726|65705816|FG001|Part B (All Participants)|Protocol non-compliance|0|||
23725090|NCT00928512|66370673|FG000|Overall Study|Administrative Problems|0|||
23725091|NCT00928512|66370674|FG001|Overall Study|Administrative Problems|1|||
23725092|NCT00928512|66370675|FG002|Overall Study|Administrative Problems|0|||
23725093|NCT00928512|66370676|FG003|Overall Study|Administrative Problems|0|||
23725094|NCT00928512|66370677|FG004|Overall Study|Administrative Problems|0|||
23725095|NCT01412151|66370678|FG000|Week 0 - 306 - Treatment Period|Death|1|||
23725096|NCT01412151|66370678|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
23725097|NCT01412151|66370678|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
23725098|NCT01412151|66370678|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
23725099|NCT03565991|66370681|FG000|Overall Study|Other|11|||
23725100|NCT03565991|66370682|FG001|Overall Study|Other|0|||
23538544|NCT02819726|65705817|FG002|Part B (All Participants)|Protocol non-compliance|1|||
23538545|NCT02819726|65705818|FG003|Part B (All Participants)|Protocol non-compliance|0|||
23538546|NCT03221257|65705819|FG000|Overall Study|Lost to Follow-up|0|||
23538547|NCT03221257|65705820|FG001|Overall Study|Lost to Follow-up|1|||
23538548|NCT03221257|65705819|FG000|Overall Study|Withdrawal by Subject|1|||
23538549|NCT03221257|65705820|FG001|Overall Study|Withdrawal by Subject|1|||
23725101|NCT03565991|66370681|FG000|Overall Study|Global deterioration of health status|14|||
23725102|NCT03565991|66370682|FG001|Overall Study|Global deterioration of health status|4|||
23725103|NCT03565991|66370681|FG000|Overall Study|Withdrawal by Subject|2|||
23725104|NCT03565991|66370682|FG001|Overall Study|Withdrawal by Subject|6|||
23725105|NCT03565991|66370681|FG000|Overall Study|Progressive disease|121|||
23725106|NCT03565991|66370682|FG001|Overall Study|Progressive disease|29|||
23725107|NCT03565991|66370681|FG000|Overall Study|Death|3|||
23538550|NCT00793910|65705823|FG000|Overall Study|discarded study pills|0|||
23538551|NCT00793910|65705824|FG001|Overall Study|discarded study pills|1|||
23538552|NCT00793910|65705823|FG000|Overall Study|did not pick up medications|1|||
23725108|NCT03565991|66370682|FG001|Overall Study|Death|0|||
23725109|NCT03565991|66370681|FG000|Overall Study|Adverse Event|7|||
23725110|NCT03565991|66370682|FG001|Overall Study|Adverse Event|2|||
23538553|NCT00793910|65705824|FG001|Overall Study|did not pick up medications|1|||
23725111|NCT01931150|66370683|FG000|Overall Study|Withdrawal by Subject|1|||
23538554|NCT00793910|65705823|FG000|Overall Study|ineligible based on entry criteria|2|||
23538555|NCT00793910|65705824|FG001|Overall Study|ineligible based on entry criteria|3|||
23538556|NCT00793910|65705823|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
23538557|NCT00793910|65705824|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
23538558|NCT00793910|65705823|FG000|Overall Study|Withdrawal by Subject|0|||
23538559|NCT00793910|65705824|FG001|Overall Study|Withdrawal by Subject|1|||
23538560|NCT00982319|65705826|FG000|Overall Study|Surgery date change|1|||
23538561|NCT00982319|65705827|FG001|Overall Study|Surgery date change|0|||
23538562|NCT00982319|65705826|FG000|Overall Study|Preop values out of acceptable range|1|||
23538563|NCT00982319|65705827|FG001|Overall Study|Preop values out of acceptable range|1|||
23538564|NCT00982319|65705826|FG000|Overall Study|Pregnancy|0|||
23538565|NCT00982319|65705827|FG001|Overall Study|Pregnancy|1|||
23538566|NCT03207750|65705828|FG000|Overall Study|Adverse Event|3|||
23538567|NCT03207750|65705829|FG001|Overall Study|Adverse Event|2|||
23538568|NCT03207750|65705828|FG000|Overall Study|Lost to Follow-up|21|||
23538569|NCT03207750|65705829|FG001|Overall Study|Lost to Follow-up|29|||
23816049|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Adverse Event|0|||
23616399|NCT00244751|65982323|FG002|Overall Study|Adverse Event|5|||
23616400|NCT00244751|65982321|FG000|Overall Study|Lost to Follow-up|0|||
23538570|NCT03207750|65705828|FG000|Overall Study|Protocol Violation|0|||
23816050|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Adverse Event|0|||
23816051|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Adverse Event|0|||
23816052|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Adverse Event|0|||
23816053|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Adverse Event|0|||
23538571|NCT03207750|65705829|FG001|Overall Study|Protocol Violation|1|||
23538572|NCT03207750|65705828|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
23538573|NCT03207750|65705829|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
23538574|NCT03207750|65705828|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
23538575|NCT03207750|65705829|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
23538576|NCT03207750|65705828|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
23538577|NCT03207750|65705829|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
23538578|NCT03207750|65705828|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
23538579|NCT03207750|65705829|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
23538580|NCT03207750|65705828|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
23538581|NCT03207750|65705829|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
23538582|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538583|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538584|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538585|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538586|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538587|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538588|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538589|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23616401|NCT00244751|65982322|FG001|Overall Study|Lost to Follow-up|1|||
23616402|NCT00244751|65982323|FG002|Overall Study|Lost to Follow-up|0|||
23616403|NCT00244751|65982321|FG000|Overall Study|Protocol Violation|1|||
23616404|NCT00244751|65982322|FG001|Overall Study|Protocol Violation|0|||
23616405|NCT00244751|65982323|FG002|Overall Study|Protocol Violation|1|||
23616406|NCT00244751|65982321|FG000|Overall Study|Withdrawal by Subject|7|||
23616407|NCT00244751|65982322|FG001|Overall Study|Withdrawal by Subject|5|||
23616408|NCT00244751|65982323|FG002|Overall Study|Withdrawal by Subject|3|||
23616409|NCT00244751|65982321|FG000|Overall Study|Elevated liver enzymes|1|||
23616410|NCT00244751|65982322|FG001|Overall Study|Elevated liver enzymes|0|||
23616411|NCT00244751|65982323|FG002|Overall Study|Elevated liver enzymes|0|||
23616412|NCT00244751|65982321|FG000|Overall Study|Lack of compliance with protocol|0|||
23616413|NCT00244751|65982322|FG001|Overall Study|Lack of compliance with protocol|1|||
23616414|NCT00244751|65982323|FG002|Overall Study|Lack of compliance with protocol|0|||
23616415|NCT00244751|65982321|FG000|Overall Study|Safety reasons|0|||
23616416|NCT00244751|65982322|FG001|Overall Study|Safety reasons|1|||
23616417|NCT00244751|65982323|FG002|Overall Study|Safety reasons|0|||
23616418|NCT00244751|65982321|FG000|Overall Study|Participant randomized by mistake|0|||
23616419|NCT00244751|65982322|FG001|Overall Study|Participant randomized by mistake|0|||
23616420|NCT00244751|65982323|FG002|Overall Study|Participant randomized by mistake|1|||
23616421|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
23616422|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
23616423|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
23816054|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Adverse Event|0|||
23816055|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Adverse Event|0|||
23816056|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Adverse Event|0|||
23538590|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538591|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23616424|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
23538592|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538593|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538594|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538595|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538596|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538597|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538598|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538599|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538600|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538601|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538602|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
23538603|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
23538604|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
23538605|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
23538606|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538607|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538608|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
23538609|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538610|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538611|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538612|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538613|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538614|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538615|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538616|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538617|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538618|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538619|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538620|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538621|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538622|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538623|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
23538624|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
23538625|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538626|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538627|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538628|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538629|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538630|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538631|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538632|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538633|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538634|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538635|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
23538636|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538637|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538638|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538639|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538640|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538641|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
23538642|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538643|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538644|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538645|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538646|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538647|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538648|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538649|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538650|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538651|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
23816057|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Adverse Event|0|||
23424151|NCT01643850|65296377|FG007|Overall Study|Adverse Event|0|||
23424152|NCT01643850|65296378|FG008|Overall Study|Adverse Event|0|||
23538652|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538653|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538654|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538655|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538656|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538657|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538658|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538659|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538660|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538661|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538662|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538663|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538664|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538665|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538666|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538667|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538668|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538669|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538670|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
23538671|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538672|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538673|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538674|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538675|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538676|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538677|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538678|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
23538679|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538680|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538681|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538682|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538683|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
23538684|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538685|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538686|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538687|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538688|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
23538689|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538690|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538691|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538692|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538693|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538694|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538695|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538696|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538697|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538698|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538699|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538700|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538701|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538702|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538703|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538704|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538705|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538706|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
23538707|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538708|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538709|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538710|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538711|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538712|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538713|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538714|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538715|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23816058|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Adverse Event|0|||
23816059|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Adverse Event|0|||
23538716|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538717|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538718|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538719|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538720|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538721|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538722|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
23816060|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Adverse Event|0|||
23816061|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Adverse Event|0|||
23538723|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
23538724|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
23538725|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
23538726|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538727|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538728|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23616425|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
23616426|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
23616427|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
23616428|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
23725112|NCT01931150|66370684|FG001|Overall Study|Withdrawal by Subject|2|||
23725113|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
23816062|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Adverse Event|0|||
23725114|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
23725115|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23725116|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23725117|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23725118|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23725119|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
23725120|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23725121|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23725122|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23725123|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23725124|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
23725125|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23725126|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23725127|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23725128|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
23725129|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
23725130|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23725131|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23725132|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23725133|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
23725134|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
23725135|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23725136|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23725137|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23725138|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
23725139|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
23725140|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23725141|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23725142|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23725143|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
23725144|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
23725145|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23725146|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23725147|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23725148|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
23725149|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
23725150|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23725151|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23816063|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Adverse Event|0|||
23816064|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Adverse Event|0|||
23816065|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Adverse Event|0|||
23725152|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23725153|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
23816066|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Adverse Event|0|||
23816067|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Adverse Event|0|||
23725154|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
23725155|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23725156|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23725157|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23725158|NCT03689972|66370691|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
23725159|NCT03689972|66370692|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
23725160|NCT03689972|66370693|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23725161|NCT03689972|66370694|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23725162|NCT03689972|66370695|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23725163|NCT03689972|66370691|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23725164|NCT03689972|66370692|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23725165|NCT03689972|66370693|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
23725166|NCT03689972|66370694|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23725167|NCT03689972|66370695|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23725168|NCT03689972|66370691|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23725169|NCT03689972|66370692|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23725170|NCT03689972|66370693|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
23725171|NCT03689972|66370694|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23725172|NCT03689972|66370695|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23725173|NCT03689972|66370691|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23725174|NCT03689972|66370692|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23725175|NCT03689972|66370693|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
23725176|NCT03689972|66370694|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23725177|NCT03689972|66370695|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23725178|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23725179|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23725180|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23725181|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
23725182|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
23725183|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23725184|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23725185|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23725186|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
23725187|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
23725188|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23725189|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23725190|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23725191|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
23725192|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
23725193|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23725194|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23725195|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23725196|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23725197|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
23725198|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23725199|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23725200|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23725201|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
23725202|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
23725203|NCT03689972|66370691|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23725204|NCT03689972|66370692|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23725205|NCT03689972|66370693|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23725206|NCT03689972|66370694|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23725207|NCT03689972|66370695|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
23725208|NCT02786836|66370696|FG000|Overall Study|Death|1|||
23725209|NCT02786836|66370696|FG000|Overall Study|Lack of Efficacy|2|||
23725210|NCT02786836|66370696|FG000|Overall Study|Protocol Violation|3|||
23725211|NCT02786836|66370696|FG000|Overall Study|Withdrawal by Subject|3|||
23725212|NCT02786836|66370696|FG000|Overall Study|Liver Transplantation|2|||
23725213|NCT02786836|66370696|FG000|Overall Study|Device or Pharmacy Issues|3|||
23725214|NCT03997760|66370697|FG000|Overall Study|Protocol Deviation|0|||
23725215|NCT03997760|66370698|FG001|Overall Study|Protocol Deviation|1|||
23725216|NCT03997760|66370699|FG002|Overall Study|Protocol Deviation|0|||
23725217|NCT03997760|66370700|FG003|Overall Study|Protocol Deviation|0|||
23816068|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Adverse Event|0|||
23725218|NCT03250624|66370701|FG000|Overall Study|Lack of Efficacy|1|||
23725219|NCT03250624|66370702|FG001|Overall Study|Lack of Efficacy|4|||
23725220|NCT03250624|66370701|FG000|Overall Study|Adverse Event|0|||
23725221|NCT03250624|66370702|FG001|Overall Study|Adverse Event|1|||
23725222|NCT03250624|66370701|FG000|Overall Study|Other|1|||
23725223|NCT03250624|66370702|FG001|Overall Study|Other|2|||
23725224|NCT01094808|66370704|FG000|Overall Study|Withdrawal by Subject|1|||
23725225|NCT01094808|66370705|FG001|Overall Study|Withdrawal by Subject|1|||
23725226|NCT01094808|66370706|FG002|Overall Study|Withdrawal by Subject|0|||
23725227|NCT02715804|66370707|FG000|Overall Study|Death|222|||
23725228|NCT02715804|66370708|FG001|Overall Study|Death|106|||
23725229|NCT02715804|66370707|FG000|Overall Study|Withdrawal by Subject|5|||
23725230|NCT02715804|66370708|FG001|Overall Study|Withdrawal by Subject|4|||
23725231|NCT02715804|66370707|FG000|Overall Study|Other than specified|2|||
23725232|NCT02715804|66370708|FG001|Overall Study|Other than specified|3|||
23725233|NCT04914819|66370712|FG000|Overall Study|Pregnancy|3|||
23725234|NCT04914819|66370713|FG001|Overall Study|Pregnancy|1|||
23725235|NCT04914819|66370712|FG000|Overall Study|Discontinued study|4|||
23725236|NCT04914819|66370713|FG001|Overall Study|Discontinued study|1|||
23725237|NCT04914819|66370712|FG000|Overall Study|Lost to Follow-up|7|||
23725238|NCT04914819|66370713|FG001|Overall Study|Lost to Follow-up|0|||
23725239|NCT01316380|66370716|FG000|Overall Study|Adverse Event|0|||
23725240|NCT01316380|66370717|FG001|Overall Study|Adverse Event|2|||
23725241|NCT01316380|66370718|FG002|Overall Study|Adverse Event|1|||
23725242|NCT01316380|66370716|FG000|Overall Study|Protocol Violation|0|||
23725243|NCT01316380|66370717|FG001|Overall Study|Protocol Violation|0|||
23725244|NCT01316380|66370718|FG002|Overall Study|Protocol Violation|1|||
23725245|NCT01316380|66370716|FG000|Overall Study|Withdrawal by Subject|1|||
23725246|NCT01316380|66370717|FG001|Overall Study|Withdrawal by Subject|2|||
23725247|NCT01316380|66370718|FG002|Overall Study|Withdrawal by Subject|0|||
23725248|NCT01316380|66370716|FG000|Overall Study|Other|0|||
23725249|NCT01316380|66370717|FG001|Overall Study|Other|1|||
23725250|NCT01316380|66370718|FG002|Overall Study|Other|1|||
23725251|NCT01316380|66370716|FG000|Overall Study|Not treated|1|||
23725252|NCT01316380|66370717|FG001|Overall Study|Not treated|0|||
23725253|NCT01316380|66370718|FG002|Overall Study|Not treated|0|||
23725254|NCT00150345|66370719|FG000|Overall Study|Death|5|||
23725255|NCT00150345|66370720|FG001|Overall Study|Death|2|||
23725256|NCT00150345|66370719|FG000|Overall Study|Adverse Event|8|||
23725257|NCT00150345|66370720|FG001|Overall Study|Adverse Event|6|||
23725258|NCT00150345|66370719|FG000|Overall Study|Lack of Efficacy|5|||
23725259|NCT00150345|66370720|FG001|Overall Study|Lack of Efficacy|4|||
23725260|NCT00150345|66370719|FG000|Overall Study|Withdrawal by Subject|3|||
23725261|NCT00150345|66370720|FG001|Overall Study|Withdrawal by Subject|4|||
23816069|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Adverse Event|0|||
23816070|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Adverse Event|0|||
23816071|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Adverse Event|0|||
23816072|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Adverse Event|1|||
23816073|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Adverse Event|0|||
23816074|NCT02393248|66708276|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816075|NCT02393248|66708277|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816076|NCT02393248|66708278|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816077|NCT02393248|66708279|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816078|NCT02393248|66708280|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816079|NCT02393248|66708281|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816080|NCT02393248|66708282|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816081|NCT02393248|66708283|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816082|NCT02393248|66708284|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816083|NCT02393248|66708285|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816084|NCT02393248|66708286|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816085|NCT02393248|66708287|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23538729|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538730|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23725262|NCT00150345|66370719|FG000|Overall Study|Laboratory abnormality|1|||
23725263|NCT00150345|66370720|FG001|Overall Study|Laboratory abnormality|2|||
23725264|NCT00150345|66370719|FG000|Overall Study|Other|12|||
23725265|NCT00150345|66370720|FG001|Overall Study|Other|14|||
23725266|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
23725267|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
23725268|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23725269|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23725270|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23725271|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
23725272|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
23725273|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23725274|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23725275|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23725276|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
23725277|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
23725278|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23725279|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23725280|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23725281|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23725282|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
23725283|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23725284|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23725285|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23725286|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
23725287|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23538731|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538732|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538733|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538734|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538735|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538736|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538737|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538738|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23538739|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23538740|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23725288|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23725289|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23725290|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23725291|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23725292|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
23725293|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23725294|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23725295|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23725296|NCT04757376|66374289|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
23725297|NCT04757376|66374290|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
23725298|NCT04757376|66374291|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23725299|NCT04757376|66374292|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23538741|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
23538742|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538743|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538744|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23725300|NCT04757376|66374293|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23725301|NCT04757376|66374289|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23725302|NCT04757376|66374290|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23725303|NCT04757376|66374291|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
23725304|NCT04757376|66374292|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23725305|NCT04757376|66374293|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23725306|NCT00294684|66374294|FG000|Overall Study|Lost to Follow-up|5|||
23725307|NCT00294684|66374295|FG001|Overall Study|Lost to Follow-up|8|||
23725308|NCT00262314|66374302|FG000|Overall Study|Changing physicians|38|||
23725309|NCT00262314|66374302|FG000|Overall Study|Death|12|||
23725310|NCT00262314|66374302|FG000|Overall Study|Patient's decision|92|||
23725311|NCT00262314|66374302|FG000|Overall Study|Other|95|||
23725312|NCT00262314|66374302|FG000|Overall Study|Lost to Follow-up|70|||
23725313|NCT00262314|66374302|FG000|Overall Study|Administrative withdrawal|30|||
23725314|NCT01680991|66374303|FG000|Overall Study|Adverse Event|1|||
23725315|NCT01680991|66374304|FG001|Overall Study|Adverse Event|0|||
23725316|NCT01680991|66374305|FG002|Overall Study|Adverse Event|0|||
23725317|NCT01680991|66374303|FG000|Overall Study|Death|1|||
23725318|NCT01680991|66374304|FG001|Overall Study|Death|0|||
23725319|NCT01680991|66374305|FG002|Overall Study|Death|1|||
23725320|NCT01680991|66374303|FG000|Overall Study|Protocol Violation|0|||
23725321|NCT01680991|66374304|FG001|Overall Study|Protocol Violation|1|||
23725322|NCT01680991|66374305|FG002|Overall Study|Protocol Violation|0|||
23725323|NCT01680991|66374303|FG000|Overall Study|Withdrawal by Subject|5|||
23725324|NCT01680991|66374304|FG001|Overall Study|Withdrawal by Subject|1|||
23725325|NCT01680991|66374305|FG002|Overall Study|Withdrawal by Subject|0|||
23725326|NCT01680991|66374303|FG000|Overall Study|Progressive disease (PD)|0|||
23725327|NCT01680991|66374304|FG001|Overall Study|Progressive disease (PD)|10|||
23725328|NCT01680991|66374305|FG002|Overall Study|Progressive disease (PD)|0|||
23725329|NCT01680991|66374303|FG000|Overall Study|Physician Decision|0|||
23725330|NCT01680991|66374304|FG001|Overall Study|Physician Decision|7|||
23725331|NCT01680991|66374305|FG002|Overall Study|Physician Decision|2|||
23538745|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538746|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538747|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538748|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538749|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538750|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538751|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23725332|NCT01680991|66374303|FG000|Overall Study|Bad physical condition|0|||
23725333|NCT01680991|66374304|FG001|Overall Study|Bad physical condition|0|||
23725334|NCT01680991|66374305|FG002|Overall Study|Bad physical condition|1|||
23725335|NCT01680991|66374303|FG000|Overall Study|PD confirmed in other hospital|1|||
23725336|NCT01680991|66374304|FG001|Overall Study|PD confirmed in other hospital|0|||
23725337|NCT01680991|66374305|FG002|Overall Study|PD confirmed in other hospital|0|||
23725338|NCT03077711|66374306|FG000|Overall Study|Lost to Follow-up|2|||
23725339|NCT03077711|66374307|FG001|Overall Study|Lost to Follow-up|2|||
23725340|NCT03077711|66374306|FG000|Overall Study|noncompliant taking medication|2|||
23725341|NCT03077711|66374307|FG001|Overall Study|noncompliant taking medication|0|||
23725342|NCT04063865|66374308|FG000|Overall Study|Physician Decision|1|||
23725343|NCT04063865|66374309|FG001|Overall Study|Physician Decision|3|||
23725344|NCT04063865|66374308|FG000|Overall Study|Study Closed Prior to Completion|4|||
23725345|NCT04063865|66374309|FG001|Overall Study|Study Closed Prior to Completion|4|||
23725346|NCT04063865|66374308|FG000|Overall Study|Withdrawal by Subject|1|||
23725347|NCT04063865|66374309|FG001|Overall Study|Withdrawal by Subject|1|||
23725348|NCT01685203|66374310|FG000|Overall Study|Lost to Follow-up|3|||
23725349|NCT01685203|66374311|FG001|Overall Study|Lost to Follow-up|3|||
23725350|NCT01685203|66374312|FG002|Overall Study|Lost to Follow-up|0|||
23725351|NCT01685203|66374313|FG003|Overall Study|Lost to Follow-up|1|||
23725352|NCT01685203|66374314|FG004|Overall Study|Lost to Follow-up|0|||
23725353|NCT01685203|66374315|FG005|Overall Study|Lost to Follow-up|0|||
23725354|NCT01685203|66374316|FG006|Overall Study|Lost to Follow-up|0|||
23725355|NCT01685203|66374310|FG000|Overall Study|Adverse Event|0|||
23725356|NCT01685203|66374311|FG001|Overall Study|Adverse Event|0|||
23725357|NCT01685203|66374312|FG002|Overall Study|Adverse Event|0|||
23725358|NCT01685203|66374313|FG003|Overall Study|Adverse Event|0|||
23725359|NCT01685203|66374314|FG004|Overall Study|Adverse Event|0|||
23725360|NCT01685203|66374315|FG005|Overall Study|Adverse Event|2|||
23725361|NCT01685203|66374316|FG006|Overall Study|Adverse Event|0|||
23725362|NCT01685203|66374310|FG000|Overall Study|Adverse event and withdrew consent|1|||
23725363|NCT01685203|66374311|FG001|Overall Study|Adverse event and withdrew consent|0|||
23725364|NCT01685203|66374312|FG002|Overall Study|Adverse event and withdrew consent|0|||
23725365|NCT01685203|66374313|FG003|Overall Study|Adverse event and withdrew consent|0|||
23725366|NCT01685203|66374314|FG004|Overall Study|Adverse event and withdrew consent|0|||
23725367|NCT01685203|66374315|FG005|Overall Study|Adverse event and withdrew consent|0|||
23725368|NCT01685203|66374316|FG006|Overall Study|Adverse event and withdrew consent|0|||
23725369|NCT01685203|66374310|FG000|Overall Study|Patient's decision|0|||
23725370|NCT01685203|66374311|FG001|Overall Study|Patient's decision|0|||
23725371|NCT01685203|66374312|FG002|Overall Study|Patient's decision|0|||
23725372|NCT01685203|66374313|FG003|Overall Study|Patient's decision|0|||
23725373|NCT01685203|66374314|FG004|Overall Study|Patient's decision|0|||
23725374|NCT01685203|66374315|FG005|Overall Study|Patient's decision|1|||
23725375|NCT01685203|66374316|FG006|Overall Study|Patient's decision|0|||
23725376|NCT02657434|66374317|FG000|Overall Study|Study Terminated By Sponsor|64|||
23725377|NCT02657434|66374318|FG001|Overall Study|Study Terminated By Sponsor|82|||
23725378|NCT02657434|66374317|FG000|Overall Study|Death|189|||
23725379|NCT02657434|66374318|FG001|Overall Study|Death|190|||
23725380|NCT02657434|66374317|FG000|Overall Study|Lost to Follow-up|2|||
23725381|NCT02657434|66374318|FG001|Overall Study|Lost to Follow-up|2|||
23725382|NCT02657434|66374317|FG000|Overall Study|Randomization by Error|2|||
23725383|NCT02657434|66374318|FG001|Overall Study|Randomization by Error|0|||
23725384|NCT02657434|66374317|FG000|Overall Study|Withdrawal by Subject|28|||
23725385|NCT02657434|66374318|FG001|Overall Study|Withdrawal by Subject|17|||
23725386|NCT02657434|66374317|FG000|Overall Study|Protocol Violation|1|||
23725387|NCT02657434|66374318|FG001|Overall Study|Protocol Violation|0|||
23725388|NCT02657434|66374317|FG000|Overall Study|Physician Decision|0|||
23725389|NCT02657434|66374318|FG001|Overall Study|Physician Decision|1|||
23725390|NCT03796195|66374319|FG000|Overall Study|Study closed early|1|||
23725391|NCT01106391|66374322|FG000|Overall Study|Death|12|||
23725392|NCT01106391|66374322|FG000|Overall Study|Withdrawal by Subject|7|||
23725393|NCT00367341|66374325|FG000|Overall Study|Physician Decision|1|||
23725394|NCT00367341|66374326|FG001|Overall Study|Physician Decision|0|||
23725395|NCT00367341|66374325|FG000|Overall Study|Protocol Violation|1|||
23725396|NCT00367341|66374326|FG001|Overall Study|Protocol Violation|0|||
23725397|NCT00610207|66374333|FG000|Overall Study|Lost to Follow-up|3|||
23725398|NCT03927911|66374334|FG000|Overall Study|problems with eDiary|0|||
23725399|NCT03927911|66374335|FG001|Overall Study|problems with eDiary|1|||
23725400|NCT03927911|66374336|FG002|Overall Study|problems with eDiary|0|||
23725401|NCT03927911|66374337|FG003|Overall Study|problems with eDiary|1|||
23725402|NCT03927911|66374338|FG004|Overall Study|problems with eDiary|0|||
23725403|NCT03927911|66374339|FG005|Overall Study|problems with eDiary|4|||
23725404|NCT03927911|66374334|FG000|Overall Study|Adverse Event|0|||
23725405|NCT03927911|66374335|FG001|Overall Study|Adverse Event|0|||
23725406|NCT03927911|66374336|FG002|Overall Study|Adverse Event|0|||
23725407|NCT03927911|66374337|FG003|Overall Study|Adverse Event|0|||
23725408|NCT03927911|66374338|FG004|Overall Study|Adverse Event|0|||
23725409|NCT03927911|66374339|FG005|Overall Study|Adverse Event|1|||
23725410|NCT03927911|66374334|FG000|Overall Study|not treated -study terminated by sponsor|0|||
23725411|NCT03927911|66374335|FG001|Overall Study|not treated -study terminated by sponsor|1|||
23725412|NCT03927911|66374336|FG002|Overall Study|not treated -study terminated by sponsor|0|||
23725413|NCT03927911|66374337|FG003|Overall Study|not treated -study terminated by sponsor|0|||
23725414|NCT03927911|66374338|FG004|Overall Study|not treated -study terminated by sponsor|0|||
23725415|NCT03927911|66374339|FG005|Overall Study|not treated -study terminated by sponsor|0|||
23725416|NCT03927911|66374334|FG000|Overall Study|Surgery cancelled|0|||
23725417|NCT03927911|66374335|FG001|Overall Study|Surgery cancelled|0|||
23725418|NCT03927911|66374336|FG002|Overall Study|Surgery cancelled|0|||
23725419|NCT03927911|66374337|FG003|Overall Study|Surgery cancelled|1|||
23725420|NCT03927911|66374338|FG004|Overall Study|Surgery cancelled|0|||
23725421|NCT03927911|66374339|FG005|Overall Study|Surgery cancelled|1|||
23725422|NCT03927911|66374334|FG000|Overall Study|Protocol Violation|0|||
23725423|NCT03927911|66374335|FG001|Overall Study|Protocol Violation|0|||
23725424|NCT03927911|66374336|FG002|Overall Study|Protocol Violation|0|||
23725425|NCT03927911|66374337|FG003|Overall Study|Protocol Violation|0|||
23725426|NCT03927911|66374338|FG004|Overall Study|Protocol Violation|0|||
23725427|NCT03927911|66374339|FG005|Overall Study|Protocol Violation|1|||
23725428|NCT01993667|66374340|FG000|Overall Study|Insufficient data to analyze|16|||
23725429|NCT01993667|66374341|FG001|Overall Study|Insufficient data to analyze|16|||
23725430|NCT01993667|66374340|FG000|Overall Study|Insufficient altitude reached|3|||
23725431|NCT01993667|66374341|FG001|Overall Study|Insufficient altitude reached|1|||
23725432|NCT01993667|66374340|FG000|Overall Study|Lost to Follow-up|2|||
23725433|NCT01993667|66374341|FG001|Overall Study|Lost to Follow-up|2|||
23725434|NCT02025530|66374342|FG000|Overall Study|No longer met elligibility criteria|5|||
23725435|NCT02025530|66374343|FG001|Overall Study|No longer met elligibility criteria|1|||
23725436|NCT04964557|66374346|FG000|Overall Study|Withdrawal by Subject|3|||
23725437|NCT04964557|66374347|FG001|Overall Study|Withdrawal by Subject|2|||
23725438|NCT04964557|66374346|FG000|Overall Study|Lost to Follow-up|1|||
23725439|NCT04964557|66374347|FG001|Overall Study|Lost to Follow-up|2|||
23725440|NCT04964557|66374346|FG000|Overall Study|Physician Decision|2|||
23725441|NCT04964557|66374347|FG001|Overall Study|Physician Decision|0|||
23725442|NCT04964557|66374346|FG000|Overall Study|Death|3|||
23725443|NCT04964557|66374347|FG001|Overall Study|Death|0|||
23725444|NCT04964557|66374346|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
23725445|NCT04964557|66374347|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
23725446|NCT05083949|66374348|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
23725447|NCT05083949|66374349|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
23725448|NCT05083949|66374348|FG000|Period 1|Adverse Event|1|||
23725449|NCT05083949|66374349|FG001|Period 1|Adverse Event|1|||
23725450|NCT05083949|66374348|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
23725451|NCT05083949|66374349|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
23725452|NCT05083949|66374348|FG000|Period 2|Adverse Event|0|||
23725453|NCT05083949|66374349|FG001|Period 2|Adverse Event|2|||
23725454|NCT03630016|66374350|FG000|Overall Study|Poor Sensor Placement|1|||
23725455|NCT00324740|66374351|FG000|Overall Study|Withdrawal by Subject|1|||
23725456|NCT00324740|66374352|FG001|Overall Study|Withdrawal by Subject|0|||
23725457|NCT00324740|66374353|FG002|Overall Study|Withdrawal by Subject|1|||
23725458|NCT03799627|66374356|FG000|Overall Study|Adverse Event|1|||
23725459|NCT03799627|66374357|FG001|Overall Study|Adverse Event|2|||
23725460|NCT03799627|66374358|FG002|Overall Study|Adverse Event|0|||
23725461|NCT03799627|66374359|FG003|Overall Study|Adverse Event|0|||
23725462|NCT03799627|66374360|FG004|Overall Study|Adverse Event|2|||
23725463|NCT03799627|66374361|FG005|Overall Study|Adverse Event|5|||
23725464|NCT03799627|66374362|FG006|Overall Study|Adverse Event|0|||
23725465|NCT03799627|66374363|FG007|Overall Study|Adverse Event|2|||
23725466|NCT03799627|66374364|FG008|Overall Study|Adverse Event|0|||
23725467|NCT03799627|66374356|FG000|Overall Study|Physician Decision|2|||
23725468|NCT03799627|66374357|FG001|Overall Study|Physician Decision|2|||
23725469|NCT03799627|66374358|FG002|Overall Study|Physician Decision|0|||
23725470|NCT03799627|66374359|FG003|Overall Study|Physician Decision|0|||
23725471|NCT03799627|66374360|FG004|Overall Study|Physician Decision|2|||
23725472|NCT03799627|66374361|FG005|Overall Study|Physician Decision|2|||
23725473|NCT03799627|66374362|FG006|Overall Study|Physician Decision|0|||
23725474|NCT03799627|66374363|FG007|Overall Study|Physician Decision|0|||
23725475|NCT03799627|66374364|FG008|Overall Study|Physician Decision|0|||
23725476|NCT03799627|66374356|FG000|Overall Study|Withdrawal by Subject|1|||
23725477|NCT03799627|66374357|FG001|Overall Study|Withdrawal by Subject|1|||
23725478|NCT03799627|66374358|FG002|Overall Study|Withdrawal by Subject|0|||
23725479|NCT03799627|66374359|FG003|Overall Study|Withdrawal by Subject|2|||
23725480|NCT03799627|66374360|FG004|Overall Study|Withdrawal by Subject|0|||
23725481|NCT03799627|66374361|FG005|Overall Study|Withdrawal by Subject|3|||
23725482|NCT03799627|66374362|FG006|Overall Study|Withdrawal by Subject|0|||
23725483|NCT03799627|66374363|FG007|Overall Study|Withdrawal by Subject|0|||
23725484|NCT03799627|66374364|FG008|Overall Study|Withdrawal by Subject|0|||
23725485|NCT03799627|66374356|FG000|Overall Study|Lack of Efficacy|0|||
23725486|NCT03799627|66374357|FG001|Overall Study|Lack of Efficacy|0|||
23725487|NCT03799627|66374358|FG002|Overall Study|Lack of Efficacy|0|||
23725488|NCT03799627|66374359|FG003|Overall Study|Lack of Efficacy|1|||
23725489|NCT03799627|66374360|FG004|Overall Study|Lack of Efficacy|0|||
23816086|NCT02393248|66708288|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816087|NCT02393248|66708289|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816088|NCT02393248|66708290|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816089|NCT02393248|66708291|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816090|NCT02393248|66708292|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816091|NCT02393248|66708293|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816092|NCT02393248|66708294|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816093|NCT02393248|66708295|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816094|NCT02393248|66708296|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816095|NCT02393248|66708297|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816096|NCT02393248|66708298|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23538752|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538753|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23725490|NCT03799627|66374361|FG005|Overall Study|Lack of Efficacy|0|||
23725491|NCT03799627|66374362|FG006|Overall Study|Lack of Efficacy|0|||
23725492|NCT03799627|66374363|FG007|Overall Study|Lack of Efficacy|0|||
23725493|NCT03799627|66374364|FG008|Overall Study|Lack of Efficacy|0|||
23725494|NCT03799627|66374356|FG000|Overall Study|Lost to Follow-up|0|||
23725495|NCT03799627|66374357|FG001|Overall Study|Lost to Follow-up|0|||
23725496|NCT03799627|66374358|FG002|Overall Study|Lost to Follow-up|0|||
23538754|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
23538755|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538756|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538757|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538758|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538759|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538760|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538761|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538762|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538763|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538764|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538765|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538766|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538767|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23725497|NCT03799627|66374359|FG003|Overall Study|Lost to Follow-up|0|||
23725498|NCT03799627|66374360|FG004|Overall Study|Lost to Follow-up|0|||
23725499|NCT03799627|66374361|FG005|Overall Study|Lost to Follow-up|0|||
23725500|NCT03799627|66374362|FG006|Overall Study|Lost to Follow-up|1|||
23725501|NCT03799627|66374363|FG007|Overall Study|Lost to Follow-up|0|||
23725502|NCT03799627|66374364|FG008|Overall Study|Lost to Follow-up|1|||
23616429|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
23725503|NCT03799627|66374356|FG000|Overall Study|Death|0|||
23725504|NCT03799627|66374357|FG001|Overall Study|Death|0|||
23725505|NCT03799627|66374358|FG002|Overall Study|Death|0|||
23725506|NCT03799627|66374359|FG003|Overall Study|Death|1|||
23725507|NCT03799627|66374360|FG004|Overall Study|Death|0|||
23725508|NCT03799627|66374361|FG005|Overall Study|Death|0|||
23816097|NCT02393248|66708299|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
23725509|NCT03799627|66374362|FG006|Overall Study|Death|0|||
23725510|NCT03799627|66374363|FG007|Overall Study|Death|0|||
23725511|NCT03799627|66374364|FG008|Overall Study|Death|0|||
23725512|NCT03799627|66374356|FG000|Overall Study|Study Drug Put on Hold|1|||
23538768|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538769|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538770|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
23538771|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
23538772|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
23538773|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
23538774|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538775|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538776|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538777|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538778|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538779|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538780|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538781|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538782|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538783|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538784|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538785|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538786|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538787|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538788|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538789|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
23538790|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538791|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538792|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538793|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538794|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538795|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538796|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538797|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538798|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538799|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538800|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538801|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538802|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
23538803|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
23538804|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538805|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
23538806|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538807|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538808|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538809|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538810|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538811|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538812|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538813|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23616430|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
23725513|NCT03799627|66374357|FG001|Overall Study|Study Drug Put on Hold|0|||
23725514|NCT03799627|66374358|FG002|Overall Study|Study Drug Put on Hold|0|||
23725515|NCT03799627|66374359|FG003|Overall Study|Study Drug Put on Hold|0|||
23725516|NCT03799627|66374360|FG004|Overall Study|Study Drug Put on Hold|0|||
23725517|NCT03799627|66374361|FG005|Overall Study|Study Drug Put on Hold|0|||
23725518|NCT03799627|66374362|FG006|Overall Study|Study Drug Put on Hold|0|||
23725519|NCT03799627|66374363|FG007|Overall Study|Study Drug Put on Hold|0|||
23725520|NCT03799627|66374364|FG008|Overall Study|Study Drug Put on Hold|0|||
23725521|NCT03799627|66374356|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
23725522|NCT03799627|66374357|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
23725523|NCT03799627|66374358|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
23725524|NCT03799627|66374359|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
23725525|NCT03799627|66374360|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
23725526|NCT03799627|66374361|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
23725527|NCT03799627|66374362|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
23725528|NCT03799627|66374363|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
23538814|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538815|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538816|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23725529|NCT03799627|66374364|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
23725530|NCT03799627|66374356|FG000|Overall Study|Kidney Transplantation|1|||
23725531|NCT03799627|66374357|FG001|Overall Study|Kidney Transplantation|0|||
23538817|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538818|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
23538819|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538820|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538821|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538822|NCT00437489|65705846|FG000|Overall Study|Study terminated by sponsor|23|||
23538823|NCT00437489|65705847|FG001|Overall Study|Study terminated by sponsor|21|||
23538824|NCT00437489|65705846|FG000|Overall Study|Lost to Follow-up|0|||
23538825|NCT00437489|65705847|FG001|Overall Study|Lost to Follow-up|1|||
23538826|NCT02613481|65705848|FG000|Overall Study|Lost to Follow-up|7|||
23538827|NCT02613481|65705848|FG000|Overall Study|Withdrawal by Subject|2|||
23538828|NCT02731131|65705849|FG000|Overall Study|Psychiatric Disorder|0|||
23538829|NCT02731131|65705850|FG001|Overall Study|Psychiatric Disorder|1|||
23538830|NCT02731131|65705849|FG000|Overall Study|Refused Therapy|0|||
23538831|NCT02731131|65705850|FG001|Overall Study|Refused Therapy|1|||
23538832|NCT02899728|65705852|FG000|Overall Study|Withdrawal by Subject|1|||
23538833|NCT02899728|65705853|FG001|Overall Study|Withdrawal by Subject|1|||
23538834|NCT02033889|65705856|FG000|Overall Study|Adverse Event|3|||
23538835|NCT02033889|65705857|FG001|Overall Study|Adverse Event|1|||
23538836|NCT02033889|65705858|FG002|Overall Study|Adverse Event|3|||
23538837|NCT02033889|65705856|FG000|Overall Study|Death|3|||
23538838|NCT02033889|65705857|FG001|Overall Study|Death|1|||
23538839|NCT02033889|65705858|FG002|Overall Study|Death|2|||
23538840|NCT02033889|65705856|FG000|Overall Study|Excluded Medication|1|||
23538841|NCT02033889|65705857|FG001|Overall Study|Excluded Medication|1|||
23538842|NCT02033889|65705858|FG002|Overall Study|Excluded Medication|0|||
23538843|NCT02033889|65705856|FG000|Overall Study|Lost to Follow-up|8|||
23538844|NCT02033889|65705857|FG001|Overall Study|Lost to Follow-up|5|||
23538845|NCT02033889|65705858|FG002|Overall Study|Lost to Follow-up|6|||
23538846|NCT02033889|65705856|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23538847|NCT02033889|65705857|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23538848|NCT02033889|65705858|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23538849|NCT02033889|65705856|FG000|Overall Study|Physician Decision|0|||
23538850|NCT02033889|65705857|FG001|Overall Study|Physician Decision|1|||
23538851|NCT02033889|65705858|FG002|Overall Study|Physician Decision|1|||
23538852|NCT02033889|65705856|FG000|Overall Study|Participant moved|0|||
23538853|NCT02033889|65705857|FG001|Overall Study|Participant moved|1|||
23538854|NCT02033889|65705858|FG002|Overall Study|Participant moved|0|||
23538855|NCT02033889|65705856|FG000|Overall Study|Withdrawal by Subject|18|||
23538856|NCT02033889|65705857|FG001|Overall Study|Withdrawal by Subject|10|||
23538857|NCT02033889|65705858|FG002|Overall Study|Withdrawal by Subject|13|||
23538858|NCT01401530|65705861|FG000|Overall Study|Disease Progression|1|||
23538859|NCT01401530|65705862|FG001|Overall Study|Disease Progression|2|||
23538860|NCT01401530|65705863|FG002|Overall Study|Disease Progression|1|||
23538861|NCT01401530|65705861|FG000|Overall Study|Adverse Event|1|||
23538862|NCT01401530|65705862|FG001|Overall Study|Adverse Event|1|||
23538863|NCT01401530|65705863|FG002|Overall Study|Adverse Event|1|||
23538864|NCT01401530|65705861|FG000|Overall Study|Participant Choice|1|||
23538865|NCT01401530|65705862|FG001|Overall Study|Participant Choice|2|||
23538866|NCT01401530|65705863|FG002|Overall Study|Participant Choice|1|||
23816098|NCT02393248|66708300|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23816099|NCT01220297|66708306|FG000|Overall Study|Death|2|||
23816100|NCT01220297|66708306|FG000|Overall Study|Lost to Follow-up|1|||
23816101|NCT00507130|66708307|FG000|Overall Study|Lost to Follow-up|0|||
23816102|NCT00507130|66708308|FG001|Overall Study|Lost to Follow-up|0|||
23816103|NCT00507130|66708309|FG002|Overall Study|Lost to Follow-up|1|||
23816104|NCT00507130|66708310|FG003|Overall Study|Lost to Follow-up|1|||
23538867|NCT01401530|65705861|FG000|Overall Study|Physician Decision|0|||
23538868|NCT01401530|65705862|FG001|Overall Study|Physician Decision|1|||
23538869|NCT01401530|65705863|FG002|Overall Study|Physician Decision|0|||
23538870|NCT03348904|65705864|FG000|Overall Study|Administrative reason by the sponsor|0|||
23725532|NCT03799627|66374358|FG002|Overall Study|Kidney Transplantation|0|||
23816105|NCT00507130|66708307|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
23538871|NCT03348904|65705865|FG001|Overall Study|Administrative reason by the sponsor|1|||
23538872|NCT03348904|65705866|FG002|Overall Study|Administrative reason by the sponsor|0|||
23538873|NCT00608829|65705867|FG000|Overall Study|Death|6|||
23538874|NCT00608829|65705867|FG000|Overall Study|Withdrawal by Subject|4|||
23538875|NCT00608829|65705867|FG000|Overall Study|Subject refuses to follow up or return.|5|||
23538876|NCT03224468|65705868|FG000|Overall Study|Did not obtain MM card|53|||
23538877|NCT03224468|65705869|FG001|Overall Study|Did not obtain MM card|0|||
23538878|NCT03224468|65705868|FG000|Overall Study|Lost to Follow-up|4|||
23538879|NCT03224468|65705869|FG001|Overall Study|Lost to Follow-up|11|||
23538880|NCT03224468|65705868|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
23538881|NCT03224468|65705869|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
23538882|NCT02031276|65705870|FG000|Period 1 Double-blind IV|Adverse Event|6|||
23538883|NCT02031276|65705871|FG001|Period 1 Double-blind IV|Adverse Event|5|||
23538884|NCT02031276|65705872|FG002|Period 1 Double-blind IV|Adverse Event|1|||
23538885|NCT02031276|65705870|FG000|Period 1 Double-blind IV|Other|0|||
23538886|NCT02031276|65705871|FG001|Period 1 Double-blind IV|Other|1|||
23538887|NCT02031276|65705872|FG002|Period 1 Double-blind IV|Other|0|||
23538888|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
23816106|NCT00507130|66708308|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23816107|NCT00507130|66708309|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23816108|NCT00507130|66708310|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23816109|NCT04711902|66708311|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
23816110|NCT04711902|66708312|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
23816111|NCT04711902|66708313|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
23816112|NCT04711902|66708314|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
23816113|NCT04711902|66708315|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
23816114|NCT04711902|66708316|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
23816115|NCT04630158|66708318|FG000|Overall Study|Adverse Event|1|||
23538889|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
23538890|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
23538891|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
23538892|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
23538893|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
23538894|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
23538895|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
23538896|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
23538897|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
23538898|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
23538899|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
23538900|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
23725533|NCT03799627|66374359|FG003|Overall Study|Kidney Transplantation|1|||
23725534|NCT03799627|66374360|FG004|Overall Study|Kidney Transplantation|1|||
23725535|NCT03799627|66374361|FG005|Overall Study|Kidney Transplantation|0|||
23725536|NCT03799627|66374362|FG006|Overall Study|Kidney Transplantation|0|||
23816116|NCT04630158|66708319|FG001|Overall Study|Adverse Event|1|||
23816117|NCT04630158|66708320|FG002|Overall Study|Adverse Event|1|||
23816118|NCT04630158|66708318|FG000|Overall Study|Physician Decision|0|||
23538901|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
23725537|NCT03799627|66374363|FG007|Overall Study|Kidney Transplantation|0|||
23725538|NCT03799627|66374364|FG008|Overall Study|Kidney Transplantation|0|||
23725539|NCT03799627|66374356|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
23725540|NCT03799627|66374357|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
23725541|NCT03799627|66374358|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
23725542|NCT03799627|66374359|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
23725543|NCT03799627|66374360|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
23725544|NCT03799627|66374361|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
23725545|NCT03799627|66374362|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
23725546|NCT03799627|66374363|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
23725547|NCT03799627|66374364|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
23725548|NCT03799627|66374356|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725549|NCT03799627|66374357|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
23725550|NCT03799627|66374358|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725551|NCT03799627|66374359|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725552|NCT03799627|66374360|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725553|NCT03799627|66374361|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725554|NCT03799627|66374362|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725555|NCT03799627|66374363|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725556|NCT03799627|66374364|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23725557|NCT03799627|66374356|FG000|Overall Study|Met Exclusion Criteria|0|||
23725558|NCT03799627|66374357|FG001|Overall Study|Met Exclusion Criteria|0|||
23725559|NCT03799627|66374358|FG002|Overall Study|Met Exclusion Criteria|0|||
23725560|NCT03799627|66374359|FG003|Overall Study|Met Exclusion Criteria|1|||
23725561|NCT03799627|66374360|FG004|Overall Study|Met Exclusion Criteria|0|||
23725562|NCT03799627|66374361|FG005|Overall Study|Met Exclusion Criteria|0|||
23725563|NCT03799627|66374362|FG006|Overall Study|Met Exclusion Criteria|0|||
23538902|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
23538903|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23538904|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23616431|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Death|1|||
23725564|NCT03799627|66374363|FG007|Overall Study|Met Exclusion Criteria|0|||
23725565|NCT03799627|66374364|FG008|Overall Study|Met Exclusion Criteria|0|||
23725566|NCT03799627|66374356|FG000|Overall Study|Investigational Product Noncompliance|0|||
23725567|NCT03799627|66374357|FG001|Overall Study|Investigational Product Noncompliance|0|||
23725568|NCT03799627|66374358|FG002|Overall Study|Investigational Product Noncompliance|0|||
23725569|NCT03799627|66374359|FG003|Overall Study|Investigational Product Noncompliance|1|||
23725570|NCT03799627|66374360|FG004|Overall Study|Investigational Product Noncompliance|0|||
23725571|NCT03799627|66374361|FG005|Overall Study|Investigational Product Noncompliance|0|||
23725572|NCT03799627|66374362|FG006|Overall Study|Investigational Product Noncompliance|0|||
23725573|NCT03799627|66374363|FG007|Overall Study|Investigational Product Noncompliance|0|||
23725574|NCT03799627|66374364|FG008|Overall Study|Investigational Product Noncompliance|0|||
23725575|NCT03799627|66374356|FG000|Overall Study|Participant Relocation|0|||
23725576|NCT03799627|66374357|FG001|Overall Study|Participant Relocation|0|||
23725577|NCT03799627|66374358|FG002|Overall Study|Participant Relocation|0|||
23725578|NCT03799627|66374359|FG003|Overall Study|Participant Relocation|1|||
23725579|NCT03799627|66374360|FG004|Overall Study|Participant Relocation|0|||
23725580|NCT03799627|66374361|FG005|Overall Study|Participant Relocation|1|||
23725581|NCT03799627|66374362|FG006|Overall Study|Participant Relocation|0|||
23725582|NCT03799627|66374363|FG007|Overall Study|Participant Relocation|0|||
23725583|NCT03799627|66374364|FG008|Overall Study|Participant Relocation|0|||
23725584|NCT03799627|66374356|FG000|Overall Study|Eurofin Issue|0|||
23725585|NCT03799627|66374357|FG001|Overall Study|Eurofin Issue|0|||
23725586|NCT03799627|66374358|FG002|Overall Study|Eurofin Issue|0|||
23725587|NCT03799627|66374359|FG003|Overall Study|Eurofin Issue|0|||
23725588|NCT03799627|66374360|FG004|Overall Study|Eurofin Issue|1|||
23725589|NCT03799627|66374361|FG005|Overall Study|Eurofin Issue|0|||
23725590|NCT03799627|66374362|FG006|Overall Study|Eurofin Issue|0|||
23725591|NCT03799627|66374363|FG007|Overall Study|Eurofin Issue|0|||
23725592|NCT03799627|66374364|FG008|Overall Study|Eurofin Issue|0|||
23725593|NCT03799627|66374356|FG000|Overall Study|Noncompliance with Site Instructions|0|||
23725594|NCT03799627|66374357|FG001|Overall Study|Noncompliance with Site Instructions|0|||
23725595|NCT03799627|66374358|FG002|Overall Study|Noncompliance with Site Instructions|0|||
23725596|NCT03799627|66374359|FG003|Overall Study|Noncompliance with Site Instructions|0|||
23725597|NCT03799627|66374360|FG004|Overall Study|Noncompliance with Site Instructions|1|||
23725598|NCT03799627|66374361|FG005|Overall Study|Noncompliance with Site Instructions|0|||
23725599|NCT03799627|66374362|FG006|Overall Study|Noncompliance with Site Instructions|0|||
23725600|NCT03799627|66374363|FG007|Overall Study|Noncompliance with Site Instructions|0|||
23725601|NCT03799627|66374364|FG008|Overall Study|Noncompliance with Site Instructions|0|||
23725602|NCT03799627|66374356|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725603|NCT03799627|66374357|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725604|NCT03799627|66374358|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725605|NCT03799627|66374359|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725606|NCT03799627|66374360|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
23725607|NCT03799627|66374361|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725608|NCT03799627|66374362|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725609|NCT03799627|66374363|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725610|NCT03799627|66374364|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23725611|NCT03799627|66374356|FG000|Overall Study|Changes In Hemoglobin Values|1|||
23725612|NCT03799627|66374357|FG001|Overall Study|Changes In Hemoglobin Values|2|||
23725613|NCT03799627|66374358|FG002|Overall Study|Changes In Hemoglobin Values|1|||
23725614|NCT03799627|66374359|FG003|Overall Study|Changes In Hemoglobin Values|0|||
23725615|NCT03799627|66374360|FG004|Overall Study|Changes In Hemoglobin Values|0|||
23725616|NCT03799627|66374361|FG005|Overall Study|Changes In Hemoglobin Values|2|||
23725617|NCT03799627|66374362|FG006|Overall Study|Changes In Hemoglobin Values|1|||
23725618|NCT03799627|66374363|FG007|Overall Study|Changes In Hemoglobin Values|0|||
23725619|NCT03799627|66374364|FG008|Overall Study|Changes In Hemoglobin Values|1|||
23725620|NCT01929707|66374365|FG000|Intervention Period 1|Lost to Follow-up|0|||
23725621|NCT01929707|66374366|FG001|Intervention Period 1|Lost to Follow-up|0|||
23725622|NCT01929707|66374367|FG002|Intervention Period 1|Lost to Follow-up|0|||
23725623|NCT01929707|66374368|FG003|Intervention Period 1|Lost to Follow-up|1|||
23725624|NCT01929707|66374369|FG004|Intervention Period 1|Lost to Follow-up|0|||
23725625|NCT01929707|66374370|FG005|Intervention Period 1|Lost to Follow-up|0|||
23725626|NCT01929707|66374371|FG006|Intervention Period 1|Lost to Follow-up|0|||
23725627|NCT01929707|66374372|FG007|Intervention Period 1|Lost to Follow-up|0|||
23725628|NCT01929707|66374365|FG000|Intervention Period 1|Withdrawal by Subject|0|||
23725629|NCT01929707|66374366|FG001|Intervention Period 1|Withdrawal by Subject|0|||
23725630|NCT01929707|66374367|FG002|Intervention Period 1|Withdrawal by Subject|0|||
23725631|NCT01929707|66374368|FG003|Intervention Period 1|Withdrawal by Subject|2|||
23725632|NCT01929707|66374369|FG004|Intervention Period 1|Withdrawal by Subject|0|||
23725633|NCT01929707|66374370|FG005|Intervention Period 1|Withdrawal by Subject|0|||
23725634|NCT01929707|66374371|FG006|Intervention Period 1|Withdrawal by Subject|0|||
23725635|NCT01929707|66374372|FG007|Intervention Period 1|Withdrawal by Subject|0|||
23725636|NCT01929707|66374365|FG000|Intervention Period 2|Withdrawal by Subject|0|||
23538905|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23538906|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
23538907|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
23538908|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
23538909|NCT02029443|65705873|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
23538910|NCT02029443|65705874|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
23538911|NCT02029443|65705875|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
23538912|NCT02029443|65705876|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
23538913|NCT02029443|65705877|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
23538914|NCT02029443|65705873|FG000|Overall Study|Death|13|||
23538915|NCT02029443|65705874|FG001|Overall Study|Death|2|||
23538916|NCT02029443|65705875|FG002|Overall Study|Death|2|||
23538917|NCT02029443|65705876|FG003|Overall Study|Death|11|||
23538918|NCT02029443|65705877|FG004|Overall Study|Death|2|||
23538919|NCT02029443|65705873|FG000|Overall Study|Lost to Follow-up|1|||
23538920|NCT02029443|65705874|FG001|Overall Study|Lost to Follow-up|0|||
23816119|NCT04630158|66708319|FG001|Overall Study|Physician Decision|2|||
23538921|NCT02029443|65705875|FG002|Overall Study|Lost to Follow-up|1|||
23538922|NCT02029443|65705876|FG003|Overall Study|Lost to Follow-up|1|||
23538923|NCT02029443|65705877|FG004|Overall Study|Lost to Follow-up|0|||
23538924|NCT02029443|65705873|FG000|Overall Study|Started other anti-cancer therapy|17|||
23538925|NCT02029443|65705874|FG001|Overall Study|Started other anti-cancer therapy|4|||
23538926|NCT02029443|65705875|FG002|Overall Study|Started other anti-cancer therapy|7|||
23538927|NCT02029443|65705876|FG003|Overall Study|Started other anti-cancer therapy|9|||
23538928|NCT02029443|65705877|FG004|Overall Study|Started other anti-cancer therapy|3|||
23538929|NCT02029443|65705873|FG000|Overall Study|Withdrawal by Subject|3|||
23538930|NCT02029443|65705874|FG001|Overall Study|Withdrawal by Subject|1|||
23538931|NCT02029443|65705875|FG002|Overall Study|Withdrawal by Subject|1|||
23538932|NCT02029443|65705876|FG003|Overall Study|Withdrawal by Subject|1|||
23538933|NCT02029443|65705877|FG004|Overall Study|Withdrawal by Subject|0|||
23538934|NCT02029443|65705873|FG000|Overall Study|Other|6|||
23538935|NCT02029443|65705874|FG001|Overall Study|Other|6|||
23538936|NCT02029443|65705875|FG002|Overall Study|Other|4|||
23538937|NCT02029443|65705876|FG003|Overall Study|Other|2|||
23538938|NCT02029443|65705877|FG004|Overall Study|Other|0|||
23538939|NCT04260191|65705878|FG000|Overall Study|Decision by Sponsor|0|||
23538940|NCT04260191|65705879|FG001|Overall Study|Decision by Sponsor|1|||
23538941|NCT04260191|65705880|FG002|Overall Study|Decision by Sponsor|0|||
23538942|NCT04260191|65705878|FG000|Overall Study|Withdrawal by Subject|1|||
23538943|NCT04260191|65705879|FG001|Overall Study|Withdrawal by Subject|0|||
23538944|NCT04260191|65705880|FG002|Overall Study|Withdrawal by Subject|3|||
23538945|NCT04260191|65705878|FG000|Overall Study|Death|4|||
23538946|NCT04260191|65705879|FG001|Overall Study|Death|3|||
23538947|NCT04260191|65705880|FG002|Overall Study|Death|2|||
23538948|NCT01358526|65705885|FG000|Open-label Titration Period|Adverse Event|95|||
23538949|NCT01358526|65705886|FG001|Open-label Titration Period|Adverse Event|0|||
23538950|NCT01358526|65705887|FG002|Open-label Titration Period|Adverse Event|0|||
23538951|NCT01358526|65705885|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
23538952|NCT01358526|65705886|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23538953|NCT01358526|65705887|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23538954|NCT01358526|65705885|FG000|Open-label Titration Period|Lost to Follow-up|25|||
23538955|NCT01358526|65705886|FG001|Open-label Titration Period|Lost to Follow-up|0|||
23538956|NCT01358526|65705887|FG002|Open-label Titration Period|Lost to Follow-up|0|||
23538957|NCT01358526|65705885|FG000|Open-label Titration Period|Lack of Efficacy|107|||
23538958|NCT01358526|65705886|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23816120|NCT04630158|66708320|FG002|Overall Study|Physician Decision|0|||
23816121|NCT04630158|66708318|FG000|Overall Study|Protocol Violation|1|||
23816122|NCT04630158|66708319|FG001|Overall Study|Protocol Violation|0|||
23538959|NCT01358526|65705887|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23538960|NCT01358526|65705885|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
23538961|NCT01358526|65705886|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
23538962|NCT01358526|65705887|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
23538963|NCT01358526|65705885|FG000|Open-label Titration Period|Administrative|8|||
23538964|NCT01358526|65705886|FG001|Open-label Titration Period|Administrative|0|||
23538965|NCT01358526|65705887|FG002|Open-label Titration Period|Administrative|0|||
23538966|NCT01358526|65705885|FG000|Open-label Titration Period|Did not qualify|178|||
23538967|NCT01358526|65705886|FG001|Open-label Titration Period|Did not qualify|0|||
23538968|NCT01358526|65705887|FG002|Open-label Titration Period|Did not qualify|0|||
23538969|NCT01358526|65705885|FG000|Double-blind Phase|Adverse Event|0|||
23538970|NCT01358526|65705886|FG001|Double-blind Phase|Adverse Event|24|||
23538971|NCT01358526|65705887|FG002|Double-blind Phase|Adverse Event|23|||
23538972|NCT01358526|65705885|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23538973|NCT01358526|65705886|FG001|Double-blind Phase|Withdrawal by Subject|10|||
23538974|NCT01358526|65705887|FG002|Double-blind Phase|Withdrawal by Subject|8|||
23538975|NCT01358526|65705885|FG000|Double-blind Phase|Lost to Follow-up|0|||
23725637|NCT01929707|66374366|FG001|Intervention Period 2|Withdrawal by Subject|0|||
23725638|NCT01929707|66374367|FG002|Intervention Period 2|Withdrawal by Subject|0|||
23725639|NCT01929707|66374368|FG003|Intervention Period 2|Withdrawal by Subject|0|||
23725640|NCT01929707|66374369|FG004|Intervention Period 2|Withdrawal by Subject|0|||
23725641|NCT01929707|66374370|FG005|Intervention Period 2|Withdrawal by Subject|2|||
23725642|NCT01929707|66374371|FG006|Intervention Period 2|Withdrawal by Subject|0|||
23725643|NCT01929707|66374372|FG007|Intervention Period 2|Withdrawal by Subject|0|||
23725644|NCT02000219|66374373|FG000|14-Week Study Period|Physician Decision|1|||
23725645|NCT02000219|66374373|FG000|14-Week Study Period|Adverse Event|1|||
23725646|NCT02000219|66374373|FG000|14-Week Study Period|Underwent transplantation|1|||
23725647|NCT02000219|66374373|FG000|Continuation Period|Withdrawal by Subject|1|||
23725648|NCT02000219|66374373|FG000|Continuation Period|Had liver transplant|2|||
23725649|NCT02000219|66374373|FG000|Continuation Period|Non-compliance with study drug|2|||
23725650|NCT00329784|66374378|FG000|Overall Study|Lost to Follow-up|0|||
23725651|NCT00329784|66374379|FG001|Overall Study|Lost to Follow-up|1|||
23725652|NCT00329784|66374380|FG002|Overall Study|Lost to Follow-up|0|||
23725653|NCT00329784|66374381|FG003|Overall Study|Lost to Follow-up|0|||
23725654|NCT00329784|66374378|FG000|Overall Study|Withdrawal by Subject|4|||
23725655|NCT00329784|66374379|FG001|Overall Study|Withdrawal by Subject|2|||
23725656|NCT00329784|66374380|FG002|Overall Study|Withdrawal by Subject|0|||
23725657|NCT00329784|66374381|FG003|Overall Study|Withdrawal by Subject|0|||
23725658|NCT00329784|66374378|FG000|Overall Study|Other|1|||
23725659|NCT00329784|66374379|FG001|Overall Study|Other|2|||
23725660|NCT00329784|66374380|FG002|Overall Study|Other|0|||
23725661|NCT00329784|66374381|FG003|Overall Study|Other|0|||
23725662|NCT03148795|66374382|FG000|Overall Study|Progressive Disease|1|||
23725663|NCT00445341|66374383|FG000|Overall Study|refused further treatment|1|||
23725664|NCT00445341|66374383|FG000|Overall Study|taken off treatment too early|1|||
23725665|NCT00865046|66374384|FG000|Overall Study|Lost to Follow-up|1|||
23725666|NCT00865046|66374385|FG001|Overall Study|Lost to Follow-up|4|||
23725667|NCT00865046|66374386|FG002|Overall Study|Lost to Follow-up|0|||
23725668|NCT00865046|66374384|FG000|Overall Study|Death|0|||
23725669|NCT00865046|66374385|FG001|Overall Study|Death|1|||
23725670|NCT00865046|66374386|FG002|Overall Study|Death|1|||
23725671|NCT00865046|66374384|FG000|Overall Study|Withdrawal by Subject|5|||
23725672|NCT00865046|66374385|FG001|Overall Study|Withdrawal by Subject|0|||
23725673|NCT00865046|66374386|FG002|Overall Study|Withdrawal by Subject|0|||
23725674|NCT01665768|66374388|FG000|Overall Study|Adverse Event|3|||
23725675|NCT01665768|66374388|FG000|Overall Study|Lack of Efficacy|19|||
23725676|NCT01665768|66374388|FG000|Overall Study|Withdrawal by Subject|1|||
23725677|NCT03037307|66374397|FG000|Period 1|Did Not Meet Study Criteria|0|||
23725678|NCT03037307|66374398|FG001|Period 1|Did Not Meet Study Criteria|0|||
23725679|NCT03037307|66374399|FG002|Period 1|Did Not Meet Study Criteria|0|||
23725680|NCT03037307|66374400|FG003|Period 1|Did Not Meet Study Criteria|1|||
23725681|NCT03037307|66374401|FG004|Period 1|Did Not Meet Study Criteria|0|||
23725682|NCT03037307|66374402|FG005|Period 1|Did Not Meet Study Criteria|0|||
23725683|NCT01690988|66374403|FG000|Overall Study|Withdrawal by Subject|2|||
23725684|NCT01690988|66374404|FG001|Overall Study|Withdrawal by Subject|2|||
23725685|NCT01690988|66374405|FG002|Overall Study|Withdrawal by Subject|3|||
23725686|NCT01690988|66374403|FG000|Overall Study|Physician Decision|0|||
23725687|NCT01690988|66374404|FG001|Overall Study|Physician Decision|0|||
23725688|NCT01690988|66374405|FG002|Overall Study|Physician Decision|1|||
23725689|NCT01690988|66374403|FG000|Overall Study|Operation Cancelled|1|||
23725690|NCT01690988|66374404|FG001|Overall Study|Operation Cancelled|1|||
23725691|NCT01690988|66374405|FG002|Overall Study|Operation Cancelled|0|||
23725692|NCT01690988|66374403|FG000|Overall Study|Determined ineligible|1|||
23725693|NCT01690988|66374404|FG001|Overall Study|Determined ineligible|0|||
23725694|NCT01690988|66374405|FG002|Overall Study|Determined ineligible|0|||
23725695|NCT01690988|66374403|FG000|Overall Study|Death|1|||
23725696|NCT01690988|66374404|FG001|Overall Study|Death|1|||
23725697|NCT01690988|66374405|FG002|Overall Study|Death|1|||
23725698|NCT01690988|66374403|FG000|Overall Study|Sedated|1|||
23725699|NCT01690988|66374404|FG001|Overall Study|Sedated|1|||
23725700|NCT01690988|66374405|FG002|Overall Study|Sedated|2|||
23725701|NCT03192176|66374408|FG000|Overall Study|Adverse Event|1|||
23725702|NCT03192176|66374409|FG001|Overall Study|Adverse Event|0|||
23725703|NCT03192176|66374410|FG002|Overall Study|Adverse Event|4|||
23725704|NCT03192176|66374411|FG003|Overall Study|Adverse Event|5|||
23725705|NCT03192176|66374412|FG004|Overall Study|Adverse Event|3|||
23725706|NCT03192176|66374413|FG005|Overall Study|Adverse Event|2|||
23725707|NCT03192176|66374414|FG006|Overall Study|Adverse Event|3|||
23725708|NCT03192176|66374415|FG007|Overall Study|Adverse Event|3|||
23538976|NCT01358526|65705886|FG001|Double-blind Phase|Lost to Follow-up|4|||
23538977|NCT01358526|65705887|FG002|Double-blind Phase|Lost to Follow-up|1|||
23725709|NCT03192176|66374408|FG000|Overall Study|Lost to Follow-up|0|||
23725710|NCT03192176|66374409|FG001|Overall Study|Lost to Follow-up|0|||
23725711|NCT03192176|66374410|FG002|Overall Study|Lost to Follow-up|1|||
23725712|NCT03192176|66374411|FG003|Overall Study|Lost to Follow-up|2|||
23725713|NCT03192176|66374412|FG004|Overall Study|Lost to Follow-up|3|||
23725714|NCT03192176|66374413|FG005|Overall Study|Lost to Follow-up|1|||
23725715|NCT03192176|66374414|FG006|Overall Study|Lost to Follow-up|1|||
23725716|NCT03192176|66374415|FG007|Overall Study|Lost to Follow-up|1|||
23725717|NCT03192176|66374408|FG000|Overall Study|Physician Decision|1|||
23725718|NCT03192176|66374409|FG001|Overall Study|Physician Decision|0|||
23725719|NCT03192176|66374410|FG002|Overall Study|Physician Decision|0|||
23816123|NCT04630158|66708320|FG002|Overall Study|Protocol Violation|1|||
23816124|NCT04630158|66708318|FG000|Overall Study|Withdrawal by Subject|2|||
23816125|NCT04630158|66708319|FG001|Overall Study|Withdrawal by Subject|1|||
23538978|NCT01358526|65705885|FG000|Double-blind Phase|Lack of Efficacy|0|||
23538979|NCT01358526|65705886|FG001|Double-blind Phase|Lack of Efficacy|31|||
23538980|NCT01358526|65705887|FG002|Double-blind Phase|Lack of Efficacy|73|||
23538981|NCT01358526|65705885|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
23538982|NCT01358526|65705886|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
23725720|NCT03192176|66374411|FG003|Overall Study|Physician Decision|0|||
23725721|NCT03192176|66374412|FG004|Overall Study|Physician Decision|0|||
23725722|NCT03192176|66374413|FG005|Overall Study|Physician Decision|2|||
23725723|NCT03192176|66374414|FG006|Overall Study|Physician Decision|1|||
23725724|NCT03192176|66374415|FG007|Overall Study|Physician Decision|0|||
23725725|NCT03192176|66374408|FG000|Overall Study|Protocol Deviation|1|||
23725726|NCT03192176|66374409|FG001|Overall Study|Protocol Deviation|1|||
23725727|NCT03192176|66374410|FG002|Overall Study|Protocol Deviation|0|||
23725728|NCT03192176|66374411|FG003|Overall Study|Protocol Deviation|0|||
23816126|NCT04630158|66708320|FG002|Overall Study|Withdrawal by Subject|2|||
23816127|NCT01959295|66708321|FG000|Overall Study|Adverse Event|2|||
23816128|NCT01959295|66708322|FG001|Overall Study|Adverse Event|0|||
23538983|NCT01358526|65705887|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
23538984|NCT01358526|65705885|FG000|Double-blind Phase|Administrative|0|||
23538985|NCT01358526|65705886|FG001|Double-blind Phase|Administrative|6|||
23538986|NCT01358526|65705887|FG002|Double-blind Phase|Administrative|10|||
23538987|NCT02480621|65705888|FG000|Randomization|Withdrawal by Subject|1|||
23538988|NCT02480621|65705889|FG001|Randomization|Withdrawal by Subject|0|||
23538989|NCT02480621|65705888|FG000|Randomization|Surgeon did not give intervention|0|||
23538990|NCT02480621|65705889|FG001|Randomization|Surgeon did not give intervention|1|||
23538991|NCT02480621|65705888|FG000|Follow Up|Lost to Follow-up|4|||
23538992|NCT02480621|65705889|FG001|Follow Up|Lost to Follow-up|2|||
23616432|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
23616433|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Missing|3|||
23616434|NCT02475733|65982339|FG000|Overall Study|Withdrawal by Subject|1|||
23616435|NCT02475733|65982340|FG001|Overall Study|Withdrawal by Subject|0|||
23616436|NCT02475733|65982339|FG000|Overall Study|Physician Decision|1|||
23616437|NCT02475733|65982340|FG001|Overall Study|Physician Decision|0|||
23616438|NCT03915951|65982344|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
23616439|NCT03915951|65982345|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
23616440|NCT03915951|65982344|FG000|Overall Study|Adverse Event|12|||
23616441|NCT03915951|65982345|FG001|Overall Study|Adverse Event|6|||
23725729|NCT03192176|66374412|FG004|Overall Study|Protocol Deviation|2|||
23725730|NCT03192176|66374413|FG005|Overall Study|Protocol Deviation|0|||
23725731|NCT03192176|66374414|FG006|Overall Study|Protocol Deviation|0|||
23725732|NCT03192176|66374415|FG007|Overall Study|Protocol Deviation|0|||
23538993|NCT01307501|65705890|FG000|Overall Study|Treatment Failure|1|||
23725733|NCT03192176|66374408|FG000|Overall Study|Withdrawal by Subject|3|||
23725734|NCT03192176|66374409|FG001|Overall Study|Withdrawal by Subject|4|||
23725735|NCT03192176|66374410|FG002|Overall Study|Withdrawal by Subject|0|||
23725736|NCT03192176|66374411|FG003|Overall Study|Withdrawal by Subject|4|||
23725737|NCT03192176|66374412|FG004|Overall Study|Withdrawal by Subject|3|||
23725738|NCT03192176|66374413|FG005|Overall Study|Withdrawal by Subject|4|||
23538994|NCT01307501|65705890|FG000|Overall Study|Death|20|||
23538995|NCT01307501|65705890|FG000|Overall Study|Lost to Follow-up|1|||
23538996|NCT01307501|65705890|FG000|Overall Study|Starting Hospice|1|||
23538997|NCT03029208|65705891|FG000|Overall Study|Withdrawal by Subject|2|||
23538998|NCT03029208|65705892|FG001|Overall Study|Withdrawal by Subject|3|||
23538999|NCT03029208|65705891|FG000|Overall Study|Lost to Follow-up|0|||
23539000|NCT03029208|65705892|FG001|Overall Study|Lost to Follow-up|1|||
23539001|NCT01047683|65705893|FG000|Overall Study|Adverse Event|3|||
23539002|NCT01047683|65705894|FG001|Overall Study|Adverse Event|1|||
23539003|NCT01047683|65705895|FG002|Overall Study|Adverse Event|0|||
23539004|NCT01047683|65705893|FG000|Overall Study|Withdrew Consent|1|||
23539005|NCT01047683|65705894|FG001|Overall Study|Withdrew Consent|4|||
23539006|NCT01047683|65705895|FG002|Overall Study|Withdrew Consent|2|||
23539007|NCT01047683|65705893|FG000|Overall Study|Lost to Follow-up|0|||
23539008|NCT01047683|65705894|FG001|Overall Study|Lost to Follow-up|1|||
23539009|NCT01047683|65705895|FG002|Overall Study|Lost to Follow-up|0|||
23539010|NCT01047683|65705893|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
23539011|NCT01047683|65705894|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
23539012|NCT01047683|65705895|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
23539013|NCT01343056|65705896|FG000|Overall Study|Lost to Follow-up|7|||
23539014|NCT01343056|65705897|FG001|Overall Study|Lost to Follow-up|5|||
23539015|NCT01343056|65705898|FG002|Overall Study|Lost to Follow-up|3|||
23539016|NCT01343056|65705899|FG003|Overall Study|Lost to Follow-up|9|||
23539017|NCT04808609|65705900|FG000|Overall Study|Lost to Follow-up|0|||
23539018|NCT04808609|65705901|FG001|Overall Study|Lost to Follow-up|2|||
23539019|NCT04808609|65705900|FG000|Overall Study|Administrative Withdrawal|0|||
23539020|NCT04808609|65705901|FG001|Overall Study|Administrative Withdrawal|1|||
23539021|NCT01040130|65705902|FG000|Overall Study|Adverse Event|1|||
23539022|NCT01040130|65705903|FG001|Overall Study|Adverse Event|1|||
23539023|NCT01040130|65705904|FG002|Overall Study|Adverse Event|0|||
23539024|NCT01040130|65705905|FG003|Overall Study|Adverse Event|5|||
23539025|NCT01040130|65705906|FG004|Overall Study|Adverse Event|0|||
23539026|NCT01040130|65705907|FG005|Overall Study|Adverse Event|3|||
23539027|NCT01040130|65705902|FG000|Overall Study|Protocol Violation|0|||
23539028|NCT01040130|65705903|FG001|Overall Study|Protocol Violation|0|||
23539029|NCT01040130|65705904|FG002|Overall Study|Protocol Violation|2|||
23539030|NCT01040130|65705905|FG003|Overall Study|Protocol Violation|0|||
23539031|NCT01040130|65705906|FG004|Overall Study|Protocol Violation|0|||
23539032|NCT01040130|65705907|FG005|Overall Study|Protocol Violation|0|||
23539033|NCT01040130|65705902|FG000|Overall Study|Withdrawal by Subject|0|||
23539034|NCT01040130|65705903|FG001|Overall Study|Withdrawal by Subject|2|||
23539035|NCT01040130|65705904|FG002|Overall Study|Withdrawal by Subject|0|||
23539036|NCT01040130|65705905|FG003|Overall Study|Withdrawal by Subject|0|||
23539037|NCT01040130|65705906|FG004|Overall Study|Withdrawal by Subject|0|||
23539038|NCT01040130|65705907|FG005|Overall Study|Withdrawal by Subject|1|||
23539039|NCT01040130|65705902|FG000|Overall Study|Other reasons not listed above|2|||
23539040|NCT01040130|65705903|FG001|Overall Study|Other reasons not listed above|0|||
23539041|NCT01040130|65705904|FG002|Overall Study|Other reasons not listed above|0|||
23539042|NCT01040130|65705905|FG003|Overall Study|Other reasons not listed above|0|||
23616442|NCT03915951|65982344|FG000|Overall Study|Disease progression (radiological)|17|||
23725739|NCT03192176|66374414|FG006|Overall Study|Withdrawal by Subject|4|||
23725740|NCT03192176|66374415|FG007|Overall Study|Withdrawal by Subject|2|||
23539043|NCT01040130|65705906|FG004|Overall Study|Other reasons not listed above|0|||
23539044|NCT01040130|65705907|FG005|Overall Study|Other reasons not listed above|0|||
23539045|NCT02715765|65705908|FG000|Overall Study|Study Termination|3|||
23539046|NCT02715765|65705909|FG001|Overall Study|Study Termination|0|||
23539047|NCT02715765|65705910|FG002|Overall Study|Study Termination|0|||
23539048|NCT03755765|65705911|FG000|Overall Study|Withdrawal by Subject|2|||
23539049|NCT03755765|65705912|FG001|Overall Study|Withdrawal by Subject|4|||
23539050|NCT03755765|65705913|FG002|Overall Study|Withdrawal by Subject|4|||
23539051|NCT01692197|65705924|FG000|Overall Study|Failed Screening|3|||
23539052|NCT02606136|65705925|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
23539053|NCT02606136|65705925|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
23539054|NCT02606136|65705925|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
23539055|NCT02606136|65705925|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
23539056|NCT03156023|65705926|FG000|Overall Study|Withdrawal by Subject|1|||
23539057|NCT03156023|65705927|FG001|Overall Study|Withdrawal by Subject|0|||
23539058|NCT03156023|65705928|FG002|Overall Study|Withdrawal by Subject|2|||
23539059|NCT03156023|65705929|FG003|Overall Study|Withdrawal by Subject|1|||
23539060|NCT03156023|65705930|FG004|Overall Study|Withdrawal by Subject|1|||
23539061|NCT03156023|65705926|FG000|Overall Study|Lost to Follow-up|0|||
23539062|NCT03156023|65705927|FG001|Overall Study|Lost to Follow-up|0|||
23539063|NCT03156023|65705928|FG002|Overall Study|Lost to Follow-up|0|||
23539064|NCT03156023|65705929|FG003|Overall Study|Lost to Follow-up|0|||
23539065|NCT03156023|65705930|FG004|Overall Study|Lost to Follow-up|1|||
23539066|NCT01898195|65705931|FG000|Smoking Abstinence|Did not have good measurements|35|||
23539067|NCT01898195|65705932|FG001|Smoking Abstinence|Did not have good measurements|38|||
23539068|NCT01898195|65705933|FG002|Smoking Abstinence|Did not have good measurements|36|||
23539069|NCT00023452|65705936|FG000|Overall Study|Ineligible for Study|163|||
23539070|NCT00023452|65705937|FG001|Overall Study|Ineligible for Study|159|||
23539071|NCT00023452|65705936|FG000|Overall Study|Out of Window|129|||
23539072|NCT00023452|65705937|FG001|Overall Study|Out of Window|69|||
23539073|NCT00023452|65705936|FG000|Overall Study|Death|2|||
23539074|NCT00023452|65705937|FG001|Overall Study|Death|0|||
23539075|NCT00023452|65705936|FG000|Overall Study|Withdrawal by Subject|66|||
23539076|NCT00023452|65705937|FG001|Overall Study|Withdrawal by Subject|54|||
23539077|NCT00023452|65705936|FG000|Overall Study|Adverse Event|139|||
23539078|NCT00023452|65705937|FG001|Overall Study|Adverse Event|196|||
23539079|NCT00023452|65705936|FG000|Overall Study|Lost to Follow-up|293|||
23539080|NCT00023452|65705937|FG001|Overall Study|Lost to Follow-up|60|||
23539081|NCT00023452|65705936|FG000|Overall Study|Physician Decision|49|||
23539082|NCT00023452|65705937|FG001|Overall Study|Physician Decision|21|||
23539083|NCT00023452|65705936|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
23539084|NCT00023452|65705937|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
23539085|NCT00023452|65705936|FG000|Overall Study|Pregnant|53|||
23539086|NCT00023452|65705937|FG001|Overall Study|Pregnant|20|||
23539087|NCT00023452|65705936|FG000|Overall Study|Other|204|||
23539088|NCT00023452|65705937|FG001|Overall Study|Other|69|||
23539089|NCT00642304|65705938|FG000|Overall Study|Adverse Event|1|||
23539090|NCT00642304|65705938|FG000|Overall Study|Death|1|||
23539091|NCT00642304|65705938|FG000|Overall Study|Blood transfusion|2|||
23539092|NCT00642304|65705938|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
23539093|NCT00642304|65705938|FG000|Overall Study|Transplantation|1|||
23539094|NCT02120924|65705941|FG000|Overall Study|Lack of Efficacy|1|||
23539095|NCT02120924|65705942|FG001|Overall Study|Lack of Efficacy|2|||
23539096|NCT02120924|65705943|FG002|Overall Study|Lack of Efficacy|3|||
23539097|NCT02120924|65705941|FG000|Overall Study|Adverse Event|0|||
23539098|NCT02120924|65705942|FG001|Overall Study|Adverse Event|1|||
23539099|NCT02120924|65705943|FG002|Overall Study|Adverse Event|3|||
23539100|NCT02120924|65705941|FG000|Overall Study|Withdrawal by Subject|16|||
23539101|NCT02120924|65705942|FG001|Overall Study|Withdrawal by Subject|20|||
23539102|NCT02120924|65705943|FG002|Overall Study|Withdrawal by Subject|8|||
23539103|NCT02120924|65705941|FG000|Overall Study|Lost to Follow-up|14|||
23539104|NCT02120924|65705942|FG001|Overall Study|Lost to Follow-up|14|||
23539105|NCT02120924|65705943|FG002|Overall Study|Lost to Follow-up|11|||
23539106|NCT02120924|65705941|FG000|Overall Study|Pregnancy|2|||
23539107|NCT02120924|65705942|FG001|Overall Study|Pregnancy|0|||
23539108|NCT02120924|65705943|FG002|Overall Study|Pregnancy|0|||
23539109|NCT02120924|65705941|FG000|Overall Study|Protocol Violation|3|||
23539110|NCT02120924|65705942|FG001|Overall Study|Protocol Violation|7|||
23539111|NCT02120924|65705943|FG002|Overall Study|Protocol Violation|2|||
23616443|NCT03915951|65982345|FG001|Overall Study|Disease progression (radiological)|15|||
23539112|NCT02120924|65705941|FG000|Overall Study|Physician Decision|0|||
23539113|NCT02120924|65705942|FG001|Overall Study|Physician Decision|1|||
23725741|NCT03192176|66374408|FG000|Overall Study|Miscellaneous|1|||
23816129|NCT01959295|66708321|FG000|Overall Study|Lost to Follow-up|0|||
23539114|NCT02120924|65705943|FG002|Overall Study|Physician Decision|1|||
23539115|NCT02120924|65705941|FG000|Overall Study|Death|1|||
23539116|NCT02120924|65705942|FG001|Overall Study|Death|0|||
23725742|NCT03192176|66374409|FG001|Overall Study|Miscellaneous|0|||
23539117|NCT02120924|65705943|FG002|Overall Study|Death|0|||
23816130|NCT01959295|66708322|FG001|Overall Study|Lost to Follow-up|2|||
23539118|NCT02120924|65705941|FG000|Overall Study|Compliance with IP|5|||
23539119|NCT02120924|65705942|FG001|Overall Study|Compliance with IP|1|||
23539120|NCT02120924|65705943|FG002|Overall Study|Compliance with IP|1|||
23539121|NCT00634647|65705944|FG000|Overall Study|death on study|3|||
23539122|NCT00634647|65705944|FG000|Overall Study|refused further treatment|3|||
23539123|NCT00634647|65705944|FG000|Overall Study|declined to participate before treatment|1|||
23539124|NCT01274637|65705945|FG000|Overall Study|Withdrawal by Subject|0|||
23539125|NCT01274637|65705946|FG001|Overall Study|Withdrawal by Subject|1|||
23539126|NCT01274637|65705945|FG000|Overall Study|Lost to Follow-up|0|||
23539127|NCT01274637|65705946|FG001|Overall Study|Lost to Follow-up|1|||
23539128|NCT00653224|65705949|FG000|Overall Study|Adverse Event|2|||
23539129|NCT00653224|65705950|FG001|Overall Study|Adverse Event|1|||
23539130|NCT00653224|65705949|FG000|Overall Study|Lack of Efficacy|1|||
23539131|NCT00653224|65705950|FG001|Overall Study|Lack of Efficacy|2|||
23539132|NCT00653224|65705949|FG000|Overall Study|Loss of efficacy|1|||
23539133|NCT00653224|65705950|FG001|Overall Study|Loss of efficacy|0|||
23539134|NCT00653224|65705949|FG000|Overall Study|Lost to Follow-up|1|||
23539135|NCT00653224|65705950|FG001|Overall Study|Lost to Follow-up|0|||
23539136|NCT00653224|65705949|FG000|Overall Study|Other|2|||
23539137|NCT00653224|65705950|FG001|Overall Study|Other|4|||
23539138|NCT04574362|65705951|FG000|Overall Study|Other|0|||
23816131|NCT01959295|66708321|FG000|Overall Study|Physician Decision|2|||
23725743|NCT03192176|66374410|FG002|Overall Study|Miscellaneous|1|||
23725744|NCT03192176|66374411|FG003|Overall Study|Miscellaneous|1|||
23816132|NCT01959295|66708322|FG001|Overall Study|Physician Decision|3|||
23816133|NCT01959295|66708321|FG000|Overall Study|Protocol Violation|16|||
23816134|NCT01959295|66708322|FG001|Overall Study|Protocol Violation|5|||
23816135|NCT01959295|66708321|FG000|Overall Study|Withdrawal by Subject|3|||
23725745|NCT03192176|66374412|FG004|Overall Study|Miscellaneous|1|||
23816136|NCT01959295|66708322|FG001|Overall Study|Withdrawal by Subject|1|||
23816137|NCT01959295|66708321|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
23725746|NCT03192176|66374413|FG005|Overall Study|Miscellaneous|2|||
23725747|NCT03192176|66374414|FG006|Overall Study|Miscellaneous|0|||
23725748|NCT03192176|66374415|FG007|Overall Study|Miscellaneous|1|||
23725749|NCT00588523|66374416|FG000|Overall Study|Not treated|3|||
23725750|NCT03039790|66374417|FG000|Overall Study|Lost to Follow-up|2|||
23725751|NCT03039790|66374418|FG001|Overall Study|Lost to Follow-up|0|||
23725752|NCT03039790|66374419|FG002|Overall Study|Lost to Follow-up|1|||
23725753|NCT03039790|66374420|FG003|Overall Study|Lost to Follow-up|1|||
23725754|NCT03039790|66374421|FG004|Overall Study|Lost to Follow-up|0|||
23725755|NCT03039790|66374422|FG005|Overall Study|Lost to Follow-up|1|||
23725756|NCT03039790|66374423|FG006|Overall Study|Lost to Follow-up|1|||
23725757|NCT03039790|66374424|FG007|Overall Study|Lost to Follow-up|1|||
23725758|NCT03039790|66374425|FG008|Overall Study|Lost to Follow-up|0|||
23725759|NCT03039790|66374426|FG009|Overall Study|Lost to Follow-up|1|||
23725760|NCT03039790|66374427|FG010|Overall Study|Lost to Follow-up|1|||
23725761|NCT03039790|66374428|FG011|Overall Study|Lost to Follow-up|0|||
23725762|NCT03039790|66374429|FG012|Overall Study|Lost to Follow-up|1|||
23725763|NCT03039790|66374430|FG013|Overall Study|Lost to Follow-up|0|||
23725764|NCT03039790|66374431|FG014|Overall Study|Lost to Follow-up|3|||
23725765|NCT03039790|66374432|FG015|Overall Study|Lost to Follow-up|1|||
23725766|NCT03039790|66374433|FG016|Overall Study|Lost to Follow-up|2|||
23725767|NCT03039790|66374434|FG017|Overall Study|Lost to Follow-up|2|||
23725768|NCT03039790|66374435|FG018|Overall Study|Lost to Follow-up|1|||
23725769|NCT03039790|66374436|FG019|Overall Study|Lost to Follow-up|3|||
23725770|NCT03039790|66374417|FG000|Overall Study|Withdrawal of Consent|1|||
23725771|NCT03039790|66374418|FG001|Overall Study|Withdrawal of Consent|0|||
23725772|NCT03039790|66374419|FG002|Overall Study|Withdrawal of Consent|0|||
23725773|NCT03039790|66374420|FG003|Overall Study|Withdrawal of Consent|1|||
23816138|NCT01959295|66708322|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
23816139|NCT01635283|66708323|FG000|Overall Study|Tumor Progression|3|||
23816140|NCT01635283|66708323|FG000|Overall Study|Lost to Follow-up|1|||
23539139|NCT04574362|65705952|FG001|Overall Study|Other|5|||
23539140|NCT04574362|65705951|FG000|Overall Study|COVID-19|0|||
23539141|NCT04574362|65705952|FG001|Overall Study|COVID-19|1|||
23539142|NCT04574362|65705951|FG000|Overall Study|Adverse Event|1|||
23539143|NCT04574362|65705952|FG001|Overall Study|Adverse Event|1|||
23725774|NCT03039790|66374421|FG004|Overall Study|Withdrawal of Consent|0|||
23725775|NCT03039790|66374422|FG005|Overall Study|Withdrawal of Consent|0|||
23725776|NCT03039790|66374423|FG006|Overall Study|Withdrawal of Consent|0|||
23725777|NCT03039790|66374424|FG007|Overall Study|Withdrawal of Consent|0|||
23725778|NCT03039790|66374425|FG008|Overall Study|Withdrawal of Consent|0|||
23725779|NCT03039790|66374426|FG009|Overall Study|Withdrawal of Consent|1|||
23725780|NCT03039790|66374427|FG010|Overall Study|Withdrawal of Consent|0|||
23725781|NCT03039790|66374428|FG011|Overall Study|Withdrawal of Consent|0|||
23816141|NCT02461160|66708324|FG000|Overall Study|Lost to Follow-up|0|||
23816142|NCT02461160|66708325|FG001|Overall Study|Lost to Follow-up|0|||
23816143|NCT02461160|66708326|FG002|Overall Study|Lost to Follow-up|0|||
23539144|NCT04574362|65705951|FG000|Overall Study|Withdrawal by Subject|2|||
23539145|NCT04574362|65705952|FG001|Overall Study|Withdrawal by Subject|4|||
23725782|NCT03039790|66374429|FG012|Overall Study|Withdrawal of Consent|2|||
23725783|NCT03039790|66374430|FG013|Overall Study|Withdrawal of Consent|0|||
23725784|NCT03039790|66374431|FG014|Overall Study|Withdrawal of Consent|1|||
23725785|NCT03039790|66374432|FG015|Overall Study|Withdrawal of Consent|5|||
23725786|NCT03039790|66374433|FG016|Overall Study|Withdrawal of Consent|3|||
23725787|NCT03039790|66374434|FG017|Overall Study|Withdrawal of Consent|0|||
23725788|NCT03039790|66374435|FG018|Overall Study|Withdrawal of Consent|2|||
23725789|NCT03039790|66374436|FG019|Overall Study|Withdrawal of Consent|5|||
23725790|NCT03039790|66374417|FG000|Overall Study|Death|0|||
23725791|NCT03039790|66374418|FG001|Overall Study|Death|0|||
23725792|NCT03039790|66374419|FG002|Overall Study|Death|0|||
23725793|NCT03039790|66374420|FG003|Overall Study|Death|0|||
23725794|NCT03039790|66374421|FG004|Overall Study|Death|0|||
23725795|NCT03039790|66374422|FG005|Overall Study|Death|0|||
23725796|NCT03039790|66374423|FG006|Overall Study|Death|0|||
23725797|NCT03039790|66374424|FG007|Overall Study|Death|0|||
23725798|NCT03039790|66374425|FG008|Overall Study|Death|0|||
23725799|NCT03039790|66374426|FG009|Overall Study|Death|0|||
23725800|NCT03039790|66374427|FG010|Overall Study|Death|0|||
23725801|NCT03039790|66374428|FG011|Overall Study|Death|0|||
23725802|NCT03039790|66374429|FG012|Overall Study|Death|0|||
23816144|NCT02461160|66708327|FG003|Overall Study|Lost to Follow-up|0|||
23816145|NCT02461160|66708328|FG004|Overall Study|Lost to Follow-up|0|||
23816146|NCT02461160|66708329|FG005|Overall Study|Lost to Follow-up|0|||
23816147|NCT02461160|66708330|FG006|Overall Study|Lost to Follow-up|0|||
23816148|NCT02461160|66708331|FG007|Overall Study|Lost to Follow-up|1|||
23816149|NCT02461160|66708332|FG008|Overall Study|Lost to Follow-up|0|||
23816150|NCT02461160|66708333|FG009|Overall Study|Lost to Follow-up|0|||
23816151|NCT02461160|66708334|FG010|Overall Study|Lost to Follow-up|0|||
23816152|NCT02461160|66708335|FG011|Overall Study|Lost to Follow-up|0|||
23816153|NCT02461160|66708336|FG012|Overall Study|Lost to Follow-up|0|||
23816154|NCT02504671|66708337|FG000|Overall Study|Withdrawal by Subject|1|||
23816155|NCT02504671|66708338|FG001|Overall Study|Withdrawal by Subject|5|||
23816156|NCT02504671|66708339|FG002|Overall Study|Withdrawal by Subject|4|||
23539146|NCT04574362|65705951|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
23725803|NCT03039790|66374430|FG013|Overall Study|Death|0|||
23725804|NCT03039790|66374431|FG014|Overall Study|Death|0|||
23725805|NCT03039790|66374432|FG015|Overall Study|Death|1|||
23725806|NCT03039790|66374433|FG016|Overall Study|Death|3|||
23725807|NCT03039790|66374434|FG017|Overall Study|Death|0|||
23725808|NCT03039790|66374435|FG018|Overall Study|Death|2|||
23725809|NCT03039790|66374436|FG019|Overall Study|Death|0|||
23725810|NCT03039790|66374417|FG000|Overall Study|Reason, not Specified|1|||
23539147|NCT04574362|65705952|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
23539148|NCT04574362|65705951|FG000|Overall Study|Participant refused to come to the hospital|1|||
23539149|NCT04574362|65705952|FG001|Overall Study|Participant refused to come to the hospital|0|||
23539150|NCT04574362|65705951|FG000|Overall Study|Participant refused the visit|1|||
23539151|NCT04574362|65705952|FG001|Overall Study|Participant refused the visit|0|||
23816157|NCT02504671|66708340|FG003|Overall Study|Withdrawal by Subject|4|||
23816158|NCT02504671|66708341|FG004|Overall Study|Withdrawal by Subject|5|||
23816159|NCT02504671|66708342|FG005|Overall Study|Withdrawal by Subject|3|||
23816160|NCT02504671|66708337|FG000|Overall Study|Lack of Efficacy|1|||
23539152|NCT04574362|65705951|FG000|Overall Study|Participant quit early because of business trip|1|||
23539153|NCT04574362|65705952|FG001|Overall Study|Participant quit early because of business trip|0|||
23539154|NCT01962974|65705953|FG000|Overall Study|Study termination|7|||
23539155|NCT00961259|65705954|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
23539156|NCT00961259|65705955|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
23539157|NCT00961259|65705956|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
23539158|NCT00093145|65705957|FG000|Overall Study|Unacceptable Toxicity Only|2|||
23539159|NCT00093145|65705957|FG000|Overall Study|Physician Decision|5|||
23539160|NCT00093145|65705957|FG000|Overall Study|Withdrawal by Subject|9|||
23539161|NCT00093145|65705957|FG000|Overall Study|Other|1|||
23539162|NCT03634579|65705964|FG000|Overall Study|study termination|9|||
23539163|NCT01038921|65705965|FG000|Overall Study|Withdrawal by Subject|1|||
23539164|NCT01038921|65705966|FG001|Overall Study|Withdrawal by Subject|0|||
23539165|NCT01038921|65705965|FG000|Overall Study|Physician Decision|1|||
23539166|NCT01038921|65705966|FG001|Overall Study|Physician Decision|0|||
23539167|NCT00439140|65705971|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23539168|NCT00439140|65705972|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
23725811|NCT03039790|66374418|FG001|Overall Study|Reason, not Specified|0|||
23725812|NCT03039790|66374419|FG002|Overall Study|Reason, not Specified|0|||
23725813|NCT03039790|66374420|FG003|Overall Study|Reason, not Specified|0|||
23725814|NCT03039790|66374421|FG004|Overall Study|Reason, not Specified|0|||
23725815|NCT03039790|66374422|FG005|Overall Study|Reason, not Specified|0|||
23725816|NCT03039790|66374423|FG006|Overall Study|Reason, not Specified|0|||
23539169|NCT00439140|65705973|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
23725817|NCT03039790|66374424|FG007|Overall Study|Reason, not Specified|0|||
23725818|NCT03039790|66374425|FG008|Overall Study|Reason, not Specified|0|||
23725819|NCT03039790|66374426|FG009|Overall Study|Reason, not Specified|0|||
23725820|NCT03039790|66374427|FG010|Overall Study|Reason, not Specified|0|||
23725821|NCT03039790|66374428|FG011|Overall Study|Reason, not Specified|0|||
23725822|NCT03039790|66374429|FG012|Overall Study|Reason, not Specified|0|||
23725823|NCT03039790|66374430|FG013|Overall Study|Reason, not Specified|0|||
23725824|NCT03039790|66374431|FG014|Overall Study|Reason, not Specified|0|||
23816161|NCT02504671|66708338|FG001|Overall Study|Lack of Efficacy|3|||
23816162|NCT02504671|66708339|FG002|Overall Study|Lack of Efficacy|1|||
23816163|NCT02504671|66708340|FG003|Overall Study|Lack of Efficacy|0|||
23725825|NCT03039790|66374432|FG015|Overall Study|Reason, not Specified|0|||
23725826|NCT03039790|66374433|FG016|Overall Study|Reason, not Specified|2|||
23725827|NCT03039790|66374434|FG017|Overall Study|Reason, not Specified|0|||
23816164|NCT02504671|66708341|FG004|Overall Study|Lack of Efficacy|4|||
23539170|NCT00439140|65705971|FG000|Treatment Cycle 1|Personal reasons|0|||
23539171|NCT00439140|65705972|FG001|Treatment Cycle 1|Personal reasons|2|||
23539172|NCT00439140|65705973|FG002|Treatment Cycle 1|Personal reasons|0|||
23539173|NCT00439140|65705971|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
23539174|NCT00439140|65705972|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
23725828|NCT03039790|66374435|FG018|Overall Study|Reason, not Specified|1|||
23539175|NCT00439140|65705973|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
23539176|NCT00439140|65705971|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
23539177|NCT00439140|65705972|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
23539178|NCT00439140|65705973|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
23539179|NCT00439140|65705971|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
23539180|NCT00439140|65705972|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
23539181|NCT00439140|65705973|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
23539182|NCT03732248|65705979|FG000|Overall Study|Withdrawal by Subject|1|||
23539183|NCT03732248|65705980|FG001|Overall Study|Withdrawal by Subject|0|||
23539184|NCT05101252|65705981|FG000|Overall Study|Unsatisfactory Test Article|1|||
23539185|NCT05101252|65705982|FG001|Overall Study|Unsatisfactory Test Article|0|||
23539186|NCT05101252|65705981|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
23539187|NCT05101252|65705982|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
23725829|NCT03039790|66374436|FG019|Overall Study|Reason, not Specified|0|||
23725830|NCT03383614|66374437|FG000|Overall Study|Withdrawal by Subject|0|||
23539188|NCT05101252|65705981|FG000|Overall Study|Withdrew Consent during study|0|||
23725831|NCT03383614|66374438|FG001|Overall Study|Withdrawal by Subject|1|||
23725832|NCT03383614|66374439|FG002|Overall Study|Withdrawal by Subject|0|||
23539189|NCT05101252|65705982|FG001|Overall Study|Withdrew Consent during study|1|||
23539190|NCT05101252|65705981|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
23539191|NCT05101252|65705982|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
23539192|NCT00975975|65705983|FG000|Overall Study|Death|6|||
23539193|NCT03738150|65705986|FG000|Base Study|Withdrawal by Subject|1|||
23539194|NCT03738150|65705986|FG000|Extension Study|Withdrawal by Subject|1|||
23539195|NCT04193202|65705987|FG000|Overall Study|Adverse Event|2|||
23539196|NCT04193202|65705988|FG001|Overall Study|Adverse Event|1|||
23539197|NCT04193202|65705987|FG000|Overall Study|Death|0|||
23539198|NCT04193202|65705988|FG001|Overall Study|Death|1|||
23539199|NCT04193202|65705987|FG000|Overall Study|Physician Decision|1|||
23539200|NCT04193202|65705988|FG001|Overall Study|Physician Decision|1|||
23725833|NCT03383614|66374440|FG003|Overall Study|Withdrawal by Subject|0|||
23725834|NCT01131078|66374441|FG000|Overall Study|Adverse Event|22|||
23725835|NCT01131078|66374442|FG001|Overall Study|Adverse Event|12|||
23725836|NCT01131078|66374443|FG002|Overall Study|Adverse Event|17|||
23725837|NCT01131078|66374441|FG000|Overall Study|Progressive Disease|58|||
23725838|NCT01131078|66374442|FG001|Overall Study|Progressive Disease|77|||
23725839|NCT01131078|66374443|FG002|Overall Study|Progressive Disease|71|||
23725840|NCT01131078|66374441|FG000|Overall Study|Protocol Violation|1|||
23725841|NCT01131078|66374442|FG001|Overall Study|Protocol Violation|0|||
23725842|NCT01131078|66374443|FG002|Overall Study|Protocol Violation|0|||
23725843|NCT01131078|66374441|FG000|Overall Study|Lost to Follow-up|1|||
23725844|NCT01131078|66374442|FG001|Overall Study|Lost to Follow-up|1|||
23816165|NCT02504671|66708342|FG005|Overall Study|Lack of Efficacy|4|||
23816166|NCT02504671|66708337|FG000|Overall Study|Adverse Event|1|||
23816167|NCT02504671|66708338|FG001|Overall Study|Adverse Event|1|||
23816168|NCT02504671|66708339|FG002|Overall Study|Adverse Event|0|||
23539201|NCT04193202|65705987|FG000|Overall Study|Protocol Violation|2|||
23539202|NCT04193202|65705988|FG001|Overall Study|Protocol Violation|2|||
23539203|NCT04193202|65705987|FG000|Overall Study|Withdrawal by Subject|11|||
23539204|NCT04193202|65705988|FG001|Overall Study|Withdrawal by Subject|5|||
23539205|NCT02809976|65705989|FG000|Overall Study|Lost to Follow-up|1|||
23816169|NCT02504671|66708340|FG003|Overall Study|Adverse Event|1|||
23816170|NCT02504671|66708341|FG004|Overall Study|Adverse Event|0|||
23816171|NCT02504671|66708342|FG005|Overall Study|Adverse Event|2|||
23816172|NCT02504671|66708337|FG000|Overall Study|Protocol Violation|2|||
23816173|NCT02504671|66708338|FG001|Overall Study|Protocol Violation|1|||
23816174|NCT02504671|66708339|FG002|Overall Study|Protocol Violation|0|||
23539206|NCT02809976|65705989|FG000|Overall Study|Withdrawal by Subject|1|||
23539207|NCT00812812|65705990|FG000|Overall Study|Adverse Event|2|||
23725845|NCT01131078|66374443|FG002|Overall Study|Lost to Follow-up|1|||
23539208|NCT00812812|65705991|FG001|Overall Study|Adverse Event|1|||
23539209|NCT00812812|65705990|FG000|Overall Study|Lack of Efficacy|1|||
23539210|NCT00812812|65705991|FG001|Overall Study|Lack of Efficacy|0|||
23539211|NCT00812812|65705990|FG000|Overall Study|Lost to Follow-up|0|||
23539212|NCT00812812|65705991|FG001|Overall Study|Lost to Follow-up|1|||
23725846|NCT01131078|66374441|FG000|Overall Study|Withdrawal by Subject|2|||
23725847|NCT01131078|66374442|FG001|Overall Study|Withdrawal by Subject|4|||
23725848|NCT01131078|66374443|FG002|Overall Study|Withdrawal by Subject|3|||
23725849|NCT01131078|66374441|FG000|Overall Study|Non-compliance|3|||
23816175|NCT02504671|66708340|FG003|Overall Study|Protocol Violation|0|||
23725850|NCT01131078|66374442|FG001|Overall Study|Non-compliance|0|||
23816176|NCT02504671|66708341|FG004|Overall Study|Protocol Violation|0|||
23725851|NCT01131078|66374443|FG002|Overall Study|Non-compliance|0|||
23539213|NCT00812812|65705990|FG000|Overall Study|Withdrawal by Subject|0|||
23539214|NCT00812812|65705991|FG001|Overall Study|Withdrawal by Subject|2|||
23539215|NCT01854554|65705999|FG000|Overall Study|Denial of Insurance Coverage|12|||
23539216|NCT01854554|65706000|FG001|Overall Study|Denial of Insurance Coverage|0|||
23539217|NCT01854554|65705999|FG000|Overall Study|Decided to get treatment locally|1|||
23539218|NCT01854554|65706000|FG001|Overall Study|Decided to get treatment locally|5|||
23539219|NCT01854554|65705999|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
23539220|NCT01854554|65706000|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
23539221|NCT01854554|65705999|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23539222|NCT01854554|65706000|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23539223|NCT01854554|65705999|FG000|Overall Study|Progression|0|||
23725852|NCT01131078|66374441|FG000|Overall Study|Physician Decision|10|||
23725853|NCT01131078|66374442|FG001|Overall Study|Physician Decision|6|||
23725854|NCT01131078|66374443|FG002|Overall Study|Physician Decision|8|||
23725855|NCT01131078|66374441|FG000|Overall Study|Death|4|||
23725856|NCT01131078|66374442|FG001|Overall Study|Death|0|||
23725857|NCT01131078|66374443|FG002|Overall Study|Death|2|||
23725858|NCT01131078|66374441|FG000|Overall Study|Other|0|||
23725859|NCT01131078|66374442|FG001|Overall Study|Other|1|||
23725860|NCT01131078|66374443|FG002|Overall Study|Other|0|||
23725861|NCT01505114|66374445|FG000|Overall Study|Withdrawal by Subject|5|||
23725862|NCT01505114|66374446|FG001|Overall Study|Withdrawal by Subject|4|||
23725863|NCT01505114|66374447|FG002|Overall Study|Withdrawal by Subject|4|||
23725864|NCT01505114|66374448|FG003|Overall Study|Withdrawal by Subject|7|||
23725865|NCT01505114|66374445|FG000|Overall Study|Death|1|||
23725866|NCT01505114|66374446|FG001|Overall Study|Death|0|||
23725867|NCT01505114|66374447|FG002|Overall Study|Death|0|||
23725868|NCT01505114|66374448|FG003|Overall Study|Death|1|||
23725869|NCT01505114|66374445|FG000|Overall Study|unable to adhere to visit schedule|3|||
23725870|NCT01505114|66374446|FG001|Overall Study|unable to adhere to visit schedule|2|||
23725871|NCT01505114|66374447|FG002|Overall Study|unable to adhere to visit schedule|3|||
23725872|NCT01505114|66374448|FG003|Overall Study|unable to adhere to visit schedule|3|||
23725873|NCT01505114|66374445|FG000|Overall Study|Lost to Follow-up|11|||
23725874|NCT01505114|66374446|FG001|Overall Study|Lost to Follow-up|5|||
23725875|NCT01505114|66374447|FG002|Overall Study|Lost to Follow-up|8|||
23725876|NCT01505114|66374448|FG003|Overall Study|Lost to Follow-up|7|||
23725877|NCT01505114|66374445|FG000|Overall Study|relocated|4|||
23725878|NCT01505114|66374446|FG001|Overall Study|relocated|2|||
23725879|NCT01505114|66374447|FG002|Overall Study|relocated|2|||
23725880|NCT01505114|66374448|FG003|Overall Study|relocated|3|||
23725881|NCT01505114|66374445|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
23725882|NCT01505114|66374446|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
23725883|NCT01505114|66374447|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
23725884|NCT01505114|66374448|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
23725885|NCT01505114|66374445|FG000|Overall Study|staff safety concerns|0|||
23725886|NCT01505114|66374446|FG001|Overall Study|staff safety concerns|0|||
23725887|NCT01505114|66374447|FG002|Overall Study|staff safety concerns|0|||
23725888|NCT01505114|66374448|FG003|Overall Study|staff safety concerns|1|||
23725889|NCT01505114|66374445|FG000|Overall Study|investigator decision|1|||
23725890|NCT01505114|66374446|FG001|Overall Study|investigator decision|0|||
23725891|NCT01505114|66374447|FG002|Overall Study|investigator decision|1|||
23725892|NCT01505114|66374448|FG003|Overall Study|investigator decision|0|||
23725893|NCT01963780|66374450|FG000|Overall Study|Death|7|||
23725894|NCT02177812|66374452|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725895|NCT02177812|66374453|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725896|NCT02177812|66374454|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725897|NCT02177812|66374455|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725898|NCT02177812|66374456|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725899|NCT02177812|66374457|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
23725900|NCT02177812|66374458|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
23725901|NCT02177812|66374459|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
23725902|NCT02177812|66374460|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23725903|NCT02177812|66374452|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725904|NCT02177812|66374453|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725905|NCT02177812|66374454|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725906|NCT02177812|66374455|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725907|NCT02177812|66374456|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725908|NCT02177812|66374457|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
23539224|NCT01854554|65706000|FG001|Overall Study|Progression|1|||
23725909|NCT02177812|66374458|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
23725910|NCT02177812|66374459|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725911|NCT02177812|66374460|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23725912|NCT02177812|66374452|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23816177|NCT02504671|66708342|FG005|Overall Study|Protocol Violation|1|||
23816178|NCT02504671|66708337|FG000|Overall Study|Lost to Follow-up|0|||
23816179|NCT02504671|66708338|FG001|Overall Study|Lost to Follow-up|0|||
23816180|NCT02504671|66708339|FG002|Overall Study|Lost to Follow-up|2|||
23816181|NCT02504671|66708340|FG003|Overall Study|Lost to Follow-up|0|||
23816182|NCT02504671|66708341|FG004|Overall Study|Lost to Follow-up|0|||
23816183|NCT02504671|66708342|FG005|Overall Study|Lost to Follow-up|1|||
23816184|NCT02504671|66708337|FG000|Overall Study|Protocol defined stopping criteria|7|||
23816185|NCT02504671|66708338|FG001|Overall Study|Protocol defined stopping criteria|4|||
23816186|NCT02504671|66708339|FG002|Overall Study|Protocol defined stopping criteria|3|||
23816187|NCT02504671|66708340|FG003|Overall Study|Protocol defined stopping criteria|5|||
23816188|NCT02504671|66708341|FG004|Overall Study|Protocol defined stopping criteria|3|||
23816189|NCT02504671|66708342|FG005|Overall Study|Protocol defined stopping criteria|3|||
23816190|NCT04971187|66708344|FG000|Overall Study|Screen failures|2|||
23816191|NCT00603837|66708347|FG000|Overall Study|Physician Decision|3|||
23816192|NCT00603837|66708348|FG001|Overall Study|Physician Decision|0|||
23816193|NCT01814553|66708349|FG000|Overall Study|PD per clinical progression|6|||
23816194|NCT01814553|66708350|FG001|Overall Study|PD per clinical progression|8|||
23816195|NCT01814553|66708349|FG000|Overall Study|Other Adverse Event|4|||
23816196|NCT01814553|66708350|FG001|Overall Study|Other Adverse Event|5|||
23816197|NCT01814553|66708349|FG000|Overall Study|Withdrawal by Subject|1|||
23816198|NCT01814553|66708350|FG001|Overall Study|Withdrawal by Subject|1|||
23816199|NCT01814553|66708349|FG000|Overall Study|Other than stated|7|||
23816200|NCT01814553|66708350|FG001|Overall Study|Other than stated|8|||
23816201|NCT00282919|66708351|FG000|Overall Study|Lack of Efficacy|4|||
23816202|NCT00282919|66708351|FG000|Overall Study|Withdrawal by Subject|1|||
23816203|NCT00282919|66708351|FG000|Overall Study|Asymptomatic Parasitemia|2|||
23816204|NCT00368979|66708352|FG000|Overall Study|Adverse Event|9|||
23816205|NCT00368979|66708353|FG001|Overall Study|Adverse Event|16|||
23816206|NCT00368979|66708352|FG000|Overall Study|Lack of Efficacy|5|||
23816207|NCT00368979|66708353|FG001|Overall Study|Lack of Efficacy|3|||
23816208|NCT00368979|66708352|FG000|Overall Study|Other|3|||
23816209|NCT00368979|66708353|FG001|Overall Study|Other|1|||
23816210|NCT00368979|66708352|FG000|Overall Study|Lost to Follow-up|1|||
23816211|NCT00368979|66708353|FG001|Overall Study|Lost to Follow-up|0|||
23816212|NCT00368979|66708352|FG000|Overall Study|Protocol Violation|2|||
23725913|NCT02177812|66374453|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23725914|NCT02177812|66374454|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23725915|NCT02177812|66374455|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23725916|NCT02177812|66374456|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23725917|NCT02177812|66374457|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23725918|NCT02177812|66374458|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
23725919|NCT02177812|66374459|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23725920|NCT02177812|66374460|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23725921|NCT00688623|66374463|FG000|Overall Study|Adverse Event|22|||
23725922|NCT00688623|66374463|FG000|Overall Study|abnormal lab value|1|||
23725923|NCT00688623|66374463|FG000|Overall Study|Withdrawal by Subject|4|||
23725924|NCT00688623|66374463|FG000|Overall Study|Death|3|||
23725925|NCT00688623|66374463|FG000|Overall Study|disease progression|23|||
23725926|NCT00688623|66374463|FG000|Overall Study|Protocol Violation|2|||
23725927|NCT03788967|66374464|FG000|Overall Study|Lost to Follow-up|14|||
23725928|NCT03788967|66374465|FG001|Overall Study|Lost to Follow-up|10|||
23725929|NCT03788967|66374464|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
23725930|NCT03788967|66374465|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
23725931|NCT03788967|66374464|FG000|Overall Study|Participant Withdrawal of Consent|13|||
23816213|NCT00368979|66708353|FG001|Overall Study|Protocol Violation|1|||
23816214|NCT00368979|66708352|FG000|Overall Study|Withdrawal by Subject|5|||
23816215|NCT00368979|66708353|FG001|Overall Study|Withdrawal by Subject|9|||
23816216|NCT02342639|66708357|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
23816217|NCT02342639|66708358|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
23816218|NCT02342639|66708357|FG000|Overall Study|Protocol Violation|0|||
23816219|NCT02342639|66708358|FG001|Overall Study|Protocol Violation|2|||
23816220|NCT04576923|66708359|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
23539225|NCT01854554|65705999|FG000|Overall Study|Lost to Follow-up|0|||
23725932|NCT03788967|66374465|FG001|Overall Study|Participant Withdrawal of Consent|5|||
23725933|NCT03788967|66374464|FG000|Overall Study|Adverse Event|1|||
23816221|NCT02335983|66708370|FG000|Overall Study|Sponsor Decision|0|||
23816222|NCT02335983|66708371|FG001|Overall Study|Sponsor Decision|0|||
23816223|NCT02335983|66708372|FG002|Overall Study|Sponsor Decision|1|||
23816224|NCT02335983|66708373|FG003|Overall Study|Sponsor Decision|1|||
23816225|NCT02335983|66708374|FG004|Overall Study|Sponsor Decision|0|||
23725934|NCT03788967|66374465|FG001|Overall Study|Adverse Event|1|||
23816226|NCT02335983|66708375|FG005|Overall Study|Sponsor Decision|1|||
23816227|NCT02335983|66708370|FG000|Overall Study|Withdrawal by Subject|3|||
23816228|NCT02335983|66708371|FG001|Overall Study|Withdrawal by Subject|2|||
23725935|NCT03788967|66374464|FG000|Overall Study|COVID-19|1|||
23816229|NCT02335983|66708372|FG002|Overall Study|Withdrawal by Subject|2|||
23816230|NCT02335983|66708373|FG003|Overall Study|Withdrawal by Subject|1|||
23816231|NCT02335983|66708374|FG004|Overall Study|Withdrawal by Subject|3|||
23816232|NCT02335983|66708375|FG005|Overall Study|Withdrawal by Subject|9|||
23816233|NCT02335983|66708370|FG000|Overall Study|Death|0|||
23816234|NCT02335983|66708371|FG001|Overall Study|Death|0|||
23816235|NCT02335983|66708372|FG002|Overall Study|Death|2|||
23816236|NCT02335983|66708373|FG003|Overall Study|Death|0|||
23816237|NCT02335983|66708374|FG004|Overall Study|Death|0|||
23816238|NCT02335983|66708375|FG005|Overall Study|Death|0|||
23816239|NCT02335983|66708370|FG000|Overall Study|Lost to Follow-up|0|||
23816240|NCT02335983|66708371|FG001|Overall Study|Lost to Follow-up|0|||
23816241|NCT02335983|66708372|FG002|Overall Study|Lost to Follow-up|0|||
23816242|NCT02335983|66708373|FG003|Overall Study|Lost to Follow-up|0|||
23816243|NCT02335983|66708374|FG004|Overall Study|Lost to Follow-up|0|||
23816244|NCT02335983|66708375|FG005|Overall Study|Lost to Follow-up|1|||
23816245|NCT02335983|66708370|FG000|Overall Study|Protocol Specified Criteria|5|||
23816246|NCT02335983|66708371|FG001|Overall Study|Protocol Specified Criteria|7|||
23816247|NCT02335983|66708372|FG002|Overall Study|Protocol Specified Criteria|27|||
23816248|NCT02335983|66708373|FG003|Overall Study|Protocol Specified Criteria|7|||
23816249|NCT02335983|66708374|FG004|Overall Study|Protocol Specified Criteria|5|||
23816250|NCT02335983|66708375|FG005|Overall Study|Protocol Specified Criteria|21|||
23816251|NCT00106964|66708376|FG000|Overall Study|Lost to Follow-up|8|||
23816252|NCT00106964|66708377|FG001|Overall Study|Lost to Follow-up|6|||
23816253|NCT00106964|66708378|FG002|Overall Study|Lost to Follow-up|2|||
23816254|NCT00106964|66708376|FG000|Overall Study|Pregnancy|2|||
23816255|NCT00106964|66708377|FG001|Overall Study|Pregnancy|3|||
23816256|NCT00106964|66708378|FG002|Overall Study|Pregnancy|2|||
23816257|NCT00106964|66708376|FG000|Overall Study|Death|1|||
23816258|NCT00106964|66708377|FG001|Overall Study|Death|1|||
23816259|NCT00106964|66708378|FG002|Overall Study|Death|0|||
23816260|NCT00106964|66708376|FG000|Overall Study|Incarceration|0|||
23816261|NCT00106964|66708377|FG001|Overall Study|Incarceration|1|||
23816262|NCT00106964|66708378|FG002|Overall Study|Incarceration|0|||
23816263|NCT00106964|66708376|FG000|Overall Study|Site Funding Terminated|0|||
23816264|NCT00106964|66708377|FG001|Overall Study|Site Funding Terminated|1|||
23816265|NCT00106964|66708378|FG002|Overall Study|Site Funding Terminated|1|||
23816266|NCT00106964|66708376|FG000|Overall Study|Failure to adhere|2|||
23816267|NCT00106964|66708377|FG001|Overall Study|Failure to adhere|0|||
23816268|NCT00106964|66708378|FG002|Overall Study|Failure to adhere|0|||
23816269|NCT00106964|66708376|FG000|Overall Study|Did not meet eligibility criteria|0|||
23816270|NCT00106964|66708377|FG001|Overall Study|Did not meet eligibility criteria|2|||
23816271|NCT00106964|66708378|FG002|Overall Study|Did not meet eligibility criteria|2|||
23725936|NCT03788967|66374465|FG001|Overall Study|COVID-19|2|||
23725937|NCT03597503|66374468|FG000|Overall Study|Withdrawal by Subject|0|||
23725938|NCT03597503|66374469|FG001|Overall Study|Withdrawal by Subject|2|||
23725939|NCT03597503|66374468|FG000|Overall Study|Lost to Follow-up|1|||
23725940|NCT03597503|66374469|FG001|Overall Study|Lost to Follow-up|2|||
23725941|NCT03597503|66374468|FG000|Overall Study|Protocol Violation|1|||
23725942|NCT03597503|66374469|FG001|Overall Study|Protocol Violation|0|||
23725943|NCT01376388|66374470|FG000|Overall Study|Adverse Event|13|||
23725944|NCT01376388|66374470|FG000|Overall Study|Lack of Efficacy|2|||
23725945|NCT01376388|66374470|FG000|Overall Study|Withdrawal by Subject|3|||
23725946|NCT01688999|66374471|FG000|Overall Study|Withdrawal by Subject|5|||
23725947|NCT01688999|66374472|FG001|Overall Study|Withdrawal by Subject|1|||
23725948|NCT01688999|66374473|FG002|Overall Study|Withdrawal by Subject|1|||
23725949|NCT01688999|66374471|FG000|Overall Study|Adverse Event|2|||
23725950|NCT01688999|66374472|FG001|Overall Study|Adverse Event|0|||
23725951|NCT01688999|66374473|FG002|Overall Study|Adverse Event|2|||
23725952|NCT01688999|66374471|FG000|Overall Study|Ineligible/Not treated|1|||
23725953|NCT01688999|66374472|FG001|Overall Study|Ineligible/Not treated|0|||
23725954|NCT01688999|66374473|FG002|Overall Study|Ineligible/Not treated|0|||
23725955|NCT01770145|66374478|FG000|Baseline|Adverse Event|20|||
23725956|NCT01770145|66374478|FG000|Baseline|Withdrawal by Subject|1|||
23725957|NCT01770145|66374478|FG000|Baseline|Lost to Follow-up|1|||
23725958|NCT01770145|66374478|FG000|Baseline|Unable to define optimal dose|4|||
23725959|NCT01770145|66374478|FG000|Treatment|Adverse Event|3|||
23725960|NCT01770145|66374478|FG000|Treatment|Withdrawal by Subject|1|||
23725961|NCT01055457|66374480|FG000|Overall Study|Lost to Follow-up|0|||
23725962|NCT01055457|66374481|FG001|Overall Study|Lost to Follow-up|1|||
23725963|NCT01055457|66374482|FG002|Overall Study|Lost to Follow-up|0|||
23725964|NCT01055457|66374483|FG003|Overall Study|Lost to Follow-up|0|||
23725965|NCT01055457|66374484|FG004|Overall Study|Lost to Follow-up|0|||
23816272|NCT00106964|66708376|FG000|Overall Study|Required disallowed medication|0|||
23816273|NCT00106964|66708377|FG001|Overall Study|Required disallowed medication|1|||
23816274|NCT00106964|66708378|FG002|Overall Study|Required disallowed medication|0|||
23725966|NCT01055457|66374485|FG005|Overall Study|Lost to Follow-up|1|||
23725967|NCT01055457|66374486|FG006|Overall Study|Lost to Follow-up|0|||
23816275|NCT01709838|66708381|FG000|Overall Study|Withdrawal by Subject|21|||
23816276|NCT01709838|66708381|FG000|Overall Study|Lost to Follow-up|16|||
23816277|NCT01709838|66708381|FG000|Overall Study|Pregnancy|10|||
23816278|NCT01709838|66708381|FG000|Overall Study|Subject/guardian decision|8|||
23816279|NCT01709838|66708381|FG000|Overall Study|Adverse Event|4|||
23816280|NCT01709838|66708381|FG000|Overall Study|Physician Decision|4|||
23816281|NCT01709838|66708381|FG000|Overall Study|Death|3|||
23816282|NCT01709838|66708381|FG000|Overall Study|Protocol Violation|1|||
23816283|NCT00856375|66708382|FG000|Overall Study|Other|0|||
23816284|NCT00856375|66708383|FG001|Overall Study|Other|1|||
23816285|NCT00856375|66708382|FG000|Overall Study|Death|32|||
23816286|NCT00856375|66708383|FG001|Overall Study|Death|30|||
23816287|NCT00856375|66708382|FG000|Overall Study|Sponsor Terminated Study|7|||
23816288|NCT00856375|66708383|FG001|Overall Study|Sponsor Terminated Study|7|||
23816289|NCT00856375|66708382|FG000|Overall Study|Withdrawal by Subject|2|||
23816290|NCT00856375|66708383|FG001|Overall Study|Withdrawal by Subject|1|||
23816291|NCT00856375|66708382|FG000|Overall Study|Lost to Follow-up|1|||
23816292|NCT00856375|66708383|FG001|Overall Study|Lost to Follow-up|2|||
23816293|NCT01094886|66708384|FG000|Overall Study|Adverse Event|2|||
23816294|NCT01094886|66708384|FG000|Overall Study|Withdrawal by Subject|5|||
23816295|NCT01340768|66708386|FG000|Overall Study|Lost to Follow-up|10|||
23816296|NCT01340768|66708387|FG001|Overall Study|Lost to Follow-up|4|||
23816297|NCT01340768|66708386|FG000|Overall Study|Withdrawal by Subject|5|||
23816298|NCT01340768|66708387|FG001|Overall Study|Withdrawal by Subject|1|||
23816299|NCT01340768|66708386|FG000|Overall Study|Other|2|||
23816300|NCT01340768|66708387|FG001|Overall Study|Other|0|||
23816301|NCT00729248|66708394|FG000|Overall Study|Physician Decision|2|||
23816302|NCT02466685|66708395|FG000|Overall Study|Adverse Event|5|||
23816303|NCT02466685|66708396|FG001|Overall Study|Adverse Event|2|||
23539226|NCT01854554|65706000|FG001|Overall Study|Lost to Follow-up|1|||
23539227|NCT03217136|65706001|FG000|Overall Study|Lost to Follow-up|2|||
23539228|NCT03217136|65706002|FG001|Overall Study|Lost to Follow-up|1|||
23816304|NCT02466685|66708395|FG000|Overall Study|Lost to Follow-up|1|||
23816305|NCT02466685|66708396|FG001|Overall Study|Lost to Follow-up|1|||
23816306|NCT02466685|66708395|FG000|Overall Study|Withdrawal by Subject|1|||
23816307|NCT02466685|66708396|FG001|Overall Study|Withdrawal by Subject|0|||
23816308|NCT02466685|66708395|FG000|Overall Study|Physician Decision|1|||
23816309|NCT02466685|66708396|FG001|Overall Study|Physician Decision|1|||
23816310|NCT02740699|66708401|FG000|Overall Study|Lost to Follow-up|5|||
23816311|NCT02740699|66708401|FG000|Overall Study|Withdrawal by Subject|14|||
23816312|NCT02740699|66708401|FG000|Overall Study|Physician Decision|5|||
23816313|NCT00186888|66708402|FG000|Overall Study|Toxicity|0|||
23816314|NCT00186888|66708403|FG001|Overall Study|Toxicity|1|||
23816315|NCT00186888|66708404|FG002|Overall Study|Toxicity|0|||
23725968|NCT01055457|66374487|FG007|Overall Study|Lost to Follow-up|0|||
23725969|NCT01055457|66374488|FG008|Overall Study|Lost to Follow-up|0|||
23725970|NCT01055457|66374489|FG009|Overall Study|Lost to Follow-up|0|||
23725971|NCT01055457|66374480|FG000|Overall Study|Protocol Violation|0|||
23725972|NCT01055457|66374481|FG001|Overall Study|Protocol Violation|0|||
23725973|NCT01055457|66374482|FG002|Overall Study|Protocol Violation|1|||
23725974|NCT01055457|66374483|FG003|Overall Study|Protocol Violation|1|||
23725975|NCT01055457|66374484|FG004|Overall Study|Protocol Violation|1|||
23725976|NCT01055457|66374485|FG005|Overall Study|Protocol Violation|2|||
23725977|NCT01055457|66374486|FG006|Overall Study|Protocol Violation|1|||
23725978|NCT01055457|66374487|FG007|Overall Study|Protocol Violation|0|||
23725979|NCT01055457|66374488|FG008|Overall Study|Protocol Violation|0|||
23816316|NCT00186888|66708402|FG000|Overall Study|Relapse or progression of disease|4|||
23539229|NCT03217136|65706001|FG000|Overall Study|Site Randomized Participant in Error|0|||
23539230|NCT03217136|65706002|FG001|Overall Study|Site Randomized Participant in Error|1|||
23539231|NCT03217136|65706001|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
23616444|NCT03915951|65982344|FG000|Overall Study|Disease progression (clinical)|4|||
23616445|NCT03915951|65982345|FG001|Overall Study|Disease progression (clinical)|1|||
23725980|NCT01055457|66374489|FG009|Overall Study|Protocol Violation|1|||
23816317|NCT00186888|66708403|FG001|Overall Study|Relapse or progression of disease|2|||
23539232|NCT03217136|65706002|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
23539233|NCT03217136|65706001|FG000|Overall Study|Dispensing Error|1|||
23539234|NCT03217136|65706002|FG001|Overall Study|Dispensing Error|0|||
23539235|NCT03217136|65706001|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23725981|NCT01055457|66374480|FG000|Overall Study|Subject Disinterest|0|||
23816318|NCT00186888|66708404|FG002|Overall Study|Relapse or progression of disease|0|||
23539236|NCT03217136|65706002|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23725982|NCT01055457|66374481|FG001|Overall Study|Subject Disinterest|0|||
23539237|NCT01459796|65706003|FG000|Overall Study|Non compliance with protocol|2|||
23616446|NCT03915951|65982344|FG000|Overall Study|Patient decision|0|||
23816319|NCT01739348|66708405|FG000|Part I (Base Study)|Adverse Event|41|||
23816320|NCT01739348|66708406|FG001|Part I (Base Study)|Adverse Event|52|||
23816321|NCT01739348|66708407|FG002|Part I (Base Study)|Adverse Event|8|||
23816322|NCT01739348|66708408|FG003|Part I (Base Study)|Adverse Event|33|||
23816323|NCT01739348|66708405|FG000|Part I (Base Study)|Death|10|||
23816324|NCT01739348|66708406|FG001|Part I (Base Study)|Death|7|||
23816325|NCT01739348|66708407|FG002|Part I (Base Study)|Death|2|||
23725983|NCT01055457|66374482|FG002|Overall Study|Subject Disinterest|0|||
23725984|NCT01055457|66374483|FG003|Overall Study|Subject Disinterest|0|||
23725985|NCT01055457|66374484|FG004|Overall Study|Subject Disinterest|0|||
23725986|NCT01055457|66374485|FG005|Overall Study|Subject Disinterest|0|||
23725987|NCT01055457|66374486|FG006|Overall Study|Subject Disinterest|0|||
23725988|NCT01055457|66374487|FG007|Overall Study|Subject Disinterest|1|||
23725989|NCT01055457|66374488|FG008|Overall Study|Subject Disinterest|0|||
23725990|NCT01055457|66374489|FG009|Overall Study|Subject Disinterest|0|||
23816326|NCT01739348|66708408|FG003|Part I (Base Study)|Death|8|||
23816327|NCT01739348|66708405|FG000|Part I (Base Study)|Lack of Efficacy|3|||
23816328|NCT01739348|66708406|FG001|Part I (Base Study)|Lack of Efficacy|8|||
23816329|NCT01739348|66708407|FG002|Part I (Base Study)|Lack of Efficacy|0|||
23816330|NCT01739348|66708408|FG003|Part I (Base Study)|Lack of Efficacy|7|||
23816331|NCT01739348|66708405|FG000|Part I (Base Study)|Lost to Follow-up|4|||
23816332|NCT01739348|66708406|FG001|Part I (Base Study)|Lost to Follow-up|2|||
23816333|NCT01739348|66708407|FG002|Part I (Base Study)|Lost to Follow-up|4|||
23816334|NCT01739348|66708408|FG003|Part I (Base Study)|Lost to Follow-up|4|||
23816335|NCT01739348|66708405|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
23816336|NCT01739348|66708406|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
23816337|NCT01739348|66708407|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
23816338|NCT01739348|66708408|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
23816339|NCT01739348|66708405|FG000|Part I (Base Study)|Physician Decision|10|||
23816340|NCT01739348|66708406|FG001|Part I (Base Study)|Physician Decision|7|||
23816341|NCT01739348|66708407|FG002|Part I (Base Study)|Physician Decision|1|||
23816342|NCT01739348|66708408|FG003|Part I (Base Study)|Physician Decision|4|||
23816343|NCT01739348|66708405|FG000|Part I (Base Study)|Protocol Violation|2|||
23816344|NCT01739348|66708406|FG001|Part I (Base Study)|Protocol Violation|0|||
23816345|NCT01739348|66708407|FG002|Part I (Base Study)|Protocol Violation|1|||
23816346|NCT01739348|66708408|FG003|Part I (Base Study)|Protocol Violation|2|||
23816347|NCT01739348|66708405|FG000|Part I (Base Study)|Screen Failure|2|||
23816348|NCT01739348|66708406|FG001|Part I (Base Study)|Screen Failure|0|||
23816349|NCT01739348|66708407|FG002|Part I (Base Study)|Screen Failure|0|||
23816350|NCT01739348|66708408|FG003|Part I (Base Study)|Screen Failure|0|||
23816351|NCT01739348|66708405|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
23816352|NCT01739348|66708406|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
23816353|NCT01739348|66708407|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
23816354|NCT01739348|66708408|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
23816355|NCT01739348|66708405|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
23816356|NCT01739348|66708406|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
23816357|NCT01739348|66708407|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
23816358|NCT01739348|66708408|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
23816359|NCT01739348|66708405|FG000|Part I (Base Study)|Participant Moved|4|||
23816360|NCT01739348|66708406|FG001|Part I (Base Study)|Participant Moved|3|||
23816361|NCT01739348|66708407|FG002|Part I (Base Study)|Participant Moved|1|||
23816362|NCT01739348|66708408|FG003|Part I (Base Study)|Participant Moved|7|||
23816363|NCT01739348|66708405|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
23816364|NCT01739348|66708406|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
23816365|NCT01739348|66708407|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
23816366|NCT01739348|66708408|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
23816367|NCT01739348|66708405|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
23816368|NCT01739348|66708406|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
23816369|NCT01739348|66708407|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
23816370|NCT01739348|66708408|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
23816371|NCT01739348|66708405|FG000|Part II (Extension Study)|Adverse Event|10|||
23816372|NCT01739348|66708406|FG001|Part II (Extension Study)|Adverse Event|11|||
23816373|NCT01739348|66708407|FG002|Part II (Extension Study)|Adverse Event|7|||
23816374|NCT01739348|66708408|FG003|Part II (Extension Study)|Adverse Event|26|||
23816375|NCT01739348|66708405|FG000|Part II (Extension Study)|Death|3|||
23816376|NCT01739348|66708406|FG001|Part II (Extension Study)|Death|3|||
23816377|NCT01739348|66708407|FG002|Part II (Extension Study)|Death|2|||
23816378|NCT01739348|66708408|FG003|Part II (Extension Study)|Death|6|||
23816379|NCT01739348|66708405|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
23816380|NCT01739348|66708406|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
23816381|NCT01739348|66708407|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
23816382|NCT01739348|66708408|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
23424153|NCT01643850|65296370|FG000|Overall Study|Administrative Problems|0|||
23725991|NCT01055457|66374480|FG000|Overall Study|Subject Ineligible|1|||
23816383|NCT01739348|66708405|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
23816384|NCT01739348|66708406|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
23816385|NCT01739348|66708407|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
23816386|NCT01739348|66708408|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
23424154|NCT01643850|65296371|FG001|Overall Study|Administrative Problems|0|||
23725992|NCT01055457|66374481|FG001|Overall Study|Subject Ineligible|0|||
23539238|NCT01459796|65706004|FG001|Overall Study|Non compliance with protocol|4|||
23539239|NCT01459796|65706003|FG000|Overall Study|Adverse Event|5|||
23539240|NCT01459796|65706004|FG001|Overall Study|Adverse Event|5|||
23539241|NCT01459796|65706003|FG000|Overall Study|Withdrawal by Subject|6|||
23539242|NCT01459796|65706004|FG001|Overall Study|Withdrawal by Subject|3|||
23539243|NCT01459796|65706003|FG000|Overall Study|Lost to Follow-up|5|||
23539244|NCT01459796|65706004|FG001|Overall Study|Lost to Follow-up|4|||
23539245|NCT01459796|65706003|FG000|Overall Study|Reason unspecified|1|||
23539246|NCT01459796|65706004|FG001|Overall Study|Reason unspecified|2|||
23539247|NCT01459796|65706003|FG000|Overall Study|Decision by the sponsor|75|||
23539248|NCT01459796|65706004|FG001|Overall Study|Decision by the sponsor|108|||
23539249|NCT00003457|65706005|FG000|Overall Study|Not evaluable|9|||
23539250|NCT03483623|65706006|FG000|Overall Study|43 complete sets achieved|1|||
23539251|NCT03370341|65706007|FG000|Overall Study|Lost to Follow-up|0|||
23539252|NCT03370341|65706008|FG001|Overall Study|Lost to Follow-up|1|||
23539253|NCT03169153|65706009|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23539254|NCT03169153|65706010|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23539255|NCT03169153|65706009|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
23539256|NCT03169153|65706010|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
23539257|NCT03169153|65706009|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
23725993|NCT01055457|66374482|FG002|Overall Study|Subject Ineligible|1|||
23725994|NCT01055457|66374483|FG003|Overall Study|Subject Ineligible|0|||
23725995|NCT01055457|66374484|FG004|Overall Study|Subject Ineligible|1|||
23725996|NCT01055457|66374485|FG005|Overall Study|Subject Ineligible|0|||
23539258|NCT03169153|65706010|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
23539259|NCT03169153|65706009|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
23539260|NCT03169153|65706010|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
23539261|NCT01060384|65706024|FG000|Overall Study|Withdrawal by Subject|0|||
23539262|NCT01060384|65706025|FG001|Overall Study|Withdrawal by Subject|1|||
23539263|NCT01060384|65706026|FG002|Overall Study|Withdrawal by Subject|0|||
23539264|NCT01060384|65706027|FG003|Overall Study|Withdrawal by Subject|0|||
23539265|NCT01060384|65706028|FG004|Overall Study|Withdrawal by Subject|0|||
23539266|NCT01060384|65706024|FG000|Overall Study|Death|0|||
23539267|NCT01060384|65706025|FG001|Overall Study|Death|0|||
23725997|NCT01055457|66374486|FG006|Overall Study|Subject Ineligible|0|||
23725998|NCT01055457|66374487|FG007|Overall Study|Subject Ineligible|0|||
23725999|NCT01055457|66374488|FG008|Overall Study|Subject Ineligible|0|||
23726000|NCT01055457|66374489|FG009|Overall Study|Subject Ineligible|0|||
23726001|NCT01055457|66374480|FG000|Overall Study|Discomfort|0|||
23726002|NCT01055457|66374481|FG001|Overall Study|Discomfort|0|||
23726003|NCT01055457|66374482|FG002|Overall Study|Discomfort|0|||
23726004|NCT01055457|66374483|FG003|Overall Study|Discomfort|0|||
23726005|NCT01055457|66374484|FG004|Overall Study|Discomfort|1|||
23726006|NCT01055457|66374485|FG005|Overall Study|Discomfort|0|||
23726007|NCT01055457|66374486|FG006|Overall Study|Discomfort|0|||
23726008|NCT01055457|66374487|FG007|Overall Study|Discomfort|0|||
23726009|NCT01055457|66374488|FG008|Overall Study|Discomfort|0|||
23726010|NCT01055457|66374489|FG009|Overall Study|Discomfort|0|||
23726011|NCT01055457|66374480|FG000|Overall Study|Pregnancy|0|||
23726012|NCT01055457|66374481|FG001|Overall Study|Pregnancy|0|||
23726013|NCT01055457|66374482|FG002|Overall Study|Pregnancy|0|||
23726014|NCT01055457|66374483|FG003|Overall Study|Pregnancy|1|||
23726015|NCT01055457|66374484|FG004|Overall Study|Pregnancy|0|||
23726016|NCT01055457|66374485|FG005|Overall Study|Pregnancy|0|||
23726017|NCT01055457|66374486|FG006|Overall Study|Pregnancy|0|||
23726018|NCT01055457|66374487|FG007|Overall Study|Pregnancy|0|||
23726019|NCT01055457|66374488|FG008|Overall Study|Pregnancy|0|||
23726020|NCT01055457|66374489|FG009|Overall Study|Pregnancy|0|||
23726021|NCT01055457|66374480|FG000|Overall Study|Adverse Event|0|||
23726022|NCT01055457|66374481|FG001|Overall Study|Adverse Event|0|||
23726023|NCT01055457|66374482|FG002|Overall Study|Adverse Event|0|||
23726024|NCT01055457|66374483|FG003|Overall Study|Adverse Event|1|||
23726025|NCT01055457|66374484|FG004|Overall Study|Adverse Event|0|||
23726026|NCT01055457|66374485|FG005|Overall Study|Adverse Event|0|||
23726027|NCT01055457|66374486|FG006|Overall Study|Adverse Event|0|||
23726028|NCT01055457|66374487|FG007|Overall Study|Adverse Event|0|||
23726029|NCT01055457|66374488|FG008|Overall Study|Adverse Event|0|||
23726030|NCT01055457|66374489|FG009|Overall Study|Adverse Event|0|||
23726031|NCT05166603|66374490|FG000|Overall Study|Withdrawal by Subject|68|||
23726032|NCT05166603|66374491|FG001|Overall Study|Withdrawal by Subject|0|||
23726033|NCT04363944|66374492|FG000|Overall Study|Withdrawal by Subject|2|||
23726034|NCT04363944|66374493|FG001|Overall Study|Withdrawal by Subject|0|||
23539268|NCT01060384|65706026|FG002|Overall Study|Death|0|||
23539269|NCT01060384|65706027|FG003|Overall Study|Death|0|||
23616447|NCT03915951|65982345|FG001|Overall Study|Patient decision|4|||
23539270|NCT01060384|65706028|FG004|Overall Study|Death|1|||
23539271|NCT01060384|65706024|FG000|Overall Study|Intercurrent illness|0|||
23726035|NCT04599972|66374496|FG000|Overall Study|Withdrawal by Subject|6|||
23726036|NCT04599972|66374497|FG001|Overall Study|Withdrawal by Subject|1|||
23726037|NCT04599972|66374496|FG000|Overall Study|Adverse Event|1|||
23726038|NCT04599972|66374497|FG001|Overall Study|Adverse Event|1|||
23726039|NCT04599972|66374496|FG000|Overall Study|Lost to Follow-up|1|||
23726040|NCT04599972|66374497|FG001|Overall Study|Lost to Follow-up|6|||
23726041|NCT04599972|66374496|FG000|Overall Study|Protocol Violation|1|||
23726042|NCT04599972|66374497|FG001|Overall Study|Protocol Violation|0|||
23726043|NCT04599972|66374496|FG000|Overall Study|Other reason|1|||
23726044|NCT04599972|66374497|FG001|Overall Study|Other reason|0|||
23726045|NCT02215616|66374500|FG000|Overall Study|Sponsor requested to stop study drug|0|||
23726046|NCT02215616|66374501|FG001|Overall Study|Sponsor requested to stop study drug|0|||
23726047|NCT02215616|66374502|FG002|Overall Study|Sponsor requested to stop study drug|1|||
23726048|NCT02215616|66374503|FG003|Overall Study|Sponsor requested to stop study drug|4|||
23726049|NCT02215616|66374500|FG000|Overall Study|Death|1|||
23726050|NCT02215616|66374501|FG001|Overall Study|Death|0|||
23726051|NCT02215616|66374502|FG002|Overall Study|Death|0|||
23726052|NCT02215616|66374503|FG003|Overall Study|Death|0|||
23726053|NCT02215616|66374500|FG000|Overall Study|Adverse Event|7|||
23726054|NCT02215616|66374501|FG001|Overall Study|Adverse Event|4|||
23726055|NCT02215616|66374502|FG002|Overall Study|Adverse Event|9|||
23726056|NCT02215616|66374503|FG003|Overall Study|Adverse Event|2|||
23726057|NCT02215616|66374500|FG000|Overall Study|Withdrawal by Subject|1|||
23726058|NCT02215616|66374501|FG001|Overall Study|Withdrawal by Subject|8|||
23726059|NCT02215616|66374502|FG002|Overall Study|Withdrawal by Subject|2|||
23726060|NCT02215616|66374503|FG003|Overall Study|Withdrawal by Subject|5|||
23726061|NCT02215616|66374500|FG000|Overall Study|Non-compliance|0|||
23726062|NCT02215616|66374501|FG001|Overall Study|Non-compliance|2|||
23726063|NCT02215616|66374502|FG002|Overall Study|Non-compliance|1|||
23726064|NCT02215616|66374503|FG003|Overall Study|Non-compliance|0|||
23726065|NCT02215616|66374500|FG000|Overall Study|Protocol Violation|0|||
23726066|NCT02215616|66374501|FG001|Overall Study|Protocol Violation|2|||
23726067|NCT02215616|66374502|FG002|Overall Study|Protocol Violation|0|||
23726068|NCT02215616|66374503|FG003|Overall Study|Protocol Violation|0|||
23726069|NCT02215616|66374500|FG000|Overall Study|Lost to Follow-up|1|||
23726070|NCT02215616|66374501|FG001|Overall Study|Lost to Follow-up|1|||
23726071|NCT02215616|66374502|FG002|Overall Study|Lost to Follow-up|0|||
23726072|NCT02215616|66374503|FG003|Overall Study|Lost to Follow-up|1|||
23726073|NCT02215616|66374500|FG000|Overall Study|Other than specified|1|||
23726074|NCT02215616|66374501|FG001|Overall Study|Other than specified|0|||
23726075|NCT02215616|66374502|FG002|Overall Study|Other than specified|1|||
23726076|NCT02215616|66374503|FG003|Overall Study|Other than specified|1|||
23726077|NCT01628393|66374511|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
23726078|NCT01628393|66374512|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23726079|NCT01628393|66374513|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23726080|NCT01628393|66374514|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23726081|NCT01628393|66374515|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23726082|NCT01628393|66374511|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
23726083|NCT01628393|66374512|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
23726084|NCT01628393|66374513|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
23726085|NCT01628393|66374514|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
23726086|NCT01628393|66374515|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
23726087|NCT01628393|66374511|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
23726088|NCT01628393|66374512|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
23726089|NCT01628393|66374513|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
23726090|NCT01628393|66374514|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23726091|NCT01628393|66374515|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23726092|NCT01628393|66374511|FG000|Blinded Active Extension Period|Adverse Event|0|||
23726093|NCT01628393|66374512|FG001|Blinded Active Extension Period|Adverse Event|1|||
23726094|NCT01628393|66374513|FG002|Blinded Active Extension Period|Adverse Event|0|||
23726095|NCT01628393|66374514|FG003|Blinded Active Extension Period|Adverse Event|2|||
23726096|NCT01628393|66374515|FG004|Blinded Active Extension Period|Adverse Event|2|||
23726097|NCT01628393|66374511|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
23726098|NCT01628393|66374512|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
23726099|NCT01628393|66374513|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
23539272|NCT01060384|65706025|FG001|Overall Study|Intercurrent illness|0|||
23539273|NCT01060384|65706026|FG002|Overall Study|Intercurrent illness|0|||
23539274|NCT01060384|65706027|FG003|Overall Study|Intercurrent illness|0|||
23539275|NCT01060384|65706028|FG004|Overall Study|Intercurrent illness|1|||
23539276|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
23539277|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
23539278|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
23539279|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
23539280|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
23539281|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
23539282|NCT02602288|65706029|FG000|12 Month Follow-up|Lost to Follow-up|0|||
23539283|NCT02602288|65706030|FG001|12 Month Follow-up|Lost to Follow-up|4|||
23539284|NCT02602288|65706029|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
23539285|NCT02602288|65706030|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
23539286|NCT02956629|65706033|FG000|Overall Study|Adverse Event|0|||
23539287|NCT02956629|65706034|FG001|Overall Study|Adverse Event|0|||
23539288|NCT02956629|65706035|FG002|Overall Study|Adverse Event|1|||
23539289|NCT02956629|65706036|FG003|Overall Study|Adverse Event|0|||
23539290|NCT02956629|65706037|FG004|Overall Study|Adverse Event|0|||
23539291|NCT02956629|65706038|FG005|Overall Study|Adverse Event|0|||
23539292|NCT02956629|65706033|FG000|Overall Study|Lost to Follow-up|2|||
23539293|NCT02956629|65706034|FG001|Overall Study|Lost to Follow-up|5|||
23539294|NCT02956629|65706035|FG002|Overall Study|Lost to Follow-up|3|||
23539295|NCT02956629|65706036|FG003|Overall Study|Lost to Follow-up|1|||
23539296|NCT02956629|65706037|FG004|Overall Study|Lost to Follow-up|0|||
23539297|NCT02956629|65706038|FG005|Overall Study|Lost to Follow-up|1|||
23539298|NCT02956629|65706033|FG000|Overall Study|Withdrawal by Subject|3|||
23539299|NCT02956629|65706034|FG001|Overall Study|Withdrawal by Subject|1|||
23539300|NCT02956629|65706035|FG002|Overall Study|Withdrawal by Subject|0|||
23539301|NCT02956629|65706036|FG003|Overall Study|Withdrawal by Subject|0|||
23539302|NCT02956629|65706037|FG004|Overall Study|Withdrawal by Subject|0|||
23539303|NCT02956629|65706038|FG005|Overall Study|Withdrawal by Subject|0|||
23539304|NCT03893448|65706039|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
23539305|NCT03893448|65706040|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
23539306|NCT03893448|65706039|FG000|Overall Study|Physician Decision|8|||
23539307|NCT03893448|65706040|FG001|Overall Study|Physician Decision|14|||
23539308|NCT03893448|65706039|FG000|Overall Study|Lost to Follow-up|34|||
23539309|NCT03893448|65706040|FG001|Overall Study|Lost to Follow-up|27|||
23539310|NCT03893448|65706039|FG000|Overall Study|Death|1|||
23539311|NCT03893448|65706040|FG001|Overall Study|Death|0|||
23539312|NCT00803023|65706041|FG000|Overall Study|Adverse Event|5|||
23539313|NCT00803023|65706042|FG001|Overall Study|Adverse Event|4|||
23539314|NCT00803023|65706043|FG002|Overall Study|Adverse Event|8|||
23539315|NCT00803023|65706044|FG003|Overall Study|Adverse Event|6|||
23539316|NCT00803023|65706041|FG000|Overall Study|Withdrawal by Subject|0|||
23539317|NCT00803023|65706042|FG001|Overall Study|Withdrawal by Subject|2|||
23539318|NCT00803023|65706043|FG002|Overall Study|Withdrawal by Subject|0|||
23539319|NCT00803023|65706044|FG003|Overall Study|Withdrawal by Subject|0|||
23539320|NCT00803023|65706041|FG000|Overall Study|Lost to Follow-up|0|||
23539321|NCT00803023|65706042|FG001|Overall Study|Lost to Follow-up|1|||
23539322|NCT00803023|65706043|FG002|Overall Study|Lost to Follow-up|2|||
23539323|NCT00803023|65706044|FG003|Overall Study|Lost to Follow-up|1|||
23539324|NCT00803023|65706041|FG000|Overall Study|Lack of Efficacy|0|||
23539325|NCT00803023|65706042|FG001|Overall Study|Lack of Efficacy|1|||
23539326|NCT00803023|65706043|FG002|Overall Study|Lack of Efficacy|1|||
23539327|NCT00803023|65706044|FG003|Overall Study|Lack of Efficacy|1|||
23539328|NCT01794949|65706045|FG000|Overall Study|Lost to Follow-up|1|||
23539329|NCT01794949|65706046|FG001|Overall Study|Lost to Follow-up|0|||
23539330|NCT04116229|65706047|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
23539331|NCT04116229|65706048|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
23726100|NCT01628393|66374514|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
23539332|NCT04116229|65706047|FG000|Overall Study|Scheduling not possible.|0|||
23726101|NCT01628393|66374515|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
23726102|NCT01628393|66374511|FG000|Blinded Active Extension Period|Physician Decision|0|||
23539333|NCT04116229|65706048|FG001|Overall Study|Scheduling not possible.|1|||
23539334|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
23539335|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
23539336|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
23539337|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539338|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539339|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539340|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539341|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539342|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539343|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
23539344|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
23539345|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
23539346|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539347|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539348|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539349|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539350|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539351|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539352|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539353|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23539354|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
23539355|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539356|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539357|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539358|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539359|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539360|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539361|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
23539362|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
23539363|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
23539364|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539365|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539366|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539367|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539368|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539369|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539370|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539371|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
23539372|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539373|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539374|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539375|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539376|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539377|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539378|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539379|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
23539380|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539381|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539382|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539383|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539384|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539385|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539386|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539387|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539388|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539389|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
23539390|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
23539391|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539392|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539393|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539394|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539395|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539396|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539397|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539398|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
23539399|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
23539400|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
23539401|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
23539402|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
23539403|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539404|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539405|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539406|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539407|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
23539408|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
23539409|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
23539410|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
23539411|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
23539412|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539413|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539414|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539415|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539416|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539417|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
23539418|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539419|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539420|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539421|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539422|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539423|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539424|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539425|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
23539426|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
23539427|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
23539428|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
23539429|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
23539430|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
23539431|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539432|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539433|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539434|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539435|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539436|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539437|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539438|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539439|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539440|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539441|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539442|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539443|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539444|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539445|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539446|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539447|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
23539448|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
23539449|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
23726103|NCT01628393|66374512|FG001|Blinded Active Extension Period|Physician Decision|3|||
23726104|NCT01628393|66374513|FG002|Blinded Active Extension Period|Physician Decision|0|||
23726105|NCT01628393|66374514|FG003|Blinded Active Extension Period|Physician Decision|1|||
23726106|NCT01628393|66374515|FG004|Blinded Active Extension Period|Physician Decision|0|||
23726107|NCT01628393|66374511|FG000|Blinded Active Extension Period|Protocol Violation|0|||
23726108|NCT01628393|66374512|FG001|Blinded Active Extension Period|Protocol Violation|0|||
23539450|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539451|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539452|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
23539453|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
23616448|NCT03915951|65982344|FG000|Overall Study|Investigator decision|0|||
23539454|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539455|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539456|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539457|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539458|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
23539459|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
23539460|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539461|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
23539462|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
23539463|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539464|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539465|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539466|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539467|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
23539468|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539469|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539470|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539471|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
23726109|NCT01628393|66374513|FG002|Blinded Active Extension Period|Protocol Violation|2|||
23726110|NCT01628393|66374514|FG003|Blinded Active Extension Period|Protocol Violation|1|||
23726111|NCT01628393|66374515|FG004|Blinded Active Extension Period|Protocol Violation|0|||
23726112|NCT01628393|66374511|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
23726113|NCT01628393|66374512|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
23726114|NCT01628393|66374513|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
23726115|NCT01628393|66374514|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
23726116|NCT01628393|66374515|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
23726117|NCT00003838|66374516|FG000|Overall Study|Death|0|||
23726118|NCT00003838|66374517|FG001|Overall Study|Death|12|||
23726119|NCT00003838|66374518|FG002|Overall Study|Death|7|||
23726120|NCT00003838|66374516|FG000|Overall Study|Lost to Follow-up|0|||
23726121|NCT00003838|66374517|FG001|Overall Study|Lost to Follow-up|1|||
23726122|NCT00003838|66374518|FG002|Overall Study|Lost to Follow-up|1|||
23726123|NCT00003838|66374516|FG000|Overall Study|Disease Progression|0|||
23726124|NCT00003838|66374517|FG001|Overall Study|Disease Progression|12|||
23726125|NCT00003838|66374518|FG002|Overall Study|Disease Progression|0|||
23726126|NCT04322682|66374519|FG000|Overall Study|Withdrawal by Subject|33|||
23726127|NCT04322682|66374520|FG001|Overall Study|Withdrawal by Subject|47|||
23726128|NCT04322682|66374519|FG000|Overall Study|Death|5|||
23726129|NCT04322682|66374520|FG001|Overall Study|Death|9|||
23726130|NCT04322682|66374519|FG000|Overall Study|Lost to Follow-up|4|||
23726131|NCT04322682|66374520|FG001|Overall Study|Lost to Follow-up|8|||
23726132|NCT04322682|66374519|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
23726133|NCT04322682|66374520|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
23726134|NCT00959894|66374521|FG000|Overall Study|Lost to Follow-up|10|||
23726135|NCT00959894|66374521|FG000|Overall Study|Adverse Event|3|||
23726136|NCT00959894|66374521|FG000|Overall Study|Withdrawal by Subject|1|||
23726137|NCT00959894|66374521|FG000|Overall Study|Need for contraindicated medication|1|||
23726138|NCT00959894|66374521|FG000|Overall Study|Subject moved out of town|1|||
23726139|NCT00422669|66374522|FG000|Overall Study|The study was terminated early.|98|||
23726140|NCT00422669|66374523|FG001|Overall Study|The study was terminated early.|100|||
23726141|NCT00422669|66374524|FG002|Overall Study|The study was terminated early.|7|||
23726142|NCT00093470|66374525|FG000|Overall Study|Disease progression|39|||
23726143|NCT00093470|66374526|FG001|Overall Study|Disease progression|0|||
23726144|NCT00093470|66374525|FG000|Overall Study|Adverse Event|15|||
23726145|NCT00093470|66374526|FG001|Overall Study|Adverse Event|0|||
23726146|NCT00093470|66374525|FG000|Overall Study|Death|2|||
23726147|NCT00093470|66374526|FG001|Overall Study|Death|0|||
23726148|NCT00093470|66374525|FG000|Overall Study|Withdrawal by Subject|8|||
23726149|NCT00093470|66374526|FG001|Overall Study|Withdrawal by Subject|0|||
23726150|NCT00093470|66374525|FG000|Overall Study|Alternative therapy|2|||
23726151|NCT00093470|66374526|FG001|Overall Study|Alternative therapy|0|||
23726152|NCT00093470|66374525|FG000|Overall Study|Other complicating disease|3|||
23726153|NCT00093470|66374526|FG001|Overall Study|Other complicating disease|0|||
23726154|NCT00093470|66374525|FG000|Overall Study|Physician Decision|2|||
23726155|NCT00093470|66374526|FG001|Overall Study|Physician Decision|0|||
23726156|NCT00093470|66374525|FG000|Overall Study|Never started treatment|1|||
23726157|NCT00093470|66374526|FG001|Overall Study|Never started treatment|0|||
23726158|NCT00093470|66374525|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
23726159|NCT00093470|66374526|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
23726160|NCT02738580|66374532|FG000|Overall Study|Adverse Event|1|||
23726161|NCT02738580|66374533|FG001|Overall Study|Adverse Event|0|||
23726162|NCT02738580|66374532|FG000|Overall Study|Lack of Efficacy|3|||
23726163|NCT02738580|66374533|FG001|Overall Study|Lack of Efficacy|2|||
23726164|NCT02738580|66374532|FG000|Overall Study|Withdrawal by Subject|0|||
23616449|NCT03915951|65982345|FG001|Overall Study|Investigator decision|1|||
23616450|NCT03915951|65982344|FG000|Overall Study|Consent withdrawn|1|||
23616451|NCT03915951|65982345|FG001|Overall Study|Consent withdrawn|1|||
23616452|NCT03915951|65982344|FG000|Overall Study|Death|0|||
23616453|NCT03915951|65982345|FG001|Overall Study|Death|3|||
23616454|NCT05006703|65982348|FG000|Overall Study|Withdrawal by Subject|1|||
23616455|NCT05006703|65982349|FG001|Overall Study|Withdrawal by Subject|0|||
23616456|NCT05006703|65982348|FG000|Overall Study|Lost to Follow-up|13|||
23616457|NCT05006703|65982349|FG001|Overall Study|Lost to Follow-up|5|||
23616458|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23616459|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23616460|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616461|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616462|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616463|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616464|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616465|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
23616466|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
23616467|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
23616468|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616469|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616470|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616471|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616472|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
23616473|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616474|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23616475|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616476|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616477|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616478|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616479|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616480|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
23616481|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616482|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616483|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616484|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616485|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616486|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
23616487|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
23616488|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
23616489|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616490|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616491|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616492|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616493|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
23616494|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
23616495|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
23616496|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616497|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616498|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616499|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616500|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616501|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616502|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616503|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616504|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616505|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
23616506|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616507|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616508|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616509|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23726165|NCT02738580|66374533|FG001|Overall Study|Withdrawal by Subject|1|||
23726166|NCT02738580|66374532|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
23726167|NCT02738580|66374533|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
23616510|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23616511|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616512|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
23616513|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
23616514|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23616515|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23616516|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23726168|NCT02009930|66374534|FG000|Overall Study|withdrawn|5|||
23539472|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539473|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539474|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539475|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23726169|NCT01915095|66374541|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
23726170|NCT01915095|66374542|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
23816387|NCT01739348|66708405|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23816388|NCT01739348|66708406|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23816389|NCT01739348|66708407|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23816390|NCT01739348|66708408|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
23816391|NCT01739348|66708405|FG000|Part II (Extension Study)|Physician Decision|7|||
23816392|NCT01739348|66708406|FG001|Part II (Extension Study)|Physician Decision|11|||
23816393|NCT01739348|66708407|FG002|Part II (Extension Study)|Physician Decision|6|||
23816394|NCT01739348|66708408|FG003|Part II (Extension Study)|Physician Decision|12|||
23816395|NCT01739348|66708405|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
23816396|NCT01739348|66708406|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
23816397|NCT01739348|66708407|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
23816398|NCT01739348|66708408|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
23816399|NCT01739348|66708405|FG000|Part II (Extension Study)|Participant Moved|3|||
23816400|NCT01739348|66708406|FG001|Part II (Extension Study)|Participant Moved|3|||
23816401|NCT01739348|66708407|FG002|Part II (Extension Study)|Participant Moved|0|||
23816402|NCT01739348|66708408|FG003|Part II (Extension Study)|Participant Moved|3|||
23816403|NCT01739348|66708405|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
23816404|NCT01739348|66708406|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
23816405|NCT01739348|66708407|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
23816406|NCT01739348|66708408|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
23539476|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539477|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23726171|NCT01915095|66374543|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
23726172|NCT01915095|66374544|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
23726173|NCT01915095|66374545|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
23726174|NCT03654560|66374546|FG000|Overall Study|Death|3|||
23726175|NCT03654560|66374547|FG001|Overall Study|Death|1|||
23726176|NCT03654560|66374546|FG000|Overall Study|Lost to Follow-up|1|||
23726177|NCT03654560|66374547|FG001|Overall Study|Lost to Follow-up|0|||
23726178|NCT00643448|66374552|FG000|Overall Study|Lack of Efficacy|2|||
23726179|NCT00643448|66374553|FG001|Overall Study|Lack of Efficacy|0|||
23726180|NCT00643448|66374554|FG002|Overall Study|Lack of Efficacy|4|||
23726181|NCT00643448|66374552|FG000|Overall Study|Adverse Event|2|||
23726182|NCT00643448|66374553|FG001|Overall Study|Adverse Event|2|||
23816407|NCT01739348|66708405|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
23816408|NCT01739348|66708406|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
23616517|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
23616518|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
23616519|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23616520|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
23816409|NCT01739348|66708407|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
23816410|NCT01739348|66708408|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
23816411|NCT00827632|66708411|FG000|Overall Study|Lost to Follow-up|8|||
23816412|NCT00827632|66708412|FG001|Overall Study|Lost to Follow-up|12|||
23816413|NCT00827632|66708411|FG000|Overall Study|Early withdrawal|14|||
23816414|NCT00827632|66708412|FG001|Overall Study|Early withdrawal|11|||
23539478|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23816415|NCT00886288|66708413|FG000|Overall Study|no respect of the 12 weeks period|657|||
23816416|NCT00886288|66708414|FG001|Overall Study|no respect of the 12 weeks period|227|||
23616521|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23616522|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23726183|NCT00643448|66374554|FG002|Overall Study|Adverse Event|2|||
23816417|NCT00886288|66708413|FG000|Overall Study|Lost to Follow-up|86|||
23726184|NCT00643448|66374552|FG000|Overall Study|QTcF>550 ms|0|||
23539479|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
23539480|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
23539481|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539482|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539483|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539484|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539485|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
23539486|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
23539487|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539488|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539489|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
23539490|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539491|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23816418|NCT00886288|66708414|FG001|Overall Study|Lost to Follow-up|0|||
23816419|NCT01085734|66708419|FG000|Overall Study|Adverse Event|0|||
23816420|NCT01085734|66708420|FG001|Overall Study|Adverse Event|2|||
23816421|NCT01085734|66708419|FG000|Overall Study|Death|1|||
23816422|NCT01085734|66708420|FG001|Overall Study|Death|0|||
23816423|NCT01085734|66708419|FG000|Overall Study|Lost to Follow-up|0|||
23539492|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539493|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539494|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539495|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539496|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539497|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
23539498|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
23539499|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539500|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539501|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539502|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539503|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
23539504|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539505|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539506|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
23539507|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539508|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539509|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539510|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23816424|NCT01085734|66708420|FG001|Overall Study|Lost to Follow-up|1|||
23816425|NCT01085734|66708419|FG000|Overall Study|Withdrawal by Subject|0|||
23816426|NCT01085734|66708420|FG001|Overall Study|Withdrawal by Subject|1|||
23816427|NCT03207867|66708421|FG000|Overall Study|Adverse Event|1|||
23816428|NCT03207867|66708422|FG001|Overall Study|Adverse Event|0|||
23816429|NCT03207867|66708423|FG002|Overall Study|Adverse Event|1|||
23816430|NCT03207867|66708424|FG003|Overall Study|Adverse Event|0|||
23816431|NCT03207867|66708425|FG004|Overall Study|Adverse Event|0|||
23816432|NCT03207867|66708426|FG005|Overall Study|Adverse Event|2|||
23816433|NCT03207867|66708427|FG006|Overall Study|Adverse Event|1|||
23816434|NCT03207867|66708428|FG007|Overall Study|Adverse Event|1|||
23816435|NCT03207867|66708429|FG008|Overall Study|Adverse Event|2|||
23816436|NCT03207867|66708430|FG009|Overall Study|Adverse Event|2|||
23816437|NCT03207867|66708431|FG010|Overall Study|Adverse Event|0|||
23816438|NCT03207867|66708432|FG011|Overall Study|Adverse Event|0|||
23816439|NCT03207867|66708433|FG012|Overall Study|Adverse Event|0|||
23816440|NCT03207867|66708434|FG013|Overall Study|Adverse Event|0|||
23816441|NCT03207867|66708435|FG014|Overall Study|Adverse Event|0|||
23816442|NCT03207867|66708436|FG015|Overall Study|Adverse Event|0|||
23816443|NCT03207867|66708437|FG016|Overall Study|Adverse Event|3|||
23816444|NCT03207867|66708438|FG017|Overall Study|Adverse Event|1|||
23816445|NCT03207867|66708439|FG018|Overall Study|Adverse Event|2|||
23816446|NCT03207867|66708440|FG019|Overall Study|Adverse Event|1|||
23816447|NCT03207867|66708441|FG020|Overall Study|Adverse Event|0|||
23816448|NCT03207867|66708442|FG021|Overall Study|Adverse Event|0|||
23539511|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539512|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539513|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
23539514|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23616523|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23816449|NCT03207867|66708443|FG022|Overall Study|Adverse Event|0|||
23816450|NCT03207867|66708444|FG023|Overall Study|Adverse Event|0|||
23816451|NCT03207867|66708421|FG000|Overall Study|Death|0|||
23816452|NCT03207867|66708422|FG001|Overall Study|Death|0|||
23816453|NCT03207867|66708423|FG002|Overall Study|Death|0|||
23816454|NCT03207867|66708424|FG003|Overall Study|Death|0|||
23816455|NCT03207867|66708425|FG004|Overall Study|Death|0|||
23816456|NCT03207867|66708426|FG005|Overall Study|Death|1|||
23816457|NCT03207867|66708427|FG006|Overall Study|Death|0|||
23816458|NCT03207867|66708428|FG007|Overall Study|Death|3|||
23816459|NCT03207867|66708429|FG008|Overall Study|Death|1|||
23816460|NCT03207867|66708430|FG009|Overall Study|Death|2|||
23816461|NCT03207867|66708431|FG010|Overall Study|Death|0|||
23816462|NCT03207867|66708432|FG011|Overall Study|Death|1|||
23816463|NCT03207867|66708433|FG012|Overall Study|Death|0|||
23816464|NCT03207867|66708434|FG013|Overall Study|Death|1|||
23816465|NCT03207867|66708435|FG014|Overall Study|Death|0|||
23816466|NCT03207867|66708436|FG015|Overall Study|Death|0|||
23816467|NCT03207867|66708437|FG016|Overall Study|Death|0|||
23816468|NCT03207867|66708438|FG017|Overall Study|Death|2|||
23816469|NCT03207867|66708439|FG018|Overall Study|Death|0|||
23816470|NCT03207867|66708440|FG019|Overall Study|Death|1|||
23539515|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
23539516|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539517|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539518|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539519|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539520|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23726185|NCT00643448|66374553|FG001|Overall Study|QTcF>550 ms|3|||
23726186|NCT00643448|66374554|FG002|Overall Study|QTcF>550 ms|0|||
23726187|NCT03073213|66374555|FG000|Multiple Dose Period|Protocol Violation|0|||
23726188|NCT03073213|66374556|FG001|Multiple Dose Period|Protocol Violation|0|||
23726189|NCT03073213|66374557|FG002|Multiple Dose Period|Protocol Violation|1|||
23726190|NCT02959970|66374558|FG000|Overall Study|Adverse Event|1|||
23726191|NCT02959970|66374559|FG001|Overall Study|Adverse Event|0|||
23726192|NCT02959970|66374558|FG000|Overall Study|Withdrawal by Subject|0|||
23726193|NCT02959970|66374559|FG001|Overall Study|Withdrawal by Subject|2|||
23726194|NCT02959970|66374558|FG000|Overall Study|Lost to Follow-up|1|||
23539521|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539522|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539523|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23424155|NCT01643850|65296372|FG002|Overall Study|Administrative Problems|1|||
23424156|NCT01643850|65296373|FG003|Overall Study|Administrative Problems|0|||
23424157|NCT01643850|65296374|FG004|Overall Study|Administrative Problems|1|||
23424158|NCT01643850|65296375|FG005|Overall Study|Administrative Problems|0|||
23424159|NCT01643850|65296376|FG006|Overall Study|Administrative Problems|0|||
23424160|NCT01643850|65296377|FG007|Overall Study|Administrative Problems|0|||
23424161|NCT01643850|65296378|FG008|Overall Study|Administrative Problems|0|||
23424162|NCT01739933|65296387|FG000|Overall Study|Death|89|||
23424163|NCT01739933|65296388|FG001|Overall Study|Death|86|||
23424164|NCT01739933|65296387|FG000|Overall Study|Withdrawal by Subject|10|||
23424165|NCT01739933|65296388|FG001|Overall Study|Withdrawal by Subject|8|||
23424166|NCT01739933|65296387|FG000|Overall Study|Lost to Follow-up|3|||
23424167|NCT01739933|65296388|FG001|Overall Study|Lost to Follow-up|10|||
23424168|NCT01739933|65296387|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
23424169|NCT01739933|65296388|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
23424170|NCT00523705|65296389|FG000|Overall Study|No time for study.|0|||
23424171|NCT00523705|65296390|FG001|Overall Study|No time for study.|1|||
23424172|NCT00966719|65296391|FG000|Overall Study|Lost to Follow-up|6|||
23424173|NCT00966719|65296392|FG001|Overall Study|Lost to Follow-up|11|||
23424174|NCT03353922|65296393|FG000|Overall Study|Withdrawal by Subject|1|||
23424175|NCT03353922|65296394|FG001|Overall Study|Withdrawal by Subject|0|||
23424176|NCT03353922|65296395|FG002|Overall Study|Withdrawal by Subject|1|||
23424177|NCT03353922|65296396|FG003|Overall Study|Withdrawal by Subject|1|||
23424178|NCT03353922|65296397|FG004|Overall Study|Withdrawal by Subject|0|||
23424179|NCT03353922|65296398|FG005|Overall Study|Withdrawal by Subject|0|||
23539524|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23616524|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
23424180|NCT03353922|65296393|FG000|Overall Study|Adverse Event|0|||
23424181|NCT03353922|65296394|FG001|Overall Study|Adverse Event|1|||
23424182|NCT03353922|65296395|FG002|Overall Study|Adverse Event|0|||
23424183|NCT03353922|65296396|FG003|Overall Study|Adverse Event|0|||
23424184|NCT03353922|65296397|FG004|Overall Study|Adverse Event|0|||
23726195|NCT02959970|66374559|FG001|Overall Study|Lost to Follow-up|5|||
23726196|NCT01201967|66374560|FG000|Overall Study|Lost to Follow-up|6|||
23816471|NCT03207867|66708441|FG020|Overall Study|Death|0|||
23816472|NCT03207867|66708442|FG021|Overall Study|Death|0|||
23816473|NCT03207867|66708443|FG022|Overall Study|Death|0|||
23816474|NCT03207867|66708444|FG023|Overall Study|Death|0|||
23816475|NCT03207867|66708421|FG000|Overall Study|Physician Decision|3|||
23816476|NCT03207867|66708422|FG001|Overall Study|Physician Decision|5|||
23816477|NCT03207867|66708423|FG002|Overall Study|Physician Decision|0|||
23539525|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539526|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539527|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539528|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539529|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539530|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539531|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
23539532|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539533|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
23539534|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539535|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539536|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539537|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539538|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539539|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539540|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539541|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539542|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
23539543|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
23539544|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539545|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539546|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539547|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23726197|NCT01201967|66374561|FG001|Overall Study|Lost to Follow-up|5|||
23726198|NCT00618813|66374566|FG000|Overall Study|Lack of Efficacy|1|||
23726199|NCT00618813|66374566|FG000|Overall Study|Physician Decision|2|||
23726200|NCT00618813|66374566|FG000|Overall Study|Withdrawal by Subject|1|||
23726201|NCT01329341|66374571|FG000|Overall Study|Withdrawal by Subject|44|||
23726202|NCT02533401|66374579|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
23726203|NCT02533401|66374579|FG000|Overall Study|Death|5|||
23726204|NCT02533401|66374579|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
23726205|NCT02533401|66374579|FG000|Overall Study|Lost to Follow-up|1|||
23726206|NCT02533401|66374579|FG000|Overall Study|Violation of Selection Criteria|1|||
23726207|NCT01607073|66374580|FG000|Overall Study|Adverse Event|1|||
23726208|NCT00422240|66374581|FG000|Overall Study|Lack of Efficacy|1|||
23726209|NCT00422240|66374582|FG001|Overall Study|Lack of Efficacy|2|||
23726210|NCT00422240|66374583|FG002|Overall Study|Lack of Efficacy|0|||
23726211|NCT00422240|66374584|FG003|Overall Study|Lack of Efficacy|1|||
23726212|NCT00422240|66374581|FG000|Overall Study|Adverse Event|11|||
23726213|NCT00422240|66374582|FG001|Overall Study|Adverse Event|4|||
23726214|NCT00422240|66374583|FG002|Overall Study|Adverse Event|5|||
23726215|NCT00422240|66374584|FG003|Overall Study|Adverse Event|2|||
23726216|NCT00422240|66374581|FG000|Overall Study|Subject request|21|||
23726217|NCT00422240|66374582|FG001|Overall Study|Subject request|17|||
23726218|NCT00422240|66374583|FG002|Overall Study|Subject request|18|||
23726219|NCT00422240|66374584|FG003|Overall Study|Subject request|30|||
23726220|NCT00422240|66374581|FG000|Overall Study|Protocol Violation|0|||
23726221|NCT00422240|66374582|FG001|Overall Study|Protocol Violation|1|||
23726222|NCT00422240|66374583|FG002|Overall Study|Protocol Violation|0|||
23726223|NCT00422240|66374584|FG003|Overall Study|Protocol Violation|1|||
23726224|NCT00422240|66374581|FG000|Overall Study|Lost to Follow-up|31|||
23726225|NCT00422240|66374582|FG001|Overall Study|Lost to Follow-up|32|||
23726226|NCT00422240|66374583|FG002|Overall Study|Lost to Follow-up|19|||
23726227|NCT00422240|66374584|FG003|Overall Study|Lost to Follow-up|34|||
23726228|NCT00422240|66374581|FG000|Overall Study|Other|1|||
23726229|NCT00422240|66374582|FG001|Overall Study|Other|0|||
23726230|NCT00422240|66374583|FG002|Overall Study|Other|0|||
23726231|NCT00422240|66374584|FG003|Overall Study|Other|1|||
23726232|NCT00422240|66374581|FG000|Overall Study|Pregnancy|3|||
23726233|NCT00422240|66374582|FG001|Overall Study|Pregnancy|1|||
23726234|NCT00422240|66374583|FG002|Overall Study|Pregnancy|1|||
23726235|NCT00422240|66374584|FG003|Overall Study|Pregnancy|2|||
23726236|NCT03370913|66374585|FG000|Overall Study|Death|1|||
23726237|NCT03370913|66374585|FG000|Overall Study|Lost to Follow-up|1|||
23726238|NCT02829775|66374586|FG000|Overall Study|Death|1|||
23726239|NCT02829775|66374586|FG000|Overall Study|Withdrawal by Subject|3|||
23726240|NCT02829775|66374586|FG000|Overall Study|Disease remission|1|||
23726241|NCT01421069|66374587|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
23816478|NCT03207867|66708424|FG003|Overall Study|Physician Decision|3|||
23726242|NCT01421069|66374587|FG000|Parent Study|Failed to return|3|||
23726243|NCT01421069|66374587|FG000|Parent Study|Withdrawal by Subject|1|||
23726244|NCT01421069|66374587|FG000|Parent Study|Lost to Follow-up|2|||
23726245|NCT01421069|66374587|FG000|Parent Study|Lack of Efficacy|1|||
23726246|NCT01421069|66374587|FG000|Overall Period for Extension Study|Other|2|||
23816479|NCT03207867|66708425|FG004|Overall Study|Physician Decision|2|||
23726247|NCT01421069|66374587|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
23726248|NCT01421069|66374587|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
23616525|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23616526|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
23726249|NCT01421069|66374587|FG000|Overall Period for Extension Study|Pregnancy|1|||
23726250|NCT01421069|66374587|FG000|Overall Period for Extension Study|Adverse Event|1|||
23726251|NCT01421069|66374587|FG000|Overall Period for Extension Study|Protocol Violation|1|||
23726252|NCT01421069|66374587|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
23726253|NCT01421069|66374587|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
23726254|NCT01421069|66374587|FG000|Active Treatment Period|Other|1|||
23726255|NCT01421069|66374587|FG000|Active Treatment Period|No longer willing to participate in study|8|||
23726256|NCT01421069|66374587|FG000|Active Treatment Period|Insufficient clinical response|1|||
23726257|NCT01421069|66374587|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
23726258|NCT01421069|66374587|FG000|Active Treatment Period|Pregnancy|1|||
23726259|NCT01421069|66374587|FG000|Active Treatment Period|Adverse Event|1|||
23726260|NCT01421069|66374587|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
23726261|NCT01421069|66374587|FG000|Active Treatment Period|Enrolled in observational period|29|||
23726262|NCT01421069|66374587|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
23726263|NCT01421069|66374587|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
23726264|NCT01421069|66374587|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
23726265|NCT01421069|66374587|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
23726266|NCT01421069|66374587|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
23726267|NCT01421069|66374587|FG000|2b. Retreatment Period|Protocol Violation|1|||
23726268|NCT01421069|66374587|FG000|Observational Period|Other|1|||
23726269|NCT01421069|66374587|FG000|Observational Period|No longer willing to participate in study|4|||
23726270|NCT01421069|66374587|FG000|Observational Period|Lost to Follow-up|3|||
23726271|NCT00285649|66374590|FG000|Overall Study|Lost to Follow-up|6|||
23726272|NCT00285649|66374591|FG001|Overall Study|Lost to Follow-up|4|||
23726273|NCT00285649|66374592|FG002|Overall Study|Lost to Follow-up|4|||
23726274|NCT00285649|66374590|FG000|Overall Study|Withdrawal by Subject|3|||
23726275|NCT00285649|66374591|FG001|Overall Study|Withdrawal by Subject|2|||
23726276|NCT00285649|66374592|FG002|Overall Study|Withdrawal by Subject|2|||
23726277|NCT01136746|66374595|FG000|Overall Study|Lost to Follow-up|0|||
23726278|NCT01136746|66374596|FG001|Overall Study|Lost to Follow-up|2|||
23726279|NCT01136746|66374595|FG000|Overall Study|Protocol Violation|2|||
23726280|NCT01136746|66374596|FG001|Overall Study|Protocol Violation|1|||
23726281|NCT01136746|66374595|FG000|Overall Study|Death|1|||
23726282|NCT01136746|66374596|FG001|Overall Study|Death|0|||
23726283|NCT02679781|66374605|FG000|Overall Study|Lost to Follow-up|1|||
23726284|NCT02679781|66374606|FG001|Overall Study|Lost to Follow-up|2|||
23726285|NCT02679781|66374605|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
23726286|NCT02679781|66374606|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
23726287|NCT00368472|66374610|FG000|Overall Study|Adverse Event|22|||
23726288|NCT00368472|66374610|FG000|Overall Study|Medication non-compliance|4|||
23726289|NCT00368472|66374610|FG000|Overall Study|Protocol Violation|2|||
23726290|NCT00368472|66374610|FG000|Overall Study|Request of Investigator or Sponsor|3|||
23726291|NCT00368472|66374610|FG000|Overall Study|Withdrawal by Subject|40|||
23726292|NCT00368472|66374610|FG000|Overall Study|Diary non-compliance|1|||
23726293|NCT00368472|66374610|FG000|Overall Study|Other|32|||
23726294|NCT00368472|66374610|FG000|Overall Study|Missing Final Disposition Date|1|||
23726295|NCT03639987|66374611|FG000|Overall Study|Study terminated by sponsor|26|||
23726296|NCT03639987|66374612|FG001|Overall Study|Study terminated by sponsor|25|||
23726297|NCT03639987|66374611|FG000|Overall Study|Lost to Follow-up|0|||
23726298|NCT03639987|66374612|FG001|Overall Study|Lost to Follow-up|1|||
23726299|NCT01611298|66374613|FG000|Overall Study|Relapsed|2|||
23726300|NCT02001688|66374618|FG000|Overall Study|Withdrawal by Subject|0|||
23726301|NCT02001688|66374619|FG001|Overall Study|Withdrawal by Subject|0|||
23726302|NCT02001688|66374620|FG002|Overall Study|Withdrawal by Subject|1|||
23726303|NCT02001688|66374618|FG000|Overall Study|Adverse Event|0|||
23726304|NCT02001688|66374619|FG001|Overall Study|Adverse Event|1|||
23726305|NCT02001688|66374620|FG002|Overall Study|Adverse Event|0|||
23726306|NCT01039428|66374621|FG000|Overall Study|Protocol Violation|1|||
23726307|NCT01039428|66374622|FG001|Overall Study|Protocol Violation|0|||
23726308|NCT01039428|66374621|FG000|Overall Study|Withdrawal by Subject|1|||
23726309|NCT01039428|66374622|FG001|Overall Study|Withdrawal by Subject|0|||
23726310|NCT01197794|66374623|FG000|Overall Study|Adverse Event|3|||
23726311|NCT01197794|66374624|FG001|Overall Study|Adverse Event|2|||
23726312|NCT01197794|66374625|FG002|Overall Study|Adverse Event|4|||
23726313|NCT01197794|66374626|FG003|Overall Study|Adverse Event|4|||
23726314|NCT01197794|66374627|FG004|Overall Study|Adverse Event|4|||
23726315|NCT01197794|66374628|FG005|Overall Study|Adverse Event|2|||
23726316|NCT01197794|66374629|FG006|Overall Study|Adverse Event|3|||
23726317|NCT01197794|66374623|FG000|Overall Study|Protocol Violation|0|||
23726318|NCT01197794|66374624|FG001|Overall Study|Protocol Violation|0|||
23726319|NCT01197794|66374625|FG002|Overall Study|Protocol Violation|0|||
23726320|NCT01197794|66374626|FG003|Overall Study|Protocol Violation|0|||
23726321|NCT01197794|66374627|FG004|Overall Study|Protocol Violation|2|||
23726322|NCT01197794|66374628|FG005|Overall Study|Protocol Violation|0|||
23726323|NCT01197794|66374629|FG006|Overall Study|Protocol Violation|1|||
23726324|NCT01197794|66374623|FG000|Overall Study|Development of study withdrawal criteria|3|||
23726325|NCT01197794|66374624|FG001|Overall Study|Development of study withdrawal criteria|0|||
23726326|NCT01197794|66374625|FG002|Overall Study|Development of study withdrawal criteria|0|||
23726327|NCT01197794|66374626|FG003|Overall Study|Development of study withdrawal criteria|1|||
23726328|NCT01197794|66374627|FG004|Overall Study|Development of study withdrawal criteria|0|||
23726329|NCT01197794|66374628|FG005|Overall Study|Development of study withdrawal criteria|0|||
23726330|NCT01197794|66374629|FG006|Overall Study|Development of study withdrawal criteria|1|||
23726331|NCT01197794|66374623|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
23726332|NCT01197794|66374624|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
23726333|NCT01197794|66374625|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23726334|NCT01197794|66374626|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
23726335|NCT01197794|66374627|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
23726336|NCT01197794|66374628|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
23726337|NCT01197794|66374629|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
23816480|NCT03207867|66708426|FG005|Overall Study|Physician Decision|0|||
23816481|NCT03207867|66708427|FG006|Overall Study|Physician Decision|0|||
23816482|NCT03207867|66708428|FG007|Overall Study|Physician Decision|0|||
23816483|NCT03207867|66708429|FG008|Overall Study|Physician Decision|4|||
23816484|NCT03207867|66708430|FG009|Overall Study|Physician Decision|2|||
23816485|NCT03207867|66708431|FG010|Overall Study|Physician Decision|0|||
23816486|NCT03207867|66708432|FG011|Overall Study|Physician Decision|4|||
23816487|NCT03207867|66708433|FG012|Overall Study|Physician Decision|0|||
23816488|NCT03207867|66708434|FG013|Overall Study|Physician Decision|0|||
23816489|NCT03207867|66708435|FG014|Overall Study|Physician Decision|2|||
23816490|NCT03207867|66708436|FG015|Overall Study|Physician Decision|1|||
23816491|NCT03207867|66708437|FG016|Overall Study|Physician Decision|1|||
23816492|NCT03207867|66708438|FG017|Overall Study|Physician Decision|2|||
23816493|NCT03207867|66708439|FG018|Overall Study|Physician Decision|1|||
23816494|NCT03207867|66708440|FG019|Overall Study|Physician Decision|3|||
23816495|NCT03207867|66708441|FG020|Overall Study|Physician Decision|0|||
23816496|NCT03207867|66708442|FG021|Overall Study|Physician Decision|0|||
23816497|NCT03207867|66708443|FG022|Overall Study|Physician Decision|0|||
23816498|NCT03207867|66708444|FG023|Overall Study|Physician Decision|0|||
23816499|NCT03207867|66708421|FG000|Overall Study|Progressive Disease|7|||
23816500|NCT03207867|66708422|FG001|Overall Study|Progressive Disease|7|||
23816501|NCT03207867|66708423|FG002|Overall Study|Progressive Disease|9|||
23816502|NCT03207867|66708424|FG003|Overall Study|Progressive Disease|10|||
23816503|NCT03207867|66708425|FG004|Overall Study|Progressive Disease|11|||
23816504|NCT03207867|66708426|FG005|Overall Study|Progressive Disease|10|||
23816505|NCT03207867|66708427|FG006|Overall Study|Progressive Disease|9|||
23816506|NCT03207867|66708428|FG007|Overall Study|Progressive Disease|8|||
23816507|NCT03207867|66708429|FG008|Overall Study|Progressive Disease|19|||
23816508|NCT03207867|66708430|FG009|Overall Study|Progressive Disease|23|||
23816509|NCT03207867|66708431|FG010|Overall Study|Progressive Disease|2|||
23726338|NCT01197794|66374623|FG000|Overall Study|Withdrawal by Subject|3|||
23816510|NCT03207867|66708432|FG011|Overall Study|Progressive Disease|24|||
23816511|NCT03207867|66708433|FG012|Overall Study|Progressive Disease|3|||
23816512|NCT03207867|66708434|FG013|Overall Study|Progressive Disease|11|||
23816513|NCT03207867|66708435|FG014|Overall Study|Progressive Disease|9|||
23816514|NCT03207867|66708436|FG015|Overall Study|Progressive Disease|5|||
23816515|NCT03207867|66708437|FG016|Overall Study|Progressive Disease|10|||
23816516|NCT03207867|66708438|FG017|Overall Study|Progressive Disease|14|||
23816517|NCT03207867|66708439|FG018|Overall Study|Progressive Disease|13|||
23539548|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
23539549|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
23539550|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539551|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539552|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539553|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539554|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539555|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539556|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
23816518|NCT03207867|66708440|FG019|Overall Study|Progressive Disease|14|||
23816519|NCT03207867|66708441|FG020|Overall Study|Progressive Disease|6|||
23816520|NCT03207867|66708442|FG021|Overall Study|Progressive Disease|3|||
23816521|NCT03207867|66708443|FG022|Overall Study|Progressive Disease|3|||
23816522|NCT03207867|66708444|FG023|Overall Study|Progressive Disease|3|||
23816523|NCT03207867|66708421|FG000|Overall Study|Patient/guardian Decision|0|||
23816524|NCT03207867|66708422|FG001|Overall Study|Patient/guardian Decision|0|||
23816525|NCT03207867|66708423|FG002|Overall Study|Patient/guardian Decision|1|||
23816526|NCT03207867|66708424|FG003|Overall Study|Patient/guardian Decision|1|||
23816527|NCT03207867|66708425|FG004|Overall Study|Patient/guardian Decision|1|||
23816528|NCT03207867|66708426|FG005|Overall Study|Patient/guardian Decision|2|||
23816529|NCT03207867|66708427|FG006|Overall Study|Patient/guardian Decision|1|||
23424185|NCT03353922|65296398|FG005|Overall Study|Adverse Event|0|||
23424186|NCT00789581|65296412|FG000|AC Therapy|Adverse Event|2|||
23539557|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
23539558|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539559|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539560|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
23539561|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539562|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539563|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23616527|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
23616528|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616529|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23539564|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539565|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539566|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539567|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539568|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539569|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539570|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
23616530|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616531|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
23424187|NCT00789581|65296413|FG001|AC Therapy|Adverse Event|3|||
23424188|NCT00789581|65296412|FG000|AC Therapy|Withdrawal by Subject|4|||
23726339|NCT01197794|66374624|FG001|Overall Study|Withdrawal by Subject|3|||
23726340|NCT01197794|66374625|FG002|Overall Study|Withdrawal by Subject|4|||
23726341|NCT01197794|66374626|FG003|Overall Study|Withdrawal by Subject|1|||
23726342|NCT01197794|66374627|FG004|Overall Study|Withdrawal by Subject|1|||
23726343|NCT01197794|66374628|FG005|Overall Study|Withdrawal by Subject|5|||
23424189|NCT00789581|65296413|FG001|AC Therapy|Withdrawal by Subject|7|||
23424190|NCT00789581|65296412|FG000|AC Therapy|Disease recurrence|3|||
23816530|NCT03207867|66708428|FG007|Overall Study|Patient/guardian Decision|0|||
23816531|NCT03207867|66708429|FG008|Overall Study|Patient/guardian Decision|1|||
23816532|NCT03207867|66708430|FG009|Overall Study|Patient/guardian Decision|0|||
23816533|NCT03207867|66708431|FG010|Overall Study|Patient/guardian Decision|0|||
23816534|NCT03207867|66708432|FG011|Overall Study|Patient/guardian Decision|1|||
23816535|NCT03207867|66708433|FG012|Overall Study|Patient/guardian Decision|0|||
23816536|NCT03207867|66708434|FG013|Overall Study|Patient/guardian Decision|1|||
23816537|NCT03207867|66708435|FG014|Overall Study|Patient/guardian Decision|2|||
23424191|NCT00789581|65296413|FG001|AC Therapy|Disease recurrence|1|||
23424192|NCT00789581|65296412|FG000|AC Therapy|Intercurrent Illness|1|||
23424193|NCT00789581|65296413|FG001|AC Therapy|Intercurrent Illness|0|||
23424194|NCT00789581|65296412|FG000|AC Therapy|Never Treated|1|||
23424195|NCT00789581|65296413|FG001|AC Therapy|Never Treated|4|||
23424196|NCT00789581|65296412|FG000|AC Therapy|Other|0|||
23726344|NCT01197794|66374629|FG006|Overall Study|Withdrawal by Subject|6|||
23726345|NCT01197794|66374623|FG000|Overall Study|Lost to Follow-up|1|||
23726346|NCT01197794|66374624|FG001|Overall Study|Lost to Follow-up|1|||
23726347|NCT01197794|66374625|FG002|Overall Study|Lost to Follow-up|0|||
23726348|NCT01197794|66374626|FG003|Overall Study|Lost to Follow-up|1|||
23726349|NCT01197794|66374627|FG004|Overall Study|Lost to Follow-up|0|||
23726350|NCT01197794|66374628|FG005|Overall Study|Lost to Follow-up|1|||
23726351|NCT01197794|66374629|FG006|Overall Study|Lost to Follow-up|0|||
23726352|NCT01197794|66374623|FG000|Overall Study|Other|1|||
23726353|NCT01197794|66374624|FG001|Overall Study|Other|1|||
23816538|NCT03207867|66708436|FG015|Overall Study|Patient/guardian Decision|0|||
23816539|NCT03207867|66708437|FG016|Overall Study|Patient/guardian Decision|1|||
23816540|NCT03207867|66708438|FG017|Overall Study|Patient/guardian Decision|3|||
23816541|NCT03207867|66708439|FG018|Overall Study|Patient/guardian Decision|4|||
23816542|NCT03207867|66708440|FG019|Overall Study|Patient/guardian Decision|1|||
23816543|NCT03207867|66708441|FG020|Overall Study|Patient/guardian Decision|0|||
23816544|NCT03207867|66708442|FG021|Overall Study|Patient/guardian Decision|0|||
23816545|NCT03207867|66708443|FG022|Overall Study|Patient/guardian Decision|0|||
23816546|NCT03207867|66708444|FG023|Overall Study|Patient/guardian Decision|0|||
23816547|NCT03058289|66708445|FG000|Overall Study|Radiographic Deterioration|0|||
23424197|NCT00789581|65296413|FG001|AC Therapy|Other|2|||
23816548|NCT03058289|66708446|FG001|Overall Study|Radiographic Deterioration|3|||
23424198|NCT00789581|65296412|FG000|Adjuvant Therapy|Never treated|2|||
23424199|NCT00789581|65296413|FG001|Adjuvant Therapy|Never treated|2|||
23424200|NCT00789581|65296412|FG000|Adjuvant Therapy|Adverse Event|20|||
23424201|NCT00789581|65296413|FG001|Adjuvant Therapy|Adverse Event|44|||
23424202|NCT00789581|65296412|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
23424203|NCT00789581|65296413|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
23424204|NCT00789581|65296412|FG000|Adjuvant Therapy|Disease recurrence|2|||
23424205|NCT00789581|65296413|FG001|Adjuvant Therapy|Disease recurrence|1|||
23539571|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539572|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539573|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539574|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539575|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539576|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539577|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23726354|NCT01197794|66374625|FG002|Overall Study|Other|3|||
23726355|NCT01197794|66374626|FG003|Overall Study|Other|0|||
23726356|NCT01197794|66374627|FG004|Overall Study|Other|2|||
23726357|NCT01197794|66374628|FG005|Overall Study|Other|2|||
23816549|NCT03058289|66708447|FG002|Overall Study|Radiographic Deterioration|1|||
23816550|NCT03058289|66708448|FG003|Overall Study|Radiographic Deterioration|2|||
23424206|NCT00789581|65296412|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
23424207|NCT00789581|65296413|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
23726358|NCT01197794|66374629|FG006|Overall Study|Other|4|||
23726359|NCT01750840|66378343|FG000|Overall Study|Lost to Follow-up|4|||
23424208|NCT00789581|65296412|FG000|Adjuvant Therapy|Protocol Violation|1|||
23424209|NCT00789581|65296413|FG001|Adjuvant Therapy|Protocol Violation|1|||
23816551|NCT03058289|66708449|FG004|Overall Study|Radiographic Deterioration|6|||
23816552|NCT03058289|66708450|FG005|Overall Study|Radiographic Deterioration|3|||
23816553|NCT03058289|66708451|FG006|Overall Study|Radiographic Deterioration|0|||
23816554|NCT03058289|66708452|FG007|Overall Study|Radiographic Deterioration|4|||
23424210|NCT00789581|65296412|FG000|Adjuvant Therapy|Other|0|||
23616532|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616533|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616534|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
23616535|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616536|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616537|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616538|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616539|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616540|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
23616541|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616542|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616543|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616544|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616545|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
23616546|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
23616547|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
23616548|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
23616549|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616550|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616551|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616552|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616553|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616554|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616555|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616556|NCT03326193|65982360|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
23616557|NCT03326193|65982360|FG000|Overall Study|Death|19|||
23816555|NCT03058289|66708453|FG008|Overall Study|Radiographic Deterioration|2|||
23816556|NCT03058289|66708445|FG000|Overall Study|Adverse Event|2|||
23816557|NCT03058289|66708446|FG001|Overall Study|Adverse Event|0|||
23424211|NCT00789581|65296413|FG001|Adjuvant Therapy|Other|1|||
23424212|NCT02153346|65296414|FG000|Overall Study|Lost to Follow-up|11|||
23539578|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
23539579|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
23539580|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539581|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539582|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539583|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539584|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
23539585|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23424213|NCT01666119|65296415|FG000|Overall Study|Adverse Event|6|||
23424214|NCT01666119|65296415|FG000|Overall Study|Withdrawal by Subject|16|||
23424215|NCT01666119|65296415|FG000|Overall Study|Lost to Follow-up|7|||
23424216|NCT01666119|65296415|FG000|Overall Study|non compliance with study medication, pa|18|||
23424217|NCT01666119|65296415|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
23424218|NCT03730012|65296416|FG000|Overall Study|Adverse Event|0|||
23424219|NCT03730012|65296417|FG001|Overall Study|Adverse Event|1|||
23424220|NCT03730012|65296416|FG000|Overall Study|Lack of Efficacy|1|||
23424221|NCT03730012|65296417|FG001|Overall Study|Lack of Efficacy|5|||
23424222|NCT03730012|65296416|FG000|Overall Study|Withdrawal by Subject|0|||
23539586|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539587|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
23539588|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
23539589|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539590|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539591|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539592|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539593|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
23539594|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
23539595|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539596|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
23816558|NCT03058289|66708447|FG002|Overall Study|Adverse Event|1|||
23424223|NCT03730012|65296417|FG001|Overall Study|Withdrawal by Subject|1|||
23424224|NCT03730012|65296416|FG000|Overall Study|Miscellaneous|2|||
23424225|NCT03730012|65296417|FG001|Overall Study|Miscellaneous|1|||
23424226|NCT03158272|65296420|FG000|Overall Study|Disease progression|3|||
23424227|NCT03158272|65296421|FG001|Overall Study|Disease progression|3|||
23424228|NCT03158272|65296422|FG002|Overall Study|Disease progression|4|||
23424229|NCT03158272|65296423|FG003|Overall Study|Disease progression|6|||
23539597|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
23539598|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539599|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539600|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539601|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539602|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
23539603|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
23539604|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539605|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539606|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
23539607|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539608|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539609|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539610|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539611|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539612|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
23539613|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539614|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539615|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539616|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539617|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539618|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539619|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539620|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
23539621|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539622|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539623|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539624|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539625|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539626|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539627|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539628|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539629|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539630|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539631|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539632|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539633|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
23539634|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539635|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539636|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539637|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539638|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539639|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539640|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539641|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
23539642|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539643|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539644|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539645|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539646|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539647|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
23539648|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539649|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539650|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
23539651|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
23539652|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539653|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539654|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539655|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539656|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
23539657|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23816559|NCT03058289|66708448|FG003|Overall Study|Adverse Event|3|||
23816560|NCT03058289|66708449|FG004|Overall Study|Adverse Event|1|||
23424230|NCT03158272|65296420|FG000|Overall Study|Death|0|||
23539658|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539659|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539660|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
23539661|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23726360|NCT04228445|66378344|FG000|Overall Study|Lost to Follow-up|1|||
23726361|NCT04228445|66378345|FG001|Overall Study|Lost to Follow-up|1|||
23726362|NCT04228445|66378344|FG000|Overall Study|Physician Decision|1|||
23726363|NCT04228445|66378345|FG001|Overall Study|Physician Decision|2|||
23726364|NCT04228445|66378344|FG000|Overall Study|Withdrawal by Subject|0|||
23726365|NCT04228445|66378345|FG001|Overall Study|Withdrawal by Subject|1|||
23726366|NCT04228445|66378344|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
23726367|NCT04228445|66378345|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
23726368|NCT00693693|66378347|FG000|Overall Study|Lost to Follow-up|1|||
23726369|NCT00693693|66378348|FG001|Overall Study|Lost to Follow-up|1|||
23726370|NCT00693693|66378349|FG002|Overall Study|Lost to Follow-up|2|||
23726371|NCT02985684|66378350|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
23726372|NCT02985684|66378350|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
23726373|NCT02985684|66378350|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
23726374|NCT04445051|66378351|FG000|Overall Study|Adverse Event|0|||
23726375|NCT04445051|66378352|FG001|Overall Study|Adverse Event|0|||
23726376|NCT04445051|66378353|FG002|Overall Study|Adverse Event|1|||
23539662|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539663|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539664|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539665|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539666|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539667|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539668|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539669|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
23539670|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539671|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539672|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539673|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539674|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539675|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539676|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539677|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539678|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539679|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539680|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539681|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539682|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539683|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539684|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
23539685|NCT03892889|65706069|FG000|Overall Study|Adverse Event|17|||
23539686|NCT03892889|65706069|FG000|Overall Study|Lack of Efficacy|1|||
23539687|NCT03892889|65706069|FG000|Overall Study|Lost to Follow-up|46|||
23539688|NCT03892889|65706069|FG000|Overall Study|Non-compliance with study drug|22|||
23539689|NCT03892889|65706069|FG000|Overall Study|Pregnancy|1|||
23539690|NCT03892889|65706069|FG000|Overall Study|Protocol Deviation|3|||
23539691|NCT03892889|65706069|FG000|Overall Study|Withdrawal by Subject|50|||
23539692|NCT03892889|65706069|FG000|Overall Study|Withdrawal by Caregiver|1|||
23539693|NCT03892889|65706069|FG000|Overall Study|Study Terminated by Sponsor|50|||
23539694|NCT03892889|65706069|FG000|Overall Study|Physician Decision|8|||
23539695|NCT03892889|65706069|FG000|Overall Study|Reason not Specified|5|||
23539696|NCT02219932|65709009|FG000|Overall Study|Other|5|||
23539697|NCT02219932|65709010|FG001|Overall Study|Other|11|||
23539698|NCT02219932|65709009|FG000|Overall Study|Death|1|||
23539699|NCT02219932|65709010|FG001|Overall Study|Death|1|||
23539700|NCT02219932|65709009|FG000|Overall Study|Investigator Decision|0|||
23539701|NCT02219932|65709010|FG001|Overall Study|Investigator Decision|1|||
23539702|NCT02219932|65709009|FG000|Overall Study|Consent Withdrawn|11|||
23616558|NCT03326193|65982360|FG000|Overall Study|Withdrawal by Subject|8|||
23726377|NCT04445051|66378354|FG003|Overall Study|Adverse Event|0|||
23726378|NCT04445051|66378355|FG004|Overall Study|Adverse Event|0|||
23726379|NCT04445051|66378356|FG005|Overall Study|Adverse Event|0|||
23539703|NCT02219932|65709010|FG001|Overall Study|Consent Withdrawn|7|||
23539704|NCT02219932|65709009|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
23539705|NCT02219932|65709010|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
23539706|NCT02219932|65709009|FG000|Overall Study|Protocol Violation|10|||
23539707|NCT02219932|65709010|FG001|Overall Study|Protocol Violation|6|||
23539708|NCT02219932|65709009|FG000|Overall Study|Pregnancy|1|||
23539709|NCT02219932|65709010|FG001|Overall Study|Pregnancy|0|||
23539710|NCT02219932|65709009|FG000|Overall Study|Lost to Follow-up|4|||
23539711|NCT02219932|65709010|FG001|Overall Study|Lost to Follow-up|2|||
23539712|NCT02219932|65709009|FG000|Overall Study|Adverse Event|23|||
23539713|NCT02219932|65709010|FG001|Overall Study|Adverse Event|21|||
23539714|NCT03832946|65709013|FG000|Overall Study|Adverse Event|3|||
23539715|NCT03832946|65709014|FG001|Overall Study|Adverse Event|1|||
23539716|NCT03832946|65709013|FG000|Overall Study|Lost to Follow-up|1|||
23539717|NCT03832946|65709014|FG001|Overall Study|Lost to Follow-up|0|||
23539718|NCT03832946|65709013|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
23539719|NCT03832946|65709014|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
23539720|NCT03832946|65709013|FG000|Overall Study|Lack of Efficacy|1|||
23539721|NCT03832946|65709014|FG001|Overall Study|Lack of Efficacy|0|||
23539722|NCT03832946|65709013|FG000|Overall Study|Withdrawal by Subject|12|||
23539723|NCT03832946|65709014|FG001|Overall Study|Withdrawal by Subject|9|||
23539724|NCT01992536|65709016|FG000|Overall Study|Administrative Reason|0|||
23539725|NCT01992536|65709017|FG001|Overall Study|Administrative Reason|0|||
23539726|NCT01992536|65709018|FG002|Overall Study|Administrative Reason|0|||
23539727|NCT01992536|65709019|FG003|Overall Study|Administrative Reason|0|||
23539728|NCT01992536|65709020|FG004|Overall Study|Administrative Reason|0|||
23539729|NCT01992536|65709021|FG005|Overall Study|Administrative Reason|0|||
23539730|NCT01992536|65709022|FG006|Overall Study|Administrative Reason|7|||
23539731|NCT01992536|65709023|FG007|Overall Study|Administrative Reason|0|||
23539732|NCT01992536|65709024|FG008|Overall Study|Administrative Reason|0|||
23539733|NCT01992536|65709025|FG009|Overall Study|Administrative Reason|0|||
23539734|NCT01992536|65709016|FG000|Overall Study|Lost to Follow-up|4|||
23539735|NCT01992536|65709017|FG001|Overall Study|Lost to Follow-up|2|||
23539736|NCT01992536|65709018|FG002|Overall Study|Lost to Follow-up|1|||
23539737|NCT01992536|65709019|FG003|Overall Study|Lost to Follow-up|0|||
23539738|NCT01992536|65709020|FG004|Overall Study|Lost to Follow-up|0|||
23539739|NCT01992536|65709021|FG005|Overall Study|Lost to Follow-up|1|||
23539740|NCT01992536|65709022|FG006|Overall Study|Lost to Follow-up|0|||
23539741|NCT01992536|65709023|FG007|Overall Study|Lost to Follow-up|0|||
23539742|NCT01992536|65709024|FG008|Overall Study|Lost to Follow-up|1|||
23539743|NCT01992536|65709025|FG009|Overall Study|Lost to Follow-up|1|||
23539744|NCT01992536|65709016|FG000|Overall Study|Withdrawal by Subject|0|||
23539745|NCT01992536|65709017|FG001|Overall Study|Withdrawal by Subject|1|||
23539746|NCT01992536|65709018|FG002|Overall Study|Withdrawal by Subject|0|||
23539747|NCT01992536|65709019|FG003|Overall Study|Withdrawal by Subject|2|||
23539748|NCT01992536|65709020|FG004|Overall Study|Withdrawal by Subject|0|||
23539749|NCT01992536|65709021|FG005|Overall Study|Withdrawal by Subject|0|||
23539750|NCT01992536|65709022|FG006|Overall Study|Withdrawal by Subject|0|||
23539751|NCT01992536|65709023|FG007|Overall Study|Withdrawal by Subject|0|||
23539752|NCT01992536|65709024|FG008|Overall Study|Withdrawal by Subject|0|||
23539753|NCT01992536|65709025|FG009|Overall Study|Withdrawal by Subject|0|||
23539754|NCT01913041|65709026|FG000|Overall Study|Protocol Violation|35|||
23539755|NCT01913041|65709026|FG000|Overall Study|Withdrawal by Subject|3|||
23539756|NCT01913041|65709026|FG000|Overall Study|Physician Decision|1|||
23539757|NCT01143259|65709030|FG000|Overall Study|Withdrawal by Subject|3|||
23539758|NCT01143259|65709031|FG001|Overall Study|Withdrawal by Subject|2|||
23539759|NCT01143259|65709030|FG000|Overall Study|Protocol Violation|13|||
23539760|NCT01143259|65709031|FG001|Overall Study|Protocol Violation|9|||
23539761|NCT01143259|65709030|FG000|Overall Study|Screen Failure|7|||
23539762|NCT01143259|65709031|FG001|Overall Study|Screen Failure|9|||
23539763|NCT03136068|65709032|FG000|Overall Study|Lost to Follow-up|1|||
23539764|NCT03136068|65709033|FG001|Overall Study|Lost to Follow-up|1|||
23539765|NCT03136068|65709032|FG000|Overall Study|Protocol Violation|1|||
23539766|NCT03136068|65709033|FG001|Overall Study|Protocol Violation|0|||
23539767|NCT04102501|65709034|FG000|Overall Study|Withdrawal by Subject|7|||
23636627|NCT01072630|66052949|FG001|Overall Study|Noncompliance with study medication|1|||
23539768|NCT04102501|65709035|FG001|Overall Study|Withdrawal by Subject|9|||
23539769|NCT04102501|65709034|FG000|Overall Study|Adverse Event|1|||
23539770|NCT04102501|65709035|FG001|Overall Study|Adverse Event|3|||
23539771|NCT02318329|65709040|FG000|Overall Study|Progressive Disease|2|||
23539772|NCT02318329|65709041|FG001|Overall Study|Progressive Disease|3|||
23539773|NCT02318329|65709042|FG002|Overall Study|Progressive Disease|2|||
23539774|NCT02318329|65709043|FG003|Overall Study|Progressive Disease|3|||
23539775|NCT02318329|65709044|FG004|Overall Study|Progressive Disease|3|||
23539776|NCT02318329|65709045|FG005|Overall Study|Progressive Disease|3|||
23539777|NCT02318329|65709046|FG006|Overall Study|Progressive Disease|1|||
23539778|NCT02318329|65709047|FG007|Overall Study|Progressive Disease|1|||
23539779|NCT02318329|65709048|FG008|Overall Study|Progressive Disease|5|||
23636628|NCT01072630|66052950|FG002|Overall Study|Noncompliance with study medication|1|||
23636629|NCT01072630|66052948|FG000|Overall Study|Noncompliance with study procedures|1|||
23636630|NCT01072630|66052949|FG001|Overall Study|Noncompliance with study procedures|2|||
23636631|NCT01072630|66052950|FG002|Overall Study|Noncompliance with study procedures|1|||
23636632|NCT01072630|66052948|FG000|Overall Study|Other|3|||
23539780|NCT02318329|65709049|FG009|Overall Study|Progressive Disease|39|||
23539781|NCT02318329|65709040|FG000|Overall Study|Death|0|||
23539782|NCT02318329|65709041|FG001|Overall Study|Death|0|||
23539783|NCT02318329|65709042|FG002|Overall Study|Death|0|||
23539784|NCT02318329|65709043|FG003|Overall Study|Death|0|||
23539785|NCT02318329|65709044|FG004|Overall Study|Death|0|||
23539786|NCT02318329|65709045|FG005|Overall Study|Death|0|||
23539787|NCT02318329|65709046|FG006|Overall Study|Death|0|||
23539788|NCT02318329|65709047|FG007|Overall Study|Death|0|||
23539789|NCT02318329|65709048|FG008|Overall Study|Death|0|||
23539790|NCT02318329|65709049|FG009|Overall Study|Death|5|||
23539791|NCT02318329|65709040|FG000|Overall Study|Lost to Follow-up|0|||
23539792|NCT02318329|65709041|FG001|Overall Study|Lost to Follow-up|0|||
23539793|NCT02318329|65709042|FG002|Overall Study|Lost to Follow-up|0|||
23539794|NCT02318329|65709043|FG003|Overall Study|Lost to Follow-up|0|||
23539795|NCT02318329|65709044|FG004|Overall Study|Lost to Follow-up|0|||
23539796|NCT02318329|65709045|FG005|Overall Study|Lost to Follow-up|0|||
23539797|NCT02318329|65709046|FG006|Overall Study|Lost to Follow-up|0|||
23539798|NCT02318329|65709047|FG007|Overall Study|Lost to Follow-up|0|||
23539799|NCT02318329|65709048|FG008|Overall Study|Lost to Follow-up|0|||
23539800|NCT02318329|65709049|FG009|Overall Study|Lost to Follow-up|1|||
23539801|NCT02318329|65709040|FG000|Overall Study|Withdrawal by Subject|0|||
23539802|NCT02318329|65709041|FG001|Overall Study|Withdrawal by Subject|0|||
23539803|NCT02318329|65709042|FG002|Overall Study|Withdrawal by Subject|0|||
23539804|NCT02318329|65709043|FG003|Overall Study|Withdrawal by Subject|0|||
23539805|NCT02318329|65709044|FG004|Overall Study|Withdrawal by Subject|0|||
23539806|NCT02318329|65709045|FG005|Overall Study|Withdrawal by Subject|0|||
23539807|NCT02318329|65709046|FG006|Overall Study|Withdrawal by Subject|0|||
23539808|NCT02318329|65709047|FG007|Overall Study|Withdrawal by Subject|0|||
23539809|NCT02318329|65709048|FG008|Overall Study|Withdrawal by Subject|0|||
23539810|NCT02318329|65709049|FG009|Overall Study|Withdrawal by Subject|6|||
23539811|NCT02318329|65709040|FG000|Overall Study|Other|1|||
23539812|NCT02318329|65709041|FG001|Overall Study|Other|1|||
23539813|NCT02318329|65709042|FG002|Overall Study|Other|1|||
23539814|NCT02318329|65709043|FG003|Overall Study|Other|0|||
23539815|NCT02318329|65709044|FG004|Overall Study|Other|0|||
23539816|NCT02318329|65709045|FG005|Overall Study|Other|0|||
23539817|NCT02318329|65709046|FG006|Overall Study|Other|0|||
23539818|NCT02318329|65709047|FG007|Overall Study|Other|0|||
23539819|NCT02318329|65709048|FG008|Overall Study|Other|1|||
23539820|NCT02318329|65709049|FG009|Overall Study|Other|1|||
23539821|NCT02447991|65709050|FG000|Overall Study|Withdrawn by subject - no data|0|||
23539822|NCT02447991|65709051|FG001|Overall Study|Withdrawn by subject - no data|2|||
23539823|NCT02447991|65709050|FG000|Overall Study|Withdrawn by Subject - with data|4|||
23539824|NCT02447991|65709051|FG001|Overall Study|Withdrawn by Subject - with data|4|||
23539825|NCT02447991|65709050|FG000|Overall Study|Lost to Follow-up - no data|3|||
23539826|NCT02447991|65709051|FG001|Overall Study|Lost to Follow-up - no data|6|||
23539827|NCT02447991|65709050|FG000|Overall Study|Lost to follow-up - with data|0|||
23539828|NCT02447991|65709051|FG001|Overall Study|Lost to follow-up - with data|3|||
23539829|NCT02447991|65709050|FG000|Overall Study|End of study - no treatment results|3|||
23539830|NCT02447991|65709051|FG001|Overall Study|End of study - no treatment results|6|||
23539831|NCT02447991|65709050|FG000|Overall Study|End of study - partial treatment results|0|||
23539832|NCT02447991|65709051|FG001|Overall Study|End of study - partial treatment results|9|||
23539833|NCT01071395|65709053|FG000|Overall Study|Withdrawal by Subject|2|||
23539834|NCT01071395|65709054|FG001|Overall Study|Withdrawal by Subject|1|||
23539835|NCT01071395|65709053|FG000|Overall Study|Adverse Event|3|||
23539836|NCT01071395|65709054|FG001|Overall Study|Adverse Event|1|||
23539837|NCT01542528|65709055|FG000|Overall Study|Lost to Follow-up|2|||
23539838|NCT01542528|65709056|FG001|Overall Study|Lost to Follow-up|1|||
23539839|NCT01542528|65709055|FG000|Overall Study|Physician Decision|1|||
23539840|NCT01542528|65709056|FG001|Overall Study|Physician Decision|0|||
23539841|NCT01542528|65709055|FG000|Overall Study|Withdrawal by Subject|9|||
23539842|NCT01542528|65709056|FG001|Overall Study|Withdrawal by Subject|6|||
23539843|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
23539844|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
23539845|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
23539846|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
23539847|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
23539848|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
23539849|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
23539850|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
23539851|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
23539852|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
23539853|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
23539854|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
23539855|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
23539856|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
23539857|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
23539858|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539859|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
23539860|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539861|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
23539862|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
23539863|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
23539864|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
23539865|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
23539866|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
23539867|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
23539868|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
23539869|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
23539870|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
23539871|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
23539872|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
23539873|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
23539874|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
23539875|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
23539876|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
23539877|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
23539878|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
23539879|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
23539880|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
23539881|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
23539882|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
23539883|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
23539884|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
23539885|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
23539886|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
23539887|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
23539888|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
23539889|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
23539890|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
23636633|NCT01072630|66052949|FG001|Overall Study|Other|2|||
23816561|NCT03058289|66708450|FG005|Overall Study|Adverse Event|0|||
23424231|NCT03158272|65296421|FG001|Overall Study|Death|0|||
23424232|NCT03158272|65296422|FG002|Overall Study|Death|1|||
23424233|NCT03158272|65296423|FG003|Overall Study|Death|0|||
23424234|NCT03158272|65296420|FG000|Overall Study|Other reasons|0|||
23424235|NCT03158272|65296421|FG001|Overall Study|Other reasons|0|||
23424236|NCT03158272|65296422|FG002|Overall Study|Other reasons|1|||
23424237|NCT03158272|65296423|FG003|Overall Study|Other reasons|0|||
23424238|NCT03158272|65296420|FG000|Overall Study|Adverse event unrelated to the drug|0|||
23424239|NCT03158272|65296421|FG001|Overall Study|Adverse event unrelated to the drug|1|||
23424240|NCT03158272|65296422|FG002|Overall Study|Adverse event unrelated to the drug|0|||
23424241|NCT03158272|65296423|FG003|Overall Study|Adverse event unrelated to the drug|0|||
23424242|NCT03215706|65296425|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23424243|NCT03215706|65296426|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23424244|NCT03215706|65296425|FG000|Randomization|participant withdrew consent|1|||
23539891|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
23539892|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539893|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
23539894|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
23539895|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
23539896|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
23539897|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
23636634|NCT01072630|66052950|FG002|Overall Study|Other|1|||
23636635|NCT02631577|66052951|FG000|Overall Study|Death|1|||
23636636|NCT02631577|66052952|FG001|Overall Study|Death|7|||
23636637|NCT02631577|66052951|FG000|Overall Study|Withdrawal by Subject|0|||
23424245|NCT03215706|65296426|FG001|Randomization|participant withdrew consent|3|||
23424246|NCT03215706|65296425|FG000|Randomization|no longer meets study criteria|1|||
23424247|NCT03215706|65296426|FG001|Randomization|no longer meets study criteria|4|||
23424248|NCT03215706|65296425|FG000|Randomization|other reasons|0|||
23424249|NCT03215706|65296426|FG001|Randomization|other reasons|2|||
23424250|NCT03215706|65296425|FG000|Treatment Period|Disease Progression|150|||
23424251|NCT03215706|65296426|FG001|Treatment Period|Disease Progression|142|||
23424252|NCT03215706|65296425|FG000|Treatment Period|Study Drug Toxicity|53|||
23539898|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
23539899|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
23539900|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
23539901|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
23539902|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
23539903|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
23539904|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
23539905|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
23539906|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
23539907|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
23539908|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
23539909|NCT01591681|65709065|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
23539910|NCT01591681|65709065|FG000|Overall Study|Failed to use system during run-in|1|||
23539911|NCT00262834|65709066|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
23539912|NCT00262834|65709067|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
23539913|NCT01462344|65709084|FG000|Overall Study|Withdrawal by Subject|245|||
23539914|NCT01462344|65709085|FG001|Overall Study|Withdrawal by Subject|226|||
23539915|NCT01462344|65709084|FG000|Overall Study|Adverse Event|24|||
23539916|NCT01462344|65709085|FG001|Overall Study|Adverse Event|23|||
23539917|NCT01462344|65709084|FG000|Overall Study|Asthma Exacerbation|34|||
23539918|NCT01462344|65709085|FG001|Overall Study|Asthma Exacerbation|35|||
23539919|NCT01462344|65709084|FG000|Overall Study|Lack of Efficacy|5|||
23539920|NCT01462344|65709085|FG001|Overall Study|Lack of Efficacy|6|||
23539921|NCT01462344|65709084|FG000|Overall Study|Protocol Violation|68|||
23539922|NCT01462344|65709085|FG001|Overall Study|Protocol Violation|53|||
23539923|NCT01462344|65709084|FG000|Overall Study|Lost to Follow-up|7|||
23539924|NCT01462344|65709085|FG001|Overall Study|Lost to Follow-up|7|||
23539925|NCT03728582|65709086|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
23539926|NCT03728582|65709087|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
23539927|NCT03728582|65709086|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
23539928|NCT03728582|65709087|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
23539929|NCT00617240|65709089|FG000|Overall Study|Lack of Efficacy|1|||
23539930|NCT00617240|65709090|FG001|Overall Study|Lack of Efficacy|0|||
23539931|NCT01969838|65709091|FG000|Double-blind Phase|Adverse Event|10|||
23539932|NCT01969838|65709092|FG001|Double-blind Phase|Adverse Event|4|||
23539933|NCT01969838|65709093|FG002|Double-blind Phase|Adverse Event|0|||
23539934|NCT01969838|65709094|FG003|Double-blind Phase|Adverse Event|0|||
23539935|NCT01969838|65709091|FG000|Double-blind Phase|Death|5|||
23539936|NCT01969838|65709092|FG001|Double-blind Phase|Death|2|||
23539937|NCT01969838|65709093|FG002|Double-blind Phase|Death|0|||
23539938|NCT01969838|65709094|FG003|Double-blind Phase|Death|0|||
23539939|NCT01969838|65709091|FG000|Double-blind Phase|Physician Decision|5|||
23539940|NCT01969838|65709092|FG001|Double-blind Phase|Physician Decision|1|||
23539941|NCT01969838|65709093|FG002|Double-blind Phase|Physician Decision|0|||
23539942|NCT01969838|65709094|FG003|Double-blind Phase|Physician Decision|0|||
23539943|NCT01969838|65709091|FG000|Double-blind Phase|Subject Decision|4|||
23539944|NCT01969838|65709092|FG001|Double-blind Phase|Subject Decision|2|||
23539945|NCT01969838|65709093|FG002|Double-blind Phase|Subject Decision|0|||
23616559|NCT05361304|65982364|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
23616560|NCT05361304|65982365|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
23539946|NCT01969838|65709094|FG003|Double-blind Phase|Subject Decision|0|||
23539947|NCT01969838|65709091|FG000|Double-blind Phase|Disease Progression|2|||
23539948|NCT01969838|65709092|FG001|Double-blind Phase|Disease Progression|0|||
23539949|NCT01969838|65709093|FG002|Double-blind Phase|Disease Progression|0|||
23539950|NCT01969838|65709094|FG003|Double-blind Phase|Disease Progression|0|||
23539951|NCT01969838|65709091|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
23539952|NCT01969838|65709092|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539953|NCT01969838|65709093|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539954|NCT01969838|65709094|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539955|NCT01969838|65709091|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
23424253|NCT03215706|65296426|FG001|Treatment Period|Study Drug Toxicity|21|||
23539956|NCT01969838|65709092|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
23539957|NCT01969838|65709093|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
23539958|NCT01969838|65709094|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
23539959|NCT01969838|65709091|FG000|Open-label Phase|Adverse Event|0|||
23539960|NCT01969838|65709092|FG001|Open-label Phase|Adverse Event|0|||
23539961|NCT01969838|65709093|FG002|Open-label Phase|Adverse Event|37|||
23424254|NCT03215706|65296425|FG000|Treatment Period|Death|2|||
23539962|NCT01969838|65709094|FG003|Open-label Phase|Adverse Event|49|||
23539963|NCT01969838|65709091|FG000|Open-label Phase|Disease Progression|0|||
23539964|NCT01969838|65709092|FG001|Open-label Phase|Disease Progression|0|||
23539965|NCT01969838|65709093|FG002|Open-label Phase|Disease Progression|26|||
23539966|NCT01969838|65709094|FG003|Open-label Phase|Disease Progression|27|||
23539967|NCT01969838|65709091|FG000|Open-label Phase|Lack of Efficacy|0|||
23539968|NCT01969838|65709092|FG001|Open-label Phase|Lack of Efficacy|0|||
23539969|NCT01969838|65709093|FG002|Open-label Phase|Lack of Efficacy|17|||
23539970|NCT01969838|65709094|FG003|Open-label Phase|Lack of Efficacy|19|||
23539971|NCT01969838|65709091|FG000|Open-label Phase|Subject Decision|0|||
23539972|NCT01969838|65709092|FG001|Open-label Phase|Subject Decision|0|||
23539973|NCT01969838|65709093|FG002|Open-label Phase|Subject Decision|14|||
23539974|NCT01969838|65709094|FG003|Open-label Phase|Subject Decision|15|||
23539975|NCT01969838|65709091|FG000|Open-label Phase|Death|0|||
23539976|NCT01969838|65709092|FG001|Open-label Phase|Death|0|||
23539977|NCT01969838|65709093|FG002|Open-label Phase|Death|13|||
23539978|NCT01969838|65709094|FG003|Open-label Phase|Death|11|||
23539979|NCT01969838|65709091|FG000|Open-label Phase|Physician Decision|0|||
23539980|NCT01969838|65709092|FG001|Open-label Phase|Physician Decision|0|||
23539981|NCT01969838|65709093|FG002|Open-label Phase|Physician Decision|9|||
23539982|NCT01969838|65709094|FG003|Open-label Phase|Physician Decision|14|||
23539983|NCT01969838|65709091|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
23539984|NCT01969838|65709092|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
23539985|NCT01969838|65709093|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
23539986|NCT01969838|65709094|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
23539987|NCT01978119|65709099|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
23539988|NCT01978119|65709100|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
23539989|NCT01978119|65709099|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23539990|NCT01978119|65709100|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23539991|NCT01978119|65709099|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23539992|NCT01978119|65709100|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
23539993|NCT00659646|65709103|FG000|Overall Study|Protocol Violation|12|||
23539994|NCT00659646|65709104|FG001|Overall Study|Protocol Violation|8|||
23539995|NCT00659646|65709103|FG000|Overall Study|Adverse Event|1|||
23539996|NCT00659646|65709104|FG001|Overall Study|Adverse Event|0|||
23539997|NCT00659646|65709103|FG000|Overall Study|Lost to Follow-up|1|||
23539998|NCT00659646|65709104|FG001|Overall Study|Lost to Follow-up|0|||
23539999|NCT00659646|65709103|FG000|Overall Study|protocol noncompliance after randomized|1|||
23540000|NCT00659646|65709104|FG001|Overall Study|protocol noncompliance after randomized|0|||
23540001|NCT00660010|65709114|FG000|Overall Study|Withdrawal by Subject|2|||
23540002|NCT00660010|65709114|FG000|Overall Study|Lost to Follow-up|3|||
23540003|NCT00660010|65709114|FG000|Overall Study|Adverse Event|1|||
23540004|NCT00660010|65709114|FG000|Overall Study|Noncompliance with visit schedule|3|||
23540005|NCT01105533|65709115|FG000|Overall Study|Death|0|||
23540006|NCT01105533|65709116|FG001|Overall Study|Death|0|||
23540007|NCT01105533|65709117|FG002|Overall Study|Death|0|||
23540008|NCT01105533|65709118|FG003|Overall Study|Death|0|||
23540009|NCT01105533|65709119|FG004|Overall Study|Death|1|||
23540010|NCT01105533|65709120|FG005|Overall Study|Death|0|||
23540011|NCT01105533|65709121|FG006|Overall Study|Death|0|||
23540012|NCT01105533|65709122|FG007|Overall Study|Death|0|||
23540013|NCT01105533|65709123|FG008|Overall Study|Death|0|||
23540014|NCT01105533|65709115|FG000|Overall Study|Lack of Efficacy|1|||
23540015|NCT01105533|65709116|FG001|Overall Study|Lack of Efficacy|1|||
23540016|NCT01105533|65709117|FG002|Overall Study|Lack of Efficacy|3|||
23540017|NCT01105533|65709118|FG003|Overall Study|Lack of Efficacy|3|||
23540018|NCT01105533|65709119|FG004|Overall Study|Lack of Efficacy|4|||
23540019|NCT01105533|65709120|FG005|Overall Study|Lack of Efficacy|5|||
23540020|NCT01105533|65709121|FG006|Overall Study|Lack of Efficacy|3|||
23540021|NCT01105533|65709122|FG007|Overall Study|Lack of Efficacy|2|||
23540022|NCT01105533|65709123|FG008|Overall Study|Lack of Efficacy|9|||
23540023|NCT01105533|65709115|FG000|Overall Study|Adverse Event|0|||
23540024|NCT01105533|65709116|FG001|Overall Study|Adverse Event|0|||
23540025|NCT01105533|65709117|FG002|Overall Study|Adverse Event|0|||
23540026|NCT01105533|65709118|FG003|Overall Study|Adverse Event|0|||
23540027|NCT01105533|65709119|FG004|Overall Study|Adverse Event|1|||
23540028|NCT01105533|65709120|FG005|Overall Study|Adverse Event|2|||
23424255|NCT03215706|65296426|FG001|Treatment Period|Death|1|||
23424256|NCT03215706|65296425|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
23540029|NCT01105533|65709121|FG006|Overall Study|Adverse Event|2|||
23540030|NCT01105533|65709122|FG007|Overall Study|Adverse Event|0|||
23540031|NCT01105533|65709123|FG008|Overall Study|Adverse Event|1|||
23540032|NCT01105533|65709115|FG000|Overall Study|Other|0|||
23540033|NCT01105533|65709116|FG001|Overall Study|Other|0|||
23616561|NCT05361304|65982364|FG000|Overall Study|COVID-19 Related|1|||
23424257|NCT03215706|65296426|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
23540034|NCT01105533|65709117|FG002|Overall Study|Other|0|||
23540035|NCT01105533|65709118|FG003|Overall Study|Other|0|||
23540036|NCT01105533|65709119|FG004|Overall Study|Other|1|||
23540037|NCT01105533|65709120|FG005|Overall Study|Other|0|||
23540038|NCT01105533|65709121|FG006|Overall Study|Other|3|||
23540039|NCT01105533|65709122|FG007|Overall Study|Other|1|||
23540040|NCT01105533|65709123|FG008|Overall Study|Other|2|||
23540041|NCT01105533|65709115|FG000|Overall Study|Physician Decision|0|||
23540042|NCT01105533|65709116|FG001|Overall Study|Physician Decision|0|||
23540043|NCT01105533|65709117|FG002|Overall Study|Physician Decision|0|||
23540044|NCT01105533|65709118|FG003|Overall Study|Physician Decision|0|||
23540045|NCT01105533|65709119|FG004|Overall Study|Physician Decision|0|||
23540046|NCT01105533|65709120|FG005|Overall Study|Physician Decision|0|||
23540047|NCT01105533|65709121|FG006|Overall Study|Physician Decision|0|||
23540048|NCT01105533|65709122|FG007|Overall Study|Physician Decision|1|||
23540049|NCT01105533|65709123|FG008|Overall Study|Physician Decision|0|||
23540050|NCT00701051|65709144|FG000|Screening|Failed Screening|40|||
23540051|NCT00701051|65709145|FG001|Screening|Failed Screening|0|||
23540052|NCT00701051|65709146|FG002|Screening|Failed Screening|0|||
23540053|NCT00701051|65709144|FG000|Screening|Time conflicts|19|||
23540054|NCT00701051|65709145|FG001|Screening|Time conflicts|0|||
23540055|NCT00701051|65709146|FG002|Screening|Time conflicts|0|||
23540056|NCT00701051|65709144|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
23540057|NCT00701051|65709145|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
23540058|NCT00701051|65709146|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
23540059|NCT02610140|65709147|FG000|Randomization and Treatment Period|Radiological progression|23|||
23540060|NCT02610140|65709148|FG001|Randomization and Treatment Period|Radiological progression|15|||
23540061|NCT02610140|65709147|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
23540062|NCT02610140|65709148|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
23540063|NCT02610140|65709147|FG000|Randomization and Treatment Period|Protocol Violation|1|||
23540064|NCT02610140|65709148|FG001|Randomization and Treatment Period|Protocol Violation|0|||
23540065|NCT02610140|65709147|FG000|Randomization and Treatment Period|Physician Decision|0|||
23540066|NCT02610140|65709148|FG001|Randomization and Treatment Period|Physician Decision|1|||
23540067|NCT02610140|65709147|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
23540068|NCT02610140|65709148|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
23540069|NCT02610140|65709147|FG000|Randomization and Treatment Period|Death|7|||
23540070|NCT02610140|65709148|FG001|Randomization and Treatment Period|Death|1|||
23540071|NCT02610140|65709147|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
23540072|NCT02610140|65709148|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
23540073|NCT02610140|65709147|FG000|Randomization and Treatment Period|Adverse Event|44|||
23540074|NCT02610140|65709148|FG001|Randomization and Treatment Period|Adverse Event|13|||
23540075|NCT02610140|65709147|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
23540076|NCT02610140|65709148|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
23540077|NCT02610140|65709147|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
23540078|NCT02610140|65709148|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
23540079|NCT02610140|65709147|FG000|Randomization and Treatment Period|Not treated|3|||
23540080|NCT02610140|65709148|FG001|Randomization and Treatment Period|Not treated|10|||
23540081|NCT02610140|65709147|FG000|Safety Follow-up|Other|0|||
23540082|NCT02610140|65709148|FG001|Safety Follow-up|Other|2|||
23540083|NCT02610140|65709147|FG000|Safety Follow-up|Lost to Follow-up|1|||
23540084|NCT02610140|65709148|FG001|Safety Follow-up|Lost to Follow-up|0|||
23540085|NCT02610140|65709147|FG000|Safety Follow-up|No follow-up|5|||
23540086|NCT02610140|65709148|FG001|Safety Follow-up|No follow-up|3|||
23540087|NCT02610140|65709147|FG000|Safety Follow-up|Death|12|||
23540088|NCT02610140|65709148|FG001|Safety Follow-up|Death|2|||
23540089|NCT02610140|65709147|FG000|Safety Follow-up|Deterioration of general conditions|15|||
23816562|NCT03058289|66708451|FG006|Overall Study|Adverse Event|1|||
23816563|NCT03058289|66708452|FG007|Overall Study|Adverse Event|3|||
23540090|NCT02610140|65709148|FG001|Safety Follow-up|Deterioration of general conditions|5|||
23540091|NCT02610140|65709147|FG000|Safety Follow-up|Withdrawal by Subject|12|||
23540092|NCT02610140|65709148|FG001|Safety Follow-up|Withdrawal by Subject|12|||
23616562|NCT05361304|65982365|FG001|Overall Study|COVID-19 Related|2|||
23816564|NCT03058289|66708453|FG008|Overall Study|Adverse Event|0|||
23816565|NCT03058289|66708445|FG000|Overall Study|Withdrawal by Subject|0|||
23816566|NCT03058289|66708446|FG001|Overall Study|Withdrawal by Subject|0|||
23816567|NCT03058289|66708447|FG002|Overall Study|Withdrawal by Subject|0|||
23540093|NCT02610140|65709147|FG000|Active Follow-up|Progressive disease - radiological|30|||
23540094|NCT02610140|65709148|FG001|Active Follow-up|Progressive disease - radiological|22|||
23540095|NCT02610140|65709147|FG000|Active Follow-up|Death|8|||
23540096|NCT02610140|65709148|FG001|Active Follow-up|Death|1|||
23540097|NCT02610140|65709147|FG000|Active Follow-up|Withdrawal by Subject|4|||
23540098|NCT02610140|65709148|FG001|Active Follow-up|Withdrawal by Subject|0|||
23540099|NCT02610140|65709147|FG000|Active Follow-up|Progressive disease - clinical|1|||
23540100|NCT02610140|65709148|FG001|Active Follow-up|Progressive disease - clinical|2|||
23816568|NCT03058289|66708448|FG003|Overall Study|Withdrawal by Subject|2|||
23540101|NCT02610140|65709147|FG000|Active Follow-up|Deterioration of general conditions|1|||
23540102|NCT02610140|65709148|FG001|Active Follow-up|Deterioration of general conditions|0|||
23540103|NCT02610140|65709147|FG000|Active Follow-up|Ongoing but not completed|4|||
23540104|NCT02610140|65709148|FG001|Active Follow-up|Ongoing but not completed|1|||
23540105|NCT02610140|65709147|FG000|Long-term Follow-up|Death|86|||
23540106|NCT02610140|65709148|FG001|Long-term Follow-up|Death|44|||
23540107|NCT02610140|65709147|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
23540108|NCT02610140|65709148|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
23540109|NCT02610140|65709147|FG000|Long-term Follow-up|Lost to Follow-up|1|||
23540110|NCT02610140|65709148|FG001|Long-term Follow-up|Lost to Follow-up|2|||
23540111|NCT02610140|65709147|FG000|Long-term Follow-up|Ongoing but not completed|30|||
23540112|NCT02610140|65709148|FG001|Long-term Follow-up|Ongoing but not completed|17|||
23540113|NCT03791398|65709150|FG000|Overall Study|Progression of Disease Under Study|2|||
23540114|NCT03791398|65709151|FG001|Overall Study|Progression of Disease Under Study|0|||
23540115|NCT03791398|65709152|FG002|Overall Study|Progression of Disease Under Study|0|||
23540116|NCT01265953|65709154|FG000|Overall Study|Non compliance|5|||
23540117|NCT01265953|65709155|FG001|Overall Study|Non compliance|3|||
23540118|NCT02604589|65709158|FG000|Overall Study|catheter dislodgement|0|||
23540119|NCT02604589|65709159|FG001|Overall Study|catheter dislodgement|0|||
23540120|NCT02604589|65709160|FG002|Overall Study|catheter dislodgement|1|||
23540121|NCT00887341|65709164|FG000|Overall Study|Refused treatment|1|||
23540122|NCT00887341|65709165|FG001|Overall Study|Refused treatment|0|||
23540123|NCT00887341|65709164|FG000|Overall Study|Withdrawal by Subject|1|||
23540124|NCT00887341|65709165|FG001|Overall Study|Withdrawal by Subject|1|||
23540125|NCT00887341|65709164|FG000|Overall Study|Adverse Event|0|||
23540126|NCT00887341|65709165|FG001|Overall Study|Adverse Event|1|||
23540127|NCT00887341|65709164|FG000|Overall Study|Lost to Follow-up|0|||
23540128|NCT00887341|65709165|FG001|Overall Study|Lost to Follow-up|1|||
23540129|NCT01640301|65709166|FG000|Overall Study|Death|0|||
23540130|NCT01640301|65709167|FG001|Overall Study|Death|8|||
23540131|NCT01709227|65709168|FG000|Overall Study|Physician Decision|1|||
23540132|NCT01709227|65709169|FG001|Overall Study|Physician Decision|0|||
23540133|NCT01709227|65709168|FG000|Overall Study|Pleural Peritoneal communication|0|||
23540134|NCT01709227|65709169|FG001|Overall Study|Pleural Peritoneal communication|9|||
23540135|NCT01332305|65709172|FG000|Overall Study|Adverse Event|1|||
23540136|NCT01332305|65709173|FG001|Overall Study|Adverse Event|4|||
23540137|NCT01332305|65709174|FG002|Overall Study|Adverse Event|6|||
23540138|NCT01332305|65709175|FG003|Overall Study|Adverse Event|3|||
23540139|NCT01332305|65709176|FG004|Overall Study|Adverse Event|5|||
23540140|NCT01332305|65709172|FG000|Overall Study|Withdrawal by Subject|6|||
23540141|NCT01332305|65709173|FG001|Overall Study|Withdrawal by Subject|5|||
23540142|NCT01332305|65709174|FG002|Overall Study|Withdrawal by Subject|4|||
23540143|NCT01332305|65709175|FG003|Overall Study|Withdrawal by Subject|1|||
23540144|NCT01332305|65709176|FG004|Overall Study|Withdrawal by Subject|0|||
23540145|NCT01332305|65709172|FG000|Overall Study|Lost to Follow-up|0|||
23540146|NCT01332305|65709173|FG001|Overall Study|Lost to Follow-up|2|||
23540147|NCT01332305|65709174|FG002|Overall Study|Lost to Follow-up|3|||
23540148|NCT01332305|65709175|FG003|Overall Study|Lost to Follow-up|2|||
23540149|NCT01332305|65709176|FG004|Overall Study|Lost to Follow-up|3|||
23540150|NCT01332305|65709172|FG000|Overall Study|Protocol Violation|1|||
23540151|NCT01332305|65709173|FG001|Overall Study|Protocol Violation|2|||
23540152|NCT01332305|65709174|FG002|Overall Study|Protocol Violation|1|||
23540153|NCT01332305|65709175|FG003|Overall Study|Protocol Violation|0|||
23540154|NCT01332305|65709176|FG004|Overall Study|Protocol Violation|3|||
23424258|NCT03215706|65296425|FG000|Treatment Period|Request to D/C treatment|1|||
23424259|NCT03215706|65296426|FG001|Treatment Period|Request to D/C treatment|6|||
23540155|NCT01332305|65709172|FG000|Overall Study|Withdrawal by Sponsor|1|||
23540156|NCT01332305|65709173|FG001|Overall Study|Withdrawal by Sponsor|0|||
23540157|NCT01332305|65709174|FG002|Overall Study|Withdrawal by Sponsor|0|||
23540158|NCT01332305|65709175|FG003|Overall Study|Withdrawal by Sponsor|1|||
23540159|NCT01332305|65709176|FG004|Overall Study|Withdrawal by Sponsor|1|||
23540160|NCT01332305|65709172|FG000|Overall Study|Treatment Failure|1|||
23540161|NCT01332305|65709173|FG001|Overall Study|Treatment Failure|1|||
23540162|NCT01332305|65709174|FG002|Overall Study|Treatment Failure|0|||
23540163|NCT01332305|65709175|FG003|Overall Study|Treatment Failure|0|||
23540164|NCT01332305|65709176|FG004|Overall Study|Treatment Failure|0|||
23540165|NCT01332305|65709172|FG000|Overall Study|Physician Decision|0|||
23540166|NCT01332305|65709173|FG001|Overall Study|Physician Decision|0|||
23540167|NCT01332305|65709174|FG002|Overall Study|Physician Decision|0|||
23616563|NCT05361304|65982364|FG000|Overall Study|Withdrawal by Subject|1|||
23424260|NCT03215706|65296425|FG000|Treatment Period|Participant withdrew consent|3|||
23424261|NCT03215706|65296426|FG001|Treatment Period|Participant withdrew consent|4|||
23424262|NCT03215706|65296425|FG000|Treatment Period|Lost to Follow-up|0|||
23424263|NCT03215706|65296426|FG001|Treatment Period|Lost to Follow-up|1|||
23424264|NCT03215706|65296425|FG000|Treatment Period|Other Reasons|4|||
23424265|NCT03215706|65296426|FG001|Treatment Period|Other Reasons|5|||
23424266|NCT03215706|65296425|FG000|Treatment Period|Ongoing in the treatment period|105|||
23540168|NCT01332305|65709175|FG003|Overall Study|Physician Decision|1|||
23540169|NCT01332305|65709176|FG004|Overall Study|Physician Decision|0|||
23540170|NCT01525082|65709177|FG000|Overall Study|Death|1|||
23540171|NCT00359762|65709182|FG000|Period II|Adverse Event|17|||
23540172|NCT00359762|65709183|FG001|Period II|Adverse Event|0|||
23540173|NCT00359762|65709184|FG002|Period II|Adverse Event|0|||
23540174|NCT00359762|65709185|FG003|Period II|Adverse Event|0|||
23540175|NCT00359762|65709186|FG004|Period II|Adverse Event|49|||
23540176|NCT00359762|65709182|FG000|Period II|Protocol Violation|18|||
23540177|NCT00359762|65709183|FG001|Period II|Protocol Violation|0|||
23540178|NCT00359762|65709184|FG002|Period II|Protocol Violation|0|||
23540179|NCT00359762|65709185|FG003|Period II|Protocol Violation|0|||
23540180|NCT00359762|65709186|FG004|Period II|Protocol Violation|11|||
23540181|NCT00359762|65709182|FG000|Period II|Physician Decision|17|||
23540182|NCT00359762|65709183|FG001|Period II|Physician Decision|0|||
23540183|NCT00359762|65709184|FG002|Period II|Physician Decision|0|||
23540184|NCT00359762|65709185|FG003|Period II|Physician Decision|0|||
23540185|NCT00359762|65709186|FG004|Period II|Physician Decision|23|||
23540186|NCT00359762|65709182|FG000|Period II|Death|2|||
23540187|NCT00359762|65709183|FG001|Period II|Death|0|||
23540188|NCT00359762|65709184|FG002|Period II|Death|0|||
23540189|NCT00359762|65709185|FG003|Period II|Death|0|||
23540190|NCT00359762|65709186|FG004|Period II|Death|4|||
23540191|NCT00359762|65709182|FG000|Period II|Lack of Efficacy|11|||
23540192|NCT00359762|65709183|FG001|Period II|Lack of Efficacy|0|||
23540193|NCT00359762|65709184|FG002|Period II|Lack of Efficacy|0|||
23540194|NCT00359762|65709185|FG003|Period II|Lack of Efficacy|0|||
23540195|NCT00359762|65709186|FG004|Period II|Lack of Efficacy|8|||
23540196|NCT00359762|65709182|FG000|Period II|Lost to follow up|5|||
23540197|NCT00359762|65709183|FG001|Period II|Lost to follow up|0|||
23540198|NCT00359762|65709184|FG002|Period II|Lost to follow up|0|||
23540199|NCT00359762|65709185|FG003|Period II|Lost to follow up|0|||
23540200|NCT00359762|65709186|FG004|Period II|Lost to follow up|5|||
23540201|NCT00359762|65709182|FG000|Period II|Entry Criteria Not Met|8|||
23540202|NCT00359762|65709183|FG001|Period II|Entry Criteria Not Met|0|||
23540203|NCT00359762|65709184|FG002|Period II|Entry Criteria Not Met|0|||
23540204|NCT00359762|65709185|FG003|Period II|Entry Criteria Not Met|0|||
23540205|NCT00359762|65709186|FG004|Period II|Entry Criteria Not Met|4|||
23540206|NCT00359762|65709182|FG000|Period II|Subject Decision|50|||
23540207|NCT00359762|65709183|FG001|Period II|Subject Decision|0|||
23540208|NCT00359762|65709184|FG002|Period II|Subject Decision|0|||
23540209|NCT00359762|65709185|FG003|Period II|Subject Decision|0|||
23540210|NCT00359762|65709186|FG004|Period II|Subject Decision|70|||
23540211|NCT00359762|65709182|FG000|Period III|Protocol Violation|0|||
23540212|NCT00359762|65709183|FG001|Period III|Protocol Violation|5|||
23540213|NCT00359762|65709184|FG002|Period III|Protocol Violation|3|||
23540214|NCT00359762|65709185|FG003|Period III|Protocol Violation|8|||
23540215|NCT00359762|65709186|FG004|Period III|Protocol Violation|0|||
23540216|NCT00359762|65709182|FG000|Period III|Adverse Event|0|||
23540217|NCT00359762|65709183|FG001|Period III|Adverse Event|3|||
23540218|NCT00359762|65709184|FG002|Period III|Adverse Event|4|||
23540219|NCT00359762|65709185|FG003|Period III|Adverse Event|10|||
23540220|NCT00359762|65709186|FG004|Period III|Adverse Event|0|||
23540221|NCT00359762|65709182|FG000|Period III|Physician Decision|0|||
23540222|NCT00359762|65709183|FG001|Period III|Physician Decision|5|||
23540223|NCT00359762|65709184|FG002|Period III|Physician Decision|9|||
23540224|NCT00359762|65709185|FG003|Period III|Physician Decision|15|||
23540225|NCT00359762|65709186|FG004|Period III|Physician Decision|0|||
23540226|NCT00359762|65709182|FG000|Period III|Lack of Efficacy|0|||
23540227|NCT00359762|65709183|FG001|Period III|Lack of Efficacy|7|||
23540228|NCT00359762|65709184|FG002|Period III|Lack of Efficacy|5|||
23540229|NCT00359762|65709185|FG003|Period III|Lack of Efficacy|9|||
23540230|NCT00359762|65709186|FG004|Period III|Lack of Efficacy|0|||
23540231|NCT00359762|65709182|FG000|Period III|Lost to follow up|0|||
23540232|NCT00359762|65709183|FG001|Period III|Lost to follow up|1|||
23540233|NCT00359762|65709184|FG002|Period III|Lost to follow up|1|||
23540234|NCT00359762|65709185|FG003|Period III|Lost to follow up|2|||
23540235|NCT00359762|65709186|FG004|Period III|Lost to follow up|0|||
23540236|NCT00359762|65709182|FG000|Period III|Entry Criteria Not Met|0|||
23540237|NCT00359762|65709183|FG001|Period III|Entry Criteria Not Met|1|||
23540238|NCT00359762|65709184|FG002|Period III|Entry Criteria Not Met|0|||
23540239|NCT00359762|65709185|FG003|Period III|Entry Criteria Not Met|1|||
23540240|NCT00359762|65709186|FG004|Period III|Entry Criteria Not Met|0|||
23540241|NCT00359762|65709182|FG000|Period III|Subject Decision|0|||
23540242|NCT00359762|65709183|FG001|Period III|Subject Decision|7|||
23540243|NCT00359762|65709184|FG002|Period III|Subject Decision|8|||
23540244|NCT00359762|65709185|FG003|Period III|Subject Decision|20|||
23540245|NCT00359762|65709186|FG004|Period III|Subject Decision|0|||
23540246|NCT00148343|65709187|FG000|Overall Study|Withdrawal by Subject|12|||
23540247|NCT00148343|65709188|FG001|Overall Study|Withdrawal by Subject|7|||
23540248|NCT00148343|65709187|FG000|Overall Study|Physician Decision|3|||
23540249|NCT00148343|65709188|FG001|Overall Study|Physician Decision|4|||
23540250|NCT01954017|65709191|FG000|Overall Study|Adverse Event|0|||
23540251|NCT01954017|65709192|FG001|Overall Study|Adverse Event|0|||
23540252|NCT01954017|65709193|FG002|Overall Study|Adverse Event|1|||
23540253|NCT01954017|65709191|FG000|Overall Study|Death|2|||
23540254|NCT01954017|65709192|FG001|Overall Study|Death|1|||
23540255|NCT01954017|65709193|FG002|Overall Study|Death|1|||
23540256|NCT01954017|65709191|FG000|Overall Study|Withdrawal by Subject|0|||
23540257|NCT01954017|65709192|FG001|Overall Study|Withdrawal by Subject|1|||
23540258|NCT01954017|65709193|FG002|Overall Study|Withdrawal by Subject|0|||
23540259|NCT01954017|65709191|FG000|Overall Study|Protocol Violation|0|||
23540260|NCT01954017|65709192|FG001|Overall Study|Protocol Violation|3|||
23726380|NCT02865928|66378359|FG000|Overall Study|Withdrawal by Subject|1|||
23726381|NCT02865928|66378360|FG001|Overall Study|Withdrawal by Subject|0|||
23726382|NCT02865928|66378359|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
23726383|NCT02865928|66378360|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
23726384|NCT02865928|66378359|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
23726385|NCT02865928|66378360|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
23726386|NCT00654420|66378361|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
23726387|NCT00654420|66378362|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
23726388|NCT00654420|66378363|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
23726389|NCT00654420|66378364|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
23726390|NCT00654420|66378361|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
23726391|NCT00654420|66378362|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
23726392|NCT00654420|66378363|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
23424267|NCT03215706|65296426|FG001|Treatment Period|Ongoing in the treatment period|43|||
23424268|NCT02256267|65296430|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
23424269|NCT02256267|65296430|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
23424270|NCT03242772|65296431|FG000|Overall Study|Lost to Follow-up|2|||
23424271|NCT03242772|65296432|FG001|Overall Study|Lost to Follow-up|0|||
23424272|NCT03242772|65296431|FG000|Overall Study|Physician Decision|0|||
23424273|NCT03242772|65296432|FG001|Overall Study|Physician Decision|1|||
23424274|NCT03242772|65296431|FG000|Overall Study|Withdrawal by Subject|1|||
23424275|NCT03242772|65296432|FG001|Overall Study|Withdrawal by Subject|0|||
23424276|NCT02725593|65296435|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
23424277|NCT02725593|65296436|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
23424278|NCT02725593|65296435|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
23424279|NCT02725593|65296436|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
23424280|NCT02725593|65296435|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
23424281|NCT02725593|65296436|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
23424282|NCT02725593|65296435|FG000|Long Term Extension|Withdrawal by Subject|1|||
23424283|NCT02725593|65296436|FG001|Long Term Extension|Withdrawal by Subject|3|||
23424284|NCT03249935|65296441|FG000|Overall Study|Discharged from facility early|36|||
23424285|NCT03249935|65296441|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
23424286|NCT03249935|65296441|FG000|Overall Study|Protocol Violation|5|||
23424287|NCT01514240|65296442|FG000|Overall Study|Adverse Event|4|||
23424288|NCT01514240|65296443|FG001|Overall Study|Adverse Event|4|||
23424289|NCT01514240|65296442|FG000|Overall Study|Subject Decision|2|||
23540261|NCT01954017|65709193|FG002|Overall Study|Protocol Violation|2|||
23540262|NCT01954017|65709191|FG000|Overall Study|Necrotizing enterocolitis|1|||
23540263|NCT01954017|65709192|FG001|Overall Study|Necrotizing enterocolitis|0|||
23540264|NCT01954017|65709193|FG002|Overall Study|Necrotizing enterocolitis|1|||
23540265|NCT01954017|65709191|FG000|Overall Study|Enteral intake stopped >7 days|0|||
23540266|NCT01954017|65709192|FG001|Overall Study|Enteral intake stopped >7 days|1|||
23540267|NCT01954017|65709193|FG002|Overall Study|Enteral intake stopped >7 days|1|||
23540268|NCT01954017|65709191|FG000|Overall Study|All other reasons|2|||
23540269|NCT01954017|65709192|FG001|Overall Study|All other reasons|2|||
23540270|NCT01954017|65709193|FG002|Overall Study|All other reasons|7|||
23540271|NCT00113516|65709194|FG000|Part 1|Adverse Event|6|||
23540272|NCT00113516|65709195|FG001|Part 1|Adverse Event|0|||
23540273|NCT00113516|65709194|FG000|Part 1|Death|3|||
23540274|NCT00113516|65709195|FG001|Part 1|Death|0|||
23540275|NCT00113516|65709194|FG000|Part 1|Other|3|||
23540276|NCT00113516|65709195|FG001|Part 1|Other|0|||
23540277|NCT00113516|65709194|FG000|Part 1|Withdrawal by Subject|2|||
23540278|NCT00113516|65709195|FG001|Part 1|Withdrawal by Subject|0|||
23616564|NCT05361304|65982365|FG001|Overall Study|Withdrawal by Subject|0|||
23616565|NCT00111839|65982366|FG000|Overall Study|Disease Progression|30|||
23616566|NCT00111839|65982367|FG001|Overall Study|Disease Progression|33|||
23726393|NCT00654420|66378364|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
23540279|NCT00113516|65709194|FG000|Part 1|Lack of Efficacy|2|||
23540280|NCT00113516|65709195|FG001|Part 1|Lack of Efficacy|0|||
23540281|NCT00113516|65709194|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
23540282|NCT00113516|65709195|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
23540283|NCT00113516|65709194|FG000|Part 1|Laboratory Abnormality|1|||
23540284|NCT00113516|65709195|FG001|Part 1|Laboratory Abnormality|0|||
23540285|NCT00113516|65709194|FG000|Part 1|Ongoing|1|||
23540286|NCT00113516|65709195|FG001|Part 1|Ongoing|0|||
23540287|NCT00113516|65709194|FG000|Part 1|Missing|65|||
23540288|NCT00113516|65709195|FG001|Part 1|Missing|0|||
23540289|NCT00113516|65709194|FG000|Part 2|Adverse Event|0|||
23540290|NCT00113516|65709195|FG001|Part 2|Adverse Event|16|||
23540291|NCT00113516|65709194|FG000|Part 2|Death|0|||
23540292|NCT00113516|65709195|FG001|Part 2|Death|5|||
23540293|NCT00113516|65709194|FG000|Part 2|Lack of Efficacy|0|||
23540294|NCT00113516|65709195|FG001|Part 2|Lack of Efficacy|37|||
23540295|NCT00113516|65709194|FG000|Part 2|Withdrawal by Subject|0|||
23540296|NCT00113516|65709195|FG001|Part 2|Withdrawal by Subject|3|||
23540297|NCT00113516|65709194|FG000|Part 2|Other|0|||
23540298|NCT00113516|65709195|FG001|Part 2|Other|3|||
23540299|NCT00113516|65709194|FG000|Part 2|Laboratory Abnormality|0|||
23540300|NCT00113516|65709195|FG001|Part 2|Laboratory Abnormality|1|||
23540301|NCT00113516|65709194|FG000|Part 2|Ongoing|0|||
23540302|NCT00113516|65709195|FG001|Part 2|Ongoing|1|||
23540303|NCT01218646|65709196|FG000|Overall Study|Adverse Event|0|||
23540304|NCT01218646|65709197|FG001|Overall Study|Adverse Event|0|||
23540305|NCT01218646|65709198|FG002|Overall Study|Adverse Event|1|||
23540306|NCT01218646|65709199|FG003|Overall Study|Adverse Event|0|||
23540307|NCT01218646|65709196|FG000|Overall Study|Lost to Follow-up|1|||
23540308|NCT01218646|65709197|FG001|Overall Study|Lost to Follow-up|0|||
23540309|NCT01218646|65709198|FG002|Overall Study|Lost to Follow-up|0|||
23540310|NCT01218646|65709199|FG003|Overall Study|Lost to Follow-up|0|||
23540311|NCT01218646|65709196|FG000|Overall Study|Protocol Violation|0|||
23540312|NCT01218646|65709197|FG001|Overall Study|Protocol Violation|0|||
23540313|NCT01218646|65709198|FG002|Overall Study|Protocol Violation|1|||
23540314|NCT01218646|65709199|FG003|Overall Study|Protocol Violation|1|||
23540315|NCT04535037|65709202|FG000|Overall Study|Protocol Violation|1|||
23540316|NCT04535037|65709203|FG001|Overall Study|Protocol Violation|0|||
23540317|NCT04535037|65709202|FG000|Overall Study|Withdrawal by Subject|8|||
23540318|NCT04535037|65709203|FG001|Overall Study|Withdrawal by Subject|9|||
23540319|NCT04535037|65709202|FG000|Overall Study|Migrated / moved from the study area|1|||
23540320|NCT04535037|65709203|FG001|Overall Study|Migrated / moved from the study area|4|||
23540321|NCT04535037|65709202|FG000|Overall Study|Other|2|||
23540322|NCT04535037|65709203|FG001|Overall Study|Other|5|||
23540323|NCT04726709|65709204|FG000|Overall Study|Withdrawal by Subject|2|||
23540324|NCT04726709|65709205|FG001|Overall Study|Withdrawal by Subject|2|||
23540325|NCT00852397|65709206|FG000|Overall Study|Adverse Event|4|||
23540326|NCT00852397|65709207|FG001|Overall Study|Adverse Event|6|||
23540327|NCT00852397|65709208|FG002|Overall Study|Adverse Event|4|||
23540328|NCT00852397|65709206|FG000|Overall Study|Death|0|||
23540329|NCT00852397|65709207|FG001|Overall Study|Death|0|||
23540330|NCT00852397|65709208|FG002|Overall Study|Death|1|||
23540331|NCT00852397|65709206|FG000|Overall Study|Withdrawal by Subject|4|||
23540332|NCT00852397|65709207|FG001|Overall Study|Withdrawal by Subject|1|||
23540333|NCT00852397|65709208|FG002|Overall Study|Withdrawal by Subject|2|||
23540334|NCT00852397|65709206|FG000|Overall Study|Study terminated by sponsor|2|||
23726394|NCT00654420|66378361|FG000|Phase II|Adverse Event|0|||
23726395|NCT00654420|66378362|FG001|Phase II|Adverse Event|0|||
23726396|NCT00654420|66378363|FG002|Phase II|Adverse Event|3|||
23726397|NCT00654420|66378364|FG003|Phase II|Adverse Event|3|||
23726398|NCT00654420|66378361|FG000|Phase II|Lost to Follow-up|0|||
23726399|NCT00654420|66378362|FG001|Phase II|Lost to Follow-up|0|||
23726400|NCT00654420|66378363|FG002|Phase II|Lost to Follow-up|0|||
23540335|NCT00852397|65709207|FG001|Overall Study|Study terminated by sponsor|1|||
23540336|NCT00852397|65709208|FG002|Overall Study|Study terminated by sponsor|6|||
23540337|NCT00852397|65709206|FG000|Overall Study|Difficulty in study site visit|1|||
23540338|NCT00852397|65709207|FG001|Overall Study|Difficulty in study site visit|0|||
23540339|NCT00852397|65709208|FG002|Overall Study|Difficulty in study site visit|0|||
23540340|NCT00852397|65709206|FG000|Overall Study|Protocol Violation|0|||
23540341|NCT00852397|65709207|FG001|Overall Study|Protocol Violation|0|||
23540342|NCT00852397|65709208|FG002|Overall Study|Protocol Violation|1|||
23540343|NCT02770391|65709209|FG000|Overall Study|Lost to Follow-up|2|||
23540344|NCT02770391|65709209|FG000|Overall Study|Withdrawal by Subject|1|||
23540345|NCT02770391|65709209|FG000|Overall Study|Surgery delayed unevaluable|2|||
23540346|NCT02770391|65709209|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
23540347|NCT02528214|65709210|FG000|Overall Study|Protocol Violation|0|||
23540348|NCT02528214|65709211|FG001|Overall Study|Protocol Violation|1|||
23540349|NCT02528214|65709210|FG000|Overall Study|Adverse Event|0|||
23540350|NCT02528214|65709211|FG001|Overall Study|Adverse Event|1|||
23540351|NCT02528214|65709210|FG000|Overall Study|Other than specified above|0|||
23540352|NCT02528214|65709211|FG001|Overall Study|Other than specified above|1|||
23816569|NCT03058289|66708449|FG004|Overall Study|Withdrawal by Subject|0|||
23816570|NCT03058289|66708450|FG005|Overall Study|Withdrawal by Subject|2|||
23540353|NCT01722331|65709212|FG000|Part 1|Adverse Event|5|||
23540354|NCT01722331|65709213|FG001|Part 1|Adverse Event|0|||
23540355|NCT01722331|65709214|FG002|Part 1|Adverse Event|0|||
23816571|NCT03058289|66708451|FG006|Overall Study|Withdrawal by Subject|0|||
23540356|NCT01722331|65709215|FG003|Part 1|Adverse Event|0|||
23726401|NCT00654420|66378364|FG003|Phase II|Lost to Follow-up|1|||
23726402|NCT00654420|66378361|FG000|Phase II|Physician Decision|0|||
23540357|NCT01722331|65709216|FG004|Part 1|Adverse Event|0|||
23540358|NCT01722331|65709217|FG005|Part 1|Adverse Event|0|||
23726403|NCT00654420|66378362|FG001|Phase II|Physician Decision|0|||
23726404|NCT00654420|66378363|FG002|Phase II|Physician Decision|0|||
23726405|NCT00654420|66378364|FG003|Phase II|Physician Decision|4|||
23726406|NCT00654420|66378361|FG000|Phase II|Progressive Disease|0|||
23726407|NCT00654420|66378362|FG001|Phase II|Progressive Disease|0|||
23726408|NCT00654420|66378363|FG002|Phase II|Progressive Disease|29|||
23726409|NCT00654420|66378364|FG003|Phase II|Progressive Disease|29|||
23726410|NCT00654420|66378361|FG000|Phase II|Withdrawal by Subject|0|||
23726411|NCT00654420|66378362|FG001|Phase II|Withdrawal by Subject|0|||
23726412|NCT00654420|66378363|FG002|Phase II|Withdrawal by Subject|4|||
23726413|NCT00654420|66378364|FG003|Phase II|Withdrawal by Subject|1|||
23726414|NCT00654420|66378361|FG000|Phase II|Missing Disposition Record|0|||
23726415|NCT00654420|66378362|FG001|Phase II|Missing Disposition Record|0|||
23726416|NCT00654420|66378363|FG002|Phase II|Missing Disposition Record|1|||
23726417|NCT00654420|66378364|FG003|Phase II|Missing Disposition Record|0|||
23726418|NCT01496274|66378365|FG000|Overall Study|Protocol Violation|0|||
23726419|NCT01496274|66378366|FG001|Overall Study|Protocol Violation|1|||
23726420|NCT01496274|66378365|FG000|Overall Study|Adverse Event|1|||
23726421|NCT01496274|66378366|FG001|Overall Study|Adverse Event|1|||
23726422|NCT01496274|66378365|FG000|Overall Study|Withdrawal by Subject|2|||
23726423|NCT01496274|66378366|FG001|Overall Study|Withdrawal by Subject|0|||
23726424|NCT01496274|66378365|FG000|Overall Study|Lost to Follow-up|0|||
23726425|NCT01496274|66378366|FG001|Overall Study|Lost to Follow-up|3|||
23726426|NCT00572728|66378371|FG000|Overall Study|Withdrawal by Subject|10|||
23726427|NCT00572728|66378371|FG000|Overall Study|Ineligible|3|||
23726428|NCT00572728|66378371|FG000|Overall Study|Enrolled under Amendment 4|5|||
23726429|NCT00572728|66378371|FG000|Overall Study|Offstudy due to complicating disease|1|||
23726430|NCT00572728|66378371|FG000|Overall Study|FLT1 not completed|4|||
23726431|NCT00572728|66378371|FG000|Overall Study|First Chemotherapy not initiated|2|||
23726432|NCT00572728|66378371|FG000|Overall Study|FLT2 not completed|5|||
23726433|NCT00572728|66378371|FG000|Overall Study|Second chemotherapy not initiated|1|||
23726434|NCT00572728|66378371|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
23726435|NCT00572728|66378371|FG000|Overall Study|Pathology missing|1|||
23726436|NCT02667236|66378374|FG000|Overall Study|Adverse Event|1|||
23726437|NCT02667236|66378375|FG001|Overall Study|Adverse Event|1|||
23726438|NCT02667236|66378374|FG000|Overall Study|Withdrawal by Subject|2|||
23726439|NCT02667236|66378375|FG001|Overall Study|Withdrawal by Subject|0|||
23726440|NCT01431521|66378376|FG000|Overall Study|Withdrawal by Subject|0|||
23726441|NCT01431521|66378377|FG001|Overall Study|Withdrawal by Subject|0|||
23726442|NCT01431521|66378378|FG002|Overall Study|Withdrawal by Subject|1|||
23726443|NCT01431521|66378379|FG003|Overall Study|Withdrawal by Subject|0|||
23726444|NCT02688153|66378382|FG000|Overall Study|Death|7|||
23726445|NCT02688153|66378383|FG001|Overall Study|Death|5|||
23726446|NCT02688153|66378382|FG000|Overall Study|Withdrawal by Subject|4|||
23726447|NCT02688153|66378383|FG001|Overall Study|Withdrawal by Subject|2|||
23726448|NCT02688153|66378382|FG000|Overall Study|Valve Explant|1|||
23726449|NCT02688153|66378383|FG001|Overall Study|Valve Explant|0|||
23726450|NCT02688153|66378382|FG000|Overall Study|Conversion to Commercial Valve|3|||
23726451|NCT02688153|66378383|FG001|Overall Study|Conversion to Commercial Valve|0|||
23726452|NCT03510910|66378384|FG000|Overall Study|Incomplete Survey|2|||
23726453|NCT03510910|66378385|FG001|Overall Study|Incomplete Survey|3|||
23726454|NCT02707601|66378386|FG000|Overall Study|Death|0|||
23726455|NCT02707601|66378387|FG001|Overall Study|Death|1|||
23540359|NCT01722331|65709218|FG006|Part 1|Adverse Event|0|||
23540360|NCT01722331|65709212|FG000|Part 1|Lack of Efficacy|0|||
23540361|NCT01722331|65709213|FG001|Part 1|Lack of Efficacy|0|||
23540362|NCT01722331|65709214|FG002|Part 1|Lack of Efficacy|1|||
23540363|NCT01722331|65709215|FG003|Part 1|Lack of Efficacy|0|||
23540364|NCT01722331|65709216|FG004|Part 1|Lack of Efficacy|2|||
23540365|NCT01722331|65709217|FG005|Part 1|Lack of Efficacy|0|||
23540366|NCT01722331|65709218|FG006|Part 1|Lack of Efficacy|0|||
23726456|NCT02707601|66378386|FG000|Overall Study|Lack of Efficacy|0|||
23726457|NCT02707601|66378387|FG001|Overall Study|Lack of Efficacy|1|||
23726458|NCT02707601|66378386|FG000|Overall Study|Investigator's Discretion|1|||
23726459|NCT02707601|66378387|FG001|Overall Study|Investigator's Discretion|0|||
23726460|NCT02707601|66378386|FG000|Overall Study|Withdrew Consent|0|||
23726461|NCT02707601|66378387|FG001|Overall Study|Withdrew Consent|1|||
23726462|NCT02707601|66378386|FG000|Overall Study|Lost to Follow-up|1|||
23726463|NCT02707601|66378387|FG001|Overall Study|Lost to Follow-up|1|||
23726464|NCT02707601|66378386|FG000|Overall Study|Participants Randomized but Not Treated|2|||
23726465|NCT02707601|66378387|FG001|Overall Study|Participants Randomized but Not Treated|0|||
23726466|NCT03128307|66378390|FG000|Overall Study|Lost to Follow-up|29|||
23540367|NCT01722331|65709212|FG000|Part 1|Lost to Follow-up|1|||
23726467|NCT03128307|66378390|FG000|Overall Study|Withdrawal by Subject|5|||
23726468|NCT03417505|66378391|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
23726469|NCT03417505|66378392|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
23726470|NCT02327078|66378393|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23726471|NCT02327078|66378394|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23726472|NCT02327078|66378395|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
23726473|NCT02327078|66378396|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23726474|NCT02327078|66378397|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23726475|NCT02327078|66378398|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23726476|NCT02327078|66378399|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23726477|NCT02327078|66378400|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
23726478|NCT02327078|66378401|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
23726479|NCT02327078|66378393|FG000|Overall Study|Death|2|||
23726480|NCT02327078|66378394|FG001|Overall Study|Death|4|||
23726481|NCT02327078|66378395|FG002|Overall Study|Death|10|||
23726482|NCT02327078|66378396|FG003|Overall Study|Death|6|||
23726483|NCT02327078|66378397|FG004|Overall Study|Death|4|||
23726484|NCT02327078|66378398|FG005|Overall Study|Death|3|||
23726485|NCT02327078|66378399|FG006|Overall Study|Death|2|||
23726486|NCT02327078|66378400|FG007|Overall Study|Death|51|||
23726487|NCT02327078|66378401|FG008|Overall Study|Death|97|||
23726488|NCT02327078|66378393|FG000|Overall Study|Lost to Follow-up|0|||
23726489|NCT02327078|66378394|FG001|Overall Study|Lost to Follow-up|1|||
23726490|NCT02327078|66378395|FG002|Overall Study|Lost to Follow-up|1|||
23726491|NCT02327078|66378396|FG003|Overall Study|Lost to Follow-up|0|||
23726492|NCT02327078|66378397|FG004|Overall Study|Lost to Follow-up|0|||
23726493|NCT02327078|66378398|FG005|Overall Study|Lost to Follow-up|0|||
23726494|NCT02327078|66378399|FG006|Overall Study|Lost to Follow-up|0|||
23726495|NCT02327078|66378400|FG007|Overall Study|Lost to Follow-up|2|||
23726496|NCT02327078|66378401|FG008|Overall Study|Lost to Follow-up|5|||
23726497|NCT02327078|66378393|FG000|Overall Study|Site Terminated by Sponsor|1|||
23726498|NCT02327078|66378394|FG001|Overall Study|Site Terminated by Sponsor|0|||
23726499|NCT02327078|66378395|FG002|Overall Study|Site Terminated by Sponsor|1|||
23726500|NCT02327078|66378396|FG003|Overall Study|Site Terminated by Sponsor|4|||
23726501|NCT02327078|66378397|FG004|Overall Study|Site Terminated by Sponsor|0|||
23726502|NCT02327078|66378398|FG005|Overall Study|Site Terminated by Sponsor|0|||
23726503|NCT02327078|66378399|FG006|Overall Study|Site Terminated by Sponsor|0|||
23726504|NCT02327078|66378400|FG007|Overall Study|Site Terminated by Sponsor|11|||
23726505|NCT02327078|66378401|FG008|Overall Study|Site Terminated by Sponsor|25|||
23726506|NCT02327078|66378393|FG000|Overall Study|Physician Decision|0|||
23726507|NCT02327078|66378394|FG001|Overall Study|Physician Decision|0|||
23726508|NCT02327078|66378395|FG002|Overall Study|Physician Decision|0|||
23726509|NCT02327078|66378396|FG003|Overall Study|Physician Decision|1|||
23726510|NCT02327078|66378397|FG004|Overall Study|Physician Decision|0|||
23726511|NCT02327078|66378398|FG005|Overall Study|Physician Decision|0|||
23726512|NCT02327078|66378399|FG006|Overall Study|Physician Decision|0|||
23726513|NCT02327078|66378400|FG007|Overall Study|Physician Decision|0|||
23726514|NCT02327078|66378401|FG008|Overall Study|Physician Decision|1|||
23726515|NCT02327078|66378393|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23726516|NCT02327078|66378394|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23726517|NCT02327078|66378395|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23726518|NCT02327078|66378396|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23726519|NCT02327078|66378397|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23726520|NCT02327078|66378398|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23726521|NCT02327078|66378399|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23726522|NCT02327078|66378400|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
23726523|NCT02327078|66378401|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
23726524|NCT02327078|66378393|FG000|Overall Study|Reason not Specified|0|||
23726525|NCT02327078|66378394|FG001|Overall Study|Reason not Specified|0|||
23726526|NCT02327078|66378395|FG002|Overall Study|Reason not Specified|0|||
23726527|NCT02327078|66378396|FG003|Overall Study|Reason not Specified|0|||
23726528|NCT02327078|66378397|FG004|Overall Study|Reason not Specified|0|||
23726529|NCT02327078|66378398|FG005|Overall Study|Reason not Specified|0|||
23726530|NCT02327078|66378399|FG006|Overall Study|Reason not Specified|0|||
23424290|NCT01514240|65296443|FG001|Overall Study|Subject Decision|7|||
23726531|NCT02327078|66378400|FG007|Overall Study|Reason not Specified|5|||
23726532|NCT02327078|66378401|FG008|Overall Study|Reason not Specified|12|||
23726533|NCT02724111|66378406|FG000|Overall Study|Protocol Violation|2|||
23726534|NCT02724111|66378407|FG001|Overall Study|Protocol Violation|5|||
23726535|NCT01047436|66378408|FG000|Overall Study|Protocol Violation|1|||
23726536|NCT01047436|66378409|FG001|Overall Study|Protocol Violation|0|||
23726537|NCT00126425|66378412|FG000|Overall Study|Withdrawal by Subject|17|||
23726538|NCT00126425|66378413|FG001|Overall Study|Withdrawal by Subject|1|||
23726539|NCT00126425|66378412|FG000|Overall Study|Lost to Follow-up|8|||
23726540|NCT00126425|66378413|FG001|Overall Study|Lost to Follow-up|4|||
23726541|NCT00126425|66378412|FG000|Overall Study|Protocol Violation|9|||
23540368|NCT01722331|65709213|FG001|Part 1|Lost to Follow-up|0|||
23540369|NCT01722331|65709214|FG002|Part 1|Lost to Follow-up|2|||
23540370|NCT01722331|65709215|FG003|Part 1|Lost to Follow-up|0|||
23540371|NCT01722331|65709216|FG004|Part 1|Lost to Follow-up|1|||
23540372|NCT01722331|65709217|FG005|Part 1|Lost to Follow-up|0|||
23540373|NCT01722331|65709218|FG006|Part 1|Lost to Follow-up|0|||
23540374|NCT01722331|65709212|FG000|Part 1|Physician Decision|0|||
23540375|NCT01722331|65709213|FG001|Part 1|Physician Decision|0|||
23540376|NCT01722331|65709214|FG002|Part 1|Physician Decision|3|||
23540377|NCT01722331|65709215|FG003|Part 1|Physician Decision|0|||
23540378|NCT01722331|65709216|FG004|Part 1|Physician Decision|1|||
23540379|NCT01722331|65709217|FG005|Part 1|Physician Decision|0|||
23540380|NCT01722331|65709218|FG006|Part 1|Physician Decision|0|||
23540381|NCT01722331|65709212|FG000|Part 1|Pregnancy|1|||
23540382|NCT01722331|65709213|FG001|Part 1|Pregnancy|0|||
23540383|NCT01722331|65709214|FG002|Part 1|Pregnancy|0|||
23540384|NCT01722331|65709215|FG003|Part 1|Pregnancy|0|||
23540385|NCT01722331|65709216|FG004|Part 1|Pregnancy|0|||
23540386|NCT01722331|65709217|FG005|Part 1|Pregnancy|0|||
23540387|NCT01722331|65709218|FG006|Part 1|Pregnancy|0|||
23540388|NCT01722331|65709212|FG000|Part 1|Progressive Disease|0|||
23540389|NCT01722331|65709213|FG001|Part 1|Progressive Disease|0|||
23540390|NCT01722331|65709214|FG002|Part 1|Progressive Disease|0|||
23540391|NCT01722331|65709215|FG003|Part 1|Progressive Disease|0|||
23540392|NCT01722331|65709216|FG004|Part 1|Progressive Disease|1|||
23540393|NCT01722331|65709217|FG005|Part 1|Progressive Disease|0|||
23540394|NCT01722331|65709218|FG006|Part 1|Progressive Disease|0|||
23540395|NCT01722331|65709212|FG000|Part 1|Protocol Violation|1|||
23540396|NCT01722331|65709213|FG001|Part 1|Protocol Violation|0|||
23540397|NCT01722331|65709214|FG002|Part 1|Protocol Violation|0|||
23540398|NCT01722331|65709215|FG003|Part 1|Protocol Violation|0|||
23540399|NCT01722331|65709216|FG004|Part 1|Protocol Violation|1|||
23540400|NCT01722331|65709217|FG005|Part 1|Protocol Violation|0|||
23540401|NCT01722331|65709218|FG006|Part 1|Protocol Violation|0|||
23540402|NCT01722331|65709212|FG000|Part 1|Withdrawal by Subject|2|||
23540403|NCT01722331|65709213|FG001|Part 1|Withdrawal by Subject|0|||
23540404|NCT01722331|65709214|FG002|Part 1|Withdrawal by Subject|3|||
23540405|NCT01722331|65709215|FG003|Part 1|Withdrawal by Subject|0|||
23540406|NCT01722331|65709216|FG004|Part 1|Withdrawal by Subject|3|||
23540407|NCT01722331|65709217|FG005|Part 1|Withdrawal by Subject|0|||
23540408|NCT01722331|65709218|FG006|Part 1|Withdrawal by Subject|0|||
23540409|NCT01722331|65709212|FG000|Part 2|Adverse Event|3|||
23540410|NCT01722331|65709213|FG001|Part 2|Adverse Event|0|||
23540411|NCT01722331|65709214|FG002|Part 2|Adverse Event|0|||
23540412|NCT01722331|65709215|FG003|Part 2|Adverse Event|0|||
23540413|NCT01722331|65709216|FG004|Part 2|Adverse Event|0|||
23540414|NCT01722331|65709217|FG005|Part 2|Adverse Event|1|||
23540415|NCT01722331|65709218|FG006|Part 2|Adverse Event|0|||
23540416|NCT01722331|65709212|FG000|Part 2|Lack of Efficacy|3|||
23540417|NCT01722331|65709213|FG001|Part 2|Lack of Efficacy|0|||
23540418|NCT01722331|65709214|FG002|Part 2|Lack of Efficacy|11|||
23540419|NCT01722331|65709215|FG003|Part 2|Lack of Efficacy|0|||
23540420|NCT01722331|65709216|FG004|Part 2|Lack of Efficacy|0|||
23540421|NCT01722331|65709217|FG005|Part 2|Lack of Efficacy|3|||
23540422|NCT01722331|65709218|FG006|Part 2|Lack of Efficacy|3|||
23540423|NCT01722331|65709212|FG000|Part 2|Lost to Follow-up|0|||
23540424|NCT01722331|65709213|FG001|Part 2|Lost to Follow-up|0|||
23540425|NCT01722331|65709214|FG002|Part 2|Lost to Follow-up|3|||
23540426|NCT01722331|65709215|FG003|Part 2|Lost to Follow-up|0|||
23540427|NCT01722331|65709216|FG004|Part 2|Lost to Follow-up|0|||
23726542|NCT00126425|66378413|FG001|Overall Study|Protocol Violation|6|||
23540428|NCT01722331|65709217|FG005|Part 2|Lost to Follow-up|1|||
23540429|NCT01722331|65709218|FG006|Part 2|Lost to Follow-up|1|||
23540430|NCT01722331|65709212|FG000|Part 2|Non-Compliance with Study Drug|1|||
23540431|NCT01722331|65709213|FG001|Part 2|Non-Compliance with Study Drug|0|||
23540432|NCT01722331|65709214|FG002|Part 2|Non-Compliance with Study Drug|1|||
23540433|NCT01722331|65709215|FG003|Part 2|Non-Compliance with Study Drug|0|||
23540434|NCT01722331|65709216|FG004|Part 2|Non-Compliance with Study Drug|0|||
23540435|NCT01722331|65709217|FG005|Part 2|Non-Compliance with Study Drug|0|||
23540436|NCT01722331|65709218|FG006|Part 2|Non-Compliance with Study Drug|0|||
23540437|NCT01722331|65709212|FG000|Part 2|Physician Decision|0|||
23540438|NCT01722331|65709213|FG001|Part 2|Physician Decision|0|||
23540439|NCT01722331|65709214|FG002|Part 2|Physician Decision|2|||
23726543|NCT00126425|66378412|FG000|Overall Study|Adverse Event|1|||
23726544|NCT00126425|66378413|FG001|Overall Study|Adverse Event|0|||
23726545|NCT00126425|66378412|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
23726546|NCT00126425|66378413|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
23726547|NCT00126425|66378412|FG000|Overall Study|Other|5|||
23726548|NCT00126425|66378413|FG001|Overall Study|Other|0|||
23726549|NCT00595868|66378414|FG000|Overall Study|Lost to Follow-up|45|||
23726550|NCT00595868|66378415|FG001|Overall Study|Lost to Follow-up|50|||
23726551|NCT00432562|66378416|FG000|Overall Study|Death|3|||
23726552|NCT00432562|66378417|FG001|Overall Study|Death|0|||
23726553|NCT02443155|66378418|FG000|Overall Study|Adverse Event|3|||
23726554|NCT02443155|66378419|FG001|Overall Study|Adverse Event|4|||
23726555|NCT02443155|66378420|FG002|Overall Study|Adverse Event|1|||
23726556|NCT02443155|66378421|FG003|Overall Study|Adverse Event|2|||
23726557|NCT02443155|66378418|FG000|Overall Study|Unclassified|0|||
23726558|NCT02443155|66378419|FG001|Overall Study|Unclassified|0|||
23726559|NCT02443155|66378420|FG002|Overall Study|Unclassified|2|||
23726560|NCT02443155|66378421|FG003|Overall Study|Unclassified|1|||
23726561|NCT02443155|66378418|FG000|Overall Study|Withdrawal by Subject|4|||
23726562|NCT02443155|66378419|FG001|Overall Study|Withdrawal by Subject|7|||
23726563|NCT02443155|66378420|FG002|Overall Study|Withdrawal by Subject|3|||
23726564|NCT02443155|66378421|FG003|Overall Study|Withdrawal by Subject|9|||
23540440|NCT01722331|65709215|FG003|Part 2|Physician Decision|0|||
23540441|NCT01722331|65709216|FG004|Part 2|Physician Decision|0|||
23540442|NCT01722331|65709217|FG005|Part 2|Physician Decision|0|||
23540443|NCT01722331|65709218|FG006|Part 2|Physician Decision|0|||
23540444|NCT01722331|65709212|FG000|Part 2|Pregnancy|0|||
23540445|NCT01722331|65709213|FG001|Part 2|Pregnancy|0|||
23540446|NCT01722331|65709214|FG002|Part 2|Pregnancy|0|||
23540447|NCT01722331|65709215|FG003|Part 2|Pregnancy|0|||
23540448|NCT01722331|65709216|FG004|Part 2|Pregnancy|0|||
23540449|NCT01722331|65709217|FG005|Part 2|Pregnancy|1|||
23540450|NCT01722331|65709218|FG006|Part 2|Pregnancy|0|||
23540451|NCT01722331|65709212|FG000|Part 2|Progressive Disease|0|||
23540452|NCT01722331|65709213|FG001|Part 2|Progressive Disease|0|||
23540453|NCT01722331|65709214|FG002|Part 2|Progressive Disease|1|||
23540454|NCT01722331|65709215|FG003|Part 2|Progressive Disease|0|||
23540455|NCT01722331|65709216|FG004|Part 2|Progressive Disease|0|||
23540456|NCT01722331|65709217|FG005|Part 2|Progressive Disease|0|||
23540457|NCT01722331|65709218|FG006|Part 2|Progressive Disease|0|||
23540458|NCT01722331|65709212|FG000|Part 2|Protocol Violation|1|||
23726565|NCT02443155|66378418|FG000|Overall Study|Pregnancy|3|||
23726566|NCT02443155|66378419|FG001|Overall Study|Pregnancy|1|||
23726567|NCT02443155|66378420|FG002|Overall Study|Pregnancy|1|||
23726568|NCT02443155|66378421|FG003|Overall Study|Pregnancy|2|||
23726569|NCT02443155|66378418|FG000|Overall Study|Lost to Follow-up|1|||
23726570|NCT02443155|66378419|FG001|Overall Study|Lost to Follow-up|2|||
23726571|NCT02443155|66378420|FG002|Overall Study|Lost to Follow-up|0|||
23726572|NCT02443155|66378421|FG003|Overall Study|Lost to Follow-up|1|||
23726573|NCT02443155|66378418|FG000|Overall Study|Protocol Violation|1|||
23726574|NCT02443155|66378419|FG001|Overall Study|Protocol Violation|0|||
23726575|NCT02443155|66378420|FG002|Overall Study|Protocol Violation|1|||
23726576|NCT02443155|66378421|FG003|Overall Study|Protocol Violation|1|||
23726577|NCT02443155|66378418|FG000|Overall Study|Death|0|||
23726578|NCT02443155|66378419|FG001|Overall Study|Death|0|||
23726579|NCT02443155|66378420|FG002|Overall Study|Death|1|||
23726580|NCT02443155|66378421|FG003|Overall Study|Death|0|||
23726581|NCT02848313|66378428|FG000|Overall Study|Adverse Event|1|||
23726582|NCT02848313|66378429|FG001|Overall Study|Adverse Event|2|||
23726583|NCT02848313|66378428|FG000|Overall Study|Lack of Efficacy|0|||
23726584|NCT02848313|66378429|FG001|Overall Study|Lack of Efficacy|1|||
23816572|NCT03058289|66708452|FG007|Overall Study|Withdrawal by Subject|4|||
23540459|NCT01722331|65709213|FG001|Part 2|Protocol Violation|0|||
23540460|NCT01722331|65709214|FG002|Part 2|Protocol Violation|0|||
23726585|NCT02848313|66378428|FG000|Overall Study|Withdrawal by Subject|1|||
23726586|NCT02848313|66378429|FG001|Overall Study|Withdrawal by Subject|1|||
23726587|NCT02848313|66378428|FG000|Overall Study|Lost to follow up|1|||
23816573|NCT03058289|66708453|FG008|Overall Study|Withdrawal by Subject|1|||
23540461|NCT01722331|65709215|FG003|Part 2|Protocol Violation|0|||
23540462|NCT01722331|65709216|FG004|Part 2|Protocol Violation|0|||
23540463|NCT01722331|65709217|FG005|Part 2|Protocol Violation|0|||
23540464|NCT01722331|65709218|FG006|Part 2|Protocol Violation|0|||
23540465|NCT01722331|65709212|FG000|Part 2|Withdrawal by Subject|5|||
23726588|NCT02848313|66378429|FG001|Overall Study|Lost to follow up|0|||
23726589|NCT02996500|66378430|FG000|Overall Study|Adverse Event|1|||
23726590|NCT02996500|66378431|FG001|Overall Study|Adverse Event|1|||
23726591|NCT02996500|66378432|FG002|Overall Study|Adverse Event|4|||
23726592|NCT02996500|66378433|FG003|Overall Study|Adverse Event|3|||
23726593|NCT02996500|66378434|FG004|Overall Study|Adverse Event|1|||
23726594|NCT02996500|66378435|FG005|Overall Study|Adverse Event|2|||
23726595|NCT02996500|66378430|FG000|Overall Study|Lack of Efficacy|0|||
23726596|NCT02996500|66378431|FG001|Overall Study|Lack of Efficacy|0|||
23726597|NCT02996500|66378432|FG002|Overall Study|Lack of Efficacy|0|||
23726598|NCT02996500|66378433|FG003|Overall Study|Lack of Efficacy|0|||
23726599|NCT02996500|66378434|FG004|Overall Study|Lack of Efficacy|2|||
23726600|NCT02996500|66378435|FG005|Overall Study|Lack of Efficacy|0|||
23726601|NCT02996500|66378430|FG000|Overall Study|Lost to Follow-up|1|||
23726602|NCT02996500|66378431|FG001|Overall Study|Lost to Follow-up|0|||
23726603|NCT02996500|66378432|FG002|Overall Study|Lost to Follow-up|0|||
23726604|NCT02996500|66378433|FG003|Overall Study|Lost to Follow-up|0|||
23726605|NCT02996500|66378434|FG004|Overall Study|Lost to Follow-up|0|||
23726606|NCT02996500|66378435|FG005|Overall Study|Lost to Follow-up|1|||
23726607|NCT02996500|66378430|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23726608|NCT02996500|66378431|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23726609|NCT02996500|66378432|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
23726610|NCT02996500|66378433|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23726611|NCT02996500|66378434|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23726612|NCT02996500|66378435|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23726613|NCT02996500|66378430|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23726614|NCT02996500|66378431|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23726615|NCT02996500|66378432|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23726616|NCT02996500|66378433|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23726617|NCT02996500|66378434|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23726618|NCT02996500|66378435|FG005|Overall Study|Non-Compliance With Study Drug|1|||
23726619|NCT02996500|66378430|FG000|Overall Study|Progressive Disease|1|||
23726620|NCT02996500|66378431|FG001|Overall Study|Progressive Disease|0|||
23726621|NCT02996500|66378432|FG002|Overall Study|Progressive Disease|0|||
23726622|NCT02996500|66378433|FG003|Overall Study|Progressive Disease|0|||
23726623|NCT02996500|66378434|FG004|Overall Study|Progressive Disease|0|||
23726624|NCT02996500|66378435|FG005|Overall Study|Progressive Disease|0|||
23726625|NCT02996500|66378430|FG000|Overall Study|Other|2|||
23726626|NCT02996500|66378431|FG001|Overall Study|Other|0|||
23726627|NCT02996500|66378432|FG002|Overall Study|Other|2|||
23726628|NCT02996500|66378433|FG003|Overall Study|Other|0|||
23726629|NCT02996500|66378434|FG004|Overall Study|Other|0|||
23726630|NCT02996500|66378435|FG005|Overall Study|Other|0|||
23726631|NCT02996500|66378430|FG000|Overall Study|Protocol Violation|0|||
23726632|NCT02996500|66378431|FG001|Overall Study|Protocol Violation|0|||
23726633|NCT02996500|66378432|FG002|Overall Study|Protocol Violation|0|||
23726634|NCT02996500|66378433|FG003|Overall Study|Protocol Violation|1|||
23726635|NCT02996500|66378434|FG004|Overall Study|Protocol Violation|0|||
23726636|NCT02996500|66378435|FG005|Overall Study|Protocol Violation|0|||
23726637|NCT02996500|66378430|FG000|Overall Study|Withdrawal by Subject|3|||
23726638|NCT02996500|66378431|FG001|Overall Study|Withdrawal by Subject|0|||
23726639|NCT02996500|66378432|FG002|Overall Study|Withdrawal by Subject|3|||
23726640|NCT02996500|66378433|FG003|Overall Study|Withdrawal by Subject|0|||
23726641|NCT02996500|66378434|FG004|Overall Study|Withdrawal by Subject|2|||
23726642|NCT02996500|66378435|FG005|Overall Study|Withdrawal by Subject|0|||
23726643|NCT00437203|66378436|FG000|Overall Study|Death|0|||
23726644|NCT00437203|66378437|FG001|Overall Study|Death|0|||
23726645|NCT00437203|66378438|FG002|Overall Study|Death|1|||
23726646|NCT00437203|66378439|FG003|Overall Study|Death|0|||
23726647|NCT00437203|66378440|FG004|Overall Study|Death|0|||
23726648|NCT00437203|66378441|FG005|Overall Study|Death|0|||
23726649|NCT00437203|66378442|FG006|Overall Study|Death|0|||
23726650|NCT00437203|66378443|FG007|Overall Study|Death|1|||
23726651|NCT00437203|66378444|FG008|Overall Study|Death|0|||
23726652|NCT00437203|66378445|FG009|Overall Study|Death|1|||
23726653|NCT00437203|66378436|FG000|Overall Study|Adverse Event|1|||
23726654|NCT00437203|66378437|FG001|Overall Study|Adverse Event|1|||
23726655|NCT00437203|66378438|FG002|Overall Study|Adverse Event|0|||
23726656|NCT00437203|66378439|FG003|Overall Study|Adverse Event|0|||
23726657|NCT00437203|66378440|FG004|Overall Study|Adverse Event|0|||
23726658|NCT00437203|66378441|FG005|Overall Study|Adverse Event|0|||
23726659|NCT00437203|66378442|FG006|Overall Study|Adverse Event|0|||
23726660|NCT00437203|66378443|FG007|Overall Study|Adverse Event|1|||
23726661|NCT00437203|66378444|FG008|Overall Study|Adverse Event|0|||
23726662|NCT00437203|66378445|FG009|Overall Study|Adverse Event|1|||
23726663|NCT00437203|66378436|FG000|Overall Study|Study terminated by sponsor|0|||
23726664|NCT00437203|66378437|FG001|Overall Study|Study terminated by sponsor|0|||
23726665|NCT00437203|66378438|FG002|Overall Study|Study terminated by sponsor|0|||
23726666|NCT00437203|66378439|FG003|Overall Study|Study terminated by sponsor|0|||
23726667|NCT00437203|66378440|FG004|Overall Study|Study terminated by sponsor|0|||
23726668|NCT00437203|66378441|FG005|Overall Study|Study terminated by sponsor|0|||
23726669|NCT00437203|66378442|FG006|Overall Study|Study terminated by sponsor|0|||
23726670|NCT00437203|66378443|FG007|Overall Study|Study terminated by sponsor|0|||
23726671|NCT00437203|66378444|FG008|Overall Study|Study terminated by sponsor|1|||
23726672|NCT00437203|66378445|FG009|Overall Study|Study terminated by sponsor|0|||
23726673|NCT00437203|66378436|FG000|Overall Study|Objective progression or relapse|5|||
23726674|NCT00437203|66378437|FG001|Overall Study|Objective progression or relapse|6|||
23726675|NCT00437203|66378438|FG002|Overall Study|Objective progression or relapse|2|||
23726676|NCT00437203|66378439|FG003|Overall Study|Objective progression or relapse|3|||
23726677|NCT00437203|66378440|FG004|Overall Study|Objective progression or relapse|3|||
23726678|NCT00437203|66378441|FG005|Overall Study|Objective progression or relapse|3|||
23726679|NCT00437203|66378442|FG006|Overall Study|Objective progression or relapse|6|||
23726680|NCT00437203|66378443|FG007|Overall Study|Objective progression or relapse|1|||
23726681|NCT00437203|66378444|FG008|Overall Study|Objective progression or relapse|2|||
23726682|NCT00437203|66378445|FG009|Overall Study|Objective progression or relapse|2|||
23726683|NCT00437203|66378436|FG000|Overall Study|Other|0|||
23726684|NCT00437203|66378437|FG001|Overall Study|Other|1|||
23726685|NCT00437203|66378438|FG002|Overall Study|Other|0|||
23726686|NCT00437203|66378439|FG003|Overall Study|Other|0|||
23726687|NCT00437203|66378440|FG004|Overall Study|Other|0|||
23726688|NCT00437203|66378441|FG005|Overall Study|Other|0|||
23726689|NCT00437203|66378442|FG006|Overall Study|Other|1|||
23726690|NCT00437203|66378443|FG007|Overall Study|Other|0|||
23726691|NCT00437203|66378444|FG008|Overall Study|Other|0|||
23726692|NCT00437203|66378445|FG009|Overall Study|Other|0|||
23726693|NCT00887068|66378454|FG000|Overall Study|Withdrawal by Subject|2|||
23726694|NCT00887068|66378455|FG001|Overall Study|Withdrawal by Subject|0|||
23726695|NCT00887068|66378454|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
23726696|NCT00887068|66378455|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
23726697|NCT04897594|66378456|FG000|Overall Study|Lost to Follow-up|0|||
23726698|NCT04897594|66378457|FG001|Overall Study|Lost to Follow-up|1|||
23726699|NCT04897594|66378458|FG002|Overall Study|Lost to Follow-up|1|||
23726700|NCT04897594|66378456|FG000|Overall Study|Sponsor Decision|0|||
23726701|NCT04897594|66378457|FG001|Overall Study|Sponsor Decision|0|||
23726702|NCT04897594|66378458|FG002|Overall Study|Sponsor Decision|1|||
23726703|NCT04897594|66378456|FG000|Overall Study|Withdrawal by Subject|1|||
23726704|NCT04897594|66378457|FG001|Overall Study|Withdrawal by Subject|0|||
23726705|NCT04897594|66378458|FG002|Overall Study|Withdrawal by Subject|1|||
23726706|NCT01826448|66378462|FG000|Overall Study|Adverse Event|1|||
23726707|NCT01826448|66378463|FG001|Overall Study|Adverse Event|3|||
23726708|NCT01826448|66378462|FG000|Overall Study|Disease progression|2|||
23726709|NCT01826448|66378463|FG001|Overall Study|Disease progression|4|||
23726710|NCT01826448|66378462|FG000|Overall Study|Withdrawal by Subject|1|||
23726711|NCT01826448|66378463|FG001|Overall Study|Withdrawal by Subject|0|||
23726712|NCT01826448|66378462|FG000|Overall Study|Physician Decision|0|||
23726713|NCT01826448|66378463|FG001|Overall Study|Physician Decision|1|||
23726714|NCT01826448|66378462|FG000|Overall Study|2 active cancers|0|||
23726715|NCT01826448|66378463|FG001|Overall Study|2 active cancers|1|||
23726716|NCT04728815|66378466|FG000|Overall Study|Lost to Follow-up|3|||
23726717|NCT04728815|66378467|FG001|Overall Study|Lost to Follow-up|0|||
23726718|NCT04728815|66378468|FG002|Overall Study|Lost to Follow-up|0|||
23726719|NCT04728815|66378469|FG003|Overall Study|Lost to Follow-up|1|||
23726720|NCT04728815|66378470|FG004|Overall Study|Lost to Follow-up|1|||
23726721|NCT04728815|66378471|FG005|Overall Study|Lost to Follow-up|0|||
23726722|NCT04728815|66378472|FG006|Overall Study|Lost to Follow-up|2|||
23726723|NCT04728815|66378473|FG007|Overall Study|Lost to Follow-up|0|||
23726724|NCT04728815|66378466|FG000|Overall Study|Physician Decision|0|||
23726725|NCT04728815|66378467|FG001|Overall Study|Physician Decision|0|||
23726726|NCT04728815|66378468|FG002|Overall Study|Physician Decision|1|||
23726727|NCT04728815|66378469|FG003|Overall Study|Physician Decision|0|||
23726728|NCT04728815|66378470|FG004|Overall Study|Physician Decision|0|||
23726729|NCT04728815|66378471|FG005|Overall Study|Physician Decision|0|||
23726730|NCT04728815|66378472|FG006|Overall Study|Physician Decision|0|||
23726731|NCT04728815|66378473|FG007|Overall Study|Physician Decision|0|||
23726732|NCT04728815|66378466|FG000|Overall Study|Treatment drop|0|||
23726733|NCT04728815|66378467|FG001|Overall Study|Treatment drop|2|||
23726734|NCT04728815|66378468|FG002|Overall Study|Treatment drop|1|||
23726735|NCT04728815|66378469|FG003|Overall Study|Treatment drop|0|||
23726736|NCT04728815|66378470|FG004|Overall Study|Treatment drop|3|||
23726737|NCT04728815|66378471|FG005|Overall Study|Treatment drop|1|||
23726738|NCT04728815|66378472|FG006|Overall Study|Treatment drop|3|||
23726739|NCT04728815|66378473|FG007|Overall Study|Treatment drop|0|||
23726740|NCT04728815|66378466|FG000|Overall Study|Study drop|0|||
23726741|NCT04728815|66378467|FG001|Overall Study|Study drop|3|||
23726742|NCT04728815|66378468|FG002|Overall Study|Study drop|3|||
23726743|NCT04728815|66378469|FG003|Overall Study|Study drop|0|||
23726744|NCT04728815|66378470|FG004|Overall Study|Study drop|0|||
23726745|NCT04728815|66378471|FG005|Overall Study|Study drop|0|||
23726746|NCT04728815|66378472|FG006|Overall Study|Study drop|7|||
23816574|NCT03058289|66708445|FG000|Overall Study|Physician Decision|1|||
23726747|NCT04728815|66378473|FG007|Overall Study|Study drop|0|||
23726748|NCT00810043|66378474|FG000|Overall Study|Withdrawal by Subject|1|||
23726749|NCT00810043|66378475|FG001|Overall Study|Withdrawal by Subject|0|||
23726750|NCT00810043|66378476|FG002|Overall Study|Withdrawal by Subject|2|||
23726751|NCT00810043|66378474|FG000|Overall Study|Lost to Follow-up|1|||
23726752|NCT00810043|66378475|FG001|Overall Study|Lost to Follow-up|0|||
23726753|NCT00810043|66378476|FG002|Overall Study|Lost to Follow-up|0|||
23726754|NCT00810043|66378474|FG000|Overall Study|Physician Decision|0|||
23726755|NCT00810043|66378475|FG001|Overall Study|Physician Decision|0|||
23726756|NCT00810043|66378476|FG002|Overall Study|Physician Decision|2|||
23726757|NCT00810043|66378474|FG000|Overall Study|Death|2|||
23726758|NCT00810043|66378475|FG001|Overall Study|Death|0|||
23726759|NCT00810043|66378476|FG002|Overall Study|Death|0|||
23726760|NCT00810043|66378474|FG000|Overall Study|Unrelated medical problem|0|||
23726761|NCT00810043|66378475|FG001|Overall Study|Unrelated medical problem|1|||
23726762|NCT00810043|66378476|FG002|Overall Study|Unrelated medical problem|0|||
23726763|NCT00810043|66378474|FG000|Overall Study|Non-medical problem|0|||
23726764|NCT00810043|66378475|FG001|Overall Study|Non-medical problem|0|||
23726765|NCT00810043|66378476|FG002|Overall Study|Non-medical problem|1|||
23726766|NCT00810043|66378474|FG000|Overall Study|No longer met enrollment criteria|0|||
23726767|NCT00810043|66378475|FG001|Overall Study|No longer met enrollment criteria|0|||
23726768|NCT00810043|66378476|FG002|Overall Study|No longer met enrollment criteria|3|||
23726769|NCT03706040|66378479|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
23726770|NCT03706040|66378480|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
23726771|NCT03706040|66378481|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
23726772|NCT03706040|66378482|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
23726773|NCT03706040|66378483|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
23726774|NCT03706040|66378484|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
23726775|NCT03706040|66378485|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
23726776|NCT03706040|66378479|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
23726777|NCT03706040|66378480|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
23726778|NCT03706040|66378481|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
23726779|NCT03706040|66378482|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23726780|NCT03706040|66378483|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23726781|NCT03706040|66378484|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23726782|NCT03706040|66378485|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23726783|NCT03706040|66378479|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
23726784|NCT03706040|66378480|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
23726785|NCT03706040|66378481|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
23726786|NCT03706040|66378482|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23726787|NCT03706040|66378483|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23726788|NCT03706040|66378484|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23726789|NCT03706040|66378485|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23726790|NCT03706040|66378479|FG000|Period A (Week 0 to Week 16)|Other|2|||
23726791|NCT03706040|66378480|FG001|Period A (Week 0 to Week 16)|Other|0|||
23726792|NCT03706040|66378481|FG002|Period A (Week 0 to Week 16)|Other|2|||
23726793|NCT03706040|66378482|FG003|Period A (Week 0 to Week 16)|Other|0|||
23726794|NCT03706040|66378483|FG004|Period A (Week 0 to Week 16)|Other|0|||
23726795|NCT03706040|66378484|FG005|Period A (Week 0 to Week 16)|Other|0|||
23726796|NCT03706040|66378485|FG006|Period A (Week 0 to Week 16)|Other|0|||
23726797|NCT03706040|66378479|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
23726798|NCT03706040|66378480|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
23726799|NCT03706040|66378481|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
23726800|NCT03706040|66378482|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
23726801|NCT03706040|66378483|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
23726802|NCT03706040|66378484|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
23726803|NCT03706040|66378485|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
23726804|NCT03706040|66378479|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23726805|NCT03706040|66378480|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23726806|NCT03706040|66378481|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23726807|NCT03706040|66378482|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
23726808|NCT03706040|66378483|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
23726809|NCT03706040|66378484|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
23726810|NCT03706040|66378485|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
23726811|NCT03706040|66378479|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23726812|NCT03706040|66378480|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23726813|NCT03706040|66378481|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23726814|NCT03706040|66378482|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23726815|NCT03706040|66378483|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23540466|NCT01722331|65709213|FG001|Part 2|Withdrawal by Subject|0|||
23540467|NCT01722331|65709214|FG002|Part 2|Withdrawal by Subject|3|||
23540468|NCT01722331|65709215|FG003|Part 2|Withdrawal by Subject|0|||
23540469|NCT01722331|65709216|FG004|Part 2|Withdrawal by Subject|0|||
23540470|NCT01722331|65709217|FG005|Part 2|Withdrawal by Subject|2|||
23540471|NCT01722331|65709218|FG006|Part 2|Withdrawal by Subject|2|||
23616567|NCT00111839|65982368|FG002|Overall Study|Disease Progression|33|||
23726816|NCT03706040|66378484|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
23726817|NCT03706040|66378485|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
23726818|NCT03706040|66378479|FG000|Period B (Week 16 to Week 52)|Other|0|||
23726819|NCT03706040|66378480|FG001|Period B (Week 16 to Week 52)|Other|0|||
23726820|NCT03706040|66378481|FG002|Period B (Week 16 to Week 52)|Other|0|||
23726821|NCT03706040|66378482|FG003|Period B (Week 16 to Week 52)|Other|4|||
23726822|NCT03706040|66378483|FG004|Period B (Week 16 to Week 52)|Other|5|||
23726823|NCT03706040|66378484|FG005|Period B (Week 16 to Week 52)|Other|23|||
23726824|NCT03706040|66378485|FG006|Period B (Week 16 to Week 52)|Other|17|||
23726825|NCT01080625|66378486|FG000|Overall Study|Physician Decision|0|||
23726826|NCT01080625|66378487|FG001|Overall Study|Physician Decision|2|||
23726827|NCT01080625|66378488|FG002|Overall Study|Physician Decision|1|||
23726828|NCT02465489|66378491|FG000|Overall Study|Adverse Event|5|||
23726829|NCT01624467|66378492|FG000|Overall Study|Withdrawal by Subject|2|||
23726830|NCT01624467|66378492|FG000|Overall Study|Lost to Follow-up|1|||
23726831|NCT01624467|66378492|FG000|Overall Study|Adverse Event|7|||
23726832|NCT01624467|66378492|FG000|Overall Study|Progressive Disease|19|||
23726833|NCT01624467|66378492|FG000|Overall Study|Per Sponsor Requirement|1|||
23726834|NCT01624467|66378492|FG000|Overall Study|Subject Withdrew from Treatment|1|||
23726835|NCT01235507|66378493|FG000|Overall Study|Adverse Event|1|||
23726836|NCT01235507|66378493|FG000|Overall Study|Withdrawal by Subject|1|||
23726837|NCT00712270|66378494|FG000|Overall Study|Withdrawal by Subject|11|||
23726838|NCT00712270|66378494|FG000|Overall Study|Screen Failure|3|||
23726839|NCT02143141|66378495|FG000|Overall Study|pain scores at 24 hours not collected|1|||
23726840|NCT02143141|66378496|FG001|Overall Study|pain scores at 24 hours not collected|0|||
23726841|NCT01553591|66378499|FG000|Overall Study|Voluntarily withdrew|94|||
23726842|NCT01553591|66378500|FG001|Overall Study|Voluntarily withdrew|79|||
23726843|NCT01553591|66378501|FG002|Overall Study|Voluntarily withdrew|96|||
23726844|NCT01553591|66378499|FG000|Overall Study|Adverse Event|36|||
23726845|NCT01553591|66378500|FG001|Overall Study|Adverse Event|45|||
23726846|NCT01553591|66378501|FG002|Overall Study|Adverse Event|16|||
23726847|NCT01553591|66378499|FG000|Overall Study|Lost to Follow-up|25|||
23726848|NCT01553591|66378500|FG001|Overall Study|Lost to Follow-up|23|||
23726849|NCT01553591|66378501|FG002|Overall Study|Lost to Follow-up|16|||
23726850|NCT01553591|66378499|FG000|Overall Study|Physician decision: other|11|||
23726851|NCT01553591|66378500|FG001|Overall Study|Physician decision: other|14|||
23726852|NCT01553591|66378501|FG002|Overall Study|Physician decision: other|16|||
23726853|NCT01553591|66378499|FG000|Overall Study|Physician decision: lack of efficacy|2|||
23726854|NCT01553591|66378500|FG001|Overall Study|Physician decision: lack of efficacy|3|||
23726855|NCT01553591|66378501|FG002|Overall Study|Physician decision: lack of efficacy|7|||
23726856|NCT01553591|66378499|FG000|Overall Study|Protocol Violation|3|||
23726857|NCT01553591|66378500|FG001|Overall Study|Protocol Violation|4|||
23726858|NCT01553591|66378501|FG002|Overall Study|Protocol Violation|4|||
23726859|NCT01553591|66378499|FG000|Overall Study|Sponsor decision|1|||
23726860|NCT01553591|66378500|FG001|Overall Study|Sponsor decision|0|||
23726861|NCT01553591|66378501|FG002|Overall Study|Sponsor decision|3|||
23726862|NCT01553591|66378499|FG000|Overall Study|Randomized and never dispensed drug|0|||
23726863|NCT01553591|66378500|FG001|Overall Study|Randomized and never dispensed drug|1|||
23726864|NCT01553591|66378501|FG002|Overall Study|Randomized and never dispensed drug|0|||
23726865|NCT02903368|66378502|FG000|Part 1|Adverse Event|3|||
23726866|NCT02903368|66378503|FG001|Part 1|Adverse Event|0|||
23726867|NCT02903368|66378504|FG002|Part 1|Adverse Event|0|||
23726868|NCT02903368|66378505|FG003|Part 1|Adverse Event|0|||
23726869|NCT02903368|66378502|FG000|Part 1|Withdrawal by Subject|1|||
23726870|NCT02903368|66378503|FG001|Part 1|Withdrawal by Subject|0|||
23726871|NCT02903368|66378504|FG002|Part 1|Withdrawal by Subject|0|||
23726872|NCT02903368|66378505|FG003|Part 1|Withdrawal by Subject|0|||
23726873|NCT02903368|66378502|FG000|Part 2|Adverse Event|0|||
23726874|NCT02903368|66378503|FG001|Part 2|Adverse Event|0|||
23726875|NCT02903368|66378504|FG002|Part 2|Adverse Event|5|||
23726876|NCT02903368|66378505|FG003|Part 2|Adverse Event|0|||
23540472|NCT01722331|65709212|FG000|Part 2|Other Protocol Specified Criteria|6|||
23726877|NCT02903368|66378502|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23726878|NCT02903368|66378503|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23726879|NCT02903368|66378504|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
23540473|NCT01722331|65709213|FG001|Part 2|Other Protocol Specified Criteria|0|||
23726880|NCT02903368|66378505|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23726881|NCT02903368|66378502|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23726882|NCT02903368|66378503|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23726883|NCT02903368|66378504|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
23726884|NCT02903368|66378505|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23540474|NCT01722331|65709214|FG002|Part 2|Other Protocol Specified Criteria|10|||
23540475|NCT01722331|65709215|FG003|Part 2|Other Protocol Specified Criteria|0|||
23540476|NCT01722331|65709216|FG004|Part 2|Other Protocol Specified Criteria|0|||
23540477|NCT01722331|65709217|FG005|Part 2|Other Protocol Specified Criteria|2|||
23540478|NCT01722331|65709218|FG006|Part 2|Other Protocol Specified Criteria|1|||
23540479|NCT01722331|65709212|FG000|Part 3|Adverse Event|2|||
23540480|NCT01722331|65709213|FG001|Part 3|Adverse Event|2|||
23540481|NCT01722331|65709214|FG002|Part 3|Adverse Event|0|||
23540482|NCT01722331|65709215|FG003|Part 3|Adverse Event|1|||
23540483|NCT01722331|65709216|FG004|Part 3|Adverse Event|0|||
23540484|NCT01722331|65709217|FG005|Part 3|Adverse Event|0|||
23540485|NCT01722331|65709218|FG006|Part 3|Adverse Event|0|||
23540486|NCT01722331|65709212|FG000|Part 3|Death|1|||
23540487|NCT01722331|65709213|FG001|Part 3|Death|0|||
23616568|NCT00111839|65982366|FG000|Overall Study|Adverse Event|5|||
23616569|NCT00111839|65982367|FG001|Overall Study|Adverse Event|3|||
23616570|NCT00111839|65982368|FG002|Overall Study|Adverse Event|1|||
23616571|NCT00111839|65982366|FG000|Overall Study|Protocol Violation|2|||
23616572|NCT00111839|65982367|FG001|Overall Study|Protocol Violation|4|||
23616573|NCT00111839|65982368|FG002|Overall Study|Protocol Violation|2|||
23616574|NCT00111839|65982366|FG000|Overall Study|Death|1|||
23616575|NCT00111839|65982367|FG001|Overall Study|Death|1|||
23616576|NCT00111839|65982368|FG002|Overall Study|Death|6|||
23616577|NCT00111839|65982366|FG000|Overall Study|Withdrawal by Subject|2|||
23616578|NCT00111839|65982367|FG001|Overall Study|Withdrawal by Subject|2|||
23616579|NCT00111839|65982368|FG002|Overall Study|Withdrawal by Subject|2|||
23616580|NCT00111839|65982366|FG000|Overall Study|Lost to Follow-up|1|||
23616581|NCT00111839|65982367|FG001|Overall Study|Lost to Follow-up|0|||
23616582|NCT00111839|65982368|FG002|Overall Study|Lost to Follow-up|0|||
23616583|NCT00111839|65982366|FG000|Overall Study|Logistical Constraint|1|||
23616584|NCT00111839|65982367|FG001|Overall Study|Logistical Constraint|0|||
23616585|NCT00111839|65982368|FG002|Overall Study|Logistical Constraint|0|||
23616586|NCT00111839|65982366|FG000|Overall Study|Other|6|||
23616587|NCT00111839|65982367|FG001|Overall Study|Other|3|||
23616588|NCT00111839|65982368|FG002|Overall Study|Other|3|||
23616589|NCT00111839|65982366|FG000|Overall Study|Randomized but Not Treated|0|||
23616590|NCT00111839|65982367|FG001|Overall Study|Randomized but Not Treated|0|||
23616591|NCT00111839|65982368|FG002|Overall Study|Randomized but Not Treated|2|||
23616592|NCT00126555|65982370|FG000|Overall Study|Withdrawal by Subject|1|||
23616593|NCT00126555|65982370|FG000|Overall Study|Adverse Event|2|||
23616594|NCT00126555|65982370|FG000|Overall Study|Progressive Disease|3|||
23616595|NCT01190228|65982371|FG000|Overall Study|Protocol Violation|4|||
23616596|NCT01190228|65982372|FG001|Overall Study|Protocol Violation|0|||
23540488|NCT01722331|65709214|FG002|Part 3|Death|0|||
23540489|NCT01722331|65709215|FG003|Part 3|Death|0|||
23540490|NCT01722331|65709216|FG004|Part 3|Death|0|||
23540491|NCT01722331|65709217|FG005|Part 3|Death|0|||
23540492|NCT01722331|65709218|FG006|Part 3|Death|0|||
23540493|NCT01722331|65709212|FG000|Part 3|Lack of Efficacy|1|||
23616597|NCT01190228|65982373|FG002|Overall Study|Protocol Violation|0|||
23616598|NCT01190228|65982371|FG000|Overall Study|Withdrawal by Subject|1|||
23616599|NCT01190228|65982372|FG001|Overall Study|Withdrawal by Subject|0|||
23616600|NCT01190228|65982373|FG002|Overall Study|Withdrawal by Subject|0|||
23616601|NCT00509925|65982377|FG000|Overall Study|Personal reasons|0|||
23616602|NCT00509925|65982378|FG001|Overall Study|Personal reasons|1|||
23616603|NCT03722485|65982384|FG000|Overall Study|Withdrawal by Subject|1|||
23816575|NCT03058289|66708446|FG001|Overall Study|Physician Decision|0|||
23816576|NCT03058289|66708447|FG002|Overall Study|Physician Decision|0|||
23816577|NCT03058289|66708448|FG003|Overall Study|Physician Decision|2|||
23816578|NCT03058289|66708449|FG004|Overall Study|Physician Decision|1|||
23816579|NCT03058289|66708450|FG005|Overall Study|Physician Decision|0|||
23816580|NCT03058289|66708451|FG006|Overall Study|Physician Decision|2|||
23816581|NCT03058289|66708452|FG007|Overall Study|Physician Decision|3|||
23816582|NCT03058289|66708453|FG008|Overall Study|Physician Decision|0|||
23816583|NCT03058289|66708445|FG000|Overall Study|Clinical Deterioration|2|||
23816584|NCT03058289|66708446|FG001|Overall Study|Clinical Deterioration|0|||
23816585|NCT03058289|66708447|FG002|Overall Study|Clinical Deterioration|0|||
23816586|NCT03058289|66708448|FG003|Overall Study|Clinical Deterioration|2|||
23816587|NCT03058289|66708449|FG004|Overall Study|Clinical Deterioration|1|||
23816588|NCT03058289|66708450|FG005|Overall Study|Clinical Deterioration|1|||
23816589|NCT03058289|66708451|FG006|Overall Study|Clinical Deterioration|0|||
23816590|NCT03058289|66708452|FG007|Overall Study|Clinical Deterioration|3|||
23816591|NCT03058289|66708453|FG008|Overall Study|Clinical Deterioration|2|||
23816592|NCT03058289|66708445|FG000|Overall Study|Lost to Follow-up|0|||
23816593|NCT03058289|66708446|FG001|Overall Study|Lost to Follow-up|0|||
23816594|NCT03058289|66708447|FG002|Overall Study|Lost to Follow-up|0|||
23816595|NCT03058289|66708448|FG003|Overall Study|Lost to Follow-up|0|||
23816596|NCT03058289|66708449|FG004|Overall Study|Lost to Follow-up|1|||
23816597|NCT03058289|66708450|FG005|Overall Study|Lost to Follow-up|0|||
23816598|NCT03058289|66708451|FG006|Overall Study|Lost to Follow-up|0|||
23816599|NCT03058289|66708452|FG007|Overall Study|Lost to Follow-up|0|||
23816600|NCT03058289|66708453|FG008|Overall Study|Lost to Follow-up|0|||
23816601|NCT03058289|66708445|FG000|Overall Study|Refused Further Treatment|0|||
23816602|NCT03058289|66708446|FG001|Overall Study|Refused Further Treatment|0|||
23816603|NCT03058289|66708447|FG002|Overall Study|Refused Further Treatment|1|||
23816604|NCT03058289|66708448|FG003|Overall Study|Refused Further Treatment|0|||
23816605|NCT03058289|66708449|FG004|Overall Study|Refused Further Treatment|1|||
23424291|NCT03593681|65296446|FG000|Overall Study|Inadequate sample collected|12|||
23424292|NCT03593681|65296446|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
23726885|NCT02903368|66378502|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
23726886|NCT02903368|66378503|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
23726887|NCT02903368|66378504|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
23726888|NCT02903368|66378505|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
23424293|NCT03593681|65296446|FG000|Overall Study|Protocol Violation|3|||
23424294|NCT03593681|65296446|FG000|Overall Study|Withdrawal by Subject|3|||
23424295|NCT03593681|65296446|FG000|Overall Study|Procedure not attempted|3|||
23424296|NCT03593681|65296446|FG000|Overall Study|Adverse Event|2|||
23424297|NCT03593681|65296446|FG000|Overall Study|Physician Decision|1|||
23424298|NCT00394901|65296456|FG000|Baseline Phase|Protocol Violation|0|||
23424299|NCT00394901|65296457|FG001|Baseline Phase|Protocol Violation|0|||
23424300|NCT00394901|65296458|FG002|Baseline Phase|Protocol Violation|1|||
23424301|NCT00394901|65296459|FG003|Baseline Phase|Protocol Violation|0|||
23424302|NCT00394901|65296456|FG000|Double-blind Phase|Adverse Event|5|||
23424303|NCT00394901|65296457|FG001|Double-blind Phase|Adverse Event|7|||
23424304|NCT00394901|65296458|FG002|Double-blind Phase|Adverse Event|16|||
23424305|NCT00394901|65296459|FG003|Double-blind Phase|Adverse Event|20|||
23424306|NCT00394901|65296456|FG000|Double-blind Phase|Lack of Efficacy|6|||
23424307|NCT00394901|65296457|FG001|Double-blind Phase|Lack of Efficacy|4|||
23424308|NCT00394901|65296458|FG002|Double-blind Phase|Lack of Efficacy|1|||
23424309|NCT00394901|65296459|FG003|Double-blind Phase|Lack of Efficacy|3|||
23424310|NCT00394901|65296456|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23424311|NCT00394901|65296457|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23424312|NCT00394901|65296458|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23424313|NCT00394901|65296459|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23424314|NCT00394901|65296456|FG000|Double-blind Phase|Lost to Follow-up|0|||
23424315|NCT00394901|65296457|FG001|Double-blind Phase|Lost to Follow-up|0|||
23424316|NCT00394901|65296458|FG002|Double-blind Phase|Lost to Follow-up|0|||
23424317|NCT00394901|65296459|FG003|Double-blind Phase|Lost to Follow-up|1|||
23424318|NCT00394901|65296456|FG000|Double-blind Phase|Protocol Violation|0|||
23424319|NCT00394901|65296457|FG001|Double-blind Phase|Protocol Violation|0|||
23424320|NCT00394901|65296458|FG002|Double-blind Phase|Protocol Violation|0|||
23424321|NCT00394901|65296459|FG003|Double-blind Phase|Protocol Violation|1|||
23424322|NCT00394901|65296456|FG000|Double-blind Phase|Death|1|||
23424323|NCT00394901|65296457|FG001|Double-blind Phase|Death|0|||
23424324|NCT00394901|65296458|FG002|Double-blind Phase|Death|0|||
23540494|NCT01722331|65709213|FG001|Part 3|Lack of Efficacy|0|||
23540495|NCT01722331|65709214|FG002|Part 3|Lack of Efficacy|0|||
23540496|NCT01722331|65709215|FG003|Part 3|Lack of Efficacy|0|||
23540497|NCT01722331|65709216|FG004|Part 3|Lack of Efficacy|0|||
23540498|NCT01722331|65709217|FG005|Part 3|Lack of Efficacy|0|||
23540499|NCT01722331|65709218|FG006|Part 3|Lack of Efficacy|0|||
23540500|NCT01722331|65709212|FG000|Part 3|Lost to Follow-up|3|||
23540501|NCT01722331|65709213|FG001|Part 3|Lost to Follow-up|4|||
23540502|NCT01722331|65709214|FG002|Part 3|Lost to Follow-up|0|||
23540503|NCT01722331|65709215|FG003|Part 3|Lost to Follow-up|0|||
23540504|NCT01722331|65709216|FG004|Part 3|Lost to Follow-up|0|||
23540505|NCT01722331|65709217|FG005|Part 3|Lost to Follow-up|1|||
23540506|NCT01722331|65709218|FG006|Part 3|Lost to Follow-up|0|||
23616604|NCT03722485|65982385|FG001|Overall Study|Withdrawal by Subject|0|||
23616605|NCT03722485|65982384|FG000|Overall Study|Adverse Event|0|||
23616606|NCT03722485|65982385|FG001|Overall Study|Adverse Event|2|||
23616607|NCT03722485|65982384|FG000|Overall Study|subject discharged prior to study completion|1|||
23726889|NCT00918346|66378507|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
23424325|NCT00394901|65296459|FG003|Double-blind Phase|Death|0|||
23424326|NCT00394901|65296456|FG000|Double-blind Phase|Subject's Personal Reason|1|||
23424327|NCT00394901|65296457|FG001|Double-blind Phase|Subject's Personal Reason|0|||
23424328|NCT00394901|65296458|FG002|Double-blind Phase|Subject's Personal Reason|0|||
23424329|NCT00394901|65296459|FG003|Double-blind Phase|Subject's Personal Reason|1|||
23424330|NCT00394901|65296456|FG000|Double-blind Phase|Lack of Compliance|0|||
23424331|NCT00394901|65296457|FG001|Double-blind Phase|Lack of Compliance|3|||
23424332|NCT00394901|65296458|FG002|Double-blind Phase|Lack of Compliance|0|||
23540507|NCT01722331|65709212|FG000|Part 3|Non-Compliance with Study Drug|0|||
23540508|NCT01722331|65709213|FG001|Part 3|Non-Compliance with Study Drug|1|||
23540509|NCT01722331|65709214|FG002|Part 3|Non-Compliance with Study Drug|0|||
23540510|NCT01722331|65709215|FG003|Part 3|Non-Compliance with Study Drug|0|||
23616608|NCT03722485|65982385|FG001|Overall Study|subject discharged prior to study completion|5|||
23616609|NCT03722485|65982384|FG000|Overall Study|eligibility criteria not met|2|||
23616610|NCT03722485|65982385|FG001|Overall Study|eligibility criteria not met|0|||
23616621|NCT01757171|65982388|FG000|Overall Study|Adverse Event|5|||
23616622|NCT01757171|65982389|FG001|Overall Study|Adverse Event|1|||
23616623|NCT01757171|65982388|FG000|Overall Study|Disease Progression|1|||
23616624|NCT01757171|65982389|FG001|Overall Study|Disease Progression|0|||
23616625|NCT01757171|65982388|FG000|Overall Study|Hospitalization|1|||
23616626|NCT01757171|65982389|FG001|Overall Study|Hospitalization|0|||
23616627|NCT01757171|65982388|FG000|Overall Study|ECOG decline|1|||
23616628|NCT01757171|65982389|FG001|Overall Study|ECOG decline|0|||
23616629|NCT05135156|65982392|FG000|Overall Study|Lost to Follow-up|0|||
23616630|NCT05135156|65982393|FG001|Overall Study|Lost to Follow-up|0|||
23616631|NCT05135156|65982394|FG002|Overall Study|Lost to Follow-up|2|||
23616632|NCT01901302|65982396|FG000|Overall Study|Adverse Event|2|||
23616633|NCT01901302|65982397|FG001|Overall Study|Adverse Event|1|||
23616634|NCT01901302|65982396|FG000|Overall Study|Lack of Efficacy|0|||
23616635|NCT01901302|65982397|FG001|Overall Study|Lack of Efficacy|2|||
23616636|NCT01901302|65982396|FG000|Overall Study|Study Terminated by Sponsor|23|||
23616637|NCT01901302|65982397|FG001|Overall Study|Study Terminated by Sponsor|20|||
23616638|NCT01901302|65982396|FG000|Overall Study|Withdrawal by Subject|2|||
23616639|NCT01901302|65982397|FG001|Overall Study|Withdrawal by Subject|0|||
23616640|NCT01945593|65982398|FG000|Overall Study|Adverse Event|0|||
23616641|NCT01945593|65982399|FG001|Overall Study|Adverse Event|0|||
23616642|NCT01945593|65982400|FG002|Overall Study|Adverse Event|0|||
23616643|NCT01945593|65982401|FG003|Overall Study|Adverse Event|5|||
23616644|NCT01945593|65982398|FG000|Overall Study|Physician Decision|0|||
23616645|NCT01945593|65982399|FG001|Overall Study|Physician Decision|0|||
23616646|NCT01945593|65982400|FG002|Overall Study|Physician Decision|1|||
23816606|NCT03058289|66708450|FG005|Overall Study|Refused Further Treatment|0|||
23816607|NCT03058289|66708451|FG006|Overall Study|Refused Further Treatment|0|||
23816608|NCT03058289|66708452|FG007|Overall Study|Refused Further Treatment|0|||
23816609|NCT03058289|66708453|FG008|Overall Study|Refused Further Treatment|0|||
23816610|NCT03058289|66708445|FG000|Overall Study|Rapid Progression of Disease|0|||
23816611|NCT03058289|66708446|FG001|Overall Study|Rapid Progression of Disease|0|||
23816612|NCT03058289|66708447|FG002|Overall Study|Rapid Progression of Disease|0|||
23816613|NCT03058289|66708448|FG003|Overall Study|Rapid Progression of Disease|1|||
23816614|NCT03058289|66708449|FG004|Overall Study|Rapid Progression of Disease|0|||
23816615|NCT03058289|66708450|FG005|Overall Study|Rapid Progression of Disease|0|||
23816616|NCT03058289|66708451|FG006|Overall Study|Rapid Progression of Disease|0|||
23816617|NCT03058289|66708452|FG007|Overall Study|Rapid Progression of Disease|0|||
23816618|NCT03058289|66708453|FG008|Overall Study|Rapid Progression of Disease|0|||
23816619|NCT01778686|66708454|FG000|Overall Study|Adverse Event|0|||
23816620|NCT01778686|66708455|FG001|Overall Study|Adverse Event|0|||
23816621|NCT01778686|66708456|FG002|Overall Study|Adverse Event|1|||
23816622|NCT03207243|66708470|FG000|Overall Study|Adverse Event|2|||
23816623|NCT03207243|66708471|FG001|Overall Study|Adverse Event|2|||
23816624|NCT03207243|66708470|FG000|Overall Study|Loss of Asthma Control|47|||
23816625|NCT03207243|66708471|FG001|Overall Study|Loss of Asthma Control|31|||
23616647|NCT01945593|65982401|FG003|Overall Study|Physician Decision|1|||
23616648|NCT01945593|65982398|FG000|Overall Study|Withdrawal by Subject|0|||
23616649|NCT01945593|65982399|FG001|Overall Study|Withdrawal by Subject|2|||
23616650|NCT01945593|65982400|FG002|Overall Study|Withdrawal by Subject|0|||
23616651|NCT01945593|65982401|FG003|Overall Study|Withdrawal by Subject|4|||
23616652|NCT01945593|65982398|FG000|Overall Study|Protocol Violation|0|||
23616653|NCT01945593|65982399|FG001|Overall Study|Protocol Violation|2|||
23616654|NCT01945593|65982400|FG002|Overall Study|Protocol Violation|1|||
23616655|NCT01945593|65982401|FG003|Overall Study|Protocol Violation|3|||
23816626|NCT03207243|66708470|FG000|Overall Study|Withdrawal by Subject|2|||
23816627|NCT03207243|66708471|FG001|Overall Study|Withdrawal by Subject|4|||
23816628|NCT03207243|66708470|FG000|Overall Study|Physician Decision|1|||
23816629|NCT03207243|66708471|FG001|Overall Study|Physician Decision|1|||
23816630|NCT03207243|66708470|FG000|Overall Study|Lost to Follow-up|0|||
23816631|NCT03207243|66708471|FG001|Overall Study|Lost to Follow-up|1|||
23816632|NCT03207243|66708470|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
23816633|NCT03207243|66708471|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
23816634|NCT03207243|66708470|FG000|Overall Study|Protocol Violation|0|||
23816635|NCT03207243|66708471|FG001|Overall Study|Protocol Violation|3|||
23816636|NCT04241315|66708472|FG000|Overall Study|Withdrawal by Subject|0|||
23816637|NCT04241315|66708473|FG001|Overall Study|Withdrawal by Subject|1|||
23816638|NCT00492024|66708474|FG000|Treatment|Adverse Event|3|||
23816639|NCT00492024|66708475|FG001|Treatment|Adverse Event|1|||
23816640|NCT00492024|66708474|FG000|Treatment|Lack of Efficacy|21|||
23816641|NCT00492024|66708475|FG001|Treatment|Lack of Efficacy|20|||
23816642|NCT00492024|66708474|FG000|Treatment|Lost to Follow-up|3|||
23816643|NCT00492024|66708475|FG001|Treatment|Lost to Follow-up|1|||
23816644|NCT00492024|66708474|FG000|Treatment|Withdrawal by Subject|2|||
23816645|NCT00492024|66708475|FG001|Treatment|Withdrawal by Subject|0|||
23816646|NCT00492024|66708474|FG000|Follow up|Lack of Efficacy|0|||
23816647|NCT00492024|66708475|FG001|Follow up|Lack of Efficacy|1|||
23816648|NCT00492024|66708474|FG000|Follow up|Lost to Follow-up|1|||
23816649|NCT00492024|66708475|FG001|Follow up|Lost to Follow-up|1|||
23816650|NCT01006135|66708476|FG000|Overall Study|Adverse Event|22|||
23816651|NCT01006135|66708476|FG000|Overall Study|Protocol Violation|14|||
23816652|NCT01006135|66708476|FG000|Overall Study|Lost to Follow-up|32|||
23816653|NCT01006135|66708476|FG000|Overall Study|Other|72|||
23816654|NCT00824616|66708477|FG000|Overall Study|Adverse Event|2|||
23816655|NCT00824616|66708478|FG001|Overall Study|Adverse Event|1|||
23816656|NCT00824616|66708477|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
23816657|NCT00824616|66708478|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
23816658|NCT00824616|66708477|FG000|Overall Study|Hyperglycemia|1|||
23816659|NCT00824616|66708478|FG001|Overall Study|Hyperglycemia|1|||
23816660|NCT00824616|66708477|FG000|Overall Study|Lack of Efficacy|2|||
23816661|NCT00824616|66708478|FG001|Overall Study|Lack of Efficacy|1|||
23816662|NCT00824616|66708477|FG000|Overall Study|Lost to Follow-up|0|||
23816663|NCT00824616|66708478|FG001|Overall Study|Lost to Follow-up|1|||
23816664|NCT00824616|66708477|FG000|Overall Study|Withdrawal by Subject|1|||
23816665|NCT00824616|66708478|FG001|Overall Study|Withdrawal by Subject|1|||
23816666|NCT05199090|66708480|FG000|Overall Study|Adverse Event|1|||
23816667|NCT05199090|66708481|FG001|Overall Study|Adverse Event|4|||
23816668|NCT05199090|66708482|FG002|Overall Study|Adverse Event|0|||
23816669|NCT05199090|66708483|FG003|Overall Study|Adverse Event|0|||
23816670|NCT05199090|66708484|FG004|Overall Study|Adverse Event|0|||
23816671|NCT05199090|66708485|FG005|Overall Study|Adverse Event|0|||
23816672|NCT05199090|66708480|FG000|Overall Study|Lost to Follow-up|1|||
23816673|NCT05199090|66708481|FG001|Overall Study|Lost to Follow-up|0|||
23816674|NCT05199090|66708482|FG002|Overall Study|Lost to Follow-up|1|||
23816675|NCT05199090|66708483|FG003|Overall Study|Lost to Follow-up|4|||
23816676|NCT05199090|66708484|FG004|Overall Study|Lost to Follow-up|0|||
23816677|NCT05199090|66708485|FG005|Overall Study|Lost to Follow-up|5|||
23816678|NCT05199090|66708480|FG000|Overall Study|Physician Decision|0|||
23816679|NCT05199090|66708481|FG001|Overall Study|Physician Decision|0|||
23816680|NCT05199090|66708482|FG002|Overall Study|Physician Decision|0|||
23816681|NCT05199090|66708483|FG003|Overall Study|Physician Decision|0|||
23816682|NCT05199090|66708484|FG004|Overall Study|Physician Decision|0|||
23816683|NCT05199090|66708485|FG005|Overall Study|Physician Decision|1|||
23816684|NCT05199090|66708480|FG000|Overall Study|Study terminated by sponsor|0|||
23816685|NCT05199090|66708481|FG001|Overall Study|Study terminated by sponsor|6|||
23816686|NCT05199090|66708482|FG002|Overall Study|Study terminated by sponsor|0|||
23816687|NCT05199090|66708483|FG003|Overall Study|Study terminated by sponsor|0|||
23816688|NCT05199090|66708484|FG004|Overall Study|Study terminated by sponsor|0|||
23816689|NCT05199090|66708485|FG005|Overall Study|Study terminated by sponsor|5|||
23816690|NCT05199090|66708480|FG000|Overall Study|Subject decision|0|||
23816691|NCT05199090|66708481|FG001|Overall Study|Subject decision|4|||
23816692|NCT05199090|66708482|FG002|Overall Study|Subject decision|0|||
23816693|NCT05199090|66708483|FG003|Overall Study|Subject decision|2|||
23816694|NCT05199090|66708484|FG004|Overall Study|Subject decision|5|||
23816695|NCT05199090|66708485|FG005|Overall Study|Subject decision|2|||
23816696|NCT03167723|66708487|FG000|Overall Study|Protocol Violation|4|||
23816697|NCT03167723|66708488|FG001|Overall Study|Protocol Violation|6|||
23816698|NCT00919854|66708491|FG000|Overall Study|Adverse Event|1|||
23816699|NCT01421511|66708492|FG000|Overall Study|Lost to Follow-up|11|||
23816700|NCT01421511|66708493|FG001|Overall Study|Lost to Follow-up|14|||
23816701|NCT01421511|66708492|FG000|Overall Study|Randomized but didn't receive study drug|1|||
23816702|NCT01421511|66708493|FG001|Overall Study|Randomized but didn't receive study drug|7|||
23816703|NCT01421511|66708492|FG000|Overall Study|Physician Decision|0|||
23816704|NCT01421511|66708493|FG001|Overall Study|Physician Decision|1|||
23816705|NCT01421511|66708492|FG000|Overall Study|Withdrawal by Subject|6|||
23816706|NCT01421511|66708493|FG001|Overall Study|Withdrawal by Subject|5|||
23816707|NCT01421511|66708492|FG000|Overall Study|Death|1|||
23816708|NCT01421511|66708493|FG001|Overall Study|Death|1|||
23816709|NCT00168818|66708494|FG000|Overall Study|Adverse Event|23|||
23816710|NCT00168818|66708495|FG001|Overall Study|Adverse Event|29|||
23816711|NCT00168818|66708496|FG002|Overall Study|Adverse Event|31|||
23816712|NCT00168818|66708494|FG000|Overall Study|Protocol Violation|16|||
23816713|NCT00168818|66708495|FG001|Overall Study|Protocol Violation|11|||
23816714|NCT00168818|66708496|FG002|Overall Study|Protocol Violation|11|||
23816715|NCT00168818|66708494|FG000|Overall Study|Lost to Follow-up|13|||
23816716|NCT00168818|66708495|FG001|Overall Study|Lost to Follow-up|4|||
23816717|NCT00168818|66708496|FG002|Overall Study|Lost to Follow-up|15|||
23816718|NCT00168818|66708494|FG000|Overall Study|Withdrawal by Subject|43|||
23816719|NCT00168818|66708495|FG001|Overall Study|Withdrawal by Subject|41|||
23816720|NCT00168818|66708496|FG002|Overall Study|Withdrawal by Subject|37|||
23816721|NCT00168818|66708494|FG000|Overall Study|Other|22|||
23816722|NCT00168818|66708495|FG001|Overall Study|Other|24|||
23816723|NCT00168818|66708496|FG002|Overall Study|Other|30|||
23816724|NCT00168818|66708494|FG000|Treatment|Adverse Event|77|||
23816725|NCT00168818|66708495|FG001|Treatment|Adverse Event|89|||
23816726|NCT00168818|66708496|FG002|Treatment|Adverse Event|68|||
23816727|NCT00168818|66708494|FG000|Treatment|Protocol Violation|8|||
23816728|NCT00168818|66708495|FG001|Treatment|Protocol Violation|11|||
23816729|NCT00168818|66708496|FG002|Treatment|Protocol Violation|11|||
23816730|NCT00168818|66708494|FG000|Treatment|Lost to Follow-up|0|||
23816731|NCT00168818|66708495|FG001|Treatment|Lost to Follow-up|2|||
23816732|NCT00168818|66708496|FG002|Treatment|Lost to Follow-up|1|||
23424333|NCT00394901|65296459|FG003|Double-blind Phase|Lack of Compliance|0|||
23424334|NCT00394901|65296456|FG000|Double-blind Phase|Entry into another study was found|0|||
23424335|NCT00394901|65296457|FG001|Double-blind Phase|Entry into another study was found|0|||
23424336|NCT00394901|65296458|FG002|Double-blind Phase|Entry into another study was found|1|||
23424337|NCT00394901|65296459|FG003|Double-blind Phase|Entry into another study was found|0|||
23424338|NCT00394901|65296456|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
23540511|NCT01722331|65709216|FG004|Part 3|Non-Compliance with Study Drug|0|||
23540512|NCT01722331|65709217|FG005|Part 3|Non-Compliance with Study Drug|0|||
23540513|NCT01722331|65709218|FG006|Part 3|Non-Compliance with Study Drug|0|||
23540514|NCT01722331|65709212|FG000|Part 3|Physician Decision|1|||
23424339|NCT00394901|65296457|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
23424340|NCT00394901|65296458|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
23424341|NCT00394901|65296459|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
23424342|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Death|4|||
23424343|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
23424344|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
23424345|NCT04224272|65296460|FG000|Part 2 - Dose Expansion|Death|10|||
23424346|NCT04224272|65296460|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
23424347|NCT01328041|65296465|FG000|Overall Study|Adverse Event|7|||
23424348|NCT01328041|65296465|FG000|Overall Study|Lack of Efficacy|27|||
23424349|NCT01328041|65296465|FG000|Overall Study|Protocol Violation|7|||
23424350|NCT01328041|65296465|FG000|Overall Study|Lost to Follow-up|7|||
23424351|NCT01328041|65296465|FG000|Overall Study|Physician Decision|2|||
23424352|NCT01328041|65296465|FG000|Overall Study|Withdrawal by Subject|7|||
23424353|NCT01969500|65296468|FG000|Overall Study|Death|0|||
23424354|NCT01969500|65296469|FG001|Overall Study|Death|1|||
23424355|NCT01969500|65296468|FG000|Overall Study|extended hospitalization|1|||
23424356|NCT01969500|65296469|FG001|Overall Study|extended hospitalization|1|||
23424357|NCT00888329|65296470|FG000|Overall Study|Physician Decision|6|||
23424358|NCT00888329|65296471|FG001|Overall Study|Physician Decision|9|||
23424359|NCT01028716|65296474|FG000|Overall Study|Physician Decision|1|||
23424360|NCT00645528|65296475|FG000|Overall Study|Did not show up for Visit 2|7|||
23540515|NCT01722331|65709213|FG001|Part 3|Physician Decision|1|||
23540516|NCT01722331|65709214|FG002|Part 3|Physician Decision|0|||
23540517|NCT01722331|65709215|FG003|Part 3|Physician Decision|0|||
23540518|NCT01722331|65709216|FG004|Part 3|Physician Decision|0|||
23540519|NCT01722331|65709217|FG005|Part 3|Physician Decision|0|||
23540520|NCT01722331|65709218|FG006|Part 3|Physician Decision|1|||
23540521|NCT01722331|65709212|FG000|Part 3|Protocol Violation|2|||
23540522|NCT01722331|65709213|FG001|Part 3|Protocol Violation|1|||
23816733|NCT00168818|66708494|FG000|Treatment|Withdrawal by Subject|25|||
23816734|NCT00168818|66708495|FG001|Treatment|Withdrawal by Subject|20|||
23816735|NCT00168818|66708496|FG002|Treatment|Withdrawal by Subject|22|||
23816736|NCT00168818|66708494|FG000|Treatment|Other|23|||
23424361|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23424362|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23540523|NCT01722331|65709214|FG002|Part 3|Protocol Violation|0|||
23540524|NCT01722331|65709215|FG003|Part 3|Protocol Violation|0|||
23816737|NCT00168818|66708495|FG001|Treatment|Other|29|||
23816738|NCT00168818|66708496|FG002|Treatment|Other|31|||
23540525|NCT01722331|65709216|FG004|Part 3|Protocol Violation|0|||
23540526|NCT01722331|65709217|FG005|Part 3|Protocol Violation|0|||
23816739|NCT04123561|66708497|FG000|Overall Study|Lost to Follow-up|20|||
23816740|NCT04123561|66708498|FG001|Overall Study|Lost to Follow-up|12|||
23424363|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
23540527|NCT01722331|65709218|FG006|Part 3|Protocol Violation|0|||
23540528|NCT01722331|65709212|FG000|Part 3|Withdrawal by Subject|4|||
23540529|NCT01722331|65709213|FG001|Part 3|Withdrawal by Subject|7|||
23540530|NCT01722331|65709214|FG002|Part 3|Withdrawal by Subject|0|||
23540531|NCT01722331|65709215|FG003|Part 3|Withdrawal by Subject|0|||
23540532|NCT01722331|65709216|FG004|Part 3|Withdrawal by Subject|0|||
23540533|NCT01722331|65709217|FG005|Part 3|Withdrawal by Subject|2|||
23540534|NCT01722331|65709218|FG006|Part 3|Withdrawal by Subject|1|||
23540535|NCT01722331|65709212|FG000|Part 3|Other Protocol Specified Criteria|1|||
23540536|NCT01722331|65709213|FG001|Part 3|Other Protocol Specified Criteria|1|||
23540537|NCT01722331|65709214|FG002|Part 3|Other Protocol Specified Criteria|0|||
23540538|NCT01722331|65709215|FG003|Part 3|Other Protocol Specified Criteria|0|||
23540539|NCT01722331|65709216|FG004|Part 3|Other Protocol Specified Criteria|0|||
23540540|NCT01722331|65709217|FG005|Part 3|Other Protocol Specified Criteria|0|||
23540541|NCT01722331|65709218|FG006|Part 3|Other Protocol Specified Criteria|0|||
23540542|NCT00346034|65709223|FG000|Overall Study|Adverse Event|34|||
23540543|NCT00346034|65709223|FG000|Overall Study|Lack of Efficacy|8|||
23540544|NCT00346034|65709223|FG000|Overall Study|Withdrawal by Subject|13|||
23540545|NCT00346034|65709223|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
23540546|NCT00346034|65709223|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
23726890|NCT00918346|66378508|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
23726891|NCT01117181|66378509|FG000|Overall Study|Lost to Follow-up|1|||
23424364|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23726892|NCT01117181|66378510|FG001|Overall Study|Lost to Follow-up|0|||
23424365|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23424366|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23424367|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
23424368|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23726893|NCT01117181|66378509|FG000|Overall Study|Withdrawal by Subject|0|||
23726894|NCT01117181|66378510|FG001|Overall Study|Withdrawal by Subject|2|||
23726895|NCT00010803|66378514|FG000|Overall Study|Withdrawal by Subject|97|||
23726896|NCT00010803|66378515|FG001|Overall Study|Withdrawal by Subject|98|||
23726897|NCT03807778|66378516|FG000|Overall Study|Adverse Event|0|||
23726898|NCT03807778|66378517|FG001|Overall Study|Adverse Event|0|||
23726899|NCT03807778|66378518|FG002|Overall Study|Adverse Event|3|||
23726900|NCT03807778|66378519|FG003|Overall Study|Adverse Event|5|||
23726901|NCT03807778|66378516|FG000|Overall Study|Progressive Disease|4|||
23726902|NCT03807778|66378517|FG001|Overall Study|Progressive Disease|2|||
23726903|NCT03807778|66378518|FG002|Overall Study|Progressive Disease|8|||
23726904|NCT03807778|66378519|FG003|Overall Study|Progressive Disease|15|||
23726905|NCT03807778|66378516|FG000|Overall Study|Symptomatic Deterioration|0|||
23726906|NCT03807778|66378517|FG001|Overall Study|Symptomatic Deterioration|1|||
23726907|NCT03807778|66378518|FG002|Overall Study|Symptomatic Deterioration|0|||
23726908|NCT03807778|66378519|FG003|Overall Study|Symptomatic Deterioration|1|||
23726909|NCT03807778|66378516|FG000|Overall Study|Withdrawal by Subject|0|||
23726910|NCT03807778|66378517|FG001|Overall Study|Withdrawal by Subject|1|||
23726911|NCT03807778|66378518|FG002|Overall Study|Withdrawal by Subject|0|||
23726912|NCT03807778|66378519|FG003|Overall Study|Withdrawal by Subject|1|||
23726913|NCT03807778|66378516|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
23726914|NCT03807778|66378517|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
23726915|NCT03807778|66378518|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
23726916|NCT03807778|66378519|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
23726917|NCT02475629|66378520|FG000|Overall Study|Adverse Event|1|||
23726918|NCT02475629|66378520|FG000|Overall Study|Death|4|||
23726919|NCT02475629|66378520|FG000|Overall Study|Physician Decision|1|||
23726920|NCT02475629|66378520|FG000|Overall Study|Withdrawal by Subject|1|||
23726921|NCT02475629|66378520|FG000|Overall Study|Lost to Follow-up|1|||
23726922|NCT02475629|66378520|FG000|Overall Study|Subject non-compliance|1|||
23726923|NCT02580591|66378521|FG000|Overall Study|Adverse Event|0|||
23726924|NCT02580591|66378522|FG001|Overall Study|Adverse Event|1|||
23726925|NCT02580591|66378523|FG002|Overall Study|Adverse Event|2|||
23726926|NCT02580591|66378524|FG003|Overall Study|Adverse Event|5|||
23726927|NCT02580591|66378521|FG000|Overall Study|Protocol Violation|3|||
23726928|NCT02580591|66378522|FG001|Overall Study|Protocol Violation|2|||
23726929|NCT02580591|66378523|FG002|Overall Study|Protocol Violation|1|||
23540547|NCT01046643|65709235|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23540548|NCT01046643|65709236|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
23540549|NCT01046643|65709237|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23816741|NCT04123561|66708499|FG002|Overall Study|Lost to Follow-up|5|||
23424369|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23540550|NCT01046643|65709238|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23726930|NCT02580591|66378524|FG003|Overall Study|Protocol Violation|1|||
23726931|NCT02580591|66378521|FG000|Overall Study|Lost to Follow-up|5|||
23726932|NCT02580591|66378522|FG001|Overall Study|Lost to Follow-up|3|||
23726933|NCT02580591|66378523|FG002|Overall Study|Lost to Follow-up|3|||
23726934|NCT02580591|66378524|FG003|Overall Study|Lost to Follow-up|1|||
23726935|NCT02580591|66378521|FG000|Overall Study|Withdrawal by Subject|6|||
23726936|NCT02580591|66378522|FG001|Overall Study|Withdrawal by Subject|1|||
23726937|NCT02580591|66378523|FG002|Overall Study|Withdrawal by Subject|2|||
23726938|NCT02580591|66378524|FG003|Overall Study|Withdrawal by Subject|3|||
23726939|NCT02580591|66378521|FG000|Overall Study|Not treated|1|||
23726940|NCT02580591|66378522|FG001|Overall Study|Not treated|1|||
23726941|NCT02580591|66378523|FG002|Overall Study|Not treated|0|||
23726942|NCT02580591|66378524|FG003|Overall Study|Not treated|0|||
23726943|NCT02580591|66378521|FG000|Overall Study|Other than specified|3|||
23726944|NCT02580591|66378522|FG001|Overall Study|Other than specified|2|||
23726945|NCT02580591|66378523|FG002|Overall Study|Other than specified|5|||
23726946|NCT02580591|66378524|FG003|Overall Study|Other than specified|2|||
23726947|NCT01249157|66378525|FG000|Overall Study|Withdrawal by Subject|1|||
23726948|NCT02971007|66378530|FG000|Overall Study|Adverse Event|1|||
23726949|NCT02971007|66378531|FG001|Overall Study|Adverse Event|0|||
23726950|NCT02971007|66378532|FG002|Overall Study|Adverse Event|0|||
23726951|NCT02971007|66378530|FG000|Overall Study|Lost to Follow-up|0|||
23726952|NCT02971007|66378531|FG001|Overall Study|Lost to Follow-up|1|||
23726953|NCT02971007|66378532|FG002|Overall Study|Lost to Follow-up|1|||
23726954|NCT02971007|66378530|FG000|Overall Study|Withdrawal by Subject|0|||
23726955|NCT02971007|66378531|FG001|Overall Study|Withdrawal by Subject|1|||
23726956|NCT02971007|66378532|FG002|Overall Study|Withdrawal by Subject|0|||
23726957|NCT02971007|66378530|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
23726958|NCT02971007|66378531|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
23726959|NCT02971007|66378532|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
23726960|NCT02971007|66378530|FG000|Overall Study|Patient discontinued study drug|0|||
23726961|NCT02971007|66378531|FG001|Overall Study|Patient discontinued study drug|1|||
23726962|NCT02971007|66378532|FG002|Overall Study|Patient discontinued study drug|0|||
23726963|NCT01838213|66378533|FG000|Overall Study|Ineligible|166|||
23726964|NCT01838213|66378534|FG001|Overall Study|Ineligible|191|||
23726965|NCT04159701|66378535|FG000|Period 1: Treatment Period|Pregnancy|1|||
23726966|NCT04159701|66378536|FG001|Period 1: Treatment Period|Pregnancy|0|||
23726967|NCT04159701|66378535|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
23726968|NCT04159701|66378536|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
23726969|NCT04159701|66378535|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
23726970|NCT04159701|66378536|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
23726971|NCT04159701|66378535|FG000|Washout Period|site terminated by sponsor|0|||
23726972|NCT04159701|66378536|FG001|Washout Period|site terminated by sponsor|1|||
23726973|NCT04159701|66378535|FG000|Washout Period|study terminated by sponsor|10|||
23726974|NCT04159701|66378536|FG001|Washout Period|study terminated by sponsor|3|||
23726975|NCT04159701|66378535|FG000|Washout Period|Withdrawal by Subject|1|||
23726976|NCT04159701|66378536|FG001|Washout Period|Withdrawal by Subject|0|||
23726977|NCT04159701|66378535|FG000|Washout Period|Inadvertent Enrollment|1|||
23726978|NCT04159701|66378536|FG001|Washout Period|Inadvertent Enrollment|0|||
23726979|NCT04159701|66378535|FG000|Washout Period|Miscellaneous|1|||
23726980|NCT04159701|66378536|FG001|Washout Period|Miscellaneous|0|||
23726981|NCT04159701|66378535|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
23726982|NCT04159701|66378536|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
23726983|NCT04159701|66378535|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
23726984|NCT04159701|66378536|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
23726985|NCT04159701|66378535|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
23726986|NCT04159701|66378536|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
23726987|NCT04159701|66378535|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
23726988|NCT04159701|66378536|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
23726989|NCT04159701|66378535|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
23726990|NCT04159701|66378536|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
23726991|NCT04847141|66378542|FG000|Overall Study|Adverse Event|1|||
23726992|NCT04847141|66378543|FG001|Overall Study|Adverse Event|0|||
23726993|NCT04847141|66378544|FG002|Overall Study|Adverse Event|1|||
23726994|NCT04847141|66378542|FG000|Overall Study|Withdrawal by Subject|2|||
23726995|NCT04847141|66378543|FG001|Overall Study|Withdrawal by Subject|4|||
23726996|NCT04847141|66378544|FG002|Overall Study|Withdrawal by Subject|3|||
23726997|NCT04847141|66378542|FG000|Overall Study|Lost to Follow-up|7|||
23726998|NCT04847141|66378543|FG001|Overall Study|Lost to Follow-up|5|||
23726999|NCT04847141|66378544|FG002|Overall Study|Lost to Follow-up|7|||
23727000|NCT04847141|66378542|FG000|Overall Study|Reason not Specified|0|||
23727001|NCT04847141|66378543|FG001|Overall Study|Reason not Specified|1|||
23727002|NCT04847141|66378544|FG002|Overall Study|Reason not Specified|0|||
23727003|NCT00415623|66378545|FG000|Overall Study|Adverse Event|3|||
23540551|NCT00466193|65709242|FG000|Overall Study|Adverse Event|0|||
23727004|NCT00415623|66378546|FG001|Overall Study|Adverse Event|4|||
23727005|NCT00415623|66378545|FG000|Overall Study|Death|1|||
23727006|NCT00415623|66378546|FG001|Overall Study|Death|0|||
23727007|NCT00415623|66378545|FG000|Overall Study|Withdrawal by Subject|1|||
23727008|NCT00415623|66378546|FG001|Overall Study|Withdrawal by Subject|1|||
23727009|NCT02910089|66378550|FG000|Overall Study|Lost insurance eligibility|22|||
23727010|NCT02910089|66378551|FG001|Overall Study|Lost insurance eligibility|16|||
23727011|NCT00126672|66378552|FG000|Overall Study|Adverse Event|4|||
23727012|NCT00126672|66378552|FG000|Overall Study|Lost to Follow-up|4|||
23727013|NCT00981682|66378553|FG000|Overall Study|Adverse Event|48|||
23727014|NCT00981682|66378553|FG000|Overall Study|Withdrawal by Subject|52|||
23727015|NCT00981682|66378553|FG000|Overall Study|Lost to Follow-up|14|||
23727016|NCT00981682|66378553|FG000|Overall Study|Lack of Efficacy|13|||
23727017|NCT00981682|66378553|FG000|Overall Study|Protocol Violation|6|||
23727018|NCT00981682|66378553|FG000|Overall Study|administrative|9|||
23727019|NCT02959190|66378554|FG000|Open Label|Adverse Event|5|||
23727020|NCT02959190|66378555|FG001|Open Label|Adverse Event|7|||
23727021|NCT02959190|66378556|FG002|Open Label|Adverse Event|3|||
23727022|NCT02959190|66378557|FG003|Open Label|Adverse Event|4|||
23727023|NCT02959190|66378554|FG000|Open Label|Pregnancy|0|||
23727024|NCT02959190|66378555|FG001|Open Label|Pregnancy|1|||
23727025|NCT02959190|66378556|FG002|Open Label|Pregnancy|0|||
23727026|NCT02959190|66378557|FG003|Open Label|Pregnancy|0|||
23727027|NCT02959190|66378554|FG000|Open Label|Withdrawal by Subject|2|||
23727028|NCT02959190|66378555|FG001|Open Label|Withdrawal by Subject|8|||
23727029|NCT02959190|66378556|FG002|Open Label|Withdrawal by Subject|0|||
23727030|NCT02959190|66378557|FG003|Open Label|Withdrawal by Subject|0|||
23727031|NCT02959190|66378554|FG000|Open Label|Physician Decision|0|||
23727032|NCT02959190|66378555|FG001|Open Label|Physician Decision|0|||
23727033|NCT02959190|66378556|FG002|Open Label|Physician Decision|1|||
23727034|NCT02959190|66378557|FG003|Open Label|Physician Decision|0|||
23727035|NCT02959190|66378554|FG000|Open Label|Protocol Violation|0|||
23727036|NCT02959190|66378555|FG001|Open Label|Protocol Violation|0|||
23727037|NCT02959190|66378556|FG002|Open Label|Protocol Violation|0|||
23727038|NCT02959190|66378557|FG003|Open Label|Protocol Violation|2|||
23727039|NCT02959190|66378554|FG000|Post Treatment Follow Up|Adverse Event|1|||
23727040|NCT02959190|66378555|FG001|Post Treatment Follow Up|Adverse Event|1|||
23727041|NCT02959190|66378556|FG002|Post Treatment Follow Up|Adverse Event|0|||
23727042|NCT02959190|66378557|FG003|Post Treatment Follow Up|Adverse Event|0|||
23727043|NCT02959190|66378554|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
23727044|NCT02959190|66378555|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
23727045|NCT02959190|66378556|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
23727046|NCT02959190|66378557|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
23727047|NCT02705755|66378558|FG000|Part A (6 Days)|Adverse Event|1|||
23727048|NCT02705755|66378559|FG001|Part A (6 Days)|Adverse Event|0|||
23727049|NCT02705755|66378560|FG002|Part A (6 Days)|Adverse Event|0|||
23727050|NCT02705755|66378561|FG003|Part A (6 Days)|Adverse Event|0|||
23727051|NCT02705755|66378558|FG000|Part A (6 Days)|Physician Decision|3|||
23727052|NCT02705755|66378559|FG001|Part A (6 Days)|Physician Decision|0|||
23727053|NCT02705755|66378560|FG002|Part A (6 Days)|Physician Decision|0|||
23727054|NCT02705755|66378561|FG003|Part A (6 Days)|Physician Decision|0|||
23727055|NCT02705755|66378558|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
23727056|NCT02705755|66378559|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
23727057|NCT02705755|66378560|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
23727058|NCT02705755|66378561|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
23727059|NCT02705755|66378558|FG000|Part C (20 Weeks)|Physician Decision|0|||
23727060|NCT02705755|66378559|FG001|Part C (20 Weeks)|Physician Decision|0|||
23727061|NCT02705755|66378560|FG002|Part C (20 Weeks)|Physician Decision|0|||
23727062|NCT02705755|66378561|FG003|Part C (20 Weeks)|Physician Decision|2|||
23727063|NCT02705755|66378558|FG000|Part C (20 Weeks)|Adverse Event|0|||
23727064|NCT02705755|66378559|FG001|Part C (20 Weeks)|Adverse Event|0|||
23727065|NCT02705755|66378560|FG002|Part C (20 Weeks)|Adverse Event|0|||
23727066|NCT02705755|66378561|FG003|Part C (20 Weeks)|Adverse Event|6|||
23727067|NCT02705755|66378558|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
23727068|NCT02705755|66378559|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
23727069|NCT02705755|66378560|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
23727070|NCT02705755|66378561|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
23727071|NCT01025232|66378562|FG000|Overall Study|Study drug no longer available|3|||
23727072|NCT01025232|66378563|FG001|Overall Study|Study drug no longer available|6|||
23727073|NCT04362189|66378565|FG000|Overall Study|Lost to Follow-up|0|||
23727074|NCT04362189|66378566|FG001|Overall Study|Lost to Follow-up|1|||
23727075|NCT04362189|66378565|FG000|Overall Study|Withdrawal by Subject|1|||
23727076|NCT04362189|66378566|FG001|Overall Study|Withdrawal by Subject|0|||
23727077|NCT04362189|66378565|FG000|Overall Study|FDA Clinical Hold|7|||
23727078|NCT04362189|66378566|FG001|Overall Study|FDA Clinical Hold|2|||
23727079|NCT04362189|66378565|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
23727080|NCT04362189|66378566|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
23727081|NCT04362189|66378565|FG000|Overall Study|Adverse Event|0|||
23727082|NCT04362189|66378566|FG001|Overall Study|Adverse Event|2|||
23727083|NCT04362189|66378565|FG000|Overall Study|Death|4|||
23727084|NCT04362189|66378566|FG001|Overall Study|Death|1|||
23727085|NCT00320190|66378567|FG000|First 12 Months|Completed but did not enter extension|5|||
23727086|NCT00320190|66378568|FG001|First 12 Months|Completed but did not enter extension|3|||
23727087|NCT00320190|66378567|FG000|First 12 Months|Sponsor terminated study|2|||
23727088|NCT00320190|66378568|FG001|First 12 Months|Sponsor terminated study|2|||
23727089|NCT00320190|66378567|FG000|First 12 Months|Lost to Follow-up|0|||
23727090|NCT00320190|66378568|FG001|First 12 Months|Lost to Follow-up|1|||
23727091|NCT00320190|66378567|FG000|First 12 Months|Enrollment failure|0|||
23727092|NCT00320190|66378568|FG001|First 12 Months|Enrollment failure|1|||
23727093|NCT00320190|66378567|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
23727094|NCT00320190|66378568|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
23727095|NCT00320190|66378567|FG000|First 12 Months|Investigator request|0|||
23727096|NCT00320190|66378568|FG001|First 12 Months|Investigator request|1|||
23727097|NCT00320190|66378567|FG000|First 12 Months|Study drug toxicity|0|||
23727098|NCT00320190|66378568|FG001|First 12 Months|Study drug toxicity|1|||
23727099|NCT00320190|66378567|FG000|First 12 Months|Withdrawal by Subject|0|||
23727100|NCT00320190|66378568|FG001|First 12 Months|Withdrawal by Subject|1|||
23727101|NCT00320190|66378567|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
23727102|NCT00320190|66378568|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
23727103|NCT00320190|66378567|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
23727104|NCT00320190|66378568|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
23727105|NCT00320190|66378567|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
23727106|NCT00320190|66378568|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
23727107|NCT02975349|66378577|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23727108|NCT02975349|66378578|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23727109|NCT02975349|66378579|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23727110|NCT02975349|66378580|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23727111|NCT02975349|66378581|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23727112|NCT02975349|66378582|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23727113|NCT02975349|66378577|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23727114|NCT02975349|66378578|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23727115|NCT02975349|66378579|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23727116|NCT02975349|66378580|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23727117|NCT02975349|66378581|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23727118|NCT02975349|66378582|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23727119|NCT02975349|66378577|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
23727120|NCT02975349|66378578|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
23727121|NCT02975349|66378579|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
23727122|NCT02975349|66378580|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
23727123|NCT02975349|66378581|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
23727124|NCT02975349|66378582|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
23727125|NCT02975349|66378577|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
23727126|NCT02975349|66378578|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
23727127|NCT02975349|66378579|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
23727128|NCT02975349|66378580|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
23727129|NCT02975349|66378581|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
23727130|NCT02975349|66378582|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
23727131|NCT02975349|66378577|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
23727132|NCT02975349|66378578|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23727133|NCT02975349|66378579|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23727134|NCT02975349|66378580|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
23727135|NCT02975349|66378581|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23727136|NCT02975349|66378582|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
23727137|NCT02975349|66378577|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
23727138|NCT02975349|66378578|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
23727139|NCT02975349|66378579|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
23424370|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23727140|NCT02975349|66378580|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
23727141|NCT02975349|66378581|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
23727142|NCT02975349|66378582|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
23727143|NCT02975349|66378577|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23424371|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23727144|NCT02975349|66378578|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23727145|NCT02975349|66378579|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
23727146|NCT02975349|66378580|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23727147|NCT02975349|66378581|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23727148|NCT02975349|66378582|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23727149|NCT02975349|66378577|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23727150|NCT02975349|66378578|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
23727151|NCT02975349|66378579|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23727152|NCT02975349|66378580|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23727153|NCT02975349|66378581|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23727154|NCT02975349|66378582|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23727155|NCT02975349|66378577|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23727156|NCT02975349|66378578|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23727157|NCT02975349|66378579|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23727158|NCT02975349|66378580|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
23727159|NCT02975349|66378581|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23727160|NCT02975349|66378582|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23727161|NCT02244619|66378584|FG000|Overall Study|Did not receive study intervention|8|||
23727162|NCT02244619|66378585|FG001|Overall Study|Did not receive study intervention|21|||
23727163|NCT02741310|66378586|FG000|Overall Study|Sponsor Decision|2|||
23727164|NCT02741310|66378587|FG001|Overall Study|Sponsor Decision|2|||
23727165|NCT01673490|66378588|FG000|Overall Study|Lost to Follow-up|1|||
23727166|NCT01673490|66378588|FG000|Overall Study|Adverse Event|3|||
23727167|NCT01673490|66378588|FG000|Overall Study|Withdrawal by Subject|3|||
23727168|NCT01782885|66378592|FG000|Overall Study|Lost to Follow-up|4|||
23727169|NCT01782885|66378593|FG001|Overall Study|Lost to Follow-up|6|||
23816742|NCT04123561|66708497|FG000|Overall Study|Withdrawal by Subject|9|||
23816743|NCT04123561|66708498|FG001|Overall Study|Withdrawal by Subject|7|||
23816744|NCT04123561|66708499|FG002|Overall Study|Withdrawal by Subject|9|||
23816745|NCT04123561|66708497|FG000|Overall Study|Lack of Efficacy|7|||
23816746|NCT04123561|66708498|FG001|Overall Study|Lack of Efficacy|8|||
23816747|NCT04123561|66708499|FG002|Overall Study|Lack of Efficacy|6|||
23816748|NCT04123561|66708497|FG000|Overall Study|Adverse Event|5|||
23816749|NCT04123561|66708498|FG001|Overall Study|Adverse Event|2|||
23816750|NCT04123561|66708499|FG002|Overall Study|Adverse Event|3|||
23816751|NCT04123561|66708497|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
23816752|NCT04123561|66708498|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
23816753|NCT04123561|66708499|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
23816754|NCT04123561|66708497|FG000|Overall Study|Death|0|||
23816755|NCT04123561|66708498|FG001|Overall Study|Death|0|||
23816756|NCT04123561|66708499|FG002|Overall Study|Death|1|||
23816757|NCT04123561|66708497|FG000|Overall Study|Protocol Violation|0|||
23816758|NCT04123561|66708498|FG001|Overall Study|Protocol Violation|1|||
23816759|NCT04123561|66708499|FG002|Overall Study|Protocol Violation|0|||
23727170|NCT01833806|66378594|FG000|Overall Study|Alternative treatment|2|||
23727171|NCT01833806|66378594|FG000|Overall Study|Death|5|||
23816760|NCT02186834|66708503|FG000|Dose Escalation|Death|0|||
23816761|NCT02186834|66708504|FG001|Dose Escalation|Death|0|||
23727172|NCT01833806|66378594|FG000|Overall Study|Physician Decision|1|||
23816762|NCT02186834|66708505|FG002|Dose Escalation|Death|0|||
23816763|NCT02186834|66708506|FG003|Dose Escalation|Death|1|||
23816764|NCT02186834|66708507|FG004|Dose Escalation|Death|0|||
23816765|NCT02186834|66708508|FG005|Dose Escalation|Death|0|||
23816766|NCT02186834|66708503|FG000|Treatment at RP2D|Died prior to treatment|0|||
23816767|NCT02186834|66708504|FG001|Treatment at RP2D|Died prior to treatment|0|||
23816768|NCT02186834|66708505|FG002|Treatment at RP2D|Died prior to treatment|0|||
23816769|NCT02186834|66708506|FG003|Treatment at RP2D|Died prior to treatment|0|||
23540552|NCT00466193|65709243|FG001|Overall Study|Adverse Event|1|||
23540553|NCT00466193|65709242|FG000|Overall Study|Lost to Follow-up|2|||
23727173|NCT01833806|66378594|FG000|Overall Study|Lost to Follow-up|1|||
23727174|NCT03748420|66378595|FG000|Overall Study|No 12 month medication adherence data available|0|||
23727175|NCT03748420|66378596|FG001|Overall Study|No 12 month medication adherence data available|1|||
23727176|NCT03748420|66378595|FG000|Overall Study|Death|24|||
23727177|NCT03748420|66378596|FG001|Overall Study|Death|28|||
23727178|NCT03748420|66378595|FG000|Overall Study|Lost to Follow-up|231|||
23727179|NCT03748420|66378596|FG001|Overall Study|Lost to Follow-up|230|||
23727180|NCT00369278|66378597|FG000|Overall Study|Adverse Event|14|||
23727181|NCT00369278|66378598|FG001|Overall Study|Adverse Event|11|||
23727182|NCT00369278|66378597|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23727183|NCT00369278|66378598|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23727184|NCT00369278|66378597|FG000|Overall Study|Protocol Violation|2|||
23727185|NCT00369278|66378598|FG001|Overall Study|Protocol Violation|1|||
23727186|NCT00369278|66378597|FG000|Overall Study|Withdrawal by Subject|2|||
23727187|NCT00369278|66378598|FG001|Overall Study|Withdrawal by Subject|2|||
23727188|NCT00369278|66378597|FG000|Overall Study|Lost to Follow-up|1|||
23727189|NCT00369278|66378598|FG001|Overall Study|Lost to Follow-up|0|||
23727190|NCT00369278|66378597|FG000|Overall Study|Graft loss|1|||
23727191|NCT00369278|66378598|FG001|Overall Study|Graft loss|2|||
23727192|NCT02392468|66378606|FG000|Overall Study|Adverse Event|0|||
23727193|NCT02392468|66378607|FG001|Overall Study|Adverse Event|1|||
23727194|NCT02392468|66378608|FG002|Overall Study|Adverse Event|0|||
23727195|NCT02392468|66378609|FG003|Overall Study|Adverse Event|0|||
23727196|NCT02392468|66378610|FG004|Overall Study|Adverse Event|0|||
23727197|NCT02392468|66378611|FG005|Overall Study|Adverse Event|1|||
23727198|NCT01474889|66378615|FG000|Overall Study|Physician Decision|1|||
23727199|NCT01474889|66378616|FG001|Overall Study|Physician Decision|0|||
23727200|NCT01474889|66378617|FG002|Overall Study|Physician Decision|0|||
23727201|NCT01474889|66378615|FG000|Overall Study|Did not meet inclusion|1|||
23727202|NCT01474889|66378616|FG001|Overall Study|Did not meet inclusion|0|||
23540554|NCT00466193|65709243|FG001|Overall Study|Lost to Follow-up|4|||
23540555|NCT00466193|65709242|FG000|Overall Study|Physician Decision|1|||
23540556|NCT00466193|65709243|FG001|Overall Study|Physician Decision|0|||
23540557|NCT00466193|65709242|FG000|Overall Study|Protocol Violation|1|||
23540558|NCT00466193|65709243|FG001|Overall Study|Protocol Violation|1|||
23540559|NCT00466193|65709242|FG000|Overall Study|Withdrawal by Subject|7|||
23540560|NCT00466193|65709243|FG001|Overall Study|Withdrawal by Subject|2|||
23540561|NCT00466193|65709242|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
23727203|NCT01474889|66378617|FG002|Overall Study|Did not meet inclusion|0|||
23727204|NCT01474889|66378615|FG000|Overall Study|Withdrawal by Subject|0|||
23727205|NCT01474889|66378616|FG001|Overall Study|Withdrawal by Subject|1|||
23727206|NCT01474889|66378617|FG002|Overall Study|Withdrawal by Subject|0|||
23727207|NCT00493467|66378618|FG000|Overall Study|Death|1|||
23727208|NCT00880100|66378619|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
23540562|NCT00466193|65709243|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
23540563|NCT00630877|65709244|FG000|Overall Study|Adverse Event|11|||
23727209|NCT00880100|66378619|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
23727210|NCT00880100|66378619|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
23727211|NCT00420342|66378623|FG000|Overall Study|Lost to Follow-up|1|||
23727212|NCT00420342|66378624|FG001|Overall Study|Lost to Follow-up|0|||
23727213|NCT00420342|66378625|FG002|Overall Study|Lost to Follow-up|1|||
23727214|NCT00420342|66378623|FG000|Overall Study|Withdrawal by Subject|0|||
23727215|NCT00420342|66378624|FG001|Overall Study|Withdrawal by Subject|2|||
23727216|NCT00420342|66378625|FG002|Overall Study|Withdrawal by Subject|0|||
23816770|NCT02186834|66708507|FG004|Treatment at RP2D|Died prior to treatment|0|||
23540564|NCT00630877|65709245|FG001|Overall Study|Adverse Event|8|||
23540565|NCT00630877|65709246|FG002|Overall Study|Adverse Event|7|||
23727217|NCT05041062|66378626|FG000|Overall Study|Adverse Event|2|||
23727218|NCT02687711|66378627|FG000|Overall Study|Adverse Event|89|||
23727219|NCT02687711|66378627|FG000|Overall Study|Lack of Efficacy|70|||
23727220|NCT02687711|66378627|FG000|Overall Study|Lost to Follow-up|20|||
23727221|NCT02687711|66378627|FG000|Overall Study|Consent withdrawn|15|||
23727222|NCT02687711|66378627|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
23727223|NCT02687711|66378627|FG000|Overall Study|Too expensive|4|||
23727224|NCT02687711|66378627|FG000|Overall Study|Participant moved abroad|1|||
23727225|NCT02687711|66378627|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
23727226|NCT02687711|66378627|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
23727227|NCT02687711|66378627|FG000|Overall Study|Disliked taste|1|||
23727228|NCT02687711|66378627|FG000|Overall Study|Low mood|1|||
23727229|NCT02687711|66378627|FG000|Overall Study|Side effects|1|||
23727230|NCT02687711|66378627|FG000|Overall Study|Change of Hospital|1|||
23727231|NCT02687711|66378627|FG000|Overall Study|Liver Encephalopathy|1|||
23727232|NCT02687711|66378627|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
23727233|NCT02687711|66378627|FG000|Overall Study|Withdrawn due to intake interruption|1|||
23727234|NCT02687711|66378627|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
23727235|NCT02687711|66378627|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
23727236|NCT02687711|66378627|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
23727237|NCT02963766|66378630|FG000|Double-Blind Period|Adverse Event|1|||
23727238|NCT02963766|66378631|FG001|Double-Blind Period|Adverse Event|0|||
23727239|NCT02963766|66378632|FG002|Double-Blind Period|Adverse Event|1|||
23727240|NCT02963766|66378630|FG000|Double-Blind Period|Physician Decision|1|||
23727241|NCT02963766|66378631|FG001|Double-Blind Period|Physician Decision|0|||
23727242|NCT02963766|66378632|FG002|Double-Blind Period|Physician Decision|0|||
23727243|NCT02963766|66378630|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23727244|NCT02963766|66378631|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23727245|NCT02963766|66378632|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23727246|NCT02963766|66378630|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
23727247|NCT02963766|66378631|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
23727248|NCT02963766|66378632|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
23727249|NCT02963766|66378630|FG000|Double-Blind Period|Protocol Violation|1|||
23727250|NCT02963766|66378631|FG001|Double-Blind Period|Protocol Violation|0|||
23816771|NCT02186834|66708508|FG005|Treatment at RP2D|Died prior to treatment|1|||
23816772|NCT00839254|66708509|FG000|Overall Study|Protocol Violation|0|||
23816773|NCT00839254|66708510|FG001|Overall Study|Protocol Violation|1|||
23816774|NCT00839254|66708511|FG002|Overall Study|Protocol Violation|1|||
23816775|NCT00839254|66708512|FG003|Overall Study|Protocol Violation|1|||
23816776|NCT00839254|66708513|FG004|Overall Study|Protocol Violation|0|||
23816777|NCT00839254|66708514|FG005|Overall Study|Protocol Violation|0|||
23816778|NCT00839254|66708515|FG006|Overall Study|Protocol Violation|1|||
23816779|NCT00839254|66708516|FG007|Overall Study|Protocol Violation|2|||
23540566|NCT00630877|65709244|FG000|Overall Study|Withdrawal by Subject|3|||
23540567|NCT00630877|65709245|FG001|Overall Study|Withdrawal by Subject|4|||
23727251|NCT02963766|66378632|FG002|Double-Blind Period|Protocol Violation|0|||
23727252|NCT02963766|66378630|FG000|Double-Blind Period|Lost to Follow-up|0|||
23727253|NCT02963766|66378631|FG001|Double-Blind Period|Lost to Follow-up|1|||
23727254|NCT02963766|66378632|FG002|Double-Blind Period|Lost to Follow-up|0|||
23727255|NCT02963766|66378630|FG000|Open Label Extension (OLE)|Physician Decision|1|||
23727256|NCT02963766|66378631|FG001|Open Label Extension (OLE)|Physician Decision|2|||
23727257|NCT02963766|66378632|FG002|Open Label Extension (OLE)|Physician Decision|2|||
23727258|NCT02963766|66378630|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
23727259|NCT02963766|66378631|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
23727260|NCT02963766|66378632|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
23540568|NCT00630877|65709246|FG002|Overall Study|Withdrawal by Subject|0|||
23540569|NCT00630877|65709244|FG000|Overall Study|Lost to Follow-up|2|||
23540570|NCT00630877|65709245|FG001|Overall Study|Lost to Follow-up|0|||
23540571|NCT00630877|65709246|FG002|Overall Study|Lost to Follow-up|0|||
23540572|NCT00630877|65709244|FG000|Overall Study|Noncompliance|2|||
23540573|NCT00630877|65709245|FG001|Overall Study|Noncompliance|3|||
23540574|NCT00630877|65709246|FG002|Overall Study|Noncompliance|1|||
23540575|NCT00630877|65709244|FG000|Overall Study|Protocol violation|1|||
23540576|NCT00630877|65709245|FG001|Overall Study|Protocol violation|0|||
23540577|NCT00630877|65709246|FG002|Overall Study|Protocol violation|1|||
23540578|NCT00630877|65709244|FG000|Overall Study|Personal reasons|0|||
23540579|NCT00630877|65709245|FG001|Overall Study|Personal reasons|0|||
23540580|NCT00630877|65709246|FG002|Overall Study|Personal reasons|1|||
23540581|NCT01324024|65709247|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
23540582|NCT01324024|65709248|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23540583|NCT00724971|65709249|FG000|Overall Study|Adverse Event|5|||
23540584|NCT00724971|65709249|FG000|Overall Study|Withdrawal by Subject|1|||
23816780|NCT00839254|66708509|FG000|Overall Study|Physician Decision|0|||
23816781|NCT00839254|66708510|FG001|Overall Study|Physician Decision|1|||
23816782|NCT00839254|66708511|FG002|Overall Study|Physician Decision|0|||
23540585|NCT00345579|65709251|FG000|Overall Study|Adverse Event|9|||
23540586|NCT00345579|65709252|FG001|Overall Study|Adverse Event|6|||
23540587|NCT00345579|65709251|FG000|Overall Study|Protocol Violation|14|||
23540588|NCT00345579|65709252|FG001|Overall Study|Protocol Violation|5|||
23540589|NCT00345579|65709251|FG000|Overall Study|Withdrawal by Subject|50|||
23540590|NCT00345579|65709252|FG001|Overall Study|Withdrawal by Subject|17|||
23616656|NCT01945593|65982398|FG000|Overall Study|Death|0|||
23727261|NCT02977507|66378633|FG000|Overall Study|Protocol Deviation|1|||
23727262|NCT02977507|66378634|FG001|Overall Study|Protocol Deviation|0|||
23727263|NCT02977507|66378633|FG000|Overall Study|Lost to Follow-up|1|||
23727264|NCT02977507|66378634|FG001|Overall Study|Lost to Follow-up|0|||
23727265|NCT04083794|66378635|FG000|Overall Study|Lost to Follow-up|9|||
23727266|NCT02723019|66378639|FG000|Overall Study|Death|17|||
23727267|NCT02723019|66378640|FG001|Overall Study|Death|13|||
23727268|NCT02723019|66378639|FG000|Overall Study|Withdrawal by Subject|11|||
23727269|NCT02723019|66378640|FG001|Overall Study|Withdrawal by Subject|7|||
23727270|NCT02723019|66378639|FG000|Overall Study|Lost to Follow-up|57|||
23727271|NCT02723019|66378640|FG001|Overall Study|Lost to Follow-up|70|||
23727272|NCT00839436|66378646|FG000|Overall Study|Developed exclusionary condition|1|||
23727273|NCT00839436|66378647|FG001|Overall Study|Developed exclusionary condition|0|||
23727274|NCT00839436|66378648|FG002|Overall Study|Developed exclusionary condition|0|||
23727275|NCT00839436|66378646|FG000|Overall Study|Withdrawal by Subject|0|||
23727276|NCT00839436|66378647|FG001|Overall Study|Withdrawal by Subject|1|||
23727277|NCT00839436|66378648|FG002|Overall Study|Withdrawal by Subject|0|||
23727278|NCT00839436|66378646|FG000|Overall Study|Study drug no longer available|0|||
23727279|NCT00839436|66378647|FG001|Overall Study|Study drug no longer available|0|||
23727280|NCT00839436|66378648|FG002|Overall Study|Study drug no longer available|1|||
23727281|NCT00741260|66378649|FG000|Overall Study|Disease Progression|3|||
23727282|NCT00741260|66378650|FG001|Overall Study|Disease Progression|5|||
23727283|NCT00741260|66378651|FG002|Overall Study|Disease Progression|3|||
23727284|NCT00741260|66378652|FG003|Overall Study|Disease Progression|3|||
23727285|NCT00741260|66378653|FG004|Overall Study|Disease Progression|5|||
23727286|NCT00741260|66378654|FG005|Overall Study|Disease Progression|37|||
23727287|NCT00741260|66378655|FG006|Overall Study|Disease Progression|4|||
23727288|NCT00741260|66378649|FG000|Overall Study|Death|0|||
23727289|NCT00741260|66378650|FG001|Overall Study|Death|1|||
23727290|NCT00741260|66378651|FG002|Overall Study|Death|0|||
23727291|NCT00741260|66378652|FG003|Overall Study|Death|1|||
23727292|NCT00741260|66378653|FG004|Overall Study|Death|2|||
23816783|NCT00839254|66708512|FG003|Overall Study|Physician Decision|0|||
23816784|NCT00839254|66708513|FG004|Overall Study|Physician Decision|0|||
23816785|NCT00839254|66708514|FG005|Overall Study|Physician Decision|0|||
23816786|NCT00839254|66708515|FG006|Overall Study|Physician Decision|0|||
23540591|NCT00345579|65709251|FG000|Overall Study|Lost to Follow-up|82|||
23616657|NCT01945593|65982399|FG001|Overall Study|Death|0|||
23616658|NCT01945593|65982400|FG002|Overall Study|Death|1|||
23616659|NCT01945593|65982401|FG003|Overall Study|Death|0|||
23616660|NCT01945593|65982398|FG000|Overall Study|Other: Terminated|0|||
23616661|NCT01945593|65982399|FG001|Overall Study|Other: Terminated|0|||
23616662|NCT01945593|65982400|FG002|Overall Study|Other: Terminated|0|||
23616663|NCT01945593|65982401|FG003|Overall Study|Other: Terminated|1|||
23616664|NCT01945593|65982398|FG000|Overall Study|Other: Surgical Procedure|0|||
23616665|NCT01945593|65982399|FG001|Overall Study|Other: Surgical Procedure|2|||
23616666|NCT01945593|65982400|FG002|Overall Study|Other: Surgical Procedure|0|||
23616667|NCT01945593|65982401|FG003|Overall Study|Other: Surgical Procedure|6|||
23616668|NCT01945593|65982398|FG000|Overall Study|Other: Screen Failure|0|||
23727293|NCT00741260|66378654|FG005|Overall Study|Death|2|||
23727294|NCT00741260|66378655|FG006|Overall Study|Death|1|||
23727295|NCT00741260|66378649|FG000|Overall Study|Withdrawal by Subject|0|||
23727296|NCT00741260|66378650|FG001|Overall Study|Withdrawal by Subject|0|||
23727297|NCT00741260|66378651|FG002|Overall Study|Withdrawal by Subject|0|||
23727298|NCT00741260|66378652|FG003|Overall Study|Withdrawal by Subject|0|||
23816787|NCT00839254|66708516|FG007|Overall Study|Physician Decision|1|||
23816788|NCT00839254|66708509|FG000|Overall Study|Wrong treatment number allocation|0|||
23540592|NCT00345579|65709252|FG001|Overall Study|Lost to Follow-up|36|||
23540593|NCT00345579|65709251|FG000|Overall Study|Other|9|||
23540594|NCT00345579|65709252|FG001|Overall Study|Other|1|||
23540595|NCT03855189|65709255|FG000|Overall Study|Adverse Event|5|||
23540596|NCT03855189|65709256|FG001|Overall Study|Adverse Event|2|||
23540597|NCT03855189|65709257|FG002|Overall Study|Adverse Event|4|||
23540598|NCT03855189|65709255|FG000|Overall Study|Treatment Failure|1|||
23540599|NCT03855189|65709256|FG001|Overall Study|Treatment Failure|1|||
23540600|NCT03855189|65709257|FG002|Overall Study|Treatment Failure|2|||
23540601|NCT03855189|65709255|FG000|Overall Study|Noncompliance with Protocol|0|||
23540602|NCT03855189|65709256|FG001|Overall Study|Noncompliance with Protocol|1|||
23540603|NCT03855189|65709257|FG002|Overall Study|Noncompliance with Protocol|0|||
23540604|NCT03855189|65709255|FG000|Overall Study|Did Not Return|4|||
23540605|NCT03855189|65709256|FG001|Overall Study|Did Not Return|3|||
23540606|NCT03855189|65709257|FG002|Overall Study|Did Not Return|0|||
23540607|NCT02199691|65709261|FG000|Overall Study|Protocol Violation|3|||
23540608|NCT02199691|65709262|FG001|Overall Study|Protocol Violation|3|||
23540609|NCT02199691|65709263|FG002|Overall Study|Protocol Violation|6|||
23540610|NCT02199691|65709264|FG003|Overall Study|Protocol Violation|7|||
23540611|NCT02199691|65709261|FG000|Overall Study|Withdrawal by Subject|5|||
23540612|NCT02199691|65709262|FG001|Overall Study|Withdrawal by Subject|3|||
23540613|NCT02199691|65709263|FG002|Overall Study|Withdrawal by Subject|12|||
23727299|NCT00741260|66378653|FG004|Overall Study|Withdrawal by Subject|1|||
23727300|NCT00741260|66378654|FG005|Overall Study|Withdrawal by Subject|3|||
23727301|NCT00741260|66378655|FG006|Overall Study|Withdrawal by Subject|1|||
23727302|NCT00741260|66378649|FG000|Overall Study|Physician Decision|1|||
23727303|NCT00741260|66378650|FG001|Overall Study|Physician Decision|1|||
23727304|NCT00741260|66378651|FG002|Overall Study|Physician Decision|0|||
23727305|NCT00741260|66378652|FG003|Overall Study|Physician Decision|0|||
23727306|NCT00741260|66378653|FG004|Overall Study|Physician Decision|0|||
23727307|NCT00741260|66378654|FG005|Overall Study|Physician Decision|0|||
23727308|NCT00741260|66378655|FG006|Overall Study|Physician Decision|0|||
23727309|NCT00741260|66378649|FG000|Overall Study|Other|2|||
23727310|NCT00741260|66378650|FG001|Overall Study|Other|1|||
23727311|NCT00741260|66378651|FG002|Overall Study|Other|1|||
23727312|NCT00741260|66378652|FG003|Overall Study|Other|2|||
23727313|NCT00741260|66378653|FG004|Overall Study|Other|1|||
23727314|NCT00741260|66378654|FG005|Overall Study|Other|3|||
23727315|NCT00741260|66378655|FG006|Overall Study|Other|1|||
23727316|NCT02756845|66378659|FG000|Overall Study|Death|12|||
23727317|NCT02756845|66378660|FG001|Overall Study|Death|2|||
23727318|NCT02756845|66378659|FG000|Overall Study|Withdrawal by Subject|1|||
23727319|NCT02756845|66378660|FG001|Overall Study|Withdrawal by Subject|0|||
23727320|NCT00107172|66378661|FG000|Overall Study|Withdrawal by Subject|1|||
23727321|NCT00107172|66378662|FG001|Overall Study|Withdrawal by Subject|0|||
23727322|NCT00107172|66378661|FG000|Overall Study|Death|0|||
23727323|NCT00107172|66378662|FG001|Overall Study|Death|2|||
23424372|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
23424373|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424374|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
23424375|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424376|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424377|NCT00610441|65296476|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424378|NCT00610441|65296477|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424379|NCT00610441|65296478|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
23424380|NCT00610441|65296479|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424381|NCT00610441|65296476|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424382|NCT00610441|65296477|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
23424383|NCT00610441|65296478|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424384|NCT00610441|65296479|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424385|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
23424386|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
23424387|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
23424388|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
23424389|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424390|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424391|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424392|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
23727324|NCT00107172|66378661|FG000|Overall Study|Other Reason|4|||
23727325|NCT00107172|66378662|FG001|Overall Study|Other Reason|3|||
23727326|NCT00515099|66382037|FG000|Overall Study|Lost to Follow-up|0|||
23727327|NCT00515099|66382038|FG001|Overall Study|Lost to Follow-up|4|||
23727328|NCT00515099|66382037|FG000|Overall Study|Withdrawal by Subject|2|||
23727329|NCT00515099|66382038|FG001|Overall Study|Withdrawal by Subject|0|||
23727330|NCT00515099|66382037|FG000|Overall Study|IRB Recommendation|1|||
23727331|NCT00515099|66382038|FG001|Overall Study|IRB Recommendation|0|||
23727332|NCT01600105|66382039|FG000|Total Participants|Withdrawal by Subject|1|||
23727333|NCT01600105|66382040|FG001|Total Participants|Withdrawal by Subject|0|||
23727334|NCT01600105|66382039|FG000|Total Participants|No images in PACS|10|||
23727335|NCT01600105|66382040|FG001|Total Participants|No images in PACS|0|||
23727336|NCT01600105|66382039|FG000|Total Participants|Insufficient image quality|30|||
23540614|NCT02199691|65709264|FG003|Overall Study|Withdrawal by Subject|13|||
23540615|NCT02199691|65709261|FG000|Overall Study|Lost to Follow-up|2|||
23540616|NCT02199691|65709262|FG001|Overall Study|Lost to Follow-up|1|||
23540617|NCT02199691|65709263|FG002|Overall Study|Lost to Follow-up|9|||
23540618|NCT02199691|65709264|FG003|Overall Study|Lost to Follow-up|10|||
23540619|NCT00612066|65709269|FG000|Overall Study|Adverse Event|1|||
23540620|NCT00572572|65709270|FG000|Overall Study|Withdrawal by Subject|3|||
23540621|NCT00572572|65709271|FG001|Overall Study|Withdrawal by Subject|6|||
23540622|NCT03036566|65709273|FG000|Overall Study|Lost to Follow-up|3|||
23540623|NCT02401672|65709274|FG000|Overall Study|Withdrawal by Subject|1|||
23540624|NCT02401672|65709275|FG001|Overall Study|Withdrawal by Subject|3|||
23540625|NCT00840970|65709278|FG000|Overall Study|Adverse Event|0|||
23540626|NCT00840970|65709279|FG001|Overall Study|Adverse Event|0|||
23540627|NCT00840970|65709280|FG002|Overall Study|Adverse Event|1|||
23540628|NCT00384085|65709284|FG000|Overall Study|Adverse Event|5|||
23540629|NCT00384085|65709285|FG001|Overall Study|Adverse Event|5|||
23540630|NCT00384085|65709286|FG002|Overall Study|Adverse Event|4|||
23540631|NCT00384085|65709284|FG000|Overall Study|Lack of Efficacy|0|||
23540632|NCT00384085|65709285|FG001|Overall Study|Lack of Efficacy|3|||
23540633|NCT00384085|65709286|FG002|Overall Study|Lack of Efficacy|2|||
23540634|NCT00384085|65709284|FG000|Overall Study|No longer Requires Study Treatment|1|||
23540635|NCT00384085|65709285|FG001|Overall Study|No longer Requires Study Treatment|0|||
23540636|NCT00384085|65709286|FG002|Overall Study|No longer Requires Study Treatment|1|||
23540637|NCT00384085|65709284|FG000|Overall Study|Protocol Violation|2|||
23540638|NCT00384085|65709285|FG001|Overall Study|Protocol Violation|2|||
23540639|NCT00384085|65709286|FG002|Overall Study|Protocol Violation|2|||
23540640|NCT00384085|65709284|FG000|Overall Study|Lost to Follow-up|9|||
23540641|NCT00384085|65709285|FG001|Overall Study|Lost to Follow-up|9|||
23540642|NCT00384085|65709286|FG002|Overall Study|Lost to Follow-up|10|||
23540643|NCT00384085|65709284|FG000|Overall Study|Progressive Disease|0|||
23540644|NCT00384085|65709285|FG001|Overall Study|Progressive Disease|1|||
23540645|NCT00384085|65709286|FG002|Overall Study|Progressive Disease|0|||
23540646|NCT00384085|65709284|FG000|Overall Study|Withdrawal by Subject|14|||
23540647|NCT00384085|65709285|FG001|Overall Study|Withdrawal by Subject|19|||
23816789|NCT00839254|66708510|FG001|Overall Study|Wrong treatment number allocation|1|||
23816790|NCT00839254|66708511|FG002|Overall Study|Wrong treatment number allocation|0|||
23816791|NCT00839254|66708512|FG003|Overall Study|Wrong treatment number allocation|0|||
23816792|NCT00839254|66708513|FG004|Overall Study|Wrong treatment number allocation|0|||
23816793|NCT00839254|66708514|FG005|Overall Study|Wrong treatment number allocation|1|||
23816794|NCT00839254|66708515|FG006|Overall Study|Wrong treatment number allocation|0|||
23816795|NCT00839254|66708516|FG007|Overall Study|Wrong treatment number allocation|0|||
23816796|NCT00839254|66708509|FG000|Overall Study|Adverse Event|12|||
23816797|NCT00839254|66708510|FG001|Overall Study|Adverse Event|6|||
23816798|NCT00839254|66708511|FG002|Overall Study|Adverse Event|3|||
23816799|NCT00839254|66708512|FG003|Overall Study|Adverse Event|5|||
23816800|NCT00839254|66708513|FG004|Overall Study|Adverse Event|2|||
23816801|NCT00839254|66708514|FG005|Overall Study|Adverse Event|1|||
23540648|NCT00384085|65709286|FG002|Overall Study|Withdrawal by Subject|29|||
23540649|NCT00384085|65709284|FG000|Overall Study|Patient non-compliant|4|||
23540650|NCT00384085|65709285|FG001|Overall Study|Patient non-compliant|4|||
23540651|NCT00384085|65709286|FG002|Overall Study|Patient non-compliant|5|||
23540652|NCT00384085|65709284|FG000|Overall Study|Physician Decision|1|||
23540653|NCT00384085|65709285|FG001|Overall Study|Physician Decision|0|||
23540654|NCT00384085|65709286|FG002|Overall Study|Physician Decision|0|||
23540655|NCT00384085|65709284|FG000|Overall Study|Loss of site personnel|1|||
23540656|NCT00384085|65709285|FG001|Overall Study|Loss of site personnel|0|||
23540657|NCT00384085|65709286|FG002|Overall Study|Loss of site personnel|1|||
23540658|NCT00384085|65709284|FG000|Overall Study|Sponsor decision|1|||
23540659|NCT00384085|65709285|FG001|Overall Study|Sponsor decision|2|||
23540660|NCT00384085|65709286|FG002|Overall Study|Sponsor decision|1|||
23540661|NCT00384085|65709284|FG000|Overall Study|Patient moved|1|||
23540662|NCT00384085|65709285|FG001|Overall Study|Patient moved|0|||
23540663|NCT00384085|65709286|FG002|Overall Study|Patient moved|1|||
23540664|NCT00384085|65709284|FG000|Overall Study|Patient required surgery|0|||
23540665|NCT00384085|65709285|FG001|Overall Study|Patient required surgery|1|||
23540666|NCT00384085|65709286|FG002|Overall Study|Patient required surgery|0|||
23727337|NCT01600105|66382040|FG001|Total Participants|Insufficient image quality|10|||
23540667|NCT01785524|65709288|FG000|Overall Study|Withdrawal by Subject|2|||
23540668|NCT01785524|65709289|FG001|Overall Study|Withdrawal by Subject|2|||
23540669|NCT01539291|65709290|FG000|Study GS-US-312-0116|Adverse Event|9|||
23540670|NCT01539291|65709291|FG001|Study GS-US-312-0116|Adverse Event|0|||
23540671|NCT01539291|65709292|FG002|Study GS-US-312-0116|Adverse Event|0|||
23540672|NCT01539291|65709293|FG003|Study GS-US-312-0116|Adverse Event|0|||
23540673|NCT01539291|65709290|FG000|Study GS-US-312-0116|Physician Decision|1|||
23540674|NCT01539291|65709291|FG001|Study GS-US-312-0116|Physician Decision|0|||
23816802|NCT00839254|66708515|FG006|Overall Study|Adverse Event|0|||
23540675|NCT01539291|65709292|FG002|Study GS-US-312-0116|Physician Decision|0|||
23727338|NCT01600105|66382039|FG000|Sub Study I|Insufficient image quality|0|||
23727339|NCT01600105|66382040|FG001|Sub Study I|Insufficient image quality|10|||
23727340|NCT01600105|66382039|FG000|Sub Study II|Withdrawal by Subject|1|||
23727341|NCT01600105|66382040|FG001|Sub Study II|Withdrawal by Subject|0|||
23727342|NCT01600105|66382039|FG000|Sub Study II|No images in PACS|1|||
23727343|NCT01600105|66382040|FG001|Sub Study II|No images in PACS|0|||
23727344|NCT01600105|66382039|FG000|Sub Study II|Insufficient image quality|3|||
23727345|NCT01600105|66382040|FG001|Sub Study II|Insufficient image quality|0|||
23727346|NCT01600105|66382039|FG000|Sub Study III|Insufficient image quality|5|||
23727347|NCT01600105|66382040|FG001|Sub Study III|Insufficient image quality|0|||
23727348|NCT01600105|66382039|FG000|Sub Study V|Poor Image Quality|2|||
23727349|NCT01600105|66382040|FG001|Sub Study V|Poor Image Quality|0|||
23727350|NCT02972593|66382041|FG000|Overall Study|Lost to Follow-up|19|||
23727351|NCT02972593|66382042|FG001|Overall Study|Lost to Follow-up|15|||
23727352|NCT02972593|66382041|FG000|Overall Study|Protocol Violation|1|||
23727353|NCT02972593|66382042|FG001|Overall Study|Protocol Violation|0|||
23727354|NCT01468701|66382046|FG000|Overall Study|Not eligible|91|||
23727355|NCT01468701|66382047|FG001|Overall Study|Not eligible|140|||
23727356|NCT01468701|66382048|FG002|Overall Study|Not eligible|29|||
23727357|NCT01468701|66382049|FG003|Overall Study|Not eligible|12|||
23727358|NCT01468701|66382050|FG004|Overall Study|Not eligible|22|||
23727359|NCT01468701|66382051|FG005|Overall Study|Not eligible|2|||
23727360|NCT01468701|66382052|FG006|Overall Study|Not eligible|39|||
23727361|NCT01468701|66382053|FG007|Overall Study|Not eligible|1|||
23727362|NCT01468701|66382054|FG008|Overall Study|Not eligible|40|||
23727363|NCT01468701|66382055|FG009|Overall Study|Not eligible|126|||
23727364|NCT01468701|66382056|FG010|Overall Study|Not eligible|39|||
23727365|NCT01468701|66382057|FG011|Overall Study|Not eligible|33|||
23727366|NCT01468701|66382058|FG012|Overall Study|Not eligible|1|||
23727367|NCT01468701|66382059|FG013|Overall Study|Not eligible|19|||
23727368|NCT01468701|66382060|FG014|Overall Study|Not eligible|1|||
23727369|NCT01468701|66382061|FG015|Overall Study|Not eligible|32|||
23727370|NCT01468701|66382062|FG016|Overall Study|Not eligible|0|||
23727371|NCT01468701|66382046|FG000|Overall Study|Lost to Follow-up|306|||
23727372|NCT01468701|66382047|FG001|Overall Study|Lost to Follow-up|0|||
23727373|NCT01468701|66382048|FG002|Overall Study|Lost to Follow-up|0|||
23727374|NCT01468701|66382049|FG003|Overall Study|Lost to Follow-up|0|||
23727375|NCT01468701|66382050|FG004|Overall Study|Lost to Follow-up|0|||
23727376|NCT01468701|66382051|FG005|Overall Study|Lost to Follow-up|0|||
23727377|NCT01468701|66382052|FG006|Overall Study|Lost to Follow-up|0|||
23727378|NCT01468701|66382053|FG007|Overall Study|Lost to Follow-up|0|||
23727379|NCT01468701|66382054|FG008|Overall Study|Lost to Follow-up|215|||
23727380|NCT01468701|66382055|FG009|Overall Study|Lost to Follow-up|309|||
23727381|NCT01468701|66382056|FG010|Overall Study|Lost to Follow-up|224|||
23727382|NCT01468701|66382057|FG011|Overall Study|Lost to Follow-up|212|||
23727383|NCT01468701|66382058|FG012|Overall Study|Lost to Follow-up|11|||
23727384|NCT01468701|66382059|FG013|Overall Study|Lost to Follow-up|164|||
23727385|NCT01468701|66382060|FG014|Overall Study|Lost to Follow-up|17|||
23727386|NCT01468701|66382061|FG015|Overall Study|Lost to Follow-up|127|||
23727387|NCT01468701|66382062|FG016|Overall Study|Lost to Follow-up|1|||
23727388|NCT01468701|66382046|FG000|Overall Study|Withdrawal by Subject|165|||
23727389|NCT01468701|66382047|FG001|Overall Study|Withdrawal by Subject|0|||
23727390|NCT01468701|66382048|FG002|Overall Study|Withdrawal by Subject|0|||
23727391|NCT01468701|66382049|FG003|Overall Study|Withdrawal by Subject|0|||
23727392|NCT01468701|66382050|FG004|Overall Study|Withdrawal by Subject|0|||
23727393|NCT01468701|66382051|FG005|Overall Study|Withdrawal by Subject|0|||
23727394|NCT01468701|66382052|FG006|Overall Study|Withdrawal by Subject|0|||
23727395|NCT01468701|66382053|FG007|Overall Study|Withdrawal by Subject|0|||
23727396|NCT01468701|66382054|FG008|Overall Study|Withdrawal by Subject|83|||
23727397|NCT01468701|66382055|FG009|Overall Study|Withdrawal by Subject|88|||
23727398|NCT01468701|66382056|FG010|Overall Study|Withdrawal by Subject|100|||
23727399|NCT01468701|66382057|FG011|Overall Study|Withdrawal by Subject|114|||
23727400|NCT01468701|66382058|FG012|Overall Study|Withdrawal by Subject|9|||
23727401|NCT01468701|66382059|FG013|Overall Study|Withdrawal by Subject|47|||
23727402|NCT01468701|66382060|FG014|Overall Study|Withdrawal by Subject|6|||
23727403|NCT01468701|66382061|FG015|Overall Study|Withdrawal by Subject|31|||
23727404|NCT01468701|66382062|FG016|Overall Study|Withdrawal by Subject|0|||
23727405|NCT01468701|66382046|FG000|Overall Study|Other reasons than listed|437|||
23727406|NCT01468701|66382047|FG001|Overall Study|Other reasons than listed|0|||
23727407|NCT01468701|66382048|FG002|Overall Study|Other reasons than listed|0|||
23727408|NCT01468701|66382049|FG003|Overall Study|Other reasons than listed|0|||
23727409|NCT01468701|66382050|FG004|Overall Study|Other reasons than listed|0|||
23727410|NCT01468701|66382051|FG005|Overall Study|Other reasons than listed|0|||
23727411|NCT01468701|66382052|FG006|Overall Study|Other reasons than listed|0|||
23727412|NCT01468701|66382053|FG007|Overall Study|Other reasons than listed|0|||
23727413|NCT01468701|66382054|FG008|Overall Study|Other reasons than listed|318|||
23727414|NCT01468701|66382055|FG009|Overall Study|Other reasons than listed|658|||
23727415|NCT01468701|66382056|FG010|Overall Study|Other reasons than listed|433|||
23727416|NCT01468701|66382057|FG011|Overall Study|Other reasons than listed|504|||
23727417|NCT01468701|66382058|FG012|Overall Study|Other reasons than listed|28|||
23727418|NCT01468701|66382059|FG013|Overall Study|Other reasons than listed|239|||
23727419|NCT01468701|66382060|FG014|Overall Study|Other reasons than listed|39|||
23727420|NCT01468701|66382061|FG015|Overall Study|Other reasons than listed|172|||
23727421|NCT01468701|66382062|FG016|Overall Study|Other reasons than listed|0|||
23727422|NCT01468701|66382046|FG000|Overall Study|No end of study case report form|0|||
23727423|NCT01468701|66382047|FG001|Overall Study|No end of study case report form|0|||
23727424|NCT01468701|66382048|FG002|Overall Study|No end of study case report form|0|||
23727425|NCT01468701|66382049|FG003|Overall Study|No end of study case report form|0|||
23727426|NCT01468701|66382050|FG004|Overall Study|No end of study case report form|0|||
23727427|NCT01468701|66382051|FG005|Overall Study|No end of study case report form|0|||
23727428|NCT01468701|66382052|FG006|Overall Study|No end of study case report form|0|||
23727429|NCT01468701|66382053|FG007|Overall Study|No end of study case report form|0|||
23727430|NCT01468701|66382054|FG008|Overall Study|No end of study case report form|4|||
23727431|NCT01468701|66382055|FG009|Overall Study|No end of study case report form|1|||
23727432|NCT01468701|66382056|FG010|Overall Study|No end of study case report form|2|||
23727433|NCT01468701|66382057|FG011|Overall Study|No end of study case report form|3|||
23727434|NCT01468701|66382058|FG012|Overall Study|No end of study case report form|0|||
23727435|NCT01468701|66382059|FG013|Overall Study|No end of study case report form|1|||
23727436|NCT01468701|66382060|FG014|Overall Study|No end of study case report form|0|||
23727437|NCT01468701|66382061|FG015|Overall Study|No end of study case report form|0|||
23727438|NCT01468701|66382062|FG016|Overall Study|No end of study case report form|0|||
23727439|NCT01468701|66382046|FG000|Overall Study|Not being followed up|0|||
23727440|NCT01468701|66382047|FG001|Overall Study|Not being followed up|4963|||
23727441|NCT01468701|66382048|FG002|Overall Study|Not being followed up|1755|||
23727442|NCT01468701|66382049|FG003|Overall Study|Not being followed up|703|||
23727443|NCT01468701|66382050|FG004|Overall Study|Not being followed up|1714|||
23727444|NCT01468701|66382051|FG005|Overall Study|Not being followed up|126|||
23727445|NCT01468701|66382052|FG006|Overall Study|Not being followed up|1170|||
23727446|NCT01468701|66382053|FG007|Overall Study|Not being followed up|4|||
23727447|NCT01468701|66382054|FG008|Overall Study|Not being followed up|0|||
23727448|NCT01468701|66382055|FG009|Overall Study|Not being followed up|0|||
23727449|NCT01468701|66382056|FG010|Overall Study|Not being followed up|0|||
23727450|NCT01468701|66382057|FG011|Overall Study|Not being followed up|0|||
23727451|NCT01468701|66382058|FG012|Overall Study|Not being followed up|0|||
23727452|NCT01468701|66382059|FG013|Overall Study|Not being followed up|0|||
23727453|NCT01468701|66382060|FG014|Overall Study|Not being followed up|0|||
23727454|NCT01468701|66382061|FG015|Overall Study|Not being followed up|0|||
23727455|NCT01468701|66382062|FG016|Overall Study|Not being followed up|0|||
23727456|NCT03099304|66382065|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
23727457|NCT03099304|66382066|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
23727458|NCT03099304|66382067|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
23727459|NCT03099304|66382068|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
23727460|NCT03099304|66382069|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
23727461|NCT03099304|66382070|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
23727462|NCT03099304|66382065|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
23727463|NCT03099304|66382066|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
23727464|NCT03099304|66382067|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23727465|NCT03099304|66382068|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23727466|NCT03099304|66382069|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23727467|NCT03099304|66382070|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23727468|NCT03099304|66382065|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
23727469|NCT03099304|66382066|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
23727470|NCT03099304|66382067|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
23727471|NCT03099304|66382068|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
23816803|NCT00839254|66708516|FG007|Overall Study|Adverse Event|1|||
23727472|NCT03099304|66382069|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
23727473|NCT03099304|66382070|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
23727474|NCT03099304|66382065|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
23727475|NCT03099304|66382066|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
23727476|NCT03099304|66382067|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
23727477|NCT03099304|66382068|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
23727478|NCT03099304|66382069|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
23727479|NCT03099304|66382070|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
23727480|NCT03099304|66382065|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23816804|NCT00839254|66708509|FG000|Overall Study|Withdrawal by Subject|87|||
23727481|NCT03099304|66382066|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23727482|NCT03099304|66382067|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
23727483|NCT03099304|66382068|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
23727484|NCT03099304|66382069|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23727485|NCT03099304|66382070|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23727486|NCT03099304|66382065|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23727487|NCT03099304|66382066|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23727488|NCT03099304|66382067|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
23727489|NCT03099304|66382068|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23727490|NCT03099304|66382069|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23727491|NCT03099304|66382070|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23727492|NCT03099304|66382065|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23727493|NCT03099304|66382066|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23727494|NCT03099304|66382067|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23727495|NCT03099304|66382068|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23727496|NCT03099304|66382069|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23727497|NCT03099304|66382070|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23727498|NCT03099304|66382065|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
23727499|NCT03099304|66382066|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
23727500|NCT03099304|66382067|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
23727501|NCT03099304|66382068|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
23727502|NCT03099304|66382069|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
23727503|NCT03099304|66382070|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
23727504|NCT03099304|66382065|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23727505|NCT03099304|66382066|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23727506|NCT03099304|66382067|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23727507|NCT03099304|66382068|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
23727508|NCT03099304|66382069|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
23727509|NCT03099304|66382070|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23727510|NCT03099304|66382065|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
23727511|NCT03099304|66382066|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
23727512|NCT03099304|66382067|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
23727513|NCT03099304|66382068|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
23727514|NCT03099304|66382069|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
23727515|NCT03099304|66382070|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
23727516|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
23727517|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
23727518|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
23727519|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
23727520|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
23727521|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
23727522|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
23727523|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
23727524|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
23727525|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
23727526|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
23727527|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
23727528|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
23727529|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
23727530|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
23727531|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
23727532|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
23727533|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
23727534|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
23727535|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
23727536|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
23727537|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
23727538|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
23727539|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
23727540|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
23727541|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
23727542|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
23727543|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
23727544|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
23727545|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
23727546|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
23727547|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
23727548|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
23727549|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
23727550|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
23727551|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
23727552|NCT03099304|66382065|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
23727553|NCT03099304|66382066|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
23727554|NCT03099304|66382067|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
23727555|NCT03099304|66382068|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
23727556|NCT03099304|66382069|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
23727557|NCT03099304|66382070|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
23727558|NCT02348840|66382083|FG000|Overall Study|Withdrawal by Subject|2|||
23727559|NCT02348840|66382084|FG001|Overall Study|Withdrawal by Subject|1|||
23727560|NCT02348840|66382085|FG002|Overall Study|Withdrawal by Subject|0|||
23727561|NCT02348840|66382086|FG003|Overall Study|Withdrawal by Subject|0|||
23727562|NCT01678313|66382087|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
23727563|NCT01678313|66382088|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
23727564|NCT01678313|66382087|FG000|Completed the 3-month Therapy|Physician Decision|3|||
23727565|NCT01678313|66382088|FG001|Completed the 3-month Therapy|Physician Decision|4|||
23727566|NCT01678313|66382087|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
23727567|NCT01678313|66382088|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
23727568|NCT01678313|66382087|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
23727569|NCT01678313|66382088|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
23816805|NCT00839254|66708510|FG001|Overall Study|Withdrawal by Subject|53|||
23540676|NCT01539291|65709293|FG003|Study GS-US-312-0116|Physician Decision|0|||
23540677|NCT01539291|65709290|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
23540678|NCT01539291|65709291|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540679|NCT01539291|65709292|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540680|NCT01539291|65709293|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540681|NCT01539291|65709290|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
23540682|NCT01539291|65709291|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540683|NCT01539291|65709292|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540684|NCT01539291|65709293|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540685|NCT01539291|65709290|FG000|Study GS-US-312-0116|Other|1|||
23540686|NCT01539291|65709291|FG001|Study GS-US-312-0116|Other|0|||
23540687|NCT01539291|65709292|FG002|Study GS-US-312-0116|Other|0|||
23540688|NCT01539291|65709293|FG003|Study GS-US-312-0116|Other|0|||
23540689|NCT01539291|65709290|FG000|Study GS-US-312-0117|Adverse Event|22|||
23540690|NCT01539291|65709291|FG001|Study GS-US-312-0117|Adverse Event|1|||
23540691|NCT01539291|65709292|FG002|Study GS-US-312-0117|Adverse Event|9|||
23540692|NCT01539291|65709293|FG003|Study GS-US-312-0117|Adverse Event|12|||
23540693|NCT01539291|65709290|FG000|Study GS-US-312-0117|Physician Decision|9|||
23540694|NCT01539291|65709291|FG001|Study GS-US-312-0117|Physician Decision|0|||
23540695|NCT01539291|65709292|FG002|Study GS-US-312-0117|Physician Decision|6|||
23540696|NCT01539291|65709293|FG003|Study GS-US-312-0117|Physician Decision|4|||
23540697|NCT01539291|65709290|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
23540698|NCT01539291|65709291|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
23816806|NCT00839254|66708511|FG002|Overall Study|Withdrawal by Subject|54|||
23816807|NCT00839254|66708512|FG003|Overall Study|Withdrawal by Subject|32|||
23816808|NCT00839254|66708513|FG004|Overall Study|Withdrawal by Subject|27|||
23816809|NCT00839254|66708514|FG005|Overall Study|Withdrawal by Subject|15|||
23816810|NCT00839254|66708515|FG006|Overall Study|Withdrawal by Subject|22|||
23816811|NCT00839254|66708516|FG007|Overall Study|Withdrawal by Subject|9|||
23816812|NCT00839254|66708509|FG000|Overall Study|Wrong group allocation|0|||
23816813|NCT00839254|66708510|FG001|Overall Study|Wrong group allocation|0|||
23816814|NCT00839254|66708511|FG002|Overall Study|Wrong group allocation|0|||
23540699|NCT01539291|65709292|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
23540700|NCT01539291|65709293|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
23540701|NCT01539291|65709290|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
23540702|NCT01539291|65709291|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
23540703|NCT01539291|65709292|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
23540704|NCT01539291|65709293|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
23540705|NCT01539291|65709290|FG000|Study GS-US-312-0117|Other|2|||
23540706|NCT01539291|65709291|FG001|Study GS-US-312-0117|Other|1|||
23540707|NCT01539291|65709292|FG002|Study GS-US-312-0117|Other|1|||
23540708|NCT01539291|65709293|FG003|Study GS-US-312-0117|Other|1|||
23540709|NCT00009737|65709294|FG000|Overall Study|Adverse Event|112|||
23727570|NCT00246376|66382091|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
23727571|NCT00246376|66382092|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
23816815|NCT00839254|66708512|FG003|Overall Study|Wrong group allocation|0|||
23540710|NCT00009737|65709295|FG001|Overall Study|Adverse Event|75|||
23540711|NCT00009737|65709294|FG000|Overall Study|Death|4|||
23540712|NCT00009737|65709295|FG001|Overall Study|Death|6|||
23540713|NCT00009737|65709294|FG000|Overall Study|Lack of Efficacy|17|||
23540714|NCT00009737|65709295|FG001|Overall Study|Lack of Efficacy|15|||
23540715|NCT00009737|65709294|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
23540716|NCT00009737|65709295|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
23540717|NCT00009737|65709294|FG000|Overall Study|Other Protocol Violation|1|||
23540718|NCT00009737|65709295|FG001|Overall Study|Other Protocol Violation|0|||
23540719|NCT00009737|65709294|FG000|Overall Study|Refused Treatment|15|||
23540720|NCT00009737|65709295|FG001|Overall Study|Refused Treatment|16|||
23540721|NCT00009737|65709294|FG000|Overall Study|Lost to Follow-up|1|||
23540722|NCT00009737|65709295|FG001|Overall Study|Lost to Follow-up|1|||
23540723|NCT00009737|65709294|FG000|Overall Study|Administrative/Other Reasons|7|||
23540724|NCT00009737|65709295|FG001|Overall Study|Administrative/Other Reasons|1|||
23540725|NCT03864900|65709298|FG000|Overall Study|Withdrawal by Subject|1|||
23540726|NCT03864900|65709299|FG001|Overall Study|Withdrawal by Subject|1|||
23540727|NCT03864900|65709298|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
23540728|NCT03864900|65709299|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
23540729|NCT01669343|65709300|FG000|Part A: All Patients|Withdrawal by Subject|7|||
23540730|NCT01669343|65709300|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
23540731|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
23540732|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
23540733|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
23540734|NCT00560833|65709301|FG000|Overall Study|Adverse Event|16|||
23540735|NCT00560833|65709302|FG001|Overall Study|Adverse Event|10|||
23540736|NCT00560833|65709303|FG002|Overall Study|Adverse Event|25|||
23540737|NCT00560833|65709304|FG003|Overall Study|Adverse Event|23|||
23540738|NCT00560833|65709305|FG004|Overall Study|Adverse Event|35|||
23540739|NCT00560833|65709301|FG000|Overall Study|Lost to Follow-up|0|||
23816816|NCT00839254|66708513|FG004|Overall Study|Wrong group allocation|0|||
23816817|NCT00839254|66708514|FG005|Overall Study|Wrong group allocation|0|||
23816818|NCT00839254|66708515|FG006|Overall Study|Wrong group allocation|1|||
23816819|NCT00839254|66708516|FG007|Overall Study|Wrong group allocation|0|||
23816820|NCT00839254|66708509|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
23816821|NCT00839254|66708510|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
23540740|NCT00560833|65709302|FG001|Overall Study|Lost to Follow-up|0|||
23540741|NCT00560833|65709303|FG002|Overall Study|Lost to Follow-up|1|||
23540742|NCT00560833|65709304|FG003|Overall Study|Lost to Follow-up|0|||
23540743|NCT00560833|65709305|FG004|Overall Study|Lost to Follow-up|0|||
23540744|NCT00560833|65709301|FG000|Overall Study|Lack of Efficacy|22|||
23540745|NCT00560833|65709302|FG001|Overall Study|Lack of Efficacy|9|||
23540746|NCT00560833|65709303|FG002|Overall Study|Lack of Efficacy|6|||
23540747|NCT00560833|65709304|FG003|Overall Study|Lack of Efficacy|4|||
23540748|NCT00560833|65709305|FG004|Overall Study|Lack of Efficacy|4|||
23540749|NCT00560833|65709301|FG000|Overall Study|Participant uncooperative|5|||
23540750|NCT00560833|65709302|FG001|Overall Study|Participant uncooperative|5|||
23540751|NCT00560833|65709303|FG002|Overall Study|Participant uncooperative|4|||
23540752|NCT00560833|65709304|FG003|Overall Study|Participant uncooperative|4|||
23540753|NCT00560833|65709305|FG004|Overall Study|Participant uncooperative|2|||
23540754|NCT00560833|65709301|FG000|Overall Study|Other|1|||
23540755|NCT00560833|65709302|FG001|Overall Study|Other|1|||
23540756|NCT00560833|65709303|FG002|Overall Study|Other|3|||
23540757|NCT00560833|65709304|FG003|Overall Study|Other|0|||
23540758|NCT00560833|65709305|FG004|Overall Study|Other|0|||
23540759|NCT00560833|65709301|FG000|Overall Study|Never received drug|0|||
23540760|NCT00560833|65709302|FG001|Overall Study|Never received drug|1|||
23540761|NCT00560833|65709303|FG002|Overall Study|Never received drug|0|||
23540762|NCT00560833|65709304|FG003|Overall Study|Never received drug|0|||
23540763|NCT00560833|65709305|FG004|Overall Study|Never received drug|1|||
23540764|NCT01877421|65709307|FG000|Phase 2|Lost to Follow-up|0|||
23816822|NCT00839254|66708511|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
23816823|NCT00839254|66708512|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
23816824|NCT00839254|66708513|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
23816825|NCT00839254|66708514|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
23816826|NCT00839254|66708515|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
23816827|NCT00839254|66708516|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
23816828|NCT00839254|66708509|FG000|Overall Study|Withdrawn due to non-compliance|2|||
23816829|NCT00839254|66708510|FG001|Overall Study|Withdrawn due to non-compliance|0|||
23540765|NCT01877421|65709308|FG001|Phase 2|Lost to Follow-up|0|||
23540766|NCT01877421|65709309|FG002|Phase 2|Lost to Follow-up|0|||
23540767|NCT01877421|65709310|FG003|Phase 2|Lost to Follow-up|0|||
23540768|NCT01877421|65709311|FG004|Phase 2|Lost to Follow-up|0|||
23540769|NCT01877421|65709312|FG005|Phase 2|Lost to Follow-up|0|||
23540770|NCT01877421|65709313|FG006|Phase 2|Lost to Follow-up|1|||
23540771|NCT01877421|65709314|FG007|Phase 2|Lost to Follow-up|0|||
23540772|NCT01877421|65709315|FG008|Phase 2|Lost to Follow-up|0|||
23540773|NCT01877421|65709316|FG009|Phase 2|Lost to Follow-up|0|||
23540774|NCT01877421|65709317|FG010|Phase 2|Lost to Follow-up|0|||
23540775|NCT01877421|65709318|FG011|Phase 2|Lost to Follow-up|0|||
23816830|NCT00839254|66708511|FG002|Overall Study|Withdrawn due to non-compliance|0|||
23816831|NCT00839254|66708512|FG003|Overall Study|Withdrawn due to non-compliance|0|||
23816832|NCT00839254|66708513|FG004|Overall Study|Withdrawn due to non-compliance|0|||
23816833|NCT00839254|66708514|FG005|Overall Study|Withdrawn due to non-compliance|0|||
23816834|NCT00839254|66708515|FG006|Overall Study|Withdrawn due to non-compliance|0|||
23816835|NCT00839254|66708516|FG007|Overall Study|Withdrawn due to non-compliance|0|||
23816836|NCT00839254|66708509|FG000|Overall Study|Lost to Follow-up|51|||
23816837|NCT00839254|66708510|FG001|Overall Study|Lost to Follow-up|30|||
23816838|NCT00839254|66708511|FG002|Overall Study|Lost to Follow-up|32|||
23816839|NCT00839254|66708512|FG003|Overall Study|Lost to Follow-up|24|||
23816840|NCT00839254|66708513|FG004|Overall Study|Lost to Follow-up|8|||
23816841|NCT00839254|66708514|FG005|Overall Study|Lost to Follow-up|8|||
23816842|NCT00839254|66708515|FG006|Overall Study|Lost to Follow-up|4|||
23816843|NCT00839254|66708516|FG007|Overall Study|Lost to Follow-up|2|||
23816844|NCT02714426|66708517|FG000|Overall Study|Withdrawal by Subject|2|||
23816845|NCT02714426|66708518|FG001|Overall Study|Withdrawal by Subject|2|||
23816846|NCT03249792|66708521|FG000|Arms 1, 2, and 4|Death|1|||
23816847|NCT03249792|66708522|FG001|Arms 1, 2, and 4|Death|1|||
23816848|NCT03249792|66708523|FG002|Arms 1, 2, and 4|Death|0|||
23816849|NCT03249792|66708524|FG003|Arms 1, 2, and 4|Death|2|||
23816850|NCT03249792|66708525|FG004|Arms 1, 2, and 4|Death|3|||
23816851|NCT03249792|66708526|FG005|Arms 1, 2, and 4|Death|2|||
23816852|NCT03249792|66708527|FG006|Arms 1, 2, and 4|Death|2|||
23816853|NCT03249792|66708528|FG007|Arms 1, 2, and 4|Death|4|||
23816854|NCT03249792|66708529|FG008|Arms 1, 2, and 4|Death|2|||
23816855|NCT03249792|66708530|FG009|Arms 1, 2, and 4|Death|1|||
23816856|NCT03249792|66708531|FG010|Arms 1, 2, and 4|Death|7|||
23816857|NCT03249792|66708532|FG011|Arms 1, 2, and 4|Death|7|||
23816858|NCT03249792|66708533|FG012|Arms 1, 2, and 4|Death|12|||
23816859|NCT03249792|66708534|FG013|Arms 1, 2, and 4|Death|7|||
23816860|NCT03249792|66708535|FG014|Arms 1, 2, and 4|Death|0|||
23816861|NCT03249792|66708536|FG015|Arms 1, 2, and 4|Death|4|||
23816862|NCT03249792|66708537|FG016|Arms 1, 2, and 4|Death|4|||
23816863|NCT03249792|66708538|FG017|Arms 1, 2, and 4|Death|12|||
23816864|NCT03249792|66708539|FG018|Arms 1, 2, and 4|Death|6|||
23816865|NCT03249792|66708540|FG019|Arms 1, 2, and 4|Death|4|||
23816866|NCT03249792|66708541|FG020|Arms 1, 2, and 4|Death|2|||
23816867|NCT03249792|66708542|FG021|Arms 1, 2, and 4|Death|3|||
23816868|NCT03249792|66708543|FG022|Arms 1, 2, and 4|Death|1|||
23816869|NCT03249792|66708544|FG023|Arms 1, 2, and 4|Death|1|||
23816870|NCT03249792|66708545|FG024|Arms 1, 2, and 4|Death|4|||
23816871|NCT03249792|66708546|FG025|Arms 1, 2, and 4|Death|0|||
23816872|NCT03249792|66708547|FG026|Arms 1, 2, and 4|Death|0|||
23540776|NCT01877421|65709319|FG012|Phase 2|Lost to Follow-up|0|||
23540777|NCT01877421|65709320|FG013|Phase 2|Lost to Follow-up|0|||
23540778|NCT01877421|65709321|FG014|Phase 2|Lost to Follow-up|0|||
23540779|NCT01877421|65709322|FG015|Phase 2|Lost to Follow-up|0|||
23540780|NCT01877421|65709323|FG016|Phase 2|Lost to Follow-up|0|||
23540781|NCT01877421|65709324|FG017|Phase 2|Lost to Follow-up|0|||
23540782|NCT01877421|65709307|FG000|Phase 2|Withdrawal by Subject|0|||
23727572|NCT00246376|66382093|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
23727573|NCT00246376|66382094|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
23727574|NCT00246376|66382095|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
23727575|NCT00246376|66382091|FG000|Overall Study|Adverse Event|2|||
23727576|NCT00246376|66382092|FG001|Overall Study|Adverse Event|3|||
23727577|NCT00246376|66382093|FG002|Overall Study|Adverse Event|1|||
23727578|NCT00246376|66382094|FG003|Overall Study|Adverse Event|3|||
23727579|NCT00246376|66382095|FG004|Overall Study|Adverse Event|1|||
23727580|NCT00246376|66382091|FG000|Overall Study|Lost to Follow-up|2|||
23727581|NCT00246376|66382092|FG001|Overall Study|Lost to Follow-up|11|||
23727582|NCT00246376|66382093|FG002|Overall Study|Lost to Follow-up|11|||
23727583|NCT00246376|66382094|FG003|Overall Study|Lost to Follow-up|16|||
23816873|NCT03249792|66708548|FG027|Arms 1, 2, and 4|Death|0|||
23816874|NCT03249792|66708549|FG028|Arms 1, 2, and 4|Death|0|||
23816875|NCT03249792|66708550|FG029|Arms 1, 2, and 4|Death|0|||
23816876|NCT03249792|66708551|FG030|Arms 1, 2, and 4|Death|0|||
23816877|NCT03249792|66708552|FG031|Arms 1, 2, and 4|Death|0|||
23540783|NCT01877421|65709308|FG001|Phase 2|Withdrawal by Subject|0|||
23540784|NCT01877421|65709309|FG002|Phase 2|Withdrawal by Subject|0|||
23727584|NCT00246376|66382095|FG004|Overall Study|Lost to Follow-up|13|||
23727585|NCT00247273|66382096|FG000|Overall Study|Adverse Event|85|||
23727586|NCT00247273|66382097|FG001|Overall Study|Adverse Event|80|||
23816878|NCT03249792|66708553|FG032|Arms 1, 2, and 4|Death|0|||
23816879|NCT03249792|66708521|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816880|NCT03249792|66708522|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816881|NCT03249792|66708523|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816882|NCT03249792|66708524|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816883|NCT03249792|66708525|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816884|NCT03249792|66708526|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816885|NCT03249792|66708527|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
23540785|NCT01877421|65709310|FG003|Phase 2|Withdrawal by Subject|0|||
23540786|NCT01877421|65709311|FG004|Phase 2|Withdrawal by Subject|0|||
23540787|NCT01877421|65709312|FG005|Phase 2|Withdrawal by Subject|0|||
23540788|NCT01877421|65709313|FG006|Phase 2|Withdrawal by Subject|0|||
23540789|NCT01877421|65709314|FG007|Phase 2|Withdrawal by Subject|0|||
23540790|NCT01877421|65709315|FG008|Phase 2|Withdrawal by Subject|1|||
23540791|NCT01877421|65709316|FG009|Phase 2|Withdrawal by Subject|0|||
23540792|NCT01877421|65709317|FG010|Phase 2|Withdrawal by Subject|1|||
23540793|NCT01877421|65709318|FG011|Phase 2|Withdrawal by Subject|0|||
23540794|NCT01877421|65709319|FG012|Phase 2|Withdrawal by Subject|1|||
23540795|NCT01877421|65709320|FG013|Phase 2|Withdrawal by Subject|0|||
23540796|NCT01877421|65709321|FG014|Phase 2|Withdrawal by Subject|0|||
23540797|NCT01877421|65709322|FG015|Phase 2|Withdrawal by Subject|1|||
23540798|NCT01877421|65709323|FG016|Phase 2|Withdrawal by Subject|0|||
23540799|NCT01877421|65709324|FG017|Phase 2|Withdrawal by Subject|0|||
23540800|NCT01877421|65709307|FG000|Phase 2|Protocol Violation|0|||
23540801|NCT01877421|65709308|FG001|Phase 2|Protocol Violation|0|||
23540802|NCT01877421|65709309|FG002|Phase 2|Protocol Violation|0|||
23540803|NCT01877421|65709310|FG003|Phase 2|Protocol Violation|0|||
23540804|NCT01877421|65709311|FG004|Phase 2|Protocol Violation|0|||
23540805|NCT01877421|65709312|FG005|Phase 2|Protocol Violation|0|||
23540806|NCT01877421|65709313|FG006|Phase 2|Protocol Violation|0|||
23540807|NCT01877421|65709314|FG007|Phase 2|Protocol Violation|0|||
23540808|NCT01877421|65709315|FG008|Phase 2|Protocol Violation|0|||
23540809|NCT01877421|65709316|FG009|Phase 2|Protocol Violation|0|||
23540810|NCT01877421|65709317|FG010|Phase 2|Protocol Violation|1|||
23540811|NCT01877421|65709318|FG011|Phase 2|Protocol Violation|0|||
23540812|NCT01877421|65709319|FG012|Phase 2|Protocol Violation|0|||
23540813|NCT01877421|65709320|FG013|Phase 2|Protocol Violation|0|||
23540814|NCT01877421|65709321|FG014|Phase 2|Protocol Violation|0|||
23540815|NCT01877421|65709322|FG015|Phase 2|Protocol Violation|0|||
23540816|NCT01877421|65709323|FG016|Phase 2|Protocol Violation|0|||
23540817|NCT01877421|65709324|FG017|Phase 2|Protocol Violation|0|||
23540818|NCT01337245|65709325|FG000|Overall Study|Lost to Follow-up|1|||
23540819|NCT04321460|65709326|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
23540820|NCT04321460|65709327|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
23540821|NCT02391948|65712804|FG000|6-month Assessment|Death|0|||
23540822|NCT02391948|65712805|FG001|6-month Assessment|Death|0|||
23540823|NCT02391948|65712806|FG002|6-month Assessment|Death|0|||
23540824|NCT02391948|65712807|FG003|6-month Assessment|Death|0|||
23540825|NCT02391948|65712808|FG004|6-month Assessment|Death|1|||
23540826|NCT02391948|65712804|FG000|6-month Assessment|Withdrawal by Subject|0|||
23540827|NCT02391948|65712805|FG001|6-month Assessment|Withdrawal by Subject|0|||
23540828|NCT02391948|65712806|FG002|6-month Assessment|Withdrawal by Subject|1|||
23540829|NCT02391948|65712807|FG003|6-month Assessment|Withdrawal by Subject|2|||
23540830|NCT02391948|65712808|FG004|6-month Assessment|Withdrawal by Subject|0|||
23540831|NCT02391948|65712804|FG000|6-month Assessment|Lost to Follow-up|4|||
23540832|NCT02391948|65712805|FG001|6-month Assessment|Lost to Follow-up|5|||
23540833|NCT02391948|65712806|FG002|6-month Assessment|Lost to Follow-up|2|||
23540834|NCT02391948|65712807|FG003|6-month Assessment|Lost to Follow-up|3|||
23540835|NCT02391948|65712808|FG004|6-month Assessment|Lost to Follow-up|1|||
23540836|NCT02391948|65712804|FG000|6-month Assessment|Medical issue/illness|1|||
23540837|NCT02391948|65712805|FG001|6-month Assessment|Medical issue/illness|1|||
23540838|NCT02391948|65712806|FG002|6-month Assessment|Medical issue/illness|0|||
23540839|NCT02391948|65712807|FG003|6-month Assessment|Medical issue/illness|0|||
23540840|NCT02391948|65712808|FG004|6-month Assessment|Medical issue/illness|0|||
23540841|NCT02391948|65712804|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
23540842|NCT02391948|65712805|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
23540843|NCT02391948|65712806|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
23540844|NCT02391948|65712807|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
23540845|NCT02391948|65712808|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
23540846|NCT02391948|65712804|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
23540847|NCT02391948|65712805|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
23540848|NCT02391948|65712806|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
23540849|NCT02391948|65712807|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
23540850|NCT02391948|65712808|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
23540851|NCT02391948|65712804|FG000|12-month Assessment|Death|0|||
23540852|NCT02391948|65712805|FG001|12-month Assessment|Death|0|||
23616669|NCT01945593|65982399|FG001|Overall Study|Other: Screen Failure|2|||
23616670|NCT01945593|65982400|FG002|Overall Study|Other: Screen Failure|0|||
23540853|NCT02391948|65712806|FG002|12-month Assessment|Death|0|||
23540854|NCT02391948|65712807|FG003|12-month Assessment|Death|1|||
23540855|NCT02391948|65712808|FG004|12-month Assessment|Death|0|||
23540856|NCT02391948|65712804|FG000|12-month Assessment|Withdrawal by Subject|1|||
23540857|NCT02391948|65712805|FG001|12-month Assessment|Withdrawal by Subject|0|||
23540858|NCT02391948|65712806|FG002|12-month Assessment|Withdrawal by Subject|0|||
23540859|NCT02391948|65712807|FG003|12-month Assessment|Withdrawal by Subject|1|||
23540860|NCT02391948|65712808|FG004|12-month Assessment|Withdrawal by Subject|0|||
23616671|NCT01945593|65982401|FG003|Overall Study|Other: Screen Failure|0|||
23540861|NCT02391948|65712804|FG000|12-month Assessment|Lost to Follow-up|5|||
23540862|NCT02391948|65712805|FG001|12-month Assessment|Lost to Follow-up|4|||
23540863|NCT02391948|65712806|FG002|12-month Assessment|Lost to Follow-up|4|||
23540864|NCT02391948|65712807|FG003|12-month Assessment|Lost to Follow-up|4|||
23540865|NCT02391948|65712808|FG004|12-month Assessment|Lost to Follow-up|5|||
23540866|NCT02391948|65712804|FG000|12-month Assessment|Medical issue/illness|0|||
23540867|NCT02391948|65712805|FG001|12-month Assessment|Medical issue/illness|1|||
23540868|NCT02391948|65712806|FG002|12-month Assessment|Medical issue/illness|0|||
23540869|NCT02391948|65712807|FG003|12-month Assessment|Medical issue/illness|1|||
23540870|NCT02391948|65712808|FG004|12-month Assessment|Medical issue/illness|0|||
23540871|NCT02391948|65712804|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
23540872|NCT02391948|65712805|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
23540873|NCT02391948|65712806|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
23540874|NCT02391948|65712807|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
23540875|NCT02391948|65712808|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
23540876|NCT02391948|65712804|FG000|18-month Assessment|Death|0|||
23540877|NCT02391948|65712805|FG001|18-month Assessment|Death|0|||
23540878|NCT02391948|65712806|FG002|18-month Assessment|Death|0|||
23540879|NCT02391948|65712807|FG003|18-month Assessment|Death|1|||
23540880|NCT02391948|65712808|FG004|18-month Assessment|Death|1|||
23540881|NCT02391948|65712804|FG000|18-month Assessment|Withdrawal by Subject|1|||
23540882|NCT02391948|65712805|FG001|18-month Assessment|Withdrawal by Subject|0|||
23540883|NCT02391948|65712806|FG002|18-month Assessment|Withdrawal by Subject|0|||
23540884|NCT02391948|65712807|FG003|18-month Assessment|Withdrawal by Subject|1|||
23540885|NCT02391948|65712808|FG004|18-month Assessment|Withdrawal by Subject|0|||
23540886|NCT02391948|65712804|FG000|18-month Assessment|Lost to Follow-up|2|||
23540887|NCT02391948|65712805|FG001|18-month Assessment|Lost to Follow-up|6|||
23540888|NCT02391948|65712806|FG002|18-month Assessment|Lost to Follow-up|2|||
23540889|NCT02391948|65712807|FG003|18-month Assessment|Lost to Follow-up|2|||
23540890|NCT02391948|65712808|FG004|18-month Assessment|Lost to Follow-up|3|||
23540891|NCT02391948|65712804|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
23540892|NCT02391948|65712805|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
23540893|NCT02391948|65712806|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
23540894|NCT02391948|65712807|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
23540895|NCT02391948|65712808|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
23540896|NCT02391948|65712804|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
23540897|NCT02391948|65712805|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
23540898|NCT02391948|65712806|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
23540899|NCT02391948|65712807|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
23540900|NCT02391948|65712808|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
23540901|NCT02391948|65712804|FG000|24-month Assessment|Death|0|||
23540902|NCT02391948|65712805|FG001|24-month Assessment|Death|0|||
23540903|NCT02391948|65712806|FG002|24-month Assessment|Death|0|||
23540904|NCT02391948|65712807|FG003|24-month Assessment|Death|0|||
23540905|NCT02391948|65712808|FG004|24-month Assessment|Death|1|||
23540906|NCT02391948|65712804|FG000|24-month Assessment|Withdrawal by Subject|1|||
23540907|NCT02391948|65712805|FG001|24-month Assessment|Withdrawal by Subject|1|||
23540908|NCT02391948|65712806|FG002|24-month Assessment|Withdrawal by Subject|0|||
23540909|NCT02391948|65712807|FG003|24-month Assessment|Withdrawal by Subject|0|||
23540910|NCT02391948|65712808|FG004|24-month Assessment|Withdrawal by Subject|1|||
23727587|NCT00247273|66382096|FG000|Overall Study|Physician Decision|6|||
23727588|NCT00247273|66382097|FG001|Overall Study|Physician Decision|3|||
23727589|NCT00247273|66382096|FG000|Overall Study|Lost to Follow-up|7|||
23540911|NCT02391948|65712804|FG000|24-month Assessment|Lost to Follow-up|5|||
23540912|NCT02391948|65712805|FG001|24-month Assessment|Lost to Follow-up|4|||
23540913|NCT02391948|65712806|FG002|24-month Assessment|Lost to Follow-up|0|||
23540914|NCT02391948|65712807|FG003|24-month Assessment|Lost to Follow-up|0|||
23540915|NCT02391948|65712808|FG004|24-month Assessment|Lost to Follow-up|0|||
23540916|NCT02391948|65712804|FG000|24-month Assessment|Medical issue/illness|0|||
23540917|NCT02391948|65712805|FG001|24-month Assessment|Medical issue/illness|0|||
23727590|NCT00247273|66382097|FG001|Overall Study|Lost to Follow-up|7|||
23540918|NCT02391948|65712806|FG002|24-month Assessment|Medical issue/illness|1|||
23540919|NCT02391948|65712807|FG003|24-month Assessment|Medical issue/illness|0|||
23540920|NCT02391948|65712808|FG004|24-month Assessment|Medical issue/illness|0|||
23540921|NCT02391948|65712804|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
23540922|NCT02391948|65712805|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
23540923|NCT02391948|65712806|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
23540924|NCT02391948|65712807|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
23540925|NCT02391948|65712808|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
23540926|NCT01958918|65712809|FG000|Overall Study|Death|1|||
23540927|NCT01958918|65712810|FG001|Overall Study|Death|3|||
23540928|NCT01958918|65712809|FG000|Overall Study|Lost to Follow-up|4|||
23727591|NCT00247273|66382096|FG000|Overall Study|Withdrawal by Subject|46|||
23816886|NCT03249792|66708528|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816887|NCT03249792|66708529|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
23816888|NCT03249792|66708530|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816889|NCT03249792|66708531|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
23816890|NCT03249792|66708532|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23816891|NCT03249792|66708533|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
23816892|NCT03249792|66708534|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23816893|NCT03249792|66708535|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816894|NCT03249792|66708536|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23540929|NCT01958918|65712810|FG001|Overall Study|Lost to Follow-up|7|||
23540930|NCT01958918|65712809|FG000|Overall Study|Withdrawal by Subject|13|||
23540931|NCT01958918|65712810|FG001|Overall Study|Withdrawal by Subject|8|||
23540932|NCT01958918|65712809|FG000|Overall Study|Lack of Efficacy|13|||
23540933|NCT01958918|65712810|FG001|Overall Study|Lack of Efficacy|10|||
23540934|NCT01958918|65712809|FG000|Overall Study|Adverse Event|12|||
23540935|NCT01958918|65712810|FG001|Overall Study|Adverse Event|12|||
23540936|NCT01958918|65712809|FG000|Overall Study|administrative problems|0|||
23540937|NCT01958918|65712810|FG001|Overall Study|administrative problems|2|||
23540938|NCT04443218|65712811|FG000|Overall Study|Exited study for other reasons|9|||
23540939|NCT04443218|65712811|FG000|Overall Study|Withdrawal by Subject|1|||
23540940|NCT04443218|65712811|FG000|Overall Study|Lost to Follow-up|4|||
23540941|NCT04443218|65712811|FG000|Overall Study|Death|19|||
23540942|NCT01610700|65712814|FG000|Overall Study|Adverse Event|3|||
23540943|NCT01610700|65712815|FG001|Overall Study|Adverse Event|1|||
23540944|NCT01610700|65712814|FG000|Overall Study|Withdrawal by Subject|0|||
23540945|NCT01610700|65712815|FG001|Overall Study|Withdrawal by Subject|1|||
23540946|NCT01610700|65712814|FG000|Overall Study|subject took one dose of street cannabis|0|||
23540947|NCT01610700|65712815|FG001|Overall Study|subject took one dose of street cannabis|1|||
23540948|NCT02032901|65712817|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
23727592|NCT00247273|66382097|FG001|Overall Study|Withdrawal by Subject|47|||
23727593|NCT00247273|66382096|FG000|Overall Study|Did not take any study drug|2|||
23727594|NCT00247273|66382097|FG001|Overall Study|Did not take any study drug|0|||
23727595|NCT01040728|66382098|FG000|Overall Study|Adverse Event|4|||
23540949|NCT02032901|65712818|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
23540950|NCT02032901|65712817|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
23540951|NCT02032901|65712818|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
23540952|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
23540953|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
23540954|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
23540955|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
23540956|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
23540957|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
23540958|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
23540959|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
23616672|NCT00116584|65982402|FG000|Overall Study|Withdrawal by Subject|1|||
23727596|NCT01040728|66382099|FG001|Overall Study|Adverse Event|8|||
23727597|NCT01040728|66382100|FG002|Overall Study|Adverse Event|0|||
23727598|NCT01040728|66382101|FG003|Overall Study|Adverse Event|4|||
23727599|NCT01040728|66382098|FG000|Overall Study|Withdrawal by Subject|0|||
23727600|NCT01040728|66382099|FG001|Overall Study|Withdrawal by Subject|1|||
23727601|NCT01040728|66382100|FG002|Overall Study|Withdrawal by Subject|1|||
23727602|NCT01040728|66382101|FG003|Overall Study|Withdrawal by Subject|0|||
23727603|NCT01040728|66382098|FG000|Overall Study|Protocol Violation|0|||
23727604|NCT01040728|66382099|FG001|Overall Study|Protocol Violation|0|||
23727605|NCT01040728|66382100|FG002|Overall Study|Protocol Violation|0|||
23727606|NCT01040728|66382101|FG003|Overall Study|Protocol Violation|1|||
23727607|NCT01040728|66382098|FG000|Overall Study|Lack of Efficacy|0|||
23727608|NCT01040728|66382099|FG001|Overall Study|Lack of Efficacy|1|||
23727609|NCT01040728|66382100|FG002|Overall Study|Lack of Efficacy|0|||
23727610|NCT01040728|66382101|FG003|Overall Study|Lack of Efficacy|1|||
23816895|NCT03249792|66708537|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23540960|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
23540961|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
23540962|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
23540963|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
23540964|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
23727611|NCT01040728|66382098|FG000|Overall Study|Other reasons not listed above|0|||
23727612|NCT01040728|66382099|FG001|Overall Study|Other reasons not listed above|1|||
23616673|NCT00116584|65982403|FG001|Overall Study|Withdrawal by Subject|0|||
23727613|NCT01040728|66382100|FG002|Overall Study|Other reasons not listed above|0|||
23727614|NCT01040728|66382101|FG003|Overall Study|Other reasons not listed above|0|||
23727615|NCT02940860|66382104|FG000|Overall Study|Non-serious AE|1|||
23727616|NCT02940860|66382105|FG001|Overall Study|Non-serious AE|2|||
23727617|NCT02940860|66382104|FG000|Overall Study|Serious AE|7|||
23727618|NCT02940860|66382105|FG001|Overall Study|Serious AE|3|||
23727619|NCT02940860|66382104|FG000|Overall Study|Withdrawal by Subject|19|||
23727620|NCT02940860|66382105|FG001|Overall Study|Withdrawal by Subject|9|||
23727621|NCT02940860|66382104|FG000|Overall Study|Lost to Follow-up|13|||
23727622|NCT02940860|66382105|FG001|Overall Study|Lost to Follow-up|7|||
23727623|NCT02940860|66382104|FG000|Overall Study|Physician Decision|5|||
23727624|NCT02940860|66382105|FG001|Overall Study|Physician Decision|3|||
23727625|NCT02940860|66382104|FG000|Overall Study|Sponsor Decision|0|||
23727626|NCT02940860|66382105|FG001|Overall Study|Sponsor Decision|1|||
23727627|NCT02940860|66382104|FG000|Overall Study|Protocol Violation|0|||
23727628|NCT02940860|66382105|FG001|Overall Study|Protocol Violation|2|||
23727629|NCT02940860|66382104|FG000|Overall Study|Death|3|||
23727630|NCT02940860|66382105|FG001|Overall Study|Death|2|||
23727631|NCT02940860|66382104|FG000|Overall Study|Moved, poor venous access, transport|6|||
23727632|NCT02940860|66382105|FG001|Overall Study|Moved, poor venous access, transport|4|||
23727633|NCT02940860|66382104|FG000|Overall Study|Not treated|2|||
23727634|NCT02940860|66382105|FG001|Overall Study|Not treated|2|||
23727635|NCT00633893|66382106|FG000|Overall Study|Death|1|||
23727636|NCT00633893|66382107|FG001|Overall Study|Death|3|||
23727637|NCT00633893|66382108|FG002|Overall Study|Death|9|||
23727638|NCT00633893|66382106|FG000|Overall Study|Adverse Event|65|||
23727639|NCT00633893|66382107|FG001|Overall Study|Adverse Event|58|||
23727640|NCT00633893|66382108|FG002|Overall Study|Adverse Event|126|||
23727641|NCT00633893|66382106|FG000|Overall Study|Withdrawal by Subject|7|||
23727642|NCT00633893|66382107|FG001|Overall Study|Withdrawal by Subject|12|||
23727643|NCT00633893|66382108|FG002|Overall Study|Withdrawal by Subject|6|||
23727644|NCT00633893|66382106|FG000|Overall Study|Lost to Follow-up|2|||
23727645|NCT00633893|66382107|FG001|Overall Study|Lost to Follow-up|4|||
23727646|NCT00633893|66382108|FG002|Overall Study|Lost to Follow-up|8|||
23727647|NCT00633893|66382106|FG000|Overall Study|Poor/non-compliance|5|||
23727648|NCT00633893|66382107|FG001|Overall Study|Poor/non-compliance|12|||
23727649|NCT00633893|66382108|FG002|Overall Study|Poor/non-compliance|3|||
23727650|NCT00633893|66382106|FG000|Overall Study|Pregnancy|2|||
23727651|NCT00633893|66382107|FG001|Overall Study|Pregnancy|1|||
23727652|NCT00633893|66382108|FG002|Overall Study|Pregnancy|1|||
23727653|NCT00633893|66382106|FG000|Overall Study|Not meet/no longer meets criteria|4|||
23727654|NCT00633893|66382107|FG001|Overall Study|Not meet/no longer meets criteria|6|||
23727655|NCT00633893|66382108|FG002|Overall Study|Not meet/no longer meets criteria|4|||
23727656|NCT00633893|66382106|FG000|Overall Study|Other|28|||
23727657|NCT00633893|66382107|FG001|Overall Study|Other|33|||
23727658|NCT00633893|66382108|FG002|Overall Study|Other|31|||
23727659|NCT02187224|66382117|FG000|Overall Study|Did not show up for test day|1|||
23727660|NCT02187224|66382118|FG001|Overall Study|Did not show up for test day|0|||
23727661|NCT01819194|66382119|FG000|Overall Study|Loss of study articles|2|||
23540965|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
23540966|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
23540967|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
23540968|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
23727662|NCT00479167|66382125|FG000|Overall Study|Withdrawal by Subject|1|||
23727663|NCT00552344|66382126|FG000|Overall Study|Lack of Efficacy|55|||
23727664|NCT00552344|66382126|FG000|Overall Study|Loss of efficacy|75|||
23727665|NCT00552344|66382126|FG000|Overall Study|Lost to Follow-up|8|||
23727666|NCT00552344|66382126|FG000|Overall Study|Withdrawal by Subject|48|||
23727667|NCT00552344|66382126|FG000|Overall Study|SAE, non-fatal|6|||
23727668|NCT00552344|66382126|FG000|Overall Study|AE, non-serious non-fatal|38|||
23727669|NCT00552344|66382126|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
23727670|NCT00552344|66382126|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
23727671|NCT00552344|66382126|FG000|Overall Study|Other Reason|22|||
23727672|NCT03238352|66382129|FG000|Overall Study|Lost to Follow-up|0|||
23727673|NCT03238352|66382130|FG001|Overall Study|Lost to Follow-up|2|||
23540969|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
23540970|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
23540971|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
23540972|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
23540973|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540974|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540975|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540976|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
23540977|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23582198|NCT02929108|65862373|FG006|Overall Study|Hospice patient death|78|||
23727674|NCT03238352|66382131|FG002|Overall Study|Lost to Follow-up|1|||
23727675|NCT03238352|66382129|FG000|Overall Study|Withdrawal by Subject|0|||
23816896|NCT03249792|66708538|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816897|NCT03249792|66708539|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816898|NCT03249792|66708540|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816899|NCT03249792|66708541|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816900|NCT03249792|66708542|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816901|NCT03249792|66708543|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816902|NCT03249792|66708544|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23816903|NCT03249792|66708545|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816904|NCT03249792|66708546|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816905|NCT03249792|66708547|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816906|NCT03249792|66708548|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816907|NCT03249792|66708549|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816908|NCT03249792|66708550|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816909|NCT03249792|66708551|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816910|NCT03249792|66708552|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816911|NCT03249792|66708553|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23816912|NCT03249792|66708521|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
23816913|NCT03249792|66708522|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
23816914|NCT03249792|66708523|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
23816915|NCT03249792|66708524|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
23727676|NCT03238352|66382130|FG001|Overall Study|Withdrawal by Subject|1|||
23727677|NCT03238352|66382131|FG002|Overall Study|Withdrawal by Subject|0|||
23540978|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23540979|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23540980|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540981|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540982|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
23540983|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540984|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540985|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540986|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540987|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
23540988|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
23540989|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
23540990|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
23540991|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
23540992|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540993|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
23540994|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540995|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540996|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
23540997|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
23540998|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
23616674|NCT00116584|65982402|FG000|Overall Study|Protocol Violation|1|||
23616675|NCT00116584|65982403|FG001|Overall Study|Protocol Violation|1|||
23540999|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
23541000|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
23541001|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
23541002|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
23541003|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
23541004|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541005|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
23541006|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541007|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541008|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541009|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541010|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541011|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
23541012|NCT01165281|65712839|FG000|Overall Study|Adverse Event|12|||
23541013|NCT01165281|65712840|FG001|Overall Study|Adverse Event|14|||
23541014|NCT01165281|65712839|FG000|Overall Study|Death|3|||
23541015|NCT01165281|65712840|FG001|Overall Study|Death|4|||
23541016|NCT01165281|65712839|FG000|Overall Study|Lack of Efficacy|4|||
23541017|NCT01165281|65712840|FG001|Overall Study|Lack of Efficacy|1|||
23541018|NCT01165281|65712839|FG000|Overall Study|Lost to Follow-up|0|||
23541019|NCT01165281|65712840|FG001|Overall Study|Lost to Follow-up|1|||
23541020|NCT01165281|65712839|FG000|Overall Study|Physician Decision|8|||
23541021|NCT01165281|65712840|FG001|Overall Study|Physician Decision|1|||
23541022|NCT01165281|65712839|FG000|Overall Study|Protocol Violation|6|||
23541023|NCT01165281|65712840|FG001|Overall Study|Protocol Violation|5|||
23541024|NCT01165281|65712839|FG000|Overall Study|Withdrawal by Subject|8|||
23541025|NCT01165281|65712840|FG001|Overall Study|Withdrawal by Subject|7|||
23541026|NCT01165281|65712839|FG000|Overall Study|Noncompliance with Study Drug|1|||
23541027|NCT01165281|65712840|FG001|Overall Study|Noncompliance with Study Drug|4|||
23541028|NCT01165281|65712839|FG000|Overall Study|Progressive Disease|10|||
23541029|NCT01165281|65712840|FG001|Overall Study|Progressive Disease|14|||
23541030|NCT01165281|65712839|FG000|Overall Study|Other|6|||
23541031|NCT01165281|65712840|FG001|Overall Study|Other|0|||
23541032|NCT02641080|65712843|FG000|Overall Study|Physician Decision|2|||
23541033|NCT02641080|65712844|FG001|Overall Study|Physician Decision|0|||
23541034|NCT02641080|65712843|FG000|Overall Study|Withdrawal by Subject|0|||
23541035|NCT02641080|65712844|FG001|Overall Study|Withdrawal by Subject|1|||
23541036|NCT02641080|65712843|FG000|Overall Study|Rehab Center denied use of pumps|0|||
23541037|NCT02641080|65712844|FG001|Overall Study|Rehab Center denied use of pumps|3|||
23541038|NCT02641080|65712843|FG000|Overall Study|Lost to Follow-up|0|||
23541039|NCT02641080|65712844|FG001|Overall Study|Lost to Follow-up|3|||
23541040|NCT01762761|65712845|FG000|Overall Study|Adverse Event|15|||
23541041|NCT01762761|65712846|FG001|Overall Study|Adverse Event|17|||
23541042|NCT01762761|65712845|FG000|Overall Study|Lack of Efficacy|9|||
23541043|NCT01762761|65712846|FG001|Overall Study|Lack of Efficacy|25|||
23541044|NCT01762761|65712845|FG000|Overall Study|Protocol Violation|1|||
23727678|NCT03839940|66382132|FG000|Overall Study|Withdrawal by Subject|3|||
23541045|NCT01762761|65712846|FG001|Overall Study|Protocol Violation|1|||
23541046|NCT01762761|65712845|FG000|Overall Study|Study closed/terminated|0|||
23541047|NCT01762761|65712846|FG001|Overall Study|Study closed/terminated|2|||
23541048|NCT01762761|65712845|FG000|Overall Study|Lost to Follow-up|3|||
23541049|NCT01762761|65712846|FG001|Overall Study|Lost to Follow-up|6|||
23541050|NCT01762761|65712845|FG000|Overall Study|Physician Decision|4|||
23541051|NCT01762761|65712846|FG001|Overall Study|Physician Decision|6|||
23541052|NCT01762761|65712845|FG000|Overall Study|Withdrawal by Subject|7|||
23541053|NCT01762761|65712846|FG001|Overall Study|Withdrawal by Subject|8|||
23424393|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
23424394|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424395|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424396|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424397|NCT00916058|65296480|FG000|Phase 1|Screen Failure|0|||
23424398|NCT00916058|65296481|FG001|Phase 1|Screen Failure|0|||
23424399|NCT00916058|65296482|FG002|Phase 1|Screen Failure|0|||
23424400|NCT00916058|65296483|FG003|Phase 1|Screen Failure|0|||
23424401|NCT00916058|65296484|FG004|Phase 1|Screen Failure|0|||
23424402|NCT00916058|65296485|FG005|Phase 1|Screen Failure|1|||
23424403|NCT00916058|65296486|FG006|Phase 1|Screen Failure|0|||
23424404|NCT00916058|65296480|FG000|Phase 2|Screen Failure|0|||
23424405|NCT00916058|65296481|FG001|Phase 2|Screen Failure|0|||
23424406|NCT00916058|65296482|FG002|Phase 2|Screen Failure|0|||
23424407|NCT00916058|65296483|FG003|Phase 2|Screen Failure|0|||
23424408|NCT00916058|65296484|FG004|Phase 2|Screen Failure|0|||
23424409|NCT00916058|65296485|FG005|Phase 2|Screen Failure|0|||
23424410|NCT00916058|65296486|FG006|Phase 2|Screen Failure|3|||
23424411|NCT01605227|65296487|FG000|Overall Study|Did not receive study treatment|2|||
23424412|NCT01605227|65296488|FG001|Overall Study|Did not receive study treatment|3|||
23424413|NCT01605227|65296487|FG000|Overall Study|Adverse Event|228|||
23424414|NCT01605227|65296488|FG001|Overall Study|Adverse Event|42|||
23424415|NCT01605227|65296487|FG000|Overall Study|Progressive Disease|132|||
23424416|NCT01605227|65296488|FG001|Overall Study|Progressive Disease|128|||
23424417|NCT01605227|65296487|FG000|Overall Study|Clinical Deterioration|227|||
23424418|NCT01605227|65296488|FG001|Overall Study|Clinical Deterioration|133|||
23424419|NCT01605227|65296487|FG000|Overall Study|Lost to Follow-up|1|||
23424420|NCT01605227|65296488|FG001|Overall Study|Lost to Follow-up|0|||
23424421|NCT01605227|65296487|FG000|Overall Study|Protocol Violation|1|||
23424422|NCT01605227|65296488|FG001|Overall Study|Protocol Violation|0|||
23424423|NCT01605227|65296487|FG000|Overall Study|Physician Decision|9|||
23424424|NCT01605227|65296488|FG001|Overall Study|Physician Decision|7|||
23424425|NCT01605227|65296487|FG000|Overall Study|Withdrawal by Subject|18|||
23424426|NCT01605227|65296488|FG001|Overall Study|Withdrawal by Subject|14|||
23424427|NCT01605227|65296487|FG000|Overall Study|Sponsor Decision|2|||
23424428|NCT01605227|65296488|FG001|Overall Study|Sponsor Decision|0|||
23424429|NCT01605227|65296487|FG000|Overall Study|Started New Therapy|1|||
23424430|NCT01605227|65296488|FG001|Overall Study|Started New Therapy|0|||
23424431|NCT01605227|65296487|FG000|Overall Study|Subject Decision|0|||
23424432|NCT01605227|65296488|FG001|Overall Study|Subject Decision|1|||
23424433|NCT01605227|65296487|FG000|Overall Study|Dose Held >6 weeks|0|||
23424434|NCT01605227|65296488|FG001|Overall Study|Dose Held >6 weeks|1|||
23424435|NCT03276052|65296489|FG000|Overall Study|Withdrawal by Subject|5|||
23424436|NCT03276052|65296489|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
23424437|NCT01740089|65296490|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
23424438|NCT01740089|65296491|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
23424439|NCT01740089|65296492|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
23424440|NCT01740089|65296490|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
23424441|NCT01740089|65296491|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
23424442|NCT01740089|65296492|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
23424443|NCT01740089|65296490|FG000|After 12 Weeks|Lack of Efficacy|3|||
23424444|NCT01740089|65296491|FG001|After 12 Weeks|Lack of Efficacy|1|||
23424445|NCT01740089|65296492|FG002|After 12 Weeks|Lack of Efficacy|4|||
23424446|NCT01740089|65296490|FG000|After 12 Weeks|Adverse Event|2|||
23424447|NCT01740089|65296491|FG001|After 12 Weeks|Adverse Event|0|||
23424448|NCT01740089|65296492|FG002|After 12 Weeks|Adverse Event|5|||
23424449|NCT01740089|65296490|FG000|After 12 Weeks|Protocol Violation|1|||
23424450|NCT01740089|65296491|FG001|After 12 Weeks|Protocol Violation|1|||
23424451|NCT01740089|65296492|FG002|After 12 Weeks|Protocol Violation|1|||
23424452|NCT01740089|65296490|FG000|After 12 Weeks|Withdrawal by Subject|1|||
23424453|NCT01740089|65296491|FG001|After 12 Weeks|Withdrawal by Subject|1|||
23424454|NCT01740089|65296492|FG002|After 12 Weeks|Withdrawal by Subject|1|||
23424455|NCT01515475|65299644|FG000|Overall Study|Lost to Follow-up|20|||
23424456|NCT01515475|65299645|FG001|Overall Study|Lost to Follow-up|15|||
23424457|NCT01515475|65299646|FG002|Overall Study|Lost to Follow-up|12|||
23424458|NCT01515475|65299647|FG003|Overall Study|Lost to Follow-up|12|||
23424459|NCT01360398|65299657|FG000|Overall Study|Withdrawal by Subject|14|||
23424460|NCT01360398|65299657|FG000|Overall Study|Other|7|||
23424461|NCT01360398|65299657|FG000|Overall Study|Migrated/moved from study area|1|||
23424462|NCT00919867|65299663|FG000|First Intervention|Withdrawal by Subject|0|||
23424463|NCT00919867|65299664|FG001|First Intervention|Withdrawal by Subject|0|||
23424464|NCT00919867|65299665|FG002|First Intervention|Withdrawal by Subject|1|||
23424465|NCT00919867|65299666|FG003|First Intervention|Withdrawal by Subject|0|||
23424466|NCT00919867|65299667|FG004|First Intervention|Withdrawal by Subject|0|||
23424467|NCT00919867|65299668|FG005|First Intervention|Withdrawal by Subject|0|||
23424468|NCT00919867|65299663|FG000|First Intervention|Physician Decision|0|||
23424469|NCT00919867|65299664|FG001|First Intervention|Physician Decision|0|||
23424470|NCT00919867|65299665|FG002|First Intervention|Physician Decision|0|||
23424471|NCT00919867|65299666|FG003|First Intervention|Physician Decision|0|||
23541054|NCT01272934|65712847|FG000|Overall Study|Adverse Event|0|||
23541055|NCT01272934|65712848|FG001|Overall Study|Adverse Event|1|||
23541056|NCT01272934|65712847|FG000|Overall Study|Abnormal Laboratory Value|0|||
23541057|NCT01272934|65712848|FG001|Overall Study|Abnormal Laboratory Value|1|||
23541058|NCT03943095|65712865|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
23541059|NCT03943095|65712866|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
23541060|NCT03943095|65712865|FG000|Overall Study|Withdrawal by Subject|1|||
23541061|NCT03943095|65712866|FG001|Overall Study|Withdrawal by Subject|0|||
23541062|NCT03359096|65712873|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
23541063|NCT03359096|65712874|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
23541064|NCT03359096|65712873|FG000|First Intervention (4 Weeks)|Death|1|||
23541065|NCT03359096|65712874|FG001|First Intervention (4 Weeks)|Death|0|||
23541066|NCT03359096|65712873|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
23541067|NCT03359096|65712874|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
23541068|NCT01602315|65712875|FG000|Overall Study|Protocol Violation|0|||
23541069|NCT01602315|65712876|FG001|Overall Study|Protocol Violation|0|||
23541070|NCT01602315|65712877|FG002|Overall Study|Protocol Violation|0|||
23541071|NCT01602315|65712878|FG003|Overall Study|Protocol Violation|0|||
23541072|NCT01602315|65712879|FG004|Overall Study|Protocol Violation|0|||
23541073|NCT01602315|65712880|FG005|Overall Study|Protocol Violation|1|||
23816916|NCT03249792|66708525|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
23816917|NCT03249792|66708526|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
23816918|NCT03249792|66708527|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
23541074|NCT01602315|65712881|FG006|Overall Study|Protocol Violation|0|||
23541075|NCT01602315|65712875|FG000|Overall Study|Physician Decision|2|||
23541076|NCT01602315|65712876|FG001|Overall Study|Physician Decision|0|||
23541077|NCT01602315|65712877|FG002|Overall Study|Physician Decision|0|||
23541078|NCT01602315|65712878|FG003|Overall Study|Physician Decision|0|||
23541079|NCT01602315|65712879|FG004|Overall Study|Physician Decision|2|||
23541080|NCT01602315|65712880|FG005|Overall Study|Physician Decision|1|||
23541081|NCT01602315|65712881|FG006|Overall Study|Physician Decision|1|||
23541082|NCT01602315|65712875|FG000|Overall Study|Disease progression|6|||
23541083|NCT01602315|65712876|FG001|Overall Study|Disease progression|3|||
23541084|NCT01602315|65712877|FG002|Overall Study|Disease progression|10|||
23541085|NCT01602315|65712878|FG003|Overall Study|Disease progression|1|||
23541086|NCT01602315|65712879|FG004|Overall Study|Disease progression|41|||
23541087|NCT01602315|65712880|FG005|Overall Study|Disease progression|12|||
23541088|NCT01602315|65712881|FG006|Overall Study|Disease progression|15|||
23541089|NCT01602315|65712875|FG000|Overall Study|Death|1|||
23541090|NCT01602315|65712876|FG001|Overall Study|Death|1|||
23541091|NCT01602315|65712877|FG002|Overall Study|Death|1|||
23541092|NCT01602315|65712878|FG003|Overall Study|Death|1|||
23541093|NCT01602315|65712879|FG004|Overall Study|Death|7|||
23541094|NCT01602315|65712880|FG005|Overall Study|Death|2|||
23541095|NCT01602315|65712881|FG006|Overall Study|Death|2|||
23541096|NCT01602315|65712875|FG000|Overall Study|Withdrawal by Subject|2|||
23541097|NCT01602315|65712876|FG001|Overall Study|Withdrawal by Subject|0|||
23541098|NCT01602315|65712877|FG002|Overall Study|Withdrawal by Subject|2|||
23541099|NCT01602315|65712878|FG003|Overall Study|Withdrawal by Subject|0|||
23541100|NCT01602315|65712879|FG004|Overall Study|Withdrawal by Subject|6|||
23541101|NCT01602315|65712880|FG005|Overall Study|Withdrawal by Subject|0|||
23541102|NCT01602315|65712881|FG006|Overall Study|Withdrawal by Subject|1|||
23541103|NCT01602315|65712875|FG000|Overall Study|Adverse Event|5|||
23541104|NCT01602315|65712876|FG001|Overall Study|Adverse Event|1|||
23541105|NCT01602315|65712877|FG002|Overall Study|Adverse Event|5|||
23541106|NCT01602315|65712878|FG003|Overall Study|Adverse Event|4|||
23541107|NCT01602315|65712879|FG004|Overall Study|Adverse Event|15|||
23541108|NCT01602315|65712880|FG005|Overall Study|Adverse Event|3|||
23541109|NCT01602315|65712881|FG006|Overall Study|Adverse Event|9|||
23541110|NCT01602315|65712875|FG000|Overall Study|Subject/guardian decision|0|||
23541111|NCT01602315|65712876|FG001|Overall Study|Subject/guardian decision|0|||
23541112|NCT01602315|65712877|FG002|Overall Study|Subject/guardian decision|0|||
23541113|NCT01602315|65712878|FG003|Overall Study|Subject/guardian decision|0|||
23541114|NCT01602315|65712879|FG004|Overall Study|Subject/guardian decision|0|||
23541115|NCT01602315|65712880|FG005|Overall Study|Subject/guardian decision|0|||
23541116|NCT01602315|65712881|FG006|Overall Study|Subject/guardian decision|1|||
23541117|NCT01602315|65712875|FG000|Overall Study|Cross-over patients to combo treatment|0|||
23541118|NCT01602315|65712876|FG001|Overall Study|Cross-over patients to combo treatment|0|||
23541119|NCT01602315|65712877|FG002|Overall Study|Cross-over patients to combo treatment|0|||
23541120|NCT01602315|65712878|FG003|Overall Study|Cross-over patients to combo treatment|0|||
23541121|NCT01602315|65712879|FG004|Overall Study|Cross-over patients to combo treatment|0|||
23541122|NCT01602315|65712880|FG005|Overall Study|Cross-over patients to combo treatment|16|||
23616676|NCT00747149|65982404|FG000|Overall Study|Adverse Event|0|||
23541123|NCT01602315|65712881|FG006|Overall Study|Cross-over patients to combo treatment|0|||
23541124|NCT00765245|65712884|FG000|Overall Study|disease progression|3|||
23541125|NCT00765245|65712885|FG001|Overall Study|disease progression|2|||
23541126|NCT00765245|65712884|FG000|Overall Study|Withdrawal by Subject|3|||
23541127|NCT00765245|65712885|FG001|Overall Study|Withdrawal by Subject|0|||
23541128|NCT00765245|65712884|FG000|Overall Study|Adverse Event|5|||
23541129|NCT00765245|65712885|FG001|Overall Study|Adverse Event|0|||
23541130|NCT00765245|65712884|FG000|Overall Study|Physician Decision|1|||
23541131|NCT00765245|65712885|FG001|Overall Study|Physician Decision|0|||
23541132|NCT00765245|65712884|FG000|Overall Study|Death|1|||
23541133|NCT00765245|65712885|FG001|Overall Study|Death|0|||
23541134|NCT00982020|65712886|FG000|Overall Study|Adverse Event|19|||
23541135|NCT00982020|65712887|FG001|Overall Study|Adverse Event|15|||
23541136|NCT00982020|65712886|FG000|Overall Study|Withdrawal by Subject|11|||
23541137|NCT00982020|65712887|FG001|Overall Study|Withdrawal by Subject|14|||
23541138|NCT00982020|65712886|FG000|Overall Study|Lost to Follow-up|5|||
23541139|NCT00982020|65712887|FG001|Overall Study|Lost to Follow-up|11|||
23541140|NCT00982020|65712886|FG000|Overall Study|Lack of Efficacy|10|||
23541141|NCT00982020|65712887|FG001|Overall Study|Lack of Efficacy|4|||
23541142|NCT00982020|65712886|FG000|Overall Study|Parent/Caregiver Decision|5|||
23541143|NCT00982020|65712887|FG001|Overall Study|Parent/Caregiver Decision|5|||
23541144|NCT00982020|65712886|FG000|Overall Study|Treatment Non-compliance|3|||
23541145|NCT00982020|65712887|FG001|Overall Study|Treatment Non-compliance|6|||
23541146|NCT00982020|65712886|FG000|Overall Study|Physician Decision|2|||
23541147|NCT00982020|65712887|FG001|Overall Study|Physician Decision|5|||
23541148|NCT00982020|65712886|FG000|Overall Study|Entry Criteria Not Met|2|||
23541149|NCT00982020|65712887|FG001|Overall Study|Entry Criteria Not Met|1|||
23541150|NCT00982020|65712886|FG000|Overall Study|Protocol Violation|0|||
23541151|NCT00982020|65712887|FG001|Overall Study|Protocol Violation|2|||
23541152|NCT00982020|65712886|FG000|Overall Study|Clinical Relapse|0|||
23541153|NCT00982020|65712887|FG001|Overall Study|Clinical Relapse|1|||
23541154|NCT00345397|65712888|FG000|Overall Study|Death|1|||
23541155|NCT00709722|65712891|FG000|Overall Study|Adverse Event|1|||
23541156|NCT02371369|65712894|FG000|Part 1|Physician Decision|0|||
23541157|NCT02371369|65712895|FG001|Part 1|Physician Decision|3|||
23541158|NCT02371369|65712894|FG000|Part 1|Adverse Event|8|||
23541159|NCT02371369|65712895|FG001|Part 1|Adverse Event|0|||
23541160|NCT02371369|65712894|FG000|Part 1|Withdrawal by Subject|1|||
23541161|NCT02371369|65712895|FG001|Part 1|Withdrawal by Subject|6|||
23541162|NCT02371369|65712894|FG000|Part 1|Disease progression|0|||
23541163|NCT02371369|65712895|FG001|Part 1|Disease progression|1|||
23541164|NCT02371369|65712894|FG000|Part 1|Protocol Violation|0|||
23541165|NCT02371369|65712895|FG001|Part 1|Protocol Violation|1|||
23541166|NCT02371369|65712894|FG000|Part 2|Adverse Event|6|||
23541167|NCT02371369|65712895|FG001|Part 2|Adverse Event|5|||
23541168|NCT02371369|65712894|FG000|Part 2|Withdrawal by Subject|16|||
23541169|NCT02371369|65712895|FG001|Part 2|Withdrawal by Subject|6|||
23541170|NCT02371369|65712894|FG000|Part 2|Investigator decision|1|||
23541171|NCT02371369|65712895|FG001|Part 2|Investigator decision|2|||
23541172|NCT02371369|65712894|FG000|Part 2|Death|0|||
23541173|NCT02371369|65712895|FG001|Part 2|Death|1|||
23541174|NCT02371369|65712894|FG000|Part 2|Disease progression|1|||
23541175|NCT02371369|65712895|FG001|Part 2|Disease progression|0|||
23541176|NCT02371369|65712894|FG000|Part 2|Subject Noncompliance|1|||
23541177|NCT02371369|65712895|FG001|Part 2|Subject Noncompliance|0|||
23541178|NCT02371369|65712894|FG000|Part 2|Lost to Follow-up|1|||
23541179|NCT02371369|65712895|FG001|Part 2|Lost to Follow-up|1|||
23541180|NCT02371369|65712894|FG000|Part 2|Subject transitioned to commercial supply|6|||
23541181|NCT02371369|65712895|FG001|Part 2|Subject transitioned to commercial supply|4|||
23541182|NCT02371369|65712894|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
23541183|NCT02371369|65712895|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
23541184|NCT02371369|65712894|FG000|Part 2|Surgical resection of tumor|1|||
23541185|NCT02371369|65712895|FG001|Part 2|Surgical resection of tumor|1|||
23541186|NCT02371369|65712894|FG000|Part 2|Other|0|||
23541187|NCT02371369|65712895|FG001|Part 2|Other|1|||
23541188|NCT01438411|65712896|FG000|Overall Study|Adverse Event|8|||
23541189|NCT01438411|65712896|FG000|Overall Study|Lost to Follow-up|1|||
23541190|NCT01438411|65712896|FG000|Overall Study|Lack of Efficacy|1|||
23541191|NCT01438411|65712896|FG000|Overall Study|Withdrawal by Subject|3|||
23541192|NCT04964089|65712897|FG000|Overall Study|Adverse Event|8|||
23541193|NCT04964089|65712898|FG001|Overall Study|Adverse Event|6|||
23541194|NCT04964089|65712897|FG000|Overall Study|Non-compliance with study schedule|1|||
23541195|NCT04964089|65712898|FG001|Overall Study|Non-compliance with study schedule|0|||
23541196|NCT04964089|65712897|FG000|Overall Study|Withdrawal by Subject|6|||
23541197|NCT04964089|65712898|FG001|Overall Study|Withdrawal by Subject|5|||
23541198|NCT04964089|65712897|FG000|Overall Study|Lost to Follow-up|1|||
23541199|NCT04964089|65712898|FG001|Overall Study|Lost to Follow-up|1|||
23541200|NCT04964089|65712897|FG000|Overall Study|Progressive disease|4|||
23541201|NCT04964089|65712898|FG001|Overall Study|Progressive disease|0|||
23541202|NCT04964089|65712897|FG000|Overall Study|Physician Decision|1|||
23541203|NCT04964089|65712898|FG001|Overall Study|Physician Decision|0|||
23541204|NCT04964089|65712897|FG000|Overall Study|Participant did not want to continue study treatment|1|||
23541205|NCT04964089|65712898|FG001|Overall Study|Participant did not want to continue study treatment|0|||
23582199|NCT02892409|65862380|FG000|Overall Study|Adverse Event|1|||
23541206|NCT04964089|65712897|FG000|Overall Study|Participant moved to different state|1|||
23541207|NCT04964089|65712898|FG001|Overall Study|Participant moved to different state|0|||
23541208|NCT04964089|65712897|FG000|Overall Study|Participant decided to discontinue|0|||
23541209|NCT04964089|65712898|FG001|Overall Study|Participant decided to discontinue|1|||
23541210|NCT01617629|65712899|FG000|Overall Study|Death|2|||
23541211|NCT01617629|65712899|FG000|Overall Study|Investigator's Clinical Judgement|1|||
23541212|NCT01617629|65712899|FG000|Overall Study|Reason Not Specified|1|||
23541213|NCT01617629|65712899|FG000|Overall Study|Participant Withdrew Consent|2|||
23541214|NCT02343458|65712900|FG000|Overall Study|Adverse Event|15|||
23541215|NCT02343458|65712901|FG001|Overall Study|Adverse Event|14|||
23541216|NCT02343458|65712902|FG002|Overall Study|Adverse Event|15|||
23541217|NCT02343458|65712903|FG003|Overall Study|Adverse Event|3|||
23541218|NCT02343458|65712900|FG000|Overall Study|Lack of Efficacy|3|||
23541219|NCT02343458|65712901|FG001|Overall Study|Lack of Efficacy|8|||
23541220|NCT02343458|65712902|FG002|Overall Study|Lack of Efficacy|4|||
23541221|NCT02343458|65712903|FG003|Overall Study|Lack of Efficacy|8|||
23541222|NCT02343458|65712900|FG000|Overall Study|Withdrawal by Subject|18|||
23541223|NCT02343458|65712901|FG001|Overall Study|Withdrawal by Subject|17|||
23541224|NCT02343458|65712902|FG002|Overall Study|Withdrawal by Subject|23|||
23541225|NCT02343458|65712903|FG003|Overall Study|Withdrawal by Subject|14|||
23541226|NCT02343458|65712900|FG000|Overall Study|Physician Decision|1|||
23541227|NCT02343458|65712901|FG001|Overall Study|Physician Decision|4|||
23541228|NCT02343458|65712902|FG002|Overall Study|Physician Decision|2|||
23541229|NCT02343458|65712903|FG003|Overall Study|Physician Decision|2|||
23541230|NCT02343458|65712900|FG000|Overall Study|Lost to Follow-up|5|||
23541231|NCT02343458|65712901|FG001|Overall Study|Lost to Follow-up|5|||
23541232|NCT02343458|65712902|FG002|Overall Study|Lost to Follow-up|3|||
23541233|NCT02343458|65712903|FG003|Overall Study|Lost to Follow-up|1|||
23541234|NCT02343458|65712900|FG000|Overall Study|Protocol Violation|2|||
23541235|NCT02343458|65712901|FG001|Overall Study|Protocol Violation|5|||
23541236|NCT02343458|65712902|FG002|Overall Study|Protocol Violation|2|||
23541237|NCT02343458|65712903|FG003|Overall Study|Protocol Violation|2|||
23541238|NCT02343458|65712900|FG000|Overall Study|Protocol Specified Criteria|17|||
23541239|NCT02343458|65712901|FG001|Overall Study|Protocol Specified Criteria|13|||
23541240|NCT02343458|65712902|FG002|Overall Study|Protocol Specified Criteria|14|||
23541241|NCT02343458|65712903|FG003|Overall Study|Protocol Specified Criteria|8|||
23541242|NCT01114646|65712904|FG000|Overall Study|Withdrawal by Subject|3|||
23541243|NCT01114646|65712905|FG001|Overall Study|Withdrawal by Subject|2|||
23541244|NCT01233817|65712906|FG000|Overall Study|Lost to Follow-up|1|||
23541245|NCT01233817|65712906|FG000|Overall Study|Withdrawal by Subject|2|||
23541246|NCT00406029|65712907|FG000|Overall Study|Adverse Event|12|||
23541247|NCT00406029|65712908|FG001|Overall Study|Adverse Event|2|||
23541248|NCT00406029|65712909|FG002|Overall Study|Adverse Event|5|||
23541249|NCT00406029|65712910|FG003|Overall Study|Adverse Event|10|||
23541250|NCT00406029|65712911|FG004|Overall Study|Adverse Event|7|||
23541251|NCT00406029|65712907|FG000|Overall Study|Withdrawal by Subject|3|||
23541252|NCT00406029|65712908|FG001|Overall Study|Withdrawal by Subject|4|||
23541253|NCT00406029|65712909|FG002|Overall Study|Withdrawal by Subject|2|||
23541254|NCT00406029|65712910|FG003|Overall Study|Withdrawal by Subject|2|||
23541255|NCT00406029|65712911|FG004|Overall Study|Withdrawal by Subject|0|||
23541256|NCT00406029|65712907|FG000|Overall Study|Protocol Violation|1|||
23541257|NCT00406029|65712908|FG001|Overall Study|Protocol Violation|2|||
23541258|NCT00406029|65712909|FG002|Overall Study|Protocol Violation|0|||
23541259|NCT00406029|65712910|FG003|Overall Study|Protocol Violation|2|||
23541260|NCT00406029|65712911|FG004|Overall Study|Protocol Violation|0|||
23541261|NCT00406029|65712907|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541262|NCT00406029|65712908|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541263|NCT00406029|65712909|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
23541264|NCT00406029|65712910|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541265|NCT00406029|65712911|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541266|NCT00406029|65712907|FG000|Overall Study|Randomized in Error|0|||
23541267|NCT00406029|65712908|FG001|Overall Study|Randomized in Error|0|||
23541268|NCT00406029|65712909|FG002|Overall Study|Randomized in Error|2|||
23541269|NCT00406029|65712910|FG003|Overall Study|Randomized in Error|3|||
23541270|NCT00406029|65712911|FG004|Overall Study|Randomized in Error|1|||
23541271|NCT00003498|65712912|FG000|Overall Study|Not evaluable.|4|||
23541272|NCT02086591|65712915|FG000|Overall Study|Adverse Event|1|||
23541273|NCT02086591|65712915|FG000|Overall Study|Withdrawal by Subject|1|||
23541274|NCT02086591|65712915|FG000|Overall Study|protocol terminated|3|||
23541275|NCT00182689|65712916|FG000|Overall Study|Adverse Event|8|||
23541276|NCT00182689|65712917|FG001|Overall Study|Adverse Event|11|||
23541277|NCT00182689|65712916|FG000|Overall Study|Withdrawal by Subject|2|||
23541278|NCT00182689|65712917|FG001|Overall Study|Withdrawal by Subject|2|||
23541279|NCT00182689|65712916|FG000|Overall Study|Progression|27|||
23541280|NCT00182689|65712917|FG001|Overall Study|Progression|29|||
23541281|NCT00182689|65712916|FG000|Overall Study|Death|1|||
23541282|NCT00182689|65712917|FG001|Overall Study|Death|0|||
23541283|NCT00182689|65712916|FG000|Overall Study|not protocol specified|0|||
23541284|NCT00182689|65712917|FG001|Overall Study|not protocol specified|3|||
23541285|NCT00182689|65712916|FG000|Overall Study|Ineligible|1|||
23541286|NCT00182689|65712917|FG001|Overall Study|Ineligible|4|||
23541287|NCT00182689|65712916|FG000|Overall Study|Never received treatment|1|||
23541288|NCT00182689|65712917|FG001|Overall Study|Never received treatment|0|||
23541289|NCT02799082|65712919|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
23541290|NCT02799082|65712920|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
23541291|NCT02799082|65712919|FG000|Overall Study|Protocol Violation|0|||
23541292|NCT02799082|65712920|FG001|Overall Study|Protocol Violation|1|||
23541293|NCT00932893|65712921|FG000|Overall Study|Death|115|||
23541294|NCT00932893|65712922|FG001|Overall Study|Death|24|||
23541295|NCT00932893|65712921|FG000|Overall Study|Lost to Follow-up|8|||
23541296|NCT00932893|65712922|FG001|Overall Study|Lost to Follow-up|0|||
23541297|NCT00932893|65712921|FG000|Overall Study|Withdrawal by Subject|5|||
23541298|NCT00932893|65712922|FG001|Overall Study|Withdrawal by Subject|2|||
23541299|NCT00932893|65712921|FG000|Overall Study|Other|5|||
23541300|NCT00932893|65712922|FG001|Overall Study|Other|144|||
23541301|NCT00364858|65712927|FG000|Overall Study|Adverse Event|1|||
23541302|NCT00364858|65712928|FG001|Overall Study|Adverse Event|5|||
23541303|NCT00364858|65712927|FG000|Overall Study|Withdrawal by Subject|1|||
23541304|NCT00364858|65712928|FG001|Overall Study|Withdrawal by Subject|1|||
23541305|NCT00364858|65712927|FG000|Overall Study|Pregnancy|1|||
23541306|NCT00364858|65712928|FG001|Overall Study|Pregnancy|1|||
23541307|NCT00364858|65712927|FG000|Overall Study|Clinical failure|2|||
23541308|NCT00364858|65712928|FG001|Overall Study|Clinical failure|13|||
23541309|NCT00364858|65712927|FG000|Overall Study|Discontinuation at baseline|1|||
23541310|NCT00364858|65712928|FG001|Overall Study|Discontinuation at baseline|0|||
23541311|NCT00364858|65712927|FG000|Overall Study|Non-compliant|1|||
23541312|NCT00364858|65712928|FG001|Overall Study|Non-compliant|0|||
23541313|NCT00364858|65712927|FG000|Overall Study|Return to Q2 regimen|0|||
23541314|NCT00364858|65712928|FG001|Overall Study|Return to Q2 regimen|1|||
23541315|NCT00364858|65712927|FG000|Overall Study|Clinical baseline issue|0|||
23541316|NCT00364858|65712928|FG001|Overall Study|Clinical baseline issue|1|||
23541317|NCT02766608|65712929|FG000|Overall Study|Adverse Event|27|||
23541318|NCT02766608|65712930|FG001|Overall Study|Adverse Event|22|||
23541319|NCT02766608|65712931|FG002|Overall Study|Adverse Event|17|||
23541320|NCT02766608|65712932|FG003|Overall Study|Adverse Event|13|||
23541321|NCT02766608|65712933|FG004|Overall Study|Adverse Event|12|||
23541322|NCT02766608|65712929|FG000|Overall Study|Withdrawal by Subject|21|||
23541323|NCT02766608|65712930|FG001|Overall Study|Withdrawal by Subject|20|||
23541324|NCT02766608|65712931|FG002|Overall Study|Withdrawal by Subject|24|||
23541325|NCT02766608|65712932|FG003|Overall Study|Withdrawal by Subject|13|||
23541326|NCT02766608|65712933|FG004|Overall Study|Withdrawal by Subject|10|||
23541327|NCT02766608|65712929|FG000|Overall Study|Lack of Efficacy|16|||
23541328|NCT02766608|65712930|FG001|Overall Study|Lack of Efficacy|15|||
23541329|NCT02766608|65712931|FG002|Overall Study|Lack of Efficacy|32|||
23541330|NCT02766608|65712932|FG003|Overall Study|Lack of Efficacy|8|||
23541331|NCT02766608|65712933|FG004|Overall Study|Lack of Efficacy|2|||
23541332|NCT02766608|65712929|FG000|Overall Study|Lost to Follow-up|6|||
23541333|NCT02766608|65712930|FG001|Overall Study|Lost to Follow-up|3|||
23541334|NCT02766608|65712931|FG002|Overall Study|Lost to Follow-up|5|||
23541335|NCT02766608|65712932|FG003|Overall Study|Lost to Follow-up|2|||
23541336|NCT02766608|65712933|FG004|Overall Study|Lost to Follow-up|2|||
23541337|NCT02766608|65712929|FG000|Overall Study|Physician Decision|3|||
23541338|NCT02766608|65712930|FG001|Overall Study|Physician Decision|2|||
23541339|NCT02766608|65712931|FG002|Overall Study|Physician Decision|3|||
23541340|NCT02766608|65712932|FG003|Overall Study|Physician Decision|1|||
23541341|NCT02766608|65712933|FG004|Overall Study|Physician Decision|2|||
23541342|NCT02766608|65712929|FG000|Overall Study|Protocol disc criteria|3|||
23541343|NCT02766608|65712930|FG001|Overall Study|Protocol disc criteria|3|||
23541344|NCT02766608|65712931|FG002|Overall Study|Protocol disc criteria|4|||
23541345|NCT02766608|65712932|FG003|Overall Study|Protocol disc criteria|0|||
23541346|NCT02766608|65712933|FG004|Overall Study|Protocol disc criteria|0|||
23541347|NCT02766608|65712929|FG000|Overall Study|Protocol Violation|0|||
23541348|NCT02766608|65712930|FG001|Overall Study|Protocol Violation|4|||
23541349|NCT02766608|65712931|FG002|Overall Study|Protocol Violation|4|||
23541350|NCT02766608|65712932|FG003|Overall Study|Protocol Violation|0|||
23541351|NCT02766608|65712933|FG004|Overall Study|Protocol Violation|1|||
23541352|NCT02766608|65712929|FG000|Overall Study|Administrative Reasons|3|||
23541353|NCT02766608|65712930|FG001|Overall Study|Administrative Reasons|1|||
23541354|NCT02766608|65712931|FG002|Overall Study|Administrative Reasons|1|||
23541355|NCT02766608|65712932|FG003|Overall Study|Administrative Reasons|0|||
23541356|NCT02766608|65712933|FG004|Overall Study|Administrative Reasons|0|||
23541357|NCT03299049|65712934|FG000|Overall Study|On-going|486|||
23541358|NCT03299049|65712935|FG001|Overall Study|On-going|481|||
23541359|NCT03299049|65712934|FG000|Overall Study|Withdrawal by Subject|6|||
23541360|NCT03299049|65712935|FG001|Overall Study|Withdrawal by Subject|21|||
23541361|NCT03299049|65712934|FG000|Overall Study|Physician Decision|5|||
23541362|NCT03299049|65712935|FG001|Overall Study|Physician Decision|1|||
23541363|NCT03299049|65712934|FG000|Overall Study|Lost to Follow-up|2|||
23541364|NCT03299049|65712935|FG001|Overall Study|Lost to Follow-up|0|||
23541365|NCT03299049|65712934|FG000|Overall Study|Pregnancy|1|||
23541366|NCT03299049|65712935|FG001|Overall Study|Pregnancy|3|||
23541367|NCT03299049|65712934|FG000|Overall Study|Protocol Violation|1|||
23541368|NCT03299049|65712935|FG001|Overall Study|Protocol Violation|1|||
23541369|NCT03299049|65712934|FG000|Overall Study|Lack of Efficacy|9|||
23541370|NCT03299049|65712935|FG001|Overall Study|Lack of Efficacy|3|||
23541371|NCT03299049|65712934|FG000|Overall Study|Adverse Event|12|||
23541372|NCT03299049|65712935|FG001|Overall Study|Adverse Event|13|||
23541373|NCT00512135|65712936|FG000|Overall Study|Not Treated|5|||
23541374|NCT00512135|65712936|FG000|Overall Study|Lack of Efficacy|2|||
23541375|NCT00512135|65712936|FG000|Overall Study|Adverse Event|6|||
23541376|NCT00512135|65712936|FG000|Overall Study|Withdrawal by Subject|22|||
23541377|NCT00512135|65712936|FG000|Overall Study|Lost to Follow-up|27|||
23541378|NCT00512135|65712936|FG000|Overall Study|Other|22|||
23541379|NCT02075593|65712942|FG000|Overall Study|Withdrawal by Subject|1|||
23541380|NCT02564198|65712943|FG000|Overall Study|Withdrawal by Subject|2|||
23541381|NCT02564198|65712944|FG001|Overall Study|Withdrawal by Subject|4|||
23541382|NCT02564198|65712945|FG002|Overall Study|Withdrawal by Subject|0|||
23541383|NCT02564198|65712943|FG000|Overall Study|Adverse Event|0|||
23541384|NCT02564198|65712944|FG001|Overall Study|Adverse Event|1|||
23541385|NCT02564198|65712945|FG002|Overall Study|Adverse Event|0|||
23541386|NCT00504829|65712946|FG000|Overall Study|Protocol Violation|6|||
23541387|NCT00504829|65712947|FG001|Overall Study|Protocol Violation|4|||
23541388|NCT00504829|65712948|FG002|Overall Study|Protocol Violation|10|||
23541389|NCT02348216|65712949|FG000|Overall Study|Death|5|||
23541390|NCT02348216|65712950|FG001|Overall Study|Death|53|||
23541391|NCT02348216|65712951|FG002|Overall Study|Death|11|||
23541392|NCT02348216|65712952|FG003|Overall Study|Death|20|||
23541393|NCT02348216|65712953|FG004|Overall Study|Death|16|||
23541394|NCT02348216|65712954|FG005|Overall Study|Death|32|||
23541395|NCT02348216|65712955|FG006|Overall Study|Death|17|||
23541396|NCT02348216|65712949|FG000|Overall Study|Full consent withdrawal|0|||
23541397|NCT02348216|65712950|FG001|Overall Study|Full consent withdrawal|0|||
23541398|NCT02348216|65712951|FG002|Overall Study|Full consent withdrawal|0|||
23541399|NCT02348216|65712952|FG003|Overall Study|Full consent withdrawal|1|||
23541400|NCT02348216|65712953|FG004|Overall Study|Full consent withdrawal|3|||
23541401|NCT02348216|65712954|FG005|Overall Study|Full consent withdrawal|0|||
23541402|NCT02348216|65712955|FG006|Overall Study|Full consent withdrawal|3|||
23541403|NCT02348216|65712949|FG000|Overall Study|Lost to Follow-up|0|||
23541404|NCT02348216|65712950|FG001|Overall Study|Lost to Follow-up|5|||
23541405|NCT02348216|65712951|FG002|Overall Study|Lost to Follow-up|2|||
23541406|NCT02348216|65712952|FG003|Overall Study|Lost to Follow-up|0|||
23541407|NCT02348216|65712953|FG004|Overall Study|Lost to Follow-up|1|||
23541408|NCT02348216|65712954|FG005|Overall Study|Lost to Follow-up|1|||
23541409|NCT02348216|65712955|FG006|Overall Study|Lost to Follow-up|1|||
23541410|NCT02348216|65712949|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
23541411|NCT02348216|65712950|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
23541412|NCT02348216|65712951|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
23541413|NCT02348216|65712952|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
23541414|NCT02348216|65712953|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
23541415|NCT02348216|65712954|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
23541416|NCT02348216|65712955|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
23541417|NCT02348216|65712949|FG000|Overall Study|Reason not specified|2|||
23541418|NCT02348216|65712950|FG001|Overall Study|Reason not specified|19|||
23541419|NCT02348216|65712951|FG002|Overall Study|Reason not specified|11|||
23541420|NCT02348216|65712952|FG003|Overall Study|Reason not specified|17|||
23541421|NCT02348216|65712953|FG004|Overall Study|Reason not specified|21|||
23541422|NCT02348216|65712954|FG005|Overall Study|Reason not specified|17|||
23541423|NCT02348216|65712955|FG006|Overall Study|Reason not specified|19|||
23541424|NCT00047463|65712956|FG000|Overall Study|Withdrawal by Subject|0|||
23541425|NCT00047463|65712957|FG001|Overall Study|Withdrawal by Subject|3|||
23541426|NCT03936244|65712960|FG000|Overall Study|Lost to Follow-up|5|||
23541427|NCT03936244|65712961|FG001|Overall Study|Lost to Follow-up|1|||
23541428|NCT03936244|65712960|FG000|Overall Study|Physician Decision|7|||
23541429|NCT03936244|65712961|FG001|Overall Study|Physician Decision|3|||
23541430|NCT01931839|65712962|FG000|Overall Study|Death|0|||
23541431|NCT01931839|65712963|FG001|Overall Study|Death|1|||
23541432|NCT01931839|65712964|FG002|Overall Study|Death|2|||
23541433|NCT01931839|65712965|FG003|Overall Study|Death|0|||
23541434|NCT01931839|65712966|FG004|Overall Study|Death|0|||
23541435|NCT01931839|65712967|FG005|Overall Study|Death|0|||
23541436|NCT01931839|65712968|FG006|Overall Study|Death|0|||
23541437|NCT01931839|65712962|FG000|Overall Study|Physician Decision|1|||
23541438|NCT01931839|65712963|FG001|Overall Study|Physician Decision|0|||
23541439|NCT01931839|65712964|FG002|Overall Study|Physician Decision|1|||
23541440|NCT01931839|65712965|FG003|Overall Study|Physician Decision|0|||
23541441|NCT01931839|65712966|FG004|Overall Study|Physician Decision|0|||
23541442|NCT01931839|65712967|FG005|Overall Study|Physician Decision|0|||
23541443|NCT01931839|65712968|FG006|Overall Study|Physician Decision|1|||
23541444|NCT01931839|65712962|FG000|Overall Study|Withdrawal of consent|0|||
23541445|NCT01931839|65712963|FG001|Overall Study|Withdrawal of consent|0|||
23541446|NCT01931839|65712964|FG002|Overall Study|Withdrawal of consent|0|||
23541447|NCT01931839|65712965|FG003|Overall Study|Withdrawal of consent|0|||
23541448|NCT01931839|65712966|FG004|Overall Study|Withdrawal of consent|1|||
23541449|NCT01931839|65712967|FG005|Overall Study|Withdrawal of consent|0|||
23541450|NCT01931839|65712968|FG006|Overall Study|Withdrawal of consent|0|||
23541451|NCT01931839|65712962|FG000|Overall Study|Adverse Event|9|||
23541452|NCT01931839|65712963|FG001|Overall Study|Adverse Event|4|||
23541453|NCT01931839|65712964|FG002|Overall Study|Adverse Event|1|||
23541454|NCT01931839|65712965|FG003|Overall Study|Adverse Event|3|||
23541455|NCT01931839|65712966|FG004|Overall Study|Adverse Event|0|||
23541456|NCT01931839|65712967|FG005|Overall Study|Adverse Event|0|||
23541457|NCT01931839|65712968|FG006|Overall Study|Adverse Event|1|||
23541458|NCT01931839|65712962|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
23541459|NCT01931839|65712963|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
23541460|NCT01931839|65712964|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
23541461|NCT01931839|65712965|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
23541462|NCT01931839|65712966|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
23541463|NCT01931839|65712967|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
23541464|NCT01931839|65712968|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
23541465|NCT01931839|65712962|FG000|Overall Study|Other non-compliance|15|||
23541466|NCT01931839|65712963|FG001|Overall Study|Other non-compliance|9|||
23541467|NCT01931839|65712964|FG002|Overall Study|Other non-compliance|12|||
23541468|NCT01931839|65712965|FG003|Overall Study|Other non-compliance|3|||
23541469|NCT01931839|65712966|FG004|Overall Study|Other non-compliance|0|||
23541470|NCT01931839|65712967|FG005|Overall Study|Other non-compliance|3|||
23541471|NCT01931839|65712968|FG006|Overall Study|Other non-compliance|0|||
23541472|NCT01931839|65712962|FG000|Overall Study|Lost to Follow-up|1|||
23541473|NCT01931839|65712963|FG001|Overall Study|Lost to Follow-up|2|||
23541474|NCT01931839|65712964|FG002|Overall Study|Lost to Follow-up|4|||
23541475|NCT01931839|65712965|FG003|Overall Study|Lost to Follow-up|5|||
23541476|NCT01931839|65712966|FG004|Overall Study|Lost to Follow-up|0|||
23541477|NCT01931839|65712967|FG005|Overall Study|Lost to Follow-up|0|||
23541478|NCT01931839|65712968|FG006|Overall Study|Lost to Follow-up|0|||
23541479|NCT01931839|65712962|FG000|Overall Study|Other|4|||
23541480|NCT01931839|65712963|FG001|Overall Study|Other|2|||
23541481|NCT01931839|65712964|FG002|Overall Study|Other|6|||
23541482|NCT01931839|65712965|FG003|Overall Study|Other|0|||
23541483|NCT01931839|65712966|FG004|Overall Study|Other|0|||
23541484|NCT01931839|65712967|FG005|Overall Study|Other|0|||
23541485|NCT01931839|65712968|FG006|Overall Study|Other|0|||
23541486|NCT02117570|65712969|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
23541487|NCT02117570|65712970|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
23541488|NCT02117570|65712971|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
23541489|NCT02117570|65712969|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
23541490|NCT02117570|65712970|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
23541491|NCT02117570|65712971|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
23541492|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
23541493|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
23541494|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
23541495|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
23541496|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
23541497|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
23541498|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
23541499|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
23541500|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
23541501|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
23541502|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
23541503|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
23541504|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
23541505|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
23541506|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
23541507|NCT01557946|65712972|FG000|Overall Study|Adverse Event|3|||
23541508|NCT01557946|65712973|FG001|Overall Study|Adverse Event|0|||
23541509|NCT01731171|65712974|FG000|Overall Study|Withdrawal by Subject|4|||
23541510|NCT01731171|65712975|FG001|Overall Study|Withdrawal by Subject|1|||
23541511|NCT01731171|65712974|FG000|Overall Study|Lost to Follow-up|3|||
23541512|NCT01731171|65712975|FG001|Overall Study|Lost to Follow-up|2|||
23541513|NCT01731171|65712974|FG000|Overall Study|Moved out of Area|0|||
23541514|NCT01731171|65712975|FG001|Overall Study|Moved out of Area|2|||
23541515|NCT01731171|65712974|FG000|Overall Study|Terminated for Lack of Adherence|0|||
23541516|NCT01731171|65712975|FG001|Overall Study|Terminated for Lack of Adherence|1|||
23541517|NCT01731171|65712974|FG000|Overall Study|Terminated for Safety Reasons|0|||
23541518|NCT01731171|65712975|FG001|Overall Study|Terminated for Safety Reasons|1|||
23541519|NCT03143829|65712978|FG000|Overall Study|Withdrawal by Subject|2|||
23541520|NCT03143829|65712979|FG001|Overall Study|Withdrawal by Subject|5|||
23541521|NCT03143829|65712978|FG000|Overall Study|Lost to Follow-up|0|||
23541522|NCT03143829|65712979|FG001|Overall Study|Lost to Follow-up|2|||
23541523|NCT03143829|65712978|FG000|Overall Study|Death|1|||
23541524|NCT03143829|65712979|FG001|Overall Study|Death|1|||
23541525|NCT03143829|65712978|FG000|Overall Study|changed treatment, no longer eligible|2|||
23541526|NCT03143829|65712979|FG001|Overall Study|changed treatment, no longer eligible|2|||
23541527|NCT03346759|65712980|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
23541528|NCT03346759|65712981|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
23541529|NCT03346759|65712980|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
23541530|NCT03346759|65712981|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
23541531|NCT03346759|65712980|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
23541532|NCT03346759|65712981|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
23541533|NCT04266028|65712982|FG000|Overall Study|Adverse Event|0|||
23541534|NCT04266028|65712983|FG001|Overall Study|Adverse Event|0|||
23541535|NCT04266028|65712984|FG002|Overall Study|Adverse Event|1|||
23541536|NCT04266028|65712985|FG003|Overall Study|Adverse Event|0|||
23541537|NCT04266028|65712986|FG004|Overall Study|Adverse Event|1|||
23541538|NCT04266028|65712987|FG005|Overall Study|Adverse Event|0|||
23541539|NCT04266028|65712988|FG006|Overall Study|Adverse Event|2|||
23541540|NCT04266028|65712989|FG007|Overall Study|Adverse Event|0|||
23541541|NCT04266028|65712982|FG000|Overall Study|temporary halt of the study|0|||
23541542|NCT04266028|65712983|FG001|Overall Study|temporary halt of the study|0|||
23541543|NCT04266028|65712984|FG002|Overall Study|temporary halt of the study|0|||
23541544|NCT04266028|65712985|FG003|Overall Study|temporary halt of the study|0|||
23541545|NCT04266028|65712986|FG004|Overall Study|temporary halt of the study|0|||
23541546|NCT04266028|65712987|FG005|Overall Study|temporary halt of the study|0|||
23541547|NCT04266028|65712988|FG006|Overall Study|temporary halt of the study|2|||
23541548|NCT04266028|65712989|FG007|Overall Study|temporary halt of the study|1|||
23541549|NCT04266028|65712982|FG000|Overall Study|Onset of birch pollen season|0|||
23541550|NCT04266028|65712983|FG001|Overall Study|Onset of birch pollen season|0|||
23541551|NCT04266028|65712984|FG002|Overall Study|Onset of birch pollen season|0|||
23541552|NCT04266028|65712985|FG003|Overall Study|Onset of birch pollen season|0|||
23541553|NCT04266028|65712986|FG004|Overall Study|Onset of birch pollen season|1|||
23541554|NCT04266028|65712987|FG005|Overall Study|Onset of birch pollen season|0|||
23541555|NCT04266028|65712988|FG006|Overall Study|Onset of birch pollen season|0|||
23541556|NCT04266028|65712989|FG007|Overall Study|Onset of birch pollen season|0|||
23541557|NCT01059617|65712990|FG000|Overall Study|Other|7|||
23541558|NCT01059617|65712991|FG001|Overall Study|Other|1|||
23541559|NCT01059617|65712992|FG002|Overall Study|Other|8|||
23541560|NCT01059617|65712993|FG003|Overall Study|Other|6|||
23541561|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
23541562|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541563|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541564|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541565|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
23541566|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541567|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541568|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541569|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
23541570|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541571|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541572|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541573|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
23541574|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541575|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541576|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541577|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
23541578|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541579|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541580|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541581|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
23541582|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541583|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541584|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541585|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
23541586|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541587|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541588|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541589|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541590|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541591|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541592|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
23541593|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
23541594|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
23541595|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
23541596|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
23541597|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
23727679|NCT03839940|66382133|FG001|Overall Study|Withdrawal by Subject|0|||
23727680|NCT03839940|66382132|FG000|Overall Study|Protocol Violation|0|||
23727681|NCT03839940|66382133|FG001|Overall Study|Protocol Violation|1|||
23727682|NCT03839940|66382132|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
23727683|NCT03839940|66382133|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
23727684|NCT03342404|66382134|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
23541598|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
23541599|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
23541600|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
23541601|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
23727685|NCT03342404|66382135|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
23727686|NCT03342404|66382134|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
23816919|NCT03249792|66708528|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
23816920|NCT03249792|66708529|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
23816921|NCT03249792|66708530|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
23816922|NCT03249792|66708531|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
23816923|NCT03249792|66708532|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
23816924|NCT03249792|66708533|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
23816925|NCT03249792|66708534|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
23816926|NCT03249792|66708535|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
23816927|NCT03249792|66708536|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
23727687|NCT03342404|66382135|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
23816928|NCT03249792|66708537|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
23816929|NCT03249792|66708538|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
23424472|NCT00919867|65299667|FG004|First Intervention|Physician Decision|0|||
23424473|NCT00919867|65299668|FG005|First Intervention|Physician Decision|1|||
23424474|NCT03455829|65299669|FG000|Overall Study|Death|2|||
23424475|NCT03455829|65299670|FG001|Overall Study|Death|3|||
23424476|NCT03455829|65299671|FG002|Overall Study|Death|2|||
23424477|NCT03455829|65299672|FG003|Overall Study|Death|4|||
23424478|NCT03455829|65299673|FG004|Overall Study|Death|2|||
23424479|NCT03455829|65299669|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
23424480|NCT03455829|65299670|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
23424481|NCT03455829|65299671|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
23424482|NCT03455829|65299672|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
23424483|NCT03455829|65299673|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
23424484|NCT03455829|65299669|FG000|Overall Study|Disease progression|0|||
23424485|NCT03455829|65299670|FG001|Overall Study|Disease progression|0|||
23424486|NCT03455829|65299671|FG002|Overall Study|Disease progression|0|||
23424487|NCT03455829|65299672|FG003|Overall Study|Disease progression|1|||
23424488|NCT03455829|65299673|FG004|Overall Study|Disease progression|1|||
23424489|NCT00107315|65299674|FG000|Overall Study|Disease Progression|9|||
23424490|NCT00107315|65299674|FG000|Overall Study|Adverse Event|4|||
23424491|NCT00107315|65299674|FG000|Overall Study|Withdrawal by Subject|2|||
23424492|NCT03383783|65299678|FG000|Overall Study|Withdrawal by Subject|2|||
23424493|NCT01655381|65299679|FG000|Overall Study|Investigator Decision|1|||
23424494|NCT01655381|65299679|FG000|Overall Study|Moved to Another City|1|||
23424495|NCT01655381|65299679|FG000|Overall Study|Insufficient Treatment Response|1|||
23727688|NCT03342404|66382134|FG000|Blinded Treatment Phase|Adverse Event|5|||
23727689|NCT03342404|66382135|FG001|Blinded Treatment Phase|Adverse Event|4|||
23727690|NCT03342404|66382134|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
23424496|NCT02914548|65299680|FG000|Overall Study|Adverse Event|15|||
23424497|NCT02914548|65299681|FG001|Overall Study|Adverse Event|7|||
23727691|NCT03342404|66382135|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
23727692|NCT03342404|66382134|FG000|Blinded Treatment Phase|Other reasons|1|||
23727693|NCT03342404|66382135|FG001|Blinded Treatment Phase|Other reasons|0|||
23727694|NCT03342404|66382134|FG000|Blinded Treatment Phase|Physician Decision|1|||
23727695|NCT03342404|66382135|FG001|Blinded Treatment Phase|Physician Decision|0|||
23727696|NCT03342404|66382134|FG000|Blinded Treatment Phase|Death|1|||
23727697|NCT03342404|66382135|FG001|Blinded Treatment Phase|Death|0|||
23727698|NCT03342404|66382134|FG000|Open-Label Phase|Lost to Follow-up|0|||
23727699|NCT03342404|66382135|FG001|Open-Label Phase|Lost to Follow-up|1|||
23727700|NCT03342404|66382134|FG000|Open-Label Phase|Other reasons|0|||
23727701|NCT03342404|66382135|FG001|Open-Label Phase|Other reasons|1|||
23424498|NCT02914548|65299682|FG002|Overall Study|Adverse Event|15|||
23424499|NCT02914548|65299680|FG000|Overall Study|Physician Decision|2|||
23424500|NCT02914548|65299681|FG001|Overall Study|Physician Decision|2|||
23424501|NCT02914548|65299682|FG002|Overall Study|Physician Decision|0|||
23424502|NCT02914548|65299680|FG000|Overall Study|Protocol Violation|1|||
23424503|NCT02914548|65299681|FG001|Overall Study|Protocol Violation|0|||
23424504|NCT02914548|65299682|FG002|Overall Study|Protocol Violation|0|||
23424505|NCT02914548|65299680|FG000|Overall Study|Withdrawal by Subject|3|||
23424506|NCT02914548|65299681|FG001|Overall Study|Withdrawal by Subject|4|||
23424507|NCT02914548|65299682|FG002|Overall Study|Withdrawal by Subject|4|||
23424508|NCT02914548|65299680|FG000|Overall Study|>40% of body surface area|0|||
23424509|NCT02914548|65299681|FG001|Overall Study|>40% of body surface area|1|||
23424510|NCT02914548|65299682|FG002|Overall Study|>40% of body surface area|1|||
23424511|NCT01628367|65299683|FG000|Overall Study|Adverse Event|1|||
23424512|NCT01628367|65299684|FG001|Overall Study|Adverse Event|0|||
23424513|NCT01007123|65299687|FG000|Overall Study|Adverse Event|3|||
23424514|NCT01007123|65299688|FG001|Overall Study|Adverse Event|4|||
23424515|NCT01007123|65299689|FG002|Overall Study|Adverse Event|7|||
23424516|NCT01007123|65299690|FG003|Overall Study|Adverse Event|1|||
23424517|NCT01007123|65299687|FG000|Overall Study|Lack of Efficacy|1|||
23424518|NCT01007123|65299688|FG001|Overall Study|Lack of Efficacy|0|||
23424519|NCT01007123|65299689|FG002|Overall Study|Lack of Efficacy|1|||
23424520|NCT01007123|65299690|FG003|Overall Study|Lack of Efficacy|4|||
23424521|NCT01007123|65299687|FG000|Overall Study|Protocol Violation|1|||
23424522|NCT01007123|65299688|FG001|Overall Study|Protocol Violation|1|||
23424523|NCT01007123|65299689|FG002|Overall Study|Protocol Violation|2|||
23424524|NCT01007123|65299690|FG003|Overall Study|Protocol Violation|1|||
23424525|NCT01007123|65299687|FG000|Overall Study|Withdrawal by Subject|1|||
23424526|NCT01007123|65299688|FG001|Overall Study|Withdrawal by Subject|0|||
23424527|NCT01007123|65299689|FG002|Overall Study|Withdrawal by Subject|1|||
23424528|NCT01007123|65299690|FG003|Overall Study|Withdrawal by Subject|0|||
23424529|NCT01007123|65299687|FG000|Overall Study|Lost to Follow-up|0|||
23424530|NCT01007123|65299688|FG001|Overall Study|Lost to Follow-up|1|||
23424531|NCT01007123|65299689|FG002|Overall Study|Lost to Follow-up|0|||
23582200|NCT02892409|65862381|FG001|Overall Study|Adverse Event|0|||
23582201|NCT02892409|65862380|FG000|Overall Study|Withdrawal by Subject|2|||
23727702|NCT03342404|66382134|FG000|Open-Label Phase|Adverse Event|0|||
23541602|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
23541603|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
23541604|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
23541605|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
23541606|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
23541607|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
23541608|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
23541609|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
23541610|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
23541611|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
23541612|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
23541613|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541614|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
23541615|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541616|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541617|NCT01055639|65713001|FG000|Overall Study|Adverse Event|0|||
23541618|NCT01055639|65713002|FG001|Overall Study|Adverse Event|1|||
23541619|NCT01055639|65713001|FG000|Overall Study|Lack of Efficacy|0|||
23541620|NCT01055639|65713002|FG001|Overall Study|Lack of Efficacy|1|||
23541621|NCT01055639|65713001|FG000|Overall Study|Lost to Follow-up|8|||
23541622|NCT01055639|65713002|FG001|Overall Study|Lost to Follow-up|11|||
23541623|NCT01055639|65713001|FG000|Overall Study|Protocol Violation|5|||
23541624|NCT01055639|65713002|FG001|Overall Study|Protocol Violation|5|||
23541625|NCT01055639|65713001|FG000|Overall Study|Withdrawal by Subject|8|||
23541626|NCT01055639|65713002|FG001|Overall Study|Withdrawal by Subject|11|||
23541627|NCT00099983|65713003|FG000|Overall Study|Lost to Follow-up|2|||
23541628|NCT00099983|65713004|FG001|Overall Study|Lost to Follow-up|3|||
23541629|NCT00099983|65713003|FG000|Overall Study|Missing Source Documents|14|||
23541630|NCT00099983|65713004|FG001|Overall Study|Missing Source Documents|15|||
23541631|NCT00099983|65713003|FG000|Overall Study|Withdrawal by Subject|3|||
23541632|NCT00099983|65713004|FG001|Overall Study|Withdrawal by Subject|2|||
23727703|NCT03342404|66382135|FG001|Open-Label Phase|Adverse Event|3|||
23727704|NCT03342404|66382134|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23727705|NCT03342404|66382135|FG001|Open-Label Phase|Withdrawal by Subject|6|||
23727706|NCT00498368|66382136|FG000|Overall Study|Withdrawal by Subject|3|||
23727707|NCT00498368|66382137|FG001|Overall Study|Withdrawal by Subject|2|||
23424532|NCT01007123|65299690|FG003|Overall Study|Lost to Follow-up|0|||
23424533|NCT00591149|65299691|FG000|Overall Study|Adverse Event|4|||
23424534|NCT00591149|65299691|FG000|Overall Study|Withdrawal by Subject|1|||
23424535|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424536|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
23424537|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424538|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424539|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424540|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424541|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
23424542|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424543|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424544|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424545|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424546|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
23541633|NCT00099983|65713003|FG000|Overall Study|Adverse Event|1|||
23541634|NCT00099983|65713004|FG001|Overall Study|Adverse Event|1|||
23541635|NCT00099983|65713003|FG000|Overall Study|Lack of Efficacy|0|||
23541636|NCT00099983|65713004|FG001|Overall Study|Lack of Efficacy|1|||
23541637|NCT00099983|65713003|FG000|Overall Study|Unable to return for appointments|1|||
23541638|NCT00099983|65713004|FG001|Overall Study|Unable to return for appointments|1|||
23727708|NCT01190020|66382138|FG000|Overall Study|Adverse Event|2|||
23424547|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424548|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424549|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424550|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424551|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
23424552|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424553|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424554|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424555|NCT02688088|65299692|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424556|NCT02688088|65299693|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424557|NCT02688088|65299694|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
23424558|NCT02688088|65299695|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424559|NCT02688088|65299696|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424560|NCT02688088|65299692|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424561|NCT02688088|65299693|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424562|NCT02688088|65299694|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
23424563|NCT02688088|65299695|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424564|NCT02688088|65299696|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424565|NCT02688088|65299692|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424566|NCT02688088|65299693|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424567|NCT02688088|65299694|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424568|NCT02688088|65299695|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
23424569|NCT02688088|65299696|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424570|NCT02688088|65299692|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424571|NCT02688088|65299693|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424572|NCT02688088|65299694|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424573|NCT02688088|65299695|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
23424574|NCT02688088|65299696|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424575|NCT02688088|65299692|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424576|NCT02688088|65299693|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424577|NCT02688088|65299694|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424578|NCT02688088|65299695|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424579|NCT02688088|65299696|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
23424580|NCT04143217|65299697|FG000|Overall Study|Withdrawal by Subject|42|||
23424581|NCT04143217|65299697|FG000|Overall Study|Adverse Event|29|||
23424582|NCT04143217|65299697|FG000|Overall Study|Lost to Follow-up|29|||
23424583|NCT04143217|65299697|FG000|Overall Study|Lack of Efficacy|15|||
23424584|NCT04143217|65299697|FG000|Overall Study|Physician Decision|1|||
23424585|NCT04143217|65299697|FG000|Overall Study|Non-Compliance With Study Drug|6|||
23424586|NCT04143217|65299697|FG000|Overall Study|Other, Multiple Categories|11|||
23424587|NCT02210689|65299698|FG000|Overall Study|Withdrawal by Subject|7|||
23424588|NCT02210689|65299699|FG001|Overall Study|Withdrawal by Subject|4|||
23424589|NCT02210689|65299700|FG002|Overall Study|Withdrawal by Subject|2|||
23424590|NCT02210689|65299698|FG000|Overall Study|Adverse Event|0|||
23424591|NCT02210689|65299699|FG001|Overall Study|Adverse Event|1|||
23424592|NCT02210689|65299700|FG002|Overall Study|Adverse Event|0|||
23424593|NCT02210689|65299698|FG000|Overall Study|Protocol Violation|1|||
23424594|NCT02210689|65299699|FG001|Overall Study|Protocol Violation|0|||
23424595|NCT02210689|65299700|FG002|Overall Study|Protocol Violation|0|||
23424596|NCT02210689|65299698|FG000|Overall Study|Lost to Follow-up|11|||
23424597|NCT02210689|65299699|FG001|Overall Study|Lost to Follow-up|9|||
23424598|NCT02210689|65299700|FG002|Overall Study|Lost to Follow-up|5|||
23424599|NCT02210689|65299698|FG000|Overall Study|Pregnancy|0|||
23424600|NCT02210689|65299699|FG001|Overall Study|Pregnancy|1|||
23424601|NCT02210689|65299700|FG002|Overall Study|Pregnancy|0|||
23424602|NCT02210689|65299698|FG000|Overall Study|Lack of Efficacy|0|||
23424603|NCT02210689|65299699|FG001|Overall Study|Lack of Efficacy|1|||
23424604|NCT02210689|65299700|FG002|Overall Study|Lack of Efficacy|5|||
23424605|NCT02210689|65299698|FG000|Overall Study|Prohibited medication|2|||
23424606|NCT02210689|65299699|FG001|Overall Study|Prohibited medication|8|||
23424607|NCT02210689|65299700|FG002|Overall Study|Prohibited medication|1|||
23424608|NCT02210689|65299698|FG000|Overall Study|Negative Nugent score at baseline|6|||
23424609|NCT02210689|65299699|FG001|Overall Study|Negative Nugent score at baseline|2|||
23424610|NCT02210689|65299700|FG002|Overall Study|Negative Nugent score at baseline|2|||
23424611|NCT02210689|65299698|FG000|Overall Study|Other|25|||
23424612|NCT02210689|65299699|FG001|Overall Study|Other|21|||
23424613|NCT02210689|65299700|FG002|Overall Study|Other|8|||
23424614|NCT00428220|65299701|FG000|Overall Study|Participant died|8|||
23424615|NCT00428220|65299701|FG000|Overall Study|Global deterioration of health status|7|||
23424616|NCT00428220|65299701|FG000|Overall Study|Lost to Follow-up|4|||
23424617|NCT00428220|65299701|FG000|Overall Study|Objective progression or relapse|123|||
23541639|NCT00099983|65713003|FG000|Overall Study|Moved|1|||
23541640|NCT00099983|65713004|FG001|Overall Study|Moved|0|||
23541641|NCT00099983|65713003|FG000|Overall Study|Other psychiatric problem|1|||
23541642|NCT00099983|65713004|FG001|Overall Study|Other psychiatric problem|0|||
23541643|NCT00099983|65713003|FG000|Overall Study|Incarcerated|0|||
23541644|NCT00099983|65713004|FG001|Overall Study|Incarcerated|1|||
23541645|NCT00099983|65713003|FG000|Overall Study|Intolerant of burden of visits|0|||
23541646|NCT00099983|65713004|FG001|Overall Study|Intolerant of burden of visits|1|||
23541647|NCT00099983|65713003|FG000|Overall Study|Other issue|1|||
23541648|NCT00099983|65713004|FG001|Overall Study|Other issue|0|||
23541649|NCT00835406|65713005|FG000|Period: First Intervention|Adverse Event|0|||
23541650|NCT00835406|65713006|FG001|Period: First Intervention|Adverse Event|1|||
23541651|NCT00835406|65713005|FG000|Period: First Intervention|Withdrawal by Subject|2|||
23541652|NCT00835406|65713006|FG001|Period: First Intervention|Withdrawal by Subject|0|||
23541653|NCT00835406|65713005|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
23541654|NCT00835406|65713006|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
23541655|NCT03647501|65713007|FG000|Overall Study|Lost to Follow-up|1|||
23541656|NCT03647501|65713008|FG001|Overall Study|Lost to Follow-up|1|||
23541657|NCT03647501|65713007|FG000|Overall Study|Withdrawal by Subject|0|||
23541658|NCT03647501|65713008|FG001|Overall Study|Withdrawal by Subject|1|||
23541659|NCT04755595|65713011|FG000|Overall Study|Lost to Follow-up|1|||
23541660|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
23541661|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
23541662|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
23541663|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
23541664|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
23541665|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
23541666|NCT02417246|65713023|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
23541667|NCT02417246|65713024|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
23541668|NCT02331134|65713027|FG000|Overall Study|Withdrawal by Subject|1|||
23541669|NCT02223390|65713032|FG000|Overall Study|Lost to Follow-up|9|||
23541670|NCT02223390|65713033|FG001|Overall Study|Lost to Follow-up|4|||
23541671|NCT00759109|65713036|FG000|Overall Study|Adverse Event|17|||
23541672|NCT00759109|65713037|FG001|Overall Study|Adverse Event|12|||
23541673|NCT00759109|65713036|FG000|Overall Study|Inability to comply|1|||
23541674|NCT00759109|65713037|FG001|Overall Study|Inability to comply|1|||
23541675|NCT00759109|65713036|FG000|Overall Study|Withdrawal by Subject|9|||
23541676|NCT00759109|65713037|FG001|Overall Study|Withdrawal by Subject|5|||
23541677|NCT00759109|65713036|FG000|Overall Study|Death|4|||
23541678|NCT00759109|65713037|FG001|Overall Study|Death|3|||
23541679|NCT00759109|65713036|FG000|Overall Study|Lost to Follow-up|4|||
23541680|NCT00759109|65713037|FG001|Overall Study|Lost to Follow-up|6|||
23541681|NCT00759109|65713036|FG000|Overall Study|Started new therapy|2|||
23541682|NCT00759109|65713037|FG001|Overall Study|Started new therapy|6|||
23541683|NCT00759109|65713036|FG000|Overall Study|HCV RNA negative|1|||
23541684|NCT00759109|65713037|FG001|Overall Study|HCV RNA negative|0|||
23541685|NCT00759109|65713036|FG000|Overall Study|Participant moved to a different city|0|||
23541686|NCT00759109|65713037|FG001|Overall Study|Participant moved to a different city|1|||
23541687|NCT00759109|65713036|FG000|Overall Study|Participant had a liver transplant|0|||
23541688|NCT00759109|65713037|FG001|Overall Study|Participant had a liver transplant|1|||
23541689|NCT00759109|65713036|FG000|Overall Study|Lost during study|1|||
23541690|NCT00759109|65713037|FG001|Overall Study|Lost during study|0|||
23541691|NCT01870843|65713040|FG000|Overall Study|Adverse Event|10|||
23727709|NCT01190020|66382139|FG001|Overall Study|Adverse Event|0|||
23727710|NCT01190020|66382138|FG000|Overall Study|Lost to Follow-up|2|||
23727711|NCT01190020|66382139|FG001|Overall Study|Lost to Follow-up|0|||
23727712|NCT01190020|66382138|FG000|Overall Study|Withdrawal by Subject|3|||
23541692|NCT01870843|65713040|FG000|Overall Study|Lost to Follow-up|24|||
23541693|NCT01870843|65713040|FG000|Overall Study|Death|1|||
23541694|NCT01870843|65713040|FG000|Overall Study|Withdrawal by Subject|18|||
23541695|NCT00965523|65713044|FG000|Study 221|Progressive Disease|4|||
23541696|NCT00965523|65713044|FG000|Study 221|Physician Decision|3|||
23541697|NCT00965523|65713044|FG000|Study 224|Progressive Disease|5|||
23541698|NCT00965523|65713044|FG000|Study 224|Physician Decision|1|||
23541699|NCT00127608|65713045|FG000|Overall Study|VZV DNA negative|1|||
23541700|NCT02806986|65713053|FG000|Treatment Stage 1|Adverse Event|1|||
23541701|NCT02806986|65713053|FG000|Treatment Stage 2|Adverse Event|3|||
23541702|NCT02806986|65713053|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
23541703|NCT03891524|65713054|FG000|Overall Study|Death|0|||
23541704|NCT03891524|65713055|FG001|Overall Study|Death|0|||
23541705|NCT03891524|65713056|FG002|Overall Study|Death|0|||
23541706|NCT03891524|65713057|FG003|Overall Study|Death|0|||
23541707|NCT03891524|65713058|FG004|Overall Study|Death|0|||
23541708|NCT03891524|65713059|FG005|Overall Study|Death|0|||
23541709|NCT03891524|65713060|FG006|Overall Study|Death|0|||
23727713|NCT01190020|66382139|FG001|Overall Study|Withdrawal by Subject|0|||
23727714|NCT01057862|66382148|FG000|Overall Study|Withdrawal by Subject|1|||
23816930|NCT03249792|66708539|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
23541710|NCT03891524|65713061|FG007|Overall Study|Death|1|||
23541711|NCT03891524|65713054|FG000|Overall Study|Withdrawal by Subject|0|||
23541712|NCT03891524|65713055|FG001|Overall Study|Withdrawal by Subject|1|||
23541713|NCT03891524|65713056|FG002|Overall Study|Withdrawal by Subject|2|||
23541714|NCT03891524|65713057|FG003|Overall Study|Withdrawal by Subject|1|||
23541715|NCT03891524|65713058|FG004|Overall Study|Withdrawal by Subject|2|||
23541716|NCT03891524|65713059|FG005|Overall Study|Withdrawal by Subject|2|||
23541717|NCT03891524|65713060|FG006|Overall Study|Withdrawal by Subject|2|||
23541718|NCT03891524|65713061|FG007|Overall Study|Withdrawal by Subject|1|||
23541719|NCT03283670|65713062|FG000|Placebo Gas|Withdrawal by Subject|2|||
23541720|NCT03283670|65713062|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
23541721|NCT03283670|65713062|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
23541722|NCT03588572|65713063|FG000|Visitation 1|Lack of Efficacy|1|||
23541723|NCT03588572|65713064|FG001|Visitation 1|Lack of Efficacy|1|||
23541724|NCT03588572|65713063|FG000|Visitation 2|Lost to Follow-up|1|||
23541725|NCT03588572|65713064|FG001|Visitation 2|Lost to Follow-up|1|||
23541726|NCT03588572|65713063|FG000|Visitation 2|Lack of Efficacy|0|||
23541727|NCT03588572|65713064|FG001|Visitation 2|Lack of Efficacy|1|||
23541728|NCT03588572|65713063|FG000|Visitation 2|Withdrawal by Subject|1|||
23541729|NCT03588572|65713064|FG001|Visitation 2|Withdrawal by Subject|0|||
23541730|NCT03588572|65713063|FG000|Visitation 3|Lost to Follow-up|1|||
23541731|NCT03588572|65713064|FG001|Visitation 3|Lost to Follow-up|1|||
23541732|NCT03588572|65713063|FG000|Visitation 3|Physician Decision|1|||
23541733|NCT03588572|65713064|FG001|Visitation 3|Physician Decision|1|||
23541734|NCT03588572|65713063|FG000|Visitation 3|Withdrawal by Subject|1|||
23541735|NCT03588572|65713064|FG001|Visitation 3|Withdrawal by Subject|0|||
23541736|NCT01296568|65713065|FG000|Continued Access Phase|Lost to Follow-up|1|||
23541737|NCT01296568|65713065|FG000|Continued Access Phase|Withdrawal by Subject|1|||
23541738|NCT01296568|65713065|FG000|Continued Access Phase|Disease Progression|1|||
23541739|NCT01793792|65713066|FG000|Overall Study|Death|5|||
23541740|NCT01793792|65713066|FG000|Overall Study|Lost to Follow-up|5|||
23541741|NCT01793792|65713066|FG000|Overall Study|Withdrawal by Subject|1|||
23541742|NCT01793792|65713066|FG000|Overall Study|Device Not Implanted|1|||
23541743|NCT02473952|65713074|FG000|Overall Study|Adverse Event|2|||
23541744|NCT02473952|65713075|FG001|Overall Study|Adverse Event|2|||
23541745|NCT02473952|65713074|FG000|Overall Study|Withdrawal by Subject|0|||
23541746|NCT02473952|65713075|FG001|Overall Study|Withdrawal by Subject|6|||
23541747|NCT01921348|65713076|FG000|Overall Study|Withdrawal by Subject|1|||
23541748|NCT01921348|65713077|FG001|Overall Study|Withdrawal by Subject|0|||
23541749|NCT01921348|65713076|FG000|Overall Study|Lost to Follow-up|0|||
23541750|NCT01921348|65713077|FG001|Overall Study|Lost to Follow-up|2|||
23541751|NCT01313559|65713078|FG000|Overall Study|Withdrawal by Subject|1|||
23541752|NCT01313559|65713079|FG001|Overall Study|Withdrawal by Subject|2|||
23541753|NCT01313559|65713078|FG000|Overall Study|Disease progression|1|||
23541754|NCT01313559|65713079|FG001|Overall Study|Disease progression|0|||
23541755|NCT01313559|65713078|FG000|Overall Study|Rising PSA|2|||
23541756|NCT01313559|65713079|FG001|Overall Study|Rising PSA|0|||
23541757|NCT02349711|65713080|FG000|Overall Study|Withdrawal by Subject|2|||
23541758|NCT02349711|65713081|FG001|Overall Study|Withdrawal by Subject|1|||
23541759|NCT02349711|65713080|FG000|Overall Study|Lost to Follow-up|1|||
23541760|NCT02349711|65713081|FG001|Overall Study|Lost to Follow-up|1|||
23541761|NCT01193556|65713082|FG000|Overall Study|Study termination|26|||
23541762|NCT01193556|65713083|FG001|Overall Study|Study termination|25|||
23541763|NCT03073603|65713086|FG000|Overall Study|Noncompliance|3|||
23541764|NCT03073603|65713087|FG001|Overall Study|Noncompliance|1|||
23541765|NCT03073603|65713086|FG000|Overall Study|Adverse Event|5|||
23541766|NCT03073603|65713087|FG001|Overall Study|Adverse Event|3|||
23541767|NCT03073603|65713086|FG000|Overall Study|Physician Decision|1|||
23541768|NCT03073603|65713087|FG001|Overall Study|Physician Decision|2|||
23541769|NCT03073603|65713086|FG000|Overall Study|Required treatment not allowed by protocol|1|||
23541770|NCT03073603|65713087|FG001|Overall Study|Required treatment not allowed by protocol|0|||
23541771|NCT03073603|65713086|FG000|Overall Study|Financial or insurance-related|8|||
23541772|NCT03073603|65713087|FG001|Overall Study|Financial or insurance-related|0|||
23541773|NCT03073603|65713086|FG000|Overall Study|Withdrawal by Subject|0|||
23541774|NCT03073603|65713087|FG001|Overall Study|Withdrawal by Subject|1|||
23541775|NCT03073603|65713086|FG000|Overall Study|Discontinued DMT|4|||
23541776|NCT03073603|65713087|FG001|Overall Study|Discontinued DMT|0|||
23541777|NCT03073603|65713086|FG000|Overall Study|Restarted DMT|0|||
23541778|NCT03073603|65713087|FG001|Overall Study|Restarted DMT|1|||
23541779|NCT03086447|65713090|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23541780|NCT03086447|65713091|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23541781|NCT03086447|65713090|FG000|Overall Study|Lost Lens|2|||
23541782|NCT03086447|65713091|FG001|Overall Study|Lost Lens|5|||
23541783|NCT03086447|65713090|FG000|Overall Study|Product quality complaint|0|||
23541784|NCT03086447|65713091|FG001|Overall Study|Product quality complaint|1|||
23541785|NCT03086447|65713090|FG000|Overall Study|Lens Damage|1|||
23541786|NCT03086447|65713091|FG001|Overall Study|Lens Damage|6|||
23541787|NCT03086447|65713090|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23541788|NCT03086447|65713091|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23541789|NCT03086447|65713090|FG000|Overall Study|Test Article No Longer Available|1|||
23541790|NCT03086447|65713091|FG001|Overall Study|Test Article No Longer Available|0|||
23541791|NCT03086447|65713090|FG000|Overall Study|Protocol Violation|2|||
23541792|NCT03086447|65713091|FG001|Overall Study|Protocol Violation|4|||
23541793|NCT03086447|65713090|FG000|Overall Study|Lost to Follow-up|0|||
23541794|NCT03086447|65713091|FG001|Overall Study|Lost to Follow-up|1|||
23541795|NCT03086447|65713090|FG000|Overall Study|Adverse Event|3|||
23541796|NCT03086447|65713091|FG001|Overall Study|Adverse Event|0|||
23541797|NCT03086447|65713090|FG000|Overall Study|Lens Discomfort|2|||
23424618|NCT00428220|65299701|FG000|Overall Study|Participant refused continued treatment|7|||
23424619|NCT00428220|65299701|FG000|Overall Study|Adverse Event|51|||
23424620|NCT00428220|65299701|FG000|Overall Study|Other|23|||
23424621|NCT00815191|65299709|FG000|Overall Study|Protocol Violation|1|||
23424622|NCT00815191|65299710|FG001|Overall Study|Protocol Violation|1|||
23424623|NCT02014480|65299711|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424624|NCT02014480|65299712|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424625|NCT02014480|65299713|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23424626|NCT02014480|65299714|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424627|NCT02014480|65299715|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424628|NCT02014480|65299716|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424629|NCT02014480|65299711|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424630|NCT02014480|65299712|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23424631|NCT02014480|65299713|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424632|NCT02014480|65299714|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
23424633|NCT02014480|65299715|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23424634|NCT02014480|65299716|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424635|NCT02014480|65299711|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424636|NCT02014480|65299712|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424637|NCT02014480|65299713|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
23424638|NCT02014480|65299714|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424639|NCT02014480|65299715|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424640|NCT02014480|65299716|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424641|NCT02014480|65299711|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424642|NCT02014480|65299712|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424643|NCT02014480|65299713|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
23424644|NCT02014480|65299714|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424645|NCT02014480|65299715|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23424646|NCT02014480|65299716|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23424647|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424648|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
23424649|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424650|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424651|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424652|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424653|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424654|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424655|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
23424656|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424657|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424658|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
23424659|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424660|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424661|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424662|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424663|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424664|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23424665|NCT02851407|65299719|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23424666|NCT02851407|65299720|FG001|Overall Study|Withdrawal by parent/guardian|7|||
23424667|NCT02851407|65299719|FG000|Overall Study|Protocol deviation|0|||
23424668|NCT02851407|65299720|FG001|Overall Study|Protocol deviation|1|||
23424669|NCT02851407|65299719|FG000|Overall Study|Transferred to another hospital to continue|1|||
23424670|NCT02851407|65299720|FG001|Overall Study|Transferred to another hospital to continue|0|||
23424671|NCT02851407|65299719|FG000|Overall Study|Other Death|30|||
23424672|NCT02851407|65299720|FG001|Overall Study|Other Death|20|||
23541798|NCT03086447|65713091|FG001|Overall Study|Lens Discomfort|1|||
23541799|NCT05282004|65713092|FG000|Overall Study|Adverse Event|2|||
23541800|NCT00214136|65713096|FG000|Overall Study|Death|5|||
23541801|NCT00889421|65713097|FG000|Overall Study|Lack of Efficacy|3|||
23541802|NCT00439777|65713098|FG000|Treatment Period|Death|29|||
23541803|NCT00439777|65713099|FG001|Treatment Period|Death|21|||
23616677|NCT00747149|65982405|FG001|Overall Study|Adverse Event|15|||
23541804|NCT00439777|65713098|FG000|Treatment Period|Study terminated by sponsor|125|||
23541805|NCT00439777|65713099|FG001|Treatment Period|Study terminated by sponsor|132|||
23541806|NCT00439777|65713098|FG000|Treatment Period|Site closed by investigator|0|||
23541807|NCT00439777|65713099|FG001|Treatment Period|Site closed by investigator|1|||
23541808|NCT00439777|65713098|FG000|Treatment Period|Did not take study treatment|7|||
23541809|NCT00439777|65713099|FG001|Treatment Period|Did not take study treatment|8|||
23541810|NCT00439777|65713098|FG000|Treatment Period|Adverse Event|111|||
23541811|NCT00439777|65713099|FG001|Treatment Period|Adverse Event|92|||
23816931|NCT03249792|66708540|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
23816932|NCT03249792|66708541|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
23816933|NCT03249792|66708542|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
23816934|NCT03249792|66708543|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
23816935|NCT03249792|66708544|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
23816936|NCT03249792|66708545|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
23816937|NCT03249792|66708546|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
23816938|NCT03249792|66708547|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
23816939|NCT03249792|66708548|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
23816940|NCT03249792|66708549|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
23816941|NCT03249792|66708550|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
23816942|NCT03249792|66708551|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
23816943|NCT03249792|66708552|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
23816944|NCT03249792|66708553|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
23816945|NCT03249792|66708521|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816946|NCT03249792|66708522|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
23541812|NCT00439777|65713098|FG000|Treatment Period|Protocol Violation|23|||
23541813|NCT00439777|65713099|FG001|Treatment Period|Protocol Violation|30|||
23541814|NCT00439777|65713098|FG000|Treatment Period|Withdrawal by Subject|66|||
23541815|NCT00439777|65713099|FG001|Treatment Period|Withdrawal by Subject|118|||
23727715|NCT01057862|66382149|FG001|Overall Study|Withdrawal by Subject|2|||
23727716|NCT00592072|66382150|FG000|Wash Out Period|Lost to Follow-up|1|||
23727717|NCT00592072|66382151|FG001|Wash Out Period|Lost to Follow-up|1|||
23727718|NCT01060124|66382152|FG000|Overall Study|Other|16|||
23727719|NCT01060124|66382152|FG000|Overall Study|Adverse Event|14|||
23727720|NCT01060124|66382152|FG000|Overall Study|Withdrawal by Subject|7|||
23727721|NCT01098032|66382153|FG000|Overall Study|Withdrawal by Subject|1|||
23727722|NCT01098032|66382154|FG001|Overall Study|Withdrawal by Subject|1|||
23727723|NCT02120469|66382155|FG000|Overall Study|HER-2/neu-amplified|1|||
23727724|NCT02120469|66382156|FG001|Overall Study|HER-2/neu-amplified|0|||
23727725|NCT02120469|66382157|FG002|Overall Study|HER-2/neu-amplified|1|||
23727726|NCT00106249|66382158|FG000|Overall Study|Lost to Follow-up|3|||
23727727|NCT00106249|66382159|FG001|Overall Study|Lost to Follow-up|2|||
23727728|NCT03924427|66382162|FG000|Overall Study|Adverse Event|4|||
23727729|NCT03924427|66382162|FG000|Overall Study|Lack of Efficacy|1|||
23727730|NCT03924427|66382162|FG000|Overall Study|Withdrawal by Subject|1|||
23727731|NCT01518309|66382163|FG000|Overall Study|Adverse Event|6|||
23727732|NCT01518309|66382163|FG000|Overall Study|Death|6|||
23727733|NCT01518309|66382163|FG000|Overall Study|Lack of Efficacy|7|||
23727734|NCT01518309|66382163|FG000|Overall Study|Withdrawal by Subject|6|||
23727735|NCT01518309|66382163|FG000|Overall Study|Physician Decision|3|||
23727736|NCT01518309|66382163|FG000|Overall Study|Sponsor Decision|2|||
23727737|NCT01518309|66382163|FG000|Overall Study|Not in Predefined Categories|9|||
23727738|NCT04058158|66382171|FG000|Period 1|Death|1|||
23727739|NCT04058158|66382172|FG001|Period 1|Death|0|||
23541816|NCT00439777|65713098|FG000|Treatment Period|Lack of Efficacy|1|||
23541817|NCT00439777|65713099|FG001|Treatment Period|Lack of Efficacy|4|||
23541818|NCT00439777|65713098|FG000|Treatment Period|Lost to Follow-up|8|||
23727740|NCT04058158|66382171|FG000|Period 1|Adverse Event|1|||
23816947|NCT03249792|66708523|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816948|NCT03249792|66708524|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
23541819|NCT00439777|65713099|FG001|Treatment Period|Lost to Follow-up|10|||
23541820|NCT00439777|65713098|FG000|Treatment Period|Protocol driven decision point|1|||
23541821|NCT00439777|65713099|FG001|Treatment Period|Protocol driven decision point|3|||
23541822|NCT00439777|65713098|FG000|Treatment Period|Physician Decision|7|||
23541823|NCT00439777|65713099|FG001|Treatment Period|Physician Decision|18|||
23541824|NCT00439777|65713098|FG000|Treatment Period|Clinical endpoint reached|26|||
23541825|NCT00439777|65713099|FG001|Treatment Period|Clinical endpoint reached|13|||
23541826|NCT00439777|65713098|FG000|Treatment Period|Technical problems|3|||
23541827|NCT00439777|65713099|FG001|Treatment Period|Technical problems|1|||
23541828|NCT00439777|65713098|FG000|Treatment Period|Participant convenience|12|||
23541829|NCT00439777|65713099|FG001|Treatment Period|Participant convenience|8|||
23727741|NCT04058158|66382172|FG001|Period 1|Adverse Event|1|||
23727742|NCT04058158|66382171|FG000|Period 1|Pregnancy|0|||
23727743|NCT04058158|66382172|FG001|Period 1|Pregnancy|1|||
23727744|NCT00707486|66382179|FG000|Overall Study|Withdrawal by Subject|1|||
23727745|NCT02658968|66382180|FG000|Received Rituximab|Adverse Event|0|||
23727746|NCT02658968|66382181|FG001|Received Rituximab|Adverse Event|0|||
23727747|NCT02658968|66382182|FG002|Received Rituximab|Adverse Event|0|||
23541830|NCT00439777|65713098|FG000|Observational Period|Protocol Violation|0|||
23541831|NCT00439777|65713099|FG001|Observational Period|Protocol Violation|2|||
23541832|NCT00439777|65713098|FG000|Observational Period|Withdrawal by Subject|9|||
23541833|NCT00439777|65713099|FG001|Observational Period|Withdrawal by Subject|5|||
23541834|NCT00439777|65713098|FG000|Observational Period|Lost to Follow-up|1|||
23541835|NCT00439777|65713099|FG001|Observational Period|Lost to Follow-up|11|||
23541836|NCT00439777|65713098|FG000|Observational Period|Death|27|||
23541837|NCT00439777|65713099|FG001|Observational Period|Death|20|||
23541838|NCT00439777|65713098|FG000|Observational Period|Study terminated by sponsor|3|||
23541839|NCT00439777|65713099|FG001|Observational Period|Study terminated by sponsor|1|||
23541840|NCT00439777|65713098|FG000|Observational Period|Protocol driven decision point|0|||
23541841|NCT00439777|65713099|FG001|Observational Period|Protocol driven decision point|1|||
23541842|NCT00439777|65713098|FG000|Observational Period|Lack of Efficacy|1|||
23541843|NCT00439777|65713099|FG001|Observational Period|Lack of Efficacy|0|||
23541844|NCT00439777|65713098|FG000|Observational Period|Technical problems|0|||
23541845|NCT00439777|65713099|FG001|Observational Period|Technical problems|1|||
23541846|NCT03062891|65713103|FG000|Overall Study|Withdrawal by Subject|2|||
23541847|NCT03062891|65713104|FG001|Overall Study|Withdrawal by Subject|0|||
23541848|NCT03062891|65713103|FG000|Overall Study|Lost to Follow-up|50|||
23541849|NCT03062891|65713104|FG001|Overall Study|Lost to Follow-up|38|||
23541850|NCT01923181|65713114|FG000|Overall Study|Protocol Violation|2|||
23541851|NCT01923181|65713115|FG001|Overall Study|Protocol Violation|2|||
23541852|NCT01923181|65713116|FG002|Overall Study|Protocol Violation|0|||
23541853|NCT01923181|65713117|FG003|Overall Study|Protocol Violation|2|||
23541854|NCT01923181|65713118|FG004|Overall Study|Protocol Violation|2|||
23541855|NCT01923181|65713119|FG005|Overall Study|Protocol Violation|1|||
23541856|NCT01923181|65713120|FG006|Overall Study|Protocol Violation|1|||
23541857|NCT01923181|65713121|FG007|Overall Study|Protocol Violation|2|||
23541858|NCT01923181|65713122|FG008|Overall Study|Protocol Violation|1|||
23541859|NCT01923181|65713114|FG000|Overall Study|Withdrawal by Subject|0|||
23541860|NCT01923181|65713115|FG001|Overall Study|Withdrawal by Subject|1|||
23541861|NCT01923181|65713116|FG002|Overall Study|Withdrawal by Subject|0|||
23541862|NCT01923181|65713117|FG003|Overall Study|Withdrawal by Subject|1|||
23541863|NCT01923181|65713118|FG004|Overall Study|Withdrawal by Subject|4|||
23541864|NCT01923181|65713119|FG005|Overall Study|Withdrawal by Subject|2|||
23541865|NCT01923181|65713120|FG006|Overall Study|Withdrawal by Subject|4|||
23541866|NCT01923181|65713121|FG007|Overall Study|Withdrawal by Subject|3|||
23541867|NCT01923181|65713122|FG008|Overall Study|Withdrawal by Subject|1|||
23541868|NCT01923181|65713114|FG000|Overall Study|Other|1|||
23541869|NCT01923181|65713115|FG001|Overall Study|Other|0|||
23541870|NCT01923181|65713116|FG002|Overall Study|Other|0|||
23541871|NCT01923181|65713117|FG003|Overall Study|Other|1|||
23541872|NCT01923181|65713118|FG004|Overall Study|Other|0|||
23541873|NCT01923181|65713119|FG005|Overall Study|Other|0|||
23541874|NCT01923181|65713120|FG006|Overall Study|Other|0|||
23541875|NCT01923181|65713121|FG007|Overall Study|Other|0|||
23541876|NCT01923181|65713122|FG008|Overall Study|Other|0|||
23541877|NCT01923181|65713114|FG000|Overall Study|Lost to Follow-up|0|||
23541878|NCT01923181|65713115|FG001|Overall Study|Lost to Follow-up|3|||
23541879|NCT01923181|65713116|FG002|Overall Study|Lost to Follow-up|2|||
23541880|NCT01923181|65713117|FG003|Overall Study|Lost to Follow-up|1|||
23541881|NCT01923181|65713118|FG004|Overall Study|Lost to Follow-up|2|||
23541882|NCT01923181|65713119|FG005|Overall Study|Lost to Follow-up|1|||
23541883|NCT01923181|65713120|FG006|Overall Study|Lost to Follow-up|3|||
23541884|NCT01923181|65713121|FG007|Overall Study|Lost to Follow-up|3|||
23541885|NCT01923181|65713122|FG008|Overall Study|Lost to Follow-up|1|||
23541886|NCT02352493|65713123|FG000|Overall Study|Pregnancy|0|||
23541887|NCT02352493|65713124|FG001|Overall Study|Pregnancy|0|||
23541888|NCT02352493|65713125|FG002|Overall Study|Pregnancy|0|||
23541889|NCT02352493|65713126|FG003|Overall Study|Pregnancy|0|||
23727748|NCT02658968|66382183|FG003|Received Rituximab|Adverse Event|0|||
23727749|NCT02658968|66382184|FG004|Received Rituximab|Adverse Event|1|||
23541890|NCT02352493|65713127|FG004|Overall Study|Pregnancy|0|||
23541891|NCT02352493|65713128|FG005|Overall Study|Pregnancy|0|||
23541892|NCT02352493|65713129|FG006|Overall Study|Pregnancy|1|||
23727750|NCT02658968|66382180|FG000|Received Rituximab|Progressive disease|0|||
23541893|NCT02352493|65713130|FG007|Overall Study|Pregnancy|0|||
23541894|NCT02352493|65713131|FG008|Overall Study|Pregnancy|1|||
23541895|NCT02352493|65713132|FG009|Overall Study|Pregnancy|0|||
23541896|NCT02352493|65713133|FG010|Overall Study|Pregnancy|0|||
23541897|NCT02352493|65713134|FG011|Overall Study|Pregnancy|0|||
23541898|NCT02352493|65713135|FG012|Overall Study|Pregnancy|0|||
23541899|NCT02352493|65713136|FG013|Overall Study|Pregnancy|0|||
23541900|NCT02352493|65713137|FG014|Overall Study|Pregnancy|0|||
23541901|NCT02352493|65713138|FG015|Overall Study|Pregnancy|0|||
23541902|NCT02352493|65713139|FG016|Overall Study|Pregnancy|0|||
23541903|NCT02352493|65713140|FG017|Overall Study|Pregnancy|0|||
23541904|NCT02352493|65713123|FG000|Overall Study|Withdrawal by Subject|0|||
23541905|NCT02352493|65713124|FG001|Overall Study|Withdrawal by Subject|0|||
23616678|NCT00747149|65982404|FG000|Overall Study|Lost to Follow-up|0|||
23541906|NCT02352493|65713125|FG002|Overall Study|Withdrawal by Subject|0|||
23541907|NCT02352493|65713126|FG003|Overall Study|Withdrawal by Subject|0|||
23541908|NCT02352493|65713127|FG004|Overall Study|Withdrawal by Subject|0|||
23541909|NCT02352493|65713128|FG005|Overall Study|Withdrawal by Subject|0|||
23424673|NCT02851407|65299719|FG000|Overall Study|Adverse event, serious fatal|6|||
23424674|NCT02851407|65299720|FG001|Overall Study|Adverse event, serious fatal|8|||
23727751|NCT02658968|66382181|FG001|Received Rituximab|Progressive disease|0|||
23727752|NCT02658968|66382182|FG002|Received Rituximab|Progressive disease|0|||
23727753|NCT02658968|66382183|FG003|Received Rituximab|Progressive disease|0|||
23727754|NCT02658968|66382184|FG004|Received Rituximab|Progressive disease|1|||
23727755|NCT02658968|66382180|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
23727756|NCT02658968|66382181|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
23727757|NCT02658968|66382182|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
23727758|NCT02658968|66382183|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
23727759|NCT02658968|66382184|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
23727760|NCT02658968|66382180|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
23727761|NCT02658968|66382181|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
23727762|NCT02658968|66382182|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
23727763|NCT02658968|66382183|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
23727764|NCT02658968|66382184|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
23727765|NCT02658968|66382180|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23727766|NCT02658968|66382181|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
23424675|NCT02851407|65299719|FG000|Overall Study|Consent withdrawn by participant|5|||
23424676|NCT02851407|65299720|FG001|Overall Study|Consent withdrawn by participant|3|||
23541910|NCT02352493|65713129|FG006|Overall Study|Withdrawal by Subject|0|||
23424677|NCT02851407|65299719|FG000|Overall Study|Screen failure|2|||
23541911|NCT02352493|65713130|FG007|Overall Study|Withdrawal by Subject|0|||
23541912|NCT02352493|65713131|FG008|Overall Study|Withdrawal by Subject|1|||
23541913|NCT02352493|65713132|FG009|Overall Study|Withdrawal by Subject|0|||
23541914|NCT02352493|65713133|FG010|Overall Study|Withdrawal by Subject|0|||
23541915|NCT02352493|65713134|FG011|Overall Study|Withdrawal by Subject|0|||
23541916|NCT02352493|65713135|FG012|Overall Study|Withdrawal by Subject|0|||
23541917|NCT02352493|65713136|FG013|Overall Study|Withdrawal by Subject|0|||
23541918|NCT02352493|65713137|FG014|Overall Study|Withdrawal by Subject|1|||
23541919|NCT02352493|65713138|FG015|Overall Study|Withdrawal by Subject|0|||
23541920|NCT02352493|65713139|FG016|Overall Study|Withdrawal by Subject|0|||
23541921|NCT02352493|65713140|FG017|Overall Study|Withdrawal by Subject|0|||
23541922|NCT02352493|65713123|FG000|Overall Study|Lost to Follow-up|0|||
23541923|NCT02352493|65713124|FG001|Overall Study|Lost to Follow-up|0|||
23541924|NCT02352493|65713125|FG002|Overall Study|Lost to Follow-up|0|||
23541925|NCT02352493|65713126|FG003|Overall Study|Lost to Follow-up|0|||
23424678|NCT02851407|65299720|FG001|Overall Study|Screen failure|1|||
23424679|NCT02851407|65299719|FG000|Overall Study|Disease relapse|9|||
23541926|NCT02352493|65713127|FG004|Overall Study|Lost to Follow-up|0|||
23541927|NCT02352493|65713128|FG005|Overall Study|Lost to Follow-up|0|||
23541928|NCT02352493|65713129|FG006|Overall Study|Lost to Follow-up|0|||
23541929|NCT02352493|65713130|FG007|Overall Study|Lost to Follow-up|0|||
23541930|NCT02352493|65713131|FG008|Overall Study|Lost to Follow-up|0|||
23541931|NCT02352493|65713132|FG009|Overall Study|Lost to Follow-up|1|||
23541932|NCT02352493|65713133|FG010|Overall Study|Lost to Follow-up|0|||
23541933|NCT02352493|65713134|FG011|Overall Study|Lost to Follow-up|0|||
23541934|NCT02352493|65713135|FG012|Overall Study|Lost to Follow-up|1|||
23541935|NCT02352493|65713136|FG013|Overall Study|Lost to Follow-up|2|||
23541936|NCT02352493|65713137|FG014|Overall Study|Lost to Follow-up|0|||
23541937|NCT02352493|65713138|FG015|Overall Study|Lost to Follow-up|0|||
23541938|NCT02352493|65713139|FG016|Overall Study|Lost to Follow-up|0|||
23541939|NCT02352493|65713140|FG017|Overall Study|Lost to Follow-up|0|||
23541940|NCT02546544|65715838|FG000|Overall Study|Disease Progression|14|||
23541941|NCT02546544|65715838|FG000|Overall Study|Adverse Event|1|||
23541942|NCT02546544|65715838|FG000|Overall Study|Withdrawal by Subject|1|||
23541943|NCT00782340|65715839|FG000|Open Label Titration|Adverse Event|12|||
23541944|NCT00782340|65715840|FG001|Open Label Titration|Adverse Event|0|||
23541945|NCT00782340|65715841|FG002|Open Label Titration|Adverse Event|0|||
23541946|NCT00782340|65715839|FG000|Open Label Titration|Treatment failure|50|||
23541947|NCT00782340|65715840|FG001|Open Label Titration|Treatment failure|0|||
23541948|NCT00782340|65715841|FG002|Open Label Titration|Treatment failure|0|||
23541949|NCT00782340|65715839|FG000|Open Label Titration|Protocol Violation|5|||
23541950|NCT00782340|65715840|FG001|Open Label Titration|Protocol Violation|0|||
23541951|NCT00782340|65715841|FG002|Open Label Titration|Protocol Violation|0|||
23541952|NCT00782340|65715839|FG000|Open Label Titration|Withdrawal by Subject|5|||
23541953|NCT00782340|65715840|FG001|Open Label Titration|Withdrawal by Subject|0|||
23541954|NCT00782340|65715841|FG002|Open Label Titration|Withdrawal by Subject|0|||
23541955|NCT00782340|65715839|FG000|Open Label Titration|Enrollment capped|16|||
23541956|NCT00782340|65715840|FG001|Open Label Titration|Enrollment capped|0|||
23541957|NCT00782340|65715841|FG002|Open Label Titration|Enrollment capped|0|||
23541958|NCT00782340|65715839|FG000|Open Label Titration|Did not meet responder criteria|2|||
23727767|NCT02658968|66382182|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23727768|NCT02658968|66382183|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
23727769|NCT02658968|66382184|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23727770|NCT02658968|66382180|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23727771|NCT02658968|66382181|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
23727772|NCT02658968|66382182|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23727773|NCT02658968|66382183|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23727774|NCT02658968|66382184|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23727775|NCT02658968|66382180|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
23727776|NCT02658968|66382181|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
23727777|NCT02658968|66382182|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
23727778|NCT02658968|66382183|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
23727779|NCT02658968|66382184|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
23727780|NCT00796224|66382188|FG000|Overall Study|Adverse Event|1|||
23424680|NCT02851407|65299720|FG001|Overall Study|Disease relapse|6|||
23424681|NCT02851407|65299719|FG000|Overall Study|Physician Decision|7|||
23541959|NCT00782340|65715840|FG001|Open Label Titration|Did not meet responder criteria|0|||
23541960|NCT00782340|65715841|FG002|Open Label Titration|Did not meet responder criteria|0|||
23541961|NCT00782340|65715839|FG000|Open Label Titration|Lost to Follow-up|5|||
23727781|NCT00796224|66382189|FG001|Overall Study|Adverse Event|0|||
23541962|NCT00782340|65715840|FG001|Open Label Titration|Lost to Follow-up|0|||
23541963|NCT00782340|65715841|FG002|Open Label Titration|Lost to Follow-up|0|||
23541964|NCT00782340|65715839|FG000|Open Label Titration|Randomized in error|6|||
23424682|NCT02851407|65299720|FG001|Overall Study|Physician Decision|6|||
23541965|NCT00782340|65715840|FG001|Open Label Titration|Randomized in error|0|||
23541966|NCT00782340|65715841|FG002|Open Label Titration|Randomized in error|0|||
23541967|NCT01153633|65715842|FG000|Overall Study|Protocol Violation|1|||
23541968|NCT01153633|65715843|FG001|Overall Study|Protocol Violation|1|||
23541969|NCT01153633|65715842|FG000|Overall Study|Therapeutic failure|3|||
23541970|NCT01153633|65715843|FG001|Overall Study|Therapeutic failure|3|||
23541971|NCT01181921|65715847|FG000|Overall Study|Lost to Follow-up|1|||
23541972|NCT01226745|65715848|FG000|Overall Study|Did not complete schedule of assessments|8|||
23541973|NCT01226745|65715849|FG001|Overall Study|Did not complete schedule of assessments|3|||
23541974|NCT01226745|65715850|FG002|Overall Study|Did not complete schedule of assessments|6|||
23541975|NCT01226745|65715851|FG003|Overall Study|Did not complete schedule of assessments|0|||
23541976|NCT01226745|65715852|FG004|Overall Study|Did not complete schedule of assessments|0|||
23541977|NCT01226745|65715853|FG005|Overall Study|Did not complete schedule of assessments|1|||
23541978|NCT01226745|65715848|FG000|Overall Study|Lost to Follow-up|2|||
23541979|NCT01226745|65715849|FG001|Overall Study|Lost to Follow-up|6|||
23541980|NCT01226745|65715850|FG002|Overall Study|Lost to Follow-up|6|||
23541981|NCT01226745|65715851|FG003|Overall Study|Lost to Follow-up|1|||
23541982|NCT01226745|65715852|FG004|Overall Study|Lost to Follow-up|1|||
23541983|NCT01226745|65715853|FG005|Overall Study|Lost to Follow-up|2|||
23541984|NCT01226745|65715848|FG000|Overall Study|Death|1|||
23541985|NCT01226745|65715849|FG001|Overall Study|Death|0|||
23541986|NCT01226745|65715850|FG002|Overall Study|Death|0|||
23541987|NCT01226745|65715851|FG003|Overall Study|Death|0|||
23541988|NCT01226745|65715852|FG004|Overall Study|Death|0|||
23541989|NCT01226745|65715853|FG005|Overall Study|Death|1|||
23541990|NCT01226745|65715848|FG000|Overall Study|Other|6|||
23541991|NCT01226745|65715849|FG001|Overall Study|Other|7|||
23541992|NCT01226745|65715850|FG002|Overall Study|Other|8|||
23541993|NCT01226745|65715851|FG003|Overall Study|Other|4|||
23541994|NCT01226745|65715852|FG004|Overall Study|Other|3|||
23541995|NCT01226745|65715853|FG005|Overall Study|Other|1|||
23541996|NCT03376321|65715854|FG000|Overall Study|Other|5|||
23541997|NCT03376321|65715855|FG001|Overall Study|Other|1|||
23541998|NCT03376321|65715854|FG000|Overall Study|Withdrawal by Subject|8|||
23541999|NCT03376321|65715855|FG001|Overall Study|Withdrawal by Subject|14|||
23542000|NCT03376321|65715854|FG000|Overall Study|Lost to Follow-up|1|||
23542001|NCT03376321|65715855|FG001|Overall Study|Lost to Follow-up|7|||
23542002|NCT03376321|65715854|FG000|Overall Study|Death|4|||
23542003|NCT03376321|65715855|FG001|Overall Study|Death|0|||
23542004|NCT03376321|65715854|FG000|Overall Study|Randomized, not treated|5|||
23542005|NCT03376321|65715855|FG001|Overall Study|Randomized, not treated|3|||
23542006|NCT01046110|65715856|FG000|Overall Study|Adverse Event|9|||
23542007|NCT01046110|65715857|FG001|Overall Study|Adverse Event|2|||
23424683|NCT02851407|65299719|FG000|Overall Study|Transferred to hospital closer to home|0|||
23424684|NCT02851407|65299720|FG001|Overall Study|Transferred to hospital closer to home|1|||
23424685|NCT02851407|65299719|FG000|Overall Study|Enrolled in an investigational study|0|||
23424686|NCT02851407|65299720|FG001|Overall Study|Enrolled in an investigational study|1|||
23424687|NCT02851407|65299719|FG000|Overall Study|Early recovery|1|||
23424688|NCT02851407|65299720|FG001|Overall Study|Early recovery|0|||
23424689|NCT02851407|65299719|FG000|Overall Study|Adverse event, non-fatal|7|||
23424690|NCT02851407|65299720|FG001|Overall Study|Adverse event, non-fatal|5|||
23424691|NCT02851407|65299719|FG000|Overall Study|Lost to Follow-up|0|||
23424692|NCT02851407|65299720|FG001|Overall Study|Lost to Follow-up|2|||
23542008|NCT01046110|65715856|FG000|Overall Study|Lack of Efficacy|0|||
23542009|NCT01046110|65715857|FG001|Overall Study|Lack of Efficacy|1|||
23542010|NCT01046110|65715856|FG000|Overall Study|Protocol Violation|7|||
23542011|NCT01046110|65715857|FG001|Overall Study|Protocol Violation|12|||
23542012|NCT01046110|65715856|FG000|Overall Study|Withdrawal Criteria|3|||
23542013|NCT01046110|65715857|FG001|Overall Study|Withdrawal Criteria|5|||
23542014|NCT01046110|65715856|FG000|Overall Study|Unclassified|36|||
23542015|NCT01046110|65715857|FG001|Overall Study|Unclassified|35|||
23542016|NCT02646423|65715858|FG000|Overall Study|Adverse Event|5|||
23616679|NCT00747149|65982405|FG001|Overall Study|Lost to Follow-up|10|||
23727782|NCT00796224|66382188|FG000|Overall Study|Protocol Violation|0|||
23727783|NCT00796224|66382189|FG001|Overall Study|Protocol Violation|1|||
23727784|NCT04737759|66382192|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
23542017|NCT02646423|65715859|FG001|Overall Study|Adverse Event|7|||
23542018|NCT02646423|65715858|FG000|Overall Study|Ineligible|2|||
23542019|NCT02646423|65715859|FG001|Overall Study|Ineligible|1|||
23542020|NCT03811912|65715860|FG000|Overall Study|Withdrew Consent|4|||
23616680|NCT00747149|65982404|FG000|Overall Study|Withdrawal by Subject|0|||
23542021|NCT03811912|65715861|FG001|Overall Study|Withdrew Consent|2|||
23542022|NCT01073618|65715865|FG000|Overall Study|Death|208|||
23542023|NCT01073618|65715865|FG000|Overall Study|Adverse Event|19|||
23616681|NCT00747149|65982405|FG001|Overall Study|Withdrawal by Subject|6|||
23542024|NCT01073618|65715865|FG000|Overall Study|Other|80|||
23542025|NCT01639001|65715870|FG000|Overall Study|Refused further follow-up|9|||
23542026|NCT01639001|65715871|FG001|Overall Study|Refused further follow-up|12|||
23542027|NCT01639001|65715870|FG000|Overall Study|Lost to Follow-up|3|||
23542028|NCT01639001|65715871|FG001|Overall Study|Lost to Follow-up|0|||
23542029|NCT01639001|65715870|FG000|Overall Study|Death|62|||
23542030|NCT01639001|65715871|FG001|Overall Study|Death|61|||
23542031|NCT01639001|65715870|FG000|Overall Study|Randomized but not treated|0|||
23542032|NCT01639001|65715871|FG001|Overall Study|Randomized but not treated|2|||
23542033|NCT01639001|65715870|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
23542034|NCT01639001|65715871|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
23542035|NCT03295201|65715878|FG000|Overall Study|Lost to Follow-up|1|||
23542036|NCT03295201|65715879|FG001|Overall Study|Lost to Follow-up|1|||
23542037|NCT03295201|65715878|FG000|Overall Study|Hospital admission|0|||
23542038|NCT03295201|65715879|FG001|Overall Study|Hospital admission|1|||
23542039|NCT00389324|65715880|FG000|Run-In Phase|Adverse Event|1|||
23542040|NCT00389324|65715880|FG000|Run-In Phase|Lost to Follow-up|1|||
23542041|NCT00389324|65715880|FG000|Run-In Phase|Withdrawal by Subject|1|||
23542042|NCT00389324|65715880|FG000|Subcutaneous Phase|Adverse Event|2|||
23542043|NCT00389324|65715880|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
23424693|NCT01691014|65299723|FG000|Overall Study|Premature Termination|1|||
23424694|NCT01691014|65299724|FG001|Overall Study|Premature Termination|6|||
23542044|NCT00389324|65715880|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
23542045|NCT00389324|65715880|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
23542046|NCT02553330|65715881|FG000|Overall Study|Study Terminated by Sponsor|2|||
23542047|NCT02553330|65715882|FG001|Overall Study|Study Terminated by Sponsor|13|||
23424695|NCT01691014|65299725|FG002|Overall Study|Premature Termination|0|||
23424696|NCT01691014|65299726|FG003|Overall Study|Premature Termination|3|||
23424697|NCT01691014|65299723|FG000|Overall Study|Other|0|||
23424698|NCT01691014|65299724|FG001|Overall Study|Other|0|||
23424699|NCT01691014|65299725|FG002|Overall Study|Other|2|||
23424700|NCT01691014|65299726|FG003|Overall Study|Other|0|||
23424701|NCT01691014|65299723|FG000|Overall Study|Withdrawal by Subject|0|||
23424702|NCT01691014|65299724|FG001|Overall Study|Withdrawal by Subject|1|||
23424703|NCT01691014|65299725|FG002|Overall Study|Withdrawal by Subject|1|||
23424704|NCT01691014|65299726|FG003|Overall Study|Withdrawal by Subject|1|||
23542048|NCT02553330|65715883|FG002|Overall Study|Study Terminated by Sponsor|12|||
23542049|NCT02553330|65715881|FG000|Overall Study|Withdrawal by Subject|3|||
23542050|NCT02553330|65715882|FG001|Overall Study|Withdrawal by Subject|19|||
23542051|NCT02553330|65715883|FG002|Overall Study|Withdrawal by Subject|21|||
23542052|NCT02553330|65715881|FG000|Overall Study|Other|0|||
23542053|NCT02553330|65715882|FG001|Overall Study|Other|1|||
23542054|NCT02553330|65715883|FG002|Overall Study|Other|0|||
23542055|NCT02553330|65715881|FG000|Overall Study|Non compliance to study treatment|0|||
23542056|NCT02553330|65715882|FG001|Overall Study|Non compliance to study treatment|1|||
23542057|NCT02553330|65715883|FG002|Overall Study|Non compliance to study treatment|0|||
23542058|NCT02553330|65715881|FG000|Overall Study|Adverse Event|0|||
23542059|NCT02553330|65715882|FG001|Overall Study|Adverse Event|1|||
23542060|NCT02553330|65715883|FG002|Overall Study|Adverse Event|0|||
23542061|NCT02553330|65715881|FG000|Overall Study|Lost to Follow-up|0|||
23542062|NCT02553330|65715882|FG001|Overall Study|Lost to Follow-up|4|||
23542063|NCT02553330|65715883|FG002|Overall Study|Lost to Follow-up|4|||
23542064|NCT03701555|65715884|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
23542065|NCT03701555|65715885|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
23816949|NCT03249792|66708525|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
23424705|NCT01691014|65299723|FG000|Overall Study|Adverse Event|0|||
23424706|NCT01691014|65299724|FG001|Overall Study|Adverse Event|5|||
23424707|NCT01691014|65299725|FG002|Overall Study|Adverse Event|1|||
23424708|NCT01691014|65299726|FG003|Overall Study|Adverse Event|1|||
23424709|NCT01691014|65299723|FG000|Overall Study|Lack of Efficacy|2|||
23424710|NCT01691014|65299724|FG001|Overall Study|Lack of Efficacy|3|||
23424711|NCT01691014|65299725|FG002|Overall Study|Lack of Efficacy|7|||
23424712|NCT01691014|65299726|FG003|Overall Study|Lack of Efficacy|0|||
23424713|NCT00554619|65299727|FG000|Overall Study|Adverse Event|1|||
23424714|NCT00554619|65299727|FG000|Overall Study|Physician Decision|1|||
23424715|NCT00554619|65299727|FG000|Overall Study|Liver Function Test Abnormality|1|||
23424716|NCT00953524|65299728|FG000|Overall Study|Adverse Event|2|||
23424717|NCT00953524|65299729|FG001|Overall Study|Adverse Event|0|||
23424718|NCT00953524|65299730|FG002|Overall Study|Adverse Event|1|||
23424719|NCT00953524|65299731|FG003|Overall Study|Adverse Event|2|||
23424720|NCT00953524|65299728|FG000|Overall Study|Protocol Violation|18|||
23542066|NCT03701555|65715886|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
23424721|NCT00953524|65299729|FG001|Overall Study|Protocol Violation|10|||
23424722|NCT00953524|65299730|FG002|Overall Study|Protocol Violation|11|||
23424723|NCT00953524|65299731|FG003|Overall Study|Protocol Violation|6|||
23424724|NCT00953524|65299728|FG000|Overall Study|Lost to Follow-up|0|||
23424725|NCT00953524|65299729|FG001|Overall Study|Lost to Follow-up|1|||
23727785|NCT04737759|66382193|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
23727786|NCT04737759|66382192|FG000|Overall Study|Death|2|||
23542067|NCT03701555|65715887|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
23542068|NCT03701555|65715888|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
23542069|NCT03701555|65715889|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
23542070|NCT03701555|65715890|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
23542071|NCT03701555|65715891|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
23542072|NCT03701555|65715892|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
23542073|NCT03701555|65715893|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
23542074|NCT03701555|65715894|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
23542075|NCT03701555|65715895|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
23542076|NCT03701555|65715896|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
23542077|NCT03701555|65715897|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
23542078|NCT03701555|65715898|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
23542079|NCT03701555|65715899|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
23542080|NCT03701555|65715900|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
23542081|NCT03701555|65715901|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
23542082|NCT03701555|65715902|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
23542083|NCT03701555|65715903|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
23542084|NCT03701555|65715904|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
23542085|NCT03701555|65715905|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
23542086|NCT03701555|65715906|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
23542087|NCT03701555|65715907|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
23542088|NCT03701555|65715908|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
23542089|NCT03701555|65715909|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
23542090|NCT03701555|65715910|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
23542091|NCT03701555|65715911|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
23542092|NCT03701555|65715912|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
23542093|NCT03701555|65715913|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
23727787|NCT04737759|66382193|FG001|Overall Study|Death|0|||
23727788|NCT04737759|66382192|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
23542094|NCT03701555|65715914|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
23542095|NCT03701555|65715915|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
23542096|NCT03701555|65715916|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
23542097|NCT03701555|65715917|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
23542098|NCT03701555|65715918|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
23542099|NCT03701555|65715919|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
23542100|NCT03701555|65715884|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
23542101|NCT03701555|65715885|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
23542102|NCT03701555|65715886|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
23727789|NCT04737759|66382193|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
23727790|NCT04737759|66382192|FG000|Overall Study|Lost to Follow-up|4|||
23727791|NCT04737759|66382193|FG001|Overall Study|Lost to Follow-up|12|||
23727792|NCT01175590|66382194|FG000|Overall Study|Lost to Follow-up|1|||
23727793|NCT01175590|66382195|FG001|Overall Study|Lost to Follow-up|0|||
23727794|NCT01175590|66382194|FG000|Overall Study|Withdrawal by Subject|0|||
23727795|NCT01175590|66382195|FG001|Overall Study|Withdrawal by Subject|2|||
23727796|NCT01175590|66382194|FG000|Overall Study|Adverse Event|4|||
23727797|NCT01175590|66382195|FG001|Overall Study|Adverse Event|0|||
23727798|NCT01175590|66382194|FG000|Overall Study|Physician Decision|1|||
23727799|NCT01175590|66382195|FG001|Overall Study|Physician Decision|4|||
23727800|NCT01175590|66382194|FG000|Overall Study|Lack of Efficacy|1|||
23727801|NCT01175590|66382195|FG001|Overall Study|Lack of Efficacy|1|||
23727802|NCT01175590|66382194|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
23727803|NCT01175590|66382195|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
23727804|NCT01175590|66382194|FG000|Overall Study|Treated not as randomized|3|||
23542103|NCT03701555|65715887|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
23542104|NCT03701555|65715888|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
23542105|NCT03701555|65715889|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
23542106|NCT03701555|65715890|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
23542107|NCT03701555|65715891|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
23542108|NCT03701555|65715892|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
23542109|NCT03701555|65715893|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
23542110|NCT03701555|65715894|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
23542111|NCT03701555|65715895|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
23542112|NCT03701555|65715896|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
23727805|NCT01175590|66382195|FG001|Overall Study|Treated not as randomized|2|||
23727806|NCT01175590|66382194|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
23727807|NCT01175590|66382195|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
23727808|NCT01175590|66382194|FG000|Overall Study|Protocol Violation|0|||
23727809|NCT01175590|66382195|FG001|Overall Study|Protocol Violation|1|||
23542113|NCT03701555|65715897|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
23542114|NCT03701555|65715898|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
23542115|NCT03701555|65715899|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
23542116|NCT03701555|65715900|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
23542117|NCT03701555|65715901|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
23542118|NCT03701555|65715902|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
23542119|NCT03701555|65715903|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
23542120|NCT03701555|65715904|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
23542121|NCT03701555|65715905|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
23542122|NCT03701555|65715906|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
23542123|NCT03701555|65715907|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
23542124|NCT03701555|65715908|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
23542125|NCT03701555|65715909|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
23542126|NCT03701555|65715910|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
23542127|NCT03701555|65715911|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
23727810|NCT04624672|66382196|FG000|Overall Study|Early Study Closure|2|||
23727811|NCT04624672|66382197|FG001|Overall Study|Early Study Closure|1|||
23727812|NCT00959699|66382198|FG000|Treatment Period|Adverse Event|3|||
23727813|NCT00959699|66382199|FG001|Treatment Period|Adverse Event|13|||
23727814|NCT00959699|66382198|FG000|Treatment Period|Lack of Efficacy|15|||
23727815|NCT00959699|66382199|FG001|Treatment Period|Lack of Efficacy|6|||
23727816|NCT00959699|66382198|FG000|Treatment Period|Lost to Follow-up|0|||
23727817|NCT00959699|66382199|FG001|Treatment Period|Lost to Follow-up|1|||
23727818|NCT00959699|66382198|FG000|Treatment Period|Withdrawal by Subject|1|||
23727819|NCT00959699|66382199|FG001|Treatment Period|Withdrawal by Subject|3|||
23727820|NCT00959699|66382198|FG000|Treatment Period|Non-Compliance with Protocol|0|||
23727821|NCT00959699|66382199|FG001|Treatment Period|Non-Compliance with Protocol|1|||
23727822|NCT00959699|66382198|FG000|Treatment Period|Did not receive treatment|0|||
23727823|NCT00959699|66382199|FG001|Treatment Period|Did not receive treatment|1|||
23727824|NCT00959699|66382198|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
23727825|NCT00959699|66382199|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
23727826|NCT00959699|66382198|FG000|Follow-up Period|Lost to Follow-up|3|||
23727827|NCT00959699|66382199|FG001|Follow-up Period|Lost to Follow-up|2|||
23727828|NCT00959699|66382198|FG000|Follow-up Period|Withdrawal by Subject|3|||
23727829|NCT00959699|66382199|FG001|Follow-up Period|Withdrawal by Subject|4|||
23727830|NCT00641706|66382200|FG000|Overall Study|Adverse Event|2|||
23727831|NCT00641706|66382201|FG001|Overall Study|Adverse Event|1|||
23727832|NCT00641706|66382200|FG000|Overall Study|Withdrawal by Subject|6|||
23727833|NCT00641706|66382201|FG001|Overall Study|Withdrawal by Subject|1|||
23727834|NCT00641706|66382200|FG000|Overall Study|Clinical Decline|1|||
23727835|NCT00641706|66382201|FG001|Overall Study|Clinical Decline|0|||
23727836|NCT00641706|66382200|FG000|Overall Study|Lead Investigator Decision|0|||
23727837|NCT00641706|66382201|FG001|Overall Study|Lead Investigator Decision|1|||
23542128|NCT03701555|65715912|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
23542129|NCT03701555|65715913|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
23542130|NCT03701555|65715914|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
23542131|NCT03701555|65715915|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
23542132|NCT03701555|65715916|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
23727838|NCT02762708|66382202|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23727839|NCT02762708|66382203|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
23727840|NCT02762708|66382204|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23727841|NCT02762708|66382205|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23727842|NCT02603172|66382208|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727843|NCT02603172|66382209|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727844|NCT02603172|66382210|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
23727845|NCT02603172|66382211|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23542133|NCT03701555|65715917|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
23542134|NCT03701555|65715918|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
23542135|NCT03701555|65715919|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
23727846|NCT02603172|66382212|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727847|NCT02603172|66382213|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727848|NCT02603172|66382214|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727849|NCT02603172|66382215|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23727850|NCT04259346|66382216|FG000|Overall Study|Lost to Follow-up|1|||
23727851|NCT04259346|66382217|FG001|Overall Study|Lost to Follow-up|3|||
23727852|NCT04259346|66382216|FG000|Overall Study|Protocol Violation|1|||
23727853|NCT04259346|66382217|FG001|Overall Study|Protocol Violation|0|||
23816950|NCT03249792|66708526|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816951|NCT03249792|66708527|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
23542136|NCT03701555|65715884|FG000|Part 2 (Day 1)|Other|0|||
23542137|NCT03701555|65715885|FG001|Part 2 (Day 1)|Other|0|||
23542138|NCT03701555|65715886|FG002|Part 2 (Day 1)|Other|0|||
23542139|NCT03701555|65715887|FG003|Part 2 (Day 1)|Other|0|||
23727854|NCT04259346|66382216|FG000|Overall Study|Withdrawal by Subject|1|||
23727855|NCT04259346|66382217|FG001|Overall Study|Withdrawal by Subject|0|||
23727856|NCT04259346|66382216|FG000|Overall Study|Adverse Event|1|||
23727857|NCT04259346|66382217|FG001|Overall Study|Adverse Event|1|||
23727858|NCT02332798|66382220|FG000|Overall Study|Unwilling to Participate in Study|0|||
23727859|NCT02332798|66382221|FG001|Overall Study|Unwilling to Participate in Study|1|||
23727860|NCT02332798|66382222|FG002|Overall Study|Unwilling to Participate in Study|1|||
23816952|NCT03249792|66708528|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
23542140|NCT03701555|65715888|FG004|Part 2 (Day 1)|Other|0|||
23542141|NCT03701555|65715889|FG005|Part 2 (Day 1)|Other|0|||
23542142|NCT03701555|65715890|FG006|Part 2 (Day 1)|Other|0|||
23727861|NCT02332798|66382220|FG000|Overall Study|Positive Urine Drug Test|0|||
23727862|NCT02332798|66382221|FG001|Overall Study|Positive Urine Drug Test|1|||
23727863|NCT02332798|66382222|FG002|Overall Study|Positive Urine Drug Test|0|||
23727864|NCT02332798|66382220|FG000|Overall Study|Abnormal Laboratory Findings|1|||
23727865|NCT02332798|66382221|FG001|Overall Study|Abnormal Laboratory Findings|0|||
23727866|NCT02332798|66382222|FG002|Overall Study|Abnormal Laboratory Findings|0|||
23727867|NCT00638690|66382227|FG000|Overall Study|Death|655|||
23727868|NCT00638690|66382228|FG001|Overall Study|Death|335|||
23727869|NCT00638690|66382227|FG000|Overall Study|Withdrawal by Subject|22|||
23727870|NCT00638690|66382228|FG001|Overall Study|Withdrawal by Subject|5|||
23542143|NCT03701555|65715891|FG007|Part 2 (Day 1)|Other|0|||
23542144|NCT03701555|65715892|FG008|Part 2 (Day 1)|Other|0|||
23542145|NCT03701555|65715893|FG009|Part 2 (Day 1)|Other|0|||
23542146|NCT03701555|65715894|FG010|Part 2 (Day 1)|Other|3|||
23542147|NCT03701555|65715895|FG011|Part 2 (Day 1)|Other|1|||
23542148|NCT03701555|65715896|FG012|Part 2 (Day 1)|Other|0|||
23542149|NCT03701555|65715897|FG013|Part 2 (Day 1)|Other|1|||
23542150|NCT03701555|65715898|FG014|Part 2 (Day 1)|Other|0|||
23542151|NCT03701555|65715899|FG015|Part 2 (Day 1)|Other|2|||
23542152|NCT03701555|65715900|FG016|Part 2 (Day 1)|Other|2|||
23542153|NCT03701555|65715901|FG017|Part 2 (Day 1)|Other|0|||
23542154|NCT03701555|65715902|FG018|Part 2 (Day 1)|Other|0|||
23542155|NCT03701555|65715903|FG019|Part 2 (Day 1)|Other|0|||
23542156|NCT03701555|65715904|FG020|Part 2 (Day 1)|Other|0|||
23542157|NCT03701555|65715905|FG021|Part 2 (Day 1)|Other|0|||
23542158|NCT03701555|65715906|FG022|Part 2 (Day 1)|Other|0|||
23542159|NCT03701555|65715907|FG023|Part 2 (Day 1)|Other|0|||
23542160|NCT03701555|65715908|FG024|Part 2 (Day 1)|Other|0|||
23542161|NCT03701555|65715909|FG025|Part 2 (Day 1)|Other|0|||
23542162|NCT03701555|65715910|FG026|Part 2 (Day 1)|Other|0|||
23542163|NCT03701555|65715911|FG027|Part 2 (Day 1)|Other|0|||
23542164|NCT03701555|65715912|FG028|Part 2 (Day 1)|Other|0|||
23542165|NCT03701555|65715913|FG029|Part 2 (Day 1)|Other|0|||
23542166|NCT03701555|65715914|FG030|Part 2 (Day 1)|Other|0|||
23542167|NCT03701555|65715915|FG031|Part 2 (Day 1)|Other|0|||
23542168|NCT03701555|65715916|FG032|Part 2 (Day 1)|Other|0|||
23542169|NCT03701555|65715917|FG033|Part 2 (Day 1)|Other|0|||
23542170|NCT03701555|65715918|FG034|Part 2 (Day 1)|Other|0|||
23542171|NCT03701555|65715919|FG035|Part 2 (Day 1)|Other|0|||
23542172|NCT03701555|65715884|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
23542173|NCT03701555|65715885|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
23542174|NCT03701555|65715886|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
23542175|NCT03701555|65715887|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
23542176|NCT03701555|65715888|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
23542177|NCT03701555|65715889|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
23542178|NCT03701555|65715890|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
23542179|NCT03701555|65715891|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
23542180|NCT03701555|65715892|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
23542181|NCT03701555|65715893|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
23542182|NCT03701555|65715894|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
23542183|NCT03701555|65715895|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
23542184|NCT03701555|65715896|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
23424726|NCT00953524|65299730|FG002|Overall Study|Lost to Follow-up|1|||
23424727|NCT00953524|65299731|FG003|Overall Study|Lost to Follow-up|0|||
23542185|NCT03701555|65715897|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
23542186|NCT03701555|65715898|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
23542187|NCT03701555|65715899|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
23542188|NCT03701555|65715900|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
23542189|NCT03701555|65715901|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
23542190|NCT03701555|65715902|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
23542191|NCT03701555|65715903|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
23542192|NCT03701555|65715904|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
23542193|NCT03701555|65715905|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
23542194|NCT03701555|65715906|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
23727871|NCT00638690|66382227|FG000|Overall Study|Lost to Follow-up|4|||
23542195|NCT03701555|65715907|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
23542196|NCT03701555|65715908|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
23542197|NCT03701555|65715909|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
23542198|NCT03701555|65715910|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
23542199|NCT03701555|65715911|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
23542200|NCT03701555|65715912|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
23542201|NCT03701555|65715913|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
23542202|NCT03701555|65715914|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
23542203|NCT03701555|65715915|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
23542204|NCT03701555|65715916|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
23542205|NCT03701555|65715917|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
23542206|NCT03701555|65715918|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
23542207|NCT03701555|65715919|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
23542208|NCT03701555|65715884|FG000|Part 3 (Day 1)|Subject Decision|0|||
23542209|NCT03701555|65715885|FG001|Part 3 (Day 1)|Subject Decision|0|||
23542210|NCT03701555|65715886|FG002|Part 3 (Day 1)|Subject Decision|0|||
23542211|NCT03701555|65715887|FG003|Part 3 (Day 1)|Subject Decision|0|||
23542212|NCT03701555|65715888|FG004|Part 3 (Day 1)|Subject Decision|0|||
23542213|NCT03701555|65715889|FG005|Part 3 (Day 1)|Subject Decision|0|||
23542214|NCT03701555|65715890|FG006|Part 3 (Day 1)|Subject Decision|0|||
23542215|NCT03701555|65715891|FG007|Part 3 (Day 1)|Subject Decision|0|||
23542216|NCT03701555|65715892|FG008|Part 3 (Day 1)|Subject Decision|0|||
23542217|NCT03701555|65715893|FG009|Part 3 (Day 1)|Subject Decision|0|||
23542218|NCT03701555|65715894|FG010|Part 3 (Day 1)|Subject Decision|0|||
23542219|NCT03701555|65715895|FG011|Part 3 (Day 1)|Subject Decision|0|||
23542220|NCT03701555|65715896|FG012|Part 3 (Day 1)|Subject Decision|0|||
23542221|NCT03701555|65715897|FG013|Part 3 (Day 1)|Subject Decision|0|||
23542222|NCT03701555|65715898|FG014|Part 3 (Day 1)|Subject Decision|0|||
23542223|NCT03701555|65715899|FG015|Part 3 (Day 1)|Subject Decision|0|||
23542224|NCT03701555|65715900|FG016|Part 3 (Day 1)|Subject Decision|0|||
23542225|NCT03701555|65715901|FG017|Part 3 (Day 1)|Subject Decision|0|||
23542226|NCT03701555|65715902|FG018|Part 3 (Day 1)|Subject Decision|0|||
23542227|NCT03701555|65715903|FG019|Part 3 (Day 1)|Subject Decision|0|||
23542228|NCT03701555|65715904|FG020|Part 3 (Day 1)|Subject Decision|0|||
23542229|NCT03701555|65715905|FG021|Part 3 (Day 1)|Subject Decision|0|||
23542230|NCT03701555|65715906|FG022|Part 3 (Day 1)|Subject Decision|0|||
23542231|NCT03701555|65715907|FG023|Part 3 (Day 1)|Subject Decision|0|||
23542232|NCT03701555|65715908|FG024|Part 3 (Day 1)|Subject Decision|0|||
23542233|NCT03701555|65715909|FG025|Part 3 (Day 1)|Subject Decision|0|||
23542234|NCT03701555|65715910|FG026|Part 3 (Day 1)|Subject Decision|1|||
23542235|NCT03701555|65715911|FG027|Part 3 (Day 1)|Subject Decision|0|||
23542236|NCT03701555|65715912|FG028|Part 3 (Day 1)|Subject Decision|0|||
23542237|NCT03701555|65715913|FG029|Part 3 (Day 1)|Subject Decision|0|||
23542238|NCT03701555|65715914|FG030|Part 3 (Day 1)|Subject Decision|0|||
23542239|NCT03701555|65715915|FG031|Part 3 (Day 1)|Subject Decision|2|||
23542240|NCT03701555|65715916|FG032|Part 3 (Day 1)|Subject Decision|1|||
23542241|NCT03701555|65715917|FG033|Part 3 (Day 1)|Subject Decision|1|||
23542242|NCT03701555|65715918|FG034|Part 3 (Day 1)|Subject Decision|0|||
23542243|NCT03701555|65715919|FG035|Part 3 (Day 1)|Subject Decision|0|||
23542244|NCT03701555|65715884|FG000|Part 3 (Day 1)|Other|0|||
23542245|NCT03701555|65715885|FG001|Part 3 (Day 1)|Other|0|||
23542246|NCT03701555|65715886|FG002|Part 3 (Day 1)|Other|0|||
23542247|NCT03701555|65715887|FG003|Part 3 (Day 1)|Other|0|||
23542248|NCT03701555|65715888|FG004|Part 3 (Day 1)|Other|0|||
23542249|NCT03701555|65715889|FG005|Part 3 (Day 1)|Other|0|||
23542250|NCT03701555|65715890|FG006|Part 3 (Day 1)|Other|0|||
23542251|NCT03701555|65715891|FG007|Part 3 (Day 1)|Other|0|||
23542252|NCT03701555|65715892|FG008|Part 3 (Day 1)|Other|0|||
23542253|NCT03701555|65715893|FG009|Part 3 (Day 1)|Other|0|||
23542254|NCT03701555|65715894|FG010|Part 3 (Day 1)|Other|0|||
23542255|NCT03701555|65715895|FG011|Part 3 (Day 1)|Other|0|||
23727872|NCT00638690|66382228|FG001|Overall Study|Lost to Follow-up|2|||
23542256|NCT03701555|65715896|FG012|Part 3 (Day 1)|Other|0|||
23542257|NCT03701555|65715897|FG013|Part 3 (Day 1)|Other|0|||
23542258|NCT03701555|65715898|FG014|Part 3 (Day 1)|Other|0|||
23542259|NCT03701555|65715899|FG015|Part 3 (Day 1)|Other|0|||
23542260|NCT03701555|65715900|FG016|Part 3 (Day 1)|Other|0|||
23542261|NCT03701555|65715901|FG017|Part 3 (Day 1)|Other|0|||
23542262|NCT03701555|65715902|FG018|Part 3 (Day 1)|Other|0|||
23542263|NCT03701555|65715903|FG019|Part 3 (Day 1)|Other|0|||
23542264|NCT03701555|65715904|FG020|Part 3 (Day 1)|Other|0|||
23727873|NCT05116683|66382229|FG000|Overall Study|Physician Decision|4|||
23727874|NCT00636155|66382230|FG000|Overall Study|Adverse Event|8|||
23727875|NCT00636155|66382230|FG000|Overall Study|Lack of Efficacy|1|||
23727876|NCT00636155|66382230|FG000|Overall Study|Withdrawal by Subject|3|||
23727877|NCT00636155|66382230|FG000|Overall Study|Stem cell transplant|1|||
23727878|NCT00636155|66382230|FG000|Overall Study|Physician Decision|5|||
23727879|NCT00608881|66382233|FG000|Overall Study|Death|22|||
23727880|NCT00608881|66382234|FG001|Overall Study|Death|13|||
23727881|NCT00608881|66382233|FG000|Overall Study|Adverse Event|5|||
23727882|NCT00608881|66382234|FG001|Overall Study|Adverse Event|3|||
23727883|NCT00608881|66382233|FG000|Overall Study|Lost to Follow-up|28|||
23727884|NCT00608881|66382234|FG001|Overall Study|Lost to Follow-up|14|||
23727885|NCT00608881|66382233|FG000|Overall Study|Withdrawal by Subject|18|||
23727886|NCT00608881|66382234|FG001|Overall Study|Withdrawal by Subject|29|||
23727887|NCT00608881|66382233|FG000|Overall Study|Physician Decision|5|||
23727888|NCT00608881|66382234|FG001|Overall Study|Physician Decision|5|||
23727889|NCT00608881|66382233|FG000|Overall Study|Institutionalized|1|||
23727890|NCT00608881|66382234|FG001|Overall Study|Institutionalized|2|||
23727891|NCT02579863|66382235|FG000|Overall Study|Final Disposition Unknown|2|||
23727892|NCT02579863|66382236|FG001|Overall Study|Final Disposition Unknown|1|||
23727893|NCT02579863|66382235|FG000|Overall Study|Adverse Event|18|||
23727894|NCT02579863|66382236|FG001|Overall Study|Adverse Event|11|||
23727895|NCT02579863|66382235|FG000|Overall Study|Death|31|||
23727896|NCT02579863|66382236|FG001|Overall Study|Death|29|||
23727897|NCT02579863|66382235|FG000|Overall Study|Lost to Follow-up|2|||
23727898|NCT02579863|66382236|FG001|Overall Study|Lost to Follow-up|1|||
23727899|NCT02579863|66382235|FG000|Overall Study|Physician Decision|1|||
23727900|NCT02579863|66382236|FG001|Overall Study|Physician Decision|2|||
23727901|NCT02579863|66382235|FG000|Overall Study|Screen Failure|0|||
23727902|NCT02579863|66382236|FG001|Overall Study|Screen Failure|2|||
23727903|NCT02579863|66382235|FG000|Overall Study|Study Terminated at Selected Sites|82|||
23727904|NCT02579863|66382236|FG001|Overall Study|Study Terminated at Selected Sites|88|||
23727905|NCT02579863|66382235|FG000|Overall Study|Withdrawal by Subject|20|||
23727906|NCT02579863|66382236|FG001|Overall Study|Withdrawal by Subject|20|||
23727907|NCT00633360|66382237|FG000|Overall Study|Lost to Follow-up|1|||
23727908|NCT00633360|66382238|FG001|Overall Study|Lost to Follow-up|1|||
23727909|NCT00633360|66382237|FG000|Overall Study|Adverse Event|3|||
23727910|NCT00633360|66382238|FG001|Overall Study|Adverse Event|1|||
23727911|NCT00633360|66382237|FG000|Overall Study|Protocol Violation|0|||
23727912|NCT00633360|66382238|FG001|Overall Study|Protocol Violation|1|||
23727913|NCT01929018|66382240|FG000|Overall Study|Lost to Follow-up|1|||
23727914|NCT01929018|66382241|FG001|Overall Study|Lost to Follow-up|0|||
23727915|NCT01929018|66382240|FG000|Overall Study|Hospitalization|0|||
23727916|NCT01929018|66382241|FG001|Overall Study|Hospitalization|1|||
23727917|NCT03938636|66382242|FG000|Overall Study|Protocol Violation|0|||
23727918|NCT03938636|66382243|FG001|Overall Study|Protocol Violation|1|||
23727919|NCT03938636|66382244|FG002|Overall Study|Protocol Violation|1|||
23727920|NCT03938636|66382242|FG000|Overall Study|Subject withdrew due to death in family|0|||
23727921|NCT03938636|66382243|FG001|Overall Study|Subject withdrew due to death in family|1|||
23727922|NCT03938636|66382244|FG002|Overall Study|Subject withdrew due to death in family|0|||
23727923|NCT03938636|66382242|FG000|Overall Study|Missed visit|0|||
23727924|NCT03938636|66382243|FG001|Overall Study|Missed visit|1|||
23727925|NCT03938636|66382244|FG002|Overall Study|Missed visit|0|||
23727926|NCT03938636|66382242|FG000|Overall Study|Adverse Event|0|||
23727927|NCT03938636|66382243|FG001|Overall Study|Adverse Event|0|||
23727928|NCT03938636|66382244|FG002|Overall Study|Adverse Event|1|||
23727929|NCT03938636|66382242|FG000|Overall Study|Lost to Follow-up|0|||
23727930|NCT03938636|66382243|FG001|Overall Study|Lost to Follow-up|0|||
23727931|NCT03938636|66382244|FG002|Overall Study|Lost to Follow-up|1|||
23727932|NCT04350372|66382245|FG000|Overall Study|Death|1|||
23727933|NCT00561340|66382246|FG000|Overall Study|refused to drink pediasure|6|||
23727934|NCT00561340|66382247|FG001|Overall Study|refused to drink pediasure|0|||
23727935|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Death|3|||
23727936|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Death|0|||
23727937|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Death|0|||
23727938|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Death|0|||
23727939|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Death|0|||
23727940|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
23727941|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
23727942|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
23727943|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
23727944|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
23542265|NCT03701555|65715905|FG021|Part 3 (Day 1)|Other|0|||
23727945|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23727946|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
23727947|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
23727948|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23727949|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
23542266|NCT03701555|65715906|FG022|Part 3 (Day 1)|Other|0|||
23542267|NCT03701555|65715907|FG023|Part 3 (Day 1)|Other|0|||
23542268|NCT03701555|65715908|FG024|Part 3 (Day 1)|Other|1|||
23542269|NCT03701555|65715909|FG025|Part 3 (Day 1)|Other|1|||
23542270|NCT03701555|65715910|FG026|Part 3 (Day 1)|Other|0|||
23424728|NCT00953524|65299728|FG000|Overall Study|Withdrawal by Subject|2|||
23424729|NCT00953524|65299729|FG001|Overall Study|Withdrawal by Subject|4|||
23424730|NCT00953524|65299730|FG002|Overall Study|Withdrawal by Subject|1|||
23424731|NCT00953524|65299731|FG003|Overall Study|Withdrawal by Subject|0|||
23424732|NCT02741570|65299732|FG000|Pre-Treatment Period|Other reasons|0|||
23424733|NCT02741570|65299733|FG001|Pre-Treatment Period|Other reasons|3|||
23424734|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
23424735|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
23424736|NCT02741570|65299732|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
23424737|NCT02741570|65299733|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
23424738|NCT02741570|65299732|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
23424739|NCT02741570|65299733|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
23424740|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23424741|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
23424742|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23424743|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
23424744|NCT02741570|65299732|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23424745|NCT02741570|65299733|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23424746|NCT02741570|65299732|FG000|Pre-Treatment Period|Death|0|||
23424747|NCT02741570|65299733|FG001|Pre-Treatment Period|Death|1|||
23424748|NCT02741570|65299732|FG000|Pre-Treatment Period|Disease progression|0|||
23424749|NCT02741570|65299733|FG001|Pre-Treatment Period|Disease progression|1|||
23542271|NCT03701555|65715911|FG027|Part 3 (Day 1)|Other|0|||
23542272|NCT03701555|65715912|FG028|Part 3 (Day 1)|Other|0|||
23542273|NCT03701555|65715913|FG029|Part 3 (Day 1)|Other|1|||
23542274|NCT03701555|65715914|FG030|Part 3 (Day 1)|Other|1|||
23542275|NCT03701555|65715915|FG031|Part 3 (Day 1)|Other|0|||
23542276|NCT03701555|65715916|FG032|Part 3 (Day 1)|Other|1|||
23727950|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Other|0|||
23542277|NCT03701555|65715917|FG033|Part 3 (Day 1)|Other|1|||
23542278|NCT03701555|65715918|FG034|Part 3 (Day 1)|Other|0|||
23542279|NCT03701555|65715919|FG035|Part 3 (Day 1)|Other|0|||
23542280|NCT00524134|65715924|FG000|Overall Study|Withdrawal by Subject|1|||
23542281|NCT00524134|65715924|FG000|Overall Study|Physician Decision|1|||
23727951|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Other|0|||
23727952|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Other|1|||
23727953|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Other|0|||
23727954|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Other|0|||
23727955|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
23542282|NCT00254982|65715925|FG000|Overall Study|Other|2|||
23424750|NCT02741570|65299732|FG000|Treatment Period|Other reasons|47|||
23424751|NCT02741570|65299733|FG001|Treatment Period|Other reasons|12|||
23542283|NCT00254982|65715926|FG001|Overall Study|Other|1|||
23542284|NCT00254982|65715925|FG000|Overall Study|Lack of Efficacy|5|||
23542285|NCT00254982|65715926|FG001|Overall Study|Lack of Efficacy|3|||
23542286|NCT00254982|65715925|FG000|Overall Study|Lost to Follow-up|5|||
23542287|NCT00254982|65715926|FG001|Overall Study|Lost to Follow-up|3|||
23542288|NCT00254982|65715925|FG000|Overall Study|Adverse Event|18|||
23542289|NCT00254982|65715926|FG001|Overall Study|Adverse Event|16|||
23542290|NCT00254982|65715925|FG000|Overall Study|Withdrawal by Subject|1|||
23542291|NCT00254982|65715926|FG001|Overall Study|Withdrawal by Subject|1|||
23542292|NCT00254982|65715925|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
23542293|NCT00254982|65715926|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
23424752|NCT02741570|65299732|FG000|Treatment Period|Poor/non-compliance|0|||
23424753|NCT02741570|65299733|FG001|Treatment Period|Poor/non-compliance|2|||
23424754|NCT02741570|65299732|FG000|Treatment Period|Maximum clinical benefit|4|||
23424755|NCT02741570|65299733|FG001|Treatment Period|Maximum clinical benefit|6|||
23424756|NCT02741570|65299732|FG000|Treatment Period|Lost to Follow-up|1|||
23424757|NCT02741570|65299733|FG001|Treatment Period|Lost to Follow-up|3|||
23424758|NCT02741570|65299732|FG000|Treatment Period|Participant withdrew consent|9|||
23424759|NCT02741570|65299733|FG001|Treatment Period|Participant withdrew consent|13|||
23424760|NCT02741570|65299732|FG000|Treatment Period|Participant request to discontinue treatment|8|||
23424761|NCT02741570|65299733|FG001|Treatment Period|Participant request to discontinue treatment|23|||
23424762|NCT02741570|65299732|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
23424763|NCT02741570|65299733|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
23424764|NCT02741570|65299732|FG000|Treatment Period|Death|9|||
23424765|NCT02741570|65299733|FG001|Treatment Period|Death|7|||
23424766|NCT02741570|65299732|FG000|Treatment Period|Study drug toxicity|55|||
23424767|NCT02741570|65299733|FG001|Treatment Period|Study drug toxicity|47|||
23542294|NCT00254982|65715925|FG000|Overall Study|Protocol deviation|1|||
23542295|NCT00254982|65715926|FG001|Overall Study|Protocol deviation|1|||
23424768|NCT02741570|65299732|FG000|Treatment Period|Disease progression|294|||
23424769|NCT02741570|65299733|FG001|Treatment Period|Disease progression|301|||
23424770|NCT02741570|65299732|FG000|Treatment Period|Administrative reason by sponsor|0|||
23424771|NCT02741570|65299733|FG001|Treatment Period|Administrative reason by sponsor|1|||
23424772|NCT00765882|65299735|FG000|Overall Study|Adverse Event|10|||
23424773|NCT00765882|65299736|FG001|Overall Study|Adverse Event|21|||
23424774|NCT00765882|65299737|FG002|Overall Study|Adverse Event|20|||
23424775|NCT00765882|65299735|FG000|Overall Study|Lack of Efficacy|4|||
23542296|NCT00254982|65715925|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
23542297|NCT00254982|65715926|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
23542298|NCT00254982|65715925|FG000|Overall Study|Malignancy|0|||
23542299|NCT00254982|65715926|FG001|Overall Study|Malignancy|2|||
23542300|NCT00254982|65715925|FG000|Overall Study|Opportunistic infection|1|||
23727956|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
23727957|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
23542301|NCT00254982|65715926|FG001|Overall Study|Opportunistic infection|0|||
23542302|NCT00254982|65715925|FG000|Overall Study|Abnormal liver function tests|2|||
23542303|NCT00254982|65715926|FG001|Overall Study|Abnormal liver function tests|1|||
23542304|NCT02317575|65715927|FG000|Period 1|Difficulty with venous cannulation|0|||
23542305|NCT02317575|65715928|FG001|Period 1|Difficulty with venous cannulation|1|||
23542306|NCT02317575|65715929|FG002|Period 1|Difficulty with venous cannulation|0|||
23542307|NCT02317575|65715930|FG003|Period 1|Difficulty with venous cannulation|0|||
23542308|NCT02317575|65715931|FG004|Period 1|Difficulty with venous cannulation|0|||
23542309|NCT02317575|65715927|FG000|Period 1|Withdrawal by Subject|1|||
23542310|NCT02317575|65715928|FG001|Period 1|Withdrawal by Subject|0|||
23542311|NCT02317575|65715929|FG002|Period 1|Withdrawal by Subject|0|||
23542312|NCT02317575|65715930|FG003|Period 1|Withdrawal by Subject|0|||
23542313|NCT02317575|65715931|FG004|Period 1|Withdrawal by Subject|0|||
23727958|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
23727959|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
23727960|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
23727961|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
23424776|NCT00765882|65299736|FG001|Overall Study|Lack of Efficacy|0|||
23542314|NCT01782131|65715932|FG000|Overall Study|Death|93|||
23727962|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
23727963|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
23727964|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
23727965|NCT01224106|66382248|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23727966|NCT01224106|66382249|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23542315|NCT01782131|65715933|FG001|Overall Study|Death|96|||
23542316|NCT01782131|65715932|FG000|Overall Study|Lost to Follow-up|1|||
23542317|NCT01782131|65715933|FG001|Overall Study|Lost to Follow-up|3|||
23542318|NCT01782131|65715932|FG000|Overall Study|Withdrawal by Subject|10|||
23542319|NCT01782131|65715933|FG001|Overall Study|Withdrawal by Subject|10|||
23542320|NCT01782131|65715932|FG000|Overall Study|Randomized but not treated|5|||
23424777|NCT00765882|65299737|FG002|Overall Study|Lack of Efficacy|1|||
23424778|NCT00765882|65299735|FG000|Overall Study|Protocol Violation|4|||
23542321|NCT01782131|65715933|FG001|Overall Study|Randomized but not treated|5|||
23542322|NCT01782131|65715932|FG000|Overall Study|Reason not provided|0|||
23542323|NCT01782131|65715933|FG001|Overall Study|Reason not provided|1|||
23542324|NCT02863991|65715934|FG000|Overall Study|Death|0|||
23542325|NCT02863991|65715935|FG001|Overall Study|Death|3|||
23542326|NCT02863991|65715934|FG000|Overall Study|Lack of Efficacy|0|||
23542327|NCT02863991|65715935|FG001|Overall Study|Lack of Efficacy|1|||
23542328|NCT02863991|65715934|FG000|Overall Study|Study Terminated|2|||
23542329|NCT02863991|65715935|FG001|Overall Study|Study Terminated|8|||
23542330|NCT00817089|65715937|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
23542331|NCT00817089|65715938|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
23424779|NCT00765882|65299736|FG001|Overall Study|Protocol Violation|3|||
23424780|NCT00765882|65299737|FG002|Overall Study|Protocol Violation|1|||
23424781|NCT00765882|65299735|FG000|Overall Study|Withdrawal by Subject|2|||
23424782|NCT00765882|65299736|FG001|Overall Study|Withdrawal by Subject|6|||
23424783|NCT00765882|65299737|FG002|Overall Study|Withdrawal by Subject|6|||
23424784|NCT00765882|65299735|FG000|Overall Study|Lost to Follow-up|1|||
23542332|NCT00817089|65715939|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
23542333|NCT00817089|65715940|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
23542334|NCT00817089|65715937|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
23542335|NCT00817089|65715938|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
23542336|NCT00817089|65715939|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
23542337|NCT00817089|65715940|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
23542338|NCT00795600|65715941|FG000|Overall Study|Adverse Event|1|||
23542339|NCT00795600|65715942|FG001|Overall Study|Adverse Event|1|||
23542340|NCT00795600|65715941|FG000|Overall Study|Protocol Violation|1|||
23542341|NCT00795600|65715942|FG001|Overall Study|Protocol Violation|2|||
23542342|NCT00795600|65715941|FG000|Overall Study|Withdrawal by Subject|1|||
23542343|NCT00795600|65715942|FG001|Overall Study|Withdrawal by Subject|0|||
23542344|NCT00795600|65715941|FG000|Overall Study|Unclassified|1|||
23542345|NCT00795600|65715942|FG001|Overall Study|Unclassified|1|||
23542346|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
23542347|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
23542348|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
23542349|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
23542350|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
23542351|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
23542352|NCT03783923|65715943|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
23542353|NCT03783923|65715944|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
23542354|NCT03783923|65715943|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
23542355|NCT03783923|65715944|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
23542356|NCT02866682|65715945|FG000|Overall Study|Death|0|||
23542357|NCT02866682|65715946|FG001|Overall Study|Death|1|||
23542358|NCT02866682|65715945|FG000|Overall Study|Lost to Follow-up|0|||
23424785|NCT00765882|65299736|FG001|Overall Study|Lost to Follow-up|9|||
23542359|NCT02866682|65715946|FG001|Overall Study|Lost to Follow-up|4|||
23542360|NCT02866682|65715945|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
23542361|NCT02866682|65715946|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
23542362|NCT02866682|65715945|FG000|Overall Study|Other|0|||
23542363|NCT02866682|65715946|FG001|Overall Study|Other|1|||
23542364|NCT01808313|65715947|FG000|Overall Study|Adverse Event|5|||
23542365|NCT01808313|65715947|FG000|Overall Study|Protocol Violation|2|||
23542366|NCT01808313|65715947|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23542367|NCT01808313|65715947|FG000|Overall Study|Lost to Follow-up|1|||
23542368|NCT01808313|65715947|FG000|Overall Study|Physician Decision|1|||
23542369|NCT01343082|65715949|FG000|The run-in Period|Not meeting criteria|3|||
23542370|NCT01343082|65715950|FG001|The run-in Period|Not meeting criteria|4|||
23542371|NCT01343082|65715951|FG002|The run-in Period|Not meeting criteria|5|||
23542372|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
23542373|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
23542374|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
23542375|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
23424786|NCT00765882|65299737|FG002|Overall Study|Lost to Follow-up|6|||
23542376|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
23542377|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
23542378|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
23424787|NCT00765882|65299735|FG000|Overall Study|Other Reason|3|||
23542379|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
23542380|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
23542381|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
23542382|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
23424788|NCT00765882|65299736|FG001|Overall Study|Other Reason|1|||
23424789|NCT00765882|65299737|FG002|Overall Study|Other Reason|2|||
23424790|NCT02075632|65299738|FG000|Overall Study|Adverse Event|1|||
23542383|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
23542384|NCT02696850|65715957|FG000|Overall Study|Withdrawal by Subject|3|||
23542385|NCT02696850|65715958|FG001|Overall Study|Withdrawal by Subject|3|||
23542386|NCT02696850|65715957|FG000|Overall Study|Lost to Follow-up|8|||
23542387|NCT02696850|65715958|FG001|Overall Study|Lost to Follow-up|5|||
23542388|NCT00714168|65715962|FG000|Overall Study|Pregnancy|5|||
23542389|NCT00714168|65715963|FG001|Overall Study|Pregnancy|4|||
23542390|NCT00714168|65715962|FG000|Overall Study|Lost to Follow-up|32|||
23542391|NCT00714168|65715963|FG001|Overall Study|Lost to Follow-up|50|||
23542392|NCT00714168|65715962|FG000|Overall Study|Relocation|4|||
23542393|NCT00714168|65715963|FG001|Overall Study|Relocation|3|||
23542394|NCT00714168|65715962|FG000|Overall Study|Non-study medical condition|3|||
23542395|NCT00714168|65715963|FG001|Overall Study|Non-study medical condition|2|||
23542396|NCT00736996|65715964|FG000|Overall Study|Lost to Follow-up|1|||
23542397|NCT00736996|65715965|FG001|Overall Study|Lost to Follow-up|9|||
23542398|NCT00736996|65715966|FG002|Overall Study|Lost to Follow-up|2|||
23542399|NCT01076400|65715969|FG000|Overall Study|Adverse Event|2|||
23542400|NCT01076400|65715970|FG001|Overall Study|Adverse Event|0|||
23542401|NCT01076400|65715971|FG002|Overall Study|Adverse Event|0|||
23542402|NCT01076400|65715969|FG000|Overall Study|Progressive Disease|5|||
23542403|NCT01076400|65715970|FG001|Overall Study|Progressive Disease|0|||
23542404|NCT01076400|65715971|FG002|Overall Study|Progressive Disease|0|||
23542405|NCT02460991|65715974|FG000|Overall Study|Withdrawal by Subject|0|||
23542406|NCT02460991|65715975|FG001|Overall Study|Withdrawal by Subject|2|||
23542407|NCT01748994|65715976|FG000|Overall Study|Lost to Follow-up|8|||
23542408|NCT01748994|65715977|FG001|Overall Study|Lost to Follow-up|6|||
23542409|NCT00360308|65715978|FG000|Overall Study|Adverse Event|15|||
23542410|NCT00360308|65715979|FG001|Overall Study|Adverse Event|14|||
23542411|NCT00360308|65715980|FG002|Overall Study|Adverse Event|25|||
23542412|NCT00360308|65715978|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23542413|NCT00360308|65715979|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23542414|NCT00360308|65715980|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23542415|NCT00360308|65715978|FG000|Overall Study|Protocol Violation|2|||
23542416|NCT00360308|65715979|FG001|Overall Study|Protocol Violation|1|||
23542417|NCT00360308|65715980|FG002|Overall Study|Protocol Violation|2|||
23542418|NCT00360308|65715978|FG000|Overall Study|Withdrawal by Subject|11|||
23542419|NCT00360308|65715979|FG001|Overall Study|Withdrawal by Subject|7|||
23542420|NCT00360308|65715980|FG002|Overall Study|Withdrawal by Subject|14|||
23542421|NCT00360308|65715978|FG000|Overall Study|Lack of Efficacy|3|||
23542422|NCT00360308|65715979|FG001|Overall Study|Lack of Efficacy|0|||
23542423|NCT00360308|65715980|FG002|Overall Study|Lack of Efficacy|2|||
23542424|NCT00360308|65715978|FG000|Overall Study|Other|2|||
23542425|NCT00360308|65715979|FG001|Overall Study|Other|1|||
23542426|NCT00360308|65715980|FG002|Overall Study|Other|1|||
23424791|NCT02075632|65299739|FG001|Overall Study|Adverse Event|1|||
23542427|NCT00360308|65715978|FG000|Overall Study|Study termination by sponsor|43|||
23542428|NCT00360308|65715979|FG001|Overall Study|Study termination by sponsor|55|||
23542429|NCT00360308|65715980|FG002|Overall Study|Study termination by sponsor|44|||
23542430|NCT02239510|65715983|FG000|Overall Study|Lost to Follow-up|2|||
23542431|NCT02239510|65715984|FG001|Overall Study|Lost to Follow-up|1|||
23542432|NCT00898677|65715994|FG000|Overall Study|Adverse Event|0|||
23542433|NCT00898677|65715995|FG001|Overall Study|Adverse Event|0|||
23542434|NCT00898677|65715996|FG002|Overall Study|Adverse Event|1|||
23542435|NCT00898677|65715997|FG003|Overall Study|Adverse Event|0|||
23542436|NCT00898677|65715994|FG000|Overall Study|Lost to Follow-up|0|||
23542437|NCT00898677|65715995|FG001|Overall Study|Lost to Follow-up|0|||
23542438|NCT00898677|65715996|FG002|Overall Study|Lost to Follow-up|2|||
23542439|NCT00898677|65715997|FG003|Overall Study|Lost to Follow-up|0|||
23727967|NCT01224106|66382250|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23727968|NCT01224106|66382251|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23727969|NCT01224106|66382252|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23727970|NCT01224106|66382248|FG000|Open-Label Extension (OLE) Phase|Death|0|||
23727971|NCT01224106|66382249|FG001|Open-Label Extension (OLE) Phase|Death|0|||
23727972|NCT01224106|66382250|FG002|Open-Label Extension (OLE) Phase|Death|0|||
23727973|NCT01224106|66382251|FG003|Open-Label Extension (OLE) Phase|Death|1|||
23727974|NCT01224106|66382252|FG004|Open-Label Extension (OLE) Phase|Death|3|||
23727975|NCT01224106|66382248|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23727976|NCT01224106|66382249|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23727977|NCT01224106|66382250|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23727978|NCT01224106|66382251|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
23727979|NCT01224106|66382252|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
23727980|NCT01224106|66382248|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23727981|NCT01224106|66382249|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23727982|NCT01224106|66382250|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23727983|NCT01224106|66382251|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
23542440|NCT00898677|65715994|FG000|Overall Study|Protocol Violation|1|||
23542441|NCT00898677|65715995|FG001|Overall Study|Protocol Violation|1|||
23542442|NCT00898677|65715996|FG002|Overall Study|Protocol Violation|2|||
23542443|NCT00898677|65715997|FG003|Overall Study|Protocol Violation|0|||
23542444|NCT00898677|65715994|FG000|Overall Study|Withdrawal by Subject|0|||
23542445|NCT00898677|65715995|FG001|Overall Study|Withdrawal by Subject|0|||
23542446|NCT00898677|65715996|FG002|Overall Study|Withdrawal by Subject|0|||
23542447|NCT00898677|65715997|FG003|Overall Study|Withdrawal by Subject|1|||
23542448|NCT00898677|65715994|FG000|Overall Study|Not Treated: Adverse Event|0|||
23542449|NCT00898677|65715995|FG001|Overall Study|Not Treated: Adverse Event|2|||
23542450|NCT00898677|65715996|FG002|Overall Study|Not Treated: Adverse Event|1|||
23542451|NCT00898677|65715997|FG003|Overall Study|Not Treated: Adverse Event|0|||
23542452|NCT00898677|65715994|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
23542453|NCT00898677|65715995|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
23542454|NCT00898677|65715996|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
23542455|NCT00898677|65715997|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
23542456|NCT00898677|65715994|FG000|Overall Study|Not Treated: Pregnancy|0|||
23542457|NCT00898677|65715995|FG001|Overall Study|Not Treated: Pregnancy|0|||
23542458|NCT00898677|65715996|FG002|Overall Study|Not Treated: Pregnancy|1|||
23542459|NCT00898677|65715997|FG003|Overall Study|Not Treated: Pregnancy|0|||
23542460|NCT00898677|65715994|FG000|Overall Study|Not Treated: Protocol Violation|2|||
23542461|NCT00898677|65715995|FG001|Overall Study|Not Treated: Protocol Violation|0|||
23542462|NCT00898677|65715996|FG002|Overall Study|Not Treated: Protocol Violation|2|||
23542463|NCT00898677|65715997|FG003|Overall Study|Not Treated: Protocol Violation|0|||
23542464|NCT00898677|65715994|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
23542465|NCT00898677|65715995|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
23542466|NCT00898677|65715996|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
23542467|NCT00898677|65715997|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
23542468|NCT00898677|65715994|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
23542469|NCT00898677|65715995|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
23542470|NCT00898677|65715996|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
23542471|NCT00898677|65715997|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
23727984|NCT01224106|66382252|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
23727985|NCT01224106|66382248|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23727986|NCT01224106|66382249|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23727987|NCT01224106|66382250|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23727988|NCT01224106|66382251|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
23727989|NCT01224106|66382252|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
23542472|NCT00898677|65715994|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542473|NCT00898677|65715995|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542474|NCT00898677|65715996|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542475|NCT00898677|65715997|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
23542476|NCT00898677|65715994|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
23542477|NCT00898677|65715995|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542478|NCT00898677|65715996|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542479|NCT00898677|65715997|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542480|NCT00898677|65715994|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
23542481|NCT00898677|65715995|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
23542482|NCT00898677|65715996|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
23542483|NCT00898677|65715997|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
23542484|NCT00898677|65715994|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
23542485|NCT00898677|65715995|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
23542486|NCT00898677|65715996|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
23542487|NCT00898677|65715997|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
23542488|NCT00898677|65715994|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
23542489|NCT00898677|65715995|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
23542490|NCT00898677|65715996|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
23542491|NCT00898677|65715997|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
23542492|NCT02823145|65715998|FG000|Enrollment|Other|1|||
23542493|NCT02823145|65715999|FG001|Enrollment|Other|0|||
23816953|NCT03249792|66708529|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
23816954|NCT03249792|66708530|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816955|NCT03249792|66708531|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
23727990|NCT01224106|66382248|FG000|Open-Label Extension (OLE) Phase|Other|0|||
23727991|NCT01224106|66382249|FG001|Open-Label Extension (OLE) Phase|Other|0|||
23727992|NCT01224106|66382250|FG002|Open-Label Extension (OLE) Phase|Other|0|||
23727993|NCT01224106|66382251|FG003|Open-Label Extension (OLE) Phase|Other|5|||
23727994|NCT01224106|66382252|FG004|Open-Label Extension (OLE) Phase|Other|3|||
23727995|NCT01510028|66382253|FG000|Overall Study|Lack of Efficacy|1|||
23727996|NCT01510028|66382254|FG001|Overall Study|Lack of Efficacy|0|||
23727997|NCT01510028|66382255|FG002|Overall Study|Lack of Efficacy|0|||
23727998|NCT01510028|66382256|FG003|Overall Study|Lack of Efficacy|0|||
23727999|NCT01614795|66382257|FG000|Overall Study|Adverse Event|0|||
23728000|NCT01614795|66382258|FG001|Overall Study|Adverse Event|0|||
23728001|NCT01614795|66382259|FG002|Overall Study|Adverse Event|1|||
23728002|NCT01614795|66382260|FG003|Overall Study|Adverse Event|1|||
23728003|NCT01614795|66382257|FG000|Overall Study|Lack of Efficacy|10|||
23728004|NCT01614795|66382258|FG001|Overall Study|Lack of Efficacy|10|||
23728005|NCT01614795|66382259|FG002|Overall Study|Lack of Efficacy|9|||
23728006|NCT01614795|66382260|FG003|Overall Study|Lack of Efficacy|8|||
23728007|NCT01614795|66382257|FG000|Overall Study|Physician Decision|1|||
23728008|NCT01614795|66382258|FG001|Overall Study|Physician Decision|0|||
23728009|NCT01614795|66382259|FG002|Overall Study|Physician Decision|1|||
23728010|NCT01614795|66382260|FG003|Overall Study|Physician Decision|1|||
23816956|NCT03249792|66708532|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816957|NCT03249792|66708533|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816958|NCT03249792|66708534|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816959|NCT03249792|66708535|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816960|NCT03249792|66708536|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816961|NCT03249792|66708537|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
23542494|NCT02823145|65715998|FG000|Treatment|Adverse Event|0|||
23542495|NCT02823145|65715999|FG001|Treatment|Adverse Event|11|||
23728011|NCT01614795|66382257|FG000|Overall Study|Withdrawal by Subject|0|||
23728012|NCT01614795|66382258|FG001|Overall Study|Withdrawal by Subject|1|||
23542496|NCT02823145|65715998|FG000|Treatment|Death|0|||
23542497|NCT02823145|65715999|FG001|Treatment|Death|3|||
23542498|NCT02823145|65715998|FG000|Treatment|Family Decision|0|||
23542499|NCT02823145|65715999|FG001|Treatment|Family Decision|1|||
23542500|NCT02823145|65715998|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
23542501|NCT02823145|65715999|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
23542502|NCT02823145|65715998|FG000|Treatment|Lack of Efficacy|0|||
23542503|NCT02823145|65715999|FG001|Treatment|Lack of Efficacy|48|||
23542504|NCT02823145|65715998|FG000|Treatment|Non-Compliance With E-Diary|0|||
23542505|NCT02823145|65715999|FG001|Treatment|Non-Compliance With E-Diary|1|||
23542506|NCT02823145|65715998|FG000|Treatment|Physician Decision|0|||
23542507|NCT02823145|65715999|FG001|Treatment|Physician Decision|2|||
23542508|NCT02823145|65715998|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
23542509|NCT02823145|65715999|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
23728013|NCT01614795|66382259|FG002|Overall Study|Withdrawal by Subject|0|||
23816962|NCT03249792|66708538|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
23728014|NCT01614795|66382260|FG003|Overall Study|Withdrawal by Subject|2|||
23728015|NCT01614795|66382257|FG000|Overall Study|Ineligible|0|||
23542510|NCT02823145|65715998|FG000|Treatment|Subject needed to take prohibited medication|0|||
23542511|NCT02823145|65715999|FG001|Treatment|Subject needed to take prohibited medication|1|||
23542512|NCT02823145|65715998|FG000|Treatment|Subject transferred to direct access programme|0|||
23542513|NCT02823145|65715999|FG001|Treatment|Subject transferred to direct access programme|1|||
23542514|NCT02823145|65715998|FG000|Treatment|Switching to commercially available drug|0|||
23728016|NCT01614795|66382258|FG001|Overall Study|Ineligible|1|||
23728017|NCT01614795|66382259|FG002|Overall Study|Ineligible|0|||
23728018|NCT01614795|66382260|FG003|Overall Study|Ineligible|0|||
23542515|NCT02823145|65715999|FG001|Treatment|Switching to commercially available drug|11|||
23542516|NCT02823145|65715998|FG000|Treatment|Transitioned to commercial supply of medication|0|||
23542517|NCT02823145|65715999|FG001|Treatment|Transitioned to commercial supply of medication|1|||
23542518|NCT02823145|65715998|FG000|Treatment|Withdrawal By Caregiver|0|||
23542519|NCT02823145|65715999|FG001|Treatment|Withdrawal By Caregiver|1|||
23542520|NCT02823145|65715998|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
23542521|NCT02823145|65715999|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
23542522|NCT02823145|65715998|FG000|Treatment|Withdrawal by Subject|0|||
23542523|NCT02823145|65715999|FG001|Treatment|Withdrawal by Subject|16|||
23542524|NCT02823145|65715998|FG000|Treatment|Reason unknown|0|||
23542525|NCT02823145|65715999|FG001|Treatment|Reason unknown|1|||
23542526|NCT00432380|65716000|FG000|Overall Study|Migrated/moved from study area|3|||
23542527|NCT00432380|65716001|FG001|Overall Study|Migrated/moved from study area|4|||
23542528|NCT00432380|65716002|FG002|Overall Study|Migrated/moved from study area|1|||
23728019|NCT00560794|66382263|FG000|Overall Study|Adverse Event|2|||
23728020|NCT00560794|66382263|FG000|Overall Study|Patient was not Compliant|1|||
23728021|NCT00560794|66382263|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
23728022|NCT00560794|66382263|FG000|Overall Study|Hematological Relapse|1|||
23728023|NCT00560794|66382263|FG000|Overall Study|Received Bone Marrow Transplant|6|||
23728024|NCT02903966|66382266|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
23728025|NCT02903966|66382267|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
23728026|NCT02903966|66382266|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
23728027|NCT02903966|66382267|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
23728028|NCT02903966|66382266|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
23728029|NCT02903966|66382267|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
23728030|NCT02224274|66382269|FG000|Overall Study|Death|1|||
23728031|NCT02224274|66382270|FG001|Overall Study|Death|0|||
23728032|NCT00446641|66382276|FG000|Overall Study|Withdrawal by Subject|8|||
23728033|NCT00446641|66382277|FG001|Overall Study|Withdrawal by Subject|3|||
23728034|NCT00446641|66382276|FG000|Overall Study|poor compliance|8|||
23728035|NCT00446641|66382277|FG001|Overall Study|poor compliance|6|||
23728036|NCT00446641|66382276|FG000|Overall Study|Lost to Follow-up|1|||
23728037|NCT00446641|66382277|FG001|Overall Study|Lost to Follow-up|1|||
23728038|NCT04095793|66382280|FG000|Overall Study|Adverse Event|3|||
23728039|NCT04095793|66382280|FG000|Overall Study|Study Terminated by Sponsor|103|||
23728040|NCT04095793|66382280|FG000|Overall Study|Withdrawal by Subject|4|||
23728041|NCT01305941|66382281|FG000|Overall Study|Adverse Event|6|||
23728042|NCT01305941|66382281|FG000|Overall Study|Clinical decline|2|||
23728043|NCT01305941|66382281|FG000|Overall Study|Withdrawal by Subject|1|||
23728044|NCT01305941|66382281|FG000|Overall Study|Death|1|||
23728045|NCT03621189|66382282|FG000|Overall Study|Withdrawal by Subject|0|||
23728046|NCT03621189|66382283|FG001|Overall Study|Withdrawal by Subject|3|||
23728047|NCT03621189|66382282|FG000|Overall Study|Physician Decision|0|||
23728048|NCT03621189|66382283|FG001|Overall Study|Physician Decision|2|||
23728049|NCT00893763|66382293|FG000|Overall Study|extubated|110|||
23728050|NCT00893763|66382294|FG001|Overall Study|extubated|110|||
23728051|NCT03887052|66382295|FG000|Overall Study|Adverse Event|2|||
23728052|NCT03887052|66382295|FG000|Overall Study|Physician Decision|2|||
23728053|NCT03887052|66382295|FG000|Overall Study|Withdrawal by Subject|3|||
23728054|NCT03887052|66382295|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
23728055|NCT03887052|66382295|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
23728056|NCT00615459|66382296|FG000|Period I|Adverse Event|2|||
23728057|NCT00615459|66382297|FG001|Period I|Adverse Event|0|||
23728058|NCT00615459|66382298|FG002|Period I|Adverse Event|1|||
23728059|NCT00615459|66382299|FG003|Period I|Adverse Event|0|||
23728060|NCT00615459|66382296|FG000|Period I|Subject withdrew consent|1|||
23728061|NCT00615459|66382297|FG001|Period I|Subject withdrew consent|0|||
23728062|NCT00615459|66382298|FG002|Period I|Subject withdrew consent|0|||
23728063|NCT00615459|66382299|FG003|Period I|Subject withdrew consent|1|||
23816963|NCT03249792|66708539|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816964|NCT03249792|66708540|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
23816965|NCT03249792|66708541|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816966|NCT03249792|66708542|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816967|NCT03249792|66708543|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816968|NCT03249792|66708544|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816969|NCT03249792|66708545|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
23728064|NCT00615459|66382296|FG000|Period I|Abnormal test procedure results|1|||
23816970|NCT03249792|66708546|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
23542529|NCT00432380|65716000|FG000|Overall Study|Adverse Event|1|||
23542530|NCT00432380|65716001|FG001|Overall Study|Adverse Event|0|||
23542531|NCT00432380|65716002|FG002|Overall Study|Adverse Event|0|||
23542532|NCT03912259|65716003|FG000|Overall Study|Adverse Event (AE)|2|||
23728065|NCT00615459|66382297|FG001|Period I|Abnormal test procedure results|1|||
23728066|NCT00615459|66382298|FG002|Period I|Abnormal test procedure results|1|||
23728067|NCT00615459|66382299|FG003|Period I|Abnormal test procedure results|0|||
23728068|NCT00615459|66382296|FG000|Period II|Adverse Event|1|||
23816971|NCT03249792|66708547|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
23542533|NCT03912259|65716004|FG001|Overall Study|Adverse Event (AE)|4|||
23542534|NCT03912259|65716003|FG000|Overall Study|Lack of Efficacy|4|||
23542535|NCT03912259|65716004|FG001|Overall Study|Lack of Efficacy|1|||
23542536|NCT03912259|65716003|FG000|Overall Study|Withdrawal by Subject|11|||
23542537|NCT03912259|65716004|FG001|Overall Study|Withdrawal by Subject|1|||
23542538|NCT03165045|65716007|FG000|Visit 1|No registration after visit 1|9|||
23542539|NCT03165045|65716007|FG000|Visit 1|No treatment documented|10|||
23542540|NCT03165045|65716007|FG000|Visit 1|No visit 1|10|||
23542541|NCT03165045|65716007|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
23542542|NCT03165045|65716007|FG000|Visit 2|No available total CCQ score at all|29|||
23542543|NCT03165045|65716007|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
23542544|NCT00462384|65716008|FG000|Overall Study|Adverse Event|2|||
23542545|NCT00462384|65716008|FG000|Overall Study|Death|2|||
23542546|NCT00462384|65716008|FG000|Overall Study|Withdrawal by Subject|1|||
23542547|NCT00462384|65716008|FG000|Overall Study|Other|4|||
23542548|NCT03095417|65716009|FG000|Overall Study|missed|1|||
23542549|NCT03095417|65716010|FG001|Overall Study|missed|2|||
23542550|NCT03095417|65716011|FG002|Overall Study|missed|0|||
23728069|NCT00615459|66382297|FG001|Period II|Adverse Event|0|||
23728070|NCT00615459|66382298|FG002|Period II|Adverse Event|0|||
23542551|NCT03095417|65716012|FG003|Overall Study|missed|1|||
23542552|NCT03095417|65716009|FG000|Overall Study|Lost to Follow-up|2|||
23542553|NCT03095417|65716010|FG001|Overall Study|Lost to Follow-up|2|||
23542554|NCT03095417|65716011|FG002|Overall Study|Lost to Follow-up|1|||
23542555|NCT03095417|65716012|FG003|Overall Study|Lost to Follow-up|0|||
23542556|NCT03095417|65716009|FG000|Overall Study|refusal|0|||
23542557|NCT03095417|65716010|FG001|Overall Study|refusal|1|||
23542558|NCT03095417|65716011|FG002|Overall Study|refusal|0|||
23542559|NCT03095417|65716012|FG003|Overall Study|refusal|1|||
23542560|NCT03095417|65716009|FG000|Overall Study|Withdrawal by Subject|8|||
23542561|NCT03095417|65716010|FG001|Overall Study|Withdrawal by Subject|2|||
23542562|NCT03095417|65716011|FG002|Overall Study|Withdrawal by Subject|5|||
23542563|NCT03095417|65716012|FG003|Overall Study|Withdrawal by Subject|4|||
23542564|NCT03095417|65716009|FG000|Overall Study|Physician Decision|1|||
23542565|NCT03095417|65716010|FG001|Overall Study|Physician Decision|2|||
23542566|NCT03095417|65716011|FG002|Overall Study|Physician Decision|2|||
23816972|NCT03249792|66708548|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816973|NCT03249792|66708549|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816974|NCT03249792|66708550|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
23542567|NCT03095417|65716012|FG003|Overall Study|Physician Decision|2|||
23542568|NCT03095417|65716009|FG000|Overall Study|Death|1|||
23542569|NCT03095417|65716010|FG001|Overall Study|Death|2|||
23542570|NCT03095417|65716011|FG002|Overall Study|Death|1|||
23542571|NCT03095417|65716012|FG003|Overall Study|Death|3|||
23542572|NCT00672477|65716014|FG000|Overall Study|Adverse Event|10|||
23816975|NCT03249792|66708551|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816976|NCT03249792|66708552|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816977|NCT03249792|66708553|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
23816978|NCT03249792|66708521|FG000|Switch Over Period|Withdrawal by Subject|0|||
23816979|NCT03249792|66708522|FG001|Switch Over Period|Withdrawal by Subject|0|||
23728071|NCT00615459|66382299|FG003|Period II|Adverse Event|0|||
23728072|NCT00615459|66382296|FG000|Period II|Lost to Follow-up|0|||
23728073|NCT00615459|66382297|FG001|Period II|Lost to Follow-up|0|||
23728074|NCT00615459|66382298|FG002|Period II|Lost to Follow-up|0|||
23728075|NCT00615459|66382299|FG003|Period II|Lost to Follow-up|1|||
23542573|NCT00672477|65716015|FG001|Overall Study|Adverse Event|7|||
23728076|NCT00615459|66382296|FG000|Period III|Adverse Event|0|||
23728077|NCT00615459|66382297|FG001|Period III|Adverse Event|1|||
23816980|NCT03249792|66708523|FG002|Switch Over Period|Withdrawal by Subject|0|||
23816981|NCT03249792|66708524|FG003|Switch Over Period|Withdrawal by Subject|0|||
23816982|NCT03249792|66708525|FG004|Switch Over Period|Withdrawal by Subject|0|||
23816983|NCT03249792|66708526|FG005|Switch Over Period|Withdrawal by Subject|0|||
23816984|NCT03249792|66708527|FG006|Switch Over Period|Withdrawal by Subject|0|||
23542574|NCT00672477|65716014|FG000|Overall Study|Death|7|||
23542575|NCT00672477|65716015|FG001|Overall Study|Death|11|||
23816985|NCT03249792|66708528|FG007|Switch Over Period|Withdrawal by Subject|0|||
23816986|NCT03249792|66708529|FG008|Switch Over Period|Withdrawal by Subject|0|||
23816987|NCT03249792|66708530|FG009|Switch Over Period|Withdrawal by Subject|0|||
23542576|NCT00672477|65716014|FG000|Overall Study|Physician Decision|2|||
23542577|NCT00672477|65716015|FG001|Overall Study|Physician Decision|0|||
23542578|NCT00672477|65716014|FG000|Overall Study|Protocol Violation|1|||
23542579|NCT00672477|65716015|FG001|Overall Study|Protocol Violation|1|||
23542580|NCT00672477|65716014|FG000|Overall Study|Withdrawal by Subject|5|||
23542581|NCT00672477|65716015|FG001|Overall Study|Withdrawal by Subject|3|||
23542582|NCT00672477|65716014|FG000|Overall Study|Lack of Efficacy|1|||
23542583|NCT00672477|65716015|FG001|Overall Study|Lack of Efficacy|1|||
23542584|NCT00672477|65716014|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
23728078|NCT00615459|66382298|FG002|Period III|Adverse Event|0|||
23728079|NCT00615459|66382299|FG003|Period III|Adverse Event|0|||
23728080|NCT00615459|66382296|FG000|Period III|Administrative problems|0|||
23542585|NCT00672477|65716015|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
23542586|NCT01490060|65716016|FG000|Cycle 1|Change of Treatment|0|||
23542587|NCT01490060|65716017|FG001|Cycle 1|Change of Treatment|1|||
23542588|NCT01490060|65716018|FG002|Cycle 1|Change of Treatment|1|||
23542589|NCT01490060|65716019|FG003|Cycle 1|Change of Treatment|1|||
23542590|NCT01490060|65716016|FG000|Cycle 1|Insurance Denied|0|||
23542591|NCT01490060|65716017|FG001|Cycle 1|Insurance Denied|0|||
23542592|NCT01490060|65716018|FG002|Cycle 1|Insurance Denied|2|||
23542593|NCT01490060|65716019|FG003|Cycle 1|Insurance Denied|0|||
23542594|NCT01490060|65716016|FG000|Cycle 1|Withdrawal by Subject|0|||
23542595|NCT01490060|65716017|FG001|Cycle 1|Withdrawal by Subject|0|||
23542596|NCT01490060|65716018|FG002|Cycle 1|Withdrawal by Subject|0|||
23542597|NCT01490060|65716019|FG003|Cycle 1|Withdrawal by Subject|1|||
23542598|NCT01490060|65716016|FG000|Cycle 1|Treatment at Another Facility|0|||
23542599|NCT01490060|65716017|FG001|Cycle 1|Treatment at Another Facility|0|||
23542600|NCT01490060|65716018|FG002|Cycle 1|Treatment at Another Facility|0|||
23728081|NCT00615459|66382297|FG001|Period III|Administrative problems|1|||
23728082|NCT00615459|66382298|FG002|Period III|Administrative problems|1|||
23728083|NCT00615459|66382299|FG003|Period III|Administrative problems|0|||
23728084|NCT00615459|66382296|FG000|Period III|Unsatisfactory therapeutic effect|0|||
23728085|NCT00615459|66382297|FG001|Period III|Unsatisfactory therapeutic effect|1|||
23728086|NCT00615459|66382298|FG002|Period III|Unsatisfactory therapeutic effect|0|||
23728087|NCT00615459|66382299|FG003|Period III|Unsatisfactory therapeutic effect|0|||
23728088|NCT01392742|66382300|FG000|Overall Study|Premature study termination|42|||
23728089|NCT01392742|66382300|FG000|Overall Study|Failure to return|35|||
23728090|NCT01392742|66382300|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
23728091|NCT01392742|66382300|FG000|Overall Study|Lost to Follow-up|34|||
23728092|NCT01392742|66382300|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
23728093|NCT01392742|66382300|FG000|Overall Study|ITR and Protocol deviation|1|||
23728094|NCT01392742|66382300|FG000|Overall Study|Adverse event/intercurrent illness|17|||
23728095|NCT01392742|66382300|FG000|Overall Study|Protocol Violation|14|||
23728096|NCT01392742|66382300|FG000|Overall Study|Other|3|||
23728097|NCT01392742|66382300|FG000|Overall Study|Missing information|13|||
23728098|NCT01010776|66382301|FG000|Main Phase|Withdrawal by Subject|14|||
23728099|NCT01010776|66382301|FG000|Main Phase|Lack of Efficacy|8|||
23728100|NCT01010776|66382301|FG000|Main Phase|Adverse Event|7|||
23728101|NCT01010776|66382301|FG000|Main Phase|Lost to Follow-up|6|||
23728102|NCT01010776|66382301|FG000|Main Phase|Non-compliance to study medication|5|||
23728103|NCT01010776|66382301|FG000|Main Phase|Selection failure|2|||
23728104|NCT01010776|66382301|FG000|Main Phase|Inform consent withdrawal|1|||
23728105|NCT01010776|66382301|FG000|Main Phase|Other|1|||
23728106|NCT01010776|66382301|FG000|Main Phase|Did not received study medication|5|||
23728107|NCT01010776|66382301|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
23728108|NCT01010776|66382301|FG000|Extension Phase|Other|3|||
23728109|NCT03074318|66382302|FG000|Overall Study|Adverse Event|0|||
23728110|NCT03074318|66382303|FG001|Overall Study|Adverse Event|1|||
23728111|NCT03074318|66382304|FG002|Overall Study|Adverse Event|1|||
23728112|NCT03074318|66382305|FG003|Overall Study|Adverse Event|1|||
23728113|NCT03074318|66382302|FG000|Overall Study|Death|1|||
23728114|NCT03074318|66382303|FG001|Overall Study|Death|0|||
23728115|NCT03074318|66382304|FG002|Overall Study|Death|0|||
23728116|NCT03074318|66382305|FG003|Overall Study|Death|0|||
23728117|NCT03074318|66382302|FG000|Overall Study|Withdrawal by Subject|1|||
23728118|NCT03074318|66382303|FG001|Overall Study|Withdrawal by Subject|2|||
23728119|NCT03074318|66382304|FG002|Overall Study|Withdrawal by Subject|2|||
23728120|NCT03074318|66382305|FG003|Overall Study|Withdrawal by Subject|4|||
23728121|NCT03074318|66382302|FG000|Overall Study|Trial Closure|2|||
23728122|NCT03074318|66382303|FG001|Overall Study|Trial Closure|2|||
23728123|NCT03074318|66382304|FG002|Overall Study|Trial Closure|3|||
23728124|NCT03074318|66382305|FG003|Overall Study|Trial Closure|11|||
23728125|NCT01831804|66382306|FG000|Overall Study|Adverse Event|0|||
23728126|NCT01831804|66382307|FG001|Overall Study|Adverse Event|0|||
23728127|NCT01831804|66382308|FG002|Overall Study|Adverse Event|0|||
23728128|NCT01831804|66382309|FG003|Overall Study|Adverse Event|0|||
23424792|NCT02075632|65299738|FG000|Overall Study|Lost to Follow-up|0|||
23728129|NCT01831804|66382310|FG004|Overall Study|Adverse Event|0|||
23728130|NCT01831804|66382311|FG005|Overall Study|Adverse Event|0|||
23728131|NCT01831804|66382312|FG006|Overall Study|Adverse Event|1|||
23728132|NCT01831804|66382313|FG007|Overall Study|Adverse Event|0|||
23728133|NCT01831804|66382314|FG008|Overall Study|Adverse Event|1|||
23728134|NCT01831804|66382306|FG000|Overall Study|Protocol Violation|0|||
23728135|NCT01831804|66382307|FG001|Overall Study|Protocol Violation|0|||
23728136|NCT01831804|66382308|FG002|Overall Study|Protocol Violation|2|||
23728137|NCT01831804|66382309|FG003|Overall Study|Protocol Violation|0|||
23728138|NCT01831804|66382310|FG004|Overall Study|Protocol Violation|0|||
23542601|NCT01490060|65716019|FG003|Cycle 1|Treatment at Another Facility|1|||
23728139|NCT01831804|66382311|FG005|Overall Study|Protocol Violation|0|||
23542602|NCT01490060|65716016|FG000|Cycle 2|Change of Treatment|1|||
23542603|NCT01490060|65716017|FG001|Cycle 2|Change of Treatment|1|||
23816988|NCT03249792|66708531|FG010|Switch Over Period|Withdrawal by Subject|0|||
23816989|NCT03249792|66708532|FG011|Switch Over Period|Withdrawal by Subject|0|||
23816990|NCT03249792|66708533|FG012|Switch Over Period|Withdrawal by Subject|0|||
23816991|NCT03249792|66708534|FG013|Switch Over Period|Withdrawal by Subject|0|||
23816992|NCT03249792|66708535|FG014|Switch Over Period|Withdrawal by Subject|0|||
23816993|NCT03249792|66708536|FG015|Switch Over Period|Withdrawal by Subject|0|||
23816994|NCT03249792|66708537|FG016|Switch Over Period|Withdrawal by Subject|0|||
23816995|NCT03249792|66708538|FG017|Switch Over Period|Withdrawal by Subject|0|||
23816996|NCT03249792|66708539|FG018|Switch Over Period|Withdrawal by Subject|0|||
23816997|NCT03249792|66708540|FG019|Switch Over Period|Withdrawal by Subject|0|||
23816998|NCT03249792|66708541|FG020|Switch Over Period|Withdrawal by Subject|0|||
23816999|NCT03249792|66708542|FG021|Switch Over Period|Withdrawal by Subject|0|||
23424793|NCT02075632|65299739|FG001|Overall Study|Lost to Follow-up|3|||
23542604|NCT01490060|65716018|FG002|Cycle 2|Change of Treatment|0|||
23542605|NCT01490060|65716019|FG003|Cycle 2|Change of Treatment|0|||
23542606|NCT01490060|65716016|FG000|Cycle 2|Non-Compliance|0|||
23542607|NCT01490060|65716017|FG001|Cycle 2|Non-Compliance|0|||
23542608|NCT01490060|65716018|FG002|Cycle 2|Non-Compliance|1|||
23542609|NCT01490060|65716019|FG003|Cycle 2|Non-Compliance|0|||
23542610|NCT01490060|65716016|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
23728140|NCT01831804|66382312|FG006|Overall Study|Protocol Violation|0|||
23728141|NCT01831804|66382313|FG007|Overall Study|Protocol Violation|0|||
23728142|NCT01831804|66382314|FG008|Overall Study|Protocol Violation|0|||
23728143|NCT01831804|66382306|FG000|Overall Study|Protocol defined stopping criteria|1|||
23728144|NCT01831804|66382307|FG001|Overall Study|Protocol defined stopping criteria|1|||
23728145|NCT01831804|66382308|FG002|Overall Study|Protocol defined stopping criteria|3|||
23728146|NCT01831804|66382309|FG003|Overall Study|Protocol defined stopping criteria|0|||
23728147|NCT01831804|66382310|FG004|Overall Study|Protocol defined stopping criteria|1|||
23728148|NCT01831804|66382311|FG005|Overall Study|Protocol defined stopping criteria|0|||
23728149|NCT01831804|66382312|FG006|Overall Study|Protocol defined stopping criteria|0|||
23728150|NCT01831804|66382313|FG007|Overall Study|Protocol defined stopping criteria|0|||
23728151|NCT01831804|66382314|FG008|Overall Study|Protocol defined stopping criteria|0|||
23728152|NCT01831804|66382306|FG000|Overall Study|Lost to Follow-up|0|||
23728153|NCT01831804|66382307|FG001|Overall Study|Lost to Follow-up|0|||
23728154|NCT01831804|66382308|FG002|Overall Study|Lost to Follow-up|1|||
23728155|NCT01831804|66382309|FG003|Overall Study|Lost to Follow-up|0|||
23728156|NCT01831804|66382310|FG004|Overall Study|Lost to Follow-up|0|||
23728157|NCT01831804|66382311|FG005|Overall Study|Lost to Follow-up|0|||
23728158|NCT01831804|66382312|FG006|Overall Study|Lost to Follow-up|0|||
23728159|NCT01831804|66382313|FG007|Overall Study|Lost to Follow-up|0|||
23817000|NCT03249792|66708543|FG022|Switch Over Period|Withdrawal by Subject|0|||
23542611|NCT01490060|65716017|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542612|NCT01490060|65716018|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542613|NCT01490060|65716019|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542614|NCT01205685|65716020|FG000|Overall Study|Disease Progression|10|||
23542615|NCT01205685|65716020|FG000|Overall Study|Withdrawal by Subject|1|||
23542616|NCT00435370|65716024|FG000|Overall Study|Adverse Event|8|||
23542617|NCT00435370|65716025|FG001|Overall Study|Adverse Event|8|||
23542618|NCT00435370|65716024|FG000|Overall Study|Withdrawal by Subject|10|||
23542619|NCT00435370|65716025|FG001|Overall Study|Withdrawal by Subject|10|||
23542620|NCT00435370|65716024|FG000|Overall Study|Antipsychotic medication changed|4|||
23542621|NCT00435370|65716025|FG001|Overall Study|Antipsychotic medication changed|2|||
23542622|NCT01024387|65716026|FG000|Overall Study|Radiographic Progression|29|||
23542623|NCT01024387|65716026|FG000|Overall Study|Symptomatic Progression|10|||
23542624|NCT01024387|65716026|FG000|Overall Study|Physician Decision|5|||
23542625|NCT01024387|65716026|FG000|Overall Study|Withdrawal by Subject|5|||
23542626|NCT01024387|65716026|FG000|Overall Study|Death|2|||
23542627|NCT01024387|65716026|FG000|Overall Study|Prolonged Treatment Delay|1|||
23542628|NCT01024387|65716026|FG000|Overall Study|Adverse Event|3|||
23542629|NCT01024387|65716026|FG000|Overall Study|Other|5|||
23542630|NCT00661492|65716032|FG000|Overall Study|Adverse Event|16|||
23542631|NCT00661492|65716033|FG001|Overall Study|Adverse Event|13|||
23542632|NCT00661492|65716032|FG000|Overall Study|Disease Progression|44|||
23542633|NCT00661492|65716033|FG001|Overall Study|Disease Progression|14|||
23728160|NCT01831804|66382314|FG008|Overall Study|Lost to Follow-up|1|||
23728161|NCT01831804|66382306|FG000|Overall Study|Investigator discretion|0|||
23728162|NCT01831804|66382307|FG001|Overall Study|Investigator discretion|0|||
23728163|NCT01831804|66382308|FG002|Overall Study|Investigator discretion|0|||
23542634|NCT00661492|65716032|FG000|Overall Study|Patient Request|6|||
23616682|NCT00747149|65982404|FG000|Overall Study|Did not receive treatment|0|||
23542635|NCT00661492|65716033|FG001|Overall Study|Patient Request|1|||
23542636|NCT00661492|65716032|FG000|Overall Study|Investigator Request|1|||
23542637|NCT00661492|65716033|FG001|Overall Study|Investigator Request|0|||
23817001|NCT03249792|66708544|FG023|Switch Over Period|Withdrawal by Subject|0|||
23817002|NCT03249792|66708545|FG024|Switch Over Period|Withdrawal by Subject|0|||
23542638|NCT00661492|65716032|FG000|Overall Study|Lost to Follow-up|0|||
23542639|NCT00661492|65716033|FG001|Overall Study|Lost to Follow-up|1|||
23728164|NCT01831804|66382309|FG003|Overall Study|Investigator discretion|0|||
23728165|NCT01831804|66382310|FG004|Overall Study|Investigator discretion|1|||
23728166|NCT01831804|66382311|FG005|Overall Study|Investigator discretion|0|||
23728167|NCT01831804|66382312|FG006|Overall Study|Investigator discretion|0|||
23728168|NCT01831804|66382313|FG007|Overall Study|Investigator discretion|1|||
23542640|NCT00661492|65716032|FG000|Overall Study|Other|1|||
23542641|NCT00661492|65716033|FG001|Overall Study|Other|0|||
23542642|NCT00363766|65716034|FG000|Overall Study|Progressive Disease|15|||
23542643|NCT00363766|65716035|FG001|Overall Study|Progressive Disease|9|||
23542644|NCT00363766|65716034|FG000|Overall Study|Adverse Event|10|||
23542645|NCT00363766|65716035|FG001|Overall Study|Adverse Event|2|||
23542646|NCT00363766|65716034|FG000|Overall Study|Disease Related Death|1|||
23542647|NCT00363766|65716035|FG001|Overall Study|Disease Related Death|3|||
23542648|NCT00363766|65716034|FG000|Overall Study|Not Disease Related Death|3|||
23542649|NCT00363766|65716035|FG001|Overall Study|Not Disease Related Death|4|||
23542650|NCT00363766|65716034|FG000|Overall Study|Withdrawal by Subject|2|||
23542651|NCT00363766|65716035|FG001|Overall Study|Withdrawal by Subject|0|||
23542652|NCT00363766|65716034|FG000|Overall Study|Physician Decision|1|||
23542653|NCT00363766|65716035|FG001|Overall Study|Physician Decision|2|||
23542654|NCT03870763|65716036|FG000|Overall Study|Study terminated by sponsor|0|||
23542655|NCT03870763|65716037|FG001|Overall Study|Study terminated by sponsor|2|||
23542656|NCT03870763|65716038|FG002|Overall Study|Study terminated by sponsor|0|||
23542657|NCT03870763|65716036|FG000|Overall Study|Withdrawal by Subject|0|||
23542658|NCT03870763|65716037|FG001|Overall Study|Withdrawal by Subject|1|||
23542659|NCT03870763|65716038|FG002|Overall Study|Withdrawal by Subject|0|||
23542660|NCT03870763|65716036|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
23542661|NCT03870763|65716037|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
23542662|NCT03870763|65716038|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
23542663|NCT03349710|65716039|FG000|Treatment Period|Death|0|||
23542664|NCT03349710|65716040|FG001|Treatment Period|Death|0|||
23542665|NCT03349710|65716041|FG002|Treatment Period|Death|1|||
23542666|NCT03349710|65716042|FG003|Treatment Period|Death|0|||
23542667|NCT03349710|65716039|FG000|Treatment Period|Disease Progression|0|||
23728169|NCT01831804|66382314|FG008|Overall Study|Investigator discretion|0|||
23728170|NCT01831804|66382306|FG000|Overall Study|Withdrew Consent|0|||
23728171|NCT01831804|66382307|FG001|Overall Study|Withdrew Consent|1|||
23728172|NCT01831804|66382308|FG002|Overall Study|Withdrew Consent|0|||
23728173|NCT01831804|66382309|FG003|Overall Study|Withdrew Consent|0|||
23728174|NCT01831804|66382310|FG004|Overall Study|Withdrew Consent|0|||
23728175|NCT01831804|66382311|FG005|Overall Study|Withdrew Consent|0|||
23728176|NCT01831804|66382312|FG006|Overall Study|Withdrew Consent|0|||
23728177|NCT01831804|66382313|FG007|Overall Study|Withdrew Consent|2|||
23728178|NCT01831804|66382314|FG008|Overall Study|Withdrew Consent|0|||
23728179|NCT00486889|66382320|FG000|Overall Study|Death|3|||
23728180|NCT00486889|66382320|FG000|Overall Study|Non-compliant|2|||
23728181|NCT00486889|66382320|FG000|Overall Study|Withdrawal by Subject|6|||
23728182|NCT01405027|66382321|FG000|Overall Study|Withdrawn consent|3|||
23728183|NCT01405027|66382322|FG001|Overall Study|Withdrawn consent|0|||
23728184|NCT01405027|66382321|FG000|Overall Study|Lost to Follow-up|16|||
23728185|NCT01405027|66382322|FG001|Overall Study|Lost to Follow-up|24|||
23728186|NCT01405027|66382321|FG000|Overall Study|Investigator judgement|0|||
23728187|NCT01405027|66382322|FG001|Overall Study|Investigator judgement|2|||
23728188|NCT01405027|66382321|FG000|Overall Study|Death|1|||
23728189|NCT01405027|66382322|FG001|Overall Study|Death|0|||
23728190|NCT01405027|66382321|FG000|Overall Study|Other or Unknown|12|||
23728191|NCT01405027|66382322|FG001|Overall Study|Other or Unknown|25|||
23728192|NCT01712490|66382323|FG000|Overall Study|Ongoing|601|||
23542668|NCT03349710|65716040|FG001|Treatment Period|Disease Progression|2|||
23542669|NCT03349710|65716041|FG002|Treatment Period|Disease Progression|0|||
23542670|NCT03349710|65716042|FG003|Treatment Period|Disease Progression|1|||
23542671|NCT03349710|65716039|FG000|Treatment Period|Study Drug Toxicity|1|||
23542672|NCT03349710|65716040|FG001|Treatment Period|Study Drug Toxicity|0|||
23542673|NCT03349710|65716041|FG002|Treatment Period|Study Drug Toxicity|1|||
23728193|NCT01712490|66382324|FG001|Overall Study|Ongoing|586|||
23728194|NCT01712490|66382323|FG000|Overall Study|Other|11|||
23728195|NCT01712490|66382324|FG001|Overall Study|Other|11|||
23728196|NCT01712490|66382323|FG000|Overall Study|Withdrawal by Subject|36|||
23728197|NCT01712490|66382324|FG001|Overall Study|Withdrawal by Subject|44|||
23817003|NCT03249792|66708546|FG025|Switch Over Period|Withdrawal by Subject|0|||
23542674|NCT03349710|65716042|FG003|Treatment Period|Study Drug Toxicity|1|||
23542675|NCT03349710|65716039|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
23542676|NCT03349710|65716040|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
23542677|NCT03349710|65716041|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
23728198|NCT01712490|66382323|FG000|Overall Study|Lost to Follow-up|16|||
23728199|NCT01712490|66382324|FG001|Overall Study|Lost to Follow-up|29|||
23728200|NCT02470429|66382336|FG000|Overall Study|Adverse Event|1|||
23728201|NCT02470429|66382337|FG001|Overall Study|Adverse Event|0|||
23817004|NCT03249792|66708547|FG026|Switch Over Period|Withdrawal by Subject|0|||
23728202|NCT02470429|66382336|FG000|Overall Study|Withdrawal by Subject|1|||
23728203|NCT02470429|66382337|FG001|Overall Study|Withdrawal by Subject|0|||
23728204|NCT05179057|66382338|FG000|Overall Study|Adverse Event|3|||
23728205|NCT05179057|66382339|FG001|Overall Study|Adverse Event|2|||
23728206|NCT05179057|66382338|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
23728207|NCT05179057|66382339|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
23728208|NCT05179057|66382338|FG000|Overall Study|Study terminated|13|||
23728209|NCT05179057|66382339|FG001|Overall Study|Study terminated|7|||
23817005|NCT03249792|66708548|FG027|Switch Over Period|Withdrawal by Subject|0|||
23542678|NCT03349710|65716042|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
23542679|NCT03349710|65716039|FG000|Treatment Period|admin reason by sponsor|0|||
23542680|NCT03349710|65716040|FG001|Treatment Period|admin reason by sponsor|7|||
23542681|NCT03349710|65716041|FG002|Treatment Period|admin reason by sponsor|0|||
23542682|NCT03349710|65716042|FG003|Treatment Period|admin reason by sponsor|19|||
23542683|NCT03349710|65716039|FG000|Treatment Period|Other Reason|2|||
23542684|NCT03349710|65716040|FG001|Treatment Period|Other Reason|0|||
23542685|NCT03349710|65716041|FG002|Treatment Period|Other Reason|2|||
23542686|NCT03349710|65716042|FG003|Treatment Period|Other Reason|1|||
23542687|NCT03349710|65716039|FG000|Treatment Period|completed|6|||
23542688|NCT03349710|65716040|FG001|Treatment Period|completed|0|||
23542689|NCT03349710|65716041|FG002|Treatment Period|completed|18|||
23542690|NCT03349710|65716042|FG003|Treatment Period|completed|1|||
23542691|NCT03349710|65716039|FG000|Treatment Period|participant request to discontinue|0|||
23542692|NCT03349710|65716040|FG001|Treatment Period|participant request to discontinue|0|||
23542693|NCT03349710|65716041|FG002|Treatment Period|participant request to discontinue|4|||
23542694|NCT03349710|65716042|FG003|Treatment Period|participant request to discontinue|0|||
23542695|NCT03349710|65716039|FG000|Treatment Period|participant withdrew consent|1|||
23542696|NCT03349710|65716040|FG001|Treatment Period|participant withdrew consent|0|||
23542697|NCT03349710|65716041|FG002|Treatment Period|participant withdrew consent|0|||
23542698|NCT03349710|65716042|FG003|Treatment Period|participant withdrew consent|0|||
23542699|NCT02162810|65716054|FG000|Overall Study|Protocol Violation|1|||
23542700|NCT02162810|65716055|FG001|Overall Study|Protocol Violation|0|||
23542701|NCT02162810|65716054|FG000|Overall Study|patients did not report compliance|4|||
23542702|NCT02162810|65716055|FG001|Overall Study|patients did not report compliance|1|||
23542703|NCT02013765|65716057|FG000|Overall Study|Trial was terminated by sponsor|1|||
23542704|NCT02138214|65716058|FG000|Overall Study|Withdrawal by Subject|0|||
23542705|NCT02138214|65716059|FG001|Overall Study|Withdrawal by Subject|1|||
23542706|NCT02138214|65716060|FG002|Overall Study|Withdrawal by Subject|0|||
23542707|NCT02138214|65716058|FG000|Overall Study|Lost to Follow-up|0|||
23542708|NCT02138214|65716059|FG001|Overall Study|Lost to Follow-up|2|||
23542709|NCT02138214|65716060|FG002|Overall Study|Lost to Follow-up|4|||
23542710|NCT02138214|65716058|FG000|Overall Study|Screen Failure|0|||
23542711|NCT02138214|65716059|FG001|Overall Study|Screen Failure|1|||
23542712|NCT02138214|65716060|FG002|Overall Study|Screen Failure|0|||
23542713|NCT03738865|65716062|FG000|Overall Study|Withdrawal by Subject|3|||
23542714|NCT03738865|65716063|FG001|Overall Study|Withdrawal by Subject|3|||
23542715|NCT03738865|65716062|FG000|Overall Study|Adverse Event|2|||
23542716|NCT03738865|65716063|FG001|Overall Study|Adverse Event|0|||
23542717|NCT03738865|65716062|FG000|Overall Study|Physician Decision|0|||
23542718|NCT03738865|65716063|FG001|Overall Study|Physician Decision|1|||
23728210|NCT05179057|66382338|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
23817006|NCT03249792|66708549|FG028|Switch Over Period|Withdrawal by Subject|0|||
23817007|NCT03249792|66708550|FG029|Switch Over Period|Withdrawal by Subject|0|||
23817008|NCT03249792|66708551|FG030|Switch Over Period|Withdrawal by Subject|0|||
23817009|NCT03249792|66708552|FG031|Switch Over Period|Withdrawal by Subject|1|||
23817010|NCT03249792|66708553|FG032|Switch Over Period|Withdrawal by Subject|0|||
23817011|NCT03249792|66708521|FG000|Switch Over Period|Progressive Disease|0|||
23817012|NCT03249792|66708522|FG001|Switch Over Period|Progressive Disease|0|||
23817013|NCT03249792|66708523|FG002|Switch Over Period|Progressive Disease|0|||
23817014|NCT03249792|66708524|FG003|Switch Over Period|Progressive Disease|0|||
23542719|NCT00581945|65716072|FG000|Overall Study|Adverse Event|4|||
23542720|NCT00581945|65716073|FG001|Overall Study|Adverse Event|4|||
23542721|NCT00581945|65716072|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23542722|NCT00581945|65716073|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23542723|NCT00581945|65716072|FG000|Overall Study|Withdrawal by Subject|2|||
23542724|NCT00581945|65716073|FG001|Overall Study|Withdrawal by Subject|6|||
23424794|NCT02075632|65299738|FG000|Overall Study|Withdrawal by Subject|0|||
23542725|NCT00581945|65716072|FG000|Overall Study|Death|1|||
23542726|NCT00581945|65716073|FG001|Overall Study|Death|0|||
23542727|NCT01344460|65716074|FG000|Overall Study|Withdrawal by Subject|1|||
23542728|NCT01344460|65716074|FG000|Overall Study|Lost to Follow-up|2|||
23542729|NCT00655980|65716075|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
23542730|NCT00655980|65716076|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
23542731|NCT00655980|65716077|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
23542732|NCT01197950|65716080|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
23542733|NCT01197950|65716081|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
23582202|NCT02892409|65862381|FG001|Overall Study|Withdrawal by Subject|1|||
23542734|NCT01197950|65716082|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
23542735|NCT02194621|65716090|FG000|Overall Study|6 withdrew prior to randomization|2|||
23542736|NCT02194621|65716091|FG001|Overall Study|6 withdrew prior to randomization|2|||
23542737|NCT02194621|65716092|FG002|Overall Study|6 withdrew prior to randomization|2|||
23542738|NCT02194621|65716090|FG000|Overall Study|Withdrawal by Subject|4|||
23542739|NCT02194621|65716091|FG001|Overall Study|Withdrawal by Subject|4|||
23542740|NCT02194621|65716092|FG002|Overall Study|Withdrawal by Subject|7|||
23542741|NCT04000165|65716097|FG000|Overall Study|Physician Decision|1|||
23728211|NCT05179057|66382339|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
23728212|NCT05179057|66382338|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
23728213|NCT05179057|66382339|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
23728214|NCT00899678|66382345|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
23728215|NCT00899678|66382346|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
23728216|NCT00899678|66382347|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
23728217|NCT00899678|66382345|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
23728218|NCT00899678|66382346|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
23728219|NCT00899678|66382347|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
23728220|NCT00899678|66382345|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
23728221|NCT00899678|66382346|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
23728222|NCT00899678|66382347|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
23728223|NCT00899678|66382345|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
23728224|NCT00899678|66382346|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
23728225|NCT00899678|66382347|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
23728226|NCT00899678|66382345|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
23728227|NCT00899678|66382346|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
23728228|NCT00899678|66382347|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
23728229|NCT00899678|66382345|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
23728230|NCT00899678|66382346|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
23728231|NCT00899678|66382347|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
23728232|NCT00899678|66382345|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
23728233|NCT00899678|66382346|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
23728234|NCT00899678|66382347|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
23728235|NCT00899678|66382345|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
23728236|NCT00899678|66382346|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
23728237|NCT00899678|66382347|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
23728238|NCT00899678|66382345|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
23728239|NCT00899678|66382346|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
23728240|NCT00899678|66382347|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
23728241|NCT00136357|66382348|FG000|Overall Study|Withdrawal by Subject|3|||
23728242|NCT00136357|66382349|FG001|Overall Study|Withdrawal by Subject|2|||
23728243|NCT00777257|66382350|FG000|Overall Study|Adverse Event|3|||
23728244|NCT00777257|66382351|FG001|Overall Study|Adverse Event|1|||
23728245|NCT00777257|66382352|FG002|Overall Study|Adverse Event|0|||
23728246|NCT00777257|66382350|FG000|Overall Study|Lost to Follow-up|3|||
23728247|NCT00777257|66382351|FG001|Overall Study|Lost to Follow-up|3|||
23728248|NCT00777257|66382352|FG002|Overall Study|Lost to Follow-up|2|||
23728249|NCT00777257|66382350|FG000|Overall Study|Protocol Violation|2|||
23728250|NCT00777257|66382351|FG001|Overall Study|Protocol Violation|2|||
23728251|NCT00777257|66382352|FG002|Overall Study|Protocol Violation|2|||
23728252|NCT00777257|66382350|FG000|Overall Study|Withdrawal by Subject|3|||
23728253|NCT00777257|66382351|FG001|Overall Study|Withdrawal by Subject|6|||
23728254|NCT00777257|66382352|FG002|Overall Study|Withdrawal by Subject|5|||
23728255|NCT03573804|66382357|FG000|Overall Study|claustrophobia or MRI table problems|10|||
23728256|NCT00225212|66382358|FG000|Overall Study|Disease progression|2|||
23728257|NCT00225212|66382358|FG000|Overall Study|Death|1|||
23728258|NCT00225212|66382358|FG000|Overall Study|Adverse Event|2|||
23728259|NCT00225212|66382358|FG000|Overall Study|Intercurrent illness|1|||
23817015|NCT03249792|66708525|FG004|Switch Over Period|Progressive Disease|0|||
23542742|NCT04000165|65716097|FG000|Overall Study|Withdrawal by Subject|1|||
23542743|NCT03579459|65716100|FG000|Overall Study|Adverse Event|7|||
23542744|NCT03579459|65716101|FG001|Overall Study|Adverse Event|6|||
23424795|NCT02075632|65299739|FG001|Overall Study|Withdrawal by Subject|1|||
23817016|NCT03249792|66708526|FG005|Switch Over Period|Progressive Disease|0|||
23817017|NCT03249792|66708527|FG006|Switch Over Period|Progressive Disease|0|||
23817018|NCT03249792|66708528|FG007|Switch Over Period|Progressive Disease|0|||
23817019|NCT03249792|66708529|FG008|Switch Over Period|Progressive Disease|0|||
23817020|NCT03249792|66708530|FG009|Switch Over Period|Progressive Disease|0|||
23817021|NCT03249792|66708531|FG010|Switch Over Period|Progressive Disease|0|||
23817022|NCT03249792|66708532|FG011|Switch Over Period|Progressive Disease|0|||
23817023|NCT03249792|66708533|FG012|Switch Over Period|Progressive Disease|0|||
23817024|NCT03249792|66708534|FG013|Switch Over Period|Progressive Disease|0|||
23817025|NCT03249792|66708535|FG014|Switch Over Period|Progressive Disease|0|||
23817026|NCT03249792|66708536|FG015|Switch Over Period|Progressive Disease|0|||
23817027|NCT03249792|66708537|FG016|Switch Over Period|Progressive Disease|0|||
23817028|NCT03249792|66708538|FG017|Switch Over Period|Progressive Disease|0|||
23817029|NCT03249792|66708539|FG018|Switch Over Period|Progressive Disease|0|||
23817030|NCT03249792|66708540|FG019|Switch Over Period|Progressive Disease|0|||
23817031|NCT03249792|66708541|FG020|Switch Over Period|Progressive Disease|0|||
23817032|NCT03249792|66708542|FG021|Switch Over Period|Progressive Disease|0|||
23817033|NCT03249792|66708543|FG022|Switch Over Period|Progressive Disease|0|||
23817034|NCT03249792|66708544|FG023|Switch Over Period|Progressive Disease|0|||
23817035|NCT03249792|66708545|FG024|Switch Over Period|Progressive Disease|0|||
23817036|NCT03249792|66708546|FG025|Switch Over Period|Progressive Disease|0|||
23817037|NCT03249792|66708547|FG026|Switch Over Period|Progressive Disease|1|||
23817038|NCT03249792|66708548|FG027|Switch Over Period|Progressive Disease|0|||
23817039|NCT03249792|66708549|FG028|Switch Over Period|Progressive Disease|1|||
23817040|NCT03249792|66708550|FG029|Switch Over Period|Progressive Disease|2|||
23817041|NCT03249792|66708551|FG030|Switch Over Period|Progressive Disease|1|||
23817042|NCT03249792|66708552|FG031|Switch Over Period|Progressive Disease|0|||
23817043|NCT03249792|66708553|FG032|Switch Over Period|Progressive Disease|1|||
23817044|NCT03249792|66708521|FG000|Switch Over Period|Adverse Event|0|||
23817045|NCT03249792|66708522|FG001|Switch Over Period|Adverse Event|0|||
23817046|NCT03249792|66708523|FG002|Switch Over Period|Adverse Event|0|||
23817047|NCT03249792|66708524|FG003|Switch Over Period|Adverse Event|0|||
23817048|NCT03249792|66708525|FG004|Switch Over Period|Adverse Event|0|||
23817049|NCT03249792|66708526|FG005|Switch Over Period|Adverse Event|0|||
23817050|NCT03249792|66708527|FG006|Switch Over Period|Adverse Event|0|||
23817051|NCT03249792|66708528|FG007|Switch Over Period|Adverse Event|0|||
23817052|NCT03249792|66708529|FG008|Switch Over Period|Adverse Event|0|||
23817053|NCT03249792|66708530|FG009|Switch Over Period|Adverse Event|0|||
23817054|NCT03249792|66708531|FG010|Switch Over Period|Adverse Event|0|||
23817055|NCT03249792|66708532|FG011|Switch Over Period|Adverse Event|0|||
23817056|NCT03249792|66708533|FG012|Switch Over Period|Adverse Event|0|||
23817057|NCT03249792|66708534|FG013|Switch Over Period|Adverse Event|0|||
23817058|NCT03249792|66708535|FG014|Switch Over Period|Adverse Event|0|||
23817059|NCT03249792|66708536|FG015|Switch Over Period|Adverse Event|0|||
23817060|NCT03249792|66708537|FG016|Switch Over Period|Adverse Event|0|||
23817061|NCT03249792|66708538|FG017|Switch Over Period|Adverse Event|0|||
23817062|NCT03249792|66708539|FG018|Switch Over Period|Adverse Event|0|||
23817063|NCT03249792|66708540|FG019|Switch Over Period|Adverse Event|0|||
23817064|NCT03249792|66708541|FG020|Switch Over Period|Adverse Event|0|||
23817065|NCT03249792|66708542|FG021|Switch Over Period|Adverse Event|0|||
23817066|NCT03249792|66708543|FG022|Switch Over Period|Adverse Event|0|||
23817067|NCT03249792|66708544|FG023|Switch Over Period|Adverse Event|0|||
23817068|NCT03249792|66708545|FG024|Switch Over Period|Adverse Event|0|||
23817069|NCT03249792|66708546|FG025|Switch Over Period|Adverse Event|1|||
23817070|NCT03249792|66708547|FG026|Switch Over Period|Adverse Event|0|||
23817071|NCT03249792|66708548|FG027|Switch Over Period|Adverse Event|1|||
23817072|NCT03249792|66708549|FG028|Switch Over Period|Adverse Event|0|||
23817073|NCT03249792|66708550|FG029|Switch Over Period|Adverse Event|0|||
23817074|NCT03249792|66708551|FG030|Switch Over Period|Adverse Event|0|||
23817075|NCT03249792|66708552|FG031|Switch Over Period|Adverse Event|0|||
23817076|NCT03249792|66708553|FG032|Switch Over Period|Adverse Event|0|||
23817077|NCT01283035|66708554|FG000|Overall Study|Subject later found ineligible|1|||
23817078|NCT01434810|66708555|FG000|Overall Study|Did not receive treatment|11|||
23817079|NCT01434810|66708556|FG001|Overall Study|Did not receive treatment|3|||
23817080|NCT01434810|66708555|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
23817081|NCT01434810|66708556|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
23817082|NCT01775189|66711287|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23424796|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
23424797|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
23817083|NCT01775189|66711288|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
23817084|NCT01775189|66711289|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23817085|NCT01775189|66711290|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23817086|NCT01775189|66711291|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23817087|NCT01775189|66711292|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23817088|NCT01775189|66711293|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23542745|NCT03579459|65716102|FG002|Overall Study|Adverse Event|2|||
23542746|NCT03579459|65716103|FG003|Overall Study|Adverse Event|6|||
23542747|NCT03579459|65716100|FG000|Overall Study|Death|1|||
23542748|NCT03579459|65716101|FG001|Overall Study|Death|0|||
23542749|NCT03579459|65716102|FG002|Overall Study|Death|1|||
23542750|NCT03579459|65716103|FG003|Overall Study|Death|2|||
23542751|NCT03579459|65716100|FG000|Overall Study|Lost to Follow-up|6|||
23542752|NCT03579459|65716101|FG001|Overall Study|Lost to Follow-up|2|||
23542753|NCT03579459|65716102|FG002|Overall Study|Lost to Follow-up|4|||
23542754|NCT03579459|65716103|FG003|Overall Study|Lost to Follow-up|1|||
23542755|NCT03579459|65716100|FG000|Overall Study|Physician Decision|0|||
23542756|NCT03579459|65716101|FG001|Overall Study|Physician Decision|1|||
23542757|NCT03579459|65716102|FG002|Overall Study|Physician Decision|0|||
23542758|NCT03579459|65716103|FG003|Overall Study|Physician Decision|1|||
23542759|NCT03579459|65716100|FG000|Overall Study|Protocol Violation|1|||
23542760|NCT03579459|65716101|FG001|Overall Study|Protocol Violation|2|||
23542761|NCT03579459|65716102|FG002|Overall Study|Protocol Violation|3|||
23542762|NCT03579459|65716103|FG003|Overall Study|Protocol Violation|5|||
23542763|NCT03579459|65716100|FG000|Overall Study|Withdrawal by Subject|12|||
23542764|NCT03579459|65716101|FG001|Overall Study|Withdrawal by Subject|8|||
23542765|NCT03579459|65716102|FG002|Overall Study|Withdrawal by Subject|11|||
23542766|NCT03579459|65716103|FG003|Overall Study|Withdrawal by Subject|8|||
23542767|NCT03579459|65716100|FG000|Overall Study|Medication error without associated adverse event|2|||
23542768|NCT03579459|65716101|FG001|Overall Study|Medication error without associated adverse event|1|||
23542769|NCT03579459|65716102|FG002|Overall Study|Medication error without associated adverse event|1|||
23542770|NCT03579459|65716103|FG003|Overall Study|Medication error without associated adverse event|0|||
23542771|NCT03579459|65716100|FG000|Overall Study|Other|0|||
23542772|NCT03579459|65716101|FG001|Overall Study|Other|1|||
23542773|NCT03579459|65716102|FG002|Overall Study|Other|1|||
23542774|NCT03579459|65716103|FG003|Overall Study|Other|0|||
23542775|NCT03579459|65716100|FG000|Overall Study|Randomized not vaccinated|0|||
23542776|NCT03579459|65716101|FG001|Overall Study|Randomized not vaccinated|2|||
23542777|NCT03579459|65716102|FG002|Overall Study|Randomized not vaccinated|0|||
23542778|NCT03579459|65716103|FG003|Overall Study|Randomized not vaccinated|1|||
23542779|NCT02571452|65716104|FG000|Overall Study Treatment|Protocol Violation|0|||
23542780|NCT02571452|65716105|FG001|Overall Study Treatment|Protocol Violation|1|||
23542781|NCT02571452|65716104|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
23542782|NCT02571452|65716105|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
23542783|NCT02571452|65716104|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
23542784|NCT02571452|65716105|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
23542785|NCT00922428|65716106|FG000|Overall Study|retrospective/extremely implausible data|2|||
23542786|NCT00922428|65716106|FG000|Overall Study|no medication use or questionable use|13|||
23542787|NCT00352534|65716107|FG000|Initial Staging|Ineligible|8|||
23542788|NCT00352534|65716108|FG001|Initial Staging|Ineligible|9|||
23542789|NCT00352534|65716109|FG002|Initial Staging|Ineligible|0|||
23542790|NCT00352534|65716110|FG003|Initial Staging|Ineligible|0|||
23542791|NCT00352534|65716111|FG004|Initial Staging|Ineligible|0|||
23542792|NCT00352534|65716112|FG005|Initial Staging|Ineligible|0|||
23542793|NCT00352534|65716113|FG006|Initial Staging|Ineligible|0|||
23542794|NCT00352534|65716107|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
23542795|NCT00352534|65716108|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
23542796|NCT00352534|65716109|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
23728260|NCT03954704|66382359|FG000|Overall Study|Death|1|||
23728261|NCT03954704|66382360|FG001|Overall Study|Death|1|||
23728262|NCT03954704|66382361|FG002|Overall Study|Death|1|||
23728263|NCT03954704|66382362|FG003|Overall Study|Death|3|||
23728264|NCT03954704|66382363|FG004|Overall Study|Death|2|||
23728265|NCT03954704|66382364|FG005|Overall Study|Death|2|||
23728266|NCT03954704|66382365|FG006|Overall Study|Death|0|||
23728267|NCT03954704|66382359|FG000|Overall Study|Withdrew Consent|0|||
23728268|NCT03954704|66382360|FG001|Overall Study|Withdrew Consent|0|||
23728269|NCT03954704|66382361|FG002|Overall Study|Withdrew Consent|1|||
23728270|NCT03954704|66382362|FG003|Overall Study|Withdrew Consent|0|||
23542797|NCT00352534|65716110|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
23542798|NCT00352534|65716111|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
23542799|NCT00352534|65716112|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
23542800|NCT00352534|65716113|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
23542801|NCT00352534|65716107|FG000|Final Risk Group Assignment|Physician Decision|0|||
23542802|NCT00352534|65716108|FG001|Final Risk Group Assignment|Physician Decision|0|||
23542803|NCT00352534|65716109|FG002|Final Risk Group Assignment|Physician Decision|0|||
23542804|NCT00352534|65716110|FG003|Final Risk Group Assignment|Physician Decision|0|||
23542805|NCT00352534|65716111|FG004|Final Risk Group Assignment|Physician Decision|0|||
23542806|NCT00352534|65716112|FG005|Final Risk Group Assignment|Physician Decision|8|||
23728271|NCT03954704|66382363|FG004|Overall Study|Withdrew Consent|0|||
23728272|NCT03954704|66382364|FG005|Overall Study|Withdrew Consent|1|||
23728273|NCT03954704|66382365|FG006|Overall Study|Withdrew Consent|0|||
23728274|NCT03954704|66382359|FG000|Overall Study|Lost to Follow-up|0|||
23542807|NCT00352534|65716113|FG006|Final Risk Group Assignment|Physician Decision|0|||
23542808|NCT00352534|65716107|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542809|NCT00352534|65716108|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542810|NCT00352534|65716109|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542811|NCT00352534|65716110|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542812|NCT00352534|65716111|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542813|NCT00352534|65716112|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
23542814|NCT00352534|65716113|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542815|NCT00352534|65716107|FG000|Final Risk Group Assignment|Ineligible|0|||
23542816|NCT00352534|65716108|FG001|Final Risk Group Assignment|Ineligible|0|||
23542817|NCT00352534|65716109|FG002|Final Risk Group Assignment|Ineligible|3|||
23542818|NCT00352534|65716110|FG003|Final Risk Group Assignment|Ineligible|1|||
23542819|NCT00352534|65716111|FG004|Final Risk Group Assignment|Ineligible|0|||
23542820|NCT00352534|65716112|FG005|Final Risk Group Assignment|Ineligible|13|||
23542821|NCT00352534|65716113|FG006|Final Risk Group Assignment|Ineligible|0|||
23542822|NCT00352534|65716107|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542823|NCT00352534|65716108|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542824|NCT00352534|65716109|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542825|NCT00352534|65716110|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542826|NCT00352534|65716111|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542827|NCT00352534|65716112|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542828|NCT00352534|65716113|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
23542829|NCT00352534|65716107|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542830|NCT00352534|65716108|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542831|NCT00352534|65716109|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542832|NCT00352534|65716110|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542833|NCT00352534|65716111|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542834|NCT00352534|65716112|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542835|NCT00352534|65716113|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
23542836|NCT00352534|65716107|FG000|Final Risk Group Assignment|Death|0|||
23542837|NCT00352534|65716108|FG001|Final Risk Group Assignment|Death|0|||
23542838|NCT00352534|65716109|FG002|Final Risk Group Assignment|Death|0|||
23542839|NCT00352534|65716110|FG003|Final Risk Group Assignment|Death|0|||
23542840|NCT00352534|65716111|FG004|Final Risk Group Assignment|Death|0|||
23542841|NCT00352534|65716112|FG005|Final Risk Group Assignment|Death|2|||
23542842|NCT00352534|65716113|FG006|Final Risk Group Assignment|Death|0|||
23542843|NCT01337089|65716114|FG000|Overall Study|Adverse Event|237|||
23817089|NCT01775189|66711287|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817090|NCT01775189|66711288|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
23817091|NCT01775189|66711289|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817092|NCT01775189|66711290|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817093|NCT01775189|66711291|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817094|NCT01775189|66711292|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817095|NCT01775189|66711293|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23817096|NCT01775189|66711287|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23817097|NCT01775189|66711288|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
23817098|NCT01775189|66711289|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
23817099|NCT01775189|66711290|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23817100|NCT01775189|66711291|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23817101|NCT01775189|66711292|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23817102|NCT01775189|66711293|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23817103|NCT01775189|66711287|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23817104|NCT01775189|66711288|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23817105|NCT01775189|66711289|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23817106|NCT01775189|66711290|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23817107|NCT01775189|66711291|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23817108|NCT01775189|66711292|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
23817109|NCT01775189|66711293|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23542844|NCT01337089|65716114|FG000|Overall Study|Withdrawal by Subject|129|||
23542845|NCT01337089|65716114|FG000|Overall Study|Withdrawal by Investigator|33|||
23542846|NCT01337089|65716114|FG000|Overall Study|Met Withdrawal Criteria|3|||
23616683|NCT00747149|65982405|FG001|Overall Study|Did not receive treatment|1|||
23728275|NCT03954704|66382360|FG001|Overall Study|Lost to Follow-up|0|||
23728276|NCT03954704|66382361|FG002|Overall Study|Lost to Follow-up|0|||
23728277|NCT03954704|66382362|FG003|Overall Study|Lost to Follow-up|0|||
23728278|NCT03954704|66382363|FG004|Overall Study|Lost to Follow-up|0|||
23728279|NCT03954704|66382364|FG005|Overall Study|Lost to Follow-up|0|||
23728280|NCT03954704|66382365|FG006|Overall Study|Lost to Follow-up|1|||
23728281|NCT03954704|66382359|FG000|Overall Study|Study Terminated by Sponsor|0|||
23728282|NCT03954704|66382360|FG001|Overall Study|Study Terminated by Sponsor|0|||
23424798|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
23424799|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
23542847|NCT01337089|65716114|FG000|Overall Study|Lost to Follow-up|2|||
23542848|NCT03867734|65716115|FG000|Overall Study|Lost to Follow-up|2|||
23542849|NCT03965052|65716116|FG000|Overall Study|Protocol Violation|1|||
23542850|NCT03965052|65716117|FG001|Overall Study|Protocol Violation|0|||
23542851|NCT02066298|65716118|FG000|Overall Study|Lost to Follow-up|3|||
23542852|NCT02066298|65716119|FG001|Overall Study|Lost to Follow-up|2|||
23542853|NCT02066298|65716120|FG002|Overall Study|Lost to Follow-up|3|||
23728283|NCT03954704|66382361|FG002|Overall Study|Study Terminated by Sponsor|1|||
23728284|NCT03954704|66382362|FG003|Overall Study|Study Terminated by Sponsor|0|||
23728285|NCT03954704|66382363|FG004|Overall Study|Study Terminated by Sponsor|1|||
23728286|NCT03954704|66382364|FG005|Overall Study|Study Terminated by Sponsor|4|||
23728287|NCT03954704|66382365|FG006|Overall Study|Study Terminated by Sponsor|2|||
23542854|NCT02066298|65716121|FG003|Overall Study|Lost to Follow-up|2|||
23542855|NCT02066298|65716122|FG004|Overall Study|Lost to Follow-up|3|||
23542856|NCT02066298|65716123|FG005|Overall Study|Lost to Follow-up|4|||
23542857|NCT02066298|65716118|FG000|Overall Study|Withdrawal by Subject|6|||
23542858|NCT02066298|65716119|FG001|Overall Study|Withdrawal by Subject|6|||
23542859|NCT02066298|65716120|FG002|Overall Study|Withdrawal by Subject|6|||
23542860|NCT02066298|65716121|FG003|Overall Study|Withdrawal by Subject|4|||
23542861|NCT02066298|65716122|FG004|Overall Study|Withdrawal by Subject|5|||
23542862|NCT02066298|65716123|FG005|Overall Study|Withdrawal by Subject|8|||
23542863|NCT02066298|65716118|FG000|Overall Study|Physician Decision|0|||
23542864|NCT02066298|65716119|FG001|Overall Study|Physician Decision|0|||
23542865|NCT02066298|65716120|FG002|Overall Study|Physician Decision|1|||
23542866|NCT02066298|65716121|FG003|Overall Study|Physician Decision|0|||
23728288|NCT03954704|66382359|FG000|Overall Study|Enrolled but not Treated|0|||
23728289|NCT03954704|66382360|FG001|Overall Study|Enrolled but not Treated|0|||
23728290|NCT03954704|66382361|FG002|Overall Study|Enrolled but not Treated|0|||
23728291|NCT03954704|66382362|FG003|Overall Study|Enrolled but not Treated|0|||
23728292|NCT03954704|66382363|FG004|Overall Study|Enrolled but not Treated|0|||
23424800|NCT02498067|65299749|FG000|Overall Study|Lost to Follow-up|22|||
23424801|NCT02498067|65299749|FG000|Overall Study|Did not meet inclusion criteria|11|||
23424802|NCT03283098|65299750|FG000|Overall Study|Withdrawal by Subject|0|||
23424803|NCT03283098|65299751|FG001|Overall Study|Withdrawal by Subject|1|||
23424804|NCT03023826|65299752|FG000|Period 1|Withdrawal by Subject|0|||
23542867|NCT02066298|65716122|FG004|Overall Study|Physician Decision|1|||
23542868|NCT02066298|65716123|FG005|Overall Study|Physician Decision|0|||
23542869|NCT01831089|65716125|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
23542870|NCT01831089|65716126|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
23542871|NCT01831089|65716127|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
23542872|NCT01831089|65716128|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
23542873|NCT01831089|65716129|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
23542874|NCT01831089|65716130|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
23542875|NCT01831089|65716125|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
23542876|NCT01831089|65716126|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
23542877|NCT01831089|65716127|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
23542878|NCT01831089|65716128|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
23542879|NCT01831089|65716129|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
23542880|NCT01831089|65716130|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
23542881|NCT01831089|65716125|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542882|NCT01831089|65716126|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
23542883|NCT01831089|65716127|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542884|NCT01831089|65716128|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542885|NCT01831089|65716129|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542886|NCT01831089|65716130|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542887|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
23542888|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
23542889|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
23542890|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
23542891|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
23542892|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
23542893|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542894|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542895|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
23542896|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542897|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542898|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542899|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
23542900|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
23542901|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
23542902|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
23542903|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
23542904|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
23542905|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Global end of study|0|||
23542906|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Global end of study|0|||
23542907|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Global end of study|1|||
23542908|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Global end of study|0|||
23542909|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Global end of study|0|||
23542910|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Global end of study|0|||
23542911|NCT01831089|65716125|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
23542912|NCT01831089|65716126|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
23542913|NCT01831089|65716127|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
23542914|NCT01831089|65716128|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
23542915|NCT01831089|65716129|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
23542916|NCT01831089|65716130|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
23542917|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
23542918|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
23542919|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
23542920|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
23542921|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
23542922|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
23542923|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542924|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542925|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542926|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23424805|NCT03023826|65299753|FG001|Period 1|Withdrawal by Subject|0|||
23728293|NCT03954704|66382364|FG005|Overall Study|Enrolled but not Treated|1|||
23728294|NCT03954704|66382365|FG006|Overall Study|Enrolled but not Treated|0|||
23728295|NCT02943668|66384759|FG000|Overall Study|Disease Progression|1|||
23728296|NCT03050307|66384760|FG000|Overall Study|Adverse Event|4|||
23728297|NCT03050307|66384761|FG001|Overall Study|Adverse Event|2|||
23728298|NCT03050307|66384760|FG000|Overall Study|Significant Protocol Deviation|0|||
23728299|NCT03050307|66384761|FG001|Overall Study|Significant Protocol Deviation|1|||
23728300|NCT03050307|66384760|FG000|Overall Study|Lost to Follow-up|0|||
23728301|NCT03050307|66384761|FG001|Overall Study|Lost to Follow-up|1|||
23728302|NCT03050307|66384760|FG000|Overall Study|Voluntary Withdrawal|3|||
23728303|NCT03050307|66384761|FG001|Overall Study|Voluntary Withdrawal|4|||
23728304|NCT03050307|66384760|FG000|Overall Study|Reason not Specified|1|||
23728305|NCT03050307|66384761|FG001|Overall Study|Reason not Specified|1|||
23728306|NCT01226472|66384766|FG000|Overall Study|Progressive Disease|1|||
23728307|NCT02015104|66384768|FG000|Overall Study|Withdrew consent after first dose drug|1|||
23728308|NCT02015104|66384769|FG001|Overall Study|Withdrew consent after first dose drug|0|||
23728309|NCT02015104|66384768|FG000|Overall Study|Withdrew consent prior to treatment|0|||
23728310|NCT02015104|66384769|FG001|Overall Study|Withdrew consent prior to treatment|1|||
23728311|NCT01268514|66384770|FG000|Overall Study|Adverse Event|20|||
23728312|NCT01268514|66384770|FG000|Overall Study|Death|8|||
23728313|NCT01268514|66384770|FG000|Overall Study|Lost to Follow-up|5|||
23728314|NCT01268514|66384770|FG000|Overall Study|Withdrawal by Subject|3|||
23728315|NCT01268514|66384770|FG000|Overall Study|Withdrawal by Surgeon|5|||
23728316|NCT01828567|66384771|FG000|Overall Study|Lost to Follow-up|27|||
23728317|NCT01828567|66384772|FG001|Overall Study|Lost to Follow-up|9|||
23728318|NCT01828567|66384771|FG000|Overall Study|Excluded - did not meet criteria|4|||
23728319|NCT01828567|66384772|FG001|Overall Study|Excluded - did not meet criteria|1|||
23728320|NCT01366534|66384773|FG000|Overall Study|Lost to Follow-up|1|||
23728321|NCT01366534|66384774|FG001|Overall Study|Lost to Follow-up|0|||
23728322|NCT01366534|66384775|FG002|Overall Study|Lost to Follow-up|0|||
23728323|NCT01366534|66384773|FG000|Overall Study|Migrated|1|||
23728324|NCT01366534|66384774|FG001|Overall Study|Migrated|1|||
23728325|NCT01366534|66384775|FG002|Overall Study|Migrated|0|||
23728326|NCT01366534|66384773|FG000|Overall Study|Declined challenged|0|||
23728327|NCT01366534|66384774|FG001|Overall Study|Declined challenged|1|||
23728328|NCT01366534|66384775|FG002|Overall Study|Declined challenged|0|||
23728329|NCT04402385|66384781|FG000|Overall Study|Withdrawal by Subject|4|||
23728330|NCT04402385|66384782|FG001|Overall Study|Withdrawal by Subject|4|||
23728331|NCT04402385|66384781|FG000|Overall Study|Lost to Follow-up|1|||
23728332|NCT04402385|66384782|FG001|Overall Study|Lost to Follow-up|1|||
23728333|NCT04402385|66384781|FG000|Overall Study|Physician Decision|0|||
23728334|NCT04402385|66384782|FG001|Overall Study|Physician Decision|1|||
23728335|NCT00333970|66384784|FG000|Overall Study|Withdrawal by Subject|13|||
23728336|NCT00333970|66384785|FG001|Overall Study|Withdrawal by Subject|7|||
23728337|NCT03878160|66384788|FG000|Overall Study|Lost to Follow-up|1|||
23728338|NCT03878160|66384789|FG001|Overall Study|Lost to Follow-up|1|||
23728339|NCT03878160|66384790|FG002|Overall Study|Lost to Follow-up|1|||
23424806|NCT03023826|65299754|FG002|Period 1|Withdrawal by Subject|0|||
23728340|NCT03878160|66384788|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
23728341|NCT03878160|66384789|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
23728342|NCT03878160|66384790|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
23728343|NCT03922711|66384795|FG000|Overall Study|Adverse Event|3|||
23817110|NCT01775189|66711287|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23817111|NCT01775189|66711288|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23817112|NCT01775189|66711289|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23728344|NCT03922711|66384796|FG001|Overall Study|Adverse Event|2|||
23728345|NCT03922711|66384797|FG002|Overall Study|Adverse Event|2|||
23728346|NCT03922711|66384795|FG000|Overall Study|Protocol Violation|1|||
23728347|NCT03922711|66384796|FG001|Overall Study|Protocol Violation|0|||
23728348|NCT03922711|66384797|FG002|Overall Study|Protocol Violation|0|||
23728349|NCT03922711|66384795|FG000|Overall Study|Withdrawal by Subject|0|||
23728350|NCT03922711|66384796|FG001|Overall Study|Withdrawal by Subject|3|||
23728351|NCT03922711|66384797|FG002|Overall Study|Withdrawal by Subject|1|||
23728352|NCT03922711|66384795|FG000|Overall Study|Not further specified|0|||
23728353|NCT03922711|66384796|FG001|Overall Study|Not further specified|0|||
23728354|NCT03922711|66384797|FG002|Overall Study|Not further specified|1|||
23728355|NCT04973085|66384801|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
23728356|NCT04973085|66384802|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
23728357|NCT03472040|66384803|FG000|Overall Study|Physician Decision|0|||
23728358|NCT03472040|66384804|FG001|Overall Study|Physician Decision|3|||
23728359|NCT03472040|66384803|FG000|Overall Study|Withdrawal by Subject|10|||
23728360|NCT03472040|66384804|FG001|Overall Study|Withdrawal by Subject|23|||
23728361|NCT03472040|66384803|FG000|Overall Study|Perceived Lack of Efficacy|29|||
23728362|NCT03472040|66384804|FG001|Overall Study|Perceived Lack of Efficacy|30|||
23728363|NCT03472040|66384803|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
23728364|NCT03472040|66384804|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
23728365|NCT03472040|66384803|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
23728366|NCT03472040|66384804|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
23728367|NCT03472040|66384803|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
23728368|NCT03472040|66384804|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
23728369|NCT03472040|66384803|FG000|Overall Study|Subject Non-compliance|2|||
23728370|NCT03472040|66384804|FG001|Overall Study|Subject Non-compliance|5|||
23728371|NCT03472040|66384803|FG000|Overall Study|Discontinuation due to Rash|0|||
23728372|NCT03472040|66384804|FG001|Overall Study|Discontinuation due to Rash|1|||
23728373|NCT03472040|66384803|FG000|Overall Study|Subsequent Ineligibility|0|||
23728374|NCT03472040|66384804|FG001|Overall Study|Subsequent Ineligibility|2|||
23728375|NCT03472040|66384803|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
23728376|NCT03472040|66384804|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
23728377|NCT03325010|66384805|FG000|Overall Study|Adverse Event|3|||
23728378|NCT03325010|66384806|FG001|Overall Study|Adverse Event|8|||
23728379|NCT03325010|66384805|FG000|Overall Study|Protocol Violation|1|||
23728380|NCT03325010|66384806|FG001|Overall Study|Protocol Violation|8|||
23728381|NCT03325010|66384805|FG000|Overall Study|Withdrawal by Subject|1|||
23728382|NCT03325010|66384806|FG001|Overall Study|Withdrawal by Subject|3|||
23728383|NCT03325010|66384805|FG000|Overall Study|Lost to Follow-up|1|||
23728384|NCT03325010|66384806|FG001|Overall Study|Lost to Follow-up|0|||
23728385|NCT03325010|66384805|FG000|Overall Study|Physician Decision|1|||
23728386|NCT03325010|66384806|FG001|Overall Study|Physician Decision|1|||
23728387|NCT03325010|66384805|FG000|Overall Study|Lack of Efficacy|2|||
23728388|NCT03325010|66384806|FG001|Overall Study|Lack of Efficacy|0|||
23728389|NCT03418376|66384809|FG000|Overall Study|Musculoskeletal injury|1|||
23728390|NCT03418376|66384810|FG001|Overall Study|Musculoskeletal injury|2|||
23424807|NCT03023826|65299755|FG003|Period 1|Withdrawal by Subject|0|||
23542927|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
23542928|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542929|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Death|0|||
23542930|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Death|0|||
23542931|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Death|0|||
23542932|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Death|0|||
23542933|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Death|1|||
23542934|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Death|0|||
23542935|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Global end of study|0|||
23542936|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Global end of study|0|||
23542937|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Global end of study|0|||
23542938|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Global end of study|0|||
23616684|NCT00747149|65982404|FG000|Overall Study|Incorrect enrollment|0|||
23616685|NCT00747149|65982405|FG001|Overall Study|Incorrect enrollment|6|||
23616686|NCT00747149|65982404|FG000|Overall Study|Severe non-compliance to protocol|0|||
23616687|NCT00747149|65982405|FG001|Overall Study|Severe non-compliance to protocol|1|||
23616688|NCT00747149|65982404|FG000|Overall Study|Not reported|1|||
23616689|NCT00747149|65982405|FG001|Overall Study|Not reported|4|||
23728391|NCT03418376|66384811|FG002|Overall Study|Musculoskeletal injury|1|||
23728392|NCT03418376|66384812|FG003|Overall Study|Musculoskeletal injury|0|||
23728393|NCT03418376|66384809|FG000|Overall Study|Personal reasons|0|||
23728394|NCT03418376|66384810|FG001|Overall Study|Personal reasons|2|||
23728395|NCT03418376|66384811|FG002|Overall Study|Personal reasons|2|||
23542939|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Global end of study|2|||
23542940|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Global end of study|0|||
23542941|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542942|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542943|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542944|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542945|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
23542946|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542947|NCT01831089|65716125|FG000|Cohort B: Arm B|Progressive disease|0|||
23542948|NCT01831089|65716126|FG001|Cohort B: Arm B|Progressive disease|0|||
23542949|NCT01831089|65716127|FG002|Cohort B: Arm B|Progressive disease|0|||
23542950|NCT01831089|65716128|FG003|Cohort B: Arm B|Progressive disease|0|||
23542951|NCT01831089|65716129|FG004|Cohort B: Arm B|Progressive disease|0|||
23542952|NCT01831089|65716130|FG005|Cohort B: Arm B|Progressive disease|8|||
23542953|NCT01831089|65716125|FG000|Cohort B: Arm B|Physician Decision|0|||
23542954|NCT01831089|65716126|FG001|Cohort B: Arm B|Physician Decision|0|||
23542955|NCT01831089|65716127|FG002|Cohort B: Arm B|Physician Decision|0|||
23542956|NCT01831089|65716128|FG003|Cohort B: Arm B|Physician Decision|0|||
23542957|NCT01831089|65716129|FG004|Cohort B: Arm B|Physician Decision|0|||
23542958|NCT01831089|65716130|FG005|Cohort B: Arm B|Physician Decision|2|||
23542959|NCT01831089|65716125|FG000|Cohort B: Arm B|Never treated|0|||
23542960|NCT01831089|65716126|FG001|Cohort B: Arm B|Never treated|0|||
23542961|NCT01831089|65716127|FG002|Cohort B: Arm B|Never treated|0|||
23542962|NCT01831089|65716128|FG003|Cohort B: Arm B|Never treated|0|||
23542963|NCT01831089|65716129|FG004|Cohort B: Arm B|Never treated|0|||
23542964|NCT01831089|65716130|FG005|Cohort B: Arm B|Never treated|2|||
23542965|NCT01831089|65716125|FG000|Cohort B: Arm B|Adverse Event|0|||
23542966|NCT01831089|65716126|FG001|Cohort B: Arm B|Adverse Event|0|||
23542967|NCT01831089|65716127|FG002|Cohort B: Arm B|Adverse Event|0|||
23542968|NCT01831089|65716128|FG003|Cohort B: Arm B|Adverse Event|0|||
23542969|NCT01831089|65716129|FG004|Cohort B: Arm B|Adverse Event|0|||
23542970|NCT01831089|65716130|FG005|Cohort B: Arm B|Adverse Event|1|||
23542971|NCT01831089|65716125|FG000|Cohort B: Arm B|Global end of study|0|||
23542972|NCT01831089|65716126|FG001|Cohort B: Arm B|Global end of study|0|||
23542973|NCT01831089|65716127|FG002|Cohort B: Arm B|Global end of study|0|||
23817113|NCT01775189|66711290|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
23817114|NCT01775189|66711291|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23817115|NCT01775189|66711292|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23817116|NCT01775189|66711293|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23817117|NCT01775189|66711287|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23817118|NCT01775189|66711288|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23817119|NCT01775189|66711289|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23817120|NCT01775189|66711290|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
23817121|NCT01775189|66711291|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23817122|NCT01775189|66711292|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23817123|NCT01775189|66711293|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
23817124|NCT00631657|66711294|FG000|6-Month Treatment Period|Adverse Event|47|||
23817125|NCT00631657|66711295|FG001|6-Month Treatment Period|Adverse Event|0|||
23817126|NCT00631657|66711296|FG002|6-Month Treatment Period|Adverse Event|7|||
23817127|NCT00631657|66711294|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
23817128|NCT00631657|66711295|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
23817129|NCT00631657|66711296|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
23817130|NCT00631657|66711294|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
23542974|NCT01831089|65716128|FG003|Cohort B: Arm B|Global end of study|0|||
23542975|NCT01831089|65716129|FG004|Cohort B: Arm B|Global end of study|0|||
23542976|NCT01831089|65716130|FG005|Cohort B: Arm B|Global end of study|1|||
23542977|NCT02080091|65716133|FG000|Overall Study|Study Terminated|22|||
23542978|NCT02080091|65716133|FG000|Overall Study|Death|1|||
23542979|NCT02080091|65716133|FG000|Overall Study|Withdrawal by Subject|1|||
23542980|NCT02080091|65716133|FG000|Overall Study|Other|1|||
23817131|NCT00631657|66711295|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
23728396|NCT03418376|66384812|FG003|Overall Study|Personal reasons|1|||
23728397|NCT03418376|66384809|FG000|Overall Study|Exacerbation|0|||
23728398|NCT03418376|66384810|FG001|Overall Study|Exacerbation|1|||
23728399|NCT03418376|66384811|FG002|Overall Study|Exacerbation|0|||
23728400|NCT03418376|66384812|FG003|Overall Study|Exacerbation|0|||
23728401|NCT04055844|66384815|FG000|Overall Study|Adverse Event|12|||
23728402|NCT04055844|66384815|FG000|Overall Study|Poor Performance|1|||
23728403|NCT04055844|66384815|FG000|Overall Study|Death|1|||
23728404|NCT01678560|66384816|FG000|Overall Study|Physician Decision|4|||
23728405|NCT01678560|66384817|FG001|Overall Study|Physician Decision|4|||
23728406|NCT01678560|66384816|FG000|Overall Study|Death|0|||
23728407|NCT01678560|66384817|FG001|Overall Study|Death|1|||
23728408|NCT01678560|66384816|FG000|Overall Study|Withdrawal by Subject|0|||
23728409|NCT01678560|66384817|FG001|Overall Study|Withdrawal by Subject|1|||
23728410|NCT01585168|66384818|FG000|Overall Study|Lost to Follow-up|3|||
23728411|NCT01585168|66384819|FG001|Overall Study|Lost to Follow-up|1|||
23728412|NCT01585168|66384820|FG002|Overall Study|Lost to Follow-up|1|||
23728413|NCT01585168|66384821|FG003|Overall Study|Lost to Follow-up|1|||
23728414|NCT00832091|66384826|FG000|Overall Study|Adverse Event|1|||
23728415|NCT00832091|66384827|FG001|Overall Study|Adverse Event|1|||
23728416|NCT00832091|66384826|FG000|Overall Study|Protocol Violation|1|||
23728417|NCT00832091|66384827|FG001|Overall Study|Protocol Violation|0|||
23728418|NCT00832091|66384826|FG000|Overall Study|Withdrawal by Subject|2|||
23728419|NCT00832091|66384827|FG001|Overall Study|Withdrawal by Subject|1|||
23728420|NCT00832091|66384826|FG000|Overall Study|Prohibited Medication|1|||
23728421|NCT00832091|66384827|FG001|Overall Study|Prohibited Medication|0|||
23728422|NCT03051217|66384830|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
23728423|NCT03051217|66384831|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23728424|NCT03051217|66384832|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23728425|NCT03051217|66384833|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23728426|NCT03051217|66384834|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23728427|NCT03051217|66384835|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23728428|NCT03051217|66384836|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23728429|NCT03051217|66384830|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23728430|NCT03051217|66384831|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
23728431|NCT03051217|66384832|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23728432|NCT03051217|66384833|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23728433|NCT03051217|66384834|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23728434|NCT03051217|66384835|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23728435|NCT03051217|66384836|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23542981|NCT00434057|65716136|FG000|Overall Study|Withdrawal by Subject|1|||
23728436|NCT03051217|66384830|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23728437|NCT03051217|66384831|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23542982|NCT01643473|65716143|FG000|Overall Study|Lost to Follow-up|1|||
23542983|NCT01643473|65716144|FG001|Overall Study|Lost to Follow-up|0|||
23542984|NCT01682837|65716145|FG000|Baseline|Withdrawal by Subject|5|||
23542985|NCT04572633|65716146|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
23542986|NCT00558285|65716147|FG000|Overall Study|Adverse Event|1|||
23542987|NCT00558285|65716148|FG001|Overall Study|Adverse Event|1|||
23728438|NCT03051217|66384832|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23817132|NCT00631657|66711296|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
23817133|NCT00631657|66711294|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
23817134|NCT00631657|66711295|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
23817135|NCT00631657|66711296|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
23817136|NCT00631657|66711294|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
23817137|NCT00631657|66711295|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
23817138|NCT00631657|66711296|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
23817139|NCT00631657|66711294|FG000|6-Month Treatment Period|Other|16|||
23817140|NCT00631657|66711295|FG001|6-Month Treatment Period|Other|0|||
23817141|NCT00631657|66711296|FG002|6-Month Treatment Period|Other|4|||
23817142|NCT00631657|66711294|FG000|6-Month Treatment Period|Not Treated|2|||
23817143|NCT00631657|66711295|FG001|6-Month Treatment Period|Not Treated|0|||
23817144|NCT00631657|66711296|FG002|6-Month Treatment Period|Not Treated|1|||
23542988|NCT00558285|65716149|FG002|Overall Study|Adverse Event|4|||
23728439|NCT03051217|66384833|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23728440|NCT03051217|66384834|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23728441|NCT03051217|66384835|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23728442|NCT03051217|66384836|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23817145|NCT00631657|66711294|FG000|7-Day Discontinuation Period|Not Treated|1|||
23542989|NCT00558285|65716150|FG003|Overall Study|Adverse Event|1|||
23542990|NCT00558285|65716151|FG004|Overall Study|Adverse Event|2|||
23817146|NCT00631657|66711295|FG001|7-Day Discontinuation Period|Not Treated|1|||
23582203|NCT01094171|65862382|FG000|Overall Study|Lost to Follow-up|2|||
23817147|NCT00631657|66711296|FG002|7-Day Discontinuation Period|Not Treated|1|||
23817148|NCT00631657|66711294|FG000|7-Day Discontinuation Period|Other|1|||
23817149|NCT00631657|66711295|FG001|7-Day Discontinuation Period|Other|0|||
23817150|NCT00631657|66711296|FG002|7-Day Discontinuation Period|Other|0|||
23817151|NCT01822275|66711297|FG000|Overall Study|Withdrawal by Subject|3|||
23817152|NCT01822275|66711297|FG000|Overall Study|Adverse Event|3|||
23817153|NCT01822275|66711297|FG000|Overall Study|Progression|14|||
23817154|NCT01822275|66711297|FG000|Overall Study|Physician Decision|2|||
23817155|NCT01398514|66711298|FG000|Overall Study|Adverse Event|1|||
23817156|NCT01398514|66711299|FG001|Overall Study|Adverse Event|0|||
23817157|NCT01398514|66711298|FG000|Overall Study|Non-compliance with study procedures|2|||
23817158|NCT01398514|66711299|FG001|Overall Study|Non-compliance with study procedures|0|||
23817159|NCT01398514|66711298|FG000|Overall Study|Physiologic non-responsiveness|1|||
23817160|NCT01398514|66711299|FG001|Overall Study|Physiologic non-responsiveness|3|||
23817161|NCT01398514|66711298|FG000|Overall Study|Failure to show a conditioned response|4|||
23817162|NCT01398514|66711299|FG001|Overall Study|Failure to show a conditioned response|3|||
23817163|NCT01136967|66711300|FG000|Overall Study|Adverse Event|9|||
23817164|NCT01136967|66711301|FG001|Overall Study|Adverse Event|12|||
23817165|NCT01136967|66711300|FG000|Overall Study|Participant Choice|8|||
23817166|NCT01136967|66711301|FG001|Overall Study|Participant Choice|3|||
23817167|NCT01136967|66711300|FG000|Overall Study|Lost to Follow-up|0|||
23542991|NCT00558285|65716147|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23542992|NCT00558285|65716148|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23542993|NCT00558285|65716149|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23542994|NCT00558285|65716150|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23542995|NCT00558285|65716151|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23542996|NCT00558285|65716147|FG000|Overall Study|Subject withdrew consent|2|||
23542997|NCT00558285|65716148|FG001|Overall Study|Subject withdrew consent|0|||
23542998|NCT00558285|65716149|FG002|Overall Study|Subject withdrew consent|1|||
23542999|NCT00558285|65716150|FG003|Overall Study|Subject withdrew consent|1|||
23817168|NCT01136967|66711301|FG001|Overall Study|Lost to Follow-up|1|||
23817169|NCT01136967|66711300|FG000|Overall Study|Withdrawal by Subject|1|||
23817170|NCT01136967|66711301|FG001|Overall Study|Withdrawal by Subject|2|||
23817171|NCT01136967|66711300|FG000|Overall Study|Clinical Progression|3|||
23817172|NCT01136967|66711301|FG001|Overall Study|Clinical Progression|5|||
23817173|NCT01136967|66711300|FG000|Overall Study|Radiation|1|||
23817174|NCT01136967|66711301|FG001|Overall Study|Radiation|0|||
23817175|NCT01136967|66711300|FG000|Overall Study|Non-compliance|1|||
23817176|NCT01136967|66711301|FG001|Overall Study|Non-compliance|0|||
23817177|NCT01136967|66711300|FG000|Overall Study|Investigator's Choice|1|||
23543000|NCT00558285|65716151|FG004|Overall Study|Subject withdrew consent|1|||
23817178|NCT01136967|66711301|FG001|Overall Study|Investigator's Choice|1|||
23728443|NCT03051217|66384830|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23728444|NCT03051217|66384831|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23728445|NCT03051217|66384832|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23728446|NCT03051217|66384833|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23728447|NCT03051217|66384834|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
23728448|NCT03051217|66384835|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23728449|NCT03051217|66384836|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23728450|NCT03051217|66384830|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23728451|NCT03051217|66384831|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23817179|NCT01136967|66711300|FG000|Overall Study|Increase in Lesion Size|0|||
23817180|NCT01136967|66711301|FG001|Overall Study|Increase in Lesion Size|2|||
23817181|NCT01136967|66711300|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
23817182|NCT01136967|66711301|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
23817183|NCT01473524|66711304|FG000|DB Phase|Adverse Event|4|||
23817184|NCT01473524|66711305|FG001|DB Phase|Adverse Event|8|||
23817185|NCT01473524|66711306|FG002|DB Phase|Adverse Event|2|||
23817186|NCT01473524|66711307|FG003|DB Phase|Adverse Event|0|||
23817187|NCT01473524|66711308|FG004|DB Phase|Adverse Event|0|||
23817188|NCT01473524|66711309|FG005|DB Phase|Adverse Event|0|||
23817189|NCT01473524|66711304|FG000|DB Phase|Death|1|||
23817190|NCT01473524|66711305|FG001|DB Phase|Death|0|||
23817191|NCT01473524|66711306|FG002|DB Phase|Death|0|||
23817192|NCT01473524|66711307|FG003|DB Phase|Death|0|||
23817193|NCT01473524|66711308|FG004|DB Phase|Death|0|||
23817194|NCT01473524|66711309|FG005|DB Phase|Death|0|||
23817195|NCT01473524|66711304|FG000|DB Phase|Withdrawal by Subject|2|||
23817196|NCT01473524|66711305|FG001|DB Phase|Withdrawal by Subject|1|||
23817197|NCT01473524|66711306|FG002|DB Phase|Withdrawal by Subject|1|||
23817198|NCT01473524|66711307|FG003|DB Phase|Withdrawal by Subject|0|||
23817199|NCT01473524|66711308|FG004|DB Phase|Withdrawal by Subject|0|||
23817200|NCT01473524|66711309|FG005|DB Phase|Withdrawal by Subject|0|||
23817201|NCT01473524|66711304|FG000|LTSE Phase|Withdrawal by Subject|0|||
23817202|NCT01473524|66711305|FG001|LTSE Phase|Withdrawal by Subject|0|||
23817203|NCT01473524|66711306|FG002|LTSE Phase|Withdrawal by Subject|0|||
23817204|NCT01473524|66711307|FG003|LTSE Phase|Withdrawal by Subject|3|||
23817205|NCT01473524|66711308|FG004|LTSE Phase|Withdrawal by Subject|3|||
23817206|NCT01473524|66711309|FG005|LTSE Phase|Withdrawal by Subject|6|||
23817207|NCT01473524|66711304|FG000|LTSE Phase|Death|0|||
23817208|NCT01473524|66711305|FG001|LTSE Phase|Death|0|||
23817209|NCT01473524|66711306|FG002|LTSE Phase|Death|0|||
23817210|NCT01473524|66711307|FG003|LTSE Phase|Death|0|||
23817211|NCT01473524|66711308|FG004|LTSE Phase|Death|1|||
23817212|NCT01473524|66711309|FG005|LTSE Phase|Death|0|||
23817213|NCT01473524|66711304|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
23817214|NCT01473524|66711305|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
23817215|NCT01473524|66711306|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
23817216|NCT01473524|66711307|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
23817217|NCT01473524|66711308|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
23817218|NCT01473524|66711309|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
23817219|NCT01473524|66711304|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23817220|NCT01473524|66711305|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23817221|NCT01473524|66711306|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23817222|NCT01473524|66711307|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
23817223|NCT01473524|66711308|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
23817224|NCT01473524|66711309|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
23817225|NCT01473524|66711304|FG000|LTSE Phase|Lost to Follow-up|0|||
23817226|NCT01473524|66711305|FG001|LTSE Phase|Lost to Follow-up|0|||
23817227|NCT01473524|66711306|FG002|LTSE Phase|Lost to Follow-up|0|||
23817228|NCT01473524|66711307|FG003|LTSE Phase|Lost to Follow-up|1|||
23817229|NCT01473524|66711308|FG004|LTSE Phase|Lost to Follow-up|3|||
23817230|NCT01473524|66711309|FG005|LTSE Phase|Lost to Follow-up|2|||
23817231|NCT01473524|66711304|FG000|LTSE Phase|Principal Investigator Decision|0|||
23817232|NCT01473524|66711305|FG001|LTSE Phase|Principal Investigator Decision|0|||
23817233|NCT01473524|66711306|FG002|LTSE Phase|Principal Investigator Decision|0|||
23817234|NCT01473524|66711307|FG003|LTSE Phase|Principal Investigator Decision|1|||
23817235|NCT01473524|66711308|FG004|LTSE Phase|Principal Investigator Decision|1|||
23817236|NCT01473524|66711309|FG005|LTSE Phase|Principal Investigator Decision|3|||
23817237|NCT01473524|66711304|FG000|LTSE Phase|Liver Transplantation|0|||
23817238|NCT01473524|66711305|FG001|LTSE Phase|Liver Transplantation|0|||
23817239|NCT01473524|66711306|FG002|LTSE Phase|Liver Transplantation|0|||
23817240|NCT01473524|66711307|FG003|LTSE Phase|Liver Transplantation|0|||
23817241|NCT01473524|66711308|FG004|LTSE Phase|Liver Transplantation|0|||
23817242|NCT01473524|66711309|FG005|LTSE Phase|Liver Transplantation|1|||
23817243|NCT01473524|66711304|FG000|LTSE Phase|Pregnancy|0|||
23817244|NCT01473524|66711305|FG001|LTSE Phase|Pregnancy|0|||
23817245|NCT01473524|66711306|FG002|LTSE Phase|Pregnancy|0|||
23728452|NCT03051217|66384832|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23728453|NCT03051217|66384833|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
23728454|NCT03051217|66384834|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23728455|NCT03051217|66384835|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23728456|NCT03051217|66384836|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23728457|NCT03051217|66384830|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728458|NCT03051217|66384831|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728459|NCT03051217|66384832|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728460|NCT03051217|66384833|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
23728461|NCT03051217|66384834|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728462|NCT03051217|66384835|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728463|NCT03051217|66384836|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23728464|NCT03051217|66384830|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728465|NCT03051217|66384831|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728466|NCT03051217|66384832|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728467|NCT03051217|66384833|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728468|NCT03051217|66384834|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
23817246|NCT01473524|66711307|FG003|LTSE Phase|Pregnancy|1|||
23817247|NCT01473524|66711308|FG004|LTSE Phase|Pregnancy|0|||
23817248|NCT01473524|66711309|FG005|LTSE Phase|Pregnancy|0|||
23817249|NCT01473524|66711304|FG000|LTSE Phase|Protocol Violation|0|||
23817250|NCT01473524|66711305|FG001|LTSE Phase|Protocol Violation|0|||
23817251|NCT01473524|66711306|FG002|LTSE Phase|Protocol Violation|0|||
23817252|NCT01473524|66711307|FG003|LTSE Phase|Protocol Violation|0|||
23817253|NCT01473524|66711308|FG004|LTSE Phase|Protocol Violation|0|||
23817254|NCT01473524|66711309|FG005|LTSE Phase|Protocol Violation|1|||
23817255|NCT00000378|66711311|FG000|Overall Study|Lack of Efficacy|16|||
23817256|NCT00000378|66711312|FG001|Overall Study|Lack of Efficacy|14|||
23817257|NCT01755767|66711315|FG000|Overall Study|Progressive Disease|8|||
23817258|NCT01755767|66711316|FG001|Overall Study|Progressive Disease|7|||
23817259|NCT01755767|66711317|FG002|Overall Study|Progressive Disease|91|||
23817260|NCT01755767|66711318|FG003|Overall Study|Progressive Disease|43|||
23817261|NCT01755767|66711315|FG000|Overall Study|Clinical Disease Progression|4|||
23817262|NCT01755767|66711316|FG001|Overall Study|Clinical Disease Progression|2|||
23817263|NCT01755767|66711317|FG002|Overall Study|Clinical Disease Progression|29|||
23817264|NCT01755767|66711318|FG003|Overall Study|Clinical Disease Progression|20|||
23817265|NCT01755767|66711315|FG000|Overall Study|Radiographic Disease Progression|9|||
23817266|NCT01755767|66711316|FG001|Overall Study|Radiographic Disease Progression|4|||
23817267|NCT01755767|66711317|FG002|Overall Study|Radiographic Disease Progression|44|||
23817268|NCT01755767|66711318|FG003|Overall Study|Radiographic Disease Progression|27|||
23817269|NCT01755767|66711315|FG000|Overall Study|Adverse Event|6|||
23817270|NCT01755767|66711316|FG001|Overall Study|Adverse Event|0|||
23817271|NCT01755767|66711317|FG002|Overall Study|Adverse Event|28|||
23817272|NCT01755767|66711318|FG003|Overall Study|Adverse Event|11|||
23817273|NCT01755767|66711315|FG000|Overall Study|Death|1|||
23817274|NCT01755767|66711316|FG001|Overall Study|Death|2|||
23817275|NCT01755767|66711317|FG002|Overall Study|Death|15|||
23817276|NCT01755767|66711318|FG003|Overall Study|Death|4|||
23817277|NCT01755767|66711315|FG000|Overall Study|Subject Decision|0|||
23817278|NCT01755767|66711316|FG001|Overall Study|Subject Decision|0|||
23817279|NCT01755767|66711317|FG002|Overall Study|Subject Decision|10|||
23817280|NCT01755767|66711318|FG003|Overall Study|Subject Decision|3|||
23817281|NCT01755767|66711315|FG000|Overall Study|Withdrawal by Subject|0|||
23817282|NCT01755767|66711316|FG001|Overall Study|Withdrawal by Subject|0|||
23817283|NCT01755767|66711317|FG002|Overall Study|Withdrawal by Subject|2|||
23817284|NCT01755767|66711318|FG003|Overall Study|Withdrawal by Subject|1|||
23817285|NCT01755767|66711315|FG000|Overall Study|Other|0|||
23728469|NCT03051217|66384835|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728470|NCT03051217|66384836|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23728471|NCT03051217|66384830|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23728472|NCT03051217|66384831|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23728473|NCT03051217|66384832|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23728474|NCT03051217|66384833|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23817286|NCT01755767|66711316|FG001|Overall Study|Other|0|||
23817287|NCT01755767|66711317|FG002|Overall Study|Other|2|||
23817288|NCT01755767|66711318|FG003|Overall Study|Other|3|||
23817289|NCT01755767|66711315|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
23817290|NCT01755767|66711316|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
23817291|NCT01755767|66711317|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
23817292|NCT01755767|66711318|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
23817293|NCT02437903|66711320|FG000|Overall Study|Adverse Event|1|||
23817294|NCT02437903|66711320|FG000|Overall Study|Withdrawal by Subject|1|||
23728475|NCT03051217|66384834|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23728476|NCT03051217|66384835|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
23728477|NCT03051217|66384836|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23728478|NCT01974440|66384838|FG000|Overall Study|Lost to Follow-up|7|||
23728479|NCT01974440|66384839|FG001|Overall Study|Lost to Follow-up|7|||
23728480|NCT01974440|66384838|FG000|Overall Study|Withdrawal by Subject|24|||
23728481|NCT01974440|66384839|FG001|Overall Study|Withdrawal by Subject|20|||
23728482|NCT01974440|66384838|FG000|Overall Study|Sponsor decision|109|||
23728483|NCT01974440|66384839|FG001|Overall Study|Sponsor decision|110|||
23728484|NCT00653068|66384842|FG000|Overall Study|Death|9|||
23728485|NCT00653068|66384842|FG000|Overall Study|Lack of Efficacy|34|||
23728486|NCT00653068|66384842|FG000|Overall Study|Physician Decision|4|||
23728487|NCT00653068|66384842|FG000|Overall Study|Withdrawal by Subject|1|||
23728488|NCT00653068|66384842|FG000|Overall Study|Ineligible|2|||
23728489|NCT01235338|66384847|FG000|Overall Study|Adverse Event|3|||
23728490|NCT01235338|66384848|FG001|Overall Study|Adverse Event|2|||
23728491|NCT01235338|66384847|FG000|Overall Study|Protocol Violation|1|||
23728492|NCT01235338|66384848|FG001|Overall Study|Protocol Violation|1|||
23728493|NCT01235338|66384847|FG000|Overall Study|Withdrawal by Subject|5|||
23728494|NCT01235338|66384848|FG001|Overall Study|Withdrawal by Subject|0|||
23728495|NCT01235338|66384847|FG000|Overall Study|Exclusion criteria violations|1|||
23728496|NCT01235338|66384848|FG001|Overall Study|Exclusion criteria violations|1|||
23728497|NCT01235338|66384847|FG000|Overall Study|Positive drug screen|0|||
23728498|NCT01235338|66384848|FG001|Overall Study|Positive drug screen|1|||
23728499|NCT01235338|66384847|FG000|Overall Study|Prohibited meds|1|||
23728500|NCT01235338|66384848|FG001|Overall Study|Prohibited meds|0|||
23728501|NCT00398138|66384849|FG000|Overall Study|Adverse Event|2|||
23728502|NCT03127852|66384853|FG000|Overall Study|Withdrawal by Subject|4|||
23728503|NCT03127852|66384854|FG001|Overall Study|Withdrawal by Subject|1|||
23728504|NCT03127852|66384853|FG000|Overall Study|Death|1|||
23728505|NCT03127852|66384854|FG001|Overall Study|Death|1|||
23728506|NCT00149890|66384857|FG000|Overall Study|Adverse Event|1|||
23728507|NCT00149890|66384858|FG001|Overall Study|Adverse Event|8|||
23728508|NCT00149890|66384857|FG000|Overall Study|Lack of Efficacy|8|||
23728509|NCT00149890|66384858|FG001|Overall Study|Lack of Efficacy|9|||
23728510|NCT00149890|66384857|FG000|Overall Study|Protocol Violation|1|||
23728511|NCT00149890|66384858|FG001|Overall Study|Protocol Violation|0|||
23728512|NCT00149890|66384857|FG000|Overall Study|Lost to Follow-up|1|||
23728513|NCT00149890|66384858|FG001|Overall Study|Lost to Follow-up|0|||
23728514|NCT00149890|66384857|FG000|Overall Study|Graft Loss|2|||
23728515|NCT00149890|66384858|FG001|Overall Study|Graft Loss|1|||
23728516|NCT02499575|66384859|FG000|Overall Study|Protocol Violation|0|||
23728517|NCT02499575|66384860|FG001|Overall Study|Protocol Violation|1|||
23728518|NCT01641081|66384861|FG000|Period 1|Sponsor request (potential unblinding)|0|||
23728519|NCT01641081|66384862|FG001|Period 1|Sponsor request (potential unblinding)|0|||
23728520|NCT01641081|66384863|FG002|Period 1|Sponsor request (potential unblinding)|0|||
23728521|NCT01641081|66384864|FG003|Period 1|Sponsor request (potential unblinding)|0|||
23728522|NCT01641081|66384865|FG004|Period 1|Sponsor request (potential unblinding)|0|||
23728523|NCT01641081|66384866|FG005|Period 1|Sponsor request (potential unblinding)|0|||
23728524|NCT01641081|66384867|FG006|Period 1|Sponsor request (potential unblinding)|1|||
23728525|NCT01641081|66384868|FG007|Period 1|Sponsor request (potential unblinding)|0|||
23728526|NCT01641081|66384869|FG008|Period 1|Sponsor request (potential unblinding)|0|||
23728527|NCT01641081|66384870|FG009|Period 1|Sponsor request (potential unblinding)|0|||
23728528|NCT01641081|66384861|FG000|Period 1|Protocol Violation|0|||
23728529|NCT01641081|66384862|FG001|Period 1|Protocol Violation|0|||
23728530|NCT01641081|66384863|FG002|Period 1|Protocol Violation|0|||
23728531|NCT01641081|66384864|FG003|Period 1|Protocol Violation|0|||
23728532|NCT01641081|66384865|FG004|Period 1|Protocol Violation|1|||
23728533|NCT01641081|66384866|FG005|Period 1|Protocol Violation|0|||
23728534|NCT01641081|66384867|FG006|Period 1|Protocol Violation|0|||
23728535|NCT01641081|66384868|FG007|Period 1|Protocol Violation|1|||
23728536|NCT01641081|66384869|FG008|Period 1|Protocol Violation|0|||
23728537|NCT01641081|66384870|FG009|Period 1|Protocol Violation|0|||
23728538|NCT01641081|66384861|FG000|Period 1|Adverse Event|1|||
23728539|NCT01641081|66384862|FG001|Period 1|Adverse Event|0|||
23728540|NCT01641081|66384863|FG002|Period 1|Adverse Event|0|||
23728541|NCT01641081|66384864|FG003|Period 1|Adverse Event|0|||
23728542|NCT01641081|66384865|FG004|Period 1|Adverse Event|0|||
23543001|NCT00558285|65716147|FG000|Overall Study|Lost to Follow-up|1|||
23728543|NCT01641081|66384866|FG005|Period 1|Adverse Event|0|||
23728544|NCT01641081|66384867|FG006|Period 1|Adverse Event|0|||
23728545|NCT01641081|66384868|FG007|Period 1|Adverse Event|2|||
23424808|NCT03023826|65299756|FG004|Period 1|Withdrawal by Subject|1|||
23728546|NCT01641081|66384869|FG008|Period 1|Adverse Event|0|||
23728547|NCT01641081|66384870|FG009|Period 1|Adverse Event|0|||
23728548|NCT01641081|66384861|FG000|Period 2|Adverse Event|0|||
23728549|NCT01641081|66384862|FG001|Period 2|Adverse Event|0|||
23728550|NCT01641081|66384863|FG002|Period 2|Adverse Event|0|||
23728551|NCT01641081|66384864|FG003|Period 2|Adverse Event|0|||
23728552|NCT01641081|66384865|FG004|Period 2|Adverse Event|0|||
23728553|NCT01641081|66384866|FG005|Period 2|Adverse Event|1|||
23728554|NCT01641081|66384867|FG006|Period 2|Adverse Event|0|||
23728555|NCT01641081|66384868|FG007|Period 2|Adverse Event|0|||
23728556|NCT01641081|66384869|FG008|Period 2|Adverse Event|0|||
23728557|NCT01641081|66384870|FG009|Period 2|Adverse Event|0|||
23728558|NCT01641081|66384861|FG000|Period 2|Withdrawal by Subject|0|||
23728559|NCT01641081|66384862|FG001|Period 2|Withdrawal by Subject|0|||
23728560|NCT01641081|66384863|FG002|Period 2|Withdrawal by Subject|0|||
23728561|NCT01641081|66384864|FG003|Period 2|Withdrawal by Subject|1|||
23728562|NCT01641081|66384865|FG004|Period 2|Withdrawal by Subject|0|||
23728563|NCT01641081|66384866|FG005|Period 2|Withdrawal by Subject|0|||
23728564|NCT01641081|66384867|FG006|Period 2|Withdrawal by Subject|2|||
23728565|NCT01641081|66384868|FG007|Period 2|Withdrawal by Subject|0|||
23728566|NCT01641081|66384869|FG008|Period 2|Withdrawal by Subject|0|||
23728567|NCT01641081|66384870|FG009|Period 2|Withdrawal by Subject|0|||
23728568|NCT01641081|66384861|FG000|Period 2|Protocol Violation|1|||
23728569|NCT01641081|66384862|FG001|Period 2|Protocol Violation|0|||
23728570|NCT01641081|66384863|FG002|Period 2|Protocol Violation|0|||
23728571|NCT01641081|66384864|FG003|Period 2|Protocol Violation|0|||
23728572|NCT01641081|66384865|FG004|Period 2|Protocol Violation|0|||
23728573|NCT01641081|66384866|FG005|Period 2|Protocol Violation|0|||
23728574|NCT01641081|66384867|FG006|Period 2|Protocol Violation|0|||
23728575|NCT01641081|66384868|FG007|Period 2|Protocol Violation|0|||
23543002|NCT00558285|65716148|FG001|Overall Study|Lost to Follow-up|1|||
23728576|NCT01641081|66384869|FG008|Period 2|Protocol Violation|0|||
23728577|NCT01641081|66384870|FG009|Period 2|Protocol Violation|0|||
23817295|NCT02437903|66711320|FG000|Overall Study|Lost to Follow-up|3|||
23728578|NCT01641081|66384861|FG000|Period 3|Adverse Event|0|||
23543003|NCT00558285|65716149|FG002|Overall Study|Lost to Follow-up|0|||
23817296|NCT04868968|66711321|FG000|Overall Study|Lost to Follow-up|1|||
23817297|NCT03456453|66711322|FG000|Overall Study|Withdrawal by Subject|2|||
23817298|NCT03456453|66711323|FG001|Overall Study|Withdrawal by Subject|0|||
23817299|NCT03456453|66711322|FG000|Overall Study|Not released to community|1|||
23817300|NCT03456453|66711323|FG001|Overall Study|Not released to community|5|||
23817301|NCT03456453|66711322|FG000|Overall Study|Lost to Follow-up|0|||
23817302|NCT03456453|66711323|FG001|Overall Study|Lost to Follow-up|2|||
23817303|NCT03745313|66711324|FG000|At 30 Days Follow-up|Death|2|||
23817304|NCT03745313|66711324|FG000|At 6 Months Follow-up|Death|1|||
23817305|NCT03745313|66711324|FG000|At 6 Months Follow-up|Missed Visit|1|||
23817306|NCT03745313|66711324|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
23817307|NCT03745313|66711324|FG000|At 1 Year Follow-up|Death|2|||
23817308|NCT03745313|66711324|FG000|At 1 Year Follow-up|Missed Visit|2|||
23817309|NCT03745313|66711324|FG000|At 2 Year Follow-up|Missed Visit|1|||
23817310|NCT01439009|66711325|FG000|Overall Study|Physician Decision|5|||
23817311|NCT01439009|66711326|FG001|Overall Study|Physician Decision|3|||
23817312|NCT01439009|66711325|FG000|Overall Study|Protocol Violation|2|||
23817313|NCT01439009|66711326|FG001|Overall Study|Protocol Violation|0|||
23817314|NCT01439009|66711325|FG000|Overall Study|Deviation of exclusion criteria|1|||
23817315|NCT01439009|66711326|FG001|Overall Study|Deviation of exclusion criteria|0|||
23817316|NCT01307111|66711327|FG000|IUD Insertion|Lost to Follow-up|2|||
23817317|NCT01307111|66711328|FG001|IUD Insertion|Lost to Follow-up|0|||
23817318|NCT01307111|66711327|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
23817319|NCT01307111|66711328|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
23817320|NCT01520870|66711329|FG000|Overall Study|Withdrawal by Subject|2|||
23817321|NCT04005352|66711330|FG000|Overall Study|Adverse Event|4|||
23817322|NCT04005352|66711331|FG001|Overall Study|Adverse Event|5|||
23817323|NCT04005352|66711330|FG000|Overall Study|Death|4|||
23817324|NCT04005352|66711331|FG001|Overall Study|Death|2|||
23817325|NCT04005352|66711330|FG000|Overall Study|Lost to Follow-up|6|||
23817326|NCT04005352|66711331|FG001|Overall Study|Lost to Follow-up|2|||
23817327|NCT04005352|66711330|FG000|Overall Study|Physician Decision|7|||
23817328|NCT04005352|66711331|FG001|Overall Study|Physician Decision|13|||
23817329|NCT04005352|66711330|FG000|Overall Study|Protocol Violation|0|||
23817330|NCT04005352|66711331|FG001|Overall Study|Protocol Violation|1|||
23817331|NCT04005352|66711330|FG000|Overall Study|Withdrawal by Subject|28|||
23817332|NCT04005352|66711331|FG001|Overall Study|Withdrawal by Subject|38|||
23817333|NCT00253448|66711332|FG000|Overall Study|Withdrawal by Subject|1|||
23817334|NCT01884337|66711333|FG000|Treatment|Adverse Event|2|||
23817335|NCT01884337|66711334|FG001|Treatment|Adverse Event|2|||
23817336|NCT01884337|66711333|FG000|Treatment|Subj. request to discont. treatment|2|||
23817337|NCT01884337|66711334|FG001|Treatment|Subj. request to discont. treatment|0|||
23817338|NCT01884337|66711333|FG000|Follow-up Period|Lost to Follow-up|1|||
23817339|NCT01884337|66711334|FG001|Follow-up Period|Lost to Follow-up|1|||
23817340|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
23817341|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
23817342|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817343|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817344|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817345|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817346|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817347|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817348|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817349|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23817350|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
23817351|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
23817352|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817353|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817354|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23728579|NCT01641081|66384862|FG001|Period 3|Adverse Event|0|||
23728580|NCT01641081|66384863|FG002|Period 3|Adverse Event|1|||
23728581|NCT01641081|66384864|FG003|Period 3|Adverse Event|0|||
23728582|NCT01641081|66384865|FG004|Period 3|Adverse Event|0|||
23728583|NCT01641081|66384866|FG005|Period 3|Adverse Event|0|||
23728584|NCT01641081|66384867|FG006|Period 3|Adverse Event|0|||
23728585|NCT01641081|66384868|FG007|Period 3|Adverse Event|0|||
23728586|NCT01641081|66384869|FG008|Period 3|Adverse Event|0|||
23728587|NCT01641081|66384870|FG009|Period 3|Adverse Event|0|||
23817355|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817356|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817357|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817358|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23817359|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23543004|NCT00558285|65716150|FG003|Overall Study|Lost to Follow-up|0|||
23543005|NCT00558285|65716151|FG004|Overall Study|Lost to Follow-up|0|||
23728588|NCT01641081|66384861|FG000|Period 3|Withdrawal by Subject|0|||
23728589|NCT01641081|66384862|FG001|Period 3|Withdrawal by Subject|0|||
23728590|NCT01641081|66384863|FG002|Period 3|Withdrawal by Subject|0|||
23728591|NCT01641081|66384864|FG003|Period 3|Withdrawal by Subject|0|||
23728592|NCT01641081|66384865|FG004|Period 3|Withdrawal by Subject|0|||
23728593|NCT01641081|66384866|FG005|Period 3|Withdrawal by Subject|0|||
23728594|NCT01641081|66384867|FG006|Period 3|Withdrawal by Subject|0|||
23728595|NCT01641081|66384868|FG007|Period 3|Withdrawal by Subject|0|||
23728596|NCT01641081|66384869|FG008|Period 3|Withdrawal by Subject|1|||
23728597|NCT01641081|66384870|FG009|Period 3|Withdrawal by Subject|0|||
23543006|NCT00558285|65716147|FG000|Overall Study|Administrative problems|0|||
23543007|NCT00558285|65716148|FG001|Overall Study|Administrative problems|0|||
23728598|NCT01641081|66384861|FG000|Period 4|Adverse Event|0|||
23728599|NCT01641081|66384862|FG001|Period 4|Adverse Event|1|||
23543008|NCT00558285|65716149|FG002|Overall Study|Administrative problems|0|||
23728600|NCT01641081|66384863|FG002|Period 4|Adverse Event|0|||
23728601|NCT01641081|66384864|FG003|Period 4|Adverse Event|1|||
23728602|NCT01641081|66384865|FG004|Period 4|Adverse Event|0|||
23728603|NCT01641081|66384866|FG005|Period 4|Adverse Event|0|||
23543009|NCT00558285|65716150|FG003|Overall Study|Administrative problems|1|||
23728604|NCT01641081|66384867|FG006|Period 4|Adverse Event|0|||
23728605|NCT01641081|66384868|FG007|Period 4|Adverse Event|0|||
23728606|NCT01641081|66384869|FG008|Period 4|Adverse Event|0|||
23543010|NCT00558285|65716151|FG004|Overall Study|Administrative problems|1|||
23543011|NCT00558285|65716147|FG000|Overall Study|Protocol deviation|1|||
23543012|NCT00558285|65716148|FG001|Overall Study|Protocol deviation|1|||
23543013|NCT00558285|65716149|FG002|Overall Study|Protocol deviation|0|||
23817360|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817361|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
23817362|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817363|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817364|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817365|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817366|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817367|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817368|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817369|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23817370|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
23817371|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817372|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817373|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817374|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817375|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817376|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817377|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23728607|NCT01641081|66384870|FG009|Period 4|Adverse Event|0|||
23817378|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817379|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23817380|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
23817381|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
23817382|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817383|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817384|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817385|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817386|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817387|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817388|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23817389|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23728608|NCT01641081|66384861|FG000|Period 5|Adverse Event|0|||
23728609|NCT01641081|66384862|FG001|Period 5|Adverse Event|0|||
23728610|NCT01641081|66384863|FG002|Period 5|Adverse Event|2|||
23728611|NCT01641081|66384864|FG003|Period 5|Adverse Event|0|||
23728612|NCT01641081|66384865|FG004|Period 5|Adverse Event|0|||
23728613|NCT01641081|66384866|FG005|Period 5|Adverse Event|0|||
23728614|NCT01641081|66384867|FG006|Period 5|Adverse Event|0|||
23728615|NCT01641081|66384868|FG007|Period 5|Adverse Event|0|||
23817390|NCT04784533|66711338|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
23817391|NCT04784533|66711339|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
23817392|NCT04784533|66711340|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817393|NCT04784533|66711341|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817394|NCT04784533|66711342|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817395|NCT04784533|66711343|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817396|NCT04784533|66711344|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817397|NCT04784533|66711345|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817398|NCT04784533|66711346|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817399|NCT04784533|66711347|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23817400|NCT04784533|66711338|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817401|NCT04784533|66711339|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817402|NCT04784533|66711340|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
23817403|NCT04784533|66711341|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817404|NCT04784533|66711342|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817405|NCT04784533|66711343|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817406|NCT04784533|66711344|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817407|NCT04784533|66711345|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817408|NCT04784533|66711346|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817409|NCT04784533|66711347|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23817410|NCT04784533|66711338|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817411|NCT04784533|66711339|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817412|NCT04784533|66711340|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817413|NCT04784533|66711341|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817414|NCT04784533|66711342|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817415|NCT04784533|66711343|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817416|NCT04784533|66711344|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817417|NCT04784533|66711345|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817418|NCT04784533|66711346|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
23817419|NCT04784533|66711347|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23817420|NCT04784533|66711338|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817421|NCT04784533|66711339|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817422|NCT04784533|66711340|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817423|NCT04784533|66711341|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817424|NCT04784533|66711342|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817425|NCT04784533|66711343|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817426|NCT04784533|66711344|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817427|NCT04784533|66711345|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23817428|NCT04784533|66711346|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
23817429|NCT04784533|66711347|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
23817430|NCT00866658|66711348|FG000|Overall Study|Adverse Event|5|||
23817431|NCT00866658|66711349|FG001|Overall Study|Adverse Event|14|||
23817432|NCT00866658|66711348|FG000|Overall Study|Lack of Efficacy|2|||
23817433|NCT00866658|66711349|FG001|Overall Study|Lack of Efficacy|1|||
23817434|NCT00866658|66711348|FG000|Overall Study|Withdrawal by Subject|1|||
23817435|NCT00866658|66711349|FG001|Overall Study|Withdrawal by Subject|0|||
23817436|NCT00866658|66711348|FG000|Overall Study|Protocol Violation|1|||
23817437|NCT00866658|66711349|FG001|Overall Study|Protocol Violation|1|||
23817438|NCT00866658|66711348|FG000|Overall Study|Familial and Personal Reasons|4|||
23817439|NCT00866658|66711349|FG001|Overall Study|Familial and Personal Reasons|5|||
23817440|NCT05478252|66711350|FG000|Overall Study|Withdrawal by Subject|2|||
23817441|NCT05478252|66711351|FG001|Overall Study|Withdrawal by Subject|3|||
23817442|NCT05478252|66711350|FG000|Overall Study|Lost to Follow-up|4|||
23817443|NCT05478252|66711351|FG001|Overall Study|Lost to Follow-up|2|||
23817444|NCT05478252|66711350|FG000|Overall Study|Physician Decision|1|||
23817445|NCT05478252|66711351|FG001|Overall Study|Physician Decision|1|||
23817446|NCT05478252|66711350|FG000|Overall Study|Death|1|||
23817447|NCT05478252|66711351|FG001|Overall Study|Death|0|||
23817448|NCT00879411|66711352|FG000|Overall Study|lost to follow-up (non-AE)|162|||
23817449|NCT00660400|66711358|FG000|Overall Study|Lack of insurance approval|1|||
23817450|NCT00660400|66711358|FG000|Overall Study|Suboptimal organ function|1|||
23817451|NCT00660400|66711358|FG000|Overall Study|Intracranial hemorrhage|1|||
23543014|NCT00558285|65716150|FG003|Overall Study|Protocol deviation|1|||
23817452|NCT00660400|66711358|FG000|Overall Study|Withdrawal by Subject|1|||
23817453|NCT02927366|66711361|FG000|Overall Study|Adverse Event|1|||
23817454|NCT02927366|66711362|FG001|Overall Study|Adverse Event|0|||
23817455|NCT02927366|66711361|FG000|Overall Study|Patient schedule|1|||
23817456|NCT02927366|66711362|FG001|Overall Study|Patient schedule|0|||
23817457|NCT02278055|66711363|FG000|Overall Study|Adverse Event|1|||
23817458|NCT02278055|66711363|FG000|Overall Study|Lost to Follow-up|1|||
23817459|NCT02278055|66711363|FG000|Overall Study|Withdrawal by Subject|2|||
23817460|NCT02278055|66711363|FG000|Overall Study|Progressive Disease|4|||
23817461|NCT03654599|66711364|FG000|Overall Study|Lost to Follow-up|14|||
23817462|NCT03654599|66711365|FG001|Overall Study|Lost to Follow-up|12|||
23817463|NCT03654599|66711364|FG000|Overall Study|Death|8|||
23817464|NCT03654599|66711365|FG001|Overall Study|Death|6|||
23817465|NCT03654599|66711364|FG000|Overall Study|Withdrawal by Subject|6|||
23817466|NCT03654599|66711365|FG001|Overall Study|Withdrawal by Subject|4|||
23817467|NCT00605540|66711375|FG000|Overall Study|Death|15|||
23424809|NCT03023826|65299757|FG005|Period 1|Withdrawal by Subject|0|||
23424810|NCT04465877|65299763|FG000|Overall Study|Noncompliant with study requirements|0|||
23543015|NCT00558285|65716151|FG004|Overall Study|Protocol deviation|0|||
23543016|NCT02055352|65716152|FG000|Overall Study|Adverse Event|0|||
23543017|NCT02055352|65716153|FG001|Overall Study|Adverse Event|1|||
23543018|NCT02055352|65716152|FG000|Overall Study|Non-eligible|0|||
23543019|NCT02055352|65716153|FG001|Overall Study|Non-eligible|1|||
23543020|NCT02055352|65716152|FG000|Overall Study|Poor compliance|1|||
23543021|NCT02055352|65716153|FG001|Overall Study|Poor compliance|1|||
23543022|NCT02055352|65716152|FG000|Overall Study|Death|1|||
23543023|NCT02055352|65716153|FG001|Overall Study|Death|2|||
23543024|NCT02055352|65716152|FG000|Overall Study|Patient decision|1|||
23543025|NCT02055352|65716153|FG001|Overall Study|Patient decision|1|||
23543026|NCT02055352|65716152|FG000|Overall Study|Use of prohibited treatment|0|||
23543027|NCT02055352|65716153|FG001|Overall Study|Use of prohibited treatment|3|||
23543028|NCT02055352|65716152|FG000|Overall Study|AE, study drug would be detrimental|1|||
23543029|NCT02055352|65716153|FG001|Overall Study|AE, study drug would be detrimental|3|||
23543030|NCT02055352|65716152|FG000|Overall Study|Withdrawal of informed consent|1|||
23543031|NCT02055352|65716153|FG001|Overall Study|Withdrawal of informed consent|0|||
23543032|NCT02055352|65716152|FG000|Overall Study|Reason unknown|1|||
23543033|NCT02055352|65716153|FG001|Overall Study|Reason unknown|5|||
23543034|NCT00766376|65716154|FG000|Overall Study|Withdrawal by Subject|27|||
23543035|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
23543036|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
23543037|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
23543038|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
23543039|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
23424811|NCT04465877|65299764|FG001|Overall Study|Noncompliant with study requirements|0|||
23424812|NCT04465877|65299765|FG002|Overall Study|Noncompliant with study requirements|1|||
23424813|NCT04465877|65299766|FG003|Overall Study|Noncompliant with study requirements|0|||
23424814|NCT01457950|65299767|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
23424815|NCT01457950|65299768|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424816|NCT01457950|65299769|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424817|NCT01457950|65299770|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424818|NCT01457950|65299767|FG000|Double-Blind Phase|Protocol Violation|2|||
23424819|NCT01457950|65299768|FG001|Double-Blind Phase|Protocol Violation|1|||
23424820|NCT01457950|65299769|FG002|Double-Blind Phase|Protocol Violation|0|||
23424821|NCT01457950|65299770|FG003|Double-Blind Phase|Protocol Violation|0|||
23424822|NCT01457950|65299767|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
23424823|NCT01457950|65299768|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
23424824|NCT01457950|65299769|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23424825|NCT01457950|65299770|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23424826|NCT01457950|65299767|FG000|Open-Label Phase|Adverse Event|0|||
23424827|NCT01457950|65299768|FG001|Open-Label Phase|Adverse Event|0|||
23424828|NCT01457950|65299769|FG002|Open-Label Phase|Adverse Event|0|||
23424829|NCT01457950|65299770|FG003|Open-Label Phase|Adverse Event|1|||
23424830|NCT01457950|65299767|FG000|Open-Label Phase|Protocol Violation|0|||
23424831|NCT01457950|65299768|FG001|Open-Label Phase|Protocol Violation|0|||
23424832|NCT01457950|65299769|FG002|Open-Label Phase|Protocol Violation|0|||
23424833|NCT01457950|65299770|FG003|Open-Label Phase|Protocol Violation|1|||
23424834|NCT01457950|65299767|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23424835|NCT01457950|65299768|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23424836|NCT01457950|65299769|FG002|Open-Label Phase|Withdrawal by Subject|2|||
23424837|NCT01457950|65299770|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23424838|NCT01703117|65299771|FG000|Overall Study|Adverse Event|4|||
23543040|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
23543041|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
23543042|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
23543043|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
23543044|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
23817468|NCT00605540|66711375|FG000|Overall Study|Lost to Follow-up|23|||
23817469|NCT01059344|66711376|FG000|Overall Study|Adverse Event|12|||
23817470|NCT01059344|66711377|FG001|Overall Study|Adverse Event|30|||
23424839|NCT01703117|65299772|FG001|Overall Study|Adverse Event|3|||
23424840|NCT01703117|65299771|FG000|Overall Study|Withdrawal by Subject|0|||
23424841|NCT01703117|65299772|FG001|Overall Study|Withdrawal by Subject|1|||
23424842|NCT03385265|65299773|FG000|Overall Study|Withdrawal by Subject|5|||
23424843|NCT03385265|65299774|FG001|Overall Study|Withdrawal by Subject|2|||
23817471|NCT01059344|66711376|FG000|Overall Study|Withdrawal by Subject|6|||
23817472|NCT01059344|66711377|FG001|Overall Study|Withdrawal by Subject|9|||
23817473|NCT01059344|66711376|FG000|Overall Study|Lost to Follow-up|1|||
23817474|NCT01059344|66711377|FG001|Overall Study|Lost to Follow-up|1|||
23817475|NCT01059344|66711376|FG000|Overall Study|Other|3|||
23817476|NCT01059344|66711377|FG001|Overall Study|Other|6|||
23817477|NCT04710979|66711381|FG000|Overall Study|Lost to Follow-up|2|||
23817478|NCT04710979|66711382|FG001|Overall Study|Lost to Follow-up|4|||
23817479|NCT04710979|66711381|FG000|Overall Study|Withdrawal by Subject|1|||
23817480|NCT04710979|66711382|FG001|Overall Study|Withdrawal by Subject|0|||
23817481|NCT00552578|66711383|FG000|Overall Study|Lost to Follow-up|1|||
23817482|NCT00552578|66711384|FG001|Overall Study|Lost to Follow-up|1|||
23817483|NCT04839692|66711386|FG000|Overall Study|Withdrawal by Subject|0|||
23817484|NCT04839692|66711387|FG001|Overall Study|Withdrawal by Subject|3|||
23817485|NCT04839692|66711386|FG000|Overall Study|Physician Decision|1|||
23817486|NCT04839692|66711387|FG001|Overall Study|Physician Decision|0|||
23817487|NCT00908310|66711391|FG000|Overall Study|Death|37|||
23817488|NCT00908310|66711391|FG000|Overall Study|Withdrawal by Subject|7|||
23817489|NCT00908310|66711391|FG000|Overall Study|Lost to Follow-up|7|||
23817490|NCT00908310|66711391|FG000|Overall Study|Screening failure|5|||
23817491|NCT00908310|66711391|FG000|Overall Study|Other reasons|4|||
23817492|NCT01137071|66711392|FG000|Overall Study|Disease Progression|11|||
23817493|NCT01137071|66711392|FG000|Overall Study|Withdrawal by Subject|2|||
23817494|NCT01137071|66711392|FG000|Overall Study|Wrongly Included|1|||
23817495|NCT01866098|66711393|FG000|Overall Study|Lost to Follow-up|11|||
23817496|NCT01866098|66711394|FG001|Overall Study|Lost to Follow-up|18|||
23817497|NCT01866098|66711395|FG002|Overall Study|Lost to Follow-up|13|||
23817498|NCT01866098|66711393|FG000|Overall Study|Physician Decision|0|||
23817499|NCT01866098|66711394|FG001|Overall Study|Physician Decision|1|||
23817500|NCT01866098|66711395|FG002|Overall Study|Physician Decision|2|||
23817501|NCT01866098|66711393|FG000|Overall Study|Adverse Event|1|||
23817502|NCT01866098|66711394|FG001|Overall Study|Adverse Event|5|||
23817503|NCT01866098|66711395|FG002|Overall Study|Adverse Event|4|||
23817504|NCT01866098|66711393|FG000|Overall Study|Protocol Violation|1|||
23817505|NCT01866098|66711394|FG001|Overall Study|Protocol Violation|0|||
23817506|NCT01866098|66711395|FG002|Overall Study|Protocol Violation|0|||
23817507|NCT01866098|66711393|FG000|Overall Study|Withdrawal by Subject|1|||
23817508|NCT01866098|66711394|FG001|Overall Study|Withdrawal by Subject|2|||
23817509|NCT01866098|66711395|FG002|Overall Study|Withdrawal by Subject|0|||
23817510|NCT01866098|66711393|FG000|Overall Study|Unrelated Hospitalization|2|||
23817511|NCT01866098|66711394|FG001|Overall Study|Unrelated Hospitalization|0|||
23817512|NCT01866098|66711395|FG002|Overall Study|Unrelated Hospitalization|1|||
23817513|NCT01866098|66711393|FG000|Overall Study|Non-compliance|1|||
23817514|NCT01866098|66711394|FG001|Overall Study|Non-compliance|0|||
23817515|NCT01866098|66711395|FG002|Overall Study|Non-compliance|1|||
23817516|NCT01866098|66711393|FG000|Overall Study|Pregnancy|2|||
23817517|NCT01866098|66711394|FG001|Overall Study|Pregnancy|0|||
23543045|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
23543046|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
23543047|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
23543048|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
23543049|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
23543050|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
23543051|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
23543052|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
23543053|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
23543054|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
23543055|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
23543056|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
23543057|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
23543058|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
23817518|NCT01866098|66711395|FG002|Overall Study|Pregnancy|0|||
23817519|NCT01866098|66711393|FG000|Overall Study|Death|0|||
23817520|NCT01866098|66711394|FG001|Overall Study|Death|1|||
23817521|NCT01866098|66711395|FG002|Overall Study|Death|0|||
23817522|NCT03196635|66711396|FG000|Overall Study|Withdrawal by Subject|1|||
23817523|NCT00789737|66711399|FG000|Overall Study|Withdrawal by Subject|13|||
23817524|NCT00789737|66711400|FG001|Overall Study|Withdrawal by Subject|22|||
23817525|NCT00789737|66711399|FG000|Overall Study|Lost to Follow-up|10|||
23817526|NCT00789737|66711400|FG001|Overall Study|Lost to Follow-up|14|||
23817527|NCT00789737|66711399|FG000|Overall Study|Adverse Event|8|||
23543059|NCT02161718|65719718|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
23543060|NCT02161718|65719719|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
23817528|NCT00789737|66711400|FG001|Overall Study|Adverse Event|8|||
23817529|NCT00789737|66711399|FG000|Overall Study|Protocol Violation|3|||
23817530|NCT00789737|66711400|FG001|Overall Study|Protocol Violation|0|||
23817531|NCT00789737|66711399|FG000|Overall Study|Lack of Efficacy|3|||
23817532|NCT00789737|66711400|FG001|Overall Study|Lack of Efficacy|0|||
23543061|NCT02161718|65719720|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
23543062|NCT02161718|65719718|FG000|Post- Randomization Period|Lost to Follow-up|0|||
23543063|NCT02161718|65719719|FG001|Post- Randomization Period|Lost to Follow-up|9|||
23543064|NCT02161718|65719720|FG002|Post- Randomization Period|Lost to Follow-up|15|||
23543065|NCT02161718|65719718|FG000|Post- Randomization Period|Adverse Event|0|||
23543066|NCT02161718|65719719|FG001|Post- Randomization Period|Adverse Event|9|||
23543067|NCT02161718|65719720|FG002|Post- Randomization Period|Adverse Event|10|||
23543068|NCT02161718|65719718|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
23543069|NCT02161718|65719719|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
23543070|NCT02161718|65719720|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
23543071|NCT02161718|65719718|FG000|Post- Randomization Period|Physician Decision|0|||
23543072|NCT02161718|65719719|FG001|Post- Randomization Period|Physician Decision|2|||
23543073|NCT02161718|65719720|FG002|Post- Randomization Period|Physician Decision|4|||
23543074|NCT02161718|65719718|FG000|Post- Randomization Period|Protocol Violation|0|||
23543075|NCT02161718|65719719|FG001|Post- Randomization Period|Protocol Violation|2|||
23543076|NCT02161718|65719720|FG002|Post- Randomization Period|Protocol Violation|3|||
23543077|NCT02161718|65719718|FG000|Post- Randomization Period|Lack of Efficacy|0|||
23543078|NCT02161718|65719719|FG001|Post- Randomization Period|Lack of Efficacy|0|||
23543079|NCT02161718|65719720|FG002|Post- Randomization Period|Lack of Efficacy|1|||
23543080|NCT02161718|65719718|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
23543081|NCT02161718|65719719|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
23543082|NCT02161718|65719720|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
23543083|NCT02161718|65719718|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
23543084|NCT02161718|65719719|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
23543085|NCT02161718|65719720|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
23543086|NCT02161718|65719718|FG000|Post- Randomization Period|Relocation|0|||
23543087|NCT02161718|65719719|FG001|Post- Randomization Period|Relocation|3|||
23543088|NCT02161718|65719720|FG002|Post- Randomization Period|Relocation|0|||
23543089|NCT03538626|65719724|FG000|Overall Study|Withdrawal by Subject|0|||
23543090|NCT03538626|65719725|FG001|Overall Study|Withdrawal by Subject|1|||
23728616|NCT01641081|66384869|FG008|Period 5|Adverse Event|0|||
23728617|NCT01641081|66384870|FG009|Period 5|Adverse Event|0|||
23728618|NCT02100813|66384871|FG000|Overall Study|Adverse Event|0|||
23728619|NCT02100813|66384872|FG001|Overall Study|Adverse Event|0|||
23728620|NCT02100813|66384873|FG002|Overall Study|Adverse Event|0|||
23728621|NCT02100813|66384874|FG003|Overall Study|Adverse Event|0|||
23728622|NCT02100813|66384875|FG004|Overall Study|Adverse Event|0|||
23728623|NCT02100813|66384876|FG005|Overall Study|Adverse Event|0|||
23728624|NCT02100813|66384877|FG006|Overall Study|Adverse Event|0|||
23728625|NCT02100813|66384878|FG007|Overall Study|Adverse Event|1|||
23728626|NCT01473355|66384888|FG000|Overall Study|Protocol Violation|2|||
23728627|NCT01473355|66384888|FG000|Overall Study|Adverse Event|2|||
23728628|NCT01473355|66384888|FG000|Overall Study|Lost to Follow-up|2|||
23728629|NCT00402285|66384890|FG000|Overall Study|insufficient RNA quality|7|||
23728630|NCT00402285|66384891|FG001|Overall Study|insufficient RNA quality|6|||
23728631|NCT00402285|66384892|FG002|Overall Study|insufficient RNA quality|2|||
23728632|NCT00430027|66384898|FG000|Overall Study|Study terminated|8|||
23728633|NCT01976624|66384899|FG000|Overall Study|Participants contraindicated|2|||
23728634|NCT01976624|66384899|FG000|Overall Study|Participants age less than 19 years|12|||
23728635|NCT03518034|66384900|FG000|Overall Study|Not Treated|5|||
23728636|NCT03518034|66384901|FG001|Overall Study|Not Treated|1|||
23728637|NCT03518034|66384900|FG000|Overall Study|Withdrawal by Subject|309|||
23728638|NCT03518034|66384901|FG001|Overall Study|Withdrawal by Subject|351|||
23728639|NCT03518034|66384900|FG000|Overall Study|Lost to Follow-up|446|||
23728640|NCT03518034|66384901|FG001|Overall Study|Lost to Follow-up|458|||
23728641|NCT03518034|66384900|FG000|Overall Study|Adverse Event|138|||
23728642|NCT03518034|66384901|FG001|Overall Study|Adverse Event|130|||
23728643|NCT03518034|66384900|FG000|Overall Study|Lack of Efficacy|11|||
23728644|NCT03518034|66384901|FG001|Overall Study|Lack of Efficacy|23|||
23728645|NCT03518034|66384900|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
23424844|NCT03385265|65299775|FG002|Overall Study|Withdrawal by Subject|5|||
23543091|NCT03538626|65719726|FG002|Overall Study|Withdrawal by Subject|0|||
23543092|NCT03538626|65719727|FG003|Overall Study|Withdrawal by Subject|0|||
23543093|NCT03538626|65719728|FG004|Overall Study|Withdrawal by Subject|0|||
23543094|NCT03538626|65719729|FG005|Overall Study|Withdrawal by Subject|0|||
23543095|NCT03538626|65719730|FG006|Overall Study|Withdrawal by Subject|0|||
23543096|NCT03538626|65719731|FG007|Overall Study|Withdrawal by Subject|0|||
23543097|NCT03538626|65719724|FG000|Overall Study|Lost to Follow-up|0|||
23543098|NCT03538626|65719725|FG001|Overall Study|Lost to Follow-up|0|||
23543099|NCT03538626|65719726|FG002|Overall Study|Lost to Follow-up|0|||
23728646|NCT03518034|66384901|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
23728647|NCT03518034|66384900|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
23728648|NCT03518034|66384901|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
23543100|NCT03538626|65719727|FG003|Overall Study|Lost to Follow-up|0|||
23543101|NCT03538626|65719728|FG004|Overall Study|Lost to Follow-up|0|||
23543102|NCT03538626|65719729|FG005|Overall Study|Lost to Follow-up|0|||
23424845|NCT03385265|65299776|FG003|Overall Study|Withdrawal by Subject|2|||
23424846|NCT02813668|65299780|FG000|Overall Study|Death|4|||
23424847|NCT02813668|65299780|FG000|Overall Study|Lost to Follow-up|509|||
23424848|NCT02813668|65299780|FG000|Overall Study|Withdrawal by Subject|148|||
23424849|NCT02813668|65299780|FG000|Overall Study|No longer at worksite|85|||
23424850|NCT02813668|65299780|FG000|Overall Study|Medical reasons not related to the study|4|||
23424851|NCT03554772|65299781|FG000|Overall Study|Lost to Follow-up|0|||
23424852|NCT03554772|65299782|FG001|Overall Study|Lost to Follow-up|0|||
23424853|NCT03554772|65299783|FG002|Overall Study|Lost to Follow-up|0|||
23424854|NCT03554772|65299784|FG003|Overall Study|Lost to Follow-up|2|||
23728649|NCT03518034|66384900|FG000|Overall Study|Other, Not Specified|84|||
23728650|NCT03518034|66384901|FG001|Overall Study|Other, Not Specified|53|||
23728651|NCT03518034|66384900|FG000|Overall Study|Reason Missing|2|||
23424855|NCT02229214|65299785|FG000|Overall Study|Adverse Event|2|||
23424856|NCT02229214|65299786|FG001|Overall Study|Adverse Event|0|||
23424857|NCT02229214|65299785|FG000|Overall Study|Withdrawal by Subject|4|||
23543103|NCT03538626|65719730|FG006|Overall Study|Lost to Follow-up|1|||
23543104|NCT03538626|65719731|FG007|Overall Study|Lost to Follow-up|0|||
23543105|NCT01202773|65719732|FG000|Overall Study|Adverse Event|4|||
23543106|NCT01202773|65719733|FG001|Overall Study|Adverse Event|5|||
23543107|NCT01202773|65719734|FG002|Overall Study|Adverse Event|5|||
23543108|NCT01202773|65719732|FG000|Overall Study|Lack of Efficacy|5|||
23543109|NCT01202773|65719733|FG001|Overall Study|Lack of Efficacy|4|||
23543110|NCT01202773|65719734|FG002|Overall Study|Lack of Efficacy|9|||
23424858|NCT02229214|65299786|FG001|Overall Study|Withdrawal by Subject|0|||
23424859|NCT01442064|65299789|FG000|Overall Study|Adverse Event|2|||
23424860|NCT01442064|65299790|FG001|Overall Study|Adverse Event|2|||
23424861|NCT01442064|65299791|FG002|Overall Study|Adverse Event|2|||
23424862|NCT01442064|65299792|FG003|Overall Study|Adverse Event|1|||
23424863|NCT01442064|65299793|FG004|Overall Study|Adverse Event|2|||
23424864|NCT01442064|65299794|FG005|Overall Study|Adverse Event|0|||
23424865|NCT01442064|65299789|FG000|Overall Study|Death|0|||
23424866|NCT01442064|65299790|FG001|Overall Study|Death|1|||
23424867|NCT01442064|65299791|FG002|Overall Study|Death|3|||
23424868|NCT01442064|65299792|FG003|Overall Study|Death|3|||
23424869|NCT01442064|65299793|FG004|Overall Study|Death|1|||
23424870|NCT01442064|65299794|FG005|Overall Study|Death|3|||
23424871|NCT01442064|65299789|FG000|Overall Study|Lost to Follow-up|5|||
23424872|NCT01442064|65299790|FG001|Overall Study|Lost to Follow-up|5|||
23424873|NCT01442064|65299791|FG002|Overall Study|Lost to Follow-up|1|||
23424874|NCT01442064|65299792|FG003|Overall Study|Lost to Follow-up|1|||
23424875|NCT01442064|65299793|FG004|Overall Study|Lost to Follow-up|3|||
23424876|NCT01442064|65299794|FG005|Overall Study|Lost to Follow-up|3|||
23424877|NCT01442064|65299789|FG000|Overall Study|Physician Decision|1|||
23424878|NCT01442064|65299790|FG001|Overall Study|Physician Decision|1|||
23424879|NCT01442064|65299791|FG002|Overall Study|Physician Decision|2|||
23424880|NCT01442064|65299792|FG003|Overall Study|Physician Decision|3|||
23424881|NCT01442064|65299793|FG004|Overall Study|Physician Decision|3|||
23424882|NCT01442064|65299794|FG005|Overall Study|Physician Decision|1|||
23424883|NCT01442064|65299789|FG000|Overall Study|Withdrawal by Subject|6|||
23424884|NCT01442064|65299790|FG001|Overall Study|Withdrawal by Subject|3|||
23424885|NCT01442064|65299791|FG002|Overall Study|Withdrawal by Subject|2|||
23424886|NCT01442064|65299792|FG003|Overall Study|Withdrawal by Subject|2|||
23424887|NCT01442064|65299793|FG004|Overall Study|Withdrawal by Subject|2|||
23424888|NCT01442064|65299794|FG005|Overall Study|Withdrawal by Subject|1|||
23424889|NCT01442064|65299789|FG000|Overall Study|Sponsor decision|82|||
23424890|NCT01442064|65299790|FG001|Overall Study|Sponsor decision|88|||
23424891|NCT01442064|65299791|FG002|Overall Study|Sponsor decision|92|||
23424892|NCT01442064|65299792|FG003|Overall Study|Sponsor decision|88|||
23424893|NCT01442064|65299793|FG004|Overall Study|Sponsor decision|95|||
23424894|NCT01442064|65299794|FG005|Overall Study|Sponsor decision|87|||
23424895|NCT01442064|65299789|FG000|Overall Study|Subject non-compliance|0|||
23424896|NCT01442064|65299790|FG001|Overall Study|Subject non-compliance|0|||
23424897|NCT01442064|65299791|FG002|Overall Study|Subject non-compliance|0|||
23543111|NCT01202773|65719732|FG000|Overall Study|Entry Criteria Not Met|2|||
23543112|NCT01202773|65719733|FG001|Overall Study|Entry Criteria Not Met|0|||
23543113|NCT01202773|65719734|FG002|Overall Study|Entry Criteria Not Met|1|||
23543114|NCT01202773|65719732|FG000|Overall Study|Lost to Follow-up|1|||
23543115|NCT01202773|65719733|FG001|Overall Study|Lost to Follow-up|2|||
23543116|NCT01202773|65719734|FG002|Overall Study|Lost to Follow-up|2|||
23424898|NCT01442064|65299792|FG003|Overall Study|Subject non-compliance|0|||
23424899|NCT01442064|65299793|FG004|Overall Study|Subject non-compliance|0|||
23543117|NCT01202773|65719732|FG000|Overall Study|Withdrawal by Subject|13|||
23424900|NCT01442064|65299794|FG005|Overall Study|Subject non-compliance|2|||
23424901|NCT01442064|65299789|FG000|Overall Study|Condition mandated other intervention|1|||
23424902|NCT01442064|65299790|FG001|Overall Study|Condition mandated other intervention|1|||
23543118|NCT01202773|65719733|FG001|Overall Study|Withdrawal by Subject|6|||
23424903|NCT01442064|65299791|FG002|Overall Study|Condition mandated other intervention|2|||
23424904|NCT01442064|65299792|FG003|Overall Study|Condition mandated other intervention|0|||
23424905|NCT01442064|65299793|FG004|Overall Study|Condition mandated other intervention|0|||
23424906|NCT01442064|65299794|FG005|Overall Study|Condition mandated other intervention|2|||
23424907|NCT03627065|65299795|FG000|Overall Study|Study Terminated by sponsor|1|||
23424908|NCT03627065|65299795|FG000|Overall Study|Withdrawal by Subject|2|||
23424909|NCT05028517|65299796|FG000|Overall Study|Lost to Follow-up|13|||
23424910|NCT05028517|65299797|FG001|Overall Study|Lost to Follow-up|20|||
23424911|NCT05028517|65299798|FG002|Overall Study|Lost to Follow-up|12|||
23424912|NCT05028517|65299796|FG000|Overall Study|Withdrawal by Subject|0|||
23424913|NCT05028517|65299797|FG001|Overall Study|Withdrawal by Subject|0|||
23424914|NCT05028517|65299798|FG002|Overall Study|Withdrawal by Subject|1|||
23424915|NCT02485925|65299799|FG000|Overall Study|Withdrawal by Subject|3|||
23424916|NCT02485925|65299799|FG000|Overall Study|Death|1|||
23424917|NCT02485925|65299799|FG000|Overall Study|Lost to Follow-up|11|||
23424918|NCT01154283|65299800|FG000|0-6 Weeks|Withdrawal by Subject|7|||
23424919|NCT01154283|65299801|FG001|0-6 Weeks|Withdrawal by Subject|2|||
23424920|NCT01154283|65299800|FG000|0-6 Weeks|Death|0|||
23424921|NCT01154283|65299801|FG001|0-6 Weeks|Death|1|||
23424922|NCT01154283|65299800|FG000|7-12 Weeks|Death|1|||
23424923|NCT01154283|65299801|FG001|7-12 Weeks|Death|0|||
23424924|NCT01154283|65299800|FG000|7-12 Weeks|Withdrawal by Subject|0|||
23424925|NCT01154283|65299801|FG001|7-12 Weeks|Withdrawal by Subject|1|||
23424926|NCT01920893|65299803|FG000|Overall Study|Adverse Event|5|||
23424927|NCT01920893|65299804|FG001|Overall Study|Adverse Event|2|||
23424928|NCT01920893|65299803|FG000|Overall Study|Lack of Efficacy|2|||
23424929|NCT01920893|65299804|FG001|Overall Study|Lack of Efficacy|0|||
23424930|NCT00623545|65299805|FG000|Overall Study|Adverse Event|6|||
23424931|NCT00623545|65299805|FG000|Overall Study|Withdrawal by Subject|4|||
23424932|NCT02825420|65299806|FG000|Overall Study|Death|30|||
23424933|NCT02825420|65299807|FG001|Overall Study|Death|12|||
23424934|NCT02825420|65299806|FG000|Overall Study|Progressive disease|6|||
23424935|NCT02825420|65299807|FG001|Overall Study|Progressive disease|1|||
23424936|NCT02825420|65299806|FG000|Overall Study|Lost to Follow-up|2|||
23424937|NCT02825420|65299807|FG001|Overall Study|Lost to Follow-up|2|||
23424938|NCT02825420|65299806|FG000|Overall Study|Withdrawal by Subject|1|||
23424939|NCT02825420|65299807|FG001|Overall Study|Withdrawal by Subject|1|||
23424940|NCT02825420|65299806|FG000|Overall Study|Protocol amendment not signed|1|||
23424941|NCT02825420|65299807|FG001|Overall Study|Protocol amendment not signed|1|||
23424942|NCT02825420|65299806|FG000|Overall Study|Physician Decision|1|||
23424943|NCT02825420|65299807|FG001|Overall Study|Physician Decision|0|||
23424944|NCT02825420|65299806|FG000|Overall Study|Did not receive PLD|2|||
23424945|NCT02825420|65299807|FG001|Overall Study|Did not receive PLD|0|||
23424946|NCT00495521|65299808|FG000|Overall Study|Physician Decision|0|||
23424947|NCT00495521|65299809|FG001|Overall Study|Physician Decision|1|||
23424948|NCT01165320|65299810|FG000|Overall Study|Clinical adverse experience|2|||
23424949|NCT01165320|65299811|FG001|Overall Study|Clinical adverse experience|1|||
23424950|NCT01165320|65299812|FG002|Overall Study|Clinical adverse experience|0|||
23424951|NCT01165320|65299810|FG000|Overall Study|Laboratory adverse experience|1|||
23424952|NCT01165320|65299811|FG001|Overall Study|Laboratory adverse experience|0|||
23424953|NCT01165320|65299812|FG002|Overall Study|Laboratory adverse experience|0|||
23424954|NCT01165320|65299810|FG000|Overall Study|Lack of Efficacy|0|||
23424955|NCT01165320|65299811|FG001|Overall Study|Lack of Efficacy|2|||
23424956|NCT01165320|65299812|FG002|Overall Study|Lack of Efficacy|0|||
23424957|NCT01165320|65299810|FG000|Overall Study|Reason unknown|0|||
23424958|NCT01165320|65299811|FG001|Overall Study|Reason unknown|1|||
23424959|NCT01165320|65299812|FG002|Overall Study|Reason unknown|0|||
23424960|NCT02046174|65299813|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
23424961|NCT02046174|65299814|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
23424962|NCT02275117|65299815|FG000|Overall Study|Adverse Event|0|||
23424963|NCT02275117|65299816|FG001|Overall Study|Adverse Event|0|||
23424964|NCT02275117|65299817|FG002|Overall Study|Adverse Event|0|||
23424965|NCT02275117|65299818|FG003|Overall Study|Adverse Event|0|||
23424966|NCT02275117|65299819|FG004|Overall Study|Adverse Event|1|||
23424967|NCT02275117|65299815|FG000|Overall Study|Lack of Efficacy|6|||
23424968|NCT02275117|65299816|FG001|Overall Study|Lack of Efficacy|7|||
23424969|NCT02275117|65299817|FG002|Overall Study|Lack of Efficacy|5|||
23424970|NCT02275117|65299818|FG003|Overall Study|Lack of Efficacy|2|||
23424971|NCT02275117|65299819|FG004|Overall Study|Lack of Efficacy|10|||
23424972|NCT02275117|65299815|FG000|Overall Study|Lost to Follow-up|11|||
23424973|NCT02275117|65299816|FG001|Overall Study|Lost to Follow-up|16|||
23424974|NCT02275117|65299817|FG002|Overall Study|Lost to Follow-up|15|||
23424975|NCT02275117|65299818|FG003|Overall Study|Lost to Follow-up|16|||
23424976|NCT02275117|65299819|FG004|Overall Study|Lost to Follow-up|8|||
23424977|NCT02275117|65299815|FG000|Overall Study|Physician Decision|0|||
23424978|NCT02275117|65299816|FG001|Overall Study|Physician Decision|1|||
23424979|NCT02275117|65299817|FG002|Overall Study|Physician Decision|1|||
23424980|NCT02275117|65299818|FG003|Overall Study|Physician Decision|0|||
23424981|NCT02275117|65299819|FG004|Overall Study|Physician Decision|1|||
23543119|NCT01202773|65719734|FG002|Overall Study|Withdrawal by Subject|5|||
23543120|NCT01202773|65719732|FG000|Overall Study|Physician Decision|2|||
23543121|NCT01202773|65719733|FG001|Overall Study|Physician Decision|0|||
23543122|NCT01202773|65719734|FG002|Overall Study|Physician Decision|0|||
23543123|NCT01202773|65719732|FG000|Overall Study|Protocol Violation|11|||
23543124|NCT01202773|65719733|FG001|Overall Study|Protocol Violation|6|||
23543125|NCT01202773|65719734|FG002|Overall Study|Protocol Violation|10|||
23543126|NCT01202773|65719732|FG000|Overall Study|Sponsor Decision|19|||
23543127|NCT01202773|65719733|FG001|Overall Study|Sponsor Decision|20|||
23543128|NCT01202773|65719734|FG002|Overall Study|Sponsor Decision|23|||
23543129|NCT02647658|65719735|FG000|Overall Study|Consent refusal|15|||
23543130|NCT02647658|65719736|FG001|Overall Study|Consent refusal|24|||
23543131|NCT01925183|65719737|FG000|Overall Study|Adverse Event|1|||
23543132|NCT01925183|65719738|FG001|Overall Study|Adverse Event|0|||
23728652|NCT03518034|66384901|FG001|Overall Study|Reason Missing|3|||
23728653|NCT00537771|66384908|FG000|Overall Study|Withdrawal by Subject|6|||
23728654|NCT00537771|66384909|FG001|Overall Study|Withdrawal by Subject|23|||
23728655|NCT00537771|66384908|FG000|Overall Study|Adverse Event|8|||
23543133|NCT03387852|65719739|FG000|Overall Study|Adverse event (AE)|3|||
23543134|NCT03387852|65719740|FG001|Overall Study|Adverse event (AE)|0|||
23616690|NCT02256488|65982408|FG000|Overall Study|Lost to Follow-up|6|||
23728656|NCT00537771|66384909|FG001|Overall Study|Adverse Event|15|||
23728657|NCT00537771|66384908|FG000|Overall Study|Lost to Follow-up|9|||
23728658|NCT00537771|66384909|FG001|Overall Study|Lost to Follow-up|15|||
23728659|NCT00537771|66384908|FG000|Overall Study|Protocol Violation|2|||
23728660|NCT00537771|66384909|FG001|Overall Study|Protocol Violation|6|||
23728661|NCT00537771|66384908|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23424982|NCT02275117|65299815|FG000|Overall Study|Protocol Violation|1|||
23424983|NCT02275117|65299816|FG001|Overall Study|Protocol Violation|0|||
23424984|NCT02275117|65299817|FG002|Overall Study|Protocol Violation|1|||
23424985|NCT02275117|65299818|FG003|Overall Study|Protocol Violation|1|||
23424986|NCT02275117|65299819|FG004|Overall Study|Protocol Violation|0|||
23424987|NCT02275117|65299815|FG000|Overall Study|Withdrawal by Subject|6|||
23424988|NCT02275117|65299816|FG001|Overall Study|Withdrawal by Subject|4|||
23424989|NCT02275117|65299817|FG002|Overall Study|Withdrawal by Subject|7|||
23424990|NCT02275117|65299818|FG003|Overall Study|Withdrawal by Subject|3|||
23424991|NCT02275117|65299819|FG004|Overall Study|Withdrawal by Subject|3|||
23424992|NCT02275117|65299815|FG000|Overall Study|Terminated by Sponsor|4|||
23424993|NCT02275117|65299816|FG001|Overall Study|Terminated by Sponsor|4|||
23424994|NCT02275117|65299817|FG002|Overall Study|Terminated by Sponsor|4|||
23424995|NCT02275117|65299818|FG003|Overall Study|Terminated by Sponsor|6|||
23424996|NCT02275117|65299819|FG004|Overall Study|Terminated by Sponsor|4|||
23424997|NCT02275117|65299815|FG000|Overall Study|Worsening of Study Indication|0|||
23424998|NCT02275117|65299816|FG001|Overall Study|Worsening of Study Indication|1|||
23424999|NCT02275117|65299817|FG002|Overall Study|Worsening of Study Indication|2|||
23425000|NCT02275117|65299818|FG003|Overall Study|Worsening of Study Indication|0|||
23425001|NCT02275117|65299819|FG004|Overall Study|Worsening of Study Indication|0|||
23425002|NCT02275117|65299815|FG000|Overall Study|Study Burden|5|||
23425003|NCT02275117|65299816|FG001|Overall Study|Study Burden|4|||
23425004|NCT02275117|65299817|FG002|Overall Study|Study Burden|7|||
23425005|NCT02275117|65299818|FG003|Overall Study|Study Burden|5|||
23425006|NCT02275117|65299819|FG004|Overall Study|Study Burden|7|||
23425007|NCT02275117|65299815|FG000|Overall Study|Other|1|||
23425008|NCT02275117|65299816|FG001|Overall Study|Other|0|||
23425009|NCT02275117|65299817|FG002|Overall Study|Other|0|||
23425010|NCT02275117|65299818|FG003|Overall Study|Other|0|||
23728662|NCT00537771|66384909|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23728663|NCT02774291|66384914|FG000|Overall Study|Lost to Follow-up|1|||
23728664|NCT01012037|66384915|FG000|Overall Study|Adverse Event|0|||
23728665|NCT01012037|66384916|FG001|Overall Study|Adverse Event|8|||
23728666|NCT01012037|66384917|FG002|Overall Study|Adverse Event|3|||
23728667|NCT01012037|66384915|FG000|Overall Study|Protocol Violation|0|||
23728668|NCT01012037|66384916|FG001|Overall Study|Protocol Violation|3|||
23728669|NCT01012037|66384917|FG002|Overall Study|Protocol Violation|5|||
23425011|NCT02275117|65299819|FG004|Overall Study|Other|2|||
23425012|NCT01294462|65299820|FG000|Overall Study|Lost to Follow-up|1|||
23425013|NCT01294462|65299821|FG001|Overall Study|Lost to Follow-up|0|||
23425014|NCT01294462|65299820|FG000|Overall Study|Withdrawal by Subject|65|||
23425015|NCT01294462|65299821|FG001|Overall Study|Withdrawal by Subject|63|||
23543135|NCT03387852|65719741|FG002|Overall Study|Adverse event (AE)|2|||
23543136|NCT03387852|65719742|FG003|Overall Study|Adverse event (AE)|0|||
23543137|NCT03387852|65719739|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
23543138|NCT03387852|65719740|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
23425016|NCT01344538|65299822|FG000|Overall Study|Adverse Event|1|||
23425017|NCT01344538|65299823|FG001|Overall Study|Adverse Event|1|||
23425018|NCT01344538|65299822|FG000|Overall Study|Lost to Follow-up|1|||
23543139|NCT03387852|65719741|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
23728670|NCT01012037|66384915|FG000|Overall Study|Withdrawal by Subject|0|||
23728671|NCT01012037|66384916|FG001|Overall Study|Withdrawal by Subject|4|||
23817533|NCT00789737|66711399|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
23817534|NCT00789737|66711400|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
23817535|NCT00789737|66711399|FG000|Overall Study|Other|11|||
23817536|NCT00789737|66711400|FG001|Overall Study|Other|7|||
23728672|NCT01012037|66384917|FG002|Overall Study|Withdrawal by Subject|1|||
23728673|NCT01012037|66384915|FG000|Overall Study|Other reason (not specified)|1|||
23728674|NCT01012037|66384916|FG001|Overall Study|Other reason (not specified)|1|||
23728675|NCT01012037|66384917|FG002|Overall Study|Other reason (not specified)|1|||
23728676|NCT01685372|66384925|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
23728677|NCT01685372|66384926|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
23728678|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
23728679|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23728680|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
23728681|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23728682|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
23728683|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23728684|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23728685|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23728686|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
23728687|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23728688|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23728689|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23728690|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
23728691|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
23728692|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
23728693|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
23728694|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
23728695|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
23728696|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23817537|NCT02648932|66711401|FG000|Overall Study|No transplant|3|||
23817538|NCT02648932|66711402|FG001|Overall Study|No transplant|1|||
23817539|NCT00086281|66711405|FG000|Phase 1|Adverse Event|0|||
23817540|NCT00086281|66711406|FG001|Phase 1|Adverse Event|0|||
23817541|NCT00086281|66711407|FG002|Phase 1|Adverse Event|0|||
23817542|NCT00086281|66711408|FG003|Phase 1|Adverse Event|0|||
23817543|NCT00086281|66711409|FG004|Phase 1|Adverse Event|0|||
23817544|NCT00086281|66711410|FG005|Phase 1|Adverse Event|0|||
23817545|NCT00086281|66711411|FG006|Phase 1|Adverse Event|0|||
23817546|NCT00086281|66711412|FG007|Phase 1|Adverse Event|0|||
23817547|NCT00086281|66711413|FG008|Phase 1|Adverse Event|0|||
23817548|NCT00086281|66711414|FG009|Phase 1|Adverse Event|1|||
23817549|NCT00086281|66711415|FG010|Phase 1|Adverse Event|2|||
23817550|NCT00086281|66711416|FG011|Phase 1|Adverse Event|1|||
23817551|NCT00086281|66711417|FG012|Phase 1|Adverse Event|1|||
23817552|NCT00086281|66711418|FG013|Phase 1|Adverse Event|1|||
23817553|NCT00086281|66711419|FG014|Phase 1|Adverse Event|2|||
23817554|NCT00086281|66711405|FG000|Phase 1|Protocol Violation|0|||
23817555|NCT00086281|66711406|FG001|Phase 1|Protocol Violation|0|||
23817556|NCT00086281|66711407|FG002|Phase 1|Protocol Violation|0|||
23817557|NCT00086281|66711408|FG003|Phase 1|Protocol Violation|0|||
23817558|NCT00086281|66711409|FG004|Phase 1|Protocol Violation|0|||
23817559|NCT00086281|66711410|FG005|Phase 1|Protocol Violation|0|||
23817560|NCT00086281|66711411|FG006|Phase 1|Protocol Violation|0|||
23817561|NCT00086281|66711412|FG007|Phase 1|Protocol Violation|0|||
23817562|NCT00086281|66711413|FG008|Phase 1|Protocol Violation|0|||
23817563|NCT00086281|66711414|FG009|Phase 1|Protocol Violation|0|||
23817564|NCT00086281|66711415|FG010|Phase 1|Protocol Violation|1|||
23817565|NCT00086281|66711416|FG011|Phase 1|Protocol Violation|0|||
23817566|NCT00086281|66711417|FG012|Phase 1|Protocol Violation|0|||
23817567|NCT00086281|66711418|FG013|Phase 1|Protocol Violation|0|||
23817568|NCT00086281|66711419|FG014|Phase 1|Protocol Violation|0|||
23616691|NCT02256488|65982409|FG001|Overall Study|Lost to Follow-up|6|||
23817569|NCT00086281|66711405|FG000|Phase 1|Serious Adverse Event|0|||
23817570|NCT00086281|66711406|FG001|Phase 1|Serious Adverse Event|0|||
23817571|NCT00086281|66711407|FG002|Phase 1|Serious Adverse Event|0|||
23728697|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
23817572|NCT00086281|66711408|FG003|Phase 1|Serious Adverse Event|0|||
23817573|NCT00086281|66711409|FG004|Phase 1|Serious Adverse Event|0|||
23425019|NCT01344538|65299823|FG001|Overall Study|Lost to Follow-up|0|||
23616692|NCT02256488|65982410|FG002|Overall Study|Lost to Follow-up|9|||
23817574|NCT00086281|66711410|FG005|Phase 1|Serious Adverse Event|0|||
23817575|NCT00086281|66711411|FG006|Phase 1|Serious Adverse Event|0|||
23817576|NCT00086281|66711412|FG007|Phase 1|Serious Adverse Event|0|||
23817577|NCT00086281|66711413|FG008|Phase 1|Serious Adverse Event|0|||
23817578|NCT00086281|66711414|FG009|Phase 1|Serious Adverse Event|0|||
23817579|NCT00086281|66711415|FG010|Phase 1|Serious Adverse Event|0|||
23817580|NCT00086281|66711416|FG011|Phase 1|Serious Adverse Event|0|||
23728698|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
23728699|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23728700|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23728701|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23728702|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Screen failure|0|||
23728703|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Screen failure|1|||
23728704|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Screen failure|2|||
23728705|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Screen failure|0|||
23728706|NCT02614261|66384927|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
23728707|NCT02614261|66384928|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23728708|NCT02614261|66384929|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
23728709|NCT02614261|66384930|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23728710|NCT02614261|66384927|FG000|Open-Label Extension Phase|Adverse Event|23|||
23728711|NCT02614261|66384928|FG001|Open-Label Extension Phase|Adverse Event|12|||
23728712|NCT02614261|66384929|FG002|Open-Label Extension Phase|Adverse Event|11|||
23728713|NCT02614261|66384930|FG003|Open-Label Extension Phase|Adverse Event|0|||
23728714|NCT02614261|66384927|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
23728715|NCT02614261|66384928|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
23728716|NCT02614261|66384929|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
23728717|NCT02614261|66384930|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
23728718|NCT02614261|66384927|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
23728719|NCT02614261|66384928|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
23728720|NCT02614261|66384929|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
23728721|NCT02614261|66384930|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
23728722|NCT02614261|66384927|FG000|Open-Label Extension Phase|Physician Decision|2|||
23728723|NCT02614261|66384928|FG001|Open-Label Extension Phase|Physician Decision|0|||
23728724|NCT02614261|66384929|FG002|Open-Label Extension Phase|Physician Decision|0|||
23728725|NCT02614261|66384930|FG003|Open-Label Extension Phase|Physician Decision|0|||
23728726|NCT02614261|66384927|FG000|Open-Label Extension Phase|Pregnancy|1|||
23728727|NCT02614261|66384928|FG001|Open-Label Extension Phase|Pregnancy|2|||
23817581|NCT00086281|66711417|FG012|Phase 1|Serious Adverse Event|0|||
23728728|NCT02614261|66384929|FG002|Open-Label Extension Phase|Pregnancy|1|||
23728729|NCT02614261|66384930|FG003|Open-Label Extension Phase|Pregnancy|0|||
23728730|NCT02614261|66384927|FG000|Open-Label Extension Phase|Protocol Violation|3|||
23728731|NCT02614261|66384928|FG001|Open-Label Extension Phase|Protocol Violation|4|||
23728732|NCT02614261|66384929|FG002|Open-Label Extension Phase|Protocol Violation|1|||
23728733|NCT02614261|66384930|FG003|Open-Label Extension Phase|Protocol Violation|0|||
23728734|NCT02614261|66384927|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
23728735|NCT02614261|66384928|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
23728736|NCT02614261|66384929|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
23728737|NCT02614261|66384930|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
23728738|NCT02614261|66384927|FG000|Follow-up Phase|Adverse Event|2|||
23728739|NCT02614261|66384928|FG001|Follow-up Phase|Adverse Event|0|||
23728740|NCT02614261|66384929|FG002|Follow-up Phase|Adverse Event|1|||
23728741|NCT02614261|66384930|FG003|Follow-up Phase|Adverse Event|0|||
23728742|NCT02614261|66384927|FG000|Follow-up Phase|Lost to Follow-up|12|||
23728743|NCT02614261|66384928|FG001|Follow-up Phase|Lost to Follow-up|5|||
23728744|NCT02614261|66384929|FG002|Follow-up Phase|Lost to Follow-up|2|||
23728745|NCT02614261|66384930|FG003|Follow-up Phase|Lost to Follow-up|0|||
23728746|NCT02614261|66384927|FG000|Follow-up Phase|Physician Decision|5|||
23728747|NCT02614261|66384928|FG001|Follow-up Phase|Physician Decision|1|||
23728748|NCT02614261|66384929|FG002|Follow-up Phase|Physician Decision|0|||
23728749|NCT02614261|66384930|FG003|Follow-up Phase|Physician Decision|0|||
23728750|NCT02614261|66384927|FG000|Follow-up Phase|Pregnancy|0|||
23728751|NCT02614261|66384928|FG001|Follow-up Phase|Pregnancy|1|||
23728752|NCT02614261|66384929|FG002|Follow-up Phase|Pregnancy|0|||
23728753|NCT02614261|66384930|FG003|Follow-up Phase|Pregnancy|0|||
23728754|NCT02614261|66384927|FG000|Follow-up Phase|Protocol Violation|1|||
23728755|NCT02614261|66384928|FG001|Follow-up Phase|Protocol Violation|0|||
23728756|NCT02614261|66384929|FG002|Follow-up Phase|Protocol Violation|0|||
23728757|NCT02614261|66384930|FG003|Follow-up Phase|Protocol Violation|0|||
23728758|NCT02614261|66384927|FG000|Follow-up Phase|Withdrawal by Subject|12|||
23728759|NCT02614261|66384928|FG001|Follow-up Phase|Withdrawal by Subject|4|||
23728760|NCT02614261|66384929|FG002|Follow-up Phase|Withdrawal by Subject|11|||
23728761|NCT02614261|66384930|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23728762|NCT02614261|66384927|FG000|Israel Addendum|Withdrawal by Subject|0|||
23728763|NCT02614261|66384928|FG001|Israel Addendum|Withdrawal by Subject|0|||
23728764|NCT02614261|66384929|FG002|Israel Addendum|Withdrawal by Subject|0|||
23728765|NCT02614261|66384930|FG003|Israel Addendum|Withdrawal by Subject|4|||
23728766|NCT01237223|66384932|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
23728767|NCT01237223|66384933|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23728768|NCT01237223|66384934|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23728769|NCT01237223|66384935|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23728770|NCT01237223|66384936|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23728771|NCT01237223|66384937|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23728772|NCT01237223|66384932|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
23728773|NCT01237223|66384933|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23728774|NCT01237223|66384934|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23728775|NCT01237223|66384935|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23728776|NCT01237223|66384936|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23728777|NCT01237223|66384937|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23728778|NCT01237223|66384932|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
23728779|NCT01237223|66384933|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23728780|NCT01237223|66384934|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23728781|NCT01237223|66384935|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23728782|NCT01237223|66384936|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23728783|NCT01237223|66384937|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23728784|NCT01237223|66384932|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
23728785|NCT01237223|66384933|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23728786|NCT01237223|66384934|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23728787|NCT01237223|66384935|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23728788|NCT01237223|66384936|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23728789|NCT01237223|66384937|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23728790|NCT01237223|66384932|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
23728791|NCT01237223|66384933|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23728792|NCT01237223|66384934|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23728793|NCT01237223|66384935|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23728794|NCT01237223|66384936|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23616693|NCT02256488|65982411|FG003|Overall Study|Lost to Follow-up|3|||
23616694|NCT02256488|65982408|FG000|Overall Study|OTHER|1|||
23616695|NCT02256488|65982409|FG001|Overall Study|OTHER|0|||
23616696|NCT02256488|65982410|FG002|Overall Study|OTHER|1|||
23616697|NCT02256488|65982411|FG003|Overall Study|OTHER|1|||
23616698|NCT02256488|65982408|FG000|Overall Study|Withdrawal by Subject|1|||
23616699|NCT02256488|65982409|FG001|Overall Study|Withdrawal by Subject|0|||
23616700|NCT02256488|65982410|FG002|Overall Study|Withdrawal by Subject|0|||
23728795|NCT01237223|66384937|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23728796|NCT01237223|66384932|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
23728797|NCT01237223|66384933|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
23728798|NCT01237223|66384934|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
23728799|NCT01237223|66384935|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
23728800|NCT01237223|66384936|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
23728801|NCT01237223|66384937|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
23728802|NCT01237223|66384932|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
23728803|NCT01237223|66384933|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
23728804|NCT01237223|66384934|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
23728805|NCT01237223|66384935|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
23728806|NCT01237223|66384936|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
23728807|NCT01237223|66384937|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
23728808|NCT01237223|66384932|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23817582|NCT00086281|66711418|FG013|Phase 1|Serious Adverse Event|0|||
23817583|NCT00086281|66711419|FG014|Phase 1|Serious Adverse Event|1|||
23425020|NCT03532932|65299824|FG000|Overall Study|Protocol Deviation|33|||
23425021|NCT03532932|65299825|FG001|Overall Study|Protocol Deviation|31|||
23425022|NCT03532932|65299824|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
23425023|NCT03532932|65299825|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
23425024|NCT03532932|65299824|FG000|Overall Study|Withdrawal by Subject|2|||
23425025|NCT03532932|65299825|FG001|Overall Study|Withdrawal by Subject|0|||
23425026|NCT03532932|65299824|FG000|Overall Study|Lost to Follow-up|15|||
23425027|NCT03532932|65299825|FG001|Overall Study|Lost to Follow-up|9|||
23425028|NCT03532932|65299824|FG000|Overall Study|Adverse Event|4|||
23425029|NCT03532932|65299825|FG001|Overall Study|Adverse Event|3|||
23425030|NCT03532932|65299824|FG000|Overall Study|Death|0|||
23425031|NCT03532932|65299825|FG001|Overall Study|Death|2|||
23425032|NCT03532932|65299824|FG000|Overall Study|Other|11|||
23425033|NCT03532932|65299825|FG001|Overall Study|Other|16|||
23425034|NCT02743780|65299826|FG000|Part 3 (7 Days)|Adverse Event|0|||
23425035|NCT02743780|65299827|FG001|Part 3 (7 Days)|Adverse Event|0|||
23425036|NCT02743780|65299828|FG002|Part 3 (7 Days)|Adverse Event|1|||
23425037|NCT02743780|65299829|FG003|Part 3 (7 Days)|Adverse Event|0|||
23425038|NCT02743780|65299830|FG004|Part 3 (7 Days)|Adverse Event|0|||
23425039|NCT02141490|65299837|FG000|Overall Study|Screening failures|4|||
23425040|NCT02141490|65299838|FG001|Overall Study|Screening failures|0|||
23425041|NCT02141490|65299839|FG002|Overall Study|Screening failures|0|||
23425042|NCT01143051|65299840|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
23425043|NCT01143051|65299841|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
23425044|NCT01143051|65299842|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
23728809|NCT01237223|66384933|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
23728810|NCT01237223|66384934|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
23728811|NCT01237223|66384935|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
23425045|NCT01143051|65299843|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
23425046|NCT01143051|65299844|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
23425047|NCT01143051|65299845|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
23425048|NCT01143051|65299840|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
23425049|NCT01143051|65299841|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
23425050|NCT01143051|65299842|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
23425051|NCT01143051|65299843|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
23425052|NCT01143051|65299844|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
23543140|NCT03387852|65719742|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
23543141|NCT03387852|65719739|FG000|Overall Study|Withdrawal by participant|1|||
23543142|NCT03387852|65719740|FG001|Overall Study|Withdrawal by participant|1|||
23543143|NCT03387852|65719741|FG002|Overall Study|Withdrawal by participant|3|||
23543144|NCT03387852|65719742|FG003|Overall Study|Withdrawal by participant|2|||
23543145|NCT03387852|65719739|FG000|Overall Study|Other- Unspecified|1|||
23543146|NCT03387852|65719740|FG001|Overall Study|Other- Unspecified|1|||
23543147|NCT03387852|65719741|FG002|Overall Study|Other- Unspecified|2|||
23616701|NCT02256488|65982411|FG003|Overall Study|Withdrawal by Subject|2|||
23616702|NCT01424189|65982412|FG000|Overall Study|Adverse Event|1|||
23616703|NCT01424189|65982413|FG001|Overall Study|Adverse Event|0|||
23616704|NCT01424189|65982412|FG000|Overall Study|Lost to Follow-up|4|||
23425053|NCT01143051|65299845|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
23425054|NCT02594098|65299846|FG000|Overall Study|Lack of Efficacy|17|||
23543148|NCT03387852|65719742|FG003|Overall Study|Other- Unspecified|1|||
23616705|NCT01424189|65982413|FG001|Overall Study|Lost to Follow-up|1|||
23728812|NCT01237223|66384936|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23728813|NCT01237223|66384937|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23728814|NCT01237223|66384932|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23728815|NCT01237223|66384933|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23728816|NCT01237223|66384934|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23728817|NCT01237223|66384935|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23728818|NCT01237223|66384936|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23728819|NCT01237223|66384937|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
23817584|NCT00086281|66711405|FG000|Phase 2|Adverse Event|0|||
23817585|NCT00086281|66711406|FG001|Phase 2|Adverse Event|0|||
23817586|NCT00086281|66711407|FG002|Phase 2|Adverse Event|0|||
23817587|NCT00086281|66711408|FG003|Phase 2|Adverse Event|0|||
23817588|NCT00086281|66711409|FG004|Phase 2|Adverse Event|0|||
23817589|NCT00086281|66711410|FG005|Phase 2|Adverse Event|0|||
23817590|NCT00086281|66711411|FG006|Phase 2|Adverse Event|0|||
23817591|NCT00086281|66711412|FG007|Phase 2|Adverse Event|0|||
23817592|NCT00086281|66711413|FG008|Phase 2|Adverse Event|0|||
23728820|NCT01237223|66384932|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
23728821|NCT01237223|66384933|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23728822|NCT01237223|66384934|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23728823|NCT01237223|66384935|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
23728824|NCT01237223|66384936|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23728825|NCT01237223|66384937|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23728826|NCT00729560|66384940|FG000|Overall Study|Withdrawal by Subject|3|||
23728827|NCT03964493|66384942|FG000|Overall Study|Withdrawal by Subject|4|||
23728828|NCT03964493|66384943|FG001|Overall Study|Withdrawal by Subject|1|||
23728829|NCT03964493|66384942|FG000|Overall Study|Lost to Follow-up|13|||
23728830|NCT03964493|66384943|FG001|Overall Study|Lost to Follow-up|4|||
23728831|NCT01432938|66384944|FG000|First Intervention|Protocol Violation|1|||
23728832|NCT01432938|66384945|FG001|First Intervention|Protocol Violation|0|||
23728833|NCT01432938|66384944|FG000|First Intervention|Physician Decision|1|||
23728834|NCT01432938|66384945|FG001|First Intervention|Physician Decision|0|||
23728835|NCT01432938|66384944|FG000|Second Intervention|Adverse Event|1|||
23728836|NCT01432938|66384945|FG001|Second Intervention|Adverse Event|0|||
23728837|NCT02623699|66384947|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728838|NCT02623699|66384948|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
23728839|NCT02623699|66384949|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728840|NCT02623699|66384950|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728841|NCT02623699|66384951|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728842|NCT02623699|66384952|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728843|NCT02623699|66384953|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728844|NCT02623699|66384954|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728845|NCT02623699|66384955|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728846|NCT02623699|66384956|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728847|NCT02623699|66384957|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728848|NCT02623699|66384958|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23728849|NCT02623699|66384947|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728850|NCT02623699|66384948|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728851|NCT02623699|66384949|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728852|NCT02623699|66384950|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728853|NCT02623699|66384951|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728854|NCT02623699|66384952|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728855|NCT02623699|66384953|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
23728856|NCT02623699|66384954|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728857|NCT02623699|66384955|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728858|NCT02623699|66384956|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728859|NCT02623699|66384957|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728860|NCT02623699|66384958|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23728861|NCT02623699|66384947|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728862|NCT02623699|66384948|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728863|NCT02623699|66384949|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23425055|NCT02594098|65299847|FG001|Overall Study|Lack of Efficacy|6|||
23728864|NCT02623699|66384950|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728865|NCT02623699|66384951|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728866|NCT02623699|66384952|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
23728867|NCT02623699|66384953|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728868|NCT02623699|66384954|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728869|NCT02623699|66384955|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728870|NCT02623699|66384956|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728871|NCT02623699|66384957|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23817593|NCT00086281|66711414|FG009|Phase 2|Adverse Event|0|||
23817594|NCT00086281|66711415|FG010|Phase 2|Adverse Event|0|||
23817595|NCT00086281|66711416|FG011|Phase 2|Adverse Event|0|||
23817596|NCT00086281|66711417|FG012|Phase 2|Adverse Event|1|||
23728872|NCT02623699|66384958|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23728873|NCT02623699|66384947|FG000|Part B (Up to 289 Days)|Death|0|||
23728874|NCT02623699|66384948|FG001|Part B (Up to 289 Days)|Death|0|||
23728875|NCT02623699|66384949|FG002|Part B (Up to 289 Days)|Death|0|||
23728876|NCT02623699|66384950|FG003|Part B (Up to 289 Days)|Death|0|||
23728877|NCT02623699|66384951|FG004|Part B (Up to 289 Days)|Death|0|||
23728878|NCT02623699|66384952|FG005|Part B (Up to 289 Days)|Death|1|||
23728879|NCT02623699|66384953|FG006|Part B (Up to 289 Days)|Death|1|||
23728880|NCT02623699|66384954|FG007|Part B (Up to 289 Days)|Death|0|||
23728881|NCT02623699|66384955|FG008|Part B (Up to 289 Days)|Death|1|||
23728882|NCT02623699|66384956|FG009|Part B (Up to 289 Days)|Death|0|||
23728883|NCT02623699|66384957|FG010|Part B (Up to 289 Days)|Death|0|||
23728884|NCT02623699|66384958|FG011|Part B (Up to 289 Days)|Death|0|||
23817597|NCT00086281|66711418|FG013|Phase 2|Adverse Event|1|||
23543149|NCT03387852|65719739|FG000|Overall Study|Poor compliance to protocol|0|||
23817598|NCT00086281|66711419|FG014|Phase 2|Adverse Event|0|||
23817599|NCT03017612|66711420|FG000|Overall Study|Adverse Event|2|||
23817600|NCT05307510|66711421|FG000|Overall Study|Lost to Follow-up|3|||
23817601|NCT05307510|66711422|FG001|Overall Study|Lost to Follow-up|6|||
23817602|NCT05307510|66711421|FG000|Overall Study|Withdrawal by Subject|0|||
23817603|NCT05307510|66711422|FG001|Overall Study|Withdrawal by Subject|1|||
23817604|NCT03839823|66711423|FG000|Overall Study|Adverse Event|8|||
23817605|NCT03839823|66711424|FG001|Overall Study|Adverse Event|4|||
23817606|NCT03839823|66711423|FG000|Overall Study|Death|1|||
23817607|NCT03839823|66711424|FG001|Overall Study|Death|0|||
23817608|NCT03839823|66711423|FG000|Overall Study|Physician Decision|1|||
23817609|NCT03839823|66711424|FG001|Overall Study|Physician Decision|5|||
23817610|NCT03839823|66711423|FG000|Overall Study|Progressive Disease (PD)|65|||
23543150|NCT03387852|65719740|FG001|Overall Study|Poor compliance to protocol|0|||
23543151|NCT03387852|65719741|FG002|Overall Study|Poor compliance to protocol|0|||
23543152|NCT03387852|65719742|FG003|Overall Study|Poor compliance to protocol|1|||
23543153|NCT03387852|65719739|FG000|Overall Study|Randomized and not treated|0|||
23543154|NCT03387852|65719740|FG001|Overall Study|Randomized and not treated|0|||
23543155|NCT03387852|65719741|FG002|Overall Study|Randomized and not treated|0|||
23543156|NCT03387852|65719742|FG003|Overall Study|Randomized and not treated|1|||
23543157|NCT02415400|65719743|FG000|Overall Study|Adverse Event|0|||
23543158|NCT02415400|65719744|FG001|Overall Study|Adverse Event|1|||
23543159|NCT02415400|65719745|FG002|Overall Study|Adverse Event|1|||
23543160|NCT02415400|65719746|FG003|Overall Study|Adverse Event|2|||
23543161|NCT02415400|65719743|FG000|Overall Study|Participant request to stop therapy|4|||
23543162|NCT02415400|65719744|FG001|Overall Study|Participant request to stop therapy|3|||
23543163|NCT02415400|65719745|FG002|Overall Study|Participant request to stop therapy|8|||
23543164|NCT02415400|65719746|FG003|Overall Study|Participant request to stop therapy|6|||
23543165|NCT02415400|65719743|FG000|Overall Study|Participant withdrew consent|14|||
23543166|NCT02415400|65719744|FG001|Overall Study|Participant withdrew consent|12|||
23543167|NCT02415400|65719745|FG002|Overall Study|Participant withdrew consent|30|||
23543168|NCT02415400|65719746|FG003|Overall Study|Participant withdrew consent|21|||
23543169|NCT02415400|65719743|FG000|Overall Study|Death|39|||
23543170|NCT02415400|65719744|FG001|Overall Study|Death|41|||
23543171|NCT02415400|65719745|FG002|Overall Study|Death|35|||
23543172|NCT02415400|65719746|FG003|Overall Study|Death|42|||
23543173|NCT02415400|65719743|FG000|Overall Study|Lost to Follow-up|3|||
23543174|NCT02415400|65719744|FG001|Overall Study|Lost to Follow-up|3|||
23543175|NCT02415400|65719745|FG002|Overall Study|Lost to Follow-up|2|||
23543176|NCT02415400|65719746|FG003|Overall Study|Lost to Follow-up|5|||
23543177|NCT02415400|65719743|FG000|Overall Study|Poor/Non-Compliance|0|||
23728885|NCT02623699|66384947|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
23728886|NCT02623699|66384948|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
23543178|NCT02415400|65719744|FG001|Overall Study|Poor/Non-Compliance|1|||
23543179|NCT02415400|65719745|FG002|Overall Study|Poor/Non-Compliance|3|||
23543180|NCT02415400|65719746|FG003|Overall Study|Poor/Non-Compliance|4|||
23543181|NCT02415400|65719743|FG000|Overall Study|Participant no longer meets criteria|2|||
23728887|NCT02623699|66384949|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
23817611|NCT03839823|66711424|FG001|Overall Study|Progressive Disease (PD)|65|||
23817612|NCT03839823|66711423|FG000|Overall Study|Subject Decision|2|||
23817613|NCT03839823|66711424|FG001|Overall Study|Subject Decision|9|||
23817614|NCT03839823|66711423|FG000|Overall Study|Not Treated|0|||
23817615|NCT03839823|66711424|FG001|Overall Study|Not Treated|10|||
23817616|NCT04380961|66711425|FG000|Overall Study|Lost to Follow-up|17|||
23817617|NCT04380961|66711426|FG001|Overall Study|Lost to Follow-up|11|||
23425056|NCT02594098|65299846|FG000|Overall Study|Withdrawal by Subject|1|||
23425057|NCT02594098|65299847|FG001|Overall Study|Withdrawal by Subject|3|||
23425058|NCT02594098|65299846|FG000|Overall Study|Terminated participation|6|||
23543182|NCT02415400|65719744|FG001|Overall Study|Participant no longer meets criteria|0|||
23543183|NCT02415400|65719745|FG002|Overall Study|Participant no longer meets criteria|0|||
23543184|NCT02415400|65719746|FG003|Overall Study|Participant no longer meets criteria|1|||
23817618|NCT04380961|66711425|FG000|Overall Study|Withdrawal by Subject|3|||
23817619|NCT04380961|66711426|FG001|Overall Study|Withdrawal by Subject|0|||
23817620|NCT04380961|66711425|FG000|Overall Study|Death|22|||
23817621|NCT04380961|66711426|FG001|Overall Study|Death|16|||
23817622|NCT04380961|66711425|FG000|Overall Study|Other|1|||
23817623|NCT04380961|66711426|FG001|Overall Study|Other|0|||
23817624|NCT04380961|66711425|FG000|Overall Study|Randomized but Not Treated|1|||
23817625|NCT04380961|66711426|FG001|Overall Study|Randomized but Not Treated|2|||
23543185|NCT02415400|65719743|FG000|Overall Study|Participant doesn't answer phone|1|||
23543186|NCT02415400|65719744|FG001|Overall Study|Participant doesn't answer phone|0|||
23543187|NCT02415400|65719745|FG002|Overall Study|Participant doesn't answer phone|0|||
23543188|NCT02415400|65719746|FG003|Overall Study|Participant doesn't answer phone|0|||
23543189|NCT02415400|65719743|FG000|Overall Study|Participant wanted home visits|1|||
23543190|NCT02415400|65719744|FG001|Overall Study|Participant wanted home visits|0|||
23543191|NCT02415400|65719745|FG002|Overall Study|Participant wanted home visits|0|||
23616706|NCT01424189|65982412|FG000|Overall Study|Withdrawal by Subject|4|||
23616707|NCT01424189|65982413|FG001|Overall Study|Withdrawal by Subject|4|||
23616708|NCT01424189|65982412|FG000|Overall Study|Subject moved|1|||
23616709|NCT01424189|65982413|FG001|Overall Study|Subject moved|0|||
23616710|NCT01424189|65982412|FG000|Overall Study|Death|3|||
23616711|NCT01424189|65982413|FG001|Overall Study|Death|1|||
23817626|NCT01982812|66711427|FG000|Overall Study|Death|1|||
23817627|NCT01982812|66711428|FG001|Overall Study|Death|5|||
23543192|NCT02415400|65719746|FG003|Overall Study|Participant wanted home visits|0|||
23543193|NCT02415400|65719743|FG000|Overall Study|Randomized in error|2|||
23543194|NCT02415400|65719744|FG001|Overall Study|Randomized in error|0|||
23543195|NCT02415400|65719745|FG002|Overall Study|Randomized in error|0|||
23616712|NCT00588341|65982418|FG000|Overall Study|Withdrawal by Subject|3|||
23616713|NCT00588341|65982418|FG000|Overall Study|Not treated due to metastatic disease|1|||
23616714|NCT00588341|65982418|FG000|Overall Study|Patient ineligible|1|||
23817628|NCT01982812|66711427|FG000|Overall Study|Adverse Event|0|||
23817629|NCT01982812|66711428|FG001|Overall Study|Adverse Event|5|||
23817630|NCT00094861|66711432|FG000|Overall Study|Adverse Event|5|||
23817631|NCT00094861|66711433|FG001|Overall Study|Adverse Event|2|||
23817632|NCT00094861|66711432|FG000|Overall Study|Withdrawal by Subject|5|||
23817633|NCT00094861|66711433|FG001|Overall Study|Withdrawal by Subject|3|||
23817634|NCT00094861|66711432|FG000|Overall Study|Physician Decision|1|||
23817635|NCT00094861|66711433|FG001|Overall Study|Physician Decision|1|||
23817636|NCT00094861|66711432|FG000|Overall Study|Lost to Follow-up|0|||
23425059|NCT02594098|65299847|FG001|Overall Study|Terminated participation|2|||
23543196|NCT02415400|65719746|FG003|Overall Study|Randomized in error|0|||
23543197|NCT02415400|65719743|FG000|Overall Study|No study drug on site|0|||
23817637|NCT00094861|66711433|FG001|Overall Study|Lost to Follow-up|1|||
23817638|NCT00094861|66711432|FG000|Overall Study|Death|4|||
23817639|NCT00094861|66711433|FG001|Overall Study|Death|2|||
23817640|NCT00094861|66711432|FG000|Overall Study|Other|3|||
23817641|NCT00094861|66711433|FG001|Overall Study|Other|0|||
23817642|NCT03485352|66711434|FG000|Overall Study|Lost to Follow-up|9|||
23616715|NCT00705614|65982422|FG000|Initial Intervention|Adverse Event|40|||
23728888|NCT02623699|66384950|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
23728889|NCT02623699|66384951|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
23728890|NCT02623699|66384952|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
23728891|NCT02623699|66384953|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
23728892|NCT02623699|66384954|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
23728893|NCT02623699|66384955|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
23728894|NCT02623699|66384956|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
23728895|NCT02623699|66384957|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
23728896|NCT02623699|66384958|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
23728897|NCT02623699|66384947|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728898|NCT02623699|66384948|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728899|NCT02623699|66384949|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728900|NCT02623699|66384950|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728901|NCT02623699|66384951|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728902|NCT02623699|66384952|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728903|NCT02623699|66384953|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728904|NCT02623699|66384954|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728905|NCT02623699|66384955|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728906|NCT02623699|66384956|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23728907|NCT02623699|66384957|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
23728908|NCT02623699|66384958|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
23728909|NCT02623699|66384947|FG000|Part C (Up to 236 Days)|Death|0|||
23728910|NCT02623699|66384948|FG001|Part C (Up to 236 Days)|Death|0|||
23728911|NCT02623699|66384949|FG002|Part C (Up to 236 Days)|Death|0|||
23728912|NCT02623699|66384950|FG003|Part C (Up to 236 Days)|Death|0|||
23728913|NCT02623699|66384951|FG004|Part C (Up to 236 Days)|Death|0|||
23728914|NCT02623699|66384952|FG005|Part C (Up to 236 Days)|Death|0|||
23728915|NCT02623699|66384953|FG006|Part C (Up to 236 Days)|Death|0|||
23728916|NCT02623699|66384954|FG007|Part C (Up to 236 Days)|Death|0|||
23728917|NCT02623699|66384955|FG008|Part C (Up to 236 Days)|Death|0|||
23728918|NCT02623699|66384956|FG009|Part C (Up to 236 Days)|Death|0|||
23728919|NCT02623699|66384957|FG010|Part C (Up to 236 Days)|Death|0|||
23728920|NCT02623699|66384958|FG011|Part C (Up to 236 Days)|Death|1|||
23728921|NCT02623699|66384947|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
23728922|NCT02623699|66384948|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
23728923|NCT02623699|66384949|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
23728924|NCT02623699|66384950|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
23728925|NCT02623699|66384951|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
23728926|NCT02623699|66384952|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
23728927|NCT02623699|66384953|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
23728928|NCT02623699|66384954|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
23728929|NCT02623699|66384955|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
23728930|NCT02623699|66384956|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
23728931|NCT02623699|66384957|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
23728932|NCT02623699|66384958|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
23728933|NCT00209092|66384959|FG000|Overall Study|Progression of disease|7|||
23728934|NCT00209092|66384960|FG001|Overall Study|Progression of disease|1|||
23728935|NCT00209092|66384959|FG000|Overall Study|Adverse Event|0|||
23616716|NCT00705614|65982423|FG001|Initial Intervention|Adverse Event|21|||
23728936|NCT00209092|66384960|FG001|Overall Study|Adverse Event|1|||
23728937|NCT00209092|66384959|FG000|Overall Study|Withdrawal by Subject|1|||
23728938|NCT00209092|66384960|FG001|Overall Study|Withdrawal by Subject|0|||
23616717|NCT00705614|65982422|FG000|Initial Intervention|Lost to Follow-up|310|||
23728939|NCT03152110|66384961|FG000|Overall Study|Withdrawal by Subject|3|||
23728940|NCT01156363|66384965|FG000|Overall Study|Adverse Event|6|||
23728941|NCT01156363|66384965|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23728942|NCT01156363|66384965|FG000|Overall Study|Failure to Return|1|||
23728943|NCT01156363|66384965|FG000|Overall Study|Refused Treatment|4|||
23728944|NCT01156363|66384965|FG000|Overall Study|Other|6|||
23728945|NCT00666536|66384966|FG000|Overall Study|Adverse Event|9|||
23728946|NCT00666536|66384967|FG001|Overall Study|Adverse Event|19|||
23728947|NCT00666536|66384966|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23728948|NCT00666536|66384967|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23728949|NCT00666536|66384966|FG000|Overall Study|Protocol deviation(s)|8|||
23817643|NCT04480710|66711435|FG000|Overall Study|Adverse Event|0|||
23425060|NCT02594098|65299846|FG000|Overall Study|Seek alternative treatment|2|||
23728950|NCT00666536|66384967|FG001|Overall Study|Protocol deviation(s)|6|||
23728951|NCT00666536|66384966|FG000|Overall Study|Withdrawal by Subject|10|||
23728952|NCT00666536|66384967|FG001|Overall Study|Withdrawal by Subject|9|||
23728953|NCT00666536|66384966|FG000|Overall Study|Lost to Follow-up|4|||
23728954|NCT00666536|66384967|FG001|Overall Study|Lost to Follow-up|3|||
23728955|NCT03860844|66384968|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
23728956|NCT03860844|66384969|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
23728957|NCT03860844|66384970|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
23728958|NCT03860844|66384968|FG000|Overall Study|Progressive disease|5|||
23728959|NCT03860844|66384969|FG001|Overall Study|Progressive disease|3|||
23728960|NCT03860844|66384970|FG002|Overall Study|Progressive disease|4|||
23728961|NCT03860844|66384968|FG000|Overall Study|Other, Not related to COVID-19|0|||
23728962|NCT03860844|66384969|FG001|Overall Study|Other, Not related to COVID-19|1|||
23728963|NCT03860844|66384970|FG002|Overall Study|Other, Not related to COVID-19|0|||
23728964|NCT03442595|66384971|FG000|Overall Study|Lost to Follow-up|94|||
23728965|NCT03442595|66384972|FG001|Overall Study|Lost to Follow-up|0|||
23728966|NCT01899768|66384978|FG000|Part A|Adverse Event|2|||
23728967|NCT01899768|66384978|FG000|Part A|Withdrawal by Subject|1|||
23728968|NCT01899768|66384978|FG000|Part B|Adverse Event|1|||
23728969|NCT01899768|66384978|FG000|Part B|Withdrawal by Subject|1|||
23728970|NCT01846208|66384982|FG000|Overall Study|Withdrew prior to treatment|1|||
23728971|NCT01846208|66384983|FG001|Overall Study|Withdrew prior to treatment|1|||
23728972|NCT01846208|66384984|FG002|Overall Study|Withdrew prior to treatment|1|||
23728973|NCT01846208|66384982|FG000|Overall Study|Dosing Symptoms|1|||
23728974|NCT01846208|66384983|FG001|Overall Study|Dosing Symptoms|2|||
23728975|NCT01846208|66384984|FG002|Overall Study|Dosing Symptoms|6|||
23728976|NCT01846208|66384982|FG000|Overall Study|Withdrawal by Subject|5|||
23728977|NCT01846208|66384983|FG001|Overall Study|Withdrawal by Subject|0|||
23728978|NCT01846208|66384984|FG002|Overall Study|Withdrawal by Subject|0|||
23728979|NCT01846208|66384982|FG000|Overall Study|Non-compliance|1|||
23728980|NCT01846208|66384983|FG001|Overall Study|Non-compliance|1|||
23728981|NCT01846208|66384984|FG002|Overall Study|Non-compliance|0|||
23728982|NCT01846208|66384982|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
23728983|NCT01846208|66384983|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
23728984|NCT01846208|66384984|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
23728985|NCT01846208|66384982|FG000|Overall Study|Refused SU OFC|0|||
23728986|NCT01846208|66384983|FG001|Overall Study|Refused SU OFC|0|||
23728987|NCT01846208|66384984|FG002|Overall Study|Refused SU OFC|1|||
23728988|NCT02177786|66384985|FG000|Overall Study|Withdrew Consent|2|||
23728989|NCT02177786|66384986|FG001|Overall Study|Withdrew Consent|6|||
23728990|NCT02177786|66384987|FG002|Overall Study|Withdrew Consent|9|||
23728991|NCT02177786|66384988|FG003|Overall Study|Withdrew Consent|5|||
23728992|NCT02177786|66384985|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
23728993|NCT02177786|66384986|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
23728994|NCT02177786|66384987|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
23728995|NCT02177786|66384988|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
23728996|NCT02177786|66384985|FG000|Overall Study|Adverse Event|1|||
23728997|NCT02177786|66384986|FG001|Overall Study|Adverse Event|1|||
23728998|NCT02177786|66384987|FG002|Overall Study|Adverse Event|2|||
23728999|NCT02177786|66384988|FG003|Overall Study|Adverse Event|3|||
23729000|NCT02177786|66384985|FG000|Overall Study|Death|1|||
23817644|NCT04480710|66711436|FG001|Overall Study|Adverse Event|2|||
23729001|NCT02177786|66384986|FG001|Overall Study|Death|1|||
23729002|NCT02177786|66384987|FG002|Overall Study|Death|1|||
23729003|NCT02177786|66384988|FG003|Overall Study|Death|1|||
23729004|NCT02177786|66384985|FG000|Overall Study|Lost to Follow-up|0|||
23425061|NCT02594098|65299847|FG001|Overall Study|Seek alternative treatment|1|||
23425062|NCT02594098|65299846|FG000|Overall Study|Other|0|||
23729005|NCT02177786|66384986|FG001|Overall Study|Lost to Follow-up|0|||
23729006|NCT02177786|66384987|FG002|Overall Study|Lost to Follow-up|2|||
23729007|NCT02177786|66384988|FG003|Overall Study|Lost to Follow-up|2|||
23729008|NCT02177786|66384985|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23729009|NCT02177786|66384986|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23729010|NCT02177786|66384987|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23817645|NCT04480710|66711437|FG002|Overall Study|Adverse Event|0|||
23729011|NCT02177786|66384988|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23729012|NCT02177786|66384985|FG000|Overall Study|Protocol Violation|0|||
23729013|NCT02177786|66384986|FG001|Overall Study|Protocol Violation|0|||
23729014|NCT02177786|66384987|FG002|Overall Study|Protocol Violation|2|||
23729015|NCT02177786|66384988|FG003|Overall Study|Protocol Violation|0|||
23729016|NCT02177786|66384985|FG000|Overall Study|Progressive Disease|0|||
23729017|NCT02177786|66384986|FG001|Overall Study|Progressive Disease|1|||
23729018|NCT02177786|66384987|FG002|Overall Study|Progressive Disease|0|||
23729019|NCT02177786|66384988|FG003|Overall Study|Progressive Disease|0|||
23729020|NCT02177786|66384985|FG000|Overall Study|Missing study completion status|0|||
23729021|NCT02177786|66384986|FG001|Overall Study|Missing study completion status|1|||
23729022|NCT02177786|66384987|FG002|Overall Study|Missing study completion status|0|||
23729023|NCT02177786|66384988|FG003|Overall Study|Missing study completion status|0|||
23729024|NCT01347073|66384989|FG000|Overall Study|Adverse Event|1|||
23729025|NCT01347073|66384989|FG000|Overall Study|Liver Transplant|1|||
23729026|NCT00063986|66384990|FG000|Overall Study|Withdrawal by Subject|1|||
23729027|NCT00063986|66384990|FG000|Overall Study|Ineligible|1|||
23729028|NCT00063986|66384990|FG000|Overall Study|Intra-operatively ineligible|4|||
23729029|NCT02182999|66384993|FG000|Overall Study|Adverse Event|4|||
23729030|NCT02182999|66384994|FG001|Overall Study|Adverse Event|3|||
23729031|NCT02182999|66384993|FG000|Overall Study|Physician Decision|1|||
23729032|NCT02182999|66384994|FG001|Overall Study|Physician Decision|0|||
23729033|NCT02280096|66384995|FG000|Overall Study|Pregnancy|1|||
23729034|NCT02280096|66384996|FG001|Overall Study|Pregnancy|0|||
23729035|NCT02280096|66384995|FG000|Overall Study|Functional neurological disorder|1|||
23729036|NCT02280096|66384996|FG001|Overall Study|Functional neurological disorder|0|||
23817646|NCT04480710|66711438|FG003|Overall Study|Adverse Event|0|||
23817647|NCT04480710|66711435|FG000|Overall Study|Withdrawal by Subject|0|||
23817648|NCT04480710|66711436|FG001|Overall Study|Withdrawal by Subject|1|||
23817649|NCT04480710|66711437|FG002|Overall Study|Withdrawal by Subject|0|||
23817650|NCT04480710|66711438|FG003|Overall Study|Withdrawal by Subject|0|||
23817651|NCT04480710|66711435|FG000|Overall Study|Physician Decision|0|||
23817652|NCT04480710|66711436|FG001|Overall Study|Physician Decision|0|||
23817653|NCT04480710|66711437|FG002|Overall Study|Physician Decision|1|||
23817654|NCT04480710|66711438|FG003|Overall Study|Physician Decision|0|||
23817655|NCT02552303|66711439|FG000|Allocation|Withdrawal by Subject|2|||
23817656|NCT02552303|66711440|FG001|Allocation|Withdrawal by Subject|1|||
23817657|NCT02552303|66711441|FG002|Allocation|Withdrawal by Subject|1|||
23817658|NCT02552303|66711442|FG003|Allocation|Withdrawal by Subject|1|||
23817659|NCT02552303|66711439|FG000|Allocation|ineligible|1|||
23817660|NCT02552303|66711440|FG001|Allocation|ineligible|1|||
23817661|NCT02552303|66711441|FG002|Allocation|ineligible|0|||
23817662|NCT02552303|66711442|FG003|Allocation|ineligible|0|||
23817663|NCT02552303|66711439|FG000|Follow-Up|Lost to Follow-up|0|||
23817664|NCT02552303|66711440|FG001|Follow-Up|Lost to Follow-up|0|||
23817665|NCT02552303|66711441|FG002|Follow-Up|Lost to Follow-up|1|||
23817666|NCT02552303|66711442|FG003|Follow-Up|Lost to Follow-up|0|||
23817667|NCT02552303|66711439|FG000|Follow-Up|ineligible|0|||
23817668|NCT02552303|66711440|FG001|Follow-Up|ineligible|2|||
23817669|NCT02552303|66711441|FG002|Follow-Up|ineligible|0|||
23729037|NCT02280096|66384995|FG000|Overall Study|Lack of attachment|0|||
23729038|NCT02280096|66384996|FG001|Overall Study|Lack of attachment|1|||
23729039|NCT00085644|66384999|FG000|Double-Blind Period|Adverse Event|5|||
23729040|NCT00085644|66385000|FG001|Double-Blind Period|Adverse Event|2|||
23729041|NCT00085644|66385001|FG002|Double-Blind Period|Adverse Event|0|||
23729042|NCT00085644|66384999|FG000|Double-Blind Period|Withdrawal by Subject|3|||
23729043|NCT00085644|66385000|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23729044|NCT00085644|66385001|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23729045|NCT00085644|66384999|FG000|Double-Blind Period|Lost to Follow-up|2|||
23729046|NCT00085644|66385000|FG001|Double-Blind Period|Lost to Follow-up|1|||
23729047|NCT00085644|66385001|FG002|Double-Blind Period|Lost to Follow-up|0|||
23817670|NCT02552303|66711442|FG003|Follow-Up|ineligible|0|||
23817671|NCT01422187|66711443|FG000|Overall Study|Personal reason|1|||
23817672|NCT01422187|66711444|FG001|Overall Study|Personal reason|0|||
23817673|NCT01422187|66711445|FG002|Overall Study|Personal reason|0|||
23817674|NCT01422187|66711443|FG000|Overall Study|Lost to Follow-up|0|||
23817675|NCT01422187|66711444|FG001|Overall Study|Lost to Follow-up|1|||
23729048|NCT00085644|66384999|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
23729049|NCT00085644|66385000|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
23729050|NCT00085644|66385001|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
23729051|NCT00085644|66384999|FG000|Double-Blind Period|Contemplating pregnancy|1|||
23729052|NCT00085644|66385000|FG001|Double-Blind Period|Contemplating pregnancy|0|||
23729053|NCT00085644|66385001|FG002|Double-Blind Period|Contemplating pregnancy|0|||
23729054|NCT00085644|66384999|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
23817676|NCT01422187|66711445|FG002|Overall Study|Lost to Follow-up|0|||
23817677|NCT04762277|66711446|FG000|Overall Study|Withdrawal by Subject|0|||
23817678|NCT04762277|66711447|FG001|Overall Study|Withdrawal by Subject|2|||
23817679|NCT04762277|66711446|FG000|Overall Study|Protocol Violation|0|||
23817680|NCT04762277|66711447|FG001|Overall Study|Protocol Violation|1|||
23729055|NCT00085644|66385000|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
23729056|NCT00085644|66385001|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
23729057|NCT00085644|66384999|FG000|Open-Label Period|Adverse Event|0|||
23729058|NCT00085644|66385000|FG001|Open-Label Period|Adverse Event|0|||
23729059|NCT00085644|66385001|FG002|Open-Label Period|Adverse Event|38|||
23729060|NCT00085644|66384999|FG000|Open-Label Period|Withdrawal by Subject|0|||
23729061|NCT00085644|66385000|FG001|Open-Label Period|Withdrawal by Subject|0|||
23729062|NCT00085644|66385001|FG002|Open-Label Period|Withdrawal by Subject|29|||
23729063|NCT00085644|66384999|FG000|Open-Label Period|Lost to Follow-up|0|||
23729064|NCT00085644|66385000|FG001|Open-Label Period|Lost to Follow-up|0|||
23729065|NCT00085644|66385001|FG002|Open-Label Period|Lost to Follow-up|13|||
23817681|NCT04762277|66711446|FG000|Overall Study|Adverse Event|1|||
23817682|NCT04762277|66711447|FG001|Overall Study|Adverse Event|0|||
23817683|NCT04325204|66711450|FG000|Overall Study|Death|0|||
23817684|NCT04325204|66711451|FG001|Overall Study|Death|1|||
23817685|NCT04325204|66711450|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
23817686|NCT04325204|66711451|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
23817687|NCT04325204|66711450|FG000|Overall Study|Lost to Follow-up|8|||
23817688|NCT04325204|66711451|FG001|Overall Study|Lost to Follow-up|8|||
23817689|NCT04325204|66711450|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
23817690|NCT04325204|66711451|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
23817691|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
23817692|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
23817693|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
23817694|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
23817695|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
23817696|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
23817697|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
23817698|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
23817699|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
23817700|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
23817701|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
23817702|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
23817703|NCT02294461|66711455|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
23817704|NCT02294461|66711456|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
23817705|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
23817706|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
23817707|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
23817708|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
23817709|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
23817710|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
23817711|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
23817712|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
23817713|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
23817714|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
23817715|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
23817716|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
23817717|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
23817718|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
23817719|NCT02294461|66711455|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
23817720|NCT02294461|66711456|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
23817721|NCT03047330|66711457|FG000|Sleep Block 1|Withdrawal by Subject|3|||
23817722|NCT03265288|66711458|FG000|Overall Study|Adverse Event|0|||
23817723|NCT03265288|66711459|FG001|Overall Study|Adverse Event|1|||
23729066|NCT00085644|66384999|FG000|Open-Label Period|Lack of Efficacy|0|||
23729067|NCT00085644|66385000|FG001|Open-Label Period|Lack of Efficacy|0|||
23729068|NCT00085644|66385001|FG002|Open-Label Period|Lack of Efficacy|15|||
23729069|NCT00085644|66384999|FG000|Open-Label Period|Pregnancy|0|||
23729070|NCT00085644|66385000|FG001|Open-Label Period|Pregnancy|0|||
23817724|NCT03265288|66711458|FG000|Overall Study|Withdrawal by Subject|13|||
23729071|NCT00085644|66385001|FG002|Open-Label Period|Pregnancy|3|||
23729072|NCT00085644|66384999|FG000|Open-Label Period|Contemplating pregnancy|0|||
23729073|NCT00085644|66385000|FG001|Open-Label Period|Contemplating pregnancy|0|||
23729074|NCT00085644|66385001|FG002|Open-Label Period|Contemplating pregnancy|3|||
23729075|NCT00085644|66384999|FG000|Open-Label Period|Protocol Violation|0|||
23817725|NCT03265288|66711459|FG001|Overall Study|Withdrawal by Subject|5|||
23817726|NCT03265288|66711458|FG000|Overall Study|Drug Withdrawn|3|||
23817727|NCT03265288|66711459|FG001|Overall Study|Drug Withdrawn|3|||
23817728|NCT03265288|66711458|FG000|Overall Study|Any Other Reason|7|||
23817729|NCT03265288|66711459|FG001|Overall Study|Any Other Reason|3|||
23817730|NCT01104779|66711461|FG000|Overall Study|Protocol Violation|1|||
23817731|NCT01104779|66711462|FG001|Overall Study|Protocol Violation|2|||
23729076|NCT00085644|66385000|FG001|Open-Label Period|Protocol Violation|0|||
23817732|NCT01104779|66711463|FG002|Overall Study|Protocol Violation|2|||
23817733|NCT01104779|66711461|FG000|Overall Study|Lack of Efficacy|26|||
23817734|NCT01104779|66711462|FG001|Overall Study|Lack of Efficacy|12|||
23817735|NCT01104779|66711463|FG002|Overall Study|Lack of Efficacy|13|||
23817736|NCT01104779|66711461|FG000|Overall Study|Adverse Event|13|||
23817737|NCT01104779|66711462|FG001|Overall Study|Adverse Event|14|||
23817738|NCT01104779|66711463|FG002|Overall Study|Adverse Event|13|||
23817739|NCT01104779|66711461|FG000|Overall Study|Did not meet inc/exc criteria|1|||
23817740|NCT01104779|66711462|FG001|Overall Study|Did not meet inc/exc criteria|1|||
23817741|NCT01104779|66711463|FG002|Overall Study|Did not meet inc/exc criteria|1|||
23817742|NCT01104779|66711461|FG000|Overall Study|Other reasons|0|||
23817743|NCT01104779|66711462|FG001|Overall Study|Other reasons|1|||
23817744|NCT01104779|66711463|FG002|Overall Study|Other reasons|0|||
23817745|NCT01104779|66711461|FG000|Overall Study|Lost to Follow-up|2|||
23817746|NCT01104779|66711462|FG001|Overall Study|Lost to Follow-up|0|||
23729077|NCT00085644|66385001|FG002|Open-Label Period|Protocol Violation|4|||
23729078|NCT00085644|66384999|FG000|Open-Label Period|Personal reason|0|||
23729079|NCT00085644|66385000|FG001|Open-Label Period|Personal reason|0|||
23729080|NCT00085644|66385001|FG002|Open-Label Period|Personal reason|4|||
23729081|NCT02201472|66385002|FG000|Overall Study|Lack of Efficacy|2|||
23729082|NCT01355497|66385003|FG000|Overall Study|Death|19|||
23729083|NCT01355497|66385004|FG001|Overall Study|Death|18|||
23729084|NCT01355497|66385003|FG000|Overall Study|Lost to Follow-up|3|||
23729085|NCT01355497|66385004|FG001|Overall Study|Lost to Follow-up|0|||
23729086|NCT01355497|66385003|FG000|Overall Study|Protocol Violation|0|||
23729087|NCT01355497|66385004|FG001|Overall Study|Protocol Violation|1|||
23729088|NCT01355497|66385003|FG000|Overall Study|other-not provided|9|||
23729089|NCT01355497|66385004|FG001|Overall Study|other-not provided|4|||
23729090|NCT01355497|66385003|FG000|Overall Study|Withdrawal by Subject|12|||
23729091|NCT01355497|66385004|FG001|Overall Study|Withdrawal by Subject|20|||
23729092|NCT01355497|66385003|FG000|Overall Study|noncompliance|1|||
23729093|NCT01355497|66385004|FG001|Overall Study|noncompliance|2|||
23729094|NCT01355497|66385003|FG000|Overall Study|progressive disease|11|||
23729095|NCT01355497|66385004|FG001|Overall Study|progressive disease|8|||
23729096|NCT01355497|66385003|FG000|Overall Study|Adverse Event|11|||
23729097|NCT01355497|66385004|FG001|Overall Study|Adverse Event|10|||
23729098|NCT01756833|66385011|FG000|Overall Study|Withdrawal by Subject|4|||
23729099|NCT01756833|66385012|FG001|Overall Study|Withdrawal by Subject|3|||
23782241|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782242|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782243|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782244|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782245|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782246|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782247|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782248|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782249|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
23782250|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782251|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782252|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
23782253|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
23782254|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23817747|NCT01104779|66711463|FG002|Overall Study|Lost to Follow-up|1|||
23817748|NCT01104779|66711461|FG000|Overall Study|Withdrawal by Subject|16|||
23817749|NCT01104779|66711462|FG001|Overall Study|Withdrawal by Subject|25|||
23817750|NCT01104779|66711463|FG002|Overall Study|Withdrawal by Subject|32|||
23817751|NCT02901548|66711464|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
23425063|NCT02594098|65299847|FG001|Overall Study|Other|1|||
23425064|NCT00539513|65299848|FG000|Overall Study|Withdrawal by Subject|2|||
23729100|NCT03858686|66388538|FG000|Period 1|Adverse Event|1|||
23729101|NCT03858686|66388539|FG001|Period 1|Adverse Event|1|||
23729102|NCT03858686|66388538|FG000|Period 1|Lack of compliance|0|||
23729103|NCT03858686|66388539|FG001|Period 1|Lack of compliance|1|||
23729104|NCT03858686|66388538|FG000|Period 1|Adverse Event|0|||
23729105|NCT03858686|66388539|FG001|Period 1|Adverse Event|1|||
23729106|NCT03858686|66388538|FG000|Period 2|Adverse Event|0|||
23729107|NCT03858686|66388539|FG001|Period 2|Adverse Event|1|||
23729108|NCT02736929|66388544|FG000|Main Study|Lost to Follow-up|7|||
23425065|NCT00539513|65299849|FG001|Overall Study|Withdrawal by Subject|1|||
23425066|NCT00539513|65299848|FG000|Overall Study|Lost to Follow-up|0|||
23425067|NCT00539513|65299849|FG001|Overall Study|Lost to Follow-up|1|||
23425068|NCT00223977|65299850|FG000|Overall Study|Adverse Event|7|||
23425069|NCT00223977|65299851|FG001|Overall Study|Adverse Event|10|||
23425070|NCT00223977|65299852|FG002|Overall Study|Adverse Event|0|||
23425071|NCT00223977|65299850|FG000|Overall Study|Protocol Violation|0|||
23425072|NCT00223977|65299851|FG001|Overall Study|Protocol Violation|0|||
23425073|NCT00223977|65299852|FG002|Overall Study|Protocol Violation|1|||
23425074|NCT00223977|65299850|FG000|Overall Study|Withdrawal by Subject|1|||
23425075|NCT00223977|65299851|FG001|Overall Study|Withdrawal by Subject|1|||
23425076|NCT00223977|65299852|FG002|Overall Study|Withdrawal by Subject|2|||
23425077|NCT00223977|65299850|FG000|Overall Study|Other|1|||
23425078|NCT00223977|65299851|FG001|Overall Study|Other|0|||
23425079|NCT00223977|65299852|FG002|Overall Study|Other|0|||
23425080|NCT04912895|65299853|FG000|Overall Study|Unable to provide specimen|2|||
23425081|NCT04912895|65299854|FG001|Overall Study|Unable to provide specimen|0|||
23425082|NCT04912895|65299855|FG002|Overall Study|Unable to provide specimen|0|||
23425083|NCT00159913|65299856|FG000|Overall Study|Adverse Event|1|||
23425084|NCT00159913|65299857|FG001|Overall Study|Adverse Event|0|||
23425085|NCT00159913|65299858|FG002|Overall Study|Adverse Event|1|||
23425086|NCT00159913|65299859|FG003|Overall Study|Adverse Event|0|||
23425087|NCT00159913|65299856|FG000|Overall Study|Withdrawal by Subject|0|||
23425088|NCT00159913|65299857|FG001|Overall Study|Withdrawal by Subject|0|||
23425089|NCT00159913|65299858|FG002|Overall Study|Withdrawal by Subject|0|||
23425090|NCT00159913|65299859|FG003|Overall Study|Withdrawal by Subject|1|||
23425091|NCT00159913|65299856|FG000|Overall Study|Lost to Follow-up|0|||
23425092|NCT00159913|65299857|FG001|Overall Study|Lost to Follow-up|0|||
23425093|NCT00159913|65299858|FG002|Overall Study|Lost to Follow-up|0|||
23425094|NCT00159913|65299859|FG003|Overall Study|Lost to Follow-up|1|||
23425095|NCT00159913|65299856|FG000|Overall Study|Protocol Violation|1|||
23425096|NCT00159913|65299857|FG001|Overall Study|Protocol Violation|0|||
23425097|NCT00159913|65299858|FG002|Overall Study|Protocol Violation|1|||
23425098|NCT00159913|65299859|FG003|Overall Study|Protocol Violation|0|||
23425099|NCT01669421|65299860|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
23425100|NCT01669421|65299860|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
23425101|NCT00355342|65299861|FG000|Overall Study|Adverse Event|13|||
23425102|NCT00355342|65299862|FG001|Overall Study|Adverse Event|15|||
23425103|NCT00355342|65299861|FG000|Overall Study|Lost to Follow-up|4|||
23425104|NCT00355342|65299862|FG001|Overall Study|Lost to Follow-up|2|||
23425105|NCT00355342|65299861|FG000|Overall Study|Withdrawal by Subject|14|||
23425106|NCT00355342|65299862|FG001|Overall Study|Withdrawal by Subject|11|||
23425107|NCT00355342|65299861|FG000|Overall Study|Sponsor terminated study|2|||
23425108|NCT00355342|65299862|FG001|Overall Study|Sponsor terminated study|2|||
23425109|NCT00355342|65299861|FG000|Overall Study|Overcompliant-PI discretion|1|||
23425110|NCT00355342|65299862|FG001|Overall Study|Overcompliant-PI discretion|0|||
23425111|NCT00355342|65299861|FG000|Overall Study|Use of prohibited medication|1|||
23425112|NCT00355342|65299862|FG001|Overall Study|Use of prohibited medication|0|||
23425113|NCT00355342|65299861|FG000|Overall Study|COPD exacerbation|1|||
23425114|NCT00355342|65299862|FG001|Overall Study|COPD exacerbation|1|||
23425115|NCT00355342|65299861|FG000|Overall Study|Dispensed wrong study drug kit|1|||
23425116|NCT00355342|65299862|FG001|Overall Study|Dispensed wrong study drug kit|0|||
23425117|NCT00355342|65299861|FG000|Overall Study|Non-compliance with Dexa scans|1|||
23425118|NCT00355342|65299862|FG001|Overall Study|Non-compliance with Dexa scans|0|||
23729109|NCT02736929|66388545|FG001|Main Study|Lost to Follow-up|1|||
23729110|NCT02736929|66388546|FG002|Main Study|Lost to Follow-up|0|||
23425119|NCT00355342|65299861|FG000|Overall Study|Withdrawal by participant and physician|1|||
23425120|NCT00355342|65299862|FG001|Overall Study|Withdrawal by participant and physician|0|||
23425121|NCT00355342|65299861|FG000|Overall Study|Participant relocated|0|||
23425122|NCT00355342|65299862|FG001|Overall Study|Participant relocated|1|||
23425123|NCT00355342|65299861|FG000|Overall Study|Participant discontinued study drug|0|||
23425124|NCT00355342|65299862|FG001|Overall Study|Participant discontinued study drug|1|||
23425125|NCT00355342|65299861|FG000|Overall Study|Study management|0|||
23425126|NCT00355342|65299862|FG001|Overall Study|Study management|1|||
23425127|NCT00355342|65299861|FG000|Overall Study|Protocol Violation|0|||
23425128|NCT00355342|65299862|FG001|Overall Study|Protocol Violation|1|||
23425129|NCT00355342|65299861|FG000|Overall Study|Use of protocol excluded medication|0|||
23425130|NCT00355342|65299862|FG001|Overall Study|Use of protocol excluded medication|1|||
23425131|NCT01967823|65299863|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
23425132|NCT02908685|65299864|FG000|Part 1 OLE|Withdrawal by Subject|0|||
23425133|NCT02908685|65299865|FG001|Part 1 OLE|Withdrawal by Subject|0|||
23425134|NCT02908685|65299866|FG002|Part 1 OLE|Withdrawal by Subject|0|||
23425135|NCT02908685|65299867|FG003|Part 1 OLE|Withdrawal by Subject|0|||
23425136|NCT02908685|65299868|FG004|Part 1 OLE|Withdrawal by Subject|0|||
23425137|NCT02908685|65299869|FG005|Part 1 OLE|Withdrawal by Subject|0|||
23425138|NCT02908685|65299870|FG006|Part 1 OLE|Withdrawal by Subject|0|||
23425139|NCT02908685|65299871|FG007|Part 1 OLE|Withdrawal by Subject|0|||
23425140|NCT02908685|65299872|FG008|Part 1 OLE|Withdrawal by Subject|0|||
23425141|NCT02908685|65299873|FG009|Part 1 OLE|Withdrawal by Subject|0|||
23425142|NCT02908685|65299874|FG010|Part 1 OLE|Withdrawal by Subject|2|||
23543198|NCT02415400|65719744|FG001|Overall Study|No study drug on site|1|||
23543199|NCT02415400|65719745|FG002|Overall Study|No study drug on site|0|||
23425143|NCT02908685|65299875|FG011|Part 1 OLE|Withdrawal by Subject|1|||
23425144|NCT02908685|65299876|FG012|Part 1 OLE|Withdrawal by Subject|0|||
23425145|NCT02908685|65299877|FG013|Part 1 OLE|Withdrawal by Subject|0|||
23425146|NCT02908685|65299864|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425147|NCT02908685|65299865|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425148|NCT02908685|65299866|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425149|NCT02908685|65299867|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425150|NCT02908685|65299868|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425151|NCT02908685|65299869|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425152|NCT02908685|65299870|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425153|NCT02908685|65299871|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425154|NCT02908685|65299872|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425155|NCT02908685|65299873|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425156|NCT02908685|65299874|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425157|NCT02908685|65299875|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425158|NCT02908685|65299876|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
23425159|NCT02908685|65299877|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
23425160|NCT02908685|65299864|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425161|NCT02908685|65299865|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425162|NCT02908685|65299866|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425163|NCT02908685|65299867|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425164|NCT02908685|65299868|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425165|NCT02908685|65299869|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425166|NCT02908685|65299870|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425167|NCT02908685|65299871|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425168|NCT02908685|65299872|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425169|NCT02908685|65299873|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23543200|NCT02415400|65719746|FG003|Overall Study|No study drug on site|0|||
23729111|NCT02736929|66388544|FG000|Main Study|Withdrawal by Subject|1|||
23729112|NCT02736929|66388545|FG001|Main Study|Withdrawal by Subject|1|||
23729113|NCT02736929|66388546|FG002|Main Study|Withdrawal by Subject|0|||
23729114|NCT02736929|66388544|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
23729115|NCT02736929|66388545|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
23425170|NCT02908685|65299874|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425171|NCT02908685|65299875|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425172|NCT02908685|65299876|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
23425173|NCT02908685|65299877|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425174|NCT02908685|65299864|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425175|NCT02908685|65299865|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425176|NCT02908685|65299866|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425177|NCT02908685|65299867|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23543201|NCT02415400|65719743|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
23543202|NCT02415400|65719744|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
23729116|NCT02736929|66388546|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
23729117|NCT02043509|66388547|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
23729118|NCT02043509|66388548|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
23729119|NCT02043509|66388547|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
23729120|NCT02043509|66388548|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
23729121|NCT02043509|66388547|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
23729122|NCT02043509|66388548|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
23729123|NCT02043509|66388547|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
23729124|NCT02043509|66388548|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
23729125|NCT00952419|66388549|FG000|Overall Study|Adverse Event|2|||
23729126|NCT00952419|66388550|FG001|Overall Study|Adverse Event|0|||
23729127|NCT00952419|66388551|FG002|Overall Study|Adverse Event|0|||
23729128|NCT00952419|66388549|FG000|Overall Study|Protocol Violation|3|||
23729129|NCT00952419|66388550|FG001|Overall Study|Protocol Violation|7|||
23729130|NCT00952419|66388551|FG002|Overall Study|Protocol Violation|0|||
23729131|NCT00952419|66388549|FG000|Overall Study|Withdrawal by Subject|1|||
23729132|NCT00952419|66388550|FG001|Overall Study|Withdrawal by Subject|3|||
23729133|NCT00952419|66388551|FG002|Overall Study|Withdrawal by Subject|0|||
23729134|NCT00464620|66388552|FG000|Overall Study|Physician Decision|1|||
23729135|NCT00464620|66388553|FG001|Overall Study|Physician Decision|0|||
23729136|NCT00464620|66388554|FG002|Overall Study|Physician Decision|0|||
23729137|NCT00464620|66388552|FG000|Overall Study|Withdrawal by Subject|1|||
23729138|NCT00464620|66388553|FG001|Overall Study|Withdrawal by Subject|0|||
23729139|NCT00464620|66388554|FG002|Overall Study|Withdrawal by Subject|3|||
23729140|NCT00464620|66388552|FG000|Overall Study|Ineligible sarcoma subtype|0|||
23729141|NCT00464620|66388553|FG001|Overall Study|Ineligible sarcoma subtype|2|||
23729142|NCT00464620|66388554|FG002|Overall Study|Ineligible sarcoma subtype|2|||
23729143|NCT00464620|66388552|FG000|Overall Study|Use of prohibited concomitant medication|0|||
23729144|NCT00464620|66388553|FG001|Overall Study|Use of prohibited concomitant medication|0|||
23729145|NCT00464620|66388554|FG002|Overall Study|Use of prohibited concomitant medication|2|||
23729146|NCT00859573|66388555|FG000|Overall Study|Withdrawal by Subject|4|||
23729147|NCT00859573|66388556|FG001|Overall Study|Withdrawal by Subject|1|||
23729148|NCT00859573|66388555|FG000|Overall Study|Physician Decision|1|||
23729149|NCT00859573|66388556|FG001|Overall Study|Physician Decision|1|||
23729150|NCT00809614|66388557|FG000|Overall Study|Lack of Efficacy|2|||
23729151|NCT00809614|66388558|FG001|Overall Study|Lack of Efficacy|3|||
23729152|NCT00809614|66388557|FG000|Overall Study|Withdrawal by Subject|1|||
23729153|NCT00809614|66388558|FG001|Overall Study|Withdrawal by Subject|1|||
23729154|NCT00509028|66388564|FG000|Overall Study|Adverse Event|2|||
23729155|NCT00509028|66388565|FG001|Overall Study|Adverse Event|0|||
23729156|NCT00509028|66388564|FG000|Overall Study|Withdrawal by Subject|4|||
23729157|NCT00509028|66388565|FG001|Overall Study|Withdrawal by Subject|3|||
23729158|NCT00509028|66388564|FG000|Overall Study|Lost to Follow-up|0|||
23729159|NCT00509028|66388565|FG001|Overall Study|Lost to Follow-up|1|||
23729160|NCT00509028|66388564|FG000|Overall Study|Protocol Violation|4|||
23729161|NCT00509028|66388565|FG001|Overall Study|Protocol Violation|2|||
23729162|NCT00509028|66388564|FG000|Overall Study|Non-compliance|2|||
23729163|NCT00509028|66388565|FG001|Overall Study|Non-compliance|1|||
23729164|NCT00290355|66388566|FG000|Overall Study|Serious adverse event|7|||
23729165|NCT00290355|66388567|FG001|Overall Study|Serious adverse event|4|||
23729166|NCT00290355|66388566|FG000|Overall Study|Study product reactogenicity|1|||
23729167|NCT00290355|66388567|FG001|Overall Study|Study product reactogenicity|0|||
23729168|NCT00290355|66388566|FG000|Overall Study|Protocol Violation|1|||
23729169|NCT00290355|66388567|FG001|Overall Study|Protocol Violation|0|||
23729170|NCT00290355|66388566|FG000|Overall Study|Withdrawal by Subject|2|||
23729171|NCT00290355|66388567|FG001|Overall Study|Withdrawal by Subject|0|||
23729172|NCT00290355|66388566|FG000|Overall Study|Migrated / moved from the study area|1|||
23729173|NCT00290355|66388567|FG001|Overall Study|Migrated / moved from the study area|0|||
23729174|NCT00290355|66388566|FG000|Overall Study|Lost to Follow-up|3|||
23729175|NCT00290355|66388567|FG001|Overall Study|Lost to Follow-up|1|||
23729176|NCT00290355|66388566|FG000|Overall Study|Other|2|||
23817752|NCT04386616|66711465|FG000|Overall Study|Death|22|||
23543203|NCT02415400|65719745|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
23543204|NCT02415400|65719746|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
23729177|NCT00290355|66388567|FG001|Overall Study|Other|0|||
23729178|NCT02809118|66388569|FG000|Overall Study|Withdrawal by Subject|0|||
23729179|NCT02809118|66388570|FG001|Overall Study|Withdrawal by Subject|1|||
23729180|NCT02809118|66388571|FG002|Overall Study|Withdrawal by Subject|1|||
23729181|NCT02691468|66388573|FG000|Overall Study|Bronchial blocker use|2|||
23729182|NCT02691468|66388574|FG001|Overall Study|Bronchial blocker use|1|||
23729183|NCT02691468|66388573|FG000|Overall Study|Lost to Follow-up|2|||
23729184|NCT02691468|66388574|FG001|Overall Study|Lost to Follow-up|1|||
23729185|NCT02691468|66388573|FG000|Overall Study|Failure to advance FOB|2|||
23729186|NCT02691468|66388574|FG001|Overall Study|Failure to advance FOB|0|||
23729187|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23729188|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
23817753|NCT04386616|66711466|FG001|Overall Study|Death|22|||
23729189|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
23729190|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23729191|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23729192|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23729193|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23729194|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
23729195|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23729196|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23729197|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23729198|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23616718|NCT00705614|65982423|FG001|Initial Intervention|Lost to Follow-up|191|||
23616719|NCT00705614|65982422|FG000|Initial Intervention|Withdrawal by Subject|114|||
23729199|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23729200|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23729201|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
23729202|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23729203|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23729204|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23817754|NCT04386616|66711467|FG002|Overall Study|Death|21|||
23425178|NCT02908685|65299868|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425179|NCT02908685|65299869|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425180|NCT02908685|65299870|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425181|NCT02908685|65299871|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425182|NCT02908685|65299872|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425183|NCT02908685|65299873|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425184|NCT02908685|65299874|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425185|NCT02908685|65299875|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425186|NCT02908685|65299876|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
23425187|NCT02908685|65299877|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425188|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Death|0|||
23425189|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Death|0|||
23425190|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Death|0|||
23425191|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Death|0|||
23425192|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Death|0|||
23425193|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Death|0|||
23425194|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Death|0|||
23543205|NCT02415400|65719743|FG000|Overall Study|Coagulation values cannot be set|0|||
23543206|NCT02415400|65719744|FG001|Overall Study|Coagulation values cannot be set|0|||
23543207|NCT02415400|65719745|FG002|Overall Study|Coagulation values cannot be set|1|||
23543208|NCT02415400|65719746|FG003|Overall Study|Coagulation values cannot be set|0|||
23543209|NCT02415400|65719743|FG000|Overall Study|State regulations prevent participation|0|||
23543210|NCT02415400|65719744|FG001|Overall Study|State regulations prevent participation|0|||
23543211|NCT02415400|65719745|FG002|Overall Study|State regulations prevent participation|1|||
23543212|NCT02415400|65719746|FG003|Overall Study|State regulations prevent participation|0|||
23543213|NCT02415400|65719743|FG000|Overall Study|Poor treatment monitoring|0|||
23543214|NCT02415400|65719744|FG001|Overall Study|Poor treatment monitoring|0|||
23543215|NCT02415400|65719745|FG002|Overall Study|Poor treatment monitoring|1|||
23543216|NCT02415400|65719746|FG003|Overall Study|Poor treatment monitoring|0|||
23616720|NCT00705614|65982423|FG001|Initial Intervention|Withdrawal by Subject|71|||
23616721|NCT00705614|65982422|FG000|Initial Intervention|Administrative Reason|51|||
23817755|NCT04386616|66711465|FG000|Overall Study|Lost to Follow-up|5|||
23817756|NCT04386616|66711466|FG001|Overall Study|Lost to Follow-up|8|||
23817757|NCT04386616|66711467|FG002|Overall Study|Lost to Follow-up|6|||
23817758|NCT04386616|66711465|FG000|Overall Study|Withdrawal by Subject|2|||
23817759|NCT04386616|66711466|FG001|Overall Study|Withdrawal by Subject|4|||
23817760|NCT04386616|66711467|FG002|Overall Study|Withdrawal by Subject|1|||
23817761|NCT04386616|66711465|FG000|Overall Study|Adverse Event|1|||
23817762|NCT04386616|66711466|FG001|Overall Study|Adverse Event|1|||
23817763|NCT04386616|66711467|FG002|Overall Study|Adverse Event|0|||
23817764|NCT02315196|66711468|FG000|Overall Study|Withdrew consent|9|||
23817765|NCT03694327|66711474|FG000|Overall Study|Lost to Follow-up|13|||
23817766|NCT03694327|66711475|FG001|Overall Study|Lost to Follow-up|23|||
23817767|NCT04400682|66711483|FG000|Period 1|Withdrawal by Subject|1|||
23729205|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23425195|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Death|0|||
23425196|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Death|0|||
23425197|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Death|0|||
23425198|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Death|0|||
23729206|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23817768|NCT04400682|66711484|FG001|Period 1|Withdrawal by Subject|4|||
23817769|NCT03275064|66711491|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23425199|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Death|0|||
23425200|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Death|1|||
23843094|NCT01738503|66805584|FG003|Treatment Period|Withdrawal by Subject|1|||
23817770|NCT03275064|66711492|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23425201|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Death|0|||
23817771|NCT03275064|66711493|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23817772|NCT03275064|66711494|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
23817773|NCT03275064|66711495|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23817774|NCT03275064|66711491|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
23817775|NCT03275064|66711492|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23817776|NCT03275064|66711493|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23817777|NCT03275064|66711494|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23817778|NCT03275064|66711495|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23616722|NCT00705614|65982423|FG001|Initial Intervention|Administrative Reason|38|||
23616723|NCT00705614|65982422|FG000|Initial Intervention|Status completion unknown|3|||
23616724|NCT00705614|65982423|FG001|Initial Intervention|Status completion unknown|0|||
23616725|NCT00705614|65982422|FG000|Switch to Remicade|Adverse Event|0|||
23616726|NCT00705614|65982423|FG001|Switch to Remicade|Adverse Event|5|||
23616727|NCT00705614|65982422|FG000|Switch to Remicade|Lost to Follow-up|0|||
23616728|NCT00705614|65982423|FG001|Switch to Remicade|Lost to Follow-up|23|||
23616729|NCT00705614|65982422|FG000|Switch to Remicade|Withdrawal by Subject|0|||
23616730|NCT00705614|65982423|FG001|Switch to Remicade|Withdrawal by Subject|12|||
23616731|NCT00705614|65982422|FG000|Switch to Remicade|Administrative Reason|0|||
23817779|NCT03275064|66711491|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
23817780|NCT03275064|66711492|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
23817781|NCT03275064|66711493|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
23817782|NCT03275064|66711494|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
23817783|NCT03275064|66711495|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
23817784|NCT03275064|66711491|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23817785|NCT03275064|66711492|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23817786|NCT03275064|66711493|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23817787|NCT03275064|66711494|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
23616732|NCT00705614|65982423|FG001|Switch to Remicade|Administrative Reason|9|||
23616733|NCT02809677|65982424|FG000|Overall Study|Withdrawal by Subject|8|||
23729207|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23729208|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23729209|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
23729210|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
23729211|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23729212|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23729213|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23729214|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23729215|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729216|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729217|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
23729218|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729219|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729220|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729221|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23729222|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
23729223|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
23729224|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
23729225|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23729226|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23729227|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23729228|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23729229|NCT04921969|66388589|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
23729230|NCT04921969|66388590|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
23729231|NCT04921969|66388591|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23729232|NCT04921969|66388592|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23729233|NCT04921969|66388593|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23729234|NCT04921969|66388594|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23729235|NCT04921969|66388595|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23729236|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729237|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729238|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729239|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729240|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729241|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23729242|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
23729243|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23729244|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23729245|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23729246|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23729247|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23729248|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
23729249|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23729250|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23729251|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23729252|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23729253|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
23729254|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
23729255|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23729256|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
23729257|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23729258|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23729259|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23729260|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
23729261|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23729262|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23729263|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
23729264|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23729265|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23729266|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23729267|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
23729268|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
23729269|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
23729270|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
23729271|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23729272|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23729273|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23729274|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
23729275|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23729276|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
23729277|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
23729278|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729279|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729280|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729281|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
23729282|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729283|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729284|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23729285|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23425202|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
23543217|NCT02415400|65719743|FG000|Overall Study|Participant in jail|0|||
23729286|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23729287|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23729288|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23729289|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23729290|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
23729291|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
23729292|NCT04921969|66388589|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23729293|NCT04921969|66388590|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23729294|NCT04921969|66388591|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23729295|NCT04921969|66388592|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
23729296|NCT04921969|66388593|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
23729297|NCT04921969|66388594|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
23729298|NCT04921969|66388595|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
23729299|NCT02640755|66388601|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
23729300|NCT02640755|66388602|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
23729301|NCT02640755|66388601|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
23729302|NCT02640755|66388602|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
23729303|NCT02640755|66388601|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
23729304|NCT02640755|66388602|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
23729305|NCT04539262|66388603|FG000|Overall Study|Adverse Event|0|||
23729306|NCT04539262|66388604|FG001|Overall Study|Adverse Event|0|||
23729307|NCT04539262|66388605|FG002|Overall Study|Adverse Event|1|||
23729308|NCT04539262|66388606|FG003|Overall Study|Adverse Event|0|||
23729309|NCT04539262|66388607|FG004|Overall Study|Adverse Event|0|||
23729310|NCT04539262|66388608|FG005|Overall Study|Adverse Event|0|||
23729311|NCT04539262|66388609|FG006|Overall Study|Adverse Event|0|||
23729312|NCT04539262|66388610|FG007|Overall Study|Adverse Event|0|||
23543218|NCT02415400|65719744|FG001|Overall Study|Participant in jail|0|||
23543219|NCT02415400|65719745|FG002|Overall Study|Participant in jail|1|||
23543220|NCT02415400|65719746|FG003|Overall Study|Participant in jail|0|||
23543221|NCT02415400|65719743|FG000|Overall Study|Investigator decision|0|||
23543222|NCT02415400|65719744|FG001|Overall Study|Investigator decision|0|||
23543223|NCT02415400|65719745|FG002|Overall Study|Investigator decision|1|||
23543224|NCT02415400|65719746|FG003|Overall Study|Investigator decision|1|||
23543225|NCT02415400|65719743|FG000|Overall Study|Site closure; participant won't transfer|0|||
23543226|NCT02415400|65719744|FG001|Overall Study|Site closure; participant won't transfer|0|||
23729313|NCT04539262|66388603|FG000|Overall Study|Withdrew Consent|0|||
23729314|NCT04539262|66388604|FG001|Overall Study|Withdrew Consent|0|||
23729315|NCT04539262|66388605|FG002|Overall Study|Withdrew Consent|0|||
23729316|NCT04539262|66388606|FG003|Overall Study|Withdrew Consent|1|||
23729317|NCT04539262|66388607|FG004|Overall Study|Withdrew Consent|0|||
23729318|NCT04539262|66388608|FG005|Overall Study|Withdrew Consent|0|||
23729319|NCT04539262|66388609|FG006|Overall Study|Withdrew Consent|0|||
23729320|NCT04539262|66388610|FG007|Overall Study|Withdrew Consent|0|||
23729321|NCT04539262|66388603|FG000|Overall Study|Randomized, Not treated|0|||
23729322|NCT04539262|66388604|FG001|Overall Study|Randomized, Not treated|1|||
23729323|NCT04539262|66388605|FG002|Overall Study|Randomized, Not treated|0|||
23616734|NCT05372913|65982425|FG000|Overall Study|Withdrawal by Subject|0|||
23616735|NCT05372913|65982426|FG001|Overall Study|Withdrawal by Subject|2|||
23616736|NCT05372913|65982425|FG000|Overall Study|Protocol Violation|2|||
23616737|NCT05372913|65982426|FG001|Overall Study|Protocol Violation|2|||
23729324|NCT04539262|66388606|FG003|Overall Study|Randomized, Not treated|0|||
23729325|NCT04539262|66388607|FG004|Overall Study|Randomized, Not treated|0|||
23729326|NCT04539262|66388608|FG005|Overall Study|Randomized, Not treated|0|||
23729327|NCT04539262|66388609|FG006|Overall Study|Randomized, Not treated|1|||
23729328|NCT04539262|66388610|FG007|Overall Study|Randomized, Not treated|0|||
23729329|NCT02332876|66388612|FG000|Overall Study|Lost to Follow-up|1|||
23729330|NCT02332876|66388613|FG001|Overall Study|Lost to Follow-up|1|||
23729331|NCT01634100|66388614|FG000|Overall Study|Withdrawal by Subject|1|||
23729332|NCT01634100|66388615|FG001|Overall Study|Withdrawal by Subject|0|||
23729333|NCT01634100|66388616|FG002|Overall Study|Withdrawal by Subject|1|||
23729334|NCT01634100|66388617|FG003|Overall Study|Withdrawal by Subject|0|||
23729335|NCT01634100|66388618|FG004|Overall Study|Withdrawal by Subject|0|||
23729336|NCT01634100|66388619|FG005|Overall Study|Withdrawal by Subject|0|||
23729337|NCT02728206|66388620|FG000|Overall Study|Death|1|||
23729338|NCT03864627|66388621|FG000|Overall Study|Adverse Event|0|||
23729339|NCT03864627|66388622|FG001|Overall Study|Adverse Event|1|||
23729340|NCT03864627|66388621|FG000|Overall Study|Lack of Efficacy|0|||
23729341|NCT03864627|66388622|FG001|Overall Study|Lack of Efficacy|1|||
23729342|NCT03864627|66388621|FG000|Overall Study|Lost to Follow-up|0|||
23729343|NCT03864627|66388622|FG001|Overall Study|Lost to Follow-up|1|||
23729344|NCT03864627|66388621|FG000|Overall Study|Withdrawal by Subject|4|||
23729345|NCT03864627|66388622|FG001|Overall Study|Withdrawal by Subject|8|||
23729346|NCT03864627|66388621|FG000|Overall Study|Study terminated by sponsor|0|||
23729347|NCT03864627|66388622|FG001|Overall Study|Study terminated by sponsor|1|||
23729348|NCT04280081|66388623|FG000|Overall Study|Adverse Event|4|||
23729349|NCT04280081|66388623|FG000|Overall Study|Death|2|||
23729350|NCT04280081|66388623|FG000|Overall Study|Progressive Disease|6|||
23729351|NCT03135262|66388624|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
23729352|NCT03135262|66388625|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23729353|NCT03135262|66388626|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23729354|NCT03135262|66388627|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23729355|NCT03135262|66388628|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23729356|NCT03135262|66388624|FG000|Overall Study|Progression of disease|0|||
23729357|NCT03135262|66388625|FG001|Overall Study|Progression of disease|0|||
23729358|NCT03135262|66388626|FG002|Overall Study|Progression of disease|0|||
23729359|NCT03135262|66388627|FG003|Overall Study|Progression of disease|1|||
23729360|NCT03135262|66388628|FG004|Overall Study|Progression of disease|0|||
23729361|NCT03135262|66388624|FG000|Overall Study|Death|6|||
23729362|NCT03135262|66388625|FG001|Overall Study|Death|2|||
23729363|NCT03135262|66388626|FG002|Overall Study|Death|2|||
23729364|NCT03135262|66388627|FG003|Overall Study|Death|2|||
23729365|NCT03135262|66388628|FG004|Overall Study|Death|0|||
23729366|NCT03135262|66388624|FG000|Overall Study|Withdrawal by Subject|0|||
23543227|NCT02415400|65719745|FG002|Overall Study|Site closure; participant won't transfer|0|||
23543228|NCT02415400|65719746|FG003|Overall Study|Site closure; participant won't transfer|1|||
23543229|NCT01660763|65719748|FG000|Overall Study|Lack of Efficacy|45|||
23729367|NCT03135262|66388625|FG001|Overall Study|Withdrawal by Subject|0|||
23543230|NCT01660763|65719749|FG001|Overall Study|Lack of Efficacy|50|||
23543231|NCT01660763|65719748|FG000|Overall Study|Adverse Event|22|||
23729368|NCT03135262|66388626|FG002|Overall Study|Withdrawal by Subject|1|||
23729369|NCT03135262|66388627|FG003|Overall Study|Withdrawal by Subject|0|||
23729370|NCT03135262|66388628|FG004|Overall Study|Withdrawal by Subject|1|||
23729371|NCT03135262|66388624|FG000|Overall Study|Study terminated by sponsor|2|||
23729372|NCT03135262|66388625|FG001|Overall Study|Study terminated by sponsor|4|||
23729373|NCT03135262|66388626|FG002|Overall Study|Study terminated by sponsor|4|||
23729374|NCT03135262|66388627|FG003|Overall Study|Study terminated by sponsor|3|||
23729375|NCT03135262|66388628|FG004|Overall Study|Study terminated by sponsor|0|||
23729376|NCT01387074|66388629|FG000|Overall Study|Lost to Follow-up|7|||
23543232|NCT01660763|65719749|FG001|Overall Study|Adverse Event|7|||
23543233|NCT01660763|65719748|FG000|Overall Study|Protocol Violation|1|||
23543234|NCT01660763|65719749|FG001|Overall Study|Protocol Violation|0|||
23543235|NCT01660763|65719748|FG000|Overall Study|Withdrawal by Subject|4|||
23425203|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
23425204|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
23425205|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
23425206|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
23425207|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
23425208|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
23425209|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
23425210|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
23425211|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
23425212|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
23425213|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
23425214|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
23425215|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
23425216|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425217|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425218|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425219|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425220|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425221|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425222|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425223|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425224|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425225|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425226|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425227|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425228|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
23425229|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
23425230|NCT00354107|65299878|FG000|Overall Study|Adverse Event|2|||
23425231|NCT00354107|65299878|FG000|Overall Study|Physician Decision|2|||
23425232|NCT00354107|65299878|FG000|Overall Study|Withdrawal by Subject|1|||
23425233|NCT00869050|65299880|FG000|Overall Study|Screen Failure|3|||
23425234|NCT02640625|65299884|FG000|Overall Study|Adverse Event|1|||
23425235|NCT01996592|65299885|FG000|Overall Study|no response to text/no diary entry|32|||
23425236|NCT01996592|65299885|FG000|Overall Study|change in surgical date|4|||
23425237|NCT01996592|65299885|FG000|Overall Study|Withdrawal by Subject|5|||
23425238|NCT01996592|65299885|FG000|Overall Study|change in mode of delivery|4|||
23425239|NCT02723006|65299886|FG000|Overall Study|Withdrawal by Subject|0|||
23425240|NCT02723006|65299887|FG001|Overall Study|Withdrawal by Subject|1|||
23425241|NCT02723006|65299888|FG002|Overall Study|Withdrawal by Subject|1|||
23425242|NCT02723006|65299886|FG000|Overall Study|Study Terminated by Sponsor|1|||
23425243|NCT02723006|65299887|FG001|Overall Study|Study Terminated by Sponsor|6|||
23425244|NCT02723006|65299888|FG002|Overall Study|Study Terminated by Sponsor|6|||
23425245|NCT01414205|65299889|FG000|Overall Study|Death|5|||
23425246|NCT01414205|65299890|FG001|Overall Study|Death|1|||
23425247|NCT01414205|65299889|FG000|Overall Study|Lost to Follow-up|1|||
23425248|NCT01414205|65299890|FG001|Overall Study|Lost to Follow-up|4|||
23425249|NCT01414205|65299889|FG000|Overall Study|Physician Decision|0|||
23425250|NCT01414205|65299890|FG001|Overall Study|Physician Decision|1|||
23425251|NCT01414205|65299889|FG000|Overall Study|Randomized but not Treated|1|||
23425252|NCT01414205|65299890|FG001|Overall Study|Randomized but not Treated|1|||
23425253|NCT04662073|65299891|FG000|Overall Study|Withdrawal by Subject|1|||
23425254|NCT04662073|65299892|FG001|Overall Study|Withdrawal by Subject|0|||
23425255|NCT01036529|65299893|FG000|Overall Study|Adverse Event|0|||
23425256|NCT01036529|65299894|FG001|Overall Study|Adverse Event|1|||
23425257|NCT01036529|65299893|FG000|Overall Study|Lost to Follow-up|0|||
23425258|NCT01036529|65299894|FG001|Overall Study|Lost to Follow-up|1|||
23425259|NCT01036529|65299893|FG000|Overall Study|Physician Decision|1|||
23425260|NCT01036529|65299894|FG001|Overall Study|Physician Decision|0|||
23425261|NCT01036529|65299893|FG000|Overall Study|Withdrawal by Subject|1|||
23425262|NCT01036529|65299894|FG001|Overall Study|Withdrawal by Subject|1|||
23425263|NCT01036529|65299893|FG000|Overall Study|Sponsor study termination|11|||
23425264|NCT01036529|65299894|FG001|Overall Study|Sponsor study termination|12|||
23425265|NCT00717522|65299895|FG000|Overall Study|Disease Progression|5|||
23425266|NCT00717522|65299895|FG000|Overall Study|Adverse Event|1|||
23425267|NCT00717522|65299895|FG000|Overall Study|Death|1|||
23425268|NCT00431951|65299899|FG000|Overall Study|Inability to follow study procedures|1|||
23425269|NCT00431951|65299900|FG001|Overall Study|Inability to follow study procedures|0|||
23425270|NCT00431951|65299901|FG002|Overall Study|Inability to follow study procedures|1|||
23425271|NCT00431951|65299902|FG003|Overall Study|Inability to follow study procedures|2|||
23425272|NCT00431951|65299899|FG000|Overall Study|Lost to Follow-up|0|||
23425273|NCT00431951|65299900|FG001|Overall Study|Lost to Follow-up|1|||
23543236|NCT01660763|65719749|FG001|Overall Study|Withdrawal by Subject|0|||
23425274|NCT00431951|65299901|FG002|Overall Study|Lost to Follow-up|0|||
23425275|NCT00431951|65299902|FG003|Overall Study|Lost to Follow-up|0|||
23425276|NCT00431951|65299899|FG000|Overall Study|Withdrawal by Subject|0|||
23425277|NCT00431951|65299900|FG001|Overall Study|Withdrawal by Subject|1|||
23425278|NCT00431951|65299901|FG002|Overall Study|Withdrawal by Subject|0|||
23425279|NCT00431951|65299902|FG003|Overall Study|Withdrawal by Subject|0|||
23425280|NCT00431951|65299899|FG000|Overall Study|Adverse Event|0|||
23425281|NCT00431951|65299900|FG001|Overall Study|Adverse Event|0|||
23425282|NCT00431951|65299901|FG002|Overall Study|Adverse Event|1|||
23425283|NCT00431951|65299902|FG003|Overall Study|Adverse Event|0|||
23425284|NCT01710527|65299903|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
23543237|NCT01660763|65719748|FG000|Overall Study|Patient ready for early discharge|28|||
23729377|NCT01387074|66388629|FG000|Overall Study|Lack of Efficacy|1|||
23729378|NCT00623766|66388632|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
23729379|NCT00623766|66388633|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
23729380|NCT00623766|66388632|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
23729381|NCT00623766|66388633|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
23729382|NCT00623766|66388632|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
23729383|NCT00623766|66388633|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
23729384|NCT00623766|66388632|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
23729385|NCT00623766|66388633|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
23729386|NCT00623766|66388632|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
23729387|NCT00623766|66388633|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
23729388|NCT03285490|66388634|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
23729389|NCT03285490|66388635|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
23817788|NCT03275064|66711495|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23817789|NCT03275064|66711491|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
23817790|NCT03275064|66711492|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23817791|NCT03275064|66711493|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
23817792|NCT03275064|66711494|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23817793|NCT03275064|66711495|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23817794|NCT03646123|66711496|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
23817795|NCT03646123|66711497|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
23817796|NCT03646123|66711498|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
23817797|NCT03646123|66711496|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
23817798|NCT03646123|66711497|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
23817799|NCT03646123|66711498|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
23543238|NCT01660763|65719749|FG001|Overall Study|Patient ready for early discharge|4|||
23543239|NCT00724282|65719752|FG000|Overall Study|Withdrawal by Subject|3|||
23543240|NCT00724282|65719752|FG000|Overall Study|Physician Decision|1|||
23543241|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
23543242|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543243|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543244|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543245|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
23543246|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543247|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543248|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543249|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543250|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
23543251|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543252|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543253|NCT01198600|65719760|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23543254|NCT01198600|65719761|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
23616738|NCT05372913|65982425|FG000|Overall Study|Adverse Event|0|||
23729390|NCT03285490|66388634|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
23729391|NCT03285490|66388635|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
23425285|NCT01710527|65299904|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
23817800|NCT03646123|66711496|FG000|Overall Study|Non-compliance to study protocol|1|||
23817801|NCT03646123|66711497|FG001|Overall Study|Non-compliance to study protocol|0|||
23817802|NCT03646123|66711498|FG002|Overall Study|Non-compliance to study protocol|0|||
23817803|NCT03646123|66711496|FG000|Overall Study|Ineligible due to progression during screening|0|||
23817804|NCT03646123|66711497|FG001|Overall Study|Ineligible due to progression during screening|0|||
23817805|NCT03646123|66711498|FG002|Overall Study|Ineligible due to progression during screening|1|||
23817806|NCT03646123|66711496|FG000|Overall Study|Withdrawal by Subject|2|||
23817807|NCT03646123|66711497|FG001|Overall Study|Withdrawal by Subject|1|||
23817808|NCT03646123|66711498|FG002|Overall Study|Withdrawal by Subject|3|||
23817809|NCT03646123|66711496|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
23817810|NCT03646123|66711497|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
23817811|NCT03646123|66711498|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
23817812|NCT03646123|66711496|FG000|Overall Study|Death|2|||
23817813|NCT03646123|66711497|FG001|Overall Study|Death|1|||
23817814|NCT03646123|66711498|FG002|Overall Study|Death|1|||
23817815|NCT03646123|66711496|FG000|Overall Study|Lost to Follow-up|4|||
23817816|NCT03646123|66711497|FG001|Overall Study|Lost to Follow-up|7|||
23817817|NCT03646123|66711498|FG002|Overall Study|Lost to Follow-up|6|||
23817818|NCT03646123|66711496|FG000|Overall Study|Participants in long term follow-up|0|||
23817819|NCT03646123|66711497|FG001|Overall Study|Participants in long term follow-up|48|||
23817820|NCT03646123|66711498|FG002|Overall Study|Participants in long term follow-up|144|||
23817821|NCT03276078|66711499|FG000|Overall Study|Adverse Event|1|||
23817822|NCT01210612|66711503|FG000|Overall Study|Withdrawal by Subject|0|||
23817823|NCT01210612|66711504|FG001|Overall Study|Withdrawal by Subject|2|||
23729392|NCT00102804|66388636|FG000|Overall Study|Progressive Disease (PD)|307|||
23729393|NCT00102804|66388637|FG001|Overall Study|Progressive Disease (PD)|196|||
23729394|NCT00102804|66388636|FG000|Overall Study|Withdrawal by Subject|46|||
23729395|NCT00102804|66388637|FG001|Overall Study|Withdrawal by Subject|7|||
23729396|NCT00102804|66388636|FG000|Overall Study|Adverse Event|37|||
23729397|NCT00102804|66388637|FG001|Overall Study|Adverse Event|3|||
23817824|NCT05005312|66711505|FG000|Overall Study|Enrolled, but not treated|0|||
23817825|NCT05005312|66711506|FG001|Overall Study|Enrolled, but not treated|1|||
23817826|NCT02643355|66711507|FG000|Overall Study|Withdrawal by Subject|1|||
23817827|NCT02643355|66711508|FG001|Overall Study|Withdrawal by Subject|3|||
23817828|NCT02643355|66711507|FG000|Overall Study|Protocol Violation|0|||
23817829|NCT02643355|66711508|FG001|Overall Study|Protocol Violation|2|||
23817830|NCT00985491|66711509|FG000|Overall Study|Adverse Event|8|||
23817831|NCT00985491|66711509|FG000|Overall Study|device migration|7|||
23817832|NCT00985491|66711509|FG000|Overall Study|Withdrawal by Subject|1|||
23817833|NCT00985491|66711509|FG000|Overall Study|implant failure|3|||
23817834|NCT00528411|66711510|FG000|Overall Study|Adverse Event|4|||
23817835|NCT00528411|66711511|FG001|Overall Study|Adverse Event|0|||
23817836|NCT00528411|66711512|FG002|Overall Study|Adverse Event|1|||
23817837|NCT00528411|66711510|FG000|Overall Study|Incorrect Enrolment|1|||
23817838|NCT00528411|66711511|FG001|Overall Study|Incorrect Enrolment|1|||
23817839|NCT00528411|66711512|FG002|Overall Study|Incorrect Enrolment|0|||
23817840|NCT00528411|66711510|FG000|Overall Study|Severe non-compliance to protocol|0|||
23817841|NCT00528411|66711511|FG001|Overall Study|Severe non-compliance to protocol|1|||
23817842|NCT00528411|66711512|FG002|Overall Study|Severe non-compliance to protocol|0|||
23817843|NCT00528411|66711510|FG000|Overall Study|Prior commitment medication|0|||
23817844|NCT00528411|66711511|FG001|Overall Study|Prior commitment medication|1|||
23817845|NCT00528411|66711512|FG002|Overall Study|Prior commitment medication|0|||
23817846|NCT04480021|66711513|FG000|Overall Study|Lost to Follow-up|3|||
23817847|NCT04480021|66711514|FG001|Overall Study|Lost to Follow-up|4|||
23817848|NCT02388906|66711515|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23817849|NCT02388906|66711516|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23817850|NCT02388906|66711515|FG000|Treatment Period|Disease progression|121|||
23817851|NCT02388906|66711516|FG001|Treatment Period|Disease progression|101|||
23817852|NCT02388906|66711515|FG000|Treatment Period|Study drug toxicity|41|||
23817853|NCT02388906|66711516|FG001|Treatment Period|Study drug toxicity|208|||
23817854|NCT02388906|66711515|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
23543255|NCT01198600|65719762|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23817855|NCT02388906|66711516|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
23817856|NCT02388906|66711515|FG000|Treatment Period|Participant request to stop treatment|5|||
23817857|NCT02388906|66711516|FG001|Treatment Period|Participant request to stop treatment|9|||
23817858|NCT02388906|66711515|FG000|Treatment Period|Participant withdrew consent|2|||
23729398|NCT00102804|66388636|FG000|Overall Study|Physician Decision|24|||
23729399|NCT00102804|66388637|FG001|Overall Study|Physician Decision|6|||
23729400|NCT00102804|66388636|FG000|Overall Study|Death|5|||
23817859|NCT02388906|66711516|FG001|Treatment Period|Participant withdrew consent|3|||
23817860|NCT02388906|66711515|FG000|Treatment Period|Poor/non-compliance|0|||
23817861|NCT02388906|66711516|FG001|Treatment Period|Poor/non-compliance|1|||
23817862|NCT02388906|66711515|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23616739|NCT05372913|65982426|FG001|Overall Study|Adverse Event|1|||
23616740|NCT05177770|65982429|FG000|Overall Study|Death|4|||
23616741|NCT05177770|65982429|FG000|Overall Study|Withdrawal by Subject|1|||
23616742|NCT05177770|65982429|FG000|Overall Study|Adverse Event prior to dosing|1|||
23616743|NCT01887418|65982430|FG000|Overall Study|Travelling difficulties|0|||
23616744|NCT01887418|65982431|FG001|Overall Study|Travelling difficulties|0|||
23616745|NCT01887418|65982432|FG002|Overall Study|Travelling difficulties|1|||
23616746|NCT01503515|65982433|FG000|Overall Study|Adverse Event|4|||
23616747|NCT01503515|65982434|FG001|Overall Study|Adverse Event|5|||
23616748|NCT01503515|65982433|FG000|Overall Study|Death|0|||
23616749|NCT01503515|65982434|FG001|Overall Study|Death|1|||
23616750|NCT01503515|65982433|FG000|Overall Study|Physician Decision|14|||
23616751|NCT01503515|65982434|FG001|Overall Study|Physician Decision|23|||
23616752|NCT01503515|65982433|FG000|Overall Study|Withdrawal by Subject|0|||
23616753|NCT01503515|65982434|FG001|Overall Study|Withdrawal by Subject|1|||
23616754|NCT01503515|65982433|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
23616755|NCT01503515|65982434|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
23616756|NCT01503515|65982433|FG000|Overall Study|Ineligible|1|||
23616757|NCT01503515|65982434|FG001|Overall Study|Ineligible|1|||
23616758|NCT02625922|65982436|FG000|Overall Study|Non-availability of IMP|1|||
23616759|NCT02625922|65982437|FG001|Overall Study|Non-availability of IMP|1|||
23616760|NCT02625922|65982436|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
23616761|NCT02625922|65982437|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
23616762|NCT00666835|65982444|FG000|Overall Study|Withdrawal by Subject|5|||
23616763|NCT00666835|65982445|FG001|Overall Study|Withdrawal by Subject|2|||
23616764|NCT00666835|65982444|FG000|Overall Study|Lack of Efficacy|0|||
23616765|NCT00666835|65982445|FG001|Overall Study|Lack of Efficacy|1|||
23616766|NCT00666835|65982444|FG000|Overall Study|Incl./excl. not fulfilled|7|||
23616767|NCT00666835|65982445|FG001|Overall Study|Incl./excl. not fulfilled|2|||
23616768|NCT00666835|65982444|FG000|Overall Study|Adverse Event|7|||
23616769|NCT00666835|65982445|FG001|Overall Study|Adverse Event|6|||
23616770|NCT00666835|65982444|FG000|Overall Study|Protocol Violation|2|||
23616771|NCT00666835|65982445|FG001|Overall Study|Protocol Violation|0|||
23616772|NCT00666835|65982444|FG000|Overall Study|Death|15|||
23616773|NCT00666835|65982445|FG001|Overall Study|Death|4|||
23616774|NCT00666835|65982444|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
23616775|NCT00666835|65982445|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
23616776|NCT00666835|65982444|FG000|Overall Study|Hemoglobulin concentration|4|||
23616777|NCT00666835|65982445|FG001|Overall Study|Hemoglobulin concentration|3|||
23616778|NCT00666835|65982444|FG000|Overall Study|Planned operation|2|||
23616779|NCT00666835|65982445|FG001|Overall Study|Planned operation|0|||
23616780|NCT00666835|65982444|FG000|Overall Study|Physician Decision|1|||
23616781|NCT00666835|65982445|FG001|Overall Study|Physician Decision|2|||
23616782|NCT01812837|65982446|FG000|Overall Study|Lost to Follow-up|1|||
23616783|NCT01812837|65982447|FG001|Overall Study|Lost to Follow-up|1|||
23616784|NCT01812837|65982448|FG002|Overall Study|Lost to Follow-up|0|||
23616785|NCT01812837|65982446|FG000|Overall Study|Protocol Violation|1|||
23616786|NCT01812837|65982447|FG001|Overall Study|Protocol Violation|0|||
23616787|NCT01812837|65982448|FG002|Overall Study|Protocol Violation|0|||
23616788|NCT03469258|65982459|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
23616789|NCT04175834|65982460|FG000|Overall Study|Withdrawal by Subject|1|||
23616790|NCT04175834|65982461|FG001|Overall Study|Withdrawal by Subject|0|||
23616791|NCT03786783|65982462|FG000|Overall Study|Death|1|||
23616792|NCT03786783|65982462|FG000|Overall Study|Physician Decision|6|||
23616793|NCT03786783|65982462|FG000|Overall Study|Withdrawal by Subject|2|||
23616794|NCT03786783|65982462|FG000|Overall Study|Disease Progression|7|||
23616795|NCT03786783|65982462|FG000|Overall Study|Patient/Parent Refusal|4|||
23616796|NCT02040532|65982464|FG000|Overall Study|Lost to Follow-up|1|||
23616797|NCT02040532|65982464|FG000|Overall Study|Physician Decision|4|||
23616798|NCT02040532|65982464|FG000|Overall Study|Adverse Event|4|||
23616799|NCT02040532|65982464|FG000|Overall Study|Withdrawal by Subject|3|||
23616800|NCT03794609|65982465|FG000|Overall Study|Other|10|||
23616801|NCT03794609|65982465|FG000|Overall Study|Withdrawal by Subject|66|||
23616802|NCT03794609|65982465|FG000|Overall Study|The child is enrolled in an interventional study|70|||
23616803|NCT03794609|65982465|FG000|Overall Study|Inclusion/exclusion criteria|8|||
23817863|NCT02388906|66711516|FG001|Treatment Period|Participant no longer meets study criteria|1|||
23616804|NCT03794609|65982465|FG000|Overall Study|At sponsor's request|151|||
23616805|NCT03794609|65982465|FG000|Overall Study|Physician Decision|1|||
23616806|NCT03794609|65982465|FG000|Overall Study|Lost to Follow-up|5|||
23616807|NCT00187135|65982467|FG000|Visit One|Withdrawal by Subject|1|||
23616808|NCT00187135|65982468|FG001|Visit One|Withdrawal by Subject|0|||
23616809|NCT00187135|65982469|FG002|Visit One|Withdrawal by Subject|0|||
23616810|NCT00187135|65982470|FG003|Visit One|Withdrawal by Subject|0|||
23616811|NCT00187135|65982471|FG004|Visit One|Withdrawal by Subject|0|||
23616812|NCT00187135|65982472|FG005|Visit One|Withdrawal by Subject|1|||
23616813|NCT00187135|65982467|FG000|Visit One|Physician Decision|3|||
23616814|NCT00187135|65982468|FG001|Visit One|Physician Decision|1|||
23616815|NCT00187135|65982469|FG002|Visit One|Physician Decision|0|||
23616816|NCT00187135|65982470|FG003|Visit One|Physician Decision|0|||
23616817|NCT00187135|65982471|FG004|Visit One|Physician Decision|0|||
23616818|NCT00187135|65982472|FG005|Visit One|Physician Decision|1|||
23616819|NCT00187135|65982467|FG000|Visit Two|Death|0|||
23616820|NCT00187135|65982468|FG001|Visit Two|Death|0|||
23616821|NCT00187135|65982469|FG002|Visit Two|Death|0|||
23616822|NCT00187135|65982470|FG003|Visit Two|Death|1|||
23616823|NCT00187135|65982471|FG004|Visit Two|Death|0|||
23616824|NCT00187135|65982472|FG005|Visit Two|Death|1|||
23616825|NCT00187135|65982467|FG000|Visit Two|Physician Decision|1|||
23616826|NCT00187135|65982468|FG001|Visit Two|Physician Decision|0|||
23616827|NCT00187135|65982469|FG002|Visit Two|Physician Decision|0|||
23616828|NCT00187135|65982470|FG003|Visit Two|Physician Decision|0|||
23616829|NCT00187135|65982471|FG004|Visit Two|Physician Decision|0|||
23616830|NCT00187135|65982472|FG005|Visit Two|Physician Decision|0|||
23616831|NCT00187135|65982467|FG000|Visit Two|Withdrawal by Subject|1|||
23616832|NCT00187135|65982468|FG001|Visit Two|Withdrawal by Subject|1|||
23616833|NCT00187135|65982469|FG002|Visit Two|Withdrawal by Subject|1|||
23616834|NCT00187135|65982470|FG003|Visit Two|Withdrawal by Subject|0|||
23616835|NCT00187135|65982471|FG004|Visit Two|Withdrawal by Subject|1|||
23616836|NCT00187135|65982472|FG005|Visit Two|Withdrawal by Subject|1|||
23616837|NCT00187135|65982467|FG000|Visit Two|Study Discontinued|3|||
23616838|NCT00187135|65982468|FG001|Visit Two|Study Discontinued|2|||
23616839|NCT00187135|65982469|FG002|Visit Two|Study Discontinued|1|||
23616840|NCT00187135|65982470|FG003|Visit Two|Study Discontinued|7|||
23616841|NCT00187135|65982471|FG004|Visit Two|Study Discontinued|5|||
23616842|NCT00187135|65982472|FG005|Visit Two|Study Discontinued|6|||
23616843|NCT00187135|65982467|FG000|Visit Three|Death|0|||
23616844|NCT00187135|65982468|FG001|Visit Three|Death|0|||
23616845|NCT00187135|65982469|FG002|Visit Three|Death|1|||
23616846|NCT00187135|65982470|FG003|Visit Three|Death|0|||
23616847|NCT00187135|65982471|FG004|Visit Three|Death|1|||
23616848|NCT00187135|65982472|FG005|Visit Three|Death|0|||
23616849|NCT00187135|65982467|FG000|Visit Three|Withdrawal by Subject|0|||
23616850|NCT00187135|65982468|FG001|Visit Three|Withdrawal by Subject|1|||
23616851|NCT00187135|65982469|FG002|Visit Three|Withdrawal by Subject|1|||
23616852|NCT00187135|65982470|FG003|Visit Three|Withdrawal by Subject|2|||
23616853|NCT00187135|65982471|FG004|Visit Three|Withdrawal by Subject|0|||
23616854|NCT00187135|65982472|FG005|Visit Three|Withdrawal by Subject|0|||
23616855|NCT00187135|65982467|FG000|Visit Three|Study Discontinued|7|||
23616856|NCT00187135|65982468|FG001|Visit Three|Study Discontinued|6|||
23616857|NCT00187135|65982469|FG002|Visit Three|Study Discontinued|7|||
23616858|NCT00187135|65982470|FG003|Visit Three|Study Discontinued|7|||
23616859|NCT00187135|65982471|FG004|Visit Three|Study Discontinued|7|||
23616860|NCT00187135|65982472|FG005|Visit Three|Study Discontinued|6|||
23616861|NCT05335005|65982473|FG000|Overall Study|Lost to Follow-up|1|||
23616862|NCT05060237|65982474|FG000|Overall Study|Withdrawal by Subject|4|||
23616863|NCT05060237|65982474|FG000|Overall Study|Screening failure|8|||
23616864|NCT00385697|65982477|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
23616865|NCT00385697|65982478|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
23616866|NCT00385697|65982479|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
23616867|NCT00385697|65982480|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
23616868|NCT00385697|65982481|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
23616869|NCT00385697|65982477|FG000|Open-label Segment 1|Lost to Follow-up|1|||
23616870|NCT00385697|65982478|FG001|Open-label Segment 1|Lost to Follow-up|0|||
23616871|NCT00385697|65982479|FG002|Open-label Segment 1|Lost to Follow-up|0|||
23616872|NCT00385697|65982480|FG003|Open-label Segment 1|Lost to Follow-up|0|||
23616873|NCT00385697|65982481|FG004|Open-label Segment 1|Lost to Follow-up|0|||
23616874|NCT00385697|65982477|FG000|Double-blind Segment 2|Adverse Event|0|||
23616875|NCT00385697|65982478|FG001|Double-blind Segment 2|Adverse Event|3|||
23616876|NCT00385697|65982479|FG002|Double-blind Segment 2|Adverse Event|1|||
23616877|NCT00385697|65982480|FG003|Double-blind Segment 2|Adverse Event|0|||
23616878|NCT00385697|65982481|FG004|Double-blind Segment 2|Adverse Event|0|||
23616879|NCT00385697|65982477|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
23616880|NCT00385697|65982478|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
23616881|NCT00385697|65982479|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
23616882|NCT00385697|65982480|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
23616883|NCT00385697|65982481|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
23616884|NCT00385697|65982477|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
23616885|NCT00385697|65982478|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
23616886|NCT00385697|65982479|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
23616887|NCT00385697|65982480|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
23616888|NCT00385697|65982481|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
23616889|NCT00385697|65982477|FG000|Double-blind Segment 2|Other|0|||
23616890|NCT00385697|65982478|FG001|Double-blind Segment 2|Other|2|||
23616891|NCT00385697|65982479|FG002|Double-blind Segment 2|Other|0|||
23616892|NCT00385697|65982480|FG003|Double-blind Segment 2|Other|0|||
23616893|NCT00385697|65982481|FG004|Double-blind Segment 2|Other|0|||
23616894|NCT00762723|65982482|FG000|Overall Study|Study Terminated slow enrollement|5|||
23616895|NCT00762723|65982483|FG001|Overall Study|Study Terminated slow enrollement|5|||
23616896|NCT00762723|65982484|FG002|Overall Study|Study Terminated slow enrollement|3|||
23616897|NCT03924193|65982489|FG000|Overall Study|Adverse Event|10|||
23616898|NCT03924193|65982490|FG001|Overall Study|Adverse Event|0|||
23616899|NCT03924193|65982491|FG002|Overall Study|Adverse Event|10|||
23616900|NCT03924193|65982489|FG000|Overall Study|Withdrawal by Subject|5|||
23616901|NCT03924193|65982490|FG001|Overall Study|Withdrawal by Subject|10|||
23616902|NCT03924193|65982491|FG002|Overall Study|Withdrawal by Subject|2|||
23616903|NCT02243605|65982492|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
23616904|NCT02243605|65982493|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
23616905|NCT02243605|65982492|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
23729401|NCT00102804|66388637|FG001|Overall Study|Death|6|||
23729402|NCT00102804|66388636|FG000|Overall Study|Enrollment Criteria Not Met|6|||
23729403|NCT00102804|66388637|FG001|Overall Study|Enrollment Criteria Not Met|0|||
23729404|NCT00102804|66388636|FG000|Overall Study|Lost to Follow-up|4|||
23817864|NCT02388906|66711515|FG000|Treatment Period|Other reasons|3|||
23817865|NCT02388906|66711516|FG001|Treatment Period|Other reasons|3|||
23817866|NCT00806286|66711522|FG000|Overall Study|Adverse Event|5|||
23817867|NCT00806286|66711523|FG001|Overall Study|Adverse Event|2|||
23817868|NCT00806286|66711524|FG002|Overall Study|Adverse Event|0|||
23817869|NCT00806286|66711522|FG000|Overall Study|Disease progression|31|||
23817870|NCT00806286|66711523|FG001|Overall Study|Disease progression|38|||
23817871|NCT00806286|66711524|FG002|Overall Study|Disease progression|1|||
23817872|NCT00806286|66711522|FG000|Overall Study|Death|1|||
23817873|NCT00806286|66711523|FG001|Overall Study|Death|6|||
23817874|NCT00806286|66711524|FG002|Overall Study|Death|0|||
23817875|NCT00806286|66711522|FG000|Overall Study|Lost to Follow-up|0|||
23817876|NCT00806286|66711523|FG001|Overall Study|Lost to Follow-up|1|||
23425286|NCT00694096|65299920|FG000|Overall Study|Withdrawal by Subject|5|||
23425287|NCT00953680|65299921|FG000|Period 1|Withdrawal by Subject|0|||
23425288|NCT00953680|65299922|FG001|Period 1|Withdrawal by Subject|1|||
23543256|NCT01198600|65719763|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23543257|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543258|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543259|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
23543260|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543261|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
23543262|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
23729405|NCT00102804|66388637|FG001|Overall Study|Lost to Follow-up|1|||
23729406|NCT00102804|66388636|FG000|Overall Study|Protocol Violation|2|||
23729407|NCT00102804|66388637|FG001|Overall Study|Protocol Violation|1|||
23729408|NCT00102804|66388636|FG000|Overall Study|Satisfactory Response|2|||
23729409|NCT00102804|66388637|FG001|Overall Study|Satisfactory Response|0|||
23817877|NCT00806286|66711524|FG002|Overall Study|Lost to Follow-up|0|||
23817878|NCT00806286|66711522|FG000|Overall Study|Withdrawal by Subject|8|||
23817879|NCT00806286|66711523|FG001|Overall Study|Withdrawal by Subject|3|||
23817880|NCT00806286|66711524|FG002|Overall Study|Withdrawal by Subject|1|||
23817881|NCT00806286|66711522|FG000|Overall Study|Physician Decision|2|||
23425289|NCT02753127|65299927|FG000|Overall Study|Lost to Follow-up|13|||
23543263|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
23543264|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
23543265|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23543266|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23425290|NCT02753127|65299928|FG001|Overall Study|Lost to Follow-up|11|||
23425291|NCT02753127|65299927|FG000|Overall Study|Withdrawal by Subject|37|||
23425292|NCT02753127|65299928|FG001|Overall Study|Withdrawal by Subject|47|||
23425293|NCT02753127|65299927|FG000|Overall Study|Other|3|||
23543267|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
23543268|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23543269|NCT01054729|65719764|FG000|Overall Study|Randomized but Not Treated|0|||
23543270|NCT01054729|65719765|FG001|Overall Study|Randomized but Not Treated|1|||
23817882|NCT00806286|66711523|FG001|Overall Study|Physician Decision|2|||
23817883|NCT00806286|66711524|FG002|Overall Study|Physician Decision|0|||
23817884|NCT00806286|66711522|FG000|Overall Study|Due to a variety of reasons|7|||
23543271|NCT01054729|65719766|FG002|Overall Study|Randomized but Not Treated|0|||
23616906|NCT02243605|65982493|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
23616907|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
23616908|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
23729410|NCT00102804|66388636|FG000|Overall Study|Sponsor Decision|1|||
23729411|NCT00102804|66388637|FG001|Overall Study|Sponsor Decision|0|||
23729412|NCT00102804|66388636|FG000|Overall Study|Alive, Receiving Treatment|7|||
23425294|NCT02753127|65299928|FG001|Overall Study|Other|8|||
23729413|NCT00102804|66388637|FG001|Overall Study|Alive, Receiving Treatment|2|||
23729414|NCT00117572|66388638|FG000|Overall Study|Site withdrew before starting treatment|2|||
23729415|NCT00117572|66388639|FG001|Overall Study|Site withdrew before starting treatment|3|||
23729416|NCT00117572|66388638|FG000|Overall Study|Withdrawal by Subject|3|||
23729417|NCT00117572|66388639|FG001|Overall Study|Withdrawal by Subject|3|||
23729418|NCT00117572|66388638|FG000|Overall Study|Protocol Violation|1|||
23729419|NCT00117572|66388639|FG001|Overall Study|Protocol Violation|0|||
23729420|NCT03369704|66388640|FG000|Treatment Epoch|technical problems|1|||
23729421|NCT03369704|66388641|FG001|Treatment Epoch|technical problems|0|||
23729422|NCT03369704|66388640|FG000|Treatment Epoch|Protocol Violation|1|||
23729423|NCT03369704|66388641|FG001|Treatment Epoch|Protocol Violation|0|||
23729424|NCT03369704|66388640|FG000|Treatment Epoch|Lost to Follow-up|0|||
23729425|NCT03369704|66388641|FG001|Treatment Epoch|Lost to Follow-up|1|||
23729426|NCT03369704|66388640|FG000|Treatment Epoch|Lack of Efficacy|0|||
23729427|NCT03369704|66388641|FG001|Treatment Epoch|Lack of Efficacy|2|||
23729428|NCT03369704|66388640|FG000|Treatment Epoch|Adverse Event|2|||
23729429|NCT03369704|66388641|FG001|Treatment Epoch|Adverse Event|0|||
23729430|NCT03369704|66388640|FG000|Follow-up Epoch|Lost to Follow-up|1|||
23729431|NCT03369704|66388641|FG001|Follow-up Epoch|Lost to Follow-up|0|||
23729432|NCT01681836|66388642|FG000|Second Intervention|Withdrawal by Subject|0|||
23729433|NCT01681836|66388643|FG001|Second Intervention|Withdrawal by Subject|1|||
23729434|NCT00732238|66388644|FG000|Overall Study|Bacteremia|4|||
23729435|NCT00732238|66388645|FG001|Overall Study|Bacteremia|1|||
23729436|NCT00732238|66388644|FG000|Overall Study|Asymptomatic bacteriuria|1|||
23729437|NCT00732238|66388645|FG001|Overall Study|Asymptomatic bacteriuria|0|||
23729438|NCT01462045|66388646|FG000|Overall Study|Family matter|0|||
23729439|NCT01462045|66388647|FG001|Overall Study|Family matter|1|||
23729440|NCT01462045|66388648|FG002|Overall Study|Family matter|0|||
23729441|NCT01347840|66388652|FG000|Overall Study|Withdrawal by Subject|1|||
23729442|NCT02415595|66388659|FG000|Overall Study|Administrative reason by sponsor|39|||
23729443|NCT02415595|66388660|FG001|Overall Study|Administrative reason by sponsor|40|||
23729444|NCT02415595|66388661|FG002|Overall Study|Administrative reason by sponsor|41|||
23729445|NCT02415595|66388662|FG003|Overall Study|Administrative reason by sponsor|39|||
23729446|NCT02415595|66388659|FG000|Overall Study|Adverse Event|1|||
23729447|NCT02415595|66388660|FG001|Overall Study|Adverse Event|3|||
23729448|NCT02415595|66388661|FG002|Overall Study|Adverse Event|5|||
23729449|NCT02415595|66388662|FG003|Overall Study|Adverse Event|10|||
23729450|NCT02415595|66388659|FG000|Overall Study|Lack of Efficacy|4|||
23729451|NCT02415595|66388660|FG001|Overall Study|Lack of Efficacy|4|||
23729452|NCT02415595|66388661|FG002|Overall Study|Lack of Efficacy|0|||
23729453|NCT02415595|66388662|FG003|Overall Study|Lack of Efficacy|0|||
23729454|NCT02415595|66388659|FG000|Overall Study|Lost to Follow-up|1|||
23729455|NCT02415595|66388660|FG001|Overall Study|Lost to Follow-up|3|||
23729456|NCT02415595|66388661|FG002|Overall Study|Lost to Follow-up|1|||
23817885|NCT00806286|66711523|FG001|Overall Study|Due to a variety of reasons|2|||
23817886|NCT00806286|66711524|FG002|Overall Study|Due to a variety of reasons|1|||
23817887|NCT05314816|66711530|FG000|Overall Study|Lost to Follow-up|5|||
23817888|NCT05314816|66711531|FG001|Overall Study|Lost to Follow-up|0|||
23817889|NCT05314816|66711532|FG002|Overall Study|Lost to Follow-up|1|||
23817890|NCT05314816|66711530|FG000|Overall Study|Protocol Violation|13|||
23817891|NCT05314816|66711531|FG001|Overall Study|Protocol Violation|8|||
23817892|NCT05314816|66711532|FG002|Overall Study|Protocol Violation|0|||
23817893|NCT01449812|66711533|FG000|Overall Study|Migrated/moved from study area|1|||
23817894|NCT01449812|66711534|FG001|Overall Study|Migrated/moved from study area|0|||
23817895|NCT01449812|66711535|FG002|Overall Study|Migrated/moved from study area|0|||
23729457|NCT02415595|66388662|FG003|Overall Study|Lost to Follow-up|1|||
23729458|NCT02415595|66388659|FG000|Overall Study|Poor/Non-compliance|1|||
23729459|NCT02415595|66388660|FG001|Overall Study|Poor/Non-compliance|0|||
23729460|NCT02415595|66388661|FG002|Overall Study|Poor/Non-compliance|1|||
23729461|NCT02415595|66388662|FG003|Overall Study|Poor/Non-compliance|0|||
23729462|NCT02415595|66388659|FG000|Overall Study|Reached stopping criteria|0|||
23729463|NCT02415595|66388660|FG001|Overall Study|Reached stopping criteria|1|||
23729464|NCT02415595|66388661|FG002|Overall Study|Reached stopping criteria|1|||
23729465|NCT02415595|66388662|FG003|Overall Study|Reached stopping criteria|0|||
23729466|NCT02415595|66388659|FG000|Overall Study|Withdrawal by Subject|4|||
23729467|NCT02415595|66388660|FG001|Overall Study|Withdrawal by Subject|0|||
23729468|NCT02415595|66388661|FG002|Overall Study|Withdrawal by Subject|1|||
23817896|NCT01449812|66711533|FG000|Overall Study|Withdrawal by Subject|0|||
23543272|NCT01054729|65719767|FG003|Overall Study|Randomized but Not Treated|0|||
23543273|NCT01054729|65719764|FG000|Overall Study|Adverse Event|1|||
23543274|NCT01054729|65719765|FG001|Overall Study|Adverse Event|1|||
23425295|NCT02753127|65299927|FG000|Overall Study|Hospice|0|||
23425296|NCT02753127|65299928|FG001|Overall Study|Hospice|2|||
23425297|NCT03618628|65299929|FG000|Overall Study|Death|1|||
23543275|NCT01054729|65719766|FG002|Overall Study|Adverse Event|2|||
23543276|NCT01054729|65719767|FG003|Overall Study|Adverse Event|1|||
23543277|NCT01054729|65719764|FG000|Overall Study|Withdrawal by Subject|1|||
23543278|NCT01054729|65719765|FG001|Overall Study|Withdrawal by Subject|0|||
23543279|NCT01054729|65719766|FG002|Overall Study|Withdrawal by Subject|1|||
23543280|NCT01054729|65719767|FG003|Overall Study|Withdrawal by Subject|0|||
23543281|NCT01054729|65719764|FG000|Overall Study|Lost to Follow-up|0|||
23543282|NCT01054729|65719765|FG001|Overall Study|Lost to Follow-up|1|||
23543283|NCT01054729|65719766|FG002|Overall Study|Lost to Follow-up|0|||
23543284|NCT01054729|65719767|FG003|Overall Study|Lost to Follow-up|0|||
23543285|NCT01054729|65719764|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23543286|NCT01054729|65719765|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
23425298|NCT03618628|65299929|FG000|Overall Study|Lost to Follow-up|1|||
23543287|NCT01054729|65719766|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23543288|NCT01054729|65719767|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23543289|NCT01054729|65719764|FG000|Overall Study|Non-responder|1|||
23543290|NCT01054729|65719765|FG001|Overall Study|Non-responder|0|||
23543291|NCT01054729|65719766|FG002|Overall Study|Non-responder|1|||
23543292|NCT01054729|65719767|FG003|Overall Study|Non-responder|1|||
23543293|NCT01054729|65719764|FG000|Overall Study|PEG/RBV Non-responder|1|||
23543294|NCT01054729|65719765|FG001|Overall Study|PEG/RBV Non-responder|0|||
23543295|NCT01054729|65719766|FG002|Overall Study|PEG/RBV Non-responder|1|||
23543296|NCT01054729|65719767|FG003|Overall Study|PEG/RBV Non-responder|0|||
23543297|NCT01054729|65719764|FG000|Overall Study|Personal/Obligations|0|||
23543298|NCT01054729|65719765|FG001|Overall Study|Personal/Obligations|1|||
23543299|NCT01054729|65719766|FG002|Overall Study|Personal/Obligations|0|||
23543300|NCT01054729|65719767|FG003|Overall Study|Personal/Obligations|0|||
23543301|NCT01054729|65719764|FG000|Overall Study|Subject moved|0|||
23543302|NCT01054729|65719765|FG001|Overall Study|Subject moved|0|||
23543303|NCT01054729|65719766|FG002|Overall Study|Subject moved|1|||
23543304|NCT01054729|65719767|FG003|Overall Study|Subject moved|0|||
23543305|NCT01054729|65719764|FG000|Overall Study|Lack of Efficacy|0|||
23543306|NCT01054729|65719765|FG001|Overall Study|Lack of Efficacy|0|||
23543307|NCT01054729|65719766|FG002|Overall Study|Lack of Efficacy|0|||
23543308|NCT01054729|65719767|FG003|Overall Study|Lack of Efficacy|1|||
23543309|NCT01965834|65719769|FG000|Overall Study|Lack of Efficacy|4|||
23543310|NCT00408993|65719770|FG000|Overall Study|Adverse Event|15|||
23543311|NCT00408993|65719771|FG001|Overall Study|Adverse Event|4|||
23543312|NCT00408993|65719770|FG000|Overall Study|Protocol Violation|1|||
23543313|NCT00408993|65719771|FG001|Overall Study|Protocol Violation|6|||
23543314|NCT00408993|65719770|FG000|Overall Study|Lack of Efficacy|1|||
23543315|NCT00408993|65719771|FG001|Overall Study|Lack of Efficacy|4|||
23543316|NCT00408993|65719770|FG000|Overall Study|Withdrawal by Subject|2|||
23543317|NCT00408993|65719771|FG001|Overall Study|Withdrawal by Subject|3|||
23543318|NCT01259713|65719772|FG000|Overall Study|Adverse Event|54|||
23543319|NCT01259713|65719773|FG001|Overall Study|Adverse Event|23|||
23543320|NCT01259713|65719772|FG000|Overall Study|Death Not Related to IFI|8|||
23425299|NCT00787930|65299930|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
23425300|NCT03352453|65299931|FG000|Overall Study|Miscellaneous Reasons|1|||
23425301|NCT03352453|65299932|FG001|Overall Study|Miscellaneous Reasons|2|||
23425302|NCT03352453|65299931|FG000|Overall Study|Lack of Efficacy|1|||
23425303|NCT03352453|65299932|FG001|Overall Study|Lack of Efficacy|0|||
23425304|NCT03352453|65299931|FG000|Overall Study|Withdrawal by Subject|8|||
23425305|NCT03352453|65299932|FG001|Overall Study|Withdrawal by Subject|14|||
23425306|NCT03352453|65299931|FG000|Overall Study|Study Terminated by Sponsor|2|||
23425307|NCT03352453|65299932|FG001|Overall Study|Study Terminated by Sponsor|1|||
23425308|NCT03352453|65299931|FG000|Overall Study|Protocol Deviation|1|||
23425309|NCT03352453|65299932|FG001|Overall Study|Protocol Deviation|0|||
23425310|NCT03352453|65299931|FG000|Overall Study|Lost to Follow-up|7|||
23425311|NCT03352453|65299932|FG001|Overall Study|Lost to Follow-up|6|||
23425312|NCT03352453|65299931|FG000|Overall Study|Adverse Event|2|||
23425313|NCT03352453|65299932|FG001|Overall Study|Adverse Event|9|||
23425314|NCT03515551|65299935|FG000|Overall Study|Death|4|||
23425315|NCT03515551|65299936|FG001|Overall Study|Death|1|||
23425316|NCT03515551|65299937|FG002|Overall Study|Death|2|||
23425317|NCT03515551|65299938|FG003|Overall Study|Death|2|||
23425318|NCT03515551|65299939|FG004|Overall Study|Death|2|||
23425319|NCT03515551|65299940|FG005|Overall Study|Death|4|||
23425320|NCT03515551|65299941|FG006|Overall Study|Death|1|||
23425321|NCT03515551|65299935|FG000|Overall Study|Lost to Follow-up|0|||
23425322|NCT03515551|65299936|FG001|Overall Study|Lost to Follow-up|0|||
23425323|NCT03515551|65299937|FG002|Overall Study|Lost to Follow-up|1|||
23425324|NCT03515551|65299938|FG003|Overall Study|Lost to Follow-up|0|||
23425325|NCT03515551|65299939|FG004|Overall Study|Lost to Follow-up|0|||
23425326|NCT03515551|65299940|FG005|Overall Study|Lost to Follow-up|0|||
23425327|NCT03515551|65299941|FG006|Overall Study|Lost to Follow-up|0|||
23425328|NCT03515551|65299935|FG000|Overall Study|Withdrawal by Subject|0|||
23425329|NCT03515551|65299936|FG001|Overall Study|Withdrawal by Subject|1|||
23425330|NCT03515551|65299937|FG002|Overall Study|Withdrawal by Subject|0|||
23425331|NCT03515551|65299938|FG003|Overall Study|Withdrawal by Subject|0|||
23425332|NCT03515551|65299939|FG004|Overall Study|Withdrawal by Subject|0|||
23425333|NCT03515551|65299940|FG005|Overall Study|Withdrawal by Subject|0|||
23425334|NCT03515551|65299941|FG006|Overall Study|Withdrawal by Subject|1|||
23425335|NCT03515551|65299935|FG000|Overall Study|Study ended by sponsor|0|||
23425336|NCT03515551|65299936|FG001|Overall Study|Study ended by sponsor|0|||
23425337|NCT03515551|65299937|FG002|Overall Study|Study ended by sponsor|2|||
23425338|NCT03515551|65299938|FG003|Overall Study|Study ended by sponsor|1|||
23425339|NCT03515551|65299939|FG004|Overall Study|Study ended by sponsor|3|||
23425340|NCT03515551|65299940|FG005|Overall Study|Study ended by sponsor|0|||
23425341|NCT03515551|65299941|FG006|Overall Study|Study ended by sponsor|3|||
23425342|NCT03515551|65299935|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425343|NCT03515551|65299936|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
23425344|NCT03515551|65299937|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425345|NCT03515551|65299938|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425346|NCT03515551|65299939|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23729469|NCT02415595|66388662|FG003|Overall Study|Withdrawal by Subject|3|||
23729470|NCT02415595|66388659|FG000|Overall Study|Other|0|||
23729471|NCT02415595|66388660|FG001|Overall Study|Other|1|||
23425347|NCT03515551|65299940|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425348|NCT03515551|65299941|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425349|NCT02279719|65299942|FG000|Overall Study|Patients randomized but never treated|0|||
23425350|NCT02279719|65299943|FG001|Overall Study|Patients randomized but never treated|0|||
23425351|NCT02279719|65299944|FG002|Overall Study|Patients randomized but never treated|0|||
23425352|NCT02279719|65299945|FG003|Overall Study|Patients randomized but never treated|0|||
23425353|NCT02279719|65299946|FG004|Overall Study|Patients randomized but never treated|3|||
23425354|NCT02279719|65299947|FG005|Overall Study|Patients randomized but never treated|0|||
23425355|NCT02279719|65299948|FG006|Overall Study|Patients randomized but never treated|3|||
23425356|NCT01371643|65299952|FG000|Overall Study|Withdrawal by Subject|3|||
23729472|NCT02415595|66388661|FG002|Overall Study|Other|1|||
23729473|NCT02415595|66388662|FG003|Overall Study|Other|0|||
23729474|NCT03073200|66388663|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23425357|NCT01371643|65299953|FG001|Overall Study|Withdrawal by Subject|0|||
23425358|NCT02142283|65299956|FG000|Overall Study|Death|20|||
23425359|NCT02142283|65299957|FG001|Overall Study|Death|18|||
23425360|NCT02142283|65299956|FG000|Overall Study|Withdrawal by Subject|1|||
23425361|NCT02142283|65299957|FG001|Overall Study|Withdrawal by Subject|3|||
23425362|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
23425363|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
23425364|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
23425365|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
23729475|NCT03073200|66388664|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23729476|NCT03073200|66388665|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23425366|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
23425367|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
23729477|NCT03073200|66388666|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23729478|NCT03073200|66388667|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23729479|NCT03073200|66388668|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23729480|NCT03073200|66388669|FG006|Double Blind Treatment Period|Protocol Violation|0|||
23729481|NCT03073200|66388670|FG007|Double Blind Treatment Period|Protocol Violation|0|||
23729482|NCT03073200|66388671|FG008|Double Blind Treatment Period|Protocol Violation|0|||
23729483|NCT03073200|66388672|FG009|Double Blind Treatment Period|Protocol Violation|0|||
23729484|NCT03073200|66388673|FG010|Double Blind Treatment Period|Protocol Violation|0|||
23729485|NCT03073200|66388674|FG011|Double Blind Treatment Period|Protocol Violation|0|||
23729486|NCT03073200|66388675|FG012|Double Blind Treatment Period|Protocol Violation|0|||
23729487|NCT03073200|66388676|FG013|Double Blind Treatment Period|Protocol Violation|0|||
23729488|NCT03073200|66388677|FG014|Double Blind Treatment Period|Protocol Violation|0|||
23729489|NCT03073200|66388663|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729490|NCT03073200|66388664|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
23729491|NCT03073200|66388665|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729492|NCT03073200|66388666|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729493|NCT03073200|66388667|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729494|NCT03073200|66388668|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729495|NCT03073200|66388669|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729496|NCT03073200|66388670|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729497|NCT03073200|66388671|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729498|NCT03073200|66388672|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729499|NCT03073200|66388673|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729500|NCT03073200|66388674|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729501|NCT03073200|66388675|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729502|NCT03073200|66388676|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729503|NCT03073200|66388677|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23729504|NCT03073200|66388663|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
23729505|NCT03073200|66388664|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729506|NCT03073200|66388665|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729507|NCT03073200|66388666|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729508|NCT03073200|66388667|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729509|NCT03073200|66388668|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729510|NCT03073200|66388669|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729511|NCT03073200|66388670|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729512|NCT03073200|66388671|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729513|NCT03073200|66388672|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729514|NCT03073200|66388673|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729515|NCT03073200|66388674|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729516|NCT03073200|66388675|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729517|NCT03073200|66388676|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729518|NCT03073200|66388677|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
23729519|NCT03073200|66388663|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729520|NCT03073200|66388664|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729521|NCT03073200|66388665|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729522|NCT03073200|66388666|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
23729523|NCT03073200|66388667|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
23729524|NCT03073200|66388668|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729525|NCT03073200|66388669|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729526|NCT03073200|66388670|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729527|NCT03073200|66388671|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729528|NCT03073200|66388672|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729529|NCT03073200|66388673|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
23425368|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
23425369|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
23425370|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23425371|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23729530|NCT03073200|66388674|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729531|NCT03073200|66388675|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729532|NCT03073200|66388676|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729533|NCT03073200|66388677|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
23729534|NCT03073200|66388663|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
23729535|NCT03073200|66388664|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
23729536|NCT03073200|66388665|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
23425372|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
23425373|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23425374|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Adverse Event|1|||
23425375|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Adverse Event|0|||
23425376|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Adverse Event|2|||
23425377|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Adverse Event|0|||
23425378|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
23729537|NCT03073200|66388666|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
23729538|NCT03073200|66388667|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
23729539|NCT03073200|66388668|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
23729540|NCT03073200|66388669|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
23729541|NCT03073200|66388670|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
23729542|NCT03073200|66388671|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
23729543|NCT03073200|66388672|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
23729544|NCT03073200|66388673|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
23729545|NCT03073200|66388674|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
23729546|NCT03073200|66388675|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
23425379|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
23425380|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
23425381|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
23425382|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425383|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425384|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425385|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
23425386|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425387|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425388|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425389|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
23425390|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425391|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425392|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425393|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
23425394|NCT00536874|65299962|FG000|Overall Study|Adverse Event|1|||
23425395|NCT00536874|65299962|FG000|Overall Study|Death|2|||
23425396|NCT00536874|65299962|FG000|Overall Study|Withdrawal by Subject|1|||
23425397|NCT00357656|65299963|FG000|Overall Study|Other, No surgery performed|0|||
23425398|NCT00357656|65299964|FG001|Overall Study|Other, No surgery performed|3|||
23425399|NCT00235391|65299965|FG000|Overall Study|Adverse Event|4|||
23425400|NCT00235391|65299966|FG001|Overall Study|Adverse Event|5|||
23425401|NCT00235391|65299967|FG002|Overall Study|Adverse Event|10|||
23425402|NCT00235391|65299968|FG003|Overall Study|Adverse Event|72|||
23425403|NCT00235391|65299969|FG004|Overall Study|Adverse Event|5|||
23425404|NCT00235391|65299970|FG005|Overall Study|Adverse Event|2|||
23425405|NCT00235391|65299965|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23425406|NCT00235391|65299966|FG001|Overall Study|Abnormal laboratory value(s)|5|||
23425407|NCT00235391|65299967|FG002|Overall Study|Abnormal laboratory value(s)|4|||
23425408|NCT00235391|65299968|FG003|Overall Study|Abnormal laboratory value(s)|27|||
23425409|NCT00235391|65299969|FG004|Overall Study|Abnormal laboratory value(s)|1|||
23425410|NCT00235391|65299970|FG005|Overall Study|Abnormal laboratory value(s)|2|||
23425411|NCT00235391|65299965|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23425412|NCT00235391|65299966|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23425413|NCT00235391|65299967|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23616909|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
23616910|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
23616911|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Progression|0|||
23425414|NCT00235391|65299968|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
23425415|NCT00235391|65299969|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
23425416|NCT00235391|65299970|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
23425417|NCT00235391|65299965|FG000|Overall Study|Condition no longer requires treatment|3|||
23425418|NCT00235391|65299966|FG001|Overall Study|Condition no longer requires treatment|0|||
23425419|NCT00235391|65299967|FG002|Overall Study|Condition no longer requires treatment|0|||
23425420|NCT00235391|65299968|FG003|Overall Study|Condition no longer requires treatment|11|||
23425421|NCT00235391|65299969|FG004|Overall Study|Condition no longer requires treatment|1|||
23425422|NCT00235391|65299970|FG005|Overall Study|Condition no longer requires treatment|0|||
23425423|NCT00235391|65299965|FG000|Overall Study|Protocol deviation|0|||
23425424|NCT00235391|65299966|FG001|Overall Study|Protocol deviation|0|||
23425425|NCT00235391|65299967|FG002|Overall Study|Protocol deviation|1|||
23425426|NCT00235391|65299968|FG003|Overall Study|Protocol deviation|11|||
23729547|NCT03073200|66388676|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
23543321|NCT01259713|65719773|FG001|Overall Study|Death Not Related to IFI|1|||
23543322|NCT01259713|65719772|FG000|Overall Study|Investigators Discretion|14|||
23543323|NCT01259713|65719773|FG001|Overall Study|Investigators Discretion|6|||
23543324|NCT01259713|65719772|FG000|Overall Study|Lack of Efficacy|2|||
23543325|NCT01259713|65719773|FG001|Overall Study|Lack of Efficacy|0|||
23543326|NCT01259713|65719772|FG000|Overall Study|Protocol Violation|5|||
23543327|NCT01259713|65719773|FG001|Overall Study|Protocol Violation|4|||
23543328|NCT01259713|65719772|FG000|Overall Study|Subject Withdrew Consent|12|||
23543329|NCT01259713|65719773|FG001|Overall Study|Subject Withdrew Consent|7|||
23543330|NCT00319098|65719774|FG000|Overall Study|Serious adverse event|3|||
23543331|NCT00319098|65719775|FG001|Overall Study|Serious adverse event|0|||
23543332|NCT00319098|65719774|FG000|Overall Study|Adverse Event|20|||
23543333|NCT00319098|65719775|FG001|Overall Study|Adverse Event|1|||
23543334|NCT00319098|65719774|FG000|Overall Study|Withdrawal by Subject|37|||
23543335|NCT00319098|65719775|FG001|Overall Study|Withdrawal by Subject|8|||
23543336|NCT00319098|65719774|FG000|Overall Study|Migrated/moved from study area|2|||
23543337|NCT00319098|65719775|FG001|Overall Study|Migrated/moved from study area|1|||
23543338|NCT00319098|65719774|FG000|Overall Study|Lost to Follow-up|37|||
23543339|NCT00319098|65719775|FG001|Overall Study|Lost to Follow-up|13|||
23543340|NCT00319098|65719774|FG000|Overall Study|Others|33|||
23543341|NCT00319098|65719775|FG001|Overall Study|Others|8|||
23543342|NCT00319098|65719774|FG000|Overall Study|Protocol Violation|3|||
23543343|NCT00319098|65719775|FG001|Overall Study|Protocol Violation|1|||
23543344|NCT02276482|65719776|FG000|Overall Study|Adverse Event|1|||
23543345|NCT02276482|65719777|FG001|Overall Study|Adverse Event|0|||
23543346|NCT02276482|65719776|FG000|Overall Study|Withdrawal by Subject|1|||
23543347|NCT02276482|65719777|FG001|Overall Study|Withdrawal by Subject|0|||
23543348|NCT02276482|65719776|FG000|Overall Study|Gram-negative infection|1|||
23543349|NCT02276482|65719777|FG001|Overall Study|Gram-negative infection|0|||
23543350|NCT02276482|65719776|FG000|Overall Study|Reason not specified|0|||
23543351|NCT02276482|65719777|FG001|Overall Study|Reason not specified|1|||
23543352|NCT03669081|65719778|FG000|Overall Study|Data could not be validated|1|||
23543353|NCT03669081|65719779|FG001|Overall Study|Data could not be validated|1|||
23543354|NCT01773226|65719782|FG000|Overall Study|Withdrawal by Subject|1|||
23543355|NCT05348681|65719783|FG000|Overall Study|Study terminated by Sponsor|8|||
23543356|NCT05348681|65719784|FG001|Overall Study|Study terminated by Sponsor|3|||
23543357|NCT05348681|65719783|FG000|Overall Study|Withdrawal by Subject|1|||
23616912|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Progression|1|||
23616913|NCT01193283|65982494|FG000|Overall Study|Death|1|||
23616914|NCT03816332|65982496|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
23543358|NCT05348681|65719784|FG001|Overall Study|Withdrawal by Subject|1|||
23543359|NCT05348681|65719783|FG000|Overall Study|Lost to Follow-up|1|||
23543360|NCT05348681|65719784|FG001|Overall Study|Lost to Follow-up|1|||
23543361|NCT05348681|65719783|FG000|Overall Study|Adverse Event|1|||
23543362|NCT05348681|65719784|FG001|Overall Study|Adverse Event|0|||
23543363|NCT05348681|65719783|FG000|Overall Study|Other|2|||
23543364|NCT05348681|65719784|FG001|Overall Study|Other|1|||
23543365|NCT00086346|65719785|FG000|Randomization|Did not receive test article|4|||
23616915|NCT03816332|65982496|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
23616916|NCT01568112|65982497|FG000|Overall Study|Randomized But Not Treated|0|||
23616917|NCT01568112|65982498|FG001|Overall Study|Randomized But Not Treated|1|||
23616918|NCT01568112|65982499|FG002|Overall Study|Randomized But Not Treated|0|||
23616919|NCT01568112|65982500|FG003|Overall Study|Randomized But Not Treated|0|||
23616920|NCT01568112|65982497|FG000|Overall Study|Withdrew due to Adverse Event|2|||
23616921|NCT01568112|65982498|FG001|Overall Study|Withdrew due to Adverse Event|4|||
23729548|NCT03073200|66388677|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
23729549|NCT03073200|66388663|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729550|NCT03073200|66388664|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
23543366|NCT00086346|65719786|FG001|Randomization|Did not receive test article|4|||
23729551|NCT03073200|66388665|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729552|NCT03073200|66388666|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729553|NCT03073200|66388667|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
23729554|NCT03073200|66388668|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
23543367|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Adverse Event|94|||
23543368|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Adverse Event|11|||
23543369|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
23543370|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
23543371|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
23543372|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
23543373|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
23543374|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
23616922|NCT01568112|65982499|FG002|Overall Study|Withdrew due to Adverse Event|6|||
23425427|NCT00235391|65299969|FG004|Overall Study|Protocol deviation|0|||
23425428|NCT00235391|65299970|FG005|Overall Study|Protocol deviation|0|||
23425429|NCT00235391|65299965|FG000|Overall Study|Withdrawal by Subject|2|||
23425430|NCT00235391|65299966|FG001|Overall Study|Withdrawal by Subject|3|||
23425431|NCT00235391|65299967|FG002|Overall Study|Withdrawal by Subject|3|||
23425432|NCT00235391|65299968|FG003|Overall Study|Withdrawal by Subject|61|||
23543375|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
23543376|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
23543377|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
23543378|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
23729555|NCT03073200|66388669|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729556|NCT03073200|66388670|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729557|NCT03073200|66388671|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729558|NCT03073200|66388672|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729559|NCT03073200|66388673|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729560|NCT03073200|66388674|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729561|NCT03073200|66388675|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729562|NCT03073200|66388676|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729563|NCT03073200|66388677|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
23729564|NCT03073200|66388663|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729565|NCT03073200|66388664|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729566|NCT03073200|66388665|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729567|NCT03073200|66388666|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
23729568|NCT03073200|66388667|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
23729569|NCT03073200|66388668|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729570|NCT03073200|66388669|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729571|NCT03073200|66388670|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729572|NCT03073200|66388671|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729573|NCT03073200|66388672|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729574|NCT03073200|66388673|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729575|NCT03073200|66388674|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729576|NCT03073200|66388675|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729577|NCT03073200|66388676|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23729578|NCT03073200|66388677|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23543379|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
23543380|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
23543381|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
23543382|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
23543383|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
23543384|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543385|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
23543386|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543387|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543388|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543389|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
23543390|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
23543391|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
23543392|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
23543393|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
23543394|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543395|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543396|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23543397|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543398|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543399|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543400|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543401|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
23543402|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543403|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543404|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23425433|NCT00235391|65299969|FG004|Overall Study|Withdrawal by Subject|5|||
23543405|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543406|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543407|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
23543408|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543409|NCT03152552|65719789|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
23543410|NCT03152552|65719790|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
23425434|NCT00235391|65299970|FG005|Overall Study|Withdrawal by Subject|0|||
23425435|NCT00235391|65299965|FG000|Overall Study|Lost to Follow-up|0|||
23817897|NCT01449812|66711534|FG001|Overall Study|Withdrawal by Subject|0|||
23817898|NCT01449812|66711535|FG002|Overall Study|Withdrawal by Subject|1|||
23817899|NCT01449812|66711533|FG000|Overall Study|Lost to Follow-up|1|||
23817900|NCT01449812|66711534|FG001|Overall Study|Lost to Follow-up|0|||
23817901|NCT01449812|66711535|FG002|Overall Study|Lost to Follow-up|0|||
23817902|NCT03480386|66714163|FG000|Overall Study|Did not complete measures at 3-months|17|||
23817903|NCT03480386|66714164|FG001|Overall Study|Did not complete measures at 3-months|14|||
23817904|NCT03480386|66714163|FG000|Overall Study|No baseline measures|11|||
23817905|NCT03480386|66714164|FG001|Overall Study|No baseline measures|14|||
23817906|NCT03480386|66714163|FG000|Overall Study|Death|0|||
23817907|NCT03480386|66714164|FG001|Overall Study|Death|5|||
23817908|NCT03480386|66714163|FG000|Overall Study|Withdrawal by Subject|12|||
23817909|NCT03480386|66714164|FG001|Overall Study|Withdrawal by Subject|8|||
23817910|NCT03480386|66714163|FG000|Overall Study|Lost to Follow-up|2|||
23817911|NCT03480386|66714164|FG001|Overall Study|Lost to Follow-up|1|||
23817912|NCT03480386|66714163|FG000|Overall Study|Complicating disease|0|||
23543411|NCT03152552|65719791|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
23543412|NCT03152552|65719792|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
23543413|NCT03152552|65719793|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
23616923|NCT01568112|65982500|FG003|Overall Study|Withdrew due to Adverse Event|3|||
23616924|NCT01568112|65982497|FG000|Overall Study|Lost to Follow-up|0|||
23616925|NCT01568112|65982498|FG001|Overall Study|Lost to Follow-up|0|||
23616926|NCT01568112|65982499|FG002|Overall Study|Lost to Follow-up|0|||
23616927|NCT01568112|65982500|FG003|Overall Study|Lost to Follow-up|1|||
23616928|NCT01568112|65982497|FG000|Overall Study|Withdrawal by Subject|2|||
23616929|NCT01568112|65982498|FG001|Overall Study|Withdrawal by Subject|3|||
23616930|NCT01568112|65982499|FG002|Overall Study|Withdrawal by Subject|0|||
23616931|NCT01568112|65982500|FG003|Overall Study|Withdrawal by Subject|7|||
23616932|NCT01568112|65982497|FG000|Overall Study|Withdrawal by Physician|1|||
23616933|NCT01568112|65982498|FG001|Overall Study|Withdrawal by Physician|0|||
23616934|NCT01568112|65982499|FG002|Overall Study|Withdrawal by Physician|1|||
23616935|NCT01568112|65982500|FG003|Overall Study|Withdrawal by Physician|1|||
23616936|NCT04783519|65982503|FG000|Overall Study|Withdrawal by Subject|2|||
23616937|NCT04783519|65982504|FG001|Overall Study|Withdrawal by Subject|7|||
23616938|NCT04783519|65982505|FG002|Overall Study|Withdrawal by Subject|3|||
23729579|NCT03073200|66388663|FG000|Extension Period|Lost to Follow-up|0|||
23729580|NCT03073200|66388664|FG001|Extension Period|Lost to Follow-up|0|||
23729581|NCT03073200|66388665|FG002|Extension Period|Lost to Follow-up|0|||
23543414|NCT00627705|65719794|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
23543415|NCT00627705|65719795|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
23543416|NCT00627705|65719794|FG000|Overall Study|Adverse Event|1|||
23543417|NCT00627705|65719795|FG001|Overall Study|Adverse Event|0|||
23543418|NCT00627705|65719794|FG000|Overall Study|Withdrawal by Subject|0|||
23543419|NCT00627705|65719795|FG001|Overall Study|Withdrawal by Subject|2|||
23543420|NCT00627705|65719794|FG000|Overall Study|Lost to Follow-up|0|||
23543421|NCT00627705|65719795|FG001|Overall Study|Lost to Follow-up|1|||
23543422|NCT04001829|65719796|FG000|Overall Study|Never start protocol therapy|5|||
23729582|NCT03073200|66388666|FG003|Extension Period|Lost to Follow-up|0|||
23729583|NCT03073200|66388667|FG004|Extension Period|Lost to Follow-up|0|||
23729584|NCT03073200|66388668|FG005|Extension Period|Lost to Follow-up|0|||
23729585|NCT03073200|66388669|FG006|Extension Period|Lost to Follow-up|1|||
23729586|NCT03073200|66388670|FG007|Extension Period|Lost to Follow-up|1|||
23729587|NCT03073200|66388671|FG008|Extension Period|Lost to Follow-up|0|||
23729588|NCT03073200|66388672|FG009|Extension Period|Lost to Follow-up|0|||
23729589|NCT03073200|66388673|FG010|Extension Period|Lost to Follow-up|0|||
23729590|NCT03073200|66388674|FG011|Extension Period|Lost to Follow-up|0|||
23729591|NCT03073200|66388675|FG012|Extension Period|Lost to Follow-up|0|||
23729592|NCT03073200|66388676|FG013|Extension Period|Lost to Follow-up|0|||
23729593|NCT03073200|66388677|FG014|Extension Period|Lost to Follow-up|0|||
23729594|NCT03073200|66388663|FG000|Extension Period|Sponsor Decision|0|||
23729595|NCT03073200|66388664|FG001|Extension Period|Sponsor Decision|0|||
23729596|NCT03073200|66388665|FG002|Extension Period|Sponsor Decision|0|||
23729597|NCT03073200|66388666|FG003|Extension Period|Sponsor Decision|0|||
23729598|NCT03073200|66388667|FG004|Extension Period|Sponsor Decision|0|||
23817913|NCT03480386|66714164|FG001|Overall Study|Complicating disease|1|||
23817914|NCT03480386|66714163|FG000|Overall Study|Disease progression|3|||
23817915|NCT03480386|66714164|FG001|Overall Study|Disease progression|0|||
23543423|NCT04001829|65719797|FG001|Overall Study|Never start protocol therapy|5|||
23616939|NCT04783519|65982503|FG000|Overall Study|Lost to Follow-up|9|||
23616940|NCT04783519|65982504|FG001|Overall Study|Lost to Follow-up|7|||
23616941|NCT04783519|65982505|FG002|Overall Study|Lost to Follow-up|6|||
23729599|NCT03073200|66388668|FG005|Extension Period|Sponsor Decision|0|||
23729600|NCT03073200|66388669|FG006|Extension Period|Sponsor Decision|0|||
23729601|NCT03073200|66388670|FG007|Extension Period|Sponsor Decision|0|||
23729602|NCT03073200|66388671|FG008|Extension Period|Sponsor Decision|1|||
23729603|NCT03073200|66388672|FG009|Extension Period|Sponsor Decision|0|||
23729604|NCT03073200|66388673|FG010|Extension Period|Sponsor Decision|0|||
23729605|NCT03073200|66388674|FG011|Extension Period|Sponsor Decision|0|||
23729606|NCT03073200|66388675|FG012|Extension Period|Sponsor Decision|0|||
23729607|NCT03073200|66388676|FG013|Extension Period|Sponsor Decision|0|||
23729608|NCT03073200|66388677|FG014|Extension Period|Sponsor Decision|0|||
23729609|NCT03073200|66388663|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
23729610|NCT03073200|66388664|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
23729611|NCT03073200|66388665|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
23729612|NCT03073200|66388666|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
23729613|NCT03073200|66388667|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
23729614|NCT03073200|66388668|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
23729615|NCT03073200|66388669|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
23729616|NCT03073200|66388670|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
23729617|NCT03073200|66388671|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
23729618|NCT03073200|66388672|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
23729619|NCT03073200|66388673|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
23729620|NCT03073200|66388674|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
23729621|NCT03073200|66388675|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
23729622|NCT03073200|66388676|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
23729623|NCT03073200|66388677|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
23729624|NCT03073200|66388663|FG000|Extension Period|Withdrawal by Subject|0|||
23729625|NCT03073200|66388664|FG001|Extension Period|Withdrawal by Subject|0|||
23729626|NCT03073200|66388665|FG002|Extension Period|Withdrawal by Subject|0|||
23729627|NCT03073200|66388666|FG003|Extension Period|Withdrawal by Subject|0|||
23543424|NCT04001829|65719796|FG000|Overall Study|Adverse Event|11|||
23543425|NCT04001829|65719797|FG001|Overall Study|Adverse Event|7|||
23543426|NCT04001829|65719796|FG000|Overall Study|Alternative therapy|1|||
23543427|NCT04001829|65719797|FG001|Overall Study|Alternative therapy|2|||
23543428|NCT04001829|65719796|FG000|Overall Study|Disease progression/relapse|2|||
23543429|NCT04001829|65719797|FG001|Overall Study|Disease progression/relapse|1|||
23543430|NCT04001829|65719796|FG000|Overall Study|Other complicating disease|1|||
23729628|NCT03073200|66388667|FG004|Extension Period|Withdrawal by Subject|0|||
23729629|NCT03073200|66388668|FG005|Extension Period|Withdrawal by Subject|0|||
23729630|NCT03073200|66388669|FG006|Extension Period|Withdrawal by Subject|1|||
23729631|NCT03073200|66388670|FG007|Extension Period|Withdrawal by Subject|2|||
23729632|NCT03073200|66388671|FG008|Extension Period|Withdrawal by Subject|0|||
23729633|NCT03073200|66388672|FG009|Extension Period|Withdrawal by Subject|0|||
23729634|NCT03073200|66388673|FG010|Extension Period|Withdrawal by Subject|0|||
23729635|NCT03073200|66388674|FG011|Extension Period|Withdrawal by Subject|0|||
23729636|NCT03073200|66388675|FG012|Extension Period|Withdrawal by Subject|0|||
23729637|NCT03073200|66388676|FG013|Extension Period|Withdrawal by Subject|0|||
23729638|NCT03073200|66388677|FG014|Extension Period|Withdrawal by Subject|0|||
23729639|NCT03073200|66388663|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729640|NCT03073200|66388664|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729641|NCT03073200|66388665|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729642|NCT03073200|66388666|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729643|NCT03073200|66388667|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729644|NCT03073200|66388668|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729645|NCT03073200|66388669|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729646|NCT03073200|66388670|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729647|NCT03073200|66388671|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729648|NCT03073200|66388672|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729649|NCT03073200|66388673|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729650|NCT03073200|66388674|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
23729651|NCT03073200|66388675|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729652|NCT03073200|66388676|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729653|NCT03073200|66388677|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
23729654|NCT03073200|66388663|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729655|NCT03073200|66388664|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729656|NCT03073200|66388665|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729657|NCT03073200|66388666|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729658|NCT03073200|66388667|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23817916|NCT03480386|66714163|FG000|Overall Study|Became ineligible|0|||
23729659|NCT03073200|66388668|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729660|NCT03073200|66388669|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729661|NCT03073200|66388670|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729662|NCT03073200|66388671|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729663|NCT03073200|66388672|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729664|NCT03073200|66388673|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729665|NCT03073200|66388674|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
23729666|NCT03073200|66388675|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23543431|NCT04001829|65719797|FG001|Overall Study|Other complicating disease|0|||
23543432|NCT04001829|65719796|FG000|Overall Study|Withdrawal by Subject|1|||
23543433|NCT04001829|65719797|FG001|Overall Study|Withdrawal by Subject|4|||
23543434|NCT04001829|65719796|FG000|Overall Study|Ineligible|2|||
23543435|NCT04001829|65719797|FG001|Overall Study|Ineligible|2|||
23543436|NCT04001829|65719796|FG000|Overall Study|Reason missing due to delinquent data|1|||
23543437|NCT04001829|65719797|FG001|Overall Study|Reason missing due to delinquent data|0|||
23543438|NCT01389973|65719799|FG000|Overall Study|Lost to Follow-up|1|||
23543439|NCT01389973|65719799|FG000|Overall Study|Trial Stopped by Sponsor|9|||
23543440|NCT01389973|65719799|FG000|Overall Study|Other|10|||
23543441|NCT02696317|65719804|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
23543442|NCT02696317|65719805|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
23543443|NCT02696317|65719804|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
23543444|NCT02696317|65719805|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
23543445|NCT00129987|65719806|FG000|1st Educational Session|Withdrawal by Subject|141|||
23543446|NCT00129987|65719807|FG001|1st Educational Session|Withdrawal by Subject|109|||
23543447|NCT00129987|65719806|FG000|1 Year|Withdrawal by Subject|32|||
23543448|NCT00129987|65719807|FG001|1 Year|Withdrawal by Subject|21|||
23543449|NCT00874029|65719810|FG000|Overall Study|Withdrawal by Subject|10|||
23543450|NCT00874029|65719810|FG000|Overall Study|Pregnancy|4|||
23543451|NCT00874029|65719810|FG000|Overall Study|Physician Decision|1|||
23543452|NCT00874029|65719810|FG000|Overall Study|Adverse Event|1|||
23543453|NCT00874029|65719810|FG000|Overall Study|Lost to Follow-up|5|||
23543454|NCT02648698|65719811|FG000|Overall Study|Protocol Violation|1|||
23543455|NCT02648698|65719812|FG001|Overall Study|Protocol Violation|5|||
23543456|NCT00784043|65719813|FG000|Overall Study|Withdrawal by Subject|8|||
23543457|NCT00784043|65719814|FG001|Overall Study|Withdrawal by Subject|5|||
23543458|NCT00784043|65719813|FG000|Overall Study|Protocol Terminated|23|||
23543459|NCT00784043|65719814|FG001|Overall Study|Protocol Terminated|1|||
23729667|NCT03073200|66388676|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729668|NCT03073200|66388677|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23729669|NCT03073200|66388663|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729670|NCT03073200|66388664|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729671|NCT03073200|66388665|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729672|NCT03073200|66388666|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729673|NCT03073200|66388667|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729674|NCT03073200|66388668|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729675|NCT03073200|66388669|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729676|NCT03073200|66388670|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729677|NCT03073200|66388671|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729678|NCT03073200|66388672|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729679|NCT03073200|66388673|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23729680|NCT03073200|66388674|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23729681|NCT03073200|66388675|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729682|NCT03073200|66388676|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729683|NCT03073200|66388677|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23729684|NCT03073200|66388663|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23729685|NCT03073200|66388664|FG001|Randomized Withdrawal Period|Adverse Event|0|||
23729686|NCT03073200|66388665|FG002|Randomized Withdrawal Period|Adverse Event|0|||
23729687|NCT03073200|66388666|FG003|Randomized Withdrawal Period|Adverse Event|0|||
23729688|NCT03073200|66388667|FG004|Randomized Withdrawal Period|Adverse Event|0|||
23729689|NCT03073200|66388668|FG005|Randomized Withdrawal Period|Adverse Event|0|||
23729690|NCT03073200|66388669|FG006|Randomized Withdrawal Period|Adverse Event|0|||
23729691|NCT03073200|66388670|FG007|Randomized Withdrawal Period|Adverse Event|0|||
23729692|NCT03073200|66388671|FG008|Randomized Withdrawal Period|Adverse Event|0|||
23729693|NCT03073200|66388672|FG009|Randomized Withdrawal Period|Adverse Event|0|||
23729694|NCT03073200|66388673|FG010|Randomized Withdrawal Period|Adverse Event|1|||
23729695|NCT03073200|66388674|FG011|Randomized Withdrawal Period|Adverse Event|0|||
23729696|NCT03073200|66388675|FG012|Randomized Withdrawal Period|Adverse Event|0|||
23729697|NCT03073200|66388676|FG013|Randomized Withdrawal Period|Adverse Event|0|||
23729698|NCT03073200|66388677|FG014|Randomized Withdrawal Period|Adverse Event|0|||
23729699|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729700|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729701|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
23425436|NCT00235391|65299966|FG001|Overall Study|Lost to Follow-up|3|||
23543460|NCT00924950|65719815|FG000|Overall Study|Lost to Follow-up|2|||
23729702|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729703|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729704|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
23425437|NCT00235391|65299967|FG002|Overall Study|Lost to Follow-up|3|||
23616942|NCT04057937|65982506|FG000|Placebo-controlled Phase|Adverse Event|3|||
23616943|NCT04057937|65982507|FG001|Placebo-controlled Phase|Adverse Event|0|||
23616944|NCT04057937|65982506|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
23616945|NCT04057937|65982507|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
23616946|NCT04057937|65982506|FG000|Active-treatment Phase|Pregnancy|0|||
23616947|NCT04057937|65982507|FG001|Active-treatment Phase|Pregnancy|1|||
23616948|NCT04057937|65982506|FG000|Active-treatment Phase|Physician Decision|0|||
23616949|NCT04057937|65982507|FG001|Active-treatment Phase|Physician Decision|1|||
23616950|NCT01533181|65985015|FG000|Overall Study|Disease progression pre-active treatment|0|||
23616951|NCT01533181|65985016|FG001|Overall Study|Disease progression pre-active treatment|1|||
23616952|NCT01533181|65985015|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
23616953|NCT01533181|65985016|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
23616954|NCT04883541|65985019|FG000|Overall Study|Not attending regular yoga class|16|||
23616955|NCT04883541|65985020|FG001|Overall Study|Not attending regular yoga class|0|||
23616956|NCT04883541|65985019|FG000|Overall Study|Not attending the pregnancy school|0|||
23616957|NCT04883541|65985020|FG001|Overall Study|Not attending the pregnancy school|9|||
23616958|NCT00230971|65985021|FG000|Randomization|No study drug administered|3|||
23616959|NCT00230971|65985022|FG001|Randomization|No study drug administered|3|||
23616960|NCT00230971|65985021|FG000|Baseline Participants|Lost to Follow-up|5|||
23616961|NCT00230971|65985022|FG001|Baseline Participants|Lost to Follow-up|12|||
23616962|NCT00230971|65985021|FG000|Baseline Participants|Death|6|||
23616963|NCT00230971|65985022|FG001|Baseline Participants|Death|5|||
23616964|NCT00230971|65985021|FG000|Baseline Participants|Withdrawal by Subject|7|||
23616965|NCT00230971|65985022|FG001|Baseline Participants|Withdrawal by Subject|1|||
23616966|NCT00230971|65985021|FG000|Baseline Participants|Adverse Event|1|||
23616967|NCT00230971|65985022|FG001|Baseline Participants|Adverse Event|0|||
23616968|NCT00230971|65985021|FG000|Baseline Participants|No bacteria observed|1|||
23616969|NCT00230971|65985022|FG001|Baseline Participants|No bacteria observed|0|||
23616970|NCT00230971|65985021|FG000|Baseline Participants|Failure to return|1|||
23616971|NCT00230971|65985022|FG001|Baseline Participants|Failure to return|1|||
23616972|NCT00230971|65985021|FG000|Baseline Participants|Reintervention|1|||
23616973|NCT00230971|65985022|FG001|Baseline Participants|Reintervention|0|||
23616974|NCT02711553|65985023|FG000|Overall Study|Withdrawal by Subject|2|||
23616975|NCT02711553|65985024|FG001|Overall Study|Withdrawal by Subject|1|||
23616976|NCT02711553|65985025|FG002|Overall Study|Withdrawal by Subject|1|||
23616977|NCT02711553|65985026|FG003|Overall Study|Withdrawal by Subject|0|||
23616978|NCT02711553|65985023|FG000|Overall Study|Lost to Follow-up|3|||
23616979|NCT02711553|65985024|FG001|Overall Study|Lost to Follow-up|3|||
23616980|NCT02711553|65985025|FG002|Overall Study|Lost to Follow-up|6|||
23616981|NCT02711553|65985026|FG003|Overall Study|Lost to Follow-up|3|||
23616982|NCT02711553|65985023|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
23616983|NCT02711553|65985024|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
23616984|NCT02711553|65985025|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
23616985|NCT02711553|65985026|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
23616986|NCT02784535|65985029|FG000|Overall Study|Adverse Event|1|||
23616987|NCT02784535|65985030|FG001|Overall Study|Adverse Event|0|||
23616988|NCT02784535|65985029|FG000|Overall Study|Withdrawal by Subject|0|||
23616989|NCT02784535|65985030|FG001|Overall Study|Withdrawal by Subject|1|||
23616990|NCT02784535|65985029|FG000|Overall Study|Physician Decision|0|||
23616991|NCT02784535|65985030|FG001|Overall Study|Physician Decision|1|||
23616992|NCT01191697|65985031|FG000|Overall Study|Death|1|||
23616993|NCT01191697|65985031|FG000|Overall Study|Physician Decision|2|||
23616994|NCT01191697|65985031|FG000|Overall Study|Pursue chemoradiation|2|||
23616995|NCT01191697|65985031|FG000|Overall Study|Break from chemotherapy|2|||
23616996|NCT01191697|65985031|FG000|Overall Study|Withdrawal by Subject|1|||
23616997|NCT01191697|65985031|FG000|Overall Study|Surveillance|1|||
23616998|NCT01191697|65985031|FG000|Overall Study|Adverse Event|2|||
23616999|NCT01191697|65985031|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
23617000|NCT01191697|65985031|FG000|Overall Study|Not completed but analyzed|25|||
23617001|NCT01837719|65985032|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
23617002|NCT01837719|65985032|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
23617003|NCT00377312|65985035|FG000|Overall Study|Adverse Event|1|||
23617004|NCT00377312|65985036|FG001|Overall Study|Adverse Event|1|||
23617005|NCT00240097|65985037|FG000|Part I|Adverse Event|1|||
23617006|NCT00240097|65985037|FG000|Part I|Death|1|||
23617007|NCT00240097|65985037|FG000|Part I|histology|1|||
23617008|NCT00240097|65985037|FG000|Part I|unevaluable|1|||
23543461|NCT01312909|65719819|FG000|Overall Study|Randomized but not treated|1|||
23543462|NCT01312909|65719820|FG001|Overall Study|Randomized but not treated|3|||
23543463|NCT01312909|65719821|FG002|Overall Study|Randomized but not treated|1|||
23543464|NCT01312909|65719819|FG000|Overall Study|Adverse Event|1|||
23543465|NCT01312909|65719820|FG001|Overall Study|Adverse Event|0|||
23543466|NCT01312909|65719821|FG002|Overall Study|Adverse Event|3|||
23543467|NCT01312909|65719819|FG000|Overall Study|Protocol Violation|2|||
23543468|NCT01312909|65719820|FG001|Overall Study|Protocol Violation|0|||
23617009|NCT00240097|65985037|FG000|Part II|did not continue from Part I|23|||
23617010|NCT01024036|65985040|FG000|Blinded Treatment|Adverse Event|1|||
23617011|NCT01024036|65985041|FG001|Blinded Treatment|Adverse Event|1|||
23617012|NCT01024036|65985040|FG000|Blinded Treatment|Lack of Efficacy|16|||
23617013|NCT01024036|65985041|FG001|Blinded Treatment|Lack of Efficacy|14|||
23617014|NCT01024036|65985040|FG000|Blinded Treatment|Physician Decision|1|||
23617015|NCT01024036|65985041|FG001|Blinded Treatment|Physician Decision|0|||
23617016|NCT01024036|65985040|FG000|Blinded Treatment|Death|0|||
23617017|NCT01024036|65985041|FG001|Blinded Treatment|Death|2|||
23817917|NCT03480386|66714164|FG001|Overall Study|Became ineligible|2|||
23817918|NCT00741286|66714165|FG000|Overall Study|Lost to Follow-up|15|||
23817919|NCT00741286|66714166|FG001|Overall Study|Lost to Follow-up|10|||
23817920|NCT00741286|66714165|FG000|Overall Study|Adverse Event|1|||
23817921|NCT00741286|66714166|FG001|Overall Study|Adverse Event|6|||
23817922|NCT00741286|66714165|FG000|Overall Study|Protocol Violation|3|||
23817923|NCT00741286|66714166|FG001|Overall Study|Protocol Violation|2|||
23817924|NCT00741286|66714165|FG000|Overall Study|Primary Outcome|1|||
23817925|NCT00741286|66714166|FG001|Overall Study|Primary Outcome|1|||
23817926|NCT02996487|66714167|FG000|Overall Study|Lost to Follow-up|1|||
23817927|NCT02996487|66714168|FG001|Overall Study|Lost to Follow-up|1|||
23817928|NCT02996487|66714169|FG002|Overall Study|Lost to Follow-up|0|||
23817929|NCT02996487|66714167|FG000|Overall Study|Death|0|||
23817930|NCT02996487|66714168|FG001|Overall Study|Death|1|||
23817931|NCT02996487|66714169|FG002|Overall Study|Death|0|||
23817932|NCT02996487|66714167|FG000|Overall Study|Withdrawal by Subject|2|||
23817933|NCT02996487|66714168|FG001|Overall Study|Withdrawal by Subject|3|||
23817934|NCT02996487|66714169|FG002|Overall Study|Withdrawal by Subject|0|||
23817935|NCT05422625|66714174|FG000|Overall Study|Withdrawal by Subject|1|||
23817936|NCT05422625|66714175|FG001|Overall Study|Withdrawal by Subject|0|||
23817937|NCT03678285|66714176|FG000|Overall Study|Adverse Event|2|||
23817938|NCT03678285|66714176|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
23817939|NCT03678285|66714176|FG000|Overall Study|Dehydrated prior to start of workout|1|||
23817940|NCT00447993|66714177|FG000|Overall Study|Lost to Follow-up|0|||
23817941|NCT00447993|66714178|FG001|Overall Study|Lost to Follow-up|0|||
23817942|NCT00447993|66714179|FG002|Overall Study|Lost to Follow-up|2|||
23817943|NCT00447993|66714180|FG003|Overall Study|Lost to Follow-up|2|||
23817944|NCT00447993|66714177|FG000|Overall Study|Withdrawal by Subject|0|||
23817945|NCT00447993|66714178|FG001|Overall Study|Withdrawal by Subject|0|||
23817946|NCT00447993|66714179|FG002|Overall Study|Withdrawal by Subject|2|||
23817947|NCT00447993|66714180|FG003|Overall Study|Withdrawal by Subject|2|||
23817948|NCT00396565|66714181|FG000|Overall Study|Physician Decision|3|||
23817949|NCT00396565|66714182|FG001|Overall Study|Physician Decision|1|||
23817950|NCT00396565|66714183|FG002|Overall Study|Physician Decision|2|||
23817951|NCT00396565|66714181|FG000|Overall Study|Adverse Event|5|||
23543469|NCT01312909|65719821|FG002|Overall Study|Protocol Violation|2|||
23543470|NCT01312909|65719819|FG000|Overall Study|Other|9|||
23543471|NCT01312909|65719820|FG001|Overall Study|Other|6|||
23617018|NCT01024036|65985040|FG000|Blinded Treatment|Withdrawal by Subject|4|||
23817952|NCT00396565|66714182|FG001|Overall Study|Adverse Event|13|||
23817953|NCT00396565|66714183|FG002|Overall Study|Adverse Event|3|||
23817954|NCT00396565|66714181|FG000|Overall Study|Withdrawal by Subject|8|||
23817955|NCT00396565|66714182|FG001|Overall Study|Withdrawal by Subject|13|||
23543472|NCT01312909|65719821|FG002|Overall Study|Other|11|||
23543473|NCT01312909|65719819|FG000|Overall Study|Withdrawal by Subject|8|||
23543474|NCT01312909|65719820|FG001|Overall Study|Withdrawal by Subject|10|||
23817956|NCT00396565|66714183|FG002|Overall Study|Withdrawal by Subject|1|||
23817957|NCT00396565|66714181|FG000|Overall Study|Lack of Efficacy|32|||
23617019|NCT01024036|65985041|FG001|Blinded Treatment|Withdrawal by Subject|3|||
23617020|NCT01024036|65985040|FG000|Unblinded Treatment|Adverse Event|0|||
23817958|NCT00396565|66714182|FG001|Overall Study|Lack of Efficacy|64|||
23817959|NCT00396565|66714183|FG002|Overall Study|Lack of Efficacy|11|||
23817960|NCT03201445|66714184|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
23543475|NCT01312909|65719821|FG002|Overall Study|Withdrawal by Subject|7|||
23543476|NCT01312909|65719819|FG000|Overall Study|Lost to Follow-up|21|||
23543477|NCT01312909|65719820|FG001|Overall Study|Lost to Follow-up|17|||
23543478|NCT01312909|65719821|FG002|Overall Study|Lost to Follow-up|20|||
23543479|NCT01312909|65719819|FG000|Overall Study|Insufficient clinical response|0|||
23543480|NCT01312909|65719820|FG001|Overall Study|Insufficient clinical response|0|||
23543481|NCT01312909|65719821|FG002|Overall Study|Insufficient clinical response|1|||
23543482|NCT01312909|65719819|FG000|Overall Study|Entrance criteria not met|0|||
23543483|NCT01312909|65719820|FG001|Overall Study|Entrance criteria not met|0|||
23543484|NCT01312909|65719821|FG002|Overall Study|Entrance criteria not met|2|||
23543485|NCT01365494|65719822|FG000|Overall Study|Adverse Event|1|||
23543486|NCT01365494|65719823|FG001|Overall Study|Adverse Event|0|||
23543487|NCT01365494|65719822|FG000|Overall Study|Withdrawal by Subject|0|||
23543488|NCT01365494|65719823|FG001|Overall Study|Withdrawal by Subject|1|||
23543489|NCT01365494|65719822|FG000|Overall Study|Lost to Follow-up|1|||
23543490|NCT01365494|65719823|FG001|Overall Study|Lost to Follow-up|2|||
23543491|NCT02576574|65719824|FG000|Overall Study|still ongoing|65|||
23543492|NCT02576574|65719825|FG001|Overall Study|still ongoing|66|||
23543493|NCT02576574|65719826|FG002|Overall Study|still ongoing|73|||
23543494|NCT02576574|65719824|FG000|Overall Study|Randomized, not treated|5|||
23543495|NCT02576574|65719825|FG001|Overall Study|Randomized, not treated|4|||
23543496|NCT02576574|65719826|FG002|Overall Study|Randomized, not treated|26|||
23543497|NCT01774903|65719827|FG000|Overall Study|Adverse Event|7|||
23543498|NCT01774903|65719827|FG000|Overall Study|Withdrawal by Subject|2|||
23543499|NCT01774903|65719827|FG000|Overall Study|Lack of Efficacy|1|||
23543500|NCT01774903|65719827|FG000|Overall Study|Ineligible to continue the trial|1|||
23543501|NCT01568047|65719828|FG000|Overall Study|Ineligibility|1|||
23543502|NCT01568047|65719829|FG001|Overall Study|Ineligibility|0|||
23543503|NCT01568047|65719830|FG002|Overall Study|Ineligibility|0|||
23543504|NCT01568047|65719831|FG003|Overall Study|Ineligibility|0|||
23543505|NCT01568047|65719828|FG000|Overall Study|Withdrawal by Subject|0|||
23543506|NCT01568047|65719829|FG001|Overall Study|Withdrawal by Subject|1|||
23543507|NCT01568047|65719830|FG002|Overall Study|Withdrawal by Subject|0|||
23543508|NCT01568047|65719831|FG003|Overall Study|Withdrawal by Subject|0|||
23543509|NCT01568047|65719828|FG000|Overall Study|Adverse Event|0|||
23543510|NCT01568047|65719829|FG001|Overall Study|Adverse Event|0|||
23543511|NCT01568047|65719830|FG002|Overall Study|Adverse Event|1|||
23543512|NCT01568047|65719831|FG003|Overall Study|Adverse Event|1|||
23543513|NCT04862143|65719834|FG000|Overall Study|Adverse Event|1|||
23543514|NCT04862143|65719834|FG000|Overall Study|Study terminated by sponsor|1|||
23543515|NCT02265237|65719844|FG000|As Treated (Overall Study)|Adverse Event|1|||
23543516|NCT02265237|65719845|FG001|As Treated (Overall Study)|Adverse Event|1|||
23543517|NCT02265237|65719846|FG002|As Treated (Overall Study)|Adverse Event|0|||
23543518|NCT02265237|65719847|FG003|As Treated (Overall Study)|Adverse Event|0|||
23543519|NCT02265237|65719844|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
23543520|NCT02265237|65719845|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
23543521|NCT02265237|65719846|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
23543522|NCT02265237|65719847|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
23543523|NCT02265237|65719844|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
23543524|NCT02265237|65719845|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
23543525|NCT02265237|65719846|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
23543526|NCT02265237|65719847|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
23543527|NCT02265237|65719844|FG000|As Treated (Overall Study)|Other|2|||
23543528|NCT02265237|65719845|FG001|As Treated (Overall Study)|Other|0|||
23543529|NCT02265237|65719846|FG002|As Treated (Overall Study)|Other|3|||
23543530|NCT02265237|65719847|FG003|As Treated (Overall Study)|Other|1|||
23543531|NCT03674177|65719848|FG000|Overall Study|Lost to Follow-up|2|||
23543532|NCT03674177|65719849|FG001|Overall Study|Lost to Follow-up|1|||
23543533|NCT03674177|65719850|FG002|Overall Study|Lost to Follow-up|0|||
23543534|NCT03674177|65719851|FG003|Overall Study|Lost to Follow-up|2|||
23543535|NCT02114892|65719852|FG000|Overall Study|Lost to Follow-up|1|||
23543536|NCT02114892|65719853|FG001|Overall Study|Lost to Follow-up|2|||
23543537|NCT01196975|65719854|FG000|Overall Study|Adverse Event|2|||
23543538|NCT01196975|65719855|FG001|Overall Study|Adverse Event|2|||
23543539|NCT01196975|65719856|FG002|Overall Study|Adverse Event|0|||
23543540|NCT01196975|65719857|FG003|Overall Study|Adverse Event|0|||
23729705|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
23543541|NCT01196975|65719858|FG004|Overall Study|Adverse Event|2|||
23543542|NCT01196975|65719854|FG000|Overall Study|Withdrawal by Subject|2|||
23543543|NCT01196975|65719855|FG001|Overall Study|Withdrawal by Subject|1|||
23543544|NCT01196975|65719856|FG002|Overall Study|Withdrawal by Subject|0|||
23543545|NCT01196975|65719857|FG003|Overall Study|Withdrawal by Subject|1|||
23543546|NCT01196975|65719858|FG004|Overall Study|Withdrawal by Subject|0|||
23543547|NCT01196975|65719854|FG000|Overall Study|Lost to Follow-up|11|||
23543548|NCT01196975|65719855|FG001|Overall Study|Lost to Follow-up|6|||
23543549|NCT01196975|65719856|FG002|Overall Study|Lost to Follow-up|5|||
23617021|NCT01024036|65985041|FG001|Unblinded Treatment|Adverse Event|1|||
23425438|NCT00235391|65299968|FG003|Overall Study|Lost to Follow-up|16|||
23543550|NCT01196975|65719857|FG003|Overall Study|Lost to Follow-up|5|||
23543551|NCT01196975|65719858|FG004|Overall Study|Lost to Follow-up|11|||
23543552|NCT02979535|65719859|FG000|Overall Study|Non compliance with the protocol|78|||
23543553|NCT02979535|65719860|FG001|Overall Study|Non compliance with the protocol|82|||
23543554|NCT02979535|65719859|FG000|Overall Study|Consent withdrawn by participant|11|||
23543555|NCT02979535|65719860|FG001|Overall Study|Consent withdrawn by participant|18|||
23543556|NCT02979535|65719859|FG000|Overall Study|Lost to Follow-up|6|||
23543557|NCT02979535|65719860|FG001|Overall Study|Lost to Follow-up|1|||
23543558|NCT00237744|65719861|FG000|Overall Study|Withdrawal by Subject|3|||
23543559|NCT00237744|65719862|FG001|Overall Study|Withdrawal by Subject|1|||
23543560|NCT00237744|65719863|FG002|Overall Study|Withdrawal by Subject|0|||
23543561|NCT03277313|65719866|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
23543562|NCT03277313|65719867|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
23543563|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
23543564|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
23543565|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
23543566|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
23543567|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
23543568|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
23543569|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
23543570|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
23543571|NCT03836053|65719868|FG000|Overall Study|Protocol-specified criteria|0|||
23543572|NCT03836053|65719869|FG001|Overall Study|Protocol-specified criteria|2|||
23543573|NCT03836053|65719870|FG002|Overall Study|Protocol-specified criteria|1|||
23543574|NCT03836053|65719868|FG000|Overall Study|Death|1|||
23543575|NCT03836053|65719869|FG001|Overall Study|Death|6|||
23543576|NCT03836053|65719870|FG002|Overall Study|Death|4|||
23543577|NCT03836053|65719868|FG000|Overall Study|Withdrawal of consent from study|0|||
23543578|NCT03836053|65719869|FG001|Overall Study|Withdrawal of consent from study|0|||
23543579|NCT03836053|65719870|FG002|Overall Study|Withdrawal of consent from study|1|||
23543580|NCT03836053|65719868|FG000|Overall Study|Decision by sponsor|0|||
23543581|NCT03836053|65719869|FG001|Overall Study|Decision by sponsor|2|||
23543582|NCT03836053|65719870|FG002|Overall Study|Decision by sponsor|4|||
23543583|NCT02802345|65719871|FG000|Overall Study|Not Treated|0|||
23543584|NCT02802345|65719872|FG001|Overall Study|Not Treated|1|||
23543585|NCT02802345|65719871|FG000|Overall Study|Adverse Event|28|||
23543586|NCT02802345|65719872|FG001|Overall Study|Adverse Event|20|||
23543587|NCT02802345|65719871|FG000|Overall Study|Withdrawal by Subject|3|||
23543588|NCT02802345|65719872|FG001|Overall Study|Withdrawal by Subject|3|||
23543589|NCT02802345|65719871|FG000|Overall Study|Protocol Violation|0|||
23543590|NCT02802345|65719872|FG001|Overall Study|Protocol Violation|1|||
23543591|NCT02802345|65719871|FG000|Overall Study|Other than listed|1|||
23543592|NCT02802345|65719872|FG001|Overall Study|Other than listed|5|||
23543593|NCT02730819|65719874|FG000|Overall Study|Lost to Follow-up|9|||
23543594|NCT01519206|65719875|FG000|Overall Study|Lost to Follow-up|3|||
23543595|NCT01519206|65719875|FG000|Overall Study|Missed Visit|2|||
23543596|NCT02370602|65719876|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23543597|NCT02370602|65719877|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23543598|NCT02370602|65719878|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23543599|NCT02370602|65719879|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23543600|NCT02370602|65719880|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23543601|NCT02370602|65719881|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23543602|NCT00506493|65719884|FG000|Overall Study|Death|6|||
23543603|NCT00506493|65719884|FG000|Overall Study|Withdrawal by Subject|5|||
23543604|NCT03478891|65719885|FG000|Overall Study|Enrolled, but product never administered|0|||
23543605|NCT03478891|65719886|FG001|Overall Study|Enrolled, but product never administered|0|||
23543606|NCT03478891|65719887|FG002|Overall Study|Enrolled, but product never administered|1|||
23543607|NCT03478891|65719885|FG000|Overall Study|Moved from area|0|||
23543608|NCT03478891|65719886|FG001|Overall Study|Moved from area|0|||
23543609|NCT03478891|65719887|FG002|Overall Study|Moved from area|1|||
23543610|NCT03478891|65719885|FG000|Overall Study|Lost to Follow-up|1|||
23543611|NCT03478891|65719886|FG001|Overall Study|Lost to Follow-up|0|||
23543612|NCT03478891|65719887|FG002|Overall Study|Lost to Follow-up|1|||
23729706|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729707|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729708|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729709|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729710|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729711|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729712|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
23729713|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
23729714|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729715|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23543613|NCT02667912|65719888|FG000|Overall Study|Death|3|||
23543614|NCT02667912|65719889|FG001|Overall Study|Death|1|||
23543615|NCT02667912|65719888|FG000|Overall Study|Withdrawal by Subject|1|||
23543616|NCT02667912|65719889|FG001|Overall Study|Withdrawal by Subject|2|||
23543617|NCT02667912|65719888|FG000|Overall Study|Withdrawal by Subject|1|||
23729716|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729717|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729718|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729719|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729720|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729721|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729722|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729723|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729724|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729725|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729726|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729727|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23729728|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23729729|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729730|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729731|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729732|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729733|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729734|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729735|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729736|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729737|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729738|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729739|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729740|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729741|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729742|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
23729743|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23729744|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729745|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729746|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729747|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729748|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729749|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729750|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729751|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729752|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729753|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729754|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729755|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729756|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729757|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
23729758|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23729759|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23543618|NCT02667912|65719889|FG001|Overall Study|Withdrawal by Subject|0|||
23543619|NCT01659021|65719892|FG000|Main Study|Adverse Event|2|||
23543620|NCT01659021|65719893|FG001|Main Study|Adverse Event|3|||
23543621|NCT01659021|65719892|FG000|Main Study|Lost to Follow-up|1|||
23729760|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729761|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729762|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729763|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729764|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729765|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729766|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729767|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729768|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729769|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729770|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23425439|NCT00235391|65299969|FG004|Overall Study|Lost to Follow-up|0|||
23543622|NCT01659021|65719893|FG001|Main Study|Lost to Follow-up|0|||
23543623|NCT01659021|65719892|FG000|Main Study|Unknown Reasons|2|||
23543624|NCT01659021|65719893|FG001|Main Study|Unknown Reasons|1|||
23543625|NCT01659021|65719892|FG000|Main Study|Physician Decision|34|||
23543626|NCT01659021|65719893|FG001|Main Study|Physician Decision|16|||
23543627|NCT01659021|65719892|FG000|Main Study|Withdrawal by Subject|19|||
23543628|NCT01659021|65719893|FG001|Main Study|Withdrawal by Subject|16|||
23543629|NCT01659021|65719892|FG000|Main Study|Study Terminated by Sponsor|16|||
23543630|NCT01659021|65719893|FG001|Main Study|Study Terminated by Sponsor|1|||
23543631|NCT01659021|65719892|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
23543632|NCT01659021|65719893|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
23543633|NCT01659021|65719892|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
23543634|NCT01659021|65719893|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
23543635|NCT00710424|65719894|FG000|Overall Study|Adverse Event|30|||
23543636|NCT00710424|65719895|FG001|Overall Study|Adverse Event|12|||
23543637|NCT00710424|65719894|FG000|Overall Study|Lack of Efficacy|4|||
23617022|NCT01024036|65985040|FG000|Unblinded Treatment|Lack of Efficacy|0|||
23729771|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729772|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23729773|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
23729774|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729775|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729776|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729777|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729778|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729779|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729780|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729781|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729782|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729783|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729784|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729785|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729786|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729787|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
23817961|NCT03201445|66714185|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
23817962|NCT03201445|66714184|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
23817963|NCT03201445|66714185|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
23817964|NCT03201445|66714184|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
23817965|NCT03201445|66714185|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
23817966|NCT03201445|66714184|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
23817967|NCT03201445|66714185|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
23817968|NCT03201445|66714184|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
23817969|NCT03201445|66714185|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
23817970|NCT03201445|66714184|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
23817971|NCT03201445|66714185|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
23817972|NCT03201445|66714184|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
23817973|NCT03201445|66714185|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
23817974|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
23817975|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
23817976|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
23817977|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
23817978|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
23817979|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
23817980|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
23817981|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
23817982|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
23817983|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
23817984|NCT03201445|66714184|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
23817985|NCT03201445|66714185|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
23817986|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
23817987|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
23817988|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
23425440|NCT00235391|65299970|FG005|Overall Study|Lost to Follow-up|0|||
23425441|NCT00235391|65299965|FG000|Overall Study|Administrative problems|0|||
23617023|NCT01024036|65985041|FG001|Unblinded Treatment|Lack of Efficacy|2|||
23729788|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23729789|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729790|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23617024|NCT01024036|65985040|FG000|Follow-Up Period|Lost to Follow-up|1|||
23617025|NCT01024036|65985041|FG001|Follow-Up Period|Lost to Follow-up|1|||
23425442|NCT00235391|65299966|FG001|Overall Study|Administrative problems|0|||
23425443|NCT00235391|65299967|FG002|Overall Study|Administrative problems|0|||
23425444|NCT00235391|65299968|FG003|Overall Study|Administrative problems|1|||
23425445|NCT00235391|65299969|FG004|Overall Study|Administrative problems|0|||
23425446|NCT00235391|65299970|FG005|Overall Study|Administrative problems|0|||
23425447|NCT00235391|65299965|FG000|Overall Study|Death|0|||
23425448|NCT00235391|65299966|FG001|Overall Study|Death|0|||
23425449|NCT00235391|65299967|FG002|Overall Study|Death|1|||
23425450|NCT00235391|65299968|FG003|Overall Study|Death|4|||
23425451|NCT00235391|65299969|FG004|Overall Study|Death|0|||
23425452|NCT00235391|65299970|FG005|Overall Study|Death|0|||
23425453|NCT00609791|65299971|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
23425454|NCT00846040|65299975|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
23425455|NCT00846040|65299976|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
23425456|NCT00846040|65299977|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
23425457|NCT00846040|65299975|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
23425458|NCT00846040|65299976|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
23425459|NCT00846040|65299977|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
23425460|NCT00824005|65299980|FG000|Overall Study|Death|0|||
23425461|NCT00824005|65299981|FG001|Overall Study|Death|1|||
23425462|NCT00824005|65299980|FG000|Overall Study|Lost to Follow-up|0|||
23425463|NCT00824005|65299981|FG001|Overall Study|Lost to Follow-up|1|||
23425464|NCT01777542|65299982|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
23729791|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729792|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23425465|NCT01777542|65299983|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
23425466|NCT00853125|65299984|FG000|Overall Study|Study participant's donor was CMV +|1|||
23425467|NCT03366103|65299985|FG000|Overall Study|Disease Progression|3|||
23425468|NCT03366103|65299986|FG001|Overall Study|Disease Progression|1|||
23425469|NCT03366103|65299987|FG002|Overall Study|Disease Progression|0|||
23425470|NCT03366103|65299985|FG000|Overall Study|Adverse Event|0|||
23729793|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729794|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729795|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729796|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23817989|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
23817990|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
23817991|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
23817992|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
23543638|NCT00710424|65719895|FG001|Overall Study|Lack of Efficacy|5|||
23543639|NCT00710424|65719894|FG000|Overall Study|Withdrawal by Subject|5|||
23543640|NCT00710424|65719895|FG001|Overall Study|Withdrawal by Subject|3|||
23543641|NCT00710424|65719894|FG000|Overall Study|Lost to Follow-up|0|||
23543642|NCT00710424|65719895|FG001|Overall Study|Lost to Follow-up|1|||
23543643|NCT00710424|65719894|FG000|Overall Study|Refused medication, no side effects|1|||
23543644|NCT00710424|65719895|FG001|Overall Study|Refused medication, no side effects|0|||
23543645|NCT00710424|65719894|FG000|Overall Study|Non-compliance with stable analgesia|1|||
23729797|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729798|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23817993|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
23817994|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
23817995|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
23817996|NCT03201445|66714184|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
23817997|NCT03201445|66714185|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
23425471|NCT03366103|65299986|FG001|Overall Study|Adverse Event|1|||
23543646|NCT00710424|65719895|FG001|Overall Study|Non-compliance with stable analgesia|0|||
23543647|NCT00710424|65719894|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
23729799|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729800|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23817998|NCT03201445|66714184|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
23817999|NCT03201445|66714185|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
23425472|NCT03366103|65299987|FG002|Overall Study|Adverse Event|0|||
23425473|NCT01174004|65299988|FG000|Overall Study|Adverse Event|2|||
23425474|NCT01174004|65299989|FG001|Overall Study|Adverse Event|10|||
23425475|NCT01174004|65299988|FG000|Overall Study|Withdrawal by Subject|2|||
23425476|NCT01174004|65299989|FG001|Overall Study|Withdrawal by Subject|3|||
23425477|NCT01174004|65299988|FG000|Overall Study|At Discretion of Sponsor|2|||
23425478|NCT01174004|65299989|FG001|Overall Study|At Discretion of Sponsor|2|||
23425479|NCT01174004|65299988|FG000|Overall Study|Protocol Violation|0|||
23543648|NCT00710424|65719895|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
23729801|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23425480|NCT01174004|65299989|FG001|Overall Study|Protocol Violation|1|||
23425481|NCT01174004|65299988|FG000|Overall Study|Physician Decision|1|||
23425482|NCT01174004|65299989|FG001|Overall Study|Physician Decision|0|||
23425483|NCT01166958|65299990|FG000|Overall Study|Withdrawal by Subject|1|||
23425484|NCT01166958|65299991|FG001|Overall Study|Withdrawal by Subject|0|||
23425485|NCT00585546|65299992|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
23425486|NCT00585546|65299992|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
23453603|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453604|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453605|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453606|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23453607|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23453608|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453609|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453610|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453611|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453612|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453613|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453614|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
23453615|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453616|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453617|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453618|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453619|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453620|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453621|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453622|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453623|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453624|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453625|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453626|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453627|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453628|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
23729802|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
23729803|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23729804|NCT03073200|66388663|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729805|NCT03073200|66388664|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729806|NCT03073200|66388665|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729807|NCT03073200|66388666|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729808|NCT03073200|66388667|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729809|NCT03073200|66388668|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729810|NCT03073200|66388669|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729811|NCT03073200|66388670|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729812|NCT03073200|66388671|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729813|NCT03073200|66388672|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729814|NCT03073200|66388673|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729815|NCT03073200|66388674|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729816|NCT03073200|66388675|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729817|NCT03073200|66388676|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
23729818|NCT03073200|66388677|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23729819|NCT02109744|66388678|FG000|Overall Study|Death|1|||
23818000|NCT03201445|66714184|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
23818001|NCT03201445|66714185|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
23818002|NCT01994291|66714186|FG000|Overall Study|Adverse Event|4|||
23818003|NCT01994291|66714187|FG001|Overall Study|Adverse Event|1|||
23818004|NCT01994291|66714188|FG002|Overall Study|Adverse Event|3|||
23818005|NCT01994291|66714186|FG000|Overall Study|Lost to Follow-up|1|||
23818006|NCT01994291|66714187|FG001|Overall Study|Lost to Follow-up|1|||
23453629|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453630|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453631|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453632|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23453633|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23729820|NCT02109744|66388679|FG001|Overall Study|Death|1|||
23729821|NCT02109744|66388678|FG000|Overall Study|no marrow exam|1|||
23729822|NCT02109744|66388679|FG001|Overall Study|no marrow exam|0|||
23729823|NCT04067011|66388680|FG000|Overall Study|Not Treated|8|||
23729824|NCT04067011|66388681|FG001|Overall Study|Not Treated|7|||
23729825|NCT04067011|66388682|FG002|Overall Study|Not Treated|5|||
23729826|NCT04067011|66388680|FG000|Overall Study|Adverse Event|2|||
23729827|NCT04067011|66388681|FG001|Overall Study|Adverse Event|1|||
23729828|NCT04067011|66388682|FG002|Overall Study|Adverse Event|0|||
23729829|NCT04067011|66388680|FG000|Overall Study|Withdrawal by Subject|6|||
23729830|NCT04067011|66388681|FG001|Overall Study|Withdrawal by Subject|2|||
23729831|NCT04067011|66388682|FG002|Overall Study|Withdrawal by Subject|1|||
23729832|NCT04067011|66388680|FG000|Overall Study|Lost to Follow-up|0|||
23729833|NCT04067011|66388681|FG001|Overall Study|Lost to Follow-up|0|||
23729834|NCT04067011|66388682|FG002|Overall Study|Lost to Follow-up|1|||
23729835|NCT04067011|66388680|FG000|Overall Study|Physician Decision|1|||
23729836|NCT04067011|66388681|FG001|Overall Study|Physician Decision|1|||
23729837|NCT04067011|66388682|FG002|Overall Study|Physician Decision|0|||
23729838|NCT04067011|66388680|FG000|Overall Study|Other Reasons|2|||
23729839|NCT04067011|66388681|FG001|Overall Study|Other Reasons|0|||
23729840|NCT04067011|66388682|FG002|Overall Study|Other Reasons|1|||
23729841|NCT04067011|66388680|FG000|Overall Study|Missing|0|||
23729842|NCT04067011|66388681|FG001|Overall Study|Missing|2|||
23425487|NCT01231321|65303325|FG000|Overall Study|Adverse Event|3|||
23425488|NCT01231321|65303325|FG000|Overall Study|Lack of Efficacy|2|||
23425489|NCT03461406|65303329|FG000|Overall Study|Death|1|||
23425490|NCT03461406|65303330|FG001|Overall Study|Death|2|||
23425491|NCT03461406|65303329|FG000|Overall Study|Consent Withdrawn by Participant|0|||
23543649|NCT00710424|65719894|FG000|Overall Study|Subject thought medication changed|1|||
23543650|NCT00710424|65719895|FG001|Overall Study|Subject thought medication changed|0|||
23543651|NCT00710424|65719894|FG000|Overall Study|Ceased treatment due to travel|1|||
23543652|NCT00710424|65719895|FG001|Overall Study|Ceased treatment due to travel|0|||
23543653|NCT00710424|65719894|FG000|Overall Study|Subject preferred paracetamol|0|||
23543654|NCT00710424|65719895|FG001|Overall Study|Subject preferred paracetamol|1|||
23543655|NCT00710424|65719894|FG000|Overall Study|Felt good so stopped treatment|0|||
23543656|NCT00710424|65719895|FG001|Overall Study|Felt good so stopped treatment|1|||
23543657|NCT04287920|65719896|FG000|Overall Study|Lost to Follow-up|1|||
23543658|NCT04287920|65719897|FG001|Overall Study|Lost to Follow-up|1|||
23543659|NCT04287920|65719896|FG000|Overall Study|Withdrawal by Subject|0|||
23543660|NCT04287920|65719897|FG001|Overall Study|Withdrawal by Subject|3|||
23543661|NCT00809757|65719900|FG000|Overall Study|Adverse Event|2|||
23543662|NCT00809757|65719901|FG001|Overall Study|Adverse Event|3|||
23543663|NCT00809757|65719902|FG002|Overall Study|Adverse Event|3|||
23543664|NCT00809757|65719900|FG000|Overall Study|Lost to Follow-up|0|||
23543665|NCT00809757|65719901|FG001|Overall Study|Lost to Follow-up|0|||
23543666|NCT00809757|65719902|FG002|Overall Study|Lost to Follow-up|1|||
23543667|NCT00809757|65719900|FG000|Overall Study|Protocol Violation|1|||
23543668|NCT00809757|65719901|FG001|Overall Study|Protocol Violation|1|||
23543669|NCT00809757|65719902|FG002|Overall Study|Protocol Violation|1|||
23543670|NCT00809757|65719900|FG000|Overall Study|Withdrawal by Subject|2|||
23543671|NCT00809757|65719901|FG001|Overall Study|Withdrawal by Subject|1|||
23543672|NCT00809757|65719902|FG002|Overall Study|Withdrawal by Subject|3|||
23543673|NCT00809757|65719900|FG000|Overall Study|Subject Uncooperative|1|||
23543674|NCT00809757|65719901|FG001|Overall Study|Subject Uncooperative|0|||
23543675|NCT00809757|65719902|FG002|Overall Study|Subject Uncooperative|2|||
23543676|NCT00809757|65719900|FG000|Overall Study|Noncompliance with Medication|0|||
23543677|NCT00809757|65719901|FG001|Overall Study|Noncompliance with Medication|0|||
23543678|NCT00809757|65719902|FG002|Overall Study|Noncompliance with Medication|1|||
23543679|NCT03329092|65719903|FG000|Overall Study|Other|2|||
23543680|NCT03329092|65719904|FG001|Overall Study|Other|2|||
23543681|NCT03329092|65719903|FG000|Overall Study|Withdrawal by Subject|16|||
23543682|NCT03329092|65719904|FG001|Overall Study|Withdrawal by Subject|3|||
23543683|NCT03329092|65719903|FG000|Overall Study|Physician Decision|1|||
23543684|NCT03329092|65719904|FG001|Overall Study|Physician Decision|0|||
23729843|NCT04067011|66388682|FG002|Overall Study|Missing|0|||
23425492|NCT03461406|65303330|FG001|Overall Study|Consent Withdrawn by Participant|1|||
23425493|NCT03461406|65303329|FG000|Overall Study|Screen Failure|3|||
23425494|NCT03461406|65303330|FG001|Overall Study|Screen Failure|1|||
23543685|NCT03329092|65719903|FG000|Overall Study|Death|17|||
23543686|NCT03329092|65719904|FG001|Overall Study|Death|11|||
23543687|NCT03329092|65719903|FG000|Overall Study|Adverse Event|3|||
23543688|NCT03329092|65719904|FG001|Overall Study|Adverse Event|1|||
23543689|NCT03329092|65719903|FG000|Overall Study|Lost to Follow-up|1|||
23543690|NCT03329092|65719904|FG001|Overall Study|Lost to Follow-up|1|||
23729844|NCT02635867|66388683|FG000|Overall Study|Lost to Follow-up|4|||
23729845|NCT02635867|66388684|FG001|Overall Study|Lost to Follow-up|3|||
23729846|NCT02635867|66388685|FG002|Overall Study|Lost to Follow-up|3|||
23729847|NCT02635867|66388686|FG003|Overall Study|Lost to Follow-up|4|||
23729848|NCT02635867|66388687|FG004|Overall Study|Lost to Follow-up|1|||
23543691|NCT00377819|65719908|FG000|Overall Study|Adverse Event|2|||
23543692|NCT00377819|65719909|FG001|Overall Study|Adverse Event|3|||
23543693|NCT00377819|65719908|FG000|Overall Study|Withdrawal by Subject|10|||
23543694|NCT00377819|65719909|FG001|Overall Study|Withdrawal by Subject|4|||
23543695|NCT00377819|65719908|FG000|Overall Study|Death|0|||
23543696|NCT00377819|65719909|FG001|Overall Study|Death|1|||
23617026|NCT01024036|65985040|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23617027|NCT01024036|65985041|FG001|Follow-Up Period|Withdrawal by Subject|1|||
23617028|NCT01024036|65985040|FG000|Follow-Up Period|Adverse Event|4|||
23617029|NCT01024036|65985041|FG001|Follow-Up Period|Adverse Event|1|||
23617030|NCT01078584|65985042|FG000|Overall Study|Final Status Unknown|1073|||
23617031|NCT01078584|65985042|FG000|Overall Study|Lost to Follow-up|670|||
23617032|NCT01078584|65985042|FG000|Overall Study|Non-serious Adverse Event|577|||
23617033|NCT01078584|65985042|FG000|Overall Study|Withdrawal of Consent|244|||
23617034|NCT01078584|65985042|FG000|Overall Study|Physician Withdrew from Study|90|||
23617035|NCT01078584|65985042|FG000|Overall Study|Non-compliance|67|||
23617036|NCT01078584|65985042|FG000|Overall Study|Blood Pressure Controlled|49|||
23617037|NCT01078584|65985042|FG000|Overall Study|Physician Switched Medication|26|||
23617038|NCT01078584|65985042|FG000|Overall Study|Physician Discontinued Patient|12|||
23617039|NCT01078584|65985042|FG000|Overall Study|Lack of Efficacy|98|||
23617040|NCT01078584|65985042|FG000|Overall Study|Protocol Violation|75|||
23617041|NCT01078584|65985042|FG000|Overall Study|Serious Adverse Event|27|||
23617042|NCT01078584|65985042|FG000|Overall Study|Multiple Reasons|2|||
23617043|NCT05008224|65985044|FG000|Overall Study|Death|3|||
23617044|NCT05008224|65985044|FG000|Overall Study|Lost to Follow-up|2|||
23617045|NCT05008224|65985044|FG000|Overall Study|Did Not Continue on Extension Study|39|||
23543697|NCT00377819|65719908|FG000|Overall Study|Lost to Follow-up|0|||
23543698|NCT00377819|65719909|FG001|Overall Study|Lost to Follow-up|1|||
23617046|NCT05008224|65985044|FG000|Overall Study|Transferred to Extension Study|100|||
23617047|NCT05008224|65985044|FG000|Overall Study|Withdrawal by Subject|2|||
23617048|NCT04688086|65985047|FG000|Overall Study|Lost to Follow-up|164|||
23617049|NCT04688086|65985047|FG000|Overall Study|Imaging error;|64|||
23617050|NCT04661150|65985050|FG000|Overall Study|Ongoing in study|19|||
23617051|NCT04661150|65985051|FG001|Overall Study|Ongoing in study|20|||
23617052|NCT04661150|65985050|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
23617053|NCT04661150|65985051|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
23617054|NCT04661150|65985050|FG000|Overall Study|Death|2|||
23617055|NCT04661150|65985051|FG001|Overall Study|Death|0|||
23617056|NCT00946088|65985052|FG000|Overall Study|Withdrawal by Subject|0|||
23617057|NCT00946088|65985053|FG001|Overall Study|Withdrawal by Subject|1|||
23617058|NCT01075100|65985056|FG000|Overall Study|Adverse Event|15|||
23617059|NCT01075100|65985057|FG001|Overall Study|Adverse Event|18|||
23617060|NCT01075100|65985056|FG000|Overall Study|Patient Request|4|||
23617061|NCT01075100|65985057|FG001|Overall Study|Patient Request|4|||
23617062|NCT01075100|65985056|FG000|Overall Study|Investigator Request|2|||
23617063|NCT01075100|65985057|FG001|Overall Study|Investigator Request|1|||
23617064|NCT01075100|65985056|FG000|Overall Study|Disease Progression|25|||
23729849|NCT02996110|66388688|FG000|Pre-Treatment|Other Reasons|0|||
23729850|NCT02996110|66388689|FG001|Pre-Treatment|Other Reasons|1|||
23729851|NCT02996110|66388690|FG002|Pre-Treatment|Other Reasons|0|||
23543699|NCT00377819|65719908|FG000|Overall Study|Protocol Violation|1|||
23543700|NCT00377819|65719909|FG001|Overall Study|Protocol Violation|1|||
23729852|NCT02996110|66388691|FG003|Pre-Treatment|Other Reasons|0|||
23729853|NCT02996110|66388692|FG004|Pre-Treatment|Other Reasons|1|||
23729854|NCT02996110|66388688|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
23729855|NCT02996110|66388689|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
23729856|NCT02996110|66388690|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
23729857|NCT02996110|66388691|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
23729858|NCT02996110|66388692|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
23729859|NCT02996110|66388688|FG000|Track 1|Disease Progression|15|||
23729860|NCT02996110|66388689|FG001|Track 1|Disease Progression|17|||
23729861|NCT02996110|66388690|FG002|Track 1|Disease Progression|0|||
23729862|NCT02996110|66388691|FG003|Track 1|Disease Progression|0|||
23729863|NCT02996110|66388692|FG004|Track 1|Disease Progression|0|||
23543701|NCT04095858|65719912|FG000|Overall Study|Death|1|||
23543702|NCT04095858|65719913|FG001|Overall Study|Death|0|||
23543703|NCT04095858|65719912|FG000|Overall Study|Study terminated by Sponsor|2|||
23543704|NCT04095858|65719913|FG001|Overall Study|Study terminated by Sponsor|4|||
23617065|NCT01075100|65985057|FG001|Overall Study|Disease Progression|29|||
23617066|NCT01075100|65985056|FG000|Overall Study|Other|3|||
23617067|NCT01075100|65985057|FG001|Overall Study|Other|1|||
23617068|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Adverse Event|3|||
23617069|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Adverse Event|0|||
23617070|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
23729864|NCT02996110|66388688|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
23543705|NCT04598152|65719914|FG000|Overall Study|Lost to Follow-up|0|||
23543706|NCT04598152|65719915|FG001|Overall Study|Lost to Follow-up|1|||
23729865|NCT02996110|66388689|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
23617071|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
23617072|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Disease Progression|23|||
23617073|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Disease Progression|22|||
23818007|NCT01994291|66714188|FG002|Overall Study|Lost to Follow-up|0|||
23818008|NCT01994291|66714186|FG000|Overall Study|Does not meet entrance criteria|1|||
23818009|NCT01994291|66714187|FG001|Overall Study|Does not meet entrance criteria|0|||
23818010|NCT01994291|66714188|FG002|Overall Study|Does not meet entrance criteria|0|||
23818011|NCT01994291|66714186|FG000|Overall Study|Medication error without associated AE|1|||
23818012|NCT01994291|66714187|FG001|Overall Study|Medication error without associated AE|0|||
23818013|NCT01994291|66714188|FG002|Overall Study|Medication error without associated AE|1|||
23818014|NCT01994291|66714186|FG000|Overall Study|Protocol Violation|1|||
23818015|NCT01994291|66714187|FG001|Overall Study|Protocol Violation|0|||
23818016|NCT01994291|66714188|FG002|Overall Study|Protocol Violation|0|||
23543707|NCT03985423|65719917|FG000|Overall Study|Adverse Event|1|||
23543708|NCT03985423|65719917|FG000|Overall Study|Death|2|||
23543709|NCT03985423|65719917|FG000|Overall Study|Physician Decision|1|||
23543710|NCT03985423|65719917|FG000|Overall Study|Withdrawal by Subject|2|||
23729866|NCT02996110|66388690|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
23729867|NCT02996110|66388691|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
23729868|NCT02996110|66388692|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
23729869|NCT02996110|66388688|FG000|Track 1|Study Drug Toxicity|5|||
23729870|NCT02996110|66388689|FG001|Track 1|Study Drug Toxicity|3|||
23729871|NCT02996110|66388690|FG002|Track 1|Study Drug Toxicity|0|||
23729872|NCT02996110|66388691|FG003|Track 1|Study Drug Toxicity|0|||
23729873|NCT02996110|66388692|FG004|Track 1|Study Drug Toxicity|0|||
23729874|NCT02996110|66388688|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
23729875|NCT02996110|66388689|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23729876|NCT02996110|66388690|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23729877|NCT02996110|66388691|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23729878|NCT02996110|66388692|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23543711|NCT03985423|65719917|FG000|Overall Study|Lack of insurance and citizenship|1|||
23543712|NCT02121847|65719921|FG000|Overall Study|Administrative Reasons|1|||
23543713|NCT02121847|65719921|FG000|Overall Study|Adverse Event|2|||
23543714|NCT00856583|65719922|FG000|Overall Study|Lack of Efficacy|389|||
23543715|NCT00856583|65719923|FG001|Overall Study|Lack of Efficacy|377|||
23543716|NCT00856583|65719922|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
23543717|NCT00856583|65719923|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
23543718|NCT00856583|65719922|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
23543719|NCT00856583|65719923|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
23543720|NCT00856583|65719922|FG000|Overall Study|Non-compliance|305|||
23543721|NCT00856583|65719923|FG001|Overall Study|Non-compliance|262|||
23543722|NCT00856583|65719922|FG000|Overall Study|Withdrawal by Subject|1092|||
23543723|NCT00856583|65719923|FG001|Overall Study|Withdrawal by Subject|919|||
23543724|NCT00856583|65719922|FG000|Overall Study|Physician Decision|59|||
23543725|NCT00856583|65719923|FG001|Overall Study|Physician Decision|82|||
23543726|NCT00856583|65719922|FG000|Overall Study|Pregnancy|14|||
23543727|NCT00856583|65719923|FG001|Overall Study|Pregnancy|5|||
23543728|NCT00856583|65719922|FG000|Overall Study|Other|92|||
23543729|NCT00856583|65719923|FG001|Overall Study|Other|104|||
23543730|NCT00856583|65719922|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
23543731|NCT00856583|65719923|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
23543732|NCT04408469|65719929|FG000|Overall Study|Lost to Follow-up|6|||
23543733|NCT04408469|65719930|FG001|Overall Study|Lost to Follow-up|9|||
23543734|NCT04408469|65719929|FG000|Overall Study|Withdrawal by Subject|6|||
23543735|NCT04408469|65719930|FG001|Overall Study|Withdrawal by Subject|1|||
23543736|NCT04408469|65719929|FG000|Overall Study|Dismissal due to ineligibility|0|||
23543737|NCT04408469|65719930|FG001|Overall Study|Dismissal due to ineligibility|1|||
23543738|NCT02345512|65719938|FG000|Overall Study|Adverse Event|1|||
23543739|NCT02345512|65719938|FG000|Overall Study|Withdrawal by Subject|1|||
23617074|NCT01379521|65985058|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
23729879|NCT02996110|66388688|FG000|Track 1|Administrative Reason by Sponsor|0|||
23729880|NCT02996110|66388689|FG001|Track 1|Administrative Reason by Sponsor|1|||
23729881|NCT02996110|66388690|FG002|Track 1|Administrative Reason by Sponsor|0|||
23818017|NCT01994291|66714186|FG000|Overall Study|Withdrawal by Subject|6|||
23818018|NCT01994291|66714187|FG001|Overall Study|Withdrawal by Subject|3|||
23818019|NCT01994291|66714188|FG002|Overall Study|Withdrawal by Subject|5|||
23818020|NCT01994291|66714186|FG000|Overall Study|Other|1|||
23543740|NCT01592708|65719939|FG000|Overall Study|Protocol Violation|3|||
23818021|NCT01994291|66714187|FG001|Overall Study|Other|2|||
23818022|NCT01994291|66714188|FG002|Overall Study|Other|0|||
23543741|NCT01592708|65719940|FG001|Overall Study|Protocol Violation|0|||
23543742|NCT00856856|65719944|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
23543743|NCT00856856|65719944|FG000|4-year Clinical Follow-up|Missed visit|1|||
23582204|NCT01094171|65862382|FG000|Overall Study|Informed consent withdrawal|4|||
23543744|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
23543745|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
23543746|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
23543747|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543748|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543749|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543750|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543751|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
23543752|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
23617075|NCT01379521|65985059|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
23617076|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
23617077|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
23543753|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
23543754|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543755|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543756|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543757|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543758|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
23543759|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543760|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543761|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543762|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543763|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543764|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543765|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543766|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543767|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543768|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
23543769|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
23543770|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
23543771|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543772|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543773|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543774|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543775|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
23543776|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
23543777|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
23543778|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543779|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543780|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543781|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543782|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
23543783|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
23543784|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
23543785|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543786|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543787|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543788|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543789|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
23543790|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543791|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543792|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543793|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543794|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23617078|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
23617079|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
23617080|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
23617081|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
23617082|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Death|2|||
23617083|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Death|1|||
23617084|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Disease Progression|22|||
23617085|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Disease Progression|20|||
23617086|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
23617087|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
23729882|NCT02996110|66388691|FG003|Track 1|Administrative Reason by Sponsor|0|||
23729883|NCT02996110|66388692|FG004|Track 1|Administrative Reason by Sponsor|0|||
23729884|NCT02996110|66388688|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
23729885|NCT02996110|66388689|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
23729886|NCT02996110|66388690|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
23729887|NCT02996110|66388691|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
23729888|NCT02996110|66388692|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
23729889|NCT02996110|66388688|FG000|Track 2|Disease Progression|33|||
23729890|NCT02996110|66388689|FG001|Track 2|Disease Progression|26|||
23729891|NCT02996110|66388690|FG002|Track 2|Disease Progression|19|||
23729892|NCT02996110|66388691|FG003|Track 2|Disease Progression|16|||
23729893|NCT02996110|66388692|FG004|Track 2|Disease Progression|15|||
23729894|NCT02996110|66388688|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
23729895|NCT02996110|66388689|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
23729896|NCT02996110|66388690|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
23729897|NCT02996110|66388691|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
23729898|NCT02996110|66388692|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
23729899|NCT02996110|66388688|FG000|Track 2|Death|0|||
23729900|NCT02996110|66388689|FG001|Track 2|Death|0|||
23729901|NCT02996110|66388690|FG002|Track 2|Death|1|||
23729902|NCT02996110|66388691|FG003|Track 2|Death|0|||
23729903|NCT02996110|66388692|FG004|Track 2|Death|1|||
23729904|NCT02996110|66388688|FG000|Track 2|Study Drug Toxicity|4|||
23729905|NCT02996110|66388689|FG001|Track 2|Study Drug Toxicity|1|||
23729906|NCT02996110|66388690|FG002|Track 2|Study Drug Toxicity|4|||
23729907|NCT02996110|66388691|FG003|Track 2|Study Drug Toxicity|1|||
23729908|NCT02996110|66388692|FG004|Track 2|Study Drug Toxicity|0|||
23729909|NCT02996110|66388688|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
23729910|NCT02996110|66388689|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
23729911|NCT02996110|66388690|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
23729912|NCT02996110|66388691|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
23729913|NCT02996110|66388692|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
23729914|NCT02996110|66388688|FG000|Track 2|Participant Withdrew Consent|1|||
23729915|NCT02996110|66388689|FG001|Track 2|Participant Withdrew Consent|2|||
23729916|NCT02996110|66388690|FG002|Track 2|Participant Withdrew Consent|3|||
23729917|NCT02996110|66388691|FG003|Track 2|Participant Withdrew Consent|1|||
23729918|NCT02996110|66388692|FG004|Track 2|Participant Withdrew Consent|1|||
23729919|NCT02996110|66388688|FG000|Track 2|Other Reasons|0|||
23729920|NCT02996110|66388689|FG001|Track 2|Other Reasons|0|||
23729921|NCT02996110|66388690|FG002|Track 2|Other Reasons|1|||
23729922|NCT02996110|66388691|FG003|Track 2|Other Reasons|0|||
23729923|NCT02996110|66388692|FG004|Track 2|Other Reasons|1|||
23729924|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Adverse Event|30|||
23729925|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Adverse Event|25|||
23729926|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Adverse Event|23|||
23729927|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Adverse Event|14|||
23729928|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Death|0|||
23729929|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Death|0|||
23729930|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Death|1|||
23729931|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Death|0|||
23729932|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Physician Decision|0|||
23729933|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Physician Decision|1|||
23729934|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Physician Decision|0|||
23729935|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Physician Decision|1|||
23729936|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
23729937|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
23729938|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
23729939|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
23543795|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23729940|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Other|6|||
23729941|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Other|1|||
23729942|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Other|0|||
23729943|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Other|2|||
23729944|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
23729945|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
23729946|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
23729947|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
23729948|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
23729949|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
23729950|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
23729951|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
23729952|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
23729953|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
23729954|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
23729955|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
23729956|NCT00242710|66388699|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
23729957|NCT00242710|66388700|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
23729958|NCT00242710|66388701|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
23729959|NCT00242710|66388702|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
23729960|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Adverse Event|2|||
23729961|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Adverse Event|3|||
23729962|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Adverse Event|5|||
23818023|NCT02538965|66714189|FG000|Treatment Period|Other = Death due to disease progression|1|||
23818024|NCT02538965|66714189|FG000|Treatment Period|Adverse Event|2|||
23818025|NCT02538965|66714189|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
23543796|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23729963|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Adverse Event|2|||
23729964|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Physician Decision|1|||
23729965|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Physician Decision|1|||
23729966|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Physician Decision|0|||
23729967|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Physician Decision|0|||
23729968|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Other|24|||
23729969|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Other|24|||
23729970|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Other|9|||
23729971|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Other|11|||
23729972|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Extension not Available|17|||
23729973|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Extension not Available|21|||
23729974|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Extension not Available|8|||
23729975|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Extension not Available|7|||
23729976|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
23729977|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
23543797|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543798|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543799|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
23543800|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543801|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543802|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543803|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543804|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23617088|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Death|1|||
23617089|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Death|0|||
23617090|NCT00428441|65985060|FG000|Overall Study|Lost to Follow-up|1|||
23617091|NCT02785900|65985067|FG000|Overall Study|Study Termination by Sponsor|64|||
23617092|NCT02785900|65985068|FG001|Overall Study|Study Termination by Sponsor|81|||
23617093|NCT02785900|65985067|FG000|Overall Study|Death|46|||
23617094|NCT02785900|65985068|FG001|Overall Study|Death|32|||
23617095|NCT02785900|65985067|FG000|Overall Study|Withdrawal by Subject|4|||
23543805|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543806|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
23543807|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543808|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543809|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543810|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543811|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543812|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543813|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
23543814|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543815|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543816|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543817|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543818|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543819|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23617096|NCT02785900|65985068|FG001|Overall Study|Withdrawal by Subject|8|||
23617097|NCT02785900|65985067|FG000|Overall Study|Physician Decision|3|||
23617098|NCT02785900|65985068|FG001|Overall Study|Physician Decision|2|||
23617099|NCT03036124|65985069|FG000|Overall Study|Lost to Follow-up|0|||
23617100|NCT03036124|65985070|FG001|Overall Study|Lost to Follow-up|2|||
23729978|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
23729979|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
23818026|NCT02538965|66714189|FG000|Treatment Period|Treatment Failure|9|||
23818027|NCT02538965|66714189|FG000|Treatment Period|Disease Progression|1|||
23729980|NCT00242710|66388699|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
23729981|NCT00242710|66388700|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
23729982|NCT00242710|66388701|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
23729983|NCT00242710|66388702|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
23729984|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
23729985|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
23729986|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
23729987|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
23729988|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Death|0|||
23729989|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Death|0|||
23729990|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Death|0|||
23729991|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Death|1|||
23729992|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
23729993|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
23729994|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
23617101|NCT03036124|65985069|FG000|Overall Study|Withdrawal by Subject|5|||
23617102|NCT03036124|65985070|FG001|Overall Study|Withdrawal by Subject|4|||
23617103|NCT01107353|65985071|FG000|Overall Study|Positive Drug Screen|1|||
23617104|NCT01107353|65985072|FG001|Overall Study|Positive Drug Screen|0|||
23617105|NCT01129115|65985073|FG000|Overall Study|Adverse Event|1|||
23617106|NCT01129115|65985074|FG001|Overall Study|Adverse Event|2|||
23617107|NCT01129115|65985075|FG002|Overall Study|Adverse Event|3|||
23617108|NCT01129115|65985076|FG003|Overall Study|Adverse Event|3|||
23617109|NCT01129115|65985073|FG000|Overall Study|Withdrawal by Subject|1|||
23617110|NCT01129115|65985074|FG001|Overall Study|Withdrawal by Subject|3|||
23617111|NCT01129115|65985075|FG002|Overall Study|Withdrawal by Subject|1|||
23617112|NCT01129115|65985076|FG003|Overall Study|Withdrawal by Subject|4|||
23617113|NCT01129115|65985073|FG000|Overall Study|Protocol Violation|0|||
23617114|NCT01129115|65985074|FG001|Overall Study|Protocol Violation|2|||
23617115|NCT01129115|65985075|FG002|Overall Study|Protocol Violation|2|||
23617116|NCT01129115|65985076|FG003|Overall Study|Protocol Violation|2|||
23617117|NCT03738397|65985077|FG000|Overall Study|Adverse Event|3|||
23617118|NCT03738397|65985078|FG001|Overall Study|Adverse Event|7|||
23617119|NCT03738397|65985077|FG000|Overall Study|Withdrawal by Subject|8|||
23617120|NCT03738397|65985078|FG001|Overall Study|Withdrawal by Subject|11|||
23617121|NCT03738397|65985077|FG000|Overall Study|Lost to Follow-up|7|||
23617122|NCT03738397|65985078|FG001|Overall Study|Lost to Follow-up|5|||
23617123|NCT03738397|65985077|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23617124|NCT03738397|65985078|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23617125|NCT03738397|65985077|FG000|Overall Study|Other|4|||
23617126|NCT03738397|65985078|FG001|Overall Study|Other|6|||
23617127|NCT01369147|65985082|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
23617128|NCT01369147|65985083|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
23617129|NCT01369147|65985084|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
23617130|NCT00990821|65985085|FG000|Overall Study|Withdrawal by Subject|0|||
23617131|NCT00990821|65985086|FG001|Overall Study|Withdrawal by Subject|2|||
23617132|NCT00990821|65985087|FG002|Overall Study|Withdrawal by Subject|0|||
23617133|NCT00990821|65985088|FG003|Overall Study|Withdrawal by Subject|0|||
23617134|NCT00990821|65985089|FG004|Overall Study|Withdrawal by Subject|3|||
23617135|NCT00990821|65985090|FG005|Overall Study|Withdrawal by Subject|3|||
23617136|NCT00990821|65985091|FG006|Overall Study|Withdrawal by Subject|1|||
23617137|NCT00990821|65985092|FG007|Overall Study|Withdrawal by Subject|0|||
23617138|NCT00990821|65985093|FG008|Overall Study|Withdrawal by Subject|0|||
23617139|NCT00990821|65985094|FG009|Overall Study|Withdrawal by Subject|1|||
23617140|NCT00990821|65985095|FG010|Overall Study|Withdrawal by Subject|3|||
23617141|NCT00990821|65985096|FG011|Overall Study|Withdrawal by Subject|5|||
23617142|NCT00990821|65985097|FG012|Overall Study|Withdrawal by Subject|2|||
23617143|NCT00990821|65985098|FG013|Overall Study|Withdrawal by Subject|1|||
23617144|NCT02392429|65985099|FG000|Screening|Screen failure|15|||
23617145|NCT02392429|65985099|FG000|Enrolled Participants|Ineligible due to disease|3|||
23617146|NCT02392429|65985099|FG000|Enrolled Participants|Withdrawal by Subject|4|||
23617147|NCT02392429|65985099|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
23617148|NCT02392429|65985099|FG000|Evaluable|Death|5|||
23617149|NCT02392429|65985099|FG000|Evaluable|Withdrawal by Subject|1|||
23617150|NCT02392429|65985099|FG000|Evaluable|Adverse Event|1|||
23617151|NCT02392429|65985099|FG000|Evaluable|remission bone marrow biopsy|3|||
23617152|NCT05878990|65985100|FG000|Overall Study|Lost to Follow-up|7|||
23617153|NCT05878990|65985100|FG000|Overall Study|Withdrawal by Subject|1|||
23617154|NCT01321073|65985101|FG000|Overall Study|Did not attempt implant|4|||
23617155|NCT01321073|65985101|FG000|Overall Study|Death|3|||
23729995|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
23729996|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Other|3|||
23543820|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
23543821|NCT03058679|65719952|FG000|Baseline to Week 6|Lost to Follow-up|3|||
23543822|NCT03058679|65719953|FG001|Baseline to Week 6|Lost to Follow-up|2|||
23543823|NCT03058679|65719952|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
23543824|NCT03058679|65719953|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
23543825|NCT03058679|65719952|FG000|Baseline to Week 6|Adverse Event|6|||
23543826|NCT03058679|65719953|FG001|Baseline to Week 6|Adverse Event|6|||
23543827|NCT03058679|65719952|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
23543828|NCT03058679|65719953|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
23543829|NCT03058679|65719952|FG000|Baseline to Week 6|Difficulty following the diet|0|||
23543830|NCT03058679|65719953|FG001|Baseline to Week 6|Difficulty following the diet|2|||
23543831|NCT03058679|65719952|FG000|Baseline to Week 6|Physician Decision|1|||
23543832|NCT03058679|65719953|FG001|Baseline to Week 6|Physician Decision|0|||
23543833|NCT03058679|65719952|FG000|Week 6 to Week 12|Change in medication|5|||
23543834|NCT03058679|65719953|FG001|Week 6 to Week 12|Change in medication|7|||
23543835|NCT03058679|65719952|FG000|Week 6 to Week 12|Adverse Event|4|||
23543836|NCT03058679|65719953|FG001|Week 6 to Week 12|Adverse Event|3|||
23543837|NCT03058679|65719952|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
23543838|NCT03058679|65719953|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
23543839|NCT03058679|65719952|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
23543840|NCT03058679|65719953|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
23543841|NCT00618514|65719954|FG000|Overall Study|Lost to Follow-up|11|||
23543842|NCT00618514|65719955|FG001|Overall Study|Lost to Follow-up|12|||
23543843|NCT00618514|65719956|FG002|Overall Study|Lost to Follow-up|4|||
23543844|NCT00464542|65719959|FG000|Pre-treatment|Withdrawal by Subject|2|||
23543845|NCT02056301|65719960|FG000|Overall Study|Protocol Violation|1|||
23543846|NCT02056301|65719961|FG001|Overall Study|Protocol Violation|2|||
23543847|NCT02056301|65719960|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
23543848|NCT02056301|65719961|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
23543849|NCT02056301|65719960|FG000|Overall Study|Withdrawal by Subject|0|||
23543850|NCT02056301|65719961|FG001|Overall Study|Withdrawal by Subject|1|||
23543851|NCT02056301|65719960|FG000|Overall Study|Issues with epidural|0|||
23543852|NCT02056301|65719961|FG001|Overall Study|Issues with epidural|3|||
23543853|NCT05245864|65719964|FG000|Overall Study|Withdrawal by Subject|1|||
23543854|NCT05245864|65719965|FG001|Overall Study|Withdrawal by Subject|1|||
23543855|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
23543856|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
23543857|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
23543858|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
23543859|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Adverse Event|5|||
23543860|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Adverse Event|3|||
23543861|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Adverse Event|4|||
23543862|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Adverse Event|10|||
23543863|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
23543864|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
23543865|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
23543866|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
23543867|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23729997|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Other|5|||
23425495|NCT03461406|65303329|FG000|Overall Study|Reason not Specified|1|||
23425496|NCT03461406|65303330|FG001|Overall Study|Reason not Specified|3|||
23425497|NCT03461406|65303329|FG000|Overall Study|Lost to Follow-up|3|||
23425498|NCT03461406|65303330|FG001|Overall Study|Lost to Follow-up|0|||
23425499|NCT03630302|65303331|FG000|Surgery|hardware issue prevented LFP recordings|1|||
23425500|NCT03630302|65303331|FG000|3 Month Visit|Adverse Event|2|||
23425501|NCT03630302|65303331|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
23425502|NCT00711113|65303335|FG000|Overall Study|Lost to Follow-up|9|||
23425503|NCT00711113|65303335|FG000|Overall Study|Implant lost|2|||
23425504|NCT00747344|65303336|FG000|Controlled Period|Adverse Event|3|||
23425505|NCT00747344|65303337|FG001|Controlled Period|Adverse Event|0|||
23425506|NCT00747344|65303338|FG002|Controlled Period|Adverse Event|0|||
23425507|NCT00747344|65303339|FG003|Controlled Period|Adverse Event|0|||
23425508|NCT00747344|65303336|FG000|Controlled Period|Lack of Efficacy|2|||
23425509|NCT00747344|65303337|FG001|Controlled Period|Lack of Efficacy|1|||
23425510|NCT00747344|65303338|FG002|Controlled Period|Lack of Efficacy|0|||
23425511|NCT00747344|65303339|FG003|Controlled Period|Lack of Efficacy|0|||
23425512|NCT00747344|65303336|FG000|Controlled Period|Other|0|||
23425513|NCT00747344|65303337|FG001|Controlled Period|Other|3|||
23425514|NCT00747344|65303338|FG002|Controlled Period|Other|0|||
23543868|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23543869|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23729998|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Other|4|||
23425515|NCT00747344|65303339|FG003|Controlled Period|Other|0|||
23425516|NCT00747344|65303336|FG000|After Controlled Period|Adverse Event|0|||
23729999|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Other|3|||
23730000|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
23730001|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
23730002|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
23730003|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
23730004|NCT00242710|66388699|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
23730005|NCT00242710|66388700|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
23730006|NCT00242710|66388701|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
23730007|NCT00242710|66388702|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
23730008|NCT03512275|66388703|FG000|Overall Study|Withdrawal by Subject|1|||
23730009|NCT03512275|66388704|FG001|Overall Study|Withdrawal by Subject|3|||
23730010|NCT03512275|66388703|FG000|Overall Study|Physician Decision|0|||
23730011|NCT03512275|66388704|FG001|Overall Study|Physician Decision|1|||
23730012|NCT03512275|66388703|FG000|Overall Study|Lost to Follow-up|0|||
23730013|NCT03512275|66388704|FG001|Overall Study|Lost to Follow-up|3|||
23730014|NCT03512275|66388703|FG000|Overall Study|Other|1|||
23730015|NCT03512275|66388704|FG001|Overall Study|Other|0|||
23730016|NCT01983683|66388705|FG000|Overall Study|Withdrawal by Subject|14|||
23730017|NCT01983683|66388706|FG001|Overall Study|Withdrawal by Subject|18|||
23730018|NCT01983683|66388705|FG000|Overall Study|Death|11|||
23730019|NCT01983683|66388706|FG001|Overall Study|Death|15|||
23730020|NCT01983683|66388705|FG000|Overall Study|Physician Decision|8|||
23730021|NCT01983683|66388706|FG001|Overall Study|Physician Decision|9|||
23730022|NCT01983683|66388705|FG000|Overall Study|Lost to Follow-up|4|||
23730023|NCT01983683|66388706|FG001|Overall Study|Lost to Follow-up|8|||
23730024|NCT01983683|66388705|FG000|Overall Study|Sponsor Decision|1|||
23730025|NCT01983683|66388706|FG001|Overall Study|Sponsor Decision|1|||
23730026|NCT00255008|66388707|FG000|Overall Study|Adverse Event|1|||
23730027|NCT00255008|66388708|FG001|Overall Study|Adverse Event|1|||
23730028|NCT00255008|66388709|FG002|Overall Study|Adverse Event|2|||
23730029|NCT00255008|66388710|FG003|Overall Study|Adverse Event|0|||
23730030|NCT00255008|66388707|FG000|Overall Study|Lost to Follow-up|1|||
23730031|NCT00255008|66388708|FG001|Overall Study|Lost to Follow-up|0|||
23730032|NCT00255008|66388709|FG002|Overall Study|Lost to Follow-up|1|||
23730033|NCT00255008|66388710|FG003|Overall Study|Lost to Follow-up|2|||
23730034|NCT00255008|66388707|FG000|Overall Study|Did not meet viral reduction criteria|4|||
23730035|NCT00255008|66388708|FG001|Overall Study|Did not meet viral reduction criteria|5|||
23730036|NCT00255008|66388709|FG002|Overall Study|Did not meet viral reduction criteria|0|||
23730037|NCT00255008|66388710|FG003|Overall Study|Did not meet viral reduction criteria|1|||
23730038|NCT00255008|66388707|FG000|Overall Study|Withdrew consent|0|||
23730039|NCT00255008|66388708|FG001|Overall Study|Withdrew consent|0|||
23730040|NCT00255008|66388709|FG002|Overall Study|Withdrew consent|2|||
23730041|NCT00255008|66388710|FG003|Overall Study|Withdrew consent|0|||
23730042|NCT00255008|66388707|FG000|Overall Study|Sponsor request|18|||
23730043|NCT00255008|66388708|FG001|Overall Study|Sponsor request|3|||
23730044|NCT00255008|66388709|FG002|Overall Study|Sponsor request|8|||
23730045|NCT00255008|66388710|FG003|Overall Study|Sponsor request|17|||
23730046|NCT00255008|66388707|FG000|Overall Study|Adverse lab experience|1|||
23730047|NCT00255008|66388708|FG001|Overall Study|Adverse lab experience|0|||
23730048|NCT00255008|66388709|FG002|Overall Study|Adverse lab experience|0|||
23730049|NCT00255008|66388710|FG003|Overall Study|Adverse lab experience|0|||
23730050|NCT00255008|66388707|FG000|Overall Study|Other|7|||
23730051|NCT00255008|66388708|FG001|Overall Study|Other|0|||
23730052|NCT00255008|66388709|FG002|Overall Study|Other|3|||
23425517|NCT00747344|65303337|FG001|After Controlled Period|Adverse Event|0|||
23543870|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
23543871|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Pregnancy|5|||
23543872|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Pregnancy|0|||
23543873|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Pregnancy|3|||
23543874|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Pregnancy|2|||
23543875|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Non-compliance|1|||
23543876|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Non-compliance|4|||
23730053|NCT00255008|66388710|FG003|Overall Study|Other|2|||
23730054|NCT01894776|66388717|FG000|Overall Study|Withdrawal by Subject|1|||
23730055|NCT00518336|66388720|FG000|Year 7|Lost to Follow-up|2|||
23730056|NCT00518336|66388721|FG001|Year 7|Lost to Follow-up|0|||
23425518|NCT00747344|65303338|FG002|After Controlled Period|Adverse Event|0|||
23425519|NCT00747344|65303339|FG003|After Controlled Period|Adverse Event|1|||
23425520|NCT01765426|65303340|FG000|Overall Study|Lost to Follow-up|0|||
23425521|NCT01765426|65303341|FG001|Overall Study|Lost to Follow-up|1|||
23425522|NCT01765426|65303342|FG002|Overall Study|Lost to Follow-up|0|||
23730057|NCT00518336|66388720|FG000|Year 7|Could not attend in time|0|||
23730058|NCT00518336|66388721|FG001|Year 7|Could not attend in time|3|||
23730059|NCT00518336|66388720|FG000|Year 8|Lost to Follow-up|1|||
23730060|NCT00518336|66388721|FG001|Year 8|Lost to Follow-up|1|||
23543877|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Non-compliance|0|||
23730061|NCT00518336|66388720|FG000|Year 8|Could not attend in time|0|||
23730062|NCT00518336|66388721|FG001|Year 8|Could not attend in time|1|||
23730063|NCT00518336|66388720|FG000|Year 9|Migrated/moved from study area|1|||
23730064|NCT00518336|66388721|FG001|Year 9|Migrated/moved from study area|1|||
23730065|NCT00518336|66388720|FG000|Year 9|Lost to Follow-up|3|||
23730066|NCT00518336|66388721|FG001|Year 9|Lost to Follow-up|0|||
23730067|NCT00518336|66388720|FG000|Year 9|Personal reasons|1|||
23730068|NCT00518336|66388721|FG001|Year 9|Personal reasons|0|||
23730069|NCT01199198|66388726|FG000|Overall Study|Adverse Event|3|||
23730070|NCT01199198|66388727|FG001|Overall Study|Adverse Event|0|||
23730071|NCT01199198|66388726|FG000|Overall Study|Lost to Follow-up|1|||
23730072|NCT01199198|66388727|FG001|Overall Study|Lost to Follow-up|5|||
23730073|NCT01199198|66388726|FG000|Overall Study|Withdrawal by Subject|1|||
23730074|NCT01199198|66388727|FG001|Overall Study|Withdrawal by Subject|2|||
23730075|NCT01199198|66388726|FG000|Overall Study|ICU Transfer|1|||
23730076|NCT01199198|66388727|FG001|Overall Study|ICU Transfer|2|||
23730077|NCT01199198|66388726|FG000|Overall Study|Hospice-care transfer|1|||
23730078|NCT01199198|66388727|FG001|Overall Study|Hospice-care transfer|2|||
23730079|NCT00373880|66388730|FG000|Overall Study|Physician Decision|3|||
23730080|NCT00373880|66388730|FG000|Overall Study|Arrested|1|||
23730081|NCT00373880|66388730|FG000|Overall Study|Protocol Violation|14|||
23730082|NCT01327573|66388733|FG000|Overall Study|Physician Decision|3|||
23730083|NCT01327573|66388734|FG001|Overall Study|Physician Decision|1|||
23730084|NCT01998906|66388736|FG000|Overall Study|Participants ongoing in follow-up|77|||
23730085|NCT01998906|66388737|FG001|Overall Study|Participants ongoing in follow-up|60|||
23730086|NCT01998906|66388738|FG002|Overall Study|Participants ongoing in follow-up|58|||
23730087|NCT01998906|66388736|FG000|Overall Study|Death|21|||
23730088|NCT01998906|66388737|FG001|Overall Study|Death|30|||
23730089|NCT01998906|66388738|FG002|Overall Study|Death|17|||
23730090|NCT01998906|66388736|FG000|Overall Study|Lack of Efficacy|10|||
23617156|NCT05244226|65985102|FG000|Overall Study|Adverse Event|1|||
23617157|NCT05244226|65985103|FG001|Overall Study|Adverse Event|0|||
23617158|NCT05244226|65985104|FG002|Overall Study|Adverse Event|0|||
23617159|NCT05244226|65985102|FG000|Overall Study|Lost to Follow-up|0|||
23617160|NCT05244226|65985103|FG001|Overall Study|Lost to Follow-up|0|||
23617161|NCT05244226|65985104|FG002|Overall Study|Lost to Follow-up|1|||
23617162|NCT05244226|65985102|FG000|Overall Study|Protocol Violation|0|||
23543878|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Non-compliance|3|||
23543879|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Other|0|||
23543880|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Other|3|||
23543881|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Other|3|||
23543882|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Other|1|||
23543883|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
23543884|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
23543885|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
23543886|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
23730091|NCT01998906|66388737|FG001|Overall Study|Lack of Efficacy|9|||
23730092|NCT01998906|66388738|FG002|Overall Study|Lack of Efficacy|8|||
23730093|NCT01998906|66388736|FG000|Overall Study|Failure to return|0|||
23425523|NCT01765426|65303343|FG003|Overall Study|Lost to Follow-up|0|||
23425524|NCT03968159|65303344|FG000|Overall Study|Adverse Event|4|||
23730094|NCT01998906|66388737|FG001|Overall Study|Failure to return|2|||
23730095|NCT01998906|66388738|FG002|Overall Study|Failure to return|4|||
23730096|NCT01998906|66388736|FG000|Overall Study|Violation of Selection Criteria|0|||
23730097|NCT01998906|66388737|FG001|Overall Study|Violation of Selection Criteria|0|||
23730098|NCT01998906|66388738|FG002|Overall Study|Violation of Selection Criteria|1|||
23730099|NCT01998906|66388736|FG000|Overall Study|Withdrawal by Subject|1|||
23730100|NCT01998906|66388737|FG001|Overall Study|Withdrawal by Subject|4|||
23730101|NCT01998906|66388738|FG002|Overall Study|Withdrawal by Subject|3|||
23730102|NCT01998906|66388736|FG000|Overall Study|Administrative/Other|2|||
23730103|NCT01998906|66388737|FG001|Overall Study|Administrative/Other|1|||
23730104|NCT01998906|66388738|FG002|Overall Study|Administrative/Other|3|||
23730105|NCT01998906|66388736|FG000|Overall Study|Other|3|||
23730106|NCT01998906|66388737|FG001|Overall Study|Other|8|||
23730107|NCT01998906|66388738|FG002|Overall Study|Other|4|||
23730108|NCT00002981|66388739|FG000|Overall Study|Inevaluable|6|||
23818028|NCT02538965|66714189|FG000|Treatment Period|Physician Decision|2|||
23730109|NCT01818765|66388741|FG000|Overall Study|Death|2|||
23818029|NCT02538965|66714189|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
23425525|NCT03968159|65303345|FG001|Overall Study|Adverse Event|4|||
23617163|NCT05244226|65985103|FG001|Overall Study|Protocol Violation|2|||
23617164|NCT05244226|65985104|FG002|Overall Study|Protocol Violation|2|||
23730110|NCT04785144|66388742|FG000|Overall Study|Withdrawal by Subject|4|||
23730111|NCT04785144|66388743|FG001|Overall Study|Withdrawal by Subject|1|||
23730112|NCT04785144|66388744|FG002|Overall Study|Withdrawal by Subject|0|||
23425526|NCT03968159|65303344|FG000|Overall Study|Lost to Follow-up|1|||
23617165|NCT00809783|65985106|FG000|Overall Study|Death|1|||
23730113|NCT04785144|66388745|FG003|Overall Study|Withdrawal by Subject|0|||
23730114|NCT04785144|66388746|FG004|Overall Study|Withdrawal by Subject|0|||
23617166|NCT00809783|65985107|FG001|Overall Study|Death|0|||
23617167|NCT00809783|65985108|FG002|Overall Study|Death|0|||
23617168|NCT00809783|65985106|FG000|Overall Study|Adverse Event|34|||
23617169|NCT00809783|65985107|FG001|Overall Study|Adverse Event|52|||
23617170|NCT00809783|65985108|FG002|Overall Study|Adverse Event|71|||
23617171|NCT00809783|65985106|FG000|Overall Study|Lack of Efficacy|39|||
23617172|NCT00809783|65985107|FG001|Overall Study|Lack of Efficacy|52|||
23617173|NCT00809783|65985108|FG002|Overall Study|Lack of Efficacy|63|||
23543887|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
23543888|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
23543889|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
23543890|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
23617174|NCT00809783|65985106|FG000|Overall Study|Lost to Follow-up|0|||
23617175|NCT00809783|65985107|FG001|Overall Study|Lost to Follow-up|3|||
23617176|NCT00809783|65985108|FG002|Overall Study|Lost to Follow-up|4|||
23617177|NCT00809783|65985106|FG000|Overall Study|Withdrawal by Subject|47|||
23543891|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23543892|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23543893|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
23543894|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
23617178|NCT00809783|65985107|FG001|Overall Study|Withdrawal by Subject|72|||
23730115|NCT04785144|66388747|FG005|Overall Study|Withdrawal by Subject|2|||
23543895|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
23543896|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
23425527|NCT03968159|65303345|FG001|Overall Study|Lost to Follow-up|1|||
23425528|NCT03968159|65303344|FG000|Overall Study|Use of prohibited medication|0|||
23425529|NCT03968159|65303345|FG001|Overall Study|Use of prohibited medication|1|||
23543897|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
23543898|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
23543899|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
23543900|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
23617179|NCT00809783|65985108|FG002|Overall Study|Withdrawal by Subject|64|||
23730116|NCT04785144|66388748|FG006|Overall Study|Withdrawal by Subject|2|||
23730117|NCT04785144|66388749|FG007|Overall Study|Withdrawal by Subject|0|||
23730118|NCT04785144|66388750|FG008|Overall Study|Withdrawal by Subject|1|||
23425530|NCT03968159|65303344|FG000|Overall Study|Protocol Violation|2|||
23617180|NCT00809783|65985106|FG000|Overall Study|Protocol Violation|2|||
23617181|NCT00809783|65985107|FG001|Overall Study|Protocol Violation|6|||
23730119|NCT04785144|66388751|FG009|Overall Study|Withdrawal by Subject|0|||
23730120|NCT04785144|66388742|FG000|Overall Study|Lost to Follow-up|1|||
23730121|NCT04785144|66388743|FG001|Overall Study|Lost to Follow-up|0|||
23617182|NCT00809783|65985108|FG002|Overall Study|Protocol Violation|5|||
23617183|NCT00809783|65985106|FG000|Overall Study|Randomized, but not treated|3|||
23617184|NCT00809783|65985107|FG001|Overall Study|Randomized, but not treated|0|||
23617185|NCT00809783|65985108|FG002|Overall Study|Randomized, but not treated|2|||
23617186|NCT00809783|65985106|FG000|Overall Study|Study Terminated by Sponsor|378|||
23617187|NCT00809783|65985107|FG001|Overall Study|Study Terminated by Sponsor|626|||
23617188|NCT00809783|65985108|FG002|Overall Study|Study Terminated by Sponsor|565|||
23617189|NCT00809783|65985106|FG000|Overall Study|Other|21|||
23617190|NCT00809783|65985107|FG001|Overall Study|Other|21|||
23617191|NCT00809783|65985108|FG002|Overall Study|Other|16|||
23617192|NCT01797705|65985109|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
23617193|NCT01797705|65985109|FG000|Overall Study|Withdrawal by Subject|1|||
23730122|NCT04785144|66388744|FG002|Overall Study|Lost to Follow-up|0|||
23730123|NCT04785144|66388745|FG003|Overall Study|Lost to Follow-up|0|||
23730124|NCT04785144|66388746|FG004|Overall Study|Lost to Follow-up|1|||
23730125|NCT04785144|66388747|FG005|Overall Study|Lost to Follow-up|2|||
23730126|NCT04785144|66388748|FG006|Overall Study|Lost to Follow-up|1|||
23730127|NCT04785144|66388749|FG007|Overall Study|Lost to Follow-up|2|||
23730128|NCT04785144|66388750|FG008|Overall Study|Lost to Follow-up|4|||
23730129|NCT04785144|66388751|FG009|Overall Study|Lost to Follow-up|1|||
23730130|NCT04785144|66388742|FG000|Overall Study|Protocol Violation|0|||
23730131|NCT04785144|66388743|FG001|Overall Study|Protocol Violation|0|||
23730132|NCT04785144|66388744|FG002|Overall Study|Protocol Violation|0|||
23730133|NCT04785144|66388745|FG003|Overall Study|Protocol Violation|0|||
23730134|NCT04785144|66388746|FG004|Overall Study|Protocol Violation|0|||
23730135|NCT04785144|66388747|FG005|Overall Study|Protocol Violation|0|||
23730136|NCT04785144|66388748|FG006|Overall Study|Protocol Violation|1|||
23730137|NCT04785144|66388749|FG007|Overall Study|Protocol Violation|0|||
23730138|NCT04785144|66388750|FG008|Overall Study|Protocol Violation|0|||
23730139|NCT04785144|66388751|FG009|Overall Study|Protocol Violation|0|||
23730140|NCT04785144|66388742|FG000|Overall Study|Physician Decision|0|||
23730141|NCT04785144|66388743|FG001|Overall Study|Physician Decision|0|||
23730142|NCT04785144|66388744|FG002|Overall Study|Physician Decision|0|||
23730143|NCT04785144|66388745|FG003|Overall Study|Physician Decision|0|||
23730144|NCT04785144|66388746|FG004|Overall Study|Physician Decision|0|||
23730145|NCT04785144|66388747|FG005|Overall Study|Physician Decision|0|||
23730146|NCT04785144|66388748|FG006|Overall Study|Physician Decision|0|||
23730147|NCT04785144|66388749|FG007|Overall Study|Physician Decision|0|||
23730148|NCT04785144|66388750|FG008|Overall Study|Physician Decision|0|||
23730149|NCT04785144|66388751|FG009|Overall Study|Physician Decision|1|||
23730150|NCT04785144|66388742|FG000|Overall Study|Unable to continue due to work schedule|0|||
23730151|NCT04785144|66388743|FG001|Overall Study|Unable to continue due to work schedule|0|||
23730152|NCT04785144|66388744|FG002|Overall Study|Unable to continue due to work schedule|0|||
23730153|NCT04785144|66388745|FG003|Overall Study|Unable to continue due to work schedule|0|||
23730154|NCT04785144|66388746|FG004|Overall Study|Unable to continue due to work schedule|0|||
23730155|NCT04785144|66388747|FG005|Overall Study|Unable to continue due to work schedule|0|||
23730156|NCT04785144|66388748|FG006|Overall Study|Unable to continue due to work schedule|0|||
23730157|NCT04785144|66388749|FG007|Overall Study|Unable to continue due to work schedule|0|||
23730158|NCT04785144|66388750|FG008|Overall Study|Unable to continue due to work schedule|0|||
23730159|NCT04785144|66388751|FG009|Overall Study|Unable to continue due to work schedule|1|||
23730160|NCT01388491|66388753|FG000|Overall Study|Adverse Event|10|||
23730161|NCT01388491|66388754|FG001|Overall Study|Adverse Event|9|||
23425531|NCT03968159|65303345|FG001|Overall Study|Protocol Violation|2|||
23730162|NCT01388491|66388753|FG000|Overall Study|Sponsor Request|9|||
23730163|NCT01388491|66388754|FG001|Overall Study|Sponsor Request|7|||
23730164|NCT01388491|66388753|FG000|Overall Study|Withdrawal by Subject|6|||
23730165|NCT01388491|66388754|FG001|Overall Study|Withdrawal by Subject|10|||
23617194|NCT02025985|65985110|FG000|Overall Study|Consent withdrawn|0|||
23617195|NCT02025985|65985111|FG001|Overall Study|Consent withdrawn|0|||
23730166|NCT01388491|66388753|FG000|Overall Study|Lost to Follow-up|4|||
23730167|NCT01388491|66388754|FG001|Overall Study|Lost to Follow-up|3|||
23730168|NCT01388491|66388753|FG000|Overall Study|Protocol Violation|2|||
23730169|NCT01388491|66388754|FG001|Overall Study|Protocol Violation|0|||
23730170|NCT01388491|66388753|FG000|Overall Study|Noncompliance|2|||
23730171|NCT01388491|66388754|FG001|Overall Study|Noncompliance|0|||
23730172|NCT01388491|66388753|FG000|Overall Study|Pregnancy|1|||
23730173|NCT01388491|66388754|FG001|Overall Study|Pregnancy|0|||
23730174|NCT03277794|66388763|FG000|Overall Study|Lost to Follow-up|2|||
23730175|NCT03277794|66388764|FG001|Overall Study|Lost to Follow-up|4|||
23730176|NCT03277794|66388763|FG000|Overall Study|Withdrew due to high acuity|1|||
23730177|NCT03277794|66388764|FG001|Overall Study|Withdrew due to high acuity|0|||
23730178|NCT01135394|66388765|FG000|Screening|Lost to Follow-up|2|||
23730179|NCT01135394|66388765|FG000|Screening|Withdrawal by Subject|10|||
23730180|NCT01135394|66388765|FG000|Screening|Screening failure|16|||
23730181|NCT01135394|66388765|FG000|Screening|Physician Decision|5|||
23730182|NCT01135394|66388765|FG000|Baseline Assessment|Withdrawal by Subject|9|||
23730183|NCT01135394|66388765|FG000|Baseline Assessment|Physician Decision|3|||
23730184|NCT01135394|66388765|FG000|Baseline Assessment|Lost to Follow-up|2|||
23730185|NCT01135394|66388765|FG000|Baseline Assessment|Adverse Event|1|||
23730186|NCT01135394|66388765|FG000|Study Treatment|Withdrawal by Subject|1|||
23730187|NCT01135394|66388765|FG000|Study Treatment|Physician Decision|1|||
23730188|NCT01135394|66388765|FG000|Study Treatment|Adverse Event|2|||
23730189|NCT02590406|66388772|FG000|Overall Study|Adverse Event|1|||
23730190|NCT02590406|66388773|FG001|Overall Study|Adverse Event|0|||
23730191|NCT02590406|66388772|FG000|Overall Study|Saturometer malfunction|0|||
23730192|NCT02590406|66388773|FG001|Overall Study|Saturometer malfunction|1|||
23730193|NCT02289833|66388774|FG000|Overall Study|Study discontinuation|0|||
23730194|NCT02289833|66388775|FG001|Overall Study|Study discontinuation|1|||
23730195|NCT02289833|66388774|FG000|Overall Study|Lost to Follow-up|4|||
23730196|NCT02289833|66388775|FG001|Overall Study|Lost to Follow-up|0|||
23730197|NCT02289833|66388774|FG000|Overall Study|Death|23|||
23730198|NCT02289833|66388775|FG001|Overall Study|Death|16|||
23730199|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
23730200|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
23730201|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
23730202|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
23730203|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
23730204|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
23730205|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
23730206|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
23730207|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
23730208|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
23730209|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
23730210|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
23730211|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23730212|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
23730213|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23730214|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23730215|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
23730216|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
23730217|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
23730218|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
23730219|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
23730220|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
23730221|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
23818030|NCT02538965|66714189|FG000|Follow-Up Period|Withdrawal by Parent|4|||
23818031|NCT02774642|66714190|FG000|Overall Study|Lost to Follow-up|9|||
23818032|NCT02774642|66714191|FG001|Overall Study|Lost to Follow-up|7|||
23818033|NCT02640690|66714192|FG000|Overall Study|Lost to Follow-up|7|||
23730222|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
23730223|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Other|0|||
23730224|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Other|1|||
23730225|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Other|0|||
23818034|NCT02640690|66714193|FG001|Overall Study|Lost to Follow-up|7|||
23617196|NCT02025985|65985112|FG002|Overall Study|Consent withdrawn|1|||
23617197|NCT02025985|65985113|FG003|Overall Study|Consent withdrawn|0|||
23617198|NCT02025985|65985114|FG004|Overall Study|Consent withdrawn|0|||
23617199|NCT02025985|65985110|FG000|Overall Study|Termination of study by Sponsor|4|||
23818035|NCT02640690|66714192|FG000|Overall Study|Withdrawal by Subject|16|||
23818036|NCT02640690|66714193|FG001|Overall Study|Withdrawal by Subject|20|||
23818037|NCT02640690|66714192|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
23730226|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Other|0|||
23730227|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
23730228|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
23730229|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
23730230|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
23730231|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
23730232|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
23730233|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
23730234|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
23730235|NCT01194414|66388780|FG000|24 Weeks Double Blind Period|Death|0|||
23730236|NCT01194414|66388781|FG001|24 Weeks Double Blind Period|Death|1|||
23730237|NCT01194414|66388782|FG002|24 Weeks Double Blind Period|Death|0|||
23730238|NCT01194414|66388783|FG003|24 Weeks Double Blind Period|Death|0|||
23730239|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
23730240|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
23730241|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
23730242|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
23730243|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
23543901|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
23543902|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
23543903|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
23730244|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
23730245|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
23730246|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
23730247|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
23730248|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
23730249|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
23543904|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
23543905|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
23543906|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
23543907|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543908|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543909|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
23543910|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543911|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
23543912|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
23543913|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
23543914|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
23543915|NCT02493361|65719970|FG000|Overall Study|Withdrawal by Subject|3|||
23543916|NCT01045447|65719971|FG000|Overall Study|Adverse Event|0|||
23543917|NCT01045447|65719972|FG001|Overall Study|Adverse Event|1|||
23543918|NCT01045447|65719971|FG000|Overall Study|Lack of Efficacy|3|||
23543919|NCT01045447|65719972|FG001|Overall Study|Lack of Efficacy|1|||
23543920|NCT01045447|65719971|FG000|Overall Study|Protocol Violation|6|||
23543921|NCT01045447|65719972|FG001|Overall Study|Protocol Violation|3|||
23543922|NCT01045447|65719971|FG000|Overall Study|Withdrawal Criteria|10|||
23543923|NCT01045447|65719972|FG001|Overall Study|Withdrawal Criteria|10|||
23617200|NCT02025985|65985111|FG001|Overall Study|Termination of study by Sponsor|3|||
23617201|NCT02025985|65985112|FG002|Overall Study|Termination of study by Sponsor|1|||
23617202|NCT02025985|65985113|FG003|Overall Study|Termination of study by Sponsor|1|||
23617203|NCT02025985|65985114|FG004|Overall Study|Termination of study by Sponsor|3|||
23617204|NCT02025985|65985110|FG000|Overall Study|Death|21|||
23617205|NCT02025985|65985111|FG001|Overall Study|Death|20|||
23617206|NCT02025985|65985112|FG002|Overall Study|Death|23|||
23617207|NCT02025985|65985113|FG003|Overall Study|Death|20|||
23617208|NCT02025985|65985114|FG004|Overall Study|Death|17|||
23617209|NCT02998918|65985115|FG000|Overall Study|Withdrawal by Subject|1|||
23617210|NCT02998918|65985116|FG001|Overall Study|Withdrawal by Subject|0|||
23617211|NCT04872101|65985117|FG000|Overall Study|Withdrawal by Subject|10|||
23617212|NCT04872101|65985118|FG001|Overall Study|Withdrawal by Subject|16|||
23617213|NCT04872101|65985117|FG000|Overall Study|Lack of Efficacy|6|||
23617214|NCT04872101|65985118|FG001|Overall Study|Lack of Efficacy|14|||
23617215|NCT04872101|65985117|FG000|Overall Study|Adverse Event|1|||
23617216|NCT04872101|65985118|FG001|Overall Study|Adverse Event|6|||
23617217|NCT04872101|65985117|FG000|Overall Study|Lost to Follow-up|2|||
23617218|NCT04872101|65985118|FG001|Overall Study|Lost to Follow-up|1|||
23617219|NCT04872101|65985117|FG000|Overall Study|Pregnancy|2|||
23617220|NCT04872101|65985118|FG001|Overall Study|Pregnancy|0|||
23617221|NCT04872101|65985117|FG000|Overall Study|Prohibited Medication|1|||
23617222|NCT04872101|65985118|FG001|Overall Study|Prohibited Medication|0|||
23617223|NCT04872101|65985117|FG000|Overall Study|Not dosed|1|||
23617224|NCT04872101|65985118|FG001|Overall Study|Not dosed|0|||
23617225|NCT01363297|65985122|FG000|Overall Study|Other|0|||
23617226|NCT01363297|65985123|FG001|Overall Study|Other|0|||
23617227|NCT01363297|65985124|FG002|Overall Study|Other|0|||
23617228|NCT01363297|65985125|FG003|Overall Study|Other|0|||
23617229|NCT01363297|65985126|FG004|Overall Study|Other|1|||
23730250|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
23730251|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
23730252|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
23730253|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
23730254|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
23730255|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
23730256|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
23730257|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
23730258|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
23730259|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
23730260|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
23730261|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
23730262|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
23730263|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Other|2|||
23730264|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Other|1|||
23730265|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Other|0|||
23730266|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Other|0|||
23730267|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
23730268|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
23730269|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
23730270|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
23730271|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
23425532|NCT03968159|65303344|FG000|Overall Study|Withdrawal by Subject|4|||
23425533|NCT03968159|65303345|FG001|Overall Study|Withdrawal by Subject|6|||
23425534|NCT03968159|65303344|FG000|Overall Study|Lack of Efficacy|0|||
23425535|NCT03968159|65303345|FG001|Overall Study|Lack of Efficacy|1|||
23425536|NCT03968159|65303344|FG000|Overall Study|Not further specified|2|||
23425537|NCT03968159|65303345|FG001|Overall Study|Not further specified|0|||
23425538|NCT02608450|65303346|FG000|Overall Study|Lost to Follow-up|39|||
23425539|NCT02608450|65303347|FG001|Overall Study|Lost to Follow-up|32|||
23425540|NCT02608450|65303346|FG000|Overall Study|Withdrawal by Subject|21|||
23425541|NCT02608450|65303347|FG001|Overall Study|Withdrawal by Subject|15|||
23425542|NCT02608450|65303346|FG000|Overall Study|Adverse Event|3|||
23425543|NCT02608450|65303347|FG001|Overall Study|Adverse Event|6|||
23425544|NCT02608450|65303346|FG000|Overall Study|Withdrawal by parent|2|||
23425545|NCT02608450|65303347|FG001|Overall Study|Withdrawal by parent|3|||
23425546|NCT02608450|65303346|FG000|Overall Study|Lack of Efficacy|0|||
23425547|NCT02608450|65303347|FG001|Overall Study|Lack of Efficacy|3|||
23425548|NCT02608450|65303346|FG000|Overall Study|Noncompliance with study drug|0|||
23425549|NCT02608450|65303347|FG001|Overall Study|Noncompliance with study drug|2|||
23425550|NCT02608450|65303346|FG000|Overall Study|Physician Decision|0|||
23425551|NCT02608450|65303347|FG001|Overall Study|Physician Decision|1|||
23425552|NCT02608450|65303346|FG000|Overall Study|Pregnancy|0|||
23425553|NCT02608450|65303347|FG001|Overall Study|Pregnancy|1|||
23425554|NCT02608450|65303346|FG000|Overall Study|Progressive disease|1|||
23425555|NCT02608450|65303347|FG001|Overall Study|Progressive disease|0|||
23425556|NCT02608450|65303346|FG000|Overall Study|Multiple reasons|0|||
23425557|NCT02608450|65303347|FG001|Overall Study|Multiple reasons|2|||
23425558|NCT00652899|65303348|FG000|Overall Study|Death|1|||
23730272|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
23730273|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
23730274|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
23730275|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
23730276|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
23730277|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
23730278|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
23730279|NCT01194414|66388780|FG000|72 Weeks Open Label Extension|Death|1|||
23730280|NCT01194414|66388781|FG001|72 Weeks Open Label Extension|Death|2|||
23730281|NCT01194414|66388782|FG002|72 Weeks Open Label Extension|Death|0|||
23730282|NCT01194414|66388783|FG003|72 Weeks Open Label Extension|Death|2|||
23730283|NCT00863317|66388787|FG000|Overall Study|Lost to Follow-up|8|||
23730284|NCT00863317|66388788|FG001|Overall Study|Lost to Follow-up|9|||
23730285|NCT01975675|66388791|FG000|Overall Study|Death|0|||
23730286|NCT01975675|66388792|FG001|Overall Study|Death|1|||
23730287|NCT01975675|66388793|FG002|Overall Study|Death|0|||
23730288|NCT01975675|66388794|FG003|Overall Study|Death|0|||
23617230|NCT01363297|65985122|FG000|Overall Study|Death|3|||
23425559|NCT00652899|65303348|FG000|Overall Study|Treating physician decision|1|||
23425560|NCT02446418|65303349|FG000|Overall Study|Adverse Event|4|||
23425561|NCT02446418|65303350|FG001|Overall Study|Adverse Event|8|||
23617231|NCT01363297|65985123|FG001|Overall Study|Death|6|||
23425562|NCT02446418|65303349|FG000|Overall Study|Physician Decision|5|||
23425563|NCT02446418|65303350|FG001|Overall Study|Physician Decision|1|||
23425564|NCT02446418|65303349|FG000|Overall Study|Withdrawal by Subject|3|||
23730289|NCT01436357|66388795|FG000|Overall Study|Death|5|||
23730290|NCT01436357|66388796|FG001|Overall Study|Death|1|||
23730291|NCT01436357|66388795|FG000|Overall Study|Enrolled but not vaccinated|1|||
23730292|NCT01436357|66388796|FG001|Overall Study|Enrolled but not vaccinated|1|||
23730293|NCT01436357|66388795|FG000|Overall Study|Incarceration|18|||
23730294|NCT01436357|66388796|FG001|Overall Study|Incarceration|20|||
23730295|NCT01436357|66388795|FG000|Overall Study|Lost to Follow-up|67|||
23730296|NCT01436357|66388796|FG001|Overall Study|Lost to Follow-up|61|||
23730297|NCT01436357|66388795|FG000|Overall Study|Protocol Violation|1|||
23730298|NCT01436357|66388796|FG001|Overall Study|Protocol Violation|0|||
23730299|NCT01436357|66388795|FG000|Overall Study|Withdrawal by Subject|26|||
23730300|NCT01436357|66388796|FG001|Overall Study|Withdrawal by Subject|38|||
23730301|NCT01436357|66388795|FG000|Overall Study|Physician Decision|3|||
23730302|NCT01436357|66388796|FG001|Overall Study|Physician Decision|4|||
23730303|NCT01436357|66388795|FG000|Overall Study|Moved out of area|1|||
23730304|NCT01436357|66388796|FG001|Overall Study|Moved out of area|2|||
23730305|NCT01436357|66388795|FG000|Overall Study|Subject in rehab|0|||
23730306|NCT01436357|66388796|FG001|Overall Study|Subject in rehab|1|||
23730307|NCT02668692|66388799|FG000|Overall Study|Adverse Event|1|||
23730308|NCT02668692|66388800|FG001|Overall Study|Adverse Event|0|||
23730309|NCT02352090|66388801|FG000|Overall Study|general malaise|1|||
23730310|NCT02352090|66388802|FG001|Overall Study|general malaise|0|||
23730311|NCT02352090|66388803|FG002|Overall Study|general malaise|0|||
23730312|NCT02352090|66388801|FG000|Overall Study|non-specified mild side-effects|0|||
23730313|NCT02352090|66388802|FG001|Overall Study|non-specified mild side-effects|0|||
23730314|NCT02352090|66388803|FG002|Overall Study|non-specified mild side-effects|2|||
23617232|NCT01363297|65985124|FG002|Overall Study|Death|6|||
23617233|NCT01363297|65985125|FG003|Overall Study|Death|10|||
23617234|NCT01363297|65985126|FG004|Overall Study|Death|30|||
23617235|NCT02136797|65985130|FG000|Overall Study|Not Treated|8|||
23617236|NCT03184519|65985132|FG000|Overall Study|Lost to Follow-up|6|||
23617237|NCT03184519|65985132|FG000|Overall Study|Physician Decision|21|||
23617238|NCT02123797|65985134|FG000|Baseline Intervention|Death|9|||
23617239|NCT02123797|65985135|FG001|Baseline Intervention|Death|16|||
23617240|NCT02123797|65985136|FG002|Baseline Intervention|Death|0|||
23617241|NCT02123797|65985137|FG003|Baseline Intervention|Death|0|||
23617242|NCT02123797|65985138|FG004|Baseline Intervention|Death|0|||
23617243|NCT02123797|65985134|FG000|Baseline Intervention|Withdrawal by Subject|2|||
23617244|NCT02123797|65985135|FG001|Baseline Intervention|Withdrawal by Subject|8|||
23617245|NCT02123797|65985136|FG002|Baseline Intervention|Withdrawal by Subject|0|||
23617246|NCT02123797|65985137|FG003|Baseline Intervention|Withdrawal by Subject|0|||
23425565|NCT02446418|65303350|FG001|Overall Study|Withdrawal by Subject|3|||
23425566|NCT02446418|65303349|FG000|Overall Study|Lost to Follow-up|2|||
23425567|NCT02446418|65303350|FG001|Overall Study|Lost to Follow-up|2|||
23425568|NCT02446418|65303349|FG000|Overall Study|Protocol Violation|1|||
23425569|NCT02446418|65303350|FG001|Overall Study|Protocol Violation|2|||
23425570|NCT02446418|65303349|FG000|Overall Study|Lack of Efficacy|2|||
23425571|NCT02446418|65303350|FG001|Overall Study|Lack of Efficacy|0|||
23425572|NCT02446418|65303349|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
23617247|NCT02123797|65985138|FG004|Baseline Intervention|Withdrawal by Subject|0|||
23617248|NCT02123797|65985134|FG000|Baseline Intervention|Relocation|2|||
23730315|NCT01188811|66388804|FG000|Overall Study|Withdrawal by Subject|0|||
23730316|NCT01188811|66388805|FG001|Overall Study|Withdrawal by Subject|2|||
23730317|NCT01188811|66388804|FG000|Overall Study|Adverse Event|6|||
23730318|NCT01188811|66388805|FG001|Overall Study|Adverse Event|0|||
23730319|NCT02147691|66388807|FG000|Overall Study|Withdrawal by Subject|2|||
23425573|NCT02446418|65303350|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
23425574|NCT00545532|65303351|FG000|Overall Study|Withdrawal by Subject|1|||
23730320|NCT02147691|66388808|FG001|Overall Study|Withdrawal by Subject|0|||
23730321|NCT02147691|66388807|FG000|Overall Study|Adverse Event|2|||
23818038|NCT02640690|66714193|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
23617249|NCT02123797|65985135|FG001|Baseline Intervention|Relocation|0|||
23617250|NCT02123797|65985136|FG002|Baseline Intervention|Relocation|0|||
23617251|NCT02123797|65985137|FG003|Baseline Intervention|Relocation|0|||
23730322|NCT02147691|66388808|FG001|Overall Study|Adverse Event|0|||
23425575|NCT00545532|65303352|FG001|Overall Study|Withdrawal by Subject|3|||
23425576|NCT00545532|65303351|FG000|Overall Study|Lost to Follow-up|5|||
23425577|NCT00545532|65303352|FG001|Overall Study|Lost to Follow-up|6|||
23425578|NCT00545532|65303351|FG000|Overall Study|Death|0|||
23425579|NCT00545532|65303352|FG001|Overall Study|Death|1|||
23425580|NCT03294135|65303354|FG000|Overall Study|Serious Adverse Event|1|||
23425581|NCT03294135|65303355|FG001|Overall Study|Serious Adverse Event|0|||
23425582|NCT03294135|65303356|FG002|Overall Study|Serious Adverse Event|0|||
23425583|NCT03294135|65303354|FG000|Overall Study|Lost to Follow-up|1|||
23425584|NCT03294135|65303355|FG001|Overall Study|Lost to Follow-up|0|||
23425585|NCT03294135|65303356|FG002|Overall Study|Lost to Follow-up|1|||
23730323|NCT02147691|66388807|FG000|Overall Study|Lost to Follow-up|0|||
23730324|NCT02147691|66388808|FG001|Overall Study|Lost to Follow-up|1|||
23730325|NCT03424044|66388813|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730326|NCT03424044|66388814|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730327|NCT03424044|66388815|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
23730328|NCT03424044|66388816|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730329|NCT03424044|66388817|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730330|NCT03424044|66388818|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730331|NCT03424044|66388819|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730332|NCT03424044|66388820|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23730333|NCT03424044|66388821|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23425586|NCT03294135|65303354|FG000|Overall Study|Withdrawal by Subject|0|||
23425587|NCT03294135|65303355|FG001|Overall Study|Withdrawal by Subject|0|||
23425588|NCT03294135|65303356|FG002|Overall Study|Withdrawal by Subject|1|||
23425589|NCT03294135|65303354|FG000|Overall Study|Other|2|||
23425590|NCT03294135|65303355|FG001|Overall Study|Other|0|||
23425591|NCT03294135|65303356|FG002|Overall Study|Other|0|||
23425592|NCT02761694|65303357|FG000|Overall Study|Lack of Efficacy|0|||
23425593|NCT02761694|65303358|FG001|Overall Study|Lack of Efficacy|0|||
23425594|NCT02761694|65303359|FG002|Overall Study|Lack of Efficacy|0|||
23425595|NCT02761694|65303360|FG003|Overall Study|Lack of Efficacy|0|||
23425596|NCT02761694|65303361|FG004|Overall Study|Lack of Efficacy|0|||
23425597|NCT02761694|65303362|FG005|Overall Study|Lack of Efficacy|0|||
23425598|NCT02761694|65303363|FG006|Overall Study|Lack of Efficacy|6|||
23425599|NCT02761694|65303364|FG007|Overall Study|Lack of Efficacy|0|||
23425600|NCT02761694|65303365|FG008|Overall Study|Lack of Efficacy|0|||
23425601|NCT02761694|65303366|FG009|Overall Study|Lack of Efficacy|1|||
23425602|NCT02761694|65303367|FG010|Overall Study|Lack of Efficacy|1|||
23425603|NCT02761694|65303368|FG011|Overall Study|Lack of Efficacy|4|||
23425604|NCT02761694|65303357|FG000|Overall Study|Death|0|||
23425605|NCT02761694|65303358|FG001|Overall Study|Death|0|||
23425606|NCT02761694|65303359|FG002|Overall Study|Death|0|||
23425607|NCT02761694|65303360|FG003|Overall Study|Death|0|||
23425608|NCT02761694|65303361|FG004|Overall Study|Death|0|||
23425609|NCT02761694|65303362|FG005|Overall Study|Death|0|||
23425610|NCT02761694|65303363|FG006|Overall Study|Death|2|||
23425611|NCT02761694|65303364|FG007|Overall Study|Death|0|||
23425612|NCT02761694|65303365|FG008|Overall Study|Death|2|||
23730334|NCT03424044|66388813|FG000|First Intervention (76 Hours)|Adverse Event|0|||
23730335|NCT03424044|66388814|FG001|First Intervention (76 Hours)|Adverse Event|0|||
23730336|NCT03424044|66388815|FG002|First Intervention (76 Hours)|Adverse Event|0|||
23730337|NCT03424044|66388816|FG003|First Intervention (76 Hours)|Adverse Event|0|||
23730338|NCT03424044|66388817|FG004|First Intervention (76 Hours)|Adverse Event|1|||
23730339|NCT03424044|66388818|FG005|First Intervention (76 Hours)|Adverse Event|0|||
23730340|NCT03424044|66388819|FG006|First Intervention (76 Hours)|Adverse Event|0|||
23818039|NCT00577395|66714194|FG000|Overall Study|Study was terminated early by Sponsor|7|||
23818040|NCT00577395|66714195|FG001|Overall Study|Study was terminated early by Sponsor|6|||
23425613|NCT02761694|65303366|FG009|Overall Study|Death|2|||
23425614|NCT02761694|65303367|FG010|Overall Study|Death|1|||
23425615|NCT02761694|65303368|FG011|Overall Study|Death|0|||
23425616|NCT02761694|65303357|FG000|Overall Study|Physician Decision|0|||
23425617|NCT02761694|65303358|FG001|Overall Study|Physician Decision|0|||
23425618|NCT02761694|65303359|FG002|Overall Study|Physician Decision|0|||
23425619|NCT02761694|65303360|FG003|Overall Study|Physician Decision|0|||
23425620|NCT02761694|65303361|FG004|Overall Study|Physician Decision|0|||
23425621|NCT02761694|65303362|FG005|Overall Study|Physician Decision|0|||
23425622|NCT02761694|65303363|FG006|Overall Study|Physician Decision|1|||
23425623|NCT02761694|65303364|FG007|Overall Study|Physician Decision|0|||
23425624|NCT02761694|65303365|FG008|Overall Study|Physician Decision|0|||
23425625|NCT02761694|65303366|FG009|Overall Study|Physician Decision|0|||
23425626|NCT02761694|65303367|FG010|Overall Study|Physician Decision|0|||
23425627|NCT02761694|65303368|FG011|Overall Study|Physician Decision|0|||
23425628|NCT02761694|65303357|FG000|Overall Study|Withdrawal by Subject|0|||
23425629|NCT02761694|65303358|FG001|Overall Study|Withdrawal by Subject|0|||
23425630|NCT02761694|65303359|FG002|Overall Study|Withdrawal by Subject|0|||
23425631|NCT02761694|65303360|FG003|Overall Study|Withdrawal by Subject|1|||
23425632|NCT02761694|65303361|FG004|Overall Study|Withdrawal by Subject|0|||
23730341|NCT03424044|66388820|FG007|First Intervention (76 Hours)|Adverse Event|0|||
23730342|NCT03424044|66388821|FG008|First Intervention (76 Hours)|Adverse Event|0|||
23730343|NCT03424044|66388813|FG000|First Intervention (76 Hours)|device issues|0|||
23730344|NCT03424044|66388814|FG001|First Intervention (76 Hours)|device issues|0|||
23730345|NCT03424044|66388815|FG002|First Intervention (76 Hours)|device issues|0|||
23730346|NCT03424044|66388816|FG003|First Intervention (76 Hours)|device issues|0|||
23730347|NCT03424044|66388817|FG004|First Intervention (76 Hours)|device issues|0|||
23730348|NCT03424044|66388818|FG005|First Intervention (76 Hours)|device issues|0|||
23818041|NCT02455518|66714196|FG000|Overall Study|Protocol Violation|0|||
23818042|NCT02455518|66714197|FG001|Overall Study|Protocol Violation|1|||
23425633|NCT02761694|65303362|FG005|Overall Study|Withdrawal by Subject|0|||
23425634|NCT02761694|65303363|FG006|Overall Study|Withdrawal by Subject|4|||
23425635|NCT02761694|65303364|FG007|Overall Study|Withdrawal by Subject|0|||
23425636|NCT02761694|65303365|FG008|Overall Study|Withdrawal by Subject|2|||
23425637|NCT02761694|65303366|FG009|Overall Study|Withdrawal by Subject|1|||
23425638|NCT02761694|65303367|FG010|Overall Study|Withdrawal by Subject|0|||
23425639|NCT02761694|65303368|FG011|Overall Study|Withdrawal by Subject|0|||
23425640|NCT02761694|65303357|FG000|Overall Study|Lost to Follow-up|0|||
23425641|NCT02761694|65303358|FG001|Overall Study|Lost to Follow-up|0|||
23425642|NCT02761694|65303359|FG002|Overall Study|Lost to Follow-up|0|||
23425643|NCT02761694|65303360|FG003|Overall Study|Lost to Follow-up|0|||
23425644|NCT02761694|65303361|FG004|Overall Study|Lost to Follow-up|0|||
23425645|NCT02761694|65303362|FG005|Overall Study|Lost to Follow-up|0|||
23425646|NCT02761694|65303363|FG006|Overall Study|Lost to Follow-up|1|||
23425647|NCT02761694|65303364|FG007|Overall Study|Lost to Follow-up|0|||
23425648|NCT02761694|65303365|FG008|Overall Study|Lost to Follow-up|0|||
23425649|NCT02761694|65303366|FG009|Overall Study|Lost to Follow-up|0|||
23425650|NCT02761694|65303367|FG010|Overall Study|Lost to Follow-up|0|||
23425651|NCT02761694|65303368|FG011|Overall Study|Lost to Follow-up|1|||
23425652|NCT02761694|65303357|FG000|Overall Study|Adverse Event|0|||
23425653|NCT02761694|65303358|FG001|Overall Study|Adverse Event|0|||
23425654|NCT02761694|65303359|FG002|Overall Study|Adverse Event|0|||
23425655|NCT02761694|65303360|FG003|Overall Study|Adverse Event|0|||
23425656|NCT02761694|65303361|FG004|Overall Study|Adverse Event|0|||
23425657|NCT02761694|65303362|FG005|Overall Study|Adverse Event|0|||
23425658|NCT02761694|65303363|FG006|Overall Study|Adverse Event|1|||
23425659|NCT02761694|65303364|FG007|Overall Study|Adverse Event|0|||
23425660|NCT02761694|65303365|FG008|Overall Study|Adverse Event|1|||
23425661|NCT02761694|65303366|FG009|Overall Study|Adverse Event|0|||
23425662|NCT02761694|65303367|FG010|Overall Study|Adverse Event|0|||
23425663|NCT02761694|65303368|FG011|Overall Study|Adverse Event|1|||
23425664|NCT02761694|65303357|FG000|Overall Study|Other|4|||
23425665|NCT02761694|65303358|FG001|Overall Study|Other|4|||
23425666|NCT02761694|65303359|FG002|Overall Study|Other|1|||
23425667|NCT02761694|65303360|FG003|Overall Study|Other|2|||
23425668|NCT02761694|65303361|FG004|Overall Study|Other|3|||
23425669|NCT02761694|65303362|FG005|Overall Study|Other|3|||
23425670|NCT02761694|65303363|FG006|Overall Study|Other|18|||
23425671|NCT02761694|65303364|FG007|Overall Study|Other|8|||
23425672|NCT02761694|65303365|FG008|Overall Study|Other|0|||
23425673|NCT02761694|65303366|FG009|Overall Study|Other|1|||
23425674|NCT02761694|65303367|FG010|Overall Study|Other|1|||
23425675|NCT02761694|65303368|FG011|Overall Study|Other|0|||
23425676|NCT00260065|65303373|FG000|Overall Study|Progressive Disease|22|||
23425677|NCT00260065|65303373|FG000|Overall Study|Adverse Event|17|||
23818043|NCT02455518|66714198|FG002|Overall Study|Protocol Violation|1|||
23818044|NCT02455518|66714199|FG003|Overall Study|Protocol Violation|3|||
23425678|NCT00260065|65303373|FG000|Overall Study|Death|13|||
23425679|NCT00260065|65303373|FG000|Overall Study|Withdrawal by Subject|13|||
23425680|NCT00260065|65303373|FG000|Overall Study|Physician Decision|19|||
23425681|NCT00260065|65303373|FG000|Overall Study|Not otherwise specified|8|||
23425682|NCT00260065|65303373|FG000|Overall Study|Medication Noncompliance|1|||
23425683|NCT01444027|65303374|FG000|Overall Study|Withdrawal by Subject|4|||
23425684|NCT01444027|65303375|FG001|Overall Study|Withdrawal by Subject|10|||
23425685|NCT01444027|65303376|FG002|Overall Study|Withdrawal by Subject|24|||
23425686|NCT01444027|65303374|FG000|Overall Study|Lost to Follow-up|26|||
23425687|NCT01444027|65303375|FG001|Overall Study|Lost to Follow-up|20|||
23818045|NCT05320887|66714200|FG000|Overall Study|Lost to Follow-up|0|||
23425688|NCT01444027|65303376|FG002|Overall Study|Lost to Follow-up|14|||
23425689|NCT00664560|65303380|FG000|Overall Study|Adverse Event|19|||
23425690|NCT00664560|65303381|FG001|Overall Study|Adverse Event|16|||
23425691|NCT00664560|65303382|FG002|Overall Study|Adverse Event|7|||
23425692|NCT00664560|65303380|FG000|Overall Study|Withdrawal by Subject|9|||
23425693|NCT00664560|65303381|FG001|Overall Study|Withdrawal by Subject|13|||
23425694|NCT00664560|65303382|FG002|Overall Study|Withdrawal by Subject|7|||
23425695|NCT00664560|65303380|FG000|Overall Study|Lost to Follow-up|0|||
23425696|NCT00664560|65303381|FG001|Overall Study|Lost to Follow-up|2|||
23425697|NCT00664560|65303382|FG002|Overall Study|Lost to Follow-up|0|||
23425698|NCT00664560|65303380|FG000|Overall Study|Other|11|||
23730349|NCT03424044|66388819|FG006|First Intervention (76 Hours)|device issues|1|||
23730350|NCT03424044|66388820|FG007|First Intervention (76 Hours)|device issues|1|||
23730351|NCT03424044|66388821|FG008|First Intervention (76 Hours)|device issues|1|||
23730352|NCT03424044|66388813|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
23730353|NCT03424044|66388814|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
23730354|NCT03424044|66388815|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
23425699|NCT00664560|65303381|FG001|Overall Study|Other|4|||
23425700|NCT00664560|65303382|FG002|Overall Study|Other|5|||
23425701|NCT00496197|65303383|FG000|Overall Study|Discontinued study due to death|43|||
23425702|NCT00496197|65303383|FG000|Overall Study|Adverse Event|13|||
23730355|NCT03424044|66388816|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
23425703|NCT00496197|65303383|FG000|Overall Study|Does not meet entrance criteria|5|||
23730356|NCT03424044|66388817|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
23425704|NCT00496197|65303383|FG000|Overall Study|Insufficient clinical response|3|||
23425705|NCT00496197|65303383|FG000|Overall Study|Insufficient bacteriological response|10|||
23425706|NCT00496197|65303383|FG000|Overall Study|Lost to Follow-up|11|||
23425707|NCT00496197|65303383|FG000|Overall Study|Withdrawal by Subject|11|||
23425708|NCT00496197|65303383|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
23425709|NCT00496197|65303383|FG000|Overall Study|Other|14|||
23425710|NCT00496197|65303383|FG000|Overall Study|Protocol Violation|8|||
23425711|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
23425712|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
23425713|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
23425714|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
23425715|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
23425716|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
23425717|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
23425718|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
23425719|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
23425720|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
23425721|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
23425722|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
23425723|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
23425724|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
23425725|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
23425726|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
23425727|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
23425728|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
23425729|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
23425730|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
23425731|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
23425732|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
23425733|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
23425734|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
23425735|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
23425736|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
23425737|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
23425738|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
23425739|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
23425740|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
23425741|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Physician Decision|0|||
23425742|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Physician Decision|0|||
23425743|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Physician Decision|0|||
23425744|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Physician Decision|0|||
23425745|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Physician Decision|1|||
23425746|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Physician Decision|0|||
23425747|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Physician Decision|0|||
23425748|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Physician Decision|0|||
23425749|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Physician Decision|0|||
23425750|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Physician Decision|0|||
23425751|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Physician Decision|0|||
23425752|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Physician Decision|0|||
23425753|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Physician Decision|0|||
23425754|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Physician Decision|0|||
23425755|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Physician Decision|0|||
23425756|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Death|0|||
23425757|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Death|0|||
23425758|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Death|0|||
23425759|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Death|0|||
23730357|NCT03424044|66388818|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
23730358|NCT03424044|66388819|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
23730359|NCT03424044|66388820|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
23730360|NCT03424044|66388821|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
23730361|NCT03424044|66388813|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23425760|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Death|0|||
23425761|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Death|0|||
23425762|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Death|0|||
23425763|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Death|0|||
23425764|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Death|0|||
23425765|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Death|0|||
23425766|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Death|0|||
23425767|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Death|0|||
23730362|NCT03424044|66388814|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730363|NCT03424044|66388815|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23818046|NCT05320887|66714201|FG001|Overall Study|Lost to Follow-up|3|||
23818047|NCT05320887|66714202|FG002|Overall Study|Lost to Follow-up|0|||
23818048|NCT05320887|66714203|FG003|Overall Study|Lost to Follow-up|0|||
23818049|NCT00340678|66714204|FG000|Overall Study|Lost to Follow-up|1|||
23818050|NCT00340678|66714205|FG001|Overall Study|Lost to Follow-up|0|||
23818051|NCT00340678|66714206|FG002|Overall Study|Lost to Follow-up|0|||
23818052|NCT00340678|66714207|FG003|Overall Study|Lost to Follow-up|0|||
23818053|NCT04893018|66714210|FG000|Overall Study|Lost to Follow-up|1|||
23425768|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Death|1|||
23425769|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Death|1|||
23425770|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Death|0|||
23425771|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Physician Decision|0|||
23425772|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Physician Decision|0|||
23425773|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Physician Decision|0|||
23425774|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Physician Decision|0|||
23425775|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Physician Decision|0|||
23425776|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Physician Decision|0|||
23425777|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Physician Decision|0|||
23425778|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Physician Decision|0|||
23425779|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Physician Decision|0|||
23425780|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Physician Decision|0|||
23425781|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Physician Decision|1|||
23425782|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Physician Decision|1|||
23425783|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Physician Decision|0|||
23425784|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Physician Decision|1|||
23425785|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Physician Decision|0|||
23425786|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Other|0|||
23425787|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Other|0|||
23425788|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Other|0|||
23425789|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Other|0|||
23425790|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Other|0|||
23425791|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Other|0|||
23425792|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Other|0|||
23425793|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Other|0|||
23425794|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Other|0|||
23425795|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Other|0|||
23425796|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Other|0|||
23425797|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Other|0|||
23425798|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Other|0|||
23425799|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Other|1|||
23425800|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Other|0|||
23425801|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
23425802|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
23425803|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
23425804|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
23425805|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
23425806|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
23425807|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
23425808|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
23425809|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
23425810|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
23425811|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
23425812|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
23425813|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
23425814|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
23425815|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
23425816|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
23425817|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
23425818|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
23425819|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
23425820|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
23425821|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
23425822|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
23425823|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
23543924|NCT01045447|65719971|FG000|Overall Study|Unclassified|17|||
23543925|NCT01045447|65719972|FG001|Overall Study|Unclassified|13|||
23818054|NCT04893018|66714211|FG001|Overall Study|Lost to Follow-up|0|||
23425824|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
23425825|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
23425826|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
23425827|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
23425828|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
23425829|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
23425830|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
23543926|NCT01753193|65719978|FG000|Overall Study|Withdrawal by Subject|23|||
23425831|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425832|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425833|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425834|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425835|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425836|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425837|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425838|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425839|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425840|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425841|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
23425842|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425843|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425844|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425845|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425846|NCT01852825|65303399|FG000|Overall Study|Withdrawal by Subject|2|||
23425847|NCT01852825|65303400|FG001|Overall Study|Withdrawal by Subject|0|||
23425848|NCT01852825|65303401|FG002|Overall Study|Withdrawal by Subject|0|||
23425849|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
23425850|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
23425851|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
23425852|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
23425853|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
23425854|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
23425855|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
23425856|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
23425857|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
23425858|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
23425859|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
23425860|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
23425861|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
23425862|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
23425863|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
23425864|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
23425865|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
23425866|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
23425867|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
23425868|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
23425869|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
23425870|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
23425871|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
23425872|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
23425873|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
23425874|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
23425875|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
23425876|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
23425877|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
23425878|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
23425879|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
23425880|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
23425881|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
23425882|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
23425883|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Death|2|||
23425884|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Death|0|||
23425885|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
23425886|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
23425887|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
23425888|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
23425889|NCT01095653|65303405|FG000|Overall Study|Lack of Efficacy|3|||
23425890|NCT01095653|65303406|FG001|Overall Study|Lack of Efficacy|0|||
23425891|NCT01095653|65303407|FG002|Overall Study|Lack of Efficacy|0|||
23425892|NCT01095653|65303405|FG000|Overall Study|Adverse Event|1|||
23543927|NCT01753193|65719978|FG000|Overall Study|Lost to Follow-up|6|||
23543928|NCT01753193|65719978|FG000|Overall Study|Death|1|||
23543929|NCT01753193|65719978|FG000|Overall Study|Other|16|||
23543930|NCT00562159|65719979|FG000|Overall Study|Adverse Event|11|||
23425893|NCT01095653|65303406|FG001|Overall Study|Adverse Event|4|||
23425894|NCT01095653|65303407|FG002|Overall Study|Adverse Event|4|||
23425895|NCT01095653|65303405|FG000|Overall Study|Lost to Follow-up|1|||
23425896|NCT01095653|65303406|FG001|Overall Study|Lost to Follow-up|0|||
23425897|NCT01095653|65303407|FG002|Overall Study|Lost to Follow-up|4|||
23425898|NCT01095653|65303405|FG000|Overall Study|Withdrawal by Subject|4|||
23425899|NCT01095653|65303406|FG001|Overall Study|Withdrawal by Subject|5|||
23425900|NCT01095653|65303407|FG002|Overall Study|Withdrawal by Subject|3|||
23425901|NCT01095653|65303405|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
23425902|NCT01095653|65303406|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
23425903|NCT01095653|65303407|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
23425904|NCT00791557|65303408|FG000|Overall Study|Adverse Event|1|||
23425905|NCT03093974|65303409|FG000|Overall Study|Withdrawal by Subject|32|||
23425906|NCT03093974|65303410|FG001|Overall Study|Withdrawal by Subject|27|||
23425907|NCT03093974|65303409|FG000|Overall Study|Adverse Event|17|||
23425908|NCT03093974|65303410|FG001|Overall Study|Adverse Event|24|||
23425909|NCT03093974|65303409|FG000|Overall Study|Death|0|||
23425910|NCT03093974|65303410|FG001|Overall Study|Death|1|||
23425911|NCT03093974|65303409|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23425912|NCT03093974|65303410|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23425913|NCT03093974|65303409|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
23425914|NCT03093974|65303410|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
23425915|NCT03093974|65303409|FG000|Overall Study|Lost to Follow-up|0|||
23425916|NCT03093974|65303410|FG001|Overall Study|Lost to Follow-up|1|||
23425917|NCT03093974|65303409|FG000|Overall Study|Other|1|||
23425918|NCT03093974|65303410|FG001|Overall Study|Other|2|||
23425919|NCT01958021|65303411|FG000|Overall Study|Progressive disease|87|||
23730364|NCT03424044|66388816|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
23730365|NCT03424044|66388817|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730366|NCT03424044|66388818|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730367|NCT03424044|66388819|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730368|NCT03424044|66388820|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730369|NCT03424044|66388821|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23730370|NCT02408484|66388822|FG000|Overall Study|Withdrawal by Subject|3|||
23730371|NCT02408484|66388822|FG000|Overall Study|Not treated during study period|1|||
23730372|NCT01131130|66388824|FG000|Period 1 - Baseline|Pregnancy|1|||
23617252|NCT02123797|65985138|FG004|Baseline Intervention|Relocation|0|||
23617253|NCT02123797|65985134|FG000|Baseline Intervention|Out of window for initial survey|6|||
23617254|NCT02123797|65985135|FG001|Baseline Intervention|Out of window for initial survey|13|||
23617255|NCT02123797|65985136|FG002|Baseline Intervention|Out of window for initial survey|0|||
23730373|NCT01131130|66388824|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
23730374|NCT02008396|66388825|FG000|Overall Study|Protocol Violation|0|||
23730375|NCT02008396|66388826|FG001|Overall Study|Protocol Violation|1|||
23730376|NCT02735044|66388827|FG000|Overall Study|Adverse Event|3|||
23730377|NCT02735044|66388828|FG001|Overall Study|Adverse Event|3|||
23818055|NCT04893018|66714210|FG000|Overall Study|Withdrawal by Subject|2|||
23818056|NCT04893018|66714211|FG001|Overall Study|Withdrawal by Subject|0|||
23425920|NCT01958021|65303412|FG001|Overall Study|Progressive disease|146|||
23730378|NCT02735044|66388827|FG000|Overall Study|Lack of Efficacy|1|||
23730379|NCT02735044|66388828|FG001|Overall Study|Lack of Efficacy|0|||
23730380|NCT02735044|66388827|FG000|Overall Study|Poor compliance to protocol|7|||
23730381|NCT02735044|66388828|FG001|Overall Study|Poor compliance to protocol|7|||
23730382|NCT02735044|66388827|FG000|Overall Study|Randomized and not treated|0|||
23730383|NCT02735044|66388828|FG001|Overall Study|Randomized and not treated|2|||
23730384|NCT02735044|66388827|FG000|Overall Study|Other, not specified above|5|||
23730385|NCT02735044|66388828|FG001|Overall Study|Other, not specified above|11|||
23730386|NCT02967562|66388832|FG000|Overall Study|Consent not obtained|1|||
23730387|NCT02967562|66388833|FG001|Overall Study|Consent not obtained|0|||
23730388|NCT02967562|66388832|FG000|Overall Study|High leak precluding analysis|1|||
23730389|NCT02967562|66388833|FG001|Overall Study|High leak precluding analysis|1|||
23730390|NCT00446797|66388837|FG000|Overall Study|Lack of Efficacy|0|||
23730391|NCT00446797|66388838|FG001|Overall Study|Lack of Efficacy|2|||
23730392|NCT00446797|66388837|FG000|Overall Study|Lost to Follow-up|5|||
23730393|NCT00446797|66388838|FG001|Overall Study|Lost to Follow-up|3|||
23730394|NCT00446797|66388837|FG000|Overall Study|Withdrawal by Subject|2|||
23730395|NCT00446797|66388838|FG001|Overall Study|Withdrawal by Subject|2|||
23730396|NCT00446797|66388837|FG000|Overall Study|Protocol Violation|1|||
23730397|NCT00446797|66388838|FG001|Overall Study|Protocol Violation|3|||
23818057|NCT04893018|66714210|FG000|Overall Study|Study Terminated|1|||
23425921|NCT01958021|65303411|FG000|Overall Study|Adverse Event|25|||
23425922|NCT01958021|65303412|FG001|Overall Study|Adverse Event|7|||
23425923|NCT01958021|65303411|FG000|Overall Study|Subject/guardian decision|12|||
23425924|NCT01958021|65303412|FG001|Overall Study|Subject/guardian decision|13|||
23425925|NCT01958021|65303411|FG000|Overall Study|Physician Decision|10|||
23425926|NCT01958021|65303412|FG001|Overall Study|Physician Decision|13|||
23617256|NCT02123797|65985137|FG003|Baseline Intervention|Out of window for initial survey|0|||
23730398|NCT00446797|66388837|FG000|Overall Study|subject entered at another site|0|||
23730399|NCT00446797|66388838|FG001|Overall Study|subject entered at another site|1|||
23730400|NCT00446797|66388837|FG000|Overall Study|did not meet entrance criteria|0|||
23730401|NCT00446797|66388838|FG001|Overall Study|did not meet entrance criteria|1|||
23730402|NCT00744991|66388839|FG000|Overall Study|Progressive Disease|11|||
23730403|NCT00744991|66388839|FG000|Overall Study|Withdrawal by Subject|8|||
23730404|NCT00744991|66388839|FG000|Overall Study|Physician Decision|3|||
23730405|NCT00744991|66388839|FG000|Overall Study|Adverse Event|2|||
23730406|NCT00744991|66388839|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
23730407|NCT02736474|66388843|FG000|Overall Study|Lost to Follow-up|0|||
23730408|NCT02736474|66388844|FG001|Overall Study|Lost to Follow-up|1|||
23730409|NCT01764022|66388845|FG000|Overall Study|Death|3|||
23730410|NCT01764022|66388846|FG001|Overall Study|Death|5|||
23730411|NCT01764022|66388845|FG000|Overall Study|Withdrawal by Subject|2|||
23730412|NCT01764022|66388846|FG001|Overall Study|Withdrawal by Subject|6|||
23730413|NCT01764022|66388845|FG000|Overall Study|Lack of Efficacy|0|||
23730414|NCT01764022|66388846|FG001|Overall Study|Lack of Efficacy|1|||
23730415|NCT01764022|66388845|FG000|Overall Study|Physician Decision|0|||
23730416|NCT01764022|66388846|FG001|Overall Study|Physician Decision|2|||
23730417|NCT01764022|66388845|FG000|Overall Study|Lost to Follow-up|2|||
23730418|NCT01764022|66388846|FG001|Overall Study|Lost to Follow-up|0|||
23730419|NCT01764022|66388845|FG000|Overall Study|Protocol Violation|1|||
23730420|NCT01764022|66388846|FG001|Overall Study|Protocol Violation|0|||
23730421|NCT05307523|66388851|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
23730422|NCT05307523|66388852|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
23730423|NCT05307523|66388851|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
23730424|NCT05307523|66388852|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
23730425|NCT03745989|66388858|FG000|Overall Study|Death|3|||
23730426|NCT03745989|66388859|FG001|Overall Study|Death|7|||
23730427|NCT03745989|66388860|FG002|Overall Study|Death|4|||
23730428|NCT03745989|66388858|FG000|Overall Study|Lost to Follow-up|0|||
23730429|NCT03745989|66388859|FG001|Overall Study|Lost to Follow-up|2|||
23730430|NCT03745989|66388860|FG002|Overall Study|Lost to Follow-up|0|||
23730431|NCT03745989|66388858|FG000|Overall Study|Sponsor Decision|0|||
23730432|NCT03745989|66388859|FG001|Overall Study|Sponsor Decision|2|||
23730433|NCT03745989|66388860|FG002|Overall Study|Sponsor Decision|8|||
23730434|NCT03745989|66388858|FG000|Overall Study|Withdrawal by Subject|0|||
23730435|NCT03745989|66388859|FG001|Overall Study|Withdrawal by Subject|1|||
23730436|NCT03745989|66388860|FG002|Overall Study|Withdrawal by Subject|3|||
23730437|NCT00985738|66388861|FG000|Overall Study|Study closed prematurely|8|||
23730438|NCT00985738|66388862|FG001|Overall Study|Study closed prematurely|8|||
23730439|NCT02656173|66388863|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
23730440|NCT02656173|66388864|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
23730441|NCT02656173|66388863|FG000|Overall Study|Adverse Event|7|||
23730442|NCT02656173|66388864|FG001|Overall Study|Adverse Event|5|||
23730443|NCT02656173|66388863|FG000|Overall Study|Withdrawal by Subject|1|||
23730444|NCT02656173|66388864|FG001|Overall Study|Withdrawal by Subject|3|||
23730445|NCT02656173|66388863|FG000|Overall Study|Protocol Violation|0|||
23730446|NCT02656173|66388864|FG001|Overall Study|Protocol Violation|1|||
23425927|NCT01958021|65303411|FG000|Overall Study|Protocol Violation|3|||
23425928|NCT01958021|65303412|FG001|Overall Study|Protocol Violation|1|||
23425929|NCT01958021|65303411|FG000|Overall Study|Death|2|||
23543931|NCT00562159|65719980|FG001|Overall Study|Adverse Event|8|||
23730447|NCT02656173|66388863|FG000|Overall Study|Miscellaneous|2|||
23730448|NCT02656173|66388864|FG001|Overall Study|Miscellaneous|0|||
23730449|NCT02692560|66388865|FG000|Overall Study|Withdrawal by Subject|0|||
23425930|NCT01958021|65303412|FG001|Overall Study|Death|0|||
23425931|NCT02421601|65303413|FG000|Overall Study|Adverse Event|4|||
23730450|NCT02692560|66388866|FG001|Overall Study|Withdrawal by Subject|6|||
23730451|NCT02148952|66388867|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
23730452|NCT02148952|66388868|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
23818058|NCT04893018|66714211|FG001|Overall Study|Study Terminated|2|||
23425932|NCT02421601|65303413|FG000|Overall Study|Lack of Efficacy|5|||
23730453|NCT02148952|66388867|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
23730454|NCT02148952|66388868|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
23730455|NCT02148952|66388867|FG000|Follow-Up|Lost to Follow-up|219|||
23730456|NCT02148952|66388868|FG001|Follow-Up|Lost to Follow-up|231|||
23730457|NCT02148952|66388867|FG000|Follow-Up|Withdrawal by Subject|46|||
23730458|NCT02148952|66388868|FG001|Follow-Up|Withdrawal by Subject|48|||
23730459|NCT00976963|66388870|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
23730460|NCT00976963|66388871|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
23730461|NCT00976963|66388870|FG000|Overall Study|administrative error|1|||
23730462|NCT00976963|66388871|FG001|Overall Study|administrative error|0|||
23730463|NCT00976963|66388870|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
23730464|NCT00976963|66388871|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
23730465|NCT03458234|66388875|FG000|Overall Study|Withdrawal by Subject|1|||
23730466|NCT02870348|66388876|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
23730467|NCT00790218|66388884|FG000|Overall Study|Death|1|||
23730468|NCT00790218|66388885|FG001|Overall Study|Death|0|||
23730469|NCT00790218|66388886|FG002|Overall Study|Death|0|||
23730470|NCT02718625|66388887|FG000|Overall Study|Adverse Event|0|||
23730471|NCT02718625|66388888|FG001|Overall Study|Adverse Event|1|||
23730472|NCT02718625|66388887|FG000|Overall Study|Termination of Study by Sponsor|0|||
23730473|NCT02718625|66388888|FG001|Overall Study|Termination of Study by Sponsor|1|||
23730474|NCT00441012|66388889|FG000|Overall Study|Adverse Event|0|||
23730475|NCT00441012|66388890|FG001|Overall Study|Adverse Event|1|||
23730476|NCT00441012|66388889|FG000|Overall Study|Lost to Follow-up|3|||
23730477|NCT00441012|66388890|FG001|Overall Study|Lost to Follow-up|3|||
23730478|NCT00441012|66388889|FG000|Overall Study|Protocol Violation|10|||
23730479|NCT00441012|66388890|FG001|Overall Study|Protocol Violation|9|||
23730480|NCT00441012|66388889|FG000|Overall Study|Withdrawal by Subject|4|||
23730481|NCT00441012|66388890|FG001|Overall Study|Withdrawal by Subject|0|||
23730482|NCT00441012|66388889|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
23730483|NCT00441012|66388890|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
23730484|NCT02343952|66388891|FG000|Study Treatment|Disease Progression|23|||
23730485|NCT02343952|66388891|FG000|Study Treatment|Death|3|||
23730486|NCT02343952|66388891|FG000|Study Treatment|Adverse Event|19|||
23730487|NCT02343952|66388891|FG000|Study Treatment|Withdrawal by Subject|7|||
23730488|NCT02343952|66388891|FG000|Study Treatment|other complicating Diseases|1|||
23730489|NCT02343952|66388891|FG000|Follow up|Withdrawal by Subject|3|||
23730490|NCT02343952|66388891|FG000|Follow up|Death|33|||
23730491|NCT02343952|66388891|FG000|Follow up|Patient does not meet eligibility for study.|1|||
23730492|NCT02343952|66388891|FG000|Follow up|Research department closed by the practice.|5|||
23730493|NCT02343952|66388891|FG000|Follow up|Patient went home to Russia|1|||
23730494|NCT02343952|66388891|FG000|Follow up|Disease Progression|1|||
23730495|NCT02343952|66388891|FG000|Follow up|study terminated|1|||
23730496|NCT00398086|66388892|FG000|Overall Study|Unacceptable Toxicity|2|||
23730497|NCT00398086|66388893|FG001|Overall Study|Unacceptable Toxicity|8|||
23730498|NCT00398086|66388894|FG002|Overall Study|Unacceptable Toxicity|2|||
23730499|NCT00398086|66388892|FG000|Overall Study|Adverse Event|1|||
23730500|NCT00398086|66388893|FG001|Overall Study|Adverse Event|4|||
23730501|NCT00398086|66388894|FG002|Overall Study|Adverse Event|0|||
23730502|NCT00398086|66388892|FG000|Overall Study|Physician Decision|1|||
23730503|NCT00398086|66388893|FG001|Overall Study|Physician Decision|4|||
23730504|NCT00398086|66388894|FG002|Overall Study|Physician Decision|0|||
23730505|NCT00398086|66388892|FG000|Overall Study|Withdrawal by Subject|5|||
23730506|NCT00398086|66388893|FG001|Overall Study|Withdrawal by Subject|7|||
23730507|NCT00398086|66388894|FG002|Overall Study|Withdrawal by Subject|0|||
23730508|NCT04247828|66388897|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
23730509|NCT04412668|66388898|FG000|Overall Study|Death - multiple comorbidities|2|||
23730510|NCT04412668|66388899|FG001|Overall Study|Death - multiple comorbidities|0|||
23730511|NCT04412668|66388900|FG002|Overall Study|Death - multiple comorbidities|0|||
23730512|NCT04412668|66388898|FG000|Overall Study|Withdrawal by Subject|3|||
23730513|NCT04412668|66388899|FG001|Overall Study|Withdrawal by Subject|0|||
23730514|NCT04412668|66388900|FG002|Overall Study|Withdrawal by Subject|0|||
23730515|NCT04412668|66388898|FG000|Overall Study|Other than Specified|2|||
23730516|NCT04412668|66388899|FG001|Overall Study|Other than Specified|0|||
23730517|NCT04412668|66388900|FG002|Overall Study|Other than Specified|0|||
23543932|NCT00562159|65719979|FG000|Overall Study|Lost to Follow-up|5|||
23730518|NCT00939055|66388901|FG000|Overall Study|Discontinuation prior to procedure|4|||
23730519|NCT00939055|66388902|FG001|Overall Study|Discontinuation prior to procedure|0|||
23730520|NCT03644173|66391823|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
23730521|NCT03644173|66391823|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
23730522|NCT03644173|66391823|FG000|Participants at the 1-month Follow up|Death|2|||
23543933|NCT00562159|65719980|FG001|Overall Study|Lost to Follow-up|4|||
23730523|NCT03644173|66391823|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
23730524|NCT00958191|66391824|FG000|Overall Study|Death|4|||
23730525|NCT00958191|66391824|FG000|Overall Study|Lost to Follow-up|5|||
23730526|NCT00958191|66391824|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
23730527|NCT00958191|66391824|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
23730528|NCT00958191|66391824|FG000|Overall Study|Revision of study device|4|||
23730529|NCT00958191|66391824|FG000|Overall Study|Site termination|11|||
23730530|NCT00958191|66391824|FG000|Overall Study|No 5 yr x-rays|56|||
23730531|NCT00511108|66391825|FG000|Overall Study|Adverse Event|2|||
23730532|NCT00511108|66391826|FG001|Overall Study|Adverse Event|0|||
23730533|NCT00511108|66391827|FG002|Overall Study|Adverse Event|1|||
23730534|NCT00511108|66391828|FG003|Overall Study|Adverse Event|2|||
23730535|NCT00511108|66391825|FG000|Overall Study|Lost to Follow-up|0|||
23730536|NCT00511108|66391826|FG001|Overall Study|Lost to Follow-up|2|||
23730537|NCT00511108|66391827|FG002|Overall Study|Lost to Follow-up|1|||
23730538|NCT00511108|66391828|FG003|Overall Study|Lost to Follow-up|0|||
23730539|NCT00511108|66391825|FG000|Overall Study|Physician Decision|0|||
23730540|NCT00511108|66391826|FG001|Overall Study|Physician Decision|0|||
23730541|NCT00511108|66391827|FG002|Overall Study|Physician Decision|0|||
23730542|NCT00511108|66391828|FG003|Overall Study|Physician Decision|1|||
23730543|NCT00511108|66391825|FG000|Overall Study|Withdrawal by Subject|4|||
23730544|NCT00511108|66391826|FG001|Overall Study|Withdrawal by Subject|0|||
23730545|NCT00511108|66391827|FG002|Overall Study|Withdrawal by Subject|3|||
23730546|NCT00511108|66391828|FG003|Overall Study|Withdrawal by Subject|2|||
23425933|NCT02421601|65303413|FG000|Overall Study|Physician Decision|1|||
23425934|NCT02421601|65303413|FG000|Overall Study|Withdrawal by Subject|31|||
23425935|NCT02421601|65303413|FG000|Overall Study|Others|41|||
23617257|NCT02123797|65985138|FG004|Baseline Intervention|Out of window for initial survey|0|||
23617258|NCT02123797|65985134|FG000|Baseline Intervention|Lost to Follow-up|0|||
23617259|NCT02123797|65985135|FG001|Baseline Intervention|Lost to Follow-up|5|||
23617260|NCT02123797|65985136|FG002|Baseline Intervention|Lost to Follow-up|0|||
23617261|NCT02123797|65985137|FG003|Baseline Intervention|Lost to Follow-up|0|||
23617262|NCT02123797|65985138|FG004|Baseline Intervention|Lost to Follow-up|0|||
23617263|NCT02123797|65985134|FG000|Baseline Intervention|Other Disease|3|||
23617264|NCT02123797|65985135|FG001|Baseline Intervention|Other Disease|0|||
23617265|NCT02123797|65985136|FG002|Baseline Intervention|Other Disease|0|||
23617266|NCT02123797|65985137|FG003|Baseline Intervention|Other Disease|0|||
23617267|NCT02123797|65985138|FG004|Baseline Intervention|Other Disease|0|||
23617268|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
23617269|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
23617270|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
23617271|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
23617272|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
23617273|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
23617274|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
23617275|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
23617276|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
23617277|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23617278|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
23617279|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
23617280|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617281|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617282|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617283|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617284|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
23617285|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617286|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617287|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617288|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
23617289|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
23617290|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617291|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617292|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617293|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
23617294|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
23617295|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
23730547|NCT00038142|66391830|FG000|Overall Study|Ineligible|1|||
23730548|NCT00038142|66391831|FG001|Overall Study|Ineligible|0|||
23730549|NCT00038142|66391830|FG000|Overall Study|Progressive Disease|11|||
23617296|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
23730550|NCT00038142|66391831|FG001|Overall Study|Progressive Disease|7|||
23730551|NCT00038142|66391830|FG000|Overall Study|Death|1|||
23425936|NCT01420627|65303414|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
23425937|NCT03444766|65303415|FG000|Overall Study|Other Reasons|2|||
23425938|NCT03444766|65303415|FG000|Overall Study|Participant Withdrew Consent|5|||
23425939|NCT03444766|65303415|FG000|Overall Study|Lost to Follow-up|2|||
23425940|NCT03444766|65303415|FG000|Overall Study|Death|2|||
23425941|NCT03444766|65303415|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
23425942|NCT03444766|65303415|FG000|Overall Study|Disease Progression|49|||
23425943|NCT02118597|65303416|FG000|Overall Study|Sponsor terminated the study|14|||
23425944|NCT02118597|65303416|FG000|Overall Study|Serious Adverse Event|1|||
23425945|NCT02118597|65303416|FG000|Overall Study|Investigator's decision|1|||
23425946|NCT02966795|65303423|FG000|Overall Study|Patient Left the Country|0|||
23425947|NCT02966795|65303424|FG001|Overall Study|Patient Left the Country|1|||
23425948|NCT00477269|65303427|FG000|Core Study|Adverse Event|6|||
23425949|NCT00477269|65303428|FG001|Core Study|Adverse Event|4|||
23425950|NCT00477269|65303429|FG002|Core Study|Adverse Event|0|||
23425951|NCT00477269|65303427|FG000|Core Study|Death|3|||
23425952|NCT00477269|65303428|FG001|Core Study|Death|3|||
23425953|NCT00477269|65303429|FG002|Core Study|Death|0|||
23425954|NCT00477269|65303427|FG000|Core Study|Withdrawn Consent|0|||
23425955|NCT00477269|65303428|FG001|Core Study|Withdrawn Consent|1|||
23425956|NCT00477269|65303429|FG002|Core Study|Withdrawn Consent|0|||
23425957|NCT00477269|65303427|FG000|Open Label Extension|Adverse Event|0|||
23425958|NCT00477269|65303428|FG001|Open Label Extension|Adverse Event|0|||
23425959|NCT00477269|65303429|FG002|Open Label Extension|Adverse Event|4|||
23425960|NCT00477269|65303427|FG000|Open Label Extension|Abnormal laboratory values|0|||
23425961|NCT00477269|65303428|FG001|Open Label Extension|Abnormal laboratory values|0|||
23425962|NCT00477269|65303429|FG002|Open Label Extension|Abnormal laboratory values|1|||
23425963|NCT00477269|65303427|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
23425964|NCT00477269|65303428|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
23425965|NCT00477269|65303429|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
23425966|NCT00477269|65303427|FG000|Open Label Extension|Adminiatrative problems|0|||
23425967|NCT00477269|65303428|FG001|Open Label Extension|Adminiatrative problems|0|||
23425968|NCT00477269|65303429|FG002|Open Label Extension|Adminiatrative problems|2|||
23425969|NCT00477269|65303427|FG000|Open Label Extension|Death|0|||
23425970|NCT00477269|65303428|FG001|Open Label Extension|Death|0|||
23425971|NCT00477269|65303429|FG002|Open Label Extension|Death|4|||
23425972|NCT01133626|65303432|FG000|Overall Study|Adverse Event|0|||
23425973|NCT01133626|65303433|FG001|Overall Study|Adverse Event|1|||
23425974|NCT01133626|65303434|FG002|Overall Study|Adverse Event|0|||
23425975|NCT01133626|65303432|FG000|Overall Study|Withdrawal by Subject|1|||
23425976|NCT01133626|65303433|FG001|Overall Study|Withdrawal by Subject|2|||
23425977|NCT01133626|65303434|FG002|Overall Study|Withdrawal by Subject|2|||
23425978|NCT01133626|65303432|FG000|Overall Study|Other|0|||
23425979|NCT01133626|65303433|FG001|Overall Study|Other|2|||
23425980|NCT01133626|65303434|FG002|Overall Study|Other|0|||
23425981|NCT02956850|65303437|FG000|Overall Study|Withdrawal by Subject|0|||
23425982|NCT02956850|65303438|FG001|Overall Study|Withdrawal by Subject|0|||
23425983|NCT02956850|65303439|FG002|Overall Study|Withdrawal by Subject|0|||
23425984|NCT02956850|65303440|FG003|Overall Study|Withdrawal by Subject|0|||
23617297|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
23617298|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23617299|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
23617300|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
23617301|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
23617302|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23818059|NCT03907878|66714212|FG000|Treatment Period|Withdrawal by Subject|5|||
23818060|NCT03907878|66714212|FG000|Treatment Period|Adverse Event|4|||
23818061|NCT03907878|66714212|FG000|Treatment Period|Lack of Efficacy|1|||
23818062|NCT03907878|66714212|FG000|Treatment Period|Protocol Violation|1|||
23818063|NCT03907878|66714212|FG000|Follow-up Period|Adverse Event|3|||
23818064|NCT03907878|66714212|FG000|Follow-up Period|Withdrawal by Subject|3|||
23425985|NCT02956850|65303441|FG004|Overall Study|Withdrawal by Subject|0|||
23617303|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
23617304|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
23425986|NCT02956850|65303442|FG005|Overall Study|Withdrawal by Subject|0|||
23425987|NCT02956850|65303443|FG006|Overall Study|Withdrawal by Subject|0|||
23425988|NCT02956850|65303444|FG007|Overall Study|Withdrawal by Subject|0|||
23425989|NCT02956850|65303445|FG008|Overall Study|Withdrawal by Subject|0|||
23425990|NCT02956850|65303446|FG009|Overall Study|Withdrawal by Subject|0|||
23425991|NCT02956850|65303447|FG010|Overall Study|Withdrawal by Subject|0|||
23425992|NCT02956850|65303448|FG011|Overall Study|Withdrawal by Subject|0|||
23425993|NCT02956850|65303449|FG012|Overall Study|Withdrawal by Subject|0|||
23425994|NCT02956850|65303450|FG013|Overall Study|Withdrawal by Subject|0|||
23425995|NCT02956850|65303451|FG014|Overall Study|Withdrawal by Subject|0|||
23818065|NCT01130597|66714213|FG000|Overall Study|Protocol-specified (High K+)|1|||
23818066|NCT01130597|66714213|FG000|Overall Study|Adverse Event|4|||
23818067|NCT01130597|66714213|FG000|Overall Study|Death|1|||
23425996|NCT02956850|65303452|FG015|Overall Study|Withdrawal by Subject|0|||
23730552|NCT00038142|66391831|FG001|Overall Study|Death|0|||
23730553|NCT00038142|66391830|FG000|Overall Study|Adverse Event|1|||
23730554|NCT00038142|66391831|FG001|Overall Study|Adverse Event|0|||
23730555|NCT00038142|66391830|FG000|Overall Study|Unknown Reason|8|||
23730556|NCT00038142|66391831|FG001|Overall Study|Unknown Reason|0|||
23730557|NCT01023516|66391834|FG000|Overall Study|Voluntary discontinuation|7|||
23730558|NCT01023516|66391835|FG001|Overall Study|Voluntary discontinuation|5|||
23730559|NCT01023516|66391834|FG000|Overall Study|Adverse Event|9|||
23425997|NCT02956850|65303453|FG016|Overall Study|Withdrawal by Subject|0|||
23425998|NCT02956850|65303454|FG017|Overall Study|Withdrawal by Subject|1|||
23425999|NCT01269385|65303460|FG000|Overall Study|Adverse Event|1|||
23426000|NCT01269385|65303461|FG001|Overall Study|Adverse Event|1|||
23426001|NCT01269385|65303462|FG002|Overall Study|Adverse Event|0|||
23426002|NCT01269385|65303463|FG003|Overall Study|Adverse Event|0|||
23426003|NCT00106691|65303471|FG000|Overall Study|Adverse Event|60|||
23426004|NCT00106691|65303472|FG001|Overall Study|Adverse Event|64|||
23426005|NCT00106691|65303471|FG000|Overall Study|Lost to Follow-up|23|||
23426006|NCT00106691|65303472|FG001|Overall Study|Lost to Follow-up|18|||
23730560|NCT01023516|66391835|FG001|Overall Study|Adverse Event|6|||
23730561|NCT01023516|66391834|FG000|Overall Study|Safety reason|0|||
23730562|NCT01023516|66391835|FG001|Overall Study|Safety reason|3|||
23730563|NCT01023516|66391834|FG000|Overall Study|Study-specific criteria|4|||
23730564|NCT01023516|66391835|FG001|Overall Study|Study-specific criteria|2|||
23730565|NCT01023516|66391834|FG000|Overall Study|Incorrect enrolment|4|||
23730566|NCT01023516|66391835|FG001|Overall Study|Incorrect enrolment|2|||
23730567|NCT02993783|66391836|FG000|Overall Study|Reason not Specified|6|||
23730568|NCT02993783|66391837|FG001|Overall Study|Reason not Specified|9|||
23730569|NCT00118040|66391838|FG000|Overall Study|Adverse Event|0|||
23730570|NCT00118040|66391839|FG001|Overall Study|Adverse Event|1|||
23730571|NCT00118040|66391840|FG002|Overall Study|Adverse Event|0|||
23730572|NCT00118040|66391838|FG000|Overall Study|Withdrawal by Subject|0|||
23730573|NCT00118040|66391839|FG001|Overall Study|Withdrawal by Subject|0|||
23730574|NCT00118040|66391840|FG002|Overall Study|Withdrawal by Subject|2|||
23730575|NCT00118040|66391838|FG000|Overall Study|Medical Contraindication|0|||
23730576|NCT00118040|66391839|FG001|Overall Study|Medical Contraindication|0|||
23730577|NCT00118040|66391840|FG002|Overall Study|Medical Contraindication|1|||
23730578|NCT00118040|66391838|FG000|Overall Study|Non-Compliant Participant|1|||
23730579|NCT00118040|66391839|FG001|Overall Study|Non-Compliant Participant|1|||
23730580|NCT00118040|66391840|FG002|Overall Study|Non-Compliant Participant|2|||
23730581|NCT00118040|66391838|FG000|Overall Study|Other|0|||
23730582|NCT00118040|66391839|FG001|Overall Study|Other|0|||
23730583|NCT00118040|66391840|FG002|Overall Study|Other|1|||
23730584|NCT02708966|66391841|FG000|Overall Study|Lost to Follow-up|2|||
23730585|NCT02708966|66391842|FG001|Overall Study|Lost to Follow-up|2|||
23730586|NCT03607994|66391843|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
23730587|NCT03607994|66391844|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
23730588|NCT00948428|66391848|FG000|Overall Study|Withdrawal by Subject|6|||
23730589|NCT00948428|66391849|FG001|Overall Study|Withdrawal by Subject|12|||
23730590|NCT00948428|66391850|FG002|Overall Study|Withdrawal by Subject|7|||
23730591|NCT00948428|66391848|FG000|Overall Study|Adverse Event|6|||
23730592|NCT00948428|66391849|FG001|Overall Study|Adverse Event|3|||
23730593|NCT00948428|66391850|FG002|Overall Study|Adverse Event|0|||
23730594|NCT00948428|66391848|FG000|Overall Study|Lost to Follow-up|2|||
23730595|NCT00948428|66391849|FG001|Overall Study|Lost to Follow-up|1|||
23730596|NCT00948428|66391850|FG002|Overall Study|Lost to Follow-up|1|||
23730597|NCT00948428|66391848|FG000|Overall Study|Death|2|||
23730598|NCT00948428|66391849|FG001|Overall Study|Death|0|||
23730599|NCT00948428|66391850|FG002|Overall Study|Death|0|||
23426007|NCT00106691|65303471|FG000|Overall Study|Physician Decision|18|||
23426008|NCT00106691|65303472|FG001|Overall Study|Physician Decision|21|||
23730600|NCT00948428|66391848|FG000|Overall Study|Intercurrent Illness|1|||
23730601|NCT00948428|66391849|FG001|Overall Study|Intercurrent Illness|0|||
23730602|NCT00948428|66391850|FG002|Overall Study|Intercurrent Illness|0|||
23730603|NCT00948428|66391848|FG000|Overall Study|Non-compliance|1|||
23426009|NCT00106691|65303471|FG000|Overall Study|Protocol Violation|13|||
23426010|NCT00106691|65303472|FG001|Overall Study|Protocol Violation|18|||
23426011|NCT00106691|65303471|FG000|Overall Study|Withdrawal by Subject|75|||
23543934|NCT00562159|65719979|FG000|Overall Study|Withdrawal by Subject|9|||
23730604|NCT00948428|66391849|FG001|Overall Study|Non-compliance|2|||
23730605|NCT00948428|66391850|FG002|Overall Study|Non-compliance|0|||
23730606|NCT02485860|66391852|FG000|Overall Study|Lost to Follow-up|4|||
23730607|NCT02485860|66391853|FG001|Overall Study|Lost to Follow-up|1|||
23730608|NCT02485860|66391852|FG000|Overall Study|Physician Decision|1|||
23730609|NCT02485860|66391853|FG001|Overall Study|Physician Decision|2|||
23730610|NCT02485860|66391852|FG000|Overall Study|Health context (COVID-19)|1|||
23730611|NCT02485860|66391853|FG001|Overall Study|Health context (COVID-19)|0|||
23730612|NCT04007367|66391858|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
23818068|NCT01130597|66714213|FG000|Overall Study|Protocol Violation|1|||
23818069|NCT00143390|66714214|FG000|Overall Study|Death|2|||
23818070|NCT00143390|66714215|FG001|Overall Study|Death|0|||
23818071|NCT00143390|66714214|FG000|Overall Study|Not meeting entry criteria|2|||
23426012|NCT00106691|65303472|FG001|Overall Study|Withdrawal by Subject|70|||
23730613|NCT04007367|66391859|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
23617305|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617306|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617307|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23730614|NCT04007367|66391860|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
23617308|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
23617309|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
23730615|NCT04007367|66391858|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
23730616|NCT04007367|66391859|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
23730617|NCT04007367|66391860|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
23730618|NCT04007367|66391858|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
23543935|NCT00562159|65719980|FG001|Overall Study|Withdrawal by Subject|8|||
23543936|NCT00562159|65719979|FG000|Overall Study|Protocol Violation|12|||
23543937|NCT00562159|65719980|FG001|Overall Study|Protocol Violation|12|||
23543938|NCT00562159|65719979|FG000|Overall Study|Did not meet protocol eligibility|1|||
23543939|NCT00562159|65719980|FG001|Overall Study|Did not meet protocol eligibility|1|||
23543940|NCT02473614|65719981|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
23543941|NCT02473614|65719982|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
23543942|NCT01178853|65719983|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
23543943|NCT01178853|65719984|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
23617310|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
23617311|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
23730619|NCT04007367|66391859|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
23730620|NCT04007367|66391860|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
23730621|NCT04007367|66391858|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
23730622|NCT04007367|66391859|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
23730623|NCT04007367|66391860|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
23730624|NCT04007367|66391858|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
23730625|NCT04007367|66391859|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
23730626|NCT04007367|66391860|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
23730627|NCT04005755|66391861|FG000|Overall Study|Adverse Event|6|||
23730628|NCT04005755|66391861|FG000|Overall Study|Physician Decision|3|||
23730629|NCT04005755|66391861|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
23730630|NCT04005755|66391861|FG000|Overall Study|Withdrawal by Subject|3|||
23730631|NCT04005755|66391861|FG000|Overall Study|Lost to Follow-up|1|||
23730632|NCT03032523|66391866|FG000|Overall Study|Withdrawal by Subject|2|||
23730633|NCT03032523|66391867|FG001|Overall Study|Withdrawal by Subject|2|||
23730634|NCT03032523|66391866|FG000|Overall Study|Physician Decision|1|||
23730635|NCT03032523|66391867|FG001|Overall Study|Physician Decision|0|||
23730636|NCT00090766|66391868|FG000|Overall Study|Nephrectomy Planned|0|||
23730637|NCT00090766|66391869|FG001|Overall Study|Nephrectomy Planned|0|||
23617312|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
23730638|NCT00090766|66391870|FG002|Overall Study|Nephrectomy Planned|1|||
23730639|NCT00090766|66391868|FG000|Overall Study|Death|1|||
23730640|NCT00090766|66391869|FG001|Overall Study|Death|0|||
23730641|NCT00090766|66391870|FG002|Overall Study|Death|0|||
23426013|NCT00106691|65303471|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
23426014|NCT00106691|65303472|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
23426015|NCT00106691|65303471|FG000|Overall Study|QTc>480|3|||
23426016|NCT00106691|65303472|FG001|Overall Study|QTc>480|1|||
23426017|NCT00106691|65303471|FG000|Overall Study|mililtary deployment|2|||
23426018|NCT00106691|65303472|FG001|Overall Study|mililtary deployment|0|||
23426019|NCT00106691|65303471|FG000|Overall Study|Study Site Closing/PI Moved|1|||
23426020|NCT00106691|65303472|FG001|Overall Study|Study Site Closing/PI Moved|2|||
23730642|NCT00090766|66391868|FG000|Overall Study|Admin|0|||
23730643|NCT00090766|66391869|FG001|Overall Study|Admin|2|||
23730644|NCT00090766|66391870|FG002|Overall Study|Admin|0|||
23730645|NCT00090766|66391868|FG000|Overall Study|Lost to Follow-up|2|||
23730646|NCT00090766|66391869|FG001|Overall Study|Lost to Follow-up|0|||
23730647|NCT00090766|66391870|FG002|Overall Study|Lost to Follow-up|2|||
23730648|NCT03344562|66391873|FG000|Overall Study|Withdrawal by Subject|2|||
23730649|NCT03344562|66391874|FG001|Overall Study|Withdrawal by Subject|0|||
23818072|NCT00143390|66714215|FG001|Overall Study|Not meeting entry criteria|5|||
23426021|NCT00106691|65303471|FG000|Overall Study|Cardiologist recommendation|1|||
23426022|NCT00106691|65303472|FG001|Overall Study|Cardiologist recommendation|0|||
23426023|NCT00106691|65303471|FG000|Overall Study|Pt. moved to another state|1|||
23730650|NCT01836549|66391875|FG000|Overall Study|Did not receive study drug|0|||
23730651|NCT01836549|66391876|FG001|Overall Study|Did not receive study drug|0|||
23730652|NCT01836549|66391877|FG002|Overall Study|Did not receive study drug|1|||
23730653|NCT01836549|66391878|FG003|Overall Study|Did not receive study drug|0|||
23730654|NCT01836549|66391879|FG004|Overall Study|Did not receive study drug|0|||
23730655|NCT01836549|66391880|FG005|Overall Study|Did not receive study drug|0|||
23730656|NCT01836549|66391881|FG006|Overall Study|Did not receive study drug|0|||
23730657|NCT01836549|66391875|FG000|Overall Study|Patient declared ineligible|0|||
23730658|NCT01836549|66391876|FG001|Overall Study|Patient declared ineligible|0|||
23730659|NCT01836549|66391877|FG002|Overall Study|Patient declared ineligible|0|||
23730660|NCT01836549|66391878|FG003|Overall Study|Patient declared ineligible|1|||
23730661|NCT01836549|66391879|FG004|Overall Study|Patient declared ineligible|0|||
23730662|NCT01836549|66391880|FG005|Overall Study|Patient declared ineligible|0|||
23730663|NCT01836549|66391881|FG006|Overall Study|Patient declared ineligible|0|||
23730664|NCT01836549|66391875|FG000|Overall Study|Patient inevaluable to start therapy|0|||
23730665|NCT01836549|66391876|FG001|Overall Study|Patient inevaluable to start therapy|0|||
23730666|NCT01836549|66391877|FG002|Overall Study|Patient inevaluable to start therapy|0|||
23730667|NCT01836549|66391878|FG003|Overall Study|Patient inevaluable to start therapy|0|||
23730668|NCT01836549|66391879|FG004|Overall Study|Patient inevaluable to start therapy|0|||
23730669|NCT01836549|66391880|FG005|Overall Study|Patient inevaluable to start therapy|0|||
23730670|NCT01836549|66391881|FG006|Overall Study|Patient inevaluable to start therapy|1|||
23730671|NCT00517634|66391882|FG000|Second Treatment Period|Withdrawal by Subject|0|||
23730672|NCT00517634|66391883|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23730673|NCT00517634|66391884|FG002|Second Treatment Period|Withdrawal by Subject|0|||
23730674|NCT00517634|66391885|FG003|Second Treatment Period|Withdrawal by Subject|0|||
23730675|NCT00517634|66391886|FG004|Second Treatment Period|Withdrawal by Subject|1|||
23730676|NCT00517634|66391887|FG005|Second Treatment Period|Withdrawal by Subject|0|||
23730677|NCT00378534|66391888|FG000|Overall Study|Participants did not receive transplant|3|||
23730678|NCT00378534|66391889|FG001|Overall Study|Participants did not receive transplant|0|||
23730679|NCT01602744|66391890|FG000|Overall Study|Death|17|||
23730680|NCT01602744|66391891|FG001|Overall Study|Death|15|||
23730681|NCT01602744|66391890|FG000|Overall Study|Lost to Follow-up|13|||
23730682|NCT01602744|66391891|FG001|Overall Study|Lost to Follow-up|8|||
23730683|NCT00608244|66391892|FG000|Overall Study|Adverse Event|1|||
23730684|NCT00608244|66391892|FG000|Overall Study|Low trough levels|1|||
23730685|NCT01326910|66391893|FG000|Overall Study|Withdrawal by Subject|3|||
23730686|NCT01326910|66391894|FG001|Overall Study|Withdrawal by Subject|2|||
23730687|NCT01326910|66391893|FG000|Overall Study|Protocol Violation|1|||
23730688|NCT01326910|66391894|FG001|Overall Study|Protocol Violation|1|||
23730689|NCT01424306|66391895|FG000|Overall Study|Protocol Violation|0|||
23730690|NCT01424306|66391896|FG001|Overall Study|Protocol Violation|0|||
23730691|NCT01424306|66391897|FG002|Overall Study|Protocol Violation|0|||
23730692|NCT01424306|66391898|FG003|Overall Study|Protocol Violation|0|||
23730693|NCT01424306|66391899|FG004|Overall Study|Protocol Violation|1|||
23730694|NCT01424306|66391900|FG005|Overall Study|Protocol Violation|0|||
23730695|NCT02355665|66391901|FG000|Overall Study|Adverse Event|16|||
23730696|NCT02355665|66391902|FG001|Overall Study|Adverse Event|24|||
23730697|NCT02355665|66391901|FG000|Overall Study|Protocol Violation|2|||
23730698|NCT02355665|66391902|FG001|Overall Study|Protocol Violation|0|||
23730699|NCT02355665|66391901|FG000|Overall Study|Withdrawal by Subject|90|||
23730700|NCT02355665|66391902|FG001|Overall Study|Withdrawal by Subject|100|||
23730701|NCT02355665|66391901|FG000|Overall Study|Lost to Follow-up|131|||
23730702|NCT02355665|66391902|FG001|Overall Study|Lost to Follow-up|103|||
23730703|NCT02355665|66391901|FG000|Overall Study|Death|4|||
23730704|NCT02355665|66391902|FG001|Overall Study|Death|2|||
23730705|NCT02355665|66391901|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
23730706|NCT02355665|66391902|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
23730707|NCT01572480|66391904|FG000|Participants Enrolled|Withdrawal by Subject|1|||
23730708|NCT01572480|66391904|FG000|Drug Administration|Discontinued drug/Off Study|1|||
23730709|NCT01572480|66391904|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
23730710|NCT01572480|66391904|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
23730711|NCT00998985|66391906|FG000|Overall Study|Withdrawal by Subject|0|||
23426024|NCT00106691|65303472|FG001|Overall Study|Pt. moved to another state|0|||
23426025|NCT00106691|65303471|FG000|Overall Study|Taking exclusionary avodart|1|||
23426026|NCT00106691|65303472|FG001|Overall Study|Taking exclusionary avodart|0|||
23730712|NCT00998985|66391907|FG001|Overall Study|Withdrawal by Subject|0|||
23730713|NCT00998985|66391908|FG002|Overall Study|Withdrawal by Subject|0|||
23730714|NCT00998985|66391909|FG003|Overall Study|Withdrawal by Subject|0|||
23426027|NCT00106691|65303471|FG000|Overall Study|Not able to discontinue plavix|0|||
23730715|NCT00998985|66391910|FG004|Overall Study|Withdrawal by Subject|0|||
23730716|NCT00998985|66391911|FG005|Overall Study|Withdrawal by Subject|0|||
23730717|NCT00998985|66391912|FG006|Overall Study|Withdrawal by Subject|0|||
23426028|NCT00106691|65303472|FG001|Overall Study|Not able to discontinue plavix|1|||
23730718|NCT00998985|66391913|FG007|Overall Study|Withdrawal by Subject|0|||
23730719|NCT00998985|66391914|FG008|Overall Study|Withdrawal by Subject|1|||
23730720|NCT00998985|66391915|FG009|Overall Study|Withdrawal by Subject|0|||
23730721|NCT00998985|66391916|FG010|Overall Study|Withdrawal by Subject|0|||
23730722|NCT00998985|66391917|FG011|Overall Study|Withdrawal by Subject|0|||
23730723|NCT00998985|66391918|FG012|Overall Study|Withdrawal by Subject|0|||
23730724|NCT00998985|66391919|FG013|Overall Study|Withdrawal by Subject|0|||
23730725|NCT00998985|66391906|FG000|Overall Study|Protocol Violation|0|||
23730726|NCT00998985|66391907|FG001|Overall Study|Protocol Violation|0|||
23730727|NCT00998985|66391908|FG002|Overall Study|Protocol Violation|0|||
23730728|NCT00998985|66391909|FG003|Overall Study|Protocol Violation|0|||
23730729|NCT00998985|66391910|FG004|Overall Study|Protocol Violation|0|||
23730730|NCT00998985|66391911|FG005|Overall Study|Protocol Violation|1|||
23730731|NCT00998985|66391912|FG006|Overall Study|Protocol Violation|0|||
23730732|NCT00998985|66391913|FG007|Overall Study|Protocol Violation|0|||
23730733|NCT00998985|66391914|FG008|Overall Study|Protocol Violation|0|||
23730734|NCT00998985|66391915|FG009|Overall Study|Protocol Violation|0|||
23730735|NCT00998985|66391916|FG010|Overall Study|Protocol Violation|0|||
23730736|NCT00998985|66391917|FG011|Overall Study|Protocol Violation|0|||
23730737|NCT00998985|66391918|FG012|Overall Study|Protocol Violation|0|||
23730738|NCT00998985|66391919|FG013|Overall Study|Protocol Violation|0|||
23730739|NCT00654368|66391921|FG000|Overall Study|Ineligibility determined|6|||
23730740|NCT00654368|66391922|FG001|Overall Study|Ineligibility determined|0|||
23730741|NCT00654368|66391923|FG002|Overall Study|Ineligibility determined|0|||
23730742|NCT00654368|66391921|FG000|Overall Study|Protocol deviation|3|||
23730743|NCT00654368|66391922|FG001|Overall Study|Protocol deviation|2|||
23730744|NCT00654368|66391923|FG002|Overall Study|Protocol deviation|1|||
23730745|NCT00654368|66391921|FG000|Overall Study|Non-compliance|2|||
23730746|NCT00654368|66391922|FG001|Overall Study|Non-compliance|1|||
23730747|NCT00654368|66391923|FG002|Overall Study|Non-compliance|2|||
23730748|NCT00654368|66391921|FG000|Overall Study|Withdrawal by Subject|5|||
23730749|NCT00654368|66391922|FG001|Overall Study|Withdrawal by Subject|2|||
23730750|NCT00654368|66391923|FG002|Overall Study|Withdrawal by Subject|2|||
23730751|NCT00654368|66391921|FG000|Overall Study|Disease progression|21|||
23730752|NCT00654368|66391922|FG001|Overall Study|Disease progression|31|||
23730753|NCT00654368|66391923|FG002|Overall Study|Disease progression|13|||
23730754|NCT00654368|66391921|FG000|Overall Study|Requirement for alternative therapy|1|||
23730755|NCT00654368|66391922|FG001|Overall Study|Requirement for alternative therapy|1|||
23730756|NCT00654368|66391923|FG002|Overall Study|Requirement for alternative therapy|1|||
23730757|NCT00654368|66391921|FG000|Overall Study|Physician Decision|0|||
23730758|NCT00654368|66391922|FG001|Overall Study|Physician Decision|0|||
23730759|NCT00654368|66391923|FG002|Overall Study|Physician Decision|2|||
23730760|NCT00654368|66391921|FG000|Overall Study|Death|1|||
23730761|NCT00654368|66391922|FG001|Overall Study|Death|0|||
23730762|NCT00654368|66391923|FG002|Overall Study|Death|0|||
23730763|NCT00654368|66391921|FG000|Overall Study|Pregnancy|0|||
23730764|NCT00654368|66391922|FG001|Overall Study|Pregnancy|0|||
23730765|NCT00654368|66391923|FG002|Overall Study|Pregnancy|2|||
23730766|NCT00654368|66391921|FG000|Overall Study|Other|0|||
23730767|NCT00654368|66391922|FG001|Overall Study|Other|2|||
23730768|NCT00654368|66391923|FG002|Overall Study|Other|3|||
23730769|NCT00654368|66391921|FG000|Overall Study|Adverse Event|14|||
23730770|NCT00654368|66391922|FG001|Overall Study|Adverse Event|9|||
23730771|NCT00654368|66391923|FG002|Overall Study|Adverse Event|6|||
23730772|NCT04476108|66391933|FG000|Overall Study|Adverse Event|4|||
23730773|NCT04476108|66391934|FG001|Overall Study|Adverse Event|1|||
23730774|NCT04476108|66391933|FG000|Overall Study|Lost to Follow-up|1|||
23730775|NCT04476108|66391934|FG001|Overall Study|Lost to Follow-up|0|||
23730776|NCT04476108|66391933|FG000|Overall Study|Inadvertent Enrollment|1|||
23730777|NCT04476108|66391934|FG001|Overall Study|Inadvertent Enrollment|0|||
23730778|NCT04476108|66391933|FG000|Overall Study|Protocol Violation|1|||
23543944|NCT01178853|65719983|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
23730779|NCT04476108|66391934|FG001|Overall Study|Protocol Violation|1|||
23730780|NCT04476108|66391933|FG000|Overall Study|Withdrawal by Subject|1|||
23730781|NCT04476108|66391934|FG001|Overall Study|Withdrawal by Subject|1|||
23730782|NCT03236506|66391938|FG000|Overall Study|Death|1|||
23730783|NCT03236506|66391939|FG001|Overall Study|Death|1|||
23730784|NCT03236506|66391940|FG002|Overall Study|Death|1|||
23730785|NCT03236506|66391938|FG000|Overall Study|Withdrawal by Subject|3|||
23730786|NCT03236506|66391939|FG001|Overall Study|Withdrawal by Subject|3|||
23730787|NCT03236506|66391940|FG002|Overall Study|Withdrawal by Subject|4|||
23730788|NCT03236506|66391938|FG000|Overall Study|Did not initiate treatment|2|||
23818073|NCT00143390|66714214|FG000|Overall Study|Withdrawal by Subject|4|||
23730789|NCT03236506|66391939|FG001|Overall Study|Did not initiate treatment|1|||
23730790|NCT03236506|66391940|FG002|Overall Study|Did not initiate treatment|2|||
23730791|NCT01369069|66391945|FG000|Overall Study|Lost to Follow-up|8|||
23730792|NCT01369069|66391946|FG001|Overall Study|Lost to Follow-up|9|||
23730793|NCT01369069|66391945|FG000|Overall Study|Withdrawal by Subject|9|||
23543945|NCT01178853|65719984|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
23543946|NCT01178853|65719983|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
23543947|NCT01178853|65719984|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
23543948|NCT01178853|65719983|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
23543949|NCT01178853|65719984|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
23730794|NCT01369069|66391946|FG001|Overall Study|Withdrawal by Subject|7|||
23730795|NCT01365091|66391947|FG000|Period 1|Adverse Event|1|||
23730796|NCT01365091|66391948|FG001|Period 1|Adverse Event|0|||
23730797|NCT01365091|66391949|FG002|Period 1|Adverse Event|2|||
23730798|NCT01365091|66391950|FG003|Period 1|Adverse Event|3|||
23730799|NCT01365091|66391947|FG000|Period 1|Positive test result for drugs of abuse|1|||
23730800|NCT01365091|66391948|FG001|Period 1|Positive test result for drugs of abuse|0|||
23730801|NCT01365091|66391949|FG002|Period 1|Positive test result for drugs of abuse|0|||
23730802|NCT01365091|66391950|FG003|Period 1|Positive test result for drugs of abuse|0|||
23730803|NCT01365091|66391947|FG000|Period 1|No longer met study criteria|0|||
23730804|NCT01365091|66391948|FG001|Period 1|No longer met study criteria|1|||
23730805|NCT01365091|66391949|FG002|Period 1|No longer met study criteria|0|||
23730806|NCT01365091|66391950|FG003|Period 1|No longer met study criteria|0|||
23730807|NCT01365091|66391947|FG000|Period 1|Withdrawal by Subject|0|||
23730808|NCT01365091|66391948|FG001|Period 1|Withdrawal by Subject|1|||
23730809|NCT01365091|66391949|FG002|Period 1|Withdrawal by Subject|0|||
23730810|NCT01365091|66391950|FG003|Period 1|Withdrawal by Subject|0|||
23730811|NCT01365091|66391947|FG000|Period 1|Personal reasons|0|||
23730812|NCT01365091|66391948|FG001|Period 1|Personal reasons|0|||
23730813|NCT01365091|66391949|FG002|Period 1|Personal reasons|1|||
23730814|NCT01365091|66391950|FG003|Period 1|Personal reasons|0|||
23543950|NCT01178853|65719983|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
23543951|NCT01178853|65719984|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
23543952|NCT00803634|65719988|FG000|Overall Study|Withdrew Consent|1|||
23543953|NCT00803634|65719989|FG001|Overall Study|Withdrew Consent|0|||
23543954|NCT00803634|65719988|FG000|Overall Study|Lost to Follow-up|2|||
23543955|NCT00803634|65719989|FG001|Overall Study|Lost to Follow-up|3|||
23543956|NCT00803634|65719988|FG000|Overall Study|Death|3|||
23543957|NCT00803634|65719989|FG001|Overall Study|Death|2|||
23730815|NCT01365091|66391947|FG000|Period 2|Withdrawal by Subject|1|||
23730816|NCT01365091|66391948|FG001|Period 2|Withdrawal by Subject|0|||
23730817|NCT01365091|66391949|FG002|Period 2|Withdrawal by Subject|0|||
23730818|NCT01365091|66391950|FG003|Period 2|Withdrawal by Subject|0|||
23730819|NCT01365091|66391947|FG000|Period 2|Adverse Event|0|||
23730820|NCT01365091|66391948|FG001|Period 2|Adverse Event|0|||
23730821|NCT01365091|66391949|FG002|Period 2|Adverse Event|1|||
23730822|NCT01365091|66391950|FG003|Period 2|Adverse Event|0|||
23730823|NCT01662986|66391951|FG000|Overall Study|Adverse Event|5|||
23730824|NCT01662986|66391952|FG001|Overall Study|Adverse Event|4|||
23730825|NCT01662986|66391951|FG000|Overall Study|Protocol Violation|2|||
23730826|NCT01662986|66391952|FG001|Overall Study|Protocol Violation|3|||
23730827|NCT01662986|66391951|FG000|Overall Study|Lost to Follow-up|5|||
23730828|NCT01662986|66391952|FG001|Overall Study|Lost to Follow-up|4|||
23730829|NCT01662986|66391951|FG000|Overall Study|Withdrawal by Subject|2|||
23730830|NCT01662986|66391952|FG001|Overall Study|Withdrawal by Subject|2|||
23730831|NCT01662986|66391951|FG000|Overall Study|Not Treated|1|||
23730832|NCT01662986|66391952|FG001|Overall Study|Not Treated|0|||
23730833|NCT01662986|66391951|FG000|Overall Study|Other than stated above|3|||
23730834|NCT01662986|66391952|FG001|Overall Study|Other than stated above|0|||
23730835|NCT03742271|66391957|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23730836|NCT03742271|66391957|FG000|Overall Study|Withdrawal by Subject|3|||
23730837|NCT03742271|66391957|FG000|Overall Study|Lost to Follow-up|4|||
23730838|NCT03742271|66391957|FG000|Overall Study|Failed Insertion & removal|3|||
23730839|NCT03742271|66391957|FG000|Overall Study|Protocol Violation|1|||
23730840|NCT03261037|66391961|FG000|Overall Study|Withdrawal by Subject|2|||
23730841|NCT03261037|66391962|FG001|Overall Study|Withdrawal by Subject|13|||
23730842|NCT03261037|66391963|FG002|Overall Study|Withdrawal by Subject|0|||
23730843|NCT03261037|66391964|FG003|Overall Study|Withdrawal by Subject|18|||
23730844|NCT03261037|66391961|FG000|Overall Study|Non-compliance with study procedures|0|||
23730845|NCT03261037|66391962|FG001|Overall Study|Non-compliance with study procedures|2|||
23730846|NCT03261037|66391963|FG002|Overall Study|Non-compliance with study procedures|0|||
23730847|NCT03261037|66391964|FG003|Overall Study|Non-compliance with study procedures|6|||
23730848|NCT03261037|66391961|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
23730849|NCT03261037|66391962|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
23730850|NCT03261037|66391963|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
23730851|NCT03261037|66391964|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
23543958|NCT04602624|65722940|FG000|Overall Study|Protocol Deviation|1|||
23543959|NCT04602624|65722940|FG000|Overall Study|Withdrawal by Participant|1|||
23543960|NCT01136291|65722945|FG000|Overall Study|Lost to Follow-up|1|||
23543961|NCT01136291|65722946|FG001|Overall Study|Lost to Follow-up|1|||
23730852|NCT03261037|66391961|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
23730853|NCT03261037|66391962|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
23730854|NCT03261037|66391963|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
23730855|NCT03261037|66391964|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
23730856|NCT03261037|66391961|FG000|Overall Study|Diagnosed but protocol deviation|1|||
23730857|NCT03261037|66391962|FG001|Overall Study|Diagnosed but protocol deviation|0|||
23730858|NCT03261037|66391963|FG002|Overall Study|Diagnosed but protocol deviation|0|||
23730859|NCT03261037|66391964|FG003|Overall Study|Diagnosed but protocol deviation|0|||
23730860|NCT03261037|66391961|FG000|Overall Study|Participant did not want to continue the study|0|||
23730861|NCT03261037|66391962|FG001|Overall Study|Participant did not want to continue the study|1|||
23730862|NCT03261037|66391963|FG002|Overall Study|Participant did not want to continue the study|0|||
23730863|NCT03261037|66391964|FG003|Overall Study|Participant did not want to continue the study|0|||
23730864|NCT03261037|66391961|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23730865|NCT03261037|66391962|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23730866|NCT03261037|66391963|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23730867|NCT03261037|66391964|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
23730868|NCT03261037|66391961|FG000|Overall Study|Participant presented clinical improvement|0|||
23730869|NCT03261037|66391962|FG001|Overall Study|Participant presented clinical improvement|2|||
23426029|NCT00526110|65303473|FG000|Overall Study|Adverse Event|2|||
23426030|NCT00526110|65303474|FG001|Overall Study|Adverse Event|9|||
23426031|NCT00526110|65303473|FG000|Overall Study|Disease Progression|0|||
23426032|NCT00526110|65303474|FG001|Overall Study|Disease Progression|19|||
23543962|NCT04154787|65722947|FG000|Overall Study|Adverse Event|0|||
23543963|NCT04154787|65722948|FG001|Overall Study|Adverse Event|1|||
23543964|NCT04154787|65722949|FG002|Overall Study|Adverse Event|0|||
23543965|NCT04154787|65722947|FG000|Overall Study|Patient Requires Other Treatment|0|||
23543966|NCT04154787|65722948|FG001|Overall Study|Patient Requires Other Treatment|1|||
23543967|NCT04154787|65722949|FG002|Overall Study|Patient Requires Other Treatment|0|||
23543968|NCT04154787|65722947|FG000|Overall Study|Study Terminated By Sponsor|0|||
23617313|NCT00168805|65985139|FG000|Overall Study|Adverse Event|7|||
23543969|NCT04154787|65722948|FG001|Overall Study|Study Terminated By Sponsor|6|||
23543970|NCT04154787|65722949|FG002|Overall Study|Study Terminated By Sponsor|1|||
23543971|NCT04154787|65722947|FG000|Overall Study|Subject Decision|0|||
23543972|NCT04154787|65722948|FG001|Overall Study|Subject Decision|1|||
23543973|NCT04154787|65722949|FG002|Overall Study|Subject Decision|0|||
23543974|NCT04154787|65722947|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
23543975|NCT04154787|65722948|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
23543976|NCT04154787|65722949|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
23543977|NCT00253864|65722950|FG000|Overall Study|Lost to Follow-up|5|||
23543978|NCT00253864|65722951|FG001|Overall Study|Lost to Follow-up|8|||
23543979|NCT02286089|65722954|FG000|Overall Study|Ongoing in Study|1|||
23543980|NCT02286089|65722955|FG001|Overall Study|Ongoing in Study|1|||
23543981|NCT02286089|65722956|FG002|Overall Study|Ongoing in Study|4|||
23543982|NCT02286089|65722957|FG003|Overall Study|Ongoing in Study|10|||
23543983|NCT02286089|65722954|FG000|Overall Study|Withdrawal by Subject|0|||
23543984|NCT02286089|65722955|FG001|Overall Study|Withdrawal by Subject|0|||
23543985|NCT02286089|65722956|FG002|Overall Study|Withdrawal by Subject|2|||
23543986|NCT02286089|65722957|FG003|Overall Study|Withdrawal by Subject|2|||
23543987|NCT00823719|65722958|FG000|Overall Study|Adverse Event|1|||
23543988|NCT00823719|65722959|FG001|Overall Study|Adverse Event|2|||
23543989|NCT00823719|65722958|FG000|Overall Study|Physician Decision|1|||
23543990|NCT00823719|65722959|FG001|Overall Study|Physician Decision|4|||
23543991|NCT00823719|65722958|FG000|Overall Study|Withdrawal by Subject|0|||
23543992|NCT00823719|65722959|FG001|Overall Study|Withdrawal by Subject|1|||
23543993|NCT00823719|65722958|FG000|Overall Study|Disease Progression|4|||
23543994|NCT00823719|65722959|FG001|Overall Study|Disease Progression|4|||
23543995|NCT00796718|65722960|FG000|Overall Study|Adverse Event|2|||
23543996|NCT00796718|65722960|FG000|Overall Study|Exclusion Criteria|1|||
23543997|NCT00796718|65722960|FG000|Overall Study|Lost to Follow-up|5|||
23543998|NCT00796718|65722960|FG000|Overall Study|Withdrawal by Informed Consent|1|||
23543999|NCT03794089|65722962|FG000|Overall Study|Lost to Follow-up|4|||
23544000|NCT03794089|65722963|FG001|Overall Study|Lost to Follow-up|1|||
23544001|NCT03794089|65722962|FG000|Overall Study|Withdrawal by Subject|2|||
23544002|NCT03794089|65722963|FG001|Overall Study|Withdrawal by Subject|0|||
23544003|NCT00993447|65722966|FG000|Overall Study|Withdrawal by Subject|23|||
23544004|NCT00993447|65722967|FG001|Overall Study|Withdrawal by Subject|8|||
23544005|NCT00993447|65722966|FG000|Overall Study|Protocol Violation|12|||
23544006|NCT00993447|65722967|FG001|Overall Study|Protocol Violation|8|||
23544007|NCT00993447|65722966|FG000|Overall Study|Lost to Follow-up|1|||
23544008|NCT00993447|65722967|FG001|Overall Study|Lost to Follow-up|3|||
23544009|NCT00993447|65722966|FG000|Overall Study|Adverse Event|1|||
23544010|NCT00993447|65722967|FG001|Overall Study|Adverse Event|0|||
23544011|NCT00680407|65722968|FG000|Overall Study|Lost to Follow-up|3|||
23544012|NCT00680407|65722969|FG001|Overall Study|Lost to Follow-up|3|||
23544013|NCT00680407|65722970|FG002|Overall Study|Lost to Follow-up|1|||
23544014|NCT00680407|65722968|FG000|Overall Study|Withdrawal by Subject|5|||
23730870|NCT03261037|66391963|FG002|Overall Study|Participant presented clinical improvement|0|||
23730871|NCT03261037|66391964|FG003|Overall Study|Participant presented clinical improvement|0|||
23730872|NCT03261037|66391961|FG000|Overall Study|Technical difficulties|0|||
23426033|NCT00526110|65303473|FG000|Overall Study|Maximal Response|0|||
23426034|NCT00526110|65303474|FG001|Overall Study|Maximal Response|6|||
23426035|NCT00526110|65303473|FG000|Overall Study|Withdrawal by Subject|0|||
23617314|NCT00168805|65985140|FG001|Overall Study|Adverse Event|11|||
23730873|NCT03261037|66391962|FG001|Overall Study|Technical difficulties|0|||
23730874|NCT03261037|66391963|FG002|Overall Study|Technical difficulties|0|||
23730875|NCT03261037|66391964|FG003|Overall Study|Technical difficulties|1|||
23730876|NCT03261037|66391961|FG000|Overall Study|Equipment failed to work|0|||
23730877|NCT03261037|66391962|FG001|Overall Study|Equipment failed to work|0|||
23730878|NCT03261037|66391963|FG002|Overall Study|Equipment failed to work|0|||
23730879|NCT03261037|66391964|FG003|Overall Study|Equipment failed to work|1|||
23730880|NCT03261037|66391961|FG000|Overall Study|End of study for participant and no follow up|0|||
23730881|NCT03261037|66391962|FG001|Overall Study|End of study for participant and no follow up|0|||
23730882|NCT03261037|66391963|FG002|Overall Study|End of study for participant and no follow up|0|||
23730883|NCT03261037|66391964|FG003|Overall Study|End of study for participant and no follow up|1|||
23730884|NCT03261037|66391961|FG000|Overall Study|Participant was too weak to continue in study|1|||
23730885|NCT03261037|66391962|FG001|Overall Study|Participant was too weak to continue in study|0|||
23730886|NCT03261037|66391963|FG002|Overall Study|Participant was too weak to continue in study|0|||
23730887|NCT03261037|66391964|FG003|Overall Study|Participant was too weak to continue in study|0|||
23730888|NCT01809691|66391965|FG000|Overall Study|Currently on Treatment|192|||
23730889|NCT01809691|66391966|FG001|Overall Study|Currently on Treatment|100|||
23730890|NCT01809691|66391965|FG000|Overall Study|No Protocol Treatment|10|||
23730891|NCT01809691|66391966|FG001|Overall Study|No Protocol Treatment|11|||
23730892|NCT01809691|66391965|FG000|Overall Study|Adverse Event|80|||
23730893|NCT01809691|66391966|FG001|Overall Study|Adverse Event|21|||
23730894|NCT01809691|66391965|FG000|Overall Study|Disease Progression|226|||
23730895|NCT01809691|66391966|FG001|Overall Study|Disease Progression|372|||
23730896|NCT01809691|66391965|FG000|Overall Study|Death|26|||
23730897|NCT01809691|66391966|FG001|Overall Study|Death|13|||
23730898|NCT01809691|66391965|FG000|Overall Study|Participant Refusal|70|||
23730899|NCT01809691|66391966|FG001|Overall Study|Participant Refusal|72|||
23730900|NCT01809691|66391965|FG000|Overall Study|Other, Not Specified|34|||
23730901|NCT01809691|66391966|FG001|Overall Study|Other, Not Specified|52|||
23730902|NCT01440972|66391967|FG000|Overall Study|Withdrawal by Subject|3|||
23730903|NCT01440972|66391968|FG001|Overall Study|Withdrawal by Subject|2|||
23730904|NCT02520141|66391970|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
23730905|NCT01867580|66391971|FG000|Overall Study|Withdrawal by Subject|2|||
23730906|NCT01867580|66391972|FG001|Overall Study|Withdrawal by Subject|3|||
23730907|NCT01867580|66391971|FG000|Overall Study|Physician Decision|17|||
23730908|NCT01867580|66391972|FG001|Overall Study|Physician Decision|12|||
23730909|NCT01867580|66391971|FG000|Overall Study|Lost to Follow-up|3|||
23730910|NCT01867580|66391972|FG001|Overall Study|Lost to Follow-up|5|||
23730911|NCT01867580|66391971|FG000|Overall Study|Sponsor terminated study|1|||
23730912|NCT01867580|66391972|FG001|Overall Study|Sponsor terminated study|0|||
23730913|NCT01867580|66391971|FG000|Overall Study|Missed follow-up assessment|2|||
23730914|NCT01867580|66391972|FG001|Overall Study|Missed follow-up assessment|1|||
23730915|NCT01867580|66391971|FG000|Overall Study|Interruption to therapy|3|||
23730916|NCT01867580|66391972|FG001|Overall Study|Interruption to therapy|0|||
23730917|NCT01867580|66391971|FG000|Overall Study|Osteomyelitis|0|||
23730918|NCT01867580|66391972|FG001|Overall Study|Osteomyelitis|1|||
23730919|NCT01867580|66391971|FG000|Overall Study|Continuation of therapy|0|||
23730920|NCT01867580|66391972|FG001|Overall Study|Continuation of therapy|1|||
23730921|NCT01867580|66391971|FG000|Overall Study|Wound recurrence|0|||
23730922|NCT01867580|66391972|FG001|Overall Study|Wound recurrence|1|||
23730923|NCT01624974|66391974|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
23730924|NCT01624974|66391975|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
23730925|NCT01624974|66391974|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
23730926|NCT01624974|66391975|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
23730927|NCT01624974|66391974|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
23730928|NCT01624974|66391975|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
23730929|NCT01624974|66391974|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
23730930|NCT01624974|66391975|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
23730931|NCT01624974|66391974|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
23730932|NCT01624974|66391975|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
23730933|NCT01624974|66391974|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
23730934|NCT01624974|66391975|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
23730935|NCT01624974|66391974|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
23617315|NCT00168805|65985141|FG002|Overall Study|Adverse Event|16|||
23730936|NCT01624974|66391975|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
23730937|NCT01624974|66391974|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
23730938|NCT01624974|66391975|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
23730939|NCT01624974|66391974|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
23730940|NCT01624974|66391975|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
23730941|NCT01624974|66391974|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
23730942|NCT01624974|66391975|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
23730943|NCT01624974|66391974|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
23730944|NCT01624974|66391975|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
23730945|NCT01624974|66391974|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
23730946|NCT01624974|66391975|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
23730947|NCT01192100|66391989|FG000|Overall Study|Withdrawal by Subject|0|||
23730948|NCT01192100|66391990|FG001|Overall Study|Withdrawal by Subject|0|||
23730949|NCT01192100|66391991|FG002|Overall Study|Withdrawal by Subject|0|||
23730950|NCT01192100|66391992|FG003|Overall Study|Withdrawal by Subject|0|||
23730951|NCT01192100|66391993|FG004|Overall Study|Withdrawal by Subject|1|||
23730952|NCT01192100|66391994|FG005|Overall Study|Withdrawal by Subject|0|||
23730953|NCT01192100|66391989|FG000|Overall Study|Protocol Violation|0|||
23730954|NCT01192100|66391990|FG001|Overall Study|Protocol Violation|0|||
23730955|NCT01192100|66391991|FG002|Overall Study|Protocol Violation|0|||
23730956|NCT01192100|66391992|FG003|Overall Study|Protocol Violation|1|||
23730957|NCT01192100|66391993|FG004|Overall Study|Protocol Violation|0|||
23730958|NCT01192100|66391994|FG005|Overall Study|Protocol Violation|0|||
23730959|NCT00528840|66391995|FG000|Overall Study|Lost to Follow-up|10|||
23730960|NCT00528840|66391995|FG000|Overall Study|Adverse Event|1|||
23730961|NCT00528840|66391995|FG000|Overall Study|Withdrawal by Subject|17|||
23730962|NCT00528840|66391995|FG000|Overall Study|Death|2|||
23730963|NCT00528840|66391995|FG000|Overall Study|Administrative Reasons|1|||
23730964|NCT00528840|66391995|FG000|Overall Study|Other|2|||
23730965|NCT04432376|66391996|FG000|Double-blind Treatment Period|Adverse Event|2|||
23730966|NCT04432376|66391997|FG001|Double-blind Treatment Period|Adverse Event|6|||
23730967|NCT04432376|66391998|FG002|Double-blind Treatment Period|Adverse Event|0|||
23730968|NCT04432376|66391996|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
23730969|NCT04432376|66391997|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23730970|NCT04432376|66391998|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23730971|NCT04432376|66391996|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23730972|NCT04432376|66391997|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23730973|NCT04432376|66391998|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23730974|NCT04432376|66391996|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23730975|NCT04432376|66391997|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23730976|NCT04432376|66391998|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23730977|NCT04432376|66391996|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
23544015|NCT00680407|65722969|FG001|Overall Study|Withdrawal by Subject|2|||
23544016|NCT00680407|65722970|FG002|Overall Study|Withdrawal by Subject|2|||
23544017|NCT00023673|65722971|FG000|Overall Study|Ineligible / no protocol treatment|0|||
23544018|NCT00023673|65722972|FG001|Overall Study|Ineligible / no protocol treatment|0|||
23544019|NCT00023673|65722973|FG002|Overall Study|Ineligible / no protocol treatment|0|||
23544020|NCT00023673|65722974|FG003|Overall Study|Ineligible / no protocol treatment|1|||
23544021|NCT00023673|65722971|FG000|Overall Study|Patient withdrew consent|0|||
23544022|NCT00023673|65722972|FG001|Overall Study|Patient withdrew consent|0|||
23544023|NCT00023673|65722973|FG002|Overall Study|Patient withdrew consent|0|||
23544024|NCT00023673|65722974|FG003|Overall Study|Patient withdrew consent|1|||
23544025|NCT02207829|65722975|FG000|Overall Study|Adverse Event|10|||
23544026|NCT02207829|65722976|FG001|Overall Study|Adverse Event|9|||
23544027|NCT02207829|65722975|FG000|Overall Study|Lack of Efficacy|7|||
23544028|NCT02207829|65722976|FG001|Overall Study|Lack of Efficacy|5|||
23544029|NCT02207829|65722975|FG000|Overall Study|Lost to Follow-up|2|||
23544030|NCT02207829|65722976|FG001|Overall Study|Lost to Follow-up|2|||
23544031|NCT02207829|65722975|FG000|Overall Study|Protocol deviation|5|||
23544032|NCT02207829|65722976|FG001|Overall Study|Protocol deviation|4|||
23544033|NCT02207829|65722975|FG000|Overall Study|Withdrew consent|18|||
23544034|NCT02207829|65722976|FG001|Overall Study|Withdrew consent|14|||
23730978|NCT04432376|66391997|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
23730979|NCT04432376|66391998|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
23544035|NCT01303627|65722977|FG000|Overall Study|the failure while performing URS|0|||
23544036|NCT01303627|65722978|FG001|Overall Study|the failure while performing URS|1|||
23544037|NCT00353704|65722979|FG000|Overall Study|Protocol Violation|3|||
23544038|NCT00353704|65722980|FG001|Overall Study|Protocol Violation|1|||
23426036|NCT00526110|65303474|FG001|Overall Study|Withdrawal by Subject|2|||
23426037|NCT00526110|65303473|FG000|Overall Study|Poor Tolerance|0|||
23544039|NCT02328326|65722983|FG000|Overall Study|Withdrawal by Subject|10|||
23544040|NCT02328326|65722984|FG001|Overall Study|Withdrawal by Subject|3|||
23544041|NCT02328326|65722983|FG000|Overall Study|Death|2|||
23544042|NCT02328326|65722984|FG001|Overall Study|Death|1|||
23544043|NCT02328326|65722983|FG000|Overall Study|Lost to Follow-up|10|||
23544044|NCT02328326|65722984|FG001|Overall Study|Lost to Follow-up|4|||
23730980|NCT00410514|66391999|FG000|Overall Study|Adverse Event|2|||
23730981|NCT00410514|66392000|FG001|Overall Study|Adverse Event|2|||
23730982|NCT00410514|66392001|FG002|Overall Study|Adverse Event|2|||
23730983|NCT00410514|66391999|FG000|Overall Study|Protocol Violation|0|||
23730984|NCT00410514|66392000|FG001|Overall Study|Protocol Violation|1|||
23730985|NCT00410514|66392001|FG002|Overall Study|Protocol Violation|1|||
23730986|NCT00410514|66391999|FG000|Overall Study|Lost to Follow-up|0|||
23730987|NCT00410514|66392000|FG001|Overall Study|Lost to Follow-up|0|||
23730988|NCT00410514|66392001|FG002|Overall Study|Lost to Follow-up|2|||
23730989|NCT00410514|66391999|FG000|Overall Study|Non-compliant with study procedures|0|||
23730990|NCT00410514|66392000|FG001|Overall Study|Non-compliant with study procedures|0|||
23730991|NCT00410514|66392001|FG002|Overall Study|Non-compliant with study procedures|2|||
23730992|NCT02886338|66392004|FG000|Overall Study|Withdrawal by Subject|1|||
23730993|NCT01642004|66392005|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23730994|NCT01642004|66392006|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23730995|NCT01642004|66392005|FG000|Randomization|Participant withdrew consent|1|||
23730996|NCT01642004|66392006|FG001|Randomization|Participant withdrew consent|6|||
23730997|NCT01642004|66392005|FG000|Randomization|No longer meets study criteria|2|||
23730998|NCT01642004|66392006|FG001|Randomization|No longer meets study criteria|2|||
23730999|NCT01642004|66392005|FG000|Treatment|Disease progression|95|||
23731000|NCT01642004|66392006|FG001|Treatment|Disease progression|79|||
23731001|NCT01642004|66392005|FG000|Treatment|Study drug toxicity|10|||
23731002|NCT01642004|66392006|FG001|Treatment|Study drug toxicity|13|||
23731003|NCT01642004|66392005|FG000|Treatment|Death|1|||
23731004|NCT01642004|66392006|FG001|Treatment|Death|1|||
23426038|NCT00526110|65303474|FG001|Overall Study|Poor Tolerance|5|||
23426039|NCT02419131|65303478|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
23426040|NCT02419131|65303479|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
23426041|NCT02419131|65303480|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
23426042|NCT02419131|65303478|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
23426043|NCT02419131|65303479|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
23426044|NCT02419131|65303480|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
23426045|NCT02744612|65303489|FG000|Overall Study|Withdrawal by Subject|0|||
23426046|NCT02744612|65303490|FG001|Overall Study|Withdrawal by Subject|2|||
23426047|NCT03943550|65303491|FG000|Overall Study|Adverse Event|0|||
23426048|NCT03943550|65303492|FG001|Overall Study|Adverse Event|0|||
23426049|NCT03943550|65303493|FG002|Overall Study|Adverse Event|1|||
23426050|NCT03943550|65303491|FG000|Overall Study|Lost to Follow-up|0|||
23426051|NCT03943550|65303492|FG001|Overall Study|Lost to Follow-up|0|||
23426052|NCT03943550|65303493|FG002|Overall Study|Lost to Follow-up|1|||
23426053|NCT03943550|65303491|FG000|Overall Study|Progressive Disease|0|||
23426054|NCT03943550|65303492|FG001|Overall Study|Progressive Disease|0|||
23426055|NCT03943550|65303493|FG002|Overall Study|Progressive Disease|2|||
23426056|NCT03943550|65303491|FG000|Overall Study|Participant Moved Out of the Country|0|||
23426057|NCT03943550|65303492|FG001|Overall Study|Participant Moved Out of the Country|1|||
23426058|NCT03943550|65303493|FG002|Overall Study|Participant Moved Out of the Country|0|||
23426059|NCT00590824|65303496|FG000|Overall Study|Disease could not be resected|0|||
23426060|NCT00590824|65303497|FG001|Overall Study|Disease could not be resected|2|||
23426061|NCT00590824|65303498|FG002|Overall Study|Disease could not be resected|1|||
23426062|NCT00590824|65303499|FG003|Overall Study|Disease could not be resected|0|||
23426063|NCT00590824|65303496|FG000|Overall Study|Adverse Event|0|||
23426064|NCT00590824|65303497|FG001|Overall Study|Adverse Event|0|||
23426065|NCT00590824|65303498|FG002|Overall Study|Adverse Event|0|||
23426066|NCT00590824|65303499|FG003|Overall Study|Adverse Event|1|||
23426067|NCT02650128|65303500|FG000|Overall Study|Death|2|||
23544045|NCT02007577|65722985|FG000|Overall Study|Adverse Event|1|||
23544046|NCT02007577|65722986|FG001|Overall Study|Adverse Event|0|||
23731005|NCT01642004|66392005|FG000|Treatment|Adverse event unrelated to study drug|9|||
23731006|NCT01642004|66392006|FG001|Treatment|Adverse event unrelated to study drug|13|||
23731007|NCT01642004|66392005|FG000|Treatment|Maximum clinical benefit|1|||
23731008|NCT01642004|66392006|FG001|Treatment|Maximum clinical benefit|9|||
23731009|NCT01642004|66392005|FG000|Treatment|Poor/non-compliance|1|||
23731010|NCT01642004|66392006|FG001|Treatment|Poor/non-compliance|0|||
23731011|NCT01642004|66392005|FG000|Treatment|No longer meets study criteria|1|||
23731012|NCT01642004|66392006|FG001|Treatment|No longer meets study criteria|2|||
23426068|NCT03002623|65303501|FG000|Overall Study|Lost to Follow-up|1|||
23617316|NCT00168805|65985139|FG000|Overall Study|Protocol Violation|12|||
23617317|NCT00168805|65985140|FG001|Overall Study|Protocol Violation|11|||
23617318|NCT00168805|65985141|FG002|Overall Study|Protocol Violation|8|||
23617319|NCT00168805|65985139|FG000|Overall Study|Lost to Follow-up|12|||
23617320|NCT00168805|65985140|FG001|Overall Study|Lost to Follow-up|17|||
23617321|NCT00168805|65985141|FG002|Overall Study|Lost to Follow-up|11|||
23617322|NCT00168805|65985139|FG000|Overall Study|Withdrawal by Subject|16|||
23731013|NCT01642004|66392005|FG000|Treatment|Other reasons|2|||
23731014|NCT01642004|66392006|FG001|Treatment|Other reasons|0|||
23731015|NCT01642004|66392005|FG000|Treatment|Not reported|0|||
23731016|NCT01642004|66392006|FG001|Treatment|Not reported|3|||
23818074|NCT00143390|66714215|FG001|Overall Study|Withdrawal by Subject|4|||
23617323|NCT00168805|65985140|FG001|Overall Study|Withdrawal by Subject|18|||
23731017|NCT01642004|66392005|FG000|Treatment|Participant request to discontinue study treatment|6|||
23544047|NCT02007577|65722985|FG000|Overall Study|Withdrawal by Subject|0|||
23544048|NCT02007577|65722986|FG001|Overall Study|Withdrawal by Subject|1|||
23544049|NCT01329029|65722987|FG000|Overall Study|Withdrawal by Subject|117|||
23544050|NCT01329029|65722988|FG001|Overall Study|Withdrawal by Subject|87|||
23544051|NCT01329029|65722987|FG000|Overall Study|Adverse Event|82|||
23544052|NCT01329029|65722988|FG001|Overall Study|Adverse Event|29|||
23426069|NCT03002623|65303502|FG001|Overall Study|Lost to Follow-up|0|||
23544053|NCT01329029|65722987|FG000|Overall Study|Death|16|||
23544054|NCT01329029|65722988|FG001|Overall Study|Death|19|||
23544055|NCT01329029|65722987|FG000|Overall Study|Other|14|||
23544056|NCT01329029|65722988|FG001|Overall Study|Other|20|||
23544057|NCT01329029|65722987|FG000|Overall Study|COPD Exacerbation|11|||
23544058|NCT01329029|65722988|FG001|Overall Study|COPD Exacerbation|18|||
23544059|NCT01329029|65722987|FG000|Overall Study|Physician Decision|16|||
23544060|NCT01329029|65722988|FG001|Overall Study|Physician Decision|13|||
23544061|NCT01329029|65722987|FG000|Overall Study|Lost to Follow-up|8|||
23544062|NCT01329029|65722988|FG001|Overall Study|Lost to Follow-up|5|||
23544063|NCT01329029|65722987|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
23426070|NCT03002623|65303501|FG000|Overall Study|Physician Decision|1|||
23544064|NCT01329029|65722988|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
23544065|NCT00833989|65722989|FG000|Overall Study|Physician Decision|0|||
23544066|NCT00833989|65722990|FG001|Overall Study|Physician Decision|0|||
23544067|NCT00833989|65722991|FG002|Overall Study|Physician Decision|0|||
23426071|NCT03002623|65303502|FG001|Overall Study|Physician Decision|1|||
23426072|NCT01697462|65303508|FG000|Overall Study|Disease Progression|1|||
23426073|NCT01697462|65303508|FG000|Overall Study|Adverse Event|6|||
23426074|NCT01697462|65303508|FG000|Overall Study|Lost to Follow-up|21|||
23426075|NCT01697462|65303508|FG000|Overall Study|Withdrawal by Subject|12|||
23731018|NCT01642004|66392006|FG001|Treatment|Participant request to discontinue study treatment|4|||
23731019|NCT01642004|66392005|FG000|Treatment|Participant withdrew consent|5|||
23731020|NCT01642004|66392006|FG001|Treatment|Participant withdrew consent|5|||
23731021|NCT00957723|66392015|FG000|Overall Study|Death|3|||
23731022|NCT00957723|66392015|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
23731023|NCT00957723|66392015|FG000|Overall Study|Lost to Follow-up|8|||
23731024|NCT00957723|66392015|FG000|Overall Study|Withdrawal by Subject|24|||
23731025|NCT00957723|66392015|FG000|Overall Study|Investigative Site Terminated|61|||
23818075|NCT00143390|66714214|FG000|Overall Study|Progressive disease|119|||
23818076|NCT00143390|66714215|FG001|Overall Study|Progressive disease|115|||
23818077|NCT00143390|66714214|FG000|Overall Study|Protocol Violation|2|||
23818078|NCT00143390|66714215|FG001|Overall Study|Protocol Violation|0|||
23818079|NCT00143390|66714214|FG000|Overall Study|Study termination|10|||
23818080|NCT00143390|66714215|FG001|Overall Study|Study termination|15|||
23818081|NCT00143390|66714214|FG000|Overall Study|Adverse Event|9|||
23818082|NCT00143390|66714215|FG001|Overall Study|Adverse Event|8|||
23818083|NCT00143390|66714214|FG000|Overall Study|Other|1|||
23818084|NCT00143390|66714215|FG001|Overall Study|Other|2|||
23818085|NCT02759692|66714217|FG000|Period 1|Test article no longer available|1|||
23818086|NCT02759692|66714218|FG001|Period 1|Test article no longer available|1|||
23818087|NCT02759692|66714217|FG000|Period 1|No longer meets eligibility criteria.|1|||
23818088|NCT02759692|66714218|FG001|Period 1|No longer meets eligibility criteria.|0|||
23818089|NCT02759692|66714217|FG000|Period 1|Miss-Randomized|1|||
23818090|NCT02759692|66714218|FG001|Period 1|Miss-Randomized|1|||
23818091|NCT02759692|66714217|FG000|Period 2|Lost to Follow-up|1|||
23818092|NCT02759692|66714218|FG001|Period 2|Lost to Follow-up|0|||
23818093|NCT02759692|66714217|FG000|Period 2|Test article no longer available|0|||
23818094|NCT02759692|66714218|FG001|Period 2|Test article no longer available|1|||
23818095|NCT02125877|66714222|FG000|Overall Study|Physician Decision|1|||
23818096|NCT02125877|66714223|FG001|Overall Study|Physician Decision|0|||
23818097|NCT02125877|66714222|FG000|Overall Study|Death|0|||
23818098|NCT02125877|66714223|FG001|Overall Study|Death|1|||
23818099|NCT02125877|66714222|FG000|Overall Study|Administrative problems|0|||
23818100|NCT02125877|66714223|FG001|Overall Study|Administrative problems|1|||
23818101|NCT02125877|66714222|FG000|Overall Study|Participant/guardian decision|0|||
23818102|NCT02125877|66714223|FG001|Overall Study|Participant/guardian decision|2|||
23426076|NCT01697462|65303508|FG000|Overall Study|Investigator Decision|21|||
23818103|NCT02125877|66714222|FG000|Overall Study|Withdrawal by Subject|2|||
23818104|NCT02125877|66714223|FG001|Overall Study|Withdrawal by Subject|1|||
23818105|NCT02125877|66714222|FG000|Overall Study|Protocol deviation|4|||
23818106|NCT02125877|66714223|FG001|Overall Study|Protocol deviation|1|||
23426077|NCT01697462|65303508|FG000|Overall Study|Death|1|||
23426078|NCT01697462|65303508|FG000|Overall Study|Other|10|||
23818107|NCT02125877|66714222|FG000|Overall Study|Adverse Event|6|||
23426079|NCT01697462|65303508|FG000|Overall Study|Missing|5|||
23731026|NCT00957723|66392015|FG000|Overall Study|Intercurrent Illness|2|||
23731027|NCT00957723|66392015|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
23731028|NCT00403390|66392016|FG000|Overall Study|Withdrawal by Subject|1|||
23731029|NCT00403390|66392017|FG001|Overall Study|Withdrawal by Subject|0|||
23426080|NCT00875056|65303511|FG000|Overall Study|Adverse Event|6|||
23426081|NCT00875056|65303512|FG001|Overall Study|Adverse Event|1|||
23731030|NCT00403390|66392016|FG000|Overall Study|samples lost|1|||
23731031|NCT00403390|66392017|FG001|Overall Study|samples lost|0|||
23731032|NCT00403390|66392016|FG000|Overall Study|non-compliant|1|||
23731033|NCT00403390|66392017|FG001|Overall Study|non-compliant|0|||
23731034|NCT02513394|66392018|FG000|Overall Study|Withdrawal by Subject|11|||
23731035|NCT02513394|66392019|FG001|Overall Study|Withdrawal by Subject|23|||
23731036|NCT02513394|66392018|FG000|Overall Study|Ineligible|1|||
23731037|NCT02513394|66392019|FG001|Overall Study|Ineligible|0|||
23731038|NCT00122317|66392020|FG000|Overall Study|Death|3|||
23731039|NCT00122317|66392020|FG000|Overall Study|Adverse Event|4|||
23731040|NCT00122317|66392020|FG000|Overall Study|Physician Decision|2|||
23731041|NCT00122317|66392020|FG000|Overall Study|patient non-compliance|1|||
23731042|NCT00122317|66392020|FG000|Overall Study|Withdrawal by Subject|1|||
23731043|NCT00589602|66392024|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
23544068|NCT00833989|65722992|FG003|Overall Study|Physician Decision|1|||
23544069|NCT00833989|65722989|FG000|Overall Study|Withdrawal by Subject|3|||
23544070|NCT00833989|65722990|FG001|Overall Study|Withdrawal by Subject|0|||
23544071|NCT00833989|65722991|FG002|Overall Study|Withdrawal by Subject|1|||
23544072|NCT00833989|65722992|FG003|Overall Study|Withdrawal by Subject|1|||
23544073|NCT02896855|65722993|FG000|Overall Study|Death|50|||
23544074|NCT02896855|65722994|FG001|Overall Study|Death|40|||
23544075|NCT02896855|65722993|FG000|Overall Study|Lost to Follow-up|15|||
23544076|NCT02896855|65722994|FG001|Overall Study|Lost to Follow-up|9|||
23544077|NCT02896855|65722993|FG000|Overall Study|Withdrawal by Subject|7|||
23544078|NCT02896855|65722994|FG001|Overall Study|Withdrawal by Subject|4|||
23731044|NCT00372489|66392026|FG000|Overall Study|Adverse Event|18|||
23731045|NCT00372489|66392026|FG000|Overall Study|Lack of Efficacy|1|||
23731046|NCT00372489|66392026|FG000|Overall Study|Lost to Follow-up|3|||
23731047|NCT00372489|66392026|FG000|Overall Study|Physician Decision|3|||
23731048|NCT00372489|66392026|FG000|Overall Study|Withdrawal by Subject|5|||
23731049|NCT00372489|66392026|FG000|Overall Study|Patient Relocation|2|||
23731050|NCT00372489|66392026|FG000|Overall Study|Renal transplant|6|||
23731051|NCT00372489|66392026|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
23731052|NCT00981292|66392027|FG000|Day 1|Protocol Violation|1|||
23731053|NCT00981292|66392028|FG001|Day 1|Protocol Violation|0|||
23426082|NCT00875056|65303513|FG002|Overall Study|Adverse Event|2|||
23426083|NCT00875056|65303511|FG000|Overall Study|Progressive Disease|14|||
23544079|NCT03579563|65722997|FG000|Overall Study|Lost to Follow-up|0|||
23544080|NCT03579563|65722998|FG001|Overall Study|Lost to Follow-up|0|||
23544081|NCT03579563|65722999|FG002|Overall Study|Lost to Follow-up|0|||
23544082|NCT03579563|65723000|FG003|Overall Study|Lost to Follow-up|0|||
23544083|NCT03579563|65723001|FG004|Overall Study|Lost to Follow-up|1|||
23544084|NCT03579563|65723002|FG005|Overall Study|Lost to Follow-up|0|||
23544085|NCT03579563|65722997|FG000|Overall Study|Lack of Efficacy|1|||
23544086|NCT03579563|65722998|FG001|Overall Study|Lack of Efficacy|1|||
23544087|NCT03579563|65722999|FG002|Overall Study|Lack of Efficacy|4|||
23544088|NCT03579563|65723000|FG003|Overall Study|Lack of Efficacy|1|||
23544089|NCT03579563|65723001|FG004|Overall Study|Lack of Efficacy|2|||
23544090|NCT03579563|65723002|FG005|Overall Study|Lack of Efficacy|3|||
23544091|NCT03579563|65722997|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544092|NCT03579563|65722998|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
23544093|NCT03579563|65722999|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
23544094|NCT03579563|65723000|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
23544095|NCT03579563|65723001|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544096|NCT03579563|65723002|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544097|NCT03579563|65722997|FG000|Overall Study|Time/distance concern|0|||
23544098|NCT03579563|65722998|FG001|Overall Study|Time/distance concern|0|||
23731054|NCT00981292|66392029|FG002|Day 1|Protocol Violation|0|||
23731055|NCT00981292|66392030|FG003|Day 1|Protocol Violation|0|||
23426084|NCT00875056|65303512|FG001|Overall Study|Progressive Disease|8|||
23544099|NCT03579563|65722999|FG002|Overall Study|Time/distance concern|1|||
23544100|NCT03579563|65723000|FG003|Overall Study|Time/distance concern|0|||
23544101|NCT03579563|65723001|FG004|Overall Study|Time/distance concern|0|||
23544102|NCT03579563|65723002|FG005|Overall Study|Time/distance concern|1|||
23544103|NCT03579563|65722997|FG000|Overall Study|COVID shutdown|2|||
23544104|NCT03579563|65722998|FG001|Overall Study|COVID shutdown|3|||
23544105|NCT03579563|65722999|FG002|Overall Study|COVID shutdown|4|||
23731056|NCT00981292|66392031|FG004|Day 1|Protocol Violation|0|||
23731057|NCT00981292|66392032|FG005|Day 1|Protocol Violation|2|||
23731058|NCT00981292|66392027|FG000|Day 2|Protocol Violation|2|||
23731059|NCT00981292|66392028|FG001|Day 2|Protocol Violation|0|||
23426085|NCT00875056|65303513|FG002|Overall Study|Progressive Disease|3|||
23544106|NCT03579563|65723000|FG003|Overall Study|COVID shutdown|3|||
23544107|NCT03579563|65723001|FG004|Overall Study|COVID shutdown|1|||
23544108|NCT03579563|65723002|FG005|Overall Study|COVID shutdown|2|||
23544109|NCT03579563|65722997|FG000|Overall Study|Protocol administration error|1|||
23544110|NCT03579563|65722998|FG001|Overall Study|Protocol administration error|0|||
23544111|NCT03579563|65722999|FG002|Overall Study|Protocol administration error|1|||
23544112|NCT03579563|65723000|FG003|Overall Study|Protocol administration error|0|||
23544113|NCT03579563|65723001|FG004|Overall Study|Protocol administration error|1|||
23544114|NCT03579563|65723002|FG005|Overall Study|Protocol administration error|5|||
23544115|NCT00968669|65723012|FG000|Overall Study|Lost to Follow-up|5|||
23544116|NCT00968669|65723013|FG001|Overall Study|Lost to Follow-up|2|||
23544117|NCT00968669|65723014|FG002|Overall Study|Lost to Follow-up|1|||
23544118|NCT00968669|65723015|FG003|Overall Study|Lost to Follow-up|4|||
23544119|NCT00968669|65723012|FG000|Overall Study|Withdrawal by Subject|9|||
23544120|NCT00968669|65723013|FG001|Overall Study|Withdrawal by Subject|7|||
23544121|NCT00968669|65723014|FG002|Overall Study|Withdrawal by Subject|5|||
23544122|NCT00968669|65723015|FG003|Overall Study|Withdrawal by Subject|3|||
23544123|NCT00968669|65723012|FG000|Overall Study|Pregnancy|0|||
23544124|NCT00968669|65723013|FG001|Overall Study|Pregnancy|0|||
23544125|NCT00968669|65723014|FG002|Overall Study|Pregnancy|2|||
23544126|NCT00968669|65723015|FG003|Overall Study|Pregnancy|0|||
23544127|NCT00968669|65723012|FG000|Overall Study|AE|1|||
23544128|NCT00968669|65723013|FG001|Overall Study|AE|0|||
23731060|NCT00981292|66392029|FG002|Day 2|Protocol Violation|0|||
23731061|NCT00981292|66392030|FG003|Day 2|Protocol Violation|0|||
23731062|NCT00981292|66392031|FG004|Day 2|Protocol Violation|0|||
23731063|NCT00981292|66392032|FG005|Day 2|Protocol Violation|0|||
23731064|NCT00981292|66392027|FG000|Day 3|Protocol Violation|0|||
23731065|NCT00981292|66392028|FG001|Day 3|Protocol Violation|0|||
23731066|NCT00981292|66392029|FG002|Day 3|Protocol Violation|0|||
23731067|NCT00981292|66392030|FG003|Day 3|Protocol Violation|0|||
23731068|NCT00981292|66392031|FG004|Day 3|Protocol Violation|0|||
23731069|NCT00981292|66392032|FG005|Day 3|Protocol Violation|1|||
23731070|NCT00693420|66392033|FG000|Overall Study|Adverse Event|4|||
23731071|NCT00693420|66392034|FG001|Overall Study|Adverse Event|4|||
23731072|NCT00693420|66392033|FG000|Overall Study|Lost to Follow-up|0|||
23731073|NCT00693420|66392034|FG001|Overall Study|Lost to Follow-up|3|||
23731074|NCT00693420|66392033|FG000|Overall Study|Withdrawal by Subject|1|||
23731075|NCT00693420|66392034|FG001|Overall Study|Withdrawal by Subject|0|||
23731076|NCT00693420|66392033|FG000|Overall Study|Protocol Violation|0|||
23731077|NCT00693420|66392034|FG001|Overall Study|Protocol Violation|2|||
23731078|NCT00693420|66392033|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
23731079|NCT00693420|66392034|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
23731080|NCT00693420|66392033|FG000|Overall Study|Personal Reasons|1|||
23818108|NCT02125877|66714223|FG001|Overall Study|Adverse Event|4|||
23544129|NCT00968669|65723014|FG002|Overall Study|AE|0|||
23544130|NCT00968669|65723015|FG003|Overall Study|AE|0|||
23544131|NCT00968669|65723012|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23544132|NCT00968669|65723013|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23544133|NCT00968669|65723014|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23617324|NCT00168805|65985141|FG002|Overall Study|Withdrawal by Subject|21|||
23617325|NCT00168805|65985139|FG000|Overall Study|Other|24|||
23617326|NCT00168805|65985140|FG001|Overall Study|Other|21|||
23617327|NCT00168805|65985141|FG002|Overall Study|Other|22|||
23617328|NCT00168805|65985139|FG000|Treatment|Adverse Event|25|||
23617329|NCT00168805|65985140|FG001|Treatment|Adverse Event|26|||
23617330|NCT00168805|65985141|FG002|Treatment|Adverse Event|32|||
23617331|NCT00168805|65985139|FG000|Treatment|Protocol Violation|3|||
23617332|NCT00168805|65985140|FG001|Treatment|Protocol Violation|5|||
23617333|NCT00168805|65985141|FG002|Treatment|Protocol Violation|5|||
23617334|NCT00168805|65985139|FG000|Treatment|Withdrawal by Subject|3|||
23617335|NCT00168805|65985140|FG001|Treatment|Withdrawal by Subject|7|||
23544134|NCT00968669|65723015|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
23544135|NCT00968669|65723012|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
23731081|NCT00693420|66392034|FG001|Overall Study|Personal Reasons|4|||
23731082|NCT01469637|66392035|FG000|First Intervention|Unacceptable behavior|0|||
23544136|NCT00968669|65723013|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23617336|NCT00168805|65985141|FG002|Treatment|Withdrawal by Subject|8|||
23617337|NCT00168805|65985139|FG000|Treatment|Other|18|||
23617338|NCT00168805|65985140|FG001|Treatment|Other|18|||
23617339|NCT00168805|65985141|FG002|Treatment|Other|17|||
23731083|NCT01469637|66392036|FG001|First Intervention|Unacceptable behavior|1|||
23731084|NCT01469637|66392035|FG000|Second Intervention|Incarcerated|1|||
23731085|NCT01469637|66392036|FG001|Second Intervention|Incarcerated|0|||
23544137|NCT00968669|65723014|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23617340|NCT00760877|65985143|FG000|Overall Study|Protocol Violation|1|||
23544138|NCT00968669|65723015|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23731086|NCT01308853|66392037|FG000|Overall Study|Adverse Event|1|||
23731087|NCT01308853|66392037|FG000|Overall Study|Lost to Follow-up|2|||
23731088|NCT01308853|66392037|FG000|Overall Study|Insertion of permanent implants|1|||
23617341|NCT00760877|65985144|FG001|Overall Study|Protocol Violation|0|||
23617342|NCT00760877|65985143|FG000|Overall Study|Non-compliance with protocol treatment|2|||
23617343|NCT00760877|65985144|FG001|Overall Study|Non-compliance with protocol treatment|1|||
23617344|NCT00760877|65985143|FG000|Overall Study|Pregnancy|1|||
23617345|NCT00760877|65985144|FG001|Overall Study|Pregnancy|4|||
23617346|NCT00760877|65985143|FG000|Overall Study|Death|2|||
23617347|NCT00760877|65985144|FG001|Overall Study|Death|1|||
23617348|NCT00760877|65985143|FG000|Overall Study|Withdrawal by Subject|7|||
23818109|NCT04683029|66714226|FG000|Overall Study|Withdrawal by Subject|1|||
23818110|NCT04683029|66714227|FG001|Overall Study|Withdrawal by Subject|0|||
23818111|NCT02593110|66714231|FG000|Overall Study|Withdrawal by Subject|0|||
23818112|NCT02593110|66714232|FG001|Overall Study|Withdrawal by Subject|3|||
23617349|NCT00760877|65985144|FG001|Overall Study|Withdrawal by Subject|3|||
23617350|NCT00760877|65985143|FG000|Overall Study|Adverse Event|19|||
23617351|NCT00760877|65985144|FG001|Overall Study|Adverse Event|12|||
23617352|NCT00760877|65985143|FG000|Overall Study|Participant diagnosed with AML|0|||
23731089|NCT02253992|66392051|FG000|Overall Study|Study drug toxicity|1|||
23731090|NCT02253992|66392052|FG001|Overall Study|Study drug toxicity|0|||
23731091|NCT02253992|66392053|FG002|Overall Study|Study drug toxicity|10|||
23731092|NCT02253992|66392051|FG000|Overall Study|Disease progression|4|||
23818113|NCT02593110|66714233|FG002|Overall Study|Withdrawal by Subject|3|||
23818114|NCT02593110|66714234|FG003|Overall Study|Withdrawal by Subject|2|||
23818115|NCT02593110|66714231|FG000|Overall Study|Death|0|||
23818116|NCT02593110|66714232|FG001|Overall Study|Death|0|||
23818117|NCT02593110|66714233|FG002|Overall Study|Death|1|||
23818118|NCT02593110|66714234|FG003|Overall Study|Death|0|||
23818119|NCT00195338|66714256|FG000|Overall Study|Lost to Follow-up|2|||
23818120|NCT00195338|66714256|FG000|Overall Study|Adverse Event|5|||
23818121|NCT00195338|66714256|FG000|Overall Study|Lack of Efficacy|1|||
23818122|NCT00195338|66714256|FG000|Overall Study|Early closure of the site|4|||
23731093|NCT02253992|66392052|FG001|Overall Study|Disease progression|3|||
23731094|NCT02253992|66392053|FG002|Overall Study|Disease progression|98|||
23731095|NCT02253992|66392051|FG000|Overall Study|Withdrawal by Subject|0|||
23731096|NCT02253992|66392052|FG001|Overall Study|Withdrawal by Subject|0|||
23731097|NCT02253992|66392053|FG002|Overall Study|Withdrawal by Subject|3|||
23731098|NCT02253992|66392051|FG000|Overall Study|Adverse Event|0|||
23731099|NCT02253992|66392052|FG001|Overall Study|Adverse Event|0|||
23731100|NCT02253992|66392053|FG002|Overall Study|Adverse Event|8|||
23731101|NCT02253992|66392051|FG000|Overall Study|Death|0|||
23731102|NCT02253992|66392052|FG001|Overall Study|Death|0|||
23731103|NCT02253992|66392053|FG002|Overall Study|Death|1|||
23731104|NCT02253992|66392051|FG000|Overall Study|Subject discontinued study drug|1|||
23731105|NCT02253992|66392052|FG001|Overall Study|Subject discontinued study drug|0|||
23731106|NCT02253992|66392053|FG002|Overall Study|Subject discontinued study drug|1|||
23731107|NCT02253992|66392051|FG000|Overall Study|Completed treatment as per protocol|0|||
23731108|NCT02253992|66392052|FG001|Overall Study|Completed treatment as per protocol|1|||
23731109|NCT02253992|66392053|FG002|Overall Study|Completed treatment as per protocol|22|||
23731110|NCT02253992|66392051|FG000|Overall Study|Other|0|||
23731111|NCT02253992|66392052|FG001|Overall Study|Other|0|||
23731112|NCT02253992|66392053|FG002|Overall Study|Other|1|||
23731113|NCT02252588|66392054|FG000|Overall Study|Withdrawal by Subject|4|||
23731114|NCT02252588|66392055|FG001|Overall Study|Withdrawal by Subject|0|||
23731115|NCT01868594|66392058|FG000|Overall Study|Do not meet inclusion criteria|4|||
23731116|NCT01868594|66392059|FG001|Overall Study|Do not meet inclusion criteria|3|||
23731117|NCT05104749|66392061|FG000|Overall Study|Lost to Follow-up|2|||
23731118|NCT05104749|66392062|FG001|Overall Study|Lost to Follow-up|3|||
23731119|NCT00844415|66392064|FG000|Overall Study|Withdrawal by Subject|1|||
23731120|NCT02044822|66392065|FG000|Overall Study|Study Terminated by Sponsor|77|||
23731121|NCT02044822|66392065|FG000|Overall Study|Investigator's Discretion|10|||
23731122|NCT02044822|66392065|FG000|Overall Study|Withdrew Consent|3|||
23731123|NCT02044822|66392065|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
23731124|NCT02044822|66392065|FG000|Overall Study|Lost to Follow-up|1|||
23731125|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
23731126|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23818123|NCT04303780|66714260|FG000|Overall Study|Death|104|||
23617353|NCT00760877|65985144|FG001|Overall Study|Participant diagnosed with AML|1|||
23617354|NCT00760877|65985143|FG000|Overall Study|Participant not eligible to cross-over|0|||
23731127|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23731128|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23731129|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
23731130|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23731131|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23818124|NCT04303780|66714261|FG001|Overall Study|Death|85|||
23818125|NCT04303780|66714260|FG000|Overall Study|Lost to Follow-up|5|||
23617355|NCT00760877|65985144|FG001|Overall Study|Participant not eligible to cross-over|1|||
23818126|NCT04303780|66714261|FG001|Overall Study|Lost to Follow-up|2|||
23818127|NCT04303780|66714260|FG000|Overall Study|Withdrawal by Subject|12|||
23818128|NCT04303780|66714261|FG001|Overall Study|Withdrawal by Subject|39|||
23818129|NCT04303780|66714260|FG000|Overall Study|Ongoing in study|50|||
23818130|NCT04303780|66714261|FG001|Overall Study|Ongoing in study|45|||
23818131|NCT04208750|66714262|FG000|Overall Study|Lost to Follow-up|16|||
23818132|NCT04208750|66714263|FG001|Overall Study|Lost to Follow-up|15|||
23818133|NCT02446600|66714269|FG000|Overall Study|Never treated|20|||
23818134|NCT02446600|66714270|FG001|Overall Study|Never treated|2|||
23818135|NCT02446600|66714271|FG002|Overall Study|Never treated|6|||
23818136|NCT02446600|66714272|FG003|Overall Study|Never treated|0|||
23818137|NCT02446600|66714269|FG000|Overall Study|Withdrawal by Subject|19|||
23818138|NCT02446600|66714270|FG001|Overall Study|Withdrawal by Subject|5|||
23818139|NCT02446600|66714271|FG002|Overall Study|Withdrawal by Subject|17|||
23818140|NCT02446600|66714272|FG003|Overall Study|Withdrawal by Subject|0|||
23818141|NCT02446600|66714269|FG000|Overall Study|Ineligible|1|||
23818142|NCT02446600|66714270|FG001|Overall Study|Ineligible|4|||
23818143|NCT02446600|66714271|FG002|Overall Study|Ineligible|4|||
23818144|NCT02446600|66714272|FG003|Overall Study|Ineligible|1|||
23818145|NCT02446600|66714269|FG000|Overall Study|Duplicate Enrollment|0|||
23818146|NCT02446600|66714270|FG001|Overall Study|Duplicate Enrollment|1|||
23818147|NCT02446600|66714271|FG002|Overall Study|Duplicate Enrollment|0|||
23818148|NCT02446600|66714272|FG003|Overall Study|Duplicate Enrollment|0|||
23818149|NCT00428116|66714273|FG000|Overall Study|Death|1|||
23818150|NCT00428116|66714274|FG001|Overall Study|Death|0|||
23818151|NCT00428116|66714273|FG000|Overall Study|Withdrawal by Subject|1|||
23818152|NCT00428116|66714274|FG001|Overall Study|Withdrawal by Subject|0|||
23818153|NCT00428116|66714273|FG000|Overall Study|Lost to Follow-up|1|||
23818154|NCT00428116|66714274|FG001|Overall Study|Lost to Follow-up|0|||
23818155|NCT04597632|66714275|FG000|Overall Study|Withdrawal by Subject|10|||
23818156|NCT04597632|66714275|FG000|Overall Study|Lost to Follow-up|1|||
23818157|NCT04597632|66714275|FG000|Overall Study|Death|1|||
23818158|NCT04597632|66714275|FG000|Overall Study|Adverse Event|5|||
23818159|NCT00805961|66714276|FG000|Modality Therapy|Withdrawal by Subject|1|||
23818160|NCT00805961|66714276|FG000|Modality Therapy|Adverse Event|1|||
23818161|NCT00805961|66714276|FG000|Modality Therapy|Disease Progression|2|||
23818162|NCT00805961|66714276|FG000|Treatment-Free Interval|Adverse Event|3|||
23818163|NCT00805961|66714276|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
23818164|NCT00805961|66714276|FG000|Treatment-Free Interval|Physician Decision|1|||
23818165|NCT00805961|66714276|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
23818166|NCT00805961|66714276|FG000|Maintenance Treatment|Lack of Efficacy|13|||
23818167|NCT00805961|66714276|FG000|Maintenance Treatment|Intercurrent Illness|7|||
23818168|NCT00805961|66714276|FG000|Maintenance Treatment|Adverse Event|6|||
23818169|NCT00805961|66714276|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
23818170|NCT00805961|66714276|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
23818171|NCT00805961|66714276|FG000|Maintenance Treatment|Withdrawn Consent|1|||
23818172|NCT04191499|66714277|FG000|Overall Study|Adverse Event|1|||
23818173|NCT04191499|66714278|FG001|Overall Study|Adverse Event|0|||
23818174|NCT04191499|66714277|FG000|Overall Study|Death|42|||
23818175|NCT04191499|66714278|FG001|Overall Study|Death|55|||
23818176|NCT04191499|66714277|FG000|Overall Study|Lost to Follow-up|4|||
23818177|NCT04191499|66714278|FG001|Overall Study|Lost to Follow-up|1|||
23818178|NCT04191499|66714277|FG000|Overall Study|Physician Decision|1|||
23818179|NCT04191499|66714278|FG001|Overall Study|Physician Decision|0|||
23818180|NCT04191499|66714277|FG000|Overall Study|Progressive Disease|1|||
23544139|NCT00968669|65723012|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
23544140|NCT00968669|65723013|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544141|NCT00968669|65723014|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544142|NCT00968669|65723015|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544143|NCT00968669|65723012|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544144|NCT00968669|65723013|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544145|NCT00968669|65723014|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
23544146|NCT00968669|65723015|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544147|NCT00968669|65723012|FG000|Overall Study|EARLY WITHDRAWAL|0|||
23544148|NCT00968669|65723013|FG001|Overall Study|EARLY WITHDRAWAL|1|||
23544149|NCT00968669|65723014|FG002|Overall Study|EARLY WITHDRAWAL|0|||
23544150|NCT00968669|65723015|FG003|Overall Study|EARLY WITHDRAWAL|0|||
23544151|NCT00968669|65723012|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23818181|NCT04191499|66714278|FG001|Overall Study|Progressive Disease|0|||
23818182|NCT04191499|66714277|FG000|Overall Study|Symptomatic Deterioration|1|||
23544152|NCT00968669|65723013|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23617356|NCT00760877|65985143|FG000|Overall Study|Physician Decision|1|||
23818183|NCT04191499|66714278|FG001|Overall Study|Symptomatic Deterioration|0|||
23818184|NCT04191499|66714277|FG000|Overall Study|Withdrawal by Subject|7|||
23818185|NCT04191499|66714278|FG001|Overall Study|Withdrawal by Subject|11|||
23818186|NCT04191499|66714277|FG000|Overall Study|Ongoing in the study|104|||
23818187|NCT04191499|66714278|FG001|Overall Study|Ongoing in the study|97|||
23818188|NCT01200992|66714283|FG000|Overall Study|Study terminated early|35|||
23818189|NCT01200992|66714284|FG001|Overall Study|Study terminated early|41|||
23818190|NCT01200992|66714283|FG000|Overall Study|Randomized but not treated|2|||
23818191|NCT01200992|66714284|FG001|Overall Study|Randomized but not treated|0|||
23818192|NCT00456300|66714285|FG000|Overall Study|Adverse Event|1|||
23818193|NCT00456300|66714286|FG001|Overall Study|Adverse Event|0|||
23818194|NCT03548337|66714287|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
23818195|NCT03548337|66714288|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
23617357|NCT00760877|65985144|FG001|Overall Study|Physician Decision|2|||
23617358|NCT00760877|65985143|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
23818196|NCT03548337|66714287|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
23818197|NCT03548337|66714288|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
23818198|NCT03548337|66714287|FG000|Infant Series|Lost to Follow-up|2|||
23818199|NCT03548337|66714288|FG001|Infant Series|Lost to Follow-up|1|||
23818200|NCT03548337|66714287|FG000|Infant Series|Adverse Event|0|||
23818201|NCT03548337|66714288|FG001|Infant Series|Adverse Event|2|||
23818202|NCT03548337|66714287|FG000|Infant Series|Randomized but Not Vaccinated|1|||
23818203|NCT03548337|66714288|FG001|Infant Series|Randomized but Not Vaccinated|0|||
23617359|NCT00760877|65985144|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
23617360|NCT00760877|65985143|FG000|Overall Study|Treatment failure|1|||
23617361|NCT00760877|65985144|FG001|Overall Study|Treatment failure|0|||
23617362|NCT01284634|65985145|FG000|Overall Study|Adverse Event|1|||
23617363|NCT01284634|65985146|FG001|Overall Study|Adverse Event|0|||
23617364|NCT01284634|65985147|FG002|Overall Study|Adverse Event|2|||
23617365|NCT01284634|65985148|FG003|Overall Study|Adverse Event|1|||
23617366|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
23617367|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
23617368|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
23617369|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
23617370|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
23731132|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23731133|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
23731134|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23731135|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23731136|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23731137|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
23731138|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23731139|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23731140|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23731141|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
23731142|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23731143|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23731144|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23731145|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
23731146|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23731147|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23731148|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23731149|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
23731150|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23731151|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23731152|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23731153|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
23731154|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23731155|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23731156|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23731157|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
23731158|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23731159|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23731160|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23731161|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
23731162|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23731163|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23731164|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23731165|NCT03605836|66392066|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
23731166|NCT03605836|66392067|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23731167|NCT03605836|66392068|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23818204|NCT03548337|66714287|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
23731168|NCT03605836|66392069|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23731169|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
23731170|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
23731171|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
23731172|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
23544153|NCT00968669|65723014|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
23544154|NCT00968669|65723015|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23544155|NCT00968669|65723012|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
23544156|NCT00968669|65723013|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544157|NCT00968669|65723014|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544158|NCT00968669|65723015|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544159|NCT00968669|65723012|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544160|NCT00968669|65723013|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
23544161|NCT00968669|65723014|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544162|NCT00968669|65723015|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544163|NCT00968669|65723012|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23617371|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
23617372|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
23617373|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
23617374|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
23617375|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
23731173|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
23731174|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
23731175|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
23617376|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
23617377|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
23617378|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
23617379|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
23617380|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
23617381|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
23617382|NCT02971683|65985159|FG000|Open-Label|Lost to Follow-up|1|||
23617383|NCT02971683|65985160|FG001|Open-Label|Lost to Follow-up|0|||
23617384|NCT02971683|65985159|FG000|Open-Label|Participants withdrew consent|0|||
23617385|NCT02971683|65985160|FG001|Open-Label|Participants withdrew consent|2|||
23617386|NCT02971683|65985159|FG000|Open-Label|Participant request to discontinue study treatment|1|||
23617387|NCT02971683|65985160|FG001|Open-Label|Participant request to discontinue study treatment|0|||
23617388|NCT02971683|65985159|FG000|Open-Label|Lack of Efficacy|2|||
23617389|NCT02971683|65985160|FG001|Open-Label|Lack of Efficacy|0|||
23617390|NCT02971683|65985159|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
23617391|NCT02971683|65985160|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
23617392|NCT02971683|65985159|FG000|Long-Term Open Label|Participant withdrew consent|1|||
23617393|NCT02971683|65985160|FG001|Long-Term Open Label|Participant withdrew consent|0|||
23617394|NCT02971683|65985159|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
23617395|NCT02971683|65985160|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
23617396|NCT02971683|65985159|FG000|Long-Term Open Label|Adverse Event|1|||
23818205|NCT03548337|66714288|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
23818206|NCT04106661|66714296|FG000|Overall Study|Protocol Violation|3|||
23617397|NCT02971683|65985160|FG001|Long-Term Open Label|Adverse Event|2|||
23617398|NCT02971683|65985159|FG000|Long-Term Open Label|Lack of Efficacy|1|||
23617399|NCT02971683|65985160|FG001|Long-Term Open Label|Lack of Efficacy|1|||
23617400|NCT03319719|65985163|FG000|Overall Study|Lost to Follow-up|1|||
23731176|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
23818207|NCT04106661|66714297|FG001|Overall Study|Protocol Violation|0|||
23818208|NCT04106661|66714296|FG000|Overall Study|Scheduling difficulties|1|||
23818209|NCT04106661|66714297|FG001|Overall Study|Scheduling difficulties|1|||
23617401|NCT01126879|65985164|FG000|Overall Study|Progressive Disease|3|||
23731177|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
23818210|NCT02121392|66714298|FG000|Prior to Intervention|Protocol Violation|40|||
23818211|NCT02121392|66714299|FG001|Prior to Intervention|Protocol Violation|35|||
23544164|NCT00968669|65723013|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
23617402|NCT01126879|65985165|FG001|Overall Study|Progressive Disease|1|||
23617403|NCT01126879|65985164|FG000|Overall Study|Withdrawal by Subject|1|||
23617404|NCT01126879|65985165|FG001|Overall Study|Withdrawal by Subject|0|||
23617405|NCT01126879|65985164|FG000|Overall Study|Adverse Event|0|||
23617406|NCT01126879|65985165|FG001|Overall Study|Adverse Event|1|||
23617407|NCT01126879|65985164|FG000|Overall Study|Physician Decision|1|||
23617408|NCT01126879|65985165|FG001|Overall Study|Physician Decision|0|||
23617409|NCT02490878|65985166|FG000|Overall Study|deemed ineligible|0|||
23617410|NCT02490878|65985167|FG001|Overall Study|deemed ineligible|1|||
23731178|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
23731179|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
23731180|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
23731181|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
23731182|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
23731183|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
23731184|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
23731185|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
23731186|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
23731187|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
23731188|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
23731189|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23731190|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
23731191|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23544165|NCT00968669|65723014|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23544166|NCT00968669|65723015|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23544167|NCT00968669|65723012|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544168|NCT00968669|65723013|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
23544169|NCT00968669|65723014|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544170|NCT00968669|65723015|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544171|NCT00968669|65723012|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23617411|NCT02490878|65985166|FG000|Overall Study|progression prior to treatment|0|||
23617412|NCT02490878|65985167|FG001|Overall Study|progression prior to treatment|1|||
23617413|NCT02490878|65985166|FG000|Overall Study|only submitted baseline QOL|0|||
23617414|NCT02490878|65985167|FG001|Overall Study|only submitted baseline QOL|1|||
23617415|NCT01685047|65985175|FG000|Overall Study|Withdrawal by Subject|20|||
23617416|NCT01685047|65985175|FG000|Overall Study|Death|26|||
23617417|NCT01685047|65985175|FG000|Overall Study|Lost to Follow-up|8|||
23617418|NCT01685047|65985175|FG000|Overall Study|Physician Decision|25|||
23617419|NCT01685047|65985175|FG000|Overall Study|Adverse Event|5|||
23617420|NCT01685047|65985175|FG000|Overall Study|patient withdrawn by sponsor|1|||
23617421|NCT03411044|65985180|FG000|Overall Study|Death|30|||
23617422|NCT03411044|65985180|FG000|Overall Study|Withdrawal by Subject|48|||
23617423|NCT03411044|65985180|FG000|Overall Study|Lost to Follow-up|78|||
23617424|NCT03411044|65985180|FG000|Overall Study|Adverse Event|30|||
23617425|NCT03411044|65985180|FG000|Overall Study|Missing status|4|||
23617426|NCT00727259|65985181|FG000|Overall Study|Not all questionnaires completed|1055|||
23617427|NCT02865135|65985182|FG000|Overall Study|Death|0|||
23617428|NCT02865135|65985183|FG001|Overall Study|Death|1|||
23617429|NCT02865135|65985184|FG002|Overall Study|Death|0|||
23617430|NCT02865135|65985182|FG000|Overall Study|Progression|6|||
23617431|NCT02865135|65985183|FG001|Overall Study|Progression|2|||
23617432|NCT02865135|65985184|FG002|Overall Study|Progression|2|||
23617433|NCT01838447|65985185|FG000|Overall Study|Change in surgical plan|1|||
23617434|NCT01838447|65985186|FG001|Overall Study|Change in surgical plan|2|||
23617435|NCT01838447|65985185|FG000|Overall Study|Withdrawal by Subject|1|||
23617436|NCT01838447|65985186|FG001|Overall Study|Withdrawal by Subject|1|||
23617437|NCT04814992|65985188|FG000|Overall Study|Withdrawal by Subject|6|||
23617438|NCT04814992|65985189|FG001|Overall Study|Withdrawal by Subject|3|||
23617439|NCT04814992|65985188|FG000|Overall Study|Lost to Follow-up|1|||
23617440|NCT04814992|65985189|FG001|Overall Study|Lost to Follow-up|4|||
23617441|NCT01049984|65985190|FG000|Overall Study|Withdrawal by Subject|1|||
23617442|NCT01049984|65985191|FG001|Overall Study|Withdrawal by Subject|5|||
23617443|NCT01049984|65985190|FG000|Overall Study|Protocol Violation|3|||
23617444|NCT01049984|65985191|FG001|Overall Study|Protocol Violation|4|||
23617445|NCT01049984|65985190|FG000|Overall Study|Lost to Follow-up|2|||
23617446|NCT01049984|65985191|FG001|Overall Study|Lost to Follow-up|1|||
23617447|NCT01049984|65985190|FG000|Overall Study|Adverse Event|13|||
23617448|NCT01049984|65985191|FG001|Overall Study|Adverse Event|7|||
23617449|NCT01049984|65985190|FG000|Overall Study|Treatment failure|0|||
23617450|NCT01049984|65985191|FG001|Overall Study|Treatment failure|2|||
23617451|NCT01114217|65985192|FG000|Overall Study|Adverse Event|5|||
23617452|NCT01114217|65985193|FG001|Overall Study|Adverse Event|3|||
23617453|NCT01114217|65985192|FG000|Overall Study|Lost to Follow-up|17|||
23617454|NCT01114217|65985193|FG001|Overall Study|Lost to Follow-up|33|||
23818212|NCT02121392|66714298|FG000|Prior to Intervention|Withdrawal by Subject|8|||
23818213|NCT02121392|66714299|FG001|Prior to Intervention|Withdrawal by Subject|6|||
23818214|NCT02121392|66714298|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
23544172|NCT00968669|65723013|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
23617455|NCT01114217|65985192|FG000|Overall Study|Withdrawal by Subject|21|||
23617456|NCT01114217|65985193|FG001|Overall Study|Withdrawal by Subject|28|||
23617457|NCT01114217|65985192|FG000|Overall Study|Other-Clerical Error|3|||
23617458|NCT01114217|65985193|FG001|Overall Study|Other-Clerical Error|0|||
23617459|NCT01114217|65985192|FG000|Overall Study|Other-Early termination|6|||
23544173|NCT00968669|65723014|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23544174|NCT00968669|65723015|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23617460|NCT01114217|65985193|FG001|Overall Study|Other-Early termination|10|||
23544175|NCT00968669|65723012|FG000|Overall Study|SPONSOR DECISION|0|||
23617461|NCT01114217|65985192|FG000|Overall Study|Other-Procedure|1|||
23617462|NCT01114217|65985193|FG001|Overall Study|Other-Procedure|1|||
23617463|NCT01114217|65985192|FG000|Overall Study|Other-Pregnancy|2|||
23617464|NCT01114217|65985193|FG001|Overall Study|Other-Pregnancy|4|||
23617465|NCT01114217|65985192|FG000|Overall Study|Other-Protocol Violation|1|||
23617466|NCT01114217|65985193|FG001|Overall Study|Other-Protocol Violation|3|||
23617467|NCT01114217|65985192|FG000|Overall Study|Other-Lack of Efficacy|1|||
23818215|NCT02121392|66714299|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
23818216|NCT02121392|66714298|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
23818217|NCT02121392|66714299|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
23544176|NCT00968669|65723013|FG001|Overall Study|SPONSOR DECISION|1|||
23617468|NCT01114217|65985193|FG001|Overall Study|Other-Lack of Efficacy|0|||
23617469|NCT01114217|65985192|FG000|Overall Study|Other-Non Compliance|2|||
23617470|NCT01114217|65985193|FG001|Overall Study|Other-Non Compliance|0|||
23617471|NCT01114217|65985192|FG000|Overall Study|Other-Physician Decision|1|||
23617472|NCT01114217|65985193|FG001|Overall Study|Other-Physician Decision|1|||
23617473|NCT01114217|65985192|FG000|Overall Study|Other-Sponsor Decision|10|||
23617474|NCT01114217|65985193|FG001|Overall Study|Other-Sponsor Decision|12|||
23617475|NCT01114217|65985192|FG000|Overall Study|Other-Study Termination|0|||
23617476|NCT01114217|65985193|FG001|Overall Study|Other-Study Termination|1|||
23731192|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23544177|NCT00968669|65723014|FG002|Overall Study|SPONSOR DECISION|0|||
23544178|NCT00968669|65723015|FG003|Overall Study|SPONSOR DECISION|0|||
23544179|NCT00968669|65723012|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544180|NCT00968669|65723013|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544181|NCT00968669|65723014|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
23544182|NCT00968669|65723015|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544183|NCT00968669|65723012|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23617477|NCT01114217|65985192|FG000|Overall Study|Other-Study Withdrawn|1|||
23617478|NCT01114217|65985193|FG001|Overall Study|Other-Study Withdrawn|1|||
23731193|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
23731194|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
23731195|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
23731196|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
23731197|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
23617479|NCT01114217|65985192|FG000|Overall Study|Other-Site Stopped Communicating|2|||
23617480|NCT01114217|65985193|FG001|Overall Study|Other-Site Stopped Communicating|0|||
23617481|NCT01114217|65985192|FG000|Overall Study|Other-Lost to Follow-up|1|||
23731198|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
23617482|NCT01114217|65985193|FG001|Overall Study|Other-Lost to Follow-up|0|||
23544184|NCT00968669|65723013|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
23617483|NCT01114217|65985192|FG000|Overall Study|Other-Withdrawal by Subject|1|||
23617484|NCT01114217|65985193|FG001|Overall Study|Other-Withdrawal by Subject|1|||
23617485|NCT01225159|65985194|FG000|Overall Study|Change operation|1|||
23426086|NCT00875056|65303511|FG000|Overall Study|Withdrawal by Subject|3|||
23731199|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
23731200|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
23731201|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
23731202|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
23731203|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
23731204|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
23731205|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
23731206|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
23731207|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
23426087|NCT00875056|65303512|FG001|Overall Study|Withdrawal by Subject|0|||
23426088|NCT00875056|65303513|FG002|Overall Study|Withdrawal by Subject|1|||
23426089|NCT02231762|65303514|FG000|Combination Phase|Adverse Event|10|||
23731208|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
23731209|NCT03605836|66392066|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
23731210|NCT03605836|66392067|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
23731211|NCT03605836|66392068|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
23731212|NCT03605836|66392069|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
23731213|NCT02243306|66392072|FG000|Overall Study|Adverse Event|0|||
23731214|NCT02243306|66392073|FG001|Overall Study|Adverse Event|1|||
23731215|NCT02243306|66392072|FG000|Overall Study|Other: Reached stopping criteria|0|||
23731216|NCT02243306|66392073|FG001|Overall Study|Other: Reached stopping criteria|1|||
23731217|NCT02243306|66392072|FG000|Overall Study|Physician Decision|0|||
23731218|NCT02243306|66392073|FG001|Overall Study|Physician Decision|1|||
23731219|NCT00610714|66392079|FG000|Overall Study|Adverse Event|3|||
23731220|NCT00610714|66392080|FG001|Overall Study|Adverse Event|1|||
23731221|NCT00610714|66392079|FG000|Overall Study|Death|12|||
23731222|NCT00610714|66392080|FG001|Overall Study|Death|18|||
23731223|NCT00610714|66392079|FG000|Overall Study|Withdrawal by Subject|9|||
23731224|NCT00610714|66392080|FG001|Overall Study|Withdrawal by Subject|3|||
23731225|NCT00610714|66392079|FG000|Overall Study|Study completion at 120 PFS events|2|||
23731226|NCT00610714|66392080|FG001|Overall Study|Study completion at 120 PFS events|2|||
23426090|NCT02231762|65303515|FG001|Combination Phase|Adverse Event|0|||
23426091|NCT02231762|65303516|FG002|Combination Phase|Adverse Event|0|||
23426092|NCT02231762|65303517|FG003|Combination Phase|Adverse Event|0|||
23426093|NCT02231762|65303514|FG000|Combination Phase|Withdrawal by Subject|2|||
23426094|NCT02231762|65303515|FG001|Combination Phase|Withdrawal by Subject|0|||
23426095|NCT02231762|65303516|FG002|Combination Phase|Withdrawal by Subject|0|||
23426096|NCT02231762|65303517|FG003|Combination Phase|Withdrawal by Subject|0|||
23426097|NCT02231762|65303514|FG000|Combination Phase|Disease Progression|6|||
23426098|NCT02231762|65303515|FG001|Combination Phase|Disease Progression|0|||
23426099|NCT02231762|65303516|FG002|Combination Phase|Disease Progression|0|||
23426100|NCT02231762|65303517|FG003|Combination Phase|Disease Progression|0|||
23426101|NCT02231762|65303514|FG000|Combination Phase|Did not meet inclusion criteria|1|||
23426102|NCT02231762|65303515|FG001|Combination Phase|Did not meet inclusion criteria|0|||
23426103|NCT02231762|65303516|FG002|Combination Phase|Did not meet inclusion criteria|0|||
23426104|NCT02231762|65303517|FG003|Combination Phase|Did not meet inclusion criteria|0|||
23426105|NCT02231762|65303514|FG000|Combination Phase|Protocol Violation|1|||
23426106|NCT02231762|65303515|FG001|Combination Phase|Protocol Violation|0|||
23426107|NCT02231762|65303516|FG002|Combination Phase|Protocol Violation|0|||
23426108|NCT02231762|65303517|FG003|Combination Phase|Protocol Violation|0|||
23426109|NCT02231762|65303514|FG000|Maintenance Phase|Disease progression|0|||
23426110|NCT02231762|65303515|FG001|Maintenance Phase|Disease progression|3|||
23731227|NCT01166386|66392081|FG000|Overall Study|Withdrawal by Subject|3|||
23544185|NCT00968669|65723014|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23544186|NCT00968669|65723015|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23426111|NCT02231762|65303516|FG002|Maintenance Phase|Disease progression|4|||
23426112|NCT02231762|65303517|FG003|Maintenance Phase|Disease progression|3|||
23544187|NCT00968669|65723012|FG000|Overall Study|SUBJECT INCARCERATED|0|||
23731228|NCT01166386|66392082|FG001|Overall Study|Withdrawal by Subject|5|||
23544188|NCT00968669|65723013|FG001|Overall Study|SUBJECT INCARCERATED|1|||
23731229|NCT01466062|66392083|FG000|Overall Study|Adverse Event|1|||
23731230|NCT01466062|66392083|FG000|Overall Study|Withdrawal by Subject|1|||
23731231|NCT02853123|66392084|FG000|Treatment Period 1|Adverse Event|0|||
23731232|NCT02853123|66392085|FG001|Treatment Period 1|Adverse Event|3|||
23731233|NCT02853123|66392084|FG000|Washout Period|Worsening of COPD|0|||
23731234|NCT02853123|66392085|FG001|Washout Period|Worsening of COPD|3|||
23731235|NCT02853123|66392084|FG000|Washout Period|Adverse Event|1|||
23731236|NCT02853123|66392085|FG001|Washout Period|Adverse Event|0|||
23731237|NCT01387594|66392086|FG000|Overall Study|Withdrawal by Subject|0|||
23731238|NCT01387594|66392087|FG001|Overall Study|Withdrawal by Subject|2|||
23731239|NCT01387594|66392086|FG000|Overall Study|Lost to Follow-up|0|||
23731240|NCT01387594|66392087|FG001|Overall Study|Lost to Follow-up|1|||
23731241|NCT00471315|66392088|FG000|Overall Study|Adverse Event|7|||
23731242|NCT00471315|66392088|FG000|Overall Study|Withdrawal by Subject|1|||
23731243|NCT00673816|66392090|FG000|Overall Study|Adverse Event|1|||
23731244|NCT00673816|66392090|FG000|Overall Study|Withdrawal by Subject|1|||
23731245|NCT02608892|66392092|FG000|Overall Study|Lost to Follow-up|1|||
23731246|NCT02608892|66392093|FG001|Overall Study|Lost to Follow-up|0|||
23731247|NCT02431793|66395513|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
23731248|NCT02431793|66395514|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
23731249|NCT02431793|66395515|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
23731250|NCT02431793|66395513|FG000|Overall Study|Withdrawal by Subject|7|||
23731251|NCT02431793|66395514|FG001|Overall Study|Withdrawal by Subject|5|||
23731252|NCT02431793|66395515|FG002|Overall Study|Withdrawal by Subject|5|||
23731253|NCT02431793|66395513|FG000|Overall Study|Lost to Follow-up|101|||
23731254|NCT02431793|66395514|FG001|Overall Study|Lost to Follow-up|122|||
23731255|NCT02431793|66395515|FG002|Overall Study|Lost to Follow-up|104|||
23731256|NCT00686699|66395516|FG000|Treatment Period 1|Adverse Event|0|||
23731257|NCT00686699|66395517|FG001|Treatment Period 1|Adverse Event|2|||
23731258|NCT01700140|66395518|FG000|Overall Study|Use of rescue drugs|3|||
23731259|NCT01700140|66395519|FG001|Overall Study|Use of rescue drugs|3|||
23731260|NCT01700140|66395520|FG002|Overall Study|Use of rescue drugs|1|||
23731261|NCT01700140|66395518|FG000|Overall Study|Discontinuation of radiotherapy|1|||
23731262|NCT01700140|66395519|FG001|Overall Study|Discontinuation of radiotherapy|0|||
23731263|NCT01700140|66395520|FG002|Overall Study|Discontinuation of radiotherapy|0|||
23731264|NCT01700140|66395518|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
23731265|NCT01700140|66395519|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
23731266|NCT01700140|66395520|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
23731267|NCT01700140|66395518|FG000|Overall Study|Aggravation of symptoms|1|||
23731268|NCT01700140|66395519|FG001|Overall Study|Aggravation of symptoms|0|||
23731269|NCT01700140|66395520|FG002|Overall Study|Aggravation of symptoms|0|||
23731270|NCT01700140|66395518|FG000|Overall Study|Adverse Event|0|||
23731271|NCT01700140|66395519|FG001|Overall Study|Adverse Event|1|||
23731272|NCT01700140|66395520|FG002|Overall Study|Adverse Event|0|||
23731273|NCT01700140|66395518|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
23731274|NCT01700140|66395519|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
23731275|NCT01700140|66395520|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
23731276|NCT00806494|66395521|FG000|Overall Study|Adverse Event|29|||
23731277|NCT00806494|66395521|FG000|Overall Study|Lack of Efficacy|6|||
23731278|NCT00806494|66395521|FG000|Overall Study|Lost to Follow-up|10|||
23731279|NCT00806494|66395521|FG000|Overall Study|Other|30|||
23731280|NCT00806494|66395521|FG000|Overall Study|Withdrawal by Subject|5|||
23544189|NCT00968669|65723014|FG002|Overall Study|SUBJECT INCARCERATED|0|||
23544190|NCT00968669|65723015|FG003|Overall Study|SUBJECT INCARCERATED|0|||
23544191|NCT00968669|65723012|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544192|NCT00968669|65723013|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
23544193|NCT00968669|65723014|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544194|NCT00968669|65723015|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544195|NCT00968669|65723012|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544196|NCT00968669|65723013|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544197|NCT00968669|65723014|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544198|NCT00968669|65723015|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
23544199|NCT01458574|65723016|FG000|Overall Study|Adverse Event|5|||
23544200|NCT01458574|65723017|FG001|Overall Study|Adverse Event|9|||
23544201|NCT01458574|65723018|FG002|Overall Study|Adverse Event|7|||
23544202|NCT01458574|65723016|FG000|Overall Study|Lack of Efficacy|70|||
23544203|NCT01458574|65723017|FG001|Overall Study|Lack of Efficacy|53|||
23544204|NCT01458574|65723018|FG002|Overall Study|Lack of Efficacy|132|||
23544205|NCT01458574|65723016|FG000|Overall Study|Lost to Follow-up|3|||
23544206|NCT01458574|65723017|FG001|Overall Study|Lost to Follow-up|2|||
23544207|NCT01458574|65723018|FG002|Overall Study|Lost to Follow-up|1|||
23544208|NCT01458574|65723016|FG000|Overall Study|Pregnancy|1|||
23544209|NCT01458574|65723017|FG001|Overall Study|Pregnancy|1|||
23544210|NCT01458574|65723018|FG002|Overall Study|Pregnancy|0|||
23731281|NCT00994890|66395522|FG000|Overall Study|Adverse Event|13|||
23731282|NCT00994890|66395523|FG001|Overall Study|Adverse Event|9|||
23731283|NCT00994890|66395524|FG002|Overall Study|Adverse Event|11|||
23731284|NCT00994890|66395522|FG000|Overall Study|Lack of Efficacy|0|||
23731285|NCT00994890|66395523|FG001|Overall Study|Lack of Efficacy|0|||
23731286|NCT00994890|66395524|FG002|Overall Study|Lack of Efficacy|1|||
23731287|NCT00994890|66395522|FG000|Overall Study|Lost to Follow-up|6|||
23426113|NCT02231762|65303514|FG000|Maintenance Phase|Adverse Event|0|||
23426114|NCT02231762|65303515|FG001|Maintenance Phase|Adverse Event|0|||
23426115|NCT02231762|65303516|FG002|Maintenance Phase|Adverse Event|1|||
23426116|NCT02231762|65303517|FG003|Maintenance Phase|Adverse Event|2|||
23426117|NCT02961790|65303518|FG000|Overall Study|Canceled|4|||
23426118|NCT02961790|65303519|FG001|Overall Study|Canceled|5|||
23426119|NCT02961790|65303520|FG002|Overall Study|Canceled|1|||
23426120|NCT02961790|65303521|FG003|Overall Study|Canceled|4|||
23426121|NCT02961790|65303518|FG000|Overall Study|without baseline data|4|||
23426122|NCT02961790|65303519|FG001|Overall Study|without baseline data|0|||
23426123|NCT02961790|65303520|FG002|Overall Study|without baseline data|1|||
23426124|NCT02961790|65303521|FG003|Overall Study|without baseline data|0|||
23426125|NCT02961790|65303518|FG000|Overall Study|without post baseline data|7|||
23426126|NCT02961790|65303519|FG001|Overall Study|without post baseline data|6|||
23426127|NCT02961790|65303520|FG002|Overall Study|without post baseline data|4|||
23426128|NCT02961790|65303521|FG003|Overall Study|without post baseline data|1|||
23426129|NCT04070326|65303522|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
23426130|NCT04070326|65303523|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
23426131|NCT02838901|65303524|FG000|Overall Study|Withdrawal by Subject|1|||
23731288|NCT00994890|66395523|FG001|Overall Study|Lost to Follow-up|1|||
23731289|NCT00994890|66395524|FG002|Overall Study|Lost to Follow-up|3|||
23731290|NCT00994890|66395522|FG000|Overall Study|No longer willing to participate|8|||
23731291|NCT00994890|66395523|FG001|Overall Study|No longer willing to participate|5|||
23426132|NCT02838901|65303525|FG001|Overall Study|Withdrawal by Subject|1|||
23731292|NCT00994890|66395524|FG002|Overall Study|No longer willing to participate|13|||
23731293|NCT00994890|66395522|FG000|Overall Study|Protocol Violation|2|||
23731294|NCT00994890|66395523|FG001|Overall Study|Protocol Violation|4|||
23731295|NCT00994890|66395524|FG002|Overall Study|Protocol Violation|0|||
23731296|NCT00994890|66395522|FG000|Overall Study|Study terminated by sponsor|199|||
23731297|NCT00994890|66395523|FG001|Overall Study|Study terminated by sponsor|201|||
23731298|NCT00994890|66395524|FG002|Overall Study|Study terminated by sponsor|197|||
23731299|NCT00994890|66395522|FG000|Overall Study|Randomized, but not treated|1|||
23731300|NCT00994890|66395523|FG001|Overall Study|Randomized, but not treated|0|||
23731301|NCT00994890|66395524|FG002|Overall Study|Randomized, but not treated|0|||
23731302|NCT00994890|66395522|FG000|Overall Study|Other|2|||
23731303|NCT00994890|66395523|FG001|Overall Study|Other|2|||
23731304|NCT00994890|66395524|FG002|Overall Study|Other|1|||
23731305|NCT01572844|66395525|FG000|Overall Study|Physician Decision|1|||
23731306|NCT01572844|66395526|FG001|Overall Study|Physician Decision|1|||
23731307|NCT05283499|66395537|FG000|Overall Study|Did not receive intervention|1|||
23731308|NCT05283499|66395538|FG001|Overall Study|Did not receive intervention|2|||
23731309|NCT02449915|66395539|FG000|Overall Study|Exclusion criteria - drug use|1|||
23731310|NCT02449915|66395540|FG001|Overall Study|Exclusion criteria - drug use|0|||
23731311|NCT02449915|66395539|FG000|Overall Study|Withdrawal by Subject|0|||
23731312|NCT02449915|66395540|FG001|Overall Study|Withdrawal by Subject|2|||
23731313|NCT02449915|66395539|FG000|Overall Study|Intraoperative surgical findings|1|||
23731314|NCT02449915|66395540|FG001|Overall Study|Intraoperative surgical findings|1|||
23731315|NCT02449915|66395539|FG000|Overall Study|Abnormal preop lab|0|||
23731316|NCT02449915|66395540|FG001|Overall Study|Abnormal preop lab|1|||
23731317|NCT00683774|66395541|FG000|Overall Study|Withdrawal by Subject|0|||
23731318|NCT00683774|66395542|FG001|Overall Study|Withdrawal by Subject|1|||
23731319|NCT00683774|66395541|FG000|Overall Study|Physician Decision|3|||
23731320|NCT00683774|66395542|FG001|Overall Study|Physician Decision|0|||
23818218|NCT05384171|66714300|FG000|Overall Study|Lost to Follow-up|9|||
23818219|NCT05384171|66714301|FG001|Overall Study|Lost to Follow-up|9|||
23818220|NCT05384171|66714300|FG000|Overall Study|Withdrawal by Subject|3|||
23818221|NCT05384171|66714301|FG001|Overall Study|Withdrawal by Subject|0|||
23818222|NCT02383810|66714302|FG000|Overall Study|Physician Decision|1|||
23818223|NCT02383810|66714303|FG001|Overall Study|Physician Decision|1|||
23426133|NCT02838901|65303524|FG000|Overall Study|Lost to Follow-up|1|||
23426134|NCT02838901|65303525|FG001|Overall Study|Lost to Follow-up|1|||
23426135|NCT01667562|65303529|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
23544211|NCT01458574|65723016|FG000|Overall Study|Protocol Violation|0|||
23544212|NCT01458574|65723017|FG001|Overall Study|Protocol Violation|1|||
23544213|NCT01458574|65723018|FG002|Overall Study|Protocol Violation|0|||
23731321|NCT02365506|66395543|FG000|Overall Study|Investigator's Discretion|0|||
23731322|NCT02365506|66395544|FG001|Overall Study|Investigator's Discretion|0|||
23731323|NCT02365506|66395545|FG002|Overall Study|Investigator's Discretion|1|||
23731324|NCT00374127|66395546|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
23731325|NCT00374127|66395546|FG000|Overall Study|Blood could not be drawn.|2|||
23731326|NCT00374127|66395546|FG000|Overall Study|Protocol Violation|5|||
23426136|NCT01667562|65303530|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
23731327|NCT00374127|66395546|FG000|Overall Study|Pregnancy|1|||
23818224|NCT02383810|66714304|FG002|Overall Study|Physician Decision|0|||
23818225|NCT02383810|66714305|FG003|Overall Study|Physician Decision|0|||
23818226|NCT02383810|66714306|FG004|Overall Study|Physician Decision|0|||
23818227|NCT02383810|66714307|FG005|Overall Study|Physician Decision|0|||
23818228|NCT02383810|66714308|FG006|Overall Study|Physician Decision|0|||
23818229|NCT02383810|66714309|FG007|Overall Study|Physician Decision|0|||
23617486|NCT01225159|65985195|FG001|Overall Study|Change operation|0|||
23617487|NCT03325608|65985196|FG000|Overall Study|Lost to Follow-up|23|||
23617488|NCT03325608|65985197|FG001|Overall Study|Lost to Follow-up|23|||
23617489|NCT03325608|65985198|FG002|Overall Study|Lost to Follow-up|30|||
23617490|NCT03325608|65985199|FG003|Overall Study|Lost to Follow-up|30|||
23617491|NCT03325608|65985196|FG000|Overall Study|Death of Caregiver|0|||
23617492|NCT03325608|65985197|FG001|Overall Study|Death of Caregiver|0|||
23617493|NCT03325608|65985198|FG002|Overall Study|Death of Caregiver|2|||
23818230|NCT02383810|66714302|FG000|Overall Study|Withdrawal by Subject|2|||
23818231|NCT02383810|66714303|FG001|Overall Study|Withdrawal by Subject|3|||
23818232|NCT02383810|66714304|FG002|Overall Study|Withdrawal by Subject|3|||
23818233|NCT02383810|66714305|FG003|Overall Study|Withdrawal by Subject|3|||
23544214|NCT01458574|65723016|FG000|Overall Study|Withdrawal by Subject|6|||
23544215|NCT01458574|65723017|FG001|Overall Study|Withdrawal by Subject|3|||
23544216|NCT01458574|65723018|FG002|Overall Study|Withdrawal by Subject|5|||
23818234|NCT02383810|66714306|FG004|Overall Study|Withdrawal by Subject|0|||
23818235|NCT02383810|66714307|FG005|Overall Study|Withdrawal by Subject|0|||
23818236|NCT02383810|66714308|FG006|Overall Study|Withdrawal by Subject|0|||
23818237|NCT02383810|66714309|FG007|Overall Study|Withdrawal by Subject|0|||
23818238|NCT02383810|66714302|FG000|Overall Study|Adverse Event|0|||
23818239|NCT02383810|66714303|FG001|Overall Study|Adverse Event|2|||
23818240|NCT02383810|66714304|FG002|Overall Study|Adverse Event|4|||
23818241|NCT02383810|66714305|FG003|Overall Study|Adverse Event|5|||
23818242|NCT02383810|66714306|FG004|Overall Study|Adverse Event|0|||
23818243|NCT02383810|66714307|FG005|Overall Study|Adverse Event|1|||
23818244|NCT02383810|66714308|FG006|Overall Study|Adverse Event|1|||
23818245|NCT02383810|66714309|FG007|Overall Study|Adverse Event|0|||
23818246|NCT02383810|66714302|FG000|Overall Study|Lost to Follow-up|0|||
23818247|NCT02383810|66714303|FG001|Overall Study|Lost to Follow-up|1|||
23818248|NCT02383810|66714304|FG002|Overall Study|Lost to Follow-up|0|||
23818249|NCT02383810|66714305|FG003|Overall Study|Lost to Follow-up|1|||
23818250|NCT02383810|66714306|FG004|Overall Study|Lost to Follow-up|0|||
23818251|NCT02383810|66714307|FG005|Overall Study|Lost to Follow-up|0|||
23818252|NCT02383810|66714308|FG006|Overall Study|Lost to Follow-up|0|||
23818253|NCT02383810|66714309|FG007|Overall Study|Lost to Follow-up|0|||
23818254|NCT02383810|66714302|FG000|Overall Study|other|0|||
23544217|NCT01458574|65723016|FG000|Overall Study|Other|2|||
23544218|NCT01458574|65723017|FG001|Overall Study|Other|1|||
23544219|NCT01458574|65723018|FG002|Overall Study|Other|0|||
23544220|NCT01458574|65723016|FG000|Overall Study|Randomized but not treated|0|||
23544221|NCT01458574|65723017|FG001|Overall Study|Randomized but not treated|1|||
23544222|NCT01458574|65723018|FG002|Overall Study|Randomized but not treated|0|||
23544223|NCT00448539|65723019|FG000|Overall Study|Medication non-compliance|4|||
23544224|NCT00448539|65723020|FG001|Overall Study|Medication non-compliance|1|||
23544225|NCT00448539|65723019|FG000|Overall Study|Protocol Violation|1|||
23544226|NCT00448539|65723020|FG001|Overall Study|Protocol Violation|0|||
23617494|NCT03325608|65985199|FG003|Overall Study|Death of Caregiver|2|||
23818255|NCT02383810|66714303|FG001|Overall Study|other|0|||
23818256|NCT02383810|66714304|FG002|Overall Study|other|0|||
23818257|NCT02383810|66714305|FG003|Overall Study|other|2|||
23818258|NCT02383810|66714306|FG004|Overall Study|other|0|||
23818259|NCT02383810|66714307|FG005|Overall Study|other|0|||
23818260|NCT02383810|66714308|FG006|Overall Study|other|0|||
23818261|NCT02383810|66714309|FG007|Overall Study|other|0|||
23818262|NCT02383810|66714302|FG000|Overall Study|subject did not receive study treatment|0|||
23426137|NCT01667562|65303529|FG000|Erlotinib Phase|Lost to Follow-up|0|||
23426138|NCT01667562|65303530|FG001|Erlotinib Phase|Lost to Follow-up|1|||
23426139|NCT01667562|65303529|FG000|Erlotinib Phase|Adverse Event|0|||
23544227|NCT00448539|65723019|FG000|Overall Study|Request of the investigator or sponsor|67|||
23818263|NCT02383810|66714303|FG001|Overall Study|subject did not receive study treatment|1|||
23818264|NCT02383810|66714304|FG002|Overall Study|subject did not receive study treatment|0|||
23544228|NCT00448539|65723020|FG001|Overall Study|Request of the investigator or sponsor|54|||
23544229|NCT00448539|65723019|FG000|Overall Study|Withdrawal by Subject|20|||
23818265|NCT02383810|66714305|FG003|Overall Study|subject did not receive study treatment|0|||
23818266|NCT02383810|66714306|FG004|Overall Study|subject did not receive study treatment|0|||
23426140|NCT01667562|65303530|FG001|Erlotinib Phase|Adverse Event|1|||
23544230|NCT00448539|65723020|FG001|Overall Study|Withdrawal by Subject|24|||
23617495|NCT03325608|65985196|FG000|Overall Study|Death of Care Recipient|34|||
23617496|NCT03325608|65985197|FG001|Overall Study|Death of Care Recipient|34|||
23818267|NCT02383810|66714307|FG005|Overall Study|subject did not receive study treatment|0|||
23818268|NCT02383810|66714308|FG006|Overall Study|subject did not receive study treatment|0|||
23818269|NCT02383810|66714309|FG007|Overall Study|subject did not receive study treatment|0|||
23544231|NCT00448539|65723019|FG000|Overall Study|Diary non-compliance|1|||
23544232|NCT00448539|65723020|FG001|Overall Study|Diary non-compliance|0|||
23544233|NCT00448539|65723019|FG000|Overall Study|Adverse Event|9|||
23544234|NCT00448539|65723020|FG001|Overall Study|Adverse Event|26|||
23544235|NCT00448539|65723019|FG000|Overall Study|Lack of Efficacy|27|||
23544236|NCT00448539|65723020|FG001|Overall Study|Lack of Efficacy|40|||
23544237|NCT00448539|65723019|FG000|Overall Study|Miscellaneous|2|||
23544238|NCT00448539|65723020|FG001|Overall Study|Miscellaneous|1|||
23544239|NCT00448539|65723019|FG000|Overall Study|Change of meds|2|||
23544240|NCT00448539|65723020|FG001|Overall Study|Change of meds|3|||
23544241|NCT00448539|65723019|FG000|Overall Study|Lost to Follow-up|1|||
23544242|NCT00448539|65723020|FG001|Overall Study|Lost to Follow-up|3|||
23544243|NCT01308749|65723021|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
23544244|NCT01308749|65723022|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
23617497|NCT03325608|65985198|FG002|Overall Study|Death of Care Recipient|28|||
23617498|NCT03325608|65985199|FG003|Overall Study|Death of Care Recipient|28|||
23617499|NCT03325608|65985196|FG000|Overall Study|Withdrawal by Subject|49|||
23617500|NCT03325608|65985197|FG001|Overall Study|Withdrawal by Subject|49|||
23617501|NCT03325608|65985198|FG002|Overall Study|Withdrawal by Subject|35|||
23617502|NCT03325608|65985199|FG003|Overall Study|Withdrawal by Subject|35|||
23617503|NCT03325608|65985196|FG000|Overall Study|Ineligible|7|||
23617504|NCT03325608|65985197|FG001|Overall Study|Ineligible|7|||
23617505|NCT03325608|65985198|FG002|Overall Study|Ineligible|5|||
23617506|NCT03325608|65985199|FG003|Overall Study|Ineligible|5|||
23617507|NCT02229396|65985200|FG000|Overall Study|Adverse Event|6|||
23617508|NCT02229396|65985201|FG001|Overall Study|Adverse Event|12|||
23617509|NCT02229396|65985202|FG002|Overall Study|Adverse Event|12|||
23617510|NCT02229396|65985200|FG000|Overall Study|Death|2|||
23617511|NCT02229396|65985201|FG001|Overall Study|Death|3|||
23617512|NCT02229396|65985202|FG002|Overall Study|Death|1|||
23617513|NCT02229396|65985200|FG000|Overall Study|Lost to Follow-up|14|||
23617514|NCT02229396|65985201|FG001|Overall Study|Lost to Follow-up|14|||
23617515|NCT02229396|65985202|FG002|Overall Study|Lost to Follow-up|21|||
23617516|NCT02229396|65985200|FG000|Overall Study|Protocol Violation|2|||
23617517|NCT02229396|65985201|FG001|Overall Study|Protocol Violation|1|||
23617518|NCT02229396|65985202|FG002|Overall Study|Protocol Violation|0|||
23617519|NCT02229396|65985200|FG000|Overall Study|Patient Incorrectly Randomized|0|||
23731328|NCT00441727|66395547|FG000|Overall Study|Protocol Violation|19|||
23731329|NCT00441727|66395548|FG001|Overall Study|Protocol Violation|28|||
23731330|NCT00441727|66395549|FG002|Overall Study|Protocol Violation|32|||
23731331|NCT00441727|66395547|FG000|Overall Study|Adverse Event|26|||
23731332|NCT00441727|66395548|FG001|Overall Study|Adverse Event|33|||
23731333|NCT00441727|66395549|FG002|Overall Study|Adverse Event|28|||
23731334|NCT00441727|66395547|FG000|Overall Study|Lack of Efficacy|7|||
23731335|NCT00441727|66395548|FG001|Overall Study|Lack of Efficacy|8|||
23731336|NCT00441727|66395549|FG002|Overall Study|Lack of Efficacy|48|||
23731337|NCT00441727|66395547|FG000|Overall Study|Withdrawal by Subject|40|||
23731338|NCT00441727|66395548|FG001|Overall Study|Withdrawal by Subject|34|||
23818270|NCT00901576|66714310|FG000|Second Intervention|Withdrawal by Subject|0|||
23544245|NCT01308749|65723021|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
23544246|NCT01308749|65723022|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
23544247|NCT01308749|65723021|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
23426141|NCT01667562|65303529|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
23426142|NCT01667562|65303530|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
23617520|NCT02229396|65985201|FG001|Overall Study|Patient Incorrectly Randomized|0|||
23617521|NCT02229396|65985202|FG002|Overall Study|Patient Incorrectly Randomized|1|||
23818271|NCT00901576|66714311|FG001|Second Intervention|Withdrawal by Subject|0|||
23818272|NCT00901576|66714312|FG002|Second Intervention|Withdrawal by Subject|0|||
23818273|NCT00901576|66714313|FG003|Second Intervention|Withdrawal by Subject|1|||
23818274|NCT00901576|66714314|FG004|Second Intervention|Withdrawal by Subject|0|||
23818275|NCT00901576|66714315|FG005|Second Intervention|Withdrawal by Subject|1|||
23426143|NCT00413374|65303535|FG000|Overall Study|Ineligible due to screening criteria.|3|||
23617522|NCT02229396|65985200|FG000|Overall Study|Other|10|||
23617523|NCT02229396|65985201|FG001|Overall Study|Other|18|||
23617524|NCT02229396|65985202|FG002|Overall Study|Other|15|||
23731339|NCT00441727|66395549|FG002|Overall Study|Withdrawal by Subject|47|||
23731340|NCT00441727|66395547|FG000|Overall Study|Lost to Follow-up|5|||
23426144|NCT00413374|65303536|FG001|Overall Study|Ineligible due to screening criteria.|0|||
23426145|NCT00413374|65303535|FG000|Overall Study|Adverse Event|1|||
23426146|NCT00413374|65303536|FG001|Overall Study|Adverse Event|0|||
23617525|NCT02229396|65985200|FG000|Overall Study|Withdrawal by Subject|42|||
23617526|NCT02229396|65985201|FG001|Overall Study|Withdrawal by Subject|28|||
23731341|NCT00441727|66395548|FG001|Overall Study|Lost to Follow-up|6|||
23731342|NCT00441727|66395549|FG002|Overall Study|Lost to Follow-up|5|||
23544248|NCT01308749|65723022|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
23544249|NCT03998618|65723027|FG000|Overall Study|Death|7|||
23544250|NCT03998618|65723028|FG001|Overall Study|Death|11|||
23544251|NCT03998618|65723027|FG000|Overall Study|hospice enrollment|3|||
23544252|NCT03998618|65723028|FG001|Overall Study|hospice enrollment|3|||
23544253|NCT03998618|65723027|FG000|Overall Study|Not feeling well/health problems|3|||
23544254|NCT03998618|65723028|FG001|Overall Study|Not feeling well/health problems|5|||
23544255|NCT03998618|65723027|FG000|Overall Study|Lost to Follow-up|6|||
23544256|NCT03998618|65723028|FG001|Overall Study|Lost to Follow-up|6|||
23544257|NCT03998618|65723027|FG000|Overall Study|Withdrawal by Subject|0|||
23544258|NCT03998618|65723028|FG001|Overall Study|Withdrawal by Subject|4|||
23544259|NCT04265755|65723029|FG000|Overall Study|Withdrawal by Subject|39|||
23544260|NCT04265755|65723029|FG000|Overall Study|Decision by sponsor|2|||
23544261|NCT04265755|65723029|FG000|Overall Study|Lost to Follow-up|11|||
23544262|NCT04265755|65723029|FG000|Overall Study|Death|1|||
23544263|NCT01343368|65723030|FG000|Overall Study|Death|1|||
23544264|NCT01343368|65723031|FG001|Overall Study|Death|0|||
23544265|NCT01343368|65723030|FG000|Overall Study|Lost to Follow-up|1|||
23544266|NCT01343368|65723031|FG001|Overall Study|Lost to Follow-up|0|||
23544267|NCT00970502|65723032|FG000|Overall Study|Withdrawal by Subject|1|||
23544268|NCT01605617|65723033|FG000|First Intervention|Adverse Event|0|||
23544269|NCT01605617|65723034|FG001|First Intervention|Adverse Event|1|||
23544270|NCT01605617|65723033|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
23544271|NCT01605617|65723034|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
23544272|NCT04313634|65723037|FG000|Overall Study|Adverse Event|2|||
23544273|NCT04313634|65723038|FG001|Overall Study|Adverse Event|2|||
23544274|NCT04313634|65723039|FG002|Overall Study|Adverse Event|0|||
23617527|NCT02229396|65985202|FG002|Overall Study|Withdrawal by Subject|41|||
23617528|NCT02229396|65985200|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23617529|NCT02229396|65985201|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23617530|NCT02229396|65985202|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
23617531|NCT02229396|65985200|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
23617532|NCT02229396|65985201|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
23617533|NCT02229396|65985202|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
23617534|NCT00776984|65985203|FG000|Overall Study|Adverse Event|8|||
23617535|NCT00776984|65985204|FG001|Overall Study|Adverse Event|2|||
23617536|NCT00776984|65985203|FG000|Overall Study|Protocol Violation|4|||
23617537|NCT00776984|65985204|FG001|Overall Study|Protocol Violation|2|||
23617538|NCT00776984|65985203|FG000|Overall Study|Lost to Follow-up|2|||
23818276|NCT00901576|66714310|FG000|Second Intervention|Physician Decision|1|||
23818277|NCT00901576|66714311|FG001|Second Intervention|Physician Decision|0|||
23818278|NCT00901576|66714312|FG002|Second Intervention|Physician Decision|0|||
23818279|NCT00901576|66714313|FG003|Second Intervention|Physician Decision|0|||
23818280|NCT00901576|66714314|FG004|Second Intervention|Physician Decision|0|||
23818281|NCT00901576|66714315|FG005|Second Intervention|Physician Decision|0|||
23818282|NCT03138655|66714316|FG000|Overall Study|Adverse Event|2|||
23818283|NCT03138655|66714317|FG001|Overall Study|Adverse Event|1|||
23818284|NCT03138655|66714318|FG002|Overall Study|Adverse Event|2|||
23818285|NCT03138655|66714319|FG003|Overall Study|Adverse Event|1|||
23818286|NCT03138655|66714320|FG004|Overall Study|Adverse Event|1|||
23818287|NCT03138655|66714321|FG005|Overall Study|Adverse Event|4|||
23818288|NCT03138655|66714322|FG006|Overall Study|Adverse Event|2|||
23818289|NCT03138655|66714323|FG007|Overall Study|Adverse Event|2|||
23818290|NCT03138655|66714316|FG000|Overall Study|Withdrawal by Subject|0|||
23818291|NCT03138655|66714317|FG001|Overall Study|Withdrawal by Subject|1|||
23818292|NCT03138655|66714318|FG002|Overall Study|Withdrawal by Subject|0|||
23818293|NCT03138655|66714319|FG003|Overall Study|Withdrawal by Subject|0|||
23818294|NCT03138655|66714320|FG004|Overall Study|Withdrawal by Subject|0|||
23818295|NCT03138655|66714321|FG005|Overall Study|Withdrawal by Subject|0|||
23818296|NCT03138655|66714322|FG006|Overall Study|Withdrawal by Subject|1|||
23818297|NCT03138655|66714323|FG007|Overall Study|Withdrawal by Subject|0|||
23818298|NCT03138655|66714316|FG000|Overall Study|Reason not Specified|1|||
23818299|NCT03138655|66714317|FG001|Overall Study|Reason not Specified|0|||
23544275|NCT04313634|65723037|FG000|Overall Study|Withdrawal by Subject|1|||
23544276|NCT04313634|65723038|FG001|Overall Study|Withdrawal by Subject|0|||
23617539|NCT00776984|65985204|FG001|Overall Study|Lost to Follow-up|0|||
23617540|NCT00776984|65985203|FG000|Overall Study|Withdrawal by Subject|12|||
23818300|NCT03138655|66714318|FG002|Overall Study|Reason not Specified|0|||
23818301|NCT03138655|66714319|FG003|Overall Study|Reason not Specified|2|||
23818302|NCT03138655|66714320|FG004|Overall Study|Reason not Specified|1|||
23818303|NCT03138655|66714321|FG005|Overall Study|Reason not Specified|1|||
23818304|NCT03138655|66714322|FG006|Overall Study|Reason not Specified|0|||
23544277|NCT04313634|65723039|FG002|Overall Study|Withdrawal by Subject|1|||
23544278|NCT04313634|65723037|FG000|Overall Study|Protocol Violation|0|||
23544279|NCT04313634|65723038|FG001|Overall Study|Protocol Violation|0|||
23544280|NCT04313634|65723039|FG002|Overall Study|Protocol Violation|1|||
23544281|NCT03314987|65723041|FG000|Overall Study|Lost to Follow-up|13|||
23617541|NCT00776984|65985204|FG001|Overall Study|Withdrawal by Subject|7|||
23617542|NCT00776984|65985203|FG000|Overall Study|Lack of Efficacy|0|||
23617543|NCT00776984|65985204|FG001|Overall Study|Lack of Efficacy|1|||
23617544|NCT00776984|65985203|FG000|Overall Study|Other|5|||
23617545|NCT00776984|65985204|FG001|Overall Study|Other|9|||
23617546|NCT00975130|65985205|FG000|Study Part 1|Adverse Event|150|||
23617547|NCT00975130|65985206|FG001|Study Part 1|Adverse Event|0|||
23617548|NCT00975130|65985207|FG002|Study Part 1|Adverse Event|0|||
23617549|NCT00975130|65985205|FG000|Study Part 1|Lost to Follow-up|19|||
23617550|NCT00975130|65985206|FG001|Study Part 1|Lost to Follow-up|0|||
23617551|NCT00975130|65985207|FG002|Study Part 1|Lost to Follow-up|0|||
23617552|NCT00975130|65985205|FG000|Study Part 1|Withdrawal by Subject|61|||
23617553|NCT00975130|65985206|FG001|Study Part 1|Withdrawal by Subject|0|||
23617554|NCT00975130|65985207|FG002|Study Part 1|Withdrawal by Subject|0|||
23617555|NCT00975130|65985205|FG000|Study Part 1|Protocol Violation|13|||
23617556|NCT00975130|65985206|FG001|Study Part 1|Protocol Violation|0|||
23617557|NCT00975130|65985207|FG002|Study Part 1|Protocol Violation|0|||
23617558|NCT00975130|65985205|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
23617559|NCT00975130|65985206|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
23617560|NCT00975130|65985207|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
23617561|NCT00975130|65985205|FG000|Study Part 1|Administrative|4|||
23617562|NCT00975130|65985206|FG001|Study Part 1|Administrative|0|||
23617563|NCT00975130|65985207|FG002|Study Part 1|Administrative|0|||
23617564|NCT00975130|65985205|FG000|Study Part 1|Withdrew Consent|24|||
23617565|NCT00975130|65985206|FG001|Study Part 1|Withdrew Consent|0|||
23617566|NCT00975130|65985207|FG002|Study Part 1|Withdrew Consent|0|||
23617567|NCT00975130|65985205|FG000|Study Part 2|Adverse Event|0|||
23617568|NCT00975130|65985206|FG001|Study Part 2|Adverse Event|14|||
23617569|NCT00975130|65985207|FG002|Study Part 2|Adverse Event|7|||
23617570|NCT00975130|65985205|FG000|Study Part 2|Lost to Follow-up|0|||
23617571|NCT00975130|65985206|FG001|Study Part 2|Lost to Follow-up|0|||
23617572|NCT00975130|65985207|FG002|Study Part 2|Lost to Follow-up|1|||
23617573|NCT00975130|65985205|FG000|Study Part 2|Withdrawal by Subject|0|||
23617574|NCT00975130|65985206|FG001|Study Part 2|Withdrawal by Subject|13|||
23617575|NCT00975130|65985207|FG002|Study Part 2|Withdrawal by Subject|5|||
23617576|NCT00975130|65985205|FG000|Study Part 2|Withdrew Consent|0|||
23617577|NCT00975130|65985206|FG001|Study Part 2|Withdrew Consent|6|||
23617578|NCT00975130|65985207|FG002|Study Part 2|Withdrew Consent|2|||
23617579|NCT00975130|65985205|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
23617580|NCT00975130|65985206|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
23617581|NCT00975130|65985207|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
23617582|NCT00975130|65985205|FG000|Study Part 2|Administrative|0|||
23617583|NCT00975130|65985206|FG001|Study Part 2|Administrative|1|||
23617584|NCT00975130|65985207|FG002|Study Part 2|Administrative|0|||
23617585|NCT00975130|65985205|FG000|Study Part 2|Protocol Violation|0|||
23617586|NCT00975130|65985206|FG001|Study Part 2|Protocol Violation|0|||
23617587|NCT00975130|65985207|FG002|Study Part 2|Protocol Violation|1|||
23617588|NCT04206384|65985208|FG000|Overall Study|Withdrawal by Subject|8|||
23617589|NCT04206384|65985208|FG000|Overall Study|Adverse Event|2|||
23617590|NCT02504502|65985209|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
23617591|NCT02504502|65985210|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
23617592|NCT02504502|65985209|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
23617593|NCT02504502|65985210|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
23617594|NCT03900715|65985211|FG000|Overall Study|Protocol Deviation|1|||
23617595|NCT03900715|65985211|FG000|Overall Study|Lack of Efficacy|1|||
23617596|NCT03900715|65985211|FG000|Overall Study|Progressive Disease|6|||
23617597|NCT03900715|65985211|FG000|Overall Study|Adverse Event|2|||
23617598|NCT03900715|65985211|FG000|Overall Study|Other reasons|11|||
23731343|NCT00441727|66395547|FG000|Overall Study|Safety Reasons|3|||
23731344|NCT00441727|66395548|FG001|Overall Study|Safety Reasons|1|||
23731345|NCT00441727|66395549|FG002|Overall Study|Safety Reasons|3|||
23731346|NCT00441727|66395547|FG000|Overall Study|Various reason specified|6|||
23731347|NCT00441727|66395548|FG001|Overall Study|Various reason specified|8|||
23731348|NCT00441727|66395549|FG002|Overall Study|Various reason specified|5|||
23731349|NCT01878175|66395550|FG000|Overall Study|Developed contraindicated health problem|2|||
23731350|NCT00846027|66395552|FG000|Overall Study|Death|3|||
23731351|NCT00846027|66395552|FG000|Overall Study|Disease Progression|30|||
23818305|NCT03138655|66714323|FG007|Overall Study|Reason not Specified|0|||
23617599|NCT02137239|65985212|FG000|Overall Study|Discontinued Study Treatment|0|||
23617600|NCT02137239|65985213|FG001|Overall Study|Discontinued Study Treatment|3|||
23617601|NCT02137239|65985212|FG000|Overall Study|Withdrew Consent|1|||
23617602|NCT02137239|65985213|FG001|Overall Study|Withdrew Consent|1|||
23617603|NCT02137239|65985212|FG000|Overall Study|Adverse Event|2|||
23731352|NCT00846027|66395552|FG000|Overall Study|Toxicity|12|||
23731353|NCT00846027|66395552|FG000|Overall Study|Patient Decision|7|||
23731354|NCT00846027|66395552|FG000|Overall Study|Investigator Discretion|29|||
23617604|NCT02137239|65985213|FG001|Overall Study|Adverse Event|2|||
23617605|NCT01747837|65985215|FG000|Overall Study|Lost to Follow-up|5|||
23731355|NCT00846027|66395552|FG000|Overall Study|Protocol Violation|2|||
23731356|NCT00846027|66395552|FG000|Overall Study|Subject Not Treated|7|||
23731357|NCT00691054|66395553|FG000|Overall Study|Withdrawal by Subject|1|||
23731358|NCT00772889|66395556|FG000|Overall Study|Adverse Event|7|||
23731359|NCT00772889|66395557|FG001|Overall Study|Adverse Event|4|||
23731360|NCT00772889|66395558|FG002|Overall Study|Adverse Event|0|||
23731361|NCT00772889|66395556|FG000|Overall Study|Withdrawal by Subject|9|||
23731362|NCT00772889|66395557|FG001|Overall Study|Withdrawal by Subject|8|||
23731363|NCT00772889|66395558|FG002|Overall Study|Withdrawal by Subject|9|||
23731364|NCT00772889|66395556|FG000|Overall Study|Lost to Follow-up|6|||
23731365|NCT00772889|66395557|FG001|Overall Study|Lost to Follow-up|6|||
23731366|NCT00772889|66395558|FG002|Overall Study|Lost to Follow-up|7|||
23731367|NCT00191386|66395561|FG000|Overall Study|Adverse Event|16|||
23731368|NCT00191386|66395561|FG000|Overall Study|Lost to Follow-up|1|||
23731369|NCT00191386|66395561|FG000|Overall Study|Entry Criteria Exclusion|3|||
23731370|NCT00191386|66395561|FG000|Overall Study|Protocol Violation|18|||
23731371|NCT00191386|66395561|FG000|Overall Study|Withdrawal by Subject|96|||
23731372|NCT00191386|66395561|FG000|Overall Study|Physician Decision|11|||
23731373|NCT00191386|66395561|FG000|Overall Study|Lack of Efficacy|15|||
23731374|NCT03137173|66395562|FG000|Overall Study|Withdrawal by Subject|8|||
23731375|NCT03137173|66395563|FG001|Overall Study|Withdrawal by Subject|13|||
23818306|NCT00813800|66714324|FG000|Overall Study|Screen Failure after Consent|2|||
23818307|NCT00813800|66714324|FG000|Overall Study|Adverse Event|1|||
23818308|NCT00813800|66714324|FG000|Overall Study|Worsening of depression|2|||
23818309|NCT00813800|66714324|FG000|Overall Study|Physician Decision|1|||
23818310|NCT04138823|66714327|FG000|Overall Study|Clinical disease progression|0|||
23818311|NCT04138823|66714328|FG001|Overall Study|Clinical disease progression|0|||
23818312|NCT04138823|66714329|FG002|Overall Study|Clinical disease progression|1|||
23818313|NCT04138823|66714327|FG000|Overall Study|Objective disease progression|3|||
23818314|NCT04138823|66714328|FG001|Overall Study|Objective disease progression|2|||
23818315|NCT04138823|66714329|FG002|Overall Study|Objective disease progression|5|||
23818316|NCT01860677|66714330|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
23617606|NCT01747837|65985216|FG001|Overall Study|Lost to Follow-up|2|||
23617607|NCT01747837|65985215|FG000|Overall Study|Death|4|||
23617608|NCT01747837|65985216|FG001|Overall Study|Death|4|||
23617609|NCT04482647|65985220|FG000|Overall Study|Time constraints|2|||
23617610|NCT04482647|65985220|FG000|Overall Study|Health issues|1|||
23617611|NCT04482647|65985220|FG000|Overall Study|Death in the family|1|||
23617612|NCT04482647|65985220|FG000|Overall Study|Disliked the intervention|1|||
23617613|NCT04482647|65985220|FG000|Overall Study|No reasons specified|7|||
23617614|NCT01287416|65985221|FG000|Pre-post Training|Withdrawal by Subject|17|||
23617615|NCT01287416|65985222|FG001|Pre-post Training|Withdrawal by Subject|24|||
23617616|NCT01287416|65985221|FG000|Pre-post Training|Lost to Follow-up|5|||
23617617|NCT01287416|65985222|FG001|Pre-post Training|Lost to Follow-up|1|||
23617618|NCT01287416|65985221|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23617619|NCT01287416|65985222|FG001|6 Month Follow-up|Lost to Follow-up|2|||
23617620|NCT01675050|65985224|FG000|Period One Treatment|Withdrawal by Subject|1|||
23617621|NCT01675050|65985225|FG001|Period One Treatment|Withdrawal by Subject|0|||
23617622|NCT02544113|65985227|FG000|Overall Study|Death|3|||
23818317|NCT01860677|66714331|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
23818318|NCT01464931|66714332|FG000|Overall Study|Withdrawal by Subject|1|||
23818319|NCT01464931|66714333|FG001|Overall Study|Withdrawal by Subject|0|||
23818320|NCT00384930|66714335|FG000|Overall Study|Adverse Event|5|||
23617623|NCT02544113|65985228|FG001|Overall Study|Death|4|||
23617624|NCT01475370|65985240|FG000|Overall Study|Exacerbation of primary disease|2|||
23617625|NCT01475370|65985241|FG001|Overall Study|Exacerbation of primary disease|2|||
23617626|NCT01475370|65985242|FG002|Overall Study|Exacerbation of primary disease|2|||
23617627|NCT01475370|65985240|FG000|Overall Study|Study drug administration difficult|0|||
23617628|NCT01475370|65985241|FG001|Overall Study|Study drug administration difficult|1|||
23617629|NCT01475370|65985242|FG002|Overall Study|Study drug administration difficult|1|||
23617630|NCT01475370|65985240|FG000|Overall Study|Other than specified|1|||
23617631|NCT01475370|65985241|FG001|Overall Study|Other than specified|0|||
23617632|NCT01475370|65985242|FG002|Overall Study|Other than specified|0|||
23617633|NCT01536535|65985244|FG000|Overall Study|Withdrawal by Subject|10|||
23617634|NCT01536535|65985245|FG001|Overall Study|Withdrawal by Subject|5|||
23731376|NCT03137173|66395562|FG000|Overall Study|Death|1|||
23731377|NCT03137173|66395563|FG001|Overall Study|Death|3|||
23731378|NCT03137173|66395562|FG000|Overall Study|Physician Decision|1|||
23731379|NCT03137173|66395563|FG001|Overall Study|Physician Decision|0|||
23731380|NCT03137173|66395562|FG000|Overall Study|Lost to Follow-up|13|||
23731381|NCT03137173|66395563|FG001|Overall Study|Lost to Follow-up|18|||
23731382|NCT03137173|66395562|FG000|Overall Study|Other reasons|3|||
23731383|NCT03137173|66395563|FG001|Overall Study|Other reasons|2|||
23731384|NCT01376908|66395566|FG000|Overall Study|Protocol Violation|1|||
23731385|NCT01376908|66395567|FG001|Overall Study|Protocol Violation|1|||
23818321|NCT00384930|66714336|FG001|Overall Study|Adverse Event|4|||
23818322|NCT00384930|66714337|FG002|Overall Study|Adverse Event|12|||
23617635|NCT01536535|65985244|FG000|Overall Study|Lost to Follow-up|4|||
23617636|NCT01536535|65985245|FG001|Overall Study|Lost to Follow-up|6|||
23544282|NCT03314987|65723042|FG001|Overall Study|Lost to Follow-up|13|||
23544283|NCT02079805|65723043|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23544284|NCT02079805|65723044|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23544285|NCT02079805|65723043|FG000|Overall Study|Voluntary Withdrawal|0|||
23544286|NCT02079805|65723044|FG001|Overall Study|Voluntary Withdrawal|1|||
23544287|NCT00941603|65723045|FG000|Overall Study|Adverse Event|10|||
23544288|NCT00941603|65723046|FG001|Overall Study|Adverse Event|15|||
23544289|NCT00941603|65723047|FG002|Overall Study|Adverse Event|5|||
23544290|NCT00941603|65723048|FG003|Overall Study|Adverse Event|1|||
23544291|NCT00941603|65723049|FG004|Overall Study|Adverse Event|4|||
23544292|NCT00941603|65723050|FG005|Overall Study|Adverse Event|0|||
23544293|NCT00941603|65723045|FG000|Overall Study|Lost to Follow-up|0|||
23544294|NCT00941603|65723046|FG001|Overall Study|Lost to Follow-up|0|||
23544295|NCT00941603|65723047|FG002|Overall Study|Lost to Follow-up|0|||
23617637|NCT01536535|65985244|FG000|Overall Study|Physician Decision|1|||
23617638|NCT01536535|65985245|FG001|Overall Study|Physician Decision|1|||
23617639|NCT01536535|65985244|FG000|Overall Study|Participant moved|0|||
23617640|NCT01536535|65985245|FG001|Overall Study|Participant moved|1|||
23617641|NCT03740737|65985246|FG000|Overall Study|Protocol deviation|13|||
23617642|NCT03740737|65985247|FG001|Overall Study|Protocol deviation|0|||
23617643|NCT03740737|65985246|FG000|Overall Study|Adverse Event|2|||
23617644|NCT03740737|65985247|FG001|Overall Study|Adverse Event|0|||
23617645|NCT03740737|65985246|FG000|Overall Study|Lost to Follow-up|1|||
23617646|NCT03740737|65985247|FG001|Overall Study|Lost to Follow-up|0|||
23617647|NCT03740737|65985246|FG000|Overall Study|Randomization failure|1|||
23617648|NCT03740737|65985247|FG001|Overall Study|Randomization failure|0|||
23617649|NCT03740737|65985246|FG000|Overall Study|Participant withdrew consent|1|||
23617650|NCT03740737|65985247|FG001|Overall Study|Participant withdrew consent|0|||
23617651|NCT03740737|65985246|FG000|Overall Study|Participant withdrew from trial|2|||
23617652|NCT03740737|65985247|FG001|Overall Study|Participant withdrew from trial|1|||
23617653|NCT01403805|65985248|FG000|Overall Study|Withdrawal by Subject|0|||
23544296|NCT00941603|65723048|FG003|Overall Study|Lost to Follow-up|1|||
23617654|NCT01403805|65985249|FG001|Overall Study|Withdrawal by Subject|4|||
23617655|NCT01403805|65985248|FG000|Overall Study|Lost to Follow-up|0|||
23617656|NCT01403805|65985249|FG001|Overall Study|Lost to Follow-up|2|||
23617657|NCT01403805|65985248|FG000|Overall Study|Death|0|||
23617658|NCT01403805|65985249|FG001|Overall Study|Death|1|||
23617659|NCT00946998|65985250|FG000|Overall Study|Exited prior to first outcome assessment|5|||
23617660|NCT00946998|65985251|FG001|Overall Study|Exited prior to first outcome assessment|3|||
23617661|NCT02186015|65988078|FG000|Overall Study|Physician Decision|1|||
23617662|NCT02186015|65988079|FG001|Overall Study|Physician Decision|0|||
23617663|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
23617664|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
23617665|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Adverse Event|4|||
23617666|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Adverse Event|1|||
23617667|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
23617668|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
23617669|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Physician Decision|0|||
23617670|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Physician Decision|2|||
23617671|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Death|1|||
23617672|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Death|0|||
23818323|NCT00384930|66714338|FG003|Overall Study|Adverse Event|11|||
23818324|NCT00384930|66714339|FG004|Overall Study|Adverse Event|14|||
23818325|NCT00384930|66714335|FG000|Overall Study|Entry Criteria Not Met|2|||
23818326|NCT00384930|66714336|FG001|Overall Study|Entry Criteria Not Met|6|||
23818327|NCT00384930|66714337|FG002|Overall Study|Entry Criteria Not Met|7|||
23818328|NCT00384930|66714338|FG003|Overall Study|Entry Criteria Not Met|8|||
23818329|NCT00384930|66714339|FG004|Overall Study|Entry Criteria Not Met|4|||
23818330|NCT00384930|66714335|FG000|Overall Study|Lack of Efficacy|1|||
23818331|NCT00384930|66714336|FG001|Overall Study|Lack of Efficacy|1|||
23818332|NCT00384930|66714337|FG002|Overall Study|Lack of Efficacy|2|||
23544297|NCT00941603|65723049|FG004|Overall Study|Lost to Follow-up|0|||
23544298|NCT00941603|65723050|FG005|Overall Study|Lost to Follow-up|2|||
23544299|NCT00941603|65723045|FG000|Overall Study|Withdrawal by Subject|0|||
23617673|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
23617674|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
23818333|NCT00384930|66714338|FG003|Overall Study|Lack of Efficacy|1|||
23544300|NCT00941603|65723046|FG001|Overall Study|Withdrawal by Subject|0|||
23544301|NCT00941603|65723047|FG002|Overall Study|Withdrawal by Subject|0|||
23544302|NCT00941603|65723048|FG003|Overall Study|Withdrawal by Subject|2|||
23544303|NCT00941603|65723049|FG004|Overall Study|Withdrawal by Subject|0|||
23617675|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
23617676|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
23617677|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Death|2|||
23818334|NCT00384930|66714339|FG004|Overall Study|Lack of Efficacy|2|||
23818335|NCT00384930|66714335|FG000|Overall Study|Lost to Follow-up|5|||
23818336|NCT00384930|66714336|FG001|Overall Study|Lost to Follow-up|3|||
23818337|NCT00384930|66714337|FG002|Overall Study|Lost to Follow-up|0|||
23818338|NCT00384930|66714338|FG003|Overall Study|Lost to Follow-up|4|||
23818339|NCT00384930|66714339|FG004|Overall Study|Lost to Follow-up|6|||
23818340|NCT00384930|66714335|FG000|Overall Study|Physician Decision|0|||
23818341|NCT00384930|66714336|FG001|Overall Study|Physician Decision|1|||
23818342|NCT00384930|66714337|FG002|Overall Study|Physician Decision|1|||
23818343|NCT00384930|66714338|FG003|Overall Study|Physician Decision|0|||
23818344|NCT00384930|66714339|FG004|Overall Study|Physician Decision|1|||
23818345|NCT00384930|66714335|FG000|Overall Study|Protocol Violation|1|||
23818346|NCT00384930|66714336|FG001|Overall Study|Protocol Violation|0|||
23818347|NCT00384930|66714337|FG002|Overall Study|Protocol Violation|1|||
23818348|NCT00384930|66714338|FG003|Overall Study|Protocol Violation|6|||
23818349|NCT00384930|66714339|FG004|Overall Study|Protocol Violation|4|||
23818350|NCT00384930|66714335|FG000|Overall Study|Sponsor Decision|3|||
23818351|NCT00384930|66714336|FG001|Overall Study|Sponsor Decision|4|||
23818352|NCT00384930|66714337|FG002|Overall Study|Sponsor Decision|0|||
23818353|NCT00384930|66714338|FG003|Overall Study|Sponsor Decision|5|||
23818354|NCT00384930|66714339|FG004|Overall Study|Sponsor Decision|0|||
23818355|NCT00384930|66714335|FG000|Overall Study|Withdrawal by Subject|9|||
23818356|NCT00384930|66714336|FG001|Overall Study|Withdrawal by Subject|7|||
23818357|NCT00384930|66714337|FG002|Overall Study|Withdrawal by Subject|7|||
23617678|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Death|1|||
23617679|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
23617680|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
23617681|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
23617682|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
23617683|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
23617684|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
23617685|NCT01946529|65988082|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
23617686|NCT01946529|65988083|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
23617687|NCT01946529|65988084|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
23617688|NCT01946529|65988082|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
23617689|NCT01946529|65988083|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
23617690|NCT01946529|65988084|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
23617691|NCT02250183|65988085|FG000|Overall Study|Withdrawal by Subject|2|||
23617692|NCT02250183|65988085|FG000|Overall Study|Adverse Event|5|||
23617693|NCT02250183|65988085|FG000|Overall Study|Lost to Follow-up|1|||
23617694|NCT01902381|65988086|FG000|Overall Study|Withdrawal by Subject|1|||
23617695|NCT00815919|65988087|FG000|Overall Study|Unrelated Fungal Infection|1|||
23617696|NCT00815919|65988087|FG000|Overall Study|AML Relapse|1|||
23617697|NCT00815919|65988087|FG000|Overall Study|Lack of Efficacy|2|||
23617698|NCT03721978|65988090|FG000|Overall Study|Withdrawal by Subject|6|||
23617699|NCT03721978|65988091|FG001|Overall Study|Withdrawal by Subject|1|||
23617700|NCT03721978|65988090|FG000|Overall Study|Adverse Event|1|||
23617701|NCT03721978|65988091|FG001|Overall Study|Adverse Event|1|||
23617702|NCT03721978|65988090|FG000|Overall Study|Progressive Disease|1|||
23617703|NCT03721978|65988091|FG001|Overall Study|Progressive Disease|0|||
23617704|NCT03721978|65988090|FG000|Overall Study|Lost to Follow-up|5|||
23617705|NCT03721978|65988091|FG001|Overall Study|Lost to Follow-up|1|||
23617706|NCT03721978|65988090|FG000|Overall Study|Reason not Specified|0|||
23617707|NCT03721978|65988091|FG001|Overall Study|Reason not Specified|2|||
23617708|NCT00630552|65988092|FG000|Overall Study|Adverse Event|0|||
23617709|NCT00630552|65988093|FG001|Overall Study|Adverse Event|1|||
23617710|NCT00630552|65988094|FG002|Overall Study|Adverse Event|5|||
23617711|NCT00630552|65988095|FG003|Overall Study|Adverse Event|4|||
23617712|NCT00630552|65988096|FG004|Overall Study|Adverse Event|2|||
23617713|NCT00630552|65988092|FG000|Overall Study|Disease progression|5|||
23617714|NCT00630552|65988093|FG001|Overall Study|Disease progression|6|||
23617715|NCT00630552|65988094|FG002|Overall Study|Disease progression|27|||
23617716|NCT00630552|65988095|FG003|Overall Study|Disease progression|22|||
23617717|NCT00630552|65988096|FG004|Overall Study|Disease progression|31|||
23818358|NCT00384930|66714338|FG003|Overall Study|Withdrawal by Subject|6|||
23818359|NCT00384930|66714339|FG004|Overall Study|Withdrawal by Subject|16|||
23818360|NCT00384930|66714335|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
23617718|NCT00630552|65988092|FG000|Overall Study|Never received IP|0|||
23617719|NCT00630552|65988093|FG001|Overall Study|Never received IP|0|||
23818361|NCT00384930|66714336|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
23818362|NCT00384930|66714337|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23818363|NCT00384930|66714338|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23818364|NCT00384930|66714339|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23617720|NCT00630552|65988094|FG002|Overall Study|Never received IP|0|||
23617721|NCT00630552|65988095|FG003|Overall Study|Never received IP|2|||
23617722|NCT00630552|65988096|FG004|Overall Study|Never received IP|2|||
23818365|NCT00459043|66714340|FG000|Overall Study|Withdrawal by Subject|1|||
23617723|NCT00630552|65988092|FG000|Overall Study|Ineligibility determined|0|||
23617724|NCT00630552|65988093|FG001|Overall Study|Ineligibility determined|0|||
23617725|NCT00630552|65988094|FG002|Overall Study|Ineligibility determined|0|||
23617726|NCT00630552|65988095|FG003|Overall Study|Ineligibility determined|0|||
23617727|NCT00630552|65988096|FG004|Overall Study|Ineligibility determined|1|||
23617728|NCT00630552|65988092|FG000|Overall Study|Protocol Violation|0|||
23617729|NCT00630552|65988093|FG001|Overall Study|Protocol Violation|0|||
23617730|NCT00630552|65988094|FG002|Overall Study|Protocol Violation|0|||
23617731|NCT00630552|65988095|FG003|Overall Study|Protocol Violation|1|||
23617732|NCT00630552|65988096|FG004|Overall Study|Protocol Violation|0|||
23617733|NCT00630552|65988092|FG000|Overall Study|Physician Decision|0|||
23617734|NCT00630552|65988093|FG001|Overall Study|Physician Decision|0|||
23617735|NCT00630552|65988094|FG002|Overall Study|Physician Decision|0|||
23617736|NCT00630552|65988095|FG003|Overall Study|Physician Decision|0|||
23818366|NCT00459043|66714341|FG001|Overall Study|Withdrawal by Subject|0|||
23818367|NCT02787408|66714344|FG000|Overall Study|Death|16|||
23818368|NCT02787408|66714344|FG000|Overall Study|Withdrawal by Subject|1|||
23818369|NCT02787408|66714344|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
23818370|NCT03597464|66714345|FG000|Overall Study|Withdrawal by Subject|4|||
23818371|NCT03597464|66714346|FG001|Overall Study|Withdrawal by Subject|5|||
23617737|NCT00630552|65988096|FG004|Overall Study|Physician Decision|1|||
23617738|NCT00630552|65988092|FG000|Overall Study|Death|0|||
23617739|NCT00630552|65988093|FG001|Overall Study|Death|0|||
23617740|NCT00630552|65988094|FG002|Overall Study|Death|1|||
23617741|NCT00630552|65988095|FG003|Overall Study|Death|2|||
23617742|NCT00630552|65988096|FG004|Overall Study|Death|2|||
23617743|NCT00630552|65988092|FG000|Overall Study|Withdrawal by Subject|0|||
23617744|NCT00630552|65988093|FG001|Overall Study|Withdrawal by Subject|0|||
23617745|NCT00630552|65988094|FG002|Overall Study|Withdrawal by Subject|0|||
23617746|NCT00630552|65988095|FG003|Overall Study|Withdrawal by Subject|1|||
23617747|NCT00630552|65988096|FG004|Overall Study|Withdrawal by Subject|0|||
23617748|NCT00630552|65988092|FG000|Overall Study|Other|0|||
23617749|NCT00630552|65988093|FG001|Overall Study|Other|0|||
23617750|NCT00630552|65988094|FG002|Overall Study|Other|4|||
23617751|NCT00630552|65988095|FG003|Overall Study|Other|2|||
23617752|NCT00630552|65988096|FG004|Overall Study|Other|0|||
23617753|NCT05012397|65988098|FG000|Overall Study|Death|10|||
23617754|NCT05012397|65988098|FG000|Overall Study|Physician Decision|9|||
23731386|NCT01376908|66395566|FG000|Overall Study|Withdrawal by Subject|1|||
23731387|NCT01376908|66395567|FG001|Overall Study|Withdrawal by Subject|2|||
23731388|NCT02142712|66395570|FG000|Overall Study|Lost to Follow-up|1|||
23731389|NCT02142712|66395571|FG001|Overall Study|Lost to Follow-up|1|||
23731390|NCT02142712|66395572|FG002|Overall Study|Lost to Follow-up|1|||
23731391|NCT02142712|66395573|FG003|Overall Study|Lost to Follow-up|0|||
23731392|NCT02181504|66395576|FG000|Overall Study|Adverse Event|1|||
23731393|NCT02181504|66395577|FG001|Overall Study|Adverse Event|1|||
23731394|NCT02181504|66395578|FG002|Overall Study|Adverse Event|1|||
23731395|NCT00068822|66395581|FG000|First Randomized Intervention|Lost to Follow-up|1|||
23731396|NCT00068822|66395582|FG001|First Randomized Intervention|Lost to Follow-up|2|||
23731397|NCT00420212|66395585|FG000|Overall Study|Adverse Event|22|||
23731398|NCT00420212|66395586|FG001|Overall Study|Adverse Event|40|||
23731399|NCT00420212|66395587|FG002|Overall Study|Adverse Event|36|||
23731400|NCT00420212|66395585|FG000|Overall Study|Lost to Follow-up|9|||
23731401|NCT00420212|66395586|FG001|Overall Study|Lost to Follow-up|11|||
23731402|NCT00420212|66395587|FG002|Overall Study|Lost to Follow-up|11|||
23731403|NCT00420212|66395585|FG000|Overall Study|Withdrawal by Subject|31|||
23731404|NCT00420212|66395586|FG001|Overall Study|Withdrawal by Subject|22|||
23731405|NCT00420212|66395587|FG002|Overall Study|Withdrawal by Subject|19|||
23731406|NCT00420212|66395585|FG000|Overall Study|Physician Decision|4|||
23731407|NCT00420212|66395586|FG001|Overall Study|Physician Decision|4|||
23731408|NCT00420212|66395587|FG002|Overall Study|Physician Decision|3|||
23731409|NCT00420212|66395585|FG000|Overall Study|Protocol Violation|4|||
23731410|NCT00420212|66395586|FG001|Overall Study|Protocol Violation|4|||
23731411|NCT00420212|66395587|FG002|Overall Study|Protocol Violation|8|||
23731412|NCT00420212|66395585|FG000|Overall Study|Death|0|||
23731413|NCT00420212|66395586|FG001|Overall Study|Death|0|||
23731414|NCT00420212|66395587|FG002|Overall Study|Death|1|||
23731415|NCT00420212|66395585|FG000|Overall Study|Other-Unspecified|21|||
23731416|NCT00420212|66395586|FG001|Overall Study|Other-Unspecified|14|||
23731417|NCT00420212|66395587|FG002|Overall Study|Other-Unspecified|18|||
23731418|NCT01100658|66395588|FG000|Overall Study|Withdrawal by Subject|1|||
23731419|NCT02096471|66395590|FG000|Overall Study|Adverse Event|1|||
23731420|NCT02096471|66395590|FG000|Overall Study|Lack of Efficacy|7|||
23731421|NCT02096471|66395590|FG000|Overall Study|Withdrawal by Subject|3|||
23617755|NCT05012397|65988098|FG000|Overall Study|Withdrawal by Subject|5|||
23617756|NCT05012397|65988098|FG000|Overall Study|Lost to Follow-up|2|||
23617757|NCT02421939|65988101|FG000|Overall Study|Progressive disease|70|||
23617758|NCT02421939|65988102|FG001|Overall Study|Progressive disease|16|||
23617759|NCT02421939|65988101|FG000|Overall Study|Lack of Efficacy|21|||
23731422|NCT02096471|66395590|FG000|Overall Study|Non-Compliant|2|||
23617760|NCT02421939|65988102|FG001|Overall Study|Lack of Efficacy|31|||
23617761|NCT02421939|65988101|FG000|Overall Study|Death|36|||
23617762|NCT02421939|65988102|FG001|Overall Study|Death|10|||
23617763|NCT02421939|65988101|FG000|Overall Study|Disease relapse|33|||
23617764|NCT02421939|65988102|FG001|Overall Study|Disease relapse|2|||
23617765|NCT02421939|65988101|FG000|Overall Study|Adverse Event|28|||
23617766|NCT02421939|65988102|FG001|Overall Study|Adverse Event|5|||
23617767|NCT02421939|65988101|FG000|Overall Study|Withdrawal by Subject|5|||
23617768|NCT02421939|65988102|FG001|Overall Study|Withdrawal by Subject|24|||
23617769|NCT02421939|65988101|FG000|Overall Study|Physician Decision|11|||
23617770|NCT02421939|65988102|FG001|Overall Study|Physician Decision|11|||
23617771|NCT02421939|65988101|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
23731423|NCT00472043|66395591|FG000|Overall Study|Withdrawal by Subject|1|||
23818372|NCT03597464|66714345|FG000|Overall Study|Lost to Follow-up|3|||
23818373|NCT03597464|66714346|FG001|Overall Study|Lost to Follow-up|1|||
23731424|NCT00472043|66395592|FG001|Overall Study|Withdrawal by Subject|0|||
23731425|NCT00472043|66395591|FG000|Overall Study|Death|1|||
23731426|NCT00472043|66395592|FG001|Overall Study|Death|0|||
23731427|NCT00364832|66395595|FG000|Core Period|Early Withdrawals|2|||
23731428|NCT00364832|66395596|FG001|Core Period|Early Withdrawals|2|||
23731429|NCT00364832|66395597|FG002|Core Period|Early Withdrawals|1|||
23731430|NCT00364832|66395598|FG003|Core Period|Early Withdrawals|1|||
23731431|NCT00364832|66395599|FG004|Core Period|Early Withdrawals|0|||
23731432|NCT00364832|66395600|FG005|Core Period|Early Withdrawals|0|||
23731433|NCT00364832|66395601|FG006|Core Period|Early Withdrawals|4|||
23731434|NCT00364832|66395602|FG007|Core Period|Early Withdrawals|1|||
23731435|NCT00364832|66395603|FG008|Core Period|Early Withdrawals|0|||
23731436|NCT00364832|66395604|FG009|Core Period|Early Withdrawals|0|||
23731437|NCT00364832|66395605|FG010|Core Period|Early Withdrawals|0|||
23731438|NCT00364832|66395606|FG011|Core Period|Early Withdrawals|0|||
23731439|NCT00364832|66395595|FG000|Extension Year 1|Early Withdrawals|0|||
23731440|NCT00364832|66395596|FG001|Extension Year 1|Early Withdrawals|0|||
23731441|NCT00364832|66395597|FG002|Extension Year 1|Early Withdrawals|0|||
23731442|NCT00364832|66395598|FG003|Extension Year 1|Early Withdrawals|0|||
23731443|NCT00364832|66395599|FG004|Extension Year 1|Early Withdrawals|0|||
23731444|NCT00364832|66395600|FG005|Extension Year 1|Early Withdrawals|0|||
23731445|NCT00364832|66395601|FG006|Extension Year 1|Early Withdrawals|0|||
23731446|NCT00364832|66395602|FG007|Extension Year 1|Early Withdrawals|0|||
23731447|NCT00364832|66395603|FG008|Extension Year 1|Early Withdrawals|0|||
23731448|NCT00364832|66395604|FG009|Extension Year 1|Early Withdrawals|4|||
23731449|NCT00364832|66395605|FG010|Extension Year 1|Early Withdrawals|2|||
23731450|NCT00364832|66395606|FG011|Extension Year 1|Early Withdrawals|10|||
23731451|NCT00364832|66395595|FG000|Extension Year 2|Early Withdrawals|0|||
23731452|NCT00364832|66395596|FG001|Extension Year 2|Early Withdrawals|0|||
23731453|NCT00364832|66395597|FG002|Extension Year 2|Early Withdrawals|0|||
23731454|NCT00364832|66395598|FG003|Extension Year 2|Early Withdrawals|0|||
23731455|NCT00364832|66395599|FG004|Extension Year 2|Early Withdrawals|0|||
23731456|NCT00364832|66395600|FG005|Extension Year 2|Early Withdrawals|0|||
23731457|NCT00364832|66395601|FG006|Extension Year 2|Early Withdrawals|0|||
23731458|NCT00364832|66395602|FG007|Extension Year 2|Early Withdrawals|0|||
23731459|NCT00364832|66395603|FG008|Extension Year 2|Early Withdrawals|0|||
23731460|NCT00364832|66395604|FG009|Extension Year 2|Early Withdrawals|5|||
23731461|NCT00364832|66395605|FG010|Extension Year 2|Early Withdrawals|5|||
23731462|NCT00364832|66395606|FG011|Extension Year 2|Early Withdrawals|3|||
23731463|NCT00621244|66395608|FG000|Overall Study|Withdrawal by Subject|7|||
23731464|NCT00621244|66395609|FG001|Overall Study|Withdrawal by Subject|3|||
23731465|NCT00621244|66395610|FG002|Overall Study|Withdrawal by Subject|3|||
23731466|NCT00621244|66395611|FG003|Overall Study|Withdrawal by Subject|3|||
23731467|NCT00621244|66395608|FG000|Overall Study|Disease progression|44|||
23731468|NCT00621244|66395609|FG001|Overall Study|Disease progression|20|||
23617772|NCT02421939|65988102|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
23617773|NCT02421939|65988101|FG000|Overall Study|Miscellaneous|4|||
23617774|NCT02421939|65988102|FG001|Overall Study|Miscellaneous|5|||
23731469|NCT00621244|66395610|FG002|Overall Study|Disease progression|20|||
23731470|NCT00621244|66395611|FG003|Overall Study|Disease progression|15|||
23731471|NCT00621244|66395608|FG000|Overall Study|Death|3|||
23731472|NCT00621244|66395609|FG001|Overall Study|Death|3|||
23731473|NCT00621244|66395610|FG002|Overall Study|Death|1|||
23731474|NCT00621244|66395611|FG003|Overall Study|Death|1|||
23731475|NCT00621244|66395608|FG000|Overall Study|Adverse Event|27|||
23731476|NCT00621244|66395609|FG001|Overall Study|Adverse Event|7|||
23731477|NCT00621244|66395610|FG002|Overall Study|Adverse Event|9|||
23731478|NCT00621244|66395611|FG003|Overall Study|Adverse Event|2|||
23731479|NCT00621244|66395608|FG000|Overall Study|Administrative problems|5|||
23731480|NCT00621244|66395609|FG001|Overall Study|Administrative problems|1|||
23617775|NCT02421939|65988101|FG000|Overall Study|Protocol deviation|1|||
23617776|NCT02421939|65988102|FG001|Overall Study|Protocol deviation|1|||
23731481|NCT00621244|66395610|FG002|Overall Study|Administrative problems|0|||
23818374|NCT03597464|66714345|FG000|Overall Study|Pregnancy|3|||
23731482|NCT00621244|66395611|FG003|Overall Study|Administrative problems|2|||
23731483|NCT05375838|66395615|FG000|Overall Study|Other|0|||
23731484|NCT05375838|66395616|FG001|Overall Study|Other|0|||
23731485|NCT05375838|66395617|FG002|Overall Study|Other|0|||
23731486|NCT05375838|66395618|FG003|Overall Study|Other|1|||
23731487|NCT05375838|66395619|FG004|Overall Study|Other|1|||
23731488|NCT05375838|66395620|FG005|Overall Study|Other|0|||
23731489|NCT05375838|66395615|FG000|Overall Study|Withdrawal by Subject|2|||
23731490|NCT05375838|66395616|FG001|Overall Study|Withdrawal by Subject|1|||
23731491|NCT05375838|66395617|FG002|Overall Study|Withdrawal by Subject|3|||
23731492|NCT05375838|66395618|FG003|Overall Study|Withdrawal by Subject|2|||
23731493|NCT05375838|66395619|FG004|Overall Study|Withdrawal by Subject|2|||
23731494|NCT05375838|66395620|FG005|Overall Study|Withdrawal by Subject|0|||
23731495|NCT05375838|66395615|FG000|Overall Study|Protocol Violation|0|||
23731496|NCT05375838|66395616|FG001|Overall Study|Protocol Violation|0|||
23731497|NCT05375838|66395617|FG002|Overall Study|Protocol Violation|0|||
23731498|NCT05375838|66395618|FG003|Overall Study|Protocol Violation|0|||
23731499|NCT05375838|66395619|FG004|Overall Study|Protocol Violation|1|||
23731500|NCT05375838|66395620|FG005|Overall Study|Protocol Violation|0|||
23731501|NCT05375838|66395615|FG000|Overall Study|Physician Decision|0|||
23731502|NCT05375838|66395616|FG001|Overall Study|Physician Decision|1|||
23731503|NCT05375838|66395617|FG002|Overall Study|Physician Decision|0|||
23731504|NCT05375838|66395618|FG003|Overall Study|Physician Decision|0|||
23731505|NCT05375838|66395619|FG004|Overall Study|Physician Decision|0|||
23731506|NCT05375838|66395620|FG005|Overall Study|Physician Decision|1|||
23731507|NCT05375838|66395615|FG000|Overall Study|Lost to Follow-up|2|||
23731508|NCT05375838|66395616|FG001|Overall Study|Lost to Follow-up|7|||
23731509|NCT05375838|66395617|FG002|Overall Study|Lost to Follow-up|0|||
23731510|NCT05375838|66395618|FG003|Overall Study|Lost to Follow-up|4|||
23731511|NCT05375838|66395619|FG004|Overall Study|Lost to Follow-up|2|||
23731512|NCT05375838|66395620|FG005|Overall Study|Lost to Follow-up|3|||
23731513|NCT02565576|66395623|FG000|Overall Study|abnormal lab value|2|||
23731514|NCT02565576|66395624|FG001|Overall Study|abnormal lab value|0|||
23731515|NCT02565576|66395623|FG000|Overall Study|subject / guardian decision|1|||
23731516|NCT02565576|66395624|FG001|Overall Study|subject / guardian decision|3|||
23731517|NCT02565576|66395623|FG000|Overall Study|Lost to Follow-up|1|||
23731518|NCT02565576|66395624|FG001|Overall Study|Lost to Follow-up|0|||
23731519|NCT02565576|66395623|FG000|Overall Study|Death|0|||
23731520|NCT02565576|66395624|FG001|Overall Study|Death|2|||
23731521|NCT02565576|66395623|FG000|Overall Study|Adverse Event|1|||
23731522|NCT02565576|66395624|FG001|Overall Study|Adverse Event|0|||
23731523|NCT01594411|66395625|FG000|Overall Study|Lost to Follow-up|2|||
23731524|NCT01222416|66395626|FG000|Overall Study|ineligible;metastasis|3|||
23731525|NCT01222416|66395627|FG001|Overall Study|ineligible;metastasis|0|||
23731526|NCT01222416|66395626|FG000|Overall Study|Adverse Event|4|||
23731527|NCT01222416|66395627|FG001|Overall Study|Adverse Event|0|||
23731528|NCT01222416|66395626|FG000|Overall Study|Withdrawal by Subject|5|||
23731529|NCT01222416|66395627|FG001|Overall Study|Withdrawal by Subject|0|||
23731530|NCT01222416|66395626|FG000|Overall Study|scheduling|6|||
23731531|NCT01222416|66395627|FG001|Overall Study|scheduling|0|||
23731532|NCT01222416|66395626|FG000|Overall Study|missed view/scan|1|||
23426147|NCT00413374|65303535|FG000|Overall Study|Lost to Follow-up|1|||
23426148|NCT00413374|65303536|FG001|Overall Study|Lost to Follow-up|0|||
23731533|NCT01222416|66395627|FG001|Overall Study|missed view/scan|0|||
23731534|NCT01222416|66395626|FG000|Overall Study|Death|1|||
23731535|NCT01222416|66395627|FG001|Overall Study|Death|0|||
23731536|NCT03303625|66395628|FG000|Overall Study|Withdrawal by Subject|2|||
23731537|NCT03303625|66395629|FG001|Overall Study|Withdrawal by Subject|0|||
23731538|NCT03303625|66395630|FG002|Overall Study|Withdrawal by Subject|0|||
23731539|NCT03303625|66395631|FG003|Overall Study|Withdrawal by Subject|0|||
23731540|NCT02274311|66395632|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
23731541|NCT01081951|66395635|FG000|Overall Study|Death|54|||
23731542|NCT01081951|66395636|FG001|Overall Study|Death|47|||
23731543|NCT01081951|66395635|FG000|Overall Study|Withdrawal by Subject|2|||
23731544|NCT01081951|66395636|FG001|Overall Study|Withdrawal by Subject|6|||
23731545|NCT01081951|66395635|FG000|Overall Study|Allocated treatment but did not take it|0|||
23731546|NCT01081951|66395636|FG001|Overall Study|Allocated treatment but did not take it|1|||
23731547|NCT01081951|66395635|FG000|Overall Study|Lost to Follow-up|0|||
23731548|NCT01081951|66395636|FG001|Overall Study|Lost to Follow-up|1|||
23731549|NCT00948194|66395637|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
23731550|NCT00948194|66395638|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
23731551|NCT02892734|66395639|FG000|Treatment on Study|Progressive Disease|2|||
23731552|NCT02892734|66395639|FG000|Follow up for 2 Years|Death|2|||
23731553|NCT02892734|66395639|FG000|Follow up for 2 Years|Study closed early|1|||
23731554|NCT01957215|66395640|FG000|Overall Study|Adverse Event|2|||
23731555|NCT01957215|66395641|FG001|Overall Study|Adverse Event|2|||
23731556|NCT01957215|66395640|FG000|Overall Study|Lost to Follow-up|3|||
23731557|NCT01957215|66395641|FG001|Overall Study|Lost to Follow-up|3|||
23617777|NCT05896696|65988107|FG000|Overall Study|Screening Failure|7|||
23617778|NCT05896696|65988107|FG000|Overall Study|Withdrawal by Subject|2|||
23617779|NCT03568708|65988109|FG000|Overall Study|Withdrawal by Subject|1|||
23617780|NCT03568708|65988110|FG001|Overall Study|Withdrawal by Subject|1|||
23617781|NCT03568708|65988109|FG000|Overall Study|Lost to Follow-up|0|||
23617782|NCT03568708|65988110|FG001|Overall Study|Lost to Follow-up|1|||
23617783|NCT02402465|65988111|FG000|Overall Study|Withdrawal by Subject|0|||
23617784|NCT02402465|65988112|FG001|Overall Study|Withdrawal by Subject|0|||
23617785|NCT02402465|65988113|FG002|Overall Study|Withdrawal by Subject|0|||
23617786|NCT02402465|65988114|FG003|Overall Study|Withdrawal by Subject|0|||
23617787|NCT02402465|65988115|FG004|Overall Study|Withdrawal by Subject|0|||
23617788|NCT02402465|65988116|FG005|Overall Study|Withdrawal by Subject|1|||
23617789|NCT02402465|65988111|FG000|Overall Study|Lost to Follow-up|0|||
23731558|NCT01957215|66395640|FG000|Overall Study|Protocol Violation|1|||
23731559|NCT01957215|66395641|FG001|Overall Study|Protocol Violation|2|||
23731560|NCT01957215|66395640|FG000|Overall Study|Withdrawal by Subject|7|||
23731561|NCT01957215|66395641|FG001|Overall Study|Withdrawal by Subject|5|||
23731562|NCT03685643|66395647|FG000|Overall Study|Lost to Follow-up|14|||
23731563|NCT03685643|66395648|FG001|Overall Study|Lost to Follow-up|22|||
23731564|NCT02094612|66395649|FG000|Overall Study|Lost to Follow-up|47|||
23731565|NCT02094612|66395650|FG001|Overall Study|Lost to Follow-up|47|||
23617790|NCT02402465|65988112|FG001|Overall Study|Lost to Follow-up|1|||
23617791|NCT02402465|65988113|FG002|Overall Study|Lost to Follow-up|0|||
23617792|NCT02402465|65988114|FG003|Overall Study|Lost to Follow-up|0|||
23617793|NCT02402465|65988115|FG004|Overall Study|Lost to Follow-up|1|||
23617794|NCT02402465|65988116|FG005|Overall Study|Lost to Follow-up|0|||
23617795|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Discomfort|1|||
23617796|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Discomfort|0|||
23617797|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23617798|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23617799|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
23617800|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
23617801|NCT02815735|65988124|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
23617802|NCT02815735|65988125|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
23617803|NCT04413149|65988128|FG000|Overall Study|Death|10|||
23818375|NCT03597464|66714346|FG001|Overall Study|Pregnancy|1|||
23818376|NCT03597464|66714345|FG000|Overall Study|Lack of Efficacy|2|||
23818377|NCT03597464|66714346|FG001|Overall Study|Lack of Efficacy|0|||
23818378|NCT03597464|66714345|FG000|Overall Study|Physician Decision|2|||
23818379|NCT03597464|66714346|FG001|Overall Study|Physician Decision|2|||
23818380|NCT03597464|66714345|FG000|Overall Study|Protocol Violation|1|||
23617804|NCT04413149|65988129|FG001|Overall Study|Death|5|||
23617805|NCT04413149|65988128|FG000|Overall Study|Lung transplantation|1|||
23617806|NCT04413149|65988129|FG001|Overall Study|Lung transplantation|0|||
23617807|NCT00744796|65988130|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
23617808|NCT02093897|65988131|FG000|Overall Study|Physician Decision|1|||
23818381|NCT03597464|66714346|FG001|Overall Study|Protocol Violation|1|||
23544304|NCT00941603|65723050|FG005|Overall Study|Withdrawal by Subject|1|||
23544305|NCT00941603|65723045|FG000|Overall Study|Protocol Violation|0|||
23544306|NCT00941603|65723046|FG001|Overall Study|Protocol Violation|1|||
23544307|NCT00941603|65723047|FG002|Overall Study|Protocol Violation|0|||
23544308|NCT00941603|65723048|FG003|Overall Study|Protocol Violation|0|||
23544309|NCT00941603|65723049|FG004|Overall Study|Protocol Violation|0|||
23544310|NCT00941603|65723050|FG005|Overall Study|Protocol Violation|0|||
23544311|NCT00941603|65723045|FG000|Overall Study|Did not meet protocol eligibility|1|||
23544312|NCT00941603|65723046|FG001|Overall Study|Did not meet protocol eligibility|0|||
23544313|NCT00941603|65723047|FG002|Overall Study|Did not meet protocol eligibility|0|||
23544314|NCT00941603|65723048|FG003|Overall Study|Did not meet protocol eligibility|0|||
23544315|NCT00941603|65723049|FG004|Overall Study|Did not meet protocol eligibility|0|||
23544316|NCT00941603|65723050|FG005|Overall Study|Did not meet protocol eligibility|0|||
23544317|NCT01043874|65723051|FG000|Overall Study|Adverse Event|3|||
23544318|NCT01043874|65723051|FG000|Overall Study|Withdrawal by Subject|1|||
23544319|NCT01043874|65723051|FG000|Overall Study|Lack of Efficacy|1|||
23544320|NCT01043874|65723051|FG000|Overall Study|Administrative Problems|1|||
23544321|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
23544322|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
23544323|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
23731566|NCT02094612|66395649|FG000|Overall Study|Never started ADHD medication|32|||
23544324|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
23544325|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Death|235|||
23544326|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Death|167|||
23617809|NCT02093897|65988131|FG000|Overall Study|Planned age group closure - no's reached|17|||
23617810|NCT02093897|65988131|FG000|Overall Study|Adverse event, non-fatal|1|||
23731567|NCT02094612|66395650|FG001|Overall Study|Never started ADHD medication|23|||
23731568|NCT02750501|66395651|FG000|Overall Study|Adverse Event|4|||
23818382|NCT03597464|66714345|FG000|Overall Study|Adverse Event|0|||
23731569|NCT02750501|66395651|FG000|Overall Study|Physician Decision|1|||
23731570|NCT02750501|66395651|FG000|Overall Study|Protocol Violation|1|||
23731571|NCT02750501|66395651|FG000|Overall Study|G-tube came out|1|||
23731572|NCT02750501|66395651|FG000|Overall Study|Non-compliant use of PERT|1|||
23731573|NCT03733249|66395658|FG000|Overall Study|Death|7|||
23731574|NCT03733249|66395658|FG000|Overall Study|Disease relapse|16|||
23731575|NCT03733249|66395658|FG000|Overall Study|Lost to Follow-up|4|||
23731576|NCT03733249|66395658|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
23731577|NCT03733249|66395658|FG000|Overall Study|Withdrawal by Subject|1|||
23731578|NCT00853112|66395659|FG000|Overall Study|Randomized but not treated|0|||
23731579|NCT00853112|66395660|FG001|Overall Study|Randomized but not treated|1|||
23731580|NCT00853112|66395661|FG002|Overall Study|Randomized but not treated|0|||
23731581|NCT00853112|66395662|FG003|Overall Study|Randomized but not treated|2|||
23731582|NCT00853112|66395663|FG004|Overall Study|Randomized but not treated|0|||
23731583|NCT00853112|66395664|FG005|Overall Study|Randomized but not treated|0|||
23731584|NCT00853112|66395665|FG006|Overall Study|Randomized but not treated|1|||
23731585|NCT03898323|66395666|FG000|Overall Study|Physician Decision|1|||
23731586|NCT00957034|66395667|FG000|Overall Study|Adverse Event|0|||
23731587|NCT00957034|66395668|FG001|Overall Study|Adverse Event|1|||
23731588|NCT00957034|66395669|FG002|Overall Study|Adverse Event|1|||
23731589|NCT00957034|66395667|FG000|Overall Study|Sponsor Terminated Study|6|||
23731590|NCT00957034|66395668|FG001|Overall Study|Sponsor Terminated Study|1|||
23731591|NCT00957034|66395669|FG002|Overall Study|Sponsor Terminated Study|5|||
23731592|NCT00957034|66395667|FG000|Overall Study|Withdrawal by Subject|0|||
23731593|NCT00957034|66395668|FG001|Overall Study|Withdrawal by Subject|2|||
23731594|NCT00957034|66395669|FG002|Overall Study|Withdrawal by Subject|0|||
23731595|NCT01708915|66395670|FG000|Overall Study|Adverse Event|1|||
23731596|NCT01708915|66395671|FG001|Overall Study|Adverse Event|0|||
23731597|NCT01708915|66395672|FG002|Overall Study|Adverse Event|9|||
23731598|NCT01708915|66395673|FG003|Overall Study|Adverse Event|13|||
23731599|NCT01708915|66395670|FG000|Overall Study|Lack of Efficacy|84|||
23731600|NCT01708915|66395671|FG001|Overall Study|Lack of Efficacy|60|||
23731601|NCT01708915|66395672|FG002|Overall Study|Lack of Efficacy|35|||
23731602|NCT01708915|66395673|FG003|Overall Study|Lack of Efficacy|15|||
23731603|NCT01708915|66395670|FG000|Overall Study|Protocol Violation|0|||
23731604|NCT01708915|66395671|FG001|Overall Study|Protocol Violation|0|||
23731605|NCT01708915|66395672|FG002|Overall Study|Protocol Violation|0|||
23731606|NCT01708915|66395673|FG003|Overall Study|Protocol Violation|1|||
23731607|NCT01708915|66395670|FG000|Overall Study|Withdrawal by Subject|0|||
23731608|NCT01708915|66395671|FG001|Overall Study|Withdrawal by Subject|1|||
23731609|NCT01708915|66395672|FG002|Overall Study|Withdrawal by Subject|2|||
23731610|NCT01708915|66395673|FG003|Overall Study|Withdrawal by Subject|2|||
23731611|NCT01708915|66395670|FG000|Overall Study|Other reasons than stated above|1|||
23731612|NCT01708915|66395671|FG001|Overall Study|Other reasons than stated above|1|||
23731613|NCT01708915|66395672|FG002|Overall Study|Other reasons than stated above|0|||
23731614|NCT01708915|66395673|FG003|Overall Study|Other reasons than stated above|2|||
23731615|NCT02574520|66395677|FG000|Overall Study|Not dosed|2|||
23731616|NCT02574520|66395678|FG001|Overall Study|Not dosed|0|||
23731617|NCT02574520|66395679|FG002|Overall Study|Not dosed|5|||
23731618|NCT02574520|66395680|FG003|Overall Study|Not dosed|4|||
23731619|NCT02574520|66395677|FG000|Overall Study|Adverse Event|0|||
23731620|NCT02574520|66395678|FG001|Overall Study|Adverse Event|0|||
23731621|NCT02574520|66395679|FG002|Overall Study|Adverse Event|0|||
23731622|NCT02574520|66395680|FG003|Overall Study|Adverse Event|1|||
23731623|NCT02574520|66395677|FG000|Overall Study|Withdrawal by Subject|0|||
23731624|NCT02574520|66395678|FG001|Overall Study|Withdrawal by Subject|0|||
23731625|NCT02574520|66395679|FG002|Overall Study|Withdrawal by Subject|0|||
23731626|NCT02574520|66395680|FG003|Overall Study|Withdrawal by Subject|1|||
23731627|NCT02574520|66395677|FG000|Overall Study|Other|0|||
23731628|NCT02574520|66395678|FG001|Overall Study|Other|0|||
23731629|NCT02574520|66395679|FG002|Overall Study|Other|0|||
23731630|NCT02574520|66395680|FG003|Overall Study|Other|2|||
23731631|NCT01875874|66395684|FG000|Overall Study|Death|3|||
23731632|NCT01362049|66395689|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
23731633|NCT01362049|66395690|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
23731634|NCT01362049|66395691|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
23731635|NCT01362049|66395692|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
23731636|NCT01362049|66395689|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
23731637|NCT01362049|66395690|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
23731638|NCT01362049|66395691|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
23731639|NCT01362049|66395692|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
23731640|NCT04315298|66395693|FG000|Overall Study|Withdrawal by Subject|0|||
23731641|NCT04315298|66395694|FG001|Overall Study|Withdrawal by Subject|0|||
23731642|NCT04315298|66395695|FG002|Overall Study|Withdrawal by Subject|0|||
23731643|NCT04315298|66395696|FG003|Overall Study|Withdrawal by Subject|2|||
23818383|NCT03597464|66714346|FG001|Overall Study|Adverse Event|2|||
23731644|NCT04315298|66395697|FG004|Overall Study|Withdrawal by Subject|2|||
23818384|NCT03597464|66714345|FG000|Overall Study|Death|0|||
23617811|NCT04491136|65988141|FG000|Overall Study|Patient withdraw informed consent|9|||
23617812|NCT04491136|65988141|FG000|Overall Study|Adverse Event|2|||
23617813|NCT04491136|65988141|FG000|Overall Study|Death|3|||
23617814|NCT04491136|65988141|FG000|Overall Study|Lost to Follow-up|3|||
23617815|NCT04491136|65988141|FG000|Overall Study|Physician Decision|45|||
23617816|NCT04491136|65988141|FG000|Overall Study|sponsor terminated the study early|16|||
23617817|NCT04491136|65988141|FG000|Overall Study|Patient/guardian's decision|1|||
23617818|NCT02394925|65988144|FG000|Overall Study|Adverse Event|1|||
23617819|NCT02394925|65988144|FG000|Overall Study|Lens Discomfort|3|||
23617820|NCT02394925|65988144|FG000|Overall Study|Lens handling difficulities|5|||
23617821|NCT02394925|65988144|FG000|Overall Study|Lost to Follow-up|9|||
23617822|NCT02394925|65988144|FG000|Overall Study|Protocol Violation|5|||
23617823|NCT02394925|65988144|FG000|Overall Study|No longer meet eligibility criteria|1|||
23617824|NCT02394925|65988144|FG000|Overall Study|Unsatisfactory Visual Response|5|||
23617825|NCT03056755|65988145|FG000|Treatment- Core Phase|Progressive disease|89|||
23617826|NCT03056755|65988146|FG001|Treatment- Core Phase|Progressive disease|88|||
23617827|NCT03056755|65988147|FG002|Treatment- Core Phase|Progressive disease|90|||
23617828|NCT03056755|65988145|FG000|Treatment- Core Phase|Adverse Event|20|||
23617829|NCT03056755|65988146|FG001|Treatment- Core Phase|Adverse Event|14|||
23617830|NCT03056755|65988147|FG002|Treatment- Core Phase|Adverse Event|13|||
23617831|NCT03056755|65988145|FG000|Treatment- Core Phase|Physician Decision|7|||
23617832|NCT03056755|65988146|FG001|Treatment- Core Phase|Physician Decision|13|||
23617833|NCT03056755|65988147|FG002|Treatment- Core Phase|Physician Decision|5|||
23617834|NCT03056755|65988145|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
23617835|NCT03056755|65988146|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
23617836|NCT03056755|65988147|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
23617837|NCT03056755|65988145|FG000|Treatment- Core Phase|Death|3|||
23617838|NCT03056755|65988146|FG001|Treatment- Core Phase|Death|2|||
23617839|NCT03056755|65988147|FG002|Treatment- Core Phase|Death|4|||
23617840|NCT03056755|65988145|FG000|Treatment- Core Phase|Protocol deviation|1|||
23617841|NCT03056755|65988146|FG001|Treatment- Core Phase|Protocol deviation|1|||
23617842|NCT03056755|65988147|FG002|Treatment- Core Phase|Protocol deviation|0|||
23617843|NCT03056755|65988145|FG000|Treatment- Core Phase|Technical problems|1|||
23617844|NCT03056755|65988146|FG001|Treatment- Core Phase|Technical problems|0|||
23617845|NCT03056755|65988147|FG002|Treatment- Core Phase|Technical problems|0|||
23617846|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
23617847|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
23617848|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
23617849|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
23617850|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
23617851|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
23617852|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
23617853|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
23617854|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
23617855|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
23617856|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
23617857|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
23617858|NCT02598934|65988148|FG000|Overall Study|Adverse Event|11|||
23617859|NCT02598934|65988149|FG001|Overall Study|Adverse Event|13|||
23617860|NCT02598934|65988148|FG000|Overall Study|Failure to Return|3|||
23617861|NCT02598934|65988149|FG001|Overall Study|Failure to Return|3|||
23617862|NCT02598934|65988148|FG000|Overall Study|Withdrawal by Subject|2|||
23617863|NCT02598934|65988149|FG001|Overall Study|Withdrawal by Subject|3|||
23617864|NCT02598934|65988148|FG000|Overall Study|Administrative|2|||
23617865|NCT02598934|65988149|FG001|Overall Study|Administrative|1|||
23617866|NCT02598934|65988148|FG000|Overall Study|Protocol Violation|1|||
23617867|NCT02598934|65988149|FG001|Overall Study|Protocol Violation|2|||
23617868|NCT02621424|65988150|FG000|Overall Study|Withdrawal by Subject|1|||
23617869|NCT02621424|65988151|FG001|Overall Study|Withdrawal by Subject|2|||
23617870|NCT03226106|65988152|FG000|Overall Study|Withdrawal by Subject|2|||
23617871|NCT03226106|65988153|FG001|Overall Study|Withdrawal by Subject|0|||
23617872|NCT03226106|65988152|FG000|Overall Study|Adverse Event|1|||
23617873|NCT03226106|65988153|FG001|Overall Study|Adverse Event|0|||
23617874|NCT03226106|65988152|FG000|Overall Study|Lost to Follow-up|2|||
23617875|NCT03226106|65988153|FG001|Overall Study|Lost to Follow-up|0|||
23617876|NCT02538471|65988154|FG000|Overall Study|Progression of disease|2|||
23617877|NCT01093222|65988155|FG000|Overall Study|Ineligible|6|||
23617878|NCT01093222|65988155|FG000|Overall Study|Adverse Event|7|||
23731645|NCT04315298|66395698|FG005|Overall Study|Withdrawal by Subject|2|||
23731646|NCT04315298|66395699|FG006|Overall Study|Withdrawal by Subject|0|||
23731647|NCT04315298|66395700|FG007|Overall Study|Withdrawal by Subject|1|||
23731648|NCT04315298|66395701|FG008|Overall Study|Withdrawal by Subject|1|||
23731649|NCT04315298|66395702|FG009|Overall Study|Withdrawal by Subject|1|||
23731650|NCT04315298|66395703|FG010|Overall Study|Withdrawal by Subject|0|||
23731651|NCT04315298|66395704|FG011|Overall Study|Withdrawal by Subject|0|||
23731652|NCT04315298|66395705|FG012|Overall Study|Withdrawal by Subject|0|||
23731653|NCT04315298|66395706|FG013|Overall Study|Withdrawal by Subject|0|||
23731654|NCT04315298|66395707|FG014|Overall Study|Withdrawal by Subject|0|||
23731655|NCT04315298|66395708|FG015|Overall Study|Withdrawal by Subject|0|||
23731656|NCT04315298|66395709|FG016|Overall Study|Withdrawal by Subject|0|||
23731657|NCT04315298|66395710|FG017|Overall Study|Withdrawal by Subject|0|||
23731658|NCT04315298|66395711|FG018|Overall Study|Withdrawal by Subject|0|||
23731659|NCT04315298|66395693|FG000|Overall Study|Physician Decision|0|||
23731660|NCT04315298|66395694|FG001|Overall Study|Physician Decision|0|||
23731661|NCT04315298|66395695|FG002|Overall Study|Physician Decision|0|||
23731662|NCT04315298|66395696|FG003|Overall Study|Physician Decision|0|||
23731663|NCT04315298|66395697|FG004|Overall Study|Physician Decision|1|||
23731664|NCT04315298|66395698|FG005|Overall Study|Physician Decision|0|||
23731665|NCT04315298|66395699|FG006|Overall Study|Physician Decision|0|||
23731666|NCT04315298|66395700|FG007|Overall Study|Physician Decision|0|||
23731667|NCT04315298|66395701|FG008|Overall Study|Physician Decision|0|||
23731668|NCT04315298|66395702|FG009|Overall Study|Physician Decision|0|||
23731669|NCT04315298|66395703|FG010|Overall Study|Physician Decision|0|||
23731670|NCT04315298|66395704|FG011|Overall Study|Physician Decision|0|||
23731671|NCT04315298|66395705|FG012|Overall Study|Physician Decision|0|||
23731672|NCT04315298|66395706|FG013|Overall Study|Physician Decision|0|||
23731673|NCT04315298|66395707|FG014|Overall Study|Physician Decision|0|||
23731674|NCT04315298|66395708|FG015|Overall Study|Physician Decision|0|||
23731675|NCT04315298|66395709|FG016|Overall Study|Physician Decision|0|||
23731676|NCT04315298|66395710|FG017|Overall Study|Physician Decision|0|||
23731677|NCT04315298|66395711|FG018|Overall Study|Physician Decision|0|||
23731678|NCT04315298|66395693|FG000|Overall Study|Lost to Follow-up|5|||
23731679|NCT04315298|66395694|FG001|Overall Study|Lost to Follow-up|10|||
23731680|NCT04315298|66395695|FG002|Overall Study|Lost to Follow-up|6|||
23731681|NCT04315298|66395696|FG003|Overall Study|Lost to Follow-up|8|||
23731682|NCT04315298|66395697|FG004|Overall Study|Lost to Follow-up|12|||
23731683|NCT04315298|66395698|FG005|Overall Study|Lost to Follow-up|13|||
23731684|NCT04315298|66395699|FG006|Overall Study|Lost to Follow-up|9|||
23731685|NCT04315298|66395700|FG007|Overall Study|Lost to Follow-up|16|||
23731686|NCT04315298|66395701|FG008|Overall Study|Lost to Follow-up|14|||
23731687|NCT04315298|66395702|FG009|Overall Study|Lost to Follow-up|0|||
23731688|NCT04315298|66395703|FG010|Overall Study|Lost to Follow-up|2|||
23731689|NCT04315298|66395704|FG011|Overall Study|Lost to Follow-up|1|||
23731690|NCT04315298|66395705|FG012|Overall Study|Lost to Follow-up|0|||
23731691|NCT04315298|66395706|FG013|Overall Study|Lost to Follow-up|0|||
23731692|NCT04315298|66395707|FG014|Overall Study|Lost to Follow-up|0|||
23731693|NCT04315298|66395708|FG015|Overall Study|Lost to Follow-up|2|||
23731694|NCT04315298|66395709|FG016|Overall Study|Lost to Follow-up|0|||
23731695|NCT04315298|66395710|FG017|Overall Study|Lost to Follow-up|0|||
23731696|NCT04315298|66395711|FG018|Overall Study|Lost to Follow-up|0|||
23731697|NCT04315298|66395693|FG000|Overall Study|Death|24|||
23731698|NCT04315298|66395694|FG001|Overall Study|Death|60|||
23731699|NCT04315298|66395695|FG002|Overall Study|Death|49|||
23731700|NCT04315298|66395696|FG003|Overall Study|Death|59|||
23731701|NCT04315298|66395697|FG004|Overall Study|Death|70|||
23731702|NCT04315298|66395698|FG005|Overall Study|Death|114|||
23731703|NCT04315298|66395699|FG006|Overall Study|Death|9|||
23731704|NCT04315298|66395700|FG007|Overall Study|Death|12|||
23731705|NCT04315298|66395701|FG008|Overall Study|Death|21|||
23731706|NCT04315298|66395702|FG009|Overall Study|Death|16|||
23731707|NCT04315298|66395703|FG010|Overall Study|Death|40|||
23731708|NCT04315298|66395704|FG011|Overall Study|Death|40|||
23731709|NCT04315298|66395705|FG012|Overall Study|Death|3|||
23731710|NCT04315298|66395706|FG013|Overall Study|Death|4|||
23731711|NCT04315298|66395707|FG014|Overall Study|Death|6|||
23731712|NCT04315298|66395708|FG015|Overall Study|Death|4|||
23731713|NCT04315298|66395709|FG016|Overall Study|Death|3|||
23544327|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Death|1|||
23731714|NCT04315298|66395710|FG017|Overall Study|Death|1|||
23731715|NCT04315298|66395711|FG018|Overall Study|Death|0|||
23731716|NCT02954952|66395712|FG000|Overall Study|Withdrawal by Subject|1|||
23731717|NCT02954952|66395713|FG001|Overall Study|Withdrawal by Subject|0|||
23731718|NCT02954952|66395714|FG002|Overall Study|Withdrawal by Subject|0|||
23731719|NCT02954952|66395712|FG000|Overall Study|No data collected|0|||
23731720|NCT02954952|66395713|FG001|Overall Study|No data collected|1|||
23731721|NCT02954952|66395714|FG002|Overall Study|No data collected|0|||
23731722|NCT04157751|66395715|FG000|Overall Study|Withdrawal by Subject|12|||
23731723|NCT04157751|66395716|FG001|Overall Study|Withdrawal by Subject|17|||
23731724|NCT04157751|66395715|FG000|Overall Study|Lost to Follow-up|6|||
23731725|NCT04157751|66395716|FG001|Overall Study|Lost to Follow-up|2|||
23731726|NCT04157751|66395715|FG000|Overall Study|Adverse Event|34|||
23731727|NCT04157751|66395716|FG001|Overall Study|Adverse Event|23|||
23731728|NCT04157751|66395715|FG000|Overall Study|Not treated|1|||
23731729|NCT04157751|66395716|FG001|Overall Study|Not treated|5|||
23731730|NCT04157751|66395715|FG000|Overall Study|Other reason not stated above|10|||
23818385|NCT03597464|66714346|FG001|Overall Study|Death|3|||
23544328|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Death|0|||
23544329|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
23544330|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
23731731|NCT04157751|66395716|FG001|Overall Study|Other reason not stated above|10|||
23731732|NCT00742391|66395717|FG000|Overall Study|Adverse Event|2|||
23731733|NCT00742391|66395718|FG001|Overall Study|Adverse Event|1|||
23731734|NCT00742391|66395717|FG000|Overall Study|Lost to Follow-up|1|||
23731735|NCT00742391|66395718|FG001|Overall Study|Lost to Follow-up|0|||
23731736|NCT00742391|66395717|FG000|Overall Study|Protocol Violation|1|||
23731737|NCT00742391|66395718|FG001|Overall Study|Protocol Violation|0|||
23731738|NCT00609167|66395719|FG000|Overall Study|Withdrawal by Subject|1|||
23731739|NCT00609167|66395720|FG001|Overall Study|Withdrawal by Subject|0|||
23731740|NCT00609167|66395719|FG000|Overall Study|Lack of Efficacy|1|||
23544331|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
23544332|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
23544333|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
23544334|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
23731741|NCT00609167|66395720|FG001|Overall Study|Lack of Efficacy|0|||
23731742|NCT00609167|66395719|FG000|Overall Study|Adverse Event|5|||
23731743|NCT00609167|66395720|FG001|Overall Study|Adverse Event|1|||
23544335|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
23731744|NCT00609167|66395719|FG000|Overall Study|Disease Progression|1|||
23731745|NCT00609167|66395720|FG001|Overall Study|Disease Progression|0|||
23731746|NCT00609167|66395719|FG000|Overall Study|Stem Cell Transplant|0|||
23617879|NCT01093222|65988155|FG000|Overall Study|Progression/relapse|24|||
23818386|NCT00843635|66714347|FG000|Overall Study|Adverse Event|2|||
23818387|NCT00843635|66714348|FG001|Overall Study|Adverse Event|2|||
23818388|NCT00843635|66714349|FG002|Overall Study|Adverse Event|0|||
23818389|NCT04660331|66714352|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
23818390|NCT04660331|66714353|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
23818391|NCT04660331|66714354|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
23818392|NCT04974749|66714355|FG000|Overall Study|Withdrawal by Subject|2|||
23617880|NCT01093222|65988155|FG000|Overall Study|Death|2|||
23544336|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
23544337|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Other|1|||
23544338|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Other|2|||
23731747|NCT00609167|66395720|FG001|Overall Study|Stem Cell Transplant|6|||
23731748|NCT00636506|66395724|FG000|Overall Study|Lost to Follow-up|8|||
23731749|NCT00636506|66395724|FG000|Overall Study|Explanted|1|||
23731750|NCT00636506|66395724|FG000|Overall Study|Withdrawal by Subject|6|||
23731751|NCT00636506|66395724|FG000|Overall Study|Procedure aborted|1|||
23731752|NCT01888965|66395725|FG000|Overall Study|Adverse Event|5|||
23731753|NCT01888965|66395725|FG000|Overall Study|Lack of Efficacy|4|||
23731754|NCT01408732|66395733|FG000|Overall Study|Withdrawal by Subject|2|||
23731755|NCT01408732|66395734|FG001|Overall Study|Withdrawal by Subject|2|||
23731756|NCT03797144|66395735|FG000|Enrollment|Protocol Violation|4|||
23731757|NCT03797144|66395736|FG001|Enrollment|Protocol Violation|1|||
23731758|NCT03797144|66395735|FG000|Surgery|Protocol Violation|1|||
23731759|NCT03797144|66395736|FG001|Surgery|Protocol Violation|0|||
23731760|NCT03797144|66395735|FG000|3 Month|Early termination cut-off date|2|||
23731761|NCT03797144|66395736|FG001|3 Month|Early termination cut-off date|0|||
23731762|NCT03797144|66395735|FG000|12 Month|Early termination cut-off date|8|||
23731763|NCT03797144|66395736|FG001|12 Month|Early termination cut-off date|9|||
23731764|NCT03797144|66395735|FG000|24 Month|Early termination cut-off date|1|||
23731765|NCT03797144|66395736|FG001|24 Month|Early termination cut-off date|1|||
23731766|NCT01590810|66395737|FG000|Overall Study|Physician Decision|0|||
23731767|NCT01590810|66395738|FG001|Overall Study|Physician Decision|1|||
23731768|NCT01590810|66395739|FG002|Overall Study|Physician Decision|1|||
23544339|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Other|0|||
23731769|NCT01590810|66395740|FG003|Overall Study|Physician Decision|0|||
23731770|NCT01590810|66395741|FG004|Overall Study|Physician Decision|0|||
23731771|NCT02158728|66395742|FG000|Overall Study|no procedure according to CIP done|3|||
23731772|NCT02158728|66395742|FG000|Overall Study|no qualified dataset|24|||
23731773|NCT01646255|66395743|FG000|Overall Study|Adverse Event|7|||
23731774|NCT01646255|66395744|FG001|Overall Study|Adverse Event|8|||
23731775|NCT01646255|66395743|FG000|Overall Study|Lack of Efficacy|2|||
23731776|NCT01646255|66395744|FG001|Overall Study|Lack of Efficacy|0|||
23731777|NCT01646255|66395743|FG000|Overall Study|Withdrawal by Subject|10|||
23731778|NCT01646255|66395744|FG001|Overall Study|Withdrawal by Subject|6|||
23731779|NCT01646255|66395743|FG000|Overall Study|Compliance is not well|1|||
23731780|NCT01646255|66395744|FG001|Overall Study|Compliance is not well|0|||
23731781|NCT01646255|66395743|FG000|Overall Study|Inclusion Criteria Deviation|1|||
23731782|NCT01646255|66395744|FG001|Overall Study|Inclusion Criteria Deviation|0|||
23731783|NCT01975376|66395745|FG000|Overall Study|Adverse Event|5|||
23731784|NCT01975376|66395746|FG001|Overall Study|Adverse Event|5|||
23731785|NCT01975376|66395745|FG000|Overall Study|Death|65|||
23731786|NCT01975376|66395746|FG001|Overall Study|Death|72|||
23731787|NCT01975376|66395745|FG000|Overall Study|Lost to Follow-up|70|||
23731788|NCT01975376|66395746|FG001|Overall Study|Lost to Follow-up|66|||
23731789|NCT01975376|66395745|FG000|Overall Study|Withdrew consent|68|||
23731790|NCT01975376|66395746|FG001|Overall Study|Withdrew consent|62|||
23731791|NCT01975376|66395745|FG000|Overall Study|Other|2|||
23731792|NCT01975376|66395746|FG001|Overall Study|Other|4|||
23731793|NCT01975376|66395745|FG000|Overall Study|Randomized, Not Treated|16|||
23731794|NCT01975376|66395746|FG001|Overall Study|Randomized, Not Treated|8|||
23731795|NCT01997892|66395749|FG000|Overall Study|Physician Decision|2|||
23731796|NCT01997892|66395749|FG000|Overall Study|Lost to Follow-up|6|||
23731797|NCT01997892|66395749|FG000|Overall Study|Death|14|||
23731798|NCT01997892|66395749|FG000|Overall Study|Renal transplant|8|||
23731799|NCT01997892|66395749|FG000|Overall Study|Other|3|||
23731800|NCT01997892|66395749|FG000|Overall Study|Study completion data not recorded|35|||
23731801|NCT00088595|66395750|FG000|Overall Study|Adverse Event|11|||
23731802|NCT00088595|66395750|FG000|Overall Study|Withdrawal by Subject|8|||
23731803|NCT00088595|66395750|FG000|Overall Study|Ongoing (After Core)|7|||
23731804|NCT00088595|66395750|FG000|Overall Study|New Cancer Therapy|2|||
23731805|NCT00882362|66395751|FG000|Overall Study|Adverse Event|13|||
23731806|NCT00882362|66395752|FG001|Overall Study|Adverse Event|10|||
23731807|NCT00882362|66395751|FG000|Overall Study|Withdrawal by Subject|13|||
23731808|NCT00882362|66395752|FG001|Overall Study|Withdrawal by Subject|10|||
23731809|NCT00882362|66395751|FG000|Overall Study|Lack of Efficacy|3|||
23731810|NCT00882362|66395752|FG001|Overall Study|Lack of Efficacy|0|||
23731811|NCT00882362|66395751|FG000|Overall Study|Protocol Violation|7|||
23731812|NCT00882362|66395752|FG001|Overall Study|Protocol Violation|2|||
23731813|NCT00882362|66395751|FG000|Overall Study|Pregnancy|1|||
23731814|NCT00882362|66395752|FG001|Overall Study|Pregnancy|0|||
23731815|NCT00882362|66395751|FG000|Overall Study|Physician Decision|5|||
23731816|NCT00882362|66395752|FG001|Overall Study|Physician Decision|1|||
23731817|NCT00882362|66395751|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
23731818|NCT00882362|66395752|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
23731819|NCT00882362|66395751|FG000|Overall Study|change of residence or other commitments|5|||
23731820|NCT00882362|66395752|FG001|Overall Study|change of residence or other commitments|0|||
23731821|NCT03228836|66395753|FG000|Overall Study|Adverse Event|3|||
23731822|NCT03228836|66395753|FG000|Overall Study|Withdrawal by Subject|1|||
23731823|NCT03228836|66395753|FG000|Overall Study|Death|1|||
23731824|NCT03228836|66395753|FG000|Overall Study|Physician Decision|1|||
23731825|NCT03228836|66395753|FG000|Overall Study|Disease Progression|7|||
23731826|NCT03228836|66395753|FG000|Overall Study|Other|4|||
23731827|NCT03196973|66395754|FG000|Overall Study|Adverse Event|1|||
23731828|NCT03196973|66395755|FG001|Overall Study|Adverse Event|1|||
23731829|NCT03196973|66395756|FG002|Overall Study|Adverse Event|2|||
23731830|NCT03196973|66395754|FG000|Overall Study|Lack of Efficacy|2|||
23731831|NCT03196973|66395755|FG001|Overall Study|Lack of Efficacy|6|||
23731832|NCT03196973|66395756|FG002|Overall Study|Lack of Efficacy|1|||
23731833|NCT03196973|66395754|FG000|Overall Study|Lost to Follow-up|4|||
23731834|NCT03196973|66395755|FG001|Overall Study|Lost to Follow-up|3|||
23544340|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Other|0|||
23731835|NCT03196973|66395756|FG002|Overall Study|Lost to Follow-up|2|||
23731836|NCT03196973|66395754|FG000|Overall Study|Consent withdrawn|2|||
23731837|NCT03196973|66395755|FG001|Overall Study|Consent withdrawn|1|||
23731838|NCT03196973|66395756|FG002|Overall Study|Consent withdrawn|0|||
23818393|NCT04974749|66714355|FG000|Overall Study|Gestation|1|||
23818394|NCT00708227|66714356|FG000|Overall Study|Physician Decision|0|||
23731839|NCT03196973|66395754|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
23731840|NCT03196973|66395755|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
23731841|NCT03196973|66395756|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
23731842|NCT00606229|66395761|FG000|Overall Study|Adverse Event|11|||
23731843|NCT00606229|66395761|FG000|Overall Study|Lack of Efficacy|1|||
23731844|NCT00606229|66395761|FG000|Overall Study|Withdrawal by Subject|4|||
23731845|NCT00606229|66395761|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
23731846|NCT00606229|66395761|FG000|Overall Study|change of residence or other commitments|2|||
23731847|NCT00394654|66395782|FG000|Overall Study|Lost to Follow-up|1|||
23731848|NCT00394654|66395783|FG001|Overall Study|Lost to Follow-up|0|||
23731849|NCT00394654|66395782|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
23731850|NCT00394654|66395783|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
23731851|NCT00397631|66395787|FG000|Overall Study|Adverse Event|5|||
23731852|NCT00397631|66395788|FG001|Overall Study|Adverse Event|6|||
23731853|NCT00397631|66395787|FG000|Overall Study|Lack of Efficacy|7|||
23544341|NCT00673049|65723052|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
23818395|NCT00708227|66714357|FG001|Overall Study|Physician Decision|3|||
23818396|NCT00708227|66714358|FG002|Overall Study|Physician Decision|1|||
23818397|NCT00708227|66714359|FG003|Overall Study|Physician Decision|2|||
23818398|NCT00708227|66714356|FG000|Overall Study|Withdrawal by Subject|1|||
23818399|NCT00708227|66714357|FG001|Overall Study|Withdrawal by Subject|2|||
23818400|NCT00708227|66714358|FG002|Overall Study|Withdrawal by Subject|0|||
23818401|NCT00708227|66714359|FG003|Overall Study|Withdrawal by Subject|1|||
23818402|NCT03583086|66714360|FG000|Overall Study|Death|2|||
23818403|NCT03583086|66714361|FG001|Overall Study|Death|6|||
23818404|NCT03583086|66714362|FG002|Overall Study|Death|12|||
23818405|NCT03583086|66714363|FG003|Overall Study|Death|10|||
23818406|NCT03583086|66714364|FG004|Overall Study|Death|14|||
23818407|NCT03583086|66714365|FG005|Overall Study|Death|14|||
23818408|NCT03583086|66714366|FG006|Overall Study|Death|4|||
23818409|NCT03583086|66714360|FG000|Overall Study|Withdrawal by Subject|0|||
23818410|NCT03583086|66714361|FG001|Overall Study|Withdrawal by Subject|0|||
23818411|NCT03583086|66714362|FG002|Overall Study|Withdrawal by Subject|1|||
23818412|NCT03583086|66714363|FG003|Overall Study|Withdrawal by Subject|0|||
23818413|NCT03583086|66714364|FG004|Overall Study|Withdrawal by Subject|0|||
23818414|NCT03583086|66714365|FG005|Overall Study|Withdrawal by Subject|0|||
23818415|NCT03583086|66714366|FG006|Overall Study|Withdrawal by Subject|1|||
23818416|NCT03583086|66714360|FG000|Overall Study|Refused follow-up|0|||
23818417|NCT03583086|66714361|FG001|Overall Study|Refused follow-up|0|||
23818418|NCT03583086|66714362|FG002|Overall Study|Refused follow-up|1|||
23818419|NCT03583086|66714363|FG003|Overall Study|Refused follow-up|0|||
23818420|NCT03583086|66714364|FG004|Overall Study|Refused follow-up|1|||
23818421|NCT03583086|66714365|FG005|Overall Study|Refused follow-up|0|||
23818422|NCT03583086|66714366|FG006|Overall Study|Refused follow-up|0|||
23818423|NCT03583086|66714360|FG000|Overall Study|Declining Performance Status|0|||
23818424|NCT03583086|66714361|FG001|Overall Study|Declining Performance Status|0|||
23818425|NCT03583086|66714362|FG002|Overall Study|Declining Performance Status|1|||
23818426|NCT03583086|66714363|FG003|Overall Study|Declining Performance Status|0|||
23818427|NCT03583086|66714364|FG004|Overall Study|Declining Performance Status|0|||
23818428|NCT03583086|66714365|FG005|Overall Study|Declining Performance Status|0|||
23731854|NCT00397631|66395788|FG001|Overall Study|Lack of Efficacy|10|||
23818429|NCT03583086|66714366|FG006|Overall Study|Declining Performance Status|0|||
23818430|NCT03583086|66714360|FG000|Overall Study|Still on study|0|||
23818431|NCT03583086|66714361|FG001|Overall Study|Still on study|0|||
23818432|NCT03583086|66714362|FG002|Overall Study|Still on study|0|||
23818433|NCT03583086|66714363|FG003|Overall Study|Still on study|1|||
23818434|NCT03583086|66714364|FG004|Overall Study|Still on study|0|||
23731855|NCT00397631|66395787|FG000|Overall Study|Lost to Follow-up|8|||
23818435|NCT03583086|66714365|FG005|Overall Study|Still on study|0|||
23818436|NCT03583086|66714366|FG006|Overall Study|Still on study|1|||
23818437|NCT03583086|66714360|FG000|Overall Study|Disease progression|0|||
23818438|NCT03583086|66714361|FG001|Overall Study|Disease progression|0|||
23818439|NCT03583086|66714362|FG002|Overall Study|Disease progression|0|||
23818440|NCT03583086|66714363|FG003|Overall Study|Disease progression|0|||
23818441|NCT03583086|66714364|FG004|Overall Study|Disease progression|0|||
23818442|NCT03583086|66714365|FG005|Overall Study|Disease progression|0|||
23818443|NCT03583086|66714366|FG006|Overall Study|Disease progression|1|||
23818444|NCT03583086|66714360|FG000|Overall Study|Undergoing radiation therapy|0|||
23818445|NCT03583086|66714361|FG001|Overall Study|Undergoing radiation therapy|0|||
23818446|NCT03583086|66714362|FG002|Overall Study|Undergoing radiation therapy|0|||
23818447|NCT03583086|66714363|FG003|Overall Study|Undergoing radiation therapy|0|||
23818448|NCT03583086|66714364|FG004|Overall Study|Undergoing radiation therapy|0|||
23818449|NCT03583086|66714365|FG005|Overall Study|Undergoing radiation therapy|0|||
23818450|NCT03583086|66714366|FG006|Overall Study|Undergoing radiation therapy|1|||
23818451|NCT03583086|66714360|FG000|Overall Study|Lost to Follow-up|0|||
23818452|NCT03583086|66714361|FG001|Overall Study|Lost to Follow-up|0|||
23818453|NCT03583086|66714362|FG002|Overall Study|Lost to Follow-up|0|||
23818454|NCT03583086|66714363|FG003|Overall Study|Lost to Follow-up|0|||
23818455|NCT03583086|66714364|FG004|Overall Study|Lost to Follow-up|0|||
23818456|NCT03583086|66714365|FG005|Overall Study|Lost to Follow-up|1|||
23818457|NCT03583086|66714366|FG006|Overall Study|Lost to Follow-up|0|||
23818458|NCT03583086|66714360|FG000|Overall Study|Adverse Event|0|||
23818459|NCT03583086|66714361|FG001|Overall Study|Adverse Event|0|||
23818460|NCT03583086|66714362|FG002|Overall Study|Adverse Event|0|||
23818461|NCT03583086|66714363|FG003|Overall Study|Adverse Event|0|||
23818462|NCT03583086|66714364|FG004|Overall Study|Adverse Event|0|||
23818463|NCT03583086|66714365|FG005|Overall Study|Adverse Event|1|||
23818464|NCT03583086|66714366|FG006|Overall Study|Adverse Event|0|||
23818465|NCT03597529|66714373|FG000|Overall Study|Lost to Follow-up|10|||
23818466|NCT03597529|66714374|FG001|Overall Study|Lost to Follow-up|12|||
23818467|NCT03597529|66714373|FG000|Overall Study|Physician Decision|3|||
23818468|NCT03597529|66714374|FG001|Overall Study|Physician Decision|1|||
23818469|NCT03597529|66714373|FG000|Overall Study|Withdrawal by Subject|6|||
23818470|NCT03597529|66714374|FG001|Overall Study|Withdrawal by Subject|3|||
23818471|NCT03597529|66714373|FG000|Overall Study|Non-compliant with study activities|1|||
23818472|NCT03597529|66714374|FG001|Overall Study|Non-compliant with study activities|2|||
23818473|NCT00025259|66714377|FG000|Overall Study|Death|1|||
23818474|NCT00025259|66714378|FG001|Overall Study|Death|3|||
23818475|NCT00025259|66714379|FG002|Overall Study|Death|0|||
23818476|NCT00025259|66714380|FG003|Overall Study|Death|3|||
23818477|NCT00025259|66714381|FG004|Overall Study|Death|0|||
23818478|NCT00025259|66714382|FG005|Overall Study|Death|1|||
23818479|NCT00025259|66714383|FG006|Overall Study|Death|2|||
23818480|NCT00025259|66714377|FG000|Overall Study|Lack of Efficacy|2|||
23818481|NCT00025259|66714378|FG001|Overall Study|Lack of Efficacy|46|||
23818482|NCT00025259|66714379|FG002|Overall Study|Lack of Efficacy|60|||
23818483|NCT00025259|66714380|FG003|Overall Study|Lack of Efficacy|78|||
23818484|NCT00025259|66714381|FG004|Overall Study|Lack of Efficacy|11|||
23818485|NCT00025259|66714382|FG005|Overall Study|Lack of Efficacy|30|||
23818486|NCT00025259|66714383|FG006|Overall Study|Lack of Efficacy|38|||
23818487|NCT00025259|66714377|FG000|Overall Study|Lost to Follow-up|2|||
23818488|NCT00025259|66714378|FG001|Overall Study|Lost to Follow-up|9|||
23818489|NCT00025259|66714379|FG002|Overall Study|Lost to Follow-up|13|||
23818490|NCT00025259|66714380|FG003|Overall Study|Lost to Follow-up|13|||
23818491|NCT00025259|66714381|FG004|Overall Study|Lost to Follow-up|1|||
23818492|NCT00025259|66714382|FG005|Overall Study|Lost to Follow-up|3|||
23818493|NCT00025259|66714383|FG006|Overall Study|Lost to Follow-up|1|||
23818494|NCT00025259|66714377|FG000|Overall Study|Physician Decision|12|||
23818495|NCT00025259|66714378|FG001|Overall Study|Physician Decision|1|||
23818496|NCT00025259|66714379|FG002|Overall Study|Physician Decision|0|||
23818497|NCT00025259|66714380|FG003|Overall Study|Physician Decision|5|||
23818498|NCT00025259|66714381|FG004|Overall Study|Physician Decision|4|||
23818499|NCT00025259|66714382|FG005|Overall Study|Physician Decision|2|||
23818500|NCT00025259|66714383|FG006|Overall Study|Physician Decision|1|||
23818501|NCT00025259|66714377|FG000|Overall Study|Protocol Violation|3|||
23818502|NCT00025259|66714378|FG001|Overall Study|Protocol Violation|2|||
23818503|NCT00025259|66714379|FG002|Overall Study|Protocol Violation|2|||
23818504|NCT00025259|66714380|FG003|Overall Study|Protocol Violation|1|||
23818505|NCT00025259|66714381|FG004|Overall Study|Protocol Violation|2|||
23818506|NCT00025259|66714382|FG005|Overall Study|Protocol Violation|1|||
23818507|NCT00025259|66714383|FG006|Overall Study|Protocol Violation|3|||
23818508|NCT00025259|66714377|FG000|Overall Study|Withdrawal by Subject|9|||
23818509|NCT00025259|66714378|FG001|Overall Study|Withdrawal by Subject|27|||
23818510|NCT00025259|66714379|FG002|Overall Study|Withdrawal by Subject|6|||
23818511|NCT00025259|66714380|FG003|Overall Study|Withdrawal by Subject|14|||
23818512|NCT00025259|66714381|FG004|Overall Study|Withdrawal by Subject|11|||
23818513|NCT00025259|66714382|FG005|Overall Study|Withdrawal by Subject|8|||
23818514|NCT00025259|66714383|FG006|Overall Study|Withdrawal by Subject|3|||
23818515|NCT00025259|66714377|FG000|Overall Study|Ineligible|14|||
23818516|NCT00025259|66714378|FG001|Overall Study|Ineligible|1|||
23818517|NCT00025259|66714379|FG002|Overall Study|Ineligible|0|||
23818518|NCT00025259|66714380|FG003|Overall Study|Ineligible|0|||
23818519|NCT00025259|66714381|FG004|Overall Study|Ineligible|6|||
23818520|NCT00025259|66714382|FG005|Overall Study|Ineligible|0|||
23818521|NCT00025259|66714383|FG006|Overall Study|Ineligible|1|||
23818522|NCT00025259|66714377|FG000|Overall Study|Randomization error|1|||
23818523|NCT00025259|66714378|FG001|Overall Study|Randomization error|0|||
23818524|NCT00025259|66714379|FG002|Overall Study|Randomization error|0|||
23818525|NCT00025259|66714380|FG003|Overall Study|Randomization error|0|||
23818526|NCT00025259|66714381|FG004|Overall Study|Randomization error|1|||
23818527|NCT00025259|66714382|FG005|Overall Study|Randomization error|7|||
23818528|NCT00025259|66714383|FG006|Overall Study|Randomization error|2|||
23818529|NCT00025259|66714377|FG000|Overall Study|Adverse Event|1|||
23818530|NCT00025259|66714378|FG001|Overall Study|Adverse Event|0|||
23818531|NCT00025259|66714379|FG002|Overall Study|Adverse Event|0|||
23818532|NCT00025259|66714380|FG003|Overall Study|Adverse Event|0|||
23818533|NCT00025259|66714381|FG004|Overall Study|Adverse Event|0|||
23818534|NCT00025259|66714382|FG005|Overall Study|Adverse Event|0|||
23818535|NCT00025259|66714383|FG006|Overall Study|Adverse Event|0|||
23818536|NCT00576316|66714393|FG000|Overall Study|Adverse Event|9|||
23818537|NCT00576316|66714393|FG000|Overall Study|Withdrawal by Subject|2|||
23818538|NCT00576316|66714393|FG000|Overall Study|Protocol Violation|9|||
23818539|NCT01831258|66714395|FG000|Overall Study|Withdrawal by Subject|2|||
23818540|NCT01831258|66714396|FG001|Overall Study|Withdrawal by Subject|1|||
23818541|NCT01831258|66714395|FG000|Overall Study|Lost to Follow-up|3|||
23818542|NCT01831258|66714396|FG001|Overall Study|Lost to Follow-up|2|||
23818543|NCT02013674|66714399|FG000|Overall Study|Death|0|||
23818544|NCT02013674|66714400|FG001|Overall Study|Death|1|||
23818545|NCT02013674|66714399|FG000|Overall Study|Lost to Follow-up|1|||
23818546|NCT02013674|66714400|FG001|Overall Study|Lost to Follow-up|0|||
23818547|NCT04759768|66714403|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23818548|NCT04759768|66714404|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23818549|NCT04759768|66714403|FG000|Washout (7 Days)|Physician Decision|0|||
23818550|NCT04759768|66714404|FG001|Washout (7 Days)|Physician Decision|1|||
23818551|NCT03819049|66714407|FG000|Overall Study|Lost to Follow-up|1|||
23818552|NCT03819049|66714408|FG001|Overall Study|Lost to Follow-up|2|||
23818553|NCT03819049|66714409|FG002|Overall Study|Lost to Follow-up|9|||
23818554|NCT03819049|66714410|FG003|Overall Study|Lost to Follow-up|0|||
23818555|NCT03819049|66714411|FG004|Overall Study|Lost to Follow-up|3|||
23818556|NCT03819049|66714412|FG005|Overall Study|Lost to Follow-up|1|||
23818557|NCT03819049|66714413|FG006|Overall Study|Lost to Follow-up|0|||
23818558|NCT03819049|66714407|FG000|Overall Study|Withdrawal by Subject|0|||
23818559|NCT03819049|66714408|FG001|Overall Study|Withdrawal by Subject|0|||
23818560|NCT03819049|66714409|FG002|Overall Study|Withdrawal by Subject|18|||
23818561|NCT03819049|66714410|FG003|Overall Study|Withdrawal by Subject|0|||
23818562|NCT03819049|66714411|FG004|Overall Study|Withdrawal by Subject|10|||
23818563|NCT03819049|66714412|FG005|Overall Study|Withdrawal by Subject|9|||
23818564|NCT03819049|66714413|FG006|Overall Study|Withdrawal by Subject|1|||
23818565|NCT03819049|66714407|FG000|Overall Study|Ongoing|0|||
23818566|NCT03819049|66714408|FG001|Overall Study|Ongoing|0|||
23818567|NCT03819049|66714409|FG002|Overall Study|Ongoing|75|||
23818568|NCT03819049|66714410|FG003|Overall Study|Ongoing|0|||
23818569|NCT03819049|66714411|FG004|Overall Study|Ongoing|41|||
23818570|NCT03819049|66714412|FG005|Overall Study|Ongoing|0|||
23818571|NCT03819049|66714413|FG006|Overall Study|Ongoing|0|||
23818572|NCT03819049|66714407|FG000|Overall Study|Other|0|||
23818573|NCT03819049|66714408|FG001|Overall Study|Other|0|||
23818574|NCT03819049|66714409|FG002|Overall Study|Other|2|||
23818575|NCT03819049|66714410|FG003|Overall Study|Other|0|||
23544342|NCT00673049|65723053|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
23544343|NCT00673049|65723054|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
23544344|NCT00673049|65723055|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
23544345|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
23544346|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
23818576|NCT03819049|66714411|FG004|Overall Study|Other|0|||
23544347|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
23818577|NCT03819049|66714412|FG005|Overall Study|Other|0|||
23426149|NCT00413374|65303535|FG000|Overall Study|Surgery|1|||
23426150|NCT00413374|65303536|FG001|Overall Study|Surgery|0|||
23818578|NCT03819049|66714413|FG006|Overall Study|Other|0|||
23818579|NCT03819049|66714407|FG000|Overall Study|Randomized but not vaccinated|0|||
23818580|NCT03819049|66714408|FG001|Overall Study|Randomized but not vaccinated|0|||
23818581|NCT03819049|66714409|FG002|Overall Study|Randomized but not vaccinated|0|||
23426151|NCT01813721|65303537|FG000|Overall Study|Ineligibility determined|63|||
23818582|NCT03819049|66714410|FG003|Overall Study|Randomized but not vaccinated|1|||
23818583|NCT03819049|66714411|FG004|Overall Study|Randomized but not vaccinated|0|||
23818584|NCT03819049|66714412|FG005|Overall Study|Randomized but not vaccinated|2|||
23818585|NCT03819049|66714413|FG006|Overall Study|Randomized but not vaccinated|1|||
23818586|NCT03819049|66714407|FG000|Overall Study|Physician Decision|0|||
23818587|NCT03819049|66714408|FG001|Overall Study|Physician Decision|0|||
23818588|NCT03819049|66714409|FG002|Overall Study|Physician Decision|0|||
23818589|NCT03819049|66714410|FG003|Overall Study|Physician Decision|0|||
23544348|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
23544349|NCT00673049|65723052|FG000|After Progression on Erlotinib|Death|0|||
23544350|NCT00673049|65723053|FG001|After Progression on Erlotinib|Death|0|||
23544351|NCT00673049|65723054|FG002|After Progression on Erlotinib|Death|0|||
23544352|NCT00673049|65723055|FG003|After Progression on Erlotinib|Death|71|||
23544353|NCT00673049|65723052|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
23544354|NCT00673049|65723053|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
23544355|NCT00673049|65723054|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
23544356|NCT00673049|65723055|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
23544357|NCT00673049|65723052|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
23544358|NCT00673049|65723053|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
23818590|NCT03819049|66714411|FG004|Overall Study|Physician Decision|0|||
23818591|NCT03819049|66714412|FG005|Overall Study|Physician Decision|0|||
23617881|NCT01093222|65988155|FG000|Overall Study|Not protocol specified|1|||
23617882|NCT00507429|65988156|FG000|Treatment Phase|Disease Progression|12|||
23617883|NCT00507429|65988157|FG001|Treatment Phase|Disease Progression|5|||
23731856|NCT00397631|66395788|FG001|Overall Study|Lost to Follow-up|9|||
23731857|NCT00397631|66395787|FG000|Overall Study|Physician Decision|2|||
23544359|NCT00673049|65723054|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
23544360|NCT00673049|65723055|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
23544361|NCT00673049|65723052|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
23544362|NCT00673049|65723053|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
23544363|NCT00673049|65723054|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
23544364|NCT00673049|65723055|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
23544365|NCT02663817|65723056|FG000|Overall Study|Screen failure|2|||
23544366|NCT04757649|65723058|FG000|Overall Study|Withdrawal by Subject|1|||
23617884|NCT00507429|65988156|FG000|Treatment Phase|Adverse Event|12|||
23617885|NCT00507429|65988157|FG001|Treatment Phase|Adverse Event|5|||
23544367|NCT04757649|65723058|FG000|Overall Study|Adverse Event|1|||
23617886|NCT00507429|65988156|FG000|Treatment Phase|Withdrawal by Subject|3|||
23731858|NCT00397631|66395788|FG001|Overall Study|Physician Decision|0|||
23731859|NCT00397631|66395787|FG000|Overall Study|Protocol Violation|0|||
23731860|NCT00397631|66395788|FG001|Overall Study|Protocol Violation|1|||
23731861|NCT00397631|66395787|FG000|Overall Study|Withdrawal by Subject|7|||
23731862|NCT00397631|66395788|FG001|Overall Study|Withdrawal by Subject|14|||
23731863|NCT00397631|66395787|FG000|Overall Study|protocol discontinuation criteria|1|||
23818592|NCT03819049|66714413|FG006|Overall Study|Physician Decision|1|||
23818593|NCT00952731|66714414|FG000|Overall Study|Drug supply expired|1|||
23818594|NCT00952731|66714415|FG001|Overall Study|Drug supply expired|0|||
23818595|NCT03954834|66714416|FG000|Overall Study|Adverse Event|1|||
23818596|NCT03954834|66714417|FG001|Overall Study|Adverse Event|3|||
23426152|NCT01813721|65303537|FG000|Overall Study|Withdrawal by Subject|1|||
23617887|NCT00507429|65988157|FG001|Treatment Phase|Withdrawal by Subject|3|||
23617888|NCT00507429|65988156|FG000|Treatment Phase|Physician Decision|4|||
23617889|NCT00507429|65988157|FG001|Treatment Phase|Physician Decision|2|||
23731864|NCT00397631|66395788|FG001|Overall Study|protocol discontinuation criteria|4|||
23731865|NCT02202161|66395789|FG000|Overall Study|Adverse Event|1|||
23731866|NCT02202161|66395790|FG001|Overall Study|Adverse Event|1|||
23731867|NCT02202161|66395791|FG002|Overall Study|Adverse Event|0|||
23731868|NCT02202161|66395792|FG003|Overall Study|Adverse Event|0|||
23731869|NCT02202161|66395793|FG004|Overall Study|Adverse Event|0|||
23731870|NCT02202161|66395794|FG005|Overall Study|Adverse Event|1|||
23731871|NCT02202161|66395795|FG006|Overall Study|Adverse Event|0|||
23731872|NCT02202161|66395796|FG007|Overall Study|Adverse Event|0|||
23818597|NCT03954834|66714418|FG002|Overall Study|Adverse Event|1|||
23617890|NCT00507429|65988156|FG000|Treatment Phase|Other|6|||
23617891|NCT00507429|65988157|FG001|Treatment Phase|Other|3|||
23617892|NCT00507429|65988156|FG000|Maintenance Phase|Progressive Disease|14|||
23617893|NCT00507429|65988157|FG001|Maintenance Phase|Progressive Disease|0|||
23617894|NCT04043806|65988158|FG000|Overall Study|Commercial drug is available for participants|13|||
23617895|NCT04043806|65988158|FG000|Overall Study|Physician Decision|2|||
23617896|NCT04043806|65988158|FG000|Overall Study|Other|12|||
23818598|NCT03954834|66714419|FG003|Overall Study|Adverse Event|1|||
23818599|NCT03954834|66714416|FG000|Overall Study|Death|0|||
23818600|NCT03954834|66714417|FG001|Overall Study|Death|0|||
23426153|NCT03958656|65303538|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23544368|NCT00659269|65723061|FG000|Overall Study|Physician Decision|1|||
23544369|NCT00659269|65723062|FG001|Overall Study|Physician Decision|1|||
23544370|NCT04258020|65723065|FG000|Overall Study|Withdrawal by Subject|1|||
23544371|NCT04258020|65723066|FG001|Overall Study|Withdrawal by Subject|0|||
23544372|NCT00511004|65723067|FG000|Overall Study|Lost to Follow-up|0|||
23617897|NCT04043806|65988158|FG000|Overall Study|Adverse Event|2|||
23617898|NCT04043806|65988158|FG000|Overall Study|Lost to Follow-up|6|||
23617899|NCT04043806|65988158|FG000|Overall Study|Other non-compliance|2|||
23731873|NCT02202161|66395789|FG000|Overall Study|Did not meet continuation criteria|0|||
23818601|NCT03954834|66714418|FG002|Overall Study|Death|0|||
23617900|NCT04043806|65988158|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
23617901|NCT04043806|65988158|FG000|Overall Study|Never Dosed|1|||
23617902|NCT02660034|65988162|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
23617903|NCT02660034|65988163|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
23617904|NCT02660034|65988164|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
23617905|NCT02660034|65988165|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
23617906|NCT02660034|65988166|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
23617907|NCT02660034|65988167|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
23617908|NCT02660034|65988168|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
23617909|NCT02660034|65988169|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
23617910|NCT02660034|65988170|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
23617911|NCT02660034|65988171|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
23617912|NCT02660034|65988172|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
23617913|NCT02660034|65988173|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
23818602|NCT03954834|66714419|FG003|Overall Study|Death|1|||
23818603|NCT03954834|66714416|FG000|Overall Study|Physician Decision|0|||
23818604|NCT03954834|66714417|FG001|Overall Study|Physician Decision|1|||
23818605|NCT03954834|66714418|FG002|Overall Study|Physician Decision|0|||
23818606|NCT03954834|66714419|FG003|Overall Study|Physician Decision|2|||
23818607|NCT03954834|66714416|FG000|Overall Study|Protocol Violation|1|||
23818608|NCT03954834|66714417|FG001|Overall Study|Protocol Violation|0|||
23818609|NCT03954834|66714418|FG002|Overall Study|Protocol Violation|0|||
23818610|NCT03954834|66714419|FG003|Overall Study|Protocol Violation|1|||
23731874|NCT02202161|66395790|FG001|Overall Study|Did not meet continuation criteria|0|||
23731875|NCT02202161|66395791|FG002|Overall Study|Did not meet continuation criteria|0|||
23731876|NCT02202161|66395792|FG003|Overall Study|Did not meet continuation criteria|0|||
23731877|NCT02202161|66395793|FG004|Overall Study|Did not meet continuation criteria|0|||
23731878|NCT02202161|66395794|FG005|Overall Study|Did not meet continuation criteria|0|||
23731879|NCT02202161|66395795|FG006|Overall Study|Did not meet continuation criteria|0|||
23731880|NCT02202161|66395796|FG007|Overall Study|Did not meet continuation criteria|3|||
23731881|NCT02202161|66395789|FG000|Overall Study|Physician Decision|0|||
23731882|NCT02202161|66395790|FG001|Overall Study|Physician Decision|0|||
23731883|NCT02202161|66395791|FG002|Overall Study|Physician Decision|0|||
23731884|NCT02202161|66395792|FG003|Overall Study|Physician Decision|0|||
23731885|NCT02202161|66395793|FG004|Overall Study|Physician Decision|0|||
23818611|NCT03954834|66714416|FG000|Overall Study|Withdrawal by Subject|2|||
23818612|NCT03954834|66714417|FG001|Overall Study|Withdrawal by Subject|3|||
23818613|NCT03954834|66714418|FG002|Overall Study|Withdrawal by Subject|13|||
23818614|NCT03954834|66714419|FG003|Overall Study|Withdrawal by Subject|6|||
23818615|NCT03954834|66714416|FG000|Overall Study|Participant left the country|0|||
23818616|NCT03954834|66714417|FG001|Overall Study|Participant left the country|0|||
23818617|NCT03954834|66714418|FG002|Overall Study|Participant left the country|1|||
23426154|NCT03958656|65303539|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
23544373|NCT00511004|65723068|FG001|Overall Study|Lost to Follow-up|0|||
23544374|NCT00511004|65723069|FG002|Overall Study|Lost to Follow-up|4|||
23544375|NCT02536508|65723070|FG000|Overall Study|Withdrawal by Subject|18|||
23544376|NCT02536508|65723071|FG001|Overall Study|Withdrawal by Subject|13|||
23544377|NCT02536508|65723072|FG002|Overall Study|Withdrawal by Subject|7|||
23544378|NCT02536508|65723070|FG000|Overall Study|Adverse Event|14|||
23544379|NCT02536508|65723071|FG001|Overall Study|Adverse Event|13|||
23544380|NCT02536508|65723072|FG002|Overall Study|Adverse Event|6|||
23544381|NCT02536508|65723070|FG000|Overall Study|Lost to Follow-up|12|||
23544382|NCT02536508|65723071|FG001|Overall Study|Lost to Follow-up|4|||
23544383|NCT02536508|65723072|FG002|Overall Study|Lost to Follow-up|0|||
23544384|NCT02536508|65723070|FG000|Overall Study|Lack of Efficacy|3|||
23544385|NCT02536508|65723071|FG001|Overall Study|Lack of Efficacy|5|||
23544386|NCT02536508|65723072|FG002|Overall Study|Lack of Efficacy|4|||
23544387|NCT02536508|65723070|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
23544388|NCT02536508|65723071|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
23544389|NCT02536508|65723072|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
23544390|NCT02536508|65723070|FG000|Overall Study|Physician Decision|0|||
23617914|NCT02660034|65988174|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
23617915|NCT02660034|65988175|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
23617916|NCT02660034|65988162|FG000|Overall Study|Progressive Disease (Clinical)|7|||
23818618|NCT03954834|66714419|FG003|Overall Study|Participant left the country|0|||
23818619|NCT03954834|66714416|FG000|Overall Study|Lost to Follow-up|3|||
23818620|NCT03954834|66714417|FG001|Overall Study|Lost to Follow-up|2|||
23818621|NCT03954834|66714418|FG002|Overall Study|Lost to Follow-up|3|||
23544391|NCT02536508|65723071|FG001|Overall Study|Physician Decision|4|||
23544392|NCT02536508|65723072|FG002|Overall Study|Physician Decision|2|||
23544393|NCT02536508|65723070|FG000|Overall Study|Major Protocol Deviation|2|||
23544394|NCT02536508|65723071|FG001|Overall Study|Major Protocol Deviation|2|||
23617917|NCT02660034|65988163|FG001|Overall Study|Progressive Disease (Clinical)|8|||
23731886|NCT02202161|66395794|FG005|Overall Study|Physician Decision|0|||
23731887|NCT02202161|66395795|FG006|Overall Study|Physician Decision|0|||
23544395|NCT02536508|65723072|FG002|Overall Study|Major Protocol Deviation|2|||
23544396|NCT02536508|65723070|FG000|Overall Study|Administrative Reasons|0|||
23544397|NCT02536508|65723071|FG001|Overall Study|Administrative Reasons|1|||
23544398|NCT02536508|65723072|FG002|Overall Study|Administrative Reasons|0|||
23544399|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Adverse Event|4|||
23544400|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Adverse Event|1|||
23544401|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Adverse Event|1|||
23544402|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
23544403|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
23544404|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
23544405|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Pregnancy|3|||
23544406|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Pregnancy|0|||
23544407|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Pregnancy|0|||
23544408|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
23544409|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
23544410|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
23544411|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
23544412|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
23544413|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
23544414|NCT03328897|65723073|FG000|Follow-up Epoch|Adverse Event|4|||
23544415|NCT03328897|65723074|FG001|Follow-up Epoch|Adverse Event|0|||
23544416|NCT03328897|65723075|FG002|Follow-up Epoch|Adverse Event|1|||
23544417|NCT03328897|65723073|FG000|Follow-up Epoch|Lack of Efficacy|1|||
23544418|NCT03328897|65723074|FG001|Follow-up Epoch|Lack of Efficacy|1|||
23544419|NCT03328897|65723075|FG002|Follow-up Epoch|Lack of Efficacy|1|||
23544420|NCT03328897|65723073|FG000|Follow-up Epoch|Lost to Follow-up|0|||
23544421|NCT03328897|65723074|FG001|Follow-up Epoch|Lost to Follow-up|1|||
23544422|NCT03328897|65723075|FG002|Follow-up Epoch|Lost to Follow-up|0|||
23544423|NCT03328897|65723073|FG000|Follow-up Epoch|Pregnancy|1|||
23544424|NCT03328897|65723074|FG001|Follow-up Epoch|Pregnancy|0|||
23544425|NCT03328897|65723075|FG002|Follow-up Epoch|Pregnancy|0|||
23544426|NCT03328897|65723073|FG000|Follow-up Epoch|Patient/guardian decision|2|||
23544427|NCT03328897|65723074|FG001|Follow-up Epoch|Patient/guardian decision|1|||
23544428|NCT03328897|65723075|FG002|Follow-up Epoch|Patient/guardian decision|0|||
23544429|NCT02660944|65723080|FG000|Overall Study|Adverse Event|3|||
23544430|NCT02660944|65723081|FG001|Overall Study|Adverse Event|4|||
23544431|NCT02660944|65723080|FG000|Overall Study|Physician Decision|3|||
23544432|NCT02660944|65723081|FG001|Overall Study|Physician Decision|1|||
23544433|NCT02660944|65723080|FG000|Overall Study|Withdrawal by Subject|5|||
23544434|NCT02660944|65723081|FG001|Overall Study|Withdrawal by Subject|3|||
23544435|NCT02660944|65723080|FG000|Overall Study|Lost to Follow-up|4|||
23544436|NCT02660944|65723081|FG001|Overall Study|Lost to Follow-up|1|||
23544437|NCT02660944|65723080|FG000|Overall Study|Subject schedule|0|||
23544438|NCT02660944|65723081|FG001|Overall Study|Subject schedule|1|||
23544439|NCT02660944|65723080|FG000|Overall Study|Exclusion criteria met|2|||
23544440|NCT02660944|65723081|FG001|Overall Study|Exclusion criteria met|0|||
23544441|NCT01286779|65723082|FG000|Overall Study|Withdrawal by Subject|9|||
23544442|NCT01286779|65723082|FG000|Overall Study|Protocol Violation|5|||
23544443|NCT01286779|65723082|FG000|Overall Study|Physician Decision|2|||
23544444|NCT01286779|65723082|FG000|Overall Study|Participant had scheduled surgery|1|||
23617918|NCT02660034|65988164|FG002|Overall Study|Progressive Disease (Clinical)|3|||
23617919|NCT02660034|65988165|FG003|Overall Study|Progressive Disease (Clinical)|9|||
23617920|NCT02660034|65988166|FG004|Overall Study|Progressive Disease (Clinical)|3|||
23617921|NCT02660034|65988167|FG005|Overall Study|Progressive Disease (Clinical)|0|||
23617922|NCT02660034|65988168|FG006|Overall Study|Progressive Disease (Clinical)|0|||
23617923|NCT02660034|65988169|FG007|Overall Study|Progressive Disease (Clinical)|0|||
23617924|NCT02660034|65988170|FG008|Overall Study|Progressive Disease (Clinical)|0|||
23617925|NCT02660034|65988171|FG009|Overall Study|Progressive Disease (Clinical)|0|||
23731888|NCT02202161|66395796|FG007|Overall Study|Physician Decision|3|||
23731889|NCT02202161|66395789|FG000|Overall Study|Withdrawal by Subject|0|||
23731890|NCT02202161|66395790|FG001|Overall Study|Withdrawal by Subject|0|||
23731891|NCT02202161|66395791|FG002|Overall Study|Withdrawal by Subject|0|||
23731892|NCT02202161|66395792|FG003|Overall Study|Withdrawal by Subject|0|||
23426155|NCT03958656|65303540|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23426156|NCT03958656|65303541|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23544445|NCT01286779|65723082|FG000|Overall Study|Participant moved to another country|1|||
23544446|NCT01286779|65723082|FG000|Overall Study|Discontinued by sponsor|1|||
23544447|NCT02159482|65723087|FG000|Overall Study|Withdrawal by Subject|2|||
23544448|NCT02159482|65723087|FG000|Overall Study|Physician Decision|3|||
23544449|NCT02525133|65723088|FG000|Overall Study|Adverse Event|0|||
23544450|NCT02525133|65723089|FG001|Overall Study|Adverse Event|1|||
23544451|NCT02525133|65723088|FG000|Overall Study|Death|0|||
23544452|NCT02525133|65723089|FG001|Overall Study|Death|1|||
23544453|NCT02525133|65723088|FG000|Overall Study|did not meet randomization criteria|1|||
23544454|NCT02525133|65723089|FG001|Overall Study|did not meet randomization criteria|0|||
23818622|NCT03954834|66714419|FG003|Overall Study|Lost to Follow-up|5|||
23544455|NCT02525133|65723088|FG000|Overall Study|Lost to Follow-up|5|||
23544456|NCT02525133|65723089|FG001|Overall Study|Lost to Follow-up|1|||
23544457|NCT02525133|65723088|FG000|Overall Study|randomized not enrolled|3|||
23544458|NCT02525133|65723089|FG001|Overall Study|randomized not enrolled|0|||
23544459|NCT02525133|65723088|FG000|Overall Study|Withdrawal by Subject|1|||
23544460|NCT02525133|65723089|FG001|Overall Study|Withdrawal by Subject|0|||
23544461|NCT02763384|65723090|FG000|Overall Study|Physician Decision|1|||
23544462|NCT02763384|65723090|FG000|Overall Study|Rapid decline - went on hospice|1|||
23544463|NCT04307186|65723091|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
23544464|NCT04307186|65723091|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
23544465|NCT04307186|65723091|FG000|Washout 3-14 Days|Progressive disease|1|||
23544466|NCT04307186|65723091|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
23544467|NCT04307186|65723091|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
23544468|NCT02043782|65723092|FG000|Period 1|Adverse Event|0|||
23544469|NCT02043782|65723093|FG001|Period 1|Adverse Event|0|||
23544470|NCT02043782|65723094|FG002|Period 1|Adverse Event|1|||
23544471|NCT02043782|65723095|FG003|Period 1|Adverse Event|0|||
23544472|NCT02043782|65723096|FG004|Period 1|Adverse Event|0|||
23544473|NCT02043782|65723097|FG005|Period 1|Adverse Event|0|||
23544474|NCT01944046|65723099|FG000|Randomized to DB|Adverse Event|5|||
23544475|NCT01944046|65723100|FG001|Randomized to DB|Adverse Event|2|||
23544476|NCT01944046|65723099|FG000|Randomized to DB|Clinical Worsening|3|||
23544477|NCT01944046|65723100|FG001|Randomized to DB|Clinical Worsening|2|||
23544478|NCT01944046|65723099|FG000|Randomized to DB|Lost to Follow-up|3|||
23544479|NCT01944046|65723100|FG001|Randomized to DB|Lost to Follow-up|3|||
23544480|NCT01944046|65723099|FG000|Randomized to DB|Withdrawal by Subject|2|||
23544481|NCT01944046|65723100|FG001|Randomized to DB|Withdrawal by Subject|4|||
23544482|NCT01944046|65723099|FG000|Randomized to DB|Physician Decision|1|||
23544483|NCT01944046|65723100|FG001|Randomized to DB|Physician Decision|2|||
23544484|NCT01944046|65723099|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
23544485|NCT01944046|65723100|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
23544486|NCT01944046|65723099|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
23544487|NCT01944046|65723100|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
23544488|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
23544489|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
23544490|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Adverse Event|6|||
23544491|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Adverse Event|1|||
23731893|NCT02202161|66395793|FG004|Overall Study|Withdrawal by Subject|1|||
23731894|NCT02202161|66395794|FG005|Overall Study|Withdrawal by Subject|0|||
23731895|NCT02202161|66395795|FG006|Overall Study|Withdrawal by Subject|0|||
23731896|NCT02202161|66395796|FG007|Overall Study|Withdrawal by Subject|0|||
23731897|NCT00537810|66395799|FG000|Overall Study|Withdrawal by Subject|4|||
23731898|NCT00537810|66395800|FG001|Overall Study|Withdrawal by Subject|11|||
23731899|NCT00537810|66395801|FG002|Overall Study|Withdrawal by Subject|4|||
23731900|NCT00537810|66395802|FG003|Overall Study|Withdrawal by Subject|3|||
23731901|NCT00537810|66395799|FG000|Overall Study|Medically withdrawn|2|||
23731902|NCT00537810|66395800|FG001|Overall Study|Medically withdrawn|2|||
23731903|NCT00537810|66395801|FG002|Overall Study|Medically withdrawn|0|||
23731904|NCT00537810|66395802|FG003|Overall Study|Medically withdrawn|1|||
23731905|NCT00355615|66395803|FG000|Randomized Double Blind Period|Adverse Event|1|||
23731906|NCT00355615|66395804|FG001|Randomized Double Blind Period|Adverse Event|0|||
23731907|NCT00355615|66395805|FG002|Randomized Double Blind Period|Adverse Event|0|||
23731908|NCT00355615|66395806|FG003|Randomized Double Blind Period|Adverse Event|0|||
23731909|NCT00355615|66395807|FG004|Randomized Double Blind Period|Adverse Event|0|||
23731910|NCT00355615|66395803|FG000|Randomized Double Blind Period|Protocol Violation|0|||
23426157|NCT03958656|65303538|FG000|Overall Study|No longer meets eligibility criteria|0|||
23426158|NCT03958656|65303539|FG001|Overall Study|No longer meets eligibility criteria|0|||
23426159|NCT03958656|65303540|FG002|Overall Study|No longer meets eligibility criteria|1|||
23426160|NCT03958656|65303541|FG003|Overall Study|No longer meets eligibility criteria|0|||
23544492|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
23544493|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
23544494|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
23544495|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
23544496|NCT01934218|65723101|FG000|Double-blind Phase|Adverse Event|8|||
23544497|NCT01934218|65723102|FG001|Double-blind Phase|Adverse Event|8|||
23731911|NCT00355615|66395804|FG001|Randomized Double Blind Period|Protocol Violation|0|||
23544498|NCT01934218|65723101|FG000|Double-blind Phase|Lack of Efficacy|6|||
23544499|NCT01934218|65723102|FG001|Double-blind Phase|Lack of Efficacy|7|||
23544500|NCT01934218|65723101|FG000|Double-blind Phase|Lost to Follow-up|7|||
23544501|NCT01934218|65723102|FG001|Double-blind Phase|Lost to Follow-up|14|||
23544502|NCT01934218|65723101|FG000|Double-blind Phase|Physician Decision|1|||
23544503|NCT01934218|65723102|FG001|Double-blind Phase|Physician Decision|2|||
23731912|NCT00355615|66395805|FG002|Randomized Double Blind Period|Protocol Violation|1|||
23731913|NCT00355615|66395806|FG003|Randomized Double Blind Period|Protocol Violation|1|||
23731914|NCT00355615|66395807|FG004|Randomized Double Blind Period|Protocol Violation|0|||
23731915|NCT00355615|66395803|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23731916|NCT00355615|66395804|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23731917|NCT00355615|66395805|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23731918|NCT00355615|66395806|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23731919|NCT00355615|66395807|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
23731920|NCT00355615|66395803|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23731921|NCT00355615|66395804|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23731922|NCT00355615|66395805|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23731923|NCT00355615|66395806|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23731924|NCT00355615|66395807|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
23818623|NCT04611529|66714420|FG000|2-day Follow up|Lost to Follow-up|5|||
23544504|NCT01934218|65723101|FG000|Double-blind Phase|Protocol Violation|4|||
23544505|NCT01934218|65723102|FG001|Double-blind Phase|Protocol Violation|0|||
23544506|NCT01934218|65723101|FG000|Double-blind Phase|Withdrawal by Subject|16|||
23818624|NCT04611529|66714421|FG001|2-day Follow up|Lost to Follow-up|6|||
23818625|NCT04611529|66714422|FG002|2-day Follow up|Lost to Follow-up|3|||
23818626|NCT00626392|66714426|FG000|Run-in Period|Adverse Event|0|||
23818627|NCT00626392|66714427|FG001|Run-in Period|Adverse Event|0|||
23818628|NCT00626392|66714428|FG002|Run-in Period|Adverse Event|1|||
23818629|NCT00626392|66714429|FG003|Run-in Period|Adverse Event|0|||
23818630|NCT00626392|66714430|FG004|Run-in Period|Adverse Event|1|||
23818631|NCT00626392|66714431|FG005|Run-in Period|Adverse Event|0|||
23818632|NCT00626392|66714426|FG000|Run-in Period|Withdrawal by Subject|0|||
23818633|NCT00626392|66714427|FG001|Run-in Period|Withdrawal by Subject|1|||
23818634|NCT00626392|66714428|FG002|Run-in Period|Withdrawal by Subject|1|||
23818635|NCT00626392|66714429|FG003|Run-in Period|Withdrawal by Subject|1|||
23818636|NCT00626392|66714430|FG004|Run-in Period|Withdrawal by Subject|3|||
23818637|NCT00626392|66714431|FG005|Run-in Period|Withdrawal by Subject|1|||
23818638|NCT00626392|66714426|FG000|Run-in Period|Noncompliance|1|||
23818639|NCT00626392|66714427|FG001|Run-in Period|Noncompliance|0|||
23818640|NCT00626392|66714428|FG002|Run-in Period|Noncompliance|1|||
23818641|NCT00626392|66714429|FG003|Run-in Period|Noncompliance|0|||
23818642|NCT00626392|66714430|FG004|Run-in Period|Noncompliance|0|||
23818643|NCT00626392|66714431|FG005|Run-in Period|Noncompliance|0|||
23818644|NCT00626392|66714426|FG000|Coadministration Period|Adverse Event|3|||
23818645|NCT00626392|66714427|FG001|Coadministration Period|Adverse Event|1|||
23818646|NCT00626392|66714428|FG002|Coadministration Period|Adverse Event|7|||
23818647|NCT00626392|66714429|FG003|Coadministration Period|Adverse Event|4|||
23818648|NCT00626392|66714430|FG004|Coadministration Period|Adverse Event|3|||
23818649|NCT00626392|66714431|FG005|Coadministration Period|Adverse Event|4|||
23818650|NCT00626392|66714426|FG000|Coadministration Period|Withdrawal by Subject|1|||
23818651|NCT00626392|66714427|FG001|Coadministration Period|Withdrawal by Subject|1|||
23818652|NCT00626392|66714428|FG002|Coadministration Period|Withdrawal by Subject|0|||
23818653|NCT00626392|66714429|FG003|Coadministration Period|Withdrawal by Subject|1|||
23818654|NCT00626392|66714430|FG004|Coadministration Period|Withdrawal by Subject|0|||
23818655|NCT00626392|66714431|FG005|Coadministration Period|Withdrawal by Subject|1|||
23818656|NCT00626392|66714426|FG000|Coadministration Period|Protocol Violation|0|||
23818657|NCT00626392|66714427|FG001|Coadministration Period|Protocol Violation|1|||
23818658|NCT00626392|66714428|FG002|Coadministration Period|Protocol Violation|0|||
23818659|NCT00626392|66714429|FG003|Coadministration Period|Protocol Violation|1|||
23818660|NCT00626392|66714430|FG004|Coadministration Period|Protocol Violation|1|||
23818661|NCT00626392|66714431|FG005|Coadministration Period|Protocol Violation|0|||
23818662|NCT00626392|66714426|FG000|Coadministration Period|Other|0|||
23818663|NCT00626392|66714427|FG001|Coadministration Period|Other|2|||
23818664|NCT00626392|66714428|FG002|Coadministration Period|Other|3|||
23818665|NCT00626392|66714429|FG003|Coadministration Period|Other|1|||
23818666|NCT00626392|66714430|FG004|Coadministration Period|Other|1|||
23818667|NCT00626392|66714431|FG005|Coadministration Period|Other|1|||
23818668|NCT01329900|66714432|FG000|Overall Study|Elevated creatinine/renal function|1|||
23818669|NCT02473523|66714433|FG000|Overall Study|Death|1|||
23818670|NCT02473523|66714433|FG000|Overall Study|Lost to Follow-up|1|||
23818671|NCT04338269|66714435|FG000|Overall Study|Death|86|||
23818672|NCT04338269|66714436|FG001|Overall Study|Death|89|||
23818673|NCT04338269|66714435|FG000|Overall Study|Lost to Follow-up|1|||
23818674|NCT04338269|66714436|FG001|Overall Study|Lost to Follow-up|2|||
23818675|NCT04338269|66714435|FG000|Overall Study|Physician Decision|1|||
23818676|NCT04338269|66714436|FG001|Overall Study|Physician Decision|0|||
23818677|NCT04338269|66714435|FG000|Overall Study|Withdrawal by Subject|14|||
23818678|NCT04338269|66714436|FG001|Overall Study|Withdrawal by Subject|11|||
23818679|NCT04003896|66714437|FG000|Overall Study|Withdrawal by Subject|3|||
23818680|NCT04003896|66714437|FG000|Overall Study|Physician Decision|1|||
23818681|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
23818682|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
23818683|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818684|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818685|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
23818686|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818687|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818688|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818689|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
23818690|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818691|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
23818692|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818693|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818694|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818695|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818696|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23818697|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23544507|NCT01934218|65723102|FG001|Double-blind Phase|Withdrawal by Subject|13|||
23544508|NCT01934218|65723101|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
23544509|NCT01934218|65723102|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
23544510|NCT01934218|65723101|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
23544511|NCT01934218|65723102|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
23544512|NCT01934218|65723101|FG000|Open-Label Phase|Adverse Event|2|||
23731925|NCT00355615|66395803|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23731926|NCT00355615|66395804|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23731927|NCT00355615|66395805|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23731928|NCT00355615|66395806|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23731929|NCT00355615|66395807|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
23731930|NCT00355615|66395803|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23731931|NCT00355615|66395804|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23731932|NCT00355615|66395805|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23731933|NCT00355615|66395806|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23731934|NCT00355615|66395807|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
23731935|NCT03462030|66395809|FG000|Overall Study|Withdrawal by Subject|1|||
23731936|NCT03462030|66395810|FG001|Overall Study|Withdrawal by Subject|1|||
23731937|NCT00886587|66395811|FG000|Overall Study|Adverse Event|2|||
23731938|NCT00886587|66395812|FG001|Overall Study|Adverse Event|1|||
23731939|NCT00886587|66395811|FG000|Overall Study|Protocol Violation|2|||
23731940|NCT00886587|66395812|FG001|Overall Study|Protocol Violation|0|||
23731941|NCT00886587|66395811|FG000|Overall Study|Withdrawal by Subject|0|||
23731942|NCT00886587|66395812|FG001|Overall Study|Withdrawal by Subject|1|||
23731943|NCT02038790|66395813|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
23731944|NCT02038790|66395814|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
23731945|NCT01263470|66395816|FG000|Overall Study|Adverse Event|2|||
23731946|NCT01263470|66395817|FG001|Overall Study|Adverse Event|2|||
23731947|NCT01263470|66395818|FG002|Overall Study|Adverse Event|1|||
23731948|NCT01263470|66395819|FG003|Overall Study|Adverse Event|1|||
23731949|NCT01263470|66395820|FG004|Overall Study|Adverse Event|2|||
23731950|NCT01263470|66395821|FG005|Overall Study|Adverse Event|2|||
23731951|NCT01263470|66395816|FG000|Overall Study|Protocol Violation|0|||
23818698|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23426161|NCT03958656|65303538|FG000|Overall Study|Started anti-cancer treatment|0|||
23731952|NCT01263470|66395817|FG001|Overall Study|Protocol Violation|1|||
23731953|NCT01263470|66395818|FG002|Overall Study|Protocol Violation|0|||
23731954|NCT01263470|66395819|FG003|Overall Study|Protocol Violation|0|||
23731955|NCT01263470|66395820|FG004|Overall Study|Protocol Violation|0|||
23731956|NCT01263470|66395821|FG005|Overall Study|Protocol Violation|1|||
23731957|NCT01263470|66395816|FG000|Overall Study|Withdrawal by Subject|0|||
23731958|NCT01263470|66395817|FG001|Overall Study|Withdrawal by Subject|1|||
23731959|NCT01263470|66395818|FG002|Overall Study|Withdrawal by Subject|1|||
23731960|NCT01263470|66395819|FG003|Overall Study|Withdrawal by Subject|2|||
23731961|NCT01263470|66395820|FG004|Overall Study|Withdrawal by Subject|0|||
23731962|NCT01263470|66395821|FG005|Overall Study|Withdrawal by Subject|2|||
23731963|NCT01263470|66395816|FG000|Overall Study|Lack of Efficacy|0|||
23731964|NCT01263470|66395817|FG001|Overall Study|Lack of Efficacy|0|||
23731965|NCT01263470|66395818|FG002|Overall Study|Lack of Efficacy|2|||
23731966|NCT01263470|66395819|FG003|Overall Study|Lack of Efficacy|0|||
23731967|NCT01263470|66395820|FG004|Overall Study|Lack of Efficacy|0|||
23731968|NCT01263470|66395821|FG005|Overall Study|Lack of Efficacy|0|||
23731969|NCT01263470|66395816|FG000|Overall Study|Participant Unavailability|0|||
23731970|NCT01263470|66395817|FG001|Overall Study|Participant Unavailability|1|||
23731971|NCT01263470|66395818|FG002|Overall Study|Participant Unavailability|0|||
23731972|NCT01263470|66395819|FG003|Overall Study|Participant Unavailability|0|||
23731973|NCT01263470|66395820|FG004|Overall Study|Participant Unavailability|0|||
23731974|NCT01263470|66395821|FG005|Overall Study|Participant Unavailability|0|||
23731975|NCT01263470|66395816|FG000|Overall Study|Study Drug Non-compliance|0|||
23731976|NCT01263470|66395817|FG001|Overall Study|Study Drug Non-compliance|0|||
23731977|NCT01263470|66395818|FG002|Overall Study|Study Drug Non-compliance|0|||
23731978|NCT01263470|66395819|FG003|Overall Study|Study Drug Non-compliance|0|||
23731979|NCT01263470|66395820|FG004|Overall Study|Study Drug Non-compliance|1|||
23731980|NCT01263470|66395821|FG005|Overall Study|Study Drug Non-compliance|0|||
23731981|NCT01266070|66395822|FG000|Overall Study|Adverse Event|3|||
23731982|NCT01266070|66395822|FG000|Overall Study|Protocol Violation|1|||
23731983|NCT03935594|66399170|FG000|Overall Study|Physician Decision|3|||
23731984|NCT00952588|66399171|FG000|Overall Study|Death|28|||
23731985|NCT00952588|66399172|FG001|Overall Study|Death|13|||
23731986|NCT00952588|66399171|FG000|Overall Study|Withdrawal by Subject|2|||
23731987|NCT00952588|66399172|FG001|Overall Study|Withdrawal by Subject|5|||
23731988|NCT00952588|66399171|FG000|Overall Study|Adverse Event|2|||
23731989|NCT00952588|66399172|FG001|Overall Study|Adverse Event|3|||
23731990|NCT00952588|66399171|FG000|Overall Study|Lost to Follow-up|2|||
23731991|NCT00952588|66399172|FG001|Overall Study|Lost to Follow-up|0|||
23731992|NCT00952588|66399171|FG000|Overall Study|Physician Decision|0|||
23731993|NCT00952588|66399172|FG001|Overall Study|Physician Decision|1|||
23731994|NCT00952588|66399171|FG000|Overall Study|Lack of Efficacy|2|||
23731995|NCT00952588|66399172|FG001|Overall Study|Lack of Efficacy|2|||
23731996|NCT02139280|66399173|FG000|Overall Study|No longer eligible|2|||
23731997|NCT02139280|66399174|FG001|Overall Study|No longer eligible|0|||
23731998|NCT05091918|66399176|FG000|Overall Study|Adverse Event|1|||
23731999|NCT05091918|66399176|FG000|Overall Study|Withdrawal by Subject|81|||
23732000|NCT01603615|66399177|FG000|Overall Study|Did not Receive Treatment|7|||
23732001|NCT01603615|66399177|FG000|Overall Study|Lost to Follow-up|9|||
23732002|NCT01603615|66399177|FG000|Overall Study|Personal Reasons|17|||
23732003|NCT01603615|66399177|FG000|Overall Study|Other Miscellaneous|1|||
23732004|NCT00439309|66399178|FG000|Follow-Up|Death|1|||
23732005|NCT00439309|66399179|FG001|Follow-Up|Death|0|||
23732006|NCT00439309|66399178|FG000|Follow-Up|Lost to Follow-up|2|||
23732007|NCT00439309|66399179|FG001|Follow-Up|Lost to Follow-up|0|||
23732008|NCT00439309|66399178|FG000|Follow-Up|Withdrawal by Subject|0|||
23732009|NCT00439309|66399179|FG001|Follow-Up|Withdrawal by Subject|1|||
23732010|NCT00439309|66399178|FG000|Follow-Up|Late response by subject|0|||
23732011|NCT00439309|66399179|FG001|Follow-Up|Late response by subject|1|||
23732012|NCT00811395|66399180|FG000|Extension Treatment|Adverse Event|1|||
23732013|NCT00811395|66399181|FG001|Extension Treatment|Adverse Event|2|||
23732014|NCT00811395|66399182|FG002|Extension Treatment|Adverse Event|2|||
23732015|NCT00811395|66399183|FG003|Extension Treatment|Adverse Event|2|||
23732016|NCT00811395|66399184|FG004|Extension Treatment|Adverse Event|0|||
23544513|NCT01934218|65723102|FG001|Open-Label Phase|Adverse Event|4|||
23732017|NCT00811395|66399185|FG005|Extension Treatment|Adverse Event|1|||
23732018|NCT00811395|66399180|FG000|Extension Treatment|Progressive disease|1|||
23818699|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23732019|NCT00811395|66399181|FG001|Extension Treatment|Progressive disease|1|||
23732020|NCT00811395|66399182|FG002|Extension Treatment|Progressive disease|0|||
23732021|NCT00811395|66399183|FG003|Extension Treatment|Progressive disease|0|||
23732022|NCT00811395|66399184|FG004|Extension Treatment|Progressive disease|0|||
23732023|NCT00811395|66399185|FG005|Extension Treatment|Progressive disease|0|||
23732024|NCT00811395|66399180|FG000|Extension Treatment|Participant did not wish to continue|0|||
23732025|NCT00811395|66399181|FG001|Extension Treatment|Participant did not wish to continue|3|||
23426162|NCT03958656|65303539|FG001|Overall Study|Started anti-cancer treatment|0|||
23426163|NCT03958656|65303540|FG002|Overall Study|Started anti-cancer treatment|1|||
23426164|NCT03958656|65303541|FG003|Overall Study|Started anti-cancer treatment|0|||
23426165|NCT01129882|65303542|FG000|Overall Study|Adverse Event|39|||
23426166|NCT01129882|65303542|FG000|Overall Study|Death|6|||
23426167|NCT01129882|65303542|FG000|Overall Study|Lack of Efficacy|5|||
23426168|NCT01129882|65303542|FG000|Overall Study|Lost to Follow-up|13|||
23426169|NCT01129882|65303542|FG000|Overall Study|Physician Decision|27|||
23426170|NCT01129882|65303542|FG000|Overall Study|Protocol Deviation|3|||
23426171|NCT01129882|65303542|FG000|Overall Study|Withdrawal Criteria Met|19|||
23426172|NCT01129882|65303542|FG000|Overall Study|Trial Termination by Sponsor|6|||
23426173|NCT01129882|65303542|FG000|Overall Study|Withdrawal by Subject|160|||
23426174|NCT01219933|65303544|FG000|Overall Study|Adverse Event|8|||
23426175|NCT01219933|65303544|FG000|Overall Study|No LDA reached|5|||
23426176|NCT01219933|65303544|FG000|Overall Study|No LDA maintained|7|||
23426177|NCT01219933|65303544|FG000|Overall Study|Lost to Follow-up|3|||
23426178|NCT01219933|65303544|FG000|Overall Study|GC free|1|||
23426179|NCT01219933|65303544|FG000|Overall Study|Withdrawal by Subject|5|||
23426180|NCT01219933|65303544|FG000|Overall Study|Protocol Violation|8|||
23426181|NCT01219933|65303544|FG000|Overall Study|Lack of Efficacy|1|||
23426182|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
23426183|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
23426184|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
23426185|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
23426186|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
23426187|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
23426188|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
23544514|NCT01934218|65723101|FG000|Open-Label Phase|Lack of Efficacy|1|||
23732026|NCT00811395|66399182|FG002|Extension Treatment|Participant did not wish to continue|0|||
23732027|NCT00811395|66399183|FG003|Extension Treatment|Participant did not wish to continue|1|||
23732028|NCT00811395|66399184|FG004|Extension Treatment|Participant did not wish to continue|0|||
23732029|NCT00811395|66399185|FG005|Extension Treatment|Participant did not wish to continue|1|||
23732030|NCT00811395|66399180|FG000|Extension Treatment|Other than above|0|||
23732031|NCT00811395|66399181|FG001|Extension Treatment|Other than above|0|||
23732032|NCT00811395|66399182|FG002|Extension Treatment|Other than above|1|||
23732033|NCT00811395|66399183|FG003|Extension Treatment|Other than above|0|||
23732034|NCT00811395|66399184|FG004|Extension Treatment|Other than above|0|||
23732035|NCT00811395|66399185|FG005|Extension Treatment|Other than above|0|||
23732036|NCT00233324|66399188|FG000|Main Study|Death|68|||
23732037|NCT00233324|66399189|FG001|Main Study|Death|60|||
23732038|NCT00233324|66399190|FG002|Main Study|Death|62|||
23732039|NCT00233324|66399191|FG003|Main Study|Death|47|||
23732040|NCT00233324|66399188|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
23732041|NCT00233324|66399189|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
23732042|NCT00233324|66399190|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
23732043|NCT00233324|66399191|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
23732044|NCT00233324|66399188|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
23732045|NCT00233324|66399189|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
23732046|NCT00233324|66399190|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
23732047|NCT00233324|66399191|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
23732048|NCT03662789|66399192|FG000|Overall Study|Lost to Follow-up|1|||
23732049|NCT03662789|66399193|FG001|Overall Study|Lost to Follow-up|2|||
23732050|NCT03662789|66399192|FG000|Overall Study|Could not perform treadmill test|4|||
23732051|NCT03662789|66399193|FG001|Overall Study|Could not perform treadmill test|4|||
23732052|NCT03662789|66399192|FG000|Overall Study|Death|0|||
23732053|NCT03662789|66399193|FG001|Overall Study|Death|1|||
23732054|NCT00216086|66399195|FG000|Overall Study|Protocol Violation|1|||
23732055|NCT00216086|66399195|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
23732056|NCT00216086|66399195|FG000|Overall Study|Social Reasons|2|||
23732057|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
23732058|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
23732059|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
23732060|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23544515|NCT01934218|65723102|FG001|Open-Label Phase|Lack of Efficacy|4|||
23544516|NCT01934218|65723101|FG000|Open-Label Phase|Lost to Follow-up|4|||
23732061|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
23732062|NCT00989664|66399196|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
23732063|NCT00989664|66399196|FG000|Long-Term Follow-Up|Death|3|||
23426189|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
23426190|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
23426191|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
23544517|NCT01934218|65723102|FG001|Open-Label Phase|Lost to Follow-up|2|||
23732064|NCT03006926|66399198|FG000|Overall Study|Adverse Event|0|||
23544518|NCT01934218|65723101|FG000|Open-Label Phase|Physician Decision|1|||
23732065|NCT03006926|66399199|FG001|Overall Study|Adverse Event|27|||
23732066|NCT03006926|66399198|FG000|Overall Study|Withdrawal by Subject|0|||
23732067|NCT03006926|66399199|FG001|Overall Study|Withdrawal by Subject|1|||
23732068|NCT03006926|66399198|FG000|Overall Study|Radiological Disease Progression|0|||
23732069|NCT03006926|66399199|FG001|Overall Study|Radiological Disease Progression|52|||
23732070|NCT03006926|66399198|FG000|Overall Study|Clinical Disease Progression|0|||
23732071|NCT03006926|66399199|FG001|Overall Study|Clinical Disease Progression|10|||
23732072|NCT03006926|66399198|FG000|Overall Study|Other|0|||
23732073|NCT03006926|66399199|FG001|Overall Study|Other|8|||
23732074|NCT01947127|66399200|FG000|Overall Study|Protocol Violation|18|||
23544519|NCT01934218|65723102|FG001|Open-Label Phase|Physician Decision|0|||
23544520|NCT01934218|65723101|FG000|Open-Label Phase|Protocol Violation|1|||
23732075|NCT01947127|66399201|FG001|Overall Study|Protocol Violation|38|||
23732076|NCT01947127|66399200|FG000|Overall Study|Withdrawal by Subject|1|||
23732077|NCT01947127|66399201|FG001|Overall Study|Withdrawal by Subject|1|||
23732078|NCT01947127|66399200|FG000|Overall Study|Data loss|4|||
23732079|NCT01947127|66399201|FG001|Overall Study|Data loss|4|||
23732080|NCT02875366|66399202|FG000|Overall Study|Adverse Event|0|||
23732081|NCT02875366|66399203|FG001|Overall Study|Adverse Event|2|||
23732082|NCT02875366|66399202|FG000|Overall Study|Noncompliance|0|||
23732083|NCT02875366|66399203|FG001|Overall Study|Noncompliance|1|||
23732084|NCT01925014|66399204|FG000|Overall Study|Inappropriate enrollment|4|||
23732085|NCT01925014|66399205|FG001|Overall Study|Inappropriate enrollment|6|||
23732086|NCT01925014|66399204|FG000|Overall Study|Withdrawal by Subject|5|||
23732087|NCT01925014|66399205|FG001|Overall Study|Withdrawal by Subject|13|||
23732088|NCT00364611|66399210|FG000|Overall Study|Did not receive study medication|0|||
23544521|NCT01934218|65723102|FG001|Open-Label Phase|Protocol Violation|0|||
23732089|NCT00364611|66399211|FG001|Overall Study|Did not receive study medication|1|||
23544522|NCT01934218|65723101|FG000|Open-Label Phase|Withdrawal by Subject|13|||
23544523|NCT01934218|65723102|FG001|Open-Label Phase|Withdrawal by Subject|11|||
23544524|NCT01934218|65723101|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
23544525|NCT01934218|65723102|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
23544526|NCT01934218|65723101|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
23544527|NCT01934218|65723102|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
23544528|NCT03832010|65723104|FG000|Overall Study|Withdrawal by Subject|2|||
23544529|NCT03832010|65723105|FG001|Overall Study|Withdrawal by Subject|1|||
23544530|NCT03832010|65723106|FG002|Overall Study|Withdrawal by Subject|0|||
23544531|NCT03832010|65723104|FG000|Overall Study|Lost to Follow-up|2|||
23544532|NCT03832010|65723105|FG001|Overall Study|Lost to Follow-up|1|||
23544533|NCT03832010|65723106|FG002|Overall Study|Lost to Follow-up|1|||
23544534|NCT02363738|65723107|FG000|Overall Study|Adverse Event|5|||
23544535|NCT02363738|65723108|FG001|Overall Study|Adverse Event|2|||
23544536|NCT02363738|65723107|FG000|Overall Study|Lack of Efficacy|1|||
23544537|NCT02363738|65723108|FG001|Overall Study|Lack of Efficacy|2|||
23544538|NCT02363738|65723107|FG000|Overall Study|Lost to Follow-up|2|||
23544539|NCT02363738|65723108|FG001|Overall Study|Lost to Follow-up|1|||
23544540|NCT01410448|65723111|FG000|Overall Study|No conversion to everolimus|0|||
23544541|NCT01410448|65723112|FG001|Overall Study|No conversion to everolimus|24|||
23544542|NCT01410448|65723111|FG000|Overall Study|Graft loss|4|||
23544543|NCT01410448|65723112|FG001|Overall Study|Graft loss|1|||
23544544|NCT01410448|65723111|FG000|Overall Study|Administrative issues|2|||
23544545|NCT01410448|65723112|FG001|Overall Study|Administrative issues|1|||
23544546|NCT01410448|65723111|FG000|Overall Study|Lost to Follow-up|1|||
23544547|NCT01410448|65723112|FG001|Overall Study|Lost to Follow-up|0|||
23544548|NCT01410448|65723111|FG000|Overall Study|Withdrawal by Subject|3|||
23544549|NCT01410448|65723112|FG001|Overall Study|Withdrawal by Subject|2|||
23544550|NCT01410448|65723111|FG000|Overall Study|Protocol Violation|0|||
23544551|NCT01410448|65723112|FG001|Overall Study|Protocol Violation|4|||
23544552|NCT01410448|65723111|FG000|Overall Study|Death|2|||
23544553|NCT01410448|65723112|FG001|Overall Study|Death|3|||
23544554|NCT02627677|65723113|FG000|Overall Study|Adverse event (not progressive disease)|1|||
23544555|NCT02627677|65723114|FG001|Overall Study|Adverse event (not progressive disease)|4|||
23732090|NCT00364611|66399210|FG000|Overall Study|Adverse Event|7|||
23818700|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
23544556|NCT02627677|65723115|FG002|Overall Study|Adverse event (not progressive disease)|1|||
23544557|NCT02627677|65723113|FG000|Overall Study|Progressive disease|1|||
23544558|NCT02627677|65723114|FG001|Overall Study|Progressive disease|3|||
23544559|NCT02627677|65723115|FG002|Overall Study|Progressive disease|0|||
23544560|NCT02627677|65723113|FG000|Overall Study|Lack of Efficacy|1|||
23617926|NCT02660034|65988172|FG010|Overall Study|Progressive Disease (Clinical)|0|||
23617927|NCT02660034|65988173|FG011|Overall Study|Progressive Disease (Clinical)|0|||
23732091|NCT00364611|66399211|FG001|Overall Study|Adverse Event|4|||
23732092|NCT00364611|66399210|FG000|Overall Study|Participant's Request|3|||
23732093|NCT00364611|66399211|FG001|Overall Study|Participant's Request|4|||
23544561|NCT02627677|65723114|FG001|Overall Study|Lack of Efficacy|2|||
23544562|NCT02627677|65723115|FG002|Overall Study|Lack of Efficacy|0|||
23544563|NCT02627677|65723113|FG000|Overall Study|Lost to Follow-up|0|||
23544564|NCT02627677|65723114|FG001|Overall Study|Lost to Follow-up|0|||
23544565|NCT02627677|65723115|FG002|Overall Study|Lost to Follow-up|1|||
23544566|NCT02627677|65723113|FG000|Overall Study|Pregnancy|0|||
23544567|NCT02627677|65723114|FG001|Overall Study|Pregnancy|1|||
23544568|NCT02627677|65723115|FG002|Overall Study|Pregnancy|0|||
23544569|NCT02627677|65723113|FG000|Overall Study|Study Terminated by Sponsor|5|||
23544570|NCT02627677|65723114|FG001|Overall Study|Study Terminated by Sponsor|10|||
23544571|NCT02627677|65723115|FG002|Overall Study|Study Terminated by Sponsor|6|||
23544572|NCT02627677|65723113|FG000|Overall Study|Physician Decision|0|||
23544573|NCT02627677|65723114|FG001|Overall Study|Physician Decision|0|||
23544574|NCT02627677|65723115|FG002|Overall Study|Physician Decision|2|||
23544575|NCT02627677|65723113|FG000|Overall Study|Withdrawal by Subject|2|||
23544576|NCT02627677|65723114|FG001|Overall Study|Withdrawal by Subject|1|||
23544577|NCT02627677|65723115|FG002|Overall Study|Withdrawal by Subject|1|||
23732094|NCT00364611|66399210|FG000|Overall Study|Disease Progression|38|||
23732095|NCT00364611|66399211|FG001|Overall Study|Disease Progression|8|||
23732096|NCT00364611|66399210|FG000|Overall Study|Investigator decision|2|||
23732097|NCT00364611|66399211|FG001|Overall Study|Investigator decision|2|||
23732098|NCT00364611|66399210|FG000|Overall Study|Found Ineligible|1|||
23732099|NCT00364611|66399211|FG001|Overall Study|Found Ineligible|0|||
23732100|NCT00364611|66399210|FG000|Overall Study|Presumed CR on Study|0|||
23732101|NCT00364611|66399211|FG001|Overall Study|Presumed CR on Study|1|||
23732102|NCT00364611|66399210|FG000|Overall Study|Receiving Liver Ablation|0|||
23732103|NCT00364611|66399211|FG001|Overall Study|Receiving Liver Ablation|1|||
23732104|NCT00672139|66399216|FG000|Overall Study|Death|14|||
23732105|NCT00672139|66399217|FG001|Overall Study|Death|23|||
23732106|NCT00672139|66399216|FG000|Overall Study|Withdrawal by Subject|2|||
23732107|NCT00672139|66399217|FG001|Overall Study|Withdrawal by Subject|11|||
23732108|NCT00672139|66399216|FG000|Overall Study|Adverse Event|4|||
23732109|NCT00672139|66399217|FG001|Overall Study|Adverse Event|7|||
23732110|NCT00672139|66399216|FG000|Overall Study|Physician Decision|2|||
23732111|NCT00672139|66399217|FG001|Overall Study|Physician Decision|0|||
23732112|NCT00672139|66399216|FG000|Overall Study|Lack of Efficacy|4|||
23732113|NCT00672139|66399217|FG001|Overall Study|Lack of Efficacy|1|||
23732114|NCT00672139|66399216|FG000|Overall Study|Protocol Violation|1|||
23732115|NCT00672139|66399217|FG001|Overall Study|Protocol Violation|1|||
23732116|NCT00672139|66399216|FG000|Overall Study|hospice discharge, caregiver requests|3|||
23732117|NCT00672139|66399217|FG001|Overall Study|hospice discharge, caregiver requests|2|||
23732118|NCT02573012|66399221|FG000|Overall Study|Adverse Event|5|||
23732119|NCT02573012|66399222|FG001|Overall Study|Adverse Event|5|||
23732120|NCT02573012|66399221|FG000|Overall Study|Lack of Efficacy|5|||
23732121|NCT02573012|66399222|FG001|Overall Study|Lack of Efficacy|4|||
23732122|NCT02573012|66399221|FG000|Overall Study|Non-compliance|1|||
23544578|NCT02627677|65723113|FG000|Overall Study|Reason not Specified|0|||
23732123|NCT02573012|66399222|FG001|Overall Study|Non-compliance|2|||
23732124|NCT02573012|66399221|FG000|Overall Study|Withdrawal by Subject|2|||
23732125|NCT02573012|66399222|FG001|Overall Study|Withdrawal by Subject|2|||
23732126|NCT02573012|66399221|FG000|Overall Study|Study Ended per Protocol|1|||
23544579|NCT02627677|65723114|FG001|Overall Study|Reason not Specified|0|||
23544580|NCT02627677|65723115|FG002|Overall Study|Reason not Specified|1|||
23544581|NCT02627677|65723113|FG000|Overall Study|Randomized but not Treated|1|||
23732127|NCT02573012|66399222|FG001|Overall Study|Study Ended per Protocol|0|||
23732128|NCT02573012|66399221|FG000|Overall Study|Physician Decision|1|||
23544582|NCT02627677|65723114|FG001|Overall Study|Randomized but not Treated|0|||
23544583|NCT02627677|65723115|FG002|Overall Study|Randomized but not Treated|0|||
23544584|NCT00305058|65723121|FG000|Overall Study|Participant too young|1|||
23544585|NCT00305058|65723122|FG001|Overall Study|Participant too young|0|||
23544586|NCT00305058|65723121|FG000|Overall Study|Missing data collection instrument|3|||
23544587|NCT00305058|65723122|FG001|Overall Study|Missing data collection instrument|2|||
23544588|NCT00305058|65723121|FG000|Overall Study|Missing outcome data|3|||
23544589|NCT00305058|65723122|FG001|Overall Study|Missing outcome data|2|||
23732129|NCT02573012|66399222|FG001|Overall Study|Physician Decision|2|||
23732130|NCT02447952|66399223|FG000|Overall Study|Adverse Event|2|||
23732131|NCT02447952|66399223|FG000|Overall Study|Physician Decision|1|||
23544590|NCT02519504|65723123|FG000|Overall Study|Protocol Violation|6|||
23544591|NCT02519504|65723124|FG001|Overall Study|Protocol Violation|5|||
23732132|NCT02447952|66399223|FG000|Overall Study|Withdrawal by Subject|4|||
23544592|NCT02519504|65723123|FG000|Overall Study|Ineligible for direct testing|12|||
23544593|NCT02519504|65723124|FG001|Overall Study|Ineligible for direct testing|12|||
23544594|NCT02519504|65723123|FG000|Overall Study|Did not participate in direct testing|95|||
23544595|NCT02519504|65723124|FG001|Overall Study|Did not participate in direct testing|86|||
23544596|NCT02617589|65723125|FG000|Randomization|Request to Discontinue Study Treatment|1|||
23544597|NCT02617589|65723126|FG001|Randomization|Request to Discontinue Study Treatment|3|||
23732133|NCT02299206|66399224|FG000|Overall Study|Lost to Follow-up|1|||
23732134|NCT02299206|66399224|FG000|Overall Study|Withdrawal by Subject|1|||
23732135|NCT04489940|66399225|FG000|Overall Study|Other|2|||
23544598|NCT02617589|65723125|FG000|Randomization|Participant Withdrew Consent|1|||
23544599|NCT02617589|65723126|FG001|Randomization|Participant Withdrew Consent|2|||
23544600|NCT02617589|65723125|FG000|Treatment|Other Reasons|3|||
23544601|NCT02617589|65723126|FG001|Treatment|Other Reasons|3|||
23544602|NCT02617589|65723125|FG000|Treatment|Poor/Non Compliance|1|||
23544603|NCT02617589|65723126|FG001|Treatment|Poor/Non Compliance|1|||
23544604|NCT02617589|65723125|FG000|Treatment|Maximum Clinical Benefit|0|||
23544605|NCT02617589|65723126|FG001|Treatment|Maximum Clinical Benefit|2|||
23544606|NCT02617589|65723125|FG000|Treatment|Participant Withdrew Consent|2|||
23544607|NCT02617589|65723126|FG001|Treatment|Participant Withdrew Consent|6|||
23544608|NCT02617589|65723125|FG000|Treatment|Participant Request to Discontinue|12|||
23544609|NCT02617589|65723126|FG001|Treatment|Participant Request to Discontinue|21|||
23544610|NCT02617589|65723125|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
23544611|NCT02617589|65723126|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
23544612|NCT02617589|65723125|FG000|Treatment|Death|1|||
23544613|NCT02617589|65723126|FG001|Treatment|Death|1|||
23544614|NCT02617589|65723125|FG000|Treatment|Study Drug Toxicity|27|||
23544615|NCT02617589|65723126|FG001|Treatment|Study Drug Toxicity|20|||
23544616|NCT02617589|65723125|FG000|Treatment|Disease Progression|216|||
23544617|NCT02617589|65723126|FG001|Treatment|Disease Progression|136|||
23544618|NCT03034577|65723127|FG000|Overall Study|Withdrawal by Subject|6|||
23544619|NCT03034577|65723128|FG001|Overall Study|Withdrawal by Subject|9|||
23544620|NCT03034577|65723127|FG000|Overall Study|Lost to Follow-up|25|||
23544621|NCT03034577|65723128|FG001|Overall Study|Lost to Follow-up|26|||
23544622|NCT01985126|65723131|FG000|Overall Study|Death|15|||
23732136|NCT04489940|66399225|FG000|Overall Study|Withdrawal by Subject|2|||
23732137|NCT04489940|66399225|FG000|Overall Study|Death|5|||
23818701|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818702|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
23818703|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818704|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818705|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818706|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23544623|NCT01985126|65723132|FG001|Overall Study|Death|69|||
23544624|NCT01985126|65723131|FG000|Overall Study|Lost to Follow-up|0|||
23544625|NCT01985126|65723132|FG001|Overall Study|Lost to Follow-up|8|||
23544626|NCT01985126|65723131|FG000|Overall Study|Study Terminated By Sponsor|1|||
23732138|NCT04489940|66399225|FG000|Overall Study|Lost to Follow-up|1|||
23544627|NCT01985126|65723132|FG001|Overall Study|Study Terminated By Sponsor|22|||
23544628|NCT01985126|65723131|FG000|Overall Study|Withdrawal by Subject|2|||
23544629|NCT01985126|65723132|FG001|Overall Study|Withdrawal by Subject|7|||
23544630|NCT03646513|65723136|FG000|Overall Study|Premature study termination|4|||
23544631|NCT02504294|65723137|FG000|Overall Study|Adverse Event|15|||
23544632|NCT02504294|65723138|FG001|Overall Study|Adverse Event|12|||
23544633|NCT02504294|65723137|FG000|Overall Study|Withdrawal by Subject|7|||
23544634|NCT02504294|65723138|FG001|Overall Study|Withdrawal by Subject|1|||
23544635|NCT02504294|65723137|FG000|Overall Study|Protocol Violation|27|||
23544636|NCT02504294|65723138|FG001|Overall Study|Protocol Violation|26|||
23544637|NCT02504294|65723137|FG000|Overall Study|Physician Decision|1|||
23544638|NCT02504294|65723138|FG001|Overall Study|Physician Decision|2|||
23544639|NCT02504294|65723137|FG000|Overall Study|Lost to Follow-up|6|||
23544640|NCT02504294|65723138|FG001|Overall Study|Lost to Follow-up|7|||
23544641|NCT01660906|65723139|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
23544642|NCT00407537|65723143|FG000|Overall Study|Death|5|||
23732139|NCT02463331|66399226|FG000|Overall Study|Adverse Event|4|||
23732140|NCT02463331|66399227|FG001|Overall Study|Adverse Event|2|||
23732141|NCT02463331|66399226|FG000|Overall Study|Lost to Follow-up|1|||
23732142|NCT02463331|66399227|FG001|Overall Study|Lost to Follow-up|1|||
23732143|NCT02463331|66399226|FG000|Overall Study|Pregnancy|2|||
23732144|NCT02463331|66399227|FG001|Overall Study|Pregnancy|3|||
23732145|NCT02463331|66399226|FG000|Overall Study|Lack of Efficacy|6|||
23732146|NCT02463331|66399227|FG001|Overall Study|Lack of Efficacy|0|||
23732147|NCT02463331|66399226|FG000|Overall Study|Physician Decision|3|||
23732148|NCT02463331|66399227|FG001|Overall Study|Physician Decision|0|||
23732149|NCT02159365|66399228|FG000|Overall Study|Disease Progression|23|||
23818707|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23544643|NCT00407537|65723144|FG001|Overall Study|Death|2|||
23544644|NCT00407537|65723143|FG000|Overall Study|Adverse Event|36|||
23544645|NCT00407537|65723144|FG001|Overall Study|Adverse Event|0|||
23544646|NCT00407537|65723143|FG000|Overall Study|Lost to Follow-up|12|||
23544647|NCT00407537|65723144|FG001|Overall Study|Lost to Follow-up|19|||
23544648|NCT00407537|65723143|FG000|Overall Study|Other|6|||
23544649|NCT00407537|65723144|FG001|Overall Study|Other|7|||
23544650|NCT00407537|65723143|FG000|Overall Study|Withdrawal by Subject|34|||
23732150|NCT02159365|66399228|FG000|Overall Study|Other reasons|11|||
23732151|NCT02159365|66399228|FG000|Overall Study|Administrative reason by Sponsor|9|||
23732152|NCT02159365|66399228|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
23732153|NCT02159365|66399228|FG000|Overall Study|Study drug toxicity|7|||
23732154|NCT02159365|66399228|FG000|Overall Study|Maximum clinical benefit|3|||
23732155|NCT02159365|66399228|FG000|Overall Study|Subject request to discontinue treatment|3|||
23732156|NCT02159365|66399228|FG000|Overall Study|Subject withdrew consent|3|||
23732157|NCT02159365|66399228|FG000|Overall Study|Death|1|||
23732158|NCT02159365|66399228|FG000|Overall Study|Lost to Follow-up|1|||
23732159|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
23544651|NCT00407537|65723144|FG001|Overall Study|Withdrawal by Subject|16|||
23732160|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
23544652|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
23732161|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
23544653|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
23544654|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
23544655|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
23544656|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
23544657|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
23544658|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
23544659|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
23544660|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
23544661|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
23544662|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
23544663|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
23732162|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
23732163|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Other|1|||
23544664|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
23544665|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
23544666|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
23732164|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Other|0|||
23732165|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Other|2|||
23732166|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Other|4|||
23732167|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
23732168|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
23732169|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
23732170|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
23732171|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Adverse Event|0|||
23732172|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Adverse Event|0|||
23732173|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Adverse Event|1|||
23732174|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Adverse Event|2|||
23732175|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
23732176|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
23732177|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
23732178|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
23732179|NCT00808028|66399229|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
23732180|NCT00808028|66399230|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
23732181|NCT00808028|66399231|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
23732182|NCT00808028|66399232|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
23732183|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
23732184|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
23732185|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
23544667|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
23544668|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
23544669|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
23544670|NCT00355082|65723145|FG000|Continuation Phase|Adverse Event|2|||
23732186|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
23544671|NCT00355082|65723146|FG001|Continuation Phase|Adverse Event|0|||
23544672|NCT00355082|65723147|FG002|Continuation Phase|Adverse Event|1|||
23544673|NCT00355082|65723145|FG000|Continuation Phase|Lost to Follow-up|2|||
23544674|NCT00355082|65723146|FG001|Continuation Phase|Lost to Follow-up|0|||
23544675|NCT00355082|65723147|FG002|Continuation Phase|Lost to Follow-up|1|||
23544676|NCT00355082|65723145|FG000|Continuation Phase|Protocol Violation|1|||
23544677|NCT00355082|65723146|FG001|Continuation Phase|Protocol Violation|0|||
23544678|NCT00355082|65723147|FG002|Continuation Phase|Protocol Violation|1|||
23544679|NCT00355082|65723145|FG000|Continuation Phase|Withdrawal by Subject|4|||
23732187|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23732188|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23732189|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
23732190|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23732191|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
23732192|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
23732193|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
23732194|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
23732195|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
23732196|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
23732197|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
23732198|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
23732199|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
23732200|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
23732201|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
23732202|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
23732203|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
23732204|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
23732205|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
23732206|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
23732207|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23732208|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23544680|NCT00355082|65723146|FG001|Continuation Phase|Withdrawal by Subject|0|||
23732209|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
23732210|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23732211|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
23732212|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
23732213|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
23732214|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
23544681|NCT00355082|65723147|FG002|Continuation Phase|Withdrawal by Subject|0|||
23544682|NCT00355082|65723145|FG000|Continuation Phase|Lack of Efficacy|5|||
23544683|NCT00355082|65723146|FG001|Continuation Phase|Lack of Efficacy|0|||
23544684|NCT00355082|65723147|FG002|Continuation Phase|Lack of Efficacy|0|||
23544685|NCT00355082|65723145|FG000|Continuation Phase|Site Closed by Sponsor|8|||
23544686|NCT00355082|65723146|FG001|Continuation Phase|Site Closed by Sponsor|0|||
23732215|NCT00808028|66399229|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23732216|NCT00808028|66399230|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23732217|NCT00808028|66399231|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
23732218|NCT00808028|66399232|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23732219|NCT00911144|66399241|FG000|Overall Study|Withdrawal by Subject|16|||
23732220|NCT00911144|66399242|FG001|Overall Study|Withdrawal by Subject|5|||
23732221|NCT03950440|66399244|FG000|Overall Study|Death|8|||
23732222|NCT03950440|66399245|FG001|Overall Study|Death|2|||
23732223|NCT03950440|66399246|FG002|Overall Study|Death|1|||
23732224|NCT00796549|66399247|FG000|Overall Study|Adverse Event|11|||
23732225|NCT00796549|66399247|FG000|Overall Study|not entered|149|||
23732226|NCT00796549|66399247|FG000|Overall Study|Other|2|||
23732227|NCT00796549|66399247|FG000|Overall Study|Progressive disease|56|||
23732228|NCT00081263|66399255|FG000|Overall Study|clerical error|1|||
23732229|NCT00081263|66399256|FG001|Overall Study|clerical error|0|||
23732230|NCT00081263|66399255|FG000|Overall Study|wrong cell type|7|||
23732231|NCT00081263|66399256|FG001|Overall Study|wrong cell type|5|||
23732232|NCT00081263|66399255|FG000|Overall Study|improper pre-protocol therapy|0|||
23732233|NCT00081263|66399256|FG001|Overall Study|improper pre-protocol therapy|1|||
23732234|NCT00081263|66399255|FG000|Overall Study|Inadequate pathology|0|||
23544687|NCT00355082|65723147|FG002|Continuation Phase|Site Closed by Sponsor|0|||
23544688|NCT00355082|65723145|FG000|Continuation Phase|Scheduling Error|1|||
23544689|NCT00355082|65723146|FG001|Continuation Phase|Scheduling Error|0|||
23544690|NCT00355082|65723147|FG002|Continuation Phase|Scheduling Error|0|||
23544691|NCT00355082|65723145|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
23544692|NCT00355082|65723146|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
23544693|NCT00355082|65723147|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
23544694|NCT02707055|65723149|FG000|Phase 1|Withdrawal by Subject|1|||
23544695|NCT02707055|65723150|FG001|Phase 1|Withdrawal by Subject|2|||
23544696|NCT02707055|65723149|FG000|Phase 1|Physician Decision|0|||
23544697|NCT02707055|65723150|FG001|Phase 1|Physician Decision|1|||
23732235|NCT00081263|66399256|FG001|Overall Study|Inadequate pathology|1|||
23732236|NCT00081263|66399255|FG000|Overall Study|Never treated|4|||
23732237|NCT00081263|66399256|FG001|Overall Study|Never treated|5|||
23732238|NCT00081263|66399255|FG000|Overall Study|Inadequate data|5|||
23732239|NCT00081263|66399256|FG001|Overall Study|Inadequate data|10|||
23732240|NCT00376675|66399257|FG000|Overall Study|Withdrawal by Subject|9|||
23732241|NCT00376675|66399258|FG001|Overall Study|Withdrawal by Subject|2|||
23732242|NCT00376675|66399257|FG000|Overall Study|Adverse Event|10|||
23732243|NCT00376675|66399258|FG001|Overall Study|Adverse Event|5|||
23732244|NCT00376675|66399257|FG000|Overall Study|Other Reason|1|||
23732245|NCT00376675|66399258|FG001|Overall Study|Other Reason|7|||
23732246|NCT02380703|66399259|FG000|Overall Study|Withdrawal by Subject|12|||
23732247|NCT02380703|66399260|FG001|Overall Study|Withdrawal by Subject|9|||
23732248|NCT02380703|66399259|FG000|Overall Study|Lost to Follow-up|12|||
23732249|NCT02380703|66399260|FG001|Overall Study|Lost to Follow-up|12|||
23732250|NCT02380703|66399259|FG000|Overall Study|Caregiver death|1|||
23732251|NCT02380703|66399260|FG001|Overall Study|Caregiver death|0|||
23732252|NCT02380703|66399259|FG000|Overall Study|Person with dementia (PWD) death|7|||
23732253|NCT02380703|66399260|FG001|Overall Study|Person with dementia (PWD) death|8|||
23732254|NCT02380703|66399259|FG000|Overall Study|Entered Long-term Care|4|||
23732255|NCT02380703|66399260|FG001|Overall Study|Entered Long-term Care|7|||
23732256|NCT02116582|66399261|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
23732257|NCT02116582|66399261|FG000|Overall Study|Adverse Event|22|||
23732258|NCT02116582|66399261|FG000|Overall Study|Death|9|||
23732259|NCT02116582|66399261|FG000|Overall Study|Progressive Disease|148|||
23732260|NCT02116582|66399261|FG000|Overall Study|Protocol Violation|3|||
23544698|NCT02707055|65723149|FG000|Phase 2|Adverse Event|1|||
23732261|NCT02116582|66399261|FG000|Overall Study|Withdrawal by Subject|8|||
23732262|NCT02116582|66399261|FG000|Overall Study|Other: Miscellaneous|11|||
23732263|NCT02116582|66399261|FG000|Overall Study|Lost to Follow-up|1|||
23544699|NCT02707055|65723150|FG001|Phase 2|Adverse Event|2|||
23544700|NCT03067441|65723151|FG000|Overall Study|Withdrawal by Subject|16|||
23544701|NCT03067441|65723152|FG001|Overall Study|Withdrawal by Subject|34|||
23732264|NCT02116582|66399261|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
23732265|NCT03452397|66399264|FG000|Overall Study|Adverse Event|1|||
23732266|NCT03452397|66399265|FG001|Overall Study|Adverse Event|0|||
23732267|NCT03452397|66399266|FG002|Overall Study|Adverse Event|0|||
23732268|NCT03452397|66399267|FG003|Overall Study|Adverse Event|0|||
23732269|NCT03452397|66399264|FG000|Overall Study|Administrative reason|0|||
23732270|NCT03452397|66399265|FG001|Overall Study|Administrative reason|0|||
23732271|NCT03452397|66399266|FG002|Overall Study|Administrative reason|1|||
23732272|NCT03452397|66399267|FG003|Overall Study|Administrative reason|1|||
23732273|NCT03452397|66399264|FG000|Overall Study|Withdrawal by Subject|0|||
23732274|NCT03452397|66399265|FG001|Overall Study|Withdrawal by Subject|0|||
23732275|NCT03452397|66399266|FG002|Overall Study|Withdrawal by Subject|1|||
23732276|NCT03452397|66399267|FG003|Overall Study|Withdrawal by Subject|0|||
23732277|NCT01017549|66399268|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
23732278|NCT01017549|66399268|FG000|One-year Follow-up|Lost to Follow-up|2|||
23732279|NCT01017549|66399268|FG000|One-year Follow-up|Withdrawal by Subject|5|||
23732280|NCT01017549|66399268|FG000|5 Year Follow-up|Lost to Follow-up|9|||
23732281|NCT01017549|66399268|FG000|5 Year Follow-up|Mastectomy|3|||
23732282|NCT03227692|66399271|FG000|Overall Study|Protocol Violation|1|||
23732283|NCT03227692|66399272|FG001|Overall Study|Protocol Violation|1|||
23732284|NCT03227692|66399271|FG000|Overall Study|Lost to Follow-up|4|||
23732285|NCT03227692|66399272|FG001|Overall Study|Lost to Follow-up|2|||
23732286|NCT03227692|66399271|FG000|Overall Study|Adverse Event|0|||
23732287|NCT03227692|66399272|FG001|Overall Study|Adverse Event|2|||
23732288|NCT01142791|66399273|FG000|Overall Study|Alternative Treatment|1|||
23732289|NCT01142791|66399274|FG001|Overall Study|Alternative Treatment|0|||
23732290|NCT01142791|66399273|FG000|Overall Study|Lost to Follow-up|1|||
23732291|NCT01142791|66399274|FG001|Overall Study|Lost to Follow-up|0|||
23732292|NCT01142791|66399273|FG000|Overall Study|Withdrawal by Subject|5|||
23732293|NCT01142791|66399274|FG001|Overall Study|Withdrawal by Subject|0|||
23732294|NCT01142791|66399273|FG000|Overall Study|Received only 1 sonication|0|||
23732295|NCT01142791|66399274|FG001|Overall Study|Received only 1 sonication|6|||
23732296|NCT00252499|66399275|FG000|Overall Study|Lost to Follow-up|1|||
23732297|NCT00252499|66399276|FG001|Overall Study|Lost to Follow-up|0|||
23732298|NCT00252499|66399277|FG002|Overall Study|Lost to Follow-up|0|||
23732299|NCT01435122|66399280|FG000|Overall Study|Early withdrawal due to toxicity|8|||
23732300|NCT03595176|66399282|FG000|Overall Study|Death|0|||
23732301|NCT03595176|66399283|FG001|Overall Study|Death|2|||
23732302|NCT03595176|66399282|FG000|Overall Study|Lost to Follow-up|0|||
23732303|NCT03595176|66399283|FG001|Overall Study|Lost to Follow-up|1|||
23732304|NCT03399786|66399284|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23732305|NCT03399786|66399285|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23732306|NCT03399786|66399286|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23732307|NCT03399786|66399287|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23732308|NCT03399786|66399284|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23426192|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
23732309|NCT03399786|66399285|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23732310|NCT03399786|66399286|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
23732311|NCT03399786|66399287|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23732312|NCT03399786|66399284|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23732313|NCT03399786|66399285|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23732314|NCT03399786|66399286|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23732315|NCT03399786|66399287|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
23732316|NCT03198728|66399288|FG000|Overall Study|Adverse Event|10|||
23426193|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23732317|NCT03198728|66399289|FG001|Overall Study|Adverse Event|5|||
23732318|NCT03198728|66399288|FG000|Overall Study|Lost to Follow-up|21|||
23732319|NCT03198728|66399289|FG001|Overall Study|Lost to Follow-up|7|||
23426194|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23426195|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23732320|NCT03198728|66399288|FG000|Overall Study|Physician Decision|7|||
23732321|NCT03198728|66399289|FG001|Overall Study|Physician Decision|2|||
23732322|NCT03198728|66399288|FG000|Overall Study|Withdrawal by Subject|14|||
23732323|NCT03198728|66399289|FG001|Overall Study|Withdrawal by Subject|10|||
23732324|NCT01984294|66399290|FG000|Overall Study|Randomized but Never Treated|0|||
23732325|NCT01984294|66399291|FG001|Overall Study|Randomized but Never Treated|0|||
23732326|NCT01984294|66399292|FG002|Overall Study|Randomized but Never Treated|1|||
23732327|NCT01984294|66399290|FG000|Overall Study|Lack of Efficacy|4|||
23732328|NCT01984294|66399291|FG001|Overall Study|Lack of Efficacy|2|||
23732329|NCT01984294|66399292|FG002|Overall Study|Lack of Efficacy|6|||
23732330|NCT01984294|66399290|FG000|Overall Study|Adverse Event|0|||
23544702|NCT03067441|65723151|FG000|Overall Study|Lost to Follow-up|7|||
23544703|NCT03067441|65723152|FG001|Overall Study|Lost to Follow-up|5|||
23732331|NCT01984294|66399291|FG001|Overall Study|Adverse Event|1|||
23732332|NCT01984294|66399292|FG002|Overall Study|Adverse Event|0|||
23732333|NCT01307046|66399293|FG000|Overall Study|Adverse Event|3|||
23732334|NCT01307046|66399294|FG001|Overall Study|Adverse Event|3|||
23732335|NCT01307046|66399293|FG000|Overall Study|Lack of Efficacy|0|||
23732336|NCT01307046|66399294|FG001|Overall Study|Lack of Efficacy|2|||
23732337|NCT01307046|66399293|FG000|Overall Study|Physician Decision|2|||
23732338|NCT01307046|66399294|FG001|Overall Study|Physician Decision|0|||
23732339|NCT01307046|66399293|FG000|Overall Study|Withdrawal by Subject|1|||
23732340|NCT01307046|66399294|FG001|Overall Study|Withdrawal by Subject|1|||
23732341|NCT01307046|66399293|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
23732342|NCT01307046|66399294|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
23732343|NCT01307046|66399293|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
23732344|NCT01307046|66399294|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
23732345|NCT01885104|66399295|FG000|Overall Study|Withdrawal of Consent|1|||
23732346|NCT01885104|66399296|FG001|Overall Study|Withdrawal of Consent|0|||
23544704|NCT03067441|65723151|FG000|Overall Study|Adverse Event|7|||
23732347|NCT01885104|66399295|FG000|Overall Study|Lost to Follow-up|0|||
23732348|NCT01885104|66399296|FG001|Overall Study|Lost to Follow-up|1|||
23732349|NCT01885104|66399295|FG000|Overall Study|Physician Decision|1|||
23732350|NCT01885104|66399296|FG001|Overall Study|Physician Decision|0|||
23732351|NCT02531633|66399297|FG000|Part A (52 Weeks)|Sponsor request|24|||
23732352|NCT02531633|66399298|FG001|Part A (52 Weeks)|Sponsor request|24|||
23732353|NCT02531633|66399299|FG002|Part A (52 Weeks)|Sponsor request|18|||
23732354|NCT02531633|66399300|FG003|Part A (52 Weeks)|Sponsor request|18|||
23732355|NCT02531633|66399301|FG004|Part A (52 Weeks)|Sponsor request|19|||
23732356|NCT02531633|66399302|FG005|Part A (52 Weeks)|Sponsor request|0|||
23732357|NCT02531633|66399303|FG006|Part A (52 Weeks)|Sponsor request|0|||
23732358|NCT02531633|66399304|FG007|Part A (52 Weeks)|Sponsor request|0|||
23732359|NCT02531633|66399305|FG008|Part A (52 Weeks)|Sponsor request|0|||
23732360|NCT02531633|66399306|FG009|Part A (52 Weeks)|Sponsor request|0|||
23732361|NCT02531633|66399297|FG000|Part A (52 Weeks)|Protocol Violation|1|||
23732362|NCT02531633|66399298|FG001|Part A (52 Weeks)|Protocol Violation|0|||
23732363|NCT02531633|66399299|FG002|Part A (52 Weeks)|Protocol Violation|0|||
23544705|NCT03067441|65723152|FG001|Overall Study|Adverse Event|14|||
23732364|NCT02531633|66399300|FG003|Part A (52 Weeks)|Protocol Violation|0|||
23732365|NCT02531633|66399301|FG004|Part A (52 Weeks)|Protocol Violation|0|||
23732366|NCT02531633|66399302|FG005|Part A (52 Weeks)|Protocol Violation|0|||
23732367|NCT02531633|66399303|FG006|Part A (52 Weeks)|Protocol Violation|0|||
23732368|NCT02531633|66399304|FG007|Part A (52 Weeks)|Protocol Violation|0|||
23732369|NCT02531633|66399305|FG008|Part A (52 Weeks)|Protocol Violation|0|||
23732370|NCT02531633|66399306|FG009|Part A (52 Weeks)|Protocol Violation|0|||
23732371|NCT02531633|66399297|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
23732372|NCT02531633|66399298|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
23732373|NCT02531633|66399299|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
23732374|NCT02531633|66399300|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
23732375|NCT02531633|66399301|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
23732376|NCT02531633|66399302|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
23732377|NCT02531633|66399303|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
23732378|NCT02531633|66399304|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
23732379|NCT02531633|66399305|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
23732380|NCT02531633|66399306|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
23732381|NCT02531633|66399297|FG000|Part A (52 Weeks)|Physician Decision|1|||
23732382|NCT02531633|66399298|FG001|Part A (52 Weeks)|Physician Decision|4|||
23732383|NCT02531633|66399299|FG002|Part A (52 Weeks)|Physician Decision|3|||
23732384|NCT02531633|66399300|FG003|Part A (52 Weeks)|Physician Decision|1|||
23732385|NCT02531633|66399301|FG004|Part A (52 Weeks)|Physician Decision|0|||
23732386|NCT02531633|66399302|FG005|Part A (52 Weeks)|Physician Decision|0|||
23732387|NCT02531633|66399303|FG006|Part A (52 Weeks)|Physician Decision|0|||
23732388|NCT02531633|66399304|FG007|Part A (52 Weeks)|Physician Decision|0|||
23732389|NCT02531633|66399305|FG008|Part A (52 Weeks)|Physician Decision|0|||
23732390|NCT02531633|66399306|FG009|Part A (52 Weeks)|Physician Decision|0|||
23732391|NCT02531633|66399297|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
23732392|NCT02531633|66399298|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
23732393|NCT02531633|66399299|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
23732394|NCT02531633|66399300|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
23732395|NCT02531633|66399301|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
23732396|NCT02531633|66399302|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
23732397|NCT02531633|66399303|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
23732398|NCT02531633|66399304|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
23732399|NCT02531633|66399305|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
23732400|NCT02531633|66399306|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
23732401|NCT02531633|66399297|FG000|Part A (52 Weeks)|Other|2|||
23732402|NCT02531633|66399298|FG001|Part A (52 Weeks)|Other|0|||
23732403|NCT02531633|66399299|FG002|Part A (52 Weeks)|Other|0|||
23732404|NCT02531633|66399300|FG003|Part A (52 Weeks)|Other|0|||
23732405|NCT02531633|66399301|FG004|Part A (52 Weeks)|Other|0|||
23732406|NCT02531633|66399302|FG005|Part A (52 Weeks)|Other|0|||
23732407|NCT02531633|66399303|FG006|Part A (52 Weeks)|Other|0|||
23732408|NCT02531633|66399304|FG007|Part A (52 Weeks)|Other|0|||
23732409|NCT02531633|66399305|FG008|Part A (52 Weeks)|Other|0|||
23732410|NCT02531633|66399306|FG009|Part A (52 Weeks)|Other|0|||
23732411|NCT02531633|66399297|FG000|Part B (104 Weeks)|Sponsor request|0|||
23732412|NCT02531633|66399298|FG001|Part B (104 Weeks)|Sponsor request|0|||
23732413|NCT02531633|66399299|FG002|Part B (104 Weeks)|Sponsor request|0|||
23732414|NCT02531633|66399300|FG003|Part B (104 Weeks)|Sponsor request|0|||
23732415|NCT02531633|66399301|FG004|Part B (104 Weeks)|Sponsor request|0|||
23732416|NCT02531633|66399302|FG005|Part B (104 Weeks)|Sponsor request|8|||
23732417|NCT02531633|66399303|FG006|Part B (104 Weeks)|Sponsor request|5|||
23732418|NCT02531633|66399304|FG007|Part B (104 Weeks)|Sponsor request|3|||
23732419|NCT02531633|66399305|FG008|Part B (104 Weeks)|Sponsor request|5|||
23732420|NCT02531633|66399306|FG009|Part B (104 Weeks)|Sponsor request|4|||
23732421|NCT02531633|66399297|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
23732422|NCT02531633|66399298|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
23732423|NCT02531633|66399299|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
23732424|NCT02531633|66399300|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
23732425|NCT02531633|66399301|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
23732426|NCT02531633|66399302|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
23732427|NCT02531633|66399303|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
23732428|NCT02531633|66399304|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
23732429|NCT02531633|66399305|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
23732430|NCT02531633|66399306|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
23732431|NCT02559115|66399307|FG000|Overall Study|Withdrawal by Subject|3|||
23732432|NCT01225211|66399310|FG000|Overall Study|Adverse Event|0|||
23732433|NCT01225211|66399311|FG001|Overall Study|Adverse Event|0|||
23732434|NCT01225211|66399312|FG002|Overall Study|Adverse Event|1|||
23732435|NCT01225211|66399313|FG003|Overall Study|Adverse Event|0|||
23732436|NCT01225211|66399314|FG004|Overall Study|Adverse Event|0|||
23732437|NCT01225211|66399315|FG005|Overall Study|Adverse Event|0|||
23732438|NCT01225211|66399316|FG006|Overall Study|Adverse Event|0|||
23732439|NCT01225211|66399317|FG007|Overall Study|Adverse Event|0|||
23732440|NCT01225211|66399318|FG008|Overall Study|Adverse Event|0|||
23732441|NCT01225211|66399319|FG009|Overall Study|Adverse Event|1|||
23732442|NCT01225211|66399310|FG000|Overall Study|Withdrawal by Subject|0|||
23732443|NCT01225211|66399311|FG001|Overall Study|Withdrawal by Subject|0|||
23732444|NCT01225211|66399312|FG002|Overall Study|Withdrawal by Subject|0|||
23732445|NCT01225211|66399313|FG003|Overall Study|Withdrawal by Subject|0|||
23732446|NCT01225211|66399314|FG004|Overall Study|Withdrawal by Subject|0|||
23732447|NCT01225211|66399315|FG005|Overall Study|Withdrawal by Subject|0|||
23732448|NCT01225211|66399316|FG006|Overall Study|Withdrawal by Subject|1|||
23732449|NCT01225211|66399317|FG007|Overall Study|Withdrawal by Subject|0|||
23732450|NCT01225211|66399318|FG008|Overall Study|Withdrawal by Subject|1|||
23732451|NCT01225211|66399319|FG009|Overall Study|Withdrawal by Subject|3|||
23732452|NCT01225211|66399310|FG000|Overall Study|Other|0|||
23732453|NCT01225211|66399311|FG001|Overall Study|Other|0|||
23544706|NCT03067441|65723151|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
23732454|NCT01225211|66399312|FG002|Overall Study|Other|0|||
23732455|NCT01225211|66399313|FG003|Overall Study|Other|0|||
23732456|NCT01225211|66399314|FG004|Overall Study|Other|0|||
23732457|NCT01225211|66399315|FG005|Overall Study|Other|0|||
23732458|NCT01225211|66399316|FG006|Overall Study|Other|0|||
23732459|NCT01225211|66399317|FG007|Overall Study|Other|0|||
23732460|NCT01225211|66399318|FG008|Overall Study|Other|0|||
23732461|NCT01225211|66399319|FG009|Overall Study|Other|1|||
23732462|NCT01536418|66399322|FG000|Overall Study|Protocol Violation|2|||
23732463|NCT01536418|66399323|FG001|Overall Study|Protocol Violation|3|||
23732464|NCT01536418|66399322|FG000|Overall Study|Physician Decision|1|||
23732465|NCT01536418|66399323|FG001|Overall Study|Physician Decision|3|||
23544707|NCT03067441|65723152|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
23732466|NCT01536418|66399322|FG000|Overall Study|Study closed/terminated|41|||
23732467|NCT01536418|66399323|FG001|Overall Study|Study closed/terminated|37|||
23732468|NCT01536418|66399322|FG000|Overall Study|Lack of Efficacy|10|||
23732469|NCT01536418|66399323|FG001|Overall Study|Lack of Efficacy|16|||
23732470|NCT01536418|66399322|FG000|Overall Study|Adverse Event|9|||
23732471|NCT01536418|66399323|FG001|Overall Study|Adverse Event|4|||
23732472|NCT01536418|66399322|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
23732473|NCT01536418|66399323|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
23732474|NCT01536418|66399322|FG000|Overall Study|Withdrawal by Subject|5|||
23544708|NCT03067441|65723151|FG000|Overall Study|Physician Decision|1|||
23544709|NCT03067441|65723152|FG001|Overall Study|Physician Decision|3|||
23544710|NCT03067441|65723151|FG000|Overall Study|Other|1|||
23544711|NCT03067441|65723152|FG001|Overall Study|Other|1|||
23544712|NCT00613951|65723153|FG000|Overall Study|Adverse Event|1|||
23544713|NCT00613951|65723154|FG001|Overall Study|Adverse Event|0|||
23732475|NCT01536418|66399323|FG001|Overall Study|Withdrawal by Subject|3|||
23732476|NCT00608894|66399324|FG000|Overall Study|Withdrawal by Subject|0|||
23732477|NCT00608894|66399325|FG001|Overall Study|Withdrawal by Subject|2|||
23732478|NCT03702166|66399326|FG000|Overall Study|Lost to Follow-up|1|||
23732479|NCT03702166|66399326|FG000|Overall Study|Withdrawal by Subject|1|||
23732480|NCT05333289|66399327|FG000|Overall Study|Other|1|||
23732481|NCT05333289|66399328|FG001|Overall Study|Other|0|||
23732482|NCT05333289|66399329|FG002|Overall Study|Other|0|||
23732483|NCT05333289|66399330|FG003|Overall Study|Other|1|||
23732484|NCT05333289|66399331|FG004|Overall Study|Other|1|||
23732485|NCT05333289|66399332|FG005|Overall Study|Other|2|||
23732486|NCT05333289|66399333|FG006|Overall Study|Other|2|||
23732487|NCT05333289|66399334|FG007|Overall Study|Other|0|||
23732488|NCT05333289|66399327|FG000|Overall Study|Withdrawal by Subject|1|||
23732489|NCT05333289|66399328|FG001|Overall Study|Withdrawal by Subject|2|||
23732490|NCT05333289|66399329|FG002|Overall Study|Withdrawal by Subject|2|||
23732491|NCT05333289|66399330|FG003|Overall Study|Withdrawal by Subject|1|||
23732492|NCT05333289|66399331|FG004|Overall Study|Withdrawal by Subject|1|||
23732493|NCT05333289|66399332|FG005|Overall Study|Withdrawal by Subject|2|||
23732494|NCT05333289|66399333|FG006|Overall Study|Withdrawal by Subject|1|||
23732495|NCT05333289|66399334|FG007|Overall Study|Withdrawal by Subject|3|||
23544714|NCT00613951|65723155|FG002|Overall Study|Adverse Event|1|||
23544715|NCT00613951|65723153|FG000|Overall Study|Lack of Efficacy|0|||
23544716|NCT00613951|65723154|FG001|Overall Study|Lack of Efficacy|1|||
23544717|NCT00613951|65723155|FG002|Overall Study|Lack of Efficacy|1|||
23544718|NCT00613951|65723153|FG000|Overall Study|Protocol Violation|1|||
23544719|NCT00613951|65723154|FG001|Overall Study|Protocol Violation|1|||
23544720|NCT00613951|65723155|FG002|Overall Study|Protocol Violation|1|||
23617928|NCT02660034|65988174|FG012|Overall Study|Progressive Disease (Clinical)|0|||
23617929|NCT02660034|65988175|FG013|Overall Study|Progressive Disease (Clinical)|0|||
23617930|NCT02660034|65988162|FG000|Overall Study|Lost to Follow-up|0|||
23544721|NCT00613951|65723153|FG000|Overall Study|Unclassified|5|||
23544722|NCT00613951|65723154|FG001|Overall Study|Unclassified|3|||
23544723|NCT00613951|65723155|FG002|Overall Study|Unclassified|2|||
23544724|NCT01306162|65723156|FG000|Period 1|Adverse Event|0|||
23544725|NCT01306162|65723157|FG001|Period 1|Adverse Event|0|||
23818708|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23818709|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
23818710|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23818711|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
23818712|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23818713|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23818714|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23426196|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23544726|NCT01306162|65723158|FG002|Period 1|Adverse Event|0|||
23544727|NCT01306162|65723159|FG003|Period 1|Adverse Event|1|||
23544728|NCT01306162|65723156|FG000|Washout 1|Non-compliance to protocol|0|||
23544729|NCT01306162|65723157|FG001|Washout 1|Non-compliance to protocol|1|||
23544730|NCT01306162|65723158|FG002|Washout 1|Non-compliance to protocol|0|||
23544731|NCT01306162|65723159|FG003|Washout 1|Non-compliance to protocol|0|||
23544732|NCT01910519|65723160|FG000|Overall Study|Withdrawal by Subject|2|||
23732496|NCT05333289|66399327|FG000|Overall Study|Protocol Violation|1|||
23732497|NCT05333289|66399328|FG001|Overall Study|Protocol Violation|0|||
23732498|NCT05333289|66399329|FG002|Overall Study|Protocol Violation|0|||
23732499|NCT05333289|66399330|FG003|Overall Study|Protocol Violation|0|||
23732500|NCT05333289|66399331|FG004|Overall Study|Protocol Violation|0|||
23732501|NCT05333289|66399332|FG005|Overall Study|Protocol Violation|0|||
23732502|NCT05333289|66399333|FG006|Overall Study|Protocol Violation|0|||
23732503|NCT05333289|66399334|FG007|Overall Study|Protocol Violation|0|||
23732504|NCT05333289|66399327|FG000|Overall Study|Physician Decision|0|||
23732505|NCT05333289|66399328|FG001|Overall Study|Physician Decision|0|||
23732506|NCT05333289|66399329|FG002|Overall Study|Physician Decision|1|||
23732507|NCT05333289|66399330|FG003|Overall Study|Physician Decision|0|||
23732508|NCT05333289|66399331|FG004|Overall Study|Physician Decision|0|||
23732509|NCT05333289|66399332|FG005|Overall Study|Physician Decision|2|||
23732510|NCT05333289|66399333|FG006|Overall Study|Physician Decision|0|||
23732511|NCT05333289|66399334|FG007|Overall Study|Physician Decision|0|||
23732512|NCT05333289|66399327|FG000|Overall Study|Lost to Follow-up|6|||
23732513|NCT05333289|66399328|FG001|Overall Study|Lost to Follow-up|0|||
23818715|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23426197|NCT00900146|65303551|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
23426198|NCT00900146|65303552|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
23426199|NCT00900146|65303553|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
23426200|NCT00900146|65303554|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
23426201|NCT00900146|65303555|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
23426202|NCT00900146|65303551|FG000|Intermediate: Period III|Lost to Follow-up|2|||
23426203|NCT00900146|65303552|FG001|Intermediate: Period III|Lost to Follow-up|0|||
23426204|NCT00900146|65303553|FG002|Intermediate: Period III|Lost to Follow-up|0|||
23426205|NCT00900146|65303554|FG003|Intermediate: Period III|Lost to Follow-up|0|||
23426206|NCT00900146|65303555|FG004|Intermediate: Period III|Lost to Follow-up|1|||
23426207|NCT00900146|65303551|FG000|Intermediate: Period III|Administrative problems|85|||
23426208|NCT00900146|65303552|FG001|Intermediate: Period III|Administrative problems|92|||
23426209|NCT00900146|65303553|FG002|Intermediate: Period III|Administrative problems|84|||
23426210|NCT00900146|65303554|FG003|Intermediate: Period III|Administrative problems|90|||
23426211|NCT00900146|65303555|FG004|Intermediate: Period III|Administrative problems|163|||
23426212|NCT01902888|65303560|FG000|Overall Study|Study Terminated|3|||
23426213|NCT03538444|65303563|FG000|Overall Study|opioid withdrawal|1|||
23426214|NCT03538444|65303564|FG001|Overall Study|opioid withdrawal|0|||
23426215|NCT00168103|65303565|FG000|Overall Study|Withdrawal by Subject|1|||
23426216|NCT00168103|65303566|FG001|Overall Study|Withdrawal by Subject|2|||
23426217|NCT00168103|65303567|FG002|Overall Study|Withdrawal by Subject|1|||
23426218|NCT00168103|65303568|FG003|Overall Study|Withdrawal by Subject|0|||
23426219|NCT00168103|65303565|FG000|Overall Study|Lost to Follow-up|1|||
23426220|NCT00168103|65303566|FG001|Overall Study|Lost to Follow-up|3|||
23544733|NCT01910519|65723161|FG001|Overall Study|Withdrawal by Subject|0|||
23732514|NCT05333289|66399329|FG002|Overall Study|Lost to Follow-up|1|||
23732515|NCT05333289|66399330|FG003|Overall Study|Lost to Follow-up|6|||
23818716|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23818717|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
23818718|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
23818719|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
23818720|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818721|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
23818722|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818723|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23732516|NCT05333289|66399331|FG004|Overall Study|Lost to Follow-up|3|||
23732517|NCT05333289|66399332|FG005|Overall Study|Lost to Follow-up|3|||
23732518|NCT05333289|66399333|FG006|Overall Study|Lost to Follow-up|2|||
23732519|NCT05333289|66399334|FG007|Overall Study|Lost to Follow-up|1|||
23732520|NCT05333289|66399327|FG000|Overall Study|Death|1|||
23732521|NCT05333289|66399328|FG001|Overall Study|Death|0|||
23732522|NCT05333289|66399329|FG002|Overall Study|Death|0|||
23732523|NCT05333289|66399330|FG003|Overall Study|Death|0|||
23732524|NCT05333289|66399331|FG004|Overall Study|Death|0|||
23818724|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23544734|NCT01910519|65723160|FG000|Overall Study|Adverse Event|2|||
23544735|NCT01910519|65723161|FG001|Overall Study|Adverse Event|0|||
23544736|NCT01175668|65723164|FG000|Overall Study|Withdrawal by Subject|2|||
23617931|NCT02660034|65988163|FG001|Overall Study|Lost to Follow-up|0|||
23617932|NCT02660034|65988164|FG002|Overall Study|Lost to Follow-up|1|||
23617933|NCT02660034|65988165|FG003|Overall Study|Lost to Follow-up|1|||
23617934|NCT02660034|65988166|FG004|Overall Study|Lost to Follow-up|0|||
23617935|NCT02660034|65988167|FG005|Overall Study|Lost to Follow-up|0|||
23617936|NCT02660034|65988168|FG006|Overall Study|Lost to Follow-up|0|||
23617937|NCT02660034|65988169|FG007|Overall Study|Lost to Follow-up|0|||
23617938|NCT02660034|65988170|FG008|Overall Study|Lost to Follow-up|0|||
23617939|NCT02660034|65988171|FG009|Overall Study|Lost to Follow-up|1|||
23617940|NCT02660034|65988172|FG010|Overall Study|Lost to Follow-up|1|||
23617941|NCT02660034|65988173|FG011|Overall Study|Lost to Follow-up|1|||
23732525|NCT05333289|66399332|FG005|Overall Study|Death|0|||
23544737|NCT01175668|65723165|FG001|Overall Study|Withdrawal by Subject|0|||
23544738|NCT02132611|65723166|FG000|Overall Study|Death|2|||
23544739|NCT01404312|65723167|FG000|Overall Study|Death|21|||
23544740|NCT01404312|65723168|FG001|Overall Study|Death|27|||
23544741|NCT01404312|65723167|FG000|Overall Study|Withdrawal by Subject|15|||
23544742|NCT01404312|65723168|FG001|Overall Study|Withdrawal by Subject|18|||
23544743|NCT01404312|65723167|FG000|Overall Study|Participant Unable to get to clinic|93|||
23544744|NCT01404312|65723168|FG001|Overall Study|Participant Unable to get to clinic|103|||
23544745|NCT01404312|65723167|FG000|Overall Study|Lost to Follow-up|115|||
23544746|NCT01404312|65723168|FG001|Overall Study|Lost to Follow-up|111|||
23544747|NCT01404312|65723167|FG000|Overall Study|Site closed|22|||
23544748|NCT01404312|65723168|FG001|Overall Study|Site closed|21|||
23544749|NCT01404312|65723167|FG000|Overall Study|Participant not willing to adhere to req|31|||
23544750|NCT01404312|65723168|FG001|Overall Study|Participant not willing to adhere to req|29|||
23544751|NCT01404312|65723167|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23544752|NCT01404312|65723168|FG001|Overall Study|Severe debilitation, unable to continue|2|||
23544753|NCT03778294|65723173|FG000|Overall Study|Death|1|||
23544754|NCT03778294|65723173|FG000|Overall Study|Issues with insurance|1|||
23544755|NCT03778294|65723173|FG000|Overall Study|disease progression before treatment|2|||
23544756|NCT03859323|65723174|FG000|Overall Study|Lost to Follow-up|0|||
23544757|NCT03859323|65723175|FG001|Overall Study|Lost to Follow-up|0|||
23544758|NCT03859323|65723176|FG002|Overall Study|Lost to Follow-up|0|||
23544759|NCT03859323|65723177|FG003|Overall Study|Lost to Follow-up|0|||
23544760|NCT03859323|65723178|FG004|Overall Study|Lost to Follow-up|0|||
23544761|NCT03859323|65723179|FG005|Overall Study|Lost to Follow-up|0|||
23544762|NCT03859323|65723180|FG006|Overall Study|Lost to Follow-up|1|||
23617942|NCT02660034|65988174|FG012|Overall Study|Lost to Follow-up|0|||
23617943|NCT02660034|65988175|FG013|Overall Study|Lost to Follow-up|0|||
23617944|NCT02660034|65988162|FG000|Overall Study|Participant moved into special access scheme|1|||
23617945|NCT02660034|65988163|FG001|Overall Study|Participant moved into special access scheme|2|||
23732526|NCT05333289|66399333|FG006|Overall Study|Death|0|||
23544763|NCT03859323|65723181|FG007|Overall Study|Lost to Follow-up|0|||
23544764|NCT03859323|65723182|FG008|Overall Study|Lost to Follow-up|0|||
23544765|NCT03859323|65723183|FG009|Overall Study|Lost to Follow-up|0|||
23544766|NCT03859323|65723184|FG010|Overall Study|Lost to Follow-up|0|||
23544767|NCT03859323|65723185|FG011|Overall Study|Lost to Follow-up|0|||
23544768|NCT03859323|65723186|FG012|Overall Study|Lost to Follow-up|0|||
23544769|NCT03859323|65723174|FG000|Overall Study|Withdrawal by Subject|0|||
23544770|NCT03859323|65723175|FG001|Overall Study|Withdrawal by Subject|0|||
23732527|NCT05333289|66399334|FG007|Overall Study|Death|0|||
23732528|NCT02309372|66399338|FG000|Overall Study|Lost to Follow-up|3|||
23732529|NCT02309372|66399339|FG001|Overall Study|Lost to Follow-up|2|||
23732530|NCT01784211|66399347|FG000|Part A (Days 1-15)|Adverse Event|1|||
23732531|NCT01784211|66399348|FG001|Part A (Days 1-15)|Adverse Event|1|||
23732532|NCT01784211|66399349|FG002|Part A (Days 1-15)|Adverse Event|0|||
23732533|NCT01784211|66399350|FG003|Part A (Days 1-15)|Adverse Event|0|||
23732534|NCT01784211|66399351|FG004|Part A (Days 1-15)|Adverse Event|0|||
23732535|NCT01784211|66399352|FG005|Part A (Days 1-15)|Adverse Event|0|||
23732536|NCT01784211|66399347|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
23732537|NCT01784211|66399348|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
23732538|NCT01784211|66399349|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
23732539|NCT01784211|66399350|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
23732540|NCT01784211|66399351|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
23732541|NCT01784211|66399352|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
23544771|NCT03859323|65723176|FG002|Overall Study|Withdrawal by Subject|1|||
23544772|NCT03859323|65723177|FG003|Overall Study|Withdrawal by Subject|0|||
23544773|NCT03859323|65723178|FG004|Overall Study|Withdrawal by Subject|0|||
23544774|NCT03859323|65723179|FG005|Overall Study|Withdrawal by Subject|1|||
23544775|NCT03859323|65723180|FG006|Overall Study|Withdrawal by Subject|0|||
23544776|NCT03859323|65723181|FG007|Overall Study|Withdrawal by Subject|0|||
23544777|NCT03859323|65723182|FG008|Overall Study|Withdrawal by Subject|0|||
23544778|NCT03859323|65723183|FG009|Overall Study|Withdrawal by Subject|1|||
23544779|NCT03859323|65723184|FG010|Overall Study|Withdrawal by Subject|1|||
23544780|NCT03859323|65723185|FG011|Overall Study|Withdrawal by Subject|2|||
23544781|NCT03859323|65723186|FG012|Overall Study|Withdrawal by Subject|1|||
23544782|NCT03859323|65723174|FG000|Overall Study|Pregnancy|0|||
23544783|NCT03859323|65723175|FG001|Overall Study|Pregnancy|0|||
23544784|NCT03859323|65723176|FG002|Overall Study|Pregnancy|0|||
23544785|NCT03859323|65723177|FG003|Overall Study|Pregnancy|0|||
23544786|NCT03859323|65723178|FG004|Overall Study|Pregnancy|0|||
23732542|NCT03687827|66399360|FG000|Treatment Period 1|Death|0|||
23732543|NCT03687827|66399361|FG001|Treatment Period 1|Death|1|||
23732544|NCT03687827|66399360|FG000|Treatment Period 1|Lost to Follow-up|2|||
23732545|NCT03687827|66399361|FG001|Treatment Period 1|Lost to Follow-up|2|||
23732546|NCT03687827|66399360|FG000|Treatment Period 1|Physician Decision|5|||
23732547|NCT03687827|66399361|FG001|Treatment Period 1|Physician Decision|2|||
23732548|NCT03687827|66399360|FG000|Treatment Period 1|Withdrawal by Subject|7|||
23732549|NCT03687827|66399361|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23732550|NCT03687827|66399360|FG000|Treatment Period 2|Physician Decision|4|||
23732551|NCT03687827|66399361|FG001|Treatment Period 2|Physician Decision|1|||
23544787|NCT03859323|65723179|FG005|Overall Study|Pregnancy|0|||
23544788|NCT03859323|65723180|FG006|Overall Study|Pregnancy|0|||
23544789|NCT03859323|65723181|FG007|Overall Study|Pregnancy|0|||
23544790|NCT03859323|65723182|FG008|Overall Study|Pregnancy|0|||
23544791|NCT03859323|65723183|FG009|Overall Study|Pregnancy|1|||
23544792|NCT03859323|65723184|FG010|Overall Study|Pregnancy|0|||
23544793|NCT03859323|65723185|FG011|Overall Study|Pregnancy|0|||
23544794|NCT03859323|65723186|FG012|Overall Study|Pregnancy|0|||
23544795|NCT04419493|65723187|FG000|Wash-out After Period 1|Adverse Event|1|||
23544796|NCT04419493|65723188|FG001|Wash-out After Period 1|Adverse Event|2|||
23544797|NCT04419493|65723189|FG002|Wash-out After Period 1|Adverse Event|1|||
23544798|NCT04419493|65723190|FG003|Wash-out After Period 1|Adverse Event|0|||
23544799|NCT00413153|65723191|FG000|Overall Study|Withdrawal by Subject|1|||
23544800|NCT00413153|65723192|FG001|Overall Study|Withdrawal by Subject|1|||
23544801|NCT00413153|65723191|FG000|Overall Study|Adverse Event|1|||
23544802|NCT00413153|65723192|FG001|Overall Study|Adverse Event|0|||
23544803|NCT01863680|65723193|FG000|Overall Study|Adverse Event|17|||
23544804|NCT01863680|65723193|FG000|Overall Study|Risk of OHSS|17|||
23544805|NCT01863680|65723193|FG000|Overall Study|Spontaneous pregnancy|2|||
23544806|NCT01863680|65723193|FG000|Overall Study|Withdrawal by Subject|1|||
23544807|NCT01863680|65723193|FG000|Overall Study|Did not undergo IVF/ET|14|||
23544808|NCT01863680|65723193|FG000|Overall Study|Other|6|||
23544809|NCT00566228|65723194|FG000|Overall Study|Withdrawal by Subject|1|||
23544810|NCT00566228|65723195|FG001|Overall Study|Withdrawal by Subject|0|||
23544811|NCT00566228|65723194|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
23544812|NCT00566228|65723195|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
23544813|NCT00566228|65723194|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
23732552|NCT03687827|66399360|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23544814|NCT00566228|65723195|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
23544815|NCT00566228|65723194|FG000|Overall Study|progressed before infusion could occur|0|||
23544816|NCT00566228|65723195|FG001|Overall Study|progressed before infusion could occur|1|||
23617946|NCT02660034|65988164|FG002|Overall Study|Participant moved into special access scheme|0|||
23732553|NCT03687827|66399361|FG001|Treatment Period 2|Withdrawal by Subject|2|||
23732554|NCT00703781|66399362|FG000|Overall Study|Withdrawal by Subject|1|||
23732555|NCT00703781|66399363|FG001|Overall Study|Withdrawal by Subject|2|||
23544817|NCT03551938|65723196|FG000|3-Month Follow Up|Lost to Follow-up|39|||
23544818|NCT03551938|65723197|FG001|3-Month Follow Up|Lost to Follow-up|38|||
23544819|NCT03551938|65723196|FG000|6-Month Follow Up|Lost to Follow-up|46|||
23617947|NCT02660034|65988165|FG003|Overall Study|Participant moved into special access scheme|0|||
23617948|NCT02660034|65988166|FG004|Overall Study|Participant moved into special access scheme|0|||
23617949|NCT02660034|65988167|FG005|Overall Study|Participant moved into special access scheme|0|||
23617950|NCT02660034|65988168|FG006|Overall Study|Participant moved into special access scheme|0|||
23617951|NCT02660034|65988169|FG007|Overall Study|Participant moved into special access scheme|0|||
23617952|NCT02660034|65988170|FG008|Overall Study|Participant moved into special access scheme|0|||
23732556|NCT00703781|66399362|FG000|Overall Study|Cancelled surgery|1|||
23732557|NCT00703781|66399363|FG001|Overall Study|Cancelled surgery|0|||
23732558|NCT01034709|66399368|FG000|Overall Study|Protocol Violation|9|||
23732559|NCT01034709|66399369|FG001|Overall Study|Protocol Violation|16|||
23732560|NCT04009824|66399370|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
23732561|NCT04009824|66399371|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
23732562|NCT04009824|66399372|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
23732563|NCT04009824|66399373|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
23732564|NCT04009824|66399374|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
23732565|NCT02010567|66399377|FG000|Overall Study|Adverse Event|0|||
23732566|NCT02010567|66399378|FG001|Overall Study|Adverse Event|0|||
23732567|NCT02010567|66399379|FG002|Overall Study|Adverse Event|1|||
23732568|NCT02010567|66399380|FG003|Overall Study|Adverse Event|0|||
23732569|NCT02010567|66399381|FG004|Overall Study|Adverse Event|1|||
23732570|NCT02933489|66399382|FG000|Overall Study|Ineligible|3|||
23732571|NCT02933489|66399383|FG001|Overall Study|Ineligible|3|||
23732572|NCT02933489|66399382|FG000|Overall Study|Withdrawal by Subject|27|||
23732573|NCT02933489|66399383|FG001|Overall Study|Withdrawal by Subject|18|||
23732574|NCT02933489|66399382|FG000|Overall Study|Unable to complete exams (other)|14|||
23732575|NCT02933489|66399383|FG001|Overall Study|Unable to complete exams (other)|7|||
23732576|NCT02710422|66399389|FG000|Overall Study|Termination of study|9|||
23732577|NCT02710422|66399390|FG001|Overall Study|Termination of study|9|||
23732578|NCT03756285|66399391|FG000|Overall Study|Lost to Follow-up|0|||
23732579|NCT03756285|66399392|FG001|Overall Study|Lost to Follow-up|1|||
23732580|NCT03756285|66399391|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
23732581|NCT03756285|66399392|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
23732582|NCT03756285|66399391|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
23732583|NCT03756285|66399392|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
23732584|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
23732585|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
23732586|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
23732587|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
23732588|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
23732589|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
23732590|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
23732591|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
23732592|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
23732593|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
23732594|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
23732595|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
23732596|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
23732597|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
23732598|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
23732599|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
23732600|NCT01291511|66399393|FG000|Cross-Titration and Stabilization Phase|Death|1|||
23732601|NCT01291511|66399394|FG001|Cross-Titration and Stabilization Phase|Death|0|||
23732602|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
23732603|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
23732604|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
23732605|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
23732606|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
23732607|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
23732608|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
23732609|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
23732610|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
23732611|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
23732612|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
23732613|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
23732614|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
23732615|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
23617953|NCT02660034|65988171|FG009|Overall Study|Participant moved into special access scheme|0|||
23617954|NCT02660034|65988172|FG010|Overall Study|Participant moved into special access scheme|0|||
23617955|NCT02660034|65988173|FG011|Overall Study|Participant moved into special access scheme|0|||
23732616|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
23732617|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
23544820|NCT03551938|65723197|FG001|6-Month Follow Up|Lost to Follow-up|42|||
23544821|NCT03551938|65723196|FG000|9-Month Follow Up|Lost to Follow-up|44|||
23544822|NCT03551938|65723197|FG001|9-Month Follow Up|Lost to Follow-up|43|||
23544823|NCT04329104|65723198|FG000|Efficacy Study|Withdrawal by Subject|0|||
23544824|NCT04329104|65723199|FG001|Efficacy Study|Withdrawal by Subject|0|||
23544825|NCT04329104|65723200|FG002|Efficacy Study|Withdrawal by Subject|0|||
23544826|NCT04329104|65723201|FG003|Efficacy Study|Withdrawal by Subject|5|||
23544827|NCT04329104|65723202|FG004|Efficacy Study|Withdrawal by Subject|6|||
23544828|NCT04329104|65723203|FG005|Efficacy Study|Withdrawal by Subject|8|||
23544829|NCT01159691|65723204|FG000|Overall Study|Lost to Follow-up|2|||
23544830|NCT01159691|65723204|FG000|Overall Study|Unknown reasons|1|||
23544831|NCT01159691|65723204|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
23544832|NCT01159691|65723204|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
23544833|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
23544834|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
23544835|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
23544836|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
23544837|NCT00727272|65723208|FG000|Washout Period A|Adverse Event|0|||
23544838|NCT00727272|65723209|FG001|Washout Period A|Adverse Event|0|||
23544839|NCT00727272|65723210|FG002|Washout Period A|Adverse Event|1|||
23544840|NCT00727272|65723208|FG000|Washout Period B|Withdrawal by Subject|0|||
23544841|NCT00727272|65723209|FG001|Washout Period B|Withdrawal by Subject|0|||
23544842|NCT00727272|65723210|FG002|Washout Period B|Withdrawal by Subject|1|||
23544843|NCT03087591|65723216|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
23544844|NCT03087591|65723216|FG000|Overall Study|Withdrawal by Subject|1|||
23544845|NCT02548962|65723217|FG000|Overall Study|Withdrawal by Subject|1|||
23544846|NCT02548962|65723218|FG001|Overall Study|Withdrawal by Subject|0|||
23544847|NCT04495374|65726986|FG000|Overall Study|Protocol Violation|2|||
23544848|NCT04495374|65726987|FG001|Overall Study|Protocol Violation|1|||
23544849|NCT03321019|65726988|FG000|Overall Study|Withdrawal by Subject|0|||
23544850|NCT03321019|65726989|FG001|Overall Study|Withdrawal by Subject|6|||
23544851|NCT03321019|65726988|FG000|Overall Study|Lost to Follow-up|0|||
23544852|NCT03321019|65726989|FG001|Overall Study|Lost to Follow-up|22|||
23544853|NCT03131648|65726990|FG000|Initial Treatment Period|Not dosed|2|||
23544854|NCT03131648|65726991|FG001|Initial Treatment Period|Not dosed|2|||
23544855|NCT03131648|65726992|FG002|Initial Treatment Period|Not dosed|0|||
23544856|NCT03131648|65726993|FG003|Initial Treatment Period|Not dosed|0|||
23544857|NCT03131648|65726994|FG004|Initial Treatment Period|Not dosed|0|||
23544858|NCT03131648|65726995|FG005|Initial Treatment Period|Not dosed|0|||
23544859|NCT03131648|65726996|FG006|Initial Treatment Period|Not dosed|0|||
23544860|NCT03131648|65726997|FG007|Initial Treatment Period|Not dosed|0|||
23544861|NCT03131648|65726990|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
23732618|NCT01291511|66399393|FG000|Double-blind Relapse Prevention Phase|Death|1|||
23732619|NCT01291511|66399394|FG001|Double-blind Relapse Prevention Phase|Death|0|||
23732620|NCT02092324|66399395|FG000|Overall Study|Adverse Event|1|||
23732621|NCT02092324|66399395|FG000|Overall Study|Lack of Efficacy|6|||
23732622|NCT02092324|66399395|FG000|Overall Study|Proceed to Transplant|3|||
23732623|NCT02092324|66399395|FG000|Overall Study|Physician Decision|7|||
23732624|NCT02092324|66399395|FG000|Overall Study|Misdiagnosis|2|||
23732625|NCT01969565|66399396|FG000|Overall Study|Withdrawal by Subject|1|||
23732626|NCT00732472|66399397|FG000|Overall Study|Adverse Event|0|||
23732627|NCT00732472|66399398|FG001|Overall Study|Adverse Event|1|||
23732628|NCT00732472|66399399|FG002|Overall Study|Adverse Event|1|||
23732629|NCT00732472|66399400|FG003|Overall Study|Adverse Event|1|||
23732630|NCT00732472|66399397|FG000|Overall Study|Protocol Violation|0|||
23732631|NCT00732472|66399398|FG001|Overall Study|Protocol Violation|0|||
23732632|NCT00732472|66399399|FG002|Overall Study|Protocol Violation|0|||
23544862|NCT03131648|65726991|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
23544863|NCT03131648|65726992|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23617956|NCT02660034|65988174|FG012|Overall Study|Participant moved into special access scheme|0|||
23617957|NCT02660034|65988175|FG013|Overall Study|Participant moved into special access scheme|0|||
23732633|NCT00732472|66399400|FG003|Overall Study|Protocol Violation|1|||
23544864|NCT03131648|65726993|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23732634|NCT00732472|66399397|FG000|Overall Study|Withdrawal by Subject|0|||
23732635|NCT00732472|66399398|FG001|Overall Study|Withdrawal by Subject|2|||
23732636|NCT00732472|66399399|FG002|Overall Study|Withdrawal by Subject|0|||
23732637|NCT00732472|66399400|FG003|Overall Study|Withdrawal by Subject|1|||
23544865|NCT03131648|65726994|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544866|NCT03131648|65726995|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544867|NCT03131648|65726996|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544868|NCT03131648|65726997|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23732638|NCT01601873|66399402|FG000|Overall Study|Lost to Follow-up|2|||
23732639|NCT01601873|66399403|FG001|Overall Study|Lost to Follow-up|3|||
23732640|NCT03523715|66399404|FG000|Overall Study|Lost to Follow-up|11|||
23732641|NCT03523715|66399405|FG001|Overall Study|Lost to Follow-up|14|||
23544869|NCT03131648|65726990|FG000|Open-label Treatment|Discontinued IMP|0|||
23544870|NCT03131648|65726991|FG001|Open-label Treatment|Discontinued IMP|0|||
23544871|NCT03131648|65726992|FG002|Open-label Treatment|Discontinued IMP|0|||
23544872|NCT03131648|65726993|FG003|Open-label Treatment|Discontinued IMP|0|||
23732642|NCT03523715|66399404|FG000|Overall Study|Did not meet inclusion criteria|1|||
23732643|NCT03523715|66399405|FG001|Overall Study|Did not meet inclusion criteria|0|||
23732644|NCT03523715|66399404|FG000|Overall Study|Internally inconsistent reporting|0|||
23732645|NCT03523715|66399405|FG001|Overall Study|Internally inconsistent reporting|2|||
23732646|NCT01183104|66399406|FG000|Overall Study|Adverse Event|8|||
23732647|NCT01183104|66399407|FG001|Overall Study|Adverse Event|6|||
23544873|NCT03131648|65726994|FG004|Open-label Treatment|Discontinued IMP|0|||
23544874|NCT03131648|65726995|FG005|Open-label Treatment|Discontinued IMP|0|||
23544875|NCT03131648|65726996|FG006|Open-label Treatment|Discontinued IMP|112|||
23544876|NCT03131648|65726997|FG007|Open-label Treatment|Discontinued IMP|0|||
23544877|NCT03131648|65726990|FG000|Open-label Treatment|Completed Week 50|0|||
23544878|NCT03131648|65726991|FG001|Open-label Treatment|Completed Week 50|0|||
23544879|NCT03131648|65726992|FG002|Open-label Treatment|Completed Week 50|0|||
23544880|NCT03131648|65726993|FG003|Open-label Treatment|Completed Week 50|0|||
23544881|NCT03131648|65726994|FG004|Open-label Treatment|Completed Week 50|0|||
23617958|NCT02660034|65988162|FG000|Overall Study|Adverse Event|1|||
23617959|NCT02660034|65988163|FG001|Overall Study|Adverse Event|0|||
23617960|NCT02660034|65988164|FG002|Overall Study|Adverse Event|0|||
23732648|NCT01183104|66399406|FG000|Overall Study|Death|0|||
23732649|NCT01183104|66399407|FG001|Overall Study|Death|1|||
23732650|NCT01183104|66399406|FG000|Overall Study|Lost to Follow-up|14|||
23732651|NCT01183104|66399407|FG001|Overall Study|Lost to Follow-up|7|||
23732652|NCT01183104|66399406|FG000|Overall Study|Physician Decision|5|||
23732653|NCT01183104|66399407|FG001|Overall Study|Physician Decision|8|||
23732654|NCT01183104|66399406|FG000|Overall Study|Withdrawal by Subject|6|||
23732655|NCT01183104|66399407|FG001|Overall Study|Withdrawal by Subject|11|||
23732656|NCT01183104|66399406|FG000|Overall Study|Nonparticipation in Extension Study|39|||
23732657|NCT01183104|66399407|FG001|Overall Study|Nonparticipation in Extension Study|50|||
23732658|NCT01183104|66399406|FG000|Overall Study|Did not receive study drug|5|||
23732659|NCT01183104|66399407|FG001|Overall Study|Did not receive study drug|9|||
23732660|NCT02871791|66399412|FG000|Phase 1b|Death|0|||
23732661|NCT02871791|66399413|FG001|Phase 1b|Death|1|||
23732662|NCT02871791|66399412|FG000|Phase 1b|progressive disease|6|||
23732663|NCT02871791|66399413|FG001|Phase 1b|progressive disease|2|||
23732664|NCT02871791|66399412|FG000|Phase 2|Death|1|||
23732665|NCT02871791|66399413|FG001|Phase 2|Death|0|||
23732666|NCT02871791|66399412|FG000|Phase 2|Lost to Follow-up|2|||
23732667|NCT02871791|66399413|FG001|Phase 2|Lost to Follow-up|0|||
23732668|NCT01332851|66399414|FG000|Overall Study|Withdrawal by Subject|4|||
23732669|NCT01332851|66399415|FG001|Overall Study|Withdrawal by Subject|2|||
23732670|NCT01332851|66399414|FG000|Overall Study|Lost to Follow-up|7|||
23732671|NCT01332851|66399415|FG001|Overall Study|Lost to Follow-up|11|||
23732672|NCT02483611|66399416|FG000|Overall Study|Protocol Violation|0|||
23732673|NCT02483611|66399417|FG001|Overall Study|Protocol Violation|0|||
23732674|NCT02483611|66399418|FG002|Overall Study|Protocol Violation|1|||
23732675|NCT01057394|66399419|FG000|Overall Study|Not eligible|0|||
23732676|NCT01057394|66399420|FG001|Overall Study|Not eligible|2|||
23732677|NCT02254304|66399421|FG000|Overall Study|Adverse Event|2|||
23732678|NCT02254304|66399422|FG001|Overall Study|Adverse Event|1|||
23732679|NCT02254304|66399421|FG000|Overall Study|Lost to Follow-up|2|||
23732680|NCT02254304|66399422|FG001|Overall Study|Lost to Follow-up|2|||
23732681|NCT02254304|66399421|FG000|Overall Study|Protocol Violation|1|||
23732682|NCT02254304|66399422|FG001|Overall Study|Protocol Violation|0|||
23732683|NCT02254304|66399421|FG000|Overall Study|Withdrawal by Subject|3|||
23732684|NCT02254304|66399422|FG001|Overall Study|Withdrawal by Subject|0|||
23732685|NCT02254304|66399421|FG000|Overall Study|Injection site pain and Injection fear|1|||
23732686|NCT02254304|66399422|FG001|Overall Study|Injection site pain and Injection fear|0|||
23732687|NCT02254304|66399421|FG000|Overall Study|Personal causes|4|||
23732688|NCT02254304|66399422|FG001|Overall Study|Personal causes|1|||
23732689|NCT02254304|66399421|FG000|Overall Study|Personal decision|1|||
23732690|NCT02254304|66399422|FG001|Overall Study|Personal decision|0|||
23544882|NCT03131648|65726995|FG005|Open-label Treatment|Completed Week 50|0|||
23544883|NCT03131648|65726996|FG006|Open-label Treatment|Completed Week 50|6|||
23617961|NCT02660034|65988165|FG003|Overall Study|Adverse Event|0|||
23544884|NCT03131648|65726997|FG007|Open-label Treatment|Completed Week 50|0|||
23544885|NCT03131648|65726990|FG000|Maintenance Treatment Period|Not dosed|0|||
23544886|NCT03131648|65726991|FG001|Maintenance Treatment Period|Not dosed|0|||
23544887|NCT03131648|65726992|FG002|Maintenance Treatment Period|Not dosed|3|||
23544888|NCT03131648|65726993|FG003|Maintenance Treatment Period|Not dosed|2|||
23544889|NCT03131648|65726994|FG004|Maintenance Treatment Period|Not dosed|1|||
23732691|NCT01625611|66399424|FG000|Overall Study|No adlib drinks Lab 1|3|||
23732692|NCT01625611|66399425|FG001|Overall Study|No adlib drinks Lab 1|0|||
23732693|NCT01625611|66399424|FG000|Overall Study|Technical issues with PET|1|||
23732694|NCT01625611|66399425|FG001|Overall Study|Technical issues with PET|0|||
23732695|NCT01625611|66399424|FG000|Overall Study|Unable to complete study procedures|1|||
23732696|NCT01625611|66399425|FG001|Overall Study|Unable to complete study procedures|0|||
23732697|NCT01625611|66399424|FG000|Overall Study|Withdrawal by Subject|3|||
23732698|NCT01625611|66399425|FG001|Overall Study|Withdrawal by Subject|0|||
23732699|NCT02274766|66399428|FG000|Overall Study|Withdrawal by Subject|3|||
23732700|NCT02274766|66399429|FG001|Overall Study|Withdrawal by Subject|6|||
23732701|NCT02274766|66399428|FG000|Overall Study|Did Not Receive Study Drug|1|||
23732702|NCT02274766|66399429|FG001|Overall Study|Did Not Receive Study Drug|1|||
23732703|NCT02274766|66399428|FG000|Overall Study|Subject Unwilling to Proceed|0|||
23732704|NCT02274766|66399429|FG001|Overall Study|Subject Unwilling to Proceed|1|||
23732705|NCT02274766|66399428|FG000|Overall Study|Adverse Event|0|||
23732706|NCT02274766|66399429|FG001|Overall Study|Adverse Event|1|||
23732707|NCT01289028|66399430|FG000|Overall Study|Progressive Disease|49|||
23732708|NCT01289028|66399430|FG000|Overall Study|Adverse Event|14|||
23732709|NCT01289028|66399430|FG000|Overall Study|Withdrawal by Subject|6|||
23732710|NCT01289028|66399430|FG000|Overall Study|Death|4|||
23732711|NCT01289028|66399430|FG000|Overall Study|Lack of Efficacy|2|||
23732712|NCT01289028|66399430|FG000|Overall Study|No longer required|2|||
23732713|NCT01289028|66399430|FG000|Overall Study|Lost to Follow-up|2|||
23732714|NCT01289028|66399430|FG000|Overall Study|New Cancer Therapy|2|||
23732715|NCT01289028|66399430|FG000|Overall Study|Abnormal Lab Value|1|||
23732716|NCT01289028|66399430|FG000|Overall Study|Missing reason for discon|1|||
23732717|NCT00112840|66399431|FG000|Overall Study|Physician Decision|1|||
23732718|NCT00112840|66399432|FG001|Overall Study|Physician Decision|0|||
23732719|NCT00112840|66399433|FG002|Overall Study|Physician Decision|0|||
23732720|NCT00112840|66399431|FG000|Overall Study|Withdrawal by Subject|1|||
23732721|NCT00112840|66399432|FG001|Overall Study|Withdrawal by Subject|0|||
23732722|NCT00112840|66399433|FG002|Overall Study|Withdrawal by Subject|1|||
23732723|NCT00112840|66399431|FG000|Overall Study|Protocol Violation|0|||
23732724|NCT00112840|66399432|FG001|Overall Study|Protocol Violation|0|||
23732725|NCT00112840|66399433|FG002|Overall Study|Protocol Violation|5|||
23732726|NCT02545049|66399434|FG000|Overall Study|Withdrawal by Subject|1|||
23732727|NCT02545049|66399435|FG001|Overall Study|Withdrawal by Subject|7|||
23732728|NCT02545049|66399434|FG000|Overall Study|Lost to Follow-up|4|||
23732729|NCT02545049|66399435|FG001|Overall Study|Lost to Follow-up|6|||
23544890|NCT03131648|65726995|FG005|Maintenance Treatment Period|Not dosed|0|||
23544891|NCT03131648|65726996|FG006|Maintenance Treatment Period|Not dosed|0|||
23544892|NCT03131648|65726997|FG007|Maintenance Treatment Period|Not dosed|0|||
23544893|NCT03131648|65726990|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
23544894|NCT03131648|65726991|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
23544895|NCT03131648|65726992|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
23544896|NCT03131648|65726993|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
23544897|NCT03131648|65726994|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
23732730|NCT02545049|66399434|FG000|Overall Study|GCP violations|37|||
23732731|NCT02545049|66399435|FG001|Overall Study|GCP violations|48|||
23732732|NCT03018340|66399437|FG000|Overall Study|Adverse Event|1|||
23732733|NCT03018340|66399438|FG001|Overall Study|Adverse Event|2|||
23732734|NCT03018340|66399437|FG000|Overall Study|Withdrawal by Subject|0|||
23732735|NCT03018340|66399438|FG001|Overall Study|Withdrawal by Subject|8|||
23732736|NCT03018340|66399437|FG000|Overall Study|Lack of Efficacy|0|||
23732737|NCT03018340|66399438|FG001|Overall Study|Lack of Efficacy|1|||
23732738|NCT03018340|66399437|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
23732739|NCT03018340|66399438|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
23732740|NCT03018340|66399437|FG000|Overall Study|Lost to Follow-up|1|||
23732741|NCT03018340|66399438|FG001|Overall Study|Lost to Follow-up|7|||
23732742|NCT03018340|66399437|FG000|Overall Study|Protocol Violation|3|||
23544898|NCT03131648|65726995|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
23544899|NCT03131648|65726996|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
23544900|NCT03131648|65726997|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
23732743|NCT03018340|66399438|FG001|Overall Study|Protocol Violation|7|||
23732744|NCT03018340|66399437|FG000|Overall Study|Not further specified|0|||
23732745|NCT03018340|66399438|FG001|Overall Study|Not further specified|1|||
23732746|NCT03661983|66399439|FG000|Open Label Stabilization Phase|Adverse Event|5|||
23732747|NCT03661983|66399440|FG001|Open Label Stabilization Phase|Adverse Event|0|||
23732748|NCT03661983|66399441|FG002|Open Label Stabilization Phase|Adverse Event|0|||
23732749|NCT03661983|66399442|FG003|Open Label Stabilization Phase|Adverse Event|0|||
23732750|NCT03661983|66399439|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
23732751|NCT03661983|66399440|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
23732752|NCT03661983|66399441|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
23732753|NCT03661983|66399442|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
23732754|NCT03661983|66399439|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
23732755|NCT03661983|66399440|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23732756|NCT03661983|66399441|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23732757|NCT03661983|66399442|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23732758|NCT03661983|66399439|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
23732759|NCT03661983|66399440|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23732760|NCT03661983|66399441|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23732761|NCT03661983|66399442|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23732762|NCT03661983|66399439|FG000|Double-blind Randomized Phase|Adverse Event|0|||
23732763|NCT03661983|66399440|FG001|Double-blind Randomized Phase|Adverse Event|1|||
23732764|NCT03661983|66399441|FG002|Double-blind Randomized Phase|Adverse Event|0|||
23732765|NCT03661983|66399442|FG003|Double-blind Randomized Phase|Adverse Event|0|||
23732766|NCT03661983|66399439|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
23732767|NCT03661983|66399440|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
23732768|NCT03661983|66399441|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
23732769|NCT03661983|66399442|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
23426221|NCT00168103|65303567|FG002|Overall Study|Lost to Follow-up|0|||
23426222|NCT00168103|65303568|FG003|Overall Study|Lost to Follow-up|0|||
23426223|NCT01537081|65303570|FG000|Overall Study|Adverse Event|5|||
23426224|NCT01537081|65303571|FG001|Overall Study|Adverse Event|2|||
23426225|NCT01537081|65303572|FG002|Overall Study|Adverse Event|2|||
23426226|NCT01537081|65303570|FG000|Overall Study|Lack of Efficacy|2|||
23426227|NCT01537081|65303571|FG001|Overall Study|Lack of Efficacy|1|||
23426228|NCT01537081|65303572|FG002|Overall Study|Lack of Efficacy|0|||
23426229|NCT01537081|65303570|FG000|Overall Study|Lost to Follow-up|17|||
23426230|NCT01537081|65303571|FG001|Overall Study|Lost to Follow-up|15|||
23426231|NCT01537081|65303572|FG002|Overall Study|Lost to Follow-up|9|||
23426232|NCT01537081|65303570|FG000|Overall Study|Protocol Violation|3|||
23426233|NCT01537081|65303571|FG001|Overall Study|Protocol Violation|2|||
23426234|NCT01537081|65303572|FG002|Overall Study|Protocol Violation|2|||
23426235|NCT01537081|65303570|FG000|Overall Study|Withdrawal by Subject|6|||
23426236|NCT01537081|65303571|FG001|Overall Study|Withdrawal by Subject|11|||
23426237|NCT01537081|65303572|FG002|Overall Study|Withdrawal by Subject|3|||
23426238|NCT01537081|65303570|FG000|Overall Study|Physician Decision|5|||
23426239|NCT01537081|65303571|FG001|Overall Study|Physician Decision|6|||
23426240|NCT01537081|65303572|FG002|Overall Study|Physician Decision|0|||
23426241|NCT01537081|65303570|FG000|Overall Study|Sponsor decision|0|||
23426242|NCT01537081|65303571|FG001|Overall Study|Sponsor decision|1|||
23426243|NCT01537081|65303572|FG002|Overall Study|Sponsor decision|0|||
23426244|NCT01537081|65303570|FG000|Overall Study|Assigned but never dosed|1|||
23426245|NCT01537081|65303571|FG001|Overall Study|Assigned but never dosed|0|||
23426246|NCT01537081|65303572|FG002|Overall Study|Assigned but never dosed|0|||
23426247|NCT02680574|65303573|FG000|Overall Study|Death|137|||
23426248|NCT02680574|65303574|FG001|Overall Study|Death|137|||
23426249|NCT02680574|65303573|FG000|Overall Study|Withdrawal by Subject|17|||
23426250|NCT02680574|65303574|FG001|Overall Study|Withdrawal by Subject|9|||
23426251|NCT02680574|65303573|FG000|Overall Study|Lost to Follow-up|4|||
23426252|NCT02680574|65303574|FG001|Overall Study|Lost to Follow-up|6|||
23426253|NCT02818036|65303575|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
23426254|NCT02818036|65303576|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
23732770|NCT03661983|66399439|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23426255|NCT02818036|65303575|FG000|Overall Study|Withdrawal by Subject|1|||
23426256|NCT02818036|65303576|FG001|Overall Study|Withdrawal by Subject|0|||
23426257|NCT00160199|65303584|FG000|Overall Study|Adverse Event|5|||
23426258|NCT00160199|65303585|FG001|Overall Study|Adverse Event|14|||
23426259|NCT00160199|65303584|FG000|Overall Study|Lack of Efficacy|0|||
23426260|NCT00160199|65303585|FG001|Overall Study|Lack of Efficacy|1|||
23426261|NCT00160199|65303584|FG000|Overall Study|Lost to Follow-up|7|||
23732771|NCT03661983|66399440|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23732772|NCT03661983|66399441|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23732773|NCT03661983|66399442|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
23732774|NCT03661983|66399439|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
23732775|NCT03661983|66399440|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23732776|NCT03661983|66399441|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23426262|NCT00160199|65303585|FG001|Overall Study|Lost to Follow-up|7|||
23544901|NCT03131648|65726990|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23426263|NCT00160199|65303584|FG000|Overall Study|Withdrawal by Subject|4|||
23426264|NCT00160199|65303585|FG001|Overall Study|Withdrawal by Subject|6|||
23426265|NCT00160199|65303584|FG000|Overall Study|Administrative|0|||
23426266|NCT00160199|65303585|FG001|Overall Study|Administrative|1|||
23426267|NCT00160199|65303584|FG000|Overall Study|Protocol Violation|8|||
23426268|NCT00160199|65303585|FG001|Overall Study|Protocol Violation|8|||
23426269|NCT00989235|65303586|FG000|Overall Study|Death|0|||
23544902|NCT03131648|65726991|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23544903|NCT03131648|65726992|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
23544904|NCT03131648|65726993|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
23732777|NCT03661983|66399442|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23732778|NCT02417935|66399446|FG000|Treatment Period|Adverse Event|12|||
23732779|NCT02417935|66399447|FG001|Treatment Period|Adverse Event|10|||
23818725|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818726|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818727|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
23818728|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818729|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818730|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23617962|NCT02660034|65988166|FG004|Overall Study|Adverse Event|0|||
23617963|NCT02660034|65988167|FG005|Overall Study|Adverse Event|0|||
23617964|NCT02660034|65988168|FG006|Overall Study|Adverse Event|0|||
23617965|NCT02660034|65988169|FG007|Overall Study|Adverse Event|0|||
23617966|NCT02660034|65988170|FG008|Overall Study|Adverse Event|0|||
23617967|NCT02660034|65988171|FG009|Overall Study|Adverse Event|0|||
23617968|NCT02660034|65988172|FG010|Overall Study|Adverse Event|0|||
23617969|NCT02660034|65988173|FG011|Overall Study|Adverse Event|0|||
23617970|NCT02660034|65988174|FG012|Overall Study|Adverse Event|0|||
23617971|NCT02660034|65988175|FG013|Overall Study|Adverse Event|0|||
23617972|NCT02660034|65988162|FG000|Overall Study|Sponsor Decision|0|||
23544905|NCT03131648|65726994|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
23544906|NCT03131648|65726995|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
23544907|NCT03131648|65726996|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23617973|NCT02660034|65988163|FG001|Overall Study|Sponsor Decision|1|||
23732780|NCT02417935|66399446|FG000|Treatment Period|Lost to Follow-up|1|||
23732781|NCT02417935|66399447|FG001|Treatment Period|Lost to Follow-up|0|||
23617974|NCT02660034|65988164|FG002|Overall Study|Sponsor Decision|2|||
23617975|NCT02660034|65988165|FG003|Overall Study|Sponsor Decision|2|||
23617976|NCT02660034|65988166|FG004|Overall Study|Sponsor Decision|3|||
23617977|NCT02660034|65988167|FG005|Overall Study|Sponsor Decision|0|||
23732782|NCT02417935|66399446|FG000|Treatment Period|Entry Criteria not met|0|||
23732783|NCT02417935|66399447|FG001|Treatment Period|Entry Criteria not met|1|||
23732784|NCT02417935|66399446|FG000|Treatment Period|Protocol Violation|2|||
23732785|NCT02417935|66399447|FG001|Treatment Period|Protocol Violation|1|||
23732786|NCT02417935|66399446|FG000|Treatment Period|Withdrawal by Subject|3|||
23732787|NCT02417935|66399447|FG001|Treatment Period|Withdrawal by Subject|3|||
23617978|NCT02660034|65988168|FG006|Overall Study|Sponsor Decision|0|||
23617979|NCT02660034|65988169|FG007|Overall Study|Sponsor Decision|0|||
23617980|NCT02660034|65988170|FG008|Overall Study|Sponsor Decision|0|||
23617981|NCT02660034|65988171|FG009|Overall Study|Sponsor Decision|0|||
23617982|NCT02660034|65988172|FG010|Overall Study|Sponsor Decision|0|||
23617983|NCT02660034|65988173|FG011|Overall Study|Sponsor Decision|0|||
23617984|NCT02660034|65988174|FG012|Overall Study|Sponsor Decision|0|||
23617985|NCT02660034|65988175|FG013|Overall Study|Sponsor Decision|1|||
23617986|NCT02660034|65988162|FG000|Overall Study|Withdrawal by Subject|0|||
23617987|NCT02660034|65988163|FG001|Overall Study|Withdrawal by Subject|0|||
23818731|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818732|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818733|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818734|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23818735|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818736|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23426270|NCT00989235|65303587|FG001|Overall Study|Death|1|||
23426271|NCT00989235|65303586|FG000|Overall Study|Adverse Event|0|||
23617988|NCT02660034|65988164|FG002|Overall Study|Withdrawal by Subject|0|||
23617989|NCT02660034|65988165|FG003|Overall Study|Withdrawal by Subject|0|||
23617990|NCT02660034|65988166|FG004|Overall Study|Withdrawal by Subject|0|||
23732788|NCT02417935|66399446|FG000|Treatment Period|Physician Decision|3|||
23732789|NCT02417935|66399447|FG001|Treatment Period|Physician Decision|1|||
23617991|NCT02660034|65988167|FG005|Overall Study|Withdrawal by Subject|0|||
23617992|NCT02660034|65988168|FG006|Overall Study|Withdrawal by Subject|1|||
23732790|NCT02881151|66399448|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
23732791|NCT03083470|66399449|FG000|Overall Study|Lost to Follow-up|0|||
23732792|NCT03083470|66399450|FG001|Overall Study|Lost to Follow-up|0|||
23732793|NCT03083470|66399451|FG002|Overall Study|Lost to Follow-up|0|||
23732794|NCT03083470|66399452|FG003|Overall Study|Lost to Follow-up|0|||
23732795|NCT03083470|66399453|FG004|Overall Study|Lost to Follow-up|1|||
23732796|NCT03083470|66399449|FG000|Overall Study|Withdrawal by Subject|0|||
23732797|NCT03083470|66399450|FG001|Overall Study|Withdrawal by Subject|0|||
23732798|NCT03083470|66399451|FG002|Overall Study|Withdrawal by Subject|0|||
23732799|NCT03083470|66399452|FG003|Overall Study|Withdrawal by Subject|0|||
23732800|NCT03083470|66399453|FG004|Overall Study|Withdrawal by Subject|1|||
23732801|NCT02045979|66399454|FG000|Overall Study|Informed Consent Withdrawn|2|||
23732802|NCT02045979|66399455|FG001|Overall Study|Informed Consent Withdrawn|0|||
23732803|NCT02045979|66399456|FG002|Overall Study|Informed Consent Withdrawn|1|||
23732804|NCT02045979|66399454|FG000|Overall Study|not specified above|0|||
23732805|NCT02045979|66399455|FG001|Overall Study|not specified above|1|||
23732806|NCT02045979|66399456|FG002|Overall Study|not specified above|0|||
23732807|NCT02811640|66401885|FG000|Overall Study|Technology malfunction|2|||
23732808|NCT03512028|66401886|FG000|Overall Study|Withdrawal by Subject|2|||
23732809|NCT03512028|66401887|FG001|Overall Study|Withdrawal by Subject|0|||
23732810|NCT03512028|66401886|FG000|Overall Study|Protocol Violation|2|||
23732811|NCT03512028|66401887|FG001|Overall Study|Protocol Violation|0|||
23732812|NCT03147495|66401890|FG000|Overall Study|Physician Decision|0|||
23732813|NCT03147495|66401891|FG001|Overall Study|Physician Decision|6|||
23732814|NCT02607865|66401892|FG000|Overall Study|Lost to Follow-up|9|||
23732815|NCT02607865|66401893|FG001|Overall Study|Lost to Follow-up|7|||
23544908|NCT03131648|65726997|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23544909|NCT03131648|65726990|FG000|Maintenance Treatment Period|Completed Week 50|0|||
23544910|NCT03131648|65726991|FG001|Maintenance Treatment Period|Completed Week 50|0|||
23732816|NCT02607865|66401894|FG002|Overall Study|Lost to Follow-up|7|||
23732817|NCT02607865|66401895|FG003|Overall Study|Lost to Follow-up|5|||
23732818|NCT02607865|66401892|FG000|Overall Study|Withdrawal by Subject|18|||
23732819|NCT02607865|66401893|FG001|Overall Study|Withdrawal by Subject|18|||
23732820|NCT02607865|66401894|FG002|Overall Study|Withdrawal by Subject|17|||
23732821|NCT02607865|66401895|FG003|Overall Study|Withdrawal by Subject|8|||
23732822|NCT02607865|66401892|FG000|Overall Study|Death|5|||
23732823|NCT02607865|66401893|FG001|Overall Study|Death|4|||
23732824|NCT02607865|66401894|FG002|Overall Study|Death|1|||
23732825|NCT02607865|66401895|FG003|Overall Study|Death|3|||
23732826|NCT02607865|66401892|FG000|Overall Study|Unclassified|1|||
23732827|NCT02607865|66401893|FG001|Overall Study|Unclassified|1|||
23732828|NCT02607865|66401894|FG002|Overall Study|Unclassified|2|||
23732829|NCT02607865|66401895|FG003|Overall Study|Unclassified|0|||
23732830|NCT01675141|66401896|FG000|Overall Study|Lenalidomide outside NIH|3|||
23732831|NCT01675141|66401896|FG000|Overall Study|Withdrawal by Subject|3|||
23732832|NCT01675141|66401896|FG000|Overall Study|Physician Decision|4|||
23732833|NCT01675141|66401896|FG000|Overall Study|No treatment, per protocol|1|||
23732834|NCT04124952|66401897|FG000|Overall Study|Lost to Follow-up|1|||
23732835|NCT00323479|66401898|FG000|Overall Study|Adverse Event|2|||
23732836|NCT00323479|66401898|FG000|Overall Study|Withdrawal by Subject|2|||
23732837|NCT00323479|66401898|FG000|Overall Study|Protocol Violation|3|||
23732838|NCT00323479|66401898|FG000|Overall Study|house moving|1|||
23732839|NCT00731666|66401899|FG000|Overall Study|Adverse Event|2|||
23732840|NCT00731666|66401899|FG000|Overall Study|Lost to Follow-up|8|||
23732841|NCT00731666|66401899|FG000|Overall Study|Withdrawal by Subject|2|||
23732842|NCT00366444|66401900|FG000|Overall Study|Withdrawal by Subject|1|||
23732843|NCT00366444|66401901|FG001|Overall Study|Withdrawal by Subject|1|||
23732844|NCT00366444|66401900|FG000|Overall Study|Lack of Efficacy|0|||
23732845|NCT00366444|66401901|FG001|Overall Study|Lack of Efficacy|1|||
23732846|NCT01487863|66401907|FG000|Overall Study|Death|19|||
23732847|NCT01487863|66401908|FG001|Overall Study|Death|19|||
23732848|NCT02306148|66401909|FG000|Overall Study|Adverse Event|12|||
23732849|NCT02306148|66401910|FG001|Overall Study|Adverse Event|6|||
23426272|NCT00989235|65303587|FG001|Overall Study|Adverse Event|1|||
23544911|NCT03131648|65726992|FG002|Maintenance Treatment Period|Completed Week 50|0|||
23544912|NCT03131648|65726993|FG003|Maintenance Treatment Period|Completed Week 50|0|||
23732850|NCT02306148|66401909|FG000|Overall Study|Lost to Follow-up|1|||
23732851|NCT02306148|66401910|FG001|Overall Study|Lost to Follow-up|4|||
23732852|NCT01950364|66401911|FG000|Overall Study|Adverse Event|3|||
23732853|NCT01950364|66401912|FG001|Overall Study|Adverse Event|0|||
23732854|NCT01950364|66401911|FG000|Overall Study|Stem Cell Transplant|2|||
23732855|NCT01950364|66401912|FG001|Overall Study|Stem Cell Transplant|6|||
23732856|NCT01950364|66401911|FG000|Overall Study|Disease Progression|5|||
23732857|NCT01950364|66401912|FG001|Overall Study|Disease Progression|2|||
23732858|NCT01950364|66401911|FG000|Overall Study|Withdrawal by Subject|0|||
23732859|NCT01950364|66401912|FG001|Overall Study|Withdrawal by Subject|1|||
23732860|NCT01950364|66401911|FG000|Overall Study|Protocol Violation|0|||
23732861|NCT01950364|66401912|FG001|Overall Study|Protocol Violation|1|||
23732862|NCT00338806|66401913|FG000|Acute Phase|Withdrawal by Subject|0|||
23732863|NCT00338806|66401914|FG001|Acute Phase|Withdrawal by Subject|1|||
23732864|NCT00338806|66401913|FG000|Follow-up|Lost to Follow-up|1|||
23732865|NCT00338806|66401914|FG001|Follow-up|Lost to Follow-up|3|||
23732866|NCT02005211|66401916|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732867|NCT02005211|66401917|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732868|NCT02005211|66401918|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732869|NCT02005211|66401919|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732870|NCT02005211|66401920|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
23732871|NCT02005211|66401921|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732872|NCT02005211|66401922|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23732873|NCT00098865|66401927|FG000|Overall Study|Progressive Disease|6|||
23732874|NCT00098865|66401927|FG000|Overall Study|Adverse Event|2|||
23732875|NCT00098865|66401927|FG000|Overall Study|Alternative Therapy|1|||
23732876|NCT00866606|66401928|FG000|Overall Study|Lost to Follow-up|3|||
23732877|NCT00866606|66401928|FG000|Overall Study|Adverse Event|1|||
23732878|NCT00405275|66401929|FG000|Overall Study|Death|1|||
23732879|NCT00405275|66401930|FG001|Overall Study|Death|0|||
23732880|NCT00405275|66401929|FG000|Overall Study|Lost to Follow-up|5|||
23732881|NCT00405275|66401930|FG001|Overall Study|Lost to Follow-up|1|||
23732882|NCT00405275|66401929|FG000|Overall Study|Withdrawal by Subject|7|||
23732883|NCT00405275|66401930|FG001|Overall Study|Withdrawal by Subject|9|||
23732884|NCT00405275|66401929|FG000|Overall Study|Unwilling to continue|10|||
23732885|NCT00405275|66401930|FG001|Overall Study|Unwilling to continue|9|||
23732886|NCT04735432|66401931|FG000|Overall Study|Other - due to personal reason|1|||
23732887|NCT04735432|66401932|FG001|Overall Study|Other - due to personal reason|0|||
23732888|NCT04735432|66401931|FG000|Overall Study|Adverse Event|2|||
23818737|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818738|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
23818739|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818740|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818741|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818742|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818743|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818744|NCT03893565|66714442|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818745|NCT03893565|66714443|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
23818746|NCT03893565|66714444|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
23818747|NCT03893565|66714445|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
23818748|NCT03893565|66714446|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818749|NCT03893565|66714447|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818750|NCT03893565|66714448|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818751|NCT03893565|66714449|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818752|NCT03893565|66714450|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23818753|NCT03893565|66714442|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
23818754|NCT03893565|66714443|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
23818755|NCT03893565|66714444|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
23818756|NCT03893565|66714445|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
23818757|NCT03893565|66714446|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
23818758|NCT03893565|66714447|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
23818759|NCT03893565|66714448|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
23426273|NCT00989235|65303586|FG000|Overall Study|Lack of Efficacy|1|||
23732889|NCT04735432|66401932|FG001|Overall Study|Adverse Event|0|||
23732890|NCT00392210|66401933|FG000|First Voiding Trial|Physician Decision|2|||
23732891|NCT00392210|66401934|FG001|First Voiding Trial|Physician Decision|2|||
23732892|NCT00784459|66401935|FG000|Overall Study|Adverse Event|0|||
23732893|NCT00784459|66401936|FG001|Overall Study|Adverse Event|2|||
23426274|NCT00989235|65303587|FG001|Overall Study|Lack of Efficacy|0|||
23426275|NCT00989235|65303586|FG000|Overall Study|Withdrawal of Consent|1|||
23426276|NCT00989235|65303587|FG001|Overall Study|Withdrawal of Consent|1|||
23426277|NCT00989235|65303586|FG000|Overall Study|Desire to Become Pregnant|1|||
23426278|NCT00989235|65303587|FG001|Overall Study|Desire to Become Pregnant|0|||
23426279|NCT00989235|65303586|FG000|Overall Study|Randomized by Mistake|0|||
23426280|NCT00989235|65303587|FG001|Overall Study|Randomized by Mistake|2|||
23426281|NCT00989235|65303586|FG000|Overall Study|Lost to Follow-up|0|||
23426282|NCT00989235|65303587|FG001|Overall Study|Lost to Follow-up|1|||
23426283|NCT02639338|65303588|FG000|Overall Study|Lost to Follow-up|2|||
23426284|NCT02639338|65303589|FG001|Overall Study|Lost to Follow-up|2|||
23426285|NCT02639338|65303588|FG000|Overall Study|Withdrew Consent|1|||
23426286|NCT02639338|65303589|FG001|Overall Study|Withdrew Consent|2|||
23426287|NCT02639338|65303588|FG000|Overall Study|Death|1|||
23426288|NCT02639338|65303589|FG001|Overall Study|Death|0|||
23732894|NCT02516306|66401937|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
23732895|NCT02516306|66401938|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
23732896|NCT04397757|66401939|FG000|Overall Study|Death|3|||
23732897|NCT04397757|66401940|FG001|Overall Study|Death|11|||
23426289|NCT02639338|65303588|FG000|Overall Study|Randomized but Not Treated|0|||
23426290|NCT02639338|65303589|FG001|Overall Study|Randomized but Not Treated|1|||
23426291|NCT01253265|65303595|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
23426292|NCT01253265|65303596|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426293|NCT01253265|65303597|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426294|NCT01253265|65303598|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426295|NCT01253265|65303599|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426296|NCT01253265|65303595|FG000|Overall Study|Withdrawal by Subject|0|||
23426297|NCT01253265|65303596|FG001|Overall Study|Withdrawal by Subject|0|||
23426298|NCT01253265|65303597|FG002|Overall Study|Withdrawal by Subject|0|||
23426299|NCT01253265|65303598|FG003|Overall Study|Withdrawal by Subject|0|||
23426300|NCT01253265|65303599|FG004|Overall Study|Withdrawal by Subject|1|||
23426301|NCT02590562|65303602|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
23426302|NCT02699450|65303607|FG000|Overall Study|Death|2|||
23426303|NCT02699450|65303608|FG001|Overall Study|Death|1|||
23426304|NCT02699450|65303609|FG002|Overall Study|Death|2|||
23426305|NCT02699450|65303607|FG000|Overall Study|Met Criteria for Study Exit|0|||
23426306|NCT02699450|65303608|FG001|Overall Study|Met Criteria for Study Exit|0|||
23426307|NCT02699450|65303609|FG002|Overall Study|Met Criteria for Study Exit|1|||
23426308|NCT02699450|65303607|FG000|Overall Study|Protocol Violation|4|||
23426309|NCT02699450|65303608|FG001|Overall Study|Protocol Violation|3|||
23732898|NCT04397757|66401939|FG000|Overall Study|Withdrawal by Subject|2|||
23732899|NCT04397757|66401940|FG001|Overall Study|Withdrawal by Subject|0|||
23426310|NCT02699450|65303609|FG002|Overall Study|Protocol Violation|5|||
23426311|NCT02699450|65303607|FG000|Overall Study|Lost to Follow-up|3|||
23426312|NCT02699450|65303608|FG001|Overall Study|Lost to Follow-up|0|||
23426313|NCT02699450|65303609|FG002|Overall Study|Lost to Follow-up|5|||
23426314|NCT02699450|65303607|FG000|Overall Study|Physician Decision|2|||
23426315|NCT02699450|65303608|FG001|Overall Study|Physician Decision|0|||
23426316|NCT02699450|65303609|FG002|Overall Study|Physician Decision|0|||
23426317|NCT02699450|65303607|FG000|Overall Study|Withdrawal by Subject|3|||
23426318|NCT02699450|65303608|FG001|Overall Study|Withdrawal by Subject|1|||
23426319|NCT02699450|65303609|FG002|Overall Study|Withdrawal by Subject|2|||
23426320|NCT02699450|65303607|FG000|Overall Study|Adverse Event|1|||
23426321|NCT02699450|65303608|FG001|Overall Study|Adverse Event|0|||
23426322|NCT02699450|65303609|FG002|Overall Study|Adverse Event|0|||
23426323|NCT01140568|65303610|FG000|Overall Study|disease progression|31|||
23426324|NCT01140568|65303610|FG000|Overall Study|Withdrawal by Subject|1|||
23426325|NCT01140568|65303610|FG000|Overall Study|Screen Fail|4|||
23426326|NCT04035564|65303616|FG000|Overall Study|Protocol Violation|1|||
23426327|NCT04035564|65303617|FG001|Overall Study|Protocol Violation|2|||
23426328|NCT04035564|65303616|FG000|Overall Study|No laboratory available|2|||
23426329|NCT04035564|65303617|FG001|Overall Study|No laboratory available|2|||
23426330|NCT04035564|65303616|FG000|Overall Study|Guardian declined consent|1|||
23426331|NCT04035564|65303617|FG001|Overall Study|Guardian declined consent|2|||
23426332|NCT00886119|65303618|FG000|Period 1|Did not meet inclusion criteria|1|||
23426333|NCT00886119|65303619|FG001|Period 1|Did not meet inclusion criteria|0|||
23426334|NCT00740714|65303622|FG000|Overall Study|Withdrawal by Subject|17|||
23426335|NCT00740714|65303623|FG001|Overall Study|Withdrawal by Subject|19|||
23426336|NCT00740714|65303624|FG002|Overall Study|Withdrawal by Subject|29|||
23732900|NCT04397757|66401939|FG000|Overall Study|Lost to Follow-up|4|||
23426337|NCT00525824|65303625|FG000|Overall Study|Adverse Event|7|||
23426338|NCT00525824|65303626|FG001|Overall Study|Adverse Event|11|||
23426339|NCT00525824|65303627|FG002|Overall Study|Adverse Event|6|||
23426340|NCT00525824|65303628|FG003|Overall Study|Adverse Event|7|||
23426341|NCT00525824|65303625|FG000|Overall Study|Withdrawal by Subject|5|||
23426342|NCT00525824|65303626|FG001|Overall Study|Withdrawal by Subject|9|||
23426343|NCT00525824|65303627|FG002|Overall Study|Withdrawal by Subject|3|||
23732901|NCT04397757|66401940|FG001|Overall Study|Lost to Follow-up|3|||
23426344|NCT00525824|65303628|FG003|Overall Study|Withdrawal by Subject|4|||
23426345|NCT00525824|65303625|FG000|Overall Study|Lost to Follow-up|4|||
23426346|NCT00525824|65303626|FG001|Overall Study|Lost to Follow-up|2|||
23426347|NCT00525824|65303627|FG002|Overall Study|Lost to Follow-up|4|||
23426348|NCT00525824|65303628|FG003|Overall Study|Lost to Follow-up|0|||
23732902|NCT00643851|66401941|FG000|Overall Study|Death|0|||
23818760|NCT03893565|66714449|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
23818761|NCT03893565|66714450|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
23818762|NCT03893565|66714442|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818763|NCT03893565|66714443|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818764|NCT03893565|66714444|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818765|NCT03893565|66714445|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818766|NCT03893565|66714446|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818767|NCT03893565|66714447|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818768|NCT03893565|66714448|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
23818769|NCT03893565|66714449|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818770|NCT03893565|66714450|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23818771|NCT03893565|66714442|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818772|NCT03893565|66714443|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818773|NCT03893565|66714444|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818774|NCT03893565|66714445|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818775|NCT03893565|66714446|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818776|NCT03893565|66714447|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
23818777|NCT03893565|66714448|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
23843095|NCT01738503|66805585|FG004|Treatment Period|Withdrawal by Subject|1|||
23732903|NCT00643851|66401942|FG001|Overall Study|Death|1|||
23732904|NCT00643851|66401943|FG002|Overall Study|Death|0|||
23732905|NCT00643851|66401941|FG000|Overall Study|Lack of Efficacy|0|||
23732906|NCT00643851|66401942|FG001|Overall Study|Lack of Efficacy|1|||
23732907|NCT00643851|66401943|FG002|Overall Study|Lack of Efficacy|0|||
23732908|NCT00643851|66401941|FG000|Overall Study|Adverse Event|2|||
23732909|NCT00643851|66401942|FG001|Overall Study|Adverse Event|6|||
23732910|NCT00643851|66401943|FG002|Overall Study|Adverse Event|6|||
23732911|NCT00643851|66401941|FG000|Overall Study|Lost to Follow-up|4|||
23732912|NCT00643851|66401942|FG001|Overall Study|Lost to Follow-up|6|||
23732913|NCT00643851|66401943|FG002|Overall Study|Lost to Follow-up|9|||
23732914|NCT00643851|66401941|FG000|Overall Study|Withdrawal by Subject|8|||
23732915|NCT00643851|66401942|FG001|Overall Study|Withdrawal by Subject|15|||
23732916|NCT00643851|66401943|FG002|Overall Study|Withdrawal by Subject|9|||
23732917|NCT00643851|66401941|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
23732918|NCT00643851|66401942|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
23732919|NCT00643851|66401943|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
23732920|NCT02425891|66401946|FG000|Overall Study|Death|333|||
23732921|NCT02425891|66401947|FG001|Overall Study|Death|314|||
23732922|NCT02425891|66401946|FG000|Overall Study|Lost to Follow-up|4|||
23732923|NCT02425891|66401947|FG001|Overall Study|Lost to Follow-up|6|||
23732924|NCT02425891|66401946|FG000|Overall Study|Non-Compliance|1|||
23732925|NCT02425891|66401947|FG001|Overall Study|Non-Compliance|1|||
23732926|NCT02425891|66401946|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
23732927|NCT02425891|66401947|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
23732928|NCT02425891|66401946|FG000|Overall Study|Physician Decision|0|||
23732929|NCT02425891|66401947|FG001|Overall Study|Physician Decision|1|||
23732930|NCT02425891|66401946|FG000|Overall Study|Protocol Violation|1|||
23732931|NCT02425891|66401947|FG001|Overall Study|Protocol Violation|1|||
23732932|NCT02425891|66401946|FG000|Overall Study|Study Terminated By Sponsor|85|||
23732933|NCT02425891|66401947|FG001|Overall Study|Study Terminated By Sponsor|95|||
23732934|NCT02425891|66401946|FG000|Overall Study|Withdrawal by Subject|27|||
23732935|NCT02425891|66401947|FG001|Overall Study|Withdrawal by Subject|32|||
23732936|NCT00083616|66401953|FG000|Overall Study|Disease Progression|16|||
23732937|NCT00083616|66401953|FG000|Overall Study|Lost to Follow-up|1|||
23732938|NCT00083616|66401953|FG000|Overall Study|Physician Decision|2|||
23732939|NCT00083616|66401953|FG000|Overall Study|Withdrawal by Subject|3|||
23732940|NCT00083616|66401953|FG000|Overall Study|Ineligibility determined|2|||
23426349|NCT00525824|65303625|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
23426350|NCT00525824|65303626|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
23732941|NCT00083616|66401953|FG000|Overall Study|Non-compliance|1|||
23732942|NCT00083616|66401953|FG000|Overall Study|Other|6|||
23732943|NCT03483012|66401954|FG000|Overall Study|Lack of Efficacy|6|||
23732944|NCT02324049|66401955|FG000|Part C|Study terminated|11|||
23732945|NCT03323086|66401961|FG000|Overall Study|Lost to Follow-up|3|||
23732946|NCT03323086|66401962|FG001|Overall Study|Lost to Follow-up|2|||
23732947|NCT01051856|66401963|FG000|Overall Study|Withdrawal by Subject|1|||
23818778|NCT03893565|66714449|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818779|NCT03893565|66714450|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23818780|NCT03893565|66714442|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
23818781|NCT03893565|66714443|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
23818782|NCT03893565|66714444|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
23818783|NCT03893565|66714445|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
23818784|NCT03893565|66714446|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
23818785|NCT03893565|66714447|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
23818786|NCT03893565|66714448|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
23818787|NCT03893565|66714449|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
23818788|NCT03893565|66714450|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
23818789|NCT03893565|66714442|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818790|NCT03893565|66714443|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818791|NCT03893565|66714444|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818792|NCT03893565|66714445|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818793|NCT03893565|66714446|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818794|NCT03893565|66714447|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818795|NCT03893565|66714448|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818796|NCT03893565|66714449|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
23426351|NCT00525824|65303627|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
23426352|NCT00525824|65303628|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
23426353|NCT00525824|65303625|FG000|Overall Study|Severe non-compliance|0|||
23732948|NCT01051856|66401964|FG001|Overall Study|Withdrawal by Subject|0|||
23732949|NCT00584987|66401965|FG000|Overall Study|Protocol Violation|1|||
23732950|NCT00584987|66401966|FG001|Overall Study|Protocol Violation|1|||
23732951|NCT00584987|66401967|FG002|Overall Study|Protocol Violation|1|||
23732952|NCT00584987|66401968|FG003|Overall Study|Protocol Violation|0|||
23732953|NCT00584987|66401965|FG000|Overall Study|Adverse Event|0|||
23732954|NCT00584987|66401966|FG001|Overall Study|Adverse Event|0|||
23732955|NCT00584987|66401967|FG002|Overall Study|Adverse Event|0|||
23426354|NCT00525824|65303626|FG001|Overall Study|Severe non-compliance|1|||
23426355|NCT00525824|65303627|FG002|Overall Study|Severe non-compliance|1|||
23426356|NCT00525824|65303628|FG003|Overall Study|Severe non-compliance|1|||
23426357|NCT00525824|65303625|FG000|Overall Study|Safety reasons|1|||
23426358|NCT00525824|65303626|FG001|Overall Study|Safety reasons|0|||
23426359|NCT00525824|65303627|FG002|Overall Study|Safety reasons|1|||
23426360|NCT00525824|65303628|FG003|Overall Study|Safety reasons|0|||
23426361|NCT00525824|65303625|FG000|Overall Study|Other|1|||
23426362|NCT00525824|65303626|FG001|Overall Study|Other|3|||
23426363|NCT00525824|65303627|FG002|Overall Study|Other|3|||
23426364|NCT00525824|65303628|FG003|Overall Study|Other|1|||
23426365|NCT02351349|65303629|FG000|Overall Study|Withdrawal by Subject|2|||
23426366|NCT02351349|65303630|FG001|Overall Study|Withdrawal by Subject|3|||
23426367|NCT00445939|65303631|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
23426368|NCT00445939|65303632|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
23426369|NCT00445939|65303633|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
23426370|NCT00445939|65303634|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
23426371|NCT00445939|65303631|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
23426372|NCT00445939|65303632|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
23426373|NCT00445939|65303633|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
23426374|NCT00445939|65303634|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
23426375|NCT00353873|65303640|FG000|Overall Study|Protocol Violation|1|||
23818797|NCT03893565|66714450|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23818798|NCT03893565|66714442|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818799|NCT03893565|66714443|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818800|NCT03893565|66714444|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818801|NCT03893565|66714445|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23732956|NCT00584987|66401968|FG003|Overall Study|Adverse Event|1|||
23732957|NCT00554840|66401969|FG000|Overall Study|Physician Decision|0|||
23732958|NCT00554840|66401970|FG001|Overall Study|Physician Decision|1|||
23426376|NCT00353873|65303641|FG001|Overall Study|Protocol Violation|2|||
23426377|NCT00353873|65303640|FG000|Overall Study|Exacerbation|1|||
23732959|NCT03231228|66401971|FG000|Overall Study|Lost to Follow-up|2|||
23426378|NCT00353873|65303641|FG001|Overall Study|Exacerbation|0|||
23426379|NCT00353873|65303640|FG000|Overall Study|Adverse Event|1|||
23426380|NCT00353873|65303641|FG001|Overall Study|Adverse Event|0|||
23426381|NCT00353873|65303640|FG000|Overall Study|Physician Decision|2|||
23544913|NCT03131648|65726994|FG004|Maintenance Treatment Period|Completed Week 50|1|||
23732960|NCT03231228|66401972|FG001|Overall Study|Lost to Follow-up|0|||
23426382|NCT00353873|65303641|FG001|Overall Study|Physician Decision|0|||
23426383|NCT00353873|65303640|FG000|Overall Study|Withdrawal by Subject|1|||
23426384|NCT00353873|65303641|FG001|Overall Study|Withdrawal by Subject|1|||
23426385|NCT01610596|65303644|FG000|Overall Study|Lost to Follow-up|0|||
23426386|NCT01610596|65303645|FG001|Overall Study|Lost to Follow-up|1|||
23426387|NCT01816906|65303646|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
23426388|NCT01816906|65303647|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
23426389|NCT01816906|65303646|FG000|Six Months|Lost to Follow-up|14|||
23426390|NCT01816906|65303647|FG001|Six Months|Lost to Follow-up|16|||
23426391|NCT01816906|65303646|FG000|12 Months|Adverse Event|2|||
23426392|NCT01816906|65303647|FG001|12 Months|Adverse Event|2|||
23426393|NCT01816906|65303646|FG000|12 Months|Death|0|||
23426394|NCT01816906|65303647|FG001|12 Months|Death|2|||
23426395|NCT01816906|65303646|FG000|12 Months|Lost to Follow-up|2|||
23426396|NCT01816906|65303647|FG001|12 Months|Lost to Follow-up|1|||
23426397|NCT02133664|65303651|FG000|Overall Study|Lost to Follow-up|2|||
23426398|NCT02133664|65303652|FG001|Overall Study|Lost to Follow-up|1|||
23426399|NCT02133664|65303651|FG000|Overall Study|Adverse Event|3|||
23426400|NCT02133664|65303652|FG001|Overall Study|Adverse Event|6|||
23426401|NCT00996801|65303653|FG000|Overall Study|Adverse Event|6|||
23426402|NCT00996801|65303654|FG001|Overall Study|Adverse Event|4|||
23426403|NCT00996801|65303655|FG002|Overall Study|Adverse Event|12|||
23426404|NCT00996801|65303656|FG003|Overall Study|Adverse Event|17|||
23426405|NCT00996801|65303657|FG004|Overall Study|Adverse Event|31|||
23426406|NCT00996801|65303658|FG005|Overall Study|Adverse Event|3|||
23544914|NCT03131648|65726995|FG005|Maintenance Treatment Period|Completed Week 50|0|||
23544915|NCT03131648|65726996|FG006|Maintenance Treatment Period|Completed Week 50|0|||
23544916|NCT03131648|65726997|FG007|Maintenance Treatment Period|Completed Week 50|0|||
23732961|NCT03231228|66401971|FG000|Overall Study|Physician Decision|1|||
23732962|NCT03231228|66401972|FG001|Overall Study|Physician Decision|0|||
23544917|NCT03131648|65726990|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544918|NCT03131648|65726991|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544919|NCT03131648|65726992|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
23732963|NCT00266695|66401973|FG000|Overall Study|Adverse Event|1|||
23732964|NCT00266695|66401973|FG000|Overall Study|Death|9|||
23732965|NCT00266695|66401973|FG000|Overall Study|Physician Decision|1|||
23732966|NCT00266695|66401973|FG000|Overall Study|Lost to Follow-up|3|||
23732967|NCT00266695|66401973|FG000|Overall Study|Withdrawal by Subject|15|||
23732968|NCT01843933|66401974|FG000|Overall Study|Data lost|6|||
23732969|NCT01843933|66401975|FG001|Overall Study|Data lost|4|||
23732970|NCT00423267|66401976|FG000|Period A|Withdrawal by Subject|0|||
23732971|NCT00423267|66401977|FG001|Period A|Withdrawal by Subject|1|||
23732972|NCT00423267|66401976|FG000|Period A|Non-compliance with protocol|1|||
23732973|NCT00423267|66401977|FG001|Period A|Non-compliance with protocol|0|||
23732974|NCT00423267|66401976|FG000|Period A|Administrative|1|||
23732975|NCT00423267|66401977|FG001|Period A|Administrative|0|||
23732976|NCT02140762|66401978|FG000|Overall Study|Adverse Event|1|||
23732977|NCT02140762|66401979|FG001|Overall Study|Adverse Event|1|||
23732978|NCT02140762|66401978|FG000|Overall Study|Lost to Follow-up|9|||
23544920|NCT03131648|65726993|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
23732979|NCT02140762|66401979|FG001|Overall Study|Lost to Follow-up|5|||
23732980|NCT02140762|66401978|FG000|Overall Study|Protocol Violation|1|||
23818802|NCT03893565|66714446|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23426407|NCT00996801|65303653|FG000|Overall Study|Lack of Efficacy|3|||
23426408|NCT00996801|65303654|FG001|Overall Study|Lack of Efficacy|0|||
23426409|NCT00996801|65303655|FG002|Overall Study|Lack of Efficacy|1|||
23426410|NCT00996801|65303656|FG003|Overall Study|Lack of Efficacy|3|||
23426411|NCT00996801|65303657|FG004|Overall Study|Lack of Efficacy|0|||
23426412|NCT00996801|65303658|FG005|Overall Study|Lack of Efficacy|1|||
23544921|NCT03131648|65726994|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544922|NCT03131648|65726995|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544923|NCT03131648|65726996|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544924|NCT03131648|65726997|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
23544925|NCT04053764|65727000|FG000|Overall Study|Withdrawal by Subject|6|||
23544926|NCT04053764|65727001|FG001|Overall Study|Withdrawal by Subject|2|||
23544927|NCT04053764|65727000|FG000|Overall Study|Physician Decision|2|||
23544928|NCT04053764|65727001|FG001|Overall Study|Physician Decision|1|||
23544929|NCT04053764|65727000|FG000|Overall Study|Adverse Event|1|||
23544930|NCT04053764|65727001|FG001|Overall Study|Adverse Event|0|||
23544931|NCT04053764|65727000|FG000|Overall Study|Pregnancy|1|||
23544932|NCT04053764|65727001|FG001|Overall Study|Pregnancy|0|||
23544933|NCT01613248|65727005|FG000|Overall Study|Adverse Event|0|||
23544934|NCT01613248|65727006|FG001|Overall Study|Adverse Event|0|||
23544935|NCT01613248|65727007|FG002|Overall Study|Adverse Event|0|||
23544936|NCT01613248|65727008|FG003|Overall Study|Adverse Event|1|||
23544937|NCT01613248|65727009|FG004|Overall Study|Adverse Event|0|||
23544938|NCT01613248|65727010|FG005|Overall Study|Adverse Event|0|||
23732981|NCT02140762|66401979|FG001|Overall Study|Protocol Violation|1|||
23732982|NCT02140762|66401978|FG000|Overall Study|Withdrawal by Subject|6|||
23732983|NCT02140762|66401979|FG001|Overall Study|Withdrawal by Subject|4|||
23732984|NCT02140762|66401978|FG000|Overall Study|Other|0|||
23732985|NCT02140762|66401979|FG001|Overall Study|Other|1|||
23732986|NCT00819052|66401980|FG000|Overall Study|Adverse Event|0|||
23732987|NCT00819052|66401981|FG001|Overall Study|Adverse Event|5|||
23732988|NCT00819052|66401980|FG000|Overall Study|Protocol Violation|1|||
23732989|NCT00819052|66401981|FG001|Overall Study|Protocol Violation|2|||
23732990|NCT00819052|66401980|FG000|Overall Study|Lost to Follow-up|1|||
23732991|NCT00819052|66401981|FG001|Overall Study|Lost to Follow-up|2|||
23732992|NCT00819052|66401980|FG000|Overall Study|Withdrawal by Subject|1|||
23732993|NCT00819052|66401981|FG001|Overall Study|Withdrawal by Subject|2|||
23732994|NCT00819052|66401980|FG000|Overall Study|Lack of Efficacy|1|||
23732995|NCT00819052|66401981|FG001|Overall Study|Lack of Efficacy|1|||
23617993|NCT02660034|65988169|FG007|Overall Study|Withdrawal by Subject|1|||
23732996|NCT00819052|66401980|FG000|Overall Study|Pregnancy|1|||
23732997|NCT00819052|66401981|FG001|Overall Study|Pregnancy|2|||
23732998|NCT00819052|66401980|FG000|Overall Study|Death or events leading to death|1|||
23732999|NCT00819052|66401981|FG001|Overall Study|Death or events leading to death|0|||
23733000|NCT03030261|66401982|FG000|Overall Study|Still receiving continuation therapy|5|||
23733001|NCT01058395|66401983|FG000|Overall Study|Death|2|||
23733002|NCT01058395|66401984|FG001|Overall Study|Death|1|||
23733003|NCT01058395|66401983|FG000|Overall Study|Lost to Follow-up|1|||
23733004|NCT01058395|66401984|FG001|Overall Study|Lost to Follow-up|0|||
23733005|NCT00715949|66402001|FG000|Overall Study|could not finish first test|4|||
23733006|NCT02850276|66402005|FG000|Overall Study|screen failure|43|||
23733007|NCT02850276|66402005|FG000|Overall Study|Withdrawal by Subject|14|||
23733008|NCT02850276|66402005|FG000|Overall Study|Physician Decision|2|||
23733009|NCT02850276|66402005|FG000|Overall Study|Lost to Follow-up|2|||
23733010|NCT00113555|66402006|FG000|Overall Study|Baseline Failure|59|||
23733011|NCT00113555|66402006|FG000|Overall Study|Permanently Explanted|7|||
23733012|NCT00113555|66402006|FG000|Overall Study|Death|1|||
23733013|NCT00113555|66402006|FG000|Overall Study|Missed Followup|4|||
23733014|NCT00113555|66402006|FG000|Overall Study|Lost to Follow-up|8|||
23733015|NCT04590963|66402008|FG000|Overall Study|Death|118|||
23733016|NCT04590963|66402009|FG001|Overall Study|Death|59|||
23733017|NCT04590963|66402008|FG000|Overall Study|Lost to Follow-up|1|||
23733018|NCT04590963|66402009|FG001|Overall Study|Lost to Follow-up|1|||
23733019|NCT04590963|66402008|FG000|Overall Study|Progressive disease|0|||
23733020|NCT04590963|66402009|FG001|Overall Study|Progressive disease|1|||
23733021|NCT04590963|66402008|FG000|Overall Study|Study terminated by sponsor|103|||
23733022|NCT04590963|66402009|FG001|Overall Study|Study terminated by sponsor|50|||
23733023|NCT04590963|66402008|FG000|Overall Study|Withdrawal by Subject|15|||
23733024|NCT04590963|66402009|FG001|Overall Study|Withdrawal by Subject|8|||
23733025|NCT04590963|66402008|FG000|Overall Study|Ongoing at data cut-off|9|||
23733026|NCT04590963|66402009|FG001|Overall Study|Ongoing at data cut-off|4|||
23733027|NCT04590963|66402008|FG000|Overall Study|Screen failure|1|||
23733028|NCT04590963|66402009|FG001|Overall Study|Screen failure|0|||
23733029|NCT01495689|66402011|FG000|Overall Study|Death|0|||
23733030|NCT01495689|66402012|FG001|Overall Study|Death|1|||
23733031|NCT01495689|66402011|FG000|Overall Study|Withdrawal by Subject|3|||
23733032|NCT01495689|66402012|FG001|Overall Study|Withdrawal by Subject|0|||
23733033|NCT01495689|66402011|FG000|Overall Study|Lost to Follow-up|7|||
23733034|NCT01495689|66402012|FG001|Overall Study|Lost to Follow-up|6|||
23733035|NCT01021293|66402013|FG000|Overall Study|Serious Adverse Event|2|||
23733036|NCT01021293|66402014|FG001|Overall Study|Serious Adverse Event|1|||
23733037|NCT01021293|66402013|FG000|Overall Study|Adverse Event|2|||
23733038|NCT01021293|66402014|FG001|Overall Study|Adverse Event|1|||
23733039|NCT01021293|66402013|FG000|Overall Study|Withdrawal by Subject|1|||
23733040|NCT01021293|66402014|FG001|Overall Study|Withdrawal by Subject|3|||
23733041|NCT01021293|66402013|FG000|Overall Study|Migrated/moved from study area|6|||
23733042|NCT01021293|66402014|FG001|Overall Study|Migrated/moved from study area|18|||
23733043|NCT01021293|66402013|FG000|Overall Study|Lost to Follow-up|1|||
23733044|NCT01021293|66402014|FG001|Overall Study|Lost to Follow-up|1|||
23733045|NCT01241318|66402015|FG000|Overall Study|Woman: false pregnancies|27|||
23733046|NCT01241318|66402016|FG001|Overall Study|Woman: false pregnancies|15|||
23733047|NCT01241318|66402015|FG000|Overall Study|Woman: miscarriage/abortion|46|||
23733048|NCT01241318|66402016|FG001|Overall Study|Woman: miscarriage/abortion|38|||
23733049|NCT01241318|66402015|FG000|Overall Study|Withdrawal by Subject|175|||
23733050|NCT01241318|66402016|FG001|Overall Study|Withdrawal by Subject|46|||
23733051|NCT01241318|66402015|FG000|Overall Study|Lost to Follow-up|740|||
23733052|NCT01241318|66402016|FG001|Overall Study|Lost to Follow-up|455|||
23733053|NCT01241318|66402015|FG000|Overall Study|Death|2|||
23733054|NCT01241318|66402016|FG001|Overall Study|Death|4|||
23733055|NCT01241318|66402015|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
23733056|NCT01241318|66402016|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
23733057|NCT01241318|66402015|FG000|Overall Study|Woman: Stillborn infant|129|||
23733058|NCT01241318|66402016|FG001|Overall Study|Woman: Stillborn infant|146|||
23818803|NCT03893565|66714447|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818804|NCT03893565|66714448|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818805|NCT03893565|66714449|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
23818806|NCT03893565|66714450|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23818807|NCT03893565|66714442|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818808|NCT03893565|66714443|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818809|NCT03893565|66714444|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818810|NCT03893565|66714445|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818811|NCT03893565|66714446|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818812|NCT03893565|66714447|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818813|NCT03893565|66714448|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818814|NCT03893565|66714449|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
23818815|NCT03893565|66714450|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23818816|NCT03893565|66714442|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23617994|NCT02660034|65988170|FG008|Overall Study|Withdrawal by Subject|1|||
23617995|NCT02660034|65988171|FG009|Overall Study|Withdrawal by Subject|0|||
23617996|NCT02660034|65988172|FG010|Overall Study|Withdrawal by Subject|0|||
23617997|NCT02660034|65988173|FG011|Overall Study|Withdrawal by Subject|1|||
23617998|NCT02660034|65988174|FG012|Overall Study|Withdrawal by Subject|2|||
23617999|NCT02660034|65988175|FG013|Overall Study|Withdrawal by Subject|0|||
23618000|NCT02660034|65988162|FG000|Overall Study|Death|0|||
23618001|NCT02660034|65988163|FG001|Overall Study|Death|0|||
23618002|NCT02660034|65988164|FG002|Overall Study|Death|0|||
23618003|NCT02660034|65988165|FG003|Overall Study|Death|0|||
23618004|NCT02660034|65988166|FG004|Overall Study|Death|0|||
23618005|NCT02660034|65988167|FG005|Overall Study|Death|13|||
23818817|NCT03893565|66714443|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23818818|NCT03893565|66714444|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23544939|NCT01613248|65727005|FG000|Overall Study|Withdrawal by Subject|3|||
23544940|NCT01613248|65727006|FG001|Overall Study|Withdrawal by Subject|2|||
23544941|NCT01613248|65727007|FG002|Overall Study|Withdrawal by Subject|2|||
23544942|NCT01613248|65727008|FG003|Overall Study|Withdrawal by Subject|5|||
23544943|NCT01613248|65727009|FG004|Overall Study|Withdrawal by Subject|0|||
23544944|NCT01613248|65727010|FG005|Overall Study|Withdrawal by Subject|1|||
23544945|NCT01613248|65727005|FG000|Overall Study|Lost to Follow-up|5|||
23544946|NCT01613248|65727006|FG001|Overall Study|Lost to Follow-up|7|||
23544947|NCT01613248|65727007|FG002|Overall Study|Lost to Follow-up|4|||
23544948|NCT01613248|65727008|FG003|Overall Study|Lost to Follow-up|8|||
23544949|NCT01613248|65727009|FG004|Overall Study|Lost to Follow-up|4|||
23544950|NCT01613248|65727010|FG005|Overall Study|Lost to Follow-up|2|||
23544951|NCT01613248|65727005|FG000|Overall Study|Study Terminated by Sponsor|4|||
23544952|NCT01613248|65727006|FG001|Overall Study|Study Terminated by Sponsor|6|||
23544953|NCT01613248|65727007|FG002|Overall Study|Study Terminated by Sponsor|8|||
23544954|NCT01613248|65727008|FG003|Overall Study|Study Terminated by Sponsor|8|||
23544955|NCT01613248|65727009|FG004|Overall Study|Study Terminated by Sponsor|9|||
23544956|NCT01613248|65727010|FG005|Overall Study|Study Terminated by Sponsor|11|||
23544957|NCT01613248|65727005|FG000|Overall Study|Physician Decision|8|||
23544958|NCT01613248|65727006|FG001|Overall Study|Physician Decision|8|||
23618006|NCT02660034|65988168|FG006|Overall Study|Death|14|||
23618007|NCT02660034|65988169|FG007|Overall Study|Death|10|||
23618008|NCT02660034|65988170|FG008|Overall Study|Death|9|||
23618009|NCT02660034|65988171|FG009|Overall Study|Death|21|||
23818819|NCT03893565|66714445|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23818820|NCT03893565|66714446|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23818821|NCT03893565|66714447|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23818822|NCT03893565|66714448|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23818823|NCT03893565|66714449|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23426413|NCT00996801|65303653|FG000|Overall Study|Lost to Follow-up|0|||
23544959|NCT01613248|65727007|FG002|Overall Study|Physician Decision|9|||
23544960|NCT01613248|65727008|FG003|Overall Study|Physician Decision|4|||
23618010|NCT02660034|65988172|FG010|Overall Study|Death|17|||
23618011|NCT02660034|65988173|FG011|Overall Study|Death|15|||
23618012|NCT02660034|65988174|FG012|Overall Study|Death|18|||
23618013|NCT02660034|65988175|FG013|Overall Study|Death|7|||
23618014|NCT02660034|65988162|FG000|Overall Study|Physician Decision|0|||
23618015|NCT02660034|65988163|FG001|Overall Study|Physician Decision|0|||
23818824|NCT03893565|66714450|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
23818825|NCT01893346|66714453|FG000|Overall Study|Lost to Follow-up|0|||
23544961|NCT01613248|65727009|FG004|Overall Study|Physician Decision|7|||
23618016|NCT02660034|65988164|FG002|Overall Study|Physician Decision|0|||
23618017|NCT02660034|65988165|FG003|Overall Study|Physician Decision|0|||
23618018|NCT02660034|65988166|FG004|Overall Study|Physician Decision|0|||
23618019|NCT02660034|65988167|FG005|Overall Study|Physician Decision|0|||
23618020|NCT02660034|65988168|FG006|Overall Study|Physician Decision|0|||
23618021|NCT02660034|65988169|FG007|Overall Study|Physician Decision|0|||
23618022|NCT02660034|65988170|FG008|Overall Study|Physician Decision|0|||
23618023|NCT02660034|65988171|FG009|Overall Study|Physician Decision|0|||
23618024|NCT02660034|65988172|FG010|Overall Study|Physician Decision|0|||
23618025|NCT02660034|65988173|FG011|Overall Study|Physician Decision|0|||
23618026|NCT02660034|65988174|FG012|Overall Study|Physician Decision|0|||
23618027|NCT02660034|65988175|FG013|Overall Study|Physician Decision|1|||
23618028|NCT02660034|65988162|FG000|Overall Study|Participants transferred to LTE|0|||
23618029|NCT02660034|65988163|FG001|Overall Study|Participants transferred to LTE|0|||
23618030|NCT02660034|65988164|FG002|Overall Study|Participants transferred to LTE|0|||
23618031|NCT02660034|65988165|FG003|Overall Study|Participants transferred to LTE|0|||
23618032|NCT02660034|65988166|FG004|Overall Study|Participants transferred to LTE|0|||
23618033|NCT02660034|65988167|FG005|Overall Study|Participants transferred to LTE|10|||
23618034|NCT02660034|65988168|FG006|Overall Study|Participants transferred to LTE|8|||
23618035|NCT02660034|65988169|FG007|Overall Study|Participants transferred to LTE|8|||
23618036|NCT02660034|65988170|FG008|Overall Study|Participants transferred to LTE|10|||
23618037|NCT02660034|65988171|FG009|Overall Study|Participants transferred to LTE|1|||
23618038|NCT02660034|65988172|FG010|Overall Study|Participants transferred to LTE|2|||
23618039|NCT02660034|65988173|FG011|Overall Study|Participants transferred to LTE|4|||
23618040|NCT02660034|65988174|FG012|Overall Study|Participants transferred to LTE|1|||
23618041|NCT02660034|65988175|FG013|Overall Study|Participants transferred to LTE|1|||
23733059|NCT05466240|66402018|FG000|Overall Study|Adverse Event|1|||
23733060|NCT05466240|66402019|FG001|Overall Study|Adverse Event|0|||
23733061|NCT05466240|66402018|FG000|Overall Study|Withdrawal by Subject|1|||
23733062|NCT05466240|66402019|FG001|Overall Study|Withdrawal by Subject|0|||
23733063|NCT00783263|66402020|FG000|Overall Study|Adverse Event|3|||
23733064|NCT00783263|66402021|FG001|Overall Study|Adverse Event|0|||
23733065|NCT00783263|66402022|FG002|Overall Study|Adverse Event|2|||
23733066|NCT00783263|66402023|FG003|Overall Study|Adverse Event|1|||
23733067|NCT00783263|66402020|FG000|Overall Study|Lost to Follow-up|1|||
23733068|NCT00783263|66402021|FG001|Overall Study|Lost to Follow-up|1|||
23733069|NCT00783263|66402022|FG002|Overall Study|Lost to Follow-up|0|||
23733070|NCT00783263|66402023|FG003|Overall Study|Lost to Follow-up|0|||
23733071|NCT00783263|66402020|FG000|Overall Study|Withdrawal by Subject|0|||
23733072|NCT00783263|66402021|FG001|Overall Study|Withdrawal by Subject|1|||
23733073|NCT00783263|66402022|FG002|Overall Study|Withdrawal by Subject|1|||
23733074|NCT00783263|66402023|FG003|Overall Study|Withdrawal by Subject|2|||
23733075|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23733076|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23733077|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23733078|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
23733079|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
23733080|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
23733081|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
23733082|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
23733083|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Death|0|||
23733084|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Death|0|||
23733085|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Death|0|||
23733086|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Death|1|||
23733087|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Death|1|||
23733088|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Death|0|||
23733089|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Death|2|||
23733090|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Death|0|||
23733091|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733092|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733093|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733094|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
23733095|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733096|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733097|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733098|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23733099|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23733100|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23618042|NCT02081196|65988176|FG000|Overall Study|Lost to Follow-up|1|||
23618043|NCT03220776|65988177|FG000|Overall Study|Claustrophobia|0|||
23618044|NCT03220776|65988178|FG001|Overall Study|Claustrophobia|1|||
23618045|NCT03220776|65988179|FG002|Overall Study|Claustrophobia|1|||
23733101|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23733102|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
23733103|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23818826|NCT01893346|66714454|FG001|Overall Study|Lost to Follow-up|1|||
23618046|NCT03220776|65988180|FG003|Overall Study|Claustrophobia|0|||
23618047|NCT03220776|65988181|FG004|Overall Study|Claustrophobia|1|||
23618048|NCT03220776|65988182|FG005|Overall Study|Claustrophobia|0|||
23618049|NCT03220776|65988177|FG000|Overall Study|MRI Equipment Failure|1|||
23618050|NCT03220776|65988178|FG001|Overall Study|MRI Equipment Failure|0|||
23618051|NCT03220776|65988179|FG002|Overall Study|MRI Equipment Failure|0|||
23618052|NCT03220776|65988180|FG003|Overall Study|MRI Equipment Failure|0|||
23618053|NCT03220776|65988181|FG004|Overall Study|MRI Equipment Failure|0|||
23618054|NCT03220776|65988182|FG005|Overall Study|MRI Equipment Failure|0|||
23618055|NCT03220776|65988177|FG000|Overall Study|Inclimate Weather|0|||
23618056|NCT03220776|65988178|FG001|Overall Study|Inclimate Weather|0|||
23618057|NCT03220776|65988179|FG002|Overall Study|Inclimate Weather|0|||
23618058|NCT03220776|65988180|FG003|Overall Study|Inclimate Weather|0|||
23618059|NCT03220776|65988181|FG004|Overall Study|Inclimate Weather|0|||
23618060|NCT03220776|65988182|FG005|Overall Study|Inclimate Weather|1|||
23618061|NCT03220776|65988177|FG000|Overall Study|Physician Decision|0|||
23618062|NCT03220776|65988178|FG001|Overall Study|Physician Decision|0|||
23618063|NCT03220776|65988179|FG002|Overall Study|Physician Decision|0|||
23618064|NCT03220776|65988180|FG003|Overall Study|Physician Decision|1|||
23618065|NCT03220776|65988181|FG004|Overall Study|Physician Decision|0|||
23618066|NCT03220776|65988182|FG005|Overall Study|Physician Decision|0|||
23618067|NCT03220776|65988177|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618068|NCT03220776|65988178|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618069|NCT03220776|65988179|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618070|NCT03220776|65988180|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
23618071|NCT03220776|65988181|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618072|NCT03220776|65988182|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618073|NCT03220776|65988177|FG000|Overall Study|Protocol Violation|0|||
23618074|NCT03220776|65988178|FG001|Overall Study|Protocol Violation|0|||
23618075|NCT03220776|65988179|FG002|Overall Study|Protocol Violation|0|||
23618076|NCT03220776|65988180|FG003|Overall Study|Protocol Violation|2|||
23618077|NCT03220776|65988181|FG004|Overall Study|Protocol Violation|0|||
23618078|NCT03220776|65988182|FG005|Overall Study|Protocol Violation|1|||
23618079|NCT03220776|65988177|FG000|Overall Study|Withdrawal by Subject|1|||
23618080|NCT03220776|65988178|FG001|Overall Study|Withdrawal by Subject|0|||
23618081|NCT03220776|65988179|FG002|Overall Study|Withdrawal by Subject|0|||
23618082|NCT03220776|65988180|FG003|Overall Study|Withdrawal by Subject|0|||
23618083|NCT03220776|65988181|FG004|Overall Study|Withdrawal by Subject|0|||
23618084|NCT03220776|65988182|FG005|Overall Study|Withdrawal by Subject|0|||
23618085|NCT02261285|65988183|FG000|Overall Study|Disease progression|0|||
23618086|NCT02261285|65988184|FG001|Overall Study|Disease progression|0|||
23618087|NCT02261285|65988185|FG002|Overall Study|Disease progression|1|||
23618088|NCT00489489|65988188|FG000|Overall Study|Not treated due to protocol violation|0|||
23618089|NCT00489489|65988189|FG001|Overall Study|Not treated due to protocol violation|1|||
23618090|NCT00489489|65988190|FG002|Overall Study|Not treated due to protocol violation|1|||
23618091|NCT00489489|65988188|FG000|Overall Study|Adverse Event|1|||
23618092|NCT00489489|65988189|FG001|Overall Study|Adverse Event|1|||
23618093|NCT00489489|65988190|FG002|Overall Study|Adverse Event|1|||
23618094|NCT00489489|65988188|FG000|Overall Study|Protocol Violation|1|||
23618095|NCT00489489|65988189|FG001|Overall Study|Protocol Violation|0|||
23618096|NCT00489489|65988190|FG002|Overall Study|Protocol Violation|1|||
23618097|NCT00489489|65988188|FG000|Overall Study|Progressive disease|0|||
23618098|NCT00489489|65988189|FG001|Overall Study|Progressive disease|1|||
23618099|NCT00489489|65988190|FG002|Overall Study|Progressive disease|0|||
23618100|NCT00489489|65988188|FG000|Overall Study|Participant did not wish to continue|1|||
23618101|NCT00489489|65988189|FG001|Overall Study|Participant did not wish to continue|1|||
23618102|NCT00489489|65988190|FG002|Overall Study|Participant did not wish to continue|0|||
23618103|NCT00489489|65988188|FG000|Overall Study|Other than above|0|||
23618104|NCT00489489|65988189|FG001|Overall Study|Other than above|1|||
23618105|NCT00489489|65988190|FG002|Overall Study|Other than above|0|||
23618106|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
23618107|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
23618108|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
23618109|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
23618110|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
23426414|NCT00996801|65303654|FG001|Overall Study|Lost to Follow-up|0|||
23618111|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
23618112|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
23618113|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
23618114|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
23618115|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
23618116|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
23618117|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
23818827|NCT01893346|66714455|FG002|Overall Study|Lost to Follow-up|0|||
23618118|NCT01020487|65988191|FG000|Part 2 Open-label Period|Adverse Event|0|||
23618119|NCT01020487|65988192|FG001|Part 2 Open-label Period|Adverse Event|4|||
23618120|NCT01020487|65988193|FG002|Part 2 Open-label Period|Adverse Event|1|||
23618121|NCT03746483|65988194|FG000|Overall Study|Adverse Event|0|||
23733104|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23733105|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23733106|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23733107|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23733108|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23733109|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23733110|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
23733111|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23782255|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23818828|NCT01893346|66714456|FG003|Overall Study|Lost to Follow-up|0|||
23818829|NCT01893346|66714453|FG000|Overall Study|Protocol Violation|1|||
23618122|NCT03746483|65988195|FG001|Overall Study|Adverse Event|1|||
23618123|NCT03746483|65988194|FG000|Overall Study|Lack of Efficacy|3|||
23618124|NCT03746483|65988195|FG001|Overall Study|Lack of Efficacy|2|||
23618125|NCT03746483|65988194|FG000|Overall Study|Lost to Follow-up|1|||
23618126|NCT03746483|65988195|FG001|Overall Study|Lost to Follow-up|0|||
23618127|NCT03746483|65988194|FG000|Overall Study|Protocol Violation|2|||
23618128|NCT03746483|65988195|FG001|Overall Study|Protocol Violation|0|||
23618129|NCT00577096|65988200|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
23618130|NCT00577096|65988201|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
23618131|NCT00577096|65988200|FG000|Short Term Participation|Withdrawal by Subject|3|||
23618132|NCT00577096|65988201|FG001|Short Term Participation|Withdrawal by Subject|5|||
23618133|NCT00577096|65988200|FG000|Short Term Participation|Death|1|||
23618134|NCT00577096|65988201|FG001|Short Term Participation|Death|1|||
23618135|NCT03168425|65988202|FG000|Overall Study|Lost to Follow-up|5|||
23618136|NCT03168425|65988203|FG001|Overall Study|Lost to Follow-up|8|||
23618137|NCT03168425|65988202|FG000|Overall Study|unable to confirm post op opioids|2|||
23618138|NCT03168425|65988203|FG001|Overall Study|unable to confirm post op opioids|3|||
23618139|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
23618140|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
23618141|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618142|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618143|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618144|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Death|1|||
23618145|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Death|0|||
23618146|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Death|0|||
23618147|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Death|0|||
23618148|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Death|0|||
23618149|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618150|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
23618151|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618152|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618153|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618154|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618155|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
23618156|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618157|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618158|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618159|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
23618160|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
23618161|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
23618162|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
23618163|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
23618164|NCT03974100|65988204|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618165|NCT03974100|65988205|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618166|NCT03974100|65988206|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618167|NCT03974100|65988207|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
23618168|NCT03974100|65988208|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618169|NCT03974100|65988204|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
23618170|NCT03974100|65988205|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
23618171|NCT03974100|65988206|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
23818830|NCT01893346|66714454|FG001|Overall Study|Protocol Violation|0|||
23818831|NCT01893346|66714455|FG002|Overall Study|Protocol Violation|0|||
23818832|NCT01893346|66714456|FG003|Overall Study|Protocol Violation|0|||
23618172|NCT03974100|65988207|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
23618173|NCT03974100|65988208|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
23618174|NCT00069277|65988209|FG000|Overall Study|Adverse Event|3|||
23618175|NCT00069277|65988209|FG000|Overall Study|Withdrawal by Subject|1|||
23618176|NCT00069277|65988209|FG000|Overall Study|Progressive Disease|15|||
23618177|NCT00069277|65988209|FG000|Overall Study|Physician Decision|2|||
23618178|NCT02030847|65988214|FG000|Overall Study|Death|10|||
23618179|NCT02030847|65988214|FG000|Overall Study|Disease Progression|15|||
23618180|NCT02030847|65988214|FG000|Overall Study|New Cancer Therapy|8|||
23618181|NCT02030847|65988214|FG000|Overall Study|Physician Decision|3|||
23618182|NCT02030847|65988214|FG000|Overall Study|Withdrawal by Subject|1|||
23618183|NCT00627523|65988217|FG000|Overall Study|Lack of Efficacy|1|||
23618184|NCT00627523|65988218|FG001|Overall Study|Lack of Efficacy|0|||
23618185|NCT00627523|65988217|FG000|Overall Study|Withdrawal by Subject|0|||
23618186|NCT00627523|65988218|FG001|Overall Study|Withdrawal by Subject|2|||
23618187|NCT00627523|65988217|FG000|Overall Study|Other|1|||
23618188|NCT00627523|65988218|FG001|Overall Study|Other|0|||
23618189|NCT03635775|65988219|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618190|NCT03635775|65988220|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618191|NCT03635775|65988221|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618192|NCT03635775|65988222|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
23618193|NCT01123642|65988224|FG000|Overall Study|Lost to Follow-up|23|||
23733112|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
23733113|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23733114|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
23733115|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23733116|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23544962|NCT01613248|65727010|FG005|Overall Study|Physician Decision|6|||
23544963|NCT01613248|65727005|FG000|Overall Study|Lack of Qualifying Event|9|||
23733117|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23733118|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
23733119|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23733120|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
23733121|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
23733122|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23733123|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23733124|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23733125|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23733126|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23733127|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
23733128|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23733129|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
23733130|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
23733131|NCT02442765|66402024|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23733132|NCT02442765|66402025|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23733133|NCT02442765|66402026|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23544964|NCT01613248|65727006|FG001|Overall Study|Lack of Qualifying Event|11|||
23544965|NCT01613248|65727007|FG002|Overall Study|Lack of Qualifying Event|10|||
23544966|NCT01613248|65727008|FG003|Overall Study|Lack of Qualifying Event|11|||
23544967|NCT01613248|65727009|FG004|Overall Study|Lack of Qualifying Event|15|||
23544968|NCT01613248|65727010|FG005|Overall Study|Lack of Qualifying Event|18|||
23544969|NCT01613248|65727005|FG000|Overall Study|Pregnancy|0|||
23544970|NCT01613248|65727006|FG001|Overall Study|Pregnancy|0|||
23544971|NCT01613248|65727007|FG002|Overall Study|Pregnancy|0|||
23544972|NCT01613248|65727008|FG003|Overall Study|Pregnancy|1|||
23544973|NCT01613248|65727009|FG004|Overall Study|Pregnancy|0|||
23544974|NCT01613248|65727010|FG005|Overall Study|Pregnancy|0|||
23544975|NCT04955639|65727012|FG000|Overall Study|Withdrawal by Subject|2|||
23544976|NCT04955639|65727013|FG001|Overall Study|Withdrawal by Subject|2|||
23544977|NCT04955639|65727012|FG000|Overall Study|Week 26 survey not completed|2|||
23544978|NCT04955639|65727013|FG001|Overall Study|Week 26 survey not completed|2|||
23544979|NCT03321981|65727016|FG000|Overall Study|Progressive Disease (PD)|15|||
23544980|NCT03321981|65727017|FG001|Overall Study|Progressive Disease (PD)|30|||
23544981|NCT03321981|65727018|FG002|Overall Study|Progressive Disease (PD)|47|||
23544982|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
23544983|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
23544984|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
23544985|NCT03321981|65727016|FG000|Overall Study|Adverse Event|0|||
23544986|NCT03321981|65727017|FG001|Overall Study|Adverse Event|0|||
23544987|NCT03321981|65727018|FG002|Overall Study|Adverse Event|2|||
23544988|NCT03321981|65727016|FG000|Overall Study|symptomatic deterioration|0|||
23544989|NCT03321981|65727017|FG001|Overall Study|symptomatic deterioration|1|||
23544990|NCT03321981|65727018|FG002|Overall Study|symptomatic deterioration|1|||
23618194|NCT01123642|65988224|FG000|Overall Study|Withdrawal by Subject|9|||
23426415|NCT00996801|65303655|FG002|Overall Study|Lost to Follow-up|0|||
23544991|NCT03321981|65727016|FG000|Overall Study|Lack of compliance|0|||
23544992|NCT03321981|65727017|FG001|Overall Study|Lack of compliance|1|||
23544993|NCT03321981|65727018|FG002|Overall Study|Lack of compliance|0|||
23818833|NCT01893346|66714453|FG000|Overall Study|Withdrawal by Subject|2|||
23818834|NCT01893346|66714454|FG001|Overall Study|Withdrawal by Subject|0|||
23818835|NCT01893346|66714455|FG002|Overall Study|Withdrawal by Subject|0|||
23818836|NCT01893346|66714456|FG003|Overall Study|Withdrawal by Subject|0|||
23618195|NCT01123642|65988224|FG000|Overall Study|ineligible at baseline assessment|36|||
23618196|NCT01959607|65988225|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23618197|NCT01959607|65988226|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
23618198|NCT01959607|65988227|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23618199|NCT01959607|65988228|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23618200|NCT01730118|65988230|FG000|Dose Escalation|Death on study|5|||
23618201|NCT01730118|65988231|FG001|Dose Escalation|Death on study|7|||
23618202|NCT01730118|65988232|FG002|Dose Escalation|Death on study|2|||
23618203|NCT01730118|65988233|FG003|Dose Escalation|Death on study|6|||
23618204|NCT01730118|65988234|FG004|Dose Escalation|Death on study|0|||
23618205|NCT01730118|65988235|FG005|Dose Escalation|Death on study|0|||
23618206|NCT01730118|65988236|FG006|Dose Escalation|Death on study|0|||
23618207|NCT01730118|65988230|FG000|Dose Escalation|Died before treatment|0|||
23618208|NCT01730118|65988231|FG001|Dose Escalation|Died before treatment|0|||
23618209|NCT01730118|65988232|FG002|Dose Escalation|Died before treatment|0|||
23618210|NCT01730118|65988233|FG003|Dose Escalation|Died before treatment|0|||
23618211|NCT01730118|65988234|FG004|Dose Escalation|Died before treatment|0|||
23618212|NCT01730118|65988235|FG005|Dose Escalation|Died before treatment|0|||
23618213|NCT01730118|65988236|FG006|Dose Escalation|Died before treatment|1|||
23618214|NCT01730118|65988230|FG000|Dose Escalation|Chose to start a different treatment|1|||
23618215|NCT01730118|65988231|FG001|Dose Escalation|Chose to start a different treatment|0|||
23618216|NCT01730118|65988232|FG002|Dose Escalation|Chose to start a different treatment|0|||
23618217|NCT01730118|65988233|FG003|Dose Escalation|Chose to start a different treatment|0|||
23618218|NCT01730118|65988234|FG004|Dose Escalation|Chose to start a different treatment|0|||
23618219|NCT01730118|65988235|FG005|Dose Escalation|Chose to start a different treatment|0|||
23618220|NCT01730118|65988236|FG006|Dose Escalation|Chose to start a different treatment|0|||
23618221|NCT01730118|65988230|FG000|Dose Escalation|Withdrawal by Subject|0|||
23618222|NCT01730118|65988231|FG001|Dose Escalation|Withdrawal by Subject|0|||
23618223|NCT01730118|65988232|FG002|Dose Escalation|Withdrawal by Subject|1|||
23618224|NCT01730118|65988233|FG003|Dose Escalation|Withdrawal by Subject|0|||
23618225|NCT01730118|65988234|FG004|Dose Escalation|Withdrawal by Subject|0|||
23618226|NCT01730118|65988235|FG005|Dose Escalation|Withdrawal by Subject|0|||
23618227|NCT01730118|65988236|FG006|Dose Escalation|Withdrawal by Subject|0|||
23618228|NCT01730118|65988230|FG000|Dose Escalation|Disease progression prior to treatment|0|||
23618229|NCT01730118|65988231|FG001|Dose Escalation|Disease progression prior to treatment|0|||
23618230|NCT01730118|65988232|FG002|Dose Escalation|Disease progression prior to treatment|0|||
23618231|NCT01730118|65988233|FG003|Dose Escalation|Disease progression prior to treatment|0|||
23618232|NCT01730118|65988234|FG004|Dose Escalation|Disease progression prior to treatment|0|||
23618233|NCT01730118|65988235|FG005|Dose Escalation|Disease progression prior to treatment|0|||
23618234|NCT01730118|65988236|FG006|Dose Escalation|Disease progression prior to treatment|1|||
23618235|NCT01730118|65988230|FG000|Dose Expansion|Death|0|||
23618236|NCT01730118|65988231|FG001|Dose Expansion|Death|0|||
23618237|NCT01730118|65988232|FG002|Dose Expansion|Death|0|||
23618238|NCT01730118|65988233|FG003|Dose Expansion|Death|0|||
23618239|NCT01730118|65988234|FG004|Dose Expansion|Death|1|||
23618240|NCT01730118|65988235|FG005|Dose Expansion|Death|0|||
23618241|NCT01730118|65988236|FG006|Dose Expansion|Death|0|||
23618242|NCT01730118|65988230|FG000|Dose Expansion|Other medical condition|0|||
23618243|NCT01730118|65988231|FG001|Dose Expansion|Other medical condition|0|||
23618244|NCT01730118|65988232|FG002|Dose Expansion|Other medical condition|0|||
23618245|NCT01730118|65988233|FG003|Dose Expansion|Other medical condition|0|||
23618246|NCT01730118|65988234|FG004|Dose Expansion|Other medical condition|1|||
23618247|NCT01730118|65988235|FG005|Dose Expansion|Other medical condition|0|||
23618248|NCT01730118|65988236|FG006|Dose Expansion|Other medical condition|0|||
23618249|NCT01730118|65988230|FG000|Dose Expansion|Withdrawal by Subject|0|||
23618250|NCT01730118|65988231|FG001|Dose Expansion|Withdrawal by Subject|0|||
23618251|NCT01730118|65988232|FG002|Dose Expansion|Withdrawal by Subject|0|||
23618252|NCT01730118|65988233|FG003|Dose Expansion|Withdrawal by Subject|0|||
23818837|NCT00811928|66714457|FG000|Overall Study|AEs and SAEs Including Death|7|||
23618253|NCT01730118|65988234|FG004|Dose Expansion|Withdrawal by Subject|1|||
23618254|NCT01730118|65988235|FG005|Dose Expansion|Withdrawal by Subject|0|||
23618255|NCT01730118|65988236|FG006|Dose Expansion|Withdrawal by Subject|0|||
23618256|NCT01730118|65988230|FG000|Dose Expansion|Disease progression|0|||
23618257|NCT01730118|65988231|FG001|Dose Expansion|Disease progression|0|||
23618258|NCT01730118|65988232|FG002|Dose Expansion|Disease progression|0|||
23618259|NCT01730118|65988233|FG003|Dose Expansion|Disease progression|0|||
23618260|NCT01730118|65988234|FG004|Dose Expansion|Disease progression|0|||
23818838|NCT00811928|66714458|FG001|Overall Study|AEs and SAEs Including Death|11|||
23818839|NCT00811928|66714457|FG000|Overall Study|Withdrawal by Subject|18|||
23818840|NCT00811928|66714458|FG001|Overall Study|Withdrawal by Subject|12|||
23733134|NCT02442765|66402027|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23733135|NCT02442765|66402028|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
23733136|NCT02442765|66402029|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23733137|NCT02442765|66402030|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23733138|NCT02442765|66402031|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
23733139|NCT03049852|66402032|FG000|Overall Study|Lost to Follow-up|0|||
23733140|NCT03049852|66402033|FG001|Overall Study|Lost to Follow-up|1|||
23733141|NCT03049852|66402034|FG002|Overall Study|Lost to Follow-up|0|||
23733142|NCT00711412|66402037|FG000|Induction Treatment|Death|2|||
23733143|NCT00711412|66402037|FG000|Induction Treatment|Adverse Event|1|||
23733144|NCT00711412|66402037|FG000|Induction Treatment|Other|1|||
23733145|NCT00711412|66402037|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
23733146|NCT00711412|66402037|FG000|Evaluated for Combination Treatment|Death|1|||
23733147|NCT00711412|66402037|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
23733148|NCT00711412|66402037|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
23733149|NCT00711412|66402037|FG000|Combination Treatment|Progressive Disease|1|||
23733150|NCT00711412|66402037|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
23733151|NCT00711412|66402037|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
23733152|NCT00711412|66402037|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
23733153|NCT00711412|66402037|FG000|Evaluation for Response and Surgery|Death|1|||
23733154|NCT00711412|66402037|FG000|Survival Follow up Until Death|Other|12|||
23733155|NCT03245840|66402038|FG000|Overall Study|Adverse Event|6|||
23733156|NCT03245840|66402039|FG001|Overall Study|Adverse Event|0|||
23733157|NCT03245840|66402038|FG000|Overall Study|Death|2|||
23733158|NCT03245840|66402039|FG001|Overall Study|Death|0|||
23733159|NCT03245840|66402038|FG000|Overall Study|Withdrawal by Subject|31|||
23733160|NCT03245840|66402039|FG001|Overall Study|Withdrawal by Subject|1|||
23733161|NCT03245840|66402038|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23733162|NCT03245840|66402039|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23733163|NCT03245840|66402038|FG000|Overall Study|Physician Decision|4|||
23733164|NCT03245840|66402039|FG001|Overall Study|Physician Decision|1|||
23733165|NCT03245840|66402038|FG000|Overall Study|Study Terminated by Sponsor|56|||
23733166|NCT03245840|66402039|FG001|Overall Study|Study Terminated by Sponsor|6|||
23733167|NCT03245840|66402038|FG000|Overall Study|Site Terminated by Sponsor|4|||
23733168|NCT03245840|66402039|FG001|Overall Study|Site Terminated by Sponsor|0|||
23733169|NCT03245840|66402038|FG000|Overall Study|Lost to Follow-up|12|||
23733170|NCT03245840|66402039|FG001|Overall Study|Lost to Follow-up|2|||
23733171|NCT03245840|66402038|FG000|Overall Study|Pregnancy|2|||
23733172|NCT03245840|66402039|FG001|Overall Study|Pregnancy|0|||
23733173|NCT03245840|66402038|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23733174|NCT03245840|66402039|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23733175|NCT03245840|66402038|FG000|Overall Study|Not treated|1|||
23733176|NCT03245840|66402039|FG001|Overall Study|Not treated|1|||
23733177|NCT01425528|66402040|FG000|Overall Study|Withdrawal by Subject|1|||
23818841|NCT00811928|66714457|FG000|Overall Study|Did Not Take Study Drug|3|||
23818842|NCT00811928|66714458|FG001|Overall Study|Did Not Take Study Drug|0|||
23733178|NCT01425528|66402041|FG001|Overall Study|Withdrawal by Subject|1|||
23733179|NCT00939094|66402043|FG000|Overall Study|Adverse Event|9|||
23733180|NCT00939094|66402044|FG001|Overall Study|Adverse Event|0|||
23733181|NCT00939094|66402043|FG000|Overall Study|Withdrawal by Subject|1|||
23733182|NCT00939094|66402044|FG001|Overall Study|Withdrawal by Subject|6|||
23733183|NCT00939094|66402043|FG000|Overall Study|Lost to Follow-up|1|||
23733184|NCT00939094|66402044|FG001|Overall Study|Lost to Follow-up|1|||
23733185|NCT00939094|66402043|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23733186|NCT00939094|66402044|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23733187|NCT00939094|66402043|FG000|Overall Study|Severe non-compliance to protocol|0|||
23733188|NCT00939094|66402044|FG001|Overall Study|Severe non-compliance to protocol|1|||
23733189|NCT00939094|66402043|FG000|Overall Study|Study stopped by sponsor|0|||
23733190|NCT00939094|66402044|FG001|Overall Study|Study stopped by sponsor|2|||
23733191|NCT00939094|66402043|FG000|Overall Study|Abnormal ECG findings|1|||
23733192|NCT00939094|66402044|FG001|Overall Study|Abnormal ECG findings|0|||
23733193|NCT00634751|66402047|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
23733194|NCT00634751|66402048|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23818843|NCT00811928|66714457|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
23818844|NCT00811928|66714458|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
23426416|NCT00996801|65303656|FG003|Overall Study|Lost to Follow-up|3|||
23733195|NCT00634751|66402049|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23733196|NCT00634751|66402050|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23818845|NCT00811928|66714457|FG000|Overall Study|Investigator Decision|2|||
23733197|NCT00634751|66402047|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23733198|NCT00634751|66402048|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
23733199|NCT00634751|66402049|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23733200|NCT00634751|66402050|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23733201|NCT00634751|66402047|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
23733202|NCT00634751|66402048|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
23733203|NCT00634751|66402049|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
23733204|NCT00634751|66402050|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
23733205|NCT02203916|66402054|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23733206|NCT02203916|66402055|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23733207|NCT02203916|66402056|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
23733208|NCT02203916|66402054|FG000|Overall Study|Major Protocol Deviation|1|||
23733209|NCT02203916|66402055|FG001|Overall Study|Major Protocol Deviation|1|||
23733210|NCT02203916|66402056|FG002|Overall Study|Major Protocol Deviation|0|||
23733211|NCT02203916|66402054|FG000|Overall Study|Lost to Follow-up|0|||
23733212|NCT02203916|66402055|FG001|Overall Study|Lost to Follow-up|1|||
23733213|NCT02203916|66402056|FG002|Overall Study|Lost to Follow-up|0|||
23733214|NCT02203916|66402054|FG000|Overall Study|Voluntary Withdrawal|3|||
23733215|NCT02203916|66402055|FG001|Overall Study|Voluntary Withdrawal|3|||
23733216|NCT02203916|66402056|FG002|Overall Study|Voluntary Withdrawal|8|||
23733217|NCT02203916|66402054|FG000|Overall Study|Lack of Efficacy|3|||
23733218|NCT02203916|66402055|FG001|Overall Study|Lack of Efficacy|0|||
23733219|NCT02203916|66402056|FG002|Overall Study|Lack of Efficacy|0|||
23733220|NCT02203916|66402054|FG000|Overall Study|Reason Not Specified|0|||
23733221|NCT02203916|66402055|FG001|Overall Study|Reason Not Specified|2|||
23733222|NCT02203916|66402056|FG002|Overall Study|Reason Not Specified|1|||
23733223|NCT01997333|66402057|FG000|Randomization and Treatment|Disease Progression|70|||
23733224|NCT01997333|66402058|FG001|Randomization and Treatment|Disease Progression|159|||
23733225|NCT01997333|66402057|FG000|Randomization and Treatment|Adverse Event|10|||
23733226|NCT01997333|66402058|FG001|Randomization and Treatment|Adverse Event|32|||
23733227|NCT01997333|66402057|FG000|Randomization and Treatment|Physician Decision|0|||
23733228|NCT01997333|66402058|FG001|Randomization and Treatment|Physician Decision|4|||
23733229|NCT01997333|66402057|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
23733230|NCT01997333|66402058|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
23733231|NCT01997333|66402057|FG000|Randomization and Treatment|Did not receive treatment|17|||
23733232|NCT01997333|66402058|FG001|Randomization and Treatment|Did not receive treatment|5|||
23733233|NCT01997333|66402057|FG000|Survival Follow up|Withdrawal by Subject|15|||
23733234|NCT01997333|66402058|FG001|Survival Follow up|Withdrawal by Subject|6|||
23733235|NCT01997333|66402057|FG000|Survival Follow up|Lost to Follow-up|0|||
23733236|NCT01997333|66402058|FG001|Survival Follow up|Lost to Follow-up|6|||
23733237|NCT01997333|66402057|FG000|Survival Follow up|Various|1|||
23733238|NCT01997333|66402058|FG001|Survival Follow up|Various|2|||
23733239|NCT01657253|66402059|FG000|Overall Study|Lost to Follow-up|6|||
23733240|NCT01657253|66402060|FG001|Overall Study|Lost to Follow-up|5|||
23733241|NCT01657253|66402059|FG000|Overall Study|Withdrawal by Subject|11|||
23733242|NCT01657253|66402060|FG001|Overall Study|Withdrawal by Subject|12|||
23733243|NCT01657253|66402059|FG000|Overall Study|Adverse Event|0|||
23733244|NCT01657253|66402060|FG001|Overall Study|Adverse Event|1|||
23733245|NCT00939341|66402067|FG000|Overall Study|Adverse Event|15|||
23733246|NCT00939341|66402067|FG000|Overall Study|Pregnancy|1|||
23733247|NCT00939341|66402067|FG000|Overall Study|Lost to Follow-up|23|||
23733248|NCT00939341|66402067|FG000|Overall Study|Withdrawal by Subject|13|||
23733249|NCT00939341|66402067|FG000|Overall Study|Protocol Violation|6|||
23733250|NCT00939341|66402067|FG000|Overall Study|Incorrect enrolment|8|||
23733251|NCT00443534|66402070|FG000|Overall Study|Lack of Efficacy|67|||
23733252|NCT00443534|66402070|FG000|Overall Study|Adverse Event|16|||
23733253|NCT00443534|66402070|FG000|Overall Study|Death|9|||
23733254|NCT00443534|66402070|FG000|Overall Study|Withdrawal by Subject|8|||
23733255|NCT00443534|66402070|FG000|Overall Study|Study Terminated by Sponsor|12|||
23733256|NCT00443534|66402070|FG000|Overall Study|Other|10|||
23733257|NCT00443534|66402070|FG000|Overall Study|Enrolled, Not Treated|1|||
23733258|NCT00631969|66402076|FG000|Overall Study|Adverse Event|3|||
23733259|NCT00631969|66402077|FG001|Overall Study|Adverse Event|1|||
23733260|NCT00631969|66402076|FG000|Overall Study|Lack of Efficacy|2|||
23733261|NCT00631969|66402077|FG001|Overall Study|Lack of Efficacy|8|||
23733262|NCT00631969|66402076|FG000|Overall Study|Lost to Follow-up|2|||
23733263|NCT00631969|66402077|FG001|Overall Study|Lost to Follow-up|1|||
23426417|NCT00996801|65303657|FG004|Overall Study|Lost to Follow-up|3|||
23733264|NCT00631969|66402076|FG000|Overall Study|Protocol Violation|1|||
23733265|NCT00631969|66402077|FG001|Overall Study|Protocol Violation|1|||
23733266|NCT00631969|66402076|FG000|Overall Study|Consent Withdrawn|5|||
23733267|NCT00631969|66402077|FG001|Overall Study|Consent Withdrawn|7|||
23733268|NCT00631969|66402076|FG000|Overall Study|Noncompliant With Study Medication|0|||
23733269|NCT00631969|66402077|FG001|Overall Study|Noncompliant With Study Medication|1|||
23733270|NCT00631969|66402076|FG000|Overall Study|No Drug Exposure|2|||
23733271|NCT00631969|66402077|FG001|Overall Study|No Drug Exposure|2|||
23733272|NCT04905563|66402078|FG000|Overall Study|Withdrawal by Subject|1|||
23733273|NCT04905563|66402079|FG001|Overall Study|Withdrawal by Subject|0|||
23733274|NCT04905563|66402078|FG000|Overall Study|Standard of care orders entered by resident|1|||
23733275|NCT04905563|66402079|FG001|Overall Study|Standard of care orders entered by resident|0|||
23733276|NCT04905563|66402078|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
23733277|NCT04905563|66402079|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
23733278|NCT04905563|66402078|FG000|Overall Study|Withdrawal by Subject|0|||
23733279|NCT04905563|66402079|FG001|Overall Study|Withdrawal by Subject|1|||
23733280|NCT03323385|66402080|FG000|Overall Study|Withdrawal by Subject|1|||
23733281|NCT03323385|66402081|FG001|Overall Study|Withdrawal by Subject|2|||
23733282|NCT03323385|66402080|FG000|Overall Study|Noncompliance|0|||
23733283|NCT03323385|66402081|FG001|Overall Study|Noncompliance|1|||
23733284|NCT00414973|66402090|FG000|Overall Study|Withdrawal by Subject|14|||
23733285|NCT00414973|66402091|FG001|Overall Study|Withdrawal by Subject|4|||
23733286|NCT00414973|66402092|FG002|Overall Study|Withdrawal by Subject|1|||
23733287|NCT00414973|66402093|FG003|Overall Study|Withdrawal by Subject|0|||
23733288|NCT00414973|66402090|FG000|Overall Study|Adverse Event|10|||
23733289|NCT00414973|66402091|FG001|Overall Study|Adverse Event|0|||
23733290|NCT00414973|66402092|FG002|Overall Study|Adverse Event|1|||
23733291|NCT00414973|66402093|FG003|Overall Study|Adverse Event|0|||
23733292|NCT00414973|66402090|FG000|Overall Study|Protocol Violation|3|||
23733293|NCT00414973|66402091|FG001|Overall Study|Protocol Violation|4|||
23733294|NCT00414973|66402092|FG002|Overall Study|Protocol Violation|0|||
23544994|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
23544995|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
23544996|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
23544997|NCT03321981|65727016|FG000|Overall Study|Death|0|||
23733295|NCT00414973|66402093|FG003|Overall Study|Protocol Violation|0|||
23733296|NCT00414973|66402090|FG000|Overall Study|Lost to Follow-up|0|||
23733297|NCT00414973|66402091|FG001|Overall Study|Lost to Follow-up|2|||
23733298|NCT00414973|66402092|FG002|Overall Study|Lost to Follow-up|0|||
23733299|NCT00414973|66402093|FG003|Overall Study|Lost to Follow-up|0|||
23733300|NCT00414973|66402090|FG000|Overall Study|Sponsor Decision|1|||
23733301|NCT00414973|66402091|FG001|Overall Study|Sponsor Decision|0|||
23733302|NCT00414973|66402092|FG002|Overall Study|Sponsor Decision|0|||
23733303|NCT00414973|66402093|FG003|Overall Study|Sponsor Decision|0|||
23733304|NCT00414973|66402090|FG000|Overall Study|Death|0|||
23733305|NCT00414973|66402091|FG001|Overall Study|Death|0|||
23733306|NCT00414973|66402092|FG002|Overall Study|Death|1|||
23733307|NCT00414973|66402093|FG003|Overall Study|Death|0|||
23733308|NCT04048876|66402094|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
23733309|NCT04048876|66402095|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
23733310|NCT04048876|66402096|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
23733311|NCT04048876|66402097|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
23733312|NCT04048876|66402094|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
23733313|NCT04048876|66402095|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
23733314|NCT04048876|66402096|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
23733315|NCT04048876|66402097|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
23733316|NCT04048876|66402094|FG000|Placebo Controlled Phase|Adverse Event|0|||
23733317|NCT04048876|66402095|FG001|Placebo Controlled Phase|Adverse Event|1|||
23426418|NCT00996801|65303658|FG005|Overall Study|Lost to Follow-up|2|||
23426419|NCT00996801|65303653|FG000|Overall Study|Physician Decision|0|||
23544998|NCT03321981|65727017|FG001|Overall Study|Death|1|||
23733318|NCT04048876|66402096|FG002|Placebo Controlled Phase|Adverse Event|0|||
23733319|NCT04048876|66402097|FG003|Placebo Controlled Phase|Adverse Event|0|||
23733320|NCT04048876|66402094|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
23733321|NCT04048876|66402095|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
23426420|NCT00996801|65303654|FG001|Overall Study|Physician Decision|0|||
23426421|NCT00996801|65303655|FG002|Overall Study|Physician Decision|0|||
23426422|NCT00996801|65303656|FG003|Overall Study|Physician Decision|1|||
23733322|NCT04048876|66402096|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
23733323|NCT04048876|66402097|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
23733324|NCT03035409|66402098|FG000|Overall Study|Adverse Event|5|||
23426423|NCT00996801|65303657|FG004|Overall Study|Physician Decision|0|||
23426424|NCT00996801|65303658|FG005|Overall Study|Physician Decision|0|||
23426425|NCT00996801|65303653|FG000|Overall Study|Progressive Disease|0|||
23426426|NCT00996801|65303654|FG001|Overall Study|Progressive Disease|1|||
23426427|NCT00996801|65303655|FG002|Overall Study|Progressive Disease|0|||
23426428|NCT00996801|65303656|FG003|Overall Study|Progressive Disease|0|||
23426429|NCT00996801|65303657|FG004|Overall Study|Progressive Disease|0|||
23426430|NCT00996801|65303658|FG005|Overall Study|Progressive Disease|0|||
23426431|NCT00996801|65303653|FG000|Overall Study|Protocol Violation|3|||
23426432|NCT00996801|65303654|FG001|Overall Study|Protocol Violation|4|||
23426433|NCT00996801|65303655|FG002|Overall Study|Protocol Violation|1|||
23426434|NCT00996801|65303656|FG003|Overall Study|Protocol Violation|2|||
23426435|NCT00996801|65303657|FG004|Overall Study|Protocol Violation|3|||
23426436|NCT00996801|65303658|FG005|Overall Study|Protocol Violation|4|||
23426437|NCT00996801|65303653|FG000|Overall Study|Study Terminated by Sponsor|0|||
23426438|NCT00996801|65303654|FG001|Overall Study|Study Terminated by Sponsor|1|||
23733325|NCT03035409|66402098|FG000|Overall Study|Death|2|||
23733326|NCT03035409|66402098|FG000|Overall Study|Withdrawal by Subject|2|||
23733327|NCT03035409|66402098|FG000|Overall Study|Non compliance|4|||
23733328|NCT03035409|66402098|FG000|Overall Study|Patient was jittery|1|||
23733329|NCT03035409|66402098|FG000|Overall Study|Did not like Questionnaire|1|||
23733330|NCT03035409|66402098|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
23733331|NCT03035409|66402098|FG000|Overall Study|Did not like taking drugs|1|||
23733332|NCT00303719|66402099|FG000|Overall Study|Not evaluable, prior therapies|0|||
23733333|NCT00303719|66402100|FG001|Overall Study|Not evaluable, prior therapies|30|||
23733334|NCT00303719|66402099|FG000|Overall Study|Lost to Follow-up|0|||
23733335|NCT00303719|66402100|FG001|Overall Study|Lost to Follow-up|7|||
23733336|NCT00444951|66402101|FG000|Overall Study|Lost to Follow-up|1|||
23733337|NCT00444951|66402102|FG001|Overall Study|Lost to Follow-up|1|||
23733338|NCT00444951|66402103|FG002|Overall Study|Lost to Follow-up|0|||
23426439|NCT00996801|65303655|FG002|Overall Study|Study Terminated by Sponsor|0|||
23426440|NCT00996801|65303656|FG003|Overall Study|Study Terminated by Sponsor|0|||
23426441|NCT00996801|65303657|FG004|Overall Study|Study Terminated by Sponsor|46|||
23426442|NCT00996801|65303658|FG005|Overall Study|Study Terminated by Sponsor|0|||
23426443|NCT00996801|65303653|FG000|Overall Study|Withdrawal by Subject|8|||
23426444|NCT00996801|65303654|FG001|Overall Study|Withdrawal by Subject|6|||
23544999|NCT03321981|65727018|FG002|Overall Study|Death|0|||
23545000|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of investigational product|0|||
23733339|NCT00444951|66402101|FG000|Overall Study|Withdrawal by Subject|4|||
23733340|NCT00444951|66402102|FG001|Overall Study|Withdrawal by Subject|5|||
23733341|NCT00444951|66402103|FG002|Overall Study|Withdrawal by Subject|3|||
23733342|NCT02060903|66402104|FG000|Overall Study|Lost to Follow-up|4|||
23733343|NCT02060903|66402105|FG001|Overall Study|Lost to Follow-up|0|||
23733344|NCT02060903|66402104|FG000|Overall Study|Withdrawal by Subject|0|||
23733345|NCT02060903|66402105|FG001|Overall Study|Withdrawal by Subject|7|||
23733346|NCT00424099|66402111|FG000|Overall Study|Adverse Event|0|||
23733347|NCT00424099|66402112|FG001|Overall Study|Adverse Event|1|||
23733348|NCT00424099|66402113|FG002|Overall Study|Adverse Event|1|||
23733349|NCT00424099|66402114|FG003|Overall Study|Adverse Event|0|||
23733350|NCT00424099|66402111|FG000|Overall Study|Death|0|||
23426445|NCT00996801|65303655|FG002|Overall Study|Withdrawal by Subject|9|||
23426446|NCT00996801|65303656|FG003|Overall Study|Withdrawal by Subject|5|||
23426447|NCT00996801|65303657|FG004|Overall Study|Withdrawal by Subject|5|||
23426448|NCT00996801|65303658|FG005|Overall Study|Withdrawal by Subject|9|||
23426449|NCT00303446|65303661|FG000|Overall Study|Withdrawal by Subject|2|||
23426450|NCT00303446|65303662|FG001|Overall Study|Withdrawal by Subject|2|||
23426451|NCT00303446|65303661|FG000|Overall Study|Death|0|||
23426452|NCT00303446|65303662|FG001|Overall Study|Death|1|||
23426453|NCT00303446|65303661|FG000|Overall Study|Physician Decision|0|||
23545001|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of investigational product|1|||
23733351|NCT00424099|66402112|FG001|Overall Study|Death|1|||
23733352|NCT00424099|66402113|FG002|Overall Study|Death|0|||
23733353|NCT00424099|66402114|FG003|Overall Study|Death|0|||
23733354|NCT00424099|66402111|FG000|Overall Study|Illness|2|||
23733355|NCT00424099|66402112|FG001|Overall Study|Illness|0|||
23733356|NCT00424099|66402113|FG002|Overall Study|Illness|1|||
23733357|NCT00424099|66402114|FG003|Overall Study|Illness|4|||
23733358|NCT00424099|66402111|FG000|Overall Study|Lost to Follow-up|0|||
23733359|NCT00424099|66402112|FG001|Overall Study|Lost to Follow-up|0|||
23733360|NCT00424099|66402113|FG002|Overall Study|Lost to Follow-up|3|||
23733361|NCT00424099|66402114|FG003|Overall Study|Lost to Follow-up|0|||
23733362|NCT00424099|66402111|FG000|Overall Study|Hospitalized|1|||
23733363|NCT00424099|66402112|FG001|Overall Study|Hospitalized|2|||
23733364|NCT00424099|66402113|FG002|Overall Study|Hospitalized|1|||
23733365|NCT00424099|66402114|FG003|Overall Study|Hospitalized|3|||
23733366|NCT00424099|66402111|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
23733367|NCT00424099|66402112|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
23733368|NCT00424099|66402113|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
23733369|NCT00424099|66402114|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
23733370|NCT00424099|66402111|FG000|Overall Study|Withdrawal by Subject|1|||
23733371|NCT00424099|66402112|FG001|Overall Study|Withdrawal by Subject|9|||
23733372|NCT00424099|66402113|FG002|Overall Study|Withdrawal by Subject|4|||
23733373|NCT00424099|66402114|FG003|Overall Study|Withdrawal by Subject|6|||
23733374|NCT00424099|66402111|FG000|Overall Study|Physician Decision|0|||
23733375|NCT00424099|66402112|FG001|Overall Study|Physician Decision|0|||
23733376|NCT00424099|66402113|FG002|Overall Study|Physician Decision|1|||
23733377|NCT00424099|66402114|FG003|Overall Study|Physician Decision|0|||
23733378|NCT00424099|66402111|FG000|Overall Study|Missing|0|||
23818846|NCT00811928|66714458|FG001|Overall Study|Investigator Decision|1|||
23818847|NCT00811928|66714457|FG000|Overall Study|Poor Compliance|2|||
23818848|NCT00811928|66714458|FG001|Overall Study|Poor Compliance|5|||
23818849|NCT02052011|66714459|FG000|Overall Study|Lost to Follow-up|3|||
23818850|NCT02052011|66714460|FG001|Overall Study|Lost to Follow-up|0|||
23818851|NCT02052011|66714459|FG000|Overall Study|Withdrawal by Subject|1|||
23818852|NCT02052011|66714460|FG001|Overall Study|Withdrawal by Subject|2|||
23818853|NCT04076059|66714461|FG000|Double Blind Phase|Progressive disease|22|||
23818854|NCT04076059|66714462|FG001|Double Blind Phase|Progressive disease|26|||
23818855|NCT04076059|66714463|FG002|Double Blind Phase|Progressive disease|0|||
23818856|NCT04076059|66714461|FG000|Double Blind Phase|Withdrawal by Subject|4|||
23818857|NCT04076059|66714462|FG001|Double Blind Phase|Withdrawal by Subject|11|||
23818858|NCT04076059|66714463|FG002|Double Blind Phase|Withdrawal by Subject|0|||
23818859|NCT04076059|66714461|FG000|Double Blind Phase|Death|1|||
23818860|NCT04076059|66714462|FG001|Double Blind Phase|Death|1|||
23818861|NCT04076059|66714463|FG002|Double Blind Phase|Death|0|||
23818862|NCT04076059|66714461|FG000|Double Blind Phase|Lost to Follow-up|1|||
23818863|NCT04076059|66714462|FG001|Double Blind Phase|Lost to Follow-up|0|||
23818864|NCT04076059|66714463|FG002|Double Blind Phase|Lost to Follow-up|0|||
23618261|NCT01730118|65988235|FG005|Dose Expansion|Disease progression|1|||
23618262|NCT01730118|65988236|FG006|Dose Expansion|Disease progression|0|||
23618263|NCT01730118|65988230|FG000|Dose Expansion|Inability to return|0|||
23618264|NCT01730118|65988231|FG001|Dose Expansion|Inability to return|0|||
23618265|NCT01730118|65988232|FG002|Dose Expansion|Inability to return|0|||
23733379|NCT00424099|66402112|FG001|Overall Study|Missing|0|||
23733380|NCT00424099|66402113|FG002|Overall Study|Missing|1|||
23733381|NCT00424099|66402114|FG003|Overall Study|Missing|0|||
23733382|NCT04474366|66402115|FG000|Overall Study|Lost to Follow-up|2|||
23733383|NCT04474366|66402116|FG001|Overall Study|Lost to Follow-up|5|||
23733384|NCT04043416|66402121|FG000|Washout|Change in health condition|0|||
23733385|NCT04043416|66402122|FG001|Washout|Change in health condition|1|||
23733386|NCT02658149|66402129|FG000|Overall Study|Physician Decision|1|||
23733387|NCT02658149|66402130|FG001|Overall Study|Physician Decision|0|||
23733388|NCT05013385|66402131|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
23733389|NCT00089505|66402133|FG000|Overall Study|Death|4|||
23733390|NCT00089505|66402134|FG001|Overall Study|Death|1|||
23733391|NCT00089505|66402135|FG002|Overall Study|Death|5|||
23733392|NCT00089505|66402136|FG003|Overall Study|Death|8|||
23733393|NCT00089505|66402133|FG000|Overall Study|Withdrawal by Subject|3|||
23733394|NCT00089505|66402134|FG001|Overall Study|Withdrawal by Subject|0|||
23733395|NCT00089505|66402135|FG002|Overall Study|Withdrawal by Subject|6|||
23733396|NCT00089505|66402136|FG003|Overall Study|Withdrawal by Subject|6|||
23733397|NCT00089505|66402133|FG000|Overall Study|Lost to Follow-up|1|||
23818865|NCT04076059|66714461|FG000|Double Blind Phase|Adverse Event|5|||
23818866|NCT04076059|66714462|FG001|Double Blind Phase|Adverse Event|1|||
23818867|NCT04076059|66714463|FG002|Double Blind Phase|Adverse Event|0|||
23618266|NCT01730118|65988233|FG003|Dose Expansion|Inability to return|0|||
23733398|NCT00089505|66402134|FG001|Overall Study|Lost to Follow-up|1|||
23733399|NCT00089505|66402135|FG002|Overall Study|Lost to Follow-up|9|||
23733400|NCT00089505|66402136|FG003|Overall Study|Lost to Follow-up|7|||
23733401|NCT00089505|66402133|FG000|Overall Study|Physician Decision|1|||
23818868|NCT04076059|66714461|FG000|Double Blind Phase|Ongoing Participants|82|||
23733402|NCT00089505|66402134|FG001|Overall Study|Physician Decision|0|||
23733403|NCT00089505|66402135|FG002|Overall Study|Physician Decision|0|||
23733404|NCT00089505|66402136|FG003|Overall Study|Physician Decision|0|||
23733405|NCT00089505|66402133|FG000|Overall Study|Protocol Violation|0|||
23733406|NCT00089505|66402134|FG001|Overall Study|Protocol Violation|0|||
23733407|NCT00089505|66402135|FG002|Overall Study|Protocol Violation|1|||
23733408|NCT00089505|66402136|FG003|Overall Study|Protocol Violation|0|||
23733409|NCT00606931|66402137|FG000|Overall Study|Withdrawal by Subject|3|||
23733410|NCT03322540|66402138|FG000|Overall Study|Death|21|||
23733411|NCT03322540|66402139|FG001|Overall Study|Death|28|||
23733412|NCT03322540|66402138|FG000|Overall Study|Lost to Follow-up|0|||
23733413|NCT03322540|66402139|FG001|Overall Study|Lost to Follow-up|1|||
23733414|NCT03322540|66402138|FG000|Overall Study|Physician Decision|7|||
23733415|NCT03322540|66402139|FG001|Overall Study|Physician Decision|6|||
23733416|NCT03322540|66402138|FG000|Overall Study|Withdrawal by Subject|3|||
23733417|NCT03322540|66402139|FG001|Overall Study|Withdrawal by Subject|1|||
23733418|NCT03322540|66402138|FG000|Overall Study|Study terminated by sponsor|0|||
23733419|NCT03322540|66402139|FG001|Overall Study|Study terminated by sponsor|1|||
23733420|NCT02405091|66402149|FG000|Overall Study|Adverse Event|16|||
23733421|NCT02405091|66402150|FG001|Overall Study|Adverse Event|10|||
23733422|NCT02405091|66402151|FG002|Overall Study|Adverse Event|0|||
23733423|NCT02405091|66402149|FG000|Overall Study|Protocol Violation|1|||
23733424|NCT02405091|66402150|FG001|Overall Study|Protocol Violation|0|||
23733425|NCT02405091|66402151|FG002|Overall Study|Protocol Violation|0|||
23733426|NCT02405091|66402149|FG000|Overall Study|Noncompliance|1|||
23733427|NCT02405091|66402150|FG001|Overall Study|Noncompliance|6|||
23733428|NCT02405091|66402151|FG002|Overall Study|Noncompliance|2|||
23733429|NCT02405091|66402149|FG000|Overall Study|Withdrawal by Subject|4|||
23733430|NCT02405091|66402150|FG001|Overall Study|Withdrawal by Subject|8|||
23733431|NCT02405091|66402151|FG002|Overall Study|Withdrawal by Subject|0|||
23733432|NCT02405091|66402149|FG000|Overall Study|Death|0|||
23733433|NCT02405091|66402150|FG001|Overall Study|Death|1|||
23733434|NCT02405091|66402151|FG002|Overall Study|Death|0|||
23733435|NCT02405091|66402149|FG000|Overall Study|Lost to Follow-up|5|||
23733436|NCT02405091|66402150|FG001|Overall Study|Lost to Follow-up|6|||
23733437|NCT02405091|66402151|FG002|Overall Study|Lost to Follow-up|0|||
23733438|NCT02405091|66402149|FG000|Overall Study|Physician Decision|2|||
23733439|NCT02405091|66402150|FG001|Overall Study|Physician Decision|2|||
23733440|NCT02405091|66402151|FG002|Overall Study|Physician Decision|0|||
23733441|NCT00736450|66402156|FG000|Overall Study|Not ABC gene eligible|19|||
23733442|NCT00736450|66402156|FG000|Overall Study|Withdrawal by Subject|5|||
23733443|NCT00736450|66402156|FG000|Overall Study|Physician Decision|1|||
23733444|NCT02828644|66402157|FG000|Overall Study|Lost to Follow-up|23|||
23733445|NCT02828644|66402158|FG001|Overall Study|Lost to Follow-up|22|||
23733446|NCT00033293|66402160|FG000|Overall Study|Death|0|||
23733447|NCT00033293|66402161|FG001|Overall Study|Death|1|||
23733448|NCT00033293|66402160|FG000|Overall Study|Lack of Efficacy|5|||
23733449|NCT00033293|66402161|FG001|Overall Study|Lack of Efficacy|8|||
23733450|NCT00033293|66402160|FG000|Overall Study|Lost to Follow-up|0|||
23733451|NCT00033293|66402161|FG001|Overall Study|Lost to Follow-up|1|||
23733452|NCT00033293|66402160|FG000|Overall Study|Physician Decision|3|||
23733453|NCT00033293|66402161|FG001|Overall Study|Physician Decision|1|||
23733454|NCT00033293|66402160|FG000|Overall Study|Withdrawal by Subject|1|||
23733455|NCT00033293|66402161|FG001|Overall Study|Withdrawal by Subject|0|||
23733456|NCT00033293|66402160|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
23733457|NCT00033293|66402161|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
23733458|NCT00033293|66402160|FG000|Overall Study|Treatment refused|0|||
23733459|NCT00033293|66402161|FG001|Overall Study|Treatment refused|6|||
23733460|NCT03480841|66402162|FG000|Overall Study|Lost to Follow-up|2|||
23733461|NCT01594749|66405514|FG000|Overall Study|Adverse Event|2|||
23733462|NCT01594749|66405515|FG001|Overall Study|Adverse Event|1|||
23733463|NCT01594749|66405514|FG000|Overall Study|Withdrawal by Subject|2|||
23733464|NCT01594749|66405515|FG001|Overall Study|Withdrawal by Subject|2|||
23733465|NCT01594749|66405514|FG000|Overall Study|Protocol Violation|2|||
23733466|NCT01594749|66405515|FG001|Overall Study|Protocol Violation|0|||
23733467|NCT01594749|66405514|FG000|Overall Study|Physician Decision|1|||
23733468|NCT01594749|66405515|FG001|Overall Study|Physician Decision|1|||
23733469|NCT01594749|66405514|FG000|Overall Study|Non-compliance with Protocol|0|||
23733470|NCT01594749|66405515|FG001|Overall Study|Non-compliance with Protocol|1|||
23618267|NCT01730118|65988234|FG004|Dose Expansion|Inability to return|0|||
23733471|NCT01594749|66405514|FG000|Overall Study|Lost to Follow-up|1|||
23733472|NCT01594749|66405515|FG001|Overall Study|Lost to Follow-up|0|||
23733473|NCT01594749|66405514|FG000|Overall Study|Death|9|||
23733474|NCT01594749|66405515|FG001|Overall Study|Death|3|||
23733475|NCT01594749|66405514|FG000|Overall Study|Not Treated|4|||
23733476|NCT01594749|66405515|FG001|Overall Study|Not Treated|10|||
23733477|NCT01594749|66405514|FG000|Overall Study|Lost Source Documentation|1|||
23733478|NCT01594749|66405515|FG001|Overall Study|Lost Source Documentation|0|||
23733479|NCT01512693|66405516|FG000|Overall Study|Withdrawal by Subject|0|||
23733480|NCT01512693|66405517|FG001|Overall Study|Withdrawal by Subject|1|||
23733481|NCT01196091|66405519|FG000|Overall Study|Adverse Event|22|||
23733482|NCT01196091|66405520|FG001|Overall Study|Adverse Event|27|||
23733483|NCT01196091|66405521|FG002|Overall Study|Adverse Event|26|||
23733484|NCT01196091|66405519|FG000|Overall Study|Death|3|||
23733485|NCT01196091|66405520|FG001|Overall Study|Death|2|||
23733486|NCT01196091|66405521|FG002|Overall Study|Death|2|||
23733487|NCT01196091|66405519|FG000|Overall Study|Entry Criteria Not Met|11|||
23733488|NCT01196091|66405520|FG001|Overall Study|Entry Criteria Not Met|11|||
23733489|NCT01196091|66405521|FG002|Overall Study|Entry Criteria Not Met|10|||
23733490|NCT01196091|66405519|FG000|Overall Study|Lack of Efficacy|15|||
23733491|NCT01196091|66405520|FG001|Overall Study|Lack of Efficacy|12|||
23733492|NCT01196091|66405521|FG002|Overall Study|Lack of Efficacy|17|||
23733493|NCT01196091|66405519|FG000|Overall Study|Lost to Follow-up|5|||
23733494|NCT01196091|66405520|FG001|Overall Study|Lost to Follow-up|5|||
23733495|NCT01196091|66405521|FG002|Overall Study|Lost to Follow-up|6|||
23733496|NCT01196091|66405519|FG000|Overall Study|Parent/Caregiver Decision|0|||
23733497|NCT01196091|66405520|FG001|Overall Study|Parent/Caregiver Decision|0|||
23733498|NCT01196091|66405521|FG002|Overall Study|Parent/Caregiver Decision|1|||
23733499|NCT01196091|66405519|FG000|Overall Study|Withdrawal by Subject|16|||
23733500|NCT01196091|66405520|FG001|Overall Study|Withdrawal by Subject|19|||
23733501|NCT01196091|66405521|FG002|Overall Study|Withdrawal by Subject|22|||
23733502|NCT01196091|66405519|FG000|Overall Study|Physician Decision|3|||
23733503|NCT01196091|66405520|FG001|Overall Study|Physician Decision|3|||
23733504|NCT01196091|66405521|FG002|Overall Study|Physician Decision|4|||
23733505|NCT01196091|66405519|FG000|Overall Study|Protocol Violation|1|||
23733506|NCT01196091|66405520|FG001|Overall Study|Protocol Violation|3|||
23733507|NCT01196091|66405521|FG002|Overall Study|Protocol Violation|3|||
23733508|NCT01196091|66405519|FG000|Overall Study|Sponsor Decision|6|||
23733509|NCT01196091|66405520|FG001|Overall Study|Sponsor Decision|5|||
23733510|NCT01196091|66405521|FG002|Overall Study|Sponsor Decision|4|||
23733511|NCT01196091|66405519|FG000|Overall Study|Excluded Site|5|||
23733512|NCT01196091|66405520|FG001|Overall Study|Excluded Site|11|||
23733513|NCT01196091|66405521|FG002|Overall Study|Excluded Site|8|||
23733514|NCT01196091|66405519|FG000|Overall Study|Randomized, No Study Drug Received|1|||
23733515|NCT01196091|66405520|FG001|Overall Study|Randomized, No Study Drug Received|0|||
23733516|NCT01196091|66405521|FG002|Overall Study|Randomized, No Study Drug Received|1|||
23733517|NCT03619902|66405522|FG000|Overall Study|Termination of Study by Investigator|1|||
23733518|NCT03619902|66405522|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
23733519|NCT01882439|66405528|FG000|Overall Study|Adverse event related to study drug|3|||
23733520|NCT01882439|66405529|FG001|Overall Study|Adverse event related to study drug|8|||
23733521|NCT01882439|66405530|FG002|Overall Study|Adverse event related to study drug|1|||
23818869|NCT04076059|66714462|FG001|Double Blind Phase|Ongoing Participants|18|||
23818870|NCT04076059|66714463|FG002|Double Blind Phase|Ongoing Participants|0|||
23818871|NCT04076059|66714461|FG000|Double Blind Phase|Miscellaneous|3|||
23818872|NCT04076059|66714462|FG001|Double Blind Phase|Miscellaneous|1|||
23818873|NCT04076059|66714463|FG002|Double Blind Phase|Miscellaneous|0|||
23818874|NCT04076059|66714461|FG000|Double Blind Phase|Protocol Deviation|1|||
23818875|NCT04076059|66714462|FG001|Double Blind Phase|Protocol Deviation|1|||
23818876|NCT04076059|66714463|FG002|Double Blind Phase|Protocol Deviation|0|||
23818877|NCT04076059|66714461|FG000|Double Blind Phase|Did not take study drug|1|||
23818878|NCT04076059|66714462|FG001|Double Blind Phase|Did not take study drug|1|||
23818879|NCT04076059|66714463|FG002|Double Blind Phase|Did not take study drug|0|||
23818880|NCT04076059|66714461|FG000|Open Label Phase|Progressive disease|0|||
23818881|NCT04076059|66714462|FG001|Open Label Phase|Progressive disease|0|||
23818882|NCT04076059|66714463|FG002|Open Label Phase|Progressive disease|7|||
23818883|NCT04076059|66714461|FG000|Open Label Phase|Withdrawal by Subject|0|||
23818884|NCT04076059|66714462|FG001|Open Label Phase|Withdrawal by Subject|0|||
23818885|NCT04076059|66714463|FG002|Open Label Phase|Withdrawal by Subject|3|||
23818886|NCT04076059|66714461|FG000|Open Label Phase|Death|0|||
23818887|NCT04076059|66714462|FG001|Open Label Phase|Death|0|||
23818888|NCT04076059|66714463|FG002|Open Label Phase|Death|2|||
23818889|NCT04076059|66714461|FG000|Open Label Phase|Ongoing Participants|0|||
23818890|NCT04076059|66714462|FG001|Open Label Phase|Ongoing Participants|0|||
23733522|NCT01882439|66405531|FG003|Overall Study|Adverse event related to study drug|2|||
23733523|NCT01882439|66405528|FG000|Overall Study|Pregnancy|0|||
23733524|NCT01882439|66405529|FG001|Overall Study|Pregnancy|1|||
23733525|NCT01882439|66405530|FG002|Overall Study|Pregnancy|0|||
23818891|NCT04076059|66714463|FG002|Open Label Phase|Ongoing Participants|11|||
23818892|NCT02242045|66714464|FG000|Overall Study|Investigator's Discretion|1|||
23818893|NCT02242045|66714464|FG000|Overall Study|Progressive Disease|2|||
23818894|NCT02242045|66714464|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
23733526|NCT01882439|66405531|FG003|Overall Study|Pregnancy|0|||
23733527|NCT01882439|66405528|FG000|Overall Study|Protocol Violation|2|||
23733528|NCT01882439|66405529|FG001|Overall Study|Protocol Violation|2|||
23733529|NCT01882439|66405530|FG002|Overall Study|Protocol Violation|0|||
23733530|NCT01882439|66405531|FG003|Overall Study|Protocol Violation|1|||
23733531|NCT01882439|66405528|FG000|Overall Study|No longer willing to participate|1|||
23818895|NCT02242045|66714464|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
23818896|NCT03496610|66714465|FG000|Overall Study|Lost to Follow-up|3|||
23733532|NCT01882439|66405529|FG001|Overall Study|No longer willing to participate|4|||
23733533|NCT01882439|66405530|FG002|Overall Study|No longer willing to participate|2|||
23733534|NCT01882439|66405531|FG003|Overall Study|No longer willing to participate|3|||
23426454|NCT00303446|65303662|FG001|Overall Study|Physician Decision|1|||
23426455|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426456|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23733535|NCT01882439|66405528|FG000|Overall Study|Medication error with no associated AE|0|||
23733536|NCT01882439|66405529|FG001|Overall Study|Medication error with no associated AE|0|||
23733537|NCT01882439|66405530|FG002|Overall Study|Medication error with no associated AE|2|||
23733538|NCT01882439|66405531|FG003|Overall Study|Medication error with no associated AE|0|||
23733539|NCT01882439|66405528|FG000|Overall Study|Insufficient clinical response|1|||
23733540|NCT01882439|66405529|FG001|Overall Study|Insufficient clinical response|4|||
23733541|NCT01882439|66405530|FG002|Overall Study|Insufficient clinical response|4|||
23733542|NCT01882439|66405531|FG003|Overall Study|Insufficient clinical response|2|||
23733543|NCT01882439|66405528|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23733544|NCT01882439|66405529|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23733545|NCT01882439|66405530|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23733546|NCT01882439|66405531|FG003|Overall Study|Adverse event unrelated to study drug|1|||
23733547|NCT00982111|66405534|FG000|Overall Study|Adverse Event|1|||
23733548|NCT00982111|66405535|FG001|Overall Study|Adverse Event|1|||
23733549|NCT00982111|66405534|FG000|Overall Study|Progressive Disease|46|||
23733550|NCT00982111|66405535|FG001|Overall Study|Progressive Disease|39|||
23733551|NCT00982111|66405534|FG000|Overall Study|Lost to Follow-up|9|||
23733552|NCT00982111|66405535|FG001|Overall Study|Lost to Follow-up|6|||
23733553|NCT00982111|66405534|FG000|Overall Study|New Anti-Cancer Therapy|5|||
23733554|NCT00982111|66405535|FG001|Overall Study|New Anti-Cancer Therapy|5|||
23733555|NCT00982111|66405534|FG000|Overall Study|Medical Decision|1|||
23733556|NCT00982111|66405535|FG001|Overall Study|Medical Decision|0|||
23733557|NCT00982111|66405534|FG000|Overall Study|Withdrawal by Subject|17|||
23733558|NCT00982111|66405535|FG001|Overall Study|Withdrawal by Subject|19|||
23733559|NCT00982111|66405534|FG000|Overall Study|Global Study End|0|||
23426457|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426458|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426459|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426460|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23733560|NCT00982111|66405535|FG001|Overall Study|Global Study End|1|||
23733561|NCT00982111|66405534|FG000|Overall Study|Sponsor's Decision|0|||
23426461|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
23426462|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426463|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426464|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426465|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426466|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
23426467|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
23426468|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
23426469|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426470|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426471|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426472|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426473|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426474|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23545002|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of investigational product|0|||
23545003|NCT03321981|65727016|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
23733562|NCT00982111|66405535|FG001|Overall Study|Sponsor's Decision|1|||
23733563|NCT02471586|66405539|FG000|Overall Study|Lost to Follow-up|3|||
23733564|NCT02471586|66405540|FG001|Overall Study|Lost to Follow-up|8|||
23733565|NCT02471586|66405541|FG002|Overall Study|Lost to Follow-up|4|||
23733566|NCT02471586|66405539|FG000|Overall Study|Death|2|||
23733567|NCT02471586|66405540|FG001|Overall Study|Death|2|||
23733568|NCT02471586|66405541|FG002|Overall Study|Death|0|||
23733569|NCT00256204|66405542|FG000|Overall Study|Adverse Event|10|||
23733570|NCT00256204|66405543|FG001|Overall Study|Adverse Event|14|||
23733571|NCT00256204|66405544|FG002|Overall Study|Adverse Event|16|||
23733572|NCT00256204|66405545|FG003|Overall Study|Adverse Event|14|||
23733573|NCT00256204|66405542|FG000|Overall Study|Death|0|||
23426475|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426476|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
23426477|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23545004|NCT03321981|65727017|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
23733574|NCT00256204|66405543|FG001|Overall Study|Death|1|||
23426478|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426479|NCT01448824|65303666|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
23426480|NCT01448824|65303667|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
23733575|NCT00256204|66405544|FG002|Overall Study|Death|0|||
23733576|NCT00256204|66405545|FG003|Overall Study|Death|0|||
23733577|NCT00256204|66405542|FG000|Overall Study|Lost to Follow-up|1|||
23733578|NCT00256204|66405543|FG001|Overall Study|Lost to Follow-up|1|||
23733579|NCT00256204|66405544|FG002|Overall Study|Lost to Follow-up|1|||
23733580|NCT00256204|66405545|FG003|Overall Study|Lost to Follow-up|2|||
23733581|NCT00256204|66405542|FG000|Overall Study|Protocol Violation|1|||
23733582|NCT00256204|66405543|FG001|Overall Study|Protocol Violation|0|||
23733583|NCT00256204|66405544|FG002|Overall Study|Protocol Violation|2|||
23733584|NCT00256204|66405545|FG003|Overall Study|Protocol Violation|1|||
23733585|NCT00256204|66405542|FG000|Overall Study|Physician Decision|0|||
23733586|NCT00256204|66405543|FG001|Overall Study|Physician Decision|0|||
23733587|NCT00256204|66405544|FG002|Overall Study|Physician Decision|1|||
23733588|NCT00256204|66405545|FG003|Overall Study|Physician Decision|2|||
23733589|NCT00256204|66405542|FG000|Overall Study|Withdrawal by Subject|17|||
23733590|NCT00256204|66405543|FG001|Overall Study|Withdrawal by Subject|6|||
23733591|NCT00256204|66405544|FG002|Overall Study|Withdrawal by Subject|7|||
23733592|NCT00256204|66405545|FG003|Overall Study|Withdrawal by Subject|5|||
23426481|NCT01448824|65303668|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
23545005|NCT03321981|65727018|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
23545006|NCT03321981|65727016|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
23545007|NCT03321981|65727017|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
23733593|NCT00256204|66405542|FG000|Overall Study|Need for additional prohibited treatment|38|||
23733594|NCT00256204|66405543|FG001|Overall Study|Need for additional prohibited treatment|28|||
23733595|NCT00256204|66405544|FG002|Overall Study|Need for additional prohibited treatment|27|||
23733596|NCT00256204|66405545|FG003|Overall Study|Need for additional prohibited treatment|25|||
23733597|NCT04129242|66405546|FG000|Overall Study|Physician Decision|1|||
23618268|NCT01730118|65988235|FG005|Dose Expansion|Inability to return|1|||
23618269|NCT01730118|65988236|FG006|Dose Expansion|Inability to return|0|||
23618270|NCT01730118|65988230|FG000|Dose Expansion|Physician Decision|0|||
23618271|NCT01730118|65988231|FG001|Dose Expansion|Physician Decision|0|||
23618272|NCT01730118|65988232|FG002|Dose Expansion|Physician Decision|0|||
23618273|NCT01730118|65988233|FG003|Dose Expansion|Physician Decision|0|||
23733598|NCT04129242|66405547|FG001|Overall Study|Physician Decision|1|||
23818897|NCT03496610|66714466|FG001|Overall Study|Lost to Follow-up|2|||
23818898|NCT03496610|66714465|FG000|Overall Study|Physician Decision|1|||
23818899|NCT03496610|66714466|FG001|Overall Study|Physician Decision|0|||
23818900|NCT03496610|66714465|FG000|Overall Study|Withdrawal by Subject|1|||
23818901|NCT03496610|66714466|FG001|Overall Study|Withdrawal by Subject|0|||
23818902|NCT02425904|66714467|FG000|Overall Study|Lost to Follow-up|1|||
23818903|NCT02425904|66714468|FG001|Overall Study|Lost to Follow-up|0|||
23818904|NCT02425904|66714467|FG000|Overall Study|Withdrawal by Subject|2|||
23818905|NCT02425904|66714468|FG001|Overall Study|Withdrawal by Subject|0|||
23545008|NCT03321981|65727018|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
23545009|NCT02308033|65727021|FG000|Overall Study|Normal Gram stain at Baseline|13|||
23545010|NCT02308033|65727022|FG001|Overall Study|Normal Gram stain at Baseline|10|||
23545011|NCT02308033|65727021|FG000|Overall Study|Positive for STD at Baseline|7|||
23545012|NCT02308033|65727022|FG001|Overall Study|Positive for STD at Baseline|4|||
23545013|NCT02308033|65727021|FG000|Overall Study|Lost to Follow-up|6|||
23545014|NCT02308033|65727022|FG001|Overall Study|Lost to Follow-up|5|||
23545015|NCT01432366|65727023|FG000|Overall Study|Non-Responder|7|||
23545016|NCT01432366|65727023|FG000|Overall Study|Adverse Event|8|||
23545017|NCT01432366|65727023|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
23618274|NCT01730118|65988234|FG004|Dose Expansion|Physician Decision|0|||
23618275|NCT01730118|65988235|FG005|Dose Expansion|Physician Decision|1|||
23733599|NCT04129242|66405546|FG000|Overall Study|Protocol Violation|0|||
23733600|NCT04129242|66405547|FG001|Overall Study|Protocol Violation|1|||
23733601|NCT00697255|66405550|FG000|Stage 1a|Insufficient ovarian response|1|||
23733602|NCT00697255|66405551|FG001|Stage 1a|Insufficient ovarian response|0|||
23818906|NCT02425904|66714467|FG000|Overall Study|Death|0|||
23818907|NCT02425904|66714468|FG001|Overall Study|Death|3|||
23733603|NCT00697255|66405550|FG000|Stage 1a|Multifollicular growth|1|||
23818908|NCT04239027|66714470|FG000|Overall Study|Adverse Event|4|||
23426482|NCT01448824|65303669|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
23545018|NCT01432366|65727023|FG000|Overall Study|Pregnancy|1|||
23818909|NCT04239027|66714470|FG000|Overall Study|Withdrawal by Subject|9|||
23818910|NCT04239027|66714470|FG000|Overall Study|Death|1|||
23818911|NCT04239027|66714470|FG000|Overall Study|Physician Decision|9|||
23733604|NCT00697255|66405551|FG001|Stage 1a|Multifollicular growth|0|||
23733605|NCT00697255|66405550|FG000|Stage 1a|Not growing of dominant follicle|1|||
23733606|NCT00697255|66405551|FG001|Stage 1a|Not growing of dominant follicle|0|||
23733607|NCT00697255|66405550|FG000|Stage 1b|Not growing of dominant follicle|0|||
23545019|NCT01432366|65727023|FG000|Overall Study|Lost to Follow-up|13|||
23818912|NCT04239027|66714470|FG000|Overall Study|Lost to Follow-up|2|||
23818913|NCT04239027|66714470|FG000|Overall Study|Lack of Efficacy|1|||
23818914|NCT02806024|66714471|FG000|Overall Study|Night Delivery|1|||
23818915|NCT02806024|66714472|FG001|Overall Study|Night Delivery|1|||
23818916|NCT02806024|66714471|FG000|Overall Study|DVT during antepartum admission|0|||
23818917|NCT02806024|66714472|FG001|Overall Study|DVT during antepartum admission|1|||
23818918|NCT05794503|66714473|FG000|Overall Study|Operation Cancelled|2|||
23818919|NCT05794503|66714474|FG001|Overall Study|Operation Cancelled|0|||
23818920|NCT05794503|66714473|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
23818921|NCT05794503|66714474|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
23818922|NCT05794503|66714473|FG000|Overall Study|Protocol Violation|1|||
23818923|NCT05794503|66714474|FG001|Overall Study|Protocol Violation|0|||
23818924|NCT04874155|66717444|FG000|Overall Study|Lost to Follow-up|1|||
23818925|NCT04874155|66717445|FG001|Overall Study|Lost to Follow-up|1|||
23818926|NCT04874155|66717444|FG000|Overall Study|Withdrawal by Subject|2|||
23818927|NCT04874155|66717445|FG001|Overall Study|Withdrawal by Subject|2|||
23818928|NCT04988087|66717446|FG000|Overall Study|Adverse Event|4|||
23818929|NCT04988087|66717447|FG001|Overall Study|Adverse Event|0|||
23818930|NCT04988087|66717448|FG002|Overall Study|Adverse Event|0|||
23818931|NCT04988087|66717449|FG003|Overall Study|Adverse Event|0|||
23818932|NCT04988087|66717446|FG000|Overall Study|Withdrawal by Subject|1|||
23818933|NCT04988087|66717447|FG001|Overall Study|Withdrawal by Subject|1|||
23818934|NCT04988087|66717448|FG002|Overall Study|Withdrawal by Subject|0|||
23818935|NCT04988087|66717449|FG003|Overall Study|Withdrawal by Subject|0|||
23818936|NCT04988087|66717446|FG000|Overall Study|Technical problems|7|||
23818937|NCT04988087|66717447|FG001|Overall Study|Technical problems|9|||
23818938|NCT04988087|66717448|FG002|Overall Study|Technical problems|1|||
23818939|NCT04988087|66717449|FG003|Overall Study|Technical problems|2|||
23818940|NCT00710866|66717451|FG000|Overall Study|Protocol Violation|5|||
23818941|NCT00710866|66717452|FG001|Overall Study|Protocol Violation|4|||
23545020|NCT01432366|65727023|FG000|Overall Study|Lack of Efficacy|1|||
23545021|NCT01432366|65727023|FG000|Overall Study|Site Closed|20|||
23545022|NCT01432366|65727023|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
23545023|NCT01432366|65727023|FG000|Overall Study|Other|14|||
23545024|NCT04304833|65727029|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
23545025|NCT04304833|65727030|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
23545026|NCT01808690|65727031|FG000|Overall Study|Withdrawal by Subject|1|||
23545027|NCT01808690|65727032|FG001|Overall Study|Withdrawal by Subject|2|||
23545028|NCT01939028|65727033|FG000|Overall Study|Withdrawal by Subject|5|||
23818942|NCT00710866|66717451|FG000|Overall Study|Withdrawal by Subject|2|||
23818943|NCT00710866|66717452|FG001|Overall Study|Withdrawal by Subject|1|||
23818944|NCT00710866|66717451|FG000|Overall Study|Lost to Follow-up|1|||
23818945|NCT00710866|66717452|FG001|Overall Study|Lost to Follow-up|0|||
23818946|NCT00710866|66717451|FG000|Overall Study|Failed to meet eligibility|1|||
23818947|NCT00710866|66717452|FG001|Overall Study|Failed to meet eligibility|1|||
23818948|NCT01874353|66717455|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
23818949|NCT01874353|66717456|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23818950|NCT01874353|66717457|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23818951|NCT01874353|66717458|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23818952|NCT01874353|66717455|FG000|Overall Study|Lost to Follow-up|2|||
23818953|NCT01874353|66717456|FG001|Overall Study|Lost to Follow-up|2|||
23818954|NCT01874353|66717457|FG002|Overall Study|Lost to Follow-up|2|||
23818955|NCT01874353|66717458|FG003|Overall Study|Lost to Follow-up|0|||
23818956|NCT01874353|66717455|FG000|Overall Study|Death|110|||
23818957|NCT01874353|66717456|FG001|Overall Study|Death|60|||
23818958|NCT01874353|66717457|FG002|Overall Study|Death|13|||
23818959|NCT01874353|66717458|FG003|Overall Study|Death|7|||
23818960|NCT01874353|66717455|FG000|Overall Study|Withdrawal by Subject|13|||
23818961|NCT01874353|66717456|FG001|Overall Study|Withdrawal by Subject|11|||
23818962|NCT01874353|66717457|FG002|Overall Study|Withdrawal by Subject|0|||
23818963|NCT01874353|66717458|FG003|Overall Study|Withdrawal by Subject|0|||
23818964|NCT04746794|66717459|FG000|Overall Study|Did not complete any study assessment|50303|||
23818965|NCT04746794|66717460|FG001|Overall Study|Did not complete any study assessment|44997|||
23818966|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
23818967|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
23545029|NCT01939028|65727033|FG000|Overall Study|Physician Decision|7|||
23545030|NCT02621606|65727036|FG000|Overall Study|Withdrawal by Subject|0|||
23818968|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
23545031|NCT02621606|65727037|FG001|Overall Study|Withdrawal by Subject|1|||
23545032|NCT02621606|65727038|FG002|Overall Study|Withdrawal by Subject|0|||
23545033|NCT02624804|65727039|FG000|Overall Study|Screen Failure|5|||
23818969|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
23818970|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
23818971|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
23818972|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
23818973|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
23818974|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
23733608|NCT00697255|66405551|FG001|Stage 1b|Not growing of dominant follicle|1|||
23733609|NCT00697255|66405550|FG000|Stage 1b|Insufficient ovarian response|0|||
23733610|NCT00697255|66405551|FG001|Stage 1b|Insufficient ovarian response|1|||
23733611|NCT01987609|66405552|FG000|Overall Study|Adverse Event|1|||
23733612|NCT03233308|66405556|FG000|Overall Study|Adverse Event|1|||
23733613|NCT03233308|66405556|FG000|Overall Study|Protocol Violation|1|||
23733614|NCT01468844|66405557|FG000|Overall Study|Adverse Event|1|||
23733615|NCT01468844|66405558|FG001|Overall Study|Adverse Event|0|||
23733616|NCT01468844|66405557|FG000|Overall Study|Withdrawal by Subject|1|||
23733617|NCT01468844|66405558|FG001|Overall Study|Withdrawal by Subject|0|||
23733618|NCT03267511|66405559|FG000|Overall Study|Lost to Follow-up|0|||
23818975|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23818976|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23733619|NCT03267511|66405560|FG001|Overall Study|Lost to Follow-up|0|||
23733620|NCT03267511|66405561|FG002|Overall Study|Lost to Follow-up|0|||
23733621|NCT03267511|66405562|FG003|Overall Study|Lost to Follow-up|1|||
23818977|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23818978|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23818979|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
23818980|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
23818981|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818982|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818983|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
23818984|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818985|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818986|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818987|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818988|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818989|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818990|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818991|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23818992|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
23818993|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
23818994|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
23818995|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
23733622|NCT00086385|66405563|FG000|Overall Study|Death|2|||
23733623|NCT00086385|66405564|FG001|Overall Study|Death|2|||
23733624|NCT00086385|66405565|FG002|Overall Study|Death|1|||
23733625|NCT00086385|66405566|FG003|Overall Study|Death|1|||
23733626|NCT01685060|66405567|FG000|Overall Study|Rollover patients|16|||
23733627|NCT01685060|66405567|FG000|Overall Study|Adverse Event|12|||
23733628|NCT01685060|66405567|FG000|Overall Study|Progressive disease|69|||
23733629|NCT01685060|66405567|FG000|Overall Study|Physician Decision|14|||
23733630|NCT01685060|66405567|FG000|Overall Study|Subject/guardian decision|20|||
23733631|NCT01685060|66405567|FG000|Overall Study|Lost to Follow-up|1|||
23818996|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
23818997|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23818998|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
23818999|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23819000|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23819001|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23819002|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23819003|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23819004|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23819005|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819006|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
23819007|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
23819008|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819009|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
23819010|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23733632|NCT01685060|66405567|FG000|Overall Study|Death|8|||
23819011|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23733633|NCT00508820|66405568|FG000|Overall Study|Adverse Event|6|||
23733634|NCT00508820|66405569|FG001|Overall Study|Adverse Event|10|||
23733635|NCT00508820|66405568|FG000|Overall Study|Death|6|||
23733636|NCT00508820|66405569|FG001|Overall Study|Death|8|||
23819012|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819013|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819014|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819015|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23733637|NCT00508820|66405568|FG000|Overall Study|Lost to Follow-up|1|||
23733638|NCT00508820|66405569|FG001|Overall Study|Lost to Follow-up|1|||
23733639|NCT00508820|66405568|FG000|Overall Study|Physician Decision|8|||
23733640|NCT00508820|66405569|FG001|Overall Study|Physician Decision|2|||
23733641|NCT00508820|66405568|FG000|Overall Study|Pregnancy|0|||
23733642|NCT00508820|66405569|FG001|Overall Study|Pregnancy|2|||
23733643|NCT00508820|66405568|FG000|Overall Study|Protocol Violation|2|||
23733644|NCT00508820|66405569|FG001|Overall Study|Protocol Violation|0|||
23733645|NCT00508820|66405568|FG000|Overall Study|Withdrawal by Subject|10|||
23733646|NCT00508820|66405569|FG001|Overall Study|Withdrawal by Subject|12|||
23733647|NCT00508820|66405568|FG000|Overall Study|Other|11|||
23733648|NCT00508820|66405569|FG001|Overall Study|Other|2|||
23733649|NCT00508820|66405568|FG000|Overall Study|Noncompliance|1|||
23733650|NCT00508820|66405569|FG001|Overall Study|Noncompliance|0|||
23733651|NCT00508820|66405568|FG000|Overall Study|Requirement for alternative therapy|7|||
23733652|NCT00508820|66405569|FG001|Overall Study|Requirement for alternative therapy|15|||
23733653|NCT00508820|66405568|FG000|Overall Study|Protocol-specified Criteria|3|||
23733654|NCT00508820|66405569|FG001|Overall Study|Protocol-specified Criteria|12|||
23733655|NCT01156012|66405570|FG000|Overall Study|Adverse Event|3|||
23733656|NCT01156012|66405571|FG001|Overall Study|Adverse Event|1|||
23819016|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819017|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23819018|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23819019|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
23819020|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23819021|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23426483|NCT01448824|65303670|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
23426484|NCT01448824|65303671|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
23426485|NCT01448824|65303672|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
23426486|NCT01448824|65303673|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
23426487|NCT01448824|65303666|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426488|NCT01448824|65303667|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426489|NCT01448824|65303668|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426490|NCT01448824|65303669|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426491|NCT01448824|65303670|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426492|NCT01448824|65303671|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426493|NCT01448824|65303672|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23545034|NCT02734212|65727046|FG000|Overall Study|Lost to Follow-up|5|||
23545035|NCT02734212|65727047|FG001|Overall Study|Lost to Follow-up|10|||
23545036|NCT01310036|65727048|FG000|Overall Study|Administrative/other|10|||
23426494|NCT01448824|65303673|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
23545037|NCT01310036|65727048|FG000|Overall Study|Withdrew Consent|11|||
23545038|NCT01310036|65727048|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
23545039|NCT01310036|65727048|FG000|Overall Study|Progression of Disease|164|||
23545040|NCT01310036|65727048|FG000|Overall Study|Death|1|||
23545041|NCT01310036|65727048|FG000|Overall Study|Adverse event or intercurrent illness|12|||
23545042|NCT01255358|65727052|FG000|Overall Study|Adverse Event|2|||
23545043|NCT01255358|65727052|FG000|Overall Study|Protocol Violation|2|||
23618276|NCT01730118|65988236|FG006|Dose Expansion|Physician Decision|0|||
23618277|NCT03045302|65988238|FG000|Overall Study|Pre-treatment adverse event|1|||
23618278|NCT02744898|65988239|FG000|Overall Study|Progressive Disease|2|||
23618279|NCT02744898|65988239|FG000|Overall Study|Physician Decision|1|||
23618280|NCT02744898|65988239|FG000|Overall Study|Toxicity|1|||
23618281|NCT02642159|65988243|FG000|Overall Study|Randomized but not treated|1|||
23618282|NCT02642159|65988244|FG001|Overall Study|Randomized but not treated|0|||
23618283|NCT02642159|65988243|FG000|Overall Study|Adverse Event|10|||
23618284|NCT02642159|65988244|FG001|Overall Study|Adverse Event|4|||
23618285|NCT02642159|65988243|FG000|Overall Study|Withdrawal by Subject|9|||
23618286|NCT02642159|65988244|FG001|Overall Study|Withdrawal by Subject|1|||
23618287|NCT02642159|65988243|FG000|Overall Study|Poor compliance to study protocol|1|||
23733657|NCT01156012|66405570|FG000|Overall Study|Lost to Follow-up|1|||
23733658|NCT01156012|66405571|FG001|Overall Study|Lost to Follow-up|0|||
23426495|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426496|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23545044|NCT02508311|65727053|FG000|Overall Study|Withdrawal by Subject|1|||
23545045|NCT02508311|65727054|FG001|Overall Study|Withdrawal by Subject|0|||
23545046|NCT00920426|65727068|FG000|ITZ111451|Adverse Event|1|||
23545047|NCT00920426|65727069|FG001|ITZ111451|Adverse Event|0|||
23733659|NCT01156012|66405570|FG000|Overall Study|Withdrawal by Subject|1|||
23733660|NCT01156012|66405571|FG001|Overall Study|Withdrawal by Subject|0|||
23733661|NCT01156012|66405570|FG000|Overall Study|use of commercial drug instead of study|0|||
23819022|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
23545048|NCT00920426|65727070|FG002|ITZ111451|Adverse Event|0|||
23545049|NCT00920426|65727071|FG003|ITZ111451|Adverse Event|0|||
23545050|NCT00374322|65727074|FG000|Overall Study|Lost to Follow-up|92|||
23545051|NCT00374322|65727075|FG001|Overall Study|Lost to Follow-up|90|||
23545052|NCT00374322|65727074|FG000|Overall Study|Protocol Violation|8|||
23545053|NCT00374322|65727075|FG001|Overall Study|Protocol Violation|3|||
23545054|NCT00374322|65727074|FG000|Overall Study|Withdrawal by Subject|235|||
23545055|NCT00374322|65727075|FG001|Overall Study|Withdrawal by Subject|167|||
23545056|NCT00374322|65727074|FG000|Overall Study|Sponsor Terminated Study|866|||
23545057|NCT00374322|65727075|FG001|Overall Study|Sponsor Terminated Study|990|||
23545058|NCT00374322|65727074|FG000|Overall Study|Physician Decision|36|||
23545059|NCT00374322|65727075|FG001|Overall Study|Physician Decision|32|||
23545060|NCT00374322|65727074|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
23545061|NCT00374322|65727075|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
23545062|NCT00374322|65727074|FG000|Overall Study|Sponsor Decision|2|||
23545063|NCT00374322|65727075|FG001|Overall Study|Sponsor Decision|3|||
23545064|NCT00374322|65727074|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
23545065|NCT00374322|65727075|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
23545066|NCT00374322|65727074|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
23545067|NCT00374322|65727075|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
23545068|NCT00374322|65727074|FG000|Overall Study|Severe Toxicity|1|||
23545069|NCT00374322|65727075|FG001|Overall Study|Severe Toxicity|0|||
23545070|NCT00374322|65727074|FG000|Overall Study|Site Closed|2|||
23545071|NCT00374322|65727075|FG001|Overall Study|Site Closed|2|||
23545072|NCT00374322|65727074|FG000|Overall Study|Participant Changed Physician|1|||
23545073|NCT00374322|65727075|FG001|Overall Study|Participant Changed Physician|0|||
23545074|NCT00374322|65727074|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
23545075|NCT00374322|65727075|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
23545076|NCT00374322|65727074|FG000|Overall Study|Noncompliance with Study Requirements|0|||
23545077|NCT00374322|65727075|FG001|Overall Study|Noncompliance with Study Requirements|1|||
23545078|NCT00374322|65727074|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
23545079|NCT00374322|65727075|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
23545080|NCT00374322|65727074|FG000|Overall Study|Did Not Receive Study Medication|8|||
23545081|NCT00374322|65727075|FG001|Overall Study|Did Not Receive Study Medication|6|||
23545082|NCT03447769|65727076|FG000|Overall Study|Progressive disease|138|||
23545083|NCT03447769|65727077|FG001|Overall Study|Progressive disease|148|||
23545084|NCT03447769|65727076|FG000|Overall Study|Study terminated by Sponsor|60|||
23545085|NCT03447769|65727077|FG001|Overall Study|Study terminated by Sponsor|44|||
23545086|NCT03447769|65727076|FG000|Overall Study|Adverse Event|34|||
23545087|NCT03447769|65727077|FG001|Overall Study|Adverse Event|31|||
23545088|NCT03447769|65727076|FG000|Overall Study|Patient decision|27|||
23545089|NCT03447769|65727077|FG001|Overall Study|Patient decision|27|||
23545090|NCT03447769|65727076|FG000|Overall Study|Protocol deviation|4|||
23545091|NCT03447769|65727077|FG001|Overall Study|Protocol deviation|6|||
23545092|NCT03447769|65727076|FG000|Overall Study|Death|2|||
23545093|NCT03447769|65727077|FG001|Overall Study|Death|7|||
23545094|NCT03447769|65727076|FG000|Overall Study|Technical problems|1|||
23545095|NCT03447769|65727077|FG001|Overall Study|Technical problems|0|||
23545096|NCT03447769|65727076|FG000|Overall Study|Lost to Follow-up|0|||
23545097|NCT03447769|65727077|FG001|Overall Study|Lost to Follow-up|1|||
23545098|NCT03447769|65727076|FG000|Overall Study|Physician Decision|13|||
23545099|NCT03447769|65727077|FG001|Overall Study|Physician Decision|5|||
23545100|NCT03759873|65727078|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
23545101|NCT03759873|65727079|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
23545102|NCT03759873|65727080|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
23545103|NCT03759873|65727081|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
23545104|NCT03759873|65727078|FG000|Overall Study|Moved outside eligible area|0|||
23545105|NCT03759873|65727079|FG001|Overall Study|Moved outside eligible area|2|||
23545106|NCT03759873|65727080|FG002|Overall Study|Moved outside eligible area|0|||
23545107|NCT03759873|65727081|FG003|Overall Study|Moved outside eligible area|0|||
23545108|NCT03759873|65727078|FG000|Overall Study|Withdrawal by Subject|0|||
23545109|NCT03759873|65727079|FG001|Overall Study|Withdrawal by Subject|0|||
23545110|NCT03759873|65727080|FG002|Overall Study|Withdrawal by Subject|1|||
23618288|NCT02642159|65988244|FG001|Overall Study|Poor compliance to study protocol|0|||
23545111|NCT03759873|65727081|FG003|Overall Study|Withdrawal by Subject|0|||
23545112|NCT00467870|65727082|FG000|Overall Study|Adverse Event|13|||
23545113|NCT00467870|65727083|FG001|Overall Study|Adverse Event|9|||
23545114|NCT00467870|65727084|FG002|Overall Study|Adverse Event|1|||
23545115|NCT00467870|65727085|FG003|Overall Study|Adverse Event|15|||
23545116|NCT00467870|65727086|FG004|Overall Study|Adverse Event|15|||
23618289|NCT02642159|65988243|FG000|Overall Study|Other than specified above|10|||
23545117|NCT00467870|65727087|FG005|Overall Study|Adverse Event|1|||
23545118|NCT00467870|65727082|FG000|Overall Study|Protocol Violation|2|||
23545119|NCT00467870|65727083|FG001|Overall Study|Protocol Violation|1|||
23545120|NCT00467870|65727084|FG002|Overall Study|Protocol Violation|1|||
23545121|NCT00467870|65727085|FG003|Overall Study|Protocol Violation|2|||
23819023|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819024|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819025|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819026|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23819027|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819028|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819029|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819030|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23819031|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23819032|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819033|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819034|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819035|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819036|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23819037|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
23819038|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23819039|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819040|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819041|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819042|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819043|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23819044|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
23819045|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
23819046|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
23819047|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
23819048|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
23819049|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23819050|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
23618290|NCT02642159|65988244|FG001|Overall Study|Other than specified above|3|||
23733662|NCT01156012|66405571|FG001|Overall Study|use of commercial drug instead of study|1|||
23733663|NCT01156012|66405570|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
23733664|NCT01156012|66405571|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
23733665|NCT01693562|66405575|FG000|Escalation Phase|Withdrawal by Subject|0|||
23733666|NCT01693562|66405576|FG001|Escalation Phase|Withdrawal by Subject|1|||
23733667|NCT01693562|66405577|FG002|Escalation Phase|Withdrawal by Subject|0|||
23733668|NCT01693562|66405578|FG003|Escalation Phase|Withdrawal by Subject|0|||
23733669|NCT01693562|66405579|FG004|Escalation Phase|Withdrawal by Subject|0|||
23733670|NCT01693562|66405580|FG005|Escalation Phase|Withdrawal by Subject|2|||
23733671|NCT01693562|66405581|FG006|Escalation Phase|Withdrawal by Subject|0|||
23733672|NCT01693562|66405582|FG007|Escalation Phase|Withdrawal by Subject|0|||
23733673|NCT01693562|66405583|FG008|Escalation Phase|Withdrawal by Subject|0|||
23733674|NCT01693562|66405584|FG009|Escalation Phase|Withdrawal by Subject|0|||
23733675|NCT01693562|66405585|FG010|Escalation Phase|Withdrawal by Subject|0|||
23733676|NCT01693562|66405586|FG011|Escalation Phase|Withdrawal by Subject|0|||
23733677|NCT01693562|66405587|FG012|Escalation Phase|Withdrawal by Subject|0|||
23733678|NCT01693562|66405588|FG013|Escalation Phase|Withdrawal by Subject|0|||
23733679|NCT01693562|66405589|FG014|Escalation Phase|Withdrawal by Subject|0|||
23733680|NCT01693562|66405590|FG015|Escalation Phase|Withdrawal by Subject|0|||
23733681|NCT01693562|66405591|FG016|Escalation Phase|Withdrawal by Subject|0|||
23733682|NCT01693562|66405592|FG017|Escalation Phase|Withdrawal by Subject|0|||
23733683|NCT01693562|66405593|FG018|Escalation Phase|Withdrawal by Subject|0|||
23733684|NCT01693562|66405594|FG019|Escalation Phase|Withdrawal by Subject|0|||
23733685|NCT01693562|66405595|FG020|Escalation Phase|Withdrawal by Subject|0|||
23733686|NCT01693562|66405596|FG021|Escalation Phase|Withdrawal by Subject|0|||
23733687|NCT01693562|66405597|FG022|Escalation Phase|Withdrawal by Subject|0|||
23733688|NCT01693562|66405575|FG000|Escalation Phase|Death|4|||
23733689|NCT01693562|66405576|FG001|Escalation Phase|Death|2|||
23733690|NCT01693562|66405577|FG002|Escalation Phase|Death|0|||
23733691|NCT01693562|66405578|FG003|Escalation Phase|Death|3|||
23733692|NCT01693562|66405579|FG004|Escalation Phase|Death|6|||
23733693|NCT01693562|66405580|FG005|Escalation Phase|Death|4|||
23733694|NCT01693562|66405581|FG006|Escalation Phase|Death|0|||
23733695|NCT01693562|66405582|FG007|Escalation Phase|Death|0|||
23733696|NCT01693562|66405583|FG008|Escalation Phase|Death|0|||
23733697|NCT01693562|66405584|FG009|Escalation Phase|Death|0|||
23733698|NCT01693562|66405585|FG010|Escalation Phase|Death|0|||
23733699|NCT01693562|66405586|FG011|Escalation Phase|Death|0|||
23819051|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23819052|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23733700|NCT01693562|66405587|FG012|Escalation Phase|Death|0|||
23733701|NCT01693562|66405588|FG013|Escalation Phase|Death|0|||
23733702|NCT01693562|66405589|FG014|Escalation Phase|Death|0|||
23733703|NCT01693562|66405590|FG015|Escalation Phase|Death|0|||
23733704|NCT01693562|66405591|FG016|Escalation Phase|Death|0|||
23426497|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23545122|NCT00467870|65727086|FG004|Overall Study|Protocol Violation|0|||
23733705|NCT01693562|66405592|FG017|Escalation Phase|Death|0|||
23733706|NCT01693562|66405593|FG018|Escalation Phase|Death|0|||
23733707|NCT01693562|66405594|FG019|Escalation Phase|Death|0|||
23733708|NCT01693562|66405595|FG020|Escalation Phase|Death|0|||
23733709|NCT01693562|66405596|FG021|Escalation Phase|Death|0|||
23733710|NCT01693562|66405597|FG022|Escalation Phase|Death|0|||
23733711|NCT01693562|66405575|FG000|Escalation Phase|Lost to Follow-up|0|||
23733712|NCT01693562|66405576|FG001|Escalation Phase|Lost to Follow-up|1|||
23733713|NCT01693562|66405577|FG002|Escalation Phase|Lost to Follow-up|1|||
23733714|NCT01693562|66405578|FG003|Escalation Phase|Lost to Follow-up|0|||
23733715|NCT01693562|66405579|FG004|Escalation Phase|Lost to Follow-up|0|||
23733716|NCT01693562|66405580|FG005|Escalation Phase|Lost to Follow-up|0|||
23733717|NCT01693562|66405581|FG006|Escalation Phase|Lost to Follow-up|0|||
23733718|NCT01693562|66405582|FG007|Escalation Phase|Lost to Follow-up|0|||
23426498|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426499|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426500|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426501|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426502|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
23426503|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426504|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23545123|NCT00467870|65727087|FG005|Overall Study|Protocol Violation|0|||
23545124|NCT00467870|65727082|FG000|Overall Study|Withdrawal by Subject|14|||
23545125|NCT00467870|65727083|FG001|Overall Study|Withdrawal by Subject|21|||
23545126|NCT00467870|65727084|FG002|Overall Study|Withdrawal by Subject|0|||
23545127|NCT00467870|65727085|FG003|Overall Study|Withdrawal by Subject|9|||
23545128|NCT00467870|65727086|FG004|Overall Study|Withdrawal by Subject|10|||
23545129|NCT00467870|65727087|FG005|Overall Study|Withdrawal by Subject|1|||
23545130|NCT00467870|65727082|FG000|Overall Study|Lost to Follow-up|5|||
23545131|NCT00467870|65727083|FG001|Overall Study|Lost to Follow-up|3|||
23545132|NCT00467870|65727084|FG002|Overall Study|Lost to Follow-up|1|||
23545133|NCT00467870|65727085|FG003|Overall Study|Lost to Follow-up|1|||
23545134|NCT00467870|65727086|FG004|Overall Study|Lost to Follow-up|3|||
23545135|NCT00467870|65727087|FG005|Overall Study|Lost to Follow-up|0|||
23545136|NCT00467870|65727082|FG000|Overall Study|Subject Non-compliance|3|||
23545137|NCT00467870|65727083|FG001|Overall Study|Subject Non-compliance|4|||
23545138|NCT00467870|65727084|FG002|Overall Study|Subject Non-compliance|0|||
23545139|NCT00467870|65727085|FG003|Overall Study|Subject Non-compliance|1|||
23545140|NCT00467870|65727086|FG004|Overall Study|Subject Non-compliance|5|||
23545141|NCT00467870|65727087|FG005|Overall Study|Subject Non-compliance|0|||
23545142|NCT00467870|65727082|FG000|Overall Study|Other/Unknown|8|||
23545143|NCT00467870|65727083|FG001|Overall Study|Other/Unknown|5|||
23545144|NCT00467870|65727084|FG002|Overall Study|Other/Unknown|1|||
23545145|NCT00467870|65727085|FG003|Overall Study|Other/Unknown|5|||
23545146|NCT00467870|65727086|FG004|Overall Study|Other/Unknown|4|||
23545147|NCT00467870|65727087|FG005|Overall Study|Other/Unknown|0|||
23545148|NCT04757753|65727088|FG000|Overall Study|Lost to Follow-up|7|||
23545149|NCT04757753|65727089|FG001|Overall Study|Lost to Follow-up|7|||
23545150|NCT04757753|65727088|FG000|Overall Study|Withdrawal by Subject|0|||
23545151|NCT04757753|65727089|FG001|Overall Study|Withdrawal by Subject|3|||
23545152|NCT04757753|65727088|FG000|Overall Study|Endodontic treatment failure|1|||
23545153|NCT04757753|65727089|FG001|Overall Study|Endodontic treatment failure|2|||
23545154|NCT04757753|65727088|FG000|Overall Study|Tooth fracture/extraction|3|||
23545155|NCT04757753|65727089|FG001|Overall Study|Tooth fracture/extraction|0|||
23545156|NCT04181762|65727090|FG000|Overall Study|Adverse Event|1|||
23545157|NCT04181762|65727091|FG001|Overall Study|Adverse Event|3|||
23545158|NCT04181762|65727090|FG000|Overall Study|Lost to Follow-up|1|||
23545159|NCT04181762|65727091|FG001|Overall Study|Lost to Follow-up|1|||
23545160|NCT04181762|65727090|FG000|Overall Study|Physician Decision|1|||
23545161|NCT04181762|65727091|FG001|Overall Study|Physician Decision|3|||
23545162|NCT04181762|65727090|FG000|Overall Study|Pregnancy|0|||
23545163|NCT04181762|65727091|FG001|Overall Study|Pregnancy|1|||
23545164|NCT04181762|65727090|FG000|Overall Study|Lack of Efficacy|2|||
23545165|NCT04181762|65727091|FG001|Overall Study|Lack of Efficacy|2|||
23545166|NCT04181762|65727090|FG000|Overall Study|Study terminated by sponsor|95|||
23545167|NCT04181762|65727091|FG001|Overall Study|Study terminated by sponsor|97|||
23545168|NCT04181762|65727090|FG000|Overall Study|Subject decision|11|||
23545169|NCT04181762|65727091|FG001|Overall Study|Subject decision|4|||
23545170|NCT04181762|65727090|FG000|Overall Study|Death|1|||
23545171|NCT04181762|65727091|FG001|Overall Study|Death|1|||
23545172|NCT04181762|65727090|FG000|Overall Study|Protocol deviation|1|||
23618291|NCT01203956|65988245|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
23733719|NCT01693562|66405583|FG008|Escalation Phase|Lost to Follow-up|0|||
23545173|NCT04181762|65727091|FG001|Overall Study|Protocol deviation|0|||
23618292|NCT01203956|65988246|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
23545174|NCT04181762|65727090|FG000|Overall Study|Withdrawal of informed consent|1|||
23545175|NCT04181762|65727091|FG001|Overall Study|Withdrawal of informed consent|3|||
23545176|NCT01672801|65727094|FG000|Overall Study|Screen Failure|0|||
23545177|NCT01672801|65727095|FG001|Overall Study|Screen Failure|1|||
23545178|NCT03879798|65727098|FG000|Overall Study|Adverse Event|0|||
23545179|NCT03879798|65727099|FG001|Overall Study|Adverse Event|0|||
23545180|NCT03879798|65727100|FG002|Overall Study|Adverse Event|0|||
23545181|NCT03879798|65727101|FG003|Overall Study|Adverse Event|0|||
23545182|NCT03879798|65727102|FG004|Overall Study|Adverse Event|0|||
23545183|NCT03879798|65727103|FG005|Overall Study|Adverse Event|1|||
23545184|NCT03879798|65727098|FG000|Overall Study|Lack of Efficacy|0|||
23545185|NCT03879798|65727099|FG001|Overall Study|Lack of Efficacy|0|||
23545186|NCT03879798|65727100|FG002|Overall Study|Lack of Efficacy|0|||
23545187|NCT03879798|65727101|FG003|Overall Study|Lack of Efficacy|0|||
23545188|NCT03879798|65727102|FG004|Overall Study|Lack of Efficacy|0|||
23545189|NCT03879798|65727103|FG005|Overall Study|Lack of Efficacy|1|||
23545190|NCT03879798|65727098|FG000|Overall Study|Withdrawal by Subject|0|||
23545191|NCT03879798|65727099|FG001|Overall Study|Withdrawal by Subject|0|||
23545192|NCT03879798|65727100|FG002|Overall Study|Withdrawal by Subject|0|||
23545193|NCT03879798|65727101|FG003|Overall Study|Withdrawal by Subject|0|||
23545194|NCT03879798|65727102|FG004|Overall Study|Withdrawal by Subject|0|||
23545195|NCT03879798|65727103|FG005|Overall Study|Withdrawal by Subject|1|||
23545196|NCT02091726|65727113|FG000|Overall Study|Lost to Follow-up|6|||
23545197|NCT01174342|65727116|FG000|Overall Study|Conversion to cesarean section|4|||
23545198|NCT00990652|65727119|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
23545199|NCT00990652|65727119|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
23545200|NCT04743908|65727120|FG000|Overall Study|Death|1|||
23618293|NCT03357471|65988247|FG000|Overall Study|Adverse Event|1|||
23618294|NCT03357471|65988248|FG001|Overall Study|Adverse Event|0|||
23618295|NCT03357471|65988247|FG000|Overall Study|Lost to Follow-up|1|||
23618296|NCT03357471|65988248|FG001|Overall Study|Lost to Follow-up|0|||
23618297|NCT01116440|65988249|FG000|Treatment|Withdrawal by Subject|2|||
23618298|NCT01116440|65988250|FG001|Treatment|Withdrawal by Subject|2|||
23733720|NCT01693562|66405584|FG009|Escalation Phase|Lost to Follow-up|0|||
23733721|NCT01693562|66405585|FG010|Escalation Phase|Lost to Follow-up|0|||
23733722|NCT01693562|66405586|FG011|Escalation Phase|Lost to Follow-up|0|||
23733723|NCT01693562|66405587|FG012|Escalation Phase|Lost to Follow-up|0|||
23733724|NCT01693562|66405588|FG013|Escalation Phase|Lost to Follow-up|0|||
23733725|NCT01693562|66405589|FG014|Escalation Phase|Lost to Follow-up|0|||
23733726|NCT01693562|66405590|FG015|Escalation Phase|Lost to Follow-up|0|||
23733727|NCT01693562|66405591|FG016|Escalation Phase|Lost to Follow-up|0|||
23733728|NCT01693562|66405592|FG017|Escalation Phase|Lost to Follow-up|0|||
23545201|NCT04743908|65727121|FG001|Overall Study|Death|0|||
23545202|NCT04743908|65727120|FG000|Overall Study|Lost to Follow-up|181|||
23545203|NCT04743908|65727121|FG001|Overall Study|Lost to Follow-up|180|||
23545204|NCT04743908|65727120|FG000|Overall Study|Withdrawal by Subject|1|||
23545205|NCT04743908|65727121|FG001|Overall Study|Withdrawal by Subject|2|||
23545206|NCT02843568|65727124|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
23618299|NCT01116440|65988249|FG000|Treatment|Lost to Follow-up|1|||
23618300|NCT01116440|65988250|FG001|Treatment|Lost to Follow-up|1|||
23618301|NCT01116440|65988249|FG000|Treatment|Protocol Violation|0|||
23733729|NCT01693562|66405593|FG018|Escalation Phase|Lost to Follow-up|0|||
23618302|NCT01116440|65988250|FG001|Treatment|Protocol Violation|2|||
23618303|NCT01116440|65988249|FG000|Treatment|Lack of Efficacy|0|||
23618304|NCT01116440|65988250|FG001|Treatment|Lack of Efficacy|1|||
23733730|NCT01693562|66405594|FG019|Escalation Phase|Lost to Follow-up|0|||
23733731|NCT01693562|66405595|FG020|Escalation Phase|Lost to Follow-up|0|||
23733732|NCT01693562|66405596|FG021|Escalation Phase|Lost to Follow-up|0|||
23733733|NCT01693562|66405597|FG022|Escalation Phase|Lost to Follow-up|0|||
23733734|NCT01693562|66405575|FG000|Escalation Phase|Other|0|||
23733735|NCT01693562|66405576|FG001|Escalation Phase|Other|0|||
23733736|NCT01693562|66405577|FG002|Escalation Phase|Other|2|||
23733737|NCT01693562|66405578|FG003|Escalation Phase|Other|0|||
23733738|NCT01693562|66405579|FG004|Escalation Phase|Other|0|||
23733739|NCT01693562|66405580|FG005|Escalation Phase|Other|1|||
23733740|NCT01693562|66405581|FG006|Escalation Phase|Other|0|||
23733741|NCT01693562|66405582|FG007|Escalation Phase|Other|0|||
23733742|NCT01693562|66405583|FG008|Escalation Phase|Other|0|||
23733743|NCT01693562|66405584|FG009|Escalation Phase|Other|0|||
23733744|NCT01693562|66405585|FG010|Escalation Phase|Other|0|||
23545207|NCT02843568|65727125|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
23545208|NCT02843568|65727124|FG000|Overall Study|Death|3|||
23545209|NCT02843568|65727125|FG001|Overall Study|Death|3|||
23618305|NCT01116440|65988249|FG000|Treatment|Adverse Event|0|||
23618306|NCT01116440|65988250|FG001|Treatment|Adverse Event|1|||
23733745|NCT01693562|66405586|FG011|Escalation Phase|Other|0|||
23733746|NCT01693562|66405587|FG012|Escalation Phase|Other|0|||
23545210|NCT02843568|65727124|FG000|Overall Study|Withdrawal by Subject|1|||
23545211|NCT02843568|65727125|FG001|Overall Study|Withdrawal by Subject|1|||
23733747|NCT01693562|66405588|FG013|Escalation Phase|Other|0|||
23733748|NCT01693562|66405589|FG014|Escalation Phase|Other|0|||
23733749|NCT01693562|66405590|FG015|Escalation Phase|Other|0|||
23733750|NCT01693562|66405591|FG016|Escalation Phase|Other|0|||
23733751|NCT01693562|66405592|FG017|Escalation Phase|Other|0|||
23733752|NCT01693562|66405593|FG018|Escalation Phase|Other|0|||
23733753|NCT01693562|66405594|FG019|Escalation Phase|Other|0|||
23733754|NCT01693562|66405595|FG020|Escalation Phase|Other|0|||
23733755|NCT01693562|66405596|FG021|Escalation Phase|Other|0|||
23819053|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23819054|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23819055|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23819056|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23819057|NCT04707313|66717461|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23733756|NCT01693562|66405597|FG022|Escalation Phase|Other|0|||
23733757|NCT01693562|66405575|FG000|Exploration Phase|Withdrawal by Subject|0|||
23819058|NCT04707313|66717462|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819059|NCT04707313|66717463|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
23819060|NCT04707313|66717464|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819061|NCT04707313|66717465|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819062|NCT04707313|66717466|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819063|NCT04707313|66717467|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819064|NCT04707313|66717468|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
23819065|NCT04707313|66717469|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819066|NCT04707313|66717470|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23819067|NCT04707313|66717471|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23545212|NCT02843568|65727124|FG000|Overall Study|Lost to Follow-up|2|||
23733758|NCT01693562|66405576|FG001|Exploration Phase|Withdrawal by Subject|0|||
23819068|NCT04707313|66717472|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23733759|NCT01693562|66405577|FG002|Exploration Phase|Withdrawal by Subject|0|||
23733760|NCT01693562|66405578|FG003|Exploration Phase|Withdrawal by Subject|0|||
23733761|NCT01693562|66405579|FG004|Exploration Phase|Withdrawal by Subject|0|||
23733762|NCT01693562|66405580|FG005|Exploration Phase|Withdrawal by Subject|0|||
23733763|NCT01693562|66405581|FG006|Exploration Phase|Withdrawal by Subject|2|||
23733764|NCT01693562|66405582|FG007|Exploration Phase|Withdrawal by Subject|0|||
23733765|NCT01693562|66405583|FG008|Exploration Phase|Withdrawal by Subject|0|||
23733766|NCT01693562|66405584|FG009|Exploration Phase|Withdrawal by Subject|0|||
23733767|NCT01693562|66405585|FG010|Exploration Phase|Withdrawal by Subject|0|||
23733768|NCT01693562|66405586|FG011|Exploration Phase|Withdrawal by Subject|0|||
23733769|NCT01693562|66405587|FG012|Exploration Phase|Withdrawal by Subject|0|||
23733770|NCT01693562|66405588|FG013|Exploration Phase|Withdrawal by Subject|0|||
23733771|NCT01693562|66405589|FG014|Exploration Phase|Withdrawal by Subject|0|||
23733772|NCT01693562|66405590|FG015|Exploration Phase|Withdrawal by Subject|0|||
23733773|NCT01693562|66405591|FG016|Exploration Phase|Withdrawal by Subject|0|||
23733774|NCT01693562|66405592|FG017|Exploration Phase|Withdrawal by Subject|0|||
23426505|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426506|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426507|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426508|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426509|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426510|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
23426511|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426512|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426513|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426514|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426515|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426516|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426517|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426518|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
23426519|NCT02634606|65307350|FG000|Overall Study|unable to obtain the drug at start|13|||
23426520|NCT01920152|65307355|FG000|Overall Study|Withdrawal by Subject|1|||
23545213|NCT02843568|65727125|FG001|Overall Study|Lost to Follow-up|0|||
23545214|NCT02103439|65727134|FG000|Overall Study|Adverse Event|0|||
23545215|NCT02103439|65727135|FG001|Overall Study|Adverse Event|2|||
23545216|NCT02103439|65727134|FG000|Overall Study|Withdrawal by Subject|3|||
23545217|NCT02103439|65727135|FG001|Overall Study|Withdrawal by Subject|1|||
23545218|NCT00744653|65727137|FG000|Overall Study|antineoplastic treatment|11|||
23545219|NCT00744653|65727137|FG000|Overall Study|Death|1|||
23545220|NCT00744653|65727137|FG000|Overall Study|Lost to Follow-up|1|||
23545221|NCT00744653|65727137|FG000|Overall Study|Physician Decision|3|||
23733775|NCT01693562|66405593|FG018|Exploration Phase|Withdrawal by Subject|0|||
23819069|NCT04707313|66717473|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23545222|NCT02691455|65727138|FG000|Overall Study|Withdrawal by Subject|1|||
23545223|NCT02691455|65727139|FG001|Overall Study|Withdrawal by Subject|2|||
23545224|NCT02691455|65727138|FG000|Overall Study|Lost to Follow-up|15|||
23545225|NCT02691455|65727139|FG001|Overall Study|Lost to Follow-up|15|||
23545226|NCT00583557|65727142|FG000|Overall Study|Withdrawal by Subject|18|||
23545227|NCT00583557|65727142|FG000|Overall Study|Adverse Event|9|||
23545228|NCT00583557|65727142|FG000|Overall Study|Lack of Efficacy|31|||
23545229|NCT00583557|65727142|FG000|Overall Study|Lack of Compliance|5|||
23545230|NCT00583557|65727142|FG000|Overall Study|Other|5|||
23545231|NCT00583557|65727142|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
23545232|NCT03713593|65727143|FG000|Overall Study|Participants Ongoing|140|||
23545233|NCT03713593|65727144|FG001|Overall Study|Participants Ongoing|114|||
23545234|NCT03713593|65727143|FG000|Overall Study|Withdrawal by Subject|3|||
23545235|NCT03713593|65727144|FG001|Overall Study|Withdrawal by Subject|6|||
23545236|NCT03713593|65727143|FG000|Overall Study|Death|252|||
23545237|NCT03713593|65727144|FG001|Overall Study|Death|279|||
23545238|NCT01221597|65727146|FG000|Overall Study|Adverse Event|4|||
23545239|NCT01221597|65727147|FG001|Overall Study|Adverse Event|1|||
23545240|NCT01221597|65727146|FG000|Overall Study|Withdrawal by Subject|20|||
23545241|NCT01221597|65727147|FG001|Overall Study|Withdrawal by Subject|6|||
23545242|NCT01221597|65727146|FG000|Overall Study|Lost to Follow-up|6|||
23545243|NCT01221597|65727147|FG001|Overall Study|Lost to Follow-up|5|||
23545244|NCT01221597|65727146|FG000|Overall Study|Protocol Violation|1|||
23545245|NCT01221597|65727147|FG001|Overall Study|Protocol Violation|0|||
23545246|NCT01221597|65727146|FG000|Overall Study|Other|3|||
23545247|NCT01221597|65727147|FG001|Overall Study|Other|4|||
23545248|NCT01221597|65727146|FG000|Overall Study|Death|2|||
23545249|NCT01221597|65727147|FG001|Overall Study|Death|0|||
23545250|NCT03021187|65727148|FG000|Overall Study|Death|0|||
23545251|NCT03021187|65727149|FG001|Overall Study|Death|0|||
23545252|NCT03021187|65727150|FG002|Overall Study|Death|3|||
23545253|NCT03021187|65727151|FG003|Overall Study|Death|0|||
23545254|NCT03021187|65727148|FG000|Overall Study|Withdrawal by Subject|0|||
23545255|NCT03021187|65727149|FG001|Overall Study|Withdrawal by Subject|6|||
23545256|NCT03021187|65727150|FG002|Overall Study|Withdrawal by Subject|2|||
23545257|NCT03021187|65727151|FG003|Overall Study|Withdrawal by Subject|5|||
23545258|NCT03021187|65727148|FG000|Overall Study|Lost to Follow-up|10|||
23545259|NCT03021187|65727149|FG001|Overall Study|Lost to Follow-up|3|||
23545260|NCT03021187|65727150|FG002|Overall Study|Lost to Follow-up|1|||
23545261|NCT03021187|65727151|FG003|Overall Study|Lost to Follow-up|4|||
23545262|NCT01615029|65727152|FG000|Overall Study|Adverse Event|0|||
23545263|NCT01615029|65727153|FG001|Overall Study|Adverse Event|0|||
23545264|NCT01615029|65727154|FG002|Overall Study|Adverse Event|0|||
23545265|NCT01615029|65727155|FG003|Overall Study|Adverse Event|0|||
23819070|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23426521|NCT01920152|65307356|FG001|Overall Study|Withdrawal by Subject|2|||
23426522|NCT02525939|65307359|FG000|Overall Study|Lost to Follow-up|27|||
23545266|NCT01615029|65727156|FG004|Overall Study|Adverse Event|1|||
23545267|NCT01615029|65727152|FG000|Overall Study|Death|0|||
23545268|NCT01615029|65727153|FG001|Overall Study|Death|0|||
23545269|NCT01615029|65727154|FG002|Overall Study|Death|0|||
23545270|NCT01615029|65727155|FG003|Overall Study|Death|0|||
23545271|NCT01615029|65727156|FG004|Overall Study|Death|1|||
23545272|NCT01615029|65727152|FG000|Overall Study|Lost to Follow-up|0|||
23545273|NCT01615029|65727153|FG001|Overall Study|Lost to Follow-up|0|||
23545274|NCT01615029|65727154|FG002|Overall Study|Lost to Follow-up|0|||
23545275|NCT01615029|65727155|FG003|Overall Study|Lost to Follow-up|0|||
23545276|NCT01615029|65727156|FG004|Overall Study|Lost to Follow-up|1|||
23545277|NCT01615029|65727152|FG000|Overall Study|Progressive disease|2|||
23426523|NCT02525939|65307360|FG001|Overall Study|Lost to Follow-up|24|||
23545278|NCT01615029|65727153|FG001|Overall Study|Progressive disease|1|||
23545279|NCT01615029|65727154|FG002|Overall Study|Progressive disease|1|||
23545280|NCT01615029|65727155|FG003|Overall Study|Progressive disease|1|||
23545281|NCT01615029|65727156|FG004|Overall Study|Progressive disease|5|||
23545282|NCT01615029|65727152|FG000|Overall Study|Physician Decision|0|||
23545283|NCT01615029|65727153|FG001|Overall Study|Physician Decision|0|||
23545284|NCT01615029|65727154|FG002|Overall Study|Physician Decision|0|||
23545285|NCT01615029|65727155|FG003|Overall Study|Physician Decision|0|||
23545286|NCT01615029|65727156|FG004|Overall Study|Physician Decision|1|||
23545287|NCT01615029|65727152|FG000|Overall Study|Ongoing|1|||
23545288|NCT01615029|65727153|FG001|Overall Study|Ongoing|2|||
23545289|NCT01615029|65727154|FG002|Overall Study|Ongoing|3|||
23545290|NCT01615029|65727155|FG003|Overall Study|Ongoing|2|||
23545291|NCT01615029|65727156|FG004|Overall Study|Ongoing|23|||
23733776|NCT01693562|66405594|FG019|Exploration Phase|Withdrawal by Subject|0|||
23733777|NCT01693562|66405595|FG020|Exploration Phase|Withdrawal by Subject|0|||
23733778|NCT01693562|66405596|FG021|Exploration Phase|Withdrawal by Subject|0|||
23733779|NCT01693562|66405597|FG022|Exploration Phase|Withdrawal by Subject|0|||
23733780|NCT01693562|66405575|FG000|Exploration Phase|Death|0|||
23733781|NCT01693562|66405576|FG001|Exploration Phase|Death|0|||
23733782|NCT01693562|66405577|FG002|Exploration Phase|Death|0|||
23733783|NCT01693562|66405578|FG003|Exploration Phase|Death|0|||
23426524|NCT02525939|65307359|FG000|Overall Study|Physician Decision|0|||
23426525|NCT02525939|65307360|FG001|Overall Study|Physician Decision|1|||
23426526|NCT02525939|65307359|FG000|Overall Study|Withdrawal by Subject|24|||
23426527|NCT02525939|65307360|FG001|Overall Study|Withdrawal by Subject|39|||
23426528|NCT02525939|65307359|FG000|Overall Study|Death|180|||
23426529|NCT02525939|65307360|FG001|Overall Study|Death|179|||
23733784|NCT01693562|66405579|FG004|Exploration Phase|Death|0|||
23733785|NCT01693562|66405580|FG005|Exploration Phase|Death|0|||
23733786|NCT01693562|66405581|FG006|Exploration Phase|Death|17|||
23733787|NCT01693562|66405582|FG007|Exploration Phase|Death|0|||
23733788|NCT01693562|66405583|FG008|Exploration Phase|Death|0|||
23733789|NCT01693562|66405584|FG009|Exploration Phase|Death|0|||
23733790|NCT01693562|66405585|FG010|Exploration Phase|Death|0|||
23733791|NCT01693562|66405586|FG011|Exploration Phase|Death|0|||
23733792|NCT01693562|66405587|FG012|Exploration Phase|Death|0|||
23733793|NCT01693562|66405588|FG013|Exploration Phase|Death|0|||
23733794|NCT01693562|66405589|FG014|Exploration Phase|Death|0|||
23733795|NCT01693562|66405590|FG015|Exploration Phase|Death|0|||
23733796|NCT01693562|66405591|FG016|Exploration Phase|Death|0|||
23733797|NCT01693562|66405592|FG017|Exploration Phase|Death|0|||
23733798|NCT01693562|66405593|FG018|Exploration Phase|Death|0|||
23733799|NCT01693562|66405594|FG019|Exploration Phase|Death|0|||
23733800|NCT01693562|66405595|FG020|Exploration Phase|Death|0|||
23733801|NCT01693562|66405596|FG021|Exploration Phase|Death|0|||
23733802|NCT01693562|66405597|FG022|Exploration Phase|Death|0|||
23733803|NCT01693562|66405575|FG000|Exploration Phase|Other|0|||
23733804|NCT01693562|66405576|FG001|Exploration Phase|Other|0|||
23733805|NCT01693562|66405577|FG002|Exploration Phase|Other|0|||
23733806|NCT01693562|66405578|FG003|Exploration Phase|Other|0|||
23733807|NCT01693562|66405579|FG004|Exploration Phase|Other|0|||
23733808|NCT01693562|66405580|FG005|Exploration Phase|Other|0|||
23733809|NCT01693562|66405581|FG006|Exploration Phase|Other|2|||
23733810|NCT01693562|66405582|FG007|Exploration Phase|Other|0|||
23733811|NCT01693562|66405583|FG008|Exploration Phase|Other|0|||
23733812|NCT01693562|66405584|FG009|Exploration Phase|Other|0|||
23733813|NCT01693562|66405585|FG010|Exploration Phase|Other|0|||
23733814|NCT01693562|66405586|FG011|Exploration Phase|Other|0|||
23733815|NCT01693562|66405587|FG012|Exploration Phase|Other|0|||
23733816|NCT01693562|66405588|FG013|Exploration Phase|Other|0|||
23733817|NCT01693562|66405589|FG014|Exploration Phase|Other|0|||
23733818|NCT01693562|66405590|FG015|Exploration Phase|Other|0|||
23733819|NCT01693562|66405591|FG016|Exploration Phase|Other|0|||
23733820|NCT01693562|66405592|FG017|Exploration Phase|Other|0|||
23819071|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819072|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819073|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819074|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819075|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819076|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819077|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819078|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23819079|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23426530|NCT01767493|65307361|FG000|Overall Study|screen failures|3|||
23426531|NCT03187834|65307365|FG000|Overall Study|Lost to Follow-up|0|||
23426532|NCT03187834|65307366|FG001|Overall Study|Lost to Follow-up|1|||
23426533|NCT03187834|65307367|FG002|Overall Study|Lost to Follow-up|2|||
23426534|NCT03187834|65307368|FG003|Overall Study|Lost to Follow-up|2|||
23819080|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
23426535|NCT03187834|65307365|FG000|Overall Study|Had invalid anthropometric measurements|5|||
23426536|NCT03187834|65307366|FG001|Overall Study|Had invalid anthropometric measurements|3|||
23426537|NCT03187834|65307367|FG002|Overall Study|Had invalid anthropometric measurements|4|||
23426538|NCT03187834|65307368|FG003|Overall Study|Had invalid anthropometric measurements|2|||
23733821|NCT01693562|66405593|FG018|Exploration Phase|Other|0|||
23733822|NCT01693562|66405594|FG019|Exploration Phase|Other|0|||
23733823|NCT01693562|66405595|FG020|Exploration Phase|Other|0|||
23733824|NCT01693562|66405596|FG021|Exploration Phase|Other|0|||
23426539|NCT02255565|65307374|FG000|Overall Study|Withdrawal by Subject|0|||
23733825|NCT01693562|66405597|FG022|Exploration Phase|Other|0|||
23733826|NCT01693562|66405575|FG000|Expansion Phase|Withdrawal by Subject|0|||
23733827|NCT01693562|66405576|FG001|Expansion Phase|Withdrawal by Subject|0|||
23733828|NCT01693562|66405577|FG002|Expansion Phase|Withdrawal by Subject|0|||
23733829|NCT01693562|66405578|FG003|Expansion Phase|Withdrawal by Subject|0|||
23733830|NCT01693562|66405579|FG004|Expansion Phase|Withdrawal by Subject|0|||
23819081|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
23819082|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
23819083|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819084|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819085|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819086|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819087|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819088|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819089|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819090|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819091|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819092|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
23819093|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
23819094|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
23819095|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23819096|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819097|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819098|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819099|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819100|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819101|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819102|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819103|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819104|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23819105|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
23819106|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
23733831|NCT01693562|66405580|FG005|Expansion Phase|Withdrawal by Subject|0|||
23733832|NCT01693562|66405581|FG006|Expansion Phase|Withdrawal by Subject|0|||
23733833|NCT01693562|66405582|FG007|Expansion Phase|Withdrawal by Subject|16|||
23733834|NCT01693562|66405583|FG008|Expansion Phase|Withdrawal by Subject|2|||
23733835|NCT01693562|66405584|FG009|Expansion Phase|Withdrawal by Subject|54|||
23733836|NCT01693562|66405585|FG010|Expansion Phase|Withdrawal by Subject|2|||
23733837|NCT01693562|66405586|FG011|Expansion Phase|Withdrawal by Subject|2|||
23733838|NCT01693562|66405587|FG012|Expansion Phase|Withdrawal by Subject|3|||
23733839|NCT01693562|66405588|FG013|Expansion Phase|Withdrawal by Subject|5|||
23733840|NCT01693562|66405589|FG014|Expansion Phase|Withdrawal by Subject|16|||
23733841|NCT01693562|66405590|FG015|Expansion Phase|Withdrawal by Subject|7|||
23733842|NCT01693562|66405591|FG016|Expansion Phase|Withdrawal by Subject|40|||
23733843|NCT01693562|66405592|FG017|Expansion Phase|Withdrawal by Subject|4|||
23733844|NCT01693562|66405593|FG018|Expansion Phase|Withdrawal by Subject|8|||
23733845|NCT01693562|66405594|FG019|Expansion Phase|Withdrawal by Subject|3|||
23733846|NCT01693562|66405595|FG020|Expansion Phase|Withdrawal by Subject|1|||
23733847|NCT01693562|66405596|FG021|Expansion Phase|Withdrawal by Subject|8|||
23733848|NCT01693562|66405597|FG022|Expansion Phase|Withdrawal by Subject|1|||
23733849|NCT01693562|66405575|FG000|Expansion Phase|Death|0|||
23733850|NCT01693562|66405576|FG001|Expansion Phase|Death|0|||
23733851|NCT01693562|66405577|FG002|Expansion Phase|Death|0|||
23733852|NCT01693562|66405578|FG003|Expansion Phase|Death|0|||
23733853|NCT01693562|66405579|FG004|Expansion Phase|Death|0|||
23733854|NCT01693562|66405580|FG005|Expansion Phase|Death|0|||
23733855|NCT01693562|66405581|FG006|Expansion Phase|Death|0|||
23733856|NCT01693562|66405582|FG007|Expansion Phase|Death|42|||
23733857|NCT01693562|66405583|FG008|Expansion Phase|Death|17|||
23733858|NCT01693562|66405584|FG009|Expansion Phase|Death|208|||
23733859|NCT01693562|66405585|FG010|Expansion Phase|Death|30|||
23733860|NCT01693562|66405586|FG011|Expansion Phase|Death|8|||
23733861|NCT01693562|66405587|FG012|Expansion Phase|Death|19|||
23733862|NCT01693562|66405588|FG013|Expansion Phase|Death|42|||
23733863|NCT01693562|66405589|FG014|Expansion Phase|Death|23|||
23733864|NCT01693562|66405590|FG015|Expansion Phase|Death|23|||
23733865|NCT01693562|66405591|FG016|Expansion Phase|Death|128|||
23733866|NCT01693562|66405592|FG017|Expansion Phase|Death|16|||
23733867|NCT01693562|66405593|FG018|Expansion Phase|Death|36|||
23733868|NCT01693562|66405594|FG019|Expansion Phase|Death|16|||
23733869|NCT01693562|66405595|FG020|Expansion Phase|Death|17|||
23733870|NCT01693562|66405596|FG021|Expansion Phase|Death|35|||
23733871|NCT01693562|66405597|FG022|Expansion Phase|Death|7|||
23733872|NCT01693562|66405575|FG000|Expansion Phase|Lost to Follow-up|0|||
23733873|NCT01693562|66405576|FG001|Expansion Phase|Lost to Follow-up|0|||
23819107|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
23819108|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
23819109|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819110|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
23733874|NCT01693562|66405577|FG002|Expansion Phase|Lost to Follow-up|0|||
23618307|NCT01116440|65988249|FG000|Withdrawal|Withdrawal by Subject|0|||
23733875|NCT01693562|66405578|FG003|Expansion Phase|Lost to Follow-up|0|||
23733876|NCT01693562|66405579|FG004|Expansion Phase|Lost to Follow-up|0|||
23733877|NCT01693562|66405580|FG005|Expansion Phase|Lost to Follow-up|0|||
23733878|NCT01693562|66405581|FG006|Expansion Phase|Lost to Follow-up|0|||
23733879|NCT01693562|66405582|FG007|Expansion Phase|Lost to Follow-up|1|||
23733880|NCT01693562|66405583|FG008|Expansion Phase|Lost to Follow-up|2|||
23733881|NCT01693562|66405584|FG009|Expansion Phase|Lost to Follow-up|10|||
23733882|NCT01693562|66405585|FG010|Expansion Phase|Lost to Follow-up|4|||
23733883|NCT01693562|66405586|FG011|Expansion Phase|Lost to Follow-up|4|||
23733884|NCT01693562|66405587|FG012|Expansion Phase|Lost to Follow-up|1|||
23733885|NCT01693562|66405588|FG013|Expansion Phase|Lost to Follow-up|3|||
23733886|NCT01693562|66405589|FG014|Expansion Phase|Lost to Follow-up|0|||
23733887|NCT01693562|66405590|FG015|Expansion Phase|Lost to Follow-up|1|||
23733888|NCT01693562|66405591|FG016|Expansion Phase|Lost to Follow-up|1|||
23733889|NCT01693562|66405592|FG017|Expansion Phase|Lost to Follow-up|0|||
23733890|NCT01693562|66405593|FG018|Expansion Phase|Lost to Follow-up|2|||
23733891|NCT01693562|66405594|FG019|Expansion Phase|Lost to Follow-up|1|||
23733892|NCT01693562|66405595|FG020|Expansion Phase|Lost to Follow-up|2|||
23733893|NCT01693562|66405596|FG021|Expansion Phase|Lost to Follow-up|2|||
23733894|NCT01693562|66405597|FG022|Expansion Phase|Lost to Follow-up|1|||
23733895|NCT01693562|66405575|FG000|Expansion Phase|Other|0|||
23733896|NCT01693562|66405576|FG001|Expansion Phase|Other|0|||
23733897|NCT01693562|66405577|FG002|Expansion Phase|Other|0|||
23733898|NCT01693562|66405578|FG003|Expansion Phase|Other|0|||
23733899|NCT01693562|66405579|FG004|Expansion Phase|Other|0|||
23426540|NCT02255565|65307375|FG001|Overall Study|Withdrawal by Subject|1|||
23733900|NCT01693562|66405580|FG005|Expansion Phase|Other|0|||
23733901|NCT01693562|66405581|FG006|Expansion Phase|Other|0|||
23733902|NCT01693562|66405582|FG007|Expansion Phase|Other|3|||
23733903|NCT01693562|66405583|FG008|Expansion Phase|Other|1|||
23733904|NCT01693562|66405584|FG009|Expansion Phase|Other|28|||
23733905|NCT01693562|66405585|FG010|Expansion Phase|Other|4|||
23733906|NCT01693562|66405586|FG011|Expansion Phase|Other|7|||
23733907|NCT01693562|66405587|FG012|Expansion Phase|Other|0|||
23733908|NCT01693562|66405588|FG013|Expansion Phase|Other|1|||
23733909|NCT01693562|66405589|FG014|Expansion Phase|Other|1|||
23733910|NCT01693562|66405590|FG015|Expansion Phase|Other|0|||
23733911|NCT01693562|66405591|FG016|Expansion Phase|Other|28|||
23733912|NCT01693562|66405592|FG017|Expansion Phase|Other|0|||
23733913|NCT01693562|66405593|FG018|Expansion Phase|Other|1|||
23733914|NCT01693562|66405594|FG019|Expansion Phase|Other|0|||
23733915|NCT01693562|66405595|FG020|Expansion Phase|Other|1|||
23733916|NCT01693562|66405596|FG021|Expansion Phase|Other|17|||
23733917|NCT01693562|66405597|FG022|Expansion Phase|Other|1|||
23733918|NCT03590613|66405599|FG000|Period 2, 4 Days|Physician Decision|0|||
23733919|NCT03590613|66405600|FG001|Period 2, 4 Days|Physician Decision|0|||
23733920|NCT03590613|66405601|FG002|Period 2, 4 Days|Physician Decision|0|||
23733921|NCT03590613|66405602|FG003|Period 2, 4 Days|Physician Decision|1|||
23733922|NCT04490499|66405603|FG000|Overall Study|Withdrawal by Subject|2|||
23733923|NCT01058356|66405616|FG000|Overall Study|Adverse Event|5|||
23733924|NCT01058356|66405616|FG000|Overall Study|Administration of contraindicated drugs|12|||
23733925|NCT01058356|66405616|FG000|Overall Study|Withdrawal by Subject|21|||
23733926|NCT01058356|66405616|FG000|Overall Study|Lost to Follow-up|4|||
23733927|NCT00775138|66405619|FG000|Overall Study|Withdrawal by Subject|0|||
23733928|NCT00775138|66405620|FG001|Overall Study|Withdrawal by Subject|0|||
23733929|NCT00775138|66405621|FG002|Overall Study|Withdrawal by Subject|2|||
23733930|NCT00775138|66405622|FG003|Overall Study|Withdrawal by Subject|2|||
23733931|NCT00775138|66405619|FG000|Overall Study|Adverse Event|0|||
23733932|NCT00775138|66405620|FG001|Overall Study|Adverse Event|0|||
23733933|NCT00775138|66405621|FG002|Overall Study|Adverse Event|1|||
23733934|NCT00775138|66405622|FG003|Overall Study|Adverse Event|0|||
23733935|NCT00836953|66405623|FG000|Overall Study|Withdrawal by Subject|1|||
23733936|NCT00836953|66405623|FG000|Overall Study|Lost to Follow-up|1|||
23733937|NCT01227252|66405624|FG000|Overall Study|Sponsor Decision|0|||
23733938|NCT01227252|66405625|FG001|Overall Study|Sponsor Decision|1|||
23733939|NCT01227252|66405626|FG002|Overall Study|Sponsor Decision|0|||
23733940|NCT01227252|66405627|FG003|Overall Study|Sponsor Decision|0|||
23733941|NCT01227252|66405624|FG000|Overall Study|Lost to Follow-up|0|||
23733942|NCT01227252|66405625|FG001|Overall Study|Lost to Follow-up|1|||
23733943|NCT01227252|66405626|FG002|Overall Study|Lost to Follow-up|0|||
23733944|NCT01227252|66405627|FG003|Overall Study|Lost to Follow-up|0|||
23733945|NCT01227252|66405624|FG000|Overall Study|Withdrawal by Subject|0|||
23733946|NCT01227252|66405625|FG001|Overall Study|Withdrawal by Subject|1|||
23733947|NCT01227252|66405626|FG002|Overall Study|Withdrawal by Subject|0|||
23733948|NCT01227252|66405627|FG003|Overall Study|Withdrawal by Subject|0|||
23733949|NCT00550615|66405628|FG000|Overall Study|Withdrawal by Subject|0|||
23733950|NCT00550615|66405629|FG001|Overall Study|Withdrawal by Subject|0|||
23733951|NCT00550615|66405630|FG002|Overall Study|Withdrawal by Subject|2|||
23733952|NCT00550615|66405631|FG003|Overall Study|Withdrawal by Subject|3|||
23733953|NCT00550615|66405628|FG000|Overall Study|Not evaluable|0|||
23733954|NCT00550615|66405629|FG001|Overall Study|Not evaluable|0|||
23733955|NCT00550615|66405630|FG002|Overall Study|Not evaluable|2|||
23733956|NCT00550615|66405631|FG003|Overall Study|Not evaluable|7|||
23733957|NCT02477800|66405634|FG000|Placebo-Controlled Period|Adverse Event|16|||
23733958|NCT02477800|66405635|FG001|Placebo-Controlled Period|Adverse Event|25|||
23733959|NCT02477800|66405636|FG002|Placebo-Controlled Period|Adverse Event|28|||
23733960|NCT02477800|66405637|FG003|Placebo-Controlled Period|Adverse Event|0|||
23733961|NCT02477800|66405638|FG004|Placebo-Controlled Period|Adverse Event|0|||
23733962|NCT02477800|66405639|FG005|Placebo-Controlled Period|Adverse Event|0|||
23733963|NCT02477800|66405640|FG006|Placebo-Controlled Period|Adverse Event|0|||
23733964|NCT02477800|66405634|FG000|Placebo-Controlled Period|Change of Treatment|1|||
23733965|NCT02477800|66405635|FG001|Placebo-Controlled Period|Change of Treatment|2|||
23733966|NCT02477800|66405636|FG002|Placebo-Controlled Period|Change of Treatment|1|||
23733967|NCT02477800|66405637|FG003|Placebo-Controlled Period|Change of Treatment|0|||
23733968|NCT02477800|66405638|FG004|Placebo-Controlled Period|Change of Treatment|0|||
23733969|NCT02477800|66405639|FG005|Placebo-Controlled Period|Change of Treatment|0|||
23733970|NCT02477800|66405640|FG006|Placebo-Controlled Period|Change of Treatment|0|||
23733971|NCT02477800|66405634|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
23733972|NCT02477800|66405635|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
23733973|NCT02477800|66405636|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
23733974|NCT02477800|66405637|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
23733975|NCT02477800|66405638|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
23733976|NCT02477800|66405639|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
23819111|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819112|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819113|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819114|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819115|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819116|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819117|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819118|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
23819119|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
23545292|NCT00096135|65727159|FG000|Overall Study|Physician Decision|20|||
23819120|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
23545293|NCT00096135|65727160|FG001|Overall Study|Physician Decision|4|||
23819121|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
23819122|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819123|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23545294|NCT00096135|65727159|FG000|Overall Study|Refusal of further protocol therapy|4|||
23545295|NCT00096135|65727160|FG001|Overall Study|Refusal of further protocol therapy|1|||
23819124|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819125|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819126|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819127|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819128|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819129|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819130|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23733977|NCT02477800|66405640|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
23733978|NCT02477800|66405634|FG000|Placebo-Controlled Period|Death|0|||
23733979|NCT02477800|66405635|FG001|Placebo-Controlled Period|Death|3|||
23733980|NCT02477800|66405636|FG002|Placebo-Controlled Period|Death|2|||
23733981|NCT02477800|66405637|FG003|Placebo-Controlled Period|Death|0|||
23733982|NCT02477800|66405638|FG004|Placebo-Controlled Period|Death|0|||
23733983|NCT02477800|66405639|FG005|Placebo-Controlled Period|Death|0|||
23733984|NCT02477800|66405640|FG006|Placebo-Controlled Period|Death|0|||
23733985|NCT02477800|66405634|FG000|Placebo-Controlled Period|Disease Progression|1|||
23733986|NCT02477800|66405635|FG001|Placebo-Controlled Period|Disease Progression|0|||
23733987|NCT02477800|66405636|FG002|Placebo-Controlled Period|Disease Progression|1|||
23733988|NCT02477800|66405637|FG003|Placebo-Controlled Period|Disease Progression|0|||
23733989|NCT02477800|66405638|FG004|Placebo-Controlled Period|Disease Progression|0|||
23733990|NCT02477800|66405639|FG005|Placebo-Controlled Period|Disease Progression|0|||
23733991|NCT02477800|66405640|FG006|Placebo-Controlled Period|Disease Progression|0|||
23733992|NCT02477800|66405634|FG000|Placebo-Controlled Period|Investigator Decision|3|||
23733993|NCT02477800|66405635|FG001|Placebo-Controlled Period|Investigator Decision|2|||
23733994|NCT02477800|66405636|FG002|Placebo-Controlled Period|Investigator Decision|1|||
23733995|NCT02477800|66405637|FG003|Placebo-Controlled Period|Investigator Decision|0|||
23733996|NCT02477800|66405638|FG004|Placebo-Controlled Period|Investigator Decision|0|||
23733997|NCT02477800|66405639|FG005|Placebo-Controlled Period|Investigator Decision|0|||
23733998|NCT02477800|66405640|FG006|Placebo-Controlled Period|Investigator Decision|0|||
23733999|NCT02477800|66405634|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
23734000|NCT02477800|66405635|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
23734001|NCT02477800|66405636|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
23734002|NCT02477800|66405637|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
23734003|NCT02477800|66405638|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
23734004|NCT02477800|66405639|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
23545296|NCT00096135|65727159|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
23545297|NCT00096135|65727160|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
23545298|NCT00096135|65727159|FG000|Overall Study|Other, specify|15|||
23545299|NCT00096135|65727160|FG001|Overall Study|Other, specify|3|||
23545300|NCT00096135|65727159|FG000|Overall Study|Ineligible|2|||
23545301|NCT00096135|65727160|FG001|Overall Study|Ineligible|0|||
23545302|NCT04837482|65727161|FG000|Period 2|Withdrawal by Subject|0|||
23545303|NCT04837482|65727162|FG001|Period 2|Withdrawal by Subject|1|||
23545304|NCT02044510|65727163|FG000|Overall Study|Adverse Event|1|||
23545305|NCT02044510|65727164|FG001|Overall Study|Adverse Event|2|||
23545306|NCT03515837|65727167|FG000|Overall Study|Death|219|||
23545307|NCT03515837|65727168|FG001|Overall Study|Death|227|||
23545308|NCT03515837|65727167|FG000|Overall Study|Lost to Follow-up|0|||
23545309|NCT03515837|65727168|FG001|Overall Study|Lost to Follow-up|1|||
23545310|NCT03515837|65727167|FG000|Overall Study|Withdrawal by Subject|0|||
23545311|NCT03515837|65727168|FG001|Overall Study|Withdrawal by Subject|4|||
23545312|NCT03515837|65727167|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
23545313|NCT03515837|65727168|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
23545314|NCT00622167|65727177|FG000|Overall Study|Did not meet angiographic criteria|20|||
23545315|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
23545316|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
23545317|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
23545318|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
23545319|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
23545320|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23545321|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
23545322|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23545323|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
23545324|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
23545325|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
23545326|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
23545327|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23819131|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
23545328|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23819132|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
23819133|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819134|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23819135|NCT04707313|66717461|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819136|NCT04707313|66717462|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819137|NCT04707313|66717463|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819138|NCT04707313|66717464|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819139|NCT04707313|66717465|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819140|NCT04707313|66717466|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819141|NCT04707313|66717467|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819142|NCT04707313|66717468|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819143|NCT04707313|66717469|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23819144|NCT04707313|66717470|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
23819145|NCT04707313|66717471|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
23819146|NCT04707313|66717472|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
23819147|NCT04707313|66717473|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
23819148|NCT00720382|66717474|FG000|Overall Study|Adverse Event|54|||
23819149|NCT00720382|66717475|FG001|Overall Study|Adverse Event|17|||
23819150|NCT00720382|66717474|FG000|Overall Study|Lack of Efficacy|18|||
23819151|NCT00720382|66717475|FG001|Overall Study|Lack of Efficacy|7|||
23819152|NCT00720382|66717474|FG000|Overall Study|Non-Compliance|15|||
23819153|NCT00720382|66717475|FG001|Overall Study|Non-Compliance|5|||
23819154|NCT00720382|66717474|FG000|Overall Study|Withdrawal by Subject|47|||
23819155|NCT00720382|66717475|FG001|Overall Study|Withdrawal by Subject|11|||
23819156|NCT00720382|66717474|FG000|Overall Study|Lost to Follow-up|28|||
23819157|NCT00720382|66717475|FG001|Overall Study|Lost to Follow-up|14|||
23819158|NCT00720382|66717474|FG000|Overall Study|administrative|14|||
23819159|NCT00720382|66717475|FG001|Overall Study|administrative|5|||
23819160|NCT04388553|66717476|FG000|Overall Study|Protocol Violation|1|||
23819161|NCT04388553|66717477|FG001|Overall Study|Protocol Violation|0|||
23819162|NCT01038297|66717479|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
23819163|NCT01038297|66717480|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
23819164|NCT01038297|66717481|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
23819165|NCT04562155|66717482|FG000|Overall Study|COVID-19 pandemic|0|||
23819166|NCT04562155|66717483|FG001|Overall Study|COVID-19 pandemic|0|||
23819167|NCT04562155|66717484|FG002|Overall Study|COVID-19 pandemic|0|||
23819168|NCT04562155|66717485|FG003|Overall Study|COVID-19 pandemic|1|||
23819169|NCT04562155|66717482|FG000|Overall Study|Adverse Event|7|||
23819170|NCT04562155|66717483|FG001|Overall Study|Adverse Event|3|||
23819171|NCT04562155|66717484|FG002|Overall Study|Adverse Event|8|||
23819172|NCT04562155|66717485|FG003|Overall Study|Adverse Event|1|||
23819173|NCT04562155|66717482|FG000|Overall Study|Withdrawal by Subject|3|||
23819174|NCT04562155|66717483|FG001|Overall Study|Withdrawal by Subject|6|||
23819175|NCT04562155|66717484|FG002|Overall Study|Withdrawal by Subject|3|||
23819176|NCT04562155|66717485|FG003|Overall Study|Withdrawal by Subject|3|||
23819177|NCT04562155|66717482|FG000|Overall Study|Participant personal reason|1|||
23819178|NCT04562155|66717483|FG001|Overall Study|Participant personal reason|0|||
23819179|NCT04562155|66717484|FG002|Overall Study|Participant personal reason|2|||
23819180|NCT04562155|66717485|FG003|Overall Study|Participant personal reason|1|||
23819181|NCT01068262|66717486|FG000|Overall Study|Adverse Event|2|||
23819182|NCT01068262|66717487|FG001|Overall Study|Adverse Event|0|||
23819183|NCT01068262|66717488|FG002|Overall Study|Adverse Event|1|||
23819184|NCT01068262|66717489|FG003|Overall Study|Adverse Event|0|||
23819185|NCT01068262|66717486|FG000|Overall Study|Protocol Violation|1|||
23819186|NCT01068262|66717487|FG001|Overall Study|Protocol Violation|0|||
23819187|NCT01068262|66717488|FG002|Overall Study|Protocol Violation|0|||
23819188|NCT01068262|66717489|FG003|Overall Study|Protocol Violation|0|||
23819189|NCT01068262|66717486|FG000|Overall Study|Withdrawal by Subject|0|||
23819190|NCT01068262|66717487|FG001|Overall Study|Withdrawal by Subject|1|||
23819191|NCT01068262|66717488|FG002|Overall Study|Withdrawal by Subject|0|||
23819192|NCT01068262|66717489|FG003|Overall Study|Withdrawal by Subject|0|||
23819193|NCT03279692|66717490|FG000|Overall Study|Withdrawal by Subject|1|||
23426541|NCT02255565|65307376|FG002|Overall Study|Withdrawal by Subject|0|||
23819194|NCT01544179|66717496|FG000|Overall Study|Death|50|||
23819195|NCT01544179|66717497|FG001|Overall Study|Death|37|||
23819196|NCT01544179|66717496|FG000|Overall Study|Lost to Follow-up|0|||
23426542|NCT00434759|65307379|FG000|Overall Study|Lack of Efficacy|5|||
23819197|NCT01544179|66717497|FG001|Overall Study|Lost to Follow-up|1|||
23819198|NCT01544179|66717496|FG000|Overall Study|Adverse Event|0|||
23819199|NCT01544179|66717497|FG001|Overall Study|Adverse Event|1|||
23819200|NCT01544179|66717496|FG000|Overall Study|Withdrawal by Subject|12|||
23819201|NCT01544179|66717497|FG001|Overall Study|Withdrawal by Subject|7|||
23819202|NCT01544179|66717496|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23819203|NCT01544179|66717497|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23819204|NCT03452137|66717498|FG000|Overall Study|Death|67|||
23819205|NCT03452137|66717499|FG001|Overall Study|Death|70|||
23819206|NCT03452137|66717498|FG000|Overall Study|Lost to Follow-up|4|||
23819207|NCT03452137|66717499|FG001|Overall Study|Lost to Follow-up|2|||
23819208|NCT03452137|66717498|FG000|Overall Study|Physician Decision|0|||
23819209|NCT03452137|66717499|FG001|Overall Study|Physician Decision|1|||
23819210|NCT03452137|66717498|FG000|Overall Study|Study Terminated by Sponsor|120|||
23819211|NCT03452137|66717499|FG001|Overall Study|Study Terminated by Sponsor|121|||
23819212|NCT03452137|66717498|FG000|Overall Study|Withdrawal by Subject|12|||
23819213|NCT03452137|66717499|FG001|Overall Study|Withdrawal by Subject|9|||
23819214|NCT03516513|66717502|FG000|Overall Study|Withdrawal by Subject|2|||
23819215|NCT03516513|66717503|FG001|Overall Study|Withdrawal by Subject|2|||
23819216|NCT03516513|66717504|FG002|Overall Study|Withdrawal by Subject|0|||
23819217|NCT03516513|66717505|FG003|Overall Study|Withdrawal by Subject|0|||
23819218|NCT00191165|66717508|FG000|Overall Study|Adverse Event|2|||
23819219|NCT00191165|66717509|FG001|Overall Study|Adverse Event|0|||
23819220|NCT00191165|66717508|FG000|Overall Study|Protocol Violation|0|||
23819221|NCT00191165|66717509|FG001|Overall Study|Protocol Violation|1|||
23819222|NCT00191165|66717508|FG000|Overall Study|Participant Moved Away|0|||
23819223|NCT00191165|66717509|FG001|Overall Study|Participant Moved Away|1|||
23819224|NCT00397514|66717510|FG000|Overall Study|Withdrawal by Subject|1|||
23819225|NCT00397514|66717510|FG000|Overall Study|Pacing wire malfunction|1|||
23819226|NCT00397514|66717510|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
23819227|NCT00397514|66717510|FG000|Overall Study|early extubation|2|||
23819228|NCT00397514|66717510|FG000|Overall Study|poor echocardiographic windows|1|||
23819229|NCT03390426|66717511|FG000|Overall Study|Protocol Violation|0|||
23819230|NCT03390426|66717512|FG001|Overall Study|Protocol Violation|1|||
23819231|NCT00801099|66717513|FG000|Overall Study|Lost to Follow-up|101|||
23819232|NCT03340974|66717515|FG000|Completion of Study -Long Term Follow up|Death|8|||
23819233|NCT03340974|66717516|FG001|Completion of Study -Long Term Follow up|Death|5|||
23819234|NCT03340974|66717517|FG002|Completion of Study -Long Term Follow up|Death|5|||
23819235|NCT03340974|66717518|FG003|Completion of Study -Long Term Follow up|Death|7|||
23819236|NCT03340974|66717515|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
23819237|NCT03340974|66717516|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
23819238|NCT03340974|66717517|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
23819239|NCT03340974|66717518|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
23819240|NCT03340974|66717515|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
23819241|NCT03340974|66717516|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
23819242|NCT03340974|66717517|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
23819243|NCT03340974|66717518|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
23819244|NCT03340974|66717515|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
23819245|NCT03340974|66717516|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
23819246|NCT03340974|66717517|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
23819247|NCT03340974|66717518|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
23819248|NCT04233073|66717524|FG000|Overall Study|Death|5|||
23819249|NCT04975191|66717529|FG000|Overall Study|Protocol Violation|1|||
23819250|NCT04975191|66717530|FG001|Overall Study|Protocol Violation|2|||
23819251|NCT04975191|66717531|FG002|Overall Study|Protocol Violation|2|||
23819252|NCT04975191|66717532|FG003|Overall Study|Protocol Violation|2|||
23819253|NCT04975191|66717529|FG000|Overall Study|Lost to Follow-up|13|||
23819254|NCT04975191|66717530|FG001|Overall Study|Lost to Follow-up|3|||
23819255|NCT04975191|66717531|FG002|Overall Study|Lost to Follow-up|8|||
23819256|NCT04975191|66717532|FG003|Overall Study|Lost to Follow-up|8|||
23819257|NCT02027428|66717538|FG000|Induction|Never treated|7|||
23819258|NCT02027428|66717539|FG001|Induction|Never treated|0|||
23819259|NCT02027428|66717540|FG002|Induction|Never treated|0|||
23819260|NCT02027428|66717538|FG000|Induction|Progressive disease|77|||
23819261|NCT02027428|66717539|FG001|Induction|Progressive disease|0|||
23819262|NCT02027428|66717540|FG002|Induction|Progressive disease|0|||
23819263|NCT02027428|66717538|FG000|Induction|Adverse Event|51|||
23819264|NCT02027428|66717539|FG001|Induction|Adverse Event|0|||
23819265|NCT02027428|66717540|FG002|Induction|Adverse Event|0|||
23819266|NCT02027428|66717538|FG000|Induction|Withdrawal by Subject|22|||
23819267|NCT02027428|66717539|FG001|Induction|Withdrawal by Subject|0|||
23819268|NCT02027428|66717540|FG002|Induction|Withdrawal by Subject|0|||
23819269|NCT02027428|66717538|FG000|Induction|Death|21|||
23819270|NCT02027428|66717539|FG001|Induction|Death|0|||
23819271|NCT02027428|66717540|FG002|Induction|Death|0|||
23819272|NCT02027428|66717538|FG000|Induction|Symptomatic deterioration|16|||
23819273|NCT02027428|66717539|FG001|Induction|Symptomatic deterioration|0|||
23819274|NCT02027428|66717540|FG002|Induction|Symptomatic deterioration|0|||
23819275|NCT02027428|66717538|FG000|Induction|Study terminated by sponsor|12|||
23819276|NCT02027428|66717539|FG001|Induction|Study terminated by sponsor|0|||
23819277|NCT02027428|66717540|FG002|Induction|Study terminated by sponsor|0|||
23819278|NCT02027428|66717538|FG000|Induction|Protocol Violation|1|||
23618308|NCT01116440|65988250|FG001|Withdrawal|Withdrawal by Subject|1|||
23618309|NCT01116440|65988249|FG000|Withdrawal|Lost to Follow-up|0|||
23618310|NCT01116440|65988250|FG001|Withdrawal|Lost to Follow-up|1|||
23618311|NCT01116440|65988249|FG000|Follow-up|Lost to Follow-up|0|||
23618312|NCT01116440|65988250|FG001|Follow-up|Lost to Follow-up|1|||
23618313|NCT01116440|65988249|FG000|Follow-up|Withdrawal by Subject|0|||
23734005|NCT02477800|66405640|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
23618314|NCT01116440|65988250|FG001|Follow-up|Withdrawal by Subject|1|||
23618315|NCT01184859|65988251|FG000|Period 1: Single Dose|Insufficient urine production|0|||
23618316|NCT01184859|65988252|FG001|Period 1: Single Dose|Insufficient urine production|1|||
23734006|NCT02477800|66405634|FG000|Placebo-Controlled Period|Relocation|2|||
23734007|NCT02477800|66405635|FG001|Placebo-Controlled Period|Relocation|0|||
23734008|NCT02477800|66405636|FG002|Placebo-Controlled Period|Relocation|0|||
23734009|NCT02477800|66405637|FG003|Placebo-Controlled Period|Relocation|0|||
23734010|NCT02477800|66405638|FG004|Placebo-Controlled Period|Relocation|0|||
23734011|NCT02477800|66405639|FG005|Placebo-Controlled Period|Relocation|0|||
23734012|NCT02477800|66405640|FG006|Placebo-Controlled Period|Relocation|0|||
23734013|NCT02477800|66405634|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23734014|NCT02477800|66405635|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23734015|NCT02477800|66405636|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23734016|NCT02477800|66405637|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23734017|NCT02477800|66405638|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23734018|NCT02477800|66405639|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23734019|NCT02477800|66405640|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23734020|NCT02477800|66405634|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
23734021|NCT02477800|66405635|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
23734022|NCT02477800|66405636|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23734023|NCT02477800|66405637|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23734024|NCT02477800|66405638|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23819279|NCT02027428|66717539|FG001|Induction|Protocol Violation|0|||
23734025|NCT02477800|66405639|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23734026|NCT02477800|66405640|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23734027|NCT02477800|66405634|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
23734028|NCT02477800|66405635|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
23426543|NCT00434759|65307380|FG001|Overall Study|Lack of Efficacy|4|||
23426544|NCT00434759|65307379|FG000|Overall Study|Withdrawal by Subject|17|||
23426545|NCT00434759|65307380|FG001|Overall Study|Withdrawal by Subject|1|||
23426546|NCT00434759|65307379|FG000|Overall Study|family affairs|2|||
23426547|NCT00434759|65307380|FG001|Overall Study|family affairs|0|||
23426548|NCT02251717|65307381|FG000|Overall Study|Adverse Event|0|||
23426549|NCT02251717|65307382|FG001|Overall Study|Adverse Event|1|||
23426550|NCT02251717|65307381|FG000|Overall Study|Withdrew Consent|1|||
23426551|NCT02251717|65307382|FG001|Overall Study|Withdrew Consent|0|||
23426552|NCT01155466|65307384|FG000|Overall Study|Adverse Event|13|||
23426553|NCT01155466|65307385|FG001|Overall Study|Adverse Event|15|||
23426554|NCT01155466|65307386|FG002|Overall Study|Adverse Event|6|||
23426555|NCT01155466|65307387|FG003|Overall Study|Adverse Event|17|||
23426556|NCT01155466|65307388|FG004|Overall Study|Adverse Event|18|||
23426557|NCT01155466|65307384|FG000|Overall Study|Lost to Follow-up|0|||
23426558|NCT01155466|65307385|FG001|Overall Study|Lost to Follow-up|0|||
23426559|NCT01155466|65307386|FG002|Overall Study|Lost to Follow-up|0|||
23426560|NCT01155466|65307387|FG003|Overall Study|Lost to Follow-up|0|||
23426561|NCT01155466|65307388|FG004|Overall Study|Lost to Follow-up|2|||
23426562|NCT01155466|65307384|FG000|Overall Study|Withdrawal by Subject|7|||
23426563|NCT01155466|65307385|FG001|Overall Study|Withdrawal by Subject|5|||
23426564|NCT01155466|65307386|FG002|Overall Study|Withdrawal by Subject|9|||
23426565|NCT01155466|65307387|FG003|Overall Study|Withdrawal by Subject|4|||
23426566|NCT01155466|65307388|FG004|Overall Study|Withdrawal by Subject|4|||
23426567|NCT01155466|65307384|FG000|Overall Study|Protocol Violation|0|||
23426568|NCT01155466|65307385|FG001|Overall Study|Protocol Violation|0|||
23426569|NCT01155466|65307386|FG002|Overall Study|Protocol Violation|2|||
23426570|NCT01155466|65307387|FG003|Overall Study|Protocol Violation|0|||
23426571|NCT01155466|65307388|FG004|Overall Study|Protocol Violation|1|||
23426572|NCT01155466|65307384|FG000|Overall Study|Administrative|0|||
23426573|NCT01155466|65307385|FG001|Overall Study|Administrative|3|||
23426574|NCT01155466|65307386|FG002|Overall Study|Administrative|0|||
23426575|NCT01155466|65307387|FG003|Overall Study|Administrative|0|||
23426576|NCT01155466|65307388|FG004|Overall Study|Administrative|0|||
23426577|NCT01155466|65307384|FG000|Overall Study|Randomized not treated|2|||
23426578|NCT01155466|65307385|FG001|Overall Study|Randomized not treated|2|||
23426579|NCT01155466|65307386|FG002|Overall Study|Randomized not treated|3|||
23426580|NCT01155466|65307387|FG003|Overall Study|Randomized not treated|0|||
23426581|NCT01155466|65307388|FG004|Overall Study|Randomized not treated|2|||
23426582|NCT02776033|65307389|FG000|Overall Study|Withdrawal by Subject|0|||
23426583|NCT02776033|65307390|FG001|Overall Study|Withdrawal by Subject|0|||
23426584|NCT02776033|65307391|FG002|Overall Study|Withdrawal by Subject|2|||
23426585|NCT02776033|65307389|FG000|Overall Study|Physician Decision|2|||
23426586|NCT02776033|65307390|FG001|Overall Study|Physician Decision|0|||
23426587|NCT02776033|65307391|FG002|Overall Study|Physician Decision|0|||
23426588|NCT02776033|65307389|FG000|Overall Study|Lost to Follow-up|1|||
23426589|NCT02776033|65307390|FG001|Overall Study|Lost to Follow-up|0|||
23426590|NCT02776033|65307391|FG002|Overall Study|Lost to Follow-up|0|||
23426591|NCT02776033|65307389|FG000|Overall Study|Adverse Event|1|||
23426592|NCT02776033|65307390|FG001|Overall Study|Adverse Event|2|||
23426593|NCT02776033|65307391|FG002|Overall Study|Adverse Event|0|||
23618317|NCT01184859|65988253|FG002|Period 1: Single Dose|Insufficient urine production|0|||
23618318|NCT01184859|65988254|FG003|Period 1: Single Dose|Insufficient urine production|0|||
23618319|NCT01184859|65988255|FG004|Period 1: Single Dose|Insufficient urine production|0|||
23618320|NCT01184859|65988251|FG000|Period 1: Single Dose|Protocol Violation|0|||
23618321|NCT01184859|65988252|FG001|Period 1: Single Dose|Protocol Violation|1|||
23618322|NCT01184859|65988253|FG002|Period 1: Single Dose|Protocol Violation|0|||
23618323|NCT01184859|65988254|FG003|Period 1: Single Dose|Protocol Violation|0|||
23618324|NCT01184859|65988255|FG004|Period 1: Single Dose|Protocol Violation|0|||
23618325|NCT01184859|65988251|FG000|Period 1: Single Dose|Adverse Event|0|||
23618326|NCT01184859|65988252|FG001|Period 1: Single Dose|Adverse Event|0|||
23618327|NCT01184859|65988253|FG002|Period 1: Single Dose|Adverse Event|0|||
23618328|NCT01184859|65988254|FG003|Period 1: Single Dose|Adverse Event|0|||
23618329|NCT01184859|65988255|FG004|Period 1: Single Dose|Adverse Event|1|||
23618330|NCT01184859|65988251|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618331|NCT01184859|65988252|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618332|NCT01184859|65988253|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618333|NCT01184859|65988254|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618334|NCT01184859|65988255|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
23618335|NCT01184859|65988251|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
23618336|NCT01184859|65988252|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618337|NCT01184859|65988253|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618338|NCT01184859|65988254|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618339|NCT01184859|65988255|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618340|NCT03275402|65988256|FG000|Overall Study|Death|17|||
23618341|NCT03275402|65988256|FG000|Overall Study|Study terminated by sponsor|21|||
23618342|NCT03275402|65988256|FG000|Overall Study|Withdrawal by Subject|1|||
23618343|NCT01732627|65988257|FG000|Overall Study|Withdrawal by Subject|1|||
23618344|NCT01732627|65988258|FG001|Overall Study|Withdrawal by Subject|0|||
23618345|NCT02131155|65988259|FG000|Overall Study|Adverse Event|1|||
23618346|NCT02131155|65988260|FG001|Overall Study|Adverse Event|0|||
23618347|NCT02131155|65988259|FG000|Overall Study|Treatment completed|1|||
23618348|NCT02131155|65988260|FG001|Overall Study|Treatment completed|0|||
23618349|NCT02131155|65988259|FG000|Overall Study|Primary tumour recurrence|2|||
23618350|NCT02131155|65988260|FG001|Overall Study|Primary tumour recurrence|1|||
23618351|NCT02131155|65988259|FG000|Overall Study|Refused to continue study medication|1|||
23618352|NCT02131155|65988260|FG001|Overall Study|Refused to continue study medication|0|||
23618353|NCT02131155|65988259|FG000|Overall Study|Study early termination|20|||
23618354|NCT02131155|65988260|FG001|Overall Study|Study early termination|10|||
23618355|NCT01878253|65988261|FG000|Overall Study|Death|1|||
23618356|NCT01878253|65988261|FG000|Overall Study|SIdus System Removal|3|||
23618357|NCT01878253|65988261|FG000|Overall Study|Withdrawal by Subject|1|||
23618358|NCT01878253|65988261|FG000|Overall Study|Lost to Follow-up|2|||
23618359|NCT01878253|65988261|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
23618360|NCT00372255|65988262|FG000|Overall Study|Withdrawn for other reasons|2|||
23618361|NCT00372255|65988263|FG001|Overall Study|Withdrawn for other reasons|1|||
23618362|NCT01251887|65988264|FG000|Overall Study|Scheduling conflict|1|||
23618363|NCT01251887|65988265|FG001|Overall Study|Scheduling conflict|2|||
23618364|NCT01251887|65988266|FG002|Overall Study|Scheduling conflict|2|||
23618365|NCT01251887|65988264|FG000|Overall Study|Physician Decision|0|||
23618366|NCT01251887|65988265|FG001|Overall Study|Physician Decision|1|||
23618367|NCT01251887|65988266|FG002|Overall Study|Physician Decision|0|||
23618368|NCT01026103|65988267|FG000|Overall Study|Physician Decision|1|||
23618369|NCT01026103|65988267|FG000|Overall Study|did not receive study device bc of error|1|||
23618370|NCT01732926|65988270|FG000|Overall Study|Study Terminated by Sponsor|168|||
23618371|NCT01732926|65988271|FG001|Overall Study|Study Terminated by Sponsor|80|||
23618372|NCT01732926|65988270|FG000|Overall Study|Withdrawal by Subject|46|||
23618373|NCT01732926|65988271|FG001|Overall Study|Withdrawal by Subject|8|||
23618374|NCT01732926|65988270|FG000|Overall Study|Physician Decision|24|||
23618375|NCT01732926|65988271|FG001|Overall Study|Physician Decision|11|||
23618376|NCT01732926|65988270|FG000|Overall Study|Other Reason|21|||
23618377|NCT01732926|65988271|FG001|Overall Study|Other Reason|4|||
23618378|NCT01732926|65988270|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
23426594|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
23426595|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
23734029|NCT02477800|66405636|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
23734030|NCT02477800|66405637|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
23734031|NCT02477800|66405638|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
23426596|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
23426597|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
23734032|NCT02477800|66405639|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
23734033|NCT02477800|66405640|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
23734034|NCT02477800|66405634|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23734035|NCT02477800|66405635|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
23734036|NCT02477800|66405636|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
23426598|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Other|2|||
23426599|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Other|2|||
23734037|NCT02477800|66405637|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23734038|NCT02477800|66405638|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23734039|NCT02477800|66405639|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23734040|NCT02477800|66405640|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23734041|NCT02477800|66405634|FG000|Placebo-Controlled Period|Reason not Specified|161|||
23734042|NCT02477800|66405635|FG001|Placebo-Controlled Period|Reason not Specified|161|||
23734043|NCT02477800|66405636|FG002|Placebo-Controlled Period|Reason not Specified|189|||
23734044|NCT02477800|66405637|FG003|Placebo-Controlled Period|Reason not Specified|0|||
23734045|NCT02477800|66405638|FG004|Placebo-Controlled Period|Reason not Specified|0|||
23734046|NCT02477800|66405639|FG005|Placebo-Controlled Period|Reason not Specified|0|||
23734047|NCT02477800|66405640|FG006|Placebo-Controlled Period|Reason not Specified|0|||
23734048|NCT02477800|66405634|FG000|Long Term Extension Period|Adverse Event|0|||
23734049|NCT02477800|66405635|FG001|Long Term Extension Period|Adverse Event|0|||
23734050|NCT02477800|66405636|FG002|Long Term Extension Period|Adverse Event|0|||
23734051|NCT02477800|66405637|FG003|Long Term Extension Period|Adverse Event|6|||
23734052|NCT02477800|66405638|FG004|Long Term Extension Period|Adverse Event|2|||
23734053|NCT02477800|66405639|FG005|Long Term Extension Period|Adverse Event|4|||
23734054|NCT02477800|66405640|FG006|Long Term Extension Period|Adverse Event|3|||
23734055|NCT02477800|66405634|FG000|Long Term Extension Period|Death|0|||
23734056|NCT02477800|66405635|FG001|Long Term Extension Period|Death|0|||
23734057|NCT02477800|66405636|FG002|Long Term Extension Period|Death|0|||
23734058|NCT02477800|66405637|FG003|Long Term Extension Period|Death|1|||
23734059|NCT02477800|66405638|FG004|Long Term Extension Period|Death|1|||
23734060|NCT02477800|66405639|FG005|Long Term Extension Period|Death|1|||
23734061|NCT02477800|66405640|FG006|Long Term Extension Period|Death|2|||
23734062|NCT02477800|66405634|FG000|Long Term Extension Period|Consent Withdrawn|0|||
23734063|NCT02477800|66405635|FG001|Long Term Extension Period|Consent Withdrawn|0|||
23734064|NCT02477800|66405636|FG002|Long Term Extension Period|Consent Withdrawn|0|||
23734065|NCT02477800|66405637|FG003|Long Term Extension Period|Consent Withdrawn|10|||
23734066|NCT02477800|66405638|FG004|Long Term Extension Period|Consent Withdrawn|4|||
23734067|NCT02477800|66405639|FG005|Long Term Extension Period|Consent Withdrawn|13|||
23734068|NCT02477800|66405640|FG006|Long Term Extension Period|Consent Withdrawn|16|||
23734069|NCT02477800|66405634|FG000|Long Term Extension Period|Disease Progression|0|||
23734070|NCT02477800|66405635|FG001|Long Term Extension Period|Disease Progression|0|||
23734071|NCT02477800|66405636|FG002|Long Term Extension Period|Disease Progression|0|||
23734072|NCT02477800|66405637|FG003|Long Term Extension Period|Disease Progression|3|||
23734073|NCT02477800|66405638|FG004|Long Term Extension Period|Disease Progression|1|||
23734074|NCT02477800|66405639|FG005|Long Term Extension Period|Disease Progression|1|||
23734075|NCT02477800|66405640|FG006|Long Term Extension Period|Disease Progression|0|||
23734076|NCT02477800|66405634|FG000|Long Term Extension Period|Investigator Decision|0|||
23734077|NCT02477800|66405635|FG001|Long Term Extension Period|Investigator Decision|0|||
23734078|NCT02477800|66405636|FG002|Long Term Extension Period|Investigator Decision|0|||
23734079|NCT02477800|66405637|FG003|Long Term Extension Period|Investigator Decision|0|||
23734080|NCT02477800|66405638|FG004|Long Term Extension Period|Investigator Decision|0|||
23734081|NCT02477800|66405639|FG005|Long Term Extension Period|Investigator Decision|0|||
23734082|NCT02477800|66405640|FG006|Long Term Extension Period|Investigator Decision|2|||
23819280|NCT02027428|66717540|FG002|Induction|Protocol Violation|0|||
23819281|NCT02027428|66717538|FG000|Induction|Miscellaneous|14|||
23734083|NCT02477800|66405634|FG000|Long Term Extension Period|Lost to Follow-up|0|||
23734084|NCT02477800|66405635|FG001|Long Term Extension Period|Lost to Follow-up|0|||
23734085|NCT02477800|66405636|FG002|Long Term Extension Period|Lost to Follow-up|0|||
23734086|NCT02477800|66405637|FG003|Long Term Extension Period|Lost to Follow-up|0|||
23734087|NCT02477800|66405638|FG004|Long Term Extension Period|Lost to Follow-up|1|||
23734088|NCT02477800|66405639|FG005|Long Term Extension Period|Lost to Follow-up|3|||
23734089|NCT02477800|66405640|FG006|Long Term Extension Period|Lost to Follow-up|0|||
23734090|NCT02477800|66405634|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
23734091|NCT02477800|66405635|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
23734092|NCT02477800|66405636|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
23734093|NCT02477800|66405637|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
23734094|NCT02477800|66405638|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
23734095|NCT02477800|66405639|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
23734096|NCT02477800|66405640|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
23734097|NCT02477800|66405634|FG000|Long Term Extension Period|Study Visit Burden|0|||
23734098|NCT02477800|66405635|FG001|Long Term Extension Period|Study Visit Burden|0|||
23734099|NCT02477800|66405636|FG002|Long Term Extension Period|Study Visit Burden|0|||
23734100|NCT02477800|66405637|FG003|Long Term Extension Period|Study Visit Burden|3|||
23734101|NCT02477800|66405638|FG004|Long Term Extension Period|Study Visit Burden|0|||
23819282|NCT02027428|66717539|FG001|Induction|Miscellaneous|0|||
23819283|NCT02027428|66717540|FG002|Induction|Miscellaneous|0|||
23819284|NCT02027428|66717538|FG000|Induction|Induction Treatment Ongoing|4|||
23819285|NCT02027428|66717539|FG001|Induction|Induction Treatment Ongoing|0|||
23819286|NCT02027428|66717540|FG002|Induction|Induction Treatment Ongoing|0|||
23618379|NCT01732926|65988271|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
23618380|NCT01732926|65988270|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
23618381|NCT01732926|65988271|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
23734102|NCT02477800|66405639|FG005|Long Term Extension Period|Study Visit Burden|2|||
23734103|NCT02477800|66405640|FG006|Long Term Extension Period|Study Visit Burden|2|||
23734104|NCT02477800|66405634|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23734105|NCT02477800|66405635|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23734106|NCT02477800|66405636|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23734107|NCT02477800|66405637|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
23734108|NCT02477800|66405638|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
23734109|NCT02477800|66405639|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
23734110|NCT02477800|66405640|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
23734111|NCT02477800|66405634|FG000|Long Term Extension Period|Reason not Specified|0|||
23734112|NCT02477800|66405635|FG001|Long Term Extension Period|Reason not Specified|0|||
23734113|NCT02477800|66405636|FG002|Long Term Extension Period|Reason not Specified|0|||
23426600|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
23426601|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
23734114|NCT02477800|66405637|FG003|Long Term Extension Period|Reason not Specified|126|||
23734115|NCT02477800|66405638|FG004|Long Term Extension Period|Reason not Specified|140|||
23734116|NCT02477800|66405639|FG005|Long Term Extension Period|Reason not Specified|270|||
23734117|NCT02477800|66405640|FG006|Long Term Extension Period|Reason not Specified|224|||
23734118|NCT01775995|66405641|FG000|Overall Study|Lost to Follow-up|1|||
23734119|NCT01775995|66405642|FG001|Overall Study|Lost to Follow-up|1|||
23734120|NCT05158244|66405645|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
23734121|NCT05158244|66405646|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23734122|NCT05158244|66405647|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23734123|NCT05158244|66405648|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23734124|NCT05158244|66405649|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23734125|NCT05158244|66405645|FG000|Overall Study|Withdrawal by Subject|0|||
23734126|NCT05158244|66405646|FG001|Overall Study|Withdrawal by Subject|0|||
23734127|NCT05158244|66405647|FG002|Overall Study|Withdrawal by Subject|1|||
23734128|NCT05158244|66405648|FG003|Overall Study|Withdrawal by Subject|0|||
23734129|NCT05158244|66405649|FG004|Overall Study|Withdrawal by Subject|0|||
23734130|NCT00877890|66405652|FG000|Overall Study|Adverse Event|6|||
23734131|NCT00877890|66405653|FG001|Overall Study|Adverse Event|6|||
23734132|NCT00877890|66405652|FG000|Overall Study|Lost to Follow-up|5|||
23618382|NCT02864147|65988272|FG000|Overall Study|Withdrawal by Subject|3|||
23618383|NCT02864147|65988273|FG001|Overall Study|Withdrawal by Subject|2|||
23618384|NCT02864147|65988274|FG002|Overall Study|Withdrawal by Subject|1|||
23618385|NCT02864147|65988272|FG000|Overall Study|Lost to Follow-up|0|||
23618386|NCT02864147|65988273|FG001|Overall Study|Lost to Follow-up|4|||
23618387|NCT02864147|65988274|FG002|Overall Study|Lost to Follow-up|0|||
23618388|NCT02864147|65988272|FG000|Overall Study|Adverse Event|0|||
23618389|NCT02864147|65988273|FG001|Overall Study|Adverse Event|1|||
23618390|NCT02864147|65988274|FG002|Overall Study|Adverse Event|0|||
23734133|NCT00877890|66405653|FG001|Overall Study|Lost to Follow-up|5|||
23734134|NCT00877890|66405652|FG000|Overall Study|Protocol Violation|0|||
23734135|NCT00877890|66405653|FG001|Overall Study|Protocol Violation|1|||
23734136|NCT00877890|66405652|FG000|Overall Study|Withdrawal of Consent|6|||
23618391|NCT02864147|65988272|FG000|Overall Study|Pregnancy|4|||
23618392|NCT02864147|65988273|FG001|Overall Study|Pregnancy|0|||
23734137|NCT00877890|66405653|FG001|Overall Study|Withdrawal of Consent|12|||
23734138|NCT00877890|66405652|FG000|Overall Study|Investigator Decision|0|||
23819287|NCT02027428|66717538|FG000|Maintenance|Death|0|||
23819288|NCT02027428|66717539|FG001|Maintenance|Death|3|||
23618393|NCT02864147|65988274|FG002|Overall Study|Pregnancy|0|||
23618394|NCT02864147|65988272|FG000|Overall Study|Physician Decision|0|||
23618395|NCT02864147|65988273|FG001|Overall Study|Physician Decision|0|||
23618396|NCT02864147|65988274|FG002|Overall Study|Physician Decision|1|||
23618397|NCT02864147|65988272|FG000|Overall Study|Opted for excisional procedures|0|||
23618398|NCT02864147|65988273|FG001|Overall Study|Opted for excisional procedures|0|||
23618399|NCT02864147|65988274|FG002|Overall Study|Opted for excisional procedures|3|||
23618400|NCT01215032|65988275|FG000|Overall Study|Adverse Event|3|||
23618401|NCT01215032|65988275|FG000|Overall Study|Lack of Efficacy|17|||
23618402|NCT02110225|65988276|FG000|Overall Study|Lost to Follow-up|0|||
23618403|NCT02110225|65988277|FG001|Overall Study|Lost to Follow-up|1|||
23618404|NCT02110225|65988278|FG002|Overall Study|Lost to Follow-up|0|||
23618405|NCT03785210|65988279|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
23618406|NCT03785210|65988280|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
23618407|NCT02996097|65988281|FG000|Overall Study|Lost to Follow-up|11|||
23618408|NCT02996097|65988282|FG001|Overall Study|Lost to Follow-up|11|||
23618409|NCT04044352|65988283|FG000|Overall Study|Lost to Follow-up|9|||
23618410|NCT04044352|65988283|FG000|Overall Study|Withdrawal by Subject|2|||
23618411|NCT01103141|65988284|FG000|Overall Study|Death|0|||
23618412|NCT01103141|65988285|FG001|Overall Study|Death|1|||
23618413|NCT01103141|65988284|FG000|Overall Study|Lost to Follow-up|2|||
23618414|NCT01103141|65988285|FG001|Overall Study|Lost to Follow-up|1|||
23618415|NCT01954771|65988286|FG000|Overall Study|Missing HbA1c of end-point|1|||
23618416|NCT01954771|65988287|FG001|Overall Study|Missing HbA1c of end-point|1|||
23618417|NCT01954771|65988288|FG002|Overall Study|Missing HbA1c of end-point|0|||
23618418|NCT01954771|65988286|FG000|Overall Study|Missing CGMS of end-point|1|||
23734139|NCT00877890|66405653|FG001|Overall Study|Investigator Decision|2|||
23734140|NCT00877890|66405652|FG000|Overall Study|Loss of Glucose Control|3|||
23734141|NCT00877890|66405653|FG001|Overall Study|Loss of Glucose Control|4|||
23734142|NCT04815291|66405654|FG000|Overall Study|Lost to Follow-up|1|||
23734143|NCT04815291|66405654|FG000|Overall Study|Physician Decision|4|||
23734144|NCT04815291|66405654|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
23734145|NCT04411472|66405655|FG000|Overall Study|Adverse Event|5|||
23734146|NCT04411472|66405656|FG001|Overall Study|Adverse Event|10|||
23734147|NCT04411472|66405657|FG002|Overall Study|Adverse Event|1|||
23734148|NCT04411472|66405658|FG003|Overall Study|Adverse Event|0|||
23734149|NCT04411472|66405659|FG004|Overall Study|Adverse Event|0|||
23734150|NCT04411472|66405660|FG005|Overall Study|Adverse Event|0|||
23734151|NCT04411472|66405655|FG000|Overall Study|Protocol Violation|1|||
23734152|NCT04411472|66405656|FG001|Overall Study|Protocol Violation|0|||
23618419|NCT01954771|65988287|FG001|Overall Study|Missing CGMS of end-point|1|||
23618420|NCT01954771|65988288|FG002|Overall Study|Missing CGMS of end-point|0|||
23426602|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
23426603|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
23426604|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
23426605|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
23426606|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
23426607|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
23426608|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Other|1|||
23426609|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Other|0|||
23426610|NCT03157583|65307398|FG000|Overall Study|Other (did not meet study criteria)|1|||
23426611|NCT05239221|65307401|FG000|Overall Study|Adverse Event|0|||
23426612|NCT05239221|65307402|FG001|Overall Study|Adverse Event|0|||
23426613|NCT05239221|65307403|FG002|Overall Study|Adverse Event|0|||
23426614|NCT05239221|65307404|FG003|Overall Study|Adverse Event|0|||
23426615|NCT05239221|65307405|FG004|Overall Study|Adverse Event|0|||
23426616|NCT05239221|65307406|FG005|Overall Study|Adverse Event|0|||
23426617|NCT05239221|65307407|FG006|Overall Study|Adverse Event|1|||
23426618|NCT05239221|65307408|FG007|Overall Study|Adverse Event|0|||
23426619|NCT05239221|65307409|FG008|Overall Study|Adverse Event|0|||
23426620|NCT05239221|65307410|FG009|Overall Study|Adverse Event|0|||
23426621|NCT05239221|65307411|FG010|Overall Study|Adverse Event|1|||
23426622|NCT05239221|65307412|FG011|Overall Study|Adverse Event|1|||
23426623|NCT05239221|65307413|FG012|Overall Study|Adverse Event|0|||
23618421|NCT01954771|65988286|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
23734153|NCT04411472|66405657|FG002|Overall Study|Protocol Violation|0|||
23734154|NCT04411472|66405658|FG003|Overall Study|Protocol Violation|0|||
23734155|NCT04411472|66405659|FG004|Overall Study|Protocol Violation|0|||
23618422|NCT01954771|65988287|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
23618423|NCT01954771|65988288|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
23618424|NCT02212197|65988289|FG000|Overall Study|Need for radiotherapy|1|||
23618425|NCT02212197|65988290|FG001|Overall Study|Need for radiotherapy|0|||
23618426|NCT02212197|65988291|FG002|Overall Study|Need for radiotherapy|0|||
23426624|NCT05239221|65307414|FG013|Overall Study|Adverse Event|0|||
23426625|NCT05239221|65307415|FG014|Overall Study|Adverse Event|0|||
23426626|NCT05239221|65307416|FG015|Overall Study|Adverse Event|0|||
23426627|NCT05239221|65307401|FG000|Overall Study|Withdrawal by Subject|0|||
23426628|NCT05239221|65307402|FG001|Overall Study|Withdrawal by Subject|0|||
23734156|NCT04411472|66405660|FG005|Overall Study|Protocol Violation|0|||
23734157|NCT04411472|66405655|FG000|Overall Study|Withdrawal by Subject|0|||
23734158|NCT04411472|66405656|FG001|Overall Study|Withdrawal by Subject|1|||
23734159|NCT04411472|66405657|FG002|Overall Study|Withdrawal by Subject|0|||
23734160|NCT04411472|66405658|FG003|Overall Study|Withdrawal by Subject|1|||
23734161|NCT04411472|66405659|FG004|Overall Study|Withdrawal by Subject|0|||
23734162|NCT04411472|66405660|FG005|Overall Study|Withdrawal by Subject|0|||
23734163|NCT04411472|66405655|FG000|Overall Study|Physician Decision|1|||
23734164|NCT04411472|66405656|FG001|Overall Study|Physician Decision|0|||
23734165|NCT04411472|66405657|FG002|Overall Study|Physician Decision|0|||
23734166|NCT04411472|66405658|FG003|Overall Study|Physician Decision|0|||
23734167|NCT04411472|66405659|FG004|Overall Study|Physician Decision|0|||
23734168|NCT04411472|66405660|FG005|Overall Study|Physician Decision|0|||
23734169|NCT04411472|66405655|FG000|Overall Study|Study terminated by sponsor|17|||
23734170|NCT04411472|66405656|FG001|Overall Study|Study terminated by sponsor|20|||
23734171|NCT04411472|66405657|FG002|Overall Study|Study terminated by sponsor|3|||
23734172|NCT04411472|66405658|FG003|Overall Study|Study terminated by sponsor|0|||
23734173|NCT04411472|66405659|FG004|Overall Study|Study terminated by sponsor|0|||
23734174|NCT04411472|66405660|FG005|Overall Study|Study terminated by sponsor|0|||
23734175|NCT04062240|66405661|FG000|Overall Study|equipment malfunction|1|||
23734176|NCT00471276|66405669|FG000|Overall Study|Death|2|||
23734177|NCT00471276|66405669|FG000|Overall Study|Adverse Event|16|||
23734178|NCT00471276|66405669|FG000|Overall Study|Protocol Violation|1|||
23734179|NCT00471276|66405669|FG000|Overall Study|Objective progression or relapse|54|||
23734180|NCT00471276|66405669|FG000|Overall Study|Global deterioration of health status|1|||
23819289|NCT02027428|66717540|FG002|Maintenance|Death|2|||
23819290|NCT02027428|66717538|FG000|Maintenance|Adverse Event|0|||
23819291|NCT02027428|66717539|FG001|Maintenance|Adverse Event|21|||
23819292|NCT02027428|66717540|FG002|Maintenance|Adverse Event|1|||
23819293|NCT02027428|66717538|FG000|Maintenance|Progressive disease|0|||
23819294|NCT02027428|66717539|FG001|Maintenance|Progressive disease|84|||
23819295|NCT02027428|66717540|FG002|Maintenance|Progressive disease|47|||
23819296|NCT02027428|66717538|FG000|Maintenance|Symptomatic deterioration|0|||
23819297|NCT02027428|66717539|FG001|Maintenance|Symptomatic deterioration|4|||
23819298|NCT02027428|66717540|FG002|Maintenance|Symptomatic deterioration|1|||
23819299|NCT02027428|66717538|FG000|Maintenance|Withdrawal by Subject|0|||
23819300|NCT02027428|66717539|FG001|Maintenance|Withdrawal by Subject|6|||
23819301|NCT02027428|66717540|FG002|Maintenance|Withdrawal by Subject|5|||
23819302|NCT02027428|66717538|FG000|Maintenance|Protocol Violation|0|||
23819303|NCT02027428|66717539|FG001|Maintenance|Protocol Violation|0|||
23819304|NCT02027428|66717540|FG002|Maintenance|Protocol Violation|1|||
23819305|NCT02027428|66717538|FG000|Maintenance|Other|0|||
23819306|NCT02027428|66717539|FG001|Maintenance|Other|6|||
23819307|NCT02027428|66717540|FG002|Maintenance|Other|3|||
23819308|NCT02027428|66717538|FG000|Survival Follow-up|Death|0|||
23819309|NCT02027428|66717539|FG001|Survival Follow-up|Death|78|||
23819310|NCT02027428|66717540|FG002|Survival Follow-up|Death|45|||
23819311|NCT02027428|66717538|FG000|Survival Follow-up|Lost to Follow-up|0|||
23819312|NCT02027428|66717539|FG001|Survival Follow-up|Lost to Follow-up|1|||
23819313|NCT02027428|66717540|FG002|Survival Follow-up|Lost to Follow-up|1|||
23819314|NCT03086551|66717541|FG000|First Intervention|Failure to meet inclusion criterion|1|||
23819315|NCT03086551|66717542|FG001|First Intervention|Failure to meet inclusion criterion|0|||
23819316|NCT03086551|66717541|FG000|First Intervention|Lost to Follow-up|0|||
23819317|NCT03086551|66717542|FG001|First Intervention|Lost to Follow-up|1|||
23819318|NCT03086551|66717541|FG000|Washout|Lost to Follow-up|1|||
23819319|NCT03086551|66717542|FG001|Washout|Lost to Follow-up|2|||
23819320|NCT03086551|66717541|FG000|Washout|Withdrawal by Subject|2|||
23819321|NCT03086551|66717542|FG001|Washout|Withdrawal by Subject|1|||
23819322|NCT00530218|66717543|FG000|Overall Study|CMV Not Detected|13|||
23819323|NCT00530218|66717543|FG000|Overall Study|Death|12|||
23819324|NCT01982448|66717544|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23819325|NCT01982448|66717545|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23819326|NCT01982448|66717544|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
23819327|NCT01982448|66717545|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
23819328|NCT01982448|66717544|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
23819329|NCT01982448|66717545|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
23819330|NCT01982448|66717544|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
23819331|NCT01982448|66717545|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
23734181|NCT00471276|66405669|FG000|Overall Study|Other|3|||
23734182|NCT00471276|66405669|FG000|Overall Study|Refused treatment|6|||
23734183|NCT01610414|66405670|FG000|Study Start - Month 13|Serious Adverse Event|65|||
23734184|NCT01610414|66405671|FG001|Study Start - Month 13|Serious Adverse Event|67|||
23734185|NCT01610414|66405670|FG000|Study Start - Month 13|Adverse Event|14|||
23819332|NCT02129608|66717555|FG000|Overall Study|Lost to Follow-up|0|||
23819333|NCT02129608|66717556|FG001|Overall Study|Lost to Follow-up|1|||
23819334|NCT02129608|66717557|FG002|Overall Study|Lost to Follow-up|1|||
23819335|NCT02129608|66717555|FG000|Overall Study|Withdrawal by Subject|0|||
23734186|NCT01610414|66405671|FG001|Study Start - Month 13|Adverse Event|14|||
23734187|NCT01610414|66405670|FG000|Study Start - Month 13|Protocol Violation|3|||
23734188|NCT01610414|66405671|FG001|Study Start - Month 13|Protocol Violation|1|||
23734189|NCT01610414|66405670|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
23734190|NCT01610414|66405671|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
23734191|NCT01610414|66405670|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
23734192|NCT01610414|66405671|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
23734193|NCT01610414|66405670|FG000|Study Start - Month 13|Lost to Follow-up|4|||
23734194|NCT01610414|66405671|FG001|Study Start - Month 13|Lost to Follow-up|6|||
23734195|NCT01610414|66405670|FG000|Study Start - Month 13|Suspected HZ episode|1|||
23734196|NCT01610414|66405671|FG001|Study Start - Month 13|Suspected HZ episode|3|||
23734197|NCT01610414|66405670|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
23734198|NCT01610414|66405671|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
23734199|NCT01610414|66405670|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
23734200|NCT01610414|66405671|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
23734201|NCT01610414|66405670|FG000|Month 13 - Month 25|Adverse Event|8|||
23734202|NCT01610414|66405671|FG001|Month 13 - Month 25|Adverse Event|4|||
23734203|NCT01610414|66405670|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
23734204|NCT01610414|66405671|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
23734205|NCT01610414|66405670|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
23734206|NCT01610414|66405671|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
23734207|NCT01610414|66405670|FG000|Month 13 - Month 25|Protocol Violation|0|||
23734208|NCT01610414|66405671|FG001|Month 13 - Month 25|Protocol Violation|2|||
23734209|NCT01610414|66405670|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
23734210|NCT01610414|66405671|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
23734211|NCT01610414|66405670|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
23734212|NCT01610414|66405671|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
23734213|NCT01610414|66405670|FG000|After Month 25|Study end not reached|48|||
23734214|NCT01610414|66405671|FG001|After Month 25|Study end not reached|53|||
23734215|NCT01320033|66405672|FG000|Overall Study|Lack of Efficacy|0|||
23734216|NCT01320033|66405673|FG001|Overall Study|Lack of Efficacy|0|||
23734217|NCT01320033|66405674|FG002|Overall Study|Lack of Efficacy|1|||
23734218|NCT01320033|66405672|FG000|Overall Study|Adverse Event|9|||
23734219|NCT01320033|66405673|FG001|Overall Study|Adverse Event|7|||
23819336|NCT02129608|66717556|FG001|Overall Study|Withdrawal by Subject|0|||
23819337|NCT02129608|66717557|FG002|Overall Study|Withdrawal by Subject|2|||
23819338|NCT02045147|66717558|FG000|Overall Study|Withdrawal by Subject|2|||
23819339|NCT02045147|66717559|FG001|Overall Study|Withdrawal by Subject|0|||
23819340|NCT02045147|66717560|FG002|Overall Study|Withdrawal by Subject|0|||
23819341|NCT02045147|66717561|FG003|Overall Study|Withdrawal by Subject|0|||
23819342|NCT02045147|66717562|FG004|Overall Study|Withdrawal by Subject|0|||
23819343|NCT02045147|66717563|FG005|Overall Study|Withdrawal by Subject|0|||
23618427|NCT00985621|65988292|FG000|Overall Study|Adverse Event|2|||
23618428|NCT00985621|65988293|FG001|Overall Study|Adverse Event|3|||
23618429|NCT00985621|65988294|FG002|Overall Study|Adverse Event|4|||
23618430|NCT00985621|65988295|FG003|Overall Study|Adverse Event|16|||
23618431|NCT00985621|65988292|FG000|Overall Study|Lack of Efficacy|10|||
23618432|NCT00985621|65988293|FG001|Overall Study|Lack of Efficacy|6|||
23618433|NCT00985621|65988294|FG002|Overall Study|Lack of Efficacy|5|||
23618434|NCT00985621|65988295|FG003|Overall Study|Lack of Efficacy|12|||
23618435|NCT00985621|65988292|FG000|Overall Study|Lost to Follow-up|2|||
23618436|NCT00985621|65988293|FG001|Overall Study|Lost to Follow-up|3|||
23618437|NCT00985621|65988294|FG002|Overall Study|Lost to Follow-up|4|||
23618438|NCT00985621|65988295|FG003|Overall Study|Lost to Follow-up|4|||
23618439|NCT00985621|65988292|FG000|Overall Study|Study Terminated by Sponsor|89|||
23618440|NCT00985621|65988293|FG001|Overall Study|Study Terminated by Sponsor|108|||
23618441|NCT00985621|65988294|FG002|Overall Study|Study Terminated by Sponsor|99|||
23618442|NCT00985621|65988295|FG003|Overall Study|Study Terminated by Sponsor|92|||
23618443|NCT00985621|65988292|FG000|Overall Study|Protocol Violation|1|||
23618444|NCT00985621|65988293|FG001|Overall Study|Protocol Violation|1|||
23618445|NCT00985621|65988294|FG002|Overall Study|Protocol Violation|1|||
23618446|NCT00985621|65988295|FG003|Overall Study|Protocol Violation|0|||
23618447|NCT00985621|65988292|FG000|Overall Study|Withdrawal by Subject|8|||
23618448|NCT00985621|65988293|FG001|Overall Study|Withdrawal by Subject|10|||
23734220|NCT01320033|66405674|FG002|Overall Study|Adverse Event|8|||
23819344|NCT02045147|66717564|FG006|Overall Study|Withdrawal by Subject|0|||
23618449|NCT00985621|65988294|FG002|Overall Study|Withdrawal by Subject|8|||
23618450|NCT00985621|65988295|FG003|Overall Study|Withdrawal by Subject|12|||
23618451|NCT00985621|65988292|FG000|Overall Study|Other|1|||
23734221|NCT01320033|66405672|FG000|Overall Study|Withdrawal by Subject|22|||
23734222|NCT01320033|66405673|FG001|Overall Study|Withdrawal by Subject|23|||
23734223|NCT01320033|66405674|FG002|Overall Study|Withdrawal by Subject|23|||
23734224|NCT01320033|66405672|FG000|Overall Study|Protocol Violation|3|||
23734225|NCT01320033|66405673|FG001|Overall Study|Protocol Violation|5|||
23819345|NCT02045147|66717565|FG007|Overall Study|Withdrawal by Subject|1|||
23618452|NCT00985621|65988293|FG001|Overall Study|Other|0|||
23734226|NCT01320033|66405674|FG002|Overall Study|Protocol Violation|3|||
23734227|NCT01320033|66405672|FG000|Overall Study|Lost to Follow-up|22|||
23734228|NCT01320033|66405673|FG001|Overall Study|Lost to Follow-up|26|||
23734229|NCT01320033|66405674|FG002|Overall Study|Lost to Follow-up|17|||
23734230|NCT01320033|66405672|FG000|Overall Study|Other|2|||
23618453|NCT00985621|65988294|FG002|Overall Study|Other|0|||
23618454|NCT00985621|65988295|FG003|Overall Study|Other|0|||
23734231|NCT01320033|66405673|FG001|Overall Study|Other|3|||
23734232|NCT01320033|66405674|FG002|Overall Study|Other|1|||
23734233|NCT02773849|66405679|FG000|Overall Study|Lost to Follow-up|11|||
23734234|NCT02773849|66405679|FG000|Overall Study|Death|26|||
23734235|NCT02773849|66405679|FG000|Overall Study|Withdrawal by Subject|5|||
23734236|NCT02773849|66405679|FG000|Overall Study|Withdrawal of Consent|9|||
23734237|NCT02773849|66405679|FG000|Overall Study|Other: not due to lack of tolerability|11|||
23734238|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
23734239|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
23734240|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
23734241|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
23734242|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
23618455|NCT00985621|65988292|FG000|Overall Study|Randomized but not Treated|1|||
23618456|NCT00985621|65988293|FG001|Overall Study|Randomized but not Treated|0|||
23734243|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
23734244|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
23734245|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
23734246|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
23734247|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
23734248|NCT02178592|66405680|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
23734249|NCT02178592|66405681|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23734250|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
23734251|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
23734252|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
23734253|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
23734254|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
23734255|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
23618457|NCT00985621|65988294|FG002|Overall Study|Randomized but not Treated|2|||
23618458|NCT00985621|65988295|FG003|Overall Study|Randomized but not Treated|1|||
23618459|NCT05600036|65988298|FG000|Overall Study|Adverse Event|0|||
23618460|NCT05600036|65988299|FG001|Overall Study|Adverse Event|2|||
23618461|NCT05600036|65988300|FG002|Overall Study|Adverse Event|1|||
23618462|NCT05600036|65988301|FG003|Overall Study|Adverse Event|0|||
23618463|NCT05600036|65988302|FG004|Overall Study|Adverse Event|1|||
23618464|NCT05600036|65988303|FG005|Overall Study|Adverse Event|0|||
23618465|NCT05600036|65988298|FG000|Overall Study|Lost to Follow-up|0|||
23618466|NCT05600036|65988299|FG001|Overall Study|Lost to Follow-up|2|||
23618467|NCT05600036|65988300|FG002|Overall Study|Lost to Follow-up|1|||
23618468|NCT05600036|65988301|FG003|Overall Study|Lost to Follow-up|1|||
23618469|NCT05600036|65988302|FG004|Overall Study|Lost to Follow-up|0|||
23618470|NCT05600036|65988303|FG005|Overall Study|Lost to Follow-up|0|||
23618471|NCT05600036|65988298|FG000|Overall Study|Protocol Violation|0|||
23618472|NCT05600036|65988299|FG001|Overall Study|Protocol Violation|0|||
23618473|NCT05600036|65988300|FG002|Overall Study|Protocol Violation|2|||
23618474|NCT05600036|65988301|FG003|Overall Study|Protocol Violation|0|||
23618475|NCT05600036|65988302|FG004|Overall Study|Protocol Violation|0|||
23618476|NCT05600036|65988303|FG005|Overall Study|Protocol Violation|0|||
23618477|NCT05600036|65988298|FG000|Overall Study|Withdrawal by Subject|0|||
23618478|NCT05600036|65988299|FG001|Overall Study|Withdrawal by Subject|1|||
23618479|NCT05600036|65988300|FG002|Overall Study|Withdrawal by Subject|2|||
23618480|NCT05600036|65988301|FG003|Overall Study|Withdrawal by Subject|0|||
23618481|NCT05600036|65988302|FG004|Overall Study|Withdrawal by Subject|3|||
23618482|NCT05600036|65988303|FG005|Overall Study|Withdrawal by Subject|5|||
23618483|NCT05600036|65988298|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618484|NCT05600036|65988299|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23734256|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
23734257|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
23734258|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
23734259|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
23618485|NCT05600036|65988300|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618486|NCT05600036|65988301|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
23734260|NCT02178592|66405680|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
23618487|NCT05600036|65988302|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618488|NCT05600036|65988303|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23734261|NCT02178592|66405681|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
23734262|NCT00679354|66405686|FG000|Overall Study|Death|3|||
23734263|NCT00679354|66405686|FG000|Overall Study|Lack of Efficacy|22|||
23734264|NCT00679354|66405686|FG000|Overall Study|Physician Decision|4|||
23734265|NCT00679354|66405686|FG000|Overall Study|Ineligible|1|||
23734266|NCT02975206|66405687|FG000|Overall Study|Withdrawal by Subject|14|||
23734267|NCT02975206|66405688|FG001|Overall Study|Withdrawal by Subject|11|||
23734268|NCT02975206|66405689|FG002|Overall Study|Withdrawal by Subject|11|||
23734269|NCT02975206|66405687|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
23734270|NCT02975206|66405688|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
23734271|NCT02975206|66405689|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
23734272|NCT04652102|66405690|FG000|Overall Study|Adverse Event|14|||
23734273|NCT04652102|66405691|FG001|Overall Study|Adverse Event|13|||
23734274|NCT04652102|66405690|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
23734275|NCT04652102|66405691|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
23734276|NCT04652102|66405690|FG000|Overall Study|Physician Decision|78|||
23734277|NCT04652102|66405691|FG001|Overall Study|Physician Decision|40|||
23426629|NCT05239221|65307403|FG002|Overall Study|Withdrawal by Subject|0|||
23426630|NCT05239221|65307404|FG003|Overall Study|Withdrawal by Subject|0|||
23426631|NCT05239221|65307405|FG004|Overall Study|Withdrawal by Subject|0|||
23426632|NCT05239221|65307406|FG005|Overall Study|Withdrawal by Subject|0|||
23426633|NCT05239221|65307407|FG006|Overall Study|Withdrawal by Subject|0|||
23426634|NCT05239221|65307408|FG007|Overall Study|Withdrawal by Subject|0|||
23426635|NCT05239221|65307409|FG008|Overall Study|Withdrawal by Subject|0|||
23426636|NCT05239221|65307410|FG009|Overall Study|Withdrawal by Subject|0|||
23426637|NCT05239221|65307411|FG010|Overall Study|Withdrawal by Subject|1|||
23426638|NCT05239221|65307412|FG011|Overall Study|Withdrawal by Subject|0|||
23426639|NCT05239221|65307413|FG012|Overall Study|Withdrawal by Subject|0|||
23426640|NCT05239221|65307414|FG013|Overall Study|Withdrawal by Subject|0|||
23426641|NCT05239221|65307415|FG014|Overall Study|Withdrawal by Subject|0|||
23426642|NCT05239221|65307416|FG015|Overall Study|Withdrawal by Subject|1|||
23426643|NCT03356977|65307419|FG000|Overall Study|Lost to Follow-up|3|||
23734278|NCT04652102|66405690|FG000|Overall Study|Study Ended by Sponsor|64|||
23734279|NCT04652102|66405691|FG001|Overall Study|Study Ended by Sponsor|17|||
23734280|NCT04652102|66405690|FG000|Overall Study|Withdrawal by Subject|4625|||
23734281|NCT04652102|66405691|FG001|Overall Study|Withdrawal by Subject|5594|||
23734282|NCT04652102|66405690|FG000|Overall Study|Lost to Follow-up|2019|||
23734283|NCT04652102|66405691|FG001|Overall Study|Lost to Follow-up|1082|||
23734284|NCT04652102|66405690|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
23734285|NCT04652102|66405691|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
23734286|NCT04652102|66405690|FG000|Overall Study|Miscellaneous|80|||
23734287|NCT04652102|66405691|FG001|Overall Study|Miscellaneous|64|||
23734288|NCT01738594|66405692|FG000|Registration and Treatment Start|Adverse Event|0|||
23734289|NCT01738594|66405693|FG001|Registration and Treatment Start|Adverse Event|1|||
23734290|NCT01738594|66405694|FG002|Registration and Treatment Start|Adverse Event|0|||
23734291|NCT01738594|66405695|FG003|Registration and Treatment Start|Adverse Event|0|||
23734292|NCT01738594|66405696|FG004|Registration and Treatment Start|Adverse Event|0|||
23734293|NCT01738594|66405697|FG005|Registration and Treatment Start|Adverse Event|0|||
23545329|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23545330|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
23819346|NCT02045147|66717558|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
23545331|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
23545332|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
23545333|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
23545334|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
23545335|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
23545336|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23545337|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
23545338|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23545339|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
23545340|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
23545341|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23545342|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
23545343|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23545344|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
23545345|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
23843096|NCT01738503|66805586|FG005|Treatment Period|Withdrawal by Subject|1|||
23426644|NCT03356977|65307419|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23426645|NCT00330928|65307420|FG000|Overall Study|Lost to Follow-up|6|||
23426646|NCT00330928|65307420|FG000|Overall Study|Physician Decision|9|||
23426647|NCT00330928|65307420|FG000|Overall Study|Death|1|||
23734294|NCT01738594|66405698|FG006|Registration and Treatment Start|Adverse Event|0|||
23734295|NCT01738594|66405699|FG007|Registration and Treatment Start|Adverse Event|0|||
23734296|NCT01738594|66405692|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734297|NCT01738594|66405693|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734298|NCT01738594|66405694|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734299|NCT01738594|66405695|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734300|NCT01738594|66405696|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734301|NCT01738594|66405697|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
23618489|NCT05600036|65988298|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618490|NCT05600036|65988299|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
23426648|NCT00330928|65307420|FG000|Overall Study|IVUS could not be performed.|1|||
23426649|NCT00320255|65307421|FG000|Overall Study|Lack of Efficacy|1|||
23426650|NCT00320255|65307422|FG001|Overall Study|Lack of Efficacy|0|||
23426651|NCT00320255|65307423|FG002|Overall Study|Lack of Efficacy|0|||
23426652|NCT00320255|65307424|FG003|Overall Study|Lack of Efficacy|0|||
23426653|NCT00320255|65307425|FG004|Overall Study|Lack of Efficacy|0|||
23426654|NCT00320255|65307426|FG005|Overall Study|Lack of Efficacy|0|||
23426655|NCT00320255|65307421|FG000|Overall Study|Adverse Event|5|||
23426656|NCT00320255|65307422|FG001|Overall Study|Adverse Event|2|||
23426657|NCT00320255|65307423|FG002|Overall Study|Adverse Event|3|||
23545346|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
23545347|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
23618491|NCT05600036|65988300|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23545348|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23545349|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
23545350|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
23618492|NCT05600036|65988301|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618493|NCT05600036|65988302|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618494|NCT05600036|65988303|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618495|NCT05600036|65988298|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618496|NCT05600036|65988299|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618497|NCT05600036|65988300|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618498|NCT05600036|65988301|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
23618499|NCT05600036|65988302|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618500|NCT05600036|65988303|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618501|NCT01537120|65988306|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
23618502|NCT01537120|65988306|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
23618503|NCT03314233|65988307|FG000|Overall Study|No longer eligible at time of delivery|1|||
23618504|NCT04750577|65988310|FG000|Overall Study|Adverse Event|2|||
23618505|NCT04750577|65988311|FG001|Overall Study|Adverse Event|10|||
23618506|NCT04750577|65988312|FG002|Overall Study|Adverse Event|8|||
23618507|NCT04750577|65988313|FG003|Overall Study|Adverse Event|1|||
23618508|NCT04750577|65988310|FG000|Overall Study|Change of residence|0|||
23618509|NCT04750577|65988311|FG001|Overall Study|Change of residence|0|||
23618510|NCT04750577|65988312|FG002|Overall Study|Change of residence|1|||
23618511|NCT04750577|65988313|FG003|Overall Study|Change of residence|0|||
23545351|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
23545352|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
23545353|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
23545354|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
23545355|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
23545356|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
23545357|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
23545358|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
23545359|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
23545360|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545361|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545362|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545363|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545364|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23545365|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23545366|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
23545367|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23545368|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23426658|NCT00320255|65307424|FG003|Overall Study|Adverse Event|2|||
23426659|NCT00320255|65307425|FG004|Overall Study|Adverse Event|0|||
23426660|NCT00320255|65307426|FG005|Overall Study|Adverse Event|0|||
23426661|NCT00320255|65307421|FG000|Overall Study|Withdrawal by Subject|1|||
23426662|NCT00320255|65307422|FG001|Overall Study|Withdrawal by Subject|2|||
23426663|NCT00320255|65307423|FG002|Overall Study|Withdrawal by Subject|2|||
23426664|NCT00320255|65307424|FG003|Overall Study|Withdrawal by Subject|4|||
23426665|NCT00320255|65307425|FG004|Overall Study|Withdrawal by Subject|0|||
23426666|NCT00320255|65307426|FG005|Overall Study|Withdrawal by Subject|0|||
23426667|NCT00320255|65307421|FG000|Overall Study|Poor compliance/noncompliance|1|||
23426668|NCT00320255|65307422|FG001|Overall Study|Poor compliance/noncompliance|1|||
23426669|NCT00320255|65307423|FG002|Overall Study|Poor compliance/noncompliance|0|||
23426670|NCT00320255|65307424|FG003|Overall Study|Poor compliance/noncompliance|1|||
23426671|NCT00320255|65307425|FG004|Overall Study|Poor compliance/noncompliance|0|||
23426672|NCT00320255|65307426|FG005|Overall Study|Poor compliance/noncompliance|0|||
23426673|NCT00320255|65307421|FG000|Overall Study|No longer meets study criteria|0|||
23426674|NCT00320255|65307422|FG001|Overall Study|No longer meets study criteria|0|||
23618512|NCT04750577|65988310|FG000|Overall Study|Burden of study procedures|0|||
23618513|NCT04750577|65988311|FG001|Overall Study|Burden of study procedures|2|||
23545369|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23545370|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23545371|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23545372|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23545373|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23545374|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
23545375|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23545376|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23545377|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
23545378|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23734302|NCT01738594|66405698|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734303|NCT01738594|66405699|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23734304|NCT01738594|66405692|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734305|NCT01738594|66405693|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
23545379|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23545380|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
23545381|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545382|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545383|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545384|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
23545385|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23545386|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23545387|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23618514|NCT04750577|65988312|FG002|Overall Study|Burden of study procedures|2|||
23618515|NCT04750577|65988313|FG003|Overall Study|Burden of study procedures|0|||
23618516|NCT04750577|65988310|FG000|Overall Study|Prematurely discontinued|0|||
23618517|NCT04750577|65988311|FG001|Overall Study|Prematurely discontinued|0|||
23618518|NCT04750577|65988312|FG002|Overall Study|Prematurely discontinued|0|||
23618519|NCT04750577|65988313|FG003|Overall Study|Prematurely discontinued|2|||
23618520|NCT04750577|65988310|FG000|Overall Study|Protocol deviation|1|||
23618521|NCT04750577|65988311|FG001|Overall Study|Protocol deviation|1|||
23618522|NCT04750577|65988312|FG002|Overall Study|Protocol deviation|1|||
23618523|NCT04750577|65988313|FG003|Overall Study|Protocol deviation|1|||
23734306|NCT01738594|66405694|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734307|NCT01738594|66405695|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734308|NCT01738594|66405696|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734309|NCT01738594|66405697|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734310|NCT01738594|66405698|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734311|NCT01738594|66405699|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
23734312|NCT01738594|66405692|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23734313|NCT01738594|66405693|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23734314|NCT01738594|66405694|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23734315|NCT01738594|66405695|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23734316|NCT01738594|66405696|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23734317|NCT01738594|66405697|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
23734318|NCT01738594|66405698|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23426675|NCT00320255|65307423|FG002|Overall Study|No longer meets study criteria|0|||
23426676|NCT00320255|65307424|FG003|Overall Study|No longer meets study criteria|1|||
23426677|NCT00320255|65307425|FG004|Overall Study|No longer meets study criteria|0|||
23426678|NCT00320255|65307426|FG005|Overall Study|No longer meets study criteria|0|||
23426679|NCT00320255|65307421|FG000|Overall Study|Other|3|||
23426680|NCT00320255|65307422|FG001|Overall Study|Other|2|||
23426681|NCT00320255|65307423|FG002|Overall Study|Other|1|||
23426682|NCT00320255|65307424|FG003|Overall Study|Other|0|||
23426683|NCT00320255|65307425|FG004|Overall Study|Other|0|||
23426684|NCT00320255|65307426|FG005|Overall Study|Other|0|||
23426685|NCT01962987|65307427|FG000|Overall Study|Adverse Event|4|||
23426686|NCT01962987|65307428|FG001|Overall Study|Adverse Event|4|||
23426687|NCT01962987|65307429|FG002|Overall Study|Adverse Event|0|||
23426688|NCT01962987|65307427|FG000|Overall Study|Lost to Follow-up|0|||
23426689|NCT01962987|65307428|FG001|Overall Study|Lost to Follow-up|0|||
23426690|NCT01962987|65307429|FG002|Overall Study|Lost to Follow-up|1|||
23426691|NCT01962987|65307427|FG000|Overall Study|Non compliance with dosing requirements|4|||
23426692|NCT01962987|65307428|FG001|Overall Study|Non compliance with dosing requirements|2|||
23426693|NCT01962987|65307429|FG002|Overall Study|Non compliance with dosing requirements|0|||
23426694|NCT01962987|65307427|FG000|Overall Study|Miscellaneous|1|||
23426695|NCT01962987|65307428|FG001|Overall Study|Miscellaneous|9|||
23426696|NCT01962987|65307429|FG002|Overall Study|Miscellaneous|2|||
23426697|NCT01962987|65307427|FG000|Overall Study|Restricted medication|5|||
23426698|NCT01962987|65307428|FG001|Overall Study|Restricted medication|1|||
23426699|NCT01962987|65307429|FG002|Overall Study|Restricted medication|1|||
23426700|NCT01962987|65307427|FG000|Overall Study|Serious Adverse Event|1|||
23426701|NCT01962987|65307428|FG001|Overall Study|Serious Adverse Event|0|||
23426702|NCT01962987|65307429|FG002|Overall Study|Serious Adverse Event|0|||
23426703|NCT01962987|65307427|FG000|Overall Study|Withdrawal by Subject|11|||
23426704|NCT01962987|65307428|FG001|Overall Study|Withdrawal by Subject|10|||
23426705|NCT01962987|65307429|FG002|Overall Study|Withdrawal by Subject|6|||
23734319|NCT01738594|66405699|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23426706|NCT01962987|65307427|FG000|Overall Study|Randomized in Error|4|||
23426707|NCT01962987|65307428|FG001|Overall Study|Randomized in Error|2|||
23426708|NCT01962987|65307429|FG002|Overall Study|Randomized in Error|2|||
23426709|NCT01510184|65307431|FG000|Overall Study|Sponsor discretion|28|||
23426710|NCT01510184|65307432|FG001|Overall Study|Sponsor discretion|28|||
23426711|NCT01510184|65307431|FG000|Overall Study|Death|1|||
23426712|NCT01510184|65307432|FG001|Overall Study|Death|2|||
23426713|NCT01510184|65307431|FG000|Overall Study|Withdrawal by Subject|1|||
23426714|NCT01510184|65307432|FG001|Overall Study|Withdrawal by Subject|4|||
23426715|NCT01510184|65307431|FG000|Overall Study|Other|0|||
23426716|NCT01510184|65307432|FG001|Overall Study|Other|1|||
23426717|NCT01646203|65307433|FG000|Overall Study|Adverse Event|2|||
23426718|NCT01646203|65307434|FG001|Overall Study|Adverse Event|0|||
23426719|NCT01646203|65307435|FG002|Overall Study|Adverse Event|1|||
23545388|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23545389|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23545390|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Administrative|1|||
23545391|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Administrative|1|||
23545392|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Administrative|0|||
23545393|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Administrative|1|||
23545394|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Administrative|0|||
23545395|NCT00987467|65727183|FG000|Overall Study|Lost to Follow-up|2|||
23545396|NCT01496976|65727184|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
23545397|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Adverse Event|5|||
23545398|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Adverse Event|8|||
23545399|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Adverse Event|4|||
23545400|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Adverse Event|8|||
23545401|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
23545402|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
23545403|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
23734320|NCT01738594|66405692|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734321|NCT01738594|66405693|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734322|NCT01738594|66405694|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734323|NCT01738594|66405695|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734324|NCT01738594|66405696|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734325|NCT01738594|66405697|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
23426720|NCT01646203|65307433|FG000|Overall Study|Withdrawal by Subject|0|||
23426721|NCT01646203|65307434|FG001|Overall Study|Withdrawal by Subject|1|||
23545404|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
23426722|NCT01646203|65307435|FG002|Overall Study|Withdrawal by Subject|0|||
23426723|NCT01646203|65307433|FG000|Overall Study|Physician's Decision|0|||
23426724|NCT01646203|65307434|FG001|Overall Study|Physician's Decision|1|||
23426725|NCT01646203|65307435|FG002|Overall Study|Physician's Decision|0|||
23426726|NCT00882908|65307442|FG000|Overall Study|Adverse Event|0|||
23426727|NCT00882908|65307443|FG001|Overall Study|Adverse Event|0|||
23426728|NCT00882908|65307444|FG002|Overall Study|Adverse Event|1|||
23426729|NCT00882908|65307445|FG003|Overall Study|Adverse Event|0|||
23618524|NCT04750577|65988310|FG000|Overall Study|Other than listed|3|||
23618525|NCT04750577|65988311|FG001|Overall Study|Other than listed|2|||
23618526|NCT04750577|65988312|FG002|Overall Study|Other than listed|2|||
23734326|NCT01738594|66405698|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734327|NCT01738594|66405699|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23734328|NCT01738594|66405692|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734329|NCT01738594|66405693|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734330|NCT01738594|66405694|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734331|NCT01738594|66405695|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734332|NCT01738594|66405696|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
23734333|NCT01738594|66405697|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734334|NCT01738594|66405698|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734335|NCT01738594|66405699|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23734336|NCT01738594|66405692|FG000|Follow up for 1 Year|Death|0|||
23734337|NCT01738594|66405693|FG001|Follow up for 1 Year|Death|0|||
23734338|NCT01738594|66405694|FG002|Follow up for 1 Year|Death|0|||
23734339|NCT01738594|66405695|FG003|Follow up for 1 Year|Death|0|||
23734340|NCT01738594|66405696|FG004|Follow up for 1 Year|Death|0|||
23734341|NCT01738594|66405697|FG005|Follow up for 1 Year|Death|1|||
23734342|NCT01738594|66405698|FG006|Follow up for 1 Year|Death|0|||
23734343|NCT01738594|66405699|FG007|Follow up for 1 Year|Death|0|||
23734344|NCT01738594|66405692|FG000|Follow up for 1 Year|Other|0|||
23734345|NCT01738594|66405693|FG001|Follow up for 1 Year|Other|0|||
23734346|NCT01738594|66405694|FG002|Follow up for 1 Year|Other|0|||
23734347|NCT01738594|66405695|FG003|Follow up for 1 Year|Other|0|||
23734348|NCT01738594|66405696|FG004|Follow up for 1 Year|Other|0|||
23734349|NCT01738594|66405697|FG005|Follow up for 1 Year|Other|2|||
23734350|NCT01738594|66405698|FG006|Follow up for 1 Year|Other|0|||
23734351|NCT01738594|66405699|FG007|Follow up for 1 Year|Other|0|||
23734352|NCT01191190|66405703|FG000|Overall Study|Withdrawal by Subject|1|||
23734353|NCT00934791|66405704|FG000|Overall Study|Withdrawal by Subject|1|||
23618527|NCT04750577|65988313|FG003|Overall Study|Other than listed|1|||
23618528|NCT04750577|65988310|FG000|Overall Study|Not treated|0|||
23618529|NCT04750577|65988311|FG001|Overall Study|Not treated|0|||
23618530|NCT04750577|65988312|FG002|Overall Study|Not treated|0|||
23618531|NCT04750577|65988313|FG003|Overall Study|Not treated|2|||
23618532|NCT02166047|65988314|FG000|Overall Study|Withdrawal by Participant|0|||
23618533|NCT02166047|65988315|FG001|Overall Study|Withdrawal by Participant|1|||
23618534|NCT02166047|65988316|FG002|Overall Study|Withdrawal by Participant|2|||
23618535|NCT02166047|65988317|FG003|Overall Study|Withdrawal by Participant|0|||
23618536|NCT02166047|65988318|FG004|Overall Study|Withdrawal by Participant|0|||
23618537|NCT02166047|65988319|FG005|Overall Study|Withdrawal by Participant|0|||
23618538|NCT02166047|65988320|FG006|Overall Study|Withdrawal by Participant|1|||
23618539|NCT02166047|65988321|FG007|Overall Study|Withdrawal by Participant|0|||
23618540|NCT02166047|65988322|FG008|Overall Study|Withdrawal by Participant|0|||
23618541|NCT02166047|65988323|FG009|Overall Study|Withdrawal by Participant|0|||
23618542|NCT02166047|65988324|FG010|Overall Study|Withdrawal by Participant|0|||
23618543|NCT02166047|65988325|FG011|Overall Study|Withdrawal by Participant|0|||
23618544|NCT02166047|65988314|FG000|Overall Study|Adverse Event|0|||
23618545|NCT02166047|65988315|FG001|Overall Study|Adverse Event|0|||
23618546|NCT02166047|65988316|FG002|Overall Study|Adverse Event|0|||
23618547|NCT02166047|65988317|FG003|Overall Study|Adverse Event|0|||
23618548|NCT02166047|65988318|FG004|Overall Study|Adverse Event|1|||
23618549|NCT02166047|65988319|FG005|Overall Study|Adverse Event|0|||
23618550|NCT02166047|65988320|FG006|Overall Study|Adverse Event|1|||
23618551|NCT02166047|65988321|FG007|Overall Study|Adverse Event|0|||
23618552|NCT02166047|65988322|FG008|Overall Study|Adverse Event|0|||
23618553|NCT02166047|65988323|FG009|Overall Study|Adverse Event|0|||
23618554|NCT02166047|65988324|FG010|Overall Study|Adverse Event|2|||
23618555|NCT02166047|65988325|FG011|Overall Study|Adverse Event|0|||
23618556|NCT01329419|65988328|FG000|Overall Study|Protocol Violation|235|||
23618557|NCT02254681|65988331|FG000|Overall Study|Lack of Efficacy|6|||
23734354|NCT00934791|66405705|FG001|Overall Study|Withdrawal by Subject|0|||
23734355|NCT03347279|66405706|FG000|Overall Study|Withdrawal by Subject|8|||
23618558|NCT01894256|65988332|FG000|Part A|Adverse Event|0|||
23618559|NCT01894256|65988333|FG001|Part A|Adverse Event|1|||
23618560|NCT01894256|65988334|FG002|Part A|Adverse Event|0|||
23734356|NCT03347279|66405707|FG001|Overall Study|Withdrawal by Subject|15|||
23618561|NCT01894256|65988332|FG000|Part B|Death|0|||
23618562|NCT01894256|65988333|FG001|Part B|Death|1|||
23618563|NCT01894256|65988334|FG002|Part B|Death|1|||
23618564|NCT01894256|65988332|FG000|Part B|Withdrawal by Subject|0|||
23618565|NCT01894256|65988333|FG001|Part B|Withdrawal by Subject|1|||
23618566|NCT01894256|65988334|FG002|Part B|Withdrawal by Subject|0|||
23734357|NCT03347279|66405706|FG000|Overall Study|Death|0|||
23734358|NCT03347279|66405707|FG001|Overall Study|Death|2|||
23734359|NCT03347279|66405706|FG000|Overall Study|Lost to Follow-up|5|||
23734360|NCT03347279|66405707|FG001|Overall Study|Lost to Follow-up|2|||
23618567|NCT01894256|65988332|FG000|Part B|Lack of Efficacy|15|||
23618568|NCT01894256|65988333|FG001|Part B|Lack of Efficacy|12|||
23618569|NCT01894256|65988334|FG002|Part B|Lack of Efficacy|13|||
23618570|NCT01040403|65988335|FG000|Overall Study|Adverse Event|10|||
23618571|NCT01040403|65988335|FG000|Overall Study|Protocol Violation|2|||
23734361|NCT03347279|66405706|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
23734362|NCT03347279|66405707|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
23734363|NCT00827112|66405710|FG000|Overall Study|Adverse Event|2|||
23734364|NCT00827112|66405711|FG001|Overall Study|Adverse Event|0|||
23734365|NCT00827112|66405710|FG000|Overall Study|Lack of Efficacy|2|||
23734366|NCT00827112|66405711|FG001|Overall Study|Lack of Efficacy|0|||
23734367|NCT00827112|66405710|FG000|Overall Study|Lost to Follow-up|3|||
23734368|NCT00827112|66405711|FG001|Overall Study|Lost to Follow-up|2|||
23734369|NCT00827112|66405710|FG000|Overall Study|Pregnancy|0|||
23734370|NCT00827112|66405711|FG001|Overall Study|Pregnancy|1|||
23734371|NCT00827112|66405710|FG000|Overall Study|Protocol Violation|0|||
23734372|NCT00827112|66405711|FG001|Overall Study|Protocol Violation|2|||
23734373|NCT00827112|66405710|FG000|Overall Study|Withdrawal by Subject|2|||
23734374|NCT00827112|66405711|FG001|Overall Study|Withdrawal by Subject|1|||
23734375|NCT00827112|66405710|FG000|Overall Study|Randomized but not treated|5|||
23734376|NCT00827112|66405711|FG001|Overall Study|Randomized but not treated|3|||
23734377|NCT00827112|66405710|FG000|Overall Study|Other|1|||
23734378|NCT00827112|66405711|FG001|Overall Study|Other|3|||
23734379|NCT01521494|66405718|FG000|Overall Study|Adverse Event|1|||
23734380|NCT01521494|66405719|FG001|Overall Study|Adverse Event|2|||
23734381|NCT01521494|66405720|FG002|Overall Study|Adverse Event|9|||
23734382|NCT01521494|66405721|FG003|Overall Study|Adverse Event|6|||
23734383|NCT01521494|66405722|FG004|Overall Study|Adverse Event|2|||
23734384|NCT01521494|66405718|FG000|Overall Study|Lack of Efficacy|0|||
23734385|NCT01521494|66405719|FG001|Overall Study|Lack of Efficacy|0|||
23734386|NCT01521494|66405720|FG002|Overall Study|Lack of Efficacy|0|||
23734387|NCT01521494|66405721|FG003|Overall Study|Lack of Efficacy|0|||
23734388|NCT01521494|66405722|FG004|Overall Study|Lack of Efficacy|2|||
23734389|NCT01521494|66405718|FG000|Overall Study|Withdrawal by Subject|1|||
23734390|NCT01521494|66405719|FG001|Overall Study|Withdrawal by Subject|1|||
23734391|NCT01521494|66405720|FG002|Overall Study|Withdrawal by Subject|0|||
23734392|NCT01521494|66405721|FG003|Overall Study|Withdrawal by Subject|2|||
23734393|NCT01521494|66405722|FG004|Overall Study|Withdrawal by Subject|0|||
23734394|NCT01521494|66405718|FG000|Overall Study|Decrease in serum phosphate|0|||
23734395|NCT01521494|66405719|FG001|Overall Study|Decrease in serum phosphate|2|||
23734396|NCT01521494|66405720|FG002|Overall Study|Decrease in serum phosphate|3|||
23734397|NCT01521494|66405721|FG003|Overall Study|Decrease in serum phosphate|12|||
23734398|NCT01521494|66405722|FG004|Overall Study|Decrease in serum phosphate|0|||
23734399|NCT01521494|66405718|FG000|Overall Study|Decrease in serum calcium|0|||
23734400|NCT01521494|66405719|FG001|Overall Study|Decrease in serum calcium|0|||
23734401|NCT01521494|66405720|FG002|Overall Study|Decrease in serum calcium|0|||
23734402|NCT01521494|66405721|FG003|Overall Study|Decrease in serum calcium|1|||
23734403|NCT01521494|66405722|FG004|Overall Study|Decrease in serum calcium|1|||
23545405|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23545406|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
23545407|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23545408|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23545409|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Physician Decision|1|||
23545410|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Physician Decision|0|||
23545411|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Physician Decision|0|||
23545412|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Physician Decision|0|||
23545413|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
23545414|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
23545415|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
23545416|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
23545417|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Pregnancy|0|||
23545418|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Pregnancy|1|||
23545419|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Pregnancy|0|||
23545420|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Pregnancy|0|||
23545421|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
23545422|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
23545423|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
23545424|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
23545425|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Death|0|||
23545426|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Death|1|||
23545427|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Death|0|||
23545428|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Death|0|||
23545429|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
23545430|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
23545431|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
23545432|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
23545433|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
23545434|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
23545435|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
23545436|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
23545437|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545438|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545439|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545440|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
23545441|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545442|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545443|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545444|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
23545445|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
23545446|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
23545447|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
23545448|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
23545449|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545450|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545451|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545452|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
23545453|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545454|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545455|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545456|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
23545457|NCT02807948|65727191|FG000|Overall Study|Physician Decision|1|||
23545458|NCT02807948|65727192|FG001|Overall Study|Physician Decision|0|||
23545459|NCT02169674|65727195|FG000|Overall Study|Withdrawal by Subject|2|||
23545460|NCT02169674|65727196|FG001|Overall Study|Withdrawal by Subject|1|||
23545461|NCT02169674|65727195|FG000|Overall Study|Seroprotected|30|||
23545462|NCT02169674|65727196|FG001|Overall Study|Seroprotected|76|||
23545463|NCT02169674|65727195|FG000|Overall Study|Lost to Follow-up|0|||
23545464|NCT02169674|65727196|FG001|Overall Study|Lost to Follow-up|1|||
23545465|NCT01730937|65727200|FG000|Overall Study|Protocol Violation|5|||
23545466|NCT01730937|65727201|FG001|Overall Study|Protocol Violation|11|||
23545467|NCT04066114|65727205|FG000|Overall Study|Adverse Event|1|||
23545468|NCT04066114|65727206|FG001|Overall Study|Adverse Event|0|||
23545469|NCT04066114|65727207|FG002|Overall Study|Adverse Event|0|||
23545470|NCT04066114|65727205|FG000|Overall Study|Withdrawal by Subject|1|||
23545471|NCT04066114|65727206|FG001|Overall Study|Withdrawal by Subject|0|||
23545472|NCT04066114|65727207|FG002|Overall Study|Withdrawal by Subject|0|||
23545473|NCT04066114|65727205|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23545474|NCT04066114|65727206|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
23545475|NCT04066114|65727207|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
23734404|NCT01521494|66405718|FG000|Overall Study|Physician Decision|0|||
23734405|NCT01521494|66405719|FG001|Overall Study|Physician Decision|0|||
23426730|NCT00882908|65307446|FG004|Overall Study|Adverse Event|1|||
23734406|NCT01521494|66405720|FG002|Overall Study|Physician Decision|0|||
23426731|NCT00882908|65307442|FG000|Overall Study|Lost to Follow-up|3|||
23426732|NCT00882908|65307443|FG001|Overall Study|Lost to Follow-up|5|||
23426733|NCT00882908|65307444|FG002|Overall Study|Lost to Follow-up|3|||
23426734|NCT00882908|65307445|FG003|Overall Study|Lost to Follow-up|1|||
23426735|NCT00882908|65307446|FG004|Overall Study|Lost to Follow-up|2|||
23426736|NCT00882908|65307442|FG000|Overall Study|Protocol Violation|0|||
23426737|NCT00882908|65307443|FG001|Overall Study|Protocol Violation|1|||
23426738|NCT00882908|65307444|FG002|Overall Study|Protocol Violation|0|||
23426739|NCT00882908|65307445|FG003|Overall Study|Protocol Violation|0|||
23426740|NCT00882908|65307446|FG004|Overall Study|Protocol Violation|0|||
23426741|NCT00882908|65307442|FG000|Overall Study|Withdrawal by Subject|0|||
23426742|NCT00882908|65307443|FG001|Overall Study|Withdrawal by Subject|0|||
23426743|NCT00882908|65307444|FG002|Overall Study|Withdrawal by Subject|3|||
23426744|NCT00882908|65307445|FG003|Overall Study|Withdrawal by Subject|5|||
23426745|NCT00882908|65307446|FG004|Overall Study|Withdrawal by Subject|2|||
23426746|NCT00882908|65307442|FG000|Overall Study|Subject reached a virologic endpoint|0|||
23426747|NCT00882908|65307443|FG001|Overall Study|Subject reached a virologic endpoint|0|||
23545476|NCT03550313|65727208|FG000|Overall Study|Adverse Event|0|||
23426748|NCT00882908|65307444|FG002|Overall Study|Subject reached a virologic endpoint|0|||
23426749|NCT00882908|65307445|FG003|Overall Study|Subject reached a virologic endpoint|0|||
23734407|NCT01521494|66405721|FG003|Overall Study|Physician Decision|0|||
23734408|NCT01521494|66405722|FG004|Overall Study|Physician Decision|2|||
23734409|NCT03258762|66405723|FG000|Overall Study|Lost to Follow-up|0|||
23734410|NCT03258762|66405724|FG001|Overall Study|Lost to Follow-up|1|||
23734411|NCT02390362|66405725|FG000|Overall Study|Withdrawal by Subject|0|||
23734412|NCT02390362|66405726|FG001|Overall Study|Withdrawal by Subject|1|||
23734413|NCT00529152|66405727|FG000|Overall Study|Adverse Event|2|||
23734414|NCT00529152|66405727|FG000|Overall Study|Withdrawal by Subject|2|||
23734415|NCT00529152|66405727|FG000|Overall Study|Lost to Follow-up|1|||
23734416|NCT02802735|66405728|FG000|Overall Study|Withdrawal by Subject|0|||
23734417|NCT02802735|66405729|FG001|Overall Study|Withdrawal by Subject|1|||
23734418|NCT02802735|66405730|FG002|Overall Study|Withdrawal by Subject|0|||
23618572|NCT01040403|65988335|FG000|Overall Study|Lost to Follow-up|1|||
23618573|NCT01040403|65988335|FG000|Overall Study|Not treated|1|||
23618574|NCT01040403|65988335|FG000|Overall Study|Other reason not defined above|6|||
23618575|NCT02777242|65988336|FG000|Overall Study|Other|2|||
23618576|NCT02777242|65988336|FG000|Overall Study|Lost to Follow-up|1|||
23618577|NCT02777242|65988336|FG000|Overall Study|Multiple|1|||
23618578|NCT02777242|65988336|FG000|Overall Study|Sponsor's request|1|||
23618579|NCT02777242|65988336|FG000|Overall Study|Withdrawal by Subject|1|||
23618580|NCT03303521|65988337|FG000|Overall Study|Withdrawal by Subject|2|||
23618581|NCT03303521|65988338|FG001|Overall Study|Withdrawal by Subject|0|||
23618582|NCT03303521|65988337|FG000|Overall Study|Death|1|||
23545477|NCT03550313|65727209|FG001|Overall Study|Adverse Event|1|||
23545478|NCT03550313|65727210|FG002|Overall Study|Adverse Event|0|||
23545479|NCT03550313|65727208|FG000|Overall Study|Lost to Follow-up|5|||
23734419|NCT02802735|66405731|FG003|Overall Study|Withdrawal by Subject|0|||
23734420|NCT02802735|66405732|FG004|Overall Study|Withdrawal by Subject|0|||
23734421|NCT00312728|66405737|FG000|Overall Study|Progressive disease|53|||
23734422|NCT00312728|66405737|FG000|Overall Study|Adverse Event|32|||
23734423|NCT00312728|66405737|FG000|Overall Study|Withdrawal by Subject|10|||
23734424|NCT00312728|66405737|FG000|Overall Study|Required non-protocol cancer treatment|2|||
23734425|NCT00312728|66405737|FG000|Overall Study|Protocol Violation|2|||
23734426|NCT00312728|66405737|FG000|Overall Study|Other|10|||
23734427|NCT00312728|66405737|FG000|Overall Study|Other|1|||
23734428|NCT01426009|66405738|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
23734429|NCT01426009|66405738|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
23545480|NCT03550313|65727209|FG001|Overall Study|Lost to Follow-up|7|||
23545481|NCT03550313|65727210|FG002|Overall Study|Lost to Follow-up|12|||
23545482|NCT03550313|65727208|FG000|Overall Study|Study terminated by sponsor|44|||
23545483|NCT03550313|65727209|FG001|Overall Study|Study terminated by sponsor|37|||
23545484|NCT03550313|65727210|FG002|Overall Study|Study terminated by sponsor|48|||
23545485|NCT03550313|65727208|FG000|Overall Study|No longer met eligibility criteria|3|||
23545486|NCT03550313|65727209|FG001|Overall Study|No longer met eligibility criteria|5|||
23734430|NCT01426009|66405738|FG000|Washout 1|Withdrawal by Subject|1|||
23734431|NCT01426009|66405738|FG000|Washout 1|Personal Reasons|1|||
23734432|NCT01426009|66405738|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
23734433|NCT01426009|66405738|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
23734434|NCT01426009|66405738|FG000|Washout 2|electrive surgery|1|||
23734435|NCT01426009|66405738|FG000|Washout 3|personal reasons|1|||
23734436|NCT01426009|66405738|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
23734437|NCT01426009|66405738|FG000|Washout 4|Lost to Follow-up|1|||
23734438|NCT01948791|66405739|FG000|Overall Study|Adverse Event|12|||
23734439|NCT01948791|66405739|FG000|Overall Study|Lack of Efficacy|3|||
23734440|NCT01948791|66405739|FG000|Overall Study|Protocol Violation|2|||
23734441|NCT01948791|66405739|FG000|Overall Study|Withdrawal by Subject|5|||
23426750|NCT00882908|65307446|FG004|Overall Study|Subject reached a virologic endpoint|1|||
23545487|NCT03550313|65727210|FG002|Overall Study|No longer met eligibility criteria|6|||
23545488|NCT03550313|65727208|FG000|Overall Study|Withdrawal by parent/guardian|20|||
23545489|NCT03550313|65727209|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23545490|NCT03550313|65727210|FG002|Overall Study|Withdrawal by parent/guardian|26|||
23618583|NCT03303521|65988338|FG001|Overall Study|Death|0|||
23734442|NCT01948791|66405739|FG000|Overall Study|Lost to Follow-up|6|||
23734443|NCT01948791|66405739|FG000|Overall Study|Management issues|1|||
23734444|NCT01948791|66405739|FG000|Overall Study|Others|7|||
23734445|NCT01948791|66405739|FG000|Overall Study|Screening failure|35|||
23734446|NCT00826540|66405743|FG000|Overall Study|ineligible|3|||
23734447|NCT00826540|66405743|FG000|Overall Study|Withdrawal by Subject|1|||
23734448|NCT02061540|66405744|FG000|Overall Study|Adverse Event|2|||
23618584|NCT03303521|65988337|FG000|Overall Study|Kidney transplantation|0|||
23618585|NCT03303521|65988338|FG001|Overall Study|Kidney transplantation|1|||
23618586|NCT03303521|65988337|FG000|Overall Study|Investigational product discontinuation|0|||
23734449|NCT02061540|66405744|FG000|Overall Study|Withdrawal by Subject|2|||
23734450|NCT00908895|66405745|FG000|Overall Study|Lost to Follow-up|1|||
23734451|NCT00908895|66405746|FG001|Overall Study|Lost to Follow-up|3|||
23545491|NCT03550313|65727208|FG000|Overall Study|Other|4|||
23545492|NCT03550313|65727209|FG001|Overall Study|Other|2|||
23545493|NCT03550313|65727210|FG002|Overall Study|Other|2|||
23545494|NCT03550313|65727208|FG000|Overall Study|Randomized but not vaccinated|3|||
23545495|NCT03550313|65727209|FG001|Overall Study|Randomized but not vaccinated|23|||
23545496|NCT03550313|65727210|FG002|Overall Study|Randomized but not vaccinated|2|||
23545497|NCT03550313|65727208|FG000|Overall Study|Sites terminated due to quality issues|18|||
23545498|NCT03550313|65727209|FG001|Overall Study|Sites terminated due to quality issues|17|||
23545499|NCT03550313|65727210|FG002|Overall Study|Sites terminated due to quality issues|18|||
23545500|NCT04401579|65727211|FG000|Overall Study|Death|23|||
23618587|NCT03303521|65988338|FG001|Overall Study|Investigational product discontinuation|1|||
23618588|NCT03303521|65988337|FG000|Overall Study|Transferred to non-study dialysis center|1|||
23618589|NCT03303521|65988338|FG001|Overall Study|Transferred to non-study dialysis center|0|||
23618590|NCT03303521|65988337|FG000|Overall Study|Non-comliance to study protocol|0|||
23618591|NCT03303521|65988338|FG001|Overall Study|Non-comliance to study protocol|1|||
23618592|NCT03303521|65988337|FG000|Overall Study|Adverse Event|1|||
23734452|NCT00908895|66405745|FG000|Overall Study|algodystrophy|2|||
23545501|NCT04401579|65727212|FG001|Overall Study|Death|36|||
23545502|NCT04401579|65727211|FG000|Overall Study|Lost to Follow-up|40|||
23545503|NCT04401579|65727212|FG001|Overall Study|Lost to Follow-up|41|||
23545504|NCT04401579|65727211|FG000|Overall Study|Withdrawal by Subject|8|||
23545505|NCT04401579|65727212|FG001|Overall Study|Withdrawal by Subject|16|||
23545506|NCT04401579|65727211|FG000|Overall Study|Physician Decision|1|||
23545507|NCT04401579|65727212|FG001|Overall Study|Physician Decision|2|||
23545508|NCT04401579|65727211|FG000|Overall Study|Became ineligible after enrollment|1|||
23545509|NCT04401579|65727212|FG001|Overall Study|Became ineligible after enrollment|1|||
23545510|NCT04401579|65727211|FG000|Overall Study|Enrolled but treatment not administered|7|||
23545511|NCT04401579|65727212|FG001|Overall Study|Enrolled but treatment not administered|9|||
23545512|NCT04401579|65727211|FG000|Overall Study|Adverse Event|2|||
23545513|NCT04401579|65727212|FG001|Overall Study|Adverse Event|1|||
23545514|NCT04401579|65727211|FG000|Overall Study|Scheduling error|1|||
23545515|NCT04401579|65727212|FG001|Overall Study|Scheduling error|2|||
23545516|NCT04401579|65727211|FG000|Overall Study|Transferred to another hospital|1|||
23734453|NCT00908895|66405746|FG001|Overall Study|algodystrophy|2|||
23734454|NCT00908895|66405745|FG000|Overall Study|Adverse Event|1|||
23734455|NCT00908895|66405746|FG001|Overall Study|Adverse Event|1|||
23734456|NCT01981096|66405748|FG000|Overall Study|Parent illness|1|||
23734457|NCT01981096|66405749|FG001|Overall Study|Parent illness|0|||
23734458|NCT01981096|66405748|FG000|Overall Study|Withdrawal by Subject|0|||
23734459|NCT01981096|66405749|FG001|Overall Study|Withdrawal by Subject|1|||
23734460|NCT01981096|66405748|FG000|Overall Study|Lost to Follow-up|2|||
23734461|NCT01981096|66405749|FG001|Overall Study|Lost to Follow-up|0|||
23734462|NCT00661362|66405756|FG000|Overall Study|Adverse Event|5|||
23734463|NCT00661362|66405757|FG001|Overall Study|Adverse Event|4|||
23734464|NCT00661362|66405756|FG000|Overall Study|Incorrect enrollment|2|||
23734465|NCT00661362|66405757|FG001|Overall Study|Incorrect enrollment|0|||
23734466|NCT00661362|66405756|FG000|Overall Study|Study specific discontinuation criteria|4|||
23734467|NCT00661362|66405757|FG001|Overall Study|Study specific discontinuation criteria|11|||
23734468|NCT00661362|66405756|FG000|Overall Study|Withdrawal by Subject|13|||
23734469|NCT00661362|66405757|FG001|Overall Study|Withdrawal by Subject|23|||
23734470|NCT00661362|66405756|FG000|Overall Study|Lost to Follow-up|3|||
23734471|NCT00661362|66405757|FG001|Overall Study|Lost to Follow-up|1|||
23734472|NCT00661362|66405756|FG000|Overall Study|Severe non-compliance to protocol|0|||
23734473|NCT00661362|66405757|FG001|Overall Study|Severe non-compliance to protocol|1|||
23734474|NCT00661362|66405756|FG000|Overall Study|Safety reasons|1|||
23734475|NCT00661362|66405757|FG001|Overall Study|Safety reasons|0|||
23734476|NCT00661362|66405756|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
23734477|NCT00661362|66405757|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
23734478|NCT01809327|66405758|FG000|Overall Study|Lost to Follow-up|5|||
23734479|NCT01809327|66405759|FG001|Overall Study|Lost to Follow-up|2|||
23734480|NCT01809327|66405760|FG002|Overall Study|Lost to Follow-up|4|||
23734481|NCT01809327|66405761|FG003|Overall Study|Lost to Follow-up|2|||
23734482|NCT01809327|66405762|FG004|Overall Study|Lost to Follow-up|3|||
23734483|NCT01809327|66405758|FG000|Overall Study|Withdrawal by Subject|6|||
23545517|NCT04401579|65727212|FG001|Overall Study|Transferred to another hospital|2|||
23545518|NCT01435577|65727215|FG000|Overall Study|Adverse Event|10|||
23545519|NCT01435577|65727216|FG001|Overall Study|Adverse Event|0|||
23618593|NCT03303521|65988338|FG001|Overall Study|Adverse Event|0|||
23734484|NCT01809327|66405759|FG001|Overall Study|Withdrawal by Subject|4|||
23545520|NCT01435577|65727215|FG000|Overall Study|Lack of Efficacy|7|||
23734485|NCT01809327|66405760|FG002|Overall Study|Withdrawal by Subject|4|||
23734486|NCT01809327|66405761|FG003|Overall Study|Withdrawal by Subject|2|||
23734487|NCT01809327|66405762|FG004|Overall Study|Withdrawal by Subject|5|||
23734488|NCT01809327|66405758|FG000|Overall Study|Adverse Event|4|||
23734489|NCT01809327|66405759|FG001|Overall Study|Adverse Event|3|||
23734490|NCT01809327|66405760|FG002|Overall Study|Adverse Event|7|||
23545521|NCT01435577|65727216|FG001|Overall Study|Lack of Efficacy|51|||
23545522|NCT01435577|65727215|FG000|Overall Study|Alternative treatment started|0|||
23545523|NCT01435577|65727216|FG001|Overall Study|Alternative treatment started|1|||
23545524|NCT04179032|65727217|FG000|Part B (Up to Week 52)|Adverse Event|1|||
23545525|NCT04179032|65727217|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
23545526|NCT04179032|65727217|FG000|Access Extension Phase|Ongoing|11|||
23545527|NCT01314118|65727219|FG000|Overall Study|Adverse Event|9|||
23545528|NCT01314118|65727219|FG000|Overall Study|Progressive disease|27|||
23545529|NCT01314118|65727219|FG000|Overall Study|Physician Decision|11|||
23545530|NCT01314118|65727219|FG000|Overall Study|Death|4|||
23545531|NCT01314118|65727219|FG000|Overall Study|Protocol Violation|5|||
23545532|NCT01314118|65727219|FG000|Overall Study|Withdrawal by Subject|11|||
23545533|NCT01314118|65727219|FG000|Overall Study|Other|2|||
23545534|NCT01314118|65727219|FG000|Overall Study|Ongoing|62|||
23545535|NCT01767116|65727220|FG000|Overall Study|Lost to Follow-up|2|||
23545536|NCT01767116|65727221|FG001|Overall Study|Lost to Follow-up|2|||
23545537|NCT02352948|65727222|FG000|Overall Study|Death|47|||
23545538|NCT02352948|65727223|FG001|Overall Study|Death|48|||
23545539|NCT02352948|65727224|FG002|Overall Study|Death|114|||
23545540|NCT02352948|65727225|FG003|Overall Study|Death|74|||
23545541|NCT02352948|65727226|FG004|Overall Study|Death|77|||
23545542|NCT02352948|65727227|FG005|Overall Study|Death|44|||
23545543|NCT02352948|65727222|FG000|Overall Study|Lost to Follow-up|1|||
23545544|NCT02352948|65727223|FG001|Overall Study|Lost to Follow-up|0|||
23545545|NCT02352948|65727224|FG002|Overall Study|Lost to Follow-up|2|||
23545546|NCT02352948|65727225|FG003|Overall Study|Lost to Follow-up|1|||
23545547|NCT02352948|65727226|FG004|Overall Study|Lost to Follow-up|2|||
23545548|NCT02352948|65727227|FG005|Overall Study|Lost to Follow-up|1|||
23545549|NCT02352948|65727222|FG000|Overall Study|Withdrawal by Subject|1|||
23545550|NCT02352948|65727223|FG001|Overall Study|Withdrawal by Subject|10|||
23545551|NCT02352948|65727224|FG002|Overall Study|Withdrawal by Subject|11|||
23545552|NCT02352948|65727225|FG003|Overall Study|Withdrawal by Subject|23|||
23545553|NCT02352948|65727226|FG004|Overall Study|Withdrawal by Subject|9|||
23545554|NCT02352948|65727227|FG005|Overall Study|Withdrawal by Subject|4|||
23545555|NCT02352948|65727222|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23545556|NCT02352948|65727223|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23545557|NCT02352948|65727224|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23545558|NCT02352948|65727225|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23545559|NCT02352948|65727226|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23545560|NCT02352948|65727227|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
23545561|NCT02352948|65727222|FG000|Overall Study|Other|0|||
23545562|NCT02352948|65727223|FG001|Overall Study|Other|0|||
23545563|NCT02352948|65727224|FG002|Overall Study|Other|2|||
23545564|NCT02352948|65727225|FG003|Overall Study|Other|0|||
23545565|NCT02352948|65727226|FG004|Overall Study|Other|0|||
23545566|NCT02352948|65727227|FG005|Overall Study|Other|0|||
23545567|NCT03264989|65727228|FG000|Overall Study|Lost to Follow-up|1|||
23545568|NCT03264989|65727229|FG001|Overall Study|Lost to Follow-up|0|||
23545569|NCT03264989|65727228|FG000|Overall Study|New Therapy for study Indication|1|||
23545570|NCT03264989|65727229|FG001|Overall Study|New Therapy for study Indication|0|||
23545571|NCT03264989|65727228|FG000|Overall Study|Protocol Violation|0|||
23545572|NCT03264989|65727229|FG001|Overall Study|Protocol Violation|1|||
23545573|NCT03264989|65727228|FG000|Overall Study|Patient decision|13|||
23545574|NCT03264989|65727229|FG001|Overall Study|Patient decision|0|||
23545575|NCT03264989|65727228|FG000|Overall Study|Physician Decision|6|||
23545576|NCT03264989|65727229|FG001|Overall Study|Physician Decision|4|||
23545577|NCT03264989|65727228|FG000|Overall Study|Adverse Event|2|||
23545578|NCT03264989|65727229|FG001|Overall Study|Adverse Event|1|||
23545579|NCT03264989|65727228|FG000|Overall Study|Death|1|||
23545580|NCT03264989|65727229|FG001|Overall Study|Death|1|||
23545581|NCT03264989|65727228|FG000|Overall Study|Pregnancy|2|||
23545582|NCT03264989|65727229|FG001|Overall Study|Pregnancy|0|||
23545583|NCT03264989|65727228|FG000|Overall Study|End of Study|19|||
23545584|NCT03264989|65727229|FG001|Overall Study|End of Study|5|||
23545585|NCT03336619|65727230|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
23545586|NCT03336619|65727231|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
23545587|NCT03336619|65727230|FG000|Overall Study|Withdrawal by Subject|17|||
23545588|NCT03336619|65727231|FG001|Overall Study|Withdrawal by Subject|16|||
23545589|NCT03336619|65727230|FG000|Overall Study|Adverse Event|2|||
23545590|NCT03336619|65727231|FG001|Overall Study|Adverse Event|5|||
23545591|NCT03336619|65727230|FG000|Overall Study|Physician Decision|3|||
23545592|NCT03336619|65727231|FG001|Overall Study|Physician Decision|0|||
23545593|NCT04782323|65727234|FG000|Overall Study|Death|1|||
23545594|NCT04782323|65727235|FG001|Overall Study|Death|0|||
23545595|NCT04782323|65727236|FG002|Overall Study|Death|0|||
23545596|NCT04782323|65727237|FG003|Overall Study|Death|0|||
23545597|NCT04782323|65727238|FG004|Overall Study|Death|1|||
23545598|NCT04782323|65727239|FG005|Overall Study|Death|1|||
23545599|NCT04782323|65727240|FG006|Overall Study|Death|1|||
23545600|NCT04782323|65727241|FG007|Overall Study|Death|0|||
23545601|NCT04782323|65727234|FG000|Overall Study|Withdrawal by Subject|0|||
23545602|NCT04782323|65727235|FG001|Overall Study|Withdrawal by Subject|0|||
23545603|NCT04782323|65727236|FG002|Overall Study|Withdrawal by Subject|1|||
23545604|NCT04782323|65727237|FG003|Overall Study|Withdrawal by Subject|0|||
23545605|NCT04782323|65727238|FG004|Overall Study|Withdrawal by Subject|0|||
23545606|NCT04782323|65727239|FG005|Overall Study|Withdrawal by Subject|1|||
23545607|NCT04782323|65727240|FG006|Overall Study|Withdrawal by Subject|0|||
23545608|NCT04782323|65727241|FG007|Overall Study|Withdrawal by Subject|1|||
23545609|NCT04782323|65727234|FG000|Overall Study|Lost to Follow-up|0|||
23545610|NCT04782323|65727235|FG001|Overall Study|Lost to Follow-up|1|||
23545611|NCT04782323|65727236|FG002|Overall Study|Lost to Follow-up|1|||
23545612|NCT04782323|65727237|FG003|Overall Study|Lost to Follow-up|0|||
23545613|NCT04782323|65727238|FG004|Overall Study|Lost to Follow-up|0|||
23545614|NCT04782323|65727239|FG005|Overall Study|Lost to Follow-up|1|||
23545615|NCT04782323|65727240|FG006|Overall Study|Lost to Follow-up|1|||
23545616|NCT04782323|65727241|FG007|Overall Study|Lost to Follow-up|2|||
23545617|NCT04782323|65727234|FG000|Overall Study|randomization in error|1|||
23545618|NCT04782323|65727235|FG001|Overall Study|randomization in error|0|||
23545619|NCT04782323|65727236|FG002|Overall Study|randomization in error|0|||
23545620|NCT04782323|65727237|FG003|Overall Study|randomization in error|0|||
23545621|NCT04782323|65727238|FG004|Overall Study|randomization in error|0|||
23545622|NCT04782323|65727239|FG005|Overall Study|randomization in error|0|||
23545623|NCT04782323|65727240|FG006|Overall Study|randomization in error|0|||
23734491|NCT01809327|66405761|FG003|Overall Study|Adverse Event|4|||
23734492|NCT01809327|66405762|FG004|Overall Study|Adverse Event|8|||
23734493|NCT01809327|66405758|FG000|Overall Study|Death|1|||
23734494|NCT01809327|66405759|FG001|Overall Study|Death|0|||
23734495|NCT01809327|66405760|FG002|Overall Study|Death|0|||
23819347|NCT02045147|66717559|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
23734496|NCT01809327|66405761|FG003|Overall Study|Death|0|||
23734497|NCT01809327|66405762|FG004|Overall Study|Death|0|||
23734498|NCT01809327|66405758|FG000|Overall Study|Protocol Violation|0|||
23734499|NCT01809327|66405759|FG001|Overall Study|Protocol Violation|1|||
23734500|NCT01809327|66405760|FG002|Overall Study|Protocol Violation|0|||
23734501|NCT01809327|66405761|FG003|Overall Study|Protocol Violation|0|||
23734502|NCT01809327|66405762|FG004|Overall Study|Protocol Violation|0|||
23734503|NCT01809327|66405758|FG000|Overall Study|Physician Decision|1|||
23734504|NCT01809327|66405759|FG001|Overall Study|Physician Decision|1|||
23734505|NCT01809327|66405760|FG002|Overall Study|Physician Decision|0|||
23734506|NCT01809327|66405761|FG003|Overall Study|Physician Decision|0|||
23734507|NCT01809327|66405762|FG004|Overall Study|Physician Decision|0|||
23734508|NCT01809327|66405758|FG000|Overall Study|Pregnancy|1|||
23734509|NCT01809327|66405759|FG001|Overall Study|Pregnancy|0|||
23734510|NCT01809327|66405760|FG002|Overall Study|Pregnancy|0|||
23734511|NCT01809327|66405761|FG003|Overall Study|Pregnancy|0|||
23734512|NCT01809327|66405762|FG004|Overall Study|Pregnancy|0|||
23734513|NCT01809327|66405758|FG000|Overall Study|Other|14|||
23819348|NCT02045147|66717560|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
23819349|NCT02045147|66717561|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
23819350|NCT02045147|66717562|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
23819351|NCT02045147|66717563|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
23819352|NCT02045147|66717564|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
23819353|NCT02045147|66717565|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
23819354|NCT01954745|66717566|FG000|Overall Study|Radiological Progression|11|||
23819355|NCT01954745|66717566|FG000|Overall Study|Clinical Progression|5|||
23819356|NCT01954745|66717566|FG000|Overall Study|Adverse Event|2|||
23819357|NCT01954745|66717566|FG000|Overall Study|Death|1|||
23819358|NCT01589497|66717569|FG000|Overall Study|Withdrawal by Subject|0|||
23819359|NCT01589497|66717570|FG001|Overall Study|Withdrawal by Subject|1|||
23545624|NCT04782323|65727241|FG007|Overall Study|randomization in error|0|||
23545625|NCT01627249|65727242|FG000|Overall Study|Death|3|||
23545626|NCT01627249|65727243|FG001|Overall Study|Death|5|||
23545627|NCT01627249|65727244|FG002|Overall Study|Death|3|||
23545628|NCT01627249|65727242|FG000|Overall Study|Withdrawal by Subject|12|||
23545629|NCT01627249|65727243|FG001|Overall Study|Withdrawal by Subject|6|||
23734514|NCT01809327|66405759|FG001|Overall Study|Other|15|||
23734515|NCT01809327|66405760|FG002|Overall Study|Other|7|||
23734516|NCT01809327|66405761|FG003|Overall Study|Other|4|||
23734517|NCT01809327|66405762|FG004|Overall Study|Other|9|||
23734518|NCT02087241|66405775|FG000|Overall Study|Death|2|||
23734519|NCT02087241|66405776|FG001|Overall Study|Death|1|||
23734520|NCT02087241|66405777|FG002|Overall Study|Death|1|||
23545630|NCT01627249|65727244|FG002|Overall Study|Withdrawal by Subject|9|||
23734521|NCT02087241|66405778|FG003|Overall Study|Death|1|||
23734522|NCT02087241|66405775|FG000|Overall Study|Withdrawal by Subject|1|||
23734523|NCT02087241|66405776|FG001|Overall Study|Withdrawal by Subject|0|||
23734524|NCT02087241|66405777|FG002|Overall Study|Withdrawal by Subject|0|||
23819360|NCT01589497|66717571|FG002|Overall Study|Withdrawal by Subject|0|||
23819361|NCT01589497|66717572|FG003|Overall Study|Withdrawal by Subject|1|||
23819362|NCT01589497|66717569|FG000|Overall Study|Death|1|||
23819363|NCT01589497|66717570|FG001|Overall Study|Death|0|||
23819364|NCT01589497|66717571|FG002|Overall Study|Death|0|||
23819365|NCT01589497|66717572|FG003|Overall Study|Death|0|||
23819366|NCT01589497|66717569|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23819367|NCT01589497|66717570|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23819368|NCT01589497|66717571|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
23819369|NCT01589497|66717572|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23819370|NCT01644617|66717573|FG000|Overall Study|Withdrawal by Subject|3|||
23819371|NCT01644617|66717574|FG001|Overall Study|Withdrawal by Subject|4|||
23819372|NCT01644617|66717575|FG002|Overall Study|Withdrawal by Subject|1|||
23819373|NCT01644617|66717573|FG000|Overall Study|Lost to Follow-up|0|||
23819374|NCT01644617|66717574|FG001|Overall Study|Lost to Follow-up|1|||
23819375|NCT01644617|66717575|FG002|Overall Study|Lost to Follow-up|0|||
23819376|NCT01644617|66717573|FG000|Overall Study|Adverse Event|3|||
23819377|NCT01644617|66717574|FG001|Overall Study|Adverse Event|0|||
23819378|NCT01644617|66717575|FG002|Overall Study|Adverse Event|6|||
23819379|NCT01332292|66717577|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23819380|NCT01332292|66717578|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23819381|NCT01332292|66717577|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23819382|NCT01332292|66717578|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23819383|NCT01332292|66717577|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
23819384|NCT01332292|66717578|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
23819385|NCT04877457|66717579|FG000|Overall Study|Early termination of study due to low enrollment|2|||
23819386|NCT04877457|66717580|FG001|Overall Study|Early termination of study due to low enrollment|1|||
23819387|NCT00796107|66717581|FG000|Overall Study|Lack of Efficacy|1|||
23819388|NCT00796107|66717581|FG000|Overall Study|Progressive Disease|5|||
23819389|NCT01559389|66717582|FG000|Overall Study|Withdrawal by Subject|20|||
23819390|NCT01559389|66717583|FG001|Overall Study|Withdrawal by Subject|20|||
23819391|NCT00338455|66717587|FG000|Overall Study|Death|2|||
23819392|NCT00338455|66717588|FG001|Overall Study|Death|1|||
23819393|NCT00338455|66717587|FG000|Overall Study|Physician Decision|1|||
23819394|NCT00338455|66717588|FG001|Overall Study|Physician Decision|0|||
23819395|NCT02552732|66717591|FG000|Overall Study|Lost to Follow-up|2|||
23819396|NCT02552732|66717591|FG000|Overall Study|Physician Decision|1|||
23819397|NCT02552732|66717591|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
23819398|NCT02552732|66717591|FG000|Overall Study|Withdrawal by Subject|6|||
23819399|NCT01721317|66717593|FG000|Overall Study|Study Closed / Terminated|2|||
23819400|NCT01721317|66717594|FG001|Overall Study|Study Closed / Terminated|2|||
23819401|NCT01721317|66717593|FG000|Overall Study|Physician Decision|0|||
23734525|NCT02087241|66405778|FG003|Overall Study|Withdrawal by Subject|1|||
23734526|NCT02087241|66405775|FG000|Overall Study|Progressive Disease|0|||
23734527|NCT02087241|66405776|FG001|Overall Study|Progressive Disease|0|||
23734528|NCT02087241|66405777|FG002|Overall Study|Progressive Disease|0|||
23734529|NCT02087241|66405778|FG003|Overall Study|Progressive Disease|1|||
23734530|NCT02087241|66405775|FG000|Overall Study|Study Terminated by Sponsor|0|||
23545631|NCT01627249|65727242|FG000|Overall Study|Missed Visit|1|||
23545632|NCT01627249|65727243|FG001|Overall Study|Missed Visit|1|||
23545633|NCT01627249|65727244|FG002|Overall Study|Missed Visit|0|||
23545634|NCT04177758|65727245|FG000|Overall Study|Lost to Follow-up|19|||
23545635|NCT04177758|65727246|FG001|Overall Study|Lost to Follow-up|11|||
23545636|NCT03449030|65727247|FG000|Overall Study|Withdrawal by Subject|0|||
23545637|NCT03449030|65727248|FG001|Overall Study|Withdrawal by Subject|0|||
23734531|NCT02087241|66405776|FG001|Overall Study|Study Terminated by Sponsor|2|||
23734532|NCT02087241|66405777|FG002|Overall Study|Study Terminated by Sponsor|0|||
23734533|NCT02087241|66405778|FG003|Overall Study|Study Terminated by Sponsor|4|||
23734534|NCT04005885|66405779|FG000|First Intervention|Withdrawal by Subject|1|||
23734535|NCT04005885|66405780|FG001|First Intervention|Withdrawal by Subject|1|||
23734536|NCT04005885|66405779|FG000|Second Intervention|Withdrawal by Subject|0|||
23734537|NCT04005885|66405780|FG001|Second Intervention|Withdrawal by Subject|2|||
23734538|NCT00397891|66405786|FG000|Overall Study|Withdrawal by Subject|1|||
23734539|NCT00397891|66405787|FG001|Overall Study|Withdrawal by Subject|0|||
23734540|NCT00397891|66405788|FG002|Overall Study|Withdrawal by Subject|0|||
23734541|NCT00397891|66405789|FG003|Overall Study|Withdrawal by Subject|0|||
23819402|NCT01721317|66717594|FG001|Overall Study|Physician Decision|1|||
23819403|NCT01721317|66717593|FG000|Overall Study|Withdrawal by Subject|0|||
23819404|NCT01721317|66717594|FG001|Overall Study|Withdrawal by Subject|1|||
23819405|NCT03155945|66717595|FG000|Overall Study|Lost to Follow-up|0|||
23819406|NCT03155945|66717596|FG001|Overall Study|Lost to Follow-up|1|||
23819407|NCT03155945|66717595|FG000|Overall Study|Withdrawal by Subject|0|||
23734542|NCT00397891|66405790|FG004|Overall Study|Withdrawal by Subject|1|||
23734543|NCT01108263|66405791|FG000|Overall Study|Adverse Event|0|||
23734544|NCT01108263|66405792|FG001|Overall Study|Adverse Event|1|||
23819408|NCT03155945|66717596|FG001|Overall Study|Withdrawal by Subject|1|||
23545638|NCT03449030|65727249|FG002|Overall Study|Withdrawal by Subject|0|||
23819409|NCT03155945|66717595|FG000|Overall Study|Other Reason|0|||
23819410|NCT03155945|66717596|FG001|Overall Study|Other Reason|1|||
23819411|NCT02257385|66717597|FG000|Overall Study|Adverse Event|12|||
23734545|NCT01731600|66405793|FG000|Overall Study|Adverse Event|2|||
23734546|NCT01731600|66405794|FG001|Overall Study|Adverse Event|0|||
23734547|NCT01731600|66405793|FG000|Overall Study|Withdrawal criteria|1|||
23734548|NCT01731600|66405794|FG001|Overall Study|Withdrawal criteria|0|||
23734549|NCT01731600|66405793|FG000|Overall Study|Other reasons|3|||
23734550|NCT01731600|66405794|FG001|Overall Study|Other reasons|0|||
23734551|NCT02639182|66405795|FG000|Overall Study|Disease Progression|50|||
23734552|NCT02639182|66405796|FG001|Overall Study|Disease Progression|49|||
23734553|NCT02639182|66405795|FG000|Overall Study|Adverse Event|7|||
23734554|NCT02639182|66405796|FG001|Overall Study|Adverse Event|5|||
23734555|NCT02639182|66405795|FG000|Overall Study|Physician Decision|3|||
23734556|NCT02639182|66405796|FG001|Overall Study|Physician Decision|3|||
23734557|NCT02639182|66405795|FG000|Overall Study|Withdrew Consent|5|||
23734558|NCT02639182|66405796|FG001|Overall Study|Withdrew Consent|4|||
23734559|NCT02639182|66405795|FG000|Overall Study|Lost to Follow-up|0|||
23734560|NCT02639182|66405796|FG001|Overall Study|Lost to Follow-up|1|||
23734561|NCT02639182|66405795|FG000|Overall Study|Study Closure|1|||
23734562|NCT02639182|66405796|FG001|Overall Study|Study Closure|2|||
23734563|NCT02639182|66405795|FG000|Overall Study|Sponsor Ended Study|0|||
23819412|NCT02257385|66717598|FG001|Overall Study|Adverse Event|8|||
23819413|NCT02257385|66717597|FG000|Overall Study|Lack of Efficacy|1|||
23819414|NCT02257385|66717598|FG001|Overall Study|Lack of Efficacy|2|||
23618594|NCT03078751|65988339|FG000|Overall Study|Adverse Event|4|||
23618595|NCT03078751|65988340|FG001|Overall Study|Adverse Event|0|||
23618596|NCT03078751|65988339|FG000|Overall Study|Physician Decision|1|||
23618597|NCT03078751|65988340|FG001|Overall Study|Physician Decision|0|||
23618598|NCT03078751|65988339|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
23618599|NCT03078751|65988340|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
23618600|NCT03078751|65988339|FG000|Overall Study|Subject/guardian decision|8|||
23618601|NCT03078751|65988340|FG001|Overall Study|Subject/guardian decision|1|||
23618602|NCT03078751|65988339|FG000|Overall Study|Untreated|0|||
23618603|NCT03078751|65988340|FG001|Overall Study|Untreated|4|||
23618604|NCT01703988|65988341|FG000|Overall Study|Investigator Judgment|0|||
23618605|NCT01703988|65988342|FG001|Overall Study|Investigator Judgment|0|||
23618606|NCT01703988|65988343|FG002|Overall Study|Investigator Judgment|0|||
23618607|NCT01703988|65988344|FG003|Overall Study|Investigator Judgment|1|||
23618608|NCT02212301|65988345|FG000|Period 1|Lost to Follow-up|0|||
23618609|NCT02212301|65988346|FG001|Period 1|Lost to Follow-up|1|||
23618610|NCT02556918|65988349|FG000|Overall Study|Protocol Violation|5|||
23618611|NCT02556918|65988350|FG001|Overall Study|Protocol Violation|6|||
23618612|NCT02556918|65988349|FG000|Overall Study|Withdrawal by Subject|4|||
23618613|NCT02556918|65988350|FG001|Overall Study|Withdrawal by Subject|4|||
23618614|NCT02368691|65988351|FG000|Overall Study|Death|13|||
23618615|NCT02368691|65988351|FG000|Overall Study|Lack of Efficacy|15|||
23734564|NCT02639182|66405796|FG001|Overall Study|Sponsor Ended Study|1|||
23734565|NCT02639182|66405795|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
23734566|NCT02639182|66405796|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
23734567|NCT00626795|66405804|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
23734568|NCT00626795|66405805|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
23734569|NCT00626795|66405806|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
23734570|NCT00626795|66405804|FG000|Blinded Treatment|Lack of Efficacy|2|||
23734571|NCT00626795|66405805|FG001|Blinded Treatment|Lack of Efficacy|0|||
23734572|NCT00626795|66405806|FG002|Blinded Treatment|Lack of Efficacy|0|||
23734573|NCT00626795|66405804|FG000|Blinded Treatment|Unacceptable adverse event|0|||
23734574|NCT00626795|66405805|FG001|Blinded Treatment|Unacceptable adverse event|0|||
23734575|NCT00626795|66405806|FG002|Blinded Treatment|Unacceptable adverse event|1|||
23734576|NCT00626795|66405804|FG000|Blinded Treatment|Protocol Violation|0|||
23734577|NCT00626795|66405805|FG001|Blinded Treatment|Protocol Violation|1|||
23734578|NCT00626795|66405806|FG002|Blinded Treatment|Protocol Violation|1|||
23734579|NCT00626795|66405804|FG000|Blinded Treatment|Withdrawal by Subject|1|||
23819415|NCT02257385|66717597|FG000|Overall Study|Protocol Violation|5|||
23819416|NCT02257385|66717598|FG001|Overall Study|Protocol Violation|7|||
23618616|NCT02368691|65988351|FG000|Overall Study|Physician Decision|4|||
23618617|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
23618618|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
23734580|NCT00626795|66405805|FG001|Blinded Treatment|Withdrawal by Subject|1|||
23734581|NCT00626795|66405806|FG002|Blinded Treatment|Withdrawal by Subject|0|||
23734582|NCT00626795|66405804|FG000|Blinded Treatment|Other reasons|2|||
23734583|NCT00626795|66405805|FG001|Blinded Treatment|Other reasons|0|||
23734584|NCT00626795|66405806|FG002|Blinded Treatment|Other reasons|2|||
23734585|NCT00626795|66405804|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
23734586|NCT00626795|66405805|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
23734587|NCT00626795|66405806|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
23819417|NCT02257385|66717597|FG000|Overall Study|Lost to Follow-up|0|||
23618619|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
23618620|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
23618621|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
23618622|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
23618623|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
23618624|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
23618625|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
23618626|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
23618627|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
23618628|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
23618629|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
23618630|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
23618631|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
23618632|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
23618633|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
23618634|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
23618635|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
23618636|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
23618637|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
23618638|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
23618639|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
23734588|NCT02630459|66405807|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23734589|NCT02630459|66405808|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
23734590|NCT02630459|66405809|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23734591|NCT02630459|66405810|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
23545639|NCT03449030|65727250|FG003|Overall Study|Withdrawal by Subject|1|||
23545640|NCT03449030|65727251|FG004|Overall Study|Withdrawal by Subject|1|||
23545641|NCT03449030|65727252|FG005|Overall Study|Withdrawal by Subject|1|||
23545642|NCT03449030|65727253|FG006|Overall Study|Withdrawal by Subject|1|||
23545643|NCT03449030|65727254|FG007|Overall Study|Withdrawal by Subject|2|||
23734592|NCT02630459|66405811|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23545644|NCT03449030|65727255|FG008|Overall Study|Withdrawal by Subject|0|||
23545645|NCT03449030|65727256|FG009|Overall Study|Withdrawal by Subject|0|||
23545646|NCT03449030|65727247|FG000|Overall Study|Symptomatic Deterioration|0|||
23545647|NCT03449030|65727248|FG001|Overall Study|Symptomatic Deterioration|1|||
23545648|NCT03449030|65727249|FG002|Overall Study|Symptomatic Deterioration|0|||
23734593|NCT02630459|66405812|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23734594|NCT02630459|66405813|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23545649|NCT03449030|65727250|FG003|Overall Study|Symptomatic Deterioration|0|||
23545650|NCT03449030|65727251|FG004|Overall Study|Symptomatic Deterioration|0|||
23545651|NCT03449030|65727252|FG005|Overall Study|Symptomatic Deterioration|1|||
23545652|NCT03449030|65727253|FG006|Overall Study|Symptomatic Deterioration|1|||
23545653|NCT03449030|65727254|FG007|Overall Study|Symptomatic Deterioration|0|||
23545654|NCT03449030|65727255|FG008|Overall Study|Symptomatic Deterioration|2|||
23545655|NCT03449030|65727256|FG009|Overall Study|Symptomatic Deterioration|0|||
23545656|NCT03449030|65727247|FG000|Overall Study|Progressive Disease|1|||
23618640|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
23734595|NCT02630459|66405814|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23734596|NCT02630459|66405807|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734597|NCT02630459|66405808|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734598|NCT02630459|66405809|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
23734599|NCT02630459|66405810|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734600|NCT02630459|66405811|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734601|NCT02630459|66405812|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734602|NCT02630459|66405813|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734603|NCT02630459|66405814|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23734604|NCT02630459|66405807|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
23734605|NCT02630459|66405808|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
23734606|NCT02630459|66405809|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
23734607|NCT02630459|66405810|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
23734608|NCT02630459|66405811|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23545657|NCT03449030|65727248|FG001|Overall Study|Progressive Disease|0|||
23545658|NCT03449030|65727249|FG002|Overall Study|Progressive Disease|1|||
23545659|NCT03449030|65727250|FG003|Overall Study|Progressive Disease|4|||
23545660|NCT03449030|65727251|FG004|Overall Study|Progressive Disease|5|||
23545661|NCT03449030|65727252|FG005|Overall Study|Progressive Disease|3|||
23545662|NCT03449030|65727253|FG006|Overall Study|Progressive Disease|0|||
23618641|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
23618642|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
23618643|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
23618644|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23618645|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23618646|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
23618647|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23618648|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23618649|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
23618650|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23618651|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23618652|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
23618653|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23618654|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23618655|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
23618656|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
23545663|NCT03449030|65727254|FG007|Overall Study|Progressive Disease|1|||
23545664|NCT03449030|65727255|FG008|Overall Study|Progressive Disease|1|||
23545665|NCT03449030|65727256|FG009|Overall Study|Progressive Disease|1|||
23545666|NCT03449030|65727247|FG000|Overall Study|Adverse Event|0|||
23545667|NCT03449030|65727248|FG001|Overall Study|Adverse Event|0|||
23545668|NCT03449030|65727249|FG002|Overall Study|Adverse Event|0|||
23545669|NCT03449030|65727250|FG003|Overall Study|Adverse Event|0|||
23545670|NCT03449030|65727251|FG004|Overall Study|Adverse Event|0|||
23545671|NCT03449030|65727252|FG005|Overall Study|Adverse Event|2|||
23545672|NCT03449030|65727253|FG006|Overall Study|Adverse Event|0|||
23545673|NCT03449030|65727254|FG007|Overall Study|Adverse Event|0|||
23545674|NCT03449030|65727255|FG008|Overall Study|Adverse Event|0|||
23545675|NCT03449030|65727256|FG009|Overall Study|Adverse Event|0|||
23545676|NCT03449030|65727247|FG000|Overall Study|Death|0|||
23545677|NCT03449030|65727248|FG001|Overall Study|Death|0|||
23545678|NCT03449030|65727249|FG002|Overall Study|Death|0|||
23545679|NCT03449030|65727250|FG003|Overall Study|Death|0|||
23545680|NCT03449030|65727251|FG004|Overall Study|Death|1|||
23545681|NCT03449030|65727252|FG005|Overall Study|Death|0|||
23545682|NCT03449030|65727253|FG006|Overall Study|Death|0|||
23545683|NCT03449030|65727254|FG007|Overall Study|Death|0|||
23545684|NCT03449030|65727255|FG008|Overall Study|Death|0|||
23545685|NCT03449030|65727256|FG009|Overall Study|Death|0|||
23545686|NCT02416791|65727258|FG000|6 Months|Lost to Follow-up|0|||
23545687|NCT02416791|65727259|FG001|6 Months|Lost to Follow-up|0|||
23545688|NCT02416791|65727260|FG002|6 Months|Lost to Follow-up|1|||
23545689|NCT01218438|65727261|FG000|Epoch 1|Physician Decision|2|||
23545690|NCT01218438|65727261|FG000|Epoch 1|Adverse Event|1|||
23545691|NCT01218438|65727261|FG000|Epoch 3|Withdrawal by Subject|3|||
23545692|NCT01218438|65727261|FG000|Epoch 3|Adverse Event|1|||
23545693|NCT01218438|65727261|FG000|Epoch 4|Physician Decision|1|||
23545694|NCT01218438|65727261|FG000|Epoch 4|Withdrawal by Subject|2|||
23545695|NCT04389840|65727264|FG000|Overall Study|Adverse Event|0|||
23545696|NCT04389840|65727265|FG001|Overall Study|Adverse Event|0|||
23545697|NCT04389840|65727266|FG002|Overall Study|Adverse Event|0|||
23545698|NCT04389840|65727267|FG003|Overall Study|Adverse Event|1|||
23545699|NCT04389840|65727268|FG004|Overall Study|Adverse Event|0|||
23545700|NCT04389840|65727269|FG005|Overall Study|Adverse Event|0|||
23545701|NCT04389840|65727264|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
23545702|NCT04389840|65727265|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
23545703|NCT04389840|65727266|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
23545704|NCT04389840|65727267|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
23545705|NCT04389840|65727268|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
23545706|NCT04389840|65727269|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
23545707|NCT04389840|65727264|FG000|Overall Study|Death|0|||
23545708|NCT04389840|65727265|FG001|Overall Study|Death|1|||
23545709|NCT04389840|65727266|FG002|Overall Study|Death|0|||
23545710|NCT04389840|65727267|FG003|Overall Study|Death|0|||
23545711|NCT04389840|65727268|FG004|Overall Study|Death|0|||
23618657|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
23618658|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
23545712|NCT04389840|65727269|FG005|Overall Study|Death|0|||
23545713|NCT04773587|65727272|FG000|Overall Study|Lost to Follow-up|11|||
23545714|NCT04773587|65727273|FG001|Overall Study|Lost to Follow-up|3|||
23545715|NCT04773587|65727272|FG000|Overall Study|Adverse Event|6|||
23545716|NCT04773587|65727273|FG001|Overall Study|Adverse Event|3|||
23734609|NCT02630459|66405812|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23734610|NCT02630459|66405813|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23734611|NCT02630459|66405814|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23734612|NCT02630459|66405807|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
23734613|NCT02630459|66405808|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734614|NCT02630459|66405809|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734615|NCT02630459|66405810|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734616|NCT02630459|66405811|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734617|NCT02630459|66405812|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734618|NCT02630459|66405813|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734619|NCT02630459|66405814|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23734620|NCT02630459|66405807|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734621|NCT02630459|66405808|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734622|NCT02630459|66405809|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734623|NCT02630459|66405810|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734624|NCT02630459|66405811|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
23734625|NCT02630459|66405812|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
23734626|NCT02630459|66405813|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734627|NCT02630459|66405814|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23734628|NCT02630459|66405807|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734629|NCT02630459|66405808|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734630|NCT02630459|66405809|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734631|NCT02630459|66405810|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734632|NCT02630459|66405811|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
23734633|NCT02630459|66405812|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
23734634|NCT02630459|66405813|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734635|NCT02630459|66405814|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23734636|NCT02630459|66405807|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734637|NCT02630459|66405808|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734638|NCT02630459|66405809|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734639|NCT02630459|66405810|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734640|NCT02630459|66405811|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
23734641|NCT02630459|66405812|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734642|NCT02630459|66405813|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734643|NCT02630459|66405814|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23734644|NCT03345849|66405817|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
23734645|NCT03345849|66405818|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
23734646|NCT03345849|66405819|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
23734647|NCT03345849|66405820|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
23734648|NCT03345849|66405817|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
23734649|NCT03345849|66405818|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
23734650|NCT03345849|66405819|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
23734651|NCT03345849|66405820|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
23819418|NCT02257385|66717598|FG001|Overall Study|Lost to Follow-up|1|||
23545717|NCT04773587|65727272|FG000|Overall Study|Lack of Efficacy|5|||
23545718|NCT04773587|65727273|FG001|Overall Study|Lack of Efficacy|2|||
23545719|NCT04773587|65727272|FG000|Overall Study|Withdrawal by Subject|4|||
23545720|NCT04773587|65727273|FG001|Overall Study|Withdrawal by Subject|5|||
23734652|NCT03345849|66405817|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23734653|NCT03345849|66405818|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
23734654|NCT03345849|66405819|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23734655|NCT03345849|66405820|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23734656|NCT03345849|66405817|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
23734657|NCT03345849|66405818|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
23734658|NCT03345849|66405819|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
23734659|NCT03345849|66405820|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
23734660|NCT03345849|66405817|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23734661|NCT03345849|66405818|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
23734662|NCT03345849|66405819|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23734663|NCT03345849|66405820|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23734664|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
23734665|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
23734666|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
23734667|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
23734668|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
23734669|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
23734670|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
23734671|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
23734672|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
23734673|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
23734674|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
23734675|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
23734676|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23734677|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23734678|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23734679|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
23734680|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23734681|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23734682|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
23734683|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23734684|NCT03345849|66405817|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
23734685|NCT03345849|66405818|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
23734686|NCT03345849|66405819|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
23734687|NCT03345849|66405820|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
23734688|NCT00887913|66405824|FG000|Overall Study|Withdrawal by Subject|6|||
23734689|NCT00764322|66405829|FG000|Overall Study|Withdrawal by Subject|11|||
23734690|NCT00764322|66405829|FG000|Overall Study|No CYP2D6 genotyping|9|||
23734691|NCT00850135|66405830|FG000|Overall Study|Physician Decision|1|||
23734692|NCT00638989|66405831|FG000|Overall Study|Lost to Follow-up|0|||
23734693|NCT00638989|66405832|FG001|Overall Study|Lost to Follow-up|0|||
23734694|NCT00638989|66405833|FG002|Overall Study|Lost to Follow-up|1|||
23734695|NCT01815099|66405834|FG000|Overall Study|Lack of Efficacy|1|||
23734696|NCT01815099|66405834|FG000|Overall Study|unable to attend study visits|1|||
23734697|NCT00942422|66405835|FG000|Overall Study|Withdrawal by Subject|1|||
23734698|NCT00942422|66405835|FG000|Overall Study|Death|1|||
23734699|NCT00942422|66405835|FG000|Overall Study|Progressive diease|1|||
23734700|NCT01682759|66405840|FG000|Overall Study|Death|2|||
23734701|NCT01682759|66405841|FG001|Overall Study|Death|1|||
23734702|NCT01682759|66405840|FG000|Overall Study|Lost to Follow-up|10|||
23734703|NCT01682759|66405841|FG001|Overall Study|Lost to Follow-up|13|||
23734704|NCT01682759|66405840|FG000|Overall Study|Physician Decision|1|||
23734705|NCT01682759|66405841|FG001|Overall Study|Physician Decision|1|||
23734706|NCT01682759|66405840|FG000|Overall Study|Withdrawal by Subject|56|||
23734707|NCT01682759|66405841|FG001|Overall Study|Withdrawal by Subject|55|||
23734708|NCT04610827|66408908|FG000|Overall Study|Withdrawal by Subject|1|||
23734709|NCT04610827|66408909|FG001|Overall Study|Withdrawal by Subject|1|||
23734710|NCT04610827|66408910|FG002|Overall Study|Withdrawal by Subject|0|||
23734711|NCT04604015|66408911|FG000|Overall Study|Incomplete Data Collection|33|||
23734712|NCT03289676|66408914|FG000|Overall Study|Withdrawal by Subject|2|||
23734713|NCT03289676|66408915|FG001|Overall Study|Withdrawal by Subject|0|||
23734714|NCT03289676|66408914|FG000|Overall Study|Protocol Violation|2|||
23734715|NCT03289676|66408915|FG001|Overall Study|Protocol Violation|0|||
23734716|NCT03289676|66408914|FG000|Overall Study|Lost to Follow-up|0|||
23734717|NCT03289676|66408915|FG001|Overall Study|Lost to Follow-up|1|||
23734718|NCT01326481|66408916|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
23734719|NCT01938391|66408917|FG000|6 Month Follow up|Withdrawal by Subject|1|||
23734720|NCT01938391|66408917|FG000|12 Month Follow up|Physician Decision|1|||
23734721|NCT01938391|66408917|FG000|12 Month Follow up|Withdrawal by Subject|1|||
23734722|NCT02757768|66408918|FG000|Overall Study|Randomized Never Received Study Drug|3|||
23734723|NCT02757768|66408919|FG001|Overall Study|Randomized Never Received Study Drug|4|||
23734724|NCT02757768|66408918|FG000|Overall Study|Adverse Event|5|||
23734725|NCT02757768|66408919|FG001|Overall Study|Adverse Event|3|||
23734726|NCT02757768|66408918|FG000|Overall Study|Lack of Efficacy|2|||
23734727|NCT02757768|66408919|FG001|Overall Study|Lack of Efficacy|1|||
23734728|NCT02757768|66408918|FG000|Overall Study|Lost to Follow-up|1|||
23734729|NCT02757768|66408919|FG001|Overall Study|Lost to Follow-up|0|||
23734730|NCT02757768|66408918|FG000|Overall Study|Protocol Deviation|2|||
23734731|NCT02757768|66408919|FG001|Overall Study|Protocol Deviation|9|||
23734732|NCT02757768|66408918|FG000|Overall Study|Withdrawal by Subject|16|||
23734733|NCT02757768|66408919|FG001|Overall Study|Withdrawal by Subject|9|||
23734734|NCT02757768|66408918|FG000|Overall Study|Miscellaneous|4|||
23734735|NCT02757768|66408919|FG001|Overall Study|Miscellaneous|2|||
23734736|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
23734737|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
23734738|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
23734739|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
23734740|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
23734741|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
23734742|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
23734743|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
23734744|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
23734745|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
23734746|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
23734747|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
23734748|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
23819419|NCT02257385|66717597|FG000|Overall Study|Withdrawal by Subject|4|||
23819420|NCT02257385|66717598|FG001|Overall Study|Withdrawal by Subject|4|||
23819421|NCT03247816|66717599|FG000|Overall Study|Adverse Event|12|||
23819422|NCT03247816|66717599|FG000|Overall Study|Physician Decision|3|||
23734749|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Death|0|||
23734750|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Death|0|||
23734751|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Death|1|||
23734752|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Death|0|||
23734753|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Death|0|||
23734754|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Death|0|||
23734755|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Death|0|||
23734756|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Death|0|||
23734757|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Death|0|||
23618659|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23618660|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23618661|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
23618662|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23618663|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23618664|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
23618665|NCT00404547|65988362|FG000|Overall Study|Adverse Event|39|||
23618666|NCT00404547|65988363|FG001|Overall Study|Adverse Event|6|||
23618667|NCT00404547|65988362|FG000|Overall Study|Withdrawal by Subject|19|||
23618668|NCT00404547|65988363|FG001|Overall Study|Withdrawal by Subject|2|||
23618669|NCT00404547|65988362|FG000|Overall Study|Protocol Violation|0|||
23734758|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Death|0|||
23734759|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Death|0|||
23734760|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Death|0|||
23734761|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Death|0|||
23734762|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
23734763|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
23819423|NCT03247816|66717599|FG000|Overall Study|Lack of Efficacy|1|||
23819424|NCT03247816|66717599|FG000|Overall Study|Lost to Follow-up|10|||
23426751|NCT00882908|65307442|FG000|Overall Study|Study terminated in error|0|||
23426752|NCT00882908|65307443|FG001|Overall Study|Study terminated in error|0|||
23819425|NCT03247816|66717599|FG000|Overall Study|Missing Feraccru stop date|3|||
23618670|NCT00404547|65988363|FG001|Overall Study|Protocol Violation|1|||
23618671|NCT00404547|65988362|FG000|Overall Study|Lost to Follow-up|20|||
23734764|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
23734765|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734766|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734767|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734768|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734769|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734770|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734771|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734772|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734773|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734774|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23734775|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734776|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734777|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
23734778|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734779|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734780|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734781|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734782|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734783|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734784|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734785|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734786|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734787|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23734788|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
23734789|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
23734790|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
23734791|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
23734792|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
23734793|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
23734794|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
23734795|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
23734796|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
23734797|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
23734798|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
23734799|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
23734800|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
23734801|NCT02407236|66408920|FG000|Induction Study (8 Weeks)|Other|2|||
23734802|NCT02407236|66408921|FG001|Induction Study (8 Weeks)|Other|1|||
23734803|NCT02407236|66408922|FG002|Induction Study (8 Weeks)|Other|5|||
23734804|NCT02407236|66408923|FG003|Induction Study (8 Weeks)|Other|0|||
23734805|NCT02407236|66408924|FG004|Induction Study (8 Weeks)|Other|0|||
23734806|NCT02407236|66408925|FG005|Induction Study (8 Weeks)|Other|0|||
23734807|NCT02407236|66408926|FG006|Induction Study (8 Weeks)|Other|0|||
23734808|NCT02407236|66408927|FG007|Induction Study (8 Weeks)|Other|0|||
23734809|NCT02407236|66408928|FG008|Induction Study (8 Weeks)|Other|0|||
23734810|NCT02407236|66408929|FG009|Induction Study (8 Weeks)|Other|0|||
23734811|NCT02407236|66408930|FG010|Induction Study (8 Weeks)|Other|0|||
23734812|NCT02407236|66408931|FG011|Induction Study (8 Weeks)|Other|0|||
23734813|NCT02407236|66408932|FG012|Induction Study (8 Weeks)|Other|0|||
23734814|NCT02407236|66408920|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734815|NCT02407236|66408921|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734816|NCT02407236|66408922|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734817|NCT02407236|66408923|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
23734818|NCT02407236|66408924|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
23734819|NCT02407236|66408925|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
23734820|NCT02407236|66408926|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
23734821|NCT02407236|66408927|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
23734822|NCT02407236|66408928|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734823|NCT02407236|66408929|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734824|NCT02407236|66408930|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734825|NCT02407236|66408931|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734826|NCT02407236|66408932|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
23734827|NCT02407236|66408920|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734828|NCT02407236|66408921|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23426753|NCT00882908|65307444|FG002|Overall Study|Study terminated in error|0|||
23734829|NCT02407236|66408922|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734830|NCT02407236|66408923|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
23734831|NCT02407236|66408924|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
23426754|NCT00882908|65307445|FG003|Overall Study|Study terminated in error|1|||
23545721|NCT04773587|65727272|FG000|Overall Study|Noncompliance|1|||
23734832|NCT02407236|66408925|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
23819426|NCT01141205|66717600|FG000|Overall Study|Physician Decision|1|||
23819427|NCT01141205|66717601|FG001|Overall Study|Physician Decision|1|||
23819428|NCT01141205|66717600|FG000|Overall Study|Lost to Follow-up|1|||
23734833|NCT02407236|66408926|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
23734834|NCT02407236|66408927|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
23734835|NCT02407236|66408928|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734836|NCT02407236|66408929|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734837|NCT02407236|66408930|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734838|NCT02407236|66408931|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734839|NCT02407236|66408932|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23734840|NCT02407236|66408920|FG000|Maintenance Study (44 Weeks)|Other|0|||
23734841|NCT02407236|66408921|FG001|Maintenance Study (44 Weeks)|Other|0|||
23734842|NCT02407236|66408922|FG002|Maintenance Study (44 Weeks)|Other|0|||
23819429|NCT01141205|66717601|FG001|Overall Study|Lost to Follow-up|0|||
23819430|NCT01141205|66717600|FG000|Overall Study|Withdrawal by Subject|1|||
23819431|NCT01141205|66717601|FG001|Overall Study|Withdrawal by Subject|1|||
23819432|NCT02766283|66717602|FG000|Overall Study|Lost to Follow-up|27|||
23819433|NCT01590277|66717603|FG000|Overall Study|Withdrawal by Subject|3|||
23819434|NCT01590277|66717603|FG000|Overall Study|Withdrawal by Subject|2|||
23819435|NCT01590277|66717603|FG000|Overall Study|Withdrawal by Subject|1|||
23819436|NCT01590277|66717603|FG000|Overall Study|Withdrawal by Subject|1|||
23819437|NCT01338870|66717604|FG000|Overall Study|Lost to Follow-up|0|||
23819438|NCT01338870|66717605|FG001|Overall Study|Lost to Follow-up|0|||
23819439|NCT01338870|66717606|FG002|Overall Study|Lost to Follow-up|1|||
23819440|NCT01338870|66717607|FG003|Overall Study|Lost to Follow-up|0|||
23819441|NCT01338870|66717608|FG004|Overall Study|Lost to Follow-up|1|||
23819442|NCT01338870|66717609|FG005|Overall Study|Lost to Follow-up|0|||
23819443|NCT01338870|66717604|FG000|Overall Study|Withdrawal by Subject|2|||
23819444|NCT01338870|66717605|FG001|Overall Study|Withdrawal by Subject|3|||
23819445|NCT01338870|66717606|FG002|Overall Study|Withdrawal by Subject|4|||
23819446|NCT01338870|66717607|FG003|Overall Study|Withdrawal by Subject|0|||
23819447|NCT01338870|66717608|FG004|Overall Study|Withdrawal by Subject|0|||
23819448|NCT01338870|66717609|FG005|Overall Study|Withdrawal by Subject|2|||
23819449|NCT01338870|66717604|FG000|Overall Study|Other|3|||
23819450|NCT01338870|66717605|FG001|Overall Study|Other|3|||
23819451|NCT01338870|66717606|FG002|Overall Study|Other|3|||
23819452|NCT01338870|66717607|FG003|Overall Study|Other|2|||
23819453|NCT01338870|66717608|FG004|Overall Study|Other|0|||
23819454|NCT01338870|66717609|FG005|Overall Study|Other|2|||
23819455|NCT01338870|66717604|FG000|Overall Study|Protocol Violation|0|||
23819456|NCT01338870|66717605|FG001|Overall Study|Protocol Violation|2|||
23819457|NCT01338870|66717606|FG002|Overall Study|Protocol Violation|2|||
23819458|NCT01338870|66717607|FG003|Overall Study|Protocol Violation|2|||
23819459|NCT01338870|66717608|FG004|Overall Study|Protocol Violation|1|||
23819460|NCT01338870|66717609|FG005|Overall Study|Protocol Violation|1|||
23819461|NCT01338870|66717604|FG000|Overall Study|Adverse Event|4|||
23819462|NCT01338870|66717605|FG001|Overall Study|Adverse Event|4|||
23819463|NCT01338870|66717606|FG002|Overall Study|Adverse Event|1|||
23819464|NCT01338870|66717607|FG003|Overall Study|Adverse Event|5|||
23819465|NCT01338870|66717608|FG004|Overall Study|Adverse Event|4|||
23819466|NCT01338870|66717609|FG005|Overall Study|Adverse Event|1|||
23734843|NCT02407236|66408923|FG003|Maintenance Study (44 Weeks)|Other|5|||
23819467|NCT02359994|66717610|FG000|Overall Population Study|Adverse Event|1|||
23819468|NCT02359994|66717611|FG001|Overall Population Study|Adverse Event|1|||
23819469|NCT02359994|66717610|FG000|Overall Population Study|Death|1|||
23618672|NCT00404547|65988363|FG001|Overall Study|Lost to Follow-up|9|||
23618673|NCT00404547|65988362|FG000|Overall Study|Lack of compliance|5|||
23618674|NCT00404547|65988363|FG001|Overall Study|Lack of compliance|1|||
23618675|NCT00404547|65988362|FG000|Overall Study|Other|4|||
23618676|NCT00404547|65988363|FG001|Overall Study|Other|0|||
23618677|NCT00404547|65988362|FG000|Overall Study|Reason not stated|3|||
23618678|NCT00404547|65988363|FG001|Overall Study|Reason not stated|6|||
23618679|NCT00497198|65991309|FG000|Overall Study|Adverse Event|4|||
23618680|NCT00497198|65991310|FG001|Overall Study|Adverse Event|2|||
23618681|NCT00497198|65991309|FG000|Overall Study|Physician Decision|1|||
23426755|NCT00882908|65307446|FG004|Overall Study|Study terminated in error|0|||
23426756|NCT00276094|65307450|FG000|Overall Study|Adverse Event|15|||
23426757|NCT00276094|65307451|FG001|Overall Study|Adverse Event|13|||
23426758|NCT00276094|65307452|FG002|Overall Study|Adverse Event|11|||
23426759|NCT00276094|65307450|FG000|Overall Study|Withdrawal by Subject|14|||
23426760|NCT00276094|65307451|FG001|Overall Study|Withdrawal by Subject|14|||
23734844|NCT02407236|66408924|FG004|Maintenance Study (44 Weeks)|Other|7|||
23819470|NCT02359994|66717611|FG001|Overall Population Study|Death|5|||
23734845|NCT02407236|66408925|FG005|Maintenance Study (44 Weeks)|Other|8|||
23734846|NCT02407236|66408926|FG006|Maintenance Study (44 Weeks)|Other|4|||
23734847|NCT02407236|66408927|FG007|Maintenance Study (44 Weeks)|Other|6|||
23734848|NCT02407236|66408928|FG008|Maintenance Study (44 Weeks)|Other|0|||
23819471|NCT02359994|66717610|FG000|Overall Population Study|Lost to Follow-up|1|||
23734849|NCT02407236|66408929|FG009|Maintenance Study (44 Weeks)|Other|0|||
23734850|NCT02407236|66408930|FG010|Maintenance Study (44 Weeks)|Other|0|||
23734851|NCT02407236|66408931|FG011|Maintenance Study (44 Weeks)|Other|0|||
23734852|NCT02407236|66408932|FG012|Maintenance Study (44 Weeks)|Other|0|||
23734853|NCT02407236|66408920|FG000|Maintenance Study (44 Weeks)|Death|0|||
23734854|NCT02407236|66408921|FG001|Maintenance Study (44 Weeks)|Death|0|||
23734855|NCT02407236|66408922|FG002|Maintenance Study (44 Weeks)|Death|0|||
23734856|NCT02407236|66408923|FG003|Maintenance Study (44 Weeks)|Death|0|||
23618682|NCT00497198|65991310|FG001|Overall Study|Physician Decision|2|||
23618683|NCT00497198|65991309|FG000|Overall Study|Withdrawal by Subject|0|||
23734857|NCT02407236|66408924|FG004|Maintenance Study (44 Weeks)|Death|0|||
23734858|NCT02407236|66408925|FG005|Maintenance Study (44 Weeks)|Death|0|||
23734859|NCT02407236|66408926|FG006|Maintenance Study (44 Weeks)|Death|0|||
23734860|NCT02407236|66408927|FG007|Maintenance Study (44 Weeks)|Death|1|||
23426761|NCT00276094|65307452|FG002|Overall Study|Withdrawal by Subject|12|||
23426762|NCT00276094|65307450|FG000|Overall Study|Protocol Violation|16|||
23426763|NCT00276094|65307451|FG001|Overall Study|Protocol Violation|7|||
23426764|NCT00276094|65307452|FG002|Overall Study|Protocol Violation|10|||
23426765|NCT00276094|65307450|FG000|Overall Study|Lost to Follow-up|8|||
23426766|NCT00276094|65307451|FG001|Overall Study|Lost to Follow-up|6|||
23426767|NCT00276094|65307452|FG002|Overall Study|Lost to Follow-up|4|||
23426768|NCT00276094|65307450|FG000|Overall Study|Other-Subject moved out of country|1|||
23426769|NCT00276094|65307451|FG001|Overall Study|Other-Subject moved out of country|0|||
23734861|NCT02407236|66408928|FG008|Maintenance Study (44 Weeks)|Death|0|||
23734862|NCT02407236|66408929|FG009|Maintenance Study (44 Weeks)|Death|0|||
23734863|NCT02407236|66408930|FG010|Maintenance Study (44 Weeks)|Death|0|||
23734864|NCT02407236|66408931|FG011|Maintenance Study (44 Weeks)|Death|0|||
23734865|NCT02407236|66408932|FG012|Maintenance Study (44 Weeks)|Death|0|||
23734866|NCT02407236|66408920|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734867|NCT02407236|66408921|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734868|NCT02407236|66408922|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734869|NCT02407236|66408923|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734870|NCT02407236|66408924|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734871|NCT02407236|66408925|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23426770|NCT00276094|65307452|FG002|Overall Study|Other-Subject moved out of country|0|||
23734872|NCT02407236|66408926|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734873|NCT02407236|66408927|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23734874|NCT02407236|66408928|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
23734875|NCT02407236|66408929|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
23734876|NCT02407236|66408930|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
23734877|NCT02407236|66408931|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
23734878|NCT02407236|66408932|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
23734879|NCT02407236|66408920|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734880|NCT02407236|66408921|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23426771|NCT00276094|65307450|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
23426772|NCT00276094|65307451|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
23426773|NCT00276094|65307452|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
23426774|NCT00276094|65307450|FG000|Overall Study|Other-Lack of efficacy|1|||
23426775|NCT00276094|65307451|FG001|Overall Study|Other-Lack of efficacy|0|||
23426776|NCT00276094|65307452|FG002|Overall Study|Other-Lack of efficacy|0|||
23426777|NCT00276094|65307450|FG000|Overall Study|Other-Refused follow-up visit|1|||
23545722|NCT04773587|65727273|FG001|Overall Study|Noncompliance|0|||
23734881|NCT02407236|66408922|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734882|NCT02407236|66408923|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734883|NCT02407236|66408924|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734884|NCT02407236|66408925|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734885|NCT02407236|66408926|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734886|NCT02407236|66408927|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734887|NCT02407236|66408928|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734888|NCT02407236|66408929|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734889|NCT02407236|66408930|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
23734890|NCT02407236|66408931|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734891|NCT02407236|66408932|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23734892|NCT02407236|66408920|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734893|NCT02407236|66408921|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734894|NCT02407236|66408922|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734895|NCT02407236|66408923|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734896|NCT02407236|66408924|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734897|NCT02407236|66408925|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734898|NCT02407236|66408926|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734899|NCT02407236|66408927|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23734900|NCT02407236|66408928|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
23734901|NCT02407236|66408929|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
23426778|NCT00276094|65307451|FG001|Overall Study|Other-Refused follow-up visit|0|||
23426779|NCT00276094|65307452|FG002|Overall Study|Other-Refused follow-up visit|0|||
23545723|NCT04773587|65727272|FG000|Overall Study|Protocol Violation|1|||
23545724|NCT04773587|65727273|FG001|Overall Study|Protocol Violation|0|||
23734902|NCT02407236|66408930|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
23734903|NCT02407236|66408931|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
23734904|NCT02407236|66408932|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
23734905|NCT02407236|66408920|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
23734906|NCT02407236|66408921|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
23618684|NCT00497198|65991310|FG001|Overall Study|Withdrawal by Subject|1|||
23618685|NCT01780545|65991311|FG000|Overall Study|Withdrawal by Subject|3|||
23618686|NCT01780545|65991312|FG001|Overall Study|Withdrawal by Subject|1|||
23618687|NCT01780545|65991311|FG000|Overall Study|Lost to Follow-up|1|||
23618688|NCT01780545|65991312|FG001|Overall Study|Lost to Follow-up|1|||
23618689|NCT01157377|65991313|FG000|Overall Study|Lost to Follow-up|0|||
23734907|NCT02407236|66408922|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
23734908|NCT02407236|66408923|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
23734909|NCT02407236|66408924|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
23734910|NCT02407236|66408925|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
23734911|NCT02407236|66408926|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
23734912|NCT02407236|66408927|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
23734913|NCT02407236|66408928|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
23734914|NCT02407236|66408929|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
23734915|NCT02407236|66408930|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
23734916|NCT02407236|66408931|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
23734917|NCT02407236|66408932|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
23734918|NCT04035473|66408933|FG000|Screening/Baseline|Death|0|||
23734919|NCT04035473|66408934|FG001|Screening/Baseline|Death|1|||
23734920|NCT04035473|66408933|FG000|Screening/Baseline|Adverse Event|0|||
23545725|NCT04773587|65727272|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
23545726|NCT04773587|65727273|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
23545727|NCT04433767|65727274|FG000|Overall Study|Adverse Event|1|||
23545728|NCT04642638|65727275|FG000|Overall Study|Withdrawal by Subject|23|||
23545729|NCT04642638|65727276|FG001|Overall Study|Withdrawal by Subject|29|||
23545730|NCT04642638|65727277|FG002|Overall Study|Withdrawal by Subject|9|||
23545731|NCT04642638|65727278|FG003|Overall Study|Withdrawal by Subject|7|||
23545732|NCT04642638|65727279|FG004|Overall Study|Withdrawal by Subject|61|||
23545733|NCT04642638|65727280|FG005|Overall Study|Withdrawal by Subject|27|||
23545734|NCT04642638|65727275|FG000|Overall Study|Lost to Follow-up|17|||
23618690|NCT01157377|65991314|FG001|Overall Study|Lost to Follow-up|0|||
23618691|NCT01157377|65991315|FG002|Overall Study|Lost to Follow-up|1|||
23618692|NCT01157377|65991316|FG003|Overall Study|Lost to Follow-up|0|||
23734921|NCT04035473|66408934|FG001|Screening/Baseline|Adverse Event|1|||
23734922|NCT04035473|66408933|FG000|Follow-up Period|Adverse Event|2|||
23734923|NCT04035473|66408934|FG001|Follow-up Period|Adverse Event|0|||
23734924|NCT00372905|66408935|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
23734925|NCT00372905|66408936|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23734926|NCT00372905|66408937|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23734927|NCT00372905|66408938|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23734928|NCT00372905|66408935|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23734929|NCT00372905|66408936|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23734930|NCT00372905|66408937|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
23734931|NCT00372905|66408938|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23734932|NCT00372905|66408935|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23734933|NCT00372905|66408936|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23734934|NCT00372905|66408937|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
23734935|NCT00372905|66408938|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23734936|NCT00372905|66408935|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23734937|NCT00372905|66408936|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23734938|NCT00372905|66408937|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23734939|NCT00372905|66408938|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
23734940|NCT00372905|66408935|FG000|Follow up Until Relapse or Progression|Study closed|0|||
23734941|NCT00372905|66408936|FG001|Follow up Until Relapse or Progression|Study closed|0|||
23734942|NCT00372905|66408937|FG002|Follow up Until Relapse or Progression|Study closed|0|||
23734943|NCT00372905|66408938|FG003|Follow up Until Relapse or Progression|Study closed|3|||
23734944|NCT00372905|66408935|FG000|Follow up Until Relapse or Progression|Other|0|||
23734945|NCT00372905|66408936|FG001|Follow up Until Relapse or Progression|Other|1|||
23734946|NCT00372905|66408937|FG002|Follow up Until Relapse or Progression|Other|0|||
23734947|NCT00372905|66408938|FG003|Follow up Until Relapse or Progression|Other|0|||
23734948|NCT01904760|66408947|FG000|Overall Study|Protocol Violation|1|||
23734949|NCT01904760|66408948|FG001|Overall Study|Protocol Violation|0|||
23734950|NCT02382276|66408949|FG000|Overall Study|Withdrawal by Subject|4|||
23734951|NCT02382276|66408950|FG001|Overall Study|Withdrawal by Subject|8|||
23819472|NCT02359994|66717611|FG001|Overall Population Study|Lost to Follow-up|1|||
23819473|NCT02359994|66717610|FG000|Overall Population Study|Withdrawal by Subject|1|||
23545735|NCT04642638|65727276|FG001|Overall Study|Lost to Follow-up|18|||
23545736|NCT04642638|65727277|FG002|Overall Study|Lost to Follow-up|5|||
23618693|NCT01157377|65991317|FG004|Overall Study|Lost to Follow-up|1|||
23618694|NCT01157377|65991318|FG005|Overall Study|Lost to Follow-up|1|||
23618695|NCT01157377|65991319|FG006|Overall Study|Lost to Follow-up|0|||
23618696|NCT01157377|65991313|FG000|Overall Study|Personal Reasons|2|||
23618697|NCT01157377|65991314|FG001|Overall Study|Personal Reasons|1|||
23618698|NCT01157377|65991315|FG002|Overall Study|Personal Reasons|0|||
23734952|NCT02382276|66408951|FG002|Overall Study|Withdrawal by Subject|5|||
23734953|NCT02382276|66408949|FG000|Overall Study|Adverse Event|7|||
23734954|NCT02382276|66408950|FG001|Overall Study|Adverse Event|2|||
23734955|NCT02382276|66408951|FG002|Overall Study|Adverse Event|32|||
23734956|NCT02382276|66408949|FG000|Overall Study|Physician Decision|0|||
23734957|NCT02382276|66408950|FG001|Overall Study|Physician Decision|0|||
23734958|NCT02382276|66408951|FG002|Overall Study|Physician Decision|2|||
23734959|NCT00281528|66408952|FG000|Overall Study|Progressive Disease|28|||
23734960|NCT00281528|66408953|FG001|Overall Study|Progressive Disease|18|||
23734961|NCT00281528|66408954|FG002|Overall Study|Progressive Disease|27|||
23734962|NCT00281528|66408952|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
23734963|NCT00281528|66408953|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
23618699|NCT01157377|65991316|FG003|Overall Study|Personal Reasons|1|||
23618700|NCT01157377|65991317|FG004|Overall Study|Personal Reasons|0|||
23618701|NCT01157377|65991318|FG005|Overall Study|Personal Reasons|0|||
23618702|NCT01157377|65991319|FG006|Overall Study|Personal Reasons|0|||
23618703|NCT01157377|65991313|FG000|Overall Study|Protocol Violation|0|||
23618704|NCT01157377|65991314|FG001|Overall Study|Protocol Violation|0|||
23618705|NCT01157377|65991315|FG002|Overall Study|Protocol Violation|0|||
23618706|NCT01157377|65991316|FG003|Overall Study|Protocol Violation|0|||
23618707|NCT01157377|65991317|FG004|Overall Study|Protocol Violation|0|||
23618708|NCT01157377|65991318|FG005|Overall Study|Protocol Violation|1|||
23734964|NCT00281528|66408954|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
23734965|NCT00281528|66408952|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
23734966|NCT00281528|66408953|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
23734967|NCT00281528|66408954|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
23734968|NCT00281528|66408952|FG000|Overall Study|Physician Decision|11|||
23734969|NCT00281528|66408953|FG001|Overall Study|Physician Decision|4|||
23618709|NCT01157377|65991319|FG006|Overall Study|Protocol Violation|0|||
23618710|NCT01157377|65991313|FG000|Overall Study|Lack of Efficacy|0|||
23618711|NCT01157377|65991314|FG001|Overall Study|Lack of Efficacy|0|||
23618712|NCT01157377|65991315|FG002|Overall Study|Lack of Efficacy|0|||
23618713|NCT01157377|65991316|FG003|Overall Study|Lack of Efficacy|0|||
23618714|NCT01157377|65991317|FG004|Overall Study|Lack of Efficacy|0|||
23618715|NCT01157377|65991318|FG005|Overall Study|Lack of Efficacy|0|||
23618716|NCT01157377|65991319|FG006|Overall Study|Lack of Efficacy|1|||
23618717|NCT01157377|65991313|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23618718|NCT01157377|65991314|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23618719|NCT01157377|65991315|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23618720|NCT01157377|65991316|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23618721|NCT01157377|65991317|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23618722|NCT01157377|65991318|FG005|Overall Study|Other Miscellaneous Reasons|1|||
23618723|NCT01157377|65991319|FG006|Overall Study|Other Miscellaneous Reasons|1|||
23618724|NCT02775214|65991322|FG000|Overall Study|Withdrawal by Subject|2|||
23618725|NCT02775214|65991323|FG001|Overall Study|Withdrawal by Subject|0|||
23618726|NCT00105521|65991324|FG000|Overall Study|Other|1|||
23618727|NCT00105521|65991325|FG001|Overall Study|Other|1|||
23618728|NCT00105521|65991326|FG002|Overall Study|Other|2|||
23618729|NCT00105521|65991327|FG003|Overall Study|Other|0|||
23618730|NCT00105521|65991324|FG000|Overall Study|Adverse Event|10|||
23618731|NCT00105521|65991325|FG001|Overall Study|Adverse Event|4|||
23618732|NCT00105521|65991326|FG002|Overall Study|Adverse Event|10|||
23618733|NCT00105521|65991327|FG003|Overall Study|Adverse Event|8|||
23618734|NCT00105521|65991324|FG000|Overall Study|Withdrawal by Subject|1|||
23734970|NCT00281528|66408954|FG002|Overall Study|Physician Decision|5|||
23734971|NCT00281528|66408952|FG000|Overall Study|Protocol Violation|1|||
23734972|NCT00281528|66408953|FG001|Overall Study|Protocol Violation|0|||
23734973|NCT00281528|66408954|FG002|Overall Study|Protocol Violation|1|||
23618735|NCT00105521|65991325|FG001|Overall Study|Withdrawal by Subject|0|||
23734974|NCT00281528|66408952|FG000|Overall Study|Withdrawal by Subject|5|||
23734975|NCT00281528|66408953|FG001|Overall Study|Withdrawal by Subject|5|||
23618736|NCT00105521|65991326|FG002|Overall Study|Withdrawal by Subject|1|||
23618737|NCT00105521|65991327|FG003|Overall Study|Withdrawal by Subject|4|||
23618738|NCT00105521|65991324|FG000|Overall Study|Lack of Efficacy|0|||
23618739|NCT00105521|65991325|FG001|Overall Study|Lack of Efficacy|0|||
23618740|NCT00105521|65991326|FG002|Overall Study|Lack of Efficacy|0|||
23618741|NCT00105521|65991327|FG003|Overall Study|Lack of Efficacy|1|||
23618742|NCT00105521|65991324|FG000|Overall Study|Protocol Violation|3|||
23618743|NCT00105521|65991325|FG001|Overall Study|Protocol Violation|5|||
23618744|NCT00105521|65991326|FG002|Overall Study|Protocol Violation|4|||
23618745|NCT00105521|65991327|FG003|Overall Study|Protocol Violation|4|||
23618746|NCT00105521|65991324|FG000|Overall Study|Lost to Follow-up|0|||
23618747|NCT00105521|65991325|FG001|Overall Study|Lost to Follow-up|1|||
23618748|NCT00105521|65991326|FG002|Overall Study|Lost to Follow-up|0|||
23618749|NCT00105521|65991327|FG003|Overall Study|Lost to Follow-up|0|||
23618750|NCT00866918|65991332|FG000|Overall Study|Death|1|||
23618751|NCT00866918|65991333|FG001|Overall Study|Death|5|||
23618752|NCT00866918|65991332|FG000|Overall Study|Lack of Efficacy|1|||
23618753|NCT00866918|65991333|FG001|Overall Study|Lack of Efficacy|1|||
23618754|NCT00866918|65991332|FG000|Overall Study|Physician Decision|10|||
23618755|NCT00866918|65991333|FG001|Overall Study|Physician Decision|2|||
23618756|NCT00866918|65991332|FG000|Overall Study|Ineligible|2|||
23734976|NCT00281528|66408954|FG002|Overall Study|Withdrawal by Subject|7|||
23734977|NCT00281528|66408952|FG000|Overall Study|Other|6|||
23734978|NCT00281528|66408953|FG001|Overall Study|Other|3|||
23734979|NCT00281528|66408954|FG002|Overall Study|Other|5|||
23734980|NCT01957111|66408957|FG000|Overall Study|Withdrawal by Subject|1|||
23734981|NCT01957111|66408958|FG001|Overall Study|Withdrawal by Subject|1|||
23734982|NCT01333865|66408959|FG000|Overall Study|Adverse Event|2|||
23734983|NCT02260791|66408960|FG000|Overall Study|Lost to Follow-up|4|||
23734984|NCT02260791|66408961|FG001|Overall Study|Lost to Follow-up|4|||
23734985|NCT02260791|66408960|FG000|Overall Study|Lack of Efficacy|2|||
23734986|NCT02260791|66408961|FG001|Overall Study|Lack of Efficacy|1|||
23734987|NCT02260791|66408960|FG000|Overall Study|Adverse Event|13|||
23734988|NCT02260791|66408961|FG001|Overall Study|Adverse Event|9|||
23734989|NCT02260791|66408960|FG000|Overall Study|Death|1|||
23734990|NCT02260791|66408961|FG001|Overall Study|Death|0|||
23734991|NCT02260791|66408960|FG000|Overall Study|Withdrawal by Subject|11|||
23734992|NCT02260791|66408961|FG001|Overall Study|Withdrawal by Subject|16|||
23734993|NCT02260791|66408960|FG000|Overall Study|Screen failure|0|||
23734994|NCT02260791|66408961|FG001|Overall Study|Screen failure|1|||
23734995|NCT02260791|66408960|FG000|Overall Study|Protocol deviation|2|||
23734996|NCT02260791|66408961|FG001|Overall Study|Protocol deviation|3|||
23734997|NCT02853318|66408962|FG000|Overall Study|Withdrawal by Subject|1|||
23734998|NCT01351415|66408963|FG000|Overall Study|Withdrawal by Subject|15|||
23734999|NCT01351415|66408964|FG001|Overall Study|Withdrawal by Subject|17|||
23735000|NCT01351415|66408963|FG000|Overall Study|Trial termination by the Sponsor|28|||
23735001|NCT01351415|66408964|FG001|Overall Study|Trial termination by the Sponsor|19|||
23735002|NCT01351415|66408963|FG000|Overall Study|Lost to Follow-up|5|||
23735003|NCT01351415|66408964|FG001|Overall Study|Lost to Follow-up|7|||
23735004|NCT01351415|66408963|FG000|Overall Study|Death|190|||
23735005|NCT01351415|66408964|FG001|Overall Study|Death|187|||
23735006|NCT01351415|66408963|FG000|Overall Study|Physician Decision|2|||
23735007|NCT01351415|66408964|FG001|Overall Study|Physician Decision|3|||
23735008|NCT01351415|66408963|FG000|Overall Study|Reason unknown|0|||
23735009|NCT01351415|66408964|FG001|Overall Study|Reason unknown|2|||
23735010|NCT01351415|66408963|FG000|Overall Study|Never Started|5|||
23735011|NCT01351415|66408964|FG001|Overall Study|Never Started|5|||
23735012|NCT00129376|66408967|FG000|Overall Study|Adverse Event|1|||
23735013|NCT00129376|66408967|FG000|Overall Study|Lack of Efficacy|1|||
23735014|NCT04554394|66408969|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
23735015|NCT04554394|66408970|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
23735016|NCT04554394|66408969|FG000|Overall Study|Withdrawal by Subject|2|||
23735017|NCT04554394|66408970|FG001|Overall Study|Withdrawal by Subject|2|||
23735018|NCT04554394|66408969|FG000|Overall Study|Lost to Follow-up|2|||
23735019|NCT04554394|66408970|FG001|Overall Study|Lost to Follow-up|2|||
23735020|NCT04554394|66408969|FG000|Overall Study|Physician Decision|1|||
23735021|NCT04554394|66408970|FG001|Overall Study|Physician Decision|1|||
23735022|NCT00901394|66408971|FG000|Overall Study|Physician Decision|1|||
23735023|NCT00901394|66408972|FG001|Overall Study|Physician Decision|1|||
23735024|NCT00901394|66408973|FG002|Overall Study|Physician Decision|2|||
23735025|NCT01279954|66408974|FG000|Overall Study|Lack of Efficacy|3|||
23735026|NCT01279954|66408975|FG001|Overall Study|Lack of Efficacy|4|||
23735027|NCT03598140|66408976|FG000|Overall Study|enrolled but didn't start|1|||
23735028|NCT03598140|66408977|FG001|Overall Study|enrolled but didn't start|0|||
23735029|NCT01970540|66408984|FG000|Overall Study|Non-treatment-related AE|0|||
23618757|NCT00866918|65991333|FG001|Overall Study|Ineligible|4|||
23735030|NCT01970540|66408985|FG001|Overall Study|Non-treatment-related AE|0|||
23735031|NCT01970540|66408986|FG002|Overall Study|Non-treatment-related AE|1|||
23735032|NCT01970540|66408984|FG000|Overall Study|Progressive disease|55|||
23735033|NCT01970540|66408985|FG001|Overall Study|Progressive disease|23|||
23735034|NCT01970540|66408986|FG002|Overall Study|Progressive disease|10|||
23735035|NCT01970540|66408984|FG000|Overall Study|Treatment delay over protocol|0|||
23426780|NCT00276094|65307450|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
23618758|NCT00866918|65991332|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
23618759|NCT00866918|65991333|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
23735036|NCT01970540|66408985|FG001|Overall Study|Treatment delay over protocol|0|||
23735037|NCT01970540|66408986|FG002|Overall Study|Treatment delay over protocol|1|||
23735038|NCT01970540|66408984|FG000|Overall Study|Physician Decision|7|||
23735039|NCT01970540|66408985|FG001|Overall Study|Physician Decision|2|||
23819474|NCT02359994|66717611|FG001|Overall Population Study|Withdrawal by Subject|0|||
23819475|NCT02359994|66717610|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
23819476|NCT02359994|66717611|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
23819477|NCT02359994|66717610|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
23819478|NCT02359994|66717611|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
23819479|NCT02359994|66717610|FG000|Extended Oncology 24-Month Survival|Death|19|||
23819480|NCT02359994|66717611|FG001|Extended Oncology 24-Month Survival|Death|21|||
23819481|NCT02359994|66717610|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
23819482|NCT02359994|66717611|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
23819483|NCT02540850|66717613|FG000|Overall Study|Lost to Follow-up|69|||
23819484|NCT02540850|66717614|FG001|Overall Study|Lost to Follow-up|66|||
23819485|NCT02540850|66717615|FG002|Overall Study|Lost to Follow-up|34|||
23819486|NCT02694328|66717616|FG000|Overall Study|Adverse Event|27|||
23819487|NCT02694328|66717617|FG001|Overall Study|Adverse Event|33|||
23819488|NCT02694328|66717616|FG000|Overall Study|Withdrawal by Subject|27|||
23819489|NCT02694328|66717617|FG001|Overall Study|Withdrawal by Subject|23|||
23819490|NCT02694328|66717616|FG000|Overall Study|Lost to Follow-up|26|||
23819491|NCT02694328|66717617|FG001|Overall Study|Lost to Follow-up|22|||
23819492|NCT02694328|66717616|FG000|Overall Study|Noncompliant with study drug|11|||
23819493|NCT02694328|66717617|FG001|Overall Study|Noncompliant with study drug|8|||
23819494|NCT02694328|66717616|FG000|Overall Study|Incarceration|1|||
23819495|NCT02694328|66717617|FG001|Overall Study|Incarceration|1|||
23819496|NCT02694328|66717616|FG000|Overall Study|Lack of Efficacy|1|||
23735040|NCT01970540|66408986|FG002|Overall Study|Physician Decision|0|||
23735041|NCT01970540|66408984|FG000|Overall Study|Clinical progression|0|||
23735042|NCT01970540|66408985|FG001|Overall Study|Clinical progression|1|||
23735043|NCT01970540|66408986|FG002|Overall Study|Clinical progression|1|||
23735044|NCT01970540|66408984|FG000|Overall Study|End of study|2|||
23735045|NCT01970540|66408985|FG001|Overall Study|End of study|0|||
23735046|NCT01970540|66408986|FG002|Overall Study|End of study|2|||
23735047|NCT01970540|66408984|FG000|Overall Study|Adverse Event|0|||
23735048|NCT01970540|66408985|FG001|Overall Study|Adverse Event|2|||
23735049|NCT01970540|66408986|FG002|Overall Study|Adverse Event|1|||
23735050|NCT01970540|66408984|FG000|Overall Study|Treatment-related AE|4|||
23735051|NCT01970540|66408985|FG001|Overall Study|Treatment-related AE|0|||
23735052|NCT01970540|66408986|FG002|Overall Study|Treatment-related AE|2|||
23735053|NCT01970540|66408984|FG000|Overall Study|Withdrawal by Subject|4|||
23735054|NCT01970540|66408985|FG001|Overall Study|Withdrawal by Subject|0|||
23735055|NCT01970540|66408986|FG002|Overall Study|Withdrawal by Subject|1|||
23735056|NCT01970540|66408984|FG000|Overall Study|Clinical deterioration|1|||
23735057|NCT01970540|66408985|FG001|Overall Study|Clinical deterioration|0|||
23735058|NCT01970540|66408986|FG002|Overall Study|Clinical deterioration|0|||
23735059|NCT05049122|66408987|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
23735060|NCT05049122|66408987|FG000|Overall Study|Participant moved|1|||
23735061|NCT05049122|66408987|FG000|Overall Study|At the direction of the doctor|1|||
23735062|NCT00125268|66408988|FG000|Overall Study|Withdrawal by Subject|1|||
23735063|NCT00125268|66408989|FG001|Overall Study|Withdrawal by Subject|1|||
23735064|NCT04439266|66408991|FG000|Overall Study|Ineligible|1|||
23735065|NCT04439266|66408991|FG000|Overall Study|Adverse Event|1|||
23735066|NCT04439266|66408991|FG000|Overall Study|Death|1|||
23735067|NCT04439266|66408991|FG000|Overall Study|Disease progression|1|||
23735068|NCT04439266|66408991|FG000|Overall Study|Still on treatment|1|||
23735069|NCT04430036|66408992|FG000|Safety Run in Phase|Progression of disease|2|||
23735070|NCT02646332|66408995|FG000|Overall Study|Lost to Follow-up|0|||
23735071|NCT02646332|66408996|FG001|Overall Study|Lost to Follow-up|3|||
23735072|NCT00545740|66408997|FG000|Overall Study|Lack of Efficacy|34|||
23735073|NCT00545740|66408998|FG001|Overall Study|Lack of Efficacy|35|||
23735074|NCT00545740|66408999|FG002|Overall Study|Lack of Efficacy|47|||
23735075|NCT00545740|66409000|FG003|Overall Study|Lack of Efficacy|36|||
23735076|NCT00545740|66408997|FG000|Overall Study|Withdrawal by Subject|17|||
23735077|NCT00545740|66408998|FG001|Overall Study|Withdrawal by Subject|15|||
23735078|NCT00545740|66408999|FG002|Overall Study|Withdrawal by Subject|16|||
23735079|NCT00545740|66409000|FG003|Overall Study|Withdrawal by Subject|18|||
23735080|NCT00545740|66408997|FG000|Overall Study|Adverse Event|10|||
23735081|NCT00545740|66408998|FG001|Overall Study|Adverse Event|18|||
23735082|NCT00545740|66408999|FG002|Overall Study|Adverse Event|19|||
23735083|NCT00545740|66409000|FG003|Overall Study|Adverse Event|9|||
23819497|NCT02694328|66717617|FG001|Overall Study|Lack of Efficacy|2|||
23819498|NCT02694328|66717616|FG000|Overall Study|Pregnancy|1|||
23735084|NCT00545740|66408997|FG000|Overall Study|Lost to Follow-up|7|||
23735085|NCT00545740|66408998|FG001|Overall Study|Lost to Follow-up|5|||
23735086|NCT00545740|66408999|FG002|Overall Study|Lost to Follow-up|5|||
23735087|NCT00545740|66409000|FG003|Overall Study|Lost to Follow-up|6|||
23735088|NCT00545740|66408997|FG000|Overall Study|Protocol Violation|1|||
23735089|NCT00545740|66408998|FG001|Overall Study|Protocol Violation|3|||
23735090|NCT00545740|66408999|FG002|Overall Study|Protocol Violation|1|||
23735091|NCT00545740|66409000|FG003|Overall Study|Protocol Violation|0|||
23735092|NCT00545740|66408997|FG000|Overall Study|Non-compliance|0|||
23735093|NCT00545740|66408998|FG001|Overall Study|Non-compliance|2|||
23735094|NCT00545740|66408999|FG002|Overall Study|Non-compliance|1|||
23735095|NCT00545740|66409000|FG003|Overall Study|Non-compliance|0|||
23735096|NCT00545740|66408997|FG000|Overall Study|Moved|2|||
23735097|NCT00545740|66408998|FG001|Overall Study|Moved|0|||
23735098|NCT00545740|66408999|FG002|Overall Study|Moved|1|||
23735099|NCT00545740|66409000|FG003|Overall Study|Moved|0|||
23735100|NCT00545740|66408997|FG000|Overall Study|Diverticulitis attack|0|||
23735101|NCT00545740|66408998|FG001|Overall Study|Diverticulitis attack|0|||
23735102|NCT00545740|66408999|FG002|Overall Study|Diverticulitis attack|1|||
23735103|NCT00545740|66409000|FG003|Overall Study|Diverticulitis attack|1|||
23735104|NCT00545740|66408997|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
23735105|NCT00545740|66408998|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
23735106|NCT00545740|66408999|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
23735107|NCT00545740|66409000|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
23735108|NCT00545740|66408997|FG000|Overall Study|Site closure|1|||
23735109|NCT00545740|66408998|FG001|Overall Study|Site closure|0|||
23735110|NCT00545740|66408999|FG002|Overall Study|Site closure|0|||
23735111|NCT00545740|66409000|FG003|Overall Study|Site closure|0|||
23735112|NCT00545740|66408997|FG000|Overall Study|Missed visit|1|||
23735113|NCT00545740|66408998|FG001|Overall Study|Missed visit|0|||
23735114|NCT00545740|66408999|FG002|Overall Study|Missed visit|0|||
23735115|NCT00545740|66409000|FG003|Overall Study|Missed visit|0|||
23735116|NCT00545740|66408997|FG000|Overall Study|Physician Decision|0|||
23735117|NCT00545740|66408998|FG001|Overall Study|Physician Decision|0|||
23735118|NCT00545740|66408999|FG002|Overall Study|Physician Decision|3|||
23735119|NCT00545740|66409000|FG003|Overall Study|Physician Decision|0|||
23819499|NCT02694328|66717617|FG001|Overall Study|Pregnancy|1|||
23819500|NCT02694328|66717616|FG000|Overall Study|Protocol Violation|6|||
23819501|NCT02694328|66717617|FG001|Overall Study|Protocol Violation|5|||
23819502|NCT02694328|66717616|FG000|Overall Study|Abnormal Laboratory Value|0|||
23819503|NCT02694328|66717617|FG001|Overall Study|Abnormal Laboratory Value|3|||
23819504|NCT00926783|66717618|FG000|Overall Study|Incomplete CFAE Procedures|3|||
23819505|NCT00926783|66717619|FG001|Overall Study|Incomplete CFAE Procedures|3|||
23819506|NCT02212379|66717620|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
23819507|NCT02212379|66717620|FG000|From Baseline to Week 48|Adverse Event|7|||
23819508|NCT02212379|66717620|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
23819509|NCT02212379|66717620|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
23819510|NCT02212379|66717620|FG000|From Week 48 to Week 96|Adverse Event|1|||
23819511|NCT02212379|66717620|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
23819512|NCT01199016|66717621|FG000|Overall Study|No longer meets eligibility criteria|4|||
23819513|NCT01199016|66717621|FG000|Overall Study|Entrance criteria|5|||
23819514|NCT01199016|66717621|FG000|Overall Study|Protocol Violation|9|||
23819515|NCT01199016|66717621|FG000|Overall Study|Other|13|||
23819516|NCT01199016|66717621|FG000|Overall Study|Withdrawal by Subject|21|||
23819517|NCT01199016|66717621|FG000|Overall Study|Lost to Follow-up|25|||
23819518|NCT00426361|66717622|FG000|Overall Study|Lost to Follow-up|3|||
23819519|NCT00426361|66717623|FG001|Overall Study|Lost to Follow-up|2|||
23819520|NCT00426361|66717624|FG002|Overall Study|Lost to Follow-up|5|||
23819521|NCT00426361|66717622|FG000|Overall Study|Withdrawal by Subject|1|||
23819522|NCT00426361|66717623|FG001|Overall Study|Withdrawal by Subject|3|||
23819523|NCT00426361|66717624|FG002|Overall Study|Withdrawal by Subject|0|||
23819524|NCT01582152|66717625|FG000|Overall Study|Disease Progression|4|||
23819525|NCT01582152|66717626|FG001|Overall Study|Disease Progression|5|||
23819526|NCT01582152|66717625|FG000|Overall Study|Adverse Event|2|||
23819527|NCT01582152|66717626|FG001|Overall Study|Adverse Event|1|||
23819528|NCT03765788|66717632|FG000|Overall Study|Subject decision|2|||
23819529|NCT03765788|66717633|FG001|Overall Study|Subject decision|3|||
23545737|NCT04642638|65727278|FG003|Overall Study|Lost to Follow-up|5|||
23735120|NCT00545740|66408997|FG000|Overall Study|Accepted only monthly telephone calls|1|||
23819530|NCT03765788|66717632|FG000|Overall Study|Physician Decision|2|||
23819531|NCT03765788|66717633|FG001|Overall Study|Physician Decision|4|||
23819532|NCT03765788|66717632|FG000|Overall Study|Death|0|||
23819533|NCT03765788|66717633|FG001|Overall Study|Death|1|||
23819534|NCT03765788|66717632|FG000|Overall Study|Lost to Follow-up|1|||
23735121|NCT00545740|66408998|FG001|Overall Study|Accepted only monthly telephone calls|0|||
23735122|NCT00545740|66408999|FG002|Overall Study|Accepted only monthly telephone calls|0|||
23735123|NCT00545740|66409000|FG003|Overall Study|Accepted only monthly telephone calls|0|||
23735124|NCT00545740|66408997|FG000|Overall Study|Sponsor decision|0|||
23735125|NCT00545740|66408998|FG001|Overall Study|Sponsor decision|1|||
23735126|NCT00545740|66408999|FG002|Overall Study|Sponsor decision|0|||
23735127|NCT00545740|66409000|FG003|Overall Study|Sponsor decision|0|||
23735128|NCT00545740|66408997|FG000|Overall Study|Lack of time|0|||
23735129|NCT00545740|66408998|FG001|Overall Study|Lack of time|1|||
23735130|NCT00545740|66408999|FG002|Overall Study|Lack of time|0|||
23735131|NCT00545740|66409000|FG003|Overall Study|Lack of time|0|||
23735132|NCT00545740|66408997|FG000|Overall Study|Non-adherence to visits|0|||
23735133|NCT00545740|66408998|FG001|Overall Study|Non-adherence to visits|1|||
23735134|NCT00545740|66408999|FG002|Overall Study|Non-adherence to visits|0|||
23735135|NCT00545740|66409000|FG003|Overall Study|Non-adherence to visits|0|||
23735136|NCT00545740|66408997|FG000|Overall Study|Patient difficulties|0|||
23735137|NCT00545740|66408998|FG001|Overall Study|Patient difficulties|1|||
23735138|NCT00545740|66408999|FG002|Overall Study|Patient difficulties|0|||
23735139|NCT00545740|66409000|FG003|Overall Study|Patient difficulties|0|||
23735140|NCT00545740|66408997|FG000|Overall Study|Husband against study|0|||
23735141|NCT00545740|66408998|FG001|Overall Study|Husband against study|0|||
23735142|NCT00545740|66408999|FG002|Overall Study|Husband against study|1|||
23735143|NCT00545740|66409000|FG003|Overall Study|Husband against study|0|||
23735144|NCT01512108|66409001|FG000|Overall Study|Adverse Event|9|||
23735145|NCT01512108|66409002|FG001|Overall Study|Adverse Event|4|||
23735146|NCT01512108|66409001|FG000|Overall Study|Protocol Violation|1|||
23735147|NCT01512108|66409002|FG001|Overall Study|Protocol Violation|2|||
23735148|NCT01512108|66409001|FG000|Overall Study|Withdrawal Criteria|1|||
23735149|NCT01512108|66409002|FG001|Overall Study|Withdrawal Criteria|0|||
23735150|NCT01512108|66409001|FG000|Overall Study|Unclassified|11|||
23735151|NCT01512108|66409002|FG001|Overall Study|Unclassified|3|||
23735152|NCT00137267|66409003|FG000|Overall Study|Lost to Follow-up|15|||
23735153|NCT00137267|66409004|FG001|Overall Study|Lost to Follow-up|21|||
23735154|NCT00286234|66409006|FG000|Overall Study|Protocol Violation|1|||
23735155|NCT00286234|66409007|FG001|Overall Study|Protocol Violation|2|||
23735156|NCT00286234|66409008|FG002|Overall Study|Protocol Violation|0|||
23735157|NCT00286234|66409009|FG003|Overall Study|Protocol Violation|1|||
23735158|NCT00286234|66409006|FG000|Overall Study|Physician Decision|1|||
23735159|NCT00286234|66409007|FG001|Overall Study|Physician Decision|0|||
23735160|NCT00286234|66409008|FG002|Overall Study|Physician Decision|0|||
23735161|NCT00286234|66409009|FG003|Overall Study|Physician Decision|1|||
23735162|NCT00286234|66409006|FG000|Overall Study|Adverse Event|0|||
23735163|NCT00286234|66409007|FG001|Overall Study|Adverse Event|0|||
23735164|NCT00286234|66409008|FG002|Overall Study|Adverse Event|0|||
23735165|NCT00286234|66409009|FG003|Overall Study|Adverse Event|1|||
23735166|NCT00286234|66409006|FG000|Overall Study|Adverse Event|0|||
23735167|NCT00286234|66409007|FG001|Overall Study|Adverse Event|0|||
23735168|NCT00286234|66409008|FG002|Overall Study|Adverse Event|0|||
23735169|NCT00286234|66409009|FG003|Overall Study|Adverse Event|1|||
23735170|NCT01535638|66409010|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
23735171|NCT01535638|66409011|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
23735172|NCT01535638|66409012|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
23735173|NCT01535638|66409013|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
23735174|NCT01535638|66409014|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
23735175|NCT01535638|66409015|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
23735176|NCT01535638|66409010|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
23735177|NCT01535638|66409011|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
23735178|NCT01535638|66409012|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
23735179|NCT01535638|66409013|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
23735180|NCT01535638|66409014|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
23735181|NCT01535638|66409015|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
23735182|NCT02504424|66409018|FG000|Overall Study|Withdrawal by Subject|2|||
23735183|NCT02177942|66409019|FG000|Overall Study|Adverse Event|1|||
23735184|NCT02177942|66409020|FG001|Overall Study|Adverse Event|0|||
23735185|NCT02177942|66409019|FG000|Overall Study|Lost to Follow-up|1|||
23735186|NCT02177942|66409020|FG001|Overall Study|Lost to Follow-up|1|||
23735187|NCT02177942|66409019|FG000|Overall Study|Protocol Violation|4|||
23735188|NCT02177942|66409020|FG001|Overall Study|Protocol Violation|6|||
23735189|NCT02177942|66409019|FG000|Overall Study|Withdrawal by Subject|71|||
23735190|NCT02177942|66409020|FG001|Overall Study|Withdrawal by Subject|81|||
23735191|NCT01021553|66409021|FG000|Overall Study|Adverse Event|1|||
23735192|NCT01021553|66409022|FG001|Overall Study|Adverse Event|0|||
23545738|NCT04642638|65727279|FG004|Overall Study|Lost to Follow-up|6|||
23735193|NCT01021553|66409023|FG002|Overall Study|Adverse Event|0|||
23735194|NCT01021553|66409021|FG000|Overall Study|Lack of Efficacy|2|||
23735195|NCT01021553|66409022|FG001|Overall Study|Lack of Efficacy|2|||
23735196|NCT01021553|66409023|FG002|Overall Study|Lack of Efficacy|0|||
23735197|NCT01021553|66409021|FG000|Overall Study|Protocol Violation|0|||
23735198|NCT01021553|66409022|FG001|Overall Study|Protocol Violation|2|||
23735199|NCT01021553|66409023|FG002|Overall Study|Protocol Violation|2|||
23735200|NCT01021553|66409021|FG000|Overall Study|Lost to Follow-up|0|||
23735201|NCT01021553|66409022|FG001|Overall Study|Lost to Follow-up|0|||
23735202|NCT01021553|66409023|FG002|Overall Study|Lost to Follow-up|1|||
23735203|NCT01021553|66409021|FG000|Overall Study|Withdrawal by Subject|1|||
23819535|NCT03765788|66717633|FG001|Overall Study|Lost to Follow-up|0|||
23819536|NCT02906358|66717634|FG000|Overall Study|Withdrawal by Subject|10|||
23819537|NCT02906358|66717635|FG001|Overall Study|Withdrawal by Subject|7|||
23819538|NCT02906358|66717634|FG000|Overall Study|Lost to Follow-up|12|||
23819539|NCT02906358|66717635|FG001|Overall Study|Lost to Follow-up|15|||
23819540|NCT00721227|66717636|FG000|Overall Study|Lost to Follow-up|3|||
23819541|NCT00721227|66717637|FG001|Overall Study|Lost to Follow-up|0|||
23819542|NCT00721227|66717636|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
23819543|NCT00721227|66717637|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
23819544|NCT00799825|66717638|FG000|Overall Study|Adverse Event|1|||
23819545|NCT00799825|66717638|FG000|Overall Study|Withdrawal by Subject|6|||
23819546|NCT00799825|66717638|FG000|Overall Study|Lost to Follow-up|38|||
23819547|NCT00799825|66717638|FG000|Overall Study|Pregnancy|3|||
23819548|NCT02114385|66717639|FG000|Overall Study|Withdrawal by Subject|3|||
23819549|NCT02114385|66717640|FG001|Overall Study|Withdrawal by Subject|2|||
23819550|NCT02114385|66717639|FG000|Overall Study|Lost to Follow-up|0|||
23545739|NCT04642638|65727280|FG005|Overall Study|Lost to Follow-up|3|||
23545740|NCT04642638|65727275|FG000|Overall Study|Adverse Event|0|||
23545741|NCT04642638|65727276|FG001|Overall Study|Adverse Event|0|||
23545742|NCT04642638|65727277|FG002|Overall Study|Adverse Event|1|||
23545743|NCT04642638|65727278|FG003|Overall Study|Adverse Event|0|||
23735204|NCT01021553|66409022|FG001|Overall Study|Withdrawal by Subject|1|||
23735205|NCT01021553|66409023|FG002|Overall Study|Withdrawal by Subject|0|||
23735206|NCT01029691|66409024|FG000|Continued APAP to Delivery|Death|0|||
23735207|NCT01029691|66409025|FG001|Continued APAP to Delivery|Death|0|||
23735208|NCT01029691|66409026|FG002|Continued APAP to Delivery|Death|1|||
23735209|NCT02918006|66409027|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
23735210|NCT02918006|66409028|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
23735211|NCT02918006|66409029|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
23735212|NCT02918006|66409027|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
23735213|NCT02918006|66409028|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
23735214|NCT02918006|66409029|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
23735215|NCT02918006|66409027|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
23735216|NCT02918006|66409028|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
23735217|NCT02918006|66409029|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
23735218|NCT02918006|66409027|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
23735219|NCT02918006|66409028|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
23735220|NCT02918006|66409029|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
23735221|NCT02918006|66409027|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
23735222|NCT02918006|66409028|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
23735223|NCT02918006|66409029|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
23735224|NCT02918006|66409027|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
23735225|NCT02918006|66409028|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
23735226|NCT02918006|66409029|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
23735227|NCT02918006|66409027|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
23735228|NCT02918006|66409028|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
23735229|NCT02918006|66409029|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
23735230|NCT02918006|66409027|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
23735231|NCT02918006|66409028|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
23735232|NCT02918006|66409029|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
23735233|NCT02918006|66409027|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
23735234|NCT02918006|66409028|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
23735235|NCT02918006|66409029|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
23735236|NCT03432819|66409030|FG000|Overall Study|Lost to Follow-up|2|||
23735237|NCT03432819|66409031|FG001|Overall Study|Lost to Follow-up|2|||
23735238|NCT03432819|66409030|FG000|Overall Study|Withdrawal by Subject|5|||
23735239|NCT03432819|66409031|FG001|Overall Study|Withdrawal by Subject|3|||
23735240|NCT03419741|66409034|FG000|Overall Study|Adverse Event|1|||
23735241|NCT03419741|66409035|FG001|Overall Study|Adverse Event|0|||
23819551|NCT02114385|66717640|FG001|Overall Study|Lost to Follow-up|6|||
23819552|NCT04895982|66717641|FG000|Overall Study|Withdrawal by Subject|0|||
23819553|NCT04895982|66717642|FG001|Overall Study|Withdrawal by Subject|0|||
23819554|NCT04895982|66717643|FG002|Overall Study|Withdrawal by Subject|0|||
23545744|NCT04642638|65727279|FG004|Overall Study|Adverse Event|10|||
23545745|NCT04642638|65727280|FG005|Overall Study|Adverse Event|3|||
23735242|NCT03419741|66409034|FG000|Overall Study|Withdrawal by Subject|1|||
23735243|NCT03419741|66409035|FG001|Overall Study|Withdrawal by Subject|2|||
23735244|NCT01603628|66409038|FG000|Overall Study|Personal Reasons|1|||
23735245|NCT01603628|66409039|FG001|Overall Study|Personal Reasons|1|||
23735246|NCT01603628|66409040|FG002|Overall Study|Personal Reasons|2|||
23819555|NCT04895982|66717644|FG003|Overall Study|Withdrawal by Subject|0|||
23819556|NCT04895982|66717645|FG004|Overall Study|Withdrawal by Subject|0|||
23735247|NCT01603628|66409038|FG000|Overall Study|Protocol Violation|1|||
23819557|NCT04895982|66717646|FG005|Overall Study|Withdrawal by Subject|1|||
23735248|NCT01603628|66409039|FG001|Overall Study|Protocol Violation|1|||
23735249|NCT01603628|66409040|FG002|Overall Study|Protocol Violation|0|||
23735250|NCT01603628|66409038|FG000|Overall Study|Lost to Follow-up|0|||
23735251|NCT01603628|66409039|FG001|Overall Study|Lost to Follow-up|1|||
23735252|NCT01603628|66409040|FG002|Overall Study|Lost to Follow-up|0|||
23735253|NCT01603628|66409038|FG000|Overall Study|Other Miscellaneous Reason|1|||
23735254|NCT01603628|66409039|FG001|Overall Study|Other Miscellaneous Reason|0|||
23735255|NCT01603628|66409040|FG002|Overall Study|Other Miscellaneous Reason|0|||
23735256|NCT03824704|66409041|FG000|Overall Study|Study Terminated by Sponsor|1|||
23735257|NCT00434876|66409047|FG000|Overall Study|Lost to Follow-up|1|||
23735258|NCT00434876|66409048|FG001|Overall Study|Lost to Follow-up|1|||
23735259|NCT01696396|66409053|FG000|Overall Study|Withdrawal by Subject|19|||
23735260|NCT01696396|66409054|FG001|Overall Study|Withdrawal by Subject|5|||
23735261|NCT01696396|66409055|FG002|Overall Study|Withdrawal by Subject|19|||
23735262|NCT01696396|66409056|FG003|Overall Study|Withdrawal by Subject|11|||
23735263|NCT01696396|66409053|FG000|Overall Study|Decision by Sponsor|3|||
23735264|NCT01696396|66409054|FG001|Overall Study|Decision by Sponsor|1|||
23735265|NCT01696396|66409055|FG002|Overall Study|Decision by Sponsor|2|||
23735266|NCT01696396|66409056|FG003|Overall Study|Decision by Sponsor|2|||
23735267|NCT01696396|66409053|FG000|Overall Study|Lost to Follow-up|9|||
23735268|NCT01696396|66409054|FG001|Overall Study|Lost to Follow-up|1|||
23735269|NCT01696396|66409055|FG002|Overall Study|Lost to Follow-up|4|||
23735270|NCT01696396|66409056|FG003|Overall Study|Lost to Follow-up|1|||
23735271|NCT01696396|66409053|FG000|Overall Study|Death|0|||
23735272|NCT01696396|66409054|FG001|Overall Study|Death|0|||
23735273|NCT01696396|66409055|FG002|Overall Study|Death|1|||
23735274|NCT01696396|66409056|FG003|Overall Study|Death|0|||
23735275|NCT00736385|66409060|FG000|Overall Study|Withdrawal by Subject|2|||
23735276|NCT00736385|66409061|FG001|Overall Study|Withdrawal by Subject|2|||
23735277|NCT00736385|66409060|FG000|Overall Study|Adverse Event|0|||
23735278|NCT00736385|66409061|FG001|Overall Study|Adverse Event|1|||
23735279|NCT01195636|66409062|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
23735280|NCT01195636|66409063|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
23735281|NCT01195636|66409062|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
23735282|NCT01195636|66409063|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
23735283|NCT01195636|66409062|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23735284|NCT01195636|66409063|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23735285|NCT01195636|66409062|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
23735286|NCT01195636|66409063|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
23735287|NCT01195636|66409062|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
23735288|NCT01195636|66409063|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
23735289|NCT01195636|66409062|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23735290|NCT01195636|66409063|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
23735291|NCT01195636|66409062|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
23735292|NCT01195636|66409063|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
23735293|NCT01195636|66409062|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23735294|NCT01195636|66409063|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23735295|NCT00462488|66409064|FG000|Overall Study|Protocol Violation|1|||
23735296|NCT00462488|66409065|FG001|Overall Study|Protocol Violation|0|||
23735297|NCT00462488|66409064|FG000|Overall Study|Lack of Efficacy|19|||
23735298|NCT00462488|66409065|FG001|Overall Study|Lack of Efficacy|17|||
23735299|NCT00303329|66409069|FG000|Overall Study|Adverse Event|7|||
23735300|NCT00303329|66409070|FG001|Overall Study|Adverse Event|14|||
23735301|NCT00303329|66409069|FG000|Overall Study|Abnormal Laboratory Values|0|||
23735302|NCT00303329|66409070|FG001|Overall Study|Abnormal Laboratory Values|1|||
23735303|NCT00303329|66409069|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23735304|NCT00303329|66409070|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23735305|NCT00303329|66409069|FG000|Overall Study|Condition no longer requires study drug|0|||
23735306|NCT00303329|66409070|FG001|Overall Study|Condition no longer requires study drug|8|||
23735307|NCT00303329|66409069|FG000|Overall Study|Protocol Violation|3|||
23735308|NCT00303329|66409070|FG001|Overall Study|Protocol Violation|0|||
23735309|NCT00303329|66409069|FG000|Overall Study|Withdrawal by Subject|9|||
23735310|NCT00303329|66409070|FG001|Overall Study|Withdrawal by Subject|15|||
23735311|NCT00303329|66409069|FG000|Overall Study|Lost to Follow-up|0|||
23545746|NCT04642638|65727275|FG000|Overall Study|Reason Not Specified|1|||
23735312|NCT00303329|66409070|FG001|Overall Study|Lost to Follow-up|1|||
23735313|NCT00303329|66409069|FG000|Overall Study|Administrative problems|1|||
23735314|NCT00303329|66409070|FG001|Overall Study|Administrative problems|0|||
23735315|NCT00303329|66409069|FG000|Overall Study|Death|2|||
23735316|NCT00303329|66409070|FG001|Overall Study|Death|12|||
23735317|NCT00303329|66409069|FG000|Overall Study|Stopped at end of core|3|||
23735318|NCT00303329|66409070|FG001|Overall Study|Stopped at end of core|9|||
23735319|NCT00303329|66409069|FG000|Overall Study|Stopped at end of extension 1|1|||
23735320|NCT00303329|66409070|FG001|Overall Study|Stopped at end of extension 1|0|||
23735321|NCT00542425|66409071|FG000|Initial 24 Weeks|Administrative reasons|0|||
23545747|NCT04642638|65727276|FG001|Overall Study|Reason Not Specified|4|||
23735322|NCT00542425|66409072|FG001|Initial 24 Weeks|Administrative reasons|0|||
23735323|NCT00542425|66409073|FG002|Initial 24 Weeks|Administrative reasons|1|||
23735324|NCT00542425|66409074|FG003|Initial 24 Weeks|Administrative reasons|1|||
23735325|NCT00542425|66409075|FG004|Initial 24 Weeks|Administrative reasons|0|||
23735326|NCT00542425|66409071|FG000|Initial 24 Weeks|Adverse Event|0|||
23735327|NCT00542425|66409072|FG001|Initial 24 Weeks|Adverse Event|1|||
23735328|NCT00542425|66409073|FG002|Initial 24 Weeks|Adverse Event|1|||
23735329|NCT00542425|66409074|FG003|Initial 24 Weeks|Adverse Event|3|||
23735330|NCT00542425|66409075|FG004|Initial 24 Weeks|Adverse Event|2|||
23735331|NCT00542425|66409071|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
23735332|NCT00542425|66409072|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
23735333|NCT00542425|66409073|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
23735334|NCT00542425|66409074|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
23735335|NCT00542425|66409075|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
23735336|NCT00542425|66409071|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
23735337|NCT00542425|66409072|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
23735338|NCT00542425|66409073|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
23735339|NCT00542425|66409074|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
23735340|NCT00542425|66409075|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
23735341|NCT00542425|66409071|FG000|Initial 24 Weeks|Non-compliance|0|||
23735342|NCT00542425|66409072|FG001|Initial 24 Weeks|Non-compliance|0|||
23735343|NCT00542425|66409073|FG002|Initial 24 Weeks|Non-compliance|0|||
23819558|NCT04895982|66717647|FG006|Overall Study|Withdrawal by Subject|1|||
23819559|NCT04895982|66717648|FG007|Overall Study|Withdrawal by Subject|0|||
23819560|NCT04895982|66717649|FG008|Overall Study|Withdrawal by Subject|0|||
23819561|NCT04895982|66717650|FG009|Overall Study|Withdrawal by Subject|1|||
23819562|NCT04895982|66717651|FG010|Overall Study|Withdrawal by Subject|0|||
23819563|NCT04895982|66717652|FG011|Overall Study|Withdrawal by Subject|1|||
23819564|NCT04895982|66717641|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23819565|NCT04895982|66717642|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23819566|NCT04895982|66717643|FG002|Overall Study|Withdrawal by parent/guardian|3|||
23819567|NCT04895982|66717644|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23735344|NCT00542425|66409074|FG003|Initial 24 Weeks|Non-compliance|1|||
23735345|NCT00542425|66409075|FG004|Initial 24 Weeks|Non-compliance|1|||
23735346|NCT00542425|66409071|FG000|Initial 24 Weeks|Protocol Violation|0|||
23735347|NCT00542425|66409072|FG001|Initial 24 Weeks|Protocol Violation|0|||
23735348|NCT00542425|66409073|FG002|Initial 24 Weeks|Protocol Violation|0|||
23735349|NCT00542425|66409074|FG003|Initial 24 Weeks|Protocol Violation|1|||
23735350|NCT00542425|66409075|FG004|Initial 24 Weeks|Protocol Violation|0|||
23735351|NCT00542425|66409071|FG000|Initial 24 Weeks|Refusal of treatment|2|||
23735352|NCT00542425|66409072|FG001|Initial 24 Weeks|Refusal of treatment|2|||
23735353|NCT00542425|66409073|FG002|Initial 24 Weeks|Refusal of treatment|1|||
23819568|NCT04895982|66717645|FG004|Overall Study|Withdrawal by parent/guardian|3|||
23735354|NCT00542425|66409074|FG003|Initial 24 Weeks|Refusal of treatment|4|||
23819569|NCT04895982|66717646|FG005|Overall Study|Withdrawal by parent/guardian|2|||
23735355|NCT00542425|66409075|FG004|Initial 24 Weeks|Refusal of treatment|1|||
23735356|NCT00542425|66409071|FG000|Initial 24 Weeks|Other|0|||
23735357|NCT00542425|66409072|FG001|Initial 24 Weeks|Other|2|||
23735358|NCT00542425|66409073|FG002|Initial 24 Weeks|Other|1|||
23735359|NCT00542425|66409074|FG003|Initial 24 Weeks|Other|0|||
23735360|NCT00542425|66409075|FG004|Initial 24 Weeks|Other|0|||
23735361|NCT00542425|66409071|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
23735362|NCT00542425|66409072|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
23735363|NCT00542425|66409073|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
23735364|NCT00542425|66409074|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
23735365|NCT00542425|66409075|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
23735366|NCT00542425|66409071|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23735367|NCT00542425|66409072|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23735368|NCT00542425|66409073|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
23735369|NCT00542425|66409074|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23735370|NCT00542425|66409075|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23735371|NCT00542425|66409071|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23735372|NCT00542425|66409072|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
23735373|NCT00542425|66409073|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23735374|NCT00542425|66409074|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23735375|NCT00542425|66409075|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23735376|NCT00542425|66409071|FG000|Extended 24 Weeks of Treatment|Other|1|||
23735377|NCT00542425|66409072|FG001|Extended 24 Weeks of Treatment|Other|1|||
23735378|NCT00542425|66409073|FG002|Extended 24 Weeks of Treatment|Other|0|||
23735379|NCT00542425|66409074|FG003|Extended 24 Weeks of Treatment|Other|0|||
23735380|NCT00542425|66409075|FG004|Extended 24 Weeks of Treatment|Other|1|||
23735381|NCT00735072|66409077|FG000|Overall Study|interrupted study med during ARV change|1|||
23735382|NCT00735072|66409078|FG001|Overall Study|interrupted study med during ARV change|0|||
23735383|NCT00735072|66409077|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
23735384|NCT00735072|66409078|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
23735385|NCT03377452|66409080|FG000|Overall Study|Refused assessment|0|||
23735386|NCT03377452|66409081|FG001|Overall Study|Refused assessment|2|||
23735387|NCT03377452|66409080|FG000|Overall Study|Lost to Follow-up|5|||
23735388|NCT03377452|66409081|FG001|Overall Study|Lost to Follow-up|4|||
23735389|NCT03125902|66409082|FG000|Overall Study|Adverse Event|0|||
23735390|NCT03125902|66409083|FG001|Overall Study|Adverse Event|1|||
23735391|NCT03125902|66409082|FG000|Overall Study|Death|119|||
23735392|NCT03125902|66409083|FG001|Overall Study|Death|229|||
23735393|NCT03125902|66409082|FG000|Overall Study|Lost to Follow-up|4|||
23735394|NCT03125902|66409083|FG001|Overall Study|Lost to Follow-up|13|||
23735395|NCT03125902|66409082|FG000|Overall Study|Other|0|||
23735396|NCT03125902|66409083|FG001|Overall Study|Other|4|||
23735397|NCT03125902|66409082|FG000|Overall Study|Physician Decision|2|||
23735398|NCT03125902|66409083|FG001|Overall Study|Physician Decision|1|||
23735399|NCT03125902|66409082|FG000|Overall Study|Progressive Disease|0|||
23735400|NCT03125902|66409083|FG001|Overall Study|Progressive Disease|3|||
23735401|NCT03125902|66409082|FG000|Overall Study|Study Terminated By Sponsor|74|||
23735402|NCT03125902|66409083|FG001|Overall Study|Study Terminated By Sponsor|143|||
23735403|NCT03125902|66409082|FG000|Overall Study|Withdrawal by Subject|21|||
23735404|NCT03125902|66409083|FG001|Overall Study|Withdrawal by Subject|37|||
23735405|NCT02543801|66409084|FG000|Overall Study|Protocol Violation|1|||
23735406|NCT02543801|66409085|FG001|Overall Study|Protocol Violation|2|||
23735407|NCT02543801|66409086|FG002|Overall Study|Protocol Violation|0|||
23735408|NCT02543801|66409087|FG003|Overall Study|Protocol Violation|0|||
23819570|NCT04895982|66717647|FG006|Overall Study|Withdrawal by parent/guardian|1|||
23735409|NCT00362297|66409088|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
23735410|NCT00362297|66409089|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
23735411|NCT00474539|66409090|FG000|Infant Series|Withdrawal by Subject|3|||
23735412|NCT00474539|66409091|FG001|Infant Series|Withdrawal by Subject|4|||
23735413|NCT00474539|66409090|FG000|Infant Series|Randomization error|5|||
23735414|NCT00474539|66409091|FG001|Infant Series|Randomization error|0|||
23735415|NCT00474539|66409090|FG000|Infant Series|Lost to Follow-up|2|||
23735416|NCT00474539|66409091|FG001|Infant Series|Lost to Follow-up|1|||
23735417|NCT00474539|66409090|FG000|Infant Series|Protocol Violation|0|||
23735418|NCT00474539|66409091|FG001|Infant Series|Protocol Violation|1|||
23735419|NCT00474539|66409090|FG000|After Infant Series|Lost to Follow-up|3|||
23735420|NCT00474539|66409091|FG001|After Infant Series|Lost to Follow-up|0|||
23735421|NCT00474539|66409090|FG000|After Infant Series|Withdrawal by Subject|1|||
23735422|NCT00474539|66409091|FG001|After Infant Series|Withdrawal by Subject|0|||
23735423|NCT00474539|66409090|FG000|Toddler Dose|Protocol Violation|1|||
23735424|NCT00474539|66409091|FG001|Toddler Dose|Protocol Violation|0|||
23735425|NCT03330106|66409098|FG000|Part A|Withdrawal by Subject|1|||
23735426|NCT03330106|66409099|FG001|Part A|Withdrawal by Subject|1|||
23735427|NCT03330106|66409100|FG002|Part A|Withdrawal by Subject|0|||
23735428|NCT03330106|66409101|FG003|Part A|Withdrawal by Subject|0|||
23735429|NCT03330106|66409098|FG000|Part A|Death|2|||
23735430|NCT03330106|66409099|FG001|Part A|Death|1|||
23735431|NCT03330106|66409100|FG002|Part A|Death|0|||
23735432|NCT03330106|66409101|FG003|Part A|Death|0|||
23735433|NCT03330106|66409098|FG000|Part A|Adverse Event|0|||
23735434|NCT03330106|66409099|FG001|Part A|Adverse Event|1|||
23735435|NCT03330106|66409100|FG002|Part A|Adverse Event|0|||
23735436|NCT03330106|66409101|FG003|Part A|Adverse Event|0|||
23735437|NCT03330106|66409098|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23735438|NCT03330106|66409099|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
23735439|NCT03330106|66409100|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23735440|NCT03330106|66409101|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23735441|NCT03330106|66409098|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
23735442|NCT03330106|66409099|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23735443|NCT03330106|66409100|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23735444|NCT03330106|66409101|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23735445|NCT03330106|66409098|FG000|Part A|Progressive Disease|0|||
23735446|NCT03330106|66409099|FG001|Part A|Progressive Disease|1|||
23735447|NCT03330106|66409100|FG002|Part A|Progressive Disease|0|||
23735448|NCT03330106|66409101|FG003|Part A|Progressive Disease|0|||
23819571|NCT04895982|66717648|FG007|Overall Study|Withdrawal by parent/guardian|0|||
23819572|NCT04895982|66717649|FG008|Overall Study|Withdrawal by parent/guardian|3|||
23735449|NCT03330106|66409098|FG000|Part B|Lost to Follow-up|0|||
23735450|NCT03330106|66409099|FG001|Part B|Lost to Follow-up|0|||
23735451|NCT03330106|66409100|FG002|Part B|Lost to Follow-up|0|||
23735452|NCT03330106|66409101|FG003|Part B|Lost to Follow-up|1|||
23735453|NCT03330106|66409098|FG000|Part B|Withdrawal by Subject|0|||
23735454|NCT03330106|66409099|FG001|Part B|Withdrawal by Subject|0|||
23735455|NCT03330106|66409100|FG002|Part B|Withdrawal by Subject|4|||
23735456|NCT03330106|66409101|FG003|Part B|Withdrawal by Subject|0|||
23735457|NCT03330106|66409098|FG000|Part B|Death|0|||
23819573|NCT04895982|66717650|FG009|Overall Study|Withdrawal by parent/guardian|0|||
23819574|NCT04895982|66717651|FG010|Overall Study|Withdrawal by parent/guardian|0|||
23819575|NCT04895982|66717652|FG011|Overall Study|Withdrawal by parent/guardian|0|||
23819576|NCT04895982|66717641|FG000|Overall Study|Other|0|||
23819577|NCT04895982|66717642|FG001|Overall Study|Other|0|||
23426781|NCT00276094|65307451|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
23735458|NCT03330106|66409099|FG001|Part B|Death|0|||
23735459|NCT03330106|66409100|FG002|Part B|Death|2|||
23735460|NCT03330106|66409101|FG003|Part B|Death|0|||
23735461|NCT03330106|66409098|FG000|Part B|Clinical Progression|0|||
23735462|NCT03330106|66409099|FG001|Part B|Clinical Progression|0|||
23735463|NCT03330106|66409100|FG002|Part B|Clinical Progression|1|||
23735464|NCT03330106|66409101|FG003|Part B|Clinical Progression|1|||
23735465|NCT03330106|66409098|FG000|Part B|Symptomatic Deterioration|0|||
23735466|NCT03330106|66409099|FG001|Part B|Symptomatic Deterioration|0|||
23735467|NCT03330106|66409100|FG002|Part B|Symptomatic Deterioration|0|||
23735468|NCT03330106|66409101|FG003|Part B|Symptomatic Deterioration|1|||
23735469|NCT03330106|66409098|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23735470|NCT03330106|66409099|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23735471|NCT03330106|66409100|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23735472|NCT03330106|66409101|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
23735473|NCT03330106|66409098|FG000|Part B|Progressive Disease|0|||
23735474|NCT03330106|66409099|FG001|Part B|Progressive Disease|0|||
23735475|NCT03330106|66409100|FG002|Part B|Progressive Disease|11|||
23735476|NCT03330106|66409101|FG003|Part B|Progressive Disease|4|||
23735477|NCT01728454|66409114|FG000|Stage 1 and 2|Pregnancy|1|||
23735478|NCT01728454|66409115|FG001|Stage 1 and 2|Pregnancy|0|||
23735479|NCT01728454|66409116|FG002|Stage 1 and 2|Pregnancy|0|||
23735480|NCT01728454|66409114|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
23735481|NCT01728454|66409115|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
23735482|NCT01728454|66409116|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
23735483|NCT01728454|66409114|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
23735484|NCT01728454|66409115|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
23735485|NCT01728454|66409116|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
23735486|NCT01728454|66409114|FG000|Stage 1 and 2|Lost to Follow-up|1|||
23735487|NCT01728454|66409115|FG001|Stage 1 and 2|Lost to Follow-up|1|||
23735488|NCT01728454|66409116|FG002|Stage 1 and 2|Lost to Follow-up|0|||
23735489|NCT01728454|66409114|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
23735490|NCT01728454|66409115|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
23735491|NCT01728454|66409116|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
23735492|NCT01728454|66409114|FG000|Stage 3|Reason Missing|0|||
23735493|NCT01728454|66409115|FG001|Stage 3|Reason Missing|0|||
23819578|NCT04895982|66717643|FG002|Overall Study|Other|1|||
23426782|NCT00276094|65307452|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
23426783|NCT00276094|65307450|FG000|Overall Study|Other-Relocation|0|||
23426784|NCT00276094|65307451|FG001|Overall Study|Other-Relocation|1|||
23735494|NCT01728454|66409116|FG002|Stage 3|Reason Missing|1|||
23735495|NCT01728454|66409114|FG000|Stage 3|Subject Required Other Treatment|0|||
23819579|NCT04895982|66717644|FG003|Overall Study|Other|1|||
23819580|NCT04895982|66717645|FG004|Overall Study|Other|0|||
23735496|NCT01728454|66409115|FG001|Stage 3|Subject Required Other Treatment|1|||
23735497|NCT01728454|66409116|FG002|Stage 3|Subject Required Other Treatment|0|||
23735498|NCT01728454|66409114|FG000|Stage 3|Pregnancy|1|||
23735499|NCT01728454|66409115|FG001|Stage 3|Pregnancy|0|||
23735500|NCT01728454|66409116|FG002|Stage 3|Pregnancy|0|||
23735501|NCT01728454|66409114|FG000|Stage 3|Withdrew Consent|1|||
23735502|NCT01728454|66409115|FG001|Stage 3|Withdrew Consent|0|||
23735503|NCT01728454|66409116|FG002|Stage 3|Withdrew Consent|1|||
23735504|NCT01728454|66409114|FG000|Stage 3|Non-compliance with Protocol|0|||
23735505|NCT01728454|66409115|FG001|Stage 3|Non-compliance with Protocol|0|||
23735506|NCT01728454|66409116|FG002|Stage 3|Non-compliance with Protocol|1|||
23735507|NCT01728454|66409114|FG000|Stage 3|Lost to Follow-up|0|||
23735508|NCT01728454|66409115|FG001|Stage 3|Lost to Follow-up|3|||
23735509|NCT01728454|66409116|FG002|Stage 3|Lost to Follow-up|1|||
23735510|NCT01728454|66409114|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
23735511|NCT01728454|66409115|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
23735512|NCT01728454|66409116|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
23735513|NCT01234337|66409117|FG000|Overall Study|Adverse Event|58|||
23735514|NCT01234337|66409118|FG001|Overall Study|Adverse Event|21|||
23735515|NCT01234337|66409117|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
23735516|NCT01234337|66409118|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
23735517|NCT01234337|66409117|FG000|Overall Study|Investi. decision not protocol driven|5|||
23735518|NCT01234337|66409118|FG001|Overall Study|Investi. decision not protocol driven|6|||
23735519|NCT01234337|66409117|FG000|Overall Study|Non-compliant with study medication|3|||
23735520|NCT01234337|66409118|FG001|Overall Study|Non-compliant with study medication|2|||
23735521|NCT01234337|66409117|FG000|Overall Study|Randomized but not treated|6|||
23735522|NCT01234337|66409118|FG001|Overall Study|Randomized but not treated|4|||
23735523|NCT01234337|66409117|FG000|Overall Study|Lost to Follow-up|0|||
23735524|NCT01234337|66409118|FG001|Overall Study|Lost to Follow-up|1|||
23735525|NCT01234337|66409117|FG000|Overall Study|Protocol Violation|2|||
23735526|NCT01234337|66409118|FG001|Overall Study|Protocol Violation|3|||
23735527|NCT01234337|66409117|FG000|Overall Study|Withdrawal by Subject|11|||
23735528|NCT01234337|66409118|FG001|Overall Study|Withdrawal by Subject|9|||
23735529|NCT01234337|66409117|FG000|Overall Study|Death|0|||
23735530|NCT01234337|66409118|FG001|Overall Study|Death|1|||
23735531|NCT01234337|66409117|FG000|Overall Study|Switch to commercial drug|0|||
23735532|NCT01234337|66409118|FG001|Overall Study|Switch to commercial drug|1|||
23735533|NCT00621764|66409119|FG000|Overall Study|Protocol Violation|0|||
23735534|NCT00621764|66409120|FG001|Overall Study|Protocol Violation|0|||
23735535|NCT00621764|66409121|FG002|Overall Study|Protocol Violation|0|||
23735536|NCT00621764|66409122|FG003|Overall Study|Protocol Violation|1|||
23735537|NCT01488994|66409123|FG000|Overall Study|Withdrawal by Subject|0|||
23735538|NCT01488994|66409124|FG001|Overall Study|Withdrawal by Subject|1|||
23735539|NCT02576652|66409129|FG000|Overall Study|Withdrawal by Subject|2|||
23735540|NCT03091920|66409130|FG000|Overall Study|Adverse Event|0|||
23735541|NCT03091920|66409131|FG001|Overall Study|Adverse Event|1|||
23735542|NCT03091920|66409132|FG002|Overall Study|Adverse Event|0|||
23735543|NCT02155660|66409133|FG000|Overall Study|Other Reason|8|||
23735544|NCT02155660|66409134|FG001|Overall Study|Other Reason|6|||
23735545|NCT02155660|66409135|FG002|Overall Study|Other Reason|10|||
23735546|NCT02155660|66409136|FG003|Overall Study|Other Reason|10|||
23735547|NCT02155660|66409133|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23735548|NCT02155660|66409134|FG001|Overall Study|Study-specific withdrawal criteria|1|||
23735549|NCT02155660|66409135|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23735550|NCT02155660|66409136|FG003|Overall Study|Study-specific withdrawal criteria|1|||
23735551|NCT02155660|66409133|FG000|Overall Study|Severe non-compliance|0|||
23735552|NCT02155660|66409134|FG001|Overall Study|Severe non-compliance|4|||
23735553|NCT02155660|66409135|FG002|Overall Study|Severe non-compliance|0|||
23735554|NCT02155660|66409136|FG003|Overall Study|Severe non-compliance|1|||
23735555|NCT02155660|66409133|FG000|Overall Study|Adverse Event|2|||
23735556|NCT02155660|66409134|FG001|Overall Study|Adverse Event|6|||
23735557|NCT02155660|66409135|FG002|Overall Study|Adverse Event|3|||
23735558|NCT02155660|66409136|FG003|Overall Study|Adverse Event|1|||
23819581|NCT04895982|66717646|FG005|Overall Study|Other|0|||
23618760|NCT00866918|65991332|FG000|Overall Study|Secondary malignancy|1|||
23735559|NCT02155660|66409133|FG000|Overall Study|Lost to Follow-up|3|||
23735560|NCT02155660|66409134|FG001|Overall Study|Lost to Follow-up|6|||
23735561|NCT02155660|66409135|FG002|Overall Study|Lost to Follow-up|5|||
23735562|NCT02155660|66409136|FG003|Overall Study|Lost to Follow-up|8|||
23735563|NCT02155660|66409133|FG000|Overall Study|Death|17|||
23735564|NCT02155660|66409134|FG001|Overall Study|Death|19|||
23735565|NCT02155660|66409135|FG002|Overall Study|Death|17|||
23735566|NCT02155660|66409136|FG003|Overall Study|Death|19|||
23735567|NCT02155660|66409133|FG000|Overall Study|Withdrawal by Subject|28|||
23735568|NCT02155660|66409134|FG001|Overall Study|Withdrawal by Subject|31|||
23735569|NCT02155660|66409135|FG002|Overall Study|Withdrawal by Subject|24|||
23735570|NCT02155660|66409136|FG003|Overall Study|Withdrawal by Subject|21|||
23819582|NCT04895982|66717647|FG006|Overall Study|Other|0|||
23819583|NCT04895982|66717648|FG007|Overall Study|Other|0|||
23819584|NCT04895982|66717649|FG008|Overall Study|Other|0|||
23819585|NCT04895982|66717650|FG009|Overall Study|Other|1|||
23819586|NCT04895982|66717651|FG010|Overall Study|Other|0|||
23819587|NCT04895982|66717652|FG011|Overall Study|Other|0|||
23819588|NCT04895982|66717641|FG000|Overall Study|Protocol Violation|0|||
23819589|NCT04895982|66717642|FG001|Overall Study|Protocol Violation|0|||
23819590|NCT04895982|66717643|FG002|Overall Study|Protocol Violation|1|||
23819591|NCT04895982|66717644|FG003|Overall Study|Protocol Violation|1|||
23819592|NCT04895982|66717645|FG004|Overall Study|Protocol Violation|1|||
23819593|NCT04895982|66717646|FG005|Overall Study|Protocol Violation|0|||
23819594|NCT04895982|66717647|FG006|Overall Study|Protocol Violation|0|||
23819595|NCT04895982|66717648|FG007|Overall Study|Protocol Violation|1|||
23819596|NCT04895982|66717649|FG008|Overall Study|Protocol Violation|0|||
23819597|NCT04895982|66717650|FG009|Overall Study|Protocol Violation|0|||
23819598|NCT04895982|66717651|FG010|Overall Study|Protocol Violation|0|||
23819599|NCT04895982|66717652|FG011|Overall Study|Protocol Violation|0|||
23819600|NCT04895982|66717641|FG000|Overall Study|Lost to Follow-up|0|||
23819601|NCT04895982|66717642|FG001|Overall Study|Lost to Follow-up|0|||
23819602|NCT04895982|66717643|FG002|Overall Study|Lost to Follow-up|1|||
23819603|NCT04895982|66717644|FG003|Overall Study|Lost to Follow-up|0|||
23545748|NCT04642638|65727277|FG002|Overall Study|Reason Not Specified|0|||
23545749|NCT04642638|65727278|FG003|Overall Study|Reason Not Specified|0|||
23545750|NCT04642638|65727279|FG004|Overall Study|Reason Not Specified|38|||
23545751|NCT04642638|65727280|FG005|Overall Study|Reason Not Specified|16|||
23545752|NCT04642638|65727275|FG000|Overall Study|Physician Decision|0|||
23545753|NCT04642638|65727276|FG001|Overall Study|Physician Decision|0|||
23735571|NCT02813681|66409143|FG000|Overall Study|Physician Decision|5|||
23735572|NCT02813681|66409144|FG001|Overall Study|Physician Decision|5|||
23735573|NCT02813681|66409145|FG002|Overall Study|Physician Decision|0|||
23545754|NCT04642638|65727277|FG002|Overall Study|Physician Decision|0|||
23545755|NCT04642638|65727278|FG003|Overall Study|Physician Decision|0|||
23735574|NCT02813681|66409143|FG000|Overall Study|Lost to Follow-up|0|||
23735575|NCT02813681|66409144|FG001|Overall Study|Lost to Follow-up|1|||
23735576|NCT02813681|66409145|FG002|Overall Study|Lost to Follow-up|0|||
23735577|NCT00381706|66409146|FG000|Overall Study|Never treated|7|||
23735578|NCT00381706|66409147|FG001|Overall Study|Never treated|2|||
23735579|NCT00381706|66409148|FG002|Overall Study|Never treated|1|||
23735580|NCT02129192|66409149|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
23735581|NCT02129192|66409150|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
23735582|NCT03557801|66409151|FG000|Overall Study|Protocol Violation|1|||
23735583|NCT03557801|66409152|FG001|Overall Study|Protocol Violation|0|||
23735584|NCT03557801|66409153|FG002|Overall Study|Protocol Violation|0|||
23735585|NCT03557801|66409151|FG000|Overall Study|Withdrawal by Subject|1|||
23735586|NCT03557801|66409152|FG001|Overall Study|Withdrawal by Subject|0|||
23735587|NCT03557801|66409153|FG002|Overall Study|Withdrawal by Subject|3|||
23735588|NCT03557801|66409151|FG000|Overall Study|Lost to Follow-up|0|||
23735589|NCT03557801|66409152|FG001|Overall Study|Lost to Follow-up|1|||
23735590|NCT03557801|66409153|FG002|Overall Study|Lost to Follow-up|0|||
23735591|NCT03969589|66409154|FG000|Overall Study|Lost to Follow-up|3|||
23735592|NCT03969589|66409155|FG001|Overall Study|Lost to Follow-up|2|||
23735593|NCT03969589|66409154|FG000|Overall Study|Declined Follow-Up|0|||
23735594|NCT03969589|66409155|FG001|Overall Study|Declined Follow-Up|1|||
23545756|NCT04642638|65727279|FG004|Overall Study|Physician Decision|2|||
23545757|NCT04642638|65727280|FG005|Overall Study|Physician Decision|1|||
23545758|NCT04642638|65727275|FG000|Overall Study|Protocol Deviation|0|||
23545759|NCT04642638|65727276|FG001|Overall Study|Protocol Deviation|0|||
23545760|NCT04642638|65727277|FG002|Overall Study|Protocol Deviation|0|||
23545761|NCT04642638|65727278|FG003|Overall Study|Protocol Deviation|0|||
23545762|NCT04642638|65727279|FG004|Overall Study|Protocol Deviation|1|||
23545763|NCT04642638|65727280|FG005|Overall Study|Protocol Deviation|3|||
23545764|NCT04642638|65727275|FG000|Overall Study|Study Terminated|0|||
23735595|NCT05643170|66409156|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
23735596|NCT05643170|66409156|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
23735597|NCT01566981|66409169|FG000|Overall Study|Lost to Follow-up|5|||
23735598|NCT01566981|66409170|FG001|Overall Study|Lost to Follow-up|8|||
23735599|NCT01790633|66409177|FG000|Overall Study|Protocol Violation|1|||
23819604|NCT04895982|66717645|FG004|Overall Study|Lost to Follow-up|0|||
23819605|NCT04895982|66717646|FG005|Overall Study|Lost to Follow-up|1|||
23819606|NCT04895982|66717647|FG006|Overall Study|Lost to Follow-up|0|||
23819607|NCT04895982|66717648|FG007|Overall Study|Lost to Follow-up|0|||
23819608|NCT04895982|66717649|FG008|Overall Study|Lost to Follow-up|1|||
23819609|NCT04895982|66717650|FG009|Overall Study|Lost to Follow-up|0|||
23735600|NCT01790633|66409178|FG001|Overall Study|Protocol Violation|2|||
23735601|NCT01790633|66409177|FG000|Overall Study|Did not have serology performed|47|||
23735602|NCT01790633|66409178|FG001|Overall Study|Did not have serology performed|0|||
23819610|NCT04895982|66717651|FG010|Overall Study|Lost to Follow-up|0|||
23819611|NCT04895982|66717652|FG011|Overall Study|Lost to Follow-up|0|||
23819612|NCT04895982|66717641|FG000|Overall Study|Refused further study procedures|0|||
23618761|NCT00866918|65991333|FG001|Overall Study|Secondary malignancy|0|||
23618762|NCT00475735|65991336|FG000|Treatment Period 1|Adverse Event|2|||
23618763|NCT00475735|65991337|FG001|Treatment Period 1|Adverse Event|0|||
23618764|NCT00475735|65991338|FG002|Treatment Period 1|Adverse Event|0|||
23618765|NCT00475735|65991339|FG003|Treatment Period 1|Adverse Event|0|||
23618766|NCT00475735|65991340|FG004|Treatment Period 1|Adverse Event|0|||
23618767|NCT00475735|65991341|FG005|Treatment Period 1|Adverse Event|0|||
23618768|NCT00475735|65991336|FG000|Treatment Period 1|Lack of Efficacy|1|||
23618769|NCT00475735|65991337|FG001|Treatment Period 1|Lack of Efficacy|0|||
23618770|NCT00475735|65991338|FG002|Treatment Period 1|Lack of Efficacy|0|||
23618771|NCT00475735|65991339|FG003|Treatment Period 1|Lack of Efficacy|0|||
23618772|NCT00475735|65991340|FG004|Treatment Period 1|Lack of Efficacy|0|||
23618773|NCT00475735|65991341|FG005|Treatment Period 1|Lack of Efficacy|0|||
23618774|NCT00475735|65991336|FG000|Treatment Period 1|Lost to Follow-up|0|||
23618775|NCT00475735|65991337|FG001|Treatment Period 1|Lost to Follow-up|0|||
23618776|NCT00475735|65991338|FG002|Treatment Period 1|Lost to Follow-up|0|||
23618777|NCT00475735|65991339|FG003|Treatment Period 1|Lost to Follow-up|0|||
23618778|NCT00475735|65991340|FG004|Treatment Period 1|Lost to Follow-up|0|||
23618779|NCT00475735|65991341|FG005|Treatment Period 1|Lost to Follow-up|1|||
23618780|NCT00475735|65991336|FG000|Treatment Period 1|Protocol Violation|0|||
23618781|NCT00475735|65991337|FG001|Treatment Period 1|Protocol Violation|0|||
23618782|NCT00475735|65991338|FG002|Treatment Period 1|Protocol Violation|0|||
23735603|NCT01790633|66409177|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
23735604|NCT01790633|66409178|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
23735605|NCT02994927|66409179|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23735606|NCT02994927|66409180|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23735607|NCT02994927|66409179|FG000|Overall Study|Did not meet eligibility criteria|0|||
23735608|NCT02994927|66409180|FG001|Overall Study|Did not meet eligibility criteria|1|||
23735609|NCT02994927|66409179|FG000|Overall Study|Physician Decision|4|||
23819613|NCT04895982|66717642|FG001|Overall Study|Refused further study procedures|0|||
23819614|NCT04895982|66717643|FG002|Overall Study|Refused further study procedures|1|||
23819615|NCT04895982|66717644|FG003|Overall Study|Refused further study procedures|0|||
23819616|NCT04895982|66717645|FG004|Overall Study|Refused further study procedures|0|||
23819617|NCT04895982|66717646|FG005|Overall Study|Refused further study procedures|0|||
23819618|NCT04895982|66717647|FG006|Overall Study|Refused further study procedures|0|||
23819619|NCT04895982|66717648|FG007|Overall Study|Refused further study procedures|0|||
23819620|NCT04895982|66717649|FG008|Overall Study|Refused further study procedures|0|||
23819621|NCT04895982|66717650|FG009|Overall Study|Refused further study procedures|0|||
23819622|NCT04895982|66717651|FG010|Overall Study|Refused further study procedures|0|||
23819623|NCT04895982|66717652|FG011|Overall Study|Refused further study procedures|0|||
23819624|NCT03696953|66717653|FG000|Overall Study|Withdrawal by Subject|6|||
23819625|NCT03696953|66717654|FG001|Overall Study|Withdrawal by Subject|1|||
23819626|NCT03696953|66717653|FG000|Overall Study|missed GBS swabs|2|||
23819627|NCT03696953|66717654|FG001|Overall Study|missed GBS swabs|2|||
23819628|NCT03696953|66717653|FG000|Overall Study|lost study bottle containing capsules|2|||
23819629|NCT03696953|66717654|FG001|Overall Study|lost study bottle containing capsules|0|||
23819630|NCT03696953|66717653|FG000|Overall Study|Premature birth|1|||
23735610|NCT02994927|66409180|FG001|Overall Study|Physician Decision|3|||
23735611|NCT02994927|66409179|FG000|Overall Study|Death|4|||
23735612|NCT02994927|66409180|FG001|Overall Study|Death|2|||
23618783|NCT00475735|65991339|FG003|Treatment Period 1|Protocol Violation|1|||
23618784|NCT00475735|65991340|FG004|Treatment Period 1|Protocol Violation|0|||
23618785|NCT00475735|65991341|FG005|Treatment Period 1|Protocol Violation|0|||
23618786|NCT00475735|65991336|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23618787|NCT00475735|65991337|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23618788|NCT00475735|65991338|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23618789|NCT00475735|65991339|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23618790|NCT00475735|65991340|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23618791|NCT00475735|65991341|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23618792|NCT00475735|65991336|FG000|Treatment Period 1|DC due to AE but continuing|0|||
23618793|NCT00475735|65991337|FG001|Treatment Period 1|DC due to AE but continuing|0|||
23618794|NCT00475735|65991338|FG002|Treatment Period 1|DC due to AE but continuing|0|||
23618795|NCT00475735|65991339|FG003|Treatment Period 1|DC due to AE but continuing|1|||
23618796|NCT00475735|65991340|FG004|Treatment Period 1|DC due to AE but continuing|2|||
23618797|NCT00475735|65991341|FG005|Treatment Period 1|DC due to AE but continuing|2|||
23618798|NCT00475735|65991336|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618799|NCT00475735|65991337|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
23618800|NCT00475735|65991338|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618801|NCT00475735|65991339|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618802|NCT00475735|65991340|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23819631|NCT03696953|66717654|FG001|Overall Study|Premature birth|4|||
23819632|NCT03696953|66717653|FG000|Overall Study|Gestational hypertension|1|||
23819633|NCT03696953|66717654|FG001|Overall Study|Gestational hypertension|1|||
23735613|NCT02994927|66409179|FG000|Overall Study|Adverse Event|2|||
23735614|NCT02994927|66409180|FG001|Overall Study|Adverse Event|1|||
23735615|NCT02994927|66409179|FG000|Overall Study|Withdrawal by Subject|3|||
23735616|NCT02994927|66409180|FG001|Overall Study|Withdrawal by Subject|6|||
23735617|NCT02994927|66409179|FG000|Overall Study|Lost to Follow-up|2|||
23735618|NCT02994927|66409180|FG001|Overall Study|Lost to Follow-up|1|||
23735619|NCT03818399|66409181|FG000|Overall Study|Lost to Follow-up|11|||
23735620|NCT03818399|66409181|FG000|Overall Study|Withdrawal by Subject|1|||
23735621|NCT03818399|66409181|FG000|Overall Study|Protocol Violation|2|||
23735622|NCT02358863|66409189|FG000|Overall Study|Physician Decision|3|||
23735623|NCT00413231|66409199|FG000|0 to 30-day Post Treatment|Death|5|||
23735624|NCT00413231|66409199|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
23735625|NCT00413231|66409199|FG000|30-day to 365-day Post Treatment|Death|13|||
23735626|NCT00413231|66409199|FG000|365-day to 60-month Post Treatment|Death|36|||
23735627|NCT00413231|66409199|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
23735628|NCT00413231|66409199|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
23735629|NCT00413231|66409199|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
23735630|NCT03395704|66409200|FG000|Overall Study|Adverse Event|2|||
23735631|NCT03395704|66409201|FG001|Overall Study|Adverse Event|1|||
23735632|NCT03395704|66409200|FG000|Overall Study|Withdrawal by Subject|2|||
23735633|NCT03395704|66409201|FG001|Overall Study|Withdrawal by Subject|1|||
23735634|NCT03395704|66409200|FG000|Overall Study|Physician Decision|0|||
23735635|NCT03395704|66409201|FG001|Overall Study|Physician Decision|1|||
23735636|NCT02607735|66409202|FG000|Primary Study|Randomized but Never Treated|1|||
23735637|NCT02607735|66409203|FG001|Primary Study|Randomized but Never Treated|0|||
23735638|NCT02607735|66409204|FG002|Primary Study|Randomized but Never Treated|0|||
23735639|NCT02607735|66409202|FG000|Primary Study|Lost to Follow-up|4|||
23735640|NCT02607735|66409203|FG001|Primary Study|Lost to Follow-up|0|||
23735641|NCT02607735|66409204|FG002|Primary Study|Lost to Follow-up|0|||
23735642|NCT02607735|66409202|FG000|Primary Study|Withdrew Consent|2|||
23735643|NCT02607735|66409203|FG001|Primary Study|Withdrew Consent|0|||
23735644|NCT02607735|66409204|FG002|Primary Study|Withdrew Consent|0|||
23735645|NCT02607735|66409202|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
23735646|NCT02607735|66409203|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
23735647|NCT02607735|66409204|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
23735648|NCT02607735|66409202|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
23735649|NCT02607735|66409203|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
23735650|NCT02607735|66409204|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
23735651|NCT02176226|66409205|FG000|Overall Study|Lost to Follow-up|3|||
23735652|NCT02176226|66409205|FG000|Overall Study|Withdrew prior to treatment|6|||
23735653|NCT04109066|66412491|FG000|Pre-treatment|Participant withdrew consent|2|||
23735654|NCT04109066|66412492|FG001|Pre-treatment|Participant withdrew consent|0|||
23735655|NCT04109066|66412491|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
23735656|NCT04109066|66412492|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
23735657|NCT04109066|66412491|FG000|Treatment|Lack of Efficacy|2|||
23735658|NCT04109066|66412492|FG001|Treatment|Lack of Efficacy|3|||
23735659|NCT04109066|66412491|FG000|Treatment|Adverse Event|19|||
23735660|NCT04109066|66412492|FG001|Treatment|Adverse Event|6|||
23735661|NCT04109066|66412491|FG000|Treatment|Participant request to discontinue Study treatment|12|||
23735662|NCT04109066|66412492|FG001|Treatment|Participant request to discontinue Study treatment|14|||
23735663|NCT04109066|66412491|FG000|Treatment|Withdrawal by Subject|7|||
23735664|NCT04109066|66412492|FG001|Treatment|Withdrawal by Subject|8|||
23735665|NCT04109066|66412491|FG000|Treatment|Death|3|||
23735666|NCT04109066|66412492|FG001|Treatment|Death|0|||
23735667|NCT04109066|66412491|FG000|Treatment|Participant no longer meets study criteria|3|||
23735668|NCT04109066|66412492|FG001|Treatment|Participant no longer meets study criteria|1|||
23735669|NCT04109066|66412491|FG000|Treatment|Administrative reasons by sponsor|2|||
23735670|NCT04109066|66412492|FG001|Treatment|Administrative reasons by sponsor|3|||
23735671|NCT04109066|66412491|FG000|Treatment|Other reasons|17|||
23735672|NCT04109066|66412492|FG001|Treatment|Other reasons|23|||
23735673|NCT04109066|66412491|FG000|Treatment|Disease Progression|4|||
23735674|NCT04109066|66412492|FG001|Treatment|Disease Progression|7|||
23735675|NCT04109066|66412491|FG000|Treatment|Study drug toxicity|13|||
23735676|NCT04109066|66412492|FG001|Treatment|Study drug toxicity|5|||
23735677|NCT04109066|66412491|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
23735678|NCT04109066|66412492|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
23735679|NCT04109066|66412491|FG000|Treatment|Disease Recurrence|0|||
23735680|NCT04109066|66412492|FG001|Treatment|Disease Recurrence|2|||
23735681|NCT04109066|66412491|FG000|Treatment|Not reported|6|||
23735682|NCT04109066|66412492|FG001|Treatment|Not reported|8|||
23735683|NCT04109066|66412491|FG000|Treatment|On-going treatment|48|||
23735684|NCT04109066|66412492|FG001|Treatment|On-going treatment|52|||
23735685|NCT03529162|66412493|FG000|Overall Study|Lost to Follow-up|2|||
23735686|NCT03529162|66412494|FG001|Overall Study|Lost to Follow-up|2|||
23735687|NCT01230489|66412497|FG000|Overall Study|Death|2|||
23735688|NCT01230489|66412497|FG000|Overall Study|Adverse Event|2|||
23735689|NCT01230489|66412497|FG000|Overall Study|Treatment modality changed|1|||
23735690|NCT01853397|66412503|FG000|Overall Study|Withdrawal by Subject|0|||
23735691|NCT01853397|66412504|FG001|Overall Study|Withdrawal by Subject|0|||
23735692|NCT01853397|66412505|FG002|Overall Study|Withdrawal by Subject|0|||
23735693|NCT01853397|66412506|FG003|Overall Study|Withdrawal by Subject|1|||
23735694|NCT01853397|66412503|FG000|Overall Study|Subject Noncompliance|0|||
23735695|NCT01853397|66412504|FG001|Overall Study|Subject Noncompliance|0|||
23735696|NCT01853397|66412505|FG002|Overall Study|Subject Noncompliance|0|||
23735697|NCT01853397|66412506|FG003|Overall Study|Subject Noncompliance|1|||
23735698|NCT01077193|66412507|FG000|Overall Study|Lost to Follow-up|1|||
23735699|NCT01077193|66412507|FG000|Overall Study|Withdrawal by Subject|2|||
23735700|NCT01077193|66412507|FG000|Overall Study|Lack of Efficacy|1|||
23735701|NCT01077193|66412507|FG000|Overall Study|Study Terminated by Sponsor|40|||
23735702|NCT00962780|66412510|FG000|Overall Study|Death|0|||
23735703|NCT00962780|66412511|FG001|Overall Study|Death|1|||
23735704|NCT00962780|66412510|FG000|Overall Study|Protocol Violation|9|||
23735705|NCT00962780|66412511|FG001|Overall Study|Protocol Violation|4|||
23735706|NCT00962780|66412510|FG000|Overall Study|Withdrawal by Subject|1|||
23735707|NCT00962780|66412511|FG001|Overall Study|Withdrawal by Subject|8|||
23735708|NCT00962780|66412510|FG000|Overall Study|Other|0|||
23735709|NCT00962780|66412511|FG001|Overall Study|Other|1|||
23735710|NCT01064622|66412512|FG000|Randomized Phase II|Withdrawal by Subject|2|||
23735711|NCT01064622|66412513|FG001|Randomized Phase II|Withdrawal by Subject|2|||
23735712|NCT01064622|66412512|FG000|Randomized Phase II|Protocol Violation|0|||
23735713|NCT01064622|66412513|FG001|Randomized Phase II|Protocol Violation|1|||
23735714|NCT04450394|66412515|FG000|Overall Study|Adverse Event|2|||
23735715|NCT04450394|66412516|FG001|Overall Study|Adverse Event|0|||
23735716|NCT04450394|66412517|FG002|Overall Study|Adverse Event|0|||
23735717|NCT04450394|66412515|FG000|Overall Study|Death|0|||
23735718|NCT04450394|66412516|FG001|Overall Study|Death|1|||
23735719|NCT04450394|66412517|FG002|Overall Study|Death|0|||
23735720|NCT04450394|66412515|FG000|Overall Study|Lost to Follow-up|0|||
23735721|NCT04450394|66412516|FG001|Overall Study|Lost to Follow-up|3|||
23735722|NCT04450394|66412517|FG002|Overall Study|Lost to Follow-up|0|||
23735723|NCT04450394|66412515|FG000|Overall Study|Physician Decision|0|||
23735724|NCT04450394|66412516|FG001|Overall Study|Physician Decision|1|||
23426785|NCT00276094|65307452|FG002|Overall Study|Other-Relocation|0|||
23545765|NCT04642638|65727276|FG001|Overall Study|Study Terminated|0|||
23545766|NCT04642638|65727277|FG002|Overall Study|Study Terminated|0|||
23545767|NCT04642638|65727278|FG003|Overall Study|Study Terminated|0|||
23545768|NCT04642638|65727279|FG004|Overall Study|Study Terminated|484|||
23545769|NCT04642638|65727280|FG005|Overall Study|Study Terminated|250|||
23545770|NCT04642638|65727275|FG000|Overall Study|Pregnancy|0|||
23545771|NCT04642638|65727276|FG001|Overall Study|Pregnancy|0|||
23545772|NCT04642638|65727277|FG002|Overall Study|Pregnancy|0|||
23545773|NCT04642638|65727278|FG003|Overall Study|Pregnancy|0|||
23545774|NCT04642638|65727279|FG004|Overall Study|Pregnancy|1|||
23545775|NCT04642638|65727280|FG005|Overall Study|Pregnancy|0|||
23545776|NCT05819749|65727281|FG000|Overall Study|Lost to Follow-up|1|||
23735725|NCT04450394|66412517|FG002|Overall Study|Physician Decision|0|||
23735726|NCT04450394|66412515|FG000|Overall Study|Protocol Violation|2|||
23735727|NCT04450394|66412516|FG001|Overall Study|Protocol Violation|0|||
23735728|NCT04450394|66412517|FG002|Overall Study|Protocol Violation|0|||
23735729|NCT04450394|66412515|FG000|Overall Study|Withdrawal by Subject|6|||
23735730|NCT04450394|66412516|FG001|Overall Study|Withdrawal by Subject|9|||
23735731|NCT04450394|66412517|FG002|Overall Study|Withdrawal by Subject|0|||
23735732|NCT00307736|66412518|FG000|Overall Study|Adverse Event|0|||
23735733|NCT00307736|66412519|FG001|Overall Study|Adverse Event|0|||
23735734|NCT00307736|66412520|FG002|Overall Study|Adverse Event|1|||
23735735|NCT00307736|66412521|FG003|Overall Study|Adverse Event|3|||
23735736|NCT00307736|66412518|FG000|Overall Study|Withdrawal by Subject|0|||
23735737|NCT00307736|66412519|FG001|Overall Study|Withdrawal by Subject|0|||
23735738|NCT00307736|66412520|FG002|Overall Study|Withdrawal by Subject|2|||
23735739|NCT00307736|66412521|FG003|Overall Study|Withdrawal by Subject|0|||
23735740|NCT00959192|66412523|FG000|Overall Study|Adverse Event|1|||
23735741|NCT00959192|66412524|FG001|Overall Study|Adverse Event|1|||
23735742|NCT00959192|66412525|FG002|Overall Study|Adverse Event|1|||
23735743|NCT00959192|66412526|FG003|Overall Study|Adverse Event|0|||
23735744|NCT00959192|66412523|FG000|Overall Study|Investigator Request|1|||
23735745|NCT00959192|66412524|FG001|Overall Study|Investigator Request|0|||
23735746|NCT00959192|66412525|FG002|Overall Study|Investigator Request|0|||
23735747|NCT00959192|66412526|FG003|Overall Study|Investigator Request|0|||
23735748|NCT00959192|66412523|FG000|Overall Study|Caregiver Request|0|||
23545777|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545778|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545779|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545780|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
23545781|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23819634|NCT03696953|66717653|FG000|Overall Study|Gestational diabetes|2|||
23735749|NCT00959192|66412524|FG001|Overall Study|Caregiver Request|0|||
23735750|NCT00959192|66412525|FG002|Overall Study|Caregiver Request|2|||
23735751|NCT00959192|66412526|FG003|Overall Study|Caregiver Request|1|||
23735752|NCT01683058|66412527|FG000|Overall Study|Lost to Follow-up|9|||
23735753|NCT01683058|66412527|FG000|Overall Study|Adverse Event|6|||
23735754|NCT01683058|66412527|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
23819635|NCT03696953|66717654|FG001|Overall Study|Gestational diabetes|1|||
23819636|NCT03696953|66717653|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
23819637|NCT03696953|66717654|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
23819638|NCT03696953|66717653|FG000|Overall Study|Changed prenatal provider|1|||
23819639|NCT03696953|66717654|FG001|Overall Study|Changed prenatal provider|1|||
23819640|NCT04058067|66717655|FG000|Overall Study|Adverse Event|2|||
23819641|NCT04058067|66717656|FG001|Overall Study|Adverse Event|0|||
23819642|NCT04058067|66717655|FG000|Overall Study|Death|0|||
23735755|NCT01683058|66412527|FG000|Overall Study|Withdrawal by Subject|7|||
23735756|NCT01683058|66412527|FG000|Overall Study|Lack of Efficacy|2|||
23735757|NCT02943577|66412532|FG000|Overall Study|Protocol Violation|0|||
23735758|NCT02943577|66412533|FG001|Overall Study|Protocol Violation|1|||
23735759|NCT02943577|66412532|FG000|Overall Study|Adverse Event|3|||
23735760|NCT02943577|66412533|FG001|Overall Study|Adverse Event|2|||
23735761|NCT02943577|66412532|FG000|Overall Study|Lost to Follow-up|0|||
23735762|NCT02943577|66412533|FG001|Overall Study|Lost to Follow-up|1|||
23735763|NCT02943577|66412532|FG000|Overall Study|Withdrawal by Subject|1|||
23735764|NCT02943577|66412533|FG001|Overall Study|Withdrawal by Subject|1|||
23735765|NCT02943577|66412532|FG000|Overall Study|Pregnancy|1|||
23735766|NCT02943577|66412533|FG001|Overall Study|Pregnancy|0|||
23735767|NCT01497899|66412534|FG000|Double-Blind Phase|Randomized but not Treated|1|||
23735768|NCT01497899|66412535|FG001|Double-Blind Phase|Randomized but not Treated|0|||
23735769|NCT01497899|66412536|FG002|Double-Blind Phase|Randomized but not Treated|0|||
23735770|NCT01497899|66412537|FG003|Double-Blind Phase|Randomized but not Treated|0|||
23735771|NCT01497899|66412534|FG000|Double-Blind Phase|Adverse Event|1|||
23735772|NCT01497899|66412535|FG001|Double-Blind Phase|Adverse Event|0|||
23735773|NCT01497899|66412536|FG002|Double-Blind Phase|Adverse Event|0|||
23735774|NCT01497899|66412537|FG003|Double-Blind Phase|Adverse Event|0|||
23735775|NCT01497899|66412534|FG000|Double-Blind Phase|Lack of Efficacy|0|||
23735776|NCT01497899|66412535|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23735777|NCT01497899|66412536|FG002|Double-Blind Phase|Lack of Efficacy|0|||
23735778|NCT01497899|66412537|FG003|Double-Blind Phase|Lack of Efficacy|0|||
23735779|NCT01497899|66412534|FG000|Double-Blind Phase|Investigator's Discretion|1|||
23735780|NCT01497899|66412535|FG001|Double-Blind Phase|Investigator's Discretion|0|||
23735781|NCT01497899|66412536|FG002|Double-Blind Phase|Investigator's Discretion|0|||
23735782|NCT01497899|66412537|FG003|Double-Blind Phase|Investigator's Discretion|0|||
23735783|NCT01497899|66412534|FG000|Double-Blind Phase|Withdrew Consent|0|||
23735784|NCT01497899|66412535|FG001|Double-Blind Phase|Withdrew Consent|1|||
23735785|NCT01497899|66412536|FG002|Double-Blind Phase|Withdrew Consent|0|||
23819643|NCT04058067|66717656|FG001|Overall Study|Death|1|||
23735786|NCT01497899|66412537|FG003|Double-Blind Phase|Withdrew Consent|0|||
23735787|NCT01497899|66412534|FG000|Double-Blind Phase|Lost to Follow-up|3|||
23426786|NCT00276094|65307450|FG000|Overall Study|Other-Study medication lost|0|||
23426787|NCT00276094|65307451|FG001|Overall Study|Other-Study medication lost|0|||
23735788|NCT01497899|66412535|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23735789|NCT01497899|66412536|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23735790|NCT01497899|66412537|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23735791|NCT01497899|66412534|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
23735792|NCT01497899|66412535|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
23735793|NCT01497899|66412536|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
23735794|NCT01497899|66412537|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
23735795|NCT01497899|66412534|FG000|Open-Label Extension Phase|Adverse Event|1|||
23426788|NCT00276094|65307452|FG002|Overall Study|Other-Study medication lost|1|||
23735796|NCT01497899|66412535|FG001|Open-Label Extension Phase|Adverse Event|0|||
23735797|NCT01497899|66412536|FG002|Open-Label Extension Phase|Adverse Event|0|||
23735798|NCT01497899|66412537|FG003|Open-Label Extension Phase|Adverse Event|0|||
23735799|NCT01497899|66412534|FG000|Open-Label Extension Phase|Death|1|||
23735800|NCT01497899|66412535|FG001|Open-Label Extension Phase|Death|0|||
23735801|NCT01497899|66412536|FG002|Open-Label Extension Phase|Death|0|||
23735802|NCT01497899|66412537|FG003|Open-Label Extension Phase|Death|0|||
23735803|NCT01497899|66412534|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
23735804|NCT01497899|66412535|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
23735805|NCT01497899|66412536|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
23735806|NCT01497899|66412537|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
23735807|NCT01497899|66412534|FG000|Open-Label Extension Phase|Pregnancy|0|||
23426789|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Adverse Event|0|||
23618803|NCT00475735|65991341|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618804|NCT00475735|65991336|FG000|Treatment Washout|Lost to Follow-up|0|||
23426790|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Adverse Event|1|||
23426791|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Adverse Event|0|||
23426792|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Adverse Event|0|||
23618805|NCT00475735|65991337|FG001|Treatment Washout|Lost to Follow-up|1|||
23735808|NCT01497899|66412535|FG001|Open-Label Extension Phase|Pregnancy|1|||
23735809|NCT01497899|66412536|FG002|Open-Label Extension Phase|Pregnancy|1|||
23735810|NCT01497899|66412537|FG003|Open-Label Extension Phase|Pregnancy|0|||
23735811|NCT01497899|66412534|FG000|Open-Label Extension Phase|Protocol Violation|0|||
23735812|NCT01497899|66412535|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23819644|NCT04058067|66717655|FG000|Overall Study|Physician Decision|3|||
23819645|NCT04058067|66717656|FG001|Overall Study|Physician Decision|1|||
23819646|NCT04058067|66717655|FG000|Overall Study|Protocol Violation|0|||
23819647|NCT04058067|66717656|FG001|Overall Study|Protocol Violation|1|||
23426793|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Adverse Event|0|||
23426794|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Adverse Event|0|||
23426795|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
23735813|NCT01497899|66412536|FG002|Open-Label Extension Phase|Protocol Violation|1|||
23735814|NCT01497899|66412537|FG003|Open-Label Extension Phase|Protocol Violation|0|||
23735815|NCT01497899|66412534|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
23735816|NCT01497899|66412535|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
23735817|NCT01497899|66412536|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
23819648|NCT04058067|66717655|FG000|Overall Study|Withdrawal by Subject|7|||
23819649|NCT04058067|66717656|FG001|Overall Study|Withdrawal by Subject|8|||
23819650|NCT03485365|66717657|FG000|Overall Study|Protocol Violation|0|||
23819651|NCT03485365|66717658|FG001|Overall Study|Protocol Violation|0|||
23819652|NCT03485365|66717659|FG002|Overall Study|Protocol Violation|0|||
23819653|NCT03485365|66717660|FG003|Overall Study|Protocol Violation|1|||
23819654|NCT03485365|66717661|FG004|Overall Study|Protocol Violation|0|||
23819655|NCT03485365|66717662|FG005|Overall Study|Protocol Violation|0|||
23819656|NCT03485365|66717663|FG006|Overall Study|Protocol Violation|1|||
23819657|NCT03485365|66717664|FG007|Overall Study|Protocol Violation|0|||
23819658|NCT03485365|66717665|FG008|Overall Study|Protocol Violation|0|||
23819659|NCT00264550|66717666|FG000|Overall Study|Death|0|||
23819660|NCT00264550|66717667|FG001|Overall Study|Death|3|||
23819661|NCT00264550|66717668|FG002|Overall Study|Death|0|||
23735818|NCT01497899|66412537|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
23735819|NCT02394028|66412538|FG000|Induction Phase|Adverse Event|2|||
23735820|NCT02394028|66412539|FG001|Induction Phase|Adverse Event|4|||
23735821|NCT02394028|66412540|FG002|Induction Phase|Adverse Event|1|||
23735822|NCT02394028|66412541|FG003|Induction Phase|Adverse Event|2|||
23735823|NCT02394028|66412542|FG004|Induction Phase|Adverse Event|5|||
23735824|NCT02394028|66412543|FG005|Induction Phase|Adverse Event|2|||
23735825|NCT02394028|66412544|FG006|Induction Phase|Adverse Event|0|||
23735826|NCT02394028|66412545|FG007|Induction Phase|Adverse Event|0|||
23426796|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426797|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426798|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426799|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426800|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426801|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
23735827|NCT02394028|66412546|FG008|Induction Phase|Adverse Event|0|||
23735828|NCT02394028|66412547|FG009|Induction Phase|Adverse Event|0|||
23735829|NCT02394028|66412548|FG010|Induction Phase|Adverse Event|0|||
23735830|NCT02394028|66412538|FG000|Induction Phase|Lack of Efficacy|3|||
23735831|NCT02394028|66412539|FG001|Induction Phase|Lack of Efficacy|6|||
23819662|NCT00264550|66717669|FG003|Overall Study|Death|0|||
23819663|NCT00264550|66717666|FG000|Overall Study|Lost to Follow-up|3|||
23819664|NCT00264550|66717667|FG001|Overall Study|Lost to Follow-up|1|||
23819665|NCT00264550|66717668|FG002|Overall Study|Lost to Follow-up|1|||
23819666|NCT00264550|66717669|FG003|Overall Study|Lost to Follow-up|1|||
23819667|NCT00264550|66717666|FG000|Overall Study|Adverse Event|23|||
23426802|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
23426803|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
23426804|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
23735832|NCT02394028|66412540|FG002|Induction Phase|Lack of Efficacy|2|||
23735833|NCT02394028|66412541|FG003|Induction Phase|Lack of Efficacy|17|||
23735834|NCT02394028|66412542|FG004|Induction Phase|Lack of Efficacy|14|||
23735835|NCT02394028|66412543|FG005|Induction Phase|Lack of Efficacy|8|||
23735836|NCT02394028|66412544|FG006|Induction Phase|Lack of Efficacy|17|||
23735837|NCT02394028|66412545|FG007|Induction Phase|Lack of Efficacy|23|||
23735838|NCT02394028|66412546|FG008|Induction Phase|Lack of Efficacy|0|||
23735839|NCT02394028|66412547|FG009|Induction Phase|Lack of Efficacy|0|||
23426805|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
23426806|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
23545782|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545783|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
23545784|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
23545785|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
23545786|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
23545787|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
23618806|NCT00475735|65991338|FG002|Treatment Washout|Lost to Follow-up|0|||
23618807|NCT00475735|65991339|FG003|Treatment Washout|Lost to Follow-up|0|||
23618808|NCT00475735|65991340|FG004|Treatment Washout|Lost to Follow-up|0|||
23618809|NCT00475735|65991341|FG005|Treatment Washout|Lost to Follow-up|0|||
23618810|NCT00475735|65991336|FG000|Treatment Washout|Protocol Violation|0|||
23618811|NCT00475735|65991337|FG001|Treatment Washout|Protocol Violation|1|||
23618812|NCT00475735|65991338|FG002|Treatment Washout|Protocol Violation|0|||
23545788|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
23545789|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545790|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545791|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545792|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
23545793|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545794|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545795|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545796|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545797|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23618813|NCT00475735|65991339|FG003|Treatment Washout|Protocol Violation|0|||
23618814|NCT00475735|65991340|FG004|Treatment Washout|Protocol Violation|0|||
23618815|NCT00475735|65991341|FG005|Treatment Washout|Protocol Violation|0|||
23618816|NCT00475735|65991336|FG000|Treatment Period 2|Adverse Event|0|||
23618817|NCT00475735|65991337|FG001|Treatment Period 2|Adverse Event|1|||
23618818|NCT00475735|65991338|FG002|Treatment Period 2|Adverse Event|0|||
23618819|NCT00475735|65991339|FG003|Treatment Period 2|Adverse Event|2|||
23618820|NCT00475735|65991340|FG004|Treatment Period 2|Adverse Event|0|||
23618821|NCT00475735|65991341|FG005|Treatment Period 2|Adverse Event|0|||
23618822|NCT00475735|65991336|FG000|Treatment Period 2|Lack of Efficacy|0|||
23618823|NCT00475735|65991337|FG001|Treatment Period 2|Lack of Efficacy|0|||
23545798|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
23545799|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545800|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545801|NCT01292603|65727284|FG000|Part 1: Regular Follow-Up Period|Death|3|||
23545802|NCT01292603|65727285|FG001|Part 1: Regular Follow-Up Period|Death|1|||
23545803|NCT01292603|65727286|FG002|Part 1: Regular Follow-Up Period|Death|3|||
23545804|NCT01292603|65727287|FG003|Part 1: Regular Follow-Up Period|Death|1|||
23545805|NCT01292603|65727288|FG004|Part 1: Regular Follow-Up Period|Death|0|||
23545806|NCT01292603|65727289|FG005|Part 1: Regular Follow-Up Period|Death|0|||
23545807|NCT01292603|65727284|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
23545808|NCT01292603|65727285|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
23545809|NCT01292603|65727286|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
23545810|NCT01292603|65727287|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545811|NCT01292603|65727288|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545812|NCT01292603|65727289|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545813|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Death|0|||
23618824|NCT00475735|65991338|FG002|Treatment Period 2|Lack of Efficacy|0|||
23426807|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Progressive disease|0|||
23545814|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Death|0|||
23545815|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Death|0|||
23618825|NCT00475735|65991339|FG003|Treatment Period 2|Lack of Efficacy|0|||
23618826|NCT00475735|65991340|FG004|Treatment Period 2|Lack of Efficacy|0|||
23618827|NCT00475735|65991341|FG005|Treatment Period 2|Lack of Efficacy|1|||
23426808|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Progressive disease|1|||
23618828|NCT00475735|65991336|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23735840|NCT02394028|66412548|FG010|Induction Phase|Lack of Efficacy|0|||
23735841|NCT02394028|66412538|FG000|Induction Phase|Lost to Follow-up|1|||
23735842|NCT02394028|66412539|FG001|Induction Phase|Lost to Follow-up|0|||
23735843|NCT02394028|66412540|FG002|Induction Phase|Lost to Follow-up|0|||
23735844|NCT02394028|66412541|FG003|Induction Phase|Lost to Follow-up|1|||
23735845|NCT02394028|66412542|FG004|Induction Phase|Lost to Follow-up|0|||
23735846|NCT02394028|66412543|FG005|Induction Phase|Lost to Follow-up|0|||
23735847|NCT02394028|66412544|FG006|Induction Phase|Lost to Follow-up|1|||
23735848|NCT02394028|66412545|FG007|Induction Phase|Lost to Follow-up|0|||
23735849|NCT02394028|66412546|FG008|Induction Phase|Lost to Follow-up|0|||
23735850|NCT02394028|66412547|FG009|Induction Phase|Lost to Follow-up|0|||
23735851|NCT02394028|66412548|FG010|Induction Phase|Lost to Follow-up|0|||
23735852|NCT02394028|66412538|FG000|Induction Phase|Non-compliance|0|||
23735853|NCT02394028|66412539|FG001|Induction Phase|Non-compliance|1|||
23735854|NCT02394028|66412540|FG002|Induction Phase|Non-compliance|3|||
23618829|NCT00475735|65991337|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23618830|NCT00475735|65991338|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23618831|NCT00475735|65991339|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23618832|NCT00475735|65991340|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23735855|NCT02394028|66412541|FG003|Induction Phase|Non-compliance|1|||
23735856|NCT02394028|66412542|FG004|Induction Phase|Non-compliance|3|||
23735857|NCT02394028|66412543|FG005|Induction Phase|Non-compliance|0|||
23819668|NCT00264550|66717667|FG001|Overall Study|Adverse Event|18|||
23819669|NCT00264550|66717668|FG002|Overall Study|Adverse Event|9|||
23819670|NCT00264550|66717669|FG003|Overall Study|Adverse Event|14|||
23819671|NCT00264550|66717666|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23819672|NCT00264550|66717667|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
23819673|NCT00264550|66717668|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23819674|NCT00264550|66717669|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
23819675|NCT00264550|66717666|FG000|Overall Study|Discontinued oral study agent|0|||
23819676|NCT00264550|66717667|FG001|Overall Study|Discontinued oral study agent|1|||
23819677|NCT00264550|66717668|FG002|Overall Study|Discontinued oral study agent|0|||
23819678|NCT00264550|66717669|FG003|Overall Study|Discontinued oral study agent|0|||
23819679|NCT00264550|66717666|FG000|Overall Study|Other|13|||
23819680|NCT00264550|66717667|FG001|Overall Study|Other|7|||
23819681|NCT00264550|66717668|FG002|Overall Study|Other|3|||
23819682|NCT00264550|66717669|FG003|Overall Study|Other|9|||
23819683|NCT02374346|66717670|FG000|Overall Study|operated or discharged during weekend|48|||
23819684|NCT02198963|66717674|FG000|Overall Study|Adverse Event|1|||
23735858|NCT02394028|66412544|FG006|Induction Phase|Non-compliance|1|||
23735859|NCT02394028|66412545|FG007|Induction Phase|Non-compliance|1|||
23735860|NCT02394028|66412546|FG008|Induction Phase|Non-compliance|0|||
23735861|NCT02394028|66412547|FG009|Induction Phase|Non-compliance|0|||
23735862|NCT02394028|66412548|FG010|Induction Phase|Non-compliance|0|||
23735863|NCT02394028|66412538|FG000|Induction Phase|Physician Decision|0|||
23735864|NCT02394028|66412539|FG001|Induction Phase|Physician Decision|0|||
23735865|NCT02394028|66412540|FG002|Induction Phase|Physician Decision|1|||
23735866|NCT02394028|66412541|FG003|Induction Phase|Physician Decision|4|||
23735867|NCT02394028|66412542|FG004|Induction Phase|Physician Decision|0|||
23735868|NCT02394028|66412543|FG005|Induction Phase|Physician Decision|2|||
23735869|NCT02394028|66412544|FG006|Induction Phase|Physician Decision|1|||
23735870|NCT02394028|66412545|FG007|Induction Phase|Physician Decision|0|||
23735871|NCT02394028|66412546|FG008|Induction Phase|Physician Decision|0|||
23735872|NCT02394028|66412547|FG009|Induction Phase|Physician Decision|0|||
23735873|NCT02394028|66412548|FG010|Induction Phase|Physician Decision|0|||
23735874|NCT02394028|66412538|FG000|Induction Phase|Protocol Violation|0|||
23735875|NCT02394028|66412539|FG001|Induction Phase|Protocol Violation|2|||
23735876|NCT02394028|66412540|FG002|Induction Phase|Protocol Violation|0|||
23735877|NCT02394028|66412541|FG003|Induction Phase|Protocol Violation|3|||
23735878|NCT02394028|66412542|FG004|Induction Phase|Protocol Violation|0|||
23735879|NCT02394028|66412543|FG005|Induction Phase|Protocol Violation|1|||
23735880|NCT02394028|66412544|FG006|Induction Phase|Protocol Violation|1|||
23819685|NCT02198963|66717674|FG000|Overall Study|Withdrawal by Subject|6|||
23819686|NCT01696058|66717677|FG000|Overall Study|Adverse Event|21|||
23819687|NCT01696058|66717678|FG001|Overall Study|Adverse Event|11|||
23819688|NCT01696058|66717677|FG000|Overall Study|Lack of Efficacy|2|||
23735881|NCT02394028|66412545|FG007|Induction Phase|Protocol Violation|0|||
23819689|NCT01696058|66717678|FG001|Overall Study|Lack of Efficacy|3|||
23819690|NCT01696058|66717677|FG000|Overall Study|Protocol Violation|9|||
23819691|NCT01696058|66717678|FG001|Overall Study|Protocol Violation|3|||
23735882|NCT02394028|66412546|FG008|Induction Phase|Protocol Violation|0|||
23735883|NCT02394028|66412547|FG009|Induction Phase|Protocol Violation|0|||
23735884|NCT02394028|66412548|FG010|Induction Phase|Protocol Violation|0|||
23618833|NCT00475735|65991341|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23735885|NCT02394028|66412538|FG000|Induction Phase|Withdrawal by Subject|1|||
23735886|NCT02394028|66412539|FG001|Induction Phase|Withdrawal by Subject|2|||
23735887|NCT02394028|66412540|FG002|Induction Phase|Withdrawal by Subject|4|||
23819692|NCT01696058|66717677|FG000|Overall Study|Lost to Follow-up|2|||
23735888|NCT02394028|66412541|FG003|Induction Phase|Withdrawal by Subject|6|||
23545816|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Death|0|||
23545817|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Death|1|||
23545818|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Death|0|||
23545819|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545820|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545821|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545822|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545823|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
23545824|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545825|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545826|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545827|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545828|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545829|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
23545830|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
23545831|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545832|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545833|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545834|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545835|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
23735889|NCT02394028|66412542|FG004|Induction Phase|Withdrawal by Subject|7|||
23735890|NCT02394028|66412543|FG005|Induction Phase|Withdrawal by Subject|4|||
23735891|NCT02394028|66412544|FG006|Induction Phase|Withdrawal by Subject|3|||
23735892|NCT02394028|66412545|FG007|Induction Phase|Withdrawal by Subject|6|||
23735893|NCT02394028|66412546|FG008|Induction Phase|Withdrawal by Subject|0|||
23735894|NCT02394028|66412547|FG009|Induction Phase|Withdrawal by Subject|0|||
23735895|NCT02394028|66412548|FG010|Induction Phase|Withdrawal by Subject|0|||
23735896|NCT02394028|66412538|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735897|NCT02394028|66412539|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735898|NCT02394028|66412540|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735899|NCT02394028|66412541|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735900|NCT02394028|66412542|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735901|NCT02394028|66412543|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735902|NCT02394028|66412544|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
23735903|NCT02394028|66412545|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735904|NCT02394028|66412546|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735905|NCT02394028|66412547|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735906|NCT02394028|66412548|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
23735907|NCT02394028|66412538|FG000|Induction Phase|Sponsor decision|0|||
23735908|NCT02394028|66412539|FG001|Induction Phase|Sponsor decision|1|||
23735909|NCT02394028|66412540|FG002|Induction Phase|Sponsor decision|2|||
23735910|NCT02394028|66412541|FG003|Induction Phase|Sponsor decision|0|||
23735911|NCT02394028|66412542|FG004|Induction Phase|Sponsor decision|0|||
23735912|NCT02394028|66412543|FG005|Induction Phase|Sponsor decision|0|||
23735913|NCT02394028|66412544|FG006|Induction Phase|Sponsor decision|0|||
23735914|NCT02394028|66412545|FG007|Induction Phase|Sponsor decision|0|||
23735915|NCT02394028|66412546|FG008|Induction Phase|Sponsor decision|0|||
23735916|NCT02394028|66412547|FG009|Induction Phase|Sponsor decision|0|||
23735917|NCT02394028|66412548|FG010|Induction Phase|Sponsor decision|0|||
23735918|NCT02394028|66412538|FG000|Induction Phase|Technical reason|0|||
23735919|NCT02394028|66412539|FG001|Induction Phase|Technical reason|0|||
23735920|NCT02394028|66412540|FG002|Induction Phase|Technical reason|0|||
23819693|NCT01696058|66717678|FG001|Overall Study|Lost to Follow-up|5|||
23545836|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
23545837|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545838|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545839|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545840|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545841|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
23545842|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
23545843|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545844|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23735921|NCT02394028|66412541|FG003|Induction Phase|Technical reason|1|||
23735922|NCT02394028|66412542|FG004|Induction Phase|Technical reason|0|||
23735923|NCT02394028|66412543|FG005|Induction Phase|Technical reason|0|||
23735924|NCT02394028|66412544|FG006|Induction Phase|Technical reason|0|||
23819694|NCT01696058|66717677|FG000|Overall Study|Withdrawal by Subject|4|||
23819695|NCT01696058|66717678|FG001|Overall Study|Withdrawal by Subject|6|||
23545845|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545846|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545847|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545848|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
23545849|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Death|0|||
23545850|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Death|0|||
23545851|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Death|0|||
23735925|NCT02394028|66412545|FG007|Induction Phase|Technical reason|0|||
23735926|NCT02394028|66412546|FG008|Induction Phase|Technical reason|0|||
23735927|NCT02394028|66412547|FG009|Induction Phase|Technical reason|0|||
23735928|NCT02394028|66412548|FG010|Induction Phase|Technical reason|0|||
23735929|NCT02394028|66412538|FG000|Induction Phase|:ack of calculation|0|||
23735930|NCT02394028|66412539|FG001|Induction Phase|:ack of calculation|0|||
23545852|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Death|0|||
23545853|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Death|6|||
23545854|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Death|3|||
23545855|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
23545856|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
23545857|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
23735931|NCT02394028|66412540|FG002|Induction Phase|:ack of calculation|0|||
23735932|NCT02394028|66412541|FG003|Induction Phase|:ack of calculation|0|||
23735933|NCT02394028|66412542|FG004|Induction Phase|:ack of calculation|0|||
23735934|NCT02394028|66412543|FG005|Induction Phase|:ack of calculation|0|||
23735935|NCT02394028|66412544|FG006|Induction Phase|:ack of calculation|0|||
23735936|NCT02394028|66412545|FG007|Induction Phase|:ack of calculation|1|||
23735937|NCT02394028|66412546|FG008|Induction Phase|:ack of calculation|0|||
23735938|NCT02394028|66412547|FG009|Induction Phase|:ack of calculation|0|||
23735939|NCT02394028|66412548|FG010|Induction Phase|:ack of calculation|0|||
23735940|NCT02394028|66412538|FG000|Maintenance Phase|Protocol Violation|0|||
23735941|NCT02394028|66412539|FG001|Maintenance Phase|Protocol Violation|0|||
23735942|NCT02394028|66412540|FG002|Maintenance Phase|Protocol Violation|0|||
23735943|NCT02394028|66412541|FG003|Maintenance Phase|Protocol Violation|0|||
23735944|NCT02394028|66412542|FG004|Maintenance Phase|Protocol Violation|0|||
23735945|NCT02394028|66412543|FG005|Maintenance Phase|Protocol Violation|0|||
23735946|NCT02394028|66412544|FG006|Maintenance Phase|Protocol Violation|0|||
23735947|NCT02394028|66412545|FG007|Maintenance Phase|Protocol Violation|0|||
23735948|NCT02394028|66412546|FG008|Maintenance Phase|Protocol Violation|0|||
23735949|NCT02394028|66412547|FG009|Maintenance Phase|Protocol Violation|0|||
23735950|NCT02394028|66412548|FG010|Maintenance Phase|Protocol Violation|1|||
23735951|NCT02394028|66412538|FG000|Maintenance Phase|Physician Decision|0|||
23735952|NCT02394028|66412539|FG001|Maintenance Phase|Physician Decision|0|||
23735953|NCT02394028|66412540|FG002|Maintenance Phase|Physician Decision|0|||
23735954|NCT02394028|66412541|FG003|Maintenance Phase|Physician Decision|0|||
23735955|NCT02394028|66412542|FG004|Maintenance Phase|Physician Decision|0|||
23819696|NCT01696058|66717677|FG000|Overall Study|Other reason prematurely discontinued|5|||
23819697|NCT01696058|66717678|FG001|Overall Study|Other reason prematurely discontinued|3|||
23819698|NCT02865460|66717679|FG000|Overall Study|Adverse Event|1|||
23819699|NCT02865460|66717680|FG001|Overall Study|Adverse Event|0|||
23819700|NCT02865460|66717679|FG000|Overall Study|Withdrawal by Subject|1|||
23819701|NCT02865460|66717680|FG001|Overall Study|Withdrawal by Subject|1|||
23735956|NCT02394028|66412543|FG005|Maintenance Phase|Physician Decision|0|||
23735957|NCT02394028|66412544|FG006|Maintenance Phase|Physician Decision|0|||
23735958|NCT02394028|66412545|FG007|Maintenance Phase|Physician Decision|0|||
23735959|NCT02394028|66412546|FG008|Maintenance Phase|Physician Decision|1|||
23735960|NCT02394028|66412547|FG009|Maintenance Phase|Physician Decision|3|||
23735961|NCT02394028|66412548|FG010|Maintenance Phase|Physician Decision|2|||
23735962|NCT02394028|66412538|FG000|Maintenance Phase|Lack of Efficacy|0|||
23735963|NCT02394028|66412539|FG001|Maintenance Phase|Lack of Efficacy|0|||
23735964|NCT02394028|66412540|FG002|Maintenance Phase|Lack of Efficacy|0|||
23735965|NCT02394028|66412541|FG003|Maintenance Phase|Lack of Efficacy|0|||
23735966|NCT02394028|66412542|FG004|Maintenance Phase|Lack of Efficacy|0|||
23819702|NCT02865460|66717679|FG000|Overall Study|Lost to Follow-up|7|||
23819703|NCT02865460|66717680|FG001|Overall Study|Lost to Follow-up|4|||
23545858|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
23545859|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
23735967|NCT02394028|66412543|FG005|Maintenance Phase|Lack of Efficacy|0|||
23735968|NCT02394028|66412544|FG006|Maintenance Phase|Lack of Efficacy|0|||
23735969|NCT02394028|66412545|FG007|Maintenance Phase|Lack of Efficacy|0|||
23819704|NCT02865460|66717679|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
23545860|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
23545861|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
23735970|NCT02394028|66412546|FG008|Maintenance Phase|Lack of Efficacy|7|||
23735971|NCT02394028|66412547|FG009|Maintenance Phase|Lack of Efficacy|25|||
23735972|NCT02394028|66412548|FG010|Maintenance Phase|Lack of Efficacy|33|||
23735973|NCT02394028|66412538|FG000|Maintenance Phase|Death|0|||
23735974|NCT02394028|66412539|FG001|Maintenance Phase|Death|0|||
23735975|NCT02394028|66412540|FG002|Maintenance Phase|Death|0|||
23735976|NCT02394028|66412541|FG003|Maintenance Phase|Death|0|||
23735977|NCT02394028|66412542|FG004|Maintenance Phase|Death|0|||
23735978|NCT02394028|66412543|FG005|Maintenance Phase|Death|0|||
23735979|NCT02394028|66412544|FG006|Maintenance Phase|Death|0|||
23735980|NCT02394028|66412545|FG007|Maintenance Phase|Death|0|||
23735981|NCT02394028|66412546|FG008|Maintenance Phase|Death|0|||
23735982|NCT02394028|66412547|FG009|Maintenance Phase|Death|0|||
23735983|NCT02394028|66412548|FG010|Maintenance Phase|Death|1|||
23735984|NCT02394028|66412538|FG000|Maintenance Phase|Adverse Event|0|||
23735985|NCT02394028|66412539|FG001|Maintenance Phase|Adverse Event|0|||
23735986|NCT02394028|66412540|FG002|Maintenance Phase|Adverse Event|0|||
23735987|NCT02394028|66412541|FG003|Maintenance Phase|Adverse Event|0|||
23735988|NCT02394028|66412542|FG004|Maintenance Phase|Adverse Event|0|||
23735989|NCT02394028|66412543|FG005|Maintenance Phase|Adverse Event|0|||
23735990|NCT02394028|66412544|FG006|Maintenance Phase|Adverse Event|0|||
23735991|NCT02394028|66412545|FG007|Maintenance Phase|Adverse Event|0|||
23735992|NCT02394028|66412546|FG008|Maintenance Phase|Adverse Event|1|||
23735993|NCT02394028|66412547|FG009|Maintenance Phase|Adverse Event|1|||
23735994|NCT02394028|66412548|FG010|Maintenance Phase|Adverse Event|3|||
23735995|NCT02394028|66412538|FG000|Maintenance Phase|Site closure|0|||
23735996|NCT02394028|66412539|FG001|Maintenance Phase|Site closure|0|||
23735997|NCT02394028|66412540|FG002|Maintenance Phase|Site closure|0|||
23735998|NCT02394028|66412541|FG003|Maintenance Phase|Site closure|0|||
23735999|NCT02394028|66412542|FG004|Maintenance Phase|Site closure|0|||
23736000|NCT02394028|66412543|FG005|Maintenance Phase|Site closure|0|||
23736001|NCT02394028|66412544|FG006|Maintenance Phase|Site closure|0|||
23736002|NCT02394028|66412545|FG007|Maintenance Phase|Site closure|0|||
23736003|NCT02394028|66412546|FG008|Maintenance Phase|Site closure|0|||
23736004|NCT02394028|66412547|FG009|Maintenance Phase|Site closure|1|||
23736005|NCT02394028|66412548|FG010|Maintenance Phase|Site closure|0|||
23736006|NCT02394028|66412538|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23736007|NCT02394028|66412539|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23736008|NCT02394028|66412540|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23736009|NCT02394028|66412541|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23736010|NCT02394028|66412542|FG004|Maintenance Phase|Withdrawal by Subject|0|||
23736011|NCT02394028|66412543|FG005|Maintenance Phase|Withdrawal by Subject|0|||
23736012|NCT02394028|66412544|FG006|Maintenance Phase|Withdrawal by Subject|0|||
23736013|NCT02394028|66412545|FG007|Maintenance Phase|Withdrawal by Subject|0|||
23736014|NCT02394028|66412546|FG008|Maintenance Phase|Withdrawal by Subject|3|||
23736015|NCT02394028|66412547|FG009|Maintenance Phase|Withdrawal by Subject|12|||
23736016|NCT02394028|66412548|FG010|Maintenance Phase|Withdrawal by Subject|12|||
23736017|NCT00925522|66412549|FG000|Overall Study|study closed -- business decision|20|||
23736018|NCT03812224|66412552|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
23736019|NCT03812224|66412553|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23736020|NCT03812224|66412552|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
23736021|NCT03812224|66412553|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
23736022|NCT03812224|66412552|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
23736023|NCT03812224|66412553|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
23736024|NCT03812224|66412552|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
23736025|NCT03812224|66412553|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
23736026|NCT02436915|66412554|FG000|Overall Study|Withdrawal by Subject|0|||
23736027|NCT02436915|66412555|FG001|Overall Study|Withdrawal by Subject|1|||
23736028|NCT04051944|66412556|FG000|Overall Study|Study ending|1|||
23736029|NCT04051944|66412557|FG001|Overall Study|Study ending|1|||
23736030|NCT04051944|66412556|FG000|Overall Study|Early study termination by participant|1|||
23736031|NCT04051944|66412557|FG001|Overall Study|Early study termination by participant|0|||
23736032|NCT04051944|66412556|FG000|Overall Study|Withdrawal by Subject|2|||
23736033|NCT04051944|66412557|FG001|Overall Study|Withdrawal by Subject|2|||
23736034|NCT04051944|66412556|FG000|Overall Study|Lack of Efficacy|3|||
23736035|NCT04051944|66412557|FG001|Overall Study|Lack of Efficacy|0|||
23736036|NCT04051944|66412556|FG000|Overall Study|Adverse event, non- fatal|1|||
23736037|NCT04051944|66412557|FG001|Overall Study|Adverse event, non- fatal|1|||
23736038|NCT04107935|66412558|FG000|Overall Study|Death|1|||
23736039|NCT04107935|66412559|FG001|Overall Study|Death|0|||
23736040|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
23736041|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23736042|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23736043|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23736044|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23736045|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23736046|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
23736047|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23736048|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23736049|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23819705|NCT02865460|66717680|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
23819706|NCT00920790|66717683|FG000|Overall Study|aggravation of general condition|14|||
23819707|NCT02800642|66717689|FG000|Overall Study|Death|3|||
23819708|NCT02800642|66717689|FG000|Overall Study|Other|10|||
23819709|NCT02800642|66717689|FG000|Overall Study|Physician Decision|2|||
23819710|NCT02800642|66717689|FG000|Overall Study|Adverse Event|6|||
23819711|NCT02800642|66717689|FG000|Overall Study|Withdrawal by Subject|3|||
23819712|NCT02800642|66717689|FG000|Overall Study|Lost to Follow-up|1|||
23819713|NCT04036110|66717690|FG000|Overall Study|Lost to Follow-up|3|||
23819714|NCT04036110|66717691|FG001|Overall Study|Lost to Follow-up|2|||
23819715|NCT04036110|66717692|FG002|Overall Study|Lost to Follow-up|1|||
23819716|NCT04036110|66717690|FG000|Overall Study|Study Suspended|4|||
23819717|NCT04036110|66717691|FG001|Overall Study|Study Suspended|5|||
23819718|NCT04036110|66717692|FG002|Overall Study|Study Suspended|1|||
23819719|NCT05297578|66717693|FG000|Overall Study|Lost to Follow-up|1|||
23819720|NCT05297578|66717694|FG001|Overall Study|Lost to Follow-up|1|||
23819721|NCT05297578|66717695|FG002|Overall Study|Lost to Follow-up|2|||
23819722|NCT05297578|66717696|FG003|Overall Study|Lost to Follow-up|1|||
23618834|NCT04491006|65991342|FG000|Overall Study|Adverse Event|0|||
23618835|NCT04491006|65991343|FG001|Overall Study|Adverse Event|3|||
23618836|NCT04491006|65991344|FG002|Overall Study|Adverse Event|5|||
23618837|NCT04491006|65991342|FG000|Overall Study|Withdrawal by Subject|1|||
23618838|NCT04491006|65991343|FG001|Overall Study|Withdrawal by Subject|0|||
23618839|NCT04491006|65991344|FG002|Overall Study|Withdrawal by Subject|2|||
23618840|NCT02604342|65991357|FG000|Overall Study|Death|32|||
23618841|NCT02604342|65991358|FG001|Overall Study|Death|16|||
23618842|NCT02604342|65991357|FG000|Overall Study|Progression of disease|1|||
23618843|NCT02604342|65991358|FG001|Overall Study|Progression of disease|0|||
23618844|NCT02604342|65991357|FG000|Overall Study|Withdrawal by Subject|5|||
23618845|NCT02604342|65991358|FG001|Overall Study|Withdrawal by Subject|6|||
23618846|NCT02604342|65991357|FG000|Overall Study|Other|1|||
23618847|NCT02604342|65991358|FG001|Overall Study|Other|0|||
23618848|NCT02604342|65991357|FG000|Overall Study|Study Termination by Sponsor|1|||
23618849|NCT02604342|65991358|FG001|Overall Study|Study Termination by Sponsor|0|||
23736050|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23736051|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23736052|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
23736053|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23819723|NCT05297578|66717693|FG000|Overall Study|Death|0|||
23819724|NCT05297578|66717694|FG001|Overall Study|Death|1|||
23819725|NCT05297578|66717695|FG002|Overall Study|Death|0|||
23819726|NCT05297578|66717696|FG003|Overall Study|Death|0|||
23736054|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23736055|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23736056|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23819727|NCT05297578|66717693|FG000|Overall Study|Withdrawal by Subject|0|||
23819728|NCT05297578|66717694|FG001|Overall Study|Withdrawal by Subject|0|||
23545862|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
23545863|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
23545864|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
23545865|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
23545866|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
23545867|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545868|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545869|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545870|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545871|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545872|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
23545873|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545874|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545875|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545876|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545877|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
23819729|NCT05297578|66717695|FG002|Overall Study|Withdrawal by Subject|1|||
23819730|NCT05297578|66717696|FG003|Overall Study|Withdrawal by Subject|0|||
23819731|NCT02794870|66717702|FG000|Overall Study|Withdrawal by Subject|2|||
23618850|NCT02604342|65991357|FG000|Overall Study|Lost to Follow-up|1|||
23618851|NCT02604342|65991358|FG001|Overall Study|Lost to Follow-up|1|||
23618852|NCT02604342|65991357|FG000|Overall Study|Physician Decision|2|||
23618853|NCT02604342|65991358|FG001|Overall Study|Physician Decision|0|||
23618854|NCT02581189|65991359|FG000|Overall Study|Failure to return|36|||
23618855|NCT02581189|65991359|FG000|Overall Study|Withdrew consent|5|||
23618856|NCT02581189|65991359|FG000|Overall Study|Death|3|||
23618857|NCT02581189|65991359|FG000|Overall Study|Insufficient virological response|2|||
23819732|NCT02794870|66717703|FG001|Overall Study|Withdrawal by Subject|0|||
23819733|NCT00810511|66717704|FG000|Overall Study|Protocol Violation|0|||
23736057|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23736058|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Other|14|||
23736059|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Other|0|||
23736060|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Other|0|||
23736061|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Other|0|||
23736062|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Other|0|||
23736063|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Other|0|||
23736064|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
23736065|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23736066|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23736067|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23736068|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23736069|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23736070|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
23736071|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23736072|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23736073|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23736074|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23736075|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23736076|NCT02141854|66412567|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
23736077|NCT02141854|66412568|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23736078|NCT02141854|66412569|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23736079|NCT02141854|66412570|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23736080|NCT02141854|66412571|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23736081|NCT02141854|66412572|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23736082|NCT02141854|66412567|FG000|Treatment Period|Protocol Violation|0|||
23736083|NCT02141854|66412568|FG001|Treatment Period|Protocol Violation|1|||
23736084|NCT02141854|66412569|FG002|Treatment Period|Protocol Violation|0|||
23736085|NCT02141854|66412570|FG003|Treatment Period|Protocol Violation|2|||
23736086|NCT02141854|66412571|FG004|Treatment Period|Protocol Violation|2|||
23736087|NCT02141854|66412572|FG005|Treatment Period|Protocol Violation|1|||
23736088|NCT02141854|66412567|FG000|Treatment Period|Noncompliance|0|||
23736089|NCT02141854|66412568|FG001|Treatment Period|Noncompliance|0|||
23736090|NCT02141854|66412569|FG002|Treatment Period|Noncompliance|0|||
23736091|NCT02141854|66412570|FG003|Treatment Period|Noncompliance|1|||
23736092|NCT02141854|66412571|FG004|Treatment Period|Noncompliance|0|||
23736093|NCT02141854|66412572|FG005|Treatment Period|Noncompliance|0|||
23736094|NCT02141854|66412567|FG000|Treatment Period|Lack of Efficacy|0|||
23736095|NCT02141854|66412568|FG001|Treatment Period|Lack of Efficacy|0|||
23736096|NCT02141854|66412569|FG002|Treatment Period|Lack of Efficacy|0|||
23736097|NCT02141854|66412570|FG003|Treatment Period|Lack of Efficacy|1|||
23736098|NCT02141854|66412571|FG004|Treatment Period|Lack of Efficacy|1|||
23736099|NCT02141854|66412572|FG005|Treatment Period|Lack of Efficacy|7|||
23736100|NCT02141854|66412567|FG000|Treatment Period|Pregnancy|0|||
23736101|NCT02141854|66412568|FG001|Treatment Period|Pregnancy|1|||
23736102|NCT02141854|66412569|FG002|Treatment Period|Pregnancy|0|||
23736103|NCT02141854|66412570|FG003|Treatment Period|Pregnancy|0|||
23736104|NCT02141854|66412571|FG004|Treatment Period|Pregnancy|0|||
23736105|NCT02141854|66412572|FG005|Treatment Period|Pregnancy|0|||
23736106|NCT02141854|66412567|FG000|Treatment Period|Other|0|||
23736107|NCT02141854|66412568|FG001|Treatment Period|Other|1|||
23736108|NCT02141854|66412569|FG002|Treatment Period|Other|2|||
23736109|NCT02141854|66412570|FG003|Treatment Period|Other|0|||
23736110|NCT02141854|66412571|FG004|Treatment Period|Other|1|||
23736111|NCT02141854|66412572|FG005|Treatment Period|Other|2|||
23736112|NCT02141854|66412567|FG000|Treatment Period|Adverse Event|0|||
23736113|NCT02141854|66412568|FG001|Treatment Period|Adverse Event|2|||
23736114|NCT02141854|66412569|FG002|Treatment Period|Adverse Event|2|||
23736115|NCT02141854|66412570|FG003|Treatment Period|Adverse Event|0|||
23736116|NCT02141854|66412571|FG004|Treatment Period|Adverse Event|2|||
23736117|NCT02141854|66412572|FG005|Treatment Period|Adverse Event|2|||
23736118|NCT02141854|66412567|FG000|Treatment Period|Withdrawal by Subject|0|||
23736119|NCT02141854|66412568|FG001|Treatment Period|Withdrawal by Subject|2|||
23736120|NCT02141854|66412569|FG002|Treatment Period|Withdrawal by Subject|3|||
23736121|NCT02141854|66412570|FG003|Treatment Period|Withdrawal by Subject|3|||
23736122|NCT02141854|66412571|FG004|Treatment Period|Withdrawal by Subject|4|||
23736123|NCT02141854|66412572|FG005|Treatment Period|Withdrawal by Subject|7|||
23736124|NCT02141854|66412567|FG000|Treatment Period|Disease progression|0|||
23736125|NCT02141854|66412568|FG001|Treatment Period|Disease progression|2|||
23736126|NCT02141854|66412569|FG002|Treatment Period|Disease progression|1|||
23736127|NCT02141854|66412570|FG003|Treatment Period|Disease progression|3|||
23736128|NCT02141854|66412571|FG004|Treatment Period|Disease progression|0|||
23736129|NCT02141854|66412572|FG005|Treatment Period|Disease progression|18|||
23736130|NCT02141854|66412567|FG000|Treatment Period|Lost to Follow-up|0|||
23736131|NCT02141854|66412568|FG001|Treatment Period|Lost to Follow-up|1|||
23736132|NCT02141854|66412569|FG002|Treatment Period|Lost to Follow-up|1|||
23736133|NCT02141854|66412570|FG003|Treatment Period|Lost to Follow-up|1|||
23736134|NCT02141854|66412571|FG004|Treatment Period|Lost to Follow-up|0|||
23736135|NCT02141854|66412572|FG005|Treatment Period|Lost to Follow-up|1|||
23736136|NCT00684073|66412573|FG000|Selection|Selection/non-selection criteria|3|||
23736137|NCT00684073|66412573|FG000|Selection|Death|1|||
23736138|NCT00684073|66412573|FG000|Selection|noncompliance|1|||
23736139|NCT00684073|66412573|FG000|Selection|Lost to Follow-up|1|||
23736140|NCT00684073|66412573|FG000|Selection|request of the sponsor|1|||
23736141|NCT00684073|66412573|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
23736142|NCT01888367|66412574|FG000|Overall Study|Physician Decision|3|||
23736143|NCT01888367|66412575|FG001|Overall Study|Physician Decision|4|||
23736144|NCT01888367|66412576|FG002|Overall Study|Physician Decision|2|||
23736145|NCT01888367|66412574|FG000|Overall Study|Death|2|||
23736146|NCT01888367|66412575|FG001|Overall Study|Death|0|||
23545878|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545879|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
23545880|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
23545881|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
23545882|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
23545883|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
23545884|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
23545885|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545886|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545887|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545888|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545889|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
23545890|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
23545891|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
23545892|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
23545893|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
23736147|NCT01888367|66412576|FG002|Overall Study|Death|1|||
23736148|NCT01888367|66412574|FG000|Overall Study|Withdrawal by Subject|1|||
23736149|NCT01888367|66412575|FG001|Overall Study|Withdrawal by Subject|0|||
23736150|NCT01888367|66412576|FG002|Overall Study|Withdrawal by Subject|1|||
23736151|NCT01888367|66412574|FG000|Overall Study|Lost to Follow-up|1|||
23736152|NCT01888367|66412575|FG001|Overall Study|Lost to Follow-up|1|||
23736153|NCT01888367|66412576|FG002|Overall Study|Lost to Follow-up|0|||
23736154|NCT01888367|66412574|FG000|Overall Study|Protocol Violation|0|||
23736155|NCT01888367|66412575|FG001|Overall Study|Protocol Violation|0|||
23736156|NCT01888367|66412576|FG002|Overall Study|Protocol Violation|1|||
23736157|NCT01888367|66412574|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
23736158|NCT01888367|66412575|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
23736159|NCT01888367|66412576|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
23736160|NCT00740116|66412589|FG000|Overall Study|Withdrawal by Subject|1|||
23736161|NCT00740116|66412590|FG001|Overall Study|Withdrawal by Subject|1|||
23736162|NCT00740116|66412589|FG000|Overall Study|Protocol Violation|1|||
23736163|NCT00740116|66412590|FG001|Overall Study|Protocol Violation|4|||
23736164|NCT00590031|66412591|FG000|Overall Study|Adverse Event|3|||
23736165|NCT00590031|66412591|FG000|Overall Study|Withdrawal by Subject|1|||
23736166|NCT00590031|66412591|FG000|Overall Study|Metastatic Disease|1|||
23736167|NCT00590031|66412591|FG000|Overall Study|Admin Hold|1|||
23736168|NCT01038635|66412592|FG000|Overall Study|Disease Progression|2|||
23736169|NCT01038635|66412593|FG001|Overall Study|Disease Progression|0|||
23736170|NCT01038635|66412594|FG002|Overall Study|Disease Progression|0|||
23736171|NCT01038635|66412595|FG003|Overall Study|Disease Progression|0|||
23736172|NCT01038635|66412596|FG004|Overall Study|Disease Progression|0|||
23736173|NCT01038635|66412597|FG005|Overall Study|Disease Progression|0|||
23736174|NCT01038635|66412598|FG006|Overall Study|Disease Progression|1|||
23736175|NCT01038635|66412599|FG007|Overall Study|Disease Progression|4|||
23736176|NCT01038635|66412600|FG008|Overall Study|Disease Progression|0|||
23736177|NCT01038635|66412592|FG000|Overall Study|Death|0|||
23736178|NCT01038635|66412593|FG001|Overall Study|Death|0|||
23736179|NCT01038635|66412594|FG002|Overall Study|Death|0|||
23736180|NCT01038635|66412595|FG003|Overall Study|Death|0|||
23736181|NCT01038635|66412596|FG004|Overall Study|Death|1|||
23736182|NCT01038635|66412597|FG005|Overall Study|Death|0|||
23545894|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
23545895|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
23545896|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
23736183|NCT01038635|66412598|FG006|Overall Study|Death|1|||
23736184|NCT01038635|66412599|FG007|Overall Study|Death|1|||
23736185|NCT01038635|66412600|FG008|Overall Study|Death|2|||
23736186|NCT03267576|66412601|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
23736187|NCT03267576|66412602|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
23736188|NCT03267576|66412601|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
23736189|NCT03267576|66412602|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
23736190|NCT01284127|66412603|FG000|Overall Study|Adverse Event|2|||
23736191|NCT01284127|66412603|FG000|Overall Study|Withdrawal by Subject|4|||
23545897|NCT01292603|65727284|FG000|Overall Survival Status|Death|3|||
23545898|NCT01292603|65727285|FG001|Overall Survival Status|Death|1|||
23736192|NCT01284127|66412603|FG000|Overall Study|Physician Decision|1|||
23736193|NCT00718887|66412604|FG000|Overall Study|Withdrawal by Subject|3|||
23736194|NCT00718887|66412605|FG001|Overall Study|Withdrawal by Subject|2|||
23736195|NCT00718887|66412604|FG000|Overall Study|Not identified|2|||
23736196|NCT00718887|66412605|FG001|Overall Study|Not identified|7|||
23736197|NCT00554229|66412606|FG000|Overall Study|Lost to Follow-up|3|||
23736198|NCT00554229|66412607|FG001|Overall Study|Lost to Follow-up|6|||
23736199|NCT00554229|66412606|FG000|Overall Study|Withdrawal by Subject|29|||
23736200|NCT00554229|66412607|FG001|Overall Study|Withdrawal by Subject|37|||
23736201|NCT00554229|66412606|FG000|Overall Study|Adverse Event|71|||
23736202|NCT00554229|66412607|FG001|Overall Study|Adverse Event|39|||
23736203|NCT00554229|66412606|FG000|Overall Study|Protocol Violation|3|||
23736204|NCT00554229|66412607|FG001|Overall Study|Protocol Violation|3|||
23736205|NCT00554229|66412606|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
23736206|NCT00554229|66412607|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
23736207|NCT00554229|66412606|FG000|Overall Study|Randomised but no treatment received|1|||
23736208|NCT00554229|66412607|FG001|Overall Study|Randomised but no treatment received|0|||
23736209|NCT03524664|66412608|FG000|Overall Study|Withdrawal by Subject|1|||
23736210|NCT03524664|66412609|FG001|Overall Study|Withdrawal by Subject|2|||
23736211|NCT03524664|66412608|FG000|Overall Study|Lost to Follow-up|4|||
23736212|NCT03524664|66412609|FG001|Overall Study|Lost to Follow-up|13|||
23736213|NCT01728194|66412612|FG000|Overall Study|Lost to Follow-up|4|||
23736214|NCT01728194|66412613|FG001|Overall Study|Lost to Follow-up|3|||
23736215|NCT01728194|66412612|FG000|Overall Study|Physician Decision|4|||
23736216|NCT01728194|66412613|FG001|Overall Study|Physician Decision|0|||
23736217|NCT01728194|66412612|FG000|Overall Study|Withdrawal by Subject|7|||
23736218|NCT01728194|66412613|FG001|Overall Study|Withdrawal by Subject|3|||
23736219|NCT01728194|66412612|FG000|Overall Study|Perceived Medication Side Effects|4|||
23736220|NCT01728194|66412613|FG001|Overall Study|Perceived Medication Side Effects|0|||
23736221|NCT01728194|66412612|FG000|Overall Study|Family Member Request|1|||
23736222|NCT01728194|66412613|FG001|Overall Study|Family Member Request|0|||
23736223|NCT02795182|66412614|FG000|Overall Study|Death|5|||
23736224|NCT02795182|66412615|FG001|Overall Study|Death|4|||
23736225|NCT02795182|66412616|FG002|Overall Study|Death|4|||
23736226|NCT02795182|66412617|FG003|Overall Study|Death|18|||
23545899|NCT01292603|65727286|FG002|Overall Survival Status|Death|3|||
23545900|NCT01292603|65727287|FG003|Overall Survival Status|Death|1|||
23545901|NCT01292603|65727288|FG004|Overall Survival Status|Death|16|||
23545902|NCT01292603|65727289|FG005|Overall Survival Status|Death|10|||
23545903|NCT03667053|65727290|FG000|Overall Study|Withdrawal by Subject|1|||
23545904|NCT03667053|65727291|FG001|Overall Study|Withdrawal by Subject|0|||
23545905|NCT03667053|65727292|FG002|Overall Study|Withdrawal by Subject|0|||
23545906|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
23545907|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
23545908|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
23545909|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
23545910|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545911|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545912|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545913|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
23545914|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Other|0|||
23736227|NCT02795182|66412614|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23736228|NCT02795182|66412615|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23736229|NCT02795182|66412616|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23736230|NCT02795182|66412617|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
23736231|NCT02795182|66412614|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23736232|NCT02795182|66412615|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23736233|NCT02795182|66412616|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23736234|NCT02795182|66412617|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
23736235|NCT02795182|66412614|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
23736236|NCT02795182|66412615|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
23819734|NCT00810511|66717705|FG001|Overall Study|Protocol Violation|1|||
23618858|NCT02581189|65991359|FG000|Overall Study|Other, not specified|7|||
23545915|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Other|1|||
23545916|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Other|0|||
23545917|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Other|0|||
23736237|NCT02795182|66412616|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
23736238|NCT02795182|66412617|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
23736239|NCT02795182|66412614|FG000|Overall Study|Withdrawal by Subject|4|||
23736240|NCT02795182|66412615|FG001|Overall Study|Withdrawal by Subject|0|||
23545918|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23545919|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23426809|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Progressive disease|1|||
23426810|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Progressive disease|0|||
23426811|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Progressive disease|0|||
23426812|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Progressive disease|0|||
23426813|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
23426814|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
23426815|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426816|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426817|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426818|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426819|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
23426820|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
23426821|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426822|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426823|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426824|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426825|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426826|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426827|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
23545920|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23545921|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
23426828|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
23426829|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426830|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426831|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426832|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426833|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
23426834|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426835|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23545922|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
23545923|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545924|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545925|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545926|NCT05799495|65727296|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23545927|NCT05799495|65727297|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23545928|NCT05799495|65727298|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
23545929|NCT05799495|65727299|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23736241|NCT02795182|66412616|FG002|Overall Study|Withdrawal by Subject|0|||
23736242|NCT02795182|66412617|FG003|Overall Study|Withdrawal by Subject|3|||
23736243|NCT02795182|66412614|FG000|Overall Study|Lost to Follow-up|0|||
23736244|NCT02795182|66412615|FG001|Overall Study|Lost to Follow-up|0|||
23736245|NCT02795182|66412616|FG002|Overall Study|Lost to Follow-up|1|||
23736246|NCT02795182|66412617|FG003|Overall Study|Lost to Follow-up|1|||
23736247|NCT02795182|66412614|FG000|Overall Study|Roll Over to Long Term Extension|3|||
23736248|NCT02795182|66412615|FG001|Overall Study|Roll Over to Long Term Extension|3|||
23736249|NCT02795182|66412616|FG002|Overall Study|Roll Over to Long Term Extension|2|||
23736250|NCT02795182|66412617|FG003|Overall Study|Roll Over to Long Term Extension|5|||
23736251|NCT02795182|66412614|FG000|Overall Study|Progressive Disease|0|||
23736252|NCT02795182|66412615|FG001|Overall Study|Progressive Disease|1|||
23736253|NCT02795182|66412616|FG002|Overall Study|Progressive Disease|0|||
23736254|NCT02795182|66412617|FG003|Overall Study|Progressive Disease|4|||
23736255|NCT02795182|66412614|FG000|Overall Study|Physician Decision|0|||
23736256|NCT02795182|66412615|FG001|Overall Study|Physician Decision|0|||
23736257|NCT02795182|66412616|FG002|Overall Study|Physician Decision|0|||
23819735|NCT00810511|66717704|FG000|Overall Study|Lack of Efficacy|9|||
23736258|NCT02795182|66412617|FG003|Overall Study|Physician Decision|1|||
23736259|NCT00540228|66412618|FG000|Overall Study|Adverse Event|2|||
23736260|NCT00540228|66412619|FG001|Overall Study|Adverse Event|0|||
23736261|NCT00540228|66412620|FG002|Overall Study|Adverse Event|0|||
23426836|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426837|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426838|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
23426839|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426840|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426841|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426842|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426843|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
23426844|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
23426845|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
23426846|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
23736262|NCT00540228|66412621|FG003|Overall Study|Adverse Event|0|||
23736263|NCT00540228|66412622|FG004|Overall Study|Adverse Event|0|||
23736264|NCT00540228|66412618|FG000|Overall Study|Lost to Follow-up|1|||
23736265|NCT00540228|66412619|FG001|Overall Study|Lost to Follow-up|1|||
23545930|NCT02462876|65727300|FG000|Overall Study|Death|3|||
23545931|NCT02462876|65727300|FG000|Overall Study|Lost to Follow-up|7|||
23545932|NCT02462876|65727300|FG000|Overall Study|Surgical Bypass|9|||
23545933|NCT02462876|65727300|FG000|Overall Study|Amputation Above the Metatarsals|1|||
23736266|NCT00540228|66412620|FG002|Overall Study|Lost to Follow-up|0|||
23736267|NCT00540228|66412621|FG003|Overall Study|Lost to Follow-up|0|||
23736268|NCT00540228|66412622|FG004|Overall Study|Lost to Follow-up|0|||
23736269|NCT00758394|66412625|FG000|2nd Intervention Order|Lost to Follow-up|0|||
23736270|NCT00758394|66412626|FG001|2nd Intervention Order|Lost to Follow-up|1|||
23736271|NCT00758394|66412627|FG002|2nd Intervention Order|Lost to Follow-up|0|||
23736272|NCT00758394|66412628|FG003|2nd Intervention Order|Lost to Follow-up|0|||
23736273|NCT00758394|66412625|FG000|3rd Intervention|Lost to Follow-up|1|||
23736274|NCT00758394|66412626|FG001|3rd Intervention|Lost to Follow-up|0|||
23736275|NCT00758394|66412627|FG002|3rd Intervention|Lost to Follow-up|0|||
23736276|NCT00758394|66412628|FG003|3rd Intervention|Lost to Follow-up|1|||
23736277|NCT05060003|66412629|FG000|Overall Study|ctDNA negative|7|||
23736278|NCT01875731|66412630|FG000|Overall Study|Fail to obtain lab sample|1|||
23736279|NCT01875731|66412631|FG001|Overall Study|Fail to obtain lab sample|0|||
23736280|NCT03500419|66412634|FG000|Overall Study|Withdrawal by Subject|2|||
23736281|NCT03500419|66412635|FG001|Overall Study|Withdrawal by Subject|25|||
23736282|NCT00951912|66412637|FG000|Overall Study|Lack of Efficacy|1|||
23736283|NCT00951912|66412638|FG001|Overall Study|Lack of Efficacy|0|||
23736284|NCT00951912|66412639|FG002|Overall Study|Lack of Efficacy|0|||
23736285|NCT00951912|66412637|FG000|Overall Study|Adverse Event|0|||
23736286|NCT00951912|66412638|FG001|Overall Study|Adverse Event|1|||
23736287|NCT00951912|66412639|FG002|Overall Study|Adverse Event|1|||
23736288|NCT00951912|66412637|FG000|Overall Study|Lost to Follow-up|2|||
23736289|NCT00951912|66412638|FG001|Overall Study|Lost to Follow-up|2|||
23736290|NCT00951912|66412639|FG002|Overall Study|Lost to Follow-up|0|||
23736291|NCT00951912|66412637|FG000|Overall Study|Physician Decision|1|||
23736292|NCT00951912|66412638|FG001|Overall Study|Physician Decision|0|||
23736293|NCT00951912|66412639|FG002|Overall Study|Physician Decision|1|||
23736294|NCT00951912|66412637|FG000|Overall Study|Withdrawal by Subject|1|||
23736295|NCT00951912|66412638|FG001|Overall Study|Withdrawal by Subject|1|||
23736296|NCT00951912|66412639|FG002|Overall Study|Withdrawal by Subject|0|||
23736297|NCT00951912|66412637|FG000|Overall Study|Other:Depression|1|||
23736298|NCT00951912|66412638|FG001|Overall Study|Other:Depression|0|||
23736299|NCT00951912|66412639|FG002|Overall Study|Other:Depression|0|||
23736300|NCT00951912|66412637|FG000|Overall Study|Other: Colon cancer|1|||
23736301|NCT00951912|66412638|FG001|Overall Study|Other: Colon cancer|0|||
23736302|NCT00951912|66412639|FG002|Overall Study|Other: Colon cancer|0|||
23736303|NCT00951912|66412637|FG000|Overall Study|Other: Stroke|0|||
23736304|NCT00951912|66412638|FG001|Overall Study|Other: Stroke|1|||
23736305|NCT00951912|66412639|FG002|Overall Study|Other: Stroke|0|||
23736306|NCT01982942|66412640|FG000|Overall Study|Adverse Event|10|||
23736307|NCT01982942|66412641|FG001|Overall Study|Adverse Event|5|||
23736308|NCT01982942|66412640|FG000|Overall Study|Lost to Follow-up|4|||
23736309|NCT01982942|66412641|FG001|Overall Study|Lost to Follow-up|3|||
23736310|NCT01982942|66412640|FG000|Overall Study|Multiple sclerosis progression|3|||
23736311|NCT01982942|66412641|FG001|Overall Study|Multiple sclerosis progression|2|||
23736312|NCT01982942|66412640|FG000|Overall Study|Wanted to try therapy not permitted|1|||
23736313|NCT01982942|66412641|FG001|Overall Study|Wanted to try therapy not permitted|0|||
23736314|NCT01982942|66412640|FG000|Overall Study|Subject declined future visits|0|||
23736315|NCT01982942|66412641|FG001|Overall Study|Subject declined future visits|1|||
23736316|NCT01982942|66412640|FG000|Overall Study|Left geographical area|2|||
23736317|NCT01982942|66412641|FG001|Overall Study|Left geographical area|0|||
23736318|NCT01982942|66412640|FG000|Overall Study|Too many pills|1|||
23736319|NCT01982942|66412641|FG001|Overall Study|Too many pills|0|||
23736320|NCT01982942|66412640|FG000|Overall Study|MS Relapse|0|||
23736321|NCT01982942|66412641|FG001|Overall Study|MS Relapse|1|||
23736322|NCT01982942|66412640|FG000|Overall Study|Chose to join a stem cell trial|0|||
23736323|NCT01982942|66412641|FG001|Overall Study|Chose to join a stem cell trial|1|||
23736324|NCT01982942|66412640|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
23736325|NCT01982942|66412641|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
23736326|NCT02608099|66412642|FG000|Overall Study|Ablation procedure not initiated|3|||
23736327|NCT02608099|66412643|FG001|Overall Study|Ablation procedure not initiated|2|||
23736328|NCT00095836|66412648|FG000|Overall Study|Lost to Follow-up|1|||
23736329|NCT00095836|66412648|FG000|Overall Study|Adverse Event|1|||
23736330|NCT00095836|66412648|FG000|Overall Study|Death|2|||
23736331|NCT04880642|66412650|FG000|Randomization|Withdrawal by Subject|2|||
23736332|NCT04880642|66412651|FG001|Randomization|Withdrawal by Subject|3|||
23736333|NCT04880642|66412650|FG000|Treatment Period|Adverse Event|0|||
23736334|NCT04880642|66412651|FG001|Treatment Period|Adverse Event|1|||
23736335|NCT04880642|66412650|FG000|Treatment Period|Death|6|||
23819736|NCT00810511|66717705|FG001|Overall Study|Lack of Efficacy|1|||
23819737|NCT00810511|66717704|FG000|Overall Study|death in the family|0|||
23736336|NCT04880642|66412651|FG001|Treatment Period|Death|6|||
23736337|NCT04880642|66412650|FG000|Treatment Period|Lost to Follow-up|1|||
23736338|NCT04880642|66412651|FG001|Treatment Period|Lost to Follow-up|0|||
23736339|NCT04880642|66412650|FG000|Treatment Period|Protocol Violation|0|||
23736340|NCT04880642|66412651|FG001|Treatment Period|Protocol Violation|1|||
23736341|NCT04880642|66412650|FG000|Treatment Period|Withdrawal by Subject|5|||
23736342|NCT04880642|66412651|FG001|Treatment Period|Withdrawal by Subject|3|||
23819738|NCT00810511|66717705|FG001|Overall Study|death in the family|1|||
23426847|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
23545934|NCT02462876|65727300|FG000|Overall Study|36 months follow-up visit missed|1|||
23545935|NCT02462876|65727300|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
23736343|NCT04880642|66412650|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
23736344|NCT04880642|66412651|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
23545936|NCT02462876|65727300|FG000|Overall Study|Patient did not come back to the vascular department|1|||
23545937|NCT02462876|65727300|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
23618859|NCT02979613|65991362|FG000|Double-Blind Phase|Withdrew Consent|2|||
23618860|NCT02979613|65991363|FG001|Double-Blind Phase|Withdrew Consent|4|||
23618861|NCT02979613|65991362|FG000|Double-Blind Phase|Pregnancy|2|||
23618862|NCT02979613|65991363|FG001|Double-Blind Phase|Pregnancy|2|||
23618863|NCT02979613|65991362|FG000|Double-Blind Phase|Adverse Event|2|||
23618864|NCT02979613|65991363|FG001|Double-Blind Phase|Adverse Event|0|||
23618865|NCT02979613|65991362|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23618866|NCT02979613|65991363|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23736345|NCT04880642|66412650|FG000|Follow-up|Death|4|||
23736346|NCT04880642|66412651|FG001|Follow-up|Death|3|||
23736347|NCT04880642|66412650|FG000|Follow-up|Withdrawal by Subject|1|||
23545938|NCT02462876|65727300|FG000|Overall Study|Patient refused to come back|1|||
23545939|NCT02462876|65727300|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
23545940|NCT02462876|65727300|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
23545941|NCT01308580|65727301|FG000|Overall Study|Lost to Follow-up|12|||
23618867|NCT02979613|65991362|FG000|Double-Blind Phase|Protocol Violation|1|||
23618868|NCT02979613|65991363|FG001|Double-Blind Phase|Protocol Violation|1|||
23736348|NCT04880642|66412651|FG001|Follow-up|Withdrawal by Subject|0|||
23736349|NCT01005875|66412653|FG000|Overall Study|Death|3|||
23736350|NCT02807376|66412654|FG000|Overall Study|Intra-operative exclusion criteria|3|||
23736351|NCT02807376|66412655|FG001|Overall Study|Intra-operative exclusion criteria|0|||
23736352|NCT02807376|66412654|FG000|Overall Study|Lost to Follow-up|0|||
23736353|NCT02807376|66412655|FG001|Overall Study|Lost to Follow-up|1|||
23736354|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
23736355|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
23426848|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
23426849|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|DLT|1|||
23426850|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|DLT|0|||
23426851|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|DLT|2|||
23426852|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|DLT|1|||
23426853|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|DLT|0|||
23426854|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|DLT|0|||
23426855|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
23426856|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
23426857|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
23426858|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
23618869|NCT02979613|65991362|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
23618870|NCT02979613|65991363|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
23618871|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
23736356|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
23736357|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
23545942|NCT01308580|65727302|FG001|Overall Study|Lost to Follow-up|7|||
23545943|NCT02005471|65727303|FG000|Main Study|Adverse Event|0|||
23545944|NCT02005471|65727304|FG001|Main Study|Adverse Event|1|||
23545945|NCT02005471|65727305|FG002|Main Study|Adverse Event|0|||
23545946|NCT02005471|65727306|FG003|Main Study|Adverse Event|0|||
23545947|NCT02005471|65727303|FG000|Main Study|Death|83|||
23545948|NCT02005471|65727304|FG001|Main Study|Death|52|||
23545949|NCT02005471|65727305|FG002|Main Study|Death|0|||
23545950|NCT02005471|65727306|FG003|Main Study|Death|0|||
23545951|NCT02005471|65727303|FG000|Main Study|Lost to Follow-up|4|||
23545952|NCT02005471|65727304|FG001|Main Study|Lost to Follow-up|5|||
23545953|NCT02005471|65727305|FG002|Main Study|Lost to Follow-up|0|||
23545954|NCT02005471|65727306|FG003|Main Study|Lost to Follow-up|0|||
23545955|NCT02005471|65727303|FG000|Main Study|Physician Decision|3|||
23545956|NCT02005471|65727304|FG001|Main Study|Physician Decision|1|||
23545957|NCT02005471|65727305|FG002|Main Study|Physician Decision|0|||
23545958|NCT02005471|65727306|FG003|Main Study|Physician Decision|0|||
23545959|NCT02005471|65727303|FG000|Main Study|Withdrawal by Subject|26|||
23545960|NCT02005471|65727304|FG001|Main Study|Withdrawal by Subject|11|||
23545961|NCT02005471|65727305|FG002|Main Study|Withdrawal by Subject|0|||
23545962|NCT02005471|65727306|FG003|Main Study|Withdrawal by Subject|0|||
23545963|NCT02005471|65727303|FG000|Main Study|Reason not Specified|0|||
23545964|NCT02005471|65727304|FG001|Main Study|Reason not Specified|6|||
23545965|NCT02005471|65727305|FG002|Main Study|Reason not Specified|0|||
23545966|NCT02005471|65727306|FG003|Main Study|Reason not Specified|0|||
23545967|NCT02005471|65727303|FG000|Main Study|Randomized but not Dosed|8|||
23545968|NCT02005471|65727304|FG001|Main Study|Randomized but not Dosed|0|||
23545969|NCT02005471|65727305|FG002|Main Study|Randomized but not Dosed|0|||
23545970|NCT02005471|65727306|FG003|Main Study|Randomized but not Dosed|0|||
23545971|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545972|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545973|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545974|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
23545975|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
23545976|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
23545977|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
23545978|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
23545979|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
23545980|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
23545981|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
23545982|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
23545983|NCT02566031|65730939|FG000|Overall Study|Patient/guardian decision|14|||
23545984|NCT02566031|65730940|FG001|Overall Study|Patient/guardian decision|7|||
23545985|NCT02566031|65730939|FG000|Overall Study|Protocol deviation|2|||
23545986|NCT02566031|65730940|FG001|Overall Study|Protocol deviation|3|||
23545987|NCT02566031|65730939|FG000|Overall Study|Adverse Event|3|||
23545988|NCT02566031|65730940|FG001|Overall Study|Adverse Event|1|||
23545989|NCT02566031|65730939|FG000|Overall Study|Lost to Follow-up|1|||
23545990|NCT02566031|65730940|FG001|Overall Study|Lost to Follow-up|1|||
23545991|NCT02827877|65730941|FG000|Overall Study|Withdrawal by Subject|1|||
23545992|NCT03389802|65730944|FG000|Overall Study|Lack of Efficacy|3|||
23736358|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
23736359|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Death|1|||
23736360|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Death|0|||
23736361|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Death|0|||
23736362|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Death|0|||
23736363|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Death|0|||
23545993|NCT03389802|65730945|FG001|Overall Study|Lack of Efficacy|3|||
23545994|NCT03389802|65730946|FG002|Overall Study|Lack of Efficacy|13|||
23736364|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
23736365|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
23819739|NCT00810511|66717704|FG000|Overall Study|Lost to Follow-up|1|||
23736366|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
23819740|NCT00810511|66717705|FG001|Overall Study|Lost to Follow-up|0|||
23819741|NCT00810511|66717704|FG000|Overall Study|deposits on contact lens|0|||
23545995|NCT03389802|65730947|FG003|Overall Study|Lack of Efficacy|6|||
23545996|NCT03389802|65730948|FG004|Overall Study|Lack of Efficacy|1|||
23545997|NCT03389802|65730944|FG000|Overall Study|Adverse Event|0|||
23545998|NCT03389802|65730945|FG001|Overall Study|Adverse Event|0|||
23545999|NCT03389802|65730946|FG002|Overall Study|Adverse Event|1|||
23546000|NCT03389802|65730947|FG003|Overall Study|Adverse Event|0|||
23546001|NCT03389802|65730948|FG004|Overall Study|Adverse Event|4|||
23546002|NCT03389802|65730944|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
23546003|NCT03389802|65730945|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
23546004|NCT03389802|65730946|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
23546005|NCT03389802|65730947|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
23546006|NCT03389802|65730948|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
23546007|NCT00688636|65730953|FG000|Overall Study|Adverse Event|2|||
23736367|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
23736368|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
23736369|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
23736370|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
23736371|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
23736372|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
23736373|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
23736374|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23736375|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
23736376|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
23546008|NCT00688636|65730954|FG001|Overall Study|Adverse Event|1|||
23546009|NCT02864082|65730955|FG000|Overall Study|Adverse Event|1|||
23546010|NCT02864082|65730956|FG001|Overall Study|Adverse Event|1|||
23546011|NCT02864082|65730955|FG000|Overall Study|Lost to Follow-up|0|||
23546012|NCT02864082|65730956|FG001|Overall Study|Lost to Follow-up|1|||
23546013|NCT02864082|65730955|FG000|Overall Study|Withdrawal by Subject|2|||
23546014|NCT02864082|65730956|FG001|Overall Study|Withdrawal by Subject|2|||
23546015|NCT02535065|65730957|FG000|Overall Study|Death|13|||
23546016|NCT02535065|65730957|FG000|Overall Study|Lost to Follow-up|1|||
23546017|NCT02535065|65730957|FG000|Overall Study|Withdrawal by Subject|6|||
23546018|NCT01949480|65730960|FG000|Overall Study|Physician Decision|5|||
23546019|NCT01949480|65730961|FG001|Overall Study|Physician Decision|8|||
23546020|NCT02459574|65730962|FG000|Overall Study|Withdrawal by Subject|6|||
23546021|NCT02459574|65730963|FG001|Overall Study|Withdrawal by Subject|6|||
23546022|NCT02459574|65730964|FG002|Overall Study|Withdrawal by Subject|2|||
23546023|NCT02459574|65730962|FG000|Overall Study|Lost to Follow-up|1|||
23546024|NCT02459574|65730963|FG001|Overall Study|Lost to Follow-up|1|||
23546025|NCT02459574|65730964|FG002|Overall Study|Lost to Follow-up|0|||
23546026|NCT02459574|65730962|FG000|Overall Study|Death|0|||
23546027|NCT02459574|65730963|FG001|Overall Study|Death|1|||
23546028|NCT02459574|65730964|FG002|Overall Study|Death|0|||
23546029|NCT00121238|65730965|FG000|Overall Study|disease progression before intervention|1|||
23546030|NCT00121238|65730965|FG000|Overall Study|Protocol Violation|2|||
23546031|NCT01369342|65730966|FG000|Overall Study|Withdrawal by Subject|7|||
23546032|NCT01369342|65730967|FG001|Overall Study|Withdrawal by Subject|7|||
23546033|NCT01369342|65730968|FG002|Overall Study|Withdrawal by Subject|2|||
23819742|NCT00810511|66717705|FG001|Overall Study|deposits on contact lens|1|||
23426859|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
23426860|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
23546034|NCT01369342|65730966|FG000|Overall Study|Lost to Follow-up|5|||
23546035|NCT01369342|65730967|FG001|Overall Study|Lost to Follow-up|2|||
23546036|NCT01369342|65730968|FG002|Overall Study|Lost to Follow-up|1|||
23546037|NCT01369342|65730966|FG000|Overall Study|Not Treated|1|||
23546038|NCT01369342|65730967|FG001|Overall Study|Not Treated|0|||
23546039|NCT01369342|65730968|FG002|Overall Study|Not Treated|0|||
23546040|NCT04786444|65730973|FG000|Overall Study|Withdrawal by Subject|4|||
23546041|NCT04786444|65730974|FG001|Overall Study|Withdrawal by Subject|7|||
23546042|NCT04786444|65730975|FG002|Overall Study|Withdrawal by Subject|2|||
23546043|NCT04786444|65730973|FG000|Overall Study|Lost to Follow-up|11|||
23546044|NCT04786444|65730974|FG001|Overall Study|Lost to Follow-up|9|||
23546045|NCT04786444|65730975|FG002|Overall Study|Lost to Follow-up|10|||
23546046|NCT04786444|65730973|FG000|Overall Study|Subject would like to become pregnant|0|||
23546047|NCT04786444|65730974|FG001|Overall Study|Subject would like to become pregnant|1|||
23546048|NCT04786444|65730975|FG002|Overall Study|Subject would like to become pregnant|0|||
23546049|NCT02937545|65730976|FG000|Overall Study|Withdrawal by Subject|1|||
23546050|NCT02937545|65730977|FG001|Overall Study|Withdrawal by Subject|2|||
23546051|NCT02937545|65730978|FG002|Overall Study|Withdrawal by Subject|6|||
23546052|NCT02937545|65730979|FG003|Overall Study|Withdrawal by Subject|7|||
23546053|NCT02937545|65730976|FG000|Overall Study|Lost to Follow-up|1|||
23546054|NCT02937545|65730977|FG001|Overall Study|Lost to Follow-up|0|||
23546055|NCT02937545|65730978|FG002|Overall Study|Lost to Follow-up|0|||
23546056|NCT02937545|65730979|FG003|Overall Study|Lost to Follow-up|0|||
23546057|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546058|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546059|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
23546060|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546061|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546062|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23736377|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23736378|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23819743|NCT01475097|66717706|FG000|Overall Study|Protocol Violation|1|||
23546063|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546064|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23736379|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23736380|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
23736381|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
23736382|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23736383|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23736384|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
23736385|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
23736386|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23736387|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23736388|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23736389|NCT00634933|66412656|FG000|Part A: Baseline to Week 24|Other|1|||
23736390|NCT00634933|66412657|FG001|Part A: Baseline to Week 24|Other|8|||
23736391|NCT00634933|66412658|FG002|Part A: Baseline to Week 24|Other|5|||
23426861|NCT02358044|65307459|FG000|Overall Study|Adverse Event|0|||
23546065|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546066|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546067|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546068|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
23546069|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546070|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546071|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546072|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546073|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546074|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
23546075|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
23546076|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546077|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546078|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546079|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546080|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546081|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
23546082|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
23546083|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
23546084|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
23546085|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
23546086|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
23546087|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546088|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
23546089|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546090|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546091|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546092|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546093|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546094|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546095|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546096|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546097|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546098|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546099|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Adverse Event|0|||
23546100|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Adverse Event|0|||
23546101|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Adverse Event|0|||
23546102|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Adverse Event|0|||
23546103|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Adverse Event|1|||
23546104|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Adverse Event|0|||
23546105|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
23546106|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
23546107|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
23546108|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
23546109|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
23546110|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
23546111|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546112|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546113|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546114|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
23736392|NCT00634933|66412659|FG003|Part A: Baseline to Week 24|Other|0|||
23736393|NCT00634933|66412660|FG004|Part A: Baseline to Week 24|Other|0|||
23546115|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546116|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
23546117|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546118|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
23736394|NCT00634933|66412656|FG000|Between Part A and Part B|Physician Decision|0|||
23819744|NCT01475097|66717707|FG001|Overall Study|Protocol Violation|1|||
23819745|NCT02542605|66717710|FG000|Part B: Challenge Phase|Sponsor decision|1|||
23426862|NCT02358044|65307460|FG001|Overall Study|Adverse Event|1|||
23426863|NCT02358044|65307459|FG000|Overall Study|Lost to Follow-up|2|||
23426864|NCT02358044|65307460|FG001|Overall Study|Lost to Follow-up|1|||
23426865|NCT02358044|65307459|FG000|Overall Study|Physician Decision|0|||
23426866|NCT02358044|65307460|FG001|Overall Study|Physician Decision|1|||
23426867|NCT02358044|65307459|FG000|Overall Study|Withdrawal by Subject|0|||
23426868|NCT02358044|65307460|FG001|Overall Study|Withdrawal by Subject|4|||
23426869|NCT01300819|65307461|FG000|Overall Study|Adverse Event|9|||
23426870|NCT01300819|65307462|FG001|Overall Study|Adverse Event|27|||
23426871|NCT01300819|65307461|FG000|Overall Study|Lack of Efficacy|2|||
23426872|NCT01300819|65307462|FG001|Overall Study|Lack of Efficacy|1|||
23426873|NCT01300819|65307461|FG000|Overall Study|Withdrawal by Subject|10|||
23426874|NCT01300819|65307462|FG001|Overall Study|Withdrawal by Subject|12|||
23426875|NCT01300819|65307461|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
23426876|NCT01300819|65307462|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
23426877|NCT01300819|65307461|FG000|Overall Study|Refusal to down titrate study drug|0|||
23426878|NCT01300819|65307462|FG001|Overall Study|Refusal to down titrate study drug|1|||
23426879|NCT01300819|65307461|FG000|Overall Study|Administrative reason|0|||
23426880|NCT01300819|65307462|FG001|Overall Study|Administrative reason|1|||
23426881|NCT01300819|65307461|FG000|Overall Study|Safety follow up not done by mistake|0|||
23426882|NCT01300819|65307462|FG001|Overall Study|Safety follow up not done by mistake|1|||
23426883|NCT01300819|65307461|FG000|Overall Study|Follow up call was not done|1|||
23426884|NCT01300819|65307462|FG001|Overall Study|Follow up call was not done|0|||
23426885|NCT02827500|65307463|FG000|Overall Study|Death|7|||
23426886|NCT02827500|65307464|FG001|Overall Study|Death|3|||
23426887|NCT02827500|65307463|FG000|Overall Study|Lost to Follow-up|1|||
23426888|NCT02827500|65307464|FG001|Overall Study|Lost to Follow-up|1|||
23426889|NCT02827500|65307463|FG000|Overall Study|Withdrawal by Subject|3|||
23426890|NCT02827500|65307464|FG001|Overall Study|Withdrawal by Subject|1|||
23426891|NCT02827500|65307463|FG000|Overall Study|Missing primary endpoint data|3|||
23546119|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
23819746|NCT02542605|66717711|FG001|Part B: Challenge Phase|Sponsor decision|0|||
23819747|NCT02542605|66717712|FG002|Part B: Challenge Phase|Sponsor decision|0|||
23819748|NCT02542605|66717710|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
23819749|NCT02542605|66717711|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
23819750|NCT02542605|66717712|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
23819751|NCT04803305|66717713|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
23819752|NCT04803305|66717714|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
23819753|NCT04803305|66717713|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
23819754|NCT04803305|66717714|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
23819755|NCT04803305|66717713|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
23819756|NCT04803305|66717714|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
23819757|NCT04803305|66717713|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
23819758|NCT04803305|66717714|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
23819759|NCT04803305|66717713|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
23819760|NCT04803305|66717714|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
23819761|NCT04803305|66717713|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
23819762|NCT04803305|66717714|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
23819763|NCT04803305|66717713|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
23819764|NCT04803305|66717714|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
23819765|NCT04803305|66717713|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
23819766|NCT04803305|66717714|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
23819767|NCT01184079|66717715|FG000|Overall Study|Lost to Follow-up|14|||
23819768|NCT01184079|66717716|FG001|Overall Study|Lost to Follow-up|2|||
23819769|NCT02296931|66717717|FG000|Overall Study|Protocol Violation|0|||
23426892|NCT02827500|65307464|FG001|Overall Study|Missing primary endpoint data|1|||
23426893|NCT02827500|65307463|FG000|Overall Study|Other|5|||
23546120|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
23426894|NCT02827500|65307464|FG001|Overall Study|Other|1|||
23426895|NCT02677844|65307465|FG000|Period 3|Withdrawal by Subject|0|||
23546121|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
23819770|NCT02296931|66717718|FG001|Overall Study|Protocol Violation|2|||
23819771|NCT02022748|66717729|FG000|Overall Study|Adverse Event|1|||
23546122|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546123|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
23546124|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546125|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546126|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546127|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546128|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546129|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
23546130|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
23546131|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
23546132|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
23546133|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
23546134|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
23546135|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
23819772|NCT02022748|66717730|FG001|Overall Study|Adverse Event|1|||
23819773|NCT02022748|66717731|FG002|Overall Study|Adverse Event|0|||
23819774|NCT02022748|66717729|FG000|Overall Study|Withdrawal by Subject|0|||
23819775|NCT02022748|66717730|FG001|Overall Study|Withdrawal by Subject|1|||
23819776|NCT02022748|66717731|FG002|Overall Study|Withdrawal by Subject|0|||
23819777|NCT01352416|66717732|FG000|Overall Study|Physician Decision|1|||
23819778|NCT01352416|66717733|FG001|Overall Study|Physician Decision|2|||
23819779|NCT01352416|66717734|FG002|Overall Study|Physician Decision|2|||
23819780|NCT01352416|66717735|FG003|Overall Study|Physician Decision|1|||
23819781|NCT01769456|66717736|FG000|Overall Study|Lost to Follow-up|19|||
23819782|NCT01769456|66717736|FG000|Overall Study|Withdrawal by Subject|3|||
23819783|NCT01769456|66717736|FG000|Overall Study|Did not receive PCC intervention|6|||
23819784|NCT01769456|66717736|FG000|Overall Study|Moved out of the area|3|||
23819785|NCT01769456|66717736|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
23819786|NCT01769456|66717736|FG000|Overall Study|Parental request to youth to withdraw|1|||
23819787|NCT02954991|66717737|FG000|Overall Study|Death|92|||
23819788|NCT02954991|66717738|FG001|Overall Study|Death|11|||
23819789|NCT02954991|66717739|FG002|Overall Study|Death|2|||
23819790|NCT02954991|66717737|FG000|Overall Study|Lost to Follow-up|3|||
23819791|NCT02954991|66717738|FG001|Overall Study|Lost to Follow-up|2|||
23819792|NCT02954991|66717739|FG002|Overall Study|Lost to Follow-up|0|||
23819793|NCT02954991|66717737|FG000|Overall Study|Withdrawal by Subject|9|||
23819794|NCT02954991|66717738|FG001|Overall Study|Withdrawal by Subject|8|||
23546136|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
23819795|NCT02954991|66717739|FG002|Overall Study|Withdrawal by Subject|1|||
23819796|NCT02954991|66717737|FG000|Overall Study|Study Terminated by Sponsor|18|||
23819797|NCT02954991|66717738|FG001|Overall Study|Study Terminated by Sponsor|10|||
23819798|NCT02954991|66717739|FG002|Overall Study|Study Terminated by Sponsor|1|||
23819799|NCT02954991|66717737|FG000|Overall Study|Miscellaneous|2|||
23819800|NCT02954991|66717738|FG001|Overall Study|Miscellaneous|1|||
23819801|NCT02954991|66717739|FG002|Overall Study|Miscellaneous|1|||
23819802|NCT05101343|66717740|FG000|Overall Study|Withdrawal by Subject|2|||
23819803|NCT05101343|66717741|FG001|Overall Study|Withdrawal by Subject|1|||
23819804|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
23819805|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
23819806|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
23819807|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
23819808|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
23819809|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
23819810|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
23819811|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
23819812|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
23819813|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
23819814|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
23819815|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
23819816|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
23819817|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
23819818|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
23819819|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
23819820|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
23819821|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
23819822|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
23736395|NCT00634933|66412657|FG001|Between Part A and Part B|Physician Decision|1|||
23736396|NCT00634933|66412658|FG002|Between Part A and Part B|Physician Decision|0|||
23736397|NCT00634933|66412659|FG003|Between Part A and Part B|Physician Decision|0|||
23736398|NCT00634933|66412660|FG004|Between Part A and Part B|Physician Decision|0|||
23736399|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
23736400|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
23736401|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
23736402|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
23736403|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
23736404|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
23736405|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
23736406|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
23736407|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
23736408|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
23736409|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
23736410|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
23736411|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
23736412|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
23736413|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
23736414|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
23736415|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
23736416|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
23736417|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
23736418|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
23736419|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23736420|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23736421|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23736422|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
23736423|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
23736424|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23736425|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
23736426|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
23736427|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23736428|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23736429|NCT00634933|66412656|FG000|Part B: Week 24 to Week 52|Other|0|||
23736430|NCT00634933|66412657|FG001|Part B: Week 24 to Week 52|Other|0|||
23736431|NCT00634933|66412658|FG002|Part B: Week 24 to Week 52|Other|5|||
23736432|NCT00634933|66412659|FG003|Part B: Week 24 to Week 52|Other|0|||
23736433|NCT00634933|66412660|FG004|Part B: Week 24 to Week 52|Other|1|||
23736434|NCT01412333|66412669|FG000|Overall Study|Adverse Event|40|||
23736435|NCT01412333|66412670|FG001|Overall Study|Adverse Event|42|||
23736436|NCT01412333|66412669|FG000|Overall Study|Death|5|||
23819823|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
23736437|NCT01412333|66412670|FG001|Overall Study|Death|6|||
23736438|NCT01412333|66412669|FG000|Overall Study|Lack of Efficacy|22|||
23736439|NCT01412333|66412670|FG001|Overall Study|Lack of Efficacy|10|||
23736440|NCT01412333|66412669|FG000|Overall Study|Lost to Follow-up|15|||
23736441|NCT01412333|66412670|FG001|Overall Study|Lost to Follow-up|12|||
23426896|NCT02677844|65307466|FG001|Period 3|Withdrawal by Subject|0|||
23426897|NCT02677844|65307467|FG002|Period 3|Withdrawal by Subject|0|||
23426898|NCT02677844|65307468|FG003|Period 3|Withdrawal by Subject|1|||
23426899|NCT02677844|65307469|FG004|Period 3|Withdrawal by Subject|0|||
23736442|NCT01412333|66412669|FG000|Overall Study|Non-Compliance|3|||
23736443|NCT01412333|66412670|FG001|Overall Study|Non-Compliance|7|||
23426900|NCT02677844|65307470|FG005|Period 3|Withdrawal by Subject|0|||
23426901|NCT02677844|65307471|FG006|Period 3|Withdrawal by Subject|0|||
23426902|NCT02174523|65307472|FG000|Overall Study|Withdrawal by Subject|1|||
23426903|NCT02174523|65307473|FG001|Overall Study|Withdrawal by Subject|0|||
23426904|NCT02653495|65307475|FG000|Overall Study|Lost to Follow-up|2|||
23426905|NCT02653495|65307476|FG001|Overall Study|Lost to Follow-up|0|||
23426906|NCT02653495|65307475|FG000|Overall Study|Screening Failure|10|||
23426907|NCT02653495|65307476|FG001|Overall Study|Screening Failure|0|||
23426908|NCT02536300|65307477|FG000|Overall Study|Investigator's Discretion|17|||
23426909|NCT02536300|65307478|FG001|Overall Study|Investigator's Discretion|11|||
23426910|NCT02536300|65307479|FG002|Overall Study|Investigator's Discretion|2|||
23426911|NCT02536300|65307477|FG000|Overall Study|Progressive Disease|11|||
23426912|NCT02536300|65307478|FG001|Overall Study|Progressive Disease|7|||
23426913|NCT02536300|65307479|FG002|Overall Study|Progressive Disease|6|||
23426914|NCT02536300|65307477|FG000|Overall Study|Study Terminated by Sponsor|6|||
23426915|NCT02536300|65307478|FG001|Overall Study|Study Terminated by Sponsor|4|||
23546137|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546138|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546139|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546140|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546141|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546142|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
23546143|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546144|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546145|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546146|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546147|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Adverse Event|0|||
23546148|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Adverse Event|1|||
23546149|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Adverse Event|0|||
23546150|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Adverse Event|0|||
23546151|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Adverse Event|0|||
23546152|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Adverse Event|0|||
23546153|NCT05073133|65730986|FG000|Overall Study|Death|2|||
23546154|NCT02493127|65730987|FG000|Overall Study|Lost to Follow-up|1|||
23546155|NCT02493127|65730988|FG001|Overall Study|Lost to Follow-up|1|||
23546156|NCT02543346|65730989|FG000|Second Priming Visit|Withdrawal by Subject|0|||
23736444|NCT01412333|66412669|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23736445|NCT01412333|66412670|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23426916|NCT02536300|65307479|FG002|Overall Study|Study Terminated by Sponsor|7|||
23546157|NCT02543346|65730990|FG001|Second Priming Visit|Withdrawal by Subject|2|||
23546158|NCT02543346|65730991|FG002|Second Priming Visit|Withdrawal by Subject|2|||
23546159|NCT02543346|65730992|FG003|Second Priming Visit|Withdrawal by Subject|2|||
23546160|NCT02543346|65730989|FG000|Second Priming Visit|Adverse Event|1|||
23736446|NCT01412333|66412669|FG000|Overall Study|Other|30|||
23426917|NCT02536300|65307477|FG000|Overall Study|Death|7|||
23736447|NCT01412333|66412670|FG001|Overall Study|Other|33|||
23736448|NCT01412333|66412669|FG000|Overall Study|Physician Decision|11|||
23736449|NCT01412333|66412670|FG001|Overall Study|Physician Decision|16|||
23736450|NCT01412333|66412669|FG000|Overall Study|Pregnancy|6|||
23736451|NCT01412333|66412670|FG001|Overall Study|Pregnancy|4|||
23736452|NCT01412333|66412669|FG000|Overall Study|Protocol Violation|1|||
23736453|NCT01412333|66412670|FG001|Overall Study|Protocol Violation|2|||
23736454|NCT01412333|66412669|FG000|Overall Study|Study Terminated By Sponsor|3|||
23736455|NCT01412333|66412670|FG001|Overall Study|Study Terminated By Sponsor|2|||
23736456|NCT01412333|66412669|FG000|Overall Study|Withdrawal by Subject|51|||
23736457|NCT01412333|66412670|FG001|Overall Study|Withdrawal by Subject|54|||
23736458|NCT01412333|66412669|FG000|Overall Study|Missing|1|||
23736459|NCT01412333|66412670|FG001|Overall Study|Missing|3|||
23736460|NCT00504595|66412671|FG000|Overall Study|Lack of Efficacy|1|||
23736461|NCT00504595|66412672|FG001|Overall Study|Lack of Efficacy|0|||
23736462|NCT00504595|66412673|FG002|Overall Study|Lack of Efficacy|0|||
23736463|NCT00504595|66412674|FG003|Overall Study|Lack of Efficacy|0|||
23736464|NCT00504595|66412671|FG000|Overall Study|Other|0|||
23736465|NCT00504595|66412672|FG001|Overall Study|Other|0|||
23736466|NCT00504595|66412673|FG002|Overall Study|Other|2|||
23736467|NCT00504595|66412674|FG003|Overall Study|Other|0|||
23736468|NCT01899729|66412681|FG000|Overall Study|Adverse Event|1|||
23736469|NCT01899729|66412682|FG001|Overall Study|Adverse Event|0|||
23736470|NCT01899729|66412683|FG002|Overall Study|Adverse Event|0|||
23736471|NCT01899729|66412684|FG003|Overall Study|Adverse Event|0|||
23736472|NCT01899729|66412685|FG004|Overall Study|Adverse Event|1|||
23736473|NCT01899729|66412681|FG000|Overall Study|Withdrawal by Subject|1|||
23736474|NCT01899729|66412682|FG001|Overall Study|Withdrawal by Subject|2|||
23736475|NCT01899729|66412683|FG002|Overall Study|Withdrawal by Subject|0|||
23736476|NCT01899729|66412684|FG003|Overall Study|Withdrawal by Subject|0|||
23736477|NCT01899729|66412685|FG004|Overall Study|Withdrawal by Subject|0|||
23736478|NCT01899729|66412681|FG000|Overall Study|Lack of Efficacy|0|||
23736479|NCT01899729|66412682|FG001|Overall Study|Lack of Efficacy|0|||
23736480|NCT01899729|66412683|FG002|Overall Study|Lack of Efficacy|2|||
23736481|NCT01899729|66412684|FG003|Overall Study|Lack of Efficacy|0|||
23736482|NCT01899729|66412685|FG004|Overall Study|Lack of Efficacy|1|||
23736483|NCT04097925|66412686|FG000|Overall Study|Withdrawal by Subject|1|||
23736484|NCT03961529|66412688|FG000|Overall Study|Adverse Event|13|||
23736485|NCT03961529|66412689|FG001|Overall Study|Adverse Event|5|||
23736486|NCT03961529|66412690|FG002|Overall Study|Adverse Event|2|||
23736487|NCT03961529|66412688|FG000|Overall Study|Withdrawal by Subject|17|||
23736488|NCT03961529|66412689|FG001|Overall Study|Withdrawal by Subject|2|||
23736489|NCT03961529|66412690|FG002|Overall Study|Withdrawal by Subject|1|||
23736490|NCT03961529|66412688|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23736491|NCT03961529|66412689|FG001|Overall Study|Withdrawal by parent/guardian|7|||
23736492|NCT03961529|66412690|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23736493|NCT03961529|66412688|FG000|Overall Study|Physician Decision|2|||
23736494|NCT03961529|66412689|FG001|Overall Study|Physician Decision|1|||
23736495|NCT03961529|66412690|FG002|Overall Study|Physician Decision|1|||
23736496|NCT03961529|66412688|FG000|Overall Study|Lost to Follow-up|2|||
23736497|NCT03961529|66412689|FG001|Overall Study|Lost to Follow-up|1|||
23736498|NCT03961529|66412690|FG002|Overall Study|Lost to Follow-up|0|||
23736499|NCT03961529|66412688|FG000|Overall Study|Lack of Efficacy|2|||
23736500|NCT03961529|66412689|FG001|Overall Study|Lack of Efficacy|0|||
23736501|NCT03961529|66412690|FG002|Overall Study|Lack of Efficacy|1|||
23736502|NCT03961529|66412688|FG000|Overall Study|Other|6|||
23736503|NCT03961529|66412689|FG001|Overall Study|Other|1|||
23736504|NCT03961529|66412690|FG002|Overall Study|Other|0|||
23736505|NCT01766401|66412699|FG000|Overall Study|Adverse Event|7|||
23736506|NCT01766401|66412700|FG001|Overall Study|Adverse Event|22|||
23736507|NCT01766401|66412699|FG000|Overall Study|Lack of Efficacy|1|||
23736508|NCT01766401|66412700|FG001|Overall Study|Lack of Efficacy|2|||
23736509|NCT01766401|66412699|FG000|Overall Study|Protocol Violation|3|||
23736510|NCT01766401|66412700|FG001|Overall Study|Protocol Violation|8|||
23736511|NCT01766401|66412699|FG000|Overall Study|Withdrawal by Subject|15|||
23736512|NCT01766401|66412700|FG001|Overall Study|Withdrawal by Subject|12|||
23618872|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
23618873|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
23618874|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23736513|NCT01766401|66412699|FG000|Overall Study|Lost to Follow-up|10|||
23736514|NCT01766401|66412700|FG001|Overall Study|Lost to Follow-up|11|||
23736515|NCT01766401|66412699|FG000|Overall Study|Pregnancy|1|||
23736516|NCT01766401|66412700|FG001|Overall Study|Pregnancy|1|||
23736517|NCT00523744|66412704|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
23736518|NCT00523744|66412704|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
23736519|NCT00523744|66412704|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
23736520|NCT00523744|66412704|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
23736521|NCT00523744|66412704|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
23736522|NCT00523744|66412704|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
23736523|NCT00626327|66412707|FG000|Overall Study|Withdrawal by Subject|21|||
23736524|NCT00626327|66412708|FG001|Overall Study|Withdrawal by Subject|29|||
23736525|NCT00626327|66412709|FG002|Overall Study|Withdrawal by Subject|30|||
23736526|NCT00626327|66412707|FG000|Overall Study|Adverse Event|1|||
23736527|NCT00626327|66412708|FG001|Overall Study|Adverse Event|0|||
23736528|NCT00626327|66412709|FG002|Overall Study|Adverse Event|0|||
23736529|NCT00626327|66412707|FG000|Overall Study|Lost to Follow-up|24|||
23736530|NCT00626327|66412708|FG001|Overall Study|Lost to Follow-up|21|||
23736531|NCT00626327|66412709|FG002|Overall Study|Lost to Follow-up|23|||
23736532|NCT00626327|66412707|FG000|Overall Study|Inappropriate enrollment|4|||
23736533|NCT00626327|66412708|FG001|Overall Study|Inappropriate enrollment|5|||
23736534|NCT00626327|66412709|FG002|Overall Study|Inappropriate enrollment|3|||
23736535|NCT00626327|66412707|FG000|Overall Study|Administrative Reason|2|||
23736536|NCT00626327|66412708|FG001|Overall Study|Administrative Reason|0|||
23736537|NCT00626327|66412709|FG002|Overall Study|Administrative Reason|6|||
23736538|NCT00626327|66412707|FG000|Overall Study|Protocol Violation|26|||
23736539|NCT00626327|66412708|FG001|Overall Study|Protocol Violation|4|||
23736540|NCT00626327|66412709|FG002|Overall Study|Protocol Violation|26|||
23736541|NCT03793010|66412712|FG000|Overall Study|Withdrawal by Subject|5|||
23736542|NCT03793010|66412713|FG001|Overall Study|Withdrawal by Subject|7|||
23736543|NCT03793010|66412712|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
23736544|NCT03793010|66412713|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
23736545|NCT03793010|66412712|FG000|Overall Study|Lost to Follow-up|1|||
23736546|NCT03793010|66412713|FG001|Overall Study|Lost to Follow-up|2|||
23736547|NCT03793010|66412712|FG000|Overall Study|Patient couldn't sit still for injection|1|||
23736548|NCT03793010|66412713|FG001|Overall Study|Patient couldn't sit still for injection|0|||
23736549|NCT03793010|66412712|FG000|Overall Study|Withdrew to pursue other treatment|1|||
23736550|NCT03793010|66412713|FG001|Overall Study|Withdrew to pursue other treatment|0|||
23426918|NCT02536300|65307478|FG001|Overall Study|Death|0|||
23546161|NCT02543346|65730990|FG001|Second Priming Visit|Adverse Event|0|||
23546162|NCT02543346|65730991|FG002|Second Priming Visit|Adverse Event|0|||
23546163|NCT02543346|65730992|FG003|Second Priming Visit|Adverse Event|0|||
23546164|NCT03712917|65730993|FG000|Overall Study|Pregnancy|0|||
23546165|NCT03712917|65730994|FG001|Overall Study|Pregnancy|0|||
23546166|NCT03712917|65730995|FG002|Overall Study|Pregnancy|1|||
23546167|NCT03712917|65730993|FG000|Overall Study|Adverse Event|0|||
23546168|NCT03712917|65730994|FG001|Overall Study|Adverse Event|4|||
23546169|NCT03712917|65730995|FG002|Overall Study|Adverse Event|3|||
23546170|NCT03712917|65730993|FG000|Overall Study|Lost to Follow-up|9|||
23546171|NCT03712917|65730994|FG001|Overall Study|Lost to Follow-up|4|||
23546172|NCT03712917|65730995|FG002|Overall Study|Lost to Follow-up|5|||
23546173|NCT02273141|65730996|FG000|Overall Study|Adverse Event|0|||
23546174|NCT02273141|65730997|FG001|Overall Study|Adverse Event|1|||
23546175|NCT02273141|65730996|FG000|Overall Study|Lost to Follow-up|1|||
23546176|NCT02273141|65730997|FG001|Overall Study|Lost to Follow-up|3|||
23546177|NCT02273141|65730996|FG000|Overall Study|Withdrawal by Subject|10|||
23546178|NCT02273141|65730997|FG001|Overall Study|Withdrawal by Subject|15|||
23546179|NCT02273141|65730996|FG000|Overall Study|Various|6|||
23546180|NCT02273141|65730997|FG001|Overall Study|Various|6|||
23546181|NCT05554237|65731000|FG000|Part 2 (7 Days)|Adverse Event|0|||
23546182|NCT05554237|65731001|FG001|Part 2 (7 Days)|Adverse Event|0|||
23546183|NCT05554237|65731002|FG002|Part 2 (7 Days)|Adverse Event|0|||
23546184|NCT05554237|65731003|FG003|Part 2 (7 Days)|Adverse Event|0|||
23546185|NCT05554237|65731004|FG004|Part 2 (7 Days)|Adverse Event|2|||
23546186|NCT05554237|65731005|FG005|Part 2 (7 Days)|Adverse Event|0|||
23546187|NCT05554237|65731006|FG006|Part 2 (7 Days)|Adverse Event|0|||
23546188|NCT05554237|65731007|FG007|Part 2 (7 Days)|Adverse Event|0|||
23546189|NCT05554237|65731008|FG008|Part 2 (7 Days)|Adverse Event|0|||
23546190|NCT05554237|65731009|FG009|Part 2 (7 Days)|Adverse Event|1|||
23546191|NCT05554237|65731010|FG010|Part 2 (7 Days)|Adverse Event|0|||
23546192|NCT05554237|65731011|FG011|Part 2 (7 Days)|Adverse Event|0|||
23546193|NCT05554237|65731012|FG012|Part 2 (7 Days)|Adverse Event|1|||
23736551|NCT03793010|66412712|FG000|Overall Study|Did not meet eligibility criteria|1|||
23736552|NCT03793010|66412713|FG001|Overall Study|Did not meet eligibility criteria|0|||
23736553|NCT00579527|66412714|FG000|Overall Study|Death|4|||
23736554|NCT01657903|66412715|FG000|Overall Study|Lost to Follow-up|1|||
23736555|NCT01657903|66412715|FG000|Overall Study|Withdrawal by Subject|1|||
23736556|NCT00890201|66412716|FG000|Overall Study|Protocol Violation|5|||
23736557|NCT00890201|66412717|FG001|Overall Study|Protocol Violation|56|||
23736558|NCT02117024|66412718|FG000|Overall Study|Progressive Disease|26|||
23736559|NCT02117024|66412719|FG001|Overall Study|Progressive Disease|9|||
23426919|NCT02536300|65307479|FG002|Overall Study|Death|5|||
23426920|NCT02536300|65307477|FG000|Overall Study|Withdrew Consent|4|||
23546194|NCT05554237|65731013|FG013|Part 2 (7 Days)|Adverse Event|0|||
23546195|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
23546196|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
23546197|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
23546198|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
23736560|NCT02117024|66412718|FG000|Overall Study|Significant Clinical Progression|7|||
23736561|NCT02117024|66412719|FG001|Overall Study|Significant Clinical Progression|4|||
23736562|NCT02117024|66412718|FG000|Overall Study|Death|5|||
23736563|NCT02117024|66412719|FG001|Overall Study|Death|0|||
23736564|NCT02117024|66412718|FG000|Overall Study|Withdrawal by Subject|3|||
23736565|NCT02117024|66412719|FG001|Overall Study|Withdrawal by Subject|1|||
23736566|NCT02117024|66412718|FG000|Overall Study|Protocol Violation|1|||
23736567|NCT02117024|66412719|FG001|Overall Study|Protocol Violation|0|||
23736568|NCT02117024|66412718|FG000|Overall Study|Adverse Event|1|||
23736569|NCT02117024|66412719|FG001|Overall Study|Adverse Event|2|||
23736570|NCT02117024|66412718|FG000|Overall Study|Randomized in Error|1|||
23736571|NCT02117024|66412719|FG001|Overall Study|Randomized in Error|0|||
23736572|NCT02117024|66412718|FG000|Overall Study|Patient returned to primary oncologist|0|||
23736573|NCT02117024|66412719|FG001|Overall Study|Patient returned to primary oncologist|1|||
23736574|NCT02117024|66412718|FG000|Overall Study|Patient took treatment break|0|||
23736575|NCT02117024|66412719|FG001|Overall Study|Patient took treatment break|1|||
23736576|NCT02117024|66412718|FG000|Overall Study|Physician Decision|0|||
23736577|NCT02117024|66412719|FG001|Overall Study|Physician Decision|2|||
23736578|NCT00805142|66412720|FG000|Titration Period|Adverse Event|3|||
23736579|NCT00805142|66412721|FG001|Titration Period|Adverse Event|3|||
23736580|NCT00805142|66412720|FG000|Titration Period|Lack of Efficacy|1|||
23736581|NCT00805142|66412721|FG001|Titration Period|Lack of Efficacy|1|||
23736582|NCT00805142|66412720|FG000|Titration Period|Lost to Follow-up|0|||
23736583|NCT00805142|66412721|FG001|Titration Period|Lost to Follow-up|1|||
23736584|NCT00805142|66412720|FG000|Titration Period|Disease Progression|2|||
23736585|NCT00805142|66412721|FG001|Titration Period|Disease Progression|1|||
23736586|NCT00805142|66412720|FG000|Titration Period|Withdrawal of consent|0|||
23736587|NCT00805142|66412721|FG001|Titration Period|Withdrawal of consent|1|||
23736588|NCT00805142|66412720|FG000|Titration Period|Other|0|||
23736589|NCT00805142|66412721|FG001|Titration Period|Other|3|||
23736590|NCT00805142|66412720|FG000|Maintenance Period|Adverse Event|0|||
23736591|NCT00805142|66412721|FG001|Maintenance Period|Adverse Event|1|||
23736592|NCT00805142|66412720|FG000|Maintenance Period|Other|0|||
23736593|NCT00805142|66412721|FG001|Maintenance Period|Other|1|||
23736594|NCT00750867|66412722|FG000|Overall Study|Adverse Event|2|||
23736595|NCT00170846|66412727|FG000|Overall Study|Subject withdrew Informed Consent|5|||
23736596|NCT00170846|66412728|FG001|Overall Study|Subject withdrew Informed Consent|12|||
23736597|NCT00170846|66412729|FG002|Overall Study|Subject withdrew Informed Consent|8|||
23736598|NCT00170846|66412727|FG000|Overall Study|Lost to Follow-up|6|||
23736599|NCT00170846|66412728|FG001|Overall Study|Lost to Follow-up|3|||
23736600|NCT00170846|66412729|FG002|Overall Study|Lost to Follow-up|2|||
23736601|NCT00170846|66412727|FG000|Overall Study|Death|0|||
23736602|NCT00170846|66412728|FG001|Overall Study|Death|3|||
23736603|NCT00170846|66412729|FG002|Overall Study|Death|3|||
23736604|NCT00170846|66412727|FG000|Overall Study|Reason Missing|0|||
23736605|NCT00170846|66412728|FG001|Overall Study|Reason Missing|1|||
23736606|NCT00170846|66412729|FG002|Overall Study|Reason Missing|0|||
23736607|NCT01797302|66412734|FG000|Overall Study|Lost to Follow-up|16|||
23736608|NCT01797302|66412735|FG001|Overall Study|Lost to Follow-up|23|||
23736609|NCT01797302|66412736|FG002|Overall Study|Lost to Follow-up|22|||
23736610|NCT01797302|66412734|FG000|Overall Study|Withdrawal by Subject|1|||
23736611|NCT01797302|66412735|FG001|Overall Study|Withdrawal by Subject|3|||
23736612|NCT01797302|66412736|FG002|Overall Study|Withdrawal by Subject|4|||
23736613|NCT00305773|66412745|FG000|Overall Study|Death|3|||
23736614|NCT00305773|66412746|FG001|Overall Study|Death|2|||
23736615|NCT00305773|66412745|FG000|Overall Study|Adverse Event|1|||
23736616|NCT00305773|66412746|FG001|Overall Study|Adverse Event|2|||
23736617|NCT00305773|66412745|FG000|Overall Study|Alternative Treatment|4|||
23736618|NCT00305773|66412746|FG001|Overall Study|Alternative Treatment|4|||
23819824|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
23546199|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
23546200|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
23546201|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
23546202|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
23736619|NCT00305773|66412745|FG000|Overall Study|Physician Decision|1|||
23736620|NCT00305773|66412746|FG001|Overall Study|Physician Decision|1|||
23736621|NCT00305773|66412745|FG000|Overall Study|Withdrawal by Subject|1|||
23736622|NCT00305773|66412746|FG001|Overall Study|Withdrawal by Subject|4|||
23736623|NCT00305773|66412745|FG000|Overall Study|Disease Progression|1|||
23736624|NCT00305773|66412746|FG001|Overall Study|Disease Progression|3|||
23819825|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
23736625|NCT00305773|66412745|FG000|Overall Study|All other reasons|3|||
23736626|NCT00305773|66412746|FG001|Overall Study|All other reasons|2|||
23736627|NCT01562327|66412747|FG000|Overall Study|Adverse Event|2|||
23736628|NCT01562327|66412747|FG000|Overall Study|Lack of Efficacy|1|||
23736629|NCT01562327|66412747|FG000|Overall Study|Participant drop-out|1|||
23736630|NCT01562327|66412747|FG000|Overall Study|Infusion not received at 6 month window|4|||
23736631|NCT02098733|66412748|FG000|Overall Study|Data Not Available|5|||
23736632|NCT02098733|66412748|FG000|Overall Study|Lost to Follow-up|5|||
23736633|NCT00656799|66412754|FG000|Overall Study|Death|2|||
23736634|NCT00935701|66412755|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
23736635|NCT02646891|66412756|FG000|Overall Study|Adverse Event|0|||
23819826|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
23819827|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
23819828|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
23546203|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
23736636|NCT02646891|66412757|FG001|Overall Study|Adverse Event|1|||
23736637|NCT02646891|66412758|FG002|Overall Study|Adverse Event|0|||
23736638|NCT02646891|66412759|FG003|Overall Study|Adverse Event|0|||
23736639|NCT02646891|66412760|FG004|Overall Study|Adverse Event|0|||
23736640|NCT02646891|66412761|FG005|Overall Study|Adverse Event|0|||
23736641|NCT02646891|66412762|FG006|Overall Study|Adverse Event|0|||
23736642|NCT02646891|66412763|FG007|Overall Study|Adverse Event|0|||
23736643|NCT02646891|66412764|FG008|Overall Study|Adverse Event|0|||
23736644|NCT02646891|66412765|FG009|Overall Study|Adverse Event|0|||
23736645|NCT02646891|66412756|FG000|Overall Study|Lost to Follow-up|0|||
23736646|NCT02646891|66412757|FG001|Overall Study|Lost to Follow-up|0|||
23736647|NCT02646891|66412758|FG002|Overall Study|Lost to Follow-up|0|||
23736648|NCT02646891|66412759|FG003|Overall Study|Lost to Follow-up|0|||
23736649|NCT02646891|66412760|FG004|Overall Study|Lost to Follow-up|0|||
23736650|NCT02646891|66412761|FG005|Overall Study|Lost to Follow-up|0|||
23736651|NCT02646891|66412762|FG006|Overall Study|Lost to Follow-up|2|||
23736652|NCT02646891|66412763|FG007|Overall Study|Lost to Follow-up|2|||
23736653|NCT02646891|66412764|FG008|Overall Study|Lost to Follow-up|2|||
23736654|NCT02646891|66412765|FG009|Overall Study|Lost to Follow-up|2|||
23736655|NCT02646891|66412756|FG000|Overall Study|Protocol Violation|0|||
23736656|NCT02646891|66412757|FG001|Overall Study|Protocol Violation|0|||
23736657|NCT02646891|66412758|FG002|Overall Study|Protocol Violation|0|||
23736658|NCT02646891|66412759|FG003|Overall Study|Protocol Violation|0|||
23736659|NCT02646891|66412760|FG004|Overall Study|Protocol Violation|0|||
23736660|NCT02646891|66412761|FG005|Overall Study|Protocol Violation|0|||
23736661|NCT02646891|66412762|FG006|Overall Study|Protocol Violation|1|||
23736662|NCT02646891|66412763|FG007|Overall Study|Protocol Violation|1|||
23736663|NCT02646891|66412764|FG008|Overall Study|Protocol Violation|0|||
23736664|NCT02646891|66412765|FG009|Overall Study|Protocol Violation|0|||
23736665|NCT02646891|66412756|FG000|Overall Study|Withdrawal by Subject|2|||
23736666|NCT02646891|66412757|FG001|Overall Study|Withdrawal by Subject|0|||
23736667|NCT02646891|66412758|FG002|Overall Study|Withdrawal by Subject|1|||
23736668|NCT02646891|66412759|FG003|Overall Study|Withdrawal by Subject|0|||
23736669|NCT02646891|66412760|FG004|Overall Study|Withdrawal by Subject|0|||
23736670|NCT02646891|66412761|FG005|Overall Study|Withdrawal by Subject|0|||
23736671|NCT02646891|66412762|FG006|Overall Study|Withdrawal by Subject|5|||
23736672|NCT02646891|66412763|FG007|Overall Study|Withdrawal by Subject|9|||
23736673|NCT02646891|66412764|FG008|Overall Study|Withdrawal by Subject|7|||
23736674|NCT02646891|66412765|FG009|Overall Study|Withdrawal by Subject|3|||
23736675|NCT02646891|66412756|FG000|Overall Study|Death|0|||
23736676|NCT02646891|66412757|FG001|Overall Study|Death|0|||
23736677|NCT02646891|66412758|FG002|Overall Study|Death|0|||
23736678|NCT02646891|66412759|FG003|Overall Study|Death|0|||
23736679|NCT02646891|66412760|FG004|Overall Study|Death|0|||
23736680|NCT02646891|66412761|FG005|Overall Study|Death|0|||
23736681|NCT02646891|66412762|FG006|Overall Study|Death|1|||
23736682|NCT02646891|66412763|FG007|Overall Study|Death|1|||
23736683|NCT02646891|66412764|FG008|Overall Study|Death|1|||
23736684|NCT02646891|66412765|FG009|Overall Study|Death|0|||
23736685|NCT03696576|66412766|FG000|Overall Study|Soreness of throat after therapy|1|||
23736686|NCT03696576|66412767|FG001|Overall Study|Soreness of throat after therapy|1|||
23736687|NCT03696576|66412766|FG000|Overall Study|Lost to Follow-up|2|||
23819829|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
23546204|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
23736688|NCT03696576|66412767|FG001|Overall Study|Lost to Follow-up|4|||
23736689|NCT00805194|66412768|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
23736690|NCT00805194|66412769|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
23736691|NCT00805194|66412768|FG000|Overall Study|Worsening or AE of underlying disease|64|||
23736692|NCT00805194|66412769|FG001|Overall Study|Worsening or AE of underlying disease|70|||
23736693|NCT00805194|66412768|FG000|Overall Study|Other AE|84|||
23736694|NCT00805194|66412769|FG001|Overall Study|Other AE|73|||
23736695|NCT00805194|66412768|FG000|Overall Study|Protocol Violation|9|||
23736696|NCT00805194|66412769|FG001|Overall Study|Protocol Violation|9|||
23736697|NCT00805194|66412768|FG000|Overall Study|Lost to Follow-up|5|||
23736698|NCT00805194|66412769|FG001|Overall Study|Lost to Follow-up|5|||
23736699|NCT00805194|66412768|FG000|Overall Study|Withdrawal by Subject|60|||
23736700|NCT00805194|66412769|FG001|Overall Study|Withdrawal by Subject|42|||
23736701|NCT00805194|66412768|FG000|Overall Study|Not treated|3|||
23736702|NCT00805194|66412769|FG001|Overall Study|Not treated|4|||
23736703|NCT00805194|66412768|FG000|Overall Study|Reasons other than stated above|20|||
23736704|NCT00805194|66412769|FG001|Overall Study|Reasons other than stated above|16|||
23736705|NCT01849289|66412775|FG000|Overall Study|Adverse Event|3|||
23736706|NCT01849289|66412776|FG001|Overall Study|Adverse Event|3|||
23736707|NCT01849289|66412775|FG000|Overall Study|Protocol Violation|3|||
23736708|NCT01849289|66412776|FG001|Overall Study|Protocol Violation|3|||
23736709|NCT01849289|66412775|FG000|Overall Study|Withdrawal criteria|1|||
23736710|NCT01849289|66412776|FG001|Overall Study|Withdrawal criteria|0|||
23736711|NCT01849289|66412775|FG000|Overall Study|Unclassified|25|||
23736712|NCT01849289|66412776|FG001|Overall Study|Unclassified|18|||
23736713|NCT04021706|66412777|FG000|Overall Study|Adverse Event|2|||
23736714|NCT04021706|66412778|FG001|Overall Study|Adverse Event|0|||
23736715|NCT04021706|66412777|FG000|Overall Study|Withdrawal by Subject|1|||
23736716|NCT04021706|66412778|FG001|Overall Study|Withdrawal by Subject|2|||
23736717|NCT04021706|66412777|FG000|Overall Study|Physician Decision|1|||
23736718|NCT04021706|66412778|FG001|Overall Study|Physician Decision|0|||
23736719|NCT00413777|66412779|FG000|Fixed-dose Period|Lost to Follow-up|1|||
23736720|NCT00413777|66412780|FG001|Fixed-dose Period|Lost to Follow-up|1|||
23736721|NCT00413777|66412779|FG000|Fixed-dose Period|Adverse Event|2|||
23736722|NCT00413777|66412780|FG001|Fixed-dose Period|Adverse Event|1|||
23736723|NCT00413777|66412779|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
23736724|NCT00413777|66412780|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
23736725|NCT00413777|66412779|FG000|Fixed-dose Period|Withdrew Consent|0|||
23736726|NCT00413777|66412780|FG001|Fixed-dose Period|Withdrew Consent|1|||
23736727|NCT02381795|66412783|FG000|Overall Study|Withdrawal by Subject|1|||
23736728|NCT02381795|66412783|FG000|Overall Study|Study Terminated|2|||
23736729|NCT02127970|66412790|FG000|Overall Study|Adverse Event|2|||
23736730|NCT02127970|66412791|FG001|Overall Study|Adverse Event|1|||
23736731|NCT02127970|66412790|FG000|Overall Study|Death|1|||
23736732|NCT02127970|66412791|FG001|Overall Study|Death|1|||
23736733|NCT02127970|66412790|FG000|Overall Study|Lost to Follow-up|14|||
23736734|NCT02127970|66412791|FG001|Overall Study|Lost to Follow-up|14|||
23736735|NCT02127970|66412790|FG000|Overall Study|Reason not Specified|4|||
23736736|NCT02127970|66412791|FG001|Overall Study|Reason not Specified|7|||
23736737|NCT02127970|66412790|FG000|Overall Study|Pregnancy|0|||
23736738|NCT02127970|66412791|FG001|Overall Study|Pregnancy|1|||
23736739|NCT02127970|66412790|FG000|Overall Study|Subject Withdrew Consent|5|||
23736740|NCT02127970|66412791|FG001|Overall Study|Subject Withdrew Consent|3|||
23736741|NCT00298766|66412792|FG000|Overall Study|Adverse Event|18|||
23736742|NCT00298766|66412792|FG000|Overall Study|Death|2|||
23736743|NCT00298766|66412792|FG000|Overall Study|Withdrawal by Subject|9|||
23736744|NCT00298766|66412792|FG000|Overall Study|Treatment ongoing|4|||
23736745|NCT00298766|66412792|FG000|Overall Study|Progression of amyloid markers|4|||
23736746|NCT00298766|66412792|FG000|Overall Study|Deterioration in KPS and organ function|1|||
23736747|NCT00298766|66412792|FG000|Overall Study|Subjects overall condition deterioration|4|||
23736748|NCT00298766|66412792|FG000|Overall Study|Other|4|||
23736749|NCT00829010|66412801|FG000|Overall Study|Adverse Event|1|||
23736750|NCT00829010|66412802|FG001|Overall Study|Adverse Event|0|||
23736751|NCT00829010|66412803|FG002|Overall Study|Adverse Event|0|||
23736752|NCT00829010|66412804|FG003|Overall Study|Adverse Event|0|||
23736753|NCT00829010|66412805|FG004|Overall Study|Adverse Event|0|||
23736754|NCT00829010|66412801|FG000|Overall Study|Withdrawal by Subject|0|||
23736755|NCT00829010|66412802|FG001|Overall Study|Withdrawal by Subject|1|||
23736756|NCT00829010|66412803|FG002|Overall Study|Withdrawal by Subject|1|||
23736757|NCT00829010|66412804|FG003|Overall Study|Withdrawal by Subject|0|||
23736758|NCT00829010|66412805|FG004|Overall Study|Withdrawal by Subject|2|||
23736759|NCT00829010|66412801|FG000|Overall Study|Lost to Follow-up|1|||
23736760|NCT00829010|66412802|FG001|Overall Study|Lost to Follow-up|0|||
23736761|NCT00829010|66412803|FG002|Overall Study|Lost to Follow-up|2|||
23736762|NCT00829010|66412804|FG003|Overall Study|Lost to Follow-up|0|||
23736763|NCT00829010|66412805|FG004|Overall Study|Lost to Follow-up|0|||
23736764|NCT00829010|66412801|FG000|Overall Study|Fatality|5|||
23736765|NCT00829010|66412802|FG001|Overall Study|Fatality|4|||
23736766|NCT00829010|66412803|FG002|Overall Study|Fatality|0|||
23736767|NCT00829010|66412804|FG003|Overall Study|Fatality|3|||
23736768|NCT00829010|66412805|FG004|Overall Study|Fatality|0|||
23736769|NCT00829010|66412801|FG000|Overall Study|Migrated/Moved from study area|3|||
23736770|NCT00829010|66412802|FG001|Overall Study|Migrated/Moved from study area|4|||
23736771|NCT00829010|66412803|FG002|Overall Study|Migrated/Moved from study area|0|||
23736772|NCT00829010|66412804|FG003|Overall Study|Migrated/Moved from study area|5|||
23736773|NCT00829010|66412805|FG004|Overall Study|Migrated/Moved from study area|0|||
23736774|NCT02354690|66412806|FG000|Overall Study|Physician Decision|1|||
23736775|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
23736776|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
23736777|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
23736778|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
23736779|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
23736780|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
23426921|NCT02536300|65307478|FG001|Overall Study|Withdrew Consent|2|||
23426922|NCT02536300|65307479|FG002|Overall Study|Withdrew Consent|0|||
23426923|NCT02536300|65307477|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
23426924|NCT02536300|65307478|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
23426925|NCT02536300|65307479|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
23426926|NCT02536300|65307477|FG000|Overall Study|Enrolled but Never Treated|0|||
23426927|NCT02536300|65307478|FG001|Overall Study|Enrolled but Never Treated|0|||
23426928|NCT02536300|65307479|FG002|Overall Study|Enrolled but Never Treated|1|||
23426929|NCT02536300|65307477|FG000|Overall Study|Non-compliance With Study Drug|1|||
23426930|NCT02536300|65307478|FG001|Overall Study|Non-compliance With Study Drug|0|||
23426931|NCT02536300|65307479|FG002|Overall Study|Non-compliance With Study Drug|0|||
23426932|NCT02536300|65307477|FG000|Overall Study|Protocol Violation|0|||
23426933|NCT02536300|65307478|FG001|Overall Study|Protocol Violation|1|||
23426934|NCT02536300|65307479|FG002|Overall Study|Protocol Violation|0|||
23426935|NCT03099148|65307482|FG000|Wash-out|scheduling conflict|0|||
23426936|NCT03099148|65307483|FG001|Wash-out|scheduling conflict|1|||
23426937|NCT03099148|65307484|FG002|Wash-out|scheduling conflict|0|||
23426938|NCT03099148|65307485|FG003|Wash-out|scheduling conflict|0|||
23426939|NCT03099148|65307482|FG000|Wash-out|Adverse Event|0|||
23426940|NCT03099148|65307483|FG001|Wash-out|Adverse Event|1|||
23426941|NCT03099148|65307484|FG002|Wash-out|Adverse Event|0|||
23426942|NCT03099148|65307485|FG003|Wash-out|Adverse Event|0|||
23426943|NCT01873729|65307486|FG000|Overall Study|Withdrawal by Subject|1|||
23426944|NCT03697993|65307490|FG000|Overall Study|Became Ineligible after Enrollment|1|||
23426945|NCT03697993|65307491|FG001|Overall Study|Became Ineligible after Enrollment|3|||
23426946|NCT03697993|65307490|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
23426947|NCT03697993|65307491|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
23426948|NCT03697993|65307490|FG000|Overall Study|Lost to Follow-up|3|||
23426949|NCT03697993|65307491|FG001|Overall Study|Lost to Follow-up|0|||
23426950|NCT03697993|65307490|FG000|Overall Study|Physician Decision|4|||
23426951|NCT03697993|65307491|FG001|Overall Study|Physician Decision|0|||
23426952|NCT03697993|65307490|FG000|Overall Study|Initial Urine Culture Negative|0|||
23426953|NCT03697993|65307491|FG001|Overall Study|Initial Urine Culture Negative|1|||
23426954|NCT00810901|65307494|FG000|Overall Study|Lost to Follow-up|88|||
23426955|NCT00810901|65307495|FG001|Overall Study|Lost to Follow-up|58|||
23426956|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
23426957|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
23426958|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
23426959|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
23426960|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
23426961|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
23426962|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23426963|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23736781|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
23736782|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
23736783|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
23736784|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
23736785|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
23736786|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
23736787|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
23736788|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
23736789|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
23736790|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|Other|6|||
23736791|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|Other|6|||
23736792|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|Other|7|||
23736793|NCT02681094|66412808|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
23736794|NCT02681094|66412809|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
23736795|NCT02681094|66412810|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
23736796|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Participant decision|7|||
23736797|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Participant decision|10|||
23736798|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Participant decision|9|||
23736799|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
23736800|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
23736801|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
23426964|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
23426965|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
23426966|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
23618875|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Death|0|||
23426967|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
23426968|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
23426969|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
23426970|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
23426971|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23426972|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
23426973|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23426974|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
23426975|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
23426976|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
23426977|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
23546205|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
23546206|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
23546207|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546208|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546209|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546210|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
23546211|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
23819830|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
23819831|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
23819832|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
23819833|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
23819834|NCT04614948|66717745|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
23819835|NCT04614948|66717746|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
23819836|NCT04614948|66717747|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
23819837|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
23819838|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
23819839|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
23819840|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
23819841|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
23819842|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
23819843|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
23819844|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
23819845|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
23819846|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
23819847|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
23819848|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
23819849|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
23819850|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
23819851|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
23819852|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
23819853|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
23819854|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
23819855|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
23819856|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
23819857|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
23819858|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
23819859|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
23819860|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
23819861|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
23819862|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
23819863|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
23819864|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
23819865|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
23819866|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
23819867|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
23819868|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
23819869|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
23819870|NCT04614948|66717745|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
23819871|NCT04614948|66717746|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
23546212|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
23546213|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
23426978|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
23426979|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
23736802|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
23736803|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
23736804|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
23736805|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
23736806|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
23736807|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
23736808|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
23736809|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
23736810|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
23736811|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|Other|6|||
23736812|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|Other|6|||
23736813|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|Other|7|||
23736814|NCT02681094|66412808|FG000|2 - Enrolled Participants Set|No treatment given|0|||
23736815|NCT02681094|66412809|FG001|2 - Enrolled Participants Set|No treatment given|1|||
23736816|NCT02681094|66412810|FG002|2 - Enrolled Participants Set|No treatment given|1|||
23736817|NCT02712008|66412816|FG000|Baseline (Day 1) up to Week 12|Death|3|||
23736818|NCT02712008|66412817|FG001|Baseline (Day 1) up to Week 12|Death|0|||
23736819|NCT02712008|66412818|FG002|Baseline (Day 1) up to Week 12|Death|0|||
23736820|NCT02712008|66412819|FG003|Baseline (Day 1) up to Week 12|Death|0|||
23736821|NCT02712008|66412820|FG004|Baseline (Day 1) up to Week 12|Death|0|||
23736822|NCT02712008|66412821|FG005|Baseline (Day 1) up to Week 12|Death|0|||
23736823|NCT02712008|66412822|FG006|Baseline (Day 1) up to Week 12|Death|0|||
23736824|NCT02712008|66412823|FG007|Baseline (Day 1) up to Week 12|Death|0|||
23736825|NCT02712008|66412816|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736826|NCT02712008|66412817|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
23736827|NCT02712008|66412818|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
23736828|NCT02712008|66412819|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736829|NCT02712008|66412820|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736830|NCT02712008|66412821|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736831|NCT02712008|66412822|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736832|NCT02712008|66412823|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23736833|NCT02712008|66412816|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
23736834|NCT02712008|66412817|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736835|NCT02712008|66412818|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
23736836|NCT02712008|66412819|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736837|NCT02712008|66412820|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736838|NCT02712008|66412821|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736839|NCT02712008|66412822|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736840|NCT02712008|66412823|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23736841|NCT02712008|66412816|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736842|NCT02712008|66412817|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736843|NCT02712008|66412818|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
23736844|NCT02712008|66412819|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736845|NCT02712008|66412820|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736846|NCT02712008|66412821|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736847|NCT02712008|66412822|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736848|NCT02712008|66412823|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23736849|NCT02712008|66412816|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736850|NCT02712008|66412817|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
23736851|NCT02712008|66412818|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736852|NCT02712008|66412819|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736853|NCT02712008|66412820|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736854|NCT02712008|66412821|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736855|NCT02712008|66412822|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23819872|NCT04614948|66717747|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
23819873|NCT03573830|66721055|FG000|Overall Study|Dropped without completing treatment|0|||
23819874|NCT03573830|66721056|FG001|Overall Study|Dropped without completing treatment|7|||
23819875|NCT03573830|66721055|FG000|Overall Study|Lost to Follow-up|4|||
23819876|NCT03573830|66721056|FG001|Overall Study|Lost to Follow-up|0|||
23546214|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
23736856|NCT02712008|66412823|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23736857|NCT02712008|66412816|FG000|From Week 12 up to Week 36|Adverse Event|0|||
23546215|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
23736858|NCT02712008|66412817|FG001|From Week 12 up to Week 36|Adverse Event|0|||
23736859|NCT02712008|66412818|FG002|From Week 12 up to Week 36|Adverse Event|0|||
23736860|NCT02712008|66412819|FG003|From Week 12 up to Week 36|Adverse Event|0|||
23736861|NCT02712008|66412820|FG004|From Week 12 up to Week 36|Adverse Event|1|||
23736862|NCT02712008|66412821|FG005|From Week 12 up to Week 36|Adverse Event|0|||
23426980|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
23426981|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
23618876|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Death|1|||
23618877|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
23736863|NCT02712008|66412822|FG006|From Week 12 up to Week 36|Adverse Event|0|||
23736864|NCT02712008|66412823|FG007|From Week 12 up to Week 36|Adverse Event|2|||
23819877|NCT00143247|66721057|FG000|Overall Study|Death|8|||
23819878|NCT00143247|66721057|FG000|Overall Study|Adverse Event|19|||
23819879|NCT00143247|66721057|FG000|Overall Study|Lack of Efficacy|3|||
23819880|NCT00143247|66721057|FG000|Overall Study|Withdrawal by Subject|55|||
23819881|NCT00143247|66721057|FG000|Overall Study|Study terminated by sponsor|31|||
23819882|NCT00143247|66721057|FG000|Overall Study|Protocol Violation|15|||
23819883|NCT00143247|66721057|FG000|Overall Study|Lost to Follow-up|12|||
23819884|NCT00143247|66721057|FG000|Overall Study|following inaccurate lab adverse event|1|||
23819885|NCT00143247|66721057|FG000|Overall Study|Other|12|||
23819886|NCT04096040|66721060|FG000|Overall Study|Protocol Violation|12|||
23736865|NCT02712008|66412816|FG000|From Week 12 up to Week 36|Death|1|||
23736866|NCT02712008|66412817|FG001|From Week 12 up to Week 36|Death|0|||
23736867|NCT02712008|66412818|FG002|From Week 12 up to Week 36|Death|0|||
23736868|NCT02712008|66412819|FG003|From Week 12 up to Week 36|Death|0|||
23736869|NCT02712008|66412820|FG004|From Week 12 up to Week 36|Death|0|||
23736870|NCT02712008|66412821|FG005|From Week 12 up to Week 36|Death|0|||
23736871|NCT02712008|66412822|FG006|From Week 12 up to Week 36|Death|1|||
23736872|NCT02712008|66412823|FG007|From Week 12 up to Week 36|Death|0|||
23736873|NCT02712008|66412816|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736874|NCT02712008|66412817|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736875|NCT02712008|66412818|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736876|NCT02712008|66412819|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
23736877|NCT02712008|66412820|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736878|NCT02712008|66412821|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736879|NCT02712008|66412822|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
23736880|NCT02712008|66412823|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
23736881|NCT02712008|66412816|FG000|From Week 12 up to Week 36|Physician Decision|0|||
23736882|NCT02712008|66412817|FG001|From Week 12 up to Week 36|Physician Decision|0|||
23736883|NCT02712008|66412818|FG002|From Week 12 up to Week 36|Physician Decision|0|||
23736884|NCT02712008|66412819|FG003|From Week 12 up to Week 36|Physician Decision|1|||
23736885|NCT02712008|66412820|FG004|From Week 12 up to Week 36|Physician Decision|1|||
23736886|NCT02712008|66412821|FG005|From Week 12 up to Week 36|Physician Decision|0|||
23736887|NCT02712008|66412822|FG006|From Week 12 up to Week 36|Physician Decision|0|||
23736888|NCT02712008|66412823|FG007|From Week 12 up to Week 36|Physician Decision|0|||
23736889|NCT02712008|66412816|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736890|NCT02712008|66412817|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736891|NCT02712008|66412818|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736892|NCT02712008|66412819|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736893|NCT02712008|66412820|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736894|NCT02712008|66412821|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23736895|NCT02712008|66412822|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
23736896|NCT02712008|66412823|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
23736897|NCT01072500|66412824|FG000|Overall Study|Death|2|||
23736898|NCT01072500|66412825|FG001|Overall Study|Death|2|||
23736899|NCT01072500|66412824|FG000|Overall Study|Lost to Follow-up|5|||
23736900|NCT01072500|66412825|FG001|Overall Study|Lost to Follow-up|2|||
23736901|NCT01072500|66412824|FG000|Overall Study|Withdrawal by Subject|17|||
23736902|NCT01072500|66412825|FG001|Overall Study|Withdrawal by Subject|10|||
23736903|NCT01524900|66412826|FG000|Overall Study|Lost to Follow-up|3|||
23736904|NCT01524900|66412827|FG001|Overall Study|Lost to Follow-up|12|||
23736905|NCT01524900|66412828|FG002|Overall Study|Lost to Follow-up|1|||
23736906|NCT01524900|66412829|FG003|Overall Study|Lost to Follow-up|0|||
23819887|NCT04096040|66721060|FG000|Overall Study|Non-compliant site|4|||
23819888|NCT02123446|66721061|FG000|Washout Period (1 Day)|Physician Decision|1|||
23618878|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
23618879|NCT03193216|65991364|FG000|Overall Study|Lost to Follow-up|1|||
23736907|NCT01524900|66412830|FG004|Overall Study|Lost to Follow-up|0|||
23736908|NCT01524900|66412826|FG000|Overall Study|Other reason than stated above|1|||
23819889|NCT02123446|66721062|FG001|Washout Period (1 Day)|Physician Decision|0|||
23819890|NCT02460679|66721070|FG000|Overall Study|Investigator Decision|1|||
23819891|NCT02460679|66721070|FG000|Overall Study|Withdrawal by Subject|4|||
23736909|NCT01524900|66412827|FG001|Overall Study|Other reason than stated above|1|||
23736910|NCT01524900|66412828|FG002|Overall Study|Other reason than stated above|0|||
23736911|NCT01524900|66412829|FG003|Overall Study|Other reason than stated above|0|||
23736912|NCT01524900|66412830|FG004|Overall Study|Other reason than stated above|0|||
23736913|NCT01524900|66412826|FG000|Overall Study|No reason documented|2|||
23736914|NCT01524900|66412827|FG001|Overall Study|No reason documented|1|||
23736915|NCT01524900|66412828|FG002|Overall Study|No reason documented|0|||
23736916|NCT01524900|66412829|FG003|Overall Study|No reason documented|1|||
23736917|NCT01524900|66412830|FG004|Overall Study|No reason documented|0|||
23736918|NCT03137433|66412837|FG000|Overall Study|Withdrawal by Subject|11|||
23736919|NCT03137433|66412838|FG001|Overall Study|Withdrawal by Subject|11|||
23736920|NCT03137433|66412837|FG000|Overall Study|Lost to Follow-up|5|||
23736921|NCT03137433|66412838|FG001|Overall Study|Lost to Follow-up|6|||
23736922|NCT03137433|66412837|FG000|Overall Study|Physician Decision|2|||
23736923|NCT03137433|66412838|FG001|Overall Study|Physician Decision|0|||
23736924|NCT03137433|66412837|FG000|Overall Study|Moved out of study area|1|||
23736925|NCT03137433|66412838|FG001|Overall Study|Moved out of study area|0|||
23736926|NCT03137433|66412837|FG000|Overall Study|Too far out of window due to COVID|0|||
23736927|NCT03137433|66412838|FG001|Overall Study|Too far out of window due to COVID|1|||
23736928|NCT01078974|66416199|FG000|Overall Study|Adverse Event|3|||
23736929|NCT02499172|66416210|FG000|Overall Study|Financial reason|0|||
23819892|NCT01377012|66721071|FG000|Core Study|Study terminated by Sponsor|47|||
23819893|NCT01377012|66721072|FG001|Core Study|Study terminated by Sponsor|54|||
23819894|NCT01377012|66721073|FG002|Core Study|Study terminated by Sponsor|46|||
23819895|NCT01377012|66721071|FG000|Core Study|Technical problems|1|||
23819896|NCT01377012|66721072|FG001|Core Study|Technical problems|0|||
23819897|NCT01377012|66721073|FG002|Core Study|Technical problems|0|||
23736930|NCT02499172|66416211|FG001|Overall Study|Financial reason|0|||
23736931|NCT02499172|66416212|FG002|Overall Study|Financial reason|523|||
23736932|NCT02499172|66416213|FG003|Overall Study|Financial reason|436|||
23736933|NCT02499172|66416210|FG000|Overall Study|Lost to Follow-up|65|||
23736934|NCT02499172|66416211|FG001|Overall Study|Lost to Follow-up|64|||
23736935|NCT02499172|66416212|FG002|Overall Study|Lost to Follow-up|0|||
23736936|NCT02499172|66416213|FG003|Overall Study|Lost to Follow-up|0|||
23736937|NCT02611037|66416214|FG000|Overall Study|Withdrawal prior to treatment|2|||
23736938|NCT02611037|66416215|FG001|Overall Study|Withdrawal prior to treatment|0|||
23736939|NCT02909504|66416216|FG000|Overall Study|Adverse Event|2|||
23736940|NCT02909504|66416216|FG000|Overall Study|Lack of Efficacy|3|||
23736941|NCT02909504|66416216|FG000|Overall Study|Withdrawal by Subject|4|||
23736942|NCT02909504|66416216|FG000|Overall Study|Pregnancy|1|||
23736943|NCT02909504|66416216|FG000|Overall Study|Subject moved|1|||
23736944|NCT02909504|66416216|FG000|Overall Study|Lost to Follow-up|1|||
23736945|NCT03055806|66416220|FG000|Overall Study|Adverse Event|0|||
23819898|NCT01377012|66721071|FG000|Core Study|Withdrawal by Subject|15|||
23819899|NCT01377012|66721072|FG001|Core Study|Withdrawal by Subject|23|||
23819900|NCT01377012|66721073|FG002|Core Study|Withdrawal by Subject|18|||
23819901|NCT01377012|66721071|FG000|Core Study|Protocol Violation|7|||
23819902|NCT01377012|66721072|FG001|Core Study|Protocol Violation|3|||
23819903|NCT01377012|66721073|FG002|Core Study|Protocol Violation|2|||
23819904|NCT01377012|66721071|FG000|Core Study|Pregnancy|0|||
23819905|NCT01377012|66721072|FG001|Core Study|Pregnancy|0|||
23819906|NCT01377012|66721073|FG002|Core Study|Pregnancy|1|||
23819907|NCT01377012|66721071|FG000|Core Study|Physician Decision|5|||
23819908|NCT01377012|66721072|FG001|Core Study|Physician Decision|4|||
23819909|NCT01377012|66721073|FG002|Core Study|Physician Decision|10|||
23819910|NCT01377012|66721071|FG000|Core Study|Non-Compliant with study treatment|0|||
23819911|NCT01377012|66721072|FG001|Core Study|Non-Compliant with study treatment|0|||
23819912|NCT01377012|66721073|FG002|Core Study|Non-Compliant with study treatment|1|||
23819913|NCT01377012|66721071|FG000|Core Study|No Longer require treatment|0|||
23819914|NCT01377012|66721072|FG001|Core Study|No Longer require treatment|0|||
23819915|NCT01377012|66721073|FG002|Core Study|No Longer require treatment|1|||
23819916|NCT01377012|66721071|FG000|Core Study|Lost to Follow-up|7|||
23819917|NCT01377012|66721072|FG001|Core Study|Lost to Follow-up|5|||
23819918|NCT01377012|66721073|FG002|Core Study|Lost to Follow-up|4|||
23819919|NCT01377012|66721071|FG000|Core Study|Lack of Efficacy|41|||
23819920|NCT01377012|66721072|FG001|Core Study|Lack of Efficacy|28|||
23819921|NCT01377012|66721073|FG002|Core Study|Lack of Efficacy|37|||
23819922|NCT01377012|66721071|FG000|Core Study|Death|1|||
23819923|NCT01377012|66721072|FG001|Core Study|Death|1|||
23819924|NCT01377012|66721073|FG002|Core Study|Death|1|||
23618880|NCT03193216|65991365|FG001|Overall Study|Lost to Follow-up|0|||
23736946|NCT03055806|66416221|FG001|Overall Study|Adverse Event|0|||
23819925|NCT01377012|66721071|FG000|Core Study|Adverse Event|10|||
23819926|NCT01377012|66721072|FG001|Core Study|Adverse Event|14|||
23819927|NCT01377012|66721073|FG002|Core Study|Adverse Event|13|||
23819928|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
23819929|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
23819930|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
23736947|NCT03055806|66416222|FG002|Overall Study|Adverse Event|1|||
23736948|NCT03055806|66416223|FG003|Overall Study|Adverse Event|1|||
23736949|NCT03055806|66416220|FG000|Overall Study|Lost to Follow-up|0|||
23736950|NCT03055806|66416221|FG001|Overall Study|Lost to Follow-up|3|||
23736951|NCT03055806|66416222|FG002|Overall Study|Lost to Follow-up|6|||
23736952|NCT03055806|66416223|FG003|Overall Study|Lost to Follow-up|7|||
23736953|NCT03055806|66416220|FG000|Overall Study|Physician Decision|1|||
23736954|NCT03055806|66416221|FG001|Overall Study|Physician Decision|0|||
23736955|NCT03055806|66416222|FG002|Overall Study|Physician Decision|0|||
23736956|NCT03055806|66416223|FG003|Overall Study|Physician Decision|1|||
23736957|NCT03055806|66416220|FG000|Overall Study|Protocol Violation|1|||
23736958|NCT03055806|66416221|FG001|Overall Study|Protocol Violation|0|||
23736959|NCT03055806|66416222|FG002|Overall Study|Protocol Violation|0|||
23736960|NCT03055806|66416223|FG003|Overall Study|Protocol Violation|0|||
23736961|NCT03055806|66416220|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
23736962|NCT03055806|66416221|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
23546216|NCT00833638|65731014|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
23546217|NCT00833638|65731015|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
23546218|NCT00833638|65731016|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
23546219|NCT00833638|65731014|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
23546220|NCT00833638|65731015|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
23546221|NCT00833638|65731016|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
23546222|NCT03564496|65731017|FG000|Overall Study|Withdrawal by Subject|1|||
23546223|NCT03564496|65731018|FG001|Overall Study|Withdrawal by Subject|1|||
23546224|NCT03564496|65731019|FG002|Overall Study|Withdrawal by Subject|0|||
23546225|NCT03564496|65731017|FG000|Overall Study|Screen failure|0|||
23546226|NCT03564496|65731018|FG001|Overall Study|Screen failure|3|||
23546227|NCT03564496|65731019|FG002|Overall Study|Screen failure|0|||
23546228|NCT03694548|65731020|FG000|Part A Survey|Protocol Violation|3|||
23546229|NCT03694548|65731021|FG001|Part A Survey|Protocol Violation|3|||
23546230|NCT03694548|65731022|FG002|Part A Survey|Protocol Violation|0|||
23736963|NCT03055806|66416222|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
23546231|NCT03694548|65731020|FG000|Part B Yoga Program|Protocol Violation|0|||
23546232|NCT03694548|65731021|FG001|Part B Yoga Program|Protocol Violation|0|||
23546233|NCT03694548|65731022|FG002|Part B Yoga Program|Protocol Violation|3|||
23546234|NCT03694548|65731020|FG000|Part B Yoga Program|Did not attend intervention|0|||
23546235|NCT03694548|65731021|FG001|Part B Yoga Program|Did not attend intervention|0|||
23546236|NCT03694548|65731022|FG002|Part B Yoga Program|Did not attend intervention|8|||
23546237|NCT04831736|65731031|FG000|Overall Study|Withdrawal by Subject|0|||
23546238|NCT04831736|65731032|FG001|Overall Study|Withdrawal by Subject|1|||
23546239|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
23546240|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
23546241|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
23546242|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
23546243|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Other|2|||
23546244|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Other|0|||
23546245|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
23546246|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
23546247|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
23546248|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
23546249|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Other|1|||
23546250|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Other|0|||
23546251|NCT04139317|65731035|FG000|Overall Study|Adverse Event|10|||
23546252|NCT04139317|65731036|FG001|Overall Study|Adverse Event|2|||
23546253|NCT04139317|65731035|FG000|Overall Study|Death|6|||
23546254|NCT04139317|65731036|FG001|Overall Study|Death|4|||
23546255|NCT04139317|65731035|FG000|Overall Study|Lost to Follow-up|1|||
23546256|NCT04139317|65731036|FG001|Overall Study|Lost to Follow-up|0|||
23546257|NCT04139317|65731035|FG000|Overall Study|Physician Decision|3|||
23546258|NCT04139317|65731036|FG001|Overall Study|Physician Decision|1|||
23546259|NCT04139317|65731035|FG000|Overall Study|Progressive Disease|19|||
23546260|NCT04139317|65731036|FG001|Overall Study|Progressive Disease|9|||
23546261|NCT04139317|65731035|FG000|Overall Study|Subject Decision|2|||
23546262|NCT04139317|65731036|FG001|Overall Study|Subject Decision|2|||
23546263|NCT04820673|65731037|FG000|Overall Study|Adverse Event|6|||
23546264|NCT04820673|65731037|FG000|Overall Study|Due to Lack of Effectiveness|1|||
23546265|NCT04820673|65731037|FG000|Overall Study|Pregnancy|1|||
23546266|NCT04820673|65731037|FG000|Overall Study|Voluntary Withdrawal|20|||
23546267|NCT04820673|65731037|FG000|Overall Study|Lost to Follow-up|10|||
23546268|NCT00288587|65731042|FG000|Overall Study|Death|4|||
23546269|NCT00288587|65731043|FG001|Overall Study|Death|4|||
23546270|NCT00288587|65731042|FG000|Overall Study|Transplant|0|||
23546271|NCT00288587|65731043|FG001|Overall Study|Transplant|3|||
23546272|NCT00288587|65731042|FG000|Overall Study|Adverse Event|0|||
23546273|NCT00288587|65731043|FG001|Overall Study|Adverse Event|1|||
23736964|NCT03055806|66416223|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
23736965|NCT03055806|66416220|FG000|Overall Study|Withdrawal of consent to continue study|2|||
23736966|NCT03055806|66416221|FG001|Overall Study|Withdrawal of consent to continue study|3|||
23736967|NCT03055806|66416222|FG002|Overall Study|Withdrawal of consent to continue study|4|||
23736968|NCT03055806|66416223|FG003|Overall Study|Withdrawal of consent to continue study|6|||
23736969|NCT03055806|66416220|FG000|Overall Study|Partner not willing to try intercourse|1|||
23736970|NCT03055806|66416221|FG001|Overall Study|Partner not willing to try intercourse|0|||
23736971|NCT03055806|66416222|FG002|Overall Study|Partner not willing to try intercourse|0|||
23736972|NCT03055806|66416223|FG003|Overall Study|Partner not willing to try intercourse|0|||
23736973|NCT00440232|66416229|FG000|Overall Study|Lost to Follow-up|1|||
23736974|NCT00440232|66416230|FG001|Overall Study|Lost to Follow-up|1|||
23736975|NCT00440232|66416229|FG000|Overall Study|Unable to treat within allowed time|0|||
23736976|NCT00440232|66416230|FG001|Overall Study|Unable to treat within allowed time|1|||
23736977|NCT00440232|66416229|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
23736978|NCT00440232|66416230|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
23736979|NCT01796106|66416231|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
23736980|NCT01796106|66416232|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
23736981|NCT00702949|66416233|FG000|Overall Study|Refusal|3|||
23736982|NCT00702949|66416234|FG001|Overall Study|Refusal|2|||
23736983|NCT00702949|66416235|FG002|Overall Study|Refusal|2|||
23736984|NCT00702949|66416233|FG000|Overall Study|Adverse Event|1|||
23736985|NCT00702949|66416234|FG001|Overall Study|Adverse Event|6|||
23736986|NCT00702949|66416235|FG002|Overall Study|Adverse Event|3|||
23736987|NCT00702949|66416233|FG000|Overall Study|Other Medical Reason/unknown|1|||
23736988|NCT00702949|66416234|FG001|Overall Study|Other Medical Reason/unknown|1|||
23736989|NCT00702949|66416235|FG002|Overall Study|Other Medical Reason/unknown|3|||
23736990|NCT02364999|66416236|FG000|Overall Study|Death|136|||
23736991|NCT02364999|66416237|FG001|Overall Study|Death|138|||
23736992|NCT02364999|66416236|FG000|Overall Study|Lost to Follow-up|10|||
23736993|NCT02364999|66416237|FG001|Overall Study|Lost to Follow-up|15|||
23736994|NCT02364999|66416236|FG000|Overall Study|Protocol Violation|3|||
23736995|NCT02364999|66416237|FG001|Overall Study|Protocol Violation|2|||
23736996|NCT02364999|66416236|FG000|Overall Study|Withdrawal by Subject|14|||
23736997|NCT02364999|66416237|FG001|Overall Study|Withdrawal by Subject|14|||
23736998|NCT02364999|66416236|FG000|Overall Study|Other|0|||
23736999|NCT02364999|66416237|FG001|Overall Study|Other|1|||
23737000|NCT02364999|66416236|FG000|Overall Study|Randomized but did not receive treatment|2|||
23737001|NCT02364999|66416237|FG001|Overall Study|Randomized but did not receive treatment|3|||
23737002|NCT00606021|66416238|FG000|Induction Phase|Death|73|||
23737003|NCT00606021|66416239|FG001|Induction Phase|Death|0|||
23737004|NCT00606021|66416240|FG002|Induction Phase|Death|0|||
23737005|NCT00606021|66416238|FG000|Induction Phase|Physician Decision|2|||
23737006|NCT00606021|66416239|FG001|Induction Phase|Physician Decision|0|||
23546274|NCT00288587|65731042|FG000|Overall Study|Physician Decision|0|||
23546275|NCT00288587|65731043|FG001|Overall Study|Physician Decision|2|||
23546276|NCT00288587|65731042|FG000|Overall Study|Severe Aortic Stenosis|1|||
23546277|NCT00288587|65731043|FG001|Overall Study|Severe Aortic Stenosis|0|||
23546278|NCT02076009|65731044|FG000|Overall Study|Death|172|||
23546279|NCT02076009|65731045|FG001|Overall Study|Death|153|||
23737007|NCT00606021|66416240|FG002|Induction Phase|Physician Decision|0|||
23737008|NCT00606021|66416238|FG000|Induction Phase|Withdrawal by Subject|2|||
23737009|NCT00606021|66416239|FG001|Induction Phase|Withdrawal by Subject|0|||
23737010|NCT00606021|66416240|FG002|Induction Phase|Withdrawal by Subject|0|||
23737011|NCT00606021|66416238|FG000|Induction Phase|Lost to Follow-up|10|||
23737012|NCT00606021|66416239|FG001|Induction Phase|Lost to Follow-up|0|||
23737013|NCT00606021|66416240|FG002|Induction Phase|Lost to Follow-up|0|||
23737014|NCT00606021|66416238|FG000|Maintenance Phase|Death|0|||
23546280|NCT02076009|65731044|FG000|Overall Study|Withdrawal by Subject|16|||
23546281|NCT02076009|65731045|FG001|Overall Study|Withdrawal by Subject|12|||
23737015|NCT00606021|66416239|FG001|Maintenance Phase|Death|17|||
23737016|NCT00606021|66416240|FG002|Maintenance Phase|Death|15|||
23737017|NCT00606021|66416238|FG000|Maintenance Phase|Physician Decision|0|||
23737018|NCT00606021|66416239|FG001|Maintenance Phase|Physician Decision|1|||
23737019|NCT00606021|66416240|FG002|Maintenance Phase|Physician Decision|0|||
23546282|NCT02076009|65731044|FG000|Overall Study|Lost to Follow-up|4|||
23737020|NCT00606021|66416238|FG000|Maintenance Phase|Lost to Follow-up|0|||
23737021|NCT00606021|66416239|FG001|Maintenance Phase|Lost to Follow-up|5|||
23737022|NCT00606021|66416240|FG002|Maintenance Phase|Lost to Follow-up|2|||
23737023|NCT02728804|66416245|FG000|Overall Study|Ineligible|3|||
23737024|NCT02728804|66416245|FG000|Overall Study|Did not complete baseline questionnaire|9|||
23737025|NCT02728804|66416245|FG000|Overall Study|Death|99|||
23737026|NCT02993731|66416259|FG000|Overall Study|Study Termination|101|||
23737027|NCT02993731|66416260|FG001|Overall Study|Study Termination|105|||
23737028|NCT01259388|66416261|FG000|Overall Study|Adverse Event|3|||
23737029|NCT01259388|66416262|FG001|Overall Study|Adverse Event|0|||
23546283|NCT02076009|65731045|FG001|Overall Study|Lost to Follow-up|2|||
23737030|NCT01259388|66416261|FG000|Overall Study|Withdrawal by Subject|1|||
23737031|NCT01259388|66416262|FG001|Overall Study|Withdrawal by Subject|1|||
23737032|NCT01259388|66416261|FG000|Overall Study|Physician Decision|1|||
23737033|NCT01259388|66416262|FG001|Overall Study|Physician Decision|0|||
23737034|NCT01716585|66416263|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
23737035|NCT01716585|66416264|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
23737036|NCT01716585|66416263|FG000|Double-blind Treatment|Adverse Event|2|||
23737037|NCT01716585|66416264|FG001|Double-blind Treatment|Adverse Event|1|||
23737038|NCT01716585|66416263|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
23737039|NCT01716585|66416264|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
23737040|NCT01716585|66416263|FG000|Double-blind Treatment|Lost to Follow-up|2|||
23737041|NCT01716585|66416264|FG001|Double-blind Treatment|Lost to Follow-up|0|||
23737042|NCT01716585|66416263|FG000|Double-blind Treatment|Subject Noncompliant|1|||
23737043|NCT01716585|66416264|FG001|Double-blind Treatment|Subject Noncompliant|0|||
23737044|NCT01716585|66416263|FG000|Double-blind Treatment|Other|1|||
23737045|NCT01716585|66416264|FG001|Double-blind Treatment|Other|0|||
23737046|NCT01716585|66416263|FG000|Open-label Treatment|Adverse Event|0|||
23737047|NCT01716585|66416264|FG001|Open-label Treatment|Adverse Event|2|||
23737048|NCT01716585|66416263|FG000|Open-label Treatment|Virologic Failure|0|||
23737049|NCT01716585|66416264|FG001|Open-label Treatment|Virologic Failure|2|||
23737050|NCT01716585|66416263|FG000|Open-label Treatment|Withdrawal by Subject|0|||
23737051|NCT01716585|66416264|FG001|Open-label Treatment|Withdrawal by Subject|3|||
23737052|NCT00917553|66416265|FG000|Overall Study|Lost to Follow-up|2|||
23737053|NCT00917553|66416266|FG001|Overall Study|Lost to Follow-up|1|||
23737054|NCT01277666|66416279|FG000|Overall Study|Adverse Event|26|||
23737055|NCT01277666|66416280|FG001|Overall Study|Adverse Event|25|||
23737056|NCT01277666|66416281|FG002|Overall Study|Adverse Event|20|||
23737057|NCT01277666|66416279|FG000|Overall Study|Lack of Efficacy|8|||
23737058|NCT01277666|66416280|FG001|Overall Study|Lack of Efficacy|20|||
23737059|NCT01277666|66416281|FG002|Overall Study|Lack of Efficacy|12|||
23737060|NCT01277666|66416279|FG000|Overall Study|Protocol Violation|2|||
23737061|NCT01277666|66416280|FG001|Overall Study|Protocol Violation|3|||
23737062|NCT01277666|66416281|FG002|Overall Study|Protocol Violation|2|||
23737063|NCT01277666|66416279|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
23737064|NCT01277666|66416280|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
23737065|NCT01277666|66416281|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
23737066|NCT01277666|66416279|FG000|Overall Study|Lost to Follow-up|1|||
23737067|NCT01277666|66416280|FG001|Overall Study|Lost to Follow-up|1|||
23737068|NCT01277666|66416281|FG002|Overall Study|Lost to Follow-up|2|||
23737069|NCT01277666|66416279|FG000|Overall Study|Withdrawal by Subject|7|||
23737070|NCT01277666|66416280|FG001|Overall Study|Withdrawal by Subject|8|||
23737071|NCT01277666|66416281|FG002|Overall Study|Withdrawal by Subject|6|||
23737072|NCT01277666|66416279|FG000|Overall Study|Death|0|||
23737073|NCT01277666|66416280|FG001|Overall Study|Death|0|||
23737074|NCT01277666|66416281|FG002|Overall Study|Death|1|||
23737075|NCT02363322|66416282|FG000|Overall Study|Lost to Follow-up|1|||
23737076|NCT02363322|66416283|FG001|Overall Study|Lost to Follow-up|0|||
23737077|NCT01265511|66416286|FG000|Overall Study|Lack of Efficacy|2|||
23737078|NCT01265511|66416287|FG001|Overall Study|Lack of Efficacy|1|||
23737079|NCT01265511|66416286|FG000|Overall Study|Met stopping rules|0|||
23737080|NCT01265511|66416287|FG001|Overall Study|Met stopping rules|2|||
23737081|NCT00591786|66416288|FG000|Overall Study|Withdrawal of Informed Consent|0|||
23737082|NCT00591786|66416289|FG001|Overall Study|Withdrawal of Informed Consent|0|||
23737083|NCT00591786|66416290|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23737084|NCT00591786|66416291|FG003|Overall Study|Withdrawal of Informed Consent|0|||
23737085|NCT00591786|66416292|FG004|Overall Study|Withdrawal of Informed Consent|0|||
23737086|NCT00591786|66416293|FG005|Overall Study|Withdrawal of Informed Consent|0|||
23737087|NCT00591786|66416294|FG006|Overall Study|Withdrawal of Informed Consent|0|||
23737088|NCT00591786|66416295|FG007|Overall Study|Withdrawal of Informed Consent|0|||
23737089|NCT00591786|66416296|FG008|Overall Study|Withdrawal of Informed Consent|0|||
23737090|NCT00591786|66416297|FG009|Overall Study|Withdrawal of Informed Consent|0|||
23737091|NCT01117428|66416298|FG000|Overall Study|Lack of Efficacy|1|||
23737092|NCT01117428|66416299|FG001|Overall Study|Lack of Efficacy|0|||
23737093|NCT01117428|66416300|FG002|Overall Study|Lack of Efficacy|0|||
23737094|NCT01117428|66416301|FG003|Overall Study|Lack of Efficacy|0|||
23737095|NCT01117428|66416302|FG004|Overall Study|Lack of Efficacy|0|||
23737096|NCT01117428|66416303|FG005|Overall Study|Lack of Efficacy|0|||
23737097|NCT01117428|66416298|FG000|Overall Study|Adverse Event|4|||
23737098|NCT01117428|66416299|FG001|Overall Study|Adverse Event|0|||
23737099|NCT01117428|66416300|FG002|Overall Study|Adverse Event|0|||
23737100|NCT01117428|66416301|FG003|Overall Study|Adverse Event|0|||
23737101|NCT01117428|66416302|FG004|Overall Study|Adverse Event|1|||
23737102|NCT01117428|66416303|FG005|Overall Study|Adverse Event|2|||
23737103|NCT01117428|66416298|FG000|Overall Study|Death|0|||
23737104|NCT01117428|66416299|FG001|Overall Study|Death|1|||
23737105|NCT01117428|66416300|FG002|Overall Study|Death|2|||
23737106|NCT01117428|66416301|FG003|Overall Study|Death|0|||
23737107|NCT01117428|66416302|FG004|Overall Study|Death|0|||
23737108|NCT01117428|66416303|FG005|Overall Study|Death|1|||
23737109|NCT01117428|66416298|FG000|Overall Study|Physician Decision|0|||
23737110|NCT01117428|66416299|FG001|Overall Study|Physician Decision|1|||
23737111|NCT01117428|66416300|FG002|Overall Study|Physician Decision|0|||
23737112|NCT01117428|66416301|FG003|Overall Study|Physician Decision|0|||
23737113|NCT01117428|66416302|FG004|Overall Study|Physician Decision|0|||
23737114|NCT01117428|66416303|FG005|Overall Study|Physician Decision|0|||
23737115|NCT01117428|66416298|FG000|Overall Study|Withdrawal by Subject|0|||
23737116|NCT01117428|66416299|FG001|Overall Study|Withdrawal by Subject|0|||
23737117|NCT01117428|66416300|FG002|Overall Study|Withdrawal by Subject|1|||
23737118|NCT01117428|66416301|FG003|Overall Study|Withdrawal by Subject|0|||
23737119|NCT01117428|66416302|FG004|Overall Study|Withdrawal by Subject|0|||
23737120|NCT01117428|66416303|FG005|Overall Study|Withdrawal by Subject|0|||
23737121|NCT01117428|66416298|FG000|Overall Study|Progressive disease|15|||
23737122|NCT01117428|66416299|FG001|Overall Study|Progressive disease|27|||
23737123|NCT01117428|66416300|FG002|Overall Study|Progressive disease|10|||
23737124|NCT01117428|66416301|FG003|Overall Study|Progressive disease|12|||
23737125|NCT01117428|66416302|FG004|Overall Study|Progressive disease|16|||
23737126|NCT01117428|66416303|FG005|Overall Study|Progressive disease|17|||
23737127|NCT00495794|66416304|FG000|Overall Study|Pharmacist did not activate patient|522|||
23737128|NCT00495794|66416305|FG001|Overall Study|Pharmacist did not activate patient|0|||
23737129|NCT02058966|66416307|FG000|Open-Label Methamphetamine|Adverse Event|1|||
23737130|NCT02058966|66416307|FG000|First Intervention|Withdrawal by Subject|1|||
23737131|NCT00963820|66416308|FG000|Dose Escalation Phase|Progressive Disease|3|||
23737132|NCT00963820|66416309|FG001|Dose Escalation Phase|Progressive Disease|3|||
23737133|NCT00963820|66416310|FG002|Dose Escalation Phase|Progressive Disease|3|||
23737134|NCT00963820|66416311|FG003|Dose Escalation Phase|Progressive Disease|3|||
23737135|NCT00963820|66416312|FG004|Dose Escalation Phase|Progressive Disease|4|||
23737136|NCT00963820|66416313|FG005|Dose Escalation Phase|Progressive Disease|3|||
23737137|NCT00963820|66416314|FG006|Dose Escalation Phase|Progressive Disease|3|||
23737138|NCT00963820|66416315|FG007|Dose Escalation Phase|Progressive Disease|2|||
23737139|NCT00963820|66416316|FG008|Dose Escalation Phase|Progressive Disease|0|||
23737140|NCT00963820|66416317|FG009|Dose Escalation Phase|Progressive Disease|0|||
23737141|NCT00963820|66416318|FG010|Dose Escalation Phase|Progressive Disease|0|||
23737142|NCT00963820|66416319|FG011|Dose Escalation Phase|Progressive Disease|0|||
23737143|NCT00963820|66416308|FG000|Dose Escalation Phase|Adverse Event|0|||
23546284|NCT02076009|65731044|FG000|Overall Study|Progressive Disease|1|||
23546285|NCT02076009|65731045|FG001|Overall Study|Progressive Disease|0|||
23546286|NCT02076009|65731044|FG000|Overall Study|Physician Decision|0|||
23546287|NCT02076009|65731045|FG001|Overall Study|Physician Decision|1|||
23546288|NCT02076009|65731044|FG000|Overall Study|End of data collection|90|||
23546289|NCT02076009|65731045|FG001|Overall Study|End of data collection|118|||
23546290|NCT01517802|65731051|FG000|Overall Study|Death|1|||
23546291|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
23546292|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
23546293|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
23546294|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
23546295|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
23546296|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
23546297|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
23546298|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
23546299|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
23546300|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
23546301|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
23546302|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
23546303|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
23546304|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
23546305|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
23546306|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
23546307|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
23546308|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
23546309|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23618881|NCT03193216|65991364|FG000|Overall Study|Withdrawal by Subject|5|||
23618882|NCT03193216|65991365|FG001|Overall Study|Withdrawal by Subject|0|||
23737144|NCT00963820|66416309|FG001|Dose Escalation Phase|Adverse Event|0|||
23737145|NCT00963820|66416310|FG002|Dose Escalation Phase|Adverse Event|0|||
23737146|NCT00963820|66416311|FG003|Dose Escalation Phase|Adverse Event|0|||
23737147|NCT00963820|66416312|FG004|Dose Escalation Phase|Adverse Event|0|||
23737148|NCT00963820|66416313|FG005|Dose Escalation Phase|Adverse Event|0|||
23737149|NCT00963820|66416314|FG006|Dose Escalation Phase|Adverse Event|3|||
23737150|NCT00963820|66416315|FG007|Dose Escalation Phase|Adverse Event|1|||
23737151|NCT00963820|66416316|FG008|Dose Escalation Phase|Adverse Event|0|||
23737152|NCT00963820|66416317|FG009|Dose Escalation Phase|Adverse Event|0|||
23546310|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
23546311|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
23546312|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23546313|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
23546314|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
23546315|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23546316|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Adverse Event|9|||
23546317|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Adverse Event|14|||
23546318|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23546319|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
23737153|NCT00963820|66416318|FG010|Dose Escalation Phase|Adverse Event|0|||
23737154|NCT00963820|66416319|FG011|Dose Escalation Phase|Adverse Event|0|||
23546320|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
23546321|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
23546322|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
23546323|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
23737155|NCT00963820|66416308|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23737156|NCT00963820|66416309|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23737157|NCT00963820|66416310|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23737158|NCT00963820|66416311|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23737159|NCT00963820|66416312|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23737160|NCT00963820|66416313|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
23737161|NCT00963820|66416314|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
23737162|NCT00963820|66416315|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
23737163|NCT00963820|66416316|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
23737164|NCT00963820|66416317|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
23737165|NCT00963820|66416318|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
23737166|NCT00963820|66416319|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
23737167|NCT00963820|66416308|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737168|NCT00963820|66416309|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737169|NCT00963820|66416310|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737170|NCT00963820|66416311|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737171|NCT00963820|66416312|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737172|NCT00963820|66416313|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737173|NCT00963820|66416314|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23737174|NCT00963820|66416315|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737175|NCT00963820|66416316|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23546324|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
23737176|NCT00963820|66416317|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737177|NCT00963820|66416318|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737178|NCT00963820|66416319|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23737179|NCT00963820|66416308|FG000|Expansion Phase|Progressive Disease|0|||
23737180|NCT00963820|66416309|FG001|Expansion Phase|Progressive Disease|0|||
23737181|NCT00963820|66416310|FG002|Expansion Phase|Progressive Disease|0|||
23737182|NCT00963820|66416311|FG003|Expansion Phase|Progressive Disease|0|||
23737183|NCT00963820|66416312|FG004|Expansion Phase|Progressive Disease|0|||
23737184|NCT00963820|66416313|FG005|Expansion Phase|Progressive Disease|0|||
23737185|NCT00963820|66416314|FG006|Expansion Phase|Progressive Disease|0|||
23737186|NCT00963820|66416315|FG007|Expansion Phase|Progressive Disease|0|||
23737187|NCT00963820|66416316|FG008|Expansion Phase|Progressive Disease|8|||
23737188|NCT00963820|66416317|FG009|Expansion Phase|Progressive Disease|6|||
23737189|NCT00963820|66416318|FG010|Expansion Phase|Progressive Disease|4|||
23737190|NCT00963820|66416319|FG011|Expansion Phase|Progressive Disease|2|||
23737191|NCT00963820|66416308|FG000|Expansion Phase|Adverse Event|0|||
23737192|NCT00963820|66416309|FG001|Expansion Phase|Adverse Event|0|||
23737193|NCT00963820|66416310|FG002|Expansion Phase|Adverse Event|0|||
23426982|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
23546325|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
23546326|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
23546327|NCT02014116|65731060|FG000|Overall Study|Progressive Disease|3|||
23546328|NCT02014116|65731061|FG001|Overall Study|Progressive Disease|4|||
23546329|NCT02014116|65731062|FG002|Overall Study|Progressive Disease|2|||
23546330|NCT02014116|65731063|FG003|Overall Study|Progressive Disease|6|||
23546331|NCT02014116|65731064|FG004|Overall Study|Progressive Disease|1|||
23737194|NCT00963820|66416311|FG003|Expansion Phase|Adverse Event|0|||
23737195|NCT00963820|66416312|FG004|Expansion Phase|Adverse Event|0|||
23737196|NCT00963820|66416313|FG005|Expansion Phase|Adverse Event|0|||
23737197|NCT00963820|66416314|FG006|Expansion Phase|Adverse Event|0|||
23737198|NCT00963820|66416315|FG007|Expansion Phase|Adverse Event|0|||
23737199|NCT00963820|66416316|FG008|Expansion Phase|Adverse Event|1|||
23737200|NCT00963820|66416317|FG009|Expansion Phase|Adverse Event|3|||
23737201|NCT00963820|66416318|FG010|Expansion Phase|Adverse Event|0|||
23546332|NCT02014116|65731065|FG005|Overall Study|Progressive Disease|13|||
23546333|NCT02014116|65731066|FG006|Overall Study|Progressive Disease|1|||
23546334|NCT02014116|65731067|FG007|Overall Study|Progressive Disease|3|||
23546335|NCT02014116|65731068|FG008|Overall Study|Progressive Disease|7|||
23546336|NCT02014116|65731060|FG000|Overall Study|Adverse Event|0|||
23546337|NCT02014116|65731061|FG001|Overall Study|Adverse Event|0|||
23546338|NCT02014116|65731062|FG002|Overall Study|Adverse Event|0|||
23546339|NCT02014116|65731063|FG003|Overall Study|Adverse Event|0|||
23546340|NCT02014116|65731064|FG004|Overall Study|Adverse Event|1|||
23546341|NCT02014116|65731065|FG005|Overall Study|Adverse Event|0|||
23546342|NCT02014116|65731066|FG006|Overall Study|Adverse Event|0|||
23546343|NCT02014116|65731067|FG007|Overall Study|Adverse Event|1|||
23546344|NCT02014116|65731068|FG008|Overall Study|Adverse Event|0|||
23546345|NCT02014116|65731060|FG000|Overall Study|Lost to Follow-up|0|||
23546346|NCT02014116|65731061|FG001|Overall Study|Lost to Follow-up|0|||
23546347|NCT02014116|65731062|FG002|Overall Study|Lost to Follow-up|0|||
23546348|NCT02014116|65731063|FG003|Overall Study|Lost to Follow-up|0|||
23546349|NCT02014116|65731064|FG004|Overall Study|Lost to Follow-up|0|||
23546350|NCT02014116|65731065|FG005|Overall Study|Lost to Follow-up|1|||
23546351|NCT02014116|65731066|FG006|Overall Study|Lost to Follow-up|0|||
23546352|NCT02014116|65731067|FG007|Overall Study|Lost to Follow-up|0|||
23546353|NCT02014116|65731068|FG008|Overall Study|Lost to Follow-up|1|||
23546354|NCT02014116|65731060|FG000|Overall Study|Death|0|||
23546355|NCT02014116|65731061|FG001|Overall Study|Death|0|||
23546356|NCT02014116|65731062|FG002|Overall Study|Death|0|||
23618883|NCT03193216|65991364|FG000|Overall Study|Physician Decision|4|||
23618884|NCT03193216|65991365|FG001|Overall Study|Physician Decision|0|||
23618885|NCT02299427|65991366|FG000|Overall Study|Withdrawal by Subject|1|||
23819931|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
23819932|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
23819933|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
23819934|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
23819935|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
23819936|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
23819937|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
23819938|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
23819939|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
23819940|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
23819941|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
23819942|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
23819943|NCT01377012|66721071|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
23819944|NCT01377012|66721072|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
23819945|NCT01377012|66721073|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
23819946|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
23819947|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
23819948|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
23819949|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
23819950|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
23819951|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
23819952|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
23819953|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
23819954|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
23819955|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
23819956|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
23819957|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
23819958|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
23819959|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
23819960|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
23426983|NCT00642369|65307501|FG000|Overall Study|Adverse Event|2|||
23546357|NCT02014116|65731063|FG003|Overall Study|Death|0|||
23546358|NCT02014116|65731064|FG004|Overall Study|Death|0|||
23546359|NCT02014116|65731065|FG005|Overall Study|Death|0|||
23546360|NCT02014116|65731066|FG006|Overall Study|Death|0|||
23618886|NCT02299427|65991367|FG001|Overall Study|Withdrawal by Subject|0|||
23618887|NCT02299427|65991366|FG000|Overall Study|Lost to Follow-up|1|||
23546361|NCT02014116|65731067|FG007|Overall Study|Death|1|||
23546362|NCT02014116|65731068|FG008|Overall Study|Death|1|||
23546363|NCT02014116|65731060|FG000|Overall Study|Withdrawal by Subject|0|||
23546364|NCT02014116|65731061|FG001|Overall Study|Withdrawal by Subject|0|||
23546365|NCT02014116|65731062|FG002|Overall Study|Withdrawal by Subject|1|||
23546366|NCT02014116|65731063|FG003|Overall Study|Withdrawal by Subject|1|||
23546367|NCT02014116|65731064|FG004|Overall Study|Withdrawal by Subject|0|||
23546368|NCT02014116|65731065|FG005|Overall Study|Withdrawal by Subject|1|||
23546369|NCT02014116|65731066|FG006|Overall Study|Withdrawal by Subject|0|||
23546370|NCT02014116|65731067|FG007|Overall Study|Withdrawal by Subject|0|||
23546371|NCT02014116|65731068|FG008|Overall Study|Withdrawal by Subject|0|||
23546372|NCT02014116|65731060|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
23546373|NCT02014116|65731061|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
23546374|NCT02014116|65731062|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
23546375|NCT02014116|65731063|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
23546376|NCT02014116|65731064|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
23546377|NCT02014116|65731065|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
23546378|NCT02014116|65731066|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
23546379|NCT02014116|65731067|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
23546380|NCT02014116|65731068|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
23546381|NCT02014116|65731060|FG000|Overall Study|Physician Decision|0|||
23737202|NCT00963820|66416319|FG011|Expansion Phase|Adverse Event|0|||
23737203|NCT00963820|66416308|FG000|Expansion Phase|Withdrawal by Subject|0|||
23737204|NCT00963820|66416309|FG001|Expansion Phase|Withdrawal by Subject|0|||
23737205|NCT00963820|66416310|FG002|Expansion Phase|Withdrawal by Subject|0|||
23737206|NCT00963820|66416311|FG003|Expansion Phase|Withdrawal by Subject|0|||
23737207|NCT00963820|66416312|FG004|Expansion Phase|Withdrawal by Subject|0|||
23737208|NCT00963820|66416313|FG005|Expansion Phase|Withdrawal by Subject|0|||
23737209|NCT00963820|66416314|FG006|Expansion Phase|Withdrawal by Subject|0|||
23737210|NCT00963820|66416315|FG007|Expansion Phase|Withdrawal by Subject|0|||
23737211|NCT00963820|66416316|FG008|Expansion Phase|Withdrawal by Subject|1|||
23737212|NCT00963820|66416317|FG009|Expansion Phase|Withdrawal by Subject|0|||
23737213|NCT00963820|66416318|FG010|Expansion Phase|Withdrawal by Subject|1|||
23737214|NCT00963820|66416319|FG011|Expansion Phase|Withdrawal by Subject|1|||
23737215|NCT00963820|66416308|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737216|NCT00963820|66416309|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737217|NCT00963820|66416310|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737218|NCT00963820|66416311|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737219|NCT00963820|66416312|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737220|NCT00963820|66416313|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737221|NCT00963820|66416314|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737222|NCT00963820|66416315|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737223|NCT00963820|66416316|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737224|NCT00963820|66416317|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737225|NCT00963820|66416318|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23737226|NCT00963820|66416319|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
23737227|NCT01024946|66416324|FG000|Overall Study|Screen Failure|3|||
23737228|NCT01024946|66416324|FG000|Overall Study|Withdrawal by Subject|1|||
23737229|NCT01024946|66416324|FG000|Overall Study|Adverse Event|1|||
23737230|NCT00760994|66416326|FG000|Overall Study|Lost to Follow-up|4|||
23737231|NCT00760994|66416327|FG001|Overall Study|Lost to Follow-up|4|||
23546382|NCT02014116|65731061|FG001|Overall Study|Physician Decision|0|||
23546383|NCT02014116|65731062|FG002|Overall Study|Physician Decision|0|||
23546384|NCT02014116|65731063|FG003|Overall Study|Physician Decision|0|||
23546385|NCT02014116|65731064|FG004|Overall Study|Physician Decision|0|||
23546386|NCT02014116|65731065|FG005|Overall Study|Physician Decision|0|||
23546387|NCT02014116|65731066|FG006|Overall Study|Physician Decision|0|||
23546388|NCT02014116|65731067|FG007|Overall Study|Physician Decision|0|||
23546389|NCT02014116|65731068|FG008|Overall Study|Physician Decision|1|||
23546390|NCT04798781|65731069|FG000|Overall Study|Withdrawal by Subject|1|||
23546391|NCT01159938|65731074|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546392|NCT01159938|65731075|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546393|NCT01159938|65731076|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
23546394|NCT01159938|65731077|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546395|NCT01159938|65731078|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546396|NCT01434602|65731082|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23618888|NCT02299427|65991367|FG001|Overall Study|Lost to Follow-up|3|||
23546397|NCT01434602|65731083|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
23546398|NCT01434602|65731084|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23582205|NCT01094171|65862382|FG000|Overall Study|Migration from the study area|3|||
23737232|NCT00760994|66416328|FG002|Overall Study|Lost to Follow-up|3|||
23737233|NCT01990339|66416329|FG000|Overall Study|Data Not Available|49|||
23737234|NCT01990339|66416329|FG000|Overall Study|Voluntary Withdrawal|1402|||
23737235|NCT01990339|66416329|FG000|Overall Study|Lost to Follow-up|861|||
23737236|NCT02041533|66416330|FG000|Pre-Treatment Period|Disease Progression|1|||
23737237|NCT02041533|66416331|FG001|Pre-Treatment Period|Disease Progression|1|||
23546399|NCT01434602|65731085|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23546400|NCT01434602|65731086|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23546401|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546402|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546403|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546404|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
23546405|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546406|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546407|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546408|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546409|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
23819961|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
23819962|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
23737238|NCT02041533|66416330|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
23737239|NCT02041533|66416331|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
23737240|NCT02041533|66416330|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
23737241|NCT02041533|66416331|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
23737242|NCT02041533|66416330|FG000|Treatment Period|Disease progression|189|||
23737243|NCT02041533|66416331|FG001|Treatment Period|Disease progression|146|||
23737244|NCT02041533|66416330|FG000|Treatment Period|Study drug toxicity|30|||
23737245|NCT02041533|66416331|FG001|Treatment Period|Study drug toxicity|34|||
23737246|NCT02041533|66416330|FG000|Treatment Period|Death|1|||
23737247|NCT02041533|66416331|FG001|Treatment Period|Death|0|||
23737248|NCT02041533|66416330|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
23819963|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
23819964|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
23819965|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
23819966|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
23819967|NCT04040192|66721074|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
23819968|NCT04040192|66721075|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
23819969|NCT04040192|66721076|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
23819970|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
23819971|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
23819972|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
23819973|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
23819974|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
23819975|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
23819976|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
23819977|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
23819978|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
23546410|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23618889|NCT02299427|65991366|FG000|Overall Study|not adherent to dog website use|21|||
23618890|NCT02299427|65991367|FG001|Overall Study|not adherent to dog website use|0|||
23618891|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Death|0|||
23618892|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Death|1|||
23618893|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Adverse Event|0|||
23618894|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Adverse Event|2|||
23618895|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
23618896|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
23618897|NCT02262364|65991377|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
23618898|NCT02329223|65991380|FG000|Overall Study|Withdrawal by Subject|1|||
23737249|NCT02041533|66416331|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
23737250|NCT02041533|66416330|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
23737251|NCT02041533|66416331|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
23737252|NCT02041533|66416330|FG000|Treatment Period|Participant withdrew consent|2|||
23819979|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
23819980|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
23819981|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
23819982|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23819983|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
23819984|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
23819985|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
23819986|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
23618899|NCT02329223|65991381|FG001|Overall Study|Withdrawal by Subject|2|||
23618900|NCT02329223|65991382|FG002|Overall Study|Withdrawal by Subject|5|||
23618901|NCT02329223|65991380|FG000|Overall Study|Physician Decision|0|||
23618902|NCT02329223|65991381|FG001|Overall Study|Physician Decision|0|||
23618903|NCT02329223|65991382|FG002|Overall Study|Physician Decision|1|||
23618904|NCT02329223|65991380|FG000|Overall Study|Adverse Event|0|||
23618905|NCT02329223|65991381|FG001|Overall Study|Adverse Event|1|||
23618906|NCT02329223|65991382|FG002|Overall Study|Adverse Event|0|||
23618907|NCT01395914|65991384|FG000|Overall Study|Unrelated to study drug AE|6|||
23618908|NCT01395914|65991385|FG001|Overall Study|Unrelated to study drug AE|1|||
23618909|NCT01395914|65991384|FG000|Overall Study|Death|23|||
23618910|NCT01395914|65991385|FG001|Overall Study|Death|17|||
23618911|NCT01395914|65991384|FG000|Overall Study|Other|9|||
23618912|NCT01395914|65991385|FG001|Overall Study|Other|3|||
23618913|NCT01395914|65991384|FG000|Overall Study|Withdrawal by patient|27|||
23618914|NCT01395914|65991385|FG001|Overall Study|Withdrawal by patient|14|||
23618915|NCT01395914|65991384|FG000|Overall Study|Study drug-related AE|1|||
23618916|NCT01395914|65991385|FG001|Overall Study|Study drug-related AE|0|||
23618917|NCT01395914|65991384|FG000|Overall Study|Lost to Follow-up|6|||
23618918|NCT01395914|65991385|FG001|Overall Study|Lost to Follow-up|2|||
23618919|NCT04362176|65991390|FG000|Overall Study|Lost to Follow-up|5|||
23618920|NCT04362176|65991391|FG001|Overall Study|Lost to Follow-up|8|||
23618921|NCT04362176|65991390|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
23618922|NCT04362176|65991391|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
23618923|NCT02930837|65991394|FG000|Overall Study|Adverse Event|6|||
23618924|NCT02930837|65991394|FG000|Overall Study|Lost to Follow-up|5|||
23819987|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
23819988|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
23819989|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
23819990|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
23819991|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
23819992|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
23819993|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
23819994|NCT04040192|66721074|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
23819995|NCT04040192|66721075|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
23819996|NCT04040192|66721076|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
23819997|NCT01547130|66721080|FG000|Overall Study|Lost to Follow-up|9|||
23819998|NCT01547130|66721081|FG001|Overall Study|Lost to Follow-up|5|||
23819999|NCT00478244|66721084|FG000|Overall Study|Did not receive transplant|1|||
23820000|NCT00230178|66721085|FG000|Overall Study|Adverse Event|1|||
23820001|NCT00230178|66721086|FG001|Overall Study|Adverse Event|5|||
23820002|NCT00230178|66721087|FG002|Overall Study|Adverse Event|2|||
23820003|NCT00230178|66721085|FG000|Overall Study|Withdrawal by Subject|0|||
23820004|NCT00230178|66721086|FG001|Overall Study|Withdrawal by Subject|0|||
23820005|NCT00230178|66721087|FG002|Overall Study|Withdrawal by Subject|1|||
23820006|NCT00230178|66721085|FG000|Overall Study|Various other reasons|3|||
23820007|NCT00230178|66721086|FG001|Overall Study|Various other reasons|2|||
23820008|NCT00230178|66721087|FG002|Overall Study|Various other reasons|4|||
23820009|NCT02111603|66721088|FG000|Overall Study|Withdrawal by Subject|1|||
23820010|NCT04693416|66721096|FG000|Overall Study|Lost to Follow-up|13|||
23546411|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546412|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546413|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546414|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
23546415|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546416|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546417|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546418|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546419|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
23546420|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546421|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546422|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23582206|NCT01094171|65862382|FG000|Overall Study|Other|1|||
23618925|NCT02930837|65991394|FG000|Overall Study|Withdrawal by Subject|1|||
23618926|NCT02024750|65991395|FG000|Overall Study|Withdrawal by Subject|2|||
23618927|NCT02024750|65991396|FG001|Overall Study|Withdrawal by Subject|1|||
23618928|NCT00317603|65991397|FG000|Overall Study|Progressive Disease|3|||
23618929|NCT02005029|65991403|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
23618930|NCT02005029|65991404|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
23618931|NCT01885936|65991405|FG000|Overall Study|Withdrawal by Subject|1|||
23618932|NCT01885936|65991406|FG001|Overall Study|Withdrawal by Subject|0|||
23820011|NCT04693416|66721097|FG001|Overall Study|Lost to Follow-up|0|||
23820012|NCT00303459|66721101|FG000|Overall Study|Death|33|||
23820013|NCT00303459|66721102|FG001|Overall Study|Death|44|||
23820014|NCT00303459|66721101|FG000|Overall Study|Withdrawal of consent|32|||
23618933|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
23618934|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
23618935|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
23618936|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
23618937|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
23618938|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
23618939|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
23618940|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
23618941|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
23618942|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
23618943|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
23546423|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546424|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
23546425|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546426|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546427|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546428|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546429|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23737253|NCT02041533|66416331|FG001|Treatment Period|Participant withdrew consent|2|||
23737254|NCT02041533|66416330|FG000|Treatment Period|Maximum clinical benefit|0|||
23737255|NCT02041533|66416331|FG001|Treatment Period|Maximum clinical benefit|18|||
23737256|NCT02041533|66416330|FG000|Treatment Period|Poor/Non-compliance|1|||
23737257|NCT02041533|66416331|FG001|Treatment Period|Poor/Non-compliance|0|||
23737258|NCT02041533|66416330|FG000|Treatment Period|Administrative reason by sponsor|1|||
23737259|NCT02041533|66416331|FG001|Treatment Period|Administrative reason by sponsor|0|||
23546430|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
23546431|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23546432|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23546433|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23737260|NCT02041533|66416330|FG000|Treatment Period|Other reasons|9|||
23737261|NCT02041533|66416331|FG001|Treatment Period|Other reasons|2|||
23737262|NCT02041533|66416330|FG000|Treatment Period|Not Reported|0|||
23737263|NCT02041533|66416331|FG001|Treatment Period|Not Reported|1|||
23737264|NCT02371980|66416333|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
23820015|NCT00303459|66721102|FG001|Overall Study|Withdrawal of consent|26|||
23820016|NCT00303459|66721101|FG000|Overall Study|Lost to Follow-up|5|||
23820017|NCT00303459|66721102|FG001|Overall Study|Lost to Follow-up|4|||
23820018|NCT00303459|66721101|FG000|Overall Study|Administrative reason|7|||
23820019|NCT00303459|66721102|FG001|Overall Study|Administrative reason|7|||
23820020|NCT00303459|66721101|FG000|Overall Study|Decision by the investigator|5|||
23820021|NCT00303459|66721102|FG001|Overall Study|Decision by the investigator|7|||
23820022|NCT00303459|66721101|FG000|Overall Study|Lung transplantation|1|||
23546434|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
23546435|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
23546436|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23546437|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23546438|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23618944|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
23618945|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
23618946|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
23618947|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
23618948|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
23618949|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
23618950|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
23618951|NCT00352053|65991408|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
23618952|NCT00352053|65991409|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
23618953|NCT00352053|65991408|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
23618954|NCT00352053|65991409|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
23737265|NCT02371980|66416334|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
23737266|NCT02371980|66416335|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
23546439|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
23546440|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23737267|NCT02371980|66416336|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
23737268|NCT02371980|66416337|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
23546441|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546442|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546443|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546444|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
23546445|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546446|NCT03923959|65731087|FG000|Overall Study|Death|16|||
23546447|NCT03923959|65731088|FG001|Overall Study|Death|12|||
23546448|NCT03923959|65731087|FG000|Overall Study|Lost to Follow-up|56|||
23546449|NCT03923959|65731088|FG001|Overall Study|Lost to Follow-up|56|||
23546450|NCT03923959|65731087|FG000|Overall Study|Withdrawal by Subject|1|||
23618955|NCT00352053|65991408|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
23618956|NCT00352053|65991409|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
23618957|NCT00352053|65991408|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
23618958|NCT00352053|65991409|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
23618959|NCT03410108|65991410|FG000|Overall Study|Ongoing|41|||
23618960|NCT03410108|65991410|FG000|Overall Study|Adverse Event|4|||
23618961|NCT03410108|65991410|FG000|Overall Study|Progressive Disease|58|||
23618962|NCT03410108|65991410|FG000|Overall Study|Withdrawal by Subject|1|||
23618963|NCT04167085|65991411|FG000|Baseline|Withdrawal by Subject|2|||
23618964|NCT04167085|65991412|FG001|Baseline|Withdrawal by Subject|1|||
23618965|NCT04167085|65991411|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
23618966|NCT04167085|65991412|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
23618967|NCT01002547|65991413|FG000|Overall Study|Withdrawal by Subject|4|||
23618968|NCT01002547|65991414|FG001|Overall Study|Withdrawal by Subject|0|||
23618969|NCT01002547|65991415|FG002|Overall Study|Withdrawal by Subject|5|||
23546451|NCT03923959|65731088|FG001|Overall Study|Withdrawal by Subject|1|||
23546452|NCT03923959|65731087|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
23546453|NCT03923959|65731088|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
23546454|NCT03776136|65731096|FG000|Overall Study|Death|85|||
23546455|NCT03776136|65731096|FG000|Overall Study|Withdrawal by Subject|3|||
23546456|NCT03776136|65731096|FG000|Overall Study|Sponsor Decision|15|||
23546457|NCT03972488|65731097|FG000|Overall Study|Progressive disease|42|||
23546458|NCT03972488|65731098|FG001|Overall Study|Progressive disease|44|||
23546459|NCT03972488|65731097|FG000|Overall Study|Physician Decision|13|||
23546460|NCT03972488|65731098|FG001|Overall Study|Physician Decision|7|||
23546461|NCT03972488|65731097|FG000|Overall Study|Adverse Event|8|||
23546462|NCT03972488|65731098|FG001|Overall Study|Adverse Event|1|||
23546463|NCT03972488|65731097|FG000|Overall Study|Death|4|||
23546464|NCT03972488|65731098|FG001|Overall Study|Death|4|||
23546465|NCT03972488|65731097|FG000|Overall Study|Withdrawal by Subject|3|||
23546466|NCT03972488|65731098|FG001|Overall Study|Withdrawal by Subject|4|||
23546467|NCT03972488|65731097|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
23546468|NCT03972488|65731098|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
23546469|NCT00599326|65731102|FG000|Overall Study|Lost to Follow-up|1|||
23546470|NCT00599326|65731102|FG000|Overall Study|Noncompliant|1|||
23546471|NCT03305016|65731106|FG000|Overall Study|Withdrawal by Subject|2|||
23546472|NCT01669122|65731112|FG000|Period I|Lost to Follow-up|1|||
23546473|NCT01669122|65731112|FG000|Washout Period II|Protocol Violation|2|||
23546474|NCT04899349|65731113|FG000|Overall Study|Study terminated by Sponsor|2|||
23546475|NCT04899349|65731114|FG001|Overall Study|Study terminated by Sponsor|0|||
23546476|NCT02246998|65731115|FG000|Overall Study|Adverse Event|0|||
23546477|NCT02246998|65731116|FG001|Overall Study|Adverse Event|1|||
23546478|NCT02246998|65731117|FG002|Overall Study|Adverse Event|1|||
23546479|NCT02246998|65731118|FG003|Overall Study|Adverse Event|0|||
23546480|NCT02246998|65731115|FG000|Overall Study|Lost to Follow-up|1|||
23546481|NCT02246998|65731116|FG001|Overall Study|Lost to Follow-up|0|||
23546482|NCT02246998|65731117|FG002|Overall Study|Lost to Follow-up|0|||
23546483|NCT02246998|65731118|FG003|Overall Study|Lost to Follow-up|1|||
23546484|NCT02246998|65731115|FG000|Overall Study|Randomized but Never Dosed|1|||
23618970|NCT01002547|65991413|FG000|Overall Study|Lost to Follow-up|2|||
23618971|NCT01002547|65991414|FG001|Overall Study|Lost to Follow-up|1|||
23737269|NCT02371980|66416333|FG000|Open-label Period|Significant Protocol Deviation|19|||
23618972|NCT01002547|65991415|FG002|Overall Study|Lost to Follow-up|1|||
23618973|NCT01002547|65991413|FG000|Overall Study|Physician Decision|1|||
23618974|NCT01002547|65991414|FG001|Overall Study|Physician Decision|0|||
23618975|NCT01002547|65991415|FG002|Overall Study|Physician Decision|0|||
23737270|NCT02371980|66416334|FG001|Open-label Period|Significant Protocol Deviation|0|||
23737271|NCT02371980|66416335|FG002|Open-label Period|Significant Protocol Deviation|0|||
23737272|NCT02371980|66416336|FG003|Open-label Period|Significant Protocol Deviation|0|||
23737273|NCT02371980|66416337|FG004|Open-label Period|Significant Protocol Deviation|0|||
23737274|NCT02371980|66416333|FG000|Open-label Period|Noncompliance with Study Drug|10|||
23737275|NCT02371980|66416334|FG001|Open-label Period|Noncompliance with Study Drug|0|||
23737276|NCT02371980|66416335|FG002|Open-label Period|Noncompliance with Study Drug|0|||
23737277|NCT02371980|66416336|FG003|Open-label Period|Noncompliance with Study Drug|0|||
23546485|NCT02246998|65731116|FG001|Overall Study|Randomized but Never Dosed|2|||
23546486|NCT02246998|65731117|FG002|Overall Study|Randomized but Never Dosed|2|||
23546487|NCT02246998|65731118|FG003|Overall Study|Randomized but Never Dosed|1|||
23546488|NCT03266588|65731129|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
23546489|NCT03266588|65731130|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
23546490|NCT03266588|65731131|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
23546491|NCT03266588|65731129|FG000|Observational Period|Withdrawal by Subject|44|||
23546492|NCT03266588|65731130|FG001|Observational Period|Withdrawal by Subject|22|||
23546493|NCT03266588|65731131|FG002|Observational Period|Withdrawal by Subject|13|||
23546494|NCT03266588|65731129|FG000|Observational Period|Non-compliance|18|||
23546495|NCT03266588|65731130|FG001|Observational Period|Non-compliance|12|||
23546496|NCT03266588|65731131|FG002|Observational Period|Non-compliance|10|||
23546497|NCT03266588|65731129|FG000|Observational Period|Lost to Follow-up|8|||
23546498|NCT03266588|65731130|FG001|Observational Period|Lost to Follow-up|12|||
23546499|NCT03266588|65731131|FG002|Observational Period|Lost to Follow-up|4|||
23546500|NCT03266588|65731129|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
23546501|NCT03266588|65731130|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
23546502|NCT03266588|65731131|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
23546503|NCT03266588|65731129|FG000|Observational Period|Protocol Deviation|1|||
23546504|NCT03266588|65731130|FG001|Observational Period|Protocol Deviation|0|||
23546505|NCT03266588|65731131|FG002|Observational Period|Protocol Deviation|0|||
23546506|NCT03266588|65731129|FG000|Observational Period|Other Reasons|3|||
23546507|NCT03266588|65731130|FG001|Observational Period|Other Reasons|0|||
23546508|NCT03266588|65731131|FG002|Observational Period|Other Reasons|1|||
23546509|NCT03266588|65731129|FG000|Long-term Treatment Period|Adverse Event|33|||
23546510|NCT03266588|65731130|FG001|Long-term Treatment Period|Adverse Event|17|||
23618976|NCT01002547|65991413|FG000|Overall Study|Death|0|||
23618977|NCT01002547|65991414|FG001|Overall Study|Death|2|||
23618978|NCT01002547|65991415|FG002|Overall Study|Death|2|||
23618979|NCT01002547|65991413|FG000|Overall Study|Adverse Event|1|||
23618980|NCT01002547|65991414|FG001|Overall Study|Adverse Event|0|||
23618981|NCT01002547|65991415|FG002|Overall Study|Adverse Event|0|||
23618982|NCT01670188|65991416|FG000|Overall Study|Death|0|||
23618983|NCT01670188|65991417|FG001|Overall Study|Death|1|||
23618984|NCT01960114|65991422|FG000|Overall Study|Adverse Event|1|||
23618985|NCT01960114|65991423|FG001|Overall Study|Adverse Event|0|||
23618986|NCT01960114|65991422|FG000|Overall Study|Could not swallow study medication|0|||
23618987|NCT01960114|65991423|FG001|Overall Study|Could not swallow study medication|1|||
23618988|NCT03214250|65991424|FG000|Overall Study|Death|5|||
23618989|NCT03214250|65991425|FG001|Overall Study|Death|5|||
23618990|NCT03214250|65991426|FG002|Overall Study|Death|7|||
23618991|NCT03214250|65991427|FG003|Overall Study|Death|4|||
23618992|NCT03214250|65991428|FG004|Overall Study|Death|23|||
23618993|NCT03214250|65991429|FG005|Overall Study|Death|23|||
23618994|NCT03214250|65991430|FG006|Overall Study|Death|24|||
23618995|NCT03214250|65991424|FG000|Overall Study|Lost to Follow-up|0|||
23618996|NCT03214250|65991425|FG001|Overall Study|Lost to Follow-up|0|||
23618997|NCT03214250|65991426|FG002|Overall Study|Lost to Follow-up|0|||
23618998|NCT03214250|65991427|FG003|Overall Study|Lost to Follow-up|1|||
23618999|NCT03214250|65991428|FG004|Overall Study|Lost to Follow-up|1|||
23619000|NCT03214250|65991429|FG005|Overall Study|Lost to Follow-up|2|||
23619001|NCT03214250|65991430|FG006|Overall Study|Lost to Follow-up|0|||
23619002|NCT03214250|65991424|FG000|Overall Study|Other|0|||
23619003|NCT03214250|65991425|FG001|Overall Study|Other|0|||
23619004|NCT03214250|65991426|FG002|Overall Study|Other|0|||
23546511|NCT03266588|65731131|FG002|Long-term Treatment Period|Adverse Event|8|||
23546512|NCT03266588|65731129|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
23546513|NCT03266588|65731130|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
23546514|NCT03266588|65731131|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
23546515|NCT03266588|65731129|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
23619005|NCT03214250|65991427|FG003|Overall Study|Other|0|||
23619006|NCT03214250|65991428|FG004|Overall Study|Other|1|||
23546516|NCT03266588|65731130|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
23546517|NCT03266588|65731131|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
23546518|NCT03266588|65731129|FG000|Long-term Treatment Period|Non-Compliance|126|||
23546519|NCT03266588|65731130|FG001|Long-term Treatment Period|Non-Compliance|57|||
23619007|NCT03214250|65991429|FG005|Overall Study|Other|1|||
23619008|NCT03214250|65991430|FG006|Overall Study|Other|2|||
23619009|NCT03214250|65991424|FG000|Overall Study|Remains on Study|2|||
23619010|NCT03214250|65991425|FG001|Overall Study|Remains on Study|2|||
23546520|NCT03266588|65731131|FG002|Long-term Treatment Period|Non-Compliance|7|||
23546521|NCT03266588|65731129|FG000|Long-term Treatment Period|Pregnancy|11|||
23619011|NCT03214250|65991426|FG002|Overall Study|Remains on Study|0|||
23619012|NCT03214250|65991427|FG003|Overall Study|Remains on Study|1|||
23619013|NCT03214250|65991428|FG004|Overall Study|Remains on Study|7|||
23619014|NCT03214250|65991429|FG005|Overall Study|Remains on Study|5|||
23619015|NCT03214250|65991430|FG006|Overall Study|Remains on Study|3|||
23820023|NCT00303459|66721102|FG001|Overall Study|Lung transplantation|1|||
23820024|NCT03414684|66721105|FG000|First-course Treatment|Complete response|0|||
23820025|NCT03414684|66721106|FG001|First-course Treatment|Complete response|1|||
23820026|NCT03414684|66721105|FG000|First-course Treatment|Intercurrent illness|1|||
23820027|NCT03414684|66721106|FG001|First-course Treatment|Intercurrent illness|0|||
23820028|NCT03414684|66721105|FG000|First-course Treatment|Progressive Disease|31|||
23820029|NCT03414684|66721106|FG001|First-course Treatment|Progressive Disease|32|||
23820030|NCT03414684|66721105|FG000|First-course Treatment|Adverse Event|1|||
23820031|NCT03414684|66721106|FG001|First-course Treatment|Adverse Event|2|||
23820032|NCT03414684|66721105|FG000|First-course Treatment|Physician Decision|0|||
23820033|NCT03414684|66721106|FG001|First-course Treatment|Physician Decision|1|||
23820034|NCT03414684|66721105|FG000|First-course Treatment|Withdrawal by Subject|0|||
23546522|NCT03266588|65731130|FG001|Long-term Treatment Period|Pregnancy|5|||
23546523|NCT03266588|65731131|FG002|Long-term Treatment Period|Pregnancy|0|||
23546524|NCT03266588|65731129|FG000|Long-term Treatment Period|Protocol Deviation|17|||
23546525|NCT03266588|65731130|FG001|Long-term Treatment Period|Protocol Deviation|10|||
23737278|NCT02371980|66416337|FG004|Open-label Period|Noncompliance with Study Drug|0|||
23737279|NCT02371980|66416333|FG000|Open-label Period|Lost to Follow-up|55|||
23737280|NCT02371980|66416334|FG001|Open-label Period|Lost to Follow-up|0|||
23737281|NCT02371980|66416335|FG002|Open-label Period|Lost to Follow-up|0|||
23737282|NCT02371980|66416336|FG003|Open-label Period|Lost to Follow-up|0|||
23737283|NCT02371980|66416337|FG004|Open-label Period|Lost to Follow-up|0|||
23737284|NCT02371980|66416333|FG000|Open-label Period|Voluntary Withdrawal|91|||
23737285|NCT02371980|66416334|FG001|Open-label Period|Voluntary Withdrawal|0|||
23737286|NCT02371980|66416335|FG002|Open-label Period|Voluntary Withdrawal|0|||
23737287|NCT02371980|66416336|FG003|Open-label Period|Voluntary Withdrawal|0|||
23737288|NCT02371980|66416337|FG004|Open-label Period|Voluntary Withdrawal|0|||
23737289|NCT02371980|66416333|FG000|Open-label Period|Pregnancy|1|||
23737290|NCT02371980|66416334|FG001|Open-label Period|Pregnancy|0|||
23737291|NCT02371980|66416335|FG002|Open-label Period|Pregnancy|0|||
23737292|NCT02371980|66416336|FG003|Open-label Period|Pregnancy|0|||
23737293|NCT02371980|66416337|FG004|Open-label Period|Pregnancy|0|||
23737294|NCT02371980|66416333|FG000|Open-label Period|Lack of Efficacy|116|||
23737295|NCT02371980|66416334|FG001|Open-label Period|Lack of Efficacy|0|||
23737296|NCT02371980|66416335|FG002|Open-label Period|Lack of Efficacy|0|||
23820035|NCT03414684|66721106|FG001|First-course Treatment|Withdrawal by Subject|1|||
23820036|NCT03414684|66721105|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
23546526|NCT03266588|65731131|FG002|Long-term Treatment Period|Protocol Deviation|4|||
23546527|NCT03266588|65731129|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
23546528|NCT03266588|65731130|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
23546529|NCT03266588|65731131|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
23546530|NCT03266588|65731129|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
23546531|NCT03266588|65731130|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
23546532|NCT03266588|65731131|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
23546533|NCT03266588|65731129|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
23546534|NCT03266588|65731130|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
23546535|NCT03266588|65731131|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
23546536|NCT03266588|65731129|FG000|Long-term Treatment Period|Other Reasons|5|||
23546537|NCT03266588|65731130|FG001|Long-term Treatment Period|Other Reasons|0|||
23546538|NCT03266588|65731131|FG002|Long-term Treatment Period|Other Reasons|0|||
23546539|NCT03266588|65731129|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
23546540|NCT03266588|65731130|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
23546541|NCT03266588|65731131|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
23546542|NCT03725982|65731132|FG000|First Intervention|Withdrawal by Subject|0|||
23546543|NCT03725982|65731133|FG001|First Intervention|Withdrawal by Subject|1|||
23546544|NCT03725982|65731132|FG000|First Intervention|Physician Decision|1|||
23546545|NCT03725982|65731133|FG001|First Intervention|Physician Decision|1|||
23546546|NCT02625623|65731136|FG000|Overall Study|Participants randomized but not treated|9|||
23546547|NCT02625623|65731137|FG001|Overall Study|Participants randomized but not treated|1|||
23546548|NCT02244944|65731138|FG000|Overall Study|Withdrawal by Subject|1|||
23546549|NCT02244944|65731138|FG000|Overall Study|Study Terminated|1|||
23546550|NCT04667117|65731140|FG000|Investigational Period|Lost to Follow-up|0|||
23546551|NCT04667117|65731141|FG001|Investigational Period|Lost to Follow-up|0|||
23737297|NCT02371980|66416336|FG003|Open-label Period|Lack of Efficacy|0|||
23546552|NCT04667117|65731142|FG002|Investigational Period|Lost to Follow-up|1|||
23737298|NCT02371980|66416337|FG004|Open-label Period|Lack of Efficacy|0|||
23737299|NCT02371980|66416333|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
23737300|NCT02371980|66416334|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
23737301|NCT02371980|66416335|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
23737302|NCT02371980|66416336|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
23737303|NCT02371980|66416337|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
23546553|NCT04667117|65731140|FG000|Investigational Period|Protocol Deviation|0|||
23546554|NCT04667117|65731141|FG001|Investigational Period|Protocol Deviation|1|||
23546555|NCT04667117|65731142|FG002|Investigational Period|Protocol Deviation|0|||
23546556|NCT04667117|65731140|FG000|Extension Period|Lost to Follow-up|1|||
23546557|NCT04667117|65731141|FG001|Extension Period|Lost to Follow-up|0|||
23546558|NCT04667117|65731142|FG002|Extension Period|Lost to Follow-up|0|||
23546559|NCT01666002|65731143|FG000|Overall Study|Lost to Follow-up|5|||
23546560|NCT01666002|65731144|FG001|Overall Study|Lost to Follow-up|0|||
23546561|NCT01075074|65731145|FG000|Overall Study|Surgeon changed to open incisional case|1|||
23619016|NCT03214250|65991424|FG000|Overall Study|Withdrawal by Subject|0|||
23619017|NCT03214250|65991425|FG001|Overall Study|Withdrawal by Subject|0|||
23619018|NCT03214250|65991426|FG002|Overall Study|Withdrawal by Subject|1|||
23619019|NCT03214250|65991427|FG003|Overall Study|Withdrawal by Subject|2|||
23619020|NCT03214250|65991428|FG004|Overall Study|Withdrawal by Subject|5|||
23619021|NCT03214250|65991429|FG005|Overall Study|Withdrawal by Subject|0|||
23619022|NCT03214250|65991430|FG006|Overall Study|Withdrawal by Subject|2|||
23619023|NCT01831726|65991431|FG000|Overall Study|Adverse Event|16|||
23619024|NCT01831726|65991431|FG000|Overall Study|Death|7|||
23619025|NCT01831726|65991431|FG000|Overall Study|Disease Progression|49|||
23619026|NCT01831726|65991431|FG000|Overall Study|Physician Decision|1|||
23426984|NCT00642369|65307502|FG001|Overall Study|Adverse Event|3|||
23619027|NCT01831726|65991431|FG000|Overall Study|Subject/guardian decision|7|||
23619028|NCT00920699|65991442|FG000|Overall Study|Withdrawal by Subject|2|||
23619029|NCT00920699|65991443|FG001|Overall Study|Withdrawal by Subject|0|||
23619030|NCT00920699|65991444|FG002|Overall Study|Withdrawal by Subject|2|||
23619031|NCT00920699|65991442|FG000|Overall Study|no longer met eligibility|0|||
23619032|NCT00920699|65991443|FG001|Overall Study|no longer met eligibility|1|||
23619033|NCT00920699|65991444|FG002|Overall Study|no longer met eligibility|0|||
23619034|NCT00920699|65991442|FG000|Overall Study|Lost to Follow-up|0|||
23619035|NCT00920699|65991443|FG001|Overall Study|Lost to Follow-up|0|||
23619036|NCT00920699|65991444|FG002|Overall Study|Lost to Follow-up|2|||
23619037|NCT00514813|65991445|FG000|Overall Study|Study terminated|14|||
23619038|NCT00514813|65991446|FG001|Overall Study|Study terminated|74|||
23619039|NCT00514813|65991447|FG002|Overall Study|Study terminated|40|||
23619040|NCT00514813|65991448|FG003|Overall Study|Study terminated|2|||
23619041|NCT00514813|65991445|FG000|Overall Study|Adverse Event|0|||
23619042|NCT00514813|65991446|FG001|Overall Study|Adverse Event|2|||
23619043|NCT00514813|65991447|FG002|Overall Study|Adverse Event|2|||
23619044|NCT00514813|65991448|FG003|Overall Study|Adverse Event|0|||
23619045|NCT00514813|65991445|FG000|Overall Study|Protocol Violation|1|||
23619046|NCT00514813|65991446|FG001|Overall Study|Protocol Violation|0|||
23619047|NCT00514813|65991447|FG002|Overall Study|Protocol Violation|0|||
23619048|NCT00514813|65991448|FG003|Overall Study|Protocol Violation|0|||
23619049|NCT00514813|65991445|FG000|Overall Study|Withdrawal by Subject|0|||
23619050|NCT00514813|65991446|FG001|Overall Study|Withdrawal by Subject|1|||
23619051|NCT00514813|65991447|FG002|Overall Study|Withdrawal by Subject|0|||
23619052|NCT00514813|65991448|FG003|Overall Study|Withdrawal by Subject|0|||
23619053|NCT00514813|65991445|FG000|Overall Study|Lack of Efficacy|0|||
23619054|NCT00514813|65991446|FG001|Overall Study|Lack of Efficacy|1|||
23619055|NCT00514813|65991447|FG002|Overall Study|Lack of Efficacy|0|||
23619056|NCT00514813|65991448|FG003|Overall Study|Lack of Efficacy|0|||
23619057|NCT00514813|65991445|FG000|Overall Study|Kidney transplant|0|||
23619058|NCT00514813|65991446|FG001|Overall Study|Kidney transplant|6|||
23619059|NCT00514813|65991447|FG002|Overall Study|Kidney transplant|2|||
23619060|NCT00514813|65991448|FG003|Overall Study|Kidney transplant|0|||
23619061|NCT00514813|65991445|FG000|Overall Study|Death|0|||
23619062|NCT00514813|65991446|FG001|Overall Study|Death|2|||
23619063|NCT00514813|65991447|FG002|Overall Study|Death|3|||
23619064|NCT00514813|65991448|FG003|Overall Study|Death|2|||
23619065|NCT04194541|65991449|FG000|Day 1 Through 13|Lost to Follow-up|3|||
23737304|NCT02371980|66416333|FG000|Open-label Period|Reason not Specified|9|||
23737305|NCT02371980|66416334|FG001|Open-label Period|Reason not Specified|0|||
23737306|NCT02371980|66416335|FG002|Open-label Period|Reason not Specified|0|||
23737307|NCT02371980|66416336|FG003|Open-label Period|Reason not Specified|0|||
23737308|NCT02371980|66416337|FG004|Open-label Period|Reason not Specified|0|||
23737309|NCT02371980|66416333|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
23737310|NCT02371980|66416334|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
23737311|NCT02371980|66416335|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
23546562|NCT01075074|65731146|FG001|Overall Study|Surgeon changed to open incisional case|2|||
23619066|NCT04194541|65991449|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
23737312|NCT02371980|66416336|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
23737313|NCT02371980|66416337|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
23619067|NCT04194541|65991449|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
23619068|NCT02600897|65991450|FG000|Overall Study|Death|1|||
23619069|NCT02600897|65991451|FG001|Overall Study|Death|2|||
23619070|NCT02600897|65991452|FG002|Overall Study|Death|1|||
23737314|NCT02371980|66416333|FG000|Double-blind Period|Significant Protocol Deviation|0|||
23737315|NCT02371980|66416334|FG001|Double-blind Period|Significant Protocol Deviation|2|||
23737316|NCT02371980|66416335|FG002|Double-blind Period|Significant Protocol Deviation|7|||
23737317|NCT02371980|66416336|FG003|Double-blind Period|Significant Protocol Deviation|3|||
23737318|NCT02371980|66416337|FG004|Double-blind Period|Significant Protocol Deviation|3|||
23737319|NCT02371980|66416333|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
23737320|NCT02371980|66416334|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
23737321|NCT02371980|66416335|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
23737322|NCT02371980|66416336|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
23737323|NCT02371980|66416337|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
23737324|NCT02371980|66416333|FG000|Double-blind Period|Lost to Follow-up|0|||
23737325|NCT02371980|66416334|FG001|Double-blind Period|Lost to Follow-up|8|||
23737326|NCT02371980|66416335|FG002|Double-blind Period|Lost to Follow-up|8|||
23737327|NCT02371980|66416336|FG003|Double-blind Period|Lost to Follow-up|6|||
23737328|NCT02371980|66416337|FG004|Double-blind Period|Lost to Follow-up|5|||
23737329|NCT02371980|66416333|FG000|Double-blind Period|Voluntary Withdrawal|0|||
23737330|NCT02371980|66416334|FG001|Double-blind Period|Voluntary Withdrawal|12|||
23737331|NCT02371980|66416335|FG002|Double-blind Period|Voluntary Withdrawal|8|||
23737332|NCT02371980|66416336|FG003|Double-blind Period|Voluntary Withdrawal|9|||
23737333|NCT02371980|66416337|FG004|Double-blind Period|Voluntary Withdrawal|11|||
23737334|NCT02371980|66416333|FG000|Double-blind Period|Relapse|0|||
23737335|NCT02371980|66416334|FG001|Double-blind Period|Relapse|50|||
23737336|NCT02371980|66416335|FG002|Double-blind Period|Relapse|25|||
23737337|NCT02371980|66416336|FG003|Double-blind Period|Relapse|25|||
23737338|NCT02371980|66416337|FG004|Double-blind Period|Relapse|26|||
23737339|NCT02371980|66416333|FG000|Double-blind Period|Reason not Specified|0|||
23737340|NCT02371980|66416334|FG001|Double-blind Period|Reason not Specified|3|||
23737341|NCT02371980|66416335|FG002|Double-blind Period|Reason not Specified|3|||
23737342|NCT02371980|66416336|FG003|Double-blind Period|Reason not Specified|2|||
23737343|NCT02371980|66416337|FG004|Double-blind Period|Reason not Specified|1|||
23820037|NCT03414684|66721106|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
23820038|NCT03414684|66721105|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
23820039|NCT03414684|66721106|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
23820040|NCT03414684|66721105|FG000|First-course Treatment|Still on treatment|3|||
23820041|NCT03414684|66721106|FG001|First-course Treatment|Still on treatment|0|||
23820042|NCT03414684|66721105|FG000|First-course Treatment|Never started protocol therapy|2|||
23820043|NCT03414684|66721106|FG001|First-course Treatment|Never started protocol therapy|1|||
23820044|NCT03414684|66721105|FG000|Crossover Treatment|Progressive disease|0|||
23820045|NCT03414684|66721106|FG001|Crossover Treatment|Progressive disease|12|||
23820046|NCT03414684|66721105|FG000|Crossover Treatment|Adverse Event|0|||
23820047|NCT03414684|66721106|FG001|Crossover Treatment|Adverse Event|3|||
23820048|NCT03414684|66721105|FG000|Crossover Treatment|Physician Decision|0|||
23820049|NCT03414684|66721106|FG001|Crossover Treatment|Physician Decision|1|||
23820050|NCT03414684|66721105|FG000|Crossover Treatment|Still on treatment|0|||
23820051|NCT03414684|66721106|FG001|Crossover Treatment|Still on treatment|2|||
23820052|NCT03097991|66721108|FG000|Overall Study|Didn't meet study criteria|8|||
23820053|NCT03097991|66721109|FG001|Overall Study|Didn't meet study criteria|0|||
23820054|NCT03097991|66721108|FG000|Overall Study|Withdrawal by Subject|12|||
23820055|NCT03097991|66721109|FG001|Overall Study|Withdrawal by Subject|6|||
23820056|NCT03097991|66721108|FG000|Overall Study|Death of Baby|3|||
23820057|NCT03097991|66721109|FG001|Overall Study|Death of Baby|1|||
23737344|NCT02371980|66416333|FG000|Double-blind Period|Missing|0|||
23820058|NCT03097991|66721108|FG000|Overall Study|Lost to Follow-up|24|||
23820059|NCT03097991|66721109|FG001|Overall Study|Lost to Follow-up|38|||
23737345|NCT02371980|66416334|FG001|Double-blind Period|Missing|1|||
23737346|NCT02371980|66416335|FG002|Double-blind Period|Missing|0|||
23737347|NCT02371980|66416336|FG003|Double-blind Period|Missing|0|||
23737348|NCT02371980|66416337|FG004|Double-blind Period|Missing|0|||
23737349|NCT00984009|66416339|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
23737350|NCT01365468|66416340|FG000|Overall Study|Physician Decision|1|||
23737351|NCT01365468|66416341|FG001|Overall Study|Physician Decision|0|||
23737352|NCT01365468|66416340|FG000|Overall Study|Disease progression|1|||
23820060|NCT03097991|66721108|FG000|Overall Study|Adverse Event|3|||
23820061|NCT03097991|66721109|FG001|Overall Study|Adverse Event|5|||
23820062|NCT00005957|66721110|FG000|Overall Study|No treated|3|||
23820063|NCT00005957|66721111|FG001|Overall Study|No treated|9|||
23820064|NCT00005957|66721110|FG000|Overall Study|Crossover to the other arm|5|||
23820065|NCT00005957|66721111|FG001|Overall Study|Crossover to the other arm|19|||
23820066|NCT00338728|66721114|FG000|Overall Study|Screen Failure|14|||
23820067|NCT05299528|66721115|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820068|NCT05299528|66721116|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
23820069|NCT05299528|66721117|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820070|NCT05299528|66721118|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820071|NCT05299528|66721119|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820072|NCT05299528|66721120|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820073|NCT05299528|66721121|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23820074|NCT05299528|66721115|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820075|NCT05299528|66721116|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820076|NCT05299528|66721117|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820077|NCT05299528|66721118|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820078|NCT05299528|66721119|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820079|NCT05299528|66721120|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
23820080|NCT05299528|66721121|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23820081|NCT05299528|66721115|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
23820082|NCT05299528|66721116|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
23820083|NCT05299528|66721117|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
23820084|NCT05299528|66721118|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
23619071|NCT02600897|65991453|FG003|Overall Study|Death|2|||
23619072|NCT02600897|65991454|FG004|Overall Study|Death|3|||
23619073|NCT02600897|65991455|FG005|Overall Study|Death|2|||
23619074|NCT02600897|65991456|FG006|Overall Study|Death|10|||
23619075|NCT02600897|65991457|FG007|Overall Study|Death|7|||
23619076|NCT02600897|65991458|FG008|Overall Study|Death|20|||
23619077|NCT02600897|65991450|FG000|Overall Study|Lost to Follow-up|1|||
23619078|NCT02600897|65991451|FG001|Overall Study|Lost to Follow-up|0|||
23619079|NCT02600897|65991452|FG002|Overall Study|Lost to Follow-up|0|||
23619080|NCT02600897|65991453|FG003|Overall Study|Lost to Follow-up|0|||
23619081|NCT02600897|65991454|FG004|Overall Study|Lost to Follow-up|0|||
23737353|NCT01365468|66416341|FG001|Overall Study|Disease progression|0|||
23737354|NCT01365468|66416340|FG000|Overall Study|Lost to Follow-up|2|||
23737355|NCT01365468|66416341|FG001|Overall Study|Lost to Follow-up|0|||
23737356|NCT00842829|66416343|FG000|Dose Titration Period|Adverse Event|11|||
23737357|NCT00842829|66416344|FG001|Dose Titration Period|Adverse Event|10|||
23737358|NCT00842829|66416345|FG002|Dose Titration Period|Adverse Event|0|||
23820085|NCT05299528|66721119|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
23820086|NCT05299528|66721120|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
23820087|NCT05299528|66721121|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
23820088|NCT01590797|66721129|FG000|Overall Study|Adverse Event|4|||
23820089|NCT01590797|66721130|FG001|Overall Study|Adverse Event|3|||
23820090|NCT01590797|66721129|FG000|Overall Study|Lack of Efficacy|0|||
23820091|NCT01590797|66721130|FG001|Overall Study|Lack of Efficacy|2|||
23737359|NCT00842829|66416343|FG000|Dose Titration Period|Lack of Efficacy|4|||
23737360|NCT00842829|66416344|FG001|Dose Titration Period|Lack of Efficacy|1|||
23737361|NCT00842829|66416345|FG002|Dose Titration Period|Lack of Efficacy|0|||
23737362|NCT00842829|66416343|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
23737363|NCT00842829|66416344|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
23737364|NCT00842829|66416345|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
23737365|NCT00842829|66416343|FG000|Dose Titration Period|Withdrawal by Subject|2|||
23737366|NCT00842829|66416344|FG001|Dose Titration Period|Withdrawal by Subject|6|||
23737367|NCT00842829|66416345|FG002|Dose Titration Period|Withdrawal by Subject|0|||
23737368|NCT00842829|66416343|FG000|Dose Titration Period|Other|5|||
23737369|NCT00842829|66416344|FG001|Dose Titration Period|Other|4|||
23820092|NCT01590797|66721129|FG000|Overall Study|Lost to Follow-up|0|||
23820093|NCT01590797|66721130|FG001|Overall Study|Lost to Follow-up|1|||
23820094|NCT01590797|66721129|FG000|Overall Study|Protocol Violation|4|||
23619082|NCT02600897|65991455|FG005|Overall Study|Lost to Follow-up|0|||
23619083|NCT02600897|65991456|FG006|Overall Study|Lost to Follow-up|0|||
23737370|NCT00842829|66416345|FG002|Dose Titration Period|Other|0|||
23737371|NCT00842829|66416343|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
23737372|NCT00842829|66416344|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
23619084|NCT02600897|65991457|FG007|Overall Study|Lost to Follow-up|1|||
23619085|NCT02600897|65991458|FG008|Overall Study|Lost to Follow-up|0|||
23619086|NCT02600897|65991450|FG000|Overall Study|Withdrawal by Subject|0|||
23820095|NCT01590797|66721130|FG001|Overall Study|Protocol Violation|1|||
23820096|NCT01590797|66721129|FG000|Overall Study|Withdrawal by Subject|7|||
23820097|NCT01590797|66721130|FG001|Overall Study|Withdrawal by Subject|5|||
23820098|NCT01590797|66721129|FG000|Overall Study|Other Protocol Specified Criteria|2|||
23737373|NCT00842829|66416345|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
23737374|NCT00842829|66416343|FG000|Dose Titration Period|Non-compliance to study drug|2|||
23737375|NCT00842829|66416344|FG001|Dose Titration Period|Non-compliance to study drug|1|||
23737376|NCT00842829|66416345|FG002|Dose Titration Period|Non-compliance to study drug|0|||
23737377|NCT00842829|66416343|FG000|Treatment Period|Adverse Event|0|||
23737378|NCT00842829|66416344|FG001|Treatment Period|Adverse Event|0|||
23737379|NCT00842829|66416345|FG002|Treatment Period|Adverse Event|15|||
23737380|NCT00842829|66416343|FG000|Treatment Period|Lack of Efficacy|0|||
23737381|NCT00842829|66416344|FG001|Treatment Period|Lack of Efficacy|0|||
23737382|NCT00842829|66416345|FG002|Treatment Period|Lack of Efficacy|6|||
23737383|NCT00842829|66416343|FG000|Treatment Period|Unstable persistent cancer pain|0|||
23737384|NCT00842829|66416344|FG001|Treatment Period|Unstable persistent cancer pain|0|||
23737385|NCT00842829|66416345|FG002|Treatment Period|Unstable persistent cancer pain|5|||
23737386|NCT00842829|66416343|FG000|Treatment Period|Withdrawal by Subject|0|||
23737387|NCT00842829|66416344|FG001|Treatment Period|Withdrawal by Subject|0|||
23737388|NCT00842829|66416345|FG002|Treatment Period|Withdrawal by Subject|11|||
23737389|NCT00842829|66416343|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
23737390|NCT00842829|66416344|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
23737391|NCT00842829|66416345|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
23737392|NCT00842829|66416343|FG000|Treatment Period|Protocol Violation|0|||
23820099|NCT01590797|66721130|FG001|Overall Study|Other Protocol Specified Criteria|4|||
23820100|NCT03700385|66721131|FG000|Overall Study|Lost to Follow-up|1|||
23820101|NCT03106987|66721137|FG000|Overall Study|Death|37|||
23820102|NCT03106987|66721138|FG001|Overall Study|Death|22|||
23820103|NCT03106987|66721139|FG002|Overall Study|Death|12|||
23820104|NCT03106987|66721140|FG003|Overall Study|Death|8|||
23820105|NCT03106987|66721137|FG000|Overall Study|Lost to Follow-up|2|||
23820106|NCT03106987|66721138|FG001|Overall Study|Lost to Follow-up|0|||
23820107|NCT03106987|66721139|FG002|Overall Study|Lost to Follow-up|2|||
23820108|NCT03106987|66721140|FG003|Overall Study|Lost to Follow-up|2|||
23820109|NCT03106987|66721137|FG000|Overall Study|Withdrawal by Subject|5|||
23820110|NCT03106987|66721138|FG001|Overall Study|Withdrawal by Subject|1|||
23820111|NCT03106987|66721139|FG002|Overall Study|Withdrawal by Subject|4|||
23820112|NCT03106987|66721140|FG003|Overall Study|Withdrawal by Subject|1|||
23820113|NCT02289729|66721143|FG000|Overall Study|Lack of Efficacy|3|||
23820114|NCT02289729|66721143|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
23820115|NCT02289729|66721143|FG000|Overall Study|Withdrawal by Subject|1|||
23820116|NCT02289729|66721143|FG000|Overall Study|Death|1|||
23820117|NCT01941498|66721144|FG000|Overall Study|Relocated out of state|1|||
23820118|NCT04435184|66721146|FG000|Overall Study|follow-up blood draws missing|3|||
23820119|NCT04435184|66721147|FG001|Overall Study|follow-up blood draws missing|5|||
23820120|NCT04646005|66721154|FG000|Overall Study|Adverse Event|1|||
23820121|NCT04646005|66721154|FG000|Overall Study|Progressive Disease|60|||
23820122|NCT04646005|66721154|FG000|Overall Study|Death|19|||
23820123|NCT04646005|66721154|FG000|Overall Study|Withdrawal by Subject|9|||
23426985|NCT00642369|65307501|FG000|Overall Study|Withdrawal by Subject|1|||
23426986|NCT00642369|65307502|FG001|Overall Study|Withdrawal by Subject|0|||
23546563|NCT01075074|65731147|FG002|Overall Study|Surgeon changed to open incisional case|2|||
23546564|NCT05132699|65731151|FG000|Overall Study|Withdrawal by Subject|3|||
23546565|NCT05132699|65731152|FG001|Overall Study|Withdrawal by Subject|0|||
23546566|NCT01131312|65731156|FG000|Overall Study|Lost to Follow-up|425|||
23546567|NCT01131312|65731157|FG001|Overall Study|Lost to Follow-up|229|||
23546568|NCT01131312|65731158|FG002|Overall Study|Lost to Follow-up|351|||
23546569|NCT03069482|65731159|FG000|Overall Study|Lost to Follow-up|0|||
23546570|NCT03069482|65731160|FG001|Overall Study|Lost to Follow-up|1|||
23546571|NCT03069482|65731159|FG000|Overall Study|Physician Decision|1|||
23737393|NCT00842829|66416344|FG001|Treatment Period|Protocol Violation|0|||
23737394|NCT00842829|66416345|FG002|Treatment Period|Protocol Violation|2|||
23737395|NCT00842829|66416343|FG000|Treatment Period|Other|0|||
23737396|NCT00842829|66416344|FG001|Treatment Period|Other|0|||
23737397|NCT00842829|66416345|FG002|Treatment Period|Other|18|||
23737398|NCT00842829|66416343|FG000|Treatment Period|Non-compliance to study procedures|0|||
23820124|NCT04646005|66721154|FG000|Overall Study|Study Ongoing|24|||
23820125|NCT01111825|66721167|FG000|Overall Study|Withdrawal by Subject|0|||
23820126|NCT01111825|66721168|FG001|Overall Study|Withdrawal by Subject|0|||
23820127|NCT01111825|66721169|FG002|Overall Study|Withdrawal by Subject|1|||
23820128|NCT01111825|66721170|FG003|Overall Study|Withdrawal by Subject|0|||
23820129|NCT01111825|66721167|FG000|Overall Study|Lost to Follow-up|0|||
23820130|NCT01111825|66721168|FG001|Overall Study|Lost to Follow-up|0|||
23820131|NCT01111825|66721169|FG002|Overall Study|Lost to Follow-up|3|||
23820132|NCT01111825|66721170|FG003|Overall Study|Lost to Follow-up|1|||
23820133|NCT01111825|66721167|FG000|Overall Study|Adverse Event|2|||
23820134|NCT01111825|66721168|FG001|Overall Study|Adverse Event|1|||
23737399|NCT00842829|66416344|FG001|Treatment Period|Non-compliance to study procedures|0|||
23737400|NCT00842829|66416345|FG002|Treatment Period|Non-compliance to study procedures|4|||
23737401|NCT00842829|66416343|FG000|Treatment Period|Unclear completion status|0|||
23737402|NCT00842829|66416344|FG001|Treatment Period|Unclear completion status|0|||
23737403|NCT00842829|66416345|FG002|Treatment Period|Unclear completion status|1|||
23737404|NCT00842829|66416343|FG000|Continuation Period|Adverse Event|0|||
23737405|NCT00842829|66416344|FG001|Continuation Period|Adverse Event|0|||
23737406|NCT00842829|66416345|FG002|Continuation Period|Adverse Event|32|||
23737407|NCT00842829|66416343|FG000|Continuation Period|Lack of Efficacy|0|||
23737408|NCT00842829|66416344|FG001|Continuation Period|Lack of Efficacy|0|||
23737409|NCT00842829|66416345|FG002|Continuation Period|Lack of Efficacy|6|||
23737410|NCT00842829|66416343|FG000|Continuation Period|Unstable persistent cancer pain|0|||
23737411|NCT00842829|66416344|FG001|Continuation Period|Unstable persistent cancer pain|0|||
23737412|NCT00842829|66416345|FG002|Continuation Period|Unstable persistent cancer pain|3|||
23737413|NCT00842829|66416343|FG000|Continuation Period|Withdrawal by Subject|0|||
23737414|NCT00842829|66416344|FG001|Continuation Period|Withdrawal by Subject|0|||
23737415|NCT00842829|66416345|FG002|Continuation Period|Withdrawal by Subject|10|||
23546572|NCT03069482|65731160|FG001|Overall Study|Physician Decision|0|||
23546573|NCT04717596|65731164|FG000|Overall Study|Withdrawal by Subject|4|||
23546574|NCT04323436|65731165|FG000|Overall Study|Adverse Event|7|||
23546575|NCT04323436|65731166|FG001|Overall Study|Adverse Event|0|||
23546576|NCT04323436|65731167|FG002|Overall Study|Adverse Event|0|||
23546577|NCT04323436|65731165|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
23546578|NCT04323436|65731166|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
23546579|NCT04323436|65731167|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
23546580|NCT04323436|65731165|FG000|Overall Study|Death|1|||
23546581|NCT04323436|65731166|FG001|Overall Study|Death|0|||
23546582|NCT04323436|65731167|FG002|Overall Study|Death|0|||
23546583|NCT04323436|65731165|FG000|Overall Study|Physician Decision|2|||
23546584|NCT04323436|65731166|FG001|Overall Study|Physician Decision|0|||
23546585|NCT04323436|65731167|FG002|Overall Study|Physician Decision|0|||
23546586|NCT04323436|65731165|FG000|Overall Study|Progressive disease|10|||
23546587|NCT04323436|65731166|FG001|Overall Study|Progressive disease|0|||
23546588|NCT04323436|65731167|FG002|Overall Study|Progressive disease|0|||
23546589|NCT04323436|65731165|FG000|Overall Study|Subject decision|3|||
23546590|NCT04323436|65731166|FG001|Overall Study|Subject decision|0|||
23546591|NCT04323436|65731167|FG002|Overall Study|Subject decision|0|||
23546592|NCT00144339|65731172|FG000|Overall Study|Adverse Event|746|||
23546593|NCT00144339|65731173|FG001|Overall Study|Adverse Event|627|||
23546594|NCT00144339|65731172|FG000|Overall Study|Protocol Violation|75|||
23737416|NCT00842829|66416343|FG000|Continuation Period|Other|0|||
23546595|NCT00144339|65731173|FG001|Overall Study|Protocol Violation|48|||
23737417|NCT00842829|66416344|FG001|Continuation Period|Other|0|||
23737418|NCT00842829|66416345|FG002|Continuation Period|Other|7|||
23737419|NCT00842829|66416343|FG000|Continuation Period|Non-compliance to study procedures|0|||
23737420|NCT00842829|66416344|FG001|Continuation Period|Non-compliance to study procedures|0|||
23737421|NCT00842829|66416345|FG002|Continuation Period|Non-compliance to study procedures|2|||
23737422|NCT00842829|66416343|FG000|Continuation Period|Non-compliance to study drug|0|||
23737423|NCT00842829|66416344|FG001|Continuation Period|Non-compliance to study drug|0|||
23737424|NCT00842829|66416345|FG002|Continuation Period|Non-compliance to study drug|1|||
23737425|NCT00535236|66416346|FG000|Overall Study|Adverse Event|1|||
23737426|NCT00535236|66416347|FG001|Overall Study|Adverse Event|0|||
23737427|NCT00535236|66416348|FG002|Overall Study|Adverse Event|9|||
23737428|NCT00535236|66416349|FG003|Overall Study|Adverse Event|3|||
23737429|NCT00535236|66416350|FG004|Overall Study|Adverse Event|3|||
23737430|NCT00535236|66416351|FG005|Overall Study|Adverse Event|0|||
23737431|NCT00535236|66416352|FG006|Overall Study|Adverse Event|5|||
23737432|NCT00535236|66416353|FG007|Overall Study|Adverse Event|1|||
23737433|NCT00535236|66416354|FG008|Overall Study|Adverse Event|2|||
23737434|NCT00535236|66416355|FG009|Overall Study|Adverse Event|1|||
23737435|NCT00535236|66416346|FG000|Overall Study|Lost to Follow-up|1|||
23737436|NCT00535236|66416347|FG001|Overall Study|Lost to Follow-up|2|||
23737437|NCT00535236|66416348|FG002|Overall Study|Lost to Follow-up|0|||
23737438|NCT00535236|66416349|FG003|Overall Study|Lost to Follow-up|0|||
23737439|NCT00535236|66416350|FG004|Overall Study|Lost to Follow-up|2|||
23737440|NCT00535236|66416351|FG005|Overall Study|Lost to Follow-up|0|||
23737441|NCT00535236|66416352|FG006|Overall Study|Lost to Follow-up|0|||
23737442|NCT00535236|66416353|FG007|Overall Study|Lost to Follow-up|0|||
23737443|NCT00535236|66416354|FG008|Overall Study|Lost to Follow-up|6|||
23737444|NCT00535236|66416355|FG009|Overall Study|Lost to Follow-up|1|||
23737445|NCT00535236|66416346|FG000|Overall Study|Physician Decision|0|||
23737446|NCT00535236|66416347|FG001|Overall Study|Physician Decision|0|||
23737447|NCT00535236|66416348|FG002|Overall Study|Physician Decision|0|||
23737448|NCT00535236|66416349|FG003|Overall Study|Physician Decision|0|||
23737449|NCT00535236|66416350|FG004|Overall Study|Physician Decision|1|||
23737450|NCT00535236|66416351|FG005|Overall Study|Physician Decision|0|||
23820135|NCT01111825|66721169|FG002|Overall Study|Adverse Event|4|||
23619087|NCT02600897|65991451|FG001|Overall Study|Withdrawal by Subject|0|||
23619088|NCT02600897|65991452|FG002|Overall Study|Withdrawal by Subject|0|||
23619089|NCT02600897|65991453|FG003|Overall Study|Withdrawal by Subject|0|||
23737451|NCT00535236|66416352|FG006|Overall Study|Physician Decision|1|||
23737452|NCT00535236|66416353|FG007|Overall Study|Physician Decision|0|||
23737453|NCT00535236|66416354|FG008|Overall Study|Physician Decision|0|||
23737454|NCT00535236|66416355|FG009|Overall Study|Physician Decision|0|||
23737455|NCT00535236|66416346|FG000|Overall Study|Protocol Violation|2|||
23737456|NCT00535236|66416347|FG001|Overall Study|Protocol Violation|0|||
23737457|NCT00535236|66416348|FG002|Overall Study|Protocol Violation|1|||
23737458|NCT00535236|66416349|FG003|Overall Study|Protocol Violation|0|||
23737459|NCT00535236|66416350|FG004|Overall Study|Protocol Violation|0|||
23737460|NCT00535236|66416351|FG005|Overall Study|Protocol Violation|0|||
23737461|NCT00535236|66416352|FG006|Overall Study|Protocol Violation|0|||
23737462|NCT00535236|66416353|FG007|Overall Study|Protocol Violation|0|||
23737463|NCT00535236|66416354|FG008|Overall Study|Protocol Violation|1|||
23737464|NCT00535236|66416355|FG009|Overall Study|Protocol Violation|0|||
23737465|NCT00535236|66416346|FG000|Overall Study|Withdrawal by Subject|3|||
23737466|NCT00535236|66416347|FG001|Overall Study|Withdrawal by Subject|0|||
23737467|NCT00535236|66416348|FG002|Overall Study|Withdrawal by Subject|2|||
23737468|NCT00535236|66416349|FG003|Overall Study|Withdrawal by Subject|1|||
23737469|NCT00535236|66416350|FG004|Overall Study|Withdrawal by Subject|6|||
23737470|NCT00535236|66416351|FG005|Overall Study|Withdrawal by Subject|1|||
23737471|NCT00535236|66416352|FG006|Overall Study|Withdrawal by Subject|5|||
23737472|NCT00535236|66416353|FG007|Overall Study|Withdrawal by Subject|0|||
23737473|NCT00535236|66416354|FG008|Overall Study|Withdrawal by Subject|4|||
23737474|NCT00535236|66416355|FG009|Overall Study|Withdrawal by Subject|2|||
23737475|NCT03018028|66416356|FG000|Overall Study|Withdrawal by Subject|3|||
23737476|NCT03018028|66416357|FG001|Overall Study|Withdrawal by Subject|0|||
23737477|NCT03018028|66416358|FG002|Overall Study|Withdrawal by Subject|1|||
23737478|NCT03018028|66416359|FG003|Overall Study|Withdrawal by Subject|2|||
23737479|NCT03018028|66416360|FG004|Overall Study|Withdrawal by Subject|0|||
23737480|NCT02500706|66416372|FG000|Overall Study|Adverse Event|0|||
23737481|NCT02500706|66416373|FG001|Overall Study|Adverse Event|0|||
23737482|NCT02500706|66416374|FG002|Overall Study|Adverse Event|1|||
23737483|NCT02500706|66416372|FG000|Overall Study|Lost to Follow-up|0|||
23737484|NCT02500706|66416373|FG001|Overall Study|Lost to Follow-up|1|||
23737485|NCT02500706|66416374|FG002|Overall Study|Lost to Follow-up|1|||
23737486|NCT02500706|66416372|FG000|Overall Study|Withdrawal by Subject|4|||
23737487|NCT02500706|66416373|FG001|Overall Study|Withdrawal by Subject|6|||
23737488|NCT02500706|66416374|FG002|Overall Study|Withdrawal by Subject|4|||
23737489|NCT02500706|66416372|FG000|Overall Study|Unclassified|0|||
23737490|NCT02500706|66416373|FG001|Overall Study|Unclassified|0|||
23737491|NCT02500706|66416374|FG002|Overall Study|Unclassified|1|||
23737492|NCT01977040|66416375|FG000|Overall Study|Vasa previa not confirmed|2|||
23619090|NCT02600897|65991454|FG004|Overall Study|Withdrawal by Subject|0|||
23619091|NCT02600897|65991455|FG005|Overall Study|Withdrawal by Subject|0|||
23619092|NCT02600897|65991456|FG006|Overall Study|Withdrawal by Subject|0|||
23619093|NCT02600897|65991457|FG007|Overall Study|Withdrawal by Subject|4|||
23619094|NCT02600897|65991458|FG008|Overall Study|Withdrawal by Subject|2|||
23619095|NCT02600897|65991450|FG000|Overall Study|Reason Not Specified|0|||
23619096|NCT02600897|65991451|FG001|Overall Study|Reason Not Specified|0|||
23619097|NCT02600897|65991452|FG002|Overall Study|Reason Not Specified|0|||
23619098|NCT02600897|65991453|FG003|Overall Study|Reason Not Specified|0|||
23619099|NCT02600897|65991454|FG004|Overall Study|Reason Not Specified|0|||
23619100|NCT02600897|65991455|FG005|Overall Study|Reason Not Specified|0|||
23619101|NCT02600897|65991456|FG006|Overall Study|Reason Not Specified|0|||
23737493|NCT00082628|66416376|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23737494|NCT00082628|66416377|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
23737495|NCT00082628|66416378|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23737496|NCT00082628|66416379|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23737497|NCT00082628|66416380|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23737498|NCT00082628|66416376|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
23737499|NCT00082628|66416377|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
23737500|NCT00082628|66416378|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23619102|NCT02600897|65991457|FG007|Overall Study|Reason Not Specified|0|||
23619103|NCT02600897|65991458|FG008|Overall Study|Reason Not Specified|1|||
23619104|NCT00678899|65991459|FG000|Overall Study|Adverse Event|1|||
23737501|NCT00082628|66416379|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23737502|NCT00082628|66416380|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23737503|NCT00082628|66416376|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
23737504|NCT00082628|66416377|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
23737505|NCT00082628|66416378|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23737506|NCT00082628|66416379|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23737507|NCT00082628|66416380|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23737508|NCT00082628|66416376|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
23737509|NCT00082628|66416377|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
23737510|NCT00082628|66416378|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23737511|NCT00082628|66416379|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23737512|NCT00082628|66416380|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23737513|NCT00082628|66416376|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23737514|NCT00082628|66416377|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23737515|NCT00082628|66416378|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23737516|NCT00082628|66416379|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23737517|NCT00082628|66416380|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
23737518|NCT00082628|66416376|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23737519|NCT00082628|66416377|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23737520|NCT00082628|66416378|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23737521|NCT00082628|66416379|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
23737522|NCT00082628|66416380|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23737523|NCT00082628|66416376|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
23737524|NCT00082628|66416377|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
23737525|NCT00082628|66416378|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
23737526|NCT00082628|66416379|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
23737527|NCT00082628|66416380|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
23737528|NCT04657003|66416381|FG000|Overall Study|Adverse Event|5|||
23737529|NCT04657003|66416382|FG001|Overall Study|Adverse Event|1|||
23737530|NCT04657003|66416383|FG002|Overall Study|Adverse Event|5|||
23737531|NCT04657003|66416381|FG000|Overall Study|Death|0|||
23737532|NCT04657003|66416382|FG001|Overall Study|Death|2|||
23737533|NCT04657003|66416383|FG002|Overall Study|Death|0|||
23737534|NCT04657003|66416381|FG000|Overall Study|Lost to Follow-up|8|||
23737535|NCT04657003|66416382|FG001|Overall Study|Lost to Follow-up|4|||
23737536|NCT04657003|66416383|FG002|Overall Study|Lost to Follow-up|10|||
23737537|NCT04657003|66416381|FG000|Overall Study|Other - As Reported by Investigator|3|||
23737538|NCT04657003|66416382|FG001|Overall Study|Other - As Reported by Investigator|2|||
23737539|NCT04657003|66416383|FG002|Overall Study|Other - As Reported by Investigator|2|||
23737540|NCT04657003|66416381|FG000|Overall Study|Pregnancy|2|||
23737541|NCT04657003|66416382|FG001|Overall Study|Pregnancy|0|||
23737542|NCT04657003|66416383|FG002|Overall Study|Pregnancy|2|||
23737543|NCT04657003|66416381|FG000|Overall Study|Withdrawal by Subject|16|||
23737544|NCT04657003|66416382|FG001|Overall Study|Withdrawal by Subject|7|||
23737545|NCT04657003|66416383|FG002|Overall Study|Withdrawal by Subject|10|||
23737546|NCT01097057|66416385|FG000|Overall Study|Physician Decision|3|||
23737547|NCT00695318|66416386|FG000|Overall Study|Lost to Follow-up|1|||
23737548|NCT00695318|66416387|FG001|Overall Study|Lost to Follow-up|0|||
23737549|NCT00695318|66416386|FG000|Overall Study|Withdrawal by Subject|2|||
23737550|NCT00695318|66416387|FG001|Overall Study|Withdrawal by Subject|0|||
23737551|NCT00695318|66416386|FG000|Overall Study|Death|1|||
23737552|NCT00695318|66416387|FG001|Overall Study|Death|1|||
23737553|NCT00695318|66416386|FG000|Overall Study|Study Terminated|1|||
23737554|NCT00695318|66416387|FG001|Overall Study|Study Terminated|0|||
23737555|NCT02059174|66416390|FG000|Period 1|Withdrawal by Subject|0|||
23737556|NCT02059174|66416391|FG001|Period 1|Withdrawal by Subject|2|||
23737557|NCT02059174|66416390|FG000|Period 2|Withdrawal by Subject|0|||
23546596|NCT00144339|65731172|FG000|Overall Study|Withdrawal by Subject|403|||
23546597|NCT00144339|65731173|FG001|Overall Study|Withdrawal by Subject|300|||
23546598|NCT00144339|65731172|FG000|Overall Study|Lost to Follow-up|76|||
23546599|NCT00144339|65731173|FG001|Overall Study|Lost to Follow-up|64|||
23546600|NCT00144339|65731172|FG000|Overall Study|Other|58|||
23546601|NCT00144339|65731173|FG001|Overall Study|Other|60|||
23546602|NCT01910129|65731174|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
23546603|NCT01910129|65731175|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
23546604|NCT01910129|65731176|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
23737558|NCT02059174|66416391|FG001|Period 2|Withdrawal by Subject|2|||
23737559|NCT02059174|66416390|FG000|Period 2|Protocol Violation|1|||
23737560|NCT02059174|66416391|FG001|Period 2|Protocol Violation|0|||
23737561|NCT02059174|66416390|FG000|Period 3|Physician Decision|1|||
23737562|NCT02059174|66416391|FG001|Period 3|Physician Decision|0|||
23737563|NCT00286156|66416392|FG000|Overall Study|Missed 12 month visit|0|||
23737564|NCT00286156|66416393|FG001|Overall Study|Missed 12 month visit|0|||
23737565|NCT00286156|66416394|FG002|Overall Study|Missed 12 month visit|1|||
23737566|NCT00286156|66416392|FG000|Overall Study|AE: pulmonary embolus|0|||
23737567|NCT00286156|66416393|FG001|Overall Study|AE: pulmonary embolus|1|||
23546605|NCT01910129|65731174|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
23546606|NCT01910129|65731175|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
23546607|NCT01910129|65731176|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
23546608|NCT02601313|65731177|FG000|Overall Study|Death|2|||
23546609|NCT02601313|65731178|FG001|Overall Study|Death|16|||
23546610|NCT02601313|65731179|FG002|Overall Study|Death|4|||
23546611|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
23546612|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
23546613|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
23546614|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
23546615|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
23546616|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
23546617|NCT02601313|65731177|FG000|Overall Study|Still on study|0|||
23546618|NCT02601313|65731178|FG001|Overall Study|Still on study|52|||
23546619|NCT02601313|65731179|FG002|Overall Study|Still on study|10|||
23546620|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate AC|4|||
23546621|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate AC|0|||
23546622|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate AC|0|||
23546623|NCT03043664|65731180|FG000|Overall Study|Lost to Follow-up|1|||
23619105|NCT03280108|65991460|FG000|Overall Study|Lost to Follow-up|2|||
23619106|NCT03280108|65991461|FG001|Overall Study|Lost to Follow-up|0|||
23619107|NCT02621047|65991462|FG000|Overall Study|Adverse Event|0|||
23619108|NCT02621047|65991463|FG001|Overall Study|Adverse Event|0|||
23619109|NCT02621047|65991464|FG002|Overall Study|Adverse Event|1|||
23619110|NCT00922441|65991465|FG000|Overall Study|Protocol Violation|0|||
23619111|NCT00922441|65991466|FG001|Overall Study|Protocol Violation|0|||
23619112|NCT00922441|65991467|FG002|Overall Study|Protocol Violation|2|||
23619113|NCT00922441|65991465|FG000|Overall Study|Withdrawal by Subject|0|||
23619114|NCT00922441|65991466|FG001|Overall Study|Withdrawal by Subject|0|||
23619115|NCT00922441|65991467|FG002|Overall Study|Withdrawal by Subject|1|||
23619116|NCT01494298|65991468|FG000|Overall Study|Protocol Violation|2|||
23737568|NCT00286156|66416394|FG002|Overall Study|AE: pulmonary embolus|0|||
23737569|NCT00286156|66416392|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
23737570|NCT00286156|66416393|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
23737571|NCT00286156|66416394|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
23737572|NCT00286156|66416392|FG000|Overall Study|AE: pneumonia|1|||
23737573|NCT00286156|66416393|FG001|Overall Study|AE: pneumonia|0|||
23737574|NCT00286156|66416394|FG002|Overall Study|AE: pneumonia|0|||
23737575|NCT00963469|66416396|FG000|Overall Study|Adverse Event|15|||
23737576|NCT00963469|66416397|FG001|Overall Study|Adverse Event|11|||
23737577|NCT00963469|66416398|FG002|Overall Study|Adverse Event|1|||
23737578|NCT00963469|66416396|FG000|Overall Study|Lack of Efficacy|10|||
23737579|NCT00963469|66416397|FG001|Overall Study|Lack of Efficacy|7|||
23737580|NCT00963469|66416398|FG002|Overall Study|Lack of Efficacy|2|||
23737581|NCT00963469|66416396|FG000|Overall Study|Lost to Follow-up|1|||
23737582|NCT00963469|66416397|FG001|Overall Study|Lost to Follow-up|1|||
23737583|NCT00963469|66416398|FG002|Overall Study|Lost to Follow-up|0|||
23737584|NCT00963469|66416396|FG000|Overall Study|Protocol Violation|5|||
23737585|NCT00963469|66416397|FG001|Overall Study|Protocol Violation|5|||
23619117|NCT01494298|65991469|FG001|Overall Study|Protocol Violation|8|||
23619118|NCT00550771|65991472|FG000|Overall Study|Adverse Event|11|||
23619119|NCT00550771|65991473|FG001|Overall Study|Adverse Event|3|||
23619120|NCT00550771|65991472|FG000|Overall Study|Discontinued for study-related reasons|0|||
23619121|NCT00550771|65991473|FG001|Overall Study|Discontinued for study-related reasons|1|||
23619122|NCT00550771|65991472|FG000|Overall Study|Physician Decision|2|||
23619123|NCT00550771|65991473|FG001|Overall Study|Physician Decision|0|||
23619124|NCT00550771|65991472|FG000|Overall Study|Withdrawal by Subject|0|||
23619125|NCT00550771|65991473|FG001|Overall Study|Withdrawal by Subject|1|||
23619126|NCT00550771|65991472|FG000|Overall Study|Protocol Violation|4|||
23737586|NCT00963469|66416398|FG002|Overall Study|Protocol Violation|3|||
23546624|NCT03690869|65731184|FG000|Overall Study|Adverse Event|0|||
23546625|NCT03690869|65731185|FG001|Overall Study|Adverse Event|0|||
23546626|NCT03690869|65731186|FG002|Overall Study|Adverse Event|0|||
23546627|NCT03690869|65731187|FG003|Overall Study|Adverse Event|1|||
23737587|NCT00963469|66416396|FG000|Overall Study|Withdrawal by Subject|4|||
23546628|NCT03690869|65731188|FG004|Overall Study|Adverse Event|0|||
23546629|NCT03690869|65731189|FG005|Overall Study|Adverse Event|0|||
23619127|NCT00550771|65991473|FG001|Overall Study|Protocol Violation|5|||
23619128|NCT03022045|65991482|FG000|Overall Study|Adverse Event|0|||
23619129|NCT03022045|65991483|FG001|Overall Study|Adverse Event|1|||
23737588|NCT00963469|66416397|FG001|Overall Study|Withdrawal by Subject|1|||
23737589|NCT00963469|66416398|FG002|Overall Study|Withdrawal by Subject|1|||
23820136|NCT01111825|66721170|FG003|Overall Study|Adverse Event|0|||
23820137|NCT01111825|66721167|FG000|Overall Study|Disease Progression|1|||
23546630|NCT03690869|65731190|FG006|Overall Study|Adverse Event|0|||
23546631|NCT03690869|65731191|FG007|Overall Study|Adverse Event|1|||
23619130|NCT03022045|65991482|FG000|Overall Study|Withdrawal by Subject|1|||
23820138|NCT01111825|66721168|FG001|Overall Study|Disease Progression|0|||
23820139|NCT01111825|66721169|FG002|Overall Study|Disease Progression|0|||
23820140|NCT01111825|66721170|FG003|Overall Study|Disease Progression|0|||
23820141|NCT01111825|66721167|FG000|Overall Study|Discontinuation by Sponsor|0|||
23820142|NCT01111825|66721168|FG001|Overall Study|Discontinuation by Sponsor|0|||
23820143|NCT01111825|66721169|FG002|Overall Study|Discontinuation by Sponsor|0|||
23820144|NCT01111825|66721170|FG003|Overall Study|Discontinuation by Sponsor|20|||
23820145|NCT03203850|66721172|FG000|Overall Study|Subject/guardian decision|4|||
23820146|NCT03203850|66721173|FG001|Overall Study|Subject/guardian decision|3|||
23820147|NCT03203850|66721172|FG000|Overall Study|Adverse Event|3|||
23820148|NCT03203850|66721173|FG001|Overall Study|Adverse Event|0|||
23820149|NCT03203850|66721172|FG000|Overall Study|Death|1|||
23820150|NCT03203850|66721173|FG001|Overall Study|Death|0|||
23820151|NCT02754856|66721176|FG000|Overall Study|Withdrawal by Subject|1|||
23820152|NCT02075515|66721178|FG000|Overall Study|Serious Adverse Event|1|||
23820153|NCT02075515|66721179|FG001|Overall Study|Serious Adverse Event|1|||
23820154|NCT02075515|66721180|FG002|Overall Study|Serious Adverse Event|1|||
23820155|NCT02075515|66721178|FG000|Overall Study|Non-Serious Adverse Event|0|||
23820156|NCT02075515|66721179|FG001|Overall Study|Non-Serious Adverse Event|1|||
23820157|NCT02075515|66721180|FG002|Overall Study|Non-Serious Adverse Event|0|||
23820158|NCT02075515|66721178|FG000|Overall Study|Withdrawal by Subject|2|||
23820159|NCT02075515|66721179|FG001|Overall Study|Withdrawal by Subject|0|||
23820160|NCT02075515|66721180|FG002|Overall Study|Withdrawal by Subject|1|||
23820161|NCT02075515|66721178|FG000|Overall Study|Lost to Follow-up|1|||
23820162|NCT02075515|66721179|FG001|Overall Study|Lost to Follow-up|3|||
23820163|NCT02075515|66721180|FG002|Overall Study|Lost to Follow-up|6|||
23426987|NCT00642369|65307501|FG000|Overall Study|misdiagnosis|0|||
23426988|NCT00642369|65307502|FG001|Overall Study|misdiagnosis|1|||
23820164|NCT02252406|66721181|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
23820165|NCT02252406|66721182|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
23820166|NCT02252406|66721181|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
23820167|NCT02252406|66721182|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
23820168|NCT02252406|66721181|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
23820169|NCT02252406|66721182|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
23820170|NCT02252406|66721181|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
23820171|NCT02252406|66721182|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
23820172|NCT02252406|66721181|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
23820173|NCT02252406|66721182|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
23820174|NCT01374269|66721183|FG000|Overall Study|Withdrawal by Subject|4|||
23820175|NCT01374269|66721184|FG001|Overall Study|Withdrawal by Subject|0|||
23820176|NCT01374269|66721183|FG000|Overall Study|Lost to Follow-up|1|||
23820177|NCT01374269|66721184|FG001|Overall Study|Lost to Follow-up|3|||
23820178|NCT01374269|66721183|FG000|Overall Study|closed research|1|||
23820179|NCT01374269|66721184|FG001|Overall Study|closed research|2|||
23820180|NCT02201277|66721185|FG000|Overall Study|Death|3|||
23820181|NCT02201277|66721186|FG001|Overall Study|Death|4|||
23426989|NCT00642369|65307501|FG000|Overall Study|Lack of Efficacy|2|||
23426990|NCT00642369|65307502|FG001|Overall Study|Lack of Efficacy|2|||
23426991|NCT03405935|65307503|FG000|Overall Study|Adverse Event|3|||
23426992|NCT03405935|65307503|FG000|Overall Study|Death|2|||
23426993|NCT03405935|65307503|FG000|Overall Study|Withdrawal by Subject|1|||
23426994|NCT03405935|65307503|FG000|Overall Study|Lost to Follow-up|2|||
23426995|NCT01479595|65307504|FG000|Overall Study|Protocol deviation|0|||
23426996|NCT01479595|65307505|FG001|Overall Study|Protocol deviation|1|||
23426997|NCT01479595|65307504|FG000|Overall Study|Adverse Event|2|||
23426998|NCT01479595|65307505|FG001|Overall Study|Adverse Event|1|||
23426999|NCT00933244|65307506|FG000|Overall Study|Withdrawal by Subject|5|||
23427000|NCT00933244|65307507|FG001|Overall Study|Withdrawal by Subject|1|||
23427001|NCT00933244|65307508|FG002|Overall Study|Withdrawal by Subject|3|||
23427002|NCT02317809|65307510|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
23427003|NCT02317809|65307511|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
23427004|NCT02317809|65307510|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
23427005|NCT02317809|65307511|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
23427006|NCT03344640|65307512|FG000|Overall Study|Adverse Event|1|||
23820182|NCT02201277|66721185|FG000|Overall Study|Lost to Follow-up|2|||
23820183|NCT02201277|66721186|FG001|Overall Study|Lost to Follow-up|1|||
23820184|NCT02201277|66721185|FG000|Overall Study|Failed retrieval|1|||
23820185|NCT02201277|66721186|FG001|Overall Study|Failed retrieval|0|||
23427007|NCT03344640|65307513|FG001|Overall Study|Adverse Event|0|||
23427008|NCT03344640|65307512|FG000|Overall Study|Physician Decision|1|||
23546632|NCT03690869|65731192|FG008|Overall Study|Adverse Event|0|||
23820186|NCT02201277|66721185|FG000|Overall Study|Physician Decision|1|||
23820187|NCT02201277|66721186|FG001|Overall Study|Physician Decision|0|||
23820188|NCT02859142|66721193|FG000|Overall Study|Adverse Event|1|||
23820189|NCT02859142|66721194|FG001|Overall Study|Adverse Event|2|||
23820190|NCT02859142|66721193|FG000|Overall Study|Lost to Follow-up|1|||
23427009|NCT03344640|65307513|FG001|Overall Study|Physician Decision|1|||
23427010|NCT03344640|65307512|FG000|Overall Study|Withdrawal by Subject|1|||
23427011|NCT03344640|65307513|FG001|Overall Study|Withdrawal by Subject|2|||
23427012|NCT03344640|65307512|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
23427013|NCT03344640|65307513|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
23427014|NCT00520013|65307515|FG000|Overall Study|Withdrawal by Subject|0|||
23427015|NCT00520013|65307516|FG001|Overall Study|Withdrawal by Subject|0|||
23427016|NCT00520013|65307517|FG002|Overall Study|Withdrawal by Subject|1|||
23427017|NCT00520013|65307515|FG000|Overall Study|Adverse Event|2|||
23427018|NCT00520013|65307516|FG001|Overall Study|Adverse Event|10|||
23427019|NCT00520013|65307517|FG002|Overall Study|Adverse Event|7|||
23427020|NCT00520013|65307515|FG000|Overall Study|Progressive Disease|7|||
23427021|NCT00520013|65307516|FG001|Overall Study|Progressive Disease|3|||
23427022|NCT00520013|65307517|FG002|Overall Study|Progressive Disease|0|||
23427023|NCT00520013|65307515|FG000|Overall Study|Clinical Progression|3|||
23427024|NCT00520013|65307516|FG001|Overall Study|Clinical Progression|1|||
23427025|NCT00520013|65307517|FG002|Overall Study|Clinical Progression|0|||
23427026|NCT00520013|65307515|FG000|Overall Study|Death|0|||
23427027|NCT00520013|65307516|FG001|Overall Study|Death|1|||
23427028|NCT00520013|65307517|FG002|Overall Study|Death|0|||
23427029|NCT00520013|65307515|FG000|Overall Study|Physician Decision|0|||
23427030|NCT00520013|65307516|FG001|Overall Study|Physician Decision|0|||
23427031|NCT00520013|65307517|FG002|Overall Study|Physician Decision|3|||
23427032|NCT01009346|65307518|FG000|Overall Study|Adverse Event|4|||
23427033|NCT01591863|65307519|FG000|Overall Study|Adverse Event|3|||
23427034|NCT01591863|65307519|FG000|Overall Study|Withdrawal by Subject|1|||
23427035|NCT01591863|65307519|FG000|Overall Study|recurrence|9|||
23427036|NCT01591863|65307519|FG000|Overall Study|Lack of Efficacy|1|||
23427037|NCT01561755|65307520|FG000|Overall Study|Lost to Follow-up|0|||
23427038|NCT01561755|65307521|FG001|Overall Study|Lost to Follow-up|1|||
23427039|NCT04676867|65307524|FG000|Overall Study|Screen failure|0|||
23427040|NCT04676867|65307525|FG001|Overall Study|Screen failure|0|||
23427041|NCT04676867|65307526|FG002|Overall Study|Screen failure|6|||
23427042|NCT04676867|65307527|FG003|Overall Study|Screen failure|2|||
23427043|NCT04676867|65307524|FG000|Overall Study|Death|0|||
23427044|NCT04676867|65307525|FG001|Overall Study|Death|0|||
23427045|NCT04676867|65307526|FG002|Overall Study|Death|1|||
23427046|NCT04676867|65307527|FG003|Overall Study|Death|0|||
23427047|NCT04676867|65307524|FG000|Overall Study|Withdrawal by Subject|2|||
23427048|NCT04676867|65307525|FG001|Overall Study|Withdrawal by Subject|2|||
23427049|NCT04676867|65307526|FG002|Overall Study|Withdrawal by Subject|4|||
23427050|NCT04676867|65307527|FG003|Overall Study|Withdrawal by Subject|4|||
23427051|NCT04676867|65307524|FG000|Overall Study|Lost to Follow-up|1|||
23427052|NCT04676867|65307525|FG001|Overall Study|Lost to Follow-up|0|||
23427053|NCT04676867|65307526|FG002|Overall Study|Lost to Follow-up|0|||
23427054|NCT04676867|65307527|FG003|Overall Study|Lost to Follow-up|0|||
23427055|NCT03684304|65307528|FG000|Overall Study|Lost to Follow-up|19|||
23820191|NCT02859142|66721194|FG001|Overall Study|Lost to Follow-up|4|||
23820192|NCT02859142|66721193|FG000|Overall Study|Withdrawal by Subject|2|||
23820193|NCT02859142|66721194|FG001|Overall Study|Withdrawal by Subject|0|||
23820194|NCT02859142|66721193|FG000|Overall Study|Scheduling difficulties|0|||
23820195|NCT02859142|66721194|FG001|Overall Study|Scheduling difficulties|3|||
23820196|NCT01808573|66721197|FG000|Overall Study|Death|212|||
23820197|NCT01808573|66721198|FG001|Overall Study|Death|240|||
23820198|NCT01808573|66721197|FG000|Overall Study|Withdrawal by Subject|12|||
23427056|NCT03684304|65307529|FG001|Overall Study|Lost to Follow-up|17|||
23427057|NCT01822535|65307535|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
23427058|NCT01822535|65307536|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
23427059|NCT01822535|65307535|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
23427060|NCT01822535|65307536|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
23427061|NCT01822535|65307535|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
23427062|NCT01822535|65307536|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
23427063|NCT01300351|65307539|FG000|Overall Study|Did not receive treatment|2|||
23427064|NCT01300351|65307540|FG001|Overall Study|Did not receive treatment|0|||
23427065|NCT01300351|65307539|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
23427066|NCT01300351|65307540|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
23820199|NCT01808573|66721198|FG001|Overall Study|Withdrawal by Subject|10|||
23427067|NCT01300351|65307539|FG000|Overall Study|Lost to Follow-up|0|||
23427068|NCT01300351|65307540|FG001|Overall Study|Lost to Follow-up|1|||
23820200|NCT01808573|66721197|FG000|Overall Study|Lost to Follow-up|3|||
23820201|NCT01808573|66721198|FG001|Overall Study|Lost to Follow-up|0|||
23820202|NCT01808573|66721197|FG000|Overall Study|Discontinuation of study by sponsor|79|||
23820203|NCT01808573|66721198|FG001|Overall Study|Discontinuation of study by sponsor|64|||
23427069|NCT01300351|65307539|FG000|Overall Study|Adverse Event|0|||
23427070|NCT01300351|65307540|FG001|Overall Study|Adverse Event|4|||
23427071|NCT01300351|65307539|FG000|Overall Study|Withdrawal by Subject|7|||
23427072|NCT01300351|65307540|FG001|Overall Study|Withdrawal by Subject|10|||
23820204|NCT01808573|66721197|FG000|Overall Study|Randomized in Error|1|||
23427073|NCT03080883|65307541|FG000|Overall Study|Withdrawal by Subject|11|||
23427074|NCT03080883|65307542|FG001|Overall Study|Withdrawal by Subject|15|||
23427075|NCT03080883|65307541|FG000|Overall Study|Adverse Event|22|||
23427076|NCT03080883|65307542|FG001|Overall Study|Adverse Event|22|||
23427077|NCT03080883|65307541|FG000|Overall Study|Alternative Therapy|0|||
23427078|NCT03080883|65307542|FG001|Overall Study|Alternative Therapy|3|||
23427079|NCT03080883|65307541|FG000|Overall Study|Other Complicating Disease|9|||
23427080|NCT03080883|65307542|FG001|Overall Study|Other Complicating Disease|5|||
23427081|NCT03080883|65307541|FG000|Overall Study|Death|21|||
23427082|NCT03080883|65307542|FG001|Overall Study|Death|16|||
23427083|NCT03080883|65307541|FG000|Overall Study|Physician Decision|2|||
23427084|NCT03080883|65307542|FG001|Overall Study|Physician Decision|2|||
23427085|NCT03080883|65307541|FG000|Overall Study|Disease Progression|2|||
23427086|NCT03080883|65307542|FG001|Overall Study|Disease Progression|8|||
23427087|NCT03080883|65307541|FG000|Overall Study|Lost to Follow-up|1|||
23427088|NCT03080883|65307542|FG001|Overall Study|Lost to Follow-up|1|||
23427089|NCT01143896|65307547|FG000|Overall Study|Did not complete Baseline Interview|5|||
23427090|NCT01143896|65307548|FG001|Overall Study|Did not complete Baseline Interview|4|||
23427091|NCT01143896|65307547|FG000|Overall Study|Lost to Follow-up|18|||
23427092|NCT01143896|65307548|FG001|Overall Study|Lost to Follow-up|13|||
23427093|NCT01143896|65307547|FG000|Overall Study|Withdrawal by Subject|13|||
23427094|NCT01143896|65307548|FG001|Overall Study|Withdrawal by Subject|5|||
23427095|NCT01143896|65307547|FG000|Overall Study|Death|6|||
23427096|NCT01143896|65307548|FG001|Overall Study|Death|3|||
23427097|NCT03323736|65307549|FG000|Overall Study|Screen Failure|14|||
23427098|NCT03323736|65307550|FG001|Overall Study|Screen Failure|9|||
23427099|NCT03323736|65307551|FG002|Overall Study|Screen Failure|1|||
23427100|NCT03323736|65307549|FG000|Overall Study|Withdrawal Before Treatment|3|||
23427101|NCT03323736|65307550|FG001|Overall Study|Withdrawal Before Treatment|1|||
23427102|NCT03323736|65307551|FG002|Overall Study|Withdrawal Before Treatment|1|||
23427103|NCT03323736|65307549|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
23427104|NCT03323736|65307550|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
23427105|NCT03323736|65307551|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
23427106|NCT04962230|65307552|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
23427107|NCT04962230|65307552|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
23427108|NCT00509093|65307553|FG000|Overall Study|Adverse Event|10|||
23427109|NCT00509093|65307553|FG000|Overall Study|Disease Progression|9|||
23427110|NCT00509093|65307553|FG000|Overall Study|Transformed into MDS|1|||
23427111|NCT00509093|65307553|FG000|Overall Study|Withdrawal by Subject|3|||
23427112|NCT00509093|65307553|FG000|Overall Study|Physician Decision|1|||
23427113|NCT00868530|65307554|FG000|Overall Study|Adverse Event|3|||
23546633|NCT03690869|65731193|FG009|Overall Study|Adverse Event|1|||
23546634|NCT03690869|65731184|FG000|Overall Study|Death|1|||
23546635|NCT03690869|65731185|FG001|Overall Study|Death|1|||
23546636|NCT03690869|65731186|FG002|Overall Study|Death|1|||
23546637|NCT03690869|65731187|FG003|Overall Study|Death|4|||
23546638|NCT03690869|65731188|FG004|Overall Study|Death|2|||
23546639|NCT03690869|65731189|FG005|Overall Study|Death|5|||
23546640|NCT03690869|65731190|FG006|Overall Study|Death|3|||
23546641|NCT03690869|65731191|FG007|Overall Study|Death|2|||
23546642|NCT03690869|65731192|FG008|Overall Study|Death|0|||
23546643|NCT03690869|65731193|FG009|Overall Study|Death|3|||
23546644|NCT03690869|65731184|FG000|Overall Study|Lost to Follow-up|0|||
23546645|NCT03690869|65731185|FG001|Overall Study|Lost to Follow-up|0|||
23546646|NCT03690869|65731186|FG002|Overall Study|Lost to Follow-up|1|||
23546647|NCT03690869|65731187|FG003|Overall Study|Lost to Follow-up|0|||
23546648|NCT03690869|65731188|FG004|Overall Study|Lost to Follow-up|0|||
23546649|NCT03690869|65731189|FG005|Overall Study|Lost to Follow-up|0|||
23546650|NCT03690869|65731190|FG006|Overall Study|Lost to Follow-up|0|||
23737590|NCT00963469|66416396|FG000|Overall Study|Pre-randomization Adverse Event|1|||
23737591|NCT00963469|66416397|FG001|Overall Study|Pre-randomization Adverse Event|2|||
23427114|NCT00868530|65307554|FG000|Overall Study|Lost to Follow-up|1|||
23427115|NCT02847858|65307555|FG000|Overall Study|Lost to Follow-up|401|||
23427116|NCT02847858|65307556|FG001|Overall Study|Lost to Follow-up|269|||
23427117|NCT01170598|65307560|FG000|Overall Study|Withdrawal by Subject|1|||
23427118|NCT01170598|65307560|FG000|Overall Study|Death|3|||
23427119|NCT01170598|65307560|FG000|Overall Study|Lost to Follow-up|1|||
23427120|NCT01170598|65307560|FG000|Overall Study|Refused|1|||
23427121|NCT02649855|65307569|FG000|Overall Study|Refused further treatment|2|||
23427122|NCT02649855|65307570|FG001|Overall Study|Refused further treatment|1|||
23546651|NCT03690869|65731191|FG007|Overall Study|Lost to Follow-up|0|||
23546652|NCT03690869|65731192|FG008|Overall Study|Lost to Follow-up|0|||
23619131|NCT03022045|65991483|FG001|Overall Study|Withdrawal by Subject|1|||
23619132|NCT02383927|65991484|FG000|Overall Study|Disease Progression|8|||
23427123|NCT02649855|65307571|FG002|Overall Study|Refused further treatment|1|||
23427124|NCT02649855|65307569|FG000|Overall Study|Withdrew consent|0|||
23546653|NCT03690869|65731193|FG009|Overall Study|Lost to Follow-up|0|||
23546654|NCT03690869|65731184|FG000|Overall Study|Other Treatment|1|||
23546655|NCT03690869|65731185|FG001|Overall Study|Other Treatment|1|||
23546656|NCT03690869|65731186|FG002|Overall Study|Other Treatment|1|||
23546657|NCT03690869|65731187|FG003|Overall Study|Other Treatment|2|||
23546658|NCT03690869|65731188|FG004|Overall Study|Other Treatment|3|||
23546659|NCT03690869|65731189|FG005|Overall Study|Other Treatment|1|||
23546660|NCT03690869|65731190|FG006|Overall Study|Other Treatment|2|||
23546661|NCT03690869|65731191|FG007|Overall Study|Other Treatment|7|||
23546662|NCT03690869|65731192|FG008|Overall Study|Other Treatment|0|||
23546663|NCT03690869|65731193|FG009|Overall Study|Other Treatment|3|||
23546664|NCT03690869|65731184|FG000|Overall Study|Physician Decision|0|||
23546665|NCT03690869|65731185|FG001|Overall Study|Physician Decision|1|||
23546666|NCT03690869|65731186|FG002|Overall Study|Physician Decision|0|||
23546667|NCT03690869|65731187|FG003|Overall Study|Physician Decision|0|||
23619133|NCT02383927|65991485|FG001|Overall Study|Disease Progression|8|||
23619134|NCT02383927|65991486|FG002|Overall Study|Disease Progression|15|||
23619135|NCT02383927|65991487|FG003|Overall Study|Disease Progression|4|||
23619136|NCT02383927|65991484|FG000|Overall Study|Physician Decision|0|||
23619137|NCT02383927|65991485|FG001|Overall Study|Physician Decision|0|||
23619138|NCT02383927|65991486|FG002|Overall Study|Physician Decision|2|||
23619139|NCT02383927|65991487|FG003|Overall Study|Physician Decision|0|||
23619140|NCT02383927|65991484|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
23619141|NCT02383927|65991485|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
23619142|NCT02383927|65991486|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
23619143|NCT02383927|65991487|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
23619144|NCT02383927|65991484|FG000|Overall Study|Adverse Event|4|||
23546668|NCT03690869|65731188|FG004|Overall Study|Physician Decision|0|||
23546669|NCT03690869|65731189|FG005|Overall Study|Physician Decision|0|||
23546670|NCT03690869|65731190|FG006|Overall Study|Physician Decision|0|||
23546671|NCT03690869|65731191|FG007|Overall Study|Physician Decision|0|||
23546672|NCT03690869|65731192|FG008|Overall Study|Physician Decision|0|||
23546673|NCT03690869|65731193|FG009|Overall Study|Physician Decision|0|||
23546674|NCT03690869|65731184|FG000|Overall Study|Progressive Disease|1|||
23546675|NCT03690869|65731185|FG001|Overall Study|Progressive Disease|2|||
23546676|NCT03690869|65731186|FG002|Overall Study|Progressive Disease|0|||
23619145|NCT02383927|65991485|FG001|Overall Study|Adverse Event|1|||
23619146|NCT02383927|65991486|FG002|Overall Study|Adverse Event|3|||
23619147|NCT02383927|65991487|FG003|Overall Study|Adverse Event|5|||
23619148|NCT02383927|65991484|FG000|Overall Study|Miscellaneous|1|||
23619149|NCT02383927|65991485|FG001|Overall Study|Miscellaneous|0|||
23619150|NCT02383927|65991486|FG002|Overall Study|Miscellaneous|0|||
23619151|NCT02383927|65991487|FG003|Overall Study|Miscellaneous|1|||
23619152|NCT02383927|65991484|FG000|Overall Study|Withdrawal by Subject|0|||
23619153|NCT02383927|65991485|FG001|Overall Study|Withdrawal by Subject|1|||
23619154|NCT02383927|65991486|FG002|Overall Study|Withdrawal by Subject|4|||
23619155|NCT02383927|65991487|FG003|Overall Study|Withdrawal by Subject|0|||
23619156|NCT02859558|65991488|FG000|Step 1|Not Eligible|0|||
23619157|NCT02859558|65991489|FG001|Step 1|Not Eligible|0|||
23619158|NCT02859558|65991490|FG002|Step 1|Not Eligible|0|||
23619159|NCT02859558|65991491|FG003|Step 1|Not Eligible|0|||
23619160|NCT02859558|65991492|FG004|Step 1|Not Eligible|3|||
23619161|NCT02859558|65991488|FG000|Step 1|Lost to Follow-up|1|||
23619162|NCT02859558|65991489|FG001|Step 1|Lost to Follow-up|3|||
23619163|NCT02859558|65991490|FG002|Step 1|Lost to Follow-up|3|||
23737592|NCT00963469|66416398|FG002|Overall Study|Pre-randomization Adverse Event|0|||
23737593|NCT00963469|66416396|FG000|Overall Study|Moved|1|||
23737594|NCT00963469|66416397|FG001|Overall Study|Moved|0|||
23737595|NCT00963469|66416398|FG002|Overall Study|Moved|0|||
23737596|NCT00963469|66416396|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
23737597|NCT00963469|66416397|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
23737598|NCT00963469|66416398|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
23737599|NCT00620815|66416406|FG000|Overall Study|Adverse Event|1|||
23737600|NCT00620815|66416407|FG001|Overall Study|Adverse Event|1|||
23737601|NCT00620815|66416408|FG002|Overall Study|Adverse Event|2|||
23737602|NCT00620815|66416406|FG000|Overall Study|Withdrawal by Subject|1|||
23546677|NCT03690869|65731187|FG003|Overall Study|Progressive Disease|1|||
23737603|NCT00620815|66416407|FG001|Overall Study|Withdrawal by Subject|2|||
23546678|NCT03690869|65731188|FG004|Overall Study|Progressive Disease|0|||
23546679|NCT03690869|65731189|FG005|Overall Study|Progressive Disease|0|||
23546680|NCT03690869|65731190|FG006|Overall Study|Progressive Disease|0|||
23546681|NCT03690869|65731191|FG007|Overall Study|Progressive Disease|0|||
23619164|NCT02859558|65991491|FG003|Step 1|Lost to Follow-up|0|||
23619165|NCT02859558|65991492|FG004|Step 1|Lost to Follow-up|0|||
23619166|NCT02859558|65991488|FG000|Step 1|Did Not Return to Clinic|2|||
23619167|NCT02859558|65991489|FG001|Step 1|Did Not Return to Clinic|3|||
23619168|NCT02859558|65991490|FG002|Step 1|Did Not Return to Clinic|4|||
23619169|NCT02859558|65991491|FG003|Step 1|Did Not Return to Clinic|0|||
23619170|NCT02859558|65991492|FG004|Step 1|Did Not Return to Clinic|0|||
23619171|NCT02859558|65991488|FG000|Step 1|Moved|0|||
23619172|NCT02859558|65991489|FG001|Step 1|Moved|1|||
23737604|NCT00620815|66416408|FG002|Overall Study|Withdrawal by Subject|0|||
23546682|NCT03690869|65731192|FG008|Overall Study|Progressive Disease|1|||
23619173|NCT02859558|65991490|FG002|Step 1|Moved|1|||
23427125|NCT02649855|65307570|FG001|Overall Study|Withdrew consent|1|||
23427126|NCT02649855|65307571|FG002|Overall Study|Withdrew consent|0|||
23546683|NCT03690869|65731193|FG009|Overall Study|Progressive Disease|1|||
23546684|NCT03690869|65731184|FG000|Overall Study|Subject Decision|0|||
23546685|NCT03690869|65731185|FG001|Overall Study|Subject Decision|0|||
23546686|NCT03690869|65731186|FG002|Overall Study|Subject Decision|0|||
23546687|NCT03690869|65731187|FG003|Overall Study|Subject Decision|1|||
23546688|NCT03690869|65731188|FG004|Overall Study|Subject Decision|0|||
23546689|NCT03690869|65731189|FG005|Overall Study|Subject Decision|0|||
23546690|NCT03690869|65731190|FG006|Overall Study|Subject Decision|0|||
23546691|NCT03690869|65731191|FG007|Overall Study|Subject Decision|1|||
23546692|NCT03690869|65731192|FG008|Overall Study|Subject Decision|0|||
23546693|NCT03690869|65731193|FG009|Overall Study|Subject Decision|0|||
23546694|NCT00110617|65731194|FG000|Overall Study|Adverse Event|2|||
23546695|NCT00110617|65731195|FG001|Overall Study|Adverse Event|4|||
23546696|NCT00110617|65731194|FG000|Overall Study|Abnormal Laboratory Value|4|||
23546697|NCT00110617|65731195|FG001|Overall Study|Abnormal Laboratory Value|2|||
23546698|NCT00110617|65731194|FG000|Overall Study|Lack of Efficacy|1|||
23546699|NCT00110617|65731195|FG001|Overall Study|Lack of Efficacy|0|||
23546700|NCT00110617|65731194|FG000|Overall Study|Patient no longer requires study drug|1|||
23546701|NCT00110617|65731195|FG001|Overall Study|Patient no longer requires study drug|0|||
23546702|NCT00110617|65731194|FG000|Overall Study|Protocol Violation|5|||
23546703|NCT00110617|65731195|FG001|Overall Study|Protocol Violation|0|||
23546704|NCT00110617|65731194|FG000|Overall Study|Withdrawal by Subject|10|||
23546705|NCT00110617|65731195|FG001|Overall Study|Withdrawal by Subject|4|||
23546706|NCT00110617|65731194|FG000|Overall Study|Lost to Follow-up|9|||
23546707|NCT00110617|65731195|FG001|Overall Study|Lost to Follow-up|1|||
23427127|NCT02649855|65307569|FG000|Overall Study|Switched to alternative treatment|0|||
23427128|NCT02649855|65307570|FG001|Overall Study|Switched to alternative treatment|1|||
23427129|NCT02649855|65307571|FG002|Overall Study|Switched to alternative treatment|1|||
23427130|NCT02649855|65307569|FG000|Overall Study|Principal investigator discretion|0|||
23546708|NCT00110617|65731194|FG000|Overall Study|Administrative problems|6|||
23546709|NCT00110617|65731195|FG001|Overall Study|Administrative problems|5|||
23546710|NCT00110617|65731194|FG000|Overall Study|Death|1|||
23546711|NCT00110617|65731195|FG001|Overall Study|Death|1|||
23546712|NCT00110617|65731194|FG000|Overall Study|Did not receive study drug|0|||
23546713|NCT00110617|65731195|FG001|Overall Study|Did not receive study drug|12|||
23546714|NCT01750268|65731196|FG000|Overall Study|Lost to Follow-up|0|||
23546715|NCT01750268|65731197|FG001|Overall Study|Lost to Follow-up|2|||
23546716|NCT01750268|65731196|FG000|Overall Study|Physician Decision|0|||
23546717|NCT01750268|65731197|FG001|Overall Study|Physician Decision|3|||
23546718|NCT01750268|65731196|FG000|Overall Study|Withdrawal by Subject|2|||
23546719|NCT01750268|65731197|FG001|Overall Study|Withdrawal by Subject|0|||
23737605|NCT00620815|66416406|FG000|Overall Study|Lost to Follow-up|1|||
23737606|NCT00620815|66416407|FG001|Overall Study|Lost to Follow-up|6|||
23737607|NCT00620815|66416408|FG002|Overall Study|Lost to Follow-up|3|||
23737608|NCT00620815|66416406|FG000|Overall Study|Inappropriate enrolment|0|||
23546720|NCT03624504|65731198|FG000|Overall Study|Unsuccessful Implant|1|||
23546721|NCT04447404|65731200|FG000|Overall Study|Death|2|||
23546722|NCT04447404|65731201|FG001|Overall Study|Death|0|||
23546723|NCT02270450|65731203|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23546724|NCT02270450|65731204|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23546725|NCT02270450|65731205|FG002|Overall Study|Refusal unrelated to adverse event|5|||
23737609|NCT00620815|66416407|FG001|Overall Study|Inappropriate enrolment|0|||
23737610|NCT00620815|66416408|FG002|Overall Study|Inappropriate enrolment|1|||
23737611|NCT00620815|66416406|FG000|Overall Study|Protocol Violation|1|||
23737612|NCT00620815|66416407|FG001|Overall Study|Protocol Violation|2|||
23737613|NCT00620815|66416408|FG002|Overall Study|Protocol Violation|1|||
23737614|NCT03558503|66416419|FG000|Overall Study|Adverse Event|1|||
23546726|NCT02270450|65731206|FG003|Overall Study|Refusal unrelated to adverse event|14|||
23546727|NCT02270450|65731203|FG000|Overall Study|Progression/relapse|1|||
23546728|NCT02270450|65731204|FG001|Overall Study|Progression/relapse|2|||
23546729|NCT02270450|65731205|FG002|Overall Study|Progression/relapse|4|||
23546730|NCT02270450|65731206|FG003|Overall Study|Progression/relapse|9|||
23546731|NCT02270450|65731203|FG000|Overall Study|Death|19|||
23737615|NCT03558503|66416419|FG000|Overall Study|Death|1|||
23737616|NCT03558503|66416419|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
23737617|NCT00412360|66416421|FG000|Overall Study|Lost to Follow-up|0|||
23737618|NCT00412360|66416422|FG001|Overall Study|Lost to Follow-up|1|||
23737619|NCT00412360|66416421|FG000|Overall Study|Not Transplanted|1|||
23737620|NCT00412360|66416422|FG001|Overall Study|Not Transplanted|2|||
23737621|NCT00508001|66416423|FG000|Overall Study|Adverse Event|2|||
23737622|NCT00508001|66416424|FG001|Overall Study|Adverse Event|0|||
23546732|NCT02270450|65731204|FG001|Overall Study|Death|19|||
23546733|NCT02270450|65731205|FG002|Overall Study|Death|31|||
23427131|NCT02649855|65307570|FG001|Overall Study|Principal investigator discretion|1|||
23427132|NCT02649855|65307571|FG002|Overall Study|Principal investigator discretion|1|||
23546734|NCT02270450|65731206|FG003|Overall Study|Death|59|||
23546735|NCT01953926|65731209|FG000|Overall Study|Withdrawal by Subject|23|||
23546736|NCT01953926|65731210|FG001|Overall Study|Withdrawal by Subject|3|||
23546737|NCT01953926|65731211|FG002|Overall Study|Withdrawal by Subject|3|||
23546738|NCT01953926|65731212|FG003|Overall Study|Withdrawal by Subject|5|||
23546739|NCT01953926|65731213|FG004|Overall Study|Withdrawal by Subject|6|||
23546740|NCT01953926|65731214|FG005|Overall Study|Withdrawal by Subject|0|||
23546741|NCT01953926|65731215|FG006|Overall Study|Withdrawal by Subject|1|||
23546742|NCT01953926|65731209|FG000|Overall Study|Physician Decision|1|||
23820205|NCT01808573|66721198|FG001|Overall Study|Randomized in Error|0|||
23820206|NCT00554190|66721199|FG000|Overall Study|Termination forms not completed|10|||
23820207|NCT00281957|66721262|FG000|Overall Study|Adverse Event|7|||
23820208|NCT00281957|66721263|FG001|Overall Study|Adverse Event|2|||
23820209|NCT00281957|66721262|FG000|Overall Study|Death|1|||
23546743|NCT01953926|65731210|FG001|Overall Study|Physician Decision|0|||
23546744|NCT01953926|65731211|FG002|Overall Study|Physician Decision|0|||
23546745|NCT01953926|65731212|FG003|Overall Study|Physician Decision|0|||
23546746|NCT01953926|65731213|FG004|Overall Study|Physician Decision|2|||
23546747|NCT01953926|65731214|FG005|Overall Study|Physician Decision|0|||
23546748|NCT01953926|65731215|FG006|Overall Study|Physician Decision|0|||
23546749|NCT01953926|65731209|FG000|Overall Study|Lost to Follow-up|18|||
23546750|NCT01953926|65731210|FG001|Overall Study|Lost to Follow-up|3|||
23546751|NCT01953926|65731211|FG002|Overall Study|Lost to Follow-up|0|||
23546752|NCT01953926|65731212|FG003|Overall Study|Lost to Follow-up|5|||
23546753|NCT01953926|65731213|FG004|Overall Study|Lost to Follow-up|3|||
23546754|NCT01953926|65731214|FG005|Overall Study|Lost to Follow-up|0|||
23546755|NCT01953926|65731215|FG006|Overall Study|Lost to Follow-up|0|||
23546756|NCT01953926|65731209|FG000|Overall Study|Protocol Violation|1|||
23546757|NCT01953926|65731210|FG001|Overall Study|Protocol Violation|0|||
23546758|NCT01953926|65731211|FG002|Overall Study|Protocol Violation|0|||
23546759|NCT01953926|65731212|FG003|Overall Study|Protocol Violation|0|||
23546760|NCT01953926|65731213|FG004|Overall Study|Protocol Violation|0|||
23546761|NCT01953926|65731214|FG005|Overall Study|Protocol Violation|0|||
23546762|NCT01953926|65731215|FG006|Overall Study|Protocol Violation|0|||
23546763|NCT01953926|65731209|FG000|Overall Study|Other, Disease progression|2|||
23546764|NCT01953926|65731210|FG001|Overall Study|Other, Disease progression|1|||
23737623|NCT00508001|66416425|FG002|Overall Study|Adverse Event|4|||
23737624|NCT00508001|66416423|FG000|Overall Study|condition under investigation worsened|13|||
23737625|NCT00508001|66416424|FG001|Overall Study|condition under investigation worsened|7|||
23737626|NCT00508001|66416425|FG002|Overall Study|condition under investigation worsened|1|||
23737627|NCT00508001|66416423|FG000|Overall Study|Death|0|||
23737628|NCT00508001|66416424|FG001|Overall Study|Death|1|||
23737629|NCT00508001|66416425|FG002|Overall Study|Death|1|||
23737630|NCT00508001|66416423|FG000|Overall Study|Withdrawal by Subject|4|||
23737631|NCT00508001|66416424|FG001|Overall Study|Withdrawal by Subject|4|||
23737632|NCT00508001|66416425|FG002|Overall Study|Withdrawal by Subject|1|||
23737633|NCT00983827|66416426|FG000|Overall Study|Withdrawal by Subject|1|||
23737634|NCT03575975|66416427|FG000|Overall Study|Lost to Follow-up|1|||
23546765|NCT01953926|65731211|FG002|Overall Study|Other, Disease progression|0|||
23546766|NCT01953926|65731212|FG003|Overall Study|Other, Disease progression|0|||
23546767|NCT01953926|65731213|FG004|Overall Study|Other, Disease progression|1|||
23546768|NCT01953926|65731214|FG005|Overall Study|Other, Disease progression|0|||
23546769|NCT01953926|65731215|FG006|Overall Study|Other, Disease progression|0|||
23546770|NCT01953926|65731209|FG000|Overall Study|Discontinuation of study by sponsor|41|||
23546771|NCT01953926|65731210|FG001|Overall Study|Discontinuation of study by sponsor|7|||
23546772|NCT01953926|65731211|FG002|Overall Study|Discontinuation of study by sponsor|5|||
23546773|NCT01953926|65731212|FG003|Overall Study|Discontinuation of study by sponsor|12|||
23546774|NCT01953926|65731213|FG004|Overall Study|Discontinuation of study by sponsor|46|||
23546775|NCT01953926|65731214|FG005|Overall Study|Discontinuation of study by sponsor|5|||
23546776|NCT01953926|65731215|FG006|Overall Study|Discontinuation of study by sponsor|6|||
23546777|NCT01953926|65731209|FG000|Overall Study|Not Treated|1|||
23546778|NCT01953926|65731210|FG001|Overall Study|Not Treated|0|||
23546779|NCT01953926|65731211|FG002|Overall Study|Not Treated|1|||
23546780|NCT01953926|65731212|FG003|Overall Study|Not Treated|0|||
23546781|NCT01953926|65731213|FG004|Overall Study|Not Treated|0|||
23546782|NCT01953926|65731214|FG005|Overall Study|Not Treated|0|||
23737635|NCT03575975|66416428|FG001|Overall Study|Lost to Follow-up|0|||
23820210|NCT00281957|66721263|FG001|Overall Study|Death|0|||
23820211|NCT00281957|66721262|FG000|Overall Study|Progression/relapse|47|||
23546783|NCT01953926|65731215|FG006|Overall Study|Not Treated|0|||
23546784|NCT00586105|65731216|FG000|Overall Study|Adverse Event|4|||
23546785|NCT00586105|65731216|FG000|Overall Study|Death|2|||
23546786|NCT00586105|65731216|FG000|Overall Study|Protocol Violation|1|||
23546787|NCT00586105|65731216|FG000|Overall Study|Withdrawal by Subject|3|||
23737636|NCT03575975|66416429|FG002|Overall Study|Lost to Follow-up|0|||
23737637|NCT02400281|66416430|FG000|Overall Study|Adverse Event|0|||
23737638|NCT02400281|66416431|FG001|Overall Study|Adverse Event|0|||
23820212|NCT00281957|66721263|FG001|Overall Study|Progression/relapse|35|||
23546788|NCT00586105|65731216|FG000|Overall Study|Disease progression|19|||
23546789|NCT00586105|65731216|FG000|Overall Study|Switched to commercial drug|9|||
23546790|NCT00586105|65731216|FG000|Overall Study|Reason not reported|1|||
23546791|NCT01682460|65731217|FG000|Overall Study|Withdrawal by Subject|2|||
23737639|NCT02400281|66416432|FG002|Overall Study|Adverse Event|1|||
23427133|NCT02649855|65307569|FG000|Overall Study|No treatment, per protocol|1|||
23427134|NCT02649855|65307570|FG001|Overall Study|No treatment, per protocol|0|||
23737640|NCT02400281|66416433|FG003|Overall Study|Adverse Event|0|||
23737641|NCT02400281|66416434|FG004|Overall Study|Adverse Event|1|||
23737642|NCT02400281|66416435|FG005|Overall Study|Adverse Event|0|||
23737643|NCT02400281|66416430|FG000|Overall Study|Physician Decision|0|||
23737644|NCT02400281|66416431|FG001|Overall Study|Physician Decision|0|||
23737645|NCT02400281|66416432|FG002|Overall Study|Physician Decision|1|||
23427135|NCT02649855|65307571|FG002|Overall Study|No treatment, per protocol|0|||
23427136|NCT02649855|65307569|FG000|Overall Study|Initiate new treatment|1|||
23427137|NCT02649855|65307570|FG001|Overall Study|Initiate new treatment|0|||
23427138|NCT02649855|65307571|FG002|Overall Study|Initiate new treatment|0|||
23427139|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
23427140|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
23427141|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
23737646|NCT02400281|66416433|FG003|Overall Study|Physician Decision|0|||
23737647|NCT02400281|66416434|FG004|Overall Study|Physician Decision|0|||
23737648|NCT02400281|66416435|FG005|Overall Study|Physician Decision|0|||
23737649|NCT01526928|66416436|FG000|Overall Study|Progressive Disease|35|||
23737650|NCT01526928|66416437|FG001|Overall Study|Progressive Disease|17|||
23737651|NCT01526928|66416438|FG002|Overall Study|Progressive Disease|150|||
23737652|NCT01526928|66416439|FG003|Overall Study|Progressive Disease|182|||
23737653|NCT01526928|66416440|FG004|Overall Study|Progressive Disease|76|||
23737654|NCT01526928|66416441|FG005|Overall Study|Progressive Disease|4|||
23737655|NCT01526928|66416436|FG000|Overall Study|Adverse Event|2|||
23737656|NCT01526928|66416437|FG001|Overall Study|Adverse Event|1|||
23737657|NCT01526928|66416438|FG002|Overall Study|Adverse Event|29|||
23737658|NCT01526928|66416439|FG003|Overall Study|Adverse Event|40|||
23737659|NCT01526928|66416440|FG004|Overall Study|Adverse Event|13|||
23737660|NCT01526928|66416441|FG005|Overall Study|Adverse Event|2|||
23737661|NCT01526928|66416436|FG000|Overall Study|Death|0|||
23737662|NCT01526928|66416437|FG001|Overall Study|Death|0|||
23427142|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
23427143|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
23427144|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
23427145|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
23427146|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
23427147|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
23427148|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
23427149|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
23427150|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
23427151|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
23427152|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
23427153|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
23427154|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
23427155|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
23427156|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
23427157|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
23427158|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
23427159|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
23427160|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
23427161|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
23546792|NCT01682460|65731217|FG000|Overall Study|Did not meet inclusion criteria|2|||
23546793|NCT02277106|65731221|FG000|Stage 2|Adverse Event|0|||
23737663|NCT01526928|66416438|FG002|Overall Study|Death|3|||
23737664|NCT01526928|66416439|FG003|Overall Study|Death|0|||
23737665|NCT01526928|66416440|FG004|Overall Study|Death|0|||
23737666|NCT01526928|66416441|FG005|Overall Study|Death|0|||
23737667|NCT01526928|66416436|FG000|Overall Study|Withdrawal by Subject|1|||
23737668|NCT01526928|66416437|FG001|Overall Study|Withdrawal by Subject|0|||
23737669|NCT01526928|66416438|FG002|Overall Study|Withdrawal by Subject|13|||
23737670|NCT01526928|66416439|FG003|Overall Study|Withdrawal by Subject|11|||
23737671|NCT01526928|66416440|FG004|Overall Study|Withdrawal by Subject|3|||
23546794|NCT02277106|65731222|FG001|Stage 2|Adverse Event|0|||
23546795|NCT02277106|65731223|FG002|Stage 2|Adverse Event|1|||
23737672|NCT01526928|66416441|FG005|Overall Study|Withdrawal by Subject|0|||
23737673|NCT01526928|66416436|FG000|Overall Study|Physician Decision|0|||
23737674|NCT01526928|66416437|FG001|Overall Study|Physician Decision|0|||
23737675|NCT01526928|66416438|FG002|Overall Study|Physician Decision|2|||
23546796|NCT03166618|65731230|FG000|Overall Study|Study was Terminated|0|||
23546797|NCT03166618|65731231|FG001|Overall Study|Study was Terminated|1|||
23546798|NCT01248884|65731232|FG000|Overall Study|Withdrawal by Subject|1|||
23546799|NCT01248884|65731233|FG001|Overall Study|Withdrawal by Subject|3|||
23546800|NCT01248884|65731234|FG002|Overall Study|Withdrawal by Subject|1|||
23546801|NCT01248884|65731232|FG000|Overall Study|Adverse Event|1|||
23546802|NCT01248884|65731233|FG001|Overall Study|Adverse Event|0|||
23546803|NCT01248884|65731234|FG002|Overall Study|Adverse Event|0|||
23546804|NCT00868439|65731239|FG000|Overall Study|Adverse Event|4|||
23619174|NCT02859558|65991491|FG003|Step 1|Moved|0|||
23619175|NCT02859558|65991492|FG004|Step 1|Moved|0|||
23546805|NCT00868439|65731240|FG001|Overall Study|Adverse Event|3|||
23546806|NCT00868439|65731239|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
23546807|NCT00868439|65731240|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
23546808|NCT00868439|65731239|FG000|Overall Study|Death|0|||
23546809|NCT00868439|65731240|FG001|Overall Study|Death|1|||
23546810|NCT00868439|65731239|FG000|Overall Study|Protocol Violation|1|||
23546811|NCT00868439|65731240|FG001|Overall Study|Protocol Violation|1|||
23546812|NCT00868439|65731239|FG000|Overall Study|Physician Decision|1|||
23546813|NCT00868439|65731240|FG001|Overall Study|Physician Decision|0|||
23546814|NCT00868439|65731239|FG000|Overall Study|Withdrawal by Subject|0|||
23546815|NCT00868439|65731240|FG001|Overall Study|Withdrawal by Subject|1|||
23546816|NCT00518115|65731241|FG000|Overall Study|Adverse Event|6|||
23546817|NCT00518115|65731242|FG001|Overall Study|Adverse Event|1|||
23619176|NCT02859558|65991488|FG000|Step 1|Withdrawal By Participant|1|||
23619177|NCT02859558|65991489|FG001|Step 1|Withdrawal By Participant|2|||
23619178|NCT02859558|65991490|FG002|Step 1|Withdrawal By Participant|1|||
23619179|NCT02859558|65991491|FG003|Step 1|Withdrawal By Participant|0|||
23619180|NCT02859558|65991492|FG004|Step 1|Withdrawal By Participant|0|||
23619181|NCT02859558|65991488|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
23619182|NCT02859558|65991489|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619183|NCT02859558|65991490|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619184|NCT02859558|65991491|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619185|NCT02859558|65991492|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619186|NCT02859558|65991488|FG000|Step 1|Incarceration|0|||
23619187|NCT02859558|65991489|FG001|Step 1|Incarceration|1|||
23619188|NCT02859558|65991490|FG002|Step 1|Incarceration|0|||
23619189|NCT02859558|65991491|FG003|Step 1|Incarceration|0|||
23619190|NCT02859558|65991492|FG004|Step 1|Incarceration|0|||
23619191|NCT02859558|65991488|FG000|Step 1|Non-Adherence to Study Drug|2|||
23619192|NCT02859558|65991489|FG001|Step 1|Non-Adherence to Study Drug|0|||
23619193|NCT02859558|65991490|FG002|Step 1|Non-Adherence to Study Drug|1|||
23619194|NCT02859558|65991491|FG003|Step 1|Non-Adherence to Study Drug|0|||
23619195|NCT02859558|65991492|FG004|Step 1|Non-Adherence to Study Drug|0|||
23619196|NCT02859558|65991488|FG000|Step 1|Non-Adherence to Study Requirements|3|||
23619197|NCT02859558|65991489|FG001|Step 1|Non-Adherence to Study Requirements|1|||
23546818|NCT00518115|65731243|FG002|Overall Study|Adverse Event|5|||
23546819|NCT00518115|65731244|FG003|Overall Study|Adverse Event|6|||
23546820|NCT00518115|65731245|FG004|Overall Study|Adverse Event|5|||
23546821|NCT00518115|65731246|FG005|Overall Study|Adverse Event|5|||
23546822|NCT00518115|65731247|FG006|Overall Study|Adverse Event|5|||
23546823|NCT00518115|65731248|FG007|Overall Study|Adverse Event|10|||
23546824|NCT00518115|65731249|FG008|Overall Study|Adverse Event|2|||
23546825|NCT00518115|65731250|FG009|Overall Study|Adverse Event|9|||
23546826|NCT00518115|65731241|FG000|Overall Study|Lost to Follow-up|0|||
23546827|NCT00518115|65731242|FG001|Overall Study|Lost to Follow-up|0|||
23546828|NCT00518115|65731243|FG002|Overall Study|Lost to Follow-up|2|||
23619198|NCT02859558|65991490|FG002|Step 1|Non-Adherence to Study Requirements|0|||
23546829|NCT00518115|65731244|FG003|Overall Study|Lost to Follow-up|3|||
23546830|NCT00518115|65731245|FG004|Overall Study|Lost to Follow-up|1|||
23546831|NCT00518115|65731246|FG005|Overall Study|Lost to Follow-up|3|||
23546832|NCT00518115|65731247|FG006|Overall Study|Lost to Follow-up|0|||
23546833|NCT00518115|65731248|FG007|Overall Study|Lost to Follow-up|1|||
23546834|NCT00518115|65731249|FG008|Overall Study|Lost to Follow-up|1|||
23546835|NCT00518115|65731250|FG009|Overall Study|Lost to Follow-up|1|||
23546836|NCT00518115|65731241|FG000|Overall Study|Protocol Violation|1|||
23546837|NCT00518115|65731242|FG001|Overall Study|Protocol Violation|3|||
23546838|NCT00518115|65731243|FG002|Overall Study|Protocol Violation|1|||
23546839|NCT00518115|65731244|FG003|Overall Study|Protocol Violation|0|||
23546840|NCT00518115|65731245|FG004|Overall Study|Protocol Violation|0|||
23546841|NCT00518115|65731246|FG005|Overall Study|Protocol Violation|0|||
23546842|NCT00518115|65731247|FG006|Overall Study|Protocol Violation|0|||
23619199|NCT02859558|65991491|FG003|Step 1|Non-Adherence to Study Requirements|0|||
23619200|NCT02859558|65991492|FG004|Step 1|Non-Adherence to Study Requirements|0|||
23619201|NCT02859558|65991488|FG000|Step 1|Virologic Failure|2|||
23619202|NCT02859558|65991489|FG001|Step 1|Virologic Failure|1|||
23619203|NCT02859558|65991490|FG002|Step 1|Virologic Failure|1|||
23546843|NCT00518115|65731248|FG007|Overall Study|Protocol Violation|0|||
23546844|NCT00518115|65731249|FG008|Overall Study|Protocol Violation|0|||
23546845|NCT00518115|65731250|FG009|Overall Study|Protocol Violation|0|||
23546846|NCT00518115|65731241|FG000|Overall Study|Withdrawal by Subject|1|||
23546847|NCT00518115|65731242|FG001|Overall Study|Withdrawal by Subject|1|||
23546848|NCT00518115|65731243|FG002|Overall Study|Withdrawal by Subject|5|||
23546849|NCT00518115|65731244|FG003|Overall Study|Withdrawal by Subject|0|||
23546850|NCT00518115|65731245|FG004|Overall Study|Withdrawal by Subject|2|||
23546851|NCT00518115|65731246|FG005|Overall Study|Withdrawal by Subject|1|||
23546852|NCT00518115|65731247|FG006|Overall Study|Withdrawal by Subject|0|||
23546853|NCT00518115|65731248|FG007|Overall Study|Withdrawal by Subject|2|||
23546854|NCT00518115|65731249|FG008|Overall Study|Withdrawal by Subject|1|||
23546855|NCT00518115|65731250|FG009|Overall Study|Withdrawal by Subject|3|||
23546856|NCT00518115|65731241|FG000|Overall Study|Lack of Efficacy|1|||
23546857|NCT00518115|65731242|FG001|Overall Study|Lack of Efficacy|0|||
23546858|NCT00518115|65731243|FG002|Overall Study|Lack of Efficacy|1|||
23546859|NCT00518115|65731244|FG003|Overall Study|Lack of Efficacy|1|||
23546860|NCT00518115|65731245|FG004|Overall Study|Lack of Efficacy|0|||
23546861|NCT00518115|65731246|FG005|Overall Study|Lack of Efficacy|0|||
23546862|NCT00518115|65731247|FG006|Overall Study|Lack of Efficacy|0|||
23546863|NCT00518115|65731248|FG007|Overall Study|Lack of Efficacy|1|||
23546864|NCT00518115|65731249|FG008|Overall Study|Lack of Efficacy|0|||
23546865|NCT00518115|65731250|FG009|Overall Study|Lack of Efficacy|0|||
23546866|NCT00518115|65731241|FG000|Overall Study|Non-Compliance|1|||
23546867|NCT00518115|65731242|FG001|Overall Study|Non-Compliance|0|||
23546868|NCT00518115|65731243|FG002|Overall Study|Non-Compliance|1|||
23546869|NCT00518115|65731244|FG003|Overall Study|Non-Compliance|0|||
23546870|NCT00518115|65731245|FG004|Overall Study|Non-Compliance|1|||
23546871|NCT00518115|65731246|FG005|Overall Study|Non-Compliance|1|||
23546872|NCT00518115|65731247|FG006|Overall Study|Non-Compliance|1|||
23546873|NCT00518115|65731248|FG007|Overall Study|Non-Compliance|1|||
23546874|NCT00518115|65731249|FG008|Overall Study|Non-Compliance|0|||
23546875|NCT00518115|65731250|FG009|Overall Study|Non-Compliance|1|||
23546876|NCT00518115|65731241|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
23546877|NCT00518115|65731242|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
23546878|NCT00518115|65731243|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546879|NCT00518115|65731244|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23619204|NCT02859558|65991491|FG003|Step 1|Virologic Failure|0|||
23619205|NCT02859558|65991492|FG004|Step 1|Virologic Failure|0|||
23619206|NCT02859558|65991488|FG000|Step 2|Active On Study|23|||
23619207|NCT02859558|65991489|FG001|Step 2|Active On Study|38|||
23619208|NCT02859558|65991490|FG002|Step 2|Active On Study|20|||
23737676|NCT01526928|66416439|FG003|Overall Study|Physician Decision|5|||
23737677|NCT01526928|66416440|FG004|Overall Study|Physician Decision|0|||
23737678|NCT01526928|66416441|FG005|Overall Study|Physician Decision|0|||
23737679|NCT01526928|66416436|FG000|Overall Study|Other Reason|0|||
23737680|NCT01526928|66416437|FG001|Overall Study|Other Reason|1|||
23737681|NCT01526928|66416438|FG002|Overall Study|Other Reason|11|||
23737682|NCT01526928|66416439|FG003|Overall Study|Other Reason|4|||
23737683|NCT01526928|66416440|FG004|Overall Study|Other Reason|1|||
23737684|NCT01526928|66416441|FG005|Overall Study|Other Reason|0|||
23737685|NCT01526928|66416436|FG000|Overall Study|Lost to Follow-up|0|||
23737686|NCT01526928|66416437|FG001|Overall Study|Lost to Follow-up|0|||
23737687|NCT01526928|66416438|FG002|Overall Study|Lost to Follow-up|0|||
23737688|NCT01526928|66416439|FG003|Overall Study|Lost to Follow-up|1|||
23737689|NCT01526928|66416440|FG004|Overall Study|Lost to Follow-up|0|||
23737690|NCT01526928|66416441|FG005|Overall Study|Lost to Follow-up|0|||
23737691|NCT01526928|66416436|FG000|Overall Study|Protocol Deviation|0|||
23737692|NCT01526928|66416437|FG001|Overall Study|Protocol Deviation|0|||
23546880|NCT00518115|65731245|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546881|NCT00518115|65731246|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
23546882|NCT00518115|65731247|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546883|NCT00518115|65731248|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546884|NCT00518115|65731249|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546885|NCT00518115|65731250|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546886|NCT00518115|65731241|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
23546887|NCT00518115|65731242|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23619209|NCT02859558|65991491|FG003|Step 2|Active On Study|0|||
23619210|NCT02859558|65991492|FG004|Step 2|Active On Study|0|||
23619211|NCT02859558|65991488|FG000|Step 2|Did Not Return to Clinic|2|||
23619212|NCT02859558|65991489|FG001|Step 2|Did Not Return to Clinic|0|||
23619213|NCT02859558|65991490|FG002|Step 2|Did Not Return to Clinic|0|||
23546888|NCT00518115|65731243|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546889|NCT00518115|65731244|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23619214|NCT02859558|65991491|FG003|Step 2|Did Not Return to Clinic|0|||
23619215|NCT02859558|65991492|FG004|Step 2|Did Not Return to Clinic|0|||
23737693|NCT01526928|66416438|FG002|Overall Study|Protocol Deviation|0|||
23737694|NCT01526928|66416439|FG003|Overall Study|Protocol Deviation|2|||
23737695|NCT01526928|66416440|FG004|Overall Study|Protocol Deviation|0|||
23427162|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
23427163|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
23427164|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
23737696|NCT01526928|66416441|FG005|Overall Study|Protocol Deviation|0|||
23737697|NCT01526928|66416436|FG000|Overall Study|Missing|0|||
23737698|NCT01526928|66416437|FG001|Overall Study|Missing|0|||
23737699|NCT01526928|66416438|FG002|Overall Study|Missing|1|||
23737700|NCT01526928|66416439|FG003|Overall Study|Missing|0|||
23737701|NCT01526928|66416440|FG004|Overall Study|Missing|2|||
23737702|NCT01526928|66416441|FG005|Overall Study|Missing|0|||
23737703|NCT01654224|66416442|FG000|Overall Study|Lost to Follow-up|2|||
23737704|NCT01654224|66416443|FG001|Overall Study|Lost to Follow-up|2|||
23737705|NCT01654224|66416442|FG000|Overall Study|Did not receive allocation|1|||
23737706|NCT01654224|66416443|FG001|Overall Study|Did not receive allocation|8|||
23737707|NCT01654224|66416442|FG000|Overall Study|Insufficient blood sample|3|||
23737708|NCT01654224|66416443|FG001|Overall Study|Insufficient blood sample|2|||
23737709|NCT02519777|66416444|FG000|Overall Study|Death|1|||
23737710|NCT02519777|66416445|FG001|Overall Study|Death|0|||
23737711|NCT02519777|66416446|FG002|Overall Study|Death|0|||
23737712|NCT02519777|66416444|FG000|Overall Study|Lost to Follow-up|0|||
23737713|NCT02519777|66416445|FG001|Overall Study|Lost to Follow-up|4|||
23737714|NCT02519777|66416446|FG002|Overall Study|Lost to Follow-up|2|||
23737715|NCT02519777|66416444|FG000|Overall Study|Withdrawal by Subject|3|||
23737716|NCT02519777|66416445|FG001|Overall Study|Withdrawal by Subject|1|||
23737717|NCT02519777|66416446|FG002|Overall Study|Withdrawal by Subject|0|||
23737718|NCT02519777|66416444|FG000|Overall Study|Severe Debilitation|1|||
23737719|NCT02519777|66416445|FG001|Overall Study|Severe Debilitation|1|||
23737720|NCT02519777|66416446|FG002|Overall Study|Severe Debilitation|1|||
23737721|NCT02519777|66416444|FG000|Overall Study|Not able to get to clinic|1|||
23737722|NCT02519777|66416445|FG001|Overall Study|Not able to get to clinic|2|||
23737723|NCT02519777|66416446|FG002|Overall Study|Not able to get to clinic|1|||
23737724|NCT01944462|66416447|FG000|PPPP Educational Program|Lost to Follow-up|60|||
23737725|NCT02709889|66416453|FG000|Overall Study|Withdrawal by Subject|11|||
23737726|NCT02709889|66416454|FG001|Overall Study|Withdrawal by Subject|10|||
23737727|NCT02709889|66416455|FG002|Overall Study|Withdrawal by Subject|2|||
23737728|NCT02709889|66416456|FG003|Overall Study|Withdrawal by Subject|12|||
23737729|NCT02709889|66416453|FG000|Overall Study|Death|25|||
23737730|NCT02709889|66416454|FG001|Overall Study|Death|38|||
23737731|NCT02709889|66416455|FG002|Overall Study|Death|4|||
23737732|NCT02709889|66416456|FG003|Overall Study|Death|44|||
23737733|NCT02709889|66416453|FG000|Overall Study|Physician Decision|1|||
23737734|NCT02709889|66416454|FG001|Overall Study|Physician Decision|2|||
23737735|NCT02709889|66416455|FG002|Overall Study|Physician Decision|3|||
23737736|NCT02709889|66416456|FG003|Overall Study|Physician Decision|5|||
23427165|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
23427166|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
23427167|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
23427168|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
23427169|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
23427170|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
23427171|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
23427172|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
23427173|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
23427174|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
23427175|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427176|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
23737737|NCT02709889|66416453|FG000|Overall Study|Lost to Follow-up|2|||
23737738|NCT02709889|66416454|FG001|Overall Study|Lost to Follow-up|0|||
23737739|NCT02709889|66416455|FG002|Overall Study|Lost to Follow-up|0|||
23737740|NCT02709889|66416456|FG003|Overall Study|Lost to Follow-up|4|||
23737741|NCT02709889|66416453|FG000|Overall Study|Study Terminated by Sponsor|4|||
23737742|NCT02709889|66416454|FG001|Overall Study|Study Terminated by Sponsor|6|||
23737743|NCT02709889|66416455|FG002|Overall Study|Study Terminated by Sponsor|2|||
23737744|NCT02709889|66416456|FG003|Overall Study|Study Terminated by Sponsor|17|||
23737745|NCT02709889|66416453|FG000|Overall Study|Other, Not Specified|0|||
23737746|NCT02709889|66416454|FG001|Overall Study|Other, Not Specified|1|||
23737747|NCT02709889|66416455|FG002|Overall Study|Other, Not Specified|1|||
23427177|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427178|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
23619216|NCT02859558|65991488|FG000|Step 2|Unexpected Closure of Site|0|||
23737748|NCT02709889|66416456|FG003|Overall Study|Other, Not Specified|6|||
23737749|NCT02612194|66416465|FG000|Overall Study|Death|5|||
23737750|NCT02612194|66416466|FG001|Overall Study|Death|0|||
23737751|NCT02612194|66416467|FG002|Overall Study|Death|2|||
23737752|NCT02612194|66416465|FG000|Overall Study|Early Study Termination|1|||
23737753|NCT02612194|66416466|FG001|Overall Study|Early Study Termination|0|||
23737754|NCT02612194|66416467|FG002|Overall Study|Early Study Termination|0|||
23737755|NCT01736176|66416471|FG000|Overall Study|Adverse Event|3|||
23737756|NCT01736176|66416471|FG000|Overall Study|Withdrawal by Subject|4|||
23737757|NCT01736176|66416471|FG000|Overall Study|Lack of Efficacy|3|||
23737758|NCT01736176|66416471|FG000|Overall Study|Unable to Complete PEG Placement|1|||
23737759|NCT01108068|66416475|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
23737760|NCT01108068|66416476|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
23737761|NCT03287830|66416477|FG000|Overall Study|Withdrawal by Subject|1|||
23737762|NCT03287830|66416478|FG001|Overall Study|Withdrawal by Subject|1|||
23737763|NCT03287830|66416477|FG000|Overall Study|not meeting inclusion criteria|5|||
23737764|NCT03287830|66416478|FG001|Overall Study|not meeting inclusion criteria|12|||
23737765|NCT01611558|66416479|FG000|Induction Phase|Study drug toxicity|15|||
23737766|NCT01611558|66416479|FG000|Induction Phase|Disease progression|18|||
23737767|NCT01611558|66416479|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
23737768|NCT01611558|66416479|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
23737769|NCT01611558|66416479|FG000|Induction Phase|Death|1|||
23737770|NCT01611558|66416479|FG000|Maintenance Phase|Withdrawal by Subject|1|||
23737771|NCT01611558|66416479|FG000|Maintenance Phase|Elevated Uric acid|1|||
23737772|NCT01432756|66416484|FG000|Overall Study|Lost to Follow-up|1|||
23737773|NCT01432756|66416485|FG001|Overall Study|Lost to Follow-up|0|||
23737774|NCT01432756|66416486|FG002|Overall Study|Lost to Follow-up|2|||
23737775|NCT01432756|66416487|FG003|Overall Study|Lost to Follow-up|1|||
23737776|NCT03958149|66416490|FG000|Overall Study|Withdrawal by Subject|0|||
23737777|NCT03958149|66416491|FG001|Overall Study|Withdrawal by Subject|1|||
23737778|NCT02067104|66416492|FG000|Overall Study|Study termination due to low accrual|4|||
23737779|NCT02067104|66416493|FG001|Overall Study|Study termination due to low accrual|5|||
23737780|NCT00087594|66416494|FG000|Overall Study|Adverse Event|2|||
23737781|NCT00087594|66416495|FG001|Overall Study|Adverse Event|3|||
23737782|NCT00087594|66416494|FG000|Overall Study|Lost to Follow-up|0|||
23737783|NCT00087594|66416495|FG001|Overall Study|Lost to Follow-up|2|||
23737784|NCT00087594|66416494|FG000|Overall Study|Withdrawal by Subject|4|||
23737785|NCT00087594|66416495|FG001|Overall Study|Withdrawal by Subject|2|||
23737786|NCT00087594|66416494|FG000|Overall Study|Lack of Efficacy|2|||
23737787|NCT00087594|66416495|FG001|Overall Study|Lack of Efficacy|5|||
23737788|NCT02694562|66416497|FG000|Overall Study|Death|8|||
23737789|NCT02694562|66416497|FG000|Overall Study|Protocol Violation|4|||
23737790|NCT02694562|66416497|FG000|Overall Study|Lost to Follow-up|3|||
23737791|NCT02694562|66416497|FG000|Overall Study|Screen Failure|2|||
23737792|NCT02694562|66416497|FG000|Overall Study|Physician Decision|1|||
23737793|NCT01842334|66416500|FG000|Overall Study|Withdrawal by Subject|3|||
23737794|NCT01842334|66416501|FG001|Overall Study|Withdrawal by Subject|3|||
23737795|NCT01842334|66416500|FG000|Overall Study|Moved away mid-study|0|||
23737796|NCT01842334|66416501|FG001|Overall Study|Moved away mid-study|1|||
23737797|NCT00417248|66416502|FG000|Overall Study|Study Terminated|6|||
23737798|NCT00417248|66416502|FG000|Overall Study|Death|1|||
23737799|NCT00417248|66416502|FG000|Overall Study|Lack of Efficacy|1|||
23737800|NCT03763942|66416503|FG000|Overall Study|Lost to Follow-up|114|||
23737801|NCT03763942|66416504|FG001|Overall Study|Lost to Follow-up|54|||
23737802|NCT03763942|66416503|FG000|Overall Study|Protocol Violation|1|||
23737803|NCT03763942|66416504|FG001|Overall Study|Protocol Violation|0|||
23737804|NCT03763942|66416503|FG000|Overall Study|Withdrawal by Subject|2|||
23737805|NCT03763942|66416504|FG001|Overall Study|Withdrawal by Subject|0|||
23737806|NCT03763942|66416503|FG000|Overall Study|Other|2|||
23737807|NCT03763942|66416504|FG001|Overall Study|Other|3|||
23737808|NCT01371721|66416506|FG000|Overall Study|Adverse Event|5|||
23737809|NCT01371721|66416507|FG001|Overall Study|Adverse Event|4|||
23737810|NCT01371721|66416508|FG002|Overall Study|Adverse Event|5|||
23737811|NCT01371721|66416506|FG000|Overall Study|Protocol Violation|6|||
23737812|NCT01371721|66416507|FG001|Overall Study|Protocol Violation|4|||
23737813|NCT01371721|66416508|FG002|Overall Study|Protocol Violation|5|||
23737814|NCT01371721|66416506|FG000|Overall Study|Lost to Follow-up|8|||
23737815|NCT01371721|66416507|FG001|Overall Study|Lost to Follow-up|2|||
23737816|NCT01371721|66416508|FG002|Overall Study|Lost to Follow-up|6|||
23737817|NCT01371721|66416506|FG000|Overall Study|Withdrawal by Subject|5|||
23737818|NCT01371721|66416507|FG001|Overall Study|Withdrawal by Subject|7|||
23737819|NCT01371721|66416508|FG002|Overall Study|Withdrawal by Subject|11|||
23737820|NCT01371721|66416506|FG000|Overall Study|Other|2|||
23820213|NCT00281957|66721262|FG000|Overall Study|Not protocol specified|8|||
23737821|NCT01371721|66416507|FG001|Overall Study|Other|3|||
23737822|NCT01371721|66416508|FG002|Overall Study|Other|0|||
23737823|NCT01371721|66416506|FG000|Overall Study|Lack of Efficacy|2|||
23737824|NCT01371721|66416507|FG001|Overall Study|Lack of Efficacy|4|||
23737825|NCT01371721|66416508|FG002|Overall Study|Lack of Efficacy|3|||
23737826|NCT01371721|66416506|FG000|Overall Study|Randomized but not treated|1|||
23737827|NCT01371721|66416507|FG001|Overall Study|Randomized but not treated|0|||
23737828|NCT01371721|66416508|FG002|Overall Study|Randomized but not treated|0|||
23427179|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
23427180|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427181|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427182|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
23737829|NCT01542632|66416509|FG000|Overall Study|Withdrawal of Consent|0|||
23737830|NCT01542632|66416510|FG001|Overall Study|Withdrawal of Consent|0|||
23427183|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427184|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
23427185|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427186|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427187|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
23427188|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
23427189|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
23427190|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
23427191|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
23427192|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
23427193|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
23427194|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
23427195|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
23427196|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
23427197|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
23427198|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
23427199|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427200|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
23427201|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
23427202|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427203|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
23427204|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427205|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
23427206|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427207|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427208|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427209|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427210|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427211|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427212|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427213|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
23427214|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427215|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427216|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427217|NCT00624780|65307572|FG000|Follow-up (Week 26)|Death|0|||
23427218|NCT00624780|65307573|FG001|Follow-up (Week 26)|Death|0|||
23427219|NCT00624780|65307574|FG002|Follow-up (Week 26)|Death|1|||
23737831|NCT01542632|66416511|FG002|Overall Study|Withdrawal of Consent|0|||
23737832|NCT01542632|66416512|FG003|Overall Study|Withdrawal of Consent|2|||
23737833|NCT01542632|66416513|FG004|Overall Study|Withdrawal of Consent|3|||
23737834|NCT01542632|66416514|FG005|Overall Study|Withdrawal of Consent|0|||
23737835|NCT01542632|66416509|FG000|Overall Study|Adverse Event|0|||
23737836|NCT01542632|66416510|FG001|Overall Study|Adverse Event|0|||
23737837|NCT01542632|66416511|FG002|Overall Study|Adverse Event|1|||
23737838|NCT01542632|66416512|FG003|Overall Study|Adverse Event|0|||
23737839|NCT01542632|66416513|FG004|Overall Study|Adverse Event|0|||
23737840|NCT01542632|66416514|FG005|Overall Study|Adverse Event|0|||
23737841|NCT01542632|66416509|FG000|Overall Study|Lost to Follow-up|0|||
23737842|NCT01542632|66416510|FG001|Overall Study|Lost to Follow-up|1|||
23737843|NCT01542632|66416511|FG002|Overall Study|Lost to Follow-up|0|||
23737844|NCT01542632|66416512|FG003|Overall Study|Lost to Follow-up|0|||
23737845|NCT01542632|66416513|FG004|Overall Study|Lost to Follow-up|0|||
23737846|NCT01542632|66416514|FG005|Overall Study|Lost to Follow-up|0|||
23737847|NCT01542632|66416509|FG000|Overall Study|Sponsor/Investigator Decision|0|||
23737848|NCT01542632|66416510|FG001|Overall Study|Sponsor/Investigator Decision|0|||
23737849|NCT01542632|66416511|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23737850|NCT01542632|66416512|FG003|Overall Study|Sponsor/Investigator Decision|0|||
23737851|NCT01542632|66416513|FG004|Overall Study|Sponsor/Investigator Decision|1|||
23427220|NCT00624780|65307575|FG003|Follow-up (Week 26)|Death|0|||
23427221|NCT00624780|65307576|FG004|Follow-up (Week 26)|Death|0|||
23427222|NCT00624780|65307577|FG005|Follow-up (Week 26)|Death|0|||
23619217|NCT02859558|65991489|FG001|Step 2|Unexpected Closure of Site|1|||
23737852|NCT01542632|66416514|FG005|Overall Study|Sponsor/Investigator Decision|0|||
23737853|NCT01747655|66416515|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
23737854|NCT01747655|66416516|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
23737855|NCT01747655|66416515|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
23737856|NCT01747655|66416516|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
23737857|NCT01747655|66416515|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
23737858|NCT01747655|66416516|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
23737859|NCT00203294|66416517|FG000|Overall Study|Withdrawal by Subject|8|||
23737860|NCT00203294|66416518|FG001|Overall Study|Withdrawal by Subject|13|||
23737861|NCT02987205|66416519|FG000|Overall Study|Adverse Event|1|||
23737862|NCT02987205|66416519|FG000|Overall Study|Withdrawal by Subject|3|||
23737863|NCT02168816|66416525|FG000|Overall Study|Lost to Follow-up|2|||
23737864|NCT02168816|66416526|FG001|Overall Study|Lost to Follow-up|2|||
23737865|NCT00526227|66416529|FG000|Overall Study|Device not implanted|1|||
23737866|NCT00526227|66416529|FG000|Overall Study|Death|1|||
23737867|NCT01287403|66416530|FG000|1st Intervention (1 Day)|Adverse Event|1|||
23737868|NCT02132312|66416531|FG000|Overall Study|Adverse Event|2|||
23737869|NCT02132312|66416532|FG001|Overall Study|Adverse Event|0|||
23737870|NCT02132312|66416531|FG000|Overall Study|Physician Decision|1|||
23737871|NCT02132312|66416532|FG001|Overall Study|Physician Decision|1|||
23737872|NCT02132312|66416531|FG000|Overall Study|Protocol Violation|0|||
23737873|NCT02132312|66416532|FG001|Overall Study|Protocol Violation|1|||
23737874|NCT02132312|66416531|FG000|Overall Study|Withdrawal by Subject|1|||
23737875|NCT02132312|66416532|FG001|Overall Study|Withdrawal by Subject|0|||
23737876|NCT02132312|66416531|FG000|Overall Study|Lost to Follow-up|2|||
23737877|NCT02132312|66416532|FG001|Overall Study|Lost to Follow-up|1|||
23737878|NCT02475564|66421001|FG000|Overall Study|Withdrawal by Subject|1|||
23737879|NCT02475564|66421002|FG001|Overall Study|Withdrawal by Subject|0|||
23737880|NCT02475564|66421001|FG000|Overall Study|Lost to Follow-up|2|||
23737881|NCT02475564|66421002|FG001|Overall Study|Lost to Follow-up|1|||
23737882|NCT02475564|66421001|FG000|Overall Study|Intense Menstrual bleeding|1|||
23737883|NCT02475564|66421002|FG001|Overall Study|Intense Menstrual bleeding|0|||
23737884|NCT01397409|66421003|FG000|Stage 2|Adverse Event|0|||
23737885|NCT01397409|66421004|FG001|Stage 2|Adverse Event|0|||
23737886|NCT01397409|66421005|FG002|Stage 2|Adverse Event|0|||
23737887|NCT01397409|66421006|FG003|Stage 2|Adverse Event|0|||
23737888|NCT01397409|66421007|FG004|Stage 2|Adverse Event|6|||
23737889|NCT01397409|66421008|FG005|Stage 2|Adverse Event|3|||
23737890|NCT01397409|66421009|FG006|Stage 2|Adverse Event|0|||
23737891|NCT01397409|66421010|FG007|Stage 2|Adverse Event|0|||
23737892|NCT01397409|66421011|FG008|Stage 2|Adverse Event|0|||
23737893|NCT01397409|66421012|FG009|Stage 2|Adverse Event|0|||
23737894|NCT01397409|66421003|FG000|Stage 2|Personal Reasons|0|||
23737895|NCT01397409|66421004|FG001|Stage 2|Personal Reasons|0|||
23737896|NCT01397409|66421005|FG002|Stage 2|Personal Reasons|0|||
23737897|NCT01397409|66421006|FG003|Stage 2|Personal Reasons|0|||
23737898|NCT01397409|66421007|FG004|Stage 2|Personal Reasons|1|||
23737899|NCT01397409|66421008|FG005|Stage 2|Personal Reasons|0|||
23737900|NCT01397409|66421009|FG006|Stage 2|Personal Reasons|0|||
23737901|NCT01397409|66421010|FG007|Stage 2|Personal Reasons|0|||
23737902|NCT01397409|66421011|FG008|Stage 2|Personal Reasons|0|||
23737903|NCT01397409|66421012|FG009|Stage 2|Personal Reasons|0|||
23737904|NCT01397409|66421003|FG000|Stage 2|Other Miscellaneous Reasons|0|||
23737905|NCT01397409|66421004|FG001|Stage 2|Other Miscellaneous Reasons|0|||
23737906|NCT01397409|66421005|FG002|Stage 2|Other Miscellaneous Reasons|0|||
23737907|NCT01397409|66421006|FG003|Stage 2|Other Miscellaneous Reasons|0|||
23737908|NCT01397409|66421007|FG004|Stage 2|Other Miscellaneous Reasons|1|||
23737909|NCT01397409|66421008|FG005|Stage 2|Other Miscellaneous Reasons|1|||
23737910|NCT01397409|66421009|FG006|Stage 2|Other Miscellaneous Reasons|0|||
23737911|NCT01397409|66421010|FG007|Stage 2|Other Miscellaneous Reasons|0|||
23427223|NCT00624780|65307572|FG000|Follow-up (Week 26)|Adverse Event|0|||
23737912|NCT01397409|66421011|FG008|Stage 2|Other Miscellaneous Reasons|0|||
23737913|NCT01397409|66421012|FG009|Stage 2|Other Miscellaneous Reasons|0|||
23737914|NCT01397409|66421003|FG000|Stage 3|Adverse Event|0|||
23737915|NCT01397409|66421004|FG001|Stage 3|Adverse Event|0|||
23737916|NCT01397409|66421005|FG002|Stage 3|Adverse Event|0|||
23737917|NCT01397409|66421006|FG003|Stage 3|Adverse Event|0|||
23737918|NCT01397409|66421007|FG004|Stage 3|Adverse Event|0|||
23737919|NCT01397409|66421008|FG005|Stage 3|Adverse Event|0|||
23737920|NCT01397409|66421009|FG006|Stage 3|Adverse Event|0|||
23737921|NCT01397409|66421010|FG007|Stage 3|Adverse Event|1|||
23737922|NCT01397409|66421011|FG008|Stage 3|Adverse Event|0|||
23737923|NCT01397409|66421012|FG009|Stage 3|Adverse Event|0|||
23737924|NCT01397409|66421003|FG000|Stage 3|Other Miscellaneous Reasons|0|||
23737925|NCT01397409|66421004|FG001|Stage 3|Other Miscellaneous Reasons|0|||
23737926|NCT01397409|66421005|FG002|Stage 3|Other Miscellaneous Reasons|0|||
23737927|NCT01397409|66421006|FG003|Stage 3|Other Miscellaneous Reasons|0|||
23737928|NCT01397409|66421007|FG004|Stage 3|Other Miscellaneous Reasons|0|||
23737929|NCT01397409|66421008|FG005|Stage 3|Other Miscellaneous Reasons|0|||
23737930|NCT01397409|66421009|FG006|Stage 3|Other Miscellaneous Reasons|0|||
23737931|NCT01397409|66421010|FG007|Stage 3|Other Miscellaneous Reasons|1|||
23737932|NCT01397409|66421011|FG008|Stage 3|Other Miscellaneous Reasons|0|||
23737933|NCT01397409|66421012|FG009|Stage 3|Other Miscellaneous Reasons|0|||
23737934|NCT02561273|66421013|FG000|Overall Study|Protocol Violation|1|||
23737935|NCT02561273|66421014|FG001|Overall Study|Protocol Violation|0|||
23737936|NCT02679222|66421028|FG000|Overall Study|No time for project|1|||
23737937|NCT02200510|66421029|FG000|Overall Study|Death|1|||
23737938|NCT02200510|66421030|FG001|Overall Study|Death|1|||
23737939|NCT02200510|66421029|FG000|Overall Study|Protocol Violation|0|||
23737940|NCT02200510|66421030|FG001|Overall Study|Protocol Violation|1|||
23737941|NCT02200510|66421029|FG000|Overall Study|Lost to Follow-up|7|||
23737942|NCT02200510|66421030|FG001|Overall Study|Lost to Follow-up|1|||
23737943|NCT02200510|66421029|FG000|Overall Study|potential COI - joined study team|1|||
23737944|NCT02200510|66421030|FG001|Overall Study|potential COI - joined study team|0|||
23737945|NCT01711359|66421031|FG000|Treatment Period|Withdrawal by Subject|18|||
23737946|NCT01711359|66421032|FG001|Treatment Period|Withdrawal by Subject|7|||
23737947|NCT01711359|66421033|FG002|Treatment Period|Withdrawal by Subject|13|||
23737948|NCT01711359|66421031|FG000|Treatment Period|Lack of Efficacy|13|||
23737949|NCT01711359|66421032|FG001|Treatment Period|Lack of Efficacy|2|||
23737950|NCT01711359|66421033|FG002|Treatment Period|Lack of Efficacy|2|||
23737951|NCT01711359|66421031|FG000|Treatment Period|Adverse Event|8|||
23737952|NCT01711359|66421032|FG001|Treatment Period|Adverse Event|10|||
23737953|NCT01711359|66421033|FG002|Treatment Period|Adverse Event|24|||
23737954|NCT01711359|66421031|FG000|Treatment Period|Physician Decision|4|||
23737955|NCT01711359|66421032|FG001|Treatment Period|Physician Decision|3|||
23737956|NCT01711359|66421033|FG002|Treatment Period|Physician Decision|2|||
23737957|NCT01711359|66421031|FG000|Treatment Period|Death|3|||
23737958|NCT01711359|66421032|FG001|Treatment Period|Death|0|||
23737959|NCT01711359|66421033|FG002|Treatment Period|Death|0|||
23737960|NCT01711359|66421031|FG000|Treatment Period|Entry Criteria Not Met|1|||
23737961|NCT01711359|66421032|FG001|Treatment Period|Entry Criteria Not Met|0|||
23737962|NCT01711359|66421033|FG002|Treatment Period|Entry Criteria Not Met|0|||
23737963|NCT01711359|66421031|FG000|Treatment Period|Sponsor Decision|1|||
23737964|NCT01711359|66421032|FG001|Treatment Period|Sponsor Decision|0|||
23737965|NCT01711359|66421033|FG002|Treatment Period|Sponsor Decision|0|||
23737966|NCT01711359|66421031|FG000|Treatment Period|Lost to Follow-up|1|||
23737967|NCT01711359|66421032|FG001|Treatment Period|Lost to Follow-up|1|||
23737968|NCT01711359|66421033|FG002|Treatment Period|Lost to Follow-up|1|||
23737969|NCT01711359|66421031|FG000|Treatment Period|Randomized, Not Treated|3|||
23737970|NCT01711359|66421032|FG001|Treatment Period|Randomized, Not Treated|1|||
23737971|NCT01711359|66421033|FG002|Treatment Period|Randomized, Not Treated|0|||
23737972|NCT02242305|66421034|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
23737973|NCT02242305|66421035|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
23820214|NCT00281957|66721263|FG001|Overall Study|Not protocol specified|1|||
23820215|NCT00281957|66721262|FG000|Overall Study|Not eligible|1|||
23820216|NCT00281957|66721263|FG001|Overall Study|Not eligible|2|||
23820217|NCT00281957|66721262|FG000|Overall Study|Did not start treatment|3|||
23820218|NCT00281957|66721263|FG001|Overall Study|Did not start treatment|1|||
23820219|NCT00281957|66721262|FG000|Overall Study|Refusal unrelated to adverse events|0|||
23427224|NCT00624780|65307573|FG001|Follow-up (Week 26)|Adverse Event|0|||
23427225|NCT00624780|65307574|FG002|Follow-up (Week 26)|Adverse Event|0|||
23427226|NCT00624780|65307575|FG003|Follow-up (Week 26)|Adverse Event|0|||
23427227|NCT00624780|65307576|FG004|Follow-up (Week 26)|Adverse Event|1|||
23427228|NCT00624780|65307577|FG005|Follow-up (Week 26)|Adverse Event|0|||
23427229|NCT00624780|65307572|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
23427230|NCT00624780|65307573|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
23427231|NCT00624780|65307574|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
23427232|NCT00624780|65307575|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
23427233|NCT00624780|65307576|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
23546890|NCT00518115|65731245|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546891|NCT00518115|65731246|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23820220|NCT00281957|66721263|FG001|Overall Study|Refusal unrelated to adverse events|1|||
23820221|NCT04623086|66721264|FG000|Overall Study|Withdrawal by Subject|0|||
23820222|NCT04623086|66721265|FG001|Overall Study|Withdrawal by Subject|0|||
23820223|NCT04623086|66721266|FG002|Overall Study|Withdrawal by Subject|10|||
23820224|NCT00352417|66721268|FG000|Overall Study|Adverse Event|1|||
23820225|NCT00352417|66721269|FG001|Overall Study|Adverse Event|0|||
23820226|NCT00352417|66721268|FG000|Overall Study|Protocol Violation|0|||
23820227|NCT00352417|66721269|FG001|Overall Study|Protocol Violation|2|||
23820228|NCT00352417|66721268|FG000|Overall Study|Withdrawal by Subject|1|||
23427234|NCT00624780|65307577|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
23737974|NCT02242305|66421034|FG000|Overall Study|Adverse Event|1|||
23737975|NCT02242305|66421035|FG001|Overall Study|Adverse Event|0|||
23737976|NCT02242305|66421034|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
23737977|NCT02242305|66421035|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
23737978|NCT02242305|66421034|FG000|Overall Study|Subject withdraws inform consent|0|||
23737979|NCT02242305|66421035|FG001|Overall Study|Subject withdraws inform consent|4|||
23737980|NCT02242305|66421034|FG000|Overall Study|Lost to Follow-up|2|||
23737981|NCT02242305|66421035|FG001|Overall Study|Lost to Follow-up|0|||
23737982|NCT03604159|66421038|FG000|Overall Study|Lost to Follow-up|6|||
23737983|NCT03604159|66421039|FG001|Overall Study|Lost to Follow-up|7|||
23737984|NCT01632345|66421040|FG000|Treatment: Part I|Adverse Event|1|||
23737985|NCT01632345|66421041|FG001|Treatment: Part I|Adverse Event|4|||
23737986|NCT01632345|66421042|FG002|Treatment: Part I|Adverse Event|2|||
23737987|NCT01632345|66421043|FG003|Treatment: Part I|Adverse Event|1|||
23737988|NCT01632345|66421044|FG004|Treatment: Part I|Adverse Event|3|||
23737989|NCT01632345|66421045|FG005|Treatment: Part I|Adverse Event|0|||
23737990|NCT01632345|66421046|FG006|Treatment: Part I|Adverse Event|0|||
23737991|NCT01632345|66421040|FG000|Treatment: Part I|Lack of Efficacy|0|||
23737992|NCT01632345|66421041|FG001|Treatment: Part I|Lack of Efficacy|1|||
23737993|NCT01632345|66421042|FG002|Treatment: Part I|Lack of Efficacy|0|||
23737994|NCT01632345|66421043|FG003|Treatment: Part I|Lack of Efficacy|1|||
23737995|NCT01632345|66421044|FG004|Treatment: Part I|Lack of Efficacy|1|||
23737996|NCT01632345|66421045|FG005|Treatment: Part I|Lack of Efficacy|0|||
23737997|NCT01632345|66421046|FG006|Treatment: Part I|Lack of Efficacy|0|||
23737998|NCT01632345|66421040|FG000|Treatment: Part I|Lost to Follow-up|3|||
23737999|NCT01632345|66421041|FG001|Treatment: Part I|Lost to Follow-up|2|||
23738000|NCT01632345|66421042|FG002|Treatment: Part I|Lost to Follow-up|1|||
23738001|NCT01632345|66421043|FG003|Treatment: Part I|Lost to Follow-up|3|||
23738002|NCT01632345|66421044|FG004|Treatment: Part I|Lost to Follow-up|4|||
23738003|NCT01632345|66421045|FG005|Treatment: Part I|Lost to Follow-up|0|||
23738004|NCT01632345|66421046|FG006|Treatment: Part I|Lost to Follow-up|0|||
23738005|NCT01632345|66421040|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
23738006|NCT01632345|66421041|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
23738007|NCT01632345|66421042|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
23738008|NCT01632345|66421043|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
23738009|NCT01632345|66421044|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
23738010|NCT01632345|66421045|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
23738011|NCT01632345|66421046|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
23738012|NCT01632345|66421040|FG000|Treatment: Part I|Physician Decision|2|||
23738013|NCT01632345|66421041|FG001|Treatment: Part I|Physician Decision|1|||
23738014|NCT01632345|66421042|FG002|Treatment: Part I|Physician Decision|0|||
23738015|NCT01632345|66421043|FG003|Treatment: Part I|Physician Decision|0|||
23738016|NCT01632345|66421044|FG004|Treatment: Part I|Physician Decision|1|||
23738017|NCT01632345|66421045|FG005|Treatment: Part I|Physician Decision|0|||
23738018|NCT01632345|66421046|FG006|Treatment: Part I|Physician Decision|0|||
23738019|NCT01632345|66421040|FG000|Treatment: Part I|Pregnancy|0|||
23738020|NCT01632345|66421041|FG001|Treatment: Part I|Pregnancy|1|||
23738021|NCT01632345|66421042|FG002|Treatment: Part I|Pregnancy|0|||
23738022|NCT01632345|66421043|FG003|Treatment: Part I|Pregnancy|0|||
23738023|NCT01632345|66421044|FG004|Treatment: Part I|Pregnancy|0|||
23738024|NCT01632345|66421045|FG005|Treatment: Part I|Pregnancy|0|||
23738025|NCT01632345|66421046|FG006|Treatment: Part I|Pregnancy|0|||
23738026|NCT01632345|66421040|FG000|Treatment: Part I|Protocol Deviation|0|||
23738027|NCT01632345|66421041|FG001|Treatment: Part I|Protocol Deviation|0|||
23738028|NCT01632345|66421042|FG002|Treatment: Part I|Protocol Deviation|1|||
23738029|NCT01632345|66421043|FG003|Treatment: Part I|Protocol Deviation|1|||
23546892|NCT00518115|65731247|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546893|NCT00518115|65731248|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546894|NCT00518115|65731249|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546895|NCT00518115|65731250|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546896|NCT00518115|65731241|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546897|NCT00518115|65731242|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546898|NCT00518115|65731243|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
23546899|NCT00518115|65731244|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546900|NCT00518115|65731245|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546901|NCT00518115|65731246|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546902|NCT00518115|65731247|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546903|NCT00518115|65731248|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546904|NCT00518115|65731249|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
23546905|NCT00518115|65731250|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
23738030|NCT01632345|66421044|FG004|Treatment: Part I|Protocol Deviation|0|||
23738031|NCT01632345|66421045|FG005|Treatment: Part I|Protocol Deviation|0|||
23738032|NCT01632345|66421046|FG006|Treatment: Part I|Protocol Deviation|0|||
23546906|NCT00518115|65731241|FG000|Overall Study|Wrong Monotherapy Administered|0|||
23546907|NCT00518115|65731242|FG001|Overall Study|Wrong Monotherapy Administered|0|||
23619218|NCT02859558|65991490|FG002|Step 2|Unexpected Closure of Site|1|||
23619219|NCT02859558|65991491|FG003|Step 2|Unexpected Closure of Site|0|||
23619220|NCT02859558|65991492|FG004|Step 2|Unexpected Closure of Site|0|||
23738033|NCT01632345|66421040|FG000|Treatment: Part I|Withdrawal by Subject|3|||
23738034|NCT01632345|66421041|FG001|Treatment: Part I|Withdrawal by Subject|4|||
23738035|NCT01632345|66421042|FG002|Treatment: Part I|Withdrawal by Subject|4|||
23738036|NCT01632345|66421043|FG003|Treatment: Part I|Withdrawal by Subject|1|||
23738037|NCT01632345|66421044|FG004|Treatment: Part I|Withdrawal by Subject|4|||
23738038|NCT01632345|66421045|FG005|Treatment: Part I|Withdrawal by Subject|0|||
23546908|NCT00518115|65731243|FG002|Overall Study|Wrong Monotherapy Administered|1|||
23546909|NCT00518115|65731244|FG003|Overall Study|Wrong Monotherapy Administered|0|||
23546910|NCT00518115|65731245|FG004|Overall Study|Wrong Monotherapy Administered|0|||
23546911|NCT00518115|65731246|FG005|Overall Study|Wrong Monotherapy Administered|0|||
23546912|NCT00518115|65731247|FG006|Overall Study|Wrong Monotherapy Administered|1|||
23546913|NCT00518115|65731248|FG007|Overall Study|Wrong Monotherapy Administered|0|||
23546914|NCT00518115|65731249|FG008|Overall Study|Wrong Monotherapy Administered|0|||
23546915|NCT00518115|65731250|FG009|Overall Study|Wrong Monotherapy Administered|0|||
23546916|NCT00518115|65731241|FG000|Overall Study|Violation of Exclusion Criteria|0|||
23546917|NCT00518115|65731242|FG001|Overall Study|Violation of Exclusion Criteria|0|||
23546918|NCT00518115|65731243|FG002|Overall Study|Violation of Exclusion Criteria|0|||
23546919|NCT00518115|65731244|FG003|Overall Study|Violation of Exclusion Criteria|1|||
23738039|NCT01632345|66421046|FG006|Treatment: Part I|Withdrawal by Subject|0|||
23738040|NCT01632345|66421040|FG000|Treatment: Part II|Adverse Event|0|||
23738041|NCT01632345|66421041|FG001|Treatment: Part II|Adverse Event|0|||
23738042|NCT01632345|66421042|FG002|Treatment: Part II|Adverse Event|0|||
23427235|NCT00624780|65307572|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
23427236|NCT00624780|65307573|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427237|NCT00624780|65307574|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427238|NCT00624780|65307575|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427239|NCT00624780|65307576|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427240|NCT00624780|65307577|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427241|NCT00624780|65307572|FG000|Follow-up (Week 26)|Other|1|||
23427242|NCT00624780|65307573|FG001|Follow-up (Week 26)|Other|1|||
23427243|NCT00624780|65307574|FG002|Follow-up (Week 26)|Other|0|||
23427244|NCT00624780|65307575|FG003|Follow-up (Week 26)|Other|0|||
23427245|NCT00624780|65307576|FG004|Follow-up (Week 26)|Other|0|||
23427246|NCT00624780|65307577|FG005|Follow-up (Week 26)|Other|0|||
23427247|NCT05590000|65307578|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
23427248|NCT00871117|65307579|FG000|Overall Study|Lost to Follow-up|5|||
23427249|NCT00871117|65307580|FG001|Overall Study|Lost to Follow-up|6|||
23427250|NCT00871117|65307579|FG000|Overall Study|Other|0|||
23427251|NCT00871117|65307580|FG001|Overall Study|Other|4|||
23427252|NCT01011933|65307581|FG000|Overall Study|Wrong cell type|1|||
23427253|NCT01011933|65307581|FG000|Overall Study|Improper pre-protocol Rx|1|||
23427254|NCT01011933|65307581|FG000|Overall Study|Inadequate pathology|1|||
23427255|NCT01011933|65307581|FG000|Overall Study|Never treated|1|||
23427256|NCT00908115|65307582|FG000|Overall Study|Other|14|||
23427257|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23427258|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23427259|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
23427260|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
23427261|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
23427262|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
23427263|NCT02549352|65307586|FG000|12-month Follow-up|Withdrawal by Subject|4|||
23427264|NCT02549352|65307587|FG001|12-month Follow-up|Withdrawal by Subject|5|||
23427265|NCT02549352|65307586|FG000|12-month Follow-up|Lost to Follow-up|3|||
23427266|NCT02549352|65307587|FG001|12-month Follow-up|Lost to Follow-up|2|||
23427267|NCT02549352|65307586|FG000|12-month Follow-up|Death|0|||
23427268|NCT02549352|65307587|FG001|12-month Follow-up|Death|1|||
23427269|NCT02549352|65307586|FG000|12-month Follow-up|Protocol Violation|0|||
23427270|NCT02549352|65307587|FG001|12-month Follow-up|Protocol Violation|1|||
23427271|NCT02549352|65307586|FG000|12-month Follow-up|Other|1|||
23427272|NCT02549352|65307587|FG001|12-month Follow-up|Other|3|||
23427273|NCT00806442|65307588|FG000|Overall Study|Lost to Follow-up|3|||
23427274|NCT00806442|65307589|FG001|Overall Study|Lost to Follow-up|2|||
23546920|NCT00518115|65731245|FG004|Overall Study|Violation of Exclusion Criteria|0|||
23546921|NCT00518115|65731246|FG005|Overall Study|Violation of Exclusion Criteria|0|||
23546922|NCT00518115|65731247|FG006|Overall Study|Violation of Exclusion Criteria|1|||
23546923|NCT00518115|65731248|FG007|Overall Study|Violation of Exclusion Criteria|0|||
23738043|NCT01632345|66421043|FG003|Treatment: Part II|Adverse Event|0|||
23427275|NCT00806442|65307588|FG000|Overall Study|Withdrawal by Subject|1|||
23427276|NCT00806442|65307589|FG001|Overall Study|Withdrawal by Subject|5|||
23427277|NCT03780959|65307590|FG000|Part 1|Adverse Event|1|||
23427278|NCT03780959|65307591|FG001|Part 1|Adverse Event|0|||
23427279|NCT03780959|65307592|FG002|Part 1|Adverse Event|0|||
23427280|NCT03780959|65307590|FG000|Part 1|Withdrawal by Subject|1|||
23427281|NCT03780959|65307591|FG001|Part 1|Withdrawal by Subject|0|||
23427282|NCT03780959|65307592|FG002|Part 1|Withdrawal by Subject|0|||
23546924|NCT00518115|65731249|FG008|Overall Study|Violation of Exclusion Criteria|0|||
23546925|NCT00518115|65731250|FG009|Overall Study|Violation of Exclusion Criteria|0|||
23427283|NCT03780959|65307590|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
23619221|NCT03494985|65991496|FG000|Overall Study|Adverse Event|3|||
23427284|NCT03780959|65307591|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
23427285|NCT03780959|65307592|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
23427286|NCT03780959|65307590|FG000|Part 1|Response Status|2|||
23427287|NCT03780959|65307591|FG001|Part 1|Response Status|0|||
23427288|NCT03780959|65307592|FG002|Part 1|Response Status|0|||
23427289|NCT03780959|65307590|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
23427290|NCT03780959|65307591|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
23427291|NCT03780959|65307592|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
23427292|NCT03780959|65307590|FG000|Part 2|Response Status|0|||
23427293|NCT03780959|65307591|FG001|Part 2|Response Status|18|||
23427294|NCT03780959|65307592|FG002|Part 2|Response Status|6|||
23427295|NCT02370095|65307593|FG000|Overall Study|Withdrawal by Subject|0|||
23427296|NCT02370095|65307594|FG001|Overall Study|Withdrawal by Subject|1|||
23427297|NCT00546260|65307598|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
23427298|NCT00546260|65307599|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
23427299|NCT00787137|65307600|FG000|Overall Study|Study Termination|0|||
23427300|NCT00787137|65307601|FG001|Overall Study|Study Termination|0|||
23427301|NCT00787137|65307602|FG002|Overall Study|Study Termination|1|||
23427302|NCT01287221|65307603|FG000|Overall Study|Lack of Perceived Benefit|1|||
23427303|NCT01287221|65307604|FG001|Overall Study|Lack of Perceived Benefit|1|||
23427304|NCT01287221|65307603|FG000|Overall Study|Adverse Event|3|||
23427305|NCT01287221|65307604|FG001|Overall Study|Adverse Event|3|||
23427306|NCT01287221|65307603|FG000|Overall Study|Withdrawal by Subject|0|||
23427307|NCT01287221|65307604|FG001|Overall Study|Withdrawal by Subject|1|||
23427308|NCT01688739|65307605|FG000|Overall Study|Administrative Decision|1|||
23427309|NCT01688739|65307606|FG001|Overall Study|Administrative Decision|0|||
23427310|NCT01688739|65307607|FG002|Overall Study|Administrative Decision|0|||
23738044|NCT01632345|66421044|FG004|Treatment: Part II|Adverse Event|0|||
23738045|NCT01632345|66421045|FG005|Treatment: Part II|Adverse Event|3|||
23738046|NCT01632345|66421046|FG006|Treatment: Part II|Adverse Event|8|||
23738047|NCT01632345|66421040|FG000|Treatment: Part II|Lost to Follow-up|0|||
23738048|NCT01632345|66421041|FG001|Treatment: Part II|Lost to Follow-up|0|||
23738049|NCT01632345|66421042|FG002|Treatment: Part II|Lost to Follow-up|0|||
23738050|NCT01632345|66421043|FG003|Treatment: Part II|Lost to Follow-up|0|||
23738051|NCT01632345|66421044|FG004|Treatment: Part II|Lost to Follow-up|0|||
23738052|NCT01632345|66421045|FG005|Treatment: Part II|Lost to Follow-up|3|||
23820229|NCT00352417|66721269|FG001|Overall Study|Withdrawal by Subject|2|||
23820230|NCT00352417|66721268|FG000|Overall Study|Lost to Follow-up|1|||
23427311|NCT01688739|65307608|FG003|Overall Study|Administrative Decision|0|||
23427312|NCT01688739|65307609|FG004|Overall Study|Administrative Decision|0|||
23427313|NCT01688739|65307610|FG005|Overall Study|Administrative Decision|0|||
23427314|NCT01688739|65307611|FG006|Overall Study|Administrative Decision|0|||
23427315|NCT01688739|65307612|FG007|Overall Study|Administrative Decision|0|||
23427316|NCT01688739|65307613|FG008|Overall Study|Administrative Decision|0|||
23427317|NCT01688739|65307614|FG009|Overall Study|Administrative Decision|0|||
23427318|NCT00042432|65307615|FG000|Overall Study|Adverse Event|4|||
23427319|NCT00042432|65307616|FG001|Overall Study|Adverse Event|1|||
23427320|NCT00042432|65307615|FG000|Overall Study|Withdrawal by Subject|1|||
23427321|NCT00042432|65307616|FG001|Overall Study|Withdrawal by Subject|3|||
23427322|NCT00042432|65307615|FG000|Overall Study|Death|0|||
23427323|NCT00042432|65307616|FG001|Overall Study|Death|2|||
23427324|NCT00042432|65307615|FG000|Overall Study|Ineligibility determined|1|||
23427325|NCT00042432|65307616|FG001|Overall Study|Ineligibility determined|0|||
23427326|NCT00042432|65307615|FG000|Overall Study|Initiation of maintenance dialysis|1|||
23427327|NCT00042432|65307616|FG001|Overall Study|Initiation of maintenance dialysis|1|||
23427328|NCT00042432|65307615|FG000|Overall Study|Other|2|||
23427329|NCT00042432|65307616|FG001|Overall Study|Other|0|||
23427330|NCT03002818|65307617|FG000|Overall Study|Decision of the investigator|1|||
23427331|NCT02046070|65307621|FG000|Overall Study|Progressive Disease|18|||
23427332|NCT02046070|65307622|FG001|Overall Study|Progressive Disease|11|||
23427333|NCT02046070|65307623|FG002|Overall Study|Progressive Disease|40|||
23427334|NCT02046070|65307621|FG000|Overall Study|Adverse Event|8|||
23427335|NCT02046070|65307622|FG001|Overall Study|Adverse Event|10|||
23427336|NCT02046070|65307623|FG002|Overall Study|Adverse Event|17|||
23427337|NCT02046070|65307621|FG000|Overall Study|Withdrawal by Subject|1|||
23427338|NCT02046070|65307622|FG001|Overall Study|Withdrawal by Subject|2|||
23738053|NCT01632345|66421046|FG006|Treatment: Part II|Lost to Follow-up|1|||
23820231|NCT00352417|66721269|FG001|Overall Study|Lost to Follow-up|0|||
23820232|NCT00352417|66721268|FG000|Overall Study|Schedule Change|2|||
23427339|NCT02046070|65307623|FG002|Overall Study|Withdrawal by Subject|6|||
23427340|NCT02046070|65307621|FG000|Overall Study|Study Terminated by Sponsor|1|||
23738054|NCT01632345|66421040|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
23820233|NCT00352417|66721269|FG001|Overall Study|Schedule Change|1|||
23427341|NCT02046070|65307622|FG001|Overall Study|Study Terminated by Sponsor|1|||
23427342|NCT02046070|65307623|FG002|Overall Study|Study Terminated by Sponsor|1|||
23427343|NCT02046070|65307621|FG000|Overall Study|Reason not Specified|4|||
23427344|NCT02046070|65307622|FG001|Overall Study|Reason not Specified|4|||
23427345|NCT02046070|65307623|FG002|Overall Study|Reason not Specified|6|||
23427346|NCT03831945|65307627|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
23453634|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23427347|NCT03831945|65307628|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
23427348|NCT03831945|65307627|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
23427349|NCT03831945|65307628|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
23427350|NCT03831945|65307627|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
23427351|NCT03831945|65307628|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
23427352|NCT01974752|65307646|FG000|Overall Study|Death|33|||
23427353|NCT01974752|65307647|FG001|Overall Study|Death|11|||
23427354|NCT01974752|65307646|FG000|Overall Study|Lost to Follow-up|2|||
23427355|NCT01974752|65307647|FG001|Overall Study|Lost to Follow-up|0|||
23427356|NCT01974752|65307646|FG000|Overall Study|Withdrawal by Subject|2|||
23427357|NCT01974752|65307647|FG001|Overall Study|Withdrawal by Subject|3|||
23427358|NCT01974752|65307646|FG000|Overall Study|Other Eligibility Criteria|0|||
23427359|NCT01974752|65307647|FG001|Overall Study|Other Eligibility Criteria|1|||
23427360|NCT01484834|65307648|FG000|Overall Study|Lost to Follow-up|5|||
23427361|NCT01484834|65307649|FG001|Overall Study|Lost to Follow-up|8|||
23427362|NCT01484834|65307650|FG002|Overall Study|Lost to Follow-up|1|||
23427363|NCT01484834|65307651|FG003|Overall Study|Lost to Follow-up|4|||
23427364|NCT00289198|65307652|FG000|Overall Study|Adverse Event|0|||
23427365|NCT00289198|65307653|FG001|Overall Study|Adverse Event|2|||
23427366|NCT00289198|65307652|FG000|Overall Study|Protocol Violation|2|||
23427367|NCT00289198|65307653|FG001|Overall Study|Protocol Violation|1|||
23427368|NCT00289198|65307652|FG000|Overall Study|Withdrawal by Subject|4|||
23427369|NCT00289198|65307653|FG001|Overall Study|Withdrawal by Subject|1|||
23427370|NCT00289198|65307652|FG000|Overall Study|Lack of Efficacy|2|||
23427371|NCT00289198|65307653|FG001|Overall Study|Lack of Efficacy|0|||
23427372|NCT00289198|65307652|FG000|Overall Study|Other: Low compliance|0|||
23427373|NCT00289198|65307653|FG001|Overall Study|Other: Low compliance|1|||
23427374|NCT00289198|65307652|FG000|Overall Study|Other: Physician's decision|0|||
23427375|NCT00289198|65307653|FG001|Overall Study|Other: Physician's decision|1|||
23427376|NCT00289198|65307652|FG000|Overall Study|Other: Unable to attend on schedule|2|||
23427377|NCT00289198|65307653|FG001|Overall Study|Other: Unable to attend on schedule|1|||
23427378|NCT00289198|65307652|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
23427379|NCT00289198|65307653|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
23427380|NCT00289198|65307652|FG000|Overall Study|Other: Impossible to come on visit|0|||
23427381|NCT00289198|65307653|FG001|Overall Study|Other: Impossible to come on visit|1|||
23427382|NCT00787202|65307654|FG000|Overall Study|Adverse Event|3|||
23427383|NCT00787202|65307655|FG001|Overall Study|Adverse Event|2|||
23427384|NCT00787202|65307656|FG002|Overall Study|Adverse Event|0|||
23427385|NCT00787202|65307657|FG003|Overall Study|Adverse Event|0|||
23427386|NCT00787202|65307658|FG004|Overall Study|Adverse Event|2|||
23427387|NCT00787202|65307654|FG000|Overall Study|Lack of Efficacy|5|||
23427388|NCT00787202|65307655|FG001|Overall Study|Lack of Efficacy|6|||
23427389|NCT00787202|65307656|FG002|Overall Study|Lack of Efficacy|5|||
23427390|NCT00787202|65307657|FG003|Overall Study|Lack of Efficacy|2|||
23427391|NCT00787202|65307658|FG004|Overall Study|Lack of Efficacy|1|||
23427392|NCT00787202|65307654|FG000|Overall Study|Lost to Follow-up|1|||
23427393|NCT00787202|65307655|FG001|Overall Study|Lost to Follow-up|0|||
23427394|NCT00787202|65307656|FG002|Overall Study|Lost to Follow-up|0|||
23427395|NCT00787202|65307657|FG003|Overall Study|Lost to Follow-up|0|||
23427396|NCT00787202|65307658|FG004|Overall Study|Lost to Follow-up|0|||
23427397|NCT00787202|65307654|FG000|Overall Study|Withdrawal by Subject|2|||
23427398|NCT00787202|65307655|FG001|Overall Study|Withdrawal by Subject|2|||
23427399|NCT00787202|65307656|FG002|Overall Study|Withdrawal by Subject|2|||
23427400|NCT00787202|65307657|FG003|Overall Study|Withdrawal by Subject|0|||
23427401|NCT00787202|65307658|FG004|Overall Study|Withdrawal by Subject|0|||
23427402|NCT00787202|65307654|FG000|Overall Study|Protocol Violation|2|||
23427403|NCT00787202|65307655|FG001|Overall Study|Protocol Violation|1|||
23427404|NCT00787202|65307656|FG002|Overall Study|Protocol Violation|0|||
23427405|NCT00787202|65307657|FG003|Overall Study|Protocol Violation|0|||
23427406|NCT00787202|65307658|FG004|Overall Study|Protocol Violation|1|||
23427407|NCT00787202|65307654|FG000|Overall Study|Randomized, not treated|1|||
23427408|NCT00787202|65307655|FG001|Overall Study|Randomized, not treated|0|||
23427409|NCT00787202|65307656|FG002|Overall Study|Randomized, not treated|0|||
23427410|NCT00787202|65307657|FG003|Overall Study|Randomized, not treated|0|||
23427411|NCT00787202|65307658|FG004|Overall Study|Randomized, not treated|0|||
23427412|NCT00857948|65307659|FG000|Overall Study|Withdrawal by Subject|2|||
23427413|NCT00857948|65307660|FG001|Overall Study|Withdrawal by Subject|0|||
23427414|NCT00857948|65307661|FG002|Overall Study|Withdrawal by Subject|0|||
23427415|NCT00857948|65307662|FG003|Overall Study|Withdrawal by Subject|0|||
23427416|NCT00857948|65307659|FG000|Overall Study|Protocol Violation|1|||
23427417|NCT00857948|65307660|FG001|Overall Study|Protocol Violation|0|||
23427418|NCT00857948|65307661|FG002|Overall Study|Protocol Violation|1|||
23427419|NCT00857948|65307662|FG003|Overall Study|Protocol Violation|0|||
23427420|NCT04316741|65307665|FG000|Baseline Enrollment|Lost to Follow-up|1|||
23546926|NCT00518115|65731241|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
23546927|NCT00518115|65731242|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
23546928|NCT00518115|65731243|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
23546929|NCT00518115|65731244|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
23546930|NCT00518115|65731245|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
23546931|NCT00518115|65731246|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
23546932|NCT00518115|65731247|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
23546933|NCT00518115|65731248|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
23546934|NCT00518115|65731249|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
23546935|NCT00518115|65731250|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
23546936|NCT00518115|65731241|FG000|Overall Study|Withdrew Consent|0|||
23546937|NCT00518115|65731242|FG001|Overall Study|Withdrew Consent|0|||
23546938|NCT00518115|65731243|FG002|Overall Study|Withdrew Consent|0|||
23546939|NCT00518115|65731244|FG003|Overall Study|Withdrew Consent|0|||
23546940|NCT00518115|65731245|FG004|Overall Study|Withdrew Consent|0|||
23546941|NCT00518115|65731246|FG005|Overall Study|Withdrew Consent|1|||
23546942|NCT00518115|65731247|FG006|Overall Study|Withdrew Consent|0|||
23546943|NCT00518115|65731248|FG007|Overall Study|Withdrew Consent|0|||
23546944|NCT00518115|65731249|FG008|Overall Study|Withdrew Consent|0|||
23546945|NCT00518115|65731250|FG009|Overall Study|Withdrew Consent|0|||
23546946|NCT00518115|65731241|FG000|Overall Study|Moved Out of State|0|||
23546947|NCT00518115|65731242|FG001|Overall Study|Moved Out of State|0|||
23546948|NCT00518115|65731243|FG002|Overall Study|Moved Out of State|0|||
23546949|NCT00518115|65731244|FG003|Overall Study|Moved Out of State|0|||
23546950|NCT00518115|65731245|FG004|Overall Study|Moved Out of State|0|||
23546951|NCT00518115|65731246|FG005|Overall Study|Moved Out of State|0|||
23546952|NCT00518115|65731247|FG006|Overall Study|Moved Out of State|0|||
23546953|NCT00518115|65731248|FG007|Overall Study|Moved Out of State|0|||
23546954|NCT00518115|65731249|FG008|Overall Study|Moved Out of State|0|||
23546955|NCT00518115|65731250|FG009|Overall Study|Moved Out of State|1|||
23546956|NCT03117738|65735638|FG000|Overall Study|Withdrawal by Subject|3|||
23546957|NCT03117738|65735639|FG001|Overall Study|Withdrawal by Subject|1|||
23546958|NCT03117738|65735638|FG000|Overall Study|Lost to Follow-up|1|||
23546959|NCT03117738|65735639|FG001|Overall Study|Lost to Follow-up|4|||
23546960|NCT00936390|65735640|FG000|Overall Study|Protocol Violation|21|||
23546961|NCT00936390|65735641|FG001|Overall Study|Protocol Violation|25|||
23546962|NCT03105362|65735642|FG000|Overall Study|Withdrawal by Subject|1|||
23546963|NCT03105362|65735642|FG000|Overall Study|Lost to Follow-up|1|||
23546964|NCT03826667|65735648|FG000|Overall Study|Protocol deviation|21|||
23546965|NCT03996473|65735650|FG000|Treatment Assignment|Withdrawal by Subject|1|||
23546966|NCT03996473|65735650|FG000|Treatment Assignment|Progressive disease|6|||
23546967|NCT03996473|65735650|FG000|Treatment Assignment|Study drug never administered|1|||
23546968|NCT03996473|65735650|FG000|Active Follow-up|Death|1|||
23546969|NCT03996473|65735650|FG000|Long-term Follow-up|Death|5|||
23546970|NCT02367911|65735651|FG000|Overall Study|Withdrawal by Subject|3|||
23546971|NCT02367911|65735652|FG001|Overall Study|Withdrawal by Subject|2|||
23546972|NCT02367911|65735651|FG000|Overall Study|Lost to Follow-up|2|||
23546973|NCT02367911|65735652|FG001|Overall Study|Lost to Follow-up|2|||
23546974|NCT02187991|65735653|FG000|Overall Study|Adverse Event|13|||
23546975|NCT02187991|65735654|FG001|Overall Study|Adverse Event|14|||
23546976|NCT02187991|65735655|FG002|Overall Study|Adverse Event|3|||
23546977|NCT02187991|65735656|FG003|Overall Study|Adverse Event|2|||
23546978|NCT02187991|65735653|FG000|Overall Study|Withdrawal by Subject|9|||
23546979|NCT02187991|65735654|FG001|Overall Study|Withdrawal by Subject|6|||
23546980|NCT02187991|65735655|FG002|Overall Study|Withdrawal by Subject|3|||
23546981|NCT02187991|65735656|FG003|Overall Study|Withdrawal by Subject|2|||
23546982|NCT02187991|65735653|FG000|Overall Study|Physician Decision|4|||
23546983|NCT02187991|65735654|FG001|Overall Study|Physician Decision|4|||
23546984|NCT02187991|65735655|FG002|Overall Study|Physician Decision|0|||
23546985|NCT02187991|65735656|FG003|Overall Study|Physician Decision|2|||
23546986|NCT02187991|65735653|FG000|Overall Study|Other, unrelated complication|7|||
23546987|NCT02187991|65735654|FG001|Overall Study|Other, unrelated complication|1|||
23546988|NCT02187991|65735655|FG002|Overall Study|Other, unrelated complication|1|||
23820234|NCT01555671|66721270|FG000|Overall Study|Physician Decision|20|||
23820235|NCT01555671|66721271|FG001|Overall Study|Physician Decision|25|||
23546989|NCT02187991|65735656|FG003|Overall Study|Other, unrelated complication|2|||
23546990|NCT02187991|65735653|FG000|Overall Study|Death|1|||
23546991|NCT02187991|65735654|FG001|Overall Study|Death|3|||
23546992|NCT02187991|65735655|FG002|Overall Study|Death|0|||
23546993|NCT02187991|65735656|FG003|Overall Study|Death|0|||
23546994|NCT00380068|65735659|FG000|Overall Study|Adverse Event|40|||
23546995|NCT00380068|65735659|FG000|Overall Study|Withdrawal by Subject|10|||
23546996|NCT00380068|65735659|FG000|Overall Study|Not compliant|6|||
23546997|NCT00380068|65735659|FG000|Overall Study|Lost to Follow-up|1|||
23546998|NCT00380068|65735659|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
23546999|NCT00380068|65735659|FG000|Overall Study|Lung transplant|3|||
23547000|NCT00380068|65735659|FG000|Overall Study|Physician Decision|2|||
23547001|NCT00380068|65735659|FG000|Overall Study|Partipant moved away|1|||
23547002|NCT00380068|65735659|FG000|Overall Study|Lack of Efficacy|5|||
23547003|NCT01026974|65735660|FG000|Overall Study|Withdrawal by Subject|0|||
23547004|NCT01026974|65735661|FG001|Overall Study|Withdrawal by Subject|1|||
23547005|NCT01026974|65735662|FG002|Overall Study|Withdrawal by Subject|7|||
23547006|NCT01026974|65735663|FG003|Overall Study|Withdrawal by Subject|2|||
23547007|NCT01026974|65735660|FG000|Overall Study|Lost to Follow-up|1|||
23547008|NCT01026974|65735661|FG001|Overall Study|Lost to Follow-up|1|||
23547009|NCT01026974|65735662|FG002|Overall Study|Lost to Follow-up|4|||
23547010|NCT01026974|65735663|FG003|Overall Study|Lost to Follow-up|0|||
23547011|NCT01026974|65735660|FG000|Overall Study|Adverse Event|0|||
23547012|NCT01026974|65735661|FG001|Overall Study|Adverse Event|0|||
23547013|NCT01026974|65735662|FG002|Overall Study|Adverse Event|0|||
23547014|NCT01026974|65735663|FG003|Overall Study|Adverse Event|1|||
23547015|NCT01026974|65735660|FG000|Overall Study|Inappropriate enrollment|0|||
23547016|NCT01026974|65735661|FG001|Overall Study|Inappropriate enrollment|0|||
23547017|NCT01026974|65735662|FG002|Overall Study|Inappropriate enrollment|1|||
23547018|NCT01026974|65735663|FG003|Overall Study|Inappropriate enrollment|0|||
23547019|NCT02682264|65735664|FG000|Overall Study|Withdrawal by Subject|56|||
23547020|NCT02682264|65735665|FG001|Overall Study|Withdrawal by Subject|45|||
23547021|NCT02682264|65735664|FG000|Overall Study|Lost to Follow-up|49|||
23547022|NCT02682264|65735665|FG001|Overall Study|Lost to Follow-up|41|||
23547023|NCT02682264|65735664|FG000|Overall Study|Lack of Efficacy|14|||
23547024|NCT02682264|65735665|FG001|Overall Study|Lack of Efficacy|16|||
23547025|NCT02682264|65735664|FG000|Overall Study|Withdrawal by Parent|6|||
23547026|NCT02682264|65735665|FG001|Overall Study|Withdrawal by Parent|7|||
23547027|NCT02682264|65735664|FG000|Overall Study|Adverse Event|9|||
23547028|NCT02682264|65735665|FG001|Overall Study|Adverse Event|0|||
23547029|NCT02682264|65735664|FG000|Overall Study|Noncompliance with study drug|1|||
23547030|NCT02682264|65735665|FG001|Overall Study|Noncompliance with study drug|4|||
23547031|NCT02682264|65735664|FG000|Overall Study|Pregnancy|1|||
23547032|NCT02682264|65735665|FG001|Overall Study|Pregnancy|2|||
23547033|NCT02682264|65735664|FG000|Overall Study|Recovery|1|||
23547034|NCT02682264|65735665|FG001|Overall Study|Recovery|2|||
23619222|NCT03494985|65991497|FG001|Overall Study|Adverse Event|2|||
23738055|NCT01632345|66421041|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
23738056|NCT01632345|66421042|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
23738057|NCT01632345|66421043|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
23738058|NCT01632345|66421044|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
23547035|NCT02682264|65735664|FG000|Overall Study|Progressive Disease|1|||
23547036|NCT02682264|65735665|FG001|Overall Study|Progressive Disease|0|||
23547037|NCT02682264|65735664|FG000|Overall Study|Technical Problems|0|||
23547038|NCT02682264|65735665|FG001|Overall Study|Technical Problems|1|||
23547039|NCT02682264|65735664|FG000|Overall Study|Moved abroad and unable to continue|0|||
23547040|NCT02682264|65735665|FG001|Overall Study|Moved abroad and unable to continue|3|||
23547041|NCT02682264|65735664|FG000|Overall Study|Stopped test article application|0|||
23547042|NCT02682264|65735665|FG001|Overall Study|Stopped test article application|1|||
23547043|NCT02590354|65735666|FG000|Phase 1|Active hepatitis B or C infection|1|||
23547044|NCT02590354|65735666|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
23547045|NCT02590354|65735666|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
23547046|NCT02590354|65735666|FG000|Phase 1|Subject does not want to participate|20|||
23547047|NCT02590354|65735666|FG000|Phase 1|Lost to Follow-up|1|||
23547048|NCT02590354|65735666|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
23547049|NCT02252211|65735668|FG000|Overall Study|Adverse Event|0|||
23547050|NCT02252211|65735669|FG001|Overall Study|Adverse Event|1|||
23547051|NCT02252211|65735670|FG002|Overall Study|Adverse Event|0|||
23547052|NCT02252211|65735668|FG000|Overall Study|Progressive disease|3|||
23547053|NCT02252211|65735669|FG001|Overall Study|Progressive disease|2|||
23547054|NCT02252211|65735670|FG002|Overall Study|Progressive disease|0|||
23547055|NCT02252211|65735668|FG000|Overall Study|Withdrawal by Subject|1|||
23547056|NCT02252211|65735669|FG001|Overall Study|Withdrawal by Subject|0|||
23547057|NCT02252211|65735670|FG002|Overall Study|Withdrawal by Subject|0|||
23547058|NCT02252211|65735668|FG000|Overall Study|Serious Adverse Event During Screening|1|||
23547059|NCT02252211|65735669|FG001|Overall Study|Serious Adverse Event During Screening|0|||
23547060|NCT02252211|65735670|FG002|Overall Study|Serious Adverse Event During Screening|1|||
23547061|NCT02096900|65735671|FG000|Overall Study|Did not receive medication|3|||
23738059|NCT01632345|66421045|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
23738060|NCT01632345|66421046|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
23547062|NCT02096900|65735672|FG001|Overall Study|Did not receive medication|1|||
23547063|NCT02096900|65735671|FG000|Overall Study|Surgery cancelled- medication received|1|||
23547064|NCT02096900|65735672|FG001|Overall Study|Surgery cancelled- medication received|1|||
23547065|NCT01775904|65735673|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
23547066|NCT01775904|65735673|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
23547067|NCT02653482|65735674|FG000|Overall Study|Death|1|||
23547068|NCT02653482|65735675|FG001|Overall Study|Death|1|||
23547069|NCT00626522|65735678|FG000|Overall Study|Protocol Violation|0|||
23547070|NCT00626522|65735679|FG001|Overall Study|Protocol Violation|0|||
23547071|NCT00626522|65735680|FG002|Overall Study|Protocol Violation|0|||
23547072|NCT00626522|65735681|FG003|Overall Study|Protocol Violation|0|||
23547073|NCT00626522|65735682|FG004|Overall Study|Protocol Violation|1|||
23547074|NCT00626522|65735683|FG005|Overall Study|Protocol Violation|0|||
23547075|NCT00626522|65735678|FG000|Overall Study|Adverse Event|2|||
23547076|NCT00626522|65735679|FG001|Overall Study|Adverse Event|1|||
23547077|NCT00626522|65735680|FG002|Overall Study|Adverse Event|2|||
23547078|NCT00626522|65735681|FG003|Overall Study|Adverse Event|0|||
23547079|NCT00626522|65735682|FG004|Overall Study|Adverse Event|1|||
23547080|NCT00626522|65735683|FG005|Overall Study|Adverse Event|1|||
23547081|NCT00626522|65735678|FG000|Overall Study|Withdrawal by Subject|2|||
23547082|NCT00626522|65735679|FG001|Overall Study|Withdrawal by Subject|5|||
23547083|NCT00626522|65735680|FG002|Overall Study|Withdrawal by Subject|5|||
23547084|NCT00626522|65735681|FG003|Overall Study|Withdrawal by Subject|0|||
23547085|NCT00626522|65735682|FG004|Overall Study|Withdrawal by Subject|4|||
23547086|NCT00626522|65735683|FG005|Overall Study|Withdrawal by Subject|1|||
23547087|NCT00626522|65735678|FG000|Overall Study|COPD exacerbation|0|||
23547088|NCT00626522|65735679|FG001|Overall Study|COPD exacerbation|0|||
23547089|NCT00626522|65735680|FG002|Overall Study|COPD exacerbation|0|||
23547090|NCT00626522|65735681|FG003|Overall Study|COPD exacerbation|1|||
23547091|NCT00626522|65735682|FG004|Overall Study|COPD exacerbation|1|||
23547092|NCT00626522|65735683|FG005|Overall Study|COPD exacerbation|0|||
23547093|NCT00626522|65735678|FG000|Overall Study|Lost to Follow-up|0|||
23547094|NCT00626522|65735679|FG001|Overall Study|Lost to Follow-up|1|||
23547095|NCT00626522|65735680|FG002|Overall Study|Lost to Follow-up|0|||
23547096|NCT00626522|65735681|FG003|Overall Study|Lost to Follow-up|0|||
23547097|NCT00626522|65735682|FG004|Overall Study|Lost to Follow-up|0|||
23547098|NCT00626522|65735683|FG005|Overall Study|Lost to Follow-up|0|||
23547099|NCT00626522|65735678|FG000|Overall Study|Inconsistent reason reported|1|||
23547100|NCT00626522|65735679|FG001|Overall Study|Inconsistent reason reported|0|||
23547101|NCT00626522|65735680|FG002|Overall Study|Inconsistent reason reported|0|||
23547102|NCT00626522|65735681|FG003|Overall Study|Inconsistent reason reported|0|||
23547103|NCT00626522|65735682|FG004|Overall Study|Inconsistent reason reported|0|||
23547104|NCT00626522|65735683|FG005|Overall Study|Inconsistent reason reported|0|||
23547105|NCT00626522|65735678|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547106|NCT00626522|65735679|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547107|NCT00626522|65735680|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547108|NCT00626522|65735681|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547109|NCT00626522|65735682|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547110|NCT00626522|65735683|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547111|NCT05553808|65735684|FG000|Overall Study|Death|25|||
23547112|NCT05553808|65735685|FG001|Overall Study|Death|62|||
23547113|NCT05553808|65735684|FG000|Overall Study|Site Closed|6|||
23547114|NCT05553808|65735685|FG001|Overall Study|Site Closed|6|||
23547115|NCT05553808|65735684|FG000|Overall Study|Lost to Follow-up|1|||
23547116|NCT05553808|65735685|FG001|Overall Study|Lost to Follow-up|0|||
23547117|NCT05553808|65735684|FG000|Overall Study|Withdrawal by Subject|3|||
23738061|NCT01632345|66421040|FG000|Treatment: Part II|Withdrawal by Subject|0|||
23738062|NCT01632345|66421041|FG001|Treatment: Part II|Withdrawal by Subject|0|||
23738063|NCT01632345|66421042|FG002|Treatment: Part II|Withdrawal by Subject|0|||
23738064|NCT01632345|66421043|FG003|Treatment: Part II|Withdrawal by Subject|0|||
23738065|NCT01632345|66421044|FG004|Treatment: Part II|Withdrawal by Subject|0|||
23738066|NCT01632345|66421045|FG005|Treatment: Part II|Withdrawal by Subject|2|||
23738067|NCT01632345|66421046|FG006|Treatment: Part II|Withdrawal by Subject|2|||
23738068|NCT00186121|66421047|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
23738069|NCT00186121|66421047|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
23738070|NCT00186121|66421047|FG000|Overall Study|Not eligible (no treatment)|1|||
23738071|NCT05047601|66421054|FG000|Overall Study|Lost to Follow-up|9|||
23738072|NCT05047601|66421055|FG001|Overall Study|Lost to Follow-up|11|||
23547118|NCT05553808|65735685|FG001|Overall Study|Withdrawal by Subject|2|||
23547119|NCT01664078|65735690|FG000|Overall Study|Death|9|||
23738073|NCT05047601|66421056|FG002|Overall Study|Lost to Follow-up|7|||
23547120|NCT01664078|65735690|FG000|Overall Study|Withdrawal by Subject|4|||
23547121|NCT01664078|65735690|FG000|Overall Study|Lost to Follow-up|2|||
23547122|NCT01664078|65735690|FG000|Overall Study|missed 5 year visit|1|||
23547123|NCT01664078|65735690|FG000|Overall Study|Other|53|||
23547124|NCT01154166|65735691|FG000|Overall Study|Adverse Event|14|||
23547125|NCT01154166|65735692|FG001|Overall Study|Adverse Event|9|||
23547126|NCT01154166|65735691|FG000|Overall Study|Lost to Follow-up|1|||
23547127|NCT01154166|65735692|FG001|Overall Study|Lost to Follow-up|1|||
23547128|NCT01154166|65735691|FG000|Overall Study|Protocol Violation|4|||
23547129|NCT01154166|65735692|FG001|Overall Study|Protocol Violation|1|||
23547130|NCT01154166|65735691|FG000|Overall Study|Withdrawal by Subject|10|||
23547131|NCT01154166|65735692|FG001|Overall Study|Withdrawal by Subject|1|||
23547132|NCT01154166|65735691|FG000|Overall Study|Lack of Efficacy|3|||
23547133|NCT01154166|65735692|FG001|Overall Study|Lack of Efficacy|0|||
23547134|NCT01154166|65735691|FG000|Overall Study|Disease Progression|1|||
23547135|NCT01154166|65735692|FG001|Overall Study|Disease Progression|0|||
23547136|NCT01154166|65735691|FG000|Overall Study|Poor Compliance|1|||
23547137|NCT01154166|65735692|FG001|Overall Study|Poor Compliance|0|||
23547138|NCT04575467|65735699|FG000|Overall Study|Adverse Event|0|||
23547139|NCT04575467|65735700|FG001|Overall Study|Adverse Event|1|||
23547140|NCT04575467|65735701|FG002|Overall Study|Adverse Event|0|||
23547141|NCT04575467|65735702|FG003|Overall Study|Adverse Event|0|||
23547142|NCT00839072|65735703|FG000|First Intervention Period|Withdrawal by Subject|1|||
23547143|NCT00839072|65735704|FG001|First Intervention Period|Withdrawal by Subject|0|||
23547144|NCT00839072|65735703|FG000|First Intervention Period|Adverse Event|1|||
23547145|NCT00839072|65735704|FG001|First Intervention Period|Adverse Event|1|||
23547146|NCT00839072|65735703|FG000|Second Intervention Period|Withdrawal by Subject|1|||
23547147|NCT00839072|65735704|FG001|Second Intervention Period|Withdrawal by Subject|0|||
23547148|NCT01914926|65735712|FG000|Overall Study|Adverse Event|1|||
23547149|NCT01914926|65735713|FG001|Overall Study|Adverse Event|0|||
23547150|NCT01914926|65735712|FG000|Overall Study|uncooperative, agitated and removed|0|||
23547151|NCT01914926|65735713|FG001|Overall Study|uncooperative, agitated and removed|1|||
23547152|NCT00574080|65735714|FG000|Overall Study|Death|10|||
23547153|NCT00574080|65735715|FG001|Overall Study|Death|10|||
23547154|NCT02232893|65735716|FG000|Overall Study|Withdrawal by Subject|4|||
23547155|NCT02232893|65735717|FG001|Overall Study|Withdrawal by Subject|1|||
23547156|NCT02232893|65735716|FG000|Overall Study|Adverse Event|0|||
23547157|NCT02232893|65735717|FG001|Overall Study|Adverse Event|1|||
23547158|NCT02232893|65735716|FG000|Overall Study|Sponsor request early termination|0|||
23738074|NCT05047601|66421054|FG000|Overall Study|Withdrawal by Subject|25|||
23738075|NCT05047601|66421055|FG001|Overall Study|Withdrawal by Subject|36|||
23738076|NCT05047601|66421056|FG002|Overall Study|Withdrawal by Subject|23|||
23738077|NCT05047601|66421054|FG000|Overall Study|Other|10|||
23738078|NCT05047601|66421055|FG001|Overall Study|Other|6|||
23738079|NCT05047601|66421056|FG002|Overall Study|Other|5|||
23738080|NCT03490734|66421057|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
23738081|NCT03490734|66421058|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
23547159|NCT02232893|65735717|FG001|Overall Study|Sponsor request early termination|1|||
23547160|NCT02232893|65735716|FG000|Overall Study|Developed exclusion criteria|0|||
23547161|NCT02232893|65735717|FG001|Overall Study|Developed exclusion criteria|1|||
23547162|NCT02232893|65735716|FG000|Overall Study|Other|0|||
23547163|NCT02232893|65735717|FG001|Overall Study|Other|3|||
23738082|NCT03490734|66421059|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
23820236|NCT02886624|66721274|FG000|12-week Post Treatment Follow-up|Death|1|||
23820237|NCT02886624|66721274|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
23820238|NCT01908907|66721275|FG000|Overall Study|Physician Decision|1|||
23820239|NCT01908907|66721276|FG001|Overall Study|Physician Decision|0|||
23820240|NCT01908907|66721275|FG000|Overall Study|Protocol Violation|1|||
23738083|NCT03490734|66421060|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
23738084|NCT03490734|66421057|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23738085|NCT03490734|66421058|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23738086|NCT03490734|66421059|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23738087|NCT03490734|66421060|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
23738088|NCT03490734|66421057|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23820241|NCT01908907|66721276|FG001|Overall Study|Protocol Violation|0|||
23820242|NCT02068092|66721283|FG000|Overall Study|Physician Decision|2|||
23820243|NCT02068092|66721283|FG000|Overall Study|Adverse Event|2|||
23427421|NCT04316741|65307666|FG001|Baseline Enrollment|Lost to Follow-up|1|||
23427422|NCT04316741|65307665|FG000|Immediate Post-Test|Lost to Follow-up|5|||
23427423|NCT04316741|65307666|FG001|Immediate Post-Test|Lost to Follow-up|1|||
23427424|NCT04316741|65307665|FG000|1-month Post-test|Lost to Follow-up|7|||
23427425|NCT04316741|65307666|FG001|1-month Post-test|Lost to Follow-up|2|||
23619223|NCT03494985|65991498|FG002|Overall Study|Adverse Event|3|||
23619224|NCT03494985|65991499|FG003|Overall Study|Adverse Event|0|||
23820244|NCT02068092|66721283|FG000|Overall Study|Lost to Follow-up|4|||
23820245|NCT02068092|66721283|FG000|Overall Study|Withdrawal by Subject|2|||
23820246|NCT01715571|66721286|FG000|Overall Study|Lost to Follow-up|8|||
23820247|NCT02856802|66721287|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23820248|NCT02856802|66721288|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
23820249|NCT02856802|66721287|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
23820250|NCT02856802|66721288|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
23820251|NCT02856802|66721287|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
23820252|NCT02856802|66721288|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
23820253|NCT02856802|66721287|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
23820254|NCT02856802|66721288|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
23820255|NCT02856802|66721287|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
23820256|NCT02856802|66721288|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
23820257|NCT02856802|66721287|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
23820258|NCT02856802|66721288|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
23427426|NCT04316741|65307665|FG000|3-month Follow-up|Lost to Follow-up|10|||
23619225|NCT03494985|65991496|FG000|Overall Study|Other (Withdrawal of consent)|2|||
23619226|NCT03494985|65991497|FG001|Overall Study|Other (Withdrawal of consent)|3|||
23619227|NCT03494985|65991498|FG002|Overall Study|Other (Withdrawal of consent)|2|||
23619228|NCT03494985|65991499|FG003|Overall Study|Other (Withdrawal of consent)|5|||
23619229|NCT03494985|65991496|FG000|Overall Study|Other (Not specified)|0|||
23619230|NCT03494985|65991497|FG001|Overall Study|Other (Not specified)|1|||
23619231|NCT03494985|65991498|FG002|Overall Study|Other (Not specified)|1|||
23619232|NCT03494985|65991499|FG003|Overall Study|Other (Not specified)|0|||
23619233|NCT02253147|65991500|FG000|Overall Study|Protocol Violation|30|||
23619234|NCT02253147|65991500|FG000|Overall Study|Did not consent to study extension|9|||
23619235|NCT02253147|65991500|FG000|Overall Study|Conditional re-treatment at W52|5|||
23619236|NCT02253147|65991500|FG000|Overall Study|Lost to Follow-up|2|||
23619237|NCT02253147|65991500|FG000|Overall Study|Withdrawal by Subject|1|||
23619238|NCT02661490|65991504|FG000|Overall Study|Lost to Follow-up|0|||
23619239|NCT02661490|65991505|FG001|Overall Study|Lost to Follow-up|1|||
23619240|NCT02661490|65991506|FG002|Overall Study|Lost to Follow-up|0|||
23619241|NCT02661490|65991507|FG003|Overall Study|Lost to Follow-up|0|||
23619242|NCT02661490|65991508|FG004|Overall Study|Lost to Follow-up|2|||
23619243|NCT02661490|65991504|FG000|Overall Study|Withdrawal by Subject|2|||
23619244|NCT02661490|65991505|FG001|Overall Study|Withdrawal by Subject|0|||
23619245|NCT02661490|65991506|FG002|Overall Study|Withdrawal by Subject|2|||
23619246|NCT02661490|65991507|FG003|Overall Study|Withdrawal by Subject|0|||
23619247|NCT02661490|65991508|FG004|Overall Study|Withdrawal by Subject|0|||
23619248|NCT02661490|65991504|FG000|Overall Study|Death|1|||
23619249|NCT02661490|65991505|FG001|Overall Study|Death|1|||
23619250|NCT02661490|65991506|FG002|Overall Study|Death|0|||
23738089|NCT03490734|66421058|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23738090|NCT03490734|66421059|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23427427|NCT04316741|65307666|FG001|3-month Follow-up|Lost to Follow-up|2|||
23427428|NCT03515941|65307669|FG000|Overall Study|Adverse Event|1|||
23619251|NCT02661490|65991507|FG003|Overall Study|Death|1|||
23820259|NCT04546724|66721289|FG000|Overall Study|Withdrawal by Subject|145|||
23820260|NCT04546724|66721290|FG001|Overall Study|Withdrawal by Subject|41|||
23820261|NCT04546724|66721289|FG000|Overall Study|Adverse Event|1|||
23619252|NCT02661490|65991508|FG004|Overall Study|Death|0|||
23619253|NCT02661490|65991504|FG000|Overall Study|Reason not Specified|0|||
23619254|NCT02661490|65991505|FG001|Overall Study|Reason not Specified|0|||
23619255|NCT02661490|65991506|FG002|Overall Study|Reason not Specified|0|||
23619256|NCT02661490|65991507|FG003|Overall Study|Reason not Specified|0|||
23619257|NCT02661490|65991508|FG004|Overall Study|Reason not Specified|1|||
23738091|NCT03490734|66421060|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
23738092|NCT03490734|66421057|FG000|Post-intervention Scan Visit|Adverse Event|2|||
23738093|NCT03490734|66421058|FG001|Post-intervention Scan Visit|Adverse Event|0|||
23738094|NCT03490734|66421059|FG002|Post-intervention Scan Visit|Adverse Event|0|||
23738095|NCT03490734|66421060|FG003|Post-intervention Scan Visit|Adverse Event|0|||
23738096|NCT03490734|66421057|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
23738097|NCT03490734|66421058|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
23738098|NCT03490734|66421059|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
23738099|NCT03490734|66421060|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
23738100|NCT03490734|66421057|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
23738101|NCT03490734|66421058|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
23427429|NCT03515941|65307670|FG001|Overall Study|Adverse Event|0|||
23427430|NCT00493636|65307671|FG000|Overall Study|Withdrawal by Subject|1|||
23427431|NCT00493636|65307672|FG001|Overall Study|Withdrawal by Subject|0|||
23427432|NCT00493636|65307671|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
23427433|NCT00493636|65307672|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
23427434|NCT00493636|65307671|FG000|Overall Study|Mis-randomization|1|||
23619258|NCT02847637|65991509|FG000|Overall Study|Withdrawal by Subject|0|||
23619259|NCT02847637|65991510|FG001|Overall Study|Withdrawal by Subject|1|||
23619260|NCT02847637|65991511|FG002|Overall Study|Withdrawal by Subject|1|||
23738102|NCT03490734|66421059|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
23738103|NCT03490734|66421060|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
23738104|NCT02146274|66421063|FG000|Overall Study|Protocol Violation|73|||
23738105|NCT01060150|66421064|FG000|Overall Study|Adverse Event|6|||
23738106|NCT01060150|66421064|FG000|Overall Study|Lost to Follow-up|1|||
23738107|NCT01060150|66421064|FG000|Overall Study|Protocol Violation|6|||
23738108|NCT01060150|66421064|FG000|Overall Study|Withdrawal by Subject|8|||
23738109|NCT01060150|66421064|FG000|Overall Study|Enrolled, but not treated|2|||
23738110|NCT01757821|66421069|FG000|Overall Study|Adverse Event|1|||
23738111|NCT01207427|66421072|FG000|Double-blind Treatment Period|Adverse Event|0|||
23738112|NCT01207427|66421073|FG001|Double-blind Treatment Period|Adverse Event|1|||
23738113|NCT01207427|66421074|FG002|Double-blind Treatment Period|Adverse Event|0|||
23738114|NCT01207427|66421072|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23738115|NCT01207427|66421073|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23738116|NCT01207427|66421074|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23738117|NCT01207427|66421072|FG000|Double-blind Treatment Period|Protocol Violation|2|||
23738118|NCT01207427|66421073|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23738119|NCT01207427|66421074|FG002|Double-blind Treatment Period|Protocol Violation|1|||
23738120|NCT01207427|66421072|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23738121|NCT01207427|66421073|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23820262|NCT04546724|66721290|FG001|Overall Study|Adverse Event|1|||
23820263|NCT04546724|66721289|FG000|Overall Study|Lost to Follow-up|186|||
23820264|NCT04546724|66721290|FG001|Overall Study|Lost to Follow-up|63|||
23738122|NCT01207427|66421074|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23738123|NCT00104299|66421075|FG000|Overall Study|Adverse Event|3|||
23738124|NCT00104299|66421076|FG001|Overall Study|Adverse Event|1|||
23738125|NCT00104299|66421075|FG000|Overall Study|Death|2|||
23738126|NCT00104299|66421076|FG001|Overall Study|Death|2|||
23738127|NCT00104299|66421075|FG000|Overall Study|Withdrawal by Subject|2|||
23738128|NCT00104299|66421076|FG001|Overall Study|Withdrawal by Subject|6|||
23738129|NCT00104299|66421075|FG000|Overall Study|Physician Decision|1|||
23738130|NCT00104299|66421076|FG001|Overall Study|Physician Decision|1|||
23738131|NCT00104299|66421075|FG000|Overall Study|To have renal transplant|1|||
23738132|NCT00104299|66421076|FG001|Overall Study|To have renal transplant|0|||
23738133|NCT00948389|66421083|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
23738134|NCT00948389|66421084|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
23738135|NCT00948389|66421085|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
23738136|NCT00948389|66421086|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
23738137|NCT00948389|66421087|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
23738138|NCT00948389|66421083|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
23820265|NCT04546724|66721289|FG000|Overall Study|Physician Decision|8|||
23427435|NCT00493636|65307672|FG001|Overall Study|Mis-randomization|1|||
23738139|NCT00948389|66421084|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
23738140|NCT00948389|66421085|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
23820266|NCT04546724|66721290|FG001|Overall Study|Physician Decision|2|||
23820267|NCT04546724|66721289|FG000|Overall Study|Death|2|||
23427436|NCT00657371|65307675|FG000|Overall Study|Poor bowel preparation|15|||
23619261|NCT02847637|65991512|FG003|Overall Study|Withdrawal by Subject|0|||
23619262|NCT02847637|65991509|FG000|Overall Study|Lost to Follow-up|1|||
23619263|NCT02847637|65991510|FG001|Overall Study|Lost to Follow-up|1|||
23619264|NCT02847637|65991511|FG002|Overall Study|Lost to Follow-up|0|||
23738141|NCT00948389|66421086|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
23738142|NCT00948389|66421087|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
23738143|NCT00948389|66421083|FG000|Overall Study|Both Progression and Toxicity|1|||
23738144|NCT00948389|66421084|FG001|Overall Study|Both Progression and Toxicity|0|||
23738145|NCT00948389|66421085|FG002|Overall Study|Both Progression and Toxicity|0|||
23738146|NCT00948389|66421086|FG003|Overall Study|Both Progression and Toxicity|0|||
23738147|NCT00948389|66421087|FG004|Overall Study|Both Progression and Toxicity|0|||
23738148|NCT02087085|66421088|FG000|Overall Study|Adverse Event|10|||
23738149|NCT02087085|66421089|FG001|Overall Study|Adverse Event|14|||
23738150|NCT02087085|66421088|FG000|Overall Study|Lack of Efficacy|4|||
23738151|NCT02087085|66421089|FG001|Overall Study|Lack of Efficacy|3|||
23738152|NCT02087085|66421088|FG000|Overall Study|Lost to Follow-up|6|||
23738153|NCT02087085|66421089|FG001|Overall Study|Lost to Follow-up|4|||
23738154|NCT02087085|66421088|FG000|Overall Study|Withdrawal by Subject|9|||
23738155|NCT02087085|66421089|FG001|Overall Study|Withdrawal by Subject|11|||
23738156|NCT02087085|66421088|FG000|Overall Study|Protocol Violation|1|||
23738157|NCT02087085|66421089|FG001|Overall Study|Protocol Violation|0|||
23738158|NCT02087085|66421088|FG000|Overall Study|Study Terminated by Sponsor|87|||
23738159|NCT02087085|66421089|FG001|Overall Study|Study Terminated by Sponsor|80|||
23738160|NCT02087085|66421088|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23738161|NCT02087085|66421089|FG001|Overall Study|Other Miscellaneous Reasons|4|||
23738162|NCT01293123|66421093|FG000|Overall Study|Lost to Follow-up|0|||
23738163|NCT01293123|66421094|FG001|Overall Study|Lost to Follow-up|1|||
23738164|NCT02698176|66421097|FG000|Overall Study|Progressive disease|4|||
23738165|NCT02698176|66421098|FG001|Overall Study|Progressive disease|3|||
23738166|NCT02698176|66421099|FG002|Overall Study|Progressive disease|1|||
23738167|NCT02698176|66421100|FG003|Overall Study|Progressive disease|0|||
23738168|NCT02698176|66421097|FG000|Overall Study|Adverse Event|2|||
23738169|NCT02698176|66421098|FG001|Overall Study|Adverse Event|0|||
23738170|NCT02698176|66421099|FG002|Overall Study|Adverse Event|0|||
23547164|NCT05557942|65735720|FG000|Overall Study|Death|0|||
23547165|NCT05557942|65735721|FG001|Overall Study|Death|0|||
23547166|NCT05557942|65735722|FG002|Overall Study|Death|0|||
23547167|NCT05557942|65735723|FG003|Overall Study|Death|2|||
23547168|NCT05557942|65735724|FG004|Overall Study|Death|1|||
23547169|NCT05557942|65735725|FG005|Overall Study|Death|1|||
23547170|NCT05557942|65735720|FG000|Overall Study|Physician Decision|1|||
23547171|NCT05557942|65735721|FG001|Overall Study|Physician Decision|1|||
23547172|NCT05557942|65735722|FG002|Overall Study|Physician Decision|2|||
23547173|NCT05557942|65735723|FG003|Overall Study|Physician Decision|3|||
23547174|NCT05557942|65735724|FG004|Overall Study|Physician Decision|0|||
23547175|NCT05557942|65735725|FG005|Overall Study|Physician Decision|2|||
23547176|NCT05557942|65735720|FG000|Overall Study|Study terminated by sponsor|17|||
23547177|NCT05557942|65735721|FG001|Overall Study|Study terminated by sponsor|17|||
23547178|NCT05557942|65735722|FG002|Overall Study|Study terminated by sponsor|14|||
23547179|NCT05557942|65735723|FG003|Overall Study|Study terminated by sponsor|40|||
23547180|NCT05557942|65735724|FG004|Overall Study|Study terminated by sponsor|45|||
23547181|NCT05557942|65735725|FG005|Overall Study|Study terminated by sponsor|37|||
23547182|NCT05557942|65735720|FG000|Overall Study|Protocol Violation|0|||
23547183|NCT05557942|65735721|FG001|Overall Study|Protocol Violation|0|||
23547184|NCT05557942|65735722|FG002|Overall Study|Protocol Violation|0|||
23547185|NCT05557942|65735723|FG003|Overall Study|Protocol Violation|0|||
23820268|NCT04546724|66721290|FG001|Overall Study|Death|1|||
23820269|NCT04546724|66721289|FG000|Overall Study|subject has been out of town|1|||
23547186|NCT05557942|65735724|FG004|Overall Study|Protocol Violation|0|||
23547187|NCT05557942|65735725|FG005|Overall Study|Protocol Violation|1|||
23547188|NCT05557942|65735720|FG000|Overall Study|Withdrawal by Subject|0|||
23738171|NCT02698176|66421100|FG003|Overall Study|Adverse Event|0|||
23738172|NCT02698176|66421097|FG000|Overall Study|Clinical progression|3|||
23820270|NCT04546724|66721290|FG001|Overall Study|subject has been out of town|0|||
23820271|NCT04546724|66721289|FG000|Overall Study|subject is incarcerated|2|||
23820272|NCT04546724|66721290|FG001|Overall Study|subject is incarcerated|0|||
23820273|NCT04546724|66721289|FG000|Overall Study|subject is relocating|12|||
23820274|NCT04546724|66721290|FG001|Overall Study|subject is relocating|4|||
23820275|NCT04546724|66721289|FG000|Overall Study|Subject in another study|1|||
23820276|NCT04546724|66721290|FG001|Overall Study|Subject in another study|1|||
23820277|NCT01128179|66721293|FG000|Overall Study|Death|1|||
23547189|NCT05557942|65735721|FG001|Overall Study|Withdrawal by Subject|0|||
23820278|NCT01128179|66721294|FG001|Overall Study|Death|0|||
23547190|NCT05557942|65735722|FG002|Overall Study|Withdrawal by Subject|0|||
23547191|NCT05557942|65735723|FG003|Overall Study|Withdrawal by Subject|0|||
23547192|NCT05557942|65735724|FG004|Overall Study|Withdrawal by Subject|2|||
23547193|NCT05557942|65735725|FG005|Overall Study|Withdrawal by Subject|0|||
23738173|NCT02698176|66421098|FG001|Overall Study|Clinical progression|0|||
23738174|NCT02698176|66421099|FG002|Overall Study|Clinical progression|0|||
23738175|NCT02698176|66421100|FG003|Overall Study|Clinical progression|0|||
23738176|NCT01266876|66421101|FG000|Overall Study|Adverse Event|0|||
23820279|NCT01128179|66721293|FG000|Overall Study|Protocol Violation|1|||
23738177|NCT01266876|66421102|FG001|Overall Study|Adverse Event|0|||
23738178|NCT01266876|66421103|FG002|Overall Study|Adverse Event|0|||
23547194|NCT01556438|65735730|FG000|Overall Study|Adverse Event|4|||
23547195|NCT01556438|65735731|FG001|Overall Study|Adverse Event|2|||
23547196|NCT01556438|65735730|FG000|Overall Study|Sponsor Decision|0|||
23547197|NCT01556438|65735731|FG001|Overall Study|Sponsor Decision|2|||
23547198|NCT01556438|65735730|FG000|Overall Study|Progressive Disease|0|||
23547199|NCT01556438|65735731|FG001|Overall Study|Progressive Disease|6|||
23547200|NCT01556438|65735730|FG000|Overall Study|Death|0|||
23547201|NCT01556438|65735731|FG001|Overall Study|Death|1|||
23547202|NCT01491854|65735732|FG000|Overall Study|mainly due to premature termination|93|||
23547203|NCT01491854|65735732|FG000|Overall Study|Death|1|||
23547204|NCT01491854|65735732|FG000|Overall Study|Withdrawal by Subject|3|||
23547205|NCT01491854|65735732|FG000|Overall Study|Lost to Follow-up|33|||
23547206|NCT02828111|65735733|FG000|Overall Study|Withdrawal by Subject|0|||
23547207|NCT02828111|65735734|FG001|Overall Study|Withdrawal by Subject|0|||
23547208|NCT02828111|65735735|FG002|Overall Study|Withdrawal by Subject|2|||
23547209|NCT02828111|65735736|FG003|Overall Study|Withdrawal by Subject|0|||
23738179|NCT01266876|66421104|FG003|Overall Study|Adverse Event|1|||
23619265|NCT02847637|65991512|FG003|Overall Study|Lost to Follow-up|0|||
23619266|NCT00463580|65991513|FG000|Overall Study|Lost to Follow-up|1|||
23619267|NCT00463580|65991514|FG001|Overall Study|Lost to Follow-up|0|||
23619268|NCT00463580|65991513|FG000|Overall Study|Schedule conflict|2|||
23547210|NCT02828111|65735737|FG004|Overall Study|Withdrawal by Subject|0|||
23547211|NCT02828111|65735733|FG000|Overall Study|Lost to Follow-up|0|||
23547212|NCT02828111|65735734|FG001|Overall Study|Lost to Follow-up|0|||
23547213|NCT02828111|65735735|FG002|Overall Study|Lost to Follow-up|0|||
23547214|NCT02828111|65735736|FG003|Overall Study|Lost to Follow-up|1|||
23547215|NCT02828111|65735737|FG004|Overall Study|Lost to Follow-up|1|||
23547216|NCT00490646|65735741|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
23547217|NCT00490646|65735742|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
23547218|NCT00490646|65735741|FG000|Overall Study|Never Treated (had an adverse event)|1|||
23547219|NCT00490646|65735742|FG001|Overall Study|Never Treated (had an adverse event)|0|||
23547220|NCT00490646|65735741|FG000|Overall Study|Never Treated (withdrew consent)|0|||
23547221|NCT00490646|65735742|FG001|Overall Study|Never Treated (withdrew consent)|1|||
23547222|NCT02105948|65735744|FG000|Overall Study|Adverse Event|10|||
23547223|NCT02105948|65735745|FG001|Overall Study|Adverse Event|7|||
23547224|NCT02105948|65735746|FG002|Overall Study|Adverse Event|11|||
23547225|NCT02105948|65735747|FG003|Overall Study|Adverse Event|11|||
23547226|NCT02105948|65735744|FG000|Overall Study|Lack of Efficacy|0|||
23547227|NCT02105948|65735745|FG001|Overall Study|Lack of Efficacy|1|||
23547228|NCT02105948|65735746|FG002|Overall Study|Lack of Efficacy|3|||
23547229|NCT02105948|65735747|FG003|Overall Study|Lack of Efficacy|2|||
23547230|NCT02105948|65735744|FG000|Overall Study|Lost to Follow-up|0|||
23619269|NCT00463580|65991514|FG001|Overall Study|Schedule conflict|0|||
23619270|NCT00463580|65991513|FG000|Overall Study|Medical/psychiatric complications|0|||
23619271|NCT00463580|65991514|FG001|Overall Study|Medical/psychiatric complications|2|||
23619272|NCT00461123|65991515|FG000|Overall Study|Adverse Event|1|||
23619273|NCT00461123|65991516|FG001|Overall Study|Adverse Event|0|||
23619274|NCT00461123|65991515|FG000|Overall Study|Lost to Follow-up|1|||
23619275|NCT00461123|65991516|FG001|Overall Study|Lost to Follow-up|1|||
23619276|NCT00461123|65991515|FG000|Overall Study|Protocol Violation|3|||
23738180|NCT01266876|66421105|FG004|Overall Study|Adverse Event|0|||
23738181|NCT00129220|66421106|FG000|Study Period II|Adverse Event|9|||
23738182|NCT00129220|66421107|FG001|Study Period II|Adverse Event|5|||
23738183|NCT00129220|66421108|FG002|Study Period II|Adverse Event|7|||
23738184|NCT00129220|66421106|FG000|Study Period II|Lack of Efficacy|15|||
23547231|NCT02105948|65735745|FG001|Overall Study|Lost to Follow-up|0|||
23547232|NCT02105948|65735746|FG002|Overall Study|Lost to Follow-up|2|||
23738185|NCT00129220|66421107|FG001|Study Period II|Lack of Efficacy|1|||
23547233|NCT02105948|65735747|FG003|Overall Study|Lost to Follow-up|1|||
23547234|NCT02105948|65735744|FG000|Overall Study|Physician Decision|2|||
23547235|NCT02105948|65735745|FG001|Overall Study|Physician Decision|2|||
23547236|NCT02105948|65735746|FG002|Overall Study|Physician Decision|2|||
23547237|NCT02105948|65735747|FG003|Overall Study|Physician Decision|2|||
23619277|NCT00461123|65991516|FG001|Overall Study|Protocol Violation|2|||
23619278|NCT00461123|65991515|FG000|Overall Study|Withdrawal by Subject|1|||
23619279|NCT00461123|65991516|FG001|Overall Study|Withdrawal by Subject|3|||
23619280|NCT00907517|65991517|FG000|Overall Study|Progressive Disease|3|||
23619281|NCT00907517|65991518|FG001|Overall Study|Progressive Disease|3|||
23738186|NCT00129220|66421108|FG002|Study Period II|Lack of Efficacy|28|||
23738187|NCT00129220|66421106|FG000|Study Period II|Entry Criteria Not Met|2|||
23547238|NCT02105948|65735744|FG000|Overall Study|Withdrawal by Subject|15|||
23547239|NCT02105948|65735745|FG001|Overall Study|Withdrawal by Subject|10|||
23547240|NCT02105948|65735746|FG002|Overall Study|Withdrawal by Subject|10|||
23547241|NCT02105948|65735747|FG003|Overall Study|Withdrawal by Subject|11|||
23547242|NCT03586648|65735748|FG000|Period 1|Withdrawal by Subject|0|||
23547243|NCT03586648|65735749|FG001|Period 1|Withdrawal by Subject|1|||
23547244|NCT03586648|65735748|FG000|Period 1|Lost to Follow-up|1|||
23547245|NCT03586648|65735749|FG001|Period 1|Lost to Follow-up|1|||
23547246|NCT03586648|65735748|FG000|Period 1|Adverse Event|1|||
23547247|NCT03586648|65735749|FG001|Period 1|Adverse Event|0|||
23547248|NCT03586648|65735748|FG000|Period 1|Study related symptoms or complaints|2|||
23547249|NCT03586648|65735749|FG001|Period 1|Study related symptoms or complaints|1|||
23547250|NCT03586648|65735748|FG000|Period 1|Physician Decision|0|||
23547251|NCT03586648|65735749|FG001|Period 1|Physician Decision|1|||
23547252|NCT03586648|65735748|FG000|Period 2|Adverse Event|1|||
23547253|NCT03586648|65735749|FG001|Period 2|Adverse Event|0|||
23547254|NCT00360529|65735761|FG000|Overall Study|Adverse Event|10|||
23547255|NCT00360529|65735762|FG001|Overall Study|Adverse Event|23|||
23547256|NCT00360529|65735763|FG002|Overall Study|Adverse Event|33|||
23547257|NCT00360529|65735761|FG000|Overall Study|Protocol Violation|3|||
23547258|NCT00360529|65735762|FG001|Overall Study|Protocol Violation|3|||
23547259|NCT00360529|65735763|FG002|Overall Study|Protocol Violation|11|||
23547260|NCT00360529|65735761|FG000|Overall Study|Lost to Follow-up|14|||
23547261|NCT00360529|65735762|FG001|Overall Study|Lost to Follow-up|10|||
23547262|NCT00360529|65735763|FG002|Overall Study|Lost to Follow-up|13|||
23547263|NCT00360529|65735761|FG000|Overall Study|Withdrawal by Subject|22|||
23547264|NCT00360529|65735762|FG001|Overall Study|Withdrawal by Subject|14|||
23547265|NCT00360529|65735763|FG002|Overall Study|Withdrawal by Subject|18|||
23547266|NCT00360529|65735761|FG000|Overall Study|Lack of Efficacy|8|||
23547267|NCT00360529|65735762|FG001|Overall Study|Lack of Efficacy|6|||
23547268|NCT00360529|65735763|FG002|Overall Study|Lack of Efficacy|5|||
23738188|NCT00129220|66421107|FG001|Study Period II|Entry Criteria Not Met|0|||
23738189|NCT00129220|66421108|FG002|Study Period II|Entry Criteria Not Met|2|||
23738190|NCT00129220|66421106|FG000|Study Period II|Protocol Violation|4|||
23738191|NCT00129220|66421107|FG001|Study Period II|Protocol Violation|2|||
23738192|NCT00129220|66421108|FG002|Study Period II|Protocol Violation|1|||
23738193|NCT00129220|66421106|FG000|Study Period II|Physician Decision|0|||
23738194|NCT00129220|66421107|FG001|Study Period II|Physician Decision|1|||
23738195|NCT00129220|66421108|FG002|Study Period II|Physician Decision|0|||
23738196|NCT00129220|66421106|FG000|Study Period II|Withdrawal by Subject|1|||
23738197|NCT00129220|66421107|FG001|Study Period II|Withdrawal by Subject|3|||
23738198|NCT00129220|66421108|FG002|Study Period II|Withdrawal by Subject|4|||
23738199|NCT00129220|66421106|FG000|Study Period II|Reason Not Specified|2|||
23738200|NCT00129220|66421107|FG001|Study Period II|Reason Not Specified|0|||
23738201|NCT00129220|66421108|FG002|Study Period II|Reason Not Specified|5|||
23738202|NCT00129220|66421106|FG000|Study Period III|Adverse Event|1|||
23738203|NCT00129220|66421107|FG001|Study Period III|Adverse Event|0|||
23738204|NCT00129220|66421108|FG002|Study Period III|Adverse Event|3|||
23738205|NCT00129220|66421106|FG000|Study Period III|Protocol Violation|1|||
23738206|NCT00129220|66421107|FG001|Study Period III|Protocol Violation|1|||
23738207|NCT00129220|66421108|FG002|Study Period III|Protocol Violation|2|||
23738208|NCT00129220|66421106|FG000|Study Period III|Withdrawal by Subject|1|||
23738209|NCT00129220|66421107|FG001|Study Period III|Withdrawal by Subject|0|||
23738210|NCT00129220|66421108|FG002|Study Period III|Withdrawal by Subject|3|||
23738211|NCT00129220|66421106|FG000|Study Period III|Sponsor Decision|1|||
23547269|NCT00360529|65735761|FG000|Overall Study|Reason discontinued not explained above|4|||
23547270|NCT00360529|65735762|FG001|Overall Study|Reason discontinued not explained above|9|||
23547271|NCT00360529|65735763|FG002|Overall Study|Reason discontinued not explained above|11|||
23547272|NCT02347761|65735766|FG000|All Collected|Death|1|||
23547273|NCT02347761|65735767|FG001|All Collected|Death|0|||
23738212|NCT00129220|66421107|FG001|Study Period III|Sponsor Decision|0|||
23738213|NCT00129220|66421108|FG002|Study Period III|Sponsor Decision|0|||
23738214|NCT00129220|66421106|FG000|Study Period III|Reason Not Specified|9|||
23738215|NCT00129220|66421107|FG001|Study Period III|Reason Not Specified|0|||
23738216|NCT00129220|66421108|FG002|Study Period III|Reason Not Specified|2|||
23738217|NCT01539720|66421109|FG000|Overall Study|Screen Fail|15|||
23619282|NCT00907517|65991519|FG002|Overall Study|Progressive Disease|4|||
23427437|NCT00657371|65307675|FG000|Overall Study|Unable to intubate the cecum|5|||
23427438|NCT00657371|65307675|FG000|Overall Study|Protocol Violation|2|||
23427439|NCT00657371|65307675|FG000|Overall Study|Device- related reasons|13|||
23427440|NCT00657371|65307675|FG000|Overall Study|Pre-existing medical condition|4|||
23427441|NCT00583791|65307676|FG000|Overall Study|Other|67|||
23427442|NCT00583791|65307676|FG000|Overall Study|Death|6|||
23427443|NCT00849875|65307684|FG000|Overall Study|Death|28|||
23427444|NCT00849875|65307684|FG000|Overall Study|Ongoing (unknown completion status)|11|||
23427445|NCT00849875|65307684|FG000|Overall Study|Others|6|||
23427446|NCT00849875|65307684|FG000|Overall Study|Lost to Follow-up|2|||
23427447|NCT00259298|65307686|FG000|Overall Study|Withdrawal by Subject|1|||
23820280|NCT01128179|66721294|FG001|Overall Study|Protocol Violation|0|||
23820281|NCT03656744|66721297|FG000|Overall Study|Adverse Event|1|||
23820282|NCT03656744|66721298|FG001|Overall Study|Adverse Event|4|||
23820283|NCT03656744|66721299|FG002|Overall Study|Adverse Event|1|||
23820284|NCT03656744|66721297|FG000|Overall Study|Protocol Violation|1|||
23820285|NCT03656744|66721298|FG001|Overall Study|Protocol Violation|0|||
23820286|NCT03656744|66721299|FG002|Overall Study|Protocol Violation|0|||
23820287|NCT03656744|66721297|FG000|Overall Study|Lost to Follow-up|2|||
23820288|NCT03656744|66721298|FG001|Overall Study|Lost to Follow-up|2|||
23820289|NCT03656744|66721299|FG002|Overall Study|Lost to Follow-up|0|||
23820290|NCT03656744|66721297|FG000|Overall Study|Withdrawal by Subject|0|||
23820291|NCT03656744|66721298|FG001|Overall Study|Withdrawal by Subject|1|||
23820292|NCT03656744|66721299|FG002|Overall Study|Withdrawal by Subject|0|||
23820293|NCT03656744|66721297|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
23820294|NCT03656744|66721298|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
23820295|NCT03656744|66721299|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
23820296|NCT02047734|66721300|FG000|Overall Study|Adverse Event|18|||
23820297|NCT02047734|66721301|FG001|Overall Study|Adverse Event|13|||
23427448|NCT00259298|65307686|FG000|Overall Study|Physician Decision|2|||
23427449|NCT00066469|65307687|FG000|Overall Study|Death|3|||
23427450|NCT00066469|65307687|FG000|Overall Study|Lack of Efficacy|9|||
23820298|NCT02047734|66721302|FG002|Overall Study|Adverse Event|13|||
23738218|NCT01539720|66421110|FG001|Overall Study|Screen Fail|3|||
23738219|NCT01539720|66421109|FG000|Overall Study|Lost to Follow-up|14|||
23738220|NCT01539720|66421110|FG001|Overall Study|Lost to Follow-up|7|||
23738221|NCT02828982|66421114|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23738222|NCT02828982|66421115|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23738223|NCT01852591|66421117|FG000|Overall Study|Withdrawal by Subject|2|||
23738224|NCT01852591|66421117|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
23738225|NCT02477215|66421120|FG000|Dose Escalation Phase|Physician Decision|1|||
23738226|NCT02477215|66421121|FG001|Dose Escalation Phase|Physician Decision|2|||
23738227|NCT02477215|66421122|FG002|Dose Escalation Phase|Physician Decision|0|||
23738228|NCT02477215|66421120|FG000|Fixed Dose Phase|Physician Decision|0|||
23738229|NCT02477215|66421121|FG001|Fixed Dose Phase|Physician Decision|7|||
23738230|NCT02477215|66421122|FG002|Fixed Dose Phase|Physician Decision|0|||
23738231|NCT00247962|66421125|FG000|Overall Study|Adverse Event|15|||
23738232|NCT00247962|66421126|FG001|Overall Study|Adverse Event|12|||
23738233|NCT00247962|66421125|FG000|Overall Study|Lost to Follow-up|3|||
23738234|NCT00247962|66421126|FG001|Overall Study|Lost to Follow-up|1|||
23738235|NCT00247962|66421125|FG000|Overall Study|Physician Decision|0|||
23738236|NCT00247962|66421126|FG001|Overall Study|Physician Decision|1|||
23738237|NCT00247962|66421125|FG000|Overall Study|Protocol Violation|1|||
23738238|NCT00247962|66421126|FG001|Overall Study|Protocol Violation|1|||
23738239|NCT00247962|66421125|FG000|Overall Study|Withdrawal by Subject|3|||
23738240|NCT00247962|66421126|FG001|Overall Study|Withdrawal by Subject|2|||
23738241|NCT00247962|66421125|FG000|Overall Study|Lack of Efficacy|4|||
23738242|NCT00247962|66421126|FG001|Overall Study|Lack of Efficacy|2|||
23738243|NCT02185040|66421135|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
23738244|NCT02185040|66421136|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
23738245|NCT02185040|66421137|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
23738246|NCT02185040|66421138|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
23738247|NCT02185040|66421139|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
23738248|NCT02185040|66421140|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
23738249|NCT02185040|66421141|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
23738250|NCT02185040|66421135|FG000|Part 1 Treatment Phase|Adverse Event|1|||
23738251|NCT02185040|66421136|FG001|Part 1 Treatment Phase|Adverse Event|0|||
23547274|NCT02347761|65735768|FG002|All Collected|Death|0|||
23547275|NCT02347761|65735766|FG000|All Collected|Lost to Follow-up|3|||
23547276|NCT02347761|65735767|FG001|All Collected|Lost to Follow-up|2|||
23547277|NCT02347761|65735768|FG002|All Collected|Lost to Follow-up|3|||
23547278|NCT02347761|65735766|FG000|All Collected|Withdrawal by Subject|11|||
23547279|NCT02347761|65735767|FG001|All Collected|Withdrawal by Subject|11|||
23547280|NCT02347761|65735768|FG002|All Collected|Withdrawal by Subject|22|||
23547281|NCT02347761|65735766|FG000|All Collected|invetigator disretion|2|||
23547282|NCT02347761|65735767|FG001|All Collected|invetigator disretion|0|||
23738252|NCT02185040|66421137|FG002|Part 1 Treatment Phase|Adverse Event|0|||
23738253|NCT02185040|66421138|FG003|Part 1 Treatment Phase|Adverse Event|2|||
23738254|NCT02185040|66421139|FG004|Part 1 Treatment Phase|Adverse Event|3|||
23738255|NCT02185040|66421140|FG005|Part 1 Treatment Phase|Adverse Event|0|||
23738256|NCT02185040|66421141|FG006|Part 1 Treatment Phase|Adverse Event|0|||
23738257|NCT02185040|66421135|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738258|NCT02185040|66421136|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
23738259|NCT02185040|66421137|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738260|NCT02185040|66421138|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738261|NCT02185040|66421139|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738262|NCT02185040|66421140|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738263|NCT02185040|66421141|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23738264|NCT02185040|66421135|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738265|NCT02185040|66421136|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
23738266|NCT02185040|66421137|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738267|NCT02185040|66421138|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738268|NCT02185040|66421139|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738269|NCT02185040|66421140|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738270|NCT02185040|66421141|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
23738271|NCT02185040|66421135|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
23738272|NCT02185040|66421136|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
23738273|NCT02185040|66421137|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
23738274|NCT02185040|66421138|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
23738275|NCT02185040|66421139|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
23738276|NCT02185040|66421140|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
23738277|NCT02185040|66421141|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
23738278|NCT02185040|66421135|FG000|Active Treatment Extension Phase|Adverse Event|0|||
23738279|NCT02185040|66421136|FG001|Active Treatment Extension Phase|Adverse Event|0|||
23547283|NCT02347761|65735768|FG002|All Collected|invetigator disretion|0|||
23738280|NCT02185040|66421137|FG002|Active Treatment Extension Phase|Adverse Event|0|||
23547284|NCT02347761|65735766|FG000|All Collected|instillation site pain|0|||
23738281|NCT02185040|66421138|FG003|Active Treatment Extension Phase|Adverse Event|0|||
23738282|NCT02185040|66421139|FG004|Active Treatment Extension Phase|Adverse Event|0|||
23738283|NCT02185040|66421140|FG005|Active Treatment Extension Phase|Adverse Event|1|||
23738284|NCT02185040|66421141|FG006|Active Treatment Extension Phase|Adverse Event|4|||
23738285|NCT02185040|66421135|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23738286|NCT02185040|66421136|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23738287|NCT02185040|66421137|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23738288|NCT02185040|66421138|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23738289|NCT02185040|66421139|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23738290|NCT02185040|66421140|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
23738291|NCT02185040|66421141|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
23738292|NCT02185040|66421135|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738293|NCT02185040|66421136|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738294|NCT02185040|66421137|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738295|NCT02185040|66421138|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738296|NCT02185040|66421139|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738297|NCT02185040|66421140|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
23738298|NCT02185040|66421141|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
23738299|NCT02269709|66421148|FG000|Time of Enrollment|Withdrawal by Subject|3|||
23738300|NCT02269709|66421148|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
23738301|NCT02269709|66421148|FG000|Six Month Follow-up|Lost to Follow-up|12|||
23738302|NCT01362062|66421149|FG000|Overall Study|Adverse Event|1|||
23738303|NCT01362062|66421150|FG001|Overall Study|Adverse Event|0|||
23738304|NCT01362062|66421149|FG000|Overall Study|Lost to Follow-up|11|||
23738305|NCT01362062|66421150|FG001|Overall Study|Lost to Follow-up|0|||
23738306|NCT01362062|66421149|FG000|Overall Study|Withdrawal by Subject|2|||
23738307|NCT01362062|66421150|FG001|Overall Study|Withdrawal by Subject|0|||
23738308|NCT01362062|66421149|FG000|Overall Study|Non-compliant participant|2|||
23738309|NCT01362062|66421150|FG001|Overall Study|Non-compliant participant|0|||
23738310|NCT01362062|66421149|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
23738311|NCT01362062|66421150|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
23738312|NCT01362062|66421149|FG000|Overall Study|Had significant improvement|9|||
23738313|NCT01362062|66421150|FG001|Overall Study|Had significant improvement|0|||
23820299|NCT02047734|66721300|FG000|Overall Study|Lack of Efficacy|4|||
23738314|NCT00612456|66421160|FG000|Overall Study|Adverse Event|1|||
23738315|NCT00612456|66421161|FG001|Overall Study|Adverse Event|0|||
23738316|NCT00612456|66421162|FG002|Overall Study|Adverse Event|0|||
23738317|NCT00612456|66421160|FG000|Overall Study|Lack of Efficacy|1|||
23738318|NCT00612456|66421161|FG001|Overall Study|Lack of Efficacy|1|||
23738319|NCT00612456|66421162|FG002|Overall Study|Lack of Efficacy|0|||
23738320|NCT00612456|66421160|FG000|Overall Study|Withdrawal by Subject|0|||
23738321|NCT00612456|66421161|FG001|Overall Study|Withdrawal by Subject|1|||
23738322|NCT00612456|66421162|FG002|Overall Study|Withdrawal by Subject|0|||
23738323|NCT00784836|66421164|FG000|Overall Study|Early Study Termination|3|||
23738324|NCT00465894|66421166|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
23738325|NCT00465894|66421167|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
23738326|NCT00465894|66421166|FG000|Treatment For 12 Weeks|Family Issues|1|||
23738327|NCT00465894|66421167|FG001|Treatment For 12 Weeks|Family Issues|1|||
23738328|NCT00465894|66421166|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
23738329|NCT00465894|66421167|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
23738330|NCT00352027|66421168|FG000|Overall Study|Progressive disease|3|||
23738331|NCT03188991|66421169|FG000|Overall Study|Withdrawal by Subject|0|||
23738332|NCT03188991|66421170|FG001|Overall Study|Withdrawal by Subject|0|||
23738333|NCT03188991|66421171|FG002|Overall Study|Withdrawal by Subject|0|||
23738334|NCT03188991|66421172|FG003|Overall Study|Withdrawal by Subject|1|||
23738335|NCT00087685|66421173|FG000|Overall Study|Adverse Event|5|||
23738336|NCT00087685|66421173|FG000|Overall Study|Non-Compliance|1|||
23738337|NCT00087685|66421173|FG000|Overall Study|Progressive Disease|5|||
23738338|NCT00087685|66421173|FG000|Overall Study|Withdrawal by Subject|3|||
23738339|NCT00808132|66421175|FG000|Overall Study|Adverse Event|34|||
23820300|NCT02047734|66721301|FG001|Overall Study|Lack of Efficacy|5|||
23820301|NCT02047734|66721302|FG002|Overall Study|Lack of Efficacy|1|||
23820302|NCT02047734|66721300|FG000|Overall Study|Protocol Violation|3|||
23738340|NCT00808132|66421176|FG001|Overall Study|Adverse Event|33|||
23738341|NCT00808132|66421177|FG002|Overall Study|Adverse Event|16|||
23738342|NCT00808132|66421178|FG003|Overall Study|Adverse Event|31|||
23738343|NCT00808132|66421179|FG004|Overall Study|Adverse Event|33|||
23738344|NCT00808132|66421175|FG000|Overall Study|Death|0|||
23738345|NCT00808132|66421176|FG001|Overall Study|Death|0|||
23738346|NCT00808132|66421177|FG002|Overall Study|Death|0|||
23738347|NCT00808132|66421178|FG003|Overall Study|Death|0|||
23738348|NCT00808132|66421179|FG004|Overall Study|Death|1|||
23820303|NCT02047734|66721301|FG001|Overall Study|Protocol Violation|1|||
23820304|NCT02047734|66721302|FG002|Overall Study|Protocol Violation|1|||
23820305|NCT02047734|66721300|FG000|Overall Study|Lost to Follow-up|1|||
23738349|NCT00808132|66421175|FG000|Overall Study|Physician Decision|0|||
23738350|NCT00808132|66421176|FG001|Overall Study|Physician Decision|1|||
23738351|NCT00808132|66421177|FG002|Overall Study|Physician Decision|0|||
23738352|NCT00808132|66421178|FG003|Overall Study|Physician Decision|0|||
23738353|NCT00808132|66421179|FG004|Overall Study|Physician Decision|0|||
23738354|NCT00808132|66421175|FG000|Overall Study|Lost to Follow-up|8|||
23738355|NCT00808132|66421176|FG001|Overall Study|Lost to Follow-up|10|||
23738356|NCT00808132|66421177|FG002|Overall Study|Lost to Follow-up|11|||
23738357|NCT00808132|66421178|FG003|Overall Study|Lost to Follow-up|8|||
23738358|NCT00808132|66421179|FG004|Overall Study|Lost to Follow-up|9|||
23738359|NCT00808132|66421175|FG000|Overall Study|Protocol Violation|8|||
23738360|NCT00808132|66421176|FG001|Overall Study|Protocol Violation|9|||
23738361|NCT00808132|66421177|FG002|Overall Study|Protocol Violation|4|||
23738362|NCT00808132|66421178|FG003|Overall Study|Protocol Violation|9|||
23738363|NCT00808132|66421179|FG004|Overall Study|Protocol Violation|5|||
23738364|NCT00808132|66421175|FG000|Overall Study|Withdrawal by Subject|27|||
23547285|NCT02347761|65735767|FG001|All Collected|instillation site pain|0|||
23547286|NCT02347761|65735768|FG002|All Collected|instillation site pain|1|||
23547287|NCT02347761|65735766|FG000|All Collected|exacerbation of COPD|0|||
23738365|NCT00808132|66421176|FG001|Overall Study|Withdrawal by Subject|18|||
23738366|NCT00808132|66421177|FG002|Overall Study|Withdrawal by Subject|2|||
23738367|NCT00808132|66421178|FG003|Overall Study|Withdrawal by Subject|7|||
23738368|NCT00808132|66421179|FG004|Overall Study|Withdrawal by Subject|16|||
23738369|NCT00808132|66421175|FG000|Overall Study|Other|6|||
23738370|NCT00808132|66421176|FG001|Overall Study|Other|4|||
23738371|NCT00808132|66421177|FG002|Overall Study|Other|6|||
23547288|NCT02347761|65735767|FG001|All Collected|exacerbation of COPD|0|||
23547289|NCT02347761|65735768|FG002|All Collected|exacerbation of COPD|1|||
23738372|NCT00808132|66421178|FG003|Overall Study|Other|2|||
23738373|NCT00808132|66421179|FG004|Overall Study|Other|15|||
23738374|NCT00808132|66421175|FG000|Overall Study|Randomized, but not treated|10|||
23738375|NCT00808132|66421176|FG001|Overall Study|Randomized, but not treated|7|||
23738376|NCT00808132|66421177|FG002|Overall Study|Randomized, but not treated|9|||
23738377|NCT00808132|66421178|FG003|Overall Study|Randomized, but not treated|8|||
23547290|NCT02347761|65735766|FG000|All Collected|moved/travel|0|||
23738378|NCT00808132|66421179|FG004|Overall Study|Randomized, but not treated|9|||
23738379|NCT00808132|66421175|FG000|Overall Study|Unsatisfactory response|5|||
23738380|NCT00808132|66421176|FG001|Overall Study|Unsatisfactory response|6|||
23738381|NCT00808132|66421177|FG002|Overall Study|Unsatisfactory response|6|||
23738382|NCT00808132|66421178|FG003|Overall Study|Unsatisfactory response|4|||
23738383|NCT00808132|66421179|FG004|Overall Study|Unsatisfactory response|12|||
23738384|NCT00426842|66421182|FG000|Overall Study|Lost to Follow-up|1|||
23738385|NCT02074059|66421183|FG000|Overall Study|Death|0|||
23738386|NCT02074059|66421184|FG001|Overall Study|Death|0|||
23738387|NCT02074059|66421185|FG002|Overall Study|Death|0|||
23547291|NCT02347761|65735767|FG001|All Collected|moved/travel|1|||
23547292|NCT02347761|65735768|FG002|All Collected|moved/travel|0|||
23547293|NCT02347761|65735766|FG000|On Study Treatment|Lack of Efficacy|2|||
23547294|NCT02347761|65735767|FG001|On Study Treatment|Lack of Efficacy|3|||
23547295|NCT02347761|65735768|FG002|On Study Treatment|Lack of Efficacy|4|||
23547296|NCT02347761|65735766|FG000|On Study Treatment|non-compliance with study medication|0|||
23547297|NCT02347761|65735767|FG001|On Study Treatment|non-compliance with study medication|0|||
23547298|NCT02347761|65735768|FG002|On Study Treatment|non-compliance with study medication|2|||
23547299|NCT02347761|65735766|FG000|On Study Treatment|Withdrawal by Subject|7|||
23547300|NCT02347761|65735767|FG001|On Study Treatment|Withdrawal by Subject|3|||
23547301|NCT02347761|65735768|FG002|On Study Treatment|Withdrawal by Subject|5|||
23547302|NCT02347761|65735766|FG000|On Study Treatment|move/travel|2|||
23547303|NCT02347761|65735767|FG001|On Study Treatment|move/travel|6|||
23547304|NCT02347761|65735768|FG002|On Study Treatment|move/travel|5|||
23547305|NCT02347761|65735766|FG000|On Study Treatment|dissastisfaction with device|2|||
23738388|NCT02074059|66421186|FG003|Overall Study|Death|0|||
23738389|NCT02074059|66421187|FG004|Overall Study|Death|1|||
23738390|NCT02074059|66421188|FG005|Overall Study|Death|1|||
23738391|NCT04524507|66421189|FG000|Overall Study|Lost to Follow-up|2|||
23738392|NCT04524507|66421190|FG001|Overall Study|Lost to Follow-up|4|||
23738393|NCT04524507|66421189|FG000|Overall Study|Withdrawal by Subject|2|||
23738394|NCT04524507|66421190|FG001|Overall Study|Withdrawal by Subject|9|||
23738395|NCT04524507|66421189|FG000|Overall Study|Death|2|||
23738396|NCT04524507|66421190|FG001|Overall Study|Death|10|||
23738397|NCT03225833|66421191|FG000|Overall Study|Adverse Event|0|||
23738398|NCT03225833|66421192|FG001|Overall Study|Adverse Event|1|||
23547306|NCT02347761|65735767|FG001|On Study Treatment|dissastisfaction with device|1|||
23547307|NCT02347761|65735768|FG002|On Study Treatment|dissastisfaction with device|4|||
23547308|NCT02347761|65735766|FG000|On Study Treatment|Lost to Follow-up|2|||
23547309|NCT02347761|65735767|FG001|On Study Treatment|Lost to Follow-up|1|||
23738399|NCT03225833|66421193|FG002|Overall Study|Adverse Event|2|||
23738400|NCT03225833|66421194|FG003|Overall Study|Adverse Event|0|||
23738401|NCT03225833|66421195|FG004|Overall Study|Adverse Event|0|||
23738402|NCT03225833|66421196|FG005|Overall Study|Adverse Event|2|||
23619283|NCT00907517|65991520|FG003|Overall Study|Progressive Disease|4|||
23619284|NCT00907517|65991521|FG004|Overall Study|Progressive Disease|4|||
23619285|NCT00907517|65991517|FG000|Overall Study|Symptomatic Deterioration|0|||
23619286|NCT00907517|65991518|FG001|Overall Study|Symptomatic Deterioration|0|||
23619287|NCT00907517|65991519|FG002|Overall Study|Symptomatic Deterioration|0|||
23619288|NCT00907517|65991520|FG003|Overall Study|Symptomatic Deterioration|0|||
23619289|NCT00907517|65991521|FG004|Overall Study|Symptomatic Deterioration|1|||
23738403|NCT03225833|66421191|FG000|Overall Study|Withdrawal by Subject|1|||
23738404|NCT03225833|66421192|FG001|Overall Study|Withdrawal by Subject|0|||
23738405|NCT03225833|66421193|FG002|Overall Study|Withdrawal by Subject|0|||
23738406|NCT03225833|66421194|FG003|Overall Study|Withdrawal by Subject|0|||
23738407|NCT03225833|66421195|FG004|Overall Study|Withdrawal by Subject|1|||
23738408|NCT03225833|66421196|FG005|Overall Study|Withdrawal by Subject|0|||
23738409|NCT03225833|66421191|FG000|Overall Study|Termination of Study by Sponsor|4|||
23738410|NCT03225833|66421192|FG001|Overall Study|Termination of Study by Sponsor|0|||
23738411|NCT03225833|66421193|FG002|Overall Study|Termination of Study by Sponsor|0|||
23738412|NCT03225833|66421194|FG003|Overall Study|Termination of Study by Sponsor|0|||
23738413|NCT03225833|66421195|FG004|Overall Study|Termination of Study by Sponsor|0|||
23738414|NCT03225833|66421196|FG005|Overall Study|Termination of Study by Sponsor|7|||
23738415|NCT03225833|66421191|FG000|Overall Study|Sponsor Decision|0|||
23738416|NCT03225833|66421192|FG001|Overall Study|Sponsor Decision|0|||
23738417|NCT03225833|66421193|FG002|Overall Study|Sponsor Decision|0|||
23738418|NCT03225833|66421194|FG003|Overall Study|Sponsor Decision|0|||
23738419|NCT03225833|66421195|FG004|Overall Study|Sponsor Decision|0|||
23738420|NCT03225833|66421196|FG005|Overall Study|Sponsor Decision|1|||
23738421|NCT00851721|66421197|FG000|Overall Study|planned surgery|1|||
23738422|NCT00851721|66421198|FG001|Overall Study|planned surgery|0|||
23738423|NCT00851721|66421197|FG000|Overall Study|Death|1|||
23738424|NCT00851721|66421198|FG001|Overall Study|Death|0|||
23738425|NCT00851721|66421197|FG000|Overall Study|Adverse Event|0|||
23738426|NCT00851721|66421198|FG001|Overall Study|Adverse Event|1|||
23738427|NCT01231620|66421199|FG000|Overall Study|Physician Decision|3|||
23738428|NCT01231620|66421200|FG001|Overall Study|Physician Decision|5|||
23738429|NCT01231620|66421201|FG002|Overall Study|Physician Decision|10|||
23738430|NCT01231620|66421199|FG000|Overall Study|Death|12|||
23738431|NCT01231620|66421200|FG001|Overall Study|Death|14|||
23738432|NCT01231620|66421201|FG002|Overall Study|Death|11|||
23738433|NCT01231620|66421199|FG000|Overall Study|Adverse Event|2|||
23738434|NCT01231620|66421200|FG001|Overall Study|Adverse Event|2|||
23738435|NCT01231620|66421201|FG002|Overall Study|Adverse Event|1|||
23738436|NCT01231620|66421199|FG000|Overall Study|Withdrawal by Subject|6|||
23738437|NCT01231620|66421200|FG001|Overall Study|Withdrawal by Subject|6|||
23738438|NCT01231620|66421201|FG002|Overall Study|Withdrawal by Subject|8|||
23738439|NCT01231620|66421199|FG000|Overall Study|Lost to Follow-up|3|||
23547310|NCT02347761|65735768|FG002|On Study Treatment|Lost to Follow-up|1|||
23547311|NCT02347761|65735766|FG000|On Study Treatment|investigator discretion|2|||
23547312|NCT02347761|65735767|FG001|On Study Treatment|investigator discretion|0|||
23547313|NCT02347761|65735768|FG002|On Study Treatment|investigator discretion|0|||
23547314|NCT02347761|65735766|FG000|On Study Treatment|durg not working|0|||
23547315|NCT02347761|65735767|FG001|On Study Treatment|durg not working|1|||
23547316|NCT02347761|65735768|FG002|On Study Treatment|durg not working|1|||
23547317|NCT02347761|65735766|FG000|On Study Treatment|Adverse Event|10|||
23547318|NCT02347761|65735767|FG001|On Study Treatment|Adverse Event|8|||
23547319|NCT02347761|65735768|FG002|On Study Treatment|Adverse Event|20|||
23427451|NCT00066469|65307687|FG000|Overall Study|Lost to Follow-up|1|||
23547320|NCT02576067|65735774|FG000|Overall Study|Death|0|||
23547321|NCT02576067|65735775|FG001|Overall Study|Death|1|||
23547322|NCT02576067|65735774|FG000|Overall Study|Lack of Efficacy|1|||
23619290|NCT00239681|65991523|FG000|Overall Study|Adverse Event|100|||
23547323|NCT02576067|65735775|FG001|Overall Study|Lack of Efficacy|0|||
23547324|NCT02576067|65735774|FG000|Overall Study|Lost to Follow-up|11|||
23547325|NCT02576067|65735775|FG001|Overall Study|Lost to Follow-up|0|||
23547326|NCT02576067|65735774|FG000|Overall Study|Withdrawal by Subject|11|||
23547327|NCT02576067|65735775|FG001|Overall Study|Withdrawal by Subject|2|||
23547328|NCT02576067|65735774|FG000|Overall Study|study closure of main CIRT trial)|0|||
23619291|NCT00239681|65991524|FG001|Overall Study|Adverse Event|99|||
23738440|NCT01231620|66421200|FG001|Overall Study|Lost to Follow-up|4|||
23738441|NCT01231620|66421201|FG002|Overall Study|Lost to Follow-up|9|||
23738442|NCT02759939|66421202|FG000|Overall Study|Missing data on first outcome assessed|11|||
23738443|NCT02759939|66421203|FG001|Overall Study|Missing data on first outcome assessed|2|||
23738444|NCT02759939|66421204|FG002|Overall Study|Missing data on first outcome assessed|5|||
23738445|NCT02759939|66421205|FG003|Overall Study|Missing data on first outcome assessed|2|||
23738446|NCT02759939|66421202|FG000|Overall Study|Ineligible for T2 and T3|310|||
23738447|NCT02759939|66421203|FG001|Overall Study|Ineligible for T2 and T3|179|||
23820306|NCT02047734|66721301|FG001|Overall Study|Lost to Follow-up|4|||
23427452|NCT00066469|65307687|FG000|Overall Study|Physician Decision|1|||
23427453|NCT00066469|65307687|FG000|Overall Study|Withdrawal by Subject|1|||
23427454|NCT00066469|65307687|FG000|Overall Study|ineligible|1|||
23427455|NCT01460407|65307688|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
23427456|NCT01460407|65307689|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
23427457|NCT02513823|65307690|FG000|Overall Study|Lost to Follow-up|4|||
23427458|NCT02513823|65307690|FG000|Overall Study|Physician Decision|1|||
23427459|NCT02193087|65307691|FG000|Overall Study|Adverse Event|2|||
23427460|NCT02193087|65307692|FG001|Overall Study|Adverse Event|0|||
23547329|NCT02576067|65735775|FG001|Overall Study|study closure of main CIRT trial)|8|||
23547330|NCT02576067|65735774|FG000|Overall Study|not randomized, failed run-in|7|||
23547331|NCT02576067|65735775|FG001|Overall Study|not randomized, failed run-in|0|||
23547332|NCT02576067|65735774|FG000|Overall Study|screen failure/ re-enrolled|0|||
23547333|NCT02576067|65735775|FG001|Overall Study|screen failure/ re-enrolled|25|||
23547334|NCT02576067|65735774|FG000|Overall Study|Physician Decision|4|||
23547335|NCT02576067|65735775|FG001|Overall Study|Physician Decision|0|||
23547336|NCT01054820|65735778|FG000|Overall Study|Withdrawal by Subject|2|||
23547337|NCT02395120|65735779|FG000|Overall Study|Missed follow-up dental exam|57|||
23547338|NCT02395120|65735780|FG001|Overall Study|Missed follow-up dental exam|62|||
23820307|NCT02047734|66721302|FG002|Overall Study|Lost to Follow-up|0|||
23820308|NCT02047734|66721300|FG000|Overall Study|Death|0|||
23820309|NCT02047734|66721301|FG001|Overall Study|Death|1|||
23820310|NCT02047734|66721302|FG002|Overall Study|Death|0|||
23547339|NCT02395120|65735781|FG002|Overall Study|Missed follow-up dental exam|6|||
23547340|NCT02395120|65735782|FG003|Overall Study|Missed follow-up dental exam|6|||
23547341|NCT02395120|65735783|FG004|Overall Study|Missed follow-up dental exam|51|||
23547342|NCT03743038|65735784|FG000|Overall Study|Physician Decision|1|||
23547343|NCT03727750|65735787|FG000|Overall Study|Death|45|||
23547344|NCT03727750|65735787|FG000|Overall Study|Withdrawal by Subject|2|||
23547345|NCT03727750|65735787|FG000|Overall Study|Lost to Follow-up|1|||
23547346|NCT03727750|65735787|FG000|Overall Study|Other|1|||
23547347|NCT01328574|65735788|FG000|Overall Study|Refused further treatment|1|||
23547348|NCT00321919|65735789|FG000|Overall Study|Adverse Event|17|||
23547349|NCT00321919|65735790|FG001|Overall Study|Adverse Event|10|||
23547350|NCT00321919|65735789|FG000|Overall Study|Death|21|||
23547351|NCT00321919|65735790|FG001|Overall Study|Death|17|||
23547352|NCT00321919|65735789|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23547353|NCT00321919|65735790|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23547354|NCT00321919|65735789|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23547355|NCT00321919|65735790|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23547356|NCT00321919|65735789|FG000|Overall Study|Refused Treatment|23|||
23547357|NCT00321919|65735790|FG001|Overall Study|Refused Treatment|14|||
23547358|NCT00321919|65735789|FG000|Overall Study|Other Protocol Violation|2|||
23547359|NCT00321919|65735790|FG001|Overall Study|Other Protocol Violation|3|||
23547360|NCT00321919|65735789|FG000|Overall Study|Failure to Return|3|||
23547361|NCT00321919|65735790|FG001|Overall Study|Failure to Return|1|||
23547362|NCT00321919|65735789|FG000|Overall Study|Other withdrawal reason|7|||
23738448|NCT02759939|66421204|FG002|Overall Study|Ineligible for T2 and T3|366|||
23738449|NCT02759939|66421205|FG003|Overall Study|Ineligible for T2 and T3|391|||
23738450|NCT02759939|66421202|FG000|Overall Study|Lost to Follow-up|735|||
23738451|NCT02759939|66421203|FG001|Overall Study|Lost to Follow-up|791|||
23738452|NCT02759939|66421204|FG002|Overall Study|Lost to Follow-up|783|||
23738453|NCT02759939|66421205|FG003|Overall Study|Lost to Follow-up|650|||
23547363|NCT00321919|65735790|FG001|Overall Study|Other withdrawal reason|6|||
23738454|NCT00931515|66421213|FG000|Overall Study|Lost to Follow-up|2|||
23738455|NCT00931515|66421214|FG001|Overall Study|Lost to Follow-up|5|||
23738456|NCT02192190|66421216|FG000|Overall Study|Adverse Event|1|||
23820311|NCT02047734|66721300|FG000|Overall Study|Withdrawal by Subject|30|||
23820312|NCT02047734|66721301|FG001|Overall Study|Withdrawal by Subject|31|||
23820313|NCT02047734|66721302|FG002|Overall Study|Withdrawal by Subject|19|||
23427461|NCT02193087|65307693|FG002|Overall Study|Adverse Event|0|||
23547364|NCT02291614|65735798|FG000|Overall Study|Lost to Follow-up|0|||
23547365|NCT02291614|65735799|FG001|Overall Study|Lost to Follow-up|0|||
23547366|NCT02291614|65735800|FG002|Overall Study|Lost to Follow-up|0|||
23547367|NCT02291614|65735801|FG003|Overall Study|Lost to Follow-up|0|||
23738457|NCT02192190|66421217|FG001|Overall Study|Adverse Event|1|||
23738458|NCT02192190|66421218|FG002|Overall Study|Adverse Event|0|||
23427462|NCT02193087|65307694|FG003|Overall Study|Adverse Event|11|||
23547368|NCT02291614|65735802|FG004|Overall Study|Lost to Follow-up|0|||
23547369|NCT02291614|65735803|FG005|Overall Study|Lost to Follow-up|0|||
23547370|NCT02291614|65735804|FG006|Overall Study|Lost to Follow-up|0|||
23738459|NCT02192190|66421219|FG003|Overall Study|Adverse Event|0|||
23738460|NCT02192190|66421220|FG004|Overall Study|Adverse Event|0|||
23820314|NCT02047734|66721300|FG000|Overall Study|Physician Decision|7|||
23547371|NCT02291614|65735805|FG007|Overall Study|Lost to Follow-up|1|||
23547372|NCT02291614|65735806|FG008|Overall Study|Lost to Follow-up|0|||
23547373|NCT02291614|65735807|FG009|Overall Study|Lost to Follow-up|0|||
23547374|NCT02291614|65735808|FG010|Overall Study|Lost to Follow-up|0|||
23547375|NCT02291614|65735798|FG000|Overall Study|Withdrawal by Subject|0|||
23547376|NCT02291614|65735799|FG001|Overall Study|Withdrawal by Subject|1|||
23547377|NCT02291614|65735800|FG002|Overall Study|Withdrawal by Subject|0|||
23547378|NCT02291614|65735801|FG003|Overall Study|Withdrawal by Subject|0|||
23547379|NCT02291614|65735802|FG004|Overall Study|Withdrawal by Subject|0|||
23547380|NCT02291614|65735803|FG005|Overall Study|Withdrawal by Subject|0|||
23547381|NCT02291614|65735804|FG006|Overall Study|Withdrawal by Subject|0|||
23547382|NCT02291614|65735805|FG007|Overall Study|Withdrawal by Subject|0|||
23547383|NCT02291614|65735806|FG008|Overall Study|Withdrawal by Subject|0|||
23547384|NCT02291614|65735807|FG009|Overall Study|Withdrawal by Subject|2|||
23547385|NCT02291614|65735808|FG010|Overall Study|Withdrawal by Subject|2|||
23738461|NCT02192190|66421221|FG005|Overall Study|Adverse Event|0|||
23738462|NCT02192190|66421216|FG000|Overall Study|Lost to Follow-up|3|||
23738463|NCT02192190|66421217|FG001|Overall Study|Lost to Follow-up|3|||
23738464|NCT02192190|66421218|FG002|Overall Study|Lost to Follow-up|2|||
23738465|NCT02192190|66421219|FG003|Overall Study|Lost to Follow-up|1|||
23738466|NCT02192190|66421220|FG004|Overall Study|Lost to Follow-up|4|||
23738467|NCT02192190|66421221|FG005|Overall Study|Lost to Follow-up|3|||
23738468|NCT02192190|66421216|FG000|Overall Study|Physician Decision|2|||
23738469|NCT02192190|66421217|FG001|Overall Study|Physician Decision|0|||
23738470|NCT02192190|66421218|FG002|Overall Study|Physician Decision|0|||
23738471|NCT02192190|66421219|FG003|Overall Study|Physician Decision|0|||
23738472|NCT02192190|66421220|FG004|Overall Study|Physician Decision|0|||
23738473|NCT02192190|66421221|FG005|Overall Study|Physician Decision|0|||
23738474|NCT02192190|66421216|FG000|Overall Study|Terminated by Sponsor|43|||
23738475|NCT02192190|66421217|FG001|Overall Study|Terminated by Sponsor|23|||
23738476|NCT02192190|66421218|FG002|Overall Study|Terminated by Sponsor|20|||
23738477|NCT02192190|66421219|FG003|Overall Study|Terminated by Sponsor|23|||
23738478|NCT02192190|66421220|FG004|Overall Study|Terminated by Sponsor|21|||
23738479|NCT02192190|66421221|FG005|Overall Study|Terminated by Sponsor|23|||
23738480|NCT02192190|66421216|FG000|Overall Study|Withdrawal by Subject|4|||
23738481|NCT02192190|66421217|FG001|Overall Study|Withdrawal by Subject|1|||
23738482|NCT02192190|66421218|FG002|Overall Study|Withdrawal by Subject|2|||
23738483|NCT02192190|66421219|FG003|Overall Study|Withdrawal by Subject|1|||
23738484|NCT02192190|66421220|FG004|Overall Study|Withdrawal by Subject|5|||
23738485|NCT02192190|66421221|FG005|Overall Study|Withdrawal by Subject|3|||
23738486|NCT02192190|66421216|FG000|Overall Study|Could not Keep Visit Schedule|1|||
23738487|NCT02192190|66421217|FG001|Overall Study|Could not Keep Visit Schedule|0|||
23738488|NCT02192190|66421218|FG002|Overall Study|Could not Keep Visit Schedule|0|||
23738489|NCT02192190|66421219|FG003|Overall Study|Could not Keep Visit Schedule|0|||
23738490|NCT02192190|66421220|FG004|Overall Study|Could not Keep Visit Schedule|0|||
23738491|NCT02192190|66421221|FG005|Overall Study|Could not Keep Visit Schedule|0|||
23738492|NCT02192190|66421216|FG000|Overall Study|Positive Drug Screen|0|||
23738493|NCT02192190|66421217|FG001|Overall Study|Positive Drug Screen|0|||
23738494|NCT02192190|66421218|FG002|Overall Study|Positive Drug Screen|0|||
23738495|NCT02192190|66421219|FG003|Overall Study|Positive Drug Screen|1|||
23738496|NCT02192190|66421220|FG004|Overall Study|Positive Drug Screen|0|||
23738497|NCT02192190|66421221|FG005|Overall Study|Positive Drug Screen|0|||
23738498|NCT02192190|66421216|FG000|Overall Study|Inadequate Pain Relief|0|||
23738499|NCT02192190|66421217|FG001|Overall Study|Inadequate Pain Relief|1|||
23738500|NCT02192190|66421218|FG002|Overall Study|Inadequate Pain Relief|1|||
23738501|NCT02192190|66421219|FG003|Overall Study|Inadequate Pain Relief|0|||
23738502|NCT02192190|66421220|FG004|Overall Study|Inadequate Pain Relief|0|||
23738503|NCT02192190|66421221|FG005|Overall Study|Inadequate Pain Relief|0|||
23738504|NCT01906489|66421222|FG000|Overall Study|Adverse Event|10|||
23738505|NCT01906489|66421223|FG001|Overall Study|Adverse Event|3|||
23820315|NCT02047734|66721301|FG001|Overall Study|Physician Decision|6|||
23820316|NCT02047734|66721302|FG002|Overall Study|Physician Decision|5|||
23820317|NCT02047734|66721300|FG000|Overall Study|Miscellaneous|2|||
23820318|NCT02047734|66721301|FG001|Overall Study|Miscellaneous|4|||
23547386|NCT02291614|65735798|FG000|Overall Study|Decision by sponsor|0|||
23547387|NCT02291614|65735799|FG001|Overall Study|Decision by sponsor|0|||
23619292|NCT00239681|65991523|FG000|Overall Study|Withdrawal by Subject|458|||
23738506|NCT01906489|66421222|FG000|Overall Study|Worsening of CKD|6|||
23738507|NCT01906489|66421223|FG001|Overall Study|Worsening of CKD|4|||
23738508|NCT01906489|66421222|FG000|Overall Study|Withdrawal by Subject|5|||
23738509|NCT01906489|66421223|FG001|Overall Study|Withdrawal by Subject|0|||
23738510|NCT01906489|66421222|FG000|Overall Study|Worsening of Anemia|1|||
23738511|NCT01906489|66421223|FG001|Overall Study|Worsening of Anemia|0|||
23738512|NCT01906489|66421222|FG000|Overall Study|Protocol Violation|0|||
23738513|NCT01906489|66421223|FG001|Overall Study|Protocol Violation|1|||
23738514|NCT01906489|66421222|FG000|Overall Study|Non- Compliance|1|||
23738515|NCT01906489|66421223|FG001|Overall Study|Non- Compliance|0|||
23820319|NCT02047734|66721302|FG002|Overall Study|Miscellaneous|6|||
23820320|NCT02047734|66721300|FG000|Overall Study|Did Not Receive Study Drug|2|||
23820321|NCT02047734|66721301|FG001|Overall Study|Did Not Receive Study Drug|4|||
23547388|NCT02291614|65735800|FG002|Overall Study|Decision by sponsor|0|||
23427463|NCT02193087|65307691|FG000|Overall Study|Lost to Follow-up|14|||
23427464|NCT02193087|65307692|FG001|Overall Study|Lost to Follow-up|6|||
23427465|NCT02193087|65307693|FG002|Overall Study|Lost to Follow-up|4|||
23427466|NCT02193087|65307694|FG003|Overall Study|Lost to Follow-up|37|||
23427467|NCT02193087|65307691|FG000|Overall Study|Protocol Violation|2|||
23427468|NCT02193087|65307692|FG001|Overall Study|Protocol Violation|0|||
23427469|NCT02193087|65307693|FG002|Overall Study|Protocol Violation|1|||
23427470|NCT02193087|65307694|FG003|Overall Study|Protocol Violation|2|||
23427471|NCT02193087|65307691|FG000|Overall Study|Withdrawal by Subject|10|||
23427472|NCT02193087|65307692|FG001|Overall Study|Withdrawal by Subject|3|||
23427473|NCT02193087|65307693|FG002|Overall Study|Withdrawal by Subject|1|||
23427474|NCT02193087|65307694|FG003|Overall Study|Withdrawal by Subject|19|||
23427475|NCT02193087|65307691|FG000|Overall Study|Other Reason Not Specified|7|||
23427476|NCT02193087|65307692|FG001|Overall Study|Other Reason Not Specified|2|||
23427477|NCT02193087|65307693|FG002|Overall Study|Other Reason Not Specified|1|||
23427478|NCT02193087|65307694|FG003|Overall Study|Other Reason Not Specified|9|||
23427479|NCT02193087|65307691|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
23427480|NCT02193087|65307692|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
23427481|NCT02193087|65307693|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
23427482|NCT02193087|65307694|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
23427483|NCT02395055|65307695|FG000|Overall Study|Withdrawal by Subject|7|||
23427484|NCT02395055|65307696|FG001|Overall Study|Withdrawal by Subject|3|||
23427485|NCT01527383|65307699|FG000|Overall Study|Adverse Event|5|||
23427486|NCT01527383|65307700|FG001|Overall Study|Adverse Event|0|||
23427487|NCT01527383|65307699|FG000|Overall Study|Lost to Follow-up|3|||
23427488|NCT01527383|65307700|FG001|Overall Study|Lost to Follow-up|0|||
23547389|NCT02291614|65735801|FG003|Overall Study|Decision by sponsor|1|||
23547390|NCT02291614|65735802|FG004|Overall Study|Decision by sponsor|0|||
23547391|NCT02291614|65735803|FG005|Overall Study|Decision by sponsor|0|||
23547392|NCT02291614|65735804|FG006|Overall Study|Decision by sponsor|0|||
23547393|NCT02291614|65735805|FG007|Overall Study|Decision by sponsor|0|||
23547394|NCT02291614|65735806|FG008|Overall Study|Decision by sponsor|0|||
23547395|NCT02291614|65735807|FG009|Overall Study|Decision by sponsor|0|||
23547396|NCT02291614|65735808|FG010|Overall Study|Decision by sponsor|0|||
23547397|NCT02291614|65735798|FG000|Overall Study|Death|0|||
23547398|NCT02291614|65735799|FG001|Overall Study|Death|0|||
23547399|NCT02291614|65735800|FG002|Overall Study|Death|1|||
23547400|NCT02291614|65735801|FG003|Overall Study|Death|0|||
23547401|NCT02291614|65735802|FG004|Overall Study|Death|1|||
23547402|NCT02291614|65735803|FG005|Overall Study|Death|1|||
23547403|NCT02291614|65735804|FG006|Overall Study|Death|1|||
23547404|NCT02291614|65735805|FG007|Overall Study|Death|0|||
23547405|NCT02291614|65735806|FG008|Overall Study|Death|0|||
23547406|NCT02291614|65735807|FG009|Overall Study|Death|0|||
23547407|NCT02291614|65735808|FG010|Overall Study|Death|0|||
23547408|NCT02479412|65735809|FG000|Overall Study|Adverse Event|0|||
23547409|NCT02479412|65735810|FG001|Overall Study|Adverse Event|0|||
23547410|NCT02479412|65735811|FG002|Overall Study|Adverse Event|1|||
23547411|NCT02479412|65735812|FG003|Overall Study|Adverse Event|0|||
23547412|NCT02479412|65735813|FG004|Overall Study|Adverse Event|0|||
23547413|NCT02479412|65735814|FG005|Overall Study|Adverse Event|0|||
23547414|NCT02479412|65735815|FG006|Overall Study|Adverse Event|0|||
23547415|NCT02479412|65735816|FG007|Overall Study|Adverse Event|0|||
23547416|NCT02479412|65735817|FG008|Overall Study|Adverse Event|0|||
23547417|NCT02479412|65735809|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23547418|NCT02479412|65735810|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23619293|NCT00239681|65991524|FG001|Overall Study|Withdrawal by Subject|489|||
23619294|NCT00239681|65991523|FG000|Overall Study|Lost to Follow-up|28|||
23619295|NCT00239681|65991524|FG001|Overall Study|Lost to Follow-up|22|||
23820322|NCT02047734|66721302|FG002|Overall Study|Did Not Receive Study Drug|1|||
23427489|NCT01527383|65307699|FG000|Overall Study|Physician Decision|2|||
23427490|NCT01527383|65307700|FG001|Overall Study|Physician Decision|0|||
23427491|NCT01527383|65307699|FG000|Overall Study|Pregnancy|1|||
23427492|NCT01527383|65307700|FG001|Overall Study|Pregnancy|0|||
23547419|NCT02479412|65735811|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23547420|NCT02479412|65735812|FG003|Overall Study|Study-specific withdrawal criteria|1|||
23547421|NCT02479412|65735813|FG004|Overall Study|Study-specific withdrawal criteria|0|||
23427493|NCT01527383|65307699|FG000|Overall Study|Protocol Violation|1|||
23427494|NCT01527383|65307700|FG001|Overall Study|Protocol Violation|0|||
23427495|NCT01527383|65307699|FG000|Overall Study|Screen failure|1|||
23427496|NCT01527383|65307700|FG001|Overall Study|Screen failure|0|||
23547422|NCT02479412|65735814|FG005|Overall Study|Study-specific withdrawal criteria|0|||
23427497|NCT01527383|65307699|FG000|Overall Study|Participant moved|0|||
23547423|NCT02479412|65735815|FG006|Overall Study|Study-specific withdrawal criteria|0|||
23547424|NCT02479412|65735816|FG007|Overall Study|Study-specific withdrawal criteria|1|||
23547425|NCT02479412|65735817|FG008|Overall Study|Study-specific withdrawal criteria|1|||
23547426|NCT02479412|65735809|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
23547427|NCT02479412|65735810|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
23547428|NCT02479412|65735811|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
23547429|NCT02479412|65735812|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
23547430|NCT02479412|65735813|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
23547431|NCT02479412|65735814|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
23547432|NCT02479412|65735815|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
23547433|NCT02479412|65735816|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
23547434|NCT02479412|65735817|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
23547435|NCT02363946|65735818|FG000|Overall Study|Lost to Follow-up|0|||
23547436|NCT02363946|65735819|FG001|Overall Study|Lost to Follow-up|0|||
23619296|NCT00239681|65991523|FG000|Overall Study|Protocol Violation|4|||
23619297|NCT00239681|65991524|FG001|Overall Study|Protocol Violation|4|||
23619298|NCT00239681|65991523|FG000|Overall Study|Physician Decision|13|||
23738516|NCT01906489|66421222|FG000|Overall Study|Sponsor Decision|1|||
23738517|NCT01906489|66421223|FG001|Overall Study|Sponsor Decision|0|||
23738518|NCT01906489|66421222|FG000|Overall Study|Lost to Follow-up|1|||
23738519|NCT01906489|66421223|FG001|Overall Study|Lost to Follow-up|1|||
23738520|NCT01906489|66421222|FG000|Overall Study|Other|1|||
23738521|NCT01906489|66421223|FG001|Overall Study|Other|0|||
23547437|NCT02363946|65735820|FG002|Overall Study|Lost to Follow-up|0|||
23619299|NCT00239681|65991524|FG001|Overall Study|Physician Decision|17|||
23738522|NCT00779506|66421224|FG000|Overall Study|Screening Failed|2|||
23738523|NCT00779506|66421224|FG000|Overall Study|Adverse Event|4|||
23738524|NCT00779506|66421224|FG000|Overall Study|Lack of Efficacy|11|||
23738525|NCT00779506|66421224|FG000|Overall Study|Protocol Violation|5|||
23820323|NCT02276807|66721303|FG000|Overall Study|Withdrawal by Subject|8|||
23820324|NCT02276807|66721304|FG001|Overall Study|Withdrawal by Subject|7|||
23820325|NCT02276807|66721303|FG000|Overall Study|Lost to Follow-up|10|||
23820326|NCT02276807|66721304|FG001|Overall Study|Lost to Follow-up|10|||
23820327|NCT02227446|66721305|FG000|Overall Study|not eligible post randomization|18|||
23820328|NCT02227446|66721306|FG001|Overall Study|not eligible post randomization|29|||
23820329|NCT02227446|66721305|FG000|Overall Study|Withdrawal by Subject|4|||
23820330|NCT02227446|66721306|FG001|Overall Study|Withdrawal by Subject|5|||
23820331|NCT02695537|66721308|FG000|Overall Study|Adverse Event|3|||
23820332|NCT02695537|66721308|FG000|Overall Study|Lack of Efficacy|28|||
23820333|NCT02695537|66721308|FG000|Overall Study|Withdrawal by Subject|4|||
23820334|NCT02695537|66721308|FG000|Overall Study|Protocol Violation|3|||
23820335|NCT04602546|66721313|FG000|Overall Study|Training|2|||
23820336|NCT04602546|66721314|FG001|Overall Study|Training|2|||
23820337|NCT04602546|66721315|FG002|Overall Study|Training|1|||
23820338|NCT04602546|66721316|FG003|Overall Study|Training|2|||
23820339|NCT04602546|66721317|FG004|Overall Study|Training|0|||
23820340|NCT04602546|66721313|FG000|Overall Study|Randomized with disqualified data|2|||
23820341|NCT04602546|66721314|FG001|Overall Study|Randomized with disqualified data|0|||
23619300|NCT00239681|65991523|FG000|Overall Study|No information chacked on CaseReportForm|90|||
23619301|NCT00239681|65991524|FG001|Overall Study|No information chacked on CaseReportForm|84|||
23619302|NCT00853021|65991525|FG000|Overall Study|Adverse Event|2|||
23619303|NCT00853021|65991525|FG000|Overall Study|Withdrawal by Subject|2|||
23619304|NCT00853021|65991525|FG000|Overall Study|Death|1|||
23619305|NCT00434577|65991526|FG000|Months 0-3|Serious Adverse Event|0|||
23619306|NCT00434577|65991527|FG001|Months 0-3|Serious Adverse Event|0|||
23619307|NCT00434577|65991528|FG002|Months 0-3|Serious Adverse Event|1|||
23619308|NCT00434577|65991529|FG003|Months 0-3|Serious Adverse Event|0|||
23619309|NCT00434577|65991530|FG004|Months 0-3|Serious Adverse Event|0|||
23619310|NCT00434577|65991526|FG000|Months 0-3|Adverse Event|0|||
23619311|NCT00434577|65991527|FG001|Months 0-3|Adverse Event|1|||
23619312|NCT00434577|65991528|FG002|Months 0-3|Adverse Event|1|||
23619313|NCT00434577|65991529|FG003|Months 0-3|Adverse Event|0|||
23619314|NCT00434577|65991530|FG004|Months 0-3|Adverse Event|0|||
23619315|NCT00434577|65991526|FG000|Months 0-3|Lost to Follow-up|0|||
23619316|NCT00434577|65991527|FG001|Months 0-3|Lost to Follow-up|0|||
23619317|NCT00434577|65991528|FG002|Months 0-3|Lost to Follow-up|0|||
23619318|NCT00434577|65991529|FG003|Months 0-3|Lost to Follow-up|0|||
23820342|NCT04602546|66721315|FG002|Overall Study|Randomized with disqualified data|2|||
23427498|NCT01527383|65307700|FG001|Overall Study|Participant moved|1|||
23619319|NCT00434577|65991530|FG004|Months 0-3|Lost to Follow-up|2|||
23619320|NCT00434577|65991526|FG000|Months 0-3|Protocol Violation|1|||
23619321|NCT00434577|65991527|FG001|Months 0-3|Protocol Violation|0|||
23619322|NCT00434577|65991528|FG002|Months 0-3|Protocol Violation|1|||
23619323|NCT00434577|65991529|FG003|Months 0-3|Protocol Violation|0|||
23619324|NCT00434577|65991530|FG004|Months 0-3|Protocol Violation|0|||
23619325|NCT00434577|65991526|FG000|Months 0-3|Withdrawal by Subject|2|||
23427499|NCT01527383|65307699|FG000|Overall Study|Withdrawal by Subject|2|||
23619326|NCT00434577|65991527|FG001|Months 0-3|Withdrawal by Subject|1|||
23619327|NCT00434577|65991528|FG002|Months 0-3|Withdrawal by Subject|1|||
23619328|NCT00434577|65991529|FG003|Months 0-3|Withdrawal by Subject|1|||
23619329|NCT00434577|65991530|FG004|Months 0-3|Withdrawal by Subject|1|||
23619330|NCT02675998|65991531|FG000|8-Week Treatment Period|Adverse Event|6|||
23619331|NCT02675998|65991532|FG001|8-Week Treatment Period|Adverse Event|5|||
23619332|NCT02675998|65991533|FG002|8-Week Treatment Period|Adverse Event|6|||
23619333|NCT02675998|65991534|FG003|8-Week Treatment Period|Adverse Event|0|||
23619334|NCT02675998|65991531|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
23619335|NCT02675998|65991532|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
23619336|NCT02675998|65991533|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
23619337|NCT02675998|65991534|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
23619338|NCT02675998|65991531|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
23619339|NCT02675998|65991532|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
23619340|NCT02675998|65991533|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
23619341|NCT02675998|65991534|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
23738526|NCT00779506|66421224|FG000|Overall Study|Withdrawal by Subject|6|||
23738527|NCT00779506|66421224|FG000|Overall Study|Lost to Follow-up|1|||
23738528|NCT04601194|66421225|FG000|Overall Study|Lost to Follow-up|7|||
23738529|NCT00157157|66421226|FG000|Overall Study|Withdrawal by Subject|6|||
23738530|NCT00157157|66421226|FG000|Overall Study|Physician Decision|1|||
23738531|NCT00157157|66421226|FG000|Overall Study|Lost to Follow-up|1|||
23820343|NCT04602546|66721316|FG003|Overall Study|Randomized with disqualified data|5|||
23820344|NCT04602546|66721317|FG004|Overall Study|Randomized with disqualified data|3|||
23820345|NCT00735397|66721318|FG000|Overall Study|Adverse Event|194|||
23820346|NCT00735397|66721318|FG000|Overall Study|Lost to Follow-up|33|||
23820347|NCT00735397|66721318|FG000|Overall Study|Participant choice|252|||
23820348|NCT00735397|66721318|FG000|Overall Study|Inadequate therapeutic effect|202|||
23820349|NCT00735397|66721318|FG000|Overall Study|Administrative/Other|502|||
23820350|NCT02224157|66721325|FG000|Overall Study|Severe non-compliance to protocol|2|||
23820351|NCT02224157|66721326|FG001|Overall Study|Severe non-compliance to protocol|2|||
23820352|NCT02224157|66721325|FG000|Overall Study|Other|13|||
23820353|NCT02224157|66721326|FG001|Overall Study|Other|10|||
23820354|NCT02224157|66721325|FG000|Overall Study|Subject decision|58|||
23820355|NCT02224157|66721326|FG001|Overall Study|Subject decision|50|||
23820356|NCT02224157|66721325|FG000|Overall Study|Prematurely closed site|4|||
23820357|NCT02224157|66721326|FG001|Overall Study|Prematurely closed site|2|||
23820358|NCT02224157|66721325|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
23820359|NCT02224157|66721326|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
23820360|NCT02224157|66721325|FG000|Overall Study|Lost to Follow-up|27|||
23820361|NCT02224157|66721326|FG001|Overall Study|Lost to Follow-up|35|||
23820362|NCT02224157|66721325|FG000|Overall Study|Death|1|||
23820363|NCT02224157|66721326|FG001|Overall Study|Death|1|||
23820364|NCT02224157|66721325|FG000|Overall Study|Adverse Event|1|||
23820365|NCT02224157|66721326|FG001|Overall Study|Adverse Event|3|||
23820366|NCT01998841|66721327|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
23820367|NCT01998841|66721328|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
23820368|NCT01998841|66721329|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
23820369|NCT01998841|66721330|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23820370|NCT01998841|66721331|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23820371|NCT01998841|66721327|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23820372|NCT01998841|66721328|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23820373|NCT01998841|66721329|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23820374|NCT01998841|66721330|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
23820375|NCT01998841|66721331|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
23547438|NCT02363946|65735821|FG003|Overall Study|Lost to Follow-up|0|||
23738532|NCT00157157|66421226|FG000|Overall Study|Enrolled in another study|1|||
23738533|NCT00157157|66421226|FG000|Overall Study|Met exclusion criteria|1|||
23547439|NCT02363946|65735822|FG004|Overall Study|Lost to Follow-up|0|||
23547440|NCT02363946|65735823|FG005|Overall Study|Lost to Follow-up|0|||
23547441|NCT02363946|65735824|FG006|Overall Study|Lost to Follow-up|0|||
23547442|NCT02363946|65735825|FG007|Overall Study|Lost to Follow-up|1|||
23547443|NCT02363946|65735826|FG008|Overall Study|Lost to Follow-up|0|||
23547444|NCT02363946|65735827|FG009|Overall Study|Lost to Follow-up|0|||
23547445|NCT02363946|65735828|FG010|Overall Study|Lost to Follow-up|0|||
23547446|NCT02363946|65735829|FG011|Overall Study|Lost to Follow-up|0|||
23547447|NCT02363946|65735830|FG012|Overall Study|Lost to Follow-up|0|||
23547448|NCT02365467|65735831|FG000|Overall Study|Death|3|||
23547449|NCT02041195|65735832|FG000|Overall Study|Adverse Event|1|||
23619342|NCT02675998|65991531|FG000|8-Week Treatment Period|Physician Decision|1|||
23619343|NCT02675998|65991532|FG001|8-Week Treatment Period|Physician Decision|0|||
23738534|NCT00157157|66421226|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
23738535|NCT01552408|66421233|FG000|Overall Study|Lost to Follow-up|2|||
23547450|NCT02041195|65735833|FG001|Overall Study|Adverse Event|2|||
23619344|NCT02675998|65991533|FG002|8-Week Treatment Period|Physician Decision|2|||
23619345|NCT02675998|65991534|FG003|8-Week Treatment Period|Physician Decision|0|||
23547451|NCT02041195|65735834|FG002|Overall Study|Adverse Event|0|||
23547452|NCT02041195|65735835|FG003|Overall Study|Adverse Event|0|||
23619346|NCT02675998|65991531|FG000|8-Week Treatment Period|GI side Effects|1|||
23619347|NCT02675998|65991532|FG001|8-Week Treatment Period|GI side Effects|4|||
23619348|NCT02675998|65991533|FG002|8-Week Treatment Period|GI side Effects|2|||
23619349|NCT02675998|65991534|FG003|8-Week Treatment Period|GI side Effects|0|||
23619350|NCT02675998|65991531|FG000|8-Week Treatment Period|Protocol Violation|1|||
23619351|NCT02675998|65991532|FG001|8-Week Treatment Period|Protocol Violation|1|||
23619352|NCT02675998|65991533|FG002|8-Week Treatment Period|Protocol Violation|1|||
23619353|NCT02675998|65991534|FG003|8-Week Treatment Period|Protocol Violation|0|||
23619354|NCT02675998|65991531|FG000|8-Week Treatment Period|Other|3|||
23619355|NCT02675998|65991532|FG001|8-Week Treatment Period|Other|1|||
23619356|NCT02675998|65991533|FG002|8-Week Treatment Period|Other|2|||
23619357|NCT02675998|65991534|FG003|8-Week Treatment Period|Other|0|||
23619358|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
23619359|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
23547453|NCT02041195|65735836|FG004|Overall Study|Adverse Event|0|||
23547454|NCT02041195|65735837|FG005|Overall Study|Adverse Event|0|||
23547455|NCT02041195|65735838|FG006|Overall Study|Adverse Event|3|||
23547456|NCT02041195|65735839|FG007|Overall Study|Adverse Event|0|||
23547457|NCT02041195|65735832|FG000|Overall Study|Withdrawal by Subject|1|||
23547458|NCT02041195|65735833|FG001|Overall Study|Withdrawal by Subject|0|||
23547459|NCT02041195|65735834|FG002|Overall Study|Withdrawal by Subject|0|||
23547460|NCT02041195|65735835|FG003|Overall Study|Withdrawal by Subject|0|||
23547461|NCT02041195|65735836|FG004|Overall Study|Withdrawal by Subject|0|||
23547462|NCT02041195|65735837|FG005|Overall Study|Withdrawal by Subject|0|||
23547463|NCT02041195|65735838|FG006|Overall Study|Withdrawal by Subject|4|||
23547464|NCT02041195|65735839|FG007|Overall Study|Withdrawal by Subject|3|||
23547465|NCT02041195|65735832|FG000|Overall Study|Unable to comply with study visits|0|||
23547466|NCT02041195|65735833|FG001|Overall Study|Unable to comply with study visits|1|||
23547467|NCT02041195|65735834|FG002|Overall Study|Unable to comply with study visits|0|||
23547468|NCT02041195|65735835|FG003|Overall Study|Unable to comply with study visits|0|||
23547469|NCT02041195|65735836|FG004|Overall Study|Unable to comply with study visits|1|||
23547470|NCT02041195|65735837|FG005|Overall Study|Unable to comply with study visits|0|||
23547471|NCT02041195|65735838|FG006|Overall Study|Unable to comply with study visits|0|||
23547472|NCT02041195|65735839|FG007|Overall Study|Unable to comply with study visits|0|||
23547473|NCT01983293|65735840|FG000|Overall Study|Withdrawal by Subject|29|||
23547474|NCT01983293|65735841|FG001|Overall Study|Withdrawal by Subject|15|||
23547475|NCT01983293|65735840|FG000|Overall Study|Missing 12-month visit|3|||
23547476|NCT01983293|65735841|FG001|Overall Study|Missing 12-month visit|3|||
23547477|NCT01983293|65735840|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
23547478|NCT01983293|65735841|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
23547479|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
23547480|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
23547481|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
23547482|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
23547483|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
23547484|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
23547485|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
23547486|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
23547487|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
23547488|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
23547489|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
23547490|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
23547491|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
23547492|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
23547493|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
23547494|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
23547495|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
23619360|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
23619361|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
23547496|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
23547497|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
23547498|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
23547499|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
23619362|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
23619363|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
23619364|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
23619365|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
23619366|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619367|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619368|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619369|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
23619370|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
23619371|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619372|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619373|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619374|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619375|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619376|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619377|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
23619378|NCT02236598|65991535|FG000|Overall Study|Adverse Event|0|||
23619379|NCT02236598|65991536|FG001|Overall Study|Adverse Event|1|||
23619380|NCT02236598|65991535|FG000|Overall Study|Withdrawal by Subject|0|||
23619381|NCT02236598|65991536|FG001|Overall Study|Withdrawal by Subject|1|||
23619382|NCT00899379|65991537|FG000|Overall Study|Adverse Event|2|||
23619383|NCT00899379|65991538|FG001|Overall Study|Adverse Event|2|||
23619384|NCT00899379|65991539|FG002|Overall Study|Adverse Event|1|||
23619385|NCT00899379|65991540|FG003|Overall Study|Adverse Event|1|||
23619386|NCT00899379|65991541|FG004|Overall Study|Adverse Event|2|||
23619387|NCT00899379|65991537|FG000|Overall Study|Lack of Efficacy|0|||
23619388|NCT00899379|65991538|FG001|Overall Study|Lack of Efficacy|4|||
23619389|NCT00899379|65991539|FG002|Overall Study|Lack of Efficacy|3|||
23619390|NCT00899379|65991540|FG003|Overall Study|Lack of Efficacy|0|||
23619391|NCT00899379|65991541|FG004|Overall Study|Lack of Efficacy|1|||
23619392|NCT00899379|65991537|FG000|Overall Study|Lost to Follow-up|9|||
23619393|NCT00899379|65991538|FG001|Overall Study|Lost to Follow-up|3|||
23619394|NCT00899379|65991539|FG002|Overall Study|Lost to Follow-up|0|||
23619395|NCT00899379|65991540|FG003|Overall Study|Lost to Follow-up|6|||
23619396|NCT00899379|65991541|FG004|Overall Study|Lost to Follow-up|2|||
23619397|NCT00899379|65991537|FG000|Overall Study|Protocol Violation|0|||
23619398|NCT00899379|65991538|FG001|Overall Study|Protocol Violation|0|||
23619399|NCT00899379|65991539|FG002|Overall Study|Protocol Violation|1|||
23619400|NCT00899379|65991540|FG003|Overall Study|Protocol Violation|1|||
23619401|NCT00899379|65991541|FG004|Overall Study|Protocol Violation|0|||
23619402|NCT00899379|65991537|FG000|Overall Study|Withdrawal by Subject|2|||
23619403|NCT00899379|65991538|FG001|Overall Study|Withdrawal by Subject|4|||
23619404|NCT00899379|65991539|FG002|Overall Study|Withdrawal by Subject|2|||
23619405|NCT00899379|65991540|FG003|Overall Study|Withdrawal by Subject|3|||
23619406|NCT00899379|65991541|FG004|Overall Study|Withdrawal by Subject|6|||
23619407|NCT00899379|65991537|FG000|Overall Study|Pregnancy|0|||
23619408|NCT00899379|65991538|FG001|Overall Study|Pregnancy|0|||
23619409|NCT00899379|65991539|FG002|Overall Study|Pregnancy|1|||
23619410|NCT00899379|65991540|FG003|Overall Study|Pregnancy|0|||
23619411|NCT00899379|65991541|FG004|Overall Study|Pregnancy|1|||
23619412|NCT00899379|65991537|FG000|Overall Study|Patient Uncooperative|0|||
23619413|NCT00899379|65991538|FG001|Overall Study|Patient Uncooperative|1|||
23619414|NCT00899379|65991539|FG002|Overall Study|Patient Uncooperative|0|||
23619415|NCT00899379|65991540|FG003|Overall Study|Patient Uncooperative|1|||
23619416|NCT00899379|65991541|FG004|Overall Study|Patient Uncooperative|2|||
23619417|NCT00899379|65991537|FG000|Overall Study|Abnormal Baseline ECG|0|||
23619418|NCT00899379|65991538|FG001|Overall Study|Abnormal Baseline ECG|0|||
23619419|NCT00899379|65991539|FG002|Overall Study|Abnormal Baseline ECG|0|||
23619420|NCT00899379|65991540|FG003|Overall Study|Abnormal Baseline ECG|1|||
23619421|NCT00899379|65991541|FG004|Overall Study|Abnormal Baseline ECG|0|||
23619422|NCT00899379|65991537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619423|NCT00899379|65991538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619424|NCT00899379|65991539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619425|NCT00899379|65991540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23738536|NCT01552408|66421234|FG001|Overall Study|Lost to Follow-up|0|||
23427500|NCT01527383|65307700|FG001|Overall Study|Withdrawal by Subject|3|||
23427501|NCT01565564|65310487|FG000|Overall Study|Lost to Follow-up|5|||
23427502|NCT01565564|65310488|FG001|Overall Study|Lost to Follow-up|1|||
23427503|NCT02981524|65310489|FG000|Overall Study|Progressive Disease|14|||
23619426|NCT00899379|65991541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619427|NCT00899379|65991537|FG000|Overall Study|Not Completed/Entered Extn|5|||
23619428|NCT00899379|65991538|FG001|Overall Study|Not Completed/Entered Extn|1|||
23619429|NCT00899379|65991539|FG002|Overall Study|Not Completed/Entered Extn|6|||
23619430|NCT00899379|65991540|FG003|Overall Study|Not Completed/Entered Extn|4|||
23619431|NCT00899379|65991541|FG004|Overall Study|Not Completed/Entered Extn|3|||
23619432|NCT00899379|65991537|FG000|Overall Study|Study Terminated|3|||
23619433|NCT00899379|65991538|FG001|Overall Study|Study Terminated|0|||
23619434|NCT00899379|65991539|FG002|Overall Study|Study Terminated|3|||
23619435|NCT00899379|65991540|FG003|Overall Study|Study Terminated|3|||
23427504|NCT02981524|65310489|FG000|Overall Study|Death (unrelated)|1|||
23547500|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
23547501|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
23547502|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
23547503|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
23547504|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
23547505|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
23547506|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
23547507|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
23547508|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
23547509|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
23547510|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
23547511|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
23738537|NCT01552408|66421233|FG000|Overall Study|Relocation|0|||
23547512|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
23547513|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
23547514|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
23547515|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
23547516|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
23547517|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
23547518|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
23547519|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
23547520|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
23547521|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
23547522|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
23547523|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
23547524|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
23547525|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
23547526|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
23547527|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
23547528|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
23547529|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23547530|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23547531|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
23547532|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
23547533|NCT00116805|65735843|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
23547534|NCT00116805|65735844|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
23547535|NCT00116805|65735843|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
23547536|NCT00116805|65735844|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
23547537|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
23547538|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
23547539|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
23547540|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
23547541|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
23547542|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
23547543|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
23547544|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
23547545|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
23547546|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
23547547|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
23547548|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
23547549|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
23547550|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
23547551|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
23547552|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
23547553|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
23547554|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
23547555|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
23547556|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
23547557|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
23547558|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
23547559|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
23547560|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
23547561|NCT00116805|65735843|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
23547562|NCT00116805|65735844|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
23738538|NCT01552408|66421234|FG001|Overall Study|Relocation|1|||
23547563|NCT00116805|65735843|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
23547564|NCT00116805|65735844|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
23547565|NCT00116805|65735843|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
23547566|NCT00116805|65735844|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
23547567|NCT00116805|65735843|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
23547568|NCT00116805|65735844|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
23547569|NCT01302119|65735851|FG000|Overall Study|Withdrawal by Subject|30|||
23547570|NCT01302119|65735852|FG001|Overall Study|Withdrawal by Subject|20|||
23547571|NCT01302119|65735851|FG000|Overall Study|Lost to Follow-up|10|||
23547572|NCT01302119|65735852|FG001|Overall Study|Lost to Follow-up|4|||
23547573|NCT01302119|65735851|FG000|Overall Study|Adverse Event|2|||
23619436|NCT00899379|65991541|FG004|Overall Study|Study Terminated|1|||
23547574|NCT01302119|65735852|FG001|Overall Study|Adverse Event|1|||
23547575|NCT01302119|65735851|FG000|Overall Study|Non-compliance|4|||
23619437|NCT00899379|65991537|FG000|Overall Study|Lost to Follow-up|3|||
23619438|NCT00899379|65991538|FG001|Overall Study|Lost to Follow-up|1|||
23619439|NCT00899379|65991539|FG002|Overall Study|Lost to Follow-up|0|||
23619440|NCT00899379|65991540|FG003|Overall Study|Lost to Follow-up|2|||
23619441|NCT00899379|65991541|FG004|Overall Study|Lost to Follow-up|5|||
23619442|NCT00899379|65991537|FG000|Overall Study|Withdrawal by Subject|4|||
23619443|NCT00899379|65991538|FG001|Overall Study|Withdrawal by Subject|7|||
23619444|NCT00899379|65991539|FG002|Overall Study|Withdrawal by Subject|4|||
23619445|NCT00899379|65991540|FG003|Overall Study|Withdrawal by Subject|7|||
23619446|NCT00899379|65991541|FG004|Overall Study|Withdrawal by Subject|2|||
23619447|NCT00899379|65991537|FG000|Overall Study|Pregnancy|1|||
23619448|NCT00899379|65991538|FG001|Overall Study|Pregnancy|0|||
23619449|NCT00899379|65991539|FG002|Overall Study|Pregnancy|0|||
23619450|NCT00899379|65991540|FG003|Overall Study|Pregnancy|0|||
23619451|NCT00899379|65991541|FG004|Overall Study|Pregnancy|0|||
23619452|NCT00899379|65991537|FG000|Overall Study|Patient Uncooperative|0|||
23619453|NCT00899379|65991538|FG001|Overall Study|Patient Uncooperative|0|||
23619454|NCT00899379|65991539|FG002|Overall Study|Patient Uncooperative|0|||
23619455|NCT00899379|65991540|FG003|Overall Study|Patient Uncooperative|1|||
23619456|NCT00899379|65991541|FG004|Overall Study|Patient Uncooperative|0|||
23619457|NCT00899379|65991537|FG000|Overall Study|Abnormal Prestudy Labs|0|||
23619458|NCT00899379|65991538|FG001|Overall Study|Abnormal Prestudy Labs|0|||
23619459|NCT00899379|65991539|FG002|Overall Study|Abnormal Prestudy Labs|0|||
23619460|NCT00899379|65991540|FG003|Overall Study|Abnormal Prestudy Labs|0|||
23619461|NCT00899379|65991541|FG004|Overall Study|Abnormal Prestudy Labs|2|||
23619462|NCT00899379|65991537|FG000|Overall Study|Abnormal Baseline ECG|0|||
23619463|NCT00899379|65991538|FG001|Overall Study|Abnormal Baseline ECG|0|||
23619464|NCT00899379|65991539|FG002|Overall Study|Abnormal Baseline ECG|1|||
23619465|NCT00899379|65991540|FG003|Overall Study|Abnormal Baseline ECG|1|||
23619466|NCT00899379|65991541|FG004|Overall Study|Abnormal Baseline ECG|0|||
23619467|NCT00899379|65991537|FG000|Overall Study|No Attack Pretreatment|3|||
23619468|NCT00899379|65991538|FG001|Overall Study|No Attack Pretreatment|5|||
23619469|NCT00899379|65991539|FG002|Overall Study|No Attack Pretreatment|5|||
23619470|NCT00899379|65991540|FG003|Overall Study|No Attack Pretreatment|6|||
23619471|NCT00899379|65991541|FG004|Overall Study|No Attack Pretreatment|4|||
23619472|NCT00899379|65991537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619473|NCT00899379|65991538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619474|NCT00899379|65991539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619475|NCT00899379|65991540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619476|NCT00899379|65991541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619477|NCT00899379|65991537|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
23619478|NCT00899379|65991538|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
23619479|NCT00899379|65991539|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
23619480|NCT00899379|65991540|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
23619481|NCT00899379|65991541|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
23738539|NCT01552408|66421233|FG000|Overall Study|Withdrawal by Subject|2|||
23738540|NCT01552408|66421234|FG001|Overall Study|Withdrawal by Subject|1|||
23738541|NCT01049360|66421235|FG000|Period 1|Adverse Event|0|||
23738542|NCT01049360|66421236|FG001|Period 1|Adverse Event|1|||
23738543|NCT01049360|66421237|FG002|Period 1|Adverse Event|0|||
23738544|NCT01049360|66421238|FG003|Period 1|Adverse Event|1|||
23738545|NCT01049360|66421239|FG004|Period 1|Adverse Event|0|||
23738546|NCT01049360|66421240|FG005|Period 1|Adverse Event|0|||
23738547|NCT01049360|66421241|FG006|Period 1|Adverse Event|0|||
23738548|NCT01049360|66421242|FG007|Period 1|Adverse Event|1|||
23738549|NCT01049360|66421243|FG008|Period 1|Adverse Event|0|||
23738550|NCT01049360|66421244|FG009|Period 1|Adverse Event|0|||
23738551|NCT01049360|66421245|FG010|Period 1|Adverse Event|0|||
23738552|NCT01049360|66421246|FG011|Period 1|Adverse Event|0|||
23738553|NCT01049360|66421247|FG012|Period 1|Adverse Event|1|||
23738554|NCT01049360|66421248|FG013|Period 1|Adverse Event|1|||
23738555|NCT01049360|66421249|FG014|Period 1|Adverse Event|0|||
23738556|NCT01049360|66421250|FG015|Period 1|Adverse Event|0|||
23738557|NCT01049360|66421251|FG016|Period 1|Adverse Event|1|||
23738558|NCT01049360|66421252|FG017|Period 1|Adverse Event|0|||
23738559|NCT01049360|66421253|FG018|Period 1|Adverse Event|1|||
23738560|NCT01049360|66421254|FG019|Period 1|Adverse Event|0|||
23738561|NCT01049360|66421235|FG000|Period 1|Did not meet inc/exc criteria|0|||
23738562|NCT01049360|66421236|FG001|Period 1|Did not meet inc/exc criteria|0|||
23738563|NCT01049360|66421237|FG002|Period 1|Did not meet inc/exc criteria|0|||
23820376|NCT01661062|66721334|FG000|Overall Study|Completed Treatment Off Study|3|||
23820377|NCT01661062|66721334|FG000|Overall Study|Withdrawal by Subject|2|||
23820378|NCT03999749|66721335|FG000|Overall Study|Toxicity|16|||
23820379|NCT03999749|66721335|FG000|Overall Study|Withdrawal by Subject|3|||
23820380|NCT03999749|66721335|FG000|Overall Study|Disease progression|26|||
23820381|NCT03999749|66721335|FG000|Overall Study|Physician Decision|4|||
23820382|NCT03999749|66721335|FG000|Overall Study|Death|5|||
23820383|NCT03999749|66721335|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
23820384|NCT03136965|66721336|FG000|Overall Study|Lost to Follow-up|0|||
23820385|NCT03136965|66721337|FG001|Overall Study|Lost to Follow-up|1|||
23820386|NCT03136965|66721338|FG002|Overall Study|Lost to Follow-up|0|||
23547576|NCT01302119|65735852|FG001|Overall Study|Non-compliance|2|||
23547577|NCT01302119|65735851|FG000|Overall Study|Non-specific|4|||
23547578|NCT01302119|65735852|FG001|Overall Study|Non-specific|1|||
23547579|NCT04084314|65735853|FG000|Overall Study|Subject/guardian decision|91|||
23547580|NCT04084314|65735853|FG000|Overall Study|Adverse Event|24|||
23738564|NCT01049360|66421238|FG003|Period 1|Did not meet inc/exc criteria|0|||
23738565|NCT01049360|66421239|FG004|Period 1|Did not meet inc/exc criteria|0|||
23738566|NCT01049360|66421240|FG005|Period 1|Did not meet inc/exc criteria|0|||
23738567|NCT01049360|66421241|FG006|Period 1|Did not meet inc/exc criteria|0|||
23738568|NCT01049360|66421242|FG007|Period 1|Did not meet inc/exc criteria|1|||
23738569|NCT01049360|66421243|FG008|Period 1|Did not meet inc/exc criteria|1|||
23738570|NCT01049360|66421244|FG009|Period 1|Did not meet inc/exc criteria|0|||
23738571|NCT01049360|66421245|FG010|Period 1|Did not meet inc/exc criteria|0|||
23738572|NCT01049360|66421246|FG011|Period 1|Did not meet inc/exc criteria|0|||
23738573|NCT01049360|66421247|FG012|Period 1|Did not meet inc/exc criteria|0|||
23738574|NCT01049360|66421248|FG013|Period 1|Did not meet inc/exc criteria|0|||
23738575|NCT01049360|66421249|FG014|Period 1|Did not meet inc/exc criteria|0|||
23738576|NCT01049360|66421250|FG015|Period 1|Did not meet inc/exc criteria|0|||
23738577|NCT01049360|66421251|FG016|Period 1|Did not meet inc/exc criteria|0|||
23738578|NCT01049360|66421252|FG017|Period 1|Did not meet inc/exc criteria|0|||
23738579|NCT01049360|66421253|FG018|Period 1|Did not meet inc/exc criteria|0|||
23738580|NCT01049360|66421254|FG019|Period 1|Did not meet inc/exc criteria|0|||
23738581|NCT01049360|66421235|FG000|Period 1|Withdrawal by Subject|0|||
23738582|NCT01049360|66421236|FG001|Period 1|Withdrawal by Subject|0|||
23738583|NCT01049360|66421237|FG002|Period 1|Withdrawal by Subject|0|||
23738584|NCT01049360|66421238|FG003|Period 1|Withdrawal by Subject|0|||
23547581|NCT04084314|65735853|FG000|Overall Study|Lost to Follow-up|19|||
23547582|NCT04084314|65735853|FG000|Overall Study|New therapy for study indication|9|||
23547583|NCT04084314|65735853|FG000|Overall Study|Pregnancy|9|||
23547584|NCT04084314|65735853|FG000|Overall Study|Withdrawal of informed consent|8|||
23547585|NCT04084314|65735853|FG000|Overall Study|Physician Decision|4|||
23547586|NCT04084314|65735853|FG000|Overall Study|Protocol Deviation|3|||
23547587|NCT03521635|65735854|FG000|Overall Study|Adverse Event|1|||
23547588|NCT03521635|65735855|FG001|Overall Study|Adverse Event|1|||
23547589|NCT03521635|65735854|FG000|Overall Study|Refused to complete study visit|1|||
23547590|NCT03521635|65735855|FG001|Overall Study|Refused to complete study visit|0|||
23547591|NCT03521635|65735854|FG000|Overall Study|Refused to continue trial medication|2|||
23547592|NCT03521635|65735855|FG001|Overall Study|Refused to continue trial medication|2|||
23547593|NCT03521635|65735854|FG000|Overall Study|Lost to Follow-up|0|||
23547594|NCT03521635|65735855|FG001|Overall Study|Lost to Follow-up|1|||
23738585|NCT01049360|66421239|FG004|Period 1|Withdrawal by Subject|0|||
23820387|NCT00534404|66721339|FG000|Overall Study|Death|0|||
23820388|NCT00534404|66721340|FG001|Overall Study|Death|0|||
23820389|NCT00534404|66721341|FG002|Overall Study|Death|2|||
23820390|NCT00534404|66721339|FG000|Overall Study|Withdrawal by Subject|8|||
23547595|NCT03521635|65735854|FG000|Overall Study|Meet exclusion criteria|0|||
23547596|NCT03521635|65735855|FG001|Overall Study|Meet exclusion criteria|1|||
23738586|NCT01049360|66421240|FG005|Period 1|Withdrawal by Subject|0|||
23738587|NCT01049360|66421241|FG006|Period 1|Withdrawal by Subject|0|||
23738588|NCT01049360|66421242|FG007|Period 1|Withdrawal by Subject|0|||
23738589|NCT01049360|66421243|FG008|Period 1|Withdrawal by Subject|1|||
23738590|NCT01049360|66421244|FG009|Period 1|Withdrawal by Subject|0|||
23738591|NCT01049360|66421245|FG010|Period 1|Withdrawal by Subject|1|||
23820391|NCT00534404|66721340|FG001|Overall Study|Withdrawal by Subject|2|||
23547597|NCT03521635|65735854|FG000|Overall Study|Patient not taken study medicine|0|||
23619482|NCT03226353|65991547|FG000|Overall Study|Withdrawal by Subject|1|||
23619483|NCT03226353|65991547|FG000|Overall Study|Screen Failure|5|||
23738592|NCT01049360|66421246|FG011|Period 1|Withdrawal by Subject|0|||
23738593|NCT01049360|66421247|FG012|Period 1|Withdrawal by Subject|1|||
23738594|NCT01049360|66421248|FG013|Period 1|Withdrawal by Subject|0|||
23820392|NCT00534404|66721341|FG002|Overall Study|Withdrawal by Subject|38|||
23738595|NCT01049360|66421249|FG014|Period 1|Withdrawal by Subject|0|||
23738596|NCT01049360|66421250|FG015|Period 1|Withdrawal by Subject|0|||
23738597|NCT01049360|66421251|FG016|Period 1|Withdrawal by Subject|0|||
23738598|NCT01049360|66421252|FG017|Period 1|Withdrawal by Subject|0|||
23738599|NCT01049360|66421253|FG018|Period 1|Withdrawal by Subject|0|||
23738600|NCT01049360|66421254|FG019|Period 1|Withdrawal by Subject|0|||
23738601|NCT01049360|66421235|FG000|Period 2|Protocol Violation|0|||
23738602|NCT01049360|66421236|FG001|Period 2|Protocol Violation|0|||
23738603|NCT01049360|66421237|FG002|Period 2|Protocol Violation|0|||
23738604|NCT01049360|66421238|FG003|Period 2|Protocol Violation|1|||
23738605|NCT01049360|66421239|FG004|Period 2|Protocol Violation|0|||
23738606|NCT01049360|66421240|FG005|Period 2|Protocol Violation|0|||
23738607|NCT01049360|66421241|FG006|Period 2|Protocol Violation|0|||
23738608|NCT01049360|66421242|FG007|Period 2|Protocol Violation|0|||
23738609|NCT01049360|66421243|FG008|Period 2|Protocol Violation|0|||
23738610|NCT01049360|66421244|FG009|Period 2|Protocol Violation|0|||
23738611|NCT01049360|66421245|FG010|Period 2|Protocol Violation|0|||
23738612|NCT01049360|66421246|FG011|Period 2|Protocol Violation|0|||
23738613|NCT01049360|66421247|FG012|Period 2|Protocol Violation|0|||
23738614|NCT01049360|66421248|FG013|Period 2|Protocol Violation|0|||
23738615|NCT01049360|66421249|FG014|Period 2|Protocol Violation|1|||
23547598|NCT03521635|65735855|FG001|Overall Study|Patient not taken study medicine|1|||
23547599|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
23547600|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
23547601|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
23547602|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
23547603|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
23547604|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
23547605|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
23547606|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
23547607|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
23547608|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
23547609|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
23547610|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
23547611|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
23547612|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
23547613|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
23547614|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
23547615|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
23547616|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
23547617|NCT00492284|65735864|FG000|Overall Study|Adverse Event|0|||
23547618|NCT00492284|65735865|FG001|Overall Study|Adverse Event|1|||
23547619|NCT00492284|65735866|FG002|Overall Study|Adverse Event|1|||
23547620|NCT00492284|65735867|FG003|Overall Study|Adverse Event|2|||
23547621|NCT00492284|65735864|FG000|Overall Study|Lost to Follow-up|0|||
23547622|NCT00492284|65735865|FG001|Overall Study|Lost to Follow-up|0|||
23547623|NCT00492284|65735866|FG002|Overall Study|Lost to Follow-up|3|||
23547624|NCT00492284|65735867|FG003|Overall Study|Lost to Follow-up|1|||
23547625|NCT00492284|65735864|FG000|Overall Study|Death|0|||
23547626|NCT00492284|65735865|FG001|Overall Study|Death|3|||
23547627|NCT00492284|65735866|FG002|Overall Study|Death|2|||
23547628|NCT00492284|65735867|FG003|Overall Study|Death|5|||
23547629|NCT00492284|65735864|FG000|Overall Study|Withdrawal by Subject|1|||
23547630|NCT00492284|65735865|FG001|Overall Study|Withdrawal by Subject|0|||
23547631|NCT00492284|65735866|FG002|Overall Study|Withdrawal by Subject|0|||
23547632|NCT00492284|65735867|FG003|Overall Study|Withdrawal by Subject|2|||
23547633|NCT02097472|65735872|FG000|Received Vaccination 2|Adverse Event|0|||
23547634|NCT02097472|65735873|FG001|Received Vaccination 2|Adverse Event|0|||
23547635|NCT02097472|65735874|FG002|Received Vaccination 2|Adverse Event|0|||
23547636|NCT02097472|65735875|FG003|Received Vaccination 2|Adverse Event|0|||
23547637|NCT02097472|65735876|FG004|Received Vaccination 2|Adverse Event|0|||
23547638|NCT02097472|65735877|FG005|Received Vaccination 2|Adverse Event|0|||
23547639|NCT02097472|65735878|FG006|Received Vaccination 2|Adverse Event|1|||
23738616|NCT01049360|66421250|FG015|Period 2|Protocol Violation|1|||
23820393|NCT00534404|66721339|FG000|Overall Study|Removed by study staff|2|||
23738617|NCT01049360|66421251|FG016|Period 2|Protocol Violation|0|||
23738618|NCT01049360|66421252|FG017|Period 2|Protocol Violation|0|||
23738619|NCT01049360|66421253|FG018|Period 2|Protocol Violation|0|||
23738620|NCT01049360|66421254|FG019|Period 2|Protocol Violation|0|||
23738621|NCT01049360|66421235|FG000|Period 2|Adverse Event|0|||
23738622|NCT01049360|66421236|FG001|Period 2|Adverse Event|1|||
23738623|NCT01049360|66421237|FG002|Period 2|Adverse Event|0|||
23738624|NCT01049360|66421238|FG003|Period 2|Adverse Event|0|||
23820394|NCT00534404|66721340|FG001|Overall Study|Removed by study staff|3|||
23547640|NCT02097472|65735879|FG007|Received Vaccination 2|Adverse Event|0|||
23738625|NCT01049360|66421239|FG004|Period 2|Adverse Event|0|||
23738626|NCT01049360|66421240|FG005|Period 2|Adverse Event|0|||
23738627|NCT01049360|66421241|FG006|Period 2|Adverse Event|0|||
23738628|NCT01049360|66421242|FG007|Period 2|Adverse Event|0|||
23738629|NCT01049360|66421243|FG008|Period 2|Adverse Event|1|||
23738630|NCT01049360|66421244|FG009|Period 2|Adverse Event|0|||
23738631|NCT01049360|66421245|FG010|Period 2|Adverse Event|0|||
23738632|NCT01049360|66421246|FG011|Period 2|Adverse Event|0|||
23738633|NCT01049360|66421247|FG012|Period 2|Adverse Event|0|||
23738634|NCT01049360|66421248|FG013|Period 2|Adverse Event|0|||
23738635|NCT01049360|66421249|FG014|Period 2|Adverse Event|0|||
23738636|NCT01049360|66421250|FG015|Period 2|Adverse Event|0|||
23738637|NCT01049360|66421251|FG016|Period 2|Adverse Event|0|||
23738638|NCT01049360|66421252|FG017|Period 2|Adverse Event|0|||
23738639|NCT01049360|66421253|FG018|Period 2|Adverse Event|0|||
23738640|NCT01049360|66421254|FG019|Period 2|Adverse Event|1|||
23738641|NCT01049360|66421235|FG000|Period 2|Withdrawal by Subject|0|||
23738642|NCT01049360|66421236|FG001|Period 2|Withdrawal by Subject|0|||
23738643|NCT01049360|66421237|FG002|Period 2|Withdrawal by Subject|0|||
23738644|NCT01049360|66421238|FG003|Period 2|Withdrawal by Subject|1|||
23738645|NCT01049360|66421239|FG004|Period 2|Withdrawal by Subject|0|||
23547641|NCT03707977|65735880|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
23547642|NCT03707977|65735881|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
23738646|NCT01049360|66421240|FG005|Period 2|Withdrawal by Subject|0|||
23738647|NCT01049360|66421241|FG006|Period 2|Withdrawal by Subject|0|||
23738648|NCT01049360|66421242|FG007|Period 2|Withdrawal by Subject|0|||
23738649|NCT01049360|66421243|FG008|Period 2|Withdrawal by Subject|0|||
23738650|NCT01049360|66421244|FG009|Period 2|Withdrawal by Subject|0|||
23738651|NCT01049360|66421245|FG010|Period 2|Withdrawal by Subject|0|||
23738652|NCT01049360|66421246|FG011|Period 2|Withdrawal by Subject|0|||
23738653|NCT01049360|66421247|FG012|Period 2|Withdrawal by Subject|0|||
23738654|NCT01049360|66421248|FG013|Period 2|Withdrawal by Subject|0|||
23738655|NCT01049360|66421249|FG014|Period 2|Withdrawal by Subject|1|||
23738656|NCT01049360|66421250|FG015|Period 2|Withdrawal by Subject|0|||
23738657|NCT01049360|66421251|FG016|Period 2|Withdrawal by Subject|0|||
23738658|NCT01049360|66421252|FG017|Period 2|Withdrawal by Subject|0|||
23738659|NCT01049360|66421253|FG018|Period 2|Withdrawal by Subject|0|||
23738660|NCT01049360|66421254|FG019|Period 2|Withdrawal by Subject|1|||
23738661|NCT01049360|66421235|FG000|Period 2|Lack of Efficacy|0|||
23738662|NCT01049360|66421236|FG001|Period 2|Lack of Efficacy|0|||
23738663|NCT01049360|66421237|FG002|Period 2|Lack of Efficacy|0|||
23738664|NCT01049360|66421238|FG003|Period 2|Lack of Efficacy|0|||
23738665|NCT01049360|66421239|FG004|Period 2|Lack of Efficacy|0|||
23738666|NCT01049360|66421240|FG005|Period 2|Lack of Efficacy|1|||
23738667|NCT01049360|66421241|FG006|Period 2|Lack of Efficacy|0|||
23738668|NCT01049360|66421242|FG007|Period 2|Lack of Efficacy|0|||
23738669|NCT01049360|66421243|FG008|Period 2|Lack of Efficacy|0|||
23738670|NCT01049360|66421244|FG009|Period 2|Lack of Efficacy|0|||
23738671|NCT01049360|66421245|FG010|Period 2|Lack of Efficacy|0|||
23738672|NCT01049360|66421246|FG011|Period 2|Lack of Efficacy|0|||
23738673|NCT01049360|66421247|FG012|Period 2|Lack of Efficacy|0|||
23738674|NCT01049360|66421248|FG013|Period 2|Lack of Efficacy|0|||
23738675|NCT01049360|66421249|FG014|Period 2|Lack of Efficacy|0|||
23738676|NCT01049360|66421250|FG015|Period 2|Lack of Efficacy|0|||
23738677|NCT01049360|66421251|FG016|Period 2|Lack of Efficacy|0|||
23738678|NCT01049360|66421252|FG017|Period 2|Lack of Efficacy|0|||
23738679|NCT01049360|66421253|FG018|Period 2|Lack of Efficacy|0|||
23820395|NCT00534404|66721341|FG002|Overall Study|Removed by study staff|1|||
23820396|NCT00534404|66721339|FG000|Overall Study|Lost to Follow-up|170|||
23820397|NCT00534404|66721340|FG001|Overall Study|Lost to Follow-up|138|||
23820398|NCT00534404|66721341|FG002|Overall Study|Lost to Follow-up|201|||
23738680|NCT01049360|66421254|FG019|Period 2|Lack of Efficacy|0|||
23738681|NCT01049360|66421235|FG000|Period 4|Protocol Violation|0|||
23738682|NCT01049360|66421236|FG001|Period 4|Protocol Violation|0|||
23738683|NCT01049360|66421237|FG002|Period 4|Protocol Violation|0|||
23738684|NCT01049360|66421238|FG003|Period 4|Protocol Violation|0|||
23738685|NCT01049360|66421239|FG004|Period 4|Protocol Violation|0|||
23738686|NCT01049360|66421240|FG005|Period 4|Protocol Violation|0|||
23738687|NCT01049360|66421241|FG006|Period 4|Protocol Violation|0|||
23738688|NCT01049360|66421242|FG007|Period 4|Protocol Violation|0|||
23738689|NCT01049360|66421243|FG008|Period 4|Protocol Violation|0|||
23738690|NCT01049360|66421244|FG009|Period 4|Protocol Violation|0|||
23738691|NCT01049360|66421245|FG010|Period 4|Protocol Violation|0|||
23738692|NCT01049360|66421246|FG011|Period 4|Protocol Violation|0|||
23738693|NCT01049360|66421247|FG012|Period 4|Protocol Violation|0|||
23738694|NCT01049360|66421248|FG013|Period 4|Protocol Violation|0|||
23738695|NCT01049360|66421249|FG014|Period 4|Protocol Violation|0|||
23820399|NCT03645863|66721342|FG000|Overall Study|Withdrawal by Subject|1|||
23820400|NCT03645863|66721343|FG001|Overall Study|Withdrawal by Subject|0|||
23738696|NCT01049360|66421250|FG015|Period 4|Protocol Violation|0|||
23738697|NCT01049360|66421251|FG016|Period 4|Protocol Violation|0|||
23738698|NCT01049360|66421252|FG017|Period 4|Protocol Violation|1|||
23738699|NCT01049360|66421253|FG018|Period 4|Protocol Violation|0|||
23738700|NCT01049360|66421254|FG019|Period 4|Protocol Violation|0|||
23820401|NCT03645863|66721344|FG002|Overall Study|Withdrawal by Subject|0|||
23738701|NCT01049360|66421235|FG000|Period 4|Withdrawal by Subject|0|||
23738702|NCT01049360|66421236|FG001|Period 4|Withdrawal by Subject|0|||
23738703|NCT01049360|66421237|FG002|Period 4|Withdrawal by Subject|0|||
23738704|NCT01049360|66421238|FG003|Period 4|Withdrawal by Subject|1|||
23738705|NCT01049360|66421239|FG004|Period 4|Withdrawal by Subject|0|||
23738706|NCT01049360|66421240|FG005|Period 4|Withdrawal by Subject|0|||
23738707|NCT01049360|66421241|FG006|Period 4|Withdrawal by Subject|0|||
23738708|NCT01049360|66421242|FG007|Period 4|Withdrawal by Subject|0|||
23820402|NCT02017015|66721345|FG000|Overall Study|Adverse Event|9|||
23820403|NCT02017015|66721345|FG000|Overall Study|Withdrawal by Subject|21|||
23820404|NCT02017015|66721345|FG000|Overall Study|Death|4|||
23820405|NCT02017015|66721345|FG000|Overall Study|Progressive Disease|31|||
23820406|NCT02017015|66721345|FG000|Overall Study|Non-compliance with study drug|2|||
23820407|NCT02017015|66721345|FG000|Overall Study|Physician Decision|2|||
23820408|NCT02960490|66721346|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
23820409|NCT02960490|66721347|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
23820410|NCT02960490|66721348|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23820411|NCT02960490|66721349|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23619484|NCT02391545|65991551|FG000|Overall Study|Death|0|||
23738709|NCT01049360|66421243|FG008|Period 4|Withdrawal by Subject|0|||
23738710|NCT01049360|66421244|FG009|Period 4|Withdrawal by Subject|0|||
23738711|NCT01049360|66421245|FG010|Period 4|Withdrawal by Subject|0|||
23738712|NCT01049360|66421246|FG011|Period 4|Withdrawal by Subject|0|||
23738713|NCT01049360|66421247|FG012|Period 4|Withdrawal by Subject|0|||
23738714|NCT01049360|66421248|FG013|Period 4|Withdrawal by Subject|0|||
23738715|NCT01049360|66421249|FG014|Period 4|Withdrawal by Subject|0|||
23738716|NCT01049360|66421250|FG015|Period 4|Withdrawal by Subject|0|||
23738717|NCT01049360|66421251|FG016|Period 4|Withdrawal by Subject|0|||
23738718|NCT01049360|66421252|FG017|Period 4|Withdrawal by Subject|0|||
23738719|NCT01049360|66421253|FG018|Period 4|Withdrawal by Subject|0|||
23738720|NCT01049360|66421254|FG019|Period 4|Withdrawal by Subject|0|||
23738721|NCT04369742|66421261|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
23738722|NCT04369742|66421262|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
23738723|NCT04369742|66421261|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
23738724|NCT04369742|66421262|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
23738725|NCT00686894|66421267|FG000|Overall Study|Relapse|2|||
23738726|NCT00686894|66421267|FG000|Overall Study|Protocol Violation|4|||
23738727|NCT00732199|66421268|FG000|Overall Study|Withdrawal by Subject|25|||
23738728|NCT00732199|66421269|FG001|Overall Study|Withdrawal by Subject|18|||
23738729|NCT00732199|66421268|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
23738730|NCT00732199|66421269|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
23738731|NCT01684930|66421272|FG000|Overall Study|Withdrawal by Subject|3|||
23738732|NCT01684930|66421273|FG001|Overall Study|Withdrawal by Subject|1|||
23738733|NCT02718131|66421275|FG000|Overall Study|Withdrawal by Subject|1|||
23738734|NCT02718131|66421276|FG001|Overall Study|Withdrawal by Subject|0|||
23738735|NCT02718131|66421275|FG000|Overall Study|Adverse Event|1|||
23738736|NCT02718131|66421276|FG001|Overall Study|Adverse Event|0|||
23738737|NCT02718131|66421275|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
23738738|NCT02718131|66421276|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
23738739|NCT04794491|66421277|FG000|Overall Study|Adverse Event|1|||
23738740|NCT04794491|66421277|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
23738741|NCT04794491|66421277|FG000|Overall Study|Noncompliance With Study Intervention|1|||
23738742|NCT04794491|66421277|FG000|Overall Study|Withdrawal by Subject|2|||
23738743|NCT00724243|66421278|FG000|Overall Study|Lack of Efficacy|10|||
23738744|NCT00724243|66421278|FG000|Overall Study|Adverse Event|5|||
23738745|NCT00795717|66421279|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
23738746|NCT00795717|66421280|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
23738747|NCT00795717|66421279|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
23738748|NCT00795717|66421280|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
23738749|NCT00795717|66421279|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
23738750|NCT00795717|66421280|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
23738751|NCT00795717|66421279|FG000|Phase II|too busy|0|||
23738752|NCT00795717|66421280|FG001|Phase II|too busy|1|||
23738753|NCT03525613|66421281|FG000|Overall Study|Adverse Event|11|||
23738754|NCT03525613|66421282|FG001|Overall Study|Adverse Event|8|||
23738755|NCT03525613|66421283|FG002|Overall Study|Adverse Event|3|||
23738756|NCT03525613|66421284|FG003|Overall Study|Adverse Event|3|||
23738757|NCT03525613|66421281|FG000|Overall Study|Lost to Follow-up|4|||
23820412|NCT02960490|66721350|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23820413|NCT02960490|66721351|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23820414|NCT02960490|66721352|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23738758|NCT03525613|66421282|FG001|Overall Study|Lost to Follow-up|5|||
23738759|NCT03525613|66421283|FG002|Overall Study|Lost to Follow-up|3|||
23738760|NCT03525613|66421284|FG003|Overall Study|Lost to Follow-up|2|||
23738761|NCT03525613|66421281|FG000|Overall Study|Physician Decision|0|||
23738762|NCT03525613|66421282|FG001|Overall Study|Physician Decision|1|||
23738763|NCT03525613|66421283|FG002|Overall Study|Physician Decision|0|||
23738764|NCT03525613|66421284|FG003|Overall Study|Physician Decision|1|||
23738765|NCT03525613|66421281|FG000|Overall Study|Consent Withdrawal|25|||
23738766|NCT03525613|66421282|FG001|Overall Study|Consent Withdrawal|16|||
23738767|NCT03525613|66421283|FG002|Overall Study|Consent Withdrawal|12|||
23738768|NCT03525613|66421284|FG003|Overall Study|Consent Withdrawal|9|||
23738769|NCT03525613|66421281|FG000|Overall Study|Death|20|||
23738770|NCT03525613|66421282|FG001|Overall Study|Death|9|||
23738771|NCT03525613|66421283|FG002|Overall Study|Death|7|||
23738772|NCT03525613|66421284|FG003|Overall Study|Death|1|||
23738773|NCT03525613|66421281|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
23738774|NCT03525613|66421282|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
23619485|NCT02391545|65991552|FG001|Overall Study|Death|2|||
23547643|NCT03707977|65735882|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
23547644|NCT03707977|65735880|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
23547645|NCT03707977|65735881|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
23547646|NCT03707977|65735882|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
23547647|NCT04969250|65735884|FG000|Overall Study|Protocol Violation|0|||
23547648|NCT04969250|65735885|FG001|Overall Study|Protocol Violation|2|||
23547649|NCT04969250|65735886|FG002|Overall Study|Protocol Violation|3|||
23547650|NCT04969250|65735887|FG003|Overall Study|Protocol Violation|8|||
23547651|NCT04969250|65735884|FG000|Overall Study|Withdrawal by Subject|0|||
23547652|NCT04969250|65735885|FG001|Overall Study|Withdrawal by Subject|1|||
23547653|NCT04969250|65735886|FG002|Overall Study|Withdrawal by Subject|0|||
23547654|NCT04969250|65735887|FG003|Overall Study|Withdrawal by Subject|0|||
23547655|NCT03434119|65735888|FG000|Overall Study|Randomized but not treated|1|||
23547656|NCT03434119|65735889|FG001|Overall Study|Randomized but not treated|0|||
23619486|NCT02391545|65991551|FG000|Overall Study|Lost to Follow-up|0|||
23619487|NCT02391545|65991552|FG001|Overall Study|Lost to Follow-up|1|||
23619488|NCT02391545|65991551|FG000|Overall Study|Termination of study by sponsor|20|||
23619489|NCT02391545|65991552|FG001|Overall Study|Termination of study by sponsor|20|||
23619490|NCT02391545|65991551|FG000|Overall Study|Withdrawal by Subject|0|||
23619491|NCT02391545|65991552|FG001|Overall Study|Withdrawal by Subject|1|||
23619492|NCT02391545|65991551|FG000|Overall Study|Other Reasons|6|||
23619493|NCT02391545|65991552|FG001|Overall Study|Other Reasons|4|||
23619494|NCT03461211|65991553|FG000|Overall Study|Adverse Event|1|||
23619495|NCT03461211|65991554|FG001|Overall Study|Adverse Event|1|||
23619496|NCT03461211|65991553|FG000|Overall Study|Lack of Efficacy|0|||
23619497|NCT03461211|65991554|FG001|Overall Study|Lack of Efficacy|1|||
23619498|NCT02573883|65991555|FG000|Six Month Follow Up|Lost to Follow-up|1|||
23619499|NCT02573883|65991556|FG001|Six Month Follow Up|Lost to Follow-up|0|||
23619500|NCT02573883|65991557|FG002|Six Month Follow Up|Lost to Follow-up|0|||
23619501|NCT02573883|65991558|FG003|Six Month Follow Up|Lost to Follow-up|0|||
23619502|NCT02573883|65991555|FG000|One Year Follow Up|Lost to Follow-up|2|||
23619503|NCT02573883|65991556|FG001|One Year Follow Up|Lost to Follow-up|1|||
23619504|NCT02573883|65991557|FG002|One Year Follow Up|Lost to Follow-up|0|||
23619505|NCT02573883|65991558|FG003|One Year Follow Up|Lost to Follow-up|0|||
23619506|NCT04414397|65991561|FG000|Control Period|Withdrawal by Subject|2|||
23619507|NCT04414397|65991562|FG001|Control Period|Withdrawal by Subject|2|||
23619508|NCT04414397|65991561|FG000|Control Period|Lost to Follow-up|0|||
23738775|NCT03525613|66421283|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
23738776|NCT03525613|66421284|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
23738777|NCT03907072|66421290|FG000|Overall Study|Study Terminated by Sponsor|2|||
23738778|NCT03907072|66421291|FG001|Overall Study|Study Terminated by Sponsor|2|||
23738779|NCT03907072|66421292|FG002|Overall Study|Study Terminated by Sponsor|2|||
23738780|NCT00141297|66421293|FG000|Overall Study|Adverse Event|0|||
23738781|NCT00141297|66421294|FG001|Overall Study|Adverse Event|0|||
23738782|NCT00141297|66421295|FG002|Overall Study|Adverse Event|1|||
23738783|NCT00141297|66421296|FG003|Overall Study|Adverse Event|0|||
23738784|NCT00141297|66421297|FG004|Overall Study|Adverse Event|1|||
23738785|NCT00141297|66421298|FG005|Overall Study|Adverse Event|1|||
23547657|NCT03434119|65735888|FG000|Overall Study|Adverse Event|1|||
23619509|NCT04414397|65991562|FG001|Control Period|Lost to Follow-up|4|||
23619510|NCT04414397|65991561|FG000|Control Period|Protocol deviation|0|||
23738786|NCT00141297|66421299|FG006|Overall Study|Adverse Event|0|||
23738787|NCT00141297|66421300|FG007|Overall Study|Adverse Event|1|||
23619511|NCT04414397|65991562|FG001|Control Period|Protocol deviation|1|||
23547658|NCT03434119|65735889|FG001|Overall Study|Adverse Event|0|||
23619512|NCT04414397|65991561|FG000|Post-Control Period|Withdrawal by Subject|3|||
23619513|NCT04414397|65991562|FG001|Post-Control Period|Withdrawal by Subject|6|||
23738788|NCT00141297|66421301|FG008|Overall Study|Adverse Event|1|||
23738789|NCT00141297|66421302|FG009|Overall Study|Adverse Event|0|||
23738790|NCT00141297|66421293|FG000|Overall Study|Death|1|||
23738791|NCT00141297|66421294|FG001|Overall Study|Death|0|||
23738792|NCT00141297|66421295|FG002|Overall Study|Death|0|||
23738793|NCT00141297|66421296|FG003|Overall Study|Death|0|||
23738794|NCT00141297|66421297|FG004|Overall Study|Death|0|||
23738795|NCT00141297|66421298|FG005|Overall Study|Death|0|||
23738796|NCT00141297|66421299|FG006|Overall Study|Death|0|||
23738797|NCT00141297|66421300|FG007|Overall Study|Death|0|||
23738798|NCT00141297|66421301|FG008|Overall Study|Death|1|||
23738799|NCT00141297|66421302|FG009|Overall Study|Death|0|||
23738800|NCT00141297|66421293|FG000|Overall Study|Withdrawal by Subject|0|||
23738801|NCT00141297|66421294|FG001|Overall Study|Withdrawal by Subject|0|||
23738802|NCT00141297|66421295|FG002|Overall Study|Withdrawal by Subject|0|||
23738803|NCT00141297|66421296|FG003|Overall Study|Withdrawal by Subject|0|||
23738804|NCT00141297|66421297|FG004|Overall Study|Withdrawal by Subject|0|||
23738805|NCT00141297|66421298|FG005|Overall Study|Withdrawal by Subject|0|||
23738806|NCT00141297|66421299|FG006|Overall Study|Withdrawal by Subject|0|||
23738807|NCT00141297|66421300|FG007|Overall Study|Withdrawal by Subject|0|||
23738808|NCT00141297|66421301|FG008|Overall Study|Withdrawal by Subject|1|||
23738809|NCT00141297|66421302|FG009|Overall Study|Withdrawal by Subject|0|||
23738810|NCT00141297|66421293|FG000|Overall Study|Other|0|||
23738811|NCT00141297|66421294|FG001|Overall Study|Other|0|||
23738812|NCT00141297|66421295|FG002|Overall Study|Other|0|||
23547659|NCT03434119|65735888|FG000|Overall Study|Poor Compliance to Protocol|0|||
23547660|NCT03434119|65735889|FG001|Overall Study|Poor Compliance to Protocol|1|||
23547661|NCT03434119|65735888|FG000|Overall Study|Study Terminated by Sponsor|91|||
23547662|NCT03434119|65735889|FG001|Overall Study|Study Terminated by Sponsor|102|||
23547663|NCT03434119|65735888|FG000|Overall Study|Withdrawal by Subject|7|||
23547664|NCT03434119|65735889|FG001|Overall Study|Withdrawal by Subject|5|||
23738813|NCT00141297|66421296|FG003|Overall Study|Other|1|||
23738814|NCT00141297|66421297|FG004|Overall Study|Other|5|||
23738815|NCT00141297|66421298|FG005|Overall Study|Other|0|||
23738816|NCT00141297|66421299|FG006|Overall Study|Other|0|||
23738817|NCT00141297|66421300|FG007|Overall Study|Other|0|||
23738818|NCT00141297|66421301|FG008|Overall Study|Other|2|||
23738819|NCT00141297|66421302|FG009|Overall Study|Other|0|||
23738820|NCT00141297|66421293|FG000|Overall Study|Progressive Disease|2|||
23738821|NCT00141297|66421294|FG001|Overall Study|Progressive Disease|3|||
23738822|NCT00141297|66421295|FG002|Overall Study|Progressive Disease|6|||
23738823|NCT00141297|66421296|FG003|Overall Study|Progressive Disease|2|||
23738824|NCT00141297|66421297|FG004|Overall Study|Progressive Disease|15|||
23738825|NCT00141297|66421298|FG005|Overall Study|Progressive Disease|2|||
23738826|NCT00141297|66421299|FG006|Overall Study|Progressive Disease|3|||
23738827|NCT00141297|66421300|FG007|Overall Study|Progressive Disease|3|||
23738828|NCT00141297|66421301|FG008|Overall Study|Progressive Disease|15|||
23738829|NCT00141297|66421302|FG009|Overall Study|Progressive Disease|6|||
23738830|NCT00141297|66421293|FG000|Overall Study|Transitioned|0|||
23738831|NCT00141297|66421294|FG001|Overall Study|Transitioned|0|||
23738832|NCT00141297|66421295|FG002|Overall Study|Transitioned|0|||
23738833|NCT00141297|66421296|FG003|Overall Study|Transitioned|0|||
23738834|NCT00141297|66421297|FG004|Overall Study|Transitioned|1|||
23738835|NCT00141297|66421298|FG005|Overall Study|Transitioned|0|||
23738836|NCT00141297|66421299|FG006|Overall Study|Transitioned|0|||
23738837|NCT00141297|66421300|FG007|Overall Study|Transitioned|0|||
23547665|NCT03434119|65735888|FG000|Overall Study|Other than specified|7|||
23547666|NCT03434119|65735889|FG001|Overall Study|Other than specified|5|||
23619514|NCT04414397|65991561|FG000|Post-Control Period|Lost to Follow-up|4|||
23619515|NCT04414397|65991562|FG001|Post-Control Period|Lost to Follow-up|9|||
23738838|NCT00141297|66421301|FG008|Overall Study|Transitioned|0|||
23738839|NCT00141297|66421302|FG009|Overall Study|Transitioned|0|||
23738840|NCT02610231|66421314|FG000|Overall Study|Withdrawal by Subject|27|||
23738841|NCT02610231|66421314|FG000|Overall Study|Adverse Event|20|||
23738842|NCT02610231|66421314|FG000|Overall Study|Death|5|||
23738843|NCT02610231|66421314|FG000|Overall Study|Surgery|2|||
23738844|NCT02610231|66421314|FG000|Overall Study|Physician Decision|1|||
23738845|NCT02610231|66421314|FG000|Overall Study|Non Compliance|2|||
23738846|NCT02610231|66421314|FG000|Overall Study|Other|3|||
23738847|NCT02505945|66421315|FG000|Overall Study|Withdrawal by Subject|13|||
23738848|NCT02505945|66421316|FG001|Overall Study|Withdrawal by Subject|2|||
23547667|NCT03555396|65735892|FG000|Overall Study|Death|3|||
23738849|NCT02505945|66421315|FG000|Overall Study|Adverse Event|1|||
23738850|NCT02505945|66421316|FG001|Overall Study|Adverse Event|0|||
23738851|NCT02505945|66421315|FG000|Overall Study|Physician Decision|2|||
23738852|NCT02505945|66421316|FG001|Overall Study|Physician Decision|1|||
23738853|NCT02505945|66421315|FG000|Overall Study|Lost to Follow-up|6|||
23738854|NCT02505945|66421316|FG001|Overall Study|Lost to Follow-up|1|||
23738855|NCT02555722|66421317|FG000|Week 2|Adverse Event|0|||
23738856|NCT02555722|66421318|FG001|Week 2|Adverse Event|1|||
23547668|NCT03555396|65735893|FG001|Overall Study|Death|1|||
23738857|NCT02555722|66421317|FG000|Week 2|Withdrawal by Subject|1|||
23738858|NCT02555722|66421318|FG001|Week 2|Withdrawal by Subject|0|||
23738859|NCT02555722|66421317|FG000|Month 1|Lens Discomfort|1|||
23738860|NCT02555722|66421318|FG001|Month 1|Lens Discomfort|0|||
23738861|NCT02555722|66421317|FG000|Month 2|Withdrawal by Subject|3|||
23738862|NCT02555722|66421318|FG001|Month 2|Withdrawal by Subject|0|||
23738863|NCT02555722|66421317|FG000|Month 2|Lost to Follow-up|1|||
23738864|NCT02555722|66421318|FG001|Month 2|Lost to Follow-up|0|||
23738865|NCT02583399|66421325|FG000|Overall Study|Able to be discharged|3|||
23738866|NCT02583399|66421325|FG000|Overall Study|Wanted to use a restricted medication|3|||
23738867|NCT01599585|66421331|FG000|Overall Study|Withdrawal by Subject|16|||
23738868|NCT01599585|66421332|FG001|Overall Study|Withdrawal by Subject|9|||
23738869|NCT01599585|66421331|FG000|Overall Study|Lost to Follow-up|3|||
23738870|NCT01599585|66421332|FG001|Overall Study|Lost to Follow-up|5|||
23738871|NCT01599585|66421331|FG000|Overall Study|randomized did not start treatment|3|||
23738872|NCT01599585|66421332|FG001|Overall Study|randomized did not start treatment|3|||
23738873|NCT04806334|66421333|FG000|Overall Study|Withdrawal by Subject|1|||
23738874|NCT01298661|66421334|FG000|Overall Study|Withdrawal by Subject|2|||
23738875|NCT01298661|66421335|FG001|Overall Study|Withdrawal by Subject|0|||
23738876|NCT01298661|66421336|FG002|Overall Study|Withdrawal by Subject|2|||
23738877|NCT01952041|66421337|FG000|Overall Study|Lost to Follow-up|9|||
23738878|NCT01952041|66421338|FG001|Overall Study|Lost to Follow-up|16|||
23738879|NCT01952041|66421337|FG000|Overall Study|Withdrawal by Subject|7|||
23738880|NCT01952041|66421338|FG001|Overall Study|Withdrawal by Subject|5|||
23738881|NCT01952041|66421337|FG000|Overall Study|Death|1|||
23738882|NCT01952041|66421338|FG001|Overall Study|Death|0|||
23738883|NCT04118127|66421339|FG000|Overall Study|Trial terminated by sponsor|0|||
23738884|NCT04118127|66421340|FG001|Overall Study|Trial terminated by sponsor|12|||
23738885|NCT04118127|66421339|FG000|Overall Study|Adverse Event|1|||
23738886|NCT04118127|66421340|FG001|Overall Study|Adverse Event|2|||
23738887|NCT04118127|66421339|FG000|Overall Study|Physician Decision|0|||
23738888|NCT04118127|66421340|FG001|Overall Study|Physician Decision|1|||
23738889|NCT04118127|66421339|FG000|Overall Study|Withdrawal by Subject|2|||
23738890|NCT04118127|66421340|FG001|Overall Study|Withdrawal by Subject|1|||
23738891|NCT01681004|66421341|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
23738892|NCT01681004|66421342|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
23738893|NCT01681004|66421341|FG000|Study Completion|Lost to Follow-up|8|||
23738894|NCT01681004|66421342|FG001|Study Completion|Lost to Follow-up|3|||
23738895|NCT01681004|66421341|FG000|Study Completion|Physician Decision|1|||
23738896|NCT01681004|66421342|FG001|Study Completion|Physician Decision|3|||
23738897|NCT01681004|66421341|FG000|Study Completion|Site Termination|2|||
23738898|NCT01681004|66421342|FG001|Study Completion|Site Termination|1|||
23738899|NCT01681004|66421341|FG000|Study Completion|Death|1|||
23738900|NCT01681004|66421342|FG001|Study Completion|Death|1|||
23738901|NCT00967343|66421343|FG000|Overall Study|Study termination by sponsor|12|||
23738902|NCT00967343|66421343|FG000|Overall Study|Death|24|||
23738903|NCT00967343|66421343|FG000|Overall Study|Relapse|1|||
23738904|NCT00967343|66421343|FG000|Overall Study|Lost to Follow-up|1|||
23738905|NCT00424463|66421351|FG000|Overall Study|Adverse Event|2|||
23738906|NCT00424463|66421352|FG001|Overall Study|Adverse Event|3|||
23738907|NCT00424463|66421353|FG002|Overall Study|Adverse Event|2|||
23738908|NCT00424463|66421351|FG000|Overall Study|Physician Decision|0|||
23738909|NCT00424463|66421352|FG001|Overall Study|Physician Decision|2|||
23738910|NCT00424463|66421353|FG002|Overall Study|Physician Decision|2|||
23738911|NCT00424463|66421351|FG000|Overall Study|Withdrawal by Subject|4|||
23738912|NCT00424463|66421352|FG001|Overall Study|Withdrawal by Subject|2|||
23738913|NCT00424463|66421353|FG002|Overall Study|Withdrawal by Subject|5|||
23738914|NCT00424463|66421351|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
23738915|NCT00424463|66421352|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
23738916|NCT00424463|66421353|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
23738917|NCT00424463|66421351|FG000|Overall Study|Patient's convenience|0|||
23738918|NCT00424463|66421352|FG001|Overall Study|Patient's convenience|0|||
23738919|NCT00424463|66421353|FG002|Overall Study|Patient's convenience|1|||
23738920|NCT01513460|66421354|FG000|Overall Study|Death|0|||
23738921|NCT01513460|66421355|FG001|Overall Study|Death|0|||
23738922|NCT01513460|66421356|FG002|Overall Study|Death|1|||
23738923|NCT01513460|66421354|FG000|Overall Study|Lost to Follow-up|0|||
23738924|NCT01513460|66421355|FG001|Overall Study|Lost to Follow-up|0|||
23738925|NCT01513460|66421356|FG002|Overall Study|Lost to Follow-up|2|||
23738926|NCT01513460|66421354|FG000|Overall Study|Abnormal laboratory value|1|||
23738927|NCT01513460|66421355|FG001|Overall Study|Abnormal laboratory value|0|||
23738928|NCT01513460|66421356|FG002|Overall Study|Abnormal laboratory value|1|||
23738929|NCT01513460|66421354|FG000|Overall Study|Lack of Efficacy|1|||
23738930|NCT01513460|66421355|FG001|Overall Study|Lack of Efficacy|2|||
23738931|NCT01513460|66421356|FG002|Overall Study|Lack of Efficacy|5|||
23738932|NCT01513460|66421354|FG000|Overall Study|Protocol deviations|3|||
23738933|NCT01513460|66421355|FG001|Overall Study|Protocol deviations|4|||
23738934|NCT01513460|66421356|FG002|Overall Study|Protocol deviations|3|||
23738935|NCT01513460|66421354|FG000|Overall Study|Withdrawal by Subject|7|||
23738936|NCT01513460|66421355|FG001|Overall Study|Withdrawal by Subject|8|||
23738937|NCT01513460|66421356|FG002|Overall Study|Withdrawal by Subject|21|||
23738938|NCT01513460|66421354|FG000|Overall Study|Adverse Event|16|||
23738939|NCT01513460|66421355|FG001|Overall Study|Adverse Event|18|||
23738940|NCT01513460|66421356|FG002|Overall Study|Adverse Event|23|||
23738941|NCT01513460|66421354|FG000|Overall Study|Abnormal test procedure|1|||
23547669|NCT03555396|65735892|FG000|Overall Study|Lost to Follow-up|0|||
23547670|NCT03555396|65735893|FG001|Overall Study|Lost to Follow-up|2|||
23738942|NCT01513460|66421355|FG001|Overall Study|Abnormal test procedure|0|||
23547671|NCT02477618|65735894|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
23547672|NCT02477618|65735895|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
23547673|NCT02477618|65735894|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
23547674|NCT02477618|65735895|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
23547675|NCT02477618|65735894|FG000|Overall Study|Adverse Event|1|||
23547676|NCT02477618|65735895|FG001|Overall Study|Adverse Event|1|||
23547677|NCT02477618|65735894|FG000|Overall Study|Transferred Away from Study Site|1|||
23547678|NCT02477618|65735895|FG001|Overall Study|Transferred Away from Study Site|0|||
23547679|NCT02477618|65735894|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
23547680|NCT02477618|65735895|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
23547681|NCT01220557|65735896|FG000|Overall Study|Lost to Follow-up|5|||
23547682|NCT01220557|65735897|FG001|Overall Study|Lost to Follow-up|3|||
23547683|NCT01220557|65735896|FG000|Overall Study|attended less than 6 lessons|1|||
23547684|NCT01220557|65735897|FG001|Overall Study|attended less than 6 lessons|2|||
23547685|NCT03568318|65735898|FG000|Overall Study|Adverse Event|3|||
23547686|NCT03568318|65735899|FG001|Overall Study|Adverse Event|1|||
23547687|NCT03568318|65735900|FG002|Overall Study|Adverse Event|1|||
23547688|NCT03568318|65735901|FG003|Overall Study|Adverse Event|0|||
23547689|NCT03568318|65735902|FG004|Overall Study|Adverse Event|1|||
23547690|NCT03568318|65735903|FG005|Overall Study|Adverse Event|0|||
23547691|NCT03568318|65735898|FG000|Overall Study|Withdrawal by Subject|6|||
23547692|NCT03568318|65735899|FG001|Overall Study|Withdrawal by Subject|5|||
23547693|NCT03568318|65735900|FG002|Overall Study|Withdrawal by Subject|2|||
23547694|NCT03568318|65735901|FG003|Overall Study|Withdrawal by Subject|1|||
23547695|NCT03568318|65735902|FG004|Overall Study|Withdrawal by Subject|0|||
23547696|NCT03568318|65735903|FG005|Overall Study|Withdrawal by Subject|0|||
23547697|NCT03568318|65735898|FG000|Overall Study|Lost to Follow-up|3|||
23547698|NCT03568318|65735899|FG001|Overall Study|Lost to Follow-up|2|||
23547699|NCT03568318|65735900|FG002|Overall Study|Lost to Follow-up|2|||
23547700|NCT03568318|65735901|FG003|Overall Study|Lost to Follow-up|2|||
23547701|NCT03568318|65735902|FG004|Overall Study|Lost to Follow-up|1|||
23547702|NCT03568318|65735903|FG005|Overall Study|Lost to Follow-up|0|||
23547703|NCT03568318|65735898|FG000|Overall Study|Other|3|||
23547704|NCT03568318|65735899|FG001|Overall Study|Other|1|||
23738943|NCT01513460|66421356|FG002|Overall Study|Abnormal test procedure|0|||
23738944|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Adverse Event|6|||
23738945|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Adverse Event|6|||
23738946|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Death|14|||
23738947|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Death|11|||
23738948|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
23738949|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
23738950|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
23738951|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
23738952|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
23738953|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
23738954|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Disease Progression|1|||
23738955|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Disease Progression|0|||
23738956|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
23738957|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
23738958|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
23738959|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
23738960|NCT04419558|66421357|FG000|DB Period (48 Weeks)|Participant Decision|4|||
23738961|NCT04419558|66421358|FG001|DB Period (48 Weeks)|Participant Decision|3|||
23738962|NCT04419558|66421357|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
23738963|NCT04419558|66421358|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
23738964|NCT04419558|66421357|FG000|OLE Period (48 Weeks)|Death|4|||
23738965|NCT04419558|66421358|FG001|OLE Period (48 Weeks)|Death|6|||
23738966|NCT04419558|66421357|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
23738967|NCT04419558|66421358|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
23738968|NCT04419558|66421357|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
23738969|NCT04419558|66421358|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
23820415|NCT02960490|66721353|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23547705|NCT03568318|65735900|FG002|Overall Study|Other|3|||
23547706|NCT03568318|65735901|FG003|Overall Study|Other|0|||
23547707|NCT03568318|65735902|FG004|Overall Study|Other|0|||
23738970|NCT00361504|66421362|FG000|Overall Study|Withdrawal by Subject|94|||
23738971|NCT00361504|66421363|FG001|Overall Study|Withdrawal by Subject|31|||
23738972|NCT00361504|66421362|FG000|Overall Study|Lost to Follow-up|40|||
23738973|NCT00361504|66421363|FG001|Overall Study|Lost to Follow-up|7|||
23738974|NCT00361504|66421362|FG000|Overall Study|Adverse Event|203|||
23820416|NCT02960490|66721354|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23547708|NCT03568318|65735903|FG005|Overall Study|Other|0|||
23738975|NCT00361504|66421363|FG001|Overall Study|Adverse Event|82|||
23738976|NCT00361504|66421362|FG000|Overall Study|Lack of Efficacy|72|||
23738977|NCT00361504|66421363|FG001|Overall Study|Lack of Efficacy|7|||
23738978|NCT00361504|66421362|FG000|Overall Study|Resolution of Pain|2|||
23738979|NCT00361504|66421363|FG001|Overall Study|Resolution of Pain|0|||
23738980|NCT00361504|66421362|FG000|Overall Study|Study medication non compliant|42|||
23738981|NCT00361504|66421363|FG001|Overall Study|Study medication non compliant|15|||
23738982|NCT00361504|66421362|FG000|Overall Study|All other|28|||
23738983|NCT00361504|66421363|FG001|Overall Study|All other|3|||
23738984|NCT01724021|66421364|FG000|Overall Study|Adverse Event|11|||
23738985|NCT01724021|66421365|FG001|Overall Study|Adverse Event|6|||
23738986|NCT01724021|66421364|FG000|Overall Study|Death|46|||
23738987|NCT01724021|66421365|FG001|Overall Study|Death|58|||
23738988|NCT01724021|66421364|FG000|Overall Study|Participant request/ Withdrew consent|18|||
23738989|NCT01724021|66421365|FG001|Overall Study|Participant request/ Withdrew consent|14|||
23738990|NCT01724021|66421364|FG000|Overall Study|Lost to Follow-up|15|||
23738991|NCT01724021|66421365|FG001|Overall Study|Lost to Follow-up|15|||
23738992|NCT01724021|66421364|FG000|Overall Study|Reason Not Specified|36|||
23738993|NCT01724021|66421365|FG001|Overall Study|Reason Not Specified|39|||
23738994|NCT01724021|66421364|FG000|Overall Study|Missing|1|||
23738995|NCT01724021|66421365|FG001|Overall Study|Missing|1|||
23738996|NCT02561572|66421368|FG000|Overall Study|Inadequate time before surgery|2|||
23738997|NCT02561572|66421369|FG001|Overall Study|Inadequate time before surgery|1|||
23738998|NCT02561572|66421368|FG000|Overall Study|Protocol Violation|0|||
23738999|NCT02561572|66421369|FG001|Overall Study|Protocol Violation|1|||
23739000|NCT00696774|66421370|FG000|Period II|Adverse Event|0|||
23739001|NCT00696774|66421371|FG001|Period II|Adverse Event|0|||
23739002|NCT00696774|66421372|FG002|Period II|Adverse Event|15|||
23739003|NCT00696774|66421370|FG000|Period II|Lost to Follow-up|0|||
23739004|NCT00696774|66421371|FG001|Period II|Lost to Follow-up|0|||
23739005|NCT00696774|66421372|FG002|Period II|Lost to Follow-up|4|||
23739006|NCT00696774|66421370|FG000|Period II|Protocol Violation|0|||
23739007|NCT00696774|66421371|FG001|Period II|Protocol Violation|0|||
23739008|NCT00696774|66421372|FG002|Period II|Protocol Violation|11|||
23739009|NCT00696774|66421370|FG000|Period II|Withdrawal by Subject|0|||
23739010|NCT00696774|66421371|FG001|Period II|Withdrawal by Subject|0|||
23739011|NCT00696774|66421372|FG002|Period II|Withdrawal by Subject|4|||
23739012|NCT00696774|66421370|FG000|Period II|Sponsor Decision|0|||
23739013|NCT00696774|66421371|FG001|Period II|Sponsor Decision|0|||
23739014|NCT00696774|66421372|FG002|Period II|Sponsor Decision|0|||
23739015|NCT00696774|66421370|FG000|Period II|Lack of Efficacy|0|||
23739016|NCT00696774|66421371|FG001|Period II|Lack of Efficacy|0|||
23739017|NCT00696774|66421372|FG002|Period II|Lack of Efficacy|2|||
23739018|NCT00696774|66421370|FG000|Period III|Adverse Event|1|||
23739019|NCT00696774|66421371|FG001|Period III|Adverse Event|1|||
23739020|NCT00696774|66421372|FG002|Period III|Adverse Event|0|||
23739021|NCT00696774|66421370|FG000|Period III|Lost to Follow-up|2|||
23739022|NCT00696774|66421371|FG001|Period III|Lost to Follow-up|1|||
23739023|NCT00696774|66421372|FG002|Period III|Lost to Follow-up|0|||
23739024|NCT00696774|66421370|FG000|Period III|Protocol Violation|1|||
23739025|NCT00696774|66421371|FG001|Period III|Protocol Violation|1|||
23739026|NCT00696774|66421372|FG002|Period III|Protocol Violation|0|||
23739027|NCT00696774|66421370|FG000|Period III|Withdrawal by Subject|1|||
23739028|NCT00696774|66421371|FG001|Period III|Withdrawal by Subject|2|||
23739029|NCT00696774|66421372|FG002|Period III|Withdrawal by Subject|0|||
23739030|NCT00696774|66421370|FG000|Period III|Sponsor Decision|2|||
23739031|NCT00696774|66421371|FG001|Period III|Sponsor Decision|0|||
23739032|NCT00696774|66421372|FG002|Period III|Sponsor Decision|0|||
23739033|NCT00696774|66421370|FG000|Period III|Lack of Efficacy|0|||
23739034|NCT00696774|66421371|FG001|Period III|Lack of Efficacy|2|||
23739035|NCT00696774|66421372|FG002|Period III|Lack of Efficacy|0|||
23739036|NCT03039699|66421373|FG000|Overall Study|Incorrect inclusion|5|||
23739037|NCT03039699|66421374|FG001|Overall Study|Incorrect inclusion|4|||
23739038|NCT03039699|66421373|FG000|Overall Study|Lack of data to assess study endpoint|5|||
23739039|NCT03039699|66421374|FG001|Overall Study|Lack of data to assess study endpoint|3|||
23739040|NCT03039699|66421373|FG000|Overall Study|Bacterial infection|12|||
23739041|NCT03039699|66421374|FG001|Overall Study|Bacterial infection|28|||
23427505|NCT02981524|65310489|FG000|Overall Study|Treatment Related Toxicity|1|||
23739042|NCT01385098|66421377|FG000|Overall Study|Adverse Event|10|||
23739043|NCT01385098|66421377|FG000|Overall Study|Lost to Follow-up|4|||
23739044|NCT01373294|66421378|FG000|Overall Study|Adverse Event|1|||
23547709|NCT03568318|65735898|FG000|Overall Study|Ongoing at Time of Analysis|5|||
23739045|NCT01373294|66421379|FG001|Overall Study|Adverse Event|0|||
23739046|NCT00027846|66421380|FG000|Overall Study|Lost to Follow-up|0|||
23739047|NCT00027846|66421381|FG001|Overall Study|Lost to Follow-up|41|||
23739048|NCT00027846|66421382|FG002|Overall Study|Lost to Follow-up|9|||
23739049|NCT00027846|66421380|FG000|Overall Study|Withdrawal by Subject|0|||
23739050|NCT00027846|66421381|FG001|Overall Study|Withdrawal by Subject|14|||
23739051|NCT00027846|66421382|FG002|Overall Study|Withdrawal by Subject|7|||
23739052|NCT00027846|66421380|FG000|Overall Study|Ineligible for study|2|||
23427506|NCT02981524|65310489|FG000|Overall Study|Withdrawal by Subject|1|||
23427507|NCT01891344|65310490|FG000|Overall Study|Ongoing|6|||
23427508|NCT01891344|65310491|FG001|Overall Study|Ongoing|2|||
23427509|NCT01891344|65310492|FG002|Overall Study|Ongoing|0|||
23427510|NCT01891344|65310493|FG003|Overall Study|Ongoing|1|||
23427511|NCT01891344|65310494|FG004|Overall Study|Ongoing|4|||
23427512|NCT01891344|65310495|FG005|Overall Study|Ongoing|1|||
23427513|NCT01891344|65310496|FG006|Overall Study|Ongoing|0|||
23427514|NCT01891344|65310497|FG007|Overall Study|Ongoing|0|||
23427515|NCT01100567|65310498|FG000|Overall Study|Withdrawal by Subject|5|||
23427516|NCT01100567|65310499|FG001|Overall Study|Withdrawal by Subject|8|||
23427517|NCT01100567|65310498|FG000|Overall Study|Early Hospital Discharge|6|||
23547710|NCT03568318|65735899|FG001|Overall Study|Ongoing at Time of Analysis|3|||
23547711|NCT03568318|65735900|FG002|Overall Study|Ongoing at Time of Analysis|2|||
23739053|NCT00027846|66421381|FG001|Overall Study|Ineligible for study|6|||
23739054|NCT00027846|66421382|FG002|Overall Study|Ineligible for study|14|||
23739055|NCT00027846|66421380|FG000|Overall Study|Entry into another COG therapeutic study|0|||
23547712|NCT03568318|65735901|FG003|Overall Study|Ongoing at Time of Analysis|1|||
23739056|NCT00027846|66421381|FG001|Overall Study|Entry into another COG therapeutic study|5|||
23739057|NCT00027846|66421382|FG002|Overall Study|Entry into another COG therapeutic study|2|||
23739058|NCT00027846|66421380|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
23739059|NCT00027846|66421381|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
23739060|NCT00027846|66421382|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
23739061|NCT01222767|66421390|FG000|Overall Study|Progressive disease|13|||
23739062|NCT01222767|66421390|FG000|Overall Study|Adverse Event|2|||
23739063|NCT01222767|66421390|FG000|Overall Study|Surgical resection|1|||
23547713|NCT03568318|65735902|FG004|Overall Study|Ongoing at Time of Analysis|0|||
23547714|NCT03568318|65735903|FG005|Overall Study|Ongoing at Time of Analysis|0|||
23547715|NCT04479618|65735904|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
23547716|NCT04479618|65735905|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
23547717|NCT04479618|65735906|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
23547718|NCT04479618|65735904|FG000|Overall Study|Lack of Efficacy|1|||
23547719|NCT04479618|65735905|FG001|Overall Study|Lack of Efficacy|0|||
23547720|NCT04479618|65735906|FG002|Overall Study|Lack of Efficacy|0|||
23547721|NCT04479618|65735904|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
23547722|NCT04479618|65735905|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
23547723|NCT04479618|65735906|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
23547724|NCT04479618|65735904|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
23547725|NCT04479618|65735905|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
23547726|NCT04479618|65735906|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
23547727|NCT04479618|65735904|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
23547728|NCT04479618|65735905|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
23547729|NCT04479618|65735906|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
23547730|NCT04479618|65735904|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
23547731|NCT04479618|65735905|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
23547732|NCT04479618|65735906|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
23547733|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
23547734|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
23547735|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Death|1|||
23547736|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Death|0|||
23547737|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
23547738|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
23547739|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
23547740|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
23547741|NCT01572727|65735909|FG000|Overall Study|Adverse Event|43|||
23547742|NCT01572727|65735910|FG001|Overall Study|Adverse Event|15|||
23547743|NCT01572727|65735909|FG000|Overall Study|Lost to Follow-up|1|||
23547744|NCT01572727|65735910|FG001|Overall Study|Lost to Follow-up|1|||
23547745|NCT01572727|65735909|FG000|Overall Study|Physician Decision|23|||
23619516|NCT04414397|65991561|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
23739064|NCT01222767|66421390|FG000|Overall Study|Never treated|1|||
23427518|NCT01100567|65310499|FG001|Overall Study|Early Hospital Discharge|4|||
23427519|NCT01100567|65310498|FG000|Overall Study|Lost to Follow-up|1|||
23427520|NCT01100567|65310499|FG001|Overall Study|Lost to Follow-up|2|||
23427521|NCT01100567|65310498|FG000|Overall Study|Physician Decision|0|||
23547746|NCT01572727|65735910|FG001|Overall Study|Physician Decision|9|||
23547747|NCT01572727|65735909|FG000|Overall Study|Progressive disease|59|||
23547748|NCT01572727|65735910|FG001|Overall Study|Progressive disease|82|||
23547749|NCT01572727|65735909|FG000|Overall Study|Protocol Violation|0|||
23547750|NCT01572727|65735910|FG001|Overall Study|Protocol Violation|1|||
23547751|NCT01572727|65735909|FG000|Overall Study|Study terminated by sponsor|61|||
23547752|NCT01572727|65735910|FG001|Overall Study|Study terminated by sponsor|83|||
23547753|NCT01572727|65735909|FG000|Overall Study|Parent/guardian decision|14|||
23547754|NCT01572727|65735910|FG001|Overall Study|Parent/guardian decision|9|||
23547755|NCT01572727|65735909|FG000|Overall Study|Death|2|||
23547756|NCT01572727|65735910|FG001|Overall Study|Death|2|||
23547757|NCT01572727|65735909|FG000|Overall Study|Untreated|4|||
23547758|NCT01572727|65735910|FG001|Overall Study|Untreated|7|||
23547759|NCT00966940|65735914|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
23547760|NCT00966940|65735915|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
23547761|NCT00966940|65735914|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
23547762|NCT00966940|65735915|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
23619517|NCT04414397|65991562|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
23619518|NCT04414397|65991561|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
23619519|NCT04414397|65991562|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
23619520|NCT02413593|65991563|FG000|Overall Study|Lost to Follow-up|3|||
23619521|NCT02413593|65991563|FG000|Overall Study|Adverse Event|1|||
23619522|NCT03322514|65991564|FG000|Overall Study|Withdrawal by Subject|1|||
23619523|NCT03322514|65991565|FG001|Overall Study|Withdrawal by Subject|1|||
23619524|NCT00740597|65991566|FG000|Overall Study|insurance would not cover treatment|1|||
23547763|NCT00605293|65735916|FG000|Overall Study|Death|2|||
23547764|NCT00605293|65735917|FG001|Overall Study|Death|1|||
23547765|NCT00605293|65735916|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23547766|NCT00605293|65735917|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23547767|NCT00605293|65735916|FG000|Overall Study|Adverse Event|1|||
23547768|NCT00605293|65735917|FG001|Overall Study|Adverse Event|0|||
23547769|NCT00605293|65735916|FG000|Overall Study|Holidays Dialysis Out|1|||
23547770|NCT00605293|65735917|FG001|Overall Study|Holidays Dialysis Out|0|||
23547771|NCT00605293|65735916|FG000|Overall Study|Blood Transfusion|7|||
23547772|NCT00605293|65735917|FG001|Overall Study|Blood Transfusion|1|||
23547773|NCT00605293|65735916|FG000|Overall Study|Renal Transplantation|3|||
23547774|NCT00605293|65735917|FG001|Overall Study|Renal Transplantation|1|||
23547775|NCT00605293|65735916|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
23547776|NCT00605293|65735917|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
23547777|NCT00605293|65735916|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
23547778|NCT00605293|65735917|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
23547779|NCT00605293|65735916|FG000|Overall Study|Principal Investigator Decision|0|||
23547780|NCT00605293|65735917|FG001|Overall Study|Principal Investigator Decision|1|||
23547781|NCT02015676|65735918|FG000|Overall Study|Adverse Event|2|||
23547782|NCT02015676|65735919|FG001|Overall Study|Adverse Event|18|||
23547783|NCT02015676|65735920|FG002|Overall Study|Adverse Event|0|||
23547784|NCT02015676|65735918|FG000|Overall Study|Lack of Efficacy|2|||
23547785|NCT02015676|65735919|FG001|Overall Study|Lack of Efficacy|4|||
23547786|NCT02015676|65735920|FG002|Overall Study|Lack of Efficacy|0|||
23547787|NCT02015676|65735918|FG000|Overall Study|Protocol Violation|1|||
23547788|NCT02015676|65735919|FG001|Overall Study|Protocol Violation|0|||
23547789|NCT02015676|65735920|FG002|Overall Study|Protocol Violation|0|||
23547790|NCT02015676|65735918|FG000|Overall Study|Withdrawal by Subject|1|||
23547791|NCT02015676|65735919|FG001|Overall Study|Withdrawal by Subject|7|||
23547792|NCT02015676|65735920|FG002|Overall Study|Withdrawal by Subject|1|||
23547793|NCT02015676|65735918|FG000|Overall Study|Administrative reasons|0|||
23547794|NCT02015676|65735919|FG001|Overall Study|Administrative reasons|3|||
23547795|NCT02015676|65735920|FG002|Overall Study|Administrative reasons|1|||
23547796|NCT02015676|65735918|FG000|Overall Study|Death|0|||
23619525|NCT04572997|65991567|FG000|Overall Study|Adverse Event|1|||
23820417|NCT02960490|66721355|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23547797|NCT02015676|65735919|FG001|Overall Study|Death|1|||
23547798|NCT02015676|65735920|FG002|Overall Study|Death|0|||
23547799|NCT02015676|65735918|FG000|Overall Study|Disease progression|3|||
23547800|NCT02015676|65735919|FG001|Overall Study|Disease progression|1|||
23547801|NCT02015676|65735920|FG002|Overall Study|Disease progression|1|||
23547802|NCT04302350|65735921|FG000|Overall Study|Physician Decision|1|||
23547803|NCT04302350|65735922|FG001|Overall Study|Physician Decision|1|||
23547804|NCT04302350|65735923|FG002|Overall Study|Physician Decision|2|||
23547805|NCT04302350|65735921|FG000|Overall Study|Lack of Efficacy|1|||
23547806|NCT04302350|65735922|FG001|Overall Study|Lack of Efficacy|1|||
23547807|NCT04302350|65735923|FG002|Overall Study|Lack of Efficacy|4|||
23547808|NCT04302350|65735921|FG000|Overall Study|Adverse Event|0|||
23547809|NCT04302350|65735922|FG001|Overall Study|Adverse Event|1|||
23547810|NCT04302350|65735923|FG002|Overall Study|Adverse Event|2|||
23619526|NCT02427958|65991572|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
23619527|NCT02427958|65991572|FG000|Overall Study|Lost to Follow-up|6|||
23547811|NCT02834780|65735928|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
23547812|NCT02834780|65735929|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547813|NCT02834780|65735930|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
23547814|NCT02834780|65735931|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
23547815|NCT02834780|65735932|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
23547816|NCT02834780|65735933|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
23547817|NCT02834780|65735934|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
23547818|NCT02834780|65735935|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
23547819|NCT02834780|65735936|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547820|NCT02834780|65735937|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
23547821|NCT02834780|65735938|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547822|NCT02834780|65735939|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
23547823|NCT02834780|65735940|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
23547824|NCT02834780|65735928|FG000|Overall Study|Withdrawal by Subject|0|||
23547825|NCT02834780|65735929|FG001|Overall Study|Withdrawal by Subject|0|||
23547826|NCT02834780|65735930|FG002|Overall Study|Withdrawal by Subject|1|||
23547827|NCT02834780|65735931|FG003|Overall Study|Withdrawal by Subject|0|||
23547828|NCT02834780|65735932|FG004|Overall Study|Withdrawal by Subject|0|||
23547829|NCT02834780|65735933|FG005|Overall Study|Withdrawal by Subject|0|||
23547830|NCT02834780|65735934|FG006|Overall Study|Withdrawal by Subject|0|||
23547831|NCT02834780|65735935|FG007|Overall Study|Withdrawal by Subject|0|||
23547832|NCT02834780|65735936|FG008|Overall Study|Withdrawal by Subject|0|||
23547833|NCT02834780|65735937|FG009|Overall Study|Withdrawal by Subject|0|||
23739065|NCT01731951|66421391|FG000|Overall Study|Documented Disease Progression|1|||
23547834|NCT02834780|65735938|FG010|Overall Study|Withdrawal by Subject|1|||
23547835|NCT02834780|65735939|FG011|Overall Study|Withdrawal by Subject|0|||
23547836|NCT02834780|65735940|FG012|Overall Study|Withdrawal by Subject|0|||
23547837|NCT02834780|65735928|FG000|Overall Study|Adverse Event|0|||
23547838|NCT02834780|65735929|FG001|Overall Study|Adverse Event|0|||
23547839|NCT02834780|65735930|FG002|Overall Study|Adverse Event|0|||
23547840|NCT02834780|65735931|FG003|Overall Study|Adverse Event|0|||
23739066|NCT01731951|66421392|FG001|Overall Study|Documented Disease Progression|0|||
23547841|NCT02834780|65735932|FG004|Overall Study|Adverse Event|1|||
23547842|NCT02834780|65735933|FG005|Overall Study|Adverse Event|0|||
23547843|NCT02834780|65735934|FG006|Overall Study|Adverse Event|1|||
23547844|NCT02834780|65735935|FG007|Overall Study|Adverse Event|1|||
23547845|NCT02834780|65735936|FG008|Overall Study|Adverse Event|0|||
23547846|NCT02834780|65735937|FG009|Overall Study|Adverse Event|2|||
23547847|NCT02834780|65735938|FG010|Overall Study|Adverse Event|0|||
23547848|NCT02834780|65735939|FG011|Overall Study|Adverse Event|3|||
23547849|NCT02834780|65735940|FG012|Overall Study|Adverse Event|2|||
23547850|NCT02834780|65735928|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547851|NCT02834780|65735929|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547852|NCT02834780|65735930|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547853|NCT02834780|65735931|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547854|NCT02834780|65735932|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547855|NCT02834780|65735933|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
23739067|NCT01731951|66421393|FG002|Overall Study|Documented Disease Progression|0|||
23739068|NCT01731951|66421394|FG003|Overall Study|Documented Disease Progression|0|||
23739069|NCT01731951|66421395|FG004|Overall Study|Documented Disease Progression|0|||
23739070|NCT01731951|66421396|FG005|Overall Study|Documented Disease Progression|0|||
23739071|NCT01731951|66421391|FG000|Overall Study|Lost to Follow-up|2|||
23739072|NCT01731951|66421392|FG001|Overall Study|Lost to Follow-up|0|||
23739073|NCT01731951|66421393|FG002|Overall Study|Lost to Follow-up|0|||
23739074|NCT01731951|66421394|FG003|Overall Study|Lost to Follow-up|1|||
23739075|NCT01731951|66421395|FG004|Overall Study|Lost to Follow-up|3|||
23739076|NCT01731951|66421396|FG005|Overall Study|Lost to Follow-up|1|||
23739077|NCT01731951|66421391|FG000|Overall Study|Withdrawal of Consent|1|||
23739078|NCT01731951|66421392|FG001|Overall Study|Withdrawal of Consent|0|||
23547856|NCT02834780|65735934|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547857|NCT02834780|65735935|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547858|NCT02834780|65735936|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547859|NCT02834780|65735937|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547860|NCT02834780|65735938|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547861|NCT02834780|65735939|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547862|NCT02834780|65735940|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
23547863|NCT02834780|65735928|FG000|Overall Study|Other|1|||
23739079|NCT01731951|66421393|FG002|Overall Study|Withdrawal of Consent|0|||
23739080|NCT01731951|66421394|FG003|Overall Study|Withdrawal of Consent|0|||
23739081|NCT01731951|66421395|FG004|Overall Study|Withdrawal of Consent|0|||
23820418|NCT02960490|66721346|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23739082|NCT01731951|66421396|FG005|Overall Study|Withdrawal of Consent|2|||
23739083|NCT01731951|66421391|FG000|Overall Study|Death|13|||
23619528|NCT02427958|65991572|FG000|Overall Study|Withdrawal by Subject|14|||
23619529|NCT02427958|65991572|FG000|Overall Study|Lack of Efficacy|1|||
23619530|NCT01649297|65991573|FG000|Overall Study|Adverse Event|5|||
23619531|NCT01649297|65991574|FG001|Overall Study|Adverse Event|5|||
23619532|NCT01649297|65991575|FG002|Overall Study|Adverse Event|4|||
23619533|NCT01649297|65991576|FG003|Overall Study|Adverse Event|13|||
23619534|NCT01649297|65991577|FG004|Overall Study|Adverse Event|1|||
23619535|NCT01649297|65991573|FG000|Overall Study|Lack of Efficacy|0|||
23619536|NCT01649297|65991574|FG001|Overall Study|Lack of Efficacy|0|||
23619537|NCT01649297|65991575|FG002|Overall Study|Lack of Efficacy|0|||
23619538|NCT01649297|65991576|FG003|Overall Study|Lack of Efficacy|0|||
23619539|NCT01649297|65991577|FG004|Overall Study|Lack of Efficacy|1|||
23619540|NCT01649297|65991573|FG000|Overall Study|Non compliant with Protocol|1|||
23619541|NCT01649297|65991574|FG001|Overall Study|Non compliant with Protocol|0|||
23619542|NCT01649297|65991575|FG002|Overall Study|Non compliant with Protocol|3|||
23619543|NCT01649297|65991576|FG003|Overall Study|Non compliant with Protocol|2|||
23619544|NCT01649297|65991577|FG004|Overall Study|Non compliant with Protocol|1|||
23619545|NCT01649297|65991573|FG000|Overall Study|Lost to Follow-up|1|||
23619546|NCT01649297|65991574|FG001|Overall Study|Lost to Follow-up|1|||
23619547|NCT01649297|65991575|FG002|Overall Study|Lost to Follow-up|4|||
23619548|NCT01649297|65991576|FG003|Overall Study|Lost to Follow-up|3|||
23619549|NCT01649297|65991577|FG004|Overall Study|Lost to Follow-up|0|||
23619550|NCT01649297|65991573|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
23619551|NCT01649297|65991574|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
23619552|NCT01649297|65991575|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
23619553|NCT01649297|65991576|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
23619554|NCT01649297|65991577|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
23619555|NCT01649297|65991573|FG000|Overall Study|For other reason|4|||
23619556|NCT01649297|65991574|FG001|Overall Study|For other reason|1|||
23619557|NCT01649297|65991575|FG002|Overall Study|For other reason|2|||
23619558|NCT01649297|65991576|FG003|Overall Study|For other reason|0|||
23619559|NCT01649297|65991577|FG004|Overall Study|For other reason|0|||
23619560|NCT01011049|65991578|FG000|Overall Study|Protocol Violation|0|||
23619561|NCT01011049|65991579|FG001|Overall Study|Protocol Violation|0|||
23619562|NCT01011049|65991580|FG002|Overall Study|Protocol Violation|2|||
23619563|NCT01011049|65991581|FG003|Overall Study|Protocol Violation|0|||
23619564|NCT01011049|65991578|FG000|Overall Study|Lost to Follow-up|1|||
23619565|NCT01011049|65991579|FG001|Overall Study|Lost to Follow-up|2|||
23619566|NCT01011049|65991580|FG002|Overall Study|Lost to Follow-up|1|||
23619567|NCT01011049|65991581|FG003|Overall Study|Lost to Follow-up|0|||
23619568|NCT01011049|65991578|FG000|Overall Study|Withdrawal by Subject|0|||
23619569|NCT01011049|65991579|FG001|Overall Study|Withdrawal by Subject|0|||
23619570|NCT01011049|65991580|FG002|Overall Study|Withdrawal by Subject|1|||
23619571|NCT01011049|65991581|FG003|Overall Study|Withdrawal by Subject|0|||
23619572|NCT00474383|65991582|FG000|Main Study|Adverse Event|11|||
23619573|NCT00474383|65991583|FG001|Main Study|Adverse Event|0|||
23619574|NCT00474383|65991582|FG000|Main Study|Symptomatic Deterioration|1|||
23619575|NCT00474383|65991583|FG001|Main Study|Symptomatic Deterioration|0|||
23619576|NCT00474383|65991582|FG000|Main Study|Progressive Disease|23|||
23619577|NCT00474383|65991583|FG001|Main Study|Progressive Disease|0|||
23619578|NCT00474383|65991582|FG000|Main Study|Other|1|||
23619579|NCT00474383|65991583|FG001|Main Study|Other|0|||
23619580|NCT00474383|65991582|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
23619581|NCT00474383|65991583|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
23619582|NCT00474383|65991582|FG000|Extension|Progressive Disease|0|||
23619583|NCT00474383|65991583|FG001|Extension|Progressive Disease|5|||
23619584|NCT03681353|65991584|FG000|Overall Study|Lost to Follow-up|2|||
23619585|NCT03681353|65991584|FG000|Overall Study|Withdrawal by Subject|3|||
23619586|NCT03681353|65991584|FG000|Overall Study|withdrawn by PI|2|||
23619587|NCT00679549|65991585|FG000|Overall Study|dropout|2|||
23619588|NCT00679549|65991586|FG001|Overall Study|dropout|4|||
23619589|NCT00679549|65991585|FG000|Overall Study|missing outcome echocardiograms|4|||
23619590|NCT00679549|65991586|FG001|Overall Study|missing outcome echocardiograms|5|||
23619591|NCT03294941|65991587|FG000|Overall Study|Withdrawal by Subject|0|||
23619592|NCT03294941|65991588|FG001|Overall Study|Withdrawal by Subject|2|||
23619593|NCT02282059|65991591|FG000|Overall Study|Other|15|||
23619594|NCT02282059|65991592|FG001|Overall Study|Other|3|||
23619595|NCT02282059|65991591|FG000|Overall Study|Participant refused further follow-up|8|||
23619596|NCT02282059|65991592|FG001|Overall Study|Participant refused further follow-up|4|||
23619597|NCT02282059|65991591|FG000|Overall Study|Lost to Follow-up|19|||
23619598|NCT02282059|65991592|FG001|Overall Study|Lost to Follow-up|3|||
23619599|NCT02282059|65991591|FG000|Overall Study|Death|40|||
23619600|NCT02282059|65991592|FG001|Overall Study|Death|8|||
23619601|NCT00255944|65991597|FG000|Overall Study|Lost to Follow-up|797|||
23619602|NCT00255944|65991598|FG001|Overall Study|Lost to Follow-up|834|||
23619603|NCT03924947|65994671|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23739084|NCT01731951|66421392|FG001|Overall Study|Death|15|||
23619604|NCT03924947|65994672|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619605|NCT03924947|65994673|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
23619606|NCT03924947|65994674|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619607|NCT03924947|65994675|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23739085|NCT01731951|66421393|FG002|Overall Study|Death|9|||
23739086|NCT01731951|66421394|FG003|Overall Study|Death|8|||
23739087|NCT01731951|66421395|FG004|Overall Study|Death|9|||
23739088|NCT01731951|66421396|FG005|Overall Study|Death|6|||
23619608|NCT03924947|65994676|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619609|NCT03334695|65994677|FG000|Overall Study|Lost to Follow-up|3|||
23619610|NCT03334695|65994678|FG001|Overall Study|Lost to Follow-up|3|||
23547864|NCT02834780|65735929|FG001|Overall Study|Other|0|||
23619611|NCT03334695|65994677|FG000|Overall Study|Physician Decision|1|||
23619612|NCT03334695|65994678|FG001|Overall Study|Physician Decision|2|||
23619613|NCT03334695|65994677|FG000|Overall Study|Protocol Violation|0|||
23619614|NCT03334695|65994678|FG001|Overall Study|Protocol Violation|1|||
23619615|NCT03042559|65994679|FG000|Overall Study|drop out|1|||
23619616|NCT03042559|65994680|FG001|Overall Study|drop out|1|||
23619617|NCT00858247|65994684|FG000|Baseline Assessment|Withdrawal by Subject|1|||
23619618|NCT00858247|65994685|FG001|Baseline Assessment|Withdrawal by Subject|1|||
23619619|NCT00858247|65994684|FG000|Baseline Assessment|Poor IV access|1|||
23619620|NCT00858247|65994685|FG001|Baseline Assessment|Poor IV access|0|||
23619621|NCT00858247|65994684|FG000|Baseline Assessment|Protocol Violation|0|||
23619622|NCT00858247|65994685|FG001|Baseline Assessment|Protocol Violation|1|||
23619623|NCT00858247|65994684|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
23619624|NCT00858247|65994685|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
23619625|NCT00925288|65994686|FG000|Overall Study|Lost to Follow-up|9|||
23619626|NCT00925288|65994687|FG001|Overall Study|Lost to Follow-up|7|||
23739089|NCT03650387|66421397|FG000|Overall Study|Withdrawal by Subject|13|||
23739090|NCT03650387|66421397|FG000|Overall Study|Lost to Follow-up|12|||
23739091|NCT03650387|66421397|FG000|Overall Study|Adverse Event (Not related)|1|||
23739092|NCT03650387|66421397|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
23547865|NCT02834780|65735930|FG002|Overall Study|Other|1|||
23547866|NCT02834780|65735931|FG003|Overall Study|Other|2|||
23547867|NCT02834780|65735932|FG004|Overall Study|Other|0|||
23547868|NCT02834780|65735933|FG005|Overall Study|Other|0|||
23547869|NCT02834780|65735934|FG006|Overall Study|Other|0|||
23547870|NCT02834780|65735935|FG007|Overall Study|Other|0|||
23547871|NCT02834780|65735936|FG008|Overall Study|Other|0|||
23547872|NCT02834780|65735937|FG009|Overall Study|Other|0|||
23547873|NCT02834780|65735938|FG010|Overall Study|Other|0|||
23547874|NCT02834780|65735939|FG011|Overall Study|Other|0|||
23547875|NCT02834780|65735940|FG012|Overall Study|Other|1|||
23547876|NCT02925455|65735941|FG000|Overall Study|Withdrawal by Subject|2|||
23547877|NCT02925455|65735942|FG001|Overall Study|Withdrawal by Subject|0|||
23547878|NCT03019536|65735945|FG000|Overall Study|Withdrawal by Subject|1|||
23547879|NCT03019536|65735946|FG001|Overall Study|Withdrawal by Subject|1|||
23547880|NCT03019536|65735947|FG002|Overall Study|Withdrawal by Subject|0|||
23547881|NCT03019536|65735945|FG000|Overall Study|Adverse Event|0|||
23547882|NCT03019536|65735946|FG001|Overall Study|Adverse Event|0|||
23547883|NCT03019536|65735947|FG002|Overall Study|Adverse Event|2|||
23547884|NCT01064739|65735948|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
23547885|NCT00659334|65735949|FG000|Overall Study|Screen Failure|8|||
23547886|NCT00659334|65735950|FG001|Overall Study|Screen Failure|5|||
23547887|NCT00659334|65735951|FG002|Overall Study|Screen Failure|0|||
23547888|NCT00659334|65735952|FG003|Overall Study|Screen Failure|0|||
23619627|NCT00651937|65994690|FG000|Overall Study|Withdrawal by Subject|4|||
23619628|NCT00651937|65994691|FG001|Overall Study|Withdrawal by Subject|1|||
23619629|NCT04124471|65994696|FG000|Overall Study|screen failure|1|||
23739093|NCT00568399|66421405|FG000|Overall Study|Death|2|||
23547889|NCT00659334|65735953|FG004|Overall Study|Screen Failure|0|||
23547890|NCT00659334|65735954|FG005|Overall Study|Screen Failure|0|||
23547891|NCT00659334|65735955|FG006|Overall Study|Screen Failure|1|||
23547892|NCT00715429|65735956|FG000|Overall Study|Did not complete the study diary|0|||
23547893|NCT00715429|65735957|FG001|Overall Study|Did not complete the study diary|1|||
23547894|NCT02053350|65735958|FG000|Overall Study|Withdrawal by Subject|1|||
23547895|NCT02053350|65735958|FG000|Overall Study|Adverse Event|4|||
23820419|NCT02960490|66721347|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
23619630|NCT00468858|65994697|FG000|Overall Study|Adverse Event|0|||
23619631|NCT00468858|65994698|FG001|Overall Study|Adverse Event|1|||
23619632|NCT00468858|65994699|FG002|Overall Study|Adverse Event|0|||
23739094|NCT00568399|66421405|FG000|Overall Study|Adverse Event|5|||
23547896|NCT04348604|65735961|FG000|Week 8|Withdrawal by Subject|1|||
23547897|NCT04348604|65735962|FG001|Week 8|Withdrawal by Subject|1|||
23547898|NCT04348604|65735961|FG000|Week 8|Lost to Follow-up|1|||
23547899|NCT04348604|65735962|FG001|Week 8|Lost to Follow-up|2|||
23547900|NCT04348604|65735961|FG000|Week 8|Suspended|0|||
23547901|NCT04348604|65735962|FG001|Week 8|Suspended|1|||
23619633|NCT00468858|65994697|FG000|Overall Study|Withdrawal by Subject|7|||
23619634|NCT00468858|65994698|FG001|Overall Study|Withdrawal by Subject|4|||
23619635|NCT00468858|65994699|FG002|Overall Study|Withdrawal by Subject|5|||
23619636|NCT00468858|65994697|FG000|Overall Study|Relocation|1|||
23619637|NCT00468858|65994698|FG001|Overall Study|Relocation|3|||
23619638|NCT00468858|65994699|FG002|Overall Study|Relocation|3|||
23619639|NCT00468858|65994697|FG000|Overall Study|Lost to Follow-up|1|||
23619640|NCT00468858|65994698|FG001|Overall Study|Lost to Follow-up|2|||
23619641|NCT00468858|65994699|FG002|Overall Study|Lost to Follow-up|5|||
23619642|NCT00468858|65994697|FG000|Overall Study|Other|0|||
23619643|NCT00468858|65994698|FG001|Overall Study|Other|0|||
23619644|NCT00468858|65994699|FG002|Overall Study|Other|1|||
23619645|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
23619646|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
23820420|NCT02960490|66721348|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820421|NCT02960490|66721349|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820422|NCT02960490|66721350|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820423|NCT02960490|66721351|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820424|NCT02960490|66721352|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820425|NCT02960490|66721353|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820426|NCT02960490|66721354|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820427|NCT02960490|66721355|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23820428|NCT02960490|66721346|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
23820429|NCT02960490|66721347|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
23820430|NCT02960490|66721348|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820431|NCT02960490|66721349|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820432|NCT02960490|66721350|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820433|NCT02960490|66721351|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820434|NCT02960490|66721352|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23547902|NCT04348604|65735961|FG000|Week 12|Lost to Follow-up|1|||
23547903|NCT04348604|65735962|FG001|Week 12|Lost to Follow-up|2|||
23547904|NCT04348604|65735961|FG000|Week 12|Withdrawal by Subject|1|||
23547905|NCT04348604|65735962|FG001|Week 12|Withdrawal by Subject|0|||
23547906|NCT04348604|65735961|FG000|Week 24|Lost to Follow-up|2|||
23547907|NCT04348604|65735962|FG001|Week 24|Lost to Follow-up|1|||
23547908|NCT00454051|65735963|FG000|Overall Study|Adverse Event|1|||
23547909|NCT00454051|65735964|FG001|Overall Study|Adverse Event|2|||
23547910|NCT00454051|65735963|FG000|Overall Study|Withdrawal by Subject|1|||
23547911|NCT00454051|65735964|FG001|Overall Study|Withdrawal by Subject|0|||
23547912|NCT00454051|65735963|FG000|Overall Study|Protocol Violation|1|||
23547913|NCT00454051|65735964|FG001|Overall Study|Protocol Violation|1|||
23547914|NCT01022762|65735965|FG000|Overall Study|Adverse Event|3|||
23619647|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
23820435|NCT02960490|66721353|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820436|NCT02960490|66721354|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820437|NCT02960490|66721355|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23820438|NCT02960490|66721346|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
23820439|NCT02960490|66721347|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
23820440|NCT02960490|66721348|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820441|NCT02960490|66721349|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820442|NCT02960490|66721350|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23547915|NCT01022762|65735966|FG001|Overall Study|Adverse Event|1|||
23547916|NCT01022762|65735965|FG000|Overall Study|Lack of Efficacy|0|||
23547917|NCT01022762|65735966|FG001|Overall Study|Lack of Efficacy|1|||
23547918|NCT01022762|65735965|FG000|Overall Study|Protocol Violation|7|||
23547919|NCT01022762|65735966|FG001|Overall Study|Protocol Violation|6|||
23547920|NCT01022762|65735965|FG000|Overall Study|Unclassified|12|||
23547921|NCT01022762|65735966|FG001|Overall Study|Unclassified|20|||
23547922|NCT03581305|65735967|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
23619648|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
23427522|NCT01100567|65310499|FG001|Overall Study|Physician Decision|1|||
23547923|NCT03581305|65735968|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
23547924|NCT03581305|65735967|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
23547925|NCT03581305|65735968|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
23619649|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
23619650|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
23619651|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
23820443|NCT02960490|66721351|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820444|NCT02960490|66721352|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820445|NCT02960490|66721353|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820446|NCT02960490|66721354|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820447|NCT02960490|66721355|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23820448|NCT02960490|66721346|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820449|NCT02960490|66721347|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820450|NCT02960490|66721348|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
23820451|NCT02960490|66721349|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
23820452|NCT02960490|66721350|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820453|NCT02960490|66721351|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
23820454|NCT02960490|66721352|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820455|NCT02960490|66721353|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820456|NCT02960490|66721354|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820457|NCT02960490|66721355|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23820458|NCT02960490|66721346|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820459|NCT02960490|66721347|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820460|NCT02960490|66721348|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
23820461|NCT02960490|66721349|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820462|NCT02960490|66721350|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
23739095|NCT00568399|66421405|FG000|Overall Study|Withdrawal by Subject|8|||
23739096|NCT01454531|66421407|FG000|Overall Study|Adverse Event|14|||
23427523|NCT01100567|65310498|FG000|Overall Study|Deemed ineligible after consent|0|||
23427524|NCT01100567|65310499|FG001|Overall Study|Deemed ineligible after consent|1|||
23427525|NCT00711802|65310500|FG000|Overall Study|Not treated (no further detail)|2|||
23427526|NCT00711802|65310501|FG001|Overall Study|Not treated (no further detail)|1|||
23427527|NCT00711802|65310502|FG002|Overall Study|Not treated (no further detail)|2|||
23427528|NCT00711802|65310503|FG003|Overall Study|Not treated (no further detail)|0|||
23427529|NCT00711802|65310504|FG004|Overall Study|Not treated (no further detail)|2|||
23427530|NCT00711802|65310505|FG005|Overall Study|Not treated (no further detail)|0|||
23427531|NCT00711802|65310506|FG006|Overall Study|Not treated (no further detail)|0|||
23427532|NCT00711802|65310507|FG007|Overall Study|Not treated (no further detail)|0|||
23427533|NCT00711802|65310500|FG000|Overall Study|Adverse Event|0|||
23619652|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
23739097|NCT01454531|66421407|FG000|Overall Study|Withdrawal by Subject|5|||
23739098|NCT01454531|66421407|FG000|Overall Study|Lost to Follow-up|1|||
23739099|NCT01454531|66421407|FG000|Overall Study|Physician Decision|1|||
23739100|NCT01454531|66421407|FG000|Overall Study|Delay in IMP administration|1|||
23739101|NCT01454531|66421407|FG000|Overall Study|Other|1|||
23739102|NCT02036476|66421408|FG000|Overall Study|Withdrawal by Subject|2|||
23739103|NCT02036476|66421408|FG000|Overall Study|Progressive Disease|4|||
23739104|NCT02036476|66421408|FG000|Overall Study|Unacceptable Toxicity|2|||
23739105|NCT03730987|66425709|FG000|Overall Study|Lost to Follow-up|2|||
23739106|NCT03730987|66425710|FG001|Overall Study|Lost to Follow-up|0|||
23739107|NCT03730987|66425711|FG002|Overall Study|Lost to Follow-up|2|||
23820463|NCT02960490|66721351|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820464|NCT02960490|66721352|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820465|NCT02960490|66721353|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820466|NCT02960490|66721354|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820467|NCT02960490|66721355|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23820468|NCT02960490|66721346|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
23820469|NCT02960490|66721347|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
23820470|NCT02960490|66721348|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
23820471|NCT02960490|66721349|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
23820472|NCT02960490|66721350|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
23820473|NCT02960490|66721351|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
23820474|NCT02960490|66721352|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
23820475|NCT02960490|66721353|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
23820476|NCT02960490|66721354|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
23820477|NCT02960490|66721355|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
23820478|NCT02960490|66721346|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820479|NCT02960490|66721347|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820480|NCT02960490|66721348|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820481|NCT02960490|66721349|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820482|NCT02960490|66721350|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23427534|NCT00711802|65310501|FG001|Overall Study|Adverse Event|0|||
23739108|NCT03730987|66425712|FG003|Overall Study|Lost to Follow-up|0|||
23739109|NCT03145207|66425713|FG000|Overall Study|volunteer started taking allergy shots|1|||
23739110|NCT03145207|66425713|FG000|Overall Study|baseline blood pressure high|1|||
23739111|NCT02500901|66425714|FG000|Overall Study|Disease ProgressionDD|2|||
23739112|NCT02516605|66425716|FG000|Overall Study|Protocol Violation|0|||
23739113|NCT02516605|66425717|FG001|Overall Study|Protocol Violation|0|||
23739114|NCT02516605|66425718|FG002|Overall Study|Protocol Violation|0|||
23739115|NCT02516605|66425719|FG003|Overall Study|Protocol Violation|0|||
23739116|NCT02516605|66425720|FG004|Overall Study|Protocol Violation|1|||
23739117|NCT02516605|66425716|FG000|Overall Study|Withdrawal by Subject|0|||
23739118|NCT02516605|66425717|FG001|Overall Study|Withdrawal by Subject|0|||
23739119|NCT02516605|66425718|FG002|Overall Study|Withdrawal by Subject|0|||
23739120|NCT02516605|66425719|FG003|Overall Study|Withdrawal by Subject|1|||
23739121|NCT02516605|66425720|FG004|Overall Study|Withdrawal by Subject|0|||
23739122|NCT01218477|66425722|FG000|Overall Study|Disease progression|2|||
23739123|NCT01218477|66425723|FG001|Overall Study|Disease progression|3|||
23739124|NCT01218477|66425724|FG002|Overall Study|Disease progression|6|||
23739125|NCT01218477|66425725|FG003|Overall Study|Disease progression|2|||
23739126|NCT01218477|66425722|FG000|Overall Study|Study drug toxicity|0|||
23739127|NCT01218477|66425723|FG001|Overall Study|Study drug toxicity|2|||
23739128|NCT01218477|66425724|FG002|Overall Study|Study drug toxicity|5|||
23739129|NCT01218477|66425725|FG003|Overall Study|Study drug toxicity|0|||
23739130|NCT01218477|66425722|FG000|Overall Study|No longer meets study criteria|1|||
23739131|NCT01218477|66425723|FG001|Overall Study|No longer meets study criteria|0|||
23739132|NCT01218477|66425724|FG002|Overall Study|No longer meets study criteria|0|||
23739133|NCT01218477|66425725|FG003|Overall Study|No longer meets study criteria|0|||
23739134|NCT01218477|66425722|FG000|Overall Study|Withdrawal by Subject|0|||
23739135|NCT01218477|66425723|FG001|Overall Study|Withdrawal by Subject|0|||
23739136|NCT01218477|66425724|FG002|Overall Study|Withdrawal by Subject|1|||
23739137|NCT01218477|66425725|FG003|Overall Study|Withdrawal by Subject|0|||
23739138|NCT01218477|66425722|FG000|Overall Study|Prepared for cell transplantation|0|||
23739139|NCT01218477|66425723|FG001|Overall Study|Prepared for cell transplantation|1|||
23739140|NCT01218477|66425724|FG002|Overall Study|Prepared for cell transplantation|1|||
23739141|NCT01218477|66425725|FG003|Overall Study|Prepared for cell transplantation|0|||
23739142|NCT01218477|66425722|FG000|Overall Study|Administrative reason by sponsor|0|||
23739143|NCT01218477|66425723|FG001|Overall Study|Administrative reason by sponsor|0|||
23739144|NCT01218477|66425724|FG002|Overall Study|Administrative reason by sponsor|1|||
23739145|NCT01218477|66425725|FG003|Overall Study|Administrative reason by sponsor|0|||
23739146|NCT01218477|66425722|FG000|Overall Study|Maximum clinical benefit|0|||
23739147|NCT01218477|66425723|FG001|Overall Study|Maximum clinical benefit|2|||
23739148|NCT01218477|66425724|FG002|Overall Study|Maximum clinical benefit|0|||
23739149|NCT01218477|66425725|FG003|Overall Study|Maximum clinical benefit|0|||
23739150|NCT00945945|66425728|FG000|Overall Study|Adverse Event|15|||
23739151|NCT00945945|66425729|FG001|Overall Study|Adverse Event|35|||
23739152|NCT00945945|66425728|FG000|Overall Study|Withdrawal by Subject|7|||
23739153|NCT00945945|66425729|FG001|Overall Study|Withdrawal by Subject|10|||
23739154|NCT00945945|66425728|FG000|Overall Study|Lost to Follow-up|4|||
23739155|NCT00945945|66425729|FG001|Overall Study|Lost to Follow-up|5|||
23739156|NCT00945945|66425728|FG000|Overall Study|Lack of Efficacy|6|||
23739157|NCT00945945|66425729|FG001|Overall Study|Lack of Efficacy|2|||
23739158|NCT00945945|66425728|FG000|Overall Study|Protocol Violation|4|||
23739159|NCT00945945|66425729|FG001|Overall Study|Protocol Violation|2|||
23739160|NCT00945945|66425728|FG000|Overall Study|Entry Criteria Not Met|0|||
23739161|NCT00945945|66425729|FG001|Overall Study|Entry Criteria Not Met|1|||
23739162|NCT02785588|66425730|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
23739163|NCT02785588|66425730|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
23739164|NCT02554721|66425731|FG000|Overall Study|Adverse Event|1|||
23739165|NCT02554721|66425732|FG001|Overall Study|Adverse Event|0|||
23739166|NCT02554721|66425733|FG002|Overall Study|Adverse Event|0|||
23739167|NCT02554721|66425734|FG003|Overall Study|Adverse Event|0|||
23739168|NCT02554721|66425735|FG004|Overall Study|Adverse Event|1|||
23739169|NCT02554721|66425731|FG000|Overall Study|Noncompliance|0|||
23739170|NCT02554721|66425732|FG001|Overall Study|Noncompliance|0|||
23739171|NCT02554721|66425733|FG002|Overall Study|Noncompliance|0|||
23739172|NCT02554721|66425734|FG003|Overall Study|Noncompliance|0|||
23739173|NCT02554721|66425735|FG004|Overall Study|Noncompliance|1|||
23739174|NCT00302731|66425736|FG000|Overall Study|Lost to Follow-up|1|||
23739175|NCT00302731|66425737|FG001|Overall Study|Lost to Follow-up|2|||
23739176|NCT00302731|66425738|FG002|Overall Study|Lost to Follow-up|0|||
23739177|NCT00302731|66425739|FG003|Overall Study|Lost to Follow-up|0|||
23739178|NCT00302731|66425736|FG000|Overall Study|Adverse Event|0|||
23739179|NCT00302731|66425737|FG001|Overall Study|Adverse Event|2|||
23739180|NCT00302731|66425738|FG002|Overall Study|Adverse Event|2|||
23739181|NCT00302731|66425739|FG003|Overall Study|Adverse Event|0|||
23739182|NCT00302731|66425736|FG000|Overall Study|Withdrawal by Subject|1|||
23739183|NCT00302731|66425737|FG001|Overall Study|Withdrawal by Subject|1|||
23739184|NCT00302731|66425738|FG002|Overall Study|Withdrawal by Subject|0|||
23739185|NCT00302731|66425739|FG003|Overall Study|Withdrawal by Subject|0|||
23739186|NCT00302731|66425736|FG000|Overall Study|Protocol Violation|1|||
23547926|NCT03581305|65735967|FG000|Serotonergic Study|Withdrawal by Subject|5|||
23547927|NCT03581305|65735968|FG001|Serotonergic Study|Withdrawal by Subject|1|||
23547928|NCT01990950|65735970|FG000|Overall Study|Death|3|||
23547929|NCT01990950|65735970|FG000|Overall Study|Lost to Follow-up|2|||
23547930|NCT01990950|65735970|FG000|Overall Study|Withdrawal by Subject|6|||
23547931|NCT00563784|65735972|FG000|Overall Study|Withdrawal by Subject|2|||
23547932|NCT00563784|65735972|FG000|Overall Study|Screen Failures|20|||
23739187|NCT00302731|66425737|FG001|Overall Study|Protocol Violation|0|||
23739188|NCT00302731|66425738|FG002|Overall Study|Protocol Violation|0|||
23739189|NCT00302731|66425739|FG003|Overall Study|Protocol Violation|0|||
23739190|NCT00302731|66425736|FG000|Overall Study|cancer unrelated to study discovered|1|||
23739191|NCT00302731|66425737|FG001|Overall Study|cancer unrelated to study discovered|0|||
23739192|NCT00302731|66425738|FG002|Overall Study|cancer unrelated to study discovered|1|||
23739193|NCT00302731|66425739|FG003|Overall Study|cancer unrelated to study discovered|0|||
23739194|NCT04594213|66425740|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23739195|NCT04594213|66425741|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
23739196|NCT04594213|66425742|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
23739197|NCT04594213|66425743|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23739198|NCT04594213|66425744|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23739199|NCT04594213|66425745|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23739200|NCT04594213|66425740|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23739201|NCT04594213|66425741|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
23739202|NCT04594213|66425742|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23739203|NCT04594213|66425743|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23739204|NCT04594213|66425744|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23739205|NCT04594213|66425745|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23739206|NCT04594213|66425740|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23739207|NCT04594213|66425741|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23739208|NCT04594213|66425742|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23739209|NCT04594213|66425743|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23739210|NCT04594213|66425744|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23739211|NCT04594213|66425745|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23739212|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23739213|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23739214|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23739215|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23739216|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
23739217|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23739218|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23739219|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23739220|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23739221|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
23739222|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
23739223|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
23739224|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23739225|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23739226|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23739227|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23739228|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23739229|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
23739230|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23739231|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23739232|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23739233|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
23739234|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23739235|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23739236|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23739237|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23739238|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23739239|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
23739240|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23739241|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23739242|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23739243|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23739244|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23739245|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
23739246|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
23547933|NCT00936858|65735973|FG000|Overall Study|Death|3|||
23739247|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
23739248|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23739249|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23739250|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23739251|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
23739252|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
23739253|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
23739254|NCT04594213|66425740|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
23739255|NCT04594213|66425741|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
23739256|NCT04594213|66425742|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
23739257|NCT04594213|66425743|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
23739258|NCT04594213|66425744|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
23739259|NCT04594213|66425745|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
23739260|NCT00121485|66425746|FG000|Overall Study|Not implanted|1|||
23739261|NCT00121485|66425747|FG001|Overall Study|Not implanted|5|||
23739262|NCT00121485|66425746|FG000|Overall Study|Crossover|0|||
23739263|NCT00121485|66425747|FG001|Overall Study|Crossover|2|||
23739264|NCT01087944|66425750|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
23739265|NCT01087944|66425751|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
23739266|NCT01087944|66425750|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
23739267|NCT01087944|66425751|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
23739268|NCT01883362|66425756|FG000|Treatment|Adverse Event|1|||
23739269|NCT01883362|66425757|FG001|Treatment|Adverse Event|8|||
23739270|NCT01883362|66425756|FG000|Treatment|Withdrawal by Subject|6|||
23739271|NCT01883362|66425757|FG001|Treatment|Withdrawal by Subject|2|||
23739272|NCT01883362|66425756|FG000|Treatment|Administrative problems|4|||
23739273|NCT01883362|66425757|FG001|Treatment|Administrative problems|1|||
23739274|NCT01883362|66425756|FG000|Treatment|Relapse|4|||
23739275|NCT01883362|66425757|FG001|Treatment|Relapse|2|||
23820483|NCT02960490|66721351|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820484|NCT02960490|66721352|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
23820485|NCT02960490|66721353|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
23820486|NCT02960490|66721354|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
23820487|NCT02960490|66721355|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23820488|NCT02960490|66721346|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820489|NCT02960490|66721347|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820490|NCT02960490|66721348|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820491|NCT02960490|66721349|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820492|NCT02960490|66721350|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820493|NCT02960490|66721351|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820494|NCT02960490|66721352|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820495|NCT02960490|66721353|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
23739276|NCT01883362|66425756|FG000|Treatment|Randomized, not treated|1|||
23739277|NCT01883362|66425757|FG001|Treatment|Randomized, not treated|1|||
23739278|NCT01883362|66425756|FG000|Post Treatment Follow-up|Protocol Violation|0|||
23739279|NCT01883362|66425757|FG001|Post Treatment Follow-up|Protocol Violation|1|||
23739280|NCT01883362|66425756|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
23739281|NCT01883362|66425757|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
23739282|NCT01883362|66425756|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
23739283|NCT01883362|66425757|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
23739284|NCT01883362|66425756|FG000|Post Treatment Follow-up|Administrative problems|2|||
23739285|NCT01883362|66425757|FG001|Post Treatment Follow-up|Administrative problems|0|||
23739286|NCT01883362|66425756|FG000|Post Treatment Follow-up|Death|8|||
23739287|NCT01883362|66425757|FG001|Post Treatment Follow-up|Death|4|||
23739288|NCT01883362|66425756|FG000|Post Treatment Follow-up|Relapse|1|||
23739289|NCT01883362|66425757|FG001|Post Treatment Follow-up|Relapse|2|||
23739290|NCT00211536|66425758|FG000|Overall Study|Withdrawal by Subject|2|||
23739291|NCT00211536|66425759|FG001|Overall Study|Withdrawal by Subject|2|||
23739292|NCT00211536|66425758|FG000|Overall Study|Physician Decision|0|||
23739293|NCT00211536|66425759|FG001|Overall Study|Physician Decision|5|||
23739294|NCT00211536|66425758|FG000|Overall Study|Adverse Event|2|||
23739295|NCT00211536|66425759|FG001|Overall Study|Adverse Event|0|||
23739296|NCT01823991|66425760|FG000|Overall Study|Withdrawal by Subject|8|||
23739297|NCT01823991|66425761|FG001|Overall Study|Withdrawal by Subject|5|||
23739298|NCT02743494|66425762|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
23739299|NCT02743494|66425763|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
23739300|NCT02743494|66425762|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
23739301|NCT02743494|66425763|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
23820496|NCT02960490|66721354|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23739302|NCT02743494|66425762|FG000|Treatment Period|Completed treatment|229|||
23739303|NCT02743494|66425763|FG001|Treatment Period|Completed treatment|99|||
23427535|NCT00711802|65310502|FG002|Overall Study|Adverse Event|0|||
23427536|NCT00711802|65310503|FG003|Overall Study|Adverse Event|0|||
23427537|NCT00711802|65310504|FG004|Overall Study|Adverse Event|1|||
23427538|NCT00711802|65310505|FG005|Overall Study|Adverse Event|1|||
23427539|NCT00711802|65310506|FG006|Overall Study|Adverse Event|0|||
23427540|NCT00711802|65310507|FG007|Overall Study|Adverse Event|0|||
23427541|NCT00711802|65310500|FG000|Overall Study|Microbiological failure|0|||
23427542|NCT00711802|65310501|FG001|Overall Study|Microbiological failure|1|||
23427543|NCT00711802|65310502|FG002|Overall Study|Microbiological failure|0|||
23427544|NCT00711802|65310503|FG003|Overall Study|Microbiological failure|0|||
23427545|NCT00711802|65310504|FG004|Overall Study|Microbiological failure|0|||
23427546|NCT00711802|65310505|FG005|Overall Study|Microbiological failure|1|||
23427547|NCT00711802|65310506|FG006|Overall Study|Microbiological failure|0|||
23427548|NCT00711802|65310507|FG007|Overall Study|Microbiological failure|0|||
23427549|NCT00711802|65310500|FG000|Overall Study|Protocol Violation|0|||
23427550|NCT00711802|65310501|FG001|Overall Study|Protocol Violation|0|||
23427551|NCT00711802|65310502|FG002|Overall Study|Protocol Violation|0|||
23427552|NCT00711802|65310503|FG003|Overall Study|Protocol Violation|1|||
23427553|NCT00711802|65310504|FG004|Overall Study|Protocol Violation|0|||
23427554|NCT00711802|65310505|FG005|Overall Study|Protocol Violation|0|||
23427555|NCT00711802|65310506|FG006|Overall Study|Protocol Violation|0|||
23427556|NCT00711802|65310507|FG007|Overall Study|Protocol Violation|0|||
23427557|NCT00711802|65310500|FG000|Overall Study|Physician Decision|0|||
23427558|NCT00711802|65310501|FG001|Overall Study|Physician Decision|2|||
23427559|NCT00711802|65310502|FG002|Overall Study|Physician Decision|0|||
23427560|NCT00711802|65310503|FG003|Overall Study|Physician Decision|0|||
23427561|NCT00711802|65310504|FG004|Overall Study|Physician Decision|0|||
23427562|NCT00711802|65310505|FG005|Overall Study|Physician Decision|0|||
23427563|NCT00711802|65310506|FG006|Overall Study|Physician Decision|0|||
23427564|NCT00711802|65310507|FG007|Overall Study|Physician Decision|0|||
23427565|NCT00711802|65310500|FG000|Overall Study|Withdrawal by Subject|0|||
23427566|NCT00711802|65310501|FG001|Overall Study|Withdrawal by Subject|1|||
23427567|NCT00711802|65310502|FG002|Overall Study|Withdrawal by Subject|0|||
23427568|NCT00711802|65310503|FG003|Overall Study|Withdrawal by Subject|1|||
23427569|NCT00711802|65310504|FG004|Overall Study|Withdrawal by Subject|0|||
23427570|NCT00711802|65310505|FG005|Overall Study|Withdrawal by Subject|0|||
23427571|NCT00711802|65310506|FG006|Overall Study|Withdrawal by Subject|0|||
23427572|NCT00711802|65310507|FG007|Overall Study|Withdrawal by Subject|0|||
23427573|NCT00711802|65310500|FG000|Overall Study|Lost to Follow-up|0|||
23427574|NCT00711802|65310501|FG001|Overall Study|Lost to Follow-up|0|||
23427575|NCT00711802|65310502|FG002|Overall Study|Lost to Follow-up|3|||
23427576|NCT00711802|65310503|FG003|Overall Study|Lost to Follow-up|1|||
23427577|NCT00711802|65310504|FG004|Overall Study|Lost to Follow-up|10|||
23427578|NCT00711802|65310505|FG005|Overall Study|Lost to Follow-up|6|||
23427579|NCT00711802|65310506|FG006|Overall Study|Lost to Follow-up|4|||
23427580|NCT00711802|65310507|FG007|Overall Study|Lost to Follow-up|2|||
23427581|NCT00711802|65310500|FG000|Overall Study|Reason not reported|0|||
23427582|NCT00711802|65310501|FG001|Overall Study|Reason not reported|1|||
23427583|NCT00711802|65310502|FG002|Overall Study|Reason not reported|1|||
23427584|NCT00711802|65310503|FG003|Overall Study|Reason not reported|0|||
23427585|NCT00711802|65310504|FG004|Overall Study|Reason not reported|1|||
23427586|NCT00711802|65310505|FG005|Overall Study|Reason not reported|0|||
23427587|NCT00711802|65310506|FG006|Overall Study|Reason not reported|1|||
23427588|NCT00711802|65310507|FG007|Overall Study|Reason not reported|0|||
23427589|NCT03283150|65310508|FG000|Overall Study|Withdrawal by Subject|6|||
23427590|NCT03283150|65310509|FG001|Overall Study|Withdrawal by Subject|0|||
23427591|NCT03283150|65310510|FG002|Overall Study|Withdrawal by Subject|0|||
23427592|NCT03869333|65310511|FG000|Overall Study|Lost to Follow-up|1|||
23427593|NCT03869333|65310512|FG001|Overall Study|Lost to Follow-up|0|||
23427594|NCT03869333|65310513|FG002|Overall Study|Lost to Follow-up|0|||
23427595|NCT03869333|65310514|FG003|Overall Study|Lost to Follow-up|0|||
23820497|NCT02960490|66721355|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23820498|NCT02960490|66721346|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23820499|NCT02960490|66721347|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23427596|NCT03869333|65310511|FG000|Overall Study|Pregnancy|1|||
23427597|NCT03869333|65310512|FG001|Overall Study|Pregnancy|0|||
23427598|NCT03869333|65310513|FG002|Overall Study|Pregnancy|0|||
23427599|NCT03869333|65310514|FG003|Overall Study|Pregnancy|0|||
23427600|NCT03869333|65310511|FG000|Overall Study|Physician Decision|0|||
23427601|NCT03869333|65310512|FG001|Overall Study|Physician Decision|1|||
23427602|NCT03869333|65310513|FG002|Overall Study|Physician Decision|0|||
23427603|NCT03869333|65310514|FG003|Overall Study|Physician Decision|0|||
23427604|NCT00490139|65310515|FG000|Overall Study|Death|106|||
23427605|NCT00490139|65310516|FG001|Overall Study|Death|119|||
23427606|NCT00490139|65310517|FG002|Overall Study|Death|168|||
23427607|NCT00490139|65310518|FG003|Overall Study|Death|135|||
23427608|NCT00490139|65310515|FG000|Overall Study|Lost to Follow-up|56|||
23427609|NCT00490139|65310516|FG001|Overall Study|Lost to Follow-up|46|||
23427610|NCT00490139|65310517|FG002|Overall Study|Lost to Follow-up|58|||
23820500|NCT02960490|66721348|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23820501|NCT02960490|66721349|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23547934|NCT00936858|65735973|FG000|Overall Study|Progression|29|||
23547935|NCT00936858|65735973|FG000|Overall Study|Withdrawal by Subject|5|||
23547936|NCT00936858|65735973|FG000|Overall Study|Adverse Event|1|||
23547937|NCT00936858|65735973|FG000|Overall Study|Physician Decision|7|||
23547938|NCT00936858|65735973|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
23547939|NCT00936858|65735973|FG000|Overall Study|Lost to Follow-up|1|||
23547940|NCT02777593|65735974|FG000|Overall Study|Still in study|28|||
23547941|NCT02777593|65735975|FG001|Overall Study|Still in study|71|||
23547942|NCT02777593|65735976|FG002|Overall Study|Still in study|5|||
23547943|NCT02777593|65735977|FG003|Overall Study|Still in study|6|||
23547944|NCT02777593|65735978|FG004|Overall Study|Still in study|6|||
23547945|NCT02777593|65735974|FG000|Overall Study|Death|19|||
23547946|NCT02777593|65735975|FG001|Overall Study|Death|24|||
23547947|NCT02777593|65735976|FG002|Overall Study|Death|0|||
23547948|NCT02777593|65735977|FG003|Overall Study|Death|5|||
23547949|NCT02777593|65735978|FG004|Overall Study|Death|0|||
23547950|NCT02777593|65735974|FG000|Overall Study|Withdrawal by Subject|6|||
23547951|NCT02777593|65735975|FG001|Overall Study|Withdrawal by Subject|3|||
23547952|NCT02777593|65735976|FG002|Overall Study|Withdrawal by Subject|1|||
23547953|NCT02777593|65735977|FG003|Overall Study|Withdrawal by Subject|1|||
23547954|NCT02777593|65735978|FG004|Overall Study|Withdrawal by Subject|0|||
23547955|NCT02777593|65735974|FG000|Overall Study|Lost to Follow-up|4|||
23547956|NCT02777593|65735975|FG001|Overall Study|Lost to Follow-up|12|||
23547957|NCT02777593|65735976|FG002|Overall Study|Lost to Follow-up|4|||
23547958|NCT02777593|65735977|FG003|Overall Study|Lost to Follow-up|0|||
23547959|NCT02777593|65735978|FG004|Overall Study|Lost to Follow-up|0|||
23547960|NCT02777593|65735974|FG000|Overall Study|Physician Decision|2|||
23547961|NCT02777593|65735975|FG001|Overall Study|Physician Decision|2|||
23547962|NCT02777593|65735976|FG002|Overall Study|Physician Decision|0|||
23547963|NCT02777593|65735977|FG003|Overall Study|Physician Decision|0|||
23547964|NCT02777593|65735978|FG004|Overall Study|Physician Decision|0|||
23547965|NCT02777593|65735974|FG000|Overall Study|Discontinued due to Other|3|||
23547966|NCT02777593|65735975|FG001|Overall Study|Discontinued due to Other|0|||
23547967|NCT02777593|65735976|FG002|Overall Study|Discontinued due to Other|0|||
23547968|NCT02777593|65735977|FG003|Overall Study|Discontinued due to Other|0|||
23547969|NCT02777593|65735978|FG004|Overall Study|Discontinued due to Other|0|||
23547970|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
23547971|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
23547972|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
23547973|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
23547974|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
23547975|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
23547976|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
23547977|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
23547978|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
23547979|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
23547980|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
23547981|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
23547982|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
23547983|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
23547984|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
23547985|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
23547986|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
23547987|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
23547988|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
23547989|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
23547990|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
23820502|NCT02960490|66721350|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23820503|NCT02960490|66721351|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23820504|NCT02960490|66721352|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
23547991|NCT01781572|65735979|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
23547992|NCT01781572|65735980|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
23547993|NCT01781572|65735981|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
23547994|NCT01781572|65735979|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
23547995|NCT01781572|65735980|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
23547996|NCT01781572|65735981|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
23547997|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
23547998|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
23547999|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
23548000|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
23548001|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
23820505|NCT02960490|66721353|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
23820506|NCT02960490|66721354|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
23820507|NCT02960490|66721355|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
23820508|NCT02960490|66721346|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820509|NCT02960490|66721347|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820510|NCT02960490|66721348|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820511|NCT02960490|66721349|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820512|NCT02960490|66721350|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820513|NCT02960490|66721351|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820514|NCT02960490|66721352|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
23820515|NCT02960490|66721353|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820516|NCT02960490|66721354|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820517|NCT02960490|66721355|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23820518|NCT02960490|66721346|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820519|NCT02960490|66721347|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820520|NCT02960490|66721348|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820521|NCT02960490|66721349|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820522|NCT02960490|66721350|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820523|NCT02960490|66721351|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820524|NCT02960490|66721352|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820525|NCT02960490|66721353|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
23820526|NCT02960490|66721354|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820527|NCT02960490|66721355|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
23820528|NCT01408043|66721356|FG000|Overall Study|unable to collect cells|1|||
23820529|NCT00660907|66721358|FG000|Overall Study|Incorrect Enrollment|1|||
23820530|NCT00660907|66721359|FG001|Overall Study|Incorrect Enrollment|1|||
23820531|NCT00660907|66721358|FG000|Overall Study|Adverse Event|33|||
23820532|NCT00660907|66721359|FG001|Overall Study|Adverse Event|19|||
23820533|NCT00660907|66721358|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
23820534|NCT00660907|66721359|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
23820535|NCT00660907|66721358|FG000|Overall Study|Withdrawal by Subject|23|||
23820536|NCT00660907|66721359|FG001|Overall Study|Withdrawal by Subject|32|||
23820537|NCT00660907|66721358|FG000|Overall Study|Lost to Follow-up|3|||
23820538|NCT00660907|66721359|FG001|Overall Study|Lost to Follow-up|3|||
23820539|NCT00660907|66721358|FG000|Overall Study|Poor/Non-Compliance|5|||
23820540|NCT00660907|66721359|FG001|Overall Study|Poor/Non-Compliance|1|||
23820541|NCT00660907|66721358|FG000|Overall Study|Safety|1|||
23820542|NCT00660907|66721359|FG001|Overall Study|Safety|0|||
23820543|NCT00660907|66721358|FG000|Overall Study|Death|1|||
23820544|NCT00660907|66721359|FG001|Overall Study|Death|3|||
23820545|NCT00660907|66721358|FG000|Overall Study|Various|11|||
23820546|NCT00660907|66721359|FG001|Overall Study|Various|8|||
23820547|NCT00243412|66721360|FG000|Overall Study|Death|0|||
23820548|NCT00243412|66721361|FG001|Overall Study|Death|1|||
23820549|NCT00243412|66721360|FG000|Overall Study|Adverse Event|4|||
23820550|NCT00243412|66721361|FG001|Overall Study|Adverse Event|2|||
23820551|NCT00243412|66721360|FG000|Overall Study|Lost to Follow-up|0|||
23820552|NCT00243412|66721361|FG001|Overall Study|Lost to Follow-up|1|||
23820553|NCT00243412|66721360|FG000|Overall Study|Physician Decision|1|||
23820554|NCT00243412|66721361|FG001|Overall Study|Physician Decision|1|||
23820555|NCT00243412|66721360|FG000|Overall Study|Withdrawal by Subject|4|||
23820556|NCT00243412|66721361|FG001|Overall Study|Withdrawal by Subject|5|||
23820557|NCT00243412|66721360|FG000|Overall Study|Other|1|||
23820558|NCT00243412|66721361|FG001|Overall Study|Other|1|||
23820559|NCT02764151|66721362|FG000|Overall Study|Subject refused further follow-up|0|||
23820560|NCT02764151|66721363|FG001|Overall Study|Subject refused further follow-up|0|||
23820561|NCT02764151|66721364|FG002|Overall Study|Subject refused further follow-up|0|||
23820562|NCT02764151|66721365|FG003|Overall Study|Subject refused further follow-up|1|||
23820563|NCT02764151|66721362|FG000|Overall Study|Other|0|||
23820564|NCT02764151|66721363|FG001|Overall Study|Other|0|||
23820565|NCT02764151|66721364|FG002|Overall Study|Other|0|||
23820566|NCT02764151|66721365|FG003|Overall Study|Other|2|||
23820567|NCT00696787|66721371|FG000|Overall Study|Adverse Event|1|||
23820568|NCT00696787|66721372|FG001|Overall Study|Adverse Event|0|||
23619653|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
23820569|NCT00696787|66721373|FG002|Overall Study|Adverse Event|6|||
23820570|NCT00696787|66721371|FG000|Overall Study|Discontinuation by Sponsor|9|||
23820571|NCT00696787|66721372|FG001|Overall Study|Discontinuation by Sponsor|13|||
23820572|NCT00696787|66721373|FG002|Overall Study|Discontinuation by Sponsor|14|||
23820573|NCT00696787|66721371|FG000|Overall Study|Lack of Efficacy|0|||
23820574|NCT00696787|66721372|FG001|Overall Study|Lack of Efficacy|1|||
23820575|NCT00696787|66721373|FG002|Overall Study|Lack of Efficacy|0|||
23820576|NCT00696787|66721371|FG000|Overall Study|Lost to Follow-up|4|||
23820577|NCT00696787|66721372|FG001|Overall Study|Lost to Follow-up|0|||
23820578|NCT00696787|66721373|FG002|Overall Study|Lost to Follow-up|3|||
23427611|NCT00490139|65310518|FG003|Overall Study|Lost to Follow-up|56|||
23427612|NCT00490139|65310515|FG000|Overall Study|Participant Withdrew Consent|146|||
23427613|NCT00490139|65310516|FG001|Overall Study|Participant Withdrew Consent|110|||
23427614|NCT00490139|65310517|FG002|Overall Study|Participant Withdrew Consent|208|||
23427615|NCT00490139|65310518|FG003|Overall Study|Participant Withdrew Consent|116|||
23427616|NCT01066780|65310519|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
23427617|NCT01066780|65310520|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
23427618|NCT02876328|65310524|FG000|Overall Study|Death|2|||
23427619|NCT02876328|65310525|FG001|Overall Study|Death|1|||
23427620|NCT02876328|65310526|FG002|Overall Study|Death|3|||
23427621|NCT02876328|65310527|FG003|Overall Study|Death|0|||
23427622|NCT02876328|65310528|FG004|Overall Study|Death|0|||
23427623|NCT02876328|65310529|FG005|Overall Study|Death|0|||
23427624|NCT02876328|65310530|FG006|Overall Study|Death|1|||
23427625|NCT02876328|65310531|FG007|Overall Study|Death|3|||
23427626|NCT02876328|65310532|FG008|Overall Study|Death|0|||
23427627|NCT02876328|65310533|FG009|Overall Study|Death|1|||
23427628|NCT02876328|65310534|FG010|Overall Study|Death|1|||
23427629|NCT02876328|65310535|FG011|Overall Study|Death|0|||
23427630|NCT02876328|65310536|FG012|Overall Study|Death|0|||
23427631|NCT02876328|65310537|FG013|Overall Study|Death|0|||
23427632|NCT02876328|65310538|FG014|Overall Study|Death|0|||
23427633|NCT02876328|65310539|FG015|Overall Study|Death|0|||
23427634|NCT02876328|65310540|FG016|Overall Study|Death|1|||
23427635|NCT02876328|65310541|FG017|Overall Study|Death|1|||
23427636|NCT02876328|65310542|FG018|Overall Study|Death|0|||
23427637|NCT02876328|65310543|FG019|Overall Study|Death|0|||
23427638|NCT02876328|65310544|FG020|Overall Study|Death|0|||
23427639|NCT02876328|65310545|FG021|Overall Study|Death|1|||
23427640|NCT02876328|65310546|FG022|Overall Study|Death|0|||
23427641|NCT02876328|65310547|FG023|Overall Study|Death|0|||
23427642|NCT02876328|65310524|FG000|Overall Study|Withdrawal by Subject|0|||
23427643|NCT02876328|65310525|FG001|Overall Study|Withdrawal by Subject|2|||
23427644|NCT02876328|65310526|FG002|Overall Study|Withdrawal by Subject|3|||
23427645|NCT02876328|65310527|FG003|Overall Study|Withdrawal by Subject|3|||
23427646|NCT02876328|65310528|FG004|Overall Study|Withdrawal by Subject|0|||
23427647|NCT02876328|65310529|FG005|Overall Study|Withdrawal by Subject|1|||
23427648|NCT02876328|65310530|FG006|Overall Study|Withdrawal by Subject|0|||
23427649|NCT02876328|65310531|FG007|Overall Study|Withdrawal by Subject|1|||
23427650|NCT02876328|65310532|FG008|Overall Study|Withdrawal by Subject|1|||
23427651|NCT02876328|65310533|FG009|Overall Study|Withdrawal by Subject|2|||
23427652|NCT02876328|65310534|FG010|Overall Study|Withdrawal by Subject|0|||
23548002|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
23548003|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
23548004|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
23548005|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
23548006|NCT01781572|65735979|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
23548007|NCT01781572|65735980|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
23548008|NCT01781572|65735981|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
23427653|NCT02876328|65310535|FG011|Overall Study|Withdrawal by Subject|0|||
23427654|NCT02876328|65310536|FG012|Overall Study|Withdrawal by Subject|0|||
23427655|NCT02876328|65310537|FG013|Overall Study|Withdrawal by Subject|0|||
23427656|NCT02876328|65310538|FG014|Overall Study|Withdrawal by Subject|0|||
23427657|NCT02876328|65310539|FG015|Overall Study|Withdrawal by Subject|0|||
23427658|NCT02876328|65310540|FG016|Overall Study|Withdrawal by Subject|1|||
23427659|NCT02876328|65310541|FG017|Overall Study|Withdrawal by Subject|3|||
23427660|NCT02876328|65310542|FG018|Overall Study|Withdrawal by Subject|0|||
23427661|NCT02876328|65310543|FG019|Overall Study|Withdrawal by Subject|0|||
23427662|NCT02876328|65310544|FG020|Overall Study|Withdrawal by Subject|1|||
23427663|NCT02876328|65310545|FG021|Overall Study|Withdrawal by Subject|0|||
23427664|NCT02876328|65310546|FG022|Overall Study|Withdrawal by Subject|0|||
23427665|NCT02876328|65310547|FG023|Overall Study|Withdrawal by Subject|0|||
23427666|NCT02876328|65310524|FG000|Overall Study|Missed 12 Month Visit|15|||
23427667|NCT02876328|65310525|FG001|Overall Study|Missed 12 Month Visit|10|||
23427668|NCT02876328|65310526|FG002|Overall Study|Missed 12 Month Visit|11|||
23427669|NCT02876328|65310527|FG003|Overall Study|Missed 12 Month Visit|6|||
23427670|NCT02876328|65310528|FG004|Overall Study|Missed 12 Month Visit|10|||
23427671|NCT02876328|65310529|FG005|Overall Study|Missed 12 Month Visit|14|||
23427672|NCT02876328|65310530|FG006|Overall Study|Missed 12 Month Visit|3|||
23427673|NCT02876328|65310531|FG007|Overall Study|Missed 12 Month Visit|8|||
23427674|NCT02876328|65310532|FG008|Overall Study|Missed 12 Month Visit|9|||
23427675|NCT02876328|65310533|FG009|Overall Study|Missed 12 Month Visit|5|||
23427676|NCT02876328|65310534|FG010|Overall Study|Missed 12 Month Visit|4|||
23427677|NCT02876328|65310535|FG011|Overall Study|Missed 12 Month Visit|1|||
23427678|NCT02876328|65310536|FG012|Overall Study|Missed 12 Month Visit|5|||
23427679|NCT02876328|65310537|FG013|Overall Study|Missed 12 Month Visit|4|||
23427680|NCT02876328|65310538|FG014|Overall Study|Missed 12 Month Visit|4|||
23427681|NCT02876328|65310539|FG015|Overall Study|Missed 12 Month Visit|4|||
23427682|NCT02876328|65310540|FG016|Overall Study|Missed 12 Month Visit|3|||
23820579|NCT00696787|66721371|FG000|Overall Study|Withdrawal by Subject|0|||
23820580|NCT00696787|66721372|FG001|Overall Study|Withdrawal by Subject|3|||
23820581|NCT00696787|66721373|FG002|Overall Study|Withdrawal by Subject|2|||
23820582|NCT00696787|66721371|FG000|Overall Study|Failed to return|1|||
23820583|NCT00696787|66721372|FG001|Overall Study|Failed to return|3|||
23820584|NCT00696787|66721373|FG002|Overall Study|Failed to return|1|||
23548009|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
23548010|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
23548011|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
23548012|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
23548013|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
23548014|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
23548015|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
23548016|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
23548017|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
23548018|NCT01781572|65735979|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
23548019|NCT01781572|65735980|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
23548020|NCT01781572|65735981|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
23548021|NCT01781572|65735979|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
23548022|NCT01781572|65735980|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
23820585|NCT03760185|66721374|FG000|Overall Study|Lost to Follow-up|1|||
23820586|NCT03760185|66721375|FG001|Overall Study|Lost to Follow-up|1|||
23820587|NCT00000620|66721382|FG000|Overall Study|Death|86|||
23820588|NCT00000620|66721383|FG001|Overall Study|Death|67|||
23820589|NCT00000620|66721384|FG002|Overall Study|Death|112|||
23820590|NCT00000620|66721385|FG003|Overall Study|Death|126|||
23820591|NCT00000620|66721386|FG004|Overall Study|Death|64|||
23820592|NCT00000620|66721387|FG005|Overall Study|Death|77|||
23820593|NCT00000620|66721388|FG006|Overall Study|Death|91|||
23820594|NCT00000620|66721389|FG007|Overall Study|Death|95|||
23820595|NCT00000620|66721382|FG000|Overall Study|Lost to Follow-up|14|||
23820596|NCT00000620|66721383|FG001|Overall Study|Lost to Follow-up|14|||
23820597|NCT00000620|66721384|FG002|Overall Study|Lost to Follow-up|14|||
23820598|NCT00000620|66721385|FG003|Overall Study|Lost to Follow-up|14|||
23820599|NCT00000620|66721386|FG004|Overall Study|Lost to Follow-up|15|||
23820600|NCT00000620|66721387|FG005|Overall Study|Lost to Follow-up|15|||
23820601|NCT00000620|66721388|FG006|Overall Study|Lost to Follow-up|13|||
23820602|NCT00000620|66721389|FG007|Overall Study|Lost to Follow-up|14|||
23820603|NCT00000620|66721382|FG000|Overall Study|Withdrawal by Subject|40|||
23820604|NCT00000620|66721383|FG001|Overall Study|Withdrawal by Subject|27|||
23820605|NCT00000620|66721384|FG002|Overall Study|Withdrawal by Subject|28|||
23820606|NCT00000620|66721385|FG003|Overall Study|Withdrawal by Subject|27|||
23820607|NCT00000620|66721386|FG004|Overall Study|Withdrawal by Subject|30|||
23820608|NCT00000620|66721387|FG005|Overall Study|Withdrawal by Subject|32|||
23820609|NCT00000620|66721388|FG006|Overall Study|Withdrawal by Subject|32|||
23820610|NCT00000620|66721389|FG007|Overall Study|Withdrawal by Subject|21|||
23820611|NCT00000620|66721382|FG000|Overall Study|missed closeout visit|22|||
23820612|NCT00000620|66721383|FG001|Overall Study|missed closeout visit|28|||
23820613|NCT00000620|66721384|FG002|Overall Study|missed closeout visit|16|||
23820614|NCT00000620|66721385|FG003|Overall Study|missed closeout visit|11|||
23820615|NCT00000620|66721386|FG004|Overall Study|missed closeout visit|26|||
23820616|NCT00000620|66721387|FG005|Overall Study|missed closeout visit|28|||
23820617|NCT00000620|66721388|FG006|Overall Study|missed closeout visit|13|||
23820618|NCT00000620|66721389|FG007|Overall Study|missed closeout visit|16|||
23820619|NCT01121562|66721394|FG000|Overall Study|Objective progression or relapse|8|||
23820620|NCT01121562|66721394|FG000|Overall Study|Withdrawal by Subject|1|||
23820621|NCT01121562|66721394|FG000|Overall Study|Adverse Event|1|||
23820622|NCT01121562|66721394|FG000|Overall Study|Sponsor Decision|1|||
23820623|NCT01121562|66721394|FG000|Overall Study|Met study discontinuation criteria|1|||
23820624|NCT01308424|66721395|FG000|Baseline Eligibility|Screen Failures|71|||
23820625|NCT01308424|66721396|FG001|Baseline Eligibility|Screen Failures|0|||
23427683|NCT02876328|65310541|FG017|Overall Study|Missed 12 Month Visit|6|||
23427684|NCT02876328|65310542|FG018|Overall Study|Missed 12 Month Visit|2|||
23427685|NCT02876328|65310543|FG019|Overall Study|Missed 12 Month Visit|2|||
23619654|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
23820626|NCT01308424|66721397|FG002|Baseline Eligibility|Screen Failures|0|||
23820627|NCT01308424|66721395|FG000|Randomization|Adverse Event|0|||
23820628|NCT01308424|66721396|FG001|Randomization|Adverse Event|1|||
23820629|NCT01308424|66721397|FG002|Randomization|Adverse Event|1|||
23820630|NCT01308424|66721395|FG000|Randomization|Lost to Follow-up|0|||
23820631|NCT01308424|66721396|FG001|Randomization|Lost to Follow-up|1|||
23820632|NCT01308424|66721397|FG002|Randomization|Lost to Follow-up|0|||
23820633|NCT01308424|66721395|FG000|Randomization|Physician Decision|0|||
23820634|NCT01308424|66721396|FG001|Randomization|Physician Decision|1|||
23820635|NCT01308424|66721397|FG002|Randomization|Physician Decision|1|||
23820636|NCT00786409|66721398|FG000|Overall Study|Withdrawal by Subject|2|||
23820637|NCT00786409|66721398|FG000|Overall Study|Adverse Event|2|||
23820638|NCT00786409|66721398|FG000|Overall Study|Pregnancy|2|||
23820639|NCT00786409|66721398|FG000|Overall Study|Lost to Follow-up|1|||
23820640|NCT01783886|66721402|FG000|Overall Study|Lost to Follow-up|0|||
23820641|NCT01783886|66721403|FG001|Overall Study|Lost to Follow-up|3|||
23820642|NCT01783886|66721404|FG002|Overall Study|Lost to Follow-up|0|||
23820643|NCT01783886|66721402|FG000|Overall Study|Protocol deviation|0|||
23820644|NCT01783886|66721403|FG001|Overall Study|Protocol deviation|0|||
23820645|NCT01783886|66721404|FG002|Overall Study|Protocol deviation|2|||
23739304|NCT02743494|66425762|FG000|Treatment Period|Disease recurrence|149|||
23739305|NCT02743494|66425763|FG001|Treatment Period|Disease recurrence|113|||
23739306|NCT02743494|66425762|FG000|Treatment Period|Study drug toxicity|57|||
23739307|NCT02743494|66425763|FG001|Treatment Period|Study drug toxicity|8|||
23739308|NCT02743494|66425762|FG000|Treatment Period|Death|1|||
23739309|NCT02743494|66425763|FG001|Treatment Period|Death|0|||
23739310|NCT02743494|66425762|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
23739311|NCT02743494|66425763|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
23739312|NCT02743494|66425762|FG000|Treatment Period|Participant request to discontinue treatment|30|||
23739313|NCT02743494|66425763|FG001|Treatment Period|Participant request to discontinue treatment|5|||
23739314|NCT02743494|66425762|FG000|Treatment Period|Participant withdrew consent|12|||
23548023|NCT01781572|65735981|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
23820646|NCT01783886|66721402|FG000|Overall Study|Withdrawal of consent by participant|1|||
23820647|NCT01783886|66721403|FG001|Overall Study|Withdrawal of consent by participant|3|||
23820648|NCT01783886|66721404|FG002|Overall Study|Withdrawal of consent by participant|4|||
23820649|NCT01783886|66721402|FG000|Overall Study|Adverse Event|4|||
23820650|NCT01783886|66721403|FG001|Overall Study|Adverse Event|5|||
23820651|NCT01783886|66721404|FG002|Overall Study|Adverse Event|4|||
23820652|NCT04807400|66721405|FG000|Overall Study|Adverse Event|2|||
23820653|NCT04807400|66721406|FG001|Overall Study|Adverse Event|3|||
23820654|NCT04807400|66721407|FG002|Overall Study|Adverse Event|3|||
23820655|NCT04807400|66721405|FG000|Overall Study|Death|2|||
23820656|NCT04807400|66721406|FG001|Overall Study|Death|0|||
23820657|NCT04807400|66721407|FG002|Overall Study|Death|0|||
23820658|NCT04807400|66721405|FG000|Overall Study|Lost to Follow-up|8|||
23820659|NCT04807400|66721406|FG001|Overall Study|Lost to Follow-up|6|||
23820660|NCT04807400|66721407|FG002|Overall Study|Lost to Follow-up|6|||
23548024|NCT01693120|65735982|FG000|Enrollment|Lost to Follow-up|1|||
23548025|NCT01693120|65735982|FG000|Enrollment|Withdrawal by Subject|10|||
23548026|NCT01693120|65735982|FG000|Enrollment|Protocol Violation|46|||
23548027|NCT01693120|65735982|FG000|Enrollment|Physician Decision|3|||
23548028|NCT01693120|65735982|FG000|Enrollment|Adverse Event|1|||
23548029|NCT01693120|65735982|FG000|Enrollment|Study closed|8|||
23548030|NCT01693120|65735982|FG000|Enrollment|Other|1|||
23548031|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
23548032|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
23548033|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
23548034|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
23548035|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
23548036|NCT02911948|65735983|FG000|Overall Study|Protocol Violation|0|||
23820661|NCT04807400|66721405|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23820662|NCT04807400|66721406|FG001|Overall Study|Non-Compliance With Study Drug|4|||
23820663|NCT04807400|66721407|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23820664|NCT04807400|66721405|FG000|Overall Study|Participant Decision|20|||
23820665|NCT04807400|66721406|FG001|Overall Study|Participant Decision|19|||
23820666|NCT04807400|66721407|FG002|Overall Study|Participant Decision|26|||
23548037|NCT02911948|65735984|FG001|Overall Study|Protocol Violation|1|||
23619655|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
23619656|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
23619657|NCT00088452|65994703|FG000|Overall Study|Did not receive intervention|1|||
23548038|NCT02911948|65735983|FG000|Overall Study|Withdrawal by Subject|0|||
23739315|NCT02743494|66425763|FG001|Treatment Period|Participant withdrew consent|4|||
23548039|NCT02911948|65735984|FG001|Overall Study|Withdrawal by Subject|2|||
23619658|NCT00088452|65994704|FG001|Overall Study|Did not receive intervention|0|||
23619659|NCT00088452|65994705|FG002|Overall Study|Did not receive intervention|1|||
23619660|NCT01772147|65994706|FG000|Overall Study|Adverse Event|13|||
23619661|NCT01772147|65994707|FG001|Overall Study|Adverse Event|10|||
23619662|NCT01772147|65994708|FG002|Overall Study|Adverse Event|6|||
23619663|NCT01772147|65994706|FG000|Overall Study|Withdrew Consent|7|||
23820667|NCT04807400|66721405|FG000|Overall Study|Physician Decision|0|||
23820668|NCT04807400|66721406|FG001|Overall Study|Physician Decision|1|||
23820669|NCT04807400|66721407|FG002|Overall Study|Physician Decision|0|||
23820670|NCT04807400|66721405|FG000|Overall Study|Protocol Violation|4|||
23820671|NCT04807400|66721406|FG001|Overall Study|Protocol Violation|3|||
23820672|NCT04807400|66721407|FG002|Overall Study|Protocol Violation|7|||
23820673|NCT04807400|66721405|FG000|Overall Study|Withdrawal by Subject|13|||
23820674|NCT04807400|66721406|FG001|Overall Study|Withdrawal by Subject|9|||
23820675|NCT04807400|66721407|FG002|Overall Study|Withdrawal by Subject|20|||
23820676|NCT04807400|66721405|FG000|Overall Study|Mis-randomized|1|||
23820677|NCT04807400|66721406|FG001|Overall Study|Mis-randomized|0|||
23820678|NCT04807400|66721407|FG002|Overall Study|Mis-randomized|0|||
23820679|NCT01696279|66725878|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
23820680|NCT01696279|66725879|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23820681|NCT01696279|66725880|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23820682|NCT01696279|66725881|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23820683|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23820684|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
23820685|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23820686|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23820687|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23820688|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
23820689|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23820690|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23548040|NCT02911948|65735983|FG000|Overall Study|Lack of Efficacy|0|||
23548041|NCT02911948|65735984|FG001|Overall Study|Lack of Efficacy|1|||
23548042|NCT02911948|65735983|FG000|Overall Study|Unclassified|0|||
23548043|NCT02911948|65735984|FG001|Overall Study|Unclassified|3|||
23820691|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23820692|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
23820693|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23820694|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23820695|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23820696|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
23820697|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23820698|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23820699|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23820700|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
23820701|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23739316|NCT02743494|66425762|FG000|Treatment Period|Lost to Follow-up|0|||
23739317|NCT02743494|66425763|FG001|Treatment Period|Lost to Follow-up|1|||
23739318|NCT02743494|66425762|FG000|Treatment Period|Poor/Non-compliance|1|||
23739319|NCT02743494|66425763|FG001|Treatment Period|Poor/Non-compliance|0|||
23739320|NCT02743494|66425762|FG000|Treatment Period|Other reasons|7|||
23739321|NCT02743494|66425763|FG001|Treatment Period|Other reasons|2|||
23739322|NCT01667731|66425764|FG000|Overall Study|Enrolled but not treated|0|||
23739323|NCT01667731|66425765|FG001|Overall Study|Enrolled but not treated|0|||
23739324|NCT01667731|66425766|FG002|Overall Study|Enrolled but not treated|0|||
23739325|NCT01667731|66425767|FG003|Overall Study|Enrolled but not treated|0|||
23739326|NCT01667731|66425768|FG004|Overall Study|Enrolled but not treated|1|||
23739327|NCT01667731|66425764|FG000|Overall Study|Efficacy Failure|1|||
23739328|NCT01667731|66425765|FG001|Overall Study|Efficacy Failure|12|||
23739329|NCT01667731|66425766|FG002|Overall Study|Efficacy Failure|0|||
23739330|NCT01667731|66425767|FG003|Overall Study|Efficacy Failure|1|||
23739331|NCT01667731|66425768|FG004|Overall Study|Efficacy Failure|24|||
23548044|NCT01300546|65735988|FG000|Overall Study|Withdrawal by Subject|1|||
23548045|NCT01300546|65735989|FG001|Overall Study|Withdrawal by Subject|0|||
23548046|NCT01300546|65735988|FG000|Overall Study|Lost to Follow-up|0|||
23548047|NCT01300546|65735989|FG001|Overall Study|Lost to Follow-up|2|||
23548048|NCT01300546|65735988|FG000|Overall Study|Lack of Efficacy|0|||
23548049|NCT01300546|65735989|FG001|Overall Study|Lack of Efficacy|3|||
23548050|NCT01300546|65735988|FG000|Overall Study|Adverse Event|0|||
23548051|NCT01300546|65735989|FG001|Overall Study|Adverse Event|1|||
23739332|NCT01667731|66425764|FG000|Overall Study|Lost to Follow-up|2|||
23739333|NCT01667731|66425765|FG001|Overall Study|Lost to Follow-up|3|||
23739334|NCT01667731|66425766|FG002|Overall Study|Lost to Follow-up|1|||
23739335|NCT01667731|66425767|FG003|Overall Study|Lost to Follow-up|1|||
23820702|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23820703|NCT01696279|66725878|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23820704|NCT01696279|66725879|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
23820705|NCT01696279|66725880|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23820706|NCT01696279|66725881|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23548052|NCT03150056|65735990|FG000|Overall Study|Withdrawal by Subject|0|||
23548053|NCT03150056|65735991|FG001|Overall Study|Withdrawal by Subject|0|||
23548054|NCT03150056|65735992|FG002|Overall Study|Withdrawal by Subject|0|||
23739336|NCT01667731|66425768|FG004|Overall Study|Lost to Follow-up|2|||
23739337|NCT01667731|66425764|FG000|Overall Study|Subject Withdrew Consent|2|||
23739338|NCT01667731|66425765|FG001|Overall Study|Subject Withdrew Consent|0|||
23739339|NCT01667731|66425766|FG002|Overall Study|Subject Withdrew Consent|1|||
23739340|NCT01667731|66425767|FG003|Overall Study|Subject Withdrew Consent|0|||
23739341|NCT01667731|66425768|FG004|Overall Study|Subject Withdrew Consent|1|||
23739342|NCT01667731|66425764|FG000|Overall Study|Death|0|||
23739343|NCT01667731|66425765|FG001|Overall Study|Death|1|||
23739344|NCT01667731|66425766|FG002|Overall Study|Death|0|||
23739345|NCT01667731|66425767|FG003|Overall Study|Death|0|||
23739346|NCT01667731|66425768|FG004|Overall Study|Death|0|||
23739347|NCT00490815|66425770|FG000|Overall Study|Adverse Event|2|||
23739348|NCT00490815|66425771|FG001|Overall Study|Adverse Event|3|||
23739349|NCT00490815|66425770|FG000|Overall Study|Withdrawal by Subject|4|||
23739350|NCT00490815|66425771|FG001|Overall Study|Withdrawal by Subject|0|||
23739351|NCT00490815|66425770|FG000|Overall Study|Lost to Follow-up|1|||
23739352|NCT00490815|66425771|FG001|Overall Study|Lost to Follow-up|3|||
23739353|NCT00490815|66425770|FG000|Overall Study|Death|1|||
23739354|NCT00490815|66425771|FG001|Overall Study|Death|3|||
23739355|NCT01354964|66425774|FG000|Overall Study|Lost to Follow-up|2|||
23739356|NCT01354964|66425775|FG001|Overall Study|Lost to Follow-up|0|||
23739357|NCT01354964|66425774|FG000|Overall Study|IV access issues|1|||
23739358|NCT01354964|66425775|FG001|Overall Study|IV access issues|1|||
23739359|NCT01354964|66425774|FG000|Overall Study|Physician Decision|1|||
23739360|NCT01354964|66425775|FG001|Overall Study|Physician Decision|0|||
23739361|NCT00285857|66425777|FG000|Overall Study|Withdrawal by Subject|2|||
23739362|NCT00285857|66425777|FG000|Overall Study|Inadequate initial breast cytology|1|||
23739363|NCT00285857|66425777|FG000|Overall Study|Adverse Event|1|||
23739364|NCT00960323|66425778|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
23739365|NCT04335929|66425781|FG000|Overall Study|Lost to Follow-up|10|||
23739366|NCT02463097|66425782|FG000|Overall Study|Withdrawal by Subject|1|||
23739367|NCT00635804|66425783|FG000|Overall Study|Adverse Event|0|||
23739368|NCT00635804|66425784|FG001|Overall Study|Adverse Event|0|||
23739369|NCT00635804|66425785|FG002|Overall Study|Adverse Event|0|||
23739370|NCT00635804|66425786|FG003|Overall Study|Adverse Event|0|||
23739371|NCT00635804|66425787|FG004|Overall Study|Adverse Event|0|||
23739372|NCT00635804|66425788|FG005|Overall Study|Adverse Event|1|||
23739373|NCT00635804|66425789|FG006|Overall Study|Adverse Event|0|||
23739374|NCT00635804|66425790|FG007|Overall Study|Adverse Event|0|||
23739375|NCT00635804|66425783|FG000|Overall Study|Withdrawal by Subject|1|||
23739376|NCT00635804|66425784|FG001|Overall Study|Withdrawal by Subject|0|||
23739377|NCT00635804|66425785|FG002|Overall Study|Withdrawal by Subject|0|||
23820707|NCT01696279|66725878|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23820708|NCT01696279|66725879|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23548055|NCT03150056|65735993|FG003|Overall Study|Withdrawal by Subject|0|||
23548056|NCT03150056|65735994|FG004|Overall Study|Withdrawal by Subject|0|||
23548057|NCT03150056|65735995|FG005|Overall Study|Withdrawal by Subject|2|||
23548058|NCT03150056|65735990|FG000|Overall Study|Study terminated by Sponsor|1|||
23548059|NCT03150056|65735991|FG001|Overall Study|Study terminated by Sponsor|3|||
23548060|NCT03150056|65735992|FG002|Overall Study|Study terminated by Sponsor|1|||
23548061|NCT03150056|65735993|FG003|Overall Study|Study terminated by Sponsor|1|||
23548062|NCT03150056|65735994|FG004|Overall Study|Study terminated by Sponsor|5|||
23548063|NCT03150056|65735995|FG005|Overall Study|Study terminated by Sponsor|6|||
23820709|NCT01696279|66725880|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
23820710|NCT01696279|66725881|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23820711|NCT01696279|66725878|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23820712|NCT01696279|66725879|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23820713|NCT01696279|66725880|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23820714|NCT01696279|66725881|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
23820715|NCT01696279|66725878|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23820716|NCT01696279|66725879|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23548064|NCT03150056|65735990|FG000|Overall Study|Death|9|||
23548065|NCT03150056|65735991|FG001|Overall Study|Death|2|||
23739378|NCT00635804|66425786|FG003|Overall Study|Withdrawal by Subject|0|||
23820717|NCT01696279|66725880|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23548066|NCT03150056|65735992|FG002|Overall Study|Death|2|||
23548067|NCT03150056|65735993|FG003|Overall Study|Death|7|||
23548068|NCT03150056|65735994|FG004|Overall Study|Death|8|||
23548069|NCT03150056|65735995|FG005|Overall Study|Death|10|||
23820718|NCT01696279|66725881|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
23739379|NCT00635804|66425787|FG004|Overall Study|Withdrawal by Subject|0|||
23739380|NCT00635804|66425788|FG005|Overall Study|Withdrawal by Subject|0|||
23739381|NCT00635804|66425789|FG006|Overall Study|Withdrawal by Subject|0|||
23739382|NCT00635804|66425790|FG007|Overall Study|Withdrawal by Subject|0|||
23739383|NCT02926833|66425791|FG000|Overall Study|Death|1|||
23739384|NCT02926833|66425792|FG001|Overall Study|Death|1|||
23739385|NCT02926833|66425793|FG002|Overall Study|Death|2|||
23548070|NCT00657618|65735998|FG000|Overall Study|Adverse Event|32|||
23548071|NCT00657618|65735998|FG000|Overall Study|Withdrawal by Subject|8|||
23739386|NCT02926833|66425794|FG003|Overall Study|Death|13|||
23548072|NCT00657618|65735998|FG000|Overall Study|negative for leishmaniasis|2|||
23548073|NCT00657618|65735998|FG000|Overall Study|didn't start due to schedule conflicts|1|||
23427686|NCT02876328|65310544|FG020|Overall Study|Missed 12 Month Visit|11|||
23427687|NCT02876328|65310545|FG021|Overall Study|Missed 12 Month Visit|7|||
23739387|NCT02926833|66425791|FG000|Overall Study|Lost to Follow-up|1|||
23739388|NCT02926833|66425792|FG001|Overall Study|Lost to Follow-up|2|||
23739389|NCT02926833|66425793|FG002|Overall Study|Lost to Follow-up|0|||
23739390|NCT02926833|66425794|FG003|Overall Study|Lost to Follow-up|3|||
23739391|NCT02926833|66425791|FG000|Overall Study|Full Consent Withdrawal|0|||
23739392|NCT02926833|66425792|FG001|Overall Study|Full Consent Withdrawal|0|||
23739393|NCT02926833|66425793|FG002|Overall Study|Full Consent Withdrawal|0|||
23739394|NCT02926833|66425794|FG003|Overall Study|Full Consent Withdrawal|2|||
23739395|NCT02926833|66425791|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
23739396|NCT02926833|66425792|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
23739397|NCT02926833|66425793|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
23739398|NCT02926833|66425794|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
23739399|NCT02926833|66425791|FG000|Overall Study|Investigator Decision|0|||
23739400|NCT02926833|66425792|FG001|Overall Study|Investigator Decision|1|||
23739401|NCT02926833|66425793|FG002|Overall Study|Investigator Decision|0|||
23739402|NCT02926833|66425794|FG003|Overall Study|Investigator Decision|0|||
23739403|NCT02926833|66425791|FG000|Overall Study|Adverse Event|0|||
23619664|NCT01772147|65994707|FG001|Overall Study|Withdrew Consent|8|||
23619665|NCT01772147|65994708|FG002|Overall Study|Withdrew Consent|4|||
23619666|NCT01772147|65994706|FG000|Overall Study|Lost to Follow-up|1|||
23619667|NCT01772147|65994707|FG001|Overall Study|Lost to Follow-up|0|||
23820719|NCT01696279|66725878|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23820720|NCT01696279|66725879|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23820721|NCT01696279|66725880|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23820722|NCT01696279|66725881|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
23820723|NCT04414618|66725885|FG000|Overall Study|Death|3|||
23820724|NCT04414618|66725886|FG001|Overall Study|Death|3|||
23820725|NCT04414618|66725885|FG000|Overall Study|Withdrawal by Subject|2|||
23820726|NCT04414618|66725886|FG001|Overall Study|Withdrawal by Subject|1|||
23427688|NCT02876328|65310546|FG022|Overall Study|Missed 12 Month Visit|1|||
23427689|NCT02876328|65310547|FG023|Overall Study|Missed 12 Month Visit|0|||
23427690|NCT01998893|65310548|FG000|Overall Study|Adverse Event|2|||
23427691|NCT01998893|65310548|FG000|Overall Study|Death|1|||
23619668|NCT01772147|65994708|FG002|Overall Study|Lost to Follow-up|1|||
23619669|NCT01772147|65994706|FG000|Overall Study|Protocol Deviation|2|||
23619670|NCT01772147|65994707|FG001|Overall Study|Protocol Deviation|1|||
23739404|NCT02926833|66425792|FG001|Overall Study|Adverse Event|0|||
23739405|NCT02926833|66425793|FG002|Overall Study|Adverse Event|1|||
23739406|NCT02926833|66425794|FG003|Overall Study|Adverse Event|0|||
23739407|NCT02926833|66425791|FG000|Overall Study|Partial Withdrawal of Consent|0|||
23739408|NCT02926833|66425792|FG001|Overall Study|Partial Withdrawal of Consent|0|||
23739409|NCT02926833|66425793|FG002|Overall Study|Partial Withdrawal of Consent|0|||
23739410|NCT02926833|66425794|FG003|Overall Study|Partial Withdrawal of Consent|1|||
23739411|NCT02906644|66425795|FG000|First 2 Weeks|Withdrawal by Subject|0|||
23739412|NCT02906644|66425796|FG001|First 2 Weeks|Withdrawal by Subject|2|||
23739413|NCT02906644|66425795|FG000|First 2 Weeks|Physician Decision|1|||
23427692|NCT01998893|65310548|FG000|Overall Study|Lost to Follow-up|8|||
23427693|NCT01998893|65310548|FG000|Overall Study|Physician Decision|2|||
23427694|NCT01998893|65310548|FG000|Overall Study|Protocol Violation|2|||
23427695|NCT01998893|65310548|FG000|Overall Study|Withdrawal by Subject|1|||
23427696|NCT01998893|65310548|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
23427697|NCT01463111|65310553|FG000|Overall Study|Withdrawal by Subject|2|||
23427698|NCT01463111|65310553|FG000|Overall Study|Lost to Follow-up|5|||
23427699|NCT01463111|65310553|FG000|Overall Study|Physician Decision|2|||
23548074|NCT01585103|65736001|FG000|Overall Study|Unable to swallow Cytosponge|6|||
23548075|NCT00058123|65739460|FG000|Overall Study|Wrong histology|9|||
23548076|NCT00058123|65739460|FG000|Overall Study|Received >3 prior treatments|1|||
23548077|NCT03695172|65739461|FG000|Overall Study|Withdrawal by Subject|1|||
23548078|NCT03695172|65739462|FG001|Overall Study|Withdrawal by Subject|1|||
23548079|NCT03695172|65739463|FG002|Overall Study|Withdrawal by Subject|0|||
23548080|NCT00321854|65739464|FG000|Overall Study|Adverse Event|41|||
23548081|NCT00321854|65739465|FG001|Overall Study|Adverse Event|43|||
23548082|NCT00321854|65739464|FG000|Overall Study|Lack of Efficacy|9|||
23548083|NCT00321854|65739465|FG001|Overall Study|Lack of Efficacy|14|||
23739414|NCT02906644|66425796|FG001|First 2 Weeks|Physician Decision|1|||
23739415|NCT02906644|66425795|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
23739416|NCT02906644|66425796|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
23820727|NCT04414618|66725885|FG000|Overall Study|Lost to Follow-up|2|||
23427700|NCT00823212|65310554|FG000|Overall Study|Death|8|||
23427701|NCT00823212|65310555|FG001|Overall Study|Death|10|||
23427702|NCT00823212|65310554|FG000|Overall Study|Withdrawal by Subject|6|||
23619671|NCT01772147|65994708|FG002|Overall Study|Protocol Deviation|1|||
23739417|NCT02906644|66425795|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
23739418|NCT02906644|66425796|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
23739419|NCT00660829|66425799|FG000|Overall Study|Adverse Event|3|||
23739420|NCT00660829|66425800|FG001|Overall Study|Adverse Event|4|||
23739421|NCT00660829|66425799|FG000|Overall Study|Lack of Efficacy|2|||
23739422|NCT00660829|66425800|FG001|Overall Study|Lack of Efficacy|3|||
23739423|NCT00660829|66425799|FG000|Overall Study|Non-Compliance|0|||
23739424|NCT00660829|66425800|FG001|Overall Study|Non-Compliance|4|||
23739425|NCT00660829|66425799|FG000|Overall Study|Withdrawal by Subject|1|||
23739426|NCT00660829|66425800|FG001|Overall Study|Withdrawal by Subject|2|||
23739427|NCT00660829|66425799|FG000|Overall Study|Lost to Follow-up|3|||
23739428|NCT00660829|66425800|FG001|Overall Study|Lost to Follow-up|2|||
23739429|NCT00660829|66425799|FG000|Overall Study|Other|9|||
23739430|NCT00660829|66425800|FG001|Overall Study|Other|4|||
23739431|NCT00723489|66425801|FG000|Overall Study|Physician Decision|0|||
23739432|NCT00723489|66425802|FG001|Overall Study|Physician Decision|1|||
23739433|NCT00723489|66425803|FG002|Overall Study|Physician Decision|0|||
23739434|NCT00723489|66425804|FG003|Overall Study|Physician Decision|0|||
23739435|NCT00723489|66425801|FG000|Overall Study|Pregnancy|0|||
23739436|NCT00723489|66425802|FG001|Overall Study|Pregnancy|0|||
23820728|NCT04414618|66725886|FG001|Overall Study|Lost to Follow-up|3|||
23820729|NCT04414618|66725885|FG000|Overall Study|Physician Decision|1|||
23820730|NCT04414618|66725886|FG001|Overall Study|Physician Decision|0|||
23820731|NCT01557517|66725889|FG000|Overall Study|Death|1|||
23820732|NCT01557517|66725890|FG001|Overall Study|Death|0|||
23820733|NCT01557517|66725889|FG000|Overall Study|Refused further treatment|0|||
23427703|NCT00823212|65310555|FG001|Overall Study|Withdrawal by Subject|1|||
23427704|NCT00823212|65310554|FG000|Overall Study|Incarcerated|0|||
23427705|NCT00823212|65310555|FG001|Overall Study|Incarcerated|1|||
23427706|NCT00823212|65310554|FG000|Overall Study|Missed 12-month visit|21|||
23427707|NCT00823212|65310555|FG001|Overall Study|Missed 12-month visit|21|||
23548084|NCT00321854|65739464|FG000|Overall Study|Protocol Violation|6|||
23548085|NCT00321854|65739465|FG001|Overall Study|Protocol Violation|5|||
23548086|NCT00321854|65739464|FG000|Overall Study|Lost to Follow-up|0|||
23548087|NCT00321854|65739465|FG001|Overall Study|Lost to Follow-up|2|||
23820734|NCT01557517|66725890|FG001|Overall Study|Refused further treatment|2|||
23820735|NCT01557517|66725889|FG000|Overall Study|Adverse Event|0|||
23820736|NCT01557517|66725890|FG001|Overall Study|Adverse Event|2|||
23820737|NCT01557517|66725889|FG000|Overall Study|Pt declined before treatment started|1|||
23820738|NCT01557517|66725890|FG001|Overall Study|Pt declined before treatment started|0|||
23820739|NCT00970593|66725896|FG000|Overall Study|Adverse Event|1|||
23820740|NCT00970593|66725897|FG001|Overall Study|Adverse Event|1|||
23820741|NCT00970593|66725898|FG002|Overall Study|Adverse Event|0|||
23820742|NCT00970593|66725899|FG003|Overall Study|Adverse Event|0|||
23820743|NCT00970593|66725900|FG004|Overall Study|Adverse Event|0|||
23820744|NCT00970593|66725901|FG005|Overall Study|Adverse Event|0|||
23820745|NCT00970593|66725902|FG006|Overall Study|Adverse Event|0|||
23820746|NCT00970593|66725896|FG000|Overall Study|Discontinuation of study by sponsor|0|||
23820747|NCT00970593|66725897|FG001|Overall Study|Discontinuation of study by sponsor|0|||
23820748|NCT00970593|66725898|FG002|Overall Study|Discontinuation of study by sponsor|5|||
23820749|NCT00970593|66725899|FG003|Overall Study|Discontinuation of study by sponsor|0|||
23820750|NCT00970593|66725900|FG004|Overall Study|Discontinuation of study by sponsor|0|||
23820751|NCT00970593|66725901|FG005|Overall Study|Discontinuation of study by sponsor|0|||
23820752|NCT00970593|66725902|FG006|Overall Study|Discontinuation of study by sponsor|2|||
23820753|NCT00970593|66725896|FG000|Overall Study|Withdrawal by Subject|0|||
23820754|NCT00970593|66725897|FG001|Overall Study|Withdrawal by Subject|0|||
23820755|NCT00970593|66725898|FG002|Overall Study|Withdrawal by Subject|1|||
23820756|NCT00970593|66725899|FG003|Overall Study|Withdrawal by Subject|0|||
23820757|NCT00970593|66725900|FG004|Overall Study|Withdrawal by Subject|0|||
23820758|NCT00970593|66725901|FG005|Overall Study|Withdrawal by Subject|0|||
23820759|NCT00970593|66725902|FG006|Overall Study|Withdrawal by Subject|0|||
23820760|NCT00445146|66725905|FG000|Overall Study|Withdrew Consent|29|||
23820761|NCT00445146|66725905|FG000|Overall Study|Lack of Efficacy|28|||
23820762|NCT00445146|66725905|FG000|Overall Study|Investigator's Discretion|22|||
23820763|NCT00445146|66725905|FG000|Overall Study|Adverse Event|13|||
23820764|NCT00445146|66725905|FG000|Overall Study|Lost to Follow-up|13|||
23820765|NCT00445146|66725905|FG000|Overall Study|Death|9|||
23820766|NCT00445146|66725905|FG000|Overall Study|Protocol Violation|4|||
23820767|NCT00445146|66725905|FG000|Overall Study|Pregnancy|1|||
23820768|NCT00794339|66725908|FG000|Overall Study|Withdrawal by Subject|3|||
23820769|NCT00794339|66725908|FG000|Overall Study|Ineligible|4|||
23820770|NCT00794339|66725908|FG000|Overall Study|Tx prior to ATSM|3|||
23427708|NCT00378599|65310557|FG000|Overall Study|Adverse Event|38|||
23427709|NCT00378599|65310557|FG000|Overall Study|Protocol Violation|2|||
23427710|NCT00378599|65310557|FG000|Overall Study|Treatment failure|7|||
23739437|NCT00723489|66425803|FG002|Overall Study|Pregnancy|0|||
23739438|NCT00723489|66425804|FG003|Overall Study|Pregnancy|1|||
23820771|NCT00794339|66725908|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
23427711|NCT00378599|65310557|FG000|Overall Study|Withdrawal by Subject|5|||
23427712|NCT03812185|65310558|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
23427713|NCT02456636|65310559|FG000|Overall Study|Death|0|||
23427714|NCT02456636|65310560|FG001|Overall Study|Death|3|||
23427715|NCT02456636|65310561|FG002|Overall Study|Death|0|||
23427716|NCT02456636|65310559|FG000|Overall Study|Pregnancy|1|||
23427717|NCT02456636|65310560|FG001|Overall Study|Pregnancy|3|||
23427718|NCT02456636|65310561|FG002|Overall Study|Pregnancy|5|||
23427719|NCT02456636|65310559|FG000|Overall Study|Physician Decision|4|||
23427720|NCT02456636|65310560|FG001|Overall Study|Physician Decision|5|||
23427721|NCT02456636|65310561|FG002|Overall Study|Physician Decision|4|||
23427722|NCT02456636|65310559|FG000|Overall Study|Withdrawal by Subject|13|||
23427723|NCT02456636|65310560|FG001|Overall Study|Withdrawal by Subject|14|||
23427724|NCT02456636|65310561|FG002|Overall Study|Withdrawal by Subject|16|||
23427725|NCT02456636|65310559|FG000|Overall Study|Lost to Follow-up|50|||
23427726|NCT02456636|65310560|FG001|Overall Study|Lost to Follow-up|44|||
23427727|NCT02456636|65310561|FG002|Overall Study|Lost to Follow-up|50|||
23427728|NCT01146288|65310562|FG000|First Intervention(1 Day)|Adverse Event|0|||
23427729|NCT01146288|65310563|FG001|First Intervention(1 Day)|Adverse Event|1|||
23427730|NCT01754194|65310564|FG000|Overall Study|Lost to Follow-up|39|||
23427731|NCT01754194|65310565|FG001|Overall Study|Lost to Follow-up|14|||
23427732|NCT01754194|65310564|FG000|Overall Study|Withdrawal by Subject|4|||
23427733|NCT01754194|65310565|FG001|Overall Study|Withdrawal by Subject|5|||
23427734|NCT01754194|65310564|FG000|Overall Study|Other|9|||
23427735|NCT01754194|65310565|FG001|Overall Study|Other|8|||
23427736|NCT02449018|65310567|FG000|Overall Study|Abnormal laboratory value|0|||
23427737|NCT02449018|65310568|FG001|Overall Study|Abnormal laboratory value|1|||
23427738|NCT02449018|65310567|FG000|Overall Study|Administrative problems|1|||
23427739|NCT02449018|65310568|FG001|Overall Study|Administrative problems|0|||
23427740|NCT02449018|65310567|FG000|Overall Study|Adverse Event|5|||
23427741|NCT02449018|65310568|FG001|Overall Study|Adverse Event|1|||
23427742|NCT02449018|65310567|FG000|Overall Study|Protocol deviation|4|||
23427743|NCT02449018|65310568|FG001|Overall Study|Protocol deviation|0|||
23427744|NCT02449018|65310567|FG000|Overall Study|Patient decision|2|||
23427745|NCT02449018|65310568|FG001|Overall Study|Patient decision|0|||
23427746|NCT02130986|65310570|FG000|Overall Study|Withdrawal by Subject|4|||
23427747|NCT02130986|65310571|FG001|Overall Study|Withdrawal by Subject|4|||
23427748|NCT02130986|65310570|FG000|Overall Study|Lost to Follow-up|151|||
23427749|NCT02130986|65310571|FG001|Overall Study|Lost to Follow-up|160|||
23427750|NCT00086502|65310572|FG000|Overall Study|Adverse Event|11|||
23427751|NCT00086502|65310573|FG001|Overall Study|Adverse Event|2|||
23427752|NCT00086502|65310572|FG000|Overall Study|Lack of Efficacy|0|||
23427753|NCT00086502|65310573|FG001|Overall Study|Lack of Efficacy|2|||
23427754|NCT00086502|65310572|FG000|Overall Study|Lost to Follow-up|3|||
23427755|NCT00086502|65310573|FG001|Overall Study|Lost to Follow-up|1|||
23427756|NCT00086502|65310572|FG000|Overall Study|Physician Decision|1|||
23427757|NCT00086502|65310573|FG001|Overall Study|Physician Decision|1|||
23427758|NCT00086502|65310572|FG000|Overall Study|Pregnancy|0|||
23427759|NCT00086502|65310573|FG001|Overall Study|Pregnancy|1|||
23427760|NCT00086502|65310572|FG000|Overall Study|Protocol Violation|3|||
23427761|NCT00086502|65310573|FG001|Overall Study|Protocol Violation|3|||
23427762|NCT00086502|65310572|FG000|Overall Study|Withdrawal by Subject|5|||
23427763|NCT00086502|65310573|FG001|Overall Study|Withdrawal by Subject|6|||
23427764|NCT00086502|65310572|FG000|Overall Study|Patient Moved|1|||
23427765|NCT00086502|65310573|FG001|Overall Study|Patient Moved|1|||
23427766|NCT00086502|65310572|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
23427767|NCT00086502|65310573|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
23427768|NCT00086502|65310572|FG000|Overall Study|Patient Accidentally Unblinded|1|||
23427769|NCT00086502|65310573|FG001|Overall Study|Patient Accidentally Unblinded|0|||
23427770|NCT02463032|65310577|FG000|Overall Study|Lack of Efficacy|61|||
23427771|NCT02463032|65310578|FG001|Overall Study|Lack of Efficacy|50|||
23427772|NCT02463032|65310577|FG000|Overall Study|Death|8|||
23427773|NCT02463032|65310578|FG001|Overall Study|Death|8|||
23427774|NCT02463032|65310577|FG000|Overall Study|Adverse Event|2|||
23427775|NCT02463032|65310578|FG001|Overall Study|Adverse Event|6|||
23427776|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
23427777|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
23427778|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
23427779|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
23427780|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
23427781|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
23427782|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
23427783|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
23427784|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
23427785|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
23427786|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
23427787|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
23427788|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
23427789|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
23427790|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
23427791|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
23427792|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
23427793|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
23427794|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
23427795|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
23427796|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
23427797|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
23427798|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
23427799|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
23427800|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
23427801|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
23427802|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
23427803|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
23427804|NCT02436408|65310589|FG000|Overall Study|Death|1|||
23427805|NCT02230683|65310593|FG000|Overall Study|Adverse Event|1|||
23427806|NCT00685373|65310594|FG000|Overall Study|Adverse Event|3|||
23427807|NCT00685373|65310594|FG000|Overall Study|Withdrawal by Subject|5|||
23427808|NCT00685373|65310594|FG000|Overall Study|Lack of Efficacy|3|||
23427809|NCT00685373|65310594|FG000|Overall Study|Condition no longer requires study drug|1|||
23427810|NCT00685373|65310594|FG000|Overall Study|Lost to Follow-up|2|||
23427811|NCT00685373|65310594|FG000|Overall Study|Protocol Violation|1|||
23427812|NCT00240110|65310595|FG000|Overall Study|Lost to Follow-up|6|||
23427813|NCT00240110|65310596|FG001|Overall Study|Lost to Follow-up|7|||
23427814|NCT00543296|65310599|FG000|Overall Study|Physician Decision|7|||
23427815|NCT04342689|65310600|FG000|Overall Study|Withdrawal by Subject|32|||
23427816|NCT04342689|65310601|FG001|Overall Study|Withdrawal by Subject|33|||
23427817|NCT04342689|65310600|FG000|Overall Study|Lost to Follow-up|10|||
23427818|NCT04342689|65310601|FG001|Overall Study|Lost to Follow-up|12|||
23427819|NCT02689076|65310605|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
23427820|NCT02689076|65310606|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
23427821|NCT02689076|65310607|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
23427822|NCT02689076|65310605|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
23427823|NCT02689076|65310606|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
23427824|NCT02689076|65310607|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
23427825|NCT02689076|65310605|FG000|Overall Study|Did not have an HIE match|2|||
23427826|NCT02689076|65310606|FG001|Overall Study|Did not have an HIE match|0|||
23427827|NCT02689076|65310607|FG002|Overall Study|Did not have an HIE match|0|||
23427828|NCT02689076|65310605|FG000|Overall Study|Death during non-VA encounter|2|||
23427829|NCT02689076|65310606|FG001|Overall Study|Death during non-VA encounter|5|||
23427830|NCT02689076|65310607|FG002|Overall Study|Death during non-VA encounter|0|||
23427831|NCT02689076|65310605|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
23427832|NCT02689076|65310606|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
23427833|NCT02689076|65310607|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
23427834|NCT02689076|65310605|FG000|Overall Study|Participant no longer active in VA system|1|||
23427835|NCT02689076|65310606|FG001|Overall Study|Participant no longer active in VA system|0|||
23427836|NCT02689076|65310607|FG002|Overall Study|Participant no longer active in VA system|0|||
23427837|NCT02689076|65310605|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
23427838|NCT02689076|65310606|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
23427839|NCT02689076|65310607|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
23427840|NCT02066415|65310608|FG000|Overall Study|Decision by Sponsor|5|||
23427841|NCT02066415|65310609|FG001|Overall Study|Decision by Sponsor|4|||
23427842|NCT02066415|65310610|FG002|Overall Study|Decision by Sponsor|2|||
23427843|NCT02066415|65310608|FG000|Overall Study|Withdrawal by Subject|9|||
23427844|NCT02066415|65310609|FG001|Overall Study|Withdrawal by Subject|1|||
23427845|NCT02066415|65310610|FG002|Overall Study|Withdrawal by Subject|4|||
23427846|NCT02066415|65310608|FG000|Overall Study|Lost to Follow-up|7|||
23820772|NCT00794339|66725908|FG000|Overall Study|Tx not per protocol|1|||
23427847|NCT02066415|65310609|FG001|Overall Study|Lost to Follow-up|2|||
23427848|NCT02066415|65310610|FG002|Overall Study|Lost to Follow-up|2|||
23427849|NCT02356887|65310611|FG000|Overall Study|poor compliance|2|||
23427850|NCT01635764|65310612|FG000|Overall Study|Adverse Event|46|||
23427851|NCT01635764|65310612|FG000|Overall Study|Lack of Efficacy|76|||
23427852|NCT01635764|65310612|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
23427853|NCT01635764|65310612|FG000|Overall Study|Protocol Deviation|1|||
23427854|NCT01635764|65310612|FG000|Overall Study|Withdrew Consent|67|||
23548088|NCT00321854|65739464|FG000|Overall Study|Withdrawal by Subject|6|||
23619672|NCT01772147|65994706|FG000|Overall Study|Lack of Efficacy|8|||
23427855|NCT01635764|65310612|FG000|Overall Study|Lost to Follow-up|53|||
23427856|NCT01635764|65310612|FG000|Overall Study|Other|28|||
23427857|NCT01416441|65310613|FG000|Overall Study|Lost to Follow-up|5|||
23427858|NCT01416441|65310613|FG000|Overall Study|Adverse Event|6|||
23427859|NCT01416441|65310613|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
23427860|NCT01416441|65310613|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
23427861|NCT01416441|65310613|FG000|Overall Study|Investigator Withdrew Subject|2|||
23427862|NCT01416441|65310613|FG000|Overall Study|Subject Withdrew Consent|12|||
23427863|NCT01416441|65310613|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
23427864|NCT00186537|65310615|FG000|Overall Study|Withdrawal by Subject|4|||
23427865|NCT00186537|65310616|FG001|Overall Study|Withdrawal by Subject|0|||
23427866|NCT00186537|65310617|FG002|Overall Study|Withdrawal by Subject|3|||
23427867|NCT00186537|65310615|FG000|Overall Study|ALT > 1.5 x ULN|3|||
23427868|NCT00186537|65310616|FG001|Overall Study|ALT > 1.5 x ULN|0|||
23427869|NCT00186537|65310617|FG002|Overall Study|ALT > 1.5 x ULN|0|||
23427870|NCT01145053|65310618|FG000|Overall Study|Adverse Event|22|||
23427871|NCT01145053|65310618|FG000|Overall Study|Lost to Follow-up|28|||
23427872|NCT01145053|65310618|FG000|Overall Study|Withdrawal by Subject|25|||
23427873|NCT01145053|65310618|FG000|Overall Study|Other|18|||
23427874|NCT04032080|65310623|FG000|Overall Study|Death|6|||
23427875|NCT02576860|65310624|FG000|Overall Study|Adverse Event|6|||
23427876|NCT02576860|65310625|FG001|Overall Study|Adverse Event|6|||
23427877|NCT02576860|65310624|FG000|Overall Study|Lost to Follow-up|5|||
23427878|NCT02576860|65310625|FG001|Overall Study|Lost to Follow-up|7|||
23427879|NCT02576860|65310624|FG000|Overall Study|Physician Decision|0|||
23427880|NCT02576860|65310625|FG001|Overall Study|Physician Decision|1|||
23427881|NCT02576860|65310624|FG000|Overall Study|Protocol Violation|0|||
23427882|NCT02576860|65310625|FG001|Overall Study|Protocol Violation|2|||
23427883|NCT02576860|65310624|FG000|Overall Study|Withdrawal by Subject|13|||
23427884|NCT02576860|65310625|FG001|Overall Study|Withdrawal by Subject|8|||
23427885|NCT02576860|65310624|FG000|Overall Study|Disallowed medication|1|||
23427886|NCT02576860|65310625|FG001|Overall Study|Disallowed medication|0|||
23427887|NCT03724981|65310628|FG000|First Device|Protocol Violation|1|||
23427888|NCT03724981|65310629|FG001|First Device|Protocol Violation|1|||
23427889|NCT00316888|65310630|FG000|Overall Study|Adverse Event|4|||
23427890|NCT00316888|65310631|FG001|Overall Study|Adverse Event|5|||
23820773|NCT00625872|66725910|FG000|Overall Study|Withdrawal by Subject|1|||
23820774|NCT00625872|66725911|FG001|Overall Study|Withdrawal by Subject|0|||
23820775|NCT00625872|66725910|FG000|Overall Study|Does not meet inclusion criteria|1|||
23820776|NCT00625872|66725911|FG001|Overall Study|Does not meet inclusion criteria|0|||
23427891|NCT00316888|65310630|FG000|Overall Study|Withdrawal by Subject|2|||
23427892|NCT00316888|65310631|FG001|Overall Study|Withdrawal by Subject|2|||
23427893|NCT00316888|65310630|FG000|Overall Study|Not start protocol therapy|0|||
23427894|NCT00316888|65310631|FG001|Overall Study|Not start protocol therapy|1|||
23820777|NCT00625872|66725910|FG000|Overall Study|Terminated by sponsor|2|||
23820778|NCT00625872|66725911|FG001|Overall Study|Terminated by sponsor|5|||
23820779|NCT00625872|66725910|FG000|Overall Study|Randomized but not treated|0|||
23820780|NCT00625872|66725911|FG001|Overall Study|Randomized but not treated|1|||
23820781|NCT00875797|66725912|FG000|Overall Study|Protocol Violation|6|||
23820782|NCT00875797|66725913|FG001|Overall Study|Protocol Violation|3|||
23548089|NCT00321854|65739465|FG001|Overall Study|Withdrawal by Subject|17|||
23548090|NCT00321854|65739464|FG000|Overall Study|Other|1|||
23548091|NCT00321854|65739465|FG001|Overall Study|Other|1|||
23820783|NCT04868500|66725914|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
23427895|NCT01459913|65310634|FG000|Overall Study|Adverse Event|0|||
23427896|NCT01459913|65310635|FG001|Overall Study|Adverse Event|0|||
23427897|NCT01459913|65310636|FG002|Overall Study|Adverse Event|0|||
23427898|NCT01459913|65310637|FG003|Overall Study|Adverse Event|3|||
23427899|NCT01459913|65310634|FG000|Overall Study|Withdrawal by Subject|4|||
23820784|NCT04868500|66725915|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
23820785|NCT04868500|66725914|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
23820786|NCT04868500|66725915|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
23820787|NCT01000961|66725916|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23427900|NCT01459913|65310635|FG001|Overall Study|Withdrawal by Subject|0|||
23427901|NCT01459913|65310636|FG002|Overall Study|Withdrawal by Subject|0|||
23427902|NCT01459913|65310637|FG003|Overall Study|Withdrawal by Subject|5|||
23427903|NCT01459913|65310634|FG000|Overall Study|Lost to Follow-up|7|||
23427904|NCT01459913|65310635|FG001|Overall Study|Lost to Follow-up|4|||
23427905|NCT01459913|65310636|FG002|Overall Study|Lost to Follow-up|1|||
23427906|NCT01459913|65310637|FG003|Overall Study|Lost to Follow-up|8|||
23427907|NCT01459913|65310634|FG000|Overall Study|Death|0|||
23427908|NCT01459913|65310635|FG001|Overall Study|Death|0|||
23427909|NCT01459913|65310636|FG002|Overall Study|Death|0|||
23427910|NCT01459913|65310637|FG003|Overall Study|Death|1|||
23427911|NCT01459913|65310634|FG000|Overall Study|Non- Compliance|0|||
23820788|NCT01000961|66725917|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23427912|NCT01459913|65310635|FG001|Overall Study|Non- Compliance|0|||
23427913|NCT01459913|65310636|FG002|Overall Study|Non- Compliance|0|||
23427914|NCT01459913|65310637|FG003|Overall Study|Non- Compliance|3|||
23427915|NCT01459913|65310634|FG000|Overall Study|Physician Decision|0|||
23427916|NCT01459913|65310635|FG001|Overall Study|Physician Decision|1|||
23427917|NCT01459913|65310636|FG002|Overall Study|Physician Decision|0|||
23427918|NCT01459913|65310637|FG003|Overall Study|Physician Decision|0|||
23427919|NCT01459913|65310634|FG000|Overall Study|Study Terminated by Sponsor|30|||
23427920|NCT01459913|65310635|FG001|Overall Study|Study Terminated by Sponsor|15|||
23427921|NCT01459913|65310636|FG002|Overall Study|Study Terminated by Sponsor|9|||
23739439|NCT00723489|66425801|FG000|Overall Study|Withdrawal by Subject|0|||
23739440|NCT00723489|66425802|FG001|Overall Study|Withdrawal by Subject|0|||
23739441|NCT00723489|66425803|FG002|Overall Study|Withdrawal by Subject|0|||
23739442|NCT00723489|66425804|FG003|Overall Study|Withdrawal by Subject|1|||
23739443|NCT00723489|66425801|FG000|Overall Study|Seropositive at baseline|1|||
23739444|NCT00723489|66425802|FG001|Overall Study|Seropositive at baseline|0|||
23739445|NCT00723489|66425803|FG002|Overall Study|Seropositive at baseline|0|||
23739446|NCT00723489|66425804|FG003|Overall Study|Seropositive at baseline|0|||
23739447|NCT00723489|66425801|FG000|Overall Study|Prohibited Medication|0|||
23739448|NCT00723489|66425802|FG001|Overall Study|Prohibited Medication|0|||
23739449|NCT00723489|66425803|FG002|Overall Study|Prohibited Medication|0|||
23739450|NCT00723489|66425804|FG003|Overall Study|Prohibited Medication|1|||
23739451|NCT00723489|66425801|FG000|Overall Study|Samples Collected Out of Window|0|||
23739452|NCT00723489|66425802|FG001|Overall Study|Samples Collected Out of Window|3|||
23739453|NCT00723489|66425803|FG002|Overall Study|Samples Collected Out of Window|0|||
23739454|NCT00723489|66425804|FG003|Overall Study|Samples Collected Out of Window|0|||
23739455|NCT01854918|66425809|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
23739456|NCT01854918|66425810|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
23739457|NCT01854918|66425809|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
23739458|NCT01854918|66425810|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
23427922|NCT01459913|65310637|FG003|Overall Study|Study Terminated by Sponsor|11|||
23427923|NCT01459913|65310634|FG000|Overall Study|Other|0|||
23820789|NCT01000961|66725916|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
23820790|NCT01000961|66725917|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
23427924|NCT01459913|65310635|FG001|Overall Study|Other|0|||
23427925|NCT01459913|65310636|FG002|Overall Study|Other|3|||
23427926|NCT01459913|65310637|FG003|Overall Study|Other|1|||
23427927|NCT01459913|65310634|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427928|NCT01459913|65310635|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427929|NCT01459913|65310636|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427930|NCT01459913|65310637|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
23427931|NCT02927262|65310638|FG000|Overall Study|Adverse Event|7|||
23427932|NCT02927262|65310639|FG001|Overall Study|Adverse Event|1|||
23427933|NCT02927262|65310638|FG000|Overall Study|Death|1|||
23739459|NCT01854918|66425809|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
23739460|NCT01854918|66425810|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
23739461|NCT01854918|66425809|FG000|SOC-controlled Period (Year 1)|Death|5|||
23820791|NCT01876446|66725927|FG000|Overall Study|Death|0|||
23427934|NCT02927262|65310639|FG001|Overall Study|Death|0|||
23427935|NCT02927262|65310638|FG000|Overall Study|Withdrawal by Subject|3|||
23427936|NCT02927262|65310639|FG001|Overall Study|Withdrawal by Subject|0|||
23427937|NCT02927262|65310638|FG000|Overall Study|Disease Relapse|23|||
23427938|NCT02927262|65310639|FG001|Overall Study|Disease Relapse|18|||
23427939|NCT02927262|65310638|FG000|Overall Study|Miscellaneous|5|||
23427940|NCT02927262|65310639|FG001|Overall Study|Miscellaneous|4|||
23548092|NCT05224050|65739466|FG000|Overall Study|Withdrawal by Subject|9|||
23548093|NCT05224050|65739466|FG000|Overall Study|Lost to Follow-up|3|||
23548094|NCT03301051|65739467|FG000|Overall Study|Adverse Event|0|||
23548095|NCT03301051|65739468|FG001|Overall Study|Adverse Event|4|||
23548096|NCT03301051|65739467|FG000|Overall Study|Withdrawal by Subject|59|||
23548097|NCT03301051|65739468|FG001|Overall Study|Withdrawal by Subject|65|||
23548098|NCT03301051|65739467|FG000|Overall Study|Lost to Follow-up|263|||
23548099|NCT03301051|65739468|FG001|Overall Study|Lost to Follow-up|282|||
23739462|NCT01854918|66425810|FG001|SOC-controlled Period (Year 1)|Death|5|||
23739463|NCT01854918|66425809|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
23427941|NCT02927262|65310638|FG000|Overall Study|Ongoing|4|||
23427942|NCT02927262|65310639|FG001|Overall Study|Ongoing|0|||
23427943|NCT02250664|65310640|FG000|Overall Study|Lost to Follow-up|18|||
23427944|NCT02250664|65310641|FG001|Overall Study|Lost to Follow-up|28|||
23739464|NCT01854918|66425810|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
23427945|NCT02250664|65310642|FG002|Overall Study|Lost to Follow-up|33|||
23427946|NCT02250664|65310640|FG000|Overall Study|Personal Reasons|7|||
23427947|NCT02250664|65310641|FG001|Overall Study|Personal Reasons|8|||
23427948|NCT02250664|65310642|FG002|Overall Study|Personal Reasons|14|||
23427949|NCT02250664|65310640|FG000|Overall Study|Adverse Event|6|||
23548100|NCT03301051|65739467|FG000|Overall Study|Protocol Violation|1|||
23427950|NCT02250664|65310641|FG001|Overall Study|Adverse Event|3|||
23427951|NCT02250664|65310642|FG002|Overall Study|Adverse Event|8|||
23427952|NCT02250664|65310640|FG000|Overall Study|Incarcerated|2|||
23427953|NCT02250664|65310641|FG001|Overall Study|Incarcerated|1|||
23427954|NCT02250664|65310642|FG002|Overall Study|Incarcerated|2|||
23427955|NCT02250664|65310640|FG000|Overall Study|Withdrawal by Subject|0|||
23427956|NCT02250664|65310641|FG001|Overall Study|Withdrawal by Subject|1|||
23427957|NCT02250664|65310642|FG002|Overall Study|Withdrawal by Subject|2|||
23427958|NCT02250664|65310640|FG000|Overall Study|Death|0|||
23427959|NCT02250664|65310641|FG001|Overall Study|Death|1|||
23427960|NCT02250664|65310642|FG002|Overall Study|Death|1|||
23427961|NCT02250664|65310640|FG000|Overall Study|Physician Decision|1|||
23427962|NCT02250664|65310641|FG001|Overall Study|Physician Decision|3|||
23427963|NCT02250664|65310642|FG002|Overall Study|Physician Decision|1|||
23427964|NCT02250664|65310640|FG000|Overall Study|Protocol Violation|1|||
23427965|NCT02250664|65310641|FG001|Overall Study|Protocol Violation|0|||
23427966|NCT02250664|65310642|FG002|Overall Study|Protocol Violation|1|||
23548101|NCT03301051|65739468|FG001|Overall Study|Protocol Violation|3|||
23548102|NCT03301051|65739467|FG000|Overall Study|Physician Decision|1|||
23548103|NCT03301051|65739468|FG001|Overall Study|Physician Decision|3|||
23548104|NCT03301051|65739467|FG000|Overall Study|Death|1|||
23548105|NCT03301051|65739468|FG001|Overall Study|Death|1|||
23548106|NCT03301051|65739467|FG000|Overall Study|Miscellaneous|8|||
23739465|NCT01854918|66425809|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
23739466|NCT01854918|66425810|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
23739467|NCT01854918|66425809|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
23739468|NCT01854918|66425810|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
23739469|NCT01854918|66425809|FG000|All-IP Period (Years 2 and 3)|Death|5|||
23820792|NCT01876446|66725928|FG001|Overall Study|Death|1|||
23820793|NCT01876446|66725927|FG000|Overall Study|Withdrawal by Subject|1|||
23427967|NCT02250664|65310640|FG000|Overall Study|Reason unknown|1|||
23427968|NCT02250664|65310641|FG001|Overall Study|Reason unknown|0|||
23739470|NCT01854918|66425810|FG001|All-IP Period (Years 2 and 3)|Death|16|||
23739471|NCT03481634|66425811|FG000|Overall Study|Withdrawal by Subject|16|||
23739472|NCT03481634|66425812|FG001|Overall Study|Withdrawal by Subject|19|||
23739473|NCT03481634|66425813|FG002|Overall Study|Withdrawal by Subject|14|||
23739474|NCT03481634|66425811|FG000|Overall Study|Protocol Violation|1|||
23739475|NCT03481634|66425812|FG001|Overall Study|Protocol Violation|0|||
23739476|NCT03481634|66425813|FG002|Overall Study|Protocol Violation|1|||
23739477|NCT03481634|66425811|FG000|Overall Study|Progressive disease|0|||
23739478|NCT03481634|66425812|FG001|Overall Study|Progressive disease|1|||
23739479|NCT03481634|66425813|FG002|Overall Study|Progressive disease|0|||
23739480|NCT03481634|66425811|FG000|Overall Study|Physician Decision|3|||
23739481|NCT03481634|66425812|FG001|Overall Study|Physician Decision|0|||
23739482|NCT03481634|66425813|FG002|Overall Study|Physician Decision|1|||
23739483|NCT03481634|66425811|FG000|Overall Study|Lost to Follow-up|3|||
23739484|NCT03481634|66425812|FG001|Overall Study|Lost to Follow-up|4|||
23739485|NCT03481634|66425813|FG002|Overall Study|Lost to Follow-up|4|||
23739486|NCT03481634|66425811|FG000|Overall Study|Death|4|||
23739487|NCT03481634|66425812|FG001|Overall Study|Death|8|||
23739488|NCT03481634|66425813|FG002|Overall Study|Death|7|||
23739489|NCT03481634|66425811|FG000|Overall Study|Adverse Event|6|||
23739490|NCT03481634|66425812|FG001|Overall Study|Adverse Event|3|||
23739491|NCT03481634|66425813|FG002|Overall Study|Adverse Event|7|||
23739492|NCT00669240|66425818|FG000|Overall Study|Lack of Efficacy|33|||
23739493|NCT00669240|66425818|FG000|Overall Study|Withdrawal by Subject|42|||
23739494|NCT00669240|66425818|FG000|Overall Study|Lost to Follow-up|34|||
23739495|NCT00669240|66425818|FG000|Overall Study|Adverse Event|21|||
23739496|NCT00669240|66425818|FG000|Overall Study|Other|19|||
23739497|NCT00669240|66425818|FG000|Overall Study|Enrolled but not treated|15|||
23427969|NCT02250664|65310642|FG002|Overall Study|Reason unknown|0|||
23548107|NCT03301051|65739468|FG001|Overall Study|Miscellaneous|4|||
23548108|NCT03301051|65739467|FG000|Overall Study|Randomized, not vaccinated|13|||
23548109|NCT03301051|65739468|FG001|Overall Study|Randomized, not vaccinated|10|||
23548110|NCT03147248|65739471|FG000|Overall Study|Adverse Event|0|||
23548111|NCT03147248|65739472|FG001|Overall Study|Adverse Event|2|||
23739498|NCT00669240|66425818|FG000|Overall Study|Enrolled but no dosing record|1|||
23427970|NCT02982018|65310644|FG000|Overall Study|Incorrect Lens Dispensed|1|||
23427971|NCT02982018|65310645|FG001|Overall Study|Incorrect Lens Dispensed|0|||
23548112|NCT03147248|65739473|FG002|Overall Study|Adverse Event|2|||
23548113|NCT03147248|65739474|FG003|Overall Study|Adverse Event|2|||
23548114|NCT03147248|65739475|FG004|Overall Study|Adverse Event|6|||
23548115|NCT03147248|65739476|FG005|Overall Study|Adverse Event|11|||
23739499|NCT04511533|66425821|FG000|Treatment|Other|2|||
23739500|NCT04511533|66425821|FG000|Treatment|Withdrawal by Subject|11|||
23739501|NCT04511533|66425821|FG000|Treatment|Death|5|||
23739502|NCT04511533|66425821|FG000|Treatment|Physician Decision|1|||
23427972|NCT02982018|65310644|FG000|Overall Study|Protocol Violation|1|||
23739503|NCT04511533|66425821|FG000|Treatment|Progressive Disease|61|||
23739504|NCT04511533|66425821|FG000|Follow-Up|Other|7|||
23427973|NCT02982018|65310645|FG001|Overall Study|Protocol Violation|1|||
23427974|NCT02982018|65310644|FG000|Overall Study|Adverse Event|1|||
23427975|NCT02982018|65310645|FG001|Overall Study|Adverse Event|1|||
23427976|NCT02982018|65310644|FG000|Overall Study|Lens Discomfort|2|||
23427977|NCT02982018|65310645|FG001|Overall Study|Lens Discomfort|0|||
23427978|NCT02982018|65310644|FG000|Overall Study|Withdrawal by Subject|0|||
23427979|NCT02982018|65310645|FG001|Overall Study|Withdrawal by Subject|1|||
23427980|NCT03987932|65310646|FG000|Overall Study|Lost to Follow-up|2|||
23427981|NCT03987932|65310647|FG001|Overall Study|Lost to Follow-up|1|||
23427982|NCT03987932|65310648|FG002|Overall Study|Lost to Follow-up|1|||
23427983|NCT03987932|65310646|FG000|Overall Study|Non-study related elective surgery|0|||
23427984|NCT03987932|65310647|FG001|Overall Study|Non-study related elective surgery|0|||
23427985|NCT03987932|65310648|FG002|Overall Study|Non-study related elective surgery|1|||
23427986|NCT02226198|65310649|FG000|Lead-in Phase|Protocol Violation|1|||
23427987|NCT02226198|65310650|FG001|Lead-in Phase|Protocol Violation|0|||
23427988|NCT02226198|65310651|FG002|Lead-in Phase|Protocol Violation|0|||
23427989|NCT02226198|65310649|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
23427990|NCT02226198|65310650|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
23427991|NCT02226198|65310651|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
23427992|NCT01636713|65310652|FG000|Overall Study|Adverse Event|16|||
23427993|NCT01636713|65310653|FG001|Overall Study|Adverse Event|16|||
23427994|NCT01636713|65310654|FG002|Overall Study|Adverse Event|7|||
23427995|NCT01636713|65310652|FG000|Overall Study|Lack of Efficacy|6|||
23427996|NCT01636713|65310653|FG001|Overall Study|Lack of Efficacy|6|||
23427997|NCT01636713|65310654|FG002|Overall Study|Lack of Efficacy|2|||
23427998|NCT01636713|65310652|FG000|Overall Study|Protocol Violation|3|||
23427999|NCT01636713|65310653|FG001|Overall Study|Protocol Violation|0|||
23428000|NCT01636713|65310654|FG002|Overall Study|Protocol Violation|1|||
23428001|NCT01636713|65310652|FG000|Overall Study|Lost to Follow-up|0|||
23428002|NCT01636713|65310653|FG001|Overall Study|Lost to Follow-up|0|||
23428003|NCT01636713|65310654|FG002|Overall Study|Lost to Follow-up|1|||
23428004|NCT01636713|65310652|FG000|Overall Study|Withdrawal by Subject|5|||
23428005|NCT01636713|65310653|FG001|Overall Study|Withdrawal by Subject|4|||
23428006|NCT01636713|65310654|FG002|Overall Study|Withdrawal by Subject|8|||
23428007|NCT01636713|65310652|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23428008|NCT01636713|65310653|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23428009|NCT01636713|65310654|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23428010|NCT01945775|65310655|FG000|Overall Study|Death|214|||
23428011|NCT01945775|65310656|FG001|Overall Study|Death|98|||
23428012|NCT01945775|65310655|FG000|Overall Study|Lost to Follow-up|12|||
23428013|NCT01945775|65310656|FG001|Overall Study|Lost to Follow-up|7|||
23428014|NCT01945775|65310655|FG000|Overall Study|Withdrawal by Subject|11|||
23428015|NCT01945775|65310656|FG001|Overall Study|Withdrawal by Subject|21|||
23428016|NCT01945775|65310655|FG000|Overall Study|Other|50|||
23428017|NCT01945775|65310656|FG001|Overall Study|Other|18|||
23428018|NCT02989805|65310659|FG000|Overall Study|invalid consent|6|||
23428019|NCT02989805|65310660|FG001|Overall Study|invalid consent|4|||
23428020|NCT00700102|65310661|FG000|Overall Study|Died|394|||
23428021|NCT00700102|65310662|FG001|Overall Study|Died|385|||
23428022|NCT00700102|65310661|FG000|Overall Study|Lost to Follow-up|8|||
23428023|NCT00700102|65310662|FG001|Overall Study|Lost to Follow-up|10|||
23548116|NCT03147248|65739471|FG000|Overall Study|Disease progression|1|||
23548117|NCT03147248|65739472|FG001|Overall Study|Disease progression|0|||
23739505|NCT04511533|66425821|FG000|Follow-Up|Withdrawal by Subject|5|||
23739506|NCT04511533|66425821|FG000|Follow-Up|Lost to Follow-up|2|||
23739507|NCT04511533|66425821|FG000|Follow-Up|Death|4|||
23739508|NCT03143855|66425822|FG000|Overall Study|Withdrawal by Subject|4|||
23739509|NCT03143855|66425823|FG001|Overall Study|Withdrawal by Subject|3|||
23739510|NCT03143855|66425822|FG000|Overall Study|Protocol Violation|1|||
23739511|NCT03143855|66425823|FG001|Overall Study|Protocol Violation|0|||
23739512|NCT03143855|66425822|FG000|Overall Study|Participant experienced withdrawal|0|||
23739513|NCT03143855|66425823|FG001|Overall Study|Participant experienced withdrawal|1|||
23739514|NCT01314261|66425826|FG000|Overall Study|Adverse Event|1|||
23739515|NCT01314261|66425827|FG001|Overall Study|Adverse Event|0|||
23428024|NCT00385723|65310663|FG000|Overall Study|Lost to Follow-up|1|||
23428025|NCT00385723|65310664|FG001|Overall Study|Lost to Follow-up|1|||
23428026|NCT00385723|65310665|FG002|Overall Study|Lost to Follow-up|0|||
23428027|NCT00385723|65310663|FG000|Overall Study|Withdrawal by Subject|1|||
23548118|NCT03147248|65739473|FG002|Overall Study|Disease progression|0|||
23739516|NCT01314261|66425828|FG002|Overall Study|Adverse Event|0|||
23739517|NCT01314261|66425829|FG003|Overall Study|Adverse Event|0|||
23428028|NCT00385723|65310664|FG001|Overall Study|Withdrawal by Subject|0|||
23428029|NCT00385723|65310665|FG002|Overall Study|Withdrawal by Subject|2|||
23428030|NCT00364533|65310671|FG000|Overall Study|Adverse Event|8|||
23428031|NCT00364533|65310672|FG001|Overall Study|Adverse Event|7|||
23739518|NCT01314261|66425826|FG000|Overall Study|Withdrawal by Subject|0|||
23820794|NCT01876446|66725928|FG001|Overall Study|Withdrawal by Subject|2|||
23820795|NCT01876446|66725927|FG000|Overall Study|Physician Decision|1|||
23820796|NCT01876446|66725928|FG001|Overall Study|Physician Decision|3|||
23820797|NCT03449446|66725929|FG000|Overall Study|Randomized but Never Treated|0|||
23820798|NCT03449446|66725930|FG001|Overall Study|Randomized but Never Treated|0|||
23820799|NCT03449446|66725931|FG002|Overall Study|Randomized but Never Treated|1|||
23820800|NCT03449446|66725932|FG003|Overall Study|Randomized but Never Treated|1|||
23820801|NCT03449446|66725933|FG004|Overall Study|Randomized but Never Treated|1|||
23820802|NCT03449446|66725934|FG005|Overall Study|Randomized but Never Treated|0|||
23820803|NCT03449446|66725935|FG006|Overall Study|Randomized but Never Treated|0|||
23820804|NCT03449446|66725929|FG000|Overall Study|Unknown Reason|33|||
23820805|NCT03449446|66725930|FG001|Overall Study|Unknown Reason|1|||
23820806|NCT03449446|66725931|FG002|Overall Study|Unknown Reason|1|||
23820807|NCT03449446|66725932|FG003|Overall Study|Unknown Reason|1|||
23820808|NCT03449446|66725933|FG004|Overall Study|Unknown Reason|2|||
23820809|NCT03449446|66725934|FG005|Overall Study|Unknown Reason|2|||
23820810|NCT03449446|66725935|FG006|Overall Study|Unknown Reason|0|||
23820811|NCT03449446|66725929|FG000|Overall Study|Withdrew Consent|1|||
23820812|NCT03449446|66725930|FG001|Overall Study|Withdrew Consent|3|||
23820813|NCT03449446|66725931|FG002|Overall Study|Withdrew Consent|1|||
23820814|NCT03449446|66725932|FG003|Overall Study|Withdrew Consent|4|||
23820815|NCT03449446|66725933|FG004|Overall Study|Withdrew Consent|4|||
23820816|NCT03449446|66725934|FG005|Overall Study|Withdrew Consent|4|||
23820817|NCT03449446|66725935|FG006|Overall Study|Withdrew Consent|1|||
23820818|NCT03449446|66725929|FG000|Overall Study|Adverse Event|1|||
23820819|NCT03449446|66725930|FG001|Overall Study|Adverse Event|2|||
23428032|NCT00364533|65310673|FG002|Overall Study|Adverse Event|15|||
23548119|NCT03147248|65739474|FG003|Overall Study|Disease progression|0|||
23739519|NCT01314261|66425827|FG001|Overall Study|Withdrawal by Subject|3|||
23739520|NCT01314261|66425828|FG002|Overall Study|Withdrawal by Subject|1|||
23739521|NCT01314261|66425829|FG003|Overall Study|Withdrawal by Subject|0|||
23739522|NCT01314261|66425826|FG000|Overall Study|Lost to Follow-up|1|||
23739523|NCT01314261|66425827|FG001|Overall Study|Lost to Follow-up|0|||
23739524|NCT01314261|66425828|FG002|Overall Study|Lost to Follow-up|2|||
23739525|NCT01314261|66425829|FG003|Overall Study|Lost to Follow-up|2|||
23739526|NCT01314261|66425826|FG000|Overall Study|Virologic Failure|0|||
23548120|NCT03147248|65739475|FG004|Overall Study|Disease progression|0|||
23548121|NCT03147248|65739476|FG005|Overall Study|Disease progression|2|||
23548122|NCT03147248|65739471|FG000|Overall Study|Withdrawal by Subject|0|||
23548123|NCT03147248|65739472|FG001|Overall Study|Withdrawal by Subject|0|||
23548124|NCT03147248|65739473|FG002|Overall Study|Withdrawal by Subject|0|||
23548125|NCT03147248|65739474|FG003|Overall Study|Withdrawal by Subject|0|||
23548126|NCT03147248|65739475|FG004|Overall Study|Withdrawal by Subject|12|||
23548127|NCT03147248|65739476|FG005|Overall Study|Withdrawal by Subject|9|||
23548128|NCT03147248|65739471|FG000|Overall Study|Protocol Violation|0|||
23548129|NCT03147248|65739472|FG001|Overall Study|Protocol Violation|0|||
23548130|NCT03147248|65739473|FG002|Overall Study|Protocol Violation|0|||
23548131|NCT03147248|65739474|FG003|Overall Study|Protocol Violation|0|||
23548132|NCT03147248|65739475|FG004|Overall Study|Protocol Violation|2|||
23548133|NCT03147248|65739476|FG005|Overall Study|Protocol Violation|0|||
23548134|NCT03147248|65739471|FG000|Overall Study|Lost to Follow-up|0|||
23548135|NCT03147248|65739472|FG001|Overall Study|Lost to Follow-up|0|||
23548136|NCT03147248|65739473|FG002|Overall Study|Lost to Follow-up|0|||
23548137|NCT03147248|65739474|FG003|Overall Study|Lost to Follow-up|0|||
23548138|NCT03147248|65739475|FG004|Overall Study|Lost to Follow-up|2|||
23548139|NCT03147248|65739476|FG005|Overall Study|Lost to Follow-up|0|||
23548140|NCT03147248|65739471|FG000|Overall Study|Pregnancy|0|||
23548141|NCT03147248|65739472|FG001|Overall Study|Pregnancy|0|||
23548142|NCT03147248|65739473|FG002|Overall Study|Pregnancy|0|||
23548143|NCT03147248|65739474|FG003|Overall Study|Pregnancy|0|||
23548144|NCT03147248|65739475|FG004|Overall Study|Pregnancy|1|||
23548145|NCT03147248|65739476|FG005|Overall Study|Pregnancy|0|||
23548146|NCT03147248|65739471|FG000|Overall Study|Death|0|||
23548147|NCT03147248|65739472|FG001|Overall Study|Death|0|||
23548148|NCT03147248|65739473|FG002|Overall Study|Death|0|||
23548149|NCT03147248|65739474|FG003|Overall Study|Death|0|||
23739527|NCT01314261|66425827|FG001|Overall Study|Virologic Failure|1|||
23820820|NCT03449446|66725931|FG002|Overall Study|Adverse Event|1|||
23820821|NCT03449446|66725932|FG003|Overall Study|Adverse Event|0|||
23428033|NCT00364533|65310674|FG003|Overall Study|Adverse Event|5|||
23820822|NCT03449446|66725933|FG004|Overall Study|Adverse Event|0|||
23820823|NCT03449446|66725934|FG005|Overall Study|Adverse Event|2|||
23820824|NCT03449446|66725935|FG006|Overall Study|Adverse Event|0|||
23548150|NCT03147248|65739475|FG004|Overall Study|Death|0|||
23548151|NCT03147248|65739476|FG005|Overall Study|Death|4|||
23548152|NCT03147248|65739471|FG000|Overall Study|Physician Decision|0|||
23548153|NCT03147248|65739472|FG001|Overall Study|Physician Decision|0|||
23548154|NCT03147248|65739473|FG002|Overall Study|Physician Decision|0|||
23548155|NCT03147248|65739474|FG003|Overall Study|Physician Decision|0|||
23739528|NCT01314261|66425828|FG002|Overall Study|Virologic Failure|0|||
23739529|NCT01314261|66425829|FG003|Overall Study|Virologic Failure|1|||
23739530|NCT00364351|66425830|FG000|Overall Study|Adverse Event|90|||
23739531|NCT00364351|66425831|FG001|Overall Study|Adverse Event|44|||
23739532|NCT00364351|66425830|FG000|Overall Study|Condition under investigation worsened|469|||
23739533|NCT00364351|66425831|FG001|Overall Study|Condition under investigation worsened|497|||
23739534|NCT00364351|66425830|FG000|Overall Study|Prohibited concomitant medication|0|||
23739535|NCT00364351|66425831|FG001|Overall Study|Prohibited concomitant medication|2|||
23739536|NCT00364351|66425830|FG000|Overall Study|Lost to Follow-up|1|||
23739537|NCT00364351|66425831|FG001|Overall Study|Lost to Follow-up|1|||
23739538|NCT00364351|66425830|FG000|Overall Study|Withdrawal by Subject|30|||
23739539|NCT00364351|66425831|FG001|Overall Study|Withdrawal by Subject|29|||
23739540|NCT00364351|66425830|FG000|Overall Study|Incorrect enrollment|1|||
23739541|NCT00364351|66425831|FG001|Overall Study|Incorrect enrollment|1|||
23739542|NCT00364351|66425830|FG000|Overall Study|Sponsor decision|1|||
23739543|NCT00364351|66425831|FG001|Overall Study|Sponsor decision|0|||
23739544|NCT00364351|66425830|FG000|Overall Study|Poor treatment compliance|0|||
23739545|NCT00364351|66425831|FG001|Overall Study|Poor treatment compliance|3|||
23739546|NCT00364351|66425830|FG000|Overall Study|Investigator error|0|||
23739547|NCT00364351|66425831|FG001|Overall Study|Investigator error|2|||
23739548|NCT00364351|66425830|FG000|Overall Study|Patient could not travel to site|0|||
23739549|NCT00364351|66425831|FG001|Overall Study|Patient could not travel to site|1|||
23739550|NCT00364351|66425830|FG000|Overall Study|Randomised treatment not started|0|||
23739551|NCT00364351|66425831|FG001|Overall Study|Randomised treatment not started|3|||
23739552|NCT00134563|66425834|FG000|Overall Study|Not treated due to protocol violation|0|||
23739553|NCT00134563|66425835|FG001|Overall Study|Not treated due to protocol violation|1|||
23739554|NCT00134563|66425836|FG002|Overall Study|Not treated due to protocol violation|1|||
23739555|NCT00134563|66425834|FG000|Overall Study|Adverse Event|29|||
23739556|NCT00134563|66425835|FG001|Overall Study|Adverse Event|37|||
23739557|NCT00134563|66425836|FG002|Overall Study|Adverse Event|38|||
23739558|NCT00134563|66425834|FG000|Overall Study|Lack of Efficacy|24|||
23739559|NCT00134563|66425835|FG001|Overall Study|Lack of Efficacy|14|||
23739560|NCT00134563|66425836|FG002|Overall Study|Lack of Efficacy|17|||
23739561|NCT00134563|66425834|FG000|Overall Study|Protocol Violation|3|||
23739562|NCT00134563|66425835|FG001|Overall Study|Protocol Violation|2|||
23739563|NCT00134563|66425836|FG002|Overall Study|Protocol Violation|5|||
23739564|NCT00134563|66425834|FG000|Overall Study|Lost to Follow-up|4|||
23739565|NCT00134563|66425835|FG001|Overall Study|Lost to Follow-up|0|||
23739566|NCT00134563|66425836|FG002|Overall Study|Lost to Follow-up|2|||
23739567|NCT00134563|66425834|FG000|Overall Study|progressive disease|11|||
23739568|NCT00134563|66425835|FG001|Overall Study|progressive disease|4|||
23739569|NCT00134563|66425836|FG002|Overall Study|progressive disease|2|||
23739570|NCT00134563|66425834|FG000|Overall Study|did not wish to continue|33|||
23739571|NCT00134563|66425835|FG001|Overall Study|did not wish to continue|32|||
23739572|NCT00134563|66425836|FG002|Overall Study|did not wish to continue|26|||
23739573|NCT00134563|66425834|FG000|Overall Study|Reason other than above|0|||
23739574|NCT00134563|66425835|FG001|Overall Study|Reason other than above|2|||
23739575|NCT00134563|66425836|FG002|Overall Study|Reason other than above|5|||
23739576|NCT02062385|66425837|FG000|Overall Study|Adverse Event|19|||
23739577|NCT02062385|66425838|FG001|Overall Study|Adverse Event|13|||
23739578|NCT02062385|66425839|FG002|Overall Study|Adverse Event|1|||
23739579|NCT02062385|66425840|FG003|Overall Study|Adverse Event|0|||
23739580|NCT02062385|66425837|FG000|Overall Study|Protocol Violation|1|||
23820825|NCT03449446|66725929|FG000|Overall Study|Lost to Follow-up|0|||
23820826|NCT03449446|66725930|FG001|Overall Study|Lost to Follow-up|0|||
23820827|NCT03449446|66725931|FG002|Overall Study|Lost to Follow-up|2|||
23820828|NCT03449446|66725932|FG003|Overall Study|Lost to Follow-up|1|||
23820829|NCT03449446|66725933|FG004|Overall Study|Lost to Follow-up|3|||
23820830|NCT03449446|66725934|FG005|Overall Study|Lost to Follow-up|0|||
23820831|NCT03449446|66725935|FG006|Overall Study|Lost to Follow-up|0|||
23820832|NCT03449446|66725929|FG000|Overall Study|Investigator's Discretion|0|||
23820833|NCT03449446|66725930|FG001|Overall Study|Investigator's Discretion|1|||
23428034|NCT00364533|65310675|FG004|Overall Study|Adverse Event|2|||
23548156|NCT03147248|65739475|FG004|Overall Study|Physician Decision|2|||
23548157|NCT03147248|65739476|FG005|Overall Study|Physician Decision|4|||
23739581|NCT02062385|66425838|FG001|Overall Study|Protocol Violation|0|||
23739582|NCT02062385|66425839|FG002|Overall Study|Protocol Violation|0|||
23739583|NCT02062385|66425840|FG003|Overall Study|Protocol Violation|0|||
23739584|NCT02062385|66425837|FG000|Overall Study|Incomplete EPI by database lock|2|||
23739585|NCT02062385|66425838|FG001|Overall Study|Incomplete EPI by database lock|0|||
23739586|NCT02062385|66425839|FG002|Overall Study|Incomplete EPI by database lock|0|||
23739587|NCT02062385|66425840|FG003|Overall Study|Incomplete EPI by database lock|0|||
23739588|NCT02062385|66425837|FG000|Overall Study|Moved|10|||
23739589|NCT02062385|66425838|FG001|Overall Study|Moved|11|||
23739590|NCT02062385|66425839|FG002|Overall Study|Moved|1|||
23739591|NCT02062385|66425840|FG003|Overall Study|Moved|0|||
23820834|NCT03449446|66725931|FG002|Overall Study|Investigator's Discretion|1|||
23820835|NCT03449446|66725932|FG003|Overall Study|Investigator's Discretion|2|||
23820836|NCT03449446|66725933|FG004|Overall Study|Investigator's Discretion|0|||
23820837|NCT03449446|66725934|FG005|Overall Study|Investigator's Discretion|0|||
23820838|NCT03449446|66725935|FG006|Overall Study|Investigator's Discretion|0|||
23619673|NCT01772147|65994707|FG001|Overall Study|Lack of Efficacy|6|||
23739592|NCT02062385|66425837|FG000|Overall Study|Withdrawn by parent/guardian|46|||
23739593|NCT02062385|66425838|FG001|Overall Study|Withdrawn by parent/guardian|41|||
23739594|NCT02062385|66425839|FG002|Overall Study|Withdrawn by parent/guardian|9|||
23739595|NCT02062385|66425840|FG003|Overall Study|Withdrawn by parent/guardian|8|||
23739596|NCT02062385|66425837|FG000|Overall Study|Death|0|||
23739597|NCT02062385|66425838|FG001|Overall Study|Death|0|||
23739598|NCT02062385|66425839|FG002|Overall Study|Death|0|||
23739599|NCT02062385|66425840|FG003|Overall Study|Death|1|||
23739600|NCT02062385|66425837|FG000|Overall Study|Lost to Follow-up|0|||
23739601|NCT02062385|66425838|FG001|Overall Study|Lost to Follow-up|0|||
23739602|NCT02062385|66425839|FG002|Overall Study|Lost to Follow-up|1|||
23739603|NCT02062385|66425840|FG003|Overall Study|Lost to Follow-up|0|||
23619674|NCT01772147|65994708|FG002|Overall Study|Lack of Efficacy|6|||
23619675|NCT02396758|65994712|FG000|Overall Study|Withdrawal by Subject|2|||
23619676|NCT02396758|65994713|FG001|Overall Study|Withdrawal by Subject|0|||
23619677|NCT02396758|65994714|FG002|Overall Study|Withdrawal by Subject|0|||
23619678|NCT02396758|65994715|FG003|Overall Study|Withdrawal by Subject|1|||
23619679|NCT02396758|65994712|FG000|Overall Study|Lost to Follow-up|8|||
23619680|NCT02396758|65994713|FG001|Overall Study|Lost to Follow-up|5|||
23619681|NCT02396758|65994714|FG002|Overall Study|Lost to Follow-up|3|||
23619682|NCT02396758|65994715|FG003|Overall Study|Lost to Follow-up|3|||
23619683|NCT02396758|65994712|FG000|Overall Study|Death|1|||
23619684|NCT02396758|65994713|FG001|Overall Study|Death|1|||
23619685|NCT02396758|65994714|FG002|Overall Study|Death|0|||
23619686|NCT02396758|65994715|FG003|Overall Study|Death|1|||
23739604|NCT01277757|66425843|FG000|Overall Study|Disease Progression|1|||
23739605|NCT01277757|66425843|FG000|Overall Study|Withdrawal by Subject|1|||
23739606|NCT00422942|66425861|FG000|Overall Study|Study terminated by Sponsor|3|||
23739607|NCT02155712|66425862|FG000|Overall Study|Death|12|||
23739608|NCT02155712|66425863|FG001|Overall Study|Death|0|||
23739609|NCT02155712|66425862|FG000|Overall Study|Lost to Follow-up|37|||
23739610|NCT02155712|66425863|FG001|Overall Study|Lost to Follow-up|22|||
23739611|NCT02155712|66425862|FG000|Overall Study|Revision of device|4|||
23739612|NCT02155712|66425863|FG001|Overall Study|Revision of device|3|||
23739613|NCT02155712|66425862|FG000|Overall Study|Withdrawal by Subject|39|||
23739614|NCT02155712|66425863|FG001|Overall Study|Withdrawal by Subject|21|||
23739615|NCT02155712|66425862|FG000|Overall Study|Site termination|77|||
23739616|NCT02155712|66425863|FG001|Overall Study|Site termination|19|||
23739617|NCT02155712|66425862|FG000|Overall Study|Sponsor terminated study early|150|||
23739618|NCT02155712|66425863|FG001|Overall Study|Sponsor terminated study early|0|||
23739619|NCT02155712|66425862|FG000|Overall Study|Missed final 5-year protocol visit|0|||
23739620|NCT02155712|66425863|FG001|Overall Study|Missed final 5-year protocol visit|32|||
23820839|NCT03449446|66725929|FG000|Overall Study|Non Compliance with Study Drug|1|||
23548158|NCT03147248|65739471|FG000|Overall Study|Prolonged Dosing Interval|0|||
23548159|NCT03147248|65739472|FG001|Overall Study|Prolonged Dosing Interval|0|||
23548160|NCT03147248|65739473|FG002|Overall Study|Prolonged Dosing Interval|0|||
23548161|NCT03147248|65739474|FG003|Overall Study|Prolonged Dosing Interval|0|||
23548162|NCT03147248|65739475|FG004|Overall Study|Prolonged Dosing Interval|1|||
23548163|NCT03147248|65739476|FG005|Overall Study|Prolonged Dosing Interval|1|||
23548164|NCT02269670|65739477|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
23548165|NCT00605280|65739478|FG000|Year 1|Protocol Violation|0|||
23548166|NCT00605280|65739479|FG001|Year 1|Protocol Violation|0|||
23548167|NCT00605280|65739480|FG002|Year 1|Protocol Violation|0|||
23548168|NCT00605280|65739481|FG003|Year 1|Protocol Violation|1|||
23548169|NCT00605280|65739478|FG000|Year 1|Adverse Event|3|||
23548170|NCT00605280|65739479|FG001|Year 1|Adverse Event|1|||
23548171|NCT00605280|65739480|FG002|Year 1|Adverse Event|1|||
23548172|NCT00605280|65739481|FG003|Year 1|Adverse Event|5|||
23548173|NCT00605280|65739478|FG000|Year 1|Physician Decision|7|||
23548174|NCT00605280|65739479|FG001|Year 1|Physician Decision|4|||
23548175|NCT00605280|65739480|FG002|Year 1|Physician Decision|0|||
23548176|NCT00605280|65739481|FG003|Year 1|Physician Decision|6|||
23548177|NCT00605280|65739478|FG000|Year 1|Withdrawal by Subject|2|||
23548178|NCT00605280|65739479|FG001|Year 1|Withdrawal by Subject|4|||
23619687|NCT02396758|65994712|FG000|Overall Study|Randomized but not treated|1|||
23619688|NCT02396758|65994713|FG001|Overall Study|Randomized but not treated|0|||
23619689|NCT02396758|65994714|FG002|Overall Study|Randomized but not treated|1|||
23619690|NCT02396758|65994715|FG003|Overall Study|Randomized but not treated|0|||
23739621|NCT02155712|66425862|FG000|Overall Study|Censored because surgery cancelled|6|||
23739622|NCT02155712|66425863|FG001|Overall Study|Censored because surgery cancelled|10|||
23739623|NCT02155712|66425862|FG000|Overall Study|Censored because study device was not implanted|61|||
23739624|NCT02155712|66425863|FG001|Overall Study|Censored because study device was not implanted|66|||
23820840|NCT03449446|66725930|FG001|Overall Study|Non Compliance with Study Drug|0|||
23619691|NCT00728884|65994718|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
23619692|NCT00728884|65994718|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
23619693|NCT03927222|65994719|FG000|Overall Study|Progression|3|||
23428035|NCT00364533|65310671|FG000|Overall Study|Withdrawal by Subject|4|||
23428036|NCT00364533|65310672|FG001|Overall Study|Withdrawal by Subject|8|||
23428037|NCT00364533|65310673|FG002|Overall Study|Withdrawal by Subject|6|||
23428038|NCT00364533|65310674|FG003|Overall Study|Withdrawal by Subject|6|||
23428039|NCT00364533|65310675|FG004|Overall Study|Withdrawal by Subject|6|||
23428040|NCT00364533|65310671|FG000|Overall Study|Lack of Efficacy|22|||
23428041|NCT00364533|65310672|FG001|Overall Study|Lack of Efficacy|22|||
23428042|NCT00364533|65310673|FG002|Overall Study|Lack of Efficacy|21|||
23619694|NCT03927222|65994719|FG000|Overall Study|CMV testing results inconclusive|1|||
23619695|NCT03927222|65994719|FG000|Overall Study|Unable to generate enough vaccines|1|||
23619696|NCT03927222|65994719|FG000|Overall Study|Early study termination|1|||
23619697|NCT00396097|65994725|FG000|Overall Study|Withdrawal by Subject|17|||
23428043|NCT00364533|65310674|FG003|Overall Study|Lack of Efficacy|17|||
23428044|NCT00364533|65310675|FG004|Overall Study|Lack of Efficacy|42|||
23428045|NCT00364533|65310671|FG000|Overall Study|Subject discharged from hospital|4|||
23428046|NCT00364533|65310672|FG001|Overall Study|Subject discharged from hospital|1|||
23428047|NCT00364533|65310673|FG002|Overall Study|Subject discharged from hospital|2|||
23428048|NCT00364533|65310674|FG003|Overall Study|Subject discharged from hospital|3|||
23428049|NCT00364533|65310675|FG004|Overall Study|Subject discharged from hospital|1|||
23428050|NCT00364533|65310671|FG000|Overall Study|Variations in drug compliance|2|||
23428051|NCT00364533|65310672|FG001|Overall Study|Variations in drug compliance|1|||
23428052|NCT00364533|65310673|FG002|Overall Study|Variations in drug compliance|1|||
23428053|NCT00364533|65310674|FG003|Overall Study|Variations in drug compliance|0|||
23428054|NCT00364533|65310675|FG004|Overall Study|Variations in drug compliance|0|||
23428055|NCT00364533|65310671|FG000|Overall Study|Non-compliance|1|||
23428056|NCT00364533|65310672|FG001|Overall Study|Non-compliance|0|||
23428057|NCT00364533|65310673|FG002|Overall Study|Non-compliance|0|||
23428058|NCT00364533|65310674|FG003|Overall Study|Non-compliance|0|||
23428059|NCT00364533|65310675|FG004|Overall Study|Non-compliance|0|||
23428060|NCT00364533|65310671|FG000|Overall Study|Protocol Violation|1|||
23428061|NCT00364533|65310672|FG001|Overall Study|Protocol Violation|1|||
23428062|NCT00364533|65310673|FG002|Overall Study|Protocol Violation|0|||
23428063|NCT00364533|65310674|FG003|Overall Study|Protocol Violation|0|||
23428064|NCT00364533|65310675|FG004|Overall Study|Protocol Violation|0|||
23428065|NCT02242981|65310678|FG000|Overall Study|Withdrawal by Subject|1|||
23428066|NCT00343915|65310680|FG000|Primary Study|Withdrawal by Subject|1|||
23428067|NCT00343915|65310681|FG001|Primary Study|Withdrawal by Subject|0|||
23428068|NCT00343915|65310680|FG000|Primary Study|Lost to Follow-up|2|||
23428069|NCT00343915|65310681|FG001|Primary Study|Lost to Follow-up|3|||
23428070|NCT00343915|65310680|FG000|Primary Study|Other|1|||
23428071|NCT00343915|65310681|FG001|Primary Study|Other|0|||
23428072|NCT00524589|65310682|FG000|Overall Study|Withdrawal by Subject|2|||
23428073|NCT00524589|65310682|FG000|Overall Study|Disease Progression|16|||
23428074|NCT01751776|65310683|FG000|Overall Study|Adverse Event|0|||
23428075|NCT01751776|65310684|FG001|Overall Study|Adverse Event|0|||
23428076|NCT01751776|65310685|FG002|Overall Study|Adverse Event|0|||
23428077|NCT01751776|65310686|FG003|Overall Study|Adverse Event|0|||
23428078|NCT01751776|65310687|FG004|Overall Study|Adverse Event|0|||
23428079|NCT01751776|65310688|FG005|Overall Study|Adverse Event|0|||
23428080|NCT01751776|65310689|FG006|Overall Study|Adverse Event|4|||
23428081|NCT01751776|65310690|FG007|Overall Study|Adverse Event|2|||
23428082|NCT01751776|65310683|FG000|Overall Study|Consent withdrawn|0|||
23428083|NCT01751776|65310684|FG001|Overall Study|Consent withdrawn|0|||
23428084|NCT01751776|65310685|FG002|Overall Study|Consent withdrawn|0|||
23428085|NCT01751776|65310686|FG003|Overall Study|Consent withdrawn|0|||
23428086|NCT01751776|65310687|FG004|Overall Study|Consent withdrawn|0|||
23428087|NCT01751776|65310688|FG005|Overall Study|Consent withdrawn|0|||
23428088|NCT01751776|65310689|FG006|Overall Study|Consent withdrawn|0|||
23428089|NCT01751776|65310690|FG007|Overall Study|Consent withdrawn|1|||
23428090|NCT01751776|65310683|FG000|Overall Study|Other reason not specified above|0|||
23428091|NCT01751776|65310684|FG001|Overall Study|Other reason not specified above|0|||
23428092|NCT01751776|65310685|FG002|Overall Study|Other reason not specified above|0|||
23428093|NCT01751776|65310686|FG003|Overall Study|Other reason not specified above|0|||
23619698|NCT00396097|65994726|FG001|Overall Study|Withdrawal by Subject|17|||
23619699|NCT00396097|65994725|FG000|Overall Study|Lost to Follow-up|4|||
23428094|NCT01751776|65310687|FG004|Overall Study|Other reason not specified above|0|||
23428095|NCT01751776|65310688|FG005|Overall Study|Other reason not specified above|0|||
23428096|NCT01751776|65310689|FG006|Overall Study|Other reason not specified above|0|||
23428097|NCT01751776|65310690|FG007|Overall Study|Other reason not specified above|1|||
23428098|NCT00089986|65310691|FG000|Overall Study|Adverse Event|6|||
23428099|NCT00089986|65310692|FG001|Overall Study|Adverse Event|9|||
23428100|NCT00089986|65310693|FG002|Overall Study|Adverse Event|6|||
23428101|NCT00089986|65310691|FG000|Overall Study|Lost to Follow-up|3|||
23428102|NCT00089986|65310692|FG001|Overall Study|Lost to Follow-up|1|||
23428103|NCT00089986|65310693|FG002|Overall Study|Lost to Follow-up|1|||
23428104|NCT00089986|65310691|FG000|Overall Study|Protocol Violation|0|||
23428105|NCT00089986|65310692|FG001|Overall Study|Protocol Violation|1|||
23428106|NCT00089986|65310693|FG002|Overall Study|Protocol Violation|0|||
23428107|NCT00089986|65310691|FG000|Overall Study|Patient transferred to another hospital|2|||
23428108|NCT00089986|65310692|FG001|Overall Study|Patient transferred to another hospital|1|||
23428109|NCT00089986|65310693|FG002|Overall Study|Patient transferred to another hospital|0|||
23428110|NCT00089986|65310691|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
23428111|NCT00089986|65310692|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
23428112|NCT00089986|65310693|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
23428113|NCT00089986|65310691|FG000|Overall Study|Hemohlobin stopping rule|0|||
23428114|NCT00089986|65310692|FG001|Overall Study|Hemohlobin stopping rule|1|||
23428115|NCT00089986|65310693|FG002|Overall Study|Hemohlobin stopping rule|0|||
23428116|NCT00089986|65310691|FG000|Overall Study|Investigator decision to withdrew|0|||
23428117|NCT00089986|65310692|FG001|Overall Study|Investigator decision to withdrew|1|||
23428118|NCT00089986|65310693|FG002|Overall Study|Investigator decision to withdrew|0|||
23428119|NCT00089986|65310691|FG000|Overall Study|Enrollment in another study|0|||
23428120|NCT00089986|65310692|FG001|Overall Study|Enrollment in another study|1|||
23428121|NCT00089986|65310693|FG002|Overall Study|Enrollment in another study|0|||
23428122|NCT00089986|65310691|FG000|Overall Study|Family decision|0|||
23428123|NCT00089986|65310692|FG001|Overall Study|Family decision|1|||
23428124|NCT00089986|65310693|FG002|Overall Study|Family decision|0|||
23428125|NCT00089986|65310691|FG000|Overall Study|Do not resuscitate (DNR)|0|||
23428126|NCT00089986|65310692|FG001|Overall Study|Do not resuscitate (DNR)|0|||
23428127|NCT00089986|65310693|FG002|Overall Study|Do not resuscitate (DNR)|1|||
23428128|NCT00089986|65310691|FG000|Overall Study|Withdrawal by Subject|3|||
23428129|NCT00089986|65310692|FG001|Overall Study|Withdrawal by Subject|6|||
23428130|NCT00089986|65310693|FG002|Overall Study|Withdrawal by Subject|2|||
23428131|NCT04438499|65310694|FG000|Overall Study|Lack of Efficacy|2|||
23428132|NCT03541187|65310695|FG000|Overall Study|Lost to Follow-up|2|||
23428133|NCT03541187|65310696|FG001|Overall Study|Lost to Follow-up|6|||
23428134|NCT03541187|65310695|FG000|Overall Study|Pregnancy|0|||
23428135|NCT03541187|65310696|FG001|Overall Study|Pregnancy|1|||
23428136|NCT03541187|65310695|FG000|Overall Study|Withdrawal by Subject|6|||
23428137|NCT03541187|65310696|FG001|Overall Study|Withdrawal by Subject|2|||
23428138|NCT03541187|65310695|FG000|Overall Study|Moved out of town|1|||
23428139|NCT03541187|65310696|FG001|Overall Study|Moved out of town|0|||
23428140|NCT03541187|65310695|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
23428141|NCT03541187|65310696|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
23428142|NCT03541187|65310695|FG000|Overall Study|Did not meet randomization criteria|1|||
23428143|NCT03541187|65310696|FG001|Overall Study|Did not meet randomization criteria|1|||
23428144|NCT03541187|65310695|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
23428145|NCT03541187|65310696|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
23428146|NCT03541187|65310695|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
23428147|NCT03541187|65310696|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
23428148|NCT02836873|65310697|FG000|Overall Study|Protocol Violation|0|||
23548179|NCT00605280|65739480|FG002|Year 1|Withdrawal by Subject|0|||
23548180|NCT00605280|65739481|FG003|Year 1|Withdrawal by Subject|4|||
23548181|NCT00605280|65739478|FG000|Year 1|Other|2|||
23548182|NCT00605280|65739479|FG001|Year 1|Other|1|||
23548183|NCT00605280|65739480|FG002|Year 1|Other|0|||
23548184|NCT00605280|65739481|FG003|Year 1|Other|1|||
23548185|NCT00605280|65739478|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
23820841|NCT03449446|66725931|FG002|Overall Study|Non Compliance with Study Drug|0|||
23820842|NCT03449446|66725932|FG003|Overall Study|Non Compliance with Study Drug|0|||
23820843|NCT03449446|66725933|FG004|Overall Study|Non Compliance with Study Drug|0|||
23820844|NCT03449446|66725934|FG005|Overall Study|Non Compliance with Study Drug|0|||
23820845|NCT03449446|66725935|FG006|Overall Study|Non Compliance with Study Drug|0|||
23820846|NCT03449446|66725929|FG000|Overall Study|Protocol Violation|0|||
23820847|NCT03449446|66725930|FG001|Overall Study|Protocol Violation|0|||
23820848|NCT03449446|66725931|FG002|Overall Study|Protocol Violation|0|||
23548186|NCT00605280|65739479|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
23820849|NCT03449446|66725932|FG003|Overall Study|Protocol Violation|0|||
23428149|NCT02836873|65310698|FG001|Overall Study|Protocol Violation|1|||
23428150|NCT02836873|65310697|FG000|Overall Study|Adverse Event|1|||
23428151|NCT02836873|65310698|FG001|Overall Study|Adverse Event|4|||
23428152|NCT02836873|65310697|FG000|Overall Study|Withdrawal by Subject|2|||
23428153|NCT02836873|65310698|FG001|Overall Study|Withdrawal by Subject|2|||
23428154|NCT02836873|65310697|FG000|Overall Study|Lost to Follow-up|1|||
23548187|NCT00605280|65739480|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
23428155|NCT02836873|65310698|FG001|Overall Study|Lost to Follow-up|3|||
23548188|NCT00605280|65739481|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
23548189|NCT00605280|65739478|FG000|Year 2|Adverse Event|4|||
23820850|NCT03449446|66725933|FG004|Overall Study|Protocol Violation|1|||
23428156|NCT02836873|65310697|FG000|Overall Study|Physician Decision|0|||
23428157|NCT02836873|65310698|FG001|Overall Study|Physician Decision|1|||
23428158|NCT02836873|65310697|FG000|Overall Study|Other|1|||
23428159|NCT02836873|65310698|FG001|Overall Study|Other|0|||
23428160|NCT00283868|65310699|FG000|Overall Study|Lost to Follow-up|7|||
23619700|NCT00396097|65994726|FG001|Overall Study|Lost to Follow-up|9|||
23619701|NCT00396097|65994725|FG000|Overall Study|Other|3|||
23739625|NCT02155712|66425862|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
23739626|NCT02155712|66425863|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
23739627|NCT00106626|66425864|FG000|Overall Study|Adverse Event|5|||
23739628|NCT00106626|66425865|FG001|Overall Study|Adverse Event|4|||
23739629|NCT00106626|66425866|FG002|Overall Study|Adverse Event|3|||
23739630|NCT00106626|66425867|FG003|Overall Study|Adverse Event|3|||
23739631|NCT00106626|66425864|FG000|Overall Study|Progressive Disease|4|||
23739632|NCT00106626|66425865|FG001|Overall Study|Progressive Disease|1|||
23739633|NCT00106626|66425866|FG002|Overall Study|Progressive Disease|9|||
23739634|NCT00106626|66425867|FG003|Overall Study|Progressive Disease|10|||
23739635|NCT00106626|66425864|FG000|Overall Study|Received radiation on new therapy|1|||
23739636|NCT00106626|66425865|FG001|Overall Study|Received radiation on new therapy|0|||
23428161|NCT00283868|65310700|FG001|Overall Study|Lost to Follow-up|8|||
23428162|NCT01344629|65310701|FG000|Crossover Period 2|Withdrawal by Subject|0|||
23428163|NCT01344629|65310702|FG001|Crossover Period 2|Withdrawal by Subject|1|||
23428164|NCT03550404|65310707|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
23428165|NCT03550404|65310708|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
23428166|NCT03550404|65310709|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
23428167|NCT03550404|65310707|FG000|Phase 2|Vacated position|1|||
23619702|NCT00396097|65994726|FG001|Overall Study|Other|5|||
23619703|NCT00396097|65994725|FG000|Overall Study|Protocol Violation|0|||
23619704|NCT00396097|65994726|FG001|Overall Study|Protocol Violation|6|||
23619705|NCT00396097|65994725|FG000|Overall Study|Adverse Event|1|||
23619706|NCT00396097|65994726|FG001|Overall Study|Adverse Event|5|||
23619707|NCT00396097|65994725|FG000|Overall Study|Insufficient Clinical Response|1|||
23619708|NCT00396097|65994726|FG001|Overall Study|Insufficient Clinical Response|4|||
23619709|NCT00496834|65994729|FG000|Overall Study|Withdrawal by Subject|4|||
23619710|NCT00496834|65994730|FG001|Overall Study|Withdrawal by Subject|6|||
23619711|NCT00496834|65994729|FG000|Overall Study|Contraindicated medication administered|0|||
23619712|NCT00496834|65994730|FG001|Overall Study|Contraindicated medication administered|1|||
23619713|NCT00496834|65994729|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
23428168|NCT03550404|65310708|FG001|Phase 2|Vacated position|0|||
23428169|NCT03550404|65310709|FG002|Phase 2|Vacated position|0|||
23428170|NCT03285958|65310710|FG000|Overall Study|Lost to Follow-up|1|||
23428171|NCT03285958|65310711|FG001|Overall Study|Lost to Follow-up|1|||
23428172|NCT03285958|65310710|FG000|Overall Study|Withdrawal by Subject|1|||
23428173|NCT03285958|65310711|FG001|Overall Study|Withdrawal by Subject|0|||
23428174|NCT03285958|65310710|FG000|Overall Study|Not able to attend required orientation|3|||
23428175|NCT03285958|65310711|FG001|Overall Study|Not able to attend required orientation|0|||
23428176|NCT00973102|65310713|FG000|Overall Study|Protocol Violation|1|||
23428177|NCT00973102|65310714|FG001|Overall Study|Protocol Violation|0|||
23428178|NCT00973102|65310713|FG000|Overall Study|Prisoner|0|||
23428179|NCT00973102|65310714|FG001|Overall Study|Prisoner|1|||
23428180|NCT00392808|65310716|FG000|Overall Study|Lost to Follow-up|3|||
23428181|NCT00392808|65310717|FG001|Overall Study|Lost to Follow-up|2|||
23428182|NCT00392808|65310718|FG002|Overall Study|Lost to Follow-up|1|||
23428183|NCT00392808|65310719|FG003|Overall Study|Lost to Follow-up|2|||
23428184|NCT00392808|65310716|FG000|Overall Study|Unable to withdraw blood|3|||
23428185|NCT00392808|65310717|FG001|Overall Study|Unable to withdraw blood|1|||
23428186|NCT00392808|65310718|FG002|Overall Study|Unable to withdraw blood|1|||
23428187|NCT00392808|65310719|FG003|Overall Study|Unable to withdraw blood|2|||
23428188|NCT00598078|65310729|FG000|Period 2 (Day 2)|Adverse Event|1|||
23428189|NCT00598078|65310730|FG001|Period 2 (Day 2)|Adverse Event|0|||
23428190|NCT01116427|65310732|FG000|Core Phase|Adverse Event|0|||
23428191|NCT01116427|65310733|FG001|Core Phase|Adverse Event|1|||
23428192|NCT01116427|65310732|FG000|Core Phase|Lost to Follow-up|1|||
23428193|NCT01116427|65310733|FG001|Core Phase|Lost to Follow-up|0|||
23428194|NCT01116427|65310732|FG000|Core Phase|Withdrawal by Subject|3|||
23428195|NCT01116427|65310733|FG001|Core Phase|Withdrawal by Subject|0|||
23619714|NCT00496834|65994730|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
23619715|NCT00496834|65994729|FG000|Overall Study|Adverse Event|5|||
23428196|NCT01116427|65310732|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
23739637|NCT00106626|66425866|FG002|Overall Study|Received radiation on new therapy|0|||
23428197|NCT01116427|65310733|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
23428198|NCT01116427|65310732|FG000|Extension Phase|Adverse Event|1|||
23428199|NCT01116427|65310733|FG001|Extension Phase|Adverse Event|1|||
23739638|NCT00106626|66425867|FG003|Overall Study|Received radiation on new therapy|0|||
23739639|NCT00106626|66425864|FG000|Overall Study|> 14 day delay in therapy start|0|||
23428200|NCT01116427|65310732|FG000|Extension Phase|Lost to Follow-up|2|||
23428201|NCT01116427|65310733|FG001|Extension Phase|Lost to Follow-up|0|||
23619716|NCT00496834|65994730|FG001|Overall Study|Adverse Event|3|||
23619717|NCT00496834|65994729|FG000|Overall Study|IP administration violation|2|||
23619718|NCT00496834|65994730|FG001|Overall Study|IP administration violation|0|||
23619719|NCT00496834|65994729|FG000|Overall Study|Lost to Follow-up|2|||
23619720|NCT00496834|65994730|FG001|Overall Study|Lost to Follow-up|0|||
23619721|NCT00496834|65994729|FG000|Overall Study|Blood Pressure control failure|2|||
23619722|NCT00496834|65994730|FG001|Overall Study|Blood Pressure control failure|1|||
23619723|NCT03675308|65994731|FG000|Overall Study|Adverse Event|3|||
23619724|NCT03675308|65994732|FG001|Overall Study|Adverse Event|2|||
23619725|NCT03675308|65994731|FG000|Overall Study|Withdrawal by Subject|6|||
23619726|NCT03675308|65994732|FG001|Overall Study|Withdrawal by Subject|4|||
23619727|NCT03675308|65994731|FG000|Overall Study|Lost to Follow-up|3|||
23619728|NCT03675308|65994732|FG001|Overall Study|Lost to Follow-up|0|||
23619729|NCT03675308|65994731|FG000|Overall Study|Lack of Efficacy|1|||
23619730|NCT03675308|65994732|FG001|Overall Study|Lack of Efficacy|1|||
23619731|NCT03675308|65994731|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
23619732|NCT03675308|65994732|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
23428202|NCT01116427|65310732|FG000|Extension Phase|Withdrawal by Subject|5|||
23428203|NCT01116427|65310733|FG001|Extension Phase|Withdrawal by Subject|1|||
23428204|NCT01116427|65310732|FG000|Extension Phase|Not using appropriate birth control|1|||
23428205|NCT01116427|65310733|FG001|Extension Phase|Not using appropriate birth control|0|||
23548190|NCT00605280|65739479|FG001|Year 2|Adverse Event|0|||
23619733|NCT03675308|65994731|FG000|Overall Study|Other|0|||
23619734|NCT03675308|65994732|FG001|Overall Study|Other|1|||
23619735|NCT03723915|65994733|FG000|Screening|Failed to meet screening requirements.|2|||
23619736|NCT03723915|65994733|FG000|On Treatment|Failed to meet treatment requirements|2|||
23548191|NCT00605280|65739480|FG002|Year 2|Adverse Event|2|||
23548192|NCT00605280|65739481|FG003|Year 2|Adverse Event|4|||
23619737|NCT03175198|65994734|FG000|Overall Study|Adverse Event|480|||
23619738|NCT03175198|65994734|FG000|Overall Study|No actual visit|120|||
23619739|NCT03175198|65994734|FG000|Overall Study|Registration rule not followed|4|||
23739640|NCT00106626|66425865|FG001|Overall Study|> 14 day delay in therapy start|1|||
23739641|NCT00106626|66425866|FG002|Overall Study|> 14 day delay in therapy start|0|||
23739642|NCT00106626|66425867|FG003|Overall Study|> 14 day delay in therapy start|0|||
23739643|NCT02624713|66425868|FG000|Overall Study|Lost to Follow-up|14|||
23739644|NCT02624713|66425869|FG001|Overall Study|Lost to Follow-up|0|||
23739645|NCT02908841|66425870|FG000|Overall Study|Physician Decision|4|||
23739646|NCT02908841|66425871|FG001|Overall Study|Physician Decision|0|||
23739647|NCT00242658|66425872|FG000|Overall Study|Lost to Follow-up|22|||
23739648|NCT00242658|66425873|FG001|Overall Study|Lost to Follow-up|19|||
23739649|NCT02207413|66425875|FG000|Overall Study|Withdrawal by Subject|1|||
23739650|NCT02207413|66425876|FG001|Overall Study|Withdrawal by Subject|0|||
23428206|NCT00432744|65310739|FG000|Months 0-6|Withdrawal by Subject|4|||
23548193|NCT00605280|65739478|FG000|Year 2|Physician Decision|11|||
23548194|NCT00605280|65739479|FG001|Year 2|Physician Decision|6|||
23548195|NCT00605280|65739480|FG002|Year 2|Physician Decision|4|||
23548196|NCT00605280|65739481|FG003|Year 2|Physician Decision|11|||
23548197|NCT00605280|65739478|FG000|Year 2|Withdrawal by Subject|4|||
23548198|NCT00605280|65739479|FG001|Year 2|Withdrawal by Subject|0|||
23548199|NCT00605280|65739480|FG002|Year 2|Withdrawal by Subject|0|||
23548200|NCT00605280|65739481|FG003|Year 2|Withdrawal by Subject|4|||
23548201|NCT00605280|65739478|FG000|Year 2|Other|1|||
23548202|NCT00605280|65739479|FG001|Year 2|Other|0|||
23619740|NCT03175198|65994734|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
23619741|NCT03175198|65994734|FG000|Overall Study|Other personal reason|509|||
23619742|NCT03175198|65994734|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
23820851|NCT03449446|66725934|FG005|Overall Study|Protocol Violation|1|||
23428207|NCT00432744|65310740|FG001|Months 0-6|Withdrawal by Subject|4|||
23428208|NCT00432744|65310739|FG000|Months 0-6|Too disabled to score|1|||
23428209|NCT00432744|65310740|FG001|Months 0-6|Too disabled to score|0|||
23428210|NCT00432744|65310739|FG000|Months 7 - 12|Withdrawal by Subject|1|||
23428211|NCT00432744|65310740|FG001|Months 7 - 12|Withdrawal by Subject|0|||
23428212|NCT00432744|65310739|FG000|Months 7 - 12|Too disabled to score|0|||
23428213|NCT00432744|65310740|FG001|Months 7 - 12|Too disabled to score|1|||
23428214|NCT04584346|65310741|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
23428215|NCT04584346|65310742|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
23428216|NCT03757130|65310745|FG000|Overall Study|Lost to Follow-up|0|||
23428217|NCT03757130|65310746|FG001|Overall Study|Lost to Follow-up|0|||
23428218|NCT03757130|65310747|FG002|Overall Study|Lost to Follow-up|0|||
23428219|NCT03757130|65310748|FG003|Overall Study|Lost to Follow-up|1|||
23548203|NCT00605280|65739480|FG002|Year 2|Other|0|||
23548204|NCT00605280|65739481|FG003|Year 2|Other|1|||
23548205|NCT00605280|65739478|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
23548206|NCT00605280|65739479|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
23548207|NCT00605280|65739480|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
23739651|NCT02207413|66425877|FG002|Overall Study|Withdrawal by Subject|0|||
23739652|NCT02207413|66425878|FG003|Overall Study|Withdrawal by Subject|0|||
23739653|NCT02207413|66425879|FG004|Overall Study|Withdrawal by Subject|3|||
23739654|NCT02207413|66425880|FG005|Overall Study|Withdrawal by Subject|7|||
23739655|NCT02207413|66425875|FG000|Overall Study|Lost to Follow-up|0|||
23739656|NCT02207413|66425876|FG001|Overall Study|Lost to Follow-up|0|||
23739657|NCT02207413|66425877|FG002|Overall Study|Lost to Follow-up|0|||
23739658|NCT02207413|66425878|FG003|Overall Study|Lost to Follow-up|1|||
23739659|NCT02207413|66425879|FG004|Overall Study|Lost to Follow-up|1|||
23739660|NCT02207413|66425880|FG005|Overall Study|Lost to Follow-up|5|||
23739661|NCT02207413|66425875|FG000|Overall Study|Adverse Event|0|||
23739662|NCT02207413|66425876|FG001|Overall Study|Adverse Event|0|||
23739663|NCT02207413|66425877|FG002|Overall Study|Adverse Event|0|||
23739664|NCT02207413|66425878|FG003|Overall Study|Adverse Event|0|||
23739665|NCT02207413|66425879|FG004|Overall Study|Adverse Event|2|||
23739666|NCT02207413|66425880|FG005|Overall Study|Adverse Event|1|||
23739667|NCT02207413|66425875|FG000|Overall Study|Migrated/moved from study area|0|||
23739668|NCT02207413|66425876|FG001|Overall Study|Migrated/moved from study area|0|||
23739669|NCT02207413|66425877|FG002|Overall Study|Migrated/moved from study area|0|||
23739670|NCT02207413|66425878|FG003|Overall Study|Migrated/moved from study area|0|||
23739671|NCT02207413|66425879|FG004|Overall Study|Migrated/moved from study area|1|||
23739672|NCT02207413|66425880|FG005|Overall Study|Migrated/moved from study area|0|||
23739673|NCT04249076|66425881|FG000|Overall Study|Adverse Event|1|||
23739674|NCT04249076|66425882|FG001|Overall Study|Adverse Event|1|||
23739675|NCT04249076|66425881|FG000|Overall Study|Protocol Violation|1|||
23739676|NCT04249076|66425882|FG001|Overall Study|Protocol Violation|2|||
23739677|NCT04249076|66425881|FG000|Overall Study|Lack of Efficacy|0|||
23739678|NCT04249076|66425882|FG001|Overall Study|Lack of Efficacy|1|||
23739679|NCT04249076|66425881|FG000|Overall Study|Withdrawal by Subject|0|||
23739680|NCT04249076|66425882|FG001|Overall Study|Withdrawal by Subject|1|||
23739681|NCT00656136|66425894|FG000|Overall Study|Progressive disease|177|||
23739682|NCT00656136|66425895|FG001|Overall Study|Progressive disease|322|||
23739683|NCT00656136|66425894|FG000|Overall Study|Other Adverse Event|5|||
23739684|NCT00656136|66425895|FG001|Overall Study|Other Adverse Event|51|||
23739685|NCT00656136|66425894|FG000|Overall Study|Protocol Violation|2|||
23739686|NCT00656136|66425895|FG001|Overall Study|Protocol Violation|3|||
23739687|NCT00656136|66425894|FG000|Overall Study|Patient refused to take study medication|7|||
23739688|NCT00656136|66425895|FG001|Overall Study|Patient refused to take study medication|10|||
23739689|NCT00656136|66425894|FG000|Overall Study|Unknown and others|4|||
23739690|NCT00656136|66425895|FG001|Overall Study|Unknown and others|4|||
23739691|NCT05102734|66425897|FG000|Overall Study|Did not require vasopressors|1|||
23739692|NCT05102734|66425898|FG001|Overall Study|Did not require vasopressors|0|||
23739693|NCT05102734|66425897|FG000|Overall Study|Did not have functioning PA catheter|1|||
23739694|NCT05102734|66425898|FG001|Overall Study|Did not have functioning PA catheter|0|||
23739695|NCT05102734|66425897|FG000|Overall Study|Inadequate video quality|2|||
23739696|NCT05102734|66425898|FG001|Overall Study|Inadequate video quality|0|||
23739697|NCT02055976|66425902|FG000|Overall Study|Other|0|||
23739698|NCT02055976|66425903|FG001|Overall Study|Other|0|||
23739699|NCT02055976|66425904|FG002|Overall Study|Other|1|||
23820852|NCT03449446|66725935|FG006|Overall Study|Protocol Violation|0|||
23428220|NCT03757130|65310749|FG004|Overall Study|Lost to Follow-up|0|||
23428221|NCT03757130|65310750|FG005|Overall Study|Lost to Follow-up|0|||
23548208|NCT00605280|65739481|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
23548209|NCT00605280|65739478|FG000|Year 3 Extension|Adverse Event|2|||
23548210|NCT00605280|65739479|FG001|Year 3 Extension|Adverse Event|0|||
23548211|NCT00605280|65739480|FG002|Year 3 Extension|Adverse Event|0|||
23548212|NCT00605280|65739481|FG003|Year 3 Extension|Adverse Event|2|||
23548213|NCT00605280|65739478|FG000|Year 3 Extension|Physician Decision|0|||
23548214|NCT00605280|65739479|FG001|Year 3 Extension|Physician Decision|0|||
23548215|NCT00605280|65739480|FG002|Year 3 Extension|Physician Decision|0|||
23548216|NCT00605280|65739481|FG003|Year 3 Extension|Physician Decision|2|||
23739700|NCT02055976|66425905|FG003|Overall Study|Other|0|||
23739701|NCT02055976|66425906|FG004|Overall Study|Other|0|||
23739702|NCT02055976|66425907|FG005|Overall Study|Other|0|||
23739703|NCT02055976|66425908|FG006|Overall Study|Other|0|||
23739704|NCT02055976|66425909|FG007|Overall Study|Other|0|||
23739705|NCT02055976|66425910|FG008|Overall Study|Other|0|||
23739706|NCT02055976|66425902|FG000|Overall Study|Adverse Event|0|||
23739707|NCT02055976|66425903|FG001|Overall Study|Adverse Event|0|||
23739708|NCT02055976|66425904|FG002|Overall Study|Adverse Event|0|||
23739709|NCT02055976|66425905|FG003|Overall Study|Adverse Event|0|||
23739710|NCT02055976|66425906|FG004|Overall Study|Adverse Event|0|||
23739711|NCT02055976|66425907|FG005|Overall Study|Adverse Event|1|||
23739712|NCT02055976|66425908|FG006|Overall Study|Adverse Event|1|||
23739713|NCT02055976|66425909|FG007|Overall Study|Adverse Event|0|||
23739714|NCT02055976|66425910|FG008|Overall Study|Adverse Event|0|||
23548217|NCT00605280|65739478|FG000|Year 3 Extension|Withdrawal by Subject|2|||
23548218|NCT00605280|65739479|FG001|Year 3 Extension|Withdrawal by Subject|0|||
23548219|NCT00605280|65739480|FG002|Year 3 Extension|Withdrawal by Subject|0|||
23548220|NCT00605280|65739481|FG003|Year 3 Extension|Withdrawal by Subject|5|||
23548221|NCT00605280|65739478|FG000|Year 3 Extension|Other|2|||
23548222|NCT00605280|65739479|FG001|Year 3 Extension|Other|0|||
23548223|NCT00605280|65739480|FG002|Year 3 Extension|Other|0|||
23548224|NCT00605280|65739481|FG003|Year 3 Extension|Other|0|||
23548225|NCT00605280|65739478|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
23548226|NCT00605280|65739479|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548227|NCT00605280|65739480|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548228|NCT00605280|65739481|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548229|NCT00617344|65739485|FG000|Overall Study|Serious adverse event|1|||
23548230|NCT00617344|65739486|FG001|Overall Study|Serious adverse event|0|||
23548231|NCT00617344|65739487|FG002|Overall Study|Serious adverse event|0|||
23548232|NCT00617344|65739485|FG000|Overall Study|Other Adverse Event|1|||
23548233|NCT00617344|65739486|FG001|Overall Study|Other Adverse Event|1|||
23548234|NCT00617344|65739487|FG002|Overall Study|Other Adverse Event|0|||
23548235|NCT00617344|65739485|FG000|Overall Study|Protocol Violation|10|||
23548236|NCT00617344|65739486|FG001|Overall Study|Protocol Violation|8|||
23739715|NCT02055976|66425902|FG000|Overall Study|Does not meet entrance criteria|0|||
23739716|NCT02055976|66425903|FG001|Overall Study|Does not meet entrance criteria|0|||
23739717|NCT02055976|66425904|FG002|Overall Study|Does not meet entrance criteria|0|||
23739718|NCT02055976|66425905|FG003|Overall Study|Does not meet entrance criteria|0|||
23739719|NCT02055976|66425906|FG004|Overall Study|Does not meet entrance criteria|0|||
23739720|NCT02055976|66425907|FG005|Overall Study|Does not meet entrance criteria|0|||
23739721|NCT02055976|66425908|FG006|Overall Study|Does not meet entrance criteria|1|||
23739722|NCT02055976|66425909|FG007|Overall Study|Does not meet entrance criteria|0|||
23739723|NCT02055976|66425910|FG008|Overall Study|Does not meet entrance criteria|0|||
23739724|NCT02055976|66425902|FG000|Overall Study|Lost to Follow-up|0|||
23548237|NCT00617344|65739487|FG002|Overall Study|Protocol Violation|5|||
23548238|NCT00617344|65739485|FG000|Overall Study|Lost to Follow-up|5|||
23548239|NCT00617344|65739486|FG001|Overall Study|Lost to Follow-up|4|||
23548240|NCT00617344|65739487|FG002|Overall Study|Lost to Follow-up|1|||
23548241|NCT00617344|65739485|FG000|Overall Study|Withdrawal by Subject|8|||
23548242|NCT00617344|65739486|FG001|Overall Study|Withdrawal by Subject|9|||
23548243|NCT00617344|65739487|FG002|Overall Study|Withdrawal by Subject|2|||
23548244|NCT00707031|65739488|FG000|Overall Study|Adverse Event|45|||
23548245|NCT00707031|65739489|FG001|Overall Study|Adverse Event|45|||
23548246|NCT00707031|65739488|FG000|Overall Study|Lack of Efficacy|19|||
23548247|NCT00707031|65739489|FG001|Overall Study|Lack of Efficacy|6|||
23548248|NCT00707031|65739488|FG000|Overall Study|Lost to Follow-up|2|||
23619743|NCT03175198|65994734|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
23619744|NCT03175198|65994734|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
23619745|NCT03175198|65994734|FG000|Overall Study|To conduct invasive treatment of operation|53|||
23619746|NCT03175198|65994734|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
23619747|NCT03840200|65994735|FG000|Overall Study|Death|6|||
23619748|NCT03840200|65994736|FG001|Overall Study|Death|3|||
23619749|NCT03840200|65994737|FG002|Overall Study|Death|6|||
23619750|NCT03840200|65994738|FG003|Overall Study|Death|10|||
23619751|NCT03840200|65994735|FG000|Overall Study|Reason Not Specified|2|||
23619752|NCT03840200|65994736|FG001|Overall Study|Reason Not Specified|2|||
23739725|NCT02055976|66425903|FG001|Overall Study|Lost to Follow-up|0|||
23739726|NCT02055976|66425904|FG002|Overall Study|Lost to Follow-up|0|||
23739727|NCT02055976|66425905|FG003|Overall Study|Lost to Follow-up|1|||
23739728|NCT02055976|66425906|FG004|Overall Study|Lost to Follow-up|0|||
23739729|NCT02055976|66425907|FG005|Overall Study|Lost to Follow-up|0|||
23739730|NCT02055976|66425908|FG006|Overall Study|Lost to Follow-up|0|||
23739731|NCT02055976|66425909|FG007|Overall Study|Lost to Follow-up|0|||
23739732|NCT02055976|66425910|FG008|Overall Study|Lost to Follow-up|0|||
23428222|NCT03757130|65310751|FG006|Overall Study|Lost to Follow-up|0|||
23428223|NCT03757130|65310752|FG007|Overall Study|Lost to Follow-up|1|||
23548249|NCT00707031|65739489|FG001|Overall Study|Lost to Follow-up|1|||
23548250|NCT00707031|65739488|FG000|Overall Study|Protocol Violation|1|||
23548251|NCT00707031|65739489|FG001|Overall Study|Protocol Violation|0|||
23548252|NCT00707031|65739488|FG000|Overall Study|Withdrawal by Subject|7|||
23548253|NCT00707031|65739489|FG001|Overall Study|Withdrawal by Subject|8|||
23548254|NCT00707031|65739488|FG000|Overall Study|Poor Compliance to Protocol|7|||
23548255|NCT00707031|65739489|FG001|Overall Study|Poor Compliance to Protocol|13|||
23548256|NCT00707031|65739488|FG000|Overall Study|Familial or Personal Reasons|12|||
23739733|NCT01791543|66425913|FG000|Overall Study|Lost to Follow-up|1|||
23739734|NCT01791543|66425913|FG000|Overall Study|Adverse Event|1|||
23739735|NCT01177943|66425914|FG000|First Intervention|Withdrawal by Subject|2|||
23739736|NCT01177943|66425915|FG001|First Intervention|Withdrawal by Subject|0|||
23739737|NCT00283062|66425919|FG000|Overall Study|Did not receive any study medication|5|||
23739738|NCT00283062|66425920|FG001|Overall Study|Did not receive any study medication|4|||
23739739|NCT00283062|66425921|FG002|Overall Study|Did not receive any study medication|36|||
23739740|NCT00283062|66425922|FG003|Overall Study|Did not receive any study medication|45|||
23739741|NCT00283062|66425919|FG000|Overall Study|Adverse Event|2|||
23739742|NCT00283062|66425920|FG001|Overall Study|Adverse Event|0|||
23739743|NCT00283062|66425921|FG002|Overall Study|Adverse Event|1|||
23739744|NCT00283062|66425922|FG003|Overall Study|Adverse Event|0|||
23739745|NCT00283062|66425919|FG000|Overall Study|Lost to Follow-up|1|||
23739746|NCT00283062|66425920|FG001|Overall Study|Lost to Follow-up|0|||
23739747|NCT00283062|66425921|FG002|Overall Study|Lost to Follow-up|1|||
23739748|NCT00283062|66425922|FG003|Overall Study|Lost to Follow-up|0|||
23739749|NCT00283062|66425919|FG000|Overall Study|Progressive disease|0|||
23739750|NCT00283062|66425920|FG001|Overall Study|Progressive disease|0|||
23739751|NCT00283062|66425921|FG002|Overall Study|Progressive disease|1|||
23739752|NCT00283062|66425922|FG003|Overall Study|Progressive disease|0|||
23739753|NCT00283062|66425919|FG000|Overall Study|Participant did not wish to continue|3|||
23739754|NCT00283062|66425920|FG001|Overall Study|Participant did not wish to continue|2|||
23739755|NCT00283062|66425921|FG002|Overall Study|Participant did not wish to continue|1|||
23739756|NCT00283062|66425922|FG003|Overall Study|Participant did not wish to continue|0|||
23739757|NCT00283062|66425919|FG000|Overall Study|Undefined|0|||
23739758|NCT00283062|66425920|FG001|Overall Study|Undefined|1|||
23739759|NCT00283062|66425921|FG002|Overall Study|Undefined|1|||
23428224|NCT03757130|65310745|FG000|Overall Study|Withdrawal by Subject|0|||
23428225|NCT03757130|65310746|FG001|Overall Study|Withdrawal by Subject|0|||
23428226|NCT03757130|65310747|FG002|Overall Study|Withdrawal by Subject|0|||
23428227|NCT03757130|65310748|FG003|Overall Study|Withdrawal by Subject|0|||
23428228|NCT03757130|65310749|FG004|Overall Study|Withdrawal by Subject|0|||
23428229|NCT03757130|65310750|FG005|Overall Study|Withdrawal by Subject|0|||
23428230|NCT03757130|65310751|FG006|Overall Study|Withdrawal by Subject|1|||
23428231|NCT03757130|65310752|FG007|Overall Study|Withdrawal by Subject|0|||
23428232|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
23428233|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
23428234|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
23428235|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
23428236|NCT03899064|65310760|FG000|Overall Study|Lost to Follow-up|1|||
23428237|NCT03899064|65310760|FG000|Overall Study|Protocol Violation|2|||
23428238|NCT03899064|65310760|FG000|Overall Study|Withdrawal by Subject|2|||
23548257|NCT00707031|65739489|FG001|Overall Study|Familial or Personal Reasons|15|||
23548258|NCT00707031|65739488|FG000|Overall Study|Serious Noncompliance|2|||
23548259|NCT00707031|65739489|FG001|Overall Study|Serious Noncompliance|3|||
23548260|NCT00707031|65739488|FG000|Overall Study|Sponsor Decision|9|||
23548261|NCT00707031|65739489|FG001|Overall Study|Sponsor Decision|8|||
23548262|NCT04085328|65739492|FG000|Overall Study|Witihdrew Consent|16|||
23548263|NCT04085328|65739493|FG001|Overall Study|Witihdrew Consent|16|||
23548264|NCT04085328|65739492|FG000|Overall Study|Adverse Event|8|||
23548265|NCT04085328|65739493|FG001|Overall Study|Adverse Event|7|||
23548266|NCT04085328|65739492|FG000|Overall Study|Lost to Follow-up|7|||
23548267|NCT04085328|65739493|FG001|Overall Study|Lost to Follow-up|2|||
23548268|NCT04085328|65739492|FG000|Overall Study|Physician Decision|0|||
23548269|NCT04085328|65739493|FG001|Overall Study|Physician Decision|1|||
23619753|NCT03840200|65994737|FG002|Overall Study|Reason Not Specified|1|||
23619754|NCT03840200|65994738|FG003|Overall Study|Reason Not Specified|15|||
23619755|NCT03840200|65994735|FG000|Overall Study|Physician Decision|0|||
23619756|NCT03840200|65994736|FG001|Overall Study|Physician Decision|0|||
23619757|NCT03840200|65994737|FG002|Overall Study|Physician Decision|0|||
23739760|NCT00283062|66425922|FG003|Overall Study|Undefined|4|||
23619758|NCT03840200|65994738|FG003|Overall Study|Physician Decision|2|||
23619759|NCT03840200|65994735|FG000|Overall Study|Progressive Disease|0|||
23619760|NCT03840200|65994736|FG001|Overall Study|Progressive Disease|0|||
23619761|NCT03840200|65994737|FG002|Overall Study|Progressive Disease|0|||
23619762|NCT03840200|65994738|FG003|Overall Study|Progressive Disease|1|||
23619763|NCT03840200|65994735|FG000|Overall Study|Withdrawal by Subject|0|||
23739761|NCT00283062|66425919|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
23739762|NCT00283062|66425920|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
23428239|NCT03899064|65310760|FG000|Overall Study|Other|2|||
23428240|NCT03779503|65310761|FG000|First Intervention|Adverse Event|0|||
23428241|NCT03779503|65310762|FG001|First Intervention|Adverse Event|1|||
23428242|NCT03779503|65310761|FG000|First Intervention|Withdrawal by Subject|1|||
23548270|NCT04085328|65739492|FG000|Overall Study|Pregnancy|0|||
23548271|NCT04085328|65739493|FG001|Overall Study|Pregnancy|1|||
23619764|NCT03840200|65994736|FG001|Overall Study|Withdrawal by Subject|1|||
23739763|NCT00283062|66425921|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
23739764|NCT00283062|66425922|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
23548272|NCT04085328|65739492|FG000|Overall Study|Reasons Related to COVID-19|5|||
23428243|NCT03779503|65310762|FG001|First Intervention|Withdrawal by Subject|0|||
23619765|NCT03840200|65994737|FG002|Overall Study|Withdrawal by Subject|0|||
23619766|NCT03840200|65994738|FG003|Overall Study|Withdrawal by Subject|2|||
23548273|NCT04085328|65739493|FG001|Overall Study|Reasons Related to COVID-19|8|||
23548274|NCT04085328|65739492|FG000|Overall Study|Did not meet inclusion criteria|1|||
23548275|NCT04085328|65739493|FG001|Overall Study|Did not meet inclusion criteria|1|||
23548276|NCT04085328|65739492|FG000|Overall Study|Early termination|1|||
23619767|NCT01276509|65994739|FG000|Overall Study|Adverse Event|9|||
23619768|NCT01276509|65994740|FG001|Overall Study|Adverse Event|8|||
23619769|NCT01276509|65994741|FG002|Overall Study|Adverse Event|4|||
23619770|NCT01276509|65994742|FG003|Overall Study|Adverse Event|3|||
23619771|NCT01276509|65994739|FG000|Overall Study|Lack of Efficacy|2|||
23619772|NCT01276509|65994740|FG001|Overall Study|Lack of Efficacy|1|||
23619773|NCT01276509|65994741|FG002|Overall Study|Lack of Efficacy|1|||
23619774|NCT01276509|65994742|FG003|Overall Study|Lack of Efficacy|2|||
23619775|NCT01276509|65994739|FG000|Overall Study|Pregnancy|1|||
23619776|NCT01276509|65994740|FG001|Overall Study|Pregnancy|0|||
23619777|NCT01276509|65994741|FG002|Overall Study|Pregnancy|0|||
23619778|NCT01276509|65994742|FG003|Overall Study|Pregnancy|0|||
23619779|NCT01276509|65994739|FG000|Overall Study|Withdrawal by Subject|1|||
23619780|NCT01276509|65994740|FG001|Overall Study|Withdrawal by Subject|2|||
23619781|NCT01276509|65994741|FG002|Overall Study|Withdrawal by Subject|0|||
23548277|NCT04085328|65739493|FG001|Overall Study|Early termination|0|||
23548278|NCT02959437|65739495|FG000|Overall Study|Death|33|||
23548279|NCT02959437|65739496|FG001|Overall Study|Death|3|||
23548280|NCT02959437|65739497|FG002|Overall Study|Death|0|||
23548281|NCT02959437|65739498|FG003|Overall Study|Death|0|||
23548282|NCT02959437|65739495|FG000|Overall Study|Lost to Follow-up|3|||
23548283|NCT02959437|65739496|FG001|Overall Study|Lost to Follow-up|1|||
23548284|NCT02959437|65739497|FG002|Overall Study|Lost to Follow-up|0|||
23548285|NCT02959437|65739498|FG003|Overall Study|Lost to Follow-up|0|||
23548286|NCT02959437|65739495|FG000|Overall Study|Withdrawal by Subject|11|||
23548287|NCT02959437|65739496|FG001|Overall Study|Withdrawal by Subject|3|||
23548288|NCT02959437|65739497|FG002|Overall Study|Withdrawal by Subject|0|||
23548289|NCT02959437|65739498|FG003|Overall Study|Withdrawal by Subject|0|||
23548290|NCT02959437|65739495|FG000|Overall Study|Progressive Disease|9|||
23548291|NCT02959437|65739496|FG001|Overall Study|Progressive Disease|1|||
23548292|NCT02959437|65739497|FG002|Overall Study|Progressive Disease|0|||
23548293|NCT02959437|65739498|FG003|Overall Study|Progressive Disease|0|||
23548294|NCT02959437|65739495|FG000|Overall Study|Study Terminated by Sponsor|4|||
23548295|NCT02959437|65739496|FG001|Overall Study|Study Terminated by Sponsor|0|||
23548296|NCT02959437|65739497|FG002|Overall Study|Study Terminated by Sponsor|0|||
23548297|NCT02959437|65739498|FG003|Overall Study|Study Terminated by Sponsor|0|||
23548298|NCT02959437|65739495|FG000|Overall Study|Other Unspecified|2|||
23548299|NCT02959437|65739496|FG001|Overall Study|Other Unspecified|0|||
23548300|NCT02959437|65739497|FG002|Overall Study|Other Unspecified|0|||
23548301|NCT02959437|65739498|FG003|Overall Study|Other Unspecified|0|||
23548302|NCT00971048|65739511|FG000|Overall Study|Protocol Violation|1|||
23548303|NCT00971048|65739512|FG001|Overall Study|Protocol Violation|2|||
23548304|NCT00971048|65739513|FG002|Overall Study|Protocol Violation|0|||
23548305|NCT00971048|65739514|FG003|Overall Study|Protocol Violation|1|||
23548306|NCT00971048|65739511|FG000|Overall Study|Adverse Event|0|||
23548307|NCT00971048|65739512|FG001|Overall Study|Adverse Event|0|||
23548308|NCT00971048|65739513|FG002|Overall Study|Adverse Event|1|||
23548309|NCT00971048|65739514|FG003|Overall Study|Adverse Event|0|||
23548310|NCT00971048|65739511|FG000|Overall Study|Physician Decision|0|||
23548311|NCT00971048|65739512|FG001|Overall Study|Physician Decision|0|||
23548312|NCT00971048|65739513|FG002|Overall Study|Physician Decision|0|||
23548313|NCT00971048|65739514|FG003|Overall Study|Physician Decision|1|||
23548314|NCT04794803|65739515|FG000|Overall Study|Death|1|||
23548315|NCT04794803|65739516|FG001|Overall Study|Death|3|||
23548316|NCT04794803|65739515|FG000|Overall Study|Lost to Follow-up|2|||
23548317|NCT04794803|65739516|FG001|Overall Study|Lost to Follow-up|2|||
23619782|NCT01276509|65994742|FG003|Overall Study|Withdrawal by Subject|0|||
23619783|NCT01276509|65994739|FG000|Overall Study|Other|0|||
23619784|NCT01276509|65994740|FG001|Overall Study|Other|1|||
23548318|NCT04794803|65739515|FG000|Overall Study|Withdrawal by Subject|1|||
23619785|NCT01276509|65994741|FG002|Overall Study|Other|0|||
23619786|NCT01276509|65994742|FG003|Overall Study|Other|0|||
23619787|NCT01904019|65994743|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
23428244|NCT00316693|65310763|FG000|Overall Study|Adverse Event|6|||
23548319|NCT04794803|65739516|FG001|Overall Study|Withdrawal by Subject|0|||
23548320|NCT04794803|65739515|FG000|Overall Study|Physician Decision|1|||
23548321|NCT04794803|65739516|FG001|Overall Study|Physician Decision|1|||
23548322|NCT04794803|65739515|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
23548323|NCT04794803|65739516|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
23548324|NCT04794803|65739515|FG000|Overall Study|Refused to continue the treatment|1|||
23548325|NCT04794803|65739516|FG001|Overall Study|Refused to continue the treatment|0|||
23619788|NCT01904019|65994743|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
23548326|NCT04794803|65739515|FG000|Overall Study|Patient admitted to ICU|0|||
23619789|NCT01904019|65994743|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
23619790|NCT01904019|65994743|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
23619791|NCT01904019|65994743|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
23619792|NCT01904019|65994743|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
23619793|NCT02995733|65994748|FG000|Overall Study|Study site closed|9|||
23619794|NCT02995733|65994749|FG001|Overall Study|Study site closed|10|||
23619795|NCT02995733|65994748|FG000|Overall Study|Death|3|||
23619796|NCT02995733|65994749|FG001|Overall Study|Death|4|||
23428245|NCT00316693|65310764|FG001|Overall Study|Adverse Event|1|||
23428246|NCT00316693|65310763|FG000|Overall Study|Protocol Violation|1|||
23548327|NCT04794803|65739516|FG001|Overall Study|Patient admitted to ICU|1|||
23548328|NCT02105116|65739517|FG000|Overall Study|not eligible for step 2 of trial|5|||
23548329|NCT02105116|65739517|FG000|Overall Study|Death|1|||
23548330|NCT00325468|65739518|FG000|Overall Study|Adverse Event|1|||
23548331|NCT00325468|65739519|FG001|Overall Study|Adverse Event|1|||
23548332|NCT00325468|65739520|FG002|Overall Study|Adverse Event|0|||
23619797|NCT02995733|65994748|FG000|Overall Study|Withdrawal by Subject|6|||
23619798|NCT02995733|65994749|FG001|Overall Study|Withdrawal by Subject|2|||
23619799|NCT02995733|65994748|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
23619800|NCT02995733|65994749|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
23619801|NCT02995733|65994748|FG000|Overall Study|Lost to Follow-up|48|||
23619802|NCT02995733|65994749|FG001|Overall Study|Lost to Follow-up|37|||
23619803|NCT02995733|65994748|FG000|Overall Study|Other|0|||
23619804|NCT02995733|65994749|FG001|Overall Study|Other|1|||
23739765|NCT01370499|66425923|FG000|Overall Study|Adverse Event|38|||
23739766|NCT01370499|66425924|FG001|Overall Study|Adverse Event|12|||
23619805|NCT01878383|65994752|FG000|Overall Study|Lost to Follow-up|0|||
23619806|NCT01878383|65994753|FG001|Overall Study|Lost to Follow-up|1499|||
23739767|NCT01370499|66425923|FG000|Overall Study|Lack of Efficacy|4|||
23619807|NCT00655668|65994754|FG000|Overall Study|Adverse Event|6|||
23619808|NCT00655668|65994754|FG000|Overall Study|Death|5|||
23619809|NCT00655668|65994754|FG000|Overall Study|Disease Progression|27|||
23619810|NCT00655668|65994754|FG000|Overall Study|Study Terminated|9|||
23619811|NCT00655668|65994754|FG000|Overall Study|Other|1|||
23619812|NCT00655668|65994754|FG000|Overall Study|New Lymphoma Treatment Started|4|||
23619813|NCT00655668|65994754|FG000|Overall Study|Withdrawal by Subject|2|||
23619814|NCT01062971|65994755|FG000|Overall Study|Protocol Violation|1|||
23619815|NCT01062971|65994756|FG001|Overall Study|Protocol Violation|3|||
23619816|NCT01062971|65994755|FG000|Overall Study|Lost to Follow-up|3|||
23619817|NCT01062971|65994756|FG001|Overall Study|Lost to Follow-up|4|||
23619818|NCT00084747|65994757|FG000|Overall Study|Relapsed|8|||
23619819|NCT00084747|65994757|FG000|Overall Study|Death|3|||
23619820|NCT00084747|65994757|FG000|Overall Study|Withdrawal by Subject|2|||
23619821|NCT01560585|65994768|FG000|Overall Study|Physician Decision|3|||
23739768|NCT01370499|66425924|FG001|Overall Study|Lack of Efficacy|2|||
23619822|NCT02109107|65994769|FG000|Overall Study|Lost to Follow-up|2|||
23619823|NCT01202409|65994774|FG000|Overall Study|Adverse Event|1|||
23619824|NCT01202409|65994774|FG000|Overall Study|Ineligible - KRAS mutants|7|||
23619825|NCT00676195|65994775|FG000|Overall Study|Lost to Follow-up|1|||
23619826|NCT00676195|65994775|FG000|Overall Study|Adverse Event|1|||
23619827|NCT00676195|65994775|FG000|Overall Study|Physician Decision|1|||
23619828|NCT02551692|65994779|FG000|Overall Study|Lost to Follow-up|0|||
23619829|NCT02551692|65994780|FG001|Overall Study|Lost to Follow-up|1|||
23619830|NCT02551692|65994781|FG002|Overall Study|Lost to Follow-up|4|||
23619831|NCT02551692|65994779|FG000|Overall Study|Withdrawal by Subject|1|||
23619832|NCT02551692|65994780|FG001|Overall Study|Withdrawal by Subject|0|||
23619833|NCT02551692|65994781|FG002|Overall Study|Withdrawal by Subject|1|||
23619834|NCT00361842|65994782|FG000|Overall Study|Withdrawal by Subject|2|||
23619835|NCT00361842|65994783|FG001|Overall Study|Withdrawal by Subject|3|||
23619836|NCT00361842|65994782|FG000|Overall Study|Death|2|||
23739769|NCT01370499|66425923|FG000|Overall Study|Lost to Follow-up|2|||
23739770|NCT01370499|66425924|FG001|Overall Study|Lost to Follow-up|1|||
23428247|NCT00316693|65310764|FG001|Overall Study|Protocol Violation|0|||
23548333|NCT00325468|65739521|FG003|Overall Study|Adverse Event|5|||
23548334|NCT00325468|65739522|FG004|Overall Study|Adverse Event|1|||
23619837|NCT00361842|65994783|FG001|Overall Study|Death|1|||
23619838|NCT00361842|65994782|FG000|Overall Study|Disease progression|19|||
23619839|NCT00361842|65994783|FG001|Overall Study|Disease progression|20|||
23619840|NCT00361842|65994782|FG000|Overall Study|Adverse Event|2|||
23619841|NCT00361842|65994783|FG001|Overall Study|Adverse Event|3|||
23619842|NCT00361842|65994782|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
23619843|NCT00361842|65994783|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
23619844|NCT00361842|65994782|FG000|Overall Study|Other|1|||
23619845|NCT00361842|65994783|FG001|Overall Study|Other|0|||
23619846|NCT00361842|65994782|FG000|Overall Study|Other|0|||
23739771|NCT01370499|66425923|FG000|Overall Study|Physician Decision|3|||
23428248|NCT00316693|65310763|FG000|Overall Study|Withdrawal by Subject|6|||
23428249|NCT00316693|65310764|FG001|Overall Study|Withdrawal by Subject|6|||
23739772|NCT01370499|66425924|FG001|Overall Study|Physician Decision|3|||
23739773|NCT01370499|66425923|FG000|Overall Study|Protocol Violation|5|||
23739774|NCT01370499|66425924|FG001|Overall Study|Protocol Violation|4|||
23739775|NCT01370499|66425923|FG000|Overall Study|Withdrawal by Subject|18|||
23739776|NCT01370499|66425924|FG001|Overall Study|Withdrawal by Subject|7|||
23739777|NCT01370499|66425923|FG000|Overall Study|Sponsor Decision|41|||
23739778|NCT01370499|66425924|FG001|Overall Study|Sponsor Decision|15|||
23739779|NCT02033369|66425937|FG000|Overall Study|Physician Decision|1|||
23739780|NCT02033369|66425938|FG001|Overall Study|Physician Decision|2|||
23739781|NCT02033369|66425937|FG000|Overall Study|Not a good demographic match|0|||
23739782|NCT02033369|66425938|FG001|Overall Study|Not a good demographic match|2|||
23739783|NCT02033369|66425937|FG000|Overall Study|Withdrawal by Subject|1|||
23739784|NCT02033369|66425938|FG001|Overall Study|Withdrawal by Subject|1|||
23739785|NCT02033369|66425937|FG000|Overall Study|Lost to Follow-up|1|||
23739786|NCT02033369|66425938|FG001|Overall Study|Lost to Follow-up|0|||
23739787|NCT02033369|66425937|FG000|Overall Study|Protocol Violation|2|||
23739788|NCT02033369|66425938|FG001|Overall Study|Protocol Violation|0|||
23739789|NCT02584660|66425943|FG000|Overall Study|Adverse Event|4|||
23739790|NCT02584660|66425944|FG001|Overall Study|Adverse Event|0|||
23739791|NCT02584660|66425943|FG000|Overall Study|Lost to Follow-up|3|||
23739792|NCT02584660|66425944|FG001|Overall Study|Lost to Follow-up|4|||
23820853|NCT03449446|66725929|FG000|Overall Study|Death|0|||
23820854|NCT03449446|66725930|FG001|Overall Study|Death|0|||
23820855|NCT03449446|66725931|FG002|Overall Study|Death|0|||
23820856|NCT03449446|66725932|FG003|Overall Study|Death|0|||
23820857|NCT03449446|66725933|FG004|Overall Study|Death|1|||
23820858|NCT03449446|66725934|FG005|Overall Study|Death|0|||
23820859|NCT03449446|66725935|FG006|Overall Study|Death|0|||
23820860|NCT01523002|66725939|FG000|Period 1|Withdrawal by Subject|1|||
23820861|NCT01523002|66725940|FG001|Period 1|Withdrawal by Subject|3|||
23820862|NCT01523002|66725939|FG000|Period 1|Lost to Follow-up|1|||
23739793|NCT02584660|66425943|FG000|Overall Study|Protocol Violation|0|||
23739794|NCT02584660|66425944|FG001|Overall Study|Protocol Violation|1|||
23739795|NCT02584660|66425943|FG000|Overall Study|Withdrawal by Subject|0|||
23739796|NCT02584660|66425944|FG001|Overall Study|Withdrawal by Subject|2|||
23739797|NCT02584660|66425943|FG000|Overall Study|Other|0|||
23739798|NCT02584660|66425944|FG001|Overall Study|Other|1|||
23739799|NCT02719028|66425948|FG000|Overall Study|Adverse Event|2|||
23739800|NCT02719028|66425949|FG001|Overall Study|Adverse Event|1|||
23739801|NCT02719028|66425950|FG002|Overall Study|Adverse Event|4|||
23739802|NCT02719028|66425951|FG003|Overall Study|Adverse Event|8|||
23739803|NCT02719028|66425948|FG000|Overall Study|Physician Decision|0|||
23739804|NCT02719028|66425949|FG001|Overall Study|Physician Decision|1|||
23739805|NCT02719028|66425950|FG002|Overall Study|Physician Decision|1|||
23739806|NCT02719028|66425951|FG003|Overall Study|Physician Decision|1|||
23739807|NCT02719028|66425948|FG000|Overall Study|Use of prohibited medication|0|||
23739808|NCT02719028|66425949|FG001|Overall Study|Use of prohibited medication|0|||
23739809|NCT02719028|66425950|FG002|Overall Study|Use of prohibited medication|1|||
23739810|NCT02719028|66425951|FG003|Overall Study|Use of prohibited medication|0|||
23739811|NCT02719028|66425948|FG000|Overall Study|Protocol Violation|0|||
23739812|NCT02719028|66425949|FG001|Overall Study|Protocol Violation|0|||
23739813|NCT02719028|66425950|FG002|Overall Study|Protocol Violation|0|||
23739814|NCT02719028|66425951|FG003|Overall Study|Protocol Violation|1|||
23739815|NCT04585789|66425961|FG000|Overall Study|Withdrawal by Subject|1|||
23739816|NCT04585789|66425962|FG001|Overall Study|Withdrawal by Subject|0|||
23739817|NCT04585789|66425961|FG000|Overall Study|Ongoing|9|||
23739818|NCT04585789|66425962|FG001|Overall Study|Ongoing|10|||
23820863|NCT01523002|66725940|FG001|Period 1|Lost to Follow-up|0|||
23548335|NCT00325468|65739518|FG000|Overall Study|Death|2|||
23548336|NCT00325468|65739519|FG001|Overall Study|Death|0|||
23548337|NCT00325468|65739520|FG002|Overall Study|Death|2|||
23548338|NCT00325468|65739521|FG003|Overall Study|Death|4|||
23548339|NCT00325468|65739522|FG004|Overall Study|Death|0|||
23548340|NCT00325468|65739518|FG000|Overall Study|Lost to Follow-up|0|||
23739819|NCT01928758|66425965|FG000|Overall Study|Lost to Follow-up|14|||
23548341|NCT00325468|65739519|FG001|Overall Study|Lost to Follow-up|0|||
23548342|NCT00325468|65739520|FG002|Overall Study|Lost to Follow-up|1|||
23548343|NCT00325468|65739521|FG003|Overall Study|Lost to Follow-up|2|||
23739820|NCT01928758|66425966|FG001|Overall Study|Lost to Follow-up|9|||
23739821|NCT01928758|66425965|FG000|Overall Study|Withdrawal by Subject|5|||
23739822|NCT01928758|66425966|FG001|Overall Study|Withdrawal by Subject|2|||
23739823|NCT01928758|66425965|FG000|Overall Study|Adverse Event|3|||
23739824|NCT01928758|66425966|FG001|Overall Study|Adverse Event|5|||
23739825|NCT01928758|66425965|FG000|Overall Study|Protocol Violation|3|||
23739826|NCT01928758|66425966|FG001|Overall Study|Protocol Violation|4|||
23739827|NCT00337935|66425967|FG000|Overall Study|Adverse Event|2|||
23739828|NCT00337935|66425968|FG001|Overall Study|Adverse Event|5|||
23739829|NCT00337935|66425967|FG000|Overall Study|Death|2|||
23820864|NCT01523002|66725939|FG000|Period 1|Adverse Event|0|||
23820865|NCT01523002|66725940|FG001|Period 1|Adverse Event|8|||
23820866|NCT01523002|66725939|FG000|Period 2|Withdrawal by Subject|4|||
23739830|NCT00337935|66425968|FG001|Overall Study|Death|8|||
23739831|NCT00337935|66425967|FG000|Overall Study|Physician Decision|1|||
23739832|NCT00337935|66425968|FG001|Overall Study|Physician Decision|1|||
23739833|NCT00337935|66425967|FG000|Overall Study|Lost to Follow-up|0|||
23739834|NCT00337935|66425968|FG001|Overall Study|Lost to Follow-up|1|||
23739835|NCT00337935|66425967|FG000|Overall Study|Protocol Violation|4|||
23739836|NCT00337935|66425968|FG001|Overall Study|Protocol Violation|3|||
23739837|NCT00337935|66425967|FG000|Overall Study|Withdrawal by Subject|1|||
23739838|NCT00337935|66425968|FG001|Overall Study|Withdrawal by Subject|7|||
23739839|NCT00337935|66425967|FG000|Overall Study|Other|0|||
23739840|NCT00337935|66425968|FG001|Overall Study|Other|1|||
23739841|NCT00337935|66425967|FG000|Overall Study|Lack of Efficacy|0|||
23739842|NCT00337935|66425968|FG001|Overall Study|Lack of Efficacy|1|||
23739843|NCT02335411|66425969|FG000|Overall Study|Death|223|||
23739844|NCT02335411|66425970|FG001|Overall Study|Death|22|||
23739845|NCT02335411|66425971|FG002|Overall Study|Death|26|||
23739846|NCT02335411|66425969|FG000|Overall Study|Physician Decision|3|||
23739847|NCT02335411|66425970|FG001|Overall Study|Physician Decision|0|||
23739848|NCT02335411|66425971|FG002|Overall Study|Physician Decision|0|||
23739849|NCT02335411|66425969|FG000|Overall Study|Protocol Violation|1|||
23739850|NCT02335411|66425970|FG001|Overall Study|Protocol Violation|0|||
23739851|NCT02335411|66425971|FG002|Overall Study|Protocol Violation|0|||
23739852|NCT02335411|66425969|FG000|Overall Study|Withdrawal by Subject|11|||
23739853|NCT02335411|66425970|FG001|Overall Study|Withdrawal by Subject|0|||
23739854|NCT02335411|66425971|FG002|Overall Study|Withdrawal by Subject|3|||
23739855|NCT02335411|66425969|FG000|Overall Study|Sponsor Decision|12|||
23739856|NCT02335411|66425970|FG001|Overall Study|Sponsor Decision|3|||
23739857|NCT02335411|66425971|FG002|Overall Study|Sponsor Decision|2|||
23739858|NCT02335411|66425969|FG000|Overall Study|Adverse Event|9|||
23739859|NCT02335411|66425970|FG001|Overall Study|Adverse Event|0|||
23739860|NCT02335411|66425971|FG002|Overall Study|Adverse Event|0|||
23739861|NCT03037489|66425972|FG000|Overall Study|Adverse Event|4|||
23739862|NCT03037489|66425973|FG001|Overall Study|Adverse Event|0|||
23739863|NCT03037489|66425972|FG000|Overall Study|Withdrawal by Subject|3|||
23739864|NCT03037489|66425973|FG001|Overall Study|Withdrawal by Subject|0|||
23739865|NCT01398176|66425974|FG000|Overall Study|Lost to Follow-up|1|||
23739866|NCT01398176|66425975|FG001|Overall Study|Lost to Follow-up|3|||
23739867|NCT01398176|66425974|FG000|Overall Study|Physician Decision|2|||
23739868|NCT01398176|66425975|FG001|Overall Study|Physician Decision|3|||
23739869|NCT01130831|66425976|FG000|Overall Study|Withdrawal by Subject|7|||
23739870|NCT01130831|66425976|FG000|Overall Study|Death|4|||
23739871|NCT01130831|66425976|FG000|Overall Study|Information was missing|3|||
23739872|NCT02924129|66425977|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
23739873|NCT02924129|66425978|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
23739874|NCT02924129|66425977|FG000|Overall Study|Withdrawal by Subject|2|||
23739875|NCT02924129|66425978|FG001|Overall Study|Withdrawal by Subject|2|||
23739876|NCT02924129|66425977|FG000|Overall Study|Physician Decision|1|||
23739877|NCT02924129|66425978|FG001|Overall Study|Physician Decision|0|||
23739878|NCT02924129|66425977|FG000|Overall Study|Missed Visit|0|||
23739879|NCT02924129|66425978|FG001|Overall Study|Missed Visit|1|||
23739880|NCT01083121|66425980|FG000|Overall Study|Use of Humira outside the approved label|81|||
23739881|NCT01140646|66425981|FG000|Overall Study|Adverse Event|4|||
23739882|NCT01140646|66425981|FG000|Overall Study|Refused Further Treatment|5|||
23739883|NCT04034225|66425982|FG000|Overall Study|Death|3|||
23739884|NCT04034225|66425982|FG000|Overall Study|Withdrawal by Subject|2|||
23739885|NCT04034225|66425982|FG000|Overall Study|Study termination by Sponsor|18|||
23739886|NCT04034225|66425982|FG000|Overall Study|Physician Decision|1|||
23739887|NCT04034225|66425982|FG000|Overall Study|Lack of Efficacy|1|||
23739888|NCT03328325|66425988|FG000|Overall Study|Lost to Follow-up|4|||
23739889|NCT03328325|66425988|FG000|Overall Study|Physician Decision|1|||
23739890|NCT03328325|66425988|FG000|Overall Study|Withdrawal by Subject|3|||
23820867|NCT01523002|66725940|FG001|Period 2|Withdrawal by Subject|1|||
23820868|NCT01523002|66725939|FG000|Period 2|Adverse Event|2|||
23739891|NCT03328325|66425988|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
23739892|NCT00386152|66425991|FG000|Overall Study|Adverse Event|6|||
23739893|NCT00386152|66425992|FG001|Overall Study|Adverse Event|5|||
23739894|NCT00386152|66425993|FG002|Overall Study|Adverse Event|4|||
23739895|NCT00386152|66425991|FG000|Overall Study|Chang from original chemo stratification|4|||
23739896|NCT00386152|66425992|FG001|Overall Study|Chang from original chemo stratification|5|||
23739897|NCT00386152|66425993|FG002|Overall Study|Chang from original chemo stratification|6|||
23739898|NCT00386152|66425991|FG000|Overall Study|Death|3|||
23739899|NCT00386152|66425992|FG001|Overall Study|Death|0|||
23739900|NCT00386152|66425993|FG002|Overall Study|Death|1|||
23739901|NCT00386152|66425991|FG000|Overall Study|Disease progression|7|||
23739902|NCT00386152|66425992|FG001|Overall Study|Disease progression|4|||
23739903|NCT00386152|66425993|FG002|Overall Study|Disease progression|5|||
23739904|NCT00386152|66425991|FG000|Overall Study|Physician Decision|13|||
23739905|NCT00386152|66425992|FG001|Overall Study|Physician Decision|10|||
23739906|NCT00386152|66425993|FG002|Overall Study|Physician Decision|4|||
23548344|NCT00325468|65739522|FG004|Overall Study|Lost to Follow-up|2|||
23548345|NCT00325468|65739518|FG000|Overall Study|Physician Decision|1|||
23548346|NCT00325468|65739519|FG001|Overall Study|Physician Decision|1|||
23548347|NCT00325468|65739520|FG002|Overall Study|Physician Decision|0|||
23548348|NCT00325468|65739521|FG003|Overall Study|Physician Decision|1|||
23548349|NCT00325468|65739522|FG004|Overall Study|Physician Decision|0|||
23548350|NCT00325468|65739518|FG000|Overall Study|Withdrawal by Subject|3|||
23548351|NCT00325468|65739519|FG001|Overall Study|Withdrawal by Subject|1|||
23548352|NCT00325468|65739520|FG002|Overall Study|Withdrawal by Subject|0|||
23548353|NCT00325468|65739521|FG003|Overall Study|Withdrawal by Subject|14|||
23548354|NCT00325468|65739522|FG004|Overall Study|Withdrawal by Subject|4|||
23548355|NCT00325468|65739518|FG000|Overall Study|site closure etc|4|||
23548356|NCT00325468|65739519|FG001|Overall Study|site closure etc|2|||
23428250|NCT00316693|65310763|FG000|Overall Study|Lost to Follow-up|26|||
23548357|NCT00325468|65739520|FG002|Overall Study|site closure etc|1|||
23739907|NCT00386152|66425991|FG000|Overall Study|Lost to Follow-up|1|||
23739908|NCT00386152|66425992|FG001|Overall Study|Lost to Follow-up|0|||
23739909|NCT00386152|66425993|FG002|Overall Study|Lost to Follow-up|0|||
23548358|NCT00325468|65739521|FG003|Overall Study|site closure etc|8|||
23548359|NCT00325468|65739522|FG004|Overall Study|site closure etc|1|||
23548360|NCT05608629|65739523|FG000|Overall Study|Lost to Follow-up|2|||
23548361|NCT01358968|65739524|FG000|Period 2|Adverse Event|0|||
23548362|NCT01358968|65739525|FG001|Period 2|Adverse Event|1|||
23548363|NCT01358968|65739526|FG002|Period 2|Adverse Event|0|||
23548364|NCT01358968|65739527|FG003|Period 2|Adverse Event|0|||
23548365|NCT01358968|65739524|FG000|Continued Access Phase|Progression of Disease|0|||
23548366|NCT01358968|65739525|FG001|Continued Access Phase|Progression of Disease|0|||
23548367|NCT01358968|65739526|FG002|Continued Access Phase|Progression of Disease|8|||
23548368|NCT01358968|65739527|FG003|Continued Access Phase|Progression of Disease|4|||
23548369|NCT01358968|65739524|FG000|Continued Access Phase|Protocol Violation|0|||
23548370|NCT01358968|65739525|FG001|Continued Access Phase|Protocol Violation|0|||
23548371|NCT01358968|65739526|FG002|Continued Access Phase|Protocol Violation|0|||
23548372|NCT01358968|65739527|FG003|Continued Access Phase|Protocol Violation|2|||
23548373|NCT01358968|65739524|FG000|Continued Access Phase|Withdrawal by Subject|0|||
23548374|NCT01358968|65739525|FG001|Continued Access Phase|Withdrawal by Subject|0|||
23548375|NCT01358968|65739526|FG002|Continued Access Phase|Withdrawal by Subject|3|||
23548376|NCT01358968|65739527|FG003|Continued Access Phase|Withdrawal by Subject|0|||
23548377|NCT01358968|65739524|FG000|Continued Access Phase|Death|0|||
23548378|NCT01358968|65739525|FG001|Continued Access Phase|Death|0|||
23548379|NCT01358968|65739526|FG002|Continued Access Phase|Death|1|||
23548380|NCT01358968|65739527|FG003|Continued Access Phase|Death|1|||
23548381|NCT00476476|65739528|FG000|Overall Study|Adverse Event|2|||
23548382|NCT00476476|65739529|FG001|Overall Study|Adverse Event|7|||
23548383|NCT00476476|65739528|FG000|Overall Study|Progressive Disease|0|||
23548384|NCT00476476|65739529|FG001|Overall Study|Progressive Disease|17|||
23548385|NCT00896168|65739530|FG000|Overall Study|Adverse Event|4|||
23548386|NCT00896168|65739531|FG001|Overall Study|Adverse Event|7|||
23739910|NCT00386152|66425991|FG000|Overall Study|Completed chemotherapy|4|||
23739911|NCT00386152|66425992|FG001|Overall Study|Completed chemotherapy|5|||
23739912|NCT00386152|66425993|FG002|Overall Study|Completed chemotherapy|1|||
23739913|NCT00386152|66425991|FG000|Overall Study|Protocol Violation|3|||
23739914|NCT00386152|66425992|FG001|Overall Study|Protocol Violation|5|||
23739915|NCT00386152|66425993|FG002|Overall Study|Protocol Violation|2|||
23739916|NCT00386152|66425991|FG000|Overall Study|Withdrawal by Subject|3|||
23739917|NCT00386152|66425992|FG001|Overall Study|Withdrawal by Subject|6|||
23739918|NCT00386152|66425993|FG002|Overall Study|Withdrawal by Subject|10|||
23739919|NCT03384316|66425999|FG000|Overall Study|Screen failure|0|||
23739920|NCT03384316|66426000|FG001|Overall Study|Screen failure|1|||
23739921|NCT01078389|66426001|FG000|Overall Study|Adverse Event|10|||
23739922|NCT01078389|66426002|FG001|Overall Study|Adverse Event|6|||
23739923|NCT01078389|66426001|FG000|Overall Study|Major Protocol Deviation|2|||
23739924|NCT01078389|66426002|FG001|Overall Study|Major Protocol Deviation|0|||
23739925|NCT01078389|66426001|FG000|Overall Study|Lost to Follow-up|23|||
23739926|NCT01078389|66426002|FG001|Overall Study|Lost to Follow-up|23|||
23739927|NCT01078389|66426001|FG000|Overall Study|Voluntary Withdrawal|20|||
23548387|NCT00896168|65739530|FG000|Overall Study|Treatment failure|8|||
23548388|NCT00896168|65739531|FG001|Overall Study|Treatment failure|10|||
23820869|NCT01523002|66725940|FG001|Period 2|Adverse Event|5|||
23548389|NCT00896168|65739530|FG000|Overall Study|Lost to Follow-up|1|||
23548390|NCT00896168|65739531|FG001|Overall Study|Lost to Follow-up|1|||
23548391|NCT00896168|65739530|FG000|Overall Study|Other|1|||
23548392|NCT00896168|65739531|FG001|Overall Study|Other|1|||
23548393|NCT04391023|65739532|FG000|Overall Study|Withdrawal by Subject|2|||
23548394|NCT04391023|65739533|FG001|Overall Study|Withdrawal by Subject|2|||
23739928|NCT01078389|66426002|FG001|Overall Study|Voluntary Withdrawal|36|||
23739929|NCT01078389|66426001|FG000|Overall Study|Other|9|||
23739930|NCT01078389|66426002|FG001|Overall Study|Other|2|||
23739931|NCT01066819|66426003|FG000|Overall Study|Adverse Event|18|||
23739932|NCT01066819|66426004|FG001|Overall Study|Adverse Event|1|||
23548395|NCT01362140|65739534|FG000|Overall Study|Noncompliance|1|||
23548396|NCT01362140|65739535|FG001|Overall Study|Noncompliance|0|||
23548397|NCT01362140|65739534|FG000|Overall Study|Adverse Event|2|||
23548398|NCT01362140|65739535|FG001|Overall Study|Adverse Event|2|||
23548399|NCT01362140|65739534|FG000|Overall Study|Withdrawal by Subject|3|||
23548400|NCT01362140|65739535|FG001|Overall Study|Withdrawal by Subject|3|||
23548401|NCT01362140|65739534|FG000|Overall Study|Administrative Decision|0|||
23548402|NCT01362140|65739535|FG001|Overall Study|Administrative Decision|1|||
23548403|NCT01362140|65739534|FG000|Overall Study|Death|2|||
23739933|NCT01066819|66426005|FG002|Overall Study|Adverse Event|6|||
23739934|NCT01066819|66426006|FG003|Overall Study|Adverse Event|0|||
23739935|NCT01066819|66426007|FG004|Overall Study|Adverse Event|0|||
23739936|NCT01066819|66426008|FG005|Overall Study|Adverse Event|0|||
23739937|NCT01066819|66426003|FG000|Overall Study|Death|5|||
23739938|NCT01066819|66426004|FG001|Overall Study|Death|0|||
23739939|NCT01066819|66426005|FG002|Overall Study|Death|1|||
23739940|NCT01066819|66426006|FG003|Overall Study|Death|0|||
23739941|NCT01066819|66426007|FG004|Overall Study|Death|0|||
23739942|NCT01066819|66426008|FG005|Overall Study|Death|0|||
23739943|NCT01066819|66426003|FG000|Overall Study|Lack of Efficacy|22|||
23739944|NCT01066819|66426004|FG001|Overall Study|Lack of Efficacy|1|||
23739945|NCT01066819|66426005|FG002|Overall Study|Lack of Efficacy|2|||
23739946|NCT01066819|66426006|FG003|Overall Study|Lack of Efficacy|1|||
23739947|NCT01066819|66426007|FG004|Overall Study|Lack of Efficacy|0|||
23739948|NCT01066819|66426008|FG005|Overall Study|Lack of Efficacy|0|||
23739949|NCT01066819|66426003|FG000|Overall Study|Physician Decision|6|||
23739950|NCT01066819|66426004|FG001|Overall Study|Physician Decision|2|||
23739951|NCT01066819|66426005|FG002|Overall Study|Physician Decision|3|||
23739952|NCT01066819|66426006|FG003|Overall Study|Physician Decision|0|||
23739953|NCT01066819|66426007|FG004|Overall Study|Physician Decision|0|||
23739954|NCT01066819|66426008|FG005|Overall Study|Physician Decision|0|||
23739955|NCT01066819|66426003|FG000|Overall Study|Protocol Violation|12|||
23739956|NCT01066819|66426004|FG001|Overall Study|Protocol Violation|6|||
23739957|NCT01066819|66426005|FG002|Overall Study|Protocol Violation|0|||
23739958|NCT01066819|66426006|FG003|Overall Study|Protocol Violation|0|||
23739959|NCT01066819|66426007|FG004|Overall Study|Protocol Violation|0|||
23739960|NCT01066819|66426008|FG005|Overall Study|Protocol Violation|0|||
23739961|NCT01066819|66426003|FG000|Overall Study|Withdrawal by Subject|29|||
23739962|NCT01066819|66426004|FG001|Overall Study|Withdrawal by Subject|11|||
23739963|NCT01066819|66426005|FG002|Overall Study|Withdrawal by Subject|6|||
23739964|NCT01066819|66426006|FG003|Overall Study|Withdrawal by Subject|0|||
23739965|NCT01066819|66426007|FG004|Overall Study|Withdrawal by Subject|0|||
23739966|NCT01066819|66426008|FG005|Overall Study|Withdrawal by Subject|0|||
23739967|NCT01066819|66426003|FG000|Overall Study|Administrative|6|||
23739968|NCT01066819|66426004|FG001|Overall Study|Administrative|4|||
23739969|NCT01066819|66426005|FG002|Overall Study|Administrative|2|||
23739970|NCT01066819|66426006|FG003|Overall Study|Administrative|0|||
23739971|NCT01066819|66426007|FG004|Overall Study|Administrative|0|||
23739972|NCT01066819|66426008|FG005|Overall Study|Administrative|0|||
23739973|NCT01066819|66426003|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
23739974|NCT01066819|66426004|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
23739975|NCT01066819|66426005|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
23739976|NCT01066819|66426006|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
23739977|NCT01066819|66426007|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
23739978|NCT01066819|66426008|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
23739979|NCT01066819|66426003|FG000|Overall Study|Early termination|2|||
23739980|NCT01066819|66426004|FG001|Overall Study|Early termination|0|||
23739981|NCT01066819|66426005|FG002|Overall Study|Early termination|0|||
23739982|NCT01066819|66426006|FG003|Overall Study|Early termination|0|||
23739983|NCT01066819|66426007|FG004|Overall Study|Early termination|0|||
23739984|NCT01066819|66426008|FG005|Overall Study|Early termination|0|||
23739985|NCT01066819|66426003|FG000|Overall Study|Failed to return|298|||
23548404|NCT01362140|65739535|FG001|Overall Study|Death|1|||
23548405|NCT01362140|65739534|FG000|Overall Study|Other|1|||
23739986|NCT01066819|66426004|FG001|Overall Study|Failed to return|107|||
23739987|NCT01066819|66426005|FG002|Overall Study|Failed to return|68|||
23739988|NCT01066819|66426006|FG003|Overall Study|Failed to return|7|||
23739989|NCT01066819|66426007|FG004|Overall Study|Failed to return|2|||
23739990|NCT01066819|66426008|FG005|Overall Study|Failed to return|3|||
23739991|NCT01066819|66426003|FG000|Overall Study|Lab test not done|9|||
23739992|NCT01066819|66426004|FG001|Overall Study|Lab test not done|0|||
23548406|NCT01362140|65739535|FG001|Overall Study|Other|1|||
23548407|NCT01362140|65739534|FG000|Overall Study|Protocol-specified Criteria|1|||
23739993|NCT01066819|66426005|FG002|Overall Study|Lab test not done|2|||
23739994|NCT01066819|66426006|FG003|Overall Study|Lab test not done|1|||
23739995|NCT01066819|66426007|FG004|Overall Study|Lab test not done|0|||
23739996|NCT01066819|66426008|FG005|Overall Study|Lab test not done|0|||
23739997|NCT01066819|66426003|FG000|Overall Study|Miscellaneous|28|||
23739998|NCT01066819|66426004|FG001|Overall Study|Miscellaneous|10|||
23739999|NCT01066819|66426005|FG002|Overall Study|Miscellaneous|18|||
23548408|NCT01362140|65739535|FG001|Overall Study|Protocol-specified Criteria|2|||
23548409|NCT01362140|65739534|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
23548410|NCT01362140|65739535|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
23548411|NCT01912612|65739538|FG000|Overall Study|Adverse Event|4|||
23548412|NCT01912612|65739539|FG001|Overall Study|Adverse Event|0|||
23548413|NCT01912612|65739540|FG002|Overall Study|Adverse Event|0|||
23548414|NCT01912612|65739538|FG000|Overall Study|Withdrew consent|1|||
23548415|NCT01912612|65739539|FG001|Overall Study|Withdrew consent|0|||
23548416|NCT01912612|65739540|FG002|Overall Study|Withdrew consent|0|||
23548417|NCT01912612|65739538|FG000|Overall Study|Study design change|0|||
23548418|NCT01912612|65739539|FG001|Overall Study|Study design change|0|||
23548419|NCT01912612|65739540|FG002|Overall Study|Study design change|3|||
23548420|NCT01764945|65739547|FG000|Overall Study|Adverse Event|0|||
23548421|NCT01764945|65739548|FG001|Overall Study|Adverse Event|1|||
23740000|NCT01066819|66426006|FG003|Overall Study|Miscellaneous|1|||
23740001|NCT01066819|66426007|FG004|Overall Study|Miscellaneous|0|||
23820870|NCT01523002|66725939|FG000|Period 3|Withdrawal by Subject|1|||
23820871|NCT01523002|66725940|FG001|Period 3|Withdrawal by Subject|0|||
23820872|NCT01523002|66725939|FG000|Period 3|Adverse Event|3|||
23820873|NCT01523002|66725940|FG001|Period 3|Adverse Event|0|||
23820874|NCT00626561|66725941|FG000|Overall Study|Withdrawal by Subject|2|||
23820875|NCT00626561|66725941|FG000|Overall Study|Disease Progression|2|||
23820876|NCT00683657|66725946|FG000|Overall Study|Adverse Event|0|||
23820877|NCT00683657|66725947|FG001|Overall Study|Adverse Event|1|||
23428251|NCT00316693|65310764|FG001|Overall Study|Lost to Follow-up|34|||
23428252|NCT00316693|65310763|FG000|Overall Study|Other|38|||
23740002|NCT01066819|66426008|FG005|Overall Study|Miscellaneous|0|||
23740003|NCT01066819|66426003|FG000|Overall Study|Non responders|123|||
23740004|NCT01066819|66426004|FG001|Overall Study|Non responders|2|||
23740005|NCT01066819|66426005|FG002|Overall Study|Non responders|7|||
23740006|NCT01066819|66426006|FG003|Overall Study|Non responders|2|||
23428253|NCT00316693|65310764|FG001|Overall Study|Other|44|||
23428254|NCT04135859|65310765|FG000|Overall Study|Withdrawal by Subject|1|||
23428255|NCT04135859|65310766|FG001|Overall Study|Withdrawal by Subject|0|||
23428256|NCT04135859|65310765|FG000|Overall Study|Withdrawal due to screening failure|1|||
23428257|NCT04135859|65310766|FG001|Overall Study|Withdrawal due to screening failure|2|||
23428258|NCT04135859|65310765|FG000|Overall Study|Did not complete stress test|3|||
23428259|NCT04135859|65310766|FG001|Overall Study|Did not complete stress test|3|||
23428260|NCT04135859|65310765|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
23428261|NCT04135859|65310766|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
23428262|NCT00680368|65310767|FG000|Overall Study|not supervised, not eligible|15|||
23428263|NCT00468845|65310768|FG000|Overall Study|Adverse Event|9|||
23428264|NCT00468845|65310769|FG001|Overall Study|Adverse Event|14|||
23428265|NCT00468845|65310770|FG002|Overall Study|Adverse Event|11|||
23428266|NCT00468845|65310768|FG000|Overall Study|Lost to Follow-up|2|||
23428267|NCT00468845|65310769|FG001|Overall Study|Lost to Follow-up|1|||
23428268|NCT00468845|65310770|FG002|Overall Study|Lost to Follow-up|2|||
23428269|NCT00468845|65310768|FG000|Overall Study|Other|4|||
23428270|NCT00468845|65310769|FG001|Overall Study|Other|9|||
23428271|NCT00468845|65310770|FG002|Overall Study|Other|5|||
23428272|NCT00468845|65310768|FG000|Overall Study|No longer willing to participate|5|||
23428273|NCT00468845|65310769|FG001|Overall Study|No longer willing to participate|6|||
23428274|NCT00468845|65310770|FG002|Overall Study|No longer willing to participate|10|||
23428275|NCT00468845|65310768|FG000|Overall Study|Randomized, not treated|1|||
23428276|NCT00468845|65310769|FG001|Overall Study|Randomized, not treated|4|||
23428277|NCT00468845|65310770|FG002|Overall Study|Randomized, not treated|2|||
23428278|NCT01318070|65310771|FG000|Overall Study|Adverse Event|1|||
23428279|NCT01318070|65310772|FG001|Overall Study|Adverse Event|1|||
23428280|NCT01318070|65310773|FG002|Overall Study|Adverse Event|5|||
23428281|NCT01318070|65310771|FG000|Overall Study|Withdrawal by Subject|0|||
23428282|NCT01318070|65310772|FG001|Overall Study|Withdrawal by Subject|1|||
23428283|NCT01318070|65310773|FG002|Overall Study|Withdrawal by Subject|1|||
23619847|NCT00361842|65994783|FG001|Overall Study|Other|2|||
23740007|NCT01066819|66426007|FG004|Overall Study|Non responders|0|||
23820878|NCT00683657|66725946|FG000|Overall Study|Subject Withdrew Consent|1|||
23740008|NCT01066819|66426008|FG005|Overall Study|Non responders|1|||
23740009|NCT01066819|66426003|FG000|Overall Study|Not categorised|9|||
23428284|NCT01318070|65310771|FG000|Overall Study|Lack of Efficacy|0|||
23428285|NCT01318070|65310772|FG001|Overall Study|Lack of Efficacy|0|||
23428286|NCT01318070|65310773|FG002|Overall Study|Lack of Efficacy|1|||
23428287|NCT01318070|65310771|FG000|Overall Study|Principal Investigator Discretion|1|||
23428288|NCT01318070|65310772|FG001|Overall Study|Principal Investigator Discretion|0|||
23548422|NCT01764945|65739549|FG002|Overall Study|Adverse Event|0|||
23548423|NCT01764945|65739550|FG003|Overall Study|Adverse Event|0|||
23548424|NCT01764945|65739551|FG004|Overall Study|Adverse Event|0|||
23820879|NCT00683657|66725947|FG001|Overall Study|Subject Withdrew Consent|0|||
23820880|NCT05513391|66725950|FG000|Overall Study|Adverse Event|1|||
23820881|NCT05513391|66725951|FG001|Overall Study|Adverse Event|0|||
23820882|NCT05513391|66725950|FG000|Overall Study|Protocol Deviation|0|||
23820883|NCT05513391|66725951|FG001|Overall Study|Protocol Deviation|1|||
23820884|NCT05513391|66725950|FG000|Overall Study|Withdrawal by Subject|3|||
23820885|NCT05513391|66725951|FG001|Overall Study|Withdrawal by Subject|1|||
23820886|NCT05513391|66725950|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23820887|NCT05513391|66725951|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23820888|NCT05513391|66725950|FG000|Overall Study|Lost to Follow-up|0|||
23820889|NCT05513391|66725951|FG001|Overall Study|Lost to Follow-up|2|||
23820890|NCT01305044|66725952|FG000|Overall Study|Withdrawal by Subject|3|||
23820891|NCT01305044|66725953|FG001|Overall Study|Withdrawal by Subject|6|||
23820892|NCT03016975|66725954|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
23740010|NCT01066819|66426004|FG001|Overall Study|Not categorised|2|||
23740011|NCT01066819|66426005|FG002|Overall Study|Not categorised|6|||
23740012|NCT01066819|66426006|FG003|Overall Study|Not categorised|1|||
23740013|NCT01066819|66426007|FG004|Overall Study|Not categorised|0|||
23740014|NCT01066819|66426008|FG005|Overall Study|Not categorised|0|||
23740015|NCT01066819|66426003|FG000|Overall Study|Relapse|16|||
23740016|NCT01066819|66426004|FG001|Overall Study|Relapse|4|||
23740017|NCT01066819|66426005|FG002|Overall Study|Relapse|3|||
23740018|NCT01066819|66426006|FG003|Overall Study|Relapse|0|||
23740019|NCT01066819|66426007|FG004|Overall Study|Relapse|0|||
23740020|NCT01066819|66426008|FG005|Overall Study|Relapse|0|||
23740021|NCT01066819|66426003|FG000|Overall Study|Results not available|1|||
23740022|NCT01066819|66426004|FG001|Overall Study|Results not available|0|||
23740023|NCT01066819|66426005|FG002|Overall Study|Results not available|0|||
23740024|NCT01066819|66426006|FG003|Overall Study|Results not available|0|||
23740025|NCT01066819|66426007|FG004|Overall Study|Results not available|0|||
23740026|NCT01066819|66426008|FG005|Overall Study|Results not available|0|||
23740027|NCT01066819|66426003|FG000|Overall Study|Screen failure|1|||
23740028|NCT01066819|66426004|FG001|Overall Study|Screen failure|0|||
23740029|NCT01066819|66426005|FG002|Overall Study|Screen failure|0|||
23740030|NCT01066819|66426006|FG003|Overall Study|Screen failure|0|||
23740031|NCT01066819|66426007|FG004|Overall Study|Screen failure|0|||
23740032|NCT01066819|66426008|FG005|Overall Study|Screen failure|0|||
23740033|NCT01066819|66426003|FG000|Overall Study|Spontaneous cure|1|||
23740034|NCT01066819|66426004|FG001|Overall Study|Spontaneous cure|0|||
23740035|NCT01066819|66426005|FG002|Overall Study|Spontaneous cure|0|||
23820893|NCT03016975|66725955|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
23820894|NCT03016975|66725956|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
23619848|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
23619849|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619850|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619851|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619852|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619853|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
23619854|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619855|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619856|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619857|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619858|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
23619859|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619860|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619861|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619862|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619863|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
23619864|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619865|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619866|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619867|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619868|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
23619869|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619870|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619871|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23740036|NCT01066819|66426006|FG003|Overall Study|Spontaneous cure|0|||
23740037|NCT01066819|66426007|FG004|Overall Study|Spontaneous cure|0|||
23740038|NCT01066819|66426008|FG005|Overall Study|Spontaneous cure|0|||
23740039|NCT01066819|66426003|FG000|Overall Study|Treatment never started|85|||
23740040|NCT01066819|66426004|FG001|Overall Study|Treatment never started|19|||
23740041|NCT01066819|66426005|FG002|Overall Study|Treatment never started|19|||
23740042|NCT01066819|66426006|FG003|Overall Study|Treatment never started|3|||
23740043|NCT01066819|66426007|FG004|Overall Study|Treatment never started|2|||
23740044|NCT01066819|66426008|FG005|Overall Study|Treatment never started|2|||
23820895|NCT03016975|66725954|FG000|At 6 Months Follow-up|Death|2|||
23820896|NCT03016975|66725955|FG001|At 6 Months Follow-up|Death|0|||
23820897|NCT03016975|66725956|FG002|At 6 Months Follow-up|Death|0|||
23740045|NCT01066819|66426003|FG000|Overall Study|Treatment stopped|12|||
23740046|NCT01066819|66426004|FG001|Overall Study|Treatment stopped|1|||
23740047|NCT01066819|66426005|FG002|Overall Study|Treatment stopped|2|||
23740048|NCT01066819|66426006|FG003|Overall Study|Treatment stopped|1|||
23740049|NCT01066819|66426007|FG004|Overall Study|Treatment stopped|0|||
23740050|NCT01066819|66426008|FG005|Overall Study|Treatment stopped|0|||
23740051|NCT01066819|66426003|FG000|Overall Study|Other|5|||
23740052|NCT01066819|66426004|FG001|Overall Study|Other|1|||
23740053|NCT01066819|66426005|FG002|Overall Study|Other|1|||
23548425|NCT01764945|65739552|FG005|Overall Study|Adverse Event|0|||
23548426|NCT01764945|65739553|FG006|Overall Study|Adverse Event|1|||
23548427|NCT01764945|65739554|FG007|Overall Study|Adverse Event|0|||
23740054|NCT01066819|66426006|FG003|Overall Study|Other|0|||
23740055|NCT01066819|66426007|FG004|Overall Study|Other|0|||
23740056|NCT01066819|66426008|FG005|Overall Study|Other|0|||
23740057|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
23740058|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
23740059|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
23740060|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23619872|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619873|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
23619874|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619875|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619876|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619877|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619878|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
23619879|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619880|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619881|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619882|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619883|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23740061|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
23740062|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
23740063|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
23740064|NCT00950755|66426009|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
23740065|NCT00950755|66426009|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
23740066|NCT00950755|66426009|FG000|Long-Term Follow-Up|Death|8|||
23548428|NCT00838110|65739555|FG000|Overall Study|Death|0|||
23548429|NCT00838110|65739556|FG001|Overall Study|Death|0|||
23548430|NCT00838110|65739557|FG002|Overall Study|Death|1|||
23548431|NCT00838110|65739558|FG003|Overall Study|Death|2|||
23548432|NCT00838110|65739555|FG000|Overall Study|Adverse Event|11|||
23548433|NCT00838110|65739556|FG001|Overall Study|Adverse Event|10|||
23548434|NCT00838110|65739557|FG002|Overall Study|Adverse Event|8|||
23548435|NCT00838110|65739558|FG003|Overall Study|Adverse Event|7|||
23548436|NCT00838110|65739555|FG000|Overall Study|Withdrawal by Subject|5|||
23548437|NCT00838110|65739556|FG001|Overall Study|Withdrawal by Subject|6|||
23619884|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23740067|NCT03172026|66426010|FG000|Overall Study|Withdrawal by Subject|1|||
23619885|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
23740068|NCT03172026|66426011|FG001|Overall Study|Withdrawal by Subject|0|||
23740069|NCT03172026|66426010|FG000|Overall Study|COVID restrictions|1|||
23740070|NCT03172026|66426011|FG001|Overall Study|COVID restrictions|0|||
23740071|NCT02275052|66426012|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23740072|NCT02275052|66426013|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23740073|NCT02275052|66426014|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23740074|NCT02275052|66426015|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23740075|NCT02275052|66426012|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23740076|NCT02275052|66426013|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
23740077|NCT02275052|66426014|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23740078|NCT02275052|66426015|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23740079|NCT02275052|66426012|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
23740080|NCT02275052|66426013|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
23740081|NCT02275052|66426014|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23740082|NCT02275052|66426015|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23740083|NCT02275052|66426012|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
23740084|NCT02275052|66426013|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23428289|NCT01318070|65310773|FG002|Overall Study|Principal Investigator Discretion|0|||
23548438|NCT00838110|65739557|FG002|Overall Study|Withdrawal by Subject|3|||
23548439|NCT00838110|65739558|FG003|Overall Study|Withdrawal by Subject|4|||
23548440|NCT00838110|65739555|FG000|Overall Study|Other|3|||
23740085|NCT02275052|66426014|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23740086|NCT02275052|66426015|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23740087|NCT02275052|66426012|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
23740088|NCT02275052|66426013|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23740089|NCT02275052|66426014|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23740090|NCT02275052|66426015|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23740091|NCT02275052|66426012|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
23740092|NCT02275052|66426013|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23740093|NCT02275052|66426014|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23740094|NCT02275052|66426015|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23740095|NCT02275052|66426012|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
23740096|NCT02275052|66426013|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23740097|NCT02275052|66426014|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23740098|NCT02275052|66426015|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23740099|NCT02275052|66426012|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23740100|NCT02275052|66426013|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23740101|NCT02275052|66426014|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
23740102|NCT02275052|66426015|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
23740103|NCT02275052|66426012|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23740104|NCT02275052|66426013|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23740105|NCT02275052|66426014|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23740106|NCT02275052|66426015|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
23740107|NCT02275052|66426012|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23740108|NCT02275052|66426013|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23740109|NCT02275052|66426014|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23820898|NCT03016975|66725954|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
23820899|NCT03016975|66725955|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
23820900|NCT03016975|66725956|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
23820901|NCT03016975|66725954|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
23820902|NCT03016975|66725955|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
23820903|NCT03016975|66725956|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
23820904|NCT03016975|66725954|FG000|At 6 Months Follow-up|Aborted implant|1|||
23820905|NCT03016975|66725955|FG001|At 6 Months Follow-up|Aborted implant|0|||
23820906|NCT03016975|66725956|FG002|At 6 Months Follow-up|Aborted implant|0|||
23820907|NCT03016975|66725954|FG000|At 2 Year Follow-up|Death|1|||
23820908|NCT03016975|66725955|FG001|At 2 Year Follow-up|Death|0|||
23820909|NCT03016975|66725956|FG002|At 2 Year Follow-up|Death|0|||
23820910|NCT03016975|66725954|FG000|At 3 Year Follow-up|Death|1|||
23820911|NCT03016975|66725955|FG001|At 3 Year Follow-up|Death|0|||
23820912|NCT03016975|66725956|FG002|At 3 Year Follow-up|Death|0|||
23548441|NCT00838110|65739556|FG001|Overall Study|Other|3|||
23548442|NCT00838110|65739557|FG002|Overall Study|Other|3|||
23548443|NCT00838110|65739558|FG003|Overall Study|Other|2|||
23548444|NCT00838110|65739555|FG000|Overall Study|Protocol Violation|0|||
23548445|NCT00838110|65739556|FG001|Overall Study|Protocol Violation|2|||
23548446|NCT00838110|65739557|FG002|Overall Study|Protocol Violation|1|||
23548447|NCT00838110|65739558|FG003|Overall Study|Protocol Violation|1|||
23619886|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
23619887|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
23619888|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23619889|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
23619890|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
23619891|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
23619892|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
23548448|NCT00838110|65739555|FG000|Overall Study|Lost to Follow-up|3|||
23548449|NCT00838110|65739556|FG001|Overall Study|Lost to Follow-up|0|||
23548450|NCT00838110|65739557|FG002|Overall Study|Lost to Follow-up|0|||
23548451|NCT00838110|65739558|FG003|Overall Study|Lost to Follow-up|0|||
23548452|NCT00838110|65739555|FG000|Overall Study|Did not meet eligibility criteria|0|||
23548453|NCT00838110|65739556|FG001|Overall Study|Did not meet eligibility criteria|0|||
23548454|NCT00838110|65739557|FG002|Overall Study|Did not meet eligibility criteria|1|||
23548455|NCT00838110|65739558|FG003|Overall Study|Did not meet eligibility criteria|2|||
23548456|NCT00838110|65739555|FG000|Overall Study|Randomized but not treated|0|||
23619893|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23619894|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
23548457|NCT00838110|65739556|FG001|Overall Study|Randomized but not treated|1|||
23740110|NCT02275052|66426015|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
23740111|NCT02275052|66426012|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23820913|NCT03016975|66725954|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
23820914|NCT03016975|66725955|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
23820915|NCT03016975|66725956|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
23548458|NCT00838110|65739557|FG002|Overall Study|Randomized but not treated|0|||
23548459|NCT00838110|65739558|FG003|Overall Study|Randomized but not treated|0|||
23548460|NCT06281548|65739559|FG000|Overall Study|Lost to Follow-up|3|||
23548461|NCT00843167|65739560|FG000|Treatment Period|Adverse Event|1|||
23548462|NCT00843167|65739561|FG001|Treatment Period|Adverse Event|5|||
23548463|NCT00843167|65739560|FG000|Treatment Period|Withdrawal by Subject|2|||
23740112|NCT02275052|66426013|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23740113|NCT02275052|66426014|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23740114|NCT02275052|66426015|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
23740115|NCT00701064|66426016|FG000|Overall Study|Protocol Violation|1|||
23740116|NCT00701064|66426017|FG001|Overall Study|Protocol Violation|1|||
23740117|NCT00701064|66426016|FG000|Overall Study|Withdrawal by Subject|1|||
23740118|NCT00701064|66426017|FG001|Overall Study|Withdrawal by Subject|1|||
23740119|NCT00701064|66426016|FG000|Overall Study|initiated other PTSD treatment|2|||
23740120|NCT00701064|66426017|FG001|Overall Study|initiated other PTSD treatment|2|||
23428290|NCT01741532|65310775|FG000|Overall Study|Adverse Event|4|||
23428291|NCT01741532|65310776|FG001|Overall Study|Adverse Event|0|||
23428292|NCT01741532|65310775|FG000|Overall Study|Withdrawal by Subject|1|||
23428293|NCT01741532|65310776|FG001|Overall Study|Withdrawal by Subject|1|||
23428294|NCT01741532|65310775|FG000|Overall Study|Protocol Violation|0|||
23428295|NCT01741532|65310776|FG001|Overall Study|Protocol Violation|1|||
23428296|NCT01741532|65310775|FG000|Overall Study|Worsening of the disease|3|||
23428297|NCT01741532|65310776|FG001|Overall Study|Worsening of the disease|1|||
23428298|NCT01741532|65310775|FG000|Overall Study|Sponsor decision|1|||
23428299|NCT01741532|65310776|FG001|Overall Study|Sponsor decision|0|||
23548464|NCT00843167|65739561|FG001|Treatment Period|Withdrawal by Subject|3|||
23740121|NCT02985541|66426018|FG000|Overall Study|Withdrawal by Subject|33|||
23740122|NCT02985541|66426018|FG000|Overall Study|Lost to Follow-up|26|||
23740123|NCT02985541|66426018|FG000|Overall Study|Adverse Event|27|||
23740124|NCT02985541|66426018|FG000|Overall Study|Physician Decision|2|||
23740125|NCT02985541|66426018|FG000|Overall Study|Pregnancy|2|||
23740126|NCT02985541|66426018|FG000|Overall Study|Wish for pregnancy|44|||
23740127|NCT02985541|66426018|FG000|Overall Study|Other reason|5|||
23740128|NCT02985541|66426018|FG000|Overall Study|Not valid for analysis|2|||
23740129|NCT02194699|66426019|FG000|Randomised|Did not receive treatment|1|||
23740130|NCT02194699|66426020|FG001|Randomised|Did not receive treatment|5|||
23740131|NCT02194699|66426019|FG000|Randomised|Without potential for 52 weeks of IP|5|||
23740132|NCT02194699|66426020|FG001|Randomised|Without potential for 52 weeks of IP|5|||
23740133|NCT02194699|66426019|FG000|Randomised|Duplicate patient|2|||
23740134|NCT02194699|66426020|FG001|Randomised|Duplicate patient|1|||
23740135|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
23740136|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
23740137|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
23740138|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
23740139|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
23740140|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
23740141|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
23740142|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
23740143|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
23740144|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
23740145|NCT02194699|66426019|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
23740146|NCT02194699|66426020|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
23740147|NCT01920061|66426023|FG000|Overall Study|Death|1|||
23740148|NCT01920061|66426024|FG001|Overall Study|Death|1|||
23740149|NCT01920061|66426025|FG002|Overall Study|Death|0|||
23740150|NCT01920061|66426026|FG003|Overall Study|Death|1|||
23740151|NCT01920061|66426027|FG004|Overall Study|Death|1|||
23740152|NCT01920061|66426028|FG005|Overall Study|Death|0|||
23740153|NCT01920061|66426029|FG006|Overall Study|Death|0|||
23740154|NCT01920061|66426030|FG007|Overall Study|Death|1|||
23740155|NCT01920061|66426031|FG008|Overall Study|Death|0|||
23740156|NCT01920061|66426032|FG009|Overall Study|Death|1|||
23548465|NCT00263666|65739564|FG000|Overall Study|Adverse Event|6|||
23740157|NCT01920061|66426033|FG010|Overall Study|Death|0|||
23740158|NCT01920061|66426034|FG011|Overall Study|Death|1|||
23740159|NCT01920061|66426035|FG012|Overall Study|Death|0|||
23740160|NCT01920061|66426036|FG013|Overall Study|Death|2|||
23740161|NCT01920061|66426037|FG014|Overall Study|Death|0|||
23740162|NCT01920061|66426038|FG015|Overall Study|Death|0|||
23740163|NCT01920061|66426039|FG016|Overall Study|Death|0|||
23428300|NCT01741532|65310775|FG000|Overall Study|Medical event|1|||
23428301|NCT01741532|65310776|FG001|Overall Study|Medical event|0|||
23548466|NCT00263666|65739565|FG001|Overall Study|Adverse Event|8|||
23740164|NCT01920061|66426040|FG017|Overall Study|Death|0|||
23740165|NCT01920061|66426041|FG018|Overall Study|Death|1|||
23740166|NCT01920061|66426042|FG019|Overall Study|Death|0|||
23740167|NCT01920061|66426023|FG000|Overall Study|Lost to Follow-up|0|||
23428302|NCT03322423|65310777|FG000|Period 1|Subject no longer eligible|0|||
23548467|NCT00263666|65739564|FG000|Overall Study|Lost to Follow-up|1|||
23548468|NCT00263666|65739565|FG001|Overall Study|Lost to Follow-up|2|||
23548469|NCT00263666|65739564|FG000|Overall Study|Withdrawal by Subject|0|||
23548470|NCT00263666|65739565|FG001|Overall Study|Withdrawal by Subject|1|||
23548471|NCT00251745|65739568|FG000|Overall Study|Adverse Event|7|||
23548472|NCT00251745|65739569|FG001|Overall Study|Adverse Event|9|||
23548473|NCT00251745|65739570|FG002|Overall Study|Adverse Event|11|||
23548474|NCT00251745|65739568|FG000|Overall Study|Lost to Follow-up|4|||
23428303|NCT03322423|65310778|FG001|Period 1|Subject no longer eligible|1|||
23428304|NCT03322423|65310777|FG000|Period 1|Withdrawal by Subject|0|||
23428305|NCT03322423|65310778|FG001|Period 1|Withdrawal by Subject|1|||
23428306|NCT03322423|65310777|FG000|Period 1|Incorrect Lens Dispensed|1|||
23428307|NCT03322423|65310778|FG001|Period 1|Incorrect Lens Dispensed|0|||
23428308|NCT03322423|65310777|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
23428309|NCT03322423|65310778|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
23428310|NCT03322423|65310777|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
23428311|NCT03322423|65310778|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
23428312|NCT03322423|65310777|FG000|Period 2|Protocol Violation|1|||
23548475|NCT00251745|65739569|FG001|Overall Study|Lost to Follow-up|2|||
23548476|NCT00251745|65739570|FG002|Overall Study|Lost to Follow-up|5|||
23740168|NCT01920061|66426024|FG001|Overall Study|Lost to Follow-up|2|||
23740169|NCT01920061|66426025|FG002|Overall Study|Lost to Follow-up|0|||
23740170|NCT01920061|66426026|FG003|Overall Study|Lost to Follow-up|0|||
23740171|NCT01920061|66426027|FG004|Overall Study|Lost to Follow-up|0|||
23740172|NCT01920061|66426028|FG005|Overall Study|Lost to Follow-up|0|||
23740173|NCT01920061|66426029|FG006|Overall Study|Lost to Follow-up|1|||
23740174|NCT01920061|66426030|FG007|Overall Study|Lost to Follow-up|0|||
23740175|NCT01920061|66426031|FG008|Overall Study|Lost to Follow-up|0|||
23740176|NCT01920061|66426032|FG009|Overall Study|Lost to Follow-up|0|||
23740177|NCT01920061|66426033|FG010|Overall Study|Lost to Follow-up|3|||
23548477|NCT00251745|65739568|FG000|Overall Study|Withdrawal by Subject|13|||
23548478|NCT00251745|65739569|FG001|Overall Study|Withdrawal by Subject|7|||
23548479|NCT00251745|65739570|FG002|Overall Study|Withdrawal by Subject|3|||
23548480|NCT00251745|65739568|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23548481|NCT00251745|65739569|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
23548482|NCT00251745|65739570|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23548483|NCT00251745|65739568|FG000|Overall Study|Lack of Efficacy|3|||
23740178|NCT01920061|66426034|FG011|Overall Study|Lost to Follow-up|0|||
23740179|NCT01920061|66426035|FG012|Overall Study|Lost to Follow-up|0|||
23740180|NCT01920061|66426036|FG013|Overall Study|Lost to Follow-up|0|||
23548484|NCT00251745|65739569|FG001|Overall Study|Lack of Efficacy|0|||
23548485|NCT00251745|65739570|FG002|Overall Study|Lack of Efficacy|0|||
23548486|NCT00251745|65739568|FG000|Overall Study|Noncompliant|0|||
23548487|NCT00251745|65739569|FG001|Overall Study|Noncompliant|2|||
23548488|NCT00251745|65739570|FG002|Overall Study|Noncompliant|2|||
23548489|NCT00251745|65739568|FG000|Overall Study|Pregnancy|0|||
23548490|NCT00251745|65739569|FG001|Overall Study|Pregnancy|1|||
23548491|NCT00251745|65739570|FG002|Overall Study|Pregnancy|0|||
23548492|NCT00251745|65739568|FG000|Overall Study|Per Subject Request|0|||
23548493|NCT00251745|65739569|FG001|Overall Study|Per Subject Request|0|||
23548494|NCT00251745|65739570|FG002|Overall Study|Per Subject Request|1|||
23548495|NCT00251745|65739568|FG000|Overall Study|Per Investigator Request|1|||
23548496|NCT00251745|65739569|FG001|Overall Study|Per Investigator Request|0|||
23548497|NCT00251745|65739570|FG002|Overall Study|Per Investigator Request|0|||
23548498|NCT00295750|65739579|FG000|Overall Study|Adverse Event|19|||
23548499|NCT00295750|65739580|FG001|Overall Study|Adverse Event|15|||
23548500|NCT00295750|65739581|FG002|Overall Study|Adverse Event|12|||
23548501|NCT00295750|65739579|FG000|Overall Study|Lack of Efficacy|1|||
23548502|NCT00295750|65739580|FG001|Overall Study|Lack of Efficacy|1|||
23548503|NCT00295750|65739581|FG002|Overall Study|Lack of Efficacy|0|||
23548504|NCT00295750|65739579|FG000|Overall Study|Lost to Follow-up|1|||
23548505|NCT00295750|65739580|FG001|Overall Study|Lost to Follow-up|4|||
23548506|NCT00295750|65739581|FG002|Overall Study|Lost to Follow-up|1|||
23740181|NCT01920061|66426037|FG014|Overall Study|Lost to Follow-up|0|||
23740182|NCT01920061|66426038|FG015|Overall Study|Lost to Follow-up|0|||
23740183|NCT01920061|66426039|FG016|Overall Study|Lost to Follow-up|0|||
23740184|NCT01920061|66426040|FG017|Overall Study|Lost to Follow-up|1|||
23548507|NCT00295750|65739579|FG000|Overall Study|Taking prohibited therapy|2|||
23548508|NCT00295750|65739580|FG001|Overall Study|Taking prohibited therapy|3|||
23548509|NCT00295750|65739581|FG002|Overall Study|Taking prohibited therapy|2|||
23548510|NCT00295750|65739579|FG000|Overall Study|Administrative errors|2|||
23740185|NCT01920061|66426041|FG018|Overall Study|Lost to Follow-up|4|||
23548511|NCT00295750|65739580|FG001|Overall Study|Administrative errors|4|||
23548512|NCT00295750|65739581|FG002|Overall Study|Administrative errors|5|||
23740186|NCT01920061|66426042|FG019|Overall Study|Lost to Follow-up|3|||
23740187|NCT01920061|66426023|FG000|Overall Study|Other|1|||
23428313|NCT03322423|65310778|FG001|Period 2|Protocol Violation|0|||
23548513|NCT00295750|65739579|FG000|Overall Study|Trial drug errors|1|||
23740188|NCT01920061|66426024|FG001|Overall Study|Other|1|||
23740189|NCT01920061|66426025|FG002|Overall Study|Other|2|||
23740190|NCT01920061|66426026|FG003|Overall Study|Other|1|||
23740191|NCT01920061|66426027|FG004|Overall Study|Other|0|||
23740192|NCT01920061|66426028|FG005|Overall Study|Other|1|||
23740193|NCT01920061|66426029|FG006|Overall Study|Other|0|||
23740194|NCT01920061|66426030|FG007|Overall Study|Other|0|||
23740195|NCT01920061|66426031|FG008|Overall Study|Other|0|||
23740196|NCT01920061|66426032|FG009|Overall Study|Other|1|||
23740197|NCT01920061|66426033|FG010|Overall Study|Other|1|||
23740198|NCT01920061|66426034|FG011|Overall Study|Other|2|||
23740199|NCT01920061|66426035|FG012|Overall Study|Other|1|||
23740200|NCT01920061|66426036|FG013|Overall Study|Other|4|||
23740201|NCT01920061|66426037|FG014|Overall Study|Other|0|||
23740202|NCT01920061|66426038|FG015|Overall Study|Other|1|||
23740203|NCT01920061|66426039|FG016|Overall Study|Other|1|||
23740204|NCT01920061|66426040|FG017|Overall Study|Other|0|||
23740205|NCT01920061|66426041|FG018|Overall Study|Other|1|||
23740206|NCT01920061|66426042|FG019|Overall Study|Other|1|||
23740207|NCT01920061|66426023|FG000|Overall Study|Participant refused further follow-up|0|||
23740208|NCT01920061|66426024|FG001|Overall Study|Participant refused further follow-up|0|||
23740209|NCT01920061|66426025|FG002|Overall Study|Participant refused further follow-up|0|||
23740210|NCT01920061|66426026|FG003|Overall Study|Participant refused further follow-up|0|||
23740211|NCT01920061|66426027|FG004|Overall Study|Participant refused further follow-up|1|||
23740212|NCT01920061|66426028|FG005|Overall Study|Participant refused further follow-up|1|||
23740213|NCT01920061|66426029|FG006|Overall Study|Participant refused further follow-up|0|||
23740214|NCT01920061|66426030|FG007|Overall Study|Participant refused further follow-up|0|||
23740215|NCT01920061|66426031|FG008|Overall Study|Participant refused further follow-up|1|||
23740216|NCT01920061|66426032|FG009|Overall Study|Participant refused further follow-up|0|||
23740217|NCT01920061|66426033|FG010|Overall Study|Participant refused further follow-up|1|||
23740218|NCT01920061|66426034|FG011|Overall Study|Participant refused further follow-up|0|||
23740219|NCT01920061|66426035|FG012|Overall Study|Participant refused further follow-up|1|||
23740220|NCT01920061|66426036|FG013|Overall Study|Participant refused further follow-up|0|||
23740221|NCT01920061|66426037|FG014|Overall Study|Participant refused further follow-up|1|||
23740222|NCT01920061|66426038|FG015|Overall Study|Participant refused further follow-up|2|||
23428314|NCT03322423|65310777|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
23428315|NCT03322423|65310778|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
23428316|NCT01460719|65310779|FG000|Overall Study|Adverse Event|1|||
23548514|NCT00295750|65739580|FG001|Overall Study|Trial drug errors|1|||
23740223|NCT01920061|66426039|FG016|Overall Study|Participant refused further follow-up|1|||
23740224|NCT01920061|66426040|FG017|Overall Study|Participant refused further follow-up|1|||
23740225|NCT01920061|66426041|FG018|Overall Study|Participant refused further follow-up|0|||
23740226|NCT01920061|66426042|FG019|Overall Study|Participant refused further follow-up|0|||
23740227|NCT01365182|66426044|FG000|Overall Study|Withdrawal by Subject|10|||
23740228|NCT01365182|66426045|FG001|Overall Study|Withdrawal by Subject|13|||
23740229|NCT01365182|66426046|FG002|Overall Study|Withdrawal by Subject|12|||
23740230|NCT00003389|66426053|FG000|Overall Study|Disease progression|6|||
23740231|NCT00003389|66426054|FG001|Overall Study|Disease progression|1|||
23740232|NCT00003389|66426053|FG000|Overall Study|Adverse Event|13|||
23740233|NCT00003389|66426054|FG001|Overall Study|Adverse Event|2|||
23548515|NCT00295750|65739581|FG002|Overall Study|Trial drug errors|0|||
23548516|NCT00295750|65739579|FG000|Overall Study|Disease progression|2|||
23548517|NCT00295750|65739580|FG001|Overall Study|Disease progression|1|||
23548518|NCT00295750|65739581|FG002|Overall Study|Disease progression|0|||
23548519|NCT00295750|65739579|FG000|Overall Study|Personal reasons|0|||
23548520|NCT00295750|65739580|FG001|Overall Study|Personal reasons|1|||
23548521|NCT00295750|65739581|FG002|Overall Study|Personal reasons|0|||
23548522|NCT00295750|65739579|FG000|Overall Study|Randomized but never received trial drug|4|||
23548523|NCT00295750|65739580|FG001|Overall Study|Randomized but never received trial drug|3|||
23548524|NCT00295750|65739581|FG002|Overall Study|Randomized but never received trial drug|3|||
23548525|NCT00295750|65739579|FG000|Overall Study|Withdrawal by Subject|9|||
23548526|NCT00295750|65739580|FG001|Overall Study|Withdrawal by Subject|4|||
23548527|NCT00295750|65739581|FG002|Overall Study|Withdrawal by Subject|7|||
23548528|NCT00295750|65739579|FG000|Overall Study|Protocol Violation|2|||
23548529|NCT00295750|65739580|FG001|Overall Study|Protocol Violation|4|||
23548530|NCT00295750|65739581|FG002|Overall Study|Protocol Violation|2|||
23548531|NCT02384954|65739582|FG000|Phase 1|Progressive Disease|2|||
23740234|NCT00003389|66426053|FG000|Overall Study|Death|0|||
23740235|NCT00003389|66426054|FG001|Overall Study|Death|3|||
23740236|NCT00003389|66426053|FG000|Overall Study|Withdrawal by Subject|12|||
23740237|NCT00003389|66426054|FG001|Overall Study|Withdrawal by Subject|5|||
23820916|NCT03016975|66725954|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
23548532|NCT02384954|65739583|FG001|Phase 1|Progressive Disease|0|||
23548533|NCT02384954|65739584|FG002|Phase 1|Progressive Disease|1|||
23740238|NCT00003389|66426053|FG000|Overall Study|Alternative therapy|2|||
23740239|NCT00003389|66426054|FG001|Overall Study|Alternative therapy|1|||
23548534|NCT02384954|65739585|FG003|Phase 1|Progressive Disease|1|||
23548535|NCT02384954|65739586|FG004|Phase 1|Progressive Disease|0|||
23548536|NCT02384954|65739587|FG005|Phase 1|Progressive Disease|0|||
23548537|NCT02384954|65739588|FG006|Phase 1|Progressive Disease|0|||
23548538|NCT02384954|65739589|FG007|Phase 1|Progressive Disease|0|||
23548539|NCT02384954|65739590|FG008|Phase 1|Progressive Disease|0|||
23548540|NCT02384954|65739582|FG000|Phase 1|Adverse Event|0|||
23548541|NCT02384954|65739583|FG001|Phase 1|Adverse Event|0|||
23548542|NCT02384954|65739584|FG002|Phase 1|Adverse Event|1|||
23548543|NCT02384954|65739585|FG003|Phase 1|Adverse Event|0|||
23548544|NCT02384954|65739586|FG004|Phase 1|Adverse Event|0|||
23548545|NCT02384954|65739587|FG005|Phase 1|Adverse Event|0|||
23548546|NCT02384954|65739588|FG006|Phase 1|Adverse Event|0|||
23548547|NCT02384954|65739589|FG007|Phase 1|Adverse Event|0|||
23548548|NCT02384954|65739590|FG008|Phase 1|Adverse Event|0|||
23548549|NCT02384954|65739582|FG000|Phase 2|Progressive Disease|0|||
23548550|NCT02384954|65739583|FG001|Phase 2|Progressive Disease|0|||
23548551|NCT02384954|65739584|FG002|Phase 2|Progressive Disease|0|||
23548552|NCT02384954|65739585|FG003|Phase 2|Progressive Disease|0|||
23548553|NCT02384954|65739586|FG004|Phase 2|Progressive Disease|0|||
23548554|NCT02384954|65739587|FG005|Phase 2|Progressive Disease|0|||
23548555|NCT02384954|65739588|FG006|Phase 2|Progressive Disease|0|||
23548556|NCT02384954|65739589|FG007|Phase 2|Progressive Disease|1|||
23548557|NCT02384954|65739590|FG008|Phase 2|Progressive Disease|2|||
23548558|NCT02384954|65739582|FG000|Phase 2|Adverse Event|0|||
23548559|NCT02384954|65739583|FG001|Phase 2|Adverse Event|0|||
23548560|NCT02384954|65739584|FG002|Phase 2|Adverse Event|0|||
23548561|NCT02384954|65739585|FG003|Phase 2|Adverse Event|0|||
23548562|NCT02384954|65739586|FG004|Phase 2|Adverse Event|0|||
23548563|NCT02384954|65739587|FG005|Phase 2|Adverse Event|0|||
23548564|NCT02384954|65739588|FG006|Phase 2|Adverse Event|0|||
23548565|NCT02384954|65739589|FG007|Phase 2|Adverse Event|1|||
23548566|NCT02384954|65739590|FG008|Phase 2|Adverse Event|1|||
23548567|NCT02384954|65739582|FG000|Phase 2|Failure to meet continuation criteria|0|||
23548568|NCT02384954|65739583|FG001|Phase 2|Failure to meet continuation criteria|0|||
23548569|NCT02384954|65739584|FG002|Phase 2|Failure to meet continuation criteria|0|||
23548570|NCT02384954|65739585|FG003|Phase 2|Failure to meet continuation criteria|0|||
23548571|NCT02384954|65739586|FG004|Phase 2|Failure to meet continuation criteria|0|||
23548572|NCT02384954|65739587|FG005|Phase 2|Failure to meet continuation criteria|0|||
23548573|NCT02384954|65739588|FG006|Phase 2|Failure to meet continuation criteria|0|||
23548574|NCT02384954|65739589|FG007|Phase 2|Failure to meet continuation criteria|1|||
23548575|NCT02384954|65739590|FG008|Phase 2|Failure to meet continuation criteria|0|||
23548576|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
23548577|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
23548578|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
23548579|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
23548580|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
23619895|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
23619896|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
23619897|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
23619898|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619899|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619900|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619901|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23619902|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23619903|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23619904|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
23619905|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23619906|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
23820917|NCT03016975|66725955|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
23428317|NCT01460719|65310779|FG000|Overall Study|Withdrawal by Subject|1|||
23548581|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
23548582|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
23548583|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
23548584|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
23548585|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
23548586|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
23548587|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
23548588|NCT00489970|65739594|FG000|Persistence Year 9|Lost to Follow-up|2|||
23548589|NCT00489970|65739595|FG001|Persistence Year 9|Lost to Follow-up|2|||
23548590|NCT00489970|65739596|FG002|Persistence Year 9|Lost to Follow-up|3|||
23548591|NCT00489970|65739594|FG000|Persistence Year 9|Other|1|||
23548592|NCT00489970|65739595|FG001|Persistence Year 9|Other|0|||
23548593|NCT00489970|65739596|FG002|Persistence Year 9|Other|2|||
23619907|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
23619908|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23548594|NCT00818753|65739599|FG000|Overall Study|Protocol Violation|1|||
23548595|NCT00818753|65739600|FG001|Overall Study|Protocol Violation|0|||
23548596|NCT00818753|65739601|FG002|Overall Study|Protocol Violation|0|||
23548597|NCT00818753|65739599|FG000|Overall Study|Other reason (not specified)|0|||
23548598|NCT00818753|65739600|FG001|Overall Study|Other reason (not specified)|0|||
23548599|NCT00818753|65739601|FG002|Overall Study|Other reason (not specified)|1|||
23548600|NCT00818753|65739599|FG000|Overall Study|Randomised and not treated|2|||
23548601|NCT00818753|65739600|FG001|Overall Study|Randomised and not treated|0|||
23548602|NCT00818753|65739601|FG002|Overall Study|Randomised and not treated|0|||
23548603|NCT03762473|65739611|FG000|Overall Study|Death|1|||
23548604|NCT03762473|65739612|FG001|Overall Study|Death|0|||
23548605|NCT03595904|65739613|FG000|Overall Study|Protocol Violation|3|||
23548606|NCT03595904|65739614|FG001|Overall Study|Protocol Violation|1|||
23740240|NCT00003389|66426053|FG000|Overall Study|Complicating disease|1|||
23740241|NCT00003389|66426054|FG001|Overall Study|Complicating disease|0|||
23740242|NCT00003389|66426053|FG000|Overall Study|Off-treatment reason missing|31|||
23740243|NCT00003389|66426054|FG001|Overall Study|Off-treatment reason missing|21|||
23740244|NCT00003389|66426053|FG000|Overall Study|Ineligible|33|||
23740245|NCT00003389|66426054|FG001|Overall Study|Ineligible|27|||
23740246|NCT04354870|66426055|FG000|Overall Study|Lost to Follow-up|32|||
23740247|NCT04354870|66426056|FG001|Overall Study|Lost to Follow-up|12|||
23740248|NCT04354870|66426055|FG000|Overall Study|Withdrawal by Subject|10|||
23740249|NCT04354870|66426056|FG001|Overall Study|Withdrawal by Subject|16|||
23740250|NCT04354870|66426055|FG000|Overall Study|Did not complete all study visits|6|||
23740251|NCT04354870|66426056|FG001|Overall Study|Did not complete all study visits|5|||
23740252|NCT01233284|66429237|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23740253|NCT01233284|66429238|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23740254|NCT01233284|66429239|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23619909|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23619910|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23619911|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
23619912|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
23820918|NCT03016975|66725956|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
23820919|NCT01118975|66725957|FG000|Overall Study|Adverse Event|0|||
23820920|NCT01118975|66725958|FG001|Overall Study|Adverse Event|1|||
23820921|NCT01128543|66725960|FG000|Overall Study|Withdrawal by Subject|3|||
23820922|NCT01128543|66725960|FG000|Overall Study|Protocol Violation|1|||
23820923|NCT03510598|66725961|FG000|Overall Study|Withdrawal by Subject|1|||
23548607|NCT03595904|65739613|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
23548608|NCT03595904|65739614|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
23740255|NCT01233284|66429240|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23740256|NCT01233284|66429241|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23740257|NCT01233284|66429237|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23740258|NCT01233284|66429238|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
23740259|NCT01233284|66429239|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23548609|NCT03595904|65739613|FG000|Overall Study|Insurance complications|1|||
23740260|NCT01233284|66429240|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23740261|NCT01233284|66429241|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23740262|NCT01233284|66429237|FG000|Period 1 (4 Weeks)|Other|0|||
23740263|NCT01233284|66429238|FG001|Period 1 (4 Weeks)|Other|0|||
23740264|NCT01233284|66429239|FG002|Period 1 (4 Weeks)|Other|1|||
23740265|NCT01233284|66429240|FG003|Period 1 (4 Weeks)|Other|0|||
23740266|NCT01233284|66429241|FG004|Period 1 (4 Weeks)|Other|0|||
23740267|NCT01233284|66429237|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23740268|NCT01233284|66429238|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23740269|NCT01233284|66429239|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
23740270|NCT01233284|66429240|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23740271|NCT01233284|66429241|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23740272|NCT01233284|66429237|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23740273|NCT01233284|66429238|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23740274|NCT01233284|66429239|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
23548610|NCT03595904|65739614|FG001|Overall Study|Insurance complications|0|||
23548611|NCT03595904|65739613|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
23582207|NCT01242085|65862383|FG000|Overall Study|Withdrawal by Subject|4|||
23740275|NCT01233284|66429240|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23740276|NCT01233284|66429241|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23740277|NCT01233284|66429237|FG000|Period 3 (4 Weeks)|Other|0|||
23740278|NCT01233284|66429238|FG001|Period 3 (4 Weeks)|Other|0|||
23740279|NCT01233284|66429239|FG002|Period 3 (4 Weeks)|Other|0|||
23740280|NCT01233284|66429240|FG003|Period 3 (4 Weeks)|Other|1|||
23740281|NCT01233284|66429241|FG004|Period 3 (4 Weeks)|Other|0|||
23820924|NCT02290223|66725962|FG000|6 Months|Lost to Follow-up|9|||
23820925|NCT02290223|66725963|FG001|6 Months|Lost to Follow-up|6|||
23548612|NCT03595904|65739614|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
23548613|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
23548614|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23548615|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23548616|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548617|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548618|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548619|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548620|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548621|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
23548622|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548623|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548624|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548625|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
23548626|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
23548627|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548628|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548629|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548630|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548631|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
23548632|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
23740282|NCT01233284|66429237|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
23740283|NCT01233284|66429238|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
23740284|NCT01233284|66429239|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
23740285|NCT01233284|66429240|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
23740286|NCT01233284|66429241|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
23740287|NCT01233284|66429237|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23619913|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23619914|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619915|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619916|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619917|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
23740288|NCT01233284|66429238|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23548633|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
23548634|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548635|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548636|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548637|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
23548638|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
23548639|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
23548640|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23548641|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23548642|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23740289|NCT01233284|66429239|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23740290|NCT01233284|66429240|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
23548643|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548644|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548645|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548646|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
23548647|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
23548648|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
23548649|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548650|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548651|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548652|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23548653|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23548654|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
23548655|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548656|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548657|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548658|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
23548659|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
23548660|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
23740291|NCT01233284|66429241|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23740292|NCT01474993|66429246|FG000|Overall Study|Lost to Follow-up|1|||
23740293|NCT01474993|66429247|FG001|Overall Study|Lost to Follow-up|2|||
23740294|NCT01474993|66429246|FG000|Overall Study|Adverse Event|0|||
23548661|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548662|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548663|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548664|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
23548665|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
23548666|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
23548667|NCT00722761|65739622|FG000|Overall Study|Lost to Follow-up|1|||
23548668|NCT00722761|65739623|FG001|Overall Study|Lost to Follow-up|4|||
23548669|NCT00722761|65739622|FG000|Overall Study|Withdrawal by Subject|5|||
23548670|NCT00722761|65739623|FG001|Overall Study|Withdrawal by Subject|2|||
23548671|NCT00317772|65739628|FG000|Overall Study|Adverse Event|0|||
23548672|NCT00317772|65739629|FG001|Overall Study|Adverse Event|0|||
23548673|NCT00317772|65739630|FG002|Overall Study|Adverse Event|0|||
23548674|NCT00317772|65739631|FG003|Overall Study|Adverse Event|2|||
23548675|NCT00317772|65739628|FG000|Overall Study|Disease Progression|2|||
23548676|NCT00317772|65739629|FG001|Overall Study|Disease Progression|2|||
23548677|NCT00317772|65739630|FG002|Overall Study|Disease Progression|1|||
23548678|NCT00317772|65739631|FG003|Overall Study|Disease Progression|7|||
23548679|NCT01881620|65739632|FG000|Overall Study|Protocol Violation|4|||
23548680|NCT00553267|65739633|FG000|Overall Study|Adverse Event|8|||
23548681|NCT00553267|65739634|FG001|Overall Study|Adverse Event|10|||
23548682|NCT00553267|65739635|FG002|Overall Study|Adverse Event|5|||
23548683|NCT00553267|65739633|FG000|Overall Study|Non compliant with protocol|3|||
23548684|NCT00553267|65739634|FG001|Overall Study|Non compliant with protocol|3|||
23619918|NCT00553605|65994791|FG000|Overall Study|Did not meet entrance criteria|1|||
23619919|NCT00553605|65994792|FG001|Overall Study|Did not meet entrance criteria|3|||
23619920|NCT00553605|65994791|FG000|Overall Study|Did not receive full dose|1|||
23619921|NCT00553605|65994792|FG001|Overall Study|Did not receive full dose|0|||
23619922|NCT00553605|65994791|FG000|Overall Study|Randomized but not treated|2|||
23619923|NCT00553605|65994792|FG001|Overall Study|Randomized but not treated|0|||
23740295|NCT01474993|66429247|FG001|Overall Study|Adverse Event|1|||
23740296|NCT00933543|66429248|FG000|Overall Study|Adverse Event|2|||
23740297|NCT00933543|66429249|FG001|Overall Study|Adverse Event|1|||
23740298|NCT00933543|66429248|FG000|Overall Study|Lost to Follow-up|0|||
23428318|NCT02726880|65310780|FG000|Overall Study|Withdrawal by Subject|2|||
23548685|NCT00553267|65739635|FG002|Overall Study|Non compliant with protocol|2|||
23740299|NCT00933543|66429249|FG001|Overall Study|Lost to Follow-up|1|||
23740300|NCT00933543|66429248|FG000|Overall Study|Withdrawal by Subject|0|||
23740301|NCT00933543|66429249|FG001|Overall Study|Withdrawal by Subject|1|||
23740302|NCT00933543|66429248|FG000|Overall Study|Lack of Efficacy|0|||
23740303|NCT00933543|66429249|FG001|Overall Study|Lack of Efficacy|3|||
23740304|NCT00933543|66429248|FG000|Overall Study|Other|1|||
23740305|NCT00933543|66429249|FG001|Overall Study|Other|1|||
23740306|NCT00027027|66429255|FG000|Overall Study|Adverse Event|0|||
23740307|NCT00027027|66429256|FG001|Overall Study|Adverse Event|0|||
23740308|NCT00027027|66429257|FG002|Overall Study|Adverse Event|1|||
23740309|NCT00027027|66429258|FG003|Overall Study|Adverse Event|0|||
23740310|NCT00027027|66429259|FG004|Overall Study|Adverse Event|1|||
23740311|NCT00027027|66429255|FG000|Overall Study|Admitted for Signs of PD|0|||
23740312|NCT00027027|66429256|FG001|Overall Study|Admitted for Signs of PD|0|||
23740313|NCT00027027|66429257|FG002|Overall Study|Admitted for Signs of PD|0|||
23740314|NCT00027027|66429258|FG003|Overall Study|Admitted for Signs of PD|0|||
23740315|NCT00027027|66429259|FG004|Overall Study|Admitted for Signs of PD|1|||
23740316|NCT00027027|66429255|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
23740317|NCT00027027|66429256|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
23740318|NCT00027027|66429257|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
23740319|NCT00027027|66429258|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
23740320|NCT00027027|66429259|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
23740321|NCT00027027|66429255|FG000|Overall Study|PD Requiring Surgery|0|||
23740322|NCT00027027|66429256|FG001|Overall Study|PD Requiring Surgery|0|||
23740323|NCT00027027|66429257|FG002|Overall Study|PD Requiring Surgery|1|||
23740324|NCT00027027|66429258|FG003|Overall Study|PD Requiring Surgery|0|||
23740325|NCT00027027|66429259|FG004|Overall Study|PD Requiring Surgery|0|||
23740326|NCT00027027|66429255|FG000|Overall Study|Physician Decision Due To PD|2|||
23740327|NCT00027027|66429256|FG001|Overall Study|Physician Decision Due To PD|3|||
23619924|NCT03449134|65994793|FG000|52-Week Treatment Period|Death|2|||
23740328|NCT00027027|66429257|FG002|Overall Study|Physician Decision Due To PD|2|||
23740329|NCT00027027|66429258|FG003|Overall Study|Physician Decision Due To PD|3|||
23740330|NCT00027027|66429259|FG004|Overall Study|Physician Decision Due To PD|5|||
23548686|NCT00553267|65739633|FG000|Overall Study|Lost to Follow-up|0|||
23548687|NCT00553267|65739634|FG001|Overall Study|Lost to Follow-up|0|||
23548688|NCT00553267|65739635|FG002|Overall Study|Lost to Follow-up|1|||
23548689|NCT00553267|65739633|FG000|Overall Study|Consent withdrawn|2|||
23740331|NCT00027027|66429255|FG000|Overall Study|Withdrawal by Subject|0|||
23740332|NCT00027027|66429256|FG001|Overall Study|Withdrawal by Subject|0|||
23548690|NCT00553267|65739634|FG001|Overall Study|Consent withdrawn|3|||
23548691|NCT00553267|65739635|FG002|Overall Study|Consent withdrawn|1|||
23548692|NCT00553267|65739633|FG000|Overall Study|Specified category|1|||
23548693|NCT00553267|65739634|FG001|Overall Study|Specified category|2|||
23548694|NCT00553267|65739635|FG002|Overall Study|Specified category|1|||
23740333|NCT00027027|66429257|FG002|Overall Study|Withdrawal by Subject|0|||
23548695|NCT01217073|65739636|FG000|Base Period|Adverse Event|1|||
23548696|NCT01217073|65739637|FG001|Base Period|Adverse Event|0|||
23548697|NCT01217073|65739638|FG002|Base Period|Adverse Event|1|||
23548698|NCT01217073|65739639|FG003|Base Period|Adverse Event|0|||
23548699|NCT01217073|65739640|FG004|Base Period|Adverse Event|4|||
23548700|NCT01217073|65739641|FG005|Base Period|Adverse Event|1|||
23548701|NCT01217073|65739642|FG006|Base Period|Adverse Event|0|||
23548702|NCT01217073|65739643|FG007|Base Period|Adverse Event|0|||
23548703|NCT01217073|65739636|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
23548704|NCT01217073|65739637|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548705|NCT01217073|65739638|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548706|NCT01217073|65739639|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548707|NCT01217073|65739640|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548708|NCT01217073|65739641|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548709|NCT01217073|65739642|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23740334|NCT00027027|66429258|FG003|Overall Study|Withdrawal by Subject|0|||
23740335|NCT00027027|66429259|FG004|Overall Study|Withdrawal by Subject|1|||
23740336|NCT01345162|66429260|FG000|Overall Study|Protocol Violation|2|||
23740337|NCT01345162|66429261|FG001|Overall Study|Protocol Violation|4|||
23740338|NCT01224171|66429264|FG000|Overall Study|Adverse Event|8|||
23740339|NCT01224171|66429265|FG001|Overall Study|Adverse Event|4|||
23740340|NCT01224171|66429264|FG000|Overall Study|Protocol Violation|0|||
23740341|NCT01224171|66429265|FG001|Overall Study|Protocol Violation|1|||
23740342|NCT01224171|66429264|FG000|Overall Study|Lack of Efficacy|5|||
23740343|NCT01224171|66429265|FG001|Overall Study|Lack of Efficacy|1|||
23740344|NCT01224171|66429264|FG000|Overall Study|Withdrawal of Consent|2|||
23740345|NCT01224171|66429265|FG001|Overall Study|Withdrawal of Consent|4|||
23740346|NCT01224171|66429264|FG000|Overall Study|Lost to Follow-up|0|||
23740347|NCT01224171|66429265|FG001|Overall Study|Lost to Follow-up|3|||
23740348|NCT00421928|66429277|FG000|Overall Study|Adverse Event|61|||
23740349|NCT00421928|66429278|FG001|Overall Study|Adverse Event|140|||
23740350|NCT00421928|66429279|FG002|Overall Study|Adverse Event|22|||
23740351|NCT00421928|66429277|FG000|Overall Study|Lost to Follow-up|5|||
23820926|NCT02290223|66725962|FG000|6 Months|Withdrawal by Subject|5|||
23820927|NCT02290223|66725963|FG001|6 Months|Withdrawal by Subject|0|||
23820928|NCT02290223|66725962|FG000|6 Months|deceased (not related to study)|2|||
23820929|NCT02290223|66725963|FG001|6 Months|deceased (not related to study)|0|||
23820930|NCT02290223|66725962|FG000|12 Months|Lost to Follow-up|16|||
23820931|NCT02290223|66725963|FG001|12 Months|Lost to Follow-up|10|||
23820932|NCT02290223|66725962|FG000|12 Months|Refusal|0|||
23820933|NCT02290223|66725963|FG001|12 Months|Refusal|1|||
23820934|NCT01450683|66725966|FG000|Overall Study|Adverse Event|2|||
23820935|NCT01512160|66725967|FG000|Overall Study|Lost to Follow-up|1|||
23820936|NCT01512160|66725968|FG001|Overall Study|Lost to Follow-up|0|||
23820937|NCT01512160|66725969|FG002|Overall Study|Lost to Follow-up|0|||
23820938|NCT01512160|66725970|FG003|Overall Study|Lost to Follow-up|0|||
23820939|NCT01512160|66725967|FG000|Overall Study|Withdrawal by Subject|1|||
23820940|NCT01512160|66725968|FG001|Overall Study|Withdrawal by Subject|0|||
23820941|NCT01512160|66725969|FG002|Overall Study|Withdrawal by Subject|0|||
23820942|NCT01512160|66725970|FG003|Overall Study|Withdrawal by Subject|1|||
23820943|NCT00101283|66725974|FG000|Overall Study|Withdrawal by Subject|0|||
23820944|NCT00101283|66725975|FG001|Overall Study|Withdrawal by Subject|1|||
23548710|NCT01217073|65739643|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548711|NCT01217073|65739636|FG000|Base Period|Excluded medication|0|||
23548712|NCT01217073|65739637|FG001|Base Period|Excluded medication|0|||
23548713|NCT01217073|65739638|FG002|Base Period|Excluded medication|0|||
23548714|NCT01217073|65739639|FG003|Base Period|Excluded medication|0|||
23740352|NCT00421928|66429278|FG001|Overall Study|Lost to Follow-up|0|||
23740353|NCT00421928|66429279|FG002|Overall Study|Lost to Follow-up|3|||
23740354|NCT00421928|66429277|FG000|Overall Study|Withdrawal by Subject|50|||
23740355|NCT00421928|66429278|FG001|Overall Study|Withdrawal by Subject|48|||
23740356|NCT00421928|66429279|FG002|Overall Study|Withdrawal by Subject|43|||
23740357|NCT00421928|66429277|FG000|Overall Study|Lack of Efficacy|15|||
23740358|NCT00421928|66429278|FG001|Overall Study|Lack of Efficacy|7|||
23548715|NCT01217073|65739640|FG004|Base Period|Excluded medication|1|||
23548716|NCT01217073|65739641|FG005|Base Period|Excluded medication|0|||
23548717|NCT01217073|65739642|FG006|Base Period|Excluded medication|0|||
23740359|NCT00421928|66429279|FG002|Overall Study|Lack of Efficacy|35|||
23820945|NCT00101283|66725974|FG000|Overall Study|Insurance Refusal|0|||
23820946|NCT00101283|66725975|FG001|Overall Study|Insurance Refusal|1|||
23820947|NCT00101283|66725974|FG000|Overall Study|Prostate Cancer Recurrence|0|||
23820948|NCT00101283|66725975|FG001|Overall Study|Prostate Cancer Recurrence|1|||
23820949|NCT02108912|66725976|FG000|Overall Study|Lost to Follow-up|1|||
23820950|NCT02108912|66725977|FG001|Overall Study|Lost to Follow-up|1|||
23820951|NCT02108912|66725976|FG000|Overall Study|lack of transportation|1|||
23820952|NCT02108912|66725977|FG001|Overall Study|lack of transportation|0|||
23820953|NCT02108912|66725976|FG000|Overall Study|high blood pressure|1|||
23820954|NCT02108912|66725977|FG001|Overall Study|high blood pressure|0|||
23820955|NCT05022212|66725978|FG000|Overall Study|Lost to Follow-up|0|||
23820956|NCT05022212|66725979|FG001|Overall Study|Lost to Follow-up|2|||
23820957|NCT00996892|66725986|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
23820958|NCT00996892|66725987|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
23740360|NCT00421928|66429277|FG000|Overall Study|Study drug non-compliant|6|||
23740361|NCT00421928|66429278|FG001|Overall Study|Study drug non-compliant|7|||
23740362|NCT00421928|66429279|FG002|Overall Study|Study drug non-compliant|4|||
23740363|NCT00421928|66429277|FG000|Overall Study|All other|26|||
23740364|NCT00421928|66429278|FG001|Overall Study|All other|21|||
23740365|NCT00421928|66429279|FG002|Overall Study|All other|27|||
23740366|NCT00421928|66429277|FG000|Overall Study|Death|0|||
23740367|NCT00421928|66429278|FG001|Overall Study|Death|1|||
23740368|NCT00421928|66429279|FG002|Overall Study|Death|0|||
23740369|NCT02911285|66429284|FG000|Overall Study|Lost to Follow-up|8|||
23740370|NCT02911285|66429285|FG001|Overall Study|Lost to Follow-up|5|||
23740371|NCT02911285|66429284|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
23740372|NCT02911285|66429285|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
23740373|NCT02079077|66429286|FG000|Overall Study|Lost to Follow-up|5|||
23740374|NCT02079077|66429287|FG001|Overall Study|Lost to Follow-up|7|||
23740375|NCT02079077|66429286|FG000|Overall Study|Became STIs Positive|1|||
23740376|NCT02079077|66429287|FG001|Overall Study|Became STIs Positive|2|||
23740377|NCT02708524|66429289|FG000|Overall Study|Adverse Event|0|||
23740378|NCT02708524|66429290|FG001|Overall Study|Adverse Event|1|||
23740379|NCT02708524|66429291|FG002|Overall Study|Adverse Event|0|||
23740380|NCT02708524|66429292|FG003|Overall Study|Adverse Event|0|||
23740381|NCT02708524|66429289|FG000|Overall Study|Lens Discomfort|1|||
23740382|NCT02708524|66429290|FG001|Overall Study|Lens Discomfort|0|||
23740383|NCT02708524|66429291|FG002|Overall Study|Lens Discomfort|1|||
23740384|NCT02708524|66429292|FG003|Overall Study|Lens Discomfort|0|||
23740385|NCT02708524|66429289|FG000|Overall Study|Lost to Follow-up|1|||
23740386|NCT02708524|66429290|FG001|Overall Study|Lost to Follow-up|1|||
23740387|NCT02708524|66429291|FG002|Overall Study|Lost to Follow-up|1|||
23740388|NCT02708524|66429292|FG003|Overall Study|Lost to Follow-up|0|||
23740389|NCT02708524|66429289|FG000|Overall Study|Protocol Violation|0|||
23740390|NCT02708524|66429290|FG001|Overall Study|Protocol Violation|1|||
23740391|NCT02708524|66429291|FG002|Overall Study|Protocol Violation|0|||
23740392|NCT02708524|66429292|FG003|Overall Study|Protocol Violation|0|||
23740393|NCT02708524|66429289|FG000|Overall Study|Withdrawal by Subject|1|||
23740394|NCT02708524|66429290|FG001|Overall Study|Withdrawal by Subject|1|||
23740395|NCT02708524|66429291|FG002|Overall Study|Withdrawal by Subject|0|||
23740396|NCT02708524|66429292|FG003|Overall Study|Withdrawal by Subject|0|||
23740397|NCT02708524|66429289|FG000|Overall Study|Dispensed incorrect study lens|0|||
23740398|NCT02708524|66429290|FG001|Overall Study|Dispensed incorrect study lens|1|||
23740399|NCT02708524|66429291|FG002|Overall Study|Dispensed incorrect study lens|1|||
23740400|NCT02708524|66429292|FG003|Overall Study|Dispensed incorrect study lens|0|||
23740401|NCT02708524|66429289|FG000|Overall Study|Did not wear lens at final visit|0|||
23740402|NCT02708524|66429290|FG001|Overall Study|Did not wear lens at final visit|1|||
23740403|NCT02708524|66429291|FG002|Overall Study|Did not wear lens at final visit|0|||
23740404|NCT02708524|66429292|FG003|Overall Study|Did not wear lens at final visit|0|||
23740405|NCT02708524|66429289|FG000|Overall Study|Subject lost study lens|1|||
23740406|NCT02708524|66429290|FG001|Overall Study|Subject lost study lens|0|||
23740407|NCT02708524|66429291|FG002|Overall Study|Subject lost study lens|0|||
23740408|NCT02708524|66429292|FG003|Overall Study|Subject lost study lens|0|||
23740409|NCT03417999|66429293|FG000|Overall Study|Withdrawal by Subject|1|||
23740410|NCT03417999|66429294|FG001|Overall Study|Withdrawal by Subject|0|||
23740411|NCT03417999|66429295|FG002|Overall Study|Withdrawal by Subject|0|||
23740412|NCT03417999|66429293|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
23740413|NCT03417999|66429294|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
23740414|NCT03417999|66429295|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
23740415|NCT03417999|66429293|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
23820959|NCT00996892|66725988|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
23740416|NCT03417999|66429294|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
23740417|NCT03417999|66429295|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
23820960|NCT00996892|66725989|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
23820961|NCT00996892|66725990|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
23820962|NCT00996892|66725991|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
23619925|NCT03449134|65994794|FG001|52-Week Treatment Period|Death|1|||
23740418|NCT03417999|66429293|FG000|Overall Study|Inadequate study staff available to process samples|0|||
23740419|NCT03417999|66429294|FG001|Overall Study|Inadequate study staff available to process samples|0|||
23740420|NCT03417999|66429295|FG002|Overall Study|Inadequate study staff available to process samples|1|||
23740421|NCT02146352|66429296|FG000|Overall Study|Death|1|||
23740422|NCT02146352|66429296|FG000|Overall Study|Patient entered hospice care|1|||
23740423|NCT00553319|66429297|FG000|Overall Study|Lost to Follow-up|10|||
23619926|NCT03449134|65994795|FG002|52-Week Treatment Period|Death|0|||
23619927|NCT03449134|65994793|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
23619928|NCT03449134|65994794|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
23619929|NCT03449134|65994795|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
23619930|NCT03449134|65994793|FG000|52-Week Treatment Period|Physician Decision|2|||
23619931|NCT03449134|65994794|FG001|52-Week Treatment Period|Physician Decision|3|||
23428319|NCT02726880|65310781|FG001|Overall Study|Withdrawal by Subject|0|||
23428320|NCT02726880|65310780|FG000|Overall Study|Lost to Follow-up|1|||
23548718|NCT01217073|65739643|FG007|Base Period|Excluded medication|0|||
23548719|NCT01217073|65739636|FG000|Base Period|Lack of Efficacy|0|||
23548720|NCT01217073|65739637|FG001|Base Period|Lack of Efficacy|0|||
23548721|NCT01217073|65739638|FG002|Base Period|Lack of Efficacy|0|||
23548722|NCT01217073|65739639|FG003|Base Period|Lack of Efficacy|0|||
23740424|NCT00553319|66429298|FG001|Overall Study|Lost to Follow-up|9|||
23740425|NCT00553319|66429299|FG002|Overall Study|Lost to Follow-up|5|||
23428321|NCT02726880|65310781|FG001|Overall Study|Lost to Follow-up|3|||
23548723|NCT01217073|65739640|FG004|Base Period|Lack of Efficacy|0|||
23820963|NCT00996892|66725992|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
23820964|NCT00996892|66725993|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
23820965|NCT00996892|66725994|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
23820966|NCT00996892|66725995|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
23820967|NCT00996892|66725996|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
23820968|NCT00996892|66725997|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
23820969|NCT00996892|66725998|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
23820970|NCT00996892|66725999|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
23820971|NCT00996892|66726000|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
23820972|NCT00996892|66726001|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
23820973|NCT00996892|66726002|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
23820974|NCT00996892|66726003|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
23820975|NCT00996892|66726004|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
23820976|NCT00996892|66726005|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
23820977|NCT00996892|66725986|FG000|Dose-Escalation Stage 1|Death|1|||
23820978|NCT00996892|66725987|FG001|Dose-Escalation Stage 1|Death|0|||
23820979|NCT00996892|66725988|FG002|Dose-Escalation Stage 1|Death|0|||
23820980|NCT00996892|66725989|FG003|Dose-Escalation Stage 1|Death|0|||
23820981|NCT00996892|66725990|FG004|Dose-Escalation Stage 1|Death|0|||
23820982|NCT00996892|66725991|FG005|Dose-Escalation Stage 1|Death|1|||
23820983|NCT00996892|66725992|FG006|Dose-Escalation Stage 1|Death|0|||
23820984|NCT00996892|66725993|FG007|Dose-Escalation Stage 1|Death|0|||
23820985|NCT00996892|66725994|FG008|Dose-Escalation Stage 1|Death|0|||
23820986|NCT00996892|66725995|FG009|Dose-Escalation Stage 1|Death|0|||
23820987|NCT00996892|66725996|FG010|Dose-Escalation Stage 1|Death|0|||
23820988|NCT00996892|66725997|FG011|Dose-Escalation Stage 1|Death|0|||
23820989|NCT00996892|66725998|FG012|Dose-Escalation Stage 1|Death|0|||
23820990|NCT00996892|66725999|FG013|Dose-Escalation Stage 1|Death|0|||
23820991|NCT00996892|66726000|FG014|Dose-Escalation Stage 1|Death|0|||
23820992|NCT00996892|66726001|FG015|Dose-Escalation Stage 1|Death|0|||
23820993|NCT00996892|66726002|FG016|Dose-Escalation Stage 1|Death|0|||
23548724|NCT01217073|65739641|FG005|Base Period|Lack of Efficacy|1|||
23820994|NCT00996892|66726003|FG017|Dose-Escalation Stage 1|Death|0|||
23548725|NCT01217073|65739642|FG006|Base Period|Lack of Efficacy|0|||
23548726|NCT01217073|65739643|FG007|Base Period|Lack of Efficacy|0|||
23548727|NCT01217073|65739636|FG000|Base Period|Lost to Follow-up|0|||
23548728|NCT01217073|65739637|FG001|Base Period|Lost to Follow-up|0|||
23619932|NCT03449134|65994795|FG002|52-Week Treatment Period|Physician Decision|3|||
23820995|NCT00996892|66726004|FG018|Dose-Escalation Stage 1|Death|0|||
23820996|NCT00996892|66726005|FG019|Dose-Escalation Stage 1|Death|0|||
23820997|NCT00996892|66725986|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
23820998|NCT00996892|66725987|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
23619933|NCT03449134|65994793|FG000|52-Week Treatment Period|Screen Failure|1|||
23548729|NCT01217073|65739638|FG002|Base Period|Lost to Follow-up|1|||
23820999|NCT00996892|66725988|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
23428322|NCT02410824|65310782|FG000|First Intervention (One Week)|Headache|0|||
23548730|NCT01217073|65739639|FG003|Base Period|Lost to Follow-up|1|||
23619934|NCT03449134|65994794|FG001|52-Week Treatment Period|Screen Failure|0|||
23740426|NCT00553319|66429297|FG000|Overall Study|wanted treatment elsewhere|2|||
23821000|NCT00996892|66725989|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
23821001|NCT00996892|66725990|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
23740427|NCT00553319|66429298|FG001|Overall Study|wanted treatment elsewhere|1|||
23740428|NCT00553319|66429299|FG002|Overall Study|wanted treatment elsewhere|1|||
23740429|NCT00553319|66429297|FG000|Overall Study|non-compliance|0|||
23740430|NCT00553319|66429298|FG001|Overall Study|non-compliance|0|||
23740431|NCT00553319|66429299|FG002|Overall Study|non-compliance|2|||
23740432|NCT00553319|66429297|FG000|Overall Study|incarceration|1|||
23740433|NCT00553319|66429298|FG001|Overall Study|incarceration|0|||
23740434|NCT00553319|66429299|FG002|Overall Study|incarceration|0|||
23740435|NCT00553319|66429297|FG000|Overall Study|moved|1|||
23740436|NCT00553319|66429298|FG001|Overall Study|moved|0|||
23740437|NCT00553319|66429299|FG002|Overall Study|moved|1|||
23740438|NCT03798366|66429300|FG000|Overall Study|Lost to Follow-up|0|||
23740439|NCT03798366|66429301|FG001|Overall Study|Lost to Follow-up|1|||
23740440|NCT00348686|66429302|FG000|Overall Study|Withdrawal by Subject|45|||
23740441|NCT00348686|66429302|FG000|Overall Study|Adverse Event|5|||
23740442|NCT00348686|66429302|FG000|Overall Study|Protocol Violation|6|||
23740443|NCT00348686|66429302|FG000|Overall Study|Lost to Follow-up|2|||
23740444|NCT00348686|66429302|FG000|Overall Study|Multiple Reasons|8|||
23740445|NCT03480360|66429303|FG000|Overall Study|Death|2|||
23740446|NCT01475214|66429305|FG000|Overall Study|Lost to Follow-up|1|||
23740447|NCT01475214|66429306|FG001|Overall Study|Lost to Follow-up|0|||
23740448|NCT01475214|66429307|FG002|Overall Study|Lost to Follow-up|1|||
23740449|NCT01475214|66429305|FG000|Overall Study|Physician Decision|2|||
23740450|NCT01475214|66429306|FG001|Overall Study|Physician Decision|0|||
23740451|NCT01475214|66429307|FG002|Overall Study|Physician Decision|0|||
23740452|NCT01475214|66429305|FG000|Overall Study|Withdrawal by Subject|2|||
23740453|NCT01475214|66429306|FG001|Overall Study|Withdrawal by Subject|4|||
23740454|NCT01475214|66429307|FG002|Overall Study|Withdrawal by Subject|1|||
23740455|NCT00565721|66429322|FG000|Overall Study|Screen Failure|2|||
23740456|NCT00565721|66429322|FG000|Overall Study|Lost to Follow-up|6|||
23740457|NCT00565721|66429322|FG000|Overall Study|Technical Problems|1|||
23740458|NCT00565721|66429322|FG000|Overall Study|Physician Decision|2|||
23740459|NCT00565721|66429322|FG000|Overall Study|Other reasons|6|||
23740460|NCT01070381|66429323|FG000|Period 2, 1 Week of Wear|Handling|0|||
23740461|NCT01070381|66429324|FG001|Period 2, 1 Week of Wear|Handling|1|||
23740462|NCT01070381|66429323|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
23740463|NCT01070381|66429324|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
23740464|NCT02452034|66429325|FG000|Overall Study|Adverse Event|0|||
23821002|NCT00996892|66725991|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
23548731|NCT01217073|65739640|FG004|Base Period|Lost to Follow-up|3|||
23548732|NCT01217073|65739641|FG005|Base Period|Lost to Follow-up|0|||
23548733|NCT01217073|65739642|FG006|Base Period|Lost to Follow-up|0|||
23548734|NCT01217073|65739643|FG007|Base Period|Lost to Follow-up|0|||
23548735|NCT01217073|65739636|FG000|Base Period|Physician Decision|0|||
23548736|NCT01217073|65739637|FG001|Base Period|Physician Decision|0|||
23548737|NCT01217073|65739638|FG002|Base Period|Physician Decision|0|||
23548738|NCT01217073|65739639|FG003|Base Period|Physician Decision|0|||
23548739|NCT01217073|65739640|FG004|Base Period|Physician Decision|1|||
23548740|NCT01217073|65739641|FG005|Base Period|Physician Decision|0|||
23548741|NCT01217073|65739642|FG006|Base Period|Physician Decision|0|||
23548742|NCT01217073|65739643|FG007|Base Period|Physician Decision|0|||
23548743|NCT01217073|65739636|FG000|Base Period|Protocol Violation|1|||
23548744|NCT01217073|65739637|FG001|Base Period|Protocol Violation|0|||
23548745|NCT01217073|65739638|FG002|Base Period|Protocol Violation|0|||
23548746|NCT01217073|65739639|FG003|Base Period|Protocol Violation|0|||
23548747|NCT01217073|65739640|FG004|Base Period|Protocol Violation|1|||
23548748|NCT01217073|65739641|FG005|Base Period|Protocol Violation|2|||
23548749|NCT01217073|65739642|FG006|Base Period|Protocol Violation|0|||
23548750|NCT01217073|65739643|FG007|Base Period|Protocol Violation|0|||
23548751|NCT01217073|65739636|FG000|Base Period|Withdrawal by Subject|4|||
23548752|NCT01217073|65739637|FG001|Base Period|Withdrawal by Subject|5|||
23548753|NCT01217073|65739638|FG002|Base Period|Withdrawal by Subject|5|||
23548754|NCT01217073|65739639|FG003|Base Period|Withdrawal by Subject|1|||
23548755|NCT01217073|65739640|FG004|Base Period|Withdrawal by Subject|5|||
23548756|NCT01217073|65739641|FG005|Base Period|Withdrawal by Subject|5|||
23548757|NCT01217073|65739642|FG006|Base Period|Withdrawal by Subject|0|||
23548758|NCT01217073|65739643|FG007|Base Period|Withdrawal by Subject|0|||
23548759|NCT01217073|65739636|FG000|Extension Period|Adverse Event|0|||
23548760|NCT01217073|65739637|FG001|Extension Period|Adverse Event|0|||
23548761|NCT01217073|65739638|FG002|Extension Period|Adverse Event|0|||
23548762|NCT01217073|65739639|FG003|Extension Period|Adverse Event|0|||
23548763|NCT01217073|65739640|FG004|Extension Period|Adverse Event|0|||
23548764|NCT01217073|65739641|FG005|Extension Period|Adverse Event|0|||
23548765|NCT01217073|65739642|FG006|Extension Period|Adverse Event|19|||
23548766|NCT01217073|65739643|FG007|Extension Period|Adverse Event|5|||
23548767|NCT01217073|65739636|FG000|Extension Period|ALT/AST|0|||
23740465|NCT02452034|66429326|FG001|Overall Study|Adverse Event|0|||
23740466|NCT02452034|66429327|FG002|Overall Study|Adverse Event|0|||
23740467|NCT02452034|66429328|FG003|Overall Study|Adverse Event|0|||
23740468|NCT02452034|66429329|FG004|Overall Study|Adverse Event|0|||
23619935|NCT03449134|65994795|FG002|52-Week Treatment Period|Screen Failure|1|||
23619936|NCT03449134|65994793|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
23619937|NCT03449134|65994794|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
23740469|NCT02452034|66429330|FG005|Overall Study|Adverse Event|1|||
23740470|NCT02452034|66429325|FG000|Overall Study|Death|0|||
23740471|NCT02452034|66429326|FG001|Overall Study|Death|0|||
23548768|NCT01217073|65739637|FG001|Extension Period|ALT/AST|0|||
23548769|NCT01217073|65739638|FG002|Extension Period|ALT/AST|0|||
23548770|NCT01217073|65739639|FG003|Extension Period|ALT/AST|0|||
23548771|NCT01217073|65739640|FG004|Extension Period|ALT/AST|0|||
23548772|NCT01217073|65739641|FG005|Extension Period|ALT/AST|0|||
23548773|NCT01217073|65739642|FG006|Extension Period|ALT/AST|2|||
23548774|NCT01217073|65739643|FG007|Extension Period|ALT/AST|0|||
23548775|NCT01217073|65739636|FG000|Extension Period|Contraindication to study medication|0|||
23548776|NCT01217073|65739637|FG001|Extension Period|Contraindication to study medication|0|||
23548777|NCT01217073|65739638|FG002|Extension Period|Contraindication to study medication|0|||
23548778|NCT01217073|65739639|FG003|Extension Period|Contraindication to study medication|0|||
23548779|NCT01217073|65739640|FG004|Extension Period|Contraindication to study medication|0|||
23548780|NCT01217073|65739641|FG005|Extension Period|Contraindication to study medication|0|||
23740472|NCT02452034|66429327|FG002|Overall Study|Death|0|||
23740473|NCT02452034|66429328|FG003|Overall Study|Death|0|||
23740474|NCT02452034|66429329|FG004|Overall Study|Death|1|||
23740475|NCT02452034|66429330|FG005|Overall Study|Death|1|||
23740476|NCT02452034|66429325|FG000|Overall Study|Physician Decision|0|||
23740477|NCT02452034|66429326|FG001|Overall Study|Physician Decision|1|||
23740478|NCT02452034|66429327|FG002|Overall Study|Physician Decision|1|||
23740479|NCT02452034|66429328|FG003|Overall Study|Physician Decision|0|||
23740480|NCT02452034|66429329|FG004|Overall Study|Physician Decision|0|||
23740481|NCT02452034|66429330|FG005|Overall Study|Physician Decision|0|||
23740482|NCT02452034|66429325|FG000|Overall Study|Protocol Violation|0|||
23740483|NCT02452034|66429326|FG001|Overall Study|Protocol Violation|0|||
23548781|NCT01217073|65739642|FG006|Extension Period|Contraindication to study medication|1|||
23548782|NCT01217073|65739643|FG007|Extension Period|Contraindication to study medication|0|||
23548783|NCT01217073|65739636|FG000|Extension Period|Creatinine/eGFR|0|||
23548784|NCT01217073|65739637|FG001|Extension Period|Creatinine/eGFR|0|||
23548785|NCT01217073|65739638|FG002|Extension Period|Creatinine/eGFR|0|||
23548786|NCT01217073|65739639|FG003|Extension Period|Creatinine/eGFR|0|||
23548787|NCT01217073|65739640|FG004|Extension Period|Creatinine/eGFR|0|||
23548788|NCT01217073|65739641|FG005|Extension Period|Creatinine/eGFR|0|||
23548789|NCT01217073|65739642|FG006|Extension Period|Creatinine/eGFR|11|||
23548790|NCT01217073|65739643|FG007|Extension Period|Creatinine/eGFR|1|||
23548791|NCT01217073|65739636|FG000|Extension Period|Death|0|||
23548792|NCT01217073|65739637|FG001|Extension Period|Death|0|||
23548793|NCT01217073|65739638|FG002|Extension Period|Death|0|||
23548794|NCT01217073|65739639|FG003|Extension Period|Death|0|||
23548795|NCT01217073|65739640|FG004|Extension Period|Death|0|||
23548796|NCT01217073|65739641|FG005|Extension Period|Death|0|||
23548797|NCT01217073|65739642|FG006|Extension Period|Death|1|||
23548798|NCT01217073|65739643|FG007|Extension Period|Death|0|||
23548799|NCT01217073|65739636|FG000|Extension Period|Excluded medication|0|||
23548800|NCT01217073|65739637|FG001|Extension Period|Excluded medication|0|||
23548801|NCT01217073|65739638|FG002|Extension Period|Excluded medication|0|||
23548802|NCT01217073|65739639|FG003|Extension Period|Excluded medication|0|||
23548803|NCT01217073|65739640|FG004|Extension Period|Excluded medication|0|||
23548804|NCT01217073|65739641|FG005|Extension Period|Excluded medication|0|||
23548805|NCT01217073|65739642|FG006|Extension Period|Excluded medication|2|||
23740484|NCT02452034|66429327|FG002|Overall Study|Protocol Violation|0|||
23740485|NCT02452034|66429328|FG003|Overall Study|Protocol Violation|0|||
23740486|NCT02452034|66429329|FG004|Overall Study|Protocol Violation|0|||
23740487|NCT02452034|66429330|FG005|Overall Study|Protocol Violation|1|||
23740488|NCT02452034|66429325|FG000|Overall Study|Screen Failure|1|||
23740489|NCT02452034|66429326|FG001|Overall Study|Screen Failure|0|||
23740490|NCT02452034|66429327|FG002|Overall Study|Screen Failure|0|||
23740491|NCT02452034|66429328|FG003|Overall Study|Screen Failure|1|||
23740492|NCT02452034|66429329|FG004|Overall Study|Screen Failure|0|||
23740493|NCT02452034|66429330|FG005|Overall Study|Screen Failure|0|||
23740494|NCT02452034|66429325|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23740495|NCT02452034|66429326|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
23740496|NCT02452034|66429327|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23740497|NCT02452034|66429328|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
23740498|NCT02452034|66429329|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
23740499|NCT02452034|66429330|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
23740500|NCT05604781|66429335|FG000|Overall Study|Lost to Follow-up|3|||
23740501|NCT05604781|66429335|FG000|Overall Study|Adverse Event|1|||
23548806|NCT01217073|65739643|FG007|Extension Period|Excluded medication|0|||
23548807|NCT01217073|65739636|FG000|Extension Period|Lack of Efficacy|0|||
23740502|NCT04863898|66429336|FG000|Overall Study|Away from study clinic during intervention training period|2|||
23740503|NCT04863898|66429336|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
23548808|NCT01217073|65739637|FG001|Extension Period|Lack of Efficacy|0|||
23548809|NCT01217073|65739638|FG002|Extension Period|Lack of Efficacy|0|||
23548810|NCT01217073|65739639|FG003|Extension Period|Lack of Efficacy|0|||
23548811|NCT01217073|65739640|FG004|Extension Period|Lack of Efficacy|0|||
23548812|NCT01217073|65739641|FG005|Extension Period|Lack of Efficacy|0|||
23548813|NCT01217073|65739642|FG006|Extension Period|Lack of Efficacy|3|||
23548814|NCT01217073|65739643|FG007|Extension Period|Lack of Efficacy|0|||
23740504|NCT04863898|66429336|FG000|Overall Study|Lost to Follow-up|3|||
23740505|NCT04863898|66429336|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
23740506|NCT04863898|66429336|FG000|Overall Study|No longer employed at clinic|3|||
23740507|NCT03287089|66429337|FG000|Overall Study|Lost to Follow-up|0|||
23740508|NCT03287089|66429338|FG001|Overall Study|Lost to Follow-up|2|||
23740509|NCT03287089|66429337|FG000|Overall Study|Physician Decision|0|||
23740510|NCT03287089|66429338|FG001|Overall Study|Physician Decision|2|||
23740511|NCT03287089|66429337|FG000|Overall Study|Withdrawal by Subject|0|||
23740512|NCT03287089|66429338|FG001|Overall Study|Withdrawal by Subject|2|||
23740513|NCT04298229|66429339|FG000|Overall Study|Physician Decision|1|||
23740514|NCT04298229|66429340|FG001|Overall Study|Physician Decision|1|||
23740515|NCT04298229|66429339|FG000|Overall Study|Withdrawal by Subject|1|||
23740516|NCT04298229|66429340|FG001|Overall Study|Withdrawal by Subject|1|||
23740517|NCT04298229|66429339|FG000|Overall Study|Did not receive IV loop diuretics|2|||
23740518|NCT04298229|66429340|FG001|Overall Study|Did not receive IV loop diuretics|0|||
23740519|NCT00103207|66429343|FG000|Overall Study|Adverse Event|3|||
23740520|NCT00103207|66429343|FG000|Overall Study|Death|1|||
23740521|NCT00103207|66429343|FG000|Overall Study|Withdrawal by Subject|2|||
23740522|NCT00103207|66429343|FG000|Overall Study|Other complicating disease|1|||
23740523|NCT00103207|66429343|FG000|Overall Study|Ineligible|4|||
23740524|NCT00103207|66429343|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
23740525|NCT00689299|66429345|FG000|Overall Study|Adverse Event|2|||
23740526|NCT00689299|66429346|FG001|Overall Study|Adverse Event|1|||
23740527|NCT00689299|66429347|FG002|Overall Study|Adverse Event|1|||
23740528|NCT00689299|66429345|FG000|Overall Study|Lost to Follow-up|0|||
23740529|NCT00689299|66429346|FG001|Overall Study|Lost to Follow-up|1|||
23740530|NCT00689299|66429347|FG002|Overall Study|Lost to Follow-up|1|||
23740531|NCT00689299|66429345|FG000|Overall Study|Withdrawal by Subject|4|||
23740532|NCT00689299|66429346|FG001|Overall Study|Withdrawal by Subject|1|||
23740533|NCT00689299|66429347|FG002|Overall Study|Withdrawal by Subject|3|||
23740534|NCT00689299|66429345|FG000|Overall Study|Protocol Violation|1|||
23740535|NCT00689299|66429346|FG001|Overall Study|Protocol Violation|0|||
23740536|NCT00689299|66429347|FG002|Overall Study|Protocol Violation|0|||
23740537|NCT01004159|66429348|FG000|Overall Study|Adverse Event|2|||
23740538|NCT01004159|66429348|FG000|Overall Study|Disease Progression|18|||
23740539|NCT00768040|66429349|FG000|Overall Study|Adverse Event|3|||
23740540|NCT00768040|66429350|FG001|Overall Study|Adverse Event|2|||
23740541|NCT00768040|66429349|FG000|Overall Study|Abnormal laboratory value|1|||
23740542|NCT00768040|66429350|FG001|Overall Study|Abnormal laboratory value|1|||
23740543|NCT02711306|66429353|FG000|Overall Study|Withdrawal by Subject|2|||
23740544|NCT02711306|66429354|FG001|Overall Study|Withdrawal by Subject|2|||
23821003|NCT00996892|66725992|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
23548815|NCT01217073|65739636|FG000|Extension Period|Lost to Follow-up|0|||
23740545|NCT00972309|66429365|FG000|Overall Study|Switched to alternative treatment|0|||
23740546|NCT00972309|66429366|FG001|Overall Study|Switched to alternative treatment|2|||
23740547|NCT00972309|66429365|FG000|Overall Study|Refused further treatment|0|||
23740548|NCT00972309|66429366|FG001|Overall Study|Refused further treatment|1|||
23740549|NCT00972309|66429365|FG000|Overall Study|Late determination of ineligibility|0|||
23740550|NCT00972309|66429366|FG001|Overall Study|Late determination of ineligibility|1|||
23740551|NCT00972309|66429365|FG000|Overall Study|Second malignancy|1|||
23740552|NCT00972309|66429366|FG001|Overall Study|Second malignancy|1|||
23740553|NCT00972309|66429365|FG000|Overall Study|Visa issues|0|||
23548816|NCT01217073|65739637|FG001|Extension Period|Lost to Follow-up|0|||
23740554|NCT00972309|66429366|FG001|Overall Study|Visa issues|1|||
23740555|NCT00972309|66429365|FG000|Overall Study|Secondary cancer (SCC)|0|||
23740556|NCT00972309|66429366|FG001|Overall Study|Secondary cancer (SCC)|1|||
23548817|NCT01217073|65739638|FG002|Extension Period|Lost to Follow-up|0|||
23548818|NCT01217073|65739639|FG003|Extension Period|Lost to Follow-up|0|||
23548819|NCT01217073|65739640|FG004|Extension Period|Lost to Follow-up|0|||
23740557|NCT00972309|66429365|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
23740558|NCT00972309|66429366|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
23740559|NCT00972309|66429365|FG000|Overall Study|Lost to Follow-up|1|||
23740560|NCT00972309|66429366|FG001|Overall Study|Lost to Follow-up|1|||
23740561|NCT00972309|66429365|FG000|Overall Study|Disease progression on study|10|||
23740562|NCT00972309|66429366|FG001|Overall Study|Disease progression on study|4|||
23740563|NCT01977573|66429367|FG000|Overall Study|Adverse Event|7|||
23548820|NCT01217073|65739641|FG005|Extension Period|Lost to Follow-up|0|||
23740564|NCT01977573|66429368|FG001|Overall Study|Adverse Event|0|||
23740565|NCT01977573|66429369|FG002|Overall Study|Adverse Event|2|||
23740566|NCT01977573|66429370|FG003|Overall Study|Adverse Event|1|||
23740567|NCT01977573|66429367|FG000|Overall Study|Lost to Follow-up|1|||
23740568|NCT01977573|66429368|FG001|Overall Study|Lost to Follow-up|0|||
23740569|NCT01977573|66429369|FG002|Overall Study|Lost to Follow-up|0|||
23740570|NCT01977573|66429370|FG003|Overall Study|Lost to Follow-up|1|||
23740571|NCT01977573|66429367|FG000|Overall Study|Physician Decision|1|||
23740572|NCT01977573|66429368|FG001|Overall Study|Physician Decision|0|||
23740573|NCT01977573|66429369|FG002|Overall Study|Physician Decision|0|||
23740574|NCT01977573|66429370|FG003|Overall Study|Physician Decision|0|||
23740575|NCT01977573|66429367|FG000|Overall Study|Protocol Violation|3|||
23740576|NCT01977573|66429368|FG001|Overall Study|Protocol Violation|1|||
23740577|NCT01977573|66429369|FG002|Overall Study|Protocol Violation|0|||
23740578|NCT01977573|66429370|FG003|Overall Study|Protocol Violation|0|||
23740579|NCT01977573|66429367|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
23740580|NCT01977573|66429368|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
23740581|NCT01977573|66429369|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
23740582|NCT01977573|66429370|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
23740583|NCT01977573|66429367|FG000|Overall Study|Withdrawal by Subject|6|||
23740584|NCT01977573|66429368|FG001|Overall Study|Withdrawal by Subject|1|||
23740585|NCT01977573|66429369|FG002|Overall Study|Withdrawal by Subject|1|||
23740586|NCT01977573|66429370|FG003|Overall Study|Withdrawal by Subject|1|||
23740587|NCT00489216|66429371|FG000|Overall Study|Adverse Event|1|||
23740588|NCT02972658|66429372|FG000|Overall Study|Adverse Event|0|||
23740589|NCT02972658|66429373|FG001|Overall Study|Adverse Event|3|||
23740590|NCT02972658|66429374|FG002|Overall Study|Adverse Event|0|||
23740591|NCT02972658|66429375|FG003|Overall Study|Adverse Event|2|||
23740592|NCT02972658|66429372|FG000|Overall Study|Other-determined by Investigator|1|||
23740593|NCT02972658|66429373|FG001|Overall Study|Other-determined by Investigator|1|||
23740594|NCT02972658|66429374|FG002|Overall Study|Other-determined by Investigator|0|||
23740595|NCT02972658|66429375|FG003|Overall Study|Other-determined by Investigator|0|||
23740596|NCT02972658|66429372|FG000|Overall Study|Death|0|||
23740597|NCT02972658|66429373|FG001|Overall Study|Death|0|||
23740598|NCT02972658|66429374|FG002|Overall Study|Death|0|||
23740599|NCT02972658|66429375|FG003|Overall Study|Death|1|||
23740600|NCT02972658|66429372|FG000|Overall Study|Lost to Follow-up|0|||
23740601|NCT02972658|66429373|FG001|Overall Study|Lost to Follow-up|1|||
23740602|NCT02972658|66429374|FG002|Overall Study|Lost to Follow-up|1|||
23740603|NCT02972658|66429375|FG003|Overall Study|Lost to Follow-up|2|||
23740604|NCT02972658|66429372|FG000|Overall Study|Progressive Disease|0|||
23740605|NCT02972658|66429373|FG001|Overall Study|Progressive Disease|1|||
23740606|NCT02972658|66429374|FG002|Overall Study|Progressive Disease|0|||
23740607|NCT02972658|66429375|FG003|Overall Study|Progressive Disease|1|||
23740608|NCT02972658|66429372|FG000|Overall Study|Withdrawal by Subject|4|||
23740609|NCT02972658|66429373|FG001|Overall Study|Withdrawal by Subject|4|||
23740610|NCT02972658|66429374|FG002|Overall Study|Withdrawal by Subject|1|||
23740611|NCT02972658|66429375|FG003|Overall Study|Withdrawal by Subject|6|||
23740612|NCT02972658|66429372|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23740613|NCT02972658|66429373|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23740614|NCT02972658|66429374|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23740615|NCT02972658|66429375|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
23740616|NCT02972658|66429372|FG000|Overall Study|Sponsor Decision|70|||
23740617|NCT02972658|66429373|FG001|Overall Study|Sponsor Decision|127|||
23740618|NCT02972658|66429374|FG002|Overall Study|Sponsor Decision|72|||
23740619|NCT02972658|66429375|FG003|Overall Study|Sponsor Decision|119|||
23740620|NCT03982069|66429376|FG000|Overall Study|Lost to Follow-up|5|||
23740621|NCT03982069|66429377|FG001|Overall Study|Lost to Follow-up|5|||
23740622|NCT03982069|66429378|FG002|Overall Study|Lost to Follow-up|3|||
23428323|NCT02410824|65310783|FG001|First Intervention (One Week)|Headache|1|||
23740623|NCT03982069|66429379|FG003|Overall Study|Lost to Follow-up|5|||
23740624|NCT03982069|66429376|FG000|Overall Study|Physician Decision|0|||
23740625|NCT03982069|66429377|FG001|Overall Study|Physician Decision|1|||
23740626|NCT03982069|66429378|FG002|Overall Study|Physician Decision|0|||
23740627|NCT03982069|66429379|FG003|Overall Study|Physician Decision|0|||
23740628|NCT03982069|66429376|FG000|Overall Study|Withdrawal by Subject|2|||
23740629|NCT03982069|66429377|FG001|Overall Study|Withdrawal by Subject|1|||
23740630|NCT03982069|66429378|FG002|Overall Study|Withdrawal by Subject|5|||
23428324|NCT00907296|65310788|FG000|Overall Study|Ineligibility Determined|1|||
23740631|NCT03982069|66429379|FG003|Overall Study|Withdrawal by Subject|2|||
23740632|NCT03982069|66429376|FG000|Overall Study|Specimen loss|3|||
23740633|NCT03982069|66429377|FG001|Overall Study|Specimen loss|3|||
23740634|NCT03982069|66429378|FG002|Overall Study|Specimen loss|1|||
23740635|NCT03982069|66429379|FG003|Overall Study|Specimen loss|1|||
23740636|NCT00911508|66429383|FG000|Overall Study|Lost to Follow-up|27|||
23740637|NCT00911508|66429384|FG001|Overall Study|Lost to Follow-up|18|||
23740638|NCT00911508|66429383|FG000|Overall Study|Withdrawal by Subject|79|||
23740639|NCT00911508|66429384|FG001|Overall Study|Withdrawal by Subject|112|||
23740640|NCT02198040|66429385|FG000|Overall Study|Work reasons|0|||
23428325|NCT00907296|65310789|FG001|Overall Study|Ineligibility Determined|0|||
23548821|NCT01217073|65739642|FG006|Extension Period|Lost to Follow-up|9|||
23548822|NCT01217073|65739643|FG007|Extension Period|Lost to Follow-up|1|||
23548823|NCT01217073|65739636|FG000|Extension Period|Non-compliance with study drug|0|||
23548824|NCT01217073|65739637|FG001|Extension Period|Non-compliance with study drug|0|||
23548825|NCT01217073|65739638|FG002|Extension Period|Non-compliance with study drug|0|||
23740641|NCT02198040|66429386|FG001|Overall Study|Work reasons|1|||
23740642|NCT02198040|66429387|FG002|Overall Study|Work reasons|0|||
23740643|NCT02198040|66429385|FG000|Overall Study|Withdrawal by Subject|0|||
23740644|NCT02198040|66429386|FG001|Overall Study|Withdrawal by Subject|0|||
23740645|NCT02198040|66429387|FG002|Overall Study|Withdrawal by Subject|1|||
23740646|NCT03417102|66429389|FG000|Overall Study|Adverse Event|0|||
23740647|NCT03417102|66429390|FG001|Overall Study|Adverse Event|1|||
23740648|NCT03417102|66429389|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
23740649|NCT03417102|66429390|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
23740650|NCT03417102|66429389|FG000|Overall Study|Other|0|||
23740651|NCT03417102|66429390|FG001|Overall Study|Other|1|||
23740652|NCT03487549|66429391|FG000|Overall Study|Protocol Violation|0|||
23740653|NCT03487549|66429392|FG001|Overall Study|Protocol Violation|1|||
23740654|NCT03487549|66429391|FG000|Overall Study|Lost to Follow-up|2|||
23740655|NCT03487549|66429392|FG001|Overall Study|Lost to Follow-up|1|||
23740656|NCT03487549|66429391|FG000|Overall Study|Withdrawal by Subject|2|||
23740657|NCT03487549|66429392|FG001|Overall Study|Withdrawal by Subject|0|||
23740658|NCT00665002|66429394|FG000|Overall Study|Progression/relapse during treatment|11|||
23740659|NCT00665002|66429394|FG000|Overall Study|Cytogenetic resistance|1|||
23740660|NCT01592773|66429395|FG000|Overall Study|Study Terminated by Sponsor|582|||
23740661|NCT01592773|66429395|FG000|Overall Study|Withdrawal by Subject|35|||
23740662|NCT01592773|66429395|FG000|Overall Study|Lost to Follow-up|19|||
23740663|NCT01592773|66429395|FG000|Overall Study|Adverse Event|17|||
23740664|NCT01592773|66429395|FG000|Overall Study|Lack of Efficacy|9|||
23740665|NCT01592773|66429395|FG000|Overall Study|Protocol Violation|2|||
23740666|NCT01592773|66429395|FG000|Overall Study|Inclusion/exclusion not meet|1|||
23740667|NCT01592773|66429395|FG000|Overall Study|Other Reason|1|||
23740668|NCT00608426|66429396|FG000|Overall Study|Death|32|||
23740669|NCT00608426|66429397|FG001|Overall Study|Death|36|||
23740670|NCT00608426|66429396|FG000|Overall Study|Lost to Follow-up|485|||
23740671|NCT00608426|66429397|FG001|Overall Study|Lost to Follow-up|521|||
23740672|NCT00608426|66429396|FG000|Overall Study|refused, health issues, wrong address|319|||
23740673|NCT00608426|66429397|FG001|Overall Study|refused, health issues, wrong address|348|||
23740674|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
23740675|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
23740676|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
23740677|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
23740678|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
23740679|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
23740680|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
23740681|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
23740682|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
23428326|NCT00907296|65310790|FG002|Overall Study|Ineligibility Determined|0|||
23428327|NCT00907296|65310791|FG003|Overall Study|Ineligibility Determined|1|||
23428328|NCT00907296|65310792|FG004|Overall Study|Ineligibility Determined|0|||
23428329|NCT00907296|65310793|FG005|Overall Study|Ineligibility Determined|0|||
23428330|NCT00907296|65310794|FG006|Overall Study|Ineligibility Determined|0|||
23428331|NCT00907296|65310795|FG007|Overall Study|Ineligibility Determined|1|||
23740683|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
23821004|NCT00996892|66725993|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
23821005|NCT00996892|66725994|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
23428332|NCT00907296|65310796|FG008|Overall Study|Ineligibility Determined|0|||
23428333|NCT00907296|65310797|FG009|Overall Study|Ineligibility Determined|0|||
23428334|NCT00907296|65310788|FG000|Overall Study|Protocol Deviation|0|||
23428335|NCT00907296|65310789|FG001|Overall Study|Protocol Deviation|1|||
23548826|NCT01217073|65739639|FG003|Extension Period|Non-compliance with study drug|0|||
23548827|NCT01217073|65739640|FG004|Extension Period|Non-compliance with study drug|0|||
23428336|NCT00907296|65310790|FG002|Overall Study|Protocol Deviation|0|||
23548828|NCT01217073|65739641|FG005|Extension Period|Non-compliance with study drug|0|||
23548829|NCT01217073|65739642|FG006|Extension Period|Non-compliance with study drug|0|||
23740684|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
23740685|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
23740686|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
23740687|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
23740688|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
23740689|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
23428337|NCT00907296|65310791|FG003|Overall Study|Protocol Deviation|0|||
23740690|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
23740691|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
23740692|NCT00570492|66429398|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
23740693|NCT00570492|66429399|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
23740694|NCT00570492|66429400|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
23740695|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23740696|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
23740697|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
23740698|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
23740699|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
23740700|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
23740701|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
23740702|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
23740703|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
23740704|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
23740705|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
23740706|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
23740707|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
23740708|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
23740709|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
23740710|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23740711|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
23740712|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23740713|NCT00570492|66429398|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
23740714|NCT00570492|66429399|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
23740715|NCT00570492|66429400|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
23740716|NCT02930889|66429401|FG000|Overall Study|Lost to Follow-up|2|||
23740717|NCT02930889|66429401|FG000|Overall Study|Withdrawal by Subject|6|||
23740718|NCT02930889|66429401|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
23740719|NCT03044730|66429402|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
23740720|NCT03044730|66429402|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
23740721|NCT03044730|66429402|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
23740722|NCT03044730|66429402|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
23740723|NCT03044730|66429402|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
23740724|NCT03044730|66429402|FG000|Cycles 4 and Beyond|Adverse Event|1|||
23740725|NCT03044730|66429402|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
23740726|NCT03044730|66429402|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
23740727|NCT03044730|66429402|FG000|On Follow-up for 2 Years|Death|17|||
23740728|NCT03922945|66429403|FG000|Overall Study|Adverse Event|1|||
23428338|NCT00907296|65310792|FG004|Overall Study|Protocol Deviation|0|||
23428339|NCT00907296|65310793|FG005|Overall Study|Protocol Deviation|0|||
23428340|NCT00907296|65310794|FG006|Overall Study|Protocol Deviation|0|||
23428341|NCT00907296|65310795|FG007|Overall Study|Protocol Deviation|0|||
23428342|NCT00907296|65310796|FG008|Overall Study|Protocol Deviation|0|||
23428343|NCT00907296|65310797|FG009|Overall Study|Protocol Deviation|0|||
23428344|NCT00907296|65310788|FG000|Overall Study|Noncompliance|1|||
23428345|NCT00907296|65310789|FG001|Overall Study|Noncompliance|1|||
23428346|NCT00907296|65310790|FG002|Overall Study|Noncompliance|1|||
23428347|NCT00907296|65310791|FG003|Overall Study|Noncompliance|0|||
23428348|NCT00907296|65310792|FG004|Overall Study|Noncompliance|0|||
23428349|NCT00907296|65310793|FG005|Overall Study|Noncompliance|1|||
23428350|NCT00907296|65310794|FG006|Overall Study|Noncompliance|0|||
23428351|NCT00907296|65310795|FG007|Overall Study|Noncompliance|2|||
23428352|NCT00907296|65310796|FG008|Overall Study|Noncompliance|0|||
23428353|NCT00907296|65310797|FG009|Overall Study|Noncompliance|0|||
23428354|NCT00907296|65310788|FG000|Overall Study|Adverse Event|2|||
23428355|NCT00907296|65310789|FG001|Overall Study|Adverse Event|0|||
23428356|NCT00907296|65310790|FG002|Overall Study|Adverse Event|0|||
23428357|NCT00907296|65310791|FG003|Overall Study|Adverse Event|0|||
23740729|NCT03922945|66429404|FG001|Overall Study|Adverse Event|1|||
23740730|NCT03922945|66429405|FG002|Overall Study|Adverse Event|2|||
23740731|NCT03922945|66429403|FG000|Overall Study|Lost to Follow-up|13|||
23740732|NCT03922945|66429404|FG001|Overall Study|Lost to Follow-up|9|||
23740733|NCT03922945|66429405|FG002|Overall Study|Lost to Follow-up|20|||
23740734|NCT03922945|66429403|FG000|Overall Study|Lack of Efficacy|2|||
23740735|NCT03922945|66429404|FG001|Overall Study|Lack of Efficacy|0|||
23740736|NCT03922945|66429405|FG002|Overall Study|Lack of Efficacy|1|||
23428358|NCT00907296|65310792|FG004|Overall Study|Adverse Event|0|||
23428359|NCT00907296|65310793|FG005|Overall Study|Adverse Event|0|||
23428360|NCT00907296|65310794|FG006|Overall Study|Adverse Event|1|||
23428361|NCT00907296|65310795|FG007|Overall Study|Adverse Event|0|||
23428362|NCT00907296|65310796|FG008|Overall Study|Adverse Event|0|||
23428363|NCT00907296|65310797|FG009|Overall Study|Adverse Event|1|||
23428364|NCT00907296|65310788|FG000|Overall Study|Withdrawal by Subject|7|||
23428365|NCT00907296|65310789|FG001|Overall Study|Withdrawal by Subject|2|||
23428366|NCT00907296|65310790|FG002|Overall Study|Withdrawal by Subject|1|||
23428367|NCT00907296|65310791|FG003|Overall Study|Withdrawal by Subject|1|||
23548830|NCT01217073|65739643|FG007|Extension Period|Non-compliance with study drug|1|||
23548831|NCT01217073|65739636|FG000|Extension Period|Physician Decision|0|||
23548832|NCT01217073|65739637|FG001|Extension Period|Physician Decision|0|||
23548833|NCT01217073|65739638|FG002|Extension Period|Physician Decision|0|||
23548834|NCT01217073|65739639|FG003|Extension Period|Physician Decision|0|||
23548835|NCT01217073|65739640|FG004|Extension Period|Physician Decision|0|||
23548836|NCT01217073|65739641|FG005|Extension Period|Physician Decision|0|||
23548837|NCT01217073|65739642|FG006|Extension Period|Physician Decision|4|||
23548838|NCT01217073|65739643|FG007|Extension Period|Physician Decision|1|||
23548839|NCT01217073|65739636|FG000|Extension Period|Protocol Violation|0|||
23548840|NCT01217073|65739637|FG001|Extension Period|Protocol Violation|0|||
23548841|NCT01217073|65739638|FG002|Extension Period|Protocol Violation|0|||
23548842|NCT01217073|65739639|FG003|Extension Period|Protocol Violation|0|||
23548843|NCT01217073|65739640|FG004|Extension Period|Protocol Violation|0|||
23548844|NCT01217073|65739641|FG005|Extension Period|Protocol Violation|0|||
23548845|NCT01217073|65739642|FG006|Extension Period|Protocol Violation|2|||
23548846|NCT01217073|65739643|FG007|Extension Period|Protocol Violation|1|||
23619938|NCT03449134|65994795|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
23619939|NCT03449134|65994793|FG000|52-Week Treatment Period|Site Closure|1|||
23619940|NCT03449134|65994794|FG001|52-Week Treatment Period|Site Closure|0|||
23821006|NCT00996892|66725995|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
23821007|NCT00996892|66725996|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
23821008|NCT00996892|66725997|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
23548847|NCT01217073|65739636|FG000|Extension Period|Site discontinued study participation|0|||
23548848|NCT01217073|65739637|FG001|Extension Period|Site discontinued study participation|0|||
23548849|NCT01217073|65739638|FG002|Extension Period|Site discontinued study participation|0|||
23619941|NCT03449134|65994795|FG002|52-Week Treatment Period|Site Closure|0|||
23619942|NCT01774019|65994796|FG000|Overall Study|No longer meets protocol criteria|2|||
23619943|NCT01774019|65994797|FG001|Overall Study|No longer meets protocol criteria|0|||
23619944|NCT01774019|65994796|FG000|Overall Study|Withdrawal by Subject|1|||
23740737|NCT03922945|66429403|FG000|Overall Study|Protocol Non-Compliance|0|||
23740738|NCT03922945|66429404|FG001|Overall Study|Protocol Non-Compliance|0|||
23740739|NCT03922945|66429405|FG002|Overall Study|Protocol Non-Compliance|1|||
23740740|NCT03922945|66429403|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
23740741|NCT03922945|66429404|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
23740742|NCT03922945|66429405|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
23740743|NCT03922945|66429403|FG000|Overall Study|All Other Personal Reasons|1|||
23740744|NCT03922945|66429404|FG001|Overall Study|All Other Personal Reasons|1|||
23740745|NCT03922945|66429405|FG002|Overall Study|All Other Personal Reasons|2|||
23740746|NCT02612129|66429406|FG000|Single Dose Treatment Period|Screening Failure|1|||
23740747|NCT02612129|66429407|FG001|Single Dose Treatment Period|Screening Failure|0|||
23740748|NCT02612129|66429408|FG002|Single Dose Treatment Period|Screening Failure|0|||
23740749|NCT02612129|66429406|FG000|Continuous Treatment Period|Early Escape|0|||
23740750|NCT02612129|66429407|FG001|Continuous Treatment Period|Early Escape|2|||
23740751|NCT02612129|66429408|FG002|Continuous Treatment Period|Early Escape|0|||
23740752|NCT02612129|66429406|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
23740753|NCT02612129|66429407|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
23740754|NCT02612129|66429408|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
23740755|NCT02612129|66429406|FG000|Continuous Treatment Period|Safety Reasons|0|||
23740756|NCT02612129|66429407|FG001|Continuous Treatment Period|Safety Reasons|3|||
23740757|NCT02612129|66429408|FG002|Continuous Treatment Period|Safety Reasons|0|||
23740758|NCT02612129|66429406|FG000|Continuous Treatment Period|Death|0|||
23740759|NCT02612129|66429407|FG001|Continuous Treatment Period|Death|1|||
23740760|NCT02612129|66429408|FG002|Continuous Treatment Period|Death|0|||
23740761|NCT02612129|66429406|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
23740762|NCT02612129|66429407|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
23740763|NCT02612129|66429408|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
23740764|NCT00699582|66429411|FG000|Overall Study|Adverse Event|4|||
23740765|NCT00699582|66429412|FG001|Overall Study|Adverse Event|11|||
23428368|NCT00907296|65310792|FG004|Overall Study|Withdrawal by Subject|1|||
23428369|NCT00907296|65310793|FG005|Overall Study|Withdrawal by Subject|5|||
23619945|NCT01774019|65994797|FG001|Overall Study|Withdrawal by Subject|0|||
23619946|NCT01774019|65994796|FG000|Overall Study|Surgery delayed > 120 days|1|||
23740766|NCT00699582|66429413|FG002|Overall Study|Adverse Event|23|||
23428370|NCT00907296|65310794|FG006|Overall Study|Withdrawal by Subject|3|||
23428371|NCT00907296|65310795|FG007|Overall Study|Withdrawal by Subject|2|||
23428372|NCT00907296|65310796|FG008|Overall Study|Withdrawal by Subject|4|||
23428373|NCT00907296|65310797|FG009|Overall Study|Withdrawal by Subject|2|||
23428374|NCT00907296|65310788|FG000|Overall Study|Lost to Follow-up|9|||
23428375|NCT00907296|65310789|FG001|Overall Study|Lost to Follow-up|1|||
23428376|NCT00907296|65310790|FG002|Overall Study|Lost to Follow-up|0|||
23428377|NCT00907296|65310791|FG003|Overall Study|Lost to Follow-up|2|||
23428378|NCT00907296|65310792|FG004|Overall Study|Lost to Follow-up|0|||
23428379|NCT00907296|65310793|FG005|Overall Study|Lost to Follow-up|3|||
23428380|NCT00907296|65310794|FG006|Overall Study|Lost to Follow-up|2|||
23428381|NCT00907296|65310795|FG007|Overall Study|Lost to Follow-up|2|||
23428382|NCT00907296|65310796|FG008|Overall Study|Lost to Follow-up|0|||
23428383|NCT00907296|65310797|FG009|Overall Study|Lost to Follow-up|4|||
23428384|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Death|8|||
23428385|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Death|8|||
23428386|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Death|0|||
23548850|NCT01217073|65739639|FG003|Extension Period|Site discontinued study participation|0|||
23548851|NCT01217073|65739640|FG004|Extension Period|Site discontinued study participation|0|||
23548852|NCT01217073|65739641|FG005|Extension Period|Site discontinued study participation|0|||
23548853|NCT01217073|65739642|FG006|Extension Period|Site discontinued study participation|7|||
23548854|NCT01217073|65739643|FG007|Extension Period|Site discontinued study participation|2|||
23548855|NCT01217073|65739636|FG000|Extension Period|Withdrawal by Subject|0|||
23548856|NCT01217073|65739637|FG001|Extension Period|Withdrawal by Subject|0|||
23548857|NCT01217073|65739638|FG002|Extension Period|Withdrawal by Subject|0|||
23548858|NCT01217073|65739639|FG003|Extension Period|Withdrawal by Subject|0|||
23548859|NCT01217073|65739640|FG004|Extension Period|Withdrawal by Subject|0|||
23548860|NCT01217073|65739641|FG005|Extension Period|Withdrawal by Subject|0|||
23548861|NCT01217073|65739642|FG006|Extension Period|Withdrawal by Subject|30|||
23548862|NCT01217073|65739643|FG007|Extension Period|Withdrawal by Subject|8|||
23548863|NCT01640808|65739647|FG000|Overall Study|Unable to continue dynamic CT|14|||
23548864|NCT01640808|65739648|FG001|Overall Study|Unable to continue dynamic CT|4|||
23548865|NCT01640808|65739647|FG000|Overall Study|Withdrawal by Subject|12|||
23548866|NCT01640808|65739648|FG001|Overall Study|Withdrawal by Subject|4|||
23548867|NCT01640808|65739647|FG000|Overall Study|Lost to Follow-up|4|||
23548868|NCT01640808|65739648|FG001|Overall Study|Lost to Follow-up|0|||
23548869|NCT01640808|65739647|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
23548870|NCT01640808|65739648|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
23548871|NCT01640808|65739647|FG000|Overall Study|Administration of anticancer drugs|2|||
23548872|NCT01640808|65739648|FG001|Overall Study|Administration of anticancer drugs|1|||
23548873|NCT01640808|65739647|FG000|Overall Study|Physician Decision|19|||
23548874|NCT01640808|65739648|FG001|Overall Study|Physician Decision|5|||
23548875|NCT01640808|65739647|FG000|Overall Study|Randomized but not treated|4|||
23548876|NCT01640808|65739648|FG001|Overall Study|Randomized but not treated|2|||
23548877|NCT01596582|65739649|FG000|Overall Study|Deemed ineligible after study visit|3|||
23548878|NCT01596582|65739650|FG001|Overall Study|Deemed ineligible after study visit|6|||
23548879|NCT01596582|65739649|FG000|Overall Study|Missing all outcome data|1|||
23548880|NCT01596582|65739650|FG001|Overall Study|Missing all outcome data|1|||
23548881|NCT02492100|65739652|FG000|Overall Study|Death|1|||
23548882|NCT03178266|65739653|FG000|Overall Study|Death|0|||
23548883|NCT03178266|65739654|FG001|Overall Study|Death|1|||
23548884|NCT03178266|65739653|FG000|Overall Study|Disont. Early|0|||
23548885|NCT03178266|65739654|FG001|Overall Study|Disont. Early|1|||
23548886|NCT03178266|65739653|FG000|Overall Study|Withdrawal by Subject|0|||
23548887|NCT03178266|65739654|FG001|Overall Study|Withdrawal by Subject|2|||
23548888|NCT02119416|65739655|FG000|Overall Study|Protocol Violation|1|||
23548889|NCT02119416|65739656|FG001|Overall Study|Protocol Violation|1|||
23548890|NCT02119416|65739657|FG002|Overall Study|Protocol Violation|1|||
23548891|NCT02119416|65739655|FG000|Overall Study|wrong pubertal stage|1|||
23548892|NCT02119416|65739656|FG001|Overall Study|wrong pubertal stage|0|||
23548893|NCT02119416|65739657|FG002|Overall Study|wrong pubertal stage|1|||
23548894|NCT00829387|65739659|FG000|Overall Study|Withdrawal by Subject|2|||
23548895|NCT00829387|65739660|FG001|Overall Study|Withdrawal by Subject|3|||
23548896|NCT00829387|65739659|FG000|Overall Study|Disqualified by PI|1|||
23619947|NCT01774019|65994797|FG001|Overall Study|Surgery delayed > 120 days|0|||
23740767|NCT00699582|66429411|FG000|Overall Study|Withdrawal by Subject|6|||
23548897|NCT00829387|65739660|FG001|Overall Study|Disqualified by PI|0|||
23548898|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
23548899|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
23619948|NCT01774019|65994796|FG000|Overall Study|Patient refused surgery|1|||
23740768|NCT00699582|66429412|FG001|Overall Study|Withdrawal by Subject|7|||
23428387|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Death|0|||
23428388|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
23428389|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23428390|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23548900|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
23548901|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
23548902|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
23548903|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
23548904|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
23548905|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
23548906|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
23548907|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
23548908|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
23548909|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
23548910|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
23548911|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
23548912|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
23548913|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
23548914|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
23548915|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
23548916|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
23548917|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
23548918|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
23548919|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
23548920|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
23548921|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
23548922|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548923|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548924|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548925|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548926|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548927|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548928|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548929|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548930|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548931|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548932|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548933|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548934|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548935|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548936|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548937|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548938|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548939|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548940|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
23548941|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
23548942|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
23548943|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548944|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548945|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548946|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548947|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548948|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548949|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548950|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548951|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548952|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548953|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548954|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548955|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548956|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548957|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548958|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
23740769|NCT00699582|66429413|FG002|Overall Study|Withdrawal by Subject|4|||
23740770|NCT00699582|66429411|FG000|Overall Study|Lack of Efficacy|1|||
23740771|NCT00699582|66429412|FG001|Overall Study|Lack of Efficacy|0|||
23740772|NCT00699582|66429413|FG002|Overall Study|Lack of Efficacy|1|||
23740773|NCT00699582|66429411|FG000|Overall Study|Progressive Disease|1|||
23740774|NCT00699582|66429412|FG001|Overall Study|Progressive Disease|0|||
23740775|NCT00699582|66429413|FG002|Overall Study|Progressive Disease|0|||
23821009|NCT00996892|66725998|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
23740776|NCT00699582|66429411|FG000|Overall Study|Administrative/Other|4|||
23740777|NCT00699582|66429412|FG001|Overall Study|Administrative/Other|3|||
23821010|NCT00996892|66725999|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
23821011|NCT00996892|66726000|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
23821012|NCT00996892|66726001|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
23821013|NCT00996892|66726002|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
23821014|NCT00996892|66726003|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
23821015|NCT00996892|66726004|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
23821016|NCT00996892|66726005|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
23821017|NCT00996892|66725986|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821018|NCT00996892|66725987|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23821019|NCT00996892|66725988|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821020|NCT00996892|66725989|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
23821021|NCT00996892|66725990|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23821022|NCT00996892|66725991|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23821023|NCT00996892|66725992|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23821024|NCT00996892|66725993|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821025|NCT00996892|66725994|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821026|NCT00996892|66725995|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821027|NCT00996892|66725996|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821028|NCT00996892|66725997|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821029|NCT00996892|66725998|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821030|NCT00996892|66725999|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23548959|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
23548960|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
23740778|NCT00699582|66429413|FG002|Overall Study|Administrative/Other|0|||
23740779|NCT00699582|66429411|FG000|Overall Study|Randomized, Not Treated|2|||
23548961|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
23548962|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
23548963|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
23548964|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
23548965|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
23548966|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
23548967|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
23740780|NCT00699582|66429412|FG001|Overall Study|Randomized, Not Treated|1|||
23740781|NCT00699582|66429413|FG002|Overall Study|Randomized, Not Treated|0|||
23740782|NCT01453439|66429414|FG000|Treatment Phase|Withdrawal by Subject|13|||
23740783|NCT01453439|66429415|FG001|Treatment Phase|Withdrawal by Subject|10|||
23740784|NCT01453439|66429414|FG000|Treatment Phase|Suicidal Ideation|2|||
23740785|NCT01453439|66429415|FG001|Treatment Phase|Suicidal Ideation|0|||
23740786|NCT01453439|66429414|FG000|Treatment Phase|Need for higher level of care|1|||
23740787|NCT01453439|66429415|FG001|Treatment Phase|Need for higher level of care|1|||
23740788|NCT01453439|66429414|FG000|Treatment Phase|Therapist conflict of interest|1|||
23740789|NCT01453439|66429415|FG001|Treatment Phase|Therapist conflict of interest|0|||
23740790|NCT01453439|66429414|FG000|Follow-up|Withdrawal by Subject|0|||
23740791|NCT01453439|66429415|FG001|Follow-up|Withdrawal by Subject|1|||
23740792|NCT01453439|66429414|FG000|Follow-up|Lost to Follow-up|5|||
23740793|NCT01453439|66429415|FG001|Follow-up|Lost to Follow-up|10|||
23740794|NCT00174460|66429419|FG000|Overall Study|Withdrawal by Subject|0|||
23740795|NCT00174460|66429420|FG001|Overall Study|Withdrawal by Subject|1|||
23740796|NCT01955005|66429424|FG000|Overall Study|Withdrawal by Subject|3|||
23740797|NCT01955005|66429425|FG001|Overall Study|Withdrawal by Subject|5|||
23740798|NCT00303602|66429426|FG000|Overall Study|Adverse Event|2|||
23740799|NCT00303602|66429427|FG001|Overall Study|Adverse Event|2|||
23740800|NCT00303602|66429426|FG000|Overall Study|Withdrawal by Subject|5|||
23740801|NCT00303602|66429427|FG001|Overall Study|Withdrawal by Subject|6|||
23740802|NCT00303602|66429426|FG000|Overall Study|Lost to Follow-up|5|||
23740803|NCT00303602|66429427|FG001|Overall Study|Lost to Follow-up|2|||
23740804|NCT00303602|66429426|FG000|Overall Study|Protocol entry criteria not met|2|||
23740805|NCT00303602|66429427|FG001|Overall Study|Protocol entry criteria not met|2|||
23740806|NCT00303602|66429426|FG000|Overall Study|Physician Decision|2|||
23740807|NCT00303602|66429427|FG001|Overall Study|Physician Decision|1|||
23740808|NCT00303602|66429426|FG000|Overall Study|Noncompliance|2|||
23740809|NCT00303602|66429427|FG001|Overall Study|Noncompliance|2|||
23740810|NCT00303602|66429426|FG000|Overall Study|Protocol Violation|1|||
23740811|NCT00303602|66429427|FG001|Overall Study|Protocol Violation|0|||
23740812|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
23821031|NCT00996892|66726000|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821032|NCT00996892|66726001|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23548968|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
23740813|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
23740814|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
23740815|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
23740816|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
23740817|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
23740818|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Death|1|||
23740819|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Death|1|||
23740820|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Death|1|||
23740821|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Death|0|||
23740822|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Death|0|||
23740823|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Death|0|||
23740824|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
23740825|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
23740826|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23740827|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23740828|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23740829|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23740830|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23740831|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23740832|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
23740833|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23740834|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23740835|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23740836|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23740837|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
23740838|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23740839|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23740840|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23740841|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23740842|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
23740843|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
23740844|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
23740845|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23740846|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23740847|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23740848|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
23740849|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
23740850|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
23740851|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
23740852|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
23740853|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
23740854|NCT03370133|66429431|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
23740855|NCT03370133|66429432|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
23740856|NCT03370133|66429433|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
23740857|NCT03370133|66429434|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
23740858|NCT03370133|66429435|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
23740859|NCT03370133|66429436|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
23740860|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23821033|NCT00996892|66726002|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821034|NCT00996892|66726003|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821035|NCT00996892|66726004|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821036|NCT00996892|66726005|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23821037|NCT00996892|66725986|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
23821038|NCT00996892|66725987|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
23821039|NCT00996892|66725988|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
23821040|NCT00996892|66725989|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
23821041|NCT00996892|66725990|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
23821042|NCT00996892|66725991|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
23821043|NCT00996892|66725992|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
23821044|NCT00996892|66725993|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
23619949|NCT01774019|65994797|FG001|Overall Study|Patient refused surgery|1|||
23619950|NCT01774019|65994796|FG000|Overall Study|Unable to implant study device|1|||
23619951|NCT01774019|65994797|FG001|Overall Study|Unable to implant study device|0|||
23619952|NCT01774019|65994796|FG000|Overall Study|Lost to Follow-up|0|||
23619953|NCT01774019|65994797|FG001|Overall Study|Lost to Follow-up|3|||
23619954|NCT00053352|65994798|FG000|Overall Study|Lost to Follow-up|0|||
23619955|NCT00053352|65994799|FG001|Overall Study|Lost to Follow-up|1|||
23619956|NCT00053352|65994798|FG000|Overall Study|Physician Decision|11|||
23619957|NCT00053352|65994799|FG001|Overall Study|Physician Decision|1|||
23619958|NCT00053352|65994798|FG000|Overall Study|Withdrawal by Subject|1|||
23619959|NCT00053352|65994799|FG001|Overall Study|Withdrawal by Subject|0|||
23821045|NCT00996892|66725994|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
23619960|NCT00053352|65994798|FG000|Overall Study|Ineligible|8|||
23619961|NCT00053352|65994799|FG001|Overall Study|Ineligible|8|||
23619962|NCT00053352|65994798|FG000|Overall Study|Disease at new site|1|||
23428391|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23428392|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428393|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
23428394|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428395|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428396|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
23428397|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
23428398|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
23428399|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
23428400|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Other|0|||
23428401|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Other|0|||
23428402|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Other|0|||
23428403|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Other|1|||
23428404|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Death|0|||
23428405|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Death|0|||
23428406|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Death|20|||
23428407|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Death|21|||
23428408|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
23428409|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
23428410|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
23428411|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
23428412|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428413|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428414|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
23428415|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428416|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428417|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428418|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428419|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
23428420|NCT01439074|65314229|FG000|Overall Study|Lost to Follow-up|3|||
23428421|NCT01439074|65314230|FG001|Overall Study|Lost to Follow-up|4|||
23428422|NCT01439074|65314229|FG000|Overall Study|Subject shedding|1|||
23428423|NCT01439074|65314230|FG001|Overall Study|Subject shedding|0|||
23428424|NCT01439074|65314229|FG000|Overall Study|Withdrawal by Subject|1|||
23428425|NCT01439074|65314230|FG001|Overall Study|Withdrawal by Subject|5|||
23428426|NCT01439074|65314229|FG000|Overall Study|Other|4|||
23428427|NCT01439074|65314230|FG001|Overall Study|Other|4|||
23428428|NCT00746733|65314236|FG000|Second Intervention|Adverse Event|1|||
23428429|NCT00746733|65314237|FG001|Second Intervention|Adverse Event|0|||
23428430|NCT00746733|65314236|FG000|Third Intervention|Withdrawal by Subject|1|||
23428431|NCT00746733|65314237|FG001|Third Intervention|Withdrawal by Subject|1|||
23428432|NCT02012686|65314250|FG000|Overall Study|muscle contraction|0|||
23428433|NCT02012686|65314251|FG001|Overall Study|muscle contraction|1|||
23428434|NCT02012686|65314250|FG000|Overall Study|electrocardiography monitoring noise|0|||
23428435|NCT02012686|65314251|FG001|Overall Study|electrocardiography monitoring noise|1|||
23428436|NCT02241187|65314252|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
23428437|NCT04384107|65314253|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
23428438|NCT04384107|65314254|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23428439|NCT04384107|65314253|FG000|Overall Study|Lost to Follow-up|1|||
23428440|NCT04384107|65314254|FG001|Overall Study|Lost to Follow-up|0|||
23428441|NCT01241760|65314260|FG000|Overall Study|Adverse Event|1|||
23428442|NCT01241760|65314261|FG001|Overall Study|Adverse Event|0|||
23428443|NCT01241760|65314260|FG000|Overall Study|Lost to Follow-up|18|||
23428444|NCT01241760|65314261|FG001|Overall Study|Lost to Follow-up|22|||
23428445|NCT01241760|65314260|FG000|Overall Study|Withdrawal by Subject|13|||
23428446|NCT01241760|65314261|FG001|Overall Study|Withdrawal by Subject|13|||
23428447|NCT01241760|65314260|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
23428448|NCT01241760|65314261|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
23428449|NCT01241760|65314260|FG000|Overall Study|Other|1|||
23428450|NCT01241760|65314261|FG001|Overall Study|Other|1|||
23740861|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23740862|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23740863|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
23740864|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
23740865|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
23740866|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23740867|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23428451|NCT04258995|65314262|FG000|Overall Study|Lost to Follow-up|1|||
23428452|NCT04258995|65314263|FG001|Overall Study|Lost to Follow-up|1|||
23428453|NCT01400243|65314264|FG000|Overall Study|Protocol Violation|8|||
23428454|NCT01400243|65314265|FG001|Overall Study|Protocol Violation|11|||
23428455|NCT03242252|65314266|FG000|Overall Study|At the Participant's own Request|18|||
23428456|NCT03242252|65314267|FG001|Overall Study|At the Participant's own Request|10|||
23548969|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
23548970|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
23548971|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
23548972|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
23548973|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
23548974|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
23548975|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
23548976|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
23548977|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
23548978|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
23548979|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548980|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548981|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548982|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548983|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548984|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548985|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548986|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548987|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548988|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548989|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548990|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548991|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548992|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548993|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548994|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548995|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548996|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548997|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548998|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23548999|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23549000|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549001|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
23549002|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23740868|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23740869|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23740870|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
23740871|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
23740872|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23740873|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23740874|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23740875|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
23740876|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
23740877|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23740878|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23740879|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23740880|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23740881|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23740882|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
23740883|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
23740884|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23740885|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23740886|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23740887|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
23740888|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
23740889|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
23740890|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23740891|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23740892|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23740893|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23740894|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
23740895|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23549003|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549004|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549005|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549006|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549007|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549008|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549009|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549010|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549011|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549012|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549013|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549014|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549015|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549016|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549017|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549018|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549019|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549020|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549021|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549022|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
23549023|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549024|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549025|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549026|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549027|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549028|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549029|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549030|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549031|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549032|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549033|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549034|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549035|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549036|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23619963|NCT00053352|65994799|FG001|Overall Study|Disease at new site|0|||
23619964|NCT02878590|65994800|FG000|Overall Study|Withdrawal by Subject|2|||
23619965|NCT02986659|65994801|FG000|First Intervention Period|Adverse Event|3|||
23619966|NCT02986659|65994802|FG001|First Intervention Period|Adverse Event|1|||
23619967|NCT02986659|65994801|FG000|First Intervention Period|Lost to Follow-up|1|||
23619968|NCT02986659|65994802|FG001|First Intervention Period|Lost to Follow-up|0|||
23619969|NCT02986659|65994801|FG000|First Intervention Period|Withdrawal by Subject|0|||
23619970|NCT02986659|65994802|FG001|First Intervention Period|Withdrawal by Subject|1|||
23619971|NCT02986659|65994801|FG000|Second Intervention Period|Adverse Event|0|||
23619972|NCT02986659|65994802|FG001|Second Intervention Period|Adverse Event|6|||
23619973|NCT03318783|65994807|FG000|Overall Study|Withdrawal by Subject|0|||
23619974|NCT03318783|65994808|FG001|Overall Study|Withdrawal by Subject|1|||
23740896|NCT03370133|66429431|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23740897|NCT03370133|66429432|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23740898|NCT03370133|66429433|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23740899|NCT03370133|66429434|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23740900|NCT03370133|66429435|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23740901|NCT03370133|66429436|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
23740902|NCT00877929|66429437|FG000|Overall Study|Adverse Event|11|||
23740903|NCT00877929|66429438|FG001|Overall Study|Adverse Event|20|||
23740904|NCT00877929|66429437|FG000|Overall Study|Protocol Violation|3|||
23740905|NCT00877929|66429438|FG001|Overall Study|Protocol Violation|3|||
23740906|NCT00877929|66429437|FG000|Overall Study|Lost to Follow-up|0|||
23740907|NCT00877929|66429438|FG001|Overall Study|Lost to Follow-up|1|||
23740908|NCT00877929|66429437|FG000|Overall Study|Withdrawal by Subject|4|||
23740909|NCT00877929|66429438|FG001|Overall Study|Withdrawal by Subject|4|||
23740910|NCT00877929|66429437|FG000|Overall Study|Lack of Efficacy|0|||
23740911|NCT00877929|66429438|FG001|Overall Study|Lack of Efficacy|1|||
23740912|NCT00877929|66429437|FG000|Overall Study|Other reason (not specified)|2|||
23740913|NCT00877929|66429438|FG001|Overall Study|Other reason (not specified)|6|||
23740914|NCT01393444|66429439|FG000|Overall Study|Withdrawal by Subject|1|||
23740915|NCT01393444|66429439|FG000|Overall Study|Determined ineligible during screening.|2|||
23740916|NCT00955682|66429440|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
23740917|NCT00955682|66429441|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
23740918|NCT03418727|66429442|FG000|Overall Study|Adverse Event|1|||
23740919|NCT03418727|66429443|FG001|Overall Study|Adverse Event|2|||
23740920|NCT03418727|66429444|FG002|Overall Study|Adverse Event|0|||
23740921|NCT03418727|66429442|FG000|Overall Study|Withdrawal by Subject|0|||
23740922|NCT03418727|66429443|FG001|Overall Study|Withdrawal by Subject|0|||
23740923|NCT03418727|66429444|FG002|Overall Study|Withdrawal by Subject|2|||
23740924|NCT00265109|66429445|FG000|Overall Study|Withdrawal by Subject|5|||
23740925|NCT00265109|66429445|FG000|Overall Study|Adverse Event|1|||
23740926|NCT01673373|66429449|FG000|Overall Study|Death|2|||
23740927|NCT00985114|66429450|FG000|Overall Study|Adverse Event|1|||
23428457|NCT03242252|65314268|FG002|Overall Study|At the Participant's own Request|15|||
23428458|NCT03242252|65314266|FG000|Overall Study|Adverse Event|8|||
23428459|NCT03242252|65314267|FG001|Overall Study|Adverse Event|6|||
23428460|NCT03242252|65314268|FG002|Overall Study|Adverse Event|9|||
23428461|NCT03242252|65314266|FG000|Overall Study|Poor Compliance to Protocol|0|||
23428462|NCT03242252|65314267|FG001|Overall Study|Poor Compliance to Protocol|2|||
23428463|NCT03242252|65314268|FG002|Overall Study|Poor Compliance to Protocol|3|||
23619975|NCT03318783|65994807|FG000|Overall Study|Death|0|||
23619976|NCT03318783|65994808|FG001|Overall Study|Death|1|||
23619977|NCT02956278|65994809|FG000|Overall Study|Withdrawal by Subject|6|||
23619978|NCT02956278|65994810|FG001|Overall Study|Withdrawal by Subject|2|||
23619979|NCT02956278|65994811|FG002|Overall Study|Withdrawal by Subject|0|||
23619980|NCT01705145|65994812|FG000|Part B|Adverse Event|1|||
23619981|NCT00875615|65994813|FG000|Overall Study|Withdrawal by Subject|1|||
23619982|NCT03605368|65994814|FG000|Overall Study|Lost to Follow-up|2|||
23740928|NCT00985114|66429451|FG001|Overall Study|Adverse Event|0|||
23619983|NCT03605368|65994815|FG001|Overall Study|Lost to Follow-up|1|||
23740929|NCT00985114|66429450|FG000|Overall Study|Withdrawal by Subject|0|||
23740930|NCT00985114|66429451|FG001|Overall Study|Withdrawal by Subject|2|||
23740931|NCT01349816|66429452|FG000|Overall Study|Withdrawal by Subject|4|||
23740932|NCT01349816|66429452|FG000|Overall Study|Physician Decision|1|||
23740933|NCT01349816|66429452|FG000|Overall Study|Adverse Event|14|||
23740934|NCT01349816|66429452|FG000|Overall Study|Lost to Follow-up|2|||
23740935|NCT01349816|66429452|FG000|Overall Study|Protocol Violation|1|||
23740936|NCT01349816|66429452|FG000|Overall Study|Protocol-specified criteria|8|||
23740937|NCT00682539|66429453|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
23428464|NCT03242252|65314266|FG000|Overall Study|Study Terminated by Sponsor|1|||
23428465|NCT03242252|65314267|FG001|Overall Study|Study Terminated by Sponsor|0|||
23740938|NCT00682539|66429454|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
23740939|NCT00682539|66429455|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
23619984|NCT03605368|65994816|FG002|Overall Study|Lost to Follow-up|3|||
23619985|NCT03605368|65994817|FG003|Overall Study|Lost to Follow-up|2|||
23740940|NCT00682539|66429453|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
23740941|NCT00682539|66429454|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
23740942|NCT00682539|66429455|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
23619986|NCT03605368|65994814|FG000|Overall Study|Withdrawal by Subject|0|||
23619987|NCT03605368|65994815|FG001|Overall Study|Withdrawal by Subject|0|||
23619988|NCT03605368|65994816|FG002|Overall Study|Withdrawal by Subject|4|||
23619989|NCT03605368|65994817|FG003|Overall Study|Withdrawal by Subject|3|||
23619990|NCT01431950|65994818|FG000|Overall Study|Study Site Closed/Terminated|7|||
23619991|NCT01431950|65994819|FG001|Overall Study|Study Site Closed/Terminated|3|||
23619992|NCT01431950|65994818|FG000|Overall Study|Withdrawal by Subject|4|||
23619993|NCT01431950|65994819|FG001|Overall Study|Withdrawal by Subject|3|||
23619994|NCT01431950|65994818|FG000|Overall Study|Protocol Violation|2|||
23619995|NCT01431950|65994819|FG001|Overall Study|Protocol Violation|3|||
23619996|NCT01431950|65994818|FG000|Overall Study|Adverse Event|2|||
23619997|NCT01431950|65994819|FG001|Overall Study|Adverse Event|2|||
23619998|NCT01431950|65994818|FG000|Overall Study|Physician Decision|2|||
23619999|NCT01431950|65994819|FG001|Overall Study|Physician Decision|1|||
23620000|NCT01431950|65994818|FG000|Overall Study|Lack of Efficacy|2|||
23620001|NCT01431950|65994819|FG001|Overall Study|Lack of Efficacy|1|||
23620002|NCT01431950|65994818|FG000|Overall Study|Lost to Follow-up|0|||
23620003|NCT01431950|65994819|FG001|Overall Study|Lost to Follow-up|1|||
23620004|NCT01431950|65994818|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23620005|NCT01431950|65994819|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23620006|NCT00644332|65994829|FG000|Overall Study|Adverse Event|11|||
23620007|NCT00644332|65994829|FG000|Overall Study|Withdrawal by Subject|6|||
23620008|NCT00644332|65994829|FG000|Overall Study|Completion Status Unknown|2|||
23620009|NCT00644332|65994829|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
23620010|NCT00644332|65994829|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
23620011|NCT02257918|65994832|FG000|Overall Study|Lost to Follow-up|4|||
23620012|NCT02257918|65994833|FG001|Overall Study|Lost to Follow-up|1|||
23620013|NCT02257918|65994834|FG002|Overall Study|Lost to Follow-up|0|||
23620014|NCT02257918|65994832|FG000|Overall Study|Withdrawal by Subject|0|||
23620015|NCT02257918|65994833|FG001|Overall Study|Withdrawal by Subject|0|||
23620016|NCT02257918|65994834|FG002|Overall Study|Withdrawal by Subject|1|||
23620017|NCT02257918|65994832|FG000|Overall Study|Pregnancy|0|||
23620018|NCT02257918|65994833|FG001|Overall Study|Pregnancy|0|||
23620019|NCT02257918|65994834|FG002|Overall Study|Pregnancy|1|||
23620020|NCT00578318|65994835|FG000|Overall Study|Lost to Follow-up|2|||
23620021|NCT00578318|65994836|FG001|Overall Study|Lost to Follow-up|0|||
23620022|NCT00578318|65994835|FG000|Overall Study|Physician Decision|1|||
23620023|NCT00578318|65994836|FG001|Overall Study|Physician Decision|0|||
23620024|NCT02973477|65994842|FG000|First Intervention|Lost to Follow-up|0|||
23620025|NCT02973477|65994843|FG001|First Intervention|Lost to Follow-up|2|||
23620026|NCT02973477|65994842|FG000|Washout|Withdrawal by Subject|1|||
23620027|NCT02973477|65994843|FG001|Washout|Withdrawal by Subject|0|||
23620028|NCT02973477|65994842|FG000|Second Intervention|Lost to Follow-up|1|||
23620029|NCT02973477|65994843|FG001|Second Intervention|Lost to Follow-up|0|||
23620030|NCT02165397|65994848|FG000|Overall Study|Death|7|||
23620031|NCT02165397|65994849|FG001|Overall Study|Death|10|||
23620032|NCT02165397|65994850|FG002|Overall Study|Death|8|||
23620033|NCT02165397|65994848|FG000|Overall Study|Lost to Follow-up|1|||
23620034|NCT02165397|65994849|FG001|Overall Study|Lost to Follow-up|3|||
23620035|NCT02165397|65994850|FG002|Overall Study|Lost to Follow-up|0|||
23620036|NCT02165397|65994848|FG000|Overall Study|Withdrawal by Subject|6|||
23620037|NCT02165397|65994849|FG001|Overall Study|Withdrawal by Subject|6|||
23620038|NCT02165397|65994850|FG002|Overall Study|Withdrawal by Subject|1|||
23620039|NCT02165397|65994848|FG000|Overall Study|Other, Not Specified|0|||
23620040|NCT02165397|65994849|FG001|Overall Study|Other, Not Specified|0|||
23620041|NCT02165397|65994850|FG002|Overall Study|Other, Not Specified|1|||
23620042|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
23620043|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
23620044|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Relocated|1|||
23620045|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Relocated|1|||
23620046|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
23620047|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
23620048|NCT02469077|65994852|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
23620049|NCT02469077|65994853|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
23740943|NCT01710709|66429461|FG000|Overall Study|Lost to Follow-up|29|||
23620050|NCT01747629|65994859|FG000|Overall Study|Adverse Event|1|||
23620051|NCT01747629|65994860|FG001|Overall Study|Adverse Event|2|||
23620052|NCT01747629|65994859|FG000|Overall Study|Withdrawal by Subject|2|||
23620053|NCT01747629|65994860|FG001|Overall Study|Withdrawal by Subject|2|||
23620054|NCT01747629|65994859|FG000|Overall Study|Noncompliance|1|||
23620055|NCT01747629|65994860|FG001|Overall Study|Noncompliance|1|||
23740944|NCT01710709|66429461|FG000|Overall Study|Adverse Event|48|||
23740945|NCT01710709|66429461|FG000|Overall Study|Participant met withdrawal criteria|33|||
23740946|NCT01710709|66429461|FG000|Overall Study|Participant withdrawn by investigator|2|||
23740947|NCT01710709|66429461|FG000|Overall Study|Withdrawal by Subject|53|||
23821046|NCT00996892|66725995|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
23821047|NCT00996892|66725996|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
23821048|NCT00996892|66725997|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
23821049|NCT00996892|66725998|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
23821050|NCT00996892|66725999|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
23821051|NCT00996892|66726000|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
23821052|NCT00996892|66726001|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
23821053|NCT00996892|66726002|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
23821054|NCT00996892|66726003|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
23821055|NCT00996892|66726004|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
23821056|NCT00996892|66726005|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
23821057|NCT00996892|66725986|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
23821058|NCT00996892|66725987|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
23740948|NCT01710709|66429461|FG000|Overall Study|Protocol Violation|5|||
23740949|NCT01710709|66429461|FG000|Overall Study|Lack of Efficacy|3|||
23740950|NCT00461552|66429468|FG000|Overall Study|Drug Dispensing error|0|||
23740951|NCT00461552|66429469|FG001|Overall Study|Drug Dispensing error|2|||
23740952|NCT03759340|66429470|FG000|Overall Study|Adverse Event|2|||
23740953|NCT03759340|66429470|FG000|Overall Study|Lost to Follow-up|1|||
23740954|NCT03759340|66429470|FG000|Overall Study|Withdrawal by Subject|15|||
23740955|NCT03759340|66429470|FG000|Overall Study|Study Terminated by Sponsor|38|||
23740956|NCT00765726|66429471|FG000|Overall Study|Withdrawal by Subject|1|||
23740957|NCT00765726|66429471|FG000|Overall Study|Discontinuation of study by sponsor|8|||
23740958|NCT02213666|66429474|FG000|Overall Study|Withdrawal by Subject|1|||
23740959|NCT00422227|66429476|FG000|Overall Study|Adverse Event|3|||
23740960|NCT00422227|66429477|FG001|Overall Study|Adverse Event|8|||
23740961|NCT00422227|66429476|FG000|Overall Study|Lost to Follow-up|1|||
23740962|NCT00422227|66429477|FG001|Overall Study|Lost to Follow-up|3|||
23740963|NCT00422227|66429476|FG000|Overall Study|Withdrawal by Subject|0|||
23740964|NCT00422227|66429477|FG001|Overall Study|Withdrawal by Subject|4|||
23740965|NCT02576951|66429478|FG000|Overall Study|Lost to Follow-up|0|||
23740966|NCT02576951|66429479|FG001|Overall Study|Lost to Follow-up|0|||
23740967|NCT02576951|66429480|FG002|Overall Study|Lost to Follow-up|2|||
23740968|NCT02576951|66429481|FG003|Overall Study|Lost to Follow-up|2|||
23740969|NCT02576951|66429478|FG000|Overall Study|Withdrawal by Subject|1|||
23740970|NCT02576951|66429479|FG001|Overall Study|Withdrawal by Subject|0|||
23740971|NCT02576951|66429480|FG002|Overall Study|Withdrawal by Subject|0|||
23740972|NCT02576951|66429481|FG003|Overall Study|Withdrawal by Subject|2|||
23740973|NCT02576951|66429478|FG000|Overall Study|Protocol Violation|0|||
23740974|NCT02576951|66429479|FG001|Overall Study|Protocol Violation|0|||
23740975|NCT02576951|66429480|FG002|Overall Study|Protocol Violation|0|||
23740976|NCT02576951|66429481|FG003|Overall Study|Protocol Violation|1|||
23740977|NCT01012765|66429482|FG000|Treatment Period 1|Adverse Event|1|||
23740978|NCT01012765|66429483|FG001|Treatment Period 1|Adverse Event|0|||
23740979|NCT01012765|66429484|FG002|Treatment Period 1|Adverse Event|1|||
23740980|NCT01012765|66429485|FG003|Treatment Period 1|Adverse Event|0|||
23740981|NCT01012765|66429486|FG004|Treatment Period 1|Adverse Event|0|||
23740982|NCT01012765|66429487|FG005|Treatment Period 1|Adverse Event|0|||
23740983|NCT01012765|66429482|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23740984|NCT01012765|66429483|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23740985|NCT01012765|66429484|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23740986|NCT01012765|66429485|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23740987|NCT01012765|66429486|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23740988|NCT01012765|66429487|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23740989|NCT01012765|66429482|FG000|Treatment Period 1|Administrative problems|0|||
23740990|NCT01012765|66429483|FG001|Treatment Period 1|Administrative problems|0|||
23821059|NCT00996892|66725988|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
23821060|NCT00996892|66725989|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
23549037|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549038|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549039|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549040|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549041|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549042|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549043|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549044|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549045|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549046|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549047|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549048|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
23740991|NCT01012765|66429484|FG002|Treatment Period 1|Administrative problems|1|||
23740992|NCT01012765|66429485|FG003|Treatment Period 1|Administrative problems|1|||
23740993|NCT01012765|66429486|FG004|Treatment Period 1|Administrative problems|1|||
23740994|NCT01012765|66429487|FG005|Treatment Period 1|Administrative problems|0|||
23740995|NCT01012765|66429482|FG000|Treatment Period 1|Protocol Violation|0|||
23740996|NCT01012765|66429483|FG001|Treatment Period 1|Protocol Violation|0|||
23740997|NCT01012765|66429484|FG002|Treatment Period 1|Protocol Violation|0|||
23740998|NCT01012765|66429485|FG003|Treatment Period 1|Protocol Violation|2|||
23740999|NCT01012765|66429486|FG004|Treatment Period 1|Protocol Violation|1|||
23741000|NCT01012765|66429487|FG005|Treatment Period 1|Protocol Violation|0|||
23741001|NCT01012765|66429482|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23741002|NCT01012765|66429483|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23741003|NCT01012765|66429484|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23741004|NCT01012765|66429485|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23741005|NCT01012765|66429486|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
23741006|NCT01012765|66429487|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23741007|NCT01012765|66429482|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23428466|NCT03242252|65314268|FG002|Overall Study|Study Terminated by Sponsor|0|||
23428467|NCT03242252|65314266|FG000|Overall Study|Reason not Specified|4|||
23428468|NCT03242252|65314267|FG001|Overall Study|Reason not Specified|4|||
23428469|NCT03242252|65314268|FG002|Overall Study|Reason not Specified|1|||
23428470|NCT03242252|65314266|FG000|Overall Study|Lost to Follow-up|5|||
23428471|NCT03242252|65314267|FG001|Overall Study|Lost to Follow-up|1|||
23428472|NCT03242252|65314268|FG002|Overall Study|Lost to Follow-up|4|||
23428473|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428474|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
23428475|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428476|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23620056|NCT01747629|65994859|FG000|Overall Study|Inclusion criteria not met|1|||
23620057|NCT01747629|65994860|FG001|Overall Study|Inclusion criteria not met|0|||
23620058|NCT01747629|65994859|FG000|Overall Study|Not treated|1|||
23620059|NCT01747629|65994860|FG001|Overall Study|Not treated|0|||
23620060|NCT01747629|65994859|FG000|Overall Study|Other|2|||
23620061|NCT01747629|65994860|FG001|Overall Study|Other|1|||
23620062|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
23620063|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
23620064|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
23428477|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428478|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428479|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428480|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428481|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428482|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428483|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428484|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428485|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428486|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428487|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428488|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23620065|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
23620066|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
23620067|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
23620068|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
23620069|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
23620070|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
23741008|NCT01012765|66429483|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23741009|NCT01012765|66429484|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23741010|NCT01012765|66429485|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23741011|NCT01012765|66429486|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23741012|NCT01012765|66429487|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23741013|NCT01012765|66429482|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
23741014|NCT01012765|66429483|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
23741015|NCT01012765|66429484|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
23741016|NCT01012765|66429485|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
23428489|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428490|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23741017|NCT01012765|66429486|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
23741018|NCT01012765|66429487|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
23428491|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23741019|NCT01012765|66429482|FG000|Treatment Period 2|Adverse Event|0|||
23741020|NCT01012765|66429483|FG001|Treatment Period 2|Adverse Event|1|||
23741021|NCT01012765|66429484|FG002|Treatment Period 2|Adverse Event|1|||
23741022|NCT01012765|66429485|FG003|Treatment Period 2|Adverse Event|0|||
23741023|NCT01012765|66429486|FG004|Treatment Period 2|Adverse Event|0|||
23741024|NCT01012765|66429487|FG005|Treatment Period 2|Adverse Event|0|||
23428492|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428493|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428494|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23549049|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
23549050|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
23741025|NCT01012765|66429482|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23741026|NCT01012765|66429483|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
23741027|NCT01012765|66429484|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
23741028|NCT01012765|66429485|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23741029|NCT01012765|66429486|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23741030|NCT01012765|66429487|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23741031|NCT01638546|66429488|FG000|Overall Study|Adverse Event|1|||
23741032|NCT01638546|66429489|FG001|Overall Study|Adverse Event|3|||
23741033|NCT04246996|66429490|FG000|Overall Study|Physician Decision|1|||
23741034|NCT04246996|66429491|FG001|Overall Study|Physician Decision|1|||
23741035|NCT04246996|66429490|FG000|Overall Study|Did not meet eligibility criteria|1|||
23741036|NCT04246996|66429491|FG001|Overall Study|Did not meet eligibility criteria|4|||
23741037|NCT02577107|66429496|FG000|Overall Study|Protocol deviation|0|||
23549051|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549052|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549053|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549054|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549055|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549056|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549057|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549058|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549059|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549060|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549061|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549062|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549063|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549064|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549065|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549066|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549067|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
23549068|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549069|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549070|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549071|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549072|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549073|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549074|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549075|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549076|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549077|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549078|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549079|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549080|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549081|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549082|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549083|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549084|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
23549085|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549086|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549087|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
23549088|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549089|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549090|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549091|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23428495|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
23428496|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428497|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
23428498|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428499|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
23428500|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23741038|NCT02577107|66429497|FG001|Overall Study|Protocol deviation|1|||
23741039|NCT01230827|66429498|FG000|Overall Study|Lost to Follow-up|0|||
23741040|NCT01230827|66429499|FG001|Overall Study|Lost to Follow-up|0|||
23428501|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23821061|NCT00996892|66725990|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
23821062|NCT00996892|66725991|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
23821063|NCT00996892|66725992|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
23821064|NCT00996892|66725993|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
23821065|NCT00996892|66725994|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
23821066|NCT00996892|66725995|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
23821067|NCT00996892|66725996|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
23821068|NCT00996892|66725997|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
23821069|NCT00996892|66725998|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
23821070|NCT00996892|66725999|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
23428502|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428503|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23741041|NCT01230827|66429500|FG002|Overall Study|Lost to Follow-up|1|||
23741042|NCT01230827|66429501|FG003|Overall Study|Lost to Follow-up|3|||
23821071|NCT00996892|66726000|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
23821072|NCT00996892|66726001|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
23741043|NCT01230827|66429498|FG000|Overall Study|Withdrawal by Subject|1|||
23821073|NCT00996892|66726002|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
23821074|NCT00996892|66726003|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
23821075|NCT00996892|66726004|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
23821076|NCT00996892|66726005|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
23741044|NCT01230827|66429499|FG001|Overall Study|Withdrawal by Subject|0|||
23741045|NCT01230827|66429500|FG002|Overall Study|Withdrawal by Subject|3|||
23741046|NCT01230827|66429501|FG003|Overall Study|Withdrawal by Subject|2|||
23741047|NCT01230827|66429498|FG000|Overall Study|Lack of Efficacy|14|||
23428504|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428505|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428506|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428507|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428508|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23741048|NCT01230827|66429499|FG001|Overall Study|Lack of Efficacy|1|||
23741049|NCT01230827|66429500|FG002|Overall Study|Lack of Efficacy|2|||
23428509|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428510|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428511|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428512|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428513|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
23428514|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428515|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
23428516|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428517|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
23428518|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
23428519|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428520|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428521|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428522|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23741050|NCT01230827|66429501|FG003|Overall Study|Lack of Efficacy|3|||
23741051|NCT01230827|66429498|FG000|Overall Study|Adverse Event|4|||
23741052|NCT01230827|66429499|FG001|Overall Study|Adverse Event|2|||
23428523|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428524|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428525|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428526|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23620071|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
23620072|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
23741053|NCT01230827|66429500|FG002|Overall Study|Adverse Event|3|||
23741054|NCT01230827|66429501|FG003|Overall Study|Adverse Event|7|||
23741055|NCT01230827|66429498|FG000|Overall Study|Recovery|0|||
23741056|NCT01230827|66429499|FG001|Overall Study|Recovery|6|||
23428527|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428528|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428529|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428530|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428531|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428532|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428533|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428534|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428535|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23453635|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23549092|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549093|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549094|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549095|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549096|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549097|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23741057|NCT01230827|66429500|FG002|Overall Study|Recovery|0|||
23741058|NCT01230827|66429501|FG003|Overall Study|Recovery|0|||
23741059|NCT01230827|66429498|FG000|Overall Study|Study terminated by Sponsor|0|||
23741060|NCT01230827|66429499|FG001|Overall Study|Study terminated by Sponsor|2|||
23741061|NCT01230827|66429500|FG002|Overall Study|Study terminated by Sponsor|56|||
23741062|NCT01230827|66429501|FG003|Overall Study|Study terminated by Sponsor|63|||
23741063|NCT01482598|66429502|FG000|Overall Study|Death|7|||
23741064|NCT01482598|66429503|FG001|Overall Study|Death|10|||
23741065|NCT01482598|66429502|FG000|Overall Study|Physician Decision|0|||
23741066|NCT01482598|66429503|FG001|Overall Study|Physician Decision|3|||
23741067|NCT01482598|66429502|FG000|Overall Study|Withdrawal by Subject|4|||
23741068|NCT01482598|66429503|FG001|Overall Study|Withdrawal by Subject|5|||
23741069|NCT01482598|66429502|FG000|Overall Study|Lost to Follow-up|5|||
23741070|NCT01482598|66429503|FG001|Overall Study|Lost to Follow-up|4|||
23741071|NCT01569568|66429512|FG000|Overall Study|Physician Decision|0|||
23741072|NCT01569568|66429513|FG001|Overall Study|Physician Decision|2|||
23741073|NCT00166504|66429522|FG000|Overall Study|Adverse Event|3|||
23741074|NCT00166504|66429523|FG001|Overall Study|Adverse Event|3|||
23741075|NCT00166504|66429522|FG000|Overall Study|Lost to Follow-up|1|||
23741076|NCT00166504|66429523|FG001|Overall Study|Lost to Follow-up|1|||
23741077|NCT00166504|66429522|FG000|Overall Study|Withdrawal by Subject|1|||
23741078|NCT00166504|66429523|FG001|Overall Study|Withdrawal by Subject|0|||
23741079|NCT04557189|66429524|FG000|Overall Study|Adverse Event|0|||
23741080|NCT04557189|66429525|FG001|Overall Study|Adverse Event|1|||
23741081|NCT04557189|66429524|FG000|Overall Study|Lost to Follow-up|1|||
23741082|NCT04557189|66429525|FG001|Overall Study|Lost to Follow-up|1|||
23741083|NCT04557189|66429524|FG000|Overall Study|Withdrawal by Subject|2|||
23741084|NCT04557189|66429525|FG001|Overall Study|Withdrawal by Subject|1|||
23741085|NCT04557189|66429524|FG000|Overall Study|Reason not Specified|3|||
23741086|NCT04557189|66429525|FG001|Overall Study|Reason not Specified|6|||
23741087|NCT00453349|66429526|FG000|Randomized|Adverse Event|12|||
23741088|NCT00453349|66429527|FG001|Randomized|Adverse Event|11|||
23741089|NCT00453349|66429526|FG000|Randomized|Lack of Efficacy|2|||
23741090|NCT00453349|66429527|FG001|Randomized|Lack of Efficacy|1|||
23741091|NCT00453349|66429526|FG000|Randomized|Lost to Follow-up|7|||
23741092|NCT00453349|66429527|FG001|Randomized|Lost to Follow-up|5|||
23741093|NCT00453349|66429526|FG000|Randomized|Protocol Violation|1|||
23741094|NCT00453349|66429527|FG001|Randomized|Protocol Violation|1|||
23741095|NCT00453349|66429526|FG000|Randomized|Withdrawal by Subject|3|||
23741096|NCT00453349|66429527|FG001|Randomized|Withdrawal by Subject|5|||
23741097|NCT00453349|66429526|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
23741098|NCT00453349|66429527|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
23741099|NCT00453349|66429526|FG000|Completed Study|Adverse Event|12|||
23741100|NCT00453349|66429527|FG001|Completed Study|Adverse Event|11|||
23741101|NCT00453349|66429526|FG000|Completed Study|Lack of Efficacy|2|||
23741102|NCT00453349|66429527|FG001|Completed Study|Lack of Efficacy|1|||
23741103|NCT00453349|66429526|FG000|Completed Study|Lost to Follow-up|7|||
23741104|NCT00453349|66429527|FG001|Completed Study|Lost to Follow-up|5|||
23741105|NCT00453349|66429526|FG000|Completed Study|Protocol Violation|1|||
23741106|NCT00453349|66429527|FG001|Completed Study|Protocol Violation|1|||
23741107|NCT00453349|66429526|FG000|Completed Study|Withdrawal by Subject|3|||
23741108|NCT00453349|66429527|FG001|Completed Study|Withdrawal by Subject|5|||
23741109|NCT00453349|66429526|FG000|Completed Study|Lost to follow up after study treatment|2|||
23821077|NCT00996892|66725986|FG000|Dose-Escalation Stage 1A|Death|0|||
23741110|NCT00453349|66429527|FG001|Completed Study|Lost to follow up after study treatment|11|||
23741111|NCT01038609|66429528|FG000|Overall Study|Adverse Event|0|||
23741112|NCT01038609|66429529|FG001|Overall Study|Adverse Event|0|||
23620073|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
23620074|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
23620075|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
23620076|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
23620077|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
23620078|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
23620079|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
23620080|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
23620081|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
23620082|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
23620083|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
23620084|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
23620085|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
23620086|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
23620087|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
23620088|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
23620089|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
23620090|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
23741113|NCT01038609|66429530|FG002|Overall Study|Adverse Event|1|||
23741114|NCT01038609|66429531|FG003|Overall Study|Adverse Event|0|||
23741115|NCT01038609|66429532|FG004|Overall Study|Adverse Event|0|||
23741116|NCT01038609|66429528|FG000|Overall Study|Dosing Error|0|||
23741117|NCT01038609|66429529|FG001|Overall Study|Dosing Error|0|||
23741118|NCT01038609|66429530|FG002|Overall Study|Dosing Error|0|||
23741119|NCT01038609|66429531|FG003|Overall Study|Dosing Error|1|||
23741120|NCT01038609|66429532|FG004|Overall Study|Dosing Error|1|||
23741121|NCT01038609|66429528|FG000|Overall Study|Death in the Family|1|||
23741122|NCT01038609|66429529|FG001|Overall Study|Death in the Family|0|||
23741123|NCT01038609|66429530|FG002|Overall Study|Death in the Family|0|||
23741124|NCT01038609|66429531|FG003|Overall Study|Death in the Family|0|||
23741125|NCT01038609|66429532|FG004|Overall Study|Death in the Family|0|||
23741126|NCT01038609|66429528|FG000|Overall Study|Refusal of Blood Draws|0|||
23741127|NCT01038609|66429529|FG001|Overall Study|Refusal of Blood Draws|1|||
23428536|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428537|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428538|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428539|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428540|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428541|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428542|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428543|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23453636|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23549098|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
23741128|NCT01038609|66429530|FG002|Overall Study|Refusal of Blood Draws|0|||
23741129|NCT01038609|66429531|FG003|Overall Study|Refusal of Blood Draws|0|||
23741130|NCT01038609|66429532|FG004|Overall Study|Refusal of Blood Draws|0|||
23741131|NCT02354599|66429536|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23741132|NCT02354599|66429537|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23741133|NCT02354599|66429538|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23741134|NCT02354599|66429539|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23741135|NCT02354599|66429540|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23741136|NCT02354599|66429541|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
23549099|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549100|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549101|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549102|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549103|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549104|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
23549105|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549106|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549107|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
23741137|NCT02354599|66429536|FG000|Overall Study|Withdrawal by Subject|1|||
23741138|NCT02354599|66429537|FG001|Overall Study|Withdrawal by Subject|1|||
23741139|NCT02354599|66429538|FG002|Overall Study|Withdrawal by Subject|0|||
23741140|NCT02354599|66429539|FG003|Overall Study|Withdrawal by Subject|0|||
23821078|NCT00996892|66725987|FG001|Dose-Escalation Stage 1A|Death|0|||
23821079|NCT00996892|66725988|FG002|Dose-Escalation Stage 1A|Death|0|||
23741141|NCT02354599|66429540|FG004|Overall Study|Withdrawal by Subject|0|||
23741142|NCT02354599|66429541|FG005|Overall Study|Withdrawal by Subject|0|||
23741143|NCT03868059|66429546|FG000|Overall Study|Adverse Event|3|||
23741144|NCT03868059|66429546|FG000|Overall Study|Lost to Follow-up|3|||
23741145|NCT03868059|66429546|FG000|Overall Study|Withdrawal by Subject|6|||
23741146|NCT01453296|66432611|FG000|Treatment Period 1|Adverse Event|0|||
23741147|NCT01453296|66432612|FG001|Treatment Period 1|Adverse Event|1|||
23741148|NCT01453296|66432611|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
23741149|NCT01453296|66432612|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
23741150|NCT01453296|66432611|FG000|Treatment Period 2|Adverse Event|1|||
23741151|NCT01453296|66432612|FG001|Treatment Period 2|Adverse Event|0|||
23741152|NCT01453296|66432611|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23741153|NCT01453296|66432612|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23741154|NCT03764813|66432613|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
23741155|NCT03764813|66432614|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
23741156|NCT03764813|66432615|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
23741157|NCT03764813|66432616|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
23741158|NCT01855919|66432617|FG000|Overall Study|Adverse Event|16|||
23741159|NCT01855919|66432618|FG001|Overall Study|Adverse Event|8|||
23741160|NCT01855919|66432617|FG000|Overall Study|Lack of Efficacy|1|||
23741161|NCT01855919|66432618|FG001|Overall Study|Lack of Efficacy|3|||
23741162|NCT01855919|66432617|FG000|Overall Study|Withdrawal by Subject|4|||
23741163|NCT01855919|66432618|FG001|Overall Study|Withdrawal by Subject|10|||
23741164|NCT01855919|66432617|FG000|Overall Study|Entry Criteria Not Met|1|||
23741165|NCT01855919|66432618|FG001|Overall Study|Entry Criteria Not Met|1|||
23741166|NCT01855919|66432617|FG000|Overall Study|Protocol Violation|1|||
23741167|NCT01855919|66432618|FG001|Overall Study|Protocol Violation|4|||
23741168|NCT01383317|66432622|FG000|Overall Study|Lost to Follow-up|2|||
23741169|NCT01383317|66432623|FG001|Overall Study|Lost to Follow-up|1|||
23741170|NCT01383317|66432622|FG000|Overall Study|Death|1|||
23741171|NCT01383317|66432623|FG001|Overall Study|Death|0|||
23741172|NCT01383317|66432622|FG000|Overall Study|Adverse Event|0|||
23741173|NCT01383317|66432623|FG001|Overall Study|Adverse Event|1|||
23741174|NCT00848965|66432627|FG000|Overall Study|Adverse Event|1|||
23741175|NCT00848965|66432627|FG000|Overall Study|Withdrawal by Subject|1|||
23741176|NCT04212221|66432628|FG000|Overall Study|Remained on Treatment|0|||
23741177|NCT04212221|66432629|FG001|Overall Study|Remained on Treatment|0|||
23741178|NCT04212221|66432630|FG002|Overall Study|Remained on Treatment|0|||
23741179|NCT04212221|66432631|FG003|Overall Study|Remained on Treatment|1|||
23741180|NCT04212221|66432632|FG004|Overall Study|Remained on Treatment|0|||
23741181|NCT04212221|66432633|FG005|Overall Study|Remained on Treatment|0|||
23741182|NCT04212221|66432634|FG006|Overall Study|Remained on Treatment|3|||
23741183|NCT04212221|66432635|FG007|Overall Study|Remained on Treatment|9|||
23741184|NCT04212221|66432628|FG000|Overall Study|Adverse Event|0|||
23741185|NCT04212221|66432629|FG001|Overall Study|Adverse Event|0|||
23741186|NCT04212221|66432630|FG002|Overall Study|Adverse Event|0|||
23741187|NCT04212221|66432631|FG003|Overall Study|Adverse Event|0|||
23741188|NCT04212221|66432632|FG004|Overall Study|Adverse Event|0|||
23741189|NCT04212221|66432633|FG005|Overall Study|Adverse Event|0|||
23741190|NCT04212221|66432634|FG006|Overall Study|Adverse Event|2|||
23741191|NCT04212221|66432635|FG007|Overall Study|Adverse Event|3|||
23741192|NCT04212221|66432628|FG000|Overall Study|Death|0|||
23549108|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549109|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549110|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549111|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549112|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549113|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
23741193|NCT04212221|66432629|FG001|Overall Study|Death|0|||
23741194|NCT04212221|66432630|FG002|Overall Study|Death|0|||
23741195|NCT04212221|66432631|FG003|Overall Study|Death|0|||
23741196|NCT04212221|66432632|FG004|Overall Study|Death|0|||
23741197|NCT04212221|66432633|FG005|Overall Study|Death|0|||
23741198|NCT04212221|66432634|FG006|Overall Study|Death|0|||
23741199|NCT04212221|66432635|FG007|Overall Study|Death|2|||
23741200|NCT04212221|66432628|FG000|Overall Study|Disease progression according to irRECIST|1|||
23741201|NCT04212221|66432629|FG001|Overall Study|Disease progression according to irRECIST|2|||
23741202|NCT04212221|66432630|FG002|Overall Study|Disease progression according to irRECIST|3|||
23741203|NCT04212221|66432631|FG003|Overall Study|Disease progression according to irRECIST|3|||
23741204|NCT04212221|66432632|FG004|Overall Study|Disease progression according to irRECIST|2|||
23741205|NCT04212221|66432633|FG005|Overall Study|Disease progression according to irRECIST|2|||
23741206|NCT04212221|66432634|FG006|Overall Study|Disease progression according to irRECIST|21|||
23741207|NCT04212221|66432635|FG007|Overall Study|Disease progression according to irRECIST|17|||
23741208|NCT04212221|66432628|FG000|Overall Study|Global Deterioration of Health Status|0|||
23741209|NCT04212221|66432629|FG001|Overall Study|Global Deterioration of Health Status|0|||
23428544|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428545|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428546|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428547|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23821080|NCT00996892|66725989|FG003|Dose-Escalation Stage 1A|Death|0|||
23821081|NCT00996892|66725990|FG004|Dose-Escalation Stage 1A|Death|0|||
23821082|NCT00996892|66725991|FG005|Dose-Escalation Stage 1A|Death|0|||
23821083|NCT00996892|66725992|FG006|Dose-Escalation Stage 1A|Death|0|||
23428548|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428549|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428550|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428551|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428552|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428553|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428554|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428555|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428556|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428557|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428558|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428559|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428560|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428561|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428562|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
23428563|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
23428564|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428565|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428566|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23549114|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549115|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549116|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549117|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549118|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549119|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549120|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23821084|NCT00996892|66725993|FG007|Dose-Escalation Stage 1A|Death|0|||
23821085|NCT00996892|66725994|FG008|Dose-Escalation Stage 1A|Death|0|||
23821086|NCT00996892|66725995|FG009|Dose-Escalation Stage 1A|Death|2|||
23821087|NCT00996892|66725996|FG010|Dose-Escalation Stage 1A|Death|0|||
23821088|NCT00996892|66725997|FG011|Dose-Escalation Stage 1A|Death|1|||
23821089|NCT00996892|66725998|FG012|Dose-Escalation Stage 1A|Death|1|||
23821090|NCT00996892|66725999|FG013|Dose-Escalation Stage 1A|Death|0|||
23821091|NCT00996892|66726000|FG014|Dose-Escalation Stage 1A|Death|0|||
23821092|NCT00996892|66726001|FG015|Dose-Escalation Stage 1A|Death|0|||
23821093|NCT00996892|66726002|FG016|Dose-Escalation Stage 1A|Death|0|||
23821094|NCT00996892|66726003|FG017|Dose-Escalation Stage 1A|Death|0|||
23821095|NCT00996892|66726004|FG018|Dose-Escalation Stage 1A|Death|0|||
23821096|NCT00996892|66726005|FG019|Dose-Escalation Stage 1A|Death|0|||
23821097|NCT00996892|66725986|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
23821098|NCT00996892|66725987|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
23549121|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549122|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549123|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
23741210|NCT04212221|66432630|FG002|Overall Study|Global Deterioration of Health Status|0|||
23741211|NCT04212221|66432631|FG003|Overall Study|Global Deterioration of Health Status|0|||
23741212|NCT04212221|66432632|FG004|Overall Study|Global Deterioration of Health Status|0|||
23741213|NCT04212221|66432633|FG005|Overall Study|Global Deterioration of Health Status|0|||
23741214|NCT04212221|66432634|FG006|Overall Study|Global Deterioration of Health Status|0|||
23741215|NCT04212221|66432635|FG007|Overall Study|Global Deterioration of Health Status|2|||
23741216|NCT04212221|66432628|FG000|Overall Study|Investigator's Decision|0|||
23741217|NCT04212221|66432629|FG001|Overall Study|Investigator's Decision|0|||
23741218|NCT04212221|66432630|FG002|Overall Study|Investigator's Decision|0|||
23741219|NCT04212221|66432631|FG003|Overall Study|Investigator's Decision|1|||
23741220|NCT04212221|66432632|FG004|Overall Study|Investigator's Decision|0|||
23821099|NCT00996892|66725988|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
23821100|NCT00996892|66725989|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
23821101|NCT00996892|66725990|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
23821102|NCT00996892|66725991|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
23741221|NCT04212221|66432633|FG005|Overall Study|Investigator's Decision|0|||
23741222|NCT04212221|66432634|FG006|Overall Study|Investigator's Decision|3|||
23741223|NCT04212221|66432635|FG007|Overall Study|Investigator's Decision|0|||
23741224|NCT04212221|66432628|FG000|Overall Study|Participant refused to continue treatment|0|||
23741225|NCT04212221|66432629|FG001|Overall Study|Participant refused to continue treatment|1|||
23741226|NCT04212221|66432630|FG002|Overall Study|Participant refused to continue treatment|0|||
23741227|NCT04212221|66432631|FG003|Overall Study|Participant refused to continue treatment|1|||
23741228|NCT04212221|66432632|FG004|Overall Study|Participant refused to continue treatment|1|||
23741229|NCT04212221|66432633|FG005|Overall Study|Participant refused to continue treatment|2|||
23741230|NCT04212221|66432634|FG006|Overall Study|Participant refused to continue treatment|4|||
23741231|NCT04212221|66432635|FG007|Overall Study|Participant refused to continue treatment|2|||
23741232|NCT04212221|66432628|FG000|Overall Study|Protocol Violation|0|||
23741233|NCT04212221|66432629|FG001|Overall Study|Protocol Violation|0|||
23741234|NCT04212221|66432630|FG002|Overall Study|Protocol Violation|0|||
23741235|NCT04212221|66432631|FG003|Overall Study|Protocol Violation|0|||
23741236|NCT04212221|66432632|FG004|Overall Study|Protocol Violation|0|||
23741237|NCT04212221|66432633|FG005|Overall Study|Protocol Violation|0|||
23741238|NCT04212221|66432634|FG006|Overall Study|Protocol Violation|0|||
23741239|NCT04212221|66432635|FG007|Overall Study|Protocol Violation|1|||
23741240|NCT02390167|66432636|FG000|Overall Study|Lost to Follow-up|1|||
23741241|NCT02127931|66432637|FG000|Overall Study|Glitch in Game|1|||
23741242|NCT01605370|66432638|FG000|Overall Study|Adverse Event|1|||
23741243|NCT01605370|66432639|FG001|Overall Study|Adverse Event|0|||
23741244|NCT00401726|66432640|FG000|Overall Study|Adverse Event|34|||
23741245|NCT00401726|66432641|FG001|Overall Study|Adverse Event|45|||
23741246|NCT00401726|66432640|FG000|Overall Study|Death|0|||
23741247|NCT00401726|66432641|FG001|Overall Study|Death|3|||
23741248|NCT00401726|66432640|FG000|Overall Study|Sponsor Request|0|||
23741249|NCT00401726|66432641|FG001|Overall Study|Sponsor Request|1|||
23741250|NCT00401726|66432640|FG000|Overall Study|Physician Decision|3|||
23821103|NCT00996892|66725992|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
23821104|NCT00996892|66725993|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
23821105|NCT00996892|66725994|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
23821106|NCT00996892|66725995|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
23821107|NCT00996892|66725996|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
23821108|NCT00996892|66725997|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
23549124|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549125|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549126|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549127|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549128|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23741251|NCT00401726|66432641|FG001|Overall Study|Physician Decision|6|||
23741252|NCT00401726|66432640|FG000|Overall Study|Lost to Follow-up|23|||
23741253|NCT00401726|66432641|FG001|Overall Study|Lost to Follow-up|20|||
23741254|NCT00401726|66432640|FG000|Overall Study|Protocol Violation|6|||
23741255|NCT00401726|66432641|FG001|Overall Study|Protocol Violation|3|||
23741256|NCT00401726|66432640|FG000|Overall Study|Withdrawal by Subject|18|||
23821109|NCT00996892|66725998|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
23741257|NCT00401726|66432641|FG001|Overall Study|Withdrawal by Subject|24|||
23741258|NCT00401726|66432640|FG000|Overall Study|Lack of Efficacy|4|||
23741259|NCT00401726|66432641|FG001|Overall Study|Lack of Efficacy|6|||
23741260|NCT00401726|66432640|FG000|Overall Study|Protocol Deviation|9|||
23741261|NCT00401726|66432641|FG001|Overall Study|Protocol Deviation|4|||
23741262|NCT03556202|66432645|FG000|Extension Treatment Period|Adverse Event|18|||
23741263|NCT03556202|66432646|FG001|Extension Treatment Period|Adverse Event|14|||
23741264|NCT03556202|66432647|FG002|Extension Treatment Period|Adverse Event|9|||
23741265|NCT03556202|66432645|FG000|Extension Treatment Period|Death|2|||
23741266|NCT03556202|66432646|FG001|Extension Treatment Period|Death|6|||
23821110|NCT00996892|66725999|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
23821111|NCT00996892|66726000|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
23821112|NCT00996892|66726001|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
23821113|NCT00996892|66726002|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
23821114|NCT00996892|66726003|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
23821115|NCT00996892|66726004|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
23821116|NCT00996892|66726005|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
23741267|NCT03556202|66432647|FG002|Extension Treatment Period|Death|0|||
23741268|NCT03556202|66432645|FG000|Extension Treatment Period|Lack of Efficacy|5|||
23741269|NCT03556202|66432646|FG001|Extension Treatment Period|Lack of Efficacy|12|||
23741270|NCT03556202|66432647|FG002|Extension Treatment Period|Lack of Efficacy|18|||
23741271|NCT03556202|66432645|FG000|Extension Treatment Period|Lost to Follow-up|9|||
23741272|NCT03556202|66432646|FG001|Extension Treatment Period|Lost to Follow-up|20|||
23741273|NCT03556202|66432647|FG002|Extension Treatment Period|Lost to Follow-up|2|||
23741274|NCT03556202|66432645|FG000|Extension Treatment Period|Pregnancy|2|||
23741275|NCT03556202|66432646|FG001|Extension Treatment Period|Pregnancy|4|||
23428567|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428568|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428569|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428570|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428571|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428572|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428573|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23549129|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23741276|NCT03556202|66432647|FG002|Extension Treatment Period|Pregnancy|3|||
23741277|NCT03556202|66432645|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
23741278|NCT03556202|66432646|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
23741279|NCT03556202|66432647|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
23741280|NCT03556202|66432645|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
23741281|NCT03556202|66432646|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
23549130|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549131|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549132|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23821117|NCT00996892|66725986|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821118|NCT00996892|66725987|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821119|NCT00996892|66725988|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821120|NCT00996892|66725989|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23549133|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549134|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23821121|NCT00996892|66725990|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821122|NCT00996892|66725991|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821123|NCT00996892|66725992|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821124|NCT00996892|66725993|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821125|NCT00996892|66725994|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23549135|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23821126|NCT00996892|66725995|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23549136|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549137|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549138|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549139|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23741282|NCT03556202|66432647|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
23741283|NCT03556202|66432645|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
23741284|NCT03556202|66432646|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
23741285|NCT03556202|66432647|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
23549140|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549141|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23741286|NCT03556202|66432645|FG000|Extension Treatment Period|Physician Decision|0|||
23741287|NCT03556202|66432646|FG001|Extension Treatment Period|Physician Decision|8|||
23741288|NCT03556202|66432647|FG002|Extension Treatment Period|Physician Decision|2|||
23741289|NCT03556202|66432645|FG000|Extension Treatment Period|Protocol Violation|0|||
23741290|NCT03556202|66432646|FG001|Extension Treatment Period|Protocol Violation|1|||
23741291|NCT03556202|66432647|FG002|Extension Treatment Period|Protocol Violation|1|||
23741292|NCT03556202|66432645|FG000|Extension Treatment Period|Sponsor Decision|0|||
23741293|NCT03556202|66432646|FG001|Extension Treatment Period|Sponsor Decision|1|||
23741294|NCT03556202|66432647|FG002|Extension Treatment Period|Sponsor Decision|0|||
23741295|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
23741296|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
23741297|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
23741298|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Death|1|||
23741299|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Death|0|||
23741300|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Death|0|||
23741301|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
23741302|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
23821127|NCT00996892|66725996|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23821128|NCT00996892|66725997|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23549142|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549143|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549144|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549145|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549146|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549147|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549148|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549149|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
23741303|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
23741304|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
23741305|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
23741306|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
23741307|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
23741308|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
23741309|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
23741310|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
23741311|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
23741312|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
23741313|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
23741314|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
23821129|NCT00996892|66725998|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23821130|NCT00996892|66725999|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821131|NCT00996892|66726000|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821132|NCT00996892|66726001|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821133|NCT00996892|66726002|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821134|NCT00996892|66726003|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821135|NCT00996892|66726004|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821136|NCT00996892|66726005|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23821137|NCT00996892|66725986|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
23821138|NCT00996892|66725987|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
23821139|NCT00996892|66725988|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
23821140|NCT00996892|66725989|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
23821141|NCT00996892|66725990|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
23821142|NCT00996892|66725991|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
23821143|NCT00996892|66725992|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
23821144|NCT00996892|66725993|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
23821145|NCT00996892|66725994|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
23821146|NCT00996892|66725995|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
23821147|NCT00996892|66725996|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
23821148|NCT00996892|66725997|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
23821149|NCT00996892|66725998|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
23821150|NCT00996892|66725999|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
23821151|NCT00996892|66726000|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
23821152|NCT00996892|66726001|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
23821153|NCT00996892|66726002|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
23821154|NCT00996892|66726003|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
23821155|NCT00996892|66726004|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
23821156|NCT00996892|66726005|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
23821157|NCT00996892|66725986|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
23821158|NCT00996892|66725987|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
23821159|NCT00996892|66725988|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
23821160|NCT00996892|66725989|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
23821161|NCT00996892|66725990|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
23821162|NCT00996892|66725991|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
23821163|NCT00996892|66725992|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
23821164|NCT00996892|66725993|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
23821165|NCT00996892|66725994|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
23821166|NCT00996892|66725995|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
23821167|NCT00996892|66725996|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
23821168|NCT00996892|66725997|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
23821169|NCT00996892|66725998|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
23821170|NCT00996892|66725999|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
23821171|NCT00996892|66726000|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
23821172|NCT00996892|66726001|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
23821173|NCT00996892|66726002|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
23821174|NCT00996892|66726003|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
23821175|NCT00996892|66726004|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
23821176|NCT00996892|66726005|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
23821177|NCT00996892|66725986|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
23821178|NCT00996892|66725987|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
23821179|NCT00996892|66725988|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
23821180|NCT00996892|66725989|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
23821181|NCT00996892|66725990|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
23821182|NCT00996892|66725991|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
23821183|NCT00996892|66725992|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
23428574|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428575|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23741315|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
23741316|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
23741317|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
23741318|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
23741319|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
23741320|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
23741321|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
23741322|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
23741323|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
23741324|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
23741325|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
23741326|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
23741327|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
23741328|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
23741329|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
23741330|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
23741331|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
23741332|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
23741333|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
23741334|NCT03556202|66432645|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
23741335|NCT03556202|66432646|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
23741336|NCT03556202|66432647|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
23741337|NCT05403502|66432657|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
23741338|NCT05403502|66432657|FG000|Humalog Lead-In Period|Physician Decision|2|||
23741339|NCT05403502|66432657|FG000|Humalog Lead-In Period|Protocol Violation|1|||
23741340|NCT05403502|66432657|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
23741341|NCT05403502|66432657|FG000|Lyumjev Treatment Period|Physician Decision|2|||
23741342|NCT02493712|66432660|FG000|Overall Study|Withdrawal by Subject|1|||
23741343|NCT02493712|66432661|FG001|Overall Study|Withdrawal by Subject|0|||
23741344|NCT02493712|66432662|FG002|Overall Study|Withdrawal by Subject|2|||
23741345|NCT02493712|66432660|FG000|Overall Study|Protocol Violation|0|||
23741346|NCT02493712|66432661|FG001|Overall Study|Protocol Violation|0|||
23741347|NCT02493712|66432662|FG002|Overall Study|Protocol Violation|1|||
23741348|NCT02493712|66432660|FG000|Overall Study|Lost to Follow-up|1|||
23741349|NCT02493712|66432661|FG001|Overall Study|Lost to Follow-up|0|||
23741350|NCT02493712|66432662|FG002|Overall Study|Lost to Follow-up|0|||
23741351|NCT02493712|66432660|FG000|Overall Study|Physician Decision|0|||
23741352|NCT02493712|66432661|FG001|Overall Study|Physician Decision|1|||
23741353|NCT02493712|66432662|FG002|Overall Study|Physician Decision|0|||
23741354|NCT02493712|66432660|FG000|Overall Study|Lack of Efficacy|0|||
23741355|NCT02493712|66432661|FG001|Overall Study|Lack of Efficacy|5|||
23741356|NCT02493712|66432662|FG002|Overall Study|Lack of Efficacy|3|||
23741357|NCT03633461|66432666|FG000|Overall Study|Lost to Follow-up|0|||
23741358|NCT03633461|66432667|FG001|Overall Study|Lost to Follow-up|1|||
23821184|NCT00996892|66725993|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
23821185|NCT00996892|66725994|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
23741359|NCT01101321|66432668|FG000|Period 1|Withdrawal by Subject|1|||
23741360|NCT01101321|66432669|FG001|Period 1|Withdrawal by Subject|1|||
23741361|NCT01101321|66432668|FG000|Period 1|Adverse Event|3|||
23741362|NCT01101321|66432669|FG001|Period 1|Adverse Event|3|||
23741363|NCT00223990|66432670|FG000|Overall Study|Moved from area|2|||
23741364|NCT00223990|66432671|FG001|Overall Study|Moved from area|1|||
23741365|NCT00223990|66432670|FG000|Overall Study|Withdrawal by Subject|4|||
23741366|NCT00223990|66432671|FG001|Overall Study|Withdrawal by Subject|8|||
23821186|NCT00996892|66725995|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
23821187|NCT00996892|66725996|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
23821188|NCT00996892|66725997|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
23821189|NCT00996892|66725998|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
23821190|NCT00996892|66725999|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
23821191|NCT00996892|66726000|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
23821192|NCT00996892|66726001|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
23821193|NCT00996892|66726002|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
23821194|NCT00996892|66726003|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
23821195|NCT00996892|66726004|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
23549150|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23741367|NCT00223990|66432670|FG000|Overall Study|Lost to Follow-up|1|||
23821196|NCT00996892|66726005|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
23549151|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23741368|NCT00223990|66432671|FG001|Overall Study|Lost to Follow-up|0|||
23741369|NCT02361307|66432674|FG000|Overall Study|Unstable medical condition.|0|||
23821197|NCT00996892|66725986|FG000|Expansion Stage 2|Adverse Event|0|||
23821198|NCT00996892|66725987|FG001|Expansion Stage 2|Adverse Event|0|||
23821199|NCT00996892|66725988|FG002|Expansion Stage 2|Adverse Event|0|||
23821200|NCT00996892|66725989|FG003|Expansion Stage 2|Adverse Event|0|||
23821201|NCT00996892|66725990|FG004|Expansion Stage 2|Adverse Event|0|||
23821202|NCT00996892|66725991|FG005|Expansion Stage 2|Adverse Event|0|||
23620091|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
23620092|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
23620093|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
23620094|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
23620095|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
23620096|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
23620097|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
23620098|NCT00125853|65994869|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
23620099|NCT00125853|65994870|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
23620100|NCT01702519|65994871|FG000|Washout Period|Lost to Follow-up|1|||
23620101|NCT01702519|65994872|FG001|Washout Period|Lost to Follow-up|0|||
23821203|NCT00996892|66725992|FG006|Expansion Stage 2|Adverse Event|0|||
23549152|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549153|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549154|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549155|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549156|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549157|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549158|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549159|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549160|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549161|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549162|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549163|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
23549164|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
23549165|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
23549166|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
23549167|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
23549168|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
23549169|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
23549170|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549171|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549172|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549173|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549174|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549175|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549176|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549177|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549178|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549179|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549180|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549181|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549182|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549183|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549184|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549185|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549186|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549187|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549188|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549189|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549190|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549191|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549192|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
23620102|NCT01702519|65994871|FG000|Washout Period|Withdrawal by Subject|0|||
23620103|NCT01702519|65994872|FG001|Washout Period|Withdrawal by Subject|2|||
23620104|NCT02435381|65994873|FG000|Overall Study|Lost to Follow-up|2|||
23620105|NCT02435381|65994874|FG001|Overall Study|Lost to Follow-up|1|||
23821204|NCT00996892|66725993|FG007|Expansion Stage 2|Adverse Event|0|||
23549193|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
23549194|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549195|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549196|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549197|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549198|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549199|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549200|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549201|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549202|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549203|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549204|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549205|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549206|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549207|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549208|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549209|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549210|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549211|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
23549212|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549213|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549214|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549215|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549216|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549217|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549218|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549219|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549220|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549221|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549222|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549223|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549224|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549225|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549226|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549227|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549228|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549229|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549230|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549231|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549232|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
23549233|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
23549234|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549235|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549236|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549237|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549238|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549239|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549240|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549241|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549242|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549243|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549244|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549245|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549246|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23620106|NCT01177137|65994883|FG000|Overall Study|Withdrawal by Subject|10|||
23620107|NCT01177137|65994884|FG001|Overall Study|Withdrawal by Subject|10|||
23821205|NCT00996892|66725994|FG008|Expansion Stage 2|Adverse Event|0|||
23821206|NCT00996892|66725995|FG009|Expansion Stage 2|Adverse Event|0|||
23821207|NCT00996892|66725996|FG010|Expansion Stage 2|Adverse Event|0|||
23620108|NCT01177137|65994885|FG002|Overall Study|Withdrawal by Subject|2|||
23620109|NCT00817336|65994886|FG000|Overall Study|Withdrawal by Subject|1|||
23821208|NCT00996892|66725997|FG011|Expansion Stage 2|Adverse Event|0|||
23428576|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23620110|NCT00817336|65994887|FG001|Overall Study|Withdrawal by Subject|1|||
23620111|NCT06247488|65994890|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
23821209|NCT00996892|66725998|FG012|Expansion Stage 2|Adverse Event|0|||
23620112|NCT06247488|65994891|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620113|NCT06247488|65994892|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620114|NCT06247488|65994893|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23741370|NCT02361307|66432675|FG001|Overall Study|Unstable medical condition.|1|||
23741371|NCT03382639|66432676|FG000|Overall Study|Adverse Event|2|||
23741372|NCT03382639|66432677|FG001|Overall Study|Adverse Event|0|||
23741373|NCT03382639|66432678|FG002|Overall Study|Adverse Event|1|||
23741374|NCT03382639|66432679|FG003|Overall Study|Adverse Event|1|||
23741375|NCT03382639|66432676|FG000|Overall Study|Lost to Follow-up|1|||
23620115|NCT06247488|65994894|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620116|NCT06247488|65994895|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23741376|NCT03382639|66432677|FG001|Overall Study|Lost to Follow-up|0|||
23549247|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549248|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549249|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549250|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
23549251|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
23549252|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
23549253|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
23549254|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549255|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23620117|NCT06247488|65994890|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23741377|NCT03382639|66432678|FG002|Overall Study|Lost to Follow-up|0|||
23741378|NCT03382639|66432679|FG003|Overall Study|Lost to Follow-up|0|||
23741379|NCT03382639|66432676|FG000|Overall Study|Withdrawal by Subject|4|||
23741380|NCT03382639|66432677|FG001|Overall Study|Withdrawal by Subject|3|||
23741381|NCT03382639|66432678|FG002|Overall Study|Withdrawal by Subject|2|||
23741382|NCT03382639|66432679|FG003|Overall Study|Withdrawal by Subject|3|||
23741383|NCT03382639|66432676|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23741384|NCT03382639|66432677|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
23741385|NCT03382639|66432678|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
23741386|NCT03382639|66432679|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
23741387|NCT03382639|66432676|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
23821210|NCT00996892|66725999|FG013|Expansion Stage 2|Adverse Event|0|||
23821211|NCT00996892|66726000|FG014|Expansion Stage 2|Adverse Event|0|||
23821212|NCT00996892|66726001|FG015|Expansion Stage 2|Adverse Event|0|||
23821213|NCT00996892|66726002|FG016|Expansion Stage 2|Adverse Event|0|||
23821214|NCT00996892|66726003|FG017|Expansion Stage 2|Adverse Event|0|||
23821215|NCT00996892|66726004|FG018|Expansion Stage 2|Adverse Event|3|||
23821216|NCT00996892|66726005|FG019|Expansion Stage 2|Adverse Event|0|||
23821217|NCT00996892|66725986|FG000|Expansion Stage 2|Death|0|||
23821218|NCT00996892|66725987|FG001|Expansion Stage 2|Death|0|||
23821219|NCT00996892|66725988|FG002|Expansion Stage 2|Death|0|||
23821220|NCT00996892|66725989|FG003|Expansion Stage 2|Death|0|||
23821221|NCT00996892|66725990|FG004|Expansion Stage 2|Death|0|||
23821222|NCT00996892|66725991|FG005|Expansion Stage 2|Death|0|||
23821223|NCT00996892|66725992|FG006|Expansion Stage 2|Death|0|||
23821224|NCT00996892|66725993|FG007|Expansion Stage 2|Death|0|||
23620118|NCT06247488|65994891|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620119|NCT06247488|65994892|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620120|NCT06247488|65994893|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
23620121|NCT06247488|65994894|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620122|NCT06247488|65994895|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620123|NCT06247488|65994890|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
23620124|NCT06247488|65994891|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620125|NCT06247488|65994892|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620126|NCT06247488|65994893|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620127|NCT06247488|65994894|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620128|NCT06247488|65994895|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620129|NCT06247488|65994890|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620130|NCT06247488|65994891|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620131|NCT06247488|65994892|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23741388|NCT03382639|66432677|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
23741389|NCT03382639|66432678|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
23821225|NCT00996892|66725994|FG008|Expansion Stage 2|Death|0|||
23821226|NCT00996892|66725995|FG009|Expansion Stage 2|Death|0|||
23821227|NCT00996892|66725996|FG010|Expansion Stage 2|Death|0|||
23741390|NCT03382639|66432679|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
23821228|NCT00996892|66725997|FG011|Expansion Stage 2|Death|0|||
23821229|NCT00996892|66725998|FG012|Expansion Stage 2|Death|0|||
23821230|NCT00996892|66725999|FG013|Expansion Stage 2|Death|0|||
23741391|NCT03382639|66432676|FG000|Overall Study|Other|2|||
23741392|NCT03382639|66432677|FG001|Overall Study|Other|0|||
23741393|NCT03382639|66432678|FG002|Overall Study|Other|0|||
23741394|NCT03382639|66432679|FG003|Overall Study|Other|3|||
23741395|NCT01616173|66432680|FG000|Overall Study|Lost to Follow-up|0|||
23741396|NCT01616173|66432681|FG001|Overall Study|Lost to Follow-up|2|||
23741397|NCT01616173|66432682|FG002|Overall Study|Lost to Follow-up|0|||
23741398|NCT04382066|66432683|FG000|Overall Study|Adverse Event|1|||
23741399|NCT04382066|66432684|FG001|Overall Study|Adverse Event|0|||
23549256|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549257|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549258|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
23549259|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
23549260|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
23549261|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
23549262|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
23549263|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
23549264|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
23549265|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
23549266|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
23620132|NCT06247488|65994893|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
23620133|NCT06247488|65994894|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620134|NCT06247488|65994895|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620135|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620136|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620137|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620138|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620139|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620140|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
23620141|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23620142|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23620143|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23741400|NCT04382066|66432685|FG002|Overall Study|Adverse Event|0|||
23741401|NCT04382066|66432683|FG000|Overall Study|Death|1|||
23620144|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23620145|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23549267|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
23549268|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
23549269|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
23549270|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
23549271|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
23549272|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
23549273|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
23549274|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
23549275|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
23549276|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
23620146|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23620147|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23741402|NCT04382066|66432684|FG001|Overall Study|Death|0|||
23821231|NCT00996892|66726000|FG014|Expansion Stage 2|Death|0|||
23821232|NCT00996892|66726001|FG015|Expansion Stage 2|Death|0|||
23821233|NCT00996892|66726002|FG016|Expansion Stage 2|Death|0|||
23821234|NCT00996892|66726003|FG017|Expansion Stage 2|Death|0|||
23821235|NCT00996892|66726004|FG018|Expansion Stage 2|Death|2|||
23549277|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
23549278|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Death|0|||
23741403|NCT04382066|66432685|FG002|Overall Study|Death|1|||
23741404|NCT00039377|66432686|FG000|Initial Registration|Adverse Event|2|||
23741405|NCT00039377|66432687|FG001|Initial Registration|Adverse Event|0|||
23741406|NCT00039377|66432688|FG002|Initial Registration|Adverse Event|0|||
23741407|NCT00039377|66432689|FG003|Initial Registration|Adverse Event|0|||
23741408|NCT00039377|66432686|FG000|Initial Registration|Relapsed|6|||
23821236|NCT00996892|66726005|FG019|Expansion Stage 2|Death|0|||
23821237|NCT00996892|66725986|FG000|Expansion Stage 2|Physician Decision|0|||
23821238|NCT00996892|66725987|FG001|Expansion Stage 2|Physician Decision|0|||
23549279|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Death|0|||
23549280|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Death|0|||
23549281|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Death|0|||
23620148|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23620149|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23821239|NCT00996892|66725988|FG002|Expansion Stage 2|Physician Decision|0|||
23741409|NCT00039377|66432687|FG001|Initial Registration|Relapsed|0|||
23741410|NCT00039377|66432688|FG002|Initial Registration|Relapsed|0|||
23741411|NCT00039377|66432689|FG003|Initial Registration|Relapsed|0|||
23741412|NCT00039377|66432686|FG000|Initial Registration|Received non-protocol therapy|11|||
23821240|NCT00996892|66725989|FG003|Expansion Stage 2|Physician Decision|0|||
23549282|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Death|0|||
23549283|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Death|0|||
23549284|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Death|0|||
23741413|NCT00039377|66432687|FG001|Initial Registration|Received non-protocol therapy|0|||
23741414|NCT00039377|66432688|FG002|Initial Registration|Received non-protocol therapy|0|||
23741415|NCT00039377|66432689|FG003|Initial Registration|Received non-protocol therapy|0|||
23741416|NCT00039377|66432686|FG000|Initial Registration|Withdrawal by Subject|3|||
23741417|NCT00039377|66432687|FG001|Initial Registration|Withdrawal by Subject|0|||
23741418|NCT00039377|66432688|FG002|Initial Registration|Withdrawal by Subject|0|||
23741419|NCT00039377|66432689|FG003|Initial Registration|Withdrawal by Subject|0|||
23741420|NCT02418000|66432691|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
23741421|NCT02418000|66432692|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741422|NCT02418000|66432693|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741423|NCT02418000|66432694|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741424|NCT02418000|66432695|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741425|NCT02418000|66432691|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
23741426|NCT02418000|66432692|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23821241|NCT00996892|66725990|FG004|Expansion Stage 2|Physician Decision|0|||
23821242|NCT00996892|66725991|FG005|Expansion Stage 2|Physician Decision|0|||
23821243|NCT00996892|66725992|FG006|Expansion Stage 2|Physician Decision|0|||
23549285|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Death|0|||
23549286|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Death|0|||
23549287|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Death|0|||
23549288|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Death|0|||
23549289|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Death|0|||
23549290|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Death|0|||
23549291|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Death|0|||
23549292|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Death|0|||
23549293|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Death|0|||
23549294|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Death|0|||
23549295|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Death|0|||
23549296|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Death|1|||
23549297|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Death|0|||
23549298|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549299|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549300|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549301|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549302|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549303|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549304|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549305|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549306|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549307|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549308|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549309|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549310|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549311|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549312|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549313|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549314|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549315|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
23549316|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
23549317|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
23549318|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549319|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549320|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549321|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549322|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549323|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549324|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549325|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549326|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549327|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549328|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549329|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23821244|NCT00996892|66725993|FG007|Expansion Stage 2|Physician Decision|0|||
23549330|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549331|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549332|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549333|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549334|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23741427|NCT02418000|66432693|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23741428|NCT02418000|66432694|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23741429|NCT02418000|66432695|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23741430|NCT02418000|66432691|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
23741431|NCT02418000|66432692|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23741432|NCT02418000|66432693|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23741433|NCT02418000|66432694|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23741434|NCT02418000|66432695|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23741435|NCT02418000|66432691|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741436|NCT02418000|66432692|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
23549335|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549336|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
23549337|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549338|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
23549339|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
23549340|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
23549341|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
23549342|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
23549343|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
23549344|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
23549345|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
23549346|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
23549347|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
23549348|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
23549349|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
23549350|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
23549351|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
23428577|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23549352|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
23549353|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
23821245|NCT00996892|66725994|FG008|Expansion Stage 2|Physician Decision|0|||
23821246|NCT00996892|66725995|FG009|Expansion Stage 2|Physician Decision|0|||
23549354|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
23549355|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
23549356|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
23549357|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
23549358|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
23549359|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
23549360|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
23549361|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
23549362|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
23549363|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
23549364|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
23549365|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
23549366|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
23549367|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
23549368|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
23549369|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
23549370|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
23549371|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
23549372|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
23549373|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
23549374|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
23821247|NCT00996892|66725996|FG010|Expansion Stage 2|Physician Decision|0|||
23821248|NCT00996892|66725997|FG011|Expansion Stage 2|Physician Decision|0|||
23821249|NCT00996892|66725998|FG012|Expansion Stage 2|Physician Decision|0|||
23821250|NCT00996892|66725999|FG013|Expansion Stage 2|Physician Decision|0|||
23821251|NCT00996892|66726000|FG014|Expansion Stage 2|Physician Decision|0|||
23821252|NCT00996892|66726001|FG015|Expansion Stage 2|Physician Decision|0|||
23821253|NCT00996892|66726002|FG016|Expansion Stage 2|Physician Decision|0|||
23821254|NCT00996892|66726003|FG017|Expansion Stage 2|Physician Decision|0|||
23821255|NCT00996892|66726004|FG018|Expansion Stage 2|Physician Decision|1|||
23549375|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
23549376|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
23741437|NCT02418000|66432693|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23821256|NCT00996892|66726005|FG019|Expansion Stage 2|Physician Decision|0|||
23821257|NCT00996892|66725986|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
23821258|NCT00996892|66725987|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
23821259|NCT00996892|66725988|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
23428578|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428579|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23821260|NCT00996892|66725989|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
23821261|NCT00996892|66725990|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
23821262|NCT00996892|66725991|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
23821263|NCT00996892|66725992|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
23821264|NCT00996892|66725993|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
23821265|NCT00996892|66725994|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
23821266|NCT00996892|66725995|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
23821267|NCT00996892|66725996|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
23821268|NCT00996892|66725997|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
23821269|NCT00996892|66725998|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
23821270|NCT00996892|66725999|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
23821271|NCT00996892|66726000|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
23821272|NCT00996892|66726001|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
23821273|NCT00996892|66726002|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
23821274|NCT00996892|66726003|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
23821275|NCT00996892|66726004|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
23821276|NCT00996892|66726005|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
23821277|NCT00996892|66725986|FG000|Expansion Stage 2|Disease Progression|0|||
23821278|NCT00996892|66725987|FG001|Expansion Stage 2|Disease Progression|0|||
23821279|NCT00996892|66725988|FG002|Expansion Stage 2|Disease Progression|0|||
23821280|NCT00996892|66725989|FG003|Expansion Stage 2|Disease Progression|0|||
23821281|NCT00996892|66725990|FG004|Expansion Stage 2|Disease Progression|0|||
23821282|NCT00996892|66725991|FG005|Expansion Stage 2|Disease Progression|0|||
23821283|NCT00996892|66725992|FG006|Expansion Stage 2|Disease Progression|0|||
23821284|NCT00996892|66725993|FG007|Expansion Stage 2|Disease Progression|0|||
23821285|NCT00996892|66725994|FG008|Expansion Stage 2|Disease Progression|0|||
23821286|NCT00996892|66725995|FG009|Expansion Stage 2|Disease Progression|0|||
23821287|NCT00996892|66725996|FG010|Expansion Stage 2|Disease Progression|0|||
23821288|NCT00996892|66725997|FG011|Expansion Stage 2|Disease Progression|0|||
23821289|NCT00996892|66725998|FG012|Expansion Stage 2|Disease Progression|0|||
23821290|NCT00996892|66725999|FG013|Expansion Stage 2|Disease Progression|0|||
23821291|NCT00996892|66726000|FG014|Expansion Stage 2|Disease Progression|0|||
23821292|NCT00996892|66726001|FG015|Expansion Stage 2|Disease Progression|0|||
23821293|NCT00996892|66726002|FG016|Expansion Stage 2|Disease Progression|0|||
23821294|NCT00996892|66726003|FG017|Expansion Stage 2|Disease Progression|0|||
23821295|NCT00996892|66726004|FG018|Expansion Stage 2|Disease Progression|28|||
23821296|NCT00996892|66726005|FG019|Expansion Stage 2|Disease Progression|0|||
23821297|NCT00996892|66725986|FG000|Expansion Stage 2A|Adverse Event|0|||
23821298|NCT00996892|66725987|FG001|Expansion Stage 2A|Adverse Event|0|||
23821299|NCT00996892|66725988|FG002|Expansion Stage 2A|Adverse Event|0|||
23821300|NCT00996892|66725989|FG003|Expansion Stage 2A|Adverse Event|0|||
23821301|NCT00996892|66725990|FG004|Expansion Stage 2A|Adverse Event|0|||
23821302|NCT00996892|66725991|FG005|Expansion Stage 2A|Adverse Event|0|||
23821303|NCT00996892|66725992|FG006|Expansion Stage 2A|Adverse Event|0|||
23821304|NCT00996892|66725993|FG007|Expansion Stage 2A|Adverse Event|0|||
23821305|NCT00996892|66725994|FG008|Expansion Stage 2A|Adverse Event|0|||
23821306|NCT00996892|66725995|FG009|Expansion Stage 2A|Adverse Event|0|||
23821307|NCT00996892|66725996|FG010|Expansion Stage 2A|Adverse Event|0|||
23821308|NCT00996892|66725997|FG011|Expansion Stage 2A|Adverse Event|0|||
23821309|NCT00996892|66725998|FG012|Expansion Stage 2A|Adverse Event|0|||
23821310|NCT00996892|66725999|FG013|Expansion Stage 2A|Adverse Event|0|||
23549377|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
23549378|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549379|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549380|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549381|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549382|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549383|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549384|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549385|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549386|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549387|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549388|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549389|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549390|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549391|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549392|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549393|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23620150|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23821311|NCT00996892|66726000|FG014|Expansion Stage 2A|Adverse Event|0|||
23821312|NCT00996892|66726001|FG015|Expansion Stage 2A|Adverse Event|0|||
23821313|NCT00996892|66726002|FG016|Expansion Stage 2A|Adverse Event|0|||
23821314|NCT00996892|66726003|FG017|Expansion Stage 2A|Adverse Event|0|||
23821315|NCT00996892|66726004|FG018|Expansion Stage 2A|Adverse Event|0|||
23549394|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23821316|NCT00996892|66726005|FG019|Expansion Stage 2A|Adverse Event|8|||
23821317|NCT00996892|66725986|FG000|Expansion Stage 2A|Physician Decision|0|||
23821318|NCT00996892|66725987|FG001|Expansion Stage 2A|Physician Decision|0|||
23821319|NCT00996892|66725988|FG002|Expansion Stage 2A|Physician Decision|0|||
23821320|NCT00996892|66725989|FG003|Expansion Stage 2A|Physician Decision|0|||
23821321|NCT00996892|66725990|FG004|Expansion Stage 2A|Physician Decision|0|||
23821322|NCT00996892|66725991|FG005|Expansion Stage 2A|Physician Decision|0|||
23821323|NCT00996892|66725992|FG006|Expansion Stage 2A|Physician Decision|0|||
23821324|NCT00996892|66725993|FG007|Expansion Stage 2A|Physician Decision|0|||
23821325|NCT00996892|66725994|FG008|Expansion Stage 2A|Physician Decision|0|||
23549395|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549396|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549397|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549398|NCT00717860|65739686|FG000|Overall Study|Clinical adverse experience|5|||
23821326|NCT00996892|66725995|FG009|Expansion Stage 2A|Physician Decision|0|||
23821327|NCT00996892|66725996|FG010|Expansion Stage 2A|Physician Decision|0|||
23821328|NCT00996892|66725997|FG011|Expansion Stage 2A|Physician Decision|0|||
23821329|NCT00996892|66725998|FG012|Expansion Stage 2A|Physician Decision|0|||
23821330|NCT00996892|66725999|FG013|Expansion Stage 2A|Physician Decision|0|||
23821331|NCT00996892|66726000|FG014|Expansion Stage 2A|Physician Decision|0|||
23549399|NCT00717860|65739687|FG001|Overall Study|Clinical adverse experience|9|||
23549400|NCT00717860|65739686|FG000|Overall Study|Laboratory adverse experience|2|||
23549401|NCT00717860|65739687|FG001|Overall Study|Laboratory adverse experience|2|||
23549402|NCT00717860|65739686|FG000|Overall Study|Lack of Efficacy|7|||
23549403|NCT00717860|65739687|FG001|Overall Study|Lack of Efficacy|13|||
23549404|NCT00717860|65739686|FG000|Overall Study|Discontinued for other reason|6|||
23549405|NCT00717860|65739687|FG001|Overall Study|Discontinued for other reason|1|||
23549406|NCT00717860|65739686|FG000|Overall Study|Withdrew consent|7|||
23549407|NCT00717860|65739687|FG001|Overall Study|Withdrew consent|3|||
23741438|NCT02418000|66432694|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23741439|NCT02418000|66432695|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23549408|NCT04313881|65739688|FG000|Overall Study|Death|138|||
23549409|NCT04313881|65739689|FG001|Overall Study|Death|126|||
23549410|NCT04313881|65739688|FG000|Overall Study|Study terminated by sponsor|108|||
23549411|NCT04313881|65739689|FG001|Overall Study|Study terminated by sponsor|129|||
23741440|NCT02418000|66432691|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23741441|NCT02418000|66432692|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
23741442|NCT02418000|66432693|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23741443|NCT02418000|66432694|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23741444|NCT02418000|66432695|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23741445|NCT02418000|66432691|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741446|NCT02418000|66432692|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741447|NCT02418000|66432693|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23741448|NCT02418000|66432694|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741449|NCT02418000|66432695|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741450|NCT02418000|66432691|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741451|NCT02418000|66432692|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741452|NCT02418000|66432693|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741453|NCT02418000|66432694|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23741454|NCT02418000|66432695|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741455|NCT02418000|66432691|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23741456|NCT02418000|66432692|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23741457|NCT02418000|66432693|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23741458|NCT02418000|66432694|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23741459|NCT02418000|66432695|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
23741460|NCT02418000|66432691|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741461|NCT02418000|66432692|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741462|NCT02418000|66432693|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23821332|NCT00996892|66726001|FG015|Expansion Stage 2A|Physician Decision|0|||
23549412|NCT04313881|65739688|FG000|Overall Study|Consent withdrawn|19|||
23549413|NCT04313881|65739689|FG001|Overall Study|Consent withdrawn|15|||
23549414|NCT04313881|65739688|FG000|Overall Study|Reason not Specified|3|||
23549415|NCT04313881|65739689|FG001|Overall Study|Reason not Specified|1|||
23620151|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23620152|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
23620153|NCT01592383|65994896|FG000|Overall Study|Adverse Event|1|||
23620154|NCT02382406|65994897|FG000|Study Treatment|Disease Progression|8|||
23620155|NCT02382406|65994898|FG001|Study Treatment|Disease Progression|0|||
23620156|NCT02382406|65994899|FG002|Study Treatment|Disease Progression|20|||
23620157|NCT02382406|65994897|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
23620158|NCT02382406|65994898|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
23620159|NCT02382406|65994899|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
23620160|NCT02382406|65994897|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
23741463|NCT02418000|66432694|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23741464|NCT02418000|66432695|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23741465|NCT02546193|66432696|FG000|Overall Study|Withdrawal by Subject|2|||
23741466|NCT02546193|66432697|FG001|Overall Study|Withdrawal by Subject|0|||
23741467|NCT02546193|66432698|FG002|Overall Study|Withdrawal by Subject|1|||
23741468|NCT02546193|66432699|FG003|Overall Study|Withdrawal by Subject|0|||
23741469|NCT02546193|66432696|FG000|Overall Study|Not eligible at time of induction|4|||
23741470|NCT02546193|66432697|FG001|Overall Study|Not eligible at time of induction|6|||
23741471|NCT02546193|66432698|FG002|Overall Study|Not eligible at time of induction|1|||
23741472|NCT02546193|66432699|FG003|Overall Study|Not eligible at time of induction|0|||
23741473|NCT01377194|66432700|FG000|Overall Study|Adverse Event|3|||
23741474|NCT01377194|66432701|FG001|Overall Study|Adverse Event|12|||
23741475|NCT01377194|66432702|FG002|Overall Study|Adverse Event|19|||
23741476|NCT01377194|66432700|FG000|Overall Study|Lack of Efficacy|3|||
23741477|NCT01377194|66432701|FG001|Overall Study|Lack of Efficacy|3|||
23741478|NCT01377194|66432702|FG002|Overall Study|Lack of Efficacy|3|||
23741479|NCT01377194|66432700|FG000|Overall Study|Protocol Violation|4|||
23741480|NCT01377194|66432701|FG001|Overall Study|Protocol Violation|10|||
23741481|NCT01377194|66432702|FG002|Overall Study|Protocol Violation|6|||
23741482|NCT01377194|66432700|FG000|Overall Study|Withdrawal by Subject|8|||
23741483|NCT01377194|66432701|FG001|Overall Study|Withdrawal by Subject|10|||
23741484|NCT01377194|66432702|FG002|Overall Study|Withdrawal by Subject|7|||
23741485|NCT01377194|66432700|FG000|Overall Study|Lost to Follow-up|14|||
23741486|NCT01377194|66432701|FG001|Overall Study|Lost to Follow-up|8|||
23741487|NCT01377194|66432702|FG002|Overall Study|Lost to Follow-up|11|||
23741488|NCT00808665|66432705|FG000|Overall Study|Withdrawal by Subject|1|||
23741489|NCT00808665|66432706|FG001|Overall Study|Withdrawal by Subject|0|||
23741490|NCT00808665|66432705|FG000|Overall Study|only required minimally invasive surgery|1|||
23741491|NCT00808665|66432706|FG001|Overall Study|only required minimally invasive surgery|0|||
23741492|NCT00808665|66432705|FG000|Overall Study|surgery cancelled|1|||
23741493|NCT00808665|66432706|FG001|Overall Study|surgery cancelled|0|||
23741494|NCT00808665|66432705|FG000|Overall Study|required an additional procedure|0|||
23741495|NCT00808665|66432706|FG001|Overall Study|required an additional procedure|1|||
23428580|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23620161|NCT02382406|65994898|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
23620162|NCT02382406|65994899|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
23620163|NCT02382406|65994897|FG000|Study Treatment|symptomatic deterioration|1|||
23620164|NCT02382406|65994898|FG001|Study Treatment|symptomatic deterioration|0|||
23620165|NCT02382406|65994899|FG002|Study Treatment|symptomatic deterioration|1|||
23620166|NCT02382406|65994897|FG000|Study Treatment|Death|0|||
23620167|NCT02382406|65994898|FG001|Study Treatment|Death|0|||
23620168|NCT02382406|65994899|FG002|Study Treatment|Death|2|||
23620169|NCT02382406|65994897|FG000|Follow up|Death|11|||
23620170|NCT02382406|65994898|FG001|Follow up|Death|0|||
23620171|NCT02382406|65994899|FG002|Follow up|Death|19|||
23620172|NCT02382406|65994897|FG000|Follow up|Symptomatic deterioration|1|||
23620173|NCT02382406|65994898|FG001|Follow up|Symptomatic deterioration|0|||
23620174|NCT02382406|65994899|FG002|Follow up|Symptomatic deterioration|1|||
23620175|NCT02382406|65994897|FG000|Follow up|Patient Refused Follow-up|1|||
23620176|NCT02382406|65994898|FG001|Follow up|Patient Refused Follow-up|0|||
23620177|NCT02382406|65994899|FG002|Follow up|Patient Refused Follow-up|0|||
23620178|NCT02382406|65994897|FG000|Follow up|Study Terminated|1|||
23620179|NCT02382406|65994898|FG001|Follow up|Study Terminated|0|||
23620180|NCT02382406|65994899|FG002|Follow up|Study Terminated|8|||
23620181|NCT02382406|65994897|FG000|Follow up|Withdrawal by Subject|0|||
23741496|NCT00808665|66432705|FG000|Overall Study|Physician Decision|3|||
23620182|NCT02382406|65994898|FG001|Follow up|Withdrawal by Subject|0|||
23620183|NCT02382406|65994899|FG002|Follow up|Withdrawal by Subject|2|||
23741497|NCT00808665|66432706|FG001|Overall Study|Physician Decision|1|||
23741498|NCT00808665|66432705|FG000|Overall Study|Medication stopped by resident|0|||
23741499|NCT00808665|66432706|FG001|Overall Study|Medication stopped by resident|1|||
23620184|NCT00451555|65994900|FG000|Overall Study|Protocol Violation|2|||
23741500|NCT01190839|66432708|FG000|Overall Study|Adverse Event|32|||
23741501|NCT01190839|66432709|FG001|Overall Study|Adverse Event|41|||
23741502|NCT01190839|66432708|FG000|Overall Study|Protocol Violation|2|||
23428581|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
23428582|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428583|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428584|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428585|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428586|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428587|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428588|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428589|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428590|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428591|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428592|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428593|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428594|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428595|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428596|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428597|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
23428598|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428599|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
23428600|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
23428601|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
23428602|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428603|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23549416|NCT01128413|65739690|FG000|Overall Study|Withdrawal by Subject|1|||
23549417|NCT01128413|65739691|FG001|Overall Study|Withdrawal by Subject|0|||
23549418|NCT01128413|65739690|FG000|Overall Study|NICOM Monitor Problems|2|||
23549419|NCT01128413|65739691|FG001|Overall Study|NICOM Monitor Problems|1|||
23549420|NCT01128413|65739690|FG000|Overall Study|Pt made DNR|1|||
23620185|NCT00451555|65994901|FG001|Overall Study|Protocol Violation|2|||
23620186|NCT00451555|65994900|FG000|Overall Study|Adverse Event|3|||
23620187|NCT00451555|65994901|FG001|Overall Study|Adverse Event|1|||
23620188|NCT00451555|65994900|FG000|Overall Study|Withdrawal by Subject|6|||
23620189|NCT00451555|65994901|FG001|Overall Study|Withdrawal by Subject|0|||
23620190|NCT00451555|65994900|FG000|Overall Study|Physician Decision|2|||
23620191|NCT00451555|65994901|FG001|Overall Study|Physician Decision|1|||
23620192|NCT02287883|65994902|FG000|Overall Study|Death|8|||
23620193|NCT02287883|65994903|FG001|Overall Study|Death|7|||
23620194|NCT02287883|65994902|FG000|Overall Study|No longer eligible|222|||
23620195|NCT02287883|65994903|FG001|Overall Study|No longer eligible|182|||
23620196|NCT02287883|65994902|FG000|Overall Study|Non-response to survey|229|||
23620197|NCT02287883|65994903|FG001|Overall Study|Non-response to survey|237|||
23620198|NCT01091519|65994904|FG000|Overall Study|Adverse Event|12|||
23620199|NCT01091519|65994905|FG001|Overall Study|Adverse Event|16|||
23620200|NCT01091519|65994904|FG000|Overall Study|Death|1|||
23620201|NCT01091519|65994905|FG001|Overall Study|Death|0|||
23620202|NCT01091519|65994904|FG000|Overall Study|Lack of Efficacy|16|||
23620203|NCT01091519|65994905|FG001|Overall Study|Lack of Efficacy|19|||
23620204|NCT01091519|65994904|FG000|Overall Study|Lost to Follow-up|14|||
23620205|NCT01091519|65994905|FG001|Overall Study|Lost to Follow-up|24|||
23620206|NCT01091519|65994904|FG000|Overall Study|Withdrawal by Subject|2|||
23741503|NCT01190839|66432709|FG001|Overall Study|Protocol Violation|2|||
23428604|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23549421|NCT01128413|65739691|FG001|Overall Study|Pt made DNR|0|||
23549422|NCT01109992|65739693|FG000|Overall Study|Withdrawal by Subject|0|||
23549423|NCT01109992|65739694|FG001|Overall Study|Withdrawal by Subject|1|||
23549424|NCT01109992|65739693|FG000|Overall Study|Movement during rest scan.|0|||
23549425|NCT01109992|65739694|FG001|Overall Study|Movement during rest scan.|1|||
23549426|NCT02862106|65739695|FG000|Overall Study|Adverse Event|4|||
23620207|NCT01091519|65994905|FG001|Overall Study|Withdrawal by Subject|2|||
23620208|NCT01091519|65994904|FG000|Overall Study|Other|6|||
23741504|NCT01190839|66432708|FG000|Overall Study|Lost to Follow-up|7|||
23549427|NCT02862106|65739696|FG001|Overall Study|Adverse Event|0|||
23549428|NCT02862106|65739695|FG000|Overall Study|Protocol Violation|16|||
23549429|NCT02862106|65739696|FG001|Overall Study|Protocol Violation|1|||
23549430|NCT02862106|65739695|FG000|Overall Study|Lost to Follow-up|15|||
23549431|NCT02862106|65739696|FG001|Overall Study|Lost to Follow-up|5|||
23620209|NCT01091519|65994905|FG001|Overall Study|Other|8|||
23620210|NCT01091519|65994904|FG000|Overall Study|Randomized not treated|4|||
23620211|NCT01091519|65994905|FG001|Overall Study|Randomized not treated|4|||
23620212|NCT03015181|65994910|FG000|Overall Study|Enrolled, but product never administered|1|||
23620213|NCT03015181|65994911|FG001|Overall Study|Enrolled, but product never administered|0|||
23620214|NCT03015181|65994912|FG002|Overall Study|Enrolled, but product never administered|0|||
23428605|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428606|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428607|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428608|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428609|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428610|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428611|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428612|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428613|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428614|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428615|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428616|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428617|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
23428618|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
23549432|NCT02862106|65739695|FG000|Overall Study|Withdrawal by Subject|2|||
23549433|NCT02862106|65739696|FG001|Overall Study|Withdrawal by Subject|0|||
23549434|NCT02862106|65739695|FG000|Overall Study|Subjects moved to other city|1|||
23549435|NCT02862106|65739696|FG001|Overall Study|Subjects moved to other city|0|||
23549436|NCT02605954|65739697|FG000|Overall Study|Adverse Event|5|||
23549437|NCT02605954|65739698|FG001|Overall Study|Adverse Event|1|||
23549438|NCT02605954|65739697|FG000|Overall Study|Investigator's Discretion|1|||
23549439|NCT02605954|65739698|FG001|Overall Study|Investigator's Discretion|0|||
23549440|NCT02605954|65739697|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23549441|NCT02605954|65739698|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23549442|NCT02605954|65739697|FG000|Overall Study|Withdrew Consent|2|||
23549443|NCT02605954|65739698|FG001|Overall Study|Withdrew Consent|2|||
23549444|NCT02605954|65739697|FG000|Overall Study|Lost to Follow-up|3|||
23549445|NCT02605954|65739698|FG001|Overall Study|Lost to Follow-up|0|||
23549446|NCT02605954|65739697|FG000|Overall Study|Randomized but not treated|0|||
23549447|NCT02605954|65739698|FG001|Overall Study|Randomized but not treated|1|||
23549448|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
23549449|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
23741505|NCT01190839|66432709|FG001|Overall Study|Lost to Follow-up|1|||
23741506|NCT01190839|66432708|FG000|Overall Study|Death|1|||
23741507|NCT01190839|66432709|FG001|Overall Study|Death|0|||
23741508|NCT01190839|66432708|FG000|Overall Study|Trial stopped by Sponsor|71|||
23741509|NCT01190839|66432709|FG001|Overall Study|Trial stopped by Sponsor|68|||
23741510|NCT01190839|66432708|FG000|Overall Study|Undefined|35|||
23741511|NCT01190839|66432709|FG001|Overall Study|Undefined|31|||
23741512|NCT01190839|66432708|FG000|Overall Study|Randomized but not treated|2|||
23741513|NCT01190839|66432709|FG001|Overall Study|Randomized but not treated|4|||
23741514|NCT01004861|66432714|FG000|Overall Study|Disease progression|3|||
23741515|NCT01004861|66432715|FG001|Overall Study|Disease progression|4|||
23741516|NCT01004861|66432716|FG002|Overall Study|Disease progression|5|||
23428619|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428620|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428621|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428622|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428623|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428624|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428625|NCT02528357|65314269|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428626|NCT02528357|65314270|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428627|NCT02528357|65314271|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428628|NCT02528357|65314272|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428629|NCT02528357|65314273|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428630|NCT02528357|65314274|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428631|NCT02528357|65314275|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428632|NCT02528357|65314276|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23549450|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23549451|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23741517|NCT01004861|66432717|FG003|Overall Study|Disease progression|4|||
23741518|NCT01004861|66432718|FG004|Overall Study|Disease progression|4|||
23741519|NCT01004861|66432719|FG005|Overall Study|Disease progression|4|||
23741520|NCT01004861|66432720|FG006|Overall Study|Disease progression|5|||
23428633|NCT02528357|65314277|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428634|NCT02528357|65314278|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428635|NCT02528357|65314279|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428636|NCT02528357|65314280|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428637|NCT02528357|65314281|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428638|NCT02528357|65314282|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428639|NCT02528357|65314283|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428640|NCT02528357|65314284|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23549452|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
23549453|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
23549454|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
23620215|NCT03015181|65994913|FG003|Overall Study|Enrolled, but product never administered|0|||
23620216|NCT03015181|65994914|FG004|Overall Study|Enrolled, but product never administered|0|||
23620217|NCT03015181|65994915|FG005|Overall Study|Enrolled, but product never administered|0|||
23620218|NCT03015181|65994916|FG006|Overall Study|Enrolled, but product never administered|0|||
23620219|NCT03015181|65994910|FG000|Overall Study|Withdrawal by Subject|0|||
23620220|NCT03015181|65994911|FG001|Overall Study|Withdrawal by Subject|0|||
23620221|NCT03015181|65994912|FG002|Overall Study|Withdrawal by Subject|0|||
23620222|NCT03015181|65994913|FG003|Overall Study|Withdrawal by Subject|0|||
23620223|NCT03015181|65994914|FG004|Overall Study|Withdrawal by Subject|0|||
23620224|NCT03015181|65994915|FG005|Overall Study|Withdrawal by Subject|1|||
23620225|NCT03015181|65994916|FG006|Overall Study|Withdrawal by Subject|0|||
23620226|NCT03015181|65994910|FG000|Overall Study|Physician Decision|0|||
23620227|NCT03015181|65994911|FG001|Overall Study|Physician Decision|0|||
23620228|NCT03015181|65994912|FG002|Overall Study|Physician Decision|0|||
23620229|NCT03015181|65994913|FG003|Overall Study|Physician Decision|0|||
23620230|NCT03015181|65994914|FG004|Overall Study|Physician Decision|0|||
23549455|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23549456|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23620231|NCT03015181|65994915|FG005|Overall Study|Physician Decision|0|||
23620232|NCT03015181|65994916|FG006|Overall Study|Physician Decision|1|||
23620233|NCT00690378|65994917|FG000|Overall Study|Adverse Event|1|||
23620234|NCT00690378|65994918|FG001|Overall Study|Adverse Event|0|||
23620235|NCT00690378|65994917|FG000|Overall Study|Withdrawal by Subject|2|||
23620236|NCT00690378|65994918|FG001|Overall Study|Withdrawal by Subject|0|||
23620237|NCT00690378|65994917|FG000|Overall Study|Protocol Violation|1|||
23620238|NCT00690378|65994918|FG001|Overall Study|Protocol Violation|0|||
23620239|NCT00690378|65994917|FG000|Overall Study|Lost to Follow-up|2|||
23620240|NCT00690378|65994918|FG001|Overall Study|Lost to Follow-up|3|||
23741521|NCT01004861|66432721|FG007|Overall Study|Disease progression|1|||
23741522|NCT01004861|66432722|FG008|Overall Study|Disease progression|4|||
23741523|NCT01004861|66432723|FG009|Overall Study|Disease progression|7|||
23741524|NCT01004861|66432724|FG010|Overall Study|Disease progression|6|||
23741525|NCT01004861|66432725|FG011|Overall Study|Disease progression|3|||
23741526|NCT01004861|66432726|FG012|Overall Study|Disease progression|8|||
23741527|NCT01004861|66432714|FG000|Overall Study|Physician Decision|0|||
23741528|NCT01004861|66432715|FG001|Overall Study|Physician Decision|2|||
23741529|NCT01004861|66432716|FG002|Overall Study|Physician Decision|1|||
23549457|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23549458|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23549459|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23549460|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
23549461|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
23549462|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
23549463|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
23549464|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
23549465|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
23549466|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
23549467|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
23549468|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
23549469|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
23549470|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Death|3|||
23549471|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Death|0|||
23620241|NCT00690378|65994917|FG000|Overall Study|Did not meet inc/exc criteria|13|||
23620242|NCT00690378|65994918|FG001|Overall Study|Did not meet inc/exc criteria|11|||
23620243|NCT00690378|65994917|FG000|Overall Study|Social problem|1|||
23620244|NCT00690378|65994918|FG001|Overall Study|Social problem|0|||
23620245|NCT02720081|65994922|FG000|Overall Study|Adverse Event|0|||
23620246|NCT02720081|65994923|FG001|Overall Study|Adverse Event|3|||
23620247|NCT02720081|65994922|FG000|Overall Study|Protocol Violation|4|||
23741530|NCT01004861|66432717|FG003|Overall Study|Physician Decision|1|||
23741531|NCT01004861|66432718|FG004|Overall Study|Physician Decision|1|||
23428641|NCT02528357|65314285|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
23428642|NCT02528357|65314286|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428643|NCT02528357|65314287|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428644|NCT02528357|65314269|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428645|NCT02528357|65314270|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428646|NCT02528357|65314271|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428647|NCT02528357|65314272|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428648|NCT02528357|65314273|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428649|NCT02528357|65314274|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428650|NCT02528357|65314275|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428651|NCT02528357|65314276|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428652|NCT02528357|65314277|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428653|NCT02528357|65314278|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428654|NCT02528357|65314279|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428655|NCT02528357|65314280|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428656|NCT02528357|65314281|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428657|NCT02528357|65314282|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428658|NCT02528357|65314283|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428659|NCT02528357|65314284|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428660|NCT02528357|65314285|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428661|NCT02528357|65314286|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
23428662|NCT02528357|65314287|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
23428663|NCT02278614|65314288|FG000|Overall Study|Withdrawal by Subject|3|||
23428664|NCT02278614|65314289|FG001|Overall Study|Withdrawal by Subject|5|||
23428665|NCT02278614|65314288|FG000|Overall Study|Adverse Event|1|||
23428666|NCT02278614|65314289|FG001|Overall Study|Adverse Event|0|||
23428667|NCT02278614|65314288|FG000|Overall Study|left eye was not eligible|1|||
23428668|NCT02278614|65314289|FG001|Overall Study|left eye was not eligible|0|||
23428669|NCT02642965|65314290|FG000|Overall Study|Lack of Efficacy|4|||
23428670|NCT02642965|65314290|FG000|Overall Study|Physician Decision|9|||
23428671|NCT04047420|65314291|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
23428672|NCT04047420|65314291|FG000|Washout Period|Refused Participation|2|||
23428673|NCT00661388|65314293|FG000|Overall Study|Adverse Event|14|||
23428674|NCT00661388|65314293|FG000|Overall Study|Protocol Violation|7|||
23428675|NCT00661388|65314293|FG000|Overall Study|Renal transplantation|1|||
23428676|NCT00661388|65314293|FG000|Overall Study|Dialysis initiation|1|||
23428677|NCT00661388|65314293|FG000|Overall Study|Administrative reasons|1|||
23428678|NCT00693472|65314294|FG000|Part 1|Adverse Event|1|||
23428679|NCT00693472|65314295|FG001|Part 1|Adverse Event|1|||
23428680|NCT00693472|65314296|FG002|Part 1|Adverse Event|0|||
23428681|NCT00693472|65314297|FG003|Part 1|Adverse Event|0|||
23428682|NCT00693472|65314294|FG000|Part 1|Lost to Follow-up|0|||
23428683|NCT00693472|65314295|FG001|Part 1|Lost to Follow-up|1|||
23428684|NCT00693472|65314296|FG002|Part 1|Lost to Follow-up|0|||
23428685|NCT00693472|65314297|FG003|Part 1|Lost to Follow-up|0|||
23428686|NCT00693472|65314294|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
23428687|NCT00693472|65314295|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
23428688|NCT00693472|65314296|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
23428689|NCT00693472|65314297|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
23428690|NCT00693472|65314294|FG000|Part 2|Adverse Event|0|||
23428691|NCT00693472|65314295|FG001|Part 2|Adverse Event|0|||
23428692|NCT00693472|65314296|FG002|Part 2|Adverse Event|1|||
23428693|NCT00693472|65314297|FG003|Part 2|Adverse Event|0|||
23428694|NCT00693472|65314294|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
23428695|NCT00693472|65314295|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
23428696|NCT00693472|65314296|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
23428697|NCT00693472|65314297|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
23428698|NCT00831701|65314306|FG000|Overall Study|Withdrawal by Subject|2|||
23428699|NCT00831701|65314307|FG001|Overall Study|Withdrawal by Subject|0|||
23428700|NCT00831701|65314306|FG000|Overall Study|Stone expulsion before first medication|2|||
23428701|NCT00831701|65314307|FG001|Overall Study|Stone expulsion before first medication|2|||
23428702|NCT00831701|65314306|FG000|Overall Study|Lost to Follow-up|1|||
23428703|NCT00831701|65314307|FG001|Overall Study|Lost to Follow-up|3|||
23428704|NCT03458702|65314308|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
23428705|NCT03458702|65314309|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
23428706|NCT03458702|65314308|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
23428707|NCT03458702|65314309|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
23428708|NCT03662659|65314315|FG000|Pre-treatment|Participant no longer met study criteria|1|||
23428709|NCT03662659|65314316|FG001|Pre-treatment|Participant no longer met study criteria|1|||
23428710|NCT03662659|65314315|FG000|Pre-treatment|Other reasons|1|||
23428711|NCT03662659|65314316|FG001|Pre-treatment|Other reasons|0|||
23428712|NCT03662659|65314315|FG000|Treatment|Completed Treatment|0|||
23428713|NCT03662659|65314316|FG001|Treatment|Completed Treatment|3|||
23428714|NCT03662659|65314315|FG000|Treatment|Disease Progression|69|||
23428715|NCT03662659|65314316|FG001|Treatment|Disease Progression|78|||
23428716|NCT03662659|65314315|FG000|Treatment|Study Drug Toxicity|18|||
23428717|NCT03662659|65314316|FG001|Treatment|Study Drug Toxicity|8|||
23428718|NCT03662659|65314315|FG000|Treatment|Death|12|||
23428719|NCT03662659|65314316|FG001|Treatment|Death|7|||
23428720|NCT03662659|65314315|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
23428721|NCT03662659|65314316|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
23428722|NCT03662659|65314315|FG000|Treatment|Withdrawal by Subject|1|||
23428723|NCT03662659|65314316|FG001|Treatment|Withdrawal by Subject|1|||
23428724|NCT03662659|65314315|FG000|Treatment|Poor/Non-compliance|1|||
23428725|NCT03662659|65314316|FG001|Treatment|Poor/Non-compliance|0|||
23428726|NCT03662659|65314315|FG000|Treatment|Participant no longer meets study criteria|1|||
23428727|NCT03662659|65314316|FG001|Treatment|Participant no longer meets study criteria|0|||
23428728|NCT03662659|65314315|FG000|Treatment|Other reasons|6|||
23428729|NCT03662659|65314316|FG001|Treatment|Other reasons|5|||
23428730|NCT02788201|65314318|FG000|Overall Study|Death|1|||
23428731|NCT02788201|65314319|FG001|Overall Study|Death|1|||
23428732|NCT02788201|65314320|FG002|Overall Study|Death|1|||
23741532|NCT01004861|66432719|FG005|Overall Study|Physician Decision|0|||
23741533|NCT01004861|66432720|FG006|Overall Study|Physician Decision|0|||
23741534|NCT01004861|66432721|FG007|Overall Study|Physician Decision|1|||
23741535|NCT01004861|66432722|FG008|Overall Study|Physician Decision|0|||
23741536|NCT01004861|66432723|FG009|Overall Study|Physician Decision|0|||
23741537|NCT01004861|66432724|FG010|Overall Study|Physician Decision|0|||
23741538|NCT01004861|66432725|FG011|Overall Study|Physician Decision|0|||
23741539|NCT01004861|66432726|FG012|Overall Study|Physician Decision|3|||
23741540|NCT01004861|66432714|FG000|Overall Study|Adverse Event|0|||
23741541|NCT01004861|66432715|FG001|Overall Study|Adverse Event|0|||
23741542|NCT01004861|66432716|FG002|Overall Study|Adverse Event|0|||
23741543|NCT01004861|66432717|FG003|Overall Study|Adverse Event|1|||
23741544|NCT01004861|66432718|FG004|Overall Study|Adverse Event|0|||
23741545|NCT01004861|66432719|FG005|Overall Study|Adverse Event|2|||
23741546|NCT01004861|66432720|FG006|Overall Study|Adverse Event|1|||
23741547|NCT01004861|66432721|FG007|Overall Study|Adverse Event|1|||
23428733|NCT02788201|65314321|FG003|Overall Study|Death|1|||
23428734|NCT02788201|65314322|FG004|Overall Study|Death|0|||
23428735|NCT02788201|65314323|FG005|Overall Study|Death|1|||
23428736|NCT02788201|65314318|FG000|Overall Study|Ineligible|0|||
23428737|NCT02788201|65314319|FG001|Overall Study|Ineligible|0|||
23428738|NCT02788201|65314320|FG002|Overall Study|Ineligible|0|||
23428739|NCT02788201|65314321|FG003|Overall Study|Ineligible|0|||
23549472|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
23549473|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
23549474|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
23549475|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
23549476|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
23549477|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
23549478|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
23549479|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
23549480|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
23549481|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
23549482|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
23549483|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
23549484|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
23549485|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
23549486|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
23549487|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
23549488|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
23549489|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
23549490|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
23549491|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
23741548|NCT01004861|66432722|FG008|Overall Study|Adverse Event|13|||
23428740|NCT02788201|65314322|FG004|Overall Study|Ineligible|0|||
23741549|NCT01004861|66432723|FG009|Overall Study|Adverse Event|1|||
23741550|NCT01004861|66432724|FG010|Overall Study|Adverse Event|1|||
23741551|NCT01004861|66432725|FG011|Overall Study|Adverse Event|0|||
23741552|NCT01004861|66432726|FG012|Overall Study|Adverse Event|2|||
23428741|NCT02788201|65314323|FG005|Overall Study|Ineligible|1|||
23741553|NCT01004861|66432714|FG000|Overall Study|Protocol Violation|0|||
23741554|NCT01004861|66432715|FG001|Overall Study|Protocol Violation|0|||
23741555|NCT01004861|66432716|FG002|Overall Study|Protocol Violation|0|||
23741556|NCT01004861|66432717|FG003|Overall Study|Protocol Violation|0|||
23741557|NCT01004861|66432718|FG004|Overall Study|Protocol Violation|1|||
23741558|NCT01004861|66432719|FG005|Overall Study|Protocol Violation|0|||
23741559|NCT01004861|66432720|FG006|Overall Study|Protocol Violation|0|||
23741560|NCT01004861|66432721|FG007|Overall Study|Protocol Violation|0|||
23741561|NCT01004861|66432722|FG008|Overall Study|Protocol Violation|0|||
23741562|NCT01004861|66432723|FG009|Overall Study|Protocol Violation|0|||
23741563|NCT01004861|66432724|FG010|Overall Study|Protocol Violation|0|||
23741564|NCT01004861|66432725|FG011|Overall Study|Protocol Violation|0|||
23741565|NCT01004861|66432726|FG012|Overall Study|Protocol Violation|0|||
23741566|NCT01004861|66432714|FG000|Overall Study|Lost to Follow-up|0|||
23741567|NCT01004861|66432715|FG001|Overall Study|Lost to Follow-up|0|||
23741568|NCT01004861|66432716|FG002|Overall Study|Lost to Follow-up|0|||
23741569|NCT01004861|66432717|FG003|Overall Study|Lost to Follow-up|0|||
23741570|NCT01004861|66432718|FG004|Overall Study|Lost to Follow-up|0|||
23741571|NCT01004861|66432719|FG005|Overall Study|Lost to Follow-up|0|||
23741572|NCT01004861|66432720|FG006|Overall Study|Lost to Follow-up|0|||
23741573|NCT01004861|66432721|FG007|Overall Study|Lost to Follow-up|1|||
23741574|NCT01004861|66432722|FG008|Overall Study|Lost to Follow-up|3|||
23741575|NCT01004861|66432723|FG009|Overall Study|Lost to Follow-up|0|||
23741576|NCT01004861|66432724|FG010|Overall Study|Lost to Follow-up|0|||
23741577|NCT01004861|66432725|FG011|Overall Study|Lost to Follow-up|1|||
23741578|NCT01004861|66432726|FG012|Overall Study|Lost to Follow-up|0|||
23741579|NCT01004861|66432714|FG000|Overall Study|Non-compliance|0|||
23741580|NCT01004861|66432715|FG001|Overall Study|Non-compliance|0|||
23741581|NCT01004861|66432716|FG002|Overall Study|Non-compliance|0|||
23741582|NCT01004861|66432717|FG003|Overall Study|Non-compliance|0|||
23741583|NCT01004861|66432718|FG004|Overall Study|Non-compliance|0|||
23741584|NCT01004861|66432719|FG005|Overall Study|Non-compliance|0|||
23741585|NCT01004861|66432720|FG006|Overall Study|Non-compliance|0|||
23741586|NCT01004861|66432721|FG007|Overall Study|Non-compliance|0|||
23741587|NCT01004861|66432722|FG008|Overall Study|Non-compliance|5|||
23741588|NCT01004861|66432723|FG009|Overall Study|Non-compliance|0|||
23741589|NCT01004861|66432724|FG010|Overall Study|Non-compliance|0|||
23549492|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
23549493|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
23549494|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
23549495|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
23549496|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
23549497|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
23549498|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
23549499|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
23549500|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
23549501|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
23549502|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
23549503|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
23549504|NCT01260350|65739708|FG000|Overall Study|Lack of Efficacy|0|||
23549505|NCT01260350|65739709|FG001|Overall Study|Lack of Efficacy|0|||
23549506|NCT01260350|65739710|FG002|Overall Study|Lack of Efficacy|0|||
23549507|NCT01260350|65739711|FG003|Overall Study|Lack of Efficacy|0|||
23549508|NCT01260350|65739712|FG004|Overall Study|Lack of Efficacy|0|||
23549509|NCT01260350|65739713|FG005|Overall Study|Lack of Efficacy|0|||
23549510|NCT01260350|65739714|FG006|Overall Study|Lack of Efficacy|0|||
23549511|NCT01260350|65739715|FG007|Overall Study|Lack of Efficacy|0|||
23549512|NCT01260350|65739716|FG008|Overall Study|Lack of Efficacy|0|||
23549513|NCT01260350|65739717|FG009|Overall Study|Lack of Efficacy|0|||
23549514|NCT01260350|65739718|FG010|Overall Study|Lack of Efficacy|0|||
23549515|NCT01260350|65739719|FG011|Overall Study|Lack of Efficacy|0|||
23549516|NCT01260350|65739720|FG012|Overall Study|Lack of Efficacy|0|||
23549517|NCT01260350|65739721|FG013|Overall Study|Lack of Efficacy|0|||
23549518|NCT01260350|65739722|FG014|Overall Study|Lack of Efficacy|0|||
23549519|NCT01260350|65739723|FG015|Overall Study|Lack of Efficacy|0|||
23549520|NCT01260350|65739724|FG016|Overall Study|Lack of Efficacy|0|||
23549521|NCT01260350|65739725|FG017|Overall Study|Lack of Efficacy|1|||
23549522|NCT01260350|65739726|FG018|Overall Study|Lack of Efficacy|0|||
23549523|NCT01260350|65739727|FG019|Overall Study|Lack of Efficacy|0|||
23549524|NCT01260350|65739728|FG020|Overall Study|Lack of Efficacy|3|||
23549525|NCT01260350|65739729|FG021|Overall Study|Lack of Efficacy|0|||
23549526|NCT01260350|65739708|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23741590|NCT01004861|66432725|FG011|Overall Study|Non-compliance|0|||
23741591|NCT01004861|66432726|FG012|Overall Study|Non-compliance|1|||
23741592|NCT01004861|66432714|FG000|Overall Study|Other|0|||
23741593|NCT01004861|66432715|FG001|Overall Study|Other|0|||
23741594|NCT01004861|66432716|FG002|Overall Study|Other|0|||
23741595|NCT01004861|66432717|FG003|Overall Study|Other|0|||
23428742|NCT02788201|65314318|FG000|Overall Study|Withdrawal by Subject|0|||
23428743|NCT02788201|65314319|FG001|Overall Study|Withdrawal by Subject|0|||
23428744|NCT02788201|65314320|FG002|Overall Study|Withdrawal by Subject|0|||
23428745|NCT02788201|65314321|FG003|Overall Study|Withdrawal by Subject|0|||
23428746|NCT02788201|65314322|FG004|Overall Study|Withdrawal by Subject|0|||
23428747|NCT02788201|65314323|FG005|Overall Study|Withdrawal by Subject|1|||
23428748|NCT00581828|65314324|FG000|Overall Study|Protocol Violation|1|||
23428749|NCT02809053|65314326|FG000|Overall Study|Death|0|||
23428750|NCT02809053|65314327|FG001|Overall Study|Death|1|||
23428751|NCT02809053|65314326|FG000|Overall Study|Lost to Follow-up|3|||
23428752|NCT02809053|65314327|FG001|Overall Study|Lost to Follow-up|1|||
23428753|NCT02809053|65314326|FG000|Overall Study|Withdrawal by Subject|2|||
23428754|NCT02809053|65314327|FG001|Overall Study|Withdrawal by Subject|3|||
23428755|NCT02809053|65314326|FG000|Overall Study|Disease Progression|2|||
23428756|NCT02809053|65314327|FG001|Overall Study|Disease Progression|1|||
23428757|NCT01100528|65314330|FG000|Overall Study|Death|1|||
23428758|NCT01100528|65314330|FG000|Overall Study|Withdrawal by Subject|2|||
23428759|NCT02616393|65314331|FG000|Overall Study|Death|5|||
23428760|NCT02616393|65314332|FG001|Overall Study|Death|12|||
23428761|NCT02616393|65314333|FG002|Overall Study|Death|1|||
23428762|NCT02616393|65314331|FG000|Overall Study|Termination by Sponsor|4|||
23428763|NCT02616393|65314332|FG001|Overall Study|Termination by Sponsor|5|||
23428764|NCT02616393|65314333|FG002|Overall Study|Termination by Sponsor|2|||
23428765|NCT02616393|65314331|FG000|Overall Study|Other|3|||
23428766|NCT02616393|65314332|FG001|Overall Study|Other|0|||
23428767|NCT02616393|65314333|FG002|Overall Study|Other|0|||
23428768|NCT02616393|65314331|FG000|Overall Study|Withdrawal by Subject|1|||
23428769|NCT02616393|65314332|FG001|Overall Study|Withdrawal by Subject|1|||
23428770|NCT02616393|65314333|FG002|Overall Study|Withdrawal by Subject|0|||
23428771|NCT02616393|65314331|FG000|Overall Study|Lost to Follow-up|0|||
23428772|NCT02616393|65314332|FG001|Overall Study|Lost to Follow-up|2|||
23428773|NCT02616393|65314333|FG002|Overall Study|Lost to Follow-up|0|||
23428774|NCT02654236|65314338|FG000|Overall Study|Withdrawal by Subject|0|||
23428775|NCT02654236|65314339|FG001|Overall Study|Withdrawal by Subject|0|||
23428776|NCT02654236|65314340|FG002|Overall Study|Withdrawal by Subject|2|||
23428777|NCT00459537|65314341|FG000|Overall Study|Adverse Event|1|||
23428778|NCT00459537|65314342|FG001|Overall Study|Adverse Event|6|||
23428779|NCT00459537|65314341|FG000|Overall Study|Lack of Efficacy|10|||
23549527|NCT01260350|65739709|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549528|NCT01260350|65739710|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549529|NCT01260350|65739711|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549530|NCT01260350|65739712|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549531|NCT01260350|65739713|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549532|NCT01260350|65739714|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549533|NCT01260350|65739715|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23821333|NCT00996892|66726002|FG016|Expansion Stage 2A|Physician Decision|0|||
23821334|NCT00996892|66726003|FG017|Expansion Stage 2A|Physician Decision|0|||
23821335|NCT00996892|66726004|FG018|Expansion Stage 2A|Physician Decision|0|||
23821336|NCT00996892|66726005|FG019|Expansion Stage 2A|Physician Decision|2|||
23821337|NCT00996892|66725986|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
23821338|NCT00996892|66725987|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
23821339|NCT00996892|66725988|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
23549534|NCT01260350|65739716|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
23549535|NCT01260350|65739717|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549536|NCT01260350|65739718|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549537|NCT01260350|65739719|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549538|NCT01260350|65739720|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549539|NCT01260350|65739721|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549540|NCT01260350|65739722|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23741596|NCT01004861|66432718|FG004|Overall Study|Other|0|||
23741597|NCT01004861|66432719|FG005|Overall Study|Other|0|||
23741598|NCT01004861|66432720|FG006|Overall Study|Other|0|||
23741599|NCT01004861|66432721|FG007|Overall Study|Other|0|||
23741600|NCT01004861|66432722|FG008|Overall Study|Other|0|||
23741601|NCT01004861|66432723|FG009|Overall Study|Other|2|||
23741602|NCT01004861|66432724|FG010|Overall Study|Other|1|||
23741603|NCT01004861|66432725|FG011|Overall Study|Other|2|||
23741604|NCT01004861|66432726|FG012|Overall Study|Other|3|||
23741605|NCT01004861|66432714|FG000|Overall Study|Patient decision|0|||
23821340|NCT00996892|66725989|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
23428780|NCT00459537|65314342|FG001|Overall Study|Lack of Efficacy|11|||
23428781|NCT00459537|65314341|FG000|Overall Study|Withdrawal by Subject|20|||
23428782|NCT00459537|65314342|FG001|Overall Study|Withdrawal by Subject|26|||
23428783|NCT00459537|65314341|FG000|Overall Study|Lost to Follow-up|27|||
23428784|NCT00459537|65314342|FG001|Overall Study|Lost to Follow-up|30|||
23549541|NCT01260350|65739723|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23741606|NCT01004861|66432715|FG001|Overall Study|Patient decision|0|||
23741607|NCT01004861|66432716|FG002|Overall Study|Patient decision|0|||
23428785|NCT00459537|65314341|FG000|Overall Study|Administrative problems|3|||
23428786|NCT00459537|65314342|FG001|Overall Study|Administrative problems|0|||
23428787|NCT00459537|65314341|FG000|Overall Study|Protocol Violation|4|||
23428788|NCT00459537|65314342|FG001|Overall Study|Protocol Violation|3|||
23428789|NCT00459537|65314341|FG000|Overall Study|Missing|1|||
23428790|NCT00459537|65314342|FG001|Overall Study|Missing|0|||
23428791|NCT02124772|65314343|FG000|Overall Study|Lack of Efficacy|2|||
23428792|NCT02124772|65314344|FG001|Overall Study|Lack of Efficacy|0|||
23428793|NCT02124772|65314345|FG002|Overall Study|Lack of Efficacy|0|||
23428794|NCT02124772|65314346|FG003|Overall Study|Lack of Efficacy|1|||
23428795|NCT02124772|65314347|FG004|Overall Study|Lack of Efficacy|2|||
23428796|NCT02124772|65314348|FG005|Overall Study|Lack of Efficacy|3|||
23428797|NCT02124772|65314349|FG006|Overall Study|Lack of Efficacy|0|||
23428798|NCT02124772|65314350|FG007|Overall Study|Lack of Efficacy|2|||
23428799|NCT02124772|65314351|FG008|Overall Study|Lack of Efficacy|0|||
23428800|NCT02124772|65314352|FG009|Overall Study|Lack of Efficacy|1|||
23428801|NCT02124772|65314353|FG010|Overall Study|Lack of Efficacy|0|||
23428802|NCT02124772|65314354|FG011|Overall Study|Lack of Efficacy|0|||
23428803|NCT02124772|65314355|FG012|Overall Study|Lack of Efficacy|1|||
23428804|NCT02124772|65314343|FG000|Overall Study|Adverse Event|1|||
23428805|NCT02124772|65314344|FG001|Overall Study|Adverse Event|4|||
23428806|NCT02124772|65314345|FG002|Overall Study|Adverse Event|1|||
23549542|NCT01260350|65739724|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549543|NCT01260350|65739725|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549544|NCT01260350|65739726|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549545|NCT01260350|65739727|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549546|NCT01260350|65739728|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23428807|NCT02124772|65314346|FG003|Overall Study|Adverse Event|5|||
23428808|NCT02124772|65314347|FG004|Overall Study|Adverse Event|2|||
23428809|NCT02124772|65314348|FG005|Overall Study|Adverse Event|1|||
23428810|NCT02124772|65314349|FG006|Overall Study|Adverse Event|1|||
23428811|NCT02124772|65314350|FG007|Overall Study|Adverse Event|5|||
23428812|NCT02124772|65314351|FG008|Overall Study|Adverse Event|0|||
23428813|NCT02124772|65314352|FG009|Overall Study|Adverse Event|3|||
23428814|NCT02124772|65314353|FG010|Overall Study|Adverse Event|1|||
23428815|NCT02124772|65314354|FG011|Overall Study|Adverse Event|3|||
23428816|NCT02124772|65314355|FG012|Overall Study|Adverse Event|1|||
23428817|NCT02124772|65314343|FG000|Overall Study|Withdrawal consent|0|||
23428818|NCT02124772|65314344|FG001|Overall Study|Withdrawal consent|1|||
23428819|NCT02124772|65314345|FG002|Overall Study|Withdrawal consent|1|||
23428820|NCT02124772|65314346|FG003|Overall Study|Withdrawal consent|1|||
23428821|NCT02124772|65314347|FG004|Overall Study|Withdrawal consent|0|||
23428822|NCT02124772|65314348|FG005|Overall Study|Withdrawal consent|1|||
23428823|NCT02124772|65314349|FG006|Overall Study|Withdrawal consent|1|||
23428824|NCT02124772|65314350|FG007|Overall Study|Withdrawal consent|0|||
23428825|NCT02124772|65314351|FG008|Overall Study|Withdrawal consent|0|||
23428826|NCT02124772|65314352|FG009|Overall Study|Withdrawal consent|1|||
23428827|NCT02124772|65314353|FG010|Overall Study|Withdrawal consent|0|||
23428828|NCT02124772|65314354|FG011|Overall Study|Withdrawal consent|1|||
23428829|NCT02124772|65314355|FG012|Overall Study|Withdrawal consent|0|||
23428830|NCT02124772|65314343|FG000|Overall Study|Investigator discretion|0|||
23428831|NCT02124772|65314344|FG001|Overall Study|Investigator discretion|2|||
23428832|NCT02124772|65314345|FG002|Overall Study|Investigator discretion|2|||
23428833|NCT02124772|65314346|FG003|Overall Study|Investigator discretion|1|||
23428834|NCT02124772|65314347|FG004|Overall Study|Investigator discretion|1|||
23428835|NCT02124772|65314348|FG005|Overall Study|Investigator discretion|0|||
23428836|NCT02124772|65314349|FG006|Overall Study|Investigator discretion|1|||
23428837|NCT02124772|65314350|FG007|Overall Study|Investigator discretion|0|||
23428838|NCT02124772|65314351|FG008|Overall Study|Investigator discretion|0|||
23428839|NCT02124772|65314352|FG009|Overall Study|Investigator discretion|1|||
23428840|NCT02124772|65314353|FG010|Overall Study|Investigator discretion|0|||
23428841|NCT02124772|65314354|FG011|Overall Study|Investigator discretion|1|||
23428842|NCT02124772|65314355|FG012|Overall Study|Investigator discretion|0|||
23428843|NCT02124772|65314343|FG000|Overall Study|Progressive disease|0|||
23428844|NCT02124772|65314344|FG001|Overall Study|Progressive disease|0|||
23428845|NCT02124772|65314345|FG002|Overall Study|Progressive disease|0|||
23549547|NCT01260350|65739729|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549548|NCT01392560|65739730|FG000|Overall Study|Adverse Event|2|||
23428846|NCT02124772|65314346|FG003|Overall Study|Progressive disease|0|||
23428847|NCT02124772|65314347|FG004|Overall Study|Progressive disease|0|||
23428848|NCT02124772|65314348|FG005|Overall Study|Progressive disease|0|||
23428849|NCT02124772|65314349|FG006|Overall Study|Progressive disease|1|||
23549549|NCT01392560|65739730|FG000|Overall Study|not entered|8|||
23428850|NCT02124772|65314350|FG007|Overall Study|Progressive disease|1|||
23428851|NCT02124772|65314351|FG008|Overall Study|Progressive disease|0|||
23428852|NCT02124772|65314352|FG009|Overall Study|Progressive disease|0|||
23428853|NCT02124772|65314353|FG010|Overall Study|Progressive disease|0|||
23428854|NCT02124772|65314354|FG011|Overall Study|Progressive disease|0|||
23428855|NCT02124772|65314355|FG012|Overall Study|Progressive disease|0|||
23428856|NCT02124772|65314343|FG000|Overall Study|Other|0|||
23428857|NCT02124772|65314344|FG001|Overall Study|Other|7|||
23428858|NCT02124772|65314345|FG002|Overall Study|Other|2|||
23428859|NCT02124772|65314346|FG003|Overall Study|Other|5|||
23428860|NCT02124772|65314347|FG004|Overall Study|Other|4|||
23428861|NCT02124772|65314348|FG005|Overall Study|Other|3|||
23428862|NCT02124772|65314349|FG006|Overall Study|Other|4|||
23428863|NCT02124772|65314350|FG007|Overall Study|Other|1|||
23428864|NCT02124772|65314351|FG008|Overall Study|Other|1|||
23428865|NCT02124772|65314352|FG009|Overall Study|Other|1|||
23428866|NCT02124772|65314353|FG010|Overall Study|Other|1|||
23428867|NCT02124772|65314354|FG011|Overall Study|Other|1|||
23428868|NCT02124772|65314355|FG012|Overall Study|Other|0|||
23428869|NCT02360293|65314357|FG000|Overall Study|Lost to Follow-up|73|||
23428870|NCT02360293|65314358|FG001|Overall Study|Lost to Follow-up|95|||
23428871|NCT02360293|65314357|FG000|Overall Study|Withdrawal by Subject|2|||
23428872|NCT02360293|65314358|FG001|Overall Study|Withdrawal by Subject|1|||
23428873|NCT02360293|65314357|FG000|Overall Study|Excluded|1|||
23428874|NCT02360293|65314358|FG001|Overall Study|Excluded|0|||
23428875|NCT01842581|65314360|FG000|Overall Study|Adverse Event|6|||
23428876|NCT01842581|65314361|FG001|Overall Study|Adverse Event|4|||
23428877|NCT01842581|65314360|FG000|Overall Study|HE breakthrough|26|||
23428878|NCT01842581|65314361|FG001|Overall Study|HE breakthrough|13|||
23428879|NCT01842581|65314360|FG000|Overall Study|Liver transplant|2|||
23428880|NCT01842581|65314361|FG001|Overall Study|Liver transplant|0|||
23428881|NCT01842581|65314360|FG000|Overall Study|Lost to Follow-up|2|||
23428882|NCT01842581|65314361|FG001|Overall Study|Lost to Follow-up|5|||
23428883|NCT01842581|65314360|FG000|Overall Study|Withdrawal by Subject|5|||
23428884|NCT01842581|65314361|FG001|Overall Study|Withdrawal by Subject|7|||
23428885|NCT01842581|65314360|FG000|Overall Study|Other than specified|3|||
23428886|NCT01842581|65314361|FG001|Overall Study|Other than specified|1|||
23428887|NCT03421743|65314366|FG000|Overall Study|Lack of Efficacy|1|||
23428888|NCT03421743|65314367|FG001|Overall Study|Lack of Efficacy|0|||
23428889|NCT03421743|65314366|FG000|Overall Study|Adverse Event|2|||
23428890|NCT03421743|65314367|FG001|Overall Study|Adverse Event|1|||
23428891|NCT03421743|65314366|FG000|Overall Study|Withdrawal by Subject|0|||
23428892|NCT03421743|65314367|FG001|Overall Study|Withdrawal by Subject|1|||
23428893|NCT00687609|65314370|FG000|Overall Study|Physician Decision|1|||
23428894|NCT00687609|65314370|FG000|Overall Study|Withdrawal by Subject|2|||
23428895|NCT00673881|65314376|FG000|Overall Study|Withdrawal by Subject|1|||
23428896|NCT00657150|65314377|FG000|Overall Study|Adverse Event|19|||
23428897|NCT00657150|65314378|FG001|Overall Study|Adverse Event|10|||
23428898|NCT00657150|65314377|FG000|Overall Study|Non-compliant with protocol|5|||
23428899|NCT00657150|65314378|FG001|Overall Study|Non-compliant with protocol|9|||
23428900|NCT00657150|65314377|FG000|Overall Study|Lost to Follow-up|2|||
23428901|NCT00657150|65314378|FG001|Overall Study|Lost to Follow-up|0|||
23428902|NCT00657150|65314377|FG000|Overall Study|Withdrawal by Subject|51|||
23428903|NCT00657150|65314378|FG001|Overall Study|Withdrawal by Subject|36|||
23428904|NCT00657150|65314377|FG000|Overall Study|Other|38|||
23428905|NCT00657150|65314378|FG001|Overall Study|Other|38|||
23428906|NCT00657150|65314377|FG000|Treatment|Adverse Event|60|||
23428907|NCT00657150|65314378|FG001|Treatment|Adverse Event|53|||
23428908|NCT00657150|65314377|FG000|Treatment|Non-compliant with protocol|10|||
23428909|NCT00657150|65314378|FG001|Treatment|Non-compliant with protocol|9|||
23428910|NCT00657150|65314377|FG000|Treatment|Lost to Follow-up|1|||
23428911|NCT00657150|65314378|FG001|Treatment|Lost to Follow-up|0|||
23428912|NCT00657150|65314377|FG000|Treatment|Withdrawal by Subject|23|||
23428913|NCT00657150|65314378|FG001|Treatment|Withdrawal by Subject|20|||
23428914|NCT00657150|65314377|FG000|Treatment|Other|13|||
23620248|NCT02720081|65994923|FG001|Overall Study|Protocol Violation|1|||
23620249|NCT03132753|65994924|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
23620250|NCT03132753|65994925|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
23428915|NCT00657150|65314378|FG001|Treatment|Other|15|||
23428916|NCT01304329|65314379|FG000|Third Intervention (3 Days)|Adverse Event|0|||
23428917|NCT01304329|65314380|FG001|Third Intervention (3 Days)|Adverse Event|1|||
23428918|NCT01304329|65314381|FG002|Third Intervention (3 Days)|Adverse Event|0|||
23428919|NCT01304329|65314382|FG003|Third Intervention (3 Days)|Adverse Event|0|||
23620251|NCT03132753|65994924|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
23428920|NCT01304329|65314383|FG004|Third Intervention (3 Days)|Adverse Event|0|||
23428921|NCT01304329|65314384|FG005|Third Intervention (3 Days)|Adverse Event|0|||
23428922|NCT05291936|65314385|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
23428923|NCT05291936|65314386|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
23428924|NCT05291936|65314385|FG000|Period 1|Withdrew Consent during study|1|||
23428925|NCT05291936|65314386|FG001|Period 1|Withdrew Consent during study|0|||
23428926|NCT05291936|65314385|FG000|Period 2|Adverse Event|0|||
23428927|NCT05291936|65314386|FG001|Period 2|Adverse Event|1|||
23428928|NCT05291936|65314385|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
23428929|NCT05291936|65314386|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
23428930|NCT00033540|65314392|FG000|Overall Study|Adverse Event|14|||
23620252|NCT03132753|65994925|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
23620253|NCT04159805|65994926|FG000|Overall Study|Withdrawal by Subject|0|||
23620254|NCT04159805|65994927|FG001|Overall Study|Withdrawal by Subject|2|||
23620255|NCT04159805|65994928|FG002|Overall Study|Withdrawal by Subject|2|||
23741608|NCT01004861|66432717|FG003|Overall Study|Patient decision|0|||
23428931|NCT00033540|65314392|FG000|Overall Study|Death|1|||
23428932|NCT00033540|65314392|FG000|Overall Study|Progression|26|||
23428933|NCT00033540|65314392|FG000|Overall Study|Withdrawal by Subject|6|||
23428934|NCT00033540|65314392|FG000|Overall Study|Other|5|||
23428935|NCT00033540|65314392|FG000|Overall Study|Ineligible|3|||
23428936|NCT00033540|65314392|FG000|Overall Study|Never received treatment|2|||
23428937|NCT00054691|65314394|FG000|Overall Study|Unmeasurable Disease|2|||
23741609|NCT01004861|66432718|FG004|Overall Study|Patient decision|1|||
23741610|NCT01004861|66432719|FG005|Overall Study|Patient decision|0|||
23741611|NCT01004861|66432720|FG006|Overall Study|Patient decision|1|||
23741612|NCT01004861|66432721|FG007|Overall Study|Patient decision|0|||
23741613|NCT01004861|66432722|FG008|Overall Study|Patient decision|7|||
23741614|NCT01004861|66432723|FG009|Overall Study|Patient decision|1|||
23741615|NCT01004861|66432724|FG010|Overall Study|Patient decision|1|||
23741616|NCT01004861|66432725|FG011|Overall Study|Patient decision|2|||
23428938|NCT00054691|65314394|FG000|Overall Study|Noncompliant|1|||
23428939|NCT00654004|65314395|FG000|Overall Study|Lost to Follow-up|1|||
23428940|NCT00654004|65314396|FG001|Overall Study|Lost to Follow-up|0|||
23428941|NCT02226549|65314397|FG000|Overall Study|Randomized but Never Treated|1|||
23428942|NCT02226549|65314398|FG001|Overall Study|Randomized but Never Treated|0|||
23428943|NCT02226549|65314397|FG000|Overall Study|Lost to Follow-up|0|||
23428944|NCT02226549|65314398|FG001|Overall Study|Lost to Follow-up|1|||
23428945|NCT00199888|65314401|FG000|Overall Study|Lost to Follow-up|1|||
23428946|NCT03149003|65314402|FG000|Overall Study|Randomized but not treated|0|||
23428947|NCT03149003|65314403|FG001|Overall Study|Randomized but not treated|1|||
23428948|NCT03149003|65314404|FG002|Overall Study|Randomized but not treated|18|||
23428949|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
23428950|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
23428951|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
23428952|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
23428953|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
23428954|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
23428955|NCT02855944|65314415|FG000|Period 1: Treatment|Ongoing|14|||
23428956|NCT02855944|65314416|FG001|Period 1: Treatment|Ongoing|0|||
23428957|NCT02855944|65314415|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
23428958|NCT02855944|65314416|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
23428959|NCT02855944|65314415|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
23428960|NCT02855944|65314416|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
23428961|NCT00096018|65314417|FG000|Overall Study|Became Ineligible (not treated)|0|||
23428962|NCT00096018|65314418|FG001|Overall Study|Became Ineligible (not treated)|3|||
23428963|NCT00096018|65314417|FG000|Overall Study|Miscellaneous (not treated)|0|||
23428964|NCT00096018|65314418|FG001|Overall Study|Miscellaneous (not treated)|2|||
23428965|NCT00096018|65314417|FG000|Overall Study|Adverse Event|0|||
23428966|NCT00096018|65314418|FG001|Overall Study|Adverse Event|5|||
23428967|NCT00096018|65314417|FG000|Overall Study|Death|0|||
23428968|NCT00096018|65314418|FG001|Overall Study|Death|1|||
23428969|NCT00096018|65314417|FG000|Overall Study|Withdrawal by Subject|0|||
23428970|NCT00096018|65314418|FG001|Overall Study|Withdrawal by Subject|2|||
23428971|NCT00096018|65314417|FG000|Overall Study|Miscellaneous|2|||
23428972|NCT00096018|65314418|FG001|Overall Study|Miscellaneous|1|||
23428973|NCT04191135|65314419|FG000|Induction Treatment|Not Treated|2|||
23428974|NCT04191135|65314420|FG001|Induction Treatment|Not Treated|0|||
23428975|NCT04191135|65314421|FG002|Induction Treatment|Not Treated|0|||
23428976|NCT04191135|65314419|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
23428977|NCT04191135|65314420|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
23428978|NCT04191135|65314421|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
23549550|NCT01392560|65739730|FG000|Overall Study|discontinued during placebo run-in|2|||
23549551|NCT00558428|65739734|FG000|Overall Study|Adverse Event|6|||
23549552|NCT00558428|65739735|FG001|Overall Study|Adverse Event|22|||
23549553|NCT00558428|65739736|FG002|Overall Study|Adverse Event|3|||
23549554|NCT00558428|65739737|FG003|Overall Study|Adverse Event|4|||
23549555|NCT00558428|65739734|FG000|Overall Study|Lost to Follow-up|0|||
23549556|NCT00558428|65739735|FG001|Overall Study|Lost to Follow-up|1|||
23549557|NCT00558428|65739736|FG002|Overall Study|Lost to Follow-up|0|||
23549558|NCT00558428|65739737|FG003|Overall Study|Lost to Follow-up|0|||
23549559|NCT00558428|65739734|FG000|Overall Study|Lack of Efficacy|0|||
23549560|NCT00558428|65739735|FG001|Overall Study|Lack of Efficacy|0|||
23549561|NCT00558428|65739736|FG002|Overall Study|Lack of Efficacy|1|||
23549562|NCT00558428|65739737|FG003|Overall Study|Lack of Efficacy|2|||
23549563|NCT00558428|65739734|FG000|Overall Study|Non compliant with protocol|1|||
23741617|NCT01004861|66432726|FG012|Overall Study|Patient decision|3|||
23741618|NCT01004861|66432714|FG000|Overall Study|Transitioned to Phase 4 study|0|||
23428979|NCT04191135|65314419|FG000|Induction Treatment|Adverse Event|25|||
23428980|NCT04191135|65314420|FG001|Induction Treatment|Adverse Event|0|||
23428981|NCT04191135|65314421|FG002|Induction Treatment|Adverse Event|0|||
23428982|NCT04191135|65314419|FG000|Induction Treatment|Clinical Progression|8|||
23428983|NCT04191135|65314420|FG001|Induction Treatment|Clinical Progression|0|||
23428984|NCT04191135|65314421|FG002|Induction Treatment|Clinical Progression|0|||
23428985|NCT04191135|65314419|FG000|Induction Treatment|Excluded Medication|1|||
23428986|NCT04191135|65314420|FG001|Induction Treatment|Excluded Medication|0|||
23428987|NCT04191135|65314421|FG002|Induction Treatment|Excluded Medication|0|||
23428988|NCT04191135|65314419|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
23428989|NCT04191135|65314420|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
23428990|NCT04191135|65314421|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
23428991|NCT04191135|65314419|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
23428992|NCT04191135|65314420|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
23428993|NCT04191135|65314421|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
23428994|NCT04191135|65314419|FG000|Induction Treatment|Physician Decision|2|||
23428995|NCT04191135|65314420|FG001|Induction Treatment|Physician Decision|0|||
23428996|NCT04191135|65314421|FG002|Induction Treatment|Physician Decision|0|||
23428997|NCT04191135|65314419|FG000|Induction Treatment|Progressive Disease|135|||
23428998|NCT04191135|65314420|FG001|Induction Treatment|Progressive Disease|0|||
23428999|NCT04191135|65314421|FG002|Induction Treatment|Progressive Disease|0|||
23429000|NCT04191135|65314419|FG000|Induction Treatment|Protocol Violation|10|||
23429001|NCT04191135|65314420|FG001|Induction Treatment|Protocol Violation|0|||
23429002|NCT04191135|65314421|FG002|Induction Treatment|Protocol Violation|0|||
23429003|NCT04191135|65314419|FG000|Induction Treatment|Withdrawal by Subject|4|||
23429004|NCT04191135|65314420|FG001|Induction Treatment|Withdrawal by Subject|0|||
23741619|NCT01004861|66432715|FG001|Overall Study|Transitioned to Phase 4 study|0|||
23429005|NCT04191135|65314421|FG002|Induction Treatment|Withdrawal by Subject|0|||
23429006|NCT04191135|65314419|FG000|Randomized Treatment|Death|0|||
23429007|NCT04191135|65314420|FG001|Randomized Treatment|Death|50|||
23429008|NCT04191135|65314421|FG002|Randomized Treatment|Death|54|||
23429009|NCT04191135|65314419|FG000|Randomized Treatment|Lost to Follow-up|0|||
23429010|NCT04191135|65314420|FG001|Randomized Treatment|Lost to Follow-up|0|||
23429011|NCT04191135|65314421|FG002|Randomized Treatment|Lost to Follow-up|1|||
23429012|NCT04191135|65314419|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23429013|NCT04191135|65314420|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23429014|NCT04191135|65314421|FG002|Randomized Treatment|Withdrawal by Subject|0|||
23429015|NCT04191135|65314419|FG000|Randomized Treatment|Ongoing in Trial|0|||
23429016|NCT04191135|65314420|FG001|Randomized Treatment|Ongoing in Trial|83|||
23429017|NCT04191135|65314421|FG002|Randomized Treatment|Ongoing in Trial|81|||
23429018|NCT03761394|65314422|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429019|NCT03761394|65314423|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
23429020|NCT03761394|65314424|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429021|NCT03761394|65314425|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429022|NCT03761394|65314422|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
23429023|NCT03761394|65314423|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
23429024|NCT03761394|65314424|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
23429025|NCT03761394|65314425|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
23429026|NCT03761394|65314422|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429027|NCT03761394|65314423|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429028|NCT03761394|65314424|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
23429029|NCT03761394|65314425|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429030|NCT03761394|65314422|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23620256|NCT03821064|65994933|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
23620257|NCT02172950|65994935|FG000|Overall Study|Physician Decision|3|||
23620258|NCT02172950|65994936|FG001|Overall Study|Physician Decision|3|||
23620259|NCT02172950|65994935|FG000|Overall Study|Lack of Efficacy|1|||
23620260|NCT02172950|65994936|FG001|Overall Study|Lack of Efficacy|0|||
23620261|NCT02172950|65994935|FG000|Overall Study|Adverse Event|4|||
23620262|NCT02172950|65994936|FG001|Overall Study|Adverse Event|1|||
23620263|NCT02172950|65994935|FG000|Overall Study|Withdrawal by Subject|10|||
23620264|NCT02172950|65994936|FG001|Overall Study|Withdrawal by Subject|0|||
23741620|NCT01004861|66432716|FG002|Overall Study|Transitioned to Phase 4 study|0|||
23741621|NCT01004861|66432717|FG003|Overall Study|Transitioned to Phase 4 study|0|||
23741622|NCT01004861|66432718|FG004|Overall Study|Transitioned to Phase 4 study|0|||
23620265|NCT02172950|65994935|FG000|Overall Study|Protocol Violation|1|||
23620266|NCT02172950|65994936|FG001|Overall Study|Protocol Violation|0|||
23620267|NCT02172950|65994935|FG000|Overall Study|Lost to Follow-up|1|||
23620268|NCT02172950|65994936|FG001|Overall Study|Lost to Follow-up|0|||
23620269|NCT02172950|65994935|FG000|Overall Study|Death|1|||
23741623|NCT01004861|66432719|FG005|Overall Study|Transitioned to Phase 4 study|0|||
23620270|NCT02172950|65994936|FG001|Overall Study|Death|0|||
23741624|NCT01004861|66432720|FG006|Overall Study|Transitioned to Phase 4 study|0|||
23741625|NCT01004861|66432721|FG007|Overall Study|Transitioned to Phase 4 study|0|||
23821341|NCT00996892|66725990|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
23821342|NCT00996892|66725991|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
23821343|NCT00996892|66725992|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
23821344|NCT00996892|66725993|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
23821345|NCT00996892|66725994|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
23821346|NCT00996892|66725995|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
23821347|NCT00996892|66725996|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
23821348|NCT00996892|66725997|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
23821349|NCT00996892|66725998|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
23821350|NCT00996892|66725999|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
23821351|NCT00996892|66726000|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
23821352|NCT00996892|66726001|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
23821353|NCT00996892|66726002|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
23821354|NCT00996892|66726003|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
23821355|NCT00996892|66726004|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
23821356|NCT00996892|66726005|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
23821357|NCT00996892|66725986|FG000|Expansion Stage 2A|Disease Progression|0|||
23821358|NCT00996892|66725987|FG001|Expansion Stage 2A|Disease Progression|0|||
23821359|NCT00996892|66725988|FG002|Expansion Stage 2A|Disease Progression|0|||
23821360|NCT00996892|66725989|FG003|Expansion Stage 2A|Disease Progression|0|||
23821361|NCT00996892|66725990|FG004|Expansion Stage 2A|Disease Progression|0|||
23821362|NCT00996892|66725991|FG005|Expansion Stage 2A|Disease Progression|0|||
23821363|NCT00996892|66725992|FG006|Expansion Stage 2A|Disease Progression|0|||
23821364|NCT00996892|66725993|FG007|Expansion Stage 2A|Disease Progression|0|||
23821365|NCT00996892|66725994|FG008|Expansion Stage 2A|Disease Progression|0|||
23821366|NCT00996892|66725995|FG009|Expansion Stage 2A|Disease Progression|0|||
23821367|NCT00996892|66725996|FG010|Expansion Stage 2A|Disease Progression|0|||
23821368|NCT00996892|66725997|FG011|Expansion Stage 2A|Disease Progression|0|||
23821369|NCT00996892|66725998|FG012|Expansion Stage 2A|Disease Progression|0|||
23821370|NCT00996892|66725999|FG013|Expansion Stage 2A|Disease Progression|0|||
23821371|NCT00996892|66726000|FG014|Expansion Stage 2A|Disease Progression|0|||
23821372|NCT00996892|66726001|FG015|Expansion Stage 2A|Disease Progression|0|||
23821373|NCT00996892|66726002|FG016|Expansion Stage 2A|Disease Progression|0|||
23821374|NCT00996892|66726003|FG017|Expansion Stage 2A|Disease Progression|0|||
23821375|NCT00996892|66726004|FG018|Expansion Stage 2A|Disease Progression|0|||
23821376|NCT00996892|66726005|FG019|Expansion Stage 2A|Disease Progression|31|||
23821377|NCT02682927|66726006|FG000|Overall Study|Adverse Event|0|||
23821378|NCT02682927|66726007|FG001|Overall Study|Adverse Event|0|||
23821379|NCT02682927|66726008|FG002|Overall Study|Adverse Event|5|||
23821380|NCT02682927|66726009|FG003|Overall Study|Adverse Event|1|||
23821381|NCT02682927|66726010|FG004|Overall Study|Adverse Event|0|||
23821382|NCT02682927|66726011|FG005|Overall Study|Adverse Event|2|||
23821383|NCT02682927|66726006|FG000|Overall Study|Death|0|||
23821384|NCT02682927|66726007|FG001|Overall Study|Death|0|||
23821385|NCT02682927|66726008|FG002|Overall Study|Death|0|||
23821386|NCT02682927|66726009|FG003|Overall Study|Death|1|||
23821387|NCT02682927|66726010|FG004|Overall Study|Death|0|||
23821388|NCT02682927|66726011|FG005|Overall Study|Death|0|||
23821389|NCT02682927|66726006|FG000|Overall Study|Lack of Efficacy|1|||
23741626|NCT01004861|66432722|FG008|Overall Study|Transitioned to Phase 4 study|2|||
23741627|NCT01004861|66432723|FG009|Overall Study|Transitioned to Phase 4 study|0|||
23741628|NCT01004861|66432724|FG010|Overall Study|Transitioned to Phase 4 study|0|||
23741629|NCT01004861|66432725|FG011|Overall Study|Transitioned to Phase 4 study|0|||
23821390|NCT02682927|66726007|FG001|Overall Study|Lack of Efficacy|0|||
23741630|NCT01004861|66432726|FG012|Overall Study|Transitioned to Phase 4 study|0|||
23741631|NCT01004861|66432714|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741632|NCT01004861|66432715|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741633|NCT01004861|66432716|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741634|NCT01004861|66432717|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741635|NCT01004861|66432718|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741636|NCT01004861|66432719|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23782256|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23821391|NCT02682927|66726008|FG002|Overall Study|Lack of Efficacy|0|||
23821392|NCT02682927|66726009|FG003|Overall Study|Lack of Efficacy|1|||
23429031|NCT03761394|65314423|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23549564|NCT00558428|65739735|FG001|Overall Study|Non compliant with protocol|0|||
23821393|NCT02682927|66726010|FG004|Overall Study|Lack of Efficacy|0|||
23821394|NCT02682927|66726011|FG005|Overall Study|Lack of Efficacy|0|||
23821395|NCT02682927|66726006|FG000|Overall Study|Other|0|||
23821396|NCT02682927|66726007|FG001|Overall Study|Other|0|||
23821397|NCT02682927|66726008|FG002|Overall Study|Other|0|||
23821398|NCT02682927|66726009|FG003|Overall Study|Other|2|||
23821399|NCT02682927|66726010|FG004|Overall Study|Other|0|||
23821400|NCT02682927|66726011|FG005|Overall Study|Other|0|||
23821401|NCT02682927|66726006|FG000|Overall Study|Withdrawal by Subject|2|||
23821402|NCT02682927|66726007|FG001|Overall Study|Withdrawal by Subject|0|||
23821403|NCT02682927|66726008|FG002|Overall Study|Withdrawal by Subject|1|||
23741637|NCT01004861|66432720|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741638|NCT01004861|66432721|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741639|NCT01004861|66432722|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
23741640|NCT01004861|66432723|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741641|NCT01004861|66432724|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741642|NCT01004861|66432725|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741643|NCT01004861|66432726|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23741644|NCT01004861|66432714|FG000|Overall Study|Patient withdrew|0|||
23741645|NCT01004861|66432715|FG001|Overall Study|Patient withdrew|0|||
23741646|NCT01004861|66432716|FG002|Overall Study|Patient withdrew|0|||
23741647|NCT01004861|66432717|FG003|Overall Study|Patient withdrew|0|||
23741648|NCT01004861|66432718|FG004|Overall Study|Patient withdrew|0|||
23741649|NCT01004861|66432719|FG005|Overall Study|Patient withdrew|0|||
23741650|NCT01004861|66432720|FG006|Overall Study|Patient withdrew|0|||
23741651|NCT01004861|66432721|FG007|Overall Study|Patient withdrew|0|||
23741652|NCT01004861|66432722|FG008|Overall Study|Patient withdrew|1|||
23741653|NCT01004861|66432723|FG009|Overall Study|Patient withdrew|0|||
23741654|NCT01004861|66432724|FG010|Overall Study|Patient withdrew|0|||
23741655|NCT01004861|66432725|FG011|Overall Study|Patient withdrew|0|||
23741656|NCT01004861|66432726|FG012|Overall Study|Patient withdrew|0|||
23821404|NCT02682927|66726009|FG003|Overall Study|Withdrawal by Subject|0|||
23821405|NCT02682927|66726010|FG004|Overall Study|Withdrawal by Subject|1|||
23821406|NCT02682927|66726011|FG005|Overall Study|Withdrawal by Subject|1|||
23741657|NCT01004861|66432714|FG000|Overall Study|Surgical resection|0|||
23741658|NCT01004861|66432715|FG001|Overall Study|Surgical resection|0|||
23741659|NCT01004861|66432716|FG002|Overall Study|Surgical resection|0|||
23741660|NCT01004861|66432717|FG003|Overall Study|Surgical resection|0|||
23741661|NCT01004861|66432718|FG004|Overall Study|Surgical resection|0|||
23741662|NCT01004861|66432719|FG005|Overall Study|Surgical resection|0|||
23741663|NCT01004861|66432720|FG006|Overall Study|Surgical resection|0|||
23741664|NCT01004861|66432721|FG007|Overall Study|Surgical resection|0|||
23741665|NCT01004861|66432722|FG008|Overall Study|Surgical resection|1|||
23741666|NCT01004861|66432723|FG009|Overall Study|Surgical resection|0|||
23821407|NCT02564887|66726017|FG000|Overall Study|Lost to Follow-up|6|||
23821408|NCT02564887|66726018|FG001|Overall Study|Lost to Follow-up|0|||
23620271|NCT02172950|65994935|FG000|Overall Study|Patient traveling|1|||
23741667|NCT01004861|66432724|FG010|Overall Study|Surgical resection|0|||
23741668|NCT01004861|66432725|FG011|Overall Study|Surgical resection|0|||
23741669|NCT01004861|66432726|FG012|Overall Study|Surgical resection|0|||
23741670|NCT01004861|66432714|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741671|NCT01004861|66432715|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741672|NCT01004861|66432716|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741673|NCT01004861|66432717|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741674|NCT01004861|66432718|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741675|NCT01004861|66432719|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741676|NCT01004861|66432720|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741677|NCT01004861|66432721|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741678|NCT01004861|66432722|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
23741679|NCT01004861|66432723|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741680|NCT01004861|66432724|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741681|NCT01004861|66432725|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741682|NCT01004861|66432726|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23741683|NCT01004861|66432714|FG000|Overall Study|Study termination by Sponsor|0|||
23741684|NCT01004861|66432715|FG001|Overall Study|Study termination by Sponsor|0|||
23741685|NCT01004861|66432716|FG002|Overall Study|Study termination by Sponsor|0|||
23741686|NCT01004861|66432717|FG003|Overall Study|Study termination by Sponsor|0|||
23821409|NCT01609023|66726025|FG000|Overall Study|Lack of Efficacy|3|||
23741687|NCT01004861|66432718|FG004|Overall Study|Study termination by Sponsor|0|||
23821410|NCT01609023|66726025|FG000|Overall Study|Withdrawal by Subject|4|||
23821411|NCT01609023|66726025|FG000|Overall Study|Lost to Follow-up|8|||
23620272|NCT02172950|65994936|FG001|Overall Study|Patient traveling|0|||
23741688|NCT01004861|66432719|FG005|Overall Study|Study termination by Sponsor|0|||
23741689|NCT01004861|66432720|FG006|Overall Study|Study termination by Sponsor|0|||
23741690|NCT01004861|66432721|FG007|Overall Study|Study termination by Sponsor|0|||
23741691|NCT01004861|66432722|FG008|Overall Study|Study termination by Sponsor|1|||
23741692|NCT01004861|66432723|FG009|Overall Study|Study termination by Sponsor|0|||
23741693|NCT01004861|66432724|FG010|Overall Study|Study termination by Sponsor|0|||
23741694|NCT01004861|66432725|FG011|Overall Study|Study termination by Sponsor|0|||
23741695|NCT01004861|66432726|FG012|Overall Study|Study termination by Sponsor|0|||
23741696|NCT00383292|66432727|FG000|Overall Study|Adverse Event|4|||
23741697|NCT00383292|66432728|FG001|Overall Study|Adverse Event|1|||
23741698|NCT00383292|66432729|FG002|Overall Study|Adverse Event|2|||
23741699|NCT00383292|66432727|FG000|Overall Study|Death|3|||
23741700|NCT00383292|66432728|FG001|Overall Study|Death|3|||
23741701|NCT00383292|66432729|FG002|Overall Study|Death|3|||
23741702|NCT00383292|66432727|FG000|Overall Study|Physician Decision|4|||
23741703|NCT00383292|66432728|FG001|Overall Study|Physician Decision|0|||
23741704|NCT00383292|66432729|FG002|Overall Study|Physician Decision|1|||
23741705|NCT00383292|66432727|FG000|Overall Study|Withdrawal by Subject|3|||
23741706|NCT00383292|66432728|FG001|Overall Study|Withdrawal by Subject|2|||
23741707|NCT00383292|66432729|FG002|Overall Study|Withdrawal by Subject|2|||
23741708|NCT00383292|66432727|FG000|Overall Study|Other|1|||
23741709|NCT00383292|66432728|FG001|Overall Study|Other|0|||
23741710|NCT00383292|66432729|FG002|Overall Study|Other|0|||
23741711|NCT00545584|66432732|FG000|Overall Study|Only one reason for discontinuation|62|||
23741712|NCT00545584|66432733|FG001|Overall Study|Only one reason for discontinuation|61|||
23741713|NCT00545584|66432734|FG002|Overall Study|Only one reason for discontinuation|48|||
23741714|NCT00545584|66432732|FG000|Overall Study|Two or more reasons for discontinuation|17|||
23741715|NCT00545584|66432733|FG001|Overall Study|Two or more reasons for discontinuation|19|||
23741716|NCT00545584|66432734|FG002|Overall Study|Two or more reasons for discontinuation|8|||
23741717|NCT03258710|66432735|FG000|Overall Study|Adverse Event|1|||
23741718|NCT03258710|66432735|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23741719|NCT03258710|66432735|FG000|Overall Study|Physician Decision|1|||
23741720|NCT01430559|66432739|FG000|Overall Study|Adverse Event|7|||
23741721|NCT01430559|66432740|FG001|Overall Study|Adverse Event|3|||
23741722|NCT01430559|66432739|FG000|Overall Study|Entry criteria not met|1|||
23741723|NCT01430559|66432740|FG001|Overall Study|Entry criteria not met|1|||
23741724|NCT01430559|66432739|FG000|Overall Study|Lost to Follow-up|1|||
23741725|NCT01430559|66432740|FG001|Overall Study|Lost to Follow-up|0|||
23741726|NCT01430559|66432739|FG000|Overall Study|Medication error|1|||
23741727|NCT01430559|66432740|FG001|Overall Study|Medication error|0|||
23741728|NCT01430559|66432739|FG000|Overall Study|Withdrawal by Subject|3|||
23549565|NCT00558428|65739736|FG002|Overall Study|Non compliant with protocol|0|||
23549566|NCT00558428|65739737|FG003|Overall Study|Non compliant with protocol|3|||
23549567|NCT00558428|65739734|FG000|Overall Study|Consent withdrawn|2|||
23549568|NCT00558428|65739735|FG001|Overall Study|Consent withdrawn|1|||
23549569|NCT00558428|65739736|FG002|Overall Study|Consent withdrawn|0|||
23549570|NCT00558428|65739737|FG003|Overall Study|Consent withdrawn|1|||
23549571|NCT00558428|65739734|FG000|Overall Study|Other|3|||
23549572|NCT00558428|65739735|FG001|Overall Study|Other|0|||
23549573|NCT00558428|65739736|FG002|Overall Study|Other|0|||
23549574|NCT00558428|65739737|FG003|Overall Study|Other|1|||
23549575|NCT05239039|65739738|FG000|Overall Study|Withdrawal by Subject|0|||
23549576|NCT05239039|65739739|FG001|Overall Study|Withdrawal by Subject|1|||
23549577|NCT02298192|65739743|FG000|Overall Study|Unclassified|3|||
23549578|NCT02298192|65739744|FG001|Overall Study|Unclassified|2|||
23549579|NCT02298192|65739743|FG000|Overall Study|Withdrawal criteria|2|||
23620273|NCT02172950|65994935|FG000|Overall Study|Patient went to other country|1|||
23620274|NCT02172950|65994936|FG001|Overall Study|Patient went to other country|0|||
23620275|NCT02172950|65994935|FG000|Overall Study|Patient relocated overseas|1|||
23620276|NCT02172950|65994936|FG001|Overall Study|Patient relocated overseas|1|||
23620277|NCT02172950|65994935|FG000|Overall Study|Patient moving|1|||
23741729|NCT01430559|66432740|FG001|Overall Study|Withdrawal by Subject|2|||
23741730|NCT01430559|66432739|FG000|Overall Study|Protocol Violation|1|||
23741731|NCT01430559|66432740|FG001|Overall Study|Protocol Violation|0|||
23741732|NCT01430559|66432739|FG000|Overall Study|Other|3|||
23741733|NCT01430559|66432740|FG001|Overall Study|Other|3|||
23741734|NCT01430559|66432739|FG000|Overall Study|Randomized, Not Treated|3|||
23741735|NCT01430559|66432740|FG001|Overall Study|Randomized, Not Treated|3|||
23741736|NCT03795233|66432741|FG000|Overall Study|Withdrawal by Subject|2|||
23741737|NCT03795233|66432742|FG001|Overall Study|Withdrawal by Subject|1|||
23741738|NCT03795233|66432741|FG000|Overall Study|Lost to Follow-up|1|||
23741739|NCT03795233|66432742|FG001|Overall Study|Lost to Follow-up|0|||
23549580|NCT02298192|65739744|FG001|Overall Study|Withdrawal criteria|0|||
23549581|NCT02298192|65739743|FG000|Overall Study|Withdrawal by Subject|6|||
23549582|NCT02298192|65739744|FG001|Overall Study|Withdrawal by Subject|1|||
23620278|NCT02172950|65994936|FG001|Overall Study|Patient moving|0|||
23620279|NCT01232569|65994937|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
23620280|NCT01232569|65994938|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23620281|NCT01232569|65994939|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23620282|NCT01232569|65994940|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
23620283|NCT01232569|65994937|FG000|Double-blind Treatment Period|Escape|2|||
23741740|NCT03795233|66432741|FG000|Overall Study|Death|1|||
23741741|NCT03795233|66432742|FG001|Overall Study|Death|0|||
23549583|NCT02298192|65739743|FG000|Overall Study|Lost to Follow-up|2|||
23429032|NCT03761394|65314424|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23429033|NCT03761394|65314425|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
23429034|NCT02068118|65314426|FG000|18-month Comparative Study Period|Death|90|||
23429035|NCT02068118|65314427|FG001|18-month Comparative Study Period|Death|97|||
23429036|NCT02068118|65314426|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
23429037|NCT02068118|65314427|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
23549584|NCT02298192|65739744|FG001|Overall Study|Lost to Follow-up|1|||
23549585|NCT02298192|65739743|FG000|Overall Study|Adverse Event|6|||
23429038|NCT02068118|65314426|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
23429039|NCT02068118|65314427|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
23429040|NCT02068118|65314426|FG000|18-month Comparative Study Period|Heart transplant|9|||
23429041|NCT02068118|65314427|FG001|18-month Comparative Study Period|Heart transplant|15|||
23549586|NCT02298192|65739744|FG001|Overall Study|Adverse Event|2|||
23549587|NCT00725296|65739745|FG000|Overall Study|Adverse Event|11|||
23741742|NCT03159455|66432743|FG000|Overall Study|Adverse Event|0|||
23741743|NCT03159455|66432744|FG001|Overall Study|Adverse Event|0|||
23741744|NCT03159455|66432745|FG002|Overall Study|Adverse Event|0|||
23741745|NCT03159455|66432746|FG003|Overall Study|Adverse Event|0|||
23741746|NCT03159455|66432747|FG004|Overall Study|Adverse Event|0|||
23741747|NCT03159455|66432748|FG005|Overall Study|Adverse Event|1|||
23741748|NCT00953576|66432749|FG000|Overall Study|Adverse Event|0|||
23741749|NCT00953576|66432750|FG001|Overall Study|Adverse Event|1|||
23741750|NCT00953576|66432749|FG000|Overall Study|Ineligible after Consent|2|||
23741751|NCT00953576|66432750|FG001|Overall Study|Ineligible after Consent|0|||
23741752|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Death|2|||
23741753|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Death|0|||
23741754|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Adverse Event|33|||
23741755|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Adverse Event|31|||
23549588|NCT00725296|65739745|FG000|Overall Study|Lack of Efficacy|7|||
23549589|NCT00725296|65739745|FG000|Overall Study|Withdrawal by Subject|3|||
23549590|NCT00725296|65739745|FG000|Overall Study|Non-Compliance|2|||
23549591|NCT00725296|65739745|FG000|Overall Study|Lost to Follow-up|1|||
23549592|NCT00725296|65739745|FG000|Overall Study|Other|38|||
23549593|NCT01540851|65739749|FG000|Overall Study|Lost to Follow-up|14|||
23549594|NCT01540851|65739750|FG001|Overall Study|Lost to Follow-up|15|||
23549595|NCT01540851|65739749|FG000|Overall Study|Withdrawal by Subject|7|||
23549596|NCT01540851|65739750|FG001|Overall Study|Withdrawal by Subject|3|||
23549597|NCT04827212|65739751|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
23549598|NCT04827212|65739752|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
23549599|NCT04827212|65739751|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
23549600|NCT04827212|65739752|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
23549601|NCT01962493|65739753|FG000|Overall Study|Adverse Event|1|||
23741756|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
23741757|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
23741758|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
23741759|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
23741760|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
23741761|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
23741762|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Other|7|||
23741763|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Other|8|||
23741764|NCT00280059|66432753|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
23429042|NCT02068118|65314426|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
23549602|NCT01962493|65739754|FG001|Overall Study|Adverse Event|2|||
23549603|NCT01962493|65739753|FG000|Overall Study|Protocol Violation|0|||
23549604|NCT01962493|65739754|FG001|Overall Study|Protocol Violation|1|||
23741765|NCT00280059|66432754|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
23741766|NCT02506101|66432759|FG000|Overall Study|Transportation issues|1|||
23741767|NCT02506101|66432760|FG001|Overall Study|Transportation issues|0|||
23741768|NCT02506101|66432759|FG000|Overall Study|No enrollment and staff unavailability|1|||
23549605|NCT01962493|65739753|FG000|Overall Study|Withdrawal by Subject|4|||
23549606|NCT01962493|65739754|FG001|Overall Study|Withdrawal by Subject|2|||
23549607|NCT00127101|65739762|FG000|Base Protocol|Adverse Event|0|||
23549608|NCT00127101|65739763|FG001|Base Protocol|Adverse Event|2|||
23549609|NCT00127101|65739764|FG002|Base Protocol|Adverse Event|1|||
23549610|NCT00127101|65739765|FG003|Base Protocol|Adverse Event|0|||
23549611|NCT00127101|65739766|FG004|Base Protocol|Adverse Event|0|||
23549612|NCT00127101|65739767|FG005|Base Protocol|Adverse Event|0|||
23429043|NCT02068118|65314427|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
23429044|NCT02068118|65314426|FG000|18-month Comparative Study Period|Hemiplegia|0|||
23429045|NCT02068118|65314427|FG001|18-month Comparative Study Period|Hemiplegia|1|||
23429046|NCT02068118|65314426|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
23429047|NCT02068118|65314427|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
23429048|NCT02068118|65314426|FG000|18-month Comparative Study Period|Move|0|||
23429049|NCT02068118|65314427|FG001|18-month Comparative Study Period|Move|1|||
23429050|NCT02068118|65314426|FG000|18-month Comparative Study Period|Hearing loss|0|||
23429051|NCT02068118|65314427|FG001|18-month Comparative Study Period|Hearing loss|1|||
23429052|NCT02068118|65314426|FG000|Extension Period|Death|0|||
23429053|NCT02068118|65314427|FG001|Extension Period|Death|2|||
23429054|NCT02068118|65314426|FG000|Extension Period|Withdrawal by Subject|1|||
23429055|NCT02068118|65314427|FG001|Extension Period|Withdrawal by Subject|0|||
23429056|NCT02068118|65314426|FG000|Extension Period|Heart transplant|1|||
23429057|NCT02068118|65314427|FG001|Extension Period|Heart transplant|0|||
23429058|NCT02068118|65314426|FG000|Extension Period|Wrong device use|0|||
23429059|NCT02068118|65314427|FG001|Extension Period|Wrong device use|1|||
23429060|NCT01703065|65314428|FG000|Overall Study|Lack of Efficacy|1|||
23429061|NCT01703065|65314429|FG001|Overall Study|Lack of Efficacy|0|||
23429062|NCT01806064|65314438|FG000|Overall Study|Randomized Not Enrolled|0|||
23429063|NCT01806064|65314439|FG001|Overall Study|Randomized Not Enrolled|0|||
23429064|NCT01806064|65314440|FG002|Overall Study|Randomized Not Enrolled|0|||
23429065|NCT01806064|65314441|FG003|Overall Study|Randomized Not Enrolled|1|||
23429066|NCT01806064|65314442|FG004|Overall Study|Randomized Not Enrolled|2|||
23429067|NCT02120365|65314448|FG000|Overall Study|Withdrawal by Subject|0|||
23429068|NCT02120365|65314449|FG001|Overall Study|Withdrawal by Subject|0|||
23429069|NCT02120365|65314450|FG002|Overall Study|Withdrawal by Subject|2|||
23429070|NCT02120365|65314451|FG003|Overall Study|Withdrawal by Subject|4|||
23429071|NCT02120365|65314452|FG004|Overall Study|Withdrawal by Subject|0|||
23429072|NCT02120365|65314453|FG005|Overall Study|Withdrawal by Subject|2|||
23429073|NCT03077698|65314454|FG000|Progestin Monotherapy|Stable Disease|8|||
23429074|NCT03077698|65314455|FG001|Progestin Monotherapy|Stable Disease|0|||
23429075|NCT03077698|65314454|FG000|Progestin Monotherapy|Adverse Event|1|||
23429076|NCT03077698|65314455|FG001|Progestin Monotherapy|Adverse Event|0|||
23429077|NCT03077698|65314454|FG000|Progestin Monotherapy|Death|1|||
23429078|NCT03077698|65314455|FG001|Progestin Monotherapy|Death|0|||
23429079|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
23429080|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
23429081|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
23429082|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
23429083|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
23429084|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
23429085|NCT03077698|65314454|FG000|Safety Follow Up|Withdrawal by Subject|2|||
23429086|NCT03077698|65314455|FG001|Safety Follow Up|Withdrawal by Subject|1|||
23429087|NCT03077698|65314454|FG000|Safety Follow Up|Transfer of care to hospice|1|||
23429088|NCT03077698|65314455|FG001|Safety Follow Up|Transfer of care to hospice|0|||
23429089|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
23429090|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
23429091|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
23429092|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
23429093|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
23429094|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
23429095|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
23429096|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
23741769|NCT02506101|66432760|FG001|Overall Study|No enrollment and staff unavailability|0|||
23741770|NCT00475657|66432761|FG000|Overall Study|Death|1|||
23741771|NCT00475657|66432761|FG000|Overall Study|Sponsor's Decision|3|||
23741772|NCT01220024|66432762|FG000|Overall Study|Lost to Follow-up|1|||
23741773|NCT01220024|66432763|FG001|Overall Study|Lost to Follow-up|1|||
23741774|NCT01249404|66432767|FG000|Overall Study|Study treatment not received|0|||
23741775|NCT01249404|66432768|FG001|Overall Study|Study treatment not received|1|||
23741776|NCT01249404|66432769|FG002|Overall Study|Study treatment not received|2|||
23741777|NCT01249404|66432767|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
23741778|NCT01249404|66432768|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
23741779|NCT01249404|66432769|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
23741780|NCT01249404|66432767|FG000|Overall Study|Adverse Event|2|||
23429097|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
23429098|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
23549613|NCT00127101|65739762|FG000|Base Protocol|Lack of Efficacy|1|||
23429099|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
23429100|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
23429101|NCT02119156|65314456|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
23429102|NCT02119156|65314457|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
23429103|NCT02119156|65314458|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
23429104|NCT02080260|65314462|FG000|Overall Study|Death|18|||
23429105|NCT02080260|65314462|FG000|Overall Study|Withdrawal by Subject|1|||
23429106|NCT00276614|65314468|FG000|Overall Study|Progression of disease under study|3|||
23429107|NCT00707746|65314471|FG000|Treatment Period|Adverse Event|2|||
23429108|NCT00707746|65314472|FG001|Treatment Period|Adverse Event|4|||
23429109|NCT00707746|65314471|FG000|Treatment Period|Ineligibility|0|||
23429110|NCT00707746|65314472|FG001|Treatment Period|Ineligibility|1|||
23429111|NCT02581930|65314473|FG000|Overall Study|Withdrawal by Subject|1|||
23429112|NCT02581930|65314473|FG000|Overall Study|patient declined further treatment|1|||
23429113|NCT05136898|65314474|FG000|Overall Study|Adverse Event|2|||
23429114|NCT03529110|65314475|FG000|Overall Study|Progressive Disease|66|||
23429115|NCT03529110|65314476|FG001|Overall Study|Progressive Disease|158|||
23429116|NCT03529110|65314475|FG000|Overall Study|Clinical Progression|4|||
23429117|NCT03529110|65314476|FG001|Overall Study|Clinical Progression|12|||
23429118|NCT03529110|65314475|FG000|Overall Study|Adverse Event|35|||
23429119|NCT03529110|65314476|FG001|Overall Study|Adverse Event|17|||
23429120|NCT03529110|65314475|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
23429121|NCT03529110|65314476|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
23429122|NCT03529110|65314475|FG000|Overall Study|Lack of Efficacy|3|||
23429123|NCT03529110|65314476|FG001|Overall Study|Lack of Efficacy|3|||
23429124|NCT03529110|65314475|FG000|Overall Study|Physician Decision|2|||
23429125|NCT03529110|65314476|FG001|Overall Study|Physician Decision|8|||
23429126|NCT03529110|65314475|FG000|Overall Study|Miscellaneous|2|||
23429127|NCT03529110|65314476|FG001|Overall Study|Miscellaneous|5|||
23429128|NCT00424190|65314483|FG000|Overall Study|Withdrew consent|3|||
23429129|NCT00424190|65314484|FG001|Overall Study|Withdrew consent|4|||
23429130|NCT00424190|65314483|FG000|Overall Study|Death|3|||
23429131|NCT00424190|65314484|FG001|Overall Study|Death|0|||
23429132|NCT00424190|65314483|FG000|Overall Study|Noncompliance|1|||
23429133|NCT00424190|65314484|FG001|Overall Study|Noncompliance|2|||
23429134|NCT00424190|65314483|FG000|Overall Study|Request of sponsor or investigator|0|||
23429135|NCT00424190|65314484|FG001|Overall Study|Request of sponsor or investigator|2|||
23429136|NCT00424190|65314483|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
23429137|NCT00424190|65314484|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
23429138|NCT00424190|65314483|FG000|Overall Study|Other|15|||
23429139|NCT00424190|65314484|FG001|Overall Study|Other|21|||
23429140|NCT01048866|65314486|FG000|Overall Study|Adverse Event|1|||
23429141|NCT01048866|65314487|FG001|Overall Study|Adverse Event|0|||
23429142|NCT01048866|65314486|FG000|Overall Study|Protocol Violation|1|||
23429143|NCT01048866|65314487|FG001|Overall Study|Protocol Violation|0|||
23429144|NCT01048866|65314486|FG000|Overall Study|Physician Decision|1|||
23429145|NCT01048866|65314487|FG001|Overall Study|Physician Decision|0|||
23429146|NCT01048866|65314486|FG000|Overall Study|Withdrawal by Subject|0|||
23429147|NCT01048866|65314487|FG001|Overall Study|Withdrawal by Subject|2|||
23429148|NCT01048866|65314486|FG000|Overall Study|Lost to Follow-up|0|||
23429149|NCT01048866|65314487|FG001|Overall Study|Lost to Follow-up|2|||
23429150|NCT01048866|65314486|FG000|Overall Study|Other|1|||
23429151|NCT01048866|65314487|FG001|Overall Study|Other|1|||
23429152|NCT00930969|65314490|FG000|Overall Study|Death|5|||
23429153|NCT00930969|65314490|FG000|Overall Study|Lost to Follow-up|1|||
23429154|NCT00930969|65314490|FG000|Overall Study|Physician Decision|13|||
23429155|NCT00930969|65314490|FG000|Overall Study|Withdrawal by Subject|19|||
23429156|NCT00334282|65314497|FG000|Overall Study|Lost to Follow-up|11|||
23429157|NCT00334282|65314498|FG001|Overall Study|Lost to Follow-up|5|||
23429158|NCT00334282|65314497|FG000|Overall Study|Withdrawal by Subject|17|||
23429159|NCT00334282|65314498|FG001|Overall Study|Withdrawal by Subject|3|||
23429160|NCT00334282|65314497|FG000|Overall Study|Death|194|||
23429161|NCT00334282|65314498|FG001|Overall Study|Death|100|||
23429162|NCT02308488|65314499|FG000|Overall Study|Withdrawal by Subject|2|||
23429163|NCT02966015|65314500|FG000|Inclusion Visit|did not answer questionnaire|8|||
23429164|NCT02966015|65314501|FG001|Inclusion Visit|did not answer questionnaire|3|||
23429165|NCT04957758|65314502|FG000|Overall Study|Adverse Event|1|||
23429166|NCT04957758|65314503|FG001|Overall Study|Adverse Event|0|||
23429167|NCT04957758|65314502|FG000|Overall Study|Lost to Follow-up|0|||
23741781|NCT01249404|66432768|FG001|Overall Study|Adverse Event|2|||
23429168|NCT04957758|65314503|FG001|Overall Study|Lost to Follow-up|2|||
23429169|NCT04957758|65314502|FG000|Overall Study|Withdrawal by Subject|4|||
23429170|NCT04957758|65314503|FG001|Overall Study|Withdrawal by Subject|2|||
23429171|NCT04957758|65314502|FG000|Overall Study|Protocol Violation|0|||
23429172|NCT04957758|65314503|FG001|Overall Study|Protocol Violation|1|||
23429173|NCT01443130|65314510|FG000|Overall Study|Lost to Follow-up|44|||
23429174|NCT01443130|65314511|FG001|Overall Study|Lost to Follow-up|42|||
23429175|NCT01443130|65314512|FG002|Overall Study|Lost to Follow-up|50|||
23429176|NCT01443130|65314513|FG003|Overall Study|Lost to Follow-up|23|||
23429177|NCT01443130|65314514|FG004|Overall Study|Lost to Follow-up|25|||
23429178|NCT01443130|65314515|FG005|Overall Study|Lost to Follow-up|21|||
23429179|NCT01443130|65314510|FG000|Overall Study|Death|0|||
23429180|NCT01443130|65314511|FG001|Overall Study|Death|1|||
23429181|NCT01443130|65314512|FG002|Overall Study|Death|0|||
23429182|NCT01443130|65314513|FG003|Overall Study|Death|7|||
23429183|NCT01443130|65314514|FG004|Overall Study|Death|10|||
23429184|NCT01443130|65314515|FG005|Overall Study|Death|8|||
23429185|NCT01443130|65314510|FG000|Overall Study|Adverse Event|2|||
23429186|NCT01443130|65314511|FG001|Overall Study|Adverse Event|1|||
23429187|NCT01443130|65314512|FG002|Overall Study|Adverse Event|1|||
23429188|NCT01443130|65314513|FG003|Overall Study|Adverse Event|0|||
23429189|NCT01443130|65314514|FG004|Overall Study|Adverse Event|0|||
23429190|NCT01443130|65314515|FG005|Overall Study|Adverse Event|0|||
23429191|NCT01443130|65314510|FG000|Overall Study|Protocol Violation|2|||
23429192|NCT01443130|65314511|FG001|Overall Study|Protocol Violation|1|||
23429193|NCT01443130|65314512|FG002|Overall Study|Protocol Violation|3|||
23429194|NCT01443130|65314513|FG003|Overall Study|Protocol Violation|2|||
23429195|NCT01443130|65314514|FG004|Overall Study|Protocol Violation|2|||
23549614|NCT00127101|65739763|FG001|Base Protocol|Lack of Efficacy|0|||
23549615|NCT00127101|65739764|FG002|Base Protocol|Lack of Efficacy|0|||
23549616|NCT00127101|65739765|FG003|Base Protocol|Lack of Efficacy|0|||
23549617|NCT00127101|65739766|FG004|Base Protocol|Lack of Efficacy|2|||
23549618|NCT00127101|65739767|FG005|Base Protocol|Lack of Efficacy|0|||
23549619|NCT00127101|65739762|FG000|Base Protocol|Withdrawal by Subject|1|||
23549620|NCT00127101|65739763|FG001|Base Protocol|Withdrawal by Subject|2|||
23549621|NCT00127101|65739764|FG002|Base Protocol|Withdrawal by Subject|1|||
23549622|NCT00127101|65739765|FG003|Base Protocol|Withdrawal by Subject|0|||
23549623|NCT00127101|65739766|FG004|Base Protocol|Withdrawal by Subject|0|||
23549624|NCT00127101|65739767|FG005|Base Protocol|Withdrawal by Subject|1|||
23549625|NCT00127101|65739762|FG000|Continuation Phase|Adverse Event|0|||
23549626|NCT00127101|65739763|FG001|Continuation Phase|Adverse Event|0|||
23549627|NCT00127101|65739764|FG002|Continuation Phase|Adverse Event|0|||
23549628|NCT00127101|65739765|FG003|Continuation Phase|Adverse Event|0|||
23549629|NCT00127101|65739766|FG004|Continuation Phase|Adverse Event|1|||
23549630|NCT00127101|65739767|FG005|Continuation Phase|Adverse Event|1|||
23549631|NCT00127101|65739762|FG000|Continuation Phase|Lack of Efficacy|0|||
23549632|NCT00127101|65739763|FG001|Continuation Phase|Lack of Efficacy|0|||
23549633|NCT00127101|65739764|FG002|Continuation Phase|Lack of Efficacy|0|||
23549634|NCT00127101|65739765|FG003|Continuation Phase|Lack of Efficacy|0|||
23549635|NCT00127101|65739766|FG004|Continuation Phase|Lack of Efficacy|0|||
23549636|NCT00127101|65739767|FG005|Continuation Phase|Lack of Efficacy|1|||
23549637|NCT00127101|65739762|FG000|Continuation Phase|Withdrawal by Subject|0|||
23549638|NCT00127101|65739763|FG001|Continuation Phase|Withdrawal by Subject|0|||
23549639|NCT00127101|65739764|FG002|Continuation Phase|Withdrawal by Subject|1|||
23549640|NCT00127101|65739765|FG003|Continuation Phase|Withdrawal by Subject|0|||
23429196|NCT01443130|65314515|FG005|Overall Study|Protocol Violation|3|||
23429197|NCT01443130|65314510|FG000|Overall Study|Withdrawal by Subject|15|||
23429198|NCT01443130|65314511|FG001|Overall Study|Withdrawal by Subject|14|||
23429199|NCT01443130|65314512|FG002|Overall Study|Withdrawal by Subject|12|||
23429200|NCT01443130|65314513|FG003|Overall Study|Withdrawal by Subject|7|||
23429201|NCT01443130|65314514|FG004|Overall Study|Withdrawal by Subject|7|||
23429202|NCT01443130|65314515|FG005|Overall Study|Withdrawal by Subject|2|||
23429203|NCT01443130|65314510|FG000|Overall Study|Death of Subject's Infant|5|||
23429204|NCT01443130|65314511|FG001|Overall Study|Death of Subject's Infant|10|||
23429205|NCT01443130|65314512|FG002|Overall Study|Death of Subject's Infant|11|||
23429206|NCT01443130|65314513|FG003|Overall Study|Death of Subject's Infant|0|||
23429207|NCT01443130|65314514|FG004|Overall Study|Death of Subject's Infant|0|||
23429208|NCT01443130|65314515|FG005|Overall Study|Death of Subject's Infant|0|||
23429209|NCT02771626|65314516|FG000|Overall Study|Adverse Event|1|||
23429210|NCT02771626|65314517|FG001|Overall Study|Adverse Event|5|||
23549641|NCT00127101|65739766|FG004|Continuation Phase|Withdrawal by Subject|2|||
23549642|NCT00127101|65739767|FG005|Continuation Phase|Withdrawal by Subject|1|||
23549643|NCT00698646|65739768|FG000|Overall Study|Adverse Event|8|||
23549644|NCT00698646|65739769|FG001|Overall Study|Adverse Event|7|||
23429211|NCT02771626|65314518|FG002|Overall Study|Adverse Event|3|||
23549645|NCT00698646|65739770|FG002|Overall Study|Adverse Event|8|||
23549646|NCT00698646|65739768|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
23429212|NCT02771626|65314519|FG003|Overall Study|Adverse Event|0|||
23429213|NCT02771626|65314520|FG004|Overall Study|Adverse Event|1|||
23429214|NCT02771626|65314521|FG005|Overall Study|Adverse Event|1|||
23429215|NCT02771626|65314516|FG000|Overall Study|Radiologic Disease Progression|6|||
23429216|NCT02771626|65314517|FG001|Overall Study|Radiologic Disease Progression|13|||
23429217|NCT02771626|65314518|FG002|Overall Study|Radiologic Disease Progression|10|||
23429218|NCT02771626|65314519|FG003|Overall Study|Radiologic Disease Progression|7|||
23429219|NCT02771626|65314520|FG004|Overall Study|Radiologic Disease Progression|28|||
23429220|NCT02771626|65314521|FG005|Overall Study|Radiologic Disease Progression|15|||
23429221|NCT02771626|65314516|FG000|Overall Study|Symptomatic Deterioration|0|||
23429222|NCT02771626|65314517|FG001|Overall Study|Symptomatic Deterioration|4|||
23429223|NCT02771626|65314518|FG002|Overall Study|Symptomatic Deterioration|2|||
23429224|NCT02771626|65314519|FG003|Overall Study|Symptomatic Deterioration|0|||
23429225|NCT02771626|65314520|FG004|Overall Study|Symptomatic Deterioration|5|||
23429226|NCT02771626|65314521|FG005|Overall Study|Symptomatic Deterioration|2|||
23429227|NCT02771626|65314516|FG000|Overall Study|Participant Request|0|||
23429228|NCT02771626|65314517|FG001|Overall Study|Participant Request|1|||
23429229|NCT02771626|65314518|FG002|Overall Study|Participant Request|0|||
23429230|NCT02771626|65314519|FG003|Overall Study|Participant Request|2|||
23429231|NCT02771626|65314520|FG004|Overall Study|Participant Request|0|||
23429232|NCT02771626|65314521|FG005|Overall Study|Participant Request|1|||
23429233|NCT02771626|65314516|FG000|Overall Study|Investigator Decision|0|||
23429234|NCT02771626|65314517|FG001|Overall Study|Investigator Decision|1|||
23429235|NCT02771626|65314518|FG002|Overall Study|Investigator Decision|0|||
23429236|NCT02771626|65314519|FG003|Overall Study|Investigator Decision|0|||
23429237|NCT02771626|65314520|FG004|Overall Study|Investigator Decision|1|||
23429238|NCT02771626|65314521|FG005|Overall Study|Investigator Decision|0|||
23429239|NCT02771626|65314516|FG000|Overall Study|Study Termination by Sponsor|0|||
23429240|NCT02771626|65314517|FG001|Overall Study|Study Termination by Sponsor|2|||
23429241|NCT02771626|65314518|FG002|Overall Study|Study Termination by Sponsor|1|||
23429242|NCT02771626|65314519|FG003|Overall Study|Study Termination by Sponsor|0|||
23429243|NCT02771626|65314520|FG004|Overall Study|Study Termination by Sponsor|1|||
23429244|NCT02771626|65314521|FG005|Overall Study|Study Termination by Sponsor|0|||
23429245|NCT02771626|65314516|FG000|Overall Study|Informed Consent Withdrawn|0|||
23429246|NCT02771626|65314517|FG001|Overall Study|Informed Consent Withdrawn|0|||
23429247|NCT02771626|65314518|FG002|Overall Study|Informed Consent Withdrawn|1|||
23429248|NCT02771626|65314519|FG003|Overall Study|Informed Consent Withdrawn|0|||
23429249|NCT02771626|65314520|FG004|Overall Study|Informed Consent Withdrawn|1|||
23429250|NCT02771626|65314521|FG005|Overall Study|Informed Consent Withdrawn|1|||
23429251|NCT02771626|65314516|FG000|Overall Study|Other, Not Specified|1|||
23429252|NCT02771626|65314517|FG001|Overall Study|Other, Not Specified|0|||
23429253|NCT02771626|65314518|FG002|Overall Study|Other, Not Specified|0|||
23429254|NCT02771626|65314519|FG003|Overall Study|Other, Not Specified|0|||
23429255|NCT02771626|65314520|FG004|Overall Study|Other, Not Specified|0|||
23429256|NCT02771626|65314521|FG005|Overall Study|Other, Not Specified|1|||
23429257|NCT00664326|65314522|FG000|Overall Study|Adverse Event|14|||
23429258|NCT00664326|65314522|FG000|Overall Study|Noncompliance with study medication|3|||
23429259|NCT00664326|65314522|FG000|Overall Study|Withdrawal by Subject|1|||
23429260|NCT00664326|65314522|FG000|Overall Study|Physician Decision|1|||
23429261|NCT00664326|65314522|FG000|Overall Study|Other Reasons|3|||
23429262|NCT00664326|65314522|FG000|Overall Study|Death|2|||
23429263|NCT00664326|65314522|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
23429264|NCT02713529|65314523|FG000|Overall Study|Withdrawal by Subject|3|||
23429265|NCT02713529|65314524|FG001|Overall Study|Withdrawal by Subject|1|||
23429266|NCT02713529|65314525|FG002|Overall Study|Withdrawal by Subject|4|||
23429267|NCT02713529|65314526|FG003|Overall Study|Withdrawal by Subject|2|||
23429268|NCT02713529|65314527|FG004|Overall Study|Withdrawal by Subject|0|||
23429269|NCT02713529|65314528|FG005|Overall Study|Withdrawal by Subject|1|||
23429270|NCT02713529|65314529|FG006|Overall Study|Withdrawal by Subject|1|||
23429271|NCT02713529|65314523|FG000|Overall Study|Lost to Follow-up|1|||
23429272|NCT02713529|65314524|FG001|Overall Study|Lost to Follow-up|0|||
23429273|NCT02713529|65314525|FG002|Overall Study|Lost to Follow-up|1|||
23429274|NCT02713529|65314526|FG003|Overall Study|Lost to Follow-up|0|||
23429275|NCT02713529|65314527|FG004|Overall Study|Lost to Follow-up|0|||
23429276|NCT02713529|65314528|FG005|Overall Study|Lost to Follow-up|0|||
23429277|NCT02713529|65314529|FG006|Overall Study|Lost to Follow-up|0|||
23429278|NCT02713529|65314523|FG000|Overall Study|Death|3|||
23429279|NCT02713529|65314524|FG001|Overall Study|Death|3|||
23429280|NCT02713529|65314525|FG002|Overall Study|Death|26|||
23429281|NCT02713529|65314526|FG003|Overall Study|Death|27|||
23429282|NCT02713529|65314527|FG004|Overall Study|Death|3|||
23429283|NCT02713529|65314528|FG005|Overall Study|Death|13|||
23429284|NCT02713529|65314529|FG006|Overall Study|Death|3|||
23429285|NCT00031460|65314530|FG000|Overall Study|Lost to Follow-up|0|||
23429286|NCT00031460|65314531|FG001|Overall Study|Lost to Follow-up|1|||
23429287|NCT00031460|65314530|FG000|Overall Study|Withdrawal by Subject|1|||
23429288|NCT00031460|65314531|FG001|Overall Study|Withdrawal by Subject|1|||
23429289|NCT00031460|65314530|FG000|Overall Study|Non-Compliant|1|||
23429290|NCT00031460|65314531|FG001|Overall Study|Non-Compliant|1|||
23429291|NCT00031460|65314530|FG000|Overall Study|Death|0|||
23429292|NCT00031460|65314531|FG001|Overall Study|Death|1|||
23429293|NCT00031460|65314530|FG000|Overall Study|Reactivation of Disease|5|||
23429294|NCT00031460|65314531|FG001|Overall Study|Reactivation of Disease|9|||
23429295|NCT00031460|65314530|FG000|Overall Study|Disruption of blinded drug supply|2|||
23429296|NCT00031460|65314531|FG001|Overall Study|Disruption of blinded drug supply|0|||
23429297|NCT00031460|65314530|FG000|Overall Study|Confirmed unevaluable|0|||
23429298|NCT00031460|65314531|FG001|Overall Study|Confirmed unevaluable|1|||
23429299|NCT02428413|65314532|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
23429300|NCT02428413|65314533|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
23429301|NCT02428413|65314532|FG000|Overall Study|Protocol Violation|1|||
23429302|NCT02428413|65314533|FG001|Overall Study|Protocol Violation|2|||
23429303|NCT02428413|65314532|FG000|Overall Study|Case Cancelled|2|||
23429304|NCT02428413|65314533|FG001|Overall Study|Case Cancelled|0|||
23429305|NCT02428413|65314532|FG000|Overall Study|Missed Cases|1|||
23429306|NCT02428413|65314533|FG001|Overall Study|Missed Cases|2|||
23429307|NCT02428413|65314532|FG000|Overall Study|Nurse Refusal|1|||
23429308|NCT02428413|65314533|FG001|Overall Study|Nurse Refusal|0|||
23429309|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
23429310|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429311|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429312|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429313|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
23429314|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429315|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429316|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429317|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
23429318|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429319|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429320|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429321|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
23429322|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23549647|NCT00698646|65739769|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
23549648|NCT00698646|65739770|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
23549649|NCT00698646|65739768|FG000|Overall Study|Protocol Deviation|6|||
23549650|NCT00698646|65739769|FG001|Overall Study|Protocol Deviation|2|||
23549651|NCT00698646|65739770|FG002|Overall Study|Protocol Deviation|3|||
23549652|NCT00698646|65739768|FG000|Overall Study|Withdrawal by Subject|10|||
23549653|NCT00698646|65739769|FG001|Overall Study|Withdrawal by Subject|11|||
23549654|NCT00698646|65739770|FG002|Overall Study|Withdrawal by Subject|8|||
23549655|NCT00698646|65739768|FG000|Overall Study|Lost to Follow-up|0|||
23549656|NCT00698646|65739769|FG001|Overall Study|Lost to Follow-up|0|||
23549657|NCT00698646|65739770|FG002|Overall Study|Lost to Follow-up|2|||
23549658|NCT00698646|65739768|FG000|Overall Study|Administrative problems|1|||
23549659|NCT00698646|65739769|FG001|Overall Study|Administrative problems|0|||
23549660|NCT00698646|65739770|FG002|Overall Study|Administrative problems|1|||
23549661|NCT01349569|65739774|FG000|Overall Study|Lack of Efficacy|4|||
23549662|NCT02216123|65739775|FG000|Overall Study|Lost to Follow-up|4|||
23549663|NCT02216123|65739776|FG001|Overall Study|Lost to Follow-up|2|||
23549664|NCT02216123|65739775|FG000|Overall Study|Withdrawal by Subject|2|||
23549665|NCT02216123|65739776|FG001|Overall Study|Withdrawal by Subject|0|||
23549666|NCT03643952|65739777|FG000|Overall Study|Lack of Efficacy|1|||
23549667|NCT02239679|65739785|FG000|Overall Study|Lost to Follow-up|1|||
23549668|NCT02239679|65739786|FG001|Overall Study|Lost to Follow-up|0|||
23549669|NCT02239679|65739787|FG002|Overall Study|Lost to Follow-up|0|||
23549670|NCT02239679|65739785|FG000|Overall Study|Withdrawal by Subject|2|||
23620284|NCT01232569|65994938|FG001|Double-blind Treatment Period|Escape|2|||
23620285|NCT01232569|65994939|FG002|Double-blind Treatment Period|Escape|0|||
23620286|NCT01232569|65994940|FG003|Double-blind Treatment Period|Escape|0|||
23620287|NCT01232569|65994937|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
23620288|NCT01232569|65994938|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23620289|NCT01232569|65994939|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23620290|NCT01232569|65994940|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23821412|NCT01609023|66726025|FG000|Overall Study|Toxicity|3|||
23821413|NCT01609023|66726025|FG000|Overall Study|Disease progression|10|||
23821414|NCT01609023|66726025|FG000|Overall Study|Physician Decision|2|||
23821415|NCT01609023|66726025|FG000|Overall Study|Death|2|||
23429323|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23549671|NCT02239679|65739786|FG001|Overall Study|Withdrawal by Subject|3|||
23549672|NCT02239679|65739787|FG002|Overall Study|Withdrawal by Subject|1|||
23429324|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23741782|NCT01249404|66432769|FG002|Overall Study|Adverse Event|2|||
23429325|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
23429326|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
23429327|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
23429328|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
23549673|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
23549674|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
23741783|NCT01249404|66432767|FG000|Overall Study|Withdrawal by Subject|2|||
23741784|NCT01249404|66432768|FG001|Overall Study|Withdrawal by Subject|2|||
23549675|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
23549676|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
23549677|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Other reason|4|||
23549678|NCT00983073|65739788|FG000|Maintenance Period|Adverse Event|5|||
23549679|NCT00983073|65739788|FG000|Maintenance Period|Withdrawal by Subject|2|||
23549680|NCT00983073|65739788|FG000|Maintenance Period|Lack of Efficacy|2|||
23549681|NCT00983073|65739788|FG000|Maintenance Period|Other Reason|7|||
23549682|NCT01178086|65739789|FG000|Overall Study|Participant refusal|7|||
23549683|NCT01178086|65739789|FG000|Overall Study|Physician Decision|44|||
23549684|NCT01178086|65739789|FG000|Overall Study|Switch to other CLL therapy|113|||
23549685|NCT01178086|65739789|FG000|Overall Study|Death|59|||
23549686|NCT01178086|65739789|FG000|Overall Study|Other unspecified|89|||
23549687|NCT01178086|65739789|FG000|Overall Study|Excluded from EAS|20|||
23549688|NCT00700401|65739790|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
23549689|NCT00700401|65739790|FG000|Overall Study|Adverse Event|5|||
23549690|NCT00700401|65739790|FG000|Overall Study|Refused Treatment|2|||
23549691|NCT00700401|65739790|FG000|Overall Study|Lost to Follow-up|1|||
23549692|NCT00700401|65739790|FG000|Overall Study|Treatment never started|1|||
23549693|NCT00700401|65739790|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
23549694|NCT00700401|65739790|FG000|Overall Study|Withdrawal by Subject|2|||
23549695|NCT01343407|65739792|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
23549696|NCT01343407|65739793|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
23549697|NCT01343407|65739794|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
23549698|NCT01343407|65739795|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
23549699|NCT01343407|65739796|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
23549700|NCT01343407|65739797|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
23549701|NCT01343407|65739792|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549702|NCT01343407|65739793|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549703|NCT01343407|65739794|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
23549704|NCT01343407|65739795|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549705|NCT01343407|65739796|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549706|NCT01343407|65739797|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549707|NCT00450411|65739801|FG000|Overall Study|Protocol Violation|6|||
23549708|NCT00450411|65739801|FG000|Overall Study|No protocol treatment|2|||
23549709|NCT00996996|65739804|FG000|Overall Study|Progressive Disease|10|||
23549710|NCT00996996|65739804|FG000|Overall Study|Non-compliance|8|||
23549711|NCT00996996|65739804|FG000|Overall Study|Lost to Follow-up|9|||
23549712|NCT00996996|65739804|FG000|Overall Study|Death|5|||
23549713|NCT00996996|65739804|FG000|Overall Study|Did Not Receive Study Medications|1|||
23549714|NCT02511431|65739805|FG000|Treatment|Lost to Follow-up|0|||
23549715|NCT02511431|65739806|FG001|Treatment|Lost to Follow-up|0|||
23549716|NCT02511431|65739807|FG002|Treatment|Lost to Follow-up|1|||
23549717|NCT02511431|65739808|FG003|Treatment|Lost to Follow-up|0|||
23549718|NCT02511431|65739809|FG004|Treatment|Lost to Follow-up|0|||
23549719|NCT02511431|65739810|FG005|Treatment|Lost to Follow-up|1|||
23549720|NCT01650259|65739811|FG000|Overall Study|Improvement|105|||
23549721|NCT01650259|65739812|FG001|Overall Study|Improvement|0|||
23549722|NCT01650259|65739811|FG000|Overall Study|Adverse Event|127|||
23549723|NCT01650259|65739812|FG001|Overall Study|Adverse Event|0|||
23549724|NCT01650259|65739811|FG000|Overall Study|Lack of Efficacy|143|||
23549725|NCT01650259|65739812|FG001|Overall Study|Lack of Efficacy|0|||
23549726|NCT01650259|65739811|FG000|Overall Study|Lost to Follow-up|435|||
23549727|NCT01650259|65739812|FG001|Overall Study|Lost to Follow-up|0|||
23549728|NCT01650259|65739811|FG000|Overall Study|Patients had no visit after entry|70|||
23549729|NCT01650259|65739812|FG001|Overall Study|Patients had no visit after entry|0|||
23821416|NCT01609023|66726025|FG000|Overall Study|Personal reasons|1|||
23821417|NCT01085357|66726026|FG000|Overall Study|Adverse Event|1|||
23821418|NCT01085357|66726027|FG001|Overall Study|Adverse Event|1|||
23821419|NCT01085357|66726026|FG000|Overall Study|Subject Decision|4|||
23821420|NCT01085357|66726027|FG001|Overall Study|Subject Decision|3|||
23821421|NCT01085357|66726026|FG000|Overall Study|Investigator Decision|1|||
23821422|NCT01085357|66726027|FG001|Overall Study|Investigator Decision|1|||
23821423|NCT01085357|66726026|FG000|Overall Study|Death|11|||
23821424|NCT01085357|66726027|FG001|Overall Study|Death|1|||
23821425|NCT01085357|66726026|FG000|Overall Study|Lost to Follow-up|2|||
23821426|NCT01085357|66726027|FG001|Overall Study|Lost to Follow-up|0|||
23549730|NCT01650259|65739811|FG000|Overall Study|CRF not collected|98|||
23549731|NCT01650259|65739812|FG001|Overall Study|CRF not collected|82|||
23549732|NCT01650259|65739811|FG000|Overall Study|Not treated|1|||
23549733|NCT01650259|65739812|FG001|Overall Study|Not treated|7|||
23549734|NCT01650259|65739811|FG000|Overall Study|Other than listed|64|||
23549735|NCT01650259|65739812|FG001|Overall Study|Other than listed|146|||
23549736|NCT00047879|65743010|FG000|Overall Study|Progressive disease|4|||
23549737|NCT00047879|65743011|FG001|Overall Study|Progressive disease|3|||
23821427|NCT03076775|66726031|FG000|Overall Study|Lost to Follow-up|1|||
23821428|NCT03076775|66726032|FG001|Overall Study|Lost to Follow-up|0|||
23821429|NCT02439970|66726033|FG000|Overall Study|Study Terminated|2|||
23429329|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
23429330|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429331|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429332|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429333|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
23429334|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429335|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429336|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429337|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
23429338|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429339|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429340|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429341|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
23429342|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429343|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429344|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429345|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
23429346|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429347|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429348|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429349|NCT02198794|65314537|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
23429350|NCT02198794|65314538|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
23429351|NCT02198794|65314539|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
23429352|NCT02198794|65314540|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
23429353|NCT02198794|65314537|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
23429354|NCT02198794|65314538|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
23429355|NCT02198794|65314539|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
23429356|NCT02198794|65314540|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
23429357|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429358|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429359|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429360|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
23429361|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23429362|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23429363|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23549738|NCT02570126|65743016|FG000|Overall Study|Lost to Follow-up|2|||
23549739|NCT02570126|65743017|FG001|Overall Study|Lost to Follow-up|0|||
23549740|NCT02570126|65743016|FG000|Overall Study|Unable To Arrange Visit 3|1|||
23549741|NCT02570126|65743017|FG001|Overall Study|Unable To Arrange Visit 3|0|||
23549742|NCT02570126|65743016|FG000|Overall Study|Violation Of Procedures GSK|0|||
23549743|NCT02570126|65743017|FG001|Overall Study|Violation Of Procedures GSK|1|||
23549744|NCT02570126|65743016|FG000|Overall Study|Protocol Violation|0|||
23549745|NCT02570126|65743017|FG001|Overall Study|Protocol Violation|1|||
23549746|NCT02570126|65743016|FG000|Overall Study|Withdrawal by Subject|3|||
23549747|NCT02570126|65743017|FG001|Overall Study|Withdrawal by Subject|7|||
23741785|NCT01249404|66432769|FG002|Overall Study|Withdrawal by Subject|0|||
23741786|NCT01249404|66432767|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
23741787|NCT01249404|66432768|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
23741788|NCT01249404|66432769|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
23741789|NCT01249404|66432767|FG000|Overall Study|Non compliance to visit schedule|0|||
23741790|NCT01249404|66432768|FG001|Overall Study|Non compliance to visit schedule|1|||
23741791|NCT01249404|66432769|FG002|Overall Study|Non compliance to visit schedule|0|||
23741792|NCT02889861|66432771|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
23741793|NCT03691831|66432772|FG000|Overall Study|Lost to Follow-up|16|||
23741794|NCT03691831|66432773|FG001|Overall Study|Lost to Follow-up|12|||
23741795|NCT03691831|66432772|FG000|Overall Study|Withdrawal by Subject|9|||
23741796|NCT03691831|66432773|FG001|Overall Study|Withdrawal by Subject|17|||
23741797|NCT03691831|66432772|FG000|Overall Study|Investigator Decision|2|||
23741798|NCT03691831|66432773|FG001|Overall Study|Investigator Decision|2|||
23741799|NCT02569398|66432775|FG000|Overall Study|Adverse Event|0|||
23741800|NCT02569398|66432776|FG001|Overall Study|Adverse Event|1|||
23741801|NCT02569398|66432777|FG002|Overall Study|Adverse Event|6|||
23741802|NCT02569398|66432775|FG000|Overall Study|Withdrawal by Subject|43|||
23741803|NCT02569398|66432776|FG001|Overall Study|Withdrawal by Subject|43|||
23741804|NCT02569398|66432777|FG002|Overall Study|Withdrawal by Subject|30|||
23741805|NCT02569398|66432775|FG000|Overall Study|Study terminated by sponsor|130|||
23741806|NCT02569398|66432776|FG001|Overall Study|Study terminated by sponsor|131|||
23429364|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
23429365|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
23741807|NCT02569398|66432777|FG002|Overall Study|Study terminated by sponsor|134|||
23429366|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
23429367|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
23429368|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
23429369|NCT04284813|65314542|FG000|Overall Study|Withdrawal by Subject|1|||
23429370|NCT00203021|65314543|FG000|Overall Study|Death|4|||
23429371|NCT00203021|65314544|FG001|Overall Study|Death|1|||
23429372|NCT00203021|65314543|FG000|Overall Study|Adverse Event|10|||
23429373|NCT00203021|65314544|FG001|Overall Study|Adverse Event|5|||
23429374|NCT00203021|65314543|FG000|Overall Study|Withdrawal by Subject|45|||
23429375|NCT00203021|65314544|FG001|Overall Study|Withdrawal by Subject|48|||
23429376|NCT00203021|65314543|FG000|Overall Study|Lost to Follow-up|9|||
23429377|NCT00203021|65314544|FG001|Overall Study|Lost to Follow-up|7|||
23429378|NCT00203021|65314543|FG000|Overall Study|Other than specified|11|||
23429379|NCT00203021|65314544|FG001|Overall Study|Other than specified|16|||
23429380|NCT01440517|65314545|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
23429381|NCT02266875|65314548|FG000|Overall Study|Withdrawal by Subject|9|||
23429382|NCT02266875|65314549|FG001|Overall Study|Withdrawal by Subject|0|||
23429383|NCT02266875|65314548|FG000|Overall Study|Lost to Follow-up|2|||
23429384|NCT02266875|65314549|FG001|Overall Study|Lost to Follow-up|0|||
23429385|NCT03691779|65314550|FG000|Part B (24 Weeks)|Adverse Event|0|||
23429386|NCT03691779|65314551|FG001|Part B (24 Weeks)|Adverse Event|1|||
23429387|NCT03691779|65314550|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
23429388|NCT03691779|65314551|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
23429389|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
23429390|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
23429391|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
23429392|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
23429393|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
23429394|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
23429395|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
23429396|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
23429397|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
23429398|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429399|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429400|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429401|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
23429402|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
23429403|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
23429404|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
23429405|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
23429406|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
23429407|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
23429408|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
23429409|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
23429410|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
23429411|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
23429412|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
23549748|NCT03137303|65743018|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
23549749|NCT03137303|65743019|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
23549750|NCT03137303|65743018|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
23549751|NCT03137303|65743019|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
23549752|NCT03137303|65743018|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
23741808|NCT02569398|66432775|FG000|Overall Study|Other|12|||
23741809|NCT02569398|66432776|FG001|Overall Study|Other|14|||
23429413|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
23429414|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
23429415|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
23429416|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
23429417|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
23429418|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
23549753|NCT03137303|65743019|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
23549754|NCT03137303|65743018|FG000|T3: 9-month Follow-up|Death|1|||
23741810|NCT02569398|66432777|FG002|Overall Study|Other|13|||
23741811|NCT03911401|66432781|FG000|Overall Study|Adverse Event|1|||
23429419|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
23429420|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
23429421|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
23429422|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
23429423|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
23549755|NCT03137303|65743019|FG001|T3: 9-month Follow-up|Death|0|||
23741812|NCT03911401|66432782|FG001|Overall Study|Adverse Event|2|||
23429424|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
23429425|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
23429426|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
23429427|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
23429428|NCT02739321|65314558|FG000|Overall Study|Lack of Efficacy|1|||
23429429|NCT02739321|65314559|FG001|Overall Study|Lack of Efficacy|1|||
23429430|NCT02739321|65314558|FG000|Overall Study|Lost to Follow-up|1|||
23429431|NCT02739321|65314559|FG001|Overall Study|Lost to Follow-up|1|||
23429432|NCT02739321|65314558|FG000|Overall Study|Withdrawal by Subject|1|||
23429433|NCT02739321|65314559|FG001|Overall Study|Withdrawal by Subject|2|||
23429434|NCT01282294|65314560|FG000|Overall Study|Lost to Follow-up|14|||
23429435|NCT01282294|65314560|FG000|Overall Study|Screening failure|1|||
23429436|NCT01282294|65314560|FG000|Overall Study|Adverse Event|1|||
23429437|NCT01282294|65314560|FG000|Overall Study|Patient non-compliance|2|||
23429438|NCT01282294|65314560|FG000|Overall Study|Physician Decision|1|||
23429439|NCT02782325|65314561|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
23429440|NCT02782325|65314562|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
23429441|NCT02782325|65314563|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
23429442|NCT02782325|65314561|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
23429443|NCT02782325|65314562|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
23429444|NCT02782325|65314563|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
23429445|NCT01288612|65314574|FG000|Overall Study|Unable to contact|11|||
23429446|NCT01288612|65314575|FG001|Overall Study|Unable to contact|16|||
23429447|NCT01288612|65314576|FG002|Overall Study|Unable to contact|20|||
23429448|NCT01288612|65314574|FG000|Overall Study|Declined|78|||
23429449|NCT01288612|65314575|FG001|Overall Study|Declined|63|||
23429450|NCT01288612|65314576|FG002|Overall Study|Declined|62|||
23429451|NCT01288612|65314574|FG000|Overall Study|Unable to intubate|0|||
23429452|NCT01288612|65314575|FG001|Overall Study|Unable to intubate|3|||
23429453|NCT01288612|65314576|FG002|Overall Study|Unable to intubate|0|||
23429454|NCT03426631|65314577|FG000|Overall Study|Lost to Follow-up|0|||
23429455|NCT03426631|65314578|FG001|Overall Study|Lost to Follow-up|1|||
23429456|NCT00844805|65314584|FG000|Treatment Phase|Adverse Event|5|||
23429457|NCT00844805|65314585|FG001|Treatment Phase|Adverse Event|1|||
23429458|NCT00844805|65314586|FG002|Treatment Phase|Adverse Event|0|||
23429459|NCT00844805|65314587|FG003|Treatment Phase|Adverse Event|0|||
23429460|NCT00844805|65314584|FG000|Treatment Phase|Withdrawal by Subject|3|||
23429461|NCT00844805|65314585|FG001|Treatment Phase|Withdrawal by Subject|4|||
23429462|NCT00844805|65314586|FG002|Treatment Phase|Withdrawal by Subject|0|||
23429463|NCT00844805|65314587|FG003|Treatment Phase|Withdrawal by Subject|0|||
23429464|NCT00844805|65314584|FG000|Treatment Phase|Noncompliance With Protocol|1|||
23429465|NCT00844805|65314585|FG001|Treatment Phase|Noncompliance With Protocol|0|||
23429466|NCT00844805|65314586|FG002|Treatment Phase|Noncompliance With Protocol|0|||
23429467|NCT00844805|65314587|FG003|Treatment Phase|Noncompliance With Protocol|0|||
23429468|NCT00844805|65314584|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
23429469|NCT00844805|65314585|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
23429470|NCT00844805|65314586|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
23429471|NCT00844805|65314587|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
23429472|NCT00844805|65314584|FG000|Follow-Up Phase|Adverse Event|0|||
23429473|NCT00844805|65314585|FG001|Follow-Up Phase|Adverse Event|0|||
23429474|NCT00844805|65314586|FG002|Follow-Up Phase|Adverse Event|1|||
23429475|NCT00844805|65314587|FG003|Follow-Up Phase|Adverse Event|0|||
23429476|NCT00844805|65314584|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23429477|NCT00844805|65314585|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23429478|NCT00844805|65314586|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
23429479|NCT00844805|65314587|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
23429480|NCT00844805|65314584|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
23429481|NCT00844805|65314585|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
23429482|NCT00844805|65314586|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
23429483|NCT00844805|65314587|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
23429484|NCT00844805|65314584|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
23429485|NCT00844805|65314585|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
23429486|NCT00844805|65314586|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
23429487|NCT00844805|65314587|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
23429488|NCT00844805|65314584|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429489|NCT00844805|65314585|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429490|NCT00844805|65314586|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429491|NCT00844805|65314587|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
23429492|NCT00461305|65317398|FG000|Treatment|Adverse Event|26|||
23429493|NCT00461305|65317399|FG001|Treatment|Adverse Event|3|||
23429494|NCT00461305|65317398|FG000|Treatment|Lost to Follow-up|4|||
23429495|NCT00461305|65317399|FG001|Treatment|Lost to Follow-up|2|||
23741813|NCT03911401|66432783|FG002|Overall Study|Adverse Event|5|||
23741814|NCT03911401|66432781|FG000|Overall Study|Lack of Efficacy|1|||
23429496|NCT00461305|65317398|FG000|Treatment|Protocol Violation|13|||
23429497|NCT00461305|65317399|FG001|Treatment|Protocol Violation|2|||
23549756|NCT03137303|65743018|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
23549757|NCT03137303|65743019|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
23549758|NCT03137303|65743018|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
23549759|NCT03137303|65743019|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
23549760|NCT03137303|65743018|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
23549761|NCT03137303|65743019|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
23549762|NCT01627327|65743020|FG000|Overall Study|Adverse Event|6|||
23429498|NCT00461305|65317398|FG000|Treatment|Withdrawal by Subject|48|||
23429499|NCT00461305|65317399|FG001|Treatment|Withdrawal by Subject|2|||
23429500|NCT00461305|65317398|FG000|Treatment|Never dispensed|5|||
23429501|NCT00461305|65317399|FG001|Treatment|Never dispensed|0|||
23429502|NCT00461305|65317398|FG000|Treatment|Study drug not taken|1|||
23429503|NCT00461305|65317399|FG001|Treatment|Study drug not taken|0|||
23429504|NCT00461305|65317398|FG000|Treatment|Partially missing diary|2|||
23429505|NCT00461305|65317399|FG001|Treatment|Partially missing diary|0|||
23429506|NCT00461305|65317398|FG000|Treatment|Other (missing drug etc)|2|||
23429507|NCT00461305|65317399|FG001|Treatment|Other (missing drug etc)|0|||
23429508|NCT00461305|65317398|FG000|Continued Treatment|Adverse Event|26|||
23549763|NCT01627327|65743021|FG001|Overall Study|Adverse Event|12|||
23549764|NCT01627327|65743020|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
23549765|NCT01627327|65743021|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
23549766|NCT01627327|65743020|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
23549767|NCT01627327|65743021|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
23549768|NCT01627327|65743020|FG000|Overall Study|Protocol Violation|4|||
23549769|NCT01627327|65743021|FG001|Overall Study|Protocol Violation|10|||
23549770|NCT01627327|65743020|FG000|Overall Study|Lost to Follow-up|1|||
23549771|NCT01627327|65743021|FG001|Overall Study|Lost to Follow-up|3|||
23549772|NCT01627327|65743020|FG000|Overall Study|Physician Decision|1|||
23549773|NCT01627327|65743021|FG001|Overall Study|Physician Decision|0|||
23549774|NCT01627327|65743020|FG000|Overall Study|Withdrawal by Subject|3|||
23549775|NCT01627327|65743021|FG001|Overall Study|Withdrawal by Subject|3|||
23549776|NCT03077724|65743022|FG000|Overall Study|Lost to Follow-up|5|||
23549777|NCT03077724|65743023|FG001|Overall Study|Lost to Follow-up|1|||
23549778|NCT03077724|65743022|FG000|Overall Study|Withdrawal by Subject|3|||
23549779|NCT03077724|65743023|FG001|Overall Study|Withdrawal by Subject|1|||
23549780|NCT03492281|65743024|FG000|Overall Study|Withdrawal by Subject|21|||
23549781|NCT03492281|65743025|FG001|Overall Study|Withdrawal by Subject|14|||
23549782|NCT03492281|65743026|FG002|Overall Study|Withdrawal by Subject|13|||
23549783|NCT03492281|65743024|FG000|Overall Study|Lost to Follow-up|14|||
23549784|NCT03492281|65743025|FG001|Overall Study|Lost to Follow-up|15|||
23549785|NCT03492281|65743026|FG002|Overall Study|Lost to Follow-up|10|||
23549786|NCT03492281|65743024|FG000|Overall Study|Adverse Event|6|||
23549787|NCT03492281|65743025|FG001|Overall Study|Adverse Event|8|||
23549788|NCT03492281|65743026|FG002|Overall Study|Adverse Event|13|||
23549789|NCT03492281|65743024|FG000|Overall Study|Lack of Efficacy|3|||
23549790|NCT03492281|65743025|FG001|Overall Study|Lack of Efficacy|0|||
23549791|NCT03492281|65743026|FG002|Overall Study|Lack of Efficacy|1|||
23549792|NCT03492281|65743024|FG000|Overall Study|Physician Decision|1|||
23549793|NCT03492281|65743025|FG001|Overall Study|Physician Decision|0|||
23549794|NCT03492281|65743026|FG002|Overall Study|Physician Decision|3|||
23549795|NCT03492281|65743024|FG000|Overall Study|Protocol Violation|0|||
23741815|NCT03911401|66432782|FG001|Overall Study|Lack of Efficacy|1|||
23741816|NCT03911401|66432783|FG002|Overall Study|Lack of Efficacy|8|||
23741817|NCT03911401|66432781|FG000|Overall Study|Physician Decision|0|||
23741818|NCT03911401|66432782|FG001|Overall Study|Physician Decision|0|||
23741819|NCT03911401|66432783|FG002|Overall Study|Physician Decision|1|||
23741820|NCT03911401|66432781|FG000|Overall Study|Withdrawal by Subject|1|||
23741821|NCT03911401|66432782|FG001|Overall Study|Withdrawal by Subject|2|||
23741822|NCT03911401|66432783|FG002|Overall Study|Withdrawal by Subject|0|||
23741823|NCT03911401|66432781|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23741824|NCT03911401|66432782|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23741825|NCT03911401|66432783|FG002|Overall Study|Withdrawal by parent/guardian|11|||
23741826|NCT04409262|66432784|FG000|Overall Study|Adverse Event|0|||
23741827|NCT04409262|66432785|FG001|Overall Study|Adverse Event|2|||
23429509|NCT00461305|65317399|FG001|Continued Treatment|Adverse Event|0|||
23549796|NCT03492281|65743025|FG001|Overall Study|Protocol Violation|2|||
23549797|NCT03492281|65743026|FG002|Overall Study|Protocol Violation|1|||
23549798|NCT03492281|65743024|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
23549799|NCT03492281|65743025|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
23821430|NCT02439970|66726034|FG001|Overall Study|Study Terminated|3|||
23549800|NCT03492281|65743026|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
23549801|NCT03492281|65743024|FG000|Overall Study|Death|0|||
23549802|NCT03492281|65743025|FG001|Overall Study|Death|0|||
23549803|NCT03492281|65743026|FG002|Overall Study|Death|1|||
23549804|NCT03492281|65743024|FG000|Overall Study|Captured as Other in Database|8|||
23549805|NCT03492281|65743025|FG001|Overall Study|Captured as Other in Database|6|||
23429510|NCT00461305|65317398|FG000|Continued Treatment|Lost to Follow-up|4|||
23741828|NCT04409262|66432784|FG000|Overall Study|Death|55|||
23549806|NCT03492281|65743026|FG002|Overall Study|Captured as Other in Database|3|||
23549807|NCT01371851|65743027|FG000|Overall Study|Lost to Follow-up|5|||
23549808|NCT01371851|65743028|FG001|Overall Study|Lost to Follow-up|8|||
23549809|NCT01371851|65743027|FG000|Overall Study|was arrested and put in jail|0|||
23549810|NCT01371851|65743028|FG001|Overall Study|was arrested and put in jail|1|||
23549811|NCT01371851|65743027|FG000|Overall Study|non study related adverse event|1|||
23549812|NCT01371851|65743028|FG001|Overall Study|non study related adverse event|0|||
23549813|NCT01371851|65743027|FG000|Overall Study|Blood Pressure outside study parameters|2|||
23549814|NCT01371851|65743028|FG001|Overall Study|Blood Pressure outside study parameters|0|||
23549815|NCT03213158|65743031|FG000|Overall Study|Withdrawal by Subject|1|||
23549816|NCT03213158|65743031|FG000|Overall Study|Physician Decision|2|||
23549817|NCT00201006|65743032|FG000|Overall Study|Withdrawal by Subject|7|||
23549818|NCT00201006|65743033|FG001|Overall Study|Withdrawal by Subject|2|||
23549819|NCT00201006|65743034|FG002|Overall Study|Withdrawal by Subject|3|||
23549820|NCT00201006|65743032|FG000|Overall Study|Adverse Event|1|||
23549821|NCT00201006|65743033|FG001|Overall Study|Adverse Event|0|||
23741829|NCT04409262|66432785|FG001|Overall Study|Death|97|||
23741830|NCT04409262|66432784|FG000|Overall Study|Lost to Follow-up|12|||
23549822|NCT00201006|65743034|FG002|Overall Study|Adverse Event|1|||
23549823|NCT02077166|65743039|FG000|Overall Study|Death|6|||
23549824|NCT02077166|65743040|FG001|Overall Study|Death|7|||
23549825|NCT02077166|65743041|FG002|Overall Study|Death|5|||
23549826|NCT02077166|65743042|FG003|Overall Study|Death|6|||
23549827|NCT02077166|65743043|FG004|Overall Study|Death|4|||
23549828|NCT02077166|65743044|FG005|Overall Study|Death|32|||
23549829|NCT02077166|65743045|FG006|Overall Study|Death|22|||
23549830|NCT02077166|65743039|FG000|Overall Study|Study Closure by Sponsor|3|||
23549831|NCT02077166|65743040|FG001|Overall Study|Study Closure by Sponsor|0|||
23549832|NCT02077166|65743041|FG002|Overall Study|Study Closure by Sponsor|2|||
23549833|NCT02077166|65743042|FG003|Overall Study|Study Closure by Sponsor|2|||
23549834|NCT02077166|65743043|FG004|Overall Study|Study Closure by Sponsor|2|||
23549835|NCT02077166|65743044|FG005|Overall Study|Study Closure by Sponsor|12|||
23549836|NCT02077166|65743045|FG006|Overall Study|Study Closure by Sponsor|4|||
23549837|NCT02077166|65743039|FG000|Overall Study|Lost to Follow-up|0|||
23549838|NCT02077166|65743040|FG001|Overall Study|Lost to Follow-up|0|||
23549839|NCT02077166|65743041|FG002|Overall Study|Lost to Follow-up|0|||
23549840|NCT02077166|65743042|FG003|Overall Study|Lost to Follow-up|0|||
23549841|NCT02077166|65743043|FG004|Overall Study|Lost to Follow-up|0|||
23549842|NCT02077166|65743044|FG005|Overall Study|Lost to Follow-up|1|||
23549843|NCT02077166|65743045|FG006|Overall Study|Lost to Follow-up|0|||
23549844|NCT02077166|65743039|FG000|Overall Study|Withdrawal by Subject|3|||
23549845|NCT02077166|65743040|FG001|Overall Study|Withdrawal by Subject|0|||
23549846|NCT02077166|65743041|FG002|Overall Study|Withdrawal by Subject|1|||
23549847|NCT02077166|65743042|FG003|Overall Study|Withdrawal by Subject|1|||
23549848|NCT02077166|65743043|FG004|Overall Study|Withdrawal by Subject|1|||
23549849|NCT02077166|65743044|FG005|Overall Study|Withdrawal by Subject|3|||
23549850|NCT02077166|65743045|FG006|Overall Study|Withdrawal by Subject|0|||
23549851|NCT02077166|65743039|FG000|Overall Study|Other, Not Specified|0|||
23549852|NCT02077166|65743040|FG001|Overall Study|Other, Not Specified|0|||
23549853|NCT02077166|65743041|FG002|Overall Study|Other, Not Specified|1|||
23549854|NCT02077166|65743042|FG003|Overall Study|Other, Not Specified|0|||
23549855|NCT02077166|65743043|FG004|Overall Study|Other, Not Specified|1|||
23549856|NCT02077166|65743044|FG005|Overall Study|Other, Not Specified|7|||
23549857|NCT02077166|65743045|FG006|Overall Study|Other, Not Specified|8|||
23741831|NCT04409262|66432785|FG001|Overall Study|Lost to Follow-up|23|||
23741832|NCT04409262|66432784|FG000|Overall Study|Lack of Staff|0|||
23741833|NCT04409262|66432785|FG001|Overall Study|Lack of Staff|1|||
23549858|NCT03565887|65743046|FG000|Overall Study|Adverse Event|1|||
23549859|NCT03565887|65743047|FG001|Overall Study|Adverse Event|0|||
23549860|NCT03565887|65743046|FG000|Overall Study|Withdrawal by Subject|0|||
23549861|NCT03565887|65743047|FG001|Overall Study|Withdrawal by Subject|2|||
23549862|NCT03896035|65743048|FG000|Overall Study|Lost to Follow-up|2|||
23549863|NCT03896035|65743049|FG001|Overall Study|Lost to Follow-up|6|||
23549864|NCT03896035|65743048|FG000|Overall Study|Withdrawal by Subject|0|||
23549865|NCT03896035|65743049|FG001|Overall Study|Withdrawal by Subject|1|||
23549866|NCT03896035|65743048|FG000|Overall Study|Health/family health issues during COVID|0|||
23549867|NCT03896035|65743049|FG001|Overall Study|Health/family health issues during COVID|4|||
23549868|NCT00784810|65743050|FG000|Overall Study|Adverse Event|32|||
23549869|NCT00784810|65743051|FG001|Overall Study|Adverse Event|20|||
23741834|NCT04409262|66432784|FG000|Overall Study|Protocol Violation|3|||
23549870|NCT00784810|65743050|FG000|Overall Study|Lack of Efficacy|14|||
23549871|NCT00784810|65743051|FG001|Overall Study|Lack of Efficacy|11|||
23549872|NCT00784810|65743050|FG000|Overall Study|Withdrawal by Subject|11|||
23549873|NCT00784810|65743051|FG001|Overall Study|Withdrawal by Subject|9|||
23549874|NCT00784810|65743050|FG000|Overall Study|Administrative|5|||
23549875|NCT00784810|65743051|FG001|Overall Study|Administrative|8|||
23741835|NCT04409262|66432785|FG001|Overall Study|Protocol Violation|1|||
23549876|NCT00784810|65743050|FG000|Overall Study|Lost to Follow-up|1|||
23549877|NCT00784810|65743051|FG001|Overall Study|Lost to Follow-up|1|||
23549878|NCT03265600|65743052|FG000|Overall Study|Lost to Follow-up|17|||
23549879|NCT03265600|65743053|FG001|Overall Study|Lost to Follow-up|5|||
23549880|NCT03265600|65743052|FG000|Overall Study|Withdrawal by Subject|4|||
23549881|NCT03265600|65743053|FG001|Overall Study|Withdrawal by Subject|2|||
23549882|NCT03265600|65743052|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
23549883|NCT03265600|65743053|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
23620291|NCT01232569|65994937|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23620292|NCT01232569|65994938|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
23620293|NCT01232569|65994939|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23620294|NCT01232569|65994940|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23620295|NCT01232569|65994937|FG000|Double-blind Treatment Period|Physician Decision|1|||
23620296|NCT01232569|65994938|FG001|Double-blind Treatment Period|Physician Decision|0|||
23620297|NCT01232569|65994939|FG002|Double-blind Treatment Period|Physician Decision|0|||
23620298|NCT01232569|65994940|FG003|Double-blind Treatment Period|Physician Decision|0|||
23620299|NCT01232569|65994937|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
23620300|NCT01232569|65994938|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
23620301|NCT01232569|65994939|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
23620302|NCT01232569|65994940|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
23620303|NCT01232569|65994937|FG000|Double-blind Treatment Period|Death|2|||
23620304|NCT01232569|65994938|FG001|Double-blind Treatment Period|Death|0|||
23620305|NCT01232569|65994939|FG002|Double-blind Treatment Period|Death|0|||
23620306|NCT01232569|65994940|FG003|Double-blind Treatment Period|Death|0|||
23620307|NCT01260142|65994942|FG000|Treatment Period 1|Study on hold|1|||
23620308|NCT01260142|65994943|FG001|Treatment Period 1|Study on hold|1|||
23620309|NCT01260142|65994944|FG002|Treatment Period 1|Study on hold|0|||
23620310|NCT01260142|65994945|FG003|Treatment Period 1|Study on hold|0|||
23620311|NCT01260142|65994946|FG004|Treatment Period 1|Study on hold|1|||
23620312|NCT01260142|65994947|FG005|Treatment Period 1|Study on hold|2|||
23620313|NCT01260142|65994942|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620314|NCT01260142|65994943|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620315|NCT01260142|65994944|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620316|NCT01260142|65994945|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620317|NCT01260142|65994946|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
23620318|NCT01260142|65994947|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620319|NCT01260142|65994942|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23620320|NCT01260142|65994943|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23620321|NCT01260142|65994944|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23620322|NCT01260142|65994945|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23620323|NCT01260142|65994946|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23549884|NCT02388724|65743056|FG000|Overall Study|Reason not Specified|0|||
23549885|NCT02388724|65743057|FG001|Overall Study|Reason not Specified|1|||
23549886|NCT02388724|65743056|FG000|Overall Study|Major Protocol Deviation|3|||
23549887|NCT02388724|65743057|FG001|Overall Study|Major Protocol Deviation|3|||
23549888|NCT02388724|65743056|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23549889|NCT02388724|65743057|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23549890|NCT02388724|65743056|FG000|Overall Study|Voluntary Withdrawal|6|||
23549891|NCT02388724|65743057|FG001|Overall Study|Voluntary Withdrawal|5|||
23549892|NCT02388724|65743056|FG000|Overall Study|Randomized but not Treated|0|||
23549893|NCT02388724|65743057|FG001|Overall Study|Randomized but not Treated|2|||
23620324|NCT01260142|65994947|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23620325|NCT01220856|65994951|FG000|Overall Study|graft loss|3|||
23620326|NCT01220856|65994952|FG001|Overall Study|graft loss|3|||
23620327|NCT01220856|65994951|FG000|Overall Study|Lost to Follow-up|1|||
23620328|NCT01220856|65994952|FG001|Overall Study|Lost to Follow-up|0|||
23620329|NCT00931918|65994953|FG000|Overall Study|Adverse Event|4|||
23620330|NCT00931918|65994954|FG001|Overall Study|Adverse Event|6|||
23620331|NCT00931918|65994953|FG000|Overall Study|Progressive Disease|2|||
23620332|NCT00931918|65994954|FG001|Overall Study|Progressive Disease|1|||
23620333|NCT00931918|65994953|FG000|Overall Study|Symptomatic Deterioration|1|||
23620334|NCT00931918|65994954|FG001|Overall Study|Symptomatic Deterioration|0|||
23620335|NCT00931918|65994953|FG000|Overall Study|Withdrawal by Patient|3|||
23741836|NCT04409262|66432784|FG000|Overall Study|Withdrawal by Subject|5|||
23741837|NCT04409262|66432785|FG001|Overall Study|Withdrawal by Subject|10|||
23741838|NCT02135848|66432795|FG000|Overall Study|Adverse Event|2|||
23741839|NCT02135848|66432796|FG001|Overall Study|Adverse Event|0|||
23741840|NCT02135848|66432795|FG000|Overall Study|Withdrawal by Subject|1|||
23741841|NCT02135848|66432796|FG001|Overall Study|Withdrawal by Subject|1|||
23741842|NCT00672490|66432797|FG000|Overall Study|Withdrawal by Subject|8|||
23741843|NCT00672490|66432798|FG001|Overall Study|Withdrawal by Subject|8|||
23741844|NCT00672490|66432797|FG000|Overall Study|Lack of Compliance|2|||
23741845|NCT00672490|66432798|FG001|Overall Study|Lack of Compliance|7|||
23741846|NCT00672490|66432797|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
23821431|NCT02088697|66726035|FG000|Period I|Physician Decision|1|||
23549894|NCT01625897|65743058|FG000|Overall Study|Adverse Event|27|||
23549895|NCT01625897|65743059|FG001|Overall Study|Adverse Event|10|||
23549896|NCT01625897|65743058|FG000|Overall Study|Physician Decision|0|||
23549897|NCT01625897|65743059|FG001|Overall Study|Physician Decision|1|||
23549898|NCT01625897|65743058|FG000|Overall Study|Withdrawal by Subject|25|||
23549899|NCT01625897|65743059|FG001|Overall Study|Withdrawal by Subject|3|||
23549900|NCT01816594|65743062|FG000|Overall Study|Local Progress|0|||
23549901|NCT01816594|65743063|FG001|Overall Study|Local Progress|2|||
23549902|NCT01816594|65743062|FG000|Overall Study|Adverse Event|9|||
23549903|NCT01816594|65743063|FG001|Overall Study|Adverse Event|0|||
23549904|NCT01816594|65743062|FG000|Overall Study|Withdrawal by Subject|1|||
23549905|NCT01816594|65743063|FG001|Overall Study|Withdrawal by Subject|0|||
23549906|NCT01816594|65743062|FG000|Overall Study|Physician Decision|1|||
23549907|NCT01816594|65743063|FG001|Overall Study|Physician Decision|0|||
23549908|NCT00514735|65743064|FG000|Overall Study|Withdrawal by Subject|13|||
23549909|NCT00514735|65743065|FG001|Overall Study|Withdrawal by Subject|5|||
23549910|NCT00514735|65743064|FG000|Overall Study|Death|1|||
23549911|NCT00514735|65743065|FG001|Overall Study|Death|0|||
23549912|NCT00514735|65743064|FG000|Overall Study|Lost to Follow-up|0|||
23549913|NCT00514735|65743065|FG001|Overall Study|Lost to Follow-up|1|||
23549914|NCT00674986|65743066|FG000|Overall Study|Adverse Event|2|||
23821432|NCT02088697|66726036|FG001|Period I|Physician Decision|4|||
23821433|NCT02088697|66726035|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
23821434|NCT02088697|66726036|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
23821435|NCT01144715|66726037|FG000|Overall Study|Lost to Follow-up|2|||
23821436|NCT01144715|66726038|FG001|Overall Study|Lost to Follow-up|1|||
23821437|NCT01144715|66726037|FG000|Overall Study|Withdrawal by Subject|2|||
23821438|NCT01144715|66726038|FG001|Overall Study|Withdrawal by Subject|1|||
23821439|NCT01144715|66726037|FG000|Overall Study|Adverse Event|0|||
23821440|NCT01144715|66726038|FG001|Overall Study|Adverse Event|1|||
23821441|NCT00061932|66726039|FG000|Overall Study|Withdrawal by Subject|13|||
23821442|NCT00061932|66726040|FG001|Overall Study|Withdrawal by Subject|4|||
23821443|NCT00995774|66726041|FG000|Training Period 2|Withdrawal by Subject|2|||
23821444|NCT00995774|66726042|FG001|Training Period 2|Withdrawal by Subject|0|||
23821445|NCT01987479|66726045|FG000|Overall Study|Protocol Violation|1|||
23821446|NCT01987479|66726045|FG000|Overall Study|Physician Decision|2|||
23821447|NCT01987479|66726045|FG000|Overall Study|Participant/legal guardian decision|1|||
23821448|NCT01987479|66726045|FG000|Overall Study|Other|5|||
23821449|NCT01987479|66726045|FG000|Overall Study|Lost to Follow-up|1|||
23821450|NCT01987479|66726045|FG000|Overall Study|Adverse Event|7|||
23821451|NCT00640315|66726046|FG000|Overall Study|Withdrawal by Subject|0|||
23821452|NCT00640315|66726047|FG001|Overall Study|Withdrawal by Subject|1|||
23821453|NCT00663026|66726050|FG000|Overall Study|Lost to Follow-up|1|||
23821454|NCT00663026|66726051|FG001|Overall Study|Lost to Follow-up|0|||
23821455|NCT00663026|66726052|FG002|Overall Study|Lost to Follow-up|0|||
23821456|NCT00663026|66726050|FG000|Overall Study|Other|1|||
23821457|NCT00663026|66726051|FG001|Overall Study|Other|2|||
23821458|NCT00663026|66726052|FG002|Overall Study|Other|0|||
23821459|NCT00663026|66726050|FG000|Overall Study|Adverse Event|0|||
23821460|NCT00663026|66726051|FG001|Overall Study|Adverse Event|2|||
23821461|NCT00663026|66726052|FG002|Overall Study|Adverse Event|3|||
23821462|NCT00663026|66726050|FG000|Overall Study|Caregiver Request|0|||
23821463|NCT00663026|66726051|FG001|Overall Study|Caregiver Request|2|||
23821464|NCT00663026|66726052|FG002|Overall Study|Caregiver Request|0|||
23821465|NCT00663026|66726050|FG000|Overall Study|Withdrawal by Subject|0|||
23821466|NCT00663026|66726051|FG001|Overall Study|Withdrawal by Subject|0|||
23821467|NCT00663026|66726052|FG002|Overall Study|Withdrawal by Subject|1|||
23821468|NCT02246114|66726053|FG000|Overall Study|miscarriage|1|||
23821469|NCT02246114|66726054|FG001|Overall Study|miscarriage|0|||
23821470|NCT01973595|66726055|FG000|Washout|Withdrawal by Subject|1|||
23821471|NCT01973595|66726056|FG001|Washout|Withdrawal by Subject|0|||
23821472|NCT01973595|66726057|FG002|Washout|Withdrawal by Subject|1|||
23821473|NCT01973595|66726058|FG003|Washout|Withdrawal by Subject|0|||
23821474|NCT01266031|66726062|FG000|Overall Study|Not treated|0|||
23821475|NCT01266031|66726063|FG001|Overall Study|Not treated|3|||
23821476|NCT01266031|66726064|FG002|Overall Study|Not treated|2|||
23821477|NCT01106014|66726074|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
23821478|NCT01106014|66726075|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
23821479|NCT01106014|66726074|FG000|Overall Study|Adverse Event|78|||
23549915|NCT00674986|65743067|FG001|Overall Study|Adverse Event|1|||
23549916|NCT00674986|65743066|FG000|Overall Study|Subject withdrew consent|12|||
23821480|NCT01106014|66726075|FG001|Overall Study|Adverse Event|42|||
23549917|NCT00674986|65743067|FG001|Overall Study|Subject withdrew consent|19|||
23821481|NCT01106014|66726074|FG000|Overall Study|Withdrawal by Subject|43|||
23821482|NCT01106014|66726075|FG001|Overall Study|Withdrawal by Subject|37|||
23821483|NCT01106014|66726074|FG000|Overall Study|Administrative reason|7|||
23549918|NCT00674986|65743066|FG000|Overall Study|Lost to Follow-up|25|||
23549919|NCT00674986|65743067|FG001|Overall Study|Lost to Follow-up|53|||
23549920|NCT00674986|65743066|FG000|Overall Study|Other reasons|4|||
23549921|NCT00674986|65743067|FG001|Overall Study|Other reasons|8|||
23549922|NCT04764396|65743069|FG000|Overall Study|Physician Decision|1|||
23549923|NCT04764396|65743070|FG001|Overall Study|Physician Decision|0|||
23549924|NCT02862457|65743077|FG000|Overall Study|Death|1|||
23549925|NCT02862457|65743078|FG001|Overall Study|Death|3|||
23549926|NCT02862457|65743079|FG002|Overall Study|Death|2|||
23549927|NCT02862457|65743080|FG003|Overall Study|Death|3|||
23549928|NCT02862457|65743081|FG004|Overall Study|Death|0|||
23549929|NCT02862457|65743082|FG005|Overall Study|Death|2|||
23549930|NCT02862457|65743083|FG006|Overall Study|Death|1|||
23549931|NCT02862457|65743077|FG000|Overall Study|Lost to Follow-up|1|||
23549932|NCT02862457|65743078|FG001|Overall Study|Lost to Follow-up|0|||
23549933|NCT02862457|65743079|FG002|Overall Study|Lost to Follow-up|0|||
23549934|NCT02862457|65743080|FG003|Overall Study|Lost to Follow-up|1|||
23549935|NCT02862457|65743081|FG004|Overall Study|Lost to Follow-up|0|||
23549936|NCT02862457|65743082|FG005|Overall Study|Lost to Follow-up|0|||
23741847|NCT00672490|66432798|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
23741848|NCT00672490|66432797|FG000|Overall Study|Adverse Event|5|||
23741849|NCT00672490|66432798|FG001|Overall Study|Adverse Event|8|||
23741850|NCT00672490|66432797|FG000|Overall Study|Violation of Concomitant Medicine|1|||
23741851|NCT00672490|66432798|FG001|Overall Study|Violation of Concomitant Medicine|0|||
23741852|NCT00672490|66432797|FG000|Overall Study|Intolerance|0|||
23741853|NCT00672490|66432798|FG001|Overall Study|Intolerance|2|||
23741854|NCT00672490|66432797|FG000|Overall Study|Lost to Follow-up|1|||
23549937|NCT02862457|65743083|FG006|Overall Study|Lost to Follow-up|0|||
23549938|NCT02862457|65743077|FG000|Overall Study|Withdrawal by Subject|0|||
23549939|NCT02862457|65743078|FG001|Overall Study|Withdrawal by Subject|0|||
23549940|NCT02862457|65743079|FG002|Overall Study|Withdrawal by Subject|1|||
23549941|NCT02862457|65743080|FG003|Overall Study|Withdrawal by Subject|0|||
23549942|NCT02862457|65743081|FG004|Overall Study|Withdrawal by Subject|0|||
23549943|NCT02862457|65743082|FG005|Overall Study|Withdrawal by Subject|1|||
23549944|NCT02862457|65743083|FG006|Overall Study|Withdrawal by Subject|0|||
23549945|NCT01798927|65743084|FG000|Overall Study|Withdrawal by Subject|1|||
23741855|NCT00672490|66432798|FG001|Overall Study|Lost to Follow-up|5|||
23741856|NCT00672490|66432797|FG000|Overall Study|No reason was provided|6|||
23741857|NCT00672490|66432798|FG001|Overall Study|No reason was provided|2|||
23741858|NCT01856920|66432799|FG000|Overall Study|Disease Progression On Study|3|||
23741859|NCT01856920|66432800|FG001|Overall Study|Disease Progression On Study|4|||
23741860|NCT01856920|66432799|FG000|Overall Study|Disease Progression before Treatment|1|||
23741861|NCT01856920|66432800|FG001|Overall Study|Disease Progression before Treatment|0|||
23741862|NCT01856920|66432799|FG000|Overall Study|Ineligible|0|||
23741863|NCT01856920|66432800|FG001|Overall Study|Ineligible|1|||
23741864|NCT01856920|66432799|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
23741865|NCT01856920|66432800|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
23741866|NCT01856920|66432799|FG000|Overall Study|Refused further Treatment|5|||
23741867|NCT01856920|66432800|FG001|Overall Study|Refused further Treatment|1|||
23741868|NCT01856920|66432799|FG000|Overall Study|Other Reasons|0|||
23741869|NCT01856920|66432800|FG001|Overall Study|Other Reasons|1|||
23741870|NCT01856920|66432799|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
23741871|NCT01856920|66432800|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
23741872|NCT00408408|66432801|FG000|Overall Study|No follow up data|2|||
23741873|NCT00408408|66432802|FG001|Overall Study|No follow up data|3|||
23741874|NCT00408408|66432803|FG002|Overall Study|No follow up data|0|||
23741875|NCT00408408|66432804|FG003|Overall Study|No follow up data|7|||
23741876|NCT00408408|66432805|FG004|Overall Study|No follow up data|5|||
23741877|NCT00408408|66432806|FG005|Overall Study|No follow up data|3|||
23741878|NCT03007472|66432807|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
23741879|NCT03007472|66432807|FG000|Overall Study|Death|2|||
23741880|NCT03007472|66432807|FG000|Overall Study|Loss to Follow Up|1|||
23741881|NCT00033514|66432808|FG000|Overall Study|Lost to Follow-up|1|||
23741882|NCT00033514|66432809|FG001|Overall Study|Lost to Follow-up|1|||
23741883|NCT00033514|66432808|FG000|Overall Study|Withdrawal by Subject|0|||
23741884|NCT00033514|66432809|FG001|Overall Study|Withdrawal by Subject|3|||
23741885|NCT01219959|66432810|FG000|Overall Study|Adverse Event|6|||
23549946|NCT02063828|65743085|FG000|Overall Study|Withdrawal by Subject|4|||
23549947|NCT02063828|65743086|FG001|Overall Study|Withdrawal by Subject|6|||
23549948|NCT02063828|65743087|FG002|Overall Study|Withdrawal by Subject|3|||
23741886|NCT01219959|66432811|FG001|Overall Study|Adverse Event|14|||
23549949|NCT02063828|65743085|FG000|Overall Study|Death|0|||
23549950|NCT02063828|65743086|FG001|Overall Study|Death|0|||
23549951|NCT02063828|65743087|FG002|Overall Study|Death|1|||
23549952|NCT00743366|65743091|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
23741887|NCT01219959|66432810|FG000|Overall Study|Physician Decision|0|||
23741888|NCT01219959|66432811|FG001|Overall Study|Physician Decision|4|||
23741889|NCT01219959|66432810|FG000|Overall Study|Withdrawal by Subject|0|||
23549953|NCT00743366|65743092|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
23549954|NCT01917526|65743095|FG000|Overall Study|Protocol Violation|1|||
23821484|NCT01106014|66726075|FG001|Overall Study|Administrative reason|6|||
23549955|NCT01917526|65743096|FG001|Overall Study|Protocol Violation|1|||
23549956|NCT00344461|65743098|FG000|Overall Study|Adverse Event|6|||
23549957|NCT00344461|65743098|FG000|Overall Study|Death|1|||
23549958|NCT00344461|65743098|FG000|Overall Study|Lack of Efficacy|2|||
23549959|NCT00344461|65743098|FG000|Overall Study|Lost to Follow-up|2|||
23549960|NCT00344461|65743098|FG000|Overall Study|Physician Decision|2|||
23549961|NCT00344461|65743098|FG000|Overall Study|Protocol Violation|6|||
23549962|NCT00344461|65743098|FG000|Overall Study|Withdrawal by Subject|2|||
23549963|NCT01353313|65743099|FG000|Overall Study|Lost to Follow-up|22|||
23549964|NCT01353313|65743100|FG001|Overall Study|Lost to Follow-up|23|||
23549965|NCT01353313|65743099|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
23549966|NCT01353313|65743100|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
23549967|NCT01018394|65743101|FG000|Overall Study|Withdrawal by Subject|5|||
23549968|NCT01018394|65743102|FG001|Overall Study|Withdrawal by Subject|5|||
23549969|NCT01018394|65743101|FG000|Overall Study|Lost to Follow-up|4|||
23549970|NCT01018394|65743102|FG001|Overall Study|Lost to Follow-up|3|||
23549971|NCT00529399|65743106|FG000|Overall Study|Lost to Follow-up|1|||
23549972|NCT00529399|65743107|FG001|Overall Study|Lost to Follow-up|0|||
23549973|NCT00529399|65743108|FG002|Overall Study|Lost to Follow-up|1|||
23549974|NCT00529399|65743106|FG000|Overall Study|Withdrawal by Subject|1|||
23549975|NCT00529399|65743107|FG001|Overall Study|Withdrawal by Subject|0|||
23549976|NCT00529399|65743108|FG002|Overall Study|Withdrawal by Subject|1|||
23549977|NCT00529399|65743106|FG000|Overall Study|Non-compliant|0|||
23549978|NCT00529399|65743107|FG001|Overall Study|Non-compliant|1|||
23549979|NCT00529399|65743108|FG002|Overall Study|Non-compliant|0|||
23549980|NCT00335322|65743112|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
23549981|NCT00335322|65743113|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
23549982|NCT00335322|65743114|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
23549983|NCT02065336|65743118|FG000|Extension Phase|Study Terminated by Sponsor|0|||
23549984|NCT02065336|65743119|FG001|Extension Phase|Study Terminated by Sponsor|0|||
23549985|NCT02065336|65743120|FG002|Extension Phase|Study Terminated by Sponsor|0|||
23549986|NCT02065336|65743121|FG003|Extension Phase|Study Terminated by Sponsor|0|||
23549987|NCT02065336|65743122|FG004|Extension Phase|Study Terminated by Sponsor|0|||
23549988|NCT02065336|65743123|FG005|Extension Phase|Study Terminated by Sponsor|0|||
23549989|NCT02065336|65743124|FG006|Extension Phase|Study Terminated by Sponsor|0|||
23549990|NCT02065336|65743125|FG007|Extension Phase|Study Terminated by Sponsor|0|||
23549991|NCT02065336|65743126|FG008|Extension Phase|Study Terminated by Sponsor|2|||
23549992|NCT02065336|65743127|FG009|Extension Phase|Study Terminated by Sponsor|8|||
23549993|NCT00381940|65743128|FG000|Overall Study|Lack of Efficacy|3|||
23549994|NCT00381940|65743128|FG000|Overall Study|Protocol Violation|1|||
23549995|NCT00381940|65743128|FG000|Overall Study|Ineligible|1|||
23549996|NCT01453595|65743129|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23549997|NCT01453595|65743130|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23549998|NCT01453595|65743131|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23549999|NCT01388816|65743132|FG000|Overall Study|Adverse Event|0|||
23550000|NCT01388816|65743133|FG001|Overall Study|Adverse Event|2|||
23550001|NCT01388816|65743134|FG002|Overall Study|Adverse Event|0|||
23550002|NCT01388816|65743135|FG003|Overall Study|Adverse Event|0|||
23550003|NCT01388816|65743132|FG000|Overall Study|Lost to Follow-up|0|||
23550004|NCT01388816|65743133|FG001|Overall Study|Lost to Follow-up|1|||
23550005|NCT01388816|65743134|FG002|Overall Study|Lost to Follow-up|0|||
23550006|NCT01388816|65743135|FG003|Overall Study|Lost to Follow-up|0|||
23550007|NCT01388816|65743132|FG000|Overall Study|Withdrawal by Subject|2|||
23550008|NCT01388816|65743133|FG001|Overall Study|Withdrawal by Subject|1|||
23550009|NCT01388816|65743134|FG002|Overall Study|Withdrawal by Subject|1|||
23550010|NCT01388816|65743135|FG003|Overall Study|Withdrawal by Subject|0|||
23550011|NCT01388816|65743132|FG000|Overall Study|Protocol Violation|0|||
23821485|NCT01106014|66726074|FG000|Overall Study|Lost to Follow-up|2|||
23821486|NCT01106014|66726075|FG001|Overall Study|Lost to Follow-up|3|||
23821487|NCT00749892|66726080|FG000|Overall Study|Withdrawal by Subject|3|||
23821488|NCT03132155|66726093|FG000|Overall Study|Lack of Efficacy|6|||
23821489|NCT03132155|66726093|FG000|Overall Study|Lost to Follow-up|1|||
23821490|NCT03132155|66726093|FG000|Overall Study|Withdrawal by Subject|1|||
23550012|NCT01388816|65743133|FG001|Overall Study|Protocol Violation|0|||
23550013|NCT01388816|65743134|FG002|Overall Study|Protocol Violation|2|||
23550014|NCT01388816|65743135|FG003|Overall Study|Protocol Violation|0|||
23550015|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
23550016|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
23821491|NCT01682811|66726099|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23821492|NCT01682811|66726100|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23821493|NCT01682811|66726101|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23550017|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
23550018|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
23821494|NCT01682811|66726102|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23550019|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
23550020|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
23550021|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
23550022|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
23550023|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
23550024|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
23550025|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
23550026|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
23550027|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
23550028|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
23550029|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
23550030|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
23550031|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
23550032|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
23550033|NCT02495025|65743138|FG000|Overall Study|Lost to Follow-up|21|||
23550034|NCT02495025|65743139|FG001|Overall Study|Lost to Follow-up|14|||
23550035|NCT02495025|65743138|FG000|Overall Study|Withdrawal by Subject|5|||
23550036|NCT02495025|65743139|FG001|Overall Study|Withdrawal by Subject|0|||
23550037|NCT01786512|65743140|FG000|Overall Study|Lost to Follow-up|0|||
23550038|NCT01786512|65743141|FG001|Overall Study|Lost to Follow-up|0|||
23550039|NCT01786512|65743142|FG002|Overall Study|Lost to Follow-up|0|||
23550040|NCT01786512|65743143|FG003|Overall Study|Lost to Follow-up|0|||
23550041|NCT01786512|65743144|FG004|Overall Study|Lost to Follow-up|0|||
23550042|NCT01786512|65743145|FG005|Overall Study|Lost to Follow-up|0|||
23550043|NCT01786512|65743146|FG006|Overall Study|Lost to Follow-up|0|||
23550044|NCT01786512|65743147|FG007|Overall Study|Lost to Follow-up|0|||
23550045|NCT01786512|65743148|FG008|Overall Study|Lost to Follow-up|0|||
23550046|NCT01786512|65743149|FG009|Overall Study|Lost to Follow-up|1|||
23550047|NCT01786512|65743150|FG010|Overall Study|Lost to Follow-up|0|||
23550048|NCT01786512|65743140|FG000|Overall Study|Decision by sponsor|0|||
23550049|NCT01786512|65743141|FG001|Overall Study|Decision by sponsor|0|||
23550050|NCT01786512|65743142|FG002|Overall Study|Decision by sponsor|0|||
23550051|NCT01786512|65743143|FG003|Overall Study|Decision by sponsor|0|||
23550052|NCT01786512|65743144|FG004|Overall Study|Decision by sponsor|0|||
23550053|NCT01786512|65743145|FG005|Overall Study|Decision by sponsor|0|||
23550054|NCT01786512|65743146|FG006|Overall Study|Decision by sponsor|0|||
23550055|NCT01786512|65743147|FG007|Overall Study|Decision by sponsor|0|||
23550056|NCT01786512|65743148|FG008|Overall Study|Decision by sponsor|0|||
23550057|NCT01786512|65743149|FG009|Overall Study|Decision by sponsor|0|||
23550058|NCT01786512|65743150|FG010|Overall Study|Decision by sponsor|2|||
23550059|NCT01786512|65743140|FG000|Overall Study|Withdrawal by Subject|0|||
23550060|NCT01786512|65743141|FG001|Overall Study|Withdrawal by Subject|1|||
23550061|NCT01786512|65743142|FG002|Overall Study|Withdrawal by Subject|0|||
23550062|NCT01786512|65743143|FG003|Overall Study|Withdrawal by Subject|0|||
23550063|NCT01786512|65743144|FG004|Overall Study|Withdrawal by Subject|0|||
23550064|NCT01786512|65743145|FG005|Overall Study|Withdrawal by Subject|0|||
23550065|NCT01786512|65743146|FG006|Overall Study|Withdrawal by Subject|1|||
23550066|NCT01786512|65743147|FG007|Overall Study|Withdrawal by Subject|0|||
23550067|NCT01786512|65743148|FG008|Overall Study|Withdrawal by Subject|0|||
23550068|NCT01786512|65743149|FG009|Overall Study|Withdrawal by Subject|3|||
23550069|NCT01786512|65743150|FG010|Overall Study|Withdrawal by Subject|7|||
23550070|NCT01786512|65743140|FG000|Overall Study|Death|0|||
23550071|NCT01786512|65743141|FG001|Overall Study|Death|0|||
23550072|NCT01786512|65743142|FG002|Overall Study|Death|0|||
23550073|NCT01786512|65743143|FG003|Overall Study|Death|0|||
23550074|NCT01786512|65743144|FG004|Overall Study|Death|0|||
23550075|NCT01786512|65743145|FG005|Overall Study|Death|0|||
23550076|NCT01786512|65743146|FG006|Overall Study|Death|0|||
23550077|NCT01786512|65743147|FG007|Overall Study|Death|0|||
23550078|NCT01786512|65743148|FG008|Overall Study|Death|4|||
23550079|NCT01786512|65743149|FG009|Overall Study|Death|1|||
23550080|NCT01786512|65743150|FG010|Overall Study|Death|3|||
23550081|NCT00951483|65743152|FG000|Overall Study|Physician Decision|4|||
23550082|NCT00951483|65743153|FG001|Overall Study|Physician Decision|0|||
23550083|NCT00951483|65743152|FG000|Overall Study|Withdrawal by Subject|15|||
23550084|NCT00951483|65743153|FG001|Overall Study|Withdrawal by Subject|0|||
23550085|NCT02137369|65743154|FG000|Overall Study|Withdrawal by Subject|3|||
23550086|NCT02137369|65743155|FG001|Overall Study|Withdrawal by Subject|2|||
23550087|NCT02137369|65743154|FG000|Overall Study|Adverse Event|2|||
23550088|NCT02137369|65743155|FG001|Overall Study|Adverse Event|0|||
23550089|NCT02137369|65743154|FG000|Overall Study|Lost to Follow-up|1|||
23550090|NCT02137369|65743155|FG001|Overall Study|Lost to Follow-up|0|||
23550091|NCT02137369|65743154|FG000|Overall Study|Moved away|2|||
23550092|NCT02137369|65743155|FG001|Overall Study|Moved away|0|||
23550093|NCT00726752|65743168|FG000|Overall Study|Lack of Efficacy|6|||
23550094|NCT02148250|65743169|FG000|Screening|Withdrawal by Subject|5|||
23550095|NCT02148250|65743170|FG001|Screening|Withdrawal by Subject|0|||
23550096|NCT00449176|65743171|FG000|Overall Study|Withdrawal by Subject|39|||
23550097|NCT00449176|65743172|FG001|Overall Study|Withdrawal by Subject|43|||
23550098|NCT00449176|65743173|FG002|Overall Study|Withdrawal by Subject|59|||
23550099|NCT00449176|65743171|FG000|Overall Study|Lost to Follow-up|13|||
23550100|NCT00449176|65743172|FG001|Overall Study|Lost to Follow-up|8|||
23550101|NCT00449176|65743173|FG002|Overall Study|Lost to Follow-up|12|||
23550102|NCT00449176|65743171|FG000|Overall Study|Adverse Event|51|||
23550103|NCT00449176|65743172|FG001|Overall Study|Adverse Event|107|||
23550104|NCT00449176|65743173|FG002|Overall Study|Adverse Event|15|||
23550105|NCT00449176|65743171|FG000|Overall Study|Lack of Efficacy|13|||
23550106|NCT00449176|65743172|FG001|Overall Study|Lack of Efficacy|7|||
23550107|NCT00449176|65743173|FG002|Overall Study|Lack of Efficacy|50|||
23550108|NCT00449176|65743171|FG000|Overall Study|Study drug non-compliant|14|||
23550109|NCT00449176|65743172|FG001|Overall Study|Study drug non-compliant|11|||
23550110|NCT00449176|65743173|FG002|Overall Study|Study drug non-compliant|11|||
23550111|NCT00449176|65743171|FG000|Overall Study|all other|22|||
23741890|NCT01219959|66432811|FG001|Overall Study|Withdrawal by Subject|2|||
23741891|NCT01219959|66432810|FG000|Overall Study|Renal Transplantation|0|||
23741892|NCT01219959|66432811|FG001|Overall Study|Renal Transplantation|3|||
23741893|NCT01219959|66432810|FG000|Overall Study|Other|1|||
23741894|NCT01219959|66432811|FG001|Overall Study|Other|0|||
23741895|NCT00787527|66432816|FG000|Overall Study|Toxicity|3|||
23741896|NCT00450814|66432824|FG000|Overall Study|Failed to complete the initial therapy|0|||
23741897|NCT00450814|66432825|FG001|Overall Study|Failed to complete the initial therapy|0|||
23741898|NCT00450814|66432826|FG002|Overall Study|Failed to complete the initial therapy|0|||
23741899|NCT00450814|66432827|FG003|Overall Study|Failed to complete the initial therapy|1|||
23741900|NCT00450814|66432828|FG004|Overall Study|Failed to complete the initial therapy|1|||
23741901|NCT00450814|66432829|FG005|Overall Study|Failed to complete the initial therapy|1|||
23741902|NCT00450814|66432830|FG006|Overall Study|Failed to complete the initial therapy|0|||
23741903|NCT00450814|66432831|FG007|Overall Study|Failed to complete the initial therapy|0|||
23741904|NCT00450814|66432832|FG008|Overall Study|Failed to complete the initial therapy|0|||
23741905|NCT00450814|66432833|FG009|Overall Study|Failed to complete the initial therapy|0|||
23741906|NCT00450814|66432834|FG010|Overall Study|Failed to complete the initial therapy|0|||
23741907|NCT00450814|66432824|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
23741908|NCT00450814|66432825|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
23741909|NCT00450814|66432826|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
23741910|NCT00450814|66432827|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
23741911|NCT00450814|66432828|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
23741912|NCT00450814|66432829|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
23741913|NCT00450814|66432830|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
23741914|NCT00450814|66432831|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
23741915|NCT00450814|66432832|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
23741916|NCT00450814|66432833|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
23741917|NCT00450814|66432834|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
23741918|NCT03726320|66432835|FG000|Overall Study|Lost to Follow-up|2|||
23741919|NCT03726320|66432836|FG001|Overall Study|Lost to Follow-up|4|||
23741920|NCT03726320|66432837|FG002|Overall Study|Lost to Follow-up|0|||
23741921|NCT03726320|66432835|FG000|Overall Study|Time Constraints|4|||
23741922|NCT03726320|66432836|FG001|Overall Study|Time Constraints|1|||
23741923|NCT03726320|66432837|FG002|Overall Study|Time Constraints|0|||
23741924|NCT03726320|66432835|FG000|Overall Study|Ineligible after enrollment|3|||
23741925|NCT03726320|66432836|FG001|Overall Study|Ineligible after enrollment|3|||
23741926|NCT03726320|66432837|FG002|Overall Study|Ineligible after enrollment|0|||
23741927|NCT03726320|66432835|FG000|Overall Study|Clinic / insurance issue|2|||
23741928|NCT03726320|66432836|FG001|Overall Study|Clinic / insurance issue|0|||
23741929|NCT03726320|66432837|FG002|Overall Study|Clinic / insurance issue|0|||
23741930|NCT03726320|66432835|FG000|Overall Study|Language barrier|1|||
23741931|NCT03726320|66432836|FG001|Overall Study|Language barrier|0|||
23741932|NCT03726320|66432837|FG002|Overall Study|Language barrier|0|||
23741933|NCT03726320|66432835|FG000|Overall Study|Provider left the clinic|0|||
23741934|NCT03726320|66432836|FG001|Overall Study|Provider left the clinic|0|||
23741935|NCT03726320|66432837|FG002|Overall Study|Provider left the clinic|1|||
23741936|NCT04391894|66432841|FG000|Overall Study|Adverse Event|1|||
23741937|NCT04391894|66432842|FG001|Overall Study|Adverse Event|1|||
23741938|NCT04391894|66432843|FG002|Overall Study|Adverse Event|1|||
23741939|NCT04391894|66432844|FG003|Overall Study|Adverse Event|1|||
23821495|NCT01682811|66726103|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
23550112|NCT00449176|65743172|FG001|Overall Study|all other|19|||
23550113|NCT00449176|65743173|FG002|Overall Study|all other|20|||
23550114|NCT03282227|65743175|FG000|Overall Study|Exposure Goals Achieved|60|||
23550115|NCT03282227|65743175|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
23550116|NCT03282227|65743175|FG000|Overall Study|Adverse Event|15|||
23550117|NCT03282227|65743175|FG000|Overall Study|Lost to Follow-up|21|||
23429511|NCT00461305|65317399|FG001|Continued Treatment|Lost to Follow-up|0|||
23429512|NCT00461305|65317398|FG000|Continued Treatment|Protocol Violation|13|||
23429513|NCT00461305|65317399|FG001|Continued Treatment|Protocol Violation|0|||
23429514|NCT00461305|65317398|FG000|Continued Treatment|Withdrawal by Subject|48|||
23429515|NCT00461305|65317399|FG001|Continued Treatment|Withdrawal by Subject|0|||
23429516|NCT00461305|65317398|FG000|Continued Treatment|Partially missing diary|2|||
23429517|NCT00461305|65317399|FG001|Continued Treatment|Partially missing diary|0|||
23429518|NCT00461305|65317398|FG000|Continued Treatment|Other (missing drug etc)|2|||
23429519|NCT00461305|65317399|FG001|Continued Treatment|Other (missing drug etc)|0|||
23429520|NCT01533922|65317400|FG000|Overall Study|Adverse Event|5|||
23429521|NCT01533922|65317401|FG001|Overall Study|Adverse Event|8|||
23429522|NCT01533922|65317402|FG002|Overall Study|Adverse Event|6|||
23429523|NCT01533922|65317403|FG003|Overall Study|Adverse Event|3|||
23429524|NCT01533922|65317404|FG004|Overall Study|Adverse Event|4|||
23429525|NCT01533922|65317400|FG000|Overall Study|Lack of Efficacy|0|||
23429526|NCT01533922|65317401|FG001|Overall Study|Lack of Efficacy|0|||
23550118|NCT03282227|65743175|FG000|Overall Study|Withdrawal by Subject|20|||
23550119|NCT03282227|65743175|FG000|Overall Study|Lack of Efficacy|12|||
23550120|NCT03282227|65743175|FG000|Overall Study|Sponsor decision|3|||
23550121|NCT03282227|65743175|FG000|Overall Study|Physician Decision|2|||
23550122|NCT03282227|65743175|FG000|Overall Study|Pregnancy|2|||
23550123|NCT03282227|65743175|FG000|Overall Study|Other|1|||
23550124|NCT01581281|65743176|FG000|Overall Study|Early Study Closure|15|||
23550125|NCT01581281|65743177|FG001|Overall Study|Early Study Closure|6|||
23550126|NCT01581281|65743178|FG002|Overall Study|Early Study Closure|12|||
23550127|NCT04137380|65743179|FG000|Overall Study|Physician Decision|0|||
23550128|NCT04137380|65743180|FG001|Overall Study|Physician Decision|0|||
23550129|NCT04137380|65743181|FG002|Overall Study|Physician Decision|0|||
23550130|NCT04137380|65743182|FG003|Overall Study|Physician Decision|1|||
23550131|NCT04137380|65743183|FG004|Overall Study|Physician Decision|0|||
23550132|NCT04137380|65743184|FG005|Overall Study|Physician Decision|0|||
23550133|NCT04137380|65743185|FG006|Overall Study|Physician Decision|0|||
23550134|NCT03905655|65743189|FG000|Overall Study|Adverse Event|1|||
23550135|NCT03905655|65743190|FG001|Overall Study|Adverse Event|0|||
23550136|NCT03905655|65743191|FG002|Overall Study|Adverse Event|1|||
23620336|NCT00931918|65994954|FG001|Overall Study|Withdrawal by Patient|4|||
23620337|NCT00931918|65994953|FG000|Overall Study|Other Reason not Specified|4|||
23620338|NCT00931918|65994954|FG001|Overall Study|Other Reason not Specified|4|||
23620339|NCT00931918|65994953|FG000|Overall Study|Did not receive study drug|3|||
23620340|NCT00931918|65994954|FG001|Overall Study|Did not receive study drug|2|||
23620341|NCT00118703|65994955|FG000|Overall Study|Protocol Violation|1|||
23620342|NCT00118703|65994956|FG001|Overall Study|Protocol Violation|0|||
23620343|NCT00118703|65994955|FG000|Overall Study|Adverse Event|1|||
23620344|NCT00118703|65994956|FG001|Overall Study|Adverse Event|1|||
23620345|NCT00118703|65994955|FG000|Overall Study|Participant took two different treatment|0|||
23620346|NCT00118703|65994956|FG001|Overall Study|Participant took two different treatment|1|||
23741940|NCT04391894|66432845|FG004|Overall Study|Adverse Event|1|||
23741941|NCT04391894|66432841|FG000|Overall Study|Lost to Follow-up|1|||
23741942|NCT04391894|66432842|FG001|Overall Study|Lost to Follow-up|0|||
23429527|NCT01533922|65317402|FG002|Overall Study|Lack of Efficacy|1|||
23429528|NCT01533922|65317403|FG003|Overall Study|Lack of Efficacy|0|||
23429529|NCT01533922|65317404|FG004|Overall Study|Lack of Efficacy|0|||
23429530|NCT01533922|65317400|FG000|Overall Study|Protocol Violation|0|||
23429531|NCT01533922|65317401|FG001|Overall Study|Protocol Violation|3|||
23429532|NCT01533922|65317402|FG002|Overall Study|Protocol Violation|0|||
23429533|NCT01533922|65317403|FG003|Overall Study|Protocol Violation|0|||
23429534|NCT01533922|65317404|FG004|Overall Study|Protocol Violation|1|||
23550137|NCT03905655|65743192|FG003|Overall Study|Adverse Event|1|||
23550138|NCT00423176|65743193|FG000|Overall Study|Adverse Event|4|||
23620347|NCT00118703|65994955|FG000|Overall Study|Withdrawal by Subject|2|||
23620348|NCT00118703|65994956|FG001|Overall Study|Withdrawal by Subject|5|||
23741943|NCT04391894|66432843|FG002|Overall Study|Lost to Follow-up|0|||
23741944|NCT04391894|66432844|FG003|Overall Study|Lost to Follow-up|0|||
23741945|NCT04391894|66432845|FG004|Overall Study|Lost to Follow-up|0|||
23741946|NCT04391894|66432841|FG000|Overall Study|Protocol Violation|0|||
23741947|NCT04391894|66432842|FG001|Overall Study|Protocol Violation|0|||
23741948|NCT04391894|66432843|FG002|Overall Study|Protocol Violation|0|||
23741949|NCT04391894|66432844|FG003|Overall Study|Protocol Violation|1|||
23741950|NCT04391894|66432845|FG004|Overall Study|Protocol Violation|0|||
23741951|NCT04391894|66432841|FG000|Overall Study|Withdrawal by Subject|2|||
23741952|NCT04391894|66432842|FG001|Overall Study|Withdrawal by Subject|0|||
23741953|NCT04391894|66432843|FG002|Overall Study|Withdrawal by Subject|3|||
23741954|NCT04391894|66432844|FG003|Overall Study|Withdrawal by Subject|0|||
23741955|NCT04391894|66432845|FG004|Overall Study|Withdrawal by Subject|1|||
23741956|NCT04391894|66432841|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
23741957|NCT04391894|66432842|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
23741958|NCT04391894|66432843|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
23741959|NCT04391894|66432844|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
23620349|NCT00118703|65994955|FG000|Overall Study|Lost to Follow-up|1|||
23620350|NCT00118703|65994956|FG001|Overall Study|Lost to Follow-up|2|||
23620351|NCT00961298|65994957|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
23620352|NCT00961298|65994957|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
23620353|NCT00961298|65994957|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
23620354|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
23620355|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
23620356|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
23620357|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
23620358|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
23620359|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
23620360|NCT00520403|65994958|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
23620361|NCT00520403|65994958|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
23620362|NCT01201915|65994960|FG000|Overall Study|Adverse Event|2|||
23620363|NCT01201915|65994961|FG001|Overall Study|Adverse Event|1|||
23620364|NCT01201915|65994962|FG002|Overall Study|Adverse Event|1|||
23620365|NCT01201915|65994960|FG000|Overall Study|Lost to Follow-up|0|||
23620366|NCT01201915|65994961|FG001|Overall Study|Lost to Follow-up|4|||
23620367|NCT01201915|65994962|FG002|Overall Study|Lost to Follow-up|0|||
23620368|NCT01201915|65994960|FG000|Overall Study|Physician Decision|3|||
23620369|NCT01201915|65994961|FG001|Overall Study|Physician Decision|0|||
23620370|NCT01201915|65994962|FG002|Overall Study|Physician Decision|0|||
23620371|NCT01201915|65994960|FG000|Overall Study|Subject Decision|3|||
23620372|NCT01201915|65994961|FG001|Overall Study|Subject Decision|3|||
23620373|NCT01201915|65994962|FG002|Overall Study|Subject Decision|5|||
23821496|NCT01682811|66726104|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23821497|NCT01682811|66726105|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23821498|NCT01682811|66726099|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
23821499|NCT01682811|66726100|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
23821500|NCT01682811|66726101|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
23821501|NCT01682811|66726102|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
23821502|NCT01682811|66726103|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
23821503|NCT01682811|66726104|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
23821504|NCT01682811|66726105|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
23821505|NCT01682811|66726099|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
23821506|NCT01682811|66726100|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
23550139|NCT00423176|65743194|FG001|Overall Study|Adverse Event|6|||
23550140|NCT00423176|65743193|FG000|Overall Study|Treatment Failure|1|||
23550141|NCT00423176|65743194|FG001|Overall Study|Treatment Failure|6|||
23550142|NCT00423176|65743193|FG000|Overall Study|Lost to Follow-up|4|||
23550143|NCT00423176|65743194|FG001|Overall Study|Lost to Follow-up|7|||
23550144|NCT00423176|65743193|FG000|Overall Study|Withdrawal by Subject|4|||
23550145|NCT00423176|65743194|FG001|Overall Study|Withdrawal by Subject|3|||
23550146|NCT00423176|65743193|FG000|Overall Study|Protocol Violation|1|||
23550147|NCT00423176|65743194|FG001|Overall Study|Protocol Violation|3|||
23550148|NCT00423176|65743193|FG000|Overall Study|Did not meet protocol eligibility|2|||
23550149|NCT00423176|65743194|FG001|Overall Study|Did not meet protocol eligibility|4|||
23550150|NCT03182868|65743197|FG000|Overall Study|Protocol Violation|3|||
23550151|NCT03182868|65743198|FG001|Overall Study|Protocol Violation|0|||
23550152|NCT03182868|65743199|FG002|Overall Study|Protocol Violation|4|||
23550153|NCT03182868|65743200|FG003|Overall Study|Protocol Violation|1|||
23550154|NCT03182868|65743201|FG004|Overall Study|Protocol Violation|8|||
23550155|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
23550156|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
23550157|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|disease progression|58|||
23550158|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|disease progression|47|||
23550159|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Death|3|||
23550160|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Death|6|||
23550161|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
23550162|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
23821507|NCT01682811|66726101|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
23821508|NCT01682811|66726102|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
23821509|NCT01682811|66726103|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
23821510|NCT01682811|66726104|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
23821511|NCT01682811|66726105|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
23550163|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
23620374|NCT01201915|65994960|FG000|Overall Study|Target Lesion Progression|0|||
23550164|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
23550165|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
23550166|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
23550167|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Other|2|||
23550168|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Other|1|||
23550169|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
23620375|NCT01201915|65994961|FG001|Overall Study|Target Lesion Progression|3|||
23620376|NCT01201915|65994962|FG002|Overall Study|Target Lesion Progression|0|||
23550170|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
23550171|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
23550172|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
23550173|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Death|0|||
23550174|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Death|1|||
23550175|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
23550176|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
23550177|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
23550178|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
23550179|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
23550180|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
23550181|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
23741960|NCT04391894|66432845|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
23821512|NCT01682811|66726099|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
23821513|NCT01682811|66726100|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
23821514|NCT01682811|66726101|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
23741961|NCT00736840|66432846|FG000|Overall Study|Lost to Follow-up|13|||
23741962|NCT03737812|66432850|FG000|Overall Study|Withdrawal by Subject|1|||
23741963|NCT03737812|66432851|FG001|Overall Study|Withdrawal by Subject|2|||
23741964|NCT03737812|66432852|FG002|Overall Study|Withdrawal by Subject|1|||
23741965|NCT03737812|66432850|FG000|Overall Study|Sponsor Discontinued the Study|4|||
23741966|NCT03737812|66432851|FG001|Overall Study|Sponsor Discontinued the Study|3|||
23741967|NCT03737812|66432852|FG002|Overall Study|Sponsor Discontinued the Study|2|||
23741968|NCT03737812|66432850|FG000|Overall Study|Adverse Event|0|||
23741969|NCT03737812|66432851|FG001|Overall Study|Adverse Event|1|||
23741970|NCT03737812|66432852|FG002|Overall Study|Adverse Event|0|||
23741971|NCT03737812|66432850|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
23741972|NCT03737812|66432851|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
23741973|NCT03737812|66432852|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
23741974|NCT03655951|66432856|FG000|Overall Study|Lost to Follow-up|39|||
23741975|NCT03655951|66432857|FG001|Overall Study|Lost to Follow-up|20|||
23741976|NCT03655951|66432856|FG000|Overall Study|Withdrawal by Subject|0|||
23741977|NCT03655951|66432857|FG001|Overall Study|Withdrawal by Subject|1|||
23741978|NCT03198559|66432858|FG000|Overall Study|Adverse Event|2|||
23741979|NCT01270139|66432862|FG000|Overall Study|Adverse Event|8|||
23741980|NCT01270139|66432863|FG001|Overall Study|Adverse Event|17|||
23741981|NCT01270139|66432864|FG002|Overall Study|Adverse Event|18|||
23741982|NCT01270139|66432862|FG000|Overall Study|Lost to Follow-up|10|||
23741983|NCT01270139|66432863|FG001|Overall Study|Lost to Follow-up|9|||
23741984|NCT01270139|66432864|FG002|Overall Study|Lost to Follow-up|2|||
23741985|NCT02039687|66432865|FG000|Overall Study|Adverse Event|0|||
23741986|NCT02039687|66432866|FG001|Overall Study|Adverse Event|0|||
23741987|NCT02039687|66432867|FG002|Overall Study|Adverse Event|1|||
23741988|NCT02039687|66432868|FG003|Overall Study|Adverse Event|0|||
23741989|NCT02039687|66432865|FG000|Overall Study|Withdrawal by Subject|0|||
23741990|NCT02039687|66432866|FG001|Overall Study|Withdrawal by Subject|1|||
23741991|NCT02039687|66432867|FG002|Overall Study|Withdrawal by Subject|0|||
23741992|NCT02039687|66432868|FG003|Overall Study|Withdrawal by Subject|0|||
23741993|NCT02039687|66432865|FG000|Overall Study|treatment assignment could not be confir|0|||
23741994|NCT02039687|66432866|FG001|Overall Study|treatment assignment could not be confir|0|||
23741995|NCT02039687|66432867|FG002|Overall Study|treatment assignment could not be confir|2|||
23741996|NCT02039687|66432868|FG003|Overall Study|treatment assignment could not be confir|0|||
23741997|NCT02406586|66432869|FG000|Overall Study|Lost to Follow-up|0|||
23741998|NCT02406586|66432870|FG001|Overall Study|Lost to Follow-up|4|||
23741999|NCT02406586|66432871|FG002|Overall Study|Lost to Follow-up|2|||
23742000|NCT02406586|66432869|FG000|Overall Study|Withdrawal by Subject|1|||
23742001|NCT02406586|66432870|FG001|Overall Study|Withdrawal by Subject|0|||
23742002|NCT02406586|66432871|FG002|Overall Study|Withdrawal by Subject|0|||
23742003|NCT03339999|66432872|FG000|Overall Study|Adverse Event|1|||
23742004|NCT03339999|66432873|FG001|Overall Study|Adverse Event|2|||
23742005|NCT03339999|66432874|FG002|Overall Study|Adverse Event|2|||
23742006|NCT03339999|66432875|FG003|Overall Study|Adverse Event|1|||
23742007|NCT03339999|66432872|FG000|Overall Study|Lack of Efficacy|0|||
23742008|NCT03339999|66432873|FG001|Overall Study|Lack of Efficacy|1|||
23742009|NCT03339999|66432874|FG002|Overall Study|Lack of Efficacy|0|||
23742010|NCT03339999|66432875|FG003|Overall Study|Lack of Efficacy|0|||
23742011|NCT03339999|66432872|FG000|Overall Study|Lost to Follow-up|0|||
23821515|NCT01682811|66726102|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
23550182|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
23620377|NCT01121185|65994963|FG000|Overall Study|Not infused|0|||
23742012|NCT03339999|66432873|FG001|Overall Study|Lost to Follow-up|0|||
23742013|NCT03339999|66432874|FG002|Overall Study|Lost to Follow-up|0|||
23742014|NCT03339999|66432875|FG003|Overall Study|Lost to Follow-up|1|||
23742015|NCT03339999|66432872|FG000|Overall Study|Study Terminated by Sponsor|6|||
23742016|NCT03339999|66432873|FG001|Overall Study|Study Terminated by Sponsor|3|||
23821516|NCT01682811|66726103|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
23620378|NCT01121185|65994964|FG001|Overall Study|Not infused|1|||
23620379|NCT01121185|65994963|FG000|Overall Study|Not transplanted|1|||
23620380|NCT01121185|65994964|FG001|Overall Study|Not transplanted|0|||
23620381|NCT01746108|65994965|FG000|Overall Study|Migrated /moved from study area|0|||
23620382|NCT01746108|65994966|FG001|Overall Study|Migrated /moved from study area|1|||
23620383|NCT01746108|65994967|FG002|Overall Study|Migrated /moved from study area|0|||
23620384|NCT01746108|65994965|FG000|Overall Study|Adverse event, non-fatal|0|||
23620385|NCT01746108|65994966|FG001|Overall Study|Adverse event, non-fatal|1|||
23620386|NCT01746108|65994967|FG002|Overall Study|Adverse event, non-fatal|0|||
23620387|NCT01746108|65994965|FG000|Overall Study|Withdrawal by Subject|0|||
23620388|NCT01746108|65994966|FG001|Overall Study|Withdrawal by Subject|1|||
23620389|NCT01746108|65994967|FG002|Overall Study|Withdrawal by Subject|0|||
23620390|NCT01746108|65994965|FG000|Overall Study|Lost to Follow-up|0|||
23620391|NCT01746108|65994966|FG001|Overall Study|Lost to Follow-up|1|||
23620392|NCT01746108|65994967|FG002|Overall Study|Lost to Follow-up|0|||
23620393|NCT02168478|65994972|FG000|Overall Study|Withdrawal by Subject|1|||
23620394|NCT02168478|65994972|FG000|Overall Study|Did Not Consent to Participation|2|||
23620395|NCT02168478|65994972|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
23742017|NCT03339999|66432874|FG002|Overall Study|Study Terminated by Sponsor|4|||
23742018|NCT03339999|66432875|FG003|Overall Study|Study Terminated by Sponsor|3|||
23742019|NCT01005966|66432876|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23742020|NCT01005966|66432877|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23742021|NCT01005966|66432878|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
23742022|NCT01005966|66432879|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
23742023|NCT01005966|66432880|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
23550183|NCT01669629|65743205|FG000|Period 1|protocol deviation|1|||
23550184|NCT01669629|65743206|FG001|Period 1|protocol deviation|2|||
23550185|NCT03230916|65743210|FG000|Overall Study|Withdrawal by Subject|0|||
23550186|NCT03230916|65743211|FG001|Overall Study|Withdrawal by Subject|0|||
23550187|NCT03230916|65743212|FG002|Overall Study|Withdrawal by Subject|0|||
23550188|NCT03230916|65743213|FG003|Overall Study|Withdrawal by Subject|0|||
23550189|NCT03230916|65743214|FG004|Overall Study|Withdrawal by Subject|0|||
23550190|NCT03230916|65743215|FG005|Overall Study|Withdrawal by Subject|1|||
23550191|NCT03230916|65743216|FG006|Overall Study|Withdrawal by Subject|0|||
23550192|NCT03230916|65743217|FG007|Overall Study|Withdrawal by Subject|0|||
23550193|NCT03230916|65743218|FG008|Overall Study|Withdrawal by Subject|0|||
23550194|NCT03230916|65743219|FG009|Overall Study|Withdrawal by Subject|0|||
23620396|NCT00510783|65994973|FG000|Overall Study|Lost to Follow-up|29|||
23620397|NCT00510783|65994974|FG001|Overall Study|Lost to Follow-up|25|||
23742024|NCT01005966|66432876|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23742025|NCT01005966|66432877|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23742026|NCT01005966|66432878|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23742027|NCT01005966|66432879|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23742028|NCT01005966|66432880|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23742029|NCT01005966|66432876|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23742030|NCT01005966|66432877|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23742031|NCT01005966|66432878|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23742032|NCT01005966|66432879|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
23742033|NCT01005966|66432880|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23742034|NCT01005966|66432876|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
23742035|NCT01005966|66432877|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
23742036|NCT01005966|66432878|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
23742037|NCT01005966|66432879|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
23742038|NCT01005966|66432880|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
23742039|NCT01005966|66432876|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23742040|NCT01005966|66432877|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23742041|NCT01005966|66432878|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23742042|NCT01005966|66432879|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23742043|NCT01005966|66432880|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23742044|NCT01005966|66432876|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23742045|NCT01005966|66432877|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23742046|NCT01005966|66432878|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23742047|NCT01005966|66432879|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23550195|NCT03230916|65743220|FG010|Overall Study|Withdrawal by Subject|0|||
23550196|NCT00791765|65743221|FG000|Weeks 1 to 12|Adverse Event|0|||
23620398|NCT00510783|65994973|FG000|Overall Study|Withdrawal by Subject|2|||
23620399|NCT00510783|65994974|FG001|Overall Study|Withdrawal by Subject|3|||
23742048|NCT01005966|66432880|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23742049|NCT01005966|66432876|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23742050|NCT01005966|66432877|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
23821517|NCT01682811|66726104|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
23620400|NCT00510783|65994973|FG000|Overall Study|Protocol Violation|0|||
23620401|NCT00510783|65994974|FG001|Overall Study|Protocol Violation|1|||
23550197|NCT00791765|65743222|FG001|Weeks 1 to 12|Adverse Event|1|||
23550198|NCT00791765|65743221|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
23550199|NCT00791765|65743222|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
23550200|NCT00791765|65743221|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
23550201|NCT00791765|65743222|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
23550202|NCT00791765|65743221|FG000|Weeks 1 to 12|Physician Decision|1|||
23742051|NCT01005966|66432878|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23742052|NCT01005966|66432879|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23742053|NCT01005966|66432880|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
23742054|NCT01005966|66432876|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23742055|NCT01005966|66432877|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
23742056|NCT01005966|66432878|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23742057|NCT01005966|66432879|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23742058|NCT01005966|66432880|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23742059|NCT01005966|66432876|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
23742060|NCT01005966|66432877|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
23742061|NCT01005966|66432878|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
23742062|NCT01005966|66432879|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
23742063|NCT01005966|66432880|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
23742064|NCT04225026|66432881|FG000|Overall Study|Withdrawal by Subject|4|||
23742065|NCT04225026|66432881|FG000|Overall Study|Adverse Event|1|||
23742066|NCT04225026|66432881|FG000|Overall Study|Other|1|||
23742067|NCT04225026|66432881|FG000|Overall Study|Death|11|||
23742068|NCT04225026|66432881|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
23742069|NCT00883896|66432882|FG000|Overall Study|Lost to Follow-up|0|||
23742070|NCT00883896|66432883|FG001|Overall Study|Lost to Follow-up|0|||
23742071|NCT00883896|66432884|FG002|Overall Study|Lost to Follow-up|0|||
23742072|NCT00883896|66432885|FG003|Overall Study|Lost to Follow-up|2|||
23742073|NCT00883896|66432882|FG000|Overall Study|Withdrawal by Subject|5|||
23742074|NCT00883896|66432883|FG001|Overall Study|Withdrawal by Subject|0|||
23742075|NCT00883896|66432884|FG002|Overall Study|Withdrawal by Subject|1|||
23742076|NCT00883896|66432885|FG003|Overall Study|Withdrawal by Subject|3|||
23742077|NCT00883896|66432882|FG000|Overall Study|Lack of Efficacy|0|||
23742078|NCT00883896|66432883|FG001|Overall Study|Lack of Efficacy|0|||
23742079|NCT00883896|66432884|FG002|Overall Study|Lack of Efficacy|0|||
23742080|NCT00883896|66432885|FG003|Overall Study|Lack of Efficacy|2|||
23742081|NCT00883896|66432882|FG000|Overall Study|Other|1|||
23742082|NCT00883896|66432883|FG001|Overall Study|Other|0|||
23742083|NCT00883896|66432884|FG002|Overall Study|Other|0|||
23742084|NCT00883896|66432885|FG003|Overall Study|Other|0|||
23742085|NCT02221882|66432892|FG000|Overall Study|Withdrawal by Subject|0|||
23742086|NCT02221882|66432893|FG001|Overall Study|Withdrawal by Subject|0|||
23742087|NCT02221882|66432894|FG002|Overall Study|Withdrawal by Subject|4|||
23742088|NCT02221882|66432895|FG003|Overall Study|Withdrawal by Subject|2|||
23742089|NCT02221882|66432896|FG004|Overall Study|Withdrawal by Subject|2|||
23742090|NCT02221882|66432897|FG005|Overall Study|Withdrawal by Subject|2|||
23742091|NCT02221882|66432892|FG000|Overall Study|Death|0|||
23742092|NCT02221882|66432893|FG001|Overall Study|Death|1|||
23742093|NCT02221882|66432894|FG002|Overall Study|Death|0|||
23742094|NCT02221882|66432895|FG003|Overall Study|Death|0|||
23742095|NCT02221882|66432896|FG004|Overall Study|Death|0|||
23742096|NCT02221882|66432897|FG005|Overall Study|Death|0|||
23742097|NCT01066546|66432898|FG000|Overall Study|Study terminated by sponsor|5|||
23742098|NCT02173158|66432899|FG000|Efficacy Phase|Adverse Event|1|||
23742099|NCT01640353|66432900|FG000|Overall Study|Withdrew prior to treatment|10|||
23742100|NCT01640353|66432900|FG000|Overall Study|Withdrawn from analysis at term site|12|||
23742101|NCT01640353|66432900|FG000|Overall Study|Withdrawal by Subject|5|||
23742102|NCT01640353|66432900|FG000|Overall Study|Death|2|||
23742103|NCT01640353|66432900|FG000|Overall Study|Early site termination|3|||
23742104|NCT01640353|66432900|FG000|Overall Study|Lost to Follow-up|12|||
23742105|NCT01640353|66432900|FG000|Overall Study|Physician Decision|1|||
23742106|NCT01016912|66432901|FG000|End of Treatment Period|Lack of Efficacy|0|||
23742107|NCT01016912|66432902|FG001|End of Treatment Period|Lack of Efficacy|1|||
23742108|NCT01016912|66432903|FG002|End of Treatment Period|Lack of Efficacy|0|||
23742109|NCT01016912|66432904|FG003|End of Treatment Period|Lack of Efficacy|4|||
23742110|NCT01016912|66432905|FG004|End of Treatment Period|Lack of Efficacy|4|||
23742111|NCT01016912|66432901|FG000|End of Treatment Period|Adverse Event|0|||
23821518|NCT01682811|66726105|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
23742112|NCT01016912|66432902|FG001|End of Treatment Period|Adverse Event|1|||
23550203|NCT00791765|65743222|FG001|Weeks 1 to 12|Physician Decision|0|||
23821519|NCT04248829|66726106|FG000|Overall Study|Disease progression|44|||
23821520|NCT04248829|66726107|FG001|Overall Study|Disease progression|109|||
23821521|NCT04248829|66726106|FG000|Overall Study|Adverse Event|19|||
23821522|NCT04248829|66726107|FG001|Overall Study|Adverse Event|18|||
23742113|NCT01016912|66432903|FG002|End of Treatment Period|Adverse Event|1|||
23742114|NCT01016912|66432904|FG003|End of Treatment Period|Adverse Event|0|||
23550204|NCT00791765|65743221|FG000|Weeks 1 to 12|Disease progression|3|||
23742115|NCT01016912|66432905|FG004|End of Treatment Period|Adverse Event|0|||
23550205|NCT00791765|65743222|FG001|Weeks 1 to 12|Disease progression|0|||
23550206|NCT00791765|65743221|FG000|Weeks 1 to 12|Ineligibility determined|0|||
23550207|NCT00791765|65743222|FG001|Weeks 1 to 12|Ineligibility determined|3|||
23550208|NCT00791765|65743221|FG000|Weeks 13 to 24|Protocol deviation|2|||
23550209|NCT00791765|65743222|FG001|Weeks 13 to 24|Protocol deviation|0|||
23550210|NCT00791765|65743221|FG000|Weeks 13 to 24|Adverse Event|0|||
23550211|NCT00791765|65743222|FG001|Weeks 13 to 24|Adverse Event|3|||
23550212|NCT00791765|65743221|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
23550213|NCT00791765|65743222|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
23550214|NCT00791765|65743221|FG000|Weeks 13 to 24|Disease progression|0|||
23550215|NCT00791765|65743222|FG001|Weeks 13 to 24|Disease progression|1|||
23550216|NCT00791765|65743221|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
23550217|NCT00791765|65743222|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
23550218|NCT00791765|65743221|FG000|Weeks 13 to 24|Other|0|||
23550219|NCT00791765|65743222|FG001|Weeks 13 to 24|Other|1|||
23550220|NCT01549613|65743231|FG000|Overall Study|Lost to Follow-up|11|||
23550221|NCT01549613|65743232|FG001|Overall Study|Lost to Follow-up|11|||
23550222|NCT02099838|65743233|FG000|Overall Study|Death|1|||
23550223|NCT02099838|65743234|FG001|Overall Study|Death|0|||
23550224|NCT02099838|65743233|FG000|Overall Study|Lost to Follow-up|3|||
23550225|NCT02099838|65743234|FG001|Overall Study|Lost to Follow-up|1|||
23550226|NCT02099838|65743233|FG000|Overall Study|Withdrawal by Subject|0|||
23550227|NCT02099838|65743234|FG001|Overall Study|Withdrawal by Subject|1|||
23550228|NCT00328510|65743235|FG000|Overall Study|Gag disorder, could not use frame|4|||
23550229|NCT00328510|65743236|FG001|Overall Study|Gag disorder, could not use frame|0|||
23550230|NCT00328510|65743235|FG000|Overall Study|Dentition problems, could not use frame|1|||
23550231|NCT00328510|65743236|FG001|Overall Study|Dentition problems, could not use frame|0|||
23550232|NCT00328510|65743235|FG000|Overall Study|Withdrawal by Subject|4|||
23550233|NCT00328510|65743236|FG001|Overall Study|Withdrawal by Subject|2|||
23550234|NCT00328510|65743235|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
23550235|NCT00328510|65743236|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
23550236|NCT00328510|65743235|FG000|Overall Study|Treatment changed to a single fraction|1|||
23550237|NCT00328510|65743236|FG001|Overall Study|Treatment changed to a single fraction|1|||
23550238|NCT02301143|65743238|FG000|Induction Period|Enrolled But Not Treated|1|||
23550239|NCT02301143|65743239|FG001|Induction Period|Enrolled But Not Treated|0|||
23550240|NCT02301143|65743238|FG000|Induction Period|Death|1|||
23550241|NCT02301143|65743239|FG001|Induction Period|Death|0|||
23550242|NCT02301143|65743238|FG000|Induction Period|Adverse Event|22|||
23550243|NCT02301143|65743239|FG001|Induction Period|Adverse Event|0|||
23550244|NCT02301143|65743238|FG000|Induction Period|Progressive Disease|8|||
23550245|NCT02301143|65743239|FG001|Induction Period|Progressive Disease|0|||
23550246|NCT02301143|65743238|FG000|Induction Period|Withdrawal by Subject|3|||
23550247|NCT02301143|65743239|FG001|Induction Period|Withdrawal by Subject|0|||
23550248|NCT02301143|65743238|FG000|Induction Period|Noncompliance with Study Drug|1|||
23742116|NCT01016912|66432901|FG000|End of Treatment Period|Completed double-blind period only|0|||
23742117|NCT01016912|66432902|FG001|End of Treatment Period|Completed double-blind period only|1|||
23742118|NCT01016912|66432903|FG002|End of Treatment Period|Completed double-blind period only|0|||
23742119|NCT01016912|66432904|FG003|End of Treatment Period|Completed double-blind period only|0|||
23742120|NCT01016912|66432905|FG004|End of Treatment Period|Completed double-blind period only|0|||
23742121|NCT01016912|66432901|FG000|Follow-up Period|Other reason|0|||
23742122|NCT01016912|66432902|FG001|Follow-up Period|Other reason|0|||
23742123|NCT01016912|66432903|FG002|Follow-up Period|Other reason|1|||
23742124|NCT01016912|66432904|FG003|Follow-up Period|Other reason|1|||
23742125|NCT01016912|66432905|FG004|Follow-up Period|Other reason|0|||
23742126|NCT03380091|66432915|FG000|Overall Study|Withdrawal by Subject|2|||
23742127|NCT03380091|66432916|FG001|Overall Study|Withdrawal by Subject|1|||
23550249|NCT02301143|65743239|FG001|Induction Period|Noncompliance with Study Drug|0|||
23550250|NCT02301143|65743238|FG000|Induction Period|Physician Decision|4|||
23550251|NCT02301143|65743239|FG001|Induction Period|Physician Decision|0|||
23550252|NCT02301143|65743238|FG000|Induction Period|Symptomatic Deterioration|2|||
23550253|NCT02301143|65743239|FG001|Induction Period|Symptomatic Deterioration|0|||
23550254|NCT02301143|65743238|FG000|Induction Period|Protocol Violation|2|||
23550255|NCT02301143|65743239|FG001|Induction Period|Protocol Violation|0|||
23550256|NCT02301143|65743238|FG000|Induction Period|Other|1|||
23550257|NCT02301143|65743239|FG001|Induction Period|Other|0|||
23550258|NCT02301143|65743238|FG000|Investigator's Choice|Adverse Event|0|||
23550259|NCT02301143|65743239|FG001|Investigator's Choice|Adverse Event|3|||
23550260|NCT02301143|65743238|FG000|Investigator's Choice|Progressive Disease|0|||
23550261|NCT02301143|65743239|FG001|Investigator's Choice|Progressive Disease|3|||
23550262|NCT02301143|65743238|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
23742128|NCT00125138|66436373|FG000|Overall Study|Adverse Event|1|||
23742129|NCT00125138|66436374|FG001|Overall Study|Adverse Event|0|||
23742130|NCT00125138|66436375|FG002|Overall Study|Adverse Event|3|||
23550263|NCT02301143|65743239|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
23742131|NCT00125138|66436376|FG003|Overall Study|Adverse Event|2|||
23742132|NCT00125138|66436373|FG000|Overall Study|Withdrawal by Subject|2|||
23742133|NCT00125138|66436374|FG001|Overall Study|Withdrawal by Subject|3|||
23742134|NCT00125138|66436375|FG002|Overall Study|Withdrawal by Subject|1|||
23821523|NCT04248829|66726106|FG000|Overall Study|Withdrawal by Subject|11|||
23821524|NCT04248829|66726107|FG001|Overall Study|Withdrawal by Subject|2|||
23821525|NCT04248829|66726106|FG000|Overall Study|Lost to Follow-up|0|||
23821526|NCT04248829|66726107|FG001|Overall Study|Lost to Follow-up|1|||
23821527|NCT04248829|66726106|FG000|Overall Study|Death|12|||
23821528|NCT04248829|66726107|FG001|Overall Study|Death|14|||
23821529|NCT04248829|66726106|FG000|Overall Study|Physician Decision|2|||
23821530|NCT04248829|66726107|FG001|Overall Study|Physician Decision|4|||
23821531|NCT04248829|66726106|FG000|Overall Study|Any reason not specifically recorded|0|||
23821532|NCT04248829|66726107|FG001|Overall Study|Any reason not specifically recorded|2|||
23821533|NCT01885195|66726108|FG000|Overall Study|Adverse Event|29|||
23821534|NCT01885195|66726108|FG000|Overall Study|Death|1|||
23821535|NCT01885195|66726108|FG000|Overall Study|Disease Progression|67|||
23821536|NCT01885195|66726108|FG000|Overall Study|Protocol Deviation|2|||
23821537|NCT01885195|66726108|FG000|Overall Study|Physician Decision|3|||
23550264|NCT02301143|65743238|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
23550265|NCT02301143|65743239|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
23550266|NCT02301143|65743238|FG000|Investigator's Choice|Other|0|||
23550267|NCT02301143|65743239|FG001|Investigator's Choice|Other|1|||
23550268|NCT02301143|65743238|FG000|Investigator's Choice|Unresectable Surgery|0|||
23550269|NCT02301143|65743239|FG001|Investigator's Choice|Unresectable Surgery|1|||
23550270|NCT03581981|65743240|FG000|Overall Study|Withdrawal by Subject|12|||
23550271|NCT03581981|65743241|FG001|Overall Study|Withdrawal by Subject|13|||
23742135|NCT00125138|66436376|FG003|Overall Study|Withdrawal by Subject|1|||
23821538|NCT01885195|66726108|FG000|Overall Study|Patient/guardian decision|8|||
23821539|NCT04015908|66726109|FG000|Overall Study|Lost to Follow-up|0|||
23821540|NCT04015908|66726110|FG001|Overall Study|Lost to Follow-up|1|||
23821541|NCT04102189|66726111|FG000|Overall Study|Withdrawal by Subject|1|||
23821542|NCT04102189|66726112|FG001|Overall Study|Withdrawal by Subject|2|||
23821543|NCT04102189|66726111|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23821544|NCT04102189|66726112|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23821545|NCT04102189|66726111|FG000|Overall Study|Lost to Follow-up|1|||
23821546|NCT04102189|66726112|FG001|Overall Study|Lost to Follow-up|0|||
23821547|NCT01449370|66726113|FG000|Overall Study|Disease Progression|5|||
23821548|NCT01449370|66726114|FG001|Overall Study|Disease Progression|4|||
23821549|NCT01449370|66726115|FG002|Overall Study|Disease Progression|8|||
23821550|NCT01449370|66726116|FG003|Overall Study|Disease Progression|3|||
23821551|NCT01449370|66726117|FG004|Overall Study|Disease Progression|3|||
23821552|NCT01449370|66726118|FG005|Overall Study|Disease Progression|3|||
23821553|NCT01449370|66726119|FG006|Overall Study|Disease Progression|3|||
23821554|NCT01449370|66726120|FG007|Overall Study|Disease Progression|2|||
23821555|NCT01449370|66726121|FG008|Overall Study|Disease Progression|9|||
23821556|NCT01449370|66726122|FG009|Overall Study|Disease Progression|1|||
23821557|NCT01449370|66726123|FG010|Overall Study|Disease Progression|3|||
23821558|NCT01449370|66726124|FG011|Overall Study|Disease Progression|3|||
23821559|NCT01449370|66726125|FG012|Overall Study|Disease Progression|2|||
23821560|NCT01449370|66726126|FG013|Overall Study|Disease Progression|8|||
23821561|NCT01449370|66726127|FG014|Overall Study|Disease Progression|3|||
23821562|NCT01449370|66726128|FG015|Overall Study|Disease Progression|1|||
23821563|NCT01449370|66726129|FG016|Overall Study|Disease Progression|4|||
23821564|NCT01449370|66726130|FG017|Overall Study|Disease Progression|3|||
23742136|NCT00125138|66436373|FG000|Overall Study|Lack of Efficacy|0|||
23742137|NCT00125138|66436374|FG001|Overall Study|Lack of Efficacy|0|||
23742138|NCT00125138|66436375|FG002|Overall Study|Lack of Efficacy|0|||
23742139|NCT00125138|66436376|FG003|Overall Study|Lack of Efficacy|1|||
23742140|NCT00125138|66436373|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
23821565|NCT01449370|66726131|FG018|Overall Study|Disease Progression|1|||
23821566|NCT01449370|66726132|FG019|Overall Study|Disease Progression|2|||
23821567|NCT01449370|66726133|FG020|Overall Study|Disease Progression|5|||
23821568|NCT01449370|66726134|FG021|Overall Study|Disease Progression|2|||
23821569|NCT01449370|66726135|FG022|Overall Study|Disease Progression|3|||
23821570|NCT01449370|66726136|FG023|Overall Study|Disease Progression|7|||
23821571|NCT01449370|66726137|FG024|Overall Study|Disease Progression|3|||
23821572|NCT01449370|66726113|FG000|Overall Study|Adverse Event|1|||
23821573|NCT01449370|66726114|FG001|Overall Study|Adverse Event|2|||
23550272|NCT03581981|65743240|FG000|Overall Study|Physician Decision|1|||
23742141|NCT00125138|66436374|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
23742142|NCT00125138|66436375|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
23742143|NCT00125138|66436376|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
23742144|NCT00496782|66436379|FG000|Overall Study|Protocol Violation|1|||
23742145|NCT00496782|66436380|FG001|Overall Study|Protocol Violation|2|||
23821574|NCT01449370|66726115|FG002|Overall Study|Adverse Event|0|||
23821575|NCT01449370|66726116|FG003|Overall Study|Adverse Event|1|||
23821576|NCT01449370|66726117|FG004|Overall Study|Adverse Event|0|||
23550273|NCT03581981|65743241|FG001|Overall Study|Physician Decision|2|||
23550274|NCT03581981|65743240|FG000|Overall Study|Lost to Follow-up|0|||
23550275|NCT03581981|65743241|FG001|Overall Study|Lost to Follow-up|4|||
23550276|NCT00175825|65743245|FG000|Overall Study|Adverse Event|3|||
23742146|NCT01258803|66436381|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23742147|NCT01258803|66436382|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23742148|NCT01258803|66436383|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23742149|NCT01258803|66436384|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23742150|NCT01258803|66436385|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23742151|NCT01258803|66436386|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23742152|NCT01258803|66436381|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23742153|NCT01258803|66436382|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
23742154|NCT01258803|66436383|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23742155|NCT01258803|66436384|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23742156|NCT01258803|66436385|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23429535|NCT01533922|65317400|FG000|Overall Study|Withdrawal by Subject|3|||
23429536|NCT01533922|65317401|FG001|Overall Study|Withdrawal by Subject|1|||
23429537|NCT01533922|65317402|FG002|Overall Study|Withdrawal by Subject|2|||
23429538|NCT01533922|65317403|FG003|Overall Study|Withdrawal by Subject|2|||
23429539|NCT01533922|65317404|FG004|Overall Study|Withdrawal by Subject|1|||
23550277|NCT00175825|65743246|FG001|Overall Study|Adverse Event|2|||
23550278|NCT00175825|65743247|FG002|Overall Study|Adverse Event|1|||
23550279|NCT00175825|65743248|FG003|Overall Study|Adverse Event|1|||
23550280|NCT00175825|65743245|FG000|Overall Study|Lost to Follow-up|1|||
23550281|NCT00175825|65743246|FG001|Overall Study|Lost to Follow-up|2|||
23550282|NCT00175825|65743247|FG002|Overall Study|Lost to Follow-up|0|||
23550283|NCT00175825|65743248|FG003|Overall Study|Lost to Follow-up|0|||
23550284|NCT00175825|65743245|FG000|Overall Study|Withdrawal by Subject|1|||
23550285|NCT00175825|65743246|FG001|Overall Study|Withdrawal by Subject|0|||
23550286|NCT00175825|65743247|FG002|Overall Study|Withdrawal by Subject|0|||
23550287|NCT00175825|65743248|FG003|Overall Study|Withdrawal by Subject|0|||
23550288|NCT00487162|65743253|FG000|Overall Study|Adverse Event|0|||
23550289|NCT00487162|65743254|FG001|Overall Study|Adverse Event|1|||
23550290|NCT00487162|65743253|FG000|Overall Study|Physician Decision|0|||
23550291|NCT00487162|65743254|FG001|Overall Study|Physician Decision|1|||
23550292|NCT00487162|65743253|FG000|Overall Study|Withdrawal by Subject|2|||
23550293|NCT00487162|65743254|FG001|Overall Study|Withdrawal by Subject|3|||
23550294|NCT01587651|65743255|FG000|Overall Study|Adverse Event|0|||
23550295|NCT01587651|65743256|FG001|Overall Study|Adverse Event|1|||
23550296|NCT01587651|65743257|FG002|Overall Study|Adverse Event|0|||
23550297|NCT01587651|65743255|FG000|Overall Study|Protocol Violation|0|||
23550298|NCT01587651|65743256|FG001|Overall Study|Protocol Violation|1|||
23550299|NCT01587651|65743257|FG002|Overall Study|Protocol Violation|1|||
23550300|NCT01587651|65743255|FG000|Overall Study|Withdrawal by Subject|0|||
23550301|NCT01587651|65743256|FG001|Overall Study|Withdrawal by Subject|1|||
23550302|NCT01587651|65743257|FG002|Overall Study|Withdrawal by Subject|0|||
23550303|NCT03966157|65743258|FG000|Overall Study|Physician Decision|1|||
23550304|NCT03966157|65743259|FG001|Overall Study|Physician Decision|0|||
23550305|NCT02526693|65743260|FG000|Overall Study|Physician Decision|3|||
23550306|NCT02526693|65743261|FG001|Overall Study|Physician Decision|1|||
23550307|NCT01857531|65743267|FG000|Overall Study|Withdrawal by Subject|4|||
23550308|NCT03053050|65743268|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
23550309|NCT03053050|65743269|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
23550310|NCT03053050|65743270|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
23550311|NCT03053050|65743271|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
23550312|NCT03053050|65743268|FG000|Randomized Phase|Withdrew Consent|16|||
23550313|NCT03053050|65743269|FG001|Randomized Phase|Withdrew Consent|8|||
23550314|NCT03053050|65743270|FG002|Randomized Phase|Withdrew Consent|9|||
23550315|NCT03053050|65743271|FG003|Randomized Phase|Withdrew Consent|0|||
23429540|NCT01533922|65317400|FG000|Overall Study|Other reason not defined above|2|||
23429541|NCT01533922|65317401|FG001|Overall Study|Other reason not defined above|0|||
23550316|NCT03053050|65743268|FG000|Randomized Phase|Investigator's Discretion|6|||
23550317|NCT03053050|65743269|FG001|Randomized Phase|Investigator's Discretion|6|||
23550318|NCT03053050|65743270|FG002|Randomized Phase|Investigator's Discretion|3|||
23550319|NCT03053050|65743271|FG003|Randomized Phase|Investigator's Discretion|0|||
23550320|NCT03053050|65743268|FG000|Randomized Phase|Lost to Follow-up|5|||
23550321|NCT03053050|65743269|FG001|Randomized Phase|Lost to Follow-up|1|||
23550322|NCT03053050|65743270|FG002|Randomized Phase|Lost to Follow-up|1|||
23550323|NCT03053050|65743271|FG003|Randomized Phase|Lost to Follow-up|0|||
23550324|NCT03053050|65743268|FG000|Randomized Phase|Adverse Event|0|||
23550325|NCT03053050|65743269|FG001|Randomized Phase|Adverse Event|1|||
23550326|NCT03053050|65743270|FG002|Randomized Phase|Adverse Event|0|||
23550327|NCT03053050|65743271|FG003|Randomized Phase|Adverse Event|0|||
23550328|NCT03053050|65743268|FG000|Randomized Phase|Randomized but Never Treated|2|||
23742157|NCT01258803|66436386|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23742158|NCT01258803|66436381|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23429542|NCT01533922|65317402|FG002|Overall Study|Other reason not defined above|1|||
23429543|NCT01533922|65317403|FG003|Overall Study|Other reason not defined above|0|||
23429544|NCT01533922|65317404|FG004|Overall Study|Other reason not defined above|0|||
23429545|NCT02698371|65317406|FG000|All Participants Flow|Lost to Follow-up|3|||
23550329|NCT03053050|65743269|FG001|Randomized Phase|Randomized but Never Treated|2|||
23550330|NCT03053050|65743270|FG002|Randomized Phase|Randomized but Never Treated|2|||
23550331|NCT03053050|65743271|FG003|Randomized Phase|Randomized but Never Treated|0|||
23550332|NCT03053050|65743268|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
23550333|NCT03053050|65743269|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
23550334|NCT03053050|65743270|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
23550335|NCT03053050|65743271|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
23550336|NCT03053050|65743268|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
23550337|NCT03053050|65743269|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
23550338|NCT03053050|65743270|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
23550339|NCT03053050|65743271|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
23550340|NCT03053050|65743268|FG000|Open-label Phase|Withdrew Consent|0|||
23550341|NCT03053050|65743269|FG001|Open-label Phase|Withdrew Consent|0|||
23550342|NCT03053050|65743270|FG002|Open-label Phase|Withdrew Consent|0|||
23550343|NCT03053050|65743271|FG003|Open-label Phase|Withdrew Consent|6|||
23550344|NCT03053050|65743268|FG000|Open-label Phase|Investigator's Discretion|0|||
23550345|NCT03053050|65743269|FG001|Open-label Phase|Investigator's Discretion|0|||
23620402|NCT00143598|65994977|FG000|Overall Study|Lost to Follow-up|23|||
23742159|NCT01258803|66436382|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23742160|NCT01258803|66436383|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
23742161|NCT01258803|66436384|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23742162|NCT01258803|66436385|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23742163|NCT01258803|66436386|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23742164|NCT00267202|66436387|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
23742165|NCT00267202|66436388|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23742166|NCT00267202|66436387|FG000|Overall Study|Withdrawal by Subject|12|||
23742167|NCT00267202|66436388|FG001|Overall Study|Withdrawal by Subject|15|||
23742168|NCT00267202|66436387|FG000|Overall Study|Adverse Event|13|||
23742169|NCT00267202|66436388|FG001|Overall Study|Adverse Event|7|||
23742170|NCT00267202|66436387|FG000|Overall Study|Protocol Violation|2|||
23742171|NCT00267202|66436388|FG001|Overall Study|Protocol Violation|3|||
23742172|NCT00267202|66436387|FG000|Overall Study|Administrative problems|2|||
23742173|NCT00267202|66436388|FG001|Overall Study|Administrative problems|1|||
23742174|NCT00267202|66436387|FG000|Overall Study|Lost to Follow-up|3|||
23742175|NCT00267202|66436388|FG001|Overall Study|Lost to Follow-up|0|||
23742176|NCT01967134|66436391|FG000|Overall Study|Lost to Follow-up|0|||
23742177|NCT01967134|66436392|FG001|Overall Study|Lost to Follow-up|1|||
23742178|NCT01967134|66436393|FG002|Overall Study|Lost to Follow-up|0|||
23742179|NCT02528331|66436394|FG000|Overall Study|Withdrawal by Subject|2|||
23742180|NCT03672006|66436395|FG000|Overall Study|exclusion criteria met|0|||
23742181|NCT03672006|66436396|FG001|Overall Study|exclusion criteria met|1|||
23742182|NCT02442284|66436398|FG000|Overall Study|Adverse Event|1|||
23742183|NCT02442284|66436398|FG000|Overall Study|Withdrew Consent|2|||
23742184|NCT02442284|66436398|FG000|Overall Study|Lost to Follow-up|3|||
23742185|NCT02442284|66436398|FG000|Overall Study|Other|1|||
23742186|NCT03287960|66436399|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
23742187|NCT03287960|66436399|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
23742188|NCT02431559|66436402|FG000|Overall Study|Adverse Event|0|||
23742189|NCT02431559|66436403|FG001|Overall Study|Adverse Event|1|||
23742190|NCT02431559|66436404|FG002|Overall Study|Adverse Event|0|||
23742191|NCT02431559|66436405|FG003|Overall Study|Adverse Event|4|||
23742192|NCT02431559|66436402|FG000|Overall Study|Progressive disease|2|||
23742193|NCT02431559|66436403|FG001|Overall Study|Progressive disease|1|||
23742194|NCT02431559|66436404|FG002|Overall Study|Progressive disease|4|||
23742195|NCT02431559|66436405|FG003|Overall Study|Progressive disease|22|||
23742196|NCT02431559|66436402|FG000|Overall Study|Withdrawal by Subject|0|||
23821577|NCT01449370|66726118|FG005|Overall Study|Adverse Event|0|||
23821578|NCT01449370|66726119|FG006|Overall Study|Adverse Event|0|||
23821579|NCT01449370|66726120|FG007|Overall Study|Adverse Event|0|||
23821580|NCT01449370|66726121|FG008|Overall Study|Adverse Event|1|||
23821581|NCT01449370|66726122|FG009|Overall Study|Adverse Event|1|||
23821582|NCT01449370|66726123|FG010|Overall Study|Adverse Event|0|||
23429546|NCT02698371|65317406|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
23742197|NCT02431559|66436403|FG001|Overall Study|Withdrawal by Subject|1|||
23742198|NCT02431559|66436404|FG002|Overall Study|Withdrawal by Subject|0|||
23429547|NCT02698371|65317406|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
23550346|NCT03053050|65743270|FG002|Open-label Phase|Investigator's Discretion|0|||
23742199|NCT02431559|66436405|FG003|Overall Study|Withdrawal by Subject|4|||
23742200|NCT02431559|66436402|FG000|Overall Study|Physician Decision|0|||
23742201|NCT02431559|66436403|FG001|Overall Study|Physician Decision|0|||
23821583|NCT01449370|66726124|FG011|Overall Study|Adverse Event|0|||
23821584|NCT01449370|66726125|FG012|Overall Study|Adverse Event|0|||
23742202|NCT02431559|66436404|FG002|Overall Study|Physician Decision|0|||
23742203|NCT02431559|66436405|FG003|Overall Study|Physician Decision|1|||
23742204|NCT00561795|66436406|FG000|Overall Study|Adverse Event|3|||
23742205|NCT00561795|66436407|FG001|Overall Study|Adverse Event|3|||
23742206|NCT00561795|66436408|FG002|Overall Study|Adverse Event|0|||
23742207|NCT00561795|66436409|FG003|Overall Study|Adverse Event|0|||
23742208|NCT00561795|66436406|FG000|Overall Study|Study Closed/Terminated|0|||
23742209|NCT00561795|66436407|FG001|Overall Study|Study Closed/Terminated|3|||
23742210|NCT00561795|66436408|FG002|Overall Study|Study Closed/Terminated|0|||
23742211|NCT00561795|66436409|FG003|Overall Study|Study Closed/Terminated|0|||
23742212|NCT00561795|66436406|FG000|Overall Study|Physician Decision|1|||
23742213|NCT00561795|66436407|FG001|Overall Study|Physician Decision|0|||
23821585|NCT01449370|66726126|FG013|Overall Study|Adverse Event|2|||
23550347|NCT03053050|65743271|FG003|Open-label Phase|Investigator's Discretion|4|||
23620403|NCT00143598|65994978|FG001|Overall Study|Lost to Follow-up|21|||
23550348|NCT02081846|65743273|FG000|Overall Study|Withdrawal by Subject|1|||
23550349|NCT02081846|65743274|FG001|Overall Study|Withdrawal by Subject|0|||
23550350|NCT02081846|65743273|FG000|Overall Study|invalid consent|1|||
23550351|NCT02081846|65743274|FG001|Overall Study|invalid consent|0|||
23550352|NCT01454583|65743275|FG000|1st Year|Lost to Follow-up|1057|||
23550353|NCT01454583|65743276|FG001|1st Year|Lost to Follow-up|318|||
23550354|NCT01454583|65743277|FG002|1st Year|Lost to Follow-up|180|||
23550355|NCT01454583|65743275|FG000|2nd Year|Lost to Follow-up|3965|||
23550356|NCT01454583|65743276|FG001|2nd Year|Lost to Follow-up|1049|||
23550357|NCT01454583|65743277|FG002|2nd Year|Lost to Follow-up|737|||
23550358|NCT01454583|65743275|FG000|3rd Year|Lost to Follow-up|1959|||
23550359|NCT01454583|65743276|FG001|3rd Year|Lost to Follow-up|512|||
23550360|NCT01454583|65743277|FG002|3rd Year|Lost to Follow-up|297|||
23550361|NCT03585244|65743279|FG000|Overall Study|Withdrawal by Subject|15|||
23550362|NCT03422250|65743280|FG000|Intervention|Adverse Event|0|||
23550363|NCT03422250|65743281|FG001|Intervention|Adverse Event|1|||
23550364|NCT03422250|65743282|FG002|Intervention|Adverse Event|0|||
23550365|NCT03422250|65743283|FG003|Intervention|Adverse Event|1|||
23550366|NCT03422250|65743280|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
23550367|NCT03422250|65743281|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
23550368|NCT03422250|65743282|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
23550369|NCT03422250|65743283|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
23550370|NCT03422250|65743280|FG000|Follow-up|Withdrawal by Subject|0|||
23550371|NCT03422250|65743281|FG001|Follow-up|Withdrawal by Subject|0|||
23550372|NCT03422250|65743282|FG002|Follow-up|Withdrawal by Subject|0|||
23550373|NCT03422250|65743283|FG003|Follow-up|Withdrawal by Subject|1|||
23550374|NCT03422250|65743280|FG000|Follow-up|Adverse Event|0|||
23550375|NCT03422250|65743281|FG001|Follow-up|Adverse Event|0|||
23620404|NCT00143598|65994977|FG000|Overall Study|Withdrawal by Subject|33|||
23620405|NCT00143598|65994978|FG001|Overall Study|Withdrawal by Subject|37|||
23620406|NCT00143598|65994977|FG000|Overall Study|Death|36|||
23620407|NCT00143598|65994978|FG001|Overall Study|Death|36|||
23620408|NCT02512861|65994979|FG000|Overall Study|Protocol Violation|3|||
23620409|NCT02512861|65994980|FG001|Overall Study|Protocol Violation|7|||
23620410|NCT02512861|65994979|FG000|Overall Study|Physician Decision|3|||
23620411|NCT02512861|65994980|FG001|Overall Study|Physician Decision|1|||
23620412|NCT02512861|65994979|FG000|Overall Study|Withdrawal by Subject|0|||
23620413|NCT02512861|65994980|FG001|Overall Study|Withdrawal by Subject|1|||
23620414|NCT00115336|65994981|FG000|Overall Study|Hospital discharge before study drug|0|||
23620415|NCT00115336|65994982|FG001|Overall Study|Hospital discharge before study drug|1|||
23620416|NCT00582114|65994983|FG000|Overall Study|Death|4|||
23620417|NCT00582114|65994984|FG001|Overall Study|Death|4|||
23620418|NCT00582114|65994983|FG000|Overall Study|Kidney Transplant|3|||
23620419|NCT00582114|65994984|FG001|Overall Study|Kidney Transplant|1|||
23620420|NCT00582114|65994983|FG000|Overall Study|Lost to Follow-up|7|||
23620421|NCT00582114|65994984|FG001|Overall Study|Lost to Follow-up|6|||
23620422|NCT00582114|65994983|FG000|Overall Study|Withdrawal by Subject|8|||
23620423|NCT00582114|65994984|FG001|Overall Study|Withdrawal by Subject|16|||
23620424|NCT00582114|65994983|FG000|Overall Study|Adverse Event|1|||
23620425|NCT00582114|65994984|FG001|Overall Study|Adverse Event|1|||
23620426|NCT00582114|65994983|FG000|Overall Study|Physician Decision|0|||
23620427|NCT00582114|65994984|FG001|Overall Study|Physician Decision|6|||
23620428|NCT00582114|65994983|FG000|Overall Study|Stopped by data safety monitoring board|19|||
23550376|NCT03422250|65743282|FG002|Follow-up|Adverse Event|0|||
23550377|NCT03422250|65743283|FG003|Follow-up|Adverse Event|1|||
23550378|NCT01597050|65743284|FG000|Overall Study|Withdrawal by Subject|1|||
23550379|NCT01597050|65743285|FG001|Overall Study|Withdrawal by Subject|0|||
23550380|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
23550381|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
23550382|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
23550383|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
23742214|NCT00561795|66436408|FG002|Overall Study|Physician Decision|0|||
23742215|NCT00561795|66436409|FG003|Overall Study|Physician Decision|0|||
23550384|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
23550385|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
23550386|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
23550387|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
23550388|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23550389|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
23550390|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
23550391|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
23550392|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
23550393|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
23550394|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
23550395|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
23550396|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
23550397|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
23550398|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
23550399|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
23550400|NCT03320070|65743288|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
23550401|NCT03320070|65743289|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
23550402|NCT03320070|65743288|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
23550403|NCT03320070|65743289|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
23550404|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
23550405|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
23550406|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
23550407|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
23550408|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
23550409|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
23550410|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
23550411|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
23550412|NCT02564523|65743290|FG000|Overall Study|Withdrawal by Subject|3|||
23550413|NCT02564523|65743291|FG001|Overall Study|Withdrawal by Subject|0|||
23550414|NCT02564523|65743292|FG002|Overall Study|Withdrawal by Subject|1|||
23550415|NCT02564523|65743293|FG003|Overall Study|Withdrawal by Subject|0|||
23550416|NCT02564523|65743294|FG004|Overall Study|Withdrawal by Subject|1|||
23550417|NCT02564523|65743295|FG005|Overall Study|Withdrawal by Subject|0|||
23550418|NCT02564523|65743296|FG006|Overall Study|Withdrawal by Subject|1|||
23550419|NCT02564523|65743297|FG007|Overall Study|Withdrawal by Subject|0|||
23550420|NCT02564523|65743298|FG008|Overall Study|Withdrawal by Subject|0|||
23550421|NCT02564523|65743299|FG009|Overall Study|Withdrawal by Subject|0|||
23550422|NCT02564523|65743300|FG010|Overall Study|Withdrawal by Subject|1|||
23550423|NCT02564523|65743301|FG011|Overall Study|Withdrawal by Subject|0|||
23550424|NCT02564523|65743302|FG012|Overall Study|Withdrawal by Subject|1|||
23550425|NCT02564523|65743303|FG013|Overall Study|Withdrawal by Subject|0|||
23550426|NCT02564523|65743304|FG014|Overall Study|Withdrawal by Subject|0|||
23550427|NCT02564523|65743305|FG015|Overall Study|Withdrawal by Subject|0|||
23550428|NCT02564523|65743306|FG016|Overall Study|Withdrawal by Subject|0|||
23550429|NCT02564523|65743307|FG017|Overall Study|Withdrawal by Subject|0|||
23550430|NCT02564523|65743290|FG000|Overall Study|Adverse Event|0|||
23550431|NCT02564523|65743291|FG001|Overall Study|Adverse Event|0|||
23550432|NCT02564523|65743292|FG002|Overall Study|Adverse Event|0|||
23550433|NCT02564523|65743293|FG003|Overall Study|Adverse Event|0|||
23550434|NCT02564523|65743294|FG004|Overall Study|Adverse Event|0|||
23550435|NCT02564523|65743295|FG005|Overall Study|Adverse Event|0|||
23550436|NCT02564523|65743296|FG006|Overall Study|Adverse Event|0|||
23550437|NCT02564523|65743297|FG007|Overall Study|Adverse Event|0|||
23550438|NCT02564523|65743298|FG008|Overall Study|Adverse Event|0|||
23550439|NCT02564523|65743299|FG009|Overall Study|Adverse Event|0|||
23550440|NCT02564523|65743300|FG010|Overall Study|Adverse Event|0|||
23550441|NCT02564523|65743301|FG011|Overall Study|Adverse Event|0|||
23550442|NCT02564523|65743302|FG012|Overall Study|Adverse Event|0|||
23550443|NCT02564523|65743303|FG013|Overall Study|Adverse Event|0|||
23550444|NCT02564523|65743304|FG014|Overall Study|Adverse Event|0|||
23550445|NCT02564523|65743305|FG015|Overall Study|Adverse Event|0|||
23550446|NCT02564523|65743306|FG016|Overall Study|Adverse Event|0|||
23550447|NCT02564523|65743307|FG017|Overall Study|Adverse Event|1|||
23550448|NCT02564523|65743290|FG000|Overall Study|Death|0|||
23550449|NCT02564523|65743291|FG001|Overall Study|Death|0|||
23550450|NCT02564523|65743292|FG002|Overall Study|Death|0|||
23550451|NCT02564523|65743293|FG003|Overall Study|Death|0|||
23550452|NCT02564523|65743294|FG004|Overall Study|Death|0|||
23550453|NCT02564523|65743295|FG005|Overall Study|Death|0|||
23550454|NCT02564523|65743296|FG006|Overall Study|Death|1|||
23550455|NCT02564523|65743297|FG007|Overall Study|Death|0|||
23550456|NCT02564523|65743298|FG008|Overall Study|Death|0|||
23550457|NCT02564523|65743299|FG009|Overall Study|Death|0|||
23550458|NCT02564523|65743300|FG010|Overall Study|Death|1|||
23742216|NCT02756182|66436410|FG000|Overall Study|StudyTechnical Difficulties|4|||
23742217|NCT01756846|66436411|FG000|Overall Study|Lost to Follow-up|5|||
23742218|NCT01756846|66436412|FG001|Overall Study|Lost to Follow-up|10|||
23821586|NCT01449370|66726127|FG014|Overall Study|Adverse Event|0|||
23821587|NCT01449370|66726128|FG015|Overall Study|Adverse Event|1|||
23821588|NCT01449370|66726129|FG016|Overall Study|Adverse Event|0|||
23821589|NCT01449370|66726130|FG017|Overall Study|Adverse Event|0|||
23821590|NCT01449370|66726131|FG018|Overall Study|Adverse Event|1|||
23821591|NCT01449370|66726132|FG019|Overall Study|Adverse Event|1|||
23821592|NCT01449370|66726133|FG020|Overall Study|Adverse Event|0|||
23742219|NCT01756846|66436411|FG000|Overall Study|Withdrawal by Subject|1|||
23742220|NCT01756846|66436412|FG001|Overall Study|Withdrawal by Subject|2|||
23742221|NCT00374452|66436413|FG000|Overall Study|Left clinic before intervention started|4|||
23742222|NCT00374452|66436414|FG001|Overall Study|Left clinic before intervention started|1|||
23742223|NCT00374452|66436413|FG000|Overall Study|Change in job role before intervention|0|||
23742224|NCT00374452|66436414|FG001|Overall Study|Change in job role before intervention|1|||
23742225|NCT00374452|66436413|FG000|Overall Study|Left clinic after intervention started|1|||
23742226|NCT00374452|66436414|FG001|Overall Study|Left clinic after intervention started|1|||
23742227|NCT00374452|66436413|FG000|Overall Study|Withdrawal by Subject|0|||
23742228|NCT00374452|66436414|FG001|Overall Study|Withdrawal by Subject|2|||
23742229|NCT02643420|66436423|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
23742230|NCT02643420|66436424|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
23742231|NCT02643420|66436423|FG000|Overall Study|Withdrawal by Subject|25|||
23742232|NCT02643420|66436424|FG001|Overall Study|Withdrawal by Subject|19|||
23742233|NCT02643420|66436423|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
23742234|NCT02643420|66436424|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
23742235|NCT02643420|66436423|FG000|Overall Study|Lost to Follow-up|6|||
23742236|NCT02643420|66436424|FG001|Overall Study|Lost to Follow-up|10|||
23742237|NCT02643420|66436423|FG000|Overall Study|Investigator Decision|2|||
23742238|NCT02643420|66436424|FG001|Overall Study|Investigator Decision|4|||
23742239|NCT02643420|66436423|FG000|Overall Study|Sponsor decision|1|||
23742240|NCT02643420|66436424|FG001|Overall Study|Sponsor decision|1|||
23742241|NCT02643420|66436423|FG000|Overall Study|Death|0|||
23742242|NCT02643420|66436424|FG001|Overall Study|Death|2|||
23742243|NCT02643420|66436423|FG000|Overall Study|Reason not Specified|8|||
23742244|NCT02643420|66436424|FG001|Overall Study|Reason not Specified|7|||
23742245|NCT03831282|66436425|FG000|Overall Study|Could not place sensor|1|||
23742246|NCT00960869|66436426|FG000|Overall Study|Adverse Event|17|||
23742247|NCT00960869|66436427|FG001|Overall Study|Adverse Event|26|||
23742248|NCT00960869|66436426|FG000|Overall Study|Withdrawal by Subject|16|||
23742249|NCT00960869|66436427|FG001|Overall Study|Withdrawal by Subject|14|||
23742250|NCT00960869|66436426|FG000|Overall Study|Lost to Follow-up|1|||
23742251|NCT00960869|66436427|FG001|Overall Study|Lost to Follow-up|4|||
23429548|NCT02698371|65317406|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
23429549|NCT02698371|65317406|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
23429550|NCT02698371|65317406|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
23742252|NCT00960869|66436426|FG000|Overall Study|Misc|19|||
23821593|NCT01449370|66726134|FG021|Overall Study|Adverse Event|1|||
23821594|NCT01449370|66726135|FG022|Overall Study|Adverse Event|0|||
23821595|NCT01449370|66726136|FG023|Overall Study|Adverse Event|1|||
23821596|NCT01449370|66726137|FG024|Overall Study|Adverse Event|3|||
23821597|NCT01449370|66726113|FG000|Overall Study|Participant Decision|0|||
23821598|NCT01449370|66726114|FG001|Overall Study|Participant Decision|0|||
23821599|NCT01449370|66726115|FG002|Overall Study|Participant Decision|0|||
23821600|NCT01449370|66726116|FG003|Overall Study|Participant Decision|0|||
23821601|NCT01449370|66726117|FG004|Overall Study|Participant Decision|0|||
23821602|NCT01449370|66726118|FG005|Overall Study|Participant Decision|0|||
23821603|NCT01449370|66726119|FG006|Overall Study|Participant Decision|0|||
23821604|NCT01449370|66726120|FG007|Overall Study|Participant Decision|1|||
23821605|NCT01449370|66726121|FG008|Overall Study|Participant Decision|1|||
23429551|NCT02698371|65317406|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
23429552|NCT00582738|65317407|FG000|Overall Study|Administrative Problems|7|||
23429553|NCT00582738|65317408|FG001|Overall Study|Administrative Problems|8|||
23429554|NCT00582738|65317407|FG000|Overall Study|Adverse Event|0|||
23429555|NCT00582738|65317408|FG001|Overall Study|Adverse Event|5|||
23429556|NCT00582738|65317407|FG000|Overall Study|Graft Lost|0|||
23550459|NCT02564523|65743301|FG011|Overall Study|Death|0|||
23550460|NCT02564523|65743302|FG012|Overall Study|Death|0|||
23742253|NCT00960869|66436427|FG001|Overall Study|Misc|18|||
23742254|NCT01189201|66436429|FG000|Overall Study|Adverse Event|1|||
23742255|NCT04308668|66436434|FG000|Overall Study|Lost to Follow-up|32|||
23742256|NCT04308668|66436435|FG001|Overall Study|Lost to Follow-up|38|||
23742257|NCT04308668|66436434|FG000|Overall Study|Withdrawal by Subject|4|||
23742258|NCT04308668|66436435|FG001|Overall Study|Withdrawal by Subject|4|||
23821606|NCT01449370|66726122|FG009|Overall Study|Participant Decision|0|||
23821607|NCT01449370|66726123|FG010|Overall Study|Participant Decision|0|||
23429557|NCT00582738|65317408|FG001|Overall Study|Graft Lost|1|||
23429558|NCT00582738|65317407|FG000|Overall Study|Other|1|||
23429559|NCT00582738|65317408|FG001|Overall Study|Other|0|||
23429560|NCT00582738|65317407|FG000|Overall Study|Protocol Violation|1|||
23429561|NCT00582738|65317408|FG001|Overall Study|Protocol Violation|1|||
23429562|NCT00582738|65317407|FG000|Overall Study|Withdrawal by Subject|0|||
23429563|NCT00582738|65317408|FG001|Overall Study|Withdrawal by Subject|3|||
23429564|NCT00350623|65317409|FG000|Overall Study|Lost to Follow-up|8|||
23429565|NCT00350623|65317410|FG001|Overall Study|Lost to Follow-up|3|||
23429566|NCT00350623|65317411|FG002|Overall Study|Lost to Follow-up|4|||
23429567|NCT00350623|65317409|FG000|Overall Study|Withdrawal by Subject|0|||
23429568|NCT00350623|65317410|FG001|Overall Study|Withdrawal by Subject|1|||
23429569|NCT00350623|65317411|FG002|Overall Study|Withdrawal by Subject|1|||
23429570|NCT00350623|65317409|FG000|Overall Study|patient traveling outside the country|0|||
23429571|NCT00350623|65317410|FG001|Overall Study|patient traveling outside the country|0|||
23429572|NCT00350623|65317411|FG002|Overall Study|patient traveling outside the country|1|||
23429573|NCT00762996|65317412|FG000|Period One|Protocol Violation|0|||
23429574|NCT00762996|65317413|FG001|Period One|Protocol Violation|0|||
23429575|NCT00762996|65317414|FG002|Period One|Protocol Violation|1|||
23429576|NCT00762996|65317415|FG003|Period One|Protocol Violation|0|||
23429577|NCT00762996|65317412|FG000|Period One|ineligible|0|||
23429578|NCT00762996|65317413|FG001|Period One|ineligible|0|||
23429579|NCT00762996|65317414|FG002|Period One|ineligible|1|||
23429580|NCT00762996|65317415|FG003|Period One|ineligible|1|||
23429581|NCT00762996|65317412|FG000|Period One|Adverse Event|0|||
23429582|NCT00762996|65317413|FG001|Period One|Adverse Event|0|||
23429583|NCT00762996|65317414|FG002|Period One|Adverse Event|1|||
23429584|NCT00762996|65317415|FG003|Period One|Adverse Event|0|||
23429585|NCT00762996|65317412|FG000|Period One|Withdrawal by Subject|0|||
23429586|NCT00762996|65317413|FG001|Period One|Withdrawal by Subject|0|||
23429587|NCT00762996|65317414|FG002|Period One|Withdrawal by Subject|1|||
23429588|NCT00762996|65317415|FG003|Period One|Withdrawal by Subject|0|||
23429589|NCT03689712|65317416|FG000|Overall Study|Adverse Event|1|||
23429590|NCT03689712|65317417|FG001|Overall Study|Adverse Event|0|||
23429591|NCT03689712|65317416|FG000|Overall Study|Death|20|||
23429592|NCT03689712|65317417|FG001|Overall Study|Death|10|||
23429593|NCT03689712|65317416|FG000|Overall Study|Lost to Follow-up|6|||
23429594|NCT03689712|65317417|FG001|Overall Study|Lost to Follow-up|6|||
23429595|NCT03689712|65317416|FG000|Overall Study|Other|1|||
23429596|NCT03689712|65317417|FG001|Overall Study|Other|0|||
23429597|NCT03689712|65317416|FG000|Overall Study|Patient Non-Compliance|0|||
23429598|NCT03689712|65317417|FG001|Overall Study|Patient Non-Compliance|1|||
23429599|NCT03689712|65317416|FG000|Overall Study|Withdrawal by Subject|20|||
23429600|NCT03689712|65317417|FG001|Overall Study|Withdrawal by Subject|4|||
23429601|NCT03689712|65317416|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
23429602|NCT03689712|65317417|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
23429603|NCT03689712|65317416|FG000|Overall Study|Randomized but not Treated|13|||
23429604|NCT03689712|65317417|FG001|Overall Study|Randomized but not Treated|7|||
23429605|NCT03689712|65317416|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
23429606|NCT03689712|65317417|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
23429607|NCT05943990|65317418|FG000|Overall Study|Study Terminated by Sponsor|0|||
23429608|NCT05943990|65317419|FG001|Overall Study|Study Terminated by Sponsor|0|||
23429609|NCT05943990|65317420|FG002|Overall Study|Study Terminated by Sponsor|1|||
23429610|NCT01995552|65317422|FG000|Overall Study|Protocol Violation|1|||
23429611|NCT01995552|65317422|FG000|Overall Study|Lack of Efficacy|15|||
23429612|NCT01995552|65317422|FG000|Overall Study|Death|1|||
23429613|NCT03262116|65317423|FG000|Overall Study|Physician Decision|0|||
23429614|NCT03262116|65317424|FG001|Overall Study|Physician Decision|2|||
23429615|NCT03262116|65317425|FG002|Overall Study|Physician Decision|1|||
23429616|NCT03262116|65317426|FG003|Overall Study|Physician Decision|1|||
23429617|NCT03262116|65317427|FG004|Overall Study|Physician Decision|1|||
23742259|NCT02600559|66436436|FG000|Overall Study|Withdrawal by Subject|3|||
23742260|NCT02600559|66436436|FG000|Overall Study|Lost to Follow-up|20|||
23429618|NCT03262116|65317428|FG005|Overall Study|Physician Decision|2|||
23429619|NCT03266172|65317429|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
23429620|NCT03266172|65317430|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
23429621|NCT03266172|65317431|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
23429622|NCT03266172|65317429|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
23429623|NCT03266172|65317430|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
23429624|NCT03266172|65317431|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
23742261|NCT02370173|66436437|FG000|Overall Study|Protocol Violation|1|||
23742262|NCT02370173|66436438|FG001|Overall Study|Protocol Violation|1|||
23429625|NCT03266172|65317429|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
23429626|NCT03266172|65317430|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
23429627|NCT03266172|65317431|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
23429628|NCT03266172|65317429|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
23742263|NCT02370173|66436437|FG000|Overall Study|Withdrawal by Subject|2|||
23742264|NCT02370173|66436438|FG001|Overall Study|Withdrawal by Subject|2|||
23742265|NCT02147132|66436439|FG000|Overall Study|Lost to Follow-up|1|||
23742266|NCT02147132|66436440|FG001|Overall Study|Lost to Follow-up|0|||
23742267|NCT02147132|66436441|FG002|Overall Study|Lost to Follow-up|0|||
23742268|NCT02147132|66436442|FG003|Overall Study|Lost to Follow-up|0|||
23742269|NCT00706901|66436448|FG000|Overall Study|Lost to Follow-up|2|||
23742270|NCT00706901|66436449|FG001|Overall Study|Lost to Follow-up|3|||
23742271|NCT00706901|66436450|FG002|Overall Study|Lost to Follow-up|2|||
23742272|NCT00706901|66436448|FG000|Overall Study|Withdrawal by Subject|4|||
23742273|NCT00706901|66436449|FG001|Overall Study|Withdrawal by Subject|2|||
23742274|NCT00706901|66436450|FG002|Overall Study|Withdrawal by Subject|5|||
23742275|NCT00706901|66436448|FG000|Overall Study|In Jail|1|||
23742276|NCT00706901|66436449|FG001|Overall Study|In Jail|0|||
23742277|NCT00706901|66436450|FG002|Overall Study|In Jail|1|||
23742278|NCT00706901|66436448|FG000|Overall Study|Death|1|||
23742279|NCT00706901|66436449|FG001|Overall Study|Death|0|||
23742280|NCT00706901|66436450|FG002|Overall Study|Death|0|||
23742281|NCT00976989|66436451|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23742282|NCT00976989|66436452|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23742283|NCT00976989|66436453|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
23742284|NCT00976989|66436451|FG000|Overall Study|Death|5|||
23742285|NCT00976989|66436452|FG001|Overall Study|Death|7|||
23742286|NCT00976989|66436453|FG002|Overall Study|Death|10|||
23742287|NCT00976989|66436451|FG000|Overall Study|Refused Treatment|4|||
23742288|NCT00976989|66436452|FG001|Overall Study|Refused Treatment|3|||
23742289|NCT00976989|66436453|FG002|Overall Study|Refused Treatment|5|||
23742290|NCT00976989|66436451|FG000|Overall Study|Failure to Return|2|||
23742291|NCT00976989|66436452|FG001|Overall Study|Failure to Return|1|||
23742292|NCT00976989|66436453|FG002|Overall Study|Failure to Return|0|||
23742293|NCT00976989|66436451|FG000|Overall Study|Recurrence of Disease|0|||
23742294|NCT00976989|66436452|FG001|Overall Study|Recurrence of Disease|1|||
23742295|NCT00976989|66436453|FG002|Overall Study|Recurrence of Disease|0|||
23742296|NCT00976989|66436451|FG000|Overall Study|Other|1|||
23742297|NCT00976989|66436452|FG001|Overall Study|Other|0|||
23742298|NCT00976989|66436453|FG002|Overall Study|Other|1|||
23742299|NCT00752895|66436454|FG000|Overall Study|Withdrawal by Subject|8|||
23742300|NCT00752895|66436455|FG001|Overall Study|Withdrawal by Subject|3|||
23742301|NCT02713490|66436458|FG000|Overall Study|Withdrawal by Subject|2|||
23742302|NCT02713490|66436459|FG001|Overall Study|Withdrawal by Subject|1|||
23742303|NCT02713490|66436458|FG000|Overall Study|Did not receive study drug|1|||
23742304|NCT02713490|66436459|FG001|Overall Study|Did not receive study drug|0|||
23742305|NCT02713490|66436458|FG000|Overall Study|Met exclusion criteria|0|||
23742306|NCT02713490|66436459|FG001|Overall Study|Met exclusion criteria|1|||
23742307|NCT01319422|66436463|FG000|Overall Study|Withdrawal by Subject|1|||
23742308|NCT01319422|66436464|FG001|Overall Study|Withdrawal by Subject|0|||
23742309|NCT03077646|66436465|FG000|Overall Study|Lost to Follow-up|29|||
23742310|NCT03077646|66436466|FG001|Overall Study|Lost to Follow-up|30|||
23742311|NCT03077646|66436467|FG002|Overall Study|Lost to Follow-up|31|||
23742312|NCT02028182|66436469|FG000|Overall Study|Protocol Violation|2|||
23742313|NCT00598442|66436471|FG000|Overall Study|Adverse Event|3|||
23742314|NCT00598442|66436472|FG001|Overall Study|Adverse Event|0|||
23742315|NCT00598442|66436473|FG002|Overall Study|Adverse Event|0|||
23742316|NCT00598442|66436471|FG000|Overall Study|Death|19|||
23742317|NCT00598442|66436472|FG001|Overall Study|Death|11|||
23742318|NCT00598442|66436473|FG002|Overall Study|Death|11|||
23742319|NCT00598442|66436471|FG000|Overall Study|Lost to Follow-up|4|||
23742320|NCT00598442|66436472|FG001|Overall Study|Lost to Follow-up|3|||
23742321|NCT00598442|66436473|FG002|Overall Study|Lost to Follow-up|3|||
23742322|NCT00598442|66436471|FG000|Overall Study|Physician Decision|2|||
23742323|NCT00598442|66436472|FG001|Overall Study|Physician Decision|1|||
23742324|NCT00598442|66436473|FG002|Overall Study|Physician Decision|1|||
23742325|NCT00598442|66436471|FG000|Overall Study|Withdrawal by Subject|8|||
23742326|NCT00598442|66436472|FG001|Overall Study|Withdrawal by Subject|16|||
23742327|NCT00598442|66436473|FG002|Overall Study|Withdrawal by Subject|6|||
23742328|NCT00598442|66436471|FG000|Overall Study|Noncompliance|0|||
23742329|NCT00598442|66436472|FG001|Overall Study|Noncompliance|2|||
23742330|NCT00598442|66436473|FG002|Overall Study|Noncompliance|1|||
23742331|NCT00598442|66436471|FG000|Overall Study|Relocation|1|||
23742332|NCT00598442|66436472|FG001|Overall Study|Relocation|4|||
23742333|NCT00598442|66436473|FG002|Overall Study|Relocation|0|||
23742334|NCT00598442|66436471|FG000|Overall Study|Renal transplant|0|||
23742335|NCT00598442|66436472|FG001|Overall Study|Renal transplant|0|||
23742336|NCT00598442|66436473|FG002|Overall Study|Renal transplant|1|||
23742337|NCT00598442|66436471|FG000|Overall Study|Site closed by sponsor|5|||
23742338|NCT00598442|66436472|FG001|Overall Study|Site closed by sponsor|2|||
23742339|NCT00598442|66436473|FG002|Overall Study|Site closed by sponsor|1|||
23742340|NCT00598442|66436471|FG000|Overall Study|Started dialysis|1|||
23742341|NCT00598442|66436472|FG001|Overall Study|Started dialysis|0|||
23742342|NCT00598442|66436473|FG002|Overall Study|Started dialysis|0|||
23742343|NCT01200758|66436481|FG000|Stage I|Death|0|||
23742344|NCT01200758|66436482|FG001|Stage I|Death|1|||
23742345|NCT01200758|66436483|FG002|Stage I|Death|0|||
23742346|NCT01200758|66436484|FG003|Stage I|Death|0|||
23742347|NCT01200758|66436481|FG000|Stage I|Physician Decision|1|||
23742348|NCT01200758|66436482|FG001|Stage I|Physician Decision|1|||
23742349|NCT01200758|66436483|FG002|Stage I|Physician Decision|0|||
23742350|NCT01200758|66436484|FG003|Stage I|Physician Decision|0|||
23742351|NCT01200758|66436481|FG000|Stage I|Lack of Efficacy|2|||
23742352|NCT01200758|66436482|FG001|Stage I|Lack of Efficacy|1|||
23742353|NCT01200758|66436483|FG002|Stage I|Lack of Efficacy|0|||
23429629|NCT03266172|65317430|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
23429630|NCT03266172|65317431|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
23429631|NCT03266172|65317429|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429632|NCT03266172|65317430|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429633|NCT03266172|65317431|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
23429634|NCT03266172|65317429|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429635|NCT03266172|65317430|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429636|NCT03266172|65317431|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
23429637|NCT02525094|65317432|FG000|Overall Study|Lost to Follow-up|2|||
23429638|NCT02525094|65317433|FG001|Overall Study|Lost to Follow-up|1|||
23429639|NCT02525094|65317432|FG000|Overall Study|Withdrawal by Subject|5|||
23429640|NCT02525094|65317433|FG001|Overall Study|Withdrawal by Subject|6|||
23429641|NCT02525094|65317432|FG000|Overall Study|Not Treated|1|||
23429642|NCT02525094|65317433|FG001|Overall Study|Not Treated|1|||
23429643|NCT01617447|65317435|FG000|Overall Study|Adverse Event|0|||
23429644|NCT01617447|65317436|FG001|Overall Study|Adverse Event|1|||
23429645|NCT01617447|65317435|FG000|Overall Study|Physician Decision|0|||
23429646|NCT01617447|65317436|FG001|Overall Study|Physician Decision|2|||
23429647|NCT00689793|65317438|FG000|Overall Study|Lost to Follow-up|4|||
23429648|NCT00689793|65317439|FG001|Overall Study|Lost to Follow-up|5|||
23429649|NCT01038713|65317440|FG000|Overall Study|Patient to hospice|1|||
23429650|NCT01038713|65317441|FG001|Overall Study|Patient to hospice|1|||
23429651|NCT01038713|65317442|FG002|Overall Study|Patient to hospice|1|||
23429652|NCT01038713|65317440|FG000|Overall Study|Lost to Follow-up|3|||
23429653|NCT01038713|65317441|FG001|Overall Study|Lost to Follow-up|0|||
23429654|NCT01038713|65317442|FG002|Overall Study|Lost to Follow-up|0|||
23429655|NCT01038713|65317440|FG000|Overall Study|Neuroendocrine Tumor|0|||
23429656|NCT01038713|65317441|FG001|Overall Study|Neuroendocrine Tumor|1|||
23429657|NCT01038713|65317442|FG002|Overall Study|Neuroendocrine Tumor|0|||
23429658|NCT01038713|65317440|FG000|Overall Study|died from PEP|0|||
23429659|NCT01038713|65317441|FG001|Overall Study|died from PEP|1|||
23429660|NCT01038713|65317442|FG002|Overall Study|died from PEP|0|||
23429661|NCT01038713|65317440|FG000|Overall Study|Autoimmune Pancreatitis|1|||
23429662|NCT01038713|65317441|FG001|Overall Study|Autoimmune Pancreatitis|0|||
23429663|NCT01038713|65317442|FG002|Overall Study|Autoimmune Pancreatitis|0|||
23429664|NCT00413010|65317443|FG000|Overall Study|Adverse Event|8|||
23429665|NCT00413010|65317444|FG001|Overall Study|Adverse Event|4|||
23429666|NCT00413010|65317443|FG000|Overall Study|Laboratory abnormality|0|||
23429667|NCT00413010|65317444|FG001|Overall Study|Laboratory abnormality|2|||
23429668|NCT00413010|65317443|FG000|Overall Study|Lack of Efficacy|0|||
23429669|NCT00413010|65317444|FG001|Overall Study|Lack of Efficacy|3|||
23429670|NCT00413010|65317443|FG000|Overall Study|Lost to Follow-up|3|||
23429671|NCT00413010|65317444|FG001|Overall Study|Lost to Follow-up|0|||
23429672|NCT00413010|65317443|FG000|Overall Study|Withdrawal by Subject|7|||
23429673|NCT00413010|65317444|FG001|Overall Study|Withdrawal by Subject|2|||
23429674|NCT00413010|65317443|FG000|Overall Study|Due to termination of the study|54|||
23429675|NCT00413010|65317444|FG001|Overall Study|Due to termination of the study|52|||
23429676|NCT00416715|65317450|FG000|Overall Study|Not evaluable for joint aches|7|||
23429677|NCT00416715|65317450|FG000|Overall Study|Vitamin D levels not evaluable|8|||
23429678|NCT02258529|65317454|FG000|Overall Study|Study Terminated by Sponsor|9|||
23429679|NCT02258529|65317454|FG000|Overall Study|Adverse Event|1|||
23429680|NCT00430937|65317455|FG000|Overall Study|Adverse Event|3|||
23429681|NCT00430937|65317456|FG001|Overall Study|Adverse Event|8|||
23429682|NCT00430937|65317455|FG000|Overall Study|Death|0|||
23429683|NCT00430937|65317456|FG001|Overall Study|Death|1|||
23429684|NCT00430937|65317455|FG000|Overall Study|Lost to Follow-up|6|||
23429685|NCT00430937|65317456|FG001|Overall Study|Lost to Follow-up|6|||
23429686|NCT00430937|65317455|FG000|Overall Study|Withdrawal by Subject|5|||
23429687|NCT00430937|65317456|FG001|Overall Study|Withdrawal by Subject|2|||
23429688|NCT00430937|65317455|FG000|Overall Study|Protocol Violation|3|||
23742354|NCT01200758|66436484|FG003|Stage I|Lack of Efficacy|0|||
23429689|NCT00430937|65317456|FG001|Overall Study|Protocol Violation|2|||
23550461|NCT02564523|65743303|FG013|Overall Study|Death|0|||
23742355|NCT01200758|66436481|FG000|Stage I|Adverse Event|5|||
23429690|NCT00430937|65317455|FG000|Overall Study|Lack of Efficacy|6|||
23550462|NCT02564523|65743304|FG014|Overall Study|Death|0|||
23742356|NCT01200758|66436482|FG001|Stage I|Adverse Event|5|||
23429691|NCT00430937|65317456|FG001|Overall Study|Lack of Efficacy|5|||
23429692|NCT00430937|65317455|FG000|Overall Study|Inappropriate enrollment|2|||
23429693|NCT00430937|65317456|FG001|Overall Study|Inappropriate enrollment|1|||
23429694|NCT00430937|65317455|FG000|Overall Study|Administrative reasons|1|||
23429695|NCT00430937|65317456|FG001|Overall Study|Administrative reasons|0|||
23429696|NCT00430937|65317455|FG000|Overall Study|Protocol discontinuation criteria met|1|||
23429697|NCT00430937|65317456|FG001|Overall Study|Protocol discontinuation criteria met|2|||
23429698|NCT00430937|65317455|FG000|Overall Study|Unable to classify|0|||
23429699|NCT00430937|65317456|FG001|Overall Study|Unable to classify|1|||
23429700|NCT00454649|65317457|FG000|Overall Study|Lack of Efficacy|2|||
23429701|NCT00454649|65317458|FG001|Overall Study|Lack of Efficacy|2|||
23429702|NCT00454649|65317459|FG002|Overall Study|Lack of Efficacy|10|||
23429703|NCT00454649|65317460|FG003|Overall Study|Lack of Efficacy|3|||
23429704|NCT00454649|65317461|FG004|Overall Study|Lack of Efficacy|0|||
23429705|NCT00454649|65317462|FG005|Overall Study|Lack of Efficacy|4|||
23429706|NCT00454649|65317463|FG006|Overall Study|Lack of Efficacy|5|||
23429707|NCT00454649|65317464|FG007|Overall Study|Lack of Efficacy|13|||
23429708|NCT00454649|65317465|FG008|Overall Study|Lack of Efficacy|10|||
23429709|NCT00454649|65317466|FG009|Overall Study|Lack of Efficacy|2|||
23429710|NCT00454649|65317457|FG000|Overall Study|Adverse Event|0|||
23429711|NCT00454649|65317458|FG001|Overall Study|Adverse Event|1|||
23429712|NCT00454649|65317459|FG002|Overall Study|Adverse Event|3|||
23429713|NCT00454649|65317460|FG003|Overall Study|Adverse Event|0|||
23429714|NCT00454649|65317461|FG004|Overall Study|Adverse Event|1|||
23429715|NCT00454649|65317462|FG005|Overall Study|Adverse Event|2|||
23429716|NCT00454649|65317463|FG006|Overall Study|Adverse Event|3|||
23429717|NCT00454649|65317464|FG007|Overall Study|Adverse Event|4|||
23742357|NCT01200758|66436483|FG002|Stage I|Adverse Event|0|||
23742358|NCT01200758|66436484|FG003|Stage I|Adverse Event|0|||
23742359|NCT01200758|66436481|FG000|Stage I|Withdrawal by Subject|1|||
23742360|NCT01200758|66436482|FG001|Stage I|Withdrawal by Subject|2|||
23742361|NCT01200758|66436483|FG002|Stage I|Withdrawal by Subject|0|||
23742362|NCT01200758|66436484|FG003|Stage I|Withdrawal by Subject|0|||
23742363|NCT01200758|66436481|FG000|Stage I|Disease Progression|9|||
23742364|NCT01200758|66436482|FG001|Stage I|Disease Progression|7|||
23821608|NCT01449370|66726124|FG011|Overall Study|Participant Decision|0|||
23821609|NCT01449370|66726125|FG012|Overall Study|Participant Decision|1|||
23821610|NCT01449370|66726126|FG013|Overall Study|Participant Decision|1|||
23821611|NCT01449370|66726127|FG014|Overall Study|Participant Decision|0|||
23821612|NCT01449370|66726128|FG015|Overall Study|Participant Decision|1|||
23821613|NCT01449370|66726129|FG016|Overall Study|Participant Decision|3|||
23821614|NCT01449370|66726130|FG017|Overall Study|Participant Decision|0|||
23821615|NCT01449370|66726131|FG018|Overall Study|Participant Decision|1|||
23821616|NCT01449370|66726132|FG019|Overall Study|Participant Decision|0|||
23620429|NCT00582114|65994984|FG001|Overall Study|Stopped by data safety monitoring board|20|||
23620430|NCT00496626|65994985|FG000|Overall Study|Lost to Follow-up|0|||
23620431|NCT00496626|65994986|FG001|Overall Study|Lost to Follow-up|1|||
23821617|NCT01449370|66726133|FG020|Overall Study|Participant Decision|0|||
23821618|NCT01449370|66726134|FG021|Overall Study|Participant Decision|1|||
23821619|NCT01449370|66726135|FG022|Overall Study|Participant Decision|0|||
23821620|NCT01449370|66726136|FG023|Overall Study|Participant Decision|0|||
23821621|NCT01449370|66726137|FG024|Overall Study|Participant Decision|1|||
23821622|NCT01449370|66726113|FG000|Overall Study|Lost to Follow-up|0|||
23821623|NCT01449370|66726114|FG001|Overall Study|Lost to Follow-up|0|||
23821624|NCT01449370|66726115|FG002|Overall Study|Lost to Follow-up|0|||
23821625|NCT01449370|66726116|FG003|Overall Study|Lost to Follow-up|0|||
23821626|NCT01449370|66726117|FG004|Overall Study|Lost to Follow-up|0|||
23821627|NCT01449370|66726118|FG005|Overall Study|Lost to Follow-up|0|||
23821628|NCT01449370|66726119|FG006|Overall Study|Lost to Follow-up|0|||
23821629|NCT01449370|66726120|FG007|Overall Study|Lost to Follow-up|0|||
23821630|NCT01449370|66726121|FG008|Overall Study|Lost to Follow-up|0|||
23821631|NCT01449370|66726122|FG009|Overall Study|Lost to Follow-up|0|||
23429718|NCT00454649|65317465|FG008|Overall Study|Adverse Event|6|||
23429719|NCT00454649|65317466|FG009|Overall Study|Adverse Event|2|||
23429720|NCT00454649|65317457|FG000|Overall Study|Lost to Follow-up|0|||
23429721|NCT00454649|65317458|FG001|Overall Study|Lost to Follow-up|0|||
23429722|NCT00454649|65317459|FG002|Overall Study|Lost to Follow-up|1|||
23742365|NCT01200758|66436483|FG002|Stage I|Disease Progression|0|||
23742366|NCT01200758|66436484|FG003|Stage I|Disease Progression|0|||
23742367|NCT01200758|66436481|FG000|Stage 2|Disease Progression|0|||
23821632|NCT01449370|66726123|FG010|Overall Study|Lost to Follow-up|0|||
23821633|NCT01449370|66726124|FG011|Overall Study|Lost to Follow-up|0|||
23821634|NCT01449370|66726125|FG012|Overall Study|Lost to Follow-up|0|||
23821635|NCT01449370|66726126|FG013|Overall Study|Lost to Follow-up|0|||
23821636|NCT01449370|66726127|FG014|Overall Study|Lost to Follow-up|0|||
23821637|NCT01449370|66726128|FG015|Overall Study|Lost to Follow-up|0|||
23429723|NCT00454649|65317460|FG003|Overall Study|Lost to Follow-up|0|||
23429724|NCT00454649|65317461|FG004|Overall Study|Lost to Follow-up|0|||
23742368|NCT01200758|66436482|FG001|Stage 2|Disease Progression|0|||
23429725|NCT00454649|65317462|FG005|Overall Study|Lost to Follow-up|0|||
23429726|NCT00454649|65317463|FG006|Overall Study|Lost to Follow-up|1|||
23429727|NCT00454649|65317464|FG007|Overall Study|Lost to Follow-up|0|||
23429728|NCT00454649|65317465|FG008|Overall Study|Lost to Follow-up|0|||
23429729|NCT00454649|65317466|FG009|Overall Study|Lost to Follow-up|0|||
23429730|NCT00454649|65317457|FG000|Overall Study|Other|1|||
23429731|NCT00454649|65317458|FG001|Overall Study|Other|1|||
23429732|NCT00454649|65317459|FG002|Overall Study|Other|5|||
23429733|NCT00454649|65317460|FG003|Overall Study|Other|3|||
23429734|NCT00454649|65317461|FG004|Overall Study|Other|0|||
23429735|NCT00454649|65317462|FG005|Overall Study|Other|0|||
23429736|NCT00454649|65317463|FG006|Overall Study|Other|0|||
23429737|NCT00454649|65317464|FG007|Overall Study|Other|0|||
23429738|NCT00454649|65317465|FG008|Overall Study|Other|3|||
23429739|NCT00454649|65317466|FG009|Overall Study|Other|1|||
23429740|NCT00454649|65317457|FG000|Overall Study|Withdrawal by Subject|0|||
23429741|NCT00454649|65317458|FG001|Overall Study|Withdrawal by Subject|0|||
23429742|NCT00454649|65317459|FG002|Overall Study|Withdrawal by Subject|0|||
23429743|NCT00454649|65317460|FG003|Overall Study|Withdrawal by Subject|0|||
23429744|NCT00454649|65317461|FG004|Overall Study|Withdrawal by Subject|0|||
23429745|NCT00454649|65317462|FG005|Overall Study|Withdrawal by Subject|1|||
23429746|NCT00454649|65317463|FG006|Overall Study|Withdrawal by Subject|0|||
23429747|NCT00454649|65317464|FG007|Overall Study|Withdrawal by Subject|2|||
23429748|NCT00454649|65317465|FG008|Overall Study|Withdrawal by Subject|1|||
23429749|NCT00454649|65317466|FG009|Overall Study|Withdrawal by Subject|0|||
23429750|NCT00613080|65317472|FG000|Overall Study|Ineligible / no protocol treatment|11|||
23429751|NCT02091284|65317476|FG000|Overall Study|Withdrawal by Subject|2|||
23429752|NCT02091284|65317477|FG001|Overall Study|Withdrawal by Subject|1|||
23429753|NCT02091284|65317476|FG000|Overall Study|unreliable data|1|||
23429754|NCT02091284|65317477|FG001|Overall Study|unreliable data|0|||
23429755|NCT03474081|65317480|FG000|Overall Study|Adverse Event|6|||
23429756|NCT03474081|65317481|FG001|Overall Study|Adverse Event|3|||
23429757|NCT03474081|65317480|FG000|Overall Study|Lost to Follow-up|2|||
23429758|NCT03474081|65317481|FG001|Overall Study|Lost to Follow-up|1|||
23429759|NCT03474081|65317480|FG000|Overall Study|Physician Decision|3|||
23429760|NCT03474081|65317481|FG001|Overall Study|Physician Decision|2|||
23429761|NCT03474081|65317480|FG000|Overall Study|Withdrawal by Subject|5|||
23429762|NCT03474081|65317481|FG001|Overall Study|Withdrawal by Subject|7|||
23429763|NCT03474081|65317480|FG000|Overall Study|Investigator site closed|1|||
23429764|NCT03474081|65317481|FG001|Overall Study|Investigator site closed|0|||
23429765|NCT04109976|65317484|FG000|Overall Study|Withdrawal by Subject|1|||
23429766|NCT04109976|65317485|FG001|Overall Study|Withdrawal by Subject|0|||
23429767|NCT00475865|65317488|FG000|Overall Study|Adverse Event|0|||
23429768|NCT00475865|65317489|FG001|Overall Study|Adverse Event|3|||
23429769|NCT00475865|65317490|FG002|Overall Study|Adverse Event|4|||
23429770|NCT00475865|65317488|FG000|Overall Study|Lack of Efficacy|1|||
23429771|NCT00475865|65317489|FG001|Overall Study|Lack of Efficacy|0|||
23429772|NCT00475865|65317490|FG002|Overall Study|Lack of Efficacy|0|||
23429773|NCT00475865|65317488|FG000|Overall Study|Progressive disease|0|||
23429774|NCT00475865|65317489|FG001|Overall Study|Progressive disease|1|||
23429775|NCT00475865|65317490|FG002|Overall Study|Progressive disease|2|||
23429776|NCT00475865|65317488|FG000|Overall Study|Participant did not wish to continue|1|||
23429777|NCT00475865|65317489|FG001|Overall Study|Participant did not wish to continue|0|||
23429778|NCT00475865|65317490|FG002|Overall Study|Participant did not wish to continue|0|||
23429779|NCT00475865|65317488|FG000|Overall Study|Other than above|0|||
23429780|NCT00475865|65317489|FG001|Overall Study|Other than above|1|||
23429781|NCT00475865|65317490|FG002|Overall Study|Other than above|0|||
23429782|NCT03374202|65317493|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
23429783|NCT03374202|65317494|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
23429784|NCT03374202|65317495|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
23429785|NCT03374202|65317493|FG000|Five Year Long Term Follow Up|Death|0|||
23429786|NCT03374202|65317494|FG001|Five Year Long Term Follow Up|Death|1|||
23429787|NCT03374202|65317495|FG002|Five Year Long Term Follow Up|Death|0|||
23429788|NCT00409344|65317496|FG000|Overall Study|no enrollment|0|||
23429789|NCT00409344|65317497|FG001|Overall Study|no enrollment|0|||
23429790|NCT03412604|65317498|FG000|Overall Study|Withdrawal by Subject|1|||
23429791|NCT02210832|65317499|FG000|Overall Study|Pregnancy termination .|3|||
23429792|NCT02210832|65317500|FG001|Overall Study|Pregnancy termination .|4|||
23429793|NCT02210832|65317501|FG002|Overall Study|Pregnancy termination .|1|||
23429794|NCT02210832|65317499|FG000|Overall Study|Lost to Follow-up|26|||
23429795|NCT02210832|65317500|FG001|Overall Study|Lost to Follow-up|32|||
23429796|NCT02210832|65317501|FG002|Overall Study|Lost to Follow-up|17|||
23429797|NCT03135210|65317502|FG000|Overall Study|Death|0|||
23550463|NCT02564523|65743305|FG015|Overall Study|Death|0|||
23550464|NCT02564523|65743306|FG016|Overall Study|Death|0|||
23429798|NCT03135210|65317503|FG001|Overall Study|Death|1|||
23429799|NCT03883113|65317504|FG000|Overall Study|Physician Decision|4|||
23429800|NCT03883113|65317505|FG001|Overall Study|Physician Decision|2|||
23550465|NCT02564523|65743307|FG017|Overall Study|Death|0|||
23821638|NCT01449370|66726129|FG016|Overall Study|Lost to Follow-up|0|||
23821639|NCT01449370|66726130|FG017|Overall Study|Lost to Follow-up|0|||
23821640|NCT01449370|66726131|FG018|Overall Study|Lost to Follow-up|0|||
23821641|NCT01449370|66726132|FG019|Overall Study|Lost to Follow-up|0|||
23821642|NCT01449370|66726133|FG020|Overall Study|Lost to Follow-up|1|||
23821643|NCT01449370|66726134|FG021|Overall Study|Lost to Follow-up|0|||
23821644|NCT01449370|66726135|FG022|Overall Study|Lost to Follow-up|0|||
23821645|NCT01449370|66726136|FG023|Overall Study|Lost to Follow-up|0|||
23821646|NCT01449370|66726137|FG024|Overall Study|Lost to Follow-up|0|||
23821647|NCT01449370|66726113|FG000|Overall Study|Other|0|||
23821648|NCT01449370|66726114|FG001|Overall Study|Other|0|||
23821649|NCT01449370|66726115|FG002|Overall Study|Other|0|||
23821650|NCT01449370|66726116|FG003|Overall Study|Other|0|||
23550466|NCT02564523|65743290|FG000|Overall Study|Lost to Follow-up|2|||
23550467|NCT02564523|65743291|FG001|Overall Study|Lost to Follow-up|1|||
23821651|NCT01449370|66726117|FG004|Overall Study|Other|0|||
23821652|NCT01449370|66726118|FG005|Overall Study|Other|0|||
23821653|NCT01449370|66726119|FG006|Overall Study|Other|0|||
23821654|NCT01449370|66726120|FG007|Overall Study|Other|0|||
23821655|NCT01449370|66726121|FG008|Overall Study|Other|1|||
23821656|NCT01449370|66726122|FG009|Overall Study|Other|1|||
23821657|NCT01449370|66726123|FG010|Overall Study|Other|0|||
23821658|NCT01449370|66726124|FG011|Overall Study|Other|0|||
23821659|NCT01449370|66726125|FG012|Overall Study|Other|0|||
23821660|NCT01449370|66726126|FG013|Overall Study|Other|0|||
23821661|NCT01449370|66726127|FG014|Overall Study|Other|0|||
23821662|NCT01449370|66726128|FG015|Overall Study|Other|0|||
23821663|NCT01449370|66726129|FG016|Overall Study|Other|0|||
23821664|NCT01449370|66726130|FG017|Overall Study|Other|0|||
23821665|NCT01449370|66726131|FG018|Overall Study|Other|0|||
23821666|NCT01449370|66726132|FG019|Overall Study|Other|0|||
23821667|NCT01449370|66726133|FG020|Overall Study|Other|0|||
23821668|NCT01449370|66726134|FG021|Overall Study|Other|0|||
23821669|NCT01449370|66726135|FG022|Overall Study|Other|1|||
23821670|NCT01449370|66726136|FG023|Overall Study|Other|1|||
23821671|NCT01449370|66726137|FG024|Overall Study|Other|0|||
23821672|NCT01449370|66726113|FG000|Overall Study|Medication Prohibited by Protocol|0|||
23550468|NCT02564523|65743292|FG002|Overall Study|Lost to Follow-up|4|||
23550469|NCT02564523|65743293|FG003|Overall Study|Lost to Follow-up|0|||
23550470|NCT02564523|65743294|FG004|Overall Study|Lost to Follow-up|1|||
23550471|NCT02564523|65743295|FG005|Overall Study|Lost to Follow-up|0|||
23550472|NCT02564523|65743296|FG006|Overall Study|Lost to Follow-up|1|||
23550473|NCT02564523|65743297|FG007|Overall Study|Lost to Follow-up|0|||
23821673|NCT01449370|66726114|FG001|Overall Study|Medication Prohibited by Protocol|0|||
23821674|NCT01449370|66726115|FG002|Overall Study|Medication Prohibited by Protocol|0|||
23821675|NCT01449370|66726116|FG003|Overall Study|Medication Prohibited by Protocol|0|||
23821676|NCT01449370|66726117|FG004|Overall Study|Medication Prohibited by Protocol|0|||
23821677|NCT01449370|66726118|FG005|Overall Study|Medication Prohibited by Protocol|0|||
23821678|NCT01449370|66726119|FG006|Overall Study|Medication Prohibited by Protocol|0|||
23821679|NCT01449370|66726120|FG007|Overall Study|Medication Prohibited by Protocol|0|||
23821680|NCT01449370|66726121|FG008|Overall Study|Medication Prohibited by Protocol|0|||
23821681|NCT01449370|66726122|FG009|Overall Study|Medication Prohibited by Protocol|0|||
23821682|NCT01449370|66726123|FG010|Overall Study|Medication Prohibited by Protocol|0|||
23821683|NCT01449370|66726124|FG011|Overall Study|Medication Prohibited by Protocol|0|||
23821684|NCT01449370|66726125|FG012|Overall Study|Medication Prohibited by Protocol|0|||
23821685|NCT01449370|66726126|FG013|Overall Study|Medication Prohibited by Protocol|0|||
23821686|NCT01449370|66726127|FG014|Overall Study|Medication Prohibited by Protocol|0|||
23821687|NCT01449370|66726128|FG015|Overall Study|Medication Prohibited by Protocol|0|||
23429801|NCT03883113|65317504|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
23429802|NCT03883113|65317505|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
23550474|NCT02564523|65743298|FG008|Overall Study|Lost to Follow-up|0|||
23550475|NCT02564523|65743299|FG009|Overall Study|Lost to Follow-up|0|||
23821688|NCT01449370|66726129|FG016|Overall Study|Medication Prohibited by Protocol|0|||
23821689|NCT01449370|66726130|FG017|Overall Study|Medication Prohibited by Protocol|0|||
23821690|NCT01449370|66726131|FG018|Overall Study|Medication Prohibited by Protocol|0|||
23821691|NCT01449370|66726132|FG019|Overall Study|Medication Prohibited by Protocol|0|||
23821692|NCT01449370|66726133|FG020|Overall Study|Medication Prohibited by Protocol|0|||
23821693|NCT01449370|66726134|FG021|Overall Study|Medication Prohibited by Protocol|0|||
23821694|NCT01449370|66726135|FG022|Overall Study|Medication Prohibited by Protocol|0|||
23821695|NCT01449370|66726136|FG023|Overall Study|Medication Prohibited by Protocol|1|||
23821696|NCT01449370|66726137|FG024|Overall Study|Medication Prohibited by Protocol|0|||
23821697|NCT01449370|66726113|FG000|Overall Study|Death|0|||
23821698|NCT01449370|66726114|FG001|Overall Study|Death|0|||
23550476|NCT02564523|65743300|FG010|Overall Study|Lost to Follow-up|0|||
23821699|NCT01449370|66726115|FG002|Overall Study|Death|0|||
23821700|NCT01449370|66726116|FG003|Overall Study|Death|0|||
23821701|NCT01449370|66726117|FG004|Overall Study|Death|0|||
23821702|NCT01449370|66726118|FG005|Overall Study|Death|0|||
23821703|NCT01449370|66726119|FG006|Overall Study|Death|0|||
23821704|NCT01449370|66726120|FG007|Overall Study|Death|0|||
23821705|NCT01449370|66726121|FG008|Overall Study|Death|0|||
23821706|NCT01449370|66726122|FG009|Overall Study|Death|0|||
23821707|NCT01449370|66726123|FG010|Overall Study|Death|0|||
23821708|NCT01449370|66726124|FG011|Overall Study|Death|0|||
23821709|NCT01449370|66726125|FG012|Overall Study|Death|0|||
23821710|NCT01449370|66726126|FG013|Overall Study|Death|0|||
23821711|NCT01449370|66726127|FG014|Overall Study|Death|0|||
23550477|NCT02564523|65743301|FG011|Overall Study|Lost to Follow-up|1|||
23821712|NCT01449370|66726128|FG015|Overall Study|Death|0|||
23821713|NCT01449370|66726129|FG016|Overall Study|Death|0|||
23821714|NCT01449370|66726130|FG017|Overall Study|Death|0|||
23821715|NCT01449370|66726131|FG018|Overall Study|Death|0|||
23821716|NCT01449370|66726132|FG019|Overall Study|Death|0|||
23821717|NCT01449370|66726133|FG020|Overall Study|Death|0|||
23821718|NCT01449370|66726134|FG021|Overall Study|Death|0|||
23821719|NCT01449370|66726135|FG022|Overall Study|Death|0|||
23821720|NCT01449370|66726136|FG023|Overall Study|Death|0|||
23821721|NCT01449370|66726137|FG024|Overall Study|Death|1|||
23821722|NCT01855828|66726138|FG000|Overall Study|Adverse Event|1|||
23821723|NCT01855828|66726138|FG000|Overall Study|Withdrawal by Subject|1|||
23550478|NCT02564523|65743302|FG012|Overall Study|Lost to Follow-up|1|||
23550479|NCT02564523|65743303|FG013|Overall Study|Lost to Follow-up|0|||
23550480|NCT02564523|65743304|FG014|Overall Study|Lost to Follow-up|0|||
23550481|NCT02564523|65743305|FG015|Overall Study|Lost to Follow-up|0|||
23550482|NCT02564523|65743306|FG016|Overall Study|Lost to Follow-up|0|||
23550483|NCT02564523|65743307|FG017|Overall Study|Lost to Follow-up|0|||
23821724|NCT02096744|66726139|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
23821725|NCT02096744|66726140|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
23550484|NCT02564523|65743290|FG000|Overall Study|Physician Decision|0|||
23550485|NCT02564523|65743291|FG001|Overall Study|Physician Decision|0|||
23550486|NCT02564523|65743292|FG002|Overall Study|Physician Decision|0|||
23550487|NCT02564523|65743293|FG003|Overall Study|Physician Decision|0|||
23550488|NCT02564523|65743294|FG004|Overall Study|Physician Decision|1|||
23550489|NCT02564523|65743295|FG005|Overall Study|Physician Decision|0|||
23550490|NCT02564523|65743296|FG006|Overall Study|Physician Decision|0|||
23620432|NCT00496626|65994985|FG000|Overall Study|Protocol Violation|1|||
23620433|NCT00496626|65994986|FG001|Overall Study|Protocol Violation|0|||
23620434|NCT00496626|65994985|FG000|Overall Study|Withdrawal by Subject|5|||
23550491|NCT02564523|65743297|FG007|Overall Study|Physician Decision|0|||
23550492|NCT02564523|65743298|FG008|Overall Study|Physician Decision|0|||
23550493|NCT02564523|65743299|FG009|Overall Study|Physician Decision|0|||
23550494|NCT02564523|65743300|FG010|Overall Study|Physician Decision|1|||
23550495|NCT02564523|65743301|FG011|Overall Study|Physician Decision|0|||
23620435|NCT00496626|65994986|FG001|Overall Study|Withdrawal by Subject|4|||
23620436|NCT00496626|65994985|FG000|Overall Study|Relocated|0|||
23550496|NCT02564523|65743302|FG012|Overall Study|Physician Decision|0|||
23550497|NCT02564523|65743303|FG013|Overall Study|Physician Decision|0|||
23550498|NCT02564523|65743304|FG014|Overall Study|Physician Decision|0|||
23550499|NCT02564523|65743305|FG015|Overall Study|Physician Decision|0|||
23550500|NCT02564523|65743306|FG016|Overall Study|Physician Decision|0|||
23550501|NCT02564523|65743307|FG017|Overall Study|Physician Decision|0|||
23550502|NCT02564523|65743290|FG000|Overall Study|Protocol Violation|2|||
23550503|NCT02564523|65743291|FG001|Overall Study|Protocol Violation|2|||
23550504|NCT02564523|65743292|FG002|Overall Study|Protocol Violation|5|||
23620437|NCT00496626|65994986|FG001|Overall Study|Relocated|1|||
23620438|NCT01393613|65994988|FG000|Overall Study|Adverse Event|11|||
23620439|NCT01393613|65994989|FG001|Overall Study|Adverse Event|11|||
23620440|NCT01393613|65994990|FG002|Overall Study|Adverse Event|13|||
23620441|NCT01393613|65994991|FG003|Overall Study|Adverse Event|22|||
23620442|NCT01393613|65994988|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
23620443|NCT01393613|65994989|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
23620444|NCT01393613|65994990|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
23821726|NCT02096744|66726139|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
23821727|NCT02096744|66726140|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
23821728|NCT02096744|66726139|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
23821729|NCT02096744|66726140|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
23821730|NCT04604795|66726141|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
23821731|NCT04604795|66726142|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
23550505|NCT02564523|65743293|FG003|Overall Study|Protocol Violation|0|||
23550506|NCT02564523|65743294|FG004|Overall Study|Protocol Violation|1|||
23550507|NCT02564523|65743295|FG005|Overall Study|Protocol Violation|0|||
23550508|NCT02564523|65743296|FG006|Overall Study|Protocol Violation|0|||
23821732|NCT04604795|66726143|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23550509|NCT02564523|65743297|FG007|Overall Study|Protocol Violation|0|||
23620445|NCT01393613|65994991|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23550510|NCT02564523|65743298|FG008|Overall Study|Protocol Violation|0|||
23550511|NCT02564523|65743299|FG009|Overall Study|Protocol Violation|0|||
23550512|NCT02564523|65743300|FG010|Overall Study|Protocol Violation|0|||
23550513|NCT02564523|65743301|FG011|Overall Study|Protocol Violation|0|||
23550514|NCT02564523|65743302|FG012|Overall Study|Protocol Violation|0|||
23550515|NCT02564523|65743303|FG013|Overall Study|Protocol Violation|0|||
23550516|NCT02564523|65743304|FG014|Overall Study|Protocol Violation|0|||
23742369|NCT01200758|66436483|FG002|Stage 2|Disease Progression|16|||
23742370|NCT01200758|66436484|FG003|Stage 2|Disease Progression|21|||
23742371|NCT01200758|66436481|FG000|Stage 2|Lack of Efficacy|0|||
23742372|NCT01200758|66436482|FG001|Stage 2|Lack of Efficacy|0|||
23742373|NCT01200758|66436483|FG002|Stage 2|Lack of Efficacy|4|||
23742374|NCT01200758|66436484|FG003|Stage 2|Lack of Efficacy|2|||
23742375|NCT01200758|66436481|FG000|Stage 2|Physician Decision|0|||
23742376|NCT01200758|66436482|FG001|Stage 2|Physician Decision|0|||
23742377|NCT01200758|66436483|FG002|Stage 2|Physician Decision|5|||
23742378|NCT01200758|66436484|FG003|Stage 2|Physician Decision|7|||
23742379|NCT01200758|66436481|FG000|Stage 2|Adverse Event|0|||
23742380|NCT01200758|66436482|FG001|Stage 2|Adverse Event|0|||
23742381|NCT01200758|66436483|FG002|Stage 2|Adverse Event|5|||
23742382|NCT01200758|66436484|FG003|Stage 2|Adverse Event|9|||
23742383|NCT01200758|66436481|FG000|Stage 2|Withdrawal by Subject|0|||
23742384|NCT01200758|66436482|FG001|Stage 2|Withdrawal by Subject|0|||
23742385|NCT01200758|66436483|FG002|Stage 2|Withdrawal by Subject|4|||
23742386|NCT01200758|66436484|FG003|Stage 2|Withdrawal by Subject|1|||
23742387|NCT01200758|66436481|FG000|Stage 2|Lost to Follow-up|0|||
23742388|NCT01200758|66436482|FG001|Stage 2|Lost to Follow-up|0|||
23742389|NCT01200758|66436483|FG002|Stage 2|Lost to Follow-up|3|||
23742390|NCT01200758|66436484|FG003|Stage 2|Lost to Follow-up|1|||
23742391|NCT01200758|66436481|FG000|Stage 2|Protocol Violation|0|||
23742392|NCT01200758|66436482|FG001|Stage 2|Protocol Violation|0|||
23742393|NCT01200758|66436483|FG002|Stage 2|Protocol Violation|1|||
23550517|NCT02564523|65743305|FG015|Overall Study|Protocol Violation|0|||
23550518|NCT02564523|65743306|FG016|Overall Study|Protocol Violation|0|||
23550519|NCT02564523|65743307|FG017|Overall Study|Protocol Violation|0|||
23550520|NCT02564523|65743290|FG000|Overall Study|Other|3|||
23550521|NCT02564523|65743291|FG001|Overall Study|Other|0|||
23550522|NCT02564523|65743292|FG002|Overall Study|Other|0|||
23550523|NCT02564523|65743293|FG003|Overall Study|Other|1|||
23550524|NCT02564523|65743294|FG004|Overall Study|Other|0|||
23550525|NCT02564523|65743295|FG005|Overall Study|Other|0|||
23550526|NCT02564523|65743296|FG006|Overall Study|Other|0|||
23550527|NCT02564523|65743297|FG007|Overall Study|Other|0|||
23550528|NCT02564523|65743298|FG008|Overall Study|Other|0|||
23550529|NCT02564523|65743299|FG009|Overall Study|Other|0|||
23550530|NCT02564523|65743300|FG010|Overall Study|Other|0|||
23550531|NCT02564523|65743301|FG011|Overall Study|Other|0|||
23550532|NCT02564523|65743302|FG012|Overall Study|Other|0|||
23550533|NCT02564523|65743303|FG013|Overall Study|Other|0|||
23550534|NCT02564523|65743304|FG014|Overall Study|Other|0|||
23550535|NCT02564523|65743305|FG015|Overall Study|Other|0|||
23550536|NCT02564523|65743306|FG016|Overall Study|Other|0|||
23550537|NCT02564523|65743307|FG017|Overall Study|Other|0|||
23550538|NCT00162370|65743312|FG000|Efficacy Population|Lost to Follow-up|51|||
23550539|NCT02062632|65743313|FG000|Overall Study|No treatment data|1|||
23550540|NCT02621931|65743314|FG000|Overall Study|Death|0|||
23550541|NCT02621931|65743315|FG001|Overall Study|Death|1|||
23550542|NCT02621931|65743316|FG002|Overall Study|Death|0|||
23550543|NCT02621931|65743314|FG000|Overall Study|Adverse Event|8|||
23550544|NCT02621931|65743315|FG001|Overall Study|Adverse Event|5|||
23550545|NCT02621931|65743316|FG002|Overall Study|Adverse Event|7|||
23550546|NCT02621931|65743314|FG000|Overall Study|Withdrawal by Subject|12|||
23550547|NCT02621931|65743315|FG001|Overall Study|Withdrawal by Subject|10|||
23550548|NCT02621931|65743316|FG002|Overall Study|Withdrawal by Subject|11|||
23550549|NCT02621931|65743314|FG000|Overall Study|Protocol Violation|2|||
23742394|NCT01200758|66436484|FG003|Stage 2|Protocol Violation|4|||
23742395|NCT01200758|66436481|FG000|Stage 2|Death|0|||
23550550|NCT02621931|65743315|FG001|Overall Study|Protocol Violation|2|||
23550551|NCT02621931|65743316|FG002|Overall Study|Protocol Violation|2|||
23550552|NCT02621931|65743314|FG000|Overall Study|Pregnancy|2|||
23550553|NCT02621931|65743315|FG001|Overall Study|Pregnancy|0|||
23550554|NCT02621931|65743316|FG002|Overall Study|Pregnancy|0|||
23550555|NCT02621931|65743314|FG000|Overall Study|Noncompliance to study procedures|0|||
23742396|NCT01200758|66436482|FG001|Stage 2|Death|0|||
23742397|NCT01200758|66436483|FG002|Stage 2|Death|3|||
23742398|NCT01200758|66436484|FG003|Stage 2|Death|5|||
23742399|NCT01003691|66436485|FG000|Overall Study|Adverse Event|0|||
23550556|NCT02621931|65743315|FG001|Overall Study|Noncompliance to study procedures|1|||
23550557|NCT02621931|65743316|FG002|Overall Study|Noncompliance to study procedures|2|||
23550558|NCT02621931|65743314|FG000|Overall Study|Lost to Follow-up|8|||
23550559|NCT02621931|65743315|FG001|Overall Study|Lost to Follow-up|7|||
23550560|NCT02621931|65743316|FG002|Overall Study|Lost to Follow-up|10|||
23550561|NCT02621931|65743314|FG000|Overall Study|Lack of Efficacy|0|||
23550562|NCT02621931|65743315|FG001|Overall Study|Lack of Efficacy|0|||
23550563|NCT02621931|65743316|FG002|Overall Study|Lack of Efficacy|1|||
23742400|NCT01003691|66436486|FG001|Overall Study|Adverse Event|0|||
23742401|NCT01003691|66436487|FG002|Overall Study|Adverse Event|0|||
23620446|NCT01393613|65994988|FG000|Overall Study|Physician Decision|2|||
23620447|NCT01393613|65994989|FG001|Overall Study|Physician Decision|0|||
23620448|NCT01393613|65994990|FG002|Overall Study|Physician Decision|0|||
23620449|NCT01393613|65994991|FG003|Overall Study|Physician Decision|1|||
23620450|NCT01393613|65994988|FG000|Overall Study|Withdrawal by Subject|15|||
23620451|NCT01393613|65994989|FG001|Overall Study|Withdrawal by Subject|25|||
23742402|NCT01003691|66436488|FG003|Overall Study|Adverse Event|1|||
23742403|NCT04115488|66436489|FG000|Overall Study|Adverse Event|8|||
23742404|NCT04115488|66436490|FG001|Overall Study|Adverse Event|4|||
23742405|NCT04115488|66436489|FG000|Overall Study|Withdrawal by Subject|3|||
23742406|NCT04115488|66436490|FG001|Overall Study|Withdrawal by Subject|6|||
23742407|NCT04115488|66436489|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
23742408|NCT04115488|66436490|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
23742409|NCT04115488|66436489|FG000|Overall Study|Patient 's location change|1|||
23742410|NCT04115488|66436490|FG001|Overall Study|Patient 's location change|0|||
23742411|NCT04115488|66436489|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
23742412|NCT04115488|66436490|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
23742413|NCT00643006|66436491|FG000|Overall Study|Lost to Follow-up|5|||
23742414|NCT00643006|66436492|FG001|Overall Study|Lost to Follow-up|4|||
23742415|NCT01265719|66436495|FG000|Overall Study|Does not meet entrance criteria|0|||
23742416|NCT01265719|66436496|FG001|Overall Study|Does not meet entrance criteria|3|||
23742417|NCT01265719|66436495|FG000|Overall Study|Other reasons|2|||
23742418|NCT01265719|66436496|FG001|Overall Study|Other reasons|0|||
23742419|NCT01265719|66436495|FG000|Overall Study|Withdrawal by Subject|8|||
23742420|NCT01265719|66436496|FG001|Overall Study|Withdrawal by Subject|3|||
23429803|NCT03883113|65317504|FG000|Overall Study|Pregnancy|1|||
23429804|NCT03883113|65317505|FG001|Overall Study|Pregnancy|0|||
23429805|NCT03883113|65317504|FG000|Overall Study|Adverse Event|0|||
23429806|NCT03883113|65317505|FG001|Overall Study|Adverse Event|1|||
23429807|NCT03883113|65317504|FG000|Overall Study|Withdrawal by Subject|1|||
23429808|NCT03883113|65317505|FG001|Overall Study|Withdrawal by Subject|2|||
23429809|NCT03883113|65317504|FG000|Overall Study|Lost to Follow-up|1|||
23429810|NCT03883113|65317505|FG001|Overall Study|Lost to Follow-up|0|||
23429811|NCT00576576|65317508|FG000|Overall Study|Lost to Follow-up|6|||
23429812|NCT00576576|65317508|FG000|Overall Study|Protocol Violation|1|||
23429813|NCT00343382|65317509|FG000|Overall Study|Adverse Event|2|||
23429814|NCT00343382|65317510|FG001|Overall Study|Adverse Event|10|||
23429815|NCT00343382|65317511|FG002|Overall Study|Adverse Event|7|||
23429816|NCT00343382|65317509|FG000|Overall Study|Withdrawal by Subject|1|||
23429817|NCT00343382|65317510|FG001|Overall Study|Withdrawal by Subject|2|||
23429818|NCT00343382|65317511|FG002|Overall Study|Withdrawal by Subject|6|||
23429819|NCT00343382|65317509|FG000|Overall Study|Other Reason Not Specified|1|||
23429820|NCT00343382|65317510|FG001|Overall Study|Other Reason Not Specified|2|||
23429821|NCT00343382|65317511|FG002|Overall Study|Other Reason Not Specified|4|||
23429822|NCT03002311|65317512|FG000|Overall Study|Lost to Follow-up|13|||
23429823|NCT03002311|65317513|FG001|Overall Study|Lost to Follow-up|26|||
23429824|NCT03002311|65317512|FG000|Overall Study|Referral provider called to schedule app|3|||
23429825|NCT03002311|65317513|FG001|Overall Study|Referral provider called to schedule app|3|||
23429826|NCT03002311|65317512|FG000|Overall Study|Physician Decision|3|||
23429827|NCT03002311|65317513|FG001|Overall Study|Physician Decision|1|||
23429828|NCT01827332|65317514|FG000|Overall Study|Lost to Follow-up|2|||
23429829|NCT01827332|65317515|FG001|Overall Study|Lost to Follow-up|1|||
23429830|NCT00864851|65317525|FG000|Overall Study|Withdrawal by Subject|0|||
23429831|NCT00864851|65317526|FG001|Overall Study|Withdrawal by Subject|1|||
23429832|NCT00864851|65317527|FG002|Overall Study|Withdrawal by Subject|0|||
23429833|NCT00864851|65317525|FG000|Overall Study|Physician Decision|1|||
23429834|NCT00864851|65317526|FG001|Overall Study|Physician Decision|0|||
23429835|NCT00864851|65317527|FG002|Overall Study|Physician Decision|0|||
23429836|NCT00864851|65317525|FG000|Overall Study|Death|1|||
23429837|NCT00864851|65317526|FG001|Overall Study|Death|0|||
23429838|NCT00864851|65317527|FG002|Overall Study|Death|0|||
23429839|NCT00864851|65317525|FG000|Overall Study|Patient uncooperative|1|||
23429840|NCT00864851|65317526|FG001|Overall Study|Patient uncooperative|0|||
23429841|NCT00864851|65317527|FG002|Overall Study|Patient uncooperative|0|||
23620452|NCT01393613|65994990|FG002|Overall Study|Withdrawal by Subject|23|||
23742421|NCT01265719|66436495|FG000|Overall Study|Lost to Follow-up|2|||
23742422|NCT01265719|66436496|FG001|Overall Study|Lost to Follow-up|7|||
23620453|NCT01393613|65994991|FG003|Overall Study|Withdrawal by Subject|21|||
23620454|NCT01393613|65994988|FG000|Overall Study|Protocol Deviation|2|||
23742423|NCT01265719|66436495|FG000|Overall Study|Adverse Event|2|||
23742424|NCT01265719|66436496|FG001|Overall Study|Adverse Event|0|||
23742425|NCT02988115|66436497|FG000|Overall Study|Adverse Event|6|||
23429842|NCT05086510|65317528|FG000|Overall Study|Lost to Follow-up|0|||
23429843|NCT05086510|65317529|FG001|Overall Study|Lost to Follow-up|2|||
23429844|NCT05086510|65317528|FG000|Overall Study|Death|0|||
23429845|NCT05086510|65317529|FG001|Overall Study|Death|2|||
23429846|NCT01595581|65317536|FG000|Overall Study|Withdrawal by Subject|1|||
23429847|NCT01595581|65317537|FG001|Overall Study|Withdrawal by Subject|0|||
23550564|NCT02621931|65743314|FG000|Overall Study|Other|1|||
23550565|NCT02621931|65743315|FG001|Overall Study|Other|1|||
23620455|NCT01393613|65994989|FG001|Overall Study|Protocol Deviation|1|||
23620456|NCT01393613|65994990|FG002|Overall Study|Protocol Deviation|0|||
23620457|NCT01393613|65994991|FG003|Overall Study|Protocol Deviation|0|||
23550566|NCT02621931|65743316|FG002|Overall Study|Other|3|||
23550567|NCT03750552|65743317|FG000|Overall Study|Adverse Event|5|||
23550568|NCT03750552|65743318|FG001|Overall Study|Adverse Event|1|||
23550569|NCT03750552|65743317|FG000|Overall Study|Withdrawal by Subject|1|||
23550570|NCT03750552|65743318|FG001|Overall Study|Withdrawal by Subject|1|||
23550571|NCT03750552|65743317|FG000|Overall Study|Other|2|||
23550572|NCT03750552|65743318|FG001|Overall Study|Other|0|||
23550573|NCT01227889|65743319|FG000|Randomized Phase (RP)|Adverse Event|13|||
23550574|NCT01227889|65743320|FG001|Randomized Phase (RP)|Adverse Event|0|||
23550575|NCT01227889|65743319|FG000|Randomized Phase (RP)|Physician Decision|13|||
23550576|NCT01227889|65743320|FG001|Randomized Phase (RP)|Physician Decision|5|||
23550577|NCT01227889|65743319|FG000|Randomized Phase (RP)|Progressive Disease|135|||
23550578|NCT01227889|65743320|FG001|Randomized Phase (RP)|Progressive Disease|52|||
23550579|NCT01227889|65743319|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
23550580|NCT01227889|65743320|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
23550581|NCT01227889|65743319|FG000|Randomized Phase (RP)|Missing|1|||
23550582|NCT01227889|65743320|FG001|Randomized Phase (RP)|Missing|3|||
23550583|NCT01227889|65743319|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
23550584|NCT01227889|65743320|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
23550585|NCT01227889|65743319|FG000|Crossover Phase|Adverse Event|0|||
23550586|NCT01227889|65743320|FG001|Crossover Phase|Adverse Event|1|||
23550587|NCT01227889|65743319|FG000|Crossover Phase|Physician Decision|0|||
23550588|NCT01227889|65743320|FG001|Crossover Phase|Physician Decision|3|||
23550589|NCT01227889|65743319|FG000|Crossover Phase|Progressive Disease|0|||
23550590|NCT01227889|65743320|FG001|Crossover Phase|Progressive Disease|31|||
23550591|NCT01227889|65743319|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
23550592|NCT01227889|65743320|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
23550593|NCT01227889|65743319|FG000|Crossover Phase|Withdrawal by Subject|0|||
23550594|NCT01227889|65743320|FG001|Crossover Phase|Withdrawal by Subject|1|||
23742426|NCT02988115|66436498|FG001|Overall Study|Adverse Event|1|||
23742427|NCT02988115|66436497|FG000|Overall Study|Sponsor Decision|5|||
23742428|NCT02988115|66436498|FG001|Overall Study|Sponsor Decision|2|||
23742429|NCT02988115|66436497|FG000|Overall Study|Withdrawal by Subject|1|||
23742430|NCT02988115|66436498|FG001|Overall Study|Withdrawal by Subject|1|||
23742431|NCT02988115|66436497|FG000|Overall Study|Withdrawn by Mistake|1|||
23742432|NCT02988115|66436498|FG001|Overall Study|Withdrawn by Mistake|0|||
23742433|NCT02988115|66436497|FG000|Overall Study|Lost to Follow-up|1|||
23742434|NCT02988115|66436498|FG001|Overall Study|Lost to Follow-up|0|||
23620458|NCT01393613|65994988|FG000|Overall Study|Lack of Efficacy|9|||
23620459|NCT01393613|65994989|FG001|Overall Study|Lack of Efficacy|20|||
23620460|NCT01393613|65994990|FG002|Overall Study|Lack of Efficacy|16|||
23620461|NCT01393613|65994991|FG003|Overall Study|Lack of Efficacy|21|||
23620462|NCT00797511|65994992|FG000|Overall Study|Withdrawal by Subject|1|||
23742435|NCT02329834|66436499|FG000|Overall Study|Physician Decision|1|||
23550595|NCT00352365|65743321|FG000|Induction Therapy|Adverse Event|7|||
23742436|NCT02329834|66436500|FG001|Overall Study|Physician Decision|0|||
23742437|NCT00750061|66436506|FG000|Overall Study|Adverse Event|2|||
23742438|NCT00750061|66436507|FG001|Overall Study|Adverse Event|0|||
23742439|NCT00750061|66436506|FG000|Overall Study|Withdrawal by Subject|0|||
23742440|NCT00750061|66436507|FG001|Overall Study|Withdrawal by Subject|1|||
23742441|NCT00750061|66436506|FG000|Overall Study|Physician Decision|0|||
23742442|NCT00750061|66436507|FG001|Overall Study|Physician Decision|1|||
23742443|NCT02743117|66436508|FG000|Overall Study|Lost to Follow-up|0|||
23821733|NCT04604795|66726144|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23550596|NCT00352365|65743321|FG000|Induction Therapy|Progression/Relapse|8|||
23550597|NCT00352365|65743321|FG000|Induction Therapy|Death|7|||
23550598|NCT00352365|65743321|FG000|Induction Therapy|Not protocol specified|1|||
23550599|NCT00352365|65743321|FG000|Induction Therapy|Not eligible|3|||
23550600|NCT00352365|65743321|FG000|Induction Therapy|Death before starting protocol therapy|1|||
23550601|NCT00352365|65743321|FG000|Maintenance Therapy|Progression/Relapse|3|||
23550602|NCT00352365|65743321|FG000|Maintenance Therapy|Death|2|||
23550603|NCT00352365|65743321|FG000|Maintenance Therapy|Not protocol specified|3|||
23550604|NCT00352365|65743321|FG000|Maintenance Therapy|Not eligible|4|||
23550605|NCT04393441|65743326|FG000|Overall Study|Adverse Event|0|||
23550606|NCT04393441|65743327|FG001|Overall Study|Adverse Event|3|||
23620463|NCT01222078|65997479|FG000|Overall Study|Early termination of the study|1|||
23620464|NCT01990664|65997480|FG000|Overall Study|Lost to Follow-up|2|||
23620465|NCT01990664|65997481|FG001|Overall Study|Lost to Follow-up|6|||
23620466|NCT01990664|65997480|FG000|Overall Study|Withdrawal by Subject|2|||
23742444|NCT02743117|66436509|FG001|Overall Study|Lost to Follow-up|1|||
23821734|NCT04604795|66726145|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23550607|NCT04393441|65743326|FG000|Overall Study|Withdrawal by Subject|5|||
23742445|NCT02743117|66436508|FG000|Overall Study|Other|1|||
23742446|NCT02743117|66436509|FG001|Overall Study|Other|0|||
23742447|NCT00451191|66436510|FG000|Overall Study|withdrawal or received alternate tx|15|||
23742448|NCT00451191|66436511|FG001|Overall Study|withdrawal or received alternate tx|11|||
23742449|NCT01020812|66436513|FG000|Overall Study|Physician Decision|1|||
23742450|NCT01020812|66436513|FG000|Overall Study|Withdrawal by Subject|1|||
23742451|NCT01020812|66436513|FG000|Overall Study|Protocol Violation|1|||
23742452|NCT00405756|66436516|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
23742453|NCT00405756|66436517|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
23742454|NCT00405756|66436518|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
23742455|NCT00405756|66436516|FG000|Double-blind Treatment|Adverse Event|31|||
23742456|NCT00405756|66436517|FG001|Double-blind Treatment|Adverse Event|27|||
23742457|NCT00405756|66436518|FG002|Double-blind Treatment|Adverse Event|12|||
23742458|NCT00405756|66436516|FG000|Double-blind Treatment|Disease Progression|47|||
23742459|NCT00405756|66436517|FG001|Double-blind Treatment|Disease Progression|81|||
23742460|NCT00405756|66436518|FG002|Double-blind Treatment|Disease Progression|102|||
23742461|NCT00405756|66436516|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23742462|NCT00405756|66436517|FG001|Double-blind Treatment|Lack of Efficacy|4|||
23742463|NCT00405756|66436518|FG002|Double-blind Treatment|Lack of Efficacy|2|||
23742464|NCT00405756|66436516|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
23742465|NCT00405756|66436517|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
23742466|NCT00405756|66436518|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
23742467|NCT00405756|66436516|FG000|Double-blind Treatment|Lost to Follow-up|1|||
23742468|NCT00405756|66436517|FG001|Double-blind Treatment|Lost to Follow-up|0|||
23742469|NCT00405756|66436518|FG002|Double-blind Treatment|Lost to Follow-up|0|||
23742470|NCT00405756|66436516|FG000|Double-blind Treatment|Death|4|||
23742471|NCT00405756|66436517|FG001|Double-blind Treatment|Death|4|||
23742472|NCT00405756|66436518|FG002|Double-blind Treatment|Death|4|||
23742473|NCT00405756|66436516|FG000|Double-blind Treatment|Protocol Violation|1|||
23742474|NCT00405756|66436517|FG001|Double-blind Treatment|Protocol Violation|0|||
23742475|NCT00405756|66436518|FG002|Double-blind Treatment|Protocol Violation|2|||
23742476|NCT00405756|66436516|FG000|Double-blind Treatment|Other|7|||
23742477|NCT00405756|66436517|FG001|Double-blind Treatment|Other|4|||
23742478|NCT00405756|66436518|FG002|Double-blind Treatment|Other|4|||
23742479|NCT00405756|66436516|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
23742480|NCT00405756|66436517|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
23742481|NCT00405756|66436518|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
23742482|NCT00405756|66436516|FG000|Open-label Extension|Adverse Event|1|||
23742483|NCT00405756|66436517|FG001|Open-label Extension|Adverse Event|3|||
23742484|NCT00405756|66436518|FG002|Open-label Extension|Adverse Event|7|||
23742485|NCT00405756|66436516|FG000|Open-label Extension|Disease Progression|8|||
23742486|NCT00405756|66436517|FG001|Open-label Extension|Disease Progression|23|||
23742487|NCT00405756|66436518|FG002|Open-label Extension|Disease Progression|26|||
23742488|NCT00405756|66436516|FG000|Open-label Extension|Withdrawal by Subject|2|||
23742489|NCT00405756|66436517|FG001|Open-label Extension|Withdrawal by Subject|3|||
23742490|NCT00405756|66436518|FG002|Open-label Extension|Withdrawal by Subject|3|||
23742491|NCT00405756|66436516|FG000|Open-label Extension|Death|1|||
23742492|NCT00405756|66436517|FG001|Open-label Extension|Death|2|||
23742493|NCT00405756|66436518|FG002|Open-label Extension|Death|4|||
23742494|NCT00405756|66436516|FG000|Open-label Extension|Other|0|||
23742495|NCT00405756|66436517|FG001|Open-label Extension|Other|1|||
23742496|NCT00405756|66436518|FG002|Open-label Extension|Other|7|||
23742497|NCT00405756|66436516|FG000|Follow-up|Ongoing in Follow-up Period|52|||
23742498|NCT00405756|66436517|FG001|Follow-up|Ongoing in Follow-up Period|51|||
23742499|NCT00405756|66436518|FG002|Follow-up|Ongoing in Follow-up Period|60|||
23742500|NCT00405756|66436516|FG000|Follow-up|Death|21|||
23742501|NCT00405756|66436517|FG001|Follow-up|Death|31|||
23742502|NCT00405756|66436518|FG002|Follow-up|Death|24|||
23742503|NCT00405756|66436516|FG000|Follow-up|Lost to Follow-up|2|||
23742504|NCT00405756|66436517|FG001|Follow-up|Lost to Follow-up|8|||
23742505|NCT00405756|66436518|FG002|Follow-up|Lost to Follow-up|4|||
23742506|NCT04491591|66436519|FG000|Overall Study|Accidently randomized|3|||
23742507|NCT04491591|66436520|FG001|Overall Study|Accidently randomized|1|||
23742508|NCT04491591|66436521|FG002|Overall Study|Accidently randomized|0|||
23742509|NCT04491591|66436519|FG000|Overall Study|Did not complete survey|28|||
23742510|NCT04491591|66436520|FG001|Overall Study|Did not complete survey|20|||
23742511|NCT04491591|66436521|FG002|Overall Study|Did not complete survey|3|||
23742512|NCT02408016|66436525|FG000|Overall Study|Death|6|||
23821735|NCT04604795|66726146|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23429848|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
23550608|NCT04393441|65743327|FG001|Overall Study|Withdrawal by Subject|7|||
23742513|NCT02408016|66436526|FG001|Overall Study|Death|1|||
23742514|NCT02408016|66436527|FG002|Overall Study|Death|0|||
23742515|NCT02408016|66436525|FG000|Overall Study|Physician Decision|0|||
23742516|NCT02408016|66436526|FG001|Overall Study|Physician Decision|2|||
23742517|NCT02408016|66436527|FG002|Overall Study|Physician Decision|0|||
23742518|NCT02145429|66436528|FG000|Overall Study|Death|4|||
23742519|NCT02145429|66436529|FG001|Overall Study|Death|5|||
23742520|NCT02145429|66436528|FG000|Overall Study|Lost to Follow-up|4|||
23742521|NCT02145429|66436529|FG001|Overall Study|Lost to Follow-up|3|||
23742522|NCT02145429|66436528|FG000|Overall Study|Withdrawal by Subject|8|||
23742523|NCT02145429|66436529|FG001|Overall Study|Withdrawal by Subject|3|||
23742524|NCT00310440|66436533|FG000|Overall Study|Lost to Follow-up|17|||
23742525|NCT00310440|66436534|FG001|Overall Study|Lost to Follow-up|8|||
23742526|NCT00310440|66436533|FG000|Overall Study|Withdrawal by Subject|2|||
23742527|NCT00310440|66436534|FG001|Overall Study|Withdrawal by Subject|1|||
23742528|NCT00310440|66436533|FG000|Overall Study|Missed 12 Month Visit|7|||
23742529|NCT00310440|66436534|FG001|Overall Study|Missed 12 Month Visit|4|||
23742530|NCT02452892|66436538|FG000|Week 1 Initial Randommization|Adverse Event|1|||
23742531|NCT02452892|66436539|FG001|Week 1 Initial Randommization|Adverse Event|0|||
23742532|NCT02452892|66436540|FG002|Week 1 Initial Randommization|Adverse Event|0|||
23742533|NCT02452892|66436541|FG003|Week 1 Initial Randommization|Adverse Event|0|||
23742534|NCT02452892|66436538|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
23429849|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
23550609|NCT04393441|65743326|FG000|Overall Study|Lost to Follow-up|0|||
23550610|NCT04393441|65743327|FG001|Overall Study|Lost to Follow-up|2|||
23550611|NCT04393441|65743326|FG000|Overall Study|Protocol Deviation|2|||
23550612|NCT04393441|65743327|FG001|Overall Study|Protocol Deviation|1|||
23550613|NCT04393441|65743326|FG000|Overall Study|Reason not Specified|1|||
23550614|NCT04393441|65743327|FG001|Overall Study|Reason not Specified|1|||
23550615|NCT01667432|65743332|FG000|Overall Study|Premature Study Termination|26|||
23550616|NCT01667432|65743332|FG000|Overall Study|Failure to Return|10|||
23550617|NCT01667432|65743332|FG000|Overall Study|Moved to Another Center|3|||
23550618|NCT01667432|65743332|FG000|Overall Study|Lost to Follow-up|3|||
23550619|NCT01667432|65743332|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
23550620|NCT01667432|65743332|FG000|Overall Study|Insufficient Therapeutic Response|4|||
23550621|NCT01667432|65743332|FG000|Overall Study|Adverse Event|1|||
23550622|NCT01667432|65743332|FG000|Overall Study|Protocol Deviation|2|||
23550623|NCT01667432|65743332|FG000|Overall Study|Principal Investigator Decision|1|||
23550624|NCT01667432|65743332|FG000|Overall Study|Reason Not Specified|2|||
23550625|NCT01667432|65743332|FG000|Overall Study|Missing Information|4|||
23550626|NCT02618967|65743334|FG000|Overall Study|Lost to Follow-up|0|||
23550627|NCT02618967|65743335|FG001|Overall Study|Lost to Follow-up|0|||
23550628|NCT02618967|65743336|FG002|Overall Study|Lost to Follow-up|1|||
23550629|NCT02618967|65743337|FG003|Overall Study|Lost to Follow-up|0|||
23550630|NCT02618967|65743338|FG004|Overall Study|Lost to Follow-up|2|||
23550631|NCT02618967|65743339|FG005|Overall Study|Lost to Follow-up|0|||
23550632|NCT02618967|65743340|FG006|Overall Study|Lost to Follow-up|0|||
23550633|NCT02618967|65743341|FG007|Overall Study|Lost to Follow-up|0|||
23550634|NCT02618967|65743334|FG000|Overall Study|Withdrawal by Subject|1|||
23550635|NCT02618967|65743335|FG001|Overall Study|Withdrawal by Subject|0|||
23550636|NCT02618967|65743336|FG002|Overall Study|Withdrawal by Subject|0|||
23550637|NCT02618967|65743337|FG003|Overall Study|Withdrawal by Subject|0|||
23550638|NCT02618967|65743338|FG004|Overall Study|Withdrawal by Subject|0|||
23550639|NCT02618967|65743339|FG005|Overall Study|Withdrawal by Subject|0|||
23550640|NCT02618967|65743340|FG006|Overall Study|Withdrawal by Subject|0|||
23550641|NCT02618967|65743341|FG007|Overall Study|Withdrawal by Subject|0|||
23550642|NCT01261338|65743344|FG000|Overall Study|Withdrawal by Subject|3|||
23550643|NCT01261338|65743345|FG001|Overall Study|Withdrawal by Subject|2|||
23550644|NCT01275625|65743346|FG000|Overall Study|Death|1|||
23550645|NCT01275625|65743346|FG000|Overall Study|Lack of Efficacy|2|||
23550646|NCT01275625|65743346|FG000|Overall Study|Lost to Follow-up|1|||
23550647|NCT01275625|65743346|FG000|Overall Study|Withdrawal by Subject|3|||
23550648|NCT01275625|65743346|FG000|Overall Study|Protocol Violation|1|||
23550649|NCT01275625|65743346|FG000|Overall Study|Adverse Event|4|||
23550650|NCT01275625|65743346|FG000|Overall Study|Other|1|||
23550651|NCT02097108|65743350|FG000|Overall Study|Adverse Event|1|||
23550652|NCT02097108|65743350|FG000|Overall Study|patient was abroad for 6 months|1|||
23550653|NCT00636610|65743351|FG000|Overall Study|Adverse Event|4|||
23550654|NCT00636610|65743352|FG001|Overall Study|Adverse Event|4|||
23550655|NCT00636610|65743351|FG000|Overall Study|Death|6|||
23550656|NCT00636610|65743352|FG001|Overall Study|Death|3|||
23550657|NCT00636610|65743351|FG000|Overall Study|Physician decision to withdraw patient|15|||
23550658|NCT00636610|65743352|FG001|Overall Study|Physician decision to withdraw patient|9|||
23550659|NCT00636610|65743351|FG000|Overall Study|Subject decision to withdraw|15|||
23550660|NCT00636610|65743352|FG001|Overall Study|Subject decision to withdraw|11|||
23742535|NCT02452892|66436539|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
23742536|NCT02452892|66436540|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
23742537|NCT02452892|66436541|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
23550661|NCT00636610|65743351|FG000|Overall Study|Disease progression - radiographic|41|||
23550662|NCT00636610|65743352|FG001|Overall Study|Disease progression - radiographic|51|||
23550663|NCT00636610|65743351|FG000|Overall Study|Disease progression - clinical|8|||
23550664|NCT00636610|65743352|FG001|Overall Study|Disease progression - clinical|3|||
23550665|NCT00636610|65743351|FG000|Overall Study|Reason for discontinuation not available|3|||
23550666|NCT00636610|65743352|FG001|Overall Study|Reason for discontinuation not available|2|||
23550667|NCT00113568|65743357|FG000|Overall Study|Adverse Event|97|||
23550668|NCT00113568|65743357|FG000|Overall Study|Death|1|||
23550669|NCT00113568|65743357|FG000|Overall Study|Lack of Efficacy|30|||
23550670|NCT00113568|65743357|FG000|Overall Study|Lost to Follow-up|156|||
23550671|NCT00113568|65743357|FG000|Overall Study|Protocol Violation|32|||
23550672|NCT00113568|65743357|FG000|Overall Study|Withdrawal by Subject|117|||
23550673|NCT00113568|65743357|FG000|Overall Study|Other|112|||
23550674|NCT04072159|65743360|FG000|Overall Study|Lost to Follow-up|6|||
23550675|NCT04072159|65743361|FG001|Overall Study|Lost to Follow-up|6|||
23550676|NCT04072159|65743360|FG000|Overall Study|Withdrawal by Subject|2|||
23550677|NCT04072159|65743361|FG001|Overall Study|Withdrawal by Subject|0|||
23550678|NCT01618838|65743362|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
23550679|NCT01297062|65743363|FG000|Overall Study|Adverse Event|2|||
23550680|NCT01297062|65743364|FG001|Overall Study|Adverse Event|0|||
23550681|NCT01297062|65743365|FG002|Overall Study|Adverse Event|1|||
23550682|NCT01297062|65743366|FG003|Overall Study|Adverse Event|0|||
23550683|NCT01297062|65743367|FG004|Overall Study|Adverse Event|0|||
23550684|NCT01297062|65743368|FG005|Overall Study|Adverse Event|0|||
23550685|NCT01297062|65743369|FG006|Overall Study|Adverse Event|0|||
23550686|NCT01297062|65743363|FG000|Overall Study|Physician Decision|1|||
23550687|NCT01297062|65743364|FG001|Overall Study|Physician Decision|0|||
23550688|NCT01297062|65743365|FG002|Overall Study|Physician Decision|1|||
23550689|NCT01297062|65743366|FG003|Overall Study|Physician Decision|0|||
23550690|NCT01297062|65743367|FG004|Overall Study|Physician Decision|0|||
23620467|NCT01990664|65997481|FG001|Overall Study|Withdrawal by Subject|3|||
23620468|NCT01990664|65997480|FG000|Overall Study|Protocol Violation|1|||
23620469|NCT01990664|65997481|FG001|Overall Study|Protocol Violation|0|||
23620470|NCT01990664|65997480|FG000|Overall Study|Lens Discomfort|1|||
23550691|NCT01297062|65743368|FG005|Overall Study|Physician Decision|0|||
23550692|NCT01297062|65743369|FG006|Overall Study|Physician Decision|6|||
23550693|NCT01297062|65743363|FG000|Overall Study|Protocol Violation|0|||
23550694|NCT01297062|65743364|FG001|Overall Study|Protocol Violation|0|||
23620471|NCT01990664|65997481|FG001|Overall Study|Lens Discomfort|1|||
23620472|NCT01990664|65997480|FG000|Overall Study|Lens Handling Difficulties|1|||
23550695|NCT01297062|65743365|FG002|Overall Study|Protocol Violation|0|||
23550696|NCT01297062|65743366|FG003|Overall Study|Protocol Violation|0|||
23550697|NCT01297062|65743367|FG004|Overall Study|Protocol Violation|1|||
23550698|NCT01297062|65743368|FG005|Overall Study|Protocol Violation|0|||
23550699|NCT01297062|65743369|FG006|Overall Study|Protocol Violation|0|||
23550700|NCT01297062|65743363|FG000|Overall Study|Subject Decision|1|||
23550701|NCT01297062|65743364|FG001|Overall Study|Subject Decision|1|||
23550702|NCT01297062|65743365|FG002|Overall Study|Subject Decision|0|||
23550703|NCT01297062|65743366|FG003|Overall Study|Subject Decision|1|||
23550704|NCT01297062|65743367|FG004|Overall Study|Subject Decision|1|||
23550705|NCT01297062|65743368|FG005|Overall Study|Subject Decision|1|||
23550706|NCT01297062|65743369|FG006|Overall Study|Subject Decision|2|||
23550707|NCT01090453|65747450|FG000|Overall Study|Withdrawal by Subject|1|||
23550708|NCT01090453|65747451|FG001|Overall Study|Withdrawal by Subject|2|||
23550709|NCT01090453|65747450|FG000|Overall Study|Lost to Follow-up|7|||
23550710|NCT01090453|65747451|FG001|Overall Study|Lost to Follow-up|7|||
23550711|NCT01090453|65747450|FG000|Overall Study|Non serious AEs|1|||
23550712|NCT01090453|65747451|FG001|Overall Study|Non serious AEs|0|||
23620473|NCT01990664|65997481|FG001|Overall Study|Lens Handling Difficulties|0|||
23742538|NCT02452892|66436538|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23742539|NCT02452892|66436539|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23742540|NCT02452892|66436540|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23742541|NCT02452892|66436541|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
23742542|NCT02452892|66436538|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
23742543|NCT02452892|66436539|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23742544|NCT02452892|66436540|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23742545|NCT02452892|66436541|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23742546|NCT02452892|66436538|FG000|Follow-up|Withdrawal by Subject|0|||
23742547|NCT02452892|66436539|FG001|Follow-up|Withdrawal by Subject|0|||
23742548|NCT02452892|66436540|FG002|Follow-up|Withdrawal by Subject|0|||
23742549|NCT02452892|66436541|FG003|Follow-up|Withdrawal by Subject|1|||
23742550|NCT02452892|66436538|FG000|Follow-up|Subject left town on Day 42|1|||
23742551|NCT02452892|66436539|FG001|Follow-up|Subject left town on Day 42|0|||
23550713|NCT01090453|65747450|FG000|Overall Study|Protocol Violation|2|||
23550714|NCT01090453|65747451|FG001|Overall Study|Protocol Violation|0|||
23550715|NCT01090453|65747450|FG000|Overall Study|Other|2|||
23550716|NCT01090453|65747451|FG001|Overall Study|Other|4|||
23550717|NCT01090453|65747450|FG000|Overall Study|Eligibility Criteria|0|||
23550718|NCT01090453|65747451|FG001|Overall Study|Eligibility Criteria|1|||
23620474|NCT01990664|65997480|FG000|Overall Study|Unsatisfactory Visual Response|0|||
23620475|NCT01990664|65997481|FG001|Overall Study|Unsatisfactory Visual Response|1|||
23742552|NCT02452892|66436540|FG002|Follow-up|Subject left town on Day 42|0|||
23742553|NCT02452892|66436541|FG003|Follow-up|Subject left town on Day 42|0|||
23742554|NCT03772574|66436546|FG000|Overall Study|Protocol Violation|2|||
23742555|NCT03772574|66436547|FG001|Overall Study|Protocol Violation|0|||
23742556|NCT03772574|66436548|FG002|Overall Study|Protocol Violation|0|||
23742557|NCT03772574|66436546|FG000|Overall Study|Discomfort|0|||
23742558|NCT03772574|66436547|FG001|Overall Study|Discomfort|5|||
23742559|NCT03772574|66436548|FG002|Overall Study|Discomfort|4|||
23742560|NCT03319368|66436549|FG000|Overall Study|Discharge swabs not collected from resident|57|||
23742561|NCT03319368|66436550|FG001|Overall Study|Discharge swabs not collected from resident|46|||
23742562|NCT00594958|66436551|FG000|Overall Study|Withdrawal by Subject|1|||
23742563|NCT00594958|66436552|FG001|Overall Study|Withdrawal by Subject|0|||
23742564|NCT00594958|66436553|FG002|Overall Study|Withdrawal by Subject|1|||
23742565|NCT00594958|66436551|FG000|Overall Study|Adverse Event|4|||
23742566|NCT00594958|66436552|FG001|Overall Study|Adverse Event|1|||
23742567|NCT00594958|66436553|FG002|Overall Study|Adverse Event|2|||
23742568|NCT00594958|66436551|FG000|Overall Study|Pregnancy|0|||
23742569|NCT00594958|66436552|FG001|Overall Study|Pregnancy|2|||
23742570|NCT00594958|66436553|FG002|Overall Study|Pregnancy|0|||
23742571|NCT00594958|66436551|FG000|Overall Study|Protocol Violation|1|||
23742572|NCT00594958|66436552|FG001|Overall Study|Protocol Violation|0|||
23742573|NCT00594958|66436553|FG002|Overall Study|Protocol Violation|2|||
23742574|NCT00594958|66436551|FG000|Overall Study|Lost to Follow-up|5|||
23742575|NCT00594958|66436552|FG001|Overall Study|Lost to Follow-up|0|||
23742576|NCT00594958|66436553|FG002|Overall Study|Lost to Follow-up|3|||
23742577|NCT00594958|66436551|FG000|Overall Study|administrative|3|||
23742578|NCT00594958|66436552|FG001|Overall Study|administrative|0|||
23742579|NCT00594958|66436553|FG002|Overall Study|administrative|2|||
23742580|NCT01654666|66436558|FG000|Overall Study|Protocol Violation|7|||
23742581|NCT01654666|66436559|FG001|Overall Study|Protocol Violation|4|||
23742582|NCT01654666|66436560|FG002|Overall Study|Protocol Violation|8|||
23742583|NCT01654666|66436558|FG000|Overall Study|Lost to Follow-up|4|||
23742584|NCT01654666|66436559|FG001|Overall Study|Lost to Follow-up|5|||
23742585|NCT01654666|66436560|FG002|Overall Study|Lost to Follow-up|5|||
23742586|NCT01654666|66436558|FG000|Overall Study|Withdrawal by Subject|4|||
23742587|NCT01654666|66436559|FG001|Overall Study|Withdrawal by Subject|4|||
23742588|NCT01654666|66436560|FG002|Overall Study|Withdrawal by Subject|1|||
23742589|NCT04576702|66436561|FG000|Overall Study|Death|1|||
23742590|NCT04576702|66436562|FG001|Overall Study|Death|0|||
23742591|NCT04576702|66436563|FG002|Overall Study|Death|0|||
23742592|NCT04576702|66436564|FG003|Overall Study|Death|0|||
23742593|NCT04576702|66436561|FG000|Overall Study|Withdrawal by Subject|0|||
23742594|NCT04576702|66436562|FG001|Overall Study|Withdrawal by Subject|2|||
23742595|NCT04576702|66436563|FG002|Overall Study|Withdrawal by Subject|1|||
23742596|NCT04576702|66436564|FG003|Overall Study|Withdrawal by Subject|0|||
23742597|NCT04576702|66436561|FG000|Overall Study|Lost to Follow-up|3|||
23742598|NCT04576702|66436562|FG001|Overall Study|Lost to Follow-up|3|||
23742599|NCT04576702|66436563|FG002|Overall Study|Lost to Follow-up|3|||
23742600|NCT04576702|66436564|FG003|Overall Study|Lost to Follow-up|4|||
23742601|NCT02331680|66436566|FG000|Overall Study|Adverse Event|3|||
23550719|NCT00989287|65747454|FG000|Overall Study|Adverse Event|1|||
23550720|NCT00989287|65747455|FG001|Overall Study|Adverse Event|0|||
23550721|NCT00989287|65747454|FG000|Overall Study|Lost to Follow-up|0|||
23550722|NCT00989287|65747455|FG001|Overall Study|Lost to Follow-up|1|||
23550723|NCT01218126|65747456|FG000|Overall Study|Adverse Event|8|||
23550724|NCT01218126|65747457|FG001|Overall Study|Adverse Event|10|||
23550725|NCT01218126|65747458|FG002|Overall Study|Adverse Event|12|||
23550726|NCT01218126|65747459|FG003|Overall Study|Adverse Event|16|||
23550727|NCT01218126|65747456|FG000|Overall Study|Lack of Efficacy|7|||
23550728|NCT01218126|65747457|FG001|Overall Study|Lack of Efficacy|2|||
23550729|NCT01218126|65747458|FG002|Overall Study|Lack of Efficacy|2|||
23550730|NCT01218126|65747459|FG003|Overall Study|Lack of Efficacy|6|||
23550731|NCT01218126|65747456|FG000|Overall Study|Protocol Violation|5|||
23550732|NCT01218126|65747457|FG001|Overall Study|Protocol Violation|2|||
23550733|NCT01218126|65747458|FG002|Overall Study|Protocol Violation|2|||
23550734|NCT01218126|65747459|FG003|Overall Study|Protocol Violation|3|||
23550735|NCT01218126|65747456|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23550736|NCT01218126|65747457|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23550737|NCT01218126|65747458|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23550738|NCT01218126|65747459|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23742602|NCT02331680|66436567|FG001|Overall Study|Adverse Event|0|||
23742603|NCT02331680|66436568|FG002|Overall Study|Adverse Event|2|||
23742604|NCT02331680|66436566|FG000|Overall Study|Physician Decision|1|||
23742605|NCT02331680|66436567|FG001|Overall Study|Physician Decision|1|||
23742606|NCT02331680|66436568|FG002|Overall Study|Physician Decision|2|||
23742607|NCT02331680|66436566|FG000|Overall Study|Withdrawal by Subject|0|||
23742608|NCT02331680|66436567|FG001|Overall Study|Withdrawal by Subject|1|||
23742609|NCT02331680|66436568|FG002|Overall Study|Withdrawal by Subject|2|||
23742610|NCT02331680|66436566|FG000|Overall Study|Met withdrawal criteria|2|||
23742611|NCT02331680|66436567|FG001|Overall Study|Met withdrawal criteria|2|||
23742612|NCT02331680|66436568|FG002|Overall Study|Met withdrawal criteria|5|||
23742613|NCT02331680|66436566|FG000|Overall Study|Non-compliance with study drug|0|||
23742614|NCT02331680|66436567|FG001|Overall Study|Non-compliance with study drug|0|||
23742615|NCT02331680|66436568|FG002|Overall Study|Non-compliance with study drug|1|||
23742616|NCT02331680|66436566|FG000|Overall Study|Protocol Violation|0|||
23742617|NCT02331680|66436567|FG001|Overall Study|Protocol Violation|0|||
23742618|NCT02331680|66436568|FG002|Overall Study|Protocol Violation|3|||
23742619|NCT00711009|66436569|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
23742620|NCT00711009|66436570|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
23550739|NCT01218126|65747456|FG000|Overall Study|Lost to Follow-up|0|||
23550740|NCT01218126|65747457|FG001|Overall Study|Lost to Follow-up|0|||
23550741|NCT01218126|65747458|FG002|Overall Study|Lost to Follow-up|0|||
23550742|NCT01218126|65747459|FG003|Overall Study|Lost to Follow-up|2|||
23550743|NCT01218126|65747456|FG000|Overall Study|Physician Decision|1|||
23550744|NCT01218126|65747457|FG001|Overall Study|Physician Decision|2|||
23550745|NCT01218126|65747458|FG002|Overall Study|Physician Decision|4|||
23550746|NCT01218126|65747459|FG003|Overall Study|Physician Decision|2|||
23550747|NCT01218126|65747456|FG000|Overall Study|Withdrawal by Subject|2|||
23550748|NCT01218126|65747457|FG001|Overall Study|Withdrawal by Subject|5|||
23550749|NCT01218126|65747458|FG002|Overall Study|Withdrawal by Subject|4|||
23550750|NCT01218126|65747459|FG003|Overall Study|Withdrawal by Subject|6|||
23550751|NCT00608582|65747466|FG000|Overall Study|Lost to Follow-up|2|||
23550752|NCT00608582|65747467|FG001|Overall Study|Lost to Follow-up|0|||
23742621|NCT00711009|66436569|FG000|Overall Study|Withdrawal by Subject|4|||
23742622|NCT00711009|66436570|FG001|Overall Study|Withdrawal by Subject|2|||
23742623|NCT00711009|66436569|FG000|Overall Study|Lost to Follow-up|3|||
23742624|NCT00711009|66436570|FG001|Overall Study|Lost to Follow-up|9|||
23742625|NCT00711009|66436569|FG000|Overall Study|Participant Noncompliant|0|||
23742626|NCT00711009|66436570|FG001|Overall Study|Participant Noncompliant|1|||
23742627|NCT00711009|66436569|FG000|Overall Study|Virologic Failure|2|||
23742628|NCT00711009|66436570|FG001|Overall Study|Virologic Failure|1|||
23742629|NCT00711009|66436569|FG000|Overall Study|Pregnancy|1|||
23742630|NCT00711009|66436570|FG001|Overall Study|Pregnancy|0|||
23742631|NCT00711009|66436569|FG000|Overall Study|Site closing|0|||
23742632|NCT00711009|66436570|FG001|Overall Study|Site closing|1|||
23742633|NCT00711009|66436569|FG000|Overall Study|Dose adjustment|1|||
23742634|NCT00711009|66436570|FG001|Overall Study|Dose adjustment|0|||
23742635|NCT02500732|66436571|FG000|Overall Study|Physician Decision|0|||
23742636|NCT02500732|66436572|FG001|Overall Study|Physician Decision|1|||
23742637|NCT03205605|66436574|FG000|Overall Study|Withdrawal by Subject|1|||
23742638|NCT01884675|66436575|FG000|Overall Study|Study closed/terminated|3|||
23742639|NCT01884675|66436576|FG001|Overall Study|Study closed/terminated|2|||
23742640|NCT01636076|66436577|FG000|Overall Study|Terminated by sponsor|1|||
23742641|NCT01636076|66436578|FG001|Overall Study|Terminated by sponsor|1|||
23742642|NCT01636076|66436577|FG000|Overall Study|Lack of Efficacy|0|||
23742643|NCT01636076|66436578|FG001|Overall Study|Lack of Efficacy|1|||
23742644|NCT01636076|66436577|FG000|Overall Study|Lost to Follow-up|1|||
23742645|NCT01636076|66436578|FG001|Overall Study|Lost to Follow-up|0|||
23742646|NCT01636076|66436577|FG000|Overall Study|Physician Decision|1|||
23742647|NCT01636076|66436578|FG001|Overall Study|Physician Decision|1|||
23742648|NCT01636076|66436577|FG000|Overall Study|Non-compliance with study treatment|1|||
23821736|NCT04604795|66726147|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23821737|NCT04604795|66726148|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23742649|NCT01636076|66436578|FG001|Overall Study|Non-compliance with study treatment|1|||
23742650|NCT01636076|66436577|FG000|Overall Study|Adverse Event|6|||
23742651|NCT01636076|66436578|FG001|Overall Study|Adverse Event|11|||
23742652|NCT01636076|66436577|FG000|Overall Study|Withdrawal by Subject|7|||
23742653|NCT01636076|66436578|FG001|Overall Study|Withdrawal by Subject|10|||
23550753|NCT00608582|65747466|FG000|Overall Study|No Best Response in Phase 1 located|1|||
23550754|NCT00608582|65747467|FG001|Overall Study|No Best Response in Phase 1 located|1|||
23550755|NCT00608582|65747466|FG000|Overall Study|Illicit Drug Use|1|||
23550756|NCT00608582|65747467|FG001|Overall Study|Illicit Drug Use|0|||
23550757|NCT00608582|65747466|FG000|Overall Study|Early stage Design Change|0|||
23550758|NCT00608582|65747467|FG001|Overall Study|Early stage Design Change|3|||
23550759|NCT01854827|65747468|FG000|Overall Study|Death|1|||
23550760|NCT00937924|65747469|FG000|Overall Study|Lost to Follow-up|44|||
23742654|NCT00649220|66436584|FG000|Overall Study|Adverse Event|2|||
23742655|NCT00649220|66436584|FG000|Overall Study|Withdrawal by Subject|1|||
23742656|NCT00486720|66436585|FG000|Overall Study|Adverse Event|1|||
23742657|NCT00486720|66436586|FG001|Overall Study|Adverse Event|2|||
23742658|NCT00486720|66436585|FG000|Overall Study|Lack of Efficacy|4|||
23742659|NCT00486720|66436586|FG001|Overall Study|Lack of Efficacy|6|||
23550761|NCT00937924|65747470|FG001|Overall Study|Lost to Follow-up|44|||
23550762|NCT00937924|65747471|FG002|Overall Study|Lost to Follow-up|41|||
23550763|NCT01328080|65747479|FG000|Overall Study|Lost to Follow-up|5|||
23550764|NCT01140880|65747484|FG000|Overall Study|Death|0|||
23742660|NCT00486720|66436585|FG000|Overall Study|Physician Decision|1|||
23742661|NCT00486720|66436586|FG001|Overall Study|Physician Decision|2|||
23742662|NCT00486720|66436585|FG000|Overall Study|Protocol Violation|1|||
23742663|NCT00486720|66436586|FG001|Overall Study|Protocol Violation|0|||
23742664|NCT00486720|66436585|FG000|Overall Study|Withdrawal by Subject|3|||
23742665|NCT00486720|66436586|FG001|Overall Study|Withdrawal by Subject|1|||
23742666|NCT00486720|66436585|FG000|Overall Study|Progressive Disease|0|||
23742667|NCT00486720|66436586|FG001|Overall Study|Progressive Disease|1|||
23742668|NCT02985996|66436587|FG000|Overall Study|Withdrawal by Subject|0|||
23742669|NCT02985996|66436588|FG001|Overall Study|Withdrawal by Subject|0|||
23742670|NCT02985996|66436589|FG002|Overall Study|Withdrawal by Subject|1|||
23742671|NCT02985996|66436590|FG003|Overall Study|Withdrawal by Subject|0|||
23742672|NCT02985996|66436591|FG004|Overall Study|Withdrawal by Subject|0|||
23742673|NCT02985996|66436587|FG000|Overall Study|Protocol Violation|0|||
23742674|NCT02985996|66436588|FG001|Overall Study|Protocol Violation|1|||
23742675|NCT02985996|66436589|FG002|Overall Study|Protocol Violation|0|||
23742676|NCT02985996|66436590|FG003|Overall Study|Protocol Violation|0|||
23742677|NCT02985996|66436591|FG004|Overall Study|Protocol Violation|0|||
23742678|NCT00772031|66436592|FG000|Overall Study|Early termination of trial|12|||
23742679|NCT00772031|66436593|FG001|Overall Study|Early termination of trial|10|||
23742680|NCT00772031|66436592|FG000|Overall Study|Lost to Follow-up|20|||
23742681|NCT00772031|66436593|FG001|Overall Study|Lost to Follow-up|33|||
23742682|NCT03053180|66436594|FG000|Overall Study|Failure to Return|1|||
23742683|NCT03799198|66436595|FG000|Overall Study|Lost to Follow-up|4|||
23742684|NCT03799198|66436596|FG001|Overall Study|Lost to Follow-up|8|||
23742685|NCT03799198|66436595|FG000|Overall Study|Death|0|||
23742686|NCT03799198|66436596|FG001|Overall Study|Death|1|||
23742687|NCT01021423|66436603|FG000|Overall Study|Study terminated|4|||
23742688|NCT01021423|66436604|FG001|Overall Study|Study terminated|5|||
23742689|NCT01786707|66436605|FG000|Overall Study|Lost to Follow-up|1|||
23742690|NCT01786707|66436606|FG001|Overall Study|Lost to Follow-up|1|||
23742691|NCT00368069|66436615|FG000|Overall Study|Adverse Event|5|||
23742692|NCT00368069|66436616|FG001|Overall Study|Adverse Event|2|||
23742693|NCT00368069|66436615|FG000|Overall Study|Lack of Efficacy|0|||
23742694|NCT00368069|66436616|FG001|Overall Study|Lack of Efficacy|1|||
23742695|NCT00368069|66436615|FG000|Overall Study|Lost to Follow-up|1|||
23742696|NCT00368069|66436616|FG001|Overall Study|Lost to Follow-up|0|||
23742697|NCT00368069|66436615|FG000|Overall Study|Protocol Violation|0|||
23742698|NCT00368069|66436616|FG001|Overall Study|Protocol Violation|2|||
23742699|NCT00368069|66436615|FG000|Overall Study|Withdrawal of Consent|2|||
23742700|NCT00368069|66436616|FG001|Overall Study|Withdrawal of Consent|1|||
23742701|NCT00368069|66436615|FG000|Overall Study|no blood sampling possible|0|||
23742702|NCT00368069|66436616|FG001|Overall Study|no blood sampling possible|1|||
23742703|NCT02569996|66436619|FG000|Overall Study|Adverse Event|6|||
23742704|NCT02569996|66436619|FG000|Overall Study|Physician Decision|3|||
23742705|NCT02569996|66436619|FG000|Overall Study|Progression of the disease|18|||
23742706|NCT02569996|66436619|FG000|Overall Study|New anti-lymphoma treatment|1|||
23742707|NCT02569996|66436619|FG000|Overall Study|Non-compliance|9|||
23742708|NCT02569996|66436619|FG000|Overall Study|Withdrawal by Subject|5|||
23742709|NCT02569996|66436619|FG000|Overall Study|Lost to Follow-up|5|||
23742710|NCT02569996|66436619|FG000|Overall Study|Complete remission|7|||
23742711|NCT02569996|66436619|FG000|Overall Study|Unknown reason|1|||
23742712|NCT00135694|66436620|FG000|Overall Study|Adverse Event|17|||
23742713|NCT00135694|66436621|FG001|Overall Study|Adverse Event|4|||
23742714|NCT00135694|66436622|FG002|Overall Study|Adverse Event|0|||
23742715|NCT00135694|66436620|FG000|Overall Study|Death|14|||
23742716|NCT00135694|66436621|FG001|Overall Study|Death|1|||
23742717|NCT00135694|66436622|FG002|Overall Study|Death|2|||
23742718|NCT00135694|66436620|FG000|Overall Study|Lost to Follow-up|8|||
23742719|NCT00135694|66436621|FG001|Overall Study|Lost to Follow-up|7|||
23742720|NCT00135694|66436622|FG002|Overall Study|Lost to Follow-up|1|||
23742721|NCT00135694|66436620|FG000|Overall Study|Withdrawal by Subject|41|||
23742722|NCT00135694|66436621|FG001|Overall Study|Withdrawal by Subject|7|||
23742723|NCT00135694|66436622|FG002|Overall Study|Withdrawal by Subject|4|||
23742724|NCT00135694|66436620|FG000|Overall Study|Protocol Violation|19|||
23742725|NCT00135694|66436621|FG001|Overall Study|Protocol Violation|1|||
23742726|NCT00135694|66436622|FG002|Overall Study|Protocol Violation|0|||
23742727|NCT00135694|66436620|FG000|Overall Study|Hepatitis C related reasons|39|||
23742728|NCT00135694|66436621|FG001|Overall Study|Hepatitis C related reasons|1|||
23742729|NCT00135694|66436622|FG002|Overall Study|Hepatitis C related reasons|0|||
23742730|NCT00135694|66436620|FG000|Overall Study|Ineligible for Random assignment|42|||
23742731|NCT00135694|66436621|FG001|Overall Study|Ineligible for Random assignment|0|||
23742732|NCT00135694|66436622|FG002|Overall Study|Ineligible for Random assignment|0|||
23742733|NCT03781167|66436623|FG000|Overall Study|Adverse Event|23|||
23742734|NCT03781167|66436624|FG001|Overall Study|Adverse Event|25|||
23742735|NCT03781167|66436623|FG000|Overall Study|Withdrew consent|16|||
23742736|NCT03781167|66436624|FG001|Overall Study|Withdrew consent|12|||
23742737|NCT03781167|66436623|FG000|Overall Study|Lost to Follow-up|0|||
23742738|NCT03781167|66436624|FG001|Overall Study|Lost to Follow-up|1|||
23742739|NCT03781167|66436623|FG000|Overall Study|Lack of Efficacy|4|||
23742740|NCT03781167|66436624|FG001|Overall Study|Lack of Efficacy|5|||
23742741|NCT03781167|66436623|FG000|Overall Study|Difficulty with drug delivery system|2|||
23742742|NCT03781167|66436624|FG001|Overall Study|Difficulty with drug delivery system|3|||
23742743|NCT03781167|66436623|FG000|Overall Study|Other, not specified|2|||
23742744|NCT03781167|66436624|FG001|Overall Study|Other, not specified|2|||
23742745|NCT01159665|66436635|FG000|Overall Study|Withdrawal by Subject|0|||
23742746|NCT01159665|66436636|FG001|Overall Study|Withdrawal by Subject|1|||
23742747|NCT01159665|66436637|FG002|Overall Study|Withdrawal by Subject|0|||
23742748|NCT01159665|66436638|FG003|Overall Study|Withdrawal by Subject|0|||
23550765|NCT01140880|65747485|FG001|Overall Study|Death|1|||
23550766|NCT01140880|65747484|FG000|Overall Study|Withdrawal by Subject|6|||
23550767|NCT01140880|65747485|FG001|Overall Study|Withdrawal by Subject|3|||
23550768|NCT01140880|65747484|FG000|Overall Study|Lost to Follow-up|8|||
23550769|NCT01140880|65747485|FG001|Overall Study|Lost to Follow-up|10|||
23550770|NCT01140880|65747484|FG000|Overall Study|Protocol Violation|0|||
23550771|NCT01140880|65747485|FG001|Overall Study|Protocol Violation|30|||
23550772|NCT04205630|65747491|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
23550773|NCT04205630|65747491|FG000|Overall Study|Disease clinical progression|7|||
23550774|NCT04205630|65747491|FG000|Overall Study|Withdrawal by Subject|2|||
23550775|NCT04205630|65747491|FG000|Overall Study|Adverse Event|17|||
23550776|NCT04205630|65747491|FG000|Overall Study|Other|1|||
23550777|NCT00773968|65747492|FG000|Overall Study|Adverse Event|2|||
23550778|NCT00773968|65747492|FG000|Overall Study|Death|1|||
23550779|NCT00773968|65747492|FG000|Overall Study|Failure to Return|2|||
23550780|NCT00773968|65747492|FG000|Overall Study|Lack of Efficacy|3|||
23550781|NCT00773968|65747492|FG000|Overall Study|Protocol Violation|1|||
23550782|NCT00773968|65747492|FG000|Overall Study|Withdrawal by Subject|11|||
23550783|NCT00773968|65747492|FG000|Overall Study|Screen Failure|17|||
23550784|NCT00773968|65747492|FG000|Overall Study|Other|8|||
23550785|NCT01475136|65747495|FG000|Overall Study|Sponsor Decision|0|||
23550786|NCT01475136|65747496|FG001|Overall Study|Sponsor Decision|1|||
23550787|NCT01475136|65747497|FG002|Overall Study|Sponsor Decision|0|||
23550788|NCT01475136|65747498|FG003|Overall Study|Sponsor Decision|0|||
23550789|NCT01475136|65747495|FG000|Overall Study|Entry Criteria Not Met|0|||
23550790|NCT01475136|65747496|FG001|Overall Study|Entry Criteria Not Met|2|||
23550791|NCT01475136|65747497|FG002|Overall Study|Entry Criteria Not Met|3|||
23550792|NCT01475136|65747498|FG003|Overall Study|Entry Criteria Not Met|1|||
23550793|NCT01475136|65747495|FG000|Overall Study|Withdrawal by Subject|0|||
23550794|NCT01475136|65747496|FG001|Overall Study|Withdrawal by Subject|0|||
23550795|NCT01475136|65747497|FG002|Overall Study|Withdrawal by Subject|0|||
23550796|NCT01475136|65747498|FG003|Overall Study|Withdrawal by Subject|2|||
23550797|NCT01475136|65747495|FG000|Overall Study|Adverse Event|1|||
23550798|NCT01475136|65747496|FG001|Overall Study|Adverse Event|0|||
23550799|NCT01475136|65747497|FG002|Overall Study|Adverse Event|0|||
23550800|NCT01475136|65747498|FG003|Overall Study|Adverse Event|1|||
23550801|NCT01475136|65747495|FG000|Overall Study|Death|0|||
23550802|NCT01475136|65747496|FG001|Overall Study|Death|0|||
23550803|NCT01475136|65747497|FG002|Overall Study|Death|0|||
23550804|NCT01475136|65747498|FG003|Overall Study|Death|1|||
23550805|NCT02012491|65747499|FG000|Overall Study|Lost to Follow-up|1|||
23550806|NCT02012491|65747500|FG001|Overall Study|Lost to Follow-up|0|||
23550807|NCT02012491|65747499|FG000|Overall Study|Protocol Violation|0|||
23550808|NCT02012491|65747500|FG001|Overall Study|Protocol Violation|1|||
23550809|NCT02012491|65747499|FG000|Overall Study|Withdrawal by Subject|1|||
23550810|NCT02012491|65747500|FG001|Overall Study|Withdrawal by Subject|0|||
23550811|NCT02310750|65747501|FG000|HP Period 1|Lost to Follow-up|0|||
23550812|NCT02310750|65747502|FG001|HP Period 1|Lost to Follow-up|0|||
23550813|NCT02310750|65747503|FG002|HP Period 1|Lost to Follow-up|0|||
23550814|NCT02310750|65747504|FG003|HP Period 1|Lost to Follow-up|0|||
23550815|NCT02310750|65747505|FG004|HP Period 1|Lost to Follow-up|0|||
23550816|NCT02310750|65747506|FG005|HP Period 1|Lost to Follow-up|0|||
23550817|NCT02310750|65747507|FG006|HP Period 1|Lost to Follow-up|1|||
23742749|NCT01159665|66436639|FG004|Overall Study|Withdrawal by Subject|0|||
23742750|NCT01159665|66436640|FG005|Overall Study|Withdrawal by Subject|0|||
23742751|NCT02534324|66436641|FG000|Overall Study|Protocol Violation|4|||
23550818|NCT02310750|65747508|FG007|HP Period 1|Lost to Follow-up|0|||
23550819|NCT02310750|65747509|FG008|HP Period 1|Lost to Follow-up|0|||
23550820|NCT02310750|65747510|FG009|HP Period 1|Lost to Follow-up|0|||
23550821|NCT02310750|65747511|FG010|HP Period 1|Lost to Follow-up|0|||
23550822|NCT02310750|65747512|FG011|HP Period 1|Lost to Follow-up|0|||
23550823|NCT02310750|65747513|FG012|HP Period 1|Lost to Follow-up|0|||
23550824|NCT02310750|65747514|FG013|HP Period 1|Lost to Follow-up|0|||
23550825|NCT02310750|65747515|FG014|HP Period 1|Lost to Follow-up|0|||
23550826|NCT02310750|65747516|FG015|HP Period 1|Lost to Follow-up|0|||
23550827|NCT02310750|65747501|FG000|HP Period 1|Withdrawal by Subject|1|||
23550828|NCT02310750|65747502|FG001|HP Period 1|Withdrawal by Subject|0|||
23550829|NCT02310750|65747503|FG002|HP Period 1|Withdrawal by Subject|0|||
23550830|NCT02310750|65747504|FG003|HP Period 1|Withdrawal by Subject|1|||
23550831|NCT02310750|65747505|FG004|HP Period 1|Withdrawal by Subject|0|||
23742752|NCT02534324|66436642|FG001|Overall Study|Protocol Violation|1|||
23742753|NCT02534324|66436641|FG000|Overall Study|Lost to Follow-up|20|||
23742754|NCT02534324|66436642|FG001|Overall Study|Lost to Follow-up|7|||
23742755|NCT02534324|66436641|FG000|Overall Study|Adverse Event|1|||
23742756|NCT02534324|66436642|FG001|Overall Study|Adverse Event|0|||
23742757|NCT02545504|66436643|FG000|Overall Study|Death|174|||
23742758|NCT02545504|66436644|FG001|Overall Study|Death|168|||
23742759|NCT02545504|66436643|FG000|Overall Study|Unknown reason|30|||
23742760|NCT02545504|66436644|FG001|Overall Study|Unknown reason|32|||
23742761|NCT02545504|66436643|FG000|Overall Study|Withdrew consent|9|||
23742762|NCT02545504|66436644|FG001|Overall Study|Withdrew consent|11|||
23742763|NCT02545504|66436643|FG000|Overall Study|Investigator's discretion|3|||
23742764|NCT02545504|66436644|FG001|Overall Study|Investigator's discretion|1|||
23742765|NCT02545504|66436643|FG000|Overall Study|Lost to Follow-up|2|||
23742766|NCT02545504|66436644|FG001|Overall Study|Lost to Follow-up|2|||
23742767|NCT00505765|66436645|FG000|Overall Study|Withdrawal by Subject|1|||
23742768|NCT00505765|66436646|FG001|Overall Study|Withdrawal by Subject|0|||
23742769|NCT00505765|66436647|FG002|Overall Study|Withdrawal by Subject|0|||
23742770|NCT00505765|66436645|FG000|Overall Study|Adverse Event|1|||
23742771|NCT00505765|66436646|FG001|Overall Study|Adverse Event|2|||
23742772|NCT00505765|66436647|FG002|Overall Study|Adverse Event|0|||
23742773|NCT00505765|66436645|FG000|Overall Study|Noncompliance|0|||
23429850|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
23429851|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23429852|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
23429853|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
23429854|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
23429855|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
23429856|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
23429857|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
23429858|NCT02636946|65317538|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
23429859|NCT02636946|65317539|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
23429860|NCT05219669|65317540|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429861|NCT05219669|65317541|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429862|NCT05219669|65317542|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
23429863|NCT05219669|65317543|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
23742774|NCT00505765|66436646|FG001|Overall Study|Noncompliance|1|||
23742775|NCT00505765|66436647|FG002|Overall Study|Noncompliance|3|||
23742776|NCT01233076|66436648|FG000|Period 2, One Week|Lost to Follow-up|1|||
23742777|NCT01233076|66436649|FG001|Period 2, One Week|Lost to Follow-up|0|||
23742778|NCT01241591|66436654|FG000|Overall Study|Lack of Efficacy|5|||
23742779|NCT01241591|66436655|FG001|Overall Study|Lack of Efficacy|2|||
23742780|NCT01241591|66436656|FG002|Overall Study|Lack of Efficacy|2|||
23742781|NCT01241591|66436657|FG003|Overall Study|Lack of Efficacy|3|||
23742782|NCT01241591|66436654|FG000|Overall Study|Protocol Violation|5|||
23742783|NCT01241591|66436655|FG001|Overall Study|Protocol Violation|2|||
23742784|NCT01241591|66436656|FG002|Overall Study|Protocol Violation|3|||
23742785|NCT01241591|66436657|FG003|Overall Study|Protocol Violation|0|||
23742786|NCT01241591|66436654|FG000|Overall Study|Lost to Follow-up|1|||
23742787|NCT01241591|66436655|FG001|Overall Study|Lost to Follow-up|2|||
23742788|NCT01241591|66436656|FG002|Overall Study|Lost to Follow-up|2|||
23742789|NCT01241591|66436657|FG003|Overall Study|Lost to Follow-up|2|||
23742790|NCT01241591|66436654|FG000|Overall Study|Screen Failure|3|||
23429864|NCT05219669|65317544|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429865|NCT05219669|65317545|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429866|NCT00748709|65317546|FG000|Overall Study|Progressive disease|15|||
23429867|NCT00748709|65317546|FG000|Overall Study|Drug reducing Toxity|2|||
23429868|NCT00748709|65317546|FG000|Overall Study|Other Adverse Event|1|||
23742791|NCT01241591|66436655|FG001|Overall Study|Screen Failure|2|||
23742792|NCT01241591|66436656|FG002|Overall Study|Screen Failure|1|||
23742793|NCT01241591|66436657|FG003|Overall Study|Screen Failure|0|||
23742794|NCT01241591|66436654|FG000|Overall Study|Withdrawal by Subject|6|||
23742795|NCT01241591|66436655|FG001|Overall Study|Withdrawal by Subject|4|||
23742796|NCT01241591|66436656|FG002|Overall Study|Withdrawal by Subject|2|||
23742797|NCT01241591|66436657|FG003|Overall Study|Withdrawal by Subject|2|||
23742798|NCT01241591|66436654|FG000|Overall Study|Other|0|||
23742799|NCT01241591|66436655|FG001|Overall Study|Other|1|||
23429869|NCT00748709|65317546|FG000|Overall Study|Withdrawal by Subject|1|||
23429870|NCT00748709|65317546|FG000|Overall Study|Other Reasons|1|||
23429871|NCT01064687|65317549|FG000|Overall Study|Adverse Event|9|||
23429872|NCT01064687|65317550|FG001|Overall Study|Adverse Event|4|||
23429873|NCT01064687|65317551|FG002|Overall Study|Adverse Event|10|||
23429874|NCT01064687|65317552|FG003|Overall Study|Adverse Event|3|||
23429875|NCT01064687|65317549|FG000|Overall Study|Death|1|||
23429876|NCT01064687|65317550|FG001|Overall Study|Death|1|||
23429877|NCT01064687|65317551|FG002|Overall Study|Death|0|||
23429878|NCT01064687|65317552|FG003|Overall Study|Death|0|||
23429879|NCT01064687|65317549|FG000|Overall Study|Entry Criteria Not Met|3|||
23429880|NCT01064687|65317550|FG001|Overall Study|Entry Criteria Not Met|0|||
23429881|NCT01064687|65317551|FG002|Overall Study|Entry Criteria Not Met|0|||
23429882|NCT01064687|65317552|FG003|Overall Study|Entry Criteria Not Met|0|||
23429883|NCT01064687|65317549|FG000|Overall Study|Lack of Efficacy|1|||
23429884|NCT01064687|65317550|FG001|Overall Study|Lack of Efficacy|0|||
23429885|NCT01064687|65317551|FG002|Overall Study|Lack of Efficacy|2|||
23429886|NCT01064687|65317552|FG003|Overall Study|Lack of Efficacy|3|||
23429887|NCT01064687|65317549|FG000|Overall Study|Lost to Follow-up|7|||
23429888|NCT01064687|65317550|FG001|Overall Study|Lost to Follow-up|10|||
23429889|NCT01064687|65317551|FG002|Overall Study|Lost to Follow-up|13|||
23429890|NCT01064687|65317552|FG003|Overall Study|Lost to Follow-up|5|||
23429891|NCT01064687|65317549|FG000|Overall Study|Physician Decision|2|||
23429892|NCT01064687|65317550|FG001|Overall Study|Physician Decision|2|||
23429893|NCT01064687|65317551|FG002|Overall Study|Physician Decision|0|||
23429894|NCT01064687|65317552|FG003|Overall Study|Physician Decision|0|||
23429895|NCT01064687|65317549|FG000|Overall Study|Protocol Violation|1|||
23429896|NCT01064687|65317550|FG001|Overall Study|Protocol Violation|1|||
23429897|NCT01064687|65317551|FG002|Overall Study|Protocol Violation|0|||
23429898|NCT01064687|65317552|FG003|Overall Study|Protocol Violation|1|||
23429899|NCT01064687|65317549|FG000|Overall Study|Sponsor Decision|0|||
23429900|NCT01064687|65317550|FG001|Overall Study|Sponsor Decision|0|||
23429901|NCT01064687|65317551|FG002|Overall Study|Sponsor Decision|3|||
23429902|NCT01064687|65317552|FG003|Overall Study|Sponsor Decision|0|||
23429903|NCT01064687|65317549|FG000|Overall Study|Withdrawal by Subject|9|||
23550832|NCT02310750|65747506|FG005|HP Period 1|Withdrawal by Subject|0|||
23550833|NCT02310750|65747507|FG006|HP Period 1|Withdrawal by Subject|0|||
23429904|NCT01064687|65317550|FG001|Overall Study|Withdrawal by Subject|7|||
23429905|NCT01064687|65317551|FG002|Overall Study|Withdrawal by Subject|12|||
23429906|NCT01064687|65317552|FG003|Overall Study|Withdrawal by Subject|5|||
23429907|NCT01064687|65317549|FG000|Overall Study|Treatment Noncompliance|1|||
23429908|NCT01064687|65317550|FG001|Overall Study|Treatment Noncompliance|1|||
23429909|NCT01064687|65317551|FG002|Overall Study|Treatment Noncompliance|1|||
23429910|NCT01064687|65317552|FG003|Overall Study|Treatment Noncompliance|0|||
23429911|NCT00969436|65317553|FG000|Overall Study|Protocol Violation|1|||
23550834|NCT02310750|65747508|FG007|HP Period 1|Withdrawal by Subject|0|||
23429912|NCT00969436|65317554|FG001|Overall Study|Protocol Violation|3|||
23429913|NCT00969436|65317555|FG002|Overall Study|Protocol Violation|0|||
23429914|NCT00969436|65317553|FG000|Overall Study|Migrated/moved from study area|12|||
23429915|NCT00969436|65317554|FG001|Overall Study|Migrated/moved from study area|10|||
23429916|NCT00969436|65317555|FG002|Overall Study|Migrated/moved from study area|2|||
23429917|NCT00969436|65317553|FG000|Overall Study|Father - serious health problem|0|||
23429918|NCT00969436|65317554|FG001|Overall Study|Father - serious health problem|0|||
23429919|NCT00969436|65317555|FG002|Overall Study|Father - serious health problem|1|||
23429920|NCT00969436|65317553|FG000|Overall Study|Parents personal problem|0|||
23429921|NCT00969436|65317554|FG001|Overall Study|Parents personal problem|0|||
23429922|NCT00969436|65317555|FG002|Overall Study|Parents personal problem|1|||
23429923|NCT00969436|65317553|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
23429924|NCT00969436|65317554|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
23429925|NCT00969436|65317555|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
23429926|NCT00969436|65317553|FG000|Overall Study|Withdrawal by Subject|3|||
23429927|NCT00969436|65317554|FG001|Overall Study|Withdrawal by Subject|0|||
23429928|NCT00969436|65317555|FG002|Overall Study|Withdrawal by Subject|2|||
23429929|NCT00969436|65317553|FG000|Overall Study|Lost to Follow-up|8|||
23429930|NCT00969436|65317554|FG001|Overall Study|Lost to Follow-up|8|||
23429931|NCT00969436|65317555|FG002|Overall Study|Lost to Follow-up|5|||
23429932|NCT01439126|65317556|FG000|Overall Study|Adverse Event|2|||
23429933|NCT01439126|65317557|FG001|Overall Study|Adverse Event|0|||
23429934|NCT01439126|65317556|FG000|Overall Study|Withdrawal by Subject|5|||
23429935|NCT01439126|65317557|FG001|Overall Study|Withdrawal by Subject|21|||
23429936|NCT01439126|65317556|FG000|Overall Study|Protocol Violation|6|||
23429937|NCT01439126|65317557|FG001|Overall Study|Protocol Violation|4|||
23429938|NCT01439126|65317556|FG000|Overall Study|Lost to Follow-up|6|||
23429939|NCT01439126|65317557|FG001|Overall Study|Lost to Follow-up|3|||
23429940|NCT01439126|65317556|FG000|Overall Study|Other-Use of prohibited treatment|0|||
23429941|NCT01439126|65317557|FG001|Overall Study|Other-Use of prohibited treatment|2|||
23429942|NCT01439126|65317556|FG000|Overall Study|Other-Miscellaneous|12|||
23429943|NCT01439126|65317557|FG001|Overall Study|Other-Miscellaneous|12|||
23429944|NCT01299571|65317560|FG000|Overall Study|Protocol Violation|107|||
23429945|NCT01561963|65317561|FG000|Overall Study|Adverse Event|1|||
23429946|NCT01930890|65317564|FG000|Overall Study|Study Termination|14|||
23429947|NCT01930890|65317565|FG001|Overall Study|Study Termination|28|||
23429948|NCT01930890|65317566|FG002|Overall Study|Study Termination|13|||
23429949|NCT01930890|65317567|FG003|Overall Study|Study Termination|25|||
23429950|NCT01930890|65317564|FG000|Overall Study|Death|0|||
23429951|NCT01930890|65317565|FG001|Overall Study|Death|0|||
23429952|NCT01930890|65317566|FG002|Overall Study|Death|0|||
23429953|NCT01930890|65317567|FG003|Overall Study|Death|1|||
23429954|NCT01930890|65317564|FG000|Overall Study|Investigator Decision|0|||
23429955|NCT01930890|65317565|FG001|Overall Study|Investigator Decision|1|||
23429956|NCT01930890|65317566|FG002|Overall Study|Investigator Decision|0|||
23429957|NCT01930890|65317567|FG003|Overall Study|Investigator Decision|0|||
23429958|NCT01930890|65317564|FG000|Overall Study|Consent Withdrawn|0|||
23429959|NCT01930890|65317565|FG001|Overall Study|Consent Withdrawn|3|||
23429960|NCT01930890|65317566|FG002|Overall Study|Consent Withdrawn|0|||
23429961|NCT01930890|65317567|FG003|Overall Study|Consent Withdrawn|1|||
23429962|NCT01930890|65317564|FG000|Overall Study|Adverse Event|0|||
23429963|NCT01930890|65317565|FG001|Overall Study|Adverse Event|1|||
23429964|NCT01930890|65317566|FG002|Overall Study|Adverse Event|0|||
23429965|NCT01930890|65317567|FG003|Overall Study|Adverse Event|0|||
23429966|NCT00117793|65317568|FG000|Overall Study|Withdrawal by Subject|12|||
23429967|NCT03230292|65317569|FG000|Overall Study|Adverse Event|1|||
23429968|NCT03230292|65317569|FG000|Overall Study|Protocol Violation|1|||
23429969|NCT03230292|65317569|FG000|Overall Study|Lost to Follow-up|1|||
23429970|NCT03230292|65317569|FG000|Overall Study|Withdrawal by Subject|3|||
23429971|NCT03559699|65317570|FG000|Overall Study|Withdrawal by Subject|6|||
23429972|NCT03559699|65317570|FG000|Overall Study|Lost to Follow-up|1|||
23429973|NCT01369680|65317573|FG000|Overall Study|Lost to Follow-up|0|||
23429974|NCT01369680|65317574|FG001|Overall Study|Lost to Follow-up|0|||
23429975|NCT01369680|65317575|FG002|Overall Study|Lost to Follow-up|1|||
23429976|NCT01369680|65317576|FG003|Overall Study|Lost to Follow-up|2|||
23429977|NCT04376827|65317580|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
23429978|NCT04376827|65317581|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
23429979|NCT04376827|65317580|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
23429980|NCT04376827|65317581|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
23429981|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
23429982|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
23429983|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
23429984|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
23429985|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
23429986|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
23429987|NCT00489736|65317582|FG000|Overall Study|Lack of Efficacy|53|||
23429988|NCT00489736|65317583|FG001|Overall Study|Lack of Efficacy|14|||
23429989|NCT00489736|65317582|FG000|Overall Study|Adverse Event|32|||
23429990|NCT00489736|65317583|FG001|Overall Study|Adverse Event|45|||
23429991|NCT00489736|65317582|FG000|Overall Study|Poor compliance|6|||
23429992|NCT00489736|65317583|FG001|Overall Study|Poor compliance|2|||
23429993|NCT00489736|65317582|FG000|Overall Study|Not coded/ Not pre-specified|5|||
23429994|NCT00489736|65317583|FG001|Overall Study|Not coded/ Not pre-specified|8|||
23429995|NCT02683668|65317584|FG000|Period 2|Withdrawal by Subject|0|||
23429996|NCT02683668|65317585|FG001|Period 2|Withdrawal by Subject|1|||
23429997|NCT02683668|65317586|FG002|Period 2|Withdrawal by Subject|0|||
23429998|NCT00530920|65317589|FG000|Overall Study|Randomized but not treated|0|||
23429999|NCT00530920|65317590|FG001|Overall Study|Randomized but not treated|2|||
23430000|NCT00530920|65317591|FG002|Overall Study|Randomized but not treated|0|||
23430001|NCT00530920|65317589|FG000|Overall Study|Adverse Event|0|||
23430002|NCT00530920|65317590|FG001|Overall Study|Adverse Event|0|||
23430003|NCT00530920|65317591|FG002|Overall Study|Adverse Event|3|||
23430004|NCT00530920|65317589|FG000|Overall Study|Withdrawal by Subject|0|||
23430005|NCT00530920|65317590|FG001|Overall Study|Withdrawal by Subject|0|||
23430006|NCT00530920|65317591|FG002|Overall Study|Withdrawal by Subject|1|||
23430007|NCT04208087|65317592|FG000|Overall Study|Adverse Event|1|||
23430008|NCT04208087|65317593|FG001|Overall Study|Adverse Event|0|||
23430009|NCT04208087|65317594|FG002|Overall Study|Adverse Event|0|||
23430010|NCT04208087|65317595|FG003|Overall Study|Adverse Event|0|||
23430011|NCT04208087|65317596|FG004|Overall Study|Adverse Event|0|||
23430012|NCT04208087|65317592|FG000|Overall Study|Withdrawal by Subject|0|||
23430013|NCT04208087|65317593|FG001|Overall Study|Withdrawal by Subject|0|||
23430014|NCT04208087|65317594|FG002|Overall Study|Withdrawal by Subject|1|||
23550835|NCT02310750|65747509|FG008|HP Period 1|Withdrawal by Subject|0|||
23430015|NCT04208087|65317595|FG003|Overall Study|Withdrawal by Subject|0|||
23430016|NCT04208087|65317596|FG004|Overall Study|Withdrawal by Subject|0|||
23430017|NCT04208087|65317592|FG000|Overall Study|Other|0|||
23430018|NCT04208087|65317593|FG001|Overall Study|Other|0|||
23430019|NCT04208087|65317594|FG002|Overall Study|Other|0|||
23430020|NCT04208087|65317595|FG003|Overall Study|Other|0|||
23430021|NCT04208087|65317596|FG004|Overall Study|Other|1|||
23430022|NCT02644356|65317597|FG000|Overall Study|Withdrawal by Subject|2|||
23430023|NCT00490022|65317598|FG000|Overall Study|Adverse Event|0|||
23430024|NCT00490022|65317599|FG001|Overall Study|Adverse Event|2|||
23430025|NCT00490022|65317598|FG000|Overall Study|Withdrawal by Subject|1|||
23430026|NCT00490022|65317599|FG001|Overall Study|Withdrawal by Subject|0|||
23430027|NCT00490022|65317598|FG000|Overall Study|Subject failed to disclose concommitant|0|||
23430028|NCT00490022|65317599|FG001|Overall Study|Subject failed to disclose concommitant|1|||
23430029|NCT02084238|65317600|FG000|Overall Study|Lost to Follow-up|2|||
23430030|NCT01719003|65317601|FG000|Overall Study|Non compliant with protocol|1|||
23430031|NCT01719003|65317602|FG001|Overall Study|Non compliant with protocol|1|||
23430032|NCT01719003|65317603|FG002|Overall Study|Non compliant with protocol|0|||
23430033|NCT01719003|65317604|FG003|Overall Study|Non compliant with protocol|1|||
23430034|NCT01719003|65317605|FG004|Overall Study|Non compliant with protocol|2|||
23430035|NCT01719003|65317606|FG005|Overall Study|Non compliant with protocol|1|||
23430036|NCT01719003|65317607|FG006|Overall Study|Non compliant with protocol|2|||
23430037|NCT01719003|65317608|FG007|Overall Study|Non compliant with protocol|3|||
23430038|NCT01719003|65317609|FG008|Overall Study|Non compliant with protocol|0|||
23430039|NCT01719003|65317601|FG000|Overall Study|Adverse Event|6|||
23430040|NCT01719003|65317602|FG001|Overall Study|Adverse Event|5|||
23550836|NCT02310750|65747510|FG009|HP Period 1|Withdrawal by Subject|0|||
23550837|NCT02310750|65747511|FG010|HP Period 1|Withdrawal by Subject|0|||
23430041|NCT01719003|65317603|FG002|Overall Study|Adverse Event|4|||
23430042|NCT01719003|65317604|FG003|Overall Study|Adverse Event|3|||
23430043|NCT01719003|65317605|FG004|Overall Study|Adverse Event|4|||
23430044|NCT01719003|65317606|FG005|Overall Study|Adverse Event|3|||
23430045|NCT01719003|65317607|FG006|Overall Study|Adverse Event|6|||
23430046|NCT01719003|65317608|FG007|Overall Study|Adverse Event|5|||
23430047|NCT01719003|65317609|FG008|Overall Study|Adverse Event|0|||
23430048|NCT01719003|65317601|FG000|Overall Study|Lost to Follow-up|0|||
23430049|NCT01719003|65317602|FG001|Overall Study|Lost to Follow-up|6|||
23430050|NCT01719003|65317603|FG002|Overall Study|Lost to Follow-up|7|||
23430051|NCT01719003|65317604|FG003|Overall Study|Lost to Follow-up|2|||
23430052|NCT01719003|65317605|FG004|Overall Study|Lost to Follow-up|3|||
23430053|NCT01719003|65317606|FG005|Overall Study|Lost to Follow-up|4|||
23430054|NCT01719003|65317607|FG006|Overall Study|Lost to Follow-up|3|||
23550838|NCT02310750|65747512|FG011|HP Period 1|Withdrawal by Subject|0|||
23550839|NCT02310750|65747513|FG012|HP Period 1|Withdrawal by Subject|0|||
23550840|NCT02310750|65747514|FG013|HP Period 1|Withdrawal by Subject|0|||
23430055|NCT01719003|65317608|FG007|Overall Study|Lost to Follow-up|2|||
23430056|NCT01719003|65317609|FG008|Overall Study|Lost to Follow-up|2|||
23430057|NCT01719003|65317601|FG000|Overall Study|Refusal to continue, not due to AE|2|||
23430058|NCT01719003|65317602|FG001|Overall Study|Refusal to continue, not due to AE|5|||
23550841|NCT02310750|65747515|FG014|HP Period 1|Withdrawal by Subject|0|||
23430059|NCT01719003|65317603|FG002|Overall Study|Refusal to continue, not due to AE|4|||
23430060|NCT01719003|65317604|FG003|Overall Study|Refusal to continue, not due to AE|4|||
23430061|NCT01719003|65317605|FG004|Overall Study|Refusal to continue, not due to AE|4|||
23430062|NCT01719003|65317606|FG005|Overall Study|Refusal to continue, not due to AE|3|||
23430063|NCT01719003|65317607|FG006|Overall Study|Refusal to continue, not due to AE|8|||
23430064|NCT01719003|65317608|FG007|Overall Study|Refusal to continue, not due to AE|7|||
23430065|NCT01719003|65317609|FG008|Overall Study|Refusal to continue, not due to AE|1|||
23430066|NCT01719003|65317601|FG000|Overall Study|Reason other than those specified|0|||
23430067|NCT01719003|65317602|FG001|Overall Study|Reason other than those specified|0|||
23430068|NCT01719003|65317603|FG002|Overall Study|Reason other than those specified|2|||
23430069|NCT01719003|65317604|FG003|Overall Study|Reason other than those specified|3|||
23430070|NCT01719003|65317605|FG004|Overall Study|Reason other than those specified|4|||
23430071|NCT01719003|65317606|FG005|Overall Study|Reason other than those specified|1|||
23430072|NCT01719003|65317607|FG006|Overall Study|Reason other than those specified|0|||
23430073|NCT01719003|65317608|FG007|Overall Study|Reason other than those specified|3|||
23430074|NCT01719003|65317609|FG008|Overall Study|Reason other than those specified|1|||
23430075|NCT01719003|65317601|FG000|Overall Study|Lack of Efficacy|0|||
23430076|NCT01719003|65317602|FG001|Overall Study|Lack of Efficacy|0|||
23430077|NCT01719003|65317603|FG002|Overall Study|Lack of Efficacy|0|||
23430078|NCT01719003|65317604|FG003|Overall Study|Lack of Efficacy|0|||
23430079|NCT01719003|65317605|FG004|Overall Study|Lack of Efficacy|0|||
23430080|NCT01719003|65317606|FG005|Overall Study|Lack of Efficacy|0|||
23430081|NCT01719003|65317607|FG006|Overall Study|Lack of Efficacy|1|||
23430082|NCT01719003|65317608|FG007|Overall Study|Lack of Efficacy|0|||
23430083|NCT01719003|65317609|FG008|Overall Study|Lack of Efficacy|0|||
23430084|NCT03464422|65317611|FG000|Overall Study|Lost to Follow-up|2|||
23430085|NCT03464422|65317611|FG000|Overall Study|Withdrawal by Subject|2|||
23430086|NCT00320372|65317612|FG000|Overall Study|Physician Decision|4|||
23430087|NCT00320372|65317613|FG001|Overall Study|Physician Decision|7|||
23430088|NCT00320372|65317612|FG000|Overall Study|Death|7|||
23430089|NCT00320372|65317613|FG001|Overall Study|Death|8|||
23430090|NCT00320372|65317612|FG000|Overall Study|Withdrawal by Subject|55|||
23430091|NCT00320372|65317613|FG001|Overall Study|Withdrawal by Subject|37|||
23430092|NCT00320372|65317612|FG000|Overall Study|Non-Compliance|40|||
23430093|NCT00320372|65317613|FG001|Overall Study|Non-Compliance|39|||
23430094|NCT00320372|65317612|FG000|Overall Study|Did not Meet (I/E)|3|||
23430095|NCT00320372|65317613|FG001|Overall Study|Did not Meet (I/E)|1|||
23430096|NCT00320372|65317612|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
23430097|NCT00320372|65317613|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
23430098|NCT02017522|65317614|FG000|Overall Study|Withdrawal by Subject|1|||
23430099|NCT01685983|65317617|FG000|Overall Study|Adverse Event|7|||
23430100|NCT01685983|65317617|FG000|Overall Study|Death|1|||
23430101|NCT01685983|65317617|FG000|Overall Study|Withdrawal by Subject|19|||
23430102|NCT01685983|65317617|FG000|Overall Study|Protocol Violation|2|||
23430103|NCT01685983|65317617|FG000|Overall Study|Physician Decision|13|||
23430104|NCT01685983|65317617|FG000|Overall Study|Other|7|||
23430105|NCT01685983|65317617|FG000|Overall Study|Progressive Disease|32|||
23430106|NCT01685983|65317617|FG000|Overall Study|Noncompliance with Study Drug|1|||
23430107|NCT02437409|65317618|FG000|Overall Study|Withdrawal by Subject|3|||
23430108|NCT02437409|65317618|FG000|Overall Study|Screening failure|12|||
23430109|NCT04021524|65317619|FG000|Overall Study|Change in surgical intervention|0|||
23430110|NCT04021524|65317620|FG001|Overall Study|Change in surgical intervention|1|||
23430111|NCT03759041|65317623|FG000|Overall Study|Withdrawal by Subject|4|||
23550842|NCT02310750|65747516|FG015|HP Period 1|Withdrawal by Subject|0|||
23550843|NCT02310750|65747501|FG000|HP Washout 1|Lost to Follow-up|0|||
23550844|NCT02310750|65747502|FG001|HP Washout 1|Lost to Follow-up|0|||
23550845|NCT02310750|65747503|FG002|HP Washout 1|Lost to Follow-up|1|||
23550846|NCT02310750|65747504|FG003|HP Washout 1|Lost to Follow-up|1|||
23550847|NCT02310750|65747505|FG004|HP Washout 1|Lost to Follow-up|2|||
23550848|NCT02310750|65747506|FG005|HP Washout 1|Lost to Follow-up|2|||
23550849|NCT02310750|65747507|FG006|HP Washout 1|Lost to Follow-up|3|||
23550850|NCT02310750|65747508|FG007|HP Washout 1|Lost to Follow-up|0|||
23550851|NCT02310750|65747509|FG008|HP Washout 1|Lost to Follow-up|0|||
23550852|NCT02310750|65747510|FG009|HP Washout 1|Lost to Follow-up|0|||
23550853|NCT02310750|65747511|FG010|HP Washout 1|Lost to Follow-up|0|||
23550854|NCT02310750|65747512|FG011|HP Washout 1|Lost to Follow-up|0|||
23550855|NCT02310750|65747513|FG012|HP Washout 1|Lost to Follow-up|0|||
23550856|NCT02310750|65747514|FG013|HP Washout 1|Lost to Follow-up|0|||
23550857|NCT02310750|65747515|FG014|HP Washout 1|Lost to Follow-up|0|||
23821738|NCT04604795|66726149|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23430112|NCT03759041|65317624|FG001|Overall Study|Withdrawal by Subject|10|||
23430113|NCT03759041|65317625|FG002|Overall Study|Withdrawal by Subject|10|||
23430114|NCT03759041|65317623|FG000|Overall Study|Adverse Event|1|||
23430115|NCT03759041|65317624|FG001|Overall Study|Adverse Event|3|||
23430116|NCT03759041|65317625|FG002|Overall Study|Adverse Event|4|||
23430117|NCT03759041|65317623|FG000|Overall Study|Lack of Efficacy|0|||
23550858|NCT02310750|65747516|FG015|HP Washout 1|Lost to Follow-up|0|||
23550859|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550860|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550861|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550862|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
23550863|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550864|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
23550865|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550866|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550867|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
23550868|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
23550869|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550870|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550871|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550872|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550873|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550874|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550875|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550876|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550877|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550878|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550879|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23620476|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
23620477|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
23620478|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
23620479|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
23620480|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
23550880|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550881|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550882|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550883|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550884|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
23550885|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550886|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550887|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550888|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550889|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550890|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550891|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550892|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620481|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
23620482|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
23620483|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
23620484|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
23620485|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
23620486|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
23620487|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
23620488|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
23620489|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
23620490|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
23620491|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
23620492|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
23620493|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
23620494|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
23620495|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
23620496|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
23620497|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
23620498|NCT02637856|65997482|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
23620499|NCT02637856|65997483|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
23620500|NCT02637856|65997482|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
23620501|NCT02637856|65997483|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
23620502|NCT04052997|65997484|FG000|Overall Study|Withdrawal by Subject|17|||
23620503|NCT04052997|65997484|FG000|Overall Study|Physician Decision|50|||
23620504|NCT04052997|65997484|FG000|Overall Study|Death|43|||
23620505|NCT04052997|65997484|FG000|Overall Study|Lost to Follow-up|5|||
23620506|NCT04052997|65997484|FG000|Overall Study|Progression of Disease|1|||
23550893|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620507|NCT04984278|65997491|FG000|Period 1|Withdrawal by Subject|1|||
23620508|NCT04984278|65997492|FG001|Period 1|Withdrawal by Subject|0|||
23620509|NCT04984278|65997491|FG000|Period 1|Other|0|||
23620510|NCT04984278|65997492|FG001|Period 1|Other|1|||
23620511|NCT04984278|65997491|FG000|Period 2|Adverse Event|1|||
23620512|NCT04984278|65997492|FG001|Period 2|Adverse Event|0|||
23620513|NCT04984278|65997491|FG000|Period 2|Other|0|||
23620514|NCT04984278|65997492|FG001|Period 2|Other|1|||
23620515|NCT01180790|65997493|FG000|Overall Study|Adverse Event|1|||
23620516|NCT01180790|65997494|FG001|Overall Study|Adverse Event|1|||
23620517|NCT01180790|65997495|FG002|Overall Study|Adverse Event|2|||
23620518|NCT01180790|65997496|FG003|Overall Study|Adverse Event|0|||
23620519|NCT01180790|65997497|FG004|Overall Study|Adverse Event|1|||
23620520|NCT01180790|65997498|FG005|Overall Study|Adverse Event|3|||
23620521|NCT01180790|65997499|FG006|Overall Study|Adverse Event|0|||
23620522|NCT01180790|65997493|FG000|Overall Study|Withdrawal by Subject|3|||
23620523|NCT01180790|65997494|FG001|Overall Study|Withdrawal by Subject|0|||
23620524|NCT01180790|65997495|FG002|Overall Study|Withdrawal by Subject|5|||
23620525|NCT01180790|65997496|FG003|Overall Study|Withdrawal by Subject|0|||
23620526|NCT01180790|65997497|FG004|Overall Study|Withdrawal by Subject|2|||
23620527|NCT01180790|65997498|FG005|Overall Study|Withdrawal by Subject|1|||
23620528|NCT01180790|65997499|FG006|Overall Study|Withdrawal by Subject|0|||
23550894|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550895|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550896|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550897|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620529|NCT01180790|65997493|FG000|Overall Study|Lost to Follow-up|3|||
23620530|NCT01180790|65997494|FG001|Overall Study|Lost to Follow-up|1|||
23620531|NCT01180790|65997495|FG002|Overall Study|Lost to Follow-up|0|||
23620532|NCT01180790|65997496|FG003|Overall Study|Lost to Follow-up|2|||
23620533|NCT01180790|65997497|FG004|Overall Study|Lost to Follow-up|1|||
23620534|NCT01180790|65997498|FG005|Overall Study|Lost to Follow-up|0|||
23550898|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550899|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550900|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550901|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550902|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620535|NCT01180790|65997499|FG006|Overall Study|Lost to Follow-up|1|||
23620536|NCT01180790|65997493|FG000|Overall Study|Physician Decision|1|||
23620537|NCT01180790|65997494|FG001|Overall Study|Physician Decision|0|||
23620538|NCT01180790|65997495|FG002|Overall Study|Physician Decision|0|||
23620539|NCT01180790|65997496|FG003|Overall Study|Physician Decision|1|||
23620540|NCT01180790|65997497|FG004|Overall Study|Physician Decision|0|||
23620541|NCT01180790|65997498|FG005|Overall Study|Physician Decision|0|||
23620542|NCT01180790|65997499|FG006|Overall Study|Physician Decision|0|||
23620543|NCT01180790|65997493|FG000|Overall Study|Lack of Efficacy|1|||
23620544|NCT01180790|65997494|FG001|Overall Study|Lack of Efficacy|2|||
23620545|NCT01180790|65997495|FG002|Overall Study|Lack of Efficacy|5|||
23620546|NCT01180790|65997496|FG003|Overall Study|Lack of Efficacy|6|||
23620547|NCT01180790|65997497|FG004|Overall Study|Lack of Efficacy|1|||
23620548|NCT01180790|65997498|FG005|Overall Study|Lack of Efficacy|3|||
23620549|NCT01180790|65997499|FG006|Overall Study|Lack of Efficacy|0|||
23620550|NCT01180790|65997493|FG000|Overall Study|compliance|0|||
23620551|NCT01180790|65997494|FG001|Overall Study|compliance|1|||
23620552|NCT01180790|65997495|FG002|Overall Study|compliance|0|||
23620553|NCT01180790|65997496|FG003|Overall Study|compliance|0|||
23620554|NCT01180790|65997497|FG004|Overall Study|compliance|0|||
23620555|NCT01180790|65997498|FG005|Overall Study|compliance|0|||
23620556|NCT01180790|65997499|FG006|Overall Study|compliance|0|||
23620557|NCT01180790|65997493|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620558|NCT01180790|65997494|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620559|NCT01180790|65997495|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
23620560|NCT01180790|65997496|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620561|NCT01180790|65997497|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620562|NCT01180790|65997498|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620563|NCT01180790|65997499|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
23550903|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620564|NCT00551135|65997500|FG000|Overall Study|Adverse Event|1|||
23620565|NCT00551135|65997501|FG001|Overall Study|Adverse Event|0|||
23620566|NCT00551135|65997502|FG002|Overall Study|Adverse Event|1|||
23620567|NCT00551135|65997503|FG003|Overall Study|Adverse Event|1|||
23620568|NCT00551135|65997500|FG000|Overall Study|Lost to Follow-up|0|||
23620569|NCT00551135|65997501|FG001|Overall Study|Lost to Follow-up|0|||
23620570|NCT00551135|65997502|FG002|Overall Study|Lost to Follow-up|0|||
23620571|NCT00551135|65997503|FG003|Overall Study|Lost to Follow-up|1|||
23620572|NCT00551135|65997500|FG000|Overall Study|Other|3|||
23620573|NCT00551135|65997501|FG001|Overall Study|Other|2|||
23620574|NCT00551135|65997502|FG002|Overall Study|Other|1|||
23430118|NCT03759041|65317624|FG001|Overall Study|Lack of Efficacy|0|||
23430119|NCT03759041|65317625|FG002|Overall Study|Lack of Efficacy|1|||
23430120|NCT03759041|65317623|FG000|Overall Study|Study Terminated by Sponsor|15|||
23430121|NCT03759041|65317624|FG001|Overall Study|Study Terminated by Sponsor|16|||
23430122|NCT03759041|65317625|FG002|Overall Study|Study Terminated by Sponsor|10|||
23430123|NCT03759041|65317623|FG000|Overall Study|Other reason for discontinuation|0|||
23430124|NCT03759041|65317624|FG001|Overall Study|Other reason for discontinuation|2|||
23430125|NCT03759041|65317625|FG002|Overall Study|Other reason for discontinuation|1|||
23430126|NCT03759041|65317623|FG000|Overall Study|Lost to Follow-up|7|||
23430127|NCT03759041|65317624|FG001|Overall Study|Lost to Follow-up|2|||
23430128|NCT03759041|65317625|FG002|Overall Study|Lost to Follow-up|2|||
23430129|NCT03759041|65317623|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
23430130|NCT03759041|65317624|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
23430131|NCT03759041|65317625|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
23430132|NCT01167907|65317626|FG000|Overall Study|Protocol Violation|1|||
23430133|NCT01167907|65317627|FG001|Overall Study|Protocol Violation|0|||
23430134|NCT01167907|65317626|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
23430135|NCT01167907|65317627|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
23430136|NCT01522404|65317628|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
23430137|NCT01522404|65317629|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
23430138|NCT01522404|65317628|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
23430139|NCT01522404|65317629|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
23430140|NCT01522404|65317628|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
23430141|NCT01522404|65317629|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
23430142|NCT03602885|65317633|FG000|Overall Study|Lost to Follow-up|3|||
23430143|NCT03602885|65317634|FG001|Overall Study|Lost to Follow-up|0|||
23430144|NCT02383433|65317637|FG000|Overall Study|Disease progression|2|||
23430145|NCT03242018|65317639|FG000|Overall Study|Adverse Event|7|||
23430146|NCT03242018|65317640|FG001|Overall Study|Adverse Event|7|||
23430147|NCT03242018|65317641|FG002|Overall Study|Adverse Event|6|||
23430148|NCT03242018|65317639|FG000|Overall Study|Lost to Follow-up|2|||
23430149|NCT03242018|65317640|FG001|Overall Study|Lost to Follow-up|2|||
23430150|NCT03242018|65317641|FG002|Overall Study|Lost to Follow-up|2|||
23430151|NCT03242018|65317639|FG000|Overall Study|At the Participant's Own Request|5|||
23430152|NCT03242018|65317640|FG001|Overall Study|At the Participant's Own Request|1|||
23430153|NCT03242018|65317641|FG002|Overall Study|At the Participant's Own Request|4|||
23430154|NCT03242018|65317639|FG000|Overall Study|Reason Not Specified|3|||
23430155|NCT03242018|65317640|FG001|Overall Study|Reason Not Specified|4|||
23430156|NCT03242018|65317641|FG002|Overall Study|Reason Not Specified|1|||
23430157|NCT03242018|65317639|FG000|Overall Study|Study Terminated by Sponsor|1|||
23430158|NCT03242018|65317640|FG001|Overall Study|Study Terminated by Sponsor|0|||
23430159|NCT03242018|65317641|FG002|Overall Study|Study Terminated by Sponsor|1|||
23430160|NCT01638559|65317654|FG000|Overall Study|Lost to Follow-up|1|||
23430161|NCT01638559|65317654|FG000|Overall Study|Withdrawal by Subject|1|||
23430162|NCT01638559|65317654|FG000|Overall Study|Subject declined to travel for biopsy|1|||
23430163|NCT01739803|65320515|FG000|Overall Study|Lost to Follow-up|9|||
23430164|NCT01739803|65320516|FG001|Overall Study|Lost to Follow-up|6|||
23430165|NCT00635089|65320517|FG000|Overall Study|Adverse Event|7|||
23430166|NCT00635089|65320517|FG000|Overall Study|Lack of Efficacy|28|||
23430167|NCT00635089|65320517|FG000|Overall Study|Protocol Deviation|4|||
23550904|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550905|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550906|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550907|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23620575|NCT00551135|65997503|FG003|Overall Study|Other|2|||
23620576|NCT00551135|65997500|FG000|Overall Study|Withdrawal by Subject|1|||
23550908|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550909|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550910|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550911|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550912|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550913|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550914|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
23620577|NCT00551135|65997501|FG001|Overall Study|Withdrawal by Subject|0|||
23620578|NCT00551135|65997502|FG002|Overall Study|Withdrawal by Subject|3|||
23430168|NCT00635089|65320517|FG000|Overall Study|Lost to Follow-up|8|||
23430169|NCT00635089|65320517|FG000|Overall Study|Other|31|||
23430170|NCT00046930|65320518|FG000|Overall Study|Ineligible|12|||
23620579|NCT00551135|65997503|FG003|Overall Study|Withdrawal by Subject|1|||
23620580|NCT00961896|65997504|FG000|Overall Study|Abnormal laboratory value|0|||
23430171|NCT00046930|65320519|FG001|Overall Study|Ineligible|4|||
23430172|NCT03626545|65320520|FG000|Overall Study|Progressive disease|3|||
23430173|NCT03626545|65320521|FG001|Overall Study|Progressive disease|82|||
23620581|NCT00961896|65997505|FG001|Overall Study|Abnormal laboratory value|0|||
23550915|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
23550916|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550917|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550918|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550919|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550920|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23620582|NCT00961896|65997506|FG002|Overall Study|Abnormal laboratory value|1|||
23620583|NCT03511378|65997508|FG000|Overall Study|Withdrawal by Subject|2|||
23620584|NCT03511378|65997509|FG001|Overall Study|Withdrawal by Subject|2|||
23620585|NCT03511378|65997508|FG000|Overall Study|Patient not coming or schedule visit|1|||
23620586|NCT03511378|65997509|FG001|Overall Study|Patient not coming or schedule visit|0|||
23620587|NCT01182181|65997511|FG000|First Intervention|Adverse Event|1|||
23620588|NCT01182181|65997512|FG001|First Intervention|Adverse Event|0|||
23620589|NCT01182181|65997511|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
23550921|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550922|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550923|NCT02310750|65747501|FG000|HP Washout 2|Lost to Follow-up|0|||
23550924|NCT02310750|65747502|FG001|HP Washout 2|Lost to Follow-up|0|||
23550925|NCT02310750|65747503|FG002|HP Washout 2|Lost to Follow-up|0|||
23550926|NCT02310750|65747504|FG003|HP Washout 2|Lost to Follow-up|0|||
23550927|NCT02310750|65747505|FG004|HP Washout 2|Lost to Follow-up|1|||
23550928|NCT02310750|65747506|FG005|HP Washout 2|Lost to Follow-up|0|||
23550929|NCT02310750|65747507|FG006|HP Washout 2|Lost to Follow-up|7|||
23550930|NCT02310750|65747508|FG007|HP Washout 2|Lost to Follow-up|0|||
23550931|NCT02310750|65747509|FG008|HP Washout 2|Lost to Follow-up|0|||
23550932|NCT02310750|65747510|FG009|HP Washout 2|Lost to Follow-up|0|||
23550933|NCT02310750|65747511|FG010|HP Washout 2|Lost to Follow-up|0|||
23620590|NCT01182181|65997512|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
23620591|NCT02388932|65997513|FG000|Overall Study|Death|1|||
23620592|NCT00523549|65997516|FG000|Overall Study|Adverse Event|6|||
23620593|NCT00523549|65997517|FG001|Overall Study|Adverse Event|3|||
23620594|NCT00523549|65997516|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23620595|NCT00523549|65997517|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23550934|NCT02310750|65747512|FG011|HP Washout 2|Lost to Follow-up|0|||
23620596|NCT00523549|65997516|FG000|Overall Study|Protocol Deviation|3|||
23620597|NCT00523549|65997517|FG001|Overall Study|Protocol Deviation|1|||
23620598|NCT00523549|65997516|FG000|Overall Study|Patient withdrew consent|7|||
23620599|NCT00523549|65997517|FG001|Overall Study|Patient withdrew consent|6|||
23620600|NCT00523549|65997516|FG000|Overall Study|Lost to Follow-up|3|||
23620601|NCT00523549|65997517|FG001|Overall Study|Lost to Follow-up|5|||
23620602|NCT01059526|65997518|FG000|Overall Study|Patient enrolled but not treated|20|||
23620603|NCT01059526|65997519|FG001|Overall Study|Patient enrolled but not treated|17|||
23620604|NCT01059526|65997518|FG000|Overall Study|Adverse Event|2|||
23620605|NCT01059526|65997519|FG001|Overall Study|Adverse Event|2|||
23620606|NCT01059526|65997518|FG000|Overall Study|Protocol Violation|0|||
23620607|NCT01059526|65997519|FG001|Overall Study|Protocol Violation|1|||
23620608|NCT01059526|65997518|FG000|Overall Study|Withdrawal by Subject|3|||
23620609|NCT01059526|65997519|FG001|Overall Study|Withdrawal by Subject|1|||
23620610|NCT01059526|65997518|FG000|Overall Study|Lost to Follow-up|4|||
23620611|NCT01059526|65997519|FG001|Overall Study|Lost to Follow-up|1|||
23620612|NCT01059526|65997518|FG000|Overall Study|Patient found to be dermatographic|1|||
23620613|NCT01059526|65997519|FG001|Overall Study|Patient found to be dermatographic|0|||
23620614|NCT01837797|65997521|FG000|Period 1|Adverse Event|9|||
23620615|NCT01837797|65997522|FG001|Period 1|Adverse Event|0|||
23620616|NCT01837797|65997523|FG002|Period 1|Adverse Event|0|||
23620617|NCT01837797|65997524|FG003|Period 1|Adverse Event|0|||
23620618|NCT01837797|65997525|FG004|Period 1|Adverse Event|0|||
23620619|NCT01837797|65997521|FG000|Period 1|Withdrawal by Subject|6|||
23620620|NCT01837797|65997522|FG001|Period 1|Withdrawal by Subject|0|||
23620621|NCT01837797|65997523|FG002|Period 1|Withdrawal by Subject|0|||
23620622|NCT01837797|65997524|FG003|Period 1|Withdrawal by Subject|0|||
23620623|NCT01837797|65997525|FG004|Period 1|Withdrawal by Subject|0|||
23620624|NCT01837797|65997521|FG000|Period 1|Administrative reasons|76|||
23620625|NCT01837797|65997522|FG001|Period 1|Administrative reasons|0|||
23620626|NCT01837797|65997523|FG002|Period 1|Administrative reasons|0|||
23620627|NCT01837797|65997524|FG003|Period 1|Administrative reasons|0|||
23620628|NCT01837797|65997525|FG004|Period 1|Administrative reasons|0|||
23620629|NCT01837797|65997521|FG000|Period 1|Withdrawal of consent before treatment|1|||
23620630|NCT01837797|65997522|FG001|Period 1|Withdrawal of consent before treatment|0|||
23620631|NCT01837797|65997523|FG002|Period 1|Withdrawal of consent before treatment|0|||
23620632|NCT01837797|65997524|FG003|Period 1|Withdrawal of consent before treatment|0|||
23620633|NCT01837797|65997525|FG004|Period 1|Withdrawal of consent before treatment|0|||
23550935|NCT02310750|65747513|FG012|HP Washout 2|Lost to Follow-up|0|||
23620634|NCT01837797|65997521|FG000|Period 1|Other|10|||
23620635|NCT01837797|65997522|FG001|Period 1|Other|0|||
23821739|NCT04604795|66726150|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23620636|NCT01837797|65997523|FG002|Period 1|Other|0|||
23620637|NCT01837797|65997524|FG003|Period 1|Other|0|||
23620638|NCT01837797|65997525|FG004|Period 1|Other|0|||
23620639|NCT01837797|65997521|FG000|Period 2|Administrative or other reasons|0|||
23620640|NCT01837797|65997522|FG001|Period 2|Administrative or other reasons|5|||
23620641|NCT01837797|65997523|FG002|Period 2|Administrative or other reasons|2|||
23620642|NCT01837797|65997524|FG003|Period 2|Administrative or other reasons|4|||
23620643|NCT01837797|65997525|FG004|Period 2|Administrative or other reasons|0|||
23620644|NCT01837797|65997521|FG000|Period 2|Adverse Event|0|||
23620645|NCT01837797|65997522|FG001|Period 2|Adverse Event|0|||
23620646|NCT01837797|65997523|FG002|Period 2|Adverse Event|0|||
23620647|NCT01837797|65997524|FG003|Period 2|Adverse Event|1|||
23620648|NCT01837797|65997525|FG004|Period 2|Adverse Event|0|||
23620649|NCT01837797|65997521|FG000|Period 3|Adverse Event|0|||
23620650|NCT01837797|65997522|FG001|Period 3|Adverse Event|0|||
23620651|NCT01837797|65997523|FG002|Period 3|Adverse Event|0|||
23620652|NCT01837797|65997524|FG003|Period 3|Adverse Event|0|||
23620653|NCT01837797|65997525|FG004|Period 3|Adverse Event|1|||
23620654|NCT01837797|65997521|FG000|Period 3|Administrative reasons|0|||
23620655|NCT01837797|65997522|FG001|Period 3|Administrative reasons|0|||
23620656|NCT01837797|65997523|FG002|Period 3|Administrative reasons|0|||
23620657|NCT01837797|65997524|FG003|Period 3|Administrative reasons|0|||
23620658|NCT01837797|65997525|FG004|Period 3|Administrative reasons|20|||
23620659|NCT01837797|65997521|FG000|Period 3|Other|0|||
23620660|NCT01837797|65997522|FG001|Period 3|Other|0|||
23620661|NCT01837797|65997523|FG002|Period 3|Other|0|||
23620662|NCT01837797|65997524|FG003|Period 3|Other|0|||
23620663|NCT01837797|65997525|FG004|Period 3|Other|2|||
23620664|NCT00292981|65997528|FG000|Overall Study|Adverse Event|1|||
23620665|NCT00292981|65997528|FG000|Overall Study|Lost to Follow-up|13|||
23620666|NCT00292981|65997528|FG000|Overall Study|Withdrawal by Subject|22|||
23620667|NCT00292981|65997528|FG000|Overall Study|Other|3|||
23620668|NCT02720198|65997529|FG000|Overall Study|Withdrawal by Subject|0|||
23620669|NCT02720198|65997530|FG001|Overall Study|Withdrawal by Subject|1|||
23620670|NCT01145417|65997533|FG000|Overall Study|Death|1|||
23620671|NCT01145417|65997534|FG001|Overall Study|Death|0|||
23620672|NCT01145417|65997533|FG000|Overall Study|Lost to Follow-up|2|||
23620673|NCT01145417|65997534|FG001|Overall Study|Lost to Follow-up|1|||
23620674|NCT01145417|65997533|FG000|Overall Study|Withdrawal by Subject|1|||
23620675|NCT01145417|65997534|FG001|Overall Study|Withdrawal by Subject|2|||
23620676|NCT01145417|65997533|FG000|Overall Study|Pregnancy|1|||
23620677|NCT01145417|65997534|FG001|Overall Study|Pregnancy|0|||
23620678|NCT01145417|65997533|FG000|Overall Study|Adverse Event|0|||
23620679|NCT01145417|65997534|FG001|Overall Study|Adverse Event|1|||
23620680|NCT01145417|65997533|FG000|Overall Study|Study terminated by sponsor|35|||
23620681|NCT01145417|65997534|FG001|Overall Study|Study terminated by sponsor|43|||
23620682|NCT01145417|65997533|FG000|Overall Study|Other|1|||
23620683|NCT01145417|65997534|FG001|Overall Study|Other|0|||
23620684|NCT01370018|65997535|FG000|Overall Study|Did not meet criteria for analysis|1|||
23550936|NCT02310750|65747514|FG013|HP Washout 2|Lost to Follow-up|0|||
23550937|NCT02310750|65747515|FG014|HP Washout 2|Lost to Follow-up|0|||
23550938|NCT02310750|65747516|FG015|HP Washout 2|Lost to Follow-up|0|||
23550939|NCT03273946|65747517|FG000|Overall Study|Withdrawal by Subject|5|||
23550940|NCT03273946|65747517|FG000|Overall Study|Unwillingness of the guardian|1|||
23620685|NCT00546078|65997536|FG000|Overall Study|Lost to Follow-up|1|||
23620686|NCT00546078|65997537|FG001|Overall Study|Lost to Follow-up|3|||
23620687|NCT00546078|65997536|FG000|Overall Study|Withdrawal by Subject|2|||
23620688|NCT00546078|65997537|FG001|Overall Study|Withdrawal by Subject|3|||
23620689|NCT00546078|65997536|FG000|Overall Study|Other reason|1|||
23550941|NCT03273946|65747517|FG000|Overall Study|Participant refused to use the drug|2|||
23550942|NCT03273946|65747517|FG000|Overall Study|Participant relative refused to use drug|1|||
23550943|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong stage|0|||
23550944|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong stage|3|||
23550945|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong cell type|2|||
23550946|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong cell type|2|||
23550947|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong primary|0|||
23550948|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong primary|1|||
23620690|NCT00546078|65997537|FG001|Overall Study|Other reason|1|||
23620691|NCT01209286|65997539|FG000|Overall Study|Adverse Event|4|||
23620692|NCT01209286|65997540|FG001|Overall Study|Adverse Event|3|||
23550949|NCT00262821|65747518|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23620693|NCT01209286|65997541|FG002|Overall Study|Adverse Event|1|||
23620694|NCT01209286|65997539|FG000|Overall Study|Hematological Relapse After Remission|0|||
23620695|NCT01209286|65997540|FG001|Overall Study|Hematological Relapse After Remission|1|||
23620696|NCT01209286|65997541|FG002|Overall Study|Hematological Relapse After Remission|1|||
23620697|NCT01209286|65997539|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
23620698|NCT01209286|65997540|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
23620699|NCT01209286|65997541|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
23620700|NCT01209286|65997539|FG000|Overall Study|Physician Decision|0|||
23620701|NCT01209286|65997540|FG001|Overall Study|Physician Decision|2|||
23550950|NCT00262821|65747519|FG001|Overall Study|Ineligible - inadequate pathology|3|||
23550951|NCT00262821|65747518|FG000|Overall Study|Ineligible - elevated creatinine|0|||
23550952|NCT00262821|65747519|FG001|Overall Study|Ineligible - elevated creatinine|2|||
23550953|NCT00262821|65747518|FG000|Overall Study|Ineligible - required test not done|1|||
23550954|NCT00262821|65747519|FG001|Overall Study|Ineligible - required test not done|4|||
23550955|NCT00262821|65747518|FG000|Overall Study|Inevaluable - inadequate data|0|||
23550956|NCT00262821|65747519|FG001|Overall Study|Inevaluable - inadequate data|4|||
23550957|NCT01830127|65747520|FG000|Overall Study|Adverse Event|1|||
23550958|NCT01830127|65747521|FG001|Overall Study|Adverse Event|6|||
23550959|NCT01830127|65747520|FG000|Overall Study|Lack of Efficacy|3|||
23550960|NCT01830127|65747521|FG001|Overall Study|Lack of Efficacy|0|||
23620702|NCT01209286|65997541|FG002|Overall Study|Physician Decision|0|||
23620703|NCT01209286|65997539|FG000|Overall Study|Other|0|||
23620704|NCT01209286|65997540|FG001|Overall Study|Other|1|||
23620705|NCT01209286|65997541|FG002|Overall Study|Other|0|||
23620706|NCT01978236|65997542|FG000|Overall Study|Discontinued due to study close|2|||
23620707|NCT01084239|65997543|FG000|28-Day Follow-up|Lost to Follow-up|4|||
23620708|NCT01084239|65997544|FG001|28-Day Follow-up|Lost to Follow-up|9|||
23620709|NCT01435798|65997547|FG000|Overall Study|Withdrawal by Subject|1|||
23620710|NCT02158247|65997548|FG000|Overall Study|Invisible vocal cords|5|||
23620711|NCT01172639|65997551|FG000|Overall Study|Death|1|||
23620712|NCT01172639|65997552|FG001|Overall Study|Death|1|||
23620713|NCT01172639|65997553|FG002|Overall Study|Death|0|||
23620714|NCT01172639|65997554|FG003|Overall Study|Death|0|||
23620715|NCT01172639|65997555|FG004|Overall Study|Death|0|||
23620716|NCT01172639|65997551|FG000|Overall Study|Lost to Follow-up|9|||
23620717|NCT01172639|65997552|FG001|Overall Study|Lost to Follow-up|7|||
23620718|NCT01172639|65997553|FG002|Overall Study|Lost to Follow-up|11|||
23620719|NCT01172639|65997554|FG003|Overall Study|Lost to Follow-up|6|||
23620720|NCT01172639|65997555|FG004|Overall Study|Lost to Follow-up|6|||
23620721|NCT01172639|65997551|FG000|Overall Study|Withdrawal by Subject|3|||
23620722|NCT01172639|65997552|FG001|Overall Study|Withdrawal by Subject|3|||
23620723|NCT01172639|65997553|FG002|Overall Study|Withdrawal by Subject|5|||
23620724|NCT01172639|65997554|FG003|Overall Study|Withdrawal by Subject|5|||
23620725|NCT01172639|65997555|FG004|Overall Study|Withdrawal by Subject|0|||
23620726|NCT00796614|65997558|FG000|Overall Study|Adverse Event|1|||
23620727|NCT00796614|65997559|FG001|Overall Study|Adverse Event|2|||
23620728|NCT00796614|65997560|FG002|Overall Study|Adverse Event|0|||
23620729|NCT00796614|65997561|FG003|Overall Study|Adverse Event|0|||
23620730|NCT00796614|65997558|FG000|Overall Study|Protocol Violation|0|||
23620731|NCT00796614|65997559|FG001|Overall Study|Protocol Violation|0|||
23620732|NCT00796614|65997560|FG002|Overall Study|Protocol Violation|2|||
23620733|NCT00796614|65997561|FG003|Overall Study|Protocol Violation|0|||
23620734|NCT00796614|65997558|FG000|Overall Study|Lost to Follow-up|2|||
23620735|NCT00796614|65997559|FG001|Overall Study|Lost to Follow-up|2|||
23620736|NCT00796614|65997560|FG002|Overall Study|Lost to Follow-up|1|||
23620737|NCT00796614|65997561|FG003|Overall Study|Lost to Follow-up|0|||
23620738|NCT00796614|65997558|FG000|Overall Study|Withdrawal by Subject|1|||
23742800|NCT01241591|66436656|FG002|Overall Study|Other|0|||
23742801|NCT01241591|66436657|FG003|Overall Study|Other|1|||
23742802|NCT01241591|66436654|FG000|Overall Study|Adverse Event|3|||
23821740|NCT04604795|66726141|FG000|Part B: Up to Day 14|Adverse Event|0|||
23620739|NCT00796614|65997559|FG001|Overall Study|Withdrawal by Subject|0|||
23620740|NCT00796614|65997560|FG002|Overall Study|Withdrawal by Subject|0|||
23742803|NCT01241591|66436655|FG001|Overall Study|Adverse Event|11|||
23742804|NCT01241591|66436656|FG002|Overall Study|Adverse Event|12|||
23742805|NCT01241591|66436657|FG003|Overall Study|Adverse Event|4|||
23742806|NCT00423137|66436658|FG000|Overall Study|Lost to Follow-up|0|||
23742807|NCT00423137|66436659|FG001|Overall Study|Lost to Follow-up|0|||
23742808|NCT00423137|66436660|FG002|Overall Study|Lost to Follow-up|1|||
23742809|NCT00423137|66436661|FG003|Overall Study|Lost to Follow-up|0|||
23742810|NCT00423137|66436658|FG000|Overall Study|Protocol Violation|0|||
23742811|NCT00423137|66436659|FG001|Overall Study|Protocol Violation|0|||
23742812|NCT00423137|66436660|FG002|Overall Study|Protocol Violation|0|||
23742813|NCT00423137|66436661|FG003|Overall Study|Protocol Violation|1|||
23742814|NCT00423137|66436658|FG000|Overall Study|Adverse Event Study disease worse|1|||
23821741|NCT04604795|66726142|FG001|Part B: Up to Day 14|Adverse Event|0|||
23620741|NCT00796614|65997561|FG003|Overall Study|Withdrawal by Subject|1|||
23742815|NCT00423137|66436659|FG001|Overall Study|Adverse Event Study disease worse|0|||
23550961|NCT01830127|65747520|FG000|Overall Study|Withdrawal by Subject|1|||
23550962|NCT01830127|65747521|FG001|Overall Study|Withdrawal by Subject|1|||
23550963|NCT01830127|65747520|FG000|Overall Study|Other reason not defined above|0|||
23620742|NCT00796614|65997558|FG000|Overall Study|Other than stated|1|||
23620743|NCT00796614|65997559|FG001|Overall Study|Other than stated|0|||
23620744|NCT00796614|65997560|FG002|Overall Study|Other than stated|0|||
23620745|NCT00796614|65997561|FG003|Overall Study|Other than stated|0|||
23742816|NCT00423137|66436660|FG002|Overall Study|Adverse Event Study disease worse|3|||
23742817|NCT00423137|66436661|FG003|Overall Study|Adverse Event Study disease worse|1|||
23742818|NCT00423137|66436658|FG000|Overall Study|Adverse Event Other|0|||
23821742|NCT04604795|66726143|FG002|Part B: Up to Day 14|Adverse Event|0|||
23821743|NCT04604795|66726144|FG003|Part B: Up to Day 14|Adverse Event|0|||
23821744|NCT04604795|66726145|FG004|Part B: Up to Day 14|Adverse Event|2|||
23821745|NCT04604795|66726146|FG005|Part B: Up to Day 14|Adverse Event|1|||
23821746|NCT04604795|66726147|FG006|Part B: Up to Day 14|Adverse Event|0|||
23821747|NCT04604795|66726148|FG007|Part B: Up to Day 14|Adverse Event|0|||
23821748|NCT04604795|66726149|FG008|Part B: Up to Day 14|Adverse Event|0|||
23821749|NCT04604795|66726150|FG009|Part B: Up to Day 14|Adverse Event|0|||
23821750|NCT04604795|66726141|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821751|NCT04604795|66726142|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821752|NCT04604795|66726143|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821753|NCT04604795|66726144|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821754|NCT04604795|66726145|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821755|NCT04604795|66726146|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821756|NCT04604795|66726147|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821757|NCT04604795|66726148|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821758|NCT04604795|66726149|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23821759|NCT04604795|66726150|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
23821760|NCT04604795|66726141|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821761|NCT04604795|66726142|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821762|NCT04604795|66726143|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821763|NCT04604795|66726144|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821764|NCT04604795|66726145|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821765|NCT04604795|66726146|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821766|NCT04604795|66726147|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821767|NCT04604795|66726148|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821768|NCT04604795|66726149|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
23821769|NCT04604795|66726150|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23821770|NCT04604795|66726141|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821771|NCT04604795|66726142|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821772|NCT04604795|66726143|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821773|NCT04604795|66726144|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821774|NCT04604795|66726145|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821775|NCT04604795|66726146|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821776|NCT04604795|66726147|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821777|NCT04604795|66726148|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821778|NCT04604795|66726149|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
23821779|NCT04604795|66726150|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23821780|NCT04604795|66726141|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821781|NCT04604795|66726142|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821782|NCT04604795|66726143|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821783|NCT04604795|66726144|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821784|NCT04604795|66726145|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821785|NCT04604795|66726146|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821786|NCT04604795|66726147|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821787|NCT04604795|66726148|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821788|NCT04604795|66726149|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
23821789|NCT04604795|66726150|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
23821790|NCT01427608|66726156|FG000|Overall Study|Death|1|||
23821791|NCT01427608|66726157|FG001|Overall Study|Death|0|||
23821792|NCT01427608|66726156|FG000|Overall Study|Withdrawal by Subject|7|||
23821793|NCT01427608|66726157|FG001|Overall Study|Withdrawal by Subject|3|||
23821794|NCT01427608|66726156|FG000|Overall Study|Relapsed-all cause|13|||
23821795|NCT01427608|66726157|FG001|Overall Study|Relapsed-all cause|34|||
23821796|NCT01427608|66726156|FG000|Overall Study|Events not attributed to study meds|0|||
23821797|NCT01427608|66726157|FG001|Overall Study|Events not attributed to study meds|1|||
23742819|NCT00423137|66436659|FG001|Overall Study|Adverse Event Other|0|||
23742820|NCT00423137|66436660|FG002|Overall Study|Adverse Event Other|2|||
23742821|NCT00423137|66436661|FG003|Overall Study|Adverse Event Other|0|||
23742822|NCT02383966|66436664|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
23742823|NCT02383966|66436665|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
23742824|NCT02383966|66436664|FG000|Overall Study|Randomized, but not treated|1|||
23742825|NCT02383966|66436665|FG001|Overall Study|Randomized, but not treated|3|||
23620746|NCT00802438|65997562|FG000|Overall Study|Screen Failure|20|||
23620747|NCT00802438|65997562|FG000|Overall Study|Withdrawal by Subject|7|||
23620748|NCT00802438|65997562|FG000|Overall Study|Physician Decision|1|||
23742826|NCT03769753|66436666|FG000|Overall Study|Not Treated|6|||
23742827|NCT03769753|66436666|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
23742828|NCT01425268|66436669|FG000|Overall Study|Withdrawal by Subject|2|||
23742829|NCT01425268|66436670|FG001|Overall Study|Withdrawal by Subject|0|||
23742830|NCT01425268|66436669|FG000|Overall Study|Sponsor Decision|5|||
23742831|NCT01425268|66436670|FG001|Overall Study|Sponsor Decision|0|||
23742832|NCT01425268|66436669|FG000|Overall Study|Physician Decision|1|||
23742833|NCT01425268|66436670|FG001|Overall Study|Physician Decision|0|||
23742834|NCT01874288|66436671|FG000|Overall Study|Withdrawal by Subject|1|||
23742835|NCT01874288|66436672|FG001|Overall Study|Withdrawal by Subject|0|||
23742836|NCT01874288|66436673|FG002|Overall Study|Withdrawal by Subject|2|||
23742837|NCT01874288|66436674|FG003|Overall Study|Withdrawal by Subject|1|||
23742838|NCT01874288|66436675|FG004|Overall Study|Withdrawal by Subject|1|||
23742839|NCT01874288|66436671|FG000|Overall Study|Physician Decision|0|||
23742840|NCT01874288|66436672|FG001|Overall Study|Physician Decision|0|||
23742841|NCT01874288|66436673|FG002|Overall Study|Physician Decision|0|||
23742842|NCT01874288|66436674|FG003|Overall Study|Physician Decision|1|||
23742843|NCT01874288|66436675|FG004|Overall Study|Physician Decision|0|||
23742844|NCT01874288|66436671|FG000|Overall Study|Progressive disease|2|||
23742845|NCT01874288|66436672|FG001|Overall Study|Progressive disease|0|||
23742846|NCT01874288|66436673|FG002|Overall Study|Progressive disease|3|||
23742847|NCT01874288|66436674|FG003|Overall Study|Progressive disease|5|||
23742848|NCT01874288|66436675|FG004|Overall Study|Progressive disease|1|||
23742849|NCT02030067|66436676|FG000|Overall Study|Disease Progression|1|||
23742850|NCT02030067|66436677|FG001|Overall Study|Disease Progression|1|||
23742851|NCT02030067|66436678|FG002|Overall Study|Disease Progression|2|||
23742852|NCT02030067|66436679|FG003|Overall Study|Disease Progression|2|||
23742853|NCT02030067|66436680|FG004|Overall Study|Disease Progression|3|||
23550964|NCT01830127|65747521|FG001|Overall Study|Other reason not defined above|2|||
23550965|NCT02280044|65747524|FG000|Overall Study|Planned alternate|0|||
23550966|NCT02280044|65747525|FG001|Overall Study|Planned alternate|2|||
23550967|NCT02261493|65747526|FG000|Overall Study|Noncompliance|0|||
23550968|NCT02261493|65747527|FG001|Overall Study|Noncompliance|0|||
23550969|NCT02261493|65747528|FG002|Overall Study|Noncompliance|2|||
23550970|NCT02261493|65747526|FG000|Overall Study|Physician Decision|0|||
23550971|NCT02261493|65747527|FG001|Overall Study|Physician Decision|1|||
23550972|NCT02261493|65747528|FG002|Overall Study|Physician Decision|0|||
23550973|NCT02261493|65747526|FG000|Overall Study|Undisclosed alcohol abuse|0|||
23550974|NCT02261493|65747527|FG001|Overall Study|Undisclosed alcohol abuse|1|||
23550975|NCT02261493|65747528|FG002|Overall Study|Undisclosed alcohol abuse|0|||
23550976|NCT02261493|65747526|FG000|Overall Study|Protocol Violation|1|||
23550977|NCT02261493|65747527|FG001|Overall Study|Protocol Violation|0|||
23550978|NCT02261493|65747528|FG002|Overall Study|Protocol Violation|0|||
23550979|NCT02261493|65747526|FG000|Overall Study|Personal Reasons|14|||
23550980|NCT02261493|65747527|FG001|Overall Study|Personal Reasons|14|||
23550981|NCT02261493|65747528|FG002|Overall Study|Personal Reasons|16|||
23550982|NCT02261493|65747526|FG000|Overall Study|Lost to Follow-up|14|||
23550983|NCT02261493|65747527|FG001|Overall Study|Lost to Follow-up|27|||
23550984|NCT02261493|65747528|FG002|Overall Study|Lost to Follow-up|8|||
23550985|NCT02261493|65747526|FG000|Overall Study|Pregnancy|1|||
23550986|NCT02261493|65747527|FG001|Overall Study|Pregnancy|2|||
23550987|NCT02261493|65747528|FG002|Overall Study|Pregnancy|0|||
23550988|NCT02261493|65747526|FG000|Overall Study|Lack of Efficacy|0|||
23550989|NCT02261493|65747527|FG001|Overall Study|Lack of Efficacy|1|||
23550990|NCT02261493|65747528|FG002|Overall Study|Lack of Efficacy|0|||
23550991|NCT02261493|65747526|FG000|Overall Study|Adverse Event|0|||
23550992|NCT02261493|65747527|FG001|Overall Study|Adverse Event|1|||
23550993|NCT02261493|65747528|FG002|Overall Study|Adverse Event|0|||
23550994|NCT04402866|65747531|FG000|Overall Study|Discontinued Prior to Treatment|0|||
23550995|NCT04402866|65747532|FG001|Overall Study|Discontinued Prior to Treatment|0|||
23550996|NCT04402866|65747533|FG002|Overall Study|Discontinued Prior to Treatment|0|||
23550997|NCT04402866|65747534|FG003|Overall Study|Discontinued Prior to Treatment|0|||
23550998|NCT04402866|65747535|FG004|Overall Study|Discontinued Prior to Treatment|2|||
23550999|NCT04402866|65747536|FG005|Overall Study|Discontinued Prior to Treatment|3|||
23551000|NCT04402866|65747531|FG000|Overall Study|Adverse Event|2|||
23551001|NCT04402866|65747532|FG001|Overall Study|Adverse Event|1|||
23551002|NCT04402866|65747533|FG002|Overall Study|Adverse Event|0|||
23551003|NCT04402866|65747534|FG003|Overall Study|Adverse Event|0|||
23551004|NCT04402866|65747535|FG004|Overall Study|Adverse Event|13|||
23551005|NCT04402866|65747536|FG005|Overall Study|Adverse Event|8|||
23551006|NCT04402866|65747531|FG000|Overall Study|Miscellaneous|0|||
23551007|NCT04402866|65747532|FG001|Overall Study|Miscellaneous|0|||
23742854|NCT02030067|66436681|FG005|Overall Study|Disease Progression|2|||
23742855|NCT02030067|66436682|FG006|Overall Study|Disease Progression|3|||
23742856|NCT02030067|66436683|FG007|Overall Study|Disease Progression|3|||
23742857|NCT02030067|66436684|FG008|Overall Study|Disease Progression|4|||
23742858|NCT02030067|66436685|FG009|Overall Study|Disease Progression|3|||
23742859|NCT02030067|66436686|FG010|Overall Study|Disease Progression|7|||
23742860|NCT02030067|66436687|FG011|Overall Study|Disease Progression|2|||
23742861|NCT02030067|66436688|FG012|Overall Study|Disease Progression|59|||
23742862|NCT02030067|66436676|FG000|Overall Study|Withdrawal by Subject|0|||
23742863|NCT02030067|66436677|FG001|Overall Study|Withdrawal by Subject|0|||
23430174|NCT03626545|65320522|FG002|Overall Study|Progressive disease|85|||
23430175|NCT03626545|65320520|FG000|Overall Study|Adverse Event|3|||
23620749|NCT00087555|65997566|FG000|Overall Study|Adverse Event|3|||
23620750|NCT00087555|65997567|FG001|Overall Study|Adverse Event|6|||
23620751|NCT00087555|65997568|FG002|Overall Study|Adverse Event|14|||
23620752|NCT00087555|65997566|FG000|Overall Study|Lost to Follow-up|0|||
23620753|NCT00087555|65997567|FG001|Overall Study|Lost to Follow-up|1|||
23620754|NCT00087555|65997568|FG002|Overall Study|Lost to Follow-up|1|||
23620755|NCT00087555|65997566|FG000|Overall Study|Non - Compliance|1|||
23620756|NCT00087555|65997567|FG001|Overall Study|Non - Compliance|0|||
23620757|NCT00087555|65997568|FG002|Overall Study|Non - Compliance|0|||
23620758|NCT00087555|65997566|FG000|Overall Study|Protocol Violation|0|||
23620759|NCT00087555|65997567|FG001|Overall Study|Protocol Violation|0|||
23620760|NCT00087555|65997568|FG002|Overall Study|Protocol Violation|2|||
23620761|NCT00087555|65997566|FG000|Overall Study|Screen Failure|1|||
23620762|NCT00087555|65997567|FG001|Overall Study|Screen Failure|1|||
23620763|NCT00087555|65997568|FG002|Overall Study|Screen Failure|0|||
23620764|NCT00087555|65997566|FG000|Overall Study|Pregnancy|0|||
23620765|NCT00087555|65997567|FG001|Overall Study|Pregnancy|1|||
23620766|NCT00087555|65997568|FG002|Overall Study|Pregnancy|1|||
23620767|NCT00087555|65997566|FG000|Overall Study|Withdrawal by Subject|3|||
23620768|NCT00087555|65997567|FG001|Overall Study|Withdrawal by Subject|2|||
23620769|NCT00087555|65997568|FG002|Overall Study|Withdrawal by Subject|1|||
23620770|NCT00087555|65997566|FG000|Overall Study|Lack of Efficacy|2|||
23620771|NCT00087555|65997567|FG001|Overall Study|Lack of Efficacy|0|||
23620772|NCT00087555|65997568|FG002|Overall Study|Lack of Efficacy|1|||
23620773|NCT00087555|65997566|FG000|Overall Study|Non Compliance|0|||
23620774|NCT00087555|65997567|FG001|Overall Study|Non Compliance|0|||
23620775|NCT00087555|65997568|FG002|Overall Study|Non Compliance|1|||
23620776|NCT00087555|65997566|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
23620777|NCT00087555|65997567|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
23620778|NCT00087555|65997568|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
23620779|NCT00087555|65997566|FG000|Overall Study|Patient wanted to go back on Med|1|||
23620780|NCT00087555|65997567|FG001|Overall Study|Patient wanted to go back on Med|0|||
23620781|NCT00087555|65997568|FG002|Overall Study|Patient wanted to go back on Med|0|||
23620782|NCT05523219|65997569|FG000|Overall Study|Wrong inclusion|1|||
23620783|NCT05523219|65997569|FG000|Overall Study|Lost to Follow-up|7|||
23620784|NCT00439647|65997570|FG000|Overall Study|Withdrawal by Subject|25|||
23620785|NCT00439647|65997571|FG001|Overall Study|Withdrawal by Subject|22|||
23620786|NCT00439647|65997570|FG000|Overall Study|Death|15|||
23620787|NCT00439647|65997571|FG001|Overall Study|Death|18|||
23620788|NCT00439647|65997570|FG000|Overall Study|Adverse Event|11|||
23620789|NCT00439647|65997571|FG001|Overall Study|Adverse Event|11|||
23620790|NCT00439647|65997570|FG000|Overall Study|Lost to Follow-up|4|||
23742864|NCT02030067|66436678|FG002|Overall Study|Withdrawal by Subject|0|||
23742865|NCT02030067|66436679|FG003|Overall Study|Withdrawal by Subject|1|||
23742866|NCT02030067|66436680|FG004|Overall Study|Withdrawal by Subject|0|||
23742867|NCT02030067|66436681|FG005|Overall Study|Withdrawal by Subject|0|||
23742868|NCT02030067|66436682|FG006|Overall Study|Withdrawal by Subject|0|||
23742869|NCT02030067|66436683|FG007|Overall Study|Withdrawal by Subject|1|||
23742870|NCT02030067|66436684|FG008|Overall Study|Withdrawal by Subject|0|||
23742871|NCT02030067|66436685|FG009|Overall Study|Withdrawal by Subject|0|||
23742872|NCT02030067|66436686|FG010|Overall Study|Withdrawal by Subject|3|||
23742873|NCT02030067|66436687|FG011|Overall Study|Withdrawal by Subject|0|||
23742874|NCT02030067|66436688|FG012|Overall Study|Withdrawal by Subject|6|||
23742875|NCT02030067|66436676|FG000|Overall Study|Physician Decision|0|||
23742876|NCT02030067|66436677|FG001|Overall Study|Physician Decision|0|||
23742877|NCT02030067|66436678|FG002|Overall Study|Physician Decision|0|||
23742878|NCT02030067|66436679|FG003|Overall Study|Physician Decision|0|||
23742879|NCT02030067|66436680|FG004|Overall Study|Physician Decision|0|||
23742880|NCT02030067|66436681|FG005|Overall Study|Physician Decision|0|||
23742881|NCT02030067|66436682|FG006|Overall Study|Physician Decision|0|||
23430176|NCT03626545|65320521|FG001|Overall Study|Adverse Event|13|||
23430177|NCT03626545|65320522|FG002|Overall Study|Adverse Event|10|||
23430178|NCT03626545|65320520|FG000|Overall Study|Physician Decision|1|||
23742882|NCT02030067|66436683|FG007|Overall Study|Physician Decision|0|||
23742883|NCT02030067|66436684|FG008|Overall Study|Physician Decision|0|||
23742884|NCT02030067|66436685|FG009|Overall Study|Physician Decision|0|||
23620791|NCT00439647|65997571|FG001|Overall Study|Lost to Follow-up|12|||
23620792|NCT00439647|65997570|FG000|Overall Study|Protocol Violation|3|||
23620793|NCT00439647|65997571|FG001|Overall Study|Protocol Violation|4|||
23620794|NCT00439647|65997570|FG000|Overall Study|Lack of Efficacy|0|||
23620795|NCT00439647|65997571|FG001|Overall Study|Lack of Efficacy|4|||
23620796|NCT00381888|65997574|FG000|Overall Study|Death|1|||
23742885|NCT02030067|66436686|FG010|Overall Study|Physician Decision|1|||
23742886|NCT02030067|66436687|FG011|Overall Study|Physician Decision|0|||
23742887|NCT02030067|66436688|FG012|Overall Study|Physician Decision|3|||
23742888|NCT02030067|66436676|FG000|Overall Study|other reasons|0|||
23742889|NCT02030067|66436677|FG001|Overall Study|other reasons|0|||
23742890|NCT02030067|66436678|FG002|Overall Study|other reasons|0|||
23742891|NCT02030067|66436679|FG003|Overall Study|other reasons|0|||
23551008|NCT04402866|65747533|FG002|Overall Study|Miscellaneous|1|||
23551009|NCT04402866|65747534|FG003|Overall Study|Miscellaneous|0|||
23551010|NCT04402866|65747535|FG004|Overall Study|Miscellaneous|0|||
23551011|NCT04402866|65747536|FG005|Overall Study|Miscellaneous|0|||
23551012|NCT04402866|65747531|FG000|Overall Study|Lost to Follow-up|0|||
23551013|NCT04402866|65747532|FG001|Overall Study|Lost to Follow-up|0|||
23551014|NCT04402866|65747533|FG002|Overall Study|Lost to Follow-up|0|||
23742892|NCT02030067|66436680|FG004|Overall Study|other reasons|0|||
23551015|NCT04402866|65747534|FG003|Overall Study|Lost to Follow-up|0|||
23551016|NCT04402866|65747535|FG004|Overall Study|Lost to Follow-up|0|||
23551017|NCT04402866|65747536|FG005|Overall Study|Lost to Follow-up|1|||
23551018|NCT04402866|65747531|FG000|Overall Study|Withdrawal by Subject|0|||
23551019|NCT04402866|65747532|FG001|Overall Study|Withdrawal by Subject|0|||
23551020|NCT04402866|65747533|FG002|Overall Study|Withdrawal by Subject|0|||
23551021|NCT04402866|65747534|FG003|Overall Study|Withdrawal by Subject|0|||
23551022|NCT04402866|65747535|FG004|Overall Study|Withdrawal by Subject|0|||
23551023|NCT04402866|65747536|FG005|Overall Study|Withdrawal by Subject|2|||
23742893|NCT02030067|66436681|FG005|Overall Study|other reasons|1|||
23742894|NCT02030067|66436682|FG006|Overall Study|other reasons|0|||
23742895|NCT02030067|66436683|FG007|Overall Study|other reasons|0|||
23742896|NCT02030067|66436684|FG008|Overall Study|other reasons|2|||
23742897|NCT02030067|66436685|FG009|Overall Study|other reasons|0|||
23742898|NCT02030067|66436686|FG010|Overall Study|other reasons|0|||
23742899|NCT02030067|66436687|FG011|Overall Study|other reasons|0|||
23821798|NCT00948155|66726164|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
23821799|NCT00948155|66726165|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
23821800|NCT00948155|66726164|FG000|Washout 14 Days|Lost to Follow-up|1|||
23821801|NCT00948155|66726165|FG001|Washout 14 Days|Lost to Follow-up|2|||
23821802|NCT01174043|66726166|FG000|Overall Study|Disease progression|5|||
23821803|NCT01174043|66726166|FG000|Overall Study|Adverse Event|3|||
23821804|NCT01174043|66726166|FG000|Overall Study|Death|1|||
23821805|NCT01174043|66726166|FG000|Overall Study|Withdrawal by Subject|2|||
23821806|NCT00380744|66726171|FG000|Overall Study|Death|0|||
23821807|NCT00380744|66726172|FG001|Overall Study|Death|0|||
23821808|NCT00380744|66726173|FG002|Overall Study|Death|0|||
23821809|NCT00380744|66726174|FG003|Overall Study|Death|0|||
23821810|NCT00380744|66726175|FG004|Overall Study|Death|0|||
23821811|NCT00380744|66726176|FG005|Overall Study|Death|0|||
23821812|NCT00380744|66726177|FG006|Overall Study|Death|1|||
23821813|NCT00380744|66726171|FG000|Overall Study|Withdrawal by Subject|1|||
23821814|NCT00380744|66726172|FG001|Overall Study|Withdrawal by Subject|0|||
23551024|NCT01292239|65747537|FG000|Overall Study|Other|1|||
23551025|NCT01292239|65747538|FG001|Overall Study|Other|1|||
23551026|NCT01292239|65747537|FG000|Overall Study|Withdrawal by Subject|3|||
23551027|NCT01292239|65747538|FG001|Overall Study|Withdrawal by Subject|6|||
23551028|NCT02372396|65747541|FG000|Overall Study|Lost to Follow-up|7|||
23742900|NCT02030067|66436688|FG012|Overall Study|other reasons|4|||
23742901|NCT02030067|66436676|FG000|Overall Study|Adverse Event|0|||
23742902|NCT02030067|66436677|FG001|Overall Study|Adverse Event|0|||
23742903|NCT02030067|66436678|FG002|Overall Study|Adverse Event|0|||
23742904|NCT02030067|66436679|FG003|Overall Study|Adverse Event|0|||
23821815|NCT00380744|66726173|FG002|Overall Study|Withdrawal by Subject|0|||
23430179|NCT03626545|65320521|FG001|Overall Study|Physician Decision|18|||
23551029|NCT02372396|65747542|FG001|Overall Study|Lost to Follow-up|9|||
23551030|NCT02522494|65747545|FG000|Overall Study|Lost to Follow-up|6|||
23551031|NCT02522494|65747546|FG001|Overall Study|Lost to Follow-up|2|||
23551032|NCT02522494|65747545|FG000|Overall Study|Withdrawal by Subject|1|||
23551033|NCT02522494|65747546|FG001|Overall Study|Withdrawal by Subject|0|||
23551034|NCT02522494|65747545|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
23551035|NCT02522494|65747546|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
23551036|NCT02522494|65747545|FG000|Overall Study|Participant did not watch the video|1|||
23551037|NCT02522494|65747546|FG001|Overall Study|Participant did not watch the video|0|||
23551038|NCT02522494|65747545|FG000|Overall Study|Death|0|||
23742905|NCT02030067|66436680|FG004|Overall Study|Adverse Event|0|||
23742906|NCT02030067|66436681|FG005|Overall Study|Adverse Event|0|||
23821816|NCT00380744|66726174|FG003|Overall Study|Withdrawal by Subject|0|||
23821817|NCT00380744|66726175|FG004|Overall Study|Withdrawal by Subject|0|||
23551039|NCT02522494|65747546|FG001|Overall Study|Death|1|||
23551040|NCT02638948|65747547|FG000|Overall Study|Withdrawal by Subject|4|||
23551041|NCT02638948|65747548|FG001|Overall Study|Withdrawal by Subject|5|||
23551042|NCT02638948|65747549|FG002|Overall Study|Withdrawal by Subject|3|||
23742907|NCT02030067|66436682|FG006|Overall Study|Adverse Event|0|||
23821818|NCT00380744|66726176|FG005|Overall Study|Withdrawal by Subject|0|||
23551043|NCT02638948|65747550|FG003|Overall Study|Withdrawal by Subject|1|||
23551044|NCT02638948|65747547|FG000|Overall Study|Administrative Reason by Sponsor|0|||
23551045|NCT02638948|65747548|FG001|Overall Study|Administrative Reason by Sponsor|1|||
23551046|NCT02638948|65747549|FG002|Overall Study|Administrative Reason by Sponsor|0|||
23551047|NCT02638948|65747550|FG003|Overall Study|Administrative Reason by Sponsor|4|||
23551048|NCT02638948|65747547|FG000|Overall Study|Adverse Event|0|||
23551049|NCT02638948|65747548|FG001|Overall Study|Adverse Event|0|||
23551050|NCT02638948|65747549|FG002|Overall Study|Adverse Event|1|||
23551051|NCT02638948|65747550|FG003|Overall Study|Adverse Event|1|||
23551052|NCT02638948|65747547|FG000|Overall Study|Lack of Efficacy|1|||
23551053|NCT02638948|65747548|FG001|Overall Study|Lack of Efficacy|1|||
23551054|NCT02638948|65747549|FG002|Overall Study|Lack of Efficacy|0|||
23551055|NCT02638948|65747550|FG003|Overall Study|Lack of Efficacy|0|||
23551056|NCT02638948|65747547|FG000|Overall Study|Lost to Follow-up|0|||
23551057|NCT02638948|65747548|FG001|Overall Study|Lost to Follow-up|0|||
23551058|NCT02638948|65747549|FG002|Overall Study|Lost to Follow-up|1|||
23551059|NCT02638948|65747550|FG003|Overall Study|Lost to Follow-up|1|||
23551060|NCT02638948|65747547|FG000|Overall Study|Poor/Non-Compliance|0|||
23551061|NCT02638948|65747548|FG001|Overall Study|Poor/Non-Compliance|2|||
23551062|NCT02638948|65747549|FG002|Overall Study|Poor/Non-Compliance|1|||
23551063|NCT02638948|65747550|FG003|Overall Study|Poor/Non-Compliance|0|||
23551064|NCT02638948|65747547|FG000|Overall Study|Participant no longer met study criteria|0|||
23551065|NCT02638948|65747548|FG001|Overall Study|Participant no longer met study criteria|1|||
23551066|NCT02638948|65747549|FG002|Overall Study|Participant no longer met study criteria|0|||
23551067|NCT02638948|65747550|FG003|Overall Study|Participant no longer met study criteria|0|||
23551068|NCT02638948|65747547|FG000|Overall Study|Other than specified above|4|||
23551069|NCT02638948|65747548|FG001|Overall Study|Other than specified above|1|||
23551070|NCT02638948|65747549|FG002|Overall Study|Other than specified above|1|||
23551071|NCT02638948|65747550|FG003|Overall Study|Other than specified above|1|||
23551072|NCT00695669|65747551|FG000|Overall Study|Adverse Event|0|||
23551073|NCT00695669|65747552|FG001|Overall Study|Adverse Event|0|||
23551074|NCT00695669|65747553|FG002|Overall Study|Adverse Event|2|||
23551075|NCT00695669|65747554|FG003|Overall Study|Adverse Event|0|||
23551076|NCT00695669|65747551|FG000|Overall Study|Lost to Follow-up|4|||
23551077|NCT00695669|65747552|FG001|Overall Study|Lost to Follow-up|4|||
23551078|NCT00695669|65747553|FG002|Overall Study|Lost to Follow-up|1|||
23551079|NCT00695669|65747554|FG003|Overall Study|Lost to Follow-up|4|||
23551080|NCT00651664|65747557|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
23551081|NCT00651664|65747558|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
23551082|NCT00651664|65747559|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
23551083|NCT00651664|65747560|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
23551084|NCT00651664|65747561|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
23551085|NCT00651664|65747562|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
23551086|NCT00651664|65747563|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
23551087|NCT00651664|65747564|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
23551088|NCT00651664|65747565|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
23551089|NCT00651664|65747566|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
23551090|NCT00651664|65747557|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551091|NCT00651664|65747558|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551092|NCT00651664|65747559|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551093|NCT00651664|65747560|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23742908|NCT02030067|66436683|FG007|Overall Study|Adverse Event|0|||
23742909|NCT02030067|66436684|FG008|Overall Study|Adverse Event|0|||
23742910|NCT02030067|66436685|FG009|Overall Study|Adverse Event|0|||
23742911|NCT02030067|66436686|FG010|Overall Study|Adverse Event|0|||
23742912|NCT02030067|66436687|FG011|Overall Study|Adverse Event|1|||
23742913|NCT02030067|66436688|FG012|Overall Study|Adverse Event|8|||
23742914|NCT03219372|66436692|FG000|Overall Study|Withdrawal by Subject|1|||
23742915|NCT03219372|66436693|FG001|Overall Study|Withdrawal by Subject|0|||
23742916|NCT01348828|66436694|FG000|Overall Study|Death|20|||
23742917|NCT01348828|66436694|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
23742918|NCT01348828|66436694|FG000|Overall Study|Conversion|2|||
23742919|NCT01348828|66436694|FG000|Overall Study|missed visit|1|||
23551094|NCT00651664|65747561|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551095|NCT00651664|65747562|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551096|NCT00651664|65747563|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551097|NCT00651664|65747564|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551098|NCT00651664|65747565|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551099|NCT00651664|65747566|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551100|NCT00651664|65747557|FG000|Overall Study|Progressive Disease|3|||
23551101|NCT00651664|65747558|FG001|Overall Study|Progressive Disease|3|||
23551102|NCT00651664|65747559|FG002|Overall Study|Progressive Disease|3|||
23742920|NCT01821391|66439666|FG000|Overall Study|Adverse Event|1|||
23742921|NCT01821391|66439667|FG001|Overall Study|Adverse Event|0|||
23742922|NCT03890731|66439668|FG000|Overall Study|Progressive disease|1|||
23742923|NCT03890731|66439668|FG000|Overall Study|Patient's decision|1|||
23742924|NCT03890731|66439668|FG000|Overall Study|Adverse Event|4|||
23742925|NCT00689611|66439669|FG000|Overall Study|Death|6|||
23742926|NCT00689611|66439670|FG001|Overall Study|Death|9|||
23742927|NCT00689611|66439669|FG000|Overall Study|Withdrawal by Subject|8|||
23742928|NCT00689611|66439670|FG001|Overall Study|Withdrawal by Subject|9|||
23742929|NCT00689611|66439669|FG000|Overall Study|Lost to Follow-up|27|||
23742930|NCT00689611|66439670|FG001|Overall Study|Lost to Follow-up|28|||
23742931|NCT01801475|66439672|FG000|Overall Study|Withdrawal by Subject|0|||
23742932|NCT01801475|66439673|FG001|Overall Study|Withdrawal by Subject|0|||
23742933|NCT01801475|66439674|FG002|Overall Study|Withdrawal by Subject|0|||
23742934|NCT01801475|66439675|FG003|Overall Study|Withdrawal by Subject|0|||
23742935|NCT01801475|66439676|FG004|Overall Study|Withdrawal by Subject|1|||
23742936|NCT03783026|66439677|FG000|Treatment Phase|Adverse Event|15|||
23742937|NCT03783026|66439677|FG000|Treatment Phase|Lack of Efficacy|11|||
23742938|NCT03783026|66439677|FG000|Treatment Phase|Withdrawal by Subject|6|||
23742939|NCT03783026|66439677|FG000|Treatment Phase|Lost to Follow-up|2|||
23742940|NCT03783026|66439677|FG000|Treatment Phase|Protocol Deviation|8|||
23742941|NCT03783026|66439677|FG000|Treatment Phase|Did Not Receive Treatment|1|||
23742942|NCT03783026|66439677|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
23742943|NCT00508872|66439685|FG000|Overall Study|Lost to Follow-up|1|||
23742944|NCT00508872|66439685|FG000|Overall Study|Physician Decision|1|||
23742945|NCT04366258|66439686|FG000|Baseline Assessments|Screen Failure|21|||
23742946|NCT04366258|66439686|FG000|Baseline Assessments|Early Termination|3|||
23742947|NCT01013207|66439687|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
23742948|NCT01072175|66439688|FG000|Part A (Drug-Drug Interaction)|Death|1|||
23742949|NCT01072175|66439689|FG001|Part A (Drug-Drug Interaction)|Death|0|||
23742950|NCT01072175|66439690|FG002|Part A (Drug-Drug Interaction)|Death|0|||
23742951|NCT01072175|66439691|FG003|Part A (Drug-Drug Interaction)|Death|0|||
23742952|NCT01072175|66439692|FG004|Part A (Drug-Drug Interaction)|Death|0|||
23742953|NCT01072175|66439693|FG005|Part A (Drug-Drug Interaction)|Death|0|||
23742954|NCT01072175|66439694|FG006|Part A (Drug-Drug Interaction)|Death|0|||
23742955|NCT01072175|66439695|FG007|Part A (Drug-Drug Interaction)|Death|0|||
23430180|NCT03626545|65320522|FG002|Overall Study|Physician Decision|14|||
23551103|NCT00651664|65747560|FG003|Overall Study|Progressive Disease|12|||
23551104|NCT00651664|65747561|FG004|Overall Study|Progressive Disease|4|||
23551105|NCT00651664|65747562|FG005|Overall Study|Progressive Disease|1|||
23551106|NCT00651664|65747563|FG006|Overall Study|Progressive Disease|3|||
23551107|NCT00651664|65747564|FG007|Overall Study|Progressive Disease|6|||
23551108|NCT00651664|65747565|FG008|Overall Study|Progressive Disease|5|||
23551109|NCT00651664|65747566|FG009|Overall Study|Progressive Disease|5|||
23551110|NCT00651664|65747557|FG000|Overall Study|Patient Declined Further Treatment|0|||
23551111|NCT00651664|65747558|FG001|Overall Study|Patient Declined Further Treatment|0|||
23551112|NCT00651664|65747559|FG002|Overall Study|Patient Declined Further Treatment|0|||
23551113|NCT00651664|65747560|FG003|Overall Study|Patient Declined Further Treatment|1|||
23551114|NCT00651664|65747561|FG004|Overall Study|Patient Declined Further Treatment|1|||
23551115|NCT00651664|65747562|FG005|Overall Study|Patient Declined Further Treatment|1|||
23551116|NCT00651664|65747563|FG006|Overall Study|Patient Declined Further Treatment|0|||
23551117|NCT00651664|65747564|FG007|Overall Study|Patient Declined Further Treatment|0|||
23551118|NCT00651664|65747565|FG008|Overall Study|Patient Declined Further Treatment|0|||
23551119|NCT00651664|65747566|FG009|Overall Study|Patient Declined Further Treatment|1|||
23551120|NCT00651664|65747557|FG000|Overall Study|Symptomatic Deterioration|0|||
23551121|NCT00651664|65747558|FG001|Overall Study|Symptomatic Deterioration|0|||
23551122|NCT00651664|65747559|FG002|Overall Study|Symptomatic Deterioration|0|||
23551123|NCT00651664|65747560|FG003|Overall Study|Symptomatic Deterioration|1|||
23620797|NCT00381888|65997574|FG000|Overall Study|Withdrawal by Subject|1|||
23620798|NCT00381888|65997574|FG000|Overall Study|Physician Decision|1|||
23620799|NCT00381888|65997574|FG000|Overall Study|Protocol Violation|9|||
23620800|NCT00381888|65997574|FG000|Overall Study|Had laparoscopic surgery|2|||
23620801|NCT00381888|65997574|FG000|Overall Study|Surgery was cancelled|2|||
23620802|NCT00381888|65997574|FG000|Overall Study|Adverse Event|1|||
23620803|NCT01037413|65997575|FG000|Part A: Skin Testing|Adverse Event|1|||
23620804|NCT01037413|65997576|FG001|Part A: Skin Testing|Adverse Event|0|||
23620805|NCT01037413|65997575|FG000|Part A: Skin Testing|Protocol Violation|1|||
23620806|NCT01037413|65997576|FG001|Part A: Skin Testing|Protocol Violation|0|||
23620807|NCT01037413|65997575|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
23742956|NCT01072175|66439696|FG008|Part A (Drug-Drug Interaction)|Death|0|||
23742957|NCT01072175|66439697|FG009|Part A (Drug-Drug Interaction)|Death|0|||
23742958|NCT01072175|66439698|FG010|Part A (Drug-Drug Interaction)|Death|0|||
23742959|NCT01072175|66439699|FG011|Part A (Drug-Drug Interaction)|Death|0|||
23551124|NCT00651664|65747561|FG004|Overall Study|Symptomatic Deterioration|0|||
23551125|NCT00651664|65747562|FG005|Overall Study|Symptomatic Deterioration|0|||
23551126|NCT00651664|65747563|FG006|Overall Study|Symptomatic Deterioration|1|||
23620808|NCT01037413|65997576|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
23620809|NCT01037413|65997575|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
23742960|NCT01072175|66439700|FG012|Part A (Drug-Drug Interaction)|Death|0|||
23742961|NCT01072175|66439688|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
23551127|NCT00651664|65747564|FG007|Overall Study|Symptomatic Deterioration|0|||
23551128|NCT00651664|65747565|FG008|Overall Study|Symptomatic Deterioration|1|||
23551129|NCT00651664|65747566|FG009|Overall Study|Symptomatic Deterioration|0|||
23551130|NCT00651664|65747557|FG000|Overall Study|Reason not Specified|0|||
23551131|NCT00651664|65747558|FG001|Overall Study|Reason not Specified|0|||
23742962|NCT01072175|66439689|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742963|NCT01072175|66439690|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742964|NCT01072175|66439691|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742965|NCT01072175|66439692|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742966|NCT01072175|66439693|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742967|NCT01072175|66439694|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742968|NCT01072175|66439695|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742969|NCT01072175|66439696|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742970|NCT01072175|66439697|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742971|NCT01072175|66439698|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742972|NCT01072175|66439699|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742973|NCT01072175|66439700|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23742974|NCT01072175|66439688|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
23742975|NCT01072175|66439689|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742976|NCT01072175|66439690|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742977|NCT01072175|66439691|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23551132|NCT00651664|65747559|FG002|Overall Study|Reason not Specified|0|||
23551133|NCT00651664|65747560|FG003|Overall Study|Reason not Specified|0|||
23551134|NCT00651664|65747561|FG004|Overall Study|Reason not Specified|0|||
23551135|NCT00651664|65747562|FG005|Overall Study|Reason not Specified|0|||
23551136|NCT00651664|65747563|FG006|Overall Study|Reason not Specified|1|||
23551137|NCT00651664|65747564|FG007|Overall Study|Reason not Specified|0|||
23551138|NCT00651664|65747565|FG008|Overall Study|Reason not Specified|0|||
23551139|NCT00651664|65747566|FG009|Overall Study|Reason not Specified|0|||
23551140|NCT02778100|65747567|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
23551141|NCT02778100|65747568|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
23551142|NCT04269889|65747573|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
23551143|NCT04269889|65747573|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
23551144|NCT02278328|65747574|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
23551145|NCT02278328|65747575|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
23551146|NCT02278328|65747576|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
23551147|NCT02278328|65747574|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
23551148|NCT02278328|65747575|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
23551149|NCT02278328|65747576|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
23551150|NCT02278328|65747574|FG000|Neuropsych Screening|incomplete consent|0|||
23551151|NCT02278328|65747575|FG001|Neuropsych Screening|incomplete consent|0|||
23551152|NCT02278328|65747576|FG002|Neuropsych Screening|incomplete consent|2|||
23551153|NCT02491671|65747577|FG000|Overall Study|Adverse Event|6|||
23551154|NCT02491671|65747578|FG001|Overall Study|Adverse Event|8|||
23551155|NCT02491671|65747577|FG000|Overall Study|Death|0|||
23551156|NCT02491671|65747578|FG001|Overall Study|Death|2|||
23551157|NCT02491671|65747577|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
23551158|NCT02491671|65747578|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
23551159|NCT01262651|65747582|FG000|Overall Study|Adverse Event|40|||
23551160|NCT01262651|65747583|FG001|Overall Study|Adverse Event|35|||
23742978|NCT01072175|66439692|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742979|NCT01072175|66439693|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742980|NCT01072175|66439694|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742981|NCT01072175|66439695|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23821819|NCT00380744|66726177|FG006|Overall Study|Withdrawal by Subject|0|||
23551161|NCT01262651|65747582|FG000|Overall Study|Withdrawal by Subject|15|||
23551162|NCT01262651|65747583|FG001|Overall Study|Withdrawal by Subject|11|||
23551163|NCT01262651|65747582|FG000|Overall Study|Withdrawal by Investigator|2|||
23551164|NCT01262651|65747583|FG001|Overall Study|Withdrawal by Investigator|2|||
23551165|NCT01262651|65747582|FG000|Overall Study|Met Withdrawal Criteria|1|||
23551166|NCT01262651|65747583|FG001|Overall Study|Met Withdrawal Criteria|0|||
23551167|NCT01474681|65747584|FG000|Overall Study|Death|0|||
23551168|NCT01474681|65747585|FG001|Overall Study|Death|3|||
23551169|NCT01474681|65747586|FG002|Overall Study|Death|2|||
23551170|NCT01474681|65747587|FG003|Overall Study|Death|6|||
23742982|NCT01072175|66439696|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742983|NCT01072175|66439697|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742984|NCT01072175|66439698|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23551171|NCT03031938|65747588|FG000|Overall Study|Death|1|||
23551172|NCT03031938|65747589|FG001|Overall Study|Death|0|||
23551173|NCT02515279|65747590|FG000|Overall Study|Adverse Event|7|||
23551174|NCT02515279|65747590|FG000|Overall Study|Lack of Efficacy|31|||
23551175|NCT02515279|65747590|FG000|Overall Study|Lost to Follow-up|9|||
23742985|NCT01072175|66439699|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742986|NCT01072175|66439700|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23742987|NCT01072175|66439688|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
23742988|NCT01072175|66439689|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
23742989|NCT01072175|66439690|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
23742990|NCT01072175|66439691|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
23742991|NCT01072175|66439692|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
23742992|NCT01072175|66439693|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
23551176|NCT02515279|65747590|FG000|Overall Study|Withdrawal by Subject|18|||
23551177|NCT02515279|65747590|FG000|Overall Study|End-of-treatment visit not attended|17|||
23551178|NCT02515279|65747590|FG000|Overall Study|Other|22|||
23551179|NCT00126438|65747591|FG000|Overall Study|Withdrawal due to adverse event|1|||
23551180|NCT00126438|65747592|FG001|Overall Study|Withdrawal due to adverse event|0|||
23551181|NCT00126438|65747591|FG000|Overall Study|Lost to Follow-up|22|||
23551182|NCT00126438|65747592|FG001|Overall Study|Lost to Follow-up|0|||
23551183|NCT00126438|65747591|FG000|Overall Study|Protocol Violation|8|||
23551184|NCT00126438|65747592|FG001|Overall Study|Protocol Violation|8|||
23551185|NCT00126438|65747591|FG000|Overall Study|Withdrawal by Subject|3|||
23551186|NCT00126438|65747592|FG001|Overall Study|Withdrawal by Subject|2|||
23742993|NCT01072175|66439694|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
23742994|NCT01072175|66439695|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
23742995|NCT01072175|66439696|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
23742996|NCT01072175|66439697|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
23742997|NCT01072175|66439698|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
23742998|NCT01072175|66439699|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
23742999|NCT01072175|66439700|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
23551187|NCT04050865|65747593|FG000|Overall Study|Adverse Event|1|||
23551188|NCT04050865|65747594|FG001|Overall Study|Adverse Event|0|||
23551189|NCT04050865|65747593|FG000|Overall Study|no insert|1|||
23551190|NCT04050865|65747594|FG001|Overall Study|no insert|0|||
23551191|NCT04050865|65747593|FG000|Overall Study|Only 1 insert|2|||
23551192|NCT04050865|65747594|FG001|Overall Study|Only 1 insert|3|||
23551193|NCT04050865|65747593|FG000|Overall Study|Physician Decision|0|||
23551194|NCT04050865|65747594|FG001|Overall Study|Physician Decision|1|||
23551195|NCT04050865|65747593|FG000|Overall Study|Withdrawal by Subject|0|||
23551196|NCT04050865|65747594|FG001|Overall Study|Withdrawal by Subject|1|||
23551197|NCT01332227|65747595|FG000|Overall Study|Adverse Event|4|||
23551198|NCT01332227|65747596|FG001|Overall Study|Adverse Event|1|||
23551199|NCT01332227|65747595|FG000|Overall Study|Withdrawal by Subject|5|||
23551200|NCT01332227|65747596|FG001|Overall Study|Withdrawal by Subject|1|||
23551201|NCT01332227|65747595|FG000|Overall Study|Lost to Follow-up|2|||
23551202|NCT01332227|65747596|FG001|Overall Study|Lost to Follow-up|0|||
23551203|NCT01332227|65747595|FG000|Overall Study|Lack of Efficacy|3|||
23551204|NCT01332227|65747596|FG001|Overall Study|Lack of Efficacy|1|||
23551205|NCT01332227|65747595|FG000|Overall Study|Poor compliance/noncompliance|1|||
23551206|NCT01332227|65747596|FG001|Overall Study|Poor compliance/noncompliance|1|||
23551207|NCT01332227|65747595|FG000|Overall Study|Patient moved from area|1|||
23551208|NCT01332227|65747596|FG001|Overall Study|Patient moved from area|0|||
23551209|NCT01332227|65747595|FG000|Overall Study|Patient began prohibited medication|0|||
23551210|NCT01332227|65747596|FG001|Overall Study|Patient began prohibited medication|1|||
23551211|NCT05374421|65747597|FG000|Overall Study|Withdrawal by Subject|3|||
23551212|NCT05374421|65747598|FG001|Overall Study|Withdrawal by Subject|4|||
23551213|NCT00675766|65747599|FG000|Overall Study|Lost to Follow-up|6|||
23551214|NCT00675766|65747600|FG001|Overall Study|Lost to Follow-up|5|||
23551215|NCT00675766|65747601|FG002|Overall Study|Lost to Follow-up|21|||
23551216|NCT00675766|65747602|FG003|Overall Study|Lost to Follow-up|26|||
23551217|NCT01477853|65747603|FG000|Phase A|Adverse Event|1|||
23551218|NCT01477853|65747604|FG001|Phase A|Adverse Event|2|||
23551219|NCT01477853|65747605|FG002|Phase A|Adverse Event|2|||
23551220|NCT01477853|65747603|FG000|Phase A|Lost to Follow-up|4|||
23551221|NCT01477853|65747604|FG001|Phase A|Lost to Follow-up|3|||
23551222|NCT01477853|65747605|FG002|Phase A|Lost to Follow-up|2|||
23551223|NCT01477853|65747603|FG000|Phase A|Physician Decision|1|||
23551224|NCT01477853|65747604|FG001|Phase A|Physician Decision|0|||
23551225|NCT01477853|65747605|FG002|Phase A|Physician Decision|1|||
23551226|NCT01477853|65747603|FG000|Phase A|Study terminated by sponsor|37|||
23743000|NCT01072175|66439688|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743001|NCT01072175|66439689|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23551227|NCT01477853|65747604|FG001|Phase A|Study terminated by sponsor|40|||
23551228|NCT01477853|65747605|FG002|Phase A|Study terminated by sponsor|39|||
23743002|NCT01072175|66439690|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
23551229|NCT01477853|65747603|FG000|Phase B|Lost to Follow-up|0|||
23551230|NCT01477853|65747604|FG001|Phase B|Lost to Follow-up|1|||
23551231|NCT01477853|65747605|FG002|Phase B|Lost to Follow-up|0|||
23551232|NCT01477853|65747603|FG000|Phase B|Study terminated by sponsor|12|||
23551233|NCT01477853|65747604|FG001|Phase B|Study terminated by sponsor|10|||
23551234|NCT01477853|65747605|FG002|Phase B|Study terminated by sponsor|11|||
23743003|NCT01072175|66439691|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743004|NCT01072175|66439692|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
23743005|NCT01072175|66439693|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743006|NCT01072175|66439694|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743007|NCT01072175|66439695|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743008|NCT01072175|66439696|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743009|NCT01072175|66439697|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743010|NCT01072175|66439698|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743011|NCT01072175|66439699|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23551235|NCT00322348|65747606|FG000|Overall Study|Adverse Event|0|||
23551236|NCT00322348|65747607|FG001|Overall Study|Adverse Event|1|||
23551237|NCT00322348|65747606|FG000|Overall Study|Withdrawal by Subject|1|||
23551238|NCT00322348|65747607|FG001|Overall Study|Withdrawal by Subject|4|||
23551239|NCT00322348|65747606|FG000|Overall Study|Lost to Follow-up|1|||
23551240|NCT00322348|65747607|FG001|Overall Study|Lost to Follow-up|0|||
23551241|NCT00322348|65747606|FG000|Overall Study|Death|0|||
23551242|NCT00322348|65747607|FG001|Overall Study|Death|2|||
23551243|NCT00322348|65747606|FG000|Overall Study|Disease Progression|30|||
23551244|NCT00322348|65747607|FG001|Overall Study|Disease Progression|25|||
23551245|NCT00322348|65747606|FG000|Overall Study|Reasons not specified|5|||
23551246|NCT00322348|65747607|FG001|Overall Study|Reasons not specified|1|||
23551247|NCT00902304|65747608|FG000|Overall Study|Adverse Event|4|||
23551248|NCT00902304|65747609|FG001|Overall Study|Adverse Event|10|||
23551249|NCT00902304|65747610|FG002|Overall Study|Adverse Event|25|||
23551250|NCT00902304|65747608|FG000|Overall Study|Investigator discretion|3|||
23551251|NCT00902304|65747609|FG001|Overall Study|Investigator discretion|5|||
23551252|NCT00902304|65747610|FG002|Overall Study|Investigator discretion|13|||
23551253|NCT00902304|65747608|FG000|Overall Study|Lost to Follow-up|7|||
23551254|NCT00902304|65747609|FG001|Overall Study|Lost to Follow-up|7|||
23551255|NCT00902304|65747610|FG002|Overall Study|Lost to Follow-up|7|||
23551256|NCT00902304|65747608|FG000|Overall Study|Protocol Violation|9|||
23551257|NCT00902304|65747609|FG001|Overall Study|Protocol Violation|18|||
23551258|NCT00902304|65747610|FG002|Overall Study|Protocol Violation|20|||
23551259|NCT00902304|65747608|FG000|Overall Study|Withdrawal by Subject|32|||
23551260|NCT00902304|65747609|FG001|Overall Study|Withdrawal by Subject|22|||
23551261|NCT00902304|65747610|FG002|Overall Study|Withdrawal by Subject|43|||
23551262|NCT00902304|65747608|FG000|Overall Study|includes pregnancy|3|||
23551263|NCT00902304|65747609|FG001|Overall Study|includes pregnancy|9|||
23551264|NCT00902304|65747610|FG002|Overall Study|includes pregnancy|2|||
23551265|NCT02962908|65747611|FG000|Overall Study|Lost to Follow-up|0|||
23551266|NCT02962908|65747612|FG001|Overall Study|Lost to Follow-up|3|||
23551267|NCT02962908|65747613|FG002|Overall Study|Lost to Follow-up|0|||
23551268|NCT02962908|65747614|FG003|Overall Study|Lost to Follow-up|1|||
23551269|NCT02962908|65747611|FG000|Overall Study|Withdrawal by Subject|0|||
23551270|NCT02962908|65747612|FG001|Overall Study|Withdrawal by Subject|3|||
23551271|NCT02962908|65747613|FG002|Overall Study|Withdrawal by Subject|0|||
23551272|NCT02962908|65747614|FG003|Overall Study|Withdrawal by Subject|2|||
23551273|NCT02962908|65747611|FG000|Overall Study|Protocol Violation|0|||
23551274|NCT02962908|65747612|FG001|Overall Study|Protocol Violation|1|||
23551275|NCT02962908|65747613|FG002|Overall Study|Protocol Violation|0|||
23551276|NCT02962908|65747614|FG003|Overall Study|Protocol Violation|0|||
23551277|NCT02962908|65747611|FG000|Overall Study|Physician Decision|0|||
23551278|NCT02962908|65747612|FG001|Overall Study|Physician Decision|1|||
23743012|NCT01072175|66439700|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23743013|NCT01072175|66439688|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743014|NCT01072175|66439689|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
23743015|NCT01072175|66439690|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743016|NCT01072175|66439691|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
23743017|NCT01072175|66439692|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
23743018|NCT01072175|66439693|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743019|NCT01072175|66439694|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743020|NCT01072175|66439695|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743021|NCT01072175|66439696|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743022|NCT01072175|66439697|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743023|NCT01072175|66439698|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23551279|NCT02962908|65747613|FG002|Overall Study|Physician Decision|0|||
23743024|NCT01072175|66439699|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23551280|NCT02962908|65747614|FG003|Overall Study|Physician Decision|0|||
23551281|NCT00917579|65747615|FG000|Washout >= 2 Weeks|Adverse Event|1|||
23551282|NCT00917579|65747616|FG001|Washout >= 2 Weeks|Adverse Event|0|||
23551283|NCT00917579|65747615|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
23551284|NCT00917579|65747616|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
23551285|NCT03593655|65747617|FG000|First Product Use Period|Withdrawal by Subject|1|||
23743025|NCT01072175|66439700|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23743026|NCT01072175|66439688|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743027|NCT01072175|66439689|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743028|NCT01072175|66439690|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
23743029|NCT01072175|66439691|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
23743030|NCT01072175|66439692|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
23743031|NCT01072175|66439693|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743032|NCT01072175|66439694|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743033|NCT01072175|66439695|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743034|NCT01072175|66439696|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743035|NCT01072175|66439697|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743036|NCT01072175|66439698|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743037|NCT01072175|66439699|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743038|NCT01072175|66439700|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23743039|NCT01072175|66439688|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743040|NCT01072175|66439689|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
23743041|NCT01072175|66439690|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743042|NCT01072175|66439691|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
23743043|NCT01072175|66439692|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
23743044|NCT01072175|66439693|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743045|NCT01072175|66439694|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743046|NCT01072175|66439695|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743047|NCT01072175|66439696|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743048|NCT01072175|66439697|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743049|NCT01072175|66439698|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743050|NCT01072175|66439699|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743051|NCT01072175|66439700|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23743052|NCT01072175|66439688|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
23743053|NCT01072175|66439689|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
23743054|NCT01072175|66439690|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
23743055|NCT01072175|66439691|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
23743056|NCT01072175|66439692|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
23743057|NCT01072175|66439693|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
23743058|NCT01072175|66439694|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
23743059|NCT01072175|66439695|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
23743060|NCT01072175|66439696|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
23743061|NCT01072175|66439697|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
23743062|NCT01072175|66439698|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
23743063|NCT01072175|66439699|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
23743064|NCT01072175|66439700|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
23743065|NCT01072175|66439688|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743066|NCT01072175|66439689|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743067|NCT01072175|66439690|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743068|NCT01072175|66439691|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743069|NCT01072175|66439692|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743070|NCT01072175|66439693|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23430181|NCT03626545|65320520|FG000|Overall Study|Subject Decision|0|||
23430182|NCT03626545|65320521|FG001|Overall Study|Subject Decision|5|||
23430183|NCT03626545|65320522|FG002|Overall Study|Subject Decision|5|||
23430184|NCT03626545|65320520|FG000|Overall Study|Death|1|||
23430185|NCT03626545|65320521|FG001|Overall Study|Death|1|||
23430186|NCT03626545|65320522|FG002|Overall Study|Death|1|||
23430187|NCT03626545|65320520|FG000|Overall Study|Protocol Deviation|0|||
23430188|NCT03626545|65320521|FG001|Overall Study|Protocol Deviation|1|||
23430189|NCT03626545|65320522|FG002|Overall Study|Protocol Deviation|1|||
23430190|NCT03626545|65320520|FG000|Overall Study|Guardian Decision|0|||
23430191|NCT03626545|65320521|FG001|Overall Study|Guardian Decision|0|||
23430192|NCT03626545|65320522|FG002|Overall Study|Guardian Decision|1|||
23430193|NCT01818492|65320523|FG000|Overall Study|Adverse Event|2|||
23430194|NCT01818492|65320523|FG000|Overall Study|Death|3|||
23430195|NCT01818492|65320523|FG000|Overall Study|Withdrawal by Subject|1|||
23430196|NCT01818492|65320523|FG000|Overall Study|Additional therapy when not allowed PP|4|||
23430197|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
23430198|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
23743071|NCT01072175|66439694|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23430199|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
23430200|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
23430201|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
23430202|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
23430203|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430204|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430205|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430206|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430207|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430208|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
23430209|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
23430210|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
23430211|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430212|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
23430213|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
23430214|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430215|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430216|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430217|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430218|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430219|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430220|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
23430221|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430222|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430223|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
23430224|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430225|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430226|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430227|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430228|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430229|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430230|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
23743072|NCT01072175|66439695|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23743073|NCT01072175|66439696|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743074|NCT01072175|66439697|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743075|NCT01072175|66439698|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743076|NCT01072175|66439699|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743077|NCT01072175|66439700|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23743078|NCT01072175|66439688|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743079|NCT01072175|66439689|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743080|NCT01072175|66439690|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743081|NCT01072175|66439691|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743082|NCT01072175|66439692|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743083|NCT01072175|66439693|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743084|NCT01072175|66439694|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
23743085|NCT01072175|66439695|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
23743086|NCT01072175|66439696|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743087|NCT01072175|66439697|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743088|NCT01072175|66439698|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743089|NCT01072175|66439699|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743090|NCT01072175|66439700|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23743091|NCT01072175|66439688|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23430231|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
23551286|NCT03593655|65747618|FG001|First Product Use Period|Withdrawal by Subject|1|||
23551287|NCT03593655|65747617|FG000|First Product Use Period|Lost to Follow-up|1|||
23551288|NCT03593655|65747618|FG001|First Product Use Period|Lost to Follow-up|3|||
23551289|NCT03593655|65747617|FG000|Second Product Use Period|Withdrawal by Subject|1|||
23551290|NCT03593655|65747618|FG001|Second Product Use Period|Withdrawal by Subject|1|||
23551291|NCT03593655|65747617|FG000|Second Product Use Period|Lost to Follow-up|1|||
23743092|NCT01072175|66439689|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743093|NCT01072175|66439690|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743094|NCT01072175|66439691|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743095|NCT01072175|66439692|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23551292|NCT03593655|65747618|FG001|Second Product Use Period|Lost to Follow-up|0|||
23551293|NCT03593655|65747617|FG000|Third Product Use Period|Lost to Follow-up|1|||
23551294|NCT03593655|65747618|FG001|Third Product Use Period|Lost to Follow-up|2|||
23551295|NCT03593655|65747617|FG000|Third Product Use Period|Physician Decision|0|||
23743096|NCT01072175|66439693|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
23551296|NCT03593655|65747618|FG001|Third Product Use Period|Physician Decision|1|||
23551297|NCT03593655|65747617|FG000|Third Product Use Period|Withdrawal by Subject|0|||
23551298|NCT03593655|65747618|FG001|Third Product Use Period|Withdrawal by Subject|1|||
23551299|NCT03583554|65747623|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
23551300|NCT03583554|65747624|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
23551301|NCT03583554|65747625|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
23551302|NCT02527798|65747626|FG000|Overall Study|Physician Decision|1|||
23620810|NCT01037413|65997576|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
23620811|NCT01713998|65997580|FG000|Overall Study|Lost to Follow-up|2|||
23620812|NCT01713998|65997581|FG001|Overall Study|Lost to Follow-up|0|||
23620813|NCT01713998|65997582|FG002|Overall Study|Lost to Follow-up|2|||
23743097|NCT01072175|66439694|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
23620814|NCT01713998|65997580|FG000|Overall Study|Withdrawal by Subject|1|||
23620815|NCT01713998|65997581|FG001|Overall Study|Withdrawal by Subject|0|||
23620816|NCT01713998|65997582|FG002|Overall Study|Withdrawal by Subject|0|||
23620817|NCT02316847|65997594|FG000|Overall Study|Adverse Event|0|||
23620818|NCT02316847|65997595|FG001|Overall Study|Adverse Event|3|||
23620819|NCT02316847|65997594|FG000|Overall Study|Lost to Follow-up|0|||
23620820|NCT02316847|65997595|FG001|Overall Study|Lost to Follow-up|2|||
23620821|NCT02316847|65997594|FG000|Overall Study|Physician Decision|0|||
23620822|NCT02316847|65997595|FG001|Overall Study|Physician Decision|1|||
23620823|NCT02316847|65997594|FG000|Overall Study|Pregnancy|0|||
23620824|NCT02316847|65997595|FG001|Overall Study|Pregnancy|1|||
23620825|NCT02316847|65997594|FG000|Overall Study|Withdrawal by Subject|2|||
23620826|NCT02316847|65997595|FG001|Overall Study|Withdrawal by Subject|9|||
23620827|NCT02316847|65997594|FG000|Overall Study|Noncompliance with study drug|0|||
23620828|NCT02316847|65997595|FG001|Overall Study|Noncompliance with study drug|3|||
23620829|NCT02316847|65997594|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
23620830|NCT02316847|65997595|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
23620831|NCT00634049|65997598|FG000|Overall Study|Never received study drug|1|||
23620832|NCT00634049|65997598|FG000|Overall Study|Died prior to receiving study drug|1|||
23620833|NCT00634049|65997598|FG000|Overall Study|Screening failure|1|||
23620834|NCT04772313|65997599|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
23620835|NCT04772313|65997599|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
23620836|NCT01967719|65997602|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
23620837|NCT01967719|65997603|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
23620838|NCT01967719|65997604|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23620839|NCT01967719|65997605|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
23620840|NCT01967719|65997602|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620841|NCT01967719|65997603|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
23620842|NCT01967719|65997604|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620843|NCT01967719|65997605|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620844|NCT03918447|65997606|FG000|Overall Study|Death|1|||
23620845|NCT03918447|65997607|FG001|Overall Study|Death|0|||
23620846|NCT03918447|65997606|FG000|Overall Study|Lost to Follow-up|13|||
23620847|NCT03918447|65997607|FG001|Overall Study|Lost to Follow-up|6|||
23620848|NCT03918447|65997606|FG000|Overall Study|Withdrawal by Subject|19|||
23620849|NCT03918447|65997607|FG001|Overall Study|Withdrawal by Subject|17|||
23620850|NCT03918447|65997606|FG000|Overall Study|Study Terminated by Sponsor|195|||
23620851|NCT03918447|65997607|FG001|Overall Study|Study Terminated by Sponsor|197|||
23620852|NCT03918447|65997606|FG000|Overall Study|Reason not Specified|0|||
23620853|NCT03918447|65997607|FG001|Overall Study|Reason not Specified|1|||
23620854|NCT00297778|65997610|FG000|Overall Study|Adverse Event|16|||
23620855|NCT00297778|65997611|FG001|Overall Study|Adverse Event|10|||
23620856|NCT00297778|65997610|FG000|Overall Study|Withdrawal by Subject|1|||
23620857|NCT00297778|65997611|FG001|Overall Study|Withdrawal by Subject|5|||
23620858|NCT00297778|65997610|FG000|Overall Study|Lack of Efficacy|2|||
23620859|NCT00297778|65997611|FG001|Overall Study|Lack of Efficacy|1|||
23620860|NCT00297778|65997610|FG000|Overall Study|Non-compliant with trial protocol|0|||
23620861|NCT00297778|65997611|FG001|Overall Study|Non-compliant with trial protocol|3|||
23743098|NCT01072175|66439695|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
23743099|NCT01072175|66439696|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743100|NCT01072175|66439697|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23430232|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
23430233|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430234|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
23551303|NCT02527798|65747627|FG001|Overall Study|Physician Decision|0|||
23551304|NCT02527798|65747628|FG002|Overall Study|Physician Decision|1|||
23551305|NCT02527798|65747629|FG003|Overall Study|Physician Decision|1|||
23551306|NCT02527798|65747630|FG004|Overall Study|Physician Decision|0|||
23620862|NCT00297778|65997610|FG000|Overall Study|Other|0|||
23620863|NCT00297778|65997611|FG001|Overall Study|Other|1|||
23620864|NCT00988117|65997617|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
23620865|NCT00988117|65997617|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
23551307|NCT02527798|65747631|FG005|Overall Study|Physician Decision|0|||
23551308|NCT02527798|65747626|FG000|Overall Study|Death|0|||
23551309|NCT02527798|65747627|FG001|Overall Study|Death|0|||
23551310|NCT02527798|65747628|FG002|Overall Study|Death|1|||
23551311|NCT02527798|65747629|FG003|Overall Study|Death|0|||
23551312|NCT02527798|65747630|FG004|Overall Study|Death|0|||
23551313|NCT02527798|65747631|FG005|Overall Study|Death|0|||
23551314|NCT02527798|65747626|FG000|Overall Study|Withdrawal by Subject|0|||
23551315|NCT02527798|65747627|FG001|Overall Study|Withdrawal by Subject|1|||
23551316|NCT02527798|65747628|FG002|Overall Study|Withdrawal by Subject|2|||
23743101|NCT01072175|66439698|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743102|NCT01072175|66439699|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743103|NCT01072175|66439700|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23743104|NCT01072175|66439688|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743105|NCT01072175|66439689|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743106|NCT01072175|66439690|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743107|NCT01072175|66439691|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743108|NCT01072175|66439692|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743109|NCT01072175|66439693|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
23743110|NCT01072175|66439694|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
23743111|NCT01072175|66439695|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743112|NCT01072175|66439696|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743113|NCT01072175|66439697|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743114|NCT01072175|66439698|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743115|NCT01072175|66439699|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743116|NCT01072175|66439700|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23743117|NCT01072175|66439688|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743118|NCT01072175|66439689|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23551317|NCT02527798|65747629|FG003|Overall Study|Withdrawal by Subject|0|||
23551318|NCT02527798|65747630|FG004|Overall Study|Withdrawal by Subject|0|||
23551319|NCT02527798|65747631|FG005|Overall Study|Withdrawal by Subject|0|||
23551320|NCT02527798|65747626|FG000|Overall Study|Reason undisclosed|1|||
23551321|NCT02527798|65747627|FG001|Overall Study|Reason undisclosed|0|||
23551322|NCT02527798|65747628|FG002|Overall Study|Reason undisclosed|1|||
23551323|NCT02527798|65747629|FG003|Overall Study|Reason undisclosed|0|||
23551324|NCT02527798|65747630|FG004|Overall Study|Reason undisclosed|0|||
23551325|NCT02527798|65747631|FG005|Overall Study|Reason undisclosed|0|||
23551326|NCT02527798|65747626|FG000|Overall Study|Did not receive intervention|1|||
23551327|NCT02527798|65747627|FG001|Overall Study|Did not receive intervention|1|||
23551328|NCT02527798|65747628|FG002|Overall Study|Did not receive intervention|0|||
23551329|NCT02527798|65747629|FG003|Overall Study|Did not receive intervention|0|||
23551330|NCT02527798|65747630|FG004|Overall Study|Did not receive intervention|0|||
23551331|NCT02527798|65747631|FG005|Overall Study|Did not receive intervention|0|||
23551332|NCT00092534|65747635|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
23551333|NCT00092534|65747636|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
23743119|NCT01072175|66439690|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743120|NCT01072175|66439691|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23551334|NCT00092534|65747637|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23551335|NCT00092534|65747638|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23743121|NCT01072175|66439692|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23821820|NCT02613182|66726180|FG000|Overall Study|Death|6|||
23821821|NCT02613182|66726180|FG000|Overall Study|Physician Decision|1|||
23551336|NCT00092534|65747639|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23551337|NCT00092534|65747635|FG000|Base Study Vaccination Period|Adverse Event|3|||
23551338|NCT00092534|65747636|FG001|Base Study Vaccination Period|Adverse Event|1|||
23551339|NCT00092534|65747637|FG002|Base Study Vaccination Period|Adverse Event|0|||
23551340|NCT00092534|65747638|FG003|Base Study Vaccination Period|Adverse Event|0|||
23551341|NCT00092534|65747639|FG004|Base Study Vaccination Period|Adverse Event|0|||
23551342|NCT00092534|65747635|FG000|Base Study Vaccination Period|Death|5|||
23551343|NCT00092534|65747636|FG001|Base Study Vaccination Period|Death|4|||
23551344|NCT00092534|65747637|FG002|Base Study Vaccination Period|Death|0|||
23551345|NCT00092534|65747638|FG003|Base Study Vaccination Period|Death|0|||
23551346|NCT00092534|65747639|FG004|Base Study Vaccination Period|Death|0|||
23551347|NCT00092534|65747635|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
23551348|NCT00092534|65747636|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
23551349|NCT00092534|65747637|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23551350|NCT00092534|65747638|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23551351|NCT00092534|65747639|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23551352|NCT00092534|65747635|FG000|Base Study Vaccination Period|Physician Decision|1|||
23821822|NCT02613182|66726180|FG000|Overall Study|Study Terminated by Sponsor|21|||
23551353|NCT00092534|65747636|FG001|Base Study Vaccination Period|Physician Decision|0|||
23551354|NCT00092534|65747637|FG002|Base Study Vaccination Period|Physician Decision|0|||
23821823|NCT02613182|66726180|FG000|Overall Study|Withdrawal by Subject|6|||
23743122|NCT01072175|66439693|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743123|NCT01072175|66439694|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23620866|NCT02720185|65997618|FG000|Overall Study|Lost to Follow-up|1|||
23620867|NCT01525641|65997624|FG000|Overall Study|Case report form not collected|25|||
23620868|NCT01525641|65997624|FG000|Overall Study|No visit since the first visit|16|||
23743124|NCT01072175|66439695|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743125|NCT01072175|66439696|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
23743126|NCT01072175|66439697|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743127|NCT01072175|66439698|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743128|NCT01072175|66439699|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743129|NCT01072175|66439700|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23743130|NCT01072175|66439688|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743131|NCT01072175|66439689|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743132|NCT01072175|66439690|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743133|NCT01072175|66439691|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743134|NCT01072175|66439692|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743135|NCT01072175|66439693|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743136|NCT01072175|66439694|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743137|NCT01072175|66439695|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743138|NCT01072175|66439696|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
23743139|NCT01072175|66439697|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743140|NCT01072175|66439698|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743141|NCT01072175|66439699|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743142|NCT01072175|66439700|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23743143|NCT01072175|66439688|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743144|NCT01072175|66439689|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743145|NCT01072175|66439690|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743146|NCT01072175|66439691|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743147|NCT01072175|66439692|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743148|NCT01072175|66439693|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743149|NCT01072175|66439694|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743150|NCT01072175|66439695|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743151|NCT01072175|66439696|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
23743152|NCT01072175|66439697|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743153|NCT01072175|66439698|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743154|NCT01072175|66439699|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743155|NCT01072175|66439700|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23743156|NCT01072175|66439688|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743157|NCT01072175|66439689|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743158|NCT01072175|66439690|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743159|NCT01072175|66439691|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743160|NCT01072175|66439692|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743161|NCT01072175|66439693|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743162|NCT01072175|66439694|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743163|NCT01072175|66439695|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743164|NCT01072175|66439696|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
23743165|NCT01072175|66439697|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743166|NCT01072175|66439698|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743167|NCT01072175|66439699|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743168|NCT01072175|66439700|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23743169|NCT01072175|66439688|FG000|Part D (HPMC Capsules)|Death|0|||
23743170|NCT01072175|66439689|FG001|Part D (HPMC Capsules)|Death|0|||
23743171|NCT01072175|66439690|FG002|Part D (HPMC Capsules)|Death|0|||
23743172|NCT01072175|66439691|FG003|Part D (HPMC Capsules)|Death|0|||
23743173|NCT01072175|66439692|FG004|Part D (HPMC Capsules)|Death|0|||
23743174|NCT01072175|66439693|FG005|Part D (HPMC Capsules)|Death|0|||
23743175|NCT01072175|66439694|FG006|Part D (HPMC Capsules)|Death|0|||
23743176|NCT01072175|66439695|FG007|Part D (HPMC Capsules)|Death|0|||
23743177|NCT01072175|66439696|FG008|Part D (HPMC Capsules)|Death|0|||
23743178|NCT01072175|66439697|FG009|Part D (HPMC Capsules)|Death|10|||
23743179|NCT01072175|66439698|FG010|Part D (HPMC Capsules)|Death|12|||
23743180|NCT01072175|66439699|FG011|Part D (HPMC Capsules)|Death|28|||
23743181|NCT01072175|66439700|FG012|Part D (HPMC Capsules)|Death|26|||
23743182|NCT01072175|66439688|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
23620869|NCT01525641|65997624|FG000|Overall Study|Adverse Event|73|||
23620870|NCT01525641|65997624|FG000|Overall Study|Lack of Efficacy|24|||
23620871|NCT01525641|65997624|FG000|Overall Study|Improvement|5|||
23743183|NCT01072175|66439689|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
23743184|NCT01072175|66439690|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
23743185|NCT01072175|66439691|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
23743186|NCT01072175|66439692|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
23743187|NCT01072175|66439693|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
23743188|NCT01072175|66439694|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
23743189|NCT01072175|66439695|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
23743190|NCT01072175|66439696|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
23743191|NCT01072175|66439697|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
23743192|NCT01072175|66439698|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
23743193|NCT01072175|66439699|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
23743194|NCT01072175|66439700|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
23743195|NCT01072175|66439688|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743196|NCT01072175|66439689|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743197|NCT01072175|66439690|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743198|NCT01072175|66439691|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743199|NCT01072175|66439692|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743200|NCT01072175|66439693|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743201|NCT01072175|66439694|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743202|NCT01072175|66439695|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23620872|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (relocation)|1|||
23620873|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
23620874|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
23743203|NCT01072175|66439696|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743204|NCT01072175|66439697|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23743205|NCT01072175|66439698|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
23743206|NCT01072175|66439699|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
23743207|NCT01072175|66439700|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
23743208|NCT01072175|66439688|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
23620875|NCT01525641|65997624|FG000|Overall Study|Other than stated above|7|||
23620876|NCT00957996|65997625|FG000|Overall Study|Death|4|||
23620877|NCT00957996|65997626|FG001|Overall Study|Death|10|||
23620878|NCT00957996|65997625|FG000|Overall Study|Lost to Follow-up|4|||
23620879|NCT00957996|65997626|FG001|Overall Study|Lost to Follow-up|7|||
23620880|NCT00957996|65997625|FG000|Overall Study|Withdrawal by Subject|9|||
23743209|NCT01072175|66439689|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743210|NCT01072175|66439690|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743211|NCT01072175|66439691|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743212|NCT01072175|66439692|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743213|NCT01072175|66439693|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743214|NCT01072175|66439694|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743215|NCT01072175|66439695|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743216|NCT01072175|66439696|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
23743217|NCT01072175|66439697|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
23743218|NCT01072175|66439698|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
23743219|NCT01072175|66439699|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
23743220|NCT01072175|66439700|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
23743221|NCT01072175|66439688|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743222|NCT01072175|66439689|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743223|NCT01072175|66439690|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743224|NCT01072175|66439691|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743225|NCT01072175|66439692|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743226|NCT01072175|66439693|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743227|NCT01072175|66439694|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743228|NCT01072175|66439695|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743229|NCT01072175|66439696|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743230|NCT01072175|66439697|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743231|NCT01072175|66439698|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
23743232|NCT01072175|66439699|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
23743233|NCT01072175|66439700|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23743234|NCT00903357|66439704|FG000|First Intervention|Withdrawal by Subject|5|||
23743235|NCT00903357|66439705|FG001|First Intervention|Withdrawal by Subject|3|||
23743236|NCT00903357|66439704|FG000|First Intervention|Flu|0|||
23430235|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
23430236|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23551355|NCT00092534|65747638|FG003|Base Study Vaccination Period|Physician Decision|0|||
23551356|NCT00092534|65747639|FG004|Base Study Vaccination Period|Physician Decision|0|||
23551357|NCT00092534|65747635|FG000|Base Study Vaccination Period|Pregnancy|9|||
23551358|NCT00092534|65747636|FG001|Base Study Vaccination Period|Pregnancy|7|||
23551359|NCT00092534|65747637|FG002|Base Study Vaccination Period|Pregnancy|0|||
23551360|NCT00092534|65747638|FG003|Base Study Vaccination Period|Pregnancy|0|||
23551361|NCT00092534|65747639|FG004|Base Study Vaccination Period|Pregnancy|0|||
23551362|NCT00092534|65747635|FG000|Base Study Vaccination Period|Protocol Violation|2|||
23743237|NCT00903357|66439705|FG001|First Intervention|Flu|1|||
23743238|NCT00903357|66439704|FG000|Wash Out Period of 2 Weeks|Flu|0|||
23743239|NCT00903357|66439705|FG001|Wash Out Period of 2 Weeks|Flu|1|||
23743240|NCT00903357|66439704|FG000|Second Intervention|Lost to Follow-up|1|||
23743241|NCT00903357|66439705|FG001|Second Intervention|Lost to Follow-up|0|||
23743242|NCT00761462|66439706|FG000|Treatment|Subjects never received study medication|23|||
23743243|NCT00761462|66439707|FG001|Treatment|Subjects never received study medication|12|||
23743244|NCT00761462|66439706|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
23551363|NCT00092534|65747636|FG001|Base Study Vaccination Period|Protocol Violation|1|||
23551364|NCT00092534|65747637|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23551365|NCT00092534|65747638|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23551366|NCT00092534|65747639|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23551367|NCT00092534|65747635|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
23551368|NCT00092534|65747636|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
23551369|NCT00092534|65747637|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551370|NCT00092534|65747638|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551371|NCT00092534|65747639|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551372|NCT00092534|65747635|FG000|Base Study Vaccination Period|Moved|14|||
23620881|NCT00957996|65997626|FG001|Overall Study|Withdrawal by Subject|2|||
23620882|NCT00957996|65997625|FG000|Overall Study|Adverse Event|2|||
23620883|NCT00957996|65997626|FG001|Overall Study|Adverse Event|1|||
23620884|NCT00957996|65997625|FG000|Overall Study|Physician Decision|1|||
23620885|NCT00957996|65997626|FG001|Overall Study|Physician Decision|1|||
23620886|NCT00957996|65997625|FG000|Overall Study|Influenza-related complication|0|||
23620887|NCT00957996|65997626|FG001|Overall Study|Influenza-related complication|1|||
23620888|NCT00957996|65997625|FG000|Overall Study|Missing|1|||
23620889|NCT00957996|65997626|FG001|Overall Study|Missing|0|||
23620890|NCT00957996|65997625|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
23620891|NCT00957996|65997626|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
23620892|NCT01274559|65997627|FG000|Overall Study|Adverse Event|57|||
23551373|NCT00092534|65747636|FG001|Base Study Vaccination Period|Moved|12|||
23743245|NCT00761462|66439707|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
23743246|NCT00761462|66439706|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
23743247|NCT00761462|66439707|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
23743248|NCT00761462|66439706|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
23743249|NCT00761462|66439707|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
23743250|NCT04678557|66439708|FG000|Overall Study|Withdrawal by Subject|1|||
23743251|NCT04678557|66439709|FG001|Overall Study|Withdrawal by Subject|0|||
23743252|NCT04678557|66439708|FG000|Overall Study|Lack of Efficacy|0|||
23743253|NCT04678557|66439709|FG001|Overall Study|Lack of Efficacy|13|||
23743254|NCT04678557|66439708|FG000|Overall Study|Safety Evaluation|0|||
23551374|NCT00092534|65747637|FG002|Base Study Vaccination Period|Moved|0|||
23551375|NCT00092534|65747638|FG003|Base Study Vaccination Period|Moved|0|||
23551376|NCT00092534|65747639|FG004|Base Study Vaccination Period|Moved|0|||
23551377|NCT00092534|65747635|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
23551378|NCT00092534|65747636|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551379|NCT00092534|65747637|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551380|NCT00092534|65747638|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551381|NCT00092534|65747639|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551382|NCT00092534|65747635|FG000|Base Study Vaccination Period|Travel|1|||
23551383|NCT00092534|65747636|FG001|Base Study Vaccination Period|Travel|0|||
23551384|NCT00092534|65747637|FG002|Base Study Vaccination Period|Travel|0|||
23551385|NCT00092534|65747638|FG003|Base Study Vaccination Period|Travel|0|||
23551386|NCT00092534|65747639|FG004|Base Study Vaccination Period|Travel|0|||
23551387|NCT00092534|65747635|FG000|Base Study Vaccination Period|Site Closed|0|||
23551388|NCT00092534|65747636|FG001|Base Study Vaccination Period|Site Closed|1|||
23620893|NCT01274559|65997628|FG001|Overall Study|Adverse Event|13|||
23620894|NCT01274559|65997627|FG000|Overall Study|Death|1|||
23620895|NCT01274559|65997628|FG001|Overall Study|Death|1|||
23620896|NCT01274559|65997627|FG000|Overall Study|Lost to Follow-up|3|||
23620897|NCT01274559|65997628|FG001|Overall Study|Lost to Follow-up|3|||
23620898|NCT01274559|65997627|FG000|Overall Study|Non-compliance with Study Drug|2|||
23620899|NCT01274559|65997628|FG001|Overall Study|Non-compliance with Study Drug|4|||
23743255|NCT04678557|66439709|FG001|Overall Study|Safety Evaluation|1|||
23743256|NCT00934661|66439710|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
23620900|NCT01274559|65997627|FG000|Overall Study|Physician Decision|2|||
23620901|NCT01274559|65997628|FG001|Overall Study|Physician Decision|1|||
23743257|NCT00934661|66439711|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
23743258|NCT00948896|66439712|FG000|Randomization to 24 Months of Age|Death|1|||
23620902|NCT01274559|65997627|FG000|Overall Study|Protocol Violation|28|||
23620903|NCT01274559|65997628|FG001|Overall Study|Protocol Violation|23|||
23620904|NCT01274559|65997627|FG000|Overall Study|Study Terminated by Sponsor|79|||
23620905|NCT01274559|65997628|FG001|Overall Study|Study Terminated by Sponsor|87|||
23620906|NCT01274559|65997627|FG000|Overall Study|Withdrawal by Subject|25|||
23620907|NCT01274559|65997628|FG001|Overall Study|Withdrawal by Subject|13|||
23620908|NCT00826228|65997629|FG000|Overall Study|Withdrawal by Subject|1|||
23620909|NCT00935259|65997630|FG000|Period 1|Administrative (scheduling conflict)|1|||
23620910|NCT00935259|65997631|FG001|Period 1|Administrative (scheduling conflict)|1|||
23620911|NCT01530087|65997632|FG000|Overall Study|Physician Decision|2|||
23620912|NCT00511797|65997635|FG000|Overall Study|Adverse Event|1|||
23620913|NCT00511797|65997636|FG001|Overall Study|Adverse Event|2|||
23620914|NCT00511797|65997637|FG002|Overall Study|Adverse Event|2|||
23620915|NCT00511797|65997638|FG003|Overall Study|Adverse Event|2|||
23620916|NCT00511797|65997635|FG000|Overall Study|Lost to Follow-up|1|||
23743259|NCT00948896|66439713|FG001|Randomization to 24 Months of Age|Death|0|||
23743260|NCT00948896|66439714|FG002|Randomization to 24 Months of Age|Death|0|||
23743261|NCT00948896|66439715|FG003|Randomization to 24 Months of Age|Death|0|||
23743262|NCT00948896|66439716|FG004|Randomization to 24 Months of Age|Death|2|||
23620917|NCT00511797|65997636|FG001|Overall Study|Lost to Follow-up|0|||
23620918|NCT00511797|65997637|FG002|Overall Study|Lost to Follow-up|0|||
23620919|NCT00511797|65997638|FG003|Overall Study|Lost to Follow-up|1|||
23620920|NCT00511797|65997635|FG000|Overall Study|Pregnancy|0|||
23620921|NCT00511797|65997636|FG001|Overall Study|Pregnancy|0|||
23620922|NCT00511797|65997637|FG002|Overall Study|Pregnancy|0|||
23620923|NCT00511797|65997638|FG003|Overall Study|Pregnancy|1|||
23743263|NCT00948896|66439717|FG005|Randomization to 24 Months of Age|Death|1|||
23743264|NCT00948896|66439718|FG006|Randomization to 24 Months of Age|Death|2|||
23743265|NCT00948896|66439719|FG007|Randomization to 24 Months of Age|Death|1|||
23743266|NCT00948896|66439712|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
23743267|NCT00948896|66439713|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
23743268|NCT00948896|66439714|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
23743269|NCT00948896|66439715|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
23821824|NCT00447876|66726181|FG000|Overall Study|Withdrawal by Subject|1|||
23620924|NCT00511797|65997635|FG000|Overall Study|Protocol Violation|0|||
23620925|NCT00511797|65997636|FG001|Overall Study|Protocol Violation|2|||
23620926|NCT00511797|65997637|FG002|Overall Study|Protocol Violation|2|||
23620927|NCT00511797|65997638|FG003|Overall Study|Protocol Violation|3|||
23620928|NCT00511797|65997635|FG000|Overall Study|Withdrawal by Subject|3|||
23620929|NCT00511797|65997636|FG001|Overall Study|Withdrawal by Subject|3|||
23620930|NCT00511797|65997637|FG002|Overall Study|Withdrawal by Subject|4|||
23620931|NCT00511797|65997638|FG003|Overall Study|Withdrawal by Subject|2|||
23620932|NCT00511797|65997635|FG000|Overall Study|Never dispensed|1|||
23743270|NCT00948896|66439716|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23743271|NCT00948896|66439717|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
23743272|NCT00948896|66439718|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23743273|NCT00948896|66439719|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23743274|NCT00948896|66439712|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
23743275|NCT00948896|66439713|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
23743276|NCT00948896|66439714|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
23743277|NCT00948896|66439715|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
23743278|NCT00948896|66439716|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23743279|NCT00948896|66439717|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23743280|NCT00948896|66439718|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
23743281|NCT00948896|66439719|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23743282|NCT00948896|66439712|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
23743283|NCT00948896|66439713|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
23743284|NCT00948896|66439714|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
23743285|NCT00948896|66439715|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
23743286|NCT00948896|66439716|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
23743287|NCT00948896|66439717|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
23743288|NCT00948896|66439718|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
23743289|NCT00948896|66439719|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
23743290|NCT00948896|66439712|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23743291|NCT00948896|66439713|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
23743292|NCT00948896|66439714|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
23620933|NCT00511797|65997636|FG001|Overall Study|Never dispensed|0|||
23620934|NCT00511797|65997637|FG002|Overall Study|Never dispensed|1|||
23743293|NCT00948896|66439715|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
23821825|NCT00447876|66726182|FG001|Overall Study|Withdrawal by Subject|4|||
23821826|NCT00447876|66726181|FG000|Overall Study|Lost to Follow-up|1|||
23620935|NCT00511797|65997638|FG003|Overall Study|Never dispensed|3|||
23620936|NCT00511797|65997635|FG000|Overall Study|Study drug not taken|0|||
23620937|NCT00511797|65997636|FG001|Overall Study|Study drug not taken|1|||
23620938|NCT00511797|65997637|FG002|Overall Study|Study drug not taken|0|||
23620939|NCT00511797|65997638|FG003|Overall Study|Study drug not taken|1|||
23620940|NCT00511797|65997635|FG000|Overall Study|Partially missing diary|0|||
23551389|NCT00092534|65747637|FG002|Base Study Vaccination Period|Site Closed|0|||
23743294|NCT00948896|66439716|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23743295|NCT00948896|66439717|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
23743296|NCT00948896|66439718|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23743297|NCT00948896|66439719|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23743298|NCT00948896|66439712|FG000|24 Months of Age to 36 Months of Age|Death|0|||
23743299|NCT00948896|66439713|FG001|24 Months of Age to 36 Months of Age|Death|2|||
23743300|NCT00948896|66439714|FG002|24 Months of Age to 36 Months of Age|Death|2|||
23743301|NCT00948896|66439715|FG003|24 Months of Age to 36 Months of Age|Death|0|||
23743302|NCT00948896|66439716|FG004|24 Months of Age to 36 Months of Age|Death|0|||
23743303|NCT00948896|66439717|FG005|24 Months of Age to 36 Months of Age|Death|1|||
23743304|NCT00948896|66439718|FG006|24 Months of Age to 36 Months of Age|Death|0|||
23430237|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430238|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430239|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430240|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430241|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430242|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430243|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
23430244|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430245|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430246|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
23430247|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430248|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430249|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23551390|NCT00092534|65747638|FG003|Base Study Vaccination Period|Site Closed|0|||
23551391|NCT00092534|65747639|FG004|Base Study Vaccination Period|Site Closed|0|||
23551392|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Adverse Event|2|||
23551393|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Adverse Event|4|||
23551394|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Adverse Event|0|||
23551395|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Adverse Event|0|||
23551396|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Adverse Event|0|||
23551397|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Death|2|||
23551398|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Death|1|||
23551399|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Death|0|||
23551400|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Death|0|||
23551401|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Death|0|||
23551402|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
23551403|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
23551404|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551405|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551406|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551407|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Pregnancy|6|||
23551408|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Pregnancy|10|||
23551409|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Pregnancy|0|||
23551410|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Pregnancy|0|||
23551411|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Pregnancy|0|||
23551412|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
23551413|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
23551414|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
23551415|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
23551416|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
23551417|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
23551418|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
23551419|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551420|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551421|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551422|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Moved|62|||
23551423|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Moved|58|||
23551424|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Moved|0|||
23551425|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Moved|0|||
23551426|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Moved|0|||
23551427|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Travel|10|||
23743305|NCT00948896|66439719|FG007|24 Months of Age to 36 Months of Age|Death|0|||
23821827|NCT00447876|66726182|FG001|Overall Study|Lost to Follow-up|0|||
23430250|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23551428|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Travel|7|||
23551429|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Travel|0|||
23551430|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Travel|0|||
23551431|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Travel|0|||
23551432|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Site Closed|0|||
23743306|NCT00948896|66439712|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23743307|NCT00948896|66439713|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23743308|NCT00948896|66439714|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23743309|NCT00948896|66439715|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23743310|NCT00948896|66439716|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23743311|NCT00948896|66439717|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23743312|NCT00948896|66439718|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23620941|NCT00511797|65997636|FG001|Overall Study|Partially missing diary|0|||
23620942|NCT00511797|65997637|FG002|Overall Study|Partially missing diary|1|||
23620943|NCT00511797|65997638|FG003|Overall Study|Partially missing diary|0|||
23551433|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Site Closed|2|||
23551434|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Site Closed|0|||
23551435|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Site Closed|0|||
23551436|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Site Closed|0|||
23551437|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
23551438|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
23551439|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
23551440|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
23551441|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
23551442|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
23551443|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
23551444|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
23551445|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
23551446|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
23551447|NCT00092534|65747635|FG000|Base Study EXT|Lost to Follow-up|0|||
23551448|NCT00092534|65747636|FG001|Base Study EXT|Lost to Follow-up|0|||
23551449|NCT00092534|65747637|FG002|Base Study EXT|Lost to Follow-up|41|||
23551450|NCT00092534|65747638|FG003|Base Study EXT|Lost to Follow-up|0|||
23551451|NCT00092534|65747639|FG004|Base Study EXT|Lost to Follow-up|0|||
23551452|NCT00092534|65747635|FG000|Base Study EXT|Physician Decision|0|||
23551453|NCT00092534|65747636|FG001|Base Study EXT|Physician Decision|0|||
23551454|NCT00092534|65747637|FG002|Base Study EXT|Physician Decision|1|||
23551455|NCT00092534|65747638|FG003|Base Study EXT|Physician Decision|0|||
23551456|NCT00092534|65747639|FG004|Base Study EXT|Physician Decision|0|||
23551457|NCT00092534|65747635|FG000|Base Study EXT|Pregnancy|0|||
23551458|NCT00092534|65747636|FG001|Base Study EXT|Pregnancy|0|||
23551459|NCT00092534|65747637|FG002|Base Study EXT|Pregnancy|12|||
23551460|NCT00092534|65747638|FG003|Base Study EXT|Pregnancy|0|||
23551461|NCT00092534|65747639|FG004|Base Study EXT|Pregnancy|0|||
23551462|NCT00092534|65747635|FG000|Base Study EXT|Withdrawal by Subject|0|||
23551463|NCT00092534|65747636|FG001|Base Study EXT|Withdrawal by Subject|0|||
23551464|NCT00092534|65747637|FG002|Base Study EXT|Withdrawal by Subject|18|||
23551465|NCT00092534|65747638|FG003|Base Study EXT|Withdrawal by Subject|0|||
23551466|NCT00092534|65747639|FG004|Base Study EXT|Withdrawal by Subject|0|||
23551467|NCT00092534|65747635|FG000|Base Study EXT|Participant moved|0|||
23551468|NCT00092534|65747636|FG001|Base Study EXT|Participant moved|0|||
23551469|NCT00092534|65747637|FG002|Base Study EXT|Participant moved|6|||
23551470|NCT00092534|65747638|FG003|Base Study EXT|Participant moved|0|||
23551471|NCT00092534|65747639|FG004|Base Study EXT|Participant moved|0|||
23551472|NCT00092534|65747635|FG000|Base Study EXT|Travel|0|||
23551473|NCT00092534|65747636|FG001|Base Study EXT|Travel|0|||
23551474|NCT00092534|65747637|FG002|Base Study EXT|Travel|2|||
23551475|NCT00092534|65747638|FG003|Base Study EXT|Travel|0|||
23551476|NCT00092534|65747639|FG004|Base Study EXT|Travel|0|||
23551477|NCT00092534|65747635|FG000|Base Study EXT|Site closed|0|||
23551478|NCT00092534|65747636|FG001|Base Study EXT|Site closed|0|||
23551479|NCT00092534|65747637|FG002|Base Study EXT|Site closed|21|||
23551480|NCT00092534|65747638|FG003|Base Study EXT|Site closed|0|||
23551481|NCT00092534|65747639|FG004|Base Study EXT|Site closed|0|||
23551482|NCT00092534|65747635|FG000|Base Study EXT|Study ended|0|||
23551483|NCT00092534|65747636|FG001|Base Study EXT|Study ended|0|||
23551484|NCT00092534|65747637|FG002|Base Study EXT|Study ended|29|||
23551485|NCT00092534|65747638|FG003|Base Study EXT|Study ended|0|||
23551486|NCT00092534|65747639|FG004|Base Study EXT|Study ended|0|||
23551487|NCT00092534|65747635|FG000|Base Study EXT|Protocol Violation|0|||
23551488|NCT00092534|65747636|FG001|Base Study EXT|Protocol Violation|0|||
23551489|NCT00092534|65747637|FG002|Base Study EXT|Protocol Violation|15|||
23620944|NCT00511797|65997635|FG000|Overall Study|Other (moving etc)|1|||
23743313|NCT00948896|66439719|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23743314|NCT00948896|66439712|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
23551490|NCT00092534|65747638|FG003|Base Study EXT|Protocol Violation|0|||
23551491|NCT00092534|65747639|FG004|Base Study EXT|Protocol Violation|0|||
23551492|NCT00092534|65747635|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551493|NCT00092534|65747636|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23620945|NCT00511797|65997636|FG001|Overall Study|Other (moving etc)|0|||
23620946|NCT00511797|65997637|FG002|Overall Study|Other (moving etc)|1|||
23620947|NCT00511797|65997638|FG003|Overall Study|Other (moving etc)|2|||
23620948|NCT02101983|65997639|FG000|Overall Study|Physician Decision|1|||
23620949|NCT02101983|65997640|FG001|Overall Study|Physician Decision|0|||
23620950|NCT00814632|65997641|FG000|Overall Study|Lack of Efficacy|2|||
23620951|NCT01077622|65997642|FG000|Overall Study|Physician Decision|2|||
23620952|NCT01077622|65997642|FG000|Overall Study|Withdrawal by Subject|1|||
23620953|NCT00726388|65997643|FG000|Overall Study|Withdrawal by Subject|5|||
23620954|NCT00726388|65997643|FG000|Overall Study|Adverse Event|3|||
23620955|NCT00726388|65997643|FG000|Overall Study|Lost to Follow-up|10|||
23620956|NCT00726388|65997643|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
23620957|NCT00726388|65997643|FG000|Overall Study|Other|5|||
23620958|NCT00726388|65997643|FG000|Overall Study|Enrolled, Not Treated|79|||
23620959|NCT03098797|65997644|FG000|Part 2 Open Label Extension|Adverse Event|2|||
23620960|NCT03098797|65997645|FG001|Part 2 Open Label Extension|Adverse Event|0|||
23620961|NCT02705625|65997656|FG000|Overall Study|Protocol Violation|1|||
23620962|NCT02705625|65997657|FG001|Overall Study|Protocol Violation|0|||
23620963|NCT02705625|65997658|FG002|Overall Study|Protocol Violation|0|||
23620964|NCT02705625|65997656|FG000|Overall Study|Adverse Event|6|||
23620965|NCT02705625|65997657|FG001|Overall Study|Adverse Event|5|||
23620966|NCT02705625|65997658|FG002|Overall Study|Adverse Event|2|||
23620967|NCT02705625|65997656|FG000|Overall Study|Death|0|||
23620968|NCT02705625|65997657|FG001|Overall Study|Death|0|||
23620969|NCT02705625|65997658|FG002|Overall Study|Death|1|||
23620970|NCT02705625|65997656|FG000|Overall Study|Withdrawal by Subject|1|||
23620971|NCT02705625|65997657|FG001|Overall Study|Withdrawal by Subject|4|||
23620972|NCT02705625|65997658|FG002|Overall Study|Withdrawal by Subject|5|||
23620973|NCT02705625|65997656|FG000|Overall Study|Lost to Follow-up|0|||
23620974|NCT02705625|65997657|FG001|Overall Study|Lost to Follow-up|0|||
23620975|NCT02705625|65997658|FG002|Overall Study|Lost to Follow-up|1|||
23620976|NCT02705625|65997656|FG000|Overall Study|Non-compliance|0|||
23620977|NCT02705625|65997657|FG001|Overall Study|Non-compliance|1|||
23620978|NCT02705625|65997658|FG002|Overall Study|Non-compliance|1|||
23620979|NCT02705625|65997656|FG000|Overall Study|Overdosing|0|||
23620980|NCT02705625|65997657|FG001|Overall Study|Overdosing|0|||
23620981|NCT02705625|65997658|FG002|Overall Study|Overdosing|1|||
23620982|NCT01820637|65997659|FG000|Overall Study|Death|2|||
23620983|NCT01820637|65997659|FG000|Overall Study|Withdrawal by Subject|1|||
23620984|NCT03891641|65997662|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
23620985|NCT03891641|65997663|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
23620986|NCT00819013|65997664|FG000|Overall Study|Not meeting continuing study eligibility|2|||
23620987|NCT00819013|65997665|FG001|Overall Study|Not meeting continuing study eligibility|1|||
23620988|NCT00819013|65997666|FG002|Overall Study|Not meeting continuing study eligibility|2|||
23620989|NCT00819013|65997667|FG003|Overall Study|Not meeting continuing study eligibility|1|||
23620990|NCT00819013|65997664|FG000|Overall Study|Adverse Event|0|||
23620991|NCT00819013|65997665|FG001|Overall Study|Adverse Event|0|||
23620992|NCT00819013|65997666|FG002|Overall Study|Adverse Event|1|||
23620993|NCT00819013|65997667|FG003|Overall Study|Adverse Event|0|||
23620994|NCT00819013|65997664|FG000|Overall Study|Withdrawal by Subject|1|||
23620995|NCT00819013|65997665|FG001|Overall Study|Withdrawal by Subject|0|||
23620996|NCT00819013|65997666|FG002|Overall Study|Withdrawal by Subject|1|||
23620997|NCT00819013|65997667|FG003|Overall Study|Withdrawal by Subject|0|||
23620998|NCT00819013|65997664|FG000|Overall Study|Lost to Follow-up|0|||
23620999|NCT00819013|65997665|FG001|Overall Study|Lost to Follow-up|0|||
23621000|NCT00819013|65997666|FG002|Overall Study|Lost to Follow-up|1|||
23621001|NCT00819013|65997667|FG003|Overall Study|Lost to Follow-up|2|||
23551494|NCT00092534|65747637|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551495|NCT00092534|65747638|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
23551496|NCT00092534|65747639|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551497|NCT02293538|65747640|FG000|Overall Study|Adverse Event|0|||
23551498|NCT02293538|65747641|FG001|Overall Study|Adverse Event|1|||
23551499|NCT02293538|65747640|FG000|Overall Study|Lost to Follow-up|1|||
23551500|NCT02293538|65747641|FG001|Overall Study|Lost to Follow-up|0|||
23551501|NCT02293538|65747640|FG000|Overall Study|Withdrawal by Subject|0|||
23551502|NCT02293538|65747641|FG001|Overall Study|Withdrawal by Subject|1|||
23621002|NCT00819013|65997664|FG000|Overall Study|Death|0|||
23621003|NCT00819013|65997665|FG001|Overall Study|Death|0|||
23621004|NCT00819013|65997666|FG002|Overall Study|Death|0|||
23621005|NCT00819013|65997667|FG003|Overall Study|Death|1|||
23621006|NCT01904136|65997669|FG000|Overall Study|Physician Decision|0|||
23621007|NCT01904136|65997670|FG001|Overall Study|Physician Decision|0|||
23621008|NCT01904136|65997671|FG002|Overall Study|Physician Decision|0|||
23621009|NCT01904136|65997672|FG003|Overall Study|Physician Decision|0|||
23621010|NCT01904136|65997673|FG004|Overall Study|Physician Decision|0|||
23621011|NCT01904136|65997674|FG005|Overall Study|Physician Decision|1|||
23621012|NCT01904136|65997675|FG006|Overall Study|Physician Decision|0|||
23621013|NCT01904136|65997676|FG007|Overall Study|Physician Decision|0|||
23621014|NCT01904136|65997677|FG008|Overall Study|Physician Decision|0|||
23621015|NCT04545476|65997678|FG000|Overall Study|Lost to Follow-up|1|||
23621016|NCT04545476|65997679|FG001|Overall Study|Lost to Follow-up|1|||
23621017|NCT04545476|65997680|FG002|Overall Study|Lost to Follow-up|0|||
23743315|NCT00948896|66439713|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23743316|NCT00948896|66439714|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
23743317|NCT00948896|66439715|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23743318|NCT00948896|66439716|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
23743319|NCT00948896|66439717|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23743320|NCT00948896|66439718|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23743321|NCT00948896|66439719|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23743322|NCT00948896|66439712|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743323|NCT00948896|66439713|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743324|NCT00948896|66439714|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
23621018|NCT04545476|65997681|FG003|Overall Study|Lost to Follow-up|0|||
23621019|NCT01704547|65997682|FG000|Overall Study|Physician Decision|4|||
23621020|NCT01704547|65997682|FG000|Overall Study|Withdrawal by Subject|1|||
23621021|NCT01161628|65997683|FG000|Overall Study|Death|6|||
23621022|NCT01161628|65997683|FG000|Overall Study|Lack of Efficacy|2|||
23621023|NCT05239598|65997684|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
23621024|NCT05239598|65997685|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
23621025|NCT05239598|65997684|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
23621026|NCT05239598|65997685|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
23621027|NCT03028012|65997690|FG000|Overall Study|Lost to Follow-up|2|||
23621028|NCT03028012|65997691|FG001|Overall Study|Lost to Follow-up|3|||
23621029|NCT03028012|65997692|FG002|Overall Study|Lost to Follow-up|3|||
23621030|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
23621031|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
23621032|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
23621033|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
23621034|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
23621035|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
23621036|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
23621037|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
23621038|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
23621039|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
23621040|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
23621041|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
23621042|NCT02412111|65997697|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
23621043|NCT02412111|65997698|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
23621044|NCT02412111|65997699|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
23621045|NCT02412111|65997697|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
23621046|NCT02412111|65997698|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
23621047|NCT02412111|65997699|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
23621048|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
23621049|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
23621050|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
23621051|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
23621052|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
23621053|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
23621054|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
23621055|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
23621056|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
23621057|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
23621058|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
23621059|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
23621060|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Other|0|||
23621061|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Other|0|||
23621062|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Other|2|||
23621063|NCT02154347|65997700|FG000|Double-blind Period|Adverse Event|1|||
23621064|NCT02154347|65997701|FG001|Double-blind Period|Adverse Event|2|||
23621065|NCT02154347|65997700|FG000|Double-blind Period|Lack of Efficacy|1|||
23621066|NCT02154347|65997701|FG001|Double-blind Period|Lack of Efficacy|0|||
23743325|NCT00948896|66439715|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743326|NCT00948896|66439716|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743327|NCT00948896|66439717|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
23743328|NCT00948896|66439718|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743329|NCT00948896|66439719|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23743330|NCT00948896|66439712|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743331|NCT00948896|66439713|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743332|NCT00948896|66439714|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743333|NCT00948896|66439715|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
23743334|NCT00948896|66439716|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743335|NCT00948896|66439717|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743336|NCT00948896|66439718|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743337|NCT00948896|66439719|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23743338|NCT00965562|66439722|FG000|Overall Study|Lost to Follow-up|1|||
23743339|NCT00965562|66439723|FG001|Overall Study|Lost to Follow-up|2|||
23743340|NCT00965562|66439724|FG002|Overall Study|Lost to Follow-up|3|||
23743341|NCT00965562|66439722|FG000|Overall Study|Withdrawal by Subject|2|||
23743342|NCT00965562|66439723|FG001|Overall Study|Withdrawal by Subject|2|||
23743343|NCT00965562|66439724|FG002|Overall Study|Withdrawal by Subject|0|||
23743344|NCT02706327|66439726|FG000|Overall Study|Lost to Follow-up|1|||
23743345|NCT02706327|66439727|FG001|Overall Study|Lost to Follow-up|1|||
23743346|NCT02706327|66439728|FG002|Overall Study|Lost to Follow-up|2|||
23743347|NCT01054443|66439729|FG000|Overall Study|Withdrawal by Subject|0|||
23743348|NCT01054443|66439730|FG001|Overall Study|Withdrawal by Subject|0|||
23743349|NCT01054443|66439731|FG002|Overall Study|Withdrawal by Subject|0|||
23743350|NCT01054443|66439732|FG003|Overall Study|Withdrawal by Subject|1|||
23743351|NCT00229931|66439735|FG000|Overall Study|Death|1|||
23743352|NCT00229931|66439736|FG001|Overall Study|Death|0|||
23743353|NCT00229931|66439735|FG000|Overall Study|Lost to Follow-up|3|||
23743354|NCT00229931|66439736|FG001|Overall Study|Lost to Follow-up|2|||
23743355|NCT01308476|66439737|FG000|Overall Study|Lost to Follow-up|2|||
23743356|NCT01308476|66439738|FG001|Overall Study|Lost to Follow-up|2|||
23743357|NCT01308476|66439737|FG000|Overall Study|Other|1|||
23743358|NCT01308476|66439738|FG001|Overall Study|Other|0|||
23743359|NCT04668066|66439739|FG000|Part 1: Treatment Phase|Adverse Event|0|||
23743360|NCT04668066|66439740|FG001|Part 1: Treatment Phase|Adverse Event|0|||
23743361|NCT04668066|66439741|FG002|Part 1: Treatment Phase|Adverse Event|0|||
23743362|NCT04668066|66439742|FG003|Part 1: Treatment Phase|Adverse Event|0|||
23743363|NCT04668066|66439743|FG004|Part 1: Treatment Phase|Adverse Event|0|||
23743364|NCT04668066|66439744|FG005|Part 1: Treatment Phase|Adverse Event|0|||
23743365|NCT04668066|66439745|FG006|Part 1: Treatment Phase|Adverse Event|0|||
23743366|NCT04668066|66439746|FG007|Part 1: Treatment Phase|Adverse Event|0|||
23743367|NCT04668066|66439747|FG008|Part 1: Treatment Phase|Adverse Event|0|||
23743368|NCT04668066|66439748|FG009|Part 1: Treatment Phase|Adverse Event|0|||
23743369|NCT04668066|66439749|FG010|Part 1: Treatment Phase|Adverse Event|0|||
23743370|NCT04668066|66439750|FG011|Part 1: Treatment Phase|Adverse Event|1|||
23743371|NCT04668066|66439751|FG012|Part 1: Treatment Phase|Adverse Event|1|||
23743372|NCT04668066|66439752|FG013|Part 1: Treatment Phase|Adverse Event|0|||
23743373|NCT04668066|66439753|FG014|Part 1: Treatment Phase|Adverse Event|0|||
23743374|NCT04668066|66439754|FG015|Part 1: Treatment Phase|Adverse Event|0|||
23743375|NCT04668066|66439755|FG016|Part 1: Treatment Phase|Adverse Event|0|||
23743376|NCT04668066|66439756|FG017|Part 1: Treatment Phase|Adverse Event|0|||
23743377|NCT04668066|66439757|FG018|Part 1: Treatment Phase|Adverse Event|0|||
23743378|NCT04668066|66439739|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743379|NCT04668066|66439740|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743380|NCT04668066|66439741|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
23743381|NCT04668066|66439742|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743382|NCT04668066|66439743|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743383|NCT04668066|66439744|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743384|NCT04668066|66439745|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743385|NCT04668066|66439746|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743386|NCT04668066|66439747|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743387|NCT04668066|66439748|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743388|NCT04668066|66439749|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743389|NCT04668066|66439750|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743390|NCT04668066|66439751|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743391|NCT04668066|66439752|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743392|NCT04668066|66439753|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743393|NCT04668066|66439754|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743394|NCT04668066|66439755|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743395|NCT04668066|66439756|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743396|NCT04668066|66439757|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
23743397|NCT04668066|66439739|FG000|Part 1: Treatment Phase|Other|0|||
23743398|NCT04668066|66439740|FG001|Part 1: Treatment Phase|Other|0|||
23743399|NCT04668066|66439741|FG002|Part 1: Treatment Phase|Other|0|||
23743400|NCT04668066|66439742|FG003|Part 1: Treatment Phase|Other|0|||
23743401|NCT04668066|66439743|FG004|Part 1: Treatment Phase|Other|0|||
23743402|NCT04668066|66439744|FG005|Part 1: Treatment Phase|Other|0|||
23743403|NCT04668066|66439745|FG006|Part 1: Treatment Phase|Other|0|||
23743404|NCT04668066|66439746|FG007|Part 1: Treatment Phase|Other|0|||
23743405|NCT04668066|66439747|FG008|Part 1: Treatment Phase|Other|0|||
23743406|NCT04668066|66439748|FG009|Part 1: Treatment Phase|Other|0|||
23743407|NCT04668066|66439749|FG010|Part 1: Treatment Phase|Other|0|||
23743408|NCT04668066|66439750|FG011|Part 1: Treatment Phase|Other|1|||
23743409|NCT04668066|66439751|FG012|Part 1: Treatment Phase|Other|0|||
23743410|NCT04668066|66439752|FG013|Part 1: Treatment Phase|Other|0|||
23743411|NCT04668066|66439753|FG014|Part 1: Treatment Phase|Other|0|||
23743412|NCT04668066|66439754|FG015|Part 1: Treatment Phase|Other|0|||
23743413|NCT04668066|66439755|FG016|Part 1: Treatment Phase|Other|0|||
23743414|NCT04668066|66439756|FG017|Part 1: Treatment Phase|Other|0|||
23743415|NCT04668066|66439757|FG018|Part 1: Treatment Phase|Other|0|||
23743416|NCT04668066|66439739|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743417|NCT04668066|66439740|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743418|NCT04668066|66439741|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743419|NCT04668066|66439742|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743420|NCT04668066|66439743|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743421|NCT04668066|66439744|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743422|NCT04668066|66439745|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743423|NCT04668066|66439746|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743424|NCT04668066|66439747|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743425|NCT04668066|66439748|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743426|NCT04668066|66439749|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743427|NCT04668066|66439750|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743428|NCT04668066|66439751|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
23743429|NCT04668066|66439752|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743430|NCT04668066|66439753|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743431|NCT04668066|66439754|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
23743432|NCT04668066|66439755|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743433|NCT04668066|66439756|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23621067|NCT02154347|65997700|FG000|Double-blind Period|Physician Decision|0|||
23743434|NCT04668066|66439757|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23743435|NCT04668066|66439739|FG000|Part 1: Follow-Up|Adverse Event|0|||
23743436|NCT04668066|66439740|FG001|Part 1: Follow-Up|Adverse Event|0|||
23743437|NCT04668066|66439741|FG002|Part 1: Follow-Up|Adverse Event|0|||
23743438|NCT04668066|66439742|FG003|Part 1: Follow-Up|Adverse Event|0|||
23743439|NCT04668066|66439743|FG004|Part 1: Follow-Up|Adverse Event|0|||
23743440|NCT04668066|66439744|FG005|Part 1: Follow-Up|Adverse Event|0|||
23551503|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
23551504|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
23551505|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
23551506|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551507|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551508|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551509|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551510|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551511|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551512|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
23551513|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
23551514|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
23551515|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551516|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551517|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551518|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551519|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551520|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551521|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
23551522|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23621068|NCT02154347|65997701|FG001|Double-blind Period|Physician Decision|1|||
23621069|NCT02154347|65997700|FG000|Double-blind Period|Withdrawal by Subject|1|||
23621070|NCT02154347|65997701|FG001|Double-blind Period|Withdrawal by Subject|1|||
23621071|NCT02154347|65997700|FG000|Open-label Period|Adverse Event|3|||
23621072|NCT02154347|65997701|FG001|Open-label Period|Adverse Event|4|||
23621073|NCT02154347|65997700|FG000|Open-label Period|Lack of Efficacy|4|||
23621074|NCT02154347|65997701|FG001|Open-label Period|Lack of Efficacy|19|||
23743441|NCT04668066|66439745|FG006|Part 1: Follow-Up|Adverse Event|0|||
23743442|NCT04668066|66439746|FG007|Part 1: Follow-Up|Adverse Event|0|||
23743443|NCT04668066|66439747|FG008|Part 1: Follow-Up|Adverse Event|0|||
23743444|NCT04668066|66439748|FG009|Part 1: Follow-Up|Adverse Event|0|||
23743445|NCT04668066|66439749|FG010|Part 1: Follow-Up|Adverse Event|0|||
23743446|NCT04668066|66439750|FG011|Part 1: Follow-Up|Adverse Event|1|||
23743447|NCT04668066|66439751|FG012|Part 1: Follow-Up|Adverse Event|0|||
23743448|NCT04668066|66439752|FG013|Part 1: Follow-Up|Adverse Event|0|||
23743449|NCT04668066|66439753|FG014|Part 1: Follow-Up|Adverse Event|0|||
23743450|NCT04668066|66439754|FG015|Part 1: Follow-Up|Adverse Event|0|||
23743451|NCT04668066|66439755|FG016|Part 1: Follow-Up|Adverse Event|0|||
23743452|NCT04668066|66439756|FG017|Part 1: Follow-Up|Adverse Event|0|||
23743453|NCT04668066|66439757|FG018|Part 1: Follow-Up|Adverse Event|0|||
23743454|NCT04668066|66439739|FG000|Part 1: Follow-Up|Other|0|||
23743455|NCT04668066|66439740|FG001|Part 1: Follow-Up|Other|0|||
23743456|NCT04668066|66439741|FG002|Part 1: Follow-Up|Other|0|||
23743457|NCT04668066|66439742|FG003|Part 1: Follow-Up|Other|0|||
23743458|NCT04668066|66439743|FG004|Part 1: Follow-Up|Other|0|||
23743459|NCT04668066|66439744|FG005|Part 1: Follow-Up|Other|0|||
23743460|NCT04668066|66439745|FG006|Part 1: Follow-Up|Other|0|||
23743461|NCT04668066|66439746|FG007|Part 1: Follow-Up|Other|0|||
23743462|NCT04668066|66439747|FG008|Part 1: Follow-Up|Other|0|||
23743463|NCT04668066|66439748|FG009|Part 1: Follow-Up|Other|0|||
23743464|NCT04668066|66439749|FG010|Part 1: Follow-Up|Other|0|||
23743465|NCT04668066|66439750|FG011|Part 1: Follow-Up|Other|1|||
23743466|NCT04668066|66439751|FG012|Part 1: Follow-Up|Other|1|||
23743467|NCT04668066|66439752|FG013|Part 1: Follow-Up|Other|0|||
23743468|NCT04668066|66439753|FG014|Part 1: Follow-Up|Other|0|||
23743469|NCT04668066|66439754|FG015|Part 1: Follow-Up|Other|0|||
23743470|NCT04668066|66439755|FG016|Part 1: Follow-Up|Other|0|||
23743471|NCT04668066|66439756|FG017|Part 1: Follow-Up|Other|0|||
23743472|NCT04668066|66439757|FG018|Part 1: Follow-Up|Other|0|||
23743473|NCT04668066|66439739|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743474|NCT04668066|66439740|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743475|NCT04668066|66439741|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743476|NCT04668066|66439742|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743477|NCT04668066|66439743|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743478|NCT04668066|66439744|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743479|NCT04668066|66439745|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743480|NCT04668066|66439746|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743481|NCT04668066|66439747|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743482|NCT04668066|66439748|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743483|NCT04668066|66439749|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743484|NCT04668066|66439750|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743485|NCT04668066|66439751|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
23743486|NCT04668066|66439752|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743487|NCT04668066|66439753|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743488|NCT04668066|66439754|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
23743489|NCT04668066|66439755|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743490|NCT04668066|66439756|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743491|NCT04668066|66439757|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
23743492|NCT04668066|66439739|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743493|NCT04668066|66439740|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23430251|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430252|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
23430253|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23743494|NCT04668066|66439741|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743495|NCT04668066|66439742|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743496|NCT04668066|66439743|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743497|NCT04668066|66439744|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743498|NCT04668066|66439745|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743499|NCT04668066|66439746|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743500|NCT04668066|66439747|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743501|NCT04668066|66439748|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743502|NCT04668066|66439749|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743503|NCT04668066|66439750|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743504|NCT04668066|66439751|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743505|NCT04668066|66439752|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743506|NCT04668066|66439753|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743507|NCT04668066|66439754|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743508|NCT04668066|66439755|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743509|NCT04668066|66439756|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23743510|NCT04668066|66439757|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
23743511|NCT04668066|66439739|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743512|NCT04668066|66439740|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
23430254|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23743513|NCT04668066|66439741|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743514|NCT04668066|66439742|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
23430255|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23743515|NCT04668066|66439743|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743516|NCT04668066|66439744|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743517|NCT04668066|66439745|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743518|NCT04668066|66439746|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743519|NCT04668066|66439747|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743520|NCT04668066|66439748|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743521|NCT04668066|66439749|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743522|NCT04668066|66439750|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743523|NCT04668066|66439751|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743524|NCT04668066|66439752|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743525|NCT04668066|66439753|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743526|NCT04668066|66439754|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743527|NCT04668066|66439755|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743528|NCT04668066|66439756|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
23743529|NCT04668066|66439757|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
23743530|NCT04668066|66439739|FG000|Part 2: Treatment Phase|Other|0|||
23743531|NCT04668066|66439740|FG001|Part 2: Treatment Phase|Other|0|||
23743532|NCT04668066|66439741|FG002|Part 2: Treatment Phase|Other|0|||
23743533|NCT04668066|66439742|FG003|Part 2: Treatment Phase|Other|0|||
23743534|NCT04668066|66439743|FG004|Part 2: Treatment Phase|Other|0|||
23743535|NCT04668066|66439744|FG005|Part 2: Treatment Phase|Other|0|||
23743536|NCT04668066|66439745|FG006|Part 2: Treatment Phase|Other|0|||
23743537|NCT04668066|66439746|FG007|Part 2: Treatment Phase|Other|0|||
23743538|NCT04668066|66439747|FG008|Part 2: Treatment Phase|Other|0|||
23743539|NCT04668066|66439748|FG009|Part 2: Treatment Phase|Other|0|||
23743540|NCT04668066|66439749|FG010|Part 2: Treatment Phase|Other|0|||
23743541|NCT04668066|66439750|FG011|Part 2: Treatment Phase|Other|0|||
23743542|NCT04668066|66439751|FG012|Part 2: Treatment Phase|Other|0|||
23743543|NCT04668066|66439752|FG013|Part 2: Treatment Phase|Other|0|||
23743544|NCT04668066|66439753|FG014|Part 2: Treatment Phase|Other|0|||
23743545|NCT04668066|66439754|FG015|Part 2: Treatment Phase|Other|0|||
23743546|NCT04668066|66439755|FG016|Part 2: Treatment Phase|Other|0|||
23743547|NCT04668066|66439756|FG017|Part 2: Treatment Phase|Other|0|||
23743548|NCT04668066|66439757|FG018|Part 2: Treatment Phase|Other|1|||
23743549|NCT04668066|66439739|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743550|NCT04668066|66439740|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743551|NCT04668066|66439741|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743552|NCT04668066|66439742|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743553|NCT04668066|66439743|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743554|NCT04668066|66439744|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743555|NCT04668066|66439745|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743556|NCT04668066|66439746|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743557|NCT04668066|66439747|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743558|NCT04668066|66439748|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743559|NCT04668066|66439749|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743560|NCT04668066|66439750|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743561|NCT04668066|66439751|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743562|NCT04668066|66439752|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743563|NCT04668066|66439753|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743564|NCT04668066|66439754|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743565|NCT04668066|66439755|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
23430256|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430257|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430258|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430259|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430260|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430261|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430262|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430263|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430264|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430265|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
23430266|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430267|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430268|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430269|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430270|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23621075|NCT02154347|65997700|FG000|Open-label Period|Protocol Violation|0|||
23621076|NCT02154347|65997701|FG001|Open-label Period|Protocol Violation|1|||
23430271|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23743566|NCT04668066|66439756|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
23743567|NCT04668066|66439757|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
23743568|NCT02983305|66439758|FG000|Overall Study|incomplete data|2|||
23743569|NCT02983305|66439759|FG001|Overall Study|incomplete data|0|||
23743570|NCT01266967|66439760|FG000|Overall Study|Death|69|||
23743571|NCT01266967|66439761|FG001|Overall Study|Death|61|||
23743572|NCT01266967|66439760|FG000|Overall Study|Study Closed/Terminated|15|||
23743573|NCT01266967|66439761|FG001|Overall Study|Study Closed/Terminated|17|||
23743574|NCT01266967|66439760|FG000|Overall Study|Lost to Follow-up|2|||
23743575|NCT01266967|66439761|FG001|Overall Study|Lost to Follow-up|1|||
23743576|NCT01266967|66439760|FG000|Overall Study|Physician Decision|0|||
23743577|NCT01266967|66439761|FG001|Overall Study|Physician Decision|1|||
23743578|NCT01266967|66439760|FG000|Overall Study|Withdrawal by Subject|3|||
23743579|NCT01266967|66439761|FG001|Overall Study|Withdrawal by Subject|3|||
23821828|NCT00447876|66726181|FG000|Overall Study|Deterioration of symptomology|1|||
23821829|NCT00447876|66726182|FG001|Overall Study|Deterioration of symptomology|0|||
23821830|NCT03336528|66726186|FG000|Overall Study|Protocol Violation|1|||
23821831|NCT03336528|66726187|FG001|Overall Study|Protocol Violation|1|||
23821832|NCT03336528|66726186|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
23821833|NCT03336528|66726187|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
23743580|NCT02815670|66439764|FG000|Overall Study|Prematurely discontinued of the trial|1|||
23743581|NCT00727246|66439765|FG000|Overall Study|could not complete MRI|0|||
23743582|NCT00727246|66439766|FG001|Overall Study|could not complete MRI|1|||
23743583|NCT00727246|66439767|FG002|Overall Study|could not complete MRI|0|||
23743584|NCT00727246|66439768|FG003|Overall Study|could not complete MRI|1|||
23743585|NCT00727246|66439765|FG000|Overall Study|incidental finding|0|||
23743586|NCT00727246|66439766|FG001|Overall Study|incidental finding|0|||
23743587|NCT00727246|66439767|FG002|Overall Study|incidental finding|0|||
23743588|NCT00727246|66439768|FG003|Overall Study|incidental finding|1|||
23743589|NCT00727246|66439765|FG000|Overall Study|withdrawn|0|||
23743590|NCT00727246|66439766|FG001|Overall Study|withdrawn|0|||
23743591|NCT00727246|66439767|FG002|Overall Study|withdrawn|1|||
23743592|NCT00727246|66439768|FG003|Overall Study|withdrawn|0|||
23743593|NCT02441517|66439769|FG000|Overall Study|Lost to Follow-up|1|||
23743594|NCT02441517|66439769|FG000|Overall Study|Withdrawal by Subject|2|||
23743595|NCT02441517|66439769|FG000|Overall Study|Study Terminated by Sponsor|1|||
23743596|NCT00596466|66439771|FG000|Overall Study|Lack of Efficacy|5|||
23743597|NCT00596466|66439771|FG000|Overall Study|Adverse Event|4|||
23743598|NCT00596466|66439771|FG000|Overall Study|Withdrawal by Subject|2|||
23743599|NCT00596466|66439771|FG000|Overall Study|Protocol Violation|2|||
23743600|NCT00596466|66439771|FG000|Overall Study|Unpecified|2|||
23743601|NCT00596466|66439771|FG000|Overall Study|Enrolled, not treated|2|||
23743602|NCT01258738|66439772|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
23743603|NCT01258738|66439773|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
23743604|NCT01258738|66439772|FG000|Double-blind Period|Withdrawal by Subject|2|||
23743605|NCT01258738|66439773|FG001|Double-blind Period|Withdrawal by Subject|2|||
23743606|NCT01258738|66439772|FG000|Double-blind Period|Protocol Violation|1|||
23743607|NCT01258738|66439773|FG001|Double-blind Period|Protocol Violation|1|||
23743608|NCT01258738|66439772|FG000|Double-blind Period|Adverse Event|3|||
23743609|NCT01258738|66439773|FG001|Double-blind Period|Adverse Event|1|||
23743610|NCT01258738|66439772|FG000|Open-label Period|Did not meet inclusion criteria|0|||
23743611|NCT01258738|66439773|FG001|Open-label Period|Did not meet inclusion criteria|1|||
23743612|NCT01258738|66439772|FG000|Open-label Period|Insufficient clinical response|5|||
23743613|NCT01258738|66439773|FG001|Open-label Period|Insufficient clinical response|3|||
23430272|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430273|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430274|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
23430275|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430276|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430277|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430278|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23743614|NCT01258738|66439772|FG000|Open-label Period|Lost to Follow-up|0|||
23743615|NCT01258738|66439773|FG001|Open-label Period|Lost to Follow-up|2|||
23743616|NCT01258738|66439772|FG000|Open-label Period|Withdrawal by Subject|5|||
23743617|NCT01258738|66439773|FG001|Open-label Period|Withdrawal by Subject|6|||
23743618|NCT01258738|66439772|FG000|Open-label Period|Protocol Violation|2|||
23743619|NCT01258738|66439773|FG001|Open-label Period|Protocol Violation|2|||
23743620|NCT01258738|66439772|FG000|Open-label Period|Adverse Event|4|||
23430279|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430280|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23743621|NCT01258738|66439773|FG001|Open-label Period|Adverse Event|5|||
23743622|NCT01258738|66439772|FG000|Open-label Period|Other Reasons|0|||
23743623|NCT01258738|66439773|FG001|Open-label Period|Other Reasons|1|||
23743624|NCT01258738|66439772|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
23743625|NCT01258738|66439773|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
23821834|NCT03336528|66726186|FG000|Overall Study|Did not receive study medication|1|||
23743626|NCT01215968|66439774|FG000|Overall Study|Adverse Event|0|||
23743627|NCT01215968|66439775|FG001|Overall Study|Adverse Event|2|||
23743628|NCT01215968|66439774|FG000|Overall Study|Protocol Violation|2|||
23743629|NCT01215968|66439775|FG001|Overall Study|Protocol Violation|4|||
23743630|NCT01215968|66439774|FG000|Overall Study|Not received study drug|0|||
23743631|NCT01215968|66439775|FG001|Overall Study|Not received study drug|1|||
23743632|NCT01495793|66439779|FG000|Overall Study|Lost to Follow-up|1|||
23743633|NCT01495793|66439779|FG000|Overall Study|Violation of inclusion criteria|1|||
23743634|NCT03532048|66439781|FG000|Overall Study|Lost to Follow-up|12|||
23743635|NCT03532048|66439782|FG001|Overall Study|Lost to Follow-up|17|||
23743636|NCT03532048|66439781|FG000|Overall Study|Withdrawal by Subject|7|||
23743637|NCT03532048|66439782|FG001|Overall Study|Withdrawal by Subject|0|||
23743638|NCT00598585|66439783|FG000|Overall Study|Lost to Follow-up|1|||
23743639|NCT00598585|66439784|FG001|Overall Study|Lost to Follow-up|0|||
23743640|NCT02061293|66439792|FG000|Overall Study|Elevated Blood Pressure|1|||
23743641|NCT02061293|66439793|FG001|Overall Study|Elevated Blood Pressure|1|||
23743642|NCT02452320|66439794|FG000|Overall Study|Adverse Event|0|||
23743643|NCT02452320|66439795|FG001|Overall Study|Adverse Event|1|||
23743644|NCT01000311|66439798|FG000|Overall Study|Adverse Event|2|||
23743645|NCT01000311|66439799|FG001|Overall Study|Adverse Event|5|||
23743646|NCT01000311|66439798|FG000|Overall Study|Withdrawal by Subject|16|||
23743647|NCT01000311|66439799|FG001|Overall Study|Withdrawal by Subject|24|||
23743648|NCT01000311|66439798|FG000|Overall Study|Lost to Follow-up|15|||
23743649|NCT01000311|66439799|FG001|Overall Study|Lost to Follow-up|24|||
23743650|NCT01000311|66439798|FG000|Overall Study|Protocol Violation|1|||
23743651|NCT01000311|66439799|FG001|Overall Study|Protocol Violation|2|||
23743652|NCT01000311|66439798|FG000|Overall Study|Inappropriate enrollment|2|||
23743653|NCT01000311|66439799|FG001|Overall Study|Inappropriate enrollment|0|||
23743654|NCT01000311|66439798|FG000|Overall Study|Administrative reason|9|||
23743655|NCT01000311|66439799|FG001|Overall Study|Administrative reason|15|||
23743656|NCT01098266|66439801|FG000|Overall Study|Physician Decision|1|||
23743657|NCT01098266|66439802|FG001|Overall Study|Physician Decision|0|||
23743658|NCT01098266|66439801|FG000|Overall Study|Death|3|||
23743659|NCT01098266|66439802|FG001|Overall Study|Death|2|||
23743660|NCT01098266|66439801|FG000|Overall Study|Withdrawal by Subject|3|||
23743661|NCT01098266|66439802|FG001|Overall Study|Withdrawal by Subject|5|||
23743662|NCT01317199|66439803|FG000|Dose-escalation Phase 1|Physician Decision|5|||
23743663|NCT01317199|66439804|FG001|Dose-escalation Phase 1|Physician Decision|0|||
23743664|NCT01317199|66439805|FG002|Dose-escalation Phase 1|Physician Decision|0|||
23743665|NCT01317199|66439806|FG003|Dose-escalation Phase 1|Physician Decision|0|||
23743666|NCT01317199|66439803|FG000|Dose-escalation Phase 1|Disease progression|1|||
23743667|NCT01317199|66439804|FG001|Dose-escalation Phase 1|Disease progression|0|||
23743668|NCT01317199|66439805|FG002|Dose-escalation Phase 1|Disease progression|0|||
23743669|NCT01317199|66439806|FG003|Dose-escalation Phase 1|Disease progression|0|||
23743670|NCT01317199|66439803|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
23743671|NCT01317199|66439804|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23743672|NCT01317199|66439805|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23743673|NCT01317199|66439806|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23743674|NCT01317199|66439803|FG000|Randomized Phase 2|Disease progression|0|||
23743675|NCT01317199|66439804|FG001|Randomized Phase 2|Disease progression|3|||
23743676|NCT01317199|66439805|FG002|Randomized Phase 2|Disease progression|7|||
23743677|NCT01317199|66439806|FG003|Randomized Phase 2|Disease progression|5|||
23743678|NCT01317199|66439803|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
23743679|NCT01317199|66439804|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
23743680|NCT01317199|66439805|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
23743681|NCT01317199|66439806|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
23743682|NCT01317199|66439803|FG000|Randomized Phase 2|Adverse Event|0|||
23743683|NCT01317199|66439804|FG001|Randomized Phase 2|Adverse Event|0|||
23743684|NCT01317199|66439805|FG002|Randomized Phase 2|Adverse Event|0|||
23743685|NCT01317199|66439806|FG003|Randomized Phase 2|Adverse Event|1|||
23743686|NCT01317199|66439803|FG000|Randomized Phase 2|Comorbidities|0|||
23743687|NCT01317199|66439804|FG001|Randomized Phase 2|Comorbidities|2|||
23743688|NCT01317199|66439805|FG002|Randomized Phase 2|Comorbidities|2|||
23621077|NCT02154347|65997700|FG000|Open-label Period|Withdrawal by Subject|0|||
23743689|NCT01317199|66439806|FG003|Randomized Phase 2|Comorbidities|2|||
23743690|NCT01317199|66439803|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
23743691|NCT01317199|66439804|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
23621078|NCT02154347|65997701|FG001|Open-label Period|Withdrawal by Subject|1|||
23743692|NCT01317199|66439805|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
23743693|NCT01317199|66439806|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
23743694|NCT01317199|66439803|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
23743695|NCT01317199|66439804|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
23743696|NCT01317199|66439805|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
23743697|NCT01317199|66439806|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
23743698|NCT01317199|66439803|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
23743699|NCT01317199|66439804|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
23743700|NCT01317199|66439805|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
23743701|NCT01317199|66439806|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
23743702|NCT01317199|66439803|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
23743703|NCT01317199|66439804|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
23743704|NCT01317199|66439805|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
23743705|NCT01317199|66439806|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
23743706|NCT02195531|66439810|FG000|Overall Study|Withdrawal by Subject|1|||
23743707|NCT02195531|66439811|FG001|Overall Study|Withdrawal by Subject|1|||
23743708|NCT02195531|66439812|FG002|Overall Study|Withdrawal by Subject|1|||
23743709|NCT01151085|66439817|FG000|Overall Study|Lost to Follow-up|31|||
23743710|NCT01151085|66439817|FG000|Overall Study|Protocol Violation|25|||
23743711|NCT02058940|66439818|FG000|Overall Study|Discharged from Critical Care Unit|1|||
23743712|NCT04988035|66439823|FG000|Overall Study|Death|19|||
23743713|NCT04988035|66439824|FG001|Overall Study|Death|13|||
23743714|NCT04988035|66439823|FG000|Overall Study|Lost to Follow-up|12|||
23743715|NCT04988035|66439824|FG001|Overall Study|Lost to Follow-up|6|||
23743716|NCT04988035|66439823|FG000|Overall Study|Protocol Violation|0|||
23743717|NCT04988035|66439824|FG001|Overall Study|Protocol Violation|1|||
23743718|NCT04988035|66439823|FG000|Overall Study|Withdrawal by Subject|2|||
23743719|NCT04988035|66439824|FG001|Overall Study|Withdrawal by Subject|4|||
23743720|NCT04988035|66439823|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
23743721|NCT04988035|66439824|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
23743722|NCT00334893|66439825|FG000|Overall Study|Not Treated|1|||
23743723|NCT00334893|66439826|FG001|Overall Study|Not Treated|0|||
23743724|NCT04145531|66439830|FG000|Part A|Adverse Event|2|||
23743725|NCT04145531|66439831|FG001|Part A|Adverse Event|12|||
23743726|NCT04145531|66439832|FG002|Part A|Adverse Event|6|||
23743727|NCT04145531|66439833|FG003|Part A|Adverse Event|0|||
23743728|NCT04145531|66439830|FG000|Part A|Death|1|||
23743729|NCT04145531|66439831|FG001|Part A|Death|2|||
23743730|NCT04145531|66439832|FG002|Part A|Death|0|||
23743731|NCT04145531|66439833|FG003|Part A|Death|0|||
23743732|NCT04145531|66439830|FG000|Part A|Physician Decision|2|||
23743733|NCT04145531|66439831|FG001|Part A|Physician Decision|5|||
23743734|NCT04145531|66439832|FG002|Part A|Physician Decision|2|||
23743735|NCT04145531|66439833|FG003|Part A|Physician Decision|0|||
23743736|NCT04145531|66439830|FG000|Part A|Progressive disease|0|||
23743737|NCT04145531|66439831|FG001|Part A|Progressive disease|2|||
23743738|NCT04145531|66439832|FG002|Part A|Progressive disease|1|||
23743739|NCT04145531|66439833|FG003|Part A|Progressive disease|0|||
23743740|NCT04145531|66439830|FG000|Part A|Protocol deviation|0|||
23743741|NCT04145531|66439831|FG001|Part A|Protocol deviation|0|||
23743742|NCT04145531|66439832|FG002|Part A|Protocol deviation|1|||
23743743|NCT04145531|66439833|FG003|Part A|Protocol deviation|0|||
23743744|NCT04145531|66439830|FG000|Part A|Withdrawal by parent or guardian|1|||
23743745|NCT04145531|66439831|FG001|Part A|Withdrawal by parent or guardian|0|||
23743746|NCT04145531|66439832|FG002|Part A|Withdrawal by parent or guardian|0|||
23743747|NCT04145531|66439833|FG003|Part A|Withdrawal by parent or guardian|0|||
23743748|NCT04145531|66439830|FG000|Part A|Withdrawal by participant|0|||
23743749|NCT04145531|66439831|FG001|Part A|Withdrawal by participant|0|||
23743750|NCT04145531|66439832|FG002|Part A|Withdrawal by participant|1|||
23743751|NCT04145531|66439833|FG003|Part A|Withdrawal by participant|0|||
23743752|NCT04145531|66439830|FG000|Part A|Other|0|||
23743753|NCT04145531|66439831|FG001|Part A|Other|0|||
23743754|NCT04145531|66439832|FG002|Part A|Other|1|||
23743755|NCT04145531|66439833|FG003|Part A|Other|0|||
23743756|NCT04145531|66439830|FG000|Part B|Adverse Event|0|||
23743757|NCT04145531|66439831|FG001|Part B|Adverse Event|0|||
23743758|NCT04145531|66439832|FG002|Part B|Adverse Event|0|||
23743759|NCT04145531|66439833|FG003|Part B|Adverse Event|21|||
23743760|NCT04145531|66439830|FG000|Part B|Physician Decision|0|||
23743761|NCT04145531|66439831|FG001|Part B|Physician Decision|0|||
23743762|NCT04145531|66439832|FG002|Part B|Physician Decision|0|||
23743763|NCT04145531|66439833|FG003|Part B|Physician Decision|7|||
23743764|NCT04145531|66439830|FG000|Part B|Progressive disease|0|||
23743765|NCT04145531|66439831|FG001|Part B|Progressive disease|0|||
23743766|NCT04145531|66439832|FG002|Part B|Progressive disease|0|||
23743767|NCT04145531|66439833|FG003|Part B|Progressive disease|1|||
23743768|NCT04145531|66439830|FG000|Part B|Recurrent disease|0|||
23743769|NCT04145531|66439831|FG001|Part B|Recurrent disease|0|||
23743770|NCT04145531|66439832|FG002|Part B|Recurrent disease|0|||
23743771|NCT04145531|66439833|FG003|Part B|Recurrent disease|1|||
23743772|NCT04145531|66439830|FG000|Part B|Withdrawal by parent or guardian|0|||
23743773|NCT04145531|66439831|FG001|Part B|Withdrawal by parent or guardian|0|||
23743774|NCT04145531|66439832|FG002|Part B|Withdrawal by parent or guardian|0|||
23743775|NCT04145531|66439833|FG003|Part B|Withdrawal by parent or guardian|3|||
23743776|NCT04145531|66439830|FG000|Part B|Withdrawal by participant|0|||
23743777|NCT04145531|66439831|FG001|Part B|Withdrawal by participant|0|||
23743778|NCT04145531|66439832|FG002|Part B|Withdrawal by participant|0|||
23743779|NCT04145531|66439833|FG003|Part B|Withdrawal by participant|1|||
23743780|NCT04145531|66439830|FG000|Part B|Other|0|||
23743781|NCT04145531|66439831|FG001|Part B|Other|0|||
23821835|NCT03336528|66726187|FG001|Overall Study|Did not receive study medication|2|||
23821836|NCT00863772|66726188|FG000|Overall Study|Adverse Event|1|||
23821837|NCT00863772|66726189|FG001|Overall Study|Adverse Event|4|||
23821838|NCT00863772|66726190|FG002|Overall Study|Adverse Event|0|||
23821839|NCT00863772|66726188|FG000|Overall Study|Lack of Efficacy|4|||
23821840|NCT00863772|66726189|FG001|Overall Study|Lack of Efficacy|2|||
23821841|NCT00863772|66726190|FG002|Overall Study|Lack of Efficacy|4|||
23821842|NCT00863772|66726188|FG000|Overall Study|Lost to Follow-up|5|||
23821843|NCT00863772|66726189|FG001|Overall Study|Lost to Follow-up|1|||
23821844|NCT00863772|66726190|FG002|Overall Study|Lost to Follow-up|1|||
23821845|NCT00863772|66726188|FG000|Overall Study|Protocol Violation|2|||
23821846|NCT00863772|66726189|FG001|Overall Study|Protocol Violation|0|||
23821847|NCT00863772|66726190|FG002|Overall Study|Protocol Violation|2|||
23821848|NCT00863772|66726188|FG000|Overall Study|Withdrawal by Subject|4|||
23821849|NCT00863772|66726189|FG001|Overall Study|Withdrawal by Subject|7|||
23821850|NCT00863772|66726190|FG002|Overall Study|Withdrawal by Subject|5|||
23821851|NCT00863772|66726188|FG000|Overall Study|Study terminated by sponsor|44|||
23821852|NCT00863772|66726189|FG001|Overall Study|Study terminated by sponsor|45|||
23821853|NCT00863772|66726190|FG002|Overall Study|Study terminated by sponsor|36|||
23821854|NCT00863772|66726188|FG000|Overall Study|Entered extension study|6|||
23821855|NCT00863772|66726189|FG001|Overall Study|Entered extension study|4|||
23821856|NCT00863772|66726190|FG002|Overall Study|Entered extension study|9|||
23821857|NCT00863772|66726188|FG000|Overall Study|Other|1|||
23821858|NCT00863772|66726189|FG001|Overall Study|Other|2|||
23821859|NCT00863772|66726190|FG002|Overall Study|Other|4|||
23821860|NCT00863772|66726188|FG000|Overall Study|Randomized but not Treated|1|||
23430281|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430282|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430283|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430284|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430285|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430286|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23743782|NCT04145531|66439832|FG002|Part B|Other|0|||
23743783|NCT04145531|66439833|FG003|Part B|Other|1|||
23743784|NCT02613910|66439834|FG000|Overall Study|Termination of study|1|||
23743785|NCT04398030|66439839|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
23743786|NCT04398030|66439840|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
23743787|NCT04398030|66439839|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
23743788|NCT04398030|66439840|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
23430287|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430288|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430289|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430290|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430291|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
23430292|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
23430293|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
23430294|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
23430295|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
23430296|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430297|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430298|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430299|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430300|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430301|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430302|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
23430303|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
23430304|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
23430305|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
23430306|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
23821861|NCT00863772|66726189|FG001|Overall Study|Randomized but not Treated|0|||
23821862|NCT00863772|66726190|FG002|Overall Study|Randomized but not Treated|0|||
23821863|NCT02552121|66726201|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
23621079|NCT01085812|65997702|FG000|Open-Label Period|Adverse Event|0|||
23743789|NCT03841331|66439841|FG000|Overall Study|Withdrawal by Subject|4|||
23743790|NCT03841331|66439842|FG001|Overall Study|Withdrawal by Subject|9|||
23821864|NCT02552121|66726202|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821865|NCT02552121|66726203|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821866|NCT02552121|66726204|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23430307|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430308|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430309|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430310|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430311|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430312|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430313|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
23430314|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
23430315|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
23430316|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
23430317|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
23430318|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430319|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430320|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430321|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430322|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430323|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430324|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
23430325|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430326|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
23430327|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430328|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
23430329|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430330|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430331|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430332|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430333|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430334|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430335|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
23430336|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430337|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
23430338|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
23430339|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
23430340|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23551523|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
23551524|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551525|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551526|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551527|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551528|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551529|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551530|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23551531|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551532|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
23551533|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551534|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551535|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551536|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551537|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551538|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551539|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551540|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551541|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23551542|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551543|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551544|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551545|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551546|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551547|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551548|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
23551549|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
23551550|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
23551551|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23430341|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430342|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430343|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430344|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23621080|NCT01085812|65997703|FG001|Open-Label Period|Adverse Event|80|||
23621081|NCT01085812|65997702|FG000|Open-Label Period|Lack of Efficacy|0|||
23621082|NCT01085812|65997703|FG001|Open-Label Period|Lack of Efficacy|26|||
23621083|NCT01085812|65997702|FG000|Open-Label Period|Protocol Violation|0|||
23621084|NCT01085812|65997703|FG001|Open-Label Period|Protocol Violation|39|||
23621085|NCT01085812|65997702|FG000|Open-Label Period|Withdrawal by Subject|0|||
23621086|NCT01085812|65997703|FG001|Open-Label Period|Withdrawal by Subject|53|||
23621087|NCT01085812|65997702|FG000|Open-Label Period|Lost to Follow-up|0|||
23621088|NCT01085812|65997703|FG001|Open-Label Period|Lost to Follow-up|42|||
23621089|NCT01085812|65997702|FG000|Double-Blind Period|Adverse Event|3|||
23621090|NCT01085812|65997703|FG001|Double-Blind Period|Adverse Event|8|||
23621091|NCT01085812|65997702|FG000|Double-Blind Period|Protocol Violation|2|||
23621092|NCT01085812|65997703|FG001|Double-Blind Period|Protocol Violation|7|||
23621093|NCT01085812|65997702|FG000|Double-Blind Period|Withdrawal by Subject|11|||
23621094|NCT01085812|65997703|FG001|Double-Blind Period|Withdrawal by Subject|24|||
23621095|NCT01085812|65997702|FG000|Double-Blind Period|Lost to Follow-up|5|||
23621096|NCT01085812|65997703|FG001|Double-Blind Period|Lost to Follow-up|17|||
23621097|NCT01085812|65997702|FG000|Double-Blind Period|Other Reasons|0|||
23621098|NCT01085812|65997703|FG001|Double-Blind Period|Other Reasons|2|||
23621099|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
23621100|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
23621101|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
23621102|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
23621103|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
23621104|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
23621105|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
23621106|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
23621107|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
23621108|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
23621109|NCT01208870|65997704|FG000|Overall Study|Lost to Follow-up|2|||
23621110|NCT01208870|65997705|FG001|Overall Study|Lost to Follow-up|8|||
23621111|NCT00487552|65997706|FG000|Overall Study|Unsuccessful magnet placements|3|||
23621112|NCT00487552|65997706|FG000|Overall Study|Death due to progressive malignancy|2|||
23621113|NCT00487552|65997706|FG000|Overall Study|Stent not placed|1|||
23621114|NCT02108652|65997708|FG000|Overall Study|Death|253|||
23621115|NCT02108652|65997708|FG000|Overall Study|Lost to Follow-up|2|||
23621116|NCT02108652|65997708|FG000|Overall Study|Withdrawal by Subject|16|||
23621117|NCT02108652|65997708|FG000|Overall Study|Study Terminated By Sponsor|31|||
23621118|NCT02108652|65997708|FG000|Overall Study|Non-Compliance|1|||
23621119|NCT02108652|65997708|FG000|Overall Study|Physician Decision|6|||
23621120|NCT02108652|65997708|FG000|Overall Study|Progression Of Disease|1|||
23621121|NCT02624869|65997709|FG000|Overall Study|Lost to Follow-up|0|||
23621122|NCT02624869|65997710|FG001|Overall Study|Lost to Follow-up|0|||
23621123|NCT02624869|65997711|FG002|Overall Study|Lost to Follow-up|1|||
23621124|NCT02624869|65997709|FG000|Overall Study|Withdrawal by Subject|1|||
23621125|NCT02624869|65997710|FG001|Overall Study|Withdrawal by Subject|3|||
23621126|NCT02624869|65997711|FG002|Overall Study|Withdrawal by Subject|1|||
23621127|NCT03772613|66000556|FG000|Overall Study|Lost to Follow-up|0|||
23621128|NCT03772613|66000557|FG001|Overall Study|Lost to Follow-up|1|||
23621129|NCT03772613|66000558|FG002|Overall Study|Lost to Follow-up|1|||
23621130|NCT00594178|66000559|FG000|Overall Study|Physician Decision|5|||
23621131|NCT00605566|66000560|FG000|Overall Study|Adverse Event|1|||
23621132|NCT00605566|66000560|FG000|Overall Study|Clinical deterioration|1|||
23743791|NCT03841331|66439841|FG000|Overall Study|Lost to Follow-up|5|||
23743792|NCT03841331|66439842|FG001|Overall Study|Lost to Follow-up|1|||
23743793|NCT00379639|66439844|FG000|Overall Study|Disease Progression|3|||
23743794|NCT00379639|66439845|FG001|Overall Study|Disease Progression|3|||
23743795|NCT00379639|66439846|FG002|Overall Study|Disease Progression|3|||
23743796|NCT00379639|66439847|FG003|Overall Study|Disease Progression|4|||
23621133|NCT00605566|66000560|FG000|Overall Study|Poor compliance in run-in period|1|||
23621134|NCT02725008|66000561|FG000|Overall Study|Lost to Follow-up|7|||
23621135|NCT02725008|66000562|FG001|Overall Study|Lost to Follow-up|9|||
23621136|NCT02725008|66000561|FG000|Overall Study|Withdrawal by Subject|2|||
23621137|NCT02725008|66000562|FG001|Overall Study|Withdrawal by Subject|2|||
23621138|NCT02725008|66000561|FG000|Overall Study|Admitted to hospital|0|||
23621139|NCT02725008|66000562|FG001|Overall Study|Admitted to hospital|1|||
23621140|NCT04225039|66000563|FG000|Overall Study|Withdrawal by Subject|1|||
23621141|NCT04225039|66000564|FG001|Overall Study|Withdrawal by Subject|0|||
23621142|NCT04225039|66000565|FG002|Overall Study|Withdrawal by Subject|0|||
23621143|NCT04225039|66000566|FG003|Overall Study|Withdrawal by Subject|1|||
23743797|NCT00379639|66439848|FG004|Overall Study|Disease Progression|4|||
23743798|NCT00379639|66439844|FG000|Overall Study|Physician Decision|0|||
23743799|NCT00379639|66439845|FG001|Overall Study|Physician Decision|2|||
23551552|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551553|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23743800|NCT00379639|66439846|FG002|Overall Study|Physician Decision|1|||
23743801|NCT00379639|66439847|FG003|Overall Study|Physician Decision|1|||
23551554|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551555|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551556|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551557|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551558|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
23551559|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
23551560|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
23551561|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551562|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551563|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
23551564|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551565|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551566|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551567|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
23551568|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
23551569|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
23551570|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
23551571|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
23551572|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551573|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551574|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551575|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551576|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
23551577|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
23551578|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
23551579|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551580|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551581|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551582|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551583|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551584|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551585|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551586|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
23551587|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551588|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551589|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551590|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551591|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551592|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551593|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551594|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23743802|NCT00379639|66439848|FG004|Overall Study|Physician Decision|0|||
23743803|NCT00379639|66439844|FG000|Overall Study|Symptomatic Deterioration|0|||
23743804|NCT00379639|66439845|FG001|Overall Study|Symptomatic Deterioration|0|||
23743805|NCT00379639|66439846|FG002|Overall Study|Symptomatic Deterioration|1|||
23743806|NCT00379639|66439847|FG003|Overall Study|Symptomatic Deterioration|0|||
23743807|NCT00379639|66439848|FG004|Overall Study|Symptomatic Deterioration|1|||
23743808|NCT00379639|66439844|FG000|Overall Study|Adverse Event|0|||
23743809|NCT00379639|66439845|FG001|Overall Study|Adverse Event|0|||
23743810|NCT00379639|66439846|FG002|Overall Study|Adverse Event|1|||
23743811|NCT00379639|66439847|FG003|Overall Study|Adverse Event|0|||
23743812|NCT00379639|66439848|FG004|Overall Study|Adverse Event|1|||
23743813|NCT00379639|66439844|FG000|Overall Study|Lost to Follow-up|0|||
23743814|NCT00379639|66439845|FG001|Overall Study|Lost to Follow-up|0|||
23743815|NCT00379639|66439846|FG002|Overall Study|Lost to Follow-up|0|||
23743816|NCT00379639|66439847|FG003|Overall Study|Lost to Follow-up|1|||
23743817|NCT00379639|66439848|FG004|Overall Study|Lost to Follow-up|0|||
23743818|NCT00379639|66439844|FG000|Overall Study|Other|0|||
23743819|NCT00379639|66439845|FG001|Overall Study|Other|0|||
23621144|NCT04225039|66000563|FG000|Overall Study|Currently active on study treatment|0|||
23621145|NCT04225039|66000564|FG001|Overall Study|Currently active on study treatment|1|||
23743820|NCT00379639|66439846|FG002|Overall Study|Other|3|||
23743821|NCT00379639|66439847|FG003|Overall Study|Other|0|||
23743822|NCT00379639|66439848|FG004|Overall Study|Other|0|||
23743823|NCT00148109|66439851|FG000|Overall Study|Lack of Efficacy|10|||
23743824|NCT00148109|66439852|FG001|Overall Study|Lack of Efficacy|18|||
23621146|NCT04225039|66000565|FG002|Overall Study|Currently active on study treatment|0|||
23621147|NCT04225039|66000566|FG003|Overall Study|Currently active on study treatment|0|||
23621148|NCT04225039|66000563|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
23621149|NCT04225039|66000564|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621150|NCT04225039|66000565|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621151|NCT04225039|66000566|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621152|NCT04225039|66000563|FG000|Overall Study|Ineligible for treatment|0|||
23621153|NCT04225039|66000564|FG001|Overall Study|Ineligible for treatment|0|||
23621154|NCT04225039|66000565|FG002|Overall Study|Ineligible for treatment|0|||
23621155|NCT04225039|66000566|FG003|Overall Study|Ineligible for treatment|4|||
23621156|NCT00510198|66000571|FG000|Overall Study|Withdrawal by Subject|5|||
23621157|NCT00510198|66000572|FG001|Overall Study|Withdrawal by Subject|4|||
23621158|NCT02101268|66000578|FG000|Randomized Treatment Phase|Subject Decision|8|||
23621159|NCT02101268|66000579|FG001|Randomized Treatment Phase|Subject Decision|4|||
23621160|NCT02101268|66000580|FG002|Randomized Treatment Phase|Subject Decision|0|||
23621161|NCT02101268|66000581|FG003|Randomized Treatment Phase|Subject Decision|0|||
23621162|NCT02101268|66000578|FG000|Randomized Treatment Phase|Physician Decision|4|||
23621163|NCT02101268|66000579|FG001|Randomized Treatment Phase|Physician Decision|1|||
23621164|NCT02101268|66000580|FG002|Randomized Treatment Phase|Physician Decision|0|||
23621165|NCT02101268|66000581|FG003|Randomized Treatment Phase|Physician Decision|0|||
23621166|NCT02101268|66000578|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621167|NCT02101268|66000579|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
23621168|NCT02101268|66000580|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621169|NCT02101268|66000581|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621170|NCT02101268|66000578|FG000|Randomized Treatment Phase|Adverse Event|6|||
23621171|NCT02101268|66000579|FG001|Randomized Treatment Phase|Adverse Event|0|||
23621172|NCT02101268|66000580|FG002|Randomized Treatment Phase|Adverse Event|0|||
23551595|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551596|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
23551597|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551598|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551599|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551600|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551601|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551602|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551603|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551604|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
23551605|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
23551606|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551607|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23621173|NCT02101268|66000581|FG003|Randomized Treatment Phase|Adverse Event|0|||
23621174|NCT02101268|66000578|FG000|Randomized Treatment Phase|Death|5|||
23621175|NCT02101268|66000579|FG001|Randomized Treatment Phase|Death|4|||
23621176|NCT02101268|66000580|FG002|Randomized Treatment Phase|Death|0|||
23621177|NCT02101268|66000581|FG003|Randomized Treatment Phase|Death|0|||
23621178|NCT02101268|66000578|FG000|Randomized Treatment Phase|Disease Progression|4|||
23621179|NCT02101268|66000579|FG001|Randomized Treatment Phase|Disease Progression|1|||
23621180|NCT02101268|66000580|FG002|Randomized Treatment Phase|Disease Progression|0|||
23621181|NCT02101268|66000581|FG003|Randomized Treatment Phase|Disease Progression|0|||
23621182|NCT02101268|66000578|FG000|Extended Treatment Phase|Subject Decision|0|||
23621183|NCT02101268|66000579|FG001|Extended Treatment Phase|Subject Decision|0|||
23621184|NCT02101268|66000580|FG002|Extended Treatment Phase|Subject Decision|3|||
23621185|NCT02101268|66000581|FG003|Extended Treatment Phase|Subject Decision|2|||
23621186|NCT02101268|66000578|FG000|Extended Treatment Phase|Physician Decision|0|||
23621187|NCT02101268|66000579|FG001|Extended Treatment Phase|Physician Decision|0|||
23621188|NCT02101268|66000580|FG002|Extended Treatment Phase|Physician Decision|5|||
23621189|NCT02101268|66000581|FG003|Extended Treatment Phase|Physician Decision|2|||
23621190|NCT02101268|66000578|FG000|Extended Treatment Phase|Adverse Event|0|||
23621191|NCT02101268|66000579|FG001|Extended Treatment Phase|Adverse Event|0|||
23621192|NCT02101268|66000580|FG002|Extended Treatment Phase|Adverse Event|14|||
23621193|NCT02101268|66000581|FG003|Extended Treatment Phase|Adverse Event|18|||
23621194|NCT02101268|66000578|FG000|Extended Treatment Phase|Death|0|||
23621195|NCT02101268|66000579|FG001|Extended Treatment Phase|Death|0|||
23621196|NCT02101268|66000580|FG002|Extended Treatment Phase|Death|5|||
23621197|NCT02101268|66000581|FG003|Extended Treatment Phase|Death|1|||
23621198|NCT02101268|66000578|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
23621199|NCT02101268|66000579|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
23621200|NCT02101268|66000580|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
23621201|NCT02101268|66000581|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
23621202|NCT02101268|66000578|FG000|Extended Treatment Phase|Disease Progression|0|||
23551608|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551609|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551610|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551611|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551612|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
23551613|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
23551614|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551615|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551616|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551617|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551618|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551619|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
23551620|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551621|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
23551622|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
23551623|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551624|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551625|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551626|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551627|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
23551628|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
23551629|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551630|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
23551631|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551632|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551633|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551634|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551635|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23621203|NCT02101268|66000579|FG001|Extended Treatment Phase|Disease Progression|0|||
23551636|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551637|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551638|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551639|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
23621204|NCT02101268|66000580|FG002|Extended Treatment Phase|Disease Progression|13|||
23621205|NCT02101268|66000581|FG003|Extended Treatment Phase|Disease Progression|6|||
23621206|NCT02101268|66000578|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
23621207|NCT02101268|66000579|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
23621208|NCT02101268|66000580|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
23621209|NCT02101268|66000581|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
23621210|NCT03845075|66000582|FG000|Part 1 - DB|Withdrawal by Subject|1|||
23621211|NCT03845075|66000583|FG001|Part 1 - DB|Withdrawal by Subject|1|||
23621212|NCT03845075|66000584|FG002|Part 1 - DB|Withdrawal by Subject|0|||
23621213|NCT03845075|66000585|FG003|Part 1 - DB|Withdrawal by Subject|0|||
23621214|NCT03845075|66000582|FG000|Part 1 - DB|Adverse Event|0|||
23621215|NCT03845075|66000583|FG001|Part 1 - DB|Adverse Event|1|||
23551640|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
23551641|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551642|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551643|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23621216|NCT03845075|66000584|FG002|Part 1 - DB|Adverse Event|0|||
23551644|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551645|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23551646|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23551647|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551648|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
23551649|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551650|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551651|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551652|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23621217|NCT03845075|66000585|FG003|Part 1 - DB|Adverse Event|0|||
23621218|NCT03845075|66000582|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
23621219|NCT03845075|66000583|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23551653|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23621220|NCT03845075|66000584|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23551654|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551655|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551656|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23621221|NCT03845075|66000585|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23621222|NCT03029819|66000586|FG000|Overall Study|Lost to Follow-up|3|||
23551657|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
23551658|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23551659|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551660|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551661|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551662|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551663|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551664|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23551665|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551666|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551667|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551668|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551669|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551670|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551671|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551672|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551673|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
23551674|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551675|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
23551676|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
23551677|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551678|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551679|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551680|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551681|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23551682|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23551683|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551684|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
23551685|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
23551686|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551687|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551688|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551689|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551690|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23551691|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23551692|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551693|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23621223|NCT03029819|66000587|FG001|Overall Study|Lost to Follow-up|5|||
23621224|NCT03029819|66000586|FG000|Overall Study|Removed due to disruptive behavior|0|||
23621225|NCT03029819|66000587|FG001|Overall Study|Removed due to disruptive behavior|1|||
23621226|NCT03464383|66000588|FG000|Overall Study|Lost to Follow-up|1|||
23621227|NCT03464383|66000589|FG001|Overall Study|Lost to Follow-up|0|||
23621228|NCT03464383|66000590|FG002|Overall Study|Lost to Follow-up|0|||
23621229|NCT03464383|66000588|FG000|Overall Study|Withdrawal by Subject|0|||
23621230|NCT03464383|66000589|FG001|Overall Study|Withdrawal by Subject|1|||
23621231|NCT03464383|66000590|FG002|Overall Study|Withdrawal by Subject|0|||
23621232|NCT02803593|66000591|FG000|Overall Study|Lost to Follow-up|17|||
23621233|NCT02803593|66000592|FG001|Overall Study|Lost to Follow-up|35|||
23621234|NCT03845023|66000594|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
23621235|NCT03845023|66000595|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621236|NCT03845023|66000596|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621237|NCT03845023|66000597|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621238|NCT03845023|66000594|FG000|Follow-Up (14 Days)|Adverse Event|0|||
23621239|NCT03845023|66000595|FG001|Follow-Up (14 Days)|Adverse Event|0|||
23621240|NCT03845023|66000596|FG002|Follow-Up (14 Days)|Adverse Event|1|||
23621241|NCT03845023|66000597|FG003|Follow-Up (14 Days)|Adverse Event|1|||
23621242|NCT04816708|66000598|FG000|Overall Study|Lost to Follow-up|10|||
23621243|NCT04816708|66000599|FG001|Overall Study|Lost to Follow-up|4|||
23621244|NCT02592707|66000600|FG000|Overall Study|Consent Withdrawn|0|||
23621245|NCT02592707|66000601|FG001|Overall Study|Consent Withdrawn|1|||
23621246|NCT02592707|66000602|FG002|Overall Study|Consent Withdrawn|2|||
23621247|NCT02592707|66000603|FG003|Overall Study|Consent Withdrawn|0|||
23621248|NCT02592707|66000600|FG000|Overall Study|Death|1|||
23551694|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551695|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551696|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23621249|NCT02592707|66000601|FG001|Overall Study|Death|0|||
23621250|NCT02592707|66000602|FG002|Overall Study|Death|0|||
23621251|NCT02592707|66000603|FG003|Overall Study|Death|0|||
23621252|NCT02592707|66000600|FG000|Overall Study|Progressive Disease|4|||
23621253|NCT02592707|66000601|FG001|Overall Study|Progressive Disease|4|||
23621254|NCT02592707|66000602|FG002|Overall Study|Progressive Disease|3|||
23621255|NCT02592707|66000603|FG003|Overall Study|Progressive Disease|3|||
23621256|NCT02592707|66000600|FG000|Overall Study|Other|0|||
23551697|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551698|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551699|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551700|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551701|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551702|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551703|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551704|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551705|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551706|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551707|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551708|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
23551709|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551710|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551711|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
23551712|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23551713|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551714|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551715|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551716|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551717|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23621257|NCT02592707|66000601|FG001|Overall Study|Other|0|||
23551718|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23621258|NCT02592707|66000602|FG002|Overall Study|Other|1|||
23621259|NCT02592707|66000603|FG003|Overall Study|Other|2|||
23621260|NCT02592707|66000600|FG000|Overall Study|Never entered LTFU period|1|||
23621261|NCT02592707|66000601|FG001|Overall Study|Never entered LTFU period|0|||
23621262|NCT02592707|66000602|FG002|Overall Study|Never entered LTFU period|0|||
23621263|NCT02592707|66000603|FG003|Overall Study|Never entered LTFU period|2|||
23621264|NCT04270747|66000604|FG000|Through Week 16|Adverse Event|1|||
23621265|NCT04270747|66000605|FG001|Through Week 16|Adverse Event|2|||
23621266|NCT04270747|66000606|FG002|Through Week 16|Adverse Event|0|||
23621267|NCT04270747|66000604|FG000|Through Week 16|Death|0|||
23621268|NCT04270747|66000605|FG001|Through Week 16|Death|2|||
23621269|NCT04270747|66000606|FG002|Through Week 16|Death|0|||
23621270|NCT04270747|66000604|FG000|Through Week 16|Consent Withdrawn|3|||
23621271|NCT04270747|66000605|FG001|Through Week 16|Consent Withdrawn|3|||
23621272|NCT04270747|66000606|FG002|Through Week 16|Consent Withdrawn|0|||
23621273|NCT04270747|66000604|FG000|Through Week 16|Physician Decision|1|||
23621274|NCT04270747|66000605|FG001|Through Week 16|Physician Decision|1|||
23621275|NCT04270747|66000606|FG002|Through Week 16|Physician Decision|0|||
23621276|NCT04270747|66000604|FG000|Through Week 16|Lost to Follow-up|2|||
23621277|NCT04270747|66000605|FG001|Through Week 16|Lost to Follow-up|0|||
23621278|NCT04270747|66000606|FG002|Through Week 16|Lost to Follow-up|0|||
23621279|NCT04270747|66000604|FG000|Through Week 16|Protocol Violation|1|||
23621280|NCT04270747|66000605|FG001|Through Week 16|Protocol Violation|2|||
23621281|NCT04270747|66000606|FG002|Through Week 16|Protocol Violation|0|||
23621282|NCT04270747|66000604|FG000|Through Week 16|Protocol Specified Criteria|6|||
23621283|NCT04270747|66000605|FG001|Through Week 16|Protocol Specified Criteria|7|||
23621284|NCT04270747|66000606|FG002|Through Week 16|Protocol Specified Criteria|0|||
23621285|NCT04270747|66000604|FG000|Through Week 16|Miscellaneous|1|||
23621286|NCT04270747|66000605|FG001|Through Week 16|Miscellaneous|1|||
23621287|NCT04270747|66000606|FG002|Through Week 16|Miscellaneous|0|||
23621288|NCT04270747|66000604|FG000|Post Week 16|Adverse Event|7|||
23621289|NCT04270747|66000605|FG001|Post Week 16|Adverse Event|5|||
23621290|NCT04270747|66000606|FG002|Post Week 16|Adverse Event|1|||
23621291|NCT04270747|66000604|FG000|Post Week 16|Death|2|||
23621292|NCT04270747|66000605|FG001|Post Week 16|Death|0|||
23621293|NCT04270747|66000606|FG002|Post Week 16|Death|2|||
23743825|NCT00148109|66439851|FG000|Overall Study|Adverse Event|0|||
23743826|NCT00148109|66439852|FG001|Overall Study|Adverse Event|2|||
23743827|NCT00148109|66439851|FG000|Overall Study|Withdrawal by Subject|2|||
23743828|NCT00148109|66439852|FG001|Overall Study|Withdrawal by Subject|0|||
23743829|NCT00777920|66439854|FG000|Overall Study|Adverse Event|39|||
23743830|NCT00777920|66439854|FG000|Overall Study|Withdrawal of Consent|4|||
23743831|NCT00777920|66439854|FG000|Overall Study|Lost to Follow-up|1|||
23743832|NCT00777920|66439854|FG000|Overall Study|Investigator's discretion|1|||
23743833|NCT00777920|66439854|FG000|Overall Study|Clinical status did not improve|1|||
23551719|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23621294|NCT04270747|66000604|FG000|Post Week 16|Consent Withdrawn|4|||
23621295|NCT04270747|66000605|FG001|Post Week 16|Consent Withdrawn|3|||
23621296|NCT04270747|66000606|FG002|Post Week 16|Consent Withdrawn|6|||
23621297|NCT04270747|66000604|FG000|Post Week 16|Physician Decision|3|||
23621298|NCT04270747|66000605|FG001|Post Week 16|Physician Decision|1|||
23743834|NCT00777920|66439854|FG000|Overall Study|Other, not specified|4|||
23743835|NCT00579059|66439855|FG000|Overall Study|Study Canceled at 1 Year|21|||
23430345|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430346|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
23430347|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430348|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
23430349|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23551720|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551721|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551722|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551723|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551724|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551725|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23430350|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430351|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23551726|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551727|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551728|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551729|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23430352|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430353|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430354|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430355|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430356|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430357|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430358|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430359|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
23430360|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430361|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430362|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430363|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430364|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430365|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430366|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430367|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430368|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
23430369|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430370|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430371|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430372|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430373|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430374|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430375|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430376|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430377|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430378|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430379|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430380|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430381|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23430382|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23430383|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23551730|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
23551731|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551732|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23821867|NCT02552121|66726205|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821868|NCT02552121|66726206|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821869|NCT02552121|66726207|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821870|NCT02552121|66726208|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23821871|NCT02552121|66726201|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
23430384|NCT02804750|65320537|FG000|Period 1|Adverse Event|0|||
23430385|NCT02804750|65320538|FG001|Period 1|Adverse Event|2|||
23430386|NCT02804750|65320537|FG000|Period 1|Withdrawal by Subject|0|||
23430387|NCT02804750|65320538|FG001|Period 1|Withdrawal by Subject|1|||
23551733|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551734|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551735|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
23551736|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551737|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23821872|NCT02552121|66726202|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23551738|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551739|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551740|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551741|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551742|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551743|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551744|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551745|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551746|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551747|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
23551748|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
23551749|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551750|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551751|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551752|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551753|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551754|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551755|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551756|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551757|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
23551758|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551759|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551760|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551761|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551762|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551763|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551764|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551765|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23551766|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551767|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551768|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551769|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551770|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551771|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551772|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23551773|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
23551774|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
23551775|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
23551776|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
23551777|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
23551778|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
23551779|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
23551780|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
23551781|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
23551782|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551783|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551784|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
23551785|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551786|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551787|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551788|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551789|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551790|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551791|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551792|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551793|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
23551794|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551795|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551796|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551797|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551798|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551799|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23551800|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551801|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23821873|NCT02552121|66726203|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23551802|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
23551803|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551804|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551805|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551806|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551807|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551808|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551809|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551810|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
23551811|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23551812|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551813|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551814|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551815|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551816|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23551817|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551818|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Death|0|||
23551819|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Death|0|||
23551820|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Death|0|||
23551821|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Death|0|||
23551822|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Death|0|||
23551823|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Death|0|||
23551824|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Death|0|||
23551825|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Death|1|||
23551826|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Death|0|||
23551827|NCT00377234|65747651|FG000|Overall Study|Adverse Event|14|||
23551828|NCT00377234|65747652|FG001|Overall Study|Adverse Event|17|||
23551829|NCT00377234|65747651|FG000|Overall Study|Withdrawal by Subject|11|||
23551830|NCT00377234|65747652|FG001|Overall Study|Withdrawal by Subject|9|||
23551831|NCT00377234|65747651|FG000|Overall Study|Lost to Follow-up|4|||
23551832|NCT00377234|65747652|FG001|Overall Study|Lost to Follow-up|2|||
23551833|NCT00377234|65747651|FG000|Overall Study|Administrative|2|||
23551834|NCT00377234|65747652|FG001|Overall Study|Administrative|1|||
23551835|NCT00377234|65747651|FG000|Overall Study|Not assigned|3|||
23551836|NCT00377234|65747652|FG001|Overall Study|Not assigned|2|||
23551837|NCT02693743|65747653|FG000|Overall Study|Physician Decision|1|||
23551838|NCT02693743|65747654|FG001|Overall Study|Physician Decision|0|||
23551839|NCT01800968|65747657|FG000|Overall Study|Death|23|||
23551840|NCT01800968|65747658|FG001|Overall Study|Death|16|||
23551841|NCT01800968|65747657|FG000|Overall Study|Lost to Follow-up|5|||
23551842|NCT01800968|65747658|FG001|Overall Study|Lost to Follow-up|7|||
23551843|NCT01800968|65747657|FG000|Overall Study|Withdrawal by Subject|7|||
23551844|NCT01800968|65747658|FG001|Overall Study|Withdrawal by Subject|9|||
23551845|NCT01800968|65747657|FG000|Overall Study|Physician Decision|1|||
23551846|NCT01800968|65747658|FG001|Overall Study|Physician Decision|0|||
23551847|NCT00522275|65747659|FG000|Overall Study|Adverse Event|35|||
23551848|NCT00522275|65747659|FG000|Overall Study|Lack of Efficacy|80|||
23551849|NCT00522275|65747659|FG000|Overall Study|Subject withdrew consent|16|||
23551850|NCT00522275|65747659|FG000|Overall Study|Protocol deviation|1|||
23551851|NCT00522275|65747659|FG000|Overall Study|Unsatisfactory compliance|11|||
23551852|NCT00522275|65747659|FG000|Overall Study|Lost to Follow-up|8|||
23551853|NCT00522275|65747659|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
23551854|NCT00522275|65747659|FG000|Overall Study|Other: Subject is pregnant|2|||
23551855|NCT00522275|65747659|FG000|Overall Study|Other: Subject relocated|2|||
23551856|NCT00522275|65747659|FG000|Overall Study|Other: Subject arrested|1|||
23551857|NCT00522275|65747659|FG000|Overall Study|Other: Site / clinic closed|4|||
23551858|NCT00522275|65747659|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
23551859|NCT00522275|65747659|FG000|Overall Study|Other: Sponsor request|2|||
23551860|NCT00522275|65747659|FG000|Overall Study|Other: Subject ran out of medication|1|||
23551861|NCT00522275|65747659|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
23551862|NCT01422408|65747660|FG000|Overall Study|Adverse Event|1|||
23551863|NCT01422408|65747660|FG000|Overall Study|Withdrawal by Subject|3|||
23551864|NCT02576678|65747662|FG000|Overall Study|Adverse Event|0|||
23551865|NCT02576678|65747663|FG001|Overall Study|Adverse Event|0|||
23551866|NCT02576678|65747664|FG002|Overall Study|Adverse Event|2|||
23621299|NCT04270747|66000606|FG002|Post Week 16|Physician Decision|1|||
23621300|NCT04270747|66000604|FG000|Post Week 16|Lost to Follow-up|2|||
23621301|NCT04270747|66000605|FG001|Post Week 16|Lost to Follow-up|1|||
23621302|NCT04270747|66000606|FG002|Post Week 16|Lost to Follow-up|0|||
23621303|NCT04270747|66000604|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
23621304|NCT04270747|66000605|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
23551867|NCT02576678|65747662|FG000|Overall Study|Withdrawal by Subject|3|||
23551868|NCT02576678|65747663|FG001|Overall Study|Withdrawal by Subject|1|||
23551869|NCT02576678|65747664|FG002|Overall Study|Withdrawal by Subject|2|||
23551870|NCT02576678|65747662|FG000|Overall Study|Lost to Follow-up|0|||
23743836|NCT00579059|66439856|FG001|Overall Study|Study Canceled at 1 Year|10|||
23551871|NCT02576678|65747663|FG001|Overall Study|Lost to Follow-up|0|||
23551872|NCT02576678|65747664|FG002|Overall Study|Lost to Follow-up|1|||
23621305|NCT04270747|66000606|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
23743837|NCT00920582|66439857|FG000|Overall Study|Lost to Follow-up|5|||
23743838|NCT00920582|66439858|FG001|Overall Study|Lost to Follow-up|1|||
23743839|NCT00920582|66439859|FG002|Overall Study|Lost to Follow-up|2|||
23743840|NCT00920582|66439860|FG003|Overall Study|Lost to Follow-up|0|||
23743841|NCT00920582|66439857|FG000|Overall Study|Withdrawal by Subject|5|||
23743842|NCT00920582|66439858|FG001|Overall Study|Withdrawal by Subject|4|||
23551873|NCT02576678|65747662|FG000|Overall Study|Miscellaneous|2|||
23551874|NCT02576678|65747663|FG001|Overall Study|Miscellaneous|0|||
23551875|NCT02576678|65747664|FG002|Overall Study|Miscellaneous|0|||
23551876|NCT04537923|65747665|FG000|Overall Study|Adverse Event|2|||
23551877|NCT04537923|65747666|FG001|Overall Study|Adverse Event|1|||
23551878|NCT04537923|65747667|FG002|Overall Study|Adverse Event|2|||
23551879|NCT04537923|65747668|FG003|Overall Study|Adverse Event|4|||
23551880|NCT04537923|65747665|FG000|Overall Study|Death|3|||
23551881|NCT04537923|65747666|FG001|Overall Study|Death|3|||
23551882|NCT04537923|65747667|FG002|Overall Study|Death|1|||
23551883|NCT04537923|65747668|FG003|Overall Study|Death|11|||
23551884|NCT04537923|65747665|FG000|Overall Study|Lost to Follow-up|1|||
23551885|NCT04537923|65747666|FG001|Overall Study|Lost to Follow-up|2|||
23551886|NCT04537923|65747667|FG002|Overall Study|Lost to Follow-up|1|||
23551887|NCT04537923|65747668|FG003|Overall Study|Lost to Follow-up|6|||
23551888|NCT04537923|65747665|FG000|Overall Study|Physician Decision|1|||
23551889|NCT04537923|65747666|FG001|Overall Study|Physician Decision|0|||
23551890|NCT04537923|65747667|FG002|Overall Study|Physician Decision|2|||
23551891|NCT04537923|65747668|FG003|Overall Study|Physician Decision|5|||
23551892|NCT04537923|65747665|FG000|Overall Study|Pregnancy|1|||
23551893|NCT04537923|65747666|FG001|Overall Study|Pregnancy|0|||
23551894|NCT04537923|65747667|FG002|Overall Study|Pregnancy|0|||
23551895|NCT04537923|65747668|FG003|Overall Study|Pregnancy|0|||
23551896|NCT04537923|65747665|FG000|Overall Study|Withdrawal by Subject|4|||
23551897|NCT04537923|65747666|FG001|Overall Study|Withdrawal by Subject|4|||
23551898|NCT04537923|65747667|FG002|Overall Study|Withdrawal by Subject|4|||
23551899|NCT04537923|65747668|FG003|Overall Study|Withdrawal by Subject|58|||
23551900|NCT04537923|65747665|FG000|Overall Study|Missed study visits|2|||
23551901|NCT04537923|65747666|FG001|Overall Study|Missed study visits|0|||
23551902|NCT04537923|65747667|FG002|Overall Study|Missed study visits|0|||
23551903|NCT04537923|65747668|FG003|Overall Study|Missed study visits|3|||
23551904|NCT04537923|65747665|FG000|Overall Study|Sponsor's decision|0|||
23551905|NCT04537923|65747666|FG001|Overall Study|Sponsor's decision|0|||
23551906|NCT04537923|65747667|FG002|Overall Study|Sponsor's decision|1|||
23551907|NCT04537923|65747668|FG003|Overall Study|Sponsor's decision|1|||
23551908|NCT04537923|65747665|FG000|Overall Study|Safety reasons|1|||
23551909|NCT04537923|65747666|FG001|Overall Study|Safety reasons|0|||
23551910|NCT04537923|65747667|FG002|Overall Study|Safety reasons|0|||
23551911|NCT04537923|65747668|FG003|Overall Study|Safety reasons|0|||
23551912|NCT03969719|65747669|FG000|Overall Study|Other reasons not specified|1|||
23551913|NCT03969719|65747670|FG001|Overall Study|Other reasons not specified|1|||
23551914|NCT03969719|65747671|FG002|Overall Study|Other reasons not specified|3|||
23743843|NCT00920582|66439859|FG002|Overall Study|Withdrawal by Subject|6|||
23430388|NCT02804750|65320537|FG000|Period 2|Adverse Event|1|||
23430389|NCT02804750|65320538|FG001|Period 2|Adverse Event|0|||
23430390|NCT02804750|65320537|FG000|Period 3|Adverse Event|0|||
23430391|NCT02804750|65320538|FG001|Period 3|Adverse Event|2|||
23430392|NCT02804750|65320537|FG000|Period 4|Adverse Event|0|||
23430393|NCT02804750|65320538|FG001|Period 4|Adverse Event|5|||
23430394|NCT02559414|65320539|FG000|Overall Study|Lost to Follow-up|0|||
23430395|NCT02559414|65320540|FG001|Overall Study|Lost to Follow-up|1|||
23430396|NCT02559414|65320541|FG002|Overall Study|Lost to Follow-up|0|||
23430397|NCT02559414|65320539|FG000|Overall Study|Withdrawal by Subject|1|||
23430398|NCT02559414|65320540|FG001|Overall Study|Withdrawal by Subject|0|||
23430399|NCT02559414|65320541|FG002|Overall Study|Withdrawal by Subject|1|||
23430400|NCT02559414|65320539|FG000|Overall Study|Other|0|||
23430401|NCT02559414|65320540|FG001|Overall Study|Other|1|||
23430402|NCT02559414|65320541|FG002|Overall Study|Other|1|||
23551915|NCT03969719|65747669|FG000|Overall Study|Withdrawal by Subject|2|||
23743844|NCT00920582|66439860|FG003|Overall Study|Withdrawal by Subject|3|||
23430403|NCT05545644|65320542|FG000|Overall Study|Lost to Follow-up|4|||
23430404|NCT05545644|65320543|FG001|Overall Study|Lost to Follow-up|3|||
23551916|NCT03969719|65747670|FG001|Overall Study|Withdrawal by Subject|3|||
23551917|NCT03969719|65747671|FG002|Overall Study|Withdrawal by Subject|2|||
23430405|NCT02758301|65320545|FG000|Overall Study|Death|12|||
23430406|NCT02758301|65320546|FG001|Overall Study|Death|0|||
23551918|NCT03969719|65747669|FG000|Overall Study|Protocol Violation|1|||
23551919|NCT03969719|65747670|FG001|Overall Study|Protocol Violation|2|||
23551920|NCT03969719|65747671|FG002|Overall Study|Protocol Violation|0|||
23551921|NCT03969719|65747669|FG000|Overall Study|Adverse Event|0|||
23551922|NCT03969719|65747670|FG001|Overall Study|Adverse Event|2|||
23551923|NCT03969719|65747671|FG002|Overall Study|Adverse Event|0|||
23551924|NCT03969719|65747669|FG000|Overall Study|Lost to Follow-up|0|||
23743845|NCT00920582|66439857|FG000|Overall Study|Protocol Violation|1|||
23743846|NCT00920582|66439858|FG001|Overall Study|Protocol Violation|0|||
23551925|NCT03969719|65747670|FG001|Overall Study|Lost to Follow-up|1|||
23551926|NCT03969719|65747671|FG002|Overall Study|Lost to Follow-up|0|||
23551927|NCT01618162|65747673|FG000|Overall Study|Protocol Violation|13|||
23551928|NCT01618162|65747674|FG001|Overall Study|Protocol Violation|10|||
23551929|NCT01618162|65747673|FG000|Overall Study|Adverse Event|9|||
23551930|NCT01618162|65747674|FG001|Overall Study|Adverse Event|2|||
23551931|NCT01618162|65747673|FG000|Overall Study|Withdrawal Criteria|2|||
23551932|NCT01618162|65747674|FG001|Overall Study|Withdrawal Criteria|10|||
23551933|NCT01618162|65747673|FG000|Overall Study|Unclassified|14|||
23551934|NCT01618162|65747674|FG001|Overall Study|Unclassified|13|||
23551935|NCT01747772|65747675|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
23551936|NCT03461003|65747676|FG000|Overall Study|Lost to Follow-up|2|||
23551937|NCT03461003|65747677|FG001|Overall Study|Lost to Follow-up|2|||
23551938|NCT03461003|65747676|FG000|Overall Study|Withdrawal by Subject|3|||
23551939|NCT03461003|65747677|FG001|Overall Study|Withdrawal by Subject|1|||
23551940|NCT00808808|65747678|FG000|Overall Study|Vaccinated; survey not completed|131|||
23551941|NCT00808808|65747679|FG001|Overall Study|Vaccinated; survey not completed|169|||
23551942|NCT00808808|65747680|FG002|Overall Study|Vaccinated; survey not completed|302|||
23551943|NCT00808808|65747678|FG000|Overall Study|Employee was not vaccinated.|2686|||
23551944|NCT00808808|65747679|FG001|Overall Study|Employee was not vaccinated.|2268|||
23551945|NCT00808808|65747680|FG002|Overall Study|Employee was not vaccinated.|2255|||
23551946|NCT01380327|65747687|FG000|Overall Study|Lost to Follow-up|0|||
23743847|NCT00920582|66439859|FG002|Overall Study|Protocol Violation|0|||
23743848|NCT00920582|66439860|FG003|Overall Study|Protocol Violation|0|||
23743849|NCT00920582|66439857|FG000|Overall Study|Other|2|||
23743850|NCT00920582|66439858|FG001|Overall Study|Other|1|||
23743851|NCT00920582|66439859|FG002|Overall Study|Other|3|||
23743852|NCT00920582|66439860|FG003|Overall Study|Other|2|||
23743853|NCT03710824|66439861|FG000|Overall Study|Withdrawal by Subject|1|||
23743854|NCT03710824|66439861|FG000|Overall Study|Lost to Follow-up|3|||
23743855|NCT03710824|66439861|FG000|Overall Study|Adverse Event|25|||
23743856|NCT03710824|66439861|FG000|Overall Study|Treatment discontinuation|2|||
23743857|NCT00660816|66439880|FG000|Overall Study|Adverse Event|1|||
23743858|NCT00660816|66439881|FG001|Overall Study|Adverse Event|2|||
23743859|NCT00660816|66439880|FG000|Overall Study|Withdrawal by Subject|1|||
23743860|NCT00660816|66439881|FG001|Overall Study|Withdrawal by Subject|0|||
23743861|NCT00660816|66439880|FG000|Overall Study|Death|0|||
23743862|NCT00660816|66439881|FG001|Overall Study|Death|2|||
23743863|NCT00660816|66439880|FG000|Overall Study|Lack of Efficacy|1|||
23743864|NCT00660816|66439881|FG001|Overall Study|Lack of Efficacy|0|||
23743865|NCT00660816|66439880|FG000|Overall Study|Physician Decision|0|||
23743866|NCT00660816|66439881|FG001|Overall Study|Physician Decision|2|||
23743867|NCT00660816|66439880|FG000|Overall Study|Protocol Violation|1|||
23743868|NCT00660816|66439881|FG001|Overall Study|Protocol Violation|0|||
23743869|NCT00660816|66439880|FG000|Overall Study|Disease Progression|16|||
23743870|NCT00660816|66439881|FG001|Overall Study|Disease Progression|12|||
23821874|NCT02552121|66726204|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23821875|NCT02552121|66726205|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23551947|NCT01380327|65747688|FG001|Overall Study|Lost to Follow-up|1|||
23551948|NCT01380327|65747689|FG002|Overall Study|Lost to Follow-up|1|||
23551949|NCT01380327|65747687|FG000|Overall Study|Protocol Violation|3|||
23551950|NCT01380327|65747688|FG001|Overall Study|Protocol Violation|2|||
23551951|NCT01380327|65747689|FG002|Overall Study|Protocol Violation|3|||
23551952|NCT01380327|65747687|FG000|Overall Study|Withdrawal by Subject|0|||
23551953|NCT01380327|65747688|FG001|Overall Study|Withdrawal by Subject|0|||
23551954|NCT01380327|65747689|FG002|Overall Study|Withdrawal by Subject|1|||
23743871|NCT00660816|66439880|FG000|Overall Study|Complicating Disease|0|||
23743872|NCT00660816|66439881|FG001|Overall Study|Complicating Disease|1|||
23743873|NCT01471197|66439882|FG000|Overall Study|Disease Progression|4|||
23743874|NCT01471197|66439883|FG001|Overall Study|Disease Progression|2|||
23743875|NCT01471197|66439882|FG000|Overall Study|Death|1|||
23743876|NCT01471197|66439883|FG001|Overall Study|Death|0|||
23743877|NCT01471197|66439882|FG000|Overall Study|Study Drug Toxicity|1|||
23743878|NCT01471197|66439883|FG001|Overall Study|Study Drug Toxicity|0|||
23743879|NCT04621227|66439884|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
23743880|NCT04621227|66439884|FG000|Period 3 (29 Days)|Adverse Event|1|||
23743881|NCT04621227|66439884|FG000|Period 8 (2 Days)|Adverse Event|1|||
23743882|NCT03359811|66439885|FG000|Overall Study|Protocol Violation|2|||
23743883|NCT03359811|66439886|FG001|Overall Study|Protocol Violation|0|||
23743884|NCT00096031|66439887|FG000|Overall Study|Adverse Event|3|||
23743885|NCT00096031|66439887|FG000|Overall Study|Lack of Efficacy|42|||
23743886|NCT00096031|66439887|FG000|Overall Study|Death|4|||
23743887|NCT00096031|66439887|FG000|Overall Study|Withdrawal by Subject|1|||
23743888|NCT00096031|66439887|FG000|Overall Study|Ineligible|8|||
23743889|NCT00096031|66439887|FG000|Overall Study|Not protocol specified|5|||
23743890|NCT00561912|66439892|FG000|Overall Study|ineligible|1|||
23743891|NCT01002573|66439893|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
23743892|NCT01002573|66439894|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
23743893|NCT01519700|66439896|FG000|Overall Study|Death|1|||
23430407|NCT02758301|65320545|FG000|Overall Study|Physician Decision|10|||
23430408|NCT02758301|65320546|FG001|Overall Study|Physician Decision|1|||
23430409|NCT02758301|65320545|FG000|Overall Study|Withdrawal by Subject|5|||
23430410|NCT02758301|65320546|FG001|Overall Study|Withdrawal by Subject|6|||
23430411|NCT02758301|65320545|FG000|Overall Study|Lost to Follow-up|7|||
23430412|NCT02758301|65320546|FG001|Overall Study|Lost to Follow-up|0|||
23430413|NCT02758301|65320545|FG000|Overall Study|Protocol Violation|0|||
23430414|NCT02758301|65320546|FG001|Overall Study|Protocol Violation|1|||
23430415|NCT02408523|65320547|FG000|Overall Study|Adverse Event|4|||
23430416|NCT02408523|65320548|FG001|Overall Study|Adverse Event|10|||
23430417|NCT02408523|65320547|FG000|Overall Study|Lack of Efficacy|0|||
23430418|NCT02408523|65320548|FG001|Overall Study|Lack of Efficacy|1|||
23430419|NCT02408523|65320547|FG000|Overall Study|Protocol Violation|1|||
23430420|NCT02408523|65320548|FG001|Overall Study|Protocol Violation|2|||
23430421|NCT02408523|65320547|FG000|Overall Study|Lost to Follow-up|2|||
23430422|NCT02408523|65320548|FG001|Overall Study|Lost to Follow-up|3|||
23430423|NCT02408523|65320547|FG000|Overall Study|Withdrawal by Subject|3|||
23430424|NCT02408523|65320548|FG001|Overall Study|Withdrawal by Subject|1|||
23430425|NCT02408523|65320547|FG000|Overall Study|Sponsor request|1|||
23430426|NCT02408523|65320548|FG001|Overall Study|Sponsor request|0|||
23430427|NCT02408523|65320547|FG000|Overall Study|Did not satisfy extension conditions|0|||
23430428|NCT02408523|65320548|FG001|Overall Study|Did not satisfy extension conditions|1|||
23430429|NCT02210091|65320550|FG000|Overall Study|Physician Decision|0|||
23430430|NCT02210091|65320551|FG001|Overall Study|Physician Decision|1|||
23430431|NCT02210091|65320550|FG000|Overall Study|Withdrawal by Sponsor|0|||
23430432|NCT02210091|65320551|FG001|Overall Study|Withdrawal by Sponsor|1|||
23430433|NCT02613169|65320557|FG000|Overall Study|Withdrawal by Subject|4|||
23430434|NCT02613169|65320558|FG001|Overall Study|Withdrawal by Subject|1|||
23430435|NCT02613169|65320557|FG000|Overall Study|Lost to Follow-up|0|||
23430436|NCT02613169|65320558|FG001|Overall Study|Lost to Follow-up|5|||
23430437|NCT02613169|65320557|FG000|Overall Study|HIV|0|||
23430438|NCT02613169|65320558|FG001|Overall Study|HIV|2|||
23430439|NCT02613169|65320557|FG000|Overall Study|No TB infection endpoint|14|||
23430440|NCT02613169|65320558|FG001|Overall Study|No TB infection endpoint|9|||
23430441|NCT02558400|65320561|FG000|Overall Study|Adverse Event|47|||
23430442|NCT02558400|65320562|FG001|Overall Study|Adverse Event|53|||
23430443|NCT02558400|65320563|FG002|Overall Study|Adverse Event|4|||
23430444|NCT02558400|65320561|FG000|Overall Study|Withdrawal by Subject|13|||
23430445|NCT02558400|65320562|FG001|Overall Study|Withdrawal by Subject|9|||
23430446|NCT02558400|65320563|FG002|Overall Study|Withdrawal by Subject|8|||
23430447|NCT02558400|65320561|FG000|Overall Study|Non-Compliant|0|||
23430448|NCT02558400|65320562|FG001|Overall Study|Non-Compliant|1|||
23430449|NCT02558400|65320563|FG002|Overall Study|Non-Compliant|3|||
23430450|NCT02558400|65320561|FG000|Overall Study|Lost to Follow-up|5|||
23430451|NCT02558400|65320562|FG001|Overall Study|Lost to Follow-up|5|||
23430452|NCT02558400|65320563|FG002|Overall Study|Lost to Follow-up|4|||
23430453|NCT02558400|65320561|FG000|Overall Study|Lack of Efficacy|0|||
23430454|NCT02558400|65320562|FG001|Overall Study|Lack of Efficacy|13|||
23743894|NCT01519700|66439897|FG001|Overall Study|Death|0|||
23743895|NCT01519700|66439898|FG002|Overall Study|Death|0|||
23743896|NCT01519700|66439899|FG003|Overall Study|Death|0|||
23430455|NCT02558400|65320563|FG002|Overall Study|Lack of Efficacy|1|||
23430456|NCT02558400|65320561|FG000|Overall Study|Disallowed Concurrent Medication|6|||
23430457|NCT02558400|65320562|FG001|Overall Study|Disallowed Concurrent Medication|7|||
23430458|NCT02558400|65320563|FG002|Overall Study|Disallowed Concurrent Medication|5|||
23430459|NCT02558400|65320561|FG000|Overall Study|Physician Decision|2|||
23430460|NCT02558400|65320562|FG001|Overall Study|Physician Decision|2|||
23430461|NCT02558400|65320563|FG002|Overall Study|Physician Decision|0|||
23430462|NCT02558400|65320561|FG000|Overall Study|Protocol Violation|6|||
23430463|NCT02558400|65320562|FG001|Overall Study|Protocol Violation|3|||
23430464|NCT02558400|65320563|FG002|Overall Study|Protocol Violation|8|||
23430465|NCT02558400|65320561|FG000|Overall Study|Death|0|||
23430466|NCT02558400|65320562|FG001|Overall Study|Death|1|||
23430467|NCT02558400|65320563|FG002|Overall Study|Death|0|||
23430468|NCT02558400|65320561|FG000|Overall Study|Ineligible for the study|0|||
23430469|NCT02558400|65320562|FG001|Overall Study|Ineligible for the study|2|||
23430470|NCT02558400|65320563|FG002|Overall Study|Ineligible for the study|0|||
23430471|NCT02366767|65320564|FG000|Overall Study|left for home after 1 day at camp|1|||
23430472|NCT02366767|65320565|FG001|Overall Study|left for home after 1 day at camp|0|||
23430473|NCT02565810|65320567|FG000|Overall Study|Withdrawal by Subject|1|||
23430474|NCT02365285|65320570|FG000|Overall Study|Physician Decision|0|||
23430475|NCT02365285|65320571|FG001|Overall Study|Physician Decision|1|||
23430476|NCT02365285|65320572|FG002|Overall Study|Physician Decision|1|||
23430477|NCT02365285|65320573|FG003|Overall Study|Physician Decision|0|||
23430478|NCT02365285|65320570|FG000|Overall Study|Adverse Event|0|||
23430479|NCT02365285|65320571|FG001|Overall Study|Adverse Event|0|||
23430480|NCT02365285|65320572|FG002|Overall Study|Adverse Event|0|||
23430481|NCT02365285|65320573|FG003|Overall Study|Adverse Event|2|||
23430482|NCT02096263|65320574|FG000|Overall Study|Adverse Event|1|||
23430483|NCT02096263|65320575|FG001|Overall Study|Adverse Event|0|||
23430484|NCT02096263|65320576|FG002|Overall Study|Adverse Event|1|||
23430485|NCT02096263|65320574|FG000|Overall Study|Lost to Follow-up|14|||
23430486|NCT02096263|65320575|FG001|Overall Study|Lost to Follow-up|18|||
23430487|NCT02096263|65320576|FG002|Overall Study|Lost to Follow-up|15|||
23430488|NCT02096263|65320574|FG000|Overall Study|Other|7|||
23430489|NCT02096263|65320575|FG001|Overall Study|Other|9|||
23551955|NCT01380327|65747687|FG000|Overall Study|Housing situation precluded ability to k|0|||
23551956|NCT01380327|65747688|FG001|Overall Study|Housing situation precluded ability to k|0|||
23551957|NCT01380327|65747689|FG002|Overall Study|Housing situation precluded ability to k|1|||
23551958|NCT01380327|65747687|FG000|Overall Study|Questionable onset of epilepsy|0|||
23551959|NCT01380327|65747688|FG001|Overall Study|Questionable onset of epilepsy|0|||
23551960|NCT01380327|65747689|FG002|Overall Study|Questionable onset of epilepsy|1|||
23551961|NCT01563536|65747691|FG000|Overall Study|Withdrawal by Subject|0|||
23743897|NCT01519700|66439896|FG000|Overall Study|Lost to Follow-up|0|||
23743898|NCT01519700|66439897|FG001|Overall Study|Lost to Follow-up|0|||
23743899|NCT01519700|66439898|FG002|Overall Study|Lost to Follow-up|1|||
23743900|NCT01519700|66439899|FG003|Overall Study|Lost to Follow-up|1|||
23743901|NCT01519700|66439896|FG000|Overall Study|Physician Decision|1|||
23743902|NCT01519700|66439897|FG001|Overall Study|Physician Decision|1|||
23743903|NCT01519700|66439898|FG002|Overall Study|Physician Decision|3|||
23743904|NCT01519700|66439899|FG003|Overall Study|Physician Decision|0|||
23743905|NCT01519700|66439896|FG000|Overall Study|Withdrawal by Subject|5|||
23743906|NCT01519700|66439897|FG001|Overall Study|Withdrawal by Subject|3|||
23743907|NCT01519700|66439898|FG002|Overall Study|Withdrawal by Subject|3|||
23743908|NCT01519700|66439899|FG003|Overall Study|Withdrawal by Subject|2|||
23743909|NCT01519700|66439896|FG000|Overall Study|Other Reason|2|||
23743910|NCT01519700|66439897|FG001|Overall Study|Other Reason|2|||
23430490|NCT02096263|65320576|FG002|Overall Study|Other|6|||
23430491|NCT02096263|65320574|FG000|Overall Study|Sponsor study termination|0|||
23430492|NCT02096263|65320575|FG001|Overall Study|Sponsor study termination|0|||
23430493|NCT02096263|65320576|FG002|Overall Study|Sponsor study termination|1|||
23430494|NCT02096263|65320574|FG000|Overall Study|Protocol Violation|7|||
23430495|NCT02096263|65320575|FG001|Overall Study|Protocol Violation|2|||
23430496|NCT02096263|65320576|FG002|Overall Study|Protocol Violation|8|||
23430497|NCT02096263|65320574|FG000|Overall Study|Withdrawal by Subject|5|||
23430498|NCT02096263|65320575|FG001|Overall Study|Withdrawal by Subject|7|||
23743911|NCT01519700|66439898|FG002|Overall Study|Other Reason|0|||
23430499|NCT02096263|65320576|FG002|Overall Study|Withdrawal by Subject|8|||
23430500|NCT00351273|65320577|FG000|Overall Study|Lost to Follow-up|1|||
23621306|NCT04270747|66000604|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
23621307|NCT04270747|66000605|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
23621308|NCT04270747|66000606|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
23621309|NCT04270747|66000604|FG000|Post Week 16|Miscellaneous|1|||
23621310|NCT04270747|66000605|FG001|Post Week 16|Miscellaneous|0|||
23621311|NCT04270747|66000606|FG002|Post Week 16|Miscellaneous|1|||
23621312|NCT03041701|66000611|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
23621313|NCT03041701|66000612|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
23621314|NCT03041701|66000613|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
23621315|NCT03041701|66000611|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
23621316|NCT03041701|66000612|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
23621317|NCT03041701|66000613|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
23621318|NCT00874497|66000623|FG000|Overall Study|Lost to Follow-up|2|||
23621319|NCT00874497|66000624|FG001|Overall Study|Lost to Follow-up|4|||
23621320|NCT00874497|66000623|FG000|Overall Study|Adverse Event|9|||
23621321|NCT00874497|66000624|FG001|Overall Study|Adverse Event|4|||
23621322|NCT00874497|66000623|FG000|Overall Study|Sponsor Discontinued Trial|7|||
23621323|NCT00874497|66000624|FG001|Overall Study|Sponsor Discontinued Trial|3|||
23621324|NCT00874497|66000623|FG000|Overall Study|Met Withdrawal Criteria|4|||
23621325|NCT00874497|66000624|FG001|Overall Study|Met Withdrawal Criteria|2|||
23621326|NCT00874497|66000623|FG000|Overall Study|Physician Decision|1|||
23621327|NCT00874497|66000624|FG001|Overall Study|Physician Decision|1|||
23621328|NCT00874497|66000623|FG000|Overall Study|Withdrawal by Subject|5|||
23621329|NCT00874497|66000624|FG001|Overall Study|Withdrawal by Subject|4|||
23621330|NCT03811834|66000625|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
23621331|NCT01920178|66000626|FG000|Overall Study|Lost to Follow-up|2|||
23621332|NCT01920178|66000627|FG001|Overall Study|Lost to Follow-up|1|||
23621333|NCT00766142|66000635|FG000|Overall Study|Protocol Violation|4|||
23621334|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|no longer interested|1|||
23621335|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|no longer interested|0|||
23621336|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
23621337|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
23621338|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
23621339|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
23621340|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
23621341|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
23621342|NCT00745121|66000644|FG000|Overall Study|Death|3|||
23621343|NCT00745121|66000645|FG001|Overall Study|Death|0|||
23621344|NCT00745121|66000644|FG000|Overall Study|Adverse Event|1|||
23621345|NCT00745121|66000645|FG001|Overall Study|Adverse Event|0|||
23621346|NCT00745121|66000644|FG000|Overall Study|Lost to Follow-up|1|||
23621347|NCT00745121|66000645|FG001|Overall Study|Lost to Follow-up|0|||
23621348|NCT00745121|66000644|FG000|Overall Study|Withdrawal by Subject|4|||
23621349|NCT00745121|66000645|FG001|Overall Study|Withdrawal by Subject|2|||
23743912|NCT01519700|66439899|FG003|Overall Study|Other Reason|4|||
23743913|NCT02260804|66439900|FG000|Induction Study Period|Protocol Violation|2|||
23743914|NCT02260804|66439901|FG001|Induction Study Period|Protocol Violation|0|||
23743915|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
23743916|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
23743917|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
23743918|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
23743919|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
23430501|NCT00351273|65320578|FG001|Overall Study|Lost to Follow-up|2|||
23430502|NCT00351273|65320579|FG002|Overall Study|Lost to Follow-up|5|||
23743920|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
23621350|NCT00904722|66000646|FG000|Overall Study|Physician Decision|1|||
23621351|NCT01891890|66000648|FG000|Overall Study|Lost to Follow-up|0|||
23743921|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
23743922|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
23743923|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
23743924|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
23621352|NCT01891890|66000649|FG001|Overall Study|Lost to Follow-up|0|||
23621353|NCT01891890|66000650|FG002|Overall Study|Lost to Follow-up|1|||
23621354|NCT01891890|66000648|FG000|Overall Study|Study ended before endpoint reached|7|||
23621355|NCT01891890|66000649|FG001|Overall Study|Study ended before endpoint reached|3|||
23621356|NCT01891890|66000650|FG002|Overall Study|Study ended before endpoint reached|6|||
23621357|NCT00583115|66000651|FG000|Overall Study|Death|1|||
23621358|NCT04358068|66000654|FG000|Overall Study|Did not initiate study treatment|2|||
23621359|NCT04358068|66000655|FG001|Overall Study|Did not initiate study treatment|2|||
23621360|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
23621361|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
23621362|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
23621363|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
23621364|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
23621365|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
23621366|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
23621367|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
23621368|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
23621369|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
23621370|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
23621371|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
23621372|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
23621373|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
23621374|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
23621375|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
23621376|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
23621377|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
23621378|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
23621379|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
23621380|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
23621381|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
23621382|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
23621383|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
23621384|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
23621385|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
23621386|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
23621387|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
23621388|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
23621389|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621390|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621391|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621392|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
23743925|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
23743926|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
23621393|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23621394|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23743927|NCT02260804|66439900|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
23743928|NCT02260804|66439901|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
23743929|NCT02260804|66439900|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
23621395|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23621396|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
23621397|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
23621398|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
23621399|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
23621400|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
23621401|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
23621402|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
23621403|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
23743930|NCT02260804|66439901|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
23743931|NCT02260804|66439900|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
23743932|NCT02260804|66439901|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
23743933|NCT02260804|66439900|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
23743934|NCT02260804|66439901|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
23621404|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
23621405|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
23621406|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
23621407|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
23621408|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Death|2|||
23621409|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Death|0|||
23621410|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Death|1|||
23621411|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Death|0|||
23621412|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
23621413|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
23621414|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
23621415|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
23621416|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
23621417|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
23621418|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
23621419|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
23621420|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
23621421|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
23621422|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
23621423|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
23621424|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Moved|32|||
23621425|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Moved|2|||
23621426|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Moved|28|||
23621427|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Moved|0|||
23621428|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
23743935|NCT02491463|66439902|FG000|Overall Study|Withdrawal by Subject|1|||
23743936|NCT02491463|66439903|FG001|Overall Study|Withdrawal by Subject|2|||
23743937|NCT02491463|66439904|FG002|Overall Study|Withdrawal by Subject|0|||
23743938|NCT02491463|66439905|FG003|Overall Study|Withdrawal by Subject|0|||
23743939|NCT02491463|66439902|FG000|Overall Study|Migrated/moved from study area|1|||
23743940|NCT02491463|66439903|FG001|Overall Study|Migrated/moved from study area|5|||
23743941|NCT02491463|66439904|FG002|Overall Study|Migrated/moved from study area|1|||
23743942|NCT02491463|66439905|FG003|Overall Study|Migrated/moved from study area|1|||
23743943|NCT02491463|66439902|FG000|Overall Study|Lost to Follow-up|0|||
23743944|NCT02491463|66439903|FG001|Overall Study|Lost to Follow-up|3|||
23743945|NCT02491463|66439904|FG002|Overall Study|Lost to Follow-up|3|||
23551962|NCT01563536|65747692|FG001|Overall Study|Withdrawal by Subject|2|||
23551963|NCT01563536|65747691|FG000|Overall Study|Lost to Follow-up|1|||
23551964|NCT01563536|65747692|FG001|Overall Study|Lost to Follow-up|0|||
23551965|NCT00729833|65747694|FG000|Overall Study|Death|5|||
23551966|NCT00729833|65747695|FG001|Overall Study|Death|1|||
23551967|NCT00729833|65747696|FG002|Overall Study|Death|3|||
23551968|NCT00729833|65747697|FG003|Overall Study|Death|5|||
23551969|NCT00729833|65747694|FG000|Overall Study|Study Terminated by Sponsor|0|||
23551970|NCT00729833|65747695|FG001|Overall Study|Study Terminated by Sponsor|0|||
23551971|NCT00729833|65747696|FG002|Overall Study|Study Terminated by Sponsor|1|||
23551972|NCT00729833|65747697|FG003|Overall Study|Study Terminated by Sponsor|0|||
23551973|NCT00729833|65747694|FG000|Overall Study|Lost to Follow-up|1|||
23551974|NCT00729833|65747695|FG001|Overall Study|Lost to Follow-up|0|||
23551975|NCT00729833|65747696|FG002|Overall Study|Lost to Follow-up|0|||
23551976|NCT00729833|65747697|FG003|Overall Study|Lost to Follow-up|0|||
23551977|NCT00729833|65747694|FG000|Overall Study|Withdrawal by Subject|3|||
23551978|NCT00729833|65747695|FG001|Overall Study|Withdrawal by Subject|1|||
23551979|NCT00729833|65747696|FG002|Overall Study|Withdrawal by Subject|3|||
23551980|NCT00729833|65747697|FG003|Overall Study|Withdrawal by Subject|0|||
23551981|NCT00729833|65747694|FG000|Overall Study|Unspecified Reasons|11|||
23551982|NCT00729833|65747695|FG001|Overall Study|Unspecified Reasons|5|||
23551983|NCT00729833|65747696|FG002|Overall Study|Unspecified Reasons|5|||
23551984|NCT00729833|65747697|FG003|Overall Study|Unspecified Reasons|1|||
23551985|NCT01880424|65747702|FG000|Overall Study|Adverse Event|7|||
23551986|NCT01880424|65747703|FG001|Overall Study|Adverse Event|6|||
23551987|NCT01880424|65747702|FG000|Overall Study|Lack of Efficacy|1|||
23551988|NCT01880424|65747703|FG001|Overall Study|Lack of Efficacy|4|||
23551989|NCT01880424|65747702|FG000|Overall Study|Lost to Follow-up|3|||
23551990|NCT01880424|65747703|FG001|Overall Study|Lost to Follow-up|2|||
23551991|NCT01880424|65747702|FG000|Overall Study|Protocol Violation|11|||
23551992|NCT01880424|65747703|FG001|Overall Study|Protocol Violation|13|||
23743946|NCT02491463|66439905|FG003|Overall Study|Lost to Follow-up|0|||
23551993|NCT01880424|65747702|FG000|Overall Study|Withdrawal by Subject|10|||
23551994|NCT01880424|65747703|FG001|Overall Study|Withdrawal by Subject|30|||
23551995|NCT01880424|65747702|FG000|Overall Study|Other|1|||
23551996|NCT01880424|65747703|FG001|Overall Study|Other|0|||
23551997|NCT02477111|65747704|FG000|Overall Study|Death|28|||
23551998|NCT02477111|65747704|FG000|Overall Study|Withdrawal by Subject|19|||
23551999|NCT02477111|65747704|FG000|Overall Study|Lost to Follow-up|4|||
23821876|NCT02552121|66726206|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23821877|NCT02552121|66726207|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23821878|NCT02552121|66726208|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23821879|NCT02552121|66726201|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821880|NCT02552121|66726202|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
23821881|NCT02552121|66726203|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821882|NCT02552121|66726204|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821883|NCT02552121|66726205|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821884|NCT02552121|66726206|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821885|NCT02552121|66726207|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821886|NCT02552121|66726208|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23821887|NCT02552121|66726201|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821888|NCT02552121|66726202|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
23821889|NCT02552121|66726203|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821890|NCT02552121|66726204|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821891|NCT02552121|66726205|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821892|NCT02552121|66726206|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23552000|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
23552001|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
23552002|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
23552003|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552004|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552005|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552006|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552007|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552008|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552009|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552010|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552011|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552012|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552013|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552014|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
23552015|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
23552016|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
23552017|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552018|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552019|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552020|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552021|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552022|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552023|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552024|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552025|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552026|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552027|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23743947|NCT01491802|66439906|FG000|Overall Study|Adverse Event|1|||
23743948|NCT01491802|66439907|FG001|Overall Study|Adverse Event|1|||
23743949|NCT01491802|66439906|FG000|Overall Study|Withdrawal by Subject|0|||
23743950|NCT01491802|66439907|FG001|Overall Study|Withdrawal by Subject|1|||
23743951|NCT02898662|66439909|FG000|Overall Study|Adverse Event|1|||
23743952|NCT02898662|66439910|FG001|Overall Study|Adverse Event|0|||
23743953|NCT02898662|66439909|FG000|Overall Study|Loss of asthma control|23|||
23743954|NCT02898662|66439910|FG001|Overall Study|Loss of asthma control|24|||
23743955|NCT02898662|66439909|FG000|Overall Study|Withdrawal by Subject|4|||
23743956|NCT02898662|66439910|FG001|Overall Study|Withdrawal by Subject|1|||
23743957|NCT02898662|66439909|FG000|Overall Study|Technical issue|0|||
23743958|NCT02898662|66439910|FG001|Overall Study|Technical issue|1|||
23743959|NCT02898662|66439909|FG000|Overall Study|Randomized in error|0|||
23743960|NCT02898662|66439910|FG001|Overall Study|Randomized in error|1|||
23743961|NCT02898662|66439909|FG000|Overall Study|Subject decision|1|||
23743962|NCT02898662|66439910|FG001|Overall Study|Subject decision|0|||
23743963|NCT02898662|66439909|FG000|Overall Study|Other|0|||
23743964|NCT02898662|66439910|FG001|Overall Study|Other|1|||
23743965|NCT04983589|66439911|FG000|Overall Study|Withdrawal by Subject|0|||
23552028|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
23743966|NCT04983589|66439912|FG001|Overall Study|Withdrawal by Subject|3|||
23743967|NCT04983589|66439911|FG000|Overall Study|COVID-19 Infection|1|||
23743968|NCT04983589|66439912|FG001|Overall Study|COVID-19 Infection|0|||
23743969|NCT04983589|66439911|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
23743970|NCT04983589|66439912|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
23821893|NCT02552121|66726207|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821894|NCT02552121|66726208|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23821895|NCT02552121|66726201|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821896|NCT02552121|66726202|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
23821897|NCT02552121|66726203|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821898|NCT02552121|66726204|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821899|NCT02552121|66726205|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821900|NCT02552121|66726206|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821901|NCT02552121|66726207|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23743971|NCT03099096|66439913|FG000|Overall Study|Adverse Event|1|||
23743972|NCT03099096|66439913|FG000|Overall Study|Physician Decision|1|||
23743973|NCT00438815|66439914|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
23743974|NCT00438815|66439914|FG000|Overall Study|3-month follow-up no longer required|12|||
23743975|NCT00438815|66439914|FG000|Overall Study|Noncompliance with protocol requirements|9|||
23743976|NCT00438815|66439914|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
23743977|NCT00438815|66439914|FG000|Overall Study|Lost to Follow-up|6|||
23743978|NCT00438815|66439914|FG000|Overall Study|Withdrawal by Subject|6|||
23743979|NCT00438815|66439914|FG000|Overall Study|Death|1|||
23743980|NCT02539160|66439915|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
23743981|NCT02539160|66439916|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
23821902|NCT02552121|66726208|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23821903|NCT02552121|66726201|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821904|NCT02552121|66726202|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
23821905|NCT02552121|66726203|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821906|NCT02552121|66726204|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821907|NCT02552121|66726205|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821908|NCT02552121|66726206|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821909|NCT02552121|66726207|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821910|NCT02552121|66726208|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23821911|NCT02552121|66726201|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
23821912|NCT02552121|66726202|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
23621429|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
23621430|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
23621431|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
23621432|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Travel|2|||
23621433|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Travel|0|||
23621434|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Travel|0|||
23621435|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Travel|0|||
23621436|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
23743982|NCT02539160|66439917|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
23743983|NCT02539160|66439918|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
23743984|NCT02539160|66439915|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
23821913|NCT02552121|66726203|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
23821914|NCT02552121|66726204|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
23821915|NCT02552121|66726205|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
23821916|NCT02552121|66726206|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
23743985|NCT02539160|66439916|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
23743986|NCT02539160|66439917|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
23743987|NCT02539160|66439918|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
23743988|NCT02539160|66439915|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
23743989|NCT02539160|66439916|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
23743990|NCT02539160|66439917|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
23743991|NCT02539160|66439918|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
23743992|NCT00265382|66439919|FG000|Overall Study|Adverse Event|21|||
23743993|NCT00265382|66439919|FG000|Overall Study|Laboratory Abnormality|1|||
23821917|NCT02552121|66726207|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
23821918|NCT02552121|66726208|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
23821919|NCT02552121|66726201|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
23821920|NCT02552121|66726202|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
23821921|NCT02552121|66726203|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
23821922|NCT02552121|66726204|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
23821923|NCT02552121|66726205|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
23821924|NCT02552121|66726206|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
23621437|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
23621438|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
23821925|NCT02552121|66726207|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
23821926|NCT02552121|66726208|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
23621439|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
23621440|NCT00092521|66000656|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23743994|NCT00265382|66439919|FG000|Overall Study|Lost to Follow-up|3|||
23743995|NCT00265382|66439919|FG000|Overall Study|Lack of Efficacy|6|||
23743996|NCT00265382|66439919|FG000|Overall Study|Miscellaneous|6|||
23743997|NCT00265382|66439919|FG000|Overall Study|Withdrawal by Subject|13|||
23821927|NCT02552121|66726201|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
23821928|NCT02552121|66726202|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
23821929|NCT02552121|66726203|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
23821930|NCT02552121|66726204|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
23821931|NCT02552121|66726205|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
23821932|NCT02552121|66726206|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
23821933|NCT02552121|66726207|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
23821934|NCT02552121|66726208|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
23821935|NCT02552121|66726201|FG000|Part 2: Cohort Expansion|Death|0|||
23821936|NCT02552121|66726202|FG001|Part 2: Cohort Expansion|Death|0|||
23821937|NCT02552121|66726203|FG002|Part 2: Cohort Expansion|Death|1|||
23821938|NCT02552121|66726204|FG003|Part 2: Cohort Expansion|Death|0|||
23821939|NCT02552121|66726205|FG004|Part 2: Cohort Expansion|Death|0|||
23821940|NCT02552121|66726206|FG005|Part 2: Cohort Expansion|Death|0|||
23821941|NCT02552121|66726207|FG006|Part 2: Cohort Expansion|Death|0|||
23821942|NCT02552121|66726208|FG007|Part 2: Cohort Expansion|Death|0|||
23821943|NCT00993421|66726209|FG000|Overall Study|Adverse Event|2|||
23821944|NCT00993421|66726210|FG001|Overall Study|Adverse Event|7|||
23821945|NCT00993421|66726211|FG002|Overall Study|Adverse Event|6|||
23821946|NCT00993421|66726212|FG003|Overall Study|Adverse Event|9|||
23821947|NCT00993421|66726213|FG004|Overall Study|Adverse Event|5|||
23821948|NCT00993421|66726214|FG005|Overall Study|Adverse Event|7|||
23821949|NCT00993421|66726215|FG006|Overall Study|Adverse Event|1|||
23821950|NCT00993421|66726209|FG000|Overall Study|Sponsor Decision|36|||
23821951|NCT00993421|66726210|FG001|Overall Study|Sponsor Decision|31|||
23821952|NCT00993421|66726211|FG002|Overall Study|Sponsor Decision|28|||
23821953|NCT00993421|66726212|FG003|Overall Study|Sponsor Decision|30|||
23821954|NCT00993421|66726213|FG004|Overall Study|Sponsor Decision|38|||
23821955|NCT00993421|66726214|FG005|Overall Study|Sponsor Decision|30|||
23821956|NCT00993421|66726215|FG006|Overall Study|Sponsor Decision|29|||
23821957|NCT00993421|66726209|FG000|Overall Study|Lost to Follow-up|3|||
23821958|NCT00993421|66726210|FG001|Overall Study|Lost to Follow-up|5|||
23821959|NCT00993421|66726211|FG002|Overall Study|Lost to Follow-up|5|||
23821960|NCT00993421|66726212|FG003|Overall Study|Lost to Follow-up|0|||
23821961|NCT00993421|66726213|FG004|Overall Study|Lost to Follow-up|0|||
23821962|NCT00993421|66726214|FG005|Overall Study|Lost to Follow-up|0|||
23821963|NCT00993421|66726215|FG006|Overall Study|Lost to Follow-up|6|||
23821964|NCT00993421|66726209|FG000|Overall Study|Withdrawal by Subject|3|||
23821965|NCT00993421|66726210|FG001|Overall Study|Withdrawal by Subject|2|||
23821966|NCT00993421|66726211|FG002|Overall Study|Withdrawal by Subject|3|||
23821967|NCT00993421|66726212|FG003|Overall Study|Withdrawal by Subject|3|||
23821968|NCT00993421|66726213|FG004|Overall Study|Withdrawal by Subject|3|||
23821969|NCT00993421|66726214|FG005|Overall Study|Withdrawal by Subject|5|||
23821970|NCT00993421|66726215|FG006|Overall Study|Withdrawal by Subject|3|||
23821971|NCT00993421|66726209|FG000|Overall Study|Death|0|||
23821972|NCT00993421|66726210|FG001|Overall Study|Death|0|||
23821973|NCT00993421|66726211|FG002|Overall Study|Death|0|||
23821974|NCT00993421|66726212|FG003|Overall Study|Death|0|||
23821975|NCT00993421|66726213|FG004|Overall Study|Death|0|||
23743998|NCT00265382|66439919|FG000|Overall Study|Study terminated by sponsor|94|||
23743999|NCT00265382|66439919|FG000|Overall Study|Death|1|||
23744000|NCT03938857|66439927|FG000|Overall Study|Physician Decision|1|||
23744001|NCT03938857|66439928|FG001|Overall Study|Physician Decision|0|||
23744002|NCT03938857|66439929|FG002|Overall Study|Physician Decision|0|||
23744003|NCT03938857|66439930|FG003|Overall Study|Physician Decision|0|||
23744004|NCT02312934|66439931|FG000|Overall Study|Lost to Follow-up|1|||
23744005|NCT02312934|66439932|FG001|Overall Study|Lost to Follow-up|0|||
23744006|NCT02312934|66439931|FG000|Overall Study|Physician Decision|1|||
23744007|NCT02312934|66439932|FG001|Overall Study|Physician Decision|0|||
23744008|NCT04533204|66439933|FG000|Overall Study|Unable to understand training instructions|1|||
23744009|NCT04533204|66439934|FG001|Overall Study|Unable to understand training instructions|1|||
23744010|NCT00542321|66439935|FG000|Overall Study|Death|0|||
23744011|NCT00542321|66439936|FG001|Overall Study|Death|1|||
23744012|NCT02545270|66439937|FG000|Overall Study|technical difficulties|0|||
23821976|NCT00993421|66726214|FG005|Overall Study|Death|0|||
23430503|NCT03361189|65320584|FG000|Overall Study|Received heart transplant|1|||
23744013|NCT02545270|66439938|FG001|Overall Study|technical difficulties|1|||
23744014|NCT02545270|66439939|FG002|Overall Study|technical difficulties|0|||
23821977|NCT00993421|66726215|FG006|Overall Study|Death|1|||
23821978|NCT00993421|66726209|FG000|Overall Study|Entry Criteria Exclusion|0|||
23821979|NCT00993421|66726210|FG001|Overall Study|Entry Criteria Exclusion|0|||
23821980|NCT00993421|66726211|FG002|Overall Study|Entry Criteria Exclusion|1|||
23821981|NCT00993421|66726212|FG003|Overall Study|Entry Criteria Exclusion|3|||
23821982|NCT00993421|66726213|FG004|Overall Study|Entry Criteria Exclusion|0|||
23821983|NCT00993421|66726214|FG005|Overall Study|Entry Criteria Exclusion|1|||
23744015|NCT02545270|66439937|FG000|Overall Study|Videos being too similar to other|0|||
23821984|NCT00993421|66726215|FG006|Overall Study|Entry Criteria Exclusion|0|||
23821985|NCT00993421|66726209|FG000|Overall Study|Physician Decision|0|||
23821986|NCT00993421|66726210|FG001|Overall Study|Physician Decision|0|||
23821987|NCT00993421|66726211|FG002|Overall Study|Physician Decision|0|||
23821988|NCT00993421|66726212|FG003|Overall Study|Physician Decision|0|||
23821989|NCT00993421|66726213|FG004|Overall Study|Physician Decision|0|||
23821990|NCT00993421|66726214|FG005|Overall Study|Physician Decision|1|||
23821991|NCT00993421|66726215|FG006|Overall Study|Physician Decision|1|||
23821992|NCT00993421|66726209|FG000|Overall Study|Protocol Violation|0|||
23430504|NCT03361189|65320585|FG001|Overall Study|Received heart transplant|0|||
23552029|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
23621441|NCT00092521|66000657|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23621442|NCT00092521|66000658|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23621443|NCT00092521|66000659|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
23621444|NCT00092521|66000656|FG000|Extension Study (Group 4)|Adverse Event|0|||
23621445|NCT00092521|66000657|FG001|Extension Study (Group 4)|Adverse Event|0|||
23621446|NCT00092521|66000658|FG002|Extension Study (Group 4)|Adverse Event|0|||
23621447|NCT00092521|66000659|FG003|Extension Study (Group 4)|Adverse Event|2|||
23621448|NCT00092521|66000656|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
23744016|NCT02545270|66439938|FG001|Overall Study|Videos being too similar to other|0|||
23744017|NCT02545270|66439939|FG002|Overall Study|Videos being too similar to other|2|||
23744018|NCT01858701|66439940|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
23744019|NCT01858701|66439941|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
23552030|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
23552031|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552032|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552033|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552034|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552035|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552036|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552037|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552038|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552039|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552040|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552041|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552042|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
23621449|NCT00092521|66000657|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
23744020|NCT01858701|66439940|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
23744021|NCT01858701|66439941|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
23744022|NCT01858701|66439940|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
23744023|NCT01858701|66439941|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
23744024|NCT01858701|66439940|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
23744025|NCT01858701|66439941|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
23744026|NCT00834366|66439942|FG000|Treatment Period 1|Adverse Event|1|||
23744027|NCT00834366|66439943|FG001|Treatment Period 1|Adverse Event|1|||
23744028|NCT03802331|66439944|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
23744029|NCT03802331|66439945|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
23744030|NCT04524663|66439946|FG000|Overall Study|Withdrawal by Subject|0|||
23744031|NCT04524663|66439947|FG001|Overall Study|Withdrawal by Subject|2|||
23744032|NCT00483119|66439954|FG000|Overall Study|Adverse Event|0|||
23744033|NCT00483119|66439955|FG001|Overall Study|Adverse Event|1|||
23744034|NCT00483119|66439954|FG000|Overall Study|Physician Decision|1|||
23744035|NCT00483119|66439955|FG001|Overall Study|Physician Decision|0|||
23744036|NCT00690612|66439956|FG000|Overall Study|Adverse Event|1|||
23744037|NCT00690612|66439956|FG000|Overall Study|Withdrawal by Subject|2|||
23744038|NCT01161173|66439957|FG000|Overall Study|Protocol Violation|13|||
23744039|NCT01161173|66439957|FG000|Overall Study|Lost to Follow-up|7|||
23744040|NCT01161173|66439957|FG000|Overall Study|Progressive Disease|82|||
23744041|NCT01161173|66439957|FG000|Overall Study|Withdrawal of Consent|5|||
23744042|NCT01161173|66439957|FG000|Overall Study|Unacceptable Toxicity|21|||
23744043|NCT01161173|66439957|FG000|Overall Study|Death|194|||
23744044|NCT01161173|66439957|FG000|Overall Study|End of Study|2|||
23744045|NCT01161173|66439957|FG000|Overall Study|Reasons Not Specified|23|||
23744046|NCT00761891|66439958|FG000|Overall Study|Withdrawal by Subject|10|||
23744047|NCT01303159|66443141|FG000|Overall Study|Death|16|||
23744048|NCT01303159|66443141|FG000|Overall Study|Study Termination|7|||
23744049|NCT00429026|66443142|FG000|Overall Study|Inevaluable for response.|40|||
23744050|NCT01590628|66443143|FG000|Overall Study|Death|2|||
23744051|NCT01590628|66443144|FG001|Overall Study|Death|0|||
23821993|NCT00993421|66726210|FG001|Overall Study|Protocol Violation|0|||
23744052|NCT02059265|66443145|FG000|Overall Study|Ineligible|4|||
23744053|NCT00726882|66443146|FG000|Overall Study|Withdrawal by Subject|5|||
23821994|NCT00993421|66726211|FG002|Overall Study|Protocol Violation|0|||
23821995|NCT00993421|66726212|FG003|Overall Study|Protocol Violation|0|||
23430505|NCT03361189|65320584|FG000|Overall Study|Pacemake replacement|0|||
23621450|NCT00092521|66000658|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
23621451|NCT00092521|66000659|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
23621452|NCT00092521|66000656|FG000|Extension Study (Group 4)|Pregnancy|0|||
23621453|NCT00092521|66000657|FG001|Extension Study (Group 4)|Pregnancy|0|||
23621454|NCT00092521|66000658|FG002|Extension Study (Group 4)|Pregnancy|0|||
23621455|NCT00092521|66000659|FG003|Extension Study (Group 4)|Pregnancy|4|||
23621456|NCT00092521|66000656|FG000|Extension Study (Group 4)|Protocol Violation|0|||
23621457|NCT00092521|66000657|FG001|Extension Study (Group 4)|Protocol Violation|0|||
23621458|NCT00092521|66000658|FG002|Extension Study (Group 4)|Protocol Violation|0|||
23621459|NCT00092521|66000659|FG003|Extension Study (Group 4)|Protocol Violation|2|||
23621460|NCT00092521|66000656|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621461|NCT00092521|66000657|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621462|NCT00092521|66000658|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621463|NCT00092521|66000659|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
23621464|NCT00092521|66000656|FG000|Extension Study (Group 4)|Moved|0|||
23621465|NCT00092521|66000657|FG001|Extension Study (Group 4)|Moved|0|||
23621466|NCT00092521|66000658|FG002|Extension Study (Group 4)|Moved|0|||
23621467|NCT00092521|66000659|FG003|Extension Study (Group 4)|Moved|16|||
23621468|NCT00092521|66000656|FG000|Extension Study (Group 4)|Site Terminated|0|||
23621469|NCT00092521|66000657|FG001|Extension Study (Group 4)|Site Terminated|0|||
23621470|NCT00092521|66000658|FG002|Extension Study (Group 4)|Site Terminated|0|||
23621471|NCT00092521|66000659|FG003|Extension Study (Group 4)|Site Terminated|4|||
23621472|NCT00092521|66000656|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621473|NCT00092521|66000657|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621474|NCT00092521|66000658|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621475|NCT00092521|66000659|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
23621476|NCT00225277|66000662|FG000|Overall Study|Adverse Event|30|||
23621477|NCT00225277|66000663|FG001|Overall Study|Adverse Event|34|||
23621478|NCT00225277|66000662|FG000|Overall Study|Lack of Efficacy|4|||
23621479|NCT00225277|66000663|FG001|Overall Study|Lack of Efficacy|1|||
23621480|NCT00225277|66000662|FG000|Overall Study|Lost to Follow-up|4|||
23621481|NCT00225277|66000663|FG001|Overall Study|Lost to Follow-up|6|||
23621482|NCT00225277|66000662|FG000|Overall Study|Physician Decision|6|||
23621483|NCT00225277|66000663|FG001|Overall Study|Physician Decision|8|||
23621484|NCT00225277|66000662|FG000|Overall Study|Protocol Violation|6|||
23621485|NCT00225277|66000663|FG001|Overall Study|Protocol Violation|3|||
23621486|NCT00225277|66000662|FG000|Overall Study|Withdrawal by Subject|40|||
23621487|NCT00225277|66000663|FG001|Overall Study|Withdrawal by Subject|34|||
23621488|NCT00225277|66000662|FG000|Overall Study|Other|7|||
23621489|NCT00225277|66000663|FG001|Overall Study|Other|9|||
23621490|NCT04191148|66000664|FG000|Overall Study|Withdrawal by Subject|1|||
23621491|NCT04191148|66000665|FG001|Overall Study|Withdrawal by Subject|0|||
23621492|NCT04191148|66000664|FG000|Overall Study|Adverse Event|1|||
23621493|NCT04191148|66000665|FG001|Overall Study|Adverse Event|0|||
23621494|NCT04531813|66000666|FG000|Overall Study|Protocol Violation|1|||
23621495|NCT04531813|66000666|FG000|Overall Study|Withdrawal by Subject|1|||
23621496|NCT02230306|66000672|FG000|Overall Study|Did not receive study treatment|1|||
23621497|NCT03036150|66000680|FG000|Overall Study|Withdrawal by Subject|8|||
23621498|NCT03036150|66000681|FG001|Overall Study|Withdrawal by Subject|3|||
23621499|NCT03036150|66000680|FG000|Overall Study|Lost to Follow-up|2|||
23621500|NCT03036150|66000681|FG001|Overall Study|Lost to Follow-up|2|||
23621501|NCT02330562|66000682|FG000|Overall Study|Adverse Event|0|||
23621502|NCT02330562|66000683|FG001|Overall Study|Adverse Event|0|||
23621503|NCT02330562|66000684|FG002|Overall Study|Adverse Event|3|||
23744054|NCT00726882|66443146|FG000|Overall Study|Lost to Follow-up|7|||
23744055|NCT00726882|66443146|FG000|Overall Study|Other|10|||
23744056|NCT01473602|66443147|FG000|Overall Study|Adverse Event|1|||
23744057|NCT01473602|66443148|FG001|Overall Study|Adverse Event|2|||
23621504|NCT02330562|66000685|FG003|Overall Study|Adverse Event|0|||
23621505|NCT02330562|66000686|FG004|Overall Study|Adverse Event|3|||
23621506|NCT02330562|66000687|FG005|Overall Study|Adverse Event|1|||
23621507|NCT02330562|66000688|FG006|Overall Study|Adverse Event|0|||
23621508|NCT02330562|66000689|FG007|Overall Study|Adverse Event|0|||
23744058|NCT01473602|66443147|FG000|Overall Study|Death|0|||
23744059|NCT01473602|66443148|FG001|Overall Study|Death|1|||
23744060|NCT01473602|66443147|FG000|Overall Study|Lost to Follow-up|1|||
23744061|NCT01473602|66443148|FG001|Overall Study|Lost to Follow-up|1|||
23621509|NCT02330562|66000690|FG008|Overall Study|Adverse Event|0|||
23621510|NCT02330562|66000691|FG009|Overall Study|Adverse Event|1|||
23621511|NCT02330562|66000692|FG010|Overall Study|Adverse Event|1|||
23621512|NCT02330562|66000682|FG000|Overall Study|Participant decision|1|||
23621513|NCT02330562|66000683|FG001|Overall Study|Participant decision|0|||
23621514|NCT02330562|66000684|FG002|Overall Study|Participant decision|4|||
23621515|NCT02330562|66000685|FG003|Overall Study|Participant decision|1|||
23621516|NCT02330562|66000686|FG004|Overall Study|Participant decision|5|||
23621517|NCT02330562|66000687|FG005|Overall Study|Participant decision|2|||
23621518|NCT02330562|66000688|FG006|Overall Study|Participant decision|0|||
23621519|NCT02330562|66000689|FG007|Overall Study|Participant decision|0|||
23621520|NCT02330562|66000690|FG008|Overall Study|Participant decision|0|||
23621521|NCT02330562|66000691|FG009|Overall Study|Participant decision|3|||
23621522|NCT02330562|66000692|FG010|Overall Study|Participant decision|0|||
23621523|NCT02330562|66000682|FG000|Overall Study|Disease progression|5|||
23621524|NCT02330562|66000683|FG001|Overall Study|Disease progression|3|||
23621525|NCT02330562|66000684|FG002|Overall Study|Disease progression|20|||
23621526|NCT02330562|66000685|FG003|Overall Study|Disease progression|28|||
23621527|NCT02330562|66000686|FG004|Overall Study|Disease progression|23|||
23621528|NCT02330562|66000687|FG005|Overall Study|Disease progression|7|||
23621529|NCT02330562|66000688|FG006|Overall Study|Disease progression|1|||
23621530|NCT02330562|66000689|FG007|Overall Study|Disease progression|1|||
23621531|NCT02330562|66000690|FG008|Overall Study|Disease progression|1|||
23621532|NCT02330562|66000691|FG009|Overall Study|Disease progression|0|||
23621533|NCT02330562|66000692|FG010|Overall Study|Disease progression|5|||
23621534|NCT02330562|66000682|FG000|Overall Study|Other reasons|0|||
23621535|NCT02330562|66000683|FG001|Overall Study|Other reasons|0|||
23621536|NCT02330562|66000684|FG002|Overall Study|Other reasons|0|||
23621537|NCT02330562|66000685|FG003|Overall Study|Other reasons|1|||
23621538|NCT02330562|66000686|FG004|Overall Study|Other reasons|0|||
23744062|NCT01473602|66443147|FG000|Overall Study|Withdrawal by Subject|5|||
23744063|NCT01473602|66443148|FG001|Overall Study|Withdrawal by Subject|4|||
23744064|NCT01473602|66443147|FG000|Overall Study|Physician Decision|1|||
23744065|NCT01473602|66443148|FG001|Overall Study|Physician Decision|0|||
23744066|NCT01911546|66443149|FG000|Overall Study|Lost to Follow-up|1|||
23744067|NCT01911546|66443149|FG000|Overall Study|Everolimus was discontinued|5|||
23744068|NCT03193996|66443156|FG000|Overall Study|Withdrawal by Subject|4|||
23744069|NCT03193996|66443156|FG000|Overall Study|Lost to Follow-up|4|||
23744070|NCT03193996|66443156|FG000|Overall Study|Physician Decision|2|||
23744071|NCT03193996|66443156|FG000|Overall Study|Pregnancy|1|||
23744072|NCT03193996|66443156|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
23744073|NCT03193996|66443156|FG000|Overall Study|Complicating disease|1|||
23744074|NCT01302366|66443160|FG000|Overall Study|patient choice or noncompliance|5|||
23744075|NCT02283411|66443161|FG000|Overall Study|Withdrawal by Subject|3|||
23744076|NCT02283411|66443161|FG000|Overall Study|Screen Failed|28|||
23744077|NCT01589185|66443162|FG000|Overall Study|Death|1|||
23744078|NCT01589185|66443163|FG001|Overall Study|Death|2|||
23744079|NCT01589185|66443164|FG002|Overall Study|Death|2|||
23744080|NCT01589185|66443165|FG003|Overall Study|Death|0|||
23552043|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
23552044|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
23552045|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552046|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552047|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552048|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552049|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552050|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552051|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552052|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552053|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552054|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552055|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552056|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552057|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
23552058|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
23552059|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552060|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552061|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552062|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552063|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23621539|NCT02330562|66000687|FG005|Overall Study|Other reasons|0|||
23621540|NCT02330562|66000688|FG006|Overall Study|Other reasons|0|||
23621541|NCT02330562|66000689|FG007|Overall Study|Other reasons|0|||
23621542|NCT02330562|66000690|FG008|Overall Study|Other reasons|0|||
23621543|NCT02330562|66000691|FG009|Overall Study|Other reasons|0|||
23621544|NCT02330562|66000692|FG010|Overall Study|Other reasons|0|||
23621545|NCT02330562|66000682|FG000|Overall Study|Withdrawal by Subject|0|||
23744081|NCT01589185|66443166|FG004|Overall Study|Death|1|||
23744082|NCT01589185|66443162|FG000|Overall Study|Lost to Follow-up|1|||
23744083|NCT01589185|66443163|FG001|Overall Study|Lost to Follow-up|0|||
23744084|NCT01589185|66443164|FG002|Overall Study|Lost to Follow-up|2|||
23744085|NCT01589185|66443165|FG003|Overall Study|Lost to Follow-up|3|||
23744086|NCT01589185|66443166|FG004|Overall Study|Lost to Follow-up|0|||
23744087|NCT04563845|66443167|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744088|NCT04563845|66443168|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744089|NCT04563845|66443169|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744090|NCT04563845|66443170|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744091|NCT04563845|66443171|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744092|NCT04563845|66443172|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744093|NCT04563845|66443173|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744094|NCT04563845|66443174|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
23744095|NCT04563845|66443175|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744096|NCT04563845|66443176|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744097|NCT04563845|66443177|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23552064|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552065|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552066|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552067|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552068|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552069|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552070|NCT02349295|65747705|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
23552071|NCT02349295|65747706|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
23552072|NCT02349295|65747707|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
23552073|NCT02349295|65747708|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
23552074|NCT02349295|65747709|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
23552075|NCT02349295|65747710|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
23744098|NCT04563845|66443178|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744099|NCT04563845|66443179|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744100|NCT04563845|66443180|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23744101|NCT04563845|66443167|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744102|NCT04563845|66443168|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744103|NCT04563845|66443169|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744104|NCT04563845|66443170|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744105|NCT04563845|66443171|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
23744106|NCT04563845|66443172|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744107|NCT04563845|66443173|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744108|NCT04563845|66443174|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744109|NCT04563845|66443175|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744110|NCT04563845|66443176|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744111|NCT04563845|66443177|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744112|NCT04563845|66443178|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744113|NCT04563845|66443179|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744114|NCT04563845|66443180|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23744115|NCT04052425|66443185|FG000|24-Week Double-blind Period|Adverse Event|0|||
23744116|NCT04052425|66443186|FG001|24-Week Double-blind Period|Adverse Event|1|||
23744117|NCT04052425|66443187|FG002|24-Week Double-blind Period|Adverse Event|0|||
23744118|NCT04052425|66443188|FG003|24-Week Double-blind Period|Adverse Event|0|||
23744119|NCT04052425|66443185|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
23744120|NCT04052425|66443186|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
23744121|NCT04052425|66443187|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
23744122|NCT04052425|66443188|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
23744123|NCT04052425|66443185|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
23744124|NCT04052425|66443186|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
23744125|NCT04052425|66443187|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
23744126|NCT04052425|66443188|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
23744127|NCT04052425|66443185|FG000|24-Week Double-blind Period|Physician Decision|1|||
23744128|NCT04052425|66443186|FG001|24-Week Double-blind Period|Physician Decision|0|||
23744129|NCT04052425|66443187|FG002|24-Week Double-blind Period|Physician Decision|0|||
23744130|NCT04052425|66443188|FG003|24-Week Double-blind Period|Physician Decision|0|||
23744131|NCT04052425|66443185|FG000|24-Week Double-blind Period|Protocol Violation|1|||
23744132|NCT04052425|66443186|FG001|24-Week Double-blind Period|Protocol Violation|0|||
23744133|NCT04052425|66443187|FG002|24-Week Double-blind Period|Protocol Violation|0|||
23744134|NCT04052425|66443188|FG003|24-Week Double-blind Period|Protocol Violation|0|||
23744135|NCT04052425|66443185|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
23744136|NCT04052425|66443186|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
23821996|NCT00993421|66726213|FG004|Overall Study|Protocol Violation|0|||
23744137|NCT04052425|66443187|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
23744138|NCT04052425|66443188|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
23821997|NCT00993421|66726214|FG005|Overall Study|Protocol Violation|2|||
23744139|NCT04052425|66443185|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
23552076|NCT02349295|65747711|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
23430506|NCT03361189|65320585|FG001|Overall Study|Pacemake replacement|1|||
23430507|NCT01977690|65320588|FG000|Overall Study|Withdrawal by Subject|0|||
23430508|NCT01977690|65320589|FG001|Overall Study|Withdrawal by Subject|4|||
23430509|NCT03582813|65320590|FG000|Overall Study|Lost to Follow-up|18|||
23430510|NCT03582813|65320591|FG001|Overall Study|Lost to Follow-up|21|||
23430511|NCT03582813|65320590|FG000|Overall Study|Withdrawal by Subject|1|||
23430512|NCT03582813|65320591|FG001|Overall Study|Withdrawal by Subject|0|||
23430513|NCT02760810|65320596|FG000|Overall Study|Protocol Violation|1|||
23430514|NCT02976103|65320601|FG000|Overall Study|Withdrawal by Subject|1|||
23430515|NCT02976103|65320602|FG001|Overall Study|Withdrawal by Subject|0|||
23430516|NCT02976103|65320601|FG000|Overall Study|Lost to Follow-up|12|||
23552077|NCT02349295|65747712|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
23552078|NCT02349295|65747713|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
23552079|NCT02349295|65747714|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
23552080|NCT02349295|65747715|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
23552081|NCT02349295|65747716|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
23552082|NCT02349295|65747717|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
23552083|NCT02349295|65747718|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
23552084|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552085|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552086|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552087|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552088|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552089|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552090|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552091|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
23552092|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
23552093|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
23552094|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
23552095|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552096|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552097|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552098|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552099|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552100|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552101|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552102|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552103|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552104|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552105|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
23552106|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
23552107|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
23552108|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
23552109|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552110|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552111|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552112|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552113|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552114|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552115|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552116|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552117|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552118|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552119|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
23552120|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552121|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
23552122|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552123|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552124|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552125|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552126|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
23552127|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
23552128|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
23744140|NCT04052425|66443186|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23430517|NCT02976103|65320602|FG001|Overall Study|Lost to Follow-up|8|||
23552129|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
23430518|NCT00758589|65320603|FG000|Overall Study|Adverse Event|3|||
23430519|NCT00758589|65320604|FG001|Overall Study|Adverse Event|2|||
23430520|NCT00758589|65320605|FG002|Overall Study|Adverse Event|5|||
23744141|NCT04052425|66443187|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23744142|NCT04052425|66443188|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23744143|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
23744144|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
23744145|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
23744146|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
23744147|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23744148|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23744149|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
23744150|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23744151|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23744152|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23744153|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
23744154|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
23744155|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
23744156|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
23744157|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
23744158|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
23744159|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23744160|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23744161|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
23744162|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
23744163|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23744164|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23744165|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
23744166|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23744167|NCT04052425|66443185|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
23744168|NCT04052425|66443186|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
23744169|NCT04052425|66443187|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
23744170|NCT04052425|66443188|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
23744171|NCT02369874|66443189|FG000|Overall Study|Lost to Follow-up|2|||
23744172|NCT02369874|66443190|FG001|Overall Study|Lost to Follow-up|2|||
23744173|NCT02369874|66443191|FG002|Overall Study|Lost to Follow-up|2|||
23744174|NCT02369874|66443189|FG000|Overall Study|Withdrawal by Subject|7|||
23744175|NCT02369874|66443190|FG001|Overall Study|Withdrawal by Subject|9|||
23744176|NCT02369874|66443191|FG002|Overall Study|Withdrawal by Subject|27|||
23744177|NCT02369874|66443189|FG000|Overall Study|Miscellaneous|1|||
23744178|NCT02369874|66443190|FG001|Overall Study|Miscellaneous|1|||
23744179|NCT02369874|66443191|FG002|Overall Study|Miscellaneous|0|||
23744180|NCT02369874|66443189|FG000|Overall Study|On Treatment/Off Study|34|||
23744181|NCT02369874|66443190|FG001|Overall Study|On Treatment/Off Study|45|||
23744182|NCT02369874|66443191|FG002|Overall Study|On Treatment/Off Study|32|||
23744183|NCT01539512|66443192|FG000|Overall Study|Adverse Event|9|||
23744184|NCT01539512|66443193|FG001|Overall Study|Adverse Event|7|||
23744185|NCT01539512|66443192|FG000|Overall Study|Physician Decision|1|||
23744186|NCT01539512|66443193|FG001|Overall Study|Physician Decision|1|||
23744187|NCT01539512|66443192|FG000|Overall Study|Withdrawal by Subject|12|||
23744188|NCT01539512|66443193|FG001|Overall Study|Withdrawal by Subject|5|||
23744189|NCT01539512|66443192|FG000|Overall Study|Richter's Transformation|1|||
23744190|NCT01539512|66443193|FG001|Overall Study|Richter's Transformation|0|||
23744191|NCT03426995|66443194|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744192|NCT03426995|66443195|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744193|NCT03426995|66443196|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
23744194|NCT03426995|66443197|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744195|NCT03426995|66443198|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744196|NCT03426995|66443199|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744197|NCT03426995|66443200|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744198|NCT03426995|66443201|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744199|NCT03426995|66443202|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744200|NCT03426995|66443203|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744201|NCT03426995|66443204|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744202|NCT03426995|66443205|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744203|NCT03426995|66443206|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744204|NCT03426995|66443207|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744205|NCT03426995|66443208|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744206|NCT03426995|66443209|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744207|NCT03426995|66443210|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744208|NCT03426995|66443211|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744209|NCT03426995|66443212|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23744210|NCT03426995|66443194|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744211|NCT03426995|66443195|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744212|NCT03426995|66443196|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744213|NCT03426995|66443197|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744214|NCT03426995|66443198|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744215|NCT03426995|66443199|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
23744216|NCT03426995|66443200|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744217|NCT03426995|66443201|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744218|NCT03426995|66443202|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744219|NCT03426995|66443203|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744220|NCT03426995|66443204|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744221|NCT03426995|66443205|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744222|NCT03426995|66443206|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744223|NCT03426995|66443207|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744224|NCT03426995|66443208|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744225|NCT03426995|66443209|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744226|NCT03426995|66443210|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744227|NCT03426995|66443211|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744228|NCT03426995|66443212|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23744229|NCT03426995|66443194|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744230|NCT03426995|66443195|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744231|NCT03426995|66443196|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744232|NCT03426995|66443197|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744233|NCT03426995|66443198|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
23744234|NCT03426995|66443199|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
23744235|NCT03426995|66443200|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744236|NCT03426995|66443201|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744237|NCT03426995|66443202|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744238|NCT03426995|66443203|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744239|NCT03426995|66443204|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744240|NCT03426995|66443205|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744241|NCT03426995|66443206|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744242|NCT03426995|66443207|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744243|NCT03426995|66443208|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23552130|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
23552131|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
23552132|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
23552133|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
23552134|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
23552135|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
23552136|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
23552137|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
23552138|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
23552139|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
23552140|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552141|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552142|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552143|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552144|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552145|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23744244|NCT03426995|66443209|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744245|NCT03426995|66443210|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744246|NCT03426995|66443211|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744247|NCT03426995|66443212|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23744248|NCT03426995|66443194|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744249|NCT03426995|66443195|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744250|NCT03426995|66443196|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744251|NCT03426995|66443197|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744252|NCT03426995|66443198|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744253|NCT03426995|66443199|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23552146|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23744254|NCT03426995|66443200|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23552147|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
23744255|NCT03426995|66443201|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744256|NCT03426995|66443202|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744257|NCT03426995|66443203|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744258|NCT03426995|66443204|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
23744259|NCT03426995|66443205|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744260|NCT03426995|66443206|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744261|NCT03426995|66443207|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744262|NCT03426995|66443208|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744263|NCT03426995|66443209|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744264|NCT03426995|66443210|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744265|NCT03426995|66443211|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744266|NCT03426995|66443212|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23744267|NCT03426995|66443194|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744268|NCT03426995|66443195|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744269|NCT03426995|66443196|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744270|NCT03426995|66443197|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744271|NCT03426995|66443198|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744272|NCT03426995|66443199|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744273|NCT03426995|66443200|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744274|NCT03426995|66443201|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
23744275|NCT03426995|66443202|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744276|NCT03426995|66443203|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744277|NCT03426995|66443204|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744278|NCT03426995|66443205|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744279|NCT03426995|66443206|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744280|NCT03426995|66443207|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744281|NCT03426995|66443208|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744282|NCT03426995|66443209|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744283|NCT03426995|66443210|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744284|NCT03426995|66443211|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23552148|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
23552149|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
23552150|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
23552151|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552152|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552153|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552154|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552155|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552156|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552157|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552158|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552159|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552160|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552161|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
23552162|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
23552163|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552164|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552165|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552166|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23744285|NCT03426995|66443212|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23744286|NCT03426995|66443194|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744287|NCT03426995|66443195|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744288|NCT03426995|66443196|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744289|NCT03426995|66443197|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744290|NCT03426995|66443198|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744291|NCT03426995|66443199|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744292|NCT03426995|66443200|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744293|NCT03426995|66443201|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744294|NCT03426995|66443202|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23821998|NCT00993421|66726215|FG006|Overall Study|Protocol Violation|1|||
23821999|NCT01862484|66726216|FG000|Overall Study|Lack of Efficacy|1|||
23552167|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552168|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552169|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552170|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552171|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552172|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552173|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23744295|NCT03426995|66443203|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744296|NCT03426995|66443204|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744297|NCT03426995|66443205|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744298|NCT03426995|66443206|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744299|NCT03426995|66443207|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744300|NCT03426995|66443208|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
23744301|NCT03426995|66443209|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
23744302|NCT03426995|66443210|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744303|NCT03426995|66443211|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744304|NCT03426995|66443212|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23744305|NCT03426995|66443194|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744306|NCT03426995|66443195|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23430521|NCT00758589|65320606|FG003|Overall Study|Adverse Event|4|||
23430522|NCT00758589|65320603|FG000|Overall Study|Withdrawal by Subject|0|||
23552174|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552175|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
23552176|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
23552177|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552178|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552179|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552180|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552181|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552182|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552183|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552184|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552185|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552186|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552187|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552188|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552189|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23430523|NCT00758589|65320604|FG001|Overall Study|Withdrawal by Subject|1|||
23430524|NCT00758589|65320605|FG002|Overall Study|Withdrawal by Subject|1|||
23552190|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552191|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552192|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552193|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
23744307|NCT03426995|66443196|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744308|NCT03426995|66443197|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744309|NCT03426995|66443198|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744310|NCT03426995|66443199|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744311|NCT03426995|66443200|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744312|NCT03426995|66443201|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23822000|NCT01862484|66726217|FG001|Overall Study|Lack of Efficacy|1|||
23822001|NCT01862484|66726216|FG000|Overall Study|Lost to Follow-up|1|||
23430525|NCT00758589|65320606|FG003|Overall Study|Withdrawal by Subject|1|||
23430526|NCT00758589|65320603|FG000|Overall Study|Palm stopped to work|0|||
23430527|NCT00758589|65320604|FG001|Overall Study|Palm stopped to work|0|||
23430528|NCT00758589|65320605|FG002|Overall Study|Palm stopped to work|0|||
23430529|NCT00758589|65320606|FG003|Overall Study|Palm stopped to work|1|||
23430530|NCT00286221|65320607|FG000|Overall Study|Protocol Violation|2|||
23430531|NCT00286221|65320608|FG001|Overall Study|Protocol Violation|1|||
23430532|NCT00286221|65320609|FG002|Overall Study|Protocol Violation|6|||
23430533|NCT00286221|65320610|FG003|Overall Study|Protocol Violation|4|||
23430534|NCT00286221|65320607|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
23430535|NCT00286221|65320608|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
23552194|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
23552195|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
23552196|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552197|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552198|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552199|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430536|NCT00286221|65320609|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
23822002|NCT01862484|66726217|FG001|Overall Study|Lost to Follow-up|2|||
23430537|NCT00286221|65320610|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
23744313|NCT03426995|66443202|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744314|NCT03426995|66443203|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744315|NCT03426995|66443204|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744316|NCT03426995|66443205|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744317|NCT03426995|66443206|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744318|NCT03426995|66443207|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744319|NCT03426995|66443208|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
23744320|NCT03426995|66443209|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
23822003|NCT01862484|66726216|FG000|Overall Study|Protocol Violation|0|||
23430538|NCT00286221|65320607|FG000|Overall Study|Inability to trigger PCA|2|||
23430539|NCT00286221|65320608|FG001|Overall Study|Inability to trigger PCA|0|||
23430540|NCT00286221|65320609|FG002|Overall Study|Inability to trigger PCA|0|||
23430541|NCT00286221|65320610|FG003|Overall Study|Inability to trigger PCA|0|||
23430542|NCT00286221|65320607|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
23430543|NCT00286221|65320608|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
23430544|NCT00286221|65320609|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
23430545|NCT00286221|65320610|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
23430546|NCT02434328|65320611|FG000|Overall Study|Adverse Event|9|||
23430547|NCT02434328|65320612|FG001|Overall Study|Adverse Event|4|||
23430548|NCT02434328|65320611|FG000|Overall Study|Lack of Efficacy|0|||
23552200|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430549|NCT02434328|65320612|FG001|Overall Study|Lack of Efficacy|2|||
23430550|NCT02434328|65320611|FG000|Overall Study|Physician Decision|0|||
23430551|NCT02434328|65320612|FG001|Overall Study|Physician Decision|1|||
23430552|NCT02434328|65320611|FG000|Overall Study|Withdrawal by Subject|12|||
23430553|NCT02434328|65320612|FG001|Overall Study|Withdrawal by Subject|21|||
23430554|NCT02434328|65320611|FG000|Overall Study|Death|4|||
23430555|NCT02434328|65320612|FG001|Overall Study|Death|7|||
23430556|NCT02434328|65320611|FG000|Overall Study|Lost to Follow-up|1|||
23430557|NCT02434328|65320612|FG001|Overall Study|Lost to Follow-up|6|||
23430558|NCT02434328|65320611|FG000|Overall Study|Other|4|||
23430559|NCT02434328|65320612|FG001|Overall Study|Other|1|||
23430560|NCT03743064|65320613|FG000|Overall Study|Adverse Event|7|||
23430561|NCT03743064|65320614|FG001|Overall Study|Adverse Event|9|||
23430562|NCT03743064|65320613|FG000|Overall Study|Death|25|||
23430563|NCT03743064|65320614|FG001|Overall Study|Death|28|||
23430564|NCT03743064|65320613|FG000|Overall Study|Lost to Follow-up|3|||
23430565|NCT03743064|65320614|FG001|Overall Study|Lost to Follow-up|6|||
23430566|NCT03743064|65320613|FG000|Overall Study|Withdrawal by Subject|28|||
23430567|NCT03743064|65320614|FG001|Overall Study|Withdrawal by Subject|25|||
23430568|NCT03743064|65320613|FG000|Overall Study|Physician Decision|2|||
23430569|NCT03743064|65320614|FG001|Overall Study|Physician Decision|4|||
23430570|NCT03743064|65320613|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
23430571|NCT03743064|65320614|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
23430572|NCT00514020|65320615|FG000|Overall Study|Adverse Event|6|||
23430573|NCT00514020|65320615|FG000|Overall Study|Withdrawal by Subject|3|||
23430574|NCT00514020|65320615|FG000|Overall Study|Physician Decision|1|||
23430575|NCT00514020|65320615|FG000|Overall Study|disease progression|9|||
23430576|NCT00514020|65320615|FG000|Overall Study|other complicating disease|2|||
23430577|NCT00514020|65320615|FG000|Overall Study|patient went to radiation treatment|1|||
23430578|NCT00514020|65320615|FG000|Overall Study|"patients moved to the no tx group"|6|||
23430579|NCT00162266|65320618|FG000|Double-Blind Period|Adverse Event|5|||
23430580|NCT00162266|65320619|FG001|Double-Blind Period|Adverse Event|9|||
23430581|NCT00162266|65320620|FG002|Double-Blind Period|Adverse Event|11|||
23430582|NCT00162266|65320621|FG003|Double-Blind Period|Adverse Event|0|||
23430583|NCT00162266|65320618|FG000|Double-Blind Period|Death|0|||
23430584|NCT00162266|65320619|FG001|Double-Blind Period|Death|1|||
23430585|NCT00162266|65320620|FG002|Double-Blind Period|Death|0|||
23552201|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23744321|NCT03426995|66443210|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23430586|NCT00162266|65320621|FG003|Double-Blind Period|Death|0|||
23430587|NCT00162266|65320618|FG000|Double-Blind Period|Lost to Follow-up|1|||
23430588|NCT00162266|65320619|FG001|Double-Blind Period|Lost to Follow-up|2|||
23430589|NCT00162266|65320620|FG002|Double-Blind Period|Lost to Follow-up|0|||
23822004|NCT01862484|66726217|FG001|Overall Study|Protocol Violation|2|||
23430590|NCT00162266|65320621|FG003|Double-Blind Period|Lost to Follow-up|0|||
23430591|NCT00162266|65320618|FG000|Double-Blind Period|Other Reason|1|||
23430592|NCT00162266|65320619|FG001|Double-Blind Period|Other Reason|0|||
23430593|NCT00162266|65320620|FG002|Double-Blind Period|Other Reason|1|||
23430594|NCT00162266|65320621|FG003|Double-Blind Period|Other Reason|0|||
23430595|NCT00162266|65320618|FG000|Double-Blind Period|Lack of Efficacy|13|||
23430596|NCT00162266|65320619|FG001|Double-Blind Period|Lack of Efficacy|17|||
23430597|NCT00162266|65320620|FG002|Double-Blind Period|Lack of Efficacy|30|||
23430598|NCT00162266|65320621|FG003|Double-Blind Period|Lack of Efficacy|0|||
23430599|NCT00162266|65320618|FG000|Double-Blind Period|Withdrawal by Subject|5|||
23430600|NCT00162266|65320619|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23430601|NCT00162266|65320620|FG002|Double-Blind Period|Withdrawal by Subject|6|||
23430602|NCT00162266|65320621|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23430603|NCT00162266|65320618|FG000|Open-Label Period|Death|0|||
23430604|NCT00162266|65320619|FG001|Open-Label Period|Death|0|||
23430605|NCT00162266|65320620|FG002|Open-Label Period|Death|0|||
23430606|NCT00162266|65320621|FG003|Open-Label Period|Death|7|||
23430607|NCT00162266|65320618|FG000|Open-Label Period|Adverse Event|0|||
23430608|NCT00162266|65320619|FG001|Open-Label Period|Adverse Event|0|||
23430609|NCT00162266|65320620|FG002|Open-Label Period|Adverse Event|0|||
23430610|NCT00162266|65320621|FG003|Open-Label Period|Adverse Event|46|||
23430611|NCT00162266|65320618|FG000|Open-Label Period|Lack of Efficacy|0|||
23430612|NCT00162266|65320619|FG001|Open-Label Period|Lack of Efficacy|0|||
23430613|NCT00162266|65320620|FG002|Open-Label Period|Lack of Efficacy|0|||
23430614|NCT00162266|65320621|FG003|Open-Label Period|Lack of Efficacy|26|||
23430615|NCT00162266|65320618|FG000|Open-Label Period|Lost to Follow-up|0|||
23430616|NCT00162266|65320619|FG001|Open-Label Period|Lost to Follow-up|0|||
23430617|NCT00162266|65320620|FG002|Open-Label Period|Lost to Follow-up|0|||
23430618|NCT00162266|65320621|FG003|Open-Label Period|Lost to Follow-up|3|||
23430619|NCT00162266|65320618|FG000|Open-Label Period|Withdrawal by Subject|0|||
23430620|NCT00162266|65320619|FG001|Open-Label Period|Withdrawal by Subject|0|||
23430621|NCT00162266|65320620|FG002|Open-Label Period|Withdrawal by Subject|0|||
23430622|NCT00162266|65320621|FG003|Open-Label Period|Withdrawal by Subject|31|||
23430623|NCT00162266|65320618|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
23430624|NCT00162266|65320619|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
23430625|NCT00162266|65320620|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
23430626|NCT00162266|65320621|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
23430627|NCT00162266|65320618|FG000|Open-Label Period|Other Reasons|0|||
23430628|NCT00162266|65320619|FG001|Open-Label Period|Other Reasons|0|||
23430629|NCT00162266|65320620|FG002|Open-Label Period|Other Reasons|0|||
23430630|NCT00162266|65320621|FG003|Open-Label Period|Other Reasons|15|||
23430631|NCT02772978|65320626|FG000|Overall Study|Withdrawal by Subject|1|||
23430632|NCT02772978|65320627|FG001|Overall Study|Withdrawal by Subject|1|||
23430633|NCT00885482|65320628|FG000|Overall Study|Pregnancy|1|||
23430634|NCT00885482|65320628|FG000|Overall Study|Lack of Efficacy|1|||
23430635|NCT00885482|65320628|FG000|Overall Study|Death|1|||
23430636|NCT00885482|65320628|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
23430637|NCT00780273|65320629|FG000|Overall Study|Death|1|||
23430638|NCT00780273|65320629|FG000|Overall Study|Lost to Follow-up|1|||
23430639|NCT00440310|65320634|FG000|Overall Study|Lost to Follow-up|4|||
23430640|NCT00440310|65320635|FG001|Overall Study|Lost to Follow-up|5|||
23430641|NCT00440310|65320634|FG000|Overall Study|Protocol Violation|0|||
23430642|NCT00440310|65320635|FG001|Overall Study|Protocol Violation|1|||
23430643|NCT00440310|65320634|FG000|Overall Study|Withdrawal by Subject|15|||
23430644|NCT00440310|65320635|FG001|Overall Study|Withdrawal by Subject|14|||
23430645|NCT00440310|65320634|FG000|Overall Study|No Reply at EOS|7|||
23430646|NCT00440310|65320635|FG001|Overall Study|No Reply at EOS|7|||
23430647|NCT00440310|65320634|FG000|Overall Study|Other|1|||
23430648|NCT00440310|65320635|FG001|Overall Study|Other|0|||
23430649|NCT00440310|65320634|FG000|Overall Study|Status Unknown|1|||
23430650|NCT00440310|65320635|FG001|Overall Study|Status Unknown|3|||
23430651|NCT03734029|65320640|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
23430652|NCT03734029|65320641|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
23430653|NCT03734029|65320640|FG000|Overall Study|Adverse Event|60|||
23430654|NCT03734029|65320641|FG001|Overall Study|Adverse Event|14|||
23430655|NCT03734029|65320640|FG000|Overall Study|Withdrawal by Subject|12|||
23430656|NCT03734029|65320641|FG001|Overall Study|Withdrawal by Subject|11|||
23430657|NCT03734029|65320640|FG000|Overall Study|Clinical progression by investigator|10|||
23430658|NCT03734029|65320641|FG001|Overall Study|Clinical progression by investigator|8|||
23430659|NCT03734029|65320640|FG000|Overall Study|Death|5|||
23430660|NCT03734029|65320641|FG001|Overall Study|Death|2|||
23430661|NCT03734029|65320640|FG000|Overall Study|Physician Decision|4|||
23430662|NCT03734029|65320641|FG001|Overall Study|Physician Decision|3|||
23430663|NCT03734029|65320640|FG000|Overall Study|Other|2|||
23430664|NCT03734029|65320641|FG001|Overall Study|Other|0|||
23430665|NCT03734029|65320640|FG000|Overall Study|Lost to Follow-up|0|||
23430666|NCT03734029|65320641|FG001|Overall Study|Lost to Follow-up|1|||
23430667|NCT03734029|65320640|FG000|Overall Study|Randomized, but not treated|2|||
23430668|NCT03734029|65320641|FG001|Overall Study|Randomized, but not treated|12|||
23430669|NCT03836677|65320648|FG000|Period 1|Adverse Event|0|||
23430670|NCT03836677|65320649|FG001|Period 1|Adverse Event|1|||
23430671|NCT03836677|65320648|FG000|Period 2|Severe non-compliance to protocol|1|||
23430672|NCT03836677|65320649|FG001|Period 2|Severe non-compliance to protocol|0|||
23430673|NCT00456599|65320651|FG000|Overall Study|Non-compliance|1|||
23430674|NCT00456599|65320651|FG000|Overall Study|Withdrawal by Subject|2|||
23430675|NCT01378429|65320655|FG000|Overall Study|Noncompliance with study drug|1|||
23430676|NCT01378429|65320656|FG001|Overall Study|Noncompliance with study drug|0|||
23430677|NCT03204890|65320657|FG000|Overall Study|Withdrawal by Subject|1|||
23430678|NCT04063787|65320658|FG000|Overall Study|Inadequate Doppler data|4|||
23430679|NCT04063787|65320658|FG000|Overall Study|Lost to Follow-up|2|||
23430680|NCT04063787|65320658|FG000|Overall Study|Death|3|||
23430681|NCT01657760|65320661|FG000|Overall Study|Withdrawal by Subject|0|||
23430682|NCT01657760|65320662|FG001|Overall Study|Withdrawal by Subject|0|||
23430683|NCT01657760|65320663|FG002|Overall Study|Withdrawal by Subject|0|||
23430684|NCT01657760|65320664|FG003|Overall Study|Withdrawal by Subject|1|||
23430685|NCT01657760|65320661|FG000|Overall Study|Physician Decision|1|||
23430686|NCT01657760|65320662|FG001|Overall Study|Physician Decision|1|||
23430687|NCT01657760|65320663|FG002|Overall Study|Physician Decision|1|||
23430688|NCT01657760|65320664|FG003|Overall Study|Physician Decision|2|||
23430689|NCT02391961|65320665|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
23430690|NCT02391961|65320666|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
23430691|NCT02391961|65320665|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23430692|NCT02391961|65320666|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
23430693|NCT02391961|65320665|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23430694|NCT02391961|65320666|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23430695|NCT00443781|65320667|FG000|Overall Study|Lost to Follow-up|10|||
23430696|NCT00443781|65320667|FG000|Overall Study|Physician Decision|2|||
23430697|NCT00443781|65320667|FG000|Overall Study|Protocol Violation|1|||
23430698|NCT00443781|65320667|FG000|Overall Study|Withdrawal by Subject|6|||
23430699|NCT00443781|65320667|FG000|Overall Study|Unable to comply with study follow up|2|||
23430700|NCT00443781|65320667|FG000|Overall Study|Investigator terminated participation|1|||
23430701|NCT00443781|65320667|FG000|Overall Study|Insurance not covered|2|||
23430702|NCT00443781|65320667|FG000|Overall Study|PD/FAD not done|1|||
23430703|NCT02621073|65320674|FG000|Overall Study|Lost to Follow-up|0|||
23430704|NCT02621073|65320675|FG001|Overall Study|Lost to Follow-up|1|||
23430705|NCT02621073|65320674|FG000|Overall Study|Physician Decision|3|||
23430706|NCT02621073|65320675|FG001|Overall Study|Physician Decision|2|||
23430707|NCT02299076|65320676|FG000|Overall Study|Fraudulent Entries|20|||
23430708|NCT02299076|65320677|FG001|Overall Study|Fraudulent Entries|14|||
23430709|NCT02117349|65320681|FG000|Overall Study|Withdrawal by Subject|1|||
23430710|NCT02117349|65320682|FG001|Overall Study|Withdrawal by Subject|0|||
23430711|NCT02117349|65320681|FG000|Overall Study|Lost to Follow-up|1|||
23430712|NCT02117349|65320682|FG001|Overall Study|Lost to Follow-up|1|||
23430713|NCT02117349|65320681|FG000|Overall Study|Death|1|||
23430714|NCT02117349|65320682|FG001|Overall Study|Death|0|||
23430715|NCT00295932|65320683|FG000|Overall Study|Not Treated|0|||
23430716|NCT00295932|65320684|FG001|Overall Study|Not Treated|0|||
23430717|NCT00295932|65320685|FG002|Overall Study|Not Treated|0|||
23430718|NCT00295932|65320686|FG003|Overall Study|Not Treated|0|||
23430719|NCT00295932|65320687|FG004|Overall Study|Not Treated|0|||
23430720|NCT00295932|65320688|FG005|Overall Study|Not Treated|0|||
23430721|NCT00295932|65320689|FG006|Overall Study|Not Treated|0|||
23430722|NCT00295932|65320690|FG007|Overall Study|Not Treated|0|||
23430723|NCT00295932|65320691|FG008|Overall Study|Not Treated|0|||
23430724|NCT00295932|65320692|FG009|Overall Study|Not Treated|0|||
23430725|NCT00295932|65320693|FG010|Overall Study|Not Treated|1|||
23430726|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
23430727|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
23430728|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
23430729|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
23430730|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
23430731|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
23430732|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
23430733|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
23430734|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
23430735|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
23430736|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
23430737|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
23430738|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
23552202|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552203|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552204|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552205|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552206|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430739|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430740|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430741|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430742|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
23430743|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
23430744|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
23430745|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
23430746|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430747|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430748|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
23430749|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430750|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430751|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430752|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
23430753|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430754|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
23430755|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
23430756|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
23430757|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
23430758|NCT01267175|65320698|FG000|Overall Study|Withdrawal by Subject|1|||
23430759|NCT01267175|65320698|FG000|Overall Study|Lost to Follow-up|1|||
23430760|NCT00084656|65320699|FG000|Overall Study|Other reasons|0|||
23430761|NCT00084656|65320700|FG001|Overall Study|Other reasons|12|||
23430762|NCT00084656|65320701|FG002|Overall Study|Other reasons|11|||
23430763|NCT00084656|65320699|FG000|Overall Study|Withdrawal by Subject|15|||
23430764|NCT00084656|65320700|FG001|Overall Study|Withdrawal by Subject|4|||
23430765|NCT00084656|65320701|FG002|Overall Study|Withdrawal by Subject|4|||
23430766|NCT00084656|65320699|FG000|Overall Study|Disease relapse|0|||
23430767|NCT00084656|65320700|FG001|Overall Study|Disease relapse|9|||
23430768|NCT00084656|65320701|FG002|Overall Study|Disease relapse|10|||
23430769|NCT00084656|65320699|FG000|Overall Study|Disease progression|9|||
23430770|NCT00084656|65320700|FG001|Overall Study|Disease progression|0|||
23430771|NCT00084656|65320701|FG002|Overall Study|Disease progression|0|||
23430772|NCT00084656|65320699|FG000|Overall Study|Lost to Follow-up|1|||
23430773|NCT00084656|65320700|FG001|Overall Study|Lost to Follow-up|0|||
23430774|NCT00084656|65320701|FG002|Overall Study|Lost to Follow-up|1|||
23430775|NCT00391391|65320704|FG000|Overall Study|Adverse Event|0|||
23430776|NCT00391391|65320705|FG001|Overall Study|Adverse Event|0|||
23430777|NCT00391391|65320706|FG002|Overall Study|Adverse Event|0|||
23430778|NCT00391391|65320707|FG003|Overall Study|Adverse Event|1|||
23430779|NCT00391391|65320704|FG000|Overall Study|Lost to Follow-up|1|||
23430780|NCT00391391|65320705|FG001|Overall Study|Lost to Follow-up|3|||
23430781|NCT00391391|65320706|FG002|Overall Study|Lost to Follow-up|7|||
23430782|NCT00391391|65320707|FG003|Overall Study|Lost to Follow-up|4|||
23430783|NCT00391391|65320704|FG000|Overall Study|Protocol Violation|2|||
23430784|NCT00391391|65320705|FG001|Overall Study|Protocol Violation|3|||
23430785|NCT00391391|65320706|FG002|Overall Study|Protocol Violation|6|||
23430786|NCT00391391|65320707|FG003|Overall Study|Protocol Violation|7|||
23430787|NCT00391391|65320704|FG000|Overall Study|Withdrawal by Subject|6|||
23430788|NCT00391391|65320705|FG001|Overall Study|Withdrawal by Subject|4|||
23430789|NCT00391391|65320706|FG002|Overall Study|Withdrawal by Subject|10|||
23430790|NCT00391391|65320707|FG003|Overall Study|Withdrawal by Subject|7|||
23430791|NCT04094584|65320708|FG000|Overall Study|No interest in study|88|||
23430792|NCT04094584|65320708|FG000|Overall Study|Unwilling to undergo screening tests|36|||
23430793|NCT04094584|65320708|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
23430794|NCT04094584|65320708|FG000|Overall Study|Opioid use|7|||
23552207|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
23552208|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
23552209|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552210|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552211|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552212|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552213|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552214|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552215|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23621546|NCT02330562|66000683|FG001|Overall Study|Withdrawal by Subject|0|||
23621547|NCT02330562|66000684|FG002|Overall Study|Withdrawal by Subject|0|||
23822005|NCT01862484|66726216|FG000|Overall Study|Withdrawal by Subject|0|||
23430795|NCT04094584|65320708|FG000|Overall Study|Need for major surgery in study period|4|||
23430796|NCT04094584|65320708|FG000|Overall Study|eligible but declined enrollment|4|||
23430797|NCT04094584|65320708|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
23430798|NCT04094584|65320708|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
23430799|NCT04094584|65320708|FG000|Overall Study|Lost to Follow-up|3|||
23552216|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552217|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552218|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23822006|NCT01862484|66726217|FG001|Overall Study|Withdrawal by Subject|3|||
23744322|NCT03426995|66443211|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744323|NCT03426995|66443212|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23744324|NCT00764465|66443213|FG000|Overall Study|Adverse Event|2|||
23744325|NCT00764465|66443214|FG001|Overall Study|Adverse Event|0|||
23744326|NCT00764465|66443215|FG002|Overall Study|Adverse Event|0|||
23744327|NCT00764465|66443216|FG003|Overall Study|Adverse Event|1|||
23744328|NCT00764465|66443217|FG004|Overall Study|Adverse Event|1|||
23744329|NCT00764465|66443218|FG005|Overall Study|Adverse Event|1|||
23744330|NCT00764465|66443213|FG000|Overall Study|Withdrawal by Subject|0|||
23744331|NCT00764465|66443214|FG001|Overall Study|Withdrawal by Subject|1|||
23744332|NCT00764465|66443215|FG002|Overall Study|Withdrawal by Subject|1|||
23744333|NCT00764465|66443216|FG003|Overall Study|Withdrawal by Subject|0|||
23744334|NCT00764465|66443217|FG004|Overall Study|Withdrawal by Subject|0|||
23744335|NCT00764465|66443218|FG005|Overall Study|Withdrawal by Subject|0|||
23744336|NCT01945034|66443221|FG000|Overall Study|Medication Error|0|||
23744337|NCT01945034|66443222|FG001|Overall Study|Medication Error|1|||
23744338|NCT01945034|66443223|FG002|Overall Study|Medication Error|0|||
23744339|NCT01945034|66443221|FG000|Overall Study|Withdrawal by Subject|0|||
23744340|NCT01945034|66443222|FG001|Overall Study|Withdrawal by Subject|3|||
23744341|NCT01945034|66443223|FG002|Overall Study|Withdrawal by Subject|1|||
23744342|NCT01945034|66443221|FG000|Overall Study|Other|0|||
23744343|NCT01945034|66443222|FG001|Overall Study|Other|1|||
23744344|NCT01945034|66443223|FG002|Overall Study|Other|3|||
23744345|NCT01945034|66443221|FG000|Overall Study|Lost to Follow-up|0|||
23744346|NCT01945034|66443222|FG001|Overall Study|Lost to Follow-up|0|||
23744347|NCT01945034|66443223|FG002|Overall Study|Lost to Follow-up|2|||
23744348|NCT01945034|66443221|FG000|Overall Study|Protocol Violation|1|||
23744349|NCT01945034|66443222|FG001|Overall Study|Protocol Violation|0|||
23744350|NCT01945034|66443223|FG002|Overall Study|Protocol Violation|1|||
23744351|NCT01283282|66443224|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
23744352|NCT01283282|66443225|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
23744353|NCT01283282|66443224|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
23744354|NCT01283282|66443225|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
23744355|NCT01283282|66443224|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
23744356|NCT01283282|66443225|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
23744357|NCT00489411|66443226|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
23744358|NCT00489411|66443227|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
23744359|NCT00489411|66443226|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
23744360|NCT00489411|66443227|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
23744361|NCT00489411|66443226|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
23744362|NCT00489411|66443227|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
23744363|NCT00489411|66443226|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
23744364|NCT00489411|66443227|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
23744365|NCT00489411|66443226|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
23744366|NCT00489411|66443227|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
23744367|NCT01474291|66443228|FG000|Overall Study|Not Evaluable for Efficacy|26|||
23744368|NCT01474291|66443228|FG000|Overall Study|Lack of Treatment Efficacy|88|||
23744369|NCT01474291|66443228|FG000|Overall Study|Adverse Event|53|||
23744370|NCT01474291|66443228|FG000|Overall Study|Lost to Follow-up|29|||
23744371|NCT01474291|66443228|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
23744372|NCT01474291|66443228|FG000|Overall Study|No Reason Reported|10|||
23744373|NCT01474291|66443228|FG000|Overall Study|Death|2|||
23744374|NCT01411917|66443229|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
23744375|NCT01411917|66443230|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
23744376|NCT02438787|66443231|FG000|Overall Study|Adverse Event|1|||
23744377|NCT02438787|66443232|FG001|Overall Study|Adverse Event|0|||
23744378|NCT02438787|66443233|FG002|Overall Study|Adverse Event|2|||
23744379|NCT02438787|66443231|FG000|Overall Study|Lack of Efficacy|1|||
23744380|NCT02438787|66443232|FG001|Overall Study|Lack of Efficacy|2|||
23621548|NCT02330562|66000685|FG003|Overall Study|Withdrawal by Subject|0|||
23744381|NCT02438787|66443233|FG002|Overall Study|Lack of Efficacy|0|||
23744382|NCT02438787|66443231|FG000|Overall Study|Lost to Follow-up|0|||
23744383|NCT02438787|66443232|FG001|Overall Study|Lost to Follow-up|1|||
23744384|NCT02438787|66443233|FG002|Overall Study|Lost to Follow-up|0|||
23744385|NCT02438787|66443231|FG000|Overall Study|Protocol Violation|0|||
23744386|NCT02438787|66443232|FG001|Overall Study|Protocol Violation|0|||
23744387|NCT02438787|66443233|FG002|Overall Study|Protocol Violation|1|||
23744388|NCT02438787|66443231|FG000|Overall Study|Withdrawal by Subject|15|||
23744389|NCT02438787|66443232|FG001|Overall Study|Withdrawal by Subject|7|||
23744390|NCT02438787|66443233|FG002|Overall Study|Withdrawal by Subject|10|||
23744391|NCT02438787|66443231|FG000|Overall Study|Study discontinued by sponsor|64|||
23744392|NCT02438787|66443232|FG001|Overall Study|Study discontinued by sponsor|72|||
23744393|NCT02438787|66443233|FG002|Overall Study|Study discontinued by sponsor|69|||
23744394|NCT02438787|66443231|FG000|Overall Study|Other|0|||
23552219|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552220|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552221|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
23552222|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
23552223|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552224|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552225|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552226|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552227|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552228|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23744395|NCT02438787|66443232|FG001|Overall Study|Other|1|||
23744396|NCT02438787|66443233|FG002|Overall Study|Other|0|||
23744397|NCT02438787|66443231|FG000|Overall Study|Site terminated by sponsor|0|||
23744398|NCT02438787|66443232|FG001|Overall Study|Site terminated by sponsor|0|||
23552229|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552230|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552231|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552232|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552233|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552234|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552235|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
23552236|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552237|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552238|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552239|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552240|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552241|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552242|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552243|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552244|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552245|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552246|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552247|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552248|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552249|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
23552250|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552251|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552252|NCT02341417|65747724|FG000|Overall Study|Withdrawal by Subject|0|||
23552253|NCT02341417|65747725|FG001|Overall Study|Withdrawal by Subject|2|||
23552254|NCT02341417|65747726|FG002|Overall Study|Withdrawal by Subject|0|||
23552255|NCT02341417|65747724|FG000|Overall Study|Decision by sponsor|2|||
23552256|NCT02341417|65747725|FG001|Overall Study|Decision by sponsor|0|||
23552257|NCT02341417|65747726|FG002|Overall Study|Decision by sponsor|0|||
23744399|NCT02438787|66443233|FG002|Overall Study|Site terminated by sponsor|1|||
23744400|NCT01641952|66443236|FG000|Overall Study|Lost to Follow-up|28|||
23744401|NCT01641952|66443236|FG000|Overall Study|Adverse Event|6|||
23744402|NCT00471237|66443238|FG000|Overall Study|Adverse Event|6|||
23744403|NCT00471237|66443239|FG001|Overall Study|Adverse Event|5|||
23744404|NCT00471237|66443240|FG002|Overall Study|Adverse Event|4|||
23744405|NCT00471237|66443241|FG003|Overall Study|Adverse Event|8|||
23744406|NCT00471237|66443242|FG004|Overall Study|Adverse Event|7|||
23744407|NCT00471237|66443243|FG005|Overall Study|Adverse Event|5|||
23744408|NCT00471237|66443244|FG006|Overall Study|Adverse Event|0|||
23744409|NCT00471237|66443238|FG000|Overall Study|Lost to Follow-up|1|||
23744410|NCT00471237|66443239|FG001|Overall Study|Lost to Follow-up|1|||
23744411|NCT00471237|66443240|FG002|Overall Study|Lost to Follow-up|0|||
23744412|NCT00471237|66443241|FG003|Overall Study|Lost to Follow-up|2|||
23744413|NCT00471237|66443242|FG004|Overall Study|Lost to Follow-up|3|||
23744414|NCT00471237|66443243|FG005|Overall Study|Lost to Follow-up|0|||
23744415|NCT00471237|66443244|FG006|Overall Study|Lost to Follow-up|0|||
23744416|NCT00471237|66443238|FG000|Overall Study|Protocol Violation|3|||
23552258|NCT02341417|65747724|FG000|Overall Study|Death|0|||
23552259|NCT02341417|65747725|FG001|Overall Study|Death|0|||
23552260|NCT02341417|65747726|FG002|Overall Study|Death|1|||
23552261|NCT02308748|65747727|FG000|Period 1|Withdrawal by Subject|0|||
23552262|NCT02308748|65747728|FG001|Period 1|Withdrawal by Subject|0|||
23552263|NCT02308748|65747729|FG002|Period 1|Withdrawal by Subject|1|||
23552264|NCT02308748|65747730|FG003|Period 1|Withdrawal by Subject|0|||
23744417|NCT00471237|66443239|FG001|Overall Study|Protocol Violation|6|||
23552265|NCT02308748|65747731|FG004|Period 1|Withdrawal by Subject|0|||
23744418|NCT00471237|66443240|FG002|Overall Study|Protocol Violation|3|||
23744419|NCT00471237|66443241|FG003|Overall Study|Protocol Violation|2|||
23744420|NCT00471237|66443242|FG004|Overall Study|Protocol Violation|2|||
23744421|NCT00471237|66443243|FG005|Overall Study|Protocol Violation|4|||
23744422|NCT00471237|66443244|FG006|Overall Study|Protocol Violation|1|||
23744423|NCT00471237|66443238|FG000|Overall Study|Withdrawal by Subject|8|||
23744424|NCT00471237|66443239|FG001|Overall Study|Withdrawal by Subject|6|||
23744425|NCT00471237|66443240|FG002|Overall Study|Withdrawal by Subject|5|||
23744426|NCT00471237|66443241|FG003|Overall Study|Withdrawal by Subject|8|||
23744427|NCT00471237|66443242|FG004|Overall Study|Withdrawal by Subject|7|||
23744428|NCT00471237|66443243|FG005|Overall Study|Withdrawal by Subject|4|||
23744429|NCT00471237|66443244|FG006|Overall Study|Withdrawal by Subject|2|||
23744430|NCT00471237|66443238|FG000|Overall Study|Sponsor terminated study|20|||
23744431|NCT00471237|66443239|FG001|Overall Study|Sponsor terminated study|23|||
23744432|NCT00471237|66443240|FG002|Overall Study|Sponsor terminated study|19|||
23744433|NCT00471237|66443241|FG003|Overall Study|Sponsor terminated study|22|||
23744434|NCT00471237|66443242|FG004|Overall Study|Sponsor terminated study|18|||
23744435|NCT00471237|66443243|FG005|Overall Study|Sponsor terminated study|24|||
23744436|NCT00471237|66443244|FG006|Overall Study|Sponsor terminated study|0|||
23744437|NCT00471237|66443238|FG000|Overall Study|Non-compliance|0|||
23744438|NCT00471237|66443239|FG001|Overall Study|Non-compliance|1|||
23744439|NCT00471237|66443240|FG002|Overall Study|Non-compliance|0|||
23744440|NCT00471237|66443241|FG003|Overall Study|Non-compliance|1|||
23744441|NCT00471237|66443242|FG004|Overall Study|Non-compliance|0|||
23744442|NCT00471237|66443243|FG005|Overall Study|Non-compliance|0|||
23744443|NCT00471237|66443244|FG006|Overall Study|Non-compliance|0|||
23744444|NCT00471237|66443238|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
23744445|NCT00471237|66443239|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
23744446|NCT00471237|66443240|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
23744447|NCT00471237|66443241|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
23744448|NCT00471237|66443242|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
23744449|NCT00471237|66443243|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
23744450|NCT00471237|66443244|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
23744451|NCT00471237|66443238|FG000|Overall Study|Early stopping due to non-efficacy|1|||
23744452|NCT00471237|66443239|FG001|Overall Study|Early stopping due to non-efficacy|0|||
23744453|NCT00471237|66443240|FG002|Overall Study|Early stopping due to non-efficacy|0|||
23744454|NCT00471237|66443241|FG003|Overall Study|Early stopping due to non-efficacy|0|||
23552266|NCT02308748|65747732|FG005|Period 1|Withdrawal by Subject|0|||
23552267|NCT02308748|65747733|FG006|Period 1|Withdrawal by Subject|0|||
23552268|NCT02308748|65747734|FG007|Period 1|Withdrawal by Subject|0|||
23552269|NCT02308748|65747735|FG008|Period 1|Withdrawal by Subject|0|||
23552270|NCT02308748|65747736|FG009|Period 1|Withdrawal by Subject|0|||
23552271|NCT02308748|65747727|FG000|Period 2|Adverse Event|0|||
23552272|NCT02308748|65747728|FG001|Period 2|Adverse Event|0|||
23552273|NCT02308748|65747729|FG002|Period 2|Adverse Event|0|||
23552274|NCT02308748|65747730|FG003|Period 2|Adverse Event|0|||
23744455|NCT00471237|66443242|FG004|Overall Study|Early stopping due to non-efficacy|1|||
23744456|NCT00471237|66443243|FG005|Overall Study|Early stopping due to non-efficacy|0|||
23744457|NCT00471237|66443244|FG006|Overall Study|Early stopping due to non-efficacy|0|||
23744458|NCT00471237|66443238|FG000|Overall Study|Participant planned to travel to abraod|1|||
23744459|NCT00471237|66443239|FG001|Overall Study|Participant planned to travel to abraod|0|||
23744460|NCT00471237|66443240|FG002|Overall Study|Participant planned to travel to abraod|0|||
23744461|NCT00471237|66443241|FG003|Overall Study|Participant planned to travel to abraod|0|||
23744462|NCT00471237|66443242|FG004|Overall Study|Participant planned to travel to abraod|0|||
23744463|NCT00471237|66443243|FG005|Overall Study|Participant planned to travel to abraod|1|||
23744464|NCT00471237|66443244|FG006|Overall Study|Participant planned to travel to abraod|0|||
23744465|NCT00471237|66443238|FG000|Overall Study|High parathyroid hormone|0|||
23744466|NCT00471237|66443239|FG001|Overall Study|High parathyroid hormone|0|||
23744467|NCT00471237|66443240|FG002|Overall Study|High parathyroid hormone|1|||
23744468|NCT00471237|66443241|FG003|Overall Study|High parathyroid hormone|0|||
23744469|NCT00471237|66443242|FG004|Overall Study|High parathyroid hormone|0|||
23744470|NCT00471237|66443243|FG005|Overall Study|High parathyroid hormone|0|||
23744471|NCT00471237|66443244|FG006|Overall Study|High parathyroid hormone|0|||
23744472|NCT00471237|66443238|FG000|Overall Study|Participant lost medication|0|||
23744473|NCT00471237|66443239|FG001|Overall Study|Participant lost medication|0|||
23744474|NCT00471237|66443240|FG002|Overall Study|Participant lost medication|0|||
23744475|NCT00471237|66443241|FG003|Overall Study|Participant lost medication|0|||
23744476|NCT00471237|66443242|FG004|Overall Study|Participant lost medication|1|||
23744477|NCT00471237|66443243|FG005|Overall Study|Participant lost medication|0|||
23552275|NCT02308748|65747731|FG004|Period 2|Adverse Event|0|||
23552276|NCT02308748|65747732|FG005|Period 2|Adverse Event|0|||
23552277|NCT02308748|65747733|FG006|Period 2|Adverse Event|0|||
23744478|NCT00471237|66443244|FG006|Overall Study|Participant lost medication|0|||
23552278|NCT02308748|65747734|FG007|Period 2|Adverse Event|1|||
23552279|NCT02308748|65747735|FG008|Period 2|Adverse Event|0|||
23744479|NCT00471237|66443238|FG000|Overall Study|Administration of prohibited medicine|0|||
23552280|NCT02308748|65747736|FG009|Period 2|Adverse Event|0|||
23552281|NCT02308748|65747727|FG000|Period 3|Protocol Violation|0|||
23744480|NCT00471237|66443239|FG001|Overall Study|Administration of prohibited medicine|0|||
23744481|NCT00471237|66443240|FG002|Overall Study|Administration of prohibited medicine|0|||
23744482|NCT00471237|66443241|FG003|Overall Study|Administration of prohibited medicine|0|||
23744483|NCT00471237|66443242|FG004|Overall Study|Administration of prohibited medicine|1|||
23552282|NCT02308748|65747728|FG001|Period 3|Protocol Violation|0|||
23552283|NCT02308748|65747729|FG002|Period 3|Protocol Violation|0|||
23552284|NCT02308748|65747730|FG003|Period 3|Protocol Violation|0|||
23552285|NCT02308748|65747731|FG004|Period 3|Protocol Violation|0|||
23552286|NCT02308748|65747732|FG005|Period 3|Protocol Violation|0|||
23552287|NCT02308748|65747733|FG006|Period 3|Protocol Violation|0|||
23552288|NCT02308748|65747734|FG007|Period 3|Protocol Violation|0|||
23552289|NCT02308748|65747735|FG008|Period 3|Protocol Violation|0|||
23552290|NCT02308748|65747736|FG009|Period 3|Protocol Violation|1|||
23552291|NCT02308748|65747727|FG000|Period 5|Adverse Event|1|||
23552292|NCT02308748|65747728|FG001|Period 5|Adverse Event|0|||
23552293|NCT02308748|65747729|FG002|Period 5|Adverse Event|0|||
23552294|NCT02308748|65747730|FG003|Period 5|Adverse Event|0|||
23552295|NCT02308748|65747731|FG004|Period 5|Adverse Event|0|||
23552296|NCT02308748|65747732|FG005|Period 5|Adverse Event|0|||
23552297|NCT02308748|65747733|FG006|Period 5|Adverse Event|0|||
23552298|NCT02308748|65747734|FG007|Period 5|Adverse Event|0|||
23552299|NCT02308748|65747735|FG008|Period 5|Adverse Event|1|||
23552300|NCT02308748|65747736|FG009|Period 5|Adverse Event|0|||
23552301|NCT00802074|65747743|FG000|Overall Study|Adverse Event|1|||
23552302|NCT00802074|65747744|FG001|Overall Study|Adverse Event|1|||
23552303|NCT00802074|65747745|FG002|Overall Study|Adverse Event|1|||
23552304|NCT00802074|65747746|FG003|Overall Study|Adverse Event|0|||
23552305|NCT00802074|65747747|FG004|Overall Study|Adverse Event|0|||
23552306|NCT00802074|65747748|FG005|Overall Study|Adverse Event|0|||
23552307|NCT00802074|65747743|FG000|Overall Study|Withdrawal by Subject|1|||
23552308|NCT00802074|65747744|FG001|Overall Study|Withdrawal by Subject|0|||
23552309|NCT00802074|65747745|FG002|Overall Study|Withdrawal by Subject|0|||
23552310|NCT00802074|65747746|FG003|Overall Study|Withdrawal by Subject|0|||
23552311|NCT00802074|65747747|FG004|Overall Study|Withdrawal by Subject|0|||
23552312|NCT00802074|65747748|FG005|Overall Study|Withdrawal by Subject|0|||
23552313|NCT01814371|65747749|FG000|Overall Study|Lost to Follow-up|30|||
23552314|NCT01814371|65747750|FG001|Overall Study|Lost to Follow-up|27|||
23552315|NCT00535730|65747751|FG000|Overall Study|Adverse Event|1|||
23552316|NCT00535730|65747752|FG001|Overall Study|Adverse Event|1|||
23552317|NCT00535730|65747751|FG000|Overall Study|Lost to Follow-up|0|||
23552318|NCT00535730|65747752|FG001|Overall Study|Lost to Follow-up|1|||
23552319|NCT00535730|65747751|FG000|Overall Study|Physician Decision|0|||
23552320|NCT00535730|65747752|FG001|Overall Study|Physician Decision|1|||
23552321|NCT00535730|65747751|FG000|Overall Study|Protocol Violation|1|||
23552322|NCT00535730|65747752|FG001|Overall Study|Protocol Violation|0|||
23552323|NCT00535730|65747751|FG000|Overall Study|Withdrawal by Subject|0|||
23552324|NCT00535730|65747752|FG001|Overall Study|Withdrawal by Subject|4|||
23552325|NCT03519854|65747753|FG000|Overall Study|Technical Error|0|||
23552326|NCT03519854|65747754|FG001|Overall Study|Technical Error|0|||
23552327|NCT03519854|65747755|FG002|Overall Study|Technical Error|1|||
23552328|NCT03519854|65747756|FG003|Overall Study|Technical Error|0|||
23552329|NCT03519854|65747757|FG004|Overall Study|Technical Error|0|||
23552330|NCT03519854|65747758|FG005|Overall Study|Technical Error|0|||
23552331|NCT03519854|65747759|FG006|Overall Study|Technical Error|0|||
23552332|NCT03519854|65747760|FG007|Overall Study|Technical Error|0|||
23552333|NCT03519854|65747761|FG008|Overall Study|Technical Error|0|||
23744484|NCT00471237|66443243|FG005|Overall Study|Administration of prohibited medicine|0|||
23744485|NCT00471237|66443244|FG006|Overall Study|Administration of prohibited medicine|0|||
23744486|NCT00471237|66443238|FG000|Overall Study|Participant shifted residence|0|||
23744487|NCT00471237|66443239|FG001|Overall Study|Participant shifted residence|0|||
23744488|NCT00471237|66443240|FG002|Overall Study|Participant shifted residence|0|||
23744489|NCT00471237|66443241|FG003|Overall Study|Participant shifted residence|0|||
23744490|NCT00471237|66443242|FG004|Overall Study|Participant shifted residence|1|||
23552334|NCT03519854|65747762|FG009|Overall Study|Technical Error|0|||
23552335|NCT03519854|65747763|FG010|Overall Study|Technical Error|0|||
23552336|NCT03519854|65747764|FG011|Overall Study|Technical Error|0|||
23552337|NCT03519854|65747765|FG012|Overall Study|Technical Error|0|||
23744491|NCT00471237|66443243|FG005|Overall Study|Participant shifted residence|0|||
23552338|NCT03519854|65747766|FG013|Overall Study|Technical Error|0|||
23744492|NCT00471237|66443244|FG006|Overall Study|Participant shifted residence|0|||
23552339|NCT03519854|65747767|FG014|Overall Study|Technical Error|0|||
23552340|NCT03519854|65747768|FG015|Overall Study|Technical Error|0|||
23552341|NCT03519854|65747769|FG016|Overall Study|Technical Error|0|||
23552342|NCT03519854|65747770|FG017|Overall Study|Technical Error|0|||
23552343|NCT01654549|65747772|FG000|Overall Study|H.pylori eradication not successful|0|||
23552344|NCT01654549|65747773|FG001|Overall Study|H.pylori eradication not successful|1|||
23552345|NCT00941330|65747774|FG000|Overall Study|Other|1|||
23552346|NCT00941330|65747775|FG001|Overall Study|Other|0|||
23552347|NCT00941330|65747774|FG000|Overall Study|Physician Decision|0|||
23552348|NCT00941330|65747775|FG001|Overall Study|Physician Decision|2|||
23552349|NCT04672941|65747793|FG000|Overall Study|Investigator decision|1|||
23552350|NCT04672941|65747793|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
23552351|NCT04672941|65747793|FG000|Overall Study|COVID-19 related but no adverse event|1|||
23552352|NCT04672941|65747793|FG000|Overall Study|Adverse Event|2|||
23552353|NCT04672941|65747793|FG000|Overall Study|Lost to Follow-up|2|||
23552354|NCT02975973|65747794|FG000|Overall Study|Adverse Event|1|||
23552355|NCT02975973|65747795|FG001|Overall Study|Adverse Event|1|||
23552356|NCT02975973|65747796|FG002|Overall Study|Adverse Event|1|||
23552357|NCT02975973|65747797|FG003|Overall Study|Adverse Event|0|||
23552358|NCT01994954|65747798|FG000|Overall Study|Death|1|||
23552359|NCT01994954|65747799|FG001|Overall Study|Death|0|||
23552360|NCT01994954|65747798|FG000|Overall Study|Withdrawal by Subject|9|||
23552361|NCT01994954|65747799|FG001|Overall Study|Withdrawal by Subject|14|||
23552362|NCT01994954|65747798|FG000|Overall Study|Physician Decision|2|||
23552363|NCT01994954|65747799|FG001|Overall Study|Physician Decision|2|||
23552364|NCT01994954|65747798|FG000|Overall Study|Lost to Follow-up|8|||
23552365|NCT01994954|65747799|FG001|Overall Study|Lost to Follow-up|10|||
23552366|NCT01994954|65747798|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
23552367|NCT01994954|65747799|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
23552368|NCT03657277|65747800|FG000|Overall Study|Physician Decision|2|||
23552369|NCT03657277|65747800|FG000|Overall Study|Lost to Follow-up|1|||
23552370|NCT03657277|65747800|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
23552371|NCT03325712|65747801|FG000|Overall Study|Protocol Violation|0|||
23552372|NCT03325712|65747802|FG001|Overall Study|Protocol Violation|0|||
23552373|NCT03325712|65747803|FG002|Overall Study|Protocol Violation|0|||
23552374|NCT03325712|65747804|FG003|Overall Study|Protocol Violation|0|||
23552375|NCT03325712|65747805|FG004|Overall Study|Protocol Violation|1|||
23552376|NCT03325712|65747806|FG005|Overall Study|Protocol Violation|0|||
23552377|NCT03325712|65747807|FG006|Overall Study|Protocol Violation|0|||
23552378|NCT03325712|65747808|FG007|Overall Study|Protocol Violation|0|||
23552379|NCT03325712|65747801|FG000|Overall Study|Adverse Event|0|||
23552380|NCT03325712|65747802|FG001|Overall Study|Adverse Event|0|||
23552381|NCT03325712|65747803|FG002|Overall Study|Adverse Event|0|||
23552382|NCT03325712|65747804|FG003|Overall Study|Adverse Event|0|||
23552383|NCT03325712|65747805|FG004|Overall Study|Adverse Event|1|||
23552384|NCT03325712|65747806|FG005|Overall Study|Adverse Event|0|||
23552385|NCT03325712|65747807|FG006|Overall Study|Adverse Event|0|||
23552386|NCT03325712|65747808|FG007|Overall Study|Adverse Event|0|||
23552387|NCT00771810|65747811|FG000|Overall Study|Adverse Event|3|||
23552388|NCT00771810|65747812|FG001|Overall Study|Adverse Event|0|||
23552389|NCT00771810|65747813|FG002|Overall Study|Adverse Event|2|||
23552390|NCT00771810|65747811|FG000|Overall Study|Lost to Follow-up|0|||
23552391|NCT00771810|65747812|FG001|Overall Study|Lost to Follow-up|0|||
23552392|NCT00771810|65747813|FG002|Overall Study|Lost to Follow-up|1|||
23552393|NCT00771810|65747811|FG000|Overall Study|Physician Decision|1|||
23552394|NCT00771810|65747812|FG001|Overall Study|Physician Decision|2|||
23552395|NCT00771810|65747813|FG002|Overall Study|Physician Decision|2|||
23552396|NCT00771810|65747811|FG000|Overall Study|Protocol Violation|0|||
23552397|NCT00771810|65747812|FG001|Overall Study|Protocol Violation|1|||
23744493|NCT00471237|66443238|FG000|Overall Study|Participant's decision|0|||
23744494|NCT00471237|66443239|FG001|Overall Study|Participant's decision|0|||
23744495|NCT00471237|66443240|FG002|Overall Study|Participant's decision|0|||
23744496|NCT00471237|66443241|FG003|Overall Study|Participant's decision|0|||
23744497|NCT00471237|66443242|FG004|Overall Study|Participant's decision|0|||
23744498|NCT00471237|66443243|FG005|Overall Study|Participant's decision|1|||
23744499|NCT00471237|66443244|FG006|Overall Study|Participant's decision|0|||
23744500|NCT02341482|66443245|FG000|Overall Study|Adverse Event|1|||
23552398|NCT00771810|65747813|FG002|Overall Study|Protocol Violation|1|||
23552399|NCT00771810|65747811|FG000|Overall Study|Withdrawal by Subject|1|||
23744501|NCT04822701|66443254|FG000|Overall Study|Not treated|2|||
23744502|NCT04822701|66443255|FG001|Overall Study|Not treated|0|||
23744503|NCT04822701|66443254|FG000|Overall Study|Lost to Follow-up|1|||
23744504|NCT04822701|66443255|FG001|Overall Study|Lost to Follow-up|0|||
23552400|NCT00771810|65747812|FG001|Overall Study|Withdrawal by Subject|2|||
23552401|NCT00771810|65747813|FG002|Overall Study|Withdrawal by Subject|0|||
23552402|NCT00771810|65747811|FG000|Overall Study|Other|0|||
23552403|NCT00771810|65747812|FG001|Overall Study|Other|0|||
23552404|NCT00771810|65747813|FG002|Overall Study|Other|1|||
23552405|NCT01967732|65747814|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552406|NCT01967732|65747815|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
23552407|NCT01967732|65747816|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552408|NCT01967732|65747817|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552409|NCT01967732|65747814|FG000|First Intervention (Day 1)|Poor venous access|0|||
23552410|NCT01967732|65747815|FG001|First Intervention (Day 1)|Poor venous access|1|||
23552411|NCT01967732|65747816|FG002|First Intervention (Day 1)|Poor venous access|0|||
23744505|NCT04822701|66443254|FG000|Overall Study|Withdrawal by Subject|1|||
23430800|NCT04094584|65320708|FG000|Overall Study|Withdrawal by Subject|2|||
23430801|NCT02535416|65320711|FG000|Overall Study|Family bereavement overseas|1|||
23430802|NCT02535416|65320712|FG001|Overall Study|Family bereavement overseas|0|||
23430803|NCT02535416|65320713|FG002|Overall Study|Family bereavement overseas|0|||
23744506|NCT04822701|66443255|FG001|Overall Study|Withdrawal by Subject|0|||
23744507|NCT00313716|66443259|FG000|Overall Study|Death|3|||
23430804|NCT02535416|65320714|FG003|Overall Study|Family bereavement overseas|0|||
23430805|NCT02535416|65320715|FG004|Overall Study|Family bereavement overseas|0|||
23430806|NCT02535416|65320716|FG005|Overall Study|Family bereavement overseas|0|||
23430807|NCT02535416|65320717|FG006|Overall Study|Family bereavement overseas|0|||
23430808|NCT02535416|65320718|FG007|Overall Study|Family bereavement overseas|0|||
23430809|NCT02535416|65320719|FG008|Overall Study|Family bereavement overseas|0|||
23430810|NCT02598128|65320720|FG000|Period A: Days -7 to -1|Adverse Event|1|||
23744508|NCT00313716|66443260|FG001|Overall Study|Death|2|||
23430811|NCT02598128|65320721|FG001|Period A: Days -7 to -1|Adverse Event|0|||
23430812|NCT02598128|65320722|FG002|Period A: Days -7 to -1|Adverse Event|0|||
23430813|NCT02598128|65320723|FG003|Period A: Days -7 to -1|Adverse Event|0|||
23744509|NCT00313716|66443261|FG002|Overall Study|Death|9|||
23744510|NCT00313716|66443262|FG003|Overall Study|Death|3|||
23744511|NCT00313716|66443263|FG004|Overall Study|Death|5|||
23430814|NCT02920957|65320724|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
23430815|NCT02920957|65320725|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
23430816|NCT02920957|65320724|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
23430817|NCT02920957|65320725|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
23430818|NCT02920957|65320724|FG000|First Intervention : 1 Month|Adverse Event|1|||
23430819|NCT02920957|65320725|FG001|First Intervention : 1 Month|Adverse Event|0|||
23430820|NCT02920957|65320724|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
23430821|NCT02920957|65320725|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
23430822|NCT00521222|65320726|FG000|Overall Study|Lost to Follow-up|0|||
23430823|NCT00521222|65320727|FG001|Overall Study|Lost to Follow-up|0|||
23430824|NCT00521222|65320728|FG002|Overall Study|Lost to Follow-up|1|||
23430825|NCT00521222|65320729|FG003|Overall Study|Lost to Follow-up|1|||
23430826|NCT00521222|65320726|FG000|Overall Study|Withdrawal by Subject|0|||
23430827|NCT00521222|65320727|FG001|Overall Study|Withdrawal by Subject|0|||
23430828|NCT00521222|65320728|FG002|Overall Study|Withdrawal by Subject|2|||
23430829|NCT00521222|65320729|FG003|Overall Study|Withdrawal by Subject|0|||
23430830|NCT00521222|65320726|FG000|Overall Study|Physician Decision|0|||
23430831|NCT00521222|65320727|FG001|Overall Study|Physician Decision|1|||
23430832|NCT00521222|65320728|FG002|Overall Study|Physician Decision|0|||
23430833|NCT00521222|65320729|FG003|Overall Study|Physician Decision|1|||
23430834|NCT02290938|65320732|FG000|Overall Study|Lost to Follow-up|14|||
23430835|NCT02290938|65320733|FG001|Overall Study|Lost to Follow-up|43|||
23552412|NCT01967732|65747817|FG003|First Intervention (Day 1)|Poor venous access|0|||
23430836|NCT02712424|65320734|FG000|Overall Study|Lost to Follow-up|34|||
23430837|NCT02712424|65320735|FG001|Overall Study|Lost to Follow-up|32|||
23430838|NCT00308074|65320737|FG000|Overall Study|Withdrawal by Subject|1|||
23430839|NCT01711866|65320740|FG000|Overall Study|Noncompliant|3|||
23430840|NCT01711866|65320740|FG000|Overall Study|Withdrawal by Subject|3|||
23430841|NCT01711866|65320740|FG000|Overall Study|Adverse Event|2|||
23430842|NCT00798317|65320741|FG000|Overall Study|Physician Decision|0|||
23430843|NCT00798317|65320742|FG001|Overall Study|Physician Decision|1|||
23744512|NCT00313716|66443264|FG005|Overall Study|Death|9|||
23744513|NCT00313716|66443259|FG000|Overall Study|Lost to Follow-up|2|||
23430844|NCT00798317|65320741|FG000|Overall Study|Withdrawal by Subject|5|||
23744514|NCT00313716|66443260|FG001|Overall Study|Lost to Follow-up|5|||
23430845|NCT00798317|65320742|FG001|Overall Study|Withdrawal by Subject|4|||
23430846|NCT00798317|65320741|FG000|Overall Study|Lost to Follow-up|2|||
23430847|NCT00798317|65320742|FG001|Overall Study|Lost to Follow-up|2|||
23430848|NCT00798317|65320741|FG000|Overall Study|Adverse Event|2|||
23430849|NCT00798317|65320742|FG001|Overall Study|Adverse Event|0|||
23430850|NCT00798317|65320741|FG000|Overall Study|Death|1|||
23430851|NCT00798317|65320742|FG001|Overall Study|Death|0|||
23430852|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
23430853|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
23430854|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
23430855|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
23430856|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
23430857|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
23430858|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
23430859|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
23430860|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
23430861|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
23430862|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
23430863|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
23430864|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
23430865|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
23430866|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
23430867|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
23430868|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
23430869|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
23430870|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
23430871|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
23430872|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
23430873|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
23430874|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
23430875|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
23430876|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
23430877|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430878|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430879|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
23430880|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
23430881|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430882|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Other Reason|1|||
23430883|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Other Reason|0|||
23430884|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Other Reason|0|||
23430885|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Other Reason|0|||
23430886|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Other Reason|0|||
23430887|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
23430888|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
23430889|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
23430890|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
23430891|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
23430892|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
23430893|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
23430894|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
23430895|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
23430896|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
23430897|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
23430898|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
23430899|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
23430900|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
23430901|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
23430902|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
23430903|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
23430904|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
23430905|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
23430906|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
23430907|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
23430908|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
23430909|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
23430910|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
23430911|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
23430912|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
23430913|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
23430914|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
23430915|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
23430916|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
23430917|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
23430918|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
23430919|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
23430920|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
23430921|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
23430922|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
23430923|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
23430924|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
23430925|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
23430926|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
23552413|NCT05054374|65747818|FG000|Overall Study|Withdrawal by Subject|1|||
23552414|NCT05054374|65747819|FG001|Overall Study|Withdrawal by Subject|0|||
23552415|NCT05054374|65747820|FG002|Overall Study|Withdrawal by Subject|0|||
23552416|NCT05054374|65747821|FG003|Overall Study|Withdrawal by Subject|0|||
23552417|NCT05054374|65747818|FG000|Overall Study|Progressive Disease|5|||
23552418|NCT05054374|65747819|FG001|Overall Study|Progressive Disease|0|||
23552419|NCT05054374|65747820|FG002|Overall Study|Progressive Disease|0|||
23552420|NCT05054374|65747821|FG003|Overall Study|Progressive Disease|0|||
23552421|NCT04058353|65747824|FG000|Overall Study|Adverse Event|2|||
23430927|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Death|0|||
23430928|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Death|0|||
23430929|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Death|0|||
23430930|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Death|1|||
23430931|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Death|0|||
23430932|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Missing|0|||
23822007|NCT02794246|66726218|FG000|Overall Study|Withdrawal by Subject|2|||
23822008|NCT02794246|66726218|FG000|Overall Study|Physician Decision|4|||
23430933|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Missing|0|||
23430934|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Missing|1|||
23430935|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Missing|0|||
23430936|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Missing|0|||
23430937|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
23430938|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
23430939|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
23430940|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
23430941|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
23430942|NCT01519674|65320748|FG000|Overall Study|Adverse Event|3|||
23430943|NCT01519674|65320749|FG001|Overall Study|Adverse Event|3|||
23430944|NCT01519674|65320750|FG002|Overall Study|Adverse Event|0|||
23430945|NCT01519674|65320748|FG000|Overall Study|Lack of Efficacy|1|||
23430946|NCT01519674|65320749|FG001|Overall Study|Lack of Efficacy|1|||
23430947|NCT01519674|65320750|FG002|Overall Study|Lack of Efficacy|1|||
23430948|NCT01519674|65320748|FG000|Overall Study|Protocol Violation|0|||
23430949|NCT01519674|65320749|FG001|Overall Study|Protocol Violation|3|||
23430950|NCT01519674|65320750|FG002|Overall Study|Protocol Violation|1|||
23430951|NCT01519674|65320748|FG000|Overall Study|Withdrawal Criteria|7|||
23430952|NCT01519674|65320749|FG001|Overall Study|Withdrawal Criteria|2|||
23430953|NCT01519674|65320750|FG002|Overall Study|Withdrawal Criteria|7|||
23430954|NCT01519674|65320748|FG000|Overall Study|Unsclassified|10|||
23430955|NCT01519674|65320749|FG001|Overall Study|Unsclassified|4|||
23430956|NCT01519674|65320750|FG002|Overall Study|Unsclassified|3|||
23430957|NCT02279498|65320752|FG000|Overall Study|Adverse Event|3|||
23430958|NCT02279498|65320753|FG001|Overall Study|Adverse Event|0|||
23552422|NCT04058353|65747825|FG001|Overall Study|Adverse Event|1|||
23822009|NCT01964976|66726221|FG000|Overall Study|Protocol Violation|31|||
23430959|NCT02279498|65320752|FG000|Overall Study|Lack of Efficacy|4|||
23430960|NCT02279498|65320753|FG001|Overall Study|Lack of Efficacy|0|||
23552423|NCT04058353|65747824|FG000|Overall Study|Physician Decision|1|||
23552424|NCT04058353|65747825|FG001|Overall Study|Physician Decision|0|||
23552425|NCT04058353|65747824|FG000|Overall Study|Other|1|||
23822010|NCT03464630|66726222|FG000|Overall Study|Lost to Follow-up|62|||
23552426|NCT04058353|65747825|FG001|Overall Study|Other|0|||
23552427|NCT03204279|65747826|FG000|Overall Study|Withdrawal by Subject|0|||
23430961|NCT02279498|65320752|FG000|Overall Study|Lost to Follow-up|0|||
23430962|NCT02279498|65320753|FG001|Overall Study|Lost to Follow-up|1|||
23430963|NCT02279498|65320752|FG000|Overall Study|Withdrawal by Subject|9|||
23430964|NCT02279498|65320753|FG001|Overall Study|Withdrawal by Subject|2|||
23430965|NCT02279498|65320752|FG000|Overall Study|Undefined|2|||
23430966|NCT02279498|65320753|FG001|Overall Study|Undefined|1|||
23430967|NCT01565941|65320754|FG000|Overall Study|Withdrawn by parent/guardian|3|||
23430968|NCT01565941|65320755|FG001|Overall Study|Withdrawn by parent/guardian|2|||
23430969|NCT01565941|65320754|FG000|Overall Study|Randomized; did not receive intevention|8|||
23430970|NCT01565941|65320755|FG001|Overall Study|Randomized; did not receive intevention|2|||
23430971|NCT05059977|65320756|FG000|Overall Study|Withdrawal by Subject|0|||
23430972|NCT05059977|65320757|FG001|Overall Study|Withdrawal by Subject|0|||
23430973|NCT05059977|65320758|FG002|Overall Study|Withdrawal by Subject|1|||
23430974|NCT01319721|65320759|FG000|Overall Study|Lost to Follow-up|1|||
23430975|NCT01319721|65320760|FG001|Overall Study|Lost to Follow-up|6|||
23430976|NCT01198509|65320761|FG000|Overall Study|Withdrawal by Subject|1|||
23430977|NCT01198509|65320762|FG001|Overall Study|Withdrawal by Subject|0|||
23430978|NCT01198509|65320763|FG002|Overall Study|Withdrawal by Subject|0|||
23430979|NCT01198509|65320764|FG003|Overall Study|Withdrawal by Subject|0|||
23430980|NCT01198509|65320765|FG004|Overall Study|Withdrawal by Subject|0|||
23430981|NCT01198509|65320766|FG005|Overall Study|Withdrawal by Subject|0|||
23430982|NCT00587847|65320769|FG000|Overall Study|Lack of Efficacy|5|||
23430983|NCT00587847|65320769|FG000|Overall Study|Adverse Event|2|||
23430984|NCT00160654|65320770|FG000|Overall Study|Adverse Event|14|||
23430985|NCT00160654|65320770|FG000|Overall Study|Lack of Efficacy|4|||
23430986|NCT00160654|65320770|FG000|Overall Study|Lost to Follow-up|2|||
23430987|NCT00160654|65320770|FG000|Overall Study|Intake of expired drug|7|||
23430988|NCT00160654|65320770|FG000|Overall Study|Psychological trauma|1|||
23430989|NCT00160654|65320770|FG000|Overall Study|Sponsor decision|1|||
23430990|NCT00160654|65320770|FG000|Overall Study|Patient met exclusion criteria|1|||
23430991|NCT00160654|65320770|FG000|Overall Study|Patient decision|1|||
23430992|NCT00160654|65320770|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
23430993|NCT00160654|65320770|FG000|Overall Study|Met exclusion criteria|1|||
23430994|NCT00870194|65320771|FG000|Overall Study|Adverse Event|10|||
23430995|NCT00870194|65320772|FG001|Overall Study|Adverse Event|5|||
23430996|NCT00870194|65320771|FG000|Overall Study|Lack of Efficacy|0|||
23430997|NCT00870194|65320772|FG001|Overall Study|Lack of Efficacy|1|||
23430998|NCT00870194|65320771|FG000|Overall Study|Lost to Follow-up|2|||
23430999|NCT00870194|65320772|FG001|Overall Study|Lost to Follow-up|0|||
23431000|NCT00870194|65320771|FG000|Overall Study|Physician Decision|3|||
23431001|NCT00870194|65320772|FG001|Overall Study|Physician Decision|1|||
23431002|NCT00870194|65320771|FG000|Overall Study|Protocol Violation|3|||
23431003|NCT00870194|65320772|FG001|Overall Study|Protocol Violation|3|||
23431004|NCT00870194|65320771|FG000|Overall Study|Entry Criteria Not Met|1|||
23431005|NCT00870194|65320772|FG001|Overall Study|Entry Criteria Not Met|2|||
23431006|NCT00870194|65320771|FG000|Overall Study|Subject Decision|7|||
23431007|NCT00870194|65320772|FG001|Overall Study|Subject Decision|2|||
23431008|NCT02544373|65320773|FG000|Overall Study|Lost to Follow-up|5|||
23431009|NCT02544373|65320774|FG001|Overall Study|Lost to Follow-up|3|||
23431010|NCT02544373|65320773|FG000|Overall Study|Withdrawal by Subject|8|||
23431011|NCT02544373|65320774|FG001|Overall Study|Withdrawal by Subject|2|||
23431012|NCT01831817|65320775|FG000|Overall Study|Lost to Follow-up|1|||
23431013|NCT01831817|65320776|FG001|Overall Study|Lost to Follow-up|0|||
23431014|NCT01831817|65320777|FG002|Overall Study|Lost to Follow-up|0|||
23431015|NCT01831817|65320778|FG003|Overall Study|Lost to Follow-up|0|||
23431016|NCT01831817|65320775|FG000|Overall Study|Withdrawl of Consent|3|||
23552428|NCT03204279|65747827|FG001|Overall Study|Withdrawal by Subject|1|||
23552429|NCT04528069|65747828|FG000|Overall Study|Adverse Event|1|||
23552430|NCT04528069|65747828|FG000|Overall Study|Lost to Follow-up|1|||
23552431|NCT04528069|65747828|FG000|Overall Study|Patient Unable to Come|1|||
23552432|NCT04528069|65747828|FG000|Overall Study|Patient Unable to Attend|1|||
23431017|NCT01831817|65320776|FG001|Overall Study|Withdrawl of Consent|0|||
23431018|NCT01831817|65320777|FG002|Overall Study|Withdrawl of Consent|0|||
23552433|NCT00626028|65747829|FG000|Overall Study|Adverse Event|1|||
23431019|NCT01831817|65320778|FG003|Overall Study|Withdrawl of Consent|0|||
23431020|NCT04375397|65320779|FG000|Overall Study|Death|1|||
23431021|NCT04375397|65320780|FG001|Overall Study|Death|1|||
23431022|NCT04375397|65320779|FG000|Overall Study|Withdrew consent|2|||
23431023|NCT04375397|65320780|FG001|Overall Study|Withdrew consent|0|||
23621549|NCT02330562|66000686|FG004|Overall Study|Withdrawal by Subject|0|||
23431024|NCT04375397|65320779|FG000|Overall Study|Lost to Follow-up|6|||
23431025|NCT04375397|65320780|FG001|Overall Study|Lost to Follow-up|4|||
23431026|NCT04375397|65320779|FG000|Overall Study|Other, not specified|0|||
23431027|NCT04375397|65320780|FG001|Overall Study|Other, not specified|1|||
23431028|NCT00869401|65320781|FG000|Overall Study|Withdrawal by Subject|0|||
23431029|NCT00869401|65320782|FG001|Overall Study|Withdrawal by Subject|0|||
23552434|NCT00626028|65747830|FG001|Overall Study|Adverse Event|1|||
23552435|NCT00626028|65747829|FG000|Overall Study|Device Failure|0|||
23552436|NCT00626028|65747830|FG001|Overall Study|Device Failure|1|||
23552437|NCT00626028|65747829|FG000|Overall Study|Physician Decision|2|||
23552438|NCT00626028|65747830|FG001|Overall Study|Physician Decision|1|||
23552439|NCT00626028|65747829|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
23552440|NCT00626028|65747830|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
23552441|NCT00763958|65747835|FG000|Overall Study|did not meet final criteria|4|||
23552442|NCT00763958|65747836|FG001|Overall Study|did not meet final criteria|4|||
23552443|NCT00763958|65747835|FG000|Overall Study|Lost to Follow-up|10|||
23744515|NCT00313716|66443261|FG002|Overall Study|Lost to Follow-up|2|||
23744516|NCT00313716|66443262|FG003|Overall Study|Lost to Follow-up|1|||
23744517|NCT00313716|66443263|FG004|Overall Study|Lost to Follow-up|0|||
23744518|NCT00313716|66443264|FG005|Overall Study|Lost to Follow-up|4|||
23744519|NCT00313716|66443259|FG000|Overall Study|Withdrawal by Subject|0|||
23744520|NCT00313716|66443260|FG001|Overall Study|Withdrawal by Subject|1|||
23744521|NCT00313716|66443261|FG002|Overall Study|Withdrawal by Subject|1|||
23744522|NCT00313716|66443262|FG003|Overall Study|Withdrawal by Subject|0|||
23744523|NCT00313716|66443263|FG004|Overall Study|Withdrawal by Subject|1|||
23744524|NCT00313716|66443264|FG005|Overall Study|Withdrawal by Subject|0|||
23744525|NCT00689728|66443265|FG000|Double-Blind Treatment|Adverse Event|1|||
23822011|NCT03464630|66726223|FG001|Overall Study|Lost to Follow-up|52|||
23552444|NCT00763958|65747836|FG001|Overall Study|Lost to Follow-up|2|||
23822012|NCT03464630|66726222|FG000|Overall Study|Withdrawal by Subject|16|||
23822013|NCT03464630|66726223|FG001|Overall Study|Withdrawal by Subject|10|||
23822014|NCT03464630|66726222|FG000|Overall Study|Passive Disengagement|8|||
23822015|NCT03464630|66726223|FG001|Overall Study|Passive Disengagement|4|||
23822016|NCT01822366|66726226|FG000|Overall Study|Lost to Follow-up|5|||
23822017|NCT01822366|66726227|FG001|Overall Study|Lost to Follow-up|1|||
23822018|NCT01822366|66726228|FG002|Overall Study|Lost to Follow-up|5|||
23822019|NCT01822366|66726229|FG003|Overall Study|Lost to Follow-up|1|||
23822020|NCT01822366|66726226|FG000|Overall Study|Withdrawal by Subject|0|||
23822021|NCT01822366|66726227|FG001|Overall Study|Withdrawal by Subject|6|||
23822022|NCT01822366|66726228|FG002|Overall Study|Withdrawal by Subject|0|||
23822023|NCT01822366|66726229|FG003|Overall Study|Withdrawal by Subject|6|||
23822024|NCT01822366|66726226|FG000|Overall Study|Partial Intervention Completion|0|||
23822025|NCT01822366|66726227|FG001|Overall Study|Partial Intervention Completion|15|||
23822026|NCT01822366|66726228|FG002|Overall Study|Partial Intervention Completion|0|||
23552445|NCT00763958|65747835|FG000|Overall Study|Believed they were receiving placebo|0|||
23552446|NCT00763958|65747836|FG001|Overall Study|Believed they were receiving placebo|5|||
23744526|NCT00689728|66443266|FG001|Double-Blind Treatment|Adverse Event|0|||
23744527|NCT00689728|66443267|FG002|Double-Blind Treatment|Adverse Event|0|||
23744528|NCT00689728|66443265|FG000|Double-Blind Treatment|Protocol Violation|0|||
23744529|NCT00689728|66443266|FG001|Double-Blind Treatment|Protocol Violation|0|||
23822027|NCT01822366|66726229|FG003|Overall Study|Partial Intervention Completion|15|||
23552447|NCT02858895|65747842|FG000|Overall Study|Disease progression|31|||
23552448|NCT02858895|65747842|FG000|Overall Study|Death|2|||
23552449|NCT02858895|65747842|FG000|Overall Study|Adverse Event|1|||
23552450|NCT02858895|65747842|FG000|Overall Study|Withdrawal by Subject|3|||
23552451|NCT02858895|65747842|FG000|Overall Study|hospice,|1|||
23552452|NCT02858895|65747842|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
23744530|NCT00689728|66443267|FG002|Double-Blind Treatment|Protocol Violation|1|||
23744531|NCT00689728|66443265|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
23744532|NCT00689728|66443266|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
23744533|NCT00689728|66443267|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
23822028|NCT01346293|66726238|FG000|Overall Study|Protocol Violation|30|||
23822029|NCT01346293|66726239|FG001|Overall Study|Protocol Violation|9|||
23744534|NCT00689728|66443265|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
23822030|NCT01346293|66726238|FG000|Overall Study|Lost to Follow-up|21|||
23552453|NCT01749982|65747843|FG000|Overall Study|Physician Decision|0|||
23552454|NCT01749982|65747844|FG001|Overall Study|Physician Decision|0|||
23552455|NCT01749982|65747845|FG002|Overall Study|Physician Decision|0|||
23552456|NCT01749982|65747846|FG003|Overall Study|Physician Decision|1|||
23552457|NCT01749982|65747843|FG000|Overall Study|Lost to Follow-up|0|||
23552458|NCT01749982|65747844|FG001|Overall Study|Lost to Follow-up|0|||
23552459|NCT01749982|65747845|FG002|Overall Study|Lost to Follow-up|0|||
23552460|NCT01749982|65747846|FG003|Overall Study|Lost to Follow-up|1|||
23552461|NCT01749982|65747843|FG000|Overall Study|Withdrawal by Subject|0|||
23552462|NCT01749982|65747844|FG001|Overall Study|Withdrawal by Subject|0|||
23552463|NCT01749982|65747845|FG002|Overall Study|Withdrawal by Subject|0|||
23552464|NCT01749982|65747846|FG003|Overall Study|Withdrawal by Subject|1|||
23552465|NCT02820623|65747847|FG000|Overall Study|Withdrawal by Subject|1|||
23744535|NCT00689728|66443266|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
23744536|NCT00689728|66443267|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
23744537|NCT00689728|66443265|FG000|Rescue|Adverse Event|0|||
23744538|NCT00689728|66443266|FG001|Rescue|Adverse Event|1|||
23744539|NCT00689728|66443267|FG002|Rescue|Adverse Event|0|||
23744540|NCT00689728|66443265|FG000|Rescue|Withdrawal by Subject|1|||
23744541|NCT00689728|66443266|FG001|Rescue|Withdrawal by Subject|1|||
23744542|NCT00689728|66443267|FG002|Rescue|Withdrawal by Subject|1|||
23744543|NCT00689728|66443265|FG000|Optional Follow-Up|Adverse Event|1|||
23744544|NCT00689728|66443266|FG001|Optional Follow-Up|Adverse Event|0|||
23552466|NCT02820623|65747848|FG001|Overall Study|Withdrawal by Subject|3|||
23552467|NCT02820623|65747849|FG002|Overall Study|Withdrawal by Subject|3|||
23552468|NCT02820623|65747847|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
23744545|NCT00689728|66443267|FG002|Optional Follow-Up|Adverse Event|0|||
23744546|NCT00689728|66443265|FG000|Optional Follow-Up|Lack of Efficacy|0|||
23744547|NCT00689728|66443266|FG001|Optional Follow-Up|Lack of Efficacy|1|||
23744548|NCT00689728|66443267|FG002|Optional Follow-Up|Lack of Efficacy|1|||
23744549|NCT00689728|66443265|FG000|Optional Follow-Up|Lost to Follow-up|0|||
23744550|NCT00689728|66443266|FG001|Optional Follow-Up|Lost to Follow-up|1|||
23744551|NCT00689728|66443267|FG002|Optional Follow-Up|Lost to Follow-up|1|||
23744552|NCT00689728|66443265|FG000|Optional Follow-Up|Protocol Violation|0|||
23744553|NCT00689728|66443266|FG001|Optional Follow-Up|Protocol Violation|0|||
23744554|NCT00689728|66443267|FG002|Optional Follow-Up|Protocol Violation|1|||
23744555|NCT00689728|66443265|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
23744556|NCT00689728|66443266|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
23744557|NCT00689728|66443267|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
23744558|NCT00663208|66443271|FG000|Treatment Period|Lost to Follow-up|0|||
23744559|NCT00663208|66443272|FG001|Treatment Period|Lost to Follow-up|1|||
23744560|NCT00663208|66443273|FG002|Treatment Period|Lost to Follow-up|0|||
23744561|NCT00663208|66443274|FG003|Treatment Period|Lost to Follow-up|0|||
23744562|NCT00663208|66443275|FG004|Treatment Period|Lost to Follow-up|0|||
23744563|NCT00663208|66443276|FG005|Treatment Period|Lost to Follow-up|0|||
23744564|NCT00663208|66443277|FG006|Treatment Period|Lost to Follow-up|0|||
23744565|NCT00663208|66443271|FG000|Follow-up Period|Lost to Follow-up|2|||
23744566|NCT00663208|66443272|FG001|Follow-up Period|Lost to Follow-up|0|||
23744567|NCT00663208|66443273|FG002|Follow-up Period|Lost to Follow-up|3|||
23744568|NCT00663208|66443274|FG003|Follow-up Period|Lost to Follow-up|2|||
23744569|NCT00663208|66443275|FG004|Follow-up Period|Lost to Follow-up|0|||
23744570|NCT00663208|66443276|FG005|Follow-up Period|Lost to Follow-up|0|||
23744571|NCT00663208|66443277|FG006|Follow-up Period|Lost to Follow-up|0|||
23744572|NCT00663208|66443271|FG000|Follow-up Period|Other reason|1|||
23744573|NCT00663208|66443272|FG001|Follow-up Period|Other reason|0|||
23744574|NCT00663208|66443273|FG002|Follow-up Period|Other reason|0|||
23744575|NCT00663208|66443274|FG003|Follow-up Period|Other reason|0|||
23744576|NCT00663208|66443275|FG004|Follow-up Period|Other reason|0|||
23744577|NCT00663208|66443276|FG005|Follow-up Period|Other reason|0|||
23744578|NCT00663208|66443277|FG006|Follow-up Period|Other reason|1|||
23744579|NCT02163759|66443278|FG000|Overall Study|Withdrawal by Subject|1|||
23744580|NCT02163759|66443279|FG001|Overall Study|Withdrawal by Subject|5|||
23744581|NCT02163759|66443280|FG002|Overall Study|Withdrawal by Subject|1|||
23744582|NCT02163759|66443278|FG000|Overall Study|Adverse Event|0|||
23744583|NCT02163759|66443279|FG001|Overall Study|Adverse Event|0|||
23744584|NCT02163759|66443280|FG002|Overall Study|Adverse Event|1|||
23744585|NCT02163759|66443278|FG000|Overall Study|Death|0|||
23552469|NCT02820623|65747848|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
23744586|NCT02163759|66443279|FG001|Overall Study|Death|0|||
23744587|NCT02163759|66443280|FG002|Overall Study|Death|1|||
23744588|NCT02543918|66443281|FG000|Overall Study|Never treated|0|||
23744589|NCT02543918|66443282|FG001|Overall Study|Never treated|1|||
23822031|NCT01346293|66726239|FG001|Overall Study|Lost to Follow-up|8|||
23744590|NCT02543918|66443281|FG000|Overall Study|Lost to Follow-up|1|||
23744591|NCT02543918|66443282|FG001|Overall Study|Lost to Follow-up|1|||
23744592|NCT02543918|66443281|FG000|Overall Study|Withdrawal by Subject|1|||
23744593|NCT02543918|66443282|FG001|Overall Study|Withdrawal by Subject|1|||
23552470|NCT02820623|65747849|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
23552471|NCT02820623|65747847|FG000|Overall Study|Therapist unable to enroll clients|1|||
23552472|NCT02820623|65747848|FG001|Overall Study|Therapist unable to enroll clients|1|||
23431030|NCT00869401|65320783|FG002|Overall Study|Withdrawal by Subject|0|||
23431031|NCT00869401|65320784|FG003|Overall Study|Withdrawal by Subject|5|||
23431032|NCT00869401|65320785|FG004|Overall Study|Withdrawal by Subject|3|||
23431033|NCT02337725|65320786|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
23431034|NCT02337725|65320787|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
23431035|NCT02337725|65320786|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
23431036|NCT02337725|65320787|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
23431037|NCT02337725|65320786|FG000|Overall Study|Major Protocol Deviation|0|||
23431038|NCT02337725|65320787|FG001|Overall Study|Major Protocol Deviation|1|||
23431039|NCT02337725|65320786|FG000|Overall Study|Voluntary Withdrawal|14|||
23431040|NCT02337725|65320787|FG001|Overall Study|Voluntary Withdrawal|3|||
23431041|NCT02337725|65320786|FG000|Overall Study|Lack of Efficacy|4|||
23431042|NCT02337725|65320787|FG001|Overall Study|Lack of Efficacy|0|||
23431043|NCT00548717|65320790|FG000|Overall Study|Death|5|||
23431044|NCT00548717|65320791|FG001|Overall Study|Death|2|||
23431045|NCT00548717|65320790|FG000|Overall Study|Relapse|3|||
23431046|NCT00548717|65320791|FG001|Overall Study|Relapse|0|||
23431047|NCT00548717|65320790|FG000|Overall Study|Alternative treatment for GVHD|1|||
23744594|NCT02543918|66443281|FG000|Overall Study|Adverse Event|1|||
23744595|NCT02543918|66443282|FG001|Overall Study|Adverse Event|1|||
23744596|NCT02992743|66443285|FG000|Overall Study|Withdrawal by Subject|1|||
23744597|NCT02992743|66443286|FG001|Overall Study|Withdrawal by Subject|1|||
23744598|NCT02992743|66443285|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
23744599|NCT02992743|66443286|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
23744600|NCT02992743|66443285|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
23744601|NCT02992743|66443286|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
23744602|NCT02992743|66443285|FG000|Overall Study|No measurable disease|1|||
23431048|NCT00548717|65320791|FG001|Overall Study|Alternative treatment for GVHD|0|||
23431049|NCT02455076|65320798|FG000|Inpatient|Withdrawal by Subject|1|||
23431050|NCT02455076|65320799|FG001|Inpatient|Withdrawal by Subject|0|||
23431051|NCT02455076|65320800|FG002|Inpatient|Withdrawal by Subject|0|||
23431052|NCT02455076|65320801|FG003|Inpatient|Withdrawal by Subject|0|||
23431053|NCT02455076|65320802|FG004|Inpatient|Withdrawal by Subject|0|||
23431054|NCT02455076|65320798|FG000|Inpatient|Discharged <24 h after admission|0|||
23431055|NCT02455076|65320799|FG001|Inpatient|Discharged <24 h after admission|1|||
23431056|NCT02455076|65320800|FG002|Inpatient|Discharged <24 h after admission|0|||
23431057|NCT02455076|65320801|FG003|Inpatient|Discharged <24 h after admission|0|||
23431058|NCT02455076|65320802|FG004|Inpatient|Discharged <24 h after admission|0|||
23431059|NCT02455076|65320798|FG000|Inpatient|Adverse Event|3|||
23431060|NCT02455076|65320799|FG001|Inpatient|Adverse Event|0|||
23431061|NCT02455076|65320800|FG002|Inpatient|Adverse Event|0|||
23431062|NCT02455076|65320801|FG003|Inpatient|Adverse Event|0|||
23431063|NCT02455076|65320802|FG004|Inpatient|Adverse Event|0|||
23431064|NCT02455076|65320798|FG000|Outpatient|Adverse Event|0|||
23431065|NCT02455076|65320799|FG001|Outpatient|Adverse Event|0|||
23431066|NCT02455076|65320800|FG002|Outpatient|Adverse Event|0|||
23431067|NCT02455076|65320801|FG003|Outpatient|Adverse Event|5|||
23431068|NCT02455076|65320802|FG004|Outpatient|Adverse Event|0|||
23431069|NCT02455076|65320798|FG000|Outpatient|Lost to Follow-up|0|||
23431070|NCT02455076|65320799|FG001|Outpatient|Lost to Follow-up|0|||
23431071|NCT02455076|65320800|FG002|Outpatient|Lost to Follow-up|0|||
23431072|NCT02455076|65320801|FG003|Outpatient|Lost to Follow-up|1|||
23431073|NCT02455076|65320802|FG004|Outpatient|Lost to Follow-up|12|||
23431074|NCT00581360|65323952|FG000|Overall Study|Withdrawal by Subject|1|||
23431075|NCT01300455|65323953|FG000|Washout|Withdrawal by Subject|1|||
23431076|NCT01300455|65323954|FG001|Washout|Withdrawal by Subject|0|||
23431077|NCT00453973|65323955|FG000|Overall Study|Adverse Event|4|||
23431078|NCT00453973|65323956|FG001|Overall Study|Adverse Event|9|||
23431079|NCT00453973|65323955|FG000|Overall Study|Withdrawal by Subject|7|||
23431080|NCT00453973|65323956|FG001|Overall Study|Withdrawal by Subject|6|||
23744603|NCT02992743|66443286|FG001|Overall Study|No measurable disease|0|||
23822032|NCT01346293|66726238|FG000|Overall Study|Withdrawal by Subject|15|||
23431081|NCT00453973|65323955|FG000|Overall Study|PI Decision|0|||
23431082|NCT00453973|65323956|FG001|Overall Study|PI Decision|2|||
23431083|NCT00453973|65323955|FG000|Overall Study|Relocation|1|||
23431084|NCT00453973|65323956|FG001|Overall Study|Relocation|0|||
23431085|NCT00453973|65323955|FG000|Overall Study|Renal transplant|1|||
23431086|NCT00453973|65323956|FG001|Overall Study|Renal transplant|1|||
23431087|NCT00453973|65323955|FG000|Overall Study|Site closed by sponsor|3|||
23431088|NCT00453973|65323956|FG001|Overall Study|Site closed by sponsor|0|||
23431089|NCT00453973|65323955|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
23431090|NCT00453973|65323956|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
23431091|NCT00300365|65323957|FG000|Overall Study|Lost to Follow-up|1|||
23431092|NCT00300365|65323958|FG001|Overall Study|Lost to Follow-up|0|||
23431093|NCT00300365|65323957|FG000|Overall Study|Physician Decision|2|||
23431094|NCT00300365|65323958|FG001|Overall Study|Physician Decision|0|||
23431095|NCT00300365|65323957|FG000|Overall Study|Withdrawal by Subject|1|||
23744604|NCT02992743|66443285|FG000|Overall Study|Lost to Follow-up|0|||
23744605|NCT02992743|66443286|FG001|Overall Study|Lost to Follow-up|1|||
23744606|NCT00938366|66443287|FG000|Overall Study|Withdrawal by Subject|1|||
23744607|NCT00938366|66443288|FG001|Overall Study|Withdrawal by Subject|0|||
23744608|NCT00690573|66443289|FG000|Overall Study|Lack of Efficacy|8|||
23744609|NCT00690573|66443289|FG000|Overall Study|Withdrawal by Subject|1|||
23744610|NCT01381068|66443290|FG000|Overall Study|Death|1|||
23744611|NCT01381068|66443291|FG001|Overall Study|Death|0|||
23744612|NCT02268214|66443295|FG000|Overall Study|Subject no longer meets study criteria|0|||
23744613|NCT02268214|66443296|FG001|Overall Study|Subject no longer meets study criteria|2|||
23744614|NCT02268214|66443297|FG002|Overall Study|Subject no longer meets study criteria|0|||
23744615|NCT02268214|66443295|FG000|Overall Study|Pregnancy|2|||
23744616|NCT02268214|66443296|FG001|Overall Study|Pregnancy|2|||
23744617|NCT02268214|66443297|FG002|Overall Study|Pregnancy|1|||
23744618|NCT02268214|66443295|FG000|Overall Study|Lost to Follow-up|3|||
23744619|NCT02268214|66443296|FG001|Overall Study|Lost to Follow-up|3|||
23744620|NCT02268214|66443297|FG002|Overall Study|Lost to Follow-up|4|||
23744621|NCT02268214|66443295|FG000|Overall Study|Lack of Efficacy|1|||
23744622|NCT02268214|66443296|FG001|Overall Study|Lack of Efficacy|0|||
23744623|NCT02268214|66443297|FG002|Overall Study|Lack of Efficacy|2|||
23744624|NCT02268214|66443295|FG000|Overall Study|Adverse Event|11|||
23744625|NCT02268214|66443296|FG001|Overall Study|Adverse Event|14|||
23744626|NCT02268214|66443297|FG002|Overall Study|Adverse Event|9|||
23744627|NCT02268214|66443295|FG000|Overall Study|Withdrawal by Subject|4|||
23744628|NCT02268214|66443296|FG001|Overall Study|Withdrawal by Subject|5|||
23744629|NCT02268214|66443297|FG002|Overall Study|Withdrawal by Subject|10|||
23744630|NCT02268214|66443295|FG000|Overall Study|Subject request to discontinue treatment|10|||
23744631|NCT02268214|66443296|FG001|Overall Study|Subject request to discontinue treatment|8|||
23744632|NCT02268214|66443297|FG002|Overall Study|Subject request to discontinue treatment|6|||
23744633|NCT02268214|66443295|FG000|Overall Study|Poor/non-compliance|2|||
23744634|NCT02268214|66443296|FG001|Overall Study|Poor/non-compliance|1|||
23744635|NCT02268214|66443297|FG002|Overall Study|Poor/non-compliance|2|||
23431096|NCT00300365|65323958|FG001|Overall Study|Withdrawal by Subject|0|||
23431097|NCT00300365|65323957|FG000|Overall Study|Adverse Event|0|||
23431098|NCT00300365|65323958|FG001|Overall Study|Adverse Event|2|||
23431099|NCT00129467|65323959|FG000|Received Intervention|Death|1|||
23431100|NCT00129467|65323960|FG001|Received Intervention|Death|1|||
23431101|NCT00129467|65323959|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
23431102|NCT00129467|65323960|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
23431103|NCT00129467|65323959|FG000|Received Intervention|Delirium|2|||
23431104|NCT00129467|65323960|FG001|Received Intervention|Delirium|0|||
23431105|NCT00129467|65323959|FG000|Received Intervention|Withdrawal by Subject|1|||
23431106|NCT00129467|65323960|FG001|Received Intervention|Withdrawal by Subject|0|||
23431107|NCT00129467|65323959|FG000|Received Intervention|Nausea|1|||
23431108|NCT00129467|65323960|FG001|Received Intervention|Nausea|0|||
23431109|NCT00129467|65323959|FG000|Received Intervention|Intolerance to citalopram|0|||
23431110|NCT00129467|65323960|FG001|Received Intervention|Intolerance to citalopram|1|||
23431111|NCT00129467|65323959|FG000|Received Intervention|Dizzyness, fatigue|0|||
23431112|NCT00129467|65323960|FG001|Received Intervention|Dizzyness, fatigue|1|||
23431113|NCT00129467|65323959|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
23431114|NCT00129467|65323960|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
23431115|NCT00129467|65323959|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
23431116|NCT00129467|65323960|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
23431117|NCT00903331|65323961|FG000|Overall Study|Death|4|||
23431118|NCT00903331|65323962|FG001|Overall Study|Death|8|||
23431119|NCT00903331|65323961|FG000|Overall Study|Withdrawal of consent|1|||
23431120|NCT00903331|65323962|FG001|Overall Study|Withdrawal of consent|8|||
23431121|NCT00903331|65323961|FG000|Overall Study|Lung transplant|0|||
23431122|NCT00903331|65323962|FG001|Overall Study|Lung transplant|2|||
23431123|NCT00708734|65323965|FG000|Overall Study|scheduling conflict|2|||
23431124|NCT00708734|65323965|FG000|Overall Study|moved|1|||
23744636|NCT02268214|66443295|FG000|Overall Study|Other reasons|7|||
23744637|NCT02268214|66443296|FG001|Overall Study|Other reasons|3|||
23431125|NCT00708734|65323965|FG000|Overall Study|leg injury|1|||
23431126|NCT00708734|65323965|FG000|Overall Study|knee replacement|1|||
23431127|NCT00708734|65323965|FG000|Overall Study|vertigo|1|||
23431128|NCT00708734|65323965|FG000|Overall Study|leg fracture|1|||
23431129|NCT01969721|65323966|FG000|Overall Study|Adverse Event|3|||
23431130|NCT01969721|65323967|FG001|Overall Study|Adverse Event|8|||
23431131|NCT01969721|65323968|FG002|Overall Study|Adverse Event|3|||
23431132|NCT01969721|65323969|FG003|Overall Study|Adverse Event|2|||
23431133|NCT01969721|65323966|FG000|Overall Study|Lack of Efficacy|0|||
23744638|NCT02268214|66443297|FG002|Overall Study|Other reasons|3|||
23744639|NCT02268214|66443295|FG000|Overall Study|Not entering long-term period|2|||
23431134|NCT01969721|65323967|FG001|Overall Study|Lack of Efficacy|0|||
23431135|NCT01969721|65323968|FG002|Overall Study|Lack of Efficacy|1|||
23431136|NCT01969721|65323969|FG003|Overall Study|Lack of Efficacy|0|||
23431137|NCT01969721|65323966|FG000|Overall Study|Non compliant with protocol|1|||
23431138|NCT01969721|65323967|FG001|Overall Study|Non compliant with protocol|1|||
23431139|NCT01969721|65323968|FG002|Overall Study|Non compliant with protocol|0|||
23431140|NCT01969721|65323969|FG003|Overall Study|Non compliant with protocol|2|||
23431141|NCT01969721|65323966|FG000|Overall Study|Other not defined above|0|||
23431142|NCT01969721|65323967|FG001|Overall Study|Other not defined above|2|||
23431143|NCT01969721|65323968|FG002|Overall Study|Other not defined above|0|||
23431144|NCT01969721|65323969|FG003|Overall Study|Other not defined above|0|||
23431145|NCT01969721|65323966|FG000|Overall Study|Discontinued during washout periods.|0|||
23431146|NCT01969721|65323967|FG001|Overall Study|Discontinued during washout periods.|1|||
23431147|NCT01969721|65323968|FG002|Overall Study|Discontinued during washout periods.|1|||
23431148|NCT01969721|65323969|FG003|Overall Study|Discontinued during washout periods.|2|||
23431149|NCT03429543|65323970|FG000|Overall Study|Adverse Event|1|||
23431150|NCT03429543|65323971|FG001|Overall Study|Adverse Event|1|||
23431151|NCT03429543|65323972|FG002|Overall Study|Adverse Event|0|||
23431152|NCT03429543|65323973|FG003|Overall Study|Adverse Event|0|||
23431153|NCT03429543|65323974|FG004|Overall Study|Adverse Event|0|||
23431154|NCT03429543|65323975|FG005|Overall Study|Adverse Event|2|||
23431155|NCT03429543|65323976|FG006|Overall Study|Adverse Event|0|||
23431156|NCT03429543|65323970|FG000|Overall Study|Lost to Follow-up|1|||
23431157|NCT03429543|65323971|FG001|Overall Study|Lost to Follow-up|0|||
23431158|NCT03429543|65323972|FG002|Overall Study|Lost to Follow-up|0|||
23431159|NCT03429543|65323973|FG003|Overall Study|Lost to Follow-up|0|||
23431160|NCT03429543|65323974|FG004|Overall Study|Lost to Follow-up|1|||
23431161|NCT03429543|65323975|FG005|Overall Study|Lost to Follow-up|0|||
23431162|NCT03429543|65323976|FG006|Overall Study|Lost to Follow-up|0|||
23431163|NCT03429543|65323970|FG000|Overall Study|Withdrawal by Subject|5|||
23431164|NCT03429543|65323971|FG001|Overall Study|Withdrawal by Subject|0|||
23431165|NCT03429543|65323972|FG002|Overall Study|Withdrawal by Subject|1|||
23431166|NCT03429543|65323973|FG003|Overall Study|Withdrawal by Subject|2|||
23431167|NCT03429543|65323974|FG004|Overall Study|Withdrawal by Subject|6|||
23431168|NCT03429543|65323975|FG005|Overall Study|Withdrawal by Subject|3|||
23431169|NCT03429543|65323976|FG006|Overall Study|Withdrawal by Subject|1|||
23431170|NCT03429543|65323970|FG000|Overall Study|Other reason than listed|0|||
23431171|NCT03429543|65323971|FG001|Overall Study|Other reason than listed|1|||
23431172|NCT03429543|65323972|FG002|Overall Study|Other reason than listed|0|||
23431173|NCT03429543|65323973|FG003|Overall Study|Other reason than listed|0|||
23431174|NCT03429543|65323974|FG004|Overall Study|Other reason than listed|4|||
23431175|NCT03429543|65323975|FG005|Overall Study|Other reason than listed|4|||
23431176|NCT03429543|65323976|FG006|Overall Study|Other reason than listed|0|||
23431177|NCT03429543|65323970|FG000|Overall Study|Not treated|0|||
23431178|NCT03429543|65323971|FG001|Overall Study|Not treated|0|||
23431179|NCT03429543|65323972|FG002|Overall Study|Not treated|0|||
23431180|NCT03429543|65323973|FG003|Overall Study|Not treated|0|||
23431181|NCT03429543|65323974|FG004|Overall Study|Not treated|1|||
23431182|NCT03429543|65323975|FG005|Overall Study|Not treated|0|||
23431183|NCT03429543|65323976|FG006|Overall Study|Not treated|0|||
23431184|NCT00895661|65323977|FG000|Overall Study|Death|1|||
23431185|NCT00895661|65323977|FG000|Overall Study|reason unknown|2|||
23431186|NCT03233438|65323982|FG000|Overall Study|Lost to Follow-up|4|||
23431187|NCT03233438|65323983|FG001|Overall Study|Lost to Follow-up|9|||
23431188|NCT03233438|65323982|FG000|Overall Study|Withdrawal by Subject|2|||
23431189|NCT03233438|65323983|FG001|Overall Study|Withdrawal by Subject|1|||
23431190|NCT03233438|65323982|FG000|Overall Study|No recording of dalbavancin|0|||
23431191|NCT03233438|65323983|FG001|Overall Study|No recording of dalbavancin|1|||
23431192|NCT00924404|65323984|FG000|Overall Study|Lost to Follow-up|6|||
23431193|NCT00924404|65323985|FG001|Overall Study|Lost to Follow-up|4|||
23552473|NCT02820623|65747849|FG002|Overall Study|Therapist unable to enroll clients|3|||
23431194|NCT03769311|65323986|FG000|Overall Study|Withdrawal by Subject|1|||
23431195|NCT00612508|65323987|FG000|Overall Study|Withdrawal by Subject|3|||
23431196|NCT00612508|65323988|FG001|Overall Study|Withdrawal by Subject|4|||
23431197|NCT00845065|65323989|FG000|Overall Study|Adverse Event|3|||
23431198|NCT00845065|65323990|FG001|Overall Study|Adverse Event|23|||
23431199|NCT00845065|65323989|FG000|Overall Study|Lack of Efficacy|43|||
23431200|NCT00845065|65323990|FG001|Overall Study|Lack of Efficacy|21|||
23431201|NCT00845065|65323989|FG000|Overall Study|Non-Medical Reasons|1|||
23431202|NCT00845065|65323990|FG001|Overall Study|Non-Medical Reasons|11|||
23431203|NCT03332160|65323992|FG000|Overall Study|Withdrawal by Subject|1|||
23431204|NCT03332160|65323993|FG001|Overall Study|Withdrawal by Subject|1|||
23431205|NCT03332160|65323992|FG000|Overall Study|Adverse Event|0|||
23431206|NCT03332160|65323993|FG001|Overall Study|Adverse Event|1|||
23431207|NCT03332160|65323992|FG000|Overall Study|Developed Exclusion Criteria|0|||
23431208|NCT03332160|65323993|FG001|Overall Study|Developed Exclusion Criteria|1|||
23431209|NCT03332160|65323992|FG000|Overall Study|Non-adherence to treatment|0|||
23431210|NCT03332160|65323993|FG001|Overall Study|Non-adherence to treatment|2|||
23431211|NCT00881504|65323996|FG000|Overall Study|Withdrawal by Subject|1|||
23431212|NCT01009086|65323997|FG000|Overall Study|Lack of Efficacy|16|||
23431213|NCT01009086|65323998|FG001|Overall Study|Lack of Efficacy|15|||
23431214|NCT01009086|65323999|FG002|Overall Study|Lack of Efficacy|9|||
23431215|NCT01009086|65323997|FG000|Overall Study|Lost to Follow-up|4|||
23431216|NCT01009086|65323998|FG001|Overall Study|Lost to Follow-up|5|||
23431217|NCT01009086|65323999|FG002|Overall Study|Lost to Follow-up|3|||
23431218|NCT01009086|65323997|FG000|Overall Study|Adverse Event|12|||
23431219|NCT01009086|65323998|FG001|Overall Study|Adverse Event|11|||
23431220|NCT01009086|65323999|FG002|Overall Study|Adverse Event|8|||
23431221|NCT01009086|65323997|FG000|Overall Study|Withdrawal by Subject|9|||
23431222|NCT01009086|65323998|FG001|Overall Study|Withdrawal by Subject|11|||
23431223|NCT01009086|65323999|FG002|Overall Study|Withdrawal by Subject|13|||
23431224|NCT01009086|65323997|FG000|Overall Study|Other|3|||
23431225|NCT01009086|65323998|FG001|Overall Study|Other|5|||
23431226|NCT01009086|65323999|FG002|Overall Study|Other|1|||
23431227|NCT02963701|65324000|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
23431228|NCT02963701|65324001|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
23431229|NCT00771615|65324002|FG000|Overall Study|Withdrawal by Subject|0|||
23822033|NCT01346293|66726239|FG001|Overall Study|Withdrawal by Subject|4|||
23822034|NCT01346293|66726238|FG000|Overall Study|Other|1|||
23822035|NCT01346293|66726239|FG001|Overall Study|Other|0|||
23822036|NCT00233948|66730235|FG000|Overall Study|Adverse Event|1|||
23431230|NCT00771615|65324003|FG001|Overall Study|Withdrawal by Subject|1|||
23431231|NCT00771615|65324004|FG002|Overall Study|Withdrawal by Subject|0|||
23431232|NCT00771615|65324005|FG003|Overall Study|Withdrawal by Subject|0|||
23431233|NCT00771615|65324006|FG004|Overall Study|Withdrawal by Subject|0|||
23431234|NCT00771615|65324007|FG005|Overall Study|Withdrawal by Subject|0|||
23431235|NCT00771615|65324008|FG006|Overall Study|Withdrawal by Subject|0|||
23431236|NCT00771615|65324009|FG007|Overall Study|Withdrawal by Subject|1|||
23431237|NCT00771615|65324010|FG008|Overall Study|Withdrawal by Subject|0|||
23431238|NCT00771615|65324002|FG000|Overall Study|Lost to Follow-up|1|||
23431239|NCT00771615|65324003|FG001|Overall Study|Lost to Follow-up|1|||
23431240|NCT00771615|65324004|FG002|Overall Study|Lost to Follow-up|1|||
23431241|NCT00771615|65324005|FG003|Overall Study|Lost to Follow-up|1|||
23431242|NCT00771615|65324006|FG004|Overall Study|Lost to Follow-up|0|||
23431243|NCT00771615|65324007|FG005|Overall Study|Lost to Follow-up|1|||
23431244|NCT00771615|65324008|FG006|Overall Study|Lost to Follow-up|1|||
23431245|NCT00771615|65324009|FG007|Overall Study|Lost to Follow-up|0|||
23431246|NCT00771615|65324010|FG008|Overall Study|Lost to Follow-up|0|||
23431247|NCT03596450|65324011|FG000|Overall Study|Death|9|||
23431248|NCT03596450|65324012|FG001|Overall Study|Death|9|||
23431249|NCT03596450|65324011|FG000|Overall Study|Protocol Violation|18|||
23431250|NCT03596450|65324012|FG001|Overall Study|Protocol Violation|26|||
23431251|NCT03596450|65324011|FG000|Overall Study|Lost to Follow-up|50|||
23431252|NCT03596450|65324012|FG001|Overall Study|Lost to Follow-up|56|||
23431253|NCT03596450|65324011|FG000|Overall Study|Adverse Event|14|||
23431254|NCT03596450|65324012|FG001|Overall Study|Adverse Event|7|||
23431255|NCT03596450|65324011|FG000|Overall Study|Withdrawal by Subject|38|||
23431256|NCT03596450|65324012|FG001|Overall Study|Withdrawal by Subject|36|||
23431257|NCT03596450|65324011|FG000|Overall Study|Accidentally Randomized|2|||
23431258|NCT03596450|65324012|FG001|Overall Study|Accidentally Randomized|0|||
23431259|NCT03596450|65324011|FG000|Overall Study|Other reasons|48|||
23431260|NCT03596450|65324012|FG001|Overall Study|Other reasons|53|||
23431261|NCT03596450|65324011|FG000|Overall Study|Pregnancy|2|||
23431262|NCT03596450|65324012|FG001|Overall Study|Pregnancy|0|||
23431263|NCT02438813|65324013|FG000|Overall Study|Patient Decision|59|||
23431264|NCT02438813|65324013|FG000|Overall Study|Patient Lost to Follow-Up|137|||
23431265|NCT02438813|65324013|FG000|Overall Study|Study Ended by Sponsor|80|||
23431266|NCT02438813|65324013|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
23431267|NCT03927404|65324014|FG000|Overall Study|Withdrawal by Subject|1|||
23431268|NCT00778895|65324015|FG000|Active Phase|Adverse Event|3|||
23621550|NCT02330562|66000687|FG005|Overall Study|Withdrawal by Subject|0|||
23822037|NCT00233948|66730236|FG001|Overall Study|Adverse Event|0|||
23431269|NCT00778895|65324016|FG001|Active Phase|Adverse Event|1|||
23431270|NCT00778895|65324017|FG002|Active Phase|Adverse Event|0|||
23431271|NCT00778895|65324015|FG000|Active Phase|Withdrawal by Subject|1|||
23431272|NCT00778895|65324016|FG001|Active Phase|Withdrawal by Subject|4|||
23431273|NCT00778895|65324017|FG002|Active Phase|Withdrawal by Subject|0|||
23431274|NCT00778895|65324015|FG000|Active Phase|Lost to Follow-up|1|||
23431275|NCT00778895|65324016|FG001|Active Phase|Lost to Follow-up|1|||
23822038|NCT00233948|66730237|FG002|Overall Study|Adverse Event|0|||
23822039|NCT00233948|66730238|FG003|Overall Study|Adverse Event|0|||
23431276|NCT00778895|65324017|FG002|Active Phase|Lost to Follow-up|0|||
23431277|NCT00778895|65324015|FG000|Active Phase|Other|2|||
23431278|NCT00778895|65324016|FG001|Active Phase|Other|0|||
23431279|NCT00778895|65324017|FG002|Active Phase|Other|0|||
23431280|NCT00778895|65324015|FG000|ESFU Phase|Adverse Event|2|||
23431281|NCT00778895|65324016|FG001|ESFU Phase|Adverse Event|1|||
23431282|NCT00778895|65324017|FG002|ESFU Phase|Adverse Event|0|||
23431283|NCT00778895|65324015|FG000|ESFU Phase|Withdrawal by Subject|1|||
23431284|NCT00778895|65324016|FG001|ESFU Phase|Withdrawal by Subject|4|||
23431285|NCT00778895|65324017|FG002|ESFU Phase|Withdrawal by Subject|0|||
23431286|NCT00778895|65324015|FG000|ESFU Phase|Lost to Follow-up|6|||
23431287|NCT00778895|65324016|FG001|ESFU Phase|Lost to Follow-up|7|||
23431288|NCT00778895|65324017|FG002|ESFU Phase|Lost to Follow-up|2|||
23431289|NCT00778895|65324015|FG000|ESFU Phase|Other|2|||
23431290|NCT00778895|65324016|FG001|ESFU Phase|Other|0|||
23431291|NCT00778895|65324017|FG002|ESFU Phase|Other|0|||
23431292|NCT01177969|65324019|FG000|Overall Study|Protocol Violation|2|||
23431293|NCT01177969|65324020|FG001|Overall Study|Protocol Violation|1|||
23431294|NCT01177969|65324019|FG000|Overall Study|Withdrawal by Subject|1|||
23431295|NCT01177969|65324020|FG001|Overall Study|Withdrawal by Subject|2|||
23431296|NCT01030874|65324029|FG000|Overall Study|Withdrawal by Subject|1|||
23431297|NCT01030874|65324030|FG001|Overall Study|Withdrawal by Subject|0|||
23431298|NCT01030874|65324029|FG000|Overall Study|Discharged in first 2 weeks|17|||
23431299|NCT01030874|65324030|FG001|Overall Study|Discharged in first 2 weeks|16|||
23431300|NCT02759315|65324038|FG000|Overall Study|Adverse Event|0|||
23431301|NCT02759315|65324039|FG001|Overall Study|Adverse Event|0|||
23431302|NCT02759315|65324040|FG002|Overall Study|Adverse Event|0|||
23431303|NCT02759315|65324041|FG003|Overall Study|Adverse Event|1|||
23431304|NCT02759315|65324042|FG004|Overall Study|Adverse Event|0|||
23431305|NCT02759315|65324038|FG000|Overall Study|Death|0|||
23431306|NCT02759315|65324039|FG001|Overall Study|Death|0|||
23431307|NCT02759315|65324040|FG002|Overall Study|Death|1|||
23431308|NCT02759315|65324041|FG003|Overall Study|Death|0|||
23431309|NCT02759315|65324042|FG004|Overall Study|Death|0|||
23431310|NCT02759315|65324038|FG000|Overall Study|Lost to Follow-up|2|||
23431311|NCT02759315|65324039|FG001|Overall Study|Lost to Follow-up|0|||
23431312|NCT02759315|65324040|FG002|Overall Study|Lost to Follow-up|4|||
23431313|NCT02759315|65324041|FG003|Overall Study|Lost to Follow-up|0|||
23431314|NCT02759315|65324042|FG004|Overall Study|Lost to Follow-up|0|||
23431315|NCT02759315|65324038|FG000|Overall Study|Protocol Violation|0|||
23431316|NCT02759315|65324039|FG001|Overall Study|Protocol Violation|1|||
23431317|NCT02759315|65324040|FG002|Overall Study|Protocol Violation|0|||
23431318|NCT02759315|65324041|FG003|Overall Study|Protocol Violation|0|||
23431319|NCT02759315|65324042|FG004|Overall Study|Protocol Violation|0|||
23431320|NCT02759315|65324038|FG000|Overall Study|Study terminated prior to completion|2|||
23431321|NCT02759315|65324039|FG001|Overall Study|Study terminated prior to completion|0|||
23431322|NCT02759315|65324040|FG002|Overall Study|Study terminated prior to completion|5|||
23431323|NCT02759315|65324041|FG003|Overall Study|Study terminated prior to completion|0|||
23431324|NCT02759315|65324042|FG004|Overall Study|Study terminated prior to completion|1|||
23431325|NCT00671437|65324050|FG000|Overall Study|Progressive disease before C1 week 8|8|||
23431326|NCT00671437|65324050|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
23431327|NCT00671437|65324050|FG000|Overall Study|Adverse Event|3|||
23431328|NCT00671437|65324050|FG000|Overall Study|Ineligible post-hoc|1|||
23431329|NCT01606787|65324051|FG000|Overall Study|Withdrawal by Subject|4|||
23431330|NCT01606787|65324052|FG001|Overall Study|Withdrawal by Subject|5|||
23552474|NCT02820623|65747847|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
23552475|NCT02820623|65747848|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
23552476|NCT02820623|65747849|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
23552477|NCT00417079|65747853|FG000|Overall Study|Disease progression|267|||
23431331|NCT01606787|65324051|FG000|Overall Study|Surgery canceled|0|||
23431332|NCT01606787|65324052|FG001|Overall Study|Surgery canceled|2|||
23431333|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
23552478|NCT00417079|65747854|FG001|Overall Study|Disease progression|180|||
23552479|NCT00417079|65747853|FG000|Overall Study|Adverse Event|32|||
23431334|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
23552480|NCT00417079|65747854|FG001|Overall Study|Adverse Event|67|||
23431335|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
23431336|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
23431337|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
23431338|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
23431339|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
23431340|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
23431341|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
23431342|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
23431343|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
23431344|NCT03959982|65324056|FG000|Overall Study|Withdrawal by Subject|1|||
23431345|NCT03959982|65324057|FG001|Overall Study|Withdrawal by Subject|0|||
23431346|NCT03959982|65324056|FG000|Overall Study|Physician Decision|2|||
23431347|NCT03959982|65324057|FG001|Overall Study|Physician Decision|0|||
23552481|NCT00417079|65747853|FG000|Overall Study|Non-compliance to protocol|0|||
23552482|NCT00417079|65747854|FG001|Overall Study|Non-compliance to protocol|1|||
23431348|NCT03959982|65324056|FG000|Overall Study|Lost to Follow-up|1|||
23431349|NCT03959982|65324057|FG001|Overall Study|Lost to Follow-up|0|||
23431350|NCT02211313|65324058|FG000|Overall Study|Treatment Failure|5|||
23431351|NCT02211313|65324059|FG001|Overall Study|Treatment Failure|2|||
23431352|NCT02211313|65324058|FG000|Overall Study|No Follow up Questionnaires|1|||
23431353|NCT02211313|65324059|FG001|Overall Study|No Follow up Questionnaires|1|||
23431354|NCT01659255|65324060|FG000|Overall Study|Adverse Event|0|||
23431355|NCT01659255|65324061|FG001|Overall Study|Adverse Event|0|||
23431356|NCT01659255|65324062|FG002|Overall Study|Adverse Event|0|||
23431357|NCT01659255|65324063|FG003|Overall Study|Adverse Event|0|||
23431358|NCT01659255|65324064|FG004|Overall Study|Adverse Event|0|||
23431359|NCT01659255|65324065|FG005|Overall Study|Adverse Event|1|||
23431360|NCT01659255|65324066|FG006|Overall Study|Adverse Event|1|||
23431361|NCT01659255|65324067|FG007|Overall Study|Adverse Event|0|||
23431362|NCT01659255|65324068|FG008|Overall Study|Adverse Event|0|||
23431363|NCT01659255|65324069|FG009|Overall Study|Adverse Event|1|||
23431364|NCT01659255|65324070|FG010|Overall Study|Adverse Event|0|||
23431365|NCT01659255|65324071|FG011|Overall Study|Adverse Event|1|||
23431366|NCT01659255|65324072|FG012|Overall Study|Adverse Event|0|||
23431367|NCT01659255|65324073|FG013|Overall Study|Adverse Event|2|||
23431368|NCT01659255|65324074|FG014|Overall Study|Adverse Event|0|||
23431369|NCT01659255|65324075|FG015|Overall Study|Adverse Event|1|||
23431370|NCT01659255|65324076|FG016|Overall Study|Adverse Event|0|||
23431371|NCT01659255|65324060|FG000|Overall Study|Death|0|||
23431372|NCT01659255|65324061|FG001|Overall Study|Death|1|||
23431373|NCT01659255|65324062|FG002|Overall Study|Death|0|||
23431374|NCT01659255|65324063|FG003|Overall Study|Death|0|||
23431375|NCT01659255|65324064|FG004|Overall Study|Death|0|||
23431376|NCT01659255|65324065|FG005|Overall Study|Death|0|||
23431377|NCT01659255|65324066|FG006|Overall Study|Death|0|||
23431378|NCT01659255|65324067|FG007|Overall Study|Death|1|||
23431379|NCT01659255|65324068|FG008|Overall Study|Death|1|||
23431380|NCT01659255|65324069|FG009|Overall Study|Death|0|||
23431381|NCT01659255|65324070|FG010|Overall Study|Death|0|||
23431382|NCT01659255|65324071|FG011|Overall Study|Death|0|||
23431383|NCT01659255|65324072|FG012|Overall Study|Death|1|||
23431384|NCT01659255|65324073|FG013|Overall Study|Death|1|||
23431385|NCT01659255|65324074|FG014|Overall Study|Death|2|||
23431386|NCT01659255|65324075|FG015|Overall Study|Death|1|||
23431387|NCT01659255|65324076|FG016|Overall Study|Death|0|||
23431388|NCT01659255|65324060|FG000|Overall Study|Progressive Disease|2|||
23431389|NCT01659255|65324061|FG001|Overall Study|Progressive Disease|0|||
23431390|NCT01659255|65324062|FG002|Overall Study|Progressive Disease|0|||
23431391|NCT01659255|65324063|FG003|Overall Study|Progressive Disease|0|||
23431392|NCT01659255|65324064|FG004|Overall Study|Progressive Disease|0|||
23431393|NCT01659255|65324065|FG005|Overall Study|Progressive Disease|0|||
23431394|NCT01659255|65324066|FG006|Overall Study|Progressive Disease|0|||
23431395|NCT01659255|65324067|FG007|Overall Study|Progressive Disease|1|||
23431396|NCT01659255|65324068|FG008|Overall Study|Progressive Disease|0|||
23431397|NCT01659255|65324069|FG009|Overall Study|Progressive Disease|2|||
23431398|NCT01659255|65324070|FG010|Overall Study|Progressive Disease|2|||
23431399|NCT01659255|65324071|FG011|Overall Study|Progressive Disease|3|||
23431400|NCT01659255|65324072|FG012|Overall Study|Progressive Disease|5|||
23431401|NCT01659255|65324073|FG013|Overall Study|Progressive Disease|13|||
23431402|NCT01659255|65324074|FG014|Overall Study|Progressive Disease|6|||
23431403|NCT01659255|65324075|FG015|Overall Study|Progressive Disease|2|||
23431404|NCT01659255|65324076|FG016|Overall Study|Progressive Disease|3|||
23431405|NCT01659255|65324060|FG000|Overall Study|Withdrew Consent|0|||
23744640|NCT02268214|66443296|FG001|Overall Study|Not entering long-term period|3|||
23431406|NCT01659255|65324061|FG001|Overall Study|Withdrew Consent|0|||
23431407|NCT01659255|65324062|FG002|Overall Study|Withdrew Consent|0|||
23431408|NCT01659255|65324063|FG003|Overall Study|Withdrew Consent|0|||
23431409|NCT01659255|65324064|FG004|Overall Study|Withdrew Consent|0|||
23431410|NCT01659255|65324065|FG005|Overall Study|Withdrew Consent|0|||
23431411|NCT01659255|65324066|FG006|Overall Study|Withdrew Consent|0|||
23431412|NCT01659255|65324067|FG007|Overall Study|Withdrew Consent|0|||
23431413|NCT01659255|65324068|FG008|Overall Study|Withdrew Consent|0|||
23431414|NCT01659255|65324069|FG009|Overall Study|Withdrew Consent|0|||
23431415|NCT01659255|65324070|FG010|Overall Study|Withdrew Consent|1|||
23431416|NCT01659255|65324071|FG011|Overall Study|Withdrew Consent|0|||
23431417|NCT01659255|65324072|FG012|Overall Study|Withdrew Consent|0|||
23431418|NCT01659255|65324073|FG013|Overall Study|Withdrew Consent|1|||
23431419|NCT01659255|65324074|FG014|Overall Study|Withdrew Consent|0|||
23431420|NCT01659255|65324075|FG015|Overall Study|Withdrew Consent|0|||
23431421|NCT01659255|65324076|FG016|Overall Study|Withdrew Consent|0|||
23431422|NCT01659255|65324060|FG000|Overall Study|Investigator Decision|0|||
23431423|NCT01659255|65324061|FG001|Overall Study|Investigator Decision|0|||
23431424|NCT01659255|65324062|FG002|Overall Study|Investigator Decision|0|||
23431425|NCT01659255|65324063|FG003|Overall Study|Investigator Decision|0|||
23431426|NCT01659255|65324064|FG004|Overall Study|Investigator Decision|0|||
23431427|NCT01659255|65324065|FG005|Overall Study|Investigator Decision|0|||
23431428|NCT01659255|65324066|FG006|Overall Study|Investigator Decision|0|||
23431429|NCT01659255|65324067|FG007|Overall Study|Investigator Decision|0|||
23744641|NCT02268214|66443297|FG002|Overall Study|Not entering long-term period|5|||
23744642|NCT00077766|66443298|FG000|Overall Study|Adverse Event|1|||
23744643|NCT00077766|66443299|FG001|Overall Study|Adverse Event|1|||
23431430|NCT01659255|65324068|FG008|Overall Study|Investigator Decision|0|||
23431431|NCT01659255|65324069|FG009|Overall Study|Investigator Decision|0|||
23431432|NCT01659255|65324070|FG010|Overall Study|Investigator Decision|0|||
23431433|NCT01659255|65324071|FG011|Overall Study|Investigator Decision|0|||
23431434|NCT01659255|65324072|FG012|Overall Study|Investigator Decision|1|||
23431435|NCT01659255|65324073|FG013|Overall Study|Investigator Decision|1|||
23431436|NCT01659255|65324074|FG014|Overall Study|Investigator Decision|0|||
23431437|NCT01659255|65324075|FG015|Overall Study|Investigator Decision|0|||
23431438|NCT01659255|65324076|FG016|Overall Study|Investigator Decision|0|||
23431439|NCT01659255|65324060|FG000|Overall Study|Sponsor's Decision|0|||
23431440|NCT01659255|65324061|FG001|Overall Study|Sponsor's Decision|0|||
23431441|NCT01659255|65324062|FG002|Overall Study|Sponsor's Decision|0|||
23431442|NCT01659255|65324063|FG003|Overall Study|Sponsor's Decision|0|||
23431443|NCT01659255|65324064|FG004|Overall Study|Sponsor's Decision|0|||
23431444|NCT01659255|65324065|FG005|Overall Study|Sponsor's Decision|0|||
23431445|NCT01659255|65324066|FG006|Overall Study|Sponsor's Decision|1|||
23431446|NCT01659255|65324067|FG007|Overall Study|Sponsor's Decision|0|||
23431447|NCT01659255|65324068|FG008|Overall Study|Sponsor's Decision|0|||
23431448|NCT01659255|65324069|FG009|Overall Study|Sponsor's Decision|0|||
23431449|NCT01659255|65324070|FG010|Overall Study|Sponsor's Decision|0|||
23431450|NCT01659255|65324071|FG011|Overall Study|Sponsor's Decision|0|||
23431451|NCT01659255|65324072|FG012|Overall Study|Sponsor's Decision|0|||
23431452|NCT01659255|65324073|FG013|Overall Study|Sponsor's Decision|0|||
23431453|NCT01659255|65324074|FG014|Overall Study|Sponsor's Decision|0|||
23431454|NCT01659255|65324075|FG015|Overall Study|Sponsor's Decision|0|||
23431455|NCT01659255|65324076|FG016|Overall Study|Sponsor's Decision|0|||
23431456|NCT01659255|65324060|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431457|NCT01659255|65324061|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431458|NCT01659255|65324062|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431459|NCT01659255|65324063|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431460|NCT01659255|65324064|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431461|NCT01659255|65324065|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431462|NCT01659255|65324066|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431463|NCT01659255|65324067|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431464|NCT01659255|65324068|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431465|NCT01659255|65324069|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431466|NCT01659255|65324070|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431467|NCT01659255|65324071|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431468|NCT01659255|65324072|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431469|NCT01659255|65324073|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23552483|NCT00417079|65747853|FG000|Overall Study|Lost to Follow-up|2|||
23552484|NCT00417079|65747854|FG001|Overall Study|Lost to Follow-up|0|||
23552485|NCT00417079|65747853|FG000|Overall Study|Withdrawal by Subject|17|||
23744644|NCT00077766|66443298|FG000|Overall Study|Withdrawal by Subject|4|||
23744645|NCT00077766|66443299|FG001|Overall Study|Withdrawal by Subject|3|||
23744646|NCT00077766|66443298|FG000|Overall Study|Death|12|||
23431470|NCT01659255|65324074|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431471|NCT01659255|65324075|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
23431472|NCT01659255|65324076|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431473|NCT01659255|65324060|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
23431474|NCT01659255|65324061|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
23431475|NCT01659255|65324062|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
23552486|NCT00417079|65747854|FG001|Overall Study|Withdrawal by Subject|8|||
23552487|NCT00417079|65747853|FG000|Overall Study|Not treated|6|||
23744647|NCT00077766|66443299|FG001|Overall Study|Death|10|||
23431476|NCT01659255|65324063|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
23431477|NCT01659255|65324064|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
23431478|NCT01659255|65324065|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
23431479|NCT01659255|65324066|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
23431480|NCT01659255|65324067|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
23431481|NCT01659255|65324068|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
23431482|NCT01659255|65324069|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
23431483|NCT01659255|65324070|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
23431484|NCT01659255|65324071|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
23431485|NCT01659255|65324072|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
23431486|NCT01659255|65324073|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
23431487|NCT01659255|65324074|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
23431488|NCT01659255|65324075|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
23431489|NCT01659255|65324076|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
23431490|NCT01571232|65324077|FG000|Overall Study|Lost to Follow-up|0|||
23431491|NCT01571232|65324078|FG001|Overall Study|Lost to Follow-up|1|||
23431492|NCT01571232|65324077|FG000|Overall Study|Withdrawal by Subject|1|||
23822040|NCT00233948|66730239|FG004|Overall Study|Adverse Event|0|||
23431493|NCT01571232|65324078|FG001|Overall Study|Withdrawal by Subject|0|||
23431494|NCT03134183|65324079|FG000|Overall Study|Withdrawal by Subject|1|||
23431495|NCT03134183|65324080|FG001|Overall Study|Withdrawal by Subject|1|||
23552488|NCT00417079|65747854|FG001|Overall Study|Not treated|7|||
23552489|NCT00417079|65747853|FG000|Overall Study|Screened failure|2|||
23552490|NCT00417079|65747854|FG001|Overall Study|Screened failure|1|||
23552491|NCT00417079|65747853|FG000|Overall Study|Investigator's decision|1|||
23552492|NCT00417079|65747854|FG001|Overall Study|Investigator's decision|4|||
23552493|NCT00417079|65747853|FG000|Overall Study|Non-confirmed Disease progression|1|||
23552494|NCT00417079|65747854|FG001|Overall Study|Non-confirmed Disease progression|1|||
23552495|NCT00417079|65747853|FG000|Overall Study|Clinical deterioration|1|||
23552496|NCT00417079|65747854|FG001|Overall Study|Clinical deterioration|0|||
23552497|NCT00417079|65747853|FG000|Overall Study|Screening error|2|||
23552498|NCT00417079|65747854|FG001|Overall Study|Screening error|1|||
23552499|NCT00417079|65747853|FG000|Overall Study|Withdrawal by subject's family|0|||
23552500|NCT00417079|65747854|FG001|Overall Study|Withdrawal by subject's family|1|||
23552501|NCT00417079|65747853|FG000|Overall Study|Patient unable to come to the clinic|0|||
23552502|NCT00417079|65747854|FG001|Overall Study|Patient unable to come to the clinic|1|||
23552503|NCT00417079|65747853|FG000|Overall Study|abnormal liver function tests|0|||
23552504|NCT00417079|65747854|FG001|Overall Study|abnormal liver function tests|1|||
23552505|NCT01428076|65747855|FG000|Overall Study|Adverse Event|0|||
23552506|NCT01428076|65747856|FG001|Overall Study|Adverse Event|1|||
23552507|NCT01618864|65747857|FG000|Overall Study|Withdrawal by Subject|2|||
23552508|NCT01618864|65747857|FG000|Overall Study|Lost to Follow-up|2|||
23552509|NCT01754467|65747858|FG000|Overall Study|Lost to Follow-up|1|||
23582208|NCT01242085|65862384|FG001|Overall Study|Withdrawal by Subject|2|||
23582209|NCT01242085|65862385|FG002|Overall Study|Withdrawal by Subject|0|||
23582210|NCT01242085|65862383|FG000|Overall Study|medically unable to have surgery|4|||
23582211|NCT01242085|65862384|FG001|Overall Study|medically unable to have surgery|5|||
23582212|NCT01242085|65862385|FG002|Overall Study|medically unable to have surgery|0|||
23582213|NCT00828945|65862386|FG000|Overall Study|Death|4|||
23582214|NCT00828945|65862386|FG000|Overall Study|Participant was missing|1|||
23582215|NCT00828945|65862386|FG000|Overall Study|Other|36|||
23582216|NCT03102242|65862387|FG000|Overall Study|Adverse Event|2|||
23582217|NCT02334306|65862392|FG000|Double-blind Period|Adverse Event|0|||
23822041|NCT00233948|66730240|FG005|Overall Study|Adverse Event|0|||
23431496|NCT00290498|65324081|FG000|Overall Study|Death|2|||
23431497|NCT00290498|65324082|FG001|Overall Study|Death|0|||
23431498|NCT00290498|65324081|FG000|Overall Study|Physician Decision|1|||
23582218|NCT02334306|65862393|FG001|Double-blind Period|Adverse Event|1|||
23582219|NCT02334306|65862392|FG000|Double-blind Period|Withdrawal by Subject|1|||
23582220|NCT02334306|65862393|FG001|Double-blind Period|Withdrawal by Subject|1|||
23582221|NCT04759131|65862396|FG000|Overall Study|Investigator's discretion|1|||
23582222|NCT04759131|65862397|FG001|Overall Study|Investigator's discretion|0|||
23582223|NCT04759131|65862396|FG000|Overall Study|Subject withdrawal|1|||
23582224|NCT04759131|65862397|FG001|Overall Study|Subject withdrawal|0|||
23582225|NCT03441984|65862398|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582226|NCT03441984|65862399|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582227|NCT03441984|65862400|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
23582228|NCT03441984|65862401|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23744648|NCT00077766|66443298|FG000|Overall Study|Lost to Follow-up|2|||
23431499|NCT00290498|65324082|FG001|Overall Study|Physician Decision|0|||
23431500|NCT00290498|65324081|FG000|Overall Study|Withdrawal by Subject|1|||
23431501|NCT00290498|65324082|FG001|Overall Study|Withdrawal by Subject|0|||
23431502|NCT00290498|65324081|FG000|Overall Study|Ineligible|3|||
23431503|NCT00290498|65324082|FG001|Overall Study|Ineligible|0|||
23431504|NCT00290498|65324081|FG000|Overall Study|Non-Compliance|1|||
23431505|NCT00290498|65324082|FG001|Overall Study|Non-Compliance|0|||
23431506|NCT02726945|65324083|FG000|Overall Study|Withdrawal by Subject|0|||
23431507|NCT02726945|65324084|FG001|Overall Study|Withdrawal by Subject|0|||
23431508|NCT02726945|65324085|FG002|Overall Study|Withdrawal by Subject|1|||
23431509|NCT02726945|65324083|FG000|Overall Study|Elected to have total knee replacement|0|||
23431510|NCT02726945|65324084|FG001|Overall Study|Elected to have total knee replacement|1|||
23431511|NCT02726945|65324085|FG002|Overall Study|Elected to have total knee replacement|0|||
23431512|NCT00619489|65324086|FG000|Overall Study|Adverse Event|0|||
23431513|NCT00619489|65324087|FG001|Overall Study|Adverse Event|7|||
23431514|NCT00619489|65324086|FG000|Overall Study|Withdrawal by Subject|1|||
23431515|NCT00619489|65324087|FG001|Overall Study|Withdrawal by Subject|1|||
23431516|NCT00619489|65324086|FG000|Overall Study|Lack of Efficacy|0|||
23431517|NCT00619489|65324087|FG001|Overall Study|Lack of Efficacy|11|||
23431518|NCT00619489|65324086|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
23431519|NCT00619489|65324087|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
23431520|NCT01287195|65324088|FG000|Overall Study|Withdrawal by Subject|2|||
23431521|NCT01114360|65324089|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
23744649|NCT00077766|66443299|FG001|Overall Study|Lost to Follow-up|0|||
23744650|NCT00077766|66443298|FG000|Overall Study|Protocol Violation|1|||
23744651|NCT00077766|66443299|FG001|Overall Study|Protocol Violation|0|||
23744652|NCT00077766|66443298|FG000|Overall Study|Kidney Transplantation|9|||
23744653|NCT00077766|66443299|FG001|Overall Study|Kidney Transplantation|5|||
23744654|NCT00077766|66443298|FG000|Overall Study|Transplantation|5|||
23744655|NCT00077766|66443299|FG001|Overall Study|Transplantation|1|||
23744656|NCT00077766|66443298|FG000|Overall Study|Investigators Discretion|1|||
23744657|NCT00077766|66443299|FG001|Overall Study|Investigators Discretion|0|||
23744658|NCT00077766|66443298|FG000|Overall Study|Participant's decision|1|||
23744659|NCT00077766|66443299|FG001|Overall Study|Participant's decision|0|||
23744660|NCT00077766|66443298|FG000|Overall Study|Dialysis Discontinued|1|||
23744661|NCT00077766|66443299|FG001|Overall Study|Dialysis Discontinued|0|||
23744662|NCT00077766|66443298|FG000|Overall Study|Dialysis|0|||
23744663|NCT00077766|66443299|FG001|Overall Study|Dialysis|1|||
23744664|NCT00077766|66443298|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
23744665|NCT00077766|66443299|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
23744666|NCT00077766|66443298|FG000|Overall Study|Started Nocturnal Dialysis|0|||
23744667|NCT00077766|66443299|FG001|Overall Study|Started Nocturnal Dialysis|1|||
23822042|NCT02445963|66730243|FG000|Overall Study|Lost to Follow-up|1|||
23822043|NCT02445963|66730244|FG001|Overall Study|Lost to Follow-up|0|||
23822044|NCT02445963|66730245|FG002|Overall Study|Lost to Follow-up|0|||
23822045|NCT02445963|66730246|FG003|Overall Study|Lost to Follow-up|0|||
23822046|NCT02445963|66730243|FG000|Overall Study|Change in employment|1|||
23822047|NCT02445963|66730244|FG001|Overall Study|Change in employment|0|||
23822048|NCT02445963|66730245|FG002|Overall Study|Change in employment|0|||
23822049|NCT02445963|66730246|FG003|Overall Study|Change in employment|0|||
23822050|NCT02445963|66730243|FG000|Overall Study|Symptoms post-vaccination|0|||
23822051|NCT02445963|66730244|FG001|Overall Study|Symptoms post-vaccination|0|||
23822052|NCT02445963|66730245|FG002|Overall Study|Symptoms post-vaccination|1|||
23822053|NCT02445963|66730246|FG003|Overall Study|Symptoms post-vaccination|0|||
23431522|NCT01114360|65324090|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
23822054|NCT02256436|66730248|FG000|Overall Study|Adverse Event|9|||
23822055|NCT02256436|66730249|FG001|Overall Study|Adverse Event|14|||
23822056|NCT02256436|66730248|FG000|Overall Study|Death|216|||
23822057|NCT02256436|66730249|FG001|Overall Study|Death|208|||
23822058|NCT02256436|66730248|FG000|Overall Study|Lost to Follow-up|1|||
23822059|NCT02256436|66730249|FG001|Overall Study|Lost to Follow-up|2|||
23431523|NCT01062061|65324091|FG000|Overall Study|Enrolled more than once|2|||
23431524|NCT01062061|65324091|FG000|Overall Study|Investigated before study start|13|||
23431525|NCT01062061|65324091|FG000|Overall Study|Outside chief indications|10|||
23744668|NCT00077766|66443298|FG000|Overall Study|Stop Dialysis|0|||
23744669|NCT00077766|66443299|FG001|Overall Study|Stop Dialysis|1|||
23822060|NCT02256436|66730248|FG000|Overall Study|Physician Decision|1|||
23822061|NCT02256436|66730249|FG001|Overall Study|Physician Decision|0|||
23822062|NCT02256436|66730248|FG000|Overall Study|Protocol Violation|0|||
23822063|NCT02256436|66730249|FG001|Overall Study|Protocol Violation|1|||
23431526|NCT01062061|65324091|FG000|Overall Study|Failed to meet inclusion criteria|2|||
23431527|NCT00495755|65324092|FG000|Overall Study|Adverse Event|3|||
23431528|NCT02717130|65324093|FG000|Overall Study|Withdrawal by Subject|1|||
23431529|NCT02717130|65324093|FG000|Overall Study|Adverse Event|1|||
23431530|NCT02717130|65324093|FG000|Overall Study|Physician Decision|1|||
23552510|NCT00092131|65751118|FG000|Treatment Period I|Adverse Event|1|||
23744670|NCT00077766|66443298|FG000|Overall Study|Participants Vacation|2|||
23744671|NCT00077766|66443299|FG001|Overall Study|Participants Vacation|1|||
23744672|NCT00535262|66443300|FG000|Overall Study|No funding|3|||
23552511|NCT00092131|65751119|FG001|Treatment Period I|Adverse Event|0|||
23552512|NCT00092131|65751118|FG000|Treatment Period II|Adverse Event|0|||
23552513|NCT00092131|65751119|FG001|Treatment Period II|Adverse Event|1|||
23552514|NCT00907153|65751121|FG000|Overall Study|Lost to Follow-up|1|||
23552515|NCT00907153|65751122|FG001|Overall Study|Lost to Follow-up|1|||
23552516|NCT00907153|65751121|FG000|Overall Study|Withdrawal by Subject|1|||
23552517|NCT00907153|65751122|FG001|Overall Study|Withdrawal by Subject|3|||
23552518|NCT01995461|65751123|FG000|Overall Study|Death|1|||
23552519|NCT01995461|65751123|FG000|Overall Study|Lost to Follow-up|2|||
23552520|NCT01995461|65751123|FG000|Overall Study|Withdrawal by Subject|2|||
23552521|NCT00265889|65751129|FG000|Overall Study|Physician Decision|1|||
23552522|NCT00265889|65751129|FG000|Overall Study|Protocol Violation|1|||
23552523|NCT00265889|65751129|FG000|Overall Study|Insurance denied the request|3|||
23552524|NCT02453685|65751138|FG000|Overall Study|Adverse Event|0|||
23552525|NCT02453685|65751139|FG001|Overall Study|Adverse Event|1|||
23552526|NCT02453685|65751138|FG000|Overall Study|Protocol Violation|7|||
23552527|NCT02453685|65751139|FG001|Overall Study|Protocol Violation|4|||
23552528|NCT02453685|65751138|FG000|Overall Study|Lost to Follow-up|0|||
23552529|NCT02453685|65751139|FG001|Overall Study|Lost to Follow-up|1|||
23552530|NCT02453685|65751138|FG000|Overall Study|Withdrawal by Subject|8|||
23552531|NCT02453685|65751139|FG001|Overall Study|Withdrawal by Subject|4|||
23552532|NCT02453685|65751138|FG000|Overall Study|Unclassified|4|||
23552533|NCT02453685|65751139|FG001|Overall Study|Unclassified|2|||
23552534|NCT02300220|65751140|FG000|Overall Study|Lost to Follow-up|1|||
23552535|NCT02300220|65751141|FG001|Overall Study|Lost to Follow-up|2|||
23552536|NCT02300220|65751140|FG000|Overall Study|Death|1|||
23552537|NCT02300220|65751141|FG001|Overall Study|Death|1|||
23552538|NCT02300220|65751140|FG000|Overall Study|Adverse Event|1|||
23552539|NCT02300220|65751141|FG001|Overall Study|Adverse Event|1|||
23552540|NCT02300220|65751140|FG000|Overall Study|Protocol Violation|1|||
23552541|NCT02300220|65751141|FG001|Overall Study|Protocol Violation|0|||
23552542|NCT02300220|65751140|FG000|Overall Study|Withdrawal by Subject|0|||
23552543|NCT02300220|65751141|FG001|Overall Study|Withdrawal by Subject|2|||
23552544|NCT02300220|65751140|FG000|Overall Study|Did not tolerate IMP|0|||
23552545|NCT02300220|65751141|FG001|Overall Study|Did not tolerate IMP|1|||
23552546|NCT00781391|65751143|FG000|Overall Study|never received study drug|24|||
23552547|NCT00781391|65751144|FG001|Overall Study|never received study drug|23|||
23552548|NCT00781391|65751145|FG002|Overall Study|never received study drug|32|||
23552549|NCT00781391|65751143|FG000|Overall Study|Protocol Violation|19|||
23552550|NCT00781391|65751144|FG001|Overall Study|Protocol Violation|17|||
23552551|NCT00781391|65751145|FG002|Overall Study|Protocol Violation|20|||
23552552|NCT00781391|65751143|FG000|Overall Study|Death|789|||
23552553|NCT00781391|65751144|FG001|Overall Study|Death|730|||
23552554|NCT00781391|65751145|FG002|Overall Study|Death|706|||
23552555|NCT00781391|65751143|FG000|Overall Study|Withdrawal by Subject|47|||
23552556|NCT00781391|65751144|FG001|Overall Study|Withdrawal by Subject|37|||
23552557|NCT00781391|65751145|FG002|Overall Study|Withdrawal by Subject|25|||
23552558|NCT00781391|65751143|FG000|Overall Study|Lost to Follow-up|0|||
23552559|NCT00781391|65751144|FG001|Overall Study|Lost to Follow-up|0|||
23552560|NCT00781391|65751145|FG002|Overall Study|Lost to Follow-up|1|||
23552561|NCT04435665|65751146|FG000|Overall Study|Lost to Follow-up|0|||
23552562|NCT04435665|65751147|FG001|Overall Study|Lost to Follow-up|0|||
23552563|NCT04435665|65751148|FG002|Overall Study|Lost to Follow-up|0|||
23621551|NCT02330562|66000688|FG006|Overall Study|Withdrawal by Subject|0|||
23744673|NCT01682876|66443301|FG000|Overall Study|Administrative reason|4|||
23744674|NCT01682876|66443302|FG001|Overall Study|Administrative reason|4|||
23744675|NCT01682876|66443303|FG002|Overall Study|Administrative reason|0|||
23744676|NCT01682876|66443304|FG003|Overall Study|Administrative reason|3|||
23744677|NCT01682876|66443301|FG000|Overall Study|Adverse Event|0|||
23552564|NCT04435665|65751149|FG003|Overall Study|Lost to Follow-up|1|||
23552565|NCT03252587|65751157|FG000|Overall Study|Adverse Event|3|||
23552566|NCT03252587|65751158|FG001|Overall Study|Adverse Event|8|||
23552567|NCT03252587|65751159|FG002|Overall Study|Adverse Event|6|||
23552568|NCT03252587|65751160|FG003|Overall Study|Adverse Event|12|||
23552569|NCT03252587|65751157|FG000|Overall Study|Lack of Efficacy|7|||
23552570|NCT03252587|65751158|FG001|Overall Study|Lack of Efficacy|2|||
23552571|NCT03252587|65751159|FG002|Overall Study|Lack of Efficacy|2|||
23552572|NCT03252587|65751160|FG003|Overall Study|Lack of Efficacy|4|||
23552573|NCT03252587|65751157|FG000|Overall Study|Lost to Follow-up|2|||
23621552|NCT02330562|66000689|FG007|Overall Study|Withdrawal by Subject|0|||
23621553|NCT02330562|66000690|FG008|Overall Study|Withdrawal by Subject|0|||
23552574|NCT03252587|65751158|FG001|Overall Study|Lost to Follow-up|0|||
23552575|NCT03252587|65751159|FG002|Overall Study|Lost to Follow-up|0|||
23552576|NCT03252587|65751160|FG003|Overall Study|Lost to Follow-up|2|||
23552577|NCT03252587|65751157|FG000|Overall Study|Pregnancy|2|||
23552578|NCT03252587|65751158|FG001|Overall Study|Pregnancy|1|||
23552579|NCT03252587|65751159|FG002|Overall Study|Pregnancy|0|||
23552580|NCT03252587|65751160|FG003|Overall Study|Pregnancy|1|||
23552581|NCT03252587|65751157|FG000|Overall Study|Withdrawal by Subject|8|||
23744678|NCT01682876|66443302|FG001|Overall Study|Adverse Event|0|||
23552582|NCT03252587|65751158|FG001|Overall Study|Withdrawal by Subject|4|||
23552583|NCT03252587|65751159|FG002|Overall Study|Withdrawal by Subject|4|||
23552584|NCT03252587|65751160|FG003|Overall Study|Withdrawal by Subject|4|||
23552585|NCT03252587|65751157|FG000|Overall Study|Other Reasons|2|||
23552586|NCT03252587|65751158|FG001|Overall Study|Other Reasons|5|||
23552587|NCT03252587|65751159|FG002|Overall Study|Other Reasons|5|||
23552588|NCT03252587|65751160|FG003|Overall Study|Other Reasons|4|||
23552589|NCT01777854|65751161|FG000|Overall Study|Physician Decision|3|||
23552590|NCT01777854|65751162|FG001|Overall Study|Physician Decision|3|||
23552591|NCT01483924|65751164|FG000|Overall Study|Withdrawal by Subject|2|||
23552592|NCT01483924|65751165|FG001|Overall Study|Withdrawal by Subject|0|||
23552593|NCT01483924|65751166|FG002|Overall Study|Withdrawal by Subject|0|||
23552594|NCT01483924|65751167|FG003|Overall Study|Withdrawal by Subject|1|||
23552595|NCT01483924|65751168|FG004|Overall Study|Withdrawal by Subject|1|||
23552596|NCT01483924|65751164|FG000|Overall Study|Adverse Event|0|||
23552597|NCT01483924|65751165|FG001|Overall Study|Adverse Event|0|||
23552598|NCT01483924|65751166|FG002|Overall Study|Adverse Event|1|||
23552599|NCT01483924|65751167|FG003|Overall Study|Adverse Event|1|||
23552600|NCT01483924|65751168|FG004|Overall Study|Adverse Event|0|||
23552601|NCT01483924|65751164|FG000|Overall Study|Non-compliance|0|||
23552602|NCT01483924|65751165|FG001|Overall Study|Non-compliance|0|||
23552603|NCT01483924|65751166|FG002|Overall Study|Non-compliance|0|||
23552604|NCT01483924|65751167|FG003|Overall Study|Non-compliance|1|||
23552605|NCT01483924|65751168|FG004|Overall Study|Non-compliance|1|||
23552606|NCT01483924|65751164|FG000|Overall Study|Sponsor concern over ECG result|0|||
23552607|NCT01483924|65751165|FG001|Overall Study|Sponsor concern over ECG result|0|||
23552608|NCT01483924|65751166|FG002|Overall Study|Sponsor concern over ECG result|0|||
23552609|NCT01483924|65751167|FG003|Overall Study|Sponsor concern over ECG result|1|||
23552610|NCT01483924|65751168|FG004|Overall Study|Sponsor concern over ECG result|0|||
23552611|NCT01152580|65751170|FG000|Overall Study|Withdrawal by Subject|0|||
23552612|NCT01152580|65751171|FG001|Overall Study|Withdrawal by Subject|1|||
23552613|NCT00289887|65751173|FG000|Overall Study|Adverse Event|3|||
23552614|NCT00289887|65751174|FG001|Overall Study|Adverse Event|3|||
23552615|NCT00289887|65751173|FG000|Overall Study|Lack of Efficacy|3|||
23552616|NCT00289887|65751174|FG001|Overall Study|Lack of Efficacy|11|||
23552617|NCT00289887|65751173|FG000|Overall Study|Lost to Follow-up|3|||
23552618|NCT00289887|65751174|FG001|Overall Study|Lost to Follow-up|3|||
23552619|NCT00289887|65751173|FG000|Overall Study|Protocol Violation|3|||
23552620|NCT00289887|65751174|FG001|Overall Study|Protocol Violation|1|||
23552621|NCT00289887|65751173|FG000|Overall Study|Withdrawal by Subject|3|||
23552622|NCT00289887|65751174|FG001|Overall Study|Withdrawal by Subject|8|||
23552623|NCT00289887|65751173|FG000|Overall Study|Other|7|||
23552624|NCT00289887|65751174|FG001|Overall Study|Other|3|||
23552625|NCT00686166|65751180|FG000|Overall Study|Adverse Event|7|||
23552626|NCT00686166|65751180|FG000|Overall Study|Withdrawal by Subject|1|||
23552627|NCT00686166|65751180|FG000|Overall Study|Progression/Relapse|1|||
23552628|NCT00686166|65751180|FG000|Overall Study|Death|1|||
23552629|NCT00686166|65751180|FG000|Overall Study|Not Protocol Specified|1|||
23552630|NCT00686166|65751180|FG000|Overall Study|Ineligible|5|||
23552631|NCT00686166|65751180|FG000|Overall Study|Did not begin protocol therapy|4|||
23552632|NCT03162224|65751186|FG000|Overall Study|Death|4|||
23552633|NCT03162224|65751187|FG001|Overall Study|Death|5|||
23552634|NCT03162224|65751188|FG002|Overall Study|Death|8|||
23552635|NCT03162224|65751186|FG000|Overall Study|Withdrawal by Subject|1|||
23552636|NCT03162224|65751187|FG001|Overall Study|Withdrawal by Subject|0|||
23621554|NCT02330562|66000691|FG009|Overall Study|Withdrawal by Subject|1|||
23621555|NCT02330562|66000692|FG010|Overall Study|Withdrawal by Subject|0|||
23621556|NCT00635570|66000696|FG000|Overall Study|Lost to Follow-up|8|||
23621557|NCT00635570|66000697|FG001|Overall Study|Lost to Follow-up|8|||
23621558|NCT00635570|66000696|FG000|Overall Study|Withdrawal by Subject|1|||
23621559|NCT00635570|66000697|FG001|Overall Study|Withdrawal by Subject|1|||
23621560|NCT00635570|66000696|FG000|Overall Study|Adverse Event|2|||
23621561|NCT00635570|66000697|FG001|Overall Study|Adverse Event|0|||
23621562|NCT00635570|66000696|FG000|Overall Study|Physician Decision|1|||
23621563|NCT00635570|66000697|FG001|Overall Study|Physician Decision|0|||
23552637|NCT03162224|65751188|FG002|Overall Study|Withdrawal by Subject|1|||
23552638|NCT03162224|65751186|FG000|Overall Study|Lost to Follow-up|0|||
23552639|NCT03162224|65751187|FG001|Overall Study|Lost to Follow-up|1|||
23552640|NCT03162224|65751188|FG002|Overall Study|Lost to Follow-up|0|||
23552641|NCT03162224|65751186|FG000|Overall Study|Other|6|||
23552642|NCT03162224|65751187|FG001|Overall Study|Other|2|||
23552643|NCT03162224|65751188|FG002|Overall Study|Other|1|||
23552644|NCT02182973|65751191|FG000|Overall Study|Withdrawal by Subject|3|||
23552645|NCT02182973|65751192|FG001|Overall Study|Withdrawal by Subject|0|||
23552646|NCT02008890|65751198|FG000|Period 1|Withdrawal by Subject|7|||
23552647|NCT02008890|65751199|FG001|Period 1|Withdrawal by Subject|7|||
23552648|NCT02008890|65751200|FG002|Period 1|Withdrawal by Subject|5|||
23552649|NCT02008890|65751201|FG003|Period 1|Withdrawal by Subject|0|||
23621564|NCT00635570|66000696|FG000|Overall Study|Did not complete survey|2|||
23431531|NCT02717130|65324093|FG000|Overall Study|Study Closure|4|||
23431532|NCT00541346|65324104|FG000|Follow-up|Adverse Event|1|||
23431533|NCT04524455|65324105|FG000|Overall Study|Death|3|||
23431534|NCT04524455|65324106|FG001|Overall Study|Death|3|||
23431535|NCT04524455|65324105|FG000|Overall Study|Decision by Sponsor|0|||
23431536|NCT04524455|65324106|FG001|Overall Study|Decision by Sponsor|2|||
23431537|NCT04524455|65324105|FG000|Overall Study|Withdrawal of Consent From Study|1|||
23431538|NCT04524455|65324106|FG001|Overall Study|Withdrawal of Consent From Study|0|||
23431539|NCT04524455|65324105|FG000|Overall Study|Lost to Follow-up|0|||
23431540|NCT04524455|65324106|FG001|Overall Study|Lost to Follow-up|1|||
23431541|NCT01498185|65324107|FG000|Overall Study|Adverse Event|0|||
23431542|NCT01498185|65324108|FG001|Overall Study|Adverse Event|0|||
23431543|NCT01498185|65324109|FG002|Overall Study|Adverse Event|0|||
23552650|NCT02008890|65751202|FG004|Period 1|Withdrawal by Subject|0|||
23552651|NCT02008890|65751198|FG000|Period 1|Pregnancy|1|||
23552652|NCT02008890|65751199|FG001|Period 1|Pregnancy|0|||
23552653|NCT02008890|65751200|FG002|Period 1|Pregnancy|0|||
23552654|NCT02008890|65751201|FG003|Period 1|Pregnancy|0|||
23552655|NCT02008890|65751202|FG004|Period 1|Pregnancy|0|||
23552656|NCT02008890|65751198|FG000|Period 1|Physician Decision|1|||
23552657|NCT02008890|65751199|FG001|Period 1|Physician Decision|0|||
23552658|NCT02008890|65751200|FG002|Period 1|Physician Decision|1|||
23552659|NCT02008890|65751201|FG003|Period 1|Physician Decision|0|||
23552660|NCT02008890|65751202|FG004|Period 1|Physician Decision|0|||
23552661|NCT02008890|65751198|FG000|Period 1|Adverse Event|6|||
23552662|NCT02008890|65751199|FG001|Period 1|Adverse Event|8|||
23552663|NCT02008890|65751200|FG002|Period 1|Adverse Event|6|||
23552664|NCT02008890|65751201|FG003|Period 1|Adverse Event|0|||
23552665|NCT02008890|65751202|FG004|Period 1|Adverse Event|0|||
23552666|NCT02008890|65751198|FG000|Period 2|Adverse Event|12|||
23552667|NCT02008890|65751199|FG001|Period 2|Adverse Event|7|||
23744679|NCT01682876|66443303|FG002|Overall Study|Adverse Event|0|||
23744680|NCT01682876|66443304|FG003|Overall Study|Adverse Event|1|||
23431544|NCT01498185|65324110|FG003|Overall Study|Adverse Event|1|||
23744681|NCT01682876|66443301|FG000|Overall Study|Lost to Follow-up|11|||
23744682|NCT01682876|66443302|FG001|Overall Study|Lost to Follow-up|15|||
23744683|NCT01682876|66443303|FG002|Overall Study|Lost to Follow-up|9|||
23744684|NCT01682876|66443304|FG003|Overall Study|Lost to Follow-up|11|||
23744685|NCT01682876|66443301|FG000|Overall Study|Protocol Violation|1|||
23744686|NCT01682876|66443302|FG001|Overall Study|Protocol Violation|1|||
23744687|NCT01682876|66443303|FG002|Overall Study|Protocol Violation|1|||
23744688|NCT01682876|66443304|FG003|Overall Study|Protocol Violation|1|||
23744689|NCT01682876|66443301|FG000|Overall Study|Withdrawal by Subject|4|||
23744690|NCT01682876|66443302|FG001|Overall Study|Withdrawal by Subject|0|||
23744691|NCT01682876|66443303|FG002|Overall Study|Withdrawal by Subject|0|||
23744692|NCT01682876|66443304|FG003|Overall Study|Withdrawal by Subject|2|||
23744693|NCT01682876|66443301|FG000|Overall Study|Other|1|||
23744694|NCT01682876|66443302|FG001|Overall Study|Other|0|||
23744695|NCT01682876|66443303|FG002|Overall Study|Other|1|||
23744696|NCT01682876|66443304|FG003|Overall Study|Other|1|||
23744697|NCT03557775|66443305|FG000|Overall Study|Withdrawal by Subject|1|||
23744698|NCT03557775|66443306|FG001|Overall Study|Withdrawal by Subject|2|||
23744699|NCT03557775|66443307|FG002|Overall Study|Withdrawal by Subject|4|||
23744700|NCT03557775|66443305|FG000|Overall Study|Physician Decision|0|||
23744701|NCT03557775|66443306|FG001|Overall Study|Physician Decision|1|||
23744702|NCT03557775|66443307|FG002|Overall Study|Physician Decision|0|||
23744703|NCT01608321|66443308|FG000|Overall Study|Withdrawal by Subject|1|||
23744704|NCT01608321|66443309|FG001|Overall Study|Withdrawal by Subject|0|||
23744705|NCT03433482|66443312|FG000|Overall Study|Lost to Follow-up|1|||
23744706|NCT03433482|66443313|FG001|Overall Study|Lost to Follow-up|0|||
23744707|NCT03433482|66443314|FG002|Overall Study|Lost to Follow-up|1|||
23744708|NCT03433482|66443315|FG003|Overall Study|Lost to Follow-up|1|||
23744709|NCT03433482|66443312|FG000|Overall Study|Withdrawal by Subject|0|||
23744710|NCT03433482|66443313|FG001|Overall Study|Withdrawal by Subject|0|||
23822064|NCT02256436|66730248|FG000|Overall Study|Withdrawal by Subject|26|||
23431545|NCT01498185|65324111|FG004|Overall Study|Adverse Event|0|||
23431546|NCT01498185|65324107|FG000|Overall Study|Withdrawal by Subject|1|||
23431547|NCT01498185|65324108|FG001|Overall Study|Withdrawal by Subject|1|||
23431548|NCT01498185|65324109|FG002|Overall Study|Withdrawal by Subject|0|||
23552668|NCT02008890|65751200|FG002|Period 2|Adverse Event|0|||
23552669|NCT02008890|65751201|FG003|Period 2|Adverse Event|5|||
23552670|NCT02008890|65751202|FG004|Period 2|Adverse Event|5|||
23552671|NCT02008890|65751198|FG000|Period 2|Withdrawal by Subject|11|||
23552672|NCT02008890|65751199|FG001|Period 2|Withdrawal by Subject|8|||
23552673|NCT02008890|65751200|FG002|Period 2|Withdrawal by Subject|0|||
23552674|NCT02008890|65751201|FG003|Period 2|Withdrawal by Subject|7|||
23744711|NCT03433482|66443314|FG002|Overall Study|Withdrawal by Subject|1|||
23744712|NCT03433482|66443315|FG003|Overall Study|Withdrawal by Subject|0|||
23744713|NCT03433482|66443312|FG000|Overall Study|Unknown reason|0|||
23744714|NCT03433482|66443313|FG001|Overall Study|Unknown reason|0|||
23744715|NCT03433482|66443314|FG002|Overall Study|Unknown reason|2|||
23552675|NCT02008890|65751202|FG004|Period 2|Withdrawal by Subject|2|||
23552676|NCT02008890|65751198|FG000|Period 2|Physician Decision|4|||
23552677|NCT02008890|65751199|FG001|Period 2|Physician Decision|0|||
23552678|NCT02008890|65751200|FG002|Period 2|Physician Decision|0|||
23552679|NCT02008890|65751201|FG003|Period 2|Physician Decision|2|||
23552680|NCT02008890|65751202|FG004|Period 2|Physician Decision|1|||
23552681|NCT02008890|65751198|FG000|Period 2|Lost to Follow-up|0|||
23552682|NCT02008890|65751199|FG001|Period 2|Lost to Follow-up|0|||
23552683|NCT02008890|65751200|FG002|Period 2|Lost to Follow-up|1|||
23822065|NCT02256436|66730249|FG001|Overall Study|Withdrawal by Subject|10|||
23431549|NCT01498185|65324110|FG003|Overall Study|Withdrawal by Subject|2|||
23431550|NCT01498185|65324111|FG004|Overall Study|Withdrawal by Subject|1|||
23431551|NCT01498185|65324107|FG000|Overall Study|No longer met criteria, etc|0|||
23431552|NCT01498185|65324108|FG001|Overall Study|No longer met criteria, etc|0|||
23431553|NCT01498185|65324109|FG002|Overall Study|No longer met criteria, etc|0|||
23431554|NCT01498185|65324110|FG003|Overall Study|No longer met criteria, etc|0|||
23431555|NCT01498185|65324111|FG004|Overall Study|No longer met criteria, etc|2|||
23431556|NCT01853072|65324112|FG000|Overall Study|Adverse event prior to treatment|0|||
23431557|NCT01853072|65324113|FG001|Overall Study|Adverse event prior to treatment|1|||
23431558|NCT01853072|65324112|FG000|Overall Study|Adverse Event|0|||
23431559|NCT01853072|65324113|FG001|Overall Study|Adverse Event|3|||
23431560|NCT01853072|65324112|FG000|Overall Study|Death|1|||
23431561|NCT01853072|65324113|FG001|Overall Study|Death|4|||
23431562|NCT01853072|65324112|FG000|Overall Study|Lost to Follow-up|0|||
23431563|NCT01853072|65324113|FG001|Overall Study|Lost to Follow-up|3|||
23431564|NCT01853072|65324112|FG000|Overall Study|Non-compliance with study drug|0|||
23431565|NCT01853072|65324113|FG001|Overall Study|Non-compliance with study drug|1|||
23431566|NCT01853072|65324112|FG000|Overall Study|Physician Decision|1|||
23431567|NCT01853072|65324113|FG001|Overall Study|Physician Decision|1|||
23431568|NCT01853072|65324112|FG000|Overall Study|Withdrawal by Subject|1|||
23431569|NCT01853072|65324113|FG001|Overall Study|Withdrawal by Subject|2|||
23431570|NCT01853072|65324112|FG000|Overall Study|Reason not specified|9|||
23431571|NCT01853072|65324113|FG001|Overall Study|Reason not specified|6|||
23431572|NCT00483041|65324117|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
23431573|NCT00483041|65324118|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
23431574|NCT00549770|65324119|FG000|Overall Study|Protocol deviation|1|||
23431575|NCT00549770|65324120|FG001|Overall Study|Protocol deviation|1|||
23431576|NCT00549770|65324121|FG002|Overall Study|Protocol deviation|1|||
23431577|NCT00549770|65324122|FG003|Overall Study|Protocol deviation|2|||
23552684|NCT02008890|65751201|FG003|Period 2|Lost to Follow-up|0|||
23822066|NCT02256436|66730248|FG000|Overall Study|Transferred to Extension Study|11|||
23822067|NCT02256436|66730249|FG001|Overall Study|Transferred to Extension Study|23|||
23822068|NCT02256436|66730248|FG000|Overall Study|Did Not Continue on Extension Study|8|||
23822069|NCT02256436|66730249|FG001|Overall Study|Did Not Continue on Extension Study|12|||
23822070|NCT04152863|66730267|FG000|Overall Study|Death|13|||
23822071|NCT04152863|66730268|FG001|Overall Study|Death|12|||
23822072|NCT04152863|66730269|FG002|Overall Study|Death|7|||
23822073|NCT04152863|66730267|FG000|Overall Study|Physician Decision|1|||
23822074|NCT04152863|66730268|FG001|Overall Study|Physician Decision|1|||
23822075|NCT04152863|66730269|FG002|Overall Study|Physician Decision|1|||
23822076|NCT04152863|66730267|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
23822077|NCT04152863|66730268|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
23822078|NCT04152863|66730269|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
23822079|NCT04152863|66730267|FG000|Overall Study|Withdrawal by Subject|2|||
23822080|NCT04152863|66730268|FG001|Overall Study|Withdrawal by Subject|1|||
23822081|NCT04152863|66730269|FG002|Overall Study|Withdrawal by Subject|3|||
23822082|NCT00911300|66730273|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
23822083|NCT00911300|66730274|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
23822084|NCT00911300|66730273|FG000|Overall Study|Death|1|||
23822085|NCT00911300|66730274|FG001|Overall Study|Death|0|||
23822086|NCT00911300|66730273|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
23822087|NCT00911300|66730274|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
23822088|NCT00911300|66730273|FG000|Overall Study|Adverse Event|14|||
23822089|NCT00911300|66730274|FG001|Overall Study|Adverse Event|6|||
23431578|NCT00549770|65324123|FG004|Overall Study|Protocol deviation|2|||
23431579|NCT00549770|65324124|FG005|Overall Study|Protocol deviation|2|||
23431580|NCT00549770|65324125|FG006|Overall Study|Protocol deviation|1|||
23431581|NCT00549770|65324126|FG007|Overall Study|Protocol deviation|2|||
23431582|NCT00549770|65324119|FG000|Overall Study|Administrative problems|0|||
23431583|NCT00549770|65324120|FG001|Overall Study|Administrative problems|1|||
23431584|NCT00549770|65324121|FG002|Overall Study|Administrative problems|0|||
23431585|NCT00549770|65324122|FG003|Overall Study|Administrative problems|0|||
23431586|NCT00549770|65324123|FG004|Overall Study|Administrative problems|0|||
23431587|NCT00549770|65324124|FG005|Overall Study|Administrative problems|0|||
23431588|NCT00549770|65324125|FG006|Overall Study|Administrative problems|0|||
23552685|NCT02008890|65751202|FG004|Period 2|Lost to Follow-up|0|||
23552686|NCT02008890|65751198|FG000|Extension Period|Withdrawal by Subject|3|||
23822090|NCT00911300|66730273|FG000|Overall Study|Protocol Violation|3|||
23822091|NCT00911300|66730274|FG001|Overall Study|Protocol Violation|2|||
23822092|NCT00911300|66730273|FG000|Overall Study|Consent Withdrawn|4|||
23822093|NCT00911300|66730274|FG001|Overall Study|Consent Withdrawn|12|||
23431589|NCT00549770|65324126|FG007|Overall Study|Administrative problems|1|||
23431590|NCT00549770|65324119|FG000|Overall Study|Lost to Follow-up|0|||
23431591|NCT00549770|65324120|FG001|Overall Study|Lost to Follow-up|0|||
23431592|NCT00549770|65324121|FG002|Overall Study|Lost to Follow-up|2|||
23431593|NCT00549770|65324122|FG003|Overall Study|Lost to Follow-up|2|||
23431594|NCT00549770|65324123|FG004|Overall Study|Lost to Follow-up|3|||
23431595|NCT00549770|65324124|FG005|Overall Study|Lost to Follow-up|2|||
23431596|NCT00549770|65324125|FG006|Overall Study|Lost to Follow-up|0|||
23431597|NCT00549770|65324126|FG007|Overall Study|Lost to Follow-up|0|||
23431598|NCT00549770|65324119|FG000|Overall Study|Withdrawal by Subject|4|||
23431599|NCT00549770|65324120|FG001|Overall Study|Withdrawal by Subject|6|||
23431600|NCT00549770|65324121|FG002|Overall Study|Withdrawal by Subject|4|||
23431601|NCT00549770|65324122|FG003|Overall Study|Withdrawal by Subject|5|||
23431602|NCT00549770|65324123|FG004|Overall Study|Withdrawal by Subject|6|||
23431603|NCT00549770|65324124|FG005|Overall Study|Withdrawal by Subject|6|||
23431604|NCT00549770|65324125|FG006|Overall Study|Withdrawal by Subject|4|||
23431605|NCT00549770|65324126|FG007|Overall Study|Withdrawal by Subject|9|||
23431606|NCT00549770|65324119|FG000|Overall Study|Lack of Efficacy|1|||
23431607|NCT00549770|65324120|FG001|Overall Study|Lack of Efficacy|0|||
23431608|NCT00549770|65324121|FG002|Overall Study|Lack of Efficacy|2|||
23431609|NCT00549770|65324122|FG003|Overall Study|Lack of Efficacy|3|||
23552687|NCT02008890|65751199|FG001|Extension Period|Withdrawal by Subject|2|||
23552688|NCT02008890|65751200|FG002|Extension Period|Withdrawal by Subject|0|||
23552689|NCT02008890|65751201|FG003|Extension Period|Withdrawal by Subject|4|||
23822094|NCT00911300|66730273|FG000|Overall Study|Coronary Angiography Performed|1|||
23822095|NCT00911300|66730274|FG001|Overall Study|Coronary Angiography Performed|0|||
23822096|NCT00911300|66730273|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
23822097|NCT00911300|66730274|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
23822098|NCT00911300|66730273|FG000|Overall Study|Received Commercial Treatment|1|||
23822099|NCT00911300|66730274|FG001|Overall Study|Received Commercial Treatment|0|||
23822100|NCT00911300|66730273|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
23822101|NCT00911300|66730274|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
23822102|NCT00911300|66730273|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
23822103|NCT00911300|66730274|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
23822104|NCT00911300|66730273|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
23822105|NCT00911300|66730274|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
23822106|NCT00911300|66730273|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
23822107|NCT00911300|66730274|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
23822108|NCT00911300|66730273|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
23822109|NCT00911300|66730274|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
23822110|NCT00911300|66730273|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
23822111|NCT00911300|66730274|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
23822112|NCT00911300|66730273|FG000|Overall Study|International Normalized Ratio Too High|0|||
23822113|NCT00911300|66730274|FG001|Overall Study|International Normalized Ratio Too High|1|||
23822114|NCT00911300|66730273|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
23822115|NCT00911300|66730274|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
23822116|NCT00911300|66730273|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
23822117|NCT00911300|66730274|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
23822118|NCT00911300|66730273|FG000|Overall Study|Physician Decision|0|||
23822119|NCT00911300|66730274|FG001|Overall Study|Physician Decision|1|||
23822120|NCT00911300|66730273|FG000|Overall Study|Treatment Stopped by Mistake|0|||
23822121|NCT00911300|66730274|FG001|Overall Study|Treatment Stopped by Mistake|1|||
23822122|NCT00911300|66730273|FG000|Overall Study|Randomized; No Study Medication Received|0|||
23822123|NCT00911300|66730274|FG001|Overall Study|Randomized; No Study Medication Received|2|||
23822124|NCT03278626|66730278|FG000|Overall Study|Death|2|||
23822125|NCT03278626|66730278|FG000|Overall Study|Toxicity|1|||
23822126|NCT03278626|66730278|FG000|Overall Study|Disease Progression|2|||
23822127|NCT00402116|66730281|FG000|Overall Study|Jaw infection after surgery-other|1|||
23822128|NCT00402116|66730282|FG001|Overall Study|Jaw infection after surgery-other|0|||
23822129|NCT00402116|66730283|FG002|Overall Study|Jaw infection after surgery-other|0|||
23822130|NCT00402116|66730281|FG000|Overall Study|Withdrawal by Subject|1|||
23431610|NCT00549770|65324123|FG004|Overall Study|Lack of Efficacy|5|||
23431611|NCT00549770|65324124|FG005|Overall Study|Lack of Efficacy|1|||
23431612|NCT00549770|65324125|FG006|Overall Study|Lack of Efficacy|3|||
23431613|NCT00549770|65324126|FG007|Overall Study|Lack of Efficacy|8|||
23431614|NCT00549770|65324119|FG000|Overall Study|Abnormal test procedure results|0|||
23431615|NCT00549770|65324120|FG001|Overall Study|Abnormal test procedure results|0|||
23431616|NCT00549770|65324121|FG002|Overall Study|Abnormal test procedure results|0|||
23431617|NCT00549770|65324122|FG003|Overall Study|Abnormal test procedure results|2|||
23621565|NCT00635570|66000697|FG001|Overall Study|Did not complete survey|1|||
23621566|NCT00635570|66000696|FG000|Overall Study|Early termination(No sexual activity)|1|||
23621567|NCT00635570|66000697|FG001|Overall Study|Early termination(No sexual activity)|1|||
23621568|NCT00853229|66000700|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
23621569|NCT00853229|66000701|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
23621570|NCT04150341|66000702|FG000|Overall Study|Physician Decision|0|||
23621571|NCT04150341|66000703|FG001|Overall Study|Physician Decision|0|||
23552690|NCT02008890|65751202|FG004|Extension Period|Withdrawal by Subject|2|||
23552691|NCT02008890|65751198|FG000|Extension Period|Lost to Follow-up|1|||
23552692|NCT02008890|65751199|FG001|Extension Period|Lost to Follow-up|0|||
23552693|NCT02008890|65751200|FG002|Extension Period|Lost to Follow-up|0|||
23552694|NCT02008890|65751201|FG003|Extension Period|Lost to Follow-up|0|||
23552695|NCT02008890|65751202|FG004|Extension Period|Lost to Follow-up|0|||
23621572|NCT04150341|66000704|FG002|Overall Study|Physician Decision|1|||
23621573|NCT04150341|66000705|FG003|Overall Study|Physician Decision|0|||
23621574|NCT04150341|66000706|FG004|Overall Study|Physician Decision|0|||
23621575|NCT04150341|66000707|FG005|Overall Study|Physician Decision|0|||
23621576|NCT04150341|66000702|FG000|Overall Study|Adverse Event|0|||
23621577|NCT04150341|66000703|FG001|Overall Study|Adverse Event|0|||
23621578|NCT04150341|66000704|FG002|Overall Study|Adverse Event|0|||
23621579|NCT04150341|66000705|FG003|Overall Study|Adverse Event|0|||
23621580|NCT04150341|66000706|FG004|Overall Study|Adverse Event|1|||
23621581|NCT04150341|66000707|FG005|Overall Study|Adverse Event|0|||
23621582|NCT01101997|66000711|FG000|Overall Study|Withdrawal by Subject|2|||
23552696|NCT02008890|65751198|FG000|Extension Period|Adverse Event|1|||
23621583|NCT00721214|66000712|FG000|Overall Study|Chose another center for transplant|1|||
23552697|NCT02008890|65751199|FG001|Extension Period|Adverse Event|3|||
23552698|NCT02008890|65751200|FG002|Extension Period|Adverse Event|0|||
23552699|NCT02008890|65751201|FG003|Extension Period|Adverse Event|0|||
23552700|NCT02008890|65751202|FG004|Extension Period|Adverse Event|2|||
23552701|NCT00683644|65751203|FG000|Overall Study|Withdrawal by Subject|4|||
23552702|NCT00683644|65751204|FG001|Overall Study|Withdrawal by Subject|2|||
23552703|NCT00683644|65751203|FG000|Overall Study|Lost to Follow-up|1|||
23552704|NCT00683644|65751204|FG001|Overall Study|Lost to Follow-up|4|||
23552705|NCT00683644|65751203|FG000|Overall Study|Adverse Event|1|||
23552706|NCT00683644|65751204|FG001|Overall Study|Adverse Event|2|||
23552707|NCT00683644|65751203|FG000|Overall Study|Low copper, other health problems,|7|||
23552708|NCT00683644|65751204|FG001|Overall Study|Low copper, other health problems,|6|||
23552709|NCT00003298|65751207|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
23552710|NCT00003298|65751207|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
23552711|NCT00003298|65751207|FG000|Surgery|Unresectable at surgery|3|||
23552712|NCT00003298|65751207|FG000|Surgery|Progression before surgery|2|||
23552713|NCT00003298|65751207|FG000|Surgery|Unevaluable and off study|2|||
23552714|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
23552715|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
23552716|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
23552717|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
23552718|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
23552719|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
23552720|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
23552721|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
23552722|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
23552723|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
23552724|NCT01258608|65751208|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
23552725|NCT01258608|65751209|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
23621584|NCT00721214|66000712|FG000|Overall Study|Death|3|||
23744716|NCT03433482|66443315|FG003|Overall Study|Unknown reason|0|||
23744717|NCT02058849|66443316|FG000|Overall Study|Hospitalization|1|||
23744718|NCT02058849|66443317|FG001|Overall Study|Hospitalization|1|||
23744719|NCT02058849|66443316|FG000|Overall Study|Death|1|||
23744720|NCT02058849|66443317|FG001|Overall Study|Death|0|||
23744721|NCT02058849|66443316|FG000|Overall Study|Lost to Follow-up|1|||
23744722|NCT02058849|66443317|FG001|Overall Study|Lost to Follow-up|0|||
23744723|NCT02058849|66443316|FG000|Overall Study|Withdrawal by Subject|4|||
23621585|NCT02554383|66000713|FG000|Overall Study|Ineligible|3|||
23621586|NCT02554383|66000714|FG001|Overall Study|Ineligible|2|||
23744724|NCT02058849|66443317|FG001|Overall Study|Withdrawal by Subject|0|||
23552726|NCT01258608|65751208|FG000|Overall Study|Clinical progression|1|||
23552727|NCT01258608|65751209|FG001|Overall Study|Clinical progression|0|||
23552728|NCT01258608|65751208|FG000|Overall Study|Sponsor decision|0|||
23552729|NCT01258608|65751209|FG001|Overall Study|Sponsor decision|1|||
23552730|NCT01258608|65751208|FG000|Overall Study|Physician Decision|6|||
23744725|NCT00083226|66443319|FG000|Overall Study|Lack of Efficacy|19|||
23552731|NCT01258608|65751209|FG001|Overall Study|Physician Decision|1|||
23552732|NCT01258608|65751208|FG000|Overall Study|Lost to Follow-up|0|||
23552733|NCT01258608|65751209|FG001|Overall Study|Lost to Follow-up|1|||
23552734|NCT01258608|65751208|FG000|Overall Study|Lack of compliance|1|||
23552735|NCT01258608|65751209|FG001|Overall Study|Lack of compliance|0|||
23552736|NCT01258608|65751208|FG000|Overall Study|Lack of Efficacy|0|||
23552737|NCT01258608|65751209|FG001|Overall Study|Lack of Efficacy|1|||
23552738|NCT01258608|65751208|FG000|Overall Study|Adverse Event|6|||
23552739|NCT01258608|65751209|FG001|Overall Study|Adverse Event|10|||
23552740|NCT01258608|65751208|FG000|Overall Study|Withdrawal by Subject|6|||
23552741|NCT01258608|65751209|FG001|Overall Study|Withdrawal by Subject|5|||
23552742|NCT03982186|65751213|FG000|Overall Study|Lost to Follow-up|0|||
23552743|NCT03982186|65751214|FG001|Overall Study|Lost to Follow-up|1|||
23552744|NCT03982186|65751215|FG002|Overall Study|Lost to Follow-up|2|||
23552745|NCT03982186|65751216|FG003|Overall Study|Lost to Follow-up|1|||
23552746|NCT03982186|65751217|FG004|Overall Study|Lost to Follow-up|1|||
23552747|NCT03982186|65751218|FG005|Overall Study|Lost to Follow-up|0|||
23552748|NCT03982186|65751213|FG000|Overall Study|Physician Decision|0|||
23552749|NCT03982186|65751214|FG001|Overall Study|Physician Decision|1|||
23552750|NCT03982186|65751215|FG002|Overall Study|Physician Decision|0|||
23552751|NCT03982186|65751216|FG003|Overall Study|Physician Decision|0|||
23552752|NCT03982186|65751217|FG004|Overall Study|Physician Decision|0|||
23552753|NCT03982186|65751218|FG005|Overall Study|Physician Decision|0|||
23552754|NCT03982186|65751213|FG000|Overall Study|Withdrawal by Subject|3|||
23552755|NCT03982186|65751214|FG001|Overall Study|Withdrawal by Subject|4|||
23552756|NCT03982186|65751215|FG002|Overall Study|Withdrawal by Subject|1|||
23552757|NCT03982186|65751216|FG003|Overall Study|Withdrawal by Subject|7|||
23552758|NCT03982186|65751217|FG004|Overall Study|Withdrawal by Subject|2|||
23552759|NCT03982186|65751218|FG005|Overall Study|Withdrawal by Subject|0|||
23552760|NCT03982186|65751213|FG000|Overall Study|Randomized and not treated|0|||
23552761|NCT03982186|65751214|FG001|Overall Study|Randomized and not treated|0|||
23552762|NCT03982186|65751215|FG002|Overall Study|Randomized and not treated|0|||
23552763|NCT03982186|65751216|FG003|Overall Study|Randomized and not treated|1|||
23552764|NCT03982186|65751217|FG004|Overall Study|Randomized and not treated|0|||
23552765|NCT03982186|65751218|FG005|Overall Study|Randomized and not treated|0|||
23552766|NCT01814748|65751219|FG000|Overall Study|Lost to Follow-up|1|||
23552767|NCT01814748|65751220|FG001|Overall Study|Lost to Follow-up|2|||
23552768|NCT01814748|65751219|FG000|Overall Study|Study site terminated by sponsor|1|||
23552769|NCT01814748|65751220|FG001|Overall Study|Study site terminated by sponsor|1|||
23552770|NCT01814748|65751219|FG000|Overall Study|Withdrawal by Subject|6|||
23552771|NCT01814748|65751220|FG001|Overall Study|Withdrawal by Subject|4|||
23552772|NCT02030015|65751223|FG000|Overall Study|Withdrawal by Subject|3|||
23552773|NCT02030015|65751223|FG000|Overall Study|Death|13|||
23552774|NCT01928719|65751224|FG000|Overall Study|Lost to Follow-up|26|||
23552775|NCT01928719|65751225|FG001|Overall Study|Lost to Follow-up|11|||
23552776|NCT01928719|65751224|FG000|Overall Study|Withdrawal by Subject|22|||
23552777|NCT01928719|65751225|FG001|Overall Study|Withdrawal by Subject|7|||
23552778|NCT01928719|65751224|FG000|Overall Study|Protocol Violation|3|||
23552779|NCT01928719|65751225|FG001|Overall Study|Protocol Violation|1|||
23552780|NCT01928719|65751224|FG000|Overall Study|Adverse Event|1|||
23552781|NCT01928719|65751225|FG001|Overall Study|Adverse Event|0|||
23552782|NCT03364751|65751226|FG000|Overall Study|Withdrawal by Subject|1|||
23552783|NCT03364751|65751227|FG001|Overall Study|Withdrawal by Subject|0|||
23552784|NCT03364751|65751228|FG002|Overall Study|Withdrawal by Subject|0|||
23552785|NCT03364751|65751229|FG003|Overall Study|Withdrawal by Subject|0|||
23552786|NCT03364751|65751226|FG000|Overall Study|Lost to Follow-up|0|||
23744726|NCT00083226|66443319|FG000|Overall Study|Adverse Event|9|||
23431618|NCT00549770|65324123|FG004|Overall Study|Abnormal test procedure results|0|||
23552787|NCT03364751|65751227|FG001|Overall Study|Lost to Follow-up|1|||
23552788|NCT03364751|65751228|FG002|Overall Study|Lost to Follow-up|0|||
23552789|NCT03364751|65751229|FG003|Overall Study|Lost to Follow-up|0|||
23431619|NCT00549770|65324124|FG005|Overall Study|Abnormal test procedure results|1|||
23552790|NCT00929162|65751230|FG000|Overall Study|Adverse Event|8|||
23552791|NCT00929162|65751231|FG001|Overall Study|Adverse Event|5|||
23552792|NCT00929162|65751230|FG000|Overall Study|Withdrawal by Subject|3|||
23552793|NCT00929162|65751231|FG001|Overall Study|Withdrawal by Subject|1|||
23552794|NCT00929162|65751230|FG000|Overall Study|Protocol Violation|32|||
23552795|NCT00929162|65751231|FG001|Overall Study|Protocol Violation|30|||
23552796|NCT00929162|65751230|FG000|Overall Study|Other termination reason|5|||
23552797|NCT00929162|65751231|FG001|Overall Study|Other termination reason|6|||
23552798|NCT02677116|65751232|FG000|Overall Study|Adverse Event|0|||
23552799|NCT02677116|65751233|FG001|Overall Study|Adverse Event|1|||
23552800|NCT02677116|65751234|FG002|Overall Study|Adverse Event|0|||
23552801|NCT02677116|65751235|FG003|Overall Study|Adverse Event|0|||
23552802|NCT02677116|65751236|FG004|Overall Study|Adverse Event|0|||
23552803|NCT02677116|65751237|FG005|Overall Study|Adverse Event|1|||
23552804|NCT02677116|65751238|FG006|Overall Study|Adverse Event|1|||
23552805|NCT02677116|65751239|FG007|Overall Study|Adverse Event|0|||
23552806|NCT02677116|65751240|FG008|Overall Study|Adverse Event|0|||
23552807|NCT02677116|65751232|FG000|Overall Study|Physician Decision|0|||
23552808|NCT02677116|65751233|FG001|Overall Study|Physician Decision|2|||
23552809|NCT02677116|65751234|FG002|Overall Study|Physician Decision|3|||
23552810|NCT02677116|65751235|FG003|Overall Study|Physician Decision|2|||
23552811|NCT02677116|65751236|FG004|Overall Study|Physician Decision|1|||
23552812|NCT02677116|65751237|FG005|Overall Study|Physician Decision|3|||
23552813|NCT02677116|65751238|FG006|Overall Study|Physician Decision|1|||
23552814|NCT02677116|65751239|FG007|Overall Study|Physician Decision|1|||
23552815|NCT02677116|65751240|FG008|Overall Study|Physician Decision|2|||
23552816|NCT02677116|65751232|FG000|Overall Study|Withdrawal by parent or guardian|2|||
23552817|NCT02677116|65751233|FG001|Overall Study|Withdrawal by parent or guardian|1|||
23552818|NCT02677116|65751234|FG002|Overall Study|Withdrawal by parent or guardian|0|||
23552819|NCT02677116|65751235|FG003|Overall Study|Withdrawal by parent or guardian|1|||
23552820|NCT02677116|65751236|FG004|Overall Study|Withdrawal by parent or guardian|0|||
23552821|NCT02677116|65751237|FG005|Overall Study|Withdrawal by parent or guardian|0|||
23552822|NCT02677116|65751238|FG006|Overall Study|Withdrawal by parent or guardian|2|||
23621587|NCT02554383|66000713|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
23621588|NCT02554383|66000714|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
23621589|NCT02554383|66000713|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
23621590|NCT02554383|66000714|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
23621591|NCT02554383|66000713|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
23621592|NCT02554383|66000714|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
23621593|NCT00843115|66000715|FG000|Overall Study|Death|4|||
23621594|NCT00843115|66000715|FG000|Overall Study|Adverse Event|30|||
23431620|NCT00549770|65324125|FG006|Overall Study|Abnormal test procedure results|1|||
23431621|NCT00549770|65324126|FG007|Overall Study|Abnormal test procedure results|1|||
23431622|NCT00549770|65324119|FG000|Overall Study|Abnormal laboratory values|0|||
23431623|NCT00549770|65324120|FG001|Overall Study|Abnormal laboratory values|0|||
23431624|NCT00549770|65324121|FG002|Overall Study|Abnormal laboratory values|0|||
23431625|NCT00549770|65324122|FG003|Overall Study|Abnormal laboratory values|0|||
23621595|NCT00843115|66000715|FG000|Overall Study|Lost to Follow-up|4|||
23621596|NCT00843115|66000715|FG000|Overall Study|Withdrawal by Subject|17|||
23621597|NCT00843115|66000715|FG000|Overall Study|Family wanted meds stopped|1|||
23621598|NCT00843115|66000715|FG000|Overall Study|Family does not want continuation|1|||
23621599|NCT00843115|66000715|FG000|Overall Study|Patient forgot to take meds|1|||
23621600|NCT00843115|66000715|FG000|Overall Study|Does not meet entrance criteria|1|||
23621601|NCT00843115|66000715|FG000|Overall Study|Physician Decision|1|||
23621602|NCT00843115|66000715|FG000|Overall Study|Family discontinued meds|1|||
23621603|NCT00843115|66000715|FG000|Overall Study|patient took for 2 days then stopped|1|||
23621604|NCT00843115|66000715|FG000|Overall Study|patient never took the medication|1|||
23621605|NCT00843115|66000715|FG000|Overall Study|hospitalized due to deterioration|1|||
23621606|NCT00843115|66000715|FG000|Overall Study|week 12 not done|1|||
23621607|NCT00843115|66000715|FG000|Overall Study|Syndrome De Glissement|1|||
23621608|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621609|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621610|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
23431626|NCT00549770|65324123|FG004|Overall Study|Abnormal laboratory values|0|||
23431627|NCT00549770|65324124|FG005|Overall Study|Abnormal laboratory values|1|||
23552823|NCT02677116|65751239|FG007|Overall Study|Withdrawal by parent or guardian|1|||
23552824|NCT02677116|65751240|FG008|Overall Study|Withdrawal by parent or guardian|0|||
23552825|NCT02677116|65751232|FG000|Overall Study|Withdrawal by Subject|1|||
23552826|NCT02677116|65751233|FG001|Overall Study|Withdrawal by Subject|0|||
23552827|NCT02677116|65751234|FG002|Overall Study|Withdrawal by Subject|0|||
23552828|NCT02677116|65751235|FG003|Overall Study|Withdrawal by Subject|0|||
23552829|NCT02677116|65751236|FG004|Overall Study|Withdrawal by Subject|0|||
23552830|NCT02677116|65751237|FG005|Overall Study|Withdrawal by Subject|0|||
23552831|NCT02677116|65751238|FG006|Overall Study|Withdrawal by Subject|0|||
23552832|NCT02677116|65751239|FG007|Overall Study|Withdrawal by Subject|0|||
23552833|NCT02677116|65751240|FG008|Overall Study|Withdrawal by Subject|0|||
23552834|NCT01292876|65751242|FG000|Overall Study|Physician Decision|4|||
23552835|NCT02131272|65751243|FG000|Overall Study|Withdrawal by parent|0|||
23552836|NCT02131272|65751244|FG001|Overall Study|Withdrawal by parent|1|||
23431628|NCT00549770|65324125|FG006|Overall Study|Abnormal laboratory values|0|||
23431629|NCT00549770|65324126|FG007|Overall Study|Abnormal laboratory values|0|||
23552837|NCT02131272|65751243|FG000|Overall Study|Withdrawal by Subject|0|||
23552838|NCT02131272|65751244|FG001|Overall Study|Withdrawal by Subject|1|||
23552839|NCT02131272|65751243|FG000|Overall Study|Withdrawal Criteria|1|||
23431630|NCT00549770|65324119|FG000|Overall Study|Adverse Event|1|||
23431631|NCT00549770|65324120|FG001|Overall Study|Adverse Event|3|||
23431632|NCT00549770|65324121|FG002|Overall Study|Adverse Event|1|||
23431633|NCT00549770|65324122|FG003|Overall Study|Adverse Event|2|||
23431634|NCT00549770|65324123|FG004|Overall Study|Adverse Event|1|||
23431635|NCT00549770|65324124|FG005|Overall Study|Adverse Event|0|||
23431636|NCT00549770|65324125|FG006|Overall Study|Adverse Event|5|||
23431637|NCT00549770|65324126|FG007|Overall Study|Adverse Event|4|||
23431638|NCT00552760|65324127|FG000|Overall Study|Adverse Event|3|||
23431639|NCT00552760|65324128|FG001|Overall Study|Adverse Event|5|||
23431640|NCT00552760|65324127|FG000|Overall Study|Relapsed- Depressed Event|10|||
23431641|NCT00552760|65324128|FG001|Overall Study|Relapsed- Depressed Event|16|||
23431642|NCT00552760|65324127|FG000|Overall Study|Relapse- Manic Event|3|||
23431643|NCT00552760|65324128|FG001|Overall Study|Relapse- Manic Event|3|||
23431644|NCT00552760|65324127|FG000|Overall Study|Relapsed- Mixed Event|3|||
23431645|NCT00552760|65324128|FG001|Overall Study|Relapsed- Mixed Event|5|||
23431646|NCT00552760|65324127|FG000|Overall Study|Protocol Violation|0|||
23431647|NCT00552760|65324128|FG001|Overall Study|Protocol Violation|1|||
23431648|NCT00552760|65324127|FG000|Overall Study|Lost to Follow-up|1|||
23431649|NCT00552760|65324128|FG001|Overall Study|Lost to Follow-up|1|||
23431650|NCT00552760|65324127|FG000|Overall Study|Non-compliance|1|||
23431651|NCT00552760|65324128|FG001|Overall Study|Non-compliance|1|||
23431652|NCT00552760|65324127|FG000|Overall Study|Medical Condition|1|||
23431653|NCT00552760|65324128|FG001|Overall Study|Medical Condition|1|||
23431654|NCT00552760|65324127|FG000|Overall Study|Withdrawal by Subject|3|||
23431655|NCT00552760|65324128|FG001|Overall Study|Withdrawal by Subject|0|||
23431656|NCT00552760|65324127|FG000|Overall Study|Medication Change|1|||
23431657|NCT00552760|65324128|FG001|Overall Study|Medication Change|0|||
23431658|NCT02715726|65324129|FG000|Overall Study|Adverse Event|2|||
23431659|NCT02715726|65324130|FG001|Overall Study|Adverse Event|6|||
23431660|NCT02715726|65324129|FG000|Overall Study|Protocol Violation|1|||
23431661|NCT02715726|65324130|FG001|Overall Study|Protocol Violation|0|||
23431662|NCT02715726|65324129|FG000|Overall Study|Death|2|||
23431663|NCT02715726|65324130|FG001|Overall Study|Death|1|||
23431664|NCT02715726|65324129|FG000|Overall Study|Participant moved|1|||
23431665|NCT02715726|65324130|FG001|Overall Study|Participant moved|3|||
23431666|NCT02715726|65324129|FG000|Overall Study|Other than specified above|11|||
23552840|NCT02131272|65751244|FG001|Overall Study|Withdrawal Criteria|0|||
23552841|NCT00815295|65751245|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
23552842|NCT00815295|65751246|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
23552843|NCT00815295|65751247|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
23552844|NCT03543254|65751248|FG000|Overall Study|Lost to Follow-up|1|||
23552845|NCT00313820|65751249|FG000|Assigned to Treatment|Other|1|||
23744727|NCT00083226|66443319|FG000|Overall Study|Death|4|||
23744728|NCT00083226|66443319|FG000|Overall Study|Withdrawal by Subject|4|||
23744729|NCT00083226|66443319|FG000|Overall Study|Other|2|||
23744730|NCT00083226|66443319|FG000|Overall Study|ineligible or not receiving treatment|4|||
23744731|NCT04196023|66443320|FG000|Overall Study|Withdrawal by Subject|0|||
23431667|NCT02715726|65324130|FG001|Overall Study|Other than specified above|15|||
23431668|NCT02715726|65324129|FG000|Overall Study|Randomized but not treated|1|||
23431669|NCT02715726|65324130|FG001|Overall Study|Randomized but not treated|2|||
23431670|NCT02049138|65324133|FG000|Overall Study|Adverse Event|46|||
23431671|NCT02049138|65324134|FG001|Overall Study|Adverse Event|25|||
23431672|NCT02049138|65324135|FG002|Overall Study|Adverse Event|1|||
23431673|NCT02049138|65324133|FG000|Overall Study|Withdrawal by Subject|57|||
23431674|NCT02049138|65324134|FG001|Overall Study|Withdrawal by Subject|21|||
23431675|NCT02049138|65324135|FG002|Overall Study|Withdrawal by Subject|5|||
23431676|NCT02049138|65324133|FG000|Overall Study|Lost to Follow-up|18|||
23431677|NCT02049138|65324134|FG001|Overall Study|Lost to Follow-up|5|||
23431678|NCT02049138|65324135|FG002|Overall Study|Lost to Follow-up|1|||
23431679|NCT02049138|65324133|FG000|Overall Study|Lack of Efficacy|10|||
23552846|NCT00313820|65751250|FG001|Assigned to Treatment|Other|0|||
23552847|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
23552848|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
23552849|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
23552850|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
23552851|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
23552852|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
23552853|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
23552854|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
23552855|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
23552856|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
23552857|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552858|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552859|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552860|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552861|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552862|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552863|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552864|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552865|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
23552866|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552867|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552868|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552869|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552870|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552871|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
23552872|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
23552873|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552874|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
23552875|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552876|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552877|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23744732|NCT04196023|66443321|FG001|Overall Study|Withdrawal by Subject|1|||
23744733|NCT04196023|66443320|FG000|Overall Study|Adverse Event|3|||
23744734|NCT04196023|66443321|FG001|Overall Study|Adverse Event|1|||
23744735|NCT04196023|66443320|FG000|Overall Study|Lost to Follow-up|0|||
23744736|NCT04196023|66443321|FG001|Overall Study|Lost to Follow-up|1|||
23744737|NCT03457701|66443322|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23744738|NCT03457701|66443323|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23744739|NCT03457701|66443322|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
23744740|NCT03457701|66443323|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23822131|NCT00402116|66730282|FG001|Overall Study|Withdrawal by Subject|0|||
23822132|NCT00402116|66730283|FG002|Overall Study|Withdrawal by Subject|5|||
23552878|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552879|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
23552880|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552881|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552882|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552883|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552884|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
23552885|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
23552886|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
23552887|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
23552888|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
23552889|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
23552890|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
23552891|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
23552892|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
23552893|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
23552894|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552895|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
23552896|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552897|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552898|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23822133|NCT00402116|66730281|FG000|Overall Study|Treatment completed per protocol|1|||
23822134|NCT00402116|66730282|FG001|Overall Study|Treatment completed per protocol|1|||
23822135|NCT00402116|66730283|FG002|Overall Study|Treatment completed per protocol|2|||
23822136|NCT00402116|66730281|FG000|Overall Study|other complicating disease|0|||
23431680|NCT02049138|65324134|FG001|Overall Study|Lack of Efficacy|26|||
23431681|NCT02049138|65324135|FG002|Overall Study|Lack of Efficacy|1|||
23822137|NCT00402116|66730282|FG001|Overall Study|other complicating disease|0|||
23822138|NCT00402116|66730283|FG002|Overall Study|other complicating disease|2|||
23822139|NCT00402116|66730281|FG000|Overall Study|Disease Progression|0|||
23822140|NCT00402116|66730282|FG001|Overall Study|Disease Progression|4|||
23822141|NCT00402116|66730283|FG002|Overall Study|Disease Progression|38|||
23822142|NCT00402116|66730281|FG000|Overall Study|mistaken thrombocytopenia|0|||
23744741|NCT02696382|66443324|FG000|Overall Study|Death|7|||
23744742|NCT02696382|66443325|FG001|Overall Study|Death|2|||
23744743|NCT02696382|66443324|FG000|Overall Study|Withdrawal by Subject|5|||
23744744|NCT02696382|66443325|FG001|Overall Study|Withdrawal by Subject|12|||
23744745|NCT02696382|66443324|FG000|Overall Study|Lost to Follow-up|4|||
23744746|NCT02696382|66443325|FG001|Overall Study|Lost to Follow-up|7|||
23744747|NCT02950831|66443329|FG000|Overall Study|Lost to Follow-up|1|||
23744748|NCT02950831|66443329|FG000|Overall Study|Withdrawal by Subject|3|||
23744749|NCT02950831|66443329|FG000|Overall Study|stimulation trail failure|5|||
23822143|NCT00402116|66730282|FG001|Overall Study|mistaken thrombocytopenia|0|||
23822144|NCT00402116|66730283|FG002|Overall Study|mistaken thrombocytopenia|1|||
23822145|NCT00402116|66730281|FG000|Overall Study|decline related hyponatremia/tumor|0|||
23822146|NCT00402116|66730282|FG001|Overall Study|decline related hyponatremia/tumor|0|||
23822147|NCT00402116|66730283|FG002|Overall Study|decline related hyponatremia/tumor|1|||
23822148|NCT00402116|66730281|FG000|Overall Study|Adverse Event|0|||
23822149|NCT00402116|66730282|FG001|Overall Study|Adverse Event|1|||
23822150|NCT00402116|66730283|FG002|Overall Study|Adverse Event|6|||
23822151|NCT01653912|66730284|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23822152|NCT01653912|66730285|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
23822153|NCT01653912|66730286|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23822154|NCT01653912|66730287|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23822155|NCT01653912|66730288|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23431682|NCT02049138|65324133|FG000|Overall Study|Non-Compliance|15|||
23431683|NCT02049138|65324134|FG001|Overall Study|Non-Compliance|6|||
23431684|NCT02049138|65324135|FG002|Overall Study|Non-Compliance|0|||
23431685|NCT02049138|65324133|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
23431686|NCT02049138|65324134|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
23431687|NCT02049138|65324135|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
23431688|NCT02049138|65324133|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
23431689|NCT02049138|65324134|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23431690|NCT02049138|65324135|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23431691|NCT02049138|65324133|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23431692|NCT02049138|65324134|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
23431693|NCT02049138|65324135|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23621611|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621612|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621613|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621614|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
23744750|NCT01729559|66443331|FG000|Overall Study|Protocol Violation|31|||
23744751|NCT01729559|66443332|FG001|Overall Study|Protocol Violation|28|||
23744752|NCT00945815|66443333|FG000|Overall Study|Death|3|||
23744753|NCT00945815|66443333|FG000|Overall Study|Not protocol specified|1|||
23744754|NCT00945815|66443333|FG000|Overall Study|Ineligible|3|||
23744755|NCT00945815|66443333|FG000|Overall Study|Did not begin protocol therapy|1|||
23744756|NCT00348348|66443334|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
23744757|NCT00348348|66443335|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
23744758|NCT00348348|66443334|FG000|Overall Study|Lack of Efficacy|1|||
23744759|NCT00348348|66443335|FG001|Overall Study|Lack of Efficacy|1|||
23744760|NCT00348348|66443334|FG000|Overall Study|Lost to Follow-up|8|||
23744761|NCT00348348|66443335|FG001|Overall Study|Lost to Follow-up|10|||
23744762|NCT00348348|66443334|FG000|Overall Study|Withdrawal by Subject|4|||
23822156|NCT01653912|66730289|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23822157|NCT01653912|66730284|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23822158|NCT01653912|66730285|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23431694|NCT02049138|65324133|FG000|Overall Study|Other|15|||
23431695|NCT02049138|65324134|FG001|Overall Study|Other|13|||
23431696|NCT02049138|65324135|FG002|Overall Study|Other|0|||
23431697|NCT02049138|65324133|FG000|Overall Study|Missing|0|||
23431698|NCT02049138|65324134|FG001|Overall Study|Missing|1|||
23744763|NCT00348348|66443335|FG001|Overall Study|Withdrawal by Subject|1|||
23744764|NCT00348348|66443334|FG000|Overall Study|Other|7|||
23744765|NCT00348348|66443335|FG001|Overall Study|Other|4|||
23822159|NCT01653912|66730286|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
23822160|NCT01653912|66730287|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23431699|NCT02049138|65324135|FG002|Overall Study|Missing|0|||
23621615|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621616|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
23621617|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23822161|NCT01653912|66730288|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23822162|NCT01653912|66730289|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23822163|NCT01653912|66730284|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23822164|NCT01653912|66730285|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23822165|NCT01653912|66730286|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23822166|NCT01653912|66730287|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
23822167|NCT01653912|66730288|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23822168|NCT01653912|66730289|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23822169|NCT01653912|66730284|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822170|NCT01653912|66730285|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23621618|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
23621619|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
23744766|NCT00348348|66443334|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
23744767|NCT00348348|66443335|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
23822171|NCT01653912|66730286|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822172|NCT01653912|66730287|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
23822173|NCT01653912|66730288|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822174|NCT01653912|66730289|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822175|NCT01653912|66730284|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23822176|NCT01653912|66730285|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23822177|NCT01653912|66730286|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23822178|NCT01653912|66730287|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23822179|NCT01653912|66730288|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23822180|NCT01653912|66730289|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
23822181|NCT01653912|66730284|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23822182|NCT01653912|66730285|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23822183|NCT01653912|66730286|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23822184|NCT01653912|66730287|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23822185|NCT01653912|66730288|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23822186|NCT01653912|66730289|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
23822187|NCT01653912|66730284|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822188|NCT01653912|66730285|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822189|NCT01653912|66730286|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822190|NCT01653912|66730287|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822191|NCT01653912|66730288|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23822192|NCT01653912|66730289|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
23822193|NCT00477633|66730292|FG000|Overall Study|Did not receive treatment|23|||
23822194|NCT00477633|66730292|FG000|Overall Study|Adverse Event|143|||
23822195|NCT00477633|66730292|FG000|Overall Study|Pregnancy|23|||
23822196|NCT00477633|66730292|FG000|Overall Study|Lost to Follow-up|271|||
23822197|NCT00477633|66730292|FG000|Overall Study|Withdrawal by Subject|149|||
23431700|NCT04969198|65324138|FG000|Overall Study|Withdrawal by Subject|20|||
23431701|NCT04969198|65324138|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
23431702|NCT04969198|65324138|FG000|Overall Study|Lost to Follow-up|20|||
23431703|NCT00007020|65324139|FG000|Overall Study|Death|16|||
23744768|NCT00348348|66443334|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
23744769|NCT00348348|66443335|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
23744770|NCT00348348|66443334|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
23744771|NCT00348348|66443335|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
23744772|NCT00348348|66443334|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
23744773|NCT00348348|66443335|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
23744774|NCT00348348|66443334|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
23744775|NCT00348348|66443335|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
23744776|NCT00348348|66443334|FG000|Overall Study|Adverse event probably related to study|1|||
23744777|NCT00348348|66443335|FG001|Overall Study|Adverse event probably related to study|0|||
23744778|NCT03522506|66443336|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23744779|NCT03522506|66443337|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23744780|NCT03522506|66443338|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23822198|NCT00477633|66730292|FG000|Overall Study|Protocol Violation|25|||
23340855|NCT01936181|64992872|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
23431704|NCT00007020|65324139|FG000|Overall Study|Lost to Follow-up|13|||
23621620|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23822199|NCT00477633|66730292|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
23822200|NCT00398866|66730294|FG000|Overall Study|Adverse Event|1|||
23822201|NCT00398866|66730295|FG001|Overall Study|Adverse Event|0|||
23822202|NCT00398866|66730296|FG002|Overall Study|Adverse Event|0|||
23822203|NCT00398866|66730294|FG000|Overall Study|Lack of Efficacy|0|||
23822204|NCT00398866|66730295|FG001|Overall Study|Lack of Efficacy|0|||
23822205|NCT00398866|66730296|FG002|Overall Study|Lack of Efficacy|1|||
23822206|NCT00398866|66730294|FG000|Overall Study|Lost to Follow-up|7|||
23822207|NCT00398866|66730295|FG001|Overall Study|Lost to Follow-up|6|||
23822208|NCT00398866|66730296|FG002|Overall Study|Lost to Follow-up|4|||
23822209|NCT00398866|66730294|FG000|Overall Study|Withdrawal by Subject|5|||
23822210|NCT00398866|66730295|FG001|Overall Study|Withdrawal by Subject|1|||
23822211|NCT00398866|66730296|FG002|Overall Study|Withdrawal by Subject|2|||
23822212|NCT00398866|66730294|FG000|Overall Study|Unable to complete requirements of study|1|||
23822213|NCT00398866|66730295|FG001|Overall Study|Unable to complete requirements of study|1|||
23822214|NCT00398866|66730296|FG002|Overall Study|Unable to complete requirements of study|1|||
23822215|NCT00171951|66730304|FG000|Overall Study|Adverse Event|1|||
23822216|NCT00171951|66730304|FG000|Overall Study|Abnormal Laboratory Values|2|||
23822217|NCT00171951|66730304|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23822218|NCT00171951|66730304|FG000|Overall Study|Participants Withdrew Consent|3|||
23822219|NCT00171951|66730304|FG000|Overall Study|New Cancer Therapy|5|||
23822220|NCT00171951|66730304|FG000|Overall Study|Reason not Specified|2|||
23340856|NCT01936181|64992873|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
23431705|NCT00007020|65324139|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
23431706|NCT00007020|65324139|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
23431707|NCT00007020|65324139|FG000|Overall Study|Pt cared for by outside physician|4|||
23431708|NCT00007020|65324139|FG000|Overall Study|No evidence of treatment|6|||
23744781|NCT03522506|66443339|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23744782|NCT03522506|66443336|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23744783|NCT03522506|66443337|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23431709|NCT04496453|65324140|FG000|Overall Study|Lost to Follow-up|6|||
23431710|NCT00637572|65324141|FG000|Overall Study|Adverse Event|1|||
23431711|NCT00637572|65324142|FG001|Overall Study|Adverse Event|2|||
23431712|NCT00637572|65324141|FG000|Overall Study|Death|0|||
23431713|NCT00637572|65324142|FG001|Overall Study|Death|1|||
23431714|NCT00637572|65324141|FG000|Overall Study|Lost to Follow-up|0|||
23431715|NCT00637572|65324142|FG001|Overall Study|Lost to Follow-up|1|||
23431716|NCT00637572|65324141|FG000|Overall Study|Physician Decision|1|||
23431717|NCT00637572|65324142|FG001|Overall Study|Physician Decision|1|||
23431718|NCT00637572|65324141|FG000|Overall Study|Withdrawal by Subject|0|||
23431719|NCT00637572|65324142|FG001|Overall Study|Withdrawal by Subject|2|||
23431720|NCT00637572|65324141|FG000|Overall Study|Illicit Drug Use|1|||
23431721|NCT00637572|65324142|FG001|Overall Study|Illicit Drug Use|0|||
23431722|NCT02404649|65324143|FG000|Overall Study|Adverse Event|1|||
23431723|NCT02404649|65324144|FG001|Overall Study|Adverse Event|2|||
23431724|NCT00840060|65324145|FG000|Overall Study|Withdrawal by Subject|1|||
23431725|NCT00840060|65324146|FG001|Overall Study|Withdrawal by Subject|0|||
23431726|NCT00840060|65324145|FG000|Overall Study|Change in emotional/behavioral status|0|||
23431727|NCT00840060|65324146|FG001|Overall Study|Change in emotional/behavioral status|1|||
23431728|NCT01927055|65324147|FG000|Open-label|Adverse Event|6|||
23431729|NCT01927055|65324148|FG001|Open-label|Adverse Event|0|||
23431730|NCT01927055|65324149|FG002|Open-label|Adverse Event|0|||
23431731|NCT01927055|65324147|FG000|Open-label|Withdrawal by Subject|1|||
23431732|NCT01927055|65324148|FG001|Open-label|Withdrawal by Subject|0|||
23431733|NCT01927055|65324149|FG002|Open-label|Withdrawal by Subject|0|||
23431734|NCT01927055|65324147|FG000|Open-label|Study Stopped|4|||
23744784|NCT03522506|66443338|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23744785|NCT03522506|66443339|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
23744786|NCT01160770|66443340|FG000|Overall Study|Adverse Event|10|||
23744787|NCT01160770|66443340|FG000|Overall Study|Protocol Violation|2|||
23744788|NCT01160770|66443340|FG000|Overall Study|Subject/parent/caregiver request|33|||
23744789|NCT01160770|66443340|FG000|Overall Study|Physician Decision|1|||
23744790|NCT01160770|66443340|FG000|Overall Study|Lost to Follow-up|7|||
23744791|NCT01160770|66443340|FG000|Overall Study|Study termination or sponsor request|1|||
23744792|NCT01160770|66443340|FG000|Overall Study|Death|9|||
23744793|NCT01160770|66443340|FG000|Overall Study|Lack of Efficacy|15|||
23744794|NCT01160770|66443340|FG000|Overall Study|Other Reasons|1|||
23744795|NCT00399542|66443341|FG000|Overall Study|Adverse Event|18|||
23744796|NCT00399542|66443342|FG001|Overall Study|Adverse Event|15|||
23431735|NCT01927055|65324148|FG001|Open-label|Study Stopped|0|||
23431736|NCT01927055|65324149|FG002|Open-label|Study Stopped|0|||
23431737|NCT01927055|65324147|FG000|Open-label|Supine Hypertension|4|||
23431738|NCT01927055|65324148|FG001|Open-label|Supine Hypertension|0|||
23431739|NCT01927055|65324149|FG002|Open-label|Supine Hypertension|0|||
23431740|NCT01927055|65324147|FG000|Open-label|Difficulty attending study visits|1|||
23431741|NCT01927055|65324148|FG001|Open-label|Difficulty attending study visits|0|||
23431742|NCT01927055|65324149|FG002|Open-label|Difficulty attending study visits|0|||
23431743|NCT01927055|65324147|FG000|Double-Blind|Adverse Event|0|||
23431744|NCT01927055|65324148|FG001|Double-Blind|Adverse Event|1|||
23431745|NCT01927055|65324149|FG002|Double-Blind|Adverse Event|1|||
23431746|NCT01927055|65324147|FG000|Double-Blind|Protocol Violation|0|||
23822221|NCT01625988|66730305|FG000|Overall Study|Lost to Follow-up|5|||
23822222|NCT01625988|66730306|FG001|Overall Study|Lost to Follow-up|6|||
23822223|NCT01625988|66730305|FG000|Overall Study|Withdrawal by Subject|8|||
23822224|NCT01625988|66730306|FG001|Overall Study|Withdrawal by Subject|3|||
23822225|NCT01625988|66730305|FG000|Overall Study|Adverse Event|0|||
23822226|NCT01625988|66730306|FG001|Overall Study|Adverse Event|1|||
23744797|NCT00399542|66443341|FG000|Overall Study|Protocol Violation|13|||
23744798|NCT00399542|66443342|FG001|Overall Study|Protocol Violation|3|||
23744799|NCT00399542|66443341|FG000|Overall Study|Withdrawal by Subject|28|||
23744800|NCT00399542|66443342|FG001|Overall Study|Withdrawal by Subject|10|||
23744801|NCT00399542|66443341|FG000|Overall Study|Lack of Efficacy|18|||
23744802|NCT00399542|66443342|FG001|Overall Study|Lack of Efficacy|8|||
23744803|NCT00399542|66443341|FG000|Overall Study|Lost to Follow-up|6|||
23744804|NCT00399542|66443342|FG001|Overall Study|Lost to Follow-up|6|||
23744805|NCT00399542|66443341|FG000|Overall Study|Other|1|||
23744806|NCT00399542|66443342|FG001|Overall Study|Other|0|||
23744807|NCT00399542|66443341|FG000|Overall Study|Physician Decision|0|||
23822227|NCT01625988|66730305|FG000|Overall Study|Lack of Efficacy|0|||
23822228|NCT01625988|66730306|FG001|Overall Study|Lack of Efficacy|1|||
23552899|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552900|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552901|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552902|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23431747|NCT01927055|65324148|FG001|Double-Blind|Protocol Violation|0|||
23552903|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
23552904|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552905|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552906|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552907|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552908|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552909|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552910|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552911|NCT00419263|65751267|FG000|Overall Study|Lost to Follow-up|2|||
23552912|NCT00419263|65751268|FG001|Overall Study|Lost to Follow-up|1|||
23552913|NCT00419263|65751269|FG002|Overall Study|Lost to Follow-up|1|||
23552914|NCT00419263|65751267|FG000|Overall Study|Randomized in Error, Not Treated|1|||
23552915|NCT00419263|65751268|FG001|Overall Study|Randomized in Error, Not Treated|1|||
23552916|NCT00419263|65751269|FG002|Overall Study|Randomized in Error, Not Treated|0|||
23552917|NCT00419263|65751267|FG000|Overall Study|Adverse Event|0|||
23552918|NCT00419263|65751268|FG001|Overall Study|Adverse Event|0|||
23552919|NCT00419263|65751269|FG002|Overall Study|Adverse Event|1|||
23552920|NCT00419263|65751267|FG000|Overall Study|Withdrawal by Subject|0|||
23552921|NCT00419263|65751268|FG001|Overall Study|Withdrawal by Subject|0|||
23552922|NCT00419263|65751269|FG002|Overall Study|Withdrawal by Subject|1|||
23552923|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
23552924|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
23552925|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
23552926|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
23552927|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
23552928|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
23552929|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23431748|NCT01927055|65324149|FG002|Double-Blind|Protocol Violation|1|||
23744808|NCT00399542|66443342|FG001|Overall Study|Physician Decision|1|||
23744809|NCT03410693|66443345|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
23552930|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23744810|NCT03410693|66443346|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
23744811|NCT03410693|66443345|FG000|Overall Study|Disc trt: Lost to follow up|0|||
23744812|NCT03410693|66443346|FG001|Overall Study|Disc trt: Lost to follow up|1|||
23744813|NCT03410693|66443345|FG000|Overall Study|Disc trt: radiological progression|58|||
23822229|NCT01625988|66730305|FG000|Overall Study|Randomized Inappropriately|1|||
23822230|NCT01625988|66730306|FG001|Overall Study|Randomized Inappropriately|0|||
23822231|NCT01625988|66730305|FG000|Overall Study|Protocol Violation|0|||
23822232|NCT01625988|66730306|FG001|Overall Study|Protocol Violation|2|||
23822233|NCT01756079|66730307|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
23621621|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
23621622|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
23621623|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23621624|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23822234|NCT01756079|66730307|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
23822235|NCT01756079|66730307|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
23822236|NCT01756079|66730307|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
23621625|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23744814|NCT03410693|66443346|FG001|Overall Study|Disc trt: radiological progression|50|||
23744815|NCT03410693|66443345|FG000|Overall Study|Disc trt: Other|1|||
23744816|NCT03410693|66443346|FG001|Overall Study|Disc trt: Other|0|||
23744817|NCT03410693|66443345|FG000|Overall Study|Study drug never administered|1|||
23744818|NCT03410693|66443346|FG001|Overall Study|Study drug never administered|6|||
23744819|NCT03410693|66443345|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
23744820|NCT03410693|66443346|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
23744821|NCT03410693|66443345|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
23744822|NCT03410693|66443346|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
23744823|NCT03410693|66443345|FG000|Overall Study|Disc trt: Physician decision|0|||
23744824|NCT03410693|66443346|FG001|Overall Study|Disc trt: Physician decision|5|||
23744825|NCT03410693|66443345|FG000|Overall Study|Disc trt: clinical progression|1|||
23744826|NCT03410693|66443346|FG001|Overall Study|Disc trt: clinical progression|5|||
23744827|NCT03410693|66443345|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
23744828|NCT03410693|66443346|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
23744829|NCT00465101|66443349|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
23744830|NCT00465101|66443349|FG000|Overall Study|Change in health precluded follow up|4|||
23744831|NCT00465101|66443349|FG000|Overall Study|Did not meet study criteria|4|||
23744832|NCT00465101|66443349|FG000|Overall Study|Lost to Follow-up|5|||
23744833|NCT00465101|66443349|FG000|Overall Study|Other|6|||
23744834|NCT00465101|66443349|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
23744835|NCT00465101|66443349|FG000|Overall Study|Patient postponed procedure|1|||
23744836|NCT00465101|66443349|FG000|Overall Study|Site closed due to IRB expiration|1|||
23744837|NCT00465101|66443349|FG000|Overall Study|Unable to obtain IRB approval|1|||
23744838|NCT00465101|66443349|FG000|Overall Study|Death|3|||
23744839|NCT00465101|66443349|FG000|Overall Study|Withdrawal by Subject|25|||
23744840|NCT00465101|66443349|FG000|Overall Study|Physician Decision|1|||
23744841|NCT00465101|66443349|FG000|Overall Study|Withdrew consent prior to procedure|3|||
23744842|NCT00887822|66443350|FG000|Overall Study|Insufficient therapeutic response|53|||
23744843|NCT00887822|66443351|FG001|Overall Study|Insufficient therapeutic response|55|||
23744844|NCT00887822|66443350|FG000|Overall Study|Adverse Event|14|||
23744845|NCT00887822|66443351|FG001|Overall Study|Adverse Event|17|||
23744846|NCT00887822|66443350|FG000|Overall Study|Failure to return|11|||
23744847|NCT00887822|66443351|FG001|Overall Study|Failure to return|11|||
23744848|NCT00887822|66443350|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
23744849|NCT00887822|66443351|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
23744850|NCT00887822|66443350|FG000|Overall Study|Administrative/Other than specified|5|||
23744851|NCT00887822|66443351|FG001|Overall Study|Administrative/Other than specified|4|||
23744852|NCT00887822|66443350|FG000|Overall Study|Death|2|||
23744853|NCT00887822|66443351|FG001|Overall Study|Death|3|||
23744854|NCT00887822|66443350|FG000|Overall Study|Protocol Violation|0|||
23744855|NCT00887822|66443351|FG001|Overall Study|Protocol Violation|1|||
23744856|NCT00887822|66443350|FG000|Overall Study|Randomized but not treated|0|||
23744857|NCT00887822|66443351|FG001|Overall Study|Randomized but not treated|1|||
23744858|NCT04652245|66443352|FG000|Wash-Out Period|Adverse Event|0|||
23744859|NCT04652245|66443353|FG001|Wash-Out Period|Adverse Event|2|||
23744860|NCT04652245|66443352|FG000|Wash-Out Period|Withdrawal by Subject|0|||
23822237|NCT01756079|66730307|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
23822238|NCT01699815|66730310|FG000|Overall Study|Protocol Violation|4|||
23822239|NCT01699815|66730311|FG001|Overall Study|Protocol Violation|7|||
23822240|NCT01699815|66730310|FG000|Overall Study|record could not be located|1|||
23744861|NCT04652245|66443353|FG001|Wash-Out Period|Withdrawal by Subject|2|||
23744862|NCT01041027|66443354|FG000|Overall Study|Withdrawal by Subject|2|||
23744863|NCT01041027|66443354|FG000|Overall Study|Protocol Violation|1|||
23744864|NCT01041027|66443354|FG000|Overall Study|Delayed Radiation Therapy|1|||
23744865|NCT01041027|66443354|FG000|Overall Study|Adverse Event|4|||
23744866|NCT02044094|66443355|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
23744867|NCT02044094|66443355|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
23744868|NCT02044094|66443355|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
23621626|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
23621627|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
23621628|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621629|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621630|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621631|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621632|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621633|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
23621634|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621635|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621636|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
23621637|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
23621638|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
23621639|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621640|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
23621641|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621642|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621643|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621644|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621645|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621646|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
23621647|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621648|NCT00937521|66000724|FG000|Booster Phase|Adverse Event|0|||
23621649|NCT00937521|66000725|FG001|Booster Phase|Adverse Event|0|||
23621650|NCT00937521|66000726|FG002|Booster Phase|Adverse Event|0|||
23621651|NCT00937521|66000727|FG003|Booster Phase|Adverse Event|0|||
23621652|NCT00937521|66000728|FG004|Booster Phase|Adverse Event|0|||
23621653|NCT00937521|66000729|FG005|Booster Phase|Adverse Event|0|||
23621654|NCT00937521|66000730|FG006|Booster Phase|Adverse Event|1|||
23621655|NCT00937521|66000731|FG007|Booster Phase|Adverse Event|0|||
23621656|NCT00937521|66000724|FG000|Booster Phase|Withdrawal by Subject|1|||
23621657|NCT00937521|66000725|FG001|Booster Phase|Withdrawal by Subject|0|||
23621658|NCT00937521|66000726|FG002|Booster Phase|Withdrawal by Subject|0|||
23431749|NCT01927055|65324147|FG000|Double-Blind|Withdrawal by Subject|0|||
23431750|NCT01927055|65324148|FG001|Double-Blind|Withdrawal by Subject|2|||
23621659|NCT00937521|66000727|FG003|Booster Phase|Withdrawal by Subject|1|||
23621660|NCT00937521|66000728|FG004|Booster Phase|Withdrawal by Subject|0|||
23621661|NCT00937521|66000729|FG005|Booster Phase|Withdrawal by Subject|0|||
23621662|NCT00937521|66000730|FG006|Booster Phase|Withdrawal by Subject|0|||
23621663|NCT00937521|66000731|FG007|Booster Phase|Withdrawal by Subject|2|||
23621664|NCT00937521|66000724|FG000|Booster Phase|Lost to Follow-up|2|||
23621665|NCT00937521|66000725|FG001|Booster Phase|Lost to Follow-up|2|||
23621666|NCT00937521|66000726|FG002|Booster Phase|Lost to Follow-up|4|||
23621667|NCT00937521|66000727|FG003|Booster Phase|Lost to Follow-up|2|||
23744869|NCT02044094|66443355|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
23744870|NCT02044094|66443355|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
23744871|NCT02044094|66443355|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
23744872|NCT02044094|66443355|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
23744873|NCT02044094|66443355|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
23744874|NCT01465958|66443356|FG000|Run-in Phase|Protocol Violation|1|||
23744875|NCT01465958|66443357|FG001|Run-in Phase|Protocol Violation|0|||
23744876|NCT01465958|66443356|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
23744877|NCT01465958|66443357|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
23744878|NCT03000075|66443358|FG000|Part A|Adverse Event|4|||
23744879|NCT03000075|66443359|FG001|Part A|Adverse Event|0|||
23744880|NCT03000075|66443360|FG002|Part A|Adverse Event|0|||
23744881|NCT03000075|66443361|FG003|Part A|Adverse Event|0|||
23744882|NCT03000075|66443362|FG004|Part A|Adverse Event|0|||
23744883|NCT03000075|66443363|FG005|Part A|Adverse Event|0|||
23744884|NCT03000075|66443364|FG006|Part A|Adverse Event|0|||
23744885|NCT03000075|66443358|FG000|Part B|Not dosed due to AE|0|||
23744886|NCT03000075|66443359|FG001|Part B|Not dosed due to AE|0|||
23744887|NCT03000075|66443360|FG002|Part B|Not dosed due to AE|0|||
23744888|NCT03000075|66443361|FG003|Part B|Not dosed due to AE|0|||
23744889|NCT03000075|66443362|FG004|Part B|Not dosed due to AE|0|||
23431751|NCT01927055|65324149|FG002|Double-Blind|Withdrawal by Subject|3|||
23431752|NCT01927055|65324147|FG000|Double-Blind|Study Stopped|0|||
23621668|NCT00937521|66000728|FG004|Booster Phase|Lost to Follow-up|4|||
23621669|NCT00937521|66000729|FG005|Booster Phase|Lost to Follow-up|4|||
23744890|NCT03000075|66443363|FG005|Part B|Not dosed due to AE|2|||
23744891|NCT03000075|66443364|FG006|Part B|Not dosed due to AE|1|||
23744892|NCT03000075|66443358|FG000|Part B|Adverse Event|0|||
23744893|NCT03000075|66443359|FG001|Part B|Adverse Event|0|||
23744894|NCT03000075|66443360|FG002|Part B|Adverse Event|0|||
23822241|NCT01699815|66730311|FG001|Overall Study|record could not be located|0|||
23822242|NCT01699815|66730310|FG000|Overall Study|Adverse Event|0|||
23822243|NCT01699815|66730311|FG001|Overall Study|Adverse Event|1|||
23822244|NCT03151304|66730314|FG000|Overall Study|Termination of study by Sponsor|23|||
23822245|NCT03151304|66730314|FG000|Overall Study|missing|3|||
23822246|NCT03151304|66730314|FG000|Overall Study|Withdrawal by Subject|8|||
23822247|NCT03151304|66730314|FG000|Overall Study|multiple reasons|30|||
23822248|NCT03281876|66730315|FG000|Overall Study|Adverse Event|4|||
23822249|NCT03281876|66730316|FG001|Overall Study|Adverse Event|15|||
23822250|NCT03281876|66730315|FG000|Overall Study|Lost to Follow-up|1|||
23552931|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23744895|NCT03000075|66443361|FG003|Part B|Adverse Event|0|||
23744896|NCT03000075|66443362|FG004|Part B|Adverse Event|1|||
23744897|NCT03000075|66443363|FG005|Part B|Adverse Event|0|||
23744898|NCT03000075|66443364|FG006|Part B|Adverse Event|0|||
23744899|NCT01610752|66443365|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
23744900|NCT01610752|66443366|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
23744901|NCT01610752|66443367|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
23744902|NCT00796367|66443368|FG000|Overall Study|Adverse Event|6|||
23744903|NCT00796367|66443369|FG001|Overall Study|Adverse Event|4|||
23744904|NCT00796367|66443370|FG002|Overall Study|Adverse Event|7|||
23744905|NCT00796367|66443368|FG000|Overall Study|Lost to Follow-up|5|||
23744906|NCT00796367|66443369|FG001|Overall Study|Lost to Follow-up|4|||
23744907|NCT00796367|66443370|FG002|Overall Study|Lost to Follow-up|21|||
23744908|NCT00796367|66443368|FG000|Overall Study|Withdrawal by Subject|9|||
23744909|NCT00796367|66443369|FG001|Overall Study|Withdrawal by Subject|11|||
23744910|NCT00796367|66443370|FG002|Overall Study|Withdrawal by Subject|12|||
23744911|NCT00796367|66443368|FG000|Overall Study|Lack of Efficacy|2|||
23744912|NCT00796367|66443369|FG001|Overall Study|Lack of Efficacy|1|||
23744913|NCT00796367|66443370|FG002|Overall Study|Lack of Efficacy|0|||
23744914|NCT00796367|66443368|FG000|Overall Study|non compliance|3|||
23744915|NCT00796367|66443369|FG001|Overall Study|non compliance|1|||
23744916|NCT00796367|66443370|FG002|Overall Study|non compliance|1|||
23744917|NCT00796367|66443368|FG000|Overall Study|Pregnancy|1|||
23744918|NCT00796367|66443369|FG001|Overall Study|Pregnancy|0|||
23744919|NCT00796367|66443370|FG002|Overall Study|Pregnancy|1|||
23744920|NCT00796367|66443368|FG000|Overall Study|Requirement for restricted medication|2|||
23744921|NCT00796367|66443369|FG001|Overall Study|Requirement for restricted medication|0|||
23744922|NCT00796367|66443370|FG002|Overall Study|Requirement for restricted medication|2|||
23744923|NCT00796367|66443368|FG000|Overall Study|other|2|||
23744924|NCT00796367|66443369|FG001|Overall Study|other|4|||
23744925|NCT00796367|66443370|FG002|Overall Study|other|3|||
23744926|NCT03237325|66443372|FG000|Overall Study|Lost to Follow-up|3|||
23744927|NCT03237325|66443373|FG001|Overall Study|Lost to Follow-up|5|||
23744928|NCT03237325|66443372|FG000|Overall Study|Physician Decision|2|||
23744929|NCT03237325|66443373|FG001|Overall Study|Physician Decision|4|||
23744930|NCT03237325|66443372|FG000|Overall Study|Withdrawal by Subject|9|||
23744931|NCT03237325|66443373|FG001|Overall Study|Withdrawal by Subject|12|||
23744932|NCT03237325|66443372|FG000|Overall Study|Noncompliance with Study Procedures|1|||
23744933|NCT03237325|66443373|FG001|Overall Study|Noncompliance with Study Procedures|1|||
23822251|NCT03281876|66730316|FG001|Overall Study|Lost to Follow-up|4|||
23552932|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23552933|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
23552934|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552935|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552936|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552937|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552938|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
23552939|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
23552940|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
23552941|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
23552942|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
23552943|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
23552944|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552945|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552946|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552947|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23744934|NCT03237325|66443372|FG000|Overall Study|Termination by Sponsor|0|||
23744935|NCT03237325|66443373|FG001|Overall Study|Termination by Sponsor|1|||
23744936|NCT03237325|66443372|FG000|Overall Study|Reason other than described|0|||
23744937|NCT03237325|66443373|FG001|Overall Study|Reason other than described|2|||
23552948|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Other|1|||
23744938|NCT01396434|66443374|FG000|Overall Study|Lost to Follow-up|1|||
23431753|NCT01927055|65324148|FG001|Double-Blind|Study Stopped|7|||
23431754|NCT01927055|65324149|FG002|Double-Blind|Study Stopped|7|||
23552949|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Other|0|||
23552950|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Other|0|||
23552951|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Other|0|||
23552952|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Other|0|||
23552953|NCT01662310|65751270|FG000|Double-Blind Phase|Adverse Event|0|||
23552954|NCT01662310|65751271|FG001|Double-Blind Phase|Adverse Event|0|||
23744939|NCT01396434|66443375|FG001|Overall Study|Lost to Follow-up|0|||
23744940|NCT01396434|66443376|FG002|Overall Study|Lost to Follow-up|0|||
23744941|NCT01396434|66443374|FG000|Overall Study|Other|10|||
23744942|NCT01396434|66443375|FG001|Overall Study|Other|0|||
23744943|NCT01396434|66443376|FG002|Overall Study|Other|0|||
23744944|NCT01119118|66443377|FG000|Overall Study|Adverse Event|1|||
23744945|NCT00532441|66443378|FG000|Overall Study|Death|1|||
23744946|NCT00532441|66443379|FG001|Overall Study|Death|0|||
23744947|NCT01250418|66443380|FG000|Overall Study|monitor data failure|1|||
23744948|NCT01250418|66443381|FG001|Overall Study|monitor data failure|1|||
23744949|NCT05056311|66443382|FG000|Overall Study|Lost to Follow-up|14|||
23744950|NCT05056311|66443382|FG000|Overall Study|Withdrawal by Subject|1|||
23744951|NCT05056311|66443382|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
23744952|NCT02451137|66443383|FG000|Overall Study|Randomized but not treated|19|||
23744953|NCT02451137|66443384|FG001|Overall Study|Randomized but not treated|27|||
23744954|NCT02451137|66443383|FG000|Overall Study|Adverse Event|43|||
23744955|NCT02451137|66443384|FG001|Overall Study|Adverse Event|42|||
23744956|NCT02451137|66443383|FG000|Overall Study|Lack of Efficacy|4|||
23744957|NCT02451137|66443384|FG001|Overall Study|Lack of Efficacy|9|||
23744958|NCT02451137|66443383|FG000|Overall Study|Participant decision:discontinue insulin|41|||
23822252|NCT03281876|66730315|FG000|Overall Study|Withdrawal by Subject|11|||
23822253|NCT03281876|66730316|FG001|Overall Study|Withdrawal by Subject|15|||
23822254|NCT03281876|66730315|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23822255|NCT03281876|66730316|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23822256|NCT03281876|66730315|FG000|Overall Study|OTHER|5|||
23822257|NCT03281876|66730316|FG001|Overall Study|OTHER|5|||
23822258|NCT00324987|66730321|FG000|Overall Study|Adverse Event|2|||
23822259|NCT00324987|66730322|FG001|Overall Study|Adverse Event|1|||
23822260|NCT00324987|66730321|FG000|Overall Study|Withdrawal by Subject|1|||
23822261|NCT00324987|66730322|FG001|Overall Study|Withdrawal by Subject|1|||
23822262|NCT00324987|66730321|FG000|Overall Study|Progression|1|||
23822263|NCT00324987|66730322|FG001|Overall Study|Progression|1|||
23822264|NCT00324987|66730321|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
23822265|NCT00324987|66730322|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
23822266|NCT02015065|66730323|FG000|Overall Study|Death on study|1|||
23822267|NCT02015065|66730324|FG001|Overall Study|Death on study|2|||
23822268|NCT02015065|66730325|FG002|Overall Study|Death on study|1|||
23822269|NCT02729909|66730326|FG000|Overall Study|Lost to Follow-up|0|||
23822270|NCT02729909|66730327|FG001|Overall Study|Lost to Follow-up|1|||
23822271|NCT02729909|66730326|FG000|Overall Study|Lack of Efficacy|0|||
23822272|NCT02729909|66730327|FG001|Overall Study|Lack of Efficacy|2|||
23822273|NCT02729909|66730326|FG000|Overall Study|Significant Protocol Deviation|0|||
23822274|NCT02729909|66730327|FG001|Overall Study|Significant Protocol Deviation|2|||
23822275|NCT02729909|66730326|FG000|Overall Study|Voluntary Withdrawal|1|||
23822276|NCT02729909|66730327|FG001|Overall Study|Voluntary Withdrawal|0|||
23822277|NCT02792699|66730328|FG000|Overall Study|Adverse Event|1|||
23822278|NCT02792699|66730329|FG001|Overall Study|Adverse Event|2|||
23822279|NCT02792699|66730330|FG002|Overall Study|Adverse Event|4|||
23822280|NCT02792699|66730328|FG000|Overall Study|Withdrawal by Subject|4|||
23822281|NCT02792699|66730329|FG001|Overall Study|Withdrawal by Subject|4|||
23822282|NCT02792699|66730330|FG002|Overall Study|Withdrawal by Subject|3|||
23822283|NCT02792699|66730328|FG000|Overall Study|Lost to Follow-up|0|||
23822284|NCT02792699|66730329|FG001|Overall Study|Lost to Follow-up|1|||
23744959|NCT02451137|66443384|FG001|Overall Study|Participant decision:discontinue insulin|43|||
23744960|NCT02451137|66443383|FG000|Overall Study|Hypoglycemia|2|||
23822285|NCT02792699|66730330|FG002|Overall Study|Lost to Follow-up|2|||
23822286|NCT02792699|66730328|FG000|Overall Study|Physician Decision|2|||
23552955|NCT01662310|65751272|FG002|Double-Blind Phase|Adverse Event|1|||
23552956|NCT01662310|65751273|FG003|Double-Blind Phase|Adverse Event|0|||
23744961|NCT02451137|66443384|FG001|Overall Study|Hypoglycemia|1|||
23744962|NCT02451137|66443383|FG000|Overall Study|Investigator's decision|23|||
23744963|NCT02451137|66443384|FG001|Overall Study|Investigator's decision|19|||
23744964|NCT02451137|66443383|FG000|Overall Study|Lost to Follow-up|53|||
23744965|NCT02451137|66443384|FG001|Overall Study|Lost to Follow-up|61|||
23822287|NCT02792699|66730329|FG001|Overall Study|Physician Decision|0|||
23822288|NCT02792699|66730330|FG002|Overall Study|Physician Decision|0|||
23822289|NCT02792699|66730328|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
23552957|NCT01662310|65751274|FG004|Double-Blind Phase|Adverse Event|0|||
23552958|NCT01662310|65751270|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23822290|NCT02792699|66730329|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
23552959|NCT01662310|65751271|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23552960|NCT01662310|65751272|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23552961|NCT01662310|65751273|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23552962|NCT01662310|65751274|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23552963|NCT01662310|65751270|FG000|Double-Blind Phase|Pregnancy|0|||
23552964|NCT01662310|65751271|FG001|Double-Blind Phase|Pregnancy|2|||
23552965|NCT01662310|65751272|FG002|Double-Blind Phase|Pregnancy|0|||
23552966|NCT01662310|65751273|FG003|Double-Blind Phase|Pregnancy|0|||
23552967|NCT01662310|65751274|FG004|Double-Blind Phase|Pregnancy|0|||
23552968|NCT01662310|65751270|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23552969|NCT01662310|65751271|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
23552970|NCT01662310|65751272|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
23552971|NCT01662310|65751273|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23552972|NCT01662310|65751274|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23552973|NCT01662310|65751270|FG000|Double-Blind Phase|Other|0|||
23552974|NCT01662310|65751271|FG001|Double-Blind Phase|Other|0|||
23552975|NCT01662310|65751272|FG002|Double-Blind Phase|Other|1|||
23552976|NCT01662310|65751273|FG003|Double-Blind Phase|Other|0|||
23552977|NCT01662310|65751274|FG004|Double-Blind Phase|Other|0|||
23552978|NCT01662310|65751270|FG000|Double-Blind Phase|Randomized but not treated|0|||
23552979|NCT01662310|65751271|FG001|Double-Blind Phase|Randomized but not treated|1|||
23744966|NCT02451137|66443383|FG000|Overall Study|Physician Decision|6|||
23744967|NCT02451137|66443384|FG001|Overall Study|Physician Decision|5|||
23744968|NCT02451137|66443383|FG000|Overall Study|Sponsor decision|13|||
23744969|NCT02451137|66443384|FG001|Overall Study|Sponsor decision|25|||
23744970|NCT02451137|66443383|FG000|Overall Study|Withdrawal by Subject|40|||
23744971|NCT02451137|66443384|FG001|Overall Study|Withdrawal by Subject|63|||
23744972|NCT02451137|66443383|FG000|Overall Study|Other than specified above|2|||
23744973|NCT02451137|66443384|FG001|Overall Study|Other than specified above|3|||
23744974|NCT01428882|66443385|FG000|Overall Study|Lack of Efficacy|2|||
23744975|NCT01428882|66443386|FG001|Overall Study|Lack of Efficacy|7|||
23744976|NCT01428882|66443385|FG000|Overall Study|Protocol Violation|4|||
23744977|NCT01428882|66443386|FG001|Overall Study|Protocol Violation|3|||
23744978|NCT01243762|66443391|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23744979|NCT01243762|66443392|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
23744980|NCT01243762|66443393|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23744981|NCT01243762|66443394|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23744982|NCT01243762|66443395|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
23744983|NCT01243762|66443396|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
23822291|NCT02792699|66730330|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
23822292|NCT02792699|66730328|FG000|Overall Study|Other|1|||
23822293|NCT02792699|66730329|FG001|Overall Study|Other|0|||
23822294|NCT02792699|66730330|FG002|Overall Study|Other|0|||
23822295|NCT02046603|66730333|FG000|Overall Study|Other|11|||
23822296|NCT02046603|66730334|FG001|Overall Study|Other|66|||
23822297|NCT02046603|66730333|FG000|Overall Study|Protocol Violation|0|||
23822298|NCT02046603|66730334|FG001|Overall Study|Protocol Violation|1|||
23822299|NCT02046603|66730333|FG000|Overall Study|Participant/legal guardian decision|1|||
23822300|NCT02046603|66730334|FG001|Overall Study|Participant/legal guardian decision|3|||
23822301|NCT02046603|66730333|FG000|Overall Study|Physician Decision|2|||
23822302|NCT02046603|66730334|FG001|Overall Study|Physician Decision|1|||
23822303|NCT02046603|66730333|FG000|Overall Study|Lost to Follow-up|1|||
23822304|NCT02046603|66730334|FG001|Overall Study|Lost to Follow-up|2|||
23822305|NCT02046603|66730333|FG000|Overall Study|Death|0|||
23822306|NCT02046603|66730334|FG001|Overall Study|Death|1|||
23822307|NCT02046603|66730333|FG000|Overall Study|Adverse Event|0|||
23822308|NCT02046603|66730334|FG001|Overall Study|Adverse Event|1|||
23822309|NCT02309138|66730335|FG000|Overall Study|Withdrawal by Subject|44|||
23822310|NCT02309138|66730336|FG001|Overall Study|Withdrawal by Subject|15|||
23822311|NCT02309138|66730335|FG000|Overall Study|Protocol Violation|4|||
23822312|NCT02309138|66730336|FG001|Overall Study|Protocol Violation|2|||
23822313|NCT02309138|66730335|FG000|Overall Study|delivered before visit 2|0|||
23822314|NCT02309138|66730336|FG001|Overall Study|delivered before visit 2|1|||
23822315|NCT03316547|66730338|FG000|Overall Study|Death|3|||
23552980|NCT01662310|65751272|FG002|Double-Blind Phase|Randomized but not treated|0|||
23552981|NCT01662310|65751273|FG003|Double-Blind Phase|Randomized but not treated|0|||
23552982|NCT01662310|65751274|FG004|Double-Blind Phase|Randomized but not treated|0|||
23744984|NCT01243762|66443397|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23744985|NCT01243762|66443391|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23744986|NCT01243762|66443392|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
23822316|NCT03316547|66730339|FG001|Overall Study|Death|1|||
23552983|NCT01662310|65751270|FG000|Open-Label Extension Phase|Adverse Event|0|||
23552984|NCT01662310|65751271|FG001|Open-Label Extension Phase|Adverse Event|0|||
23552985|NCT01662310|65751272|FG002|Open-Label Extension Phase|Adverse Event|0|||
23552986|NCT01662310|65751273|FG003|Open-Label Extension Phase|Adverse Event|3|||
23822317|NCT03316547|66730338|FG000|Overall Study|Lost to Follow-up|6|||
23822318|NCT03316547|66730339|FG001|Overall Study|Lost to Follow-up|6|||
23822319|NCT03316547|66730338|FG000|Overall Study|Withdrawal by Subject|3|||
23552987|NCT01662310|65751274|FG004|Open-Label Extension Phase|Adverse Event|0|||
23552988|NCT01662310|65751270|FG000|Open-Label Extension Phase|Death|0|||
23552989|NCT01662310|65751271|FG001|Open-Label Extension Phase|Death|0|||
23552990|NCT01662310|65751272|FG002|Open-Label Extension Phase|Death|0|||
23621670|NCT00937521|66000730|FG006|Booster Phase|Lost to Follow-up|3|||
23552991|NCT01662310|65751273|FG003|Open-Label Extension Phase|Death|1|||
23552992|NCT01662310|65751274|FG004|Open-Label Extension Phase|Death|0|||
23552993|NCT01662310|65751270|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
23552994|NCT01662310|65751271|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
23552995|NCT01662310|65751272|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
23552996|NCT01662310|65751273|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
23552997|NCT01662310|65751274|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
23552998|NCT01662310|65751270|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23552999|NCT01662310|65751271|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23553000|NCT01662310|65751272|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23553001|NCT01662310|65751273|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
23553002|NCT01662310|65751274|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
23621671|NCT00937521|66000731|FG007|Booster Phase|Lost to Follow-up|0|||
23621672|NCT00937521|66000724|FG000|Booster Phase|Administrative Reason|0|||
23621673|NCT00937521|66000725|FG001|Booster Phase|Administrative Reason|0|||
23621674|NCT00937521|66000726|FG002|Booster Phase|Administrative Reason|1|||
23621675|NCT00937521|66000727|FG003|Booster Phase|Administrative Reason|0|||
23621676|NCT00937521|66000728|FG004|Booster Phase|Administrative Reason|1|||
23621677|NCT00937521|66000729|FG005|Booster Phase|Administrative Reason|1|||
23621678|NCT00937521|66000730|FG006|Booster Phase|Administrative Reason|0|||
23621679|NCT00937521|66000731|FG007|Booster Phase|Administrative Reason|0|||
23621680|NCT00937521|66000724|FG000|Booster Phase|Protocol Deviation|0|||
23621681|NCT00937521|66000725|FG001|Booster Phase|Protocol Deviation|0|||
23621682|NCT00937521|66000726|FG002|Booster Phase|Protocol Deviation|0|||
23744987|NCT01243762|66443393|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23744988|NCT01243762|66443394|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
23744989|NCT01243762|66443395|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23744990|NCT01243762|66443396|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23744991|NCT01243762|66443397|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23744992|NCT01243762|66443391|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
23744993|NCT01243762|66443392|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
23744994|NCT01243762|66443393|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
23553003|NCT01662310|65751270|FG000|Open-Label Extension Phase|Pregnancy|0|||
23553004|NCT01662310|65751271|FG001|Open-Label Extension Phase|Pregnancy|0|||
23553005|NCT01662310|65751272|FG002|Open-Label Extension Phase|Pregnancy|0|||
23553006|NCT01662310|65751273|FG003|Open-Label Extension Phase|Pregnancy|1|||
23553007|NCT01662310|65751274|FG004|Open-Label Extension Phase|Pregnancy|0|||
23553008|NCT01662310|65751270|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553009|NCT01662310|65751271|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553010|NCT01662310|65751272|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553011|NCT01662310|65751273|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
23553012|NCT01662310|65751274|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
23553013|NCT05045625|65751275|FG000|Overall Study|Lost to Follow-up|3|||
23553014|NCT00955357|65751276|FG000|Titration Phase|Adverse Event|9|||
23553015|NCT00955357|65751277|FG001|Titration Phase|Adverse Event|46|||
23553016|NCT00955357|65751276|FG000|Titration Phase|Lack of Efficacy|0|||
23553017|NCT00955357|65751277|FG001|Titration Phase|Lack of Efficacy|2|||
23553018|NCT00955357|65751276|FG000|Titration Phase|Protocol Violation|3|||
23744995|NCT01243762|66443394|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
23744996|NCT01243762|66443395|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
23744997|NCT01243762|66443396|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
23744998|NCT01243762|66443397|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
23744999|NCT01243762|66443391|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23553019|NCT00955357|65751277|FG001|Titration Phase|Protocol Violation|7|||
23553020|NCT00955357|65751276|FG000|Titration Phase|Lost to Follow-up|1|||
23553021|NCT00955357|65751277|FG001|Titration Phase|Lost to Follow-up|3|||
23553022|NCT00955357|65751276|FG000|Titration Phase|Withdrawal by Subject|3|||
23553023|NCT00955357|65751277|FG001|Titration Phase|Withdrawal by Subject|5|||
23553024|NCT00955357|65751276|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
23621683|NCT00937521|66000727|FG003|Booster Phase|Protocol Deviation|0|||
23621684|NCT00937521|66000728|FG004|Booster Phase|Protocol Deviation|0|||
23621685|NCT00937521|66000729|FG005|Booster Phase|Protocol Deviation|0|||
23621686|NCT00937521|66000730|FG006|Booster Phase|Protocol Deviation|1|||
23621687|NCT00937521|66000731|FG007|Booster Phase|Protocol Deviation|0|||
23621688|NCT00264498|66000734|FG000|Randomized Treatment|Death|0|||
23621689|NCT00264498|66000735|FG001|Randomized Treatment|Death|3|||
23621690|NCT00264498|66000734|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23621691|NCT00264498|66000735|FG001|Randomized Treatment|Withdrawal by Subject|1|||
23621692|NCT00264498|66000734|FG000|Randomized Treatment|Objective disease Progression|13|||
23621693|NCT00264498|66000735|FG001|Randomized Treatment|Objective disease Progression|14|||
23621694|NCT00264498|66000734|FG000|Randomized Treatment|Physician Decision|1|||
23621695|NCT00264498|66000735|FG001|Randomized Treatment|Physician Decision|0|||
23621696|NCT00264498|66000734|FG000|Randomized Treatment|Incorrectly randomized|1|||
23745000|NCT01243762|66443392|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
23745001|NCT01243762|66443393|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23745002|NCT01243762|66443394|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23745003|NCT01243762|66443395|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23553025|NCT00955357|65751277|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
23553026|NCT00955357|65751276|FG000|Titration Phase|Study medication not tolerated|0|||
23553027|NCT00955357|65751277|FG001|Titration Phase|Study medication not tolerated|1|||
23553028|NCT00955357|65751276|FG000|Titration Phase|Non compliance to study procedures|0|||
23553029|NCT00955357|65751277|FG001|Titration Phase|Non compliance to study procedures|1|||
23553030|NCT00955357|65751276|FG000|Maintenance Phase|Adverse Event|3|||
23553031|NCT00955357|65751277|FG001|Maintenance Phase|Adverse Event|23|||
23553032|NCT00955357|65751276|FG000|Maintenance Phase|Lack of Efficacy|0|||
23553033|NCT00955357|65751277|FG001|Maintenance Phase|Lack of Efficacy|4|||
23553034|NCT00955357|65751276|FG000|Maintenance Phase|Protocol Violation|2|||
23553035|NCT00955357|65751277|FG001|Maintenance Phase|Protocol Violation|6|||
23553036|NCT00955357|65751276|FG000|Maintenance Phase|Lost to Follow-up|2|||
23553037|NCT00955357|65751277|FG001|Maintenance Phase|Lost to Follow-up|7|||
23745004|NCT01243762|66443396|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23745005|NCT01243762|66443397|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23745006|NCT01243762|66443391|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23745007|NCT01243762|66443392|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
23745008|NCT01243762|66443393|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23745009|NCT01243762|66443394|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23745010|NCT01243762|66443395|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23745011|NCT01243762|66443396|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23745012|NCT01243762|66443397|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
23745013|NCT01243762|66443391|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
23745014|NCT01243762|66443392|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
23745015|NCT01243762|66443393|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
23745016|NCT01243762|66443394|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
23745017|NCT01243762|66443395|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
23745018|NCT01243762|66443396|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
23745019|NCT01243762|66443397|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
23745020|NCT01243762|66443391|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23745021|NCT01243762|66443392|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
23745022|NCT01243762|66443393|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23745023|NCT01243762|66443394|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23745024|NCT01243762|66443395|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
23745025|NCT01243762|66443396|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23745026|NCT01243762|66443397|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23745027|NCT01243762|66443391|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23745028|NCT01243762|66443392|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23745029|NCT01243762|66443393|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23745030|NCT01243762|66443394|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
23745031|NCT01243762|66443395|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
23745032|NCT01243762|66443396|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23745033|NCT01243762|66443397|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23745034|NCT00227591|66443398|FG000|Overall Study|Withdrawal by Subject|1|||
23745035|NCT00499694|66443401|FG000|Overall Study|Patient never received treatment.|1|||
23745036|NCT00003526|66443403|FG000|Overall Study|Not evaluable|6|||
23745037|NCT00914940|66443404|FG000|D0 to D100 Post-transplant|Death|2|||
23745038|NCT00914940|66443404|FG000|D101 to 2 Years Post-transplant|Death|8|||
23745039|NCT00914940|66443404|FG000|2 Years to 5 Years Post-transplant|Death|3|||
23745040|NCT03288987|66447296|FG000|Overall Study|Protocol Violation|10|||
23745041|NCT03288987|66447297|FG001|Overall Study|Protocol Violation|4|||
23553038|NCT00955357|65751276|FG000|Maintenance Phase|Withdrawal by Subject|4|||
23745042|NCT04177862|66447300|FG000|Overall Study|Protocol Violation|2|||
23553039|NCT00955357|65751277|FG001|Maintenance Phase|Withdrawal by Subject|4|||
23621697|NCT00264498|66000735|FG001|Randomized Treatment|Incorrectly randomized|0|||
23621698|NCT00264498|66000734|FG000|Randomized Treatment|Study Closure|1|||
23621699|NCT00264498|66000735|FG001|Randomized Treatment|Study Closure|0|||
23553040|NCT00955357|65751276|FG000|Maintenance Phase|Patient moving out of area|0|||
23553041|NCT00955357|65751277|FG001|Maintenance Phase|Patient moving out of area|1|||
23553042|NCT00955357|65751276|FG000|Maintenance Phase|Non compliance to study procedures|1|||
23553043|NCT00955357|65751277|FG001|Maintenance Phase|Non compliance to study procedures|0|||
23553044|NCT01988779|65751280|FG000|Overall Study|Withdrawal by Subject|2|||
23553045|NCT01988779|65751281|FG001|Overall Study|Withdrawal by Subject|2|||
23553046|NCT01988779|65751280|FG000|Overall Study|Protocol Violation|1|||
23431755|NCT01927055|65324147|FG000|Double-Blind|Supine Hypertension|0|||
23431756|NCT01927055|65324148|FG001|Double-Blind|Supine Hypertension|0|||
23431757|NCT01927055|65324149|FG002|Double-Blind|Supine Hypertension|1|||
23431758|NCT01927055|65324147|FG000|Double-Blind|Extended Vacation|0|||
23553047|NCT01988779|65751281|FG001|Overall Study|Protocol Violation|0|||
23553048|NCT04546581|65751282|FG000|Overall Study|Adverse Event|9|||
23553049|NCT04546581|65751283|FG001|Overall Study|Adverse Event|3|||
23822320|NCT03316547|66730339|FG001|Overall Study|Withdrawal by Subject|2|||
23822321|NCT03316547|66730338|FG000|Overall Study|Transfer to another hospital|6|||
23822322|NCT03316547|66730339|FG001|Overall Study|Transfer to another hospital|4|||
23822323|NCT02203331|66730340|FG000|Overall Study|Pregnancy|1|||
23822324|NCT02203331|66730341|FG001|Overall Study|Pregnancy|0|||
23822325|NCT02203331|66730342|FG002|Overall Study|Pregnancy|0|||
23822326|NCT02203331|66730343|FG003|Overall Study|Pregnancy|0|||
23822327|NCT02203331|66730344|FG004|Overall Study|Pregnancy|2|||
23822328|NCT02203331|66730345|FG005|Overall Study|Pregnancy|0|||
23822329|NCT02203331|66730340|FG000|Overall Study|Withdrawal by Subject|1|||
23822330|NCT02203331|66730341|FG001|Overall Study|Withdrawal by Subject|0|||
23822331|NCT02203331|66730342|FG002|Overall Study|Withdrawal by Subject|1|||
23822332|NCT02203331|66730343|FG003|Overall Study|Withdrawal by Subject|0|||
23822333|NCT02203331|66730344|FG004|Overall Study|Withdrawal by Subject|0|||
23431759|NCT01927055|65324148|FG001|Double-Blind|Extended Vacation|1|||
23431760|NCT01927055|65324149|FG002|Double-Blind|Extended Vacation|0|||
23553050|NCT04546581|65751282|FG000|Overall Study|Physician Decision|0|||
23553051|NCT04546581|65751283|FG001|Overall Study|Physician Decision|1|||
23553052|NCT04546581|65751282|FG000|Overall Study|Protocol Violation|1|||
23553053|NCT04546581|65751283|FG001|Overall Study|Protocol Violation|2|||
23553054|NCT04546581|65751282|FG000|Overall Study|Withdrawal by Subject|3|||
23553055|NCT04546581|65751283|FG001|Overall Study|Withdrawal by Subject|7|||
23553056|NCT03561090|65751284|FG000|Overall Study|Adverse Event|11|||
23553057|NCT03561090|65751285|FG001|Overall Study|Adverse Event|7|||
23553058|NCT03561090|65751284|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23553059|NCT03561090|65751285|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23553060|NCT03561090|65751284|FG000|Overall Study|Protocol Violation|2|||
23553061|NCT03561090|65751285|FG001|Overall Study|Protocol Violation|2|||
23553062|NCT03561090|65751284|FG000|Overall Study|Withdrawal by Subject|7|||
23553063|NCT03561090|65751285|FG001|Overall Study|Withdrawal by Subject|7|||
23553064|NCT03561090|65751284|FG000|Overall Study|Lost to Follow-up|7|||
23553065|NCT03561090|65751285|FG001|Overall Study|Lost to Follow-up|2|||
23553066|NCT03561090|65751284|FG000|Overall Study|Study Terminated by Sponsor|10|||
23553067|NCT03561090|65751285|FG001|Overall Study|Study Terminated by Sponsor|15|||
23553068|NCT03561090|65751284|FG000|Overall Study|Randomized by Mistake|1|||
23553069|NCT03561090|65751285|FG001|Overall Study|Randomized by Mistake|1|||
23553070|NCT03561090|65751284|FG000|Overall Study|Other Not Specified|0|||
23553071|NCT03561090|65751285|FG001|Overall Study|Other Not Specified|2|||
23553072|NCT01881126|65751289|FG000|Overall Study|Non-compliance|1|||
23553073|NCT01881126|65751290|FG001|Overall Study|Non-compliance|1|||
23553074|NCT01881126|65751289|FG000|Overall Study|Adverse Event|0|||
23553075|NCT01881126|65751290|FG001|Overall Study|Adverse Event|1|||
23553076|NCT04368429|65751292|FG000|Overall Study|Adverse Event|1|||
23553077|NCT04368429|65751293|FG001|Overall Study|Adverse Event|0|||
23431761|NCT03369431|65324157|FG000|Overall Study|Lost to Follow-up|1|||
23431762|NCT03369431|65324158|FG001|Overall Study|Lost to Follow-up|3|||
23431763|NCT03369431|65324157|FG000|Overall Study|Withdrawal by Subject|2|||
23431764|NCT03369431|65324158|FG001|Overall Study|Withdrawal by Subject|3|||
23431765|NCT03369431|65324157|FG000|Overall Study|Protocol Violation|1|||
23431766|NCT03369431|65324158|FG001|Overall Study|Protocol Violation|1|||
23553078|NCT03834779|65751294|FG000|Overall Study|Death|1|||
23553079|NCT03834779|65751295|FG001|Overall Study|Death|2|||
23553080|NCT03834779|65751294|FG000|Overall Study|Lost to Follow-up|6|||
23553081|NCT03834779|65751295|FG001|Overall Study|Lost to Follow-up|4|||
23553082|NCT05763628|65751302|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
23553083|NCT05763628|65751303|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
23553084|NCT05763628|65751302|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
23745043|NCT04177862|66447301|FG001|Overall Study|Protocol Violation|7|||
23745044|NCT01876901|66447309|FG000|Overall Study|Protocol Violation|10|||
23745045|NCT01876901|66447310|FG001|Overall Study|Protocol Violation|2|||
23745046|NCT01876901|66447309|FG000|Overall Study|No or other surgical intervention|7|||
23745047|NCT01876901|66447310|FG001|Overall Study|No or other surgical intervention|5|||
23745048|NCT04221373|66447311|FG000|Overall Study|Physician Decision|4|||
23745049|NCT04221373|66447312|FG001|Overall Study|Physician Decision|0|||
23553085|NCT05763628|65751303|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
23553086|NCT05763628|65751302|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
23553087|NCT05763628|65751303|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
23553088|NCT02794285|65751306|FG000|Overall Study|Adverse Event|11|||
23553089|NCT02794285|65751307|FG001|Overall Study|Adverse Event|4|||
23553090|NCT02794285|65751308|FG002|Overall Study|Adverse Event|5|||
23553091|NCT02794285|65751309|FG003|Overall Study|Adverse Event|8|||
23553092|NCT02794285|65751306|FG000|Overall Study|Condition Under Investigation Improved|1|||
23621700|NCT00264498|66000734|FG000|Randomized Treatment|Protocol Violation|1|||
23621701|NCT00264498|66000735|FG001|Randomized Treatment|Protocol Violation|0|||
23621702|NCT00264498|66000734|FG000|Crossover Treatment|Death|1|||
23822334|NCT02203331|66730345|FG005|Overall Study|Withdrawal by Subject|3|||
23822335|NCT02203331|66730340|FG000|Overall Study|Adverse Event|4|||
23822336|NCT02203331|66730341|FG001|Overall Study|Adverse Event|8|||
23822337|NCT02203331|66730342|FG002|Overall Study|Adverse Event|3|||
23822338|NCT02203331|66730343|FG003|Overall Study|Adverse Event|4|||
23822339|NCT02203331|66730344|FG004|Overall Study|Adverse Event|3|||
23822340|NCT02203331|66730345|FG005|Overall Study|Adverse Event|3|||
23822341|NCT02203331|66730340|FG000|Overall Study|Other Reasons|1|||
23822342|NCT02203331|66730341|FG001|Overall Study|Other Reasons|2|||
23822343|NCT02203331|66730342|FG002|Overall Study|Other Reasons|0|||
23822344|NCT02203331|66730343|FG003|Overall Study|Other Reasons|2|||
23553093|NCT02794285|65751307|FG001|Overall Study|Condition Under Investigation Improved|0|||
23553094|NCT02794285|65751308|FG002|Overall Study|Condition Under Investigation Improved|0|||
23621703|NCT00264498|66000735|FG001|Crossover Treatment|Death|3|||
23822345|NCT02203331|66730344|FG004|Overall Study|Other Reasons|0|||
23822346|NCT02203331|66730345|FG005|Overall Study|Other Reasons|0|||
23822347|NCT02203331|66730340|FG000|Overall Study|Lack of Efficacy|0|||
23745050|NCT03919669|66447320|FG000|Overall Study|Withdrawal by Subject|1|||
23745051|NCT03919669|66447321|FG001|Overall Study|Withdrawal by Subject|0|||
23745052|NCT03919669|66447322|FG002|Overall Study|Withdrawal by Subject|0|||
23745053|NCT00219349|66447323|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
23745054|NCT00219349|66447323|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
23745055|NCT00219349|66447323|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
23745056|NCT00219349|66447323|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
23745057|NCT04640168|66447325|FG000|Overall Study|Withdrawal by Subject|8|||
23745058|NCT04640168|66447326|FG001|Overall Study|Withdrawal by Subject|7|||
23745059|NCT04640168|66447325|FG000|Overall Study|Lost to Follow-up|1|||
23745060|NCT04640168|66447326|FG001|Overall Study|Lost to Follow-up|0|||
23745061|NCT04640168|66447325|FG000|Overall Study|Enrolled but not treated|12|||
23745062|NCT04640168|66447326|FG001|Overall Study|Enrolled but not treated|12|||
23745063|NCT04235959|66447329|FG000|Overall Study|Protocol Violation|0|||
23745064|NCT04235959|66447330|FG001|Overall Study|Protocol Violation|1|||
23745065|NCT04235959|66447331|FG002|Overall Study|Protocol Violation|0|||
23745066|NCT04235959|66447329|FG000|Overall Study|Adverse Event|1|||
23745067|NCT04235959|66447330|FG001|Overall Study|Adverse Event|0|||
23745068|NCT04235959|66447331|FG002|Overall Study|Adverse Event|0|||
23745069|NCT00525499|66447346|FG000|Overall Study|Lost to Follow-up|2|||
23745070|NCT00525499|66447347|FG001|Overall Study|Lost to Follow-up|4|||
23745071|NCT00525499|66447348|FG002|Overall Study|Lost to Follow-up|1|||
23822348|NCT02203331|66730341|FG001|Overall Study|Lack of Efficacy|2|||
23822349|NCT02203331|66730342|FG002|Overall Study|Lack of Efficacy|1|||
23822350|NCT02203331|66730343|FG003|Overall Study|Lack of Efficacy|0|||
23822351|NCT02203331|66730344|FG004|Overall Study|Lack of Efficacy|0|||
23822352|NCT02203331|66730345|FG005|Overall Study|Lack of Efficacy|1|||
23822353|NCT02203331|66730340|FG000|Overall Study|Protocol Violation|0|||
23822354|NCT02203331|66730341|FG001|Overall Study|Protocol Violation|2|||
23822355|NCT02203331|66730342|FG002|Overall Study|Protocol Violation|0|||
23822356|NCT02203331|66730343|FG003|Overall Study|Protocol Violation|1|||
23822357|NCT02203331|66730344|FG004|Overall Study|Protocol Violation|1|||
23822358|NCT02203331|66730345|FG005|Overall Study|Protocol Violation|0|||
23822359|NCT02203331|66730340|FG000|Overall Study|Lost to Follow-up|0|||
23822360|NCT02203331|66730341|FG001|Overall Study|Lost to Follow-up|0|||
23822361|NCT02203331|66730342|FG002|Overall Study|Lost to Follow-up|0|||
23822362|NCT02203331|66730343|FG003|Overall Study|Lost to Follow-up|0|||
23822363|NCT02203331|66730344|FG004|Overall Study|Lost to Follow-up|1|||
23553095|NCT02794285|65751309|FG003|Overall Study|Condition Under Investigation Improved|0|||
23553096|NCT02794285|65751306|FG000|Overall Study|Condition Under Investigation Worsened|0|||
23553097|NCT02794285|65751307|FG001|Overall Study|Condition Under Investigation Worsened|2|||
23745072|NCT00525499|66447349|FG003|Overall Study|Lost to Follow-up|4|||
23745073|NCT00525499|66447346|FG000|Overall Study|Adverse Event|0|||
23745074|NCT00525499|66447347|FG001|Overall Study|Adverse Event|1|||
23745075|NCT00525499|66447348|FG002|Overall Study|Adverse Event|0|||
23745076|NCT00525499|66447349|FG003|Overall Study|Adverse Event|1|||
23745077|NCT00525499|66447346|FG000|Overall Study|Withdrawal by Subject|5|||
23745078|NCT00525499|66447347|FG001|Overall Study|Withdrawal by Subject|1|||
23745079|NCT00525499|66447348|FG002|Overall Study|Withdrawal by Subject|5|||
23745080|NCT00525499|66447349|FG003|Overall Study|Withdrawal by Subject|2|||
23745081|NCT00525499|66447346|FG000|Overall Study|Protocol Violation|0|||
23745082|NCT00525499|66447347|FG001|Overall Study|Protocol Violation|1|||
23745083|NCT00525499|66447348|FG002|Overall Study|Protocol Violation|1|||
23745084|NCT00525499|66447349|FG003|Overall Study|Protocol Violation|0|||
23745085|NCT02190604|66447350|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745086|NCT02190604|66447351|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745087|NCT02190604|66447352|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745088|NCT02190604|66447353|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745089|NCT02190604|66447354|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745090|NCT02190604|66447355|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745091|NCT02190604|66447356|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745092|NCT02190604|66447357|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745093|NCT02190604|66447358|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745094|NCT02190604|66447359|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745095|NCT02190604|66447360|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745096|NCT02190604|66447361|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745097|NCT02190604|66447362|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745098|NCT02190604|66447363|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23553098|NCT02794285|65751308|FG002|Overall Study|Condition Under Investigation Worsened|1|||
23553099|NCT02794285|65751309|FG003|Overall Study|Condition Under Investigation Worsened|0|||
23745099|NCT02190604|66447364|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
23745100|NCT02190604|66447365|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745101|NCT02190604|66447366|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23822364|NCT02203331|66730345|FG005|Overall Study|Lost to Follow-up|0|||
23822365|NCT02213510|66730346|FG000|Overall Study|Death|0|||
23822366|NCT02213510|66730347|FG001|Overall Study|Death|1|||
23822367|NCT02213510|66730346|FG000|Overall Study|Lost to Follow-up|1|||
23822368|NCT02213510|66730347|FG001|Overall Study|Lost to Follow-up|0|||
23822369|NCT05093829|66730348|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23822370|NCT05093829|66730349|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23822371|NCT05093829|66730350|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
23822372|NCT05093829|66730351|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23822373|NCT05093829|66730352|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23822374|NCT00587860|66730357|FG000|Overall Study|Lost to Follow-up|2|||
23822375|NCT00587860|66730358|FG001|Overall Study|Lost to Follow-up|2|||
23822376|NCT00587860|66730357|FG000|Overall Study|Withdrawal by Subject|3|||
23822377|NCT00587860|66730358|FG001|Overall Study|Withdrawal by Subject|3|||
23822378|NCT00359801|66730359|FG000|Overall Study|Lost to Follow-up|72|||
23822379|NCT00359801|66730360|FG001|Overall Study|Lost to Follow-up|58|||
23822380|NCT00359801|66730359|FG000|Overall Study|Withdrawal by Subject|143|||
23822381|NCT00359801|66730360|FG001|Overall Study|Withdrawal by Subject|96|||
23822382|NCT00359801|66730359|FG000|Overall Study|Other|66|||
23822383|NCT00359801|66730360|FG001|Overall Study|Other|46|||
23822384|NCT00359801|66730359|FG000|Overall Study|Final Status Unknown: missing data|7|||
23822385|NCT00359801|66730360|FG001|Overall Study|Final Status Unknown: missing data|4|||
23822386|NCT00359801|66730359|FG000|Overall Study|Sponsor Decision|17|||
23822387|NCT00359801|66730360|FG001|Overall Study|Sponsor Decision|16|||
23822388|NCT01098474|66730363|FG000|Active Phase|Other|0|||
23822389|NCT01098474|66730364|FG001|Active Phase|Other|0|||
23822390|NCT01098474|66730365|FG002|Active Phase|Other|3|||
23822391|NCT01098474|66730366|FG003|Active Phase|Other|0|||
23822392|NCT01098474|66730367|FG004|Active Phase|Other|0|||
23553100|NCT02794285|65751306|FG000|Overall Study|Death|2|||
23553101|NCT02794285|65751307|FG001|Overall Study|Death|1|||
23745102|NCT02190604|66447367|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745103|NCT02190604|66447368|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23745104|NCT02190604|66447350|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745105|NCT02190604|66447351|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23822393|NCT01098474|66730368|FG005|Active Phase|Other|0|||
23822394|NCT01098474|66730363|FG000|Active Phase|Withdrawal by Subject|1|||
23822395|NCT01098474|66730364|FG001|Active Phase|Withdrawal by Subject|1|||
23822396|NCT01098474|66730365|FG002|Active Phase|Withdrawal by Subject|2|||
23553102|NCT02794285|65751308|FG002|Overall Study|Death|2|||
23553103|NCT02794285|65751309|FG003|Overall Study|Death|0|||
23553104|NCT02794285|65751306|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
23553105|NCT02794285|65751307|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
23553106|NCT02794285|65751308|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
23553107|NCT02794285|65751309|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
23553108|NCT02794285|65751306|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553109|NCT02794285|65751307|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553110|NCT02794285|65751308|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
23553111|NCT02794285|65751309|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553112|NCT02794285|65751306|FG000|Overall Study|Lack of Efficacy|10|||
23553113|NCT02794285|65751307|FG001|Overall Study|Lack of Efficacy|6|||
23553114|NCT02794285|65751308|FG002|Overall Study|Lack of Efficacy|3|||
23553115|NCT02794285|65751309|FG003|Overall Study|Lack of Efficacy|3|||
23553116|NCT02794285|65751306|FG000|Overall Study|Lost to Follow-up|5|||
23745106|NCT02190604|66447352|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23553117|NCT02794285|65751307|FG001|Overall Study|Lost to Follow-up|6|||
23553118|NCT02794285|65751308|FG002|Overall Study|Lost to Follow-up|3|||
23745107|NCT02190604|66447353|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23553119|NCT02794285|65751309|FG003|Overall Study|Lost to Follow-up|1|||
23553120|NCT02794285|65751306|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
23745108|NCT02190604|66447354|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745109|NCT02190604|66447355|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745110|NCT02190604|66447356|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745111|NCT02190604|66447357|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745112|NCT02190604|66447358|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745113|NCT02190604|66447359|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745114|NCT02190604|66447360|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745115|NCT02190604|66447361|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745116|NCT02190604|66447362|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745117|NCT02190604|66447363|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
23822397|NCT01098474|66730366|FG003|Active Phase|Withdrawal by Subject|0|||
23822398|NCT01098474|66730367|FG004|Active Phase|Withdrawal by Subject|0|||
23822399|NCT01098474|66730368|FG005|Active Phase|Withdrawal by Subject|0|||
23822400|NCT01098474|66730363|FG000|Active Phase|Lost to Follow-up|1|||
23621704|NCT00264498|66000734|FG000|Crossover Treatment|Objective disease progression|4|||
23745118|NCT02190604|66447364|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745119|NCT02190604|66447365|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745120|NCT02190604|66447366|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745121|NCT02190604|66447367|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745122|NCT02190604|66447368|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23745123|NCT02967055|66447369|FG000|Overall Study|Excluded|40|||
23745124|NCT02967055|66447369|FG000|Overall Study|Screen fail|3|||
23745125|NCT02967055|66447369|FG000|Overall Study|Lost to Follow-up|2|||
23745126|NCT02967055|66447369|FG000|Overall Study|Stopped due to side effects|3|||
23745127|NCT02967055|66447369|FG000|Overall Study|Stopped due to drug cost|1|||
23745128|NCT04823494|66447370|FG000|Overall Study|Programming software malfunction.|1|||
23745129|NCT04823494|66447371|FG001|Overall Study|Programming software malfunction.|0|||
23745130|NCT04823494|66447370|FG000|Overall Study|Withdrawal by Subject|1|||
23745131|NCT04823494|66447371|FG001|Overall Study|Withdrawal by Subject|0|||
23745132|NCT04823494|66447370|FG000|Overall Study|Devices lost|0|||
23745133|NCT04823494|66447371|FG001|Overall Study|Devices lost|1|||
23745134|NCT01886105|66447372|FG000|Overall Study|Lack of Efficacy|3|||
23745135|NCT01361308|66447373|FG000|Overall Study|Withdrawal by Subject|9|||
23745136|NCT01361308|66447374|FG001|Overall Study|Withdrawal by Subject|13|||
23745137|NCT01361308|66447373|FG000|Overall Study|Physician Decision|3|||
23745138|NCT01361308|66447374|FG001|Overall Study|Physician Decision|3|||
23745139|NCT01361308|66447373|FG000|Overall Study|Lack of Efficacy|2|||
23745140|NCT01361308|66447374|FG001|Overall Study|Lack of Efficacy|0|||
23745141|NCT01361308|66447373|FG000|Overall Study|Protocol Violation|1|||
23621705|NCT00264498|66000735|FG001|Crossover Treatment|Objective disease progression|5|||
23745142|NCT01361308|66447374|FG001|Overall Study|Protocol Violation|0|||
23745143|NCT01361308|66447373|FG000|Overall Study|Lost to Follow-up|5|||
23745144|NCT01361308|66447374|FG001|Overall Study|Lost to Follow-up|4|||
23822401|NCT01098474|66730364|FG001|Active Phase|Lost to Follow-up|0|||
23822402|NCT01098474|66730365|FG002|Active Phase|Lost to Follow-up|0|||
23553121|NCT02794285|65751307|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
23553122|NCT02794285|65751308|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
23553123|NCT02794285|65751309|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
23553124|NCT02794285|65751306|FG000|Overall Study|Withdrawal by Subject|38|||
23553125|NCT02794285|65751307|FG001|Overall Study|Withdrawal by Subject|29|||
23621706|NCT00264498|66000734|FG000|Crossover Treatment|Study closure|0|||
23553126|NCT02794285|65751308|FG002|Overall Study|Withdrawal by Subject|20|||
23553127|NCT02794285|65751309|FG003|Overall Study|Withdrawal by Subject|12|||
23553128|NCT02794285|65751306|FG000|Overall Study|Missing|1|||
23553129|NCT02794285|65751307|FG001|Overall Study|Missing|0|||
23553130|NCT02794285|65751308|FG002|Overall Study|Missing|0|||
23553131|NCT02794285|65751309|FG003|Overall Study|Missing|0|||
23553132|NCT02794285|65751306|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
23553133|NCT02794285|65751307|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
23553134|NCT02794285|65751308|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
23553135|NCT02794285|65751309|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
23553136|NCT02794285|65751306|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
23553137|NCT02794285|65751307|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
23745145|NCT01361308|66447373|FG000|Overall Study|Adverse Event|8|||
23745146|NCT01361308|66447374|FG001|Overall Study|Adverse Event|4|||
23745147|NCT01361308|66447373|FG000|Overall Study|Eligibility Criteria Not Met|2|||
23745148|NCT01361308|66447374|FG001|Overall Study|Eligibility Criteria Not Met|3|||
23745149|NCT01361308|66447373|FG000|Overall Study|Failed C-SSRS|5|||
23745150|NCT01361308|66447374|FG001|Overall Study|Failed C-SSRS|2|||
23745151|NCT01361308|66447373|FG000|Overall Study|Other|0|||
23745152|NCT01361308|66447374|FG001|Overall Study|Other|1|||
23745153|NCT03186794|66447375|FG000|Overall Study|Physician Decision|2|||
23745154|NCT03186794|66447375|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
23745155|NCT01869959|66447376|FG000|Randomization Period|Physician Decision|0|||
23745156|NCT01869959|66447377|FG001|Randomization Period|Physician Decision|0|||
23745157|NCT01869959|66447378|FG002|Randomization Period|Physician Decision|0|||
23745158|NCT01869959|66447379|FG003|Randomization Period|Physician Decision|0|||
23745159|NCT01869959|66447380|FG004|Randomization Period|Physician Decision|1|||
23745160|NCT01869959|66447376|FG000|Treatment Period|Adverse Event|1|||
23553138|NCT02794285|65751308|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
23553139|NCT02794285|65751309|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
23553140|NCT01822587|65751310|FG000|Overall Study|Lost to Follow-up|7|||
23553141|NCT01822587|65751311|FG001|Overall Study|Lost to Follow-up|9|||
23553142|NCT01822587|65751312|FG002|Overall Study|Lost to Follow-up|12|||
23553143|NCT01822587|65751310|FG000|Overall Study|Physician Decision|9|||
23745161|NCT01869959|66447377|FG001|Treatment Period|Adverse Event|0|||
23745162|NCT01869959|66447378|FG002|Treatment Period|Adverse Event|3|||
23745163|NCT01869959|66447379|FG003|Treatment Period|Adverse Event|1|||
23822403|NCT01098474|66730366|FG003|Active Phase|Lost to Follow-up|0|||
23822404|NCT01098474|66730367|FG004|Active Phase|Lost to Follow-up|0|||
23822405|NCT01098474|66730368|FG005|Active Phase|Lost to Follow-up|0|||
23553144|NCT01822587|65751311|FG001|Overall Study|Physician Decision|6|||
23553145|NCT01822587|65751312|FG002|Overall Study|Physician Decision|6|||
23553146|NCT03086330|65751315|FG000|Overall Study|Withdrawal by Subject|3|||
23553147|NCT03086330|65751316|FG001|Overall Study|Withdrawal by Subject|2|||
23553148|NCT03086330|65751315|FG000|Overall Study|Lost to Follow-up|1|||
23822406|NCT01098474|66730363|FG000|Follow Up Phase|Travelled out of study area|0|||
23431767|NCT01490294|65324159|FG000|Overall Study|Prematurely discontinuation|4|||
23431768|NCT01490294|65324160|FG001|Overall Study|Prematurely discontinuation|0|||
23431769|NCT01490294|65324161|FG002|Overall Study|Prematurely discontinuation|1|||
23431770|NCT01490294|65324162|FG003|Overall Study|Prematurely discontinuation|1|||
23431771|NCT01490294|65324159|FG000|Overall Study|Adverse Event|1|||
23431772|NCT01490294|65324160|FG001|Overall Study|Adverse Event|0|||
23431773|NCT01490294|65324161|FG002|Overall Study|Adverse Event|0|||
23431774|NCT01490294|65324162|FG003|Overall Study|Adverse Event|0|||
23431775|NCT01541917|65324171|FG000|Overall Study|Lost to Follow-up|2|||
23431776|NCT01541917|65324172|FG001|Overall Study|Lost to Follow-up|2|||
23431777|NCT01541917|65324171|FG000|Overall Study|Withdrawal by Subject|13|||
23431778|NCT01541917|65324172|FG001|Overall Study|Withdrawal by Subject|7|||
23431779|NCT01475162|65324180|FG000|Overall Study|Physician Decision|1|||
23431780|NCT01475162|65324180|FG000|Overall Study|Death|10|||
23431781|NCT01475162|65324180|FG000|Overall Study|Study closed for safety|3|||
23431782|NCT02456857|65324183|FG000|Overall Study|Disease Progression|4|||
23431783|NCT02723175|65324187|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
23745164|NCT01869959|66447380|FG004|Treatment Period|Adverse Event|0|||
23745165|NCT01869959|66447376|FG000|Treatment Period|Sponsor decision|0|||
23745166|NCT01869959|66447377|FG001|Treatment Period|Sponsor decision|1|||
23745167|NCT01869959|66447378|FG002|Treatment Period|Sponsor decision|0|||
23745168|NCT01869959|66447379|FG003|Treatment Period|Sponsor decision|1|||
23745169|NCT01869959|66447380|FG004|Treatment Period|Sponsor decision|0|||
23431784|NCT02723175|65324188|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
23431785|NCT02723175|65324187|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
23553149|NCT03086330|65751316|FG001|Overall Study|Lost to Follow-up|2|||
23553150|NCT02753595|65751317|FG000|Overall Study|Sponsor termination|2|||
23553151|NCT02753595|65751318|FG001|Overall Study|Sponsor termination|2|||
23553152|NCT02782169|65751319|FG000|Overall Study|Lost to Follow-up|1|||
23553153|NCT02782169|65751320|FG001|Overall Study|Lost to Follow-up|2|||
23553154|NCT02489500|65751321|FG000|Overall Study|Death|1|||
23822407|NCT01098474|66730364|FG001|Follow Up Phase|Travelled out of study area|0|||
23553155|NCT02489500|65751322|FG001|Overall Study|Death|1|||
23822408|NCT01098474|66730365|FG002|Follow Up Phase|Travelled out of study area|0|||
23822409|NCT01098474|66730366|FG003|Follow Up Phase|Travelled out of study area|0|||
23822410|NCT01098474|66730367|FG004|Follow Up Phase|Travelled out of study area|1|||
23822411|NCT01098474|66730368|FG005|Follow Up Phase|Travelled out of study area|0|||
23822412|NCT01098474|66730363|FG000|Follow Up Phase|Other|0|||
23822413|NCT01098474|66730364|FG001|Follow Up Phase|Other|0|||
23822414|NCT01098474|66730365|FG002|Follow Up Phase|Other|0|||
23822415|NCT01098474|66730366|FG003|Follow Up Phase|Other|0|||
23822416|NCT01098474|66730367|FG004|Follow Up Phase|Other|0|||
23822417|NCT01098474|66730368|FG005|Follow Up Phase|Other|4|||
23822418|NCT01098474|66730363|FG000|Follow Up Phase|Withdrawal by Subject|0|||
23822419|NCT01098474|66730364|FG001|Follow Up Phase|Withdrawal by Subject|0|||
23822420|NCT01098474|66730365|FG002|Follow Up Phase|Withdrawal by Subject|0|||
23822421|NCT01098474|66730366|FG003|Follow Up Phase|Withdrawal by Subject|2|||
23822422|NCT01098474|66730367|FG004|Follow Up Phase|Withdrawal by Subject|0|||
23822423|NCT01098474|66730368|FG005|Follow Up Phase|Withdrawal by Subject|1|||
23822424|NCT01098474|66730363|FG000|Follow Up Phase|Lost to Follow-up|0|||
23822425|NCT01098474|66730364|FG001|Follow Up Phase|Lost to Follow-up|0|||
23822426|NCT01098474|66730365|FG002|Follow Up Phase|Lost to Follow-up|0|||
23822427|NCT01098474|66730366|FG003|Follow Up Phase|Lost to Follow-up|0|||
23822428|NCT01098474|66730367|FG004|Follow Up Phase|Lost to Follow-up|1|||
23822429|NCT01098474|66730368|FG005|Follow Up Phase|Lost to Follow-up|0|||
23822430|NCT04778904|66730369|FG000|Overall Study|Protocol Violation|1|||
23822431|NCT04778904|66730370|FG001|Overall Study|Protocol Violation|0|||
23822432|NCT04778904|66730371|FG002|Overall Study|Protocol Violation|0|||
23822433|NCT04778904|66730372|FG003|Overall Study|Protocol Violation|0|||
23822434|NCT04778904|66730369|FG000|Overall Study|Withdrawal by Subject|0|||
23822435|NCT04778904|66730370|FG001|Overall Study|Withdrawal by Subject|0|||
23822436|NCT04778904|66730371|FG002|Overall Study|Withdrawal by Subject|1|||
23822437|NCT04778904|66730372|FG003|Overall Study|Withdrawal by Subject|0|||
23822438|NCT00258960|66730377|FG000|Overall Study|Death|2|||
23822439|NCT00258960|66730377|FG000|Overall Study|Disease Progression|7|||
23822440|NCT00258960|66730377|FG000|Overall Study|Adverse Event|4|||
23822441|NCT00258960|66730377|FG000|Overall Study|Physician Decision|1|||
23822442|NCT00258960|66730377|FG000|Overall Study|Withdrawal by Subject|1|||
23822443|NCT00258960|66730377|FG000|Overall Study|Mistake|2|||
23822444|NCT01632280|66730378|FG000|Overall Study|Withdrawal by Subject|1|||
23553156|NCT01506193|65751323|FG000|Overall Study|Protocol Violation|1|||
23553157|NCT01506193|65751324|FG001|Overall Study|Protocol Violation|0|||
23553158|NCT01506193|65751325|FG002|Overall Study|Protocol Violation|1|||
23553159|NCT01506193|65751323|FG000|Overall Study|Migrated/moved from study area|0|||
23553160|NCT01506193|65751324|FG001|Overall Study|Migrated/moved from study area|0|||
23553161|NCT01506193|65751325|FG002|Overall Study|Migrated/moved from study area|1|||
23553162|NCT01506193|65751323|FG000|Overall Study|Adverse event, non-fatal|0|||
23553163|NCT01506193|65751324|FG001|Overall Study|Adverse event, non-fatal|0|||
23553164|NCT01506193|65751325|FG002|Overall Study|Adverse event, non-fatal|1|||
23553165|NCT01506193|65751323|FG000|Overall Study|Withdrawal by Subject|5|||
23553166|NCT01506193|65751324|FG001|Overall Study|Withdrawal by Subject|1|||
23553167|NCT01506193|65751325|FG002|Overall Study|Withdrawal by Subject|8|||
23553168|NCT01506193|65751323|FG000|Overall Study|Lost to Follow-up|8|||
23553169|NCT01506193|65751324|FG001|Overall Study|Lost to Follow-up|3|||
23553170|NCT01506193|65751325|FG002|Overall Study|Lost to Follow-up|3|||
23553171|NCT01261611|65751326|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
23553172|NCT01261611|65751327|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
23553173|NCT01261611|65751328|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
23553174|NCT01261611|65751326|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23553175|NCT01261611|65751327|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
23553176|NCT01261611|65751328|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
23553177|NCT01261611|65751326|FG000|Treatment Cycle 1|Adverse Event|0|||
23553178|NCT01261611|65751327|FG001|Treatment Cycle 1|Adverse Event|1|||
23553179|NCT01261611|65751328|FG002|Treatment Cycle 1|Adverse Event|0|||
23553180|NCT01261611|65751326|FG000|Treatment Cycle 1|Protocol Violation|0|||
23553181|NCT01261611|65751327|FG001|Treatment Cycle 1|Protocol Violation|0|||
23553182|NCT01261611|65751328|FG002|Treatment Cycle 1|Protocol Violation|2|||
23822445|NCT01632280|66730379|FG001|Overall Study|Withdrawal by Subject|0|||
23822446|NCT04052620|66730380|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
23822447|NCT04052620|66730381|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
23553183|NCT01261611|65751326|FG000|Treatment Cycle 2|Completed study|4|||
23553184|NCT01261611|65751327|FG001|Treatment Cycle 2|Completed study|0|||
23553185|NCT01261611|65751328|FG002|Treatment Cycle 2|Completed study|0|||
23553186|NCT01261611|65751326|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
23553187|NCT01261611|65751327|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
23553188|NCT01261611|65751328|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
23553189|NCT01261611|65751326|FG000|Treatment Cycle 2|Adverse Event|1|||
23553190|NCT01261611|65751327|FG001|Treatment Cycle 2|Adverse Event|0|||
23822448|NCT04052620|66730380|FG000|Overall Study|Withdrawal by Subject|1|||
23431786|NCT02723175|65324188|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
23431787|NCT02704689|65324191|FG000|Overall Study|Physician Decision|1|||
23431788|NCT02704689|65324191|FG000|Overall Study|Study device not implanted|2|||
23431789|NCT02191605|65324192|FG000|Overall Study|Lost to Follow-up|9|||
23431790|NCT02191605|65324193|FG001|Overall Study|Lost to Follow-up|4|||
23431791|NCT02191605|65324194|FG002|Overall Study|Lost to Follow-up|7|||
23431792|NCT02191605|65324195|FG003|Overall Study|Lost to Follow-up|3|||
23431793|NCT02191605|65324196|FG004|Overall Study|Lost to Follow-up|4|||
23431794|NCT00897390|65324197|FG000|Overall Study|Adverse Event|2|||
23431795|NCT00897390|65324197|FG000|Overall Study|No Longer Met Study Criteria|1|||
23431796|NCT00897390|65324197|FG000|Overall Study|Personal Reasons|1|||
23431797|NCT00897390|65324197|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
23431798|NCT00257660|65324198|FG000|Overall Study|Lack of Efficacy|5|||
23431799|NCT00257660|65324199|FG001|Overall Study|Lack of Efficacy|23|||
23431800|NCT00257660|65324198|FG000|Overall Study|Withdrawal by Subject|2|||
23431801|NCT00257660|65324199|FG001|Overall Study|Withdrawal by Subject|0|||
23431802|NCT00257660|65324198|FG000|Overall Study|Lost to Follow-up|1|||
23431803|NCT00257660|65324199|FG001|Overall Study|Lost to Follow-up|0|||
23431804|NCT00257660|65324198|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
23431805|NCT00257660|65324199|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
23431806|NCT00257660|65324198|FG000|Overall Study|No longer wanted to do blood draws|1|||
23431807|NCT00257660|65324199|FG001|Overall Study|No longer wanted to do blood draws|0|||
23431808|NCT02006069|65324200|FG000|Overall Study|MPP other programming|239|||
23431809|NCT02006069|65324201|FG001|Overall Study|MPP other programming|0|||
23431810|NCT02006069|65324200|FG000|Overall Study|RV only pacing|0|||
23431811|NCT02006069|65324201|FG001|Overall Study|RV only pacing|3|||
23431812|NCT01839656|65324204|FG000|Overall Study|Withdrawal by Subject|1|||
23431813|NCT01839656|65324205|FG001|Overall Study|Withdrawal by Subject|1|||
23431814|NCT01839656|65324204|FG000|Overall Study|Adverse event, serious fatal|1|||
23431815|NCT01839656|65324205|FG001|Overall Study|Adverse event, serious fatal|4|||
23431816|NCT01839656|65324204|FG000|Overall Study|Early study closure|0|||
23431817|NCT01839656|65324205|FG001|Overall Study|Early study closure|11|||
23431818|NCT01839656|65324204|FG000|Overall Study|Adverse Event|1|||
23431819|NCT01839656|65324205|FG001|Overall Study|Adverse Event|0|||
23431820|NCT04033068|65324206|FG000|Overall Study|Withdrawal by Subject|0|||
23431821|NCT04033068|65324207|FG001|Overall Study|Withdrawal by Subject|0|||
23431822|NCT04033068|65324208|FG002|Overall Study|Withdrawal by Subject|1|||
23431823|NCT04033068|65324209|FG003|Overall Study|Withdrawal by Subject|0|||
23431824|NCT04033068|65324206|FG000|Overall Study|Lost to Follow-up|0|||
23431825|NCT04033068|65324207|FG001|Overall Study|Lost to Follow-up|1|||
23431826|NCT04033068|65324208|FG002|Overall Study|Lost to Follow-up|0|||
23431827|NCT04033068|65324209|FG003|Overall Study|Lost to Follow-up|0|||
23431828|NCT04033068|65324206|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431829|NCT04033068|65324207|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431830|NCT04033068|65324208|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431831|NCT04033068|65324209|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
23431832|NCT03199391|65324211|FG000|Overall Study|Death|1|||
23431833|NCT03199391|65324211|FG000|Overall Study|Lost to Follow-up|3|||
23431834|NCT03199391|65324211|FG000|Overall Study|Adverse Event|2|||
23822449|NCT04052620|66730381|FG001|Overall Study|Withdrawal by Subject|0|||
23822450|NCT04052620|66730380|FG000|Overall Study|Lost to Follow-up|1|||
23822451|NCT04052620|66730381|FG001|Overall Study|Lost to Follow-up|1|||
23822452|NCT04052620|66730380|FG000|Overall Study|Adverse Event|1|||
23822453|NCT04052620|66730381|FG001|Overall Study|Adverse Event|0|||
23822454|NCT04052620|66730380|FG000|Overall Study|Subject did not meet study Criteria|0|||
23822455|NCT04052620|66730381|FG001|Overall Study|Subject did not meet study Criteria|1|||
23822456|NCT04052620|66730380|FG000|Overall Study|Screened failure, randomized by mistake|0|||
23822457|NCT04052620|66730381|FG001|Overall Study|Screened failure, randomized by mistake|1|||
23822458|NCT04052620|66730380|FG000|Overall Study|Personal reasons|2|||
23822459|NCT04052620|66730381|FG001|Overall Study|Personal reasons|4|||
23822460|NCT04052620|66730380|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
23822461|NCT04052620|66730381|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
23822462|NCT01611857|66730383|FG000|Overall Study|Withdrawal by Subject|0|||
23431835|NCT03199391|65324211|FG000|Overall Study|Withdrawal by Subject|10|||
23822463|NCT01611857|66730384|FG001|Overall Study|Withdrawal by Subject|2|||
23822464|NCT01420965|66730385|FG000|Overall Study|Withdrawal by Subject|1|||
23822465|NCT01420965|66730386|FG001|Overall Study|Withdrawal by Subject|0|||
23822466|NCT01420965|66730387|FG002|Overall Study|Withdrawal by Subject|0|||
23431836|NCT02177838|65324212|FG000|Overall Study|Withdrawal by Subject|1|||
23822467|NCT01420965|66730385|FG000|Overall Study|Adverse Event|0|||
23431837|NCT02177838|65324212|FG000|Overall Study|Physician Decision|1|||
23431838|NCT02177838|65324212|FG000|Overall Study|Death|1|||
23431839|NCT01545050|65324217|FG000|Overall Study|Lack of Efficacy|0|||
23431840|NCT01545050|65324218|FG001|Overall Study|Lack of Efficacy|0|||
23431841|NCT01545050|65324219|FG002|Overall Study|Lack of Efficacy|0|||
23431842|NCT01545050|65324220|FG003|Overall Study|Lack of Efficacy|3|||
23745170|NCT01869959|66447376|FG000|Treatment Period|Withdrawal by Subject|0|||
23553191|NCT01261611|65751328|FG002|Treatment Cycle 2|Adverse Event|0|||
23553192|NCT01261611|65751326|FG000|Treatment Cycle 2|Protocol Violation|2|||
23553193|NCT01261611|65751327|FG001|Treatment Cycle 2|Protocol Violation|0|||
23553194|NCT01261611|65751328|FG002|Treatment Cycle 2|Protocol Violation|0|||
23553195|NCT01261611|65751326|FG000|Treatment Cycle 2|Not otherwise specified|2|||
23553196|NCT01261611|65751327|FG001|Treatment Cycle 2|Not otherwise specified|0|||
23553197|NCT01261611|65751328|FG002|Treatment Cycle 2|Not otherwise specified|0|||
23553198|NCT01261611|65751326|FG000|Treatment Cycle 3|Completed study|24|||
23553199|NCT01261611|65751327|FG001|Treatment Cycle 3|Completed study|0|||
23553200|NCT01261611|65751328|FG002|Treatment Cycle 3|Completed study|0|||
23553201|NCT01261611|65751326|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
23553202|NCT01261611|65751327|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
23553203|NCT01261611|65751328|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
23553204|NCT01261611|65751326|FG000|Treatment Cycle 3|Adverse Event|1|||
23553205|NCT01261611|65751327|FG001|Treatment Cycle 3|Adverse Event|0|||
23553206|NCT01261611|65751328|FG002|Treatment Cycle 3|Adverse Event|0|||
23553207|NCT01261611|65751326|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
23553208|NCT01261611|65751327|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
23553209|NCT01261611|65751328|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
23553210|NCT01261611|65751326|FG000|Treatment Cycle 4|Completed study|87|||
23553211|NCT01261611|65751327|FG001|Treatment Cycle 4|Completed study|0|||
23553212|NCT01261611|65751328|FG002|Treatment Cycle 4|Completed study|0|||
23553213|NCT01261611|65751326|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
23553214|NCT01261611|65751327|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
23553215|NCT01261611|65751328|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
23553216|NCT01261611|65751326|FG000|Treatment Cycle 4|Adverse Event|1|||
23553217|NCT01261611|65751327|FG001|Treatment Cycle 4|Adverse Event|0|||
23553218|NCT01261611|65751328|FG002|Treatment Cycle 4|Adverse Event|0|||
23553219|NCT01261611|65751326|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
23553220|NCT01261611|65751327|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
23553221|NCT01261611|65751328|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
23553222|NCT01261611|65751326|FG000|Treatment Cycle 4|Not otherwise specified|3|||
23553223|NCT01261611|65751327|FG001|Treatment Cycle 4|Not otherwise specified|0|||
23553224|NCT01261611|65751328|FG002|Treatment Cycle 4|Not otherwise specified|0|||
23553225|NCT01261611|65751326|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
23553226|NCT01261611|65751327|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
23553227|NCT01261611|65751328|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
23553228|NCT01261611|65751326|FG000|Treatment Cycle 5|Adverse Event|1|||
23553229|NCT01261611|65751327|FG001|Treatment Cycle 5|Adverse Event|0|||
23553230|NCT01261611|65751328|FG002|Treatment Cycle 5|Adverse Event|0|||
23553231|NCT01261611|65751326|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
23553232|NCT01261611|65751327|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
23553233|NCT01261611|65751328|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
23553234|NCT01925950|65751329|FG000|Part 2|Withdrawal by Subject|1|||
23553235|NCT01925950|65751330|FG001|Part 2|Withdrawal by Subject|0|||
23553236|NCT03342638|65751331|FG000|Overall Study|Withdrawal by Subject|1|||
23553237|NCT03342638|65751332|FG001|Overall Study|Withdrawal by Subject|0|||
23553238|NCT03342638|65751331|FG000|Overall Study|Physician Decision|0|||
23553239|NCT03342638|65751332|FG001|Overall Study|Physician Decision|1|||
23553240|NCT02943408|65751334|FG000|Overall Study|Lost to Follow-up|7|||
23553241|NCT02943408|65751335|FG001|Overall Study|Lost to Follow-up|1|||
23553242|NCT02943408|65751334|FG000|Overall Study|Withdrawal by Subject|0|||
23553243|NCT02943408|65751335|FG001|Overall Study|Withdrawal by Subject|1|||
23553244|NCT03221387|65751338|FG000|Overall Study|Lost to Follow-up|1|||
23553245|NCT03221387|65751338|FG000|Overall Study|Lung transplant|1|||
23553246|NCT02454101|65751339|FG000|Overall Study|Adverse Event|2|||
23553247|NCT02454101|65751340|FG001|Overall Study|Adverse Event|3|||
23553248|NCT02454101|65751339|FG000|Overall Study|Lost to Follow-up|3|||
23553249|NCT02454101|65751340|FG001|Overall Study|Lost to Follow-up|4|||
23553250|NCT00827918|65751348|FG000|Overall Study|Adverse Event|4|||
23553251|NCT00827918|65751349|FG001|Overall Study|Adverse Event|0|||
23745171|NCT01869959|66447377|FG001|Treatment Period|Withdrawal by Subject|1|||
23745172|NCT01869959|66447378|FG002|Treatment Period|Withdrawal by Subject|0|||
23553252|NCT00827918|65751350|FG002|Overall Study|Adverse Event|0|||
23553253|NCT00827918|65751348|FG000|Overall Study|Lack of Efficacy|16|||
23553254|NCT00827918|65751349|FG001|Overall Study|Lack of Efficacy|4|||
23553255|NCT00827918|65751350|FG002|Overall Study|Lack of Efficacy|15|||
23553256|NCT00827918|65751348|FG000|Overall Study|Physician Decision|1|||
23553257|NCT00827918|65751349|FG001|Overall Study|Physician Decision|0|||
23553258|NCT00827918|65751350|FG002|Overall Study|Physician Decision|0|||
23553259|NCT00827918|65751348|FG000|Overall Study|Pregnancy|0|||
23553260|NCT00827918|65751349|FG001|Overall Study|Pregnancy|1|||
23553261|NCT00827918|65751350|FG002|Overall Study|Pregnancy|0|||
23553262|NCT00827918|65751348|FG000|Overall Study|Progressive Disease|1|||
23553263|NCT00827918|65751349|FG001|Overall Study|Progressive Disease|1|||
23553264|NCT00827918|65751350|FG002|Overall Study|Progressive Disease|0|||
23553265|NCT00827918|65751348|FG000|Overall Study|Protocol Violation|0|||
23553266|NCT00827918|65751349|FG001|Overall Study|Protocol Violation|1|||
23745173|NCT01869959|66447379|FG003|Treatment Period|Withdrawal by Subject|0|||
23745174|NCT01869959|66447380|FG004|Treatment Period|Withdrawal by Subject|0|||
23745175|NCT02503215|66447381|FG000|Overall Study|Unable to wear compression stockings|1|||
23745176|NCT02503215|66447381|FG000|Overall Study|Unable to use positive airway pressure|2|||
23745177|NCT01711736|66447384|FG000|Overall Study|Lost to Follow-up|4|||
23745178|NCT01711736|66447385|FG001|Overall Study|Lost to Follow-up|1|||
23745179|NCT01711736|66447384|FG000|Overall Study|Withdrawal by Subject|6|||
23745180|NCT01711736|66447385|FG001|Overall Study|Withdrawal by Subject|6|||
23745181|NCT01711736|66447384|FG000|Overall Study|Migrated/moved from study area|2|||
23745182|NCT01711736|66447385|FG001|Overall Study|Migrated/moved from study area|1|||
23745183|NCT01326312|66447386|FG000|Overall Study|Adverse Event|11|||
23745184|NCT01326312|66447387|FG001|Overall Study|Adverse Event|11|||
23745185|NCT01326312|66447388|FG002|Overall Study|Adverse Event|1|||
23745186|NCT01326312|66447386|FG000|Overall Study|Withdrawal by Subject|1|||
23745187|NCT01326312|66447387|FG001|Overall Study|Withdrawal by Subject|2|||
23745188|NCT01326312|66447388|FG002|Overall Study|Withdrawal by Subject|1|||
23745189|NCT01326312|66447386|FG000|Overall Study|Protocol Violation|0|||
23745190|NCT01326312|66447387|FG001|Overall Study|Protocol Violation|1|||
23745191|NCT01326312|66447388|FG002|Overall Study|Protocol Violation|0|||
23745192|NCT01326312|66447386|FG000|Overall Study|Lack of Efficacy|13|||
23745193|NCT01326312|66447387|FG001|Overall Study|Lack of Efficacy|7|||
23822468|NCT01420965|66730386|FG001|Overall Study|Adverse Event|1|||
23822469|NCT01420965|66730387|FG002|Overall Study|Adverse Event|0|||
23822470|NCT00796757|66730398|FG000|Overall Study|Withdrawal by Subject|14|||
23822471|NCT00796757|66730398|FG000|Overall Study|Death|61|||
23822472|NCT00796757|66730398|FG000|Overall Study|Protocol Violation|1|||
23822473|NCT00796757|66730398|FG000|Overall Study|Participant noncompliance|1|||
23822474|NCT00796757|66730398|FG000|Overall Study|Investigator's decision|2|||
23822475|NCT00796757|66730398|FG000|Overall Study|Other|7|||
23822476|NCT00442962|66730399|FG000|Overall Study|Pregnancy|1|||
23822477|NCT00442962|66730399|FG000|Overall Study|Lost to Follow-up|7|||
23822478|NCT04825912|66730400|FG000|Overall Study|Death|3|||
23822479|NCT04825912|66730400|FG000|Overall Study|Withdrawal by Subject|1|||
23553267|NCT00827918|65751350|FG002|Overall Study|Protocol Violation|0|||
23553268|NCT00827918|65751348|FG000|Overall Study|Withdrawal by Subject|6|||
23553269|NCT00827918|65751349|FG001|Overall Study|Withdrawal by Subject|2|||
23553270|NCT00827918|65751350|FG002|Overall Study|Withdrawal by Subject|6|||
23553271|NCT00862134|65751351|FG000|Overall Study|Death|1|||
23553272|NCT00862134|65751352|FG001|Overall Study|Death|0|||
23553273|NCT00862134|65751351|FG000|Overall Study|Physician Decision|0|||
23553274|NCT00862134|65751352|FG001|Overall Study|Physician Decision|1|||
23553275|NCT00862134|65751351|FG000|Overall Study|Withdrawal by Subject|1|||
23553276|NCT00862134|65751352|FG001|Overall Study|Withdrawal by Subject|2|||
23553277|NCT00862134|65751351|FG000|Overall Study|Sponsor terminated study|5|||
23553278|NCT00862134|65751352|FG001|Overall Study|Sponsor terminated study|7|||
23553279|NCT00862134|65751351|FG000|Overall Study|Adverse Event|2|||
23553280|NCT00862134|65751352|FG001|Overall Study|Adverse Event|2|||
23553281|NCT00862134|65751351|FG000|Overall Study|Withdrew prior to dosing|2|||
23553282|NCT00862134|65751352|FG001|Overall Study|Withdrew prior to dosing|0|||
23553283|NCT00584727|65751357|FG000|First Intervention|Discontinuation|0|||
23553284|NCT00584727|65751358|FG001|First Intervention|Discontinuation|0|||
23553285|NCT00584727|65751359|FG002|First Intervention|Discontinuation|1|||
23553286|NCT00584727|65751360|FG003|First Intervention|Discontinuation|0|||
23553287|NCT00584727|65751361|FG004|First Intervention|Discontinuation|0|||
23553288|NCT00584727|65751362|FG005|First Intervention|Discontinuation|0|||
23553289|NCT00584727|65751357|FG000|Third Intervention|Protocol Violation|0|||
23553290|NCT00584727|65751358|FG001|Third Intervention|Protocol Violation|0|||
23553291|NCT00584727|65751359|FG002|Third Intervention|Protocol Violation|1|||
23553292|NCT00584727|65751360|FG003|Third Intervention|Protocol Violation|0|||
23553293|NCT00584727|65751361|FG004|Third Intervention|Protocol Violation|4|||
23553294|NCT00584727|65751362|FG005|Third Intervention|Protocol Violation|2|||
23553295|NCT03835533|65751363|FG000|Overall Study|Death|5|||
23553296|NCT03835533|65751364|FG001|Overall Study|Death|10|||
23553297|NCT03835533|65751365|FG002|Overall Study|Death|9|||
23745194|NCT01326312|66447388|FG002|Overall Study|Lack of Efficacy|1|||
23745195|NCT01326312|66447386|FG000|Overall Study|Death|1|||
23745196|NCT01326312|66447387|FG001|Overall Study|Death|0|||
23745197|NCT01326312|66447388|FG002|Overall Study|Death|1|||
23745198|NCT01326312|66447386|FG000|Overall Study|progressive disease|0|||
23553298|NCT03835533|65751363|FG000|Overall Study|Withdrawal by Subject|2|||
23553299|NCT03835533|65751364|FG001|Overall Study|Withdrawal by Subject|2|||
23553300|NCT03835533|65751365|FG002|Overall Study|Withdrawal by Subject|2|||
23553301|NCT03835533|65751363|FG000|Overall Study|Lost to Follow-up|1|||
23553302|NCT03835533|65751364|FG001|Overall Study|Lost to Follow-up|0|||
23553303|NCT03835533|65751365|FG002|Overall Study|Lost to Follow-up|0|||
23553304|NCT00530855|65751368|FG000|Overall Study|Lack of Efficacy|20|||
23822480|NCT00233402|66730401|FG000|Overall Study|No pathology data|12|||
23822481|NCT00233402|66730402|FG001|Overall Study|No pathology data|9|||
23621707|NCT00264498|66000735|FG001|Crossover Treatment|Study closure|1|||
23745199|NCT01326312|66447387|FG001|Overall Study|progressive disease|1|||
23745200|NCT01326312|66447388|FG002|Overall Study|progressive disease|1|||
23745201|NCT01326312|66447386|FG000|Overall Study|Study terminated by Sponsor|8|||
23745202|NCT01326312|66447387|FG001|Overall Study|Study terminated by Sponsor|32|||
23745203|NCT01326312|66447388|FG002|Overall Study|Study terminated by Sponsor|46|||
23822482|NCT00233402|66730401|FG000|Overall Study|No Ta/T1|89|||
23822483|NCT00233402|66730402|FG001|Overall Study|No Ta/T1|94|||
23822484|NCT00233402|66730401|FG000|Overall Study|Lost to follow up etc|3|||
23822485|NCT00233402|66730402|FG001|Overall Study|Lost to follow up etc|21|||
23822486|NCT03323398|66730403|FG000|Overall Study|Other than Specified|0|||
23822487|NCT03323398|66730404|FG001|Overall Study|Other than Specified|1|||
23822488|NCT03323398|66730405|FG002|Overall Study|Other than Specified|2|||
23822489|NCT03323398|66730406|FG003|Overall Study|Other than Specified|0|||
23822490|NCT03323398|66730407|FG004|Overall Study|Other than Specified|0|||
23822491|NCT03323398|66730408|FG005|Overall Study|Other than Specified|0|||
23822492|NCT03323398|66730409|FG006|Overall Study|Other than Specified|1|||
23822493|NCT03323398|66730410|FG007|Overall Study|Other than Specified|0|||
23431843|NCT01545050|65324221|FG004|Overall Study|Lack of Efficacy|2|||
23822494|NCT03323398|66730411|FG008|Overall Study|Other than Specified|2|||
23822495|NCT03323398|66730403|FG000|Overall Study|Lost to Follow-up|1|||
23822496|NCT03323398|66730404|FG001|Overall Study|Lost to Follow-up|2|||
23822497|NCT03323398|66730405|FG002|Overall Study|Lost to Follow-up|1|||
23822498|NCT03323398|66730406|FG003|Overall Study|Lost to Follow-up|0|||
23822499|NCT03323398|66730407|FG004|Overall Study|Lost to Follow-up|0|||
23431844|NCT01545050|65324217|FG000|Overall Study|Adverse Event|1|||
23431845|NCT01545050|65324218|FG001|Overall Study|Adverse Event|1|||
23431846|NCT01545050|65324219|FG002|Overall Study|Adverse Event|2|||
23431847|NCT01545050|65324220|FG003|Overall Study|Adverse Event|2|||
23431848|NCT01545050|65324221|FG004|Overall Study|Adverse Event|0|||
23431849|NCT01545050|65324217|FG000|Overall Study|Discontinued study treatment|1|||
23745204|NCT01326312|66447386|FG000|Overall Study|Treatment arm terminated|19|||
23745205|NCT01326312|66447387|FG001|Overall Study|Treatment arm terminated|0|||
23745206|NCT01326312|66447388|FG002|Overall Study|Treatment arm terminated|0|||
23745207|NCT01326312|66447386|FG000|Overall Study|QTc > 500|0|||
23745208|NCT01326312|66447387|FG001|Overall Study|QTc > 500|1|||
23745209|NCT01326312|66447388|FG002|Overall Study|QTc > 500|0|||
23745210|NCT03358407|66447390|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745211|NCT03358407|66447391|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745212|NCT03358407|66447392|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
23745213|NCT03358407|66447393|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745214|NCT03358407|66447394|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23822500|NCT03323398|66730408|FG005|Overall Study|Lost to Follow-up|0|||
23822501|NCT03323398|66730409|FG006|Overall Study|Lost to Follow-up|0|||
23822502|NCT03323398|66730410|FG007|Overall Study|Lost to Follow-up|0|||
23822503|NCT03323398|66730411|FG008|Overall Study|Lost to Follow-up|0|||
23822504|NCT03323398|66730403|FG000|Overall Study|Death|4|||
23431850|NCT01545050|65324218|FG001|Overall Study|Discontinued study treatment|0|||
23431851|NCT01545050|65324219|FG002|Overall Study|Discontinued study treatment|0|||
23431852|NCT01545050|65324220|FG003|Overall Study|Discontinued study treatment|0|||
23431853|NCT01545050|65324221|FG004|Overall Study|Discontinued study treatment|0|||
23431854|NCT01545050|65324217|FG000|Overall Study|Withdrawal by Subject|1|||
23431855|NCT01545050|65324218|FG001|Overall Study|Withdrawal by Subject|0|||
23431856|NCT01545050|65324219|FG002|Overall Study|Withdrawal by Subject|0|||
23553305|NCT00530855|65751368|FG000|Overall Study|Withdrawal by Subject|30|||
23553306|NCT00530855|65751368|FG000|Overall Study|Fatal Serious AE|3|||
23553307|NCT00530855|65751368|FG000|Overall Study|Non Fatal Serious AE|7|||
23553308|NCT00530855|65751368|FG000|Overall Study|Non Fatal Non Serious AE|12|||
23553309|NCT00530855|65751368|FG000|Overall Study|Protocol Violation|3|||
23553310|NCT00530855|65751368|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
23553311|NCT00530855|65751368|FG000|Overall Study|Lost to Follow-up|9|||
23553312|NCT00530855|65751368|FG000|Overall Study|Other reason for premature termination|17|||
23553313|NCT01860703|65751369|FG000|Overall Study|Adverse Event|1|||
23553314|NCT01860703|65751370|FG001|Overall Study|Adverse Event|4|||
23553315|NCT01860703|65751371|FG002|Overall Study|Adverse Event|0|||
23553316|NCT01860703|65751372|FG003|Overall Study|Adverse Event|2|||
23553317|NCT01860703|65751369|FG000|Overall Study|Withdrawal by Subject|0|||
23553318|NCT01860703|65751370|FG001|Overall Study|Withdrawal by Subject|1|||
23822505|NCT03323398|66730404|FG001|Overall Study|Death|6|||
23822506|NCT03323398|66730405|FG002|Overall Study|Death|2|||
23822507|NCT03323398|66730406|FG003|Overall Study|Death|2|||
23621708|NCT00264498|66000734|FG000|Crossover Treatment|Withdrawal by Subject|1|||
23621709|NCT00264498|66000735|FG001|Crossover Treatment|Withdrawal by Subject|0|||
23621710|NCT01349036|66000736|FG000|Overall Study|Disease progression|13|||
23621711|NCT01349036|66000737|FG001|Overall Study|Disease progression|22|||
23621712|NCT01349036|66000736|FG000|Overall Study|Other|1|||
23621713|NCT01349036|66000737|FG001|Overall Study|Other|0|||
23621714|NCT01349036|66000736|FG000|Overall Study|Withdrawal by Subject|0|||
23621715|NCT01349036|66000737|FG001|Overall Study|Withdrawal by Subject|2|||
23621716|NCT00706914|66000738|FG000|Overall Study|Lack of Efficacy|0|||
23621717|NCT00706914|66000739|FG001|Overall Study|Lack of Efficacy|1|||
23621718|NCT00706914|66000740|FG002|Overall Study|Lack of Efficacy|0|||
23621719|NCT00706914|66000738|FG000|Overall Study|Lost to Follow-up|1|||
23621720|NCT00706914|66000739|FG001|Overall Study|Lost to Follow-up|0|||
23621721|NCT00706914|66000740|FG002|Overall Study|Lost to Follow-up|0|||
23621722|NCT00706914|66000738|FG000|Overall Study|Adverse Event|2|||
23621723|NCT00706914|66000739|FG001|Overall Study|Adverse Event|2|||
23621724|NCT00706914|66000740|FG002|Overall Study|Adverse Event|0|||
23621725|NCT00706914|66000738|FG000|Overall Study|Protocol Violation|3|||
23621726|NCT00706914|66000739|FG001|Overall Study|Protocol Violation|1|||
23621727|NCT00706914|66000740|FG002|Overall Study|Protocol Violation|1|||
23621728|NCT00730847|66000744|FG000|Overall Study|Adverse Event|1|||
23621729|NCT00730847|66000744|FG000|Overall Study|Protocol Violation|2|||
23621730|NCT00730847|66000744|FG000|Overall Study|Withdrawal by Subject|16|||
23621731|NCT00730847|66000744|FG000|Overall Study|Lost to Follow-up|67|||
23621732|NCT00730847|66000744|FG000|Overall Study|Unknown completion status|21|||
23621733|NCT00730847|66000744|FG000|Overall Study|Other|24|||
23621734|NCT00233389|66000745|FG000|Overall Study|Adverse Event|5|||
23621735|NCT00233389|66000746|FG001|Overall Study|Adverse Event|5|||
23621736|NCT00233389|66000745|FG000|Overall Study|Lack of Efficacy|11|||
23621737|NCT00233389|66000746|FG001|Overall Study|Lack of Efficacy|8|||
23621738|NCT00233389|66000745|FG000|Overall Study|Lost to Follow-up|1|||
23621739|NCT00233389|66000746|FG001|Overall Study|Lost to Follow-up|1|||
23745215|NCT03358407|66447395|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745216|NCT03358407|66447396|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745217|NCT03358407|66447397|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745218|NCT03358407|66447398|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745219|NCT03358407|66447399|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23745220|NCT03358407|66447390|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745221|NCT03358407|66447391|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745222|NCT03358407|66447392|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745223|NCT03358407|66447393|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745224|NCT03358407|66447394|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23745225|NCT03358407|66447395|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745226|NCT03358407|66447396|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745227|NCT03358407|66447397|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745228|NCT03358407|66447398|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745229|NCT03358407|66447399|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745230|NCT03358407|66447390|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745231|NCT03358407|66447391|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745232|NCT03358407|66447392|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745233|NCT03358407|66447393|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745234|NCT03358407|66447394|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745235|NCT03358407|66447395|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
23745236|NCT03358407|66447396|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745237|NCT03358407|66447397|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
23745238|NCT03358407|66447398|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23745239|NCT03358407|66447399|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23822508|NCT03323398|66730407|FG004|Overall Study|Death|1|||
23621740|NCT00233389|66000745|FG000|Overall Study|Physician Decision|1|||
23621741|NCT00233389|66000746|FG001|Overall Study|Physician Decision|0|||
23621742|NCT00233389|66000745|FG000|Overall Study|Protocol Violation|0|||
23621743|NCT00233389|66000746|FG001|Overall Study|Protocol Violation|1|||
23621744|NCT00233389|66000745|FG000|Overall Study|Withdrawal by Subject|0|||
23621745|NCT00233389|66000746|FG001|Overall Study|Withdrawal by Subject|1|||
23621746|NCT01960348|66000749|FG000|Overall Study|Adverse event, not serious|2|||
23621747|NCT01960348|66000750|FG001|Overall Study|Adverse event, not serious|2|||
23621748|NCT01960348|66000749|FG000|Overall Study|Adverse event, serious fatal|6|||
23621749|NCT01960348|66000750|FG001|Overall Study|Adverse event, serious fatal|5|||
23621750|NCT01960348|66000749|FG000|Overall Study|Adverse event, serious non-fatal|0|||
23621751|NCT01960348|66000750|FG001|Overall Study|Adverse event, serious non-fatal|3|||
23621752|NCT01960348|66000749|FG000|Overall Study|Withdrawal by Subject|1|||
23621753|NCT01960348|66000750|FG001|Overall Study|Withdrawal by Subject|11|||
23621754|NCT01960348|66000749|FG000|Overall Study|Physician Decision|0|||
23822509|NCT03323398|66730408|FG005|Overall Study|Death|2|||
23822510|NCT03323398|66730409|FG006|Overall Study|Death|0|||
23745240|NCT03358407|66447390|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23621755|NCT01960348|66000750|FG001|Overall Study|Physician Decision|1|||
23621756|NCT01960348|66000749|FG000|Overall Study|Protocol Violation|1|||
23621757|NCT01960348|66000750|FG001|Overall Study|Protocol Violation|0|||
23745241|NCT03358407|66447391|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23745242|NCT03358407|66447392|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23822511|NCT03323398|66730410|FG007|Overall Study|Death|0|||
23822512|NCT03323398|66730411|FG008|Overall Study|Death|6|||
23822513|NCT03323398|66730403|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
23822514|NCT03323398|66730404|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
23822515|NCT03323398|66730405|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
23431857|NCT01545050|65324220|FG003|Overall Study|Withdrawal by Subject|2|||
23745243|NCT03358407|66447393|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23745244|NCT03358407|66447394|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23745245|NCT03358407|66447395|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
23745246|NCT03358407|66447396|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23822516|NCT03323398|66730406|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
23431858|NCT01545050|65324221|FG004|Overall Study|Withdrawal by Subject|1|||
23431859|NCT01545050|65324217|FG000|Overall Study|Participant no longer meets study criteria|0|||
23431860|NCT01545050|65324218|FG001|Overall Study|Participant no longer meets study criteria|2|||
23431861|NCT01545050|65324219|FG002|Overall Study|Participant no longer meets study criteria|0|||
23431862|NCT01545050|65324220|FG003|Overall Study|Participant no longer meets study criteria|0|||
23431863|NCT01545050|65324221|FG004|Overall Study|Participant no longer meets study criteria|1|||
23431864|NCT01545050|65324217|FG000|Overall Study|Administrative reason by sponsor|4|||
23431865|NCT01545050|65324218|FG001|Overall Study|Administrative reason by sponsor|2|||
23431866|NCT01545050|65324219|FG002|Overall Study|Administrative reason by sponsor|3|||
23431867|NCT01545050|65324220|FG003|Overall Study|Administrative reason by sponsor|5|||
23431868|NCT01545050|65324221|FG004|Overall Study|Administrative reason by sponsor|5|||
23431869|NCT00462748|65324222|FG000|Overall Study|Adverse Event|7|||
23431870|NCT00462748|65324223|FG001|Overall Study|Adverse Event|5|||
23431871|NCT00462748|65324224|FG002|Overall Study|Adverse Event|9|||
23431872|NCT00462748|65324222|FG000|Overall Study|Protocol Violation|0|||
23431873|NCT00462748|65324223|FG001|Overall Study|Protocol Violation|2|||
23553319|NCT01860703|65751371|FG002|Overall Study|Withdrawal by Subject|0|||
23553320|NCT01860703|65751372|FG003|Overall Study|Withdrawal by Subject|0|||
23553321|NCT01860703|65751369|FG000|Overall Study|Personal reason|1|||
23553322|NCT01860703|65751370|FG001|Overall Study|Personal reason|0|||
23553323|NCT01860703|65751371|FG002|Overall Study|Personal reason|1|||
23553324|NCT01860703|65751372|FG003|Overall Study|Personal reason|0|||
23553325|NCT00924287|65751376|FG000|Overall Study|Death|1|||
23553326|NCT05711641|65751377|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
23553327|NCT05711641|65751378|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
23553328|NCT05711641|65751377|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
23553329|NCT05711641|65751378|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
23553330|NCT01588184|65751379|FG000|Overall Study|Death|1|||
23553331|NCT01588184|65751380|FG001|Overall Study|Death|0|||
23553332|NCT01588184|65751381|FG002|Overall Study|Death|0|||
23553333|NCT01588184|65751382|FG003|Overall Study|Death|1|||
23553334|NCT01588184|65751383|FG004|Overall Study|Death|1|||
23553335|NCT01588184|65751384|FG005|Overall Study|Death|1|||
23553336|NCT01588184|65751379|FG000|Overall Study|Withdrawal by Subject|2|||
23553337|NCT01588184|65751380|FG001|Overall Study|Withdrawal by Subject|4|||
23553338|NCT01588184|65751381|FG002|Overall Study|Withdrawal by Subject|0|||
23553339|NCT01588184|65751382|FG003|Overall Study|Withdrawal by Subject|1|||
23553340|NCT01588184|65751383|FG004|Overall Study|Withdrawal by Subject|0|||
23553341|NCT01588184|65751384|FG005|Overall Study|Withdrawal by Subject|0|||
23553342|NCT01588184|65751379|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
23553343|NCT01588184|65751380|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
23553344|NCT01588184|65751381|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
23553345|NCT01588184|65751382|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
23553346|NCT01588184|65751383|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
23553347|NCT01588184|65751384|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
23553348|NCT01588184|65751379|FG000|Overall Study|multiple reasons|0|||
23553349|NCT01588184|65751380|FG001|Overall Study|multiple reasons|3|||
23553350|NCT01588184|65751381|FG002|Overall Study|multiple reasons|0|||
23553351|NCT01588184|65751382|FG003|Overall Study|multiple reasons|1|||
23553352|NCT01588184|65751383|FG004|Overall Study|multiple reasons|0|||
23553353|NCT01588184|65751384|FG005|Overall Study|multiple reasons|0|||
23621758|NCT01821729|66000751|FG000|Overall Study|Withdrawal by Subject|1|||
23621759|NCT00280683|66000761|FG000|Overall Study|Withdrawal by Subject|1|||
23621760|NCT00280683|66000762|FG001|Overall Study|Withdrawal by Subject|2|||
23621761|NCT00280683|66000761|FG000|Overall Study|Adverse Event|1|||
23621762|NCT00280683|66000762|FG001|Overall Study|Adverse Event|1|||
23621763|NCT00746356|66000763|FG000|Overall Study|Withdrawal by Subject|2|||
23621764|NCT00746356|66000764|FG001|Overall Study|Withdrawal by Subject|3|||
23621765|NCT00746356|66000763|FG000|Overall Study|Death|7|||
23745247|NCT03358407|66447397|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
23745248|NCT03358407|66447398|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23745249|NCT03358407|66447399|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23745250|NCT03358407|66447390|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23553354|NCT03263429|65751386|FG000|Overall Study|Withdrawal by Subject|0|||
23553355|NCT03263429|65751387|FG001|Overall Study|Withdrawal by Subject|1|||
23553356|NCT03263429|65751388|FG002|Overall Study|Withdrawal by Subject|0|||
23553357|NCT03263429|65751386|FG000|Overall Study|Follow-Up Period Completed|0|||
23553358|NCT03263429|65751387|FG001|Overall Study|Follow-Up Period Completed|2|||
23553359|NCT03263429|65751388|FG002|Overall Study|Follow-Up Period Completed|0|||
23553360|NCT03263429|65751386|FG000|Overall Study|Death|3|||
23553361|NCT03263429|65751387|FG001|Overall Study|Death|5|||
23553362|NCT03263429|65751388|FG002|Overall Study|Death|16|||
23553363|NCT03263429|65751386|FG000|Overall Study|Participant unable to return|0|||
23553364|NCT03263429|65751387|FG001|Overall Study|Participant unable to return|0|||
23553365|NCT03263429|65751388|FG002|Overall Study|Participant unable to return|1|||
23553366|NCT03263429|65751386|FG000|Overall Study|Study Closed|0|||
23745251|NCT03358407|66447391|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745252|NCT03358407|66447392|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745253|NCT03358407|66447393|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745254|NCT03358407|66447394|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745255|NCT03358407|66447395|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23745256|NCT03358407|66447396|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23553367|NCT03263429|65751387|FG001|Overall Study|Study Closed|0|||
23553368|NCT03263429|65751388|FG002|Overall Study|Study Closed|1|||
23553369|NCT03822533|65751391|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
23553370|NCT03822533|65751392|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
23553371|NCT03822533|65751391|FG000|3 Month Follow-up|Lost to Follow-up|2|||
23553372|NCT03822533|65751392|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23553373|NCT03822533|65751391|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23553374|NCT03822533|65751392|FG001|6 Month Follow-up|Lost to Follow-up|0|||
23553375|NCT03822533|65751391|FG000|12 Month Follow-up|Lost to Follow-up|2|||
23553376|NCT03822533|65751392|FG001|12 Month Follow-up|Lost to Follow-up|3|||
23553377|NCT03822533|65751391|FG000|12 Month Follow-up|Pregnancy|0|||
23553378|NCT03822533|65751392|FG001|12 Month Follow-up|Pregnancy|1|||
23553379|NCT03822533|65751391|FG000|12 Month Follow-up|Surgery|2|||
23553380|NCT03822533|65751392|FG001|12 Month Follow-up|Surgery|0|||
23553381|NCT03822533|65751391|FG000|12 Month Follow-up|Wrong address|1|||
23553382|NCT03822533|65751392|FG001|12 Month Follow-up|Wrong address|0|||
23553383|NCT03822533|65751391|FG000|12 Month Follow-up|No symptoms|1|||
23553384|NCT03822533|65751392|FG001|12 Month Follow-up|No symptoms|0|||
23553385|NCT03822533|65751391|FG000|12 Month Follow-up|Changed primary care center|0|||
23553386|NCT03822533|65751392|FG001|12 Month Follow-up|Changed primary care center|1|||
23553387|NCT02844946|65751395|FG000|Overall Study|Lost to Follow-up|7|||
23553388|NCT02844946|65751396|FG001|Overall Study|Lost to Follow-up|0|||
23553389|NCT01738984|65751405|FG000|Overall Study|Pregnancy|4|||
23553390|NCT01738984|65751406|FG001|Overall Study|Pregnancy|0|||
23553391|NCT01738984|65751405|FG000|Overall Study|Withdrawal by Subject|1|||
23553392|NCT01738984|65751406|FG001|Overall Study|Withdrawal by Subject|0|||
23553393|NCT01738984|65751405|FG000|Overall Study|Lost to Follow-up|59|||
23553394|NCT01738984|65751406|FG001|Overall Study|Lost to Follow-up|39|||
23553395|NCT00701038|65751407|FG000|Overall Study|study amended pilot group of patients|4|||
23553396|NCT00701038|65751408|FG001|Overall Study|study amended pilot group of patients|4|||
23553397|NCT01059175|65751414|FG000|Overall Study|Death|17|||
23553398|NCT01059175|65751415|FG001|Overall Study|Death|17|||
23553399|NCT01059175|65751414|FG000|Overall Study|Adverse Event|4|||
23553400|NCT01059175|65751415|FG001|Overall Study|Adverse Event|2|||
23553401|NCT01059175|65751414|FG000|Overall Study|Lost to Follow-up|0|||
23553402|NCT01059175|65751415|FG001|Overall Study|Lost to Follow-up|1|||
23553403|NCT01939548|65751416|FG000|Overall Study|Non compliance|0|||
23553404|NCT01939548|65751417|FG001|Overall Study|Non compliance|2|||
23553405|NCT01939548|65751418|FG002|Overall Study|Non compliance|0|||
23553406|NCT01939548|65751416|FG000|Overall Study|Study Terminated by Sponsor|17|||
23621766|NCT00746356|66000764|FG001|Overall Study|Death|3|||
23621767|NCT00746356|66000763|FG000|Overall Study|Lost to Follow-up|1|||
23621768|NCT00746356|66000764|FG001|Overall Study|Lost to Follow-up|0|||
23553407|NCT01939548|65751417|FG001|Overall Study|Study Terminated by Sponsor|19|||
23553408|NCT01939548|65751418|FG002|Overall Study|Study Terminated by Sponsor|12|||
23621769|NCT00746356|66000763|FG000|Overall Study|Removal of Device|0|||
23553409|NCT01939548|65751416|FG000|Overall Study|Insufficient Clinical Response|1|||
23553410|NCT01939548|65751417|FG001|Overall Study|Insufficient Clinical Response|0|||
23553411|NCT01939548|65751418|FG002|Overall Study|Insufficient Clinical Response|0|||
23553412|NCT01939548|65751416|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23553413|NCT01939548|65751417|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23553414|NCT01939548|65751418|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
23553415|NCT01939548|65751416|FG000|Overall Study|Withdrawal by Subject|4|||
23553416|NCT01939548|65751417|FG001|Overall Study|Withdrawal by Subject|4|||
23553417|NCT01939548|65751418|FG002|Overall Study|Withdrawal by Subject|1|||
23553418|NCT01939548|65751416|FG000|Overall Study|Protocol Violation|7|||
23553419|NCT01939548|65751417|FG001|Overall Study|Protocol Violation|6|||
23553420|NCT01939548|65751418|FG002|Overall Study|Protocol Violation|5|||
23553421|NCT01939548|65751416|FG000|Overall Study|Lost to Follow-up|5|||
23553422|NCT01939548|65751417|FG001|Overall Study|Lost to Follow-up|5|||
23553423|NCT01939548|65751418|FG002|Overall Study|Lost to Follow-up|3|||
23553424|NCT01939548|65751416|FG000|Overall Study|Adverse Event|2|||
23553425|NCT01939548|65751417|FG001|Overall Study|Adverse Event|9|||
23553426|NCT01939548|65751418|FG002|Overall Study|Adverse Event|7|||
23553427|NCT01939548|65751416|FG000|Overall Study|Death|0|||
23553428|NCT01939548|65751417|FG001|Overall Study|Death|0|||
23553429|NCT01939548|65751418|FG002|Overall Study|Death|1|||
23553430|NCT01939548|65751416|FG000|Overall Study|Participant dropped|0|||
23553431|NCT01939548|65751417|FG001|Overall Study|Participant dropped|0|||
23553432|NCT01939548|65751418|FG002|Overall Study|Participant dropped|1|||
23553433|NCT01939548|65751416|FG000|Overall Study|Participant unwilling to continue|0|||
23553434|NCT01939548|65751417|FG001|Overall Study|Participant unwilling to continue|1|||
23553435|NCT01939548|65751418|FG002|Overall Study|Participant unwilling to continue|0|||
23553436|NCT01939548|65751416|FG000|Overall Study|Participant withdrew consent|0|||
23553437|NCT01939548|65751417|FG001|Overall Study|Participant withdrew consent|2|||
23553438|NCT01939548|65751418|FG002|Overall Study|Participant withdrew consent|0|||
23553439|NCT01939548|65751416|FG000|Overall Study|Did not complete follow-up|0|||
23553440|NCT01939548|65751417|FG001|Overall Study|Did not complete follow-up|1|||
23553441|NCT01939548|65751418|FG002|Overall Study|Did not complete follow-up|0|||
23553442|NCT00713648|65751422|FG000|Overall Study|Adverse Event|1|||
23553443|NCT00713648|65751422|FG000|Overall Study|Unclassified|2|||
23553444|NCT00713648|65751422|FG000|Overall Study|According to Protocol|2|||
23553445|NCT00713648|65751422|FG000|Overall Study|Development of antibodies|3|||
23553446|NCT00483184|65751423|FG000|Overall Study|Withdrawal by Subject|2|||
23553447|NCT00483184|65751424|FG001|Overall Study|Withdrawal by Subject|2|||
23553448|NCT00483184|65751425|FG002|Overall Study|Withdrawal by Subject|0|||
23553449|NCT00483184|65751423|FG000|Overall Study|Lost to Follow-up|1|||
23553450|NCT00483184|65751424|FG001|Overall Study|Lost to Follow-up|0|||
23553451|NCT00483184|65751425|FG002|Overall Study|Lost to Follow-up|0|||
23553452|NCT00483184|65751423|FG000|Overall Study|Adverse Event|1|||
23553453|NCT00483184|65751424|FG001|Overall Study|Adverse Event|2|||
23553454|NCT00483184|65751425|FG002|Overall Study|Adverse Event|2|||
23553455|NCT00483184|65751423|FG000|Overall Study|Protocol Violation|1|||
23553456|NCT00483184|65751424|FG001|Overall Study|Protocol Violation|0|||
23553457|NCT00483184|65751425|FG002|Overall Study|Protocol Violation|1|||
23553458|NCT03311373|65751428|FG000|Overall Study|Adverse Event|1|||
23553459|NCT03311373|65751428|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
23553460|NCT03311373|65751428|FG000|Overall Study|Lost to Follow-up|1|||
23553461|NCT03311373|65751428|FG000|Overall Study|Physician Decision|1|||
23553462|NCT03311373|65751428|FG000|Overall Study|Withdrawal by Subject|3|||
23553463|NCT02207816|65751431|FG000|Overall Study|Serious Adverse Event|0|||
23553464|NCT02207816|65751432|FG001|Overall Study|Serious Adverse Event|5|||
23553465|NCT02207816|65751433|FG002|Overall Study|Serious Adverse Event|2|||
23553466|NCT02207816|65751431|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23553467|NCT02207816|65751432|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23553468|NCT02207816|65751433|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23745257|NCT03358407|66447397|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745258|NCT03358407|66447398|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23745259|NCT03358407|66447399|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23553469|NCT02207816|65751431|FG000|Overall Study|Withdrawal by Subject|4|||
23553470|NCT02207816|65751432|FG001|Overall Study|Withdrawal by Subject|9|||
23553471|NCT02207816|65751433|FG002|Overall Study|Withdrawal by Subject|7|||
23553472|NCT02207816|65751431|FG000|Overall Study|Migrated/Moved From Study Area|41|||
23553473|NCT02207816|65751432|FG001|Overall Study|Migrated/Moved From Study Area|60|||
23553474|NCT02207816|65751433|FG002|Overall Study|Migrated/Moved From Study Area|51|||
23553475|NCT02207816|65751431|FG000|Overall Study|Lost to Follow-up|3|||
23553476|NCT02207816|65751432|FG001|Overall Study|Lost to Follow-up|9|||
23553477|NCT02207816|65751433|FG002|Overall Study|Lost to Follow-up|1|||
23553478|NCT02207816|65751431|FG000|Overall Study|Other|1|||
23553479|NCT02207816|65751432|FG001|Overall Study|Other|2|||
23553480|NCT02207816|65751433|FG002|Overall Study|Other|4|||
23553481|NCT02085252|65751437|FG000|Overall Study|Withdrawal of Consent|1|||
23431874|NCT00462748|65324224|FG002|Overall Study|Protocol Violation|1|||
23431875|NCT00462748|65324222|FG000|Overall Study|Withdrew consent|3|||
23431876|NCT00462748|65324223|FG001|Overall Study|Withdrew consent|3|||
23431877|NCT00462748|65324224|FG002|Overall Study|Withdrew consent|0|||
23431878|NCT00462748|65324222|FG000|Overall Study|Lost to Follow-up|1|||
23431879|NCT00462748|65324223|FG001|Overall Study|Lost to Follow-up|1|||
23431880|NCT00462748|65324224|FG002|Overall Study|Lost to Follow-up|1|||
23431881|NCT00462748|65324222|FG000|Overall Study|Discontinued after 41 days Rx|1|||
23431882|NCT00462748|65324223|FG001|Overall Study|Discontinued after 41 days Rx|0|||
23431883|NCT00462748|65324224|FG002|Overall Study|Discontinued after 41 days Rx|0|||
23431884|NCT00025155|65324225|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
23431885|NCT00025155|65324225|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
23431886|NCT00444067|65324234|FG000|Overall Study|Lost to Follow-up|0|||
23431887|NCT00444067|65324235|FG001|Overall Study|Lost to Follow-up|1|||
23431888|NCT00975143|65324236|FG000|Overall Study|Adverse Event|19|||
23431889|NCT00975143|65324237|FG001|Overall Study|Adverse Event|15|||
23431890|NCT00975143|65324236|FG000|Overall Study|Withdrawal by Subject|15|||
23431891|NCT00975143|65324237|FG001|Overall Study|Withdrawal by Subject|15|||
23431892|NCT00975143|65324236|FG000|Overall Study|Lost to Follow-up|20|||
23431893|NCT00975143|65324237|FG001|Overall Study|Lost to Follow-up|16|||
23431894|NCT00975143|65324236|FG000|Overall Study|Non-compliance|5|||
23431895|NCT00975143|65324237|FG001|Overall Study|Non-compliance|8|||
23431896|NCT00975143|65324236|FG000|Overall Study|Physician Decision|1|||
23431897|NCT00975143|65324237|FG001|Overall Study|Physician Decision|2|||
23431898|NCT00975143|65324236|FG000|Overall Study|Details not available|10|||
23431899|NCT00975143|65324237|FG001|Overall Study|Details not available|4|||
23431900|NCT00871923|65324241|FG000|Overall Study|Death|1|||
23431901|NCT00871923|65324241|FG000|Overall Study|Withdrawal by Subject|1|||
23431902|NCT04881747|65324242|FG000|Period 2 Washout|Adverse Event|1|||
23431903|NCT04881747|65324243|FG001|Period 2 Washout|Adverse Event|0|||
23431904|NCT04881747|65324244|FG002|Period 2 Washout|Adverse Event|0|||
23431905|NCT04881747|65324245|FG003|Period 2 Washout|Adverse Event|0|||
23431906|NCT04881747|65324246|FG004|Period 2 Washout|Adverse Event|1|||
23431907|NCT04881747|65324247|FG005|Period 2 Washout|Adverse Event|0|||
23431908|NCT04881747|65324242|FG000|Period 2 Washout|Withdrawal by Subject|1|||
23431909|NCT04881747|65324243|FG001|Period 2 Washout|Withdrawal by Subject|0|||
23431910|NCT04881747|65324244|FG002|Period 2 Washout|Withdrawal by Subject|0|||
23431911|NCT04881747|65324245|FG003|Period 2 Washout|Withdrawal by Subject|1|||
23431912|NCT04881747|65324246|FG004|Period 2 Washout|Withdrawal by Subject|0|||
23431913|NCT04881747|65324247|FG005|Period 2 Washout|Withdrawal by Subject|0|||
23431914|NCT02469415|65324248|FG000|Overall Study|Withdrawal by Subject|1|||
23431915|NCT02469415|65324248|FG000|Overall Study|Investigational agent placed on hold|2|||
23431916|NCT03159104|65324249|FG000|Overall Study|Violation of inclusion criteria|1|||
23431917|NCT03159104|65324250|FG001|Overall Study|Violation of inclusion criteria|2|||
23745260|NCT03358407|66447390|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745261|NCT03358407|66447391|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745262|NCT03358407|66447392|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23431918|NCT00454584|65327453|FG000|Controlled Period|Adverse Event|5|||
23431919|NCT00454584|65327454|FG001|Controlled Period|Adverse Event|2|||
23431920|NCT00454584|65327455|FG002|Controlled Period|Adverse Event|1|||
23431921|NCT00454584|65327456|FG003|Controlled Period|Adverse Event|0|||
23431922|NCT00454584|65327457|FG004|Controlled Period|Adverse Event|0|||
23431923|NCT00454584|65327458|FG005|Controlled Period|Adverse Event|0|||
23431924|NCT00454584|65327453|FG000|Controlled Period|Lost to Follow-up|1|||
23745263|NCT03358407|66447393|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745264|NCT03358407|66447394|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745265|NCT03358407|66447395|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
23745266|NCT03358407|66447396|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
23745267|NCT03358407|66447397|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
23745268|NCT03358407|66447398|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745269|NCT03358407|66447399|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23745270|NCT01733758|66447405|FG000|Overall Study|Adverse Event|5|||
23431925|NCT00454584|65327454|FG001|Controlled Period|Lost to Follow-up|2|||
23431926|NCT00454584|65327455|FG002|Controlled Period|Lost to Follow-up|2|||
23431927|NCT00454584|65327456|FG003|Controlled Period|Lost to Follow-up|0|||
23431928|NCT00454584|65327457|FG004|Controlled Period|Lost to Follow-up|0|||
23431929|NCT00454584|65327458|FG005|Controlled Period|Lost to Follow-up|0|||
23431930|NCT00454584|65327453|FG000|Controlled Period|Other|5|||
23431931|NCT00454584|65327454|FG001|Controlled Period|Other|4|||
23431932|NCT00454584|65327455|FG002|Controlled Period|Other|2|||
23431933|NCT00454584|65327456|FG003|Controlled Period|Other|0|||
23431934|NCT00454584|65327457|FG004|Controlled Period|Other|0|||
23431935|NCT00454584|65327458|FG005|Controlled Period|Other|0|||
23431936|NCT00454584|65327453|FG000|After Controlled Period|Adverse Event|0|||
23431937|NCT00454584|65327454|FG001|After Controlled Period|Adverse Event|0|||
23822517|NCT03323398|66730407|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
23822518|NCT03323398|66730408|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
23553482|NCT02085252|65751438|FG001|Overall Study|Withdrawal of Consent|0|||
23553483|NCT02085252|65751437|FG000|Overall Study|Adverse Event|0|||
23553484|NCT02085252|65751438|FG001|Overall Study|Adverse Event|1|||
23822519|NCT03323398|66730409|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
23822520|NCT03323398|66730410|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
23822521|NCT03323398|66730411|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
23822522|NCT03323398|66730403|FG000|Overall Study|Withdrawal by Subject|2|||
23822523|NCT03323398|66730404|FG001|Overall Study|Withdrawal by Subject|1|||
23431938|NCT00454584|65327455|FG002|After Controlled Period|Adverse Event|0|||
23621770|NCT00746356|66000764|FG001|Overall Study|Removal of Device|1|||
23621771|NCT00746356|66000763|FG000|Overall Study|Patient relocated|1|||
23621772|NCT00746356|66000764|FG001|Overall Study|Patient relocated|0|||
23621773|NCT00001941|66000765|FG000|Overall Study|not treated- rapidly progressing disease|0|||
23621774|NCT00001941|66000766|FG001|Overall Study|not treated- rapidly progressing disease|0|||
23621775|NCT00001941|66000767|FG002|Overall Study|not treated- rapidly progressing disease|0|||
23621776|NCT00001941|66000768|FG003|Overall Study|not treated- rapidly progressing disease|0|||
23621777|NCT00001941|66000769|FG004|Overall Study|not treated- rapidly progressing disease|1|||
23621778|NCT00619983|66000770|FG000|Test Drug Alone|Withdrawal by Subject|1|||
23621779|NCT00619983|66000771|FG001|Test Drug Alone|Withdrawal by Subject|0|||
23621780|NCT00619983|66000772|FG002|Test Drug Alone|Withdrawal by Subject|0|||
23745271|NCT01733758|66447406|FG001|Overall Study|Adverse Event|7|||
23745272|NCT01733758|66447407|FG002|Overall Study|Adverse Event|8|||
23745273|NCT01733758|66447408|FG003|Overall Study|Adverse Event|1|||
23745274|NCT01733758|66447405|FG000|Overall Study|Withdrawal by Subject|1|||
23745275|NCT01733758|66447406|FG001|Overall Study|Withdrawal by Subject|1|||
23431939|NCT00454584|65327456|FG003|After Controlled Period|Adverse Event|9|||
23431940|NCT00454584|65327457|FG004|After Controlled Period|Adverse Event|3|||
23431941|NCT00454584|65327458|FG005|After Controlled Period|Adverse Event|9|||
23431942|NCT00454584|65327453|FG000|After Controlled Period|Lack of Efficacy|0|||
23431943|NCT00454584|65327454|FG001|After Controlled Period|Lack of Efficacy|0|||
23431944|NCT00454584|65327455|FG002|After Controlled Period|Lack of Efficacy|0|||
23553485|NCT02085252|65751437|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
23553486|NCT02085252|65751438|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
23553487|NCT02085252|65751437|FG000|Overall Study|Reason Not Specified|0|||
23553488|NCT02085252|65751438|FG001|Overall Study|Reason Not Specified|1|||
23553489|NCT02085252|65751437|FG000|Overall Study|Reason Unknown|0|||
23553490|NCT02085252|65751438|FG001|Overall Study|Reason Unknown|1|||
23745276|NCT01733758|66447407|FG002|Overall Study|Withdrawal by Subject|5|||
23745277|NCT01733758|66447408|FG003|Overall Study|Withdrawal by Subject|3|||
23553491|NCT01003899|65751439|FG000|Overall Study|Other Adverse Event|8|||
23553492|NCT01003899|65751439|FG000|Overall Study|Not entered|4|||
23553493|NCT01003899|65751439|FG000|Overall Study|Not treated|1|||
23553494|NCT01003899|65751439|FG000|Overall Study|Progressive disease|34|||
23553495|NCT03141359|65751451|FG000|Overall Study|Death|32|||
23745278|NCT01733758|66447405|FG000|Overall Study|Persistent Hyperglycemia|3|||
23822524|NCT03323398|66730405|FG002|Overall Study|Withdrawal by Subject|3|||
23822525|NCT03323398|66730406|FG003|Overall Study|Withdrawal by Subject|0|||
23822526|NCT03323398|66730407|FG004|Overall Study|Withdrawal by Subject|0|||
23822527|NCT03323398|66730408|FG005|Overall Study|Withdrawal by Subject|1|||
23822528|NCT03323398|66730409|FG006|Overall Study|Withdrawal by Subject|0|||
23822529|NCT03323398|66730410|FG007|Overall Study|Withdrawal by Subject|0|||
23822530|NCT03323398|66730411|FG008|Overall Study|Withdrawal by Subject|0|||
23822531|NCT03323398|66730403|FG000|Overall Study|Participant was Put on Hospice|0|||
23822532|NCT03323398|66730404|FG001|Overall Study|Participant was Put on Hospice|0|||
23822533|NCT03323398|66730405|FG002|Overall Study|Participant was Put on Hospice|0|||
23822534|NCT03323398|66730406|FG003|Overall Study|Participant was Put on Hospice|0|||
23431945|NCT00454584|65327456|FG003|After Controlled Period|Lack of Efficacy|1|||
23431946|NCT00454584|65327457|FG004|After Controlled Period|Lack of Efficacy|0|||
23431947|NCT00454584|65327458|FG005|After Controlled Period|Lack of Efficacy|0|||
23431948|NCT00454584|65327453|FG000|After Controlled Period|Lost to Follow-up|0|||
23553496|NCT03141359|65751451|FG000|Overall Study|Still On Study (in follow up)|29|||
23553497|NCT00499031|65751452|FG000|Overall Study|Improper pre-protocol treatment|1|||
23553498|NCT00499031|65751452|FG000|Overall Study|Required test not done|1|||
23553499|NCT00499031|65751452|FG000|Overall Study|Never treated|1|||
23553500|NCT04570436|65754510|FG000|Overall Study|Adverse Event|0|||
23621781|NCT00619983|66000773|FG003|Test Drug Alone|Withdrawal by Subject|1|||
23621782|NCT00619983|66000770|FG000|Test Drug Alone|Failure of daily diary device|1|||
23621783|NCT00619983|66000771|FG001|Test Drug Alone|Failure of daily diary device|1|||
23621784|NCT00619983|66000772|FG002|Test Drug Alone|Failure of daily diary device|2|||
23621785|NCT00619983|66000773|FG003|Test Drug Alone|Failure of daily diary device|2|||
23745279|NCT01733758|66447406|FG001|Overall Study|Persistent Hyperglycemia|2|||
23745280|NCT01733758|66447407|FG002|Overall Study|Persistent Hyperglycemia|0|||
23745281|NCT01733758|66447408|FG003|Overall Study|Persistent Hyperglycemia|0|||
23745282|NCT01733758|66447405|FG000|Overall Study|Protocol Violation|0|||
23745283|NCT01733758|66447406|FG001|Overall Study|Protocol Violation|1|||
23745284|NCT01733758|66447407|FG002|Overall Study|Protocol Violation|2|||
23745285|NCT01733758|66447408|FG003|Overall Study|Protocol Violation|2|||
23745286|NCT01733758|66447405|FG000|Overall Study|Non-compliance|1|||
23745287|NCT01733758|66447406|FG001|Overall Study|Non-compliance|0|||
23745288|NCT01733758|66447407|FG002|Overall Study|Non-compliance|0|||
23745289|NCT01733758|66447408|FG003|Overall Study|Non-compliance|0|||
23745290|NCT01733758|66447405|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
23745291|NCT01733758|66447406|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
23745292|NCT01733758|66447407|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
23745293|NCT01733758|66447408|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
23745294|NCT01733758|66447405|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
23621786|NCT00702650|66000784|FG000|Overall Study|Withdrawal by Subject|9|||
23621787|NCT00702650|66000784|FG000|Overall Study|Non-Compliance of Study Drug|3|||
23745295|NCT01733758|66447406|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
23745296|NCT01733758|66447407|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
23745297|NCT01733758|66447408|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
23745298|NCT02184988|66447409|FG000|Overall Study|Pregnancy|2|||
23745299|NCT02184988|66447409|FG000|Overall Study|Adverse Event|2|||
23745300|NCT02184988|66447409|FG000|Overall Study|moving away/travelling/unable to complet|6|||
23745301|NCT02184988|66447409|FG000|Overall Study|work scheduling issues|4|||
23431949|NCT00454584|65327454|FG001|After Controlled Period|Lost to Follow-up|0|||
23431950|NCT00454584|65327455|FG002|After Controlled Period|Lost to Follow-up|0|||
23431951|NCT00454584|65327456|FG003|After Controlled Period|Lost to Follow-up|2|||
23431952|NCT00454584|65327457|FG004|After Controlled Period|Lost to Follow-up|4|||
23431953|NCT00454584|65327458|FG005|After Controlled Period|Lost to Follow-up|6|||
23431954|NCT00454584|65327453|FG000|After Controlled Period|Other|0|||
23431955|NCT00454584|65327454|FG001|After Controlled Period|Other|0|||
23431956|NCT00454584|65327455|FG002|After Controlled Period|Other|0|||
23431957|NCT00454584|65327456|FG003|After Controlled Period|Other|1|||
23431958|NCT00454584|65327457|FG004|After Controlled Period|Other|0|||
23431959|NCT00454584|65327458|FG005|After Controlled Period|Other|0|||
23431960|NCT00454584|65327453|FG000|After Controlled Period|Other|0|||
23431961|NCT00454584|65327454|FG001|After Controlled Period|Other|0|||
23431962|NCT00454584|65327455|FG002|After Controlled Period|Other|0|||
23431963|NCT00454584|65327456|FG003|After Controlled Period|Other|13|||
23431964|NCT00454584|65327457|FG004|After Controlled Period|Other|5|||
23431965|NCT00454584|65327458|FG005|After Controlled Period|Other|17|||
23431966|NCT00330668|65327459|FG000|BID Dosing Period|Adverse Event|1|||
23431967|NCT00330668|65327459|FG000|BID Dosing Period|Lost to Follow-up|7|||
23431968|NCT00330668|65327459|FG000|BID Dosing Period|Non-Compliance|5|||
23431969|NCT00330668|65327459|FG000|BID Dosing Period|Withdrawal by Subject|19|||
23431970|NCT00330668|65327459|FG000|BID Dosing Period|Sponsor's decision|1|||
23621788|NCT00702650|66000784|FG000|Overall Study|Lost to Follow-up|2|||
23745302|NCT02184988|66447409|FG000|Overall Study|various other reasons|9|||
23745303|NCT02184988|66447409|FG000|Overall Study|Lost to Follow-up|32|||
23745304|NCT02046993|66447416|FG000|Overall Study|Withdrawal by Subject|2|||
23745305|NCT02046993|66447417|FG001|Overall Study|Withdrawal by Subject|10|||
23745306|NCT02046993|66447416|FG000|Overall Study|Lost to Follow-up|1|||
23745307|NCT02046993|66447417|FG001|Overall Study|Lost to Follow-up|1|||
23745308|NCT02158949|66447419|FG000|Overall Study|Withdrawal by Subject|1|||
23745309|NCT02158949|66447420|FG001|Overall Study|Withdrawal by Subject|0|||
23745310|NCT02158949|66447419|FG000|Overall Study|Lost to Follow-up|5|||
23745311|NCT02158949|66447420|FG001|Overall Study|Lost to Follow-up|11|||
23745312|NCT01871870|66447430|FG000|Overall Study|Hardware issues|7|||
23745313|NCT01871870|66447430|FG000|Overall Study|hyperglycemia|2|||
23745314|NCT00812968|66447431|FG000|Overall Study|Relapse after erythroid response|6|||
23745315|NCT00812968|66447431|FG000|Overall Study|Disease progression|1|||
23745316|NCT00812968|66447431|FG000|Overall Study|No further treatment required|1|||
23745317|NCT00812968|66447431|FG000|Overall Study|Study closed due to marketing approval|3|||
23745318|NCT00792467|66447434|FG000|Overall Study|progression of disease|17|||
23745319|NCT00792467|66447434|FG000|Overall Study|Adverse Event|1|||
23745320|NCT00792467|66447434|FG000|Overall Study|patient request|1|||
23745321|NCT00792467|66447434|FG000|Overall Study|Lost to Follow-up|1|||
23745322|NCT00792467|66447434|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
23745323|NCT00792467|66447434|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
23431971|NCT00330668|65327459|FG000|BID Dosing Period|Other|3|||
23431972|NCT00330668|65327459|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
23431973|NCT00330668|65327459|FG000|QD Dosing Period|Other|1|||
23431974|NCT00330668|65327459|FG000|QD Dosing Period|Withdrawal by Subject|1|||
23431975|NCT00330668|65327459|FG000|QD Dosing Period|Lost to Follow-up|2|||
23431976|NCT00387647|65327460|FG000|Overall Study|Death|18|||
23621789|NCT00702650|66000784|FG000|Overall Study|Non-Compliance with Site Directives|1|||
23745324|NCT01339273|66447435|FG000|Overall Study|Lost to Follow-up|8|||
23745325|NCT01339273|66447436|FG001|Overall Study|Lost to Follow-up|8|||
23745326|NCT02120456|66447437|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745327|NCT02120456|66447438|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745328|NCT02120456|66447439|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745329|NCT02120456|66447440|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745330|NCT02120456|66447441|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745331|NCT02120456|66447442|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745332|NCT02120456|66447443|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
23745333|NCT02120456|66447444|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745334|NCT02120456|66447445|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23745335|NCT02120456|66447437|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745336|NCT02120456|66447438|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745337|NCT02120456|66447439|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745338|NCT02120456|66447440|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745339|NCT02120456|66447441|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23553501|NCT04570436|65754511|FG001|Overall Study|Adverse Event|0|||
23553502|NCT04570436|65754512|FG002|Overall Study|Adverse Event|1|||
23553503|NCT04570436|65754513|FG003|Overall Study|Adverse Event|0|||
23553504|NCT04570436|65754514|FG004|Overall Study|Adverse Event|0|||
23553505|NCT04570436|65754515|FG005|Overall Study|Adverse Event|0|||
23553506|NCT04570436|65754516|FG006|Overall Study|Adverse Event|0|||
23553507|NCT04570436|65754517|FG007|Overall Study|Adverse Event|0|||
23553508|NCT04570436|65754518|FG008|Overall Study|Adverse Event|0|||
23553509|NCT04570436|65754519|FG009|Overall Study|Adverse Event|0|||
23553510|NCT04570436|65754510|FG000|Overall Study|Physician Decision|1|||
23553511|NCT04570436|65754511|FG001|Overall Study|Physician Decision|0|||
23553512|NCT04570436|65754512|FG002|Overall Study|Physician Decision|0|||
23553513|NCT04570436|65754513|FG003|Overall Study|Physician Decision|0|||
23553514|NCT04570436|65754514|FG004|Overall Study|Physician Decision|0|||
23553515|NCT04570436|65754515|FG005|Overall Study|Physician Decision|0|||
23553516|NCT04570436|65754516|FG006|Overall Study|Physician Decision|0|||
23553517|NCT04570436|65754517|FG007|Overall Study|Physician Decision|0|||
23745340|NCT02120456|66447442|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745341|NCT02120456|66447443|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
23745342|NCT02120456|66447444|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745343|NCT02120456|66447445|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23745344|NCT02120456|66447437|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745345|NCT02120456|66447438|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745346|NCT02120456|66447439|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745347|NCT02120456|66447440|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745348|NCT02120456|66447441|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745349|NCT02120456|66447442|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745350|NCT02120456|66447443|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745351|NCT02120456|66447444|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23745352|NCT02120456|66447445|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
23745353|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
23745354|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
23745355|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
23745356|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
23745357|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
23745358|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
23745359|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
23745360|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
23745361|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
23745362|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
23745363|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
23745364|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
23745365|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
23745366|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
23745367|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
23745368|NCT01694849|66447446|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
23745369|NCT01694849|66447447|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
23553518|NCT04570436|65754518|FG008|Overall Study|Physician Decision|0|||
23553519|NCT04570436|65754519|FG009|Overall Study|Physician Decision|0|||
23431977|NCT01440881|65327461|FG000|Overall Study|Death|0|||
23431978|NCT01440881|65327462|FG001|Overall Study|Death|1|||
23553520|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
23553521|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
23553522|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
23431979|NCT01141478|65327463|FG000|Overall Study|Withdrawal by Subject|1|||
23745370|NCT01694849|66447448|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
23745371|NCT01694849|66447446|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
23431980|NCT01141478|65327464|FG001|Overall Study|Withdrawal by Subject|1|||
23431981|NCT03480009|65327465|FG000|Overall Study|Lost to Follow-up|4|||
23431982|NCT03480009|65327466|FG001|Overall Study|Lost to Follow-up|5|||
23431983|NCT03480009|65327467|FG002|Overall Study|Lost to Follow-up|4|||
23431984|NCT03480009|65327468|FG003|Overall Study|Lost to Follow-up|0|||
23431985|NCT02745535|65327469|FG000|Overall Study|Death|1|||
23431986|NCT02745535|65327469|FG000|Overall Study|Adverse Event|3|||
23431987|NCT02745535|65327469|FG000|Overall Study|Lost to Follow-up|2|||
23431988|NCT03238924|65327470|FG000|Overall Study|Withdrawal by Subject|2|||
23431989|NCT03238924|65327471|FG001|Overall Study|Withdrawal by Subject|2|||
23431990|NCT02445573|65327477|FG000|Overall Study|Withdrawal by Subject|1|||
23431991|NCT02445573|65327478|FG001|Overall Study|Withdrawal by Subject|1|||
23431992|NCT02445573|65327477|FG000|Overall Study|Lost to Follow-up|0|||
23431993|NCT02445573|65327478|FG001|Overall Study|Lost to Follow-up|1|||
23431994|NCT00491608|65327479|FG000|Overall Study|Death|2|||
23431995|NCT00491608|65327479|FG000|Overall Study|Withdrawal by Subject|1|||
23431996|NCT01331291|65327481|FG000|Overall Study|Lack of Efficacy|2|||
23431997|NCT01331291|65327482|FG001|Overall Study|Lack of Efficacy|8|||
23431998|NCT01331291|65327481|FG000|Overall Study|Death|0|||
23431999|NCT01331291|65327482|FG001|Overall Study|Death|1|||
23432000|NCT02198235|65327488|FG000|Overall Study|Lost to Follow-up|3|||
23432001|NCT02198235|65327489|FG001|Overall Study|Lost to Follow-up|2|||
23432002|NCT02198235|65327490|FG002|Overall Study|Lost to Follow-up|2|||
23432003|NCT03238248|65327492|FG000|Overall Study|Death|5|||
23432004|NCT03238248|65327492|FG000|Overall Study|Withdrawal by Subject|7|||
23432005|NCT03238248|65327492|FG000|Overall Study|Participant proceeding to transplant|10|||
23432006|NCT03238248|65327492|FG000|Overall Study|Lack of Efficacy|4|||
23432007|NCT03238248|65327492|FG000|Overall Study|Physician Decision|3|||
23432008|NCT03238248|65327492|FG000|Overall Study|Transitioning to another study|1|||
23432009|NCT03238248|65327492|FG000|Overall Study|No longer benefiting|1|||
23432010|NCT03238248|65327492|FG000|Overall Study|Other complicating disease|1|||
23432011|NCT03238248|65327492|FG000|Overall Study|Adverse Event|5|||
23432012|NCT03238248|65327492|FG000|Overall Study|Disease progression|26|||
23745372|NCT01694849|66447447|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
23745373|NCT01694849|66447448|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
23745374|NCT01694849|66447446|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
23745375|NCT01694849|66447447|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
23745376|NCT01694849|66447448|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
23745377|NCT01340794|66447449|FG000|Overall Study|Withdrawal by Subject|0|||
23745378|NCT01340794|66447450|FG001|Overall Study|Withdrawal by Subject|1|||
23745379|NCT03326323|66447451|FG000|Overall Study|Unable to receive ANH protocol|3|||
23745380|NCT00968539|66447452|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
23745381|NCT00968539|66447453|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23745382|NCT03233009|66447456|FG000|Overall Study|Lost to Follow-up|1|||
23745383|NCT02304484|66447457|FG000|Overall Study|Death|9|||
23745384|NCT02304484|66447457|FG000|Overall Study|Withdrawal by Subject|14|||
23745385|NCT02304484|66447457|FG000|Overall Study|Lost to Follow-up|2|||
23745386|NCT02734290|66447460|FG000|Overall Study|Adverse Event|1|||
23745387|NCT02734290|66447461|FG001|Overall Study|Adverse Event|0|||
23745388|NCT02734290|66447460|FG000|Overall Study|Death|1|||
23745389|NCT02734290|66447461|FG001|Overall Study|Death|0|||
23745390|NCT01459016|66447462|FG000|Overall Study|Withdrawal by Subject|11|||
23745391|NCT01459016|66447462|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
23745392|NCT01748162|66447463|FG000|Overall Study|no additional croup episodes to evaluate|2|||
23745393|NCT01748162|66447464|FG001|Overall Study|no additional croup episodes to evaluate|2|||
23745394|NCT01748162|66447463|FG000|Overall Study|participant consented but did not begin|0|||
23745395|NCT01748162|66447464|FG001|Overall Study|participant consented but did not begin|1|||
23745396|NCT01748162|66447463|FG000|Overall Study|reasons not available|3|||
23745397|NCT01748162|66447464|FG001|Overall Study|reasons not available|2|||
23745398|NCT02684370|66447468|FG000|Part A|Adverse Event|2|||
23745399|NCT02684370|66447469|FG001|Part A|Adverse Event|0|||
23745400|NCT02684370|66447470|FG002|Part A|Adverse Event|1|||
23745401|NCT02684370|66447471|FG003|Part A|Adverse Event|0|||
23745402|NCT02684370|66447472|FG004|Part A|Adverse Event|0|||
23745403|NCT02684370|66447473|FG005|Part A|Adverse Event|0|||
23745404|NCT02684370|66447468|FG000|Part A|Lost to Follow-up|1|||
23745405|NCT02684370|66447469|FG001|Part A|Lost to Follow-up|1|||
23745406|NCT02684370|66447470|FG002|Part A|Lost to Follow-up|0|||
23745407|NCT02684370|66447471|FG003|Part A|Lost to Follow-up|0|||
23745408|NCT02684370|66447472|FG004|Part A|Lost to Follow-up|0|||
23745409|NCT02684370|66447473|FG005|Part A|Lost to Follow-up|0|||
23745410|NCT02684370|66447468|FG000|Part A|Subject Withdrawal|1|||
23745411|NCT02684370|66447469|FG001|Part A|Subject Withdrawal|0|||
23432013|NCT03238248|65327492|FG000|Overall Study|N/A participant is still on treatment|1|||
23432014|NCT03238248|65327492|FG000|Overall Study|Decline in condition|1|||
23745412|NCT02684370|66447470|FG002|Part A|Subject Withdrawal|3|||
23745413|NCT02684370|66447471|FG003|Part A|Subject Withdrawal|0|||
23745414|NCT02684370|66447472|FG004|Part A|Subject Withdrawal|0|||
23745415|NCT02684370|66447473|FG005|Part A|Subject Withdrawal|0|||
23745416|NCT02684370|66447468|FG000|Part A|Other|0|||
23745417|NCT02684370|66447469|FG001|Part A|Other|0|||
23745418|NCT02684370|66447470|FG002|Part A|Other|1|||
23745419|NCT02684370|66447471|FG003|Part A|Other|0|||
23745420|NCT02684370|66447472|FG004|Part A|Other|0|||
23745421|NCT02684370|66447473|FG005|Part A|Other|0|||
23745422|NCT02684370|66447468|FG000|Part B|Adverse Event|0|||
23745423|NCT02684370|66447469|FG001|Part B|Adverse Event|0|||
23745424|NCT02684370|66447470|FG002|Part B|Adverse Event|0|||
23745425|NCT02684370|66447471|FG003|Part B|Adverse Event|0|||
23745426|NCT02684370|66447472|FG004|Part B|Adverse Event|2|||
23745427|NCT02684370|66447473|FG005|Part B|Adverse Event|1|||
23745428|NCT02684370|66447468|FG000|Part B|Lost to Follow-up|0|||
23745429|NCT02684370|66447469|FG001|Part B|Lost to Follow-up|0|||
23745430|NCT02684370|66447470|FG002|Part B|Lost to Follow-up|0|||
23745431|NCT02684370|66447471|FG003|Part B|Lost to Follow-up|1|||
23745432|NCT02684370|66447472|FG004|Part B|Lost to Follow-up|2|||
23745433|NCT02684370|66447473|FG005|Part B|Lost to Follow-up|5|||
23745434|NCT02684370|66447468|FG000|Part B|Subject Withdrawal|0|||
23745435|NCT02684370|66447469|FG001|Part B|Subject Withdrawal|0|||
23745436|NCT02684370|66447470|FG002|Part B|Subject Withdrawal|0|||
23745437|NCT02684370|66447471|FG003|Part B|Subject Withdrawal|1|||
23745438|NCT02684370|66447472|FG004|Part B|Subject Withdrawal|1|||
23745439|NCT02684370|66447473|FG005|Part B|Subject Withdrawal|2|||
23745440|NCT01761565|66447474|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
23745441|NCT03246152|66447475|FG000|Overall Study|Lost to Follow-up|2|||
23745442|NCT03246152|66447475|FG000|Overall Study|Protocol Violation|1|||
23745443|NCT00381680|66447476|FG000|Overall Study|Adverse Event|9|||
23745444|NCT00381680|66447477|FG001|Overall Study|Adverse Event|3|||
23745445|NCT00381680|66447476|FG000|Overall Study|Death|10|||
23745446|NCT00381680|66447477|FG001|Overall Study|Death|7|||
23745447|NCT00381680|66447476|FG000|Overall Study|Lost to Follow-up|3|||
23745448|NCT00381680|66447477|FG001|Overall Study|Lost to Follow-up|2|||
23745449|NCT00381680|66447476|FG000|Overall Study|Physician Decision|25|||
23745450|NCT00381680|66447477|FG001|Overall Study|Physician Decision|6|||
23745451|NCT00381680|66447476|FG000|Overall Study|Withdrawal by Subject|3|||
23822535|NCT03323398|66730407|FG004|Overall Study|Participant was Put on Hospice|0|||
23553523|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
23553524|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
23553525|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
23553526|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
23553527|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
23553528|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Other|18|||
23553529|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
23553530|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
23553531|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Other|1|||
23553532|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
23553533|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
23553534|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
23553535|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
23553536|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
23553537|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
23553538|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
23553539|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
23553540|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
23553541|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
23621790|NCT00702650|66000784|FG000|Overall Study|Sponsor Request|1|||
23553542|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
23553543|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
23553544|NCT02816138|65754521|FG000|Overall Study|Adverse Event|1|||
23553545|NCT02883062|65754522|FG000|Overall Study|Withdrawal by Subject|6|||
23553546|NCT02883062|65754523|FG001|Overall Study|Withdrawal by Subject|0|||
23553547|NCT04026165|65754530|FG000|Run-in Placebo Period|Enrollment Error|13|||
23553548|NCT04026165|65754531|FG001|Run-in Placebo Period|Enrollment Error|0|||
23553549|NCT04026165|65754532|FG002|Run-in Placebo Period|Enrollment Error|0|||
23553550|NCT04026165|65754533|FG003|Run-in Placebo Period|Enrollment Error|0|||
23553551|NCT04026165|65754530|FG000|Run-in Placebo Period|Run-in Failure|4|||
23621791|NCT00702650|66000784|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
23745452|NCT00381680|66447477|FG001|Overall Study|Withdrawal by Subject|1|||
23745453|NCT00381680|66447476|FG000|Overall Study|Entry onto another COG Trial|1|||
23745454|NCT00381680|66447477|FG001|Overall Study|Entry onto another COG Trial|2|||
23745455|NCT00381680|66447476|FG000|Overall Study|Alternative Therapy|11|||
23745456|NCT00381680|66447477|FG001|Overall Study|Alternative Therapy|5|||
23745457|NCT00381680|66447476|FG000|Overall Study|Secondary Malignancy|3|||
23553552|NCT04026165|65754531|FG001|Run-in Placebo Period|Run-in Failure|0|||
23553553|NCT04026165|65754532|FG002|Run-in Placebo Period|Run-in Failure|0|||
23553554|NCT04026165|65754533|FG003|Run-in Placebo Period|Run-in Failure|0|||
23553555|NCT04026165|65754530|FG000|Run-in Placebo Period|Protocol Violation|2|||
23432015|NCT03238248|65327492|FG000|Overall Study|Alternative therapy|2|||
23432016|NCT01300260|65327494|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
23432017|NCT01300260|65327495|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
23432018|NCT01300260|65327494|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
23432019|NCT01300260|65327495|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
23432020|NCT01300260|65327494|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
23432021|NCT01300260|65327495|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
23432022|NCT02265796|65327501|FG000|Overall Study|Death|1|||
23432023|NCT02265796|65327502|FG001|Overall Study|Death|0|||
23432024|NCT02265796|65327501|FG000|Overall Study|started on excluded medication|1|||
23432025|NCT02265796|65327502|FG001|Overall Study|started on excluded medication|0|||
23432026|NCT02265796|65327501|FG000|Overall Study|Withdrawal by Subject|1|||
23432027|NCT02265796|65327502|FG001|Overall Study|Withdrawal by Subject|1|||
23432028|NCT00701805|65327503|FG000|Overall Study|Withdrawal by Subject|3|||
23432029|NCT00701805|65327504|FG001|Overall Study|Withdrawal by Subject|1|||
23432030|NCT00701805|65327505|FG002|Overall Study|Withdrawal by Subject|4|||
23432031|NCT00701805|65327506|FG003|Overall Study|Withdrawal by Subject|3|||
23432032|NCT00701805|65327503|FG000|Overall Study|Adverse Event|0|||
23432033|NCT00701805|65327504|FG001|Overall Study|Adverse Event|1|||
23432034|NCT00701805|65327505|FG002|Overall Study|Adverse Event|1|||
23432035|NCT00701805|65327506|FG003|Overall Study|Adverse Event|0|||
23432036|NCT00701805|65327503|FG000|Overall Study|Missed 7 consecutive doses|0|||
23432037|NCT00701805|65327504|FG001|Overall Study|Missed 7 consecutive doses|1|||
23432038|NCT00701805|65327505|FG002|Overall Study|Missed 7 consecutive doses|0|||
23432039|NCT00701805|65327506|FG003|Overall Study|Missed 7 consecutive doses|0|||
23621792|NCT00702650|66000784|FG000|Overall Study|Adverse Event|3|||
23553556|NCT04026165|65754531|FG001|Run-in Placebo Period|Protocol Violation|0|||
23553557|NCT04026165|65754532|FG002|Run-in Placebo Period|Protocol Violation|0|||
23553558|NCT04026165|65754533|FG003|Run-in Placebo Period|Protocol Violation|0|||
23553559|NCT04026165|65754530|FG000|Run-in Placebo Period|Withdrew Consent|2|||
23553560|NCT04026165|65754531|FG001|Run-in Placebo Period|Withdrew Consent|0|||
23553561|NCT04026165|65754532|FG002|Run-in Placebo Period|Withdrew Consent|0|||
23553562|NCT04026165|65754533|FG003|Run-in Placebo Period|Withdrew Consent|0|||
23553563|NCT04026165|65754530|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
23553564|NCT04026165|65754531|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553565|NCT04026165|65754532|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553566|NCT04026165|65754533|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553567|NCT04026165|65754530|FG000|Run-in SEL Period|Run-in Failure|0|||
23553568|NCT04026165|65754531|FG001|Run-in SEL Period|Run-in Failure|26|||
23553569|NCT04026165|65754532|FG002|Run-in SEL Period|Run-in Failure|0|||
23553570|NCT04026165|65754533|FG003|Run-in SEL Period|Run-in Failure|0|||
23553571|NCT04026165|65754530|FG000|Run-in SEL Period|Withdrew Consent|0|||
23553572|NCT04026165|65754531|FG001|Run-in SEL Period|Withdrew Consent|10|||
23553573|NCT04026165|65754532|FG002|Run-in SEL Period|Withdrew Consent|0|||
23553574|NCT04026165|65754533|FG003|Run-in SEL Period|Withdrew Consent|0|||
23553575|NCT04026165|65754530|FG000|Run-in SEL Period|Enrollment Error|0|||
23553576|NCT04026165|65754531|FG001|Run-in SEL Period|Enrollment Error|4|||
23553577|NCT04026165|65754532|FG002|Run-in SEL Period|Enrollment Error|0|||
23553578|NCT04026165|65754533|FG003|Run-in SEL Period|Enrollment Error|0|||
23553579|NCT04026165|65754530|FG000|Run-in SEL Period|Protocol Violation|0|||
23553580|NCT04026165|65754531|FG001|Run-in SEL Period|Protocol Violation|3|||
23553581|NCT04026165|65754532|FG002|Run-in SEL Period|Protocol Violation|0|||
23553582|NCT04026165|65754533|FG003|Run-in SEL Period|Protocol Violation|0|||
23553583|NCT04026165|65754530|FG000|Run-in SEL Period|Investigator's Discretion|0|||
23553584|NCT04026165|65754531|FG001|Run-in SEL Period|Investigator's Discretion|2|||
23553585|NCT04026165|65754532|FG002|Run-in SEL Period|Investigator's Discretion|0|||
23553586|NCT04026165|65754533|FG003|Run-in SEL Period|Investigator's Discretion|0|||
23553587|NCT04026165|65754530|FG000|Run-in SEL Period|Death|0|||
23553588|NCT04026165|65754531|FG001|Run-in SEL Period|Death|1|||
23553589|NCT04026165|65754532|FG002|Run-in SEL Period|Death|0|||
23553590|NCT04026165|65754533|FG003|Run-in SEL Period|Death|0|||
23553591|NCT04026165|65754530|FG000|Randomized Period|Withdrew Consent|0|||
23553592|NCT04026165|65754531|FG001|Randomized Period|Withdrew Consent|0|||
23432040|NCT00701805|65327503|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
23432041|NCT00701805|65327504|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
23553593|NCT04026165|65754532|FG002|Randomized Period|Withdrew Consent|5|||
23553594|NCT04026165|65754533|FG003|Randomized Period|Withdrew Consent|8|||
23553595|NCT04026165|65754530|FG000|Randomized Period|Death|0|||
23432042|NCT00701805|65327505|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
23432043|NCT00701805|65327506|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
23432044|NCT00701805|65327503|FG000|Overall Study|Physician decision, change of therapy|0|||
23432045|NCT00701805|65327504|FG001|Overall Study|Physician decision, change of therapy|0|||
23432046|NCT00701805|65327505|FG002|Overall Study|Physician decision, change of therapy|0|||
23432047|NCT00701805|65327506|FG003|Overall Study|Physician decision, change of therapy|1|||
23432048|NCT00701805|65327503|FG000|Overall Study|Difficult to travel to dialysis site|0|||
23432049|NCT00701805|65327504|FG001|Overall Study|Difficult to travel to dialysis site|0|||
23432050|NCT00701805|65327505|FG002|Overall Study|Difficult to travel to dialysis site|1|||
23432051|NCT00701805|65327506|FG003|Overall Study|Difficult to travel to dialysis site|0|||
23432052|NCT00701805|65327503|FG000|Overall Study|Resumption criteria were not met|0|||
23432053|NCT00701805|65327504|FG001|Overall Study|Resumption criteria were not met|1|||
23432054|NCT00701805|65327505|FG002|Overall Study|Resumption criteria were not met|0|||
23432055|NCT00701805|65327506|FG003|Overall Study|Resumption criteria were not met|0|||
23432056|NCT01110382|65327508|FG000|Overall Study|Withdrawal by Subject|0|||
23432057|NCT01110382|65327509|FG001|Overall Study|Withdrawal by Subject|1|||
23432058|NCT01110382|65327508|FG000|Overall Study|Protocol Violation|0|||
23432059|NCT01110382|65327509|FG001|Overall Study|Protocol Violation|1|||
23432060|NCT01716104|65327510|FG000|Overall Study|Do not meet inclusion criteria|6|||
23432061|NCT01716104|65327511|FG001|Overall Study|Do not meet inclusion criteria|7|||
23432062|NCT03729245|65327514|FG000|Overall Study|Lost to Follow-up|5|||
23432063|NCT03729245|65327515|FG001|Overall Study|Lost to Follow-up|6|||
23432064|NCT03729245|65327514|FG000|Overall Study|Withdrawal by Subject|16|||
23432065|NCT03729245|65327515|FG001|Overall Study|Withdrawal by Subject|19|||
23432066|NCT03729245|65327514|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
23432067|NCT03729245|65327515|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
23432068|NCT00249613|65327525|FG000|12 Month Follow-up|Death|1|||
23432069|NCT00249613|65327526|FG001|12 Month Follow-up|Death|1|||
23432070|NCT00249613|65327525|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
23432071|NCT00249613|65327526|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
23432072|NCT00249613|65327525|FG000|12 Month Follow-up|Lost to Follow-up|10|||
23432073|NCT00249613|65327526|FG001|12 Month Follow-up|Lost to Follow-up|8|||
23432074|NCT02228096|65327527|FG000|Overall Study|Study terminated by Sponsor|24|||
23432075|NCT02228096|65327527|FG000|Overall Study|Lack of Efficacy|18|||
23432076|NCT02228096|65327527|FG000|Overall Study|Death|12|||
23432077|NCT02228096|65327527|FG000|Overall Study|Physician Decision|3|||
23432078|NCT02228096|65327527|FG000|Overall Study|Subject/guardian decision|2|||
23432079|NCT02228096|65327527|FG000|Overall Study|New therapy for study indication|1|||
23432080|NCT02228096|65327527|FG000|Overall Study|Enrolled, not infused|11|||
23432081|NCT03442296|65327530|FG000|3 Month Follow-up|Death|3|||
23432082|NCT03442296|65327531|FG001|3 Month Follow-up|Death|1|||
23432083|NCT03442296|65327530|FG000|3 Month Follow-up|Lost to Follow-up|1|||
23553596|NCT04026165|65754531|FG001|Randomized Period|Death|0|||
23553597|NCT04026165|65754532|FG002|Randomized Period|Death|5|||
23553598|NCT04026165|65754533|FG003|Randomized Period|Death|7|||
23553599|NCT04026165|65754530|FG000|Randomized Period|Investigator's Discretion|0|||
23553600|NCT04026165|65754531|FG001|Randomized Period|Investigator's Discretion|0|||
23553601|NCT04026165|65754532|FG002|Randomized Period|Investigator's Discretion|2|||
23553602|NCT04026165|65754533|FG003|Randomized Period|Investigator's Discretion|2|||
23553603|NCT04026165|65754530|FG000|Randomized Period|Lost to Follow-up|0|||
23553604|NCT04026165|65754531|FG001|Randomized Period|Lost to Follow-up|0|||
23553605|NCT04026165|65754532|FG002|Randomized Period|Lost to Follow-up|2|||
23553606|NCT04026165|65754533|FG003|Randomized Period|Lost to Follow-up|2|||
23553607|NCT03240692|65754534|FG000|Overall Study|Physician Decision|1|||
23553608|NCT03240692|65754534|FG000|Overall Study|Withdrawal by Subject|1|||
23553609|NCT05072080|65754537|FG000|Overall Study|Death|0|||
23553610|NCT05072080|65754538|FG001|Overall Study|Death|0|||
23553611|NCT05072080|65754539|FG002|Overall Study|Death|1|||
23553612|NCT05072080|65754540|FG003|Overall Study|Death|0|||
23553613|NCT05072080|65754537|FG000|Overall Study|Lost to Follow-up|65|||
23621793|NCT00338949|66000785|FG000|Subject Screening|Screen failures|11|||
23432084|NCT03442296|65327531|FG001|3 Month Follow-up|Lost to Follow-up|1|||
23553614|NCT05072080|65754538|FG001|Overall Study|Lost to Follow-up|70|||
23553615|NCT05072080|65754539|FG002|Overall Study|Lost to Follow-up|58|||
23553616|NCT05072080|65754540|FG003|Overall Study|Lost to Follow-up|23|||
23553617|NCT05072080|65754537|FG000|Overall Study|Physician Decision|2|||
23553618|NCT05072080|65754538|FG001|Overall Study|Physician Decision|1|||
23553619|NCT05072080|65754539|FG002|Overall Study|Physician Decision|1|||
23432085|NCT03442296|65327530|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
23432086|NCT03442296|65327531|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
23553620|NCT05072080|65754540|FG003|Overall Study|Physician Decision|0|||
23553621|NCT05072080|65754537|FG000|Overall Study|Withdrawal by Subject|45|||
23553622|NCT05072080|65754538|FG001|Overall Study|Withdrawal by Subject|30|||
23553623|NCT05072080|65754539|FG002|Overall Study|Withdrawal by Subject|27|||
23553624|NCT05072080|65754540|FG003|Overall Study|Withdrawal by Subject|7|||
23553625|NCT05072080|65754537|FG000|Overall Study|Sponsor Decision|0|||
23553626|NCT05072080|65754538|FG001|Overall Study|Sponsor Decision|1|||
23553627|NCT05072080|65754539|FG002|Overall Study|Sponsor Decision|0|||
23553628|NCT05072080|65754540|FG003|Overall Study|Sponsor Decision|0|||
23553629|NCT05072080|65754537|FG000|Overall Study|Subject moved|1|||
23553630|NCT05072080|65754538|FG001|Overall Study|Subject moved|3|||
23553631|NCT05072080|65754539|FG002|Overall Study|Subject moved|5|||
23553632|NCT05072080|65754540|FG003|Overall Study|Subject moved|2|||
23553633|NCT05072080|65754537|FG000|Overall Study|Withdrawal by parent|0|||
23553634|NCT05072080|65754538|FG001|Overall Study|Withdrawal by parent|0|||
23553635|NCT05072080|65754539|FG002|Overall Study|Withdrawal by parent|1|||
23553636|NCT05072080|65754540|FG003|Overall Study|Withdrawal by parent|0|||
23553637|NCT05072080|65754537|FG000|Overall Study|Subject was deployed|0|||
23553638|NCT05072080|65754538|FG001|Overall Study|Subject was deployed|1|||
23553639|NCT05072080|65754539|FG002|Overall Study|Subject was deployed|0|||
23553640|NCT05072080|65754540|FG003|Overall Study|Subject was deployed|0|||
23553641|NCT05072080|65754537|FG000|Overall Study|Subject left site without receiving dose|0|||
23553642|NCT05072080|65754538|FG001|Overall Study|Subject left site without receiving dose|1|||
23553643|NCT05072080|65754539|FG002|Overall Study|Subject left site without receiving dose|0|||
23553644|NCT05072080|65754540|FG003|Overall Study|Subject left site without receiving dose|0|||
23553645|NCT05072080|65754537|FG000|Overall Study|Subject incarcerated|0|||
23553646|NCT05072080|65754538|FG001|Overall Study|Subject incarcerated|1|||
23553647|NCT05072080|65754539|FG002|Overall Study|Subject incarcerated|0|||
23553648|NCT05072080|65754540|FG003|Overall Study|Subject incarcerated|1|||
23553649|NCT05072080|65754537|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
23553650|NCT05072080|65754538|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
23553651|NCT05072080|65754539|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
23553652|NCT05072080|65754540|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
23553653|NCT05072080|65754537|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
23553654|NCT05072080|65754538|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
23553655|NCT05072080|65754539|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
23553656|NCT05072080|65754540|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
23553657|NCT03365882|65754541|FG000|Randomization|Still Receiving Protocol Treatment|2|||
23553658|NCT03365882|65754542|FG001|Randomization|Still Receiving Protocol Treatment|0|||
23553659|NCT03365882|65754541|FG000|Randomization|Adverse Event|1|||
23553660|NCT03365882|65754542|FG001|Randomization|Adverse Event|2|||
23553661|NCT03365882|65754541|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
23553662|NCT03365882|65754542|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
23553663|NCT03365882|65754541|FG000|Randomization|Progression/Relapse|21|||
23745458|NCT00381680|66447477|FG001|Overall Study|Secondary Malignancy|0|||
23745459|NCT00381680|66447476|FG000|Overall Study|Delay initiation|1|||
23745460|NCT00381680|66447477|FG001|Overall Study|Delay initiation|0|||
23745461|NCT00381680|66447476|FG000|Overall Study|Stem Cell Transplant|26|||
23745462|NCT00381680|66447477|FG001|Overall Study|Stem Cell Transplant|10|||
23745463|NCT00381680|66447476|FG000|Overall Study|Relapse|18|||
23745464|NCT00381680|66447477|FG001|Overall Study|Relapse|9|||
23745465|NCT00381680|66447476|FG000|Overall Study|Induction Failure|4|||
23745466|NCT00381680|66447477|FG001|Overall Study|Induction Failure|1|||
23745467|NCT00381680|66447476|FG000|Overall Study|Progression|1|||
23745468|NCT00381680|66447477|FG001|Overall Study|Progression|1|||
23745469|NCT00381680|66447476|FG000|Overall Study|Other not otherwise specified|7|||
23745470|NCT00381680|66447477|FG001|Overall Study|Other not otherwise specified|2|||
23745471|NCT00381680|66447476|FG000|Overall Study|Ineligible|3|||
23745472|NCT00381680|66447477|FG001|Overall Study|Ineligible|1|||
23745473|NCT03778021|66447480|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
23745474|NCT03778021|66447481|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
23745475|NCT00700115|66447482|FG000|Overall Study|Withdrawal by Subject|1|||
23745476|NCT00700115|66447483|FG001|Overall Study|Withdrawal by Subject|0|||
23745477|NCT00700115|66447482|FG000|Overall Study|Lost to Follow-up|0|||
23745478|NCT00700115|66447483|FG001|Overall Study|Lost to Follow-up|1|||
23745479|NCT01479777|66447484|FG000|Overall Study|Physician Decision|2|||
23745480|NCT01399619|66447485|FG000|Overall Study|Adverse Event|10|||
23745481|NCT01399619|66447486|FG001|Overall Study|Adverse Event|0|||
23745482|NCT01399619|66447487|FG002|Overall Study|Adverse Event|4|||
23745483|NCT01399619|66447488|FG003|Overall Study|Adverse Event|10|||
23745484|NCT01399619|66447485|FG000|Overall Study|Lack of Efficacy|9|||
23745485|NCT01399619|66447486|FG001|Overall Study|Lack of Efficacy|0|||
23553664|NCT03365882|65754542|FG001|Randomization|Progression/Relapse|3|||
23553665|NCT03365882|65754541|FG000|Randomization|Death|1|||
23553666|NCT03365882|65754542|FG001|Randomization|Death|0|||
23553667|NCT03365882|65754541|FG000|Randomization|Other - Not Protocol Specified|1|||
23553668|NCT03365882|65754542|FG001|Randomization|Other - Not Protocol Specified|1|||
23553669|NCT03365882|65754541|FG000|Randomization|Major Protocol Deviation|0|||
23745486|NCT01399619|66447487|FG002|Overall Study|Lack of Efficacy|5|||
23745487|NCT01399619|66447488|FG003|Overall Study|Lack of Efficacy|0|||
23745488|NCT01399619|66447485|FG000|Overall Study|Withdrawal by Subject|6|||
23745489|NCT01399619|66447486|FG001|Overall Study|Withdrawal by Subject|0|||
23745490|NCT01399619|66447487|FG002|Overall Study|Withdrawal by Subject|3|||
23745491|NCT01399619|66447488|FG003|Overall Study|Withdrawal by Subject|4|||
23745492|NCT01399619|66447485|FG000|Overall Study|Protocol Violation|0|||
23745493|NCT01399619|66447486|FG001|Overall Study|Protocol Violation|0|||
23745494|NCT01399619|66447487|FG002|Overall Study|Protocol Violation|0|||
23745495|NCT01399619|66447488|FG003|Overall Study|Protocol Violation|1|||
23745496|NCT01399619|66447485|FG000|Overall Study|Not treated|0|||
23745497|NCT01399619|66447486|FG001|Overall Study|Not treated|0|||
23745498|NCT01399619|66447487|FG002|Overall Study|Not treated|0|||
23745499|NCT01399619|66447488|FG003|Overall Study|Not treated|2|||
23745500|NCT03075826|66447489|FG000|Overall Study|Withdrawal by Subject|1|||
23745501|NCT03075826|66447489|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
23745502|NCT02180659|66447492|FG000|Overall Study|Adverse Event|1|||
23745503|NCT02180659|66447493|FG001|Overall Study|Adverse Event|0|||
23745504|NCT02180659|66447492|FG000|Overall Study|Lost to Follow-up|4|||
23745505|NCT02180659|66447493|FG001|Overall Study|Lost to Follow-up|2|||
23745506|NCT02180659|66447492|FG000|Overall Study|Subject incarcerated during conduct|1|||
23745507|NCT02180659|66447493|FG001|Overall Study|Subject incarcerated during conduct|0|||
23745508|NCT02180659|66447492|FG000|Overall Study|Withdrawal by Subject|0|||
23745509|NCT02180659|66447493|FG001|Overall Study|Withdrawal by Subject|2|||
23745510|NCT02180659|66447492|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
23745511|NCT02180659|66447493|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
23553670|NCT03365882|65754542|FG001|Randomization|Major Protocol Deviation|1|||
23553671|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
23553672|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
23553673|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
23553674|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
23553675|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
23553676|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
23553677|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
23553678|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
23553679|NCT04330638|65754543|FG000|Overall Study|Adverse Event|9|||
23553680|NCT04330638|65754544|FG001|Overall Study|Adverse Event|10|||
23553681|NCT04330638|65754545|FG002|Overall Study|Adverse Event|15|||
23553682|NCT04330638|65754546|FG003|Overall Study|Adverse Event|6|||
23553683|NCT04330638|65754547|FG004|Overall Study|Adverse Event|10|||
23553684|NCT04330638|65754548|FG005|Overall Study|Adverse Event|5|||
23553685|NCT04330638|65754543|FG000|Overall Study|Other|2|||
23553686|NCT04330638|65754544|FG001|Overall Study|Other|2|||
23553687|NCT04330638|65754545|FG002|Overall Study|Other|5|||
23553688|NCT04330638|65754546|FG003|Overall Study|Other|1|||
23553689|NCT04330638|65754547|FG004|Overall Study|Other|3|||
23553690|NCT04330638|65754548|FG005|Overall Study|Other|2|||
23553691|NCT04330638|65754543|FG000|Overall Study|Withdrawal by Subject|4|||
23553692|NCT04330638|65754544|FG001|Overall Study|Withdrawal by Subject|0|||
23553693|NCT04330638|65754545|FG002|Overall Study|Withdrawal by Subject|0|||
23553694|NCT04330638|65754546|FG003|Overall Study|Withdrawal by Subject|0|||
23553695|NCT04330638|65754547|FG004|Overall Study|Withdrawal by Subject|0|||
23553696|NCT04330638|65754548|FG005|Overall Study|Withdrawal by Subject|0|||
23553697|NCT04330638|65754543|FG000|Overall Study|Lost to Follow-up|3|||
23553698|NCT04330638|65754544|FG001|Overall Study|Lost to Follow-up|2|||
23553699|NCT04330638|65754545|FG002|Overall Study|Lost to Follow-up|3|||
23553700|NCT04330638|65754546|FG003|Overall Study|Lost to Follow-up|2|||
23553701|NCT04330638|65754547|FG004|Overall Study|Lost to Follow-up|3|||
23553702|NCT04330638|65754548|FG005|Overall Study|Lost to Follow-up|0|||
23745512|NCT00234533|66447494|FG000|Overall Study|Withdrawal by Subject|6|||
23745513|NCT00234533|66447494|FG000|Overall Study|Adverse Event|2|||
23745514|NCT00234533|66447494|FG000|Overall Study|Enrolled but not treated|3|||
23745515|NCT04120116|66447497|FG000|Overall Study|Lost to Follow-up|0|||
23745516|NCT04120116|66447498|FG001|Overall Study|Lost to Follow-up|1|||
23432087|NCT03442296|65327530|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
23745517|NCT04120116|66447499|FG002|Overall Study|Lost to Follow-up|0|||
23553703|NCT01112579|65754552|FG000|Overall Study|Missed Visit|1|||
23553704|NCT01112579|65754553|FG001|Overall Study|Missed Visit|1|||
23553705|NCT01112579|65754552|FG000|Overall Study|Death|0|||
23553706|NCT01112579|65754553|FG001|Overall Study|Death|2|||
23553707|NCT02134587|65754554|FG000|Overall Study|Did not completed all meetings|30|||
23621794|NCT00338949|66000786|FG001|Subject Screening|Screen failures|11|||
23553708|NCT02660827|65754558|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
23553709|NCT02660827|65754558|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
23553710|NCT02660827|65754558|FG000|From Study to End of Continued Access|Adverse Event|3|||
23553711|NCT02660827|65754558|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
23553712|NCT02660827|65754558|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
23553713|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
23553714|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
23553715|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Adverse Event|3|||
23553716|NCT03538951|65754559|FG000|Overall Study|Withdrawal by Subject|1|||
23553717|NCT03538951|65754560|FG001|Overall Study|Withdrawal by Subject|2|||
23553718|NCT03832595|65754563|FG000|Overall Study|Death|142|||
23553719|NCT03832595|65754564|FG001|Overall Study|Death|130|||
23553720|NCT03832595|65754563|FG000|Overall Study|Medical management without dialysis|37|||
23553721|NCT03832595|65754564|FG001|Overall Study|Medical management without dialysis|1|||
23553722|NCT00160680|65754565|FG000|Overall Study|Adverse Event|0|||
23553723|NCT00160680|65754566|FG001|Overall Study|Adverse Event|1|||
23553724|NCT00160680|65754565|FG000|Overall Study|Lack of Efficacy|2|||
23553725|NCT00160680|65754566|FG001|Overall Study|Lack of Efficacy|1|||
23553726|NCT00160680|65754565|FG000|Overall Study|Lost to Follow-up|3|||
23553727|NCT00160680|65754566|FG001|Overall Study|Lost to Follow-up|2|||
23553728|NCT00160680|65754565|FG000|Overall Study|Withdrawal by Subject|4|||
23553729|NCT00160680|65754566|FG001|Overall Study|Withdrawal by Subject|9|||
23553730|NCT00951275|65754573|FG000|Overall Study|Administrative Reason|1|||
23553731|NCT00951275|65754573|FG000|Overall Study|Adverse Event|7|||
23553732|NCT00951275|65754573|FG000|Overall Study|Withdrawal by Subject|4|||
23553733|NCT00951275|65754573|FG000|Overall Study|Protocol Violation|1|||
23553734|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
23553735|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
23553736|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
23553737|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
23553738|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
23553739|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
23553740|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
23553741|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
23621795|NCT00338949|66000785|FG000|Randomization|Withdrawal by Subject|1|||
23621796|NCT00338949|66000786|FG001|Randomization|Withdrawal by Subject|0|||
23621797|NCT00338949|66000785|FG000|Randomization|Adverse Event|0|||
23621798|NCT00338949|66000786|FG001|Randomization|Adverse Event|5|||
23621799|NCT01194271|66000787|FG000|Overall Study|Withdrawal by Subject|1|||
23621800|NCT01194271|66000787|FG000|Overall Study|Ineligible, Screen Failure|1|||
23621801|NCT01194271|66000787|FG000|Overall Study|Death|1|||
23621802|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
23621803|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
23621804|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
23621805|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
23822536|NCT03323398|66730408|FG005|Overall Study|Participant was Put on Hospice|0|||
23822537|NCT03323398|66730409|FG006|Overall Study|Participant was Put on Hospice|1|||
23822538|NCT03323398|66730410|FG007|Overall Study|Participant was Put on Hospice|0|||
23822539|NCT03323398|66730411|FG008|Overall Study|Participant was Put on Hospice|0|||
23822540|NCT03323398|66730403|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
23553742|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
23553743|NCT03321396|65754577|FG000|Overall Study|Physician Decision|1|||
23553744|NCT02195986|65754580|FG000|Overall Study|Adverse Event|3|||
23553745|NCT02195986|65754581|FG001|Overall Study|Adverse Event|0|||
23553746|NCT02195986|65754582|FG002|Overall Study|Adverse Event|0|||
23553747|NCT02195986|65754580|FG000|Overall Study|Withdrawal by Subject|0|||
23553748|NCT02195986|65754581|FG001|Overall Study|Withdrawal by Subject|3|||
23553749|NCT02195986|65754582|FG002|Overall Study|Withdrawal by Subject|0|||
23553750|NCT02195986|65754580|FG000|Overall Study|Family Emergency|0|||
23553751|NCT02195986|65754581|FG001|Overall Study|Family Emergency|0|||
23621806|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
23553752|NCT02195986|65754582|FG002|Overall Study|Family Emergency|1|||
23553753|NCT02195986|65754580|FG000|Overall Study|Protocol Violation|0|||
23553754|NCT02195986|65754581|FG001|Overall Study|Protocol Violation|1|||
23553755|NCT02195986|65754582|FG002|Overall Study|Protocol Violation|1|||
23553756|NCT02195986|65754580|FG000|Overall Study|Non-compliance|0|||
23553757|NCT02195986|65754581|FG001|Overall Study|Non-compliance|1|||
23553758|NCT02195986|65754582|FG002|Overall Study|Non-compliance|0|||
23553759|NCT00602667|65754590|FG000|Overall Study|Still on Therapy|0|||
23553760|NCT00602667|65754591|FG001|Overall Study|Still on Therapy|2|||
23553761|NCT00602667|65754592|FG002|Overall Study|Still on Therapy|2|||
23621807|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
23621808|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
23745518|NCT04120116|66447500|FG003|Overall Study|Lost to Follow-up|2|||
23745519|NCT04120116|66447497|FG000|Overall Study|Withdrawal by Subject|1|||
23745520|NCT04120116|66447498|FG001|Overall Study|Withdrawal by Subject|0|||
23822541|NCT03323398|66730404|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
23822542|NCT03323398|66730405|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
23822543|NCT03323398|66730406|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
23822544|NCT03323398|66730407|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
23822545|NCT03323398|66730408|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
23822546|NCT03323398|66730409|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
23822547|NCT03323398|66730410|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
23822548|NCT03323398|66730411|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
23822549|NCT03447743|66730412|FG000|Overall Study|Withdrawal by Subject|2|||
23822550|NCT03447743|66730412|FG000|Overall Study|Lost to Follow-up|3|||
23822551|NCT03447743|66730412|FG000|Overall Study|Adverse Event|1|||
23822552|NCT03447743|66730412|FG000|Overall Study|Did not meet criteria to continue|1|||
23822553|NCT01473407|66730413|FG000|Overall Study|Physician Decision|1|||
23822554|NCT01473407|66730414|FG001|Overall Study|Physician Decision|4|||
23822555|NCT01473407|66730413|FG000|Overall Study|Lost to Follow-up|10|||
23822556|NCT01473407|66730414|FG001|Overall Study|Lost to Follow-up|4|||
23822557|NCT01473407|66730413|FG000|Overall Study|Adverse Event|8|||
23822558|NCT01473407|66730414|FG001|Overall Study|Adverse Event|8|||
23822559|NCT01473407|66730413|FG000|Overall Study|Randomization Error|3|||
23822560|NCT01473407|66730414|FG001|Overall Study|Randomization Error|1|||
23822561|NCT01473407|66730413|FG000|Overall Study|Withdrawal by Subject|4|||
23822562|NCT01473407|66730414|FG001|Overall Study|Withdrawal by Subject|7|||
23822563|NCT01473407|66730413|FG000|Overall Study|Kidney Transplant|7|||
23822564|NCT01473407|66730414|FG001|Overall Study|Kidney Transplant|6|||
23822565|NCT01473407|66730413|FG000|Overall Study|Vacation/Travel|1|||
23822566|NCT01473407|66730414|FG001|Overall Study|Vacation/Travel|1|||
23822567|NCT01473407|66730413|FG000|Overall Study|Elevated Hemoglobin|1|||
23822568|NCT01473407|66730414|FG001|Overall Study|Elevated Hemoglobin|0|||
23621809|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
23621810|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
23621811|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
23621812|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
23553762|NCT00602667|65754590|FG000|Overall Study|Death|0|||
23553763|NCT00602667|65754591|FG001|Overall Study|Death|1|||
23553764|NCT00602667|65754592|FG002|Overall Study|Death|1|||
23553765|NCT00602667|65754590|FG000|Overall Study|Family request|3|||
23553766|NCT00602667|65754591|FG001|Overall Study|Family request|25|||
23553767|NCT00602667|65754592|FG002|Overall Study|Family request|6|||
23621813|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
23553768|NCT00602667|65754590|FG000|Overall Study|Excessive toxicity|1|||
23553769|NCT00602667|65754591|FG001|Overall Study|Excessive toxicity|1|||
23553770|NCT00602667|65754592|FG002|Overall Study|Excessive toxicity|0|||
23553771|NCT00602667|65754590|FG000|Overall Study|Second malignancy|0|||
23745521|NCT04120116|66447499|FG002|Overall Study|Withdrawal by Subject|1|||
23745522|NCT04120116|66447500|FG003|Overall Study|Withdrawal by Subject|1|||
23745523|NCT04120116|66447497|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23745524|NCT04120116|66447498|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23745525|NCT04120116|66447499|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
23745526|NCT04120116|66447500|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23745527|NCT00346775|66447509|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
23745528|NCT00346775|66447510|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
23745529|NCT00346775|66447509|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
23745530|NCT00346775|66447510|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
23745531|NCT00346775|66447509|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
23822569|NCT01473407|66730413|FG000|Overall Study|Patient Received Aranesp|1|||
23822570|NCT01473407|66730414|FG001|Overall Study|Patient Received Aranesp|0|||
23822571|NCT01473407|66730413|FG000|Overall Study|Patient Lost Green Card Status|1|||
23822572|NCT01473407|66730414|FG001|Overall Study|Patient Lost Green Card Status|0|||
23822573|NCT01473407|66730413|FG000|Overall Study|Temperature Excursion|2|||
23822574|NCT01473407|66730414|FG001|Overall Study|Temperature Excursion|3|||
23553772|NCT00602667|65754591|FG001|Overall Study|Second malignancy|1|||
23553773|NCT00602667|65754592|FG002|Overall Study|Second malignancy|0|||
23553774|NCT00602667|65754590|FG000|Overall Study|Physician Decision|2|||
23621814|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
23621815|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
23621816|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
23621817|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
23621818|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
23621819|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
23621820|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
23621821|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
23621822|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
23621823|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
23621824|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
23621825|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
23621826|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
23621827|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
23621828|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
23621829|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
23621830|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
23621831|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
23621832|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
23621833|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
23621834|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
23621835|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
23621836|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
23621837|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
23621838|NCT03463577|66000791|FG000|Overall Study|Lost to Follow-up|238|||
23745532|NCT00346775|66447510|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
23745533|NCT00824993|66447516|FG000|Overall Study|Withdrawal by Subject|1|||
23745534|NCT00824993|66447517|FG001|Overall Study|Withdrawal by Subject|1|||
23745535|NCT00824993|66447516|FG000|Overall Study|Malignancy Relapse|9|||
23745536|NCT00824993|66447517|FG001|Overall Study|Malignancy Relapse|10|||
23745537|NCT00824993|66447516|FG000|Overall Study|Rapid Bone Loss|0|||
23745538|NCT00824993|66447517|FG001|Overall Study|Rapid Bone Loss|1|||
23745539|NCT00824993|66447516|FG000|Overall Study|Non-Compliant|2|||
23745540|NCT00824993|66447517|FG001|Overall Study|Non-Compliant|1|||
23745541|NCT00824993|66447516|FG000|Overall Study|Insurance Issue|2|||
23745542|NCT00824993|66447517|FG001|Overall Study|Insurance Issue|1|||
23745543|NCT00824993|66447516|FG000|Overall Study|Death|0|||
23745544|NCT00824993|66447517|FG001|Overall Study|Death|3|||
23745545|NCT03732534|66447524|FG000|Overall Study|Study terminated by Sponsor|6|||
23745546|NCT01503229|66447525|FG000|Overall Study|Withdrew consent|1|||
23745547|NCT02146365|66447528|FG000|Overall Study|Lost to Follow-up|2|||
23745548|NCT02146365|66447529|FG001|Overall Study|Lost to Follow-up|1|||
23745549|NCT02146365|66447530|FG002|Overall Study|Lost to Follow-up|3|||
23745550|NCT02146365|66447531|FG003|Overall Study|Lost to Follow-up|3|||
23745551|NCT02146365|66447532|FG004|Overall Study|Lost to Follow-up|1|||
23745552|NCT02146365|66447533|FG005|Overall Study|Lost to Follow-up|1|||
23745553|NCT02146365|66447534|FG006|Overall Study|Lost to Follow-up|0|||
23745554|NCT02146365|66447535|FG007|Overall Study|Lost to Follow-up|1|||
23745555|NCT02146365|66447528|FG000|Overall Study|Withdrawal by Subject|1|||
23745556|NCT02146365|66447529|FG001|Overall Study|Withdrawal by Subject|2|||
23745557|NCT02146365|66447530|FG002|Overall Study|Withdrawal by Subject|1|||
23745558|NCT02146365|66447531|FG003|Overall Study|Withdrawal by Subject|5|||
23745559|NCT02146365|66447532|FG004|Overall Study|Withdrawal by Subject|1|||
23745560|NCT02146365|66447533|FG005|Overall Study|Withdrawal by Subject|0|||
23745561|NCT02146365|66447534|FG006|Overall Study|Withdrawal by Subject|0|||
23745562|NCT02146365|66447535|FG007|Overall Study|Withdrawal by Subject|0|||
23745563|NCT02146365|66447528|FG000|Overall Study|Unable to Comply with Protocol|0|||
23745564|NCT02146365|66447529|FG001|Overall Study|Unable to Comply with Protocol|1|||
23745565|NCT02146365|66447530|FG002|Overall Study|Unable to Comply with Protocol|1|||
23745566|NCT02146365|66447531|FG003|Overall Study|Unable to Comply with Protocol|0|||
23745567|NCT02146365|66447532|FG004|Overall Study|Unable to Comply with Protocol|0|||
23745568|NCT02146365|66447533|FG005|Overall Study|Unable to Comply with Protocol|0|||
23745569|NCT02146365|66447534|FG006|Overall Study|Unable to Comply with Protocol|0|||
23745570|NCT02146365|66447535|FG007|Overall Study|Unable to Comply with Protocol|0|||
23745571|NCT02146365|66447528|FG000|Overall Study|Other|1|||
23745572|NCT02146365|66447529|FG001|Overall Study|Other|0|||
23745573|NCT02146365|66447530|FG002|Overall Study|Other|2|||
23621839|NCT03463577|66000792|FG001|Overall Study|Lost to Follow-up|435|||
23621840|NCT03463577|66000793|FG002|Overall Study|Lost to Follow-up|0|||
23621841|NCT03463577|66000794|FG003|Overall Study|Lost to Follow-up|0|||
23621842|NCT03463577|66000795|FG004|Overall Study|Lost to Follow-up|0|||
23621843|NCT03463577|66000796|FG005|Overall Study|Lost to Follow-up|0|||
23822575|NCT01473407|66730413|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
23822576|NCT01473407|66730414|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
23822577|NCT01473407|66730413|FG000|Overall Study|Sponsor's Decision|10|||
23822578|NCT01473407|66730414|FG001|Overall Study|Sponsor's Decision|10|||
23822579|NCT01473407|66730413|FG000|Overall Study|Site Closure|1|||
23822580|NCT01473407|66730414|FG001|Overall Study|Site Closure|0|||
23822581|NCT01191944|66730417|FG000|Overall Study|Adverse Event|11|||
23822582|NCT01191944|66730418|FG001|Overall Study|Adverse Event|12|||
23822583|NCT01191944|66730417|FG000|Overall Study|Protocol Violation|1|||
23822584|NCT01191944|66730418|FG001|Overall Study|Protocol Violation|2|||
23822585|NCT01191944|66730417|FG000|Overall Study|Withdrawal by Subject|4|||
23822586|NCT01191944|66730418|FG001|Overall Study|Withdrawal by Subject|2|||
23822587|NCT01191944|66730417|FG000|Overall Study|Other|1|||
23822588|NCT01191944|66730418|FG001|Overall Study|Other|3|||
23822589|NCT00799058|66730419|FG000|Overall Study|Withdrawal by Subject|2|||
23822590|NCT00799058|66730420|FG001|Overall Study|Withdrawal by Subject|2|||
23822591|NCT00799058|66730421|FG002|Overall Study|Withdrawal by Subject|2|||
23822592|NCT00799058|66730419|FG000|Overall Study|Lost to Follow-up|1|||
23553775|NCT00602667|65754591|FG001|Overall Study|Physician Decision|3|||
23553776|NCT00602667|65754592|FG002|Overall Study|Physician Decision|8|||
23553777|NCT00602667|65754590|FG000|Overall Study|Progressive disease|13|||
23621844|NCT03463577|66000791|FG000|Overall Study|With unknown pregnancy outcome|0|||
23621845|NCT03463577|66000792|FG001|Overall Study|With unknown pregnancy outcome|5|||
23621846|NCT03463577|66000793|FG002|Overall Study|With unknown pregnancy outcome|0|||
23621847|NCT03463577|66000794|FG003|Overall Study|With unknown pregnancy outcome|0|||
23621848|NCT03463577|66000795|FG004|Overall Study|With unknown pregnancy outcome|0|||
23621849|NCT03463577|66000796|FG005|Overall Study|With unknown pregnancy outcome|0|||
23621850|NCT03463577|66000791|FG000|Overall Study|Maternal death|2|||
23621851|NCT03463577|66000792|FG001|Overall Study|Maternal death|0|||
23621852|NCT03463577|66000793|FG002|Overall Study|Maternal death|0|||
23621853|NCT03463577|66000794|FG003|Overall Study|Maternal death|0|||
23621854|NCT03463577|66000795|FG004|Overall Study|Maternal death|0|||
23621855|NCT03463577|66000796|FG005|Overall Study|Maternal death|0|||
23621856|NCT03463577|66000791|FG000|Overall Study|Neonatal death|0|||
23621857|NCT03463577|66000792|FG001|Overall Study|Neonatal death|0|||
23621858|NCT03463577|66000793|FG002|Overall Study|Neonatal death|0|||
23621859|NCT03463577|66000794|FG003|Overall Study|Neonatal death|15|||
23822593|NCT00799058|66730420|FG001|Overall Study|Lost to Follow-up|2|||
23822594|NCT00799058|66730421|FG002|Overall Study|Lost to Follow-up|1|||
23553778|NCT00602667|65754591|FG001|Overall Study|Progressive disease|48|||
23553779|NCT00602667|65754592|FG002|Overall Study|Progressive disease|45|||
23553780|NCT00602667|65754590|FG000|Overall Study|Progressive disease prior to therapy|0|||
23553781|NCT00602667|65754591|FG001|Overall Study|Progressive disease prior to therapy|0|||
23553782|NCT00602667|65754592|FG002|Overall Study|Progressive disease prior to therapy|1|||
23553783|NCT00951041|65754593|FG000|Overall Study|Withdrawal by Subject|1|||
23553784|NCT00951041|65754594|FG001|Overall Study|Withdrawal by Subject|1|||
23553785|NCT00951041|65754593|FG000|Overall Study|Lost to Follow-up|1|||
23553786|NCT00951041|65754594|FG001|Overall Study|Lost to Follow-up|0|||
23553787|NCT00951041|65754593|FG000|Overall Study|Other|3|||
23553788|NCT00951041|65754594|FG001|Overall Study|Other|0|||
23553789|NCT03355326|65754595|FG000|Overall Study|Protocol Violation|3|||
23553790|NCT03355326|65754596|FG001|Overall Study|Protocol Violation|3|||
23553791|NCT02395042|65754597|FG000|Treatment 1 Period|Adverse Event|1|||
23553792|NCT02395042|65754598|FG001|Treatment 1 Period|Adverse Event|3|||
23553793|NCT02395042|65754599|FG002|Treatment 1 Period|Adverse Event|1|||
23553794|NCT02395042|65754597|FG000|Treatment 1 Period|Lack of Efficacy|1|||
23553795|NCT02395042|65754598|FG001|Treatment 1 Period|Lack of Efficacy|1|||
23553796|NCT02395042|65754599|FG002|Treatment 1 Period|Lack of Efficacy|0|||
23553797|NCT02395042|65754597|FG000|Treatment 1 Period|Lost to Follow-up|1|||
23621860|NCT03463577|66000795|FG004|Overall Study|Neonatal death|17|||
23822595|NCT00799058|66730419|FG000|Overall Study|Adverse Event|0|||
23822596|NCT00799058|66730420|FG001|Overall Study|Adverse Event|2|||
23822597|NCT00799058|66730421|FG002|Overall Study|Adverse Event|0|||
23822598|NCT00799058|66730419|FG000|Overall Study|Pregnancy|1|||
23553798|NCT02395042|65754598|FG001|Treatment 1 Period|Lost to Follow-up|0|||
23621861|NCT03463577|66000796|FG005|Overall Study|Neonatal death|0|||
23621862|NCT01182207|66000797|FG000|First Intervention|Positive Hepatitis Results|0|||
23621863|NCT01182207|66000798|FG001|First Intervention|Positive Hepatitis Results|1|||
23621864|NCT01182207|66000797|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
23553799|NCT02395042|65754599|FG002|Treatment 1 Period|Lost to Follow-up|0|||
23822599|NCT00799058|66730420|FG001|Overall Study|Pregnancy|0|||
23822600|NCT00799058|66730421|FG002|Overall Study|Pregnancy|0|||
23822601|NCT00799058|66730419|FG000|Overall Study|Not adherent|3|||
23553800|NCT02395042|65754597|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
23553801|NCT02395042|65754598|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
23553802|NCT02395042|65754599|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
23553803|NCT02395042|65754597|FG000|Treatment 2 Period|Lack of Efficacy|1|||
23553804|NCT02395042|65754598|FG001|Treatment 2 Period|Lack of Efficacy|1|||
23553805|NCT02395042|65754599|FG002|Treatment 2 Period|Lack of Efficacy|0|||
23553806|NCT01041638|65754601|FG000|Overall Study|Adverse Event|4|||
23553807|NCT01041638|65754601|FG000|Overall Study|Death|1|||
23553808|NCT01041638|65754601|FG000|Overall Study|Lack of Efficacy|7|||
23553809|NCT01041638|65754601|FG000|Overall Study|Physician Decision|4|||
23553810|NCT01041638|65754601|FG000|Overall Study|Withdrawal by Subject|11|||
23553811|NCT02123108|65754602|FG000|Overall Study|Death|2|||
23553812|NCT02123108|65754603|FG001|Overall Study|Death|3|||
23553813|NCT00831779|65754607|FG000|Overall Study|Lost to Follow-up|1|||
23553814|NCT00831779|65754608|FG001|Overall Study|Lost to Follow-up|0|||
23553815|NCT00831779|65754607|FG000|Overall Study|No longer met criteria|0|||
23553816|NCT00831779|65754608|FG001|Overall Study|No longer met criteria|1|||
23745574|NCT02146365|66447531|FG003|Overall Study|Other|1|||
23745575|NCT02146365|66447532|FG004|Overall Study|Other|0|||
23745576|NCT02146365|66447533|FG005|Overall Study|Other|0|||
23745577|NCT02146365|66447534|FG006|Overall Study|Other|0|||
23745578|NCT02146365|66447535|FG007|Overall Study|Other|0|||
23745579|NCT01418365|66447536|FG000|First Intervention|Withdrawal by Subject|0|||
23745580|NCT01418365|66447537|FG001|First Intervention|Withdrawal by Subject|1|||
23745581|NCT01418365|66447536|FG000|First Intervention|Non-compliance|1|||
23745582|NCT01418365|66447537|FG001|First Intervention|Non-compliance|0|||
23745583|NCT01418365|66447536|FG000|Second Intervention|Withdrawal by Subject|0|||
23745584|NCT01418365|66447537|FG001|Second Intervention|Withdrawal by Subject|1|||
23745585|NCT00066573|66447539|FG000|Overall Study|Did not received protocol treatment|28|||
23745586|NCT00066573|66447540|FG001|Overall Study|Did not received protocol treatment|28|||
23745587|NCT00719706|66447545|FG000|Overall Study|Adverse Event|5|||
23745588|NCT00719706|66447546|FG001|Overall Study|Adverse Event|4|||
23745589|NCT00719706|66447545|FG000|Overall Study|Withdrawal by Subject|1|||
23745590|NCT00719706|66447546|FG001|Overall Study|Withdrawal by Subject|2|||
23745591|NCT00719706|66447545|FG000|Overall Study|Protocol Violation|3|||
23745592|NCT00719706|66447546|FG001|Overall Study|Protocol Violation|0|||
23745593|NCT00344968|66447547|FG000|Overall Study|Adverse Event|5|||
23745594|NCT00344968|66447548|FG001|Overall Study|Adverse Event|4|||
23745595|NCT00344968|66447549|FG002|Overall Study|Adverse Event|15|||
23745596|NCT00344968|66447547|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23745597|NCT00344968|66447548|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23745598|NCT00344968|66447549|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23745599|NCT00344968|66447547|FG000|Overall Study|Protocol Violation|2|||
23745600|NCT00344968|66447548|FG001|Overall Study|Protocol Violation|2|||
23745601|NCT00344968|66447549|FG002|Overall Study|Protocol Violation|5|||
23745602|NCT00344968|66447547|FG000|Overall Study|Withdrawal by Subject|14|||
23745603|NCT00344968|66447548|FG001|Overall Study|Withdrawal by Subject|31|||
23745604|NCT00344968|66447549|FG002|Overall Study|Withdrawal by Subject|27|||
23745605|NCT00344968|66447547|FG000|Overall Study|Lost to Follow-up|24|||
23745606|NCT00344968|66447548|FG001|Overall Study|Lost to Follow-up|37|||
23745607|NCT00344968|66447549|FG002|Overall Study|Lost to Follow-up|37|||
23745608|NCT00344968|66447547|FG000|Overall Study|Death|11|||
23745609|NCT00344968|66447548|FG001|Overall Study|Death|27|||
23745610|NCT00344968|66447549|FG002|Overall Study|Death|31|||
23745611|NCT00344968|66447547|FG000|Overall Study|Other|0|||
23745612|NCT00344968|66447548|FG001|Overall Study|Other|1|||
23745613|NCT00344968|66447549|FG002|Overall Study|Other|0|||
23745614|NCT01347931|66447550|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
23745615|NCT00909857|66447554|FG000|Overall Study|Withdrawal by Subject|6|||
23745616|NCT00909857|66447555|FG001|Overall Study|Withdrawal by Subject|10|||
23745617|NCT00909857|66447554|FG000|Overall Study|Adverse Event|5|||
23745618|NCT00909857|66447555|FG001|Overall Study|Adverse Event|5|||
23745619|NCT00909857|66447554|FG000|Overall Study|Lost to Follow-up|2|||
23745620|NCT00909857|66447555|FG001|Overall Study|Lost to Follow-up|5|||
23745621|NCT00909857|66447554|FG000|Overall Study|Protocol Violation|2|||
23745622|NCT00909857|66447555|FG001|Overall Study|Protocol Violation|1|||
23553817|NCT01381692|65754610|FG000|Overall Study|Adverse Event|1|||
23553818|NCT01381692|65754611|FG001|Overall Study|Adverse Event|0|||
23553819|NCT01381692|65754612|FG002|Overall Study|Adverse Event|0|||
23745623|NCT00909857|66447554|FG000|Overall Study|Pregnancy|1|||
23745624|NCT00909857|66447555|FG001|Overall Study|Pregnancy|0|||
23745625|NCT00909857|66447554|FG000|Overall Study|Other|1|||
23745626|NCT00909857|66447555|FG001|Overall Study|Other|0|||
23553820|NCT01381692|65754613|FG003|Overall Study|Adverse Event|0|||
23553821|NCT01381692|65754614|FG004|Overall Study|Adverse Event|0|||
23745627|NCT00909857|66447554|FG000|Overall Study|Did not receive study medication|19|||
23745628|NCT00909857|66447555|FG001|Overall Study|Did not receive study medication|24|||
23745629|NCT00650806|66447556|FG000|Overall Study|Adverse Event|0|||
23745630|NCT00650806|66447557|FG001|Overall Study|Adverse Event|5|||
23745631|NCT00650806|66447558|FG002|Overall Study|Adverse Event|3|||
23745632|NCT00650806|66447559|FG003|Overall Study|Adverse Event|4|||
23745633|NCT00650806|66447556|FG000|Overall Study|Lost to Follow-up|7|||
23745634|NCT00650806|66447557|FG001|Overall Study|Lost to Follow-up|6|||
23745635|NCT00650806|66447558|FG002|Overall Study|Lost to Follow-up|11|||
23745636|NCT00650806|66447559|FG003|Overall Study|Lost to Follow-up|10|||
23745637|NCT00650806|66447556|FG000|Overall Study|Protocol Violation|0|||
23745638|NCT00650806|66447557|FG001|Overall Study|Protocol Violation|0|||
23745639|NCT00650806|66447558|FG002|Overall Study|Protocol Violation|0|||
23745640|NCT00650806|66447559|FG003|Overall Study|Protocol Violation|1|||
23745641|NCT00650806|66447556|FG000|Overall Study|Pregnancy|0|||
23745642|NCT00650806|66447557|FG001|Overall Study|Pregnancy|0|||
23745643|NCT00650806|66447558|FG002|Overall Study|Pregnancy|0|||
23745644|NCT00650806|66447559|FG003|Overall Study|Pregnancy|1|||
23745645|NCT00650806|66447556|FG000|Overall Study|Withdrawal by Subject|7|||
23745646|NCT00650806|66447557|FG001|Overall Study|Withdrawal by Subject|5|||
23745647|NCT00650806|66447558|FG002|Overall Study|Withdrawal by Subject|8|||
23553822|NCT01381692|65754615|FG005|Overall Study|Adverse Event|0|||
23553823|NCT00677352|65754616|FG000|Treatment Phase|Adverse Event|14|||
23553824|NCT00677352|65754617|FG001|Treatment Phase|Adverse Event|22|||
23553825|NCT00677352|65754616|FG000|Treatment Phase|Lack of Efficacy|2|||
23553826|NCT00677352|65754617|FG001|Treatment Phase|Lack of Efficacy|3|||
23745648|NCT00650806|66447559|FG003|Overall Study|Withdrawal by Subject|6|||
23745649|NCT00650806|66447556|FG000|Overall Study|Noncompliance with study drug regimen|1|||
23745650|NCT00650806|66447557|FG001|Overall Study|Noncompliance with study drug regimen|1|||
23745651|NCT00650806|66447558|FG002|Overall Study|Noncompliance with study drug regimen|0|||
23745652|NCT00650806|66447559|FG003|Overall Study|Noncompliance with study drug regimen|0|||
23745653|NCT00650806|66447556|FG000|Overall Study|Study terminated by sponsor|2|||
23745654|NCT00650806|66447557|FG001|Overall Study|Study terminated by sponsor|3|||
23745655|NCT00650806|66447558|FG002|Overall Study|Study terminated by sponsor|5|||
23745656|NCT00650806|66447559|FG003|Overall Study|Study terminated by sponsor|4|||
23745657|NCT00650806|66447556|FG000|Overall Study|Other|1|||
23745658|NCT00650806|66447557|FG001|Overall Study|Other|1|||
23745659|NCT00650806|66447558|FG002|Overall Study|Other|2|||
23745660|NCT00650806|66447559|FG003|Overall Study|Other|0|||
23745661|NCT00965458|66447562|FG000|Overall Study|Adverse Event|1|||
23745662|NCT00965458|66447563|FG001|Overall Study|Adverse Event|0|||
23745663|NCT00965458|66447562|FG000|Overall Study|Lost to Follow-up|1|||
23745664|NCT00965458|66447563|FG001|Overall Study|Lost to Follow-up|3|||
23745665|NCT00965458|66447562|FG000|Overall Study|Withdrawal by Subject|0|||
23745666|NCT00965458|66447563|FG001|Overall Study|Withdrawal by Subject|1|||
23745667|NCT03878108|66447564|FG000|Overall Study|Adverse Event|1|||
23745668|NCT03878108|66447565|FG001|Overall Study|Adverse Event|0|||
23745669|NCT01333501|66447567|FG000|Overall Study|Adverse Event|3|||
23745670|NCT01333501|66447568|FG001|Overall Study|Adverse Event|1|||
23745671|NCT01333501|66447567|FG000|Overall Study|Abnormal laboratory value|2|||
23745672|NCT01333501|66447568|FG001|Overall Study|Abnormal laboratory value|1|||
23745673|NCT01333501|66447567|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23745674|NCT01333501|66447568|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
23745675|NCT01333501|66447567|FG000|Overall Study|Withdrawn consent|3|||
23745676|NCT01333501|66447568|FG001|Overall Study|Withdrawn consent|12|||
23745677|NCT04837807|66447569|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
23745678|NCT04837807|66447570|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
23745679|NCT00604175|66447576|FG000|Entry Through Week 28|Death|2|||
23553827|NCT00677352|65754616|FG000|Treatment Phase|Lost to Follow-up|0|||
23553828|NCT00677352|65754617|FG001|Treatment Phase|Lost to Follow-up|1|||
23553829|NCT00677352|65754616|FG000|Treatment Phase|Withdrawal by Subject|7|||
23553830|NCT00677352|65754617|FG001|Treatment Phase|Withdrawal by Subject|7|||
23553831|NCT00677352|65754616|FG000|Treatment Phase|Physician Decision|1|||
23621865|NCT01182207|66000798|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
23745680|NCT00604175|66447577|FG001|Entry Through Week 28|Death|0|||
23745681|NCT00604175|66447578|FG002|Entry Through Week 28|Death|0|||
23745682|NCT00604175|66447576|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
23745683|NCT00604175|66447577|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
23745684|NCT00604175|66447578|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
23553832|NCT00677352|65754617|FG001|Treatment Phase|Physician Decision|0|||
23745685|NCT00604175|66447576|FG000|Entry Through Week 28|Lost to Follow-up|4|||
23745686|NCT00604175|66447577|FG001|Entry Through Week 28|Lost to Follow-up|3|||
23745687|NCT00604175|66447578|FG002|Entry Through Week 28|Lost to Follow-up|0|||
23745688|NCT00604175|66447576|FG000|Entry Through Week 28|Ineligible|1|||
23745689|NCT00604175|66447577|FG001|Entry Through Week 28|Ineligible|0|||
23745690|NCT00604175|66447578|FG002|Entry Through Week 28|Ineligible|0|||
23745691|NCT00604175|66447576|FG000|Entry Through Week 28|Did not start intervention|2|||
23621866|NCT00002597|66000799|FG000|Overall Study|Protocol Violation|19|||
23621867|NCT00002597|66000800|FG001|Overall Study|Protocol Violation|17|||
23621868|NCT00002597|66000799|FG000|Overall Study|Withdrawal by Subject|7|||
23621869|NCT00002597|66000800|FG001|Overall Study|Withdrawal by Subject|6|||
23621870|NCT04334278|66000801|FG000|Overall Study|Lost to Follow-up|0|||
23621871|NCT04334278|66000802|FG001|Overall Study|Lost to Follow-up|3|||
23621872|NCT04334278|66000801|FG000|Overall Study|Withdrawal by Subject|4|||
23621873|NCT04334278|66000802|FG001|Overall Study|Withdrawal by Subject|2|||
23621874|NCT01183013|66000803|FG000|Overall Study|Adverse Event|6|||
23621875|NCT01183013|66000804|FG001|Overall Study|Adverse Event|8|||
23822602|NCT00799058|66730420|FG001|Overall Study|Not adherent|2|||
23822603|NCT00799058|66730421|FG002|Overall Study|Not adherent|1|||
23553833|NCT00677352|65754616|FG000|Treatment Phase|Pregnancy|0|||
23553834|NCT00677352|65754617|FG001|Treatment Phase|Pregnancy|1|||
23553835|NCT00677352|65754616|FG000|Treatment Phase|Protocol Violation|1|||
23553836|NCT00677352|65754617|FG001|Treatment Phase|Protocol Violation|1|||
23553837|NCT00677352|65754616|FG000|Treatment Phase|Transference or work related matter|0|||
23553838|NCT00677352|65754617|FG001|Treatment Phase|Transference or work related matter|5|||
23553839|NCT00677352|65754616|FG000|Treatment Phase|Not treated|0|||
23553840|NCT00677352|65754617|FG001|Treatment Phase|Not treated|2|||
23553841|NCT00677352|65754616|FG000|Tapering Phase|Adverse Event|1|||
23553842|NCT00677352|65754617|FG001|Tapering Phase|Adverse Event|5|||
23553843|NCT00677352|65754616|FG000|Tapering Phase|Withdrawal by Subject|5|||
23553844|NCT00677352|65754617|FG001|Tapering Phase|Withdrawal by Subject|3|||
23553845|NCT00677352|65754616|FG000|Tapering Phase|Pregnancy|0|||
23553846|NCT00677352|65754617|FG001|Tapering Phase|Pregnancy|1|||
23553847|NCT00677352|65754616|FG000|Tapering Phase|Job transfer|0|||
23553848|NCT00677352|65754617|FG001|Tapering Phase|Job transfer|1|||
23553849|NCT04089865|65754618|FG000|Overall Study|Withdrawal by Subject|2|||
23553850|NCT04089865|65754619|FG001|Overall Study|Withdrawal by Subject|2|||
23553851|NCT04089865|65754620|FG002|Overall Study|Withdrawal by Subject|7|||
23553852|NCT04089865|65754621|FG003|Overall Study|Withdrawal by Subject|2|||
23553853|NCT03015402|65754622|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23553854|NCT03015402|65754623|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
23553855|NCT03015402|65754622|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23553856|NCT03015402|65754623|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23553857|NCT01292928|65754624|FG000|Overall Study|Death|8|||
23553858|NCT01292928|65754624|FG000|Overall Study|Withdrawal by Subject|8|||
23553859|NCT01292928|65754624|FG000|Overall Study|Lost to Follow-up|6|||
23553860|NCT01292928|65754624|FG000|Overall Study|Physician Decision|2|||
23553861|NCT01592370|65754625|FG000|Overall Study|Disease Progression|62|||
23553862|NCT01592370|65754626|FG001|Overall Study|Disease Progression|16|||
23553863|NCT01592370|65754627|FG002|Overall Study|Disease Progression|52|||
23553864|NCT01592370|65754628|FG003|Overall Study|Disease Progression|3|||
23553865|NCT01592370|65754629|FG004|Overall Study|Disease Progression|3|||
23553866|NCT01592370|65754630|FG005|Overall Study|Disease Progression|31|||
23553867|NCT01592370|65754631|FG006|Overall Study|Disease Progression|14|||
23553868|NCT01592370|65754625|FG000|Overall Study|Study Drug Toxicity|14|||
23553869|NCT01592370|65754626|FG001|Overall Study|Study Drug Toxicity|3|||
23553870|NCT01592370|65754627|FG002|Overall Study|Study Drug Toxicity|0|||
23553871|NCT01592370|65754628|FG003|Overall Study|Study Drug Toxicity|0|||
23553872|NCT01592370|65754629|FG004|Overall Study|Study Drug Toxicity|0|||
23553873|NCT01592370|65754630|FG005|Overall Study|Study Drug Toxicity|0|||
23553874|NCT01592370|65754631|FG006|Overall Study|Study Drug Toxicity|1|||
23553875|NCT01592370|65754625|FG000|Overall Study|AE unrelated to study drug|4|||
23553876|NCT01592370|65754626|FG001|Overall Study|AE unrelated to study drug|3|||
23553877|NCT01592370|65754627|FG002|Overall Study|AE unrelated to study drug|0|||
23553878|NCT01592370|65754628|FG003|Overall Study|AE unrelated to study drug|0|||
23621876|NCT01183013|66000805|FG002|Overall Study|Adverse Event|5|||
23553879|NCT01592370|65754629|FG004|Overall Study|AE unrelated to study drug|0|||
23553880|NCT01592370|65754630|FG005|Overall Study|AE unrelated to study drug|0|||
23553881|NCT01592370|65754631|FG006|Overall Study|AE unrelated to study drug|1|||
23621877|NCT01183013|66000806|FG003|Overall Study|Adverse Event|5|||
23621878|NCT01183013|66000807|FG004|Overall Study|Adverse Event|10|||
23621879|NCT01183013|66000808|FG005|Overall Study|Adverse Event|10|||
23621880|NCT01183013|66000809|FG006|Overall Study|Adverse Event|6|||
23553882|NCT01592370|65754625|FG000|Overall Study|Request to discontinue study treatment|5|||
23621881|NCT01183013|66000803|FG000|Overall Study|Lack of Efficacy|3|||
23621882|NCT01183013|66000804|FG001|Overall Study|Lack of Efficacy|2|||
23621883|NCT01183013|66000805|FG002|Overall Study|Lack of Efficacy|1|||
23621884|NCT01183013|66000806|FG003|Overall Study|Lack of Efficacy|2|||
23621885|NCT01183013|66000807|FG004|Overall Study|Lack of Efficacy|1|||
23621886|NCT01183013|66000808|FG005|Overall Study|Lack of Efficacy|2|||
23621887|NCT01183013|66000809|FG006|Overall Study|Lack of Efficacy|0|||
23621888|NCT01183013|66000803|FG000|Overall Study|Protocol Violation|5|||
23621889|NCT01183013|66000804|FG001|Overall Study|Protocol Violation|2|||
23621890|NCT01183013|66000805|FG002|Overall Study|Protocol Violation|4|||
23621891|NCT01183013|66000806|FG003|Overall Study|Protocol Violation|0|||
23621892|NCT01183013|66000807|FG004|Overall Study|Protocol Violation|4|||
23621893|NCT01183013|66000808|FG005|Overall Study|Protocol Violation|3|||
23822604|NCT00799058|66730419|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
23822605|NCT00799058|66730420|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
23822606|NCT00799058|66730421|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
23822607|NCT00799058|66730419|FG000|Overall Study|IP dispensing error|1|||
23822608|NCT00799058|66730420|FG001|Overall Study|IP dispensing error|0|||
23822609|NCT00799058|66730421|FG002|Overall Study|IP dispensing error|0|||
23432088|NCT03442296|65327531|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
23432089|NCT03442296|65327530|FG000|12 Month Follow-up|Incomplete measurement|1|||
23432090|NCT03442296|65327531|FG001|12 Month Follow-up|Incomplete measurement|1|||
23432091|NCT00884832|65327532|FG000|Overall Study|Withdrawal by Subject|0|||
23432092|NCT00884832|65327533|FG001|Overall Study|Withdrawal by Subject|1|||
23432093|NCT00752726|65327534|FG000|Overall Study|Lost to Follow-up|2|||
23432094|NCT00752726|65327535|FG001|Overall Study|Lost to Follow-up|1|||
23432095|NCT00752726|65327534|FG000|Overall Study|Adverse Event|3|||
23432096|NCT00752726|65327535|FG001|Overall Study|Adverse Event|0|||
23432097|NCT00752726|65327534|FG000|Overall Study|Withdrawal by Subject|5|||
23432098|NCT00752726|65327535|FG001|Overall Study|Withdrawal by Subject|10|||
23553883|NCT01592370|65754626|FG001|Overall Study|Request to discontinue study treatment|0|||
23553884|NCT01592370|65754627|FG002|Overall Study|Request to discontinue study treatment|2|||
23553885|NCT01592370|65754628|FG003|Overall Study|Request to discontinue study treatment|0|||
23553886|NCT01592370|65754629|FG004|Overall Study|Request to discontinue study treatment|1|||
23553887|NCT01592370|65754630|FG005|Overall Study|Request to discontinue study treatment|2|||
23822610|NCT00799058|66730419|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
23553888|NCT01592370|65754631|FG006|Overall Study|Request to discontinue study treatment|0|||
23553889|NCT01592370|65754625|FG000|Overall Study|Withdrew consent|1|||
23553890|NCT01592370|65754626|FG001|Overall Study|Withdrew consent|2|||
23553891|NCT01592370|65754627|FG002|Overall Study|Withdrew consent|1|||
23553892|NCT01592370|65754628|FG003|Overall Study|Withdrew consent|1|||
23553893|NCT01592370|65754629|FG004|Overall Study|Withdrew consent|0|||
23553894|NCT01592370|65754630|FG005|Overall Study|Withdrew consent|0|||
23553895|NCT01592370|65754631|FG006|Overall Study|Withdrew consent|0|||
23553896|NCT01592370|65754625|FG000|Overall Study|Maximum clinical benefit|11|||
23553897|NCT01592370|65754626|FG001|Overall Study|Maximum clinical benefit|1|||
23553898|NCT01592370|65754627|FG002|Overall Study|Maximum clinical benefit|7|||
23553899|NCT01592370|65754628|FG003|Overall Study|Maximum clinical benefit|1|||
23553900|NCT01592370|65754629|FG004|Overall Study|Maximum clinical benefit|0|||
23553901|NCT01592370|65754630|FG005|Overall Study|Maximum clinical benefit|0|||
23553902|NCT01592370|65754631|FG006|Overall Study|Maximum clinical benefit|0|||
23553903|NCT01592370|65754625|FG000|Overall Study|No longer meets study criteria|1|||
23553904|NCT01592370|65754626|FG001|Overall Study|No longer meets study criteria|0|||
23553905|NCT01592370|65754627|FG002|Overall Study|No longer meets study criteria|0|||
23553906|NCT01592370|65754628|FG003|Overall Study|No longer meets study criteria|0|||
23553907|NCT01592370|65754629|FG004|Overall Study|No longer meets study criteria|0|||
23553908|NCT01592370|65754630|FG005|Overall Study|No longer meets study criteria|0|||
23553909|NCT01592370|65754631|FG006|Overall Study|No longer meets study criteria|0|||
23553910|NCT01592370|65754625|FG000|Overall Study|Other Reasons|6|||
23553911|NCT01592370|65754626|FG001|Overall Study|Other Reasons|0|||
23843097|NCT01738503|66805587|FG006|Treatment Period|Withdrawal by Subject|1|||
23432099|NCT00752726|65327534|FG000|Overall Study|Other Reason|1|||
23432100|NCT00752726|65327535|FG001|Overall Study|Other Reason|2|||
23432101|NCT01999218|65327537|FG000|Overall Study|Hyperglycemia|18|||
23553912|NCT01592370|65754627|FG002|Overall Study|Other Reasons|10|||
23432102|NCT01999218|65327538|FG001|Overall Study|Hyperglycemia|17|||
23553913|NCT01592370|65754628|FG003|Overall Study|Other Reasons|0|||
23553914|NCT01592370|65754629|FG004|Overall Study|Other Reasons|0|||
23432103|NCT01999218|65327539|FG002|Overall Study|Hyperglycemia|17|||
23553915|NCT01592370|65754630|FG005|Overall Study|Other Reasons|1|||
23621894|NCT01183013|66000809|FG006|Overall Study|Protocol Violation|3|||
23621895|NCT01183013|66000803|FG000|Overall Study|Lost to Follow-up|7|||
23621896|NCT01183013|66000804|FG001|Overall Study|Lost to Follow-up|3|||
23621897|NCT01183013|66000805|FG002|Overall Study|Lost to Follow-up|4|||
23621898|NCT01183013|66000806|FG003|Overall Study|Lost to Follow-up|3|||
23621899|NCT01183013|66000807|FG004|Overall Study|Lost to Follow-up|2|||
23822611|NCT00799058|66730420|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
23822612|NCT00799058|66730421|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
23822613|NCT00799058|66730419|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
23822614|NCT00799058|66730420|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
23822615|NCT00799058|66730421|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
23553916|NCT01592370|65754631|FG006|Overall Study|Other Reasons|0|||
23553917|NCT00810264|65754632|FG000|Overall Study|Lost to Follow-up|191|||
23553918|NCT00810264|65754632|FG000|Overall Study|Withdrawal by subject or physician|721|||
23553919|NCT00810264|65754632|FG000|Overall Study|Death|641|||
23553920|NCT01207102|65754637|FG000|Overall Study|Withdrawal by Subject|5|||
23553921|NCT01207102|65754637|FG000|Overall Study|Adverse Event|2|||
23553922|NCT01207102|65754637|FG000|Overall Study|progression|2|||
23553923|NCT01207102|65754637|FG000|Overall Study|Withdrawal by Treating Physician|1|||
23553924|NCT01864564|65754638|FG000|Overall Study|Lost to Follow-up|17|||
23553925|NCT01864564|65754639|FG001|Overall Study|Lost to Follow-up|23|||
23553926|NCT01864564|65754638|FG000|Overall Study|Withdrawal by Subject|20|||
23822616|NCT00799058|66730419|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
23822617|NCT00799058|66730420|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
23553927|NCT01864564|65754639|FG001|Overall Study|Withdrawal by Subject|11|||
23553928|NCT01864564|65754638|FG000|Overall Study|Protocol Violation|0|||
23553929|NCT01864564|65754639|FG001|Overall Study|Protocol Violation|27|||
23553930|NCT01864564|65754638|FG000|Overall Study|not reported|0|||
23553931|NCT01864564|65754639|FG001|Overall Study|not reported|34|||
23553932|NCT01692782|65754640|FG000|Overall Study|Adverse Event|12|||
23553933|NCT01692782|65754641|FG001|Overall Study|Adverse Event|32|||
23553934|NCT01692782|65754642|FG002|Overall Study|Adverse Event|2|||
23553935|NCT01692782|65754640|FG000|Overall Study|Lack of Efficacy|1|||
23553936|NCT01692782|65754641|FG001|Overall Study|Lack of Efficacy|2|||
23553937|NCT01692782|65754642|FG002|Overall Study|Lack of Efficacy|0|||
23553938|NCT01692782|65754640|FG000|Overall Study|Lost to Follow-up|2|||
23553939|NCT01692782|65754641|FG001|Overall Study|Lost to Follow-up|7|||
23553940|NCT01692782|65754642|FG002|Overall Study|Lost to Follow-up|1|||
23553941|NCT01692782|65754640|FG000|Overall Study|Pregnancy|1|||
23553942|NCT01692782|65754641|FG001|Overall Study|Pregnancy|0|||
23553943|NCT01692782|65754642|FG002|Overall Study|Pregnancy|0|||
23553944|NCT01692782|65754640|FG000|Overall Study|Protocol Violation|1|||
23553945|NCT01692782|65754641|FG001|Overall Study|Protocol Violation|0|||
23553946|NCT01692782|65754642|FG002|Overall Study|Protocol Violation|2|||
23553947|NCT01692782|65754640|FG000|Overall Study|Non-complance with study drug|0|||
23553948|NCT01692782|65754641|FG001|Overall Study|Non-complance with study drug|4|||
23822618|NCT00799058|66730421|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
23822619|NCT00799058|66730419|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
23822620|NCT00799058|66730420|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
23822621|NCT00799058|66730421|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
23822622|NCT00306995|66730424|FG000|Study Part I|Withdrawal by Subject|0|||
23822623|NCT00306995|66730425|FG001|Study Part I|Withdrawal by Subject|0|||
23822624|NCT00306995|66730426|FG002|Study Part I|Withdrawal by Subject|0|||
23822625|NCT00306995|66730427|FG003|Study Part I|Withdrawal by Subject|0|||
23553949|NCT01692782|65754642|FG002|Overall Study|Non-complance with study drug|1|||
23553950|NCT01692782|65754640|FG000|Overall Study|Non-compliant with study visits|0|||
23553951|NCT01692782|65754641|FG001|Overall Study|Non-compliant with study visits|0|||
23553952|NCT01692782|65754642|FG002|Overall Study|Non-compliant with study visits|1|||
23553953|NCT01692782|65754640|FG000|Overall Study|SAE not related to study drug|0|||
23553954|NCT01692782|65754641|FG001|Overall Study|SAE not related to study drug|1|||
23553955|NCT01692782|65754642|FG002|Overall Study|SAE not related to study drug|0|||
23553956|NCT01692782|65754640|FG000|Overall Study|Withdrawal by Subject|3|||
23822626|NCT00306995|66730428|FG004|Study Part I|Withdrawal by Subject|0|||
23822627|NCT00306995|66730429|FG005|Study Part I|Withdrawal by Subject|0|||
23822628|NCT00306995|66730430|FG006|Study Part I|Withdrawal by Subject|1|||
23822629|NCT00306995|66730424|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
23822630|NCT00306995|66730425|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
23822631|NCT00306995|66730426|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
23822632|NCT00306995|66730427|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
23822633|NCT00306995|66730428|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
23822634|NCT00306995|66730429|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
23822635|NCT00306995|66730430|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
23822636|NCT02871492|66730434|FG000|Overall Study|Lost to Follow-up|6|||
23621900|NCT01183013|66000808|FG005|Overall Study|Lost to Follow-up|6|||
23822637|NCT02871492|66730435|FG001|Overall Study|Lost to Follow-up|3|||
23553957|NCT01692782|65754641|FG001|Overall Study|Withdrawal by Subject|10|||
23553958|NCT01692782|65754642|FG002|Overall Study|Withdrawal by Subject|3|||
23553959|NCT00279201|65754647|FG000|Initiation|Death|1|||
23553960|NCT00279201|65754648|FG001|Initiation|Death|5|||
23553961|NCT00279201|65754649|FG002|Initiation|Death|0|||
23745692|NCT00604175|66447577|FG001|Entry Through Week 28|Did not start intervention|0|||
23745693|NCT00604175|66447578|FG002|Entry Through Week 28|Did not start intervention|1|||
23745694|NCT00604175|66447576|FG000|Week 29 Through Week 72|Death|0|||
23745695|NCT00604175|66447577|FG001|Week 29 Through Week 72|Death|0|||
23745696|NCT00604175|66447578|FG002|Week 29 Through Week 72|Death|1|||
23745697|NCT00604175|66447576|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
23745698|NCT00604175|66447577|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
23745699|NCT00604175|66447578|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
23745700|NCT00604175|66447576|FG000|Week 29 Through Week 72|Site closure|0|||
23745701|NCT00604175|66447577|FG001|Week 29 Through Week 72|Site closure|1|||
23745702|NCT00604175|66447578|FG002|Week 29 Through Week 72|Site closure|0|||
23745703|NCT00604175|66447576|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
23745704|NCT00604175|66447577|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
23745705|NCT00604175|66447578|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
23745706|NCT01050998|66447579|FG000|Overall Study|Adverse Event|1|||
23745707|NCT01050998|66447580|FG001|Overall Study|Adverse Event|0|||
23745708|NCT01050998|66447581|FG002|Overall Study|Adverse Event|1|||
23745709|NCT01050998|66447582|FG003|Overall Study|Adverse Event|0|||
23745710|NCT01050998|66447583|FG004|Overall Study|Adverse Event|2|||
23822638|NCT02871492|66730436|FG002|Overall Study|Lost to Follow-up|5|||
23822639|NCT02871492|66730434|FG000|Overall Study|Withdrawal by Subject|0|||
23432104|NCT01999218|65327537|FG000|Overall Study|Lack of Efficacy|1|||
23822640|NCT02871492|66730435|FG001|Overall Study|Withdrawal by Subject|0|||
23822641|NCT02871492|66730436|FG002|Overall Study|Withdrawal by Subject|1|||
23822642|NCT02463357|66730439|FG000|Overall Study|Withdrawal by Subject|1|||
23822643|NCT02463357|66730440|FG001|Overall Study|Withdrawal by Subject|0|||
23822644|NCT02463357|66730441|FG002|Overall Study|Withdrawal by Subject|0|||
23822645|NCT02463357|66730442|FG003|Overall Study|Withdrawal by Subject|0|||
23822646|NCT02463357|66730443|FG004|Overall Study|Withdrawal by Subject|0|||
23822647|NCT02463357|66730439|FG000|Overall Study|Withdrawal by Subject|0|||
23822648|NCT02463357|66730440|FG001|Overall Study|Withdrawal by Subject|0|||
23822649|NCT02463357|66730441|FG002|Overall Study|Withdrawal by Subject|0|||
23822650|NCT02463357|66730442|FG003|Overall Study|Withdrawal by Subject|0|||
23822651|NCT02463357|66730443|FG004|Overall Study|Withdrawal by Subject|1|||
23822652|NCT02289456|66730446|FG000|Induction Period|Death|2|||
23822653|NCT02289456|66730446|FG000|Induction Period|Adverse Event|11|||
23822654|NCT02289456|66730446|FG000|Induction Period|Progressive Disease (PD)|4|||
23822655|NCT02289456|66730446|FG000|Induction Period|Symptomatic Deterioration|4|||
23822656|NCT02289456|66730446|FG000|Induction Period|Withdrawal by Subject|2|||
23822657|NCT02289456|66730446|FG000|Induction Period|Miscellaneous|1|||
23822658|NCT02289456|66730446|FG000|Monotherapy Period|Death|1|||
23822659|NCT02289456|66730446|FG000|Monotherapy Period|Adverse Event|1|||
23822660|NCT02289456|66730446|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
23822661|NCT02289456|66730446|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
23822662|NCT02289456|66730446|FG000|Monotherapy Period|Withdrawal by Subject|2|||
23822663|NCT02289456|66730446|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
23432105|NCT01999218|65327538|FG001|Overall Study|Lack of Efficacy|0|||
23745711|NCT01050998|66447579|FG000|Overall Study|Withdrawal by Subject|0|||
23745712|NCT01050998|66447580|FG001|Overall Study|Withdrawal by Subject|0|||
23745713|NCT01050998|66447581|FG002|Overall Study|Withdrawal by Subject|0|||
23745714|NCT01050998|66447582|FG003|Overall Study|Withdrawal by Subject|1|||
23745715|NCT01050998|66447583|FG004|Overall Study|Withdrawal by Subject|3|||
23822664|NCT02289456|66730446|FG000|Monotherapy Period|Miscellaneous|1|||
23822665|NCT01130493|66730447|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
23822666|NCT01130493|66730448|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
23822667|NCT01130493|66730449|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
23822668|NCT01130493|66730447|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
23822669|NCT01130493|66730448|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
23822670|NCT01130493|66730449|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
23822671|NCT01130493|66730447|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
23822672|NCT01130493|66730448|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
23822673|NCT01130493|66730449|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
23822674|NCT01130493|66730447|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
23553962|NCT00279201|65754650|FG003|Initiation|Death|0|||
23553963|NCT00279201|65754651|FG004|Initiation|Death|0|||
23553964|NCT00279201|65754652|FG005|Initiation|Death|0|||
23553965|NCT00279201|65754647|FG000|Initiation|Adverse Event|6|||
23553966|NCT00279201|65754648|FG001|Initiation|Adverse Event|15|||
23553967|NCT00279201|65754649|FG002|Initiation|Adverse Event|0|||
23553968|NCT00279201|65754650|FG003|Initiation|Adverse Event|0|||
23553969|NCT00279201|65754651|FG004|Initiation|Adverse Event|0|||
23553970|NCT00279201|65754652|FG005|Initiation|Adverse Event|0|||
23553971|NCT00279201|65754647|FG000|Initiation|Lost to Follow-up|42|||
23553972|NCT00279201|65754648|FG001|Initiation|Lost to Follow-up|41|||
23553973|NCT00279201|65754649|FG002|Initiation|Lost to Follow-up|0|||
23553974|NCT00279201|65754650|FG003|Initiation|Lost to Follow-up|0|||
23553975|NCT00279201|65754651|FG004|Initiation|Lost to Follow-up|0|||
23553976|NCT00279201|65754652|FG005|Initiation|Lost to Follow-up|0|||
23553977|NCT00279201|65754647|FG000|Initiation|Entry Criteria Exclusion|7|||
23553978|NCT00279201|65754648|FG001|Initiation|Entry Criteria Exclusion|9|||
23553979|NCT00279201|65754649|FG002|Initiation|Entry Criteria Exclusion|0|||
23553980|NCT00279201|65754650|FG003|Initiation|Entry Criteria Exclusion|0|||
23553981|NCT00279201|65754651|FG004|Initiation|Entry Criteria Exclusion|0|||
23553982|NCT00279201|65754652|FG005|Initiation|Entry Criteria Exclusion|0|||
23553983|NCT00279201|65754647|FG000|Initiation|Protocol Violation|9|||
23553984|NCT00279201|65754648|FG001|Initiation|Protocol Violation|10|||
23553985|NCT00279201|65754649|FG002|Initiation|Protocol Violation|0|||
23553986|NCT00279201|65754650|FG003|Initiation|Protocol Violation|0|||
23553987|NCT00279201|65754651|FG004|Initiation|Protocol Violation|0|||
23553988|NCT00279201|65754652|FG005|Initiation|Protocol Violation|0|||
23553989|NCT00279201|65754647|FG000|Initiation|Withdrawal by Subject|35|||
23553990|NCT00279201|65754648|FG001|Initiation|Withdrawal by Subject|41|||
23553991|NCT00279201|65754649|FG002|Initiation|Withdrawal by Subject|0|||
23553992|NCT00279201|65754650|FG003|Initiation|Withdrawal by Subject|0|||
23553993|NCT00279201|65754651|FG004|Initiation|Withdrawal by Subject|0|||
23553994|NCT00279201|65754652|FG005|Initiation|Withdrawal by Subject|0|||
23553995|NCT00279201|65754647|FG000|Initiation|Physician Decision|15|||
23553996|NCT00279201|65754648|FG001|Initiation|Physician Decision|18|||
23553997|NCT00279201|65754649|FG002|Initiation|Physician Decision|0|||
23553998|NCT00279201|65754650|FG003|Initiation|Physician Decision|0|||
23553999|NCT00279201|65754651|FG004|Initiation|Physician Decision|0|||
23554000|NCT00279201|65754652|FG005|Initiation|Physician Decision|0|||
23554001|NCT00279201|65754647|FG000|Initiation|Sponsor Decision|13|||
23554002|NCT00279201|65754648|FG001|Initiation|Sponsor Decision|5|||
23554003|NCT00279201|65754649|FG002|Initiation|Sponsor Decision|0|||
23554004|NCT00279201|65754650|FG003|Initiation|Sponsor Decision|0|||
23554005|NCT00279201|65754651|FG004|Initiation|Sponsor Decision|0|||
23554006|NCT00279201|65754652|FG005|Initiation|Sponsor Decision|0|||
23554007|NCT00279201|65754647|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554008|NCT00279201|65754648|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
23554009|NCT00279201|65754649|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554010|NCT00279201|65754650|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554011|NCT00279201|65754651|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554012|NCT00279201|65754652|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554013|NCT00279201|65754647|FG000|Maintenance|Lack of Efficacy|32|||
23554014|NCT00279201|65754648|FG001|Maintenance|Lack of Efficacy|30|||
23554015|NCT00279201|65754649|FG002|Maintenance|Lack of Efficacy|0|||
23554016|NCT00279201|65754650|FG003|Maintenance|Lack of Efficacy|0|||
23554017|NCT00279201|65754651|FG004|Maintenance|Lack of Efficacy|0|||
23554018|NCT00279201|65754652|FG005|Maintenance|Lack of Efficacy|0|||
23621901|NCT01183013|66000809|FG006|Overall Study|Lost to Follow-up|5|||
23554019|NCT00279201|65754647|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
23554020|NCT00279201|65754648|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
23554021|NCT00279201|65754649|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554022|NCT00279201|65754650|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554023|NCT00279201|65754651|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554024|NCT00279201|65754652|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554025|NCT00279201|65754647|FG000|Maintenance|Adverse Event|4|||
23554026|NCT00279201|65754648|FG001|Maintenance|Adverse Event|4|||
23554027|NCT00279201|65754649|FG002|Maintenance|Adverse Event|0|||
23554028|NCT00279201|65754650|FG003|Maintenance|Adverse Event|0|||
23554029|NCT00279201|65754651|FG004|Maintenance|Adverse Event|0|||
23554030|NCT00279201|65754652|FG005|Maintenance|Adverse Event|0|||
23554031|NCT00279201|65754647|FG000|Maintenance|Death|4|||
23554032|NCT00279201|65754648|FG001|Maintenance|Death|4|||
23554033|NCT00279201|65754649|FG002|Maintenance|Death|0|||
23822675|NCT01130493|66730448|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
23822676|NCT01130493|66730449|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
23822677|NCT01130493|66730447|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
23822678|NCT01130493|66730448|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
23554034|NCT00279201|65754650|FG003|Maintenance|Death|0|||
23554035|NCT00279201|65754651|FG004|Maintenance|Death|0|||
23554036|NCT00279201|65754652|FG005|Maintenance|Death|0|||
23554037|NCT00279201|65754647|FG000|Maintenance|Lost to Follow-up|17|||
23554038|NCT00279201|65754648|FG001|Maintenance|Lost to Follow-up|13|||
23554039|NCT00279201|65754649|FG002|Maintenance|Lost to Follow-up|0|||
23554040|NCT00279201|65754650|FG003|Maintenance|Lost to Follow-up|0|||
23554041|NCT00279201|65754651|FG004|Maintenance|Lost to Follow-up|0|||
23822679|NCT01130493|66730449|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
23822680|NCT01130493|66730447|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
23554042|NCT00279201|65754652|FG005|Maintenance|Lost to Follow-up|0|||
23554043|NCT00279201|65754647|FG000|Maintenance|Entry Criteria Exclusion|1|||
23554044|NCT00279201|65754648|FG001|Maintenance|Entry Criteria Exclusion|4|||
23554045|NCT00279201|65754649|FG002|Maintenance|Entry Criteria Exclusion|0|||
23554046|NCT00279201|65754650|FG003|Maintenance|Entry Criteria Exclusion|0|||
23554047|NCT00279201|65754651|FG004|Maintenance|Entry Criteria Exclusion|0|||
23554048|NCT00279201|65754652|FG005|Maintenance|Entry Criteria Exclusion|0|||
23554049|NCT00279201|65754647|FG000|Maintenance|Protocol Violation|16|||
23554050|NCT00279201|65754648|FG001|Maintenance|Protocol Violation|24|||
23554051|NCT00279201|65754649|FG002|Maintenance|Protocol Violation|0|||
23554052|NCT00279201|65754650|FG003|Maintenance|Protocol Violation|0|||
23554053|NCT00279201|65754651|FG004|Maintenance|Protocol Violation|0|||
23554054|NCT00279201|65754652|FG005|Maintenance|Protocol Violation|0|||
23554055|NCT00279201|65754647|FG000|Maintenance|Withdrawal by Subject|18|||
23554056|NCT00279201|65754648|FG001|Maintenance|Withdrawal by Subject|18|||
23554057|NCT00279201|65754649|FG002|Maintenance|Withdrawal by Subject|0|||
23554058|NCT00279201|65754650|FG003|Maintenance|Withdrawal by Subject|0|||
23554059|NCT00279201|65754651|FG004|Maintenance|Withdrawal by Subject|0|||
23554060|NCT00279201|65754652|FG005|Maintenance|Withdrawal by Subject|0|||
23621902|NCT01183013|66000803|FG000|Overall Study|Withdrawal by Subject|9|||
23621903|NCT01183013|66000804|FG001|Overall Study|Withdrawal by Subject|13|||
23621904|NCT01183013|66000805|FG002|Overall Study|Withdrawal by Subject|10|||
23745716|NCT01050998|66447579|FG000|Overall Study|Other|3|||
23822681|NCT01130493|66730448|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
23822682|NCT01130493|66730449|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
23822683|NCT01130493|66730447|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
23822684|NCT01130493|66730448|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
23822685|NCT01130493|66730449|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
23822686|NCT01130493|66730447|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
23432106|NCT01999218|65327539|FG002|Overall Study|Lack of Efficacy|1|||
23554061|NCT00279201|65754647|FG000|Maintenance|Physician Decision|9|||
23554062|NCT00279201|65754648|FG001|Maintenance|Physician Decision|9|||
23554063|NCT00279201|65754649|FG002|Maintenance|Physician Decision|0|||
23554064|NCT00279201|65754650|FG003|Maintenance|Physician Decision|0|||
23554065|NCT00279201|65754651|FG004|Maintenance|Physician Decision|0|||
23554066|NCT00279201|65754652|FG005|Maintenance|Physician Decision|0|||
23554067|NCT00279201|65754647|FG000|Maintenance|Sponsor Decision|4|||
23554068|NCT00279201|65754648|FG001|Maintenance|Sponsor Decision|0|||
23554069|NCT00279201|65754649|FG002|Maintenance|Sponsor Decision|0|||
23745717|NCT01050998|66447580|FG001|Overall Study|Other|2|||
23745718|NCT01050998|66447581|FG002|Overall Study|Other|1|||
23745719|NCT01050998|66447582|FG003|Overall Study|Other|1|||
23745720|NCT01050998|66447583|FG004|Overall Study|Other|5|||
23745721|NCT01050998|66447579|FG000|Overall Study|Data integrity issues|0|||
23745722|NCT01050998|66447580|FG001|Overall Study|Data integrity issues|0|||
23745723|NCT01050998|66447581|FG002|Overall Study|Data integrity issues|1|||
23745724|NCT01050998|66447582|FG003|Overall Study|Data integrity issues|1|||
23745725|NCT01050998|66447583|FG004|Overall Study|Data integrity issues|4|||
23822687|NCT01130493|66730448|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
23554070|NCT00279201|65754650|FG003|Maintenance|Sponsor Decision|0|||
23554071|NCT00279201|65754651|FG004|Maintenance|Sponsor Decision|0|||
23621905|NCT01183013|66000806|FG003|Overall Study|Withdrawal by Subject|8|||
23554072|NCT00279201|65754652|FG005|Maintenance|Sponsor Decision|0|||
23554073|NCT00279201|65754647|FG000|Maintenance|HbA1c>7.5%|123|||
23621906|NCT01183013|66000807|FG004|Overall Study|Withdrawal by Subject|7|||
23745726|NCT01846442|66447586|FG000|Overall Study|Adverse Event|2|||
23554074|NCT00279201|65754648|FG001|Maintenance|HbA1c>7.5%|126|||
23554075|NCT00279201|65754649|FG002|Maintenance|HbA1c>7.5%|0|||
23554076|NCT00279201|65754650|FG003|Maintenance|HbA1c>7.5%|0|||
23554077|NCT00279201|65754651|FG004|Maintenance|HbA1c>7.5%|0|||
23554078|NCT00279201|65754652|FG005|Maintenance|HbA1c>7.5%|0|||
23554079|NCT00279201|65754647|FG000|Intensification Addendum|Withdrawal by Subject|0|||
23554080|NCT00279201|65754648|FG001|Intensification Addendum|Withdrawal by Subject|0|||
23554081|NCT00279201|65754649|FG002|Intensification Addendum|Withdrawal by Subject|12|||
23554082|NCT00279201|65754650|FG003|Intensification Addendum|Withdrawal by Subject|14|||
23554083|NCT00279201|65754651|FG004|Intensification Addendum|Withdrawal by Subject|9|||
23554084|NCT00279201|65754652|FG005|Intensification Addendum|Withdrawal by Subject|18|||
23554085|NCT00279201|65754647|FG000|Intensification Addendum|Lost to Follow-up|0|||
23554086|NCT00279201|65754648|FG001|Intensification Addendum|Lost to Follow-up|0|||
23554087|NCT00279201|65754649|FG002|Intensification Addendum|Lost to Follow-up|4|||
23554088|NCT00279201|65754650|FG003|Intensification Addendum|Lost to Follow-up|6|||
23554089|NCT00279201|65754651|FG004|Intensification Addendum|Lost to Follow-up|7|||
23554090|NCT00279201|65754652|FG005|Intensification Addendum|Lost to Follow-up|7|||
23554091|NCT00279201|65754647|FG000|Intensification Addendum|Protocol Violation|0|||
23554092|NCT00279201|65754648|FG001|Intensification Addendum|Protocol Violation|0|||
23554093|NCT00279201|65754649|FG002|Intensification Addendum|Protocol Violation|2|||
23554094|NCT00279201|65754650|FG003|Intensification Addendum|Protocol Violation|2|||
23554095|NCT00279201|65754651|FG004|Intensification Addendum|Protocol Violation|6|||
23554096|NCT00279201|65754652|FG005|Intensification Addendum|Protocol Violation|6|||
23554097|NCT00279201|65754647|FG000|Intensification Addendum|Adverse Event|0|||
23554098|NCT00279201|65754648|FG001|Intensification Addendum|Adverse Event|0|||
23554099|NCT00279201|65754649|FG002|Intensification Addendum|Adverse Event|0|||
23554100|NCT00279201|65754650|FG003|Intensification Addendum|Adverse Event|4|||
23554101|NCT00279201|65754651|FG004|Intensification Addendum|Adverse Event|1|||
23554102|NCT00279201|65754652|FG005|Intensification Addendum|Adverse Event|3|||
23554103|NCT00279201|65754647|FG000|Intensification Addendum|Physician Decision|0|||
23554104|NCT00279201|65754648|FG001|Intensification Addendum|Physician Decision|0|||
23554105|NCT00279201|65754649|FG002|Intensification Addendum|Physician Decision|4|||
23554106|NCT00279201|65754650|FG003|Intensification Addendum|Physician Decision|1|||
23554107|NCT00279201|65754651|FG004|Intensification Addendum|Physician Decision|3|||
23554108|NCT00279201|65754652|FG005|Intensification Addendum|Physician Decision|2|||
23554109|NCT00279201|65754647|FG000|Intensification Addendum|Sponsor Decision|0|||
23554110|NCT00279201|65754648|FG001|Intensification Addendum|Sponsor Decision|0|||
23554111|NCT00279201|65754649|FG002|Intensification Addendum|Sponsor Decision|0|||
23554112|NCT00279201|65754650|FG003|Intensification Addendum|Sponsor Decision|0|||
23554113|NCT00279201|65754651|FG004|Intensification Addendum|Sponsor Decision|1|||
23554114|NCT00279201|65754652|FG005|Intensification Addendum|Sponsor Decision|1|||
23554115|NCT00279201|65754647|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
23554116|NCT00279201|65754648|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
23554117|NCT00279201|65754649|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
23554118|NCT00279201|65754650|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
23621907|NCT01183013|66000808|FG005|Overall Study|Withdrawal by Subject|9|||
23621908|NCT01183013|66000809|FG006|Overall Study|Withdrawal by Subject|10|||
23621909|NCT01183013|66000803|FG000|Overall Study|Reasons other than stated above|15|||
23621910|NCT01183013|66000804|FG001|Overall Study|Reasons other than stated above|11|||
23554119|NCT00279201|65754651|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
23554120|NCT00279201|65754652|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
23554121|NCT00279201|65754647|FG000|Intensification Addendum|Lack of Efficacy|0|||
23554122|NCT00279201|65754648|FG001|Intensification Addendum|Lack of Efficacy|0|||
23554123|NCT00279201|65754649|FG002|Intensification Addendum|Lack of Efficacy|0|||
23554124|NCT00279201|65754650|FG003|Intensification Addendum|Lack of Efficacy|1|||
23554125|NCT00279201|65754651|FG004|Intensification Addendum|Lack of Efficacy|1|||
23554126|NCT00279201|65754652|FG005|Intensification Addendum|Lack of Efficacy|0|||
23621911|NCT01183013|66000805|FG002|Overall Study|Reasons other than stated above|17|||
23621912|NCT01183013|66000806|FG003|Overall Study|Reasons other than stated above|12|||
23621913|NCT01183013|66000807|FG004|Overall Study|Reasons other than stated above|12|||
23621914|NCT01183013|66000808|FG005|Overall Study|Reasons other than stated above|15|||
23621915|NCT01183013|66000809|FG006|Overall Study|Reasons other than stated above|13|||
23621916|NCT02564718|66000810|FG000|Overall Study|Withdrew from treatment|0|||
23554127|NCT00279201|65754647|FG000|Intensification Addendum|Death|0|||
23554128|NCT00279201|65754648|FG001|Intensification Addendum|Death|0|||
23554129|NCT00279201|65754649|FG002|Intensification Addendum|Death|0|||
23554130|NCT00279201|65754650|FG003|Intensification Addendum|Death|0|||
23554131|NCT00279201|65754651|FG004|Intensification Addendum|Death|1|||
23621917|NCT02564718|66000811|FG001|Overall Study|Withdrew from treatment|1|||
23621918|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
23621919|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
23621920|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
23621921|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
23621922|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
23621923|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
23621924|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
23621925|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
23621926|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
23621927|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
23621928|NCT02845375|66000813|FG000|Overall Study|upper airway obstruction|1|||
23621929|NCT02845375|66000814|FG001|Overall Study|upper airway obstruction|2|||
23822688|NCT01130493|66730449|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
23822689|NCT01130493|66730447|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
23822690|NCT01130493|66730448|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
23822691|NCT01130493|66730449|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
23822692|NCT01130493|66730447|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
23822693|NCT01130493|66730448|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
23822694|NCT01130493|66730449|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
23822695|NCT01130493|66730447|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
23822696|NCT01130493|66730448|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
23822697|NCT01130493|66730449|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23822698|NCT01130493|66730447|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
23822699|NCT01130493|66730448|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
23822700|NCT01130493|66730449|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
23822701|NCT01130493|66730447|FG000|Part 2: OLE|Adverse Event|0|||
23822702|NCT01130493|66730448|FG001|Part 2: OLE|Adverse Event|2|||
23822703|NCT01130493|66730449|FG002|Part 2: OLE|Adverse Event|1|||
23822704|NCT01130493|66730447|FG000|Part 2: OLE|Withdrawal by Subject|0|||
23822705|NCT01130493|66730448|FG001|Part 2: OLE|Withdrawal by Subject|1|||
23822706|NCT01130493|66730449|FG002|Part 2: OLE|Withdrawal by Subject|4|||
23822707|NCT04194645|66730450|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822708|NCT04194645|66730451|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822709|NCT04194645|66730452|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822710|NCT04194645|66730453|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23554132|NCT00279201|65754652|FG005|Intensification Addendum|Death|0|||
23554133|NCT00765388|65754661|FG000|Period 1|Lack of Efficacy|1|||
23554134|NCT00765388|65754662|FG001|Period 1|Lack of Efficacy|2|||
23554135|NCT00765388|65754661|FG000|Period 1|Lost to Follow-up|0|||
23554136|NCT00765388|65754662|FG001|Period 1|Lost to Follow-up|1|||
23554137|NCT00765388|65754661|FG000|Period 1|Herpes Zoster|0|||
23554138|NCT00765388|65754662|FG001|Period 1|Herpes Zoster|1|||
23554139|NCT00765388|65754661|FG000|Period 1|Hip operation|0|||
23554140|NCT00765388|65754662|FG001|Period 1|Hip operation|1|||
23554141|NCT01368965|65754675|FG000|Overall Study|Lost to Follow-up|12|||
23554142|NCT01970982|65754676|FG000|Overall Study|Withdrawal by Subject|0|||
23554143|NCT01970982|65754677|FG001|Overall Study|Withdrawal by Subject|0|||
23554144|NCT01970982|65754678|FG002|Overall Study|Withdrawal by Subject|2|||
23554145|NCT02013622|65754683|FG000|Overall Study|Lost to Follow-up|10|||
23554146|NCT02013622|65754683|FG000|Overall Study|Adverse Event|3|||
23554147|NCT02013622|65754683|FG000|Overall Study|Met Withdrawal Criteria|3|||
23554148|NCT02013622|65754683|FG000|Overall Study|Withdrawal by Subject|6|||
23554149|NCT02013622|65754683|FG000|Overall Study|Protocol Deviation|1|||
23554150|NCT02013622|65754683|FG000|Overall Study|Lack of Efficacy|1|||
23554151|NCT01783418|65754684|FG000|Overall Study|Withdrawal by Subject|1|||
23554152|NCT01783418|65754685|FG001|Overall Study|Withdrawal by Subject|0|||
23554153|NCT02080871|65754686|FG000|Overall Study|Death|1|||
23554154|NCT02080871|65754686|FG000|Overall Study|Lost to Follow-up|1|||
23554155|NCT01059565|65754703|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
23554156|NCT01059565|65754704|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
23554157|NCT01059565|65754703|FG000|24-Week Randomized Phase|Adverse Event|5|||
23554158|NCT01059565|65754704|FG001|24-Week Randomized Phase|Adverse Event|0|||
23554159|NCT01059565|65754703|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
23554160|NCT01059565|65754704|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
23554161|NCT01059565|65754703|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
23554162|NCT01059565|65754704|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
23554163|NCT01059565|65754703|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
23822711|NCT04194645|66730454|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822712|NCT04194645|66730455|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822713|NCT04194645|66730456|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822714|NCT04194645|66730457|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23554164|NCT01059565|65754704|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
23554165|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Adverse Event|2|||
23554166|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Adverse Event|0|||
23621930|NCT02845375|66000815|FG002|Overall Study|upper airway obstruction|1|||
23621931|NCT01816685|66000824|FG000|Overall Study|Lost to Follow-up|7|||
23554167|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
23554168|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
23554169|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
23554170|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
23554171|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
23554172|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
23554173|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
23554174|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
23554175|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
23554176|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
23554177|NCT02436330|65754708|FG000|Cohort 1|Lost to Follow-up|5|||
23822715|NCT04194645|66730458|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822716|NCT04194645|66730459|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
23822717|NCT04194645|66730460|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822718|NCT04194645|66730461|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822719|NCT04194645|66730462|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23621932|NCT01816685|66000825|FG001|Overall Study|Lost to Follow-up|9|||
23621933|NCT01816685|66000824|FG000|Overall Study|Surgery Cancelled|3|||
23621934|NCT01816685|66000825|FG001|Overall Study|Surgery Cancelled|2|||
23621935|NCT03503162|66000826|FG000|Overall Study|did not meet eligibility|1|||
23621936|NCT01087814|66000827|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
23554178|NCT02436330|65754709|FG001|Cohort 1|Lost to Follow-up|2|||
23554179|NCT02436330|65754708|FG000|Cohort 1|Withdrawal by Subject|0|||
23554180|NCT02436330|65754709|FG001|Cohort 1|Withdrawal by Subject|1|||
23554181|NCT02436330|65754708|FG000|Cohort 2|Lost to Follow-up|2|||
23554182|NCT02436330|65754709|FG001|Cohort 2|Lost to Follow-up|0|||
23554183|NCT02436330|65754708|FG000|Cohort 2|Withdrawal by Subject|2|||
23554184|NCT02436330|65754709|FG001|Cohort 2|Withdrawal by Subject|3|||
23554185|NCT02436330|65754708|FG000|Cohort 3|Lost to Follow-up|1|||
23554186|NCT02436330|65754709|FG001|Cohort 3|Lost to Follow-up|0|||
23554187|NCT02436330|65754708|FG000|Cohort 3|Withdrawal by Subject|4|||
23554188|NCT02436330|65754709|FG001|Cohort 3|Withdrawal by Subject|0|||
23554189|NCT02436330|65754708|FG000|Cohort 4|Lost to Follow-up|1|||
23554190|NCT02436330|65754709|FG001|Cohort 4|Lost to Follow-up|0|||
23554191|NCT02436330|65754708|FG000|Cohort 4|Withdrawal by Subject|1|||
23554192|NCT02436330|65754709|FG001|Cohort 4|Withdrawal by Subject|0|||
23554193|NCT02436330|65754708|FG000|Cohort 5|Lost to Follow-up|3|||
23554194|NCT02436330|65754709|FG001|Cohort 5|Lost to Follow-up|2|||
23554195|NCT02436330|65754708|FG000|Cohort 5|Withdrawal by Subject|3|||
23554196|NCT02436330|65754709|FG001|Cohort 5|Withdrawal by Subject|2|||
23554197|NCT02436330|65754708|FG000|Cohort 6|Lost to Follow-up|2|||
23554198|NCT02436330|65754709|FG001|Cohort 6|Lost to Follow-up|0|||
23554199|NCT02436330|65754708|FG000|Cohort 6|Withdrawal by Subject|1|||
23554200|NCT02436330|65754709|FG001|Cohort 6|Withdrawal by Subject|1|||
23554201|NCT00074282|65754710|FG000|Step 1|Adverse Event|32|||
23554202|NCT00074282|65754711|FG001|Step 1|Adverse Event|0|||
23621937|NCT01087814|66000828|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
23621938|NCT01087814|66000827|FG000|Second Intervention (5 Days)|Physician Decision|1|||
23554203|NCT00074282|65754712|FG002|Step 1|Adverse Event|0|||
23554204|NCT00074282|65754710|FG000|Step 1|Death|6|||
23621939|NCT01087814|66000828|FG001|Second Intervention (5 Days)|Physician Decision|0|||
23621940|NCT04357964|66000829|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
23621941|NCT04357964|66000830|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
23621942|NCT04357964|66000829|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
23822720|NCT04194645|66730463|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822721|NCT04194645|66730464|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23822722|NCT01461538|66730465|FG000|Overall Study|Death|15|||
23554205|NCT00074282|65754711|FG001|Step 1|Death|0|||
23822723|NCT01461538|66730466|FG001|Overall Study|Death|6|||
23822724|NCT01461538|66730467|FG002|Overall Study|Death|2|||
23822725|NCT01461538|66730465|FG000|Overall Study|Study Stopped by Sponsor|2|||
23822726|NCT01461538|66730466|FG001|Overall Study|Study Stopped by Sponsor|1|||
23822727|NCT01461538|66730467|FG002|Overall Study|Study Stopped by Sponsor|0|||
23822728|NCT01461538|66730465|FG000|Overall Study|Withdrawal by Subject|1|||
23822729|NCT01461538|66730466|FG001|Overall Study|Withdrawal by Subject|1|||
23822730|NCT01461538|66730467|FG002|Overall Study|Withdrawal by Subject|0|||
23822731|NCT00403585|66730468|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
23822732|NCT00403585|66730468|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
23554206|NCT00074282|65754712|FG002|Step 1|Death|0|||
23554207|NCT00074282|65754710|FG000|Step 1|Withdrawal by Subject|7|||
23554208|NCT00074282|65754711|FG001|Step 1|Withdrawal by Subject|0|||
23554209|NCT00074282|65754712|FG002|Step 1|Withdrawal by Subject|0|||
23621943|NCT04357964|66000830|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
23554210|NCT00074282|65754710|FG000|Step 1|Disease progression|2|||
23554211|NCT00074282|65754711|FG001|Step 1|Disease progression|0|||
23554212|NCT00074282|65754712|FG002|Step 1|Disease progression|0|||
23554213|NCT00074282|65754710|FG000|Step 1|Alternative therapy|2|||
23554214|NCT00074282|65754711|FG001|Step 1|Alternative therapy|0|||
23554215|NCT00074282|65754712|FG002|Step 1|Alternative therapy|0|||
23554216|NCT00074282|65754710|FG000|Step 1|Other complicating disease|2|||
23554217|NCT00074282|65754711|FG001|Step 1|Other complicating disease|0|||
23554218|NCT00074282|65754712|FG002|Step 1|Other complicating disease|0|||
23554219|NCT00074282|65754710|FG000|Step 1|Physician Decision|1|||
23554220|NCT00074282|65754711|FG001|Step 1|Physician Decision|0|||
23554221|NCT00074282|65754712|FG002|Step 1|Physician Decision|0|||
23554222|NCT00074282|65754710|FG000|Step 1|Ineligible|4|||
23554223|NCT00074282|65754711|FG001|Step 1|Ineligible|0|||
23554224|NCT00074282|65754712|FG002|Step 1|Ineligible|0|||
23554225|NCT00074282|65754710|FG000|Step 1|Never started treatment|2|||
23554226|NCT00074282|65754711|FG001|Step 1|Never started treatment|0|||
23554227|NCT00074282|65754712|FG002|Step 1|Never started treatment|0|||
23554228|NCT00074282|65754710|FG000|Step 2|Adverse Event|0|||
23554229|NCT00074282|65754711|FG001|Step 2|Adverse Event|2|||
23554230|NCT00074282|65754712|FG002|Step 2|Adverse Event|12|||
23554231|NCT00074282|65754710|FG000|Step 2|Disease progression|0|||
23554232|NCT00074282|65754711|FG001|Step 2|Disease progression|0|||
23554233|NCT00074282|65754712|FG002|Step 2|Disease progression|5|||
23554234|NCT00074282|65754710|FG000|Step 2|Death|0|||
23554235|NCT00074282|65754711|FG001|Step 2|Death|0|||
23554236|NCT00074282|65754712|FG002|Step 2|Death|3|||
23554237|NCT00074282|65754710|FG000|Step 2|Withdrawal by Subject|0|||
23554238|NCT00074282|65754711|FG001|Step 2|Withdrawal by Subject|0|||
23554239|NCT00074282|65754712|FG002|Step 2|Withdrawal by Subject|2|||
23554240|NCT00074282|65754710|FG000|Step 2|Physician Decision|0|||
23554241|NCT00074282|65754711|FG001|Step 2|Physician Decision|0|||
23554242|NCT00074282|65754712|FG002|Step 2|Physician Decision|1|||
23554243|NCT00074282|65754710|FG000|Step 2|Ineligible|0|||
23554244|NCT00074282|65754711|FG001|Step 2|Ineligible|0|||
23745727|NCT01846442|66447587|FG001|Overall Study|Adverse Event|4|||
23745728|NCT01846442|66447588|FG002|Overall Study|Adverse Event|2|||
23745729|NCT01846442|66447589|FG003|Overall Study|Adverse Event|1|||
23745730|NCT01846442|66447586|FG000|Overall Study|Lost to Follow-up|0|||
23745731|NCT01846442|66447587|FG001|Overall Study|Lost to Follow-up|0|||
23745732|NCT01846442|66447588|FG002|Overall Study|Lost to Follow-up|1|||
23745733|NCT01846442|66447589|FG003|Overall Study|Lost to Follow-up|0|||
23745734|NCT01846442|66447586|FG000|Overall Study|Withdrawal by Subject|3|||
23745735|NCT01846442|66447587|FG001|Overall Study|Withdrawal by Subject|2|||
23745736|NCT01846442|66447588|FG002|Overall Study|Withdrawal by Subject|0|||
23745737|NCT01846442|66447589|FG003|Overall Study|Withdrawal by Subject|1|||
23745738|NCT01846442|66447586|FG000|Overall Study|Left the city/Lost medication|1|||
23745739|NCT01846442|66447587|FG001|Overall Study|Left the city/Lost medication|0|||
23745740|NCT01846442|66447588|FG002|Overall Study|Left the city/Lost medication|1|||
23745741|NCT01846442|66447589|FG003|Overall Study|Left the city/Lost medication|1|||
23745742|NCT01484691|66447590|FG000|Overall Study|Withdrawal by Subject|1|||
23745743|NCT01484691|66447591|FG001|Overall Study|Withdrawal by Subject|1|||
23745744|NCT01484691|66447592|FG002|Overall Study|Withdrawal by Subject|1|||
23745745|NCT01484691|66447590|FG000|Overall Study|Physician Decision|0|||
23745746|NCT01484691|66447591|FG001|Overall Study|Physician Decision|2|||
23745747|NCT01484691|66447592|FG002|Overall Study|Physician Decision|1|||
23745748|NCT01958619|66447598|FG000|Overall Study|Protocol Violation|2|||
23745749|NCT01958619|66447599|FG001|Overall Study|Protocol Violation|0|||
23745750|NCT01958619|66447600|FG002|Overall Study|Protocol Violation|1|||
23745751|NCT01958619|66447601|FG003|Overall Study|Protocol Violation|0|||
23745752|NCT02210559|66447603|FG000|Overall Study|Progressive Disease|3|||
23745753|NCT02210559|66447604|FG001|Overall Study|Progressive Disease|2|||
23745754|NCT02210559|66447603|FG000|Overall Study|Adverse Event|2|||
23745755|NCT02210559|66447604|FG001|Overall Study|Adverse Event|2|||
23745756|NCT02210559|66447603|FG000|Overall Study|Physician Decision|1|||
23554245|NCT00074282|65754712|FG002|Step 2|Ineligible|1|||
23554246|NCT00130533|65754713|FG000|Overall Study|Withdrawal by Subject|33|||
23554247|NCT00130533|65754714|FG001|Overall Study|Withdrawal by Subject|6|||
23554248|NCT00130533|65754713|FG000|Overall Study|Adverse Event|34|||
23554249|NCT00130533|65754714|FG001|Overall Study|Adverse Event|1|||
23745757|NCT02210559|66447604|FG001|Overall Study|Physician Decision|0|||
23554250|NCT00130533|65754713|FG000|Overall Study|Disease relapse|9|||
23745758|NCT02210559|66447603|FG000|Overall Study|Withdrawal by Subject|0|||
23745759|NCT02210559|66447604|FG001|Overall Study|Withdrawal by Subject|1|||
23745760|NCT02210559|66447603|FG000|Overall Study|Other than specified|0|||
23745761|NCT02210559|66447604|FG001|Overall Study|Other than specified|1|||
23745762|NCT00718809|66447605|FG000|Overall Study|Disease progression|9|||
23554251|NCT00130533|65754714|FG001|Overall Study|Disease relapse|13|||
23554252|NCT00130533|65754713|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
23554253|NCT00130533|65754714|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
23554254|NCT00130533|65754713|FG000|Overall Study|Death|4|||
23554255|NCT00130533|65754714|FG001|Overall Study|Death|2|||
23621944|NCT04357964|66000829|FG000|Overall Study|Adipose sample was insufficient quality|0|||
23621945|NCT04357964|66000830|FG001|Overall Study|Adipose sample was insufficient quality|1|||
23621946|NCT00560313|66000831|FG000|Overall Study|Adverse Events or Death|2|||
23621947|NCT00560313|66000831|FG000|Overall Study|Withdrawal by Subject|2|||
23621948|NCT00560313|66000831|FG000|Overall Study|Lost to Follow-up|1|||
23621949|NCT00560313|66000831|FG000|Overall Study|Protocol Violation|1|||
23621950|NCT00857233|66000834|FG000|Overall Study|Adverse Event|24|||
23621951|NCT00857233|66000834|FG000|Overall Study|Lack of Efficacy|1|||
23621952|NCT00857233|66000834|FG000|Overall Study|Non-compliance|1|||
23621953|NCT00857233|66000834|FG000|Overall Study|Withdrawal of Consent|9|||
23621954|NCT00857233|66000834|FG000|Overall Study|Lost to Follow-up|4|||
23621955|NCT00857233|66000834|FG000|Overall Study|Nursing Home Placement|14|||
23621956|NCT00857233|66000834|FG000|Overall Study|Other Reasons|2|||
23621957|NCT01379703|66000835|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
23621958|NCT01379703|66000836|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
23621959|NCT01379703|66000837|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
23621960|NCT01379703|66000835|FG000|Study Start Through 9 Months|Adverse Event|0|||
23621961|NCT01379703|66000836|FG001|Study Start Through 9 Months|Adverse Event|14|||
23621962|NCT01379703|66000837|FG002|Study Start Through 9 Months|Adverse Event|10|||
23621963|NCT01379703|66000835|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
23745763|NCT00718809|66447606|FG001|Overall Study|Disease progression|7|||
23745764|NCT00718809|66447605|FG000|Overall Study|Adverse Event|1|||
23745765|NCT00718809|66447606|FG001|Overall Study|Adverse Event|1|||
23745766|NCT00718809|66447605|FG000|Overall Study|Withdrawal by Subject|0|||
23745767|NCT00718809|66447606|FG001|Overall Study|Withdrawal by Subject|1|||
23745768|NCT00718809|66447605|FG000|Overall Study|Lost to Follow-up|1|||
23745769|NCT00718809|66447606|FG001|Overall Study|Lost to Follow-up|0|||
23745770|NCT00718809|66447605|FG000|Overall Study|Noncompliance|1|||
23745771|NCT00718809|66447606|FG001|Overall Study|Noncompliance|0|||
23745772|NCT00422058|66447607|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
23745773|NCT00422058|66447608|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
23745774|NCT00422058|66447609|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
23745775|NCT00422058|66447610|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
23745776|NCT00422058|66447611|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
23745777|NCT00422058|66447612|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
23745778|NCT00422058|66447607|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
23745779|NCT00422058|66447608|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
23745780|NCT00422058|66447609|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
23745781|NCT00422058|66447610|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
23745782|NCT00422058|66447611|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
23745783|NCT00422058|66447612|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
23745784|NCT00422058|66447607|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
23745785|NCT00422058|66447608|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23745786|NCT00422058|66447609|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23745787|NCT00422058|66447610|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
23745788|NCT00422058|66447611|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
23745789|NCT00422058|66447612|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23745790|NCT00422058|66447607|FG000|Double-Blind, Week 0-20|Other|11|||
23745791|NCT00422058|66447608|FG001|Double-Blind, Week 0-20|Other|3|||
23745792|NCT00422058|66447609|FG002|Double-Blind, Week 0-20|Other|8|||
23745793|NCT00422058|66447610|FG003|Double-Blind, Week 0-20|Other|8|||
23745794|NCT00422058|66447611|FG004|Double-Blind, Week 0-20|Other|4|||
23745795|NCT00422058|66447612|FG005|Double-Blind, Week 0-20|Other|10|||
23745796|NCT00422058|66447607|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
23745797|NCT00422058|66447608|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
23621964|NCT01379703|66000836|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
23621965|NCT01379703|66000837|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
23621966|NCT01379703|66000835|FG000|Study Start Through 9 Months|Treatment Failure|0|||
23621967|NCT01379703|66000836|FG001|Study Start Through 9 Months|Treatment Failure|2|||
23621968|NCT01379703|66000837|FG002|Study Start Through 9 Months|Treatment Failure|2|||
23621969|NCT01379703|66000835|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
23432107|NCT01999218|65327537|FG000|Overall Study|Lost to Follow-up|22|||
23554256|NCT00130533|65754713|FG000|Overall Study|Protocol Violation|5|||
23554257|NCT00130533|65754714|FG001|Overall Study|Protocol Violation|1|||
23554258|NCT00130533|65754713|FG000|Overall Study|Lost to Follow-up|1|||
23554259|NCT00130533|65754714|FG001|Overall Study|Lost to Follow-up|1|||
23554260|NCT00130533|65754713|FG000|Overall Study|Sponsor´s decision|2|||
23554261|NCT00130533|65754714|FG001|Overall Study|Sponsor´s decision|0|||
23554262|NCT00130533|65754713|FG000|Overall Study|Second Primary Malignancy|0|||
23554263|NCT00130533|65754714|FG001|Overall Study|Second Primary Malignancy|1|||
23554264|NCT00130533|65754713|FG000|Overall Study|Other|12|||
23554265|NCT00130533|65754714|FG001|Overall Study|Other|5|||
23554266|NCT00760929|65754715|FG000|Overall Study|Adverse Event|2|||
23621970|NCT01379703|66000836|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
23745798|NCT00422058|66447609|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
23745799|NCT00422058|66447610|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
23745800|NCT00422058|66447611|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
23745801|NCT00422058|66447612|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
23745802|NCT00422058|66447607|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
23745803|NCT00422058|66447608|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
23745804|NCT00422058|66447609|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
23745805|NCT00422058|66447610|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
23745806|NCT00422058|66447611|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
23745807|NCT00422058|66447612|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
23745808|NCT00422058|66447607|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
23745809|NCT00422058|66447608|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
23745810|NCT00422058|66447609|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
23745811|NCT00422058|66447610|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
23745812|NCT00422058|66447611|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
23745813|NCT00422058|66447612|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
23745814|NCT00422058|66447607|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
23745815|NCT00422058|66447608|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
23745816|NCT00422058|66447609|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
23745817|NCT00422058|66447610|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
23745818|NCT00422058|66447611|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
23745819|NCT00422058|66447612|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
23745820|NCT00422058|66447607|FG000|Open-Label Extension, Week 20-104|Other|13|||
23745821|NCT00422058|66447608|FG001|Open-Label Extension, Week 20-104|Other|14|||
23745822|NCT00422058|66447609|FG002|Open-Label Extension, Week 20-104|Other|6|||
23745823|NCT00422058|66447610|FG003|Open-Label Extension, Week 20-104|Other|13|||
23745824|NCT00422058|66447611|FG004|Open-Label Extension, Week 20-104|Other|16|||
23745825|NCT00422058|66447612|FG005|Open-Label Extension, Week 20-104|Other|18|||
23745826|NCT00314262|66451074|FG000|Overall Study|Adverse Event|2|||
23745827|NCT00314262|66451074|FG000|Overall Study|Withdrawal by Subject|2|||
23745828|NCT00314262|66451074|FG000|Overall Study|Physician Decision|1|||
23745829|NCT00594568|66451075|FG000|Initial Treatment|Adverse Event|51|||
23745830|NCT00594568|66451076|FG001|Initial Treatment|Adverse Event|121|||
23432108|NCT01999218|65327538|FG001|Overall Study|Lost to Follow-up|17|||
23432109|NCT01999218|65327539|FG002|Overall Study|Lost to Follow-up|18|||
23432110|NCT01999218|65327537|FG000|Overall Study|Non-Compliance With Study Drug|6|||
23432111|NCT01999218|65327538|FG001|Overall Study|Non-Compliance With Study Drug|4|||
23432112|NCT01999218|65327539|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23432113|NCT01999218|65327537|FG000|Overall Study|Physician Decision|1|||
23432114|NCT01999218|65327538|FG001|Overall Study|Physician Decision|4|||
23432115|NCT01999218|65327539|FG002|Overall Study|Physician Decision|6|||
23432116|NCT01999218|65327537|FG000|Overall Study|Protocol Violation|4|||
23432117|NCT01999218|65327538|FG001|Overall Study|Protocol Violation|5|||
23432118|NCT01999218|65327539|FG002|Overall Study|Protocol Violation|4|||
23432119|NCT01999218|65327537|FG000|Overall Study|Screen failure|0|||
23432120|NCT01999218|65327538|FG001|Overall Study|Screen failure|1|||
23554267|NCT00760929|65754716|FG001|Overall Study|Adverse Event|0|||
23621971|NCT01379703|66000837|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
23745831|NCT00594568|66451077|FG002|Initial Treatment|Adverse Event|144|||
23432121|NCT01999218|65327539|FG002|Overall Study|Screen failure|0|||
23432122|NCT01999218|65327537|FG000|Overall Study|Study Terminated By Sponsor|7|||
23432123|NCT01999218|65327538|FG001|Overall Study|Study Terminated By Sponsor|5|||
23554268|NCT00760929|65754717|FG002|Overall Study|Adverse Event|6|||
23554269|NCT00760929|65754718|FG003|Overall Study|Adverse Event|10|||
23554270|NCT00760929|65754715|FG000|Overall Study|Lack of Efficacy|0|||
23554271|NCT00760929|65754716|FG001|Overall Study|Lack of Efficacy|2|||
23621972|NCT01379703|66000835|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
23621973|NCT01379703|66000836|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
23621974|NCT01379703|66000837|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
23745832|NCT00594568|66451075|FG000|Initial Treatment|Death|6|||
23822733|NCT00403585|66730468|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
23822734|NCT00582010|66730469|FG000|Overall Study|Death|0|||
23822735|NCT00582010|66730470|FG001|Overall Study|Death|1|||
23822736|NCT01851330|66730471|FG000|Overall Study|Lack of Efficacy|10|||
23822737|NCT01851330|66730472|FG001|Overall Study|Lack of Efficacy|9|||
23822738|NCT01851330|66730473|FG002|Overall Study|Lack of Efficacy|2|||
23822739|NCT01851330|66730471|FG000|Overall Study|Lost to Follow-up|1|||
23822740|NCT01851330|66730472|FG001|Overall Study|Lost to Follow-up|6|||
23822741|NCT01851330|66730473|FG002|Overall Study|Lost to Follow-up|9|||
23822742|NCT01851330|66730471|FG000|Overall Study|Withdrew Consent|2|||
23822743|NCT01851330|66730472|FG001|Overall Study|Withdrew Consent|1|||
23822744|NCT01851330|66730473|FG002|Overall Study|Withdrew Consent|0|||
23822745|NCT01851330|66730471|FG000|Overall Study|Investigator's Discretion|0|||
23822746|NCT01851330|66730472|FG001|Overall Study|Investigator's Discretion|0|||
23822747|NCT01851330|66730473|FG002|Overall Study|Investigator's Discretion|1|||
23822748|NCT00261950|66730475|FG000|Overall Study|Lost to Follow-up|2|||
23822749|NCT00261950|66730475|FG000|Overall Study|Death|6|||
23822750|NCT00261950|66730475|FG000|Overall Study|Withdrawal by Subject|5|||
23822751|NCT00261950|66730475|FG000|Overall Study|Other|1|||
23822752|NCT00261950|66730475|FG000|Overall Study|Physician Decision|1|||
23822753|NCT00261950|66730475|FG000|Overall Study|Protocol specified Criteria|11|||
23822754|NCT01442688|66730476|FG000|First Intervention|Withdrawal by Subject|1|||
23822755|NCT01442688|66730477|FG001|First Intervention|Withdrawal by Subject|0|||
23822756|NCT01442688|66730476|FG000|First Intervention|subject incarcerated|1|||
23822757|NCT01442688|66730477|FG001|First Intervention|subject incarcerated|0|||
23822758|NCT01442688|66730476|FG000|Second Intervention|Adverse Event|1|||
23822759|NCT01442688|66730477|FG001|Second Intervention|Adverse Event|0|||
23822760|NCT00461253|66730488|FG000|Overall Study|Death|985|||
23822761|NCT00461253|66730489|FG001|Overall Study|Death|0|||
23822762|NCT00461253|66730488|FG000|Overall Study|Protocol Violation|613|||
23822763|NCT00461253|66730489|FG001|Overall Study|Protocol Violation|236|||
23822764|NCT00461253|66730488|FG000|Overall Study|no response|2609|||
23822765|NCT00461253|66730489|FG001|Overall Study|no response|11789|||
23554272|NCT00760929|65754717|FG002|Overall Study|Lack of Efficacy|1|||
23554273|NCT00760929|65754718|FG003|Overall Study|Lack of Efficacy|0|||
23554274|NCT00760929|65754715|FG000|Overall Study|Withdrawal by Subject|1|||
23554275|NCT00760929|65754716|FG001|Overall Study|Withdrawal by Subject|0|||
23554276|NCT00760929|65754717|FG002|Overall Study|Withdrawal by Subject|9|||
23554277|NCT00760929|65754718|FG003|Overall Study|Withdrawal by Subject|1|||
23554278|NCT00760929|65754715|FG000|Overall Study|Lost to Follow-up|0|||
23554279|NCT00760929|65754716|FG001|Overall Study|Lost to Follow-up|0|||
23554280|NCT00760929|65754717|FG002|Overall Study|Lost to Follow-up|1|||
23554281|NCT00760929|65754718|FG003|Overall Study|Lost to Follow-up|0|||
23554282|NCT00760929|65754715|FG000|Overall Study|Progression of Disease|21|||
23554283|NCT00760929|65754716|FG001|Overall Study|Progression of Disease|26|||
23554284|NCT00760929|65754717|FG002|Overall Study|Progression of Disease|38|||
23554285|NCT00760929|65754718|FG003|Overall Study|Progression of Disease|42|||
23554286|NCT00760929|65754715|FG000|Overall Study|Other|2|||
23554287|NCT00760929|65754716|FG001|Overall Study|Other|0|||
23554288|NCT00760929|65754717|FG002|Overall Study|Other|2|||
23554289|NCT00760929|65754718|FG003|Overall Study|Other|1|||
23554290|NCT00760929|65754715|FG000|Overall Study|Death|0|||
23554291|NCT00760929|65754716|FG001|Overall Study|Death|0|||
23554292|NCT00760929|65754717|FG002|Overall Study|Death|1|||
23554293|NCT00760929|65754718|FG003|Overall Study|Death|0|||
23554294|NCT00760929|65754715|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23554295|NCT00760929|65754716|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23554296|NCT00760929|65754717|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23554297|NCT00760929|65754718|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
23554298|NCT00528775|65754720|FG000|Overall Study|Other not specified|1|||
23554299|NCT00828984|65754721|FG000|Overall Study|Adverse Event|2|||
23554300|NCT00828984|65754722|FG001|Overall Study|Adverse Event|3|||
23554301|NCT00828984|65754723|FG002|Overall Study|Adverse Event|0|||
23554302|NCT00828984|65754721|FG000|Overall Study|Lost to Follow-up|5|||
23554303|NCT00828984|65754722|FG001|Overall Study|Lost to Follow-up|3|||
23554304|NCT00828984|65754723|FG002|Overall Study|Lost to Follow-up|1|||
23554305|NCT00828984|65754721|FG000|Overall Study|Withdrawal by Subject|4|||
23554306|NCT00828984|65754722|FG001|Overall Study|Withdrawal by Subject|4|||
23554307|NCT00828984|65754723|FG002|Overall Study|Withdrawal by Subject|4|||
23554308|NCT00828984|65754721|FG000|Overall Study|Ineligable|1|||
23554309|NCT00828984|65754722|FG001|Overall Study|Ineligable|2|||
23554310|NCT00828984|65754723|FG002|Overall Study|Ineligable|0|||
23554311|NCT00828984|65754721|FG000|Overall Study|Medical Contraindication|0|||
23554312|NCT00828984|65754722|FG001|Overall Study|Medical Contraindication|1|||
23554313|NCT00828984|65754723|FG002|Overall Study|Medical Contraindication|0|||
23554314|NCT00828984|65754721|FG000|Overall Study|Noncompliant|1|||
23554315|NCT00828984|65754722|FG001|Overall Study|Noncompliant|2|||
23554316|NCT00828984|65754723|FG002|Overall Study|Noncompliant|3|||
23554317|NCT00828984|65754721|FG000|Overall Study|ConMed|1|||
23554318|NCT00828984|65754722|FG001|Overall Study|ConMed|1|||
23554319|NCT00828984|65754723|FG002|Overall Study|ConMed|1|||
23554320|NCT01400503|65754724|FG000|Overall Study|Withdrawal by Subject|1|||
23554321|NCT01400503|65754724|FG000|Overall Study|Study Terminated by Sponsor|58|||
23554322|NCT01400503|65754724|FG000|Overall Study|Other|1|||
23554323|NCT04683926|65754725|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
23554324|NCT04683926|65754726|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
23554325|NCT04683926|65754727|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
23554326|NCT04683926|65754728|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
23554327|NCT03152526|65754729|FG000|Overall Study|Withdrawal by Subject|0|||
23554328|NCT03152526|65754730|FG001|Overall Study|Withdrawal by Subject|1|||
23554329|NCT01239030|65754731|FG000|Double Blind|Adverse Event|0|||
23554330|NCT01239030|65754732|FG001|Double Blind|Adverse Event|1|||
23554331|NCT01239030|65754733|FG002|Double Blind|Adverse Event|0|||
23554332|NCT01239030|65754734|FG003|Double Blind|Adverse Event|2|||
23554333|NCT01239030|65754735|FG004|Double Blind|Adverse Event|0|||
23554334|NCT01239030|65754731|FG000|Double Blind|Withdrawal by Subject|0|||
23554335|NCT01239030|65754732|FG001|Double Blind|Withdrawal by Subject|1|||
23554336|NCT01239030|65754733|FG002|Double Blind|Withdrawal by Subject|1|||
23554337|NCT01239030|65754734|FG003|Double Blind|Withdrawal by Subject|0|||
23554338|NCT01239030|65754735|FG004|Double Blind|Withdrawal by Subject|1|||
23554339|NCT01239030|65754731|FG000|Double Blind|Lost to Follow-up|1|||
23554340|NCT01239030|65754732|FG001|Double Blind|Lost to Follow-up|1|||
23554341|NCT01239030|65754733|FG002|Double Blind|Lost to Follow-up|0|||
23554342|NCT01239030|65754734|FG003|Double Blind|Lost to Follow-up|0|||
23554343|NCT01239030|65754735|FG004|Double Blind|Lost to Follow-up|0|||
23554344|NCT01239030|65754731|FG000|Double Blind|Physician Decision|0|||
23621975|NCT01379703|66000835|FG000|Study Start Through 9 Months|Medication not available|0|||
23745833|NCT00594568|66451076|FG001|Initial Treatment|Death|11|||
23745834|NCT00594568|66451077|FG002|Initial Treatment|Death|15|||
23745835|NCT00594568|66451075|FG000|Initial Treatment|Lost to Follow-up|4|||
23745836|NCT00594568|66451076|FG001|Initial Treatment|Lost to Follow-up|1|||
23745837|NCT00594568|66451077|FG002|Initial Treatment|Lost to Follow-up|4|||
23745838|NCT00594568|66451075|FG000|Initial Treatment|Physician Decision|3|||
23745839|NCT00594568|66451076|FG001|Initial Treatment|Physician Decision|2|||
23745840|NCT00594568|66451077|FG002|Initial Treatment|Physician Decision|4|||
23745841|NCT00594568|66451075|FG000|Initial Treatment|Protocol Violation|2|||
23745842|NCT00594568|66451076|FG001|Initial Treatment|Protocol Violation|2|||
23745843|NCT00594568|66451077|FG002|Initial Treatment|Protocol Violation|5|||
23745844|NCT00594568|66451075|FG000|Initial Treatment|Withdrawal by Subject|25|||
23745845|NCT00594568|66451076|FG001|Initial Treatment|Withdrawal by Subject|31|||
23745846|NCT00594568|66451077|FG002|Initial Treatment|Withdrawal by Subject|46|||
23745847|NCT00594568|66451075|FG000|Initial Treatment|Sponsor decision|193|||
23745848|NCT00594568|66451076|FG001|Initial Treatment|Sponsor decision|142|||
23554345|NCT01239030|65754732|FG001|Double Blind|Physician Decision|1|||
23554346|NCT01239030|65754733|FG002|Double Blind|Physician Decision|0|||
23554347|NCT01239030|65754734|FG003|Double Blind|Physician Decision|0|||
23745849|NCT00594568|66451077|FG002|Initial Treatment|Sponsor decision|147|||
23745850|NCT00594568|66451075|FG000|Initial Treatment|Caregiver decision|21|||
23745851|NCT00594568|66451076|FG001|Initial Treatment|Caregiver decision|36|||
23745852|NCT00594568|66451077|FG002|Initial Treatment|Caregiver decision|36|||
23554348|NCT01239030|65754735|FG004|Double Blind|Physician Decision|0|||
23554349|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
23554350|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
23554351|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
23554352|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
23554353|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
23554354|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
23554355|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
23822766|NCT00461253|66730488|FG000|Overall Study|administrative|773|||
23822767|NCT00461253|66730489|FG001|Overall Study|administrative|7773|||
23822768|NCT02899195|66730490|FG000|Concurrent Durvalumab|Adverse Event|4|||
23822769|NCT02899195|66730490|FG000|Concurrent Durvalumab|Physician Decision|1|||
23822770|NCT02899195|66730490|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
23822771|NCT02899195|66730490|FG000|Concurrent Durvalumab|Progressive Disease|5|||
23822772|NCT02899195|66730490|FG000|Maintenance Durvalumab|Adverse Event|1|||
23822773|NCT02899195|66730490|FG000|Maintenance Durvalumab|Physician Decision|1|||
23822774|NCT02899195|66730490|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
23822775|NCT02899195|66730490|FG000|Maintenance Durvalumab|Progressive Disease|31|||
23822776|NCT00658879|66730501|FG000|Overall Study|Protocol Violation|1|||
23822777|NCT00852202|66730502|FG000|Overall Study|Adverse Event|2|||
23822778|NCT00852202|66730503|FG001|Overall Study|Adverse Event|3|||
23822779|NCT00852202|66730504|FG002|Overall Study|Adverse Event|7|||
23822780|NCT00852202|66730502|FG000|Overall Study|Lack of Efficacy|4|||
23822781|NCT00852202|66730503|FG001|Overall Study|Lack of Efficacy|1|||
23822782|NCT00852202|66730504|FG002|Overall Study|Lack of Efficacy|2|||
23822783|NCT00852202|66730502|FG000|Overall Study|Protocol Violation|2|||
23822784|NCT00852202|66730503|FG001|Overall Study|Protocol Violation|2|||
23822785|NCT00852202|66730504|FG002|Overall Study|Protocol Violation|7|||
23822786|NCT00852202|66730502|FG000|Overall Study|Withdrawal by Subject|3|||
23822787|NCT00852202|66730503|FG001|Overall Study|Withdrawal by Subject|1|||
23745853|NCT00594568|66451075|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
23745854|NCT00594568|66451076|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
23745855|NCT00594568|66451077|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
23745856|NCT00594568|66451075|FG000|Initial Treatment|Entry criteria exclusion|0|||
23745857|NCT00594568|66451076|FG001|Initial Treatment|Entry criteria exclusion|1|||
23745858|NCT00594568|66451077|FG002|Initial Treatment|Entry criteria exclusion|1|||
23745859|NCT00594568|66451075|FG000|Delayed Start|Death|0|||
23745860|NCT00594568|66451076|FG001|Delayed Start|Death|0|||
23745861|NCT00594568|66451077|FG002|Delayed Start|Death|1|||
23745862|NCT00594568|66451075|FG000|Delayed Start|Adverse Event|12|||
23745863|NCT00594568|66451076|FG001|Delayed Start|Adverse Event|2|||
23745864|NCT00594568|66451077|FG002|Delayed Start|Adverse Event|2|||
23745865|NCT00594568|66451075|FG000|Delayed Start|Withdrawal by Subject|4|||
23745866|NCT00594568|66451076|FG001|Delayed Start|Withdrawal by Subject|3|||
23745867|NCT00594568|66451077|FG002|Delayed Start|Withdrawal by Subject|0|||
23822788|NCT00852202|66730504|FG002|Overall Study|Withdrawal by Subject|2|||
23822789|NCT00852202|66730502|FG000|Overall Study|Lost to Follow-up|5|||
23822790|NCT00852202|66730503|FG001|Overall Study|Lost to Follow-up|5|||
23554356|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
23554357|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
23554358|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
23554359|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554360|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554361|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
23554362|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
23554363|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554364|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
23554365|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
23554366|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
23554367|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
23554368|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
23554369|NCT01812655|65754738|FG000|Overall Study|Protocol Violation|1|||
23554370|NCT01812655|65754739|FG001|Overall Study|Protocol Violation|1|||
23554371|NCT01812655|65754740|FG002|Overall Study|Protocol Violation|0|||
23554372|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
23554373|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
23554374|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
23554375|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
23554376|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
23554377|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
23554378|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
23554379|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
23822791|NCT00852202|66730504|FG002|Overall Study|Lost to Follow-up|6|||
23822792|NCT00852202|66730502|FG000|Overall Study|pregnancy,moving away and surgery|1|||
23745868|NCT00594568|66451075|FG000|Delayed Start|Physician Decision|0|||
23745869|NCT00594568|66451076|FG001|Delayed Start|Physician Decision|0|||
23745870|NCT00594568|66451077|FG002|Delayed Start|Physician Decision|1|||
23745871|NCT00594568|66451075|FG000|Delayed Start|Lost to Follow-up|0|||
23822793|NCT00852202|66730503|FG001|Overall Study|pregnancy,moving away and surgery|0|||
23554380|NCT02251990|65754741|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
23554381|NCT02251990|65754742|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
23745872|NCT00594568|66451076|FG001|Delayed Start|Lost to Follow-up|0|||
23554382|NCT02251990|65754741|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
23554383|NCT02251990|65754742|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
23554384|NCT02313428|65754743|FG000|Overall Study|Lost to Follow-up|1|||
23554385|NCT02313428|65754744|FG001|Overall Study|Lost to Follow-up|1|||
23554386|NCT04052204|65754748|FG000|Overall Study|Death|1|||
23554387|NCT04052204|65754749|FG001|Overall Study|Death|0|||
23554388|NCT04052204|65754750|FG002|Overall Study|Death|0|||
23554389|NCT04052204|65754748|FG000|Overall Study|Progressive disease|1|||
23554390|NCT04052204|65754749|FG001|Overall Study|Progressive disease|0|||
23621976|NCT01379703|66000836|FG001|Study Start Through 9 Months|Medication not available|2|||
23621977|NCT01379703|66000837|FG002|Study Start Through 9 Months|Medication not available|1|||
23621978|NCT01379703|66000835|FG000|Study Start Through 9 Months|Poor general condition|0|||
23621979|NCT01379703|66000836|FG001|Study Start Through 9 Months|Poor general condition|1|||
23621980|NCT01379703|66000837|FG002|Study Start Through 9 Months|Poor general condition|0|||
23621981|NCT01379703|66000835|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
23621982|NCT01379703|66000836|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
23621983|NCT01379703|66000837|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
23621984|NCT01379703|66000835|FG000|Study Start Through 9 Months|Reason unknown|2|||
23621985|NCT01379703|66000836|FG001|Study Start Through 9 Months|Reason unknown|31|||
23621986|NCT01379703|66000837|FG002|Study Start Through 9 Months|Reason unknown|24|||
23621987|NCT01379703|66000835|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
23621988|NCT01379703|66000836|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
23621989|NCT01379703|66000837|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
23621990|NCT01379703|66000835|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
23621991|NCT01379703|66000836|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
23621992|NCT01379703|66000837|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
23621993|NCT01379703|66000835|FG000|9 Months Through 18 Months|Adverse Event|0|||
23621994|NCT01379703|66000836|FG001|9 Months Through 18 Months|Adverse Event|6|||
23621995|NCT01379703|66000837|FG002|9 Months Through 18 Months|Adverse Event|0|||
23621996|NCT01379703|66000835|FG000|9 Months Through 18 Months|Treatment failure|0|||
23621997|NCT01379703|66000836|FG001|9 Months Through 18 Months|Treatment failure|5|||
23621998|NCT01379703|66000837|FG002|9 Months Through 18 Months|Treatment failure|0|||
23621999|NCT01379703|66000835|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
23622000|NCT01379703|66000836|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
23622001|NCT01379703|66000837|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
23622002|NCT01379703|66000835|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
23622003|NCT01379703|66000836|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
23622004|NCT01379703|66000837|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
23622005|NCT01379703|66000835|FG000|9 Months Through 18 Months|Fatigue|0|||
23622006|NCT01379703|66000836|FG001|9 Months Through 18 Months|Fatigue|1|||
23622007|NCT01379703|66000837|FG002|9 Months Through 18 Months|Fatigue|0|||
23622008|NCT01379703|66000835|FG000|9 Months Through 18 Months|Reason Unknown|0|||
23622009|NCT01379703|66000836|FG001|9 Months Through 18 Months|Reason Unknown|23|||
23622010|NCT01379703|66000837|FG002|9 Months Through 18 Months|Reason Unknown|0|||
23622011|NCT02176356|66000839|FG000|Overall Study|Screen Failure|14|||
23622012|NCT02176356|66000839|FG000|Overall Study|Lost to Follow-up|4|||
23622013|NCT02176356|66000839|FG000|Overall Study|Personal Reasons|3|||
23622014|NCT02176356|66000839|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23622015|NCT00905359|66000840|FG000|Overall Study|Lost to Follow-up|17|||
23622016|NCT00905359|66000841|FG001|Overall Study|Lost to Follow-up|10|||
23622017|NCT00905359|66000840|FG000|Overall Study|Death|2|||
23622018|NCT00905359|66000841|FG001|Overall Study|Death|0|||
23622019|NCT00905359|66000840|FG000|Overall Study|Withdrawal consent|5|||
23622020|NCT00905359|66000841|FG001|Overall Study|Withdrawal consent|6|||
23622021|NCT03807700|66000842|FG000|Overall Study|Withdrawal by Subject|2|||
23622022|NCT03807700|66000843|FG001|Overall Study|Withdrawal by Subject|1|||
23622023|NCT02201771|66000851|FG000|Overall Study|Death|3|||
23622024|NCT02201771|66000852|FG001|Overall Study|Death|2|||
23622025|NCT02201771|66000853|FG002|Overall Study|Death|0|||
23622026|NCT02201771|66000851|FG000|Overall Study|Protocol Violation|10|||
23622027|NCT02201771|66000852|FG001|Overall Study|Protocol Violation|8|||
23622028|NCT02201771|66000853|FG002|Overall Study|Protocol Violation|10|||
23622029|NCT00691678|66000856|FG000|Overall Study|Adverse Event|5|||
23622030|NCT00691678|66000856|FG000|Overall Study|life events, pain|11|||
23622031|NCT01128114|66000857|FG000|Overall Study|Treatment Withdrawn|6|||
23622032|NCT01128114|66000857|FG000|Overall Study|Screening Failed|2|||
23622033|NCT01990313|66000858|FG000|Overall Study|Lost to Follow-up|1|||
23622034|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
23622035|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
23622036|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
23622037|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
23622038|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
23622039|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
23622040|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Rejections|0|||
23745873|NCT00594568|66451077|FG002|Delayed Start|Lost to Follow-up|1|||
23745874|NCT00594568|66451075|FG000|Delayed Start|Caregiver Decision|5|||
23745875|NCT00594568|66451076|FG001|Delayed Start|Caregiver Decision|6|||
23745876|NCT00594568|66451077|FG002|Delayed Start|Caregiver Decision|2|||
23745877|NCT00594568|66451075|FG000|Delayed Start|Sponsor Decision|77|||
23745878|NCT00594568|66451076|FG001|Delayed Start|Sponsor Decision|66|||
23745879|NCT00594568|66451077|FG002|Delayed Start|Sponsor Decision|59|||
23745880|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
23745881|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
23745882|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
23745883|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
23745884|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23745885|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23745886|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
23432124|NCT01999218|65327539|FG002|Overall Study|Study Terminated By Sponsor|12|||
23432125|NCT01999218|65327537|FG000|Overall Study|Participant moves|2|||
23432126|NCT01999218|65327538|FG001|Overall Study|Participant moves|5|||
23432127|NCT01999218|65327539|FG002|Overall Study|Participant moves|3|||
23554391|NCT04052204|65754750|FG002|Overall Study|Progressive disease|0|||
23554392|NCT04052204|65754748|FG000|Overall Study|Other|1|||
23554393|NCT04052204|65754749|FG001|Overall Study|Other|0|||
23622041|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Rejections|0|||
23622042|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Rejections|55|||
23622043|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
23622044|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
23622045|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
23622046|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
23622047|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
23622048|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
23745887|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
23745888|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
23745889|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
23745890|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
23745891|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
23745892|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
23745893|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
23432128|NCT01999218|65327537|FG000|Overall Study|Withdrawal by Subject|28|||
23554394|NCT04052204|65754750|FG002|Overall Study|Other|0|||
23554395|NCT00765674|65754751|FG000|Overall Study|Adverse Event|7|||
23554396|NCT00765674|65754752|FG001|Overall Study|Adverse Event|2|||
23622049|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Other issues|0|||
23622050|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Other issues|0|||
23622051|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Other issues|6|||
23622052|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
23622053|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
23622054|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
23622055|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Rejection|11|||
23622056|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Rejection|5|||
23622057|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Rejection|0|||
23622058|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Death|2|||
23622059|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Death|5|||
23622060|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Death|0|||
23622061|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
23622062|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
23554397|NCT00765674|65754753|FG002|Overall Study|Adverse Event|8|||
23554398|NCT00765674|65754754|FG003|Overall Study|Adverse Event|11|||
23554399|NCT00765674|65754751|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23554400|NCT00765674|65754752|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
23554401|NCT00765674|65754753|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
23554402|NCT00765674|65754754|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23554403|NCT00765674|65754751|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23554404|NCT00765674|65754752|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
23622063|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
23622064|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
23622065|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
23745894|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
23745895|NCT00594568|66451075|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
23745896|NCT00594568|66451076|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
23745897|NCT00594568|66451077|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
23745898|NCT00924820|66451078|FG000|Overall Study|Death|2|||
23554405|NCT00765674|65754753|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
23554406|NCT00765674|65754754|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
23745899|NCT00924820|66451078|FG000|Overall Study|Ineligible, Screen Failure|5|||
23745900|NCT02842736|66451079|FG000|Overall Study|Lost to Follow-up|13|||
23745901|NCT02842736|66451079|FG000|Overall Study|Intervention for menstrual bleeding|17|||
23745902|NCT02842736|66451079|FG000|Overall Study|Withdrawal by Subject|4|||
23745903|NCT02842736|66451079|FG000|Overall Study|Pregnancy|3|||
23745904|NCT02842736|66451079|FG000|Overall Study|Hysterectomy for fibroids|2|||
23745905|NCT02842736|66451079|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
23745906|NCT02842736|66451079|FG000|Overall Study|IUD: Mirena|1|||
23745907|NCT03446157|66451080|FG000|Overall Study|Death|11|||
23745908|NCT03446157|66451081|FG001|Overall Study|Death|9|||
23745909|NCT03446157|66451080|FG000|Overall Study|Lost to Follow-up|0|||
23745910|NCT03446157|66451081|FG001|Overall Study|Lost to Follow-up|1|||
23745911|NCT03446157|66451080|FG000|Overall Study|Withdrawal by Subject|2|||
23745912|NCT03446157|66451081|FG001|Overall Study|Withdrawal by Subject|1|||
23745913|NCT01593761|66451082|FG000|Overall Study|Lost to Follow-up|1|||
23745914|NCT01593761|66451082|FG000|Overall Study|culture negative for MRSA at baseline|5|||
23745915|NCT01593761|66451082|FG000|Overall Study|positive for hepatitis C virus|1|||
23745916|NCT01593761|66451082|FG000|Overall Study|secondary cellulitis|1|||
23745917|NCT01409382|66451087|FG000|Overall Study|Lost to Follow-up|1|||
23745918|NCT01409382|66451088|FG001|Overall Study|Lost to Follow-up|1|||
23745919|NCT01409382|66451087|FG000|Overall Study|Protocol Violation|0|||
23745920|NCT01409382|66451088|FG001|Overall Study|Protocol Violation|3|||
23745921|NCT01409382|66451087|FG000|Overall Study|Multiple pregnancy|2|||
23745922|NCT01409382|66451088|FG001|Overall Study|Multiple pregnancy|4|||
23745923|NCT01409382|66451087|FG000|Overall Study|Still pregnant when study ended|13|||
23745924|NCT01409382|66451088|FG001|Overall Study|Still pregnant when study ended|2|||
23745925|NCT01409382|66451087|FG000|Overall Study|Did not manage to get pregnant|64|||
23745926|NCT01409382|66451088|FG001|Overall Study|Did not manage to get pregnant|70|||
23432129|NCT01999218|65327538|FG001|Overall Study|Withdrawal by Subject|29|||
23745927|NCT01409382|66451087|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
23745928|NCT01409382|66451088|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
23554407|NCT00765674|65754751|FG000|Overall Study|Lack of Efficacy|2|||
23745929|NCT00464308|66451093|FG000|Overall Study|Adverse Event|22|||
23745930|NCT00464308|66451094|FG001|Overall Study|Adverse Event|27|||
23745931|NCT00464308|66451095|FG002|Overall Study|Adverse Event|16|||
23745932|NCT00464308|66451093|FG000|Overall Study|Lost to Follow-up|29|||
23745933|NCT00464308|66451094|FG001|Overall Study|Lost to Follow-up|19|||
23745934|NCT00464308|66451095|FG002|Overall Study|Lost to Follow-up|20|||
23745935|NCT00464308|66451093|FG000|Overall Study|Patient discontinued and other reasons|17|||
23745936|NCT00464308|66451094|FG001|Overall Study|Patient discontinued and other reasons|17|||
23745937|NCT00464308|66451095|FG002|Overall Study|Patient discontinued and other reasons|23|||
23745938|NCT00464308|66451093|FG000|Overall Study|Physician Decision|1|||
23745939|NCT00464308|66451094|FG001|Overall Study|Physician Decision|0|||
23745940|NCT00464308|66451095|FG002|Overall Study|Physician Decision|0|||
23745941|NCT00198107|66451101|FG000|Double-Blind Period|Adverse Event|1|||
23745942|NCT00198107|66451102|FG001|Double-Blind Period|Adverse Event|1|||
23745943|NCT00198107|66451103|FG002|Double-Blind Period|Adverse Event|0|||
23745944|NCT00198107|66451101|FG000|Double-Blind Period|Lack of Efficacy|2|||
23745945|NCT00198107|66451102|FG001|Double-Blind Period|Lack of Efficacy|0|||
23745946|NCT00198107|66451103|FG002|Double-Blind Period|Lack of Efficacy|0|||
23745947|NCT00198107|66451101|FG000|Double-Blind Period|Lost to Follow-up|2|||
23745948|NCT00198107|66451102|FG001|Double-Blind Period|Lost to Follow-up|1|||
23745949|NCT00198107|66451103|FG002|Double-Blind Period|Lost to Follow-up|0|||
23745950|NCT00198107|66451101|FG000|Double-Blind Period|Physician Decision|1|||
23745951|NCT00198107|66451102|FG001|Double-Blind Period|Physician Decision|0|||
23745952|NCT00198107|66451103|FG002|Double-Blind Period|Physician Decision|0|||
23745953|NCT00198107|66451101|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23745954|NCT00198107|66451102|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23745955|NCT00198107|66451103|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23745956|NCT00198107|66451101|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
23745957|NCT00198107|66451102|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
23745958|NCT00198107|66451103|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
23745959|NCT00483717|66451104|FG000|Overall Study|Protocol Violation|5|||
23745960|NCT00483717|66451105|FG001|Overall Study|Protocol Violation|7|||
23745961|NCT00483717|66451104|FG000|Overall Study|Time of dosing missing|1|||
23745962|NCT00483717|66451105|FG001|Overall Study|Time of dosing missing|1|||
23745963|NCT00483717|66451104|FG000|Overall Study|No treatment for migraine|16|||
23745964|NCT00483717|66451105|FG001|Overall Study|No treatment for migraine|13|||
23745965|NCT00483717|66451104|FG000|Overall Study|Lost to Follow-up|1|||
23745966|NCT00483717|66451105|FG001|Overall Study|Lost to Follow-up|0|||
23745967|NCT00483717|66451104|FG000|Overall Study|Withdrawal by Subject|1|||
23745968|NCT00483717|66451105|FG001|Overall Study|Withdrawal by Subject|0|||
23745969|NCT01336647|66451106|FG000|Overall Study|Lost to Follow-up|4|||
23745970|NCT01336647|66451107|FG001|Overall Study|Lost to Follow-up|1|||
23745971|NCT01336647|66451108|FG002|Overall Study|Lost to Follow-up|3|||
23745972|NCT00621309|66451110|FG000|Overall Study|Withdrawal by Subject|2|||
23745973|NCT00621309|66451111|FG001|Overall Study|Withdrawal by Subject|0|||
23745974|NCT00621309|66451112|FG002|Overall Study|Withdrawal by Subject|1|||
23745975|NCT00621309|66451113|FG003|Overall Study|Withdrawal by Subject|1|||
23745976|NCT00621309|66451114|FG004|Overall Study|Withdrawal by Subject|1|||
23745977|NCT00621309|66451115|FG005|Overall Study|Withdrawal by Subject|1|||
23745978|NCT00462501|66451116|FG000|Overall Study|Not treated|3|||
23745979|NCT00462501|66451116|FG000|Overall Study|Adverse Event|2|||
23745980|NCT01646268|66451117|FG000|Overall Study|Adverse Event|6|||
23745981|NCT01646268|66451118|FG001|Overall Study|Adverse Event|7|||
23745982|NCT01646268|66451117|FG000|Overall Study|Lack of Efficacy|1|||
23822794|NCT00852202|66730504|FG002|Overall Study|pregnancy,moving away and surgery|2|||
23554408|NCT00765674|65754752|FG001|Overall Study|Lack of Efficacy|3|||
23554409|NCT00765674|65754753|FG002|Overall Study|Lack of Efficacy|1|||
23745983|NCT01646268|66451118|FG001|Overall Study|Lack of Efficacy|3|||
23745984|NCT01646268|66451117|FG000|Overall Study|Protocol Violation|0|||
23745985|NCT01646268|66451118|FG001|Overall Study|Protocol Violation|1|||
23745986|NCT01646268|66451117|FG000|Overall Study|Withdrawal by Subject|2|||
23745987|NCT01646268|66451118|FG001|Overall Study|Withdrawal by Subject|5|||
23745988|NCT01646268|66451117|FG000|Overall Study|Other|2|||
23745989|NCT01646268|66451118|FG001|Overall Study|Other|0|||
23745990|NCT00627094|66451119|FG000|Overall Study|Adverse Event|8|||
23745991|NCT00627094|66451120|FG001|Overall Study|Adverse Event|7|||
23745992|NCT00627094|66451119|FG000|Overall Study|Lost to Follow-up|1|||
23745993|NCT00627094|66451120|FG001|Overall Study|Lost to Follow-up|0|||
23554410|NCT00765674|65754754|FG003|Overall Study|Lack of Efficacy|2|||
23745994|NCT00627094|66451119|FG000|Overall Study|Withdrawal by Subject|1|||
23745995|NCT00627094|66451120|FG001|Overall Study|Withdrawal by Subject|1|||
23745996|NCT00627094|66451119|FG000|Overall Study|ulcer healed|1|||
23745997|NCT00627094|66451120|FG001|Overall Study|ulcer healed|7|||
23745998|NCT00627094|66451119|FG000|Overall Study|Other reason|1|||
23745999|NCT00627094|66451120|FG001|Overall Study|Other reason|0|||
23746000|NCT05102162|66451121|FG000|Overall Study|Withdrawal by Subject|3|||
23746001|NCT05102162|66451122|FG001|Overall Study|Withdrawal by Subject|0|||
23554411|NCT00765674|65754751|FG000|Overall Study|Protocol Violation|2|||
23554412|NCT00765674|65754752|FG001|Overall Study|Protocol Violation|0|||
23554413|NCT00765674|65754753|FG002|Overall Study|Protocol Violation|1|||
23554414|NCT00765674|65754754|FG003|Overall Study|Protocol Violation|0|||
23554415|NCT00765674|65754751|FG000|Overall Study|Withdrawal by Subject|5|||
23554416|NCT00765674|65754752|FG001|Overall Study|Withdrawal by Subject|7|||
23554417|NCT00765674|65754753|FG002|Overall Study|Withdrawal by Subject|3|||
23554418|NCT00765674|65754754|FG003|Overall Study|Withdrawal by Subject|8|||
23554419|NCT00765674|65754751|FG000|Overall Study|Lost to Follow-up|4|||
23554420|NCT00765674|65754752|FG001|Overall Study|Lost to Follow-up|6|||
23554421|NCT00765674|65754753|FG002|Overall Study|Lost to Follow-up|2|||
23554422|NCT00765674|65754754|FG003|Overall Study|Lost to Follow-up|1|||
23554423|NCT00765674|65754751|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
23554424|NCT00765674|65754752|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
23554425|NCT00765674|65754753|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
23746002|NCT05102162|66451121|FG000|Overall Study|Baseline cultures negative|4|||
23746003|NCT05102162|66451122|FG001|Overall Study|Baseline cultures negative|2|||
23746004|NCT05102162|66451121|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
23746005|NCT05102162|66451122|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
23746006|NCT05102162|66451121|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
23746007|NCT05102162|66451122|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
23622066|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
23622067|NCT00545571|66000864|FG000|Overall Study|Administrative Reasons|1|||
23746008|NCT02230332|66451123|FG000|Overall Study|Adverse Event|2|||
23746009|NCT02230332|66451124|FG001|Overall Study|Adverse Event|1|||
23746010|NCT02230332|66451123|FG000|Overall Study|Lost to Follow-up|1|||
23746011|NCT02230332|66451124|FG001|Overall Study|Lost to Follow-up|0|||
23746012|NCT02230332|66451123|FG000|Overall Study|Protocol Violation|1|||
23746013|NCT02230332|66451124|FG001|Overall Study|Protocol Violation|0|||
23746014|NCT01096017|66451125|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
23746015|NCT01096017|66451126|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
23746016|NCT01714726|66451130|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
23746017|NCT01714726|66451131|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
23746018|NCT01714726|66451132|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
23746019|NCT01714726|66451133|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
23746020|NCT01714726|66451130|FG000|Double-Blinded Induction Period|Adverse Event|0|||
23746021|NCT01714726|66451131|FG001|Double-Blinded Induction Period|Adverse Event|1|||
23746022|NCT01714726|66451132|FG002|Double-Blinded Induction Period|Adverse Event|0|||
23746023|NCT01714726|66451133|FG003|Double-Blinded Induction Period|Adverse Event|0|||
23746024|NCT01714726|66451130|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
23746025|NCT01714726|66451131|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
23746026|NCT01714726|66451132|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
23746027|NCT01714726|66451133|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
23746028|NCT01714726|66451130|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
23746029|NCT01714726|66451131|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
23746030|NCT01714726|66451132|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
23746031|NCT01714726|66451133|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
23746032|NCT01714726|66451130|FG000|Open-Label Period|Other|0|||
23746033|NCT01714726|66451131|FG001|Open-Label Period|Other|0|||
23746034|NCT01714726|66451132|FG002|Open-Label Period|Other|1|||
23746035|NCT01714726|66451133|FG003|Open-Label Period|Other|3|||
23746036|NCT01714726|66451130|FG000|Open-Label Period|Adverse Event|0|||
23746037|NCT01714726|66451131|FG001|Open-Label Period|Adverse Event|0|||
23746038|NCT01714726|66451132|FG002|Open-Label Period|Adverse Event|1|||
23622068|NCT00545571|66000864|FG000|Overall Study|Adverse Event|2|||
23746039|NCT01714726|66451133|FG003|Open-Label Period|Adverse Event|0|||
23746040|NCT01714726|66451130|FG000|Open-Label Period|Withdrawal by Subject|0|||
23746041|NCT01714726|66451131|FG001|Open-Label Period|Withdrawal by Subject|0|||
23746042|NCT01714726|66451132|FG002|Open-Label Period|Withdrawal by Subject|9|||
23746043|NCT01714726|66451133|FG003|Open-Label Period|Withdrawal by Subject|19|||
23746044|NCT01714726|66451130|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
23746045|NCT01714726|66451131|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
23554426|NCT00765674|65754754|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
23554427|NCT02366910|65754755|FG000|Overall Study|Withdrawal by Subject|2|||
23554428|NCT02366910|65754755|FG000|Overall Study|Screen Failure|3|||
23554429|NCT03804710|65754760|FG000|Overall Study|Adverse Event|0|||
23746046|NCT01714726|66451132|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
23746047|NCT01714726|66451133|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
23746048|NCT01714726|66451130|FG000|Open-Label Period|Lost to Follow-up|0|||
23746049|NCT01714726|66451131|FG001|Open-Label Period|Lost to Follow-up|0|||
23746050|NCT01714726|66451132|FG002|Open-Label Period|Lost to Follow-up|3|||
23746051|NCT01714726|66451133|FG003|Open-Label Period|Lost to Follow-up|4|||
23746052|NCT00779857|66451135|FG000|Overall Study|Death|1|||
23746053|NCT00779857|66451135|FG000|Overall Study|Withdrawal by Subject|3|||
23746054|NCT00779857|66451135|FG000|Overall Study|Missed Visit|2|||
23746055|NCT00752206|66451136|FG000|Overall Study|Disease progression|8|||
23432130|NCT01999218|65327539|FG002|Overall Study|Withdrawal by Subject|34|||
23432131|NCT01999218|65327537|FG000|Overall Study|Creatinine/eGFR|0|||
23432132|NCT01999218|65327538|FG001|Overall Study|Creatinine/eGFR|0|||
23432133|NCT01999218|65327539|FG002|Overall Study|Creatinine/eGFR|1|||
23432134|NCT01999218|65327537|FG000|Overall Study|Death|7|||
23432135|NCT01999218|65327538|FG001|Overall Study|Death|1|||
23432136|NCT01999218|65327539|FG002|Overall Study|Death|2|||
23432137|NCT01999218|65327537|FG000|Overall Study|Excluded Medication|1|||
23432138|NCT01999218|65327538|FG001|Overall Study|Excluded Medication|1|||
23432139|NCT01999218|65327539|FG002|Overall Study|Excluded Medication|2|||
23432140|NCT01999218|65327537|FG000|Overall Study|Adverse Event|9|||
23432141|NCT01999218|65327538|FG001|Overall Study|Adverse Event|7|||
23432142|NCT01999218|65327539|FG002|Overall Study|Adverse Event|7|||
23432143|NCT01999218|65327537|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
23432144|NCT01999218|65327538|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
23432145|NCT01999218|65327539|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
23432146|NCT05026853|65327540|FG000|Overall Study|Cancelled appointment|1|||
23432147|NCT05026853|65327541|FG001|Overall Study|Cancelled appointment|0|||
23432148|NCT05026853|65327540|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
23432149|NCT05026853|65327541|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
23432150|NCT05026853|65327540|FG000|Overall Study|Did not complete 12-week survey|16|||
23432151|NCT05026853|65327541|FG001|Overall Study|Did not complete 12-week survey|16|||
23432152|NCT00262847|65327543|FG000|Overall Study|Disease Progression|309|||
23432153|NCT00262847|65327544|FG001|Overall Study|Disease Progression|274|||
23432154|NCT00262847|65327545|FG002|Overall Study|Disease Progression|195|||
23432155|NCT00262847|65327543|FG000|Overall Study|Patient Refusal|41|||
23432156|NCT00262847|65327544|FG001|Overall Study|Patient Refusal|52|||
23432157|NCT00262847|65327545|FG002|Overall Study|Patient Refusal|47|||
23432158|NCT00262847|65327543|FG000|Overall Study|Adverse Event|74|||
23554430|NCT03804710|65754761|FG001|Overall Study|Adverse Event|3|||
23554431|NCT03804710|65754760|FG000|Overall Study|Withdrawal by Subject|2|||
23554432|NCT03804710|65754761|FG001|Overall Study|Withdrawal by Subject|1|||
23554433|NCT03804710|65754760|FG000|Overall Study|Other|0|||
23554434|NCT03804710|65754761|FG001|Overall Study|Other|1|||
23554435|NCT03185481|65754762|FG000|Overall Study|Adverse Event|1|||
23746056|NCT00752206|66451137|FG001|Overall Study|Disease progression|11|||
23746057|NCT00752206|66451136|FG000|Overall Study|Pregnancy|1|||
23432159|NCT00262847|65327544|FG001|Overall Study|Adverse Event|88|||
23432160|NCT00262847|65327545|FG002|Overall Study|Adverse Event|108|||
23432161|NCT00262847|65327543|FG000|Overall Study|Death|8|||
23432162|NCT00262847|65327544|FG001|Overall Study|Death|8|||
23432163|NCT00262847|65327545|FG002|Overall Study|Death|11|||
23432164|NCT00262847|65327543|FG000|Overall Study|Concomitant disease|3|||
23432165|NCT00262847|65327544|FG001|Overall Study|Concomitant disease|2|||
23432166|NCT00262847|65327545|FG002|Overall Study|Concomitant disease|4|||
23432167|NCT00262847|65327543|FG000|Overall Study|Other Reasons|79|||
23554436|NCT03185481|65754762|FG000|Overall Study|Study Terminated by Sponsor|4|||
23554437|NCT00686881|65754763|FG000|Overall Study|Withdrawal by Subject|11|||
23746058|NCT00752206|66451137|FG001|Overall Study|Pregnancy|0|||
23746059|NCT04409509|66451138|FG000|Overall Study|Failure to meet randomization requirement|1|||
23746060|NCT04409509|66451139|FG001|Overall Study|Failure to meet randomization requirement|0|||
23746061|NCT04409509|66451138|FG000|Overall Study|Adverse Event|0|||
23822795|NCT03280381|66730505|FG000|Overall Study|Physician Decision|0|||
23432168|NCT00262847|65327544|FG001|Overall Study|Other Reasons|88|||
23432169|NCT00262847|65327545|FG002|Overall Study|Other Reasons|27|||
23432170|NCT00262847|65327543|FG000|Overall Study|Did not receive study treatment|4|||
23554438|NCT00686881|65754764|FG001|Overall Study|Withdrawal by Subject|18|||
23746062|NCT04409509|66451139|FG001|Overall Study|Adverse Event|1|||
23746063|NCT04409509|66451138|FG000|Overall Study|Death|11|||
23746064|NCT04409509|66451139|FG001|Overall Study|Death|10|||
23822796|NCT03280381|66730506|FG001|Overall Study|Physician Decision|2|||
23432171|NCT00262847|65327544|FG001|Overall Study|Did not receive study treatment|1|||
23432172|NCT00262847|65327545|FG002|Overall Study|Did not receive study treatment|4|||
23432173|NCT00946322|65327546|FG000|Pre-treatment|participant failure to follow up|1|||
23554439|NCT00686881|65754763|FG000|Overall Study|Lost to Follow-up|0|||
23554440|NCT00686881|65754764|FG001|Overall Study|Lost to Follow-up|1|||
23554441|NCT00686881|65754763|FG000|Overall Study|Treatment-related adverse event|10|||
23432174|NCT00946322|65327546|FG000|Post-treatment|participant failure to follow up|2|||
23432175|NCT01345682|65327547|FG000|Overall Study|Progressive disease per RECIST|226|||
23432176|NCT01345682|65327548|FG001|Overall Study|Progressive disease per RECIST|93|||
23432177|NCT01345682|65327547|FG000|Overall Study|Worsening of underlying cancer disease|23|||
23432178|NCT01345682|65327548|FG001|Overall Study|Worsening of underlying cancer disease|12|||
23746065|NCT04409509|66451138|FG000|Overall Study|Non-compliance with study drug|0|||
23822797|NCT00704132|66730521|FG000|Overall Study|Clinical Adverse Experience|1|||
23822798|NCT00704132|66730522|FG001|Overall Study|Clinical Adverse Experience|0|||
23822799|NCT00704132|66730521|FG000|Overall Study|Lack of Efficacy|0|||
23822800|NCT00704132|66730522|FG001|Overall Study|Lack of Efficacy|1|||
23432179|NCT01345682|65327547|FG000|Overall Study|Adverse Event|51|||
23746066|NCT04409509|66451139|FG001|Overall Study|Non-compliance with study drug|1|||
23746067|NCT04409509|66451138|FG000|Overall Study|Lost to Follow-up|0|||
23746068|NCT04409509|66451139|FG001|Overall Study|Lost to Follow-up|3|||
23746069|NCT04409509|66451138|FG000|Overall Study|Withdrawal by Subject|0|||
23746070|NCT04409509|66451139|FG001|Overall Study|Withdrawal by Subject|3|||
23746071|NCT04409509|66451138|FG000|Overall Study|Randomized by mistake|0|||
23746072|NCT04409509|66451139|FG001|Overall Study|Randomized by mistake|1|||
23746073|NCT04409509|66451138|FG000|Overall Study|Other|1|||
23746074|NCT04409509|66451139|FG001|Overall Study|Other|1|||
23746075|NCT04144140|66451147|FG000|Overall Study|Other|0|||
23746076|NCT04144140|66451148|FG001|Overall Study|Other|0|||
23746077|NCT04144140|66451149|FG002|Overall Study|Other|0|||
23746078|NCT04144140|66451150|FG003|Overall Study|Other|0|||
23746079|NCT04144140|66451151|FG004|Overall Study|Other|0|||
23746080|NCT04144140|66451152|FG005|Overall Study|Other|1|||
23746081|NCT04144140|66451153|FG006|Overall Study|Other|0|||
23746082|NCT01976104|66451154|FG000|Overall Study|Adverse Event|0|||
23746083|NCT01976104|66451155|FG001|Overall Study|Adverse Event|0|||
23746084|NCT01976104|66451156|FG002|Overall Study|Adverse Event|1|||
23746085|NCT01976104|66451157|FG003|Overall Study|Adverse Event|0|||
23746086|NCT01976104|66451154|FG000|Overall Study|Lost to Follow-up|3|||
23746087|NCT01976104|66451155|FG001|Overall Study|Lost to Follow-up|0|||
23746088|NCT01976104|66451156|FG002|Overall Study|Lost to Follow-up|1|||
23746089|NCT01976104|66451157|FG003|Overall Study|Lost to Follow-up|1|||
23746090|NCT01976104|66451154|FG000|Overall Study|Subject Choice|0|||
23746091|NCT01976104|66451155|FG001|Overall Study|Subject Choice|1|||
23746092|NCT01976104|66451156|FG002|Overall Study|Subject Choice|0|||
23746093|NCT01976104|66451157|FG003|Overall Study|Subject Choice|1|||
23746094|NCT01976104|66451154|FG000|Overall Study|Withdrawal by Subject|3|||
23746095|NCT01976104|66451155|FG001|Overall Study|Withdrawal by Subject|0|||
23746096|NCT01976104|66451156|FG002|Overall Study|Withdrawal by Subject|0|||
23746097|NCT01976104|66451157|FG003|Overall Study|Withdrawal by Subject|1|||
23746098|NCT01976104|66451154|FG000|Overall Study|Other|0|||
23746099|NCT01976104|66451155|FG001|Overall Study|Other|1|||
23746100|NCT01976104|66451156|FG002|Overall Study|Other|0|||
23746101|NCT01976104|66451157|FG003|Overall Study|Other|0|||
23746102|NCT00869362|66451161|FG000|Overall Study|Death|0|||
23746103|NCT00869362|66451162|FG001|Overall Study|Death|2|||
23746104|NCT00869362|66451161|FG000|Overall Study|Lost to Follow-up|1|||
23746105|NCT00869362|66451162|FG001|Overall Study|Lost to Follow-up|3|||
23746106|NCT00998166|66451164|FG000|Overall Study|Early Study Termination|8|||
23746107|NCT03704194|66451165|FG000|Overall Study|Withdrawal by Subject|0|||
23746108|NCT03704194|66451166|FG001|Overall Study|Withdrawal by Subject|1|||
23746109|NCT00577382|66451168|FG000|Overall Study|Adverse Event|0|||
23746110|NCT00577382|66451169|FG001|Overall Study|Adverse Event|6|||
23746111|NCT00577382|66451168|FG000|Overall Study|Withdrawal by Subject|0|||
23746112|NCT00577382|66451169|FG001|Overall Study|Withdrawal by Subject|1|||
23746113|NCT00577382|66451168|FG000|Overall Study|Progressive Disease|17|||
23746114|NCT00577382|66451169|FG001|Overall Study|Progressive Disease|19|||
23746115|NCT00577382|66451168|FG000|Overall Study|Intercurrent Illness|1|||
23746116|NCT00577382|66451169|FG001|Overall Study|Intercurrent Illness|2|||
23746117|NCT00577382|66451168|FG000|Overall Study|Death|1|||
23746118|NCT00577382|66451169|FG001|Overall Study|Death|1|||
23746119|NCT00577382|66451168|FG000|Overall Study|Lost to Follow-up|2|||
23746120|NCT00577382|66451169|FG001|Overall Study|Lost to Follow-up|2|||
23822801|NCT00704132|66730521|FG000|Overall Study|Withdrawal by Subject|0|||
23746121|NCT00633217|66451173|FG000|Overall Study|Adverse Event|5|||
23746122|NCT00633217|66451174|FG001|Overall Study|Adverse Event|9|||
23746123|NCT00633217|66451173|FG000|Overall Study|Lack of Efficacy|0|||
23746124|NCT00633217|66451174|FG001|Overall Study|Lack of Efficacy|2|||
23746125|NCT00633217|66451173|FG000|Overall Study|Protocol Violation|3|||
23746126|NCT00633217|66451174|FG001|Overall Study|Protocol Violation|7|||
23746127|NCT00633217|66451173|FG000|Overall Study|Lost to Follow-up|2|||
23746128|NCT00633217|66451174|FG001|Overall Study|Lost to Follow-up|2|||
23746129|NCT00633217|66451173|FG000|Overall Study|Investigator Discretion|2|||
23822802|NCT00704132|66730522|FG001|Overall Study|Withdrawal by Subject|1|||
23746130|NCT00633217|66451174|FG001|Overall Study|Investigator Discretion|0|||
23746131|NCT00633217|66451173|FG000|Overall Study|Withdrew Consent|3|||
23746132|NCT00633217|66451174|FG001|Overall Study|Withdrew Consent|3|||
23746133|NCT01707667|66451175|FG000|Period 1|expulsion of colonic sensor catheter|1|||
23746134|NCT01707667|66451176|FG001|Period 1|expulsion of colonic sensor catheter|0|||
23746135|NCT04139642|66451177|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
23746136|NCT04139642|66451178|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
23746137|NCT04753606|66451179|FG000|Overall Study|Adverse Event|1|||
23746138|NCT04753606|66451180|FG001|Overall Study|Adverse Event|0|||
23746139|NCT04753606|66451181|FG002|Overall Study|Adverse Event|0|||
23746140|NCT02764229|66451182|FG000|Overall Study|Withdrawal by Subject|15|||
23746141|NCT02764229|66451182|FG000|Overall Study|Adverse Event|9|||
23746142|NCT02764229|66451182|FG000|Overall Study|Physician Decision|5|||
23746143|NCT02764229|66451182|FG000|Overall Study|Lost to Follow-up|3|||
23746144|NCT02764229|66451182|FG000|Overall Study|Lack of Efficacy|1|||
23746145|NCT02764229|66451182|FG000|Overall Study|Study Stopped by Sponsor|69|||
23746146|NCT01519635|66451183|FG000|Overall Study|Withdrawal by Subject|0|||
23746147|NCT01519635|66451184|FG001|Overall Study|Withdrawal by Subject|1|||
23746148|NCT01519635|66451183|FG000|Overall Study|No possibility to put a catheter|1|||
23746149|NCT01519635|66451184|FG001|Overall Study|No possibility to put a catheter|2|||
23746150|NCT02777554|66451185|FG000|Overall Study|Adverse Event|4|||
23746151|NCT02777554|66451186|FG001|Overall Study|Adverse Event|4|||
23746152|NCT02777554|66451187|FG002|Overall Study|Adverse Event|0|||
23746153|NCT02777554|66451188|FG003|Overall Study|Adverse Event|1|||
23746154|NCT02777554|66451189|FG004|Overall Study|Adverse Event|0|||
23746155|NCT02777554|66451190|FG005|Overall Study|Adverse Event|0|||
23746156|NCT02777554|66451185|FG000|Overall Study|Withdrawal by Subject|3|||
23746157|NCT02777554|66451186|FG001|Overall Study|Withdrawal by Subject|1|||
23746158|NCT02777554|66451187|FG002|Overall Study|Withdrawal by Subject|1|||
23822803|NCT00450801|66730537|FG000|Overall Study|Death|1|||
23822804|NCT00492778|66730538|FG000|Overall Study|Ineligible by Pathology Review|8|||
23822805|NCT00492778|66730539|FG001|Overall Study|Ineligible by Pathology Review|1|||
23432180|NCT01345682|65327548|FG001|Overall Study|Adverse Event|41|||
23432181|NCT01345682|65327547|FG000|Overall Study|Non-compliance with protocol|0|||
23432182|NCT01345682|65327548|FG001|Overall Study|Non-compliance with protocol|1|||
23432183|NCT01345682|65327547|FG000|Overall Study|Lost to Follow-up|0|||
23432184|NCT01345682|65327548|FG001|Overall Study|Lost to Follow-up|1|||
23432185|NCT01345682|65327547|FG000|Overall Study|Refused to continue trial medication|16|||
23432186|NCT01345682|65327548|FG001|Overall Study|Refused to continue trial medication|9|||
23432187|NCT01345682|65327547|FG000|Overall Study|Not treated|2|||
23432188|NCT01345682|65327548|FG001|Overall Study|Not treated|1|||
23432189|NCT01345682|65327547|FG000|Overall Study|Reason other than those specified above|4|||
23432190|NCT01345682|65327548|FG001|Overall Study|Reason other than those specified above|3|||
23432191|NCT01985360|65327551|FG000|Overall Study|Withdrawal by Subject|4|||
23432192|NCT01985360|65327552|FG001|Overall Study|Withdrawal by Subject|0|||
23432193|NCT01985360|65327551|FG000|Overall Study|Lost to Follow-up|5|||
23432194|NCT01985360|65327552|FG001|Overall Study|Lost to Follow-up|3|||
23432195|NCT00760838|65327555|FG000|Overall Study|Adverse Event|1|||
23432196|NCT00760838|65327556|FG001|Overall Study|Adverse Event|1|||
23432197|NCT00760838|65327555|FG000|Overall Study|Lack of Efficacy|1|||
23432198|NCT00760838|65327556|FG001|Overall Study|Lack of Efficacy|0|||
23432199|NCT00760838|65327555|FG000|Overall Study|Lost to Follow-up|2|||
23432200|NCT00760838|65327556|FG001|Overall Study|Lost to Follow-up|0|||
23432201|NCT00760838|65327555|FG000|Overall Study|Withdrawal by Subject|1|||
23432202|NCT00760838|65327556|FG001|Overall Study|Withdrawal by Subject|1|||
23432203|NCT03847909|65327562|FG000|Overall Study|Withdrawal by Subject|1|||
23432204|NCT03847909|65327563|FG001|Overall Study|Withdrawal by Subject|1|||
23432205|NCT00844558|65327567|FG000|Overall Study|Withdrawal by Subject|9|||
23432206|NCT00844558|65327568|FG001|Overall Study|Withdrawal by Subject|2|||
23432207|NCT00844558|65327567|FG000|Overall Study|Death|1|||
23432208|NCT00844558|65327568|FG001|Overall Study|Death|0|||
23746159|NCT02777554|66451188|FG003|Overall Study|Withdrawal by Subject|0|||
23746160|NCT02777554|66451189|FG004|Overall Study|Withdrawal by Subject|0|||
23746161|NCT02777554|66451190|FG005|Overall Study|Withdrawal by Subject|0|||
23746162|NCT02777554|66451185|FG000|Overall Study|Discharged early due to hurricane|22|||
23746163|NCT02777554|66451186|FG001|Overall Study|Discharged early due to hurricane|20|||
23746164|NCT02777554|66451187|FG002|Overall Study|Discharged early due to hurricane|0|||
23746165|NCT02777554|66451188|FG003|Overall Study|Discharged early due to hurricane|0|||
23746166|NCT02777554|66451189|FG004|Overall Study|Discharged early due to hurricane|0|||
23746167|NCT02777554|66451190|FG005|Overall Study|Discharged early due to hurricane|0|||
23432209|NCT00844558|65327567|FG000|Overall Study|Protocol Violation|1|||
23432210|NCT00844558|65327568|FG001|Overall Study|Protocol Violation|1|||
23432211|NCT00844558|65327567|FG000|Overall Study|Lost to Follow-up|0|||
23432212|NCT00844558|65327568|FG001|Overall Study|Lost to Follow-up|1|||
23432213|NCT00844558|65327567|FG000|Overall Study|Physician Decision|1|||
23432214|NCT00844558|65327568|FG001|Overall Study|Physician Decision|0|||
23432215|NCT04311463|65327569|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
23622069|NCT00545571|66000864|FG000|Overall Study|Death|5|||
23432216|NCT04311463|65327570|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
23432217|NCT04311463|65327569|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
23432218|NCT04311463|65327570|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
23432219|NCT04311463|65327569|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
23432220|NCT04311463|65327570|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
23432221|NCT01423916|65327582|FG000|Overall Study|Adverse Event|5|||
23432222|NCT01423916|65327583|FG001|Overall Study|Adverse Event|9|||
23432223|NCT01423916|65327584|FG002|Overall Study|Adverse Event|2|||
23432224|NCT01423916|65327582|FG000|Overall Study|Met Withdrawal Criteria|1|||
23432225|NCT01423916|65327583|FG001|Overall Study|Met Withdrawal Criteria|1|||
23432226|NCT01423916|65327584|FG002|Overall Study|Met Withdrawal Criteria|1|||
23432227|NCT01423916|65327582|FG000|Overall Study|Physician Decision|1|||
23432228|NCT01423916|65327583|FG001|Overall Study|Physician Decision|0|||
23432229|NCT01423916|65327584|FG002|Overall Study|Physician Decision|1|||
23432230|NCT01423916|65327582|FG000|Overall Study|Withdrawal by Subject|3|||
23554442|NCT00686881|65754764|FG001|Overall Study|Treatment-related adverse event|9|||
23554443|NCT00686881|65754763|FG000|Overall Study|Met discontinuation criteria|5|||
23746168|NCT02777554|66451185|FG000|Overall Study|Other - Miscellaneous|1|||
23746169|NCT02777554|66451186|FG001|Overall Study|Other - Miscellaneous|0|||
23746170|NCT02777554|66451187|FG002|Overall Study|Other - Miscellaneous|0|||
23746171|NCT02777554|66451188|FG003|Overall Study|Other - Miscellaneous|0|||
23746172|NCT02777554|66451189|FG004|Overall Study|Other - Miscellaneous|0|||
23746173|NCT02777554|66451190|FG005|Overall Study|Other - Miscellaneous|0|||
23432231|NCT01423916|65327583|FG001|Overall Study|Withdrawal by Subject|10|||
23432232|NCT01423916|65327584|FG002|Overall Study|Withdrawal by Subject|3|||
23554444|NCT00686881|65754764|FG001|Overall Study|Met discontinuation criteria|0|||
23554445|NCT00686881|65754763|FG000|Overall Study|Onset of malignant tumor|11|||
23554446|NCT00686881|65754764|FG001|Overall Study|Onset of malignant tumor|11|||
23554447|NCT00686881|65754763|FG000|Overall Study|Lack of Efficacy|4|||
23554448|NCT00686881|65754764|FG001|Overall Study|Lack of Efficacy|3|||
23554449|NCT00686881|65754763|FG000|Overall Study|Physician Decision|1|||
23554450|NCT00686881|65754764|FG001|Overall Study|Physician Decision|0|||
23554451|NCT00686881|65754763|FG000|Overall Study|Circumstances of site|1|||
23554452|NCT00686881|65754764|FG001|Overall Study|Circumstances of site|1|||
23554453|NCT00686881|65754763|FG000|Overall Study|Did not meet protocol eligibility|1|||
23554454|NCT00686881|65754764|FG001|Overall Study|Did not meet protocol eligibility|0|||
23554455|NCT00686881|65754763|FG000|Overall Study|Irregular visits|1|||
23554456|NCT00686881|65754764|FG001|Overall Study|Irregular visits|0|||
23554457|NCT00686881|65754763|FG000|Overall Study|Study discontinuation|35|||
23554458|NCT00686881|65754764|FG001|Overall Study|Study discontinuation|32|||
23554459|NCT00686881|65754763|FG000|Overall Study|Never received study drug|2|||
23554460|NCT00686881|65754764|FG001|Overall Study|Never received study drug|6|||
23554461|NCT02199028|65754771|FG000|Week 1|Adverse Event|1|||
23554462|NCT02199028|65754772|FG001|Week 1|Adverse Event|0|||
23554463|NCT02199028|65754771|FG000|Week 3|Adverse Event|1|||
23554464|NCT02199028|65754772|FG001|Week 3|Adverse Event|0|||
23554465|NCT00643916|65754773|FG000|Overall Study|Protocol Violation|0|||
23554466|NCT00643916|65754774|FG001|Overall Study|Protocol Violation|1|||
23554467|NCT00643916|65754775|FG002|Overall Study|Protocol Violation|1|||
23554468|NCT00643916|65754776|FG003|Overall Study|Protocol Violation|1|||
23554469|NCT00643916|65754777|FG004|Overall Study|Protocol Violation|0|||
23554470|NCT00643916|65754778|FG005|Overall Study|Protocol Violation|0|||
23554471|NCT00643916|65754773|FG000|Overall Study|Lost to Follow-up|0|||
23554472|NCT00643916|65754774|FG001|Overall Study|Lost to Follow-up|1|||
23554473|NCT00643916|65754775|FG002|Overall Study|Lost to Follow-up|0|||
23554474|NCT00643916|65754776|FG003|Overall Study|Lost to Follow-up|0|||
23554475|NCT00643916|65754777|FG004|Overall Study|Lost to Follow-up|0|||
23554476|NCT00643916|65754778|FG005|Overall Study|Lost to Follow-up|0|||
23554477|NCT00643916|65754773|FG000|Overall Study|Withdrawal by Subject|2|||
23554478|NCT00643916|65754774|FG001|Overall Study|Withdrawal by Subject|2|||
23746174|NCT00442572|66451192|FG000|Overall Study|Relapse|8|||
23746175|NCT00442572|66451193|FG001|Overall Study|Relapse|1|||
23746176|NCT00442572|66451192|FG000|Overall Study|Lost to Follow-up|0|||
23554479|NCT00643916|65754775|FG002|Overall Study|Withdrawal by Subject|2|||
23554480|NCT00643916|65754776|FG003|Overall Study|Withdrawal by Subject|1|||
23554481|NCT00643916|65754777|FG004|Overall Study|Withdrawal by Subject|0|||
23554482|NCT00643916|65754778|FG005|Overall Study|Withdrawal by Subject|1|||
23554483|NCT00643916|65754773|FG000|Overall Study|Not Vaccinated|2|||
23554484|NCT00643916|65754774|FG001|Overall Study|Not Vaccinated|2|||
23554485|NCT00643916|65754775|FG002|Overall Study|Not Vaccinated|3|||
23554486|NCT00643916|65754776|FG003|Overall Study|Not Vaccinated|0|||
23554487|NCT00643916|65754777|FG004|Overall Study|Not Vaccinated|2|||
23554488|NCT00643916|65754778|FG005|Overall Study|Not Vaccinated|0|||
23554489|NCT03923933|65754779|FG000|Overall Study|Lost to Follow-up|1|||
23554490|NCT03923933|65754780|FG001|Overall Study|Lost to Follow-up|0|||
23746177|NCT00442572|66451193|FG001|Overall Study|Lost to Follow-up|1|||
23746178|NCT00442572|66451192|FG000|Overall Study|Withdrawal by Subject|0|||
23554491|NCT03923933|65754779|FG000|Overall Study|Withdrawal by Subject|0|||
23554492|NCT03923933|65754780|FG001|Overall Study|Withdrawal by Subject|1|||
23554493|NCT00234052|65754782|FG000|Treatment|Withdrawal by Subject|3|||
23554494|NCT00234052|65754782|FG000|Treatment|Adverse Event|5|||
23554495|NCT00234052|65754782|FG000|Treatment|Death|2|||
23554496|NCT00234052|65754782|FG000|Treatment|Progressive Disease|11|||
23554497|NCT00234052|65754782|FG000|Follow-up for 5 Years|Death|41|||
23554498|NCT00234052|65754782|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
23554499|NCT00234052|65754782|FG000|Follow-up for 5 Years|Other|7|||
23554500|NCT03393000|65754785|FG000|Overall Study|Death|11|||
23554501|NCT03393000|65754785|FG000|Overall Study|Withdrawal by Subject|2|||
23554502|NCT03393000|65754785|FG000|Overall Study|Physician Decision|1|||
23554503|NCT02633800|65754790|FG000|Overall Study|Death|3|||
23554504|NCT02633800|65754791|FG001|Overall Study|Death|3|||
23554505|NCT02633800|65754790|FG000|Overall Study|Reason not provided|1|||
23554506|NCT02633800|65754791|FG001|Overall Study|Reason not provided|0|||
23554507|NCT02633800|65754790|FG000|Overall Study|Radiologic(al) progression|23|||
23554508|NCT02633800|65754791|FG001|Overall Study|Radiologic(al) progression|23|||
23554509|NCT02633800|65754790|FG000|Overall Study|Clinical progression|3|||
23554510|NCT02633800|65754791|FG001|Overall Study|Clinical progression|6|||
23554511|NCT02633800|65754790|FG000|Overall Study|Study terminated by sponsor|6|||
23554512|NCT02633800|65754791|FG001|Overall Study|Study terminated by sponsor|5|||
23554513|NCT02633800|65754790|FG000|Overall Study|Adverse event, non-fatal|7|||
23554514|NCT02633800|65754791|FG001|Overall Study|Adverse event, non-fatal|2|||
23554515|NCT02633800|65754790|FG000|Overall Study|Withdrawal by Subject|0|||
23554516|NCT02633800|65754791|FG001|Overall Study|Withdrawal by Subject|3|||
23554517|NCT02633800|65754790|FG000|Overall Study|Patient Request|1|||
23746179|NCT00442572|66451193|FG001|Overall Study|Withdrawal by Subject|1|||
23746180|NCT00563706|66451194|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
23746181|NCT00563706|66451195|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23746182|NCT00563706|66451196|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23746183|NCT00563706|66451197|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23746184|NCT00563706|66451198|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23746185|NCT00563706|66451199|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23746186|NCT00563706|66451200|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23746187|NCT00563706|66451201|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23746188|NCT00563706|66451202|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
23746189|NCT00563706|66451194|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23746190|NCT00563706|66451195|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23746191|NCT00563706|66451196|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23746192|NCT00563706|66451197|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
23746193|NCT00563706|66451198|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23746194|NCT00563706|66451199|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23746195|NCT00563706|66451200|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23746196|NCT00563706|66451201|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
23746197|NCT00563706|66451202|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23746198|NCT00563706|66451194|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
23746199|NCT00563706|66451195|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23746200|NCT00563706|66451196|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
23746201|NCT00563706|66451197|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
23554518|NCT02633800|65754791|FG001|Overall Study|Patient Request|1|||
23554519|NCT00594854|65754794|FG000|Overall Study|Study terminated|7|||
23554520|NCT00594854|65754795|FG001|Overall Study|Study terminated|10|||
23554521|NCT01813474|65754799|FG000|Overall Study|Withdrawal by Subject|0|||
23554522|NCT01813474|65754800|FG001|Overall Study|Withdrawal by Subject|0|||
23554523|NCT01813474|65754801|FG002|Overall Study|Withdrawal by Subject|1|||
23554524|NCT01813474|65754799|FG000|Overall Study|Adverse Event|1|||
23554525|NCT01813474|65754800|FG001|Overall Study|Adverse Event|1|||
23554526|NCT01813474|65754801|FG002|Overall Study|Adverse Event|0|||
23554527|NCT01813474|65754799|FG000|Overall Study|Lack of Efficacy|2|||
23554528|NCT01813474|65754800|FG001|Overall Study|Lack of Efficacy|6|||
23554529|NCT01813474|65754801|FG002|Overall Study|Lack of Efficacy|9|||
23746202|NCT00563706|66451198|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
23746203|NCT00563706|66451199|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23822806|NCT00822692|66730540|FG000|Overall Study|Lost to Follow-up|17|||
23554530|NCT01813474|65754799|FG000|Overall Study|Death|0|||
23554531|NCT01813474|65754800|FG001|Overall Study|Death|0|||
23554532|NCT01813474|65754801|FG002|Overall Study|Death|1|||
23554533|NCT00911534|65754802|FG000|Overall Study|Adverse Event|4|||
23554534|NCT00911534|65754803|FG001|Overall Study|Adverse Event|4|||
23554535|NCT00911534|65754802|FG000|Overall Study|Lost to Follow-up|2|||
23554536|NCT00911534|65754803|FG001|Overall Study|Lost to Follow-up|4|||
23554537|NCT00911534|65754802|FG000|Overall Study|Withdrawal by Subject|2|||
23554538|NCT00911534|65754803|FG001|Overall Study|Withdrawal by Subject|1|||
23554539|NCT00911534|65754802|FG000|Overall Study|Lack of Efficacy|4|||
23554540|NCT00911534|65754803|FG001|Overall Study|Lack of Efficacy|1|||
23554541|NCT00911534|65754802|FG000|Overall Study|Withdrawal of consent|1|||
23554542|NCT00911534|65754803|FG001|Overall Study|Withdrawal of consent|4|||
23554543|NCT00911534|65754802|FG000|Overall Study|Other|2|||
23554544|NCT00911534|65754803|FG001|Overall Study|Other|2|||
23554545|NCT02061202|65754806|FG000|Overall Study|Lost to Follow-up|1|||
23554546|NCT02061202|65754807|FG001|Overall Study|Lost to Follow-up|1|||
23554547|NCT02525874|65754808|FG000|Overall Study|Other|1|||
23554548|NCT02525874|65754808|FG000|Overall Study|Investigator Decision|1|||
23746204|NCT00563706|66451200|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
23746205|NCT00563706|66451201|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
23746206|NCT00563706|66451202|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23746207|NCT00563706|66451194|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
23746208|NCT00563706|66451195|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746209|NCT00563706|66451196|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746210|NCT00563706|66451197|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746211|NCT00563706|66451198|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746212|NCT00563706|66451199|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746213|NCT00563706|66451200|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746214|NCT00563706|66451201|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
23746215|NCT00563706|66451202|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23746216|NCT00563706|66451194|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746217|NCT00563706|66451195|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746218|NCT00563706|66451196|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746219|NCT00563706|66451197|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746220|NCT00563706|66451198|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746221|NCT00563706|66451199|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746222|NCT00563706|66451200|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23746223|NCT00563706|66451201|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
23746224|NCT00563706|66451202|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
23746225|NCT02087865|66451208|FG000|Overall Study|Withdrawal by Subject|6|||
23746226|NCT02087865|66451209|FG001|Overall Study|Withdrawal by Subject|0|||
23822807|NCT00822692|66730541|FG001|Overall Study|Lost to Follow-up|25|||
23822808|NCT00425373|66730544|FG000|Overall Study|Adverse Event|2|||
23822809|NCT00425373|66730545|FG001|Overall Study|Adverse Event|2|||
23822810|NCT00425373|66730546|FG002|Overall Study|Adverse Event|0|||
23822811|NCT00425373|66730547|FG003|Overall Study|Adverse Event|1|||
23822812|NCT00425373|66730548|FG004|Overall Study|Adverse Event|4|||
23822813|NCT00425373|66730549|FG005|Overall Study|Adverse Event|6|||
23822814|NCT00425373|66730550|FG006|Overall Study|Adverse Event|2|||
23822815|NCT00425373|66730551|FG007|Overall Study|Adverse Event|3|||
23822816|NCT00425373|66730552|FG008|Overall Study|Adverse Event|8|||
23822817|NCT00425373|66730544|FG000|Overall Study|Lost to Follow-up|0|||
23822818|NCT00425373|66730545|FG001|Overall Study|Lost to Follow-up|1|||
23822819|NCT00425373|66730546|FG002|Overall Study|Lost to Follow-up|0|||
23822820|NCT00425373|66730547|FG003|Overall Study|Lost to Follow-up|0|||
23822821|NCT00425373|66730548|FG004|Overall Study|Lost to Follow-up|1|||
23822822|NCT00425373|66730549|FG005|Overall Study|Lost to Follow-up|0|||
23822823|NCT00425373|66730550|FG006|Overall Study|Lost to Follow-up|0|||
23822824|NCT00425373|66730551|FG007|Overall Study|Lost to Follow-up|0|||
23822825|NCT00425373|66730552|FG008|Overall Study|Lost to Follow-up|0|||
23822826|NCT00425373|66730544|FG000|Overall Study|Protocol Violation|1|||
23822827|NCT00425373|66730545|FG001|Overall Study|Protocol Violation|0|||
23554549|NCT02525874|65754808|FG000|Overall Study|Consent withdrawn|22|||
23554550|NCT02525874|65754808|FG000|Overall Study|Non-compliance with study drug|3|||
23746227|NCT02087865|66451210|FG002|Overall Study|Withdrawal by Subject|1|||
23746228|NCT02087865|66451208|FG000|Overall Study|Lost to Follow-up|0|||
23746229|NCT02087865|66451209|FG001|Overall Study|Lost to Follow-up|0|||
23746230|NCT02087865|66451210|FG002|Overall Study|Lost to Follow-up|1|||
23746231|NCT02087865|66451208|FG000|Overall Study|Drug Non-compliance|0|||
23822828|NCT00425373|66730546|FG002|Overall Study|Protocol Violation|1|||
23822829|NCT00425373|66730547|FG003|Overall Study|Protocol Violation|0|||
23822830|NCT00425373|66730548|FG004|Overall Study|Protocol Violation|0|||
23822831|NCT00425373|66730549|FG005|Overall Study|Protocol Violation|0|||
23822832|NCT00425373|66730550|FG006|Overall Study|Protocol Violation|0|||
23554551|NCT02525874|65754808|FG000|Overall Study|Adverse Event|17|||
23554552|NCT02525874|65754808|FG000|Overall Study|Lost to Follow-up|7|||
23822833|NCT00425373|66730551|FG007|Overall Study|Protocol Violation|5|||
23822834|NCT00425373|66730552|FG008|Overall Study|Protocol Violation|3|||
23554553|NCT02525874|65754808|FG000|Overall Study|Disease progression, defined by protocol|2|||
23746232|NCT02087865|66451209|FG001|Overall Study|Drug Non-compliance|2|||
23746233|NCT02087865|66451210|FG002|Overall Study|Drug Non-compliance|0|||
23746234|NCT02087865|66451208|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
23746235|NCT02087865|66451209|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
23746236|NCT02087865|66451210|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
23746237|NCT01012609|66451214|FG000|Overall Study|Withdrawal by Subject|1|||
23746238|NCT01012609|66451215|FG001|Overall Study|Withdrawal by Subject|1|||
23746239|NCT02674568|66451217|FG000|Overall Study|Withdrawal by Subject|5|||
23746240|NCT02674568|66451217|FG000|Overall Study|Death|303|||
23746241|NCT02674568|66451217|FG000|Overall Study|Physician Decision|2|||
23746242|NCT02674568|66451217|FG000|Overall Study|Lost to Follow-up|9|||
23746243|NCT02674568|66451217|FG000|Overall Study|Other, Not Specified|20|||
23746244|NCT01422876|66451219|FG000|Week 24|Lost to Follow-up|1|||
23746245|NCT01422876|66451220|FG001|Week 24|Lost to Follow-up|1|||
23746246|NCT01422876|66451221|FG002|Week 24|Lost to Follow-up|2|||
23746247|NCT01422876|66451222|FG003|Week 24|Lost to Follow-up|4|||
23746248|NCT01422876|66451223|FG004|Week 24|Lost to Follow-up|2|||
23746249|NCT01422876|66451224|FG005|Week 24|Lost to Follow-up|0|||
23746250|NCT01422876|66451225|FG006|Week 24|Lost to Follow-up|1|||
23746251|NCT01422876|66451226|FG007|Week 24|Lost to Follow-up|3|||
23746252|NCT01422876|66451227|FG008|Week 24|Lost to Follow-up|3|||
23746253|NCT01422876|66451228|FG009|Week 24|Lost to Follow-up|4|||
23746254|NCT01422876|66451219|FG000|Week 24|Consent withdrawn|5|||
23746255|NCT01422876|66451220|FG001|Week 24|Consent withdrawn|1|||
23746256|NCT01422876|66451221|FG002|Week 24|Consent withdrawn|3|||
23746257|NCT01422876|66451222|FG003|Week 24|Consent withdrawn|4|||
23746258|NCT01422876|66451223|FG004|Week 24|Consent withdrawn|5|||
23746259|NCT01422876|66451224|FG005|Week 24|Consent withdrawn|6|||
23746260|NCT01422876|66451225|FG006|Week 24|Consent withdrawn|5|||
23746261|NCT01422876|66451226|FG007|Week 24|Consent withdrawn|4|||
23746262|NCT01422876|66451227|FG008|Week 24|Consent withdrawn|3|||
23746263|NCT01422876|66451228|FG009|Week 24|Consent withdrawn|6|||
23746264|NCT01422876|66451219|FG000|Week 24|Death|0|||
23746265|NCT01422876|66451220|FG001|Week 24|Death|1|||
23746266|NCT01422876|66451221|FG002|Week 24|Death|0|||
23746267|NCT01422876|66451222|FG003|Week 24|Death|0|||
23746268|NCT01422876|66451223|FG004|Week 24|Death|0|||
23746269|NCT01422876|66451224|FG005|Week 24|Death|0|||
23746270|NCT01422876|66451225|FG006|Week 24|Death|0|||
23746271|NCT01422876|66451226|FG007|Week 24|Death|0|||
23746272|NCT01422876|66451227|FG008|Week 24|Death|0|||
23746273|NCT01422876|66451228|FG009|Week 24|Death|0|||
23746274|NCT01422876|66451219|FG000|Week 52|Lost to Follow-up|3|||
23746275|NCT01422876|66451220|FG001|Week 52|Lost to Follow-up|5|||
23746276|NCT01422876|66451221|FG002|Week 52|Lost to Follow-up|7|||
23746277|NCT01422876|66451222|FG003|Week 52|Lost to Follow-up|5|||
23746278|NCT01422876|66451223|FG004|Week 52|Lost to Follow-up|8|||
23746279|NCT01422876|66451224|FG005|Week 52|Lost to Follow-up|5|||
23746280|NCT01422876|66451225|FG006|Week 52|Lost to Follow-up|5|||
23554554|NCT02525874|65754808|FG000|Overall Study|Disease relapse|4|||
23554555|NCT02525874|65754808|FG000|Overall Study|Alternative Treatment for MS|2|||
23554556|NCT02525874|65754808|FG000|Overall Study|New lesions in Brain|1|||
23554557|NCT00447057|65754809|FG000|Overall Study|Adverse Event|4|||
23554558|NCT00447057|65754810|FG001|Overall Study|Adverse Event|10|||
23554559|NCT00447057|65754811|FG002|Overall Study|Adverse Event|0|||
23554560|NCT00447057|65754812|FG003|Overall Study|Adverse Event|3|||
23746281|NCT01422876|66451226|FG007|Week 52|Lost to Follow-up|8|||
23746282|NCT01422876|66451227|FG008|Week 52|Lost to Follow-up|7|||
23746283|NCT01422876|66451228|FG009|Week 52|Lost to Follow-up|8|||
23554561|NCT00447057|65754809|FG000|Overall Study|Death due to study disease|6|||
23554562|NCT00447057|65754810|FG001|Overall Study|Death due to study disease|4|||
23746284|NCT01422876|66451219|FG000|Week 52|Consent withdrawn|9|||
23746285|NCT01422876|66451220|FG001|Week 52|Consent withdrawn|4|||
23746286|NCT01422876|66451221|FG002|Week 52|Consent withdrawn|6|||
23746287|NCT01422876|66451222|FG003|Week 52|Consent withdrawn|12|||
23746288|NCT01422876|66451223|FG004|Week 52|Consent withdrawn|7|||
23746289|NCT01422876|66451224|FG005|Week 52|Consent withdrawn|12|||
23746290|NCT01422876|66451225|FG006|Week 52|Consent withdrawn|10|||
23746291|NCT01422876|66451226|FG007|Week 52|Consent withdrawn|12|||
23746292|NCT01422876|66451227|FG008|Week 52|Consent withdrawn|13|||
23746293|NCT01422876|66451228|FG009|Week 52|Consent withdrawn|9|||
23746294|NCT01422876|66451219|FG000|Week 52|Death|0|||
23746295|NCT01422876|66451220|FG001|Week 52|Death|1|||
23746296|NCT01422876|66451221|FG002|Week 52|Death|0|||
23746297|NCT01422876|66451222|FG003|Week 52|Death|1|||
23746298|NCT01422876|66451223|FG004|Week 52|Death|0|||
23746299|NCT01422876|66451224|FG005|Week 52|Death|0|||
23746300|NCT01422876|66451225|FG006|Week 52|Death|1|||
23746301|NCT01422876|66451226|FG007|Week 52|Death|3|||
23746302|NCT01422876|66451227|FG008|Week 52|Death|1|||
23746303|NCT01422876|66451228|FG009|Week 52|Death|0|||
23746304|NCT03155269|66451229|FG000|Overall Study|Withdrawal by Subject|4|||
23746305|NCT03155269|66451230|FG001|Overall Study|Withdrawal by Subject|5|||
23746306|NCT03155269|66451229|FG000|Overall Study|Lost to Follow-up|1|||
23746307|NCT03155269|66451230|FG001|Overall Study|Lost to Follow-up|2|||
23746308|NCT00501969|66451231|FG000|Overall Study|Major Protocol Violation|4|||
23746309|NCT00501969|66451231|FG000|Overall Study|Lack of Efficacy|29|||
23746310|NCT00501969|66451231|FG000|Overall Study|Adverse Event|76|||
23746311|NCT00501969|66451231|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
23746312|NCT00501969|66451231|FG000|Overall Study|Subject withdrew consent|51|||
23746313|NCT00501969|66451231|FG000|Overall Study|Lost to Follow-up|4|||
23746314|NCT00501969|66451231|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
23746315|NCT00501969|66451231|FG000|Overall Study|Other: Sponsors Request|10|||
23554563|NCT00447057|65754811|FG002|Overall Study|Death due to study disease|1|||
23554564|NCT00447057|65754812|FG003|Overall Study|Death due to study disease|1|||
23554565|NCT00447057|65754809|FG000|Overall Study|Lost to Follow-up|0|||
23554566|NCT00447057|65754810|FG001|Overall Study|Lost to Follow-up|1|||
23554567|NCT00447057|65754811|FG002|Overall Study|Lost to Follow-up|0|||
23554568|NCT00447057|65754812|FG003|Overall Study|Lost to Follow-up|0|||
23554569|NCT00447057|65754809|FG000|Overall Study|Entry criteria not met|1|||
23554570|NCT00447057|65754810|FG001|Overall Study|Entry criteria not met|1|||
23554571|NCT00447057|65754811|FG002|Overall Study|Entry criteria not met|0|||
23554572|NCT00447057|65754812|FG003|Overall Study|Entry criteria not met|0|||
23554573|NCT00447057|65754809|FG000|Overall Study|Protocol Violation|0|||
23554574|NCT00447057|65754810|FG001|Overall Study|Protocol Violation|1|||
23554575|NCT00447057|65754811|FG002|Overall Study|Protocol Violation|0|||
23554576|NCT00447057|65754812|FG003|Overall Study|Protocol Violation|0|||
23554577|NCT00447057|65754809|FG000|Overall Study|Withdrawal by Subject|4|||
23554578|NCT00447057|65754810|FG001|Overall Study|Withdrawal by Subject|5|||
23554579|NCT00447057|65754811|FG002|Overall Study|Withdrawal by Subject|1|||
23554580|NCT00447057|65754812|FG003|Overall Study|Withdrawal by Subject|1|||
23554581|NCT00447057|65754809|FG000|Overall Study|Physician Decision|9|||
23554582|NCT00447057|65754810|FG001|Overall Study|Physician Decision|6|||
23554583|NCT00447057|65754811|FG002|Overall Study|Physician Decision|3|||
23554584|NCT00447057|65754812|FG003|Overall Study|Physician Decision|1|||
23554585|NCT00447057|65754809|FG000|Overall Study|Sponsor decision|1|||
23554586|NCT00447057|65754810|FG001|Overall Study|Sponsor decision|1|||
23554587|NCT00447057|65754811|FG002|Overall Study|Sponsor decision|0|||
23554588|NCT00447057|65754812|FG003|Overall Study|Sponsor decision|0|||
23554589|NCT00447057|65754809|FG000|Overall Study|Progressive disease|58|||
23554590|NCT00447057|65754810|FG001|Overall Study|Progressive disease|43|||
23554591|NCT00447057|65754811|FG002|Overall Study|Progressive disease|13|||
23554592|NCT00447057|65754812|FG003|Overall Study|Progressive disease|18|||
23554593|NCT00447057|65754809|FG000|Overall Study|Death due to adverse event|0|||
23554594|NCT00447057|65754810|FG001|Overall Study|Death due to adverse event|0|||
23554595|NCT00447057|65754811|FG002|Overall Study|Death due to adverse event|1|||
23554596|NCT00447057|65754812|FG003|Overall Study|Death due to adverse event|2|||
23554597|NCT00447057|65754809|FG000|Overall Study|Death, study drug related|0|||
23554598|NCT00447057|65754810|FG001|Overall Study|Death, study drug related|1|||
23554599|NCT00447057|65754811|FG002|Overall Study|Death, study drug related|0|||
23554600|NCT00447057|65754812|FG003|Overall Study|Death, study drug related|0|||
23554601|NCT00234065|65757852|FG000|Overall Study|Adverse Event|268|||
23554602|NCT00234065|65757853|FG001|Overall Study|Adverse Event|166|||
23554603|NCT00234065|65757852|FG000|Overall Study|Withdrawal by Subject|73|||
23554604|NCT00234065|65757853|FG001|Overall Study|Withdrawal by Subject|56|||
23554605|NCT00234065|65757852|FG000|Overall Study|Physician Decision|23|||
23554606|NCT00234065|65757853|FG001|Overall Study|Physician Decision|22|||
23554607|NCT00234065|65757852|FG000|Overall Study|Not Classified|111|||
23554608|NCT00234065|65757853|FG001|Overall Study|Not Classified|112|||
23554609|NCT00724152|65757854|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
23554610|NCT00724152|65757855|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
23554611|NCT00724152|65757856|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
23554612|NCT00724152|65757854|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
23554613|NCT00724152|65757855|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
23554614|NCT00724152|65757856|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
23554615|NCT03599349|65757857|FG000|Overall Study|Lost to Follow-up|1|||
23746316|NCT00501969|66451231|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
23554616|NCT01298999|65757858|FG000|Overall Study|Physician Decision|0|||
23554617|NCT01298999|65757859|FG001|Overall Study|Physician Decision|1|||
23746317|NCT00501969|66451231|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
23746318|NCT00501969|66451231|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
23554618|NCT01298999|65757858|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
23554619|NCT01298999|65757859|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
23554620|NCT00224874|65757860|FG000|Overall Study|Withdrawal by Subject|0|||
23554621|NCT00224874|65757861|FG001|Overall Study|Withdrawal by Subject|0|||
23554622|NCT00224874|65757862|FG002|Overall Study|Withdrawal by Subject|1|||
23554623|NCT00224874|65757863|FG003|Overall Study|Withdrawal by Subject|0|||
23554624|NCT02985866|65757864|FG000|Overall Study|Poor CGM data|1|||
23554625|NCT02985866|65757865|FG001|Overall Study|Poor CGM data|1|||
23554626|NCT01064297|65757866|FG000|Overall Study|Lost to Follow-up|791|||
23554627|NCT01064297|65757867|FG001|Overall Study|Lost to Follow-up|48|||
23622070|NCT00545571|66000864|FG000|Overall Study|Lack of Efficacy|1|||
23622071|NCT00545571|66000864|FG000|Overall Study|Protocol Violation|2|||
23622072|NCT00545571|66000864|FG000|Overall Study|Refused Treatment|1|||
23622073|NCT00545571|66000864|FG000|Overall Study|Screen Failure|16|||
23622074|NCT00545571|66000864|FG000|Overall Study|Transfusion|12|||
23622075|NCT00545571|66000864|FG000|Overall Study|Early Termination of Study|24|||
23622076|NCT00545571|66000864|FG000|Overall Study|Kidney Transplantation|3|||
23622077|NCT04969224|66000865|FG000|Overall Study|Adverse Event|1|||
23622078|NCT04969224|66000865|FG000|Overall Study|Enrolled but never dosed|1|||
23622079|NCT02647788|66004823|FG000|Overall Study|Lost to Follow-up|13|||
23622080|NCT02647788|66004824|FG001|Overall Study|Lost to Follow-up|11|||
23622081|NCT02647788|66004823|FG000|Overall Study|Did not want opiate|0|||
23622082|NCT02647788|66004824|FG001|Overall Study|Did not want opiate|1|||
23622083|NCT02647788|66004823|FG000|Overall Study|Withdrawal by Subject|1|||
23622084|NCT02647788|66004824|FG001|Overall Study|Withdrawal by Subject|0|||
23622085|NCT02647788|66004823|FG000|Overall Study|Felt itchy with assigned medication|1|||
23622086|NCT02647788|66004824|FG001|Overall Study|Felt itchy with assigned medication|0|||
23622087|NCT02647788|66004823|FG000|Overall Study|Felt nauseous with assigned medication|1|||
23622088|NCT02647788|66004824|FG001|Overall Study|Felt nauseous with assigned medication|1|||
23622089|NCT02973802|66004828|FG000|Overall Study|Lost to Follow-up|1|||
23622090|NCT02973802|66004828|FG000|Overall Study|Withdrawal by Subject|1|||
23622091|NCT01560871|66004831|FG000|Overall Study|transportation issues|2|||
23622092|NCT01560871|66004832|FG001|Overall Study|transportation issues|1|||
23622093|NCT01560871|66004831|FG000|Overall Study|relocation|1|||
23622094|NCT01560871|66004832|FG001|Overall Study|relocation|0|||
23622095|NCT01560871|66004831|FG000|Overall Study|readmission to a hospital|2|||
23622096|NCT01560871|66004832|FG001|Overall Study|readmission to a hospital|1|||
23622097|NCT01560871|66004831|FG000|Overall Study|Lost to Follow-up|1|||
23622098|NCT01560871|66004832|FG001|Overall Study|Lost to Follow-up|0|||
23622099|NCT01644188|66004833|FG000|Overall Study|Adverse Event|44|||
23622100|NCT01644188|66004834|FG001|Overall Study|Adverse Event|20|||
23622101|NCT01644188|66004833|FG000|Overall Study|Poor compliance to protocol|26|||
23622102|NCT01644188|66004834|FG001|Overall Study|Poor compliance to protocol|14|||
23622103|NCT01644188|66004833|FG000|Overall Study|Physician Decision|1|||
23622104|NCT01644188|66004834|FG001|Overall Study|Physician Decision|3|||
23622105|NCT01644188|66004833|FG000|Overall Study|Participant moved|7|||
23622106|NCT01644188|66004834|FG001|Overall Study|Participant moved|2|||
23746319|NCT00501969|66451231|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
23746320|NCT00501969|66451231|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
23746321|NCT00501969|66451231|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
23746322|NCT00501969|66451231|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
23746323|NCT00501969|66451231|FG000|Overall Study|Other: As Required by Local EC|2|||
23746324|NCT00501969|66451231|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
23746325|NCT00501969|66451231|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
23746326|NCT03480243|66451235|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
23746327|NCT03480243|66451235|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
23746328|NCT01569074|66451245|FG000|Overall Study|Study stopped|6|||
23746329|NCT01569074|66451246|FG001|Overall Study|Study stopped|6|||
23746330|NCT01569074|66451247|FG002|Overall Study|Study stopped|8|||
23746331|NCT01569074|66451248|FG003|Overall Study|Study stopped|7|||
23746332|NCT01569074|66451249|FG004|Overall Study|Study stopped|7|||
23554628|NCT01064297|65757868|FG002|Overall Study|Lost to Follow-up|133|||
23554629|NCT01896869|65757871|FG000|Overall Study|Withdrawal by Subject|0|||
23554630|NCT01896869|65757872|FG001|Overall Study|Withdrawal by Subject|6|||
23554631|NCT01896869|65757871|FG000|Overall Study|Lost to Follow-up|1|||
23554632|NCT01896869|65757872|FG001|Overall Study|Lost to Follow-up|0|||
23554633|NCT02255357|65757873|FG000|Overall Study|Physician Decision|10|||
23554634|NCT02255357|65757874|FG001|Overall Study|Physician Decision|24|||
23554635|NCT02275065|65757875|FG000|Overall Study|Randomized but not treated|1|||
23554636|NCT02275065|65757876|FG001|Overall Study|Randomized but not treated|0|||
23554637|NCT02275065|65757877|FG002|Overall Study|Randomized but not treated|1|||
23622107|NCT01644188|66004833|FG000|Overall Study|Related to auto-injector administration|2|||
23622108|NCT01644188|66004834|FG001|Overall Study|Related to auto-injector administration|2|||
23622109|NCT01644188|66004833|FG000|Overall Study|Consent withdrawn by participant|14|||
23622110|NCT01644188|66004834|FG001|Overall Study|Consent withdrawn by participant|7|||
23746333|NCT01569074|66451245|FG000|Overall Study|Study-specific discontinuation criteria|0|||
23554638|NCT02275065|65757878|FG003|Overall Study|Randomized but not treated|1|||
23622111|NCT01644188|66004833|FG000|Overall Study|Selection criteria finally not met|2|||
23554639|NCT02275065|65757879|FG004|Overall Study|Randomized but not treated|0|||
23622112|NCT01644188|66004834|FG001|Overall Study|Selection criteria finally not met|0|||
23622113|NCT01644188|66004833|FG000|Overall Study|Lost to Follow-up|1|||
23746334|NCT01569074|66451246|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23746335|NCT01569074|66451247|FG002|Overall Study|Study-specific discontinuation criteria|0|||
23746336|NCT01569074|66451248|FG003|Overall Study|Study-specific discontinuation criteria|0|||
23554640|NCT03494166|65757880|FG000|Overall Study|Death|0|||
23746337|NCT01569074|66451249|FG004|Overall Study|Study-specific discontinuation criteria|0|||
23746338|NCT01569074|66451245|FG000|Overall Study|Severe non-compliance to protocol|0|||
23746339|NCT01569074|66451246|FG001|Overall Study|Severe non-compliance to protocol|0|||
23746340|NCT01569074|66451247|FG002|Overall Study|Severe non-compliance to protocol|1|||
23746341|NCT01569074|66451248|FG003|Overall Study|Severe non-compliance to protocol|0|||
23746342|NCT01569074|66451249|FG004|Overall Study|Severe non-compliance to protocol|0|||
23746343|NCT01569074|66451245|FG000|Overall Study|eg change in circumstances|0|||
23746344|NCT01569074|66451246|FG001|Overall Study|eg change in circumstances|2|||
23746345|NCT01569074|66451247|FG002|Overall Study|eg change in circumstances|0|||
23746346|NCT01569074|66451248|FG003|Overall Study|eg change in circumstances|1|||
23746347|NCT01569074|66451249|FG004|Overall Study|eg change in circumstances|1|||
23746348|NCT01569074|66451245|FG000|Overall Study|Adverse Event|1|||
23746349|NCT01569074|66451246|FG001|Overall Study|Adverse Event|0|||
23746350|NCT01569074|66451247|FG002|Overall Study|Adverse Event|3|||
23746351|NCT01569074|66451248|FG003|Overall Study|Adverse Event|0|||
23746352|NCT01569074|66451249|FG004|Overall Study|Adverse Event|0|||
23746353|NCT00145795|66451250|FG000|Overall Study|Adverse Event|1|||
23746354|NCT00145795|66451251|FG001|Overall Study|Adverse Event|0|||
23746355|NCT01891669|66451258|FG000|Overall Study|Death|0|||
23746356|NCT01891669|66451259|FG001|Overall Study|Death|0|||
23746357|NCT01891669|66451260|FG002|Overall Study|Death|0|||
23746358|NCT01891669|66451261|FG003|Overall Study|Death|0|||
23746359|NCT01891669|66451262|FG004|Overall Study|Death|0|||
23746360|NCT01891669|66451263|FG005|Overall Study|Death|0|||
23746361|NCT01891669|66451264|FG006|Overall Study|Death|0|||
23746362|NCT01891669|66451265|FG007|Overall Study|Death|1|||
23746363|NCT01891669|66451266|FG008|Overall Study|Death|0|||
23746364|NCT01891669|66451267|FG009|Overall Study|Death|1|||
23746365|NCT01891669|66451258|FG000|Overall Study|Withdrawal by Subject|1|||
23746366|NCT01891669|66451259|FG001|Overall Study|Withdrawal by Subject|1|||
23746367|NCT01891669|66451260|FG002|Overall Study|Withdrawal by Subject|0|||
23746368|NCT01891669|66451261|FG003|Overall Study|Withdrawal by Subject|0|||
23746369|NCT01891669|66451262|FG004|Overall Study|Withdrawal by Subject|0|||
23746370|NCT01891669|66451263|FG005|Overall Study|Withdrawal by Subject|0|||
23746371|NCT01891669|66451264|FG006|Overall Study|Withdrawal by Subject|1|||
23746372|NCT01891669|66451265|FG007|Overall Study|Withdrawal by Subject|2|||
23746373|NCT01891669|66451266|FG008|Overall Study|Withdrawal by Subject|1|||
23746374|NCT01891669|66451267|FG009|Overall Study|Withdrawal by Subject|1|||
23746375|NCT01891669|66451258|FG000|Overall Study|Other|1|||
23746376|NCT01891669|66451259|FG001|Overall Study|Other|0|||
23746377|NCT01891669|66451260|FG002|Overall Study|Other|0|||
23746378|NCT01891669|66451261|FG003|Overall Study|Other|0|||
23746379|NCT01891669|66451262|FG004|Overall Study|Other|0|||
23746380|NCT01891669|66451263|FG005|Overall Study|Other|0|||
23746381|NCT01891669|66451264|FG006|Overall Study|Other|0|||
23822835|NCT00425373|66730544|FG000|Overall Study|Withdrawal by Subject|2|||
23822836|NCT00425373|66730545|FG001|Overall Study|Withdrawal by Subject|0|||
23822837|NCT00425373|66730546|FG002|Overall Study|Withdrawal by Subject|2|||
23822838|NCT00425373|66730547|FG003|Overall Study|Withdrawal by Subject|1|||
23822839|NCT00425373|66730548|FG004|Overall Study|Withdrawal by Subject|4|||
23746382|NCT01891669|66451265|FG007|Overall Study|Other|1|||
23746383|NCT01891669|66451266|FG008|Overall Study|Other|0|||
23746384|NCT01891669|66451267|FG009|Overall Study|Other|0|||
23746385|NCT04189224|66451268|FG000|Period 2|Adverse Event|0|||
23822840|NCT00425373|66730549|FG005|Overall Study|Withdrawal by Subject|0|||
23822841|NCT00425373|66730550|FG006|Overall Study|Withdrawal by Subject|2|||
23622114|NCT01644188|66004834|FG001|Overall Study|Lost to Follow-up|0|||
23622115|NCT01644188|66004833|FG000|Overall Study|Death|4|||
23622116|NCT01644188|66004834|FG001|Overall Study|Death|3|||
23746386|NCT04189224|66451269|FG001|Period 2|Adverse Event|1|||
23746387|NCT00494234|66451270|FG000|Overall Study|Withdrawal by Subject|1|||
23746388|NCT00494234|66451271|FG001|Overall Study|Withdrawal by Subject|0|||
23746389|NCT00494234|66451270|FG000|Overall Study|Disease progression|11|||
23746390|NCT00494234|66451271|FG001|Overall Study|Disease progression|8|||
23746391|NCT00494234|66451270|FG000|Overall Study|Death|2|||
23746392|NCT00494234|66451271|FG001|Overall Study|Death|1|||
23746393|NCT00978120|66451272|FG000|Overall Study|Death|0|||
23746394|NCT00978120|66451273|FG001|Overall Study|Death|0|||
23746395|NCT00978120|66451274|FG002|Overall Study|Death|0|||
23746396|NCT00978120|66451275|FG003|Overall Study|Death|1|||
23746397|NCT00978120|66451272|FG000|Overall Study|Lost to Follow-up|0|||
23746398|NCT00978120|66451273|FG001|Overall Study|Lost to Follow-up|0|||
23746399|NCT00978120|66451274|FG002|Overall Study|Lost to Follow-up|3|||
23746400|NCT00978120|66451275|FG003|Overall Study|Lost to Follow-up|0|||
23746401|NCT00978120|66451272|FG000|Overall Study|Withdrawal by Subject|2|||
23746402|NCT00978120|66451273|FG001|Overall Study|Withdrawal by Subject|0|||
23746403|NCT00978120|66451274|FG002|Overall Study|Withdrawal by Subject|0|||
23746404|NCT00978120|66451275|FG003|Overall Study|Withdrawal by Subject|0|||
23746405|NCT00978120|66451272|FG000|Overall Study|Moved out of state|0|||
23746406|NCT00978120|66451273|FG001|Overall Study|Moved out of state|0|||
23746407|NCT00978120|66451274|FG002|Overall Study|Moved out of state|0|||
23746408|NCT00978120|66451275|FG003|Overall Study|Moved out of state|1|||
23746409|NCT00762073|66451277|FG000|Overall Study|Lack of Efficacy|1|||
23746410|NCT00762073|66451278|FG001|Overall Study|Lack of Efficacy|1|||
23746411|NCT00762073|66451279|FG002|Overall Study|Lack of Efficacy|0|||
23746412|NCT00762073|66451280|FG003|Overall Study|Lack of Efficacy|0|||
23746413|NCT00762073|66451277|FG000|Overall Study|Adverse Event|1|||
23746414|NCT00762073|66451278|FG001|Overall Study|Adverse Event|0|||
23746415|NCT00762073|66451279|FG002|Overall Study|Adverse Event|1|||
23746416|NCT00762073|66451280|FG003|Overall Study|Adverse Event|1|||
23746417|NCT00762073|66451277|FG000|Overall Study|Significant Subject Noncompliance|0|||
23746418|NCT00762073|66451278|FG001|Overall Study|Significant Subject Noncompliance|1|||
23746419|NCT00762073|66451279|FG002|Overall Study|Significant Subject Noncompliance|0|||
23746420|NCT00762073|66451280|FG003|Overall Study|Significant Subject Noncompliance|1|||
23746421|NCT00762073|66451277|FG000|Overall Study|Withdrawal by Subject|1|||
23746422|NCT00762073|66451278|FG001|Overall Study|Withdrawal by Subject|2|||
23746423|NCT00762073|66451279|FG002|Overall Study|Withdrawal by Subject|1|||
23746424|NCT00762073|66451280|FG003|Overall Study|Withdrawal by Subject|1|||
23746425|NCT00762073|66451277|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
23746426|NCT00762073|66451278|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
23746427|NCT00762073|66451279|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
23746428|NCT00762073|66451280|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
23746429|NCT01195662|66451282|FG000|Double Blind Treatment Period|Adverse Event|4|||
23746430|NCT01195662|66451283|FG001|Double Blind Treatment Period|Adverse Event|1|||
23746431|NCT01195662|66451284|FG002|Double Blind Treatment Period|Adverse Event|2|||
23746432|NCT01195662|66451282|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
23746433|NCT01195662|66451283|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
23746434|NCT01195662|66451284|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
23746435|NCT01195662|66451282|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
23554641|NCT03494166|65757881|FG001|Overall Study|Death|0|||
23554642|NCT03494166|65757882|FG002|Overall Study|Death|0|||
23746436|NCT01195662|66451283|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
23746437|NCT01195662|66451284|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
23746438|NCT01195662|66451282|FG000|Double Blind Treatment Period|Administrative reason|2|||
23746439|NCT01195662|66451283|FG001|Double Blind Treatment Period|Administrative reason|1|||
23746440|NCT01195662|66451284|FG002|Double Blind Treatment Period|Administrative reason|1|||
23746441|NCT01195662|66451282|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
23746442|NCT01195662|66451283|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
23746443|NCT01195662|66451284|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
23746444|NCT01195662|66451282|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
23746445|NCT01195662|66451283|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
23746446|NCT01195662|66451284|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
23746447|NCT01195662|66451282|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
23746448|NCT01195662|66451283|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23746449|NCT01195662|66451284|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23746450|NCT01195662|66451282|FG000|Double Blind Treatment Period|Non-specified|3|||
23746451|NCT01195662|66451283|FG001|Double Blind Treatment Period|Non-specified|0|||
23746452|NCT01195662|66451284|FG002|Double Blind Treatment Period|Non-specified|0|||
23746453|NCT01195662|66451282|FG000|Double Blind Treatment Period|Missing disposition information|0|||
23746454|NCT01195662|66451283|FG001|Double Blind Treatment Period|Missing disposition information|1|||
23746455|NCT01195662|66451284|FG002|Double Blind Treatment Period|Missing disposition information|1|||
23746456|NCT01195662|66451282|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
23746457|NCT01195662|66451283|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
23746458|NCT01195662|66451284|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
23746459|NCT01195662|66451282|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
23554643|NCT03494166|65757883|FG003|Overall Study|Death|1|||
23746460|NCT01195662|66451283|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
23746461|NCT01195662|66451284|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
23746462|NCT01846039|66451286|FG000|Overall Study|Protocol Violation|1|||
23746463|NCT01846039|66451286|FG000|Overall Study|Subject Withdrew Consent|1|||
23746464|NCT03179462|66451288|FG000|Overall Study|screening failure|1|||
23746465|NCT03179462|66451289|FG001|Overall Study|screening failure|2|||
23746466|NCT03179462|66451290|FG002|Overall Study|screening failure|0|||
23746467|NCT02501642|66451291|FG000|Overall Study|Lost to Follow-up|7|||
23746468|NCT02501642|66451292|FG001|Overall Study|Lost to Follow-up|11|||
23746469|NCT01353209|66451295|FG000|Overall Study|Adverse Event|1|||
23746470|NCT01353209|66451296|FG001|Overall Study|Adverse Event|1|||
23554644|NCT03494166|65757884|FG004|Overall Study|Death|3|||
23554645|NCT03494166|65757885|FG005|Overall Study|Death|0|||
23554646|NCT03494166|65757880|FG000|Overall Study|Lost to Follow-up|2|||
23554647|NCT03494166|65757881|FG001|Overall Study|Lost to Follow-up|2|||
23554648|NCT03494166|65757882|FG002|Overall Study|Lost to Follow-up|2|||
23746471|NCT04516291|66451304|FG000|Treatment Period (24 Weeks)|Other|1|||
23746472|NCT04516291|66451305|FG001|Treatment Period (24 Weeks)|Other|0|||
23746473|NCT04516291|66451306|FG002|Treatment Period (24 Weeks)|Other|0|||
23746474|NCT04516291|66451307|FG003|Treatment Period (24 Weeks)|Other|2|||
23746475|NCT04516291|66451308|FG004|Treatment Period (24 Weeks)|Other|2|||
23746476|NCT04516291|66451309|FG005|Treatment Period (24 Weeks)|Other|4|||
23746477|NCT04516291|66451310|FG006|Treatment Period (24 Weeks)|Other|2|||
23746478|NCT04516291|66451311|FG007|Treatment Period (24 Weeks)|Other|0|||
23746479|NCT04516291|66451304|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23746480|NCT04516291|66451305|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23746481|NCT04516291|66451306|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23746482|NCT04516291|66451307|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23746483|NCT04516291|66451308|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23746484|NCT04516291|66451309|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23746485|NCT04516291|66451310|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23746486|NCT04516291|66451311|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23746487|NCT04516291|66451304|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746488|NCT04516291|66451305|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746489|NCT04516291|66451306|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746490|NCT04516291|66451307|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
23746491|NCT04516291|66451308|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746492|NCT04516291|66451309|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
23554649|NCT03494166|65757883|FG003|Overall Study|Lost to Follow-up|2|||
23554650|NCT03494166|65757884|FG004|Overall Study|Lost to Follow-up|14|||
23554651|NCT03494166|65757885|FG005|Overall Study|Lost to Follow-up|0|||
23746493|NCT04516291|66451310|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746494|NCT04516291|66451311|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
23746495|NCT04516291|66451304|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746496|NCT04516291|66451305|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23746497|NCT04516291|66451306|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746498|NCT04516291|66451307|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746499|NCT04516291|66451308|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746500|NCT04516291|66451309|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746501|NCT04516291|66451310|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746502|NCT04516291|66451311|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23746503|NCT04516291|66451304|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
23746504|NCT04516291|66451305|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
23746505|NCT04516291|66451306|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
23746506|NCT04516291|66451307|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
23746507|NCT04516291|66451308|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
23746508|NCT04516291|66451309|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
23746509|NCT04516291|66451310|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
23746510|NCT04516291|66451311|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
23746511|NCT04516291|66451304|FG000|Follow-up Period (12 Weeks)|Other|0|||
23746512|NCT04516291|66451305|FG001|Follow-up Period (12 Weeks)|Other|1|||
23746513|NCT04516291|66451306|FG002|Follow-up Period (12 Weeks)|Other|0|||
23746514|NCT04516291|66451307|FG003|Follow-up Period (12 Weeks)|Other|2|||
23746515|NCT04516291|66451308|FG004|Follow-up Period (12 Weeks)|Other|0|||
23746516|NCT04516291|66451309|FG005|Follow-up Period (12 Weeks)|Other|0|||
23746517|NCT04516291|66451310|FG006|Follow-up Period (12 Weeks)|Other|0|||
23746518|NCT04516291|66451311|FG007|Follow-up Period (12 Weeks)|Other|0|||
23746519|NCT04516291|66451304|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746520|NCT04516291|66451305|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746521|NCT04516291|66451306|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746522|NCT04516291|66451307|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746523|NCT04516291|66451308|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23746524|NCT04516291|66451309|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23554652|NCT03494166|65757880|FG000|Overall Study|Withdrawal by Subject|10|||
23746525|NCT04516291|66451310|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746526|NCT04516291|66451311|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23746527|NCT04516291|66451304|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746528|NCT04516291|66451305|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746529|NCT04516291|66451306|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
23746530|NCT04516291|66451307|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746531|NCT04516291|66451308|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
23746532|NCT04516291|66451309|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746533|NCT04516291|66451310|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746534|NCT04516291|66451311|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
23746535|NCT03668613|66451318|FG000|Overall Study|Adverse Event|1|||
23746536|NCT03668613|66451319|FG001|Overall Study|Adverse Event|2|||
23746537|NCT03668613|66451318|FG000|Overall Study|Lack of Efficacy|5|||
23554653|NCT03494166|65757881|FG001|Overall Study|Withdrawal by Subject|7|||
23554654|NCT03494166|65757882|FG002|Overall Study|Withdrawal by Subject|0|||
23746538|NCT03668613|66451319|FG001|Overall Study|Lack of Efficacy|1|||
23746539|NCT03668613|66451318|FG000|Overall Study|Pregnancy|0|||
23746540|NCT03668613|66451319|FG001|Overall Study|Pregnancy|2|||
23746541|NCT03668613|66451318|FG000|Overall Study|Protocol Violation|1|||
23746542|NCT03668613|66451319|FG001|Overall Study|Protocol Violation|0|||
23746543|NCT03668613|66451318|FG000|Overall Study|Physician Decision|1|||
23746544|NCT03668613|66451319|FG001|Overall Study|Physician Decision|0|||
23746545|NCT03668613|66451318|FG000|Overall Study|Withdrawal by Subject|2|||
23746546|NCT03668613|66451319|FG001|Overall Study|Withdrawal by Subject|1|||
23746547|NCT03668613|66451318|FG000|Overall Study|Guardian decision|1|||
23746548|NCT03668613|66451319|FG001|Overall Study|Guardian decision|0|||
23746549|NCT00656669|66451330|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
23746550|NCT00656669|66451330|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
23746551|NCT00656669|66451330|FG000|AC (Cycles 6-9)|Adverse Event|1|||
23746552|NCT00656669|66451330|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
23746553|NCT01826201|66451337|FG000|Overall Study|Non compliance with protocol|4|||
23746554|NCT00122954|66451338|FG000|Overall Study|Withdrawal by Subject|2|||
23746555|NCT00122954|66451339|FG001|Overall Study|Withdrawal by Subject|2|||
23746556|NCT00122954|66451338|FG000|Overall Study|Protocol Violation|0|||
23746557|NCT00122954|66451339|FG001|Overall Study|Protocol Violation|1|||
23746558|NCT00253747|66451344|FG000|Overall Study|Lost to Follow-up|13|||
23746559|NCT00253747|66451345|FG001|Overall Study|Lost to Follow-up|14|||
23746560|NCT00253747|66451344|FG000|Overall Study|Withdrawal by Subject|10|||
23746561|NCT00253747|66451345|FG001|Overall Study|Withdrawal by Subject|11|||
23746562|NCT00253747|66451344|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
23746563|NCT00253747|66451345|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
23746564|NCT00131937|66451346|FG000|Overall Study|Adverse Event|3|||
23746565|NCT00131937|66451346|FG000|Overall Study|Withdrawal by Subject|2|||
23746566|NCT00131937|66451346|FG000|Overall Study|Physician Decision|1|||
23746567|NCT00131937|66451346|FG000|Overall Study|Disease Progression|7|||
23746568|NCT00131937|66451346|FG000|Overall Study|Alternative therapy|1|||
23746569|NCT02067728|66451347|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
23746570|NCT02067728|66451348|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
23746571|NCT02067728|66451347|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
23746572|NCT02067728|66451348|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
23746573|NCT02067728|66451347|FG000|6 Month Measurements|Unable to attend|114|||
23746574|NCT02067728|66451348|FG001|6 Month Measurements|Unable to attend|97|||
23746575|NCT03927846|66451352|FG000|Overall Study|Lost to Follow-up|10|||
23746576|NCT03927846|66451353|FG001|Overall Study|Lost to Follow-up|11|||
23746577|NCT02687815|66451356|FG000|Overall Study|Lost to Follow-up|2|||
23746578|NCT02687815|66451357|FG001|Overall Study|Lost to Follow-up|4|||
23746579|NCT02687815|66451356|FG000|Overall Study|Withdrawal by Subject|2|||
23746580|NCT02687815|66451357|FG001|Overall Study|Withdrawal by Subject|4|||
23746581|NCT02551874|66451358|FG000|Overall Study|Lost to Follow-up|0|||
23746582|NCT02551874|66451359|FG001|Overall Study|Lost to Follow-up|2|||
23746583|NCT02551874|66451358|FG000|Overall Study|Pregnancy|0|||
23746584|NCT02551874|66451359|FG001|Overall Study|Pregnancy|1|||
23746585|NCT02551874|66451358|FG000|Overall Study|Reason not reported|10|||
23746586|NCT02551874|66451359|FG001|Overall Study|Reason not reported|4|||
23746587|NCT02551874|66451358|FG000|Overall Study|Did not receive randomized treatment|0|||
23746588|NCT02551874|66451359|FG001|Overall Study|Did not receive randomized treatment|7|||
23746589|NCT02551874|66451358|FG000|Overall Study|Did not enter long-term study|18|||
23746590|NCT02551874|66451359|FG001|Overall Study|Did not enter long-term study|25|||
23746591|NCT04150107|66451360|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
23746592|NCT04150107|66451361|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
23746593|NCT04150107|66451360|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
23746594|NCT04150107|66451361|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
23746595|NCT00536991|66454123|FG000|Overall Study|Withdrawal by Subject|10|||
23746596|NCT00536991|66454123|FG000|Overall Study|Physician Decision|1|||
23746597|NCT00536991|66454123|FG000|Overall Study|patient ineligible|2|||
23746598|NCT00483574|66454124|FG000|Overall Study|Adverse Event|6|||
23746599|NCT00483574|66454125|FG001|Overall Study|Adverse Event|0|||
23746600|NCT00483574|66454124|FG000|Overall Study|Protocol Violation|28|||
23746601|NCT00483574|66454125|FG001|Overall Study|Protocol Violation|9|||
23746602|NCT00483574|66454124|FG000|Overall Study|Lost to Follow-up|16|||
23746603|NCT00483574|66454125|FG001|Overall Study|Lost to Follow-up|4|||
23746604|NCT00483574|66454124|FG000|Overall Study|Withdrawal by Subject|52|||
23746605|NCT00483574|66454125|FG001|Overall Study|Withdrawal by Subject|0|||
23746606|NCT02243709|66454126|FG000|Phase 1|Lost to Follow-up|0|||
23746607|NCT02243709|66454127|FG001|Phase 1|Lost to Follow-up|1|||
23746608|NCT02243709|66454126|FG000|Phase 1|Withdrawal by Subject|1|||
23746609|NCT02243709|66454127|FG001|Phase 1|Withdrawal by Subject|0|||
23746610|NCT02243709|66454126|FG000|Phase 1|Protocol Violation|0|||
23746611|NCT02243709|66454127|FG001|Phase 1|Protocol Violation|1|||
23746612|NCT02243709|66454126|FG000|Phase 1|Adverse Event|0|||
23746613|NCT02243709|66454127|FG001|Phase 1|Adverse Event|1|||
23746614|NCT00625846|66454128|FG000|Overall Study|Withdrawal by Subject|2|||
23432233|NCT01423916|65327582|FG000|Overall Study|Protocol Deviation|1|||
23746615|NCT00625846|66454129|FG001|Overall Study|Withdrawal by Subject|0|||
23746616|NCT00625846|66454130|FG002|Overall Study|Withdrawal by Subject|1|||
23746617|NCT00625846|66454131|FG003|Overall Study|Withdrawal by Subject|2|||
23746618|NCT01740297|66454132|FG000|Overall Study|Withdrawal by Subject|4|||
23746619|NCT01740297|66454133|FG001|Overall Study|Withdrawal by Subject|16|||
23432234|NCT01423916|65327583|FG001|Overall Study|Protocol Deviation|0|||
23432235|NCT01423916|65327584|FG002|Overall Study|Protocol Deviation|0|||
23432236|NCT02066129|65327590|FG000|Overall Study|Lost to Follow-up|13|||
23432237|NCT02066129|65327591|FG001|Overall Study|Lost to Follow-up|12|||
23622117|NCT01644188|66004833|FG000|Overall Study|Last visit outside protocol visit window|14|||
23622118|NCT01644188|66004834|FG001|Overall Study|Last visit outside protocol visit window|16|||
23622119|NCT01644188|66004833|FG000|Overall Study|Site closure|1|||
23622120|NCT01644188|66004834|FG001|Overall Study|Site closure|1|||
23622121|NCT01644188|66004833|FG000|Overall Study|Other than specified above|6|||
23622122|NCT01644188|66004834|FG001|Overall Study|Other than specified above|7|||
23622123|NCT00468130|66004835|FG000|Overall Study|Adverse Event|2|||
23622124|NCT00468130|66004836|FG001|Overall Study|Adverse Event|1|||
23622125|NCT00468130|66004835|FG000|Overall Study|Withdrawal by Subject|0|||
23622126|NCT00468130|66004836|FG001|Overall Study|Withdrawal by Subject|1|||
23432238|NCT02066129|65327590|FG000|Overall Study|Withdrawal by Subject|7|||
23432239|NCT02066129|65327591|FG001|Overall Study|Withdrawal by Subject|10|||
23432240|NCT02066129|65327590|FG000|Overall Study|Lack of Efficacy|8|||
23432241|NCT02066129|65327591|FG001|Overall Study|Lack of Efficacy|10|||
23432242|NCT02066129|65327590|FG000|Overall Study|Physician Decision|1|||
23432243|NCT02066129|65327591|FG001|Overall Study|Physician Decision|1|||
23432244|NCT04566692|65327592|FG000|Overall Study|Adverse Event|2|||
23432245|NCT04566692|65327593|FG001|Overall Study|Adverse Event|0|||
23432246|NCT04566692|65327592|FG000|Overall Study|Withdrawal by Subject|1|||
23432247|NCT04566692|65327593|FG001|Overall Study|Withdrawal by Subject|1|||
23432248|NCT04896593|65327594|FG000|Overall Study|Withdrawal by Subject|2|||
23432249|NCT04896593|65327594|FG000|Overall Study|Lost to Follow-up|1|||
23432250|NCT04896593|65327594|FG000|Overall Study|Did not complete onboarding|2|||
23432251|NCT00098306|65327596|FG000|Double Blind|Randomized, not treated|9|||
23432252|NCT00098306|65327597|FG001|Double Blind|Randomized, not treated|5|||
23432253|NCT00098306|65327598|FG002|Double Blind|Randomized, not treated|2|||
23432254|NCT00098306|65327599|FG003|Double Blind|Randomized, not treated|0|||
23432255|NCT00098306|65327600|FG004|Double Blind|Randomized, not treated|0|||
23432256|NCT00098306|65327601|FG005|Double Blind|Randomized, not treated|0|||
23432257|NCT00098306|65327602|FG006|Double Blind|Randomized, not treated|0|||
23432258|NCT00098306|65327596|FG000|Double Blind|Ongoing at cut-off date|151|||
23432259|NCT00098306|65327597|FG001|Double Blind|Ongoing at cut-off date|166|||
23432260|NCT00098306|65327598|FG002|Double Blind|Ongoing at cut-off date|72|||
23432261|NCT00098306|65327599|FG003|Double Blind|Ongoing at cut-off date|0|||
23432262|NCT00098306|65327600|FG004|Double Blind|Ongoing at cut-off date|0|||
23432263|NCT00098306|65327601|FG005|Double Blind|Ongoing at cut-off date|0|||
23432264|NCT00098306|65327602|FG006|Double Blind|Ongoing at cut-off date|0|||
23432265|NCT00098306|65327596|FG000|Double Blind|Adverse Event|11|||
23432266|NCT00098306|65327597|FG001|Double Blind|Adverse Event|10|||
23432267|NCT00098306|65327598|FG002|Double Blind|Adverse Event|6|||
23432268|NCT00098306|65327599|FG003|Double Blind|Adverse Event|0|||
23432269|NCT00098306|65327600|FG004|Double Blind|Adverse Event|0|||
23432270|NCT00098306|65327601|FG005|Double Blind|Adverse Event|0|||
23432271|NCT00098306|65327602|FG006|Double Blind|Adverse Event|0|||
23432272|NCT00098306|65327596|FG000|Double Blind|Lack of Efficacy|43|||
23432273|NCT00098306|65327597|FG001|Double Blind|Lack of Efficacy|34|||
23432274|NCT00098306|65327598|FG002|Double Blind|Lack of Efficacy|17|||
23432275|NCT00098306|65327599|FG003|Double Blind|Lack of Efficacy|0|||
23432276|NCT00098306|65327600|FG004|Double Blind|Lack of Efficacy|0|||
23432277|NCT00098306|65327601|FG005|Double Blind|Lack of Efficacy|0|||
23622127|NCT03842436|66004840|FG000|Overall Study|Lost to Follow-up|1|||
23622128|NCT00236184|66004841|FG000|Overall Study|Adverse Event|5|||
23746620|NCT01740297|66454134|FG002|Overall Study|Withdrawal by Subject|17|||
23746621|NCT01740297|66454132|FG000|Overall Study|Death|8|||
23746622|NCT01740297|66454133|FG001|Overall Study|Death|46|||
23622129|NCT00236184|66004842|FG001|Overall Study|Adverse Event|2|||
23622130|NCT00236184|66004841|FG000|Overall Study|Lack of Efficacy|0|||
23746623|NCT01740297|66454134|FG002|Overall Study|Death|40|||
23746624|NCT01740297|66454132|FG000|Overall Study|Lost to Follow-up|1|||
23746625|NCT01740297|66454133|FG001|Overall Study|Lost to Follow-up|2|||
23432278|NCT00098306|65327602|FG006|Double Blind|Lack of Efficacy|0|||
23432279|NCT00098306|65327596|FG000|Double Blind|Death|1|||
23432280|NCT00098306|65327597|FG001|Double Blind|Death|4|||
23432281|NCT00098306|65327598|FG002|Double Blind|Death|1|||
23432282|NCT00098306|65327599|FG003|Double Blind|Death|0|||
23432283|NCT00098306|65327600|FG004|Double Blind|Death|0|||
23432284|NCT00098306|65327601|FG005|Double Blind|Death|0|||
23432285|NCT00098306|65327602|FG006|Double Blind|Death|0|||
23432286|NCT00098306|65327596|FG000|Double Blind|Participant defaulted|19|||
23746626|NCT01740297|66454134|FG002|Overall Study|Lost to Follow-up|4|||
23432287|NCT00098306|65327597|FG001|Double Blind|Participant defaulted|18|||
23432288|NCT00098306|65327598|FG002|Double Blind|Participant defaulted|11|||
23432289|NCT00098306|65327599|FG003|Double Blind|Participant defaulted|0|||
23432290|NCT00098306|65327600|FG004|Double Blind|Participant defaulted|0|||
23432291|NCT00098306|65327601|FG005|Double Blind|Participant defaulted|0|||
23432292|NCT00098306|65327602|FG006|Double Blind|Participant defaulted|0|||
23432293|NCT00098306|65327596|FG000|Double Blind|Un-specified|7|||
23432294|NCT00098306|65327597|FG001|Double Blind|Un-specified|3|||
23432295|NCT00098306|65327598|FG002|Double Blind|Un-specified|11|||
23432296|NCT00098306|65327599|FG003|Double Blind|Un-specified|0|||
23432297|NCT00098306|65327600|FG004|Double Blind|Un-specified|0|||
23432298|NCT00098306|65327601|FG005|Double Blind|Un-specified|0|||
23432299|NCT00098306|65327602|FG006|Double Blind|Un-specified|0|||
23432300|NCT00098306|65327596|FG000|Open Label|Lack of Efficacy|0|||
23432301|NCT00098306|65327597|FG001|Open Label|Lack of Efficacy|0|||
23432302|NCT00098306|65327598|FG002|Open Label|Lack of Efficacy|0|||
23432303|NCT00098306|65327599|FG003|Open Label|Lack of Efficacy|13|||
23432304|NCT00098306|65327600|FG004|Open Label|Lack of Efficacy|0|||
23432305|NCT00098306|65327601|FG005|Open Label|Lack of Efficacy|0|||
23432306|NCT00098306|65327602|FG006|Open Label|Lack of Efficacy|0|||
23432307|NCT00098306|65327596|FG000|Open Label|Adverse Event|0|||
23432308|NCT00098306|65327597|FG001|Open Label|Adverse Event|0|||
23432309|NCT00098306|65327598|FG002|Open Label|Adverse Event|0|||
23432310|NCT00098306|65327599|FG003|Open Label|Adverse Event|2|||
23432311|NCT00098306|65327600|FG004|Open Label|Adverse Event|0|||
23432312|NCT00098306|65327601|FG005|Open Label|Adverse Event|0|||
23432313|NCT00098306|65327602|FG006|Open Label|Adverse Event|0|||
23432314|NCT00098306|65327596|FG000|Open Label|Death|0|||
23432315|NCT00098306|65327597|FG001|Open Label|Death|0|||
23432316|NCT00098306|65327598|FG002|Open Label|Death|0|||
23432317|NCT00098306|65327599|FG003|Open Label|Death|4|||
23432318|NCT00098306|65327600|FG004|Open Label|Death|0|||
23432319|NCT00098306|65327601|FG005|Open Label|Death|0|||
23432320|NCT00098306|65327602|FG006|Open Label|Death|0|||
23746627|NCT02389621|66454135|FG000|Treatment Period|Withdrawal by Subject|1|||
23432321|NCT00098306|65327596|FG000|Open Label|Participant defaulted|0|||
23432322|NCT00098306|65327597|FG001|Open Label|Participant defaulted|0|||
23432323|NCT00098306|65327598|FG002|Open Label|Participant defaulted|0|||
23432324|NCT00098306|65327599|FG003|Open Label|Participant defaulted|24|||
23432325|NCT00098306|65327600|FG004|Open Label|Participant defaulted|0|||
23432326|NCT00098306|65327601|FG005|Open Label|Participant defaulted|0|||
23432327|NCT00098306|65327602|FG006|Open Label|Participant defaulted|0|||
23432328|NCT00098306|65327596|FG000|Open Label|Un-specified|0|||
23432329|NCT00098306|65327597|FG001|Open Label|Un-specified|0|||
23432330|NCT00098306|65327598|FG002|Open Label|Un-specified|0|||
23432331|NCT00098306|65327599|FG003|Open Label|Un-specified|15|||
23432332|NCT00098306|65327600|FG004|Open Label|Un-specified|0|||
23432333|NCT00098306|65327601|FG005|Open Label|Un-specified|0|||
23432334|NCT00098306|65327602|FG006|Open Label|Un-specified|0|||
23432335|NCT00098306|65327596|FG000|Open Label|Ongoing at cut-off date|0|||
23432336|NCT00098306|65327597|FG001|Open Label|Ongoing at cut-off date|0|||
23432337|NCT00098306|65327598|FG002|Open Label|Ongoing at cut-off date|0|||
23432338|NCT00098306|65327599|FG003|Open Label|Ongoing at cut-off date|269|||
23432339|NCT00098306|65327600|FG004|Open Label|Ongoing at cut-off date|62|||
23432340|NCT00098306|65327601|FG005|Open Label|Ongoing at cut-off date|0|||
23432341|NCT00098306|65327602|FG006|Open Label|Ongoing at cut-off date|0|||
23432342|NCT00098306|65327596|FG000|Observational Phase|Death|0|||
23432343|NCT00098306|65327597|FG001|Observational Phase|Death|0|||
23432344|NCT00098306|65327598|FG002|Observational Phase|Death|0|||
23432345|NCT00098306|65327599|FG003|Observational Phase|Death|0|||
23432346|NCT00098306|65327600|FG004|Observational Phase|Death|0|||
23432347|NCT00098306|65327601|FG005|Observational Phase|Death|5|||
23432348|NCT00098306|65327602|FG006|Observational Phase|Death|4|||
23432349|NCT00098306|65327596|FG000|Observational Phase|Participant defaulted|0|||
23432350|NCT00098306|65327597|FG001|Observational Phase|Participant defaulted|0|||
23432351|NCT00098306|65327598|FG002|Observational Phase|Participant defaulted|0|||
23432352|NCT00098306|65327599|FG003|Observational Phase|Participant defaulted|0|||
23746628|NCT02389621|66454136|FG001|Treatment Period|Withdrawal by Subject|1|||
23432353|NCT00098306|65327600|FG004|Observational Phase|Participant defaulted|0|||
23432354|NCT00098306|65327601|FG005|Observational Phase|Participant defaulted|34|||
23432355|NCT00098306|65327602|FG006|Observational Phase|Participant defaulted|18|||
23432356|NCT00098306|65327596|FG000|Observational Phase|Un-specified|0|||
23432357|NCT00098306|65327597|FG001|Observational Phase|Un-specified|0|||
23432358|NCT00098306|65327598|FG002|Observational Phase|Un-specified|0|||
23432359|NCT00098306|65327599|FG003|Observational Phase|Un-specified|0|||
23432360|NCT00098306|65327600|FG004|Observational Phase|Un-specified|0|||
23432361|NCT00098306|65327601|FG005|Observational Phase|Un-specified|7|||
23432362|NCT00098306|65327602|FG006|Observational Phase|Un-specified|4|||
23432363|NCT03443427|65327605|FG000|Overall Study|Adverse Event|2|||
23432364|NCT03443427|65327606|FG001|Overall Study|Adverse Event|3|||
23432365|NCT03443427|65327605|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
23432366|NCT03443427|65327606|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23432367|NCT03443427|65327605|FG000|Overall Study|Other|4|||
23432368|NCT03443427|65327606|FG001|Overall Study|Other|6|||
23432369|NCT01422824|65327607|FG000|Overall Study|Case record form not evaluated|1|||
23432370|NCT01422824|65327607|FG000|Overall Study|Lost to Follow-up|37|||
23432371|NCT02014584|65327610|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432372|NCT02014584|65327611|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
23432373|NCT02014584|65327612|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432374|NCT02014584|65327613|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432375|NCT02014584|65327614|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432376|NCT02014584|65327615|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432377|NCT02014584|65327610|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
23432378|NCT02014584|65327611|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
23432379|NCT02014584|65327612|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432380|NCT02014584|65327613|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432381|NCT02014584|65327614|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432382|NCT02014584|65327615|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432383|NCT02014584|65327610|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432384|NCT02014584|65327611|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432385|NCT02014584|65327612|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
23432386|NCT02014584|65327613|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432387|NCT02014584|65327614|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432388|NCT02014584|65327615|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432389|NCT02014584|65327610|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432390|NCT02014584|65327611|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432391|NCT02014584|65327612|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
23432392|NCT02014584|65327613|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
23622131|NCT00236184|66004842|FG001|Overall Study|Lack of Efficacy|1|||
23622132|NCT00236184|66004841|FG000|Overall Study|Lost to Follow-up|3|||
23622133|NCT00236184|66004842|FG001|Overall Study|Lost to Follow-up|4|||
23622134|NCT00236184|66004841|FG000|Overall Study|Physician Decision|1|||
23622135|NCT00236184|66004842|FG001|Overall Study|Physician Decision|1|||
23622136|NCT00236184|66004841|FG000|Overall Study|Withdrawal by Subject|3|||
23746629|NCT02389621|66454135|FG000|Posttreatment Period|Adverse Event|3|||
23746630|NCT02389621|66454136|FG001|Posttreatment Period|Adverse Event|1|||
23746631|NCT02389621|66454135|FG000|Posttreatment Period|Withdrawal by Subject|3|||
23746632|NCT02389621|66454136|FG001|Posttreatment Period|Withdrawal by Subject|2|||
23746633|NCT02389621|66454135|FG000|Posttreatment Period|Lost to Follow-up|1|||
23746634|NCT02389621|66454136|FG001|Posttreatment Period|Lost to Follow-up|1|||
23746635|NCT02389621|66454135|FG000|Posttreatment Period|Other - Miscellaneous|2|||
23746636|NCT02389621|66454136|FG001|Posttreatment Period|Other - Miscellaneous|0|||
23746637|NCT03014570|66454137|FG000|Overall Study|COVID-19 Restrictions|38|||
23746638|NCT03014570|66454138|FG001|Overall Study|COVID-19 Restrictions|24|||
23746639|NCT03014570|66454137|FG000|Overall Study|Death|70|||
23746640|NCT03014570|66454138|FG001|Overall Study|Death|79|||
23746641|NCT03014570|66454137|FG000|Overall Study|Transfer from facility|11|||
23746642|NCT03014570|66454138|FG001|Overall Study|Transfer from facility|14|||
23746643|NCT03014570|66454137|FG000|Overall Study|Hospitalized|5|||
23822842|NCT00425373|66730551|FG007|Overall Study|Withdrawal by Subject|2|||
23822843|NCT00425373|66730552|FG008|Overall Study|Withdrawal by Subject|2|||
23822844|NCT00425373|66730544|FG000|Overall Study|Lack of Efficacy|0|||
23822845|NCT00425373|66730545|FG001|Overall Study|Lack of Efficacy|0|||
23822846|NCT00425373|66730546|FG002|Overall Study|Lack of Efficacy|0|||
23822847|NCT00425373|66730547|FG003|Overall Study|Lack of Efficacy|0|||
23822848|NCT00425373|66730548|FG004|Overall Study|Lack of Efficacy|1|||
23822849|NCT00425373|66730549|FG005|Overall Study|Lack of Efficacy|3|||
23822850|NCT00425373|66730550|FG006|Overall Study|Lack of Efficacy|3|||
23822851|NCT00425373|66730551|FG007|Overall Study|Lack of Efficacy|0|||
23822852|NCT00425373|66730552|FG008|Overall Study|Lack of Efficacy|5|||
23822853|NCT02862730|66730553|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23822854|NCT02862730|66730554|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23822855|NCT02862730|66730555|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
23822856|NCT02862730|66730556|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23822857|NCT02862730|66730557|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23432393|NCT02014584|65327614|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432394|NCT02014584|65327615|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23622137|NCT00236184|66004842|FG001|Overall Study|Withdrawal by Subject|0|||
23746644|NCT03014570|66454138|FG001|Overall Study|Hospitalized|3|||
23622138|NCT00236184|66004841|FG000|Overall Study|Protocol Violation|3|||
23746645|NCT03014570|66454137|FG000|Overall Study|Transfer within facility|1|||
23746646|NCT03014570|66454138|FG001|Overall Study|Transfer within facility|0|||
23822858|NCT02862730|66730558|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23822859|NCT02862730|66730559|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23822860|NCT02862730|66730553|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
23822861|NCT02862730|66730554|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822862|NCT02862730|66730555|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822863|NCT02862730|66730556|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822864|NCT02862730|66730557|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822865|NCT02862730|66730558|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822866|NCT02862730|66730559|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23822867|NCT02862730|66730553|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23822868|NCT02862730|66730554|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23822869|NCT02862730|66730555|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
23822870|NCT02862730|66730556|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23822871|NCT02862730|66730557|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
23822872|NCT02862730|66730558|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23822873|NCT02862730|66730559|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23822874|NCT02862730|66730553|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822875|NCT02862730|66730554|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822876|NCT02862730|66730555|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822877|NCT02862730|66730556|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
23822878|NCT02862730|66730557|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822879|NCT02862730|66730558|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822880|NCT02862730|66730559|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23822881|NCT04138043|66730560|FG000|Overall Study|Withdrawal by Subject|0|||
23822882|NCT04138043|66730561|FG001|Overall Study|Withdrawal by Subject|1|||
23822883|NCT00489255|66730564|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
23822884|NCT00489255|66730565|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
23822885|NCT00489255|66730564|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
23822886|NCT00489255|66730565|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
23822887|NCT00489255|66730564|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
23822888|NCT00489255|66730565|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
23822889|NCT00489255|66730564|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
23822890|NCT00489255|66730565|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
23822891|NCT00489255|66730564|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
23822892|NCT00489255|66730565|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
23822893|NCT00489255|66730564|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
23822894|NCT00489255|66730565|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
23822895|NCT00489255|66730564|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
23554655|NCT03494166|65757883|FG003|Overall Study|Withdrawal by Subject|5|||
23554656|NCT03494166|65757884|FG004|Overall Study|Withdrawal by Subject|3|||
23554657|NCT03494166|65757885|FG005|Overall Study|Withdrawal by Subject|17|||
23554658|NCT03494166|65757880|FG000|Overall Study|Screen failure|1|||
23554659|NCT03494166|65757881|FG001|Overall Study|Screen failure|0|||
23746647|NCT03014570|66454137|FG000|Overall Study|Site refusal|0|||
23746648|NCT03014570|66454138|FG001|Overall Study|Site refusal|11|||
23554660|NCT03494166|65757882|FG002|Overall Study|Screen failure|0|||
23554661|NCT03494166|65757883|FG003|Overall Study|Screen failure|0|||
23554662|NCT03494166|65757884|FG004|Overall Study|Screen failure|1|||
23554663|NCT03494166|65757885|FG005|Overall Study|Screen failure|0|||
23554664|NCT03151005|65757889|FG000|Overall Study|Lost to Follow-up|5|||
23554665|NCT03151005|65757890|FG001|Overall Study|Lost to Follow-up|5|||
23554666|NCT02450331|65757899|FG000|Overall Study|Death|162|||
23554667|NCT02450331|65757900|FG001|Overall Study|Death|171|||
23554668|NCT02450331|65757899|FG000|Overall Study|Lost to Follow-up|14|||
23554669|NCT02450331|65757900|FG001|Overall Study|Lost to Follow-up|12|||
23746649|NCT01789476|66454140|FG000|Overall Study|Lack of Efficacy|6|||
23746650|NCT01789476|66454141|FG001|Overall Study|Lack of Efficacy|2|||
23746651|NCT01789476|66454140|FG000|Overall Study|Adverse Event|1|||
23746652|NCT01789476|66454141|FG001|Overall Study|Adverse Event|0|||
23746653|NCT01789476|66454140|FG000|Overall Study|Unable to get IV access|1|||
23746654|NCT01789476|66454141|FG001|Overall Study|Unable to get IV access|0|||
23746655|NCT02219477|66454144|FG000|Overall Study|Adverse Event|0|||
23746656|NCT02219477|66454145|FG001|Overall Study|Adverse Event|1|||
23746657|NCT02219477|66454146|FG002|Overall Study|Adverse Event|1|||
23746658|NCT02219477|66454144|FG000|Overall Study|Withdrawal by Subject|0|||
23822896|NCT00489255|66730565|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
23554670|NCT02450331|65757899|FG000|Overall Study|Withdrawal by Subject|55|||
23554671|NCT02450331|65757900|FG001|Overall Study|Withdrawal by Subject|44|||
23554672|NCT02450331|65757899|FG000|Overall Study|Non-specified other|1|||
23554673|NCT02450331|65757900|FG001|Overall Study|Non-specified other|1|||
23554674|NCT04252742|65757902|FG000|Overall Study|Decision by sponsor|0|||
23554675|NCT04252742|65757903|FG001|Overall Study|Decision by sponsor|2|||
23746659|NCT02219477|66454145|FG001|Overall Study|Withdrawal by Subject|1|||
23746660|NCT02219477|66454146|FG002|Overall Study|Withdrawal by Subject|0|||
23746661|NCT02064231|66454149|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
23746662|NCT02064231|66454150|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
23746663|NCT02064231|66454151|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
23746664|NCT02064231|66454152|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
23746665|NCT02064231|66454149|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
23746666|NCT02064231|66454150|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
23746667|NCT02064231|66454151|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
23746668|NCT02064231|66454152|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
23746669|NCT02064231|66454149|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
23746670|NCT02064231|66454150|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
23746671|NCT02064231|66454151|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
23746672|NCT02064231|66454152|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
23746673|NCT02064231|66454149|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
23746674|NCT02064231|66454150|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
23746675|NCT02064231|66454151|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
23746676|NCT02064231|66454152|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
23746677|NCT02851069|66454155|FG000|Overall Study|Failure to Return|3|||
23822897|NCT00489255|66730564|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
23822898|NCT00489255|66730565|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
23822899|NCT00489255|66730564|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
23822900|NCT00489255|66730565|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
23822901|NCT00489255|66730564|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
23822902|NCT00489255|66730565|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
23822903|NCT00550459|66730566|FG000|Overall Study|Adverse Event|0|||
23822904|NCT00550459|66730567|FG001|Overall Study|Adverse Event|2|||
23822905|NCT00550459|66730566|FG000|Overall Study|Withdrawal by Subject|1|||
23822906|NCT00550459|66730567|FG001|Overall Study|Withdrawal by Subject|1|||
23822907|NCT01371539|66730568|FG000|Period One: One Week|Lost to Follow-up|0|||
23822908|NCT01371539|66730569|FG001|Period One: One Week|Lost to Follow-up|1|||
23822909|NCT01371539|66730568|FG000|Period Two: One Week|Lost to Follow-up|0|||
23822910|NCT01371539|66730569|FG001|Period Two: One Week|Lost to Follow-up|1|||
23822911|NCT01371539|66730568|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
23822912|NCT01371539|66730569|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
23822913|NCT01371539|66730568|FG000|Period Two: One Week|Time/job conflict|0|||
23822914|NCT01371539|66730569|FG001|Period Two: One Week|Time/job conflict|1|||
23822915|NCT00958893|66730570|FG000|Overall Study|Study prematurely terminated|4|||
23822916|NCT05013008|66730571|FG000|Overall Study|Exclusion from mBFAS|5|||
23822917|NCT05013008|66730572|FG001|Overall Study|Exclusion from mBFAS|25|||
23822918|NCT01757275|66730577|FG000|Overall Study|Lost to Follow-up|1|||
23822919|NCT01757275|66730578|FG001|Overall Study|Lost to Follow-up|2|||
23822920|NCT01757275|66730577|FG000|Overall Study|Adverse Event|3|||
23822921|NCT01757275|66730578|FG001|Overall Study|Adverse Event|3|||
23822922|NCT01757275|66730577|FG000|Overall Study|Withdrawal by Subject|2|||
23822923|NCT01757275|66730578|FG001|Overall Study|Withdrawal by Subject|4|||
23822924|NCT01757275|66730577|FG000|Overall Study|Not treated|3|||
23822925|NCT01757275|66730578|FG001|Overall Study|Not treated|4|||
23822926|NCT00805675|66730589|FG000|Overall Study|Adverse Event|0|||
23822927|NCT00805675|66730590|FG001|Overall Study|Adverse Event|0|||
23822928|NCT00805675|66730591|FG002|Overall Study|Adverse Event|1|||
23822929|NCT01890434|66730594|FG000|Overall Study|Adverse Event|8|||
23822930|NCT01890434|66730594|FG000|Overall Study|PCI at external hospital|1|||
23822931|NCT01890434|66730594|FG000|Overall Study|Assessment discrepancy|1|||
23822932|NCT01890434|66730594|FG000|Overall Study|CRC didn't contact participant for FU|1|||
23822933|NCT01890434|66730594|FG000|Overall Study|Could not get whole set of images|1|||
23822934|NCT01890434|66730594|FG000|Overall Study|Decline to return for GSPECT|1|||
23822935|NCT01890434|66730594|FG000|Overall Study|GSPECT at rest was not done|1|||
23822936|NCT01890434|66730594|FG000|Overall Study|Participant didn't complete MRI|1|||
23822937|NCT01890434|66730594|FG000|Overall Study|Uncontactable by phone|1|||
23822938|NCT01890434|66730594|FG000|Overall Study|Moved out of position|1|||
23822939|NCT01890434|66730594|FG000|Overall Study|Unable to contact|1|||
23822940|NCT01890434|66730594|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
23822941|NCT01098487|66730597|FG000|Overall Study|Adverse Event|22|||
23822942|NCT01098487|66730597|FG000|Overall Study|Lack of Efficacy|11|||
23822943|NCT01098487|66730597|FG000|Overall Study|Withdrawal by Subject|7|||
23822944|NCT01098487|66730597|FG000|Overall Study|Lost to Follow-up|3|||
23746678|NCT02851069|66454155|FG000|Overall Study|Other|3|||
23746679|NCT03735680|66454156|FG000|Overall Study|Withdrawal by Subject|0|||
23822945|NCT01098487|66730597|FG000|Overall Study|Physician Decision|1|||
23822946|NCT02842073|66730598|FG000|Overall Study|Withdrawal by Subject|1|||
23822947|NCT00741338|66730602|FG000|Overall Study|Adverse Event|0|||
23822948|NCT00741338|66730603|FG001|Overall Study|Adverse Event|1|||
23822949|NCT04172597|66730604|FG000|Overall Study|Disease Progression|0|||
23622139|NCT00236184|66004842|FG001|Overall Study|Protocol Violation|0|||
23554676|NCT04252742|65757902|FG000|Overall Study|Withdrawal by Subject|15|||
23554677|NCT04252742|65757903|FG001|Overall Study|Withdrawal by Subject|9|||
23554678|NCT04252742|65757902|FG000|Overall Study|Lost to Follow-up|0|||
23554679|NCT04252742|65757903|FG001|Overall Study|Lost to Follow-up|1|||
23554680|NCT00736645|65757904|FG000|Overall Study|Adverse Event|0|||
23554681|NCT00736645|65757905|FG001|Overall Study|Adverse Event|2|||
23554682|NCT00736645|65757906|FG002|Overall Study|Adverse Event|0|||
23554683|NCT00736645|65757907|FG003|Overall Study|Adverse Event|0|||
23554684|NCT01936857|65757908|FG000|Overall Study|Sent to prison or 06 center|11|||
23554685|NCT01936857|65757909|FG001|Overall Study|Sent to prison or 06 center|12|||
23554686|NCT01936857|65757908|FG000|Overall Study|Lost to Follow-up|10|||
23554687|NCT01936857|65757909|FG001|Overall Study|Lost to Follow-up|7|||
23554688|NCT01936857|65757908|FG000|Overall Study|Death|7|||
23554689|NCT01936857|65757909|FG001|Overall Study|Death|3|||
23554690|NCT01936857|65757908|FG000|Overall Study|Moved|2|||
23554691|NCT01936857|65757909|FG001|Overall Study|Moved|1|||
23554692|NCT01936857|65757908|FG000|Overall Study|Withdrawal by Subject|1|||
23554693|NCT01936857|65757909|FG001|Overall Study|Withdrawal by Subject|0|||
23554694|NCT01936857|65757908|FG000|Overall Study|Side effect of medication|1|||
23554695|NCT01936857|65757909|FG001|Overall Study|Side effect of medication|0|||
23554696|NCT01936857|65757908|FG000|Overall Study|Other|2|||
23554697|NCT01936857|65757909|FG001|Overall Study|Other|2|||
23554698|NCT01235546|65757910|FG000|Overall Study|Staff error, medication not administered|1|||
23554699|NCT01235546|65757911|FG001|Overall Study|Staff error, medication not administered|0|||
23554700|NCT01235546|65757910|FG000|Overall Study|Protocol Violation|1|||
23554701|NCT01235546|65757911|FG001|Overall Study|Protocol Violation|1|||
23554702|NCT01569438|65757912|FG000|Overall Study|Lack of Efficacy|1|||
23554703|NCT01569438|65757913|FG001|Overall Study|Lack of Efficacy|2|||
23554704|NCT01569438|65757912|FG000|Overall Study|Withdrawal by Subject|0|||
23554705|NCT01569438|65757913|FG001|Overall Study|Withdrawal by Subject|3|||
23554706|NCT01569438|65757912|FG000|Overall Study|Adverse Event|2|||
23554707|NCT01569438|65757913|FG001|Overall Study|Adverse Event|15|||
23554708|NCT01569438|65757912|FG000|Overall Study|Protocol Violation|2|||
23554709|NCT01569438|65757913|FG001|Overall Study|Protocol Violation|0|||
23554710|NCT01569438|65757912|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
23554711|NCT01569438|65757913|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
23554712|NCT01569438|65757912|FG000|Overall Study|Sponsor/Physician decision|1|||
23554713|NCT01569438|65757913|FG001|Overall Study|Sponsor/Physician decision|1|||
23554714|NCT01569438|65757912|FG000|Overall Study|Unable to adhere to study schedule|0|||
23554715|NCT01569438|65757913|FG001|Overall Study|Unable to adhere to study schedule|1|||
23554716|NCT02047045|65757915|FG000|Baseline|Withdrawal by Subject|3|||
23554717|NCT02047045|65757916|FG001|Baseline|Withdrawal by Subject|2|||
23554718|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
23554719|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
23554720|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
23554721|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
23554722|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
23554723|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
23554724|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
23554725|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
23554726|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
23554727|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
23622140|NCT00236184|66004841|FG000|Overall Study|non-compliance with study drug|2|||
23622141|NCT00236184|66004842|FG001|Overall Study|non-compliance with study drug|1|||
23822950|NCT04172597|66730605|FG001|Overall Study|Disease Progression|0|||
23822951|NCT04172597|66730606|FG002|Overall Study|Disease Progression|0|||
23822952|NCT04172597|66730607|FG003|Overall Study|Disease Progression|0|||
23822953|NCT04172597|66730608|FG004|Overall Study|Disease Progression|1|||
23822954|NCT01333397|66730609|FG000|Overall Study|Lost to Follow-up|1|||
23822955|NCT01333397|66730610|FG001|Overall Study|Lost to Follow-up|0|||
23822956|NCT01333397|66730611|FG002|Overall Study|Lost to Follow-up|0|||
23822957|NCT01333397|66730612|FG003|Overall Study|Lost to Follow-up|1|||
23822958|NCT01333397|66730613|FG004|Overall Study|Lost to Follow-up|0|||
23822959|NCT01560416|66730614|FG000|Randomized Phase|Crossover Participants|7|||
23554728|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
23554729|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
23554730|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
23554731|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
23554732|NCT02047045|65757915|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
23554733|NCT02047045|65757916|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
23554734|NCT00541450|65757917|FG000|Phase A|Adverse Event|3|||
23554735|NCT00541450|65757918|FG001|Phase A|Adverse Event|0|||
23554736|NCT00541450|65757917|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
23822960|NCT01560416|66730615|FG001|Randomized Phase|Crossover Participants|0|||
23746680|NCT03735680|66454157|FG001|Overall Study|Withdrawal by Subject|1|||
23746681|NCT03735680|66454158|FG002|Overall Study|Withdrawal by Subject|0|||
23746682|NCT03735680|66454159|FG003|Overall Study|Withdrawal by Subject|0|||
23746683|NCT03735680|66454160|FG004|Overall Study|Withdrawal by Subject|0|||
23746684|NCT03735680|66454161|FG005|Overall Study|Withdrawal by Subject|1|||
23746685|NCT03735680|66454156|FG000|Overall Study|Patient unable or unwilling to continue|0|||
23746686|NCT03735680|66454157|FG001|Overall Study|Patient unable or unwilling to continue|0|||
23746687|NCT03735680|66454158|FG002|Overall Study|Patient unable or unwilling to continue|1|||
23746688|NCT03735680|66454159|FG003|Overall Study|Patient unable or unwilling to continue|0|||
23746689|NCT03735680|66454160|FG004|Overall Study|Patient unable or unwilling to continue|0|||
23746690|NCT03735680|66454161|FG005|Overall Study|Patient unable or unwilling to continue|0|||
23746691|NCT00347776|66454162|FG000|1.5 Month Follow-up|Death|2|||
23746692|NCT00347776|66454163|FG001|1.5 Month Follow-up|Death|0|||
23746693|NCT00347776|66454164|FG002|1.5 Month Follow-up|Death|0|||
23746694|NCT00347776|66454162|FG000|1.5 Month Follow-up|reached the endpoint|12|||
23746695|NCT00347776|66454163|FG001|1.5 Month Follow-up|reached the endpoint|8|||
23746696|NCT00347776|66454164|FG002|1.5 Month Follow-up|reached the endpoint|12|||
23746697|NCT00347776|66454162|FG000|6 Month Follow-up|Death|2|||
23746698|NCT00347776|66454163|FG001|6 Month Follow-up|Death|1|||
23746699|NCT00347776|66454164|FG002|6 Month Follow-up|Death|3|||
23746700|NCT00347776|66454162|FG000|6 Month Follow-up|reached endpont|20|||
23746701|NCT00347776|66454163|FG001|6 Month Follow-up|reached endpont|12|||
23746702|NCT00347776|66454164|FG002|6 Month Follow-up|reached endpont|15|||
23746703|NCT00347776|66454162|FG000|12 Month Follow-up|Lost to Follow-up|7|||
23746704|NCT00347776|66454163|FG001|12 Month Follow-up|Lost to Follow-up|6|||
23746705|NCT00347776|66454164|FG002|12 Month Follow-up|Lost to Follow-up|6|||
23746706|NCT00347776|66454162|FG000|12 Month Follow-up|Death|3|||
23746707|NCT00347776|66454163|FG001|12 Month Follow-up|Death|4|||
23746708|NCT00347776|66454164|FG002|12 Month Follow-up|Death|4|||
23746709|NCT00347776|66454162|FG000|12 Month Follow-up|Reached endpoint|13|||
23746710|NCT00347776|66454163|FG001|12 Month Follow-up|Reached endpoint|6|||
23746711|NCT00347776|66454164|FG002|12 Month Follow-up|Reached endpoint|9|||
23746712|NCT00556166|66454165|FG000|Overall Study|Withdrawal by Subject|1|||
23746713|NCT04984889|66454170|FG000|Extension Part|Ongoing|5|||
23746714|NCT01945866|66454171|FG000|Overall Study|Eyes did not complete or were dropped|2|||
23746715|NCT01945866|66454172|FG001|Overall Study|Eyes did not complete or were dropped|0|||
23746716|NCT00071006|66454173|FG000|Overall Study|Lack of Efficacy|7|||
23746717|NCT00071006|66454173|FG000|Overall Study|Adverse Event|1|||
23746718|NCT00071006|66454173|FG000|Overall Study|Withdrawal by Subject|1|||
23746719|NCT00071006|66454173|FG000|Overall Study|Other|3|||
23746720|NCT03329404|66454174|FG000|Overall Study|The study was suspended.|1|||
23746721|NCT03329404|66454175|FG001|Overall Study|The study was suspended.|4|||
23746722|NCT01855607|66454177|FG000|Overall Study|Withdrawal by Subject|1|||
23746723|NCT01855607|66454177|FG000|Overall Study|Study was terminated|11|||
23746724|NCT00779142|66454185|FG000|Overall Study|Screen Failures|3|||
23746725|NCT00548340|66454186|FG000|Overall Study|Protocol Violation|2|||
23746726|NCT00548340|66454187|FG001|Overall Study|Protocol Violation|3|||
23746727|NCT00548340|66454188|FG002|Overall Study|Protocol Violation|3|||
23746728|NCT00548340|66454186|FG000|Overall Study|Adverse Event|2|||
23746729|NCT00548340|66454187|FG001|Overall Study|Adverse Event|2|||
23746730|NCT00548340|66454188|FG002|Overall Study|Adverse Event|2|||
23746731|NCT00548340|66454186|FG000|Overall Study|Lost to Follow-up|1|||
23746732|NCT00548340|66454187|FG001|Overall Study|Lost to Follow-up|1|||
23746733|NCT00548340|66454188|FG002|Overall Study|Lost to Follow-up|0|||
23746734|NCT00548340|66454186|FG000|Overall Study|Withdrawal by Subject|2|||
23746735|NCT00548340|66454187|FG001|Overall Study|Withdrawal by Subject|4|||
23746736|NCT00548340|66454188|FG002|Overall Study|Withdrawal by Subject|3|||
23746737|NCT00548340|66454186|FG000|Overall Study|Other|1|||
23746738|NCT00548340|66454187|FG001|Overall Study|Other|1|||
23746739|NCT00548340|66454188|FG002|Overall Study|Other|1|||
23746740|NCT01374516|66454190|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
23746741|NCT01374516|66454191|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
23746742|NCT01374516|66454190|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
23746743|NCT01374516|66454191|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
23746744|NCT01374516|66454190|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
23746745|NCT01374516|66454191|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
23746746|NCT01374516|66454190|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
23746747|NCT01374516|66454191|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
23746748|NCT01374516|66454190|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
23746749|NCT01374516|66454191|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
23746750|NCT01374516|66454190|FG000|Surveillance Expansion Period|Protocol Violation|386|||
23746751|NCT01374516|66454191|FG001|Surveillance Expansion Period|Protocol Violation|217|||
23746752|NCT01374516|66454190|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
23822961|NCT00345631|66730616|FG000|Overall Study|Withdrawal by Subject|1|||
23822962|NCT00345631|66730617|FG001|Overall Study|Withdrawal by Subject|0|||
23822963|NCT00345631|66730618|FG002|Overall Study|Withdrawal by Subject|1|||
23822964|NCT00345631|66730616|FG000|Overall Study|Adverse Event|0|||
23822965|NCT00345631|66730617|FG001|Overall Study|Adverse Event|1|||
23822966|NCT00345631|66730618|FG002|Overall Study|Adverse Event|0|||
23822967|NCT00345631|66730616|FG000|Overall Study|Lost to Follow-up|3|||
23822968|NCT00345631|66730617|FG001|Overall Study|Lost to Follow-up|7|||
23822969|NCT00345631|66730618|FG002|Overall Study|Lost to Follow-up|4|||
23822970|NCT00345631|66730616|FG000|Overall Study|Other reasons|0|||
23822971|NCT00345631|66730617|FG001|Overall Study|Other reasons|0|||
23822972|NCT00345631|66730618|FG002|Overall Study|Other reasons|1|||
23822973|NCT02586155|66734317|FG000|Overall Study|Adverse Event|2|||
23822974|NCT02586155|66734318|FG001|Overall Study|Adverse Event|3|||
23822975|NCT02586155|66734317|FG000|Overall Study|Withdrawal by Subject|31|||
23822976|NCT02586155|66734318|FG001|Overall Study|Withdrawal by Subject|24|||
23822977|NCT02586155|66734317|FG000|Overall Study|Lost to Follow-up|7|||
23822978|NCT02586155|66734318|FG001|Overall Study|Lost to Follow-up|13|||
23822979|NCT02586155|66734317|FG000|Overall Study|Death|61|||
23822980|NCT02586155|66734318|FG001|Overall Study|Death|72|||
23822981|NCT02586155|66734317|FG000|Overall Study|Other reasons|26|||
23822982|NCT02586155|66734318|FG001|Overall Study|Other reasons|15|||
23822983|NCT04779879|66734319|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23822984|NCT04779879|66734320|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23822985|NCT04779879|66734321|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23822986|NCT04779879|66734322|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
23822987|NCT04779879|66734323|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23822988|NCT04779879|66734324|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23822989|NCT04779879|66734319|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
23822990|NCT04779879|66734320|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
23822991|NCT04779879|66734321|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
23822992|NCT04779879|66734322|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
23822993|NCT04779879|66734323|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
23822994|NCT04779879|66734324|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
23822995|NCT04779879|66734319|FG000|Part C: Up to Week 36|Death|0|||
23822996|NCT04779879|66734320|FG001|Part C: Up to Week 36|Death|0|||
23822997|NCT04779879|66734321|FG002|Part C: Up to Week 36|Death|0|||
23822998|NCT04779879|66734322|FG003|Part C: Up to Week 36|Death|0|||
23822999|NCT04779879|66734323|FG004|Part C: Up to Week 36|Death|0|||
23823000|NCT04779879|66734324|FG005|Part C: Up to Week 36|Death|1|||
23823001|NCT04779879|66734319|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
23823002|NCT04779879|66734320|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
23823003|NCT04779879|66734321|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
23823004|NCT04779879|66734322|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
23823005|NCT04779879|66734323|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
23823006|NCT04779879|66734324|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
23823007|NCT03284723|66734327|FG000|Overall Study|Death|0|||
23823008|NCT03284723|66734328|FG001|Overall Study|Death|0|||
23823009|NCT03284723|66734329|FG002|Overall Study|Death|0|||
23823010|NCT03284723|66734330|FG003|Overall Study|Death|1|||
23823011|NCT03284723|66734331|FG004|Overall Study|Death|0|||
23823012|NCT03284723|66734332|FG005|Overall Study|Death|0|||
23823013|NCT03284723|66734333|FG006|Overall Study|Death|1|||
23823014|NCT03284723|66734334|FG007|Overall Study|Death|0|||
23823015|NCT03284723|66734335|FG008|Overall Study|Death|0|||
23823016|NCT03284723|66734336|FG009|Overall Study|Death|2|||
23823017|NCT03284723|66734337|FG010|Overall Study|Death|1|||
23823018|NCT03284723|66734338|FG011|Overall Study|Death|0|||
23823019|NCT03284723|66734327|FG000|Overall Study|Lost to Follow-up|0|||
23823020|NCT03284723|66734328|FG001|Overall Study|Lost to Follow-up|0|||
23823021|NCT03284723|66734329|FG002|Overall Study|Lost to Follow-up|0|||
23823022|NCT03284723|66734330|FG003|Overall Study|Lost to Follow-up|0|||
23622142|NCT00236184|66004841|FG000|Overall Study|other|1|||
23622143|NCT00236184|66004842|FG001|Overall Study|other|2|||
23823023|NCT03284723|66734331|FG004|Overall Study|Lost to Follow-up|0|||
23823024|NCT03284723|66734332|FG005|Overall Study|Lost to Follow-up|2|||
23823025|NCT03284723|66734333|FG006|Overall Study|Lost to Follow-up|1|||
23823026|NCT03284723|66734334|FG007|Overall Study|Lost to Follow-up|0|||
23823027|NCT03284723|66734335|FG008|Overall Study|Lost to Follow-up|0|||
23823028|NCT03284723|66734336|FG009|Overall Study|Lost to Follow-up|2|||
23823029|NCT03284723|66734337|FG010|Overall Study|Lost to Follow-up|0|||
23823030|NCT03284723|66734338|FG011|Overall Study|Lost to Follow-up|0|||
23432395|NCT02014584|65327610|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23823031|NCT03284723|66734327|FG000|Overall Study|Study Terminated By Sponsor|0|||
23823032|NCT03284723|66734328|FG001|Overall Study|Study Terminated By Sponsor|0|||
23823033|NCT03284723|66734329|FG002|Overall Study|Study Terminated By Sponsor|0|||
23823034|NCT03284723|66734330|FG003|Overall Study|Study Terminated By Sponsor|0|||
23823035|NCT03284723|66734331|FG004|Overall Study|Study Terminated By Sponsor|1|||
23823036|NCT03284723|66734332|FG005|Overall Study|Study Terminated By Sponsor|0|||
23823037|NCT03284723|66734333|FG006|Overall Study|Study Terminated By Sponsor|0|||
23823038|NCT03284723|66734334|FG007|Overall Study|Study Terminated By Sponsor|0|||
23823039|NCT03284723|66734335|FG008|Overall Study|Study Terminated By Sponsor|1|||
23823040|NCT03284723|66734336|FG009|Overall Study|Study Terminated By Sponsor|1|||
23823041|NCT03284723|66734337|FG010|Overall Study|Study Terminated By Sponsor|1|||
23823042|NCT03284723|66734338|FG011|Overall Study|Study Terminated By Sponsor|1|||
23823043|NCT03284723|66734327|FG000|Overall Study|Withdrawal by Subject|0|||
23823044|NCT03284723|66734328|FG001|Overall Study|Withdrawal by Subject|0|||
23823045|NCT03284723|66734329|FG002|Overall Study|Withdrawal by Subject|0|||
23823046|NCT03284723|66734330|FG003|Overall Study|Withdrawal by Subject|0|||
23823047|NCT03284723|66734331|FG004|Overall Study|Withdrawal by Subject|5|||
23823048|NCT03284723|66734332|FG005|Overall Study|Withdrawal by Subject|3|||
23823049|NCT03284723|66734333|FG006|Overall Study|Withdrawal by Subject|1|||
23823050|NCT03284723|66734334|FG007|Overall Study|Withdrawal by Subject|0|||
23823051|NCT03284723|66734335|FG008|Overall Study|Withdrawal by Subject|6|||
23823052|NCT03284723|66734336|FG009|Overall Study|Withdrawal by Subject|0|||
23622144|NCT00505414|66004843|FG000|Titration Phase|Adverse Event|0|||
23622145|NCT00505414|66004844|FG001|Titration Phase|Adverse Event|0|||
23622146|NCT00505414|66004845|FG002|Titration Phase|Adverse Event|0|||
23622147|NCT00505414|66004846|FG003|Titration Phase|Adverse Event|8|||
23622148|NCT00505414|66004847|FG004|Titration Phase|Adverse Event|3|||
23622149|NCT00505414|66004843|FG000|Titration Phase|Death|0|||
23622150|NCT00505414|66004844|FG001|Titration Phase|Death|0|||
23622151|NCT00505414|66004845|FG002|Titration Phase|Death|0|||
23622152|NCT00505414|66004846|FG003|Titration Phase|Death|2|||
23622153|NCT00505414|66004847|FG004|Titration Phase|Death|0|||
23622154|NCT00505414|66004843|FG000|Titration Phase|Lack of Efficacy|0|||
23622155|NCT00505414|66004844|FG001|Titration Phase|Lack of Efficacy|0|||
23746753|NCT01374516|66454191|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
23823053|NCT03284723|66734337|FG010|Overall Study|Withdrawal by Subject|3|||
23622156|NCT00505414|66004845|FG002|Titration Phase|Lack of Efficacy|0|||
23622157|NCT00505414|66004846|FG003|Titration Phase|Lack of Efficacy|10|||
23746754|NCT01374516|66454190|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
23746755|NCT01374516|66454191|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
23746756|NCT01374516|66454190|FG000|Surveillance Expansion Period|Serious adverse event|20|||
23746757|NCT01374516|66454191|FG001|Surveillance Expansion Period|Serious adverse event|5|||
23746758|NCT03471507|66454194|FG000|Overall Study|Lost to Follow-up|1|||
23746759|NCT03471507|66454195|FG001|Overall Study|Lost to Follow-up|3|||
23746760|NCT03471507|66454194|FG000|Overall Study|Physician Decision|0|||
23746761|NCT03471507|66454195|FG001|Overall Study|Physician Decision|1|||
23746762|NCT03471507|66454194|FG000|Overall Study|Withdrawal by Subject|2|||
23746763|NCT03471507|66454195|FG001|Overall Study|Withdrawal by Subject|1|||
23746764|NCT00090259|66454198|FG000|Overall Study|Lost to Follow-up|30|||
23746765|NCT00090259|66454199|FG001|Overall Study|Lost to Follow-up|26|||
23746766|NCT00090259|66454198|FG000|Overall Study|Withdrawal by Subject|21|||
23746767|NCT00090259|66454199|FG001|Overall Study|Withdrawal by Subject|15|||
23746768|NCT00090259|66454198|FG000|Overall Study|Investigator site closed|11|||
23746769|NCT00090259|66454199|FG001|Overall Study|Investigator site closed|7|||
23746770|NCT05147311|66454201|FG000|Overall Study|Did not complete survey|2|||
23746771|NCT05147311|66454202|FG001|Overall Study|Did not complete survey|1|||
23746772|NCT05147311|66454201|FG000|Overall Study|Patient too sick|1|||
23746773|NCT05147311|66454202|FG001|Overall Study|Patient too sick|2|||
23746774|NCT05147311|66454201|FG000|Overall Study|Death|0|||
23746775|NCT05147311|66454202|FG001|Overall Study|Death|1|||
23746776|NCT05147311|66454201|FG000|Overall Study|Declined survey|1|||
23746777|NCT05147311|66454202|FG001|Overall Study|Declined survey|0|||
23746778|NCT01060007|66454203|FG000|Overall Study|Withdrawal by Subject|1|||
23746779|NCT01060007|66454203|FG000|Overall Study|Inevaluable for response at surgery|3|||
23746780|NCT01014442|66454211|FG000|Overall Study|Adverse Event|0|||
23746781|NCT01014442|66454212|FG001|Overall Study|Adverse Event|8|||
23746782|NCT01014442|66454211|FG000|Overall Study|Withdrawal by Subject|4|||
23746783|NCT01014442|66454212|FG001|Overall Study|Withdrawal by Subject|4|||
23746784|NCT01014442|66454211|FG000|Overall Study|Protocol Violation|2|||
23746785|NCT01014442|66454212|FG001|Overall Study|Protocol Violation|5|||
23746786|NCT01014442|66454211|FG000|Overall Study|Lack of Compliance|0|||
23746787|NCT01014442|66454212|FG001|Overall Study|Lack of Compliance|1|||
23746788|NCT01014442|66454211|FG000|Overall Study|Unspecified Reason|1|||
23746789|NCT01014442|66454212|FG001|Overall Study|Unspecified Reason|1|||
23823054|NCT03284723|66734338|FG011|Overall Study|Withdrawal by Subject|1|||
23746790|NCT01864746|66454213|FG000|Overall Study|Disease recurrence|25|||
23746791|NCT01864746|66454214|FG001|Overall Study|Disease recurrence|40|||
23746792|NCT01864746|66454213|FG000|Overall Study|Second primary invasive nonbreast|2|||
23746793|NCT01864746|66454214|FG001|Overall Study|Second primary invasive nonbreast|3|||
23746794|NCT01864746|66454213|FG000|Overall Study|Death|2|||
23746795|NCT01864746|66454214|FG001|Overall Study|Death|1|||
23823055|NCT03284723|66734327|FG000|Overall Study|Other|1|||
23622158|NCT00505414|66004847|FG004|Titration Phase|Lack of Efficacy|1|||
23622159|NCT00505414|66004843|FG000|Titration Phase|Protocol Violation|0|||
23622160|NCT00505414|66004844|FG001|Titration Phase|Protocol Violation|0|||
23622161|NCT00505414|66004845|FG002|Titration Phase|Protocol Violation|0|||
23622162|NCT00505414|66004846|FG003|Titration Phase|Protocol Violation|0|||
23622163|NCT00505414|66004847|FG004|Titration Phase|Protocol Violation|1|||
23622164|NCT00505414|66004843|FG000|Titration Phase|Withdrawal by Subject|0|||
23746796|NCT01864746|66454213|FG000|Overall Study|Adverse Event|33|||
23746797|NCT01864746|66454214|FG001|Overall Study|Adverse Event|5|||
23746798|NCT01864746|66454213|FG000|Overall Study|Withdrawal by Subject|56|||
23432396|NCT02014584|65327611|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432397|NCT02014584|65327612|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432398|NCT02014584|65327613|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432399|NCT02014584|65327614|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
23432400|NCT02014584|65327615|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432401|NCT02648217|65327616|FG000|Overall Study|Adverse Event|0|||
23746799|NCT01864746|66454214|FG001|Overall Study|Withdrawal by Subject|41|||
23746800|NCT01864746|66454213|FG000|Overall Study|Physician Decision|5|||
23746801|NCT01864746|66454214|FG001|Overall Study|Physician Decision|6|||
23746802|NCT00859313|66454215|FG000|Overall Study|Lack of Efficacy|2|||
23554737|NCT00541450|65757918|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
23554738|NCT00541450|65757917|FG000|Phase A|Hyperglycemia|0|||
23554739|NCT00541450|65757918|FG001|Phase A|Hyperglycemia|1|||
23554740|NCT00541450|65757917|FG000|Phase A|Lost to Follow-up|6|||
23554741|NCT00541450|65757918|FG001|Phase A|Lost to Follow-up|4|||
23554742|NCT00541450|65757917|FG000|Phase A|Physician Decision|2|||
23554743|NCT00541450|65757918|FG001|Phase A|Physician Decision|0|||
23554744|NCT00541450|65757917|FG000|Phase A|Protocol Violation|2|||
23554745|NCT00541450|65757918|FG001|Phase A|Protocol Violation|3|||
23554746|NCT00541450|65757917|FG000|Phase A|Withdrawal by Subject|7|||
23554747|NCT00541450|65757918|FG001|Phase A|Withdrawal by Subject|7|||
23554748|NCT00541450|65757917|FG000|Phase B|Adverse Event|6|||
23554749|NCT00541450|65757918|FG001|Phase B|Adverse Event|6|||
23746803|NCT00859313|66454215|FG000|Overall Study|Adverse Event|1|||
23746804|NCT00859313|66454215|FG000|Overall Study|staff error|1|||
23746805|NCT01980056|66454218|FG000|Overall Study|Death|1|||
23746806|NCT01980056|66454219|FG001|Overall Study|Death|1|||
23746807|NCT01980056|66454220|FG002|Overall Study|Death|0|||
23746808|NCT00814502|66454227|FG000|Overall Study|Adverse Event|1|||
23432402|NCT02648217|65327617|FG001|Overall Study|Adverse Event|1|||
23746809|NCT00814502|66454228|FG001|Overall Study|Adverse Event|0|||
23746810|NCT00814502|66454227|FG000|Overall Study|Withdrawal by Subject|0|||
23746811|NCT00814502|66454228|FG001|Overall Study|Withdrawal by Subject|2|||
23746812|NCT02513732|66454229|FG000|Overall Study|Lost to Follow-up|11|||
23746813|NCT02513732|66454229|FG000|Overall Study|Death|9|||
23746814|NCT02513732|66454229|FG000|Overall Study|Changing hospital|2|||
23746815|NCT01298362|66454230|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
23746816|NCT01298362|66454231|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
23746817|NCT02409680|66454238|FG000|Overall Study|Lost to Follow-up|15|||
23746818|NCT02409680|66454239|FG001|Overall Study|Lost to Follow-up|30|||
23746819|NCT01366846|66454250|FG000|Overall Study|Withdrawal by Subject|2|||
23746820|NCT01366846|66454251|FG001|Overall Study|Withdrawal by Subject|0|||
23746821|NCT01366846|66454252|FG002|Overall Study|Withdrawal by Subject|0|||
23746822|NCT01366846|66454253|FG003|Overall Study|Withdrawal by Subject|0|||
23746823|NCT01366846|66454250|FG000|Overall Study|Communication Difficulties|1|||
23746824|NCT01366846|66454251|FG001|Overall Study|Communication Difficulties|4|||
23746825|NCT01366846|66454252|FG002|Overall Study|Communication Difficulties|0|||
23746826|NCT01366846|66454253|FG003|Overall Study|Communication Difficulties|1|||
23746827|NCT01366846|66454250|FG000|Overall Study|Scheduling Conflicts|0|||
23746828|NCT01366846|66454251|FG001|Overall Study|Scheduling Conflicts|0|||
23746829|NCT01366846|66454252|FG002|Overall Study|Scheduling Conflicts|1|||
23746830|NCT01366846|66454253|FG003|Overall Study|Scheduling Conflicts|0|||
23432403|NCT02648217|65327616|FG000|Overall Study|Lost to Follow-up|1|||
23622165|NCT00505414|66004844|FG001|Titration Phase|Withdrawal by Subject|0|||
23622166|NCT00505414|66004845|FG002|Titration Phase|Withdrawal by Subject|0|||
23622167|NCT00505414|66004846|FG003|Titration Phase|Withdrawal by Subject|3|||
23746831|NCT00467051|66454254|FG000|Overall Study|Adverse Event|2|||
23746832|NCT00795886|66454256|FG000|Overall Study|Death|10|||
23746833|NCT00326625|66454257|FG000|Overall Study|Adverse Event|20|||
23746834|NCT00326625|66454258|FG001|Overall Study|Adverse Event|9|||
23746835|NCT00326625|66454257|FG000|Overall Study|Withdrawal by Subject|15|||
23746836|NCT00326625|66454258|FG001|Overall Study|Withdrawal by Subject|12|||
23432404|NCT02648217|65327617|FG001|Overall Study|Lost to Follow-up|1|||
23554750|NCT00541450|65757917|FG000|Phase B|Hyperglycemia|10|||
23554751|NCT00541450|65757918|FG001|Phase B|Hyperglycemia|9|||
23554752|NCT00541450|65757917|FG000|Phase B|Lost to Follow-up|6|||
23554753|NCT00541450|65757918|FG001|Phase B|Lost to Follow-up|4|||
23746837|NCT00326625|66454257|FG000|Overall Study|Death|18|||
23746838|NCT00326625|66454258|FG001|Overall Study|Death|16|||
23823056|NCT03284723|66734328|FG001|Overall Study|Other|0|||
23823057|NCT03284723|66734329|FG002|Overall Study|Other|1|||
23823058|NCT03284723|66734330|FG003|Overall Study|Other|0|||
23823059|NCT03284723|66734331|FG004|Overall Study|Other|1|||
23823060|NCT03284723|66734332|FG005|Overall Study|Other|0|||
23823061|NCT03284723|66734333|FG006|Overall Study|Other|0|||
23823062|NCT03284723|66734334|FG007|Overall Study|Other|0|||
23823063|NCT03284723|66734335|FG008|Overall Study|Other|0|||
23823064|NCT03284723|66734336|FG009|Overall Study|Other|0|||
23823065|NCT03284723|66734337|FG010|Overall Study|Other|1|||
23823066|NCT03284723|66734338|FG011|Overall Study|Other|0|||
23823067|NCT03284723|66734327|FG000|Overall Study|Adverse Event|0|||
23823068|NCT03284723|66734328|FG001|Overall Study|Adverse Event|0|||
23823069|NCT03284723|66734329|FG002|Overall Study|Adverse Event|0|||
23746839|NCT00326625|66454257|FG000|Overall Study|Lost to Follow-up|1|||
23746840|NCT00326625|66454258|FG001|Overall Study|Lost to Follow-up|0|||
23746841|NCT00326625|66454257|FG000|Overall Study|prescheduled medical intervention|0|||
23746842|NCT00326625|66454258|FG001|Overall Study|prescheduled medical intervention|1|||
23746843|NCT00054639|66454260|FG000|Overall Study|Lack of Efficacy|1|||
23746844|NCT00054639|66454260|FG000|Overall Study|Physician Decision|1|||
23746845|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
23746846|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23746847|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
23746848|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23746849|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23746850|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
23746851|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
23746852|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23746853|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
23746854|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
23746855|NCT02422186|66454261|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
23746856|NCT02422186|66454262|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
23746857|NCT02422186|66454261|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
23746858|NCT02422186|66454262|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
23746859|NCT02422186|66454261|FG000|Follow-up Phase (2 Weeks)|Other|3|||
23746860|NCT02422186|66454262|FG001|Follow-up Phase (2 Weeks)|Other|0|||
23746861|NCT00061568|66454265|FG000|Overall Study|Lost to Follow-up|12|||
23746862|NCT00061568|66454266|FG001|Overall Study|Lost to Follow-up|0|||
23746863|NCT00061568|66454265|FG000|Overall Study|Death|6|||
23746864|NCT00061568|66454266|FG001|Overall Study|Death|0|||
23746865|NCT00061568|66454265|FG000|Overall Study|Withdrawal by Subject|1|||
23746866|NCT00061568|66454266|FG001|Overall Study|Withdrawal by Subject|0|||
23746867|NCT02074982|66454267|FG000|Overall Study|Adverse Event|15|||
23746868|NCT02074982|66454268|FG001|Overall Study|Adverse Event|7|||
23746869|NCT02074982|66454267|FG000|Overall Study|Lack of Efficacy|6|||
23746870|NCT02074982|66454268|FG001|Overall Study|Lack of Efficacy|1|||
23746871|NCT02074982|66454267|FG000|Overall Study|Lost to Follow-up|9|||
23746872|NCT02074982|66454268|FG001|Overall Study|Lost to Follow-up|10|||
23746873|NCT02074982|66454267|FG000|Overall Study|Non-compliance with study treatment|0|||
23746874|NCT02074982|66454268|FG001|Overall Study|Non-compliance with study treatment|2|||
23746875|NCT02074982|66454267|FG000|Overall Study|Physician Decision|1|||
23746876|NCT02074982|66454268|FG001|Overall Study|Physician Decision|1|||
23746877|NCT02074982|66454267|FG000|Overall Study|Pregnancy|1|||
23746878|NCT02074982|66454268|FG001|Overall Study|Pregnancy|2|||
23746879|NCT02074982|66454267|FG000|Overall Study|Protocol deviation|4|||
23746880|NCT02074982|66454268|FG001|Overall Study|Protocol deviation|3|||
23746881|NCT02074982|66454267|FG000|Overall Study|Technical problems|0|||
23746882|NCT02074982|66454268|FG001|Overall Study|Technical problems|2|||
23746883|NCT02074982|66454267|FG000|Overall Study|Subject/guardian decision|15|||
23746884|NCT02074982|66454268|FG001|Overall Study|Subject/guardian decision|24|||
23746885|NCT02074982|66454267|FG000|Overall Study|Death|0|||
23746886|NCT02074982|66454268|FG001|Overall Study|Death|2|||
23746887|NCT00943826|66454272|FG000|Concurrent Phase|Adverse Event|50|||
23746888|NCT00943826|66454273|FG001|Concurrent Phase|Adverse Event|27|||
23746889|NCT00943826|66454272|FG000|Concurrent Phase|Withdrew consent|3|||
23746890|NCT00943826|66454273|FG001|Concurrent Phase|Withdrew consent|7|||
23746891|NCT00943826|66454272|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
23746892|NCT00943826|66454273|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
23746893|NCT00943826|66454272|FG000|Concurrent Phase|Administrative reasons|2|||
23823070|NCT03284723|66734330|FG003|Overall Study|Adverse Event|0|||
23823071|NCT03284723|66734331|FG004|Overall Study|Adverse Event|0|||
23746894|NCT00943826|66454273|FG001|Concurrent Phase|Administrative reasons|1|||
23746895|NCT00943826|66454272|FG000|Concurrent Phase|Protocol Violation|1|||
23746896|NCT00943826|66454273|FG001|Concurrent Phase|Protocol Violation|0|||
23746897|NCT00943826|66454272|FG000|Maintenance Phase|Adverse Event|31|||
23746898|NCT00943826|66454273|FG001|Maintenance Phase|Adverse Event|30|||
23823072|NCT03284723|66734332|FG005|Overall Study|Adverse Event|0|||
23823073|NCT03284723|66734333|FG006|Overall Study|Adverse Event|0|||
23823074|NCT03284723|66734334|FG007|Overall Study|Adverse Event|0|||
23823075|NCT03284723|66734335|FG008|Overall Study|Adverse Event|1|||
23823076|NCT03284723|66734336|FG009|Overall Study|Adverse Event|0|||
23823077|NCT03284723|66734337|FG010|Overall Study|Adverse Event|0|||
23823078|NCT03284723|66734338|FG011|Overall Study|Adverse Event|0|||
23823079|NCT02905032|66734339|FG000|Overall Study|Withdrawal by Subject|2|||
23823080|NCT02905032|66734340|FG001|Overall Study|Withdrawal by Subject|0|||
23823081|NCT02905032|66734341|FG002|Overall Study|Withdrawal by Subject|0|||
23823082|NCT02905032|66734339|FG000|Overall Study|Protocol Violation|6|||
23823083|NCT02905032|66734340|FG001|Overall Study|Protocol Violation|12|||
23823084|NCT02905032|66734341|FG002|Overall Study|Protocol Violation|0|||
23432405|NCT02648217|65327616|FG000|Overall Study|Withdrawal by Subject|4|||
23432406|NCT02648217|65327617|FG001|Overall Study|Withdrawal by Subject|3|||
23432407|NCT02648217|65327616|FG000|Overall Study|Unclassified|5|||
23746899|NCT00943826|66454272|FG000|Maintenance Phase|Withdrew consent|2|||
23746900|NCT00943826|66454273|FG001|Maintenance Phase|Withdrew consent|4|||
23746901|NCT00943826|66454272|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
23746902|NCT00943826|66454273|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
23746903|NCT00943826|66454272|FG000|Maintenance Phase|Administrative reasons|4|||
23746904|NCT00943826|66454273|FG001|Maintenance Phase|Administrative reasons|1|||
23746905|NCT00943826|66454272|FG000|Maintenance Phase|Failure to return|0|||
23746906|NCT00943826|66454273|FG001|Maintenance Phase|Failure to return|1|||
23746907|NCT00943826|66454272|FG000|Monotherapy Phase|Adverse Event|42|||
23746908|NCT00943826|66454273|FG001|Monotherapy Phase|Adverse Event|5|||
23746909|NCT00943826|66454272|FG000|Monotherapy Phase|Administrative reasons|11|||
23746910|NCT00943826|66454273|FG001|Monotherapy Phase|Administrative reasons|5|||
23746911|NCT00943826|66454272|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
23746912|NCT00943826|66454273|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
23746913|NCT00943826|66454272|FG000|Monotherapy Phase|Withdrew Consent|2|||
23746914|NCT00943826|66454273|FG001|Monotherapy Phase|Withdrew Consent|3|||
23746915|NCT00943826|66454272|FG000|Monotherapy Phase|Failure to return|2|||
23746916|NCT00943826|66454273|FG001|Monotherapy Phase|Failure to return|1|||
23746917|NCT00943826|66454272|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
23746918|NCT00943826|66454273|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
23746919|NCT00943826|66454272|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
23746920|NCT00943826|66454273|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
23746921|NCT00943826|66454272|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
23746922|NCT00943826|66454273|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
23746923|NCT00943826|66454272|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
23746924|NCT00943826|66454273|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
23746925|NCT00908375|66454276|FG000|Overall Study|Withdrawal by Subject|2|||
23746926|NCT00908375|66454277|FG001|Overall Study|Withdrawal by Subject|4|||
23746927|NCT00908375|66454276|FG000|Overall Study|Lost to Follow-up|8|||
23746928|NCT00908375|66454277|FG001|Overall Study|Lost to Follow-up|6|||
23746929|NCT03253809|66454278|FG000|Overall Study|Unable to obtain study related data|14|||
23746930|NCT00664066|66454279|FG000|Overall Study|Study terminated|3|||
23823085|NCT03519087|66734345|FG000|Clinic Evaluation|Physician Decision|15|||
23823086|NCT03519087|66734346|FG001|Clinic Evaluation|Physician Decision|18|||
23823087|NCT03519087|66734347|FG002|Clinic Evaluation|Physician Decision|0|||
23823088|NCT03519087|66734348|FG003|Clinic Evaluation|Physician Decision|0|||
23823089|NCT03519087|66734349|FG004|Clinic Evaluation|Physician Decision|0|||
23823090|NCT03519087|66734345|FG000|Clinic Evaluation|Protocol Violation|1|||
23823091|NCT03519087|66734346|FG001|Clinic Evaluation|Protocol Violation|0|||
23823092|NCT03519087|66734347|FG002|Clinic Evaluation|Protocol Violation|0|||
23823093|NCT03519087|66734348|FG003|Clinic Evaluation|Protocol Violation|0|||
23823094|NCT03519087|66734349|FG004|Clinic Evaluation|Protocol Violation|0|||
23823095|NCT03519087|66734345|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
23823096|NCT03519087|66734346|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
23823097|NCT03519087|66734347|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
23432408|NCT02648217|65327617|FG001|Overall Study|Unclassified|0|||
23823098|NCT03519087|66734348|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
23823099|NCT03519087|66734349|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
23823100|NCT03519087|66734345|FG000|Re-randomization for Treatment|Not appropriate|2|||
23823101|NCT03519087|66734346|FG001|Re-randomization for Treatment|Not appropriate|3|||
23823102|NCT03519087|66734347|FG002|Re-randomization for Treatment|Not appropriate|0|||
23823103|NCT03519087|66734348|FG003|Re-randomization for Treatment|Not appropriate|0|||
23432409|NCT02345330|65327618|FG000|Overall Study|Death|1|||
23746931|NCT05022121|66454285|FG000|Overall Study|Lack of Efficacy|1|||
23746932|NCT05022121|66454286|FG001|Overall Study|Lack of Efficacy|0|||
23432410|NCT02345330|65327618|FG000|Overall Study|Progressive Disease|2|||
23746933|NCT05022121|66454285|FG000|Overall Study|Lost to Follow-up|0|||
23746934|NCT05022121|66454286|FG001|Overall Study|Lost to Follow-up|2|||
23746935|NCT01329562|66454290|FG000|Overall Study|Protocol Violation|5|||
23746936|NCT01329562|66454291|FG001|Overall Study|Protocol Violation|3|||
23746937|NCT01329562|66454290|FG000|Overall Study|Lost to Follow-up|1|||
23746938|NCT01329562|66454291|FG001|Overall Study|Lost to Follow-up|1|||
23746939|NCT01329562|66454290|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
23746940|NCT01329562|66454291|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
23746941|NCT01329562|66454290|FG000|Overall Study|Physician Decision|0|||
23746942|NCT01329562|66454291|FG001|Overall Study|Physician Decision|1|||
23746943|NCT00905437|66454292|FG000|Overall Study|Adverse Event|3|||
23554754|NCT00541450|65757917|FG000|Phase B|Physician Decision|4|||
23554755|NCT00541450|65757918|FG001|Phase B|Physician Decision|2|||
23554756|NCT00541450|65757917|FG000|Phase B|Pregnancy|0|||
23554757|NCT00541450|65757918|FG001|Phase B|Pregnancy|1|||
23746944|NCT00905437|66454293|FG001|Overall Study|Adverse Event|2|||
23554758|NCT00541450|65757917|FG000|Phase B|Protocol Violation|3|||
23554759|NCT00541450|65757918|FG001|Phase B|Protocol Violation|3|||
23554760|NCT00541450|65757917|FG000|Phase B|Withdrawal by Subject|8|||
23554761|NCT00541450|65757918|FG001|Phase B|Withdrawal by Subject|6|||
23554762|NCT03266770|65757928|FG000|Overall Study|Physician Decision|3|||
23554763|NCT03266770|65757928|FG000|Overall Study|Insufficient study supplies|1|||
23554764|NCT03266770|65757928|FG000|Overall Study|Adverse Event|1|||
23554765|NCT01274182|65757929|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23554766|NCT01274182|65757930|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23746945|NCT00905437|66454292|FG000|Overall Study|Lost to Follow-up|0|||
23746946|NCT00905437|66454293|FG001|Overall Study|Lost to Follow-up|1|||
23746947|NCT00905437|66454292|FG000|Overall Study|Withdrawal by Subject|0|||
23746948|NCT00905437|66454293|FG001|Overall Study|Withdrawal by Subject|1|||
23823104|NCT03519087|66734349|FG004|Re-randomization for Treatment|Not appropriate|0|||
23823105|NCT03519087|66734345|FG000|Laboratory Testing|Lost to Follow-up|0|||
23823106|NCT03519087|66734346|FG001|Laboratory Testing|Lost to Follow-up|0|||
23823107|NCT03519087|66734347|FG002|Laboratory Testing|Lost to Follow-up|2|||
23823108|NCT03519087|66734348|FG003|Laboratory Testing|Lost to Follow-up|3|||
23823109|NCT03519087|66734349|FG004|Laboratory Testing|Lost to Follow-up|6|||
23823110|NCT03519087|66734345|FG000|Laboratory Testing|Protocol Violation|0|||
23823111|NCT03519087|66734346|FG001|Laboratory Testing|Protocol Violation|0|||
23823112|NCT03519087|66734347|FG002|Laboratory Testing|Protocol Violation|0|||
23554767|NCT01274182|65757931|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23554768|NCT01274182|65757929|FG000|Overall Study|Adverse Event|4|||
23554769|NCT01274182|65757930|FG001|Overall Study|Adverse Event|5|||
23554770|NCT01274182|65757931|FG002|Overall Study|Adverse Event|3|||
23746949|NCT00905437|66454292|FG000|Overall Study|Other|5|||
23554771|NCT01274182|65757929|FG000|Overall Study|Withdrawal by Subject|5|||
23746950|NCT00905437|66454293|FG001|Overall Study|Other|6|||
23746951|NCT01207219|66454297|FG000|Overall Study|changed diagnosis during study period|5|||
23746952|NCT01207219|66454298|FG001|Overall Study|changed diagnosis during study period|3|||
23746953|NCT01207219|66454299|FG002|Overall Study|changed diagnosis during study period|1|||
23746954|NCT01207219|66454297|FG000|Overall Study|Lost to Follow-up|6|||
23746955|NCT01207219|66454298|FG001|Overall Study|Lost to Follow-up|8|||
23746956|NCT01207219|66454299|FG002|Overall Study|Lost to Follow-up|6|||
23746957|NCT01640964|66454306|FG000|Overall Study|Lost to Follow-up|0|||
23746958|NCT01640964|66454307|FG001|Overall Study|Lost to Follow-up|0|||
23746959|NCT01640964|66454308|FG002|Overall Study|Lost to Follow-up|1|||
23746960|NCT01640964|66454306|FG000|Overall Study|Protocol Deviation|1|||
23746961|NCT01640964|66454307|FG001|Overall Study|Protocol Deviation|1|||
23746962|NCT01640964|66454308|FG002|Overall Study|Protocol Deviation|2|||
23746963|NCT00956813|66454309|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
23746964|NCT00956813|66454310|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
23746965|NCT00956813|66454309|FG000|Flaxseed and Placebo|Ineligible|3|||
23746966|NCT00956813|66454310|FG001|Flaxseed and Placebo|Ineligible|1|||
23746967|NCT00124709|66454311|FG000|Overall Study|Randomized but did not take medication|3|||
23746968|NCT00124709|66454312|FG001|Overall Study|Randomized but did not take medication|1|||
23746969|NCT00124709|66454311|FG000|Overall Study|Adverse Event|3|||
23746970|NCT00124709|66454312|FG001|Overall Study|Adverse Event|0|||
23746971|NCT00124709|66454311|FG000|Overall Study|Lack of Efficacy|5|||
23746972|NCT00124709|66454312|FG001|Overall Study|Lack of Efficacy|10|||
23746973|NCT00124709|66454311|FG000|Overall Study|Protocol Violation|3|||
23746974|NCT00124709|66454312|FG001|Overall Study|Protocol Violation|5|||
23746975|NCT00124709|66454311|FG000|Overall Study|Withdrawal by Subject|127|||
23746976|NCT00124709|66454312|FG001|Overall Study|Withdrawal by Subject|136|||
23746977|NCT00124709|66454311|FG000|Overall Study|Lost to Follow-up|114|||
23746978|NCT00124709|66454312|FG001|Overall Study|Lost to Follow-up|120|||
23746979|NCT00240331|66454313|FG000|Overall Study|Withdrawal by Subject|125|||
23746980|NCT00240331|66454314|FG001|Overall Study|Withdrawal by Subject|132|||
23746981|NCT00240331|66454313|FG000|Overall Study|Option selected by investigator|1|||
23746982|NCT00240331|66454314|FG001|Overall Study|Option selected by investigator|2|||
23746983|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
23746984|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
23746985|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
23746986|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
23746987|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
23746988|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
23746989|NCT00828009|66454315|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
23746990|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
23746991|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
23746992|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Death|1|||
23746993|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
23746994|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
23746995|NCT00828009|66454315|FG000|Step 2 - Maintenance Therapy|Other|1|||
23746996|NCT00593385|66454316|FG000|Overall Study|Death|14|||
23746997|NCT00593385|66454316|FG000|Overall Study|Lost to Follow-up|17|||
23746998|NCT00593385|66454316|FG000|Overall Study|Withdrawal by Subject|9|||
23746999|NCT01004822|66454325|FG000|Overall Study|Objective progression or relapse|3|||
23747000|NCT01004822|66454326|FG001|Overall Study|Objective progression or relapse|3|||
23747001|NCT01004822|66454327|FG002|Overall Study|Objective progression or relapse|0|||
23747002|NCT01004822|66454328|FG003|Overall Study|Objective progression or relapse|1|||
23747003|NCT01004822|66454329|FG004|Overall Study|Objective progression or relapse|2|||
23747004|NCT01004822|66454330|FG005|Overall Study|Objective progression or relapse|2|||
23747005|NCT01004822|66454331|FG006|Overall Study|Objective progression or relapse|1|||
23747006|NCT01004822|66454332|FG007|Overall Study|Objective progression or relapse|4|||
23747007|NCT01004822|66454325|FG000|Overall Study|Global deterioration of health status|0|||
23747008|NCT01004822|66454326|FG001|Overall Study|Global deterioration of health status|0|||
23747009|NCT01004822|66454327|FG002|Overall Study|Global deterioration of health status|0|||
23747010|NCT01004822|66454328|FG003|Overall Study|Global deterioration of health status|1|||
23747011|NCT01004822|66454329|FG004|Overall Study|Global deterioration of health status|0|||
23747012|NCT01004822|66454330|FG005|Overall Study|Global deterioration of health status|0|||
23747013|NCT01004822|66454331|FG006|Overall Study|Global deterioration of health status|1|||
23747014|NCT01004822|66454332|FG007|Overall Study|Global deterioration of health status|0|||
23747015|NCT01004822|66454325|FG000|Overall Study|No longer willing to continue|0|||
23747016|NCT01004822|66454326|FG001|Overall Study|No longer willing to continue|0|||
23747017|NCT01004822|66454327|FG002|Overall Study|No longer willing to continue|0|||
23747018|NCT01004822|66454328|FG003|Overall Study|No longer willing to continue|1|||
23747019|NCT01004822|66454329|FG004|Overall Study|No longer willing to continue|2|||
23747020|NCT01004822|66454330|FG005|Overall Study|No longer willing to continue|1|||
23747021|NCT01004822|66454331|FG006|Overall Study|No longer willing to continue|1|||
23747022|NCT01004822|66454332|FG007|Overall Study|No longer willing to continue|0|||
23747023|NCT01004822|66454325|FG000|Overall Study|Adverse Event|0|||
23747024|NCT01004822|66454326|FG001|Overall Study|Adverse Event|0|||
23747025|NCT01004822|66454327|FG002|Overall Study|Adverse Event|0|||
23747026|NCT01004822|66454328|FG003|Overall Study|Adverse Event|0|||
23747027|NCT01004822|66454329|FG004|Overall Study|Adverse Event|0|||
23747028|NCT01004822|66454330|FG005|Overall Study|Adverse Event|0|||
23747029|NCT01004822|66454331|FG006|Overall Study|Adverse Event|1|||
23747030|NCT01004822|66454332|FG007|Overall Study|Adverse Event|1|||
23747031|NCT01004822|66454325|FG000|Overall Study|Other|0|||
23747032|NCT01004822|66454326|FG001|Overall Study|Other|0|||
23747033|NCT01004822|66454327|FG002|Overall Study|Other|4|||
23747034|NCT01004822|66454328|FG003|Overall Study|Other|1|||
23747035|NCT01004822|66454329|FG004|Overall Study|Other|0|||
23747036|NCT01004822|66454330|FG005|Overall Study|Other|1|||
23747037|NCT01004822|66454331|FG006|Overall Study|Other|0|||
23747038|NCT01004822|66454332|FG007|Overall Study|Other|0|||
23747039|NCT04281030|66454333|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
23747040|NCT04281030|66454334|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
23747041|NCT04281030|66454333|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
23747042|NCT04281030|66454334|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
23747043|NCT00975000|66454335|FG000|Overall Study|Other|1|||
23747044|NCT00975000|66454336|FG001|Overall Study|Other|0|||
23747045|NCT00975000|66454335|FG000|Overall Study|Adverse Event|1|||
23747046|NCT00975000|66454336|FG001|Overall Study|Adverse Event|1|||
23747047|NCT00975000|66454335|FG000|Overall Study|Withdrawal by Subject|2|||
23747048|NCT00975000|66454336|FG001|Overall Study|Withdrawal by Subject|2|||
23823113|NCT03519087|66734348|FG003|Laboratory Testing|Protocol Violation|1|||
23432411|NCT00734071|65327619|FG000|Overall Study|Adverse Event|4|||
23432412|NCT00734071|65327620|FG001|Overall Study|Adverse Event|3|||
23432413|NCT00734071|65327619|FG000|Overall Study|Lack of Efficacy|3|||
23432414|NCT00734071|65327620|FG001|Overall Study|Lack of Efficacy|1|||
23432415|NCT00734071|65327619|FG000|Overall Study|Noncompliance|2|||
23432416|NCT00734071|65327620|FG001|Overall Study|Noncompliance|2|||
23432417|NCT00734071|65327619|FG000|Overall Study|Protocol Deviations|3|||
23432418|NCT00734071|65327620|FG001|Overall Study|Protocol Deviations|4|||
23432419|NCT00734071|65327619|FG000|Overall Study|Voluntary Withdrawal|9|||
23432420|NCT00734071|65327620|FG001|Overall Study|Voluntary Withdrawal|7|||
23432421|NCT00734071|65327619|FG000|Overall Study|Lost to Follow-up|16|||
23432422|NCT00734071|65327620|FG001|Overall Study|Lost to Follow-up|8|||
23432423|NCT00734071|65327619|FG000|Overall Study|Other|1|||
23432424|NCT00734071|65327620|FG001|Overall Study|Other|2|||
23432425|NCT01291277|65327621|FG000|Overall Study|Death|2|||
23432426|NCT01291277|65327622|FG001|Overall Study|Death|2|||
23432427|NCT01291277|65327621|FG000|Overall Study|Lost to Follow-up|3|||
23554772|NCT01274182|65757930|FG001|Overall Study|Withdrawal by Subject|5|||
23554773|NCT01274182|65757931|FG002|Overall Study|Withdrawal by Subject|3|||
23554774|NCT01274182|65757929|FG000|Overall Study|Lost to Follow-up|2|||
23554775|NCT01274182|65757930|FG001|Overall Study|Lost to Follow-up|3|||
23554776|NCT01274182|65757931|FG002|Overall Study|Lost to Follow-up|1|||
23554777|NCT01274182|65757929|FG000|Overall Study|Protocol Violation|3|||
23554778|NCT01274182|65757930|FG001|Overall Study|Protocol Violation|2|||
23554779|NCT01274182|65757931|FG002|Overall Study|Protocol Violation|0|||
23554780|NCT01274182|65757929|FG000|Overall Study|Death|1|||
23554781|NCT01274182|65757930|FG001|Overall Study|Death|0|||
23554782|NCT01274182|65757931|FG002|Overall Study|Death|1|||
23554783|NCT00377403|65757932|FG000|Overall Study|Unable to contact for telephone intervie|4|||
23554784|NCT00377403|65757933|FG001|Overall Study|Unable to contact for telephone intervie|7|||
23554785|NCT00803452|65757935|FG000|Overall Study|Adverse Event|0|||
23747049|NCT00975000|66454335|FG000|Overall Study|Lost to Follow-up|0|||
23747050|NCT00975000|66454336|FG001|Overall Study|Lost to Follow-up|1|||
23747051|NCT00975000|66454335|FG000|Overall Study|Protocol-specified Criteria|1|||
23747052|NCT00975000|66454336|FG001|Overall Study|Protocol-specified Criteria|0|||
23747053|NCT00975000|66454335|FG000|Overall Study|Non-compliance|0|||
23747054|NCT00975000|66454336|FG001|Overall Study|Non-compliance|1|||
23747055|NCT03602976|66454337|FG000|Overall Study|Withdrawal by Subject|1|||
23432428|NCT01291277|65327622|FG001|Overall Study|Lost to Follow-up|1|||
23747056|NCT01683565|66454338|FG000|Overall Study|Lost to Follow-up|2|||
23747057|NCT01683565|66454339|FG001|Overall Study|Lost to Follow-up|0|||
23747058|NCT01683565|66454338|FG000|Overall Study|Discontinued Intervention|1|||
23747059|NCT01683565|66454339|FG001|Overall Study|Discontinued Intervention|1|||
23622168|NCT00505414|66004847|FG004|Titration Phase|Withdrawal by Subject|4|||
23622169|NCT00505414|66004843|FG000|Titration Phase|Underlying disease and therapy required|0|||
23622170|NCT00505414|66004844|FG001|Titration Phase|Underlying disease and therapy required|0|||
23622171|NCT00505414|66004845|FG002|Titration Phase|Underlying disease and therapy required|0|||
23622172|NCT00505414|66004846|FG003|Titration Phase|Underlying disease and therapy required|7|||
23622173|NCT00505414|66004847|FG004|Titration Phase|Underlying disease and therapy required|3|||
23622174|NCT00505414|66004843|FG000|Maintenance Phase|Adverse Event|2|||
23622175|NCT00505414|66004844|FG001|Maintenance Phase|Adverse Event|2|||
23622176|NCT00505414|66004845|FG002|Maintenance Phase|Adverse Event|3|||
23622177|NCT00505414|66004846|FG003|Maintenance Phase|Adverse Event|0|||
23622178|NCT00505414|66004847|FG004|Maintenance Phase|Adverse Event|0|||
23622179|NCT00505414|66004843|FG000|Maintenance Phase|Death|2|||
23622180|NCT00505414|66004844|FG001|Maintenance Phase|Death|0|||
23622181|NCT00505414|66004845|FG002|Maintenance Phase|Death|1|||
23622182|NCT00505414|66004846|FG003|Maintenance Phase|Death|0|||
23747060|NCT01808508|66454340|FG000|Overall Study|Lost to Follow-up|1|||
23747061|NCT01808508|66454341|FG001|Overall Study|Lost to Follow-up|0|||
23747062|NCT01808508|66454342|FG002|Overall Study|Lost to Follow-up|0|||
23622183|NCT00505414|66004847|FG004|Maintenance Phase|Death|0|||
23622184|NCT00505414|66004843|FG000|Maintenance Phase|Lack of Efficacy|2|||
23622185|NCT00505414|66004844|FG001|Maintenance Phase|Lack of Efficacy|1|||
23622186|NCT00505414|66004845|FG002|Maintenance Phase|Lack of Efficacy|1|||
23747063|NCT01283009|66454343|FG000|Overall Study|Death|83|||
23747064|NCT01283009|66454344|FG001|Overall Study|Death|78|||
23747065|NCT01283009|66454343|FG000|Overall Study|Study ended early|23|||
23554786|NCT00803452|65757936|FG001|Overall Study|Adverse Event|2|||
23554787|NCT00803452|65757935|FG000|Overall Study|Lost to Follow-up|0|||
23554788|NCT00803452|65757936|FG001|Overall Study|Lost to Follow-up|3|||
23554789|NCT01515748|65757938|FG000|Overall Study|Withdrawal by Subject|32|||
23554790|NCT01515748|65757939|FG001|Overall Study|Withdrawal by Subject|41|||
23554791|NCT01515748|65757938|FG000|Overall Study|Lost to Follow-up|2|||
23554792|NCT01515748|65757939|FG001|Overall Study|Lost to Follow-up|4|||
23554793|NCT01515748|65757938|FG000|Overall Study|Other than specified above|5|||
23554794|NCT01515748|65757939|FG001|Overall Study|Other than specified above|10|||
23554795|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
23554796|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
23554797|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
23554798|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
23554799|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
23554800|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
23554801|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
23554802|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
23554803|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554804|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554805|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554806|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554807|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
23554808|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
23554809|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
23554810|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554811|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554812|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554813|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
23554814|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554815|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
23554816|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554817|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554818|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554819|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Adverse Event|4|||
23554820|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Adverse Event|2|||
23554821|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Adverse Event|1|||
23622187|NCT00505414|66004846|FG003|Maintenance Phase|Lack of Efficacy|0|||
23747066|NCT01283009|66454344|FG001|Overall Study|Study ended early|26|||
23747067|NCT01283009|66454343|FG000|Overall Study|Withdrawal by Subject|10|||
23747068|NCT01283009|66454344|FG001|Overall Study|Withdrawal by Subject|8|||
23747069|NCT01283009|66454343|FG000|Overall Study|Physician Decision|1|||
23823114|NCT03519087|66734349|FG004|Laboratory Testing|Protocol Violation|0|||
23823115|NCT00739063|66734354|FG000|Overall Study|Screen failures|8|||
23554822|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Adverse Event|0|||
23554823|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Adverse Event|0|||
23622188|NCT00505414|66004847|FG004|Maintenance Phase|Lack of Efficacy|0|||
23622189|NCT00505414|66004843|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23747070|NCT01283009|66454344|FG001|Overall Study|Physician Decision|1|||
23747071|NCT01283009|66454343|FG000|Overall Study|Lost to Follow-up|1|||
23622190|NCT00505414|66004844|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23622191|NCT00505414|66004845|FG002|Maintenance Phase|Withdrawal by Subject|1|||
23622192|NCT00505414|66004846|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23622193|NCT00505414|66004847|FG004|Maintenance Phase|Withdrawal by Subject|0|||
23622194|NCT00505414|66004843|FG000|Maintenance Phase|underlying disease and therapy required|0|||
23622195|NCT00505414|66004844|FG001|Maintenance Phase|underlying disease and therapy required|2|||
23622196|NCT00505414|66004845|FG002|Maintenance Phase|underlying disease and therapy required|2|||
23622197|NCT00505414|66004846|FG003|Maintenance Phase|underlying disease and therapy required|0|||
23622198|NCT00505414|66004847|FG004|Maintenance Phase|underlying disease and therapy required|0|||
23622199|NCT00792259|66004848|FG000|Overall Study|Poor Quality Scans|1|||
23622200|NCT00792259|66004849|FG001|Overall Study|Poor Quality Scans|0|||
23432429|NCT04405245|65327623|FG000|Overall Study|Adverse Event|0|||
23432430|NCT04405245|65327624|FG001|Overall Study|Adverse Event|1|||
23432431|NCT04405245|65327625|FG002|Overall Study|Adverse Event|0|||
23432432|NCT00852241|65327627|FG000|Overall Study|Physician Decision|18|||
23432433|NCT01554514|65327630|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
23432434|NCT01554514|65327630|FG000|Overall Study|Physician Decision|1|||
23432435|NCT00109577|65327631|FG000|Overall Study|Withdrawal by Subject|3|||
23432436|NCT00109577|65327632|FG001|Overall Study|Withdrawal by Subject|3|||
23432437|NCT01424228|65327634|FG000|Overall Study|Withdrawal by Subject|27|||
23432438|NCT01424228|65327635|FG001|Overall Study|Withdrawal by Subject|11|||
23432439|NCT01424228|65327634|FG000|Overall Study|Adverse Event|10|||
23432440|NCT01424228|65327635|FG001|Overall Study|Adverse Event|14|||
23432441|NCT01424228|65327634|FG000|Overall Study|Sponsor's decision|9|||
23432442|NCT01424228|65327635|FG001|Overall Study|Sponsor's decision|12|||
23432443|NCT01424228|65327634|FG000|Overall Study|Lack of Efficacy|5|||
23432444|NCT01424228|65327635|FG001|Overall Study|Lack of Efficacy|7|||
23432445|NCT01424228|65327634|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
23432446|NCT01424228|65327635|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
23432447|NCT01424228|65327634|FG000|Overall Study|Non-compliance|2|||
23432448|NCT01424228|65327635|FG001|Overall Study|Non-compliance|0|||
23432449|NCT01424228|65327634|FG000|Overall Study|Worsening of symptoms|1|||
23432450|NCT01424228|65327635|FG001|Overall Study|Worsening of symptoms|0|||
23432451|NCT01424228|65327634|FG000|Overall Study|Unplanned journey|0|||
23432452|NCT01424228|65327635|FG001|Overall Study|Unplanned journey|1|||
23432453|NCT00565136|65327636|FG000|Overall Study|Lost to Follow-up|1|||
23432454|NCT00565136|65327636|FG000|Overall Study|Withdrawal by Subject|1|||
23432455|NCT00565136|65327636|FG000|Overall Study|Protocol Violation|1|||
23432456|NCT00588094|65327641|FG000|Overall Study|Adverse Event|3|||
23432457|NCT00588094|65327641|FG000|Overall Study|Progression of Disease|2|||
23432458|NCT03966885|65327642|FG000|Overall Study|Death|1|||
23432459|NCT03966885|65327643|FG001|Overall Study|Death|0|||
23432460|NCT03966885|65327642|FG000|Overall Study|Lost to Follow-up|1|||
23432461|NCT03966885|65327643|FG001|Overall Study|Lost to Follow-up|2|||
23432462|NCT03966885|65327642|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
23432463|NCT03966885|65327643|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
23432464|NCT03966885|65327642|FG000|Overall Study|Moved from study area.|0|||
23432465|NCT03966885|65327643|FG001|Overall Study|Moved from study area.|2|||
23432466|NCT01424566|65327647|FG000|Single-blind Treatment|Adverse Event|71|||
23432467|NCT01424566|65327648|FG001|Single-blind Treatment|Adverse Event|0|||
23432468|NCT01424566|65327649|FG002|Single-blind Treatment|Adverse Event|0|||
23432469|NCT01424566|65327647|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
23432470|NCT01424566|65327648|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
23432471|NCT01424566|65327649|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
23432472|NCT01424566|65327647|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
23432473|NCT01424566|65327648|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
23432474|NCT01424566|65327649|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
23432475|NCT01424566|65327647|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
23432476|NCT01424566|65327648|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
23432477|NCT01424566|65327649|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
23432478|NCT01424566|65327647|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
23622201|NCT00792259|66004850|FG002|Overall Study|Poor Quality Scans|0|||
23622202|NCT01951378|66004851|FG000|Overall Study|Study Terminated-Not completed|23|||
23622203|NCT01951378|66004852|FG001|Overall Study|Study Terminated-Not completed|17|||
23432479|NCT01424566|65327648|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
23432480|NCT01424566|65327649|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
23432481|NCT01424566|65327647|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
23432482|NCT01424566|65327648|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
23432483|NCT01424566|65327649|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
23432484|NCT01424566|65327647|FG000|Double-blind Treatment|Adverse Event|0|||
23432485|NCT01424566|65327648|FG001|Double-blind Treatment|Adverse Event|21|||
23432486|NCT01424566|65327649|FG002|Double-blind Treatment|Adverse Event|13|||
23432487|NCT01424566|65327647|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
23622204|NCT01253447|66004853|FG000|Overall Study|Adverse Event|2|||
23554824|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Adverse Event|0|||
23554825|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554826|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554827|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554828|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554829|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
23554830|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
23554831|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554832|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554833|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554834|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554835|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554836|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
23554837|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23747072|NCT01283009|66454344|FG001|Overall Study|Lost to Follow-up|0|||
23747073|NCT01283009|66454343|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
23747074|NCT01283009|66454344|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
23747075|NCT05111548|66454345|FG000|Overall Study|Withdrawal by Subject|2|||
23554838|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554839|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554840|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554841|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
23554842|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554843|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554844|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554845|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554846|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554847|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
23554848|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
23554849|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554850|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554851|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554852|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554853|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
23554854|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
23554855|NCT00857207|65757952|FG000|Overall Study|Withdrawal by Subject|13|||
23554856|NCT00857207|65757953|FG001|Overall Study|Withdrawal by Subject|0|||
23554857|NCT00857207|65757952|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
23554858|NCT00857207|65757953|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
23554859|NCT00857207|65757952|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
23554860|NCT00857207|65757953|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
23554861|NCT03574597|65757954|FG000|Overall Study|Withdrawal by Subject|67|||
23554862|NCT03574597|65757955|FG001|Overall Study|Withdrawal by Subject|96|||
23554863|NCT03574597|65757954|FG000|Overall Study|Lost to Follow-up|192|||
23554864|NCT03574597|65757955|FG001|Overall Study|Lost to Follow-up|188|||
23622205|NCT04016805|66004854|FG000|Overall Study|Sponsor's Discretion|30|||
23747076|NCT05111548|66454346|FG001|Overall Study|Withdrawal by Subject|1|||
23432488|NCT01424566|65327648|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
23747077|NCT05111548|66454345|FG000|Overall Study|Adverse Event|1|||
23747078|NCT05111548|66454346|FG001|Overall Study|Adverse Event|0|||
23432489|NCT01424566|65327649|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
23432490|NCT01424566|65327647|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
23432491|NCT01424566|65327648|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
23432492|NCT01424566|65327649|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
23432493|NCT01424566|65327647|FG000|Double-blind Treatment|Lack of Efficacy|0|||
23432494|NCT01424566|65327648|FG001|Double-blind Treatment|Lack of Efficacy|1|||
23432495|NCT01424566|65327649|FG002|Double-blind Treatment|Lack of Efficacy|1|||
23432496|NCT01704456|65327650|FG000|Overall Study|Lost to Follow-up|8|||
23432497|NCT01704456|65327651|FG001|Overall Study|Lost to Follow-up|14|||
23432498|NCT00952614|65327652|FG000|Overall Study|Death|3|||
23432499|NCT00952614|65327652|FG000|Overall Study|Lost to Follow-up|3|||
23432500|NCT00952614|65327652|FG000|Overall Study|other reason|1|||
23554865|NCT01843374|65757956|FG000|Overall Study|Death|155|||
23554866|NCT01843374|65757957|FG001|Overall Study|Death|313|||
23554867|NCT01843374|65757956|FG000|Overall Study|Withdrawal by Subject|14|||
23747079|NCT01319994|66454347|FG000|Overall Study|Protocol Violation|7|||
23823116|NCT01173120|66734355|FG000|Overall Study|Lack of Efficacy|2|||
23823117|NCT01173120|66734355|FG000|Overall Study|Lost to Follow-up|1|||
23432501|NCT01283542|65327653|FG000|Main Phase|Acute or progressive vision loss|1|||
23432502|NCT01283542|65327653|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
23432503|NCT01283542|65327653|FG000|Main Phase|abnormal laboratory values|5|||
23432504|NCT01283542|65327653|FG000|Extension Phase|Physician Decision|1|||
23432505|NCT01283542|65327653|FG000|Extension Phase|Adverse Event|1|||
23747080|NCT01319994|66454348|FG001|Overall Study|Protocol Violation|6|||
23747081|NCT00509223|66454349|FG000|Overall Study|Lost to Follow-up|1|||
23747082|NCT00509223|66454350|FG001|Overall Study|Lost to Follow-up|1|||
23747083|NCT00509223|66454349|FG000|Overall Study|Adverse Event|1|||
23747084|NCT00509223|66454350|FG001|Overall Study|Adverse Event|1|||
23747085|NCT00509223|66454349|FG000|Overall Study|Withdrawal by Subject|25|||
23747086|NCT00509223|66454350|FG001|Overall Study|Withdrawal by Subject|6|||
23747087|NCT00509223|66454349|FG000|Overall Study|Including: subject change of address|5|||
23747088|NCT00509223|66454350|FG001|Overall Study|Including: subject change of address|2|||
23747089|NCT00509223|66454349|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
23747090|NCT00509223|66454350|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
23747091|NCT01556490|66454351|FG000|Randomized Patients Summary|Protocol Violation|22|||
23747092|NCT01556490|66454352|FG001|Randomized Patients Summary|Protocol Violation|23|||
23747093|NCT01556490|66454351|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
23747094|NCT01556490|66454352|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
23747095|NCT00698009|66454353|FG000|Overall Study|Withdrawal by Subject|1|||
23747096|NCT03205046|66454354|FG000|Overall Study|Death|10|||
23747097|NCT03205046|66454355|FG001|Overall Study|Death|6|||
23747098|NCT03205046|66454354|FG000|Overall Study|Withdrawal by Subject|1|||
23747099|NCT03205046|66454355|FG001|Overall Study|Withdrawal by Subject|2|||
23747100|NCT03205046|66454354|FG000|Overall Study|Lost to Follow-up|0|||
23747101|NCT03205046|66454355|FG001|Overall Study|Lost to Follow-up|1|||
23747102|NCT03205046|66454354|FG000|Overall Study|Study terminated by sponsor|2|||
23747103|NCT03205046|66454355|FG001|Overall Study|Study terminated by sponsor|1|||
23747104|NCT02325414|66454356|FG000|Overall Study|Withdrawal by Subject|3|||
23747105|NCT02325414|66454357|FG001|Overall Study|Withdrawal by Subject|1|||
23747106|NCT02325414|66454356|FG000|Overall Study|Lost to Follow-up|5|||
23747107|NCT02325414|66454357|FG001|Overall Study|Lost to Follow-up|5|||
23747108|NCT03808298|66454358|FG000|Overall Study|Adverse Event|3|||
23747109|NCT03808298|66454358|FG000|Overall Study|Physician Decision|1|||
23747110|NCT03808298|66454358|FG000|Overall Study|Withdrawal by Subject|1|||
23747111|NCT03808298|66454358|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
23747112|NCT01545375|66454359|FG000|Overall Study|Adverse Event|2|||
23747113|NCT01545375|66454360|FG001|Overall Study|Adverse Event|1|||
23747114|NCT01545375|66454359|FG000|Overall Study|Lost to Follow-up|34|||
23747115|NCT01545375|66454360|FG001|Overall Study|Lost to Follow-up|31|||
23747116|NCT01545375|66454359|FG000|Overall Study|Protocol Violation|3|||
23747117|NCT01545375|66454360|FG001|Overall Study|Protocol Violation|3|||
23747118|NCT01545375|66454359|FG000|Overall Study|Withdrawal by Subject|58|||
23432506|NCT01283542|65327653|FG000|Extension Phase|Administrative problems|1|||
23747119|NCT01545375|66454360|FG001|Overall Study|Withdrawal by Subject|55|||
23747120|NCT02396849|66454361|FG000|Overall Study|Lost to Follow-up|1|||
23747121|NCT02396849|66454362|FG001|Overall Study|Lost to Follow-up|1|||
23747122|NCT02396849|66454361|FG000|Overall Study|Did not tolerate intervention|1|||
23747123|NCT02396849|66454362|FG001|Overall Study|Did not tolerate intervention|1|||
23747124|NCT00620776|66454368|FG000|Overall Study|Did not receive treatment|3|||
23747125|NCT00620776|66454369|FG001|Overall Study|Did not receive treatment|5|||
23747126|NCT00620776|66454368|FG000|Overall Study|Adverse Event|2|||
23747127|NCT00620776|66454369|FG001|Overall Study|Adverse Event|3|||
23747128|NCT00620776|66454368|FG000|Overall Study|Lack of Efficacy|2|||
23747129|NCT00620776|66454369|FG001|Overall Study|Lack of Efficacy|1|||
23823118|NCT01173120|66734355|FG000|Overall Study|Participant Decision|2|||
23823119|NCT01173120|66734355|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
23823120|NCT01173120|66734355|FG000|Overall Study|Switch-Participant Decision|12|||
23823121|NCT01173120|66734355|FG000|Overall Study|Switch-Difficulty With Device|12|||
23823122|NCT03845296|66734356|FG000|Overall Study|On Treatment|2|||
23823123|NCT03845296|66734357|FG001|Overall Study|On Treatment|1|||
23823124|NCT03845296|66734356|FG000|Overall Study|Adverse Event|4|||
23823125|NCT03845296|66734357|FG001|Overall Study|Adverse Event|11|||
23622206|NCT04016805|66004855|FG001|Overall Study|Sponsor's Discretion|6|||
23823126|NCT03845296|66734356|FG000|Overall Study|Refusal unrelated to adverse event|0|||
23823127|NCT03845296|66734357|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23823128|NCT03845296|66734356|FG000|Overall Study|Progression/relapse|14|||
23823129|NCT03845296|66734357|FG001|Overall Study|Progression/relapse|18|||
23823130|NCT03845296|66734356|FG000|Overall Study|Death|4|||
23823131|NCT03845296|66734357|FG001|Overall Study|Death|0|||
23823132|NCT03845296|66734356|FG000|Overall Study|Other - not protocol specified|1|||
23823133|NCT03845296|66734357|FG001|Overall Study|Other - not protocol specified|3|||
23823134|NCT01399658|66734358|FG000|Overall Study|Ineligible|1|||
23823135|NCT01399658|66734358|FG000|Overall Study|Machine Technical Issue|3|||
23823136|NCT01399658|66734358|FG000|Overall Study|Alternative therapy|1|||
23823137|NCT01399658|66734358|FG000|Overall Study|No reason given|1|||
23823138|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
23823139|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
23823140|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
23823141|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
23823142|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
23823143|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
23823144|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
23823145|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
23823146|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
23823147|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
23823148|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
23823149|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
23823150|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23622207|NCT04016805|66004856|FG002|Overall Study|Sponsor's Discretion|5|||
23622208|NCT04680637|66004860|FG000|Overall Study|Lost to Follow-up|0|||
23622209|NCT04680637|66004861|FG001|Overall Study|Lost to Follow-up|1|||
23823151|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
23823152|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
23823153|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23823154|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23823155|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23823156|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
23823157|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
23823158|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
23823159|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23622210|NCT04680637|66004862|FG002|Overall Study|Lost to Follow-up|0|||
23622211|NCT04680637|66004863|FG003|Overall Study|Lost to Follow-up|1|||
23432507|NCT01896271|65327654|FG000|Overall Study|Physician Decision|10|||
23432508|NCT00989781|65327661|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
23432509|NCT00989781|65327662|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
23747130|NCT00620776|66454368|FG000|Overall Study|Lost to Follow-up|2|||
23747131|NCT00620776|66454369|FG001|Overall Study|Lost to Follow-up|5|||
23432510|NCT03022981|65327663|FG000|Overall Study|Adverse Event|0|||
23432511|NCT03022981|65327664|FG001|Overall Study|Adverse Event|1|||
23747132|NCT00620776|66454368|FG000|Overall Study|Withdrawal by Subject|3|||
23432512|NCT03022981|65327665|FG002|Overall Study|Adverse Event|0|||
23432513|NCT03022981|65327663|FG000|Overall Study|Investigator's Discretion|0|||
23432514|NCT03022981|65327664|FG001|Overall Study|Investigator's Discretion|1|||
23432515|NCT03022981|65327665|FG002|Overall Study|Investigator's Discretion|2|||
23432516|NCT03022981|65327663|FG000|Overall Study|Lost to Follow-up|6|||
23432517|NCT03022981|65327664|FG001|Overall Study|Lost to Follow-up|2|||
23432518|NCT03022981|65327665|FG002|Overall Study|Lost to Follow-up|1|||
23432519|NCT03022981|65327663|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23432520|NCT03022981|65327664|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23432521|NCT03022981|65327665|FG002|Overall Study|Non-Compliance With Study Drug|2|||
23432522|NCT03022981|65327663|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
23432523|NCT03022981|65327664|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
23432524|NCT03022981|65327665|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
23432525|NCT02477553|65327670|FG000|Overall Study|Screening up-to-date|12|||
23432526|NCT02477553|65327671|FG001|Overall Study|Screening up-to-date|13|||
23432527|NCT02477553|65327670|FG000|Overall Study|No MD visit|1|||
23432528|NCT02477553|65327671|FG001|Overall Study|No MD visit|1|||
23747133|NCT00620776|66454369|FG001|Overall Study|Withdrawal by Subject|2|||
23747134|NCT01269346|66454374|FG000|Treatment Phase|Disease progression|3|||
23747135|NCT01269346|66454374|FG000|Treatment Phase|Adverse Event|3|||
23747136|NCT01269346|66454374|FG000|Treatment Phase|Withdrawal by Subject|1|||
23747137|NCT01269346|66454374|FG000|Treatment Phase|Other|2|||
23747138|NCT01269346|66454374|FG000|Extension Phase|Adverse Event|6|||
23747139|NCT01269346|66454374|FG000|Extension Phase|Withdrawal by Subject|4|||
23747140|NCT01269346|66454374|FG000|Extension Phase|Disease progression|22|||
23747141|NCT01269346|66454374|FG000|Extension Phase|Physician decision or participant choice|9|||
23747142|NCT01269346|66454374|FG000|Extension Phase|Clinical progression|1|||
23747143|NCT01269346|66454374|FG000|Extension Phase|Started a prohibited con med|1|||
23747144|NCT03417245|66454375|FG000|Overall Study|Adverse Event|1|||
23747145|NCT03417245|66454376|FG001|Overall Study|Adverse Event|0|||
23747146|NCT03417245|66454375|FG000|Overall Study|Protocol Violation|1|||
23747147|NCT03417245|66454376|FG001|Overall Study|Protocol Violation|0|||
23747148|NCT03417245|66454375|FG000|Overall Study|Withdrawal by Subject|1|||
23747149|NCT03417245|66454376|FG001|Overall Study|Withdrawal by Subject|1|||
23747150|NCT03605758|66454381|FG000|Overall Study|Lost to Follow-up|2|||
23747151|NCT03605758|66454382|FG001|Overall Study|Lost to Follow-up|1|||
23747152|NCT03605758|66454381|FG000|Overall Study|Illness|0|||
23747153|NCT03605758|66454382|FG001|Overall Study|Illness|1|||
23747154|NCT03605758|66454381|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
23747155|NCT03605758|66454382|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
23747156|NCT00167414|66454390|FG000|Overall Study|Death|10|||
23747157|NCT02057549|66454391|FG000|Overall Study|Lost to Follow-up|1|||
23747158|NCT02057549|66454392|FG001|Overall Study|Lost to Follow-up|0|||
23747159|NCT02057549|66454391|FG000|Overall Study|Physician Decision|1|||
23747160|NCT02057549|66454392|FG001|Overall Study|Physician Decision|0|||
23747161|NCT02057549|66454391|FG000|Overall Study|Withdrawal by Subject|1|||
23747162|NCT02057549|66454392|FG001|Overall Study|Withdrawal by Subject|0|||
23747163|NCT01275170|66454393|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
23747164|NCT01275170|66454394|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747165|NCT01275170|66454395|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747166|NCT01275170|66454396|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747167|NCT01275170|66454397|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747168|NCT01275170|66454398|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
23432529|NCT02477553|65327670|FG000|Overall Study|Workup consistent w/CRC|1|||
23432530|NCT02477553|65327671|FG001|Overall Study|Workup consistent w/CRC|1|||
23432531|NCT02477553|65327670|FG000|Overall Study|Technical issues with intervention|2|||
23432532|NCT02477553|65327671|FG001|Overall Study|Technical issues with intervention|0|||
23432533|NCT02477553|65327670|FG000|Overall Study|Elevated risk for CRC|2|||
23747169|NCT01275170|66454399|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747170|NCT01275170|66454400|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
23747171|NCT02319642|66454406|FG000|Overall Study|Adverse Event|2|||
23747172|NCT02319642|66454407|FG001|Overall Study|Adverse Event|4|||
23747173|NCT02319642|66454406|FG000|Overall Study|Lack of Efficacy|1|||
23747174|NCT02319642|66454407|FG001|Overall Study|Lack of Efficacy|1|||
23823160|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23823161|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23823162|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23823163|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
23823164|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23823165|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23823166|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23823167|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23823168|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
23823169|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23823170|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23823171|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23823172|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23823173|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23823174|NCT04043455|66734362|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23823175|NCT04043455|66734363|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
23823176|NCT04043455|66734364|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23823177|NCT04043455|66734365|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23823178|NCT04043455|66734366|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23823179|NCT04043455|66734367|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23823180|NCT04043455|66734362|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
23823181|NCT04043455|66734363|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
23823182|NCT04043455|66734364|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
23432534|NCT02477553|65327671|FG001|Overall Study|Elevated risk for CRC|2|||
23432535|NCT02477553|65327670|FG000|Overall Study|MD advised against screening|1|||
23432536|NCT02477553|65327671|FG001|Overall Study|MD advised against screening|3|||
23432537|NCT02477553|65327670|FG000|Overall Study|patient deceased|1|||
23432538|NCT02477553|65327671|FG001|Overall Study|patient deceased|0|||
23432539|NCT01274429|65327672|FG000|Overall Study|Study closed do to lack of funding|5|||
23432540|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
23432541|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
23432542|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
23432543|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
23432544|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
23823183|NCT04043455|66734365|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
23432545|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
23432546|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
23432547|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
23432548|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
23432549|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
23432550|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
23432551|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
23432552|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
23432553|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
23747175|NCT02319642|66454406|FG000|Overall Study|Withdrawal by Subject|1|||
23747176|NCT02319642|66454407|FG001|Overall Study|Withdrawal by Subject|1|||
23747177|NCT01360021|66454411|FG000|Overall Study|Eligibility criteria + other|2|||
23747178|NCT01360021|66454412|FG001|Overall Study|Eligibility criteria + other|1|||
23747179|NCT01360021|66454413|FG002|Overall Study|Eligibility criteria + other|1|||
23747180|NCT01360021|66454411|FG000|Overall Study|Protocol Violation|0|||
23747181|NCT01360021|66454412|FG001|Overall Study|Protocol Violation|0|||
23747182|NCT01360021|66454413|FG002|Overall Study|Protocol Violation|1|||
23747183|NCT01360021|66454411|FG000|Overall Study|Withdrawal by Subject|4|||
23747184|NCT01360021|66454412|FG001|Overall Study|Withdrawal by Subject|0|||
23747185|NCT01360021|66454413|FG002|Overall Study|Withdrawal by Subject|2|||
23747186|NCT01360021|66454411|FG000|Overall Study|Adverse Event|2|||
23747187|NCT01360021|66454412|FG001|Overall Study|Adverse Event|3|||
23747188|NCT01360021|66454413|FG002|Overall Study|Adverse Event|3|||
23747189|NCT03644927|66457297|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
23823184|NCT04043455|66734366|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
23823185|NCT04043455|66734367|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
23823186|NCT04043455|66734362|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23823187|NCT04043455|66734363|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23823188|NCT04043455|66734364|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23823189|NCT04043455|66734365|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23823190|NCT04043455|66734366|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
23823191|NCT04043455|66734367|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
23823192|NCT04043455|66734362|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23823193|NCT04043455|66734363|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23823194|NCT04043455|66734364|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23823195|NCT04043455|66734365|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23823196|NCT04043455|66734366|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
23823197|NCT04043455|66734367|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23823198|NCT04043455|66734362|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23823199|NCT04043455|66734363|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23823200|NCT04043455|66734364|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23823201|NCT04043455|66734365|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23823202|NCT04043455|66734366|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
23432554|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
23432555|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
23432556|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
23432557|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
23432558|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
23432559|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
23432560|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
23432561|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
23432562|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
23432563|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
23432564|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
23432565|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
23432566|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
23432567|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
23432568|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
23432569|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
23432570|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
23432571|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
23622212|NCT04680637|66004860|FG000|Overall Study|Death|1|||
23747190|NCT03644927|66457298|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
23747191|NCT00684645|66457306|FG000|Overall Study|Death|2|||
23823203|NCT04043455|66734367|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
23432572|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
23432573|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
23432574|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
23432575|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
23432576|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
23432577|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
23432578|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
23432579|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
23432580|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
23432581|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
23432582|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
23432583|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
23432584|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
23432585|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
23432586|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
23432587|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
23747192|NCT00684645|66457306|FG000|Overall Study|Progressive disease|67|||
23747193|NCT00684645|66457306|FG000|Overall Study|Adverse Event|27|||
23747194|NCT00684645|66457306|FG000|Overall Study|Lost to Follow-up|3|||
23747195|NCT00684645|66457306|FG000|Overall Study|Other|15|||
23747196|NCT00761969|66457307|FG000|Overall Study|Death|112|||
23747197|NCT00761969|66457308|FG001|Overall Study|Death|47|||
23747198|NCT00761969|66457307|FG000|Overall Study|Lost to Follow-up|88|||
23747199|NCT00761969|66457308|FG001|Overall Study|Lost to Follow-up|93|||
23747200|NCT00648739|66457309|FG000|Overall Study|Adverse Event|1|||
23747201|NCT00648739|66457310|FG001|Overall Study|Adverse Event|0|||
23747202|NCT00648739|66457311|FG002|Overall Study|Adverse Event|1|||
23747203|NCT00648739|66457312|FG003|Overall Study|Adverse Event|2|||
23747204|NCT00648739|66457313|FG004|Overall Study|Adverse Event|1|||
23747205|NCT00648739|66457314|FG005|Overall Study|Adverse Event|0|||
23747206|NCT00648739|66457315|FG006|Overall Study|Adverse Event|0|||
23747207|NCT00648739|66457309|FG000|Overall Study|Withdrawal by Subject|1|||
23747208|NCT00648739|66457310|FG001|Overall Study|Withdrawal by Subject|0|||
23747209|NCT00648739|66457311|FG002|Overall Study|Withdrawal by Subject|1|||
23747210|NCT00648739|66457312|FG003|Overall Study|Withdrawal by Subject|0|||
23747211|NCT00648739|66457313|FG004|Overall Study|Withdrawal by Subject|0|||
23747212|NCT00648739|66457314|FG005|Overall Study|Withdrawal by Subject|2|||
23747213|NCT00648739|66457315|FG006|Overall Study|Withdrawal by Subject|0|||
23747214|NCT00648739|66457309|FG000|Overall Study|Lack of Efficacy|0|||
23747215|NCT00648739|66457310|FG001|Overall Study|Lack of Efficacy|0|||
23747216|NCT00648739|66457311|FG002|Overall Study|Lack of Efficacy|0|||
23747217|NCT00648739|66457312|FG003|Overall Study|Lack of Efficacy|0|||
23747218|NCT00648739|66457313|FG004|Overall Study|Lack of Efficacy|1|||
23747219|NCT00648739|66457314|FG005|Overall Study|Lack of Efficacy|2|||
23747220|NCT00648739|66457315|FG006|Overall Study|Lack of Efficacy|0|||
23747221|NCT00648739|66457309|FG000|Overall Study|Investigator Considered it Advisable|0|||
23747222|NCT00648739|66457310|FG001|Overall Study|Investigator Considered it Advisable|0|||
23432588|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
23432589|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
23432590|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
23432591|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
23432592|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
23432593|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
23432594|NCT02008357|65327673|FG000|Open-label Extension Period|Adverse Event|8|||
23432595|NCT02008357|65327674|FG001|Open-label Extension Period|Adverse Event|7|||
23432596|NCT02008357|65327673|FG000|Open-label Extension Period|Death|7|||
23432597|NCT02008357|65327674|FG001|Open-label Extension Period|Death|4|||
23432598|NCT02008357|65327673|FG000|Open-label Extension Period|Lack of Efficacy|9|||
23432599|NCT02008357|65327674|FG001|Open-label Extension Period|Lack of Efficacy|5|||
23432600|NCT02008357|65327673|FG000|Open-label Extension Period|Lost to Follow-up|2|||
23432601|NCT02008357|65327674|FG001|Open-label Extension Period|Lost to Follow-up|2|||
23432602|NCT02008357|65327673|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
23823204|NCT01301729|66734368|FG000|Overall Study|Withdrawal by Subject|2|||
23823205|NCT01301729|66734368|FG000|Overall Study|Participant did not Return for Treatment|1|||
23823206|NCT01301729|66734368|FG000|Overall Study|Violated Selection Criteria|1|||
23432603|NCT02008357|65327674|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
23432604|NCT02008357|65327673|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
23432605|NCT02008357|65327674|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
23432606|NCT02008357|65327673|FG000|Open-label Extension Period|Safety Risk|2|||
23622213|NCT04680637|66004861|FG001|Overall Study|Death|0|||
23622214|NCT04680637|66004862|FG002|Overall Study|Death|0|||
23622215|NCT04680637|66004863|FG003|Overall Study|Death|0|||
23622216|NCT04680637|66004860|FG000|Overall Study|Withdrawal by Subject|7|||
23622217|NCT04680637|66004861|FG001|Overall Study|Withdrawal by Subject|10|||
23622218|NCT04680637|66004862|FG002|Overall Study|Withdrawal by Subject|17|||
23622219|NCT04680637|66004863|FG003|Overall Study|Withdrawal by Subject|15|||
23622220|NCT04680637|66004860|FG000|Overall Study|Decision by Sponsor|21|||
23622221|NCT04680637|66004861|FG001|Overall Study|Decision by Sponsor|15|||
23622222|NCT04680637|66004862|FG002|Overall Study|Decision by Sponsor|7|||
23622223|NCT04680637|66004863|FG003|Overall Study|Decision by Sponsor|32|||
23622224|NCT00661713|66004864|FG000|Overall Study|Death|1|||
23622225|NCT00661713|66004865|FG001|Overall Study|Death|0|||
23622226|NCT00661713|66004866|FG002|Overall Study|Death|0|||
23622227|NCT00661713|66004867|FG003|Overall Study|Death|0|||
23622228|NCT00661713|66004868|FG004|Overall Study|Death|1|||
23622229|NCT00661713|66004869|FG005|Overall Study|Death|0|||
23622230|NCT00661713|66004870|FG006|Overall Study|Death|0|||
23622231|NCT00661713|66004871|FG007|Overall Study|Death|0|||
23622232|NCT00661713|66004864|FG000|Overall Study|Unable to Classify|1|||
23622233|NCT00661713|66004865|FG001|Overall Study|Unable to Classify|0|||
23622234|NCT00661713|66004866|FG002|Overall Study|Unable to Classify|0|||
23622235|NCT00661713|66004867|FG003|Overall Study|Unable to Classify|0|||
23622236|NCT00661713|66004868|FG004|Overall Study|Unable to Classify|0|||
23622237|NCT00661713|66004869|FG005|Overall Study|Unable to Classify|0|||
23622238|NCT00661713|66004870|FG006|Overall Study|Unable to Classify|0|||
23622239|NCT00661713|66004871|FG007|Overall Study|Unable to Classify|0|||
23622240|NCT00661713|66004864|FG000|Overall Study|Protocol Violation|1|||
23622241|NCT00661713|66004865|FG001|Overall Study|Protocol Violation|6|||
23432607|NCT02008357|65327674|FG001|Open-label Extension Period|Safety Risk|1|||
23622242|NCT00661713|66004866|FG002|Overall Study|Protocol Violation|3|||
23622243|NCT00661713|66004867|FG003|Overall Study|Protocol Violation|3|||
23622244|NCT00661713|66004868|FG004|Overall Study|Protocol Violation|0|||
23622245|NCT00661713|66004869|FG005|Overall Study|Protocol Violation|2|||
23622246|NCT00661713|66004870|FG006|Overall Study|Protocol Violation|2|||
23622247|NCT00661713|66004871|FG007|Overall Study|Protocol Violation|1|||
23622248|NCT00661713|66004864|FG000|Overall Study|Withdrawal by Subject|11|||
23622249|NCT00661713|66004865|FG001|Overall Study|Withdrawal by Subject|25|||
23622250|NCT00661713|66004866|FG002|Overall Study|Withdrawal by Subject|12|||
23432608|NCT02008357|65327673|FG000|Open-label Extension Period|Non-Compliance|0|||
23432609|NCT02008357|65327674|FG001|Open-label Extension Period|Non-Compliance|1|||
23622251|NCT00661713|66004867|FG003|Overall Study|Withdrawal by Subject|21|||
23622252|NCT00661713|66004868|FG004|Overall Study|Withdrawal by Subject|12|||
23622253|NCT00661713|66004869|FG005|Overall Study|Withdrawal by Subject|26|||
23622254|NCT00661713|66004870|FG006|Overall Study|Withdrawal by Subject|45|||
23432610|NCT02008357|65327673|FG000|Open-label Extension Period|Investigator Recommendation|0|||
23622255|NCT00661713|66004871|FG007|Overall Study|Withdrawal by Subject|9|||
23432611|NCT02008357|65327674|FG001|Open-label Extension Period|Investigator Recommendation|1|||
23432612|NCT02008357|65327673|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
23432613|NCT02008357|65327674|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
23432614|NCT02008357|65327673|FG000|Open-label Extension Period|Coordinating Center Request|2|||
23432615|NCT02008357|65327674|FG001|Open-label Extension Period|Coordinating Center Request|4|||
23432616|NCT02008357|65327673|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
23432617|NCT02008357|65327674|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
23432618|NCT02008357|65327673|FG000|Open-label Extension Period|Study Ended|20|||
23432619|NCT02008357|65327674|FG001|Open-label Extension Period|Study Ended|25|||
23432620|NCT02008357|65327673|FG000|Open-label Extension Period|Personal Reasons|0|||
23432621|NCT02008357|65327674|FG001|Open-label Extension Period|Personal Reasons|1|||
23432622|NCT02008357|65327673|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
23432623|NCT02008357|65327674|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
23432624|NCT02008357|65327673|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
23554868|NCT01843374|65757957|FG001|Overall Study|Withdrawal by Subject|20|||
23554869|NCT01843374|65757956|FG000|Overall Study|Withdrawing due to Other reason|20|||
23554870|NCT01843374|65757957|FG001|Overall Study|Withdrawing due to Other reason|46|||
23554871|NCT02723864|65757958|FG000|Overall Study|Refused further treatment|1|||
23554872|NCT02723864|65757959|FG001|Overall Study|Refused further treatment|0|||
23554873|NCT02723864|65757960|FG002|Overall Study|Refused further treatment|0|||
23554874|NCT02723864|65757961|FG003|Overall Study|Refused further treatment|0|||
23554875|NCT02723864|65757962|FG004|Overall Study|Refused further treatment|1|||
23554876|NCT02723864|65757963|FG005|Overall Study|Refused further treatment|2|||
23554877|NCT02723864|65757964|FG006|Overall Study|Refused further treatment|0|||
23554878|NCT02723864|65757958|FG000|Overall Study|Exceed treatment hold time|0|||
23554879|NCT02723864|65757959|FG001|Overall Study|Exceed treatment hold time|1|||
23554880|NCT02723864|65757960|FG002|Overall Study|Exceed treatment hold time|0|||
23554881|NCT02723864|65757961|FG003|Overall Study|Exceed treatment hold time|0|||
23554882|NCT02723864|65757962|FG004|Overall Study|Exceed treatment hold time|0|||
23554883|NCT02723864|65757963|FG005|Overall Study|Exceed treatment hold time|0|||
23554884|NCT02723864|65757964|FG006|Overall Study|Exceed treatment hold time|0|||
23554885|NCT02723864|65757958|FG000|Overall Study|Clinical progression|0|||
23554886|NCT02723864|65757959|FG001|Overall Study|Clinical progression|0|||
23554887|NCT02723864|65757960|FG002|Overall Study|Clinical progression|1|||
23554888|NCT02723864|65757961|FG003|Overall Study|Clinical progression|0|||
23554889|NCT02723864|65757962|FG004|Overall Study|Clinical progression|0|||
23554890|NCT02723864|65757963|FG005|Overall Study|Clinical progression|3|||
23554891|NCT02723864|65757964|FG006|Overall Study|Clinical progression|1|||
23554892|NCT02723864|65757958|FG000|Overall Study|Physician Decision|0|||
23554893|NCT02723864|65757959|FG001|Overall Study|Physician Decision|0|||
23554894|NCT02723864|65757960|FG002|Overall Study|Physician Decision|0|||
23554895|NCT02723864|65757961|FG003|Overall Study|Physician Decision|0|||
23554896|NCT02723864|65757962|FG004|Overall Study|Physician Decision|0|||
23554897|NCT02723864|65757963|FG005|Overall Study|Physician Decision|0|||
23554898|NCT02723864|65757964|FG006|Overall Study|Physician Decision|1|||
23554899|NCT02723864|65757958|FG000|Overall Study|Changes in patient condition|0|||
23554900|NCT02723864|65757959|FG001|Overall Study|Changes in patient condition|0|||
23554901|NCT02723864|65757960|FG002|Overall Study|Changes in patient condition|0|||
23554902|NCT02723864|65757961|FG003|Overall Study|Changes in patient condition|0|||
23432625|NCT02008357|65327674|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
23432626|NCT02008357|65327673|FG000|Open-label Extension Period|Other|2|||
23622256|NCT00661713|66004864|FG000|Overall Study|Lost to Follow-up|2|||
23622257|NCT00661713|66004865|FG001|Overall Study|Lost to Follow-up|7|||
23622258|NCT00661713|66004866|FG002|Overall Study|Lost to Follow-up|2|||
23622259|NCT00661713|66004867|FG003|Overall Study|Lost to Follow-up|2|||
23622260|NCT00661713|66004868|FG004|Overall Study|Lost to Follow-up|5|||
23622261|NCT00661713|66004869|FG005|Overall Study|Lost to Follow-up|7|||
23622262|NCT00661713|66004870|FG006|Overall Study|Lost to Follow-up|14|||
23622263|NCT00661713|66004871|FG007|Overall Study|Lost to Follow-up|1|||
23823207|NCT01277211|66734369|FG000|Overall Study|Adverse Event|60|||
23823208|NCT01277211|66734370|FG001|Overall Study|Adverse Event|22|||
23823209|NCT01277211|66734369|FG000|Overall Study|Pregnancy|9|||
23823210|NCT01277211|66734370|FG001|Overall Study|Pregnancy|4|||
23823211|NCT01277211|66734369|FG000|Overall Study|Lost to Follow-up|14|||
23823212|NCT01277211|66734370|FG001|Overall Study|Lost to Follow-up|9|||
23432627|NCT02008357|65327674|FG001|Open-label Extension Period|Other|0|||
23622264|NCT00661713|66004864|FG000|Overall Study|Administrative Reason|0|||
23622265|NCT00661713|66004865|FG001|Overall Study|Administrative Reason|1|||
23747223|NCT00648739|66457311|FG002|Overall Study|Investigator Considered it Advisable|0|||
23747224|NCT00648739|66457312|FG003|Overall Study|Investigator Considered it Advisable|0|||
23747225|NCT00648739|66457313|FG004|Overall Study|Investigator Considered it Advisable|0|||
23747226|NCT00648739|66457314|FG005|Overall Study|Investigator Considered it Advisable|1|||
23432628|NCT01375608|65327678|FG000|Overall Study|Withdrawal by Subject|2|||
23432629|NCT01948063|65327679|FG000|Overall Study|Boston MCI halted research protocol|0|||
23432630|NCT01948063|65327680|FG001|Overall Study|Boston MCI halted research protocol|1|||
23432631|NCT01948063|65327679|FG000|Overall Study|Discovered an enrollment in other study|0|||
23432632|NCT01948063|65327680|FG001|Overall Study|Discovered an enrollment in other study|1|||
23432633|NCT01948063|65327679|FG000|Overall Study|Blood samples were accidentally thawed|1|||
23747227|NCT00648739|66457315|FG006|Overall Study|Investigator Considered it Advisable|1|||
23747228|NCT00648739|66457309|FG000|Overall Study|Death|0|||
23747229|NCT00648739|66457310|FG001|Overall Study|Death|1|||
23432634|NCT01948063|65327680|FG001|Overall Study|Blood samples were accidentally thawed|0|||
23432635|NCT01353911|65327687|FG000|Overall Study|Lost to Follow-up|2|||
23432636|NCT01353911|65327688|FG001|Overall Study|Lost to Follow-up|6|||
23432637|NCT01353911|65327689|FG002|Overall Study|Lost to Follow-up|4|||
23432638|NCT01353911|65327690|FG003|Overall Study|Lost to Follow-up|0|||
23432639|NCT01353911|65327691|FG004|Overall Study|Lost to Follow-up|4|||
23432640|NCT01353911|65327692|FG005|Overall Study|Lost to Follow-up|4|||
23622266|NCT00661713|66004866|FG002|Overall Study|Administrative Reason|0|||
23747230|NCT00648739|66457311|FG002|Overall Study|Death|0|||
23747231|NCT00648739|66457312|FG003|Overall Study|Death|0|||
23747232|NCT00648739|66457313|FG004|Overall Study|Death|0|||
23823213|NCT01277211|66734369|FG000|Overall Study|Did not wish to continue|17|||
23823214|NCT01277211|66734370|FG001|Overall Study|Did not wish to continue|0|||
23823215|NCT01277211|66734369|FG000|Overall Study|Withdrew Consent|9|||
23747233|NCT00648739|66457314|FG005|Overall Study|Death|0|||
23747234|NCT00648739|66457315|FG006|Overall Study|Death|0|||
23432641|NCT01353911|65327693|FG006|Overall Study|Lost to Follow-up|3|||
23432642|NCT01353911|65327694|FG007|Overall Study|Lost to Follow-up|6|||
23823216|NCT01277211|66734370|FG001|Overall Study|Withdrew Consent|9|||
23432643|NCT01353911|65327687|FG000|Overall Study|Withdrawal by Subject|2|||
23432644|NCT01353911|65327688|FG001|Overall Study|Withdrawal by Subject|3|||
23622267|NCT00661713|66004867|FG003|Overall Study|Administrative Reason|2|||
23432645|NCT01353911|65327689|FG002|Overall Study|Withdrawal by Subject|4|||
23432646|NCT01353911|65327690|FG003|Overall Study|Withdrawal by Subject|2|||
23432647|NCT01353911|65327691|FG004|Overall Study|Withdrawal by Subject|2|||
23432648|NCT01353911|65327692|FG005|Overall Study|Withdrawal by Subject|3|||
23432649|NCT01353911|65327693|FG006|Overall Study|Withdrawal by Subject|3|||
23432650|NCT01353911|65327694|FG007|Overall Study|Withdrawal by Subject|9|||
23432651|NCT01353911|65327687|FG000|Overall Study|Status Not Recorded|4|||
23432652|NCT01353911|65327688|FG001|Overall Study|Status Not Recorded|0|||
23340857|NCT01936181|64992870|FG000|Randomised, Double-blind|Pregnancy|0|||
23747235|NCT00648739|66457309|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
23747236|NCT00648739|66457310|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
23747237|NCT00648739|66457311|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
23747238|NCT00648739|66457312|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
23747239|NCT00648739|66457313|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
23747240|NCT00648739|66457314|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
23747241|NCT00648739|66457315|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
23747242|NCT00648739|66457309|FG000|Overall Study|Follow-up Visits Not Completed|0|||
23747243|NCT00648739|66457310|FG001|Overall Study|Follow-up Visits Not Completed|1|||
23747244|NCT00648739|66457311|FG002|Overall Study|Follow-up Visits Not Completed|0|||
23747245|NCT00648739|66457312|FG003|Overall Study|Follow-up Visits Not Completed|0|||
23747246|NCT00648739|66457313|FG004|Overall Study|Follow-up Visits Not Completed|0|||
23747247|NCT00648739|66457314|FG005|Overall Study|Follow-up Visits Not Completed|0|||
23747248|NCT00648739|66457315|FG006|Overall Study|Follow-up Visits Not Completed|0|||
23747249|NCT00578448|66457318|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
23747250|NCT00578448|66457318|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
23747251|NCT00578448|66457318|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
23747252|NCT00578448|66457318|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
23747253|NCT04066894|66457319|FG000|Overall Study|Lack of Efficacy|1|||
23747254|NCT04066894|66457319|FG000|Overall Study|Screen Failure|1|||
23747255|NCT01301625|66457320|FG000|Overall Study|Death|5|||
23747256|NCT01301625|66457320|FG000|Overall Study|Not Due|21|||
23747257|NCT01301625|66457320|FG000|Overall Study|Expected|8|||
23747258|NCT01301625|66457320|FG000|Overall Study|Lost to Follow-up|1|||
23747259|NCT01600755|66457323|FG000|Overall Study|Withdrawal by Subject|6|||
23747260|NCT00669110|66457328|FG000|Overall Study|Adverse Event|4|||
23747261|NCT00669110|66457329|FG001|Overall Study|Adverse Event|3|||
23747262|NCT00669110|66457328|FG000|Overall Study|Caregiver request|3|||
23747263|NCT00669110|66457329|FG001|Overall Study|Caregiver request|2|||
23747264|NCT00669110|66457328|FG000|Overall Study|Physician Decision|0|||
23747265|NCT00669110|66457329|FG001|Overall Study|Physician Decision|1|||
23747266|NCT00669110|66457328|FG000|Overall Study|Lost to Follow-up|1|||
23747267|NCT00669110|66457329|FG001|Overall Study|Lost to Follow-up|0|||
23747268|NCT00669110|66457328|FG000|Overall Study|Protocol Violation|0|||
23747269|NCT00669110|66457329|FG001|Overall Study|Protocol Violation|5|||
23747270|NCT00669110|66457328|FG000|Overall Study|Withdrawal by Subject|0|||
23747271|NCT00669110|66457329|FG001|Overall Study|Withdrawal by Subject|2|||
23747272|NCT01656850|66457337|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
23747273|NCT01656850|66457338|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
23747274|NCT00446134|66457339|FG000|Overall Study|Adverse Event|7|||
23747275|NCT00446134|66457340|FG001|Overall Study|Adverse Event|17|||
23747276|NCT00446134|66457341|FG002|Overall Study|Adverse Event|13|||
23747277|NCT00446134|66457342|FG003|Overall Study|Adverse Event|18|||
23747278|NCT00446134|66457339|FG000|Overall Study|Lack of Efficacy|19|||
23747279|NCT00446134|66457340|FG001|Overall Study|Lack of Efficacy|19|||
23747280|NCT00446134|66457341|FG002|Overall Study|Lack of Efficacy|24|||
23747281|NCT00446134|66457342|FG003|Overall Study|Lack of Efficacy|19|||
23747282|NCT00446134|66457339|FG000|Overall Study|Protocol Violation|0|||
23747283|NCT00446134|66457340|FG001|Overall Study|Protocol Violation|2|||
23747284|NCT00446134|66457341|FG002|Overall Study|Protocol Violation|1|||
23747285|NCT00446134|66457342|FG003|Overall Study|Protocol Violation|0|||
23747286|NCT00446134|66457339|FG000|Overall Study|Lost to Follow-up|1|||
23432653|NCT01353911|65327689|FG002|Overall Study|Status Not Recorded|1|||
23432654|NCT01353911|65327690|FG003|Overall Study|Status Not Recorded|0|||
23747287|NCT00446134|66457340|FG001|Overall Study|Lost to Follow-up|3|||
23747288|NCT00446134|66457341|FG002|Overall Study|Lost to Follow-up|1|||
23823217|NCT01277211|66734369|FG000|Overall Study|Non-compliance with protocol|13|||
23432655|NCT01353911|65327691|FG004|Overall Study|Status Not Recorded|0|||
23432656|NCT01353911|65327692|FG005|Overall Study|Status Not Recorded|0|||
23747289|NCT00446134|66457342|FG003|Overall Study|Lost to Follow-up|1|||
23747290|NCT00446134|66457339|FG000|Overall Study|Withdrawal by Subject|3|||
23747291|NCT00446134|66457340|FG001|Overall Study|Withdrawal by Subject|3|||
23747292|NCT00446134|66457341|FG002|Overall Study|Withdrawal by Subject|1|||
23747293|NCT00446134|66457342|FG003|Overall Study|Withdrawal by Subject|3|||
23747294|NCT00446134|66457339|FG000|Overall Study|Physician Decision|0|||
23747295|NCT00446134|66457340|FG001|Overall Study|Physician Decision|0|||
23747296|NCT00446134|66457341|FG002|Overall Study|Physician Decision|0|||
23747297|NCT00446134|66457342|FG003|Overall Study|Physician Decision|2|||
23747298|NCT00446134|66457339|FG000|Overall Study|Adverse Event-Diarrhea|1|||
23747299|NCT00446134|66457340|FG001|Overall Study|Adverse Event-Diarrhea|1|||
23432657|NCT01353911|65327693|FG006|Overall Study|Status Not Recorded|0|||
23432658|NCT01353911|65327694|FG007|Overall Study|Status Not Recorded|0|||
23432659|NCT01264419|65327695|FG000|Overall Study|Lost to Follow-up|3|||
23432660|NCT03131596|65327696|FG000|Overall Study|Protocol Violation|3|||
23554903|NCT02723864|65757962|FG004|Overall Study|Changes in patient condition|0|||
23554904|NCT02723864|65757963|FG005|Overall Study|Changes in patient condition|1|||
23554905|NCT02723864|65757964|FG006|Overall Study|Changes in patient condition|0|||
23554906|NCT02723864|65757958|FG000|Overall Study|Patient choice|0|||
23554907|NCT02723864|65757959|FG001|Overall Study|Patient choice|0|||
23554908|NCT02723864|65757960|FG002|Overall Study|Patient choice|0|||
23554909|NCT02723864|65757961|FG003|Overall Study|Patient choice|0|||
23554910|NCT02723864|65757962|FG004|Overall Study|Patient choice|0|||
23554911|NCT02723864|65757963|FG005|Overall Study|Patient choice|1|||
23554912|NCT02723864|65757964|FG006|Overall Study|Patient choice|0|||
23554913|NCT02723864|65757958|FG000|Overall Study|Adverse Event|0|||
23554914|NCT02723864|65757959|FG001|Overall Study|Adverse Event|0|||
23554915|NCT02723864|65757960|FG002|Overall Study|Adverse Event|0|||
23554916|NCT02723864|65757961|FG003|Overall Study|Adverse Event|0|||
23554917|NCT02723864|65757962|FG004|Overall Study|Adverse Event|0|||
23554918|NCT02723864|65757963|FG005|Overall Study|Adverse Event|1|||
23554919|NCT02723864|65757964|FG006|Overall Study|Adverse Event|0|||
23554920|NCT02723864|65757958|FG000|Overall Study|Started new treatment|0|||
23554921|NCT02723864|65757959|FG001|Overall Study|Started new treatment|0|||
23554922|NCT02723864|65757960|FG002|Overall Study|Started new treatment|0|||
23554923|NCT02723864|65757961|FG003|Overall Study|Started new treatment|0|||
23554924|NCT02723864|65757962|FG004|Overall Study|Started new treatment|0|||
23554925|NCT02723864|65757963|FG005|Overall Study|Started new treatment|1|||
23747300|NCT00446134|66457341|FG002|Overall Study|Adverse Event-Diarrhea|2|||
23554926|NCT02723864|65757964|FG006|Overall Study|Started new treatment|0|||
23747301|NCT00446134|66457342|FG003|Overall Study|Adverse Event-Diarrhea|0|||
23432661|NCT03131596|65327697|FG001|Overall Study|Protocol Violation|3|||
23823218|NCT01277211|66734370|FG001|Overall Study|Non-compliance with protocol|4|||
23432662|NCT03131596|65327696|FG000|Overall Study|Lost to Follow-up|3|||
23554927|NCT02723864|65757958|FG000|Overall Study|Switched to alternative treatment|0|||
23747302|NCT00446134|66457339|FG000|Overall Study|Reason Not Completed|3|||
23823219|NCT01277211|66734369|FG000|Overall Study|Did not meet protocol eligibility|1|||
23747303|NCT00446134|66457340|FG001|Overall Study|Reason Not Completed|0|||
23747304|NCT00446134|66457341|FG002|Overall Study|Reason Not Completed|1|||
23747305|NCT00446134|66457342|FG003|Overall Study|Reason Not Completed|2|||
23747306|NCT03107715|66457343|FG000|Overall Study|did not deliver at the home hospital|4|||
23747307|NCT03107715|66457344|FG001|Overall Study|did not deliver at the home hospital|6|||
23747308|NCT03107715|66457343|FG000|Overall Study|infant stillborn|0|||
23747309|NCT03107715|66457344|FG001|Overall Study|infant stillborn|1|||
23747310|NCT03290131|66457347|FG000|Overall Study|Adverse Event|22|||
23747311|NCT03290131|66457348|FG001|Overall Study|Adverse Event|57|||
23747312|NCT03290131|66457349|FG002|Overall Study|Adverse Event|11|||
23747313|NCT03290131|66457347|FG000|Overall Study|Withdrawal by Subject|18|||
23747314|NCT03290131|66457348|FG001|Overall Study|Withdrawal by Subject|13|||
23747315|NCT03290131|66457349|FG002|Overall Study|Withdrawal by Subject|8|||
23747316|NCT03290131|66457347|FG000|Overall Study|MS Relapse|2|||
23747317|NCT03290131|66457348|FG001|Overall Study|MS Relapse|1|||
23747318|NCT03290131|66457349|FG002|Overall Study|MS Relapse|0|||
23747319|NCT03290131|66457347|FG000|Overall Study|Unknown reason|0|||
23747320|NCT03290131|66457348|FG001|Overall Study|Unknown reason|1|||
23747321|NCT03290131|66457349|FG002|Overall Study|Unknown reason|0|||
23747322|NCT02985515|66457350|FG000|Olfaction Testing|Lost to Follow-up|0|||
23747323|NCT02985515|66457351|FG001|Olfaction Testing|Lost to Follow-up|5|||
23747324|NCT02985515|66457350|FG000|Olfaction Testing|Protocol Violation|0|||
23747325|NCT02985515|66457351|FG001|Olfaction Testing|Protocol Violation|3|||
23747326|NCT00592007|66457352|FG000|Overall Study|Withdrawal by Subject|1|||
23747327|NCT00592007|66457352|FG000|Overall Study|patient ineligible (out of lab range)|1|||
23747328|NCT02508649|66457353|FG000|Overall Study|Withdrawal by Subject|4|||
23747329|NCT02508649|66457354|FG001|Overall Study|Withdrawal by Subject|6|||
23747330|NCT02508649|66457355|FG002|Overall Study|Withdrawal by Subject|5|||
23747331|NCT02508649|66457356|FG003|Overall Study|Withdrawal by Subject|6|||
23747332|NCT02508649|66457353|FG000|Overall Study|Investigator withdrew the subject|1|||
23747333|NCT02508649|66457354|FG001|Overall Study|Investigator withdrew the subject|2|||
23747334|NCT02508649|66457355|FG002|Overall Study|Investigator withdrew the subject|1|||
23747335|NCT02508649|66457356|FG003|Overall Study|Investigator withdrew the subject|0|||
23747336|NCT02508649|66457353|FG000|Overall Study|Post randomization screening failure|12|||
23747337|NCT02508649|66457354|FG001|Overall Study|Post randomization screening failure|4|||
23747338|NCT02508649|66457355|FG002|Overall Study|Post randomization screening failure|9|||
23747339|NCT02508649|66457356|FG003|Overall Study|Post randomization screening failure|3|||
23747340|NCT02508649|66457353|FG000|Overall Study|Lost to Follow-up|1|||
23747341|NCT02508649|66457354|FG001|Overall Study|Lost to Follow-up|1|||
23747342|NCT02508649|66457355|FG002|Overall Study|Lost to Follow-up|0|||
23747343|NCT02508649|66457356|FG003|Overall Study|Lost to Follow-up|1|||
23747344|NCT00953017|66457357|FG000|Overall Study|DId not show up for colonoscopy|4|||
23747345|NCT00953017|66457358|FG001|Overall Study|DId not show up for colonoscopy|4|||
23747346|NCT00953017|66457359|FG002|Overall Study|DId not show up for colonoscopy|5|||
23747347|NCT00953017|66457360|FG003|Overall Study|DId not show up for colonoscopy|4|||
23747348|NCT00953017|66457357|FG000|Overall Study|Incomplete data|1|||
23747349|NCT00953017|66457358|FG001|Overall Study|Incomplete data|1|||
23747350|NCT00953017|66457359|FG002|Overall Study|Incomplete data|0|||
23747351|NCT00953017|66457360|FG003|Overall Study|Incomplete data|0|||
23747352|NCT00953017|66457357|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
23747353|NCT00953017|66457358|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
23747354|NCT00953017|66457359|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
23747355|NCT00953017|66457360|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
23747356|NCT00953017|66457357|FG000|Overall Study|Brown stool prior to procedure|0|||
23747357|NCT00953017|66457358|FG001|Overall Study|Brown stool prior to procedure|0|||
23747358|NCT00953017|66457359|FG002|Overall Study|Brown stool prior to procedure|1|||
23747359|NCT00953017|66457360|FG003|Overall Study|Brown stool prior to procedure|0|||
23747360|NCT01018680|66457361|FG000|Overall Study|Adverse Event|23|||
23747361|NCT01018680|66457362|FG001|Overall Study|Adverse Event|40|||
23747362|NCT01018680|66457361|FG000|Overall Study|Withdrawal by Subject|10|||
23747363|NCT01018680|66457362|FG001|Overall Study|Withdrawal by Subject|10|||
23747364|NCT01018680|66457361|FG000|Overall Study|Protocol Violation|5|||
23747365|NCT01018680|66457362|FG001|Overall Study|Protocol Violation|8|||
23747366|NCT01018680|66457361|FG000|Overall Study|Sponsor Decision|6|||
23747367|NCT01018680|66457362|FG001|Overall Study|Sponsor Decision|7|||
23747368|NCT01018680|66457361|FG000|Overall Study|Lack of Efficacy|8|||
23747369|NCT01018680|66457362|FG001|Overall Study|Lack of Efficacy|2|||
23747370|NCT01018680|66457361|FG000|Overall Study|Lost to Follow-up|5|||
23747371|NCT01018680|66457362|FG001|Overall Study|Lost to Follow-up|3|||
23747372|NCT01018680|66457361|FG000|Overall Study|Entry Criteria Not Met|1|||
23747373|NCT01018680|66457362|FG001|Overall Study|Entry Criteria Not Met|4|||
23747374|NCT01018680|66457361|FG000|Overall Study|Physician Decision|3|||
23747375|NCT01018680|66457362|FG001|Overall Study|Physician Decision|1|||
23747376|NCT00437294|66457363|FG000|Overall Study|Adverse Event|5|||
23747377|NCT00437294|66457364|FG001|Overall Study|Adverse Event|4|||
23747378|NCT00437294|66457363|FG000|Overall Study|Death|5|||
23747379|NCT00437294|66457364|FG001|Overall Study|Death|2|||
23747380|NCT00437294|66457363|FG000|Overall Study|Physician Decision|0|||
23747381|NCT00437294|66457364|FG001|Overall Study|Physician Decision|3|||
23747382|NCT00437294|66457363|FG000|Overall Study|Withdrawal by Subject|5|||
23747383|NCT00437294|66457364|FG001|Overall Study|Withdrawal by Subject|0|||
23747384|NCT00437294|66457363|FG000|Overall Study|Progressive Disease|19|||
23747385|NCT00437294|66457364|FG001|Overall Study|Progressive Disease|23|||
23747386|NCT00437294|66457363|FG000|Overall Study|Sponsor Decision|8|||
23747387|NCT00437294|66457364|FG001|Overall Study|Sponsor Decision|9|||
23747388|NCT00437294|66457363|FG000|Overall Study|Protocol Violation|0|||
23747389|NCT00437294|66457364|FG001|Overall Study|Protocol Violation|1|||
23747390|NCT00437294|66457363|FG000|Overall Study|Entry criteria not met|1|||
23747391|NCT00437294|66457364|FG001|Overall Study|Entry criteria not met|1|||
23747392|NCT00285012|66457367|FG000|Assigned to Study Treatment (Tx)|Other|2|||
23747393|NCT00285012|66457368|FG001|Assigned to Study Treatment (Tx)|Other|3|||
23747394|NCT00285012|66457367|FG000|Received Study Tx|Death|2|||
23747395|NCT00285012|66457368|FG001|Received Study Tx|Death|1|||
23747396|NCT00285012|66457367|FG000|Received Study Tx|Adverse Event|5|||
23747397|NCT00285012|66457368|FG001|Received Study Tx|Adverse Event|11|||
23747398|NCT00285012|66457367|FG000|Received Study Tx|Lack of Efficacy|0|||
23747399|NCT00285012|66457368|FG001|Received Study Tx|Lack of Efficacy|3|||
23747400|NCT00285012|66457367|FG000|Received Study Tx|Lost to Follow-up|29|||
23747401|NCT00285012|66457368|FG001|Received Study Tx|Lost to Follow-up|31|||
23747402|NCT00285012|66457367|FG000|Received Study Tx|Withdrawal by Subject|31|||
23747403|NCT00285012|66457368|FG001|Received Study Tx|Withdrawal by Subject|43|||
23747404|NCT00285012|66457367|FG000|Received Study Tx|Other|5|||
23747405|NCT00285012|66457368|FG001|Received Study Tx|Other|5|||
23747406|NCT00924313|66457369|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
23747407|NCT04478994|66457375|FG000|Overall Study|Withdrawal by Subject|1|||
23747408|NCT04478994|66457376|FG001|Overall Study|Withdrawal by Subject|1|||
23747409|NCT00572910|66457381|FG000|Overall Study|Adverse Event|1|||
23747410|NCT00572910|66457382|FG001|Overall Study|Adverse Event|2|||
23747411|NCT00572910|66457383|FG002|Overall Study|Adverse Event|0|||
23747412|NCT00572910|66457384|FG003|Overall Study|Adverse Event|2|||
23747413|NCT00572910|66457385|FG004|Overall Study|Adverse Event|0|||
23432663|NCT03131596|65327697|FG001|Overall Study|Lost to Follow-up|0|||
23432664|NCT00558272|65327701|FG000|Overall Study|Adverse Event|10|||
23432665|NCT00558272|65327702|FG001|Overall Study|Adverse Event|0|||
23432666|NCT00558272|65327701|FG000|Overall Study|Death|1|||
23432667|NCT00558272|65327702|FG001|Overall Study|Death|0|||
23432668|NCT00558272|65327701|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
23432669|NCT00558272|65327702|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
23432670|NCT00558272|65327701|FG000|Overall Study|AZ study team decision|0|||
23432671|NCT00558272|65327702|FG001|Overall Study|AZ study team decision|1|||
23432672|NCT00558272|65327701|FG000|Overall Study|Incorrectly enrolled|1|||
23432673|NCT00558272|65327702|FG001|Overall Study|Incorrectly enrolled|0|||
23432674|NCT00558272|65327701|FG000|Overall Study|Withdrawal by Subject|0|||
23432675|NCT00558272|65327702|FG001|Overall Study|Withdrawal by Subject|1|||
23432676|NCT01220180|65327703|FG000|Overall Study|Lost to Follow-up|76|||
23432677|NCT01220180|65327703|FG000|Overall Study|Other|72|||
23432678|NCT01220180|65327703|FG000|Overall Study|Adverse Event|35|||
23432679|NCT01220180|65327703|FG000|Overall Study|Lack of Efficacy|22|||
23554928|NCT02723864|65757959|FG001|Overall Study|Switched to alternative treatment|0|||
23554929|NCT02723864|65757960|FG002|Overall Study|Switched to alternative treatment|0|||
23554930|NCT02723864|65757961|FG003|Overall Study|Switched to alternative treatment|0|||
23554931|NCT02723864|65757962|FG004|Overall Study|Switched to alternative treatment|0|||
23554932|NCT02723864|65757963|FG005|Overall Study|Switched to alternative treatment|1|||
23554933|NCT02723864|65757964|FG006|Overall Study|Switched to alternative treatment|0|||
23554934|NCT02723864|65757958|FG000|Overall Study|Late determination of ineligibility|0|||
23554935|NCT02723864|65757959|FG001|Overall Study|Late determination of ineligibility|0|||
23747414|NCT00572910|66457386|FG005|Overall Study|Adverse Event|0|||
23747415|NCT00572910|66457387|FG006|Overall Study|Adverse Event|4|||
23432680|NCT01220180|65327703|FG000|Overall Study|Death|1|||
23432681|NCT01220180|65327703|FG000|Overall Study|Randomized but not treated|1|||
23432682|NCT00483002|65327708|FG000|Overall Study|Adverse Event|68|||
23432683|NCT00483002|65327708|FG000|Overall Study|Lack of Efficacy|555|||
23747416|NCT00572910|66457388|FG007|Overall Study|Adverse Event|2|||
23747417|NCT00572910|66457389|FG008|Overall Study|Adverse Event|1|||
23432684|NCT00483002|65327708|FG000|Overall Study|Lost to Follow-up|962|||
23747418|NCT00572910|66457390|FG009|Overall Study|Adverse Event|3|||
23747419|NCT00572910|66457391|FG010|Overall Study|Adverse Event|2|||
23747420|NCT00572910|66457381|FG000|Overall Study|Lost to Follow-up|0|||
23554936|NCT02723864|65757960|FG002|Overall Study|Late determination of ineligibility|0|||
23554937|NCT02723864|65757961|FG003|Overall Study|Late determination of ineligibility|0|||
23554938|NCT02723864|65757962|FG004|Overall Study|Late determination of ineligibility|0|||
23554939|NCT02723864|65757963|FG005|Overall Study|Late determination of ineligibility|1|||
23554940|NCT02723864|65757964|FG006|Overall Study|Late determination of ineligibility|0|||
23554941|NCT00428090|65757967|FG000|Overall Study|Adverse Event|10|||
23554942|NCT00428090|65757968|FG001|Overall Study|Adverse Event|8|||
23554943|NCT00428090|65757969|FG002|Overall Study|Adverse Event|10|||
23554944|NCT00428090|65757970|FG003|Overall Study|Adverse Event|11|||
23554945|NCT00428090|65757967|FG000|Overall Study|Lost to Follow-up|3|||
23554946|NCT00428090|65757968|FG001|Overall Study|Lost to Follow-up|6|||
23554947|NCT00428090|65757969|FG002|Overall Study|Lost to Follow-up|1|||
23554948|NCT00428090|65757970|FG003|Overall Study|Lost to Follow-up|4|||
23554949|NCT00428090|65757967|FG000|Overall Study|Protocol Violation|3|||
23554950|NCT00428090|65757968|FG001|Overall Study|Protocol Violation|1|||
23554951|NCT00428090|65757969|FG002|Overall Study|Protocol Violation|3|||
23554952|NCT00428090|65757970|FG003|Overall Study|Protocol Violation|3|||
23554953|NCT00428090|65757967|FG000|Overall Study|Withdrawal by Subject|10|||
23554954|NCT00428090|65757968|FG001|Overall Study|Withdrawal by Subject|12|||
23554955|NCT00428090|65757969|FG002|Overall Study|Withdrawal by Subject|15|||
23554956|NCT00428090|65757970|FG003|Overall Study|Withdrawal by Subject|5|||
23554957|NCT00428090|65757967|FG000|Overall Study|Sponsor terminated study|0|||
23554958|NCT00428090|65757968|FG001|Overall Study|Sponsor terminated study|1|||
23554959|NCT00428090|65757969|FG002|Overall Study|Sponsor terminated study|0|||
23554960|NCT00428090|65757970|FG003|Overall Study|Sponsor terminated study|0|||
23554961|NCT00428090|65757967|FG000|Overall Study|Non-compliance|4|||
23554962|NCT00428090|65757968|FG001|Overall Study|Non-compliance|0|||
23554963|NCT00428090|65757969|FG002|Overall Study|Non-compliance|1|||
23554964|NCT00428090|65757970|FG003|Overall Study|Non-compliance|3|||
23747421|NCT00572910|66457382|FG001|Overall Study|Lost to Follow-up|1|||
23747422|NCT00572910|66457383|FG002|Overall Study|Lost to Follow-up|1|||
23747423|NCT00572910|66457384|FG003|Overall Study|Lost to Follow-up|2|||
23747424|NCT00572910|66457385|FG004|Overall Study|Lost to Follow-up|1|||
23747425|NCT00572910|66457386|FG005|Overall Study|Lost to Follow-up|0|||
23747426|NCT00572910|66457387|FG006|Overall Study|Lost to Follow-up|0|||
23554965|NCT00428090|65757967|FG000|Overall Study|Par. did not returned to visit|1|||
23554966|NCT00428090|65757968|FG001|Overall Study|Par. did not returned to visit|0|||
23554967|NCT00428090|65757969|FG002|Overall Study|Par. did not returned to visit|0|||
23554968|NCT00428090|65757970|FG003|Overall Study|Par. did not returned to visit|1|||
23554969|NCT00428090|65757967|FG000|Overall Study|Follow-Up visit not possible|1|||
23554970|NCT00428090|65757968|FG001|Overall Study|Follow-Up visit not possible|0|||
23554971|NCT00428090|65757969|FG002|Overall Study|Follow-Up visit not possible|0|||
23554972|NCT00428090|65757970|FG003|Overall Study|Follow-Up visit not possible|0|||
23554973|NCT00428090|65757967|FG000|Overall Study|Prohibited medication used for SAE|1|||
23554974|NCT00428090|65757968|FG001|Overall Study|Prohibited medication used for SAE|0|||
23554975|NCT00428090|65757969|FG002|Overall Study|Prohibited medication used for SAE|0|||
23622268|NCT00661713|66004868|FG004|Overall Study|Administrative Reason|2|||
23622269|NCT00661713|66004869|FG005|Overall Study|Administrative Reason|2|||
23622270|NCT00661713|66004870|FG006|Overall Study|Administrative Reason|1|||
23622271|NCT00661713|66004871|FG007|Overall Study|Administrative Reason|0|||
23622272|NCT00661713|66004864|FG000|Overall Study|Adverse Event|0|||
23622273|NCT00661713|66004865|FG001|Overall Study|Adverse Event|0|||
23622274|NCT00661713|66004866|FG002|Overall Study|Adverse Event|0|||
23622275|NCT00661713|66004867|FG003|Overall Study|Adverse Event|0|||
23622276|NCT00661713|66004868|FG004|Overall Study|Adverse Event|0|||
23622277|NCT00661713|66004869|FG005|Overall Study|Adverse Event|0|||
23622278|NCT00661713|66004870|FG006|Overall Study|Adverse Event|1|||
23622279|NCT00661713|66004871|FG007|Overall Study|Adverse Event|0|||
23622280|NCT00661713|66004864|FG000|Overall Study|Inappropriate Enrollment|0|||
23622281|NCT00661713|66004865|FG001|Overall Study|Inappropriate Enrollment|0|||
23622282|NCT00661713|66004866|FG002|Overall Study|Inappropriate Enrollment|0|||
23622283|NCT00661713|66004867|FG003|Overall Study|Inappropriate Enrollment|0|||
23622284|NCT00661713|66004868|FG004|Overall Study|Inappropriate Enrollment|0|||
23622285|NCT00661713|66004869|FG005|Overall Study|Inappropriate Enrollment|0|||
23622286|NCT00661713|66004870|FG006|Overall Study|Inappropriate Enrollment|1|||
23622287|NCT00661713|66004871|FG007|Overall Study|Inappropriate Enrollment|0|||
23622288|NCT02049515|66004872|FG000|Overall Study|Adverse Event|46|||
23747427|NCT00572910|66457388|FG007|Overall Study|Lost to Follow-up|0|||
23622289|NCT02049515|66004873|FG001|Overall Study|Adverse Event|2|||
23622290|NCT02049515|66004872|FG000|Overall Study|Protocol-specified Disease Progression|23|||
23823220|NCT01277211|66734370|FG001|Overall Study|Did not meet protocol eligibility|0|||
23622291|NCT02049515|66004873|FG001|Overall Study|Protocol-specified Disease Progression|2|||
23554976|NCT00428090|65757970|FG003|Overall Study|Prohibited medication used for SAE|0|||
23622292|NCT02049515|66004872|FG000|Overall Study|Death|6|||
23554977|NCT00428090|65757967|FG000|Overall Study|Death of par.|1|||
23747428|NCT00572910|66457389|FG008|Overall Study|Lost to Follow-up|0|||
23432685|NCT00483002|65327708|FG000|Overall Study|Other|2|||
23432686|NCT00483002|65327708|FG000|Overall Study|Other|967|||
23432687|NCT00527319|65327709|FG000|Overall Study|Withdrawal by Subject|5|||
23432688|NCT00527319|65327710|FG001|Overall Study|Withdrawal by Subject|0|||
23432689|NCT00527319|65327711|FG002|Overall Study|Withdrawal by Subject|1|||
23432690|NCT00527319|65327709|FG000|Overall Study|Lost to Follow-up|1|||
23432691|NCT00527319|65327710|FG001|Overall Study|Lost to Follow-up|0|||
23432692|NCT00527319|65327711|FG002|Overall Study|Lost to Follow-up|0|||
23432693|NCT00527319|65327709|FG000|Overall Study|Death|0|||
23432694|NCT00527319|65327710|FG001|Overall Study|Death|3|||
23432695|NCT00527319|65327711|FG002|Overall Study|Death|1|||
23432696|NCT00527319|65327709|FG000|Overall Study|Intercurrent Medical Illness|0|||
23432697|NCT00527319|65327710|FG001|Overall Study|Intercurrent Medical Illness|1|||
23432698|NCT00527319|65327711|FG002|Overall Study|Intercurrent Medical Illness|3|||
23432699|NCT00527319|65327709|FG000|Overall Study|Adverse Event|0|||
23432700|NCT00527319|65327710|FG001|Overall Study|Adverse Event|0|||
23432701|NCT00527319|65327711|FG002|Overall Study|Adverse Event|1|||
23432702|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432703|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
23432704|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432705|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432706|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
23432707|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
23432708|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
23432709|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
23432710|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432711|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
23432712|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432713|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432714|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
23432715|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
23432716|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
23432717|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
23432718|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432719|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432720|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432721|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
23432722|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
23432723|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
23432724|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
23432725|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
23432726|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
23432727|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
23432728|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
23432729|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
23432730|NCT00576472|65327716|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432731|NCT00576472|65327717|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432732|NCT00576472|65327718|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432733|NCT00576472|65327719|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
23432734|NCT00576472|65327720|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432735|NCT00576472|65327721|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432736|NCT00576472|65327722|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432737|NCT00576472|65327723|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432738|NCT00576472|65327724|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432739|NCT00576472|65327725|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432740|NCT00576472|65327726|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432741|NCT00576472|65327727|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432742|NCT00576472|65327728|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432743|NCT00576472|65327729|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
23747429|NCT00572910|66457390|FG009|Overall Study|Lost to Follow-up|1|||
23747430|NCT00572910|66457391|FG010|Overall Study|Lost to Follow-up|0|||
23747431|NCT00572910|66457381|FG000|Overall Study|Withdrawal by Subject|3|||
23747432|NCT00572910|66457382|FG001|Overall Study|Withdrawal by Subject|0|||
23747433|NCT00572910|66457383|FG002|Overall Study|Withdrawal by Subject|1|||
23747434|NCT00572910|66457384|FG003|Overall Study|Withdrawal by Subject|0|||
23747435|NCT00572910|66457385|FG004|Overall Study|Withdrawal by Subject|1|||
23823221|NCT01277211|66734369|FG000|Overall Study|Administrative|3|||
23432744|NCT00576472|65327730|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432745|NCT00576472|65327716|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
23747436|NCT00572910|66457386|FG005|Overall Study|Withdrawal by Subject|3|||
23823222|NCT01277211|66734370|FG001|Overall Study|Administrative|0|||
23823223|NCT01277211|66734369|FG000|Overall Study|Pregnancy wish|0|||
23432746|NCT00576472|65327717|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
23432747|NCT00576472|65327718|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
23432748|NCT00576472|65327719|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
23432749|NCT00576472|65327720|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
23432750|NCT00576472|65327721|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
23432751|NCT00576472|65327722|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
23432752|NCT00576472|65327723|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
23432753|NCT00576472|65327724|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
23432754|NCT00576472|65327725|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
23432755|NCT00576472|65327726|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
23432756|NCT00576472|65327727|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
23432757|NCT00576472|65327728|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
23432758|NCT00576472|65327729|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
23432759|NCT00576472|65327730|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
23432760|NCT00576472|65327716|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432761|NCT00576472|65327717|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432762|NCT00576472|65327718|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432763|NCT00576472|65327719|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
23432764|NCT00576472|65327720|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432765|NCT00576472|65327721|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432766|NCT00576472|65327722|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432767|NCT00576472|65327723|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432768|NCT00576472|65327724|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432769|NCT00576472|65327725|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432770|NCT00576472|65327726|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432771|NCT00576472|65327727|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432772|NCT00576472|65327728|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432773|NCT00576472|65327729|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432774|NCT00576472|65327730|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432775|NCT00576472|65327716|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
23432776|NCT00576472|65327717|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
23432777|NCT00576472|65327718|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
23432778|NCT00576472|65327719|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
23432779|NCT00576472|65327720|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
23432780|NCT00576472|65327721|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
23432781|NCT00576472|65327722|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
23432782|NCT00576472|65327723|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
23432783|NCT00576472|65327724|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
23432784|NCT00576472|65327725|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
23432785|NCT00576472|65327726|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
23432786|NCT00576472|65327727|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
23432787|NCT00576472|65327728|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
23432788|NCT00576472|65327729|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
23432789|NCT00576472|65327730|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
23432790|NCT00576472|65327716|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432791|NCT00576472|65327717|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432792|NCT00576472|65327718|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432793|NCT00576472|65327719|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
23432794|NCT00576472|65327720|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432795|NCT00576472|65327721|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432796|NCT00576472|65327722|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432797|NCT00576472|65327723|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432798|NCT00576472|65327724|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432799|NCT00576472|65327725|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432800|NCT00576472|65327726|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432801|NCT00576472|65327727|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432802|NCT00576472|65327728|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432803|NCT00576472|65327729|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432804|NCT00576472|65327730|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432805|NCT00576472|65327716|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432806|NCT00576472|65327717|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432807|NCT00576472|65327718|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432808|NCT00576472|65327719|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432809|NCT00576472|65327720|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432810|NCT00576472|65327721|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432811|NCT00576472|65327722|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
23432812|NCT00576472|65327723|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432813|NCT00576472|65327724|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432814|NCT00576472|65327725|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432815|NCT00576472|65327726|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432816|NCT00576472|65327727|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432817|NCT00576472|65327728|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432818|NCT00576472|65327729|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432819|NCT00576472|65327730|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432820|NCT00576472|65327716|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
23432821|NCT00576472|65327717|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
23432822|NCT00576472|65327718|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
23432823|NCT00576472|65327719|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
23432824|NCT00576472|65327720|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
23432825|NCT00576472|65327721|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
23432826|NCT00576472|65327722|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
23747437|NCT00572910|66457387|FG006|Overall Study|Withdrawal by Subject|0|||
23747438|NCT00572910|66457388|FG007|Overall Study|Withdrawal by Subject|2|||
23747439|NCT00572910|66457389|FG008|Overall Study|Withdrawal by Subject|2|||
23432827|NCT00576472|65327723|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
23432828|NCT00576472|65327724|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
23432829|NCT00576472|65327725|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
23432830|NCT00576472|65327726|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
23432831|NCT00576472|65327727|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
23432832|NCT00576472|65327728|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
23432833|NCT00576472|65327729|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
23432834|NCT00576472|65327730|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
23432835|NCT00576472|65327716|FG000|MPH Cross Over Phase|Physician Decision|0|||
23432836|NCT00576472|65327717|FG001|MPH Cross Over Phase|Physician Decision|0|||
23432837|NCT00576472|65327718|FG002|MPH Cross Over Phase|Physician Decision|0|||
23432838|NCT00576472|65327719|FG003|MPH Cross Over Phase|Physician Decision|0|||
23432839|NCT00576472|65327720|FG004|MPH Cross Over Phase|Physician Decision|0|||
23432840|NCT00576472|65327721|FG005|MPH Cross Over Phase|Physician Decision|0|||
23432841|NCT00576472|65327722|FG006|MPH Cross Over Phase|Physician Decision|4|||
23432842|NCT00576472|65327723|FG007|MPH Cross Over Phase|Physician Decision|0|||
23432843|NCT00576472|65327724|FG008|MPH Cross Over Phase|Physician Decision|0|||
23432844|NCT00576472|65327725|FG009|MPH Cross Over Phase|Physician Decision|0|||
23432845|NCT00576472|65327726|FG010|MPH Cross Over Phase|Physician Decision|0|||
23432846|NCT00576472|65327727|FG011|MPH Cross Over Phase|Physician Decision|0|||
23432847|NCT00576472|65327728|FG012|MPH Cross Over Phase|Physician Decision|0|||
23432848|NCT00576472|65327729|FG013|MPH Cross Over Phase|Physician Decision|0|||
23432849|NCT00576472|65327730|FG014|MPH Cross Over Phase|Physician Decision|0|||
23432850|NCT00576472|65327716|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432851|NCT00576472|65327717|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
23554978|NCT00428090|65757968|FG001|Overall Study|Death of par.|0|||
23554979|NCT00428090|65757969|FG002|Overall Study|Death of par.|1|||
23554980|NCT00428090|65757970|FG003|Overall Study|Death of par.|0|||
23554981|NCT00428090|65757967|FG000|Overall Study|Visit 7 exceed the visit window|0|||
23432852|NCT00576472|65327718|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432853|NCT00576472|65327719|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432854|NCT00576472|65327720|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
23554982|NCT00428090|65757968|FG001|Overall Study|Visit 7 exceed the visit window|1|||
23747440|NCT00572910|66457390|FG009|Overall Study|Withdrawal by Subject|2|||
23747441|NCT00572910|66457391|FG010|Overall Study|Withdrawal by Subject|1|||
23747442|NCT03075215|66457392|FG000|12-Month Primary Endpoint|Death|152|||
23747443|NCT03075215|66457392|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
23747444|NCT03075215|66457392|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
23747445|NCT03075215|66457392|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
23747446|NCT00247416|66457393|FG000|Overall Study|3 patients were found to be ineligible|1|||
23747447|NCT00247416|66457394|FG001|Overall Study|3 patients were found to be ineligible|2|||
23747448|NCT00807040|66457395|FG000|Overall Study|Death|24|||
23747449|NCT00807040|66457396|FG001|Overall Study|Death|29|||
23747450|NCT00807040|66457395|FG000|Overall Study|Withdrawal by Subject|8|||
23747451|NCT00807040|66457396|FG001|Overall Study|Withdrawal by Subject|6|||
23747452|NCT00807040|66457395|FG000|Overall Study|Lost to Follow-up|4|||
23747453|NCT00807040|66457396|FG001|Overall Study|Lost to Follow-up|6|||
23747454|NCT01071278|66457397|FG000|Overall Study|Premature Discontinuation|254|||
23747455|NCT01071278|66457397|FG000|Overall Study|Completion Status Unknown|459|||
23747456|NCT00539006|66457398|FG000|Pre-treatment|Other|0|||
23747457|NCT00539006|66457399|FG001|Pre-treatment|Other|1|||
23747458|NCT00539006|66457400|FG002|Pre-treatment|Other|0|||
23747459|NCT00539006|66457401|FG003|Pre-treatment|Other|0|||
23747460|NCT00539006|66457398|FG000|Treatment Period 1|Lost to Follow-up|0|||
23747461|NCT00539006|66457399|FG001|Treatment Period 1|Lost to Follow-up|0|||
23747462|NCT00539006|66457400|FG002|Treatment Period 1|Lost to Follow-up|1|||
23747463|NCT00539006|66457401|FG003|Treatment Period 1|Lost to Follow-up|0|||
23747464|NCT00539006|66457398|FG000|Treatment Period 1|Protocol Violation|0|||
23747465|NCT00539006|66457399|FG001|Treatment Period 1|Protocol Violation|0|||
23747466|NCT00539006|66457400|FG002|Treatment Period 1|Protocol Violation|1|||
23747467|NCT00539006|66457401|FG003|Treatment Period 1|Protocol Violation|0|||
23747468|NCT00539006|66457398|FG000|Treatment Period 1|Lack of Efficacy|0|||
23747469|NCT00539006|66457399|FG001|Treatment Period 1|Lack of Efficacy|0|||
23823224|NCT01277211|66734370|FG001|Overall Study|Pregnancy wish|2|||
23823225|NCT01277211|66734369|FG000|Overall Study|Discontinued prior to treatment|24|||
23823226|NCT01277211|66734370|FG001|Overall Study|Discontinued prior to treatment|13|||
23823227|NCT00041132|66734372|FG000|Overall Study|Adverse Event|19|||
23823228|NCT00041132|66734372|FG000|Overall Study|Death|1|||
23823229|NCT00041132|66734372|FG000|Overall Study|Not Eligible|7|||
23823230|NCT00041132|66734372|FG000|Overall Study|Withdrawal by Subject|1|||
23823231|NCT00041132|66734372|FG000|Overall Study|Physician Decision|2|||
23747470|NCT00539006|66457400|FG002|Treatment Period 1|Lack of Efficacy|0|||
23747471|NCT00539006|66457401|FG003|Treatment Period 1|Lack of Efficacy|1|||
23747472|NCT00539006|66457398|FG000|Washout|Adverse Event|2|||
23747473|NCT00539006|66457399|FG001|Washout|Adverse Event|1|||
23747474|NCT00539006|66457400|FG002|Washout|Adverse Event|0|||
23747475|NCT00539006|66457401|FG003|Washout|Adverse Event|0|||
23747476|NCT00539006|66457398|FG000|Washout|Protocol Violation|1|||
23747477|NCT00539006|66457399|FG001|Washout|Protocol Violation|1|||
23747478|NCT00539006|66457400|FG002|Washout|Protocol Violation|0|||
23747479|NCT00539006|66457401|FG003|Washout|Protocol Violation|0|||
23747480|NCT00539006|66457398|FG000|Washout|Withdrawal by Subject|0|||
23747481|NCT00539006|66457399|FG001|Washout|Withdrawal by Subject|2|||
23747482|NCT00539006|66457400|FG002|Washout|Withdrawal by Subject|0|||
23747483|NCT00539006|66457401|FG003|Washout|Withdrawal by Subject|0|||
23823232|NCT02856555|66734373|FG000|Overall Study|Adverse Event|1|||
23554983|NCT00428090|65757969|FG002|Overall Study|Visit 7 exceed the visit window|0|||
23554984|NCT00428090|65757970|FG003|Overall Study|Visit 7 exceed the visit window|0|||
23554985|NCT00428090|65757967|FG000|Overall Study|Medical monitor terminated par.|0|||
23554986|NCT00428090|65757968|FG001|Overall Study|Medical monitor terminated par.|1|||
23554987|NCT00428090|65757969|FG002|Overall Study|Medical monitor terminated par.|0|||
23554988|NCT00428090|65757970|FG003|Overall Study|Medical monitor terminated par.|0|||
23554989|NCT00428090|65757967|FG000|Overall Study|Mental status of par. was|0|||
23554990|NCT00428090|65757968|FG001|Overall Study|Mental status of par. was|1|||
23554991|NCT00428090|65757969|FG002|Overall Study|Mental status of par. was|0|||
23622293|NCT02049515|66004873|FG001|Overall Study|Death|0|||
23622294|NCT02049515|66004872|FG000|Overall Study|Physician Decision|5|||
23823233|NCT02856555|66734374|FG001|Overall Study|Adverse Event|0|||
23823234|NCT02856555|66734375|FG002|Overall Study|Adverse Event|0|||
23823235|NCT02856555|66734373|FG000|Overall Study|Lost to Follow-up|1|||
23823236|NCT02856555|66734374|FG001|Overall Study|Lost to Follow-up|3|||
23823237|NCT02856555|66734375|FG002|Overall Study|Lost to Follow-up|0|||
23823238|NCT02856555|66734373|FG000|Overall Study|Withdrawal by Subject|3|||
23823239|NCT02856555|66734374|FG001|Overall Study|Withdrawal by Subject|0|||
23823240|NCT02856555|66734375|FG002|Overall Study|Withdrawal by Subject|0|||
23823241|NCT02856555|66734373|FG000|Overall Study|Randomized but Never Treated|0|||
23823242|NCT02856555|66734374|FG001|Overall Study|Randomized but Never Treated|1|||
23823243|NCT02856555|66734375|FG002|Overall Study|Randomized but Never Treated|0|||
23823244|NCT00887289|66734376|FG000|Overall Study|Lack of Efficacy|14|||
23823245|NCT00887289|66734376|FG000|Overall Study|Adverse Event|27|||
23823246|NCT00887289|66734376|FG000|Overall Study|Withdrawal by Subject|26|||
23823247|NCT00887289|66734376|FG000|Overall Study|Lost to Follow-up|8|||
23823248|NCT00887289|66734376|FG000|Overall Study|Other|20|||
23823249|NCT04439201|66734377|FG000|Overall Study|Ineligible|2|||
23554992|NCT00428090|65757970|FG003|Overall Study|Mental status of par. was|0|||
23554993|NCT00428090|65757967|FG000|Overall Study|Worsening of AD|0|||
23554994|NCT00428090|65757968|FG001|Overall Study|Worsening of AD|0|||
23554995|NCT00428090|65757969|FG002|Overall Study|Worsening of AD|1|||
23554996|NCT00428090|65757970|FG003|Overall Study|Worsening of AD|0|||
23554997|NCT00428090|65757967|FG000|Overall Study|Excluded for concerning QTc value|0|||
23554998|NCT00428090|65757968|FG001|Overall Study|Excluded for concerning QTc value|0|||
23554999|NCT00428090|65757969|FG002|Overall Study|Excluded for concerning QTc value|1|||
23555000|NCT00428090|65757970|FG003|Overall Study|Excluded for concerning QTc value|0|||
23555001|NCT00428090|65757967|FG000|Overall Study|Insufficient AD documentation|0|||
23555002|NCT00428090|65757968|FG001|Overall Study|Insufficient AD documentation|0|||
23555003|NCT00428090|65757969|FG002|Overall Study|Insufficient AD documentation|1|||
23555004|NCT00428090|65757970|FG003|Overall Study|Insufficient AD documentation|0|||
23555005|NCT00428090|65757967|FG000|Overall Study|High MMSE scores|0|||
23555006|NCT00428090|65757968|FG001|Overall Study|High MMSE scores|0|||
23555007|NCT00428090|65757969|FG002|Overall Study|High MMSE scores|1|||
23555008|NCT00428090|65757970|FG003|Overall Study|High MMSE scores|0|||
23555009|NCT00428090|65757967|FG000|Overall Study|Deterioration of cognitive status|0|||
23555010|NCT00428090|65757968|FG001|Overall Study|Deterioration of cognitive status|0|||
23555011|NCT00428090|65757969|FG002|Overall Study|Deterioration of cognitive status|1|||
23555012|NCT00428090|65757970|FG003|Overall Study|Deterioration of cognitive status|0|||
23555013|NCT00428090|65757967|FG000|Overall Study|Serious adverse event|0|||
23555014|NCT00428090|65757968|FG001|Overall Study|Serious adverse event|0|||
23555015|NCT00428090|65757969|FG002|Overall Study|Serious adverse event|1|||
23555016|NCT00428090|65757970|FG003|Overall Study|Serious adverse event|0|||
23555017|NCT00428090|65757967|FG000|Overall Study|Excluded for heart insufficiency|0|||
23555018|NCT00428090|65757968|FG001|Overall Study|Excluded for heart insufficiency|0|||
23555019|NCT00428090|65757969|FG002|Overall Study|Excluded for heart insufficiency|1|||
23555020|NCT00428090|65757970|FG003|Overall Study|Excluded for heart insufficiency|0|||
23555021|NCT00428090|65757967|FG000|Overall Study|Raised Creatinine Value|0|||
23555022|NCT00428090|65757968|FG001|Overall Study|Raised Creatinine Value|0|||
23555023|NCT00428090|65757969|FG002|Overall Study|Raised Creatinine Value|0|||
23555024|NCT00428090|65757970|FG003|Overall Study|Raised Creatinine Value|1|||
23823250|NCT04439201|66734377|FG000|Overall Study|Never start protocol therapy|1|||
23555025|NCT01024608|65757973|FG000|Overall Study|Adverse Event|1|||
23555026|NCT01024608|65757974|FG001|Overall Study|Adverse Event|0|||
23555027|NCT01024608|65757973|FG000|Overall Study|Withdrawal by Subject|1|||
23555028|NCT01024608|65757974|FG001|Overall Study|Withdrawal by Subject|0|||
23555029|NCT01024608|65757973|FG000|Overall Study|Lost to Follow-up|0|||
23555030|NCT01024608|65757974|FG001|Overall Study|Lost to Follow-up|1|||
23555031|NCT01024608|65757973|FG000|Overall Study|Protocol Violation|0|||
23823251|NCT04439201|66734377|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
23823252|NCT04439201|66734377|FG000|Overall Study|Mutation status not confirmed|4|||
23555032|NCT01024608|65757974|FG001|Overall Study|Protocol Violation|3|||
23555033|NCT01024608|65757973|FG000|Overall Study|Never received study treatment|2|||
23555034|NCT01024608|65757974|FG001|Overall Study|Never received study treatment|0|||
23823253|NCT04439201|66734377|FG000|Overall Study|Adverse Event|1|||
23555035|NCT02925676|65757975|FG000|Overall Study|Withdrawal by Subject|1|||
23555036|NCT02626780|65757979|FG000|Overall Study|Withdrawal by Subject|3|||
23555037|NCT00166296|65757980|FG000|Overall Study|Withdrawal by Subject|1|||
23555038|NCT00166296|65757981|FG001|Overall Study|Withdrawal by Subject|3|||
23555039|NCT00166296|65757980|FG000|Overall Study|Adverse Event|2|||
23555040|NCT00166296|65757981|FG001|Overall Study|Adverse Event|4|||
23555041|NCT00166296|65757980|FG000|Overall Study|Lost to Follow-up|4|||
23555042|NCT00166296|65757981|FG001|Overall Study|Lost to Follow-up|2|||
23555043|NCT04512066|65757984|FG000|Double-blind Treatment Period|Adverse Event|6|||
23555044|NCT04512066|65757985|FG001|Double-blind Treatment Period|Adverse Event|4|||
23555045|NCT04512066|65757986|FG002|Double-blind Treatment Period|Adverse Event|5|||
23555046|NCT04512066|65757987|FG003|Double-blind Treatment Period|Adverse Event|1|||
23555047|NCT04512066|65757988|FG004|Double-blind Treatment Period|Adverse Event|0|||
23555048|NCT04512066|65757989|FG005|Double-blind Treatment Period|Adverse Event|0|||
23555049|NCT04512066|65757984|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
23555050|NCT04512066|65757985|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
23555051|NCT04512066|65757986|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
23555052|NCT04512066|65757987|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
23555053|NCT04512066|65757988|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
23555054|NCT04512066|65757989|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
23555055|NCT04512066|65757984|FG000|Double-blind Treatment Period|Physician Decision|1|||
23555056|NCT04512066|65757985|FG001|Double-blind Treatment Period|Physician Decision|0|||
23555057|NCT04512066|65757986|FG002|Double-blind Treatment Period|Physician Decision|1|||
23555058|NCT04512066|65757987|FG003|Double-blind Treatment Period|Physician Decision|0|||
23555059|NCT04512066|65757988|FG004|Double-blind Treatment Period|Physician Decision|0|||
23555060|NCT04512066|65757989|FG005|Double-blind Treatment Period|Physician Decision|0|||
23555061|NCT04512066|65757984|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
23555062|NCT04512066|65757985|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
23555063|NCT04512066|65757986|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
23555064|NCT04512066|65757987|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
23555065|NCT04512066|65757988|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23555066|NCT04512066|65757989|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
23555067|NCT04512066|65757984|FG000|Extension Period|Adverse Event|0|||
23555068|NCT04512066|65757985|FG001|Extension Period|Adverse Event|1|||
23555069|NCT04512066|65757986|FG002|Extension Period|Adverse Event|4|||
23555070|NCT04512066|65757987|FG003|Extension Period|Adverse Event|3|||
23555071|NCT04512066|65757988|FG004|Extension Period|Adverse Event|1|||
23555072|NCT04512066|65757989|FG005|Extension Period|Adverse Event|3|||
23555073|NCT04512066|65757984|FG000|Extension Period|Death|0|||
23555074|NCT04512066|65757985|FG001|Extension Period|Death|0|||
23555075|NCT04512066|65757986|FG002|Extension Period|Death|0|||
23555076|NCT04512066|65757987|FG003|Extension Period|Death|0|||
23555077|NCT04512066|65757988|FG004|Extension Period|Death|0|||
23555078|NCT04512066|65757989|FG005|Extension Period|Death|1|||
23555079|NCT04512066|65757984|FG000|Extension Period|Lack of Efficacy|0|||
23555080|NCT04512066|65757985|FG001|Extension Period|Lack of Efficacy|4|||
23555081|NCT04512066|65757986|FG002|Extension Period|Lack of Efficacy|4|||
23555082|NCT04512066|65757987|FG003|Extension Period|Lack of Efficacy|1|||
23823254|NCT04439201|66734377|FG000|Overall Study|Death|7|||
23555083|NCT04512066|65757988|FG004|Extension Period|Lack of Efficacy|3|||
23555084|NCT04512066|65757989|FG005|Extension Period|Lack of Efficacy|3|||
23555085|NCT04512066|65757984|FG000|Extension Period|Lost to Follow-up|0|||
23555086|NCT04512066|65757985|FG001|Extension Period|Lost to Follow-up|1|||
23555087|NCT04512066|65757986|FG002|Extension Period|Lost to Follow-up|5|||
23555088|NCT04512066|65757987|FG003|Extension Period|Lost to Follow-up|2|||
23555089|NCT04512066|65757988|FG004|Extension Period|Lost to Follow-up|3|||
23555090|NCT04512066|65757989|FG005|Extension Period|Lost to Follow-up|2|||
23622295|NCT02049515|66004873|FG001|Overall Study|Physician Decision|1|||
23622296|NCT02049515|66004872|FG000|Overall Study|Withdrawal by Subject|3|||
23622297|NCT02049515|66004873|FG001|Overall Study|Withdrawal by Subject|0|||
23622298|NCT02049515|66004872|FG000|Overall Study|Termination of the Study by Sponsor|2|||
23823255|NCT04439201|66734377|FG000|Overall Study|Withdrawal by Subject|2|||
23432855|NCT00576472|65327721|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432856|NCT00576472|65327722|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432857|NCT00576472|65327723|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432858|NCT00576472|65327724|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
23432859|NCT00576472|65327725|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432860|NCT00576472|65327726|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
23432861|NCT00576472|65327727|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
23432862|NCT00576472|65327728|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432863|NCT00576472|65327729|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
23622299|NCT02049515|66004873|FG001|Overall Study|Termination of the Study by Sponsor|0|||
23622300|NCT02049515|66004872|FG000|Overall Study|Protocol Violation|1|||
23622301|NCT02049515|66004873|FG001|Overall Study|Protocol Violation|1|||
23622302|NCT02049515|66004872|FG000|Overall Study|Clinical Deterioration|1|||
23622303|NCT02049515|66004873|FG001|Overall Study|Clinical Deterioration|0|||
23622304|NCT02049515|66004872|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
23622305|NCT02049515|66004873|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
23622306|NCT02049515|66004872|FG000|Overall Study|Treatment Interruption >42 Days|1|||
23622307|NCT02049515|66004873|FG001|Overall Study|Treatment Interruption >42 Days|0|||
23432864|NCT00576472|65327730|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
23622308|NCT02049515|66004872|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
23622309|NCT02049515|66004873|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
23622310|NCT00570921|66004877|FG000|Overall Study|Protocol Violation|1|||
23622311|NCT00570921|66004877|FG000|Overall Study|Physician Decision|1|||
23622312|NCT02507687|66004878|FG000|Overall Study|Adverse Event|3|||
23622313|NCT02507687|66004879|FG001|Overall Study|Adverse Event|2|||
23622314|NCT02507687|66004880|FG002|Overall Study|Adverse Event|2|||
23622315|NCT02507687|66004881|FG003|Overall Study|Adverse Event|2|||
23622316|NCT02507687|66004878|FG000|Overall Study|Withdrawal by Subject|1|||
23622317|NCT02507687|66004879|FG001|Overall Study|Withdrawal by Subject|4|||
23622318|NCT02507687|66004880|FG002|Overall Study|Withdrawal by Subject|6|||
23622319|NCT02507687|66004881|FG003|Overall Study|Withdrawal by Subject|6|||
23622320|NCT02507687|66004878|FG000|Overall Study|Protocol Violation|1|||
23622321|NCT02507687|66004879|FG001|Overall Study|Protocol Violation|0|||
23622322|NCT02507687|66004880|FG002|Overall Study|Protocol Violation|2|||
23622323|NCT02507687|66004881|FG003|Overall Study|Protocol Violation|0|||
23555091|NCT04512066|65757984|FG000|Extension Period|Non-compliance with study drug|0|||
23555092|NCT04512066|65757985|FG001|Extension Period|Non-compliance with study drug|1|||
23555093|NCT04512066|65757986|FG002|Extension Period|Non-compliance with study drug|0|||
23555094|NCT04512066|65757987|FG003|Extension Period|Non-compliance with study drug|0|||
23555095|NCT04512066|65757988|FG004|Extension Period|Non-compliance with study drug|0|||
23555096|NCT04512066|65757989|FG005|Extension Period|Non-compliance with study drug|1|||
23555097|NCT04512066|65757984|FG000|Extension Period|Other|0|||
23555098|NCT04512066|65757985|FG001|Extension Period|Other|2|||
23555099|NCT04512066|65757986|FG002|Extension Period|Other|0|||
23555100|NCT04512066|65757987|FG003|Extension Period|Other|0|||
23555101|NCT04512066|65757988|FG004|Extension Period|Other|0|||
23555102|NCT04512066|65757989|FG005|Extension Period|Other|0|||
23555103|NCT04512066|65757984|FG000|Extension Period|Physician Decision|0|||
23555104|NCT04512066|65757985|FG001|Extension Period|Physician Decision|2|||
23555105|NCT04512066|65757986|FG002|Extension Period|Physician Decision|0|||
23555106|NCT04512066|65757987|FG003|Extension Period|Physician Decision|1|||
23555107|NCT04512066|65757988|FG004|Extension Period|Physician Decision|1|||
23555108|NCT04512066|65757989|FG005|Extension Period|Physician Decision|0|||
23555109|NCT04512066|65757984|FG000|Extension Period|Withdrawal by Subject|0|||
23555110|NCT04512066|65757985|FG001|Extension Period|Withdrawal by Subject|3|||
23555111|NCT04512066|65757986|FG002|Extension Period|Withdrawal by Subject|7|||
23555112|NCT04512066|65757987|FG003|Extension Period|Withdrawal by Subject|11|||
23555113|NCT04512066|65757988|FG004|Extension Period|Withdrawal by Subject|8|||
23622324|NCT02507687|66004878|FG000|Overall Study|Lost to Follow-up|0|||
23622325|NCT02507687|66004879|FG001|Overall Study|Lost to Follow-up|0|||
23622326|NCT02507687|66004880|FG002|Overall Study|Lost to Follow-up|2|||
23622327|NCT02507687|66004881|FG003|Overall Study|Lost to Follow-up|1|||
23432865|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23555114|NCT04512066|65757989|FG005|Extension Period|Withdrawal by Subject|4|||
23555115|NCT02178566|65757990|FG000|Overall Study|patient did not complete due to noncompliance|0|||
23555116|NCT02178566|65757991|FG001|Overall Study|patient did not complete due to noncompliance|1|||
23555117|NCT00645164|65757992|FG000|Overall Study|Lost to Follow-up|2|||
23555118|NCT00645164|65757992|FG000|Overall Study|Withdrawal by Subject|4|||
23622328|NCT02507687|66004878|FG000|Overall Study|Screen Failure|0|||
23622329|NCT02507687|66004879|FG001|Overall Study|Screen Failure|0|||
23555119|NCT00645164|65757992|FG000|Overall Study|Protocol Violation|1|||
23555120|NCT03489304|65757995|FG000|Overall Study|Lost to Follow-up|4|||
23622330|NCT02507687|66004880|FG002|Overall Study|Screen Failure|1|||
23622331|NCT02507687|66004881|FG003|Overall Study|Screen Failure|0|||
23622332|NCT02507687|66004878|FG000|Overall Study|Other, Not Specified|0|||
23622333|NCT02507687|66004879|FG001|Overall Study|Other, Not Specified|0|||
23622334|NCT02507687|66004880|FG002|Overall Study|Other, Not Specified|2|||
23622335|NCT02507687|66004881|FG003|Overall Study|Other, Not Specified|4|||
23622336|NCT03371485|66004882|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
23823256|NCT04439201|66734377|FG000|Overall Study|Disease progression|20|||
23823257|NCT04439201|66734377|FG000|Overall Study|Alternative therapy|1|||
23555121|NCT00952367|65757996|FG000|Overall Study|Withdrawal by Subject|2|||
23555122|NCT00952367|65757996|FG000|Overall Study|Noncoordination|1|||
23555123|NCT00952367|65757996|FG000|Overall Study|Protocol Violation|3|||
23555124|NCT00886340|65757999|FG000|Overall Study|Withdrawal by Subject|0|||
23555125|NCT00886340|65758000|FG001|Overall Study|Withdrawal by Subject|7|||
23555126|NCT02181803|65758004|FG000|Overall Study|Withdrawal by Subject|0|||
23555127|NCT02181803|65758005|FG001|Overall Study|Withdrawal by Subject|2|||
23555128|NCT02181803|65758006|FG002|Overall Study|Withdrawal by Subject|0|||
23823258|NCT04439201|66734377|FG000|Overall Study|Physician Decision|1|||
23823259|NCT00396812|66734380|FG000|Overall Study|Physician Decision|1|||
23823260|NCT03685344|66734383|FG000|Overall Study|Withdrawal by Subject|1|||
23555129|NCT02181803|65758007|FG003|Overall Study|Withdrawal by Subject|0|||
23823261|NCT03685344|66734384|FG001|Overall Study|Withdrawal by Subject|1|||
23823262|NCT03685344|66734385|FG002|Overall Study|Withdrawal by Subject|2|||
23823263|NCT03685344|66734386|FG003|Overall Study|Withdrawal by Subject|0|||
23823264|NCT03685344|66734383|FG000|Overall Study|Physician Decision|1|||
23823265|NCT03685344|66734384|FG001|Overall Study|Physician Decision|1|||
23823266|NCT03685344|66734385|FG002|Overall Study|Physician Decision|5|||
23823267|NCT03685344|66734386|FG003|Overall Study|Physician Decision|0|||
23823268|NCT03685344|66734383|FG000|Overall Study|Death|1|||
23823269|NCT03685344|66734384|FG001|Overall Study|Death|1|||
23823270|NCT03685344|66734385|FG002|Overall Study|Death|0|||
23823271|NCT03685344|66734386|FG003|Overall Study|Death|0|||
23823272|NCT01256502|66734387|FG000|Overall Study|Had scaffold removed|4|||
23823273|NCT01256502|66734387|FG000|Overall Study|Personal reasons|5|||
23823274|NCT01256502|66734387|FG000|Overall Study|Protocol deviation|1|||
23823275|NCT03296527|66734388|FG000|Overall Study|Adverse Event|15|||
23823276|NCT03296527|66734389|FG001|Overall Study|Adverse Event|33|||
23823277|NCT03296527|66734388|FG000|Overall Study|Protocol Deviation|4|||
23823278|NCT03296527|66734389|FG001|Overall Study|Protocol Deviation|0|||
23555130|NCT02181803|65758008|FG004|Overall Study|Withdrawal by Subject|0|||
23555131|NCT02181803|65758009|FG005|Overall Study|Withdrawal by Subject|0|||
23622337|NCT03371485|66004882|FG000|2-year Follow-up|Death|5|||
23622338|NCT03022578|66004884|FG000|Overall Study|Adverse Event|1|||
23622339|NCT03022578|66004884|FG000|Overall Study|Lack of Efficacy|2|||
23622340|NCT03022578|66004884|FG000|Overall Study|Withdrawal by Subject|1|||
23622341|NCT01004185|66004887|FG000|Overall Study|Adverse Event|1|||
23622342|NCT01004185|66004888|FG001|Overall Study|Adverse Event|1|||
23622343|NCT01004185|66004887|FG000|Overall Study|Lost to Follow-up|0|||
23622344|NCT01004185|66004888|FG001|Overall Study|Lost to Follow-up|1|||
23622345|NCT01004185|66004887|FG000|Overall Study|Lack of Efficacy|2|||
23622346|NCT01004185|66004888|FG001|Overall Study|Lack of Efficacy|1|||
23622347|NCT01004185|66004887|FG000|Overall Study|Sponsor Terminated Study|4|||
23622348|NCT01004185|66004888|FG001|Overall Study|Sponsor Terminated Study|5|||
23555132|NCT02181803|65758010|FG006|Overall Study|Withdrawal by Subject|0|||
23555133|NCT02181803|65758011|FG007|Overall Study|Withdrawal by Subject|0|||
23555134|NCT02181803|65758012|FG008|Overall Study|Withdrawal by Subject|0|||
23622349|NCT01004185|66004887|FG000|Overall Study|Withdrawal by Subject|2|||
23622350|NCT01004185|66004888|FG001|Overall Study|Withdrawal by Subject|1|||
23823279|NCT03296527|66734388|FG000|Overall Study|Participant withdrew consent|3|||
23823280|NCT03296527|66734389|FG001|Overall Study|Participant withdrew consent|1|||
23823281|NCT03296527|66734388|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
23823282|NCT03296527|66734389|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
23823283|NCT03296527|66734388|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
23823284|NCT03296527|66734389|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
23823285|NCT03296527|66734388|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
23843098|NCT01738503|66805581|FG000|Treatment Period|Protocol Violation|0|||
23555135|NCT02181803|65758004|FG000|Overall Study|Physician Decision|0|||
23555136|NCT02181803|65758005|FG001|Overall Study|Physician Decision|0|||
23432866|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432867|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23622351|NCT01101061|66004891|FG000|Overall Study|Adverse Event|0|||
23555137|NCT02181803|65758006|FG002|Overall Study|Physician Decision|0|||
23555138|NCT02181803|65758007|FG003|Overall Study|Physician Decision|1|||
23747484|NCT00539006|66457398|FG000|Washout|Failed to meet continuation criteria|16|||
23747485|NCT00539006|66457399|FG001|Washout|Failed to meet continuation criteria|5|||
23747486|NCT00539006|66457400|FG002|Washout|Failed to meet continuation criteria|14|||
23747487|NCT00539006|66457401|FG003|Washout|Failed to meet continuation criteria|6|||
23747488|NCT00539006|66457398|FG000|Washout|Other|1|||
23747489|NCT00539006|66457399|FG001|Washout|Other|1|||
23747490|NCT00539006|66457400|FG002|Washout|Other|2|||
23747491|NCT00539006|66457401|FG003|Washout|Other|3|||
23432868|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432869|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432870|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432871|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432872|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432873|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432874|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432875|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432876|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432877|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432878|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
23432879|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432880|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
23555139|NCT02181803|65758008|FG004|Overall Study|Physician Decision|0|||
23555140|NCT02181803|65758009|FG005|Overall Study|Physician Decision|0|||
23555141|NCT02181803|65758010|FG006|Overall Study|Physician Decision|0|||
23555142|NCT02181803|65758011|FG007|Overall Study|Physician Decision|1|||
23555143|NCT02181803|65758012|FG008|Overall Study|Physician Decision|0|||
23747492|NCT00539006|66457398|FG000|Treatment Period 2|Protocol Violation|1|||
23747493|NCT00539006|66457399|FG001|Treatment Period 2|Protocol Violation|0|||
23747494|NCT00539006|66457400|FG002|Treatment Period 2|Protocol Violation|0|||
23747495|NCT00539006|66457401|FG003|Treatment Period 2|Protocol Violation|0|||
23747496|NCT00539006|66457398|FG000|Treatment Period 2|Other|0|||
23555144|NCT02181803|65758004|FG000|Overall Study|Adverse Event|0|||
23747497|NCT00539006|66457399|FG001|Treatment Period 2|Other|1|||
23747498|NCT00539006|66457400|FG002|Treatment Period 2|Other|0|||
23747499|NCT00539006|66457401|FG003|Treatment Period 2|Other|0|||
23747500|NCT02222246|66457402|FG000|Overall Study|No Emergency Department Visits|27|||
23555145|NCT02181803|65758005|FG001|Overall Study|Adverse Event|2|||
23555146|NCT02181803|65758006|FG002|Overall Study|Adverse Event|0|||
23555147|NCT02181803|65758007|FG003|Overall Study|Adverse Event|1|||
23555148|NCT02181803|65758008|FG004|Overall Study|Adverse Event|0|||
23555149|NCT02181803|65758009|FG005|Overall Study|Adverse Event|0|||
23555150|NCT02181803|65758010|FG006|Overall Study|Adverse Event|1|||
23555151|NCT02181803|65758011|FG007|Overall Study|Adverse Event|0|||
23555152|NCT02181803|65758012|FG008|Overall Study|Adverse Event|0|||
23555153|NCT02487810|65758014|FG000|Overall Study|Withdrawal by Subject|1|||
23555154|NCT02487810|65758015|FG001|Overall Study|Withdrawal by Subject|0|||
23555155|NCT02732938|65758019|FG000|Overall Study|Death|0|||
23622352|NCT01101061|66004892|FG001|Overall Study|Adverse Event|0|||
23747501|NCT02222246|66457403|FG001|Overall Study|No Emergency Department Visits|26|||
23747502|NCT02222246|66457402|FG000|Overall Study|Physician Decision|0|||
23747503|NCT02222246|66457403|FG001|Overall Study|Physician Decision|1|||
23747504|NCT00877799|66457405|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
23747505|NCT00877799|66457406|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
23747506|NCT00877799|66457407|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
23747507|NCT00877799|66457408|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
23747508|NCT00877799|66457409|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
23747509|NCT00877799|66457405|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
23747510|NCT00877799|66457406|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
23747511|NCT00877799|66457407|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
23747512|NCT00877799|66457408|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
23747513|NCT00877799|66457409|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
23747514|NCT00877799|66457405|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23747515|NCT00877799|66457406|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
23747516|NCT00877799|66457407|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23747517|NCT00877799|66457408|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23747518|NCT00877799|66457409|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23432881|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
23747519|NCT00877799|66457405|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23747520|NCT00877799|66457406|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23747521|NCT00877799|66457407|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23747522|NCT00877799|66457408|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
23747523|NCT00877799|66457409|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23747524|NCT00877799|66457405|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23747525|NCT00877799|66457406|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23747526|NCT00877799|66457407|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23747527|NCT00877799|66457408|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
23747528|NCT00877799|66457409|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
23747529|NCT02322866|66457410|FG000|Overall Study|Adverse Event|6|||
23747530|NCT02322866|66457411|FG001|Overall Study|Adverse Event|11|||
23823286|NCT03296527|66734389|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
23823287|NCT03296527|66734388|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
23823288|NCT03296527|66734389|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
23432882|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
23432883|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
23432884|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
23432885|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
23432886|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
23747531|NCT02322866|66457410|FG000|Overall Study|Withdrawal of Consent|16|||
23823289|NCT03296527|66734388|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
23823290|NCT03296527|66734389|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
23823291|NCT03629184|66734390|FG000|Overall Study|Withdrawal by Subject|2|||
23823292|NCT03629184|66734391|FG001|Overall Study|Withdrawal by Subject|1|||
23823293|NCT03629184|66734390|FG000|Overall Study|Physician Decision|1|||
23823294|NCT03629184|66734391|FG001|Overall Study|Physician Decision|0|||
23823295|NCT01645787|66734392|FG000|Washout (2 Weeks)|Adverse Event|1|||
23823296|NCT01645787|66734393|FG001|Washout (2 Weeks)|Adverse Event|0|||
23823297|NCT00270855|66734405|FG000|Overall Study|Withdrawal by Subject|8|||
23823298|NCT00270855|66734406|FG001|Overall Study|Withdrawal by Subject|8|||
23823299|NCT02565511|66734409|FG000|Overall Study|Study terminated by Sponsor|35|||
23823300|NCT02565511|66734410|FG001|Overall Study|Study terminated by Sponsor|22|||
23823301|NCT02565511|66734411|FG002|Overall Study|Study terminated by Sponsor|235|||
23823302|NCT02565511|66734412|FG003|Overall Study|Study terminated by Sponsor|156|||
23823303|NCT02565511|66734409|FG000|Overall Study|Withdrawal by Subject|3|||
23823304|NCT02565511|66734410|FG001|Overall Study|Withdrawal by Subject|0|||
23823305|NCT02565511|66734411|FG002|Overall Study|Withdrawal by Subject|12|||
23823306|NCT02565511|66734412|FG003|Overall Study|Withdrawal by Subject|5|||
23823307|NCT02565511|66734409|FG000|Overall Study|Adverse Event|0|||
23823308|NCT02565511|66734410|FG001|Overall Study|Adverse Event|0|||
23823309|NCT02565511|66734411|FG002|Overall Study|Adverse Event|1|||
23823310|NCT02565511|66734412|FG003|Overall Study|Adverse Event|1|||
23823311|NCT02565511|66734409|FG000|Overall Study|Lost to Follow-up|4|||
23823312|NCT02565511|66734410|FG001|Overall Study|Lost to Follow-up|1|||
23823313|NCT02565511|66734411|FG002|Overall Study|Lost to Follow-up|0|||
23823314|NCT02565511|66734412|FG003|Overall Study|Lost to Follow-up|1|||
23823315|NCT02565511|66734409|FG000|Overall Study|Physician Decision|0|||
23823316|NCT02565511|66734410|FG001|Overall Study|Physician Decision|0|||
23823317|NCT02565511|66734411|FG002|Overall Study|Physician Decision|0|||
23823318|NCT02565511|66734412|FG003|Overall Study|Physician Decision|1|||
23823319|NCT02565511|66734409|FG000|Overall Study|Protocol deviation|0|||
23823320|NCT02565511|66734410|FG001|Overall Study|Protocol deviation|0|||
23747532|NCT02322866|66457411|FG001|Overall Study|Withdrawal of Consent|25|||
23747533|NCT02322866|66457410|FG000|Overall Study|Lost to Follow-up|36|||
23747534|NCT02322866|66457411|FG001|Overall Study|Lost to Follow-up|39|||
23747535|NCT02322866|66457410|FG000|Overall Study|Protocol Violation|1|||
23747536|NCT02322866|66457411|FG001|Overall Study|Protocol Violation|0|||
23747537|NCT02322866|66457410|FG000|Overall Study|Noncompliance with Treatment|3|||
23747538|NCT02322866|66457411|FG001|Overall Study|Noncompliance with Treatment|4|||
23747539|NCT02322866|66457410|FG000|Overall Study|Lack of Efficacy|3|||
23747540|NCT02322866|66457411|FG001|Overall Study|Lack of Efficacy|1|||
23747541|NCT02322866|66457410|FG000|Overall Study|Other Miscellaneous Reasons|6|||
23747542|NCT02322866|66457411|FG001|Overall Study|Other Miscellaneous Reasons|6|||
23747543|NCT03586427|66457412|FG000|Overall Study|Lost to Follow-up|0|||
23747544|NCT03586427|66457413|FG001|Overall Study|Lost to Follow-up|3|||
23747545|NCT03586427|66457414|FG002|Overall Study|Lost to Follow-up|1|||
23747546|NCT03586427|66457415|FG003|Overall Study|Lost to Follow-up|3|||
23747547|NCT03586427|66457416|FG004|Overall Study|Lost to Follow-up|3|||
23747548|NCT03586427|66457412|FG000|Overall Study|Withdrawal by Subject|0|||
23747549|NCT03586427|66457413|FG001|Overall Study|Withdrawal by Subject|1|||
23747550|NCT03586427|66457414|FG002|Overall Study|Withdrawal by Subject|2|||
23747551|NCT03586427|66457415|FG003|Overall Study|Withdrawal by Subject|1|||
23747552|NCT03586427|66457416|FG004|Overall Study|Withdrawal by Subject|1|||
23747553|NCT03586427|66457412|FG000|Overall Study|Adverse Event|0|||
23747554|NCT03586427|66457413|FG001|Overall Study|Adverse Event|0|||
23747555|NCT03586427|66457414|FG002|Overall Study|Adverse Event|1|||
23747556|NCT03586427|66457415|FG003|Overall Study|Adverse Event|0|||
23747557|NCT03586427|66457416|FG004|Overall Study|Adverse Event|0|||
23747558|NCT03586427|66457412|FG000|Overall Study|Protocol Violation|0|||
23747559|NCT03586427|66457413|FG001|Overall Study|Protocol Violation|0|||
23747560|NCT03586427|66457414|FG002|Overall Study|Protocol Violation|1|||
23747561|NCT03586427|66457415|FG003|Overall Study|Protocol Violation|0|||
23747562|NCT03586427|66457416|FG004|Overall Study|Protocol Violation|1|||
23747563|NCT03586427|66457412|FG000|Overall Study|Noncompliance with study drug|0|||
23747564|NCT03586427|66457413|FG001|Overall Study|Noncompliance with study drug|0|||
23747565|NCT03586427|66457414|FG002|Overall Study|Noncompliance with study drug|1|||
23747566|NCT03586427|66457415|FG003|Overall Study|Noncompliance with study drug|0|||
23747567|NCT03586427|66457416|FG004|Overall Study|Noncompliance with study drug|0|||
23747568|NCT01458535|66457422|FG000|Overall Study|Other|0|||
23747569|NCT01458535|66457423|FG001|Overall Study|Other|0|||
23747570|NCT01458535|66457424|FG002|Overall Study|Other|0|||
23747571|NCT01458535|66457425|FG003|Overall Study|Other|0|||
23747572|NCT01458535|66457426|FG004|Overall Study|Other|1|||
23747573|NCT01458535|66457427|FG005|Overall Study|Other|1|||
23747574|NCT01458535|66457422|FG000|Overall Study|Withdrawal by Subject|0|||
23747575|NCT01458535|66457423|FG001|Overall Study|Withdrawal by Subject|0|||
23747576|NCT01458535|66457424|FG002|Overall Study|Withdrawal by Subject|2|||
23747577|NCT01458535|66457425|FG003|Overall Study|Withdrawal by Subject|0|||
23747578|NCT01458535|66457426|FG004|Overall Study|Withdrawal by Subject|1|||
23747579|NCT01458535|66457427|FG005|Overall Study|Withdrawal by Subject|1|||
23747580|NCT01458535|66457422|FG000|Overall Study|Lost to Follow-up|0|||
23747581|NCT01458535|66457423|FG001|Overall Study|Lost to Follow-up|2|||
23747582|NCT01458535|66457424|FG002|Overall Study|Lost to Follow-up|0|||
23747583|NCT01458535|66457425|FG003|Overall Study|Lost to Follow-up|3|||
23747584|NCT01458535|66457426|FG004|Overall Study|Lost to Follow-up|2|||
23747585|NCT01458535|66457427|FG005|Overall Study|Lost to Follow-up|2|||
23747586|NCT01458535|66457422|FG000|Overall Study|Adverse Event|0|||
23747587|NCT01458535|66457423|FG001|Overall Study|Adverse Event|0|||
23747588|NCT01458535|66457424|FG002|Overall Study|Adverse Event|0|||
23747589|NCT01458535|66457425|FG003|Overall Study|Adverse Event|1|||
23747590|NCT01458535|66457426|FG004|Overall Study|Adverse Event|0|||
23747591|NCT01458535|66457427|FG005|Overall Study|Adverse Event|0|||
23747592|NCT01725217|66457428|FG000|Overall Study|Withdrawal by Subject|1|||
23747593|NCT01725217|66457429|FG001|Overall Study|Withdrawal by Subject|0|||
23747594|NCT01725217|66457430|FG002|Overall Study|Withdrawal by Subject|0|||
23747595|NCT03526549|66457431|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
23747596|NCT03526549|66457432|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
23747597|NCT03526549|66457431|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
23747598|NCT03526549|66457432|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
23747599|NCT03526549|66457431|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
23747600|NCT03526549|66457432|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
23747601|NCT03526549|66457431|FG000|Open-label Phase|Adverse Event|4|||
23747602|NCT03526549|66457432|FG001|Open-label Phase|Adverse Event|0|||
23747603|NCT03526549|66457431|FG000|Open-label Phase|Withdrawal by Subject|54|||
23747604|NCT03526549|66457432|FG001|Open-label Phase|Withdrawal by Subject|0|||
23747605|NCT03526549|66457431|FG000|Open-label Phase|Lost to Follow-up|35|||
23747606|NCT03526549|66457432|FG001|Open-label Phase|Lost to Follow-up|0|||
23747607|NCT03526549|66457431|FG000|Open-label Phase|Other than Specified|5|||
23747608|NCT03526549|66457432|FG001|Open-label Phase|Other than Specified|0|||
23747609|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
23747610|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
23747611|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747612|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747613|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747614|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747615|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747616|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747617|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747618|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747619|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747620|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23747621|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23747622|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747623|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747624|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747625|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747626|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747627|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23747628|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747629|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747630|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747631|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23747632|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23747633|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747634|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
23747635|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747636|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747637|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747638|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747639|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747640|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747641|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747642|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747643|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747644|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23747645|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
23747646|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
23747647|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
23747648|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
23747649|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
23747650|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
23747651|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
23747652|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
23747653|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
23747654|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
23747655|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
23747656|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
23747657|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747658|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747659|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747660|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747661|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747662|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
23747663|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747664|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747665|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747666|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747667|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747668|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23747669|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23622353|NCT01101061|66004893|FG002|Overall Study|Adverse Event|1|||
23747670|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747671|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747672|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747673|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747674|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
23747675|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747676|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747677|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747678|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747679|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747680|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23747681|NCT00151775|66457433|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747682|NCT00151775|66457434|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747683|NCT00151775|66457435|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747684|NCT00151775|66457436|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747685|NCT00151775|66457437|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747686|NCT00151775|66457438|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747687|NCT00151775|66457439|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
23747688|NCT00151775|66457440|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747689|NCT00151775|66457441|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747690|NCT00151775|66457442|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747691|NCT00151775|66457443|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747692|NCT00151775|66457444|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23747693|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747694|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747695|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747696|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747697|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747698|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
23747699|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747700|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747701|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747702|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747703|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747704|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23747705|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
23747706|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
23747707|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
23747708|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
23747709|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
23747710|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
23747711|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
23747712|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
23747713|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
23747714|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
23747715|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
23747716|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
23747717|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747718|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747719|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747720|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747721|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747722|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747723|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
23747724|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747725|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747726|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747727|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747728|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23747729|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747730|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747731|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
23747732|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747733|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747734|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747735|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747736|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23823321|NCT02565511|66734411|FG002|Overall Study|Protocol deviation|3|||
23823322|NCT02565511|66734412|FG003|Overall Study|Protocol deviation|0|||
23747737|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747738|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747739|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747740|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23747741|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747742|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747743|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
23747744|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747745|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747746|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747747|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747748|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747749|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747750|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747751|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747752|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23747753|NCT00151775|66457433|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747754|NCT00151775|66457434|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747755|NCT00151775|66457435|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747756|NCT00151775|66457436|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747757|NCT00151775|66457437|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747758|NCT00151775|66457438|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747759|NCT00151775|66457439|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747760|NCT00151775|66457440|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747761|NCT00151775|66457441|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747762|NCT00151775|66457442|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747763|NCT00151775|66457443|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23747764|NCT00151775|66457444|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
23747765|NCT00151775|66457433|FG000|Period 4: Open Label|Increased blood pressure|0|||
23747766|NCT00151775|66457434|FG001|Period 4: Open Label|Increased blood pressure|0|||
23747767|NCT00151775|66457435|FG002|Period 4: Open Label|Increased blood pressure|0|||
23747768|NCT00151775|66457436|FG003|Period 4: Open Label|Increased blood pressure|0|||
23747769|NCT00151775|66457437|FG004|Period 4: Open Label|Increased blood pressure|1|||
23747770|NCT00151775|66457438|FG005|Period 4: Open Label|Increased blood pressure|0|||
23747771|NCT00151775|66457439|FG006|Period 4: Open Label|Increased blood pressure|0|||
23747772|NCT00151775|66457440|FG007|Period 4: Open Label|Increased blood pressure|0|||
23747773|NCT00151775|66457441|FG008|Period 4: Open Label|Increased blood pressure|0|||
23747774|NCT00151775|66457442|FG009|Period 4: Open Label|Increased blood pressure|1|||
23747775|NCT00151775|66457443|FG010|Period 4: Open Label|Increased blood pressure|0|||
23747776|NCT00151775|66457444|FG011|Period 4: Open Label|Increased blood pressure|0|||
23747777|NCT00151775|66457433|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
23747778|NCT00151775|66457434|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
23747779|NCT00151775|66457435|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
23747780|NCT00151775|66457436|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
23747781|NCT00151775|66457437|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
23747782|NCT00151775|66457438|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
23747783|NCT00151775|66457439|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
23747784|NCT00151775|66457440|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
23747785|NCT00151775|66457441|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
23747786|NCT00151775|66457442|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
23747787|NCT00151775|66457443|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
23747788|NCT00151775|66457444|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
23747789|NCT00151775|66457433|FG000|Period 4: Open Label|Adverse Event|0|||
23747790|NCT00151775|66457434|FG001|Period 4: Open Label|Adverse Event|0|||
23747791|NCT00151775|66457435|FG002|Period 4: Open Label|Adverse Event|0|||
23747792|NCT00151775|66457436|FG003|Period 4: Open Label|Adverse Event|0|||
23747793|NCT00151775|66457437|FG004|Period 4: Open Label|Adverse Event|1|||
23823323|NCT00535405|66734413|FG000|Overall Study|Adverse Event|6|||
23823324|NCT00535405|66734414|FG001|Overall Study|Adverse Event|8|||
23747794|NCT00151775|66457438|FG005|Period 4: Open Label|Adverse Event|0|||
23747795|NCT00151775|66457439|FG006|Period 4: Open Label|Adverse Event|0|||
23747796|NCT00151775|66457440|FG007|Period 4: Open Label|Adverse Event|0|||
23747797|NCT00151775|66457441|FG008|Period 4: Open Label|Adverse Event|0|||
23823325|NCT00535405|66734415|FG002|Overall Study|Adverse Event|3|||
23823326|NCT00535405|66734416|FG003|Overall Study|Adverse Event|8|||
23747798|NCT00151775|66457442|FG009|Period 4: Open Label|Adverse Event|2|||
23432887|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
23432888|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
23432889|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
23432890|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
23432891|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
23432892|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
23432893|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
23432894|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
23432895|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
23432896|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
23432897|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
23432898|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
23432899|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
23432900|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
23622354|NCT01101061|66004894|FG003|Overall Study|Adverse Event|0|||
23622355|NCT01101061|66004895|FG004|Overall Study|Adverse Event|0|||
23747799|NCT00151775|66457443|FG010|Period 4: Open Label|Adverse Event|0|||
23432901|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
23432902|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
23432903|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
23432904|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
23432905|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
23432906|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
23432907|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
23432908|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
23432909|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
23432910|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Side effects|0|||
23432911|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Side effects|0|||
23432912|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Side effects|0|||
23747800|NCT00151775|66457444|FG011|Period 4: Open Label|Adverse Event|0|||
23622356|NCT01101061|66004896|FG005|Overall Study|Adverse Event|0|||
23622357|NCT00469859|66004897|FG000|Overall Study|Inevaluable|0|||
23622358|NCT00469859|66004898|FG001|Overall Study|Inevaluable|2|||
23622359|NCT03481556|66004899|FG000|Overall Study|Adverse Event|1|||
23622360|NCT03481556|66004900|FG001|Overall Study|Adverse Event|0|||
23622361|NCT03481556|66004901|FG002|Overall Study|Adverse Event|0|||
23622362|NCT03481556|66004902|FG003|Overall Study|Adverse Event|0|||
23622363|NCT03481556|66004899|FG000|Overall Study|Death|4|||
23622364|NCT03481556|66004900|FG001|Overall Study|Death|2|||
23622365|NCT03481556|66004901|FG002|Overall Study|Death|3|||
23622366|NCT03481556|66004902|FG003|Overall Study|Death|16|||
23622367|NCT03481556|66004899|FG000|Overall Study|Study Terminated by Sponsor|10|||
23622368|NCT03481556|66004900|FG001|Overall Study|Study Terminated by Sponsor|5|||
23622369|NCT03481556|66004901|FG002|Overall Study|Study Terminated by Sponsor|2|||
23622370|NCT03481556|66004902|FG003|Overall Study|Study Terminated by Sponsor|9|||
23747801|NCT00151775|66457433|FG000|Period 4: Open Label|Lost to Follow-up|0|||
23747802|NCT00151775|66457434|FG001|Period 4: Open Label|Lost to Follow-up|0|||
23432913|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Side effects|0|||
23747803|NCT00151775|66457435|FG002|Period 4: Open Label|Lost to Follow-up|0|||
23747804|NCT00151775|66457436|FG003|Period 4: Open Label|Lost to Follow-up|0|||
23747805|NCT00151775|66457437|FG004|Period 4: Open Label|Lost to Follow-up|17|||
23747806|NCT00151775|66457438|FG005|Period 4: Open Label|Lost to Follow-up|0|||
23747807|NCT00151775|66457439|FG006|Period 4: Open Label|Lost to Follow-up|0|||
23747808|NCT00151775|66457440|FG007|Period 4: Open Label|Lost to Follow-up|0|||
23747809|NCT00151775|66457441|FG008|Period 4: Open Label|Lost to Follow-up|0|||
23747810|NCT00151775|66457442|FG009|Period 4: Open Label|Lost to Follow-up|7|||
23747811|NCT00151775|66457443|FG010|Period 4: Open Label|Lost to Follow-up|0|||
23747812|NCT00151775|66457444|FG011|Period 4: Open Label|Lost to Follow-up|0|||
23747813|NCT00151775|66457433|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
23747814|NCT00151775|66457434|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
23747815|NCT00151775|66457435|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
23747816|NCT00151775|66457436|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
23747817|NCT00151775|66457437|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
23747818|NCT00151775|66457438|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
23747819|NCT00151775|66457439|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
23747820|NCT00151775|66457440|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
23747821|NCT00151775|66457441|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
23747822|NCT00151775|66457442|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
23747823|NCT00151775|66457443|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
23747824|NCT00151775|66457444|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
23747825|NCT00151775|66457433|FG000|Period 4: Open Label|Other|0|||
23747826|NCT00151775|66457434|FG001|Period 4: Open Label|Other|0|||
23747827|NCT00151775|66457435|FG002|Period 4: Open Label|Other|0|||
23747828|NCT00151775|66457436|FG003|Period 4: Open Label|Other|0|||
23747829|NCT00151775|66457437|FG004|Period 4: Open Label|Other|1|||
23747830|NCT00151775|66457438|FG005|Period 4: Open Label|Other|0|||
23747831|NCT00151775|66457439|FG006|Period 4: Open Label|Other|0|||
23747832|NCT00151775|66457440|FG007|Period 4: Open Label|Other|0|||
23747833|NCT00151775|66457441|FG008|Period 4: Open Label|Other|0|||
23747834|NCT00151775|66457442|FG009|Period 4: Open Label|Other|3|||
23747835|NCT00151775|66457443|FG010|Period 4: Open Label|Other|0|||
23747836|NCT00151775|66457444|FG011|Period 4: Open Label|Other|0|||
23747837|NCT00151775|66457433|FG000|Period 4: Open Label|Physician Decision|0|||
23823327|NCT00535405|66734417|FG004|Overall Study|Adverse Event|6|||
23555156|NCT02732938|65758020|FG001|Overall Study|Death|11|||
23555157|NCT02732938|65758021|FG002|Overall Study|Death|0|||
23555158|NCT02732938|65758019|FG000|Overall Study|Randomized but did not receive treatment|0|||
23555159|NCT02732938|65758020|FG001|Overall Study|Randomized but did not receive treatment|1|||
23555160|NCT02732938|65758021|FG002|Overall Study|Randomized but did not receive treatment|0|||
23555161|NCT02732938|65758019|FG000|Overall Study|Refused further follow-up|1|||
23555162|NCT02732938|65758020|FG001|Overall Study|Refused further follow-up|0|||
23555163|NCT02732938|65758021|FG002|Overall Study|Refused further follow-up|0|||
23555164|NCT02732938|65758019|FG000|Overall Study|Study terminated by sponsor|3|||
23622371|NCT00552513|66004903|FG000|Overall Study|Lost to Follow-up|5|||
23622372|NCT00552513|66004904|FG001|Overall Study|Lost to Follow-up|1|||
23622373|NCT03864341|66004905|FG000|Overall Study|Withdrawal by Subject|1|||
23622374|NCT02204319|66004909|FG000|Overall Study|Pregnancy|1|||
23622375|NCT02204319|66004909|FG000|Overall Study|Withdrawal by Subject|2|||
23622376|NCT02853305|66004910|FG000|Overall Study|Death|287|||
23622377|NCT02853305|66004911|FG001|Overall Study|Death|249|||
23622378|NCT02853305|66004912|FG002|Overall Study|Death|300|||
23622379|NCT02853305|66004910|FG000|Overall Study|Withdrawal by Subject|2|||
23622380|NCT02853305|66004911|FG001|Overall Study|Withdrawal by Subject|8|||
23622381|NCT02853305|66004912|FG002|Overall Study|Withdrawal by Subject|3|||
23622382|NCT02853305|66004910|FG000|Overall Study|Transferred to Extension Study|46|||
23622383|NCT02853305|66004911|FG001|Overall Study|Transferred to Extension Study|30|||
23622384|NCT02853305|66004912|FG002|Overall Study|Transferred to Extension Study|25|||
23622385|NCT02853305|66004910|FG000|Overall Study|Did Not Continue on Extension Study|16|||
23622386|NCT02853305|66004911|FG001|Overall Study|Did Not Continue on Extension Study|20|||
23622387|NCT02853305|66004912|FG002|Overall Study|Did Not Continue on Extension Study|24|||
23622388|NCT00848393|66004915|FG000|Overall Study|Protocol Violation|0|||
23622389|NCT00848393|66004916|FG001|Overall Study|Protocol Violation|0|||
23622390|NCT00848393|66004917|FG002|Overall Study|Protocol Violation|1|||
23622391|NCT00848393|66004915|FG000|Overall Study|surgical complications unrelated to stud|0|||
23622392|NCT00848393|66004916|FG001|Overall Study|surgical complications unrelated to stud|0|||
23622393|NCT00848393|66004917|FG002|Overall Study|surgical complications unrelated to stud|2|||
23622394|NCT02972242|66004920|FG000|Overall Study|Withdrawal by Subject|1|||
23622395|NCT02972242|66004921|FG001|Overall Study|Withdrawal by Subject|0|||
23622396|NCT01281917|66004922|FG000|Overall Study|Withdrawal by Subject|1|||
23622397|NCT02633397|66004926|FG000|Overall Study|Adverse Event|8|||
23622398|NCT02633397|66004927|FG001|Overall Study|Adverse Event|8|||
23622399|NCT02633397|66004926|FG000|Overall Study|Study Burden|4|||
23622400|NCT02633397|66004927|FG001|Overall Study|Study Burden|1|||
23622401|NCT02633397|66004926|FG000|Overall Study|Treatment interruption|2|||
23622402|NCT02633397|66004927|FG001|Overall Study|Treatment interruption|5|||
23622403|NCT02633397|66004926|FG000|Overall Study|Death|2|||
23622404|NCT02633397|66004927|FG001|Overall Study|Death|2|||
23622405|NCT02633397|66004926|FG000|Overall Study|Physician Decision|0|||
23622406|NCT02633397|66004927|FG001|Overall Study|Physician Decision|1|||
23622407|NCT04353817|66004928|FG000|Overall Study|Adverse Event|0|||
23622408|NCT04353817|66004929|FG001|Overall Study|Adverse Event|1|||
23622409|NCT01222533|66004930|FG000|Overall Study|Adverse Event|5|||
23622410|NCT01222533|66004930|FG000|Overall Study|Withdrawal by Subject|5|||
23622411|NCT01222533|66004930|FG000|Overall Study|Other|4|||
23622412|NCT00519285|66004931|FG000|Overall Study|Adverse Event|127|||
23622413|NCT00519285|66004932|FG001|Overall Study|Adverse Event|266|||
23622414|NCT00519285|66004931|FG000|Overall Study|Disease progression|334|||
23622415|NCT00519285|66004932|FG001|Overall Study|Disease progression|186|||
23622416|NCT00519285|66004931|FG000|Overall Study|Physician Decision|75|||
23622417|NCT00519285|66004932|FG001|Overall Study|Physician Decision|47|||
23622418|NCT00519285|66004931|FG000|Overall Study|Participant's request|53|||
23622419|NCT00519285|66004932|FG001|Overall Study|Participant's request|84|||
23622420|NCT00519285|66004931|FG000|Overall Study|Consent withdrawn|4|||
23622421|NCT00519285|66004932|FG001|Overall Study|Consent withdrawn|5|||
23747838|NCT00151775|66457434|FG001|Period 4: Open Label|Physician Decision|0|||
23622422|NCT00519285|66004931|FG000|Overall Study|Poor compliance to protocol|5|||
23622423|NCT00519285|66004932|FG001|Overall Study|Poor compliance to protocol|7|||
23622424|NCT00519285|66004931|FG000|Overall Study|Reason unspecified|5|||
23622425|NCT00519285|66004932|FG001|Overall Study|Reason unspecified|8|||
23622426|NCT00519285|66004931|FG000|Overall Study|Not treated|8|||
23622427|NCT00519285|66004932|FG001|Overall Study|Not treated|7|||
23622428|NCT00519285|66004931|FG000|Overall Study|Treatment ongoing|1|||
23622429|NCT00519285|66004932|FG001|Overall Study|Treatment ongoing|2|||
23622430|NCT03269695|66004933|FG000|Overall Study|Adverse Event|2|||
23622431|NCT03269695|66004934|FG001|Overall Study|Adverse Event|1|||
23622432|NCT03269695|66004933|FG000|Overall Study|Lack of Efficacy|0|||
23622433|NCT03269695|66004934|FG001|Overall Study|Lack of Efficacy|1|||
23622434|NCT03269695|66004933|FG000|Overall Study|Withdrawal by Subject|0|||
23622435|NCT03269695|66004934|FG001|Overall Study|Withdrawal by Subject|1|||
23622436|NCT02246218|66004935|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23622437|NCT02246218|66004936|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23622438|NCT02246218|66004935|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
23622439|NCT02246218|66004936|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
23622440|NCT02246218|66004935|FG000|Overall Study|Adverse Event|1|||
23622441|NCT02246218|66004936|FG001|Overall Study|Adverse Event|1|||
23622442|NCT02246218|66004935|FG000|Overall Study|Lost to Follow-up|1|||
23622443|NCT02246218|66004936|FG001|Overall Study|Lost to Follow-up|0|||
23622444|NCT01880437|66004937|FG000|Overall Study|Death|12|||
23622445|NCT01880437|66004938|FG001|Overall Study|Death|4|||
23622446|NCT01880437|66004939|FG002|Overall Study|Death|17|||
23622447|NCT01880437|66004937|FG000|Overall Study|Study terminated by Sponsor|3|||
23622448|NCT01880437|66004938|FG001|Overall Study|Study terminated by Sponsor|0|||
23622449|NCT01880437|66004939|FG002|Overall Study|Study terminated by Sponsor|2|||
23622450|NCT00591409|66004940|FG000|Overall Study|Not Treated|0|||
23622451|NCT00591409|66004941|FG001|Overall Study|Not Treated|0|||
23622452|NCT00591409|66004942|FG002|Overall Study|Not Treated|0|||
23622453|NCT00591409|66004943|FG003|Overall Study|Not Treated|0|||
23622454|NCT00591409|66004944|FG004|Overall Study|Not Treated|1|||
23622455|NCT00591409|66004945|FG005|Overall Study|Not Treated|0|||
23622456|NCT00591409|66004946|FG006|Overall Study|Not Treated|0|||
23622457|NCT00591409|66004947|FG007|Overall Study|Not Treated|0|||
23622458|NCT00591409|66004948|FG008|Overall Study|Not Treated|0|||
23622459|NCT00591409|66004949|FG009|Overall Study|Not Treated|1|||
23622460|NCT00349622|66004952|FG000|Overall Study|Death|168|||
23622461|NCT00349622|66004953|FG001|Overall Study|Death|86|||
23622462|NCT00349622|66004952|FG000|Overall Study|Lost to Follow-up|5|||
23622463|NCT00349622|66004953|FG001|Overall Study|Lost to Follow-up|1|||
23622464|NCT00349622|66004952|FG000|Overall Study|Withdrawal by Subject|5|||
23622465|NCT00349622|66004953|FG001|Overall Study|Withdrawal by Subject|9|||
23622466|NCT02482935|66004956|FG000|Period 1|Withdrawal by Subject|1|||
23622467|NCT02482935|66004957|FG001|Period 1|Withdrawal by Subject|0|||
23622468|NCT01388478|66004962|FG000|Overall Study|Adverse Event|4|||
23622469|NCT01388478|66004962|FG000|Overall Study|Withdrawal by Subject|1|||
23622470|NCT01874665|66004963|FG000|Overall Study|Adverse Event|6|||
23622471|NCT01874665|66004964|FG001|Overall Study|Adverse Event|2|||
23622472|NCT01874665|66004963|FG000|Overall Study|Withdrawal by Subject|4|||
23622473|NCT01874665|66004964|FG001|Overall Study|Withdrawal by Subject|1|||
23622474|NCT01874665|66004963|FG000|Overall Study|Physician Decision|3|||
23622475|NCT01874665|66004964|FG001|Overall Study|Physician Decision|0|||
23622476|NCT01874665|66004963|FG000|Overall Study|Clinical Progressive Disease|4|||
23622477|NCT01874665|66004964|FG001|Overall Study|Clinical Progressive Disease|3|||
23622478|NCT01874665|66004963|FG000|Overall Study|Study Terminated by Sponsor|0|||
23622479|NCT01874665|66004964|FG001|Overall Study|Study Terminated by Sponsor|2|||
23747839|NCT00151775|66457435|FG002|Period 4: Open Label|Physician Decision|0|||
23747840|NCT00151775|66457436|FG003|Period 4: Open Label|Physician Decision|0|||
23622480|NCT01874665|66004963|FG000|Overall Study|Documented Progressive Disease|11|||
23747841|NCT00151775|66457437|FG004|Period 4: Open Label|Physician Decision|0|||
23747842|NCT00151775|66457438|FG005|Period 4: Open Label|Physician Decision|0|||
23747843|NCT00151775|66457439|FG006|Period 4: Open Label|Physician Decision|0|||
23747844|NCT00151775|66457440|FG007|Period 4: Open Label|Physician Decision|0|||
23747845|NCT00151775|66457441|FG008|Period 4: Open Label|Physician Decision|0|||
23747846|NCT00151775|66457442|FG009|Period 4: Open Label|Physician Decision|2|||
23747847|NCT00151775|66457443|FG010|Period 4: Open Label|Physician Decision|0|||
23747848|NCT00151775|66457444|FG011|Period 4: Open Label|Physician Decision|0|||
23747849|NCT00151775|66457433|FG000|Period 4: Open Label|Protocol Violation|0|||
23747850|NCT00151775|66457434|FG001|Period 4: Open Label|Protocol Violation|0|||
23747851|NCT00151775|66457435|FG002|Period 4: Open Label|Protocol Violation|0|||
23747852|NCT00151775|66457436|FG003|Period 4: Open Label|Protocol Violation|0|||
23747853|NCT00151775|66457437|FG004|Period 4: Open Label|Protocol Violation|1|||
23747854|NCT00151775|66457438|FG005|Period 4: Open Label|Protocol Violation|0|||
23747855|NCT00151775|66457439|FG006|Period 4: Open Label|Protocol Violation|0|||
23747856|NCT00151775|66457440|FG007|Period 4: Open Label|Protocol Violation|0|||
23747857|NCT00151775|66457441|FG008|Period 4: Open Label|Protocol Violation|0|||
23747858|NCT00151775|66457442|FG009|Period 4: Open Label|Protocol Violation|0|||
23747859|NCT00151775|66457443|FG010|Period 4: Open Label|Protocol Violation|0|||
23747860|NCT00151775|66457444|FG011|Period 4: Open Label|Protocol Violation|0|||
23747861|NCT03466060|66457445|FG000|Period 1|Test Lens Damage|0|||
23747862|NCT03466060|66457446|FG001|Period 1|Test Lens Damage|2|||
23747863|NCT03466060|66457447|FG002|Period 1|Test Lens Damage|0|||
23747864|NCT03466060|66457448|FG003|Period 1|Test Lens Damage|0|||
23747865|NCT03466060|66457449|FG004|Period 1|Test Lens Damage|0|||
23823328|NCT00535405|66734413|FG000|Overall Study|Lost to Follow-up|1|||
23823329|NCT00535405|66734414|FG001|Overall Study|Lost to Follow-up|3|||
23823330|NCT00535405|66734415|FG002|Overall Study|Lost to Follow-up|3|||
23823331|NCT00535405|66734416|FG003|Overall Study|Lost to Follow-up|2|||
23823332|NCT00535405|66734417|FG004|Overall Study|Lost to Follow-up|1|||
23823333|NCT00535405|66734413|FG000|Overall Study|Physician Decision|3|||
23823334|NCT00535405|66734414|FG001|Overall Study|Physician Decision|2|||
23823335|NCT00535405|66734415|FG002|Overall Study|Physician Decision|0|||
23823336|NCT00535405|66734416|FG003|Overall Study|Physician Decision|1|||
23823337|NCT00535405|66734417|FG004|Overall Study|Physician Decision|1|||
23823338|NCT00535405|66734413|FG000|Overall Study|Protocol Violation|2|||
23823339|NCT00535405|66734414|FG001|Overall Study|Protocol Violation|2|||
23823340|NCT00535405|66734415|FG002|Overall Study|Protocol Violation|2|||
23823341|NCT00535405|66734416|FG003|Overall Study|Protocol Violation|1|||
23823342|NCT00535405|66734417|FG004|Overall Study|Protocol Violation|0|||
23823343|NCT00535405|66734413|FG000|Overall Study|Withdrawal by Subject|5|||
23823344|NCT00535405|66734414|FG001|Overall Study|Withdrawal by Subject|11|||
23823345|NCT00535405|66734415|FG002|Overall Study|Withdrawal by Subject|10|||
23823346|NCT00535405|66734416|FG003|Overall Study|Withdrawal by Subject|10|||
23823347|NCT00535405|66734417|FG004|Overall Study|Withdrawal by Subject|8|||
23823348|NCT01198132|66734419|FG000|Overall Study|Withdrawal by Subject|4|||
23823349|NCT01198132|66734420|FG001|Overall Study|Withdrawal by Subject|5|||
23823350|NCT01198132|66734419|FG000|Overall Study|Physician Decision|5|||
23823351|NCT01198132|66734420|FG001|Overall Study|Physician Decision|4|||
23747866|NCT03466060|66457450|FG005|Period 1|Test Lens Damage|0|||
23747867|NCT03466060|66457445|FG000|Period 1|Withdrawal by Subject|0|||
23747868|NCT03466060|66457446|FG001|Period 1|Withdrawal by Subject|0|||
23747869|NCT03466060|66457447|FG002|Period 1|Withdrawal by Subject|2|||
23747870|NCT03466060|66457448|FG003|Period 1|Withdrawal by Subject|0|||
23747871|NCT03466060|66457449|FG004|Period 1|Withdrawal by Subject|0|||
23747872|NCT03466060|66457450|FG005|Period 1|Withdrawal by Subject|0|||
23747873|NCT03466060|66457445|FG000|Period 1|Lost to Follow-up|0|||
23747874|NCT03466060|66457446|FG001|Period 1|Lost to Follow-up|0|||
23823352|NCT01198132|66734419|FG000|Overall Study|Other Unspecified|3|||
23432914|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Side effects|0|||
23823353|NCT01198132|66734420|FG001|Overall Study|Other Unspecified|6|||
23823354|NCT01198132|66734419|FG000|Overall Study|Lack of Efficacy|2|||
23747875|NCT03466060|66457447|FG002|Period 1|Lost to Follow-up|0|||
23823355|NCT01198132|66734420|FG001|Overall Study|Lack of Efficacy|3|||
23747876|NCT03466060|66457448|FG003|Period 1|Lost to Follow-up|1|||
23747877|NCT03466060|66457449|FG004|Period 1|Lost to Follow-up|0|||
23747878|NCT03466060|66457450|FG005|Period 1|Lost to Follow-up|0|||
23747879|NCT03466060|66457445|FG000|Period 1|Grade 2 Conjunctivitis|0|||
23747880|NCT03466060|66457446|FG001|Period 1|Grade 2 Conjunctivitis|0|||
23747881|NCT03466060|66457447|FG002|Period 1|Grade 2 Conjunctivitis|1|||
23747882|NCT03466060|66457448|FG003|Period 1|Grade 2 Conjunctivitis|0|||
23747883|NCT03466060|66457449|FG004|Period 1|Grade 2 Conjunctivitis|0|||
23747884|NCT03466060|66457450|FG005|Period 1|Grade 2 Conjunctivitis|0|||
23747885|NCT03466060|66457445|FG000|Period 2|Lens Handling Difficulties|0|||
23747886|NCT03466060|66457446|FG001|Period 2|Lens Handling Difficulties|0|||
23747887|NCT03466060|66457447|FG002|Period 2|Lens Handling Difficulties|1|||
23747888|NCT03466060|66457448|FG003|Period 2|Lens Handling Difficulties|0|||
23747889|NCT03466060|66457449|FG004|Period 2|Lens Handling Difficulties|0|||
23747890|NCT03466060|66457450|FG005|Period 2|Lens Handling Difficulties|0|||
23747891|NCT04456998|66457453|FG000|Overall Study|Adverse Event|0|||
23747892|NCT04456998|66457454|FG001|Overall Study|Adverse Event|4|||
23747893|NCT04456998|66457453|FG000|Overall Study|Protocol Deviation|0|||
23747894|NCT04456998|66457454|FG001|Overall Study|Protocol Deviation|1|||
23747895|NCT04456998|66457453|FG000|Overall Study|Withdrawal by Subject|0|||
23747896|NCT04456998|66457454|FG001|Overall Study|Withdrawal by Subject|1|||
23747897|NCT00910000|66457457|FG000|Overall Study|Adverse Event|0|||
23823356|NCT01198132|66734419|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
23823357|NCT01198132|66734420|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
23823358|NCT01198132|66734419|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
23823359|NCT01198132|66734420|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
23823360|NCT01198132|66734419|FG000|Overall Study|Adverse Event|0|||
23823361|NCT01198132|66734420|FG001|Overall Study|Adverse Event|1|||
23823362|NCT01198132|66734419|FG000|Overall Study|Protocol Violation|1|||
23823363|NCT01198132|66734420|FG001|Overall Study|Protocol Violation|0|||
23823364|NCT00996489|66734422|FG000|Overall Study|Device failure|45|||
23823365|NCT00996489|66734422|FG000|Overall Study|Discontinued|116|||
23823366|NCT03257865|66734423|FG000|Overall Study|Adverse Event|4|||
23823367|NCT03257865|66734424|FG001|Overall Study|Adverse Event|8|||
23823368|NCT03257865|66734423|FG000|Overall Study|Lack of Efficacy|1|||
23823369|NCT03257865|66734424|FG001|Overall Study|Lack of Efficacy|2|||
23823370|NCT03257865|66734423|FG000|Overall Study|Non-compliance with Study Drug|0|||
23823371|NCT03257865|66734424|FG001|Overall Study|Non-compliance with Study Drug|2|||
23823372|NCT03257865|66734423|FG000|Overall Study|Withdrawal by Subject|23|||
23823373|NCT03257865|66734424|FG001|Overall Study|Withdrawal by Subject|17|||
23823374|NCT03257865|66734423|FG000|Overall Study|Physician Decision|3|||
23823375|NCT03257865|66734424|FG001|Overall Study|Physician Decision|1|||
23823376|NCT03257865|66734423|FG000|Overall Study|Other|0|||
23823377|NCT03257865|66734424|FG001|Overall Study|Other|1|||
23823378|NCT03257865|66734423|FG000|Overall Study|Lost to Follow-up|4|||
23823379|NCT03257865|66734424|FG001|Overall Study|Lost to Follow-up|4|||
23823380|NCT03142191|66734428|FG000|Placebo Controlled Period|Death|0|||
23823381|NCT03142191|66734429|FG001|Placebo Controlled Period|Death|1|||
23823382|NCT03142191|66734430|FG002|Placebo Controlled Period|Death|1|||
23823383|NCT03142191|66734431|FG003|Placebo Controlled Period|Death|0|||
23823384|NCT03142191|66734432|FG004|Placebo Controlled Period|Death|0|||
23823385|NCT03142191|66734428|FG000|Placebo Controlled Period|Adverse Event|4|||
23823386|NCT03142191|66734429|FG001|Placebo Controlled Period|Adverse Event|5|||
23823387|NCT03142191|66734430|FG002|Placebo Controlled Period|Adverse Event|1|||
23432915|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Side effects|0|||
23432916|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Side effects|0|||
23432917|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Side effects|0|||
23432918|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Side effects|0|||
23432919|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Side effects|0|||
23432920|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Side effects|0|||
23432921|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Side effects|0|||
23432922|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Side effects|0|||
23747898|NCT00910000|66457458|FG001|Overall Study|Adverse Event|3|||
23747899|NCT00910000|66457459|FG002|Overall Study|Adverse Event|2|||
23747900|NCT00910000|66457460|FG003|Overall Study|Adverse Event|2|||
23747901|NCT00910000|66457461|FG004|Overall Study|Adverse Event|0|||
23747902|NCT00910000|66457462|FG005|Overall Study|Adverse Event|1|||
23747903|NCT00910000|66457457|FG000|Overall Study|Withdrawal by Subject|0|||
23747904|NCT00910000|66457458|FG001|Overall Study|Withdrawal by Subject|0|||
23747905|NCT00910000|66457459|FG002|Overall Study|Withdrawal by Subject|1|||
23747906|NCT00910000|66457460|FG003|Overall Study|Withdrawal by Subject|0|||
23747907|NCT00910000|66457461|FG004|Overall Study|Withdrawal by Subject|1|||
23747908|NCT00910000|66457462|FG005|Overall Study|Withdrawal by Subject|0|||
23823388|NCT03142191|66734431|FG003|Placebo Controlled Period|Adverse Event|0|||
23823389|NCT03142191|66734432|FG004|Placebo Controlled Period|Adverse Event|0|||
23747909|NCT01463631|66457469|FG000|Overall Study|Withdrawal by Subject|0|||
23747910|NCT01463631|66457470|FG001|Overall Study|Withdrawal by Subject|0|||
23747911|NCT01463631|66457471|FG002|Overall Study|Withdrawal by Subject|0|||
23747912|NCT01463631|66457472|FG003|Overall Study|Withdrawal by Subject|1|||
23823390|NCT03142191|66734428|FG000|Placebo Controlled Period|Progressive Disease|1|||
23823391|NCT03142191|66734429|FG001|Placebo Controlled Period|Progressive Disease|0|||
23823392|NCT03142191|66734430|FG002|Placebo Controlled Period|Progressive Disease|1|||
23747913|NCT01463631|66457469|FG000|Overall Study|Death|0|||
23747914|NCT01463631|66457470|FG001|Overall Study|Death|0|||
23747915|NCT01463631|66457471|FG002|Overall Study|Death|1|||
23747916|NCT01463631|66457472|FG003|Overall Study|Death|0|||
23747917|NCT01463631|66457469|FG000|Overall Study|Progressive Disease|0|||
23747918|NCT01463631|66457470|FG001|Overall Study|Progressive Disease|0|||
23747919|NCT01463631|66457471|FG002|Overall Study|Progressive Disease|0|||
23555165|NCT02732938|65758020|FG001|Overall Study|Study terminated by sponsor|6|||
23747920|NCT01463631|66457472|FG003|Overall Study|Progressive Disease|5|||
23747921|NCT01803464|66457473|FG000|Overall Study|Incomplete data|0|||
23747922|NCT01803464|66457474|FG001|Overall Study|Incomplete data|0|||
23747923|NCT01803464|66457475|FG002|Overall Study|Incomplete data|4|||
23747924|NCT01803464|66457476|FG003|Overall Study|Incomplete data|0|||
23823393|NCT03142191|66734431|FG003|Placebo Controlled Period|Progressive Disease|0|||
23555166|NCT02732938|65758021|FG002|Overall Study|Study terminated by sponsor|0|||
23747925|NCT01803464|66457473|FG000|Overall Study|Withdrawal by Subject|1|||
23747926|NCT01803464|66457474|FG001|Overall Study|Withdrawal by Subject|0|||
23555167|NCT05159622|65758022|FG000|Overall Study|Lost to Follow-up|4|||
23555168|NCT05159622|65758023|FG001|Overall Study|Lost to Follow-up|5|||
23823394|NCT03142191|66734432|FG004|Placebo Controlled Period|Progressive Disease|0|||
23823395|NCT03142191|66734428|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
23823396|NCT03142191|66734429|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
23622481|NCT01874665|66004964|FG001|Overall Study|Documented Progressive Disease|7|||
23622482|NCT01874665|66004963|FG000|Overall Study|Other|2|||
23747927|NCT01803464|66457475|FG002|Overall Study|Withdrawal by Subject|0|||
23747928|NCT01803464|66457476|FG003|Overall Study|Withdrawal by Subject|0|||
23747929|NCT02769832|66457477|FG000|Overall Study|Death|30|||
23747930|NCT01682681|66457478|FG000|Overall Study|Lack of Efficacy|62|||
23747931|NCT01682681|66457478|FG000|Overall Study|Withdrawal by Subject|1|||
23747932|NCT01682681|66457478|FG000|Overall Study|Moved to other hospital|10|||
23747933|NCT01682681|66457478|FG000|Overall Study|Lost to Follow-up|174|||
23823397|NCT03142191|66734430|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
23823398|NCT03142191|66734431|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
23747934|NCT01682681|66457478|FG000|Overall Study|Adverse Event|46|||
23747935|NCT01682681|66457478|FG000|Overall Study|tapering of topiramate|5|||
23747936|NCT01682681|66457478|FG000|Overall Study|Other|21|||
23747937|NCT01682681|66457478|FG000|Overall Study|Low compliance|13|||
23747938|NCT04768881|66457479|FG000|Overall Study|Completed Study Follow-up|0|||
23747939|NCT04768881|66457480|FG001|Overall Study|Completed Study Follow-up|2|||
23747940|NCT04768881|66457479|FG000|Overall Study|Death|3|||
23747941|NCT04768881|66457480|FG001|Overall Study|Death|2|||
23747942|NCT04768881|66457479|FG000|Overall Study|Study Terminated by Sponsor|2|||
23747943|NCT04768881|66457480|FG001|Overall Study|Study Terminated by Sponsor|2|||
23747944|NCT04768881|66457479|FG000|Overall Study|Withdrawal by Subject|2|||
23823399|NCT03142191|66734432|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
23823400|NCT03142191|66734428|FG000|Placebo Controlled Period|Other Reasons|1|||
23823401|NCT03142191|66734429|FG001|Placebo Controlled Period|Other Reasons|0|||
23823402|NCT03142191|66734430|FG002|Placebo Controlled Period|Other Reasons|0|||
23823403|NCT03142191|66734431|FG003|Placebo Controlled Period|Other Reasons|0|||
23622483|NCT01874665|66004964|FG001|Overall Study|Other|0|||
23622484|NCT02971228|66004965|FG000|Overall Study|Withdrawal by Subject|1|||
23622485|NCT02971228|66004966|FG001|Overall Study|Withdrawal by Subject|1|||
23622486|NCT02971228|66004967|FG002|Overall Study|Withdrawal by Subject|0|||
23747945|NCT04768881|66457480|FG001|Overall Study|Withdrawal by Subject|0|||
23747946|NCT04768881|66457479|FG000|Overall Study|Other|2|||
23747947|NCT04768881|66457480|FG001|Overall Study|Other|0|||
23747948|NCT00678652|66457481|FG000|Overall Study|Protocol Violation|2|||
23747949|NCT00678652|66457482|FG001|Overall Study|Protocol Violation|0|||
23747950|NCT00678652|66457483|FG002|Overall Study|Protocol Violation|0|||
23747951|NCT00678652|66457484|FG003|Overall Study|Protocol Violation|0|||
23747952|NCT00678652|66457481|FG000|Overall Study|Pregnancy|0|||
23747953|NCT00678652|66457482|FG001|Overall Study|Pregnancy|0|||
23747954|NCT00678652|66457483|FG002|Overall Study|Pregnancy|1|||
23747955|NCT00678652|66457484|FG003|Overall Study|Pregnancy|0|||
23747956|NCT00678652|66457481|FG000|Overall Study|Relocation|1|||
23747957|NCT00678652|66457482|FG001|Overall Study|Relocation|0|||
23747958|NCT00678652|66457483|FG002|Overall Study|Relocation|0|||
23747959|NCT00678652|66457484|FG003|Overall Study|Relocation|0|||
23823404|NCT03142191|66734432|FG004|Placebo Controlled Period|Other Reasons|0|||
23823405|NCT03142191|66734428|FG000|Active Treatment Extension Period|Death|2|||
23823406|NCT03142191|66734429|FG001|Active Treatment Extension Period|Death|1|||
23622487|NCT02971228|66004968|FG003|Overall Study|Withdrawal by Subject|0|||
23747960|NCT01165424|66457493|FG000|Overall Study|Clinical adverse experiences|1|||
23747961|NCT01165424|66457493|FG000|Overall Study|Laboratory adverse experiences|1|||
23747962|NCT01165424|66457493|FG000|Overall Study|Did not meet entry criteria|1|||
23747963|NCT01165424|66457493|FG000|Overall Study|Participant moved (relocated)|1|||
23622488|NCT02971228|66004969|FG004|Overall Study|Withdrawal by Subject|0|||
23747964|NCT04113746|66457495|FG000|Overall Study|Lost to Follow-up|4|||
23747965|NCT04113746|66457496|FG001|Overall Study|Lost to Follow-up|4|||
23747966|NCT01153971|66457497|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
23747967|NCT01153971|66457497|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
23747968|NCT01153971|66457497|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
23747969|NCT01153971|66457497|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
23747970|NCT01153971|66457497|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
23747971|NCT01153971|66457497|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
23747972|NCT01153971|66457497|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
23747973|NCT00822237|66457498|FG000|Dose 1 Vaccination|Not vaccinated|3|||
23747974|NCT00822237|66457499|FG001|Dose 1 Vaccination|Not vaccinated|0|||
23432923|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Side effects|0|||
23432924|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Side effects|8|||
23555169|NCT03076970|65758024|FG000|Washout Period 2|Adverse Event|0|||
23555170|NCT03076970|65758025|FG001|Washout Period 2|Adverse Event|0|||
23555171|NCT03076970|65758026|FG002|Washout Period 2|Adverse Event|0|||
23555172|NCT03076970|65758027|FG003|Washout Period 2|Adverse Event|0|||
23555173|NCT03076970|65758028|FG004|Washout Period 2|Adverse Event|1|||
23555174|NCT03076970|65758029|FG005|Washout Period 2|Adverse Event|0|||
23555175|NCT03076970|65758024|FG000|Period 3|Withdrawal by Subject|0|||
23555176|NCT03076970|65758025|FG001|Period 3|Withdrawal by Subject|0|||
23555177|NCT03076970|65758026|FG002|Period 3|Withdrawal by Subject|0|||
23555178|NCT03076970|65758027|FG003|Period 3|Withdrawal by Subject|0|||
23555179|NCT03076970|65758028|FG004|Period 3|Withdrawal by Subject|0|||
23555180|NCT03076970|65758029|FG005|Period 3|Withdrawal by Subject|1|||
23555181|NCT03076970|65758024|FG000|Period 3|Failure to meet I/E criteria|0|||
23555182|NCT03076970|65758025|FG001|Period 3|Failure to meet I/E criteria|0|||
23555183|NCT03076970|65758026|FG002|Period 3|Failure to meet I/E criteria|0|||
23555184|NCT03076970|65758027|FG003|Period 3|Failure to meet I/E criteria|0|||
23555185|NCT03076970|65758028|FG004|Period 3|Failure to meet I/E criteria|1|||
23555186|NCT03076970|65758029|FG005|Period 3|Failure to meet I/E criteria|0|||
23555187|NCT00511875|65758030|FG000|Overall Study|Lost to Follow-up|4|||
23555188|NCT00511875|65758031|FG001|Overall Study|Lost to Follow-up|0|||
23555189|NCT00511875|65758030|FG000|Overall Study|Missing variables|1|||
23555190|NCT00511875|65758031|FG001|Overall Study|Missing variables|0|||
23555191|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
23555192|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
23555193|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
23555194|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
23555195|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Other|13|||
23555196|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
23555197|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
23555198|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
23555199|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
23555200|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
23555201|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
23555202|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
23747975|NCT00822237|66457498|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
23747976|NCT00822237|66457499|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
23747977|NCT00822237|66457498|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
23747978|NCT00822237|66457499|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
23747979|NCT00822237|66457498|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
23747980|NCT00822237|66457499|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
23747981|NCT00822237|66457498|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
23747982|NCT00822237|66457499|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
23747983|NCT03575806|66457500|FG000|Overall Study|Withdrawal by Subject|0|||
23747984|NCT03575806|66457501|FG001|Overall Study|Withdrawal by Subject|2|||
23747985|NCT03575806|66457500|FG000|Overall Study|Protocol Violation|0|||
23747986|NCT03575806|66457501|FG001|Overall Study|Protocol Violation|2|||
23747987|NCT01157065|66457502|FG000|Overall Study|Death|0|||
23747988|NCT01157065|66457503|FG001|Overall Study|Death|1|||
23747989|NCT01541644|66457504|FG000|Overall Study|Withdrawal by Subject|3|||
23747990|NCT02116309|66457505|FG000|Overall Study|Lost to Follow-up|0|||
23747991|NCT02116309|66457506|FG001|Overall Study|Lost to Follow-up|1|||
23747992|NCT00457249|66457507|FG000|Overall Study|Lost to Follow-up|3|||
23747993|NCT00457249|66457508|FG001|Overall Study|Lost to Follow-up|0|||
23747994|NCT00457249|66457507|FG000|Overall Study|Protocol Violation|4|||
23747995|NCT00457249|66457508|FG001|Overall Study|Protocol Violation|1|||
23747996|NCT00457249|66457507|FG000|Overall Study|Withdrawal by Subject|3|||
23747997|NCT00457249|66457508|FG001|Overall Study|Withdrawal by Subject|1|||
23747998|NCT00457249|66457507|FG000|Overall Study|Serious Adverse Events|2|||
23747999|NCT00457249|66457508|FG001|Overall Study|Serious Adverse Events|0|||
23748000|NCT02875340|66457509|FG000|Overall Study|Death|2|||
23748001|NCT02875340|66457509|FG000|Overall Study|Withdrawal by Subject|2|||
23748002|NCT02875340|66457509|FG000|Overall Study|Physician Decision|3|||
23748003|NCT02875340|66457509|FG000|Overall Study|Adverse Event|1|||
23748004|NCT03930615|66457510|FG000|Overall Study|Death|9|||
23748005|NCT03930615|66457511|FG001|Overall Study|Death|3|||
23748006|NCT03930615|66457510|FG000|Overall Study|Lost to Follow-up|1|||
23748007|NCT03930615|66457511|FG001|Overall Study|Lost to Follow-up|2|||
23748008|NCT03930615|66457510|FG000|Overall Study|Physician Decision|3|||
23748009|NCT03930615|66457511|FG001|Overall Study|Physician Decision|4|||
23748010|NCT03930615|66457510|FG000|Overall Study|Withdrawal by Subject|13|||
23748011|NCT03930615|66457511|FG001|Overall Study|Withdrawal by Subject|2|||
23748012|NCT03930615|66457510|FG000|Overall Study|Not treated|1|||
23748013|NCT03930615|66457511|FG001|Overall Study|Not treated|1|||
23748014|NCT01392469|66457519|FG000|Overall Study|Adverse Event|2|||
23748015|NCT01392469|66457519|FG000|Overall Study|Withdrawal by Subject|1|||
23748016|NCT01392469|66457519|FG000|Overall Study|Protocol Violation|1|||
23748017|NCT01607398|66457520|FG000|Overall Study|Adverse Event|0|||
23748018|NCT01607398|66457521|FG001|Overall Study|Adverse Event|2|||
23748019|NCT01607398|66457520|FG000|Overall Study|Severe COPD|2|||
23748020|NCT01607398|66457521|FG001|Overall Study|Severe COPD|0|||
23748021|NCT00308555|66457524|FG000|Overall Study|Withdrawal by Subject|1|||
23748022|NCT00308555|66457525|FG001|Overall Study|Withdrawal by Subject|0|||
23748023|NCT00308555|66457524|FG000|Overall Study|Physician Decision|2|||
23748024|NCT00308555|66457525|FG001|Overall Study|Physician Decision|0|||
23748025|NCT00538473|66457526|FG000|Overall Study|Adverse Event|1|||
23748026|NCT00538473|66457527|FG001|Overall Study|Adverse Event|0|||
23748027|NCT00183170|66457536|FG000|First Intervention|Did not complete study|1|||
23748028|NCT00183170|66457537|FG001|First Intervention|Did not complete study|0|||
23748029|NCT00183170|66457536|FG000|First Intervention|Did not meet targeted BrAC|1|||
23748030|NCT00183170|66457537|FG001|First Intervention|Did not meet targeted BrAC|0|||
23748031|NCT00183170|66457536|FG000|Washout 1 Week|Did not complete study|6|||
23748032|NCT00183170|66457537|FG001|Washout 1 Week|Did not complete study|8|||
23748033|NCT00183170|66457536|FG000|Second Intervention|Did not complete study|1|||
23748034|NCT00183170|66457537|FG001|Second Intervention|Did not complete study|0|||
23748035|NCT00183170|66457536|FG000|Second Intervention|Did not meet targeted BrAC|0|||
23748036|NCT00183170|66457537|FG001|Second Intervention|Did not meet targeted BrAC|2|||
23748037|NCT03409328|66457538|FG000|Overall Study|Lost to Follow-up|6|||
23748038|NCT03409328|66457539|FG001|Overall Study|Lost to Follow-up|3|||
23748039|NCT04003103|66457540|FG000|Overall Study|Death|1|||
23748040|NCT04003103|66457541|FG001|Overall Study|Death|0|||
23748041|NCT04003103|66457542|FG002|Overall Study|Death|0|||
23748042|NCT04003103|66457540|FG000|Overall Study|Lost to Follow-up|4|||
23748043|NCT04003103|66457541|FG001|Overall Study|Lost to Follow-up|3|||
23748044|NCT04003103|66457542|FG002|Overall Study|Lost to Follow-up|2|||
23748045|NCT04003103|66457540|FG000|Overall Study|Withdrawal by Subject|10|||
23748046|NCT04003103|66457541|FG001|Overall Study|Withdrawal by Subject|1|||
23748047|NCT04003103|66457542|FG002|Overall Study|Withdrawal by Subject|1|||
23748048|NCT04003103|66457540|FG000|Overall Study|Status not recorded|0|||
23748049|NCT04003103|66457541|FG001|Overall Study|Status not recorded|2|||
23748050|NCT04003103|66457542|FG002|Overall Study|Status not recorded|0|||
23748051|NCT03839693|66457544|FG000|Overall Study|Lost to Follow-up|0|||
23748052|NCT03839693|66457545|FG001|Overall Study|Lost to Follow-up|2|||
23748053|NCT03839693|66457546|FG002|Overall Study|Lost to Follow-up|2|||
23748054|NCT03839693|66457544|FG000|Overall Study|Withdrawal by Subject|1|||
23748055|NCT03839693|66457545|FG001|Overall Study|Withdrawal by Subject|0|||
23748056|NCT03839693|66457546|FG002|Overall Study|Withdrawal by Subject|2|||
23748057|NCT03839693|66457544|FG000|Overall Study|subject moved out of the area|1|||
23748058|NCT03839693|66457545|FG001|Overall Study|subject moved out of the area|0|||
23748059|NCT03839693|66457546|FG002|Overall Study|subject moved out of the area|0|||
23748060|NCT04887922|66457548|FG000|1st Randomization|Decided not to have surgery|0|||
23748061|NCT04887922|66457549|FG001|1st Randomization|Decided not to have surgery|1|||
23748062|NCT04887922|66457550|FG002|1st Randomization|Decided not to have surgery|0|||
23748063|NCT04887922|66457551|FG003|1st Randomization|Decided not to have surgery|0|||
23748064|NCT04887922|66457552|FG004|1st Randomization|Decided not to have surgery|0|||
23748065|NCT00798161|66457555|FG000|Overall Study|Adverse Event|3|||
23748066|NCT00798161|66457556|FG001|Overall Study|Adverse Event|4|||
23748067|NCT00798161|66457557|FG002|Overall Study|Adverse Event|6|||
23748068|NCT00798161|66457558|FG003|Overall Study|Adverse Event|6|||
23748069|NCT00798161|66457559|FG004|Overall Study|Adverse Event|5|||
23748070|NCT00798161|66457560|FG005|Overall Study|Adverse Event|2|||
23748071|NCT00798161|66457561|FG006|Overall Study|Adverse Event|4|||
23748072|NCT00798161|66457555|FG000|Overall Study|Protocol Violation|2|||
23748073|NCT00798161|66457556|FG001|Overall Study|Protocol Violation|1|||
23748074|NCT00798161|66457557|FG002|Overall Study|Protocol Violation|3|||
23748075|NCT00798161|66457558|FG003|Overall Study|Protocol Violation|3|||
23748076|NCT00798161|66457559|FG004|Overall Study|Protocol Violation|3|||
23748077|NCT00798161|66457560|FG005|Overall Study|Protocol Violation|2|||
23748078|NCT00798161|66457561|FG006|Overall Study|Protocol Violation|0|||
23748079|NCT00798161|66457555|FG000|Overall Study|Lost to Follow-up|1|||
23748080|NCT00798161|66457556|FG001|Overall Study|Lost to Follow-up|3|||
23748081|NCT00798161|66457557|FG002|Overall Study|Lost to Follow-up|4|||
23748082|NCT00798161|66457558|FG003|Overall Study|Lost to Follow-up|3|||
23748083|NCT00798161|66457559|FG004|Overall Study|Lost to Follow-up|4|||
23748084|NCT00798161|66457560|FG005|Overall Study|Lost to Follow-up|0|||
23748085|NCT00798161|66457561|FG006|Overall Study|Lost to Follow-up|0|||
23748086|NCT00798161|66457555|FG000|Overall Study|Withdrawal by Subject|5|||
23748087|NCT00798161|66457556|FG001|Overall Study|Withdrawal by Subject|4|||
23748088|NCT00798161|66457557|FG002|Overall Study|Withdrawal by Subject|5|||
23748089|NCT00798161|66457558|FG003|Overall Study|Withdrawal by Subject|4|||
23748090|NCT00798161|66457559|FG004|Overall Study|Withdrawal by Subject|2|||
23748091|NCT00798161|66457560|FG005|Overall Study|Withdrawal by Subject|3|||
23748092|NCT00798161|66457561|FG006|Overall Study|Withdrawal by Subject|1|||
23748093|NCT00798161|66457555|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
23748094|NCT00798161|66457556|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
23748095|NCT00798161|66457557|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
23748096|NCT00798161|66457558|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
23748097|NCT00798161|66457559|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
23748098|NCT00798161|66457560|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
23748099|NCT00798161|66457561|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
23748100|NCT02392377|66457562|FG000|Overall Study|Withdrawal by Subject|0|||
23748101|NCT02392377|66457563|FG001|Overall Study|Withdrawal by Subject|1|||
23748102|NCT02646566|66457565|FG000|Overall Study|Lost to Follow-up|5|||
23748103|NCT02646566|66457566|FG001|Overall Study|Lost to Follow-up|4|||
23748104|NCT02646566|66457567|FG002|Overall Study|Lost to Follow-up|5|||
23748105|NCT02646566|66457565|FG000|Overall Study|Treatment failure|1|||
23748106|NCT02646566|66457566|FG001|Overall Study|Treatment failure|0|||
23748107|NCT02646566|66457567|FG002|Overall Study|Treatment failure|0|||
23748108|NCT04054011|66457568|FG000|Overall Study|COVID|3|||
23748109|NCT03917654|66457573|FG000|Year 1|Withdrawal by Subject|1|||
23748110|NCT03917654|66457574|FG001|Year 1|Withdrawal by Subject|0|||
23748111|NCT03917654|66457575|FG002|Year 1|Withdrawal by Subject|0|||
23748112|NCT03917654|66457576|FG003|Year 1|Withdrawal by Subject|0|||
23748113|NCT03917654|66457577|FG004|Year 1|Withdrawal by Subject|0|||
23748114|NCT03917654|66457578|FG005|Year 1|Withdrawal by Subject|1|||
23748115|NCT03917654|66457579|FG006|Year 1|Withdrawal by Subject|6|||
23748116|NCT03917654|66457580|FG007|Year 1|Withdrawal by Subject|2|||
23748117|NCT03917654|66457581|FG008|Year 1|Withdrawal by Subject|5|||
23748118|NCT03917654|66457582|FG009|Year 1|Withdrawal by Subject|3|||
23748119|NCT03917654|66457583|FG010|Year 1|Withdrawal by Subject|1|||
23748120|NCT03917654|66457584|FG011|Year 1|Withdrawal by Subject|0|||
23748121|NCT03917654|66457573|FG000|Year 1|Travel|0|||
23748122|NCT03917654|66457574|FG001|Year 1|Travel|1|||
23748123|NCT03917654|66457575|FG002|Year 1|Travel|1|||
23748124|NCT03917654|66457576|FG003|Year 1|Travel|0|||
23748125|NCT03917654|66457577|FG004|Year 1|Travel|4|||
23748126|NCT03917654|66457578|FG005|Year 1|Travel|4|||
23748127|NCT03917654|66457579|FG006|Year 1|Travel|10|||
23748128|NCT03917654|66457580|FG007|Year 1|Travel|8|||
23748129|NCT03917654|66457581|FG008|Year 1|Travel|2|||
23748130|NCT03917654|66457582|FG009|Year 1|Travel|5|||
23748131|NCT03917654|66457583|FG010|Year 1|Travel|3|||
23748132|NCT03917654|66457584|FG011|Year 1|Travel|3|||
23823407|NCT03142191|66734430|FG002|Active Treatment Extension Period|Death|1|||
23823408|NCT03142191|66734431|FG003|Active Treatment Extension Period|Death|1|||
23823409|NCT03142191|66734432|FG004|Active Treatment Extension Period|Death|0|||
23823410|NCT03142191|66734428|FG000|Active Treatment Extension Period|Adverse Event|6|||
23823411|NCT03142191|66734429|FG001|Active Treatment Extension Period|Adverse Event|5|||
23823412|NCT03142191|66734430|FG002|Active Treatment Extension Period|Adverse Event|4|||
23823413|NCT03142191|66734431|FG003|Active Treatment Extension Period|Adverse Event|1|||
23823414|NCT03142191|66734432|FG004|Active Treatment Extension Period|Adverse Event|0|||
23823415|NCT03142191|66734428|FG000|Active Treatment Extension Period|Progressive Disease|10|||
23823416|NCT03142191|66734429|FG001|Active Treatment Extension Period|Progressive Disease|5|||
23823417|NCT03142191|66734430|FG002|Active Treatment Extension Period|Progressive Disease|4|||
23823418|NCT03142191|66734431|FG003|Active Treatment Extension Period|Progressive Disease|1|||
23823419|NCT03142191|66734432|FG004|Active Treatment Extension Period|Progressive Disease|2|||
23823420|NCT03142191|66734428|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
23823421|NCT03142191|66734429|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
23823422|NCT03142191|66734430|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
23823423|NCT03142191|66734431|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
23823424|NCT03142191|66734432|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
23823425|NCT03142191|66734428|FG000|Active Treatment Extension Period|Physician Decision|2|||
23823426|NCT03142191|66734429|FG001|Active Treatment Extension Period|Physician Decision|0|||
23823427|NCT03142191|66734430|FG002|Active Treatment Extension Period|Physician Decision|0|||
23823428|NCT03142191|66734431|FG003|Active Treatment Extension Period|Physician Decision|0|||
23823429|NCT03142191|66734432|FG004|Active Treatment Extension Period|Physician Decision|0|||
23823430|NCT03142191|66734428|FG000|Active Treatment Extension Period|Other Reasons|3|||
23823431|NCT03142191|66734429|FG001|Active Treatment Extension Period|Other Reasons|3|||
23823432|NCT03142191|66734430|FG002|Active Treatment Extension Period|Other Reasons|3|||
23823433|NCT03142191|66734431|FG003|Active Treatment Extension Period|Other Reasons|8|||
23823434|NCT03142191|66734432|FG004|Active Treatment Extension Period|Other Reasons|3|||
23823435|NCT03142191|66734428|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
23823436|NCT03142191|66734429|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
23823437|NCT03142191|66734430|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
23823438|NCT03142191|66734431|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
23823439|NCT03142191|66734432|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
23823440|NCT01911273|66734433|FG000|Overall Study|Progression of Disease|1|||
23823441|NCT01911273|66734434|FG001|Overall Study|Progression of Disease|0|||
23823442|NCT01911273|66734433|FG000|Overall Study|Withdrawal by Subject|0|||
23823443|NCT01911273|66734434|FG001|Overall Study|Withdrawal by Subject|2|||
23823444|NCT01295320|66734435|FG000|Overall Study|Adverse Event|2|||
23823445|NCT01295320|66734435|FG000|Overall Study|Lost to Follow-up|4|||
23823446|NCT01295320|66734435|FG000|Overall Study|Withdrawal by Subject|2|||
23823447|NCT01295320|66734435|FG000|Overall Study|Subject was bedridden|1|||
23823448|NCT01295320|66734435|FG000|Overall Study|Unable to travel|1|||
23823449|NCT03971474|66734436|FG000|Overall Study|Adverse Event|11|||
23823450|NCT03971474|66734437|FG001|Overall Study|Adverse Event|7|||
23823451|NCT03971474|66734436|FG000|Overall Study|Refusal unrelated to adverse event|5|||
23823452|NCT03971474|66734437|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23823453|NCT03971474|66734436|FG000|Overall Study|Progression/relapse|40|||
23823454|NCT03971474|66734437|FG001|Overall Study|Progression/relapse|47|||
23823455|NCT03971474|66734436|FG000|Overall Study|Death|6|||
23823456|NCT03971474|66734437|FG001|Overall Study|Death|3|||
23823457|NCT03971474|66734436|FG000|Overall Study|Other - not protocol specified|5|||
23823458|NCT03971474|66734437|FG001|Overall Study|Other - not protocol specified|4|||
23823459|NCT03971474|66734436|FG000|Overall Study|On treatment|0|||
23823460|NCT03971474|66734437|FG001|Overall Study|On treatment|7|||
23823461|NCT04071405|66734439|FG000|Overall Study|Protocol Violation|3|||
23823462|NCT02633787|66734450|FG000|Overall Study|Withdrawal by Subject|1|||
23823463|NCT00339144|66734451|FG000|Overall Study|Disease progression|5|||
23823464|NCT00339144|66734452|FG001|Overall Study|Disease progression|2|||
23823465|NCT00339144|66734453|FG002|Overall Study|Disease progression|2|||
23823466|NCT00339144|66734451|FG000|Overall Study|Study drug toxicity|3|||
23823467|NCT00339144|66734452|FG001|Overall Study|Study drug toxicity|1|||
23432925|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432926|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23823468|NCT00339144|66734453|FG002|Overall Study|Study drug toxicity|1|||
23823469|NCT00339144|66734451|FG000|Overall Study|Participant's request to discontinuation|1|||
23823470|NCT00339144|66734452|FG001|Overall Study|Participant's request to discontinuation|0|||
23823471|NCT00339144|66734453|FG002|Overall Study|Participant's request to discontinuation|1|||
23823472|NCT04238650|66734454|FG000|Overall Study|Withdrawal by Subject|0|||
23823473|NCT04238650|66734455|FG001|Overall Study|Withdrawal by Subject|1|||
23823474|NCT00998309|66734456|FG000|Overall Study|Protocol Violation|4|||
23823475|NCT01108718|66734457|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
23432927|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432928|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432929|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432930|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432931|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432932|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432933|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432934|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432935|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432936|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432937|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432938|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432939|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
23432940|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
23432941|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
23432942|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
23432943|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
23432944|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
23432945|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
23432946|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
23432947|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
23432948|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
23432949|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
23432950|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
23432951|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
23432952|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
23432953|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
23432954|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
23432955|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432956|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432957|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432958|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432959|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432960|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432961|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432962|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432963|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432964|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432965|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432966|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432967|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432968|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432969|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
23432970|NCT00940485|65327733|FG000|Overall Study|HBeAb positive at Baseline|3|||
23432971|NCT00940485|65327734|FG001|Overall Study|HBeAb positive at Baseline|2|||
23432972|NCT00940485|65327733|FG000|Overall Study|Lost to Follow-up|2|||
23748133|NCT03917654|66457573|FG000|Year 1|Subject moved away from site|0|||
23432973|NCT00940485|65327734|FG001|Overall Study|Lost to Follow-up|3|||
23432974|NCT00940485|65327733|FG000|Overall Study|Adverse Event|8|||
23432975|NCT00940485|65327734|FG001|Overall Study|Adverse Event|0|||
23432976|NCT00940485|65327733|FG000|Overall Study|Withdrawal by Subject|1|||
23555203|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
23555204|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
23555205|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
23555206|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
23555207|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
23555208|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
23555209|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
23555210|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
23555211|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
23555212|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
23555213|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
23555214|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Other|1|||
23823476|NCT01108718|66734458|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
23823477|NCT02929056|66734461|FG000|Overall Study|Lost to Follow-up|0|||
23823478|NCT02929056|66734462|FG001|Overall Study|Lost to Follow-up|1|||
23748134|NCT03917654|66457574|FG001|Year 1|Subject moved away from site|1|||
23823479|NCT04564092|66734469|FG000|Overall Study|Withdrawal by Subject|1|||
23823480|NCT00490841|66734470|FG000|Overall Study|Death|5|||
23823481|NCT00490841|66734470|FG000|Overall Study|Withdrawal by Subject|4|||
23823482|NCT00490841|66734470|FG000|Overall Study|Lost to Follow-up|1|||
23823483|NCT00490841|66734470|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
23823484|NCT02756611|66734471|FG000|Overall Study|Death|70|||
23748135|NCT03917654|66457575|FG002|Year 1|Subject moved away from site|0|||
23748136|NCT03917654|66457576|FG003|Year 1|Subject moved away from site|0|||
23748137|NCT03917654|66457577|FG004|Year 1|Subject moved away from site|0|||
23748138|NCT03917654|66457578|FG005|Year 1|Subject moved away from site|0|||
23748139|NCT03917654|66457579|FG006|Year 1|Subject moved away from site|1|||
23748140|NCT03917654|66457580|FG007|Year 1|Subject moved away from site|2|||
23748141|NCT03917654|66457581|FG008|Year 1|Subject moved away from site|1|||
23748142|NCT03917654|66457582|FG009|Year 1|Subject moved away from site|0|||
23748143|NCT03917654|66457583|FG010|Year 1|Subject moved away from site|0|||
23748144|NCT03917654|66457584|FG011|Year 1|Subject moved away from site|3|||
23748145|NCT03917654|66457573|FG000|Year 1|Spouse/Family member request|0|||
23748146|NCT03917654|66457574|FG001|Year 1|Spouse/Family member request|0|||
23748147|NCT03917654|66457575|FG002|Year 1|Spouse/Family member request|1|||
23748148|NCT03917654|66457576|FG003|Year 1|Spouse/Family member request|0|||
23748149|NCT03917654|66457577|FG004|Year 1|Spouse/Family member request|1|||
23748150|NCT03917654|66457578|FG005|Year 1|Spouse/Family member request|0|||
23748151|NCT03917654|66457579|FG006|Year 1|Spouse/Family member request|0|||
23748152|NCT03917654|66457580|FG007|Year 1|Spouse/Family member request|2|||
23748153|NCT03917654|66457581|FG008|Year 1|Spouse/Family member request|0|||
23748154|NCT03917654|66457582|FG009|Year 1|Spouse/Family member request|0|||
23748155|NCT03917654|66457583|FG010|Year 1|Spouse/Family member request|0|||
23748156|NCT03917654|66457584|FG011|Year 1|Spouse/Family member request|1|||
23748157|NCT03917654|66457573|FG000|Year 1|Death|0|||
23748158|NCT03917654|66457574|FG001|Year 1|Death|0|||
23748159|NCT03917654|66457575|FG002|Year 1|Death|0|||
23748160|NCT03917654|66457576|FG003|Year 1|Death|0|||
23748161|NCT03917654|66457577|FG004|Year 1|Death|0|||
23748162|NCT03917654|66457578|FG005|Year 1|Death|0|||
23748163|NCT03917654|66457579|FG006|Year 1|Death|0|||
23748164|NCT03917654|66457580|FG007|Year 1|Death|0|||
23748165|NCT03917654|66457581|FG008|Year 1|Death|1|||
23748166|NCT03917654|66457582|FG009|Year 1|Death|1|||
23748167|NCT03917654|66457583|FG010|Year 1|Death|0|||
23748168|NCT03917654|66457584|FG011|Year 1|Death|0|||
23748169|NCT03917654|66457573|FG000|Year 1|Lost to Follow-up|0|||
23748170|NCT03917654|66457574|FG001|Year 1|Lost to Follow-up|0|||
23748171|NCT03917654|66457575|FG002|Year 1|Lost to Follow-up|0|||
23823485|NCT02756611|66734471|FG000|Overall Study|Withdrawal by Subject|2|||
23748172|NCT03917654|66457576|FG003|Year 1|Lost to Follow-up|0|||
23748173|NCT03917654|66457577|FG004|Year 1|Lost to Follow-up|0|||
23748174|NCT03917654|66457578|FG005|Year 1|Lost to Follow-up|0|||
23823486|NCT02756611|66734471|FG000|Overall Study|Lost to Follow-up|3|||
23823487|NCT02756611|66734471|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
23823488|NCT02756611|66734471|FG000|Overall Study|Other|10|||
23823489|NCT03624192|66734472|FG000|Overall Study|Lost to Follow-up|1|||
23823490|NCT03624192|66734473|FG001|Overall Study|Lost to Follow-up|1|||
23823491|NCT02481869|66734478|FG000|Overall Study|Lost to Follow-up|3|||
23823492|NCT02481869|66734479|FG001|Overall Study|Lost to Follow-up|4|||
23823493|NCT02481869|66734478|FG000|Overall Study|Withdrawal by Subject|2|||
23823494|NCT02481869|66734479|FG001|Overall Study|Withdrawal by Subject|0|||
23823495|NCT02620579|66734483|FG000|Overall Study|Physician Decision|0|||
23823496|NCT02620579|66734484|FG001|Overall Study|Physician Decision|0|||
23823497|NCT02620579|66734485|FG002|Overall Study|Physician Decision|0|||
23823498|NCT02620579|66734486|FG003|Overall Study|Physician Decision|1|||
23823499|NCT02620579|66734483|FG000|Overall Study|Withdrawal by Subject|0|||
23823500|NCT02620579|66734484|FG001|Overall Study|Withdrawal by Subject|1|||
23823501|NCT02620579|66734485|FG002|Overall Study|Withdrawal by Subject|1|||
23823502|NCT02620579|66734486|FG003|Overall Study|Withdrawal by Subject|0|||
23823503|NCT00591773|66734487|FG000|Overall Study|Adverse Event|9|||
23823504|NCT00591773|66734488|FG001|Overall Study|Adverse Event|9|||
23823505|NCT00591773|66734489|FG002|Overall Study|Adverse Event|6|||
23823506|NCT00591773|66734487|FG000|Overall Study|Protocol Violation|2|||
23622489|NCT02971228|66004965|FG000|Overall Study|Logistical challenges|0|||
23622490|NCT02971228|66004966|FG001|Overall Study|Logistical challenges|1|||
23622491|NCT02971228|66004967|FG002|Overall Study|Logistical challenges|0|||
23622492|NCT02971228|66004968|FG003|Overall Study|Logistical challenges|0|||
23622493|NCT02971228|66004969|FG004|Overall Study|Logistical challenges|0|||
23622494|NCT01732588|66004970|FG000|First Intervention (7 Days)|Adverse Event|0|||
23622495|NCT01732588|66004971|FG001|First Intervention (7 Days)|Adverse Event|1|||
23622496|NCT01732588|66004972|FG002|First Intervention (7 Days)|Adverse Event|0|||
23622497|NCT00526097|66004975|FG000|Overall Study|Adverse Event|6|||
23622498|NCT00526097|66004976|FG001|Overall Study|Adverse Event|44|||
23622499|NCT00526097|66004975|FG000|Overall Study|Protocol Violation|4|||
23622500|NCT00526097|66004976|FG001|Overall Study|Protocol Violation|10|||
23622501|NCT00526097|66004975|FG000|Overall Study|Withdrawal by Subject|3|||
23622502|NCT00526097|66004976|FG001|Overall Study|Withdrawal by Subject|1|||
23622503|NCT00526097|66004975|FG000|Overall Study|Other|2|||
23622504|NCT00526097|66004976|FG001|Overall Study|Other|1|||
23622505|NCT01665599|66004977|FG000|Overall Study|Adverse Event|1|||
23622506|NCT01665599|66004977|FG000|Overall Study|Consent Withdrawn|1|||
23622507|NCT01665599|66004977|FG000|Overall Study|Investigator/Sponsor decision|1|||
23622508|NCT01665599|66004977|FG000|Overall Study|Death|1|||
23622509|NCT01665599|66004977|FG000|Overall Study|Lost to Follow-up|2|||
23622510|NCT01665599|66004977|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
23622511|NCT01665599|66004977|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
23622512|NCT04522778|66004978|FG000|Overall Study|Patient did not want to wear the device|1|||
23622513|NCT04522778|66004979|FG001|Overall Study|Patient did not want to wear the device|0|||
23622514|NCT04522778|66004978|FG000|Overall Study|Lost to Follow-up|0|||
23622515|NCT04522778|66004979|FG001|Overall Study|Lost to Follow-up|1|||
23622516|NCT02138253|66004982|FG000|Overall Study|Adverse Event|3|||
23622517|NCT02138253|66004983|FG001|Overall Study|Adverse Event|3|||
23622518|NCT02138253|66004982|FG000|Overall Study|Lost to Follow-up|2|||
23622519|NCT02138253|66004983|FG001|Overall Study|Lost to Follow-up|1|||
23622520|NCT02138253|66004982|FG000|Overall Study|Physician Decision|2|||
23622521|NCT02138253|66004983|FG001|Overall Study|Physician Decision|0|||
23823507|NCT00591773|66734488|FG001|Overall Study|Protocol Violation|3|||
23823508|NCT00591773|66734489|FG002|Overall Study|Protocol Violation|0|||
23823509|NCT00591773|66734487|FG000|Overall Study|Lost to Follow-up|1|||
23823510|NCT00591773|66734488|FG001|Overall Study|Lost to Follow-up|4|||
23823511|NCT00591773|66734489|FG002|Overall Study|Lost to Follow-up|1|||
23823512|NCT00591773|66734487|FG000|Overall Study|Withdrawal by Subject|2|||
23823513|NCT00591773|66734488|FG001|Overall Study|Withdrawal by Subject|5|||
23823514|NCT00591773|66734489|FG002|Overall Study|Withdrawal by Subject|3|||
23823515|NCT00591773|66734487|FG000|Overall Study|Lack of Efficacy|1|||
23823516|NCT00591773|66734488|FG001|Overall Study|Lack of Efficacy|2|||
23823517|NCT00591773|66734489|FG002|Overall Study|Lack of Efficacy|2|||
23823518|NCT00591773|66734487|FG000|Overall Study|Other|1|||
23622522|NCT02138253|66004982|FG000|Overall Study|Non compliance|1|||
23622523|NCT02138253|66004983|FG001|Overall Study|Non compliance|0|||
23823519|NCT00591773|66734488|FG001|Overall Study|Other|1|||
23823520|NCT00591773|66734489|FG002|Overall Study|Other|4|||
23823521|NCT00474266|66734490|FG000|Overall Study|Withdrawal by Subject|7|||
23823522|NCT00474266|66734491|FG001|Overall Study|Withdrawal by Subject|20|||
23823523|NCT00474266|66734492|FG002|Overall Study|Withdrawal by Subject|4|||
23622524|NCT02138253|66004982|FG000|Overall Study|Withdrawal by Subject|1|||
23622525|NCT02138253|66004983|FG001|Overall Study|Withdrawal by Subject|0|||
23823524|NCT00474266|66734493|FG003|Overall Study|Withdrawal by Subject|7|||
23823525|NCT01433055|66734494|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
23823526|NCT01433055|66734495|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
23823527|NCT01433055|66734494|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
23823528|NCT01433055|66734495|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
23823529|NCT01755091|66734500|FG000|Overall Study|Withdrawal by Subject|6|||
23823530|NCT01755091|66734501|FG001|Overall Study|Withdrawal by Subject|1|||
23823531|NCT01755091|66734502|FG002|Overall Study|Withdrawal by Subject|3|||
23823532|NCT01755091|66734500|FG000|Overall Study|Adverse Event|1|||
23823533|NCT01755091|66734501|FG001|Overall Study|Adverse Event|1|||
23823534|NCT01755091|66734502|FG002|Overall Study|Adverse Event|1|||
23823535|NCT01755091|66734500|FG000|Overall Study|Lost to Follow-up|1|||
23823536|NCT01755091|66734501|FG001|Overall Study|Lost to Follow-up|0|||
23823537|NCT01755091|66734502|FG002|Overall Study|Lost to Follow-up|1|||
23432977|NCT00940485|65327734|FG001|Overall Study|Withdrawal by Subject|1|||
23432978|NCT00940485|65327733|FG000|Overall Study|Others|1|||
23432979|NCT00940485|65327734|FG001|Overall Study|Others|1|||
23432980|NCT03517566|65327735|FG000|Overall Study|Adverse Event|5|||
23432981|NCT03517566|65327736|FG001|Overall Study|Adverse Event|2|||
23432982|NCT03517566|65327737|FG002|Overall Study|Adverse Event|2|||
23432983|NCT03517566|65327738|FG003|Overall Study|Adverse Event|8|||
23432984|NCT03517566|65327739|FG004|Overall Study|Adverse Event|7|||
23432985|NCT03517566|65327735|FG000|Overall Study|Lack of Efficacy|3|||
23432986|NCT03517566|65327736|FG001|Overall Study|Lack of Efficacy|2|||
23432987|NCT03517566|65327737|FG002|Overall Study|Lack of Efficacy|1|||
23432988|NCT03517566|65327738|FG003|Overall Study|Lack of Efficacy|1|||
23432989|NCT03517566|65327739|FG004|Overall Study|Lack of Efficacy|4|||
23432990|NCT03517566|65327735|FG000|Overall Study|Lost to Follow-up|3|||
23432991|NCT03517566|65327736|FG001|Overall Study|Lost to Follow-up|1|||
23432992|NCT03517566|65327737|FG002|Overall Study|Lost to Follow-up|1|||
23432993|NCT03517566|65327738|FG003|Overall Study|Lost to Follow-up|1|||
23432994|NCT03517566|65327739|FG004|Overall Study|Lost to Follow-up|0|||
23432995|NCT03517566|65327735|FG000|Overall Study|Physician Decision|1|||
23432996|NCT03517566|65327736|FG001|Overall Study|Physician Decision|1|||
23432997|NCT03517566|65327737|FG002|Overall Study|Physician Decision|0|||
23432998|NCT03517566|65327738|FG003|Overall Study|Physician Decision|1|||
23432999|NCT03517566|65327739|FG004|Overall Study|Physician Decision|0|||
23433000|NCT03517566|65327735|FG000|Overall Study|Pregnancy|0|||
23433001|NCT03517566|65327736|FG001|Overall Study|Pregnancy|1|||
23433002|NCT03517566|65327737|FG002|Overall Study|Pregnancy|0|||
23433003|NCT03517566|65327738|FG003|Overall Study|Pregnancy|0|||
23433004|NCT03517566|65327739|FG004|Overall Study|Pregnancy|0|||
23433005|NCT03517566|65327735|FG000|Overall Study|Protocol Deviation|0|||
23433006|NCT03517566|65327736|FG001|Overall Study|Protocol Deviation|1|||
23433007|NCT03517566|65327737|FG002|Overall Study|Protocol Deviation|0|||
23433008|NCT03517566|65327738|FG003|Overall Study|Protocol Deviation|1|||
23433009|NCT03517566|65327739|FG004|Overall Study|Protocol Deviation|1|||
23433010|NCT03517566|65327735|FG000|Overall Study|Study terminated by Sponsor|11|||
23433011|NCT03517566|65327736|FG001|Overall Study|Study terminated by Sponsor|5|||
23433012|NCT03517566|65327737|FG002|Overall Study|Study terminated by Sponsor|6|||
23433013|NCT03517566|65327738|FG003|Overall Study|Study terminated by Sponsor|14|||
23433014|NCT03517566|65327739|FG004|Overall Study|Study terminated by Sponsor|12|||
23433015|NCT03517566|65327735|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
23748175|NCT03917654|66457579|FG006|Year 1|Lost to Follow-up|2|||
23748176|NCT03917654|66457580|FG007|Year 1|Lost to Follow-up|0|||
23748177|NCT03917654|66457581|FG008|Year 1|Lost to Follow-up|0|||
23748178|NCT03917654|66457582|FG009|Year 1|Lost to Follow-up|0|||
23748179|NCT03917654|66457583|FG010|Year 1|Lost to Follow-up|0|||
23748180|NCT03917654|66457584|FG011|Year 1|Lost to Follow-up|0|||
23748181|NCT03917654|66457573|FG000|Year 1|Missed visits|0|||
23748182|NCT03917654|66457574|FG001|Year 1|Missed visits|0|||
23748183|NCT03917654|66457575|FG002|Year 1|Missed visits|0|||
23748184|NCT03917654|66457576|FG003|Year 1|Missed visits|0|||
23748185|NCT03917654|66457577|FG004|Year 1|Missed visits|0|||
23748186|NCT03917654|66457578|FG005|Year 1|Missed visits|0|||
23748187|NCT03917654|66457579|FG006|Year 1|Missed visits|0|||
23748188|NCT03917654|66457580|FG007|Year 1|Missed visits|0|||
23748189|NCT03917654|66457581|FG008|Year 1|Missed visits|0|||
23748190|NCT03917654|66457582|FG009|Year 1|Missed visits|0|||
23748191|NCT03917654|66457583|FG010|Year 1|Missed visits|1|||
23748192|NCT03917654|66457584|FG011|Year 1|Missed visits|1|||
23748193|NCT03917654|66457573|FG000|Year 1|Pregnancy|0|||
23748194|NCT03917654|66457574|FG001|Year 1|Pregnancy|0|||
23748195|NCT03917654|66457575|FG002|Year 1|Pregnancy|0|||
23748196|NCT03917654|66457576|FG003|Year 1|Pregnancy|0|||
23748197|NCT03917654|66457577|FG004|Year 1|Pregnancy|0|||
23433016|NCT03517566|65327736|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
23433017|NCT03517566|65327737|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
23433018|NCT03517566|65327738|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
23433019|NCT03517566|65327739|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
23433020|NCT03157037|65327740|FG000|Overall Study|Death|1|||
23433021|NCT03688555|65327746|FG000|Treatment Period|Adverse Event|0|||
23433022|NCT03688555|65327747|FG001|Treatment Period|Adverse Event|0|||
23433023|NCT03688555|65327748|FG002|Treatment Period|Adverse Event|1|||
23433024|NCT00324233|65327751|FG000|First Period|unable to insert catheter|1|||
23433025|NCT00324233|65327752|FG001|First Period|unable to insert catheter|0|||
23433026|NCT00324233|65327751|FG000|Second Period|unable to insert catheter|1|||
23433027|NCT00324233|65327752|FG001|Second Period|unable to insert catheter|1|||
23433028|NCT00324233|65327751|FG000|Second Period|Protocol Violation|4|||
23433029|NCT00324233|65327752|FG001|Second Period|Protocol Violation|6|||
23433030|NCT01581619|65327753|FG000|Overall Study|Withdrawal by Subject|1|||
23433031|NCT01581619|65327753|FG000|Overall Study|Lost to Follow-up|1|||
23433032|NCT00820222|65327754|FG000|Overall Study|Lost to Follow-up|10|||
23433033|NCT00820222|65327755|FG001|Overall Study|Lost to Follow-up|9|||
23433034|NCT00820222|65327754|FG000|Overall Study|Withdrawal by Subject|19|||
23433035|NCT00820222|65327755|FG001|Overall Study|Withdrawal by Subject|21|||
23433036|NCT00820222|65327754|FG000|Overall Study|Physician Decision|93|||
23433037|NCT00820222|65327755|FG001|Overall Study|Physician Decision|88|||
23433038|NCT00820222|65327754|FG000|Overall Study|Sponsor Terminated Study|43|||
23433039|NCT00820222|65327755|FG001|Overall Study|Sponsor Terminated Study|65|||
23433040|NCT00820222|65327754|FG000|Overall Study|Unkown|11|||
23433041|NCT00820222|65327755|FG001|Overall Study|Unkown|7|||
23433042|NCT00896649|65327758|FG000|Overall Study|Physician Decision|1|||
23433043|NCT00896649|65327758|FG000|Overall Study|Pregnancy|1|||
23433044|NCT00896649|65327758|FG000|Overall Study|missing documentation|1|||
23433045|NCT00896649|65327758|FG000|Overall Study|technical difficulties|2|||
23433046|NCT02831933|65327761|FG000|Overall Study|Physician Decision|11|||
23433047|NCT04598269|65327762|FG000|Overall Study|Adverse Event|0|||
23433048|NCT04598269|65327763|FG001|Overall Study|Adverse Event|3|||
23433049|NCT04598269|65327762|FG000|Overall Study|Withdrawal by Subject|1|||
23433050|NCT04598269|65327763|FG001|Overall Study|Withdrawal by Subject|4|||
23433051|NCT04598269|65327762|FG000|Overall Study|Lost to Follow-up|1|||
23433052|NCT04598269|65327763|FG001|Overall Study|Lost to Follow-up|0|||
23433053|NCT04598269|65327762|FG000|Overall Study|Not Treated|2|||
23433054|NCT04598269|65327763|FG001|Overall Study|Not Treated|0|||
23433055|NCT01751139|65327764|FG000|Overall Study|Other|135|||
23433056|NCT01751139|65327764|FG000|Overall Study|Sponsor study termination|1609|||
23433057|NCT01751139|65327764|FG000|Overall Study|Lost to Follow-up|240|||
23433058|NCT01751139|65327764|FG000|Overall Study|Withdrawal by Subject|251|||
23433059|NCT01751139|65327764|FG000|Overall Study|Adverse Event|1|||
23433060|NCT01751139|65327764|FG000|Overall Study|Death|31|||
23433061|NCT00958217|65327768|FG000|Overall Study|Death|2|||
23433062|NCT00958217|65327769|FG001|Overall Study|Death|1|||
23433063|NCT00958217|65327768|FG000|Overall Study|Withdrawal by Subject|4|||
23433064|NCT00958217|65327769|FG001|Overall Study|Withdrawal by Subject|3|||
23433065|NCT00958217|65327768|FG000|Overall Study|Lost to Follow-up|17|||
23433066|NCT00958217|65327769|FG001|Overall Study|Lost to Follow-up|19|||
23433067|NCT00958217|65327768|FG000|Overall Study|Moved out of area|1|||
23433068|NCT00958217|65327769|FG001|Overall Study|Moved out of area|1|||
23433069|NCT00958217|65327768|FG000|Overall Study|Inpatient hospitalization|0|||
23433070|NCT00958217|65327769|FG001|Overall Study|Inpatient hospitalization|1|||
23433071|NCT01943552|65327770|FG000|Overall Study|Adverse Event|3|||
23433072|NCT01943552|65327771|FG001|Overall Study|Adverse Event|2|||
23433073|NCT01943552|65327770|FG000|Overall Study|Withdrawal by Subject|6|||
23433074|NCT01943552|65327771|FG001|Overall Study|Withdrawal by Subject|6|||
23433075|NCT01943552|65327770|FG000|Overall Study|Other Reasons|16|||
23433076|NCT01943552|65327771|FG001|Overall Study|Other Reasons|17|||
23433077|NCT01272869|65327774|FG000|Period 2 (14 Days)|Adverse Event|1|||
23433078|NCT01272869|65327775|FG001|Period 2 (14 Days)|Adverse Event|0|||
23433079|NCT00086411|65327776|FG000|Overall Study|Lost to Follow-up|11|||
23433080|NCT00086411|65327777|FG001|Overall Study|Lost to Follow-up|11|||
23433081|NCT00086411|65327778|FG002|Overall Study|Lost to Follow-up|13|||
23433082|NCT00086411|65327779|FG003|Overall Study|Lost to Follow-up|12|||
23433083|NCT02440789|65327781|FG000|Overall Study|Withdrawal by Subject|3|||
23433084|NCT02440789|65327781|FG000|Overall Study|Not willing to adhere to reqs|1|||
23433085|NCT03149029|65327782|FG000|Overall Study|Adverse Event|2|||
23433086|NCT03149029|65327783|FG001|Overall Study|Adverse Event|0|||
23433087|NCT01732913|65327784|FG000|Overall Study|Study Terminated by Sponsor|105|||
23433088|NCT01732913|65327785|FG001|Overall Study|Study Terminated by Sponsor|55|||
23433089|NCT01732913|65327784|FG000|Overall Study|Withdrawal by Subject|27|||
23433090|NCT01732913|65327785|FG001|Overall Study|Withdrawal by Subject|4|||
23433091|NCT01732913|65327784|FG000|Overall Study|Physician Decision|14|||
23433092|NCT01732913|65327785|FG001|Overall Study|Physician Decision|7|||
23433093|NCT01732913|65327784|FG000|Overall Study|Other|7|||
23433094|NCT01732913|65327785|FG001|Overall Study|Other|1|||
23748198|NCT03917654|66457578|FG005|Year 1|Pregnancy|0|||
23823538|NCT01755091|66734500|FG000|Overall Study|Physician Decision|1|||
23823539|NCT01755091|66734501|FG001|Overall Study|Physician Decision|1|||
23823540|NCT01755091|66734502|FG002|Overall Study|Physician Decision|2|||
23823541|NCT03567980|66734503|FG000|Overall Study|Adverse Event|1|||
23823542|NCT02925403|66734505|FG000|Overall Study|Lost to Follow-up|0|||
23823543|NCT02925403|66734506|FG001|Overall Study|Lost to Follow-up|1|||
23823544|NCT00134901|66734507|FG000|Overall Study|Lost to Follow-up|5|||
23823545|NCT00134901|66734508|FG001|Overall Study|Lost to Follow-up|5|||
23823546|NCT00134901|66734507|FG000|Overall Study|discontinued intervention|12|||
23823547|NCT00134901|66734508|FG001|Overall Study|discontinued intervention|10|||
23823548|NCT00104572|66734510|FG000|Overall Study|Withdrawal by Subject|3|||
23823549|NCT00104572|66734511|FG001|Overall Study|Withdrawal by Subject|3|||
23823550|NCT00104572|66734512|FG002|Overall Study|Withdrawal by Subject|0|||
23823551|NCT00314951|66734513|FG000|Treatment|Didn't meet criteria for mITT population|16|||
23823552|NCT00314951|66734514|FG001|Treatment|Didn't meet criteria for mITT population|11|||
23823553|NCT00314951|66734513|FG000|Follow-up|mITT failure|44|||
23823554|NCT00314951|66734514|FG001|Follow-up|mITT failure|34|||
23823555|NCT02368314|66734515|FG000|Overall Study|Withdrawal by Subject|2|||
23823556|NCT02368314|66734516|FG001|Overall Study|Withdrawal by Subject|1|||
23823557|NCT02368314|66734515|FG000|Overall Study|Adverse Event|1|||
23823558|NCT02368314|66734516|FG001|Overall Study|Adverse Event|2|||
23823559|NCT01597778|66734518|FG000|Overall Study|Death|7|||
23823560|NCT01597778|66734519|FG001|Overall Study|Death|10|||
23823561|NCT01597778|66734518|FG000|Overall Study|Withdrawal by Subject|3|||
23823562|NCT01597778|66734519|FG001|Overall Study|Withdrawal by Subject|4|||
23823563|NCT01597778|66734518|FG000|Overall Study|Adverse Event|1|||
23823564|NCT01597778|66734519|FG001|Overall Study|Adverse Event|1|||
23823565|NCT01597778|66734518|FG000|Overall Study|Protocol Violation|1|||
23622526|NCT03599622|66004988|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23748199|NCT03917654|66457579|FG006|Year 1|Pregnancy|0|||
23748200|NCT03917654|66457580|FG007|Year 1|Pregnancy|1|||
23748201|NCT03917654|66457581|FG008|Year 1|Pregnancy|0|||
23748202|NCT03917654|66457582|FG009|Year 1|Pregnancy|1|||
23748203|NCT03917654|66457583|FG010|Year 1|Pregnancy|0|||
23748204|NCT03917654|66457584|FG011|Year 1|Pregnancy|0|||
23748205|NCT03917654|66457573|FG000|Year 2|Travel|1|||
23748206|NCT03917654|66457574|FG001|Year 2|Travel|0|||
23748207|NCT03917654|66457575|FG002|Year 2|Travel|0|||
23748208|NCT03917654|66457576|FG003|Year 2|Travel|0|||
23748209|NCT03917654|66457577|FG004|Year 2|Travel|1|||
23748210|NCT03917654|66457578|FG005|Year 2|Travel|1|||
23748211|NCT03917654|66457579|FG006|Year 2|Travel|2|||
23748212|NCT03917654|66457580|FG007|Year 2|Travel|1|||
23748213|NCT03917654|66457581|FG008|Year 2|Travel|0|||
23748214|NCT03917654|66457582|FG009|Year 2|Travel|1|||
23748215|NCT03917654|66457583|FG010|Year 2|Travel|0|||
23748216|NCT03917654|66457584|FG011|Year 2|Travel|1|||
23748217|NCT03917654|66457573|FG000|Year 2|Married|1|||
23748218|NCT03917654|66457574|FG001|Year 2|Married|0|||
23748219|NCT03917654|66457575|FG002|Year 2|Married|0|||
23748220|NCT03917654|66457576|FG003|Year 2|Married|0|||
23748221|NCT03917654|66457577|FG004|Year 2|Married|0|||
23748222|NCT03917654|66457578|FG005|Year 2|Married|0|||
23748223|NCT03917654|66457579|FG006|Year 2|Married|1|||
23748224|NCT03917654|66457580|FG007|Year 2|Married|1|||
23748225|NCT03917654|66457581|FG008|Year 2|Married|0|||
23748226|NCT03917654|66457582|FG009|Year 2|Married|0|||
23748227|NCT03917654|66457583|FG010|Year 2|Married|0|||
23748228|NCT03917654|66457584|FG011|Year 2|Married|0|||
23748229|NCT03917654|66457573|FG000|Year 2|Subject moved away from site|1|||
23748230|NCT03917654|66457574|FG001|Year 2|Subject moved away from site|0|||
23748231|NCT03917654|66457575|FG002|Year 2|Subject moved away from site|0|||
23748232|NCT03917654|66457576|FG003|Year 2|Subject moved away from site|0|||
23748233|NCT03917654|66457577|FG004|Year 2|Subject moved away from site|1|||
23748234|NCT03917654|66457578|FG005|Year 2|Subject moved away from site|0|||
23748235|NCT03917654|66457579|FG006|Year 2|Subject moved away from site|2|||
23748236|NCT03917654|66457580|FG007|Year 2|Subject moved away from site|3|||
23748237|NCT03917654|66457581|FG008|Year 2|Subject moved away from site|0|||
23823566|NCT01597778|66734519|FG001|Overall Study|Protocol Violation|11|||
23823567|NCT01597778|66734518|FG000|Overall Study|Transplanted off protocol|2|||
23823568|NCT01597778|66734519|FG001|Overall Study|Transplanted off protocol|3|||
23823569|NCT00129545|66734520|FG000|Overall Study|Death|5|||
23823570|NCT00129545|66734521|FG001|Overall Study|Death|60|||
23748238|NCT03917654|66457582|FG009|Year 2|Subject moved away from site|2|||
23748239|NCT03917654|66457583|FG010|Year 2|Subject moved away from site|0|||
23748240|NCT03917654|66457584|FG011|Year 2|Subject moved away from site|1|||
23748241|NCT03917654|66457573|FG000|Year 2|Year 2 Screening failure|0|||
23748242|NCT03917654|66457574|FG001|Year 2|Year 2 Screening failure|1|||
23748243|NCT03917654|66457575|FG002|Year 2|Year 2 Screening failure|0|||
23748244|NCT03917654|66457576|FG003|Year 2|Year 2 Screening failure|0|||
23748245|NCT03917654|66457577|FG004|Year 2|Year 2 Screening failure|2|||
23748246|NCT03917654|66457578|FG005|Year 2|Year 2 Screening failure|0|||
23823571|NCT00129545|66734522|FG002|Overall Study|Death|44|||
23748247|NCT03917654|66457579|FG006|Year 2|Year 2 Screening failure|4|||
23748248|NCT03917654|66457580|FG007|Year 2|Year 2 Screening failure|3|||
23748249|NCT03917654|66457581|FG008|Year 2|Year 2 Screening failure|10|||
23748250|NCT03917654|66457582|FG009|Year 2|Year 2 Screening failure|2|||
23823572|NCT00129545|66734520|FG000|Overall Study|Withdrawal by Subject|3|||
23823573|NCT00129545|66734521|FG001|Overall Study|Withdrawal by Subject|18|||
23823574|NCT00129545|66734522|FG002|Overall Study|Withdrawal by Subject|44|||
23823575|NCT00129545|66734520|FG000|Overall Study|Lost to Follow-up|2|||
23433095|NCT01732913|65327784|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
23433096|NCT01732913|65327785|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
23748251|NCT03917654|66457583|FG010|Year 2|Year 2 Screening failure|1|||
23748252|NCT03917654|66457584|FG011|Year 2|Year 2 Screening failure|1|||
23748253|NCT03917654|66457573|FG000|Year 2|Death|0|||
23748254|NCT03917654|66457574|FG001|Year 2|Death|0|||
23748255|NCT03917654|66457575|FG002|Year 2|Death|0|||
23823576|NCT00129545|66734521|FG001|Overall Study|Lost to Follow-up|22|||
23823577|NCT00129545|66734522|FG002|Overall Study|Lost to Follow-up|13|||
23433097|NCT01814670|65330360|FG000|Overall Study|Protocol Violation|12|||
23433098|NCT00042666|65330362|FG000|Overall Study|Adverse Event|2|||
23433099|NCT00042666|65330362|FG000|Overall Study|Death|4|||
23433100|NCT00042666|65330362|FG000|Overall Study|Protocol Violation|1|||
23433101|NCT00042666|65330362|FG000|Overall Study|Participant/Physician Perception|1|||
23433102|NCT00042666|65330362|FG000|Overall Study|Progressive Disease|41|||
23433103|NCT00042666|65330362|FG000|Overall Study|Other|1|||
23433104|NCT00042666|65330362|FG000|Overall Study|Other|4|||
23433105|NCT02943915|65330363|FG000|Overall Study|Withdrawal by Subject|2|||
23748256|NCT03917654|66457576|FG003|Year 2|Death|0|||
23823578|NCT00129545|66734520|FG000|Overall Study|Physician Decision|0|||
23823579|NCT00129545|66734521|FG001|Overall Study|Physician Decision|3|||
23433106|NCT02943915|65330364|FG001|Overall Study|Withdrawal by Subject|1|||
23433107|NCT02943915|65330365|FG002|Overall Study|Withdrawal by Subject|0|||
23433108|NCT02943915|65330366|FG003|Overall Study|Withdrawal by Subject|0|||
23433109|NCT02943915|65330363|FG000|Overall Study|Lost to Follow-up|3|||
23433110|NCT02943915|65330364|FG001|Overall Study|Lost to Follow-up|1|||
23433111|NCT02943915|65330365|FG002|Overall Study|Lost to Follow-up|0|||
23748257|NCT03917654|66457577|FG004|Year 2|Death|0|||
23433112|NCT02943915|65330366|FG003|Overall Study|Lost to Follow-up|0|||
23748258|NCT03917654|66457578|FG005|Year 2|Death|1|||
23748259|NCT03917654|66457579|FG006|Year 2|Death|0|||
23823580|NCT00129545|66734522|FG002|Overall Study|Physician Decision|10|||
23823581|NCT00129545|66734520|FG000|Overall Study|Device not implanted|16|||
23748260|NCT03917654|66457580|FG007|Year 2|Death|0|||
23823582|NCT00129545|66734521|FG001|Overall Study|Device not implanted|61|||
23433113|NCT02943915|65330363|FG000|Overall Study|excluded|0|||
23433114|NCT02943915|65330364|FG001|Overall Study|excluded|1|||
23433115|NCT02943915|65330365|FG002|Overall Study|excluded|0|||
23433116|NCT02943915|65330366|FG003|Overall Study|excluded|0|||
23433117|NCT01825941|65330367|FG000|Overall Study|Lost to Follow-up|4|||
23433118|NCT01825941|65330368|FG001|Overall Study|Lost to Follow-up|1|||
23433119|NCT03006887|65330369|FG000|Overall Study|Adverse Event|1|||
23748261|NCT03917654|66457581|FG008|Year 2|Death|1|||
23748262|NCT03917654|66457582|FG009|Year 2|Death|1|||
23748263|NCT03917654|66457583|FG010|Year 2|Death|0|||
23748264|NCT03917654|66457584|FG011|Year 2|Death|0|||
23748265|NCT03917654|66457573|FG000|Year 2|Withdrawal by Subject|0|||
23748266|NCT03917654|66457574|FG001|Year 2|Withdrawal by Subject|0|||
23748267|NCT03917654|66457575|FG002|Year 2|Withdrawal by Subject|0|||
23748268|NCT03917654|66457576|FG003|Year 2|Withdrawal by Subject|0|||
23748269|NCT03917654|66457577|FG004|Year 2|Withdrawal by Subject|0|||
23748270|NCT03917654|66457578|FG005|Year 2|Withdrawal by Subject|0|||
23748271|NCT03917654|66457579|FG006|Year 2|Withdrawal by Subject|3|||
23748272|NCT03917654|66457580|FG007|Year 2|Withdrawal by Subject|0|||
23748273|NCT03917654|66457581|FG008|Year 2|Withdrawal by Subject|2|||
23748274|NCT03917654|66457582|FG009|Year 2|Withdrawal by Subject|5|||
23748275|NCT03917654|66457583|FG010|Year 2|Withdrawal by Subject|0|||
23748276|NCT03917654|66457584|FG011|Year 2|Withdrawal by Subject|0|||
23748277|NCT03917654|66457573|FG000|Year 2|Spouse/family member request|0|||
23748278|NCT03917654|66457574|FG001|Year 2|Spouse/family member request|0|||
23748279|NCT03917654|66457575|FG002|Year 2|Spouse/family member request|0|||
23748280|NCT03917654|66457576|FG003|Year 2|Spouse/family member request|0|||
23622527|NCT03599622|66004989|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
23622528|NCT03599622|66004990|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
23622529|NCT03599622|66004991|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
23622530|NCT03599622|66004988|FG000|Pre-Treatment Period|Other reasons|1|||
23622531|NCT03599622|66004989|FG001|Pre-Treatment Period|Other reasons|1|||
23622532|NCT03599622|66004990|FG002|Pre-Treatment Period|Other reasons|1|||
23622533|NCT03599622|66004991|FG003|Pre-Treatment Period|Other reasons|0|||
23622534|NCT03599622|66004988|FG000|Treatment Period|Adverse Event|11|||
23622535|NCT03599622|66004989|FG001|Treatment Period|Adverse Event|20|||
23622536|NCT03599622|66004990|FG002|Treatment Period|Adverse Event|18|||
23622537|NCT03599622|66004991|FG003|Treatment Period|Adverse Event|2|||
23622538|NCT03599622|66004988|FG000|Treatment Period|Lack of Efficacy|18|||
23622539|NCT03599622|66004989|FG001|Treatment Period|Lack of Efficacy|12|||
23622540|NCT03599622|66004990|FG002|Treatment Period|Lack of Efficacy|13|||
23622541|NCT03599622|66004991|FG003|Treatment Period|Lack of Efficacy|2|||
23622542|NCT03599622|66004988|FG000|Treatment Period|Withdrawal by Subject|5|||
23622543|NCT03599622|66004989|FG001|Treatment Period|Withdrawal by Subject|11|||
23622544|NCT03599622|66004990|FG002|Treatment Period|Withdrawal by Subject|16|||
23622545|NCT03599622|66004991|FG003|Treatment Period|Withdrawal by Subject|1|||
23622546|NCT03599622|66004988|FG000|Treatment Period|Other reasons|4|||
23622547|NCT03599622|66004989|FG001|Treatment Period|Other reasons|6|||
23622548|NCT03599622|66004990|FG002|Treatment Period|Other reasons|7|||
23622549|NCT03599622|66004991|FG003|Treatment Period|Other reasons|0|||
23622550|NCT03599622|66004988|FG000|Treatment Period|Lost to Follow-up|1|||
23622551|NCT03599622|66004989|FG001|Treatment Period|Lost to Follow-up|0|||
23622552|NCT03599622|66004990|FG002|Treatment Period|Lost to Follow-up|0|||
23622553|NCT03599622|66004991|FG003|Treatment Period|Lost to Follow-up|0|||
23622554|NCT03599622|66004988|FG000|Treatment Period|Study terminated by sponsor|7|||
23622555|NCT03599622|66004989|FG001|Treatment Period|Study terminated by sponsor|20|||
23622556|NCT03599622|66004990|FG002|Treatment Period|Study terminated by sponsor|15|||
23622557|NCT03599622|66004991|FG003|Treatment Period|Study terminated by sponsor|0|||
23622558|NCT03599622|66004988|FG000|Treatment Period|Site terminated by sponsor|0|||
23622559|NCT03599622|66004989|FG001|Treatment Period|Site terminated by sponsor|1|||
23622560|NCT03599622|66004990|FG002|Treatment Period|Site terminated by sponsor|0|||
23622561|NCT03599622|66004991|FG003|Treatment Period|Site terminated by sponsor|0|||
23622562|NCT00107978|66004993|FG000|Overall Study|Adverse Event|1|||
23622563|NCT00107978|66004994|FG001|Overall Study|Adverse Event|5|||
23622564|NCT00107978|66004993|FG000|Overall Study|Death|3|||
23622565|NCT00107978|66004994|FG001|Overall Study|Death|3|||
23622566|NCT00107978|66004993|FG000|Overall Study|Lost to Follow-up|20|||
23622567|NCT00107978|66004994|FG001|Overall Study|Lost to Follow-up|28|||
23622568|NCT00107978|66004993|FG000|Overall Study|Withdrawal by Subject|4|||
23622569|NCT00107978|66004994|FG001|Overall Study|Withdrawal by Subject|9|||
23622570|NCT00107978|66004993|FG000|Overall Study|Protocol Violation|0|||
23622571|NCT00107978|66004994|FG001|Overall Study|Protocol Violation|1|||
23823583|NCT00129545|66734522|FG002|Overall Study|Device not implanted|0|||
23823584|NCT02290405|66734523|FG000|Overall Study|Withdrawal by Subject|1|||
23823585|NCT02290405|66734524|FG001|Overall Study|Withdrawal by Subject|0|||
23823586|NCT00111241|66734525|FG000|Overall Study|Lost to Follow-up|1|||
23823587|NCT00111241|66734526|FG001|Overall Study|Lost to Follow-up|0|||
23622572|NCT00107978|66004993|FG000|Overall Study|Other|5|||
23622573|NCT00107978|66004994|FG001|Overall Study|Other|4|||
23622574|NCT00436956|66004995|FG000|Overall Study|Not evaluable|1|||
23622575|NCT00436956|66004996|FG001|Overall Study|Not evaluable|0|||
23622576|NCT03796208|66004997|FG000|Overall Study|Withdrawal by Subject|3|||
23622577|NCT03796208|66004998|FG001|Overall Study|Withdrawal by Subject|0|||
23622578|NCT03796208|66004997|FG000|Overall Study|Loss of pregnancy|1|||
23622579|NCT03796208|66004998|FG001|Overall Study|Loss of pregnancy|1|||
23622580|NCT03796208|66004997|FG000|Overall Study|Changed prenatal clinics|0|||
23622581|NCT03796208|66004998|FG001|Overall Study|Changed prenatal clinics|5|||
23622582|NCT03796208|66004997|FG000|Overall Study|Lost to Follow-up|20|||
23622583|NCT03796208|66004998|FG001|Overall Study|Lost to Follow-up|16|||
23622584|NCT00337285|66004999|FG000|Overall Study|Withdrawal by Subject|42|||
23622585|NCT00337285|66004999|FG000|Overall Study|Lost to Follow-up|41|||
23622586|NCT00337285|66004999|FG000|Overall Study|Adverse Event|28|||
23622587|NCT00337285|66004999|FG000|Overall Study|Protocol Violation|27|||
23622588|NCT00337285|66004999|FG000|Overall Study|Lack of Efficacy|11|||
23622589|NCT00337285|66004999|FG000|Overall Study|Death|1|||
23748281|NCT03917654|66457577|FG004|Year 2|Spouse/family member request|0|||
23748282|NCT03917654|66457578|FG005|Year 2|Spouse/family member request|0|||
23748283|NCT03917654|66457579|FG006|Year 2|Spouse/family member request|1|||
23748284|NCT03917654|66457580|FG007|Year 2|Spouse/family member request|0|||
23748285|NCT03917654|66457581|FG008|Year 2|Spouse/family member request|0|||
23748286|NCT03917654|66457582|FG009|Year 2|Spouse/family member request|0|||
23748287|NCT03917654|66457583|FG010|Year 2|Spouse/family member request|0|||
23748288|NCT03917654|66457584|FG011|Year 2|Spouse/family member request|0|||
23748289|NCT03917654|66457573|FG000|Year 2|Lost to Follow-up|0|||
23748290|NCT03917654|66457574|FG001|Year 2|Lost to Follow-up|0|||
23748291|NCT03917654|66457575|FG002|Year 2|Lost to Follow-up|0|||
23748292|NCT03917654|66457576|FG003|Year 2|Lost to Follow-up|0|||
23748293|NCT03917654|66457577|FG004|Year 2|Lost to Follow-up|0|||
23622590|NCT00337285|66004999|FG000|Overall Study|Physician Decision|1|||
23622591|NCT00337285|66004999|FG000|Overall Study|Lack of protocol compliance|7|||
23622592|NCT01101334|66005000|FG000|Overall Study|Adverse Event|9|||
23622593|NCT01101334|66005001|FG001|Overall Study|Adverse Event|4|||
23622594|NCT01101334|66005000|FG000|Overall Study|Death|7|||
23748294|NCT03917654|66457578|FG005|Year 2|Lost to Follow-up|0|||
23622595|NCT01101334|66005001|FG001|Overall Study|Death|1|||
23622596|NCT01101334|66005000|FG000|Overall Study|Withdrawal by Subject|4|||
23622597|NCT01101334|66005001|FG001|Overall Study|Withdrawal by Subject|3|||
23622598|NCT01101334|66005000|FG000|Overall Study|Withdrawal by Sponsor|1|||
23748295|NCT03917654|66457579|FG006|Year 2|Lost to Follow-up|1|||
23748296|NCT03917654|66457580|FG007|Year 2|Lost to Follow-up|0|||
23748297|NCT03917654|66457581|FG008|Year 2|Lost to Follow-up|1|||
23433120|NCT01183065|65330372|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
23433121|NCT02713867|65330376|FG000|Randomization|Other Reason|2|||
23433122|NCT02713867|65330377|FG001|Randomization|Other Reason|1|||
23433123|NCT02713867|65330376|FG000|Randomization|Participant Withdrew consent|0|||
23433124|NCT02713867|65330377|FG001|Randomization|Participant Withdrew consent|2|||
23433125|NCT02713867|65330376|FG000|Treatment Period|Other Reasons|22|||
23433126|NCT02713867|65330377|FG001|Treatment Period|Other Reasons|28|||
23433127|NCT02713867|65330376|FG000|Treatment Period|Administrative reason by sponsor|21|||
23433128|NCT02713867|65330377|FG001|Treatment Period|Administrative reason by sponsor|16|||
23433129|NCT02713867|65330376|FG000|Treatment Period|No longer meets study criteria|2|||
23433130|NCT02713867|65330377|FG001|Treatment Period|No longer meets study criteria|1|||
23433131|NCT02713867|65330376|FG000|Treatment Period|Poor/Non Compliance|1|||
23433132|NCT02713867|65330377|FG001|Treatment Period|Poor/Non Compliance|0|||
23433133|NCT02713867|65330376|FG000|Treatment Period|Maximum Clinical Benefit|5|||
23433134|NCT02713867|65330377|FG001|Treatment Period|Maximum Clinical Benefit|6|||
23433135|NCT02713867|65330376|FG000|Treatment Period|Withdrew consent|3|||
23433136|NCT02713867|65330377|FG001|Treatment Period|Withdrew consent|6|||
23433137|NCT02713867|65330376|FG000|Treatment Period|Requested to Discontinue|8|||
23433138|NCT02713867|65330377|FG001|Treatment Period|Requested to Discontinue|8|||
23433139|NCT02713867|65330376|FG000|Treatment Period|AE unrelated to Study Drug|11|||
23433140|NCT02713867|65330377|FG001|Treatment Period|AE unrelated to Study Drug|10|||
23433141|NCT02713867|65330376|FG000|Treatment Period|Death|7|||
23433142|NCT02713867|65330377|FG001|Treatment Period|Death|3|||
23433143|NCT02713867|65330376|FG000|Treatment Period|Study Drug Toxicity|16|||
23433144|NCT02713867|65330377|FG001|Treatment Period|Study Drug Toxicity|19|||
23433145|NCT02713867|65330376|FG000|Treatment Period|Disease Progression|82|||
23433146|NCT02713867|65330377|FG001|Treatment Period|Disease Progression|83|||
23433147|NCT00924443|65330380|FG000|Overall Study|Physician Decision|2|||
23433148|NCT00924443|65330380|FG000|Overall Study|Protocol Violation|1|||
23433149|NCT00082381|65330381|FG000|Overall Study|Adverse Event|27|||
23433150|NCT00082381|65330382|FG001|Overall Study|Adverse Event|2|||
23433151|NCT00082381|65330381|FG000|Overall Study|Lost to Follow-up|5|||
23433152|NCT00082381|65330382|FG001|Overall Study|Lost to Follow-up|7|||
23433153|NCT00082381|65330381|FG000|Overall Study|Patient Decision|8|||
23433154|NCT00082381|65330382|FG001|Overall Study|Patient Decision|4|||
23433155|NCT00082381|65330381|FG000|Overall Study|Physician Decision|1|||
23433156|NCT00082381|65330382|FG001|Overall Study|Physician Decision|2|||
23433157|NCT00082381|65330381|FG000|Overall Study|Protocol Violation|10|||
23433158|NCT00082381|65330382|FG001|Overall Study|Protocol Violation|11|||
23433159|NCT00082381|65330381|FG000|Overall Study|Loss of Glucose Control|4|||
23433160|NCT00082381|65330382|FG001|Overall Study|Loss of Glucose Control|0|||
23433161|NCT02553538|65330385|FG000|Overall Study|Could Not Reach by Telephone|133|||
23433162|NCT02553538|65330386|FG001|Overall Study|Could Not Reach by Telephone|0|||
23433163|NCT02553538|65330385|FG000|Overall Study|Died or Left Network|54|||
23433164|NCT02553538|65330386|FG001|Overall Study|Died or Left Network|56|||
23433165|NCT00094107|65330387|FG000|Overall Study|Lack of Efficacy|23|||
23433166|NCT00094107|65330387|FG000|Overall Study|Death|5|||
23433167|NCT00094107|65330387|FG000|Overall Study|Adverse Event|3|||
23748298|NCT03917654|66457582|FG009|Year 2|Lost to Follow-up|0|||
23433168|NCT00094107|65330387|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
23433169|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
23433170|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
23433171|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
23748299|NCT03917654|66457583|FG010|Year 2|Lost to Follow-up|0|||
23748300|NCT03917654|66457584|FG011|Year 2|Lost to Follow-up|1|||
23748301|NCT03917654|66457573|FG000|Year 2|Adverse Event|0|||
23748302|NCT03917654|66457574|FG001|Year 2|Adverse Event|0|||
23748303|NCT03917654|66457575|FG002|Year 2|Adverse Event|0|||
23748304|NCT03917654|66457576|FG003|Year 2|Adverse Event|0|||
23748305|NCT03917654|66457577|FG004|Year 2|Adverse Event|0|||
23748306|NCT03917654|66457578|FG005|Year 2|Adverse Event|0|||
23748307|NCT03917654|66457579|FG006|Year 2|Adverse Event|0|||
23748308|NCT03917654|66457580|FG007|Year 2|Adverse Event|0|||
23823588|NCT00111241|66734525|FG000|Overall Study|Withdrawal by Subject|4|||
23823589|NCT00111241|66734526|FG001|Overall Study|Withdrawal by Subject|0|||
23823590|NCT00111241|66734525|FG000|Overall Study|Protocol Violation|9|||
23555215|NCT04791761|65758038|FG000|Overall Study|Lost to Follow-up|8|||
23748309|NCT03917654|66457581|FG008|Year 2|Adverse Event|0|||
23748310|NCT03917654|66457582|FG009|Year 2|Adverse Event|1|||
23748311|NCT03917654|66457583|FG010|Year 2|Adverse Event|0|||
23748312|NCT03917654|66457584|FG011|Year 2|Adverse Event|0|||
23748313|NCT01798056|66457585|FG000|Overall Study|Serious Adverse Event|13|||
23748314|NCT01798056|66457586|FG001|Overall Study|Serious Adverse Event|12|||
23748315|NCT01798056|66457585|FG000|Overall Study|Withdrawal by Subject|12|||
23748316|NCT01798056|66457586|FG001|Overall Study|Withdrawal by Subject|9|||
23748317|NCT01798056|66457585|FG000|Overall Study|Migrated/moved from study area|1|||
23748318|NCT01798056|66457586|FG001|Overall Study|Migrated/moved from study area|1|||
23748319|NCT01798056|66457585|FG000|Overall Study|Lost to Follow-up|1|||
23748320|NCT01798056|66457586|FG001|Overall Study|Lost to Follow-up|1|||
23748321|NCT01798056|66457585|FG000|Overall Study|Other|0|||
23748322|NCT01798056|66457586|FG001|Overall Study|Other|2|||
23748323|NCT00938015|66457587|FG000|Overall Study|Death|2|||
23748324|NCT00938015|66457587|FG000|Overall Study|Lost to Follow-up|32|||
23748325|NCT00938015|66457587|FG000|Overall Study|Adverse Event|32|||
23748326|NCT00938015|66457587|FG000|Overall Study|Non-responder|52|||
23748327|NCT00938015|66457587|FG000|Overall Study|Reason not related to Etanercept|29|||
23748328|NCT00352664|66457588|FG000|Overall Study|Withdrawal by Subject|7|||
23748329|NCT00352664|66457589|FG001|Overall Study|Withdrawal by Subject|0|||
23748330|NCT01118949|66457591|FG000|Overall Study|Adverse Event|5|||
23748331|NCT01118949|66457591|FG000|Overall Study|Withdrawal by Subject|4|||
23748332|NCT02596009|66457595|FG000|Overall Study|Administrative problems|0|||
23748333|NCT02596009|66457596|FG001|Overall Study|Administrative problems|1|||
23748334|NCT02596009|66457597|FG002|Overall Study|Administrative problems|0|||
23748335|NCT02596009|66457598|FG003|Overall Study|Administrative problems|0|||
23748336|NCT02596009|66457599|FG004|Overall Study|Administrative problems|0|||
23748337|NCT02596009|66457600|FG005|Overall Study|Administrative problems|0|||
23748338|NCT01674010|66457601|FG000|Open Treatment Phase 1|Adverse Event|10|||
23748339|NCT01674010|66457602|FG001|Open Treatment Phase 1|Adverse Event|0|||
23748340|NCT01674010|66457603|FG002|Open Treatment Phase 1|Adverse Event|0|||
23748341|NCT01674010|66457601|FG000|Open Treatment Phase 1|Death|1|||
23748342|NCT01674010|66457602|FG001|Open Treatment Phase 1|Death|0|||
23748343|NCT01674010|66457603|FG002|Open Treatment Phase 1|Death|0|||
23748344|NCT01674010|66457601|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
23748345|NCT01674010|66457602|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
23748346|NCT01674010|66457603|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
23555216|NCT04791761|65758039|FG001|Overall Study|Lost to Follow-up|6|||
23555217|NCT04791761|65758040|FG002|Overall Study|Lost to Follow-up|10|||
23555218|NCT04791761|65758038|FG000|Overall Study|Withdrawal by Subject|0|||
23555219|NCT04791761|65758039|FG001|Overall Study|Withdrawal by Subject|1|||
23555220|NCT04791761|65758040|FG002|Overall Study|Withdrawal by Subject|1|||
23555221|NCT04791761|65758038|FG000|Overall Study|Protocol Violation|0|||
23555222|NCT04791761|65758039|FG001|Overall Study|Protocol Violation|1|||
23555223|NCT04791761|65758040|FG002|Overall Study|Protocol Violation|1|||
23555224|NCT04020341|65758041|FG000|Overall Study|Adverse Event|8|||
23555225|NCT04020341|65758042|FG001|Overall Study|Adverse Event|6|||
23555226|NCT04020341|65758041|FG000|Overall Study|Lost to Follow-up|8|||
23555227|NCT04020341|65758042|FG001|Overall Study|Lost to Follow-up|2|||
23555228|NCT04020341|65758041|FG000|Overall Study|Withdrawal by Subject|16|||
23555229|NCT04020341|65758042|FG001|Overall Study|Withdrawal by Subject|16|||
23555230|NCT04020341|65758041|FG000|Overall Study|Participant not able to swallow the tablet|1|||
23555231|NCT04020341|65758042|FG001|Overall Study|Participant not able to swallow the tablet|0|||
23555232|NCT04020341|65758041|FG000|Overall Study|Physician Decision|0|||
23555233|NCT04020341|65758042|FG001|Overall Study|Physician Decision|2|||
23555234|NCT04020341|65758041|FG000|Overall Study|Protocol Deviation|0|||
23555235|NCT04020341|65758042|FG001|Overall Study|Protocol Deviation|2|||
23555236|NCT04987762|65758045|FG000|Overall Study|Study was Terminated by Sponsor|103|||
23555237|NCT01970462|65758046|FG000|Overall Study|Lost to Follow-up|0|||
23555238|NCT01970462|65758047|FG001|Overall Study|Lost to Follow-up|2|||
23555239|NCT00440531|65758054|FG000|Overall Study|Adverse Event|1|||
23823591|NCT00111241|66734526|FG001|Overall Study|Protocol Violation|8|||
23823592|NCT00111241|66734525|FG000|Overall Study|Adverse Event|1|||
23823593|NCT00111241|66734526|FG001|Overall Study|Adverse Event|0|||
23823594|NCT00761657|66734536|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
23823595|NCT00761657|66734537|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
23823596|NCT00761657|66734538|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
23823597|NCT00761657|66734539|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
23823598|NCT00761657|66734540|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
23823599|NCT00761657|66734541|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
23823600|NCT00761657|66734542|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
23823601|NCT00761657|66734543|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
23823602|NCT00761657|66734544|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
23823603|NCT00761657|66734536|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823604|NCT00761657|66734537|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823605|NCT00761657|66734538|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
23823606|NCT00761657|66734539|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
23823607|NCT00761657|66734540|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823608|NCT00761657|66734541|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823609|NCT00761657|66734542|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823610|NCT00761657|66734543|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823611|NCT00761657|66734544|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23823612|NCT00761657|66734536|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
23823613|NCT00761657|66734537|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
23823614|NCT00761657|66734538|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
23823615|NCT00761657|66734539|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
23823616|NCT00761657|66734540|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
23823617|NCT00761657|66734541|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
23823618|NCT00761657|66734542|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
23823619|NCT00761657|66734543|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
23823620|NCT00761657|66734544|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
23823621|NCT00761657|66734536|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
23823622|NCT00761657|66734537|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
23823623|NCT00761657|66734538|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
23823624|NCT00761657|66734539|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
23823625|NCT00761657|66734540|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
23823626|NCT00761657|66734541|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
23823627|NCT00761657|66734542|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
23823628|NCT00761657|66734543|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
23823629|NCT00761657|66734544|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
23823630|NCT02215967|66734545|FG000|Overall Study|Patient became ineligible for treatment|0|||
23823631|NCT02215967|66734546|FG001|Overall Study|Patient became ineligible for treatment|0|||
23823632|NCT02215967|66734547|FG002|Overall Study|Patient became ineligible for treatment|0|||
23823633|NCT02215967|66734548|FG003|Overall Study|Patient became ineligible for treatment|3|||
23823634|NCT02215967|66734545|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
23823635|NCT02215967|66734546|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
23823636|NCT02215967|66734547|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
23823637|NCT02215967|66734548|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
23823638|NCT01478373|66734551|FG000|Treatment Phase|Protocol Violation|1|||
23823639|NCT01478373|66734551|FG000|Survival Phase|Adverse Event|8|||
23823640|NCT01478373|66734551|FG000|Survival Phase|Protocol Violation|1|||
23823641|NCT01478373|66734551|FG000|Survival Phase|crossover to another study|2|||
23823642|NCT01478373|66734551|FG000|Survival Phase|Progressive Disease|27|||
23823643|NCT02006732|66734552|FG000|Overall Study|Adverse Event|10|||
23823644|NCT02006732|66734553|FG001|Overall Study|Adverse Event|7|||
23823645|NCT02006732|66734554|FG002|Overall Study|Adverse Event|4|||
23823646|NCT02006732|66734555|FG003|Overall Study|Adverse Event|2|||
23823647|NCT02006732|66734552|FG000|Overall Study|Lack of Efficacy|6|||
23823648|NCT02006732|66734553|FG001|Overall Study|Lack of Efficacy|3|||
23823649|NCT02006732|66734554|FG002|Overall Study|Lack of Efficacy|1|||
23823650|NCT02006732|66734555|FG003|Overall Study|Lack of Efficacy|1|||
23823651|NCT02006732|66734552|FG000|Overall Study|Protocol Violation|1|||
23823652|NCT02006732|66734553|FG001|Overall Study|Protocol Violation|1|||
23823653|NCT02006732|66734554|FG002|Overall Study|Protocol Violation|0|||
23823654|NCT02006732|66734555|FG003|Overall Study|Protocol Violation|0|||
23823655|NCT02006732|66734552|FG000|Overall Study|Lost to Follow-up|0|||
23823656|NCT02006732|66734553|FG001|Overall Study|Lost to Follow-up|1|||
23823657|NCT02006732|66734554|FG002|Overall Study|Lost to Follow-up|0|||
23823658|NCT02006732|66734555|FG003|Overall Study|Lost to Follow-up|0|||
23823659|NCT02006732|66734552|FG000|Overall Study|Withdrawal by Subject|3|||
23823660|NCT02006732|66734553|FG001|Overall Study|Withdrawal by Subject|0|||
23823661|NCT02006732|66734554|FG002|Overall Study|Withdrawal by Subject|4|||
23823662|NCT02006732|66734555|FG003|Overall Study|Withdrawal by Subject|1|||
23823663|NCT01023035|66734556|FG000|Treatment Period|Adverse Event|27|||
23823664|NCT01023035|66734557|FG001|Treatment Period|Adverse Event|32|||
23823665|NCT01023035|66734558|FG002|Treatment Period|Adverse Event|50|||
23823666|NCT01023035|66734556|FG000|Treatment Period|Non-Medical Reasons|19|||
23823667|NCT01023035|66734557|FG001|Treatment Period|Non-Medical Reasons|22|||
23823668|NCT01023035|66734558|FG002|Treatment Period|Non-Medical Reasons|44|||
23823669|NCT01023035|66734556|FG000|Treatment Period|Treatment Failure|26|||
23823670|NCT01023035|66734557|FG001|Treatment Period|Treatment Failure|31|||
23823671|NCT01023035|66734558|FG002|Treatment Period|Treatment Failure|24|||
23823672|NCT01023035|66734556|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
23823673|NCT01023035|66734557|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
23823674|NCT01023035|66734558|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
23823675|NCT01023035|66734556|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
23823676|NCT01023035|66734557|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
23823677|NCT01023035|66734558|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
23823678|NCT03180645|66734559|FG000|Overall Study|Adverse Event|0|||
23555240|NCT00440531|65758055|FG001|Overall Study|Adverse Event|0|||
23555241|NCT00440531|65758056|FG002|Overall Study|Adverse Event|2|||
23555242|NCT00440531|65758054|FG000|Overall Study|Withdrawal by Subject|2|||
23555243|NCT00440531|65758055|FG001|Overall Study|Withdrawal by Subject|0|||
23555244|NCT00440531|65758056|FG002|Overall Study|Withdrawal by Subject|0|||
23555245|NCT00440531|65758054|FG000|Overall Study|Protocol Violation|1|||
23555246|NCT00440531|65758055|FG001|Overall Study|Protocol Violation|2|||
23555247|NCT00440531|65758056|FG002|Overall Study|Protocol Violation|0|||
23555248|NCT00440531|65758054|FG000|Overall Study|Lost to Follow-up|4|||
23555249|NCT00440531|65758055|FG001|Overall Study|Lost to Follow-up|3|||
23555250|NCT00440531|65758056|FG002|Overall Study|Lost to Follow-up|5|||
23555251|NCT00440531|65758054|FG000|Overall Study|see pre-assignment details|2|||
23555252|NCT00440531|65758055|FG001|Overall Study|see pre-assignment details|0|||
23555253|NCT00440531|65758056|FG002|Overall Study|see pre-assignment details|0|||
23555254|NCT01773070|65758057|FG000|Overall Study|Withdrawal by Subject|24|||
23555255|NCT01773070|65758057|FG000|Overall Study|Lost to Follow-up|39|||
23555256|NCT01773070|65758057|FG000|Overall Study|Other|15|||
23555257|NCT01773070|65758057|FG000|Overall Study|Death (unrelated to study procedures)|3|||
23555258|NCT02355743|65758058|FG000|Overall Study|Withdrawal by Subject|1|||
23555259|NCT02355743|65758058|FG000|Overall Study|Lost to Follow-up|1|||
23555260|NCT03927950|65758059|FG000|Overall Study|Adverse Event|9|||
23555261|NCT01693068|65758060|FG000|Randomization Period|On-study|2|||
23555262|NCT01693068|65758061|FG001|Randomization Period|On-study|5|||
23555263|NCT01693068|65758062|FG002|Randomization Period|On-study|0|||
23555264|NCT01693068|65758060|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
23555265|NCT01693068|65758061|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
23555266|NCT01693068|65758062|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
23555267|NCT04385368|65758063|FG000|Overall Study|Death|5|||
23555268|NCT04385368|65758064|FG001|Overall Study|Death|5|||
23555269|NCT04385368|65758063|FG000|Overall Study|Physician Decision|3|||
23555270|NCT04385368|65758064|FG001|Overall Study|Physician Decision|0|||
23555271|NCT04385368|65758063|FG000|Overall Study|Withdrawal by Subject|4|||
23555272|NCT04385368|65758064|FG001|Overall Study|Withdrawal by Subject|3|||
23555273|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
23555274|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
23555275|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
23555276|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
23555277|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
23555278|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
23555279|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
23555280|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
23622599|NCT01101334|66005001|FG001|Overall Study|Withdrawal by Sponsor|1|||
23622600|NCT01101334|66005000|FG000|Overall Study|Progressive Disease|22|||
23622601|NCT01101334|66005001|FG001|Overall Study|Progressive Disease|35|||
23622602|NCT01101334|66005000|FG000|Overall Study|Other|2|||
23622603|NCT01101334|66005001|FG001|Overall Study|Other|1|||
23622604|NCT01066936|66005002|FG000|Overall Study|Death|2|||
23622605|NCT01066936|66005002|FG000|Overall Study|Device revised/removed|1|||
23622606|NCT01066936|66005002|FG000|Overall Study|Lost to Follow-up|3|||
23622607|NCT01066936|66005002|FG000|Overall Study|Withdrawal by Subject|4|||
23622608|NCT04969276|66005003|FG000|Overall Study|Protocol Deviation|0|||
23622609|NCT04969276|66005004|FG001|Overall Study|Protocol Deviation|1|||
23622610|NCT04969276|66005005|FG002|Overall Study|Protocol Deviation|0|||
23622611|NCT04969276|66005003|FG000|Overall Study|Withdrawal by Subject|1|||
23622612|NCT04969276|66005004|FG001|Overall Study|Withdrawal by Subject|10|||
23622613|NCT04969276|66005005|FG002|Overall Study|Withdrawal by Subject|0|||
23622614|NCT04969276|66005003|FG000|Overall Study|Lost to Follow-up|0|||
23622615|NCT04969276|66005004|FG001|Overall Study|Lost to Follow-up|1|||
23622616|NCT04969276|66005005|FG002|Overall Study|Lost to Follow-up|0|||
23622617|NCT00604188|66005006|FG000|Overall Study|Adverse Event|1|||
23622618|NCT00604188|66005007|FG001|Overall Study|Adverse Event|4|||
23622619|NCT00604188|66005006|FG000|Overall Study|Lost to Follow-up|17|||
23823679|NCT03180645|66734560|FG001|Overall Study|Adverse Event|1|||
23823680|NCT03180645|66734561|FG002|Overall Study|Adverse Event|2|||
23823681|NCT04411914|66734562|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
23823682|NCT04411914|66734563|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
23823683|NCT02536846|66734564|FG000|Overall Study|Withdrawal by Subject|1|||
23823684|NCT02181790|66734567|FG000|Overall Study|study terminated|2|||
23622620|NCT00604188|66005007|FG001|Overall Study|Lost to Follow-up|15|||
23622621|NCT00604188|66005006|FG000|Overall Study|Withdrawal by Subject|5|||
23622622|NCT00604188|66005007|FG001|Overall Study|Withdrawal by Subject|1|||
23622623|NCT00604188|66005006|FG000|Overall Study|Non-compliance with protocol|4|||
23622624|NCT00604188|66005007|FG001|Overall Study|Non-compliance with protocol|4|||
23823685|NCT02181790|66734568|FG001|Overall Study|study terminated|0|||
23823686|NCT02498392|66734577|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
23823687|NCT02498392|66734578|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
23823688|NCT02498392|66734577|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
23823689|NCT02498392|66734578|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
23823690|NCT02498392|66734577|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
23823691|NCT02498392|66734578|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
23823692|NCT02498392|66734577|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
23823693|NCT02498392|66734578|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
23823694|NCT02498392|66734577|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
23823695|NCT02498392|66734578|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
23823696|NCT02498392|66734577|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
23823697|NCT02498392|66734578|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
23823698|NCT00715624|66734587|FG000|Overall Study|Adverse Event|12|||
23823699|NCT00715624|66734588|FG001|Overall Study|Adverse Event|37|||
23823700|NCT00715624|66734587|FG000|Overall Study|Lack of Efficacy|11|||
23823701|NCT00715624|66734588|FG001|Overall Study|Lack of Efficacy|11|||
23823702|NCT00715624|66734587|FG000|Overall Study|Lost to Follow-up|1|||
23823703|NCT00715624|66734588|FG001|Overall Study|Lost to Follow-up|2|||
23823704|NCT00715624|66734587|FG000|Overall Study|Protocol Violation|1|||
23823705|NCT00715624|66734588|FG001|Overall Study|Protocol Violation|0|||
23823706|NCT00715624|66734587|FG000|Overall Study|Withdrawal by Subject|11|||
23823707|NCT00715624|66734588|FG001|Overall Study|Withdrawal by Subject|25|||
23823708|NCT00715624|66734587|FG000|Overall Study|Familial and personal reasons|10|||
23823709|NCT00715624|66734588|FG001|Overall Study|Familial and personal reasons|22|||
23823710|NCT00715624|66734587|FG000|Overall Study|Poor compliance|6|||
23823711|NCT00715624|66734588|FG001|Overall Study|Poor compliance|13|||
23622625|NCT00604188|66005006|FG000|Overall Study|Did not receive study drug|0|||
23622626|NCT00604188|66005007|FG001|Overall Study|Did not receive study drug|1|||
23622627|NCT01193218|66005008|FG000|0-12 Weeks|Adverse Event|6|||
23823712|NCT00715624|66734587|FG000|Overall Study|Sponsor decision|0|||
23622628|NCT01193218|66005009|FG001|0-12 Weeks|Adverse Event|0|||
23622629|NCT01193218|66005010|FG002|0-12 Weeks|Adverse Event|1|||
23622630|NCT01193218|66005011|FG003|0-12 Weeks|Adverse Event|0|||
23622631|NCT01193218|66005012|FG004|0-12 Weeks|Adverse Event|0|||
23622632|NCT01193218|66005013|FG005|0-12 Weeks|Adverse Event|2|||
23622633|NCT01193218|66005014|FG006|0-12 Weeks|Adverse Event|2|||
23622634|NCT01193218|66005015|FG007|0-12 Weeks|Adverse Event|0|||
23622635|NCT01193218|66005008|FG000|0-12 Weeks|Protocol Violation|0|||
23622636|NCT01193218|66005009|FG001|0-12 Weeks|Protocol Violation|0|||
23622637|NCT01193218|66005010|FG002|0-12 Weeks|Protocol Violation|0|||
23622638|NCT01193218|66005011|FG003|0-12 Weeks|Protocol Violation|0|||
23622639|NCT01193218|66005012|FG004|0-12 Weeks|Protocol Violation|1|||
23622640|NCT01193218|66005013|FG005|0-12 Weeks|Protocol Violation|1|||
23622641|NCT01193218|66005014|FG006|0-12 Weeks|Protocol Violation|0|||
23622642|NCT01193218|66005015|FG007|0-12 Weeks|Protocol Violation|0|||
23622643|NCT01193218|66005008|FG000|0-12 Weeks|Withdrawal by Subject|3|||
23622644|NCT01193218|66005009|FG001|0-12 Weeks|Withdrawal by Subject|0|||
23622645|NCT01193218|66005010|FG002|0-12 Weeks|Withdrawal by Subject|2|||
23622646|NCT01193218|66005011|FG003|0-12 Weeks|Withdrawal by Subject|0|||
23622647|NCT01193218|66005012|FG004|0-12 Weeks|Withdrawal by Subject|0|||
23622648|NCT01193218|66005013|FG005|0-12 Weeks|Withdrawal by Subject|0|||
23622649|NCT01193218|66005014|FG006|0-12 Weeks|Withdrawal by Subject|1|||
23622650|NCT01193218|66005015|FG007|0-12 Weeks|Withdrawal by Subject|0|||
23622651|NCT01193218|66005008|FG000|12-52 Weeks|Adverse Event|1|||
23823713|NCT00715624|66734588|FG001|Overall Study|Sponsor decision|4|||
23823714|NCT00715624|66734587|FG000|Overall Study|Incorrect randomization (not treated)|0|||
23823715|NCT00715624|66734588|FG001|Overall Study|Incorrect randomization (not treated)|1|||
23823716|NCT00715624|66734587|FG000|Overall Study|Other|0|||
23823717|NCT00715624|66734588|FG001|Overall Study|Other|1|||
23823718|NCT02503787|66734594|FG000|Enrollment|Withdrawal by Subject|6|||
23823719|NCT02503787|66734594|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
23823720|NCT02503787|66734594|FG000|Enrollment|Physician Decision|2|||
23823721|NCT02503787|66734594|FG000|Enrollment|Insurance issue|2|||
23823722|NCT02503787|66734594|FG000|Enrollment|Lost to Follow-up|1|||
23823723|NCT02503787|66734594|FG000|Enrollment|Study closure|1|||
23823724|NCT02503787|66734594|FG000|Enrollment|Adverse Event|1|||
23823725|NCT02503787|66734594|FG000|Enrollment|Protocol Violation|1|||
23622652|NCT01193218|66005009|FG001|12-52 Weeks|Adverse Event|0|||
23622653|NCT01193218|66005010|FG002|12-52 Weeks|Adverse Event|1|||
23622654|NCT01193218|66005011|FG003|12-52 Weeks|Adverse Event|2|||
23823726|NCT02503787|66734594|FG000|Enrollment|Inability to implant system|1|||
23823727|NCT02503787|66734594|FG000|Enrollment|Unable to be programmed|1|||
23748347|NCT01674010|66457601|FG000|Open Treatment Phase 1|Physician Decision|9|||
23748348|NCT01674010|66457602|FG001|Open Treatment Phase 1|Physician Decision|0|||
23748349|NCT01674010|66457603|FG002|Open Treatment Phase 1|Physician Decision|0|||
23748350|NCT01674010|66457601|FG000|Open Treatment Phase 1|Protocol Violation|7|||
23748351|NCT01674010|66457602|FG001|Open Treatment Phase 1|Protocol Violation|0|||
23748352|NCT01674010|66457603|FG002|Open Treatment Phase 1|Protocol Violation|0|||
23748353|NCT01674010|66457601|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
23748354|NCT01674010|66457602|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
23748355|NCT01674010|66457603|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
23748356|NCT01674010|66457601|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
23748357|NCT01674010|66457602|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
23748358|NCT01674010|66457603|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
23748359|NCT01674010|66457601|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
23748360|NCT01674010|66457602|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
23748361|NCT01674010|66457603|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
23748362|NCT01674010|66457601|FG000|Randomization Phase 2|Adverse Event|0|||
23748363|NCT01674010|66457602|FG001|Randomization Phase 2|Adverse Event|1|||
23748364|NCT01674010|66457603|FG002|Randomization Phase 2|Adverse Event|1|||
23748365|NCT01674010|66457601|FG000|Randomization Phase 2|Lost to Follow-up|0|||
23748366|NCT01674010|66457602|FG001|Randomization Phase 2|Lost to Follow-up|1|||
23748367|NCT01674010|66457603|FG002|Randomization Phase 2|Lost to Follow-up|2|||
23748368|NCT01674010|66457601|FG000|Randomization Phase 2|Mood episode recurrence|0|||
23748369|NCT01674010|66457602|FG001|Randomization Phase 2|Mood episode recurrence|8|||
23748370|NCT01674010|66457603|FG002|Randomization Phase 2|Mood episode recurrence|2|||
23748371|NCT01674010|66457601|FG000|Randomization Phase 2|Physician Decision|0|||
23748372|NCT01674010|66457602|FG001|Randomization Phase 2|Physician Decision|0|||
23748373|NCT01674010|66457603|FG002|Randomization Phase 2|Physician Decision|2|||
23622655|NCT01193218|66005012|FG004|12-52 Weeks|Adverse Event|3|||
23622656|NCT01193218|66005013|FG005|12-52 Weeks|Adverse Event|3|||
23622657|NCT01193218|66005014|FG006|12-52 Weeks|Adverse Event|1|||
23622658|NCT01193218|66005015|FG007|12-52 Weeks|Adverse Event|2|||
23823728|NCT02503787|66734594|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
23823729|NCT02503787|66734594|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
23823730|NCT02503787|66734594|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
23823731|NCT02503787|66734594|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
23823732|NCT02503787|66734594|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
23823733|NCT02503787|66734594|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
23823734|NCT02430480|66734595|FG000|Overall Study|Death|1|||
23823735|NCT02430480|66734595|FG000|Overall Study|Anesthesia concerns|1|||
23823736|NCT02430480|66734595|FG000|Overall Study|Progressed on treatment|1|||
23823737|NCT00524420|66734596|FG000|Overall Study|Lack of Efficacy|1|||
23823738|NCT00524420|66734597|FG001|Overall Study|Lack of Efficacy|0|||
23823739|NCT02652949|66734598|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
23823740|NCT02652949|66734598|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
23823741|NCT02652949|66734598|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
23823742|NCT02652949|66734598|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23823743|NCT02652949|66734598|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23823744|NCT02652949|66734598|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
23823745|NCT02652949|66734598|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
23823746|NCT02652949|66734598|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
23823747|NCT02652949|66734598|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
23823748|NCT02652949|66734598|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
23823749|NCT02652949|66734598|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
23823750|NCT02652949|66734598|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23823751|NCT02652949|66734598|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
23823752|NCT02652949|66734598|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23823753|NCT02652949|66734598|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23823754|NCT02652949|66734598|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
23823755|NCT02652949|66734598|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23823756|NCT00141778|66734599|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
23823757|NCT00141778|66734600|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
23823758|NCT00141778|66734601|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
23823759|NCT00141778|66734599|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
23823760|NCT00141778|66734600|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
23823761|NCT00141778|66734601|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
23823762|NCT00141778|66734599|FG000|Started Study Medication|Withdrawal by Subject|0|||
23823763|NCT00141778|66734600|FG001|Started Study Medication|Withdrawal by Subject|2|||
23823764|NCT00141778|66734601|FG002|Started Study Medication|Withdrawal by Subject|0|||
23823765|NCT00141778|66734599|FG000|Started Study Medication|Difficulty Swallowing|0|||
23823766|NCT00141778|66734600|FG001|Started Study Medication|Difficulty Swallowing|1|||
23823767|NCT00141778|66734601|FG002|Started Study Medication|Difficulty Swallowing|0|||
23823768|NCT00141778|66734599|FG000|Started Study Medication|Chest Discomfort|0|||
23823769|NCT00141778|66734600|FG001|Started Study Medication|Chest Discomfort|0|||
23823770|NCT00141778|66734601|FG002|Started Study Medication|Chest Discomfort|1|||
23748374|NCT01674010|66457601|FG000|Randomization Phase 2|Pregnancy|0|||
23748375|NCT01674010|66457602|FG001|Randomization Phase 2|Pregnancy|1|||
23748376|NCT01674010|66457603|FG002|Randomization Phase 2|Pregnancy|1|||
23748377|NCT01674010|66457601|FG000|Randomization Phase 2|Protocol Violation|0|||
23748378|NCT01674010|66457602|FG001|Randomization Phase 2|Protocol Violation|1|||
23748379|NCT01674010|66457603|FG002|Randomization Phase 2|Protocol Violation|1|||
23748380|NCT01674010|66457601|FG000|Randomization Phase 2|Sponsor Decision|0|||
23748381|NCT01674010|66457602|FG001|Randomization Phase 2|Sponsor Decision|42|||
23748382|NCT01674010|66457603|FG002|Randomization Phase 2|Sponsor Decision|45|||
23748383|NCT01674010|66457601|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
23748384|NCT01674010|66457602|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
23748385|NCT01674010|66457603|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
23748386|NCT00276458|66457604|FG000|Overall Study|Adverse Event|0|||
23748387|NCT00276458|66457605|FG001|Overall Study|Adverse Event|2|||
23748388|NCT00276458|66457604|FG000|Overall Study|Lost to Follow-up|2|||
23748389|NCT00276458|66457605|FG001|Overall Study|Lost to Follow-up|2|||
23748390|NCT00276458|66457604|FG000|Overall Study|Protocol Violation|4|||
23748391|NCT00276458|66457605|FG001|Overall Study|Protocol Violation|3|||
23622659|NCT01193218|66005008|FG000|12-52 Weeks|Lack of Efficacy|0|||
23748392|NCT00290511|66457608|FG000|Overall Study|Adverse Event|1|||
23748393|NCT00290511|66457608|FG000|Overall Study|Death|1|||
23748394|NCT00290511|66457608|FG000|Overall Study|Physician Decision|1|||
23748395|NCT00290511|66457608|FG000|Overall Study|Withdrawal by Subject|1|||
23748396|NCT02325739|66457609|FG000|Phase I Part|Adverse Event|1|||
23748397|NCT02325739|66457610|FG001|Phase I Part|Adverse Event|0|||
23748398|NCT02325739|66457611|FG002|Phase I Part|Adverse Event|1|||
23748399|NCT02325739|66457612|FG003|Phase I Part|Adverse Event|2|||
23433172|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
23433173|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
23433174|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
23433175|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
23433176|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
23433177|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
23433178|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
23433179|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
23748400|NCT02325739|66457613|FG004|Phase I Part|Adverse Event|3|||
23748401|NCT02325739|66457614|FG005|Phase I Part|Adverse Event|1|||
23748402|NCT02325739|66457615|FG006|Phase I Part|Adverse Event|0|||
23748403|NCT02325739|66457616|FG007|Phase I Part|Adverse Event|2|||
23748404|NCT02325739|66457617|FG008|Phase I Part|Adverse Event|0|||
23748405|NCT02325739|66457618|FG009|Phase I Part|Adverse Event|0|||
23748406|NCT02325739|66457619|FG010|Phase I Part|Adverse Event|0|||
23748407|NCT02325739|66457609|FG000|Phase I Part|Progressive disease|9|||
23748408|NCT02325739|66457610|FG001|Phase I Part|Progressive disease|6|||
23748409|NCT02325739|66457611|FG002|Phase I Part|Progressive disease|3|||
23748410|NCT02325739|66457612|FG003|Phase I Part|Progressive disease|23|||
23748411|NCT02325739|66457613|FG004|Phase I Part|Progressive disease|14|||
23748412|NCT02325739|66457614|FG005|Phase I Part|Progressive disease|6|||
23748413|NCT02325739|66457615|FG006|Phase I Part|Progressive disease|6|||
23748414|NCT02325739|66457616|FG007|Phase I Part|Progressive disease|3|||
23748415|NCT02325739|66457617|FG008|Phase I Part|Progressive disease|0|||
23748416|NCT02325739|66457618|FG009|Phase I Part|Progressive disease|0|||
23748417|NCT02325739|66457619|FG010|Phase I Part|Progressive disease|0|||
23748418|NCT02325739|66457609|FG000|Phase I Part|Subject/guardian decision|1|||
23748419|NCT02325739|66457610|FG001|Phase I Part|Subject/guardian decision|0|||
23748420|NCT02325739|66457611|FG002|Phase I Part|Subject/guardian decision|1|||
23748421|NCT02325739|66457612|FG003|Phase I Part|Subject/guardian decision|1|||
23748422|NCT02325739|66457613|FG004|Phase I Part|Subject/guardian decision|0|||
23748423|NCT02325739|66457614|FG005|Phase I Part|Subject/guardian decision|0|||
23748424|NCT02325739|66457615|FG006|Phase I Part|Subject/guardian decision|0|||
23748425|NCT02325739|66457616|FG007|Phase I Part|Subject/guardian decision|1|||
23748426|NCT02325739|66457617|FG008|Phase I Part|Subject/guardian decision|0|||
23748427|NCT02325739|66457618|FG009|Phase I Part|Subject/guardian decision|0|||
23748428|NCT02325739|66457619|FG010|Phase I Part|Subject/guardian decision|0|||
23748429|NCT02325739|66457609|FG000|Phase I Part|Death|0|||
23748430|NCT02325739|66457610|FG001|Phase I Part|Death|0|||
23748431|NCT02325739|66457611|FG002|Phase I Part|Death|0|||
23433180|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
23748432|NCT02325739|66457612|FG003|Phase I Part|Death|0|||
23748433|NCT02325739|66457613|FG004|Phase I Part|Death|2|||
23748434|NCT02325739|66457614|FG005|Phase I Part|Death|0|||
23748435|NCT02325739|66457615|FG006|Phase I Part|Death|0|||
23748436|NCT02325739|66457616|FG007|Phase I Part|Death|0|||
23748437|NCT02325739|66457617|FG008|Phase I Part|Death|0|||
23748438|NCT02325739|66457618|FG009|Phase I Part|Death|0|||
23748439|NCT02325739|66457619|FG010|Phase I Part|Death|0|||
23748440|NCT02325739|66457609|FG000|Phase II Part|Adverse Event|0|||
23748441|NCT02325739|66457610|FG001|Phase II Part|Adverse Event|0|||
23748442|NCT02325739|66457611|FG002|Phase II Part|Adverse Event|0|||
23748443|NCT02325739|66457612|FG003|Phase II Part|Adverse Event|0|||
23823771|NCT00193050|66737637|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
23433181|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
23622660|NCT01193218|66005009|FG001|12-52 Weeks|Lack of Efficacy|0|||
23748444|NCT02325739|66457613|FG004|Phase II Part|Adverse Event|0|||
23748445|NCT02325739|66457614|FG005|Phase II Part|Adverse Event|0|||
23748446|NCT02325739|66457615|FG006|Phase II Part|Adverse Event|0|||
23748447|NCT02325739|66457616|FG007|Phase II Part|Adverse Event|0|||
23748448|NCT02325739|66457617|FG008|Phase II Part|Adverse Event|4|||
23748449|NCT02325739|66457618|FG009|Phase II Part|Adverse Event|5|||
23748450|NCT02325739|66457619|FG010|Phase II Part|Adverse Event|1|||
23748451|NCT02325739|66457609|FG000|Phase II Part|Physician Decision|0|||
23748452|NCT02325739|66457610|FG001|Phase II Part|Physician Decision|0|||
23748453|NCT02325739|66457611|FG002|Phase II Part|Physician Decision|0|||
23748454|NCT02325739|66457612|FG003|Phase II Part|Physician Decision|0|||
23748455|NCT02325739|66457613|FG004|Phase II Part|Physician Decision|0|||
23622661|NCT01193218|66005010|FG002|12-52 Weeks|Lack of Efficacy|0|||
23622662|NCT01193218|66005011|FG003|12-52 Weeks|Lack of Efficacy|0|||
23622663|NCT01193218|66005012|FG004|12-52 Weeks|Lack of Efficacy|0|||
23622664|NCT01193218|66005013|FG005|12-52 Weeks|Lack of Efficacy|0|||
23622665|NCT01193218|66005014|FG006|12-52 Weeks|Lack of Efficacy|1|||
23622666|NCT01193218|66005015|FG007|12-52 Weeks|Lack of Efficacy|0|||
23823772|NCT00193050|66737637|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
23823773|NCT00193050|66737637|FG000|Neoadjuvant Treatment|Physician Decision|2|||
23823774|NCT00193050|66737637|FG000|Neoadjuvant Treatment|Adverse Event|2|||
23823775|NCT00193050|66737637|FG000|Adjuvant|Physician Decision|5|||
23823776|NCT00193050|66737637|FG000|Adjuvant|Intercurrent Hospitalization|3|||
23823777|NCT00193050|66737637|FG000|Adjuvant|Lack of Efficacy|2|||
23823778|NCT02288312|66737638|FG000|Overall Study|Pregnancy|1|||
23823779|NCT02288312|66737639|FG001|Overall Study|Pregnancy|0|||
23823780|NCT02288312|66737640|FG002|Overall Study|Pregnancy|0|||
23823781|NCT02964312|66737645|FG000|Overall Study|Lost to Follow-up|28|||
23823782|NCT02964312|66737645|FG000|Overall Study|Withdrawal by Subject|11|||
23823783|NCT02964312|66737645|FG000|Overall Study|Lack of Efficacy|10|||
23823784|NCT02964312|66737645|FG000|Overall Study|Did not consent to long-term FU|14|||
23823785|NCT02964312|66737645|FG000|Overall Study|Death|1|||
23823786|NCT03200717|66737649|FG000|Overall Study|Progressive disease|24|||
23823787|NCT03200717|66737650|FG001|Overall Study|Progressive disease|5|||
23823788|NCT03200717|66737649|FG000|Overall Study|Adverse Event|11|||
23823789|NCT03200717|66737650|FG001|Overall Study|Adverse Event|8|||
23823790|NCT03200717|66737649|FG000|Overall Study|Physician Decision|3|||
23823791|NCT03200717|66737650|FG001|Overall Study|Physician Decision|2|||
23823792|NCT03200717|66737649|FG000|Overall Study|Death|2|||
23823793|NCT03200717|66737650|FG001|Overall Study|Death|0|||
23823794|NCT03200717|66737649|FG000|Overall Study|Subject/Guardian Decision|1|||
23823795|NCT03200717|66737650|FG001|Overall Study|Subject/Guardian Decision|0|||
23823796|NCT02452476|66737651|FG000|Overall Study|Death|4|||
23823797|NCT02452476|66737652|FG001|Overall Study|Death|7|||
23823798|NCT02452476|66737651|FG000|Overall Study|Lost to Follow-up|1|||
23823799|NCT02452476|66737652|FG001|Overall Study|Lost to Follow-up|1|||
23823800|NCT02452476|66737651|FG000|Overall Study|Physician Decision|1|||
23823801|NCT02452476|66737652|FG001|Overall Study|Physician Decision|1|||
23823802|NCT02452476|66737651|FG000|Overall Study|Not treated|5|||
23823803|NCT02452476|66737652|FG001|Overall Study|Not treated|1|||
23622667|NCT01193218|66005008|FG000|12-52 Weeks|Withdrawal by Subject|3|||
23823804|NCT01260701|66737656|FG000|Overall Study|Adverse Event|9|||
23823805|NCT01260701|66737656|FG000|Overall Study|Withdrawal by Subject|2|||
23823806|NCT01260701|66737656|FG000|Overall Study|Progression|53|||
23823807|NCT01260701|66737656|FG000|Overall Study|Death|2|||
23823808|NCT01260701|66737656|FG000|Overall Study|Not protocol specified|3|||
23748456|NCT02325739|66457614|FG005|Phase II Part|Physician Decision|0|||
23748457|NCT02325739|66457615|FG006|Phase II Part|Physician Decision|0|||
23748458|NCT02325739|66457616|FG007|Phase II Part|Physician Decision|0|||
23748459|NCT02325739|66457617|FG008|Phase II Part|Physician Decision|0|||
23748460|NCT02325739|66457618|FG009|Phase II Part|Physician Decision|1|||
23748461|NCT02325739|66457619|FG010|Phase II Part|Physician Decision|0|||
23748462|NCT02325739|66457609|FG000|Phase II Part|Progressive disease|0|||
23748463|NCT02325739|66457610|FG001|Phase II Part|Progressive disease|0|||
23748464|NCT02325739|66457611|FG002|Phase II Part|Progressive disease|0|||
23748465|NCT02325739|66457612|FG003|Phase II Part|Progressive disease|0|||
23748466|NCT02325739|66457613|FG004|Phase II Part|Progressive disease|0|||
23748467|NCT02325739|66457614|FG005|Phase II Part|Progressive disease|0|||
23748468|NCT02325739|66457615|FG006|Phase II Part|Progressive disease|0|||
23748469|NCT02325739|66457616|FG007|Phase II Part|Progressive disease|0|||
23748470|NCT02325739|66457617|FG008|Phase II Part|Progressive disease|22|||
23748471|NCT02325739|66457618|FG009|Phase II Part|Progressive disease|29|||
23748472|NCT02325739|66457619|FG010|Phase II Part|Progressive disease|18|||
23748473|NCT02325739|66457609|FG000|Phase II Part|Subject/guardian decision|0|||
23823809|NCT01260701|66737656|FG000|Overall Study|Under review|1|||
23748474|NCT02325739|66457610|FG001|Phase II Part|Subject/guardian decision|0|||
23748475|NCT02325739|66457611|FG002|Phase II Part|Subject/guardian decision|0|||
23748476|NCT02325739|66457612|FG003|Phase II Part|Subject/guardian decision|0|||
23748477|NCT02325739|66457613|FG004|Phase II Part|Subject/guardian decision|0|||
23748478|NCT02325739|66457614|FG005|Phase II Part|Subject/guardian decision|0|||
23748479|NCT02325739|66457615|FG006|Phase II Part|Subject/guardian decision|0|||
23748480|NCT02325739|66457616|FG007|Phase II Part|Subject/guardian decision|0|||
23748481|NCT02325739|66457617|FG008|Phase II Part|Subject/guardian decision|4|||
23748482|NCT02325739|66457618|FG009|Phase II Part|Subject/guardian decision|1|||
23748483|NCT02325739|66457619|FG010|Phase II Part|Subject/guardian decision|1|||
23748484|NCT00351611|66457621|FG000|Overall Study|Adverse Event|11|||
23748485|NCT00351611|66457622|FG001|Overall Study|Adverse Event|3|||
23748486|NCT00351611|66457621|FG000|Overall Study|Death|1|||
23748487|NCT00351611|66457622|FG001|Overall Study|Death|0|||
23748488|NCT00351611|66457621|FG000|Overall Study|Lost to Follow-up|1|||
23748489|NCT00351611|66457622|FG001|Overall Study|Lost to Follow-up|0|||
23748490|NCT00351611|66457621|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
23748491|NCT00351611|66457622|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
23748492|NCT00351611|66457621|FG000|Overall Study|Other|1|||
23748493|NCT00351611|66457622|FG001|Overall Study|Other|0|||
23748494|NCT00351611|66457621|FG000|Overall Study|Protocol Violation|0|||
23748495|NCT00351611|66457622|FG001|Overall Study|Protocol Violation|2|||
23748496|NCT00054275|66457623|FG000|Overall Study|Withdrawal by Subject|4|||
23748497|NCT00054275|66457623|FG000|Overall Study|Adverse Event|5|||
23748498|NCT00054275|66457623|FG000|Overall Study|Progressive disease in cycle 1|1|||
23748499|NCT00054275|66457623|FG000|Overall Study|Physician Decision|1|||
23748500|NCT01300741|66457629|FG000|Overall Study|Lens deposits|1|||
23748501|NCT01300741|66457629|FG000|Overall Study|Lost to Follow-up|1|||
23748502|NCT01300741|66457629|FG000|Overall Study|Discomfort|1|||
23748503|NCT00902265|66460197|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
23748504|NCT00902265|66460197|FG000|Overall Study|Adverse Event|2|||
23748505|NCT00902265|66460197|FG000|Overall Study|Lack of Efficacy|2|||
23748506|NCT00902265|66460197|FG000|Overall Study|Protocol Violation|1|||
23748507|NCT02871921|66460198|FG000|Overall Study|Withdrawal by Subject|34|||
23748508|NCT02871921|66460199|FG001|Overall Study|Withdrawal by Subject|27|||
23748509|NCT02871921|66460200|FG002|Overall Study|Withdrawal by Subject|27|||
23748510|NCT02871921|66460201|FG003|Overall Study|Withdrawal by Subject|30|||
23748511|NCT00674440|66460202|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
23823810|NCT01260701|66737656|FG000|Overall Study|Ineligible|4|||
23823811|NCT01260701|66737656|FG000|Overall Study|Did not begin protocol therapy|1|||
23823812|NCT00369486|66737663|FG000|4-Week Visit|Missed visit|2|||
23823813|NCT00369486|66737664|FG001|4-Week Visit|Missed visit|2|||
23823814|NCT00369486|66737665|FG002|4-Week Visit|Missed visit|0|||
23823815|NCT00369486|66737666|FG003|4-Week Visit|Missed visit|2|||
23622668|NCT01193218|66005009|FG001|12-52 Weeks|Withdrawal by Subject|0|||
23823816|NCT00369486|66737667|FG004|4-Week Visit|Missed visit|1|||
23823817|NCT00369486|66737663|FG000|4-Week Visit|Dropped|0|||
23622669|NCT01193218|66005010|FG002|12-52 Weeks|Withdrawal by Subject|3|||
23622670|NCT01193218|66005011|FG003|12-52 Weeks|Withdrawal by Subject|0|||
23748512|NCT00674440|66460202|FG000|Overall Study|did not have surgery, so unevaluable|7|||
23748513|NCT00674440|66460202|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
23748514|NCT00646282|66460203|FG000|Overall Study|Protocol terminated|4|||
23748515|NCT00646282|66460204|FG001|Overall Study|Protocol terminated|4|||
23823818|NCT00369486|66737664|FG001|4-Week Visit|Dropped|0|||
23823819|NCT00369486|66737665|FG002|4-Week Visit|Dropped|1|||
23823820|NCT00369486|66737666|FG003|4-Week Visit|Dropped|0|||
23823821|NCT00369486|66737667|FG004|4-Week Visit|Dropped|0|||
23823822|NCT00369486|66737663|FG000|8-Week Visit|Missed visit|0|||
23622671|NCT01193218|66005012|FG004|12-52 Weeks|Withdrawal by Subject|0|||
23622672|NCT01193218|66005013|FG005|12-52 Weeks|Withdrawal by Subject|2|||
23622673|NCT01193218|66005014|FG006|12-52 Weeks|Withdrawal by Subject|1|||
23622674|NCT01193218|66005015|FG007|12-52 Weeks|Withdrawal by Subject|2|||
23622675|NCT01193218|66005008|FG000|12-52 Weeks|Other reason than above|1|||
23622676|NCT01193218|66005009|FG001|12-52 Weeks|Other reason than above|0|||
23622677|NCT01193218|66005010|FG002|12-52 Weeks|Other reason than above|0|||
23622678|NCT01193218|66005011|FG003|12-52 Weeks|Other reason than above|1|||
23622679|NCT01193218|66005012|FG004|12-52 Weeks|Other reason than above|1|||
23622680|NCT01193218|66005013|FG005|12-52 Weeks|Other reason than above|0|||
23622681|NCT01193218|66005014|FG006|12-52 Weeks|Other reason than above|0|||
23622682|NCT01193218|66005015|FG007|12-52 Weeks|Other reason than above|0|||
23433182|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
23433183|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
23433184|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
23433185|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23433186|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
23433187|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
23433188|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23433189|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
23433190|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
23433191|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
23433192|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
23433193|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23433194|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23433195|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23748516|NCT00665366|66460205|FG000|Overall Study|Lack of Efficacy|11|||
23748517|NCT00665366|66460206|FG001|Overall Study|Lack of Efficacy|10|||
23748518|NCT00665366|66460205|FG000|Overall Study|Adverse Event|25|||
23748519|NCT00665366|66460206|FG001|Overall Study|Adverse Event|23|||
23748520|NCT00665366|66460205|FG000|Overall Study|Withdrawal by Subject|11|||
23748521|NCT00665366|66460206|FG001|Overall Study|Withdrawal by Subject|14|||
23748522|NCT00665366|66460205|FG000|Overall Study|Lost to Follow-up|3|||
23748523|NCT00665366|66460206|FG001|Overall Study|Lost to Follow-up|5|||
23748524|NCT00665366|66460205|FG000|Overall Study|Poor compliance/noncompliance|3|||
23748525|NCT00665366|66460206|FG001|Overall Study|Poor compliance/noncompliance|5|||
23748526|NCT00665366|66460205|FG000|Overall Study|Pregnancy|1|||
23748527|NCT00665366|66460206|FG001|Overall Study|Pregnancy|0|||
23748528|NCT00665366|66460205|FG000|Overall Study|No longer meets study criteria|0|||
23748529|NCT00665366|66460206|FG001|Overall Study|No longer meets study criteria|1|||
23748530|NCT00665366|66460205|FG000|Overall Study|Other reasons|4|||
23748531|NCT00665366|66460206|FG001|Overall Study|Other reasons|1|||
23748532|NCT00209560|66460209|FG000|Overall Study|Lack of Efficacy|1|||
23748533|NCT00209560|66460210|FG001|Overall Study|Lack of Efficacy|0|||
23748534|NCT02797951|66460211|FG000|Overall Study|Adverse Event|4|||
23748535|NCT02797951|66460211|FG000|Overall Study|Death|1|||
23748536|NCT02797951|66460211|FG000|Overall Study|Lack of Efficacy|19|||
23748537|NCT02797951|66460211|FG000|Overall Study|Lost to Follow-up|4|||
23748538|NCT02797951|66460211|FG000|Overall Study|Physician Decision|6|||
23748539|NCT02797951|66460211|FG000|Overall Study|Withdrawal by Subject|15|||
23433196|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
23433197|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
23433198|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
23622683|NCT02561078|66005016|FG000|Overall Study|Adverse Event|5|||
23622684|NCT02561078|66005017|FG001|Overall Study|Adverse Event|2|||
23622685|NCT02561078|66005016|FG000|Overall Study|Death|2|||
23622686|NCT02561078|66005017|FG001|Overall Study|Death|1|||
23622687|NCT02561078|66005016|FG000|Overall Study|Lost to Follow-up|2|||
23622688|NCT02561078|66005017|FG001|Overall Study|Lost to Follow-up|6|||
23622689|NCT02561078|66005016|FG000|Overall Study|Non-Compliance with Study Drug|6|||
23622690|NCT02561078|66005017|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23622691|NCT02561078|66005016|FG000|Overall Study|Physician Decision|2|||
23622692|NCT02561078|66005017|FG001|Overall Study|Physician Decision|3|||
23622693|NCT02561078|66005016|FG000|Overall Study|Withdrawal by Subject|13|||
23748540|NCT02325401|66460213|FG000|Overall Study|Withdrawal by Subject|0|||
23823823|NCT00369486|66737664|FG001|8-Week Visit|Missed visit|1|||
23622694|NCT02561078|66005017|FG001|Overall Study|Withdrawal by Subject|10|||
23748541|NCT02325401|66460214|FG001|Overall Study|Withdrawal by Subject|1|||
23748542|NCT02325401|66460215|FG002|Overall Study|Withdrawal by Subject|1|||
23748543|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
23748544|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
23748545|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
23748546|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
23748547|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
23748548|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23748549|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23622695|NCT01227928|66005018|FG000|Overall Study|Lost to Follow-up|4|||
23622696|NCT01227928|66005019|FG001|Overall Study|Lost to Follow-up|2|||
23622697|NCT01227928|66005018|FG000|Overall Study|Withdrawal by Subject|4|||
23622698|NCT01227928|66005019|FG001|Overall Study|Withdrawal by Subject|3|||
23622699|NCT01227928|66005018|FG000|Overall Study|Death|14|||
23622700|NCT01227928|66005019|FG001|Overall Study|Death|12|||
23622701|NCT00713206|66005020|FG000|Overall Study|Lost to Follow-up|4|||
23622702|NCT00713206|66005021|FG001|Overall Study|Lost to Follow-up|4|||
23622703|NCT00713206|66005020|FG000|Overall Study|Death|1|||
23622704|NCT00713206|66005021|FG001|Overall Study|Death|0|||
23622705|NCT03082612|66005022|FG000|Overall Study|Lost to Follow-up|2|||
23622706|NCT03082612|66005023|FG001|Overall Study|Lost to Follow-up|0|||
23622707|NCT01845649|66005024|FG000|Overall Study|Adverse Event|7|||
23622708|NCT01845649|66005025|FG001|Overall Study|Adverse Event|10|||
23622709|NCT01845649|66005024|FG000|Overall Study|Lack of Efficacy|1|||
23622710|NCT01845649|66005025|FG001|Overall Study|Lack of Efficacy|1|||
23622711|NCT01845649|66005024|FG000|Overall Study|Lost to Follow-up|2|||
23622712|NCT01845649|66005025|FG001|Overall Study|Lost to Follow-up|2|||
23622713|NCT01845649|66005024|FG000|Overall Study|Withdrew Consent|12|||
23622714|NCT01845649|66005025|FG001|Overall Study|Withdrew Consent|4|||
23622715|NCT01845649|66005024|FG000|Overall Study|Protocol Deviation|7|||
23622716|NCT01845649|66005025|FG001|Overall Study|Protocol Deviation|4|||
23622717|NCT01845649|66005024|FG000|Overall Study|Reason not Specified|2|||
23622718|NCT01845649|66005025|FG001|Overall Study|Reason not Specified|1|||
23622719|NCT02037256|66005026|FG000|Overall Study|Protocol Violation|0|||
23622720|NCT02037256|66005027|FG001|Overall Study|Protocol Violation|1|||
23622721|NCT02037256|66005026|FG000|Overall Study|Withdrawn prior to Velcade|0|||
23622722|NCT02037256|66005027|FG001|Overall Study|Withdrawn prior to Velcade|2|||
23622723|NCT03305809|66005028|FG000|Overall Study|Adverse Event|2|||
23622724|NCT03305809|66005029|FG001|Overall Study|Adverse Event|2|||
23622725|NCT03305809|66005030|FG002|Overall Study|Adverse Event|6|||
23622726|NCT03305809|66005031|FG003|Overall Study|Adverse Event|6|||
23622727|NCT03305809|66005028|FG000|Overall Study|Death|0|||
23622728|NCT03305809|66005029|FG001|Overall Study|Death|0|||
23622729|NCT03305809|66005030|FG002|Overall Study|Death|1|||
23622730|NCT03305809|66005031|FG003|Overall Study|Death|1|||
23622731|NCT03305809|66005028|FG000|Overall Study|Lost to Follow-up|1|||
23622732|NCT03305809|66005029|FG001|Overall Study|Lost to Follow-up|2|||
23622733|NCT03305809|66005030|FG002|Overall Study|Lost to Follow-up|0|||
23622734|NCT03305809|66005031|FG003|Overall Study|Lost to Follow-up|0|||
23622735|NCT03305809|66005028|FG000|Overall Study|Sponsor Decision|1|||
23622736|NCT03305809|66005029|FG001|Overall Study|Sponsor Decision|0|||
23622737|NCT03305809|66005030|FG002|Overall Study|Sponsor Decision|1|||
23622738|NCT03305809|66005031|FG003|Overall Study|Sponsor Decision|8|||
23622739|NCT03305809|66005028|FG000|Overall Study|Physician Decision|0|||
23622740|NCT03305809|66005029|FG001|Overall Study|Physician Decision|0|||
23622741|NCT03305809|66005030|FG002|Overall Study|Physician Decision|2|||
23622742|NCT03305809|66005031|FG003|Overall Study|Physician Decision|4|||
23622743|NCT03305809|66005028|FG000|Overall Study|Progressive Disease|0|||
23622744|NCT03305809|66005029|FG001|Overall Study|Progressive Disease|0|||
23622745|NCT03305809|66005030|FG002|Overall Study|Progressive Disease|1|||
23748550|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23622746|NCT03305809|66005031|FG003|Overall Study|Progressive Disease|0|||
23622747|NCT03305809|66005028|FG000|Overall Study|Protocol Violation|1|||
23622748|NCT03305809|66005029|FG001|Overall Study|Protocol Violation|0|||
23622749|NCT03305809|66005030|FG002|Overall Study|Protocol Violation|2|||
23622750|NCT03305809|66005031|FG003|Overall Study|Protocol Violation|3|||
23622751|NCT03305809|66005028|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622752|NCT03305809|66005029|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622753|NCT03305809|66005030|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622754|NCT03305809|66005031|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
23622755|NCT03305809|66005028|FG000|Overall Study|Withdrawal by Subject|2|||
23622756|NCT03305809|66005029|FG001|Overall Study|Withdrawal by Subject|4|||
23622757|NCT03305809|66005030|FG002|Overall Study|Withdrawal by Subject|5|||
23622758|NCT03305809|66005031|FG003|Overall Study|Withdrawal by Subject|2|||
23622759|NCT03305809|66005028|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
23622760|NCT03305809|66005029|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
23622761|NCT03305809|66005030|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
23622762|NCT03305809|66005031|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
23622763|NCT01316887|66005032|FG000|Overall Study|Adverse Event|13|||
23622764|NCT01316887|66005033|FG001|Overall Study|Adverse Event|21|||
23622765|NCT01316887|66005034|FG002|Overall Study|Adverse Event|17|||
23622766|NCT01316887|66005032|FG000|Overall Study|Lack of Efficacy|9|||
23622767|NCT01316887|66005033|FG001|Overall Study|Lack of Efficacy|3|||
23622768|NCT01316887|66005034|FG002|Overall Study|Lack of Efficacy|1|||
23622769|NCT01316887|66005032|FG000|Overall Study|Protocol Violation|2|||
23622770|NCT01316887|66005033|FG001|Overall Study|Protocol Violation|6|||
23622771|NCT01316887|66005034|FG002|Overall Study|Protocol Violation|6|||
23622772|NCT01316887|66005032|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
23622773|NCT01316887|66005033|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
23622774|NCT01316887|66005034|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
23622775|NCT01316887|66005032|FG000|Overall Study|Study Closed/Terminated|2|||
23622776|NCT01316887|66005033|FG001|Overall Study|Study Closed/Terminated|4|||
23622777|NCT01316887|66005034|FG002|Overall Study|Study Closed/Terminated|3|||
23622778|NCT01316887|66005032|FG000|Overall Study|Lost to Follow-up|1|||
23622779|NCT01316887|66005033|FG001|Overall Study|Lost to Follow-up|7|||
23622780|NCT01316887|66005034|FG002|Overall Study|Lost to Follow-up|5|||
23622781|NCT01316887|66005032|FG000|Overall Study|Withdrawal by Subject|8|||
23622782|NCT01316887|66005033|FG001|Overall Study|Withdrawal by Subject|16|||
23622783|NCT01316887|66005034|FG002|Overall Study|Withdrawal by Subject|15|||
23622784|NCT02175745|66005036|FG000|Overall Study|Not Eligible|1|||
23622785|NCT05043883|66005037|FG000|Overall Study|Minimum required measurements could not be taken|4|||
23622786|NCT00043186|66005040|FG000|Overall Study|Physician Decision|0|||
23622787|NCT00043186|66005041|FG001|Overall Study|Physician Decision|0|||
23622788|NCT00043186|66005042|FG002|Overall Study|Physician Decision|3|||
23622789|NCT00043186|66005043|FG003|Overall Study|Physician Decision|0|||
23622790|NCT00043186|66005044|FG004|Overall Study|Physician Decision|1|||
23622791|NCT00043186|66005045|FG005|Overall Study|Physician Decision|0|||
23622792|NCT00043186|66005046|FG006|Overall Study|Physician Decision|0|||
23622793|NCT00043186|66005047|FG007|Overall Study|Physician Decision|1|||
23622794|NCT00043186|66005048|FG008|Overall Study|Physician Decision|1|||
23622795|NCT00043186|66005040|FG000|Overall Study|Adverse Event|2|||
23622796|NCT00043186|66005041|FG001|Overall Study|Adverse Event|2|||
23622797|NCT00043186|66005042|FG002|Overall Study|Adverse Event|2|||
23622798|NCT00043186|66005043|FG003|Overall Study|Adverse Event|3|||
23622799|NCT00043186|66005044|FG004|Overall Study|Adverse Event|2|||
23622800|NCT00043186|66005045|FG005|Overall Study|Adverse Event|1|||
23622801|NCT00043186|66005046|FG006|Overall Study|Adverse Event|2|||
23622802|NCT00043186|66005047|FG007|Overall Study|Adverse Event|1|||
23622803|NCT00043186|66005048|FG008|Overall Study|Adverse Event|3|||
23622804|NCT00043186|66005040|FG000|Overall Study|Withdrawal by Subject|11|||
23622805|NCT00043186|66005041|FG001|Overall Study|Withdrawal by Subject|8|||
23622806|NCT00043186|66005042|FG002|Overall Study|Withdrawal by Subject|11|||
23622807|NCT00043186|66005043|FG003|Overall Study|Withdrawal by Subject|13|||
23622808|NCT00043186|66005044|FG004|Overall Study|Withdrawal by Subject|14|||
23622809|NCT00043186|66005045|FG005|Overall Study|Withdrawal by Subject|6|||
23622810|NCT00043186|66005046|FG006|Overall Study|Withdrawal by Subject|12|||
23622811|NCT00043186|66005047|FG007|Overall Study|Withdrawal by Subject|9|||
23622812|NCT00043186|66005048|FG008|Overall Study|Withdrawal by Subject|10|||
23622813|NCT00043186|66005040|FG000|Overall Study|Death|0|||
23622814|NCT00043186|66005041|FG001|Overall Study|Death|0|||
23622815|NCT00043186|66005042|FG002|Overall Study|Death|1|||
23622816|NCT00043186|66005043|FG003|Overall Study|Death|0|||
23622817|NCT00043186|66005044|FG004|Overall Study|Death|0|||
23622818|NCT00043186|66005045|FG005|Overall Study|Death|0|||
23622819|NCT00043186|66005046|FG006|Overall Study|Death|2|||
23622820|NCT00043186|66005047|FG007|Overall Study|Death|0|||
23622821|NCT00043186|66005048|FG008|Overall Study|Death|0|||
23622822|NCT00043186|66005040|FG000|Overall Study|Disease progression|1|||
23622823|NCT00043186|66005041|FG001|Overall Study|Disease progression|0|||
23622824|NCT00043186|66005042|FG002|Overall Study|Disease progression|0|||
23622825|NCT00043186|66005043|FG003|Overall Study|Disease progression|3|||
23622826|NCT00043186|66005044|FG004|Overall Study|Disease progression|0|||
23622827|NCT00043186|66005045|FG005|Overall Study|Disease progression|0|||
23622828|NCT00043186|66005046|FG006|Overall Study|Disease progression|0|||
23622829|NCT00043186|66005047|FG007|Overall Study|Disease progression|4|||
23622830|NCT00043186|66005048|FG008|Overall Study|Disease progression|0|||
23622831|NCT00043186|66005040|FG000|Overall Study|Ineligibility determined|0|||
23433199|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
23433200|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
23433201|NCT00599638|65330390|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
23622832|NCT00043186|66005041|FG001|Overall Study|Ineligibility determined|0|||
23622833|NCT00043186|66005042|FG002|Overall Study|Ineligibility determined|0|||
23622834|NCT00043186|66005043|FG003|Overall Study|Ineligibility determined|0|||
23622835|NCT00043186|66005044|FG004|Overall Study|Ineligibility determined|0|||
23622836|NCT00043186|66005045|FG005|Overall Study|Ineligibility determined|0|||
23622837|NCT00043186|66005046|FG006|Overall Study|Ineligibility determined|0|||
23622838|NCT00043186|66005047|FG007|Overall Study|Ineligibility determined|0|||
23622839|NCT00043186|66005048|FG008|Overall Study|Ineligibility determined|1|||
23748551|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
23433202|NCT00599638|65330391|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23622840|NCT00043186|66005040|FG000|Overall Study|Lost to Follow-up|3|||
23748552|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23748553|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23748554|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23622841|NCT00043186|66005041|FG001|Overall Study|Lost to Follow-up|5|||
23622842|NCT00043186|66005042|FG002|Overall Study|Lost to Follow-up|1|||
23622843|NCT00043186|66005043|FG003|Overall Study|Lost to Follow-up|1|||
23622844|NCT00043186|66005044|FG004|Overall Study|Lost to Follow-up|1|||
23622845|NCT00043186|66005045|FG005|Overall Study|Lost to Follow-up|1|||
23622846|NCT00043186|66005046|FG006|Overall Study|Lost to Follow-up|1|||
23622847|NCT00043186|66005047|FG007|Overall Study|Lost to Follow-up|1|||
23622848|NCT00043186|66005048|FG008|Overall Study|Lost to Follow-up|2|||
23622849|NCT00043186|66005040|FG000|Overall Study|Noncompliance|0|||
23622850|NCT00043186|66005041|FG001|Overall Study|Noncompliance|0|||
23622851|NCT00043186|66005042|FG002|Overall Study|Noncompliance|1|||
23748555|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23622852|NCT00043186|66005043|FG003|Overall Study|Noncompliance|1|||
23622853|NCT00043186|66005044|FG004|Overall Study|Noncompliance|0|||
23622854|NCT00043186|66005045|FG005|Overall Study|Noncompliance|0|||
23622855|NCT00043186|66005046|FG006|Overall Study|Noncompliance|0|||
23622856|NCT00043186|66005047|FG007|Overall Study|Noncompliance|0|||
23622857|NCT00043186|66005048|FG008|Overall Study|Noncompliance|0|||
23622858|NCT00043186|66005040|FG000|Overall Study|Other|0|||
23622859|NCT00043186|66005041|FG001|Overall Study|Other|0|||
23622860|NCT00043186|66005042|FG002|Overall Study|Other|1|||
23748556|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
23748557|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23748558|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
23748559|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
23748560|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23748561|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23748562|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23748563|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23748564|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23748565|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23748566|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
23748567|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23748568|NCT02918318|66460216|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
23748569|NCT02918318|66460217|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
23748570|NCT02918318|66460218|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
23748571|NCT02918318|66460219|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
23748572|NCT02918318|66460220|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
23748573|NCT02918318|66460216|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23748574|NCT02918318|66460217|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23748575|NCT02918318|66460218|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23748576|NCT02918318|66460219|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
23748577|NCT02918318|66460220|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23748578|NCT02918318|66460216|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23748579|NCT02918318|66460217|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748580|NCT02918318|66460218|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23748581|NCT02918318|66460219|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23748582|NCT02918318|66460220|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748583|NCT02918318|66460216|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
23748584|NCT02918318|66460217|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23748585|NCT02918318|66460218|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23748586|NCT02918318|66460219|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
23748587|NCT02918318|66460220|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23748588|NCT02918318|66460216|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
23748589|NCT02918318|66460217|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
23748590|NCT02918318|66460218|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
23748591|NCT02918318|66460219|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
23748592|NCT02918318|66460220|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
23748593|NCT02918318|66460216|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23622861|NCT00043186|66005043|FG003|Overall Study|Other|1|||
23622862|NCT00043186|66005044|FG004|Overall Study|Other|0|||
23622863|NCT00043186|66005045|FG005|Overall Study|Other|0|||
23622864|NCT00043186|66005046|FG006|Overall Study|Other|0|||
23622865|NCT00043186|66005047|FG007|Overall Study|Other|0|||
23622866|NCT00043186|66005048|FG008|Overall Study|Other|0|||
23622867|NCT00197106|66005049|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
23622868|NCT00197106|66005050|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
23622869|NCT00197106|66005051|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
23622870|NCT00197106|66005049|FG000|Overall Treatment Period|Lack of Efficacy|0|||
23748594|NCT02918318|66460217|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23622871|NCT00197106|66005050|FG001|Overall Treatment Period|Lack of Efficacy|1|||
23622872|NCT00197106|66005051|FG002|Overall Treatment Period|Lack of Efficacy|0|||
23622873|NCT00197106|66005049|FG000|Overall Treatment Period|Lost to Follow-up|0|||
23622874|NCT00197106|66005050|FG001|Overall Treatment Period|Lost to Follow-up|0|||
23622875|NCT00197106|66005051|FG002|Overall Treatment Period|Lost to Follow-up|2|||
23622876|NCT00197106|66005049|FG000|Overall Treatment Period|Protocol Violation|0|||
23622877|NCT00197106|66005050|FG001|Overall Treatment Period|Protocol Violation|0|||
23622878|NCT00197106|66005051|FG002|Overall Treatment Period|Protocol Violation|2|||
23823824|NCT00369486|66737665|FG002|8-Week Visit|Missed visit|0|||
23823825|NCT00369486|66737666|FG003|8-Week Visit|Missed visit|0|||
23823826|NCT00369486|66737667|FG004|8-Week Visit|Missed visit|1|||
23823827|NCT00369486|66737663|FG000|8-Week Visit|Dropped|0|||
23555281|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Death|41|||
23555282|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Death|33|||
23555283|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Death|0|||
23555284|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Death|0|||
23555285|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23555286|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
23555287|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23555288|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23555289|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555290|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555291|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
23555292|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555293|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
23555294|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
23555295|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
23555296|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
23555297|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
23555298|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
23555299|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
23555300|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
23555301|NCT00386022|65758074|FG000|Plus Estrogen|Lost to Follow-up|2|||
23555302|NCT00386022|65758075|FG001|Plus Estrogen|Lost to Follow-up|0|||
23555303|NCT00386022|65758074|FG000|Plus Estrogen|Adverse Event|0|||
23555304|NCT00386022|65758075|FG001|Plus Estrogen|Adverse Event|1|||
23555305|NCT01441102|65758076|FG000|Overall Study|Adverse Event|1|||
23555306|NCT01441102|65758076|FG000|Overall Study|Withdrawal by Subject|2|||
23555307|NCT03371940|65758077|FG000|Overall Study|Withdrawal by Subject|8|||
23555308|NCT03371940|65758078|FG001|Overall Study|Withdrawal by Subject|1|||
23555309|NCT03371940|65758079|FG002|Overall Study|Withdrawal by Subject|3|||
23555310|NCT03371940|65758080|FG003|Overall Study|Withdrawal by Subject|4|||
23555311|NCT00689026|65758081|FG000|Overall Study|Withdrawal by Subject|13|||
23433203|NCT00599638|65330392|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23433204|NCT00599638|65330393|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23823828|NCT00369486|66737664|FG001|8-Week Visit|Dropped|0|||
23823829|NCT00369486|66737665|FG002|8-Week Visit|Dropped|0|||
23823830|NCT00369486|66737666|FG003|8-Week Visit|Dropped|1|||
23823831|NCT00369486|66737667|FG004|8-Week Visit|Dropped|0|||
23823832|NCT00369486|66737663|FG000|17-Week Visit|Missed visit|0|||
23823833|NCT00369486|66737664|FG001|17-Week Visit|Missed visit|0|||
23823834|NCT00369486|66737665|FG002|17-Week Visit|Missed visit|1|||
23823835|NCT00369486|66737666|FG003|17-Week Visit|Missed visit|1|||
23823836|NCT00369486|66737667|FG004|17-Week Visit|Missed visit|1|||
23823837|NCT00369486|66737663|FG000|34-Week Visit|Dropped|0|||
23823838|NCT00369486|66737664|FG001|34-Week Visit|Dropped|1|||
23823839|NCT00369486|66737665|FG002|34-Week Visit|Dropped|1|||
23823840|NCT00369486|66737666|FG003|34-Week Visit|Dropped|3|||
23823841|NCT00369486|66737667|FG004|34-Week Visit|Dropped|3|||
23823842|NCT03541317|66737668|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
23823843|NCT03541317|66737669|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23823844|NCT03541317|66737670|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23823845|NCT03541317|66737671|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23823846|NCT03541317|66737672|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23823847|NCT03541317|66737673|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23823848|NCT02952586|66737674|FG000|Lead-In Phase (7 Days)|Death|0|||
23823849|NCT02952586|66737675|FG001|Lead-In Phase (7 Days)|Death|1|||
23823850|NCT02952586|66737674|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
23823851|NCT02952586|66737675|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
23823852|NCT02952586|66737674|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
23823853|NCT02952586|66737675|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
23823854|NCT02952586|66737674|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
23823855|NCT02952586|66737675|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
23823856|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
23823857|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
23823858|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
23823859|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
23823860|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
23823861|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
23823862|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
23823863|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
23823864|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
23823865|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
23823866|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
23823867|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
23823868|NCT02952586|66737674|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
23823869|NCT02952586|66737675|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
23823870|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Death|3|||
23823871|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Death|8|||
23823872|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
23823873|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
23823874|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
23823875|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
23823876|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
23823877|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
23823878|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
23823879|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
23823880|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
23823881|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
23823882|NCT02952586|66737674|FG000|CRT for Cisplatin (63 Days)|Other|1|||
23823883|NCT02952586|66737675|FG001|CRT for Cisplatin (63 Days)|Other|1|||
23433205|NCT04232215|65330394|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23433206|NCT04232215|65330395|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23823884|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Death|5|||
23823885|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Death|8|||
23555312|NCT00689026|65758082|FG001|Overall Study|Withdrawal by Subject|6|||
23555313|NCT02459262|65758083|FG000|Overall Study|Withdrawal by Subject|0|||
23555314|NCT02459262|65758084|FG001|Overall Study|Withdrawal by Subject|0|||
23555315|NCT02459262|65758085|FG002|Overall Study|Withdrawal by Subject|0|||
23555316|NCT02459262|65758086|FG003|Overall Study|Withdrawal by Subject|0|||
23823886|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
23823887|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
23823888|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
23823889|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
23823890|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
23823891|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
23823892|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
23823893|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
23823894|NCT02952586|66737674|FG000|CRT for IMRT (63 Days)|Other|1|||
23823895|NCT02952586|66737675|FG001|CRT for IMRT (63 Days)|Other|0|||
23823896|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Death|17|||
23823897|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Death|11|||
23823898|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
23823899|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
23823900|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
23823901|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
23823902|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
23555317|NCT02459262|65758087|FG004|Overall Study|Withdrawal by Subject|0|||
23823903|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
23823904|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
23823905|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
23823906|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
23823907|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
23823908|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
23823909|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
23748595|NCT02918318|66460218|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23748596|NCT02918318|66460219|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23748597|NCT02918318|66460220|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
23748598|NCT02918318|66460216|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748599|NCT02918318|66460217|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748600|NCT02918318|66460218|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748601|NCT02918318|66460219|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23748602|NCT02918318|66460220|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
23748603|NCT02641730|66460258|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
23748604|NCT02641730|66460259|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23748605|NCT02641730|66460260|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23748606|NCT02641730|66460261|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
23748607|NCT02641730|66460262|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
23748608|NCT02641730|66460258|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23748609|NCT02641730|66460259|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23748610|NCT02641730|66460260|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23748611|NCT02641730|66460261|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
23748612|NCT02641730|66460262|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
23748613|NCT02641730|66460258|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23748614|NCT02641730|66460259|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
23748615|NCT02641730|66460260|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23748616|NCT02641730|66460261|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
23748617|NCT02641730|66460262|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23748618|NCT02641730|66460258|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23748619|NCT02641730|66460259|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23748620|NCT02641730|66460260|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23748621|NCT02641730|66460261|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23748622|NCT02641730|66460262|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23748623|NCT02641730|66460258|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
23748624|NCT02641730|66460259|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
23748625|NCT02641730|66460260|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
23748626|NCT02641730|66460261|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
23748627|NCT02641730|66460262|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
23748628|NCT02641730|66460258|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
23748629|NCT02641730|66460259|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
23748630|NCT02641730|66460260|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
23748631|NCT02641730|66460261|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
23748632|NCT02641730|66460262|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
23748633|NCT04165824|66460265|FG000|Overall Study|Adverse Event|23|||
23748634|NCT04165824|66460265|FG000|Overall Study|Physician Decision|1|||
23748635|NCT04165824|66460265|FG000|Overall Study|Withdrawal by Subject|17|||
23748636|NCT04165824|66460265|FG000|Overall Study|Other|5|||
23748637|NCT03185949|66460267|FG000|ITT Analysis|Withdrawal by Subject|4|||
23748638|NCT03185949|66460268|FG001|ITT Analysis|Withdrawal by Subject|3|||
23748639|NCT03185949|66460267|FG000|PP Analysis|Protocol Violation|2|||
23748640|NCT03185949|66460268|FG001|PP Analysis|Protocol Violation|2|||
23748641|NCT03185949|66460267|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
23748642|NCT03185949|66460268|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
23748643|NCT01965600|66460269|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
23748644|NCT01965600|66460270|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
23748645|NCT01965600|66460271|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
23748646|NCT01965600|66460272|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
23433207|NCT00129961|65330396|FG000|Overall Study|Adverse Event|1|||
23748647|NCT01965600|66460269|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23748648|NCT01965600|66460270|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
23748649|NCT01965600|66460271|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23748650|NCT01965600|66460272|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23748651|NCT01965600|66460269|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
23748652|NCT01965600|66460270|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23748653|NCT01965600|66460271|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23748654|NCT01965600|66460272|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23748655|NCT01965600|66460269|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
23748656|NCT01965600|66460270|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
23748657|NCT01965600|66460271|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
23748658|NCT01965600|66460272|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
23748659|NCT01965600|66460269|FG000|Second Intervention|Study terminated by Sponsor|0|||
23748660|NCT01965600|66460270|FG001|Second Intervention|Study terminated by Sponsor|0|||
23748661|NCT01965600|66460271|FG002|Second Intervention|Study terminated by Sponsor|2|||
23748662|NCT01965600|66460272|FG003|Second Intervention|Study terminated by Sponsor|2|||
23748663|NCT03053102|66460273|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
23748664|NCT03053102|66460273|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
23748665|NCT01238861|66460276|FG000|Overall Study|Lost to Follow-up|4|||
23748666|NCT01238861|66460277|FG001|Overall Study|Lost to Follow-up|2|||
23748667|NCT01238861|66460278|FG002|Overall Study|Lost to Follow-up|3|||
23748668|NCT01238861|66460279|FG003|Overall Study|Lost to Follow-up|1|||
23748669|NCT01238861|66460280|FG004|Overall Study|Lost to Follow-up|1|||
23748670|NCT01238861|66460281|FG005|Overall Study|Lost to Follow-up|2|||
23748671|NCT01238861|66460276|FG000|Overall Study|Unplanned surgery|1|||
23748672|NCT01238861|66460277|FG001|Overall Study|Unplanned surgery|0|||
23748673|NCT01238861|66460278|FG002|Overall Study|Unplanned surgery|0|||
23748674|NCT01238861|66460279|FG003|Overall Study|Unplanned surgery|0|||
23748675|NCT01238861|66460280|FG004|Overall Study|Unplanned surgery|0|||
23748676|NCT01238861|66460281|FG005|Overall Study|Unplanned surgery|0|||
23748677|NCT01238861|66460276|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23748678|NCT01238861|66460277|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23748679|NCT01238861|66460278|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23748680|NCT01238861|66460279|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23748681|NCT01238861|66460280|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23748682|NCT01238861|66460281|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23748683|NCT01238861|66460276|FG000|Overall Study|Incorrect enrollment/randomization|0|||
23748684|NCT01238861|66460277|FG001|Overall Study|Incorrect enrollment/randomization|0|||
23748685|NCT01238861|66460278|FG002|Overall Study|Incorrect enrollment/randomization|1|||
23748686|NCT01238861|66460279|FG003|Overall Study|Incorrect enrollment/randomization|0|||
23748687|NCT01238861|66460280|FG004|Overall Study|Incorrect enrollment/randomization|1|||
23748688|NCT01238861|66460281|FG005|Overall Study|Incorrect enrollment/randomization|0|||
23748689|NCT01238861|66460276|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
23748690|NCT01238861|66460277|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
23748691|NCT01238861|66460278|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
23748692|NCT01238861|66460279|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
23748693|NCT01238861|66460280|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
23748694|NCT01238861|66460281|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
23748695|NCT01238861|66460276|FG000|Overall Study|Subject moved out of state/area|0|||
23748696|NCT01238861|66460277|FG001|Overall Study|Subject moved out of state/area|0|||
23748697|NCT01238861|66460278|FG002|Overall Study|Subject moved out of state/area|1|||
23748698|NCT01238861|66460279|FG003|Overall Study|Subject moved out of state/area|1|||
23748699|NCT01238861|66460280|FG004|Overall Study|Subject moved out of state/area|0|||
23748700|NCT01238861|66460281|FG005|Overall Study|Subject moved out of state/area|0|||
23748701|NCT01238861|66460276|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
23748702|NCT01238861|66460277|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
23748703|NCT01238861|66460278|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
23748704|NCT01238861|66460279|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
23748705|NCT01238861|66460280|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
23748706|NCT01238861|66460281|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
23748707|NCT01238861|66460276|FG000|Overall Study|Personal problems|0|||
23748708|NCT01238861|66460277|FG001|Overall Study|Personal problems|0|||
23748709|NCT01238861|66460278|FG002|Overall Study|Personal problems|0|||
23748710|NCT01238861|66460279|FG003|Overall Study|Personal problems|1|||
23748711|NCT01238861|66460280|FG004|Overall Study|Personal problems|0|||
23748712|NCT01238861|66460281|FG005|Overall Study|Personal problems|0|||
23748713|NCT01238861|66460276|FG000|Overall Study|Unable to continue visits|0|||
23748714|NCT01238861|66460277|FG001|Overall Study|Unable to continue visits|0|||
23748715|NCT01238861|66460278|FG002|Overall Study|Unable to continue visits|0|||
23748716|NCT01238861|66460279|FG003|Overall Study|Unable to continue visits|1|||
23748717|NCT01238861|66460280|FG004|Overall Study|Unable to continue visits|0|||
23748718|NCT01238861|66460281|FG005|Overall Study|Unable to continue visits|1|||
23748719|NCT01238861|66460276|FG000|Overall Study|Serious adverse event|0|||
23748720|NCT01238861|66460277|FG001|Overall Study|Serious adverse event|0|||
23748721|NCT01238861|66460278|FG002|Overall Study|Serious adverse event|0|||
23748722|NCT01238861|66460279|FG003|Overall Study|Serious adverse event|0|||
23748723|NCT01238861|66460280|FG004|Overall Study|Serious adverse event|0|||
23748724|NCT01238861|66460281|FG005|Overall Study|Serious adverse event|1|||
23748725|NCT01238861|66460276|FG000|Overall Study|Lack of compliance|0|||
23748726|NCT01238861|66460277|FG001|Overall Study|Lack of compliance|0|||
23748727|NCT01238861|66460278|FG002|Overall Study|Lack of compliance|0|||
23748728|NCT01238861|66460279|FG003|Overall Study|Lack of compliance|0|||
23748729|NCT01238861|66460280|FG004|Overall Study|Lack of compliance|0|||
23748730|NCT01238861|66460281|FG005|Overall Study|Lack of compliance|1|||
23748731|NCT01238861|66460276|FG000|Overall Study|Adverse Event|0|||
23748732|NCT01238861|66460277|FG001|Overall Study|Adverse Event|1|||
23748733|NCT01238861|66460278|FG002|Overall Study|Adverse Event|0|||
23748734|NCT01238861|66460279|FG003|Overall Study|Adverse Event|0|||
23748735|NCT01238861|66460280|FG004|Overall Study|Adverse Event|0|||
23748736|NCT01238861|66460281|FG005|Overall Study|Adverse Event|0|||
23748737|NCT01238861|66460276|FG000|Overall Study|Withdrawal by Subject|6|||
23748738|NCT01238861|66460277|FG001|Overall Study|Withdrawal by Subject|5|||
23748739|NCT01238861|66460278|FG002|Overall Study|Withdrawal by Subject|4|||
23748740|NCT01238861|66460279|FG003|Overall Study|Withdrawal by Subject|8|||
23748741|NCT01238861|66460280|FG004|Overall Study|Withdrawal by Subject|10|||
23748742|NCT01238861|66460281|FG005|Overall Study|Withdrawal by Subject|9|||
23748743|NCT03292731|66460286|FG000|Overall Study|Protocol Violation|4|||
23748744|NCT03292731|66460287|FG001|Overall Study|Protocol Violation|11|||
23748745|NCT03292731|66460288|FG002|Overall Study|Protocol Violation|1|||
23748746|NCT01058707|66460289|FG000|Overall Study|Disease Progression|15|||
23748747|NCT01058707|66460290|FG001|Overall Study|Disease Progression|20|||
23748748|NCT01058707|66460291|FG002|Overall Study|Disease Progression|20|||
23748749|NCT01058707|66460292|FG003|Overall Study|Disease Progression|15|||
23748750|NCT01058707|66460293|FG004|Overall Study|Disease Progression|23|||
23748751|NCT01058707|66460294|FG005|Overall Study|Disease Progression|10|||
23748752|NCT01058707|66460295|FG006|Overall Study|Disease Progression|12|||
23748753|NCT01058707|66460289|FG000|Overall Study|Adverse Event|11|||
23748754|NCT01058707|66460290|FG001|Overall Study|Adverse Event|4|||
23748755|NCT01058707|66460291|FG002|Overall Study|Adverse Event|7|||
23748756|NCT01058707|66460292|FG003|Overall Study|Adverse Event|6|||
23748757|NCT01058707|66460293|FG004|Overall Study|Adverse Event|7|||
23433208|NCT00129961|65330397|FG001|Overall Study|Adverse Event|0|||
23748758|NCT01058707|66460294|FG005|Overall Study|Adverse Event|3|||
23748759|NCT01058707|66460295|FG006|Overall Study|Adverse Event|1|||
23748760|NCT01058707|66460289|FG000|Overall Study|Subject Decision|5|||
23748761|NCT01058707|66460290|FG001|Overall Study|Subject Decision|3|||
23748762|NCT01058707|66460291|FG002|Overall Study|Subject Decision|3|||
23748763|NCT01058707|66460292|FG003|Overall Study|Subject Decision|1|||
23748764|NCT01058707|66460293|FG004|Overall Study|Subject Decision|2|||
23748765|NCT01058707|66460294|FG005|Overall Study|Subject Decision|3|||
23748766|NCT01058707|66460295|FG006|Overall Study|Subject Decision|6|||
23748767|NCT01058707|66460289|FG000|Overall Study|Lost to Follow-up|0|||
23748768|NCT01058707|66460290|FG001|Overall Study|Lost to Follow-up|0|||
23748769|NCT01058707|66460291|FG002|Overall Study|Lost to Follow-up|1|||
23748770|NCT01058707|66460292|FG003|Overall Study|Lost to Follow-up|0|||
23748771|NCT01058707|66460293|FG004|Overall Study|Lost to Follow-up|0|||
23748772|NCT01058707|66460294|FG005|Overall Study|Lost to Follow-up|0|||
23748773|NCT01058707|66460295|FG006|Overall Study|Lost to Follow-up|0|||
23748774|NCT01058707|66460289|FG000|Overall Study|Reason Not Specified|0|||
23748775|NCT01058707|66460290|FG001|Overall Study|Reason Not Specified|3|||
23748776|NCT01058707|66460291|FG002|Overall Study|Reason Not Specified|2|||
23748777|NCT01058707|66460292|FG003|Overall Study|Reason Not Specified|0|||
23748778|NCT01058707|66460293|FG004|Overall Study|Reason Not Specified|7|||
23748779|NCT01058707|66460294|FG005|Overall Study|Reason Not Specified|1|||
23748780|NCT01058707|66460295|FG006|Overall Study|Reason Not Specified|7|||
23748781|NCT03628781|66460296|FG000|Overall Study|Lost to Follow-up|16|||
23748782|NCT03628781|66460297|FG001|Overall Study|Lost to Follow-up|8|||
23748783|NCT03628781|66460296|FG000|Overall Study|Withdrawal by Subject|16|||
23748784|NCT03628781|66460297|FG001|Overall Study|Withdrawal by Subject|1|||
23748785|NCT01907516|66460299|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
23748786|NCT01907516|66460300|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
23748787|NCT01907516|66460299|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
23748788|NCT01907516|66460300|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
23748789|NCT01907516|66460299|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
23748790|NCT01907516|66460300|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
23748791|NCT01907516|66460299|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
23748792|NCT01907516|66460300|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
23748793|NCT04355767|66460301|FG000|Overall Study|Withdrawal by Subject|2|||
23748794|NCT04355767|66460302|FG001|Overall Study|Withdrawal by Subject|2|||
23748795|NCT04355767|66460301|FG000|Overall Study|Death|5|||
23748796|NCT04355767|66460302|FG001|Overall Study|Death|1|||
23748797|NCT02946515|66460308|FG000|Overall Study|Lost to Follow-up|2|||
23748798|NCT02946515|66460309|FG001|Overall Study|Lost to Follow-up|1|||
23748799|NCT03209973|66460314|FG000|Overall Study|Withdrawal by Subject|7|||
23748800|NCT03209973|66460314|FG000|Overall Study|Lost to Follow-up|2|||
23748801|NCT03209973|66460314|FG000|Overall Study|Death|8|||
23748802|NCT03209973|66460314|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
23748803|NCT03209973|66460314|FG000|Overall Study|Sponsor Decision|18|||
23748804|NCT03209973|66460314|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
23748805|NCT03209973|66460314|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
23748806|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
23748807|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
23748808|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Death|5|||
23748809|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Death|2|||
23748810|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
23748811|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
23748812|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
23748813|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
23748814|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
23748815|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
23622879|NCT00197106|66005049|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
23748816|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Relapse|1|||
23748817|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Relapse|0|||
23748818|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
23748819|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
23748820|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
23748821|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
23748822|NCT00111007|66460317|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
23748823|NCT00111007|66460318|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
23748824|NCT00111007|66460317|FG000|Active Follow-up|Adverse Event|1|||
23748825|NCT00111007|66460318|FG001|Active Follow-up|Adverse Event|0|||
23748826|NCT00111007|66460317|FG000|Active Follow-up|Death|2|||
23748827|NCT00111007|66460318|FG001|Active Follow-up|Death|0|||
23748828|NCT00111007|66460317|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
23748829|NCT00111007|66460318|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
23748830|NCT00111007|66460317|FG000|Long Term Follow-up|Death|34|||
23748831|NCT00111007|66460318|FG001|Long Term Follow-up|Death|39|||
23748832|NCT00111007|66460317|FG000|Long Term Follow-up|Lost to Follow-up|1|||
23748833|NCT00111007|66460318|FG001|Long Term Follow-up|Lost to Follow-up|1|||
23748834|NCT00111007|66460317|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
23748835|NCT00111007|66460318|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
23748836|NCT00111007|66460317|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
23748837|NCT00111007|66460318|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
23748838|NCT00111007|66460317|FG000|Long Term Follow-up|Missing|10|||
23748839|NCT00111007|66460318|FG001|Long Term Follow-up|Missing|3|||
23748840|NCT03128931|66460323|FG000|Overall Study|Physician Decision|1|||
23748841|NCT03128931|66460323|FG000|Overall Study|Equipment Issues|3|||
23748842|NCT01353586|66460326|FG000|Overall Study|Procedure terminated prior to ablation|3|||
23748843|NCT01353586|66460327|FG001|Overall Study|Procedure terminated prior to ablation|0|||
23748844|NCT01353586|66460326|FG000|Overall Study|Never had insertion of study catheter|4|||
23748845|NCT01353586|66460327|FG001|Overall Study|Never had insertion of study catheter|1|||
23748846|NCT01353586|66460326|FG000|Overall Study|Neurological exam not done|0|||
23748847|NCT01353586|66460327|FG001|Overall Study|Neurological exam not done|1|||
23748848|NCT01819467|66460334|FG000|Overall Study|Physician Decision|20|||
23748849|NCT01819467|66460335|FG001|Overall Study|Physician Decision|9|||
23748850|NCT00883129|66460336|FG000|Overall Study|Adverse Event|7|||
23748851|NCT00883129|66460337|FG001|Overall Study|Adverse Event|15|||
23748852|NCT00883129|66460336|FG000|Overall Study|Withdrawal by Subject|8|||
23748853|NCT00883129|66460337|FG001|Overall Study|Withdrawal by Subject|9|||
23748854|NCT00883129|66460336|FG000|Overall Study|Non-compliance|3|||
23748855|NCT00883129|66460337|FG001|Overall Study|Non-compliance|6|||
23748856|NCT00883129|66460336|FG000|Overall Study|Lost to Follow-up|1|||
23748857|NCT00883129|66460337|FG001|Overall Study|Lost to Follow-up|2|||
23748858|NCT00883129|66460336|FG000|Overall Study|Death|1|||
23748859|NCT00883129|66460337|FG001|Overall Study|Death|2|||
23748860|NCT00883129|66460336|FG000|Overall Study|Defined Treatment Failure|0|||
23748861|NCT00883129|66460337|FG001|Overall Study|Defined Treatment Failure|2|||
23748862|NCT03353415|66460338|FG000|Masked CGM Wear|Lost to Follow-up|2|||
23748863|NCT03353415|66460338|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
23748864|NCT00070499|66460339|FG000|Overall Study|Adverse Event|6|||
23748865|NCT00070499|66460340|FG001|Overall Study|Adverse Event|6|||
23748866|NCT00070499|66460341|FG002|Overall Study|Adverse Event|19|||
23748867|NCT00070499|66460342|FG003|Overall Study|Adverse Event|15|||
23748868|NCT00070499|66460339|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
23748869|NCT00070499|66460340|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
23748870|NCT00070499|66460341|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
23748871|NCT00070499|66460342|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
23748872|NCT00070499|66460339|FG000|Overall Study|Progression/relapse|4|||
23748873|NCT00070499|66460340|FG001|Overall Study|Progression/relapse|2|||
23748874|NCT00070499|66460341|FG002|Overall Study|Progression/relapse|1|||
23748875|NCT00070499|66460342|FG003|Overall Study|Progression/relapse|4|||
23748876|NCT00070499|66460339|FG000|Overall Study|Death|1|||
23748877|NCT00070499|66460340|FG001|Overall Study|Death|1|||
23748878|NCT00070499|66460341|FG002|Overall Study|Death|1|||
23748879|NCT00070499|66460342|FG003|Overall Study|Death|2|||
23555318|NCT02459262|65758088|FG005|Overall Study|Withdrawal by Subject|0|||
23555319|NCT02459262|65758089|FG006|Overall Study|Withdrawal by Subject|0|||
23555320|NCT02459262|65758090|FG007|Overall Study|Withdrawal by Subject|0|||
23555321|NCT02459262|65758091|FG008|Overall Study|Withdrawal by Subject|0|||
23555322|NCT02459262|65758092|FG009|Overall Study|Withdrawal by Subject|1|||
23555323|NCT02459262|65758093|FG010|Overall Study|Withdrawal by Subject|0|||
23555324|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
23748880|NCT00070499|66460339|FG000|Overall Study|Other - not protocol specified|7|||
23748881|NCT00070499|66460340|FG001|Overall Study|Other - not protocol specified|3|||
23748882|NCT00070499|66460341|FG002|Overall Study|Other - not protocol specified|12|||
23748883|NCT00070499|66460342|FG003|Overall Study|Other - not protocol specified|20|||
23748884|NCT00070499|66460339|FG000|Overall Study|Still on protocol treatment|10|||
23748885|NCT00070499|66460340|FG001|Overall Study|Still on protocol treatment|4|||
23555325|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
23555326|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
23748886|NCT00070499|66460341|FG002|Overall Study|Still on protocol treatment|79|||
23748887|NCT00070499|66460342|FG003|Overall Study|Still on protocol treatment|57|||
23748888|NCT00070499|66460339|FG000|Overall Study|Did not start treatment|1|||
23748889|NCT00070499|66460340|FG001|Overall Study|Did not start treatment|0|||
23748890|NCT00070499|66460341|FG002|Overall Study|Did not start treatment|0|||
23622880|NCT00197106|66005050|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
23622881|NCT00197106|66005051|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
23823910|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
23433209|NCT00129961|65330396|FG000|Overall Study|Death|1|||
23555327|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
23555328|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
23555329|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
23555330|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
23555331|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
23555332|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
23555333|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
23555334|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
23555335|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
23555336|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
23555337|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
23555338|NCT03014674|65758096|FG000|Overall Study|Withdrawal by Subject|1|||
23555339|NCT03014674|65758097|FG001|Overall Study|Withdrawal by Subject|0|||
23555340|NCT03014674|65758098|FG002|Overall Study|Withdrawal by Subject|0|||
23555341|NCT02481310|65758103|FG000|Follow up|Still in follow up|0|||
23555342|NCT02481310|65758104|FG001|Follow up|Still in follow up|3|||
23555343|NCT02481310|65758105|FG002|Follow up|Still in follow up|0|||
23555344|NCT00156065|65758106|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
23555345|NCT00156065|65758107|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
23555346|NCT00156065|65758108|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
23555347|NCT00156065|65758106|FG000|Overall Study|Adverse Event|8|||
23555348|NCT00156065|65758107|FG001|Overall Study|Adverse Event|11|||
23555349|NCT00156065|65758108|FG002|Overall Study|Adverse Event|4|||
23555350|NCT00156065|65758106|FG000|Overall Study|Lack of Efficacy|2|||
23555351|NCT00156065|65758107|FG001|Overall Study|Lack of Efficacy|9|||
23555352|NCT00156065|65758108|FG002|Overall Study|Lack of Efficacy|3|||
23555353|NCT00156065|65758106|FG000|Overall Study|Withdrawal by Subject|13|||
23555354|NCT00156065|65758107|FG001|Overall Study|Withdrawal by Subject|26|||
23555355|NCT00156065|65758108|FG002|Overall Study|Withdrawal by Subject|16|||
23555356|NCT00156065|65758106|FG000|Overall Study|Lost to Follow-up|5|||
23555357|NCT00156065|65758107|FG001|Overall Study|Lost to Follow-up|7|||
23555358|NCT00156065|65758108|FG002|Overall Study|Lost to Follow-up|1|||
23555359|NCT00156065|65758106|FG000|Overall Study|Other|2|||
23555360|NCT00156065|65758107|FG001|Overall Study|Other|9|||
23555361|NCT00156065|65758108|FG002|Overall Study|Other|3|||
23555362|NCT04198805|65758109|FG000|Overall Study|Death|0|||
23555363|NCT04198805|65758110|FG001|Overall Study|Death|0|||
23555364|NCT04198805|65758111|FG002|Overall Study|Death|0|||
23555365|NCT04198805|65758112|FG003|Overall Study|Death|1|||
23555366|NCT04198805|65758109|FG000|Overall Study|Early Termination|8|||
23555367|NCT04198805|65758110|FG001|Overall Study|Early Termination|4|||
23555368|NCT04198805|65758111|FG002|Overall Study|Early Termination|6|||
23555369|NCT04198805|65758112|FG003|Overall Study|Early Termination|9|||
23555370|NCT05338333|65758113|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
23555371|NCT05338333|65758114|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
23555372|NCT02747238|65758135|FG000|Overall Study|Lack of Efficacy|0|||
23555373|NCT02747238|65758136|FG001|Overall Study|Lack of Efficacy|1|||
23555374|NCT02747238|65758135|FG000|Overall Study|Data lost|3|||
23555375|NCT02747238|65758136|FG001|Overall Study|Data lost|5|||
23555376|NCT01688466|65758137|FG000|Overall Study|Withdrawal by Subject|2|||
23555377|NCT01688466|65758138|FG001|Overall Study|Withdrawal by Subject|1|||
23555378|NCT01688466|65758137|FG000|Overall Study|Death|0|||
23555379|NCT01688466|65758138|FG001|Overall Study|Death|1|||
23555380|NCT01688466|65758137|FG000|Overall Study|Adverse Event|0|||
23555381|NCT01688466|65758138|FG001|Overall Study|Adverse Event|4|||
23555382|NCT01688466|65758137|FG000|Overall Study|Not evaluable|0|||
23622882|NCT01589523|66005052|FG000|Overall Study|Withdrawal by Subject|1|||
23622883|NCT00576823|66005053|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
23433210|NCT00129961|65330397|FG001|Overall Study|Death|1|||
23555383|NCT01688466|65758138|FG001|Overall Study|Not evaluable|1|||
23555384|NCT01181726|65758140|FG000|First Intervention|Adverse Event|1|||
23555385|NCT01181726|65758141|FG001|First Intervention|Adverse Event|0|||
23555386|NCT02332720|65758142|FG000|Part A and Part B|Lost to Follow-up|1|||
23555387|NCT02332720|65758143|FG001|Part A and Part B|Lost to Follow-up|0|||
23555388|NCT02332720|65758144|FG002|Part A and Part B|Lost to Follow-up|0|||
23555389|NCT02332720|65758145|FG003|Part A and Part B|Lost to Follow-up|0|||
23555390|NCT02332720|65758146|FG004|Part A and Part B|Lost to Follow-up|0|||
23555391|NCT02332720|65758147|FG005|Part A and Part B|Lost to Follow-up|2|||
23555392|NCT02332720|65758148|FG006|Part A and Part B|Lost to Follow-up|1|||
23555393|NCT02332720|65758149|FG007|Part A and Part B|Lost to Follow-up|1|||
23555394|NCT02332720|65758150|FG008|Part A and Part B|Lost to Follow-up|0|||
23555395|NCT02332720|65758151|FG009|Part A and Part B|Lost to Follow-up|0|||
23555396|NCT02332720|65758152|FG010|Part A and Part B|Lost to Follow-up|0|||
23555397|NCT02332720|65758153|FG011|Part A and Part B|Lost to Follow-up|0|||
23555398|NCT02332720|65758154|FG012|Part A and Part B|Lost to Follow-up|0|||
23555399|NCT02332720|65758155|FG013|Part A and Part B|Lost to Follow-up|0|||
23555400|NCT02332720|65758156|FG014|Part A and Part B|Lost to Follow-up|0|||
23555401|NCT02332720|65758157|FG015|Part A and Part B|Lost to Follow-up|1|||
23555402|NCT02332720|65758158|FG016|Part A and Part B|Lost to Follow-up|0|||
23555403|NCT02332720|65758159|FG017|Part A and Part B|Lost to Follow-up|0|||
23555404|NCT02332720|65758160|FG018|Part A and Part B|Lost to Follow-up|0|||
23555405|NCT02332720|65758161|FG019|Part A and Part B|Lost to Follow-up|0|||
23555406|NCT02332720|65758162|FG020|Part A and Part B|Lost to Follow-up|0|||
23555407|NCT02332720|65758163|FG021|Part A and Part B|Lost to Follow-up|0|||
23555408|NCT02332720|65758164|FG022|Part A and Part B|Lost to Follow-up|0|||
23555409|NCT02332720|65758142|FG000|Part A and Part B|Adverse Event|0|||
23555410|NCT02332720|65758143|FG001|Part A and Part B|Adverse Event|0|||
23555411|NCT02332720|65758144|FG002|Part A and Part B|Adverse Event|0|||
23555412|NCT02332720|65758145|FG003|Part A and Part B|Adverse Event|0|||
23555413|NCT02332720|65758146|FG004|Part A and Part B|Adverse Event|0|||
23555414|NCT02332720|65758147|FG005|Part A and Part B|Adverse Event|0|||
23555415|NCT02332720|65758148|FG006|Part A and Part B|Adverse Event|0|||
23555416|NCT02332720|65758149|FG007|Part A and Part B|Adverse Event|0|||
23555417|NCT02332720|65758150|FG008|Part A and Part B|Adverse Event|0|||
23555418|NCT02332720|65758151|FG009|Part A and Part B|Adverse Event|0|||
23555419|NCT02332720|65758152|FG010|Part A and Part B|Adverse Event|0|||
23555420|NCT02332720|65758153|FG011|Part A and Part B|Adverse Event|0|||
23555421|NCT02332720|65758154|FG012|Part A and Part B|Adverse Event|0|||
23555422|NCT02332720|65758155|FG013|Part A and Part B|Adverse Event|0|||
23555423|NCT02332720|65758156|FG014|Part A and Part B|Adverse Event|0|||
23555424|NCT02332720|65758157|FG015|Part A and Part B|Adverse Event|0|||
23555425|NCT02332720|65758158|FG016|Part A and Part B|Adverse Event|0|||
23555426|NCT02332720|65758159|FG017|Part A and Part B|Adverse Event|1|||
23555427|NCT02332720|65758160|FG018|Part A and Part B|Adverse Event|0|||
23555428|NCT02332720|65758161|FG019|Part A and Part B|Adverse Event|0|||
23555429|NCT02332720|65758162|FG020|Part A and Part B|Adverse Event|0|||
23555430|NCT02332720|65758163|FG021|Part A and Part B|Adverse Event|0|||
23555431|NCT02332720|65758164|FG022|Part A and Part B|Adverse Event|0|||
23555432|NCT02332720|65758142|FG000|Part A and Part B|Physician Decision|0|||
23555433|NCT02332720|65758143|FG001|Part A and Part B|Physician Decision|0|||
23555434|NCT02332720|65758144|FG002|Part A and Part B|Physician Decision|0|||
23555435|NCT02332720|65758145|FG003|Part A and Part B|Physician Decision|0|||
23555436|NCT02332720|65758146|FG004|Part A and Part B|Physician Decision|0|||
23555437|NCT02332720|65758147|FG005|Part A and Part B|Physician Decision|0|||
23555438|NCT02332720|65758148|FG006|Part A and Part B|Physician Decision|0|||
23555439|NCT02332720|65758149|FG007|Part A and Part B|Physician Decision|0|||
23555440|NCT02332720|65758150|FG008|Part A and Part B|Physician Decision|0|||
23555441|NCT02332720|65758151|FG009|Part A and Part B|Physician Decision|0|||
23555442|NCT02332720|65758152|FG010|Part A and Part B|Physician Decision|0|||
23622884|NCT00576823|66005054|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
23622885|NCT00576823|66005055|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
23622886|NCT00576823|66005053|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
23622887|NCT00576823|66005054|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
23622888|NCT00576823|66005055|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
23622889|NCT00733226|66005060|FG000|Overall Study|Withdrawal by Subject|1|||
23622890|NCT00733226|66005061|FG001|Overall Study|Withdrawal by Subject|0|||
23622891|NCT00733226|66005060|FG000|Overall Study|Lost to Follow-up|2|||
23622892|NCT00733226|66005061|FG001|Overall Study|Lost to Follow-up|0|||
23622893|NCT00733226|66005060|FG000|Overall Study|moved to another place|2|||
23622894|NCT00733226|66005061|FG001|Overall Study|moved to another place|0|||
23622895|NCT03544229|66005062|FG000|Overall Study|Adverse Event|1|||
23622896|NCT03544229|66005063|FG001|Overall Study|Adverse Event|0|||
23622897|NCT03544229|66005064|FG002|Overall Study|Adverse Event|1|||
23823911|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
23555443|NCT02332720|65758153|FG011|Part A and Part B|Physician Decision|0|||
23555444|NCT02332720|65758154|FG012|Part A and Part B|Physician Decision|0|||
23555445|NCT02332720|65758155|FG013|Part A and Part B|Physician Decision|0|||
23555446|NCT02332720|65758156|FG014|Part A and Part B|Physician Decision|0|||
23555447|NCT02332720|65758157|FG015|Part A and Part B|Physician Decision|0|||
23555448|NCT02332720|65758158|FG016|Part A and Part B|Physician Decision|0|||
23555449|NCT02332720|65758159|FG017|Part A and Part B|Physician Decision|0|||
23555450|NCT02332720|65758160|FG018|Part A and Part B|Physician Decision|1|||
23555451|NCT02332720|65758161|FG019|Part A and Part B|Physician Decision|0|||
23555452|NCT02332720|65758162|FG020|Part A and Part B|Physician Decision|0|||
23622898|NCT03544229|66005065|FG003|Overall Study|Adverse Event|0|||
23622899|NCT03544229|66005062|FG000|Overall Study|Protocol Deviation|0|||
23622900|NCT03544229|66005063|FG001|Overall Study|Protocol Deviation|0|||
23622901|NCT03544229|66005064|FG002|Overall Study|Protocol Deviation|1|||
23555453|NCT02332720|65758163|FG021|Part A and Part B|Physician Decision|0|||
23555454|NCT02332720|65758164|FG022|Part A and Part B|Physician Decision|0|||
23555455|NCT02332720|65758142|FG000|Part A and Part B|Withdrawal by Subject|0|||
23555456|NCT02332720|65758143|FG001|Part A and Part B|Withdrawal by Subject|0|||
23622902|NCT03544229|66005065|FG003|Overall Study|Protocol Deviation|0|||
23622903|NCT03544229|66005062|FG000|Overall Study|Lost to Follow-up|3|||
23622904|NCT03544229|66005063|FG001|Overall Study|Lost to Follow-up|0|||
23622905|NCT03544229|66005064|FG002|Overall Study|Lost to Follow-up|0|||
23555457|NCT02332720|65758144|FG002|Part A and Part B|Withdrawal by Subject|0|||
23555458|NCT02332720|65758145|FG003|Part A and Part B|Withdrawal by Subject|0|||
23555459|NCT02332720|65758146|FG004|Part A and Part B|Withdrawal by Subject|0|||
23555460|NCT02332720|65758147|FG005|Part A and Part B|Withdrawal by Subject|1|||
23555461|NCT02332720|65758148|FG006|Part A and Part B|Withdrawal by Subject|0|||
23555462|NCT02332720|65758149|FG007|Part A and Part B|Withdrawal by Subject|0|||
23555463|NCT02332720|65758150|FG008|Part A and Part B|Withdrawal by Subject|0|||
23555464|NCT02332720|65758151|FG009|Part A and Part B|Withdrawal by Subject|0|||
23555465|NCT02332720|65758152|FG010|Part A and Part B|Withdrawal by Subject|0|||
23555466|NCT02332720|65758153|FG011|Part A and Part B|Withdrawal by Subject|0|||
23555467|NCT02332720|65758154|FG012|Part A and Part B|Withdrawal by Subject|0|||
23555468|NCT02332720|65758155|FG013|Part A and Part B|Withdrawal by Subject|0|||
23555469|NCT02332720|65758156|FG014|Part A and Part B|Withdrawal by Subject|0|||
23555470|NCT02332720|65758157|FG015|Part A and Part B|Withdrawal by Subject|0|||
23555471|NCT02332720|65758158|FG016|Part A and Part B|Withdrawal by Subject|0|||
23555472|NCT02332720|65758159|FG017|Part A and Part B|Withdrawal by Subject|0|||
23555473|NCT02332720|65758160|FG018|Part A and Part B|Withdrawal by Subject|0|||
23555474|NCT02332720|65758161|FG019|Part A and Part B|Withdrawal by Subject|1|||
23622906|NCT03544229|66005065|FG003|Overall Study|Lost to Follow-up|2|||
23622907|NCT03544229|66005062|FG000|Overall Study|Voluntary Withdrawal|2|||
23622908|NCT03544229|66005063|FG001|Overall Study|Voluntary Withdrawal|1|||
23748891|NCT00070499|66460342|FG003|Overall Study|Did not start treatment|2|||
23748892|NCT00070499|66460339|FG000|Overall Study|Not eligible|2|||
23748893|NCT00070499|66460340|FG001|Overall Study|Not eligible|5|||
23748894|NCT00070499|66460341|FG002|Overall Study|Not eligible|3|||
23748895|NCT00070499|66460342|FG003|Overall Study|Not eligible|2|||
23748896|NCT03345485|66460345|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
23748897|NCT03345485|66460346|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
23748898|NCT03345485|66460347|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
23748899|NCT03345485|66460348|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
23748900|NCT03345485|66460349|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
23748901|NCT03345485|66460350|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
23748902|NCT03345485|66460351|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
23748903|NCT03345485|66460352|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
23748904|NCT03345485|66460353|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
23748905|NCT03345485|66460354|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
23555475|NCT02332720|65758162|FG020|Part A and Part B|Withdrawal by Subject|0|||
23555476|NCT02332720|65758163|FG021|Part A and Part B|Withdrawal by Subject|0|||
23555477|NCT02332720|65758164|FG022|Part A and Part B|Withdrawal by Subject|0|||
23622909|NCT03544229|66005064|FG002|Overall Study|Voluntary Withdrawal|3|||
23748906|NCT03345485|66460355|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
23748907|NCT03345485|66460356|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
23748908|NCT03345485|66460357|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
23748909|NCT01513759|66460358|FG000|Overall Study|Protocol Violation|4|||
23555478|NCT01410474|65758165|FG000|Overall Study|Withdrawal by Subject|0|||
23555479|NCT01410474|65758166|FG001|Overall Study|Withdrawal by Subject|1|||
23555480|NCT03945188|65758167|FG000|Overall Study|Protocol Violation|1|||
23748910|NCT01513759|66460358|FG000|Overall Study|Death during catheter placement|1|||
23748911|NCT00554788|66460359|FG000|Overall Study|Adverse Event|0|||
23748912|NCT00554788|66460360|FG001|Overall Study|Adverse Event|1|||
23748913|NCT00554788|66460361|FG002|Overall Study|Adverse Event|2|||
23748914|NCT00554788|66460359|FG000|Overall Study|Lost to Follow-up|4|||
23748915|NCT00554788|66460360|FG001|Overall Study|Lost to Follow-up|3|||
23748916|NCT00554788|66460361|FG002|Overall Study|Lost to Follow-up|3|||
23748917|NCT00554788|66460359|FG000|Overall Study|Physician Decision|1|||
23748918|NCT00554788|66460360|FG001|Overall Study|Physician Decision|1|||
23748919|NCT00554788|66460361|FG002|Overall Study|Physician Decision|3|||
23748920|NCT00554788|66460359|FG000|Overall Study|Withdrawal by Subject|0|||
23748921|NCT00554788|66460360|FG001|Overall Study|Withdrawal by Subject|0|||
23748922|NCT00554788|66460361|FG002|Overall Study|Withdrawal by Subject|1|||
23748923|NCT00554788|66460359|FG000|Overall Study|Refusal of further protocol therapy|0|||
23748924|NCT00554788|66460360|FG001|Overall Study|Refusal of further protocol therapy|1|||
23748925|NCT00554788|66460361|FG002|Overall Study|Refusal of further protocol therapy|1|||
23748926|NCT00554788|66460359|FG000|Overall Study|Progressive disease|0|||
23748927|NCT00554788|66460360|FG001|Overall Study|Progressive disease|0|||
23748928|NCT00554788|66460361|FG002|Overall Study|Progressive disease|3|||
23748929|NCT00554788|66460359|FG000|Overall Study|Ineligible|2|||
23748930|NCT00554788|66460360|FG001|Overall Study|Ineligible|0|||
23555481|NCT03945188|65758168|FG001|Overall Study|Protocol Violation|0|||
23555482|NCT03945188|65758167|FG000|Overall Study|Disease worsening|79|||
23555483|NCT03945188|65758168|FG001|Overall Study|Disease worsening|73|||
23555484|NCT03945188|65758167|FG000|Overall Study|Physician Decision|2|||
23555485|NCT03945188|65758168|FG001|Overall Study|Physician Decision|2|||
23555486|NCT03945188|65758167|FG000|Overall Study|Lack of Efficacy|7|||
23555487|NCT03945188|65758168|FG001|Overall Study|Lack of Efficacy|4|||
23555488|NCT03945188|65758167|FG000|Overall Study|Pregnancy|2|||
23555489|NCT03945188|65758168|FG001|Overall Study|Pregnancy|0|||
23555490|NCT03945188|65758167|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
23555491|NCT03945188|65758168|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
23555492|NCT03945188|65758167|FG000|Overall Study|Adverse Event|10|||
23555493|NCT03945188|65758168|FG001|Overall Study|Adverse Event|5|||
23555494|NCT03945188|65758167|FG000|Overall Study|Other|2|||
23555495|NCT03945188|65758168|FG001|Overall Study|Other|2|||
23555496|NCT03945188|65758167|FG000|Overall Study|Lost to Follow-up|1|||
23555497|NCT03945188|65758168|FG001|Overall Study|Lost to Follow-up|2|||
23555498|NCT02163733|65758176|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
23748931|NCT00554788|66460361|FG002|Overall Study|Ineligible|1|||
23748932|NCT02476916|66460362|FG000|Core Period|Adverse Event|2|||
23748933|NCT02476916|66460363|FG001|Core Period|Adverse Event|2|||
23748934|NCT02476916|66460362|FG000|Core Period|Investigator decision|1|||
23748935|NCT02476916|66460363|FG001|Core Period|Investigator decision|1|||
23555499|NCT02163733|65758177|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
23555500|NCT02163733|65758178|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
23748936|NCT02476916|66460362|FG000|Core Period|Withdrawal by Subject|3|||
23748937|NCT02476916|66460363|FG001|Core Period|Withdrawal by Subject|0|||
23748938|NCT02476916|66460362|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
23748939|NCT02476916|66460363|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
23748940|NCT02476916|66460362|FG000|Extension Period|On Treatment|12|||
23823912|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Other|2|||
23823913|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Other|1|||
23823914|NCT02952586|66737674|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
23823915|NCT02952586|66737675|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
23555501|NCT02163733|65758176|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
23555502|NCT02163733|65758177|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
23555503|NCT02163733|65758178|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
23555504|NCT00504426|65758183|FG000|Overall Study|Adverse Event|0|||
23555505|NCT00504426|65758184|FG001|Overall Study|Adverse Event|0|||
23555506|NCT00504426|65758185|FG002|Overall Study|Adverse Event|2|||
23555507|NCT00504426|65758186|FG003|Overall Study|Adverse Event|0|||
23555508|NCT00504426|65758183|FG000|Overall Study|Protocol Violation|1|||
23555509|NCT00504426|65758184|FG001|Overall Study|Protocol Violation|1|||
23555510|NCT00504426|65758185|FG002|Overall Study|Protocol Violation|2|||
23555511|NCT00504426|65758186|FG003|Overall Study|Protocol Violation|0|||
23555512|NCT00504426|65758183|FG000|Overall Study|Withdrawal by Subject|2|||
23555513|NCT00504426|65758184|FG001|Overall Study|Withdrawal by Subject|0|||
23555514|NCT00504426|65758185|FG002|Overall Study|Withdrawal by Subject|0|||
23555515|NCT00504426|65758186|FG003|Overall Study|Withdrawal by Subject|0|||
23555516|NCT01922076|65762256|FG000|Overall Study|Adverse Event|0|||
23555517|NCT01922076|65762257|FG001|Overall Study|Adverse Event|0|||
23555518|NCT01922076|65762258|FG002|Overall Study|Adverse Event|0|||
23555519|NCT01922076|65762259|FG003|Overall Study|Adverse Event|0|||
23555520|NCT01922076|65762260|FG004|Overall Study|Adverse Event|1|||
23555521|NCT01922076|65762261|FG005|Overall Study|Adverse Event|0|||
23555522|NCT01922076|65762262|FG006|Overall Study|Adverse Event|0|||
23555523|NCT01922076|65762256|FG000|Overall Study|Physician Decision|0|||
23555524|NCT01922076|65762257|FG001|Overall Study|Physician Decision|0|||
23555525|NCT01922076|65762258|FG002|Overall Study|Physician Decision|1|||
23555526|NCT01922076|65762259|FG003|Overall Study|Physician Decision|0|||
23555527|NCT01922076|65762260|FG004|Overall Study|Physician Decision|0|||
23555528|NCT01922076|65762261|FG005|Overall Study|Physician Decision|0|||
23555529|NCT01922076|65762262|FG006|Overall Study|Physician Decision|0|||
23555530|NCT01922076|65762256|FG000|Overall Study|Withdrawal by Subject|0|||
23555531|NCT01922076|65762257|FG001|Overall Study|Withdrawal by Subject|0|||
23555532|NCT01922076|65762258|FG002|Overall Study|Withdrawal by Subject|0|||
23555533|NCT01922076|65762259|FG003|Overall Study|Withdrawal by Subject|1|||
23555534|NCT01922076|65762260|FG004|Overall Study|Withdrawal by Subject|0|||
23555535|NCT01922076|65762261|FG005|Overall Study|Withdrawal by Subject|1|||
23555536|NCT01922076|65762262|FG006|Overall Study|Withdrawal by Subject|1|||
23555537|NCT00453986|65762263|FG000|Overall Study|Lost to Follow-up|6|||
23555538|NCT00453986|65762264|FG001|Overall Study|Lost to Follow-up|5|||
23555539|NCT00453986|65762265|FG002|Overall Study|Lost to Follow-up|6|||
23555540|NCT00453986|65762266|FG003|Overall Study|Lost to Follow-up|2|||
23555541|NCT00453986|65762267|FG004|Overall Study|Lost to Follow-up|0|||
23555542|NCT00689221|65762268|FG000|Overall Study|Ongoing at cut-off date|39|||
23555543|NCT00689221|65762269|FG001|Overall Study|Ongoing at cut-off date|36|||
23555544|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
23555545|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
23555546|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
23555547|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
23555548|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
23555549|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
23555550|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
23555551|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
23555552|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
23555553|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
23555554|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
23555555|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
23555556|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
23555557|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
23555558|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
23823916|NCT02952586|66737674|FG000|Follow-Up Phase (90 Days)|Death|12|||
23555559|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
23555560|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
23555561|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
23622910|NCT03544229|66005065|FG003|Overall Study|Voluntary Withdrawal|0|||
23823917|NCT02952586|66737675|FG001|Follow-Up Phase (90 Days)|Death|10|||
23823918|NCT02952586|66737674|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
23555562|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
23555563|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
23555564|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
23555565|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
23555566|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
23555567|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
23555568|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
23555569|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
23555570|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
23622911|NCT03544229|66005062|FG000|Overall Study|Lack of Efficacy|0|||
23622912|NCT03544229|66005063|FG001|Overall Study|Lack of Efficacy|1|||
23622913|NCT03544229|66005064|FG002|Overall Study|Lack of Efficacy|0|||
23622914|NCT03544229|66005065|FG003|Overall Study|Lack of Efficacy|0|||
23622915|NCT01726517|66005068|FG000|Overall Study|Withdrawal by Subject|0|||
23433211|NCT00129961|65330396|FG000|Overall Study|Withdrawal by Sponsor|14|||
23433212|NCT00129961|65330397|FG001|Overall Study|Withdrawal by Sponsor|20|||
23433213|NCT00129961|65330396|FG000|Overall Study|Physician Decision|1|||
23433214|NCT00129961|65330397|FG001|Overall Study|Physician Decision|0|||
23555571|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
23555572|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
23555573|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
23555574|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
23748941|NCT02476916|66460363|FG001|Extension Period|On Treatment|17|||
23748942|NCT00564486|66460364|FG000|Overall Study|Adverse Event|0|||
23748943|NCT00564486|66460365|FG001|Overall Study|Adverse Event|1|||
23748944|NCT00564486|66460366|FG002|Overall Study|Adverse Event|0|||
23748945|NCT00564486|66460367|FG003|Overall Study|Adverse Event|0|||
23748946|NCT00564486|66460364|FG000|Overall Study|Withdrawal by Subject|4|||
23748947|NCT00564486|66460365|FG001|Overall Study|Withdrawal by Subject|0|||
23748948|NCT00564486|66460366|FG002|Overall Study|Withdrawal by Subject|0|||
23748949|NCT00564486|66460367|FG003|Overall Study|Withdrawal by Subject|5|||
23748950|NCT00564486|66460364|FG000|Overall Study|Subject refused to have blood drawn|0|||
23748951|NCT00564486|66460365|FG001|Overall Study|Subject refused to have blood drawn|0|||
23748952|NCT00564486|66460366|FG002|Overall Study|Subject refused to have blood drawn|1|||
23748953|NCT00564486|66460367|FG003|Overall Study|Subject refused to have blood drawn|0|||
23748954|NCT00564486|66460364|FG000|Overall Study|Lost to Follow-up|3|||
23748955|NCT00564486|66460365|FG001|Overall Study|Lost to Follow-up|0|||
23748956|NCT00564486|66460366|FG002|Overall Study|Lost to Follow-up|2|||
23748957|NCT00564486|66460367|FG003|Overall Study|Lost to Follow-up|2|||
23748958|NCT02916056|66460370|FG000|Overall Study|Adverse Event|6|||
23748959|NCT02916056|66460370|FG000|Overall Study|Lost to Follow-up|1|||
23748960|NCT02916056|66460370|FG000|Overall Study|Other|12|||
23748961|NCT02916056|66460370|FG000|Overall Study|Protocol Violation|1|||
23748962|NCT02916056|66460370|FG000|Overall Study|Withdrawal by Subject|8|||
23748963|NCT02916056|66460370|FG000|Overall Study|Study Terminated by Sponsor|269|||
23748964|NCT03707145|66460371|FG000|Overall Study|Lost to Follow-up|0|||
23748965|NCT03707145|66460372|FG001|Overall Study|Lost to Follow-up|1|||
23748966|NCT03707145|66460373|FG002|Overall Study|Lost to Follow-up|1|||
23748967|NCT03707145|66460374|FG003|Overall Study|Lost to Follow-up|0|||
23748968|NCT03323034|66460375|FG000|Overall Study|Lack of Efficacy|5|||
23748969|NCT03323034|66460376|FG001|Overall Study|Lack of Efficacy|5|||
23748970|NCT03323034|66460377|FG002|Overall Study|Lack of Efficacy|6|||
23748971|NCT03323034|66460378|FG003|Overall Study|Lack of Efficacy|5|||
23748972|NCT03323034|66460379|FG004|Overall Study|Lack of Efficacy|5|||
23748973|NCT03323034|66460375|FG000|Overall Study|Physician Decision|0|||
23748974|NCT03323034|66460376|FG001|Overall Study|Physician Decision|0|||
23748975|NCT03323034|66460377|FG002|Overall Study|Physician Decision|0|||
23748976|NCT03323034|66460378|FG003|Overall Study|Physician Decision|0|||
23748977|NCT03323034|66460379|FG004|Overall Study|Physician Decision|1|||
23748978|NCT03323034|66460375|FG000|Overall Study|Withdrawal by Subject|1|||
23748979|NCT03323034|66460376|FG001|Overall Study|Withdrawal by Subject|1|||
23748980|NCT03323034|66460377|FG002|Overall Study|Withdrawal by Subject|0|||
23748981|NCT03323034|66460378|FG003|Overall Study|Withdrawal by Subject|1|||
23748982|NCT03323034|66460379|FG004|Overall Study|Withdrawal by Subject|0|||
23748983|NCT02279888|66460380|FG000|Overall Study|Death|326|||
23748984|NCT02279888|66460380|FG000|Overall Study|Withdrawal by Subject|38|||
23748985|NCT02279888|66460380|FG000|Overall Study|Lost to Follow-up|21|||
23748986|NCT02279888|66460380|FG000|Overall Study|Physician Decision|62|||
23748987|NCT02279888|66460380|FG000|Overall Study|Subject Non-compliance|43|||
23748988|NCT02279888|66460380|FG000|Overall Study|Not implanted|14|||
23748989|NCT02279888|66460380|FG000|Overall Study|Visit not performed|26|||
23748990|NCT01068418|66460381|FG000|Overall Study|Physician Decision|12|||
23748991|NCT04629534|66460384|FG000|Overall Study|Physician Decision|1|||
23433215|NCT00129961|65330396|FG000|Overall Study|Withdrawal by Subject|2|||
23433216|NCT00129961|65330397|FG001|Overall Study|Withdrawal by Subject|1|||
23433217|NCT00129961|65330396|FG000|Overall Study|Missing Record|0|||
23433218|NCT00129961|65330397|FG001|Overall Study|Missing Record|1|||
23433219|NCT02925741|65330398|FG000|Overall Study|Withdrawal by Subject|11|||
23433220|NCT02925741|65330399|FG001|Overall Study|Withdrawal by Subject|0|||
23433221|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
23555575|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
23555576|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23555577|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
23555578|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
23555579|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
23555580|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
23555581|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
23555582|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
23555583|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
23555584|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
23748992|NCT04629534|66460385|FG001|Overall Study|Physician Decision|0|||
23748993|NCT04629534|66460384|FG000|Overall Study|Protocol Violation|0|||
23748994|NCT04629534|66460385|FG001|Overall Study|Protocol Violation|2|||
23748995|NCT02975882|66460386|FG000|Overall Study|Adverse Event|1|||
23622916|NCT01726517|66005069|FG001|Overall Study|Withdrawal by Subject|0|||
23748996|NCT02975882|66460387|FG001|Overall Study|Adverse Event|2|||
23823919|NCT02952586|66737675|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
23823920|NCT02952586|66737674|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
23823921|NCT02952586|66737675|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
23823922|NCT02952586|66737674|FG000|Follow-Up Phase (90 Days)|Other|7|||
23823923|NCT02952586|66737675|FG001|Follow-Up Phase (90 Days)|Other|5|||
23823924|NCT02952586|66737674|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
23823925|NCT02952586|66737675|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
23823926|NCT02952586|66737674|FG000|LT Follow-up (up to 45 Months)|Death|51|||
23823927|NCT02952586|66737675|FG001|LT Follow-up (up to 45 Months)|Death|31|||
23823928|NCT02952586|66737674|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
23823929|NCT02952586|66737675|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
23823930|NCT02952586|66737674|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
23823931|NCT02952586|66737675|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
23823932|NCT02952586|66737674|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
23823933|NCT02952586|66737675|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
23823934|NCT02681510|66737676|FG000|Overall Study|Withdrawal by Subject|1|||
23622917|NCT01726517|66005070|FG002|Overall Study|Withdrawal by Subject|1|||
23748997|NCT02975882|66460388|FG002|Overall Study|Adverse Event|1|||
23748998|NCT02975882|66460389|FG003|Overall Study|Adverse Event|1|||
23748999|NCT02975882|66460386|FG000|Overall Study|Death|0|||
23749000|NCT02975882|66460387|FG001|Overall Study|Death|1|||
23749001|NCT02975882|66460388|FG002|Overall Study|Death|0|||
23749002|NCT02975882|66460389|FG003|Overall Study|Death|0|||
23749003|NCT02975882|66460386|FG000|Overall Study|Lack of Efficacy|3|||
23749004|NCT02975882|66460387|FG001|Overall Study|Lack of Efficacy|7|||
23749005|NCT02975882|66460388|FG002|Overall Study|Lack of Efficacy|4|||
23749006|NCT02975882|66460389|FG003|Overall Study|Lack of Efficacy|3|||
23749007|NCT02975882|66460386|FG000|Overall Study|Physician Decision|0|||
23749008|NCT02975882|66460387|FG001|Overall Study|Physician Decision|2|||
23823935|NCT02681510|66737676|FG000|Overall Study|Lost to Follow-up|9|||
23823936|NCT01982955|66737677|FG000|Overall Study|Randomized but not treated|0|||
23823937|NCT01982955|66737678|FG001|Overall Study|Randomized but not treated|0|||
23622918|NCT01726517|66005071|FG003|Overall Study|Withdrawal by Subject|0|||
23749009|NCT02975882|66460388|FG002|Overall Study|Physician Decision|4|||
23749010|NCT02975882|66460389|FG003|Overall Study|Physician Decision|2|||
23749011|NCT02975882|66460386|FG000|Overall Study|Ineligible|0|||
23823938|NCT01982955|66737679|FG002|Overall Study|Randomized but not treated|0|||
23749012|NCT02975882|66460387|FG001|Overall Study|Ineligible|1|||
23749013|NCT02975882|66460388|FG002|Overall Study|Ineligible|0|||
23749014|NCT02975882|66460389|FG003|Overall Study|Ineligible|0|||
23749015|NCT03958045|66460393|FG000|Overall Study|Withdrawal by Subject|1|||
23749016|NCT03387423|66460396|FG000|Overall Study|Lost to Follow-up|16|||
23749017|NCT03387423|66460397|FG001|Overall Study|Lost to Follow-up|12|||
23749018|NCT03387423|66460398|FG002|Overall Study|Lost to Follow-up|1|||
23749019|NCT03387423|66460399|FG003|Overall Study|Lost to Follow-up|0|||
23749020|NCT03387423|66460396|FG000|Overall Study|Other|0|||
23749021|NCT03387423|66460397|FG001|Overall Study|Other|3|||
23749022|NCT03387423|66460398|FG002|Overall Study|Other|0|||
23749023|NCT03387423|66460399|FG003|Overall Study|Other|0|||
23749024|NCT03387423|66460396|FG000|Overall Study|Administrative Reason|166|||
23749025|NCT03387423|66460397|FG001|Overall Study|Administrative Reason|89|||
23749026|NCT03387423|66460398|FG002|Overall Study|Administrative Reason|17|||
23749027|NCT03387423|66460399|FG003|Overall Study|Administrative Reason|19|||
23749028|NCT03387423|66460396|FG000|Overall Study|Revocation Consent|76|||
23749029|NCT03387423|66460397|FG001|Overall Study|Revocation Consent|32|||
23749030|NCT03387423|66460398|FG002|Overall Study|Revocation Consent|3|||
23749031|NCT03387423|66460399|FG003|Overall Study|Revocation Consent|5|||
23749032|NCT04637815|66460402|FG000|Overall Study|Death|1|||
23749033|NCT04637815|66460403|FG001|Overall Study|Death|0|||
23749034|NCT04637815|66460402|FG000|Overall Study|Lost to Follow-up|5|||
23749035|NCT04637815|66460403|FG001|Overall Study|Lost to Follow-up|2|||
23749036|NCT01142388|66460422|FG000|Overall Study|Lack of Efficacy|21|||
23749037|NCT01142388|66460423|FG001|Overall Study|Lack of Efficacy|31|||
23749038|NCT01142388|66460422|FG000|Overall Study|Adverse Event|9|||
23749039|NCT01142388|66460423|FG001|Overall Study|Adverse Event|5|||
23749040|NCT01142388|66460422|FG000|Overall Study|Death|3|||
23749041|NCT01142388|66460423|FG001|Overall Study|Death|2|||
23749042|NCT01142388|66460422|FG000|Overall Study|Withdrawal by Subject|5|||
23749043|NCT01142388|66460423|FG001|Overall Study|Withdrawal by Subject|3|||
23433222|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433223|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433224|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433225|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
23433226|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433227|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433228|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433229|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
23433230|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433231|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433232|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433233|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
23433234|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
23433235|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
23433236|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
23433237|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
23433238|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433239|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433240|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433241|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
23433242|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23749044|NCT01142388|66460422|FG000|Overall Study|Alternative therapy|1|||
23749045|NCT01142388|66460423|FG001|Overall Study|Alternative therapy|0|||
23749046|NCT01142388|66460422|FG000|Overall Study|Other complications|0|||
23749047|NCT01142388|66460423|FG001|Overall Study|Other complications|2|||
23749048|NCT01142388|66460422|FG000|Overall Study|Other|1|||
23749049|NCT01142388|66460423|FG001|Overall Study|Other|1|||
23749050|NCT01142388|66460422|FG000|Overall Study|Never started therapy|7|||
23749051|NCT01142388|66460423|FG001|Overall Study|Never started therapy|3|||
23749052|NCT03382561|66460424|FG000|Overall Study|Disease progression|47|||
23749053|NCT03382561|66460425|FG001|Overall Study|Disease progression|6|||
23749054|NCT03382561|66460424|FG000|Overall Study|Adverse Event|10|||
23749055|NCT03382561|66460425|FG001|Overall Study|Adverse Event|2|||
23749056|NCT03382561|66460424|FG000|Overall Study|Death|8|||
23749057|NCT03382561|66460425|FG001|Overall Study|Death|3|||
23749058|NCT03382561|66460424|FG000|Overall Study|Withdrawal by Subject|6|||
23749059|NCT03382561|66460425|FG001|Overall Study|Withdrawal by Subject|5|||
23749060|NCT03382561|66460424|FG000|Overall Study|Alternative therapy|2|||
23749061|NCT03382561|66460425|FG001|Overall Study|Alternative therapy|8|||
23749062|NCT03382561|66460424|FG000|Overall Study|Never started treatment|3|||
23749063|NCT03382561|66460425|FG001|Overall Study|Never started treatment|6|||
23749064|NCT03382561|66460424|FG000|Overall Study|Lack of Efficacy|0|||
23749065|NCT03382561|66460425|FG001|Overall Study|Lack of Efficacy|1|||
23749066|NCT03382561|66460424|FG000|Overall Study|Physician Decision|0|||
23749067|NCT03382561|66460425|FG001|Overall Study|Physician Decision|1|||
23749068|NCT03382561|66460424|FG000|Overall Study|Other complicating disease|0|||
23749069|NCT03382561|66460425|FG001|Overall Study|Other complicating disease|1|||
23749070|NCT00433511|66460426|FG000|Step 1|Adverse Event|50|||
23749071|NCT00433511|66460427|FG001|Step 1|Adverse Event|157|||
23749072|NCT00433511|66460428|FG002|Step 1|Adverse Event|153|||
23823939|NCT01982955|66737680|FG003|Overall Study|Randomized but not treated|1|||
23823940|NCT01982955|66737681|FG004|Overall Study|Randomized but not treated|0|||
23823941|NCT00789035|66737686|FG000|Overall Study|Adverse Event|0|||
23823942|NCT00789035|66737687|FG001|Overall Study|Adverse Event|2|||
23823943|NCT00789035|66737688|FG002|Overall Study|Adverse Event|0|||
23823944|NCT00789035|66737689|FG003|Overall Study|Adverse Event|1|||
23823945|NCT00789035|66737690|FG004|Overall Study|Adverse Event|3|||
23749073|NCT00433511|66460426|FG000|Step 1|Withdrawal by Subject|45|||
23749074|NCT00433511|66460427|FG001|Step 1|Withdrawal by Subject|143|||
23749075|NCT00433511|66460428|FG002|Step 1|Withdrawal by Subject|154|||
23749076|NCT00433511|66460426|FG000|Step 1|Death|3|||
23749077|NCT00433511|66460427|FG001|Step 1|Death|1|||
23749078|NCT00433511|66460428|FG002|Step 1|Death|1|||
23749079|NCT00433511|66460426|FG000|Step 1|Physician Decision|1|||
23749080|NCT00433511|66460427|FG001|Step 1|Physician Decision|4|||
23749081|NCT00433511|66460428|FG002|Step 1|Physician Decision|3|||
23749082|NCT00433511|66460426|FG000|Step 1|Never started protocol therapy|28|||
23749083|NCT00433511|66460427|FG001|Step 1|Never started protocol therapy|64|||
23823946|NCT00789035|66737686|FG000|Overall Study|Lack of Efficacy|3|||
23823947|NCT00789035|66737687|FG001|Overall Study|Lack of Efficacy|0|||
23823948|NCT00789035|66737688|FG002|Overall Study|Lack of Efficacy|0|||
23433243|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23433244|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23823949|NCT00789035|66737689|FG003|Overall Study|Lack of Efficacy|0|||
23823950|NCT00789035|66737690|FG004|Overall Study|Lack of Efficacy|2|||
23823951|NCT00789035|66737686|FG000|Overall Study|Protocol Violation|1|||
23823952|NCT00789035|66737687|FG001|Overall Study|Protocol Violation|0|||
23823953|NCT00789035|66737688|FG002|Overall Study|Protocol Violation|0|||
23823954|NCT00789035|66737689|FG003|Overall Study|Protocol Violation|0|||
23823955|NCT00789035|66737690|FG004|Overall Study|Protocol Violation|0|||
23823956|NCT00789035|66737686|FG000|Overall Study|Withdrawal by Subject|0|||
23823957|NCT00789035|66737687|FG001|Overall Study|Withdrawal by Subject|2|||
23823958|NCT00789035|66737688|FG002|Overall Study|Withdrawal by Subject|0|||
23823959|NCT00789035|66737689|FG003|Overall Study|Withdrawal by Subject|0|||
23823960|NCT00789035|66737690|FG004|Overall Study|Withdrawal by Subject|0|||
23823961|NCT00789035|66737686|FG000|Overall Study|Other reason not defined above|2|||
23823962|NCT00789035|66737687|FG001|Overall Study|Other reason not defined above|3|||
23823963|NCT00789035|66737688|FG002|Overall Study|Other reason not defined above|1|||
23622919|NCT01726517|66005072|FG004|Overall Study|Withdrawal by Subject|0|||
23622920|NCT01482429|66005073|FG000|Care Usual|Protocol Violation|0|||
23622921|NCT01482429|66005074|FG001|Care Usual|Protocol Violation|172|||
23622922|NCT01482429|66005073|FG000|Care Usual|Lost to Follow-up|0|||
23622923|NCT01482429|66005074|FG001|Care Usual|Lost to Follow-up|1|||
23622924|NCT01482429|66005073|FG000|Protocol|Protocol Violation|275|||
23622925|NCT01482429|66005074|FG001|Protocol|Protocol Violation|0|||
23622926|NCT03279978|66005076|FG000|Overall Study|Withdrawal by Subject|0|||
23622927|NCT03279978|66005077|FG001|Overall Study|Withdrawal by Subject|1|||
23622928|NCT03279978|66005078|FG002|Overall Study|Withdrawal by Subject|0|||
23622929|NCT03279978|66005079|FG003|Overall Study|Withdrawal by Subject|0|||
23622930|NCT03279978|66005080|FG004|Overall Study|Withdrawal by Subject|0|||
23622931|NCT03279978|66005081|FG005|Overall Study|Withdrawal by Subject|0|||
23622932|NCT03279978|66005082|FG006|Overall Study|Withdrawal by Subject|0|||
23622933|NCT03279978|66005083|FG007|Overall Study|Withdrawal by Subject|0|||
23622934|NCT03279978|66005084|FG008|Overall Study|Withdrawal by Subject|0|||
23622935|NCT03279978|66005085|FG009|Overall Study|Withdrawal by Subject|1|||
23622936|NCT03279978|66005076|FG000|Overall Study|Lost to Follow-up|1|||
23749084|NCT00433511|66460428|FG002|Step 1|Never started protocol therapy|66|||
23823964|NCT00789035|66737689|FG003|Overall Study|Other reason not defined above|0|||
23823965|NCT00789035|66737690|FG004|Overall Study|Other reason not defined above|1|||
23823966|NCT02189837|66737693|FG000|Overall Study|Withdrawal by Subject|2|||
23433245|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
23433246|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23622937|NCT03279978|66005077|FG001|Overall Study|Lost to Follow-up|0|||
23823967|NCT02189837|66737694|FG001|Overall Study|Withdrawal by Subject|1|||
23749085|NCT00433511|66460426|FG000|Step 1|Alternative therapy|2|||
23749086|NCT00433511|66460427|FG001|Step 1|Alternative therapy|1|||
23749087|NCT00433511|66460428|FG002|Step 1|Alternative therapy|3|||
23433247|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23433248|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23433249|NCT04583956|65330404|FG000|Overall Study|Death|9|||
23433250|NCT04583956|65330405|FG001|Overall Study|Death|11|||
23433251|NCT04583956|65330404|FG000|Overall Study|Lost to Follow-up|7|||
23433252|NCT04583956|65330405|FG001|Overall Study|Lost to Follow-up|9|||
23433253|NCT04583956|65330404|FG000|Overall Study|Protocol Violation|2|||
23433254|NCT04583956|65330405|FG001|Overall Study|Protocol Violation|0|||
23433255|NCT04583956|65330404|FG000|Overall Study|Withdrawal by Subject|0|||
23622938|NCT03279978|66005078|FG002|Overall Study|Lost to Follow-up|1|||
23622939|NCT03279978|66005079|FG003|Overall Study|Lost to Follow-up|0|||
23622940|NCT03279978|66005080|FG004|Overall Study|Lost to Follow-up|0|||
23622941|NCT03279978|66005081|FG005|Overall Study|Lost to Follow-up|0|||
23622942|NCT03279978|66005082|FG006|Overall Study|Lost to Follow-up|0|||
23622943|NCT03279978|66005083|FG007|Overall Study|Lost to Follow-up|0|||
23622944|NCT03279978|66005084|FG008|Overall Study|Lost to Follow-up|0|||
23622945|NCT03279978|66005085|FG009|Overall Study|Lost to Follow-up|0|||
23622946|NCT03279978|66005076|FG000|Overall Study|Other than stated above|0|||
23622947|NCT03279978|66005077|FG001|Overall Study|Other than stated above|0|||
23622948|NCT03279978|66005078|FG002|Overall Study|Other than stated above|0|||
23622949|NCT03279978|66005079|FG003|Overall Study|Other than stated above|0|||
23622950|NCT03279978|66005080|FG004|Overall Study|Other than stated above|0|||
23622951|NCT03279978|66005081|FG005|Overall Study|Other than stated above|0|||
23622952|NCT03279978|66005082|FG006|Overall Study|Other than stated above|1|||
23622953|NCT03279978|66005083|FG007|Overall Study|Other than stated above|0|||
23622954|NCT03279978|66005084|FG008|Overall Study|Other than stated above|0|||
23622955|NCT03279978|66005085|FG009|Overall Study|Other than stated above|0|||
23622956|NCT03245619|66005090|FG000|Part A (Up to Day 22)|Physician Decision|4|||
23622957|NCT03245619|66005091|FG001|Part A (Up to Day 22)|Physician Decision|6|||
23622958|NCT03245619|66005092|FG002|Part A (Up to Day 22)|Physician Decision|6|||
23622959|NCT03245619|66005093|FG003|Part A (Up to Day 22)|Physician Decision|0|||
23622960|NCT03245619|66005094|FG004|Part A (Up to Day 22)|Physician Decision|0|||
23622961|NCT03245619|66005095|FG005|Part A (Up to Day 22)|Physician Decision|0|||
23622962|NCT03245619|66005096|FG006|Part A (Up to Day 22)|Physician Decision|0|||
23622963|NCT03245619|66005097|FG007|Part A (Up to Day 22)|Physician Decision|0|||
23622964|NCT03245619|66005098|FG008|Part A (Up to Day 22)|Physician Decision|0|||
23622965|NCT03245619|66005099|FG009|Part A (Up to Day 22)|Physician Decision|0|||
23823968|NCT02189837|66737695|FG002|Overall Study|Withdrawal by Subject|3|||
23823969|NCT02189837|66737696|FG003|Overall Study|Withdrawal by Subject|1|||
23823970|NCT02189837|66737693|FG000|Overall Study|Sponsor Decision|0|||
23823971|NCT02189837|66737694|FG001|Overall Study|Sponsor Decision|0|||
23433256|NCT04583956|65330405|FG001|Overall Study|Withdrawal by Subject|2|||
23433257|NCT04583956|65330404|FG000|Overall Study|Randomized but not dosed|2|||
23823972|NCT02189837|66737695|FG002|Overall Study|Sponsor Decision|0|||
23823973|NCT02189837|66737696|FG003|Overall Study|Sponsor Decision|1|||
23433258|NCT04583956|65330405|FG001|Overall Study|Randomized but not dosed|3|||
23433259|NCT04583956|65330404|FG000|Overall Study|Withdrawal of consent before product administration|1|||
23622966|NCT03245619|66005100|FG010|Part A (Up to Day 22)|Physician Decision|0|||
23622967|NCT03245619|66005101|FG011|Part A (Up to Day 22)|Physician Decision|0|||
23622968|NCT03245619|66005102|FG012|Part A (Up to Day 22)|Physician Decision|0|||
23823974|NCT01570686|66737697|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23622969|NCT03245619|66005103|FG013|Part A (Up to Day 22)|Physician Decision|0|||
23622970|NCT03245619|66005104|FG014|Part A (Up to Day 22)|Physician Decision|0|||
23823975|NCT01570686|66737698|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23433260|NCT04583956|65330405|FG001|Overall Study|Withdrawal of consent before product administration|0|||
23433261|NCT01504204|65330408|FG000|Overall Study|Lost to Follow-up|1|||
23433262|NCT01504204|65330409|FG001|Overall Study|Lost to Follow-up|1|||
23433263|NCT05098509|65330413|FG000|Overall Study|Withdrawal by Subject|0|||
23433264|NCT05098509|65330414|FG001|Overall Study|Withdrawal by Subject|0|||
23433265|NCT05098509|65330415|FG002|Overall Study|Withdrawal by Subject|1|||
23433266|NCT05098509|65330416|FG003|Overall Study|Withdrawal by Subject|0|||
23433267|NCT05098509|65330413|FG000|Overall Study|Early study termination|1|||
23433268|NCT05098509|65330414|FG001|Overall Study|Early study termination|1|||
23433269|NCT05098509|65330415|FG002|Overall Study|Early study termination|1|||
23433270|NCT05098509|65330416|FG003|Overall Study|Early study termination|0|||
23433271|NCT01600053|65330417|FG000|Overall Study|Adverse Event|2|||
23433272|NCT01600053|65330417|FG000|Overall Study|trial will not meet the interim endpoint|9|||
23433273|NCT01176565|65330418|FG000|Overall Study|Lost to Follow-up|12|||
23433274|NCT01176565|65330419|FG001|Overall Study|Lost to Follow-up|16|||
23433275|NCT01176565|65330418|FG000|Overall Study|Withdrawal by Subject|7|||
23555585|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
23555586|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
23555587|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
23555588|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
23555589|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
23555590|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
23555591|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
23555592|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
23555593|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
23555594|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
23555595|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
23555596|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
23555597|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
23555598|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
23555599|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
23555600|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
23555601|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
23555602|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
23555603|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
23555604|NCT00117676|65762270|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
23433276|NCT01176565|65330419|FG001|Overall Study|Withdrawal by Subject|1|||
23433277|NCT01176565|65330418|FG000|Overall Study|Not Analyzed (any other reason)|1|||
23433278|NCT01176565|65330419|FG001|Overall Study|Not Analyzed (any other reason)|2|||
23433279|NCT03344172|65330420|FG000|Overall Study|Received <1 dose of treatment|1|||
23433280|NCT03344172|65330421|FG001|Overall Study|Received <1 dose of treatment|0|||
23433281|NCT01455220|65330422|FG000|Overall Study|screen fail|30|||
23433282|NCT02392403|65330424|FG000|Overall Study|Adverse Event|1|||
23433283|NCT02392403|65330424|FG000|Overall Study|Death|1|||
23433284|NCT02392403|65330424|FG000|Overall Study|Withdrawal by Subject|1|||
23433285|NCT01147900|65330425|FG000|At Year 10|Lost to Follow-up|0|||
23433286|NCT01147900|65330426|FG001|At Year 10|Lost to Follow-up|1|||
23433287|NCT01147900|65330427|FG002|At Year 10|Lost to Follow-up|0|||
23433288|NCT00694304|65330428|FG000|Overall Study|Adverse Event|42|||
23433289|NCT00694304|65330428|FG000|Overall Study|Lack of Efficacy|35|||
23433290|NCT00694304|65330428|FG000|Overall Study|Non-compliance With Study Product|16|||
23433291|NCT00694304|65330428|FG000|Overall Study|Protocol Violation|6|||
23433292|NCT00694304|65330428|FG000|Overall Study|Withdrawal of Consent|61|||
23433293|NCT00694304|65330428|FG000|Overall Study|Lost to Follow-up|15|||
23433294|NCT00694304|65330428|FG000|Overall Study|Administrative or Other Reasons|32|||
23433295|NCT02540265|65330429|FG000|Overall Study|Lost to Follow-up|0|||
23433296|NCT02540265|65330430|FG001|Overall Study|Lost to Follow-up|0|||
23433297|NCT02540265|65330431|FG002|Overall Study|Lost to Follow-up|1|||
23433298|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
23433299|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
23433300|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
23749088|NCT00433511|66460426|FG000|Step 1|Disease progression, relapse|5|||
23749089|NCT00433511|66460427|FG001|Step 1|Disease progression, relapse|3|||
23749090|NCT00433511|66460428|FG002|Step 1|Disease progression, relapse|3|||
23749091|NCT00433511|66460426|FG000|Step 1|Other complicating disease|2|||
23749092|NCT00433511|66460427|FG001|Step 1|Other complicating disease|6|||
23749093|NCT00433511|66460428|FG002|Step 1|Other complicating disease|3|||
23749094|NCT00433511|66460426|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
23749095|NCT00433511|66460427|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
23749096|NCT00433511|66460428|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
23749097|NCT00433511|66460426|FG000|Step 1|Suspected recurrence|0|||
23749098|NCT00433511|66460427|FG001|Step 1|Suspected recurrence|1|||
23749099|NCT00433511|66460428|FG002|Step 1|Suspected recurrence|0|||
23749100|NCT00433511|66460426|FG000|Step 1|Insurance/drug distribution issues|0|||
23749101|NCT00433511|66460427|FG001|Step 1|Insurance/drug distribution issues|1|||
23749102|NCT00433511|66460428|FG002|Step 1|Insurance/drug distribution issues|2|||
23749103|NCT00433511|66460426|FG000|Step 1|Patient moved|0|||
23749104|NCT00433511|66460427|FG001|Step 1|Patient moved|0|||
23823976|NCT01570686|66737697|FG000|Overall Study|Administrative problems|0|||
23823977|NCT01570686|66737698|FG001|Overall Study|Administrative problems|1|||
23823978|NCT01570686|66737697|FG000|Overall Study|Adverse Event|8|||
23823979|NCT01570686|66737698|FG001|Overall Study|Adverse Event|6|||
23433301|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
23433302|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
23433303|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
23433304|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
23433305|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
23433306|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
23433307|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
23433308|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
23433309|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
23433310|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
23433311|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
23433312|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
23823980|NCT01570686|66737697|FG000|Overall Study|Lost to Follow-up|4|||
23749105|NCT00433511|66460428|FG002|Step 1|Patient moved|1|||
23749106|NCT00433511|66460426|FG000|Step 2 (Arm D)|Adverse Event|0|||
23749107|NCT00433511|66460427|FG001|Step 2 (Arm D)|Adverse Event|0|||
23749108|NCT00433511|66460428|FG002|Step 2 (Arm D)|Adverse Event|135|||
23749109|NCT00433511|66460426|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
23749110|NCT00433511|66460427|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
23749111|NCT00433511|66460428|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
23749112|NCT00433511|66460426|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
23749113|NCT00433511|66460427|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
23749114|NCT00433511|66460428|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
23749115|NCT00433511|66460426|FG000|Step 2 (Arm D)|Physician Decision|0|||
23749116|NCT00433511|66460427|FG001|Step 2 (Arm D)|Physician Decision|0|||
23749117|NCT00433511|66460428|FG002|Step 2 (Arm D)|Physician Decision|9|||
23749118|NCT00433511|66460426|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
23433313|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
23433314|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
23433315|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
23433316|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
23433317|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
23433318|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
23622971|NCT03245619|66005105|FG015|Part A (Up to Day 22)|Physician Decision|0|||
23749119|NCT00433511|66460427|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
23749120|NCT00433511|66460428|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
23749121|NCT00433511|66460426|FG000|Step 2 (Arm D)|Other complicating disease|0|||
23749122|NCT00433511|66460427|FG001|Step 2 (Arm D)|Other complicating disease|0|||
23749123|NCT00433511|66460428|FG002|Step 2 (Arm D)|Other complicating disease|3|||
23749124|NCT00433511|66460426|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
23749125|NCT00433511|66460427|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
23749126|NCT00433511|66460428|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
23749127|NCT00433511|66460426|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
23749128|NCT00433511|66460427|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
23749129|NCT00433511|66460428|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
23749130|NCT00433511|66460426|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
23749131|NCT00433511|66460427|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
23749132|NCT00433511|66460428|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
23749133|NCT00433511|66460426|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
23749134|NCT00433511|66460427|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
23749135|NCT00433511|66460428|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
23749136|NCT02526017|66460432|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749137|NCT02526017|66460433|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749138|NCT02526017|66460434|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749139|NCT02526017|66460435|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749140|NCT02526017|66460436|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
23749141|NCT02526017|66460437|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749142|NCT02526017|66460438|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749143|NCT02526017|66460439|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749144|NCT02526017|66460440|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23749145|NCT03843775|66460441|FG000|Overall Study|Adverse Event|1|||
23749146|NCT03843775|66460442|FG001|Overall Study|Adverse Event|1|||
23749147|NCT03843775|66460441|FG000|Overall Study|Lack of Efficacy|2|||
23749148|NCT03843775|66460442|FG001|Overall Study|Lack of Efficacy|6|||
23749149|NCT03843775|66460441|FG000|Overall Study|Withdrawal by Subject|0|||
23749150|NCT03843775|66460442|FG001|Overall Study|Withdrawal by Subject|1|||
23749151|NCT01134614|66460445|FG000|Overall Study|Still on treatment as of March 2013|21|||
23749152|NCT01134614|66460446|FG001|Overall Study|Still on treatment as of March 2013|13|||
23749153|NCT01134614|66460445|FG000|Overall Study|Progressive disease|60|||
23823981|NCT01570686|66737698|FG001|Overall Study|Lost to Follow-up|3|||
23823982|NCT01570686|66737697|FG000|Overall Study|Protocol Deviation|3|||
23823983|NCT01570686|66737698|FG001|Overall Study|Protocol Deviation|0|||
23823984|NCT01570686|66737697|FG000|Overall Study|Withdrawal by Subject|4|||
23823985|NCT01570686|66737698|FG001|Overall Study|Withdrawal by Subject|4|||
23749154|NCT01134614|66460446|FG001|Overall Study|Progressive disease|54|||
23749155|NCT01134614|66460445|FG000|Overall Study|Adverse Event|26|||
23823986|NCT01570686|66737697|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23823987|NCT01570686|66737698|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23823988|NCT02439216|66737699|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
23823989|NCT02439216|66737700|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23433319|NCT01302054|65330435|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
23433320|NCT01302054|65330436|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
23433321|NCT01302054|65330437|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
23749156|NCT01134614|66460446|FG001|Overall Study|Adverse Event|39|||
23433322|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23433323|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
23433324|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
23433325|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23433326|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23433327|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23433328|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23433329|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
23433330|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
23433331|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23433332|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
23433333|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
23433334|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23433335|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
23433336|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
23433337|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
23433338|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
23433339|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
23433340|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Other|0|||
23433341|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Other|4|||
23433342|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Other|9|||
23433343|NCT01452919|65330438|FG000|Open-Label Treatment|Adverse Event|5|||
23433344|NCT01452919|65330439|FG001|Open-Label Treatment|Adverse Event|0|||
23433345|NCT01452919|65330440|FG002|Open-Label Treatment|Adverse Event|0|||
23433346|NCT01452919|65330438|FG000|Open-Label Treatment|Lost to Follow-up|4|||
23433347|NCT01452919|65330439|FG001|Open-Label Treatment|Lost to Follow-up|0|||
23433348|NCT01452919|65330440|FG002|Open-Label Treatment|Lost to Follow-up|0|||
23433349|NCT01452919|65330438|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
23433350|NCT01452919|65330439|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
23433351|NCT01452919|65330440|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
23433352|NCT01452919|65330438|FG000|Open-Label Treatment|Protocol Violation|4|||
23433353|NCT01452919|65330439|FG001|Open-Label Treatment|Protocol Violation|0|||
23433354|NCT01452919|65330440|FG002|Open-Label Treatment|Protocol Violation|0|||
23433355|NCT01452919|65330438|FG000|Open-Label Treatment|Sponsor Decision|1|||
23749157|NCT01134614|66460445|FG000|Overall Study|Death|5|||
23749158|NCT01134614|66460446|FG001|Overall Study|Death|8|||
23749159|NCT01134614|66460445|FG000|Overall Study|Withdrawal by Subject|3|||
23749160|NCT01134614|66460446|FG001|Overall Study|Withdrawal by Subject|2|||
23749161|NCT01134614|66460445|FG000|Overall Study|Alternative therapy|2|||
23749162|NCT01134614|66460446|FG001|Overall Study|Alternative therapy|0|||
23749163|NCT01134614|66460445|FG000|Overall Study|Complicating disease|2|||
23749164|NCT01134614|66460446|FG001|Overall Study|Complicating disease|1|||
23749165|NCT01134614|66460445|FG000|Overall Study|Physician's decision|0|||
23749166|NCT01134614|66460446|FG001|Overall Study|Physician's decision|1|||
23749167|NCT01134614|66460445|FG000|Overall Study|Never started treatment|4|||
23749168|NCT01134614|66460446|FG001|Overall Study|Never started treatment|1|||
23749169|NCT01134614|66460445|FG000|Overall Study|Pt received tx not allowed on study|0|||
23749170|NCT01134614|66460446|FG001|Overall Study|Pt received tx not allowed on study|1|||
23749171|NCT01134614|66460445|FG000|Overall Study|Symptomatic deterioration|0|||
23749172|NCT01134614|66460446|FG001|Overall Study|Symptomatic deterioration|1|||
23749173|NCT01134614|66460445|FG000|Overall Study|Patient in hospice care|0|||
23749174|NCT01134614|66460446|FG001|Overall Study|Patient in hospice care|1|||
23749175|NCT05182840|66460447|FG000|Run-in Period|Not treated|0|||
23749176|NCT05182840|66460448|FG001|Run-in Period|Not treated|1|||
23749177|NCT05182840|66460449|FG002|Run-in Period|Not treated|0|||
23749178|NCT05182840|66460450|FG003|Run-in Period|Not treated|0|||
23749179|NCT05182840|66460451|FG004|Run-in Period|Not treated|0|||
23749180|NCT05182840|66460452|FG005|Run-in Period|Not treated|0|||
23749181|NCT05182840|66460453|FG006|Run-in Period|Not treated|0|||
23749182|NCT05182840|66460454|FG007|Run-in Period|Not treated|0|||
23749183|NCT05182840|66460455|FG008|Run-in Period|Not treated|0|||
23749184|NCT05182840|66460456|FG009|Run-in Period|Not treated|0|||
23749185|NCT05182840|66460447|FG000|Run-in Period|Other reason but not sponsor termination|14|||
23749186|NCT05182840|66460448|FG001|Run-in Period|Other reason but not sponsor termination|18|||
23749187|NCT05182840|66460449|FG002|Run-in Period|Other reason but not sponsor termination|0|||
23749188|NCT05182840|66460450|FG003|Run-in Period|Other reason but not sponsor termination|0|||
23433356|NCT01452919|65330439|FG001|Open-Label Treatment|Sponsor Decision|0|||
23433357|NCT01452919|65330440|FG002|Open-Label Treatment|Sponsor Decision|0|||
23433358|NCT01452919|65330438|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
23433359|NCT01452919|65330439|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23433360|NCT01452919|65330440|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
23433361|NCT01452919|65330438|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
23433362|NCT01452919|65330439|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
23433363|NCT01452919|65330440|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
23433364|NCT01452919|65330438|FG000|Randomization Treatment|Adverse Event|0|||
23433365|NCT01452919|65330439|FG001|Randomization Treatment|Adverse Event|0|||
23433366|NCT01452919|65330440|FG002|Randomization Treatment|Adverse Event|2|||
23433367|NCT01452919|65330438|FG000|Randomization Treatment|Sponsor Decision|0|||
23433368|NCT01452919|65330439|FG001|Randomization Treatment|Sponsor Decision|1|||
23433369|NCT01452919|65330440|FG002|Randomization Treatment|Sponsor Decision|0|||
23433370|NCT01452919|65330438|FG000|Randomization Treatment|Withdrawal by Subject|0|||
23433371|NCT01452919|65330439|FG001|Randomization Treatment|Withdrawal by Subject|1|||
23433372|NCT01452919|65330440|FG002|Randomization Treatment|Withdrawal by Subject|0|||
23433373|NCT01452919|65330438|FG000|Randomization Treatment|Subject is moving or has moved|0|||
23433374|NCT01452919|65330439|FG001|Randomization Treatment|Subject is moving or has moved|1|||
23433375|NCT01452919|65330440|FG002|Randomization Treatment|Subject is moving or has moved|0|||
23433376|NCT03908476|65330443|FG000|Overall Study|Death|3|||
23433377|NCT03908476|65330444|FG001|Overall Study|Death|0|||
23433378|NCT03908476|65330443|FG000|Overall Study|Lost to Follow-up|3|||
23433379|NCT03908476|65330444|FG001|Overall Study|Lost to Follow-up|1|||
23622972|NCT03245619|66005106|FG016|Part A (Up to Day 22)|Physician Decision|0|||
23622973|NCT02143063|66005109|FG000|Overall Study|Lost to Follow-up|16|||
23622974|NCT02143063|66005110|FG001|Overall Study|Lost to Follow-up|28|||
23622975|NCT02143063|66005111|FG002|Overall Study|Lost to Follow-up|29|||
23622976|NCT02143063|66005109|FG000|Overall Study|Withdrawal by Subject|0|||
23622977|NCT02143063|66005110|FG001|Overall Study|Withdrawal by Subject|1|||
23622978|NCT02143063|66005111|FG002|Overall Study|Withdrawal by Subject|0|||
23622979|NCT02143063|66005109|FG000|Overall Study|Death|0|||
23622980|NCT02143063|66005110|FG001|Overall Study|Death|1|||
23622981|NCT02143063|66005111|FG002|Overall Study|Death|1|||
23749189|NCT05182840|66460451|FG004|Run-in Period|Other reason but not sponsor termination|0|||
23749190|NCT05182840|66460452|FG005|Run-in Period|Other reason but not sponsor termination|0|||
23749191|NCT05182840|66460453|FG006|Run-in Period|Other reason but not sponsor termination|0|||
23749192|NCT05182840|66460454|FG007|Run-in Period|Other reason but not sponsor termination|0|||
23749193|NCT05182840|66460455|FG008|Run-in Period|Other reason but not sponsor termination|0|||
23749194|NCT05182840|66460456|FG009|Run-in Period|Other reason but not sponsor termination|0|||
23749195|NCT05182840|66460447|FG000|Run-in Period|No reason available|2|||
23749196|NCT05182840|66460448|FG001|Run-in Period|No reason available|2|||
23749197|NCT05182840|66460449|FG002|Run-in Period|No reason available|0|||
23749198|NCT05182840|66460450|FG003|Run-in Period|No reason available|0|||
23749199|NCT05182840|66460451|FG004|Run-in Period|No reason available|0|||
23749200|NCT05182840|66460452|FG005|Run-in Period|No reason available|0|||
23749201|NCT05182840|66460453|FG006|Run-in Period|No reason available|0|||
23749202|NCT05182840|66460454|FG007|Run-in Period|No reason available|0|||
23749203|NCT05182840|66460455|FG008|Run-in Period|No reason available|0|||
23749204|NCT05182840|66460456|FG009|Run-in Period|No reason available|0|||
23749205|NCT05182840|66460447|FG000|Run-in Period|Burden of study procedures|2|||
23749206|NCT05182840|66460448|FG001|Run-in Period|Burden of study procedures|2|||
23749207|NCT05182840|66460449|FG002|Run-in Period|Burden of study procedures|0|||
23749208|NCT05182840|66460450|FG003|Run-in Period|Burden of study procedures|0|||
23749209|NCT05182840|66460451|FG004|Run-in Period|Burden of study procedures|0|||
23749210|NCT05182840|66460452|FG005|Run-in Period|Burden of study procedures|0|||
23749211|NCT05182840|66460453|FG006|Run-in Period|Burden of study procedures|0|||
23749212|NCT05182840|66460454|FG007|Run-in Period|Burden of study procedures|0|||
23749213|NCT05182840|66460455|FG008|Run-in Period|Burden of study procedures|0|||
23749214|NCT05182840|66460456|FG009|Run-in Period|Burden of study procedures|0|||
23749215|NCT05182840|66460447|FG000|Run-in Period|Change of residence|1|||
23749216|NCT05182840|66460448|FG001|Run-in Period|Change of residence|0|||
23749217|NCT05182840|66460449|FG002|Run-in Period|Change of residence|0|||
23749218|NCT05182840|66460450|FG003|Run-in Period|Change of residence|0|||
23749219|NCT05182840|66460451|FG004|Run-in Period|Change of residence|0|||
23749220|NCT05182840|66460452|FG005|Run-in Period|Change of residence|0|||
23749221|NCT05182840|66460453|FG006|Run-in Period|Change of residence|0|||
23749222|NCT05182840|66460454|FG007|Run-in Period|Change of residence|0|||
23749223|NCT05182840|66460455|FG008|Run-in Period|Change of residence|0|||
23749224|NCT05182840|66460456|FG009|Run-in Period|Change of residence|0|||
23749225|NCT05182840|66460447|FG000|Run-in Period|Adverse Event|5|||
23749226|NCT05182840|66460448|FG001|Run-in Period|Adverse Event|5|||
23749227|NCT05182840|66460449|FG002|Run-in Period|Adverse Event|0|||
23749228|NCT05182840|66460450|FG003|Run-in Period|Adverse Event|0|||
23749229|NCT05182840|66460451|FG004|Run-in Period|Adverse Event|0|||
23749230|NCT05182840|66460452|FG005|Run-in Period|Adverse Event|0|||
23749231|NCT05182840|66460453|FG006|Run-in Period|Adverse Event|0|||
23749232|NCT05182840|66460454|FG007|Run-in Period|Adverse Event|0|||
23749233|NCT05182840|66460455|FG008|Run-in Period|Adverse Event|0|||
23749234|NCT05182840|66460456|FG009|Run-in Period|Adverse Event|0|||
23749235|NCT05182840|66460447|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
23749236|NCT05182840|66460448|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
23749237|NCT05182840|66460449|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749238|NCT05182840|66460450|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749239|NCT05182840|66460451|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749240|NCT05182840|66460452|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749241|NCT05182840|66460453|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749242|NCT05182840|66460454|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749243|NCT05182840|66460455|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749244|NCT05182840|66460456|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23749245|NCT05182840|66460447|FG000|Treatment Period|Reason missing|0|||
23749246|NCT05182840|66460448|FG001|Treatment Period|Reason missing|0|||
23749247|NCT05182840|66460449|FG002|Treatment Period|Reason missing|1|||
23749248|NCT05182840|66460450|FG003|Treatment Period|Reason missing|0|||
23749249|NCT05182840|66460451|FG004|Treatment Period|Reason missing|0|||
23749250|NCT05182840|66460452|FG005|Treatment Period|Reason missing|0|||
23749251|NCT05182840|66460453|FG006|Treatment Period|Reason missing|0|||
23749252|NCT05182840|66460454|FG007|Treatment Period|Reason missing|0|||
23749253|NCT05182840|66460455|FG008|Treatment Period|Reason missing|0|||
23749254|NCT05182840|66460456|FG009|Treatment Period|Reason missing|0|||
23749255|NCT05182840|66460447|FG000|Treatment Period|Other but not sponsor termination|0|||
23749256|NCT05182840|66460448|FG001|Treatment Period|Other but not sponsor termination|0|||
23749257|NCT05182840|66460449|FG002|Treatment Period|Other but not sponsor termination|8|||
23749258|NCT05182840|66460450|FG003|Treatment Period|Other but not sponsor termination|6|||
23749259|NCT05182840|66460451|FG004|Treatment Period|Other but not sponsor termination|6|||
23749260|NCT05182840|66460452|FG005|Treatment Period|Other but not sponsor termination|7|||
23749261|NCT05182840|66460453|FG006|Treatment Period|Other but not sponsor termination|5|||
23749262|NCT05182840|66460454|FG007|Treatment Period|Other but not sponsor termination|8|||
23749263|NCT05182840|66460455|FG008|Treatment Period|Other but not sponsor termination|7|||
23749264|NCT05182840|66460456|FG009|Treatment Period|Other but not sponsor termination|2|||
23749265|NCT05182840|66460447|FG000|Treatment Period|Protocol deviation|0|||
23749266|NCT05182840|66460448|FG001|Treatment Period|Protocol deviation|0|||
23749267|NCT05182840|66460449|FG002|Treatment Period|Protocol deviation|0|||
23749268|NCT05182840|66460450|FG003|Treatment Period|Protocol deviation|0|||
23749269|NCT05182840|66460451|FG004|Treatment Period|Protocol deviation|0|||
23749270|NCT05182840|66460452|FG005|Treatment Period|Protocol deviation|0|||
23749271|NCT05182840|66460453|FG006|Treatment Period|Protocol deviation|0|||
23749272|NCT05182840|66460454|FG007|Treatment Period|Protocol deviation|0|||
23749273|NCT05182840|66460455|FG008|Treatment Period|Protocol deviation|1|||
23749274|NCT05182840|66460456|FG009|Treatment Period|Protocol deviation|0|||
23749275|NCT05182840|66460447|FG000|Treatment Period|No reason available|0|||
23749276|NCT05182840|66460448|FG001|Treatment Period|No reason available|0|||
23749277|NCT05182840|66460449|FG002|Treatment Period|No reason available|0|||
23749278|NCT05182840|66460450|FG003|Treatment Period|No reason available|1|||
23749279|NCT05182840|66460451|FG004|Treatment Period|No reason available|0|||
23749280|NCT05182840|66460452|FG005|Treatment Period|No reason available|2|||
23749281|NCT05182840|66460453|FG006|Treatment Period|No reason available|0|||
23749282|NCT05182840|66460454|FG007|Treatment Period|No reason available|1|||
23749283|NCT05182840|66460455|FG008|Treatment Period|No reason available|0|||
23749284|NCT05182840|66460456|FG009|Treatment Period|No reason available|0|||
23749285|NCT05182840|66460447|FG000|Treatment Period|Burden of study procedures|0|||
23749286|NCT05182840|66460448|FG001|Treatment Period|Burden of study procedures|0|||
23749287|NCT05182840|66460449|FG002|Treatment Period|Burden of study procedures|0|||
23749288|NCT05182840|66460450|FG003|Treatment Period|Burden of study procedures|0|||
23749289|NCT05182840|66460451|FG004|Treatment Period|Burden of study procedures|1|||
23749290|NCT05182840|66460452|FG005|Treatment Period|Burden of study procedures|0|||
23749291|NCT05182840|66460453|FG006|Treatment Period|Burden of study procedures|0|||
23749292|NCT05182840|66460454|FG007|Treatment Period|Burden of study procedures|0|||
23749293|NCT05182840|66460455|FG008|Treatment Period|Burden of study procedures|0|||
23749294|NCT05182840|66460456|FG009|Treatment Period|Burden of study procedures|0|||
23749295|NCT05182840|66460447|FG000|Treatment Period|Change of residence|0|||
23749296|NCT05182840|66460448|FG001|Treatment Period|Change of residence|0|||
23749297|NCT05182840|66460449|FG002|Treatment Period|Change of residence|0|||
23749298|NCT05182840|66460450|FG003|Treatment Period|Change of residence|0|||
23749299|NCT05182840|66460451|FG004|Treatment Period|Change of residence|0|||
23749300|NCT05182840|66460452|FG005|Treatment Period|Change of residence|1|||
23823990|NCT02439216|66737701|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823991|NCT02439216|66737702|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823992|NCT02439216|66737703|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823993|NCT02439216|66737704|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823994|NCT02439216|66737705|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823995|NCT02439216|66737706|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823996|NCT02439216|66737707|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23823997|NCT02439216|66737699|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23823998|NCT02439216|66737700|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23823999|NCT02439216|66737701|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23824000|NCT02439216|66737702|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23824001|NCT02439216|66737703|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23824002|NCT02439216|66737704|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23824003|NCT02439216|66737705|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23749301|NCT05182840|66460453|FG006|Treatment Period|Change of residence|0|||
23749302|NCT05182840|66460454|FG007|Treatment Period|Change of residence|0|||
23749303|NCT05182840|66460455|FG008|Treatment Period|Change of residence|0|||
23749304|NCT05182840|66460456|FG009|Treatment Period|Change of residence|0|||
23749305|NCT05182840|66460447|FG000|Treatment Period|Adverse Event|0|||
23749306|NCT05182840|66460448|FG001|Treatment Period|Adverse Event|0|||
23749307|NCT05182840|66460449|FG002|Treatment Period|Adverse Event|4|||
23749308|NCT05182840|66460450|FG003|Treatment Period|Adverse Event|16|||
23749309|NCT05182840|66460451|FG004|Treatment Period|Adverse Event|12|||
23749310|NCT05182840|66460452|FG005|Treatment Period|Adverse Event|6|||
23749311|NCT05182840|66460453|FG006|Treatment Period|Adverse Event|4|||
23749312|NCT05182840|66460454|FG007|Treatment Period|Adverse Event|8|||
23749313|NCT05182840|66460455|FG008|Treatment Period|Adverse Event|16|||
23749314|NCT05182840|66460456|FG009|Treatment Period|Adverse Event|5|||
23749315|NCT05182840|66460447|FG000|Treatment Period|Not treated with study drug|0|||
23749316|NCT05182840|66460448|FG001|Treatment Period|Not treated with study drug|0|||
23749317|NCT05182840|66460449|FG002|Treatment Period|Not treated with study drug|0|||
23749318|NCT05182840|66460450|FG003|Treatment Period|Not treated with study drug|1|||
23749319|NCT05182840|66460451|FG004|Treatment Period|Not treated with study drug|0|||
23749320|NCT05182840|66460452|FG005|Treatment Period|Not treated with study drug|0|||
23749321|NCT05182840|66460453|FG006|Treatment Period|Not treated with study drug|1|||
23749322|NCT05182840|66460454|FG007|Treatment Period|Not treated with study drug|1|||
23749323|NCT05182840|66460455|FG008|Treatment Period|Not treated with study drug|0|||
23749324|NCT05182840|66460456|FG009|Treatment Period|Not treated with study drug|0|||
23749325|NCT04059484|66463368|FG000|Overall Study|Adverse Event|2|||
23749326|NCT04059484|66463369|FG001|Overall Study|Adverse Event|5|||
23749327|NCT04059484|66463368|FG000|Overall Study|Withdrawal by Subject|5|||
23749328|NCT04059484|66463369|FG001|Overall Study|Withdrawal by Subject|3|||
23749329|NCT04059484|66463368|FG000|Overall Study|Progressive disease|112|||
23749330|NCT04059484|66463369|FG001|Overall Study|Progressive disease|112|||
23749331|NCT04059484|66463368|FG000|Overall Study|Other|8|||
23749332|NCT04059484|66463369|FG001|Overall Study|Other|3|||
23749333|NCT04059484|66463368|FG000|Overall Study|Ongoing|20|||
23749334|NCT04059484|66463369|FG001|Overall Study|Ongoing|20|||
23749335|NCT00602641|66463370|FG000|Overall Study|Never started protocol therapy|6|||
23749336|NCT00602641|66463371|FG001|Overall Study|Never started protocol therapy|2|||
23749337|NCT00602641|66463370|FG000|Overall Study|Still on treatment at time of analysis|8|||
23749338|NCT00602641|66463371|FG001|Overall Study|Still on treatment at time of analysis|15|||
23749339|NCT00602641|66463370|FG000|Overall Study|Adverse Event|62|||
23749340|NCT00602641|66463371|FG001|Overall Study|Adverse Event|53|||
23749341|NCT00602641|66463370|FG000|Overall Study|Disease progression|38|||
23622982|NCT01121913|66005112|FG000|First Intervention Period|Adverse Event|0|||
23622983|NCT01121913|66005113|FG001|First Intervention Period|Adverse Event|0|||
23749342|NCT00602641|66463371|FG001|Overall Study|Disease progression|55|||
23749343|NCT00602641|66463370|FG000|Overall Study|Death|6|||
23824004|NCT02439216|66737706|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
23824005|NCT02439216|66737707|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23824006|NCT02439216|66737699|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824007|NCT02439216|66737700|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824008|NCT02439216|66737701|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23749344|NCT00602641|66463371|FG001|Overall Study|Death|5|||
23749345|NCT00602641|66463370|FG000|Overall Study|Withdrawal by Subject|15|||
23749346|NCT00602641|66463371|FG001|Overall Study|Withdrawal by Subject|12|||
23749347|NCT00602641|66463370|FG000|Overall Study|Alternative therapy|5|||
23749348|NCT00602641|66463371|FG001|Overall Study|Alternative therapy|2|||
23749349|NCT00602641|66463370|FG000|Overall Study|Other Complicating Disease|5|||
23749350|NCT00602641|66463371|FG001|Overall Study|Other Complicating Disease|2|||
23749351|NCT00602641|66463370|FG000|Overall Study|Physician Decision|5|||
23749352|NCT00602641|66463371|FG001|Overall Study|Physician Decision|4|||
23749353|NCT00602641|66463370|FG000|Overall Study|Administrative Closure|1|||
23749354|NCT00602641|66463371|FG001|Overall Study|Administrative Closure|1|||
23749355|NCT00602641|66463370|FG000|Overall Study|Other|3|||
23749356|NCT00602641|66463371|FG001|Overall Study|Other|1|||
23749357|NCT00408005|66463372|FG000|Induction|Adverse Event|19|||
23749358|NCT00408005|66463373|FG001|Induction|Adverse Event|3|||
23749359|NCT00408005|66463374|FG002|Induction|Adverse Event|0|||
23749360|NCT00408005|66463375|FG003|Induction|Adverse Event|0|||
23749361|NCT00408005|66463376|FG004|Induction|Adverse Event|0|||
23749362|NCT00408005|66463377|FG005|Induction|Adverse Event|0|||
23749363|NCT00408005|66463378|FG006|Induction|Adverse Event|0|||
23749364|NCT00408005|66463379|FG007|Induction|Adverse Event|0|||
23749365|NCT00408005|66463372|FG000|Induction|Death|6|||
23749366|NCT00408005|66463373|FG001|Induction|Death|0|||
23749367|NCT00408005|66463374|FG002|Induction|Death|0|||
23749368|NCT00408005|66463375|FG003|Induction|Death|0|||
23749369|NCT00408005|66463376|FG004|Induction|Death|0|||
23749370|NCT00408005|66463377|FG005|Induction|Death|0|||
23749371|NCT00408005|66463378|FG006|Induction|Death|0|||
23749372|NCT00408005|66463379|FG007|Induction|Death|0|||
23749373|NCT00408005|66463372|FG000|Induction|Physician Decision|83|||
23749374|NCT00408005|66463373|FG001|Induction|Physician Decision|9|||
23749375|NCT00408005|66463374|FG002|Induction|Physician Decision|0|||
23749376|NCT00408005|66463375|FG003|Induction|Physician Decision|0|||
23749377|NCT00408005|66463376|FG004|Induction|Physician Decision|0|||
23749378|NCT00408005|66463377|FG005|Induction|Physician Decision|0|||
23749379|NCT00408005|66463378|FG006|Induction|Physician Decision|0|||
23749380|NCT00408005|66463379|FG007|Induction|Physician Decision|0|||
23749381|NCT00408005|66463372|FG000|Induction|Withdrawal by Subject|2|||
23749382|NCT00408005|66463373|FG001|Induction|Withdrawal by Subject|4|||
23749383|NCT00408005|66463374|FG002|Induction|Withdrawal by Subject|0|||
23749384|NCT00408005|66463375|FG003|Induction|Withdrawal by Subject|0|||
23749385|NCT00408005|66463376|FG004|Induction|Withdrawal by Subject|0|||
23749386|NCT00408005|66463377|FG005|Induction|Withdrawal by Subject|0|||
23749387|NCT00408005|66463378|FG006|Induction|Withdrawal by Subject|0|||
23749388|NCT00408005|66463379|FG007|Induction|Withdrawal by Subject|0|||
23749389|NCT00408005|66463372|FG000|Induction|Ineligible|33|||
23749390|NCT00408005|66463373|FG001|Induction|Ineligible|14|||
23749391|NCT00408005|66463374|FG002|Induction|Ineligible|0|||
23749392|NCT00408005|66463375|FG003|Induction|Ineligible|0|||
23749393|NCT00408005|66463376|FG004|Induction|Ineligible|0|||
23749394|NCT00408005|66463377|FG005|Induction|Ineligible|0|||
23749395|NCT00408005|66463378|FG006|Induction|Ineligible|0|||
23749396|NCT00408005|66463379|FG007|Induction|Ineligible|0|||
23749397|NCT00408005|66463372|FG000|Induction|Refusal of Further Protocol Therapy|225|||
23749398|NCT00408005|66463373|FG001|Induction|Refusal of Further Protocol Therapy|44|||
23749399|NCT00408005|66463374|FG002|Induction|Refusal of Further Protocol Therapy|0|||
23749400|NCT00408005|66463375|FG003|Induction|Refusal of Further Protocol Therapy|0|||
23749401|NCT00408005|66463376|FG004|Induction|Refusal of Further Protocol Therapy|0|||
23749402|NCT00408005|66463377|FG005|Induction|Refusal of Further Protocol Therapy|0|||
23749403|NCT00408005|66463378|FG006|Induction|Refusal of Further Protocol Therapy|0|||
23749404|NCT00408005|66463379|FG007|Induction|Refusal of Further Protocol Therapy|0|||
23749405|NCT00408005|66463372|FG000|Induction|Entered another COG therapeutic protocol|4|||
23749406|NCT00408005|66463373|FG001|Induction|Entered another COG therapeutic protocol|0|||
23749407|NCT00408005|66463374|FG002|Induction|Entered another COG therapeutic protocol|0|||
23749408|NCT00408005|66463375|FG003|Induction|Entered another COG therapeutic protocol|0|||
23749409|NCT00408005|66463376|FG004|Induction|Entered another COG therapeutic protocol|0|||
23749410|NCT00408005|66463377|FG005|Induction|Entered another COG therapeutic protocol|0|||
23749411|NCT00408005|66463378|FG006|Induction|Entered another COG therapeutic protocol|0|||
23749412|NCT00408005|66463379|FG007|Induction|Entered another COG therapeutic protocol|0|||
23433380|NCT03908476|65330443|FG000|Overall Study|Withdrawal by Subject|7|||
23749413|NCT00408005|66463372|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
23749414|NCT00408005|66463373|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
23749415|NCT00408005|66463374|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
23749416|NCT00408005|66463375|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
23749417|NCT00408005|66463376|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
23749418|NCT00408005|66463377|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
23749419|NCT00408005|66463378|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
23749420|NCT00408005|66463379|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
23749421|NCT00408005|66463372|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
23749422|NCT00408005|66463373|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
23749423|NCT00408005|66463374|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
23749424|NCT00408005|66463375|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
23749425|NCT00408005|66463376|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
23749426|NCT00408005|66463377|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
23749427|NCT00408005|66463378|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
23749428|NCT00408005|66463379|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
23749429|NCT00408005|66463372|FG000|Induction|Progressive Disease|0|||
23749430|NCT00408005|66463373|FG001|Induction|Progressive Disease|1|||
23749431|NCT00408005|66463374|FG002|Induction|Progressive Disease|0|||
23749432|NCT00408005|66463375|FG003|Induction|Progressive Disease|0|||
23749433|NCT00408005|66463376|FG004|Induction|Progressive Disease|0|||
23749434|NCT00408005|66463377|FG005|Induction|Progressive Disease|0|||
23824009|NCT02439216|66737702|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824010|NCT02439216|66737703|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824011|NCT02439216|66737704|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824012|NCT02439216|66737705|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23824013|NCT02439216|66737706|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
23824014|NCT02439216|66737707|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
23824015|NCT02439216|66737699|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23749435|NCT00408005|66463378|FG006|Induction|Progressive Disease|0|||
23824016|NCT02439216|66737700|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23824017|NCT02439216|66737701|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23749436|NCT00408005|66463379|FG007|Induction|Progressive Disease|0|||
23749437|NCT00408005|66463372|FG000|Induction|Inevaluable|18|||
23824018|NCT02439216|66737702|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23749438|NCT00408005|66463373|FG001|Induction|Inevaluable|14|||
23749439|NCT00408005|66463374|FG002|Induction|Inevaluable|0|||
23749440|NCT00408005|66463375|FG003|Induction|Inevaluable|0|||
23749441|NCT00408005|66463376|FG004|Induction|Inevaluable|0|||
23749442|NCT00408005|66463377|FG005|Induction|Inevaluable|0|||
23749443|NCT00408005|66463378|FG006|Induction|Inevaluable|0|||
23749444|NCT00408005|66463379|FG007|Induction|Inevaluable|0|||
23749445|NCT00408005|66463372|FG000|Induction|Failed to Complete Randomization|3|||
23749446|NCT00408005|66463373|FG001|Induction|Failed to Complete Randomization|2|||
23749447|NCT00408005|66463374|FG002|Induction|Failed to Complete Randomization|0|||
23749448|NCT00408005|66463375|FG003|Induction|Failed to Complete Randomization|0|||
23749449|NCT00408005|66463376|FG004|Induction|Failed to Complete Randomization|0|||
23749450|NCT00408005|66463377|FG005|Induction|Failed to Complete Randomization|0|||
23749451|NCT00408005|66463378|FG006|Induction|Failed to Complete Randomization|0|||
23749452|NCT00408005|66463379|FG007|Induction|Failed to Complete Randomization|0|||
23749453|NCT00408005|66463372|FG000|Induction|Protocol Deviation|3|||
23749454|NCT00408005|66463373|FG001|Induction|Protocol Deviation|1|||
23749455|NCT00408005|66463374|FG002|Induction|Protocol Deviation|0|||
23749456|NCT00408005|66463375|FG003|Induction|Protocol Deviation|0|||
23749457|NCT00408005|66463376|FG004|Induction|Protocol Deviation|0|||
23433381|NCT03908476|65330444|FG001|Overall Study|Withdrawal by Subject|1|||
23433382|NCT03908476|65330443|FG000|Overall Study|Physician Decision|2|||
23433383|NCT03908476|65330444|FG001|Overall Study|Physician Decision|0|||
23433384|NCT03908476|65330443|FG000|Overall Study|System Explanted and not Replaced|4|||
23433385|NCT03908476|65330444|FG001|Overall Study|System Explanted and not Replaced|0|||
23433386|NCT03908476|65330443|FG000|Overall Study|Intrathecal Pump|1|||
23749458|NCT00408005|66463377|FG005|Induction|Protocol Deviation|0|||
23749459|NCT00408005|66463378|FG006|Induction|Protocol Deviation|0|||
23749460|NCT00408005|66463379|FG007|Induction|Protocol Deviation|0|||
23749461|NCT00408005|66463372|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
23749462|NCT00408005|66463373|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749463|NCT00408005|66463374|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749464|NCT00408005|66463375|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749465|NCT00408005|66463376|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749466|NCT00408005|66463377|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749467|NCT00408005|66463378|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749468|NCT00408005|66463379|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
23749469|NCT00408005|66463372|FG000|Induction|Recurrent leukemia|1|||
23749470|NCT00408005|66463373|FG001|Induction|Recurrent leukemia|0|||
23749471|NCT00408005|66463374|FG002|Induction|Recurrent leukemia|0|||
23749472|NCT00408005|66463375|FG003|Induction|Recurrent leukemia|0|||
23749473|NCT00408005|66463376|FG004|Induction|Recurrent leukemia|0|||
23749474|NCT00408005|66463377|FG005|Induction|Recurrent leukemia|0|||
23749475|NCT00408005|66463378|FG006|Induction|Recurrent leukemia|0|||
23749476|NCT00408005|66463379|FG007|Induction|Recurrent leukemia|0|||
23749477|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23749478|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23749479|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
23749480|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
23749481|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
23749482|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
23749483|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
23749484|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23749485|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
23749486|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
23749487|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
23749488|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
23749489|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
23749490|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
23749491|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
23749492|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
23749493|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23749494|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23749495|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
23749496|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23749497|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
23749498|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23749499|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23824019|NCT02439216|66737703|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23824020|NCT02439216|66737704|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23824021|NCT02439216|66737705|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23749500|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23749501|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23749502|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23749503|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
23749504|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
23749505|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
23749506|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
23824022|NCT02439216|66737706|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23824023|NCT02439216|66737707|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
23433387|NCT03908476|65330444|FG001|Overall Study|Intrathecal Pump|0|||
23749507|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
23824024|NCT02439216|66737699|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824025|NCT02439216|66737700|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824026|NCT02439216|66737701|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824027|NCT02439216|66737702|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824028|NCT02439216|66737703|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824029|NCT02439216|66737704|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824030|NCT02439216|66737705|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23824031|NCT02439216|66737706|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
23824032|NCT02439216|66737707|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
23824033|NCT02717455|66737708|FG000|Overall Study|Adverse Event|1|||
23824034|NCT02717455|66737709|FG001|Overall Study|Adverse Event|0|||
23824035|NCT02717455|66737710|FG002|Overall Study|Adverse Event|0|||
23824036|NCT02717455|66737711|FG003|Overall Study|Adverse Event|2|||
23824037|NCT02717455|66737712|FG004|Overall Study|Adverse Event|2|||
23824038|NCT02717455|66737713|FG005|Overall Study|Adverse Event|2|||
23824039|NCT02717455|66737708|FG000|Overall Study|Withdrawal by Subject|1|||
23622984|NCT01121913|66005114|FG002|First Intervention Period|Adverse Event|1|||
23824040|NCT02717455|66737709|FG001|Overall Study|Withdrawal by Subject|1|||
23824041|NCT02717455|66737710|FG002|Overall Study|Withdrawal by Subject|0|||
23824042|NCT02717455|66737711|FG003|Overall Study|Withdrawal by Subject|2|||
23824043|NCT02717455|66737712|FG004|Overall Study|Withdrawal by Subject|2|||
23824044|NCT02717455|66737713|FG005|Overall Study|Withdrawal by Subject|1|||
23824045|NCT02717455|66737708|FG000|Overall Study|Death|1|||
23824046|NCT02717455|66737709|FG001|Overall Study|Death|0|||
23824047|NCT02717455|66737710|FG002|Overall Study|Death|0|||
23824048|NCT02717455|66737711|FG003|Overall Study|Death|0|||
23824049|NCT02717455|66737712|FG004|Overall Study|Death|1|||
23824050|NCT02717455|66737713|FG005|Overall Study|Death|0|||
23824051|NCT02717455|66737708|FG000|Overall Study|Did not receive study drug|0|||
23824052|NCT02717455|66737709|FG001|Overall Study|Did not receive study drug|0|||
23622985|NCT01121913|66005115|FG003|First Intervention Period|Adverse Event|0|||
23622986|NCT01121913|66005112|FG000|First Washout Period|Withdrawal by Subject|1|||
23622987|NCT01121913|66005113|FG001|First Washout Period|Withdrawal by Subject|0|||
23622988|NCT01121913|66005114|FG002|First Washout Period|Withdrawal by Subject|0|||
23622989|NCT01121913|66005115|FG003|First Washout Period|Withdrawal by Subject|0|||
23622990|NCT01121913|66005112|FG000|Second Intervention Period|Adverse Event|0|||
23622991|NCT01121913|66005113|FG001|Second Intervention Period|Adverse Event|0|||
23622992|NCT01121913|66005114|FG002|Second Intervention Period|Adverse Event|1|||
23622993|NCT01121913|66005115|FG003|Second Intervention Period|Adverse Event|0|||
23622994|NCT01121913|66005112|FG000|Second Washout Period|Withdrawal by Subject|0|||
23622995|NCT01121913|66005113|FG001|Second Washout Period|Withdrawal by Subject|0|||
23622996|NCT01121913|66005114|FG002|Second Washout Period|Withdrawal by Subject|1|||
23622997|NCT01121913|66005115|FG003|Second Washout Period|Withdrawal by Subject|0|||
23622998|NCT01121913|66005112|FG000|Third Washout Period|Adverse Event|1|||
23622999|NCT01121913|66005113|FG001|Third Washout Period|Adverse Event|0|||
23623000|NCT01121913|66005114|FG002|Third Washout Period|Adverse Event|0|||
23623001|NCT01121913|66005115|FG003|Third Washout Period|Adverse Event|0|||
23623002|NCT01192776|66005116|FG000|Overall Study|Death|8|||
23623003|NCT01192776|66005117|FG001|Overall Study|Death|15|||
23623004|NCT01192776|66005118|FG002|Overall Study|Death|18|||
23623005|NCT01192776|66005119|FG003|Overall Study|Death|15|||
23623006|NCT01192776|66005116|FG000|Overall Study|Lost to Follow-up|3|||
23623007|NCT01192776|66005117|FG001|Overall Study|Lost to Follow-up|6|||
23623008|NCT01192776|66005118|FG002|Overall Study|Lost to Follow-up|3|||
23623009|NCT01192776|66005119|FG003|Overall Study|Lost to Follow-up|5|||
23623010|NCT02560389|66005120|FG000|Overall Study|Lost to Follow-up|1|||
23623011|NCT02560389|66005121|FG001|Overall Study|Lost to Follow-up|2|||
23623012|NCT02560389|66005122|FG002|Overall Study|Lost to Follow-up|2|||
23623013|NCT02560389|66005120|FG000|Overall Study|Tested positive for illicit substance|0|||
23824053|NCT02717455|66737710|FG002|Overall Study|Did not receive study drug|0|||
23824054|NCT02717455|66737711|FG003|Overall Study|Did not receive study drug|1|||
23824055|NCT02717455|66737712|FG004|Overall Study|Did not receive study drug|0|||
23824056|NCT02717455|66737713|FG005|Overall Study|Did not receive study drug|1|||
23824057|NCT02717455|66737708|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23824058|NCT02717455|66737709|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23824059|NCT02717455|66737710|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23623014|NCT02560389|66005121|FG001|Overall Study|Tested positive for illicit substance|1|||
23623015|NCT02560389|66005122|FG002|Overall Study|Tested positive for illicit substance|0|||
23623016|NCT00363649|66005124|FG000|Overall Study|Withdrawal by Subject|1|||
23623017|NCT00363649|66005125|FG001|Overall Study|Withdrawal by Subject|1|||
23623018|NCT00363649|66005124|FG000|Overall Study|Adverse Event|6|||
23824060|NCT02717455|66737711|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23824061|NCT02717455|66737712|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23824062|NCT02717455|66737713|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
23824063|NCT02717455|66737708|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
23824064|NCT02717455|66737709|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
23824065|NCT02717455|66737710|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
23623019|NCT00363649|66005125|FG001|Overall Study|Adverse Event|0|||
23623020|NCT02396953|66005133|FG000|Overall Study|Withdrawal by Subject|0|||
23623021|NCT02396953|66005134|FG001|Overall Study|Withdrawal by Subject|0|||
23623022|NCT02396953|66005135|FG002|Overall Study|Withdrawal by Subject|1|||
23623023|NCT02396953|66005133|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
23623024|NCT02396953|66005134|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
23824066|NCT02717455|66737711|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
23824067|NCT02717455|66737712|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
23824068|NCT02717455|66737713|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
23824069|NCT03775486|66737726|FG000|Initial Therapy Phase|Other reason provided|0|||
23824070|NCT03775486|66737727|FG001|Initial Therapy Phase|Other reason provided|15|||
23824071|NCT03775486|66737726|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
23824072|NCT03775486|66737727|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
23824073|NCT03775486|66737726|FG000|Initial Therapy Phase|Protocol Violation|0|||
23824074|NCT03775486|66737727|FG001|Initial Therapy Phase|Protocol Violation|2|||
23824075|NCT03775486|66737726|FG000|Initial Therapy Phase|Adverse Event|0|||
23824076|NCT03775486|66737727|FG001|Initial Therapy Phase|Adverse Event|34|||
23824077|NCT03775486|66737726|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
23824078|NCT03775486|66737727|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
23824079|NCT03775486|66737726|FG000|Maintenance Phase|Withdrawal by Subject|13|||
23824080|NCT03775486|66737727|FG001|Maintenance Phase|Withdrawal by Subject|12|||
23824081|NCT03775486|66737726|FG000|Maintenance Phase|Death|44|||
23824082|NCT03775486|66737727|FG001|Maintenance Phase|Death|45|||
23433388|NCT03908476|65330443|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
23555605|NCT00117676|65762271|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
23623025|NCT02396953|66005135|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
23623026|NCT02396953|66005133|FG000|Overall Study|Personal Reasons|1|||
23623027|NCT02396953|66005134|FG001|Overall Study|Personal Reasons|1|||
23623028|NCT02396953|66005135|FG002|Overall Study|Personal Reasons|0|||
23623029|NCT00405912|66005136|FG000|Overall Study|Withdrawal by Subject|12|||
23623030|NCT00405912|66005137|FG001|Overall Study|Withdrawal by Subject|11|||
23623031|NCT00405912|66005138|FG002|Overall Study|Withdrawal by Subject|12|||
23623032|NCT00405912|66005136|FG000|Overall Study|Lost to Follow-up|4|||
23623033|NCT00405912|66005137|FG001|Overall Study|Lost to Follow-up|8|||
23623034|NCT00405912|66005138|FG002|Overall Study|Lost to Follow-up|4|||
23623035|NCT01020747|66005139|FG000|Overall Study|Withdrawal by Subject|1|||
23623036|NCT02151643|66005140|FG000|Overall Study|Adverse Event|2|||
23623037|NCT02151643|66005141|FG001|Overall Study|Adverse Event|0|||
23623038|NCT02151643|66005142|FG002|Overall Study|Adverse Event|1|||
23623039|NCT02151643|66005143|FG003|Overall Study|Adverse Event|4|||
23623040|NCT02151643|66005144|FG004|Overall Study|Adverse Event|0|||
23623041|NCT02151643|66005140|FG000|Overall Study|Withdrawal by Subject|0|||
23623042|NCT02151643|66005141|FG001|Overall Study|Withdrawal by Subject|1|||
23623043|NCT02151643|66005142|FG002|Overall Study|Withdrawal by Subject|1|||
23623044|NCT02151643|66005143|FG003|Overall Study|Withdrawal by Subject|1|||
23623045|NCT02151643|66005144|FG004|Overall Study|Withdrawal by Subject|1|||
23623046|NCT02151643|66005140|FG000|Overall Study|Hyperphosphataemia|1|||
23623047|NCT02151643|66005141|FG001|Overall Study|Hyperphosphataemia|0|||
23623048|NCT02151643|66005142|FG002|Overall Study|Hyperphosphataemia|0|||
23623049|NCT02151643|66005143|FG003|Overall Study|Hyperphosphataemia|0|||
23623050|NCT02151643|66005144|FG004|Overall Study|Hyperphosphataemia|1|||
23555606|NCT00117676|65762270|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
23555607|NCT00117676|65762271|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
23555608|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
23555609|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
23555610|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
23623051|NCT02151643|66005140|FG000|Overall Study|High Ferritin levels|3|||
23623052|NCT02151643|66005141|FG001|Overall Study|High Ferritin levels|3|||
23623053|NCT02151643|66005142|FG002|Overall Study|High Ferritin levels|2|||
23623054|NCT02151643|66005143|FG003|Overall Study|High Ferritin levels|2|||
23824083|NCT01597973|66737743|FG000|Overall Study|Found ineligible before study medication started|4|||
23824084|NCT01597973|66737744|FG001|Overall Study|Found ineligible before study medication started|2|||
23824085|NCT01597973|66737743|FG000|Overall Study|Eligible pathogen not confirmed|14|||
23623055|NCT02151643|66005144|FG004|Overall Study|High Ferritin levels|1|||
23824086|NCT01597973|66737744|FG001|Overall Study|Eligible pathogen not confirmed|15|||
23623056|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
23623057|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Duplication|2|||
23623058|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
23623059|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
23623060|NCT02016690|66005145|FG000|Overall Study|Did not meet inclusion criteria|13|||
23623061|NCT02016690|66005145|FG000|Overall Study|Hospitalized for RSV at study start|3|||
23623062|NCT03440047|66005150|FG000|Overall Study|Withdrawal by Subject|2|||
23623063|NCT00833898|66005151|FG000|Overall Study|Withdrawal by Subject|33|||
23623064|NCT00833898|66005152|FG001|Overall Study|Withdrawal by Subject|27|||
23623065|NCT00833898|66005151|FG000|Overall Study|Lost to Follow-up|7|||
23623066|NCT00833898|66005152|FG001|Overall Study|Lost to Follow-up|7|||
23623067|NCT00833898|66005151|FG000|Overall Study|Patient did not receive transplant|0|||
23623068|NCT00833898|66005152|FG001|Overall Study|Patient did not receive transplant|2|||
23623069|NCT04696146|66005153|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
23623070|NCT04696146|66005154|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
23623071|NCT04696146|66005153|FG000|Overall Study|Off hours issue with product|1|||
23623072|NCT04696146|66005154|FG001|Overall Study|Off hours issue with product|0|||
23623073|NCT02381652|66005157|FG000|Overall Study|Withdrawal by Subject|0|||
23623074|NCT02381652|66005158|FG001|Overall Study|Withdrawal by Subject|0|||
23623075|NCT02381652|66005159|FG002|Overall Study|Withdrawal by Subject|1|||
23623076|NCT00460564|66005165|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
23623077|NCT00460564|66005166|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
23623078|NCT00460564|66005167|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623079|NCT00460564|66005168|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623080|NCT00460564|66005169|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623081|NCT00460564|66005170|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623082|NCT00460564|66005171|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623083|NCT00460564|66005172|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623084|NCT00460564|66005165|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
23749508|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
23749509|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23749510|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23749511|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
23623085|NCT00460564|66005166|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623086|NCT00460564|66005167|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623087|NCT00460564|66005168|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623088|NCT00460564|66005169|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623089|NCT00460564|66005170|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623090|NCT00460564|66005171|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623091|NCT00460564|66005172|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623092|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623093|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623094|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623095|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623096|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
23623097|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
23623098|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
23623099|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623100|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623101|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623102|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23749512|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
23749513|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23749514|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
23749515|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23749516|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23749517|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
23824087|NCT01597973|66737743|FG000|Overall Study|LAR not authorized to consent|0|||
23824088|NCT01597973|66737744|FG001|Overall Study|LAR not authorized to consent|1|||
23824089|NCT01597973|66737743|FG000|Overall Study|Ineligible due to early seizures|1|||
23824090|NCT01597973|66737744|FG001|Overall Study|Ineligible due to early seizures|0|||
23824091|NCT01597973|66737743|FG000|Overall Study|Ineligible due to non-target infection|1|||
23623103|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623104|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
23623105|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
23623106|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23824092|NCT01597973|66737744|FG001|Overall Study|Ineligible due to non-target infection|1|||
23623107|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23824093|NCT01495000|66737748|FG000|Overall Study|Lost to Follow-up|2|||
23749518|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
23749519|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
23749520|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
23749521|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
23749522|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
23749523|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
23749524|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
23749525|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749526|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749527|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749528|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749529|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
23749530|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749531|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749532|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23749533|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23749534|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23749535|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
23749536|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23749537|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23555611|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
23555612|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
23555613|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
23555614|NCT04120233|65762274|FG000|Overall Study|Adverse Event|0|||
23555615|NCT04120233|65762275|FG001|Overall Study|Adverse Event|0|||
23555616|NCT04120233|65762276|FG002|Overall Study|Adverse Event|0|||
23555617|NCT04120233|65762277|FG003|Overall Study|Adverse Event|0|||
23555618|NCT04120233|65762278|FG004|Overall Study|Adverse Event|1|||
23555619|NCT04120233|65762279|FG005|Overall Study|Adverse Event|0|||
23555620|NCT00677833|65762280|FG000|Overall Study|Withdrawal by Subject|4|||
23555621|NCT00677833|65762281|FG001|Overall Study|Withdrawal by Subject|0|||
23555622|NCT00677833|65762282|FG002|Overall Study|Withdrawal by Subject|1|||
23749538|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23749539|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23749540|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23824094|NCT01495000|66737749|FG001|Overall Study|Lost to Follow-up|2|||
23824095|NCT01495000|66737748|FG000|Overall Study|Protocol Violation|1|||
23623108|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623109|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623110|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623111|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623112|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
23623113|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623114|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623115|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623116|NCT00537329|66008309|FG000|Overall Study|Death|10|||
23623117|NCT00537329|66008309|FG000|Overall Study|Adverse Event|3|||
23623118|NCT00537329|66008309|FG000|Overall Study|Lack of Efficacy|2|||
23623119|NCT00537329|66008309|FG000|Overall Study|Lost to Follow-up|6|||
23623120|NCT00537329|66008309|FG000|Overall Study|Withdrawal by Subject|4|||
23623121|NCT00537329|66008309|FG000|Overall Study|Other|1|||
23623122|NCT03772041|66008314|FG000|Overall Study|Adverse Event|8|||
23623123|NCT03772041|66008315|FG001|Overall Study|Adverse Event|3|||
23623124|NCT03772041|66008314|FG000|Overall Study|Withdrawal by Subject|0|||
23623125|NCT03772041|66008315|FG001|Overall Study|Withdrawal by Subject|2|||
23623126|NCT03772041|66008314|FG000|Overall Study|Protocol Violation|4|||
23623127|NCT03772041|66008315|FG001|Overall Study|Protocol Violation|2|||
23623128|NCT03772041|66008314|FG000|Overall Study|Physician Decision|2|||
23623129|NCT03772041|66008315|FG001|Overall Study|Physician Decision|3|||
23623130|NCT01161446|66008319|FG000|Overall Study|Lost to Follow-up|18|||
23623131|NCT01161446|66008320|FG001|Overall Study|Lost to Follow-up|14|||
23623132|NCT01161446|66008319|FG000|Overall Study|Withdrawal by Subject|0|||
23623133|NCT01161446|66008320|FG001|Overall Study|Withdrawal by Subject|1|||
23824096|NCT01495000|66737749|FG001|Overall Study|Protocol Violation|0|||
23623134|NCT01313624|66008321|FG000|Double-Blind Phase|Adverse Event|27|||
23623135|NCT01313624|66008322|FG001|Double-Blind Phase|Adverse Event|4|||
23623136|NCT01313624|66008321|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
23623137|NCT01313624|66008322|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
23623138|NCT01313624|66008321|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23623139|NCT01313624|66008322|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23623140|NCT01313624|66008321|FG000|Double-Blind Phase|Physician Decision|1|||
23623141|NCT01313624|66008322|FG001|Double-Blind Phase|Physician Decision|0|||
23623142|NCT01313624|66008321|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23623143|NCT01313624|66008322|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23623144|NCT01313624|66008321|FG000|Open-Label Phase|Adverse Event|1|||
23623145|NCT01313624|66008322|FG001|Open-Label Phase|Adverse Event|10|||
23623146|NCT01313624|66008321|FG000|Open-Label Phase|Withdrawal by Subject|2|||
23623147|NCT01313624|66008322|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23623148|NCT01313624|66008321|FG000|Open-Label Phase|Lost to Follow-up|1|||
23824097|NCT01495000|66737748|FG000|Overall Study|Withdrawal by Subject|10|||
23824098|NCT01495000|66737749|FG001|Overall Study|Withdrawal by Subject|10|||
23824099|NCT02016183|66737753|FG000|Overall Study|Case Report Forms Uncollected|13|||
23824100|NCT02016183|66737753|FG000|Overall Study|Protocol Violation|52|||
23824101|NCT00307086|66737756|FG000|Overall Study|ineligible|5|||
23824102|NCT02135614|66737759|FG000|Overall Study|Randomized but Not Treated|2|||
23824103|NCT02135614|66737760|FG001|Overall Study|Randomized but Not Treated|1|||
23824104|NCT02135614|66737759|FG000|Overall Study|Adverse Event|0|||
23824105|NCT02135614|66737760|FG001|Overall Study|Adverse Event|1|||
23824106|NCT02135614|66737759|FG000|Overall Study|Death|1|||
23824107|NCT02135614|66737760|FG001|Overall Study|Death|0|||
23824108|NCT02135614|66737759|FG000|Overall Study|Investigator's Discretion|0|||
23824109|NCT02135614|66737760|FG001|Overall Study|Investigator's Discretion|1|||
23824110|NCT02135614|66737759|FG000|Overall Study|Withdrew Consent|2|||
23824111|NCT02135614|66737760|FG001|Overall Study|Withdrew Consent|2|||
23824112|NCT02135614|66737759|FG000|Overall Study|Lost to Follow-up|3|||
23824113|NCT02135614|66737760|FG001|Overall Study|Lost to Follow-up|0|||
23824114|NCT05445492|66737761|FG000|Overall Study|Physician Decision|1|||
23824115|NCT01232452|66737762|FG000|Overall Study|Adverse Event|17|||
23824116|NCT01232452|66737763|FG001|Overall Study|Adverse Event|15|||
23824117|NCT01232452|66737762|FG000|Overall Study|Withdrawal by Subject|11|||
23824118|NCT01232452|66737763|FG001|Overall Study|Withdrawal by Subject|8|||
23824119|NCT01232452|66737762|FG000|Overall Study|Physician Decision|8|||
23824120|NCT01232452|66737763|FG001|Overall Study|Physician Decision|12|||
23824121|NCT01232452|66737762|FG000|Overall Study|Protocol entry criterion not met|0|||
23824122|NCT01232452|66737763|FG001|Overall Study|Protocol entry criterion not met|2|||
23824123|NCT01232452|66737762|FG000|Overall Study|Sponsor Decision|3|||
23824124|NCT01232452|66737763|FG001|Overall Study|Sponsor Decision|1|||
23824125|NCT01232452|66737762|FG000|Overall Study|Protocol Violation|0|||
23824126|NCT01232452|66737763|FG001|Overall Study|Protocol Violation|1|||
23824127|NCT01625091|66737774|FG000|Intervention|Death|1|||
23824128|NCT01625091|66737775|FG001|Intervention|Death|1|||
23824129|NCT01625091|66737774|FG000|Intervention|Withdrawal by Subject|4|||
23824130|NCT01625091|66737775|FG001|Intervention|Withdrawal by Subject|1|||
23824131|NCT01625091|66737774|FG000|Intervention|Adverse Event|0|||
23824132|NCT01625091|66737775|FG001|Intervention|Adverse Event|2|||
23824133|NCT01625091|66737774|FG000|Intervention|Lost to Follow-up|4|||
23824134|NCT01625091|66737775|FG001|Intervention|Lost to Follow-up|4|||
23824135|NCT01625091|66737774|FG000|Intervention|Study termination|2|||
23824136|NCT01625091|66737775|FG001|Intervention|Study termination|3|||
23623149|NCT01313624|66008322|FG001|Open-Label Phase|Lost to Follow-up|1|||
23623150|NCT01114139|66008323|FG000|Overall Study|Adverse Event|3|||
23623151|NCT01114139|66008324|FG001|Overall Study|Adverse Event|2|||
23824137|NCT01625091|66737774|FG000|Post-intervention|Death|0|||
23623152|NCT01114139|66008323|FG000|Overall Study|Lost to Follow-up|15|||
23824138|NCT01625091|66737775|FG001|Post-intervention|Death|1|||
23824139|NCT01625091|66737774|FG000|Post-intervention|Lost to Follow-up|2|||
23824140|NCT01625091|66737775|FG001|Post-intervention|Lost to Follow-up|0|||
23824141|NCT01625091|66737774|FG000|Post-intervention|Study termination|2|||
23824142|NCT01625091|66737775|FG001|Post-intervention|Study termination|1|||
23824143|NCT03156504|66737776|FG000|Overall Study|Withdrawal by Subject|1|||
23824144|NCT00805467|66737777|FG000|Overall Study|Lack of Efficacy|0|||
23824145|NCT00805467|66737778|FG001|Overall Study|Lack of Efficacy|8|||
23824146|NCT00805467|66737779|FG002|Overall Study|Lack of Efficacy|13|||
23824147|NCT00805467|66737780|FG003|Overall Study|Lack of Efficacy|86|||
23824148|NCT00805467|66737777|FG000|Overall Study|Lost to Follow-up|0|||
23824149|NCT00805467|66737778|FG001|Overall Study|Lost to Follow-up|1|||
23623153|NCT01114139|66008324|FG001|Overall Study|Lost to Follow-up|3|||
23623154|NCT01114139|66008323|FG000|Overall Study|Withdrawal by Subject|17|||
23623155|NCT01114139|66008324|FG001|Overall Study|Withdrawal by Subject|6|||
23623156|NCT01114139|66008323|FG000|Overall Study|Other-Missed 1 visit|1|||
23623157|NCT01114139|66008324|FG001|Overall Study|Other-Missed 1 visit|0|||
23623158|NCT01114139|66008323|FG000|Overall Study|Other-Protocol Violation|1|||
23623159|NCT01114139|66008324|FG001|Overall Study|Other-Protocol Violation|0|||
23623160|NCT01114139|66008323|FG000|Overall Study|Other-Out of window for study drug dose|1|||
23623161|NCT01114139|66008324|FG001|Overall Study|Other-Out of window for study drug dose|0|||
23623162|NCT01114139|66008323|FG000|Overall Study|Other-Participant falsified records|0|||
23623163|NCT01114139|66008324|FG001|Overall Study|Other-Participant falsified records|1|||
23623164|NCT01114139|66008323|FG000|Overall Study|Other-Participant went on hospice|0|||
23623165|NCT01114139|66008324|FG001|Overall Study|Other-Participant went on hospice|1|||
23623166|NCT01114139|66008323|FG000|Overall Study|Other-Physician changed treatment|1|||
23623167|NCT01114139|66008324|FG001|Overall Study|Other-Physician changed treatment|0|||
23623168|NCT01114139|66008323|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
23623169|NCT01114139|66008324|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
23623170|NCT02760485|66008325|FG000|Phase 1|Death|3|||
23623171|NCT02760485|66008326|FG001|Phase 1|Death|6|||
23623172|NCT02760485|66008327|FG002|Phase 1|Death|0|||
23623173|NCT02760485|66008325|FG000|Phase 1|Withdrawal by Subject|2|||
23623174|NCT02760485|66008326|FG001|Phase 1|Withdrawal by Subject|0|||
23623175|NCT02760485|66008327|FG002|Phase 1|Withdrawal by Subject|0|||
23623176|NCT02760485|66008325|FG000|Phase 1|Progressive Disease|1|||
23623177|NCT02760485|66008326|FG001|Phase 1|Progressive Disease|0|||
23623178|NCT02760485|66008327|FG002|Phase 1|Progressive Disease|0|||
23623179|NCT02760485|66008325|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
23623180|NCT02760485|66008326|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
23623181|NCT02760485|66008327|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
23623182|NCT02760485|66008325|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
23623183|NCT02760485|66008326|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
23623184|NCT02760485|66008327|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
23623185|NCT02760485|66008325|FG000|Phase 2|Death|0|||
23623186|NCT02760485|66008326|FG001|Phase 2|Death|0|||
23623187|NCT02760485|66008327|FG002|Phase 2|Death|12|||
23623188|NCT02760485|66008325|FG000|Phase 2|Withdrawal by Subject|0|||
23623189|NCT02760485|66008326|FG001|Phase 2|Withdrawal by Subject|0|||
23623190|NCT02760485|66008327|FG002|Phase 2|Withdrawal by Subject|3|||
23623191|NCT02760485|66008325|FG000|Phase 2|Progressive Disease|0|||
23623192|NCT02760485|66008326|FG001|Phase 2|Progressive Disease|0|||
23623193|NCT02760485|66008327|FG002|Phase 2|Progressive Disease|1|||
23623194|NCT02760485|66008325|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
23623195|NCT02760485|66008326|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
23623196|NCT02760485|66008327|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
23623197|NCT01278615|66008328|FG000|Overall Study|Withdrawal by Subject|2|||
23623198|NCT03475056|66008329|FG000|Overall Study|Lost to Follow-up|0|||
23623199|NCT03475056|66008330|FG001|Overall Study|Lost to Follow-up|1|||
23623200|NCT03475056|66008329|FG000|Overall Study|Moved from Area|0|||
23623201|NCT03475056|66008330|FG001|Overall Study|Moved from Area|2|||
23623202|NCT00677092|66008331|FG000|Overall Study|Adverse Event|1|||
23623203|NCT00677092|66008331|FG000|Overall Study|Lost to Follow-up|1|||
23623204|NCT00677092|66008331|FG000|Overall Study|Withdrawal by Subject|3|||
23623205|NCT00677092|66008331|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
23623206|NCT01243411|66008332|FG000|Overall Study|Withdrawal by Subject|18|||
23623207|NCT01243411|66008332|FG000|Overall Study|Lost to Follow-up|10|||
23623208|NCT01243411|66008332|FG000|Overall Study|Adverse Event|5|||
23623209|NCT01243411|66008332|FG000|Overall Study|Other|8|||
23623210|NCT01264887|66008333|FG000|Overall Study|Adverse Event|5|||
23623211|NCT01264887|66008333|FG000|Overall Study|Death|7|||
23623212|NCT01264887|66008333|FG000|Overall Study|Lack of Efficacy|5|||
23824150|NCT00805467|66737779|FG002|Overall Study|Lost to Follow-up|7|||
23623213|NCT01264887|66008333|FG000|Overall Study|Physician Decision|4|||
23623214|NCT01264887|66008333|FG000|Overall Study|Withdrawal by Subject|6|||
23623215|NCT01264887|66008333|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
23623216|NCT01264887|66008333|FG000|Overall Study|Other|2|||
23623217|NCT00409409|66008337|FG000|Overall Study|Adverse Event|7|||
23623218|NCT00409409|66008338|FG001|Overall Study|Adverse Event|2|||
23623219|NCT00409409|66008337|FG000|Overall Study|Withdrawal by Subject|1|||
23623220|NCT00409409|66008338|FG001|Overall Study|Withdrawal by Subject|1|||
23623221|NCT00409409|66008337|FG000|Overall Study|Any other reason not above-mentioned|0|||
23623222|NCT00409409|66008338|FG001|Overall Study|Any other reason not above-mentioned|1|||
23623223|NCT01722045|66008339|FG000|Overall Study|Adverse Event|8|||
23623224|NCT01722045|66008339|FG000|Overall Study|Death|3|||
23824151|NCT00805467|66737780|FG003|Overall Study|Lost to Follow-up|21|||
23824152|NCT00805467|66737777|FG000|Overall Study|Withdrawal by Subject|0|||
23824153|NCT00805467|66737778|FG001|Overall Study|Withdrawal by Subject|6|||
23824154|NCT00805467|66737779|FG002|Overall Study|Withdrawal by Subject|45|||
23824155|NCT00805467|66737780|FG003|Overall Study|Withdrawal by Subject|50|||
23824156|NCT00805467|66737777|FG000|Overall Study|Protocol Violation|0|||
23824157|NCT00805467|66737778|FG001|Overall Study|Protocol Violation|3|||
23824158|NCT00805467|66737779|FG002|Overall Study|Protocol Violation|0|||
23555623|NCT00677833|65762283|FG003|Overall Study|Withdrawal by Subject|3|||
23555624|NCT00677833|65762280|FG000|Overall Study|Lost to Follow-up|0|||
23555625|NCT00677833|65762281|FG001|Overall Study|Lost to Follow-up|0|||
23555626|NCT00677833|65762282|FG002|Overall Study|Lost to Follow-up|1|||
23555627|NCT00677833|65762283|FG003|Overall Study|Lost to Follow-up|0|||
23555628|NCT02657031|65762287|FG000|Overall Study|Adverse Event|1|||
23555629|NCT02657031|65762288|FG001|Overall Study|Adverse Event|2|||
23555630|NCT02355028|65762289|FG000|Overall Study|Adverse Event|2|||
23555631|NCT02355028|65762290|FG001|Overall Study|Adverse Event|0|||
23555632|NCT02355028|65762289|FG000|Overall Study|Withdrawal by Subject|1|||
23555633|NCT02355028|65762290|FG001|Overall Study|Withdrawal by Subject|1|||
23555634|NCT02355028|65762289|FG000|Overall Study|Deemed ineligible after randomization|8|||
23555635|NCT02355028|65762290|FG001|Overall Study|Deemed ineligible after randomization|4|||
23555636|NCT01111123|65762291|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
23555637|NCT01111123|65762292|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
23555638|NCT01111123|65762291|FG000|Maintenance Phase|Lost to Follow-up|0|||
23555639|NCT01111123|65762292|FG001|Maintenance Phase|Lost to Follow-up|2|||
23555640|NCT01791725|65762296|FG000|Overall Study|Withdrawal by Subject|0|||
23555641|NCT01791725|65762297|FG001|Overall Study|Withdrawal by Subject|1|||
23555642|NCT01791725|65762298|FG002|Overall Study|Withdrawal by Subject|0|||
23555643|NCT02314624|65762299|FG000|Overall Study|No participating patient|16|||
23555644|NCT02314624|65762300|FG001|Overall Study|No participating patient|13|||
23555645|NCT02314624|65762299|FG000|Overall Study|Participant withdrew|7|||
23555646|NCT02314624|65762300|FG001|Overall Study|Participant withdrew|2|||
23555647|NCT02314624|65762299|FG000|Overall Study|Lost to Follow-up|2|||
23555648|NCT02314624|65762300|FG001|Overall Study|Lost to Follow-up|5|||
23555649|NCT02314624|65762299|FG000|Overall Study|Dropped/Excluded by PI|6|||
23555650|NCT02314624|65762300|FG001|Overall Study|Dropped/Excluded by PI|6|||
23555651|NCT02822222|65762301|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
23555652|NCT02822222|65762302|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
23555653|NCT02291679|65762303|FG000|Overall Study|Adverse Event|2|||
23555654|NCT02291679|65762304|FG001|Overall Study|Adverse Event|12|||
23555655|NCT02291679|65762305|FG002|Overall Study|Adverse Event|19|||
23555656|NCT02291679|65762303|FG000|Overall Study|Protocol Violation|5|||
23555657|NCT02291679|65762304|FG001|Overall Study|Protocol Violation|1|||
23555658|NCT02291679|65762305|FG002|Overall Study|Protocol Violation|7|||
23555659|NCT02291679|65762303|FG000|Overall Study|Withdrew Consent|18|||
23555660|NCT02291679|65762304|FG001|Overall Study|Withdrew Consent|10|||
23555661|NCT02291679|65762305|FG002|Overall Study|Withdrew Consent|15|||
23555662|NCT02291679|65762303|FG000|Overall Study|Lost to Follow-up|12|||
23555663|NCT02291679|65762304|FG001|Overall Study|Lost to Follow-up|10|||
23555664|NCT02291679|65762305|FG002|Overall Study|Lost to Follow-up|9|||
23824159|NCT00805467|66737780|FG003|Overall Study|Protocol Violation|5|||
23824160|NCT00805467|66737777|FG000|Overall Study|Adverse Event|0|||
23749541|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23749542|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23749543|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23749544|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23749545|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
23749546|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23749547|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
23749548|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
23824161|NCT00805467|66737778|FG001|Overall Study|Adverse Event|13|||
23623225|NCT01722045|66008339|FG000|Overall Study|Withdrawal by Subject|8|||
23623226|NCT01722045|66008339|FG000|Overall Study|Lost to Follow-up|4|||
23623227|NCT01722045|66008339|FG000|Overall Study|Protocol Deviation|1|||
23623228|NCT01722045|66008339|FG000|Overall Study|Physician Decision|3|||
23623229|NCT01722045|66008339|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
23623230|NCT02344173|66008340|FG000|Procedure|Ablation Procedure Not Performed|7|||
23623231|NCT02344173|66008340|FG000|12-month Visit|Death|8|||
23623232|NCT02344173|66008340|FG000|12-month Visit|Withdrawal by Subject|30|||
23623233|NCT02344173|66008340|FG000|12-month Visit|Lost to Follow-up|58|||
23623234|NCT03016598|66008341|FG000|Overall Study|Lost to Follow-up|0|||
23623235|NCT03016598|66008342|FG001|Overall Study|Lost to Follow-up|2|||
23623236|NCT00104637|66008343|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
23623237|NCT00104637|66008344|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
23623238|NCT01255761|66008349|FG000|Overall Study|Adverse Event|29|||
23623239|NCT01255761|66008350|FG001|Overall Study|Adverse Event|43|||
23623240|NCT01255761|66008349|FG000|Overall Study|Lack of Efficacy|86|||
23623241|NCT01255761|66008350|FG001|Overall Study|Lack of Efficacy|74|||
23623242|NCT01255761|66008349|FG000|Overall Study|Protocol Violation|9|||
23623243|NCT01255761|66008350|FG001|Overall Study|Protocol Violation|5|||
23623244|NCT01255761|66008349|FG000|Overall Study|Lost to Follow-up|10|||
23623245|NCT01255761|66008350|FG001|Overall Study|Lost to Follow-up|8|||
23623246|NCT01255761|66008349|FG000|Overall Study|Withdrawal by Subject|11|||
23623247|NCT01255761|66008350|FG001|Overall Study|Withdrawal by Subject|27|||
23623248|NCT01255761|66008349|FG000|Overall Study|Other Reasons|37|||
23623249|NCT01255761|66008350|FG001|Overall Study|Other Reasons|18|||
23623250|NCT00263575|66008354|FG000|Titration Period|Adverse Event|14|||
23623251|NCT00263575|66008354|FG000|Titration Period|Withdrawal by Subject|10|||
23623252|NCT00263575|66008354|FG000|Titration Period|Protocol Violation|9|||
23623253|NCT00263575|66008354|FG000|Titration Period|Sponsor Decision|2|||
23623254|NCT00263575|66008354|FG000|Titration Period|Other|2|||
23623255|NCT00263575|66008354|FG000|Titration Period|Lack of Efficacy|6|||
23623256|NCT00263575|66008354|FG000|Maintence Period|Adverse Event|23|||
23623257|NCT00263575|66008354|FG000|Maintence Period|Withdrawal by Subject|8|||
23623258|NCT00263575|66008354|FG000|Maintence Period|Protocol Violation|4|||
23623259|NCT00263575|66008354|FG000|Maintence Period|Lack of Efficacy|4|||
23623260|NCT00263575|66008354|FG000|Maintence Period|Physician Decision|6|||
23623261|NCT00263575|66008354|FG000|Maintence Period|Lost to Follow-up|1|||
23623262|NCT00263575|66008354|FG000|Maintence Period|Sponsor Decision|24|||
23623263|NCT00263575|66008354|FG000|Maintence Period|Other|7|||
23623264|NCT02980705|66008357|FG000|Overall Study|Adverse Event|0|||
23623265|NCT02980705|66008358|FG001|Overall Study|Adverse Event|1|||
23623266|NCT02980705|66008357|FG000|Overall Study|Withdrawal by Subject|6|||
23623267|NCT02980705|66008358|FG001|Overall Study|Withdrawal by Subject|9|||
23623268|NCT02980705|66008357|FG000|Overall Study|withdrew participation|0|||
23623269|NCT02980705|66008358|FG001|Overall Study|withdrew participation|1|||
23623270|NCT02980705|66008357|FG000|Overall Study|Lost to Follow-up|2|||
23623271|NCT02980705|66008358|FG001|Overall Study|Lost to Follow-up|0|||
23623272|NCT01850823|66008363|FG000|Overall Study|Early Visit Window|0|||
23623273|NCT01850823|66008364|FG001|Overall Study|Early Visit Window|1|||
23623274|NCT01850823|66008365|FG002|Overall Study|Early Visit Window|4|||
23623275|NCT01850823|66008363|FG000|Overall Study|Enrolled in Error|0|||
23623276|NCT01850823|66008364|FG001|Overall Study|Enrolled in Error|1|||
23623277|NCT01850823|66008365|FG002|Overall Study|Enrolled in Error|2|||
23623278|NCT01850823|66008363|FG000|Overall Study|Lack of Efficacy|1|||
23623279|NCT01850823|66008364|FG001|Overall Study|Lack of Efficacy|0|||
23623280|NCT01850823|66008365|FG002|Overall Study|Lack of Efficacy|0|||
23623281|NCT01850823|66008363|FG000|Overall Study|Lost to Follow-up|0|||
23749549|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749550|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23623282|NCT01850823|66008364|FG001|Overall Study|Lost to Follow-up|0|||
23623283|NCT01850823|66008365|FG002|Overall Study|Lost to Follow-up|1|||
23623284|NCT01850823|66008363|FG000|Overall Study|Restricted Medication|0|||
23623285|NCT01850823|66008364|FG001|Overall Study|Restricted Medication|0|||
23623286|NCT01850823|66008365|FG002|Overall Study|Restricted Medication|2|||
23623287|NCT01850823|66008363|FG000|Overall Study|Significant worstening of SAR|0|||
23623288|NCT01850823|66008364|FG001|Overall Study|Significant worstening of SAR|1|||
23623289|NCT01850823|66008365|FG002|Overall Study|Significant worstening of SAR|0|||
23623290|NCT01850823|66008363|FG000|Overall Study|Withdrawal by Subject|2|||
23623291|NCT01850823|66008364|FG001|Overall Study|Withdrawal by Subject|0|||
23623292|NCT01850823|66008365|FG002|Overall Study|Withdrawal by Subject|1|||
23623293|NCT04811339|66008369|FG000|Overall Study|lack of transportation not wanting to return|4|||
23623294|NCT04811339|66008370|FG001|Overall Study|lack of transportation not wanting to return|8|||
23623295|NCT04811339|66008371|FG002|Overall Study|lack of transportation not wanting to return|0|||
23623296|NCT04811339|66008369|FG000|Overall Study|Adverse Event|3|||
23623297|NCT04811339|66008370|FG001|Overall Study|Adverse Event|0|||
23623298|NCT04811339|66008371|FG002|Overall Study|Adverse Event|0|||
23623299|NCT04811339|66008369|FG000|Overall Study|Lost to Follow-up|1|||
23623300|NCT04811339|66008370|FG001|Overall Study|Lost to Follow-up|0|||
23623301|NCT04811339|66008371|FG002|Overall Study|Lost to Follow-up|0|||
23623302|NCT04811339|66008369|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
23623303|NCT04811339|66008370|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
23623304|NCT04811339|66008371|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
23623305|NCT04811339|66008369|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
23623306|NCT04811339|66008370|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
23623307|NCT04811339|66008371|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
23623308|NCT04811339|66008369|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
23623309|NCT04811339|66008370|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
23623310|NCT04811339|66008371|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
23623311|NCT04811339|66008369|FG000|Overall Study|Withdrawal by Subject|0|||
23623312|NCT04811339|66008370|FG001|Overall Study|Withdrawal by Subject|3|||
23623313|NCT04811339|66008371|FG002|Overall Study|Withdrawal by Subject|0|||
23623314|NCT04811339|66008369|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
23749551|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749552|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749553|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749554|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
23749555|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749556|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23749557|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23749558|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23749559|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
23749560|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
23749561|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
23749562|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
23749563|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23749564|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23749565|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749566|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749567|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749568|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749569|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
23749570|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
23555665|NCT02291679|65762303|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23555666|NCT02291679|65762304|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23555667|NCT02291679|65762305|FG002|Overall Study|Insufficient Therapeutic Response|7|||
23555668|NCT02291679|65762303|FG000|Overall Study|Other|2|||
23555669|NCT02291679|65762304|FG001|Overall Study|Other|4|||
23555670|NCT02291679|65762305|FG002|Overall Study|Other|2|||
23555671|NCT00981084|65762306|FG000|Post Intervention (Data Analysis)|poor effort|1|||
23555672|NCT00981084|65762307|FG001|Post Intervention (Data Analysis)|poor effort|1|||
23555673|NCT00981084|65762306|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
23555674|NCT00981084|65762307|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
23555675|NCT03318523|65762310|FG000|PC Period: Up to Year 1|Adverse Event|1|||
23555676|NCT03318523|65762311|FG001|PC Period: Up to Year 1|Adverse Event|0|||
23555677|NCT03318523|65762312|FG002|PC Period: Up to Year 1|Adverse Event|2|||
23555678|NCT03318523|65762313|FG003|PC Period: Up to Year 1|Adverse Event|0|||
23555679|NCT03318523|65762314|FG004|PC Period: Up to Year 1|Adverse Event|0|||
23555680|NCT03318523|65762315|FG005|PC Period: Up to Year 1|Adverse Event|0|||
23555681|NCT03318523|65762316|FG006|PC Period: Up to Year 1|Adverse Event|0|||
23555682|NCT03318523|65762317|FG007|PC Period: Up to Year 1|Adverse Event|0|||
23555683|NCT03318523|65762318|FG008|PC Period: Up to Year 1|Adverse Event|0|||
23555684|NCT03318523|65762319|FG009|PC Period: Up to Year 1|Adverse Event|0|||
23555685|NCT03318523|65762310|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
23555686|NCT03318523|65762311|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
23555687|NCT03318523|65762312|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555688|NCT03318523|65762313|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
23555689|NCT03318523|65762314|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
23749571|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749572|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23749573|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23749574|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23749575|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
23749576|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
23749577|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
23749578|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
23749579|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
23749580|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23749581|NCT00408005|66463372|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23749582|NCT00408005|66463373|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23749583|NCT00408005|66463374|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
23749584|NCT00408005|66463375|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23749585|NCT00408005|66463376|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23749586|NCT00408005|66463377|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23749587|NCT00408005|66463378|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23749588|NCT00408005|66463379|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23749589|NCT03728257|66463381|FG000|Overall Study|Death|3|||
23749590|NCT03728257|66463382|FG001|Overall Study|Death|0|||
23749591|NCT00761735|66463386|FG000|Overall Study|Lost to Follow-up|6|||
23749592|NCT00761735|66463386|FG000|Overall Study|Withdrawal by Subject|6|||
23749593|NCT00761735|66463386|FG000|Overall Study|Non-compliance with protocol|1|||
23749594|NCT00761735|66463386|FG000|Overall Study|Administrative|1|||
23749595|NCT03690206|66463389|FG000|Overall Study|Withdrawal by Subject|2|||
23749596|NCT03690206|66463390|FG001|Overall Study|Withdrawal by Subject|0|||
23749597|NCT03690206|66463391|FG002|Overall Study|Withdrawal by Subject|0|||
23749598|NCT03690206|66463389|FG000|Overall Study|ICF withdrawal|2|||
23749599|NCT03690206|66463390|FG001|Overall Study|ICF withdrawal|0|||
23749600|NCT03690206|66463391|FG002|Overall Study|ICF withdrawal|0|||
23749601|NCT02297438|66463392|FG000|Overall Study|Death|79|||
23749602|NCT02297438|66463393|FG001|Overall Study|Death|86|||
23749603|NCT02297438|66463392|FG000|Overall Study|Lost to Follow-up|9|||
23749604|NCT02297438|66463393|FG001|Overall Study|Lost to Follow-up|7|||
23749605|NCT02297438|66463392|FG000|Overall Study|Withdrawal by Subject|7|||
23749606|NCT02297438|66463393|FG001|Overall Study|Withdrawal by Subject|0|||
23749607|NCT02297438|66463392|FG000|Overall Study|Other|9|||
23749608|NCT02297438|66463393|FG001|Overall Study|Other|5|||
23749609|NCT02297438|66463392|FG000|Overall Study|Ongoing|65|||
23749610|NCT02297438|66463393|FG001|Overall Study|Ongoing|73|||
23749611|NCT00337727|66463394|FG000|Overall Study|Adverse Event|5|||
23824162|NCT00805467|66737779|FG002|Overall Study|Adverse Event|26|||
23749612|NCT00337727|66463395|FG001|Overall Study|Adverse Event|3|||
23749613|NCT00337727|66463394|FG000|Overall Study|Lost to Follow-up|5|||
23749614|NCT00337727|66463395|FG001|Overall Study|Lost to Follow-up|4|||
23749615|NCT00337727|66463394|FG000|Overall Study|Physician Decision|1|||
23749616|NCT00337727|66463395|FG001|Overall Study|Physician Decision|0|||
23749617|NCT00337727|66463394|FG000|Overall Study|Protocol Violation|4|||
23824163|NCT00805467|66737780|FG003|Overall Study|Adverse Event|57|||
23555690|NCT03318523|65762315|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555691|NCT03318523|65762316|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555692|NCT03318523|65762317|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555693|NCT03318523|65762318|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555694|NCT03318523|65762319|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555695|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555696|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555697|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555698|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555699|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
23555700|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555701|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555702|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
23555703|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555704|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
23555705|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555706|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555707|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555708|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23623315|NCT04811339|66008370|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
23623316|NCT04811339|66008371|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
23623317|NCT04811339|66008369|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
23623318|NCT04811339|66008370|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
23623319|NCT04811339|66008371|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
23623320|NCT02210208|66008372|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
23623321|NCT02210208|66008372|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
23623322|NCT02210208|66008372|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
23623323|NCT02514577|66008373|FG000|Overall Study|Lost to Follow-up|6|||
23623324|NCT02514577|66008374|FG001|Overall Study|Lost to Follow-up|6|||
23623325|NCT02514577|66008373|FG000|Overall Study|Protocol Violation|1|||
23623326|NCT02514577|66008374|FG001|Overall Study|Protocol Violation|0|||
23623327|NCT02514577|66008373|FG000|Overall Study|Withdrawal by Subject|6|||
23623328|NCT02514577|66008374|FG001|Overall Study|Withdrawal by Subject|6|||
23623329|NCT02514577|66008373|FG000|Overall Study|Adverse Event|1|||
23623330|NCT02514577|66008374|FG001|Overall Study|Adverse Event|1|||
23623331|NCT01836198|66008375|FG000|Part A, Period 2|Protocol Violation|0|||
23623332|NCT01836198|66008376|FG001|Part A, Period 2|Protocol Violation|1|||
23749618|NCT00337727|66463395|FG001|Overall Study|Protocol Violation|0|||
23824164|NCT00805467|66737777|FG000|Overall Study|Death|0|||
23824165|NCT00805467|66737778|FG001|Overall Study|Death|2|||
23824166|NCT00805467|66737779|FG002|Overall Study|Death|7|||
23824167|NCT00805467|66737780|FG003|Overall Study|Death|5|||
23824168|NCT00805467|66737777|FG000|Overall Study|Physician Decision|0|||
23824169|NCT00805467|66737778|FG001|Overall Study|Physician Decision|1|||
23824170|NCT00805467|66737779|FG002|Overall Study|Physician Decision|2|||
23824171|NCT00805467|66737780|FG003|Overall Study|Physician Decision|6|||
23555709|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
23555710|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555711|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555712|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
23555713|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
23555714|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
23623333|NCT01836198|66008377|FG002|Part A, Period 2|Protocol Violation|0|||
23749619|NCT00337727|66463394|FG000|Overall Study|Withdrawal by Subject|3|||
23749620|NCT00337727|66463395|FG001|Overall Study|Withdrawal by Subject|5|||
23749621|NCT01251861|66463397|FG000|Overall Study|Disease progression|6|||
23749622|NCT01251861|66463398|FG001|Overall Study|Disease progression|6|||
23749623|NCT01251861|66463397|FG000|Overall Study|Adverse Event|2|||
23749624|NCT01251861|66463398|FG001|Overall Study|Adverse Event|17|||
23749625|NCT01251861|66463397|FG000|Overall Study|Withdrawal by Subject|2|||
23749626|NCT01251861|66463398|FG001|Overall Study|Withdrawal by Subject|2|||
23749627|NCT01251861|66463397|FG000|Overall Study|Alternative therapy|1|||
23749628|NCT01251861|66463398|FG001|Overall Study|Alternative therapy|0|||
23749629|NCT01251861|66463397|FG000|Overall Study|Other complicating disease|0|||
23749630|NCT01251861|66463398|FG001|Overall Study|Other complicating disease|1|||
23824172|NCT00805467|66737777|FG000|Overall Study|Not reported|0|||
23749631|NCT01251861|66463397|FG000|Overall Study|Physician Decision|1|||
23749632|NCT01251861|66463398|FG001|Overall Study|Physician Decision|0|||
23824173|NCT00805467|66737778|FG001|Overall Study|Not reported|0|||
23824174|NCT00805467|66737779|FG002|Overall Study|Not reported|3|||
23824175|NCT00805467|66737780|FG003|Overall Study|Not reported|7|||
23749633|NCT01251861|66463397|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
23749634|NCT01251861|66463398|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
23749635|NCT01251861|66463397|FG000|Overall Study|Other|1|||
23555715|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23749636|NCT01251861|66463398|FG001|Overall Study|Other|0|||
23824176|NCT01514461|66737785|FG000|Overall Study|Adverse Event|2|||
23824177|NCT01514461|66737786|FG001|Overall Study|Adverse Event|1|||
23824178|NCT01514461|66737787|FG002|Overall Study|Adverse Event|3|||
23824179|NCT01514461|66737785|FG000|Overall Study|Physician Decision|1|||
23824180|NCT01514461|66737786|FG001|Overall Study|Physician Decision|1|||
23824181|NCT01514461|66737787|FG002|Overall Study|Physician Decision|0|||
23824182|NCT01514461|66737785|FG000|Overall Study|Patient/guardian decision|1|||
23824183|NCT01514461|66737786|FG001|Overall Study|Patient/guardian decision|1|||
23824184|NCT01514461|66737787|FG002|Overall Study|Patient/guardian decision|1|||
23824185|NCT01514461|66737785|FG000|Overall Study|Death|1|||
23824186|NCT01514461|66737786|FG001|Overall Study|Death|0|||
23824187|NCT01514461|66737787|FG002|Overall Study|Death|0|||
23824188|NCT01284361|66737790|FG000|Overall Study|Withdrawal by Subject|1|||
23824189|NCT01284361|66737790|FG000|Overall Study|Protocol Violation|5|||
23824190|NCT01284361|66737790|FG000|Overall Study|Adverse Event|1|||
23824191|NCT01284361|66737790|FG000|Overall Study|Lost to Follow-up|2|||
23824192|NCT02211417|66737794|FG000|Overall Study|Withdrawal by Subject|11|||
23824193|NCT02211417|66737795|FG001|Overall Study|Withdrawal by Subject|8|||
23824194|NCT02211417|66737794|FG000|Overall Study|Protocol Violation|1|||
23824195|NCT02211417|66737795|FG001|Overall Study|Protocol Violation|0|||
23824196|NCT02211417|66737794|FG000|Overall Study|Pregnancy|0|||
23824197|NCT02211417|66737795|FG001|Overall Study|Pregnancy|1|||
23824198|NCT02211417|66737794|FG000|Overall Study|Lost to Follow-up|2|||
23824199|NCT02211417|66737795|FG001|Overall Study|Lost to Follow-up|3|||
23824200|NCT02211417|66737794|FG000|Overall Study|Adverse Event|1|||
23824201|NCT02211417|66737795|FG001|Overall Study|Adverse Event|4|||
23824202|NCT01439802|66737796|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
23824203|NCT01439802|66737796|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
23749637|NCT01251861|66463397|FG000|Overall Study|Never started therapy|4|||
23749638|NCT01251861|66463398|FG001|Overall Study|Never started therapy|1|||
23749639|NCT01251861|66463397|FG000|Overall Study|Potential interaction of drugs|0|||
23749640|NCT01251861|66463398|FG001|Overall Study|Potential interaction of drugs|1|||
23749641|NCT02860039|66463399|FG000|Overall Study|Death|4|||
23749642|NCT02860039|66463400|FG001|Overall Study|Death|0|||
23749643|NCT02860039|66463399|FG000|Overall Study|Lost to Follow-up|2|||
23749644|NCT02860039|66463400|FG001|Overall Study|Lost to Follow-up|2|||
23749645|NCT02860039|66463399|FG000|Overall Study|Protocol Violation|3|||
23749646|NCT02860039|66463400|FG001|Overall Study|Protocol Violation|1|||
23749647|NCT02860039|66463399|FG000|Overall Study|Withdrawal by Subject|1|||
23749648|NCT02860039|66463400|FG001|Overall Study|Withdrawal by Subject|0|||
23749649|NCT02860039|66463399|FG000|Overall Study|Not otherwise eligible|1|||
23749650|NCT02860039|66463400|FG001|Overall Study|Not otherwise eligible|1|||
23749651|NCT02842086|66463401|FG000|Overall Study|Randomized but Never Treated|6|||
23749652|NCT02842086|66463402|FG001|Overall Study|Randomized but Never Treated|6|||
23749653|NCT02842086|66463401|FG000|Overall Study|Still in Double-Blind Phase|7|||
23749654|NCT02842086|66463402|FG001|Overall Study|Still in Double-Blind Phase|3|||
23749655|NCT02842086|66463401|FG000|Overall Study|Adverse Event|18|||
23749656|NCT02842086|66463402|FG001|Overall Study|Adverse Event|20|||
23749657|NCT02842086|66463401|FG000|Overall Study|Death|3|||
23749658|NCT02842086|66463402|FG001|Overall Study|Death|3|||
23749659|NCT02842086|66463401|FG000|Overall Study|Investigator's Discretion|9|||
23749660|NCT02842086|66463402|FG001|Overall Study|Investigator's Discretion|13|||
23749661|NCT02842086|66463401|FG000|Overall Study|Non-Compliance with Study Drug|9|||
23749662|NCT02842086|66463402|FG001|Overall Study|Non-Compliance with Study Drug|8|||
23749663|NCT02842086|66463401|FG000|Overall Study|Protocol Violation|8|||
23749664|NCT02842086|66463402|FG001|Overall Study|Protocol Violation|4|||
23824204|NCT03071276|66737799|FG000|Overall Study|Adverse Event|1|||
23824205|NCT03071276|66737799|FG000|Overall Study|Lack of Efficacy|14|||
23824206|NCT00185588|66737802|FG000|Overall Study|Adverse Event|3|||
23824207|NCT00185588|66737803|FG001|Overall Study|Adverse Event|1|||
23824208|NCT00185588|66737804|FG002|Overall Study|Adverse Event|4|||
23824209|NCT00185588|66737805|FG003|Overall Study|Adverse Event|2|||
23824210|NCT00185588|66737802|FG000|Overall Study|Lost to Follow-up|0|||
23824211|NCT00185588|66737803|FG001|Overall Study|Lost to Follow-up|0|||
23555716|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555717|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555718|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23824212|NCT00185588|66737804|FG002|Overall Study|Lost to Follow-up|1|||
23824213|NCT00185588|66737805|FG003|Overall Study|Lost to Follow-up|2|||
23824214|NCT00185588|66737802|FG000|Overall Study|Withdrawal by Subject|0|||
23824215|NCT00185588|66737803|FG001|Overall Study|Withdrawal by Subject|1|||
23824216|NCT00185588|66737804|FG002|Overall Study|Withdrawal by Subject|0|||
23824217|NCT00185588|66737805|FG003|Overall Study|Withdrawal by Subject|0|||
23824218|NCT00185588|66737802|FG000|Overall Study|Physician Decision|0|||
23824219|NCT00185588|66737803|FG001|Overall Study|Physician Decision|0|||
23824220|NCT00185588|66737804|FG002|Overall Study|Physician Decision|1|||
23824221|NCT00185588|66737805|FG003|Overall Study|Physician Decision|0|||
23749665|NCT02842086|66463401|FG000|Overall Study|Withdrew Consent|205|||
23749666|NCT02842086|66463402|FG001|Overall Study|Withdrew Consent|194|||
23555719|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555720|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
23555721|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555722|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555723|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555724|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555725|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23749667|NCT02842086|66463401|FG000|Overall Study|Lost to Follow-up|274|||
23824222|NCT00451204|66737812|FG000|Overall Study|Adverse Event|4|||
23824223|NCT00451204|66737813|FG001|Overall Study|Adverse Event|6|||
23749668|NCT02842086|66463402|FG001|Overall Study|Lost to Follow-up|236|||
23433389|NCT03908476|65330444|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
23623334|NCT01580995|66008378|FG000|Overall Study|Lost to Follow-up|2|||
23623335|NCT01580995|66008379|FG001|Overall Study|Lost to Follow-up|2|||
23623336|NCT00217022|66008380|FG000|Overall Study|Withdrawal by Subject|1|||
23749669|NCT02842086|66463401|FG000|Overall Study|HIV-1 Infection|5|||
23749670|NCT02842086|66463402|FG001|Overall Study|HIV-1 Infection|6|||
23749671|NCT03375320|66463403|FG000|Overall Study|Adverse Event|34|||
23749672|NCT03375320|66463404|FG001|Overall Study|Adverse Event|9|||
23749673|NCT03375320|66463405|FG002|Overall Study|Adverse Event|10|||
23749674|NCT03375320|66463406|FG003|Overall Study|Adverse Event|0|||
23749675|NCT03375320|66463403|FG000|Overall Study|Death|6|||
23749676|NCT03375320|66463404|FG001|Overall Study|Death|3|||
23749677|NCT03375320|66463405|FG002|Overall Study|Death|0|||
23749678|NCT03375320|66463406|FG003|Overall Study|Death|0|||
23824224|NCT00451204|66737812|FG000|Overall Study|Lack of Efficacy|4|||
23824225|NCT00451204|66737813|FG001|Overall Study|Lack of Efficacy|4|||
23824226|NCT00451204|66737812|FG000|Overall Study|Lost to Follow-up|4|||
23824227|NCT00451204|66737813|FG001|Overall Study|Lost to Follow-up|4|||
23824228|NCT00451204|66737812|FG000|Overall Study|Protocol Violation|1|||
23824229|NCT00451204|66737813|FG001|Overall Study|Protocol Violation|0|||
23824230|NCT00451204|66737812|FG000|Overall Study|Patient refusal|8|||
23749679|NCT03375320|66463403|FG000|Overall Study|Withdrawal by Subject|7|||
23749680|NCT03375320|66463404|FG001|Overall Study|Withdrawal by Subject|4|||
23555726|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555727|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555728|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555729|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555730|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555731|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555732|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555733|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555734|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
23555735|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555736|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555737|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555738|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555739|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
23555740|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
23555741|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
23555742|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
23555743|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
23555744|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
23555745|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555746|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555747|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555748|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555749|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
23555750|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555751|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555752|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
23555753|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
23555754|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555755|NCT00734630|65762320|FG000|Overall Study|Lack of Efficacy|4|||
23555756|NCT00734630|65762321|FG001|Overall Study|Lack of Efficacy|4|||
23555757|NCT00734630|65762320|FG000|Overall Study|Withdrawal by Subject|7|||
23555758|NCT00734630|65762321|FG001|Overall Study|Withdrawal by Subject|9|||
23749681|NCT03375320|66463405|FG002|Overall Study|Withdrawal by Subject|5|||
23749682|NCT03375320|66463406|FG003|Overall Study|Withdrawal by Subject|4|||
23749683|NCT03375320|66463403|FG000|Overall Study|Progressive disease|55|||
23749684|NCT03375320|66463404|FG001|Overall Study|Progressive disease|41|||
23749685|NCT03375320|66463405|FG002|Overall Study|Progressive disease|29|||
23555759|NCT00734630|65762320|FG000|Overall Study|Lost to Follow-up|13|||
23555760|NCT00734630|65762321|FG001|Overall Study|Lost to Follow-up|7|||
23555761|NCT00734630|65762320|FG000|Overall Study|Protocol Violation|0|||
23555762|NCT00734630|65762321|FG001|Overall Study|Protocol Violation|3|||
23555763|NCT00734630|65762320|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23555764|NCT00734630|65762321|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23555765|NCT00734630|65762320|FG000|Overall Study|Adverse Event|3|||
23555766|NCT00734630|65762321|FG001|Overall Study|Adverse Event|6|||
23555767|NCT00734630|65762320|FG000|Overall Study|Randomized in Error|0|||
23555768|NCT00734630|65762321|FG001|Overall Study|Randomized in Error|1|||
23555769|NCT00734630|65762320|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
23555770|NCT00734630|65762321|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
23555771|NCT00734630|65762320|FG000|Overall Study|Poor Compliance|1|||
23555772|NCT00734630|65762321|FG001|Overall Study|Poor Compliance|1|||
23555773|NCT01338025|65762322|FG000|Overall Study|Unexpected closure of study|10|||
23555774|NCT01338025|65762323|FG001|Overall Study|Unexpected closure of study|9|||
23555775|NCT01338025|65762322|FG000|Overall Study|Withdrawal by Subject|0|||
23555776|NCT01338025|65762323|FG001|Overall Study|Withdrawal by Subject|2|||
23555777|NCT01338025|65762322|FG000|Overall Study|Found ineligible after starting|1|||
23555778|NCT01338025|65762323|FG001|Overall Study|Found ineligible after starting|0|||
23555779|NCT01313286|65762328|FG000|Period 1|Withdrawal by Subject|2|||
23555780|NCT01313286|65762329|FG001|Period 1|Withdrawal by Subject|0|||
23555781|NCT00952822|65762330|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555782|NCT00952822|65762331|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
23555783|NCT00952822|65762332|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555784|NCT00952822|65762333|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555785|NCT00952822|65762330|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555786|NCT00952822|65762331|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555787|NCT00952822|65762332|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
23555788|NCT00952822|65762333|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555789|NCT04495179|65762336|FG000|Overall Study|Lost to Follow-up|0|||
23555790|NCT04495179|65762337|FG001|Overall Study|Lost to Follow-up|1|||
23555791|NCT04495179|65762336|FG000|Overall Study|Withdrawal by Subject|2|||
23555792|NCT04495179|65762337|FG001|Overall Study|Withdrawal by Subject|4|||
23555793|NCT04495179|65762336|FG000|Overall Study|Study terminated by sponsor|0|||
23555794|NCT04495179|65762337|FG001|Overall Study|Study terminated by sponsor|18|||
23555795|NCT04495179|65762336|FG000|Overall Study|Death|0|||
23555796|NCT04495179|65762337|FG001|Overall Study|Death|4|||
23555797|NCT04495179|65762336|FG000|Overall Study|Adverse Event|0|||
23555798|NCT04495179|65762337|FG001|Overall Study|Adverse Event|1|||
23555799|NCT02192502|65762338|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
23555800|NCT02192502|65762339|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
23555801|NCT02192502|65762338|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
23555802|NCT02192502|65762339|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
23555803|NCT02192502|65762338|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
23555804|NCT02192502|65762339|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
23555805|NCT01944631|65762340|FG000|Overall Study|Adverse Event|1|||
23555806|NCT01944631|65762341|FG001|Overall Study|Adverse Event|0|||
23555807|NCT01944631|65762340|FG000|Overall Study|Lost to Follow-up|3|||
23555808|NCT01944631|65762341|FG001|Overall Study|Lost to Follow-up|1|||
23555809|NCT01944631|65762340|FG000|Overall Study|Withdrawal by Subject|0|||
23555810|NCT01944631|65762341|FG001|Overall Study|Withdrawal by Subject|1|||
23555811|NCT01685138|65762345|FG000|Overall Study|Lost to Follow-up|1|||
23555812|NCT01685138|65762345|FG000|Overall Study|Protocol Violation|1|||
23555813|NCT01685138|65762345|FG000|Overall Study|No longer requires treatment|1|||
23555814|NCT01685138|65762345|FG000|Overall Study|Subject/guardian decision|2|||
23555815|NCT01685138|65762345|FG000|Overall Study|Physician Decision|6|||
23555816|NCT01685138|65762345|FG000|Overall Study|Death|10|||
23555817|NCT01685138|65762345|FG000|Overall Study|Adverse Event|18|||
23433390|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23555818|NCT01685138|65762345|FG000|Overall Study|Progressive disease|53|||
23555819|NCT00999466|65762346|FG000|Main Part|Withdrawal by Subject|0|||
23555820|NCT00999466|65762347|FG001|Main Part|Withdrawal by Subject|0|||
23555821|NCT00999466|65762348|FG002|Main Part|Withdrawal by Subject|2|||
23555822|NCT00999466|65762346|FG000|Main Part|Adverse Event|0|||
23555823|NCT00999466|65762347|FG001|Main Part|Adverse Event|4|||
23555824|NCT00999466|65762348|FG002|Main Part|Adverse Event|2|||
23555825|NCT03432364|65762349|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
23433391|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23555826|NCT01040260|65762350|FG000|Overall Study|Withdrawal by Subject|12|||
23555827|NCT01040260|65762351|FG001|Overall Study|Withdrawal by Subject|6|||
23555828|NCT01040260|65762350|FG000|Overall Study|Lost to Follow-up|3|||
23555829|NCT01040260|65762351|FG001|Overall Study|Lost to Follow-up|5|||
23555830|NCT02384759|65762356|FG000|Overall Study|Patients not treated|3|||
23555831|NCT02384759|65762357|FG001|Overall Study|Patients not treated|2|||
23555832|NCT02633137|65762361|FG000|Overall Study|Adverse Event|1|||
23555833|NCT02633137|65762361|FG000|Overall Study|Lack of Efficacy|2|||
23555834|NCT02633137|65762361|FG000|Overall Study|Withdrawal by Subject|1|||
23555835|NCT01050816|65762362|FG000|Overall Study|Lost to Follow-up|2|||
23555836|NCT01050816|65762362|FG000|Overall Study|patient's refusal|2|||
23555837|NCT00045305|65762366|FG000|Overall Study|Lack of Efficacy|6|||
23555838|NCT00045305|65762366|FG000|Overall Study|Adverse Event|3|||
23555839|NCT00045305|65762366|FG000|Overall Study|Death|3|||
23555840|NCT00045305|65762366|FG000|Overall Study|site error|2|||
23555841|NCT00746590|65762367|FG000|Overall Study|Death|1|||
23555842|NCT00569582|65762368|FG000|Overall Study|Withdrawal by Subject|5|||
23555843|NCT00569582|65762368|FG000|Overall Study|Death|2|||
23555844|NCT00569582|65762368|FG000|Overall Study|Adverse Event|7|||
23555845|NCT00569582|65762368|FG000|Overall Study|Subject was too ill to travel.|1|||
23749686|NCT03375320|66463406|FG003|Overall Study|Progressive disease|24|||
23749687|NCT03375320|66463403|FG000|Overall Study|Alternative treatment|6|||
23749688|NCT03375320|66463404|FG001|Overall Study|Alternative treatment|1|||
23749689|NCT03375320|66463405|FG002|Overall Study|Alternative treatment|1|||
23749690|NCT03375320|66463406|FG003|Overall Study|Alternative treatment|0|||
23749691|NCT03375320|66463403|FG000|Overall Study|Other disease|1|||
23749692|NCT03375320|66463404|FG001|Overall Study|Other disease|1|||
23749693|NCT03375320|66463405|FG002|Overall Study|Other disease|3|||
23749694|NCT03375320|66463406|FG003|Overall Study|Other disease|0|||
23433392|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433393|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
23433394|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433395|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
23433396|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433397|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433398|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433399|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433400|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433401|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433402|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433403|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433404|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23555846|NCT00569582|65762368|FG000|Overall Study|Subject was non-compliant.|1|||
23555847|NCT01756352|65762369|FG000|Overall Study|moved away and lost to followup|1|||
23555848|NCT01615328|65762370|FG000|Overall Study|Lost to Follow-up|3|||
23555849|NCT01615328|65762371|FG001|Overall Study|Lost to Follow-up|5|||
23555850|NCT00708916|65762372|FG000|Overall Study|Subject Noncompliance|2|||
23555851|NCT00708916|65762372|FG000|Overall Study|Adverse Event|2|||
23555852|NCT04279314|65762381|FG000|Overall Study|Adverse Event|55|||
23749695|NCT03375320|66463403|FG000|Overall Study|Withdrawal prior to initiation|2|||
23749696|NCT03375320|66463404|FG001|Overall Study|Withdrawal prior to initiation|2|||
23749697|NCT03375320|66463405|FG002|Overall Study|Withdrawal prior to initiation|1|||
23555853|NCT04279314|65762381|FG000|Overall Study|Withdrawal by Subject|5|||
23749698|NCT03375320|66463406|FG003|Overall Study|Withdrawal prior to initiation|0|||
23749699|NCT03375320|66463403|FG000|Overall Study|Physician Decision|1|||
23824231|NCT00451204|66737813|FG001|Overall Study|Patient refusal|4|||
23824232|NCT00451204|66737812|FG000|Overall Study|Other|1|||
23824233|NCT00451204|66737813|FG001|Overall Study|Other|2|||
23824234|NCT00616421|66737814|FG000|Overall Study|Withdrawal by Subject|9|||
23824235|NCT00616421|66737815|FG001|Overall Study|Withdrawal by Subject|11|||
23824236|NCT00616421|66737816|FG002|Overall Study|Withdrawal by Subject|8|||
23824237|NCT00616421|66737814|FG000|Overall Study|Lost to Follow-up|12|||
23824238|NCT00616421|66737815|FG001|Overall Study|Lost to Follow-up|26|||
23824239|NCT00616421|66737816|FG002|Overall Study|Lost to Follow-up|30|||
23824240|NCT00616421|66737814|FG000|Overall Study|Inappropriate enrollment|3|||
23824241|NCT00616421|66737815|FG001|Overall Study|Inappropriate enrollment|0|||
23824242|NCT00616421|66737816|FG002|Overall Study|Inappropriate enrollment|1|||
23824243|NCT00616421|66737814|FG000|Overall Study|Administrative reason|1|||
23824244|NCT00616421|66737815|FG001|Overall Study|Administrative reason|0|||
23433405|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
23555854|NCT04279314|65762381|FG000|Overall Study|Lack of Efficacy|5|||
23433406|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
23433407|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433408|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
23433409|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433410|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433411|NCT01966445|65330445|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433412|NCT01966445|65330446|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433413|NCT01966445|65330447|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433414|NCT01966445|65330448|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433415|NCT01966445|65330449|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433416|NCT01966445|65330450|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433417|NCT01966445|65330451|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
23433418|NCT01966445|65330445|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433419|NCT01966445|65330446|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433420|NCT01966445|65330447|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433421|NCT01966445|65330448|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433422|NCT01966445|65330449|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433423|NCT01966445|65330450|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433424|NCT01966445|65330451|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
23433425|NCT02273960|65330452|FG000|Short Term Period|Lost to Follow-up|1|||
23433426|NCT02273960|65330453|FG001|Short Term Period|Lost to Follow-up|0|||
23433427|NCT02273960|65330454|FG002|Short Term Period|Lost to Follow-up|0|||
23433428|NCT02273960|65330455|FG003|Short Term Period|Lost to Follow-up|0|||
23433429|NCT02273960|65330452|FG000|Short Term Period|Lack of Efficacy|0|||
23433430|NCT02273960|65330453|FG001|Short Term Period|Lack of Efficacy|0|||
23433431|NCT02273960|65330454|FG002|Short Term Period|Lack of Efficacy|0|||
23433432|NCT02273960|65330455|FG003|Short Term Period|Lack of Efficacy|1|||
23433433|NCT02273960|65330452|FG000|Short Term Period|ST complete, not entering LTE|4|||
23433434|NCT02273960|65330453|FG001|Short Term Period|ST complete, not entering LTE|6|||
23433435|NCT02273960|65330454|FG002|Short Term Period|ST complete, not entering LTE|4|||
23433436|NCT02273960|65330455|FG003|Short Term Period|ST complete, not entering LTE|5|||
23433437|NCT02273960|65330452|FG000|Long Term Extension|Death|0|||
23433438|NCT02273960|65330453|FG001|Long Term Extension|Death|0|||
23433439|NCT02273960|65330454|FG002|Long Term Extension|Death|0|||
23433440|NCT02273960|65330455|FG003|Long Term Extension|Death|1|||
23433441|NCT02032407|65330457|FG000|Overall Study|Lost to Follow-up|2|||
23433442|NCT02032407|65330457|FG000|Overall Study|Pregnancy|1|||
23433443|NCT02032407|65330457|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23433444|NCT00619099|65330458|FG000|Overall Study|Progressive Disease|7|||
23433445|NCT00619099|65330459|FG001|Overall Study|Progressive Disease|5|||
23433446|NCT00619099|65330458|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
23433447|NCT00619099|65330459|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
23433448|NCT00619099|65330458|FG000|Overall Study|Adverse Event|4|||
23433449|NCT00619099|65330459|FG001|Overall Study|Adverse Event|3|||
23433450|NCT00619099|65330458|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
23433451|NCT00619099|65330459|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
23433452|NCT00619099|65330458|FG000|Overall Study|Withdrawal by Subject|10|||
23433453|NCT00619099|65330459|FG001|Overall Study|Withdrawal by Subject|2|||
23433454|NCT00619099|65330458|FG000|Overall Study|Physician Decision|9|||
23433455|NCT00619099|65330459|FG001|Overall Study|Physician Decision|6|||
23433456|NCT00500760|65330460|FG000|Overall Study|Death|32|||
23433457|NCT00500760|65330461|FG001|Overall Study|Death|15|||
23433458|NCT00500760|65330460|FG000|Overall Study|Withdrawal by Subject|5|||
23433459|NCT00500760|65330461|FG001|Overall Study|Withdrawal by Subject|7|||
23433460|NCT00500760|65330460|FG000|Overall Study|Administrative decision|2|||
23433461|NCT00500760|65330461|FG001|Overall Study|Administrative decision|0|||
23433462|NCT00500760|65330460|FG000|Overall Study|Lost to Follow-up|3|||
23433463|NCT00500760|65330461|FG001|Overall Study|Lost to Follow-up|0|||
23433464|NCT00500760|65330460|FG000|Overall Study|Other|1|||
23433465|NCT00500760|65330461|FG001|Overall Study|Other|2|||
23433466|NCT01309269|65330464|FG000|Overall Study|Adverse Event|56|||
23749700|NCT03375320|66463404|FG001|Overall Study|Physician Decision|1|||
23749701|NCT03375320|66463405|FG002|Overall Study|Physician Decision|1|||
23749702|NCT03375320|66463406|FG003|Overall Study|Physician Decision|1|||
23749703|NCT03375320|66463403|FG000|Overall Study|Non-compliance|1|||
23749704|NCT03375320|66463404|FG001|Overall Study|Non-compliance|0|||
23749705|NCT03375320|66463405|FG002|Overall Study|Non-compliance|0|||
23749706|NCT03375320|66463406|FG003|Overall Study|Non-compliance|0|||
23433467|NCT01309269|65330464|FG000|Overall Study|Withdrawal by Subject|25|||
23433468|NCT01309269|65330464|FG000|Overall Study|Lack of Acceptance|15|||
23555855|NCT04279314|65762381|FG000|Overall Study|Protocol Violation|3|||
23749707|NCT04964960|66463407|FG000|Overall Study|Withdrawal by Subject|1|||
23749708|NCT01946204|66463408|FG000|Overall Study|Death|38|||
23433469|NCT01309269|65330464|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
23433470|NCT01309269|65330464|FG000|Overall Study|Kidney Transplant|25|||
23433471|NCT01309269|65330464|FG000|Overall Study|Administrative Problems|141|||
23433472|NCT01309269|65330464|FG000|Overall Study|Other|256|||
23433473|NCT01309269|65330464|FG000|Overall Study|Other|1|||
23433474|NCT01309269|65330464|FG000|Overall Study|Study Completion Data Not Recorded|95|||
23433475|NCT01309269|65330464|FG000|Overall Study|Enrolled but not Treated|107|||
23433476|NCT04268173|65330471|FG000|Overall Study|Lost to Follow-up|75|||
23433477|NCT04268173|65330472|FG001|Overall Study|Lost to Follow-up|108|||
23433478|NCT01306656|65330473|FG000|Overall Study|Lost to Follow-up|1|||
23433479|NCT01306656|65330474|FG001|Overall Study|Lost to Follow-up|0|||
23433480|NCT02690649|65330475|FG000|Overall Study|Withdrawal by Subject|1|||
23433481|NCT02690649|65330476|FG001|Overall Study|Withdrawal by Subject|1|||
23433482|NCT02690649|65330475|FG000|Overall Study|Protocol Violation|0|||
23433483|NCT02690649|65330476|FG001|Overall Study|Protocol Violation|3|||
23433484|NCT01012323|65330477|FG000|Overall Study|Investigator Judgment|1|||
23433485|NCT03320330|65330478|FG000|Overall Study|Lack of Efficacy|5|||
23433486|NCT03320330|65330479|FG001|Overall Study|Lack of Efficacy|5|||
23433487|NCT03320330|65330480|FG002|Overall Study|Lack of Efficacy|14|||
23433488|NCT03320330|65330478|FG000|Overall Study|Physician Decision|1|||
23433489|NCT03320330|65330479|FG001|Overall Study|Physician Decision|0|||
23433490|NCT03320330|65330480|FG002|Overall Study|Physician Decision|0|||
23433491|NCT02891382|65330481|FG000|Overall Study|Lost to Follow-up|3|||
23433492|NCT02891382|65330482|FG001|Overall Study|Lost to Follow-up|4|||
23433493|NCT02891382|65330483|FG002|Overall Study|Lost to Follow-up|5|||
23433494|NCT02891382|65330484|FG003|Overall Study|Lost to Follow-up|3|||
23433495|NCT02891382|65330485|FG004|Overall Study|Lost to Follow-up|4|||
23433496|NCT03203291|65330486|FG000|Overall Study|Withdrawal by Subject|1|||
23433497|NCT02658656|65330489|FG000|Screening|Failed eligibility criteria|0|||
23433498|NCT02658656|65330490|FG001|Screening|Failed eligibility criteria|0|||
23433499|NCT02658656|65330491|FG002|Screening|Failed eligibility criteria|263|||
23433500|NCT02658656|65330489|FG000|Randomization|Withdrawal by Subject|8|||
23433501|NCT02658656|65330490|FG001|Randomization|Withdrawal by Subject|7|||
23433502|NCT02658656|65330491|FG002|Randomization|Withdrawal by Subject|0|||
23433503|NCT02658656|65330489|FG000|Randomization|Lost to Follow-up|1|||
23433504|NCT02658656|65330490|FG001|Randomization|Lost to Follow-up|3|||
23433505|NCT02658656|65330491|FG002|Randomization|Lost to Follow-up|0|||
23433506|NCT02658656|65330489|FG000|Randomization|Adverse Event|4|||
23433507|NCT02658656|65330490|FG001|Randomization|Adverse Event|0|||
23433508|NCT02658656|65330491|FG002|Randomization|Adverse Event|0|||
23433509|NCT02658656|65330489|FG000|Randomization|Administrative Termination|3|||
23433510|NCT02658656|65330490|FG001|Randomization|Administrative Termination|1|||
23433511|NCT02658656|65330491|FG002|Randomization|Administrative Termination|0|||
23433512|NCT02658656|65330489|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
23433513|NCT02658656|65330490|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
23433514|NCT02658656|65330491|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
23433515|NCT02658656|65330489|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
23433516|NCT02658656|65330490|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
23433517|NCT02658656|65330491|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
23623337|NCT00217022|66008381|FG001|Overall Study|Withdrawal by Subject|1|||
23433518|NCT02658656|65330489|FG000|Randomization|Not eligible for Randomization|1|||
23433519|NCT02658656|65330490|FG001|Randomization|Not eligible for Randomization|0|||
23433520|NCT02658656|65330491|FG002|Randomization|Not eligible for Randomization|0|||
23433521|NCT02658656|65330489|FG000|Randomization|Protocol Violation|1|||
23433522|NCT02658656|65330490|FG001|Randomization|Protocol Violation|0|||
23433523|NCT02658656|65330491|FG002|Randomization|Protocol Violation|0|||
23433524|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
23433525|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
23433526|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
23433527|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
23433528|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
23433529|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
23623338|NCT01013740|66008385|FG000|Overall Study|Lost to Follow-up|3|||
23433530|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
23433531|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
23433532|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Death|0|||
23433533|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Death|1|||
23433534|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
23433535|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
23433536|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Other|0|||
23433537|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Other|2|||
23433538|NCT03281304|65330496|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
23433539|NCT03281304|65330497|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
23433540|NCT03773107|65330499|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
23433541|NCT03773107|65330500|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
23433542|NCT03773107|65330501|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
23433543|NCT03773107|65330502|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
23433544|NCT00590577|65330503|FG000|Overall Study|Lack of Efficacy|31|||
23433545|NCT00590577|65330504|FG001|Overall Study|Lack of Efficacy|28|||
23433546|NCT00590577|65330505|FG002|Overall Study|Lack of Efficacy|23|||
23433547|NCT00590577|65330506|FG003|Overall Study|Lack of Efficacy|45|||
23433548|NCT00590577|65330503|FG000|Overall Study|Withdrawal by Subject|23|||
23433549|NCT00590577|65330504|FG001|Overall Study|Withdrawal by Subject|28|||
23433550|NCT00590577|65330505|FG002|Overall Study|Withdrawal by Subject|30|||
23433551|NCT00590577|65330506|FG003|Overall Study|Withdrawal by Subject|26|||
23433552|NCT00590577|65330503|FG000|Overall Study|Adverse Event|10|||
23433553|NCT00590577|65330504|FG001|Overall Study|Adverse Event|10|||
23433554|NCT00590577|65330505|FG002|Overall Study|Adverse Event|13|||
23433555|NCT00590577|65330506|FG003|Overall Study|Adverse Event|11|||
23433556|NCT00590577|65330503|FG000|Overall Study|Lost to Follow-up|12|||
23433557|NCT00590577|65330504|FG001|Overall Study|Lost to Follow-up|6|||
23433558|NCT00590577|65330505|FG002|Overall Study|Lost to Follow-up|6|||
23433559|NCT00590577|65330506|FG003|Overall Study|Lost to Follow-up|9|||
23433560|NCT00590577|65330503|FG000|Overall Study|Pregnancy|0|||
23433561|NCT00590577|65330504|FG001|Overall Study|Pregnancy|1|||
23433562|NCT00590577|65330505|FG002|Overall Study|Pregnancy|0|||
23433563|NCT00590577|65330506|FG003|Overall Study|Pregnancy|0|||
23433564|NCT00590577|65330503|FG000|Overall Study|Various reasons|1|||
23433565|NCT00590577|65330504|FG001|Overall Study|Various reasons|3|||
23433566|NCT00590577|65330505|FG002|Overall Study|Various reasons|1|||
23433567|NCT00590577|65330506|FG003|Overall Study|Various reasons|2|||
23433568|NCT01406015|65330510|FG000|Overall Study|Withdrawal by Subject|3|||
23433569|NCT01406015|65330511|FG001|Overall Study|Withdrawal by Subject|3|||
23433570|NCT04030247|65330514|FG000|Overall Study|Withdrawal by Subject|4|||
23433571|NCT04030247|65330514|FG000|Overall Study|Lost to Follow-up|13|||
23433572|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
23433573|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
23433574|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
23433575|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
23433576|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
23433577|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
23433578|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
23433579|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
23433580|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
23433581|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
23433582|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
23433583|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
23433584|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
23433585|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
23433586|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Death|0|||
23433587|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Death|2|||
23433588|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
23749709|NCT01946204|66463409|FG001|Overall Study|Death|59|||
23749710|NCT01946204|66463408|FG000|Overall Study|Withdrawal by Subject|37|||
23433589|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
23433590|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
23433591|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
23433592|NCT02102399|65330518|FG000|Overall Study|Withdrawal by Subject|6|||
23433593|NCT02102399|65330519|FG001|Overall Study|Withdrawal by Subject|4|||
23433594|NCT01641822|65330522|FG000|Run-in Phase|Noncompliance with study drug|1|||
23433595|NCT01641822|65330523|FG001|Run-in Phase|Noncompliance with study drug|0|||
23433596|NCT01641822|65330524|FG002|Run-in Phase|Noncompliance with study drug|0|||
23433597|NCT01641822|65330522|FG000|Run-in Phase|Adverse Event|3|||
23433598|NCT01641822|65330523|FG001|Run-in Phase|Adverse Event|0|||
23749711|NCT01946204|66463409|FG001|Overall Study|Withdrawal by Subject|50|||
23749712|NCT01946204|66463408|FG000|Overall Study|Lost to Follow-up|3|||
23749713|NCT01946204|66463409|FG001|Overall Study|Lost to Follow-up|7|||
23749714|NCT01946204|66463408|FG000|Overall Study|Ongoing|316|||
23749715|NCT01946204|66463409|FG001|Overall Study|Ongoing|687|||
23749716|NCT01946204|66463408|FG000|Overall Study|Other|7|||
23749717|NCT01946204|66463409|FG001|Overall Study|Other|3|||
23749718|NCT00944125|66463410|FG000|3 to 6 Months|Withdrawal by Subject|0|||
23749719|NCT00944125|66463411|FG001|3 to 6 Months|Withdrawal by Subject|2|||
23749720|NCT00944125|66463410|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
23749721|NCT00944125|66463411|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
23749722|NCT04505592|66463412|FG000|Overall Study|Death|2|||
23433599|NCT01641822|65330524|FG002|Run-in Phase|Adverse Event|0|||
23433600|NCT01641822|65330522|FG000|Run-in Phase|Withdrew consent|1|||
23824245|NCT00616421|66737816|FG002|Overall Study|Administrative reason|0|||
23824246|NCT00616421|66737814|FG000|Overall Study|Protocol Violation|0|||
23824247|NCT00616421|66737815|FG001|Overall Study|Protocol Violation|1|||
23824248|NCT00616421|66737816|FG002|Overall Study|Protocol Violation|2|||
23824249|NCT00616421|66737814|FG000|Overall Study|Unable to classify|1|||
23824250|NCT00616421|66737815|FG001|Overall Study|Unable to classify|0|||
23433601|NCT01641822|65330523|FG001|Run-in Phase|Withdrew consent|0|||
23433602|NCT01641822|65330524|FG002|Run-in Phase|Withdrew consent|0|||
23433603|NCT01641822|65330522|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
23433604|NCT01641822|65330523|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
23433605|NCT01641822|65330524|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
23433606|NCT01641822|65330522|FG000|Comparative Phase|Noncompliance with study drug|0|||
23433607|NCT01641822|65330523|FG001|Comparative Phase|Noncompliance with study drug|1|||
23433608|NCT01641822|65330524|FG002|Comparative Phase|Noncompliance with study drug|0|||
23433609|NCT01641822|65330522|FG000|Comparative Phase|Investigator's discretion|0|||
23433610|NCT01641822|65330523|FG001|Comparative Phase|Investigator's discretion|0|||
23433611|NCT01641822|65330524|FG002|Comparative Phase|Investigator's discretion|1|||
23433612|NCT01641822|65330522|FG000|Comparative Phase|Pregnancy|0|||
23433613|NCT01641822|65330523|FG001|Comparative Phase|Pregnancy|0|||
23433614|NCT01641822|65330524|FG002|Comparative Phase|Pregnancy|1|||
23433615|NCT01641822|65330522|FG000|Comparative Phase|Adverse event, serious fatal|0|||
23433616|NCT01641822|65330523|FG001|Comparative Phase|Adverse event, serious fatal|1|||
23433617|NCT01641822|65330524|FG002|Comparative Phase|Adverse event, serious fatal|0|||
23433618|NCT01641822|65330522|FG000|Comparative Phase|Withdrew consent|0|||
23433619|NCT01641822|65330523|FG001|Comparative Phase|Withdrew consent|3|||
23433620|NCT01641822|65330524|FG002|Comparative Phase|Withdrew consent|7|||
23433621|NCT01641822|65330522|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
23433622|NCT01641822|65330523|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
23433623|NCT01641822|65330524|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
23433624|NCT02271945|65330525|FG000|Overall Study|Death|3|||
23433625|NCT02271945|65330526|FG001|Overall Study|Death|3|||
23433626|NCT02271945|65330525|FG000|Overall Study|Withdrawal by Subject|1|||
23433627|NCT02271945|65330526|FG001|Overall Study|Withdrawal by Subject|1|||
23749723|NCT04505592|66463413|FG001|Overall Study|Death|1|||
23749724|NCT05168657|66463414|FG000|Overall Study|Adverse Event|0|||
23749725|NCT05168657|66463415|FG001|Overall Study|Adverse Event|0|||
23749726|NCT05168657|66463416|FG002|Overall Study|Adverse Event|1|||
23749727|NCT05168657|66463417|FG003|Overall Study|Adverse Event|0|||
23824251|NCT00616421|66737816|FG002|Overall Study|Unable to classify|0|||
23824252|NCT02766335|66737817|FG000|Initial Registration|Adverse Event|6|||
23824253|NCT02766335|66737818|FG001|Initial Registration|Adverse Event|3|||
23824254|NCT02766335|66737819|FG002|Initial Registration|Adverse Event|0|||
23824255|NCT02766335|66737817|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
23824256|NCT02766335|66737818|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
23824257|NCT02766335|66737819|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
23824258|NCT02766335|66737817|FG000|Initial Registration|Progression/relapse|49|||
23824259|NCT02766335|66737818|FG001|Initial Registration|Progression/relapse|15|||
23824260|NCT02766335|66737819|FG002|Initial Registration|Progression/relapse|0|||
23433628|NCT02271945|65330525|FG000|Overall Study|Other|1|||
23433629|NCT02271945|65330526|FG001|Overall Study|Other|1|||
23433630|NCT00710385|65330529|FG000|Overall Study|Did not qualify|1|||
23433631|NCT00710385|65330529|FG000|Overall Study|Withdrawal by Subject|1|||
23749728|NCT05168657|66463418|FG004|Overall Study|Adverse Event|0|||
23749729|NCT05168657|66463419|FG005|Overall Study|Adverse Event|0|||
23749730|NCT05168657|66463420|FG006|Overall Study|Adverse Event|0|||
23824261|NCT02766335|66737817|FG000|Initial Registration|Death|1|||
23824262|NCT02766335|66737818|FG001|Initial Registration|Death|3|||
23824263|NCT02766335|66737819|FG002|Initial Registration|Death|0|||
23824264|NCT02766335|66737817|FG000|Initial Registration|not protocol specified|1|||
23824265|NCT02766335|66737818|FG001|Initial Registration|not protocol specified|9|||
23824266|NCT02766335|66737819|FG002|Initial Registration|not protocol specified|0|||
23749731|NCT05168657|66463421|FG007|Overall Study|Adverse Event|0|||
23749732|NCT03941860|66463422|FG000|Overall Study|Withdrawal by Subject|0|||
23749733|NCT03941860|66463423|FG001|Overall Study|Withdrawal by Subject|1|||
23824267|NCT02766335|66737817|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
23824268|NCT02766335|66737818|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
23824269|NCT02766335|66737819|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
23555856|NCT04279314|65762381|FG000|Overall Study|Other (not COVID-19 related)|2|||
23555857|NCT01368900|65762382|FG000|Overall Study|Lost to Follow-up|7|||
23555858|NCT00335452|65762383|FG000|Overall Study|Death|156|||
23555859|NCT00335452|65762384|FG001|Overall Study|Death|144|||
23555860|NCT00335452|65762385|FG002|Overall Study|Death|158|||
23555861|NCT00335452|65762386|FG003|Overall Study|Death|129|||
23555862|NCT00335452|65762383|FG000|Overall Study|Lost to Follow-up|2|||
23555863|NCT00335452|65762384|FG001|Overall Study|Lost to Follow-up|3|||
23555864|NCT00335452|65762385|FG002|Overall Study|Lost to Follow-up|1|||
23824270|NCT02766335|66737817|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
23824271|NCT02766335|66737818|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
23824272|NCT02766335|66737819|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
23824273|NCT00191191|66737820|FG000|Overall Study|Entry Criteria Exclusion|2|||
23824274|NCT00191191|66737821|FG001|Overall Study|Entry Criteria Exclusion|0|||
23555865|NCT00335452|65762386|FG003|Overall Study|Lost to Follow-up|2|||
23555866|NCT01221948|65762389|FG000|Overall Study|Physician Decision|5|||
23555867|NCT01221948|65762389|FG000|Overall Study|Withdrawal by Subject|2|||
23824275|NCT00191191|66737820|FG000|Overall Study|Treated with Another Systemic Agent|1|||
23824276|NCT00191191|66737821|FG001|Overall Study|Treated with Another Systemic Agent|1|||
23824277|NCT00191191|66737820|FG000|Overall Study|Adverse Event|11|||
23824278|NCT00191191|66737821|FG001|Overall Study|Adverse Event|21|||
23824279|NCT00191191|66737820|FG000|Overall Study|Progressive Disease|84|||
23824280|NCT00191191|66737821|FG001|Overall Study|Progressive Disease|72|||
23824281|NCT00191191|66737820|FG000|Overall Study|Toxicity After Dose Reduction|7|||
23824282|NCT00191191|66737821|FG001|Overall Study|Toxicity After Dose Reduction|8|||
23824283|NCT00191191|66737820|FG000|Overall Study|Family/Caregiver Decision|5|||
23824284|NCT00191191|66737821|FG001|Overall Study|Family/Caregiver Decision|7|||
23824285|NCT00191191|66737820|FG000|Overall Study|Lost to Follow-up|1|||
23555868|NCT01221948|65762389|FG000|Overall Study|not disclosed|2|||
23824286|NCT00191191|66737821|FG001|Overall Study|Lost to Follow-up|0|||
23824287|NCT00191191|66737820|FG000|Overall Study|Physician Decision|3|||
23824288|NCT00191191|66737821|FG001|Overall Study|Physician Decision|2|||
23824289|NCT00191191|66737820|FG000|Overall Study|Good Clinical Practice Violation|0|||
23824290|NCT00191191|66737821|FG001|Overall Study|Good Clinical Practice Violation|1|||
23824291|NCT02165735|66737832|FG000|Overall Study|Lost to Follow-up|12|||
23824292|NCT02165735|66737833|FG001|Overall Study|Lost to Follow-up|10|||
23824293|NCT02165735|66737832|FG000|Overall Study|Withdrawal by Subject|3|||
23824294|NCT02165735|66737833|FG001|Overall Study|Withdrawal by Subject|0|||
23824295|NCT02165735|66737832|FG000|Overall Study|Participant indicated lack of time|1|||
23824296|NCT02165735|66737833|FG001|Overall Study|Participant indicated lack of time|3|||
23824297|NCT02165735|66737832|FG000|Overall Study|Protocol Violation|0|||
23824298|NCT02165735|66737833|FG001|Overall Study|Protocol Violation|1|||
23824299|NCT01659151|66737834|FG000|Overall Study|Inadequate TIL growth|1|||
23824300|NCT00064987|66737835|FG000|Overall Study|Physician Decision|3|||
23824301|NCT00064987|66737836|FG001|Overall Study|Physician Decision|0|||
23824302|NCT04146012|66737839|FG000|Overall Study|Study Terminated|30|||
23824303|NCT04146012|66737840|FG001|Overall Study|Study Terminated|15|||
23824304|NCT01924754|66737841|FG000|Overall Study|Lost to Follow-up|1|||
23824305|NCT01924754|66737842|FG001|Overall Study|Lost to Follow-up|2|||
23824306|NCT01924754|66737843|FG002|Overall Study|Lost to Follow-up|1|||
23824307|NCT01924754|66737841|FG000|Overall Study|Pregnancy|0|||
23824308|NCT01924754|66737842|FG001|Overall Study|Pregnancy|1|||
23824309|NCT01924754|66737843|FG002|Overall Study|Pregnancy|2|||
23824310|NCT01200069|66737844|FG000|Overall Study|Withdrawal by Subject|0|||
23824311|NCT01200069|66737845|FG001|Overall Study|Withdrawal by Subject|1|||
23824312|NCT00489827|66737846|FG000|Overall Study|Intraoperative exclusion criteria|1|||
23824313|NCT00489827|66737847|FG001|Overall Study|Intraoperative exclusion criteria|1|||
23824314|NCT00489827|66737846|FG000|Overall Study|Intraoperative exclusion criteria|1|||
23824315|NCT00489827|66737847|FG001|Overall Study|Intraoperative exclusion criteria|1|||
23824316|NCT01107197|66737848|FG000|Overall Study|Death|12|||
23824317|NCT01107197|66737849|FG001|Overall Study|Death|10|||
23824318|NCT01107197|66737848|FG000|Overall Study|Lost to Follow-up|5|||
23824319|NCT01107197|66737849|FG001|Overall Study|Lost to Follow-up|8|||
23824320|NCT01107197|66737848|FG000|Overall Study|Withdrawal by Subject|3|||
23824321|NCT01107197|66737849|FG001|Overall Study|Withdrawal by Subject|5|||
23824322|NCT00362336|66737852|FG000|Overall Study|Serious Adverse Event|1|||
23824323|NCT00362336|66737853|FG001|Overall Study|Serious Adverse Event|0|||
23824324|NCT00362336|66737854|FG002|Overall Study|Serious Adverse Event|1|||
23824325|NCT00362336|66737852|FG000|Overall Study|Protocol Violation|0|||
23824326|NCT00362336|66737853|FG001|Overall Study|Protocol Violation|0|||
23824327|NCT00362336|66737854|FG002|Overall Study|Protocol Violation|1|||
23824328|NCT00362336|66737852|FG000|Overall Study|Lost to Follow-up|6|||
23824329|NCT00362336|66737853|FG001|Overall Study|Lost to Follow-up|4|||
23824330|NCT00362336|66737854|FG002|Overall Study|Lost to Follow-up|0|||
23824331|NCT00362336|66737852|FG000|Overall Study|Withdrawal by Subject|3|||
23824332|NCT00362336|66737853|FG001|Overall Study|Withdrawal by Subject|3|||
23824333|NCT00362336|66737854|FG002|Overall Study|Withdrawal by Subject|1|||
23824334|NCT00613171|66737856|FG000|Overall Study|Adverse Event|7|||
23824335|NCT00613171|66737856|FG000|Overall Study|Withdrawal by Subject|3|||
23824336|NCT00613171|66737856|FG000|Overall Study|Reason not Specified|4|||
23824337|NCT02892149|66737857|FG000|Overall Study|Death|262|||
23824338|NCT02892149|66737858|FG001|Overall Study|Death|278|||
23824339|NCT02892149|66737857|FG000|Overall Study|Withdrawal by Subject|53|||
23824340|NCT02892149|66737858|FG001|Overall Study|Withdrawal by Subject|47|||
23623339|NCT01013740|66008386|FG001|Overall Study|Lost to Follow-up|5|||
23623340|NCT01013740|66008385|FG000|Overall Study|Physician Decision|2|||
23623341|NCT01013740|66008386|FG001|Overall Study|Physician Decision|0|||
23623342|NCT01013740|66008385|FG000|Overall Study|Withdrawal by Subject|2|||
23623343|NCT01013740|66008386|FG001|Overall Study|Withdrawal by Subject|10|||
23623344|NCT01013740|66008385|FG000|Overall Study|study close / terminated : done in error|2|||
23623345|NCT01013740|66008386|FG001|Overall Study|study close / terminated : done in error|1|||
23623346|NCT01013740|66008385|FG000|Overall Study|Missing|2|||
23623347|NCT01013740|66008386|FG001|Overall Study|Missing|1|||
23623348|NCT01013740|66008385|FG000|Overall Study|Ongoing: Study records not completed|0|||
23623349|NCT01013740|66008386|FG001|Overall Study|Ongoing: Study records not completed|2|||
23623350|NCT01657877|66008389|FG000|Overall Study|Withdrawal by Subject|4|||
23623351|NCT01657877|66008389|FG000|Overall Study|Protocol Violation|6|||
23623352|NCT01657877|66008389|FG000|Overall Study|Adverse Event|2|||
23623353|NCT01657877|66008389|FG000|Overall Study|Other Reason|2|||
23623354|NCT02670122|66008390|FG000|Overall Study|Lost to Follow-up|4|||
23749734|NCT05257109|66463424|FG000|Overall Study|Withdrawal by Subject|1|||
23749735|NCT05257109|66463425|FG001|Overall Study|Withdrawal by Subject|0|||
23749736|NCT05257109|66463426|FG002|Overall Study|Withdrawal by Subject|0|||
23749737|NCT05257109|66463427|FG003|Overall Study|Withdrawal by Subject|0|||
23824341|NCT02892149|66737857|FG000|Overall Study|Lost to Follow-up|37|||
23824342|NCT02892149|66737858|FG001|Overall Study|Lost to Follow-up|31|||
23824343|NCT02676765|66737859|FG000|Overall Study|Lost to Follow-up|0|||
23824344|NCT02676765|66737860|FG001|Overall Study|Lost to Follow-up|1|||
23824345|NCT01056289|66737863|FG000|Open-label Phase|Adverse Event|29|||
23824346|NCT01056289|66737864|FG001|Open-label Phase|Adverse Event|0|||
23824347|NCT01056289|66737865|FG002|Open-label Phase|Adverse Event|0|||
23824348|NCT01056289|66737866|FG003|Open-label Phase|Adverse Event|0|||
23824349|NCT01056289|66737863|FG000|Open-label Phase|Lost to Follow-up|30|||
23824350|NCT01056289|66737864|FG001|Open-label Phase|Lost to Follow-up|0|||
23824351|NCT01056289|66737865|FG002|Open-label Phase|Lost to Follow-up|0|||
23824352|NCT01056289|66737866|FG003|Open-label Phase|Lost to Follow-up|0|||
23824353|NCT01056289|66737863|FG000|Open-label Phase|Other|9|||
23824354|NCT01056289|66737864|FG001|Open-label Phase|Other|0|||
23824355|NCT01056289|66737865|FG002|Open-label Phase|Other|0|||
23824356|NCT01056289|66737866|FG003|Open-label Phase|Other|0|||
23824357|NCT01056289|66737863|FG000|Open-label Phase|Protocol Violation|6|||
23824358|NCT01056289|66737864|FG001|Open-label Phase|Protocol Violation|0|||
23824359|NCT01056289|66737865|FG002|Open-label Phase|Protocol Violation|0|||
23824360|NCT01056289|66737866|FG003|Open-label Phase|Protocol Violation|0|||
23824361|NCT01056289|66737863|FG000|Open-label Phase|Withdrawal by Subject|26|||
23824362|NCT01056289|66737864|FG001|Open-label Phase|Withdrawal by Subject|0|||
23824363|NCT01056289|66737865|FG002|Open-label Phase|Withdrawal by Subject|0|||
23824364|NCT01056289|66737866|FG003|Open-label Phase|Withdrawal by Subject|0|||
23824365|NCT01056289|66737863|FG000|Open-label Phase|Lack of Efficacy|18|||
23824366|NCT01056289|66737864|FG001|Open-label Phase|Lack of Efficacy|0|||
23824367|NCT01056289|66737865|FG002|Open-label Phase|Lack of Efficacy|0|||
23824368|NCT01056289|66737866|FG003|Open-label Phase|Lack of Efficacy|0|||
23824369|NCT01056289|66737863|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
23749753|NCT00110084|66463431|FG000|Overall Study|Adverse Event|9|||
23749754|NCT00110084|66463431|FG000|Overall Study|Death|1|||
23749755|NCT00110084|66463431|FG000|Overall Study|Patient Refusal|10|||
23749756|NCT00110084|66463431|FG000|Overall Study|Alternate Therapy|5|||
23749757|NCT00110084|66463431|FG000|Overall Study|Intercurrent Illness|1|||
23749758|NCT00110084|66463431|FG000|Overall Study|Other|2|||
23824370|NCT01056289|66737864|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
23824371|NCT01056289|66737865|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
23824372|NCT01056289|66737866|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
23824373|NCT01056289|66737863|FG000|Double-blind Phase|Adverse Event|0|||
23824374|NCT01056289|66737864|FG001|Double-blind Phase|Adverse Event|1|||
23824375|NCT01056289|66737865|FG002|Double-blind Phase|Adverse Event|2|||
23824376|NCT01056289|66737866|FG003|Double-blind Phase|Adverse Event|1|||
23824377|NCT01056289|66737863|FG000|Double-blind Phase|Lost to Follow-up|0|||
23824378|NCT01056289|66737864|FG001|Double-blind Phase|Lost to Follow-up|2|||
23824379|NCT01056289|66737865|FG002|Double-blind Phase|Lost to Follow-up|2|||
23824380|NCT01056289|66737866|FG003|Double-blind Phase|Lost to Follow-up|2|||
23824381|NCT01056289|66737863|FG000|Double-blind Phase|Other|0|||
23824382|NCT01056289|66737864|FG001|Double-blind Phase|Other|0|||
23824383|NCT01056289|66737865|FG002|Double-blind Phase|Other|1|||
23824384|NCT01056289|66737866|FG003|Double-blind Phase|Other|2|||
23824385|NCT01056289|66737863|FG000|Double-blind Phase|Protocol Violation|0|||
23824386|NCT01056289|66737864|FG001|Double-blind Phase|Protocol Violation|0|||
23824387|NCT01056289|66737865|FG002|Double-blind Phase|Protocol Violation|1|||
23824388|NCT01056289|66737866|FG003|Double-blind Phase|Protocol Violation|1|||
23824389|NCT01056289|66737863|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23555869|NCT01221948|65762389|FG000|Overall Study|Death|1|||
23555870|NCT01221948|65762389|FG000|Overall Study|Protocol Violation|4|||
23555871|NCT01951638|65762393|FG000|Treatment Period|Protocol Violation|0|||
23555872|NCT01951638|65762394|FG001|Treatment Period|Protocol Violation|0|||
23555873|NCT01951638|65762395|FG002|Treatment Period|Protocol Violation|0|||
23555874|NCT01951638|65762396|FG003|Treatment Period|Protocol Violation|2|||
23555875|NCT01951638|65762397|FG004|Treatment Period|Protocol Violation|0|||
23555876|NCT01951638|65762393|FG000|Treatment Period|Protocol-driven decision point|1|||
23555877|NCT01951638|65762394|FG001|Treatment Period|Protocol-driven decision point|3|||
23555878|NCT01951638|65762395|FG002|Treatment Period|Protocol-driven decision point|0|||
23555879|NCT01951638|65762396|FG003|Treatment Period|Protocol-driven decision point|0|||
23555880|NCT01951638|65762397|FG004|Treatment Period|Protocol-driven decision point|0|||
23555881|NCT01951638|65762393|FG000|Treatment Period|Logistical difficulties|0|||
23555882|NCT01951638|65762394|FG001|Treatment Period|Logistical difficulties|1|||
23555883|NCT01951638|65762395|FG002|Treatment Period|Logistical difficulties|1|||
23749759|NCT04449354|66463441|FG000|Overall Study|Withdrawal by Subject|1|||
23749760|NCT04158739|66463443|FG000|Overall Study|Adverse Event|1|||
23749761|NCT04158739|66463444|FG001|Overall Study|Adverse Event|0|||
23749762|NCT04158739|66463443|FG000|Overall Study|Death|0|||
23749763|NCT04158739|66463444|FG001|Overall Study|Death|1|||
23749764|NCT04158739|66463443|FG000|Overall Study|Lack of Efficacy|3|||
23749765|NCT04158739|66463444|FG001|Overall Study|Lack of Efficacy|7|||
23749766|NCT04158739|66463443|FG000|Overall Study|Physician Decision|0|||
23749767|NCT04158739|66463444|FG001|Overall Study|Physician Decision|1|||
23749768|NCT04158739|66463443|FG000|Overall Study|Withdrawal by Subject|3|||
23749769|NCT04158739|66463444|FG001|Overall Study|Withdrawal by Subject|0|||
23749770|NCT03940742|66463449|FG000|Overall Study|Lost to Follow-up|0|||
23749771|NCT03940742|66463450|FG001|Overall Study|Lost to Follow-up|0|||
23749772|NCT03940742|66463451|FG002|Overall Study|Lost to Follow-up|0|||
23749773|NCT03940742|66463452|FG003|Overall Study|Lost to Follow-up|1|||
23749774|NCT02007512|66463454|FG000|Double Blind Treatment Period|Adverse Event|4|||
23749775|NCT02007512|66463455|FG001|Double Blind Treatment Period|Adverse Event|2|||
23749776|NCT02007512|66463456|FG002|Double Blind Treatment Period|Adverse Event|6|||
23749777|NCT02007512|66463457|FG003|Double Blind Treatment Period|Adverse Event|2|||
23749778|NCT02007512|66463454|FG000|Double Blind Treatment Period|Death|1|||
23749779|NCT02007512|66463455|FG001|Double Blind Treatment Period|Death|0|||
23749780|NCT02007512|66463456|FG002|Double Blind Treatment Period|Death|0|||
23749781|NCT02007512|66463457|FG003|Double Blind Treatment Period|Death|0|||
23749782|NCT02007512|66463454|FG000|Double Blind Treatment Period|Disease progression|44|||
23749783|NCT02007512|66463455|FG001|Double Blind Treatment Period|Disease progression|49|||
23749784|NCT02007512|66463456|FG002|Double Blind Treatment Period|Disease progression|45|||
23749785|NCT02007512|66463457|FG003|Double Blind Treatment Period|Disease progression|51|||
23749786|NCT02007512|66463454|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
23749787|NCT02007512|66463455|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
23749788|NCT02007512|66463456|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
23749789|NCT02007512|66463457|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
23749790|NCT02007512|66463454|FG000|Double Blind Treatment Period|Protocol Violation|0|||
23749791|NCT02007512|66463455|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23749792|NCT02007512|66463456|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23749793|NCT02007512|66463457|FG003|Double Blind Treatment Period|Protocol Violation|1|||
23749794|NCT02007512|66463454|FG000|Double Blind Treatment Period|Other|0|||
23749795|NCT02007512|66463455|FG001|Double Blind Treatment Period|Other|0|||
23749796|NCT02007512|66463456|FG002|Double Blind Treatment Period|Other|1|||
23749797|NCT02007512|66463457|FG003|Double Blind Treatment Period|Other|2|||
23749798|NCT02007512|66463454|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
23749799|NCT02007512|66463455|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
23749800|NCT02007512|66463456|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
23749801|NCT02007512|66463457|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
23749802|NCT02007512|66463454|FG000|Open Label Treatment Period|Adverse Event|0|||
23749803|NCT02007512|66463455|FG001|Open Label Treatment Period|Adverse Event|1|||
23433632|NCT00710385|65330529|FG000|Overall Study|Undisclosed back pain|1|||
23749804|NCT02007512|66463456|FG002|Open Label Treatment Period|Adverse Event|0|||
23749805|NCT02007512|66463457|FG003|Open Label Treatment Period|Adverse Event|0|||
23749806|NCT02007512|66463454|FG000|Open Label Treatment Period|Other|0|||
23749807|NCT02007512|66463455|FG001|Open Label Treatment Period|Other|0|||
23749808|NCT02007512|66463456|FG002|Open Label Treatment Period|Other|0|||
23749809|NCT02007512|66463457|FG003|Open Label Treatment Period|Other|1|||
23749810|NCT02007512|66463454|FG000|Open Label Treatment Period|Disease progression|0|||
23824390|NCT01056289|66737864|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23824391|NCT01056289|66737865|FG002|Double-blind Phase|Withdrawal by Subject|4|||
23824392|NCT01056289|66737866|FG003|Double-blind Phase|Withdrawal by Subject|2|||
23824393|NCT01056289|66737863|FG000|Double-blind Phase|Discontinuation symptom|0|||
23824394|NCT01056289|66737864|FG001|Double-blind Phase|Discontinuation symptom|1|||
23824395|NCT01056289|66737865|FG002|Double-blind Phase|Discontinuation symptom|2|||
23824396|NCT01056289|66737866|FG003|Double-blind Phase|Discontinuation symptom|2|||
23824397|NCT01056289|66737863|FG000|Double-blind Phase|Physician Decision|0|||
23824398|NCT01056289|66737864|FG001|Double-blind Phase|Physician Decision|0|||
23824399|NCT01056289|66737865|FG002|Double-blind Phase|Physician Decision|1|||
23824400|NCT01056289|66737866|FG003|Double-blind Phase|Physician Decision|0|||
23824401|NCT03092219|66737869|FG000|Overall Study|Protocol Violation|7|||
23824402|NCT03092219|66737870|FG001|Overall Study|Protocol Violation|4|||
23824403|NCT01320293|66737873|FG000|Overall Study|Lack of Efficacy|1|||
23824404|NCT01320293|66737873|FG000|Overall Study|Adverse Event|1|||
23824405|NCT02064296|66737874|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
23824406|NCT02064296|66737875|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
23824407|NCT02064296|66737876|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
23824408|NCT02064296|66737874|FG000|Intervention|Withdrawal by Subject|0|||
23824409|NCT02064296|66737875|FG001|Intervention|Withdrawal by Subject|1|||
23824410|NCT02064296|66737876|FG002|Intervention|Withdrawal by Subject|2|||
23433633|NCT00710385|65330529|FG000|Overall Study|Physician Decision|1|||
23555884|NCT01951638|65762396|FG003|Treatment Period|Logistical difficulties|0|||
23555885|NCT01951638|65762397|FG004|Treatment Period|Logistical difficulties|0|||
23749811|NCT02007512|66463455|FG001|Open Label Treatment Period|Disease progression|17|||
23824411|NCT00699998|66737877|FG000|Overall Study|Withdrawal by Subject|194|||
23824412|NCT00699998|66737878|FG001|Overall Study|Withdrawal by Subject|83|||
23824413|NCT00699998|66737879|FG002|Overall Study|Withdrawal by Subject|202|||
23433634|NCT00710385|65330529|FG000|Overall Study|Undisclosed excessive methadone use|1|||
23749812|NCT02007512|66463456|FG002|Open Label Treatment Period|Disease progression|0|||
23749813|NCT02007512|66463457|FG003|Open Label Treatment Period|Disease progression|11|||
23749814|NCT02007512|66463454|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23749815|NCT02007512|66463455|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
23749816|NCT02007512|66463456|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23749817|NCT02007512|66463457|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23749818|NCT01901393|66463458|FG000|Overall Study|Adverse Event|1|||
23749819|NCT01901393|66463459|FG001|Overall Study|Adverse Event|0|||
23749820|NCT00816166|66463460|FG000|Overall Study|Lost to Follow-up|6|||
23749821|NCT00816166|66463461|FG001|Overall Study|Lost to Follow-up|10|||
23749822|NCT00816166|66463460|FG000|Overall Study|Death|4|||
23433635|NCT01278407|65330530|FG000|Confirmatory Phase|Adverse Event|5|||
23433636|NCT01278407|65330531|FG001|Confirmatory Phase|Adverse Event|10|||
23555886|NCT01951638|65762393|FG000|Treatment Period|Withdrawal by Subject|9|||
23555887|NCT01951638|65762394|FG001|Treatment Period|Withdrawal by Subject|6|||
23555888|NCT01951638|65762395|FG002|Treatment Period|Withdrawal by Subject|4|||
23749823|NCT00816166|66463461|FG001|Overall Study|Death|2|||
23749824|NCT03768414|66463462|FG000|Overall Study|Adverse Event or side effects|72|||
23749825|NCT03768414|66463463|FG001|Overall Study|Adverse Event or side effects|28|||
23555889|NCT01951638|65762396|FG003|Treatment Period|Withdrawal by Subject|5|||
23555890|NCT01951638|65762397|FG004|Treatment Period|Withdrawal by Subject|4|||
23555891|NCT01951638|65762393|FG000|Treatment Period|Death|0|||
23555892|NCT01951638|65762394|FG001|Treatment Period|Death|0|||
23555893|NCT01951638|65762395|FG002|Treatment Period|Death|0|||
23555894|NCT01951638|65762396|FG003|Treatment Period|Death|3|||
23555895|NCT01951638|65762397|FG004|Treatment Period|Death|1|||
23555896|NCT01951638|65762393|FG000|Treatment Period|Adverse Event|3|||
23555897|NCT01951638|65762394|FG001|Treatment Period|Adverse Event|4|||
23555898|NCT01951638|65762395|FG002|Treatment Period|Adverse Event|8|||
23555899|NCT01951638|65762396|FG003|Treatment Period|Adverse Event|6|||
23555900|NCT01951638|65762397|FG004|Treatment Period|Adverse Event|5|||
23555901|NCT01951638|65762393|FG000|Follow-up Period|Protocol Violation|0|||
23555902|NCT01951638|65762394|FG001|Follow-up Period|Protocol Violation|0|||
23555903|NCT01951638|65762395|FG002|Follow-up Period|Protocol Violation|0|||
23555904|NCT01951638|65762396|FG003|Follow-up Period|Protocol Violation|1|||
23555905|NCT01951638|65762397|FG004|Follow-up Period|Protocol Violation|0|||
23555906|NCT01951638|65762393|FG000|Follow-up Period|Logistical difficulties|0|||
23555907|NCT01951638|65762394|FG001|Follow-up Period|Logistical difficulties|2|||
23555908|NCT01951638|65762395|FG002|Follow-up Period|Logistical difficulties|0|||
23555909|NCT01951638|65762396|FG003|Follow-up Period|Logistical difficulties|0|||
23555910|NCT01951638|65762397|FG004|Follow-up Period|Logistical difficulties|1|||
23555911|NCT01951638|65762393|FG000|Follow-up Period|Withdrawal by Subject|1|||
23555912|NCT01951638|65762394|FG001|Follow-up Period|Withdrawal by Subject|5|||
23555913|NCT01951638|65762395|FG002|Follow-up Period|Withdrawal by Subject|2|||
23555914|NCT01951638|65762396|FG003|Follow-up Period|Withdrawal by Subject|1|||
23555915|NCT01951638|65762397|FG004|Follow-up Period|Withdrawal by Subject|2|||
23555916|NCT01951638|65762393|FG000|Follow-up Period|Lost to Follow-up|0|||
23555917|NCT01951638|65762394|FG001|Follow-up Period|Lost to Follow-up|1|||
23555918|NCT01951638|65762395|FG002|Follow-up Period|Lost to Follow-up|0|||
23555919|NCT01951638|65762396|FG003|Follow-up Period|Lost to Follow-up|1|||
23555920|NCT01951638|65762397|FG004|Follow-up Period|Lost to Follow-up|0|||
23555921|NCT01951638|65762393|FG000|Follow-up Period|Death|1|||
23555922|NCT01951638|65762394|FG001|Follow-up Period|Death|0|||
23749826|NCT03768414|66463462|FG000|Overall Study|Refusal unrelated to adverse event|33|||
23749827|NCT03768414|66463463|FG001|Overall Study|Refusal unrelated to adverse event|33|||
23749828|NCT03768414|66463462|FG000|Overall Study|Progression/relapse|132|||
23749829|NCT03768414|66463463|FG001|Overall Study|Progression/relapse|60|||
23749830|NCT03768414|66463462|FG000|Overall Study|Death|9|||
23749831|NCT03768414|66463463|FG001|Overall Study|Death|6|||
23749832|NCT03768414|66463462|FG000|Overall Study|Other - not protocol specified|45|||
23749833|NCT03768414|66463463|FG001|Overall Study|Other - not protocol specified|18|||
23749834|NCT03768414|66463462|FG000|Overall Study|Reason under review|3|||
23749835|NCT03768414|66463463|FG001|Overall Study|Reason under review|2|||
23749836|NCT03273257|66463470|FG000|Overall Study|Death|0|||
23749837|NCT03273257|66463471|FG001|Overall Study|Death|1|||
23749838|NCT03273257|66463470|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
23749839|NCT03273257|66463471|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
23824414|NCT00699998|66737880|FG003|Overall Study|Withdrawal by Subject|80|||
23555923|NCT01951638|65762395|FG002|Follow-up Period|Death|1|||
23555924|NCT01951638|65762396|FG003|Follow-up Period|Death|4|||
23555925|NCT01951638|65762397|FG004|Follow-up Period|Death|1|||
23555926|NCT01951638|65762393|FG000|Follow-up Period|Adverse Event|0|||
23555927|NCT01951638|65762394|FG001|Follow-up Period|Adverse Event|1|||
23555928|NCT01951638|65762395|FG002|Follow-up Period|Adverse Event|2|||
23555929|NCT01951638|65762396|FG003|Follow-up Period|Adverse Event|1|||
23555930|NCT01951638|65762397|FG004|Follow-up Period|Adverse Event|1|||
23555931|NCT05099926|65762398|FG000|Overall Study|Lost to Follow-up|1|||
23555932|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Adverse Event|1|||
23555933|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Adverse Event|0|||
23555934|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
23555935|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
23555936|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
23555937|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
23749840|NCT03273257|66463470|FG000|Overall Study|Study terminated|3|||
23555938|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
23555939|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
23555940|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Adverse Event|1|||
23555941|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Adverse Event|0|||
23555942|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
23749841|NCT03273257|66463471|FG001|Overall Study|Study terminated|2|||
23555943|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
23555944|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
23749842|NCT04513665|66463472|FG000|Overall Study|Adverse Event|2|||
23555945|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
23555946|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Physician Decision|1|||
23555947|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Physician Decision|0|||
23555948|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
23555949|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
23555950|NCT04517864|65762401|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
23555951|NCT04517864|65762402|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
23555952|NCT01297959|65762403|FG000|Overall Study|Adverse Event|0|||
23555953|NCT01297959|65762404|FG001|Overall Study|Adverse Event|1|||
23555954|NCT01297959|65762403|FG000|Overall Study|Protocol Violation|2|||
23555955|NCT01297959|65762404|FG001|Overall Study|Protocol Violation|1|||
23623355|NCT05006417|66008391|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
23749843|NCT04513665|66463473|FG001|Overall Study|Adverse Event|0|||
23749844|NCT04513665|66463472|FG000|Overall Study|Lack of Efficacy|14|||
23749845|NCT04513665|66463473|FG001|Overall Study|Lack of Efficacy|0|||
23749846|NCT01036594|66463475|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
23749847|NCT01036594|66463476|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
23749848|NCT01036594|66463475|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
23749849|NCT01036594|66463476|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
23749850|NCT01036594|66463475|FG000|Week 12 Evaluation|Adverse Event|5|||
23749851|NCT01036594|66463476|FG001|Week 12 Evaluation|Adverse Event|0|||
23749852|NCT01036594|66463475|FG000|Week 12 Evaluation|Physician Decision|1|||
23749853|NCT01036594|66463476|FG001|Week 12 Evaluation|Physician Decision|0|||
23749854|NCT01036594|66463475|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
23749855|NCT01036594|66463476|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
23749856|NCT01036594|66463475|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
23749857|NCT01036594|66463476|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
23749858|NCT01036594|66463475|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
23749859|NCT01036594|66463476|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
23749860|NCT01036594|66463475|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
23749861|NCT01036594|66463476|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
23749862|NCT01036594|66463475|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
23749863|NCT01036594|66463476|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
23749864|NCT00891527|66463477|FG000|Overall Study|Withdrawal by Subject|2|||
23749865|NCT03505606|66463482|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
23749866|NCT03505606|66463483|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
23749867|NCT03505606|66463484|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
23749868|NCT03505606|66463482|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
23749869|NCT03505606|66463483|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
23749870|NCT03505606|66463484|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
23749871|NCT03505606|66463482|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
23749872|NCT03505606|66463483|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
23749873|NCT03505606|66463484|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
23749874|NCT03505606|66463482|FG000|Overall Study|Poor compliance with refractive correction|0|||
23749875|NCT03505606|66463483|FG001|Overall Study|Poor compliance with refractive correction|0|||
23749876|NCT03505606|66463484|FG002|Overall Study|Poor compliance with refractive correction|1|||
23749877|NCT03505606|66463482|FG000|Overall Study|Insufficient anisometropia|0|||
23749878|NCT03505606|66463483|FG001|Overall Study|Insufficient anisometropia|0|||
23749879|NCT03505606|66463484|FG002|Overall Study|Insufficient anisometropia|2|||
23749880|NCT03505606|66463482|FG000|Overall Study|Ectopia Lentis|0|||
23749881|NCT03505606|66463483|FG001|Overall Study|Ectopia Lentis|0|||
23749882|NCT03505606|66463484|FG002|Overall Study|Ectopia Lentis|1|||
23749883|NCT03505606|66463482|FG000|Overall Study|alternation of amblyopic eye|0|||
23749884|NCT03505606|66463483|FG001|Overall Study|alternation of amblyopic eye|1|||
23749885|NCT03505606|66463484|FG002|Overall Study|alternation of amblyopic eye|0|||
23749886|NCT06067191|66463485|FG000|Overall Study|Withdrawal by Subject|0|||
23749887|NCT06067191|66463486|FG001|Overall Study|Withdrawal by Subject|1|||
23749888|NCT04882085|66463488|FG000|Overall Study|Death|6|||
23749889|NCT04882085|66463489|FG001|Overall Study|Death|9|||
23749890|NCT04882085|66463488|FG000|Overall Study|Withdrawal by Subject|0|||
23749891|NCT04882085|66463489|FG001|Overall Study|Withdrawal by Subject|3|||
23749892|NCT04882085|66463488|FG000|Overall Study|Randomized not treated|1|||
23749893|NCT04882085|66463489|FG001|Overall Study|Randomized not treated|0|||
23749894|NCT02152631|66463490|FG000|Overall Study|Adverse Event|32|||
23555956|NCT01297959|65762403|FG000|Overall Study|Withdrawal by Subject|5|||
23749895|NCT02152631|66463491|FG001|Overall Study|Adverse Event|4|||
23749896|NCT02152631|66463490|FG000|Overall Study|Withdrawal by Subject|13|||
23749897|NCT02152631|66463491|FG001|Overall Study|Withdrawal by Subject|16|||
23824415|NCT00699998|66737877|FG000|Overall Study|Physician Decision|3|||
23433637|NCT01278407|65330532|FG002|Confirmatory Phase|Adverse Event|1|||
23433638|NCT01278407|65330533|FG003|Confirmatory Phase|Adverse Event|0|||
23433639|NCT01278407|65330534|FG004|Confirmatory Phase|Adverse Event|0|||
23433640|NCT01278407|65330530|FG000|Confirmatory Phase|Participant's Choice|3|||
23433641|NCT01278407|65330531|FG001|Confirmatory Phase|Participant's Choice|5|||
23433642|NCT01278407|65330532|FG002|Confirmatory Phase|Participant's Choice|3|||
23433643|NCT01278407|65330533|FG003|Confirmatory Phase|Participant's Choice|0|||
23433644|NCT01278407|65330534|FG004|Confirmatory Phase|Participant's Choice|0|||
23433645|NCT01278407|65330530|FG000|Confirmatory Phase|Other|1|||
23824416|NCT00699998|66737878|FG001|Overall Study|Physician Decision|2|||
23433646|NCT01278407|65330531|FG001|Confirmatory Phase|Other|1|||
23433647|NCT01278407|65330532|FG002|Confirmatory Phase|Other|2|||
23433648|NCT01278407|65330533|FG003|Confirmatory Phase|Other|0|||
23433649|NCT01278407|65330534|FG004|Confirmatory Phase|Other|0|||
23623356|NCT02194829|66008398|FG000|Overall Study|Adverse Event|2|||
23623357|NCT02194829|66008399|FG001|Overall Study|Adverse Event|2|||
23623358|NCT02194829|66008398|FG000|Overall Study|Death|0|||
23623359|NCT02194829|66008399|FG001|Overall Study|Death|1|||
23623360|NCT02194829|66008398|FG000|Overall Study|Disease progression|0|||
23623361|NCT02194829|66008399|FG001|Overall Study|Disease progression|1|||
23623362|NCT02194829|66008398|FG000|Overall Study|Withdrawal by Subject|0|||
23623363|NCT02194829|66008399|FG001|Overall Study|Withdrawal by Subject|1|||
23623364|NCT02194829|66008398|FG000|Overall Study|Never started protocol therapy|0|||
23623365|NCT02194829|66008399|FG001|Overall Study|Never started protocol therapy|1|||
23623366|NCT00813098|66008400|FG000|Overall Study|Adverse Event|2|||
23623367|NCT00813098|66008401|FG001|Overall Study|Adverse Event|4|||
23623368|NCT00813098|66008402|FG002|Overall Study|Adverse Event|1|||
23623369|NCT00813098|66008400|FG000|Overall Study|Withdrawal by Subject|0|||
23623370|NCT00813098|66008401|FG001|Overall Study|Withdrawal by Subject|1|||
23623371|NCT00813098|66008402|FG002|Overall Study|Withdrawal by Subject|0|||
23623372|NCT00813098|66008400|FG000|Overall Study|Inability to complete study procedures|1|||
23623373|NCT00813098|66008401|FG001|Overall Study|Inability to complete study procedures|0|||
23623374|NCT00813098|66008402|FG002|Overall Study|Inability to complete study procedures|0|||
23623375|NCT00813098|66008400|FG000|Overall Study|Lost to Follow-up|0|||
23623376|NCT00813098|66008401|FG001|Overall Study|Lost to Follow-up|1|||
23623377|NCT00813098|66008402|FG002|Overall Study|Lost to Follow-up|0|||
23623378|NCT00813098|66008400|FG000|Overall Study|Protocol Violation|0|||
23623379|NCT00813098|66008401|FG001|Overall Study|Protocol Violation|0|||
23623380|NCT00813098|66008402|FG002|Overall Study|Protocol Violation|1|||
23623381|NCT00813098|66008400|FG000|Overall Study|Principal Investigator decision|0|||
23623382|NCT00813098|66008401|FG001|Overall Study|Principal Investigator decision|1|||
23623383|NCT00813098|66008402|FG002|Overall Study|Principal Investigator decision|0|||
23623384|NCT00813098|66008400|FG000|Overall Study|Withdrew Consent|0|||
23623385|NCT00813098|66008401|FG001|Overall Study|Withdrew Consent|1|||
23623386|NCT00813098|66008402|FG002|Overall Study|Withdrew Consent|0|||
23623387|NCT01263925|66008403|FG000|Overall Study|Protocol Violation|1|||
23623388|NCT01263925|66008404|FG001|Overall Study|Protocol Violation|0|||
23623389|NCT01263925|66008403|FG000|Overall Study|Lack of Efficacy|0|||
23623390|NCT01263925|66008404|FG001|Overall Study|Lack of Efficacy|1|||
23749898|NCT02152631|66463490|FG000|Overall Study|Noncompliance with study drug|1|||
23749899|NCT02152631|66463491|FG001|Overall Study|Noncompliance with study drug|0|||
23749900|NCT02152631|66463490|FG000|Overall Study|Physician Decision|1|||
23749901|NCT02152631|66463491|FG001|Overall Study|Physician Decision|2|||
23749902|NCT02152631|66463490|FG000|Overall Study|Lost to Follow-up|0|||
23749903|NCT02152631|66463491|FG001|Overall Study|Lost to Follow-up|1|||
23749904|NCT02152631|66463490|FG000|Overall Study|On Treatment|19|||
23824417|NCT00699998|66737879|FG002|Overall Study|Physician Decision|1|||
23824418|NCT00699998|66737880|FG003|Overall Study|Physician Decision|1|||
23824419|NCT00699998|66737877|FG000|Overall Study|Lost to Follow-up|2|||
23824420|NCT00699998|66737878|FG001|Overall Study|Lost to Follow-up|1|||
23623391|NCT01263925|66008403|FG000|Overall Study|Adverse Event|23|||
23623392|NCT01263925|66008404|FG001|Overall Study|Adverse Event|22|||
23623393|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
23623394|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
23623395|NCT01263925|66008403|FG000|Overall Study|Withdrawal by Subject|6|||
23623396|NCT01263925|66008404|FG001|Overall Study|Withdrawal by Subject|8|||
23623397|NCT01263925|66008403|FG000|Overall Study|Other|4|||
23623398|NCT01263925|66008404|FG001|Overall Study|Other|4|||
23433650|NCT01278407|65330530|FG000|Extension Phase|Adverse Event|0|||
23433651|NCT01278407|65330531|FG001|Extension Phase|Adverse Event|0|||
23433652|NCT01278407|65330532|FG002|Extension Phase|Adverse Event|0|||
23433653|NCT01278407|65330533|FG003|Extension Phase|Adverse Event|7|||
23749905|NCT02152631|66463491|FG001|Overall Study|On Treatment|3|||
23749906|NCT03170271|66463492|FG000|Overall Study|Adverse Event|7|||
23433654|NCT01278407|65330534|FG004|Extension Phase|Adverse Event|16|||
23433655|NCT01278407|65330530|FG000|Extension Phase|Participant's Choice|0|||
23433656|NCT01278407|65330531|FG001|Extension Phase|Participant's Choice|0|||
23433657|NCT01278407|65330532|FG002|Extension Phase|Participant's Choice|0|||
23433658|NCT01278407|65330533|FG003|Extension Phase|Participant's Choice|4|||
23433659|NCT01278407|65330534|FG004|Extension Phase|Participant's Choice|11|||
23433660|NCT01278407|65330530|FG000|Extension Phase|Other|0|||
23433661|NCT01278407|65330531|FG001|Extension Phase|Other|0|||
23433662|NCT01278407|65330532|FG002|Extension Phase|Other|0|||
23433663|NCT01278407|65330533|FG003|Extension Phase|Other|1|||
23433664|NCT01278407|65330534|FG004|Extension Phase|Other|3|||
23433665|NCT05392803|65330538|FG000|Overall Study|Lost to Follow-up|0|||
23433666|NCT05392803|65330539|FG001|Overall Study|Lost to Follow-up|2|||
23433667|NCT02690714|65330544|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
23433668|NCT02690714|65330544|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
23433669|NCT04732949|65330545|FG000|Overall Study|Withdrawal by Subject|23|||
23433670|NCT04732949|65330546|FG001|Overall Study|Withdrawal by Subject|27|||
23433671|NCT04732949|65330545|FG000|Overall Study|Protocol Violation|0|||
23433672|NCT04732949|65330546|FG001|Overall Study|Protocol Violation|1|||
23433673|NCT04732949|65330545|FG000|Overall Study|Non-compliance|0|||
23433674|NCT04732949|65330546|FG001|Overall Study|Non-compliance|2|||
23433675|NCT04732949|65330545|FG000|Overall Study|Physician Decision|2|||
23433676|NCT04732949|65330546|FG001|Overall Study|Physician Decision|1|||
23433677|NCT04732949|65330545|FG000|Overall Study|Serious adverse event (Fatal)|16|||
23433678|NCT04732949|65330546|FG001|Overall Study|Serious adverse event (Fatal)|18|||
23555957|NCT01297959|65762404|FG001|Overall Study|Withdrawal by Subject|4|||
23749907|NCT03170271|66463493|FG001|Overall Study|Adverse Event|2|||
23749908|NCT03170271|66463492|FG000|Overall Study|Lost to Follow-up|0|||
23749909|NCT03170271|66463493|FG001|Overall Study|Lost to Follow-up|1|||
23749910|NCT03170271|66463492|FG000|Overall Study|Physician Decision|1|||
23749911|NCT03170271|66463493|FG001|Overall Study|Physician Decision|0|||
23749912|NCT03170271|66463492|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
23749913|NCT03170271|66463493|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
23749914|NCT03170271|66463492|FG000|Overall Study|Withdrawal by Subject|17|||
23749915|NCT03170271|66463493|FG001|Overall Study|Withdrawal by Subject|5|||
23749916|NCT03170271|66463492|FG000|Overall Study|Other|2|||
23749917|NCT03170271|66463493|FG001|Overall Study|Other|2|||
23433679|NCT04732949|65330545|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
23433680|NCT04732949|65330546|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
23749918|NCT03170271|66463492|FG000|Overall Study|Randomized in error|4|||
23433681|NCT04732949|65330545|FG000|Overall Study|Non-serious adverse event|1|||
23433682|NCT04732949|65330546|FG001|Overall Study|Non-serious adverse event|3|||
23433683|NCT04732949|65330545|FG000|Overall Study|Lost to Follow-up|26|||
23749919|NCT03170271|66463493|FG001|Overall Study|Randomized in error|0|||
23749920|NCT04780776|66463496|FG000|Titration Week 1-5|Lost to Follow-up|2|||
23555958|NCT01297959|65762403|FG000|Overall Study|Physician Decision|0|||
23555959|NCT01297959|65762404|FG001|Overall Study|Physician Decision|1|||
23555960|NCT01297959|65762403|FG000|Overall Study|Unrelated medical illness / complication|0|||
23555961|NCT01297959|65762404|FG001|Overall Study|Unrelated medical illness / complication|2|||
23555962|NCT01297959|65762403|FG000|Overall Study|Other|13|||
23555963|NCT01297959|65762404|FG001|Overall Study|Other|7|||
23555964|NCT02618616|65762405|FG000|Overall Study|Lack of Efficacy|4|||
23623399|NCT01263925|66008403|FG000|Overall Study|Lost to Follow-up|3|||
23623400|NCT01263925|66008404|FG001|Overall Study|Lost to Follow-up|1|||
23623401|NCT01263925|66008403|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
23623402|NCT01263925|66008404|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
23623403|NCT01263925|66008403|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
23623404|NCT01263925|66008404|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
23623405|NCT01263925|66008403|FG000|Overall Study|AE/ Withdrawal|1|||
23623406|NCT01263925|66008404|FG001|Overall Study|AE/ Withdrawal|4|||
23623407|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
23623408|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
23623409|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
23555965|NCT02618616|65762406|FG001|Overall Study|Lack of Efficacy|0|||
23623410|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
23433684|NCT04732949|65330546|FG001|Overall Study|Lost to Follow-up|27|||
23433685|NCT04732949|65330545|FG000|Overall Study|Other|6|||
23749921|NCT04780776|66463497|FG001|Titration Week 1-5|Lost to Follow-up|8|||
23749922|NCT04780776|66463496|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
23749923|NCT04780776|66463497|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
23749924|NCT04780776|66463496|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
23749925|NCT04780776|66463497|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
23749926|NCT02666768|66463498|FG000|Overall Study|Withdrawal by Subject|4|||
23749927|NCT01569594|66463499|FG000|Overall Study|Physician Decision|4|||
23749928|NCT01569594|66463499|FG000|Overall Study|Death|13|||
23749929|NCT01569594|66463499|FG000|Overall Study|Lost to Follow-up|22|||
23749930|NCT01569594|66463499|FG000|Overall Study|Adverse Event|2|||
23749931|NCT01569594|66463499|FG000|Overall Study|Withdrawal by Subject|13|||
23749932|NCT01569594|66463499|FG000|Overall Study|Other|4|||
23749933|NCT01569594|66463499|FG000|Overall Study|No ECM used|9|||
23749934|NCT00026312|66463500|FG000|Overall Study|Adverse Event|0|||
23749935|NCT00026312|66463501|FG001|Overall Study|Adverse Event|32|||
23749936|NCT00026312|66463500|FG000|Overall Study|Death|1|||
23433686|NCT04732949|65330546|FG001|Overall Study|Other|3|||
23433687|NCT02202538|65330549|FG000|Overall Study|Withdrawal by Subject|5|||
23749937|NCT00026312|66463501|FG001|Overall Study|Death|7|||
23749938|NCT00026312|66463500|FG000|Overall Study|Lack of Efficacy|19|||
23824421|NCT00699998|66737879|FG002|Overall Study|Lost to Follow-up|3|||
23824422|NCT00699998|66737880|FG003|Overall Study|Lost to Follow-up|1|||
23824423|NCT04315506|66737881|FG000|Overall Study|Lost to Follow-up|74|||
23824424|NCT04315506|66737882|FG001|Overall Study|Lost to Follow-up|82|||
23824425|NCT04315506|66737881|FG000|Overall Study|Withdrawal by Subject|8|||
23824426|NCT04315506|66737882|FG001|Overall Study|Withdrawal by Subject|8|||
23824427|NCT04315506|66737881|FG000|Overall Study|Physician Decision|0|||
23824428|NCT04315506|66737882|FG001|Overall Study|Physician Decision|1|||
23824429|NCT04578535|66737885|FG000|Overall Study|Lost to Follow-up|1|||
23824430|NCT04578535|66737886|FG001|Overall Study|Lost to Follow-up|0|||
23824431|NCT04578535|66737887|FG002|Overall Study|Lost to Follow-up|0|||
23824432|NCT04578535|66737888|FG003|Overall Study|Lost to Follow-up|1|||
23824433|NCT04578535|66737889|FG004|Overall Study|Lost to Follow-up|0|||
23824434|NCT04578535|66737890|FG005|Overall Study|Lost to Follow-up|2|||
23824435|NCT04578535|66737885|FG000|Overall Study|Pregnancy|1|||
23824436|NCT04578535|66737886|FG001|Overall Study|Pregnancy|0|||
23824437|NCT04578535|66737887|FG002|Overall Study|Pregnancy|0|||
23824438|NCT04578535|66737888|FG003|Overall Study|Pregnancy|0|||
23749939|NCT00026312|66463501|FG001|Overall Study|Lack of Efficacy|114|||
23749940|NCT00026312|66463500|FG000|Overall Study|Lost to Follow-up|0|||
23749941|NCT00026312|66463501|FG001|Overall Study|Lost to Follow-up|5|||
23749942|NCT00026312|66463500|FG000|Overall Study|Physician Decision|1|||
23749943|NCT00026312|66463501|FG001|Overall Study|Physician Decision|37|||
23749944|NCT00026312|66463500|FG000|Overall Study|Protocol Violation|0|||
23749945|NCT00026312|66463501|FG001|Overall Study|Protocol Violation|3|||
23824439|NCT04578535|66737889|FG004|Overall Study|Pregnancy|0|||
23824440|NCT04578535|66737890|FG005|Overall Study|Pregnancy|0|||
23824441|NCT04578535|66737885|FG000|Overall Study|Withdrawal by Subject|0|||
23824442|NCT04578535|66737886|FG001|Overall Study|Withdrawal by Subject|0|||
23824443|NCT04578535|66737887|FG002|Overall Study|Withdrawal by Subject|0|||
23824444|NCT04578535|66737888|FG003|Overall Study|Withdrawal by Subject|1|||
23433688|NCT02202538|65330549|FG000|Overall Study|Did not meet all inclusion criteria|2|||
23749946|NCT00026312|66463500|FG000|Overall Study|Withdrawal by Subject|1|||
23749947|NCT00026312|66463501|FG001|Overall Study|Withdrawal by Subject|6|||
23749948|NCT00026312|66463500|FG000|Overall Study|Ineligible|4|||
23749949|NCT00026312|66463501|FG001|Overall Study|Ineligible|5|||
23749950|NCT00026312|66463500|FG000|Overall Study|Entry onto another COG study|0|||
23824445|NCT04578535|66737889|FG004|Overall Study|Withdrawal by Subject|1|||
23824446|NCT04578535|66737890|FG005|Overall Study|Withdrawal by Subject|5|||
23824447|NCT04578535|66737885|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
23824448|NCT04578535|66737886|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
23749951|NCT00026312|66463501|FG001|Overall Study|Entry onto another COG study|1|||
23749952|NCT00026312|66463500|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
23749953|NCT00026312|66463501|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
23749954|NCT04619004|66463504|FG000|Overall Study|Death|114|||
23749955|NCT04619004|66463505|FG001|Overall Study|Death|28|||
23749956|NCT04619004|66463504|FG000|Overall Study|Lost to Follow-up|1|||
23623411|NCT01263925|66008403|FG000|Overall Study|Withdrawal/ Not specified|0|||
23623412|NCT01263925|66008404|FG001|Overall Study|Withdrawal/ Not specified|1|||
23623413|NCT00746785|66008407|FG000|Overall Study|Lost to Follow-up|29|||
23623414|NCT00746785|66008408|FG001|Overall Study|Lost to Follow-up|25|||
23623415|NCT00746785|66008409|FG002|Overall Study|Lost to Follow-up|27|||
23623416|NCT02019641|66008412|FG000|10-Week Follow up|Withdrawal by investigator|2|||
23623417|NCT02019641|66008413|FG001|10-Week Follow up|Withdrawal by investigator|0|||
23623418|NCT02019641|66008414|FG002|10-Week Follow up|Withdrawal by investigator|0|||
23749957|NCT04619004|66463505|FG001|Overall Study|Lost to Follow-up|1|||
23749958|NCT04619004|66463504|FG000|Overall Study|Withdrawal by Subject|24|||
23749959|NCT04619004|66463505|FG001|Overall Study|Withdrawal by Subject|7|||
23623419|NCT02019641|66008412|FG000|10-Week Follow up|Withdrawal by Subject|1|||
23623420|NCT02019641|66008413|FG001|10-Week Follow up|Withdrawal by Subject|1|||
23623421|NCT02019641|66008414|FG002|10-Week Follow up|Withdrawal by Subject|0|||
23623422|NCT02019641|66008412|FG000|20-Week Follow up|Withdrawal by investigator|0|||
23749960|NCT04619004|66463504|FG000|Overall Study|Other - Not specified|0|||
23749961|NCT04619004|66463505|FG001|Overall Study|Other - Not specified|1|||
23824449|NCT04578535|66737887|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
23824450|NCT04578535|66737888|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
23824451|NCT04578535|66737889|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
23824452|NCT04578535|66737890|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
23824453|NCT02575833|66737891|FG000|Overall Study|Withdrawal by Subject|0|||
23824454|NCT02575833|66737892|FG001|Overall Study|Withdrawal by Subject|1|||
23824455|NCT02575833|66737891|FG000|Overall Study|Lost to Follow-up|1|||
23824456|NCT02575833|66737892|FG001|Overall Study|Lost to Follow-up|0|||
23824457|NCT01406574|66737894|FG000|Overall Study|Adverse Event|0|||
23824458|NCT01406574|66737895|FG001|Overall Study|Adverse Event|0|||
23824459|NCT01406574|66737896|FG002|Overall Study|Adverse Event|1|||
23824460|NCT01406574|66737897|FG003|Overall Study|Adverse Event|3|||
23824461|NCT01406574|66737894|FG000|Overall Study|Physician Decision|0|||
23824462|NCT01406574|66737895|FG001|Overall Study|Physician Decision|0|||
23824463|NCT01406574|66737896|FG002|Overall Study|Physician Decision|0|||
23824464|NCT01406574|66737897|FG003|Overall Study|Physician Decision|1|||
23824465|NCT01406574|66737894|FG000|Overall Study|Withdrawal by Subject|0|||
23824466|NCT01406574|66737895|FG001|Overall Study|Withdrawal by Subject|1|||
23824467|NCT01406574|66737896|FG002|Overall Study|Withdrawal by Subject|0|||
23824468|NCT01406574|66737897|FG003|Overall Study|Withdrawal by Subject|0|||
23824469|NCT01406574|66737894|FG000|Overall Study|Definite progression of primary disease|1|||
23824470|NCT01406574|66737895|FG001|Overall Study|Definite progression of primary disease|0|||
23824471|NCT01406574|66737896|FG002|Overall Study|Definite progression of primary disease|0|||
23824472|NCT01406574|66737897|FG003|Overall Study|Definite progression of primary disease|0|||
23824473|NCT00754650|66737898|FG000|Overall Study|Disease Progression|2|||
23824474|NCT01937871|66737899|FG000|Overall Study|Adverse Event|6|||
23824475|NCT01937871|66737900|FG001|Overall Study|Adverse Event|6|||
23824476|NCT01937871|66737901|FG002|Overall Study|Adverse Event|2|||
23824477|NCT01937871|66737899|FG000|Overall Study|Lost to Follow-up|8|||
23824478|NCT01937871|66737900|FG001|Overall Study|Lost to Follow-up|2|||
23824479|NCT01937871|66737901|FG002|Overall Study|Lost to Follow-up|4|||
23824480|NCT01937871|66737899|FG000|Overall Study|Withdrawal by Subject|9|||
23824481|NCT01937871|66737900|FG001|Overall Study|Withdrawal by Subject|6|||
23824482|NCT01937871|66737901|FG002|Overall Study|Withdrawal by Subject|4|||
23824483|NCT01937871|66737899|FG000|Overall Study|Physician Decision|0|||
23433689|NCT02202538|65330549|FG000|Overall Study|Investigator Decision|1|||
23433690|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
23433691|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
23433692|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
23433693|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
23623423|NCT02019641|66008413|FG001|20-Week Follow up|Withdrawal by investigator|0|||
23749962|NCT02181673|66463507|FG000|Up to Week 24|Adverse Event|2|||
23749963|NCT02181673|66463508|FG001|Up to Week 24|Adverse Event|0|||
23749964|NCT02181673|66463509|FG002|Up to Week 24|Adverse Event|3|||
23749965|NCT02181673|66463507|FG000|Up to Week 24|Death|1|||
23824484|NCT01937871|66737900|FG001|Overall Study|Physician Decision|1|||
23824485|NCT01937871|66737901|FG002|Overall Study|Physician Decision|0|||
23824486|NCT01937871|66737899|FG000|Overall Study|Entry Criteria Not Met|1|||
23824487|NCT01937871|66737900|FG001|Overall Study|Entry Criteria Not Met|2|||
23824488|NCT01937871|66737901|FG002|Overall Study|Entry Criteria Not Met|1|||
23824489|NCT01262872|66737902|FG000|Step 2|Death|0|||
23824490|NCT01262872|66737903|FG001|Step 2|Death|0|||
23824491|NCT01262872|66737904|FG002|Step 2|Death|0|||
23749966|NCT02181673|66463508|FG001|Up to Week 24|Death|0|||
23555966|NCT02618616|65762405|FG000|Overall Study|Pregnancy|0|||
23555967|NCT02618616|65762406|FG001|Overall Study|Pregnancy|1|||
23555968|NCT02618616|65762405|FG000|Overall Study|Adverse Event|8|||
23555969|NCT02618616|65762406|FG001|Overall Study|Adverse Event|0|||
23555970|NCT02618616|65762405|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
23555971|NCT02618616|65762406|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
23749967|NCT02181673|66463509|FG002|Up to Week 24|Death|0|||
23824492|NCT01262872|66737905|FG003|Step 2|Death|1|||
23824493|NCT01262872|66737906|FG004|Step 2|Death|0|||
23824494|NCT01262872|66737907|FG005|Step 2|Death|2|||
23824495|NCT01262872|66737908|FG006|Step 2|Death|2|||
23824496|NCT01262872|66737909|FG007|Step 2|Death|1|||
23824497|NCT01262872|66737902|FG000|Step 2|Protocol Violation|0|||
23824498|NCT01262872|66737903|FG001|Step 2|Protocol Violation|0|||
23824499|NCT01262872|66737904|FG002|Step 2|Protocol Violation|1|||
23824500|NCT01262872|66737905|FG003|Step 2|Protocol Violation|0|||
23824501|NCT01262872|66737906|FG004|Step 2|Protocol Violation|0|||
23824502|NCT01262872|66737907|FG005|Step 2|Protocol Violation|0|||
23824503|NCT01262872|66737908|FG006|Step 2|Protocol Violation|3|||
23824504|NCT01262872|66737909|FG007|Step 2|Protocol Violation|1|||
23824505|NCT01262872|66737902|FG000|Step 2|Withdrawal by Subject|0|||
23824506|NCT01262872|66737903|FG001|Step 2|Withdrawal by Subject|0|||
23824507|NCT01262872|66737904|FG002|Step 2|Withdrawal by Subject|4|||
23824508|NCT01262872|66737905|FG003|Step 2|Withdrawal by Subject|6|||
23824509|NCT01262872|66737906|FG004|Step 2|Withdrawal by Subject|3|||
23824510|NCT01262872|66737907|FG005|Step 2|Withdrawal by Subject|1|||
23555972|NCT02618616|65762405|FG000|Overall Study|Consent withdrawn by subject|8|||
23749968|NCT02181673|66463507|FG000|Up to Week 24|Lack of Efficacy|1|||
23749969|NCT02181673|66463508|FG001|Up to Week 24|Lack of Efficacy|0|||
23749970|NCT02181673|66463509|FG002|Up to Week 24|Lack of Efficacy|0|||
23749971|NCT02181673|66463507|FG000|Up to Week 24|Lost to Follow-up|1|||
23749972|NCT02181673|66463508|FG001|Up to Week 24|Lost to Follow-up|0|||
23749973|NCT02181673|66463509|FG002|Up to Week 24|Lost to Follow-up|0|||
23824511|NCT01262872|66737908|FG006|Step 2|Withdrawal by Subject|2|||
23824512|NCT01262872|66737909|FG007|Step 2|Withdrawal by Subject|1|||
23824513|NCT01262872|66737902|FG000|Step 2|Migrated/moved from study area|0|||
23824514|NCT01262872|66737903|FG001|Step 2|Migrated/moved from study area|0|||
23824515|NCT01262872|66737904|FG002|Step 2|Migrated/moved from study area|4|||
23824516|NCT01262872|66737905|FG003|Step 2|Migrated/moved from study area|3|||
23824517|NCT01262872|66737906|FG004|Step 2|Migrated/moved from study area|2|||
23824518|NCT01262872|66737907|FG005|Step 2|Migrated/moved from study area|6|||
23824519|NCT01262872|66737908|FG006|Step 2|Migrated/moved from study area|2|||
23824520|NCT01262872|66737909|FG007|Step 2|Migrated/moved from study area|3|||
23824521|NCT00853099|66737910|FG000|Double-blind Period|Adverse Event|7|||
23824522|NCT00853099|66737911|FG001|Double-blind Period|Adverse Event|9|||
23824523|NCT00853099|66737912|FG002|Double-blind Period|Adverse Event|13|||
23824524|NCT00853099|66737913|FG003|Double-blind Period|Adverse Event|0|||
23824525|NCT00853099|66737910|FG000|Double-blind Period|Withdrawal by Subject|2|||
23824526|NCT00853099|66737911|FG001|Double-blind Period|Withdrawal by Subject|3|||
23824527|NCT00853099|66737912|FG002|Double-blind Period|Withdrawal by Subject|0|||
23824528|NCT00853099|66737913|FG003|Double-blind Period|Withdrawal by Subject|0|||
23824529|NCT00853099|66737910|FG000|Double-blind Period|Lack of Efficacy|14|||
23824530|NCT00853099|66737911|FG001|Double-blind Period|Lack of Efficacy|17|||
23824531|NCT00853099|66737912|FG002|Double-blind Period|Lack of Efficacy|16|||
23824532|NCT00853099|66737913|FG003|Double-blind Period|Lack of Efficacy|0|||
23824533|NCT00853099|66737910|FG000|Double-blind Period|Other|0|||
23824534|NCT00853099|66737911|FG001|Double-blind Period|Other|0|||
23824535|NCT00853099|66737912|FG002|Double-blind Period|Other|1|||
23824536|NCT00853099|66737913|FG003|Double-blind Period|Other|0|||
23824537|NCT00853099|66737910|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
23555973|NCT02618616|65762406|FG001|Overall Study|Consent withdrawn by subject|5|||
23555974|NCT02618616|65762405|FG000|Overall Study|Lost to Follow-up|0|||
23555975|NCT02618616|65762406|FG001|Overall Study|Lost to Follow-up|1|||
23555976|NCT02953938|65762407|FG000|Overall Study|Adverse Event|0|||
23555977|NCT02953938|65762408|FG001|Overall Study|Adverse Event|1|||
23824538|NCT00853099|66737911|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
23555978|NCT02953938|65762407|FG000|Overall Study|Withdrawal by Subject|1|||
23555979|NCT02953938|65762408|FG001|Overall Study|Withdrawal by Subject|1|||
23824539|NCT00853099|66737912|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
23555980|NCT01345630|65762409|FG000|Overall Study|Adverse Event|22|||
23555981|NCT01345630|65762410|FG001|Overall Study|Adverse Event|23|||
23749974|NCT02181673|66463507|FG000|Up to Week 24|Physician Decision|0|||
23749975|NCT02181673|66463508|FG001|Up to Week 24|Physician Decision|0|||
23824540|NCT00853099|66737913|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
23824541|NCT00853099|66737910|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23824542|NCT00853099|66737911|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23824543|NCT00853099|66737912|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23824544|NCT00853099|66737913|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
23555982|NCT01345630|65762409|FG000|Overall Study|Lost to Follow-up|17|||
23555983|NCT01345630|65762410|FG001|Overall Study|Lost to Follow-up|16|||
23555984|NCT01345630|65762409|FG000|Overall Study|Protocol Violation|4|||
23555985|NCT01345630|65762410|FG001|Overall Study|Protocol Violation|1|||
23555986|NCT01345630|65762409|FG000|Overall Study|Medication error without associated AE|0|||
23749976|NCT02181673|66463509|FG002|Up to Week 24|Physician Decision|3|||
23749977|NCT02181673|66463507|FG000|Up to Week 24|Withdrawal by Subject|10|||
23749978|NCT02181673|66463508|FG001|Up to Week 24|Withdrawal by Subject|0|||
23749979|NCT02181673|66463509|FG002|Up to Week 24|Withdrawal by Subject|1|||
23749980|NCT02181673|66463507|FG000|Up to Week 24|Other|2|||
23749981|NCT02181673|66463508|FG001|Up to Week 24|Other|0|||
23749982|NCT02181673|66463509|FG002|Up to Week 24|Other|3|||
23749983|NCT02181673|66463507|FG000|Up to Week 24|Randomized not Treated|0|||
23749984|NCT02181673|66463508|FG001|Up to Week 24|Randomized not Treated|0|||
23749985|NCT02181673|66463509|FG002|Up to Week 24|Randomized not Treated|1|||
23749986|NCT02181673|66463507|FG000|Week 24-Week 60|Adverse Event|0|||
23749987|NCT02181673|66463508|FG001|Week 24-Week 60|Adverse Event|4|||
23749988|NCT02181673|66463509|FG002|Week 24-Week 60|Adverse Event|10|||
23749989|NCT02181673|66463507|FG000|Week 24-Week 60|Other|0|||
23749990|NCT02181673|66463508|FG001|Week 24-Week 60|Other|2|||
23749991|NCT02181673|66463509|FG002|Week 24-Week 60|Other|1|||
23749992|NCT02181673|66463507|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
23749993|NCT02181673|66463508|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
23749994|NCT02181673|66463509|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
23749995|NCT02181673|66463507|FG000|Week 24-Week 60|Pregnancy|0|||
23433694|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
23433695|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
23433696|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
23433697|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
23433698|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
23433699|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
23433700|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
23433701|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
23433702|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
23749996|NCT02181673|66463508|FG001|Week 24-Week 60|Pregnancy|0|||
23824545|NCT00853099|66737910|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
23824546|NCT00853099|66737911|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
23824547|NCT00853099|66737912|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
23824548|NCT00853099|66737913|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
23824549|NCT00853099|66737910|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23824550|NCT00853099|66737911|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23824551|NCT00853099|66737912|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23555987|NCT01345630|65762410|FG001|Overall Study|Medication error without associated AE|1|||
23555988|NCT01345630|65762409|FG000|Overall Study|Study terminated by sponsor|254|||
23555989|NCT01345630|65762410|FG001|Overall Study|Study terminated by sponsor|285|||
23824552|NCT00853099|66737913|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
23824553|NCT00853099|66737910|FG000|Double-blind + Open-label Periods|Other|0|||
23824554|NCT00853099|66737911|FG001|Double-blind + Open-label Periods|Other|0|||
23824555|NCT00853099|66737912|FG002|Double-blind + Open-label Periods|Other|0|||
23824556|NCT00853099|66737913|FG003|Double-blind + Open-label Periods|Other|6|||
23824557|NCT02861014|66737914|FG000|Primary Analysis|Adverse Event|7|||
23824558|NCT02861014|66737914|FG000|Primary Analysis|Death|1|||
23824559|NCT02861014|66737914|FG000|Primary Analysis|Lack of Efficacy|3|||
23824560|NCT02861014|66737914|FG000|Primary Analysis|Physician Decision|2|||
23824561|NCT02861014|66737914|FG000|Primary Analysis|Pregnancy|4|||
23433703|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
23433704|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
23555990|NCT01345630|65762409|FG000|Overall Study|Other reasons|6|||
23749997|NCT02181673|66463509|FG002|Week 24-Week 60|Pregnancy|1|||
23555991|NCT01345630|65762410|FG001|Overall Study|Other reasons|8|||
23824562|NCT02861014|66737914|FG000|Primary Analysis|Protocol Violation|2|||
23824563|NCT02861014|66737914|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
23824564|NCT02861014|66737914|FG000|Primary Analysis|Withdrawal by Subject|14|||
23749998|NCT02181673|66463507|FG000|Week 24-Week 60|Lack of Efficacy|0|||
23749999|NCT02181673|66463508|FG001|Week 24-Week 60|Lack of Efficacy|0|||
23750000|NCT02181673|66463509|FG002|Week 24-Week 60|Lack of Efficacy|1|||
23750001|NCT02181673|66463507|FG000|Week 24-Week 60|Lost to Follow-up|0|||
23750002|NCT02181673|66463508|FG001|Week 24-Week 60|Lost to Follow-up|0|||
23750003|NCT02181673|66463509|FG002|Week 24-Week 60|Lost to Follow-up|1|||
23750004|NCT02181673|66463507|FG000|Week 24-Week 60|Physician Decision|0|||
23750005|NCT02181673|66463508|FG001|Week 24-Week 60|Physician Decision|0|||
23750006|NCT02181673|66463509|FG002|Week 24-Week 60|Physician Decision|1|||
23750007|NCT04359758|66463510|FG000|Overall Study|Protocol Violation|3|||
23750008|NCT04359758|66463511|FG001|Overall Study|Protocol Violation|2|||
23750009|NCT02353572|66463516|FG000|Overall Study|Withdrawal by Subject|1|||
23750010|NCT02353572|66463516|FG000|Overall Study|Study terminated|2|||
23750011|NCT01015118|66463517|FG000|Overall Study|Protocol Violation|5|||
23750012|NCT01015118|66463518|FG001|Overall Study|Protocol Violation|6|||
23750013|NCT01015118|66463517|FG000|Overall Study|Withdrawal by Subject|103|||
23433705|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
23555992|NCT01345630|65762409|FG000|Overall Study|Withdrawn due to pregnancy|1|||
23433706|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
23555993|NCT01345630|65762410|FG001|Overall Study|Withdrawn due to pregnancy|2|||
23555994|NCT01345630|65762409|FG000|Overall Study|No longer willing to participate|9|||
23750014|NCT01015118|66463518|FG001|Overall Study|Withdrawal by Subject|27|||
23750015|NCT01015118|66463517|FG000|Overall Study|Other Adverse Event (AE)|141|||
23750016|NCT01015118|66463518|FG001|Overall Study|Other Adverse Event (AE)|33|||
23750017|NCT01015118|66463517|FG000|Overall Study|Worsening or AE of underlying disease|5|||
23750018|NCT01015118|66463518|FG001|Overall Study|Worsening or AE of underlying disease|4|||
23750019|NCT01015118|66463517|FG000|Overall Study|Progressive disease|364|||
23750020|NCT01015118|66463518|FG001|Overall Study|Progressive disease|229|||
23750021|NCT01015118|66463517|FG000|Overall Study|Not treated|9|||
23750022|NCT01015118|66463518|FG001|Overall Study|Not treated|5|||
23750023|NCT01015118|66463517|FG000|Overall Study|Other than stated above|42|||
23750024|NCT01015118|66463518|FG001|Overall Study|Other than stated above|23|||
23555995|NCT01345630|65762410|FG001|Overall Study|No longer willing to participate|12|||
23433707|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
23433708|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
23433709|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
23433710|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
23433711|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
23433712|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
23750025|NCT05378269|66463519|FG000|Overall Study|Protocol Violation|1|||
23750026|NCT05378269|66463520|FG001|Overall Study|Protocol Violation|0|||
23750027|NCT05378269|66463521|FG002|Overall Study|Protocol Violation|2|||
23750028|NCT05378269|66463522|FG003|Overall Study|Protocol Violation|0|||
23750029|NCT05378269|66463523|FG004|Overall Study|Protocol Violation|0|||
23750030|NCT05153629|66463524|FG000|Overall Study|Withdrawal by Subject|0|||
23750031|NCT05153629|66463525|FG001|Overall Study|Withdrawal by Subject|2|||
23750032|NCT00278473|66463529|FG000|Overall Study|drop out|4|||
23750033|NCT00278473|66463530|FG001|Overall Study|drop out|3|||
23750034|NCT04936334|66463534|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
23750035|NCT03743571|66463537|FG000|Overall Study|Withdrawal by Subject|1|||
23750036|NCT03743571|66463538|FG001|Overall Study|Withdrawal by Subject|1|||
23750037|NCT03743571|66463537|FG000|Overall Study|Lost to Follow-up|1|||
23750038|NCT03743571|66463538|FG001|Overall Study|Lost to Follow-up|2|||
23750039|NCT00585468|66463543|FG000|First Intervention|Withdrawal by Subject|1|||
23750040|NCT00585468|66463544|FG001|First Intervention|Withdrawal by Subject|1|||
23750041|NCT00770809|66463545|FG000|Overall Study|Adverse Event|9|||
23750042|NCT00770809|66463546|FG001|Overall Study|Adverse Event|1|||
23750043|NCT00770809|66463547|FG002|Overall Study|Adverse Event|12|||
23750044|NCT00770809|66463545|FG000|Overall Study|Death|1|||
23750045|NCT00770809|66463546|FG001|Overall Study|Death|0|||
23750046|NCT00770809|66463547|FG002|Overall Study|Death|0|||
23750047|NCT00770809|66463545|FG000|Overall Study|Withdrawal by Subject|3|||
23750048|NCT00770809|66463546|FG001|Overall Study|Withdrawal by Subject|3|||
23750049|NCT00770809|66463547|FG002|Overall Study|Withdrawal by Subject|7|||
23750050|NCT00770809|66463545|FG000|Overall Study|Progression|2|||
23750051|NCT00770809|66463546|FG001|Overall Study|Progression|2|||
23750052|NCT00770809|66463547|FG002|Overall Study|Progression|0|||
23750053|NCT00770809|66463545|FG000|Overall Study|Complicating illness|0|||
23750054|NCT00770809|66463546|FG001|Overall Study|Complicating illness|0|||
23750055|NCT00770809|66463547|FG002|Overall Study|Complicating illness|1|||
23750056|NCT00770809|66463545|FG000|Overall Study|Other Medical Reasons|2|||
23750057|NCT00770809|66463546|FG001|Overall Study|Other Medical Reasons|4|||
23750058|NCT00770809|66463547|FG002|Overall Study|Other Medical Reasons|3|||
23750059|NCT05993299|66463548|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
23750060|NCT05993299|66463548|FG000|Overall Study|Ongoing|4|||
23750061|NCT02257736|66463549|FG000|Overall Study|Progressive disease|365|||
23750062|NCT02257736|66463550|FG001|Overall Study|Progressive disease|327|||
23750063|NCT02257736|66463549|FG000|Overall Study|Adverse Event|45|||
23750064|NCT02257736|66463550|FG001|Overall Study|Adverse Event|56|||
23750065|NCT02257736|66463549|FG000|Overall Study|Withdrawal by Subject|21|||
23750066|NCT02257736|66463550|FG001|Overall Study|Withdrawal by Subject|38|||
23750067|NCT02257736|66463549|FG000|Overall Study|Death|11|||
23750068|NCT02257736|66463550|FG001|Overall Study|Death|6|||
23750069|NCT02257736|66463549|FG000|Overall Study|Physician Decision|5|||
23750070|NCT02257736|66463550|FG001|Overall Study|Physician Decision|9|||
23750071|NCT02257736|66463549|FG000|Overall Study|Non-Compliance with study drug|1|||
23750072|NCT02257736|66463550|FG001|Overall Study|Non-Compliance with study drug|2|||
23750073|NCT02257736|66463549|FG000|Overall Study|Protocol Violation|1|||
23750074|NCT02257736|66463550|FG001|Overall Study|Protocol Violation|0|||
23750075|NCT02257736|66463549|FG000|Overall Study|Other|1|||
23750076|NCT02257736|66463550|FG001|Overall Study|Other|7|||
23750077|NCT02257736|66463549|FG000|Overall Study|Randomized, not treated|1|||
23750078|NCT02257736|66463550|FG001|Overall Study|Randomized, not treated|2|||
23433713|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
23433714|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
23750079|NCT04888377|66463551|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
23750080|NCT04888377|66463552|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
23750081|NCT04888377|66463551|FG000|Overall Study|Physician Decision|6|||
23750082|NCT04888377|66463552|FG001|Overall Study|Physician Decision|6|||
23750083|NCT04888377|66463551|FG000|Overall Study|Withdrawal by Subject|7|||
23750084|NCT04888377|66463552|FG001|Overall Study|Withdrawal by Subject|3|||
23750085|NCT00270205|66463554|FG000|Overall Study|Lost to Follow-up|1|||
23750086|NCT00270205|66463555|FG001|Overall Study|Lost to Follow-up|0|||
23750087|NCT00270205|66463556|FG002|Overall Study|Lost to Follow-up|0|||
23750088|NCT00270205|66463557|FG003|Overall Study|Lost to Follow-up|1|||
23750089|NCT05299359|66463561|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
23750090|NCT05299359|66463562|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
23750091|NCT05299359|66463561|FG000|Main Part: Day 1 up to Day 366|Other|2|||
23750092|NCT05299359|66463562|FG001|Main Part: Day 1 up to Day 366|Other|0|||
23433715|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
23433716|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
23555996|NCT01345630|65762409|FG000|Overall Study|Insufficient clinical response|48|||
23555997|NCT01345630|65762410|FG001|Overall Study|Insufficient clinical response|11|||
23555998|NCT00654901|65762411|FG000|Overall Study|Lost to Follow-up|1|||
23555999|NCT00654901|65762412|FG001|Overall Study|Lost to Follow-up|0|||
23556000|NCT00654901|65762413|FG002|Overall Study|Lost to Follow-up|1|||
23556001|NCT00654901|65762414|FG003|Overall Study|Lost to Follow-up|0|||
23556002|NCT00654901|65762411|FG000|Overall Study|Withdrawal by Subject|3|||
23556003|NCT00654901|65762412|FG001|Overall Study|Withdrawal by Subject|0|||
23556004|NCT00654901|65762413|FG002|Overall Study|Withdrawal by Subject|1|||
23556005|NCT00654901|65762414|FG003|Overall Study|Withdrawal by Subject|0|||
23556006|NCT02184611|65762415|FG000|Overall Study|Lack of Efficacy|11|||
23556007|NCT02184611|65762416|FG001|Overall Study|Lack of Efficacy|15|||
23556008|NCT02184611|65762415|FG000|Overall Study|Withdrawal by Subject|5|||
23556009|NCT02184611|65762416|FG001|Overall Study|Withdrawal by Subject|6|||
23556010|NCT02184611|65762415|FG000|Overall Study|Adverse Event|4|||
23556011|NCT02184611|65762416|FG001|Overall Study|Adverse Event|5|||
23556012|NCT02184611|65762415|FG000|Overall Study|Protocol Violation|1|||
23556013|NCT02184611|65762416|FG001|Overall Study|Protocol Violation|1|||
23556014|NCT02184611|65762415|FG000|Overall Study|Protocol defined stopping criteria|0|||
23556015|NCT02184611|65762416|FG001|Overall Study|Protocol defined stopping criteria|1|||
23556016|NCT03403426|65762417|FG000|Overall Study|Death|1|||
23556017|NCT03403426|65762417|FG000|Overall Study|Lost to Follow-up|2|||
23750093|NCT05299359|66463561|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
23750094|NCT05299359|66463562|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
23750095|NCT05299359|66463561|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
23750096|NCT05299359|66463562|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
23750097|NCT05299359|66463561|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
23750098|NCT05299359|66463562|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
23750099|NCT05299359|66463561|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
23750100|NCT05299359|66463562|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
23750101|NCT05299359|66463561|FG000|Extension Part: Day 1 to Day 366|Other|0|||
23750102|NCT05299359|66463562|FG001|Extension Part: Day 1 to Day 366|Other|1|||
23750103|NCT00938392|66463563|FG000|Overall Study|Adverse Event|0|||
23750104|NCT00938392|66463564|FG001|Overall Study|Adverse Event|1|||
23750105|NCT00938392|66463563|FG000|Overall Study|Withdrawal by Subject|0|||
23750106|NCT00938392|66463564|FG001|Overall Study|Withdrawal by Subject|1|||
23750107|NCT00938392|66463563|FG000|Overall Study|Lost to Follow-up|2|||
23750108|NCT00938392|66463564|FG001|Overall Study|Lost to Follow-up|2|||
23750109|NCT02304302|66463565|FG000|Overall Study|Adverse Event|2|||
23750110|NCT02304302|66463566|FG001|Overall Study|Adverse Event|3|||
23750111|NCT02304302|66463565|FG000|Overall Study|Lost to Follow-up|1|||
23750112|NCT02304302|66463566|FG001|Overall Study|Lost to Follow-up|4|||
23750113|NCT02304302|66463565|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
23750114|NCT02304302|66463566|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
23750115|NCT00679042|66463569|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
23750116|NCT00679042|66463569|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
23750117|NCT00679042|66463569|FG000|5-Year Follow Up|Death|1|||
23750118|NCT00679042|66463569|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
23750119|NCT00679042|66463569|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
23750120|NCT03971422|66463570|FG000|Overall Study|Lost to Follow-up|0|||
23750121|NCT03971422|66463571|FG001|Overall Study|Lost to Follow-up|1|||
23750122|NCT03971422|66463572|FG002|Overall Study|Lost to Follow-up|0|||
23750123|NCT03971422|66463570|FG000|Overall Study|Lack of Efficacy|5|||
23750124|NCT03971422|66463571|FG001|Overall Study|Lack of Efficacy|1|||
23750125|NCT03971422|66463572|FG002|Overall Study|Lack of Efficacy|1|||
23750126|NCT03971422|66463570|FG000|Overall Study|Adverse event, not fatal|2|||
23433717|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
23556018|NCT03338894|65762418|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
23556019|NCT00671931|65762419|FG000|Overall Study|Physician Decision|1|||
23556020|NCT00671931|65762420|FG001|Overall Study|Physician Decision|0|||
23556021|NCT00671931|65762421|FG002|Overall Study|Physician Decision|0|||
23623424|NCT02019641|66008414|FG002|20-Week Follow up|Withdrawal by investigator|1|||
23623425|NCT02353871|66008415|FG000|Overall Study|Protocol deviation|0|||
23750127|NCT03971422|66463571|FG001|Overall Study|Adverse event, not fatal|2|||
23750128|NCT03971422|66463572|FG002|Overall Study|Adverse event, not fatal|5|||
23750129|NCT03971422|66463570|FG000|Overall Study|Worsening of MG Symptoms|1|||
23556022|NCT00671931|65762422|FG003|Overall Study|Physician Decision|2|||
23556023|NCT00671931|65762423|FG004|Overall Study|Physician Decision|1|||
23556024|NCT03382782|65762424|FG000|Cohort 1|Withdrawal by Subject|11|||
23750130|NCT03971422|66463571|FG001|Overall Study|Worsening of MG Symptoms|4|||
23623426|NCT02353871|66008416|FG001|Overall Study|Protocol deviation|1|||
23433718|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
23556025|NCT03382782|65762425|FG001|Cohort 1|Withdrawal by Subject|5|||
23556026|NCT03382782|65762426|FG002|Cohort 1|Withdrawal by Subject|0|||
23556027|NCT03382782|65762424|FG000|Cohort 2|Withdrawal by Subject|1|||
23556028|NCT03382782|65762425|FG001|Cohort 2|Withdrawal by Subject|1|||
23556029|NCT03382782|65762426|FG002|Cohort 2|Withdrawal by Subject|0|||
23556030|NCT03382782|65762424|FG000|Cohort 3|Withdrawal by Subject|1|||
23556031|NCT03382782|65762425|FG001|Cohort 3|Withdrawal by Subject|2|||
23556032|NCT03382782|65762426|FG002|Cohort 3|Withdrawal by Subject|0|||
23556033|NCT04870710|65762429|FG000|Overall Study|Lost to Follow-up|3|||
23556034|NCT04040751|65762430|FG000|Overall Study|Withdrawal by Subject|2|||
23556035|NCT04040751|65762431|FG001|Overall Study|Withdrawal by Subject|0|||
23556036|NCT04040751|65762432|FG002|Overall Study|Withdrawal by Subject|2|||
23556037|NCT04040751|65762433|FG003|Overall Study|Withdrawal by Subject|0|||
23556038|NCT03685591|65762434|FG000|Overall Study|Global Deterioration of Health Status|0|||
23556039|NCT03685591|65762435|FG001|Overall Study|Global Deterioration of Health Status|0|||
23556040|NCT03685591|65762436|FG002|Overall Study|Global Deterioration of Health Status|0|||
23556041|NCT03685591|65762437|FG003|Overall Study|Global Deterioration of Health Status|1|||
23556042|NCT03685591|65762438|FG004|Overall Study|Global Deterioration of Health Status|2|||
23556043|NCT03685591|65762439|FG005|Overall Study|Global Deterioration of Health Status|4|||
23556044|NCT03685591|65762440|FG006|Overall Study|Global Deterioration of Health Status|1|||
23556045|NCT03685591|65762441|FG007|Overall Study|Global Deterioration of Health Status|1|||
23556046|NCT03685591|65762442|FG008|Overall Study|Global Deterioration of Health Status|0|||
23556047|NCT03685591|65762434|FG000|Overall Study|Progressive Disease|1|||
23556048|NCT03685591|65762435|FG001|Overall Study|Progressive Disease|1|||
23556049|NCT03685591|65762436|FG002|Overall Study|Progressive Disease|0|||
23556050|NCT03685591|65762437|FG003|Overall Study|Progressive Disease|3|||
23750131|NCT03971422|66463572|FG002|Overall Study|Worsening of MG Symptoms|2|||
23750132|NCT03971422|66463570|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
23750133|NCT03971422|66463571|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
23750134|NCT03971422|66463572|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
23750135|NCT03971422|66463570|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
23750136|NCT03971422|66463571|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
23750137|NCT03971422|66463572|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
23750138|NCT03971422|66463570|FG000|Overall Study|Due to COVID-19 pandemic|0|||
23750139|NCT03971422|66463571|FG001|Overall Study|Due to COVID-19 pandemic|1|||
23750140|NCT03971422|66463572|FG002|Overall Study|Due to COVID-19 pandemic|1|||
23750141|NCT03901339|66463573|FG000|Overall Study|Death|220|||
23750142|NCT03901339|66463574|FG001|Overall Study|Death|192|||
23750143|NCT03901339|66463573|FG000|Overall Study|Informed consent withdrawn|13|||
23750144|NCT03901339|66463574|FG001|Overall Study|Informed consent withdrawn|40|||
23750145|NCT03901339|66463573|FG000|Overall Study|Sponsor request|30|||
23750146|NCT03901339|66463574|FG001|Overall Study|Sponsor request|23|||
23750147|NCT03901339|66463573|FG000|Overall Study|Reason not specified|5|||
23750148|NCT03901339|66463574|FG001|Overall Study|Reason not specified|7|||
23750149|NCT03901339|66463573|FG000|Overall Study|Lost to Follow-up|4|||
23750150|NCT03901339|66463574|FG001|Overall Study|Lost to Follow-up|7|||
23750151|NCT03901339|66463573|FG000|Overall Study|Covid19|0|||
23750152|NCT03901339|66463574|FG001|Overall Study|Covid19|2|||
23750153|NCT03239340|66463575|FG000|Overall Study|Other|26|||
23750154|NCT03239340|66463575|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
23750155|NCT03239340|66463575|FG000|Overall Study|Death|40|||
23750156|NCT03239340|66463575|FG000|Overall Study|Lost to Follow-up|2|||
23750157|NCT03239340|66463575|FG000|Overall Study|Physician Decision|16|||
23750158|NCT03239340|66463575|FG000|Overall Study|Withdrawal by Subject|27|||
23750159|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
23750160|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
23750161|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
23750162|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
23750163|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
23750164|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
23750165|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
23750166|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23433719|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
23750167|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
23750168|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23750169|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23750170|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
23750171|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23556051|NCT03685591|65762438|FG004|Overall Study|Progressive Disease|5|||
23556052|NCT03685591|65762439|FG005|Overall Study|Progressive Disease|4|||
23556053|NCT03685591|65762440|FG006|Overall Study|Progressive Disease|3|||
23556054|NCT03685591|65762441|FG007|Overall Study|Progressive Disease|2|||
23824565|NCT02861014|66737914|FG000|Primary Analysis|Commercial ocrelizumab|3|||
23824566|NCT02861014|66737914|FG000|Safety Follow-up|Adverse Event|1|||
23824567|NCT02861014|66737914|FG000|Safety Follow-up|Pregnancy|1|||
23824568|NCT02861014|66737914|FG000|Safety Follow-up|Withdrawal by Subject|9|||
23824569|NCT02861014|66737914|FG000|Safety Follow-up|Study terminated by sponsor|1|||
23824570|NCT02861014|66737914|FG000|Safety Follow-up|Physician Decision|1|||
23824571|NCT02861014|66737914|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
23824572|NCT02861014|66737914|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
23824573|NCT01526057|66737915|FG000|Overall Study|Withdrawal by Subject|3|||
23824574|NCT01526057|66737916|FG001|Overall Study|Withdrawal by Subject|2|||
23824575|NCT01526057|66737917|FG002|Overall Study|Withdrawal by Subject|2|||
23824576|NCT01526057|66737915|FG000|Overall Study|Adverse Event|3|||
23824577|NCT01526057|66737916|FG001|Overall Study|Adverse Event|1|||
23824578|NCT01526057|66737917|FG002|Overall Study|Adverse Event|1|||
23824579|NCT01526057|66737915|FG000|Overall Study|Death|1|||
23824580|NCT01526057|66737916|FG001|Overall Study|Death|0|||
23824581|NCT01526057|66737917|FG002|Overall Study|Death|0|||
23556055|NCT03685591|65762442|FG008|Overall Study|Progressive Disease|1|||
23556056|NCT03685591|65762434|FG000|Overall Study|Other|0|||
23556057|NCT03685591|65762435|FG001|Overall Study|Other|0|||
23556058|NCT03685591|65762436|FG002|Overall Study|Other|1|||
23556059|NCT03685591|65762437|FG003|Overall Study|Other|0|||
23556060|NCT03685591|65762438|FG004|Overall Study|Other|2|||
23556061|NCT03685591|65762439|FG005|Overall Study|Other|3|||
23556062|NCT03685591|65762440|FG006|Overall Study|Other|0|||
23556063|NCT03685591|65762441|FG007|Overall Study|Other|0|||
23556064|NCT03685591|65762442|FG008|Overall Study|Other|0|||
23556065|NCT03685591|65762434|FG000|Overall Study|Withdrawal by Subject|0|||
23556066|NCT03685591|65762435|FG001|Overall Study|Withdrawal by Subject|0|||
23556067|NCT03685591|65762436|FG002|Overall Study|Withdrawal by Subject|0|||
23556068|NCT03685591|65762437|FG003|Overall Study|Withdrawal by Subject|0|||
23556069|NCT03685591|65762438|FG004|Overall Study|Withdrawal by Subject|3|||
23556070|NCT03685591|65762439|FG005|Overall Study|Withdrawal by Subject|2|||
23556071|NCT03685591|65762440|FG006|Overall Study|Withdrawal by Subject|0|||
23556072|NCT03685591|65762441|FG007|Overall Study|Withdrawal by Subject|0|||
23556073|NCT03685591|65762442|FG008|Overall Study|Withdrawal by Subject|1|||
23556074|NCT03685591|65762434|FG000|Overall Study|Adverse Event|0|||
23556075|NCT03685591|65762435|FG001|Overall Study|Adverse Event|0|||
23556076|NCT03685591|65762436|FG002|Overall Study|Adverse Event|0|||
23556077|NCT03685591|65762437|FG003|Overall Study|Adverse Event|1|||
23556078|NCT03685591|65762438|FG004|Overall Study|Adverse Event|1|||
23556079|NCT03685591|65762439|FG005|Overall Study|Adverse Event|4|||
23556080|NCT03685591|65762440|FG006|Overall Study|Adverse Event|0|||
23556081|NCT03685591|65762441|FG007|Overall Study|Adverse Event|1|||
23556082|NCT03685591|65762442|FG008|Overall Study|Adverse Event|1|||
23556083|NCT02889133|65762443|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
23556084|NCT02889133|65762444|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
23556085|NCT02889133|65762443|FG000|Completed Primary Outcome|Manufacturing error|3|||
23556086|NCT02889133|65762444|FG001|Completed Primary Outcome|Manufacturing error|8|||
23556087|NCT02889133|65762443|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
23556088|NCT02889133|65762444|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
23556089|NCT02889133|65762443|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
23556090|NCT02889133|65762444|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
23556091|NCT02889133|65762443|FG000|Completed Primary Outcome|Protocol Violation|1|||
23556092|NCT02889133|65762444|FG001|Completed Primary Outcome|Protocol Violation|0|||
23556093|NCT02889133|65762443|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
23824582|NCT01526057|66737915|FG000|Overall Study|Lost to Follow-up|1|||
23824583|NCT01526057|66737916|FG001|Overall Study|Lost to Follow-up|0|||
23556094|NCT02889133|65762444|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
23556095|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
23556096|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
23556097|NCT02889133|65762443|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
23556098|NCT02889133|65762444|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
23824584|NCT01526057|66737917|FG002|Overall Study|Lost to Follow-up|1|||
23824585|NCT01526057|66737915|FG000|Overall Study|Other|1|||
23824586|NCT01526057|66737916|FG001|Overall Study|Other|0|||
23824587|NCT01526057|66737917|FG002|Overall Study|Other|1|||
23750172|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23750173|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23750174|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23750175|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23750176|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23750177|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
23750178|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
23750179|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
23750180|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
23750181|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
23750182|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
23750183|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
23750184|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
23750185|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23750186|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23750187|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23750188|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
23750189|NCT03985293|66463578|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
23750190|NCT03985293|66463579|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
23750191|NCT03985293|66463580|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
23750192|NCT03985293|66463581|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
23750193|NCT03985293|66463582|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
23750194|NCT03985293|66463583|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
23750195|NCT03985293|66463578|FG000|FOLLOW-UP|Lost to Follow-up|0|||
23750196|NCT03985293|66463579|FG001|FOLLOW-UP|Lost to Follow-up|0|||
23750197|NCT03985293|66463580|FG002|FOLLOW-UP|Lost to Follow-up|1|||
23750198|NCT03985293|66463581|FG003|FOLLOW-UP|Lost to Follow-up|0|||
23750199|NCT03985293|66463582|FG004|FOLLOW-UP|Lost to Follow-up|0|||
23750200|NCT03985293|66463583|FG005|FOLLOW-UP|Lost to Follow-up|0|||
23750201|NCT03733301|66463584|FG000|Overall Study|Screen Fail|1|||
23750202|NCT03733301|66463585|FG001|Overall Study|Screen Fail|0|||
23750203|NCT03733301|66463586|FG002|Overall Study|Screen Fail|0|||
23750204|NCT03733301|66463584|FG000|Overall Study|Non-compliance|1|||
23556099|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
23556100|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
23556101|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
23556102|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
23556103|NCT00948974|65762452|FG000|Overall Study|Lost to Follow-up|23|||
23556104|NCT00948974|65762453|FG001|Overall Study|Lost to Follow-up|20|||
23556105|NCT00330174|65762454|FG000|Overall Study|Withdrawal by Subject|7|||
23556106|NCT00330174|65762455|FG001|Overall Study|Withdrawal by Subject|7|||
23556107|NCT00330174|65762454|FG000|Overall Study|Lost to Follow-up|4|||
23556108|NCT00330174|65762455|FG001|Overall Study|Lost to Follow-up|1|||
23556109|NCT00330174|65762454|FG000|Overall Study|Clinical deterioration|1|||
23556110|NCT00330174|65762455|FG001|Overall Study|Clinical deterioration|2|||
23556111|NCT00330174|65762454|FG000|Overall Study|Excessive missed visits|3|||
23556112|NCT00330174|65762455|FG001|Overall Study|Excessive missed visits|8|||
23556113|NCT00330174|65762454|FG000|Overall Study|Miscellaneous reasons|7|||
23556114|NCT00330174|65762455|FG001|Overall Study|Miscellaneous reasons|1|||
23556115|NCT01514448|65762456|FG000|Overall Study|Death|7|||
23556116|NCT01514448|65762457|FG001|Overall Study|Death|8|||
23623427|NCT02353871|66008415|FG000|Overall Study|Consent withdrawn|1|||
23750205|NCT03733301|66463585|FG001|Overall Study|Non-compliance|0|||
23750206|NCT03733301|66463586|FG002|Overall Study|Non-compliance|0|||
23750207|NCT03733301|66463584|FG000|Overall Study|Lack of Efficacy|2|||
23750208|NCT03733301|66463585|FG001|Overall Study|Lack of Efficacy|3|||
23750209|NCT03733301|66463586|FG002|Overall Study|Lack of Efficacy|0|||
23750210|NCT03733301|66463584|FG000|Overall Study|Adverse Event|0|||
23750211|NCT03733301|66463585|FG001|Overall Study|Adverse Event|1|||
23556117|NCT01514448|65762456|FG000|Overall Study|Withdrawal by Subject|2|||
23623428|NCT02353871|66008416|FG001|Overall Study|Consent withdrawn|8|||
23556118|NCT01514448|65762457|FG001|Overall Study|Withdrawal by Subject|0|||
23556119|NCT01514448|65762456|FG000|Overall Study|Lost to Follow-up|2|||
23556120|NCT01514448|65762457|FG001|Overall Study|Lost to Follow-up|0|||
23556121|NCT01514448|65762456|FG000|Overall Study|New Cancer Therapy|1|||
23556122|NCT01514448|65762457|FG001|Overall Study|New Cancer Therapy|0|||
23556123|NCT03750006|65762461|FG000|Overall Study|Withdrawal by Subject|8|||
23556124|NCT03750006|65762461|FG000|Overall Study|COVID PANDEMIC|11|||
23556125|NCT03238300|65762463|FG000|Baseline (Before Intervention)|Physician Decision|0|||
23556126|NCT03238300|65762464|FG001|Baseline (Before Intervention)|Physician Decision|1|||
23556127|NCT03238300|65762463|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
23556128|NCT03238300|65762464|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
23556129|NCT03238300|65762463|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
23556130|NCT03238300|65762464|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
23556131|NCT03238300|65762463|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
23556132|NCT03238300|65762464|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
23556133|NCT03848403|65762470|FG000|Period 2 (Day 8)|Adverse Event|1|||
23556134|NCT03848403|65762471|FG001|Period 2 (Day 8)|Adverse Event|2|||
23750212|NCT03733301|66463586|FG002|Overall Study|Adverse Event|3|||
23750213|NCT03733301|66463584|FG000|Overall Study|Withdrawal by Subject|3|||
23750214|NCT03733301|66463585|FG001|Overall Study|Withdrawal by Subject|5|||
23750215|NCT03733301|66463586|FG002|Overall Study|Withdrawal by Subject|1|||
23750216|NCT03151707|66463587|FG000|Overall Study|Lost to Follow-up|6|||
23750217|NCT05000931|66463592|FG000|Overall Study|Lost to Follow-up|1|||
23750218|NCT01265875|66463593|FG000|Overall Study|Uncooperative/unreliable|1|||
23750219|NCT02660489|66463594|FG000|Overall Study|Lost to Follow-up|1|||
23750220|NCT02660489|66463595|FG001|Overall Study|Lost to Follow-up|1|||
23750221|NCT02660489|66463594|FG000|Overall Study|Adverse Event|1|||
23750222|NCT02660489|66463595|FG001|Overall Study|Adverse Event|3|||
23750223|NCT02660489|66463594|FG000|Overall Study|no rhinovirus infection|4|||
23750224|NCT02660489|66463595|FG001|Overall Study|no rhinovirus infection|4|||
23750225|NCT01308762|66463596|FG000|Overall Study|Protocol Violation|0|||
23750226|NCT01308762|66463597|FG001|Overall Study|Protocol Violation|1|||
23750227|NCT01308762|66463598|FG002|Overall Study|Protocol Violation|0|||
23750228|NCT03083639|66463599|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
23750229|NCT03083639|66463600|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
23750230|NCT03083639|66463599|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
23750231|NCT03083639|66463600|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
23750232|NCT03563716|66463605|FG000|Overall Study|Death|20|||
23750233|NCT03563716|66463606|FG001|Overall Study|Death|14|||
23750234|NCT03563716|66463605|FG000|Overall Study|Withdrawal by Subject|3|||
23750235|NCT03563716|66463606|FG001|Overall Study|Withdrawal by Subject|3|||
23750236|NCT03563716|66463605|FG000|Overall Study|Still on Study|45|||
23750237|NCT03563716|66463606|FG001|Overall Study|Still on Study|50|||
23750238|NCT03231709|66463607|FG000|Treatment Period 1|Reason not Specified|0|||
23750239|NCT03231709|66463608|FG001|Treatment Period 1|Reason not Specified|1|||
23750240|NCT03231709|66463607|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
23750241|NCT03231709|66463608|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
23750242|NCT04775953|66463610|FG000|Overall Study|Lost to Follow-up|6|||
23750243|NCT04775953|66463611|FG001|Overall Study|Lost to Follow-up|11|||
23750244|NCT04775953|66463610|FG000|Overall Study|Death|5|||
23750245|NCT04775953|66463611|FG001|Overall Study|Death|4|||
23750246|NCT04775953|66463610|FG000|Overall Study|Withdrawal by Subject|3|||
23750247|NCT04775953|66463611|FG001|Overall Study|Withdrawal by Subject|3|||
23750248|NCT04775953|66463610|FG000|Overall Study|Protocol Violation|2|||
23750249|NCT04775953|66463611|FG001|Overall Study|Protocol Violation|0|||
23750250|NCT04775953|66463610|FG000|Overall Study|Participant non-compliance|0|||
23750251|NCT04775953|66463611|FG001|Overall Study|Participant non-compliance|1|||
23750252|NCT04812548|66463612|FG000|Overall Study|Adverse Event|2|||
23750253|NCT04812548|66463613|FG001|Overall Study|Adverse Event|7|||
23750254|NCT04812548|66463612|FG000|Overall Study|HSCT Planned|2|||
23750255|NCT04812548|66463613|FG001|Overall Study|HSCT Planned|3|||
23750256|NCT04812548|66463612|FG000|Overall Study|Progressive Disease|0|||
23750257|NCT04812548|66463613|FG001|Overall Study|Progressive Disease|2|||
23556135|NCT03848403|65762472|FG002|Period 2 (Day 8)|Adverse Event|2|||
23556136|NCT03848403|65762470|FG000|Period 2 (Day 8)|Physician Decision|0|||
23556137|NCT03848403|65762471|FG001|Period 2 (Day 8)|Physician Decision|1|||
23750258|NCT04812548|66463612|FG000|Overall Study|Death|0|||
23750259|NCT04812548|66463613|FG001|Overall Study|Death|1|||
23750260|NCT04812548|66463612|FG000|Overall Study|Post Study Access to Treatment|0|||
23433720|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
23433721|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
23433722|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
23433723|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
23433724|NCT00772109|65330552|FG000|Overall Study|Serious adverse event|1|||
23556138|NCT03848403|65762472|FG002|Period 2 (Day 8)|Physician Decision|0|||
23433725|NCT00772109|65330553|FG001|Overall Study|Serious adverse event|0|||
23556139|NCT03848403|65762470|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
23556140|NCT03848403|65762471|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
23556141|NCT03848403|65762472|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
23556142|NCT00540124|65762483|FG000|Overall Study|Adverse Event|0|||
23556143|NCT00540124|65762484|FG001|Overall Study|Adverse Event|2|||
23556144|NCT00540124|65762485|FG002|Overall Study|Adverse Event|1|||
23556145|NCT00540124|65762483|FG000|Overall Study|Entry Criteria Not Met|2|||
23556146|NCT00540124|65762484|FG001|Overall Study|Entry Criteria Not Met|0|||
23556147|NCT00540124|65762485|FG002|Overall Study|Entry Criteria Not Met|0|||
23556148|NCT00540124|65762483|FG000|Overall Study|Lack of Efficacy|1|||
23556149|NCT00540124|65762484|FG001|Overall Study|Lack of Efficacy|0|||
23556150|NCT00540124|65762485|FG002|Overall Study|Lack of Efficacy|0|||
23556151|NCT00540124|65762483|FG000|Overall Study|Withdrawal by Subject|1|||
23556152|NCT00540124|65762484|FG001|Overall Study|Withdrawal by Subject|1|||
23556153|NCT00540124|65762485|FG002|Overall Study|Withdrawal by Subject|0|||
23556154|NCT00833560|65762486|FG000|Overall Study|Toxicity|13|||
23556155|NCT00833560|65762486|FG000|Overall Study|Adverse Event|11|||
23556156|NCT00833560|65762486|FG000|Overall Study|Protocol Violation|6|||
23556157|NCT00833560|65762486|FG000|Overall Study|Lack of Efficacy|4|||
23556158|NCT00833560|65762486|FG000|Overall Study|Death|2|||
23556159|NCT00833560|65762486|FG000|Overall Study|Pregression of other disease|1|||
23556160|NCT00833560|65762486|FG000|Overall Study|Other|5|||
23556161|NCT01137474|65762487|FG000|Overall Study|Adverse Event|3|||
23556162|NCT01137474|65762488|FG001|Overall Study|Adverse Event|5|||
23556163|NCT01137474|65762489|FG002|Overall Study|Adverse Event|1|||
23556164|NCT01137474|65762490|FG003|Overall Study|Adverse Event|3|||
23556165|NCT01137474|65762487|FG000|Overall Study|Withdrawal by Subject|7|||
23556166|NCT01137474|65762488|FG001|Overall Study|Withdrawal by Subject|2|||
23556167|NCT01137474|65762489|FG002|Overall Study|Withdrawal by Subject|6|||
23556168|NCT01137474|65762490|FG003|Overall Study|Withdrawal by Subject|9|||
23556169|NCT01137474|65762487|FG000|Overall Study|No longer met study criteria|6|||
23556170|NCT01137474|65762488|FG001|Overall Study|No longer met study criteria|1|||
23556171|NCT01137474|65762489|FG002|Overall Study|No longer met study criteria|0|||
23556172|NCT01137474|65762490|FG003|Overall Study|No longer met study criteria|5|||
23556173|NCT01137474|65762487|FG000|Overall Study|Lost to Follow-up|5|||
23556174|NCT01137474|65762488|FG001|Overall Study|Lost to Follow-up|1|||
23623429|NCT02353871|66008415|FG000|Overall Study|Lost to Follow-up|2|||
23750261|NCT04812548|66463613|FG001|Overall Study|Post Study Access to Treatment|1|||
23750262|NCT04812548|66463612|FG000|Overall Study|Withdrawal by Subject|0|||
23750263|NCT04812548|66463613|FG001|Overall Study|Withdrawal by Subject|1|||
23750264|NCT04812548|66463612|FG000|Overall Study|Physician Decision|1|||
23750265|NCT04812548|66463613|FG001|Overall Study|Physician Decision|0|||
23750266|NCT01898884|66463614|FG000|Multiple Dose Period|Adverse Event|0|||
23750267|NCT01898884|66463615|FG001|Multiple Dose Period|Adverse Event|0|||
23750268|NCT01898884|66463616|FG002|Multiple Dose Period|Adverse Event|0|||
23750269|NCT01898884|66463617|FG003|Multiple Dose Period|Adverse Event|0|||
23750270|NCT01898884|66463618|FG004|Multiple Dose Period|Adverse Event|0|||
23750271|NCT01898884|66463619|FG005|Multiple Dose Period|Adverse Event|0|||
23750272|NCT01898884|66463620|FG006|Multiple Dose Period|Adverse Event|1|||
23750273|NCT01898884|66463621|FG007|Multiple Dose Period|Adverse Event|0|||
23750274|NCT01898884|66463622|FG008|Multiple Dose Period|Adverse Event|0|||
23750275|NCT01898884|66463614|FG000|Multiple Dose Period|Randomized Not Treated|0|||
23750276|NCT01898884|66463615|FG001|Multiple Dose Period|Randomized Not Treated|0|||
23750277|NCT01898884|66463616|FG002|Multiple Dose Period|Randomized Not Treated|0|||
23750278|NCT01898884|66463617|FG003|Multiple Dose Period|Randomized Not Treated|0|||
23750279|NCT01898884|66463618|FG004|Multiple Dose Period|Randomized Not Treated|0|||
23750280|NCT01898884|66463619|FG005|Multiple Dose Period|Randomized Not Treated|0|||
23750281|NCT01898884|66463620|FG006|Multiple Dose Period|Randomized Not Treated|0|||
23556175|NCT01137474|65762489|FG002|Overall Study|Lost to Follow-up|0|||
23556176|NCT01137474|65762490|FG003|Overall Study|Lost to Follow-up|2|||
23556177|NCT01137474|65762487|FG000|Overall Study|Lack of Efficacy|0|||
23556178|NCT01137474|65762488|FG001|Overall Study|Lack of Efficacy|0|||
23556179|NCT01137474|65762489|FG002|Overall Study|Lack of Efficacy|0|||
23556180|NCT01137474|65762490|FG003|Overall Study|Lack of Efficacy|2|||
23556181|NCT01137474|65762487|FG000|Overall Study|Other|3|||
23556182|NCT01137474|65762488|FG001|Overall Study|Other|1|||
23556183|NCT01137474|65762489|FG002|Overall Study|Other|0|||
23750282|NCT01898884|66463621|FG007|Multiple Dose Period|Randomized Not Treated|0|||
23750283|NCT01898884|66463622|FG008|Multiple Dose Period|Randomized Not Treated|1|||
23750284|NCT02867592|66463624|FG000|Overall Study|Adverse Event|3|||
23750285|NCT02867592|66463625|FG001|Overall Study|Adverse Event|0|||
23824588|NCT01526057|66737915|FG000|Overall Study|Protocol Violation|0|||
23824589|NCT01526057|66737916|FG001|Overall Study|Protocol Violation|0|||
23824590|NCT01526057|66737917|FG002|Overall Study|Protocol Violation|1|||
23824591|NCT01750190|66737918|FG000|Overall Study|Adverse Event|47|||
23750286|NCT02867592|66463626|FG002|Overall Study|Adverse Event|2|||
23750287|NCT02867592|66463627|FG003|Overall Study|Adverse Event|1|||
23750288|NCT02867592|66463628|FG004|Overall Study|Adverse Event|1|||
23750289|NCT02867592|66463629|FG005|Overall Study|Adverse Event|5|||
23750290|NCT02867592|66463624|FG000|Overall Study|Death|0|||
23750291|NCT02867592|66463625|FG001|Overall Study|Death|0|||
23556184|NCT01137474|65762490|FG003|Overall Study|Other|0|||
23623430|NCT02353871|66008416|FG001|Overall Study|Lost to Follow-up|0|||
23750292|NCT02867592|66463626|FG002|Overall Study|Death|0|||
23750293|NCT02867592|66463627|FG003|Overall Study|Death|1|||
23750294|NCT02867592|66463628|FG004|Overall Study|Death|0|||
23750295|NCT02867592|66463629|FG005|Overall Study|Death|1|||
23750296|NCT02867592|66463624|FG000|Overall Study|Lack of Efficacy|8|||
23556185|NCT01137474|65762487|FG000|Overall Study|Pregnancy|0|||
23750297|NCT02867592|66463625|FG001|Overall Study|Lack of Efficacy|10|||
23750298|NCT02867592|66463626|FG002|Overall Study|Lack of Efficacy|8|||
23750299|NCT02867592|66463627|FG003|Overall Study|Lack of Efficacy|8|||
23750300|NCT02867592|66463628|FG004|Overall Study|Lack of Efficacy|12|||
23750301|NCT02867592|66463629|FG005|Overall Study|Lack of Efficacy|17|||
23750302|NCT02867592|66463624|FG000|Overall Study|Physician Decision|1|||
23824592|NCT01750190|66737919|FG001|Overall Study|Adverse Event|19|||
23824593|NCT01750190|66737918|FG000|Overall Study|Death|38|||
23824594|NCT01750190|66737919|FG001|Overall Study|Death|11|||
23824595|NCT01750190|66737918|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
23824596|NCT01750190|66737919|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
23824597|NCT01750190|66737918|FG000|Overall Study|Lost to Follow-up|28|||
23824598|NCT01750190|66737919|FG001|Overall Study|Lost to Follow-up|7|||
23824599|NCT01750190|66737918|FG000|Overall Study|Physician Decision|16|||
23824600|NCT01750190|66737919|FG001|Overall Study|Physician Decision|17|||
23824601|NCT01750190|66737918|FG000|Overall Study|Protocol Violation|6|||
23824602|NCT01750190|66737919|FG001|Overall Study|Protocol Violation|5|||
23824603|NCT01750190|66737918|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
23824604|NCT01750190|66737919|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
23556186|NCT01137474|65762488|FG001|Overall Study|Pregnancy|1|||
23556187|NCT01137474|65762489|FG002|Overall Study|Pregnancy|0|||
23556188|NCT01137474|65762490|FG003|Overall Study|Pregnancy|0|||
23556189|NCT01137474|65762487|FG000|Overall Study|Administrative reason by sponsor|0|||
23556190|NCT01137474|65762488|FG001|Overall Study|Administrative reason by sponsor|1|||
23750303|NCT02867592|66463625|FG001|Overall Study|Physician Decision|2|||
23750304|NCT02867592|66463626|FG002|Overall Study|Physician Decision|2|||
23556191|NCT01137474|65762489|FG002|Overall Study|Administrative reason by sponsor|0|||
23556192|NCT01137474|65762490|FG003|Overall Study|Administrative reason by sponsor|0|||
23556193|NCT02390531|65762491|FG000|Overall Study|Death|0|||
23556194|NCT02390531|65762492|FG001|Overall Study|Death|2|||
23556195|NCT02390531|65762493|FG002|Overall Study|Death|0|||
23556196|NCT02390531|65762494|FG003|Overall Study|Death|1|||
23556197|NCT02390531|65762495|FG004|Overall Study|Death|0|||
23556198|NCT02390531|65762496|FG005|Overall Study|Death|0|||
23556199|NCT02390531|65762497|FG006|Overall Study|Death|0|||
23556200|NCT02390531|65762498|FG007|Overall Study|Death|1|||
23556201|NCT02390531|65762491|FG000|Overall Study|Protocol Violation|0|||
23556202|NCT02390531|65762492|FG001|Overall Study|Protocol Violation|0|||
23556203|NCT02390531|65762493|FG002|Overall Study|Protocol Violation|0|||
23623431|NCT01231464|66008423|FG000|Overall Study|Adverse Event|0|||
23623432|NCT01231464|66008424|FG001|Overall Study|Adverse Event|1|||
23623433|NCT01231464|66008423|FG000|Overall Study|Protocol Violation|1|||
23623434|NCT01231464|66008424|FG001|Overall Study|Protocol Violation|2|||
23623435|NCT01231464|66008423|FG000|Overall Study|Lost to Follow-up|1|||
23750305|NCT02867592|66463627|FG003|Overall Study|Physician Decision|0|||
23750306|NCT02867592|66463628|FG004|Overall Study|Physician Decision|5|||
23750307|NCT02867592|66463629|FG005|Overall Study|Physician Decision|1|||
23750308|NCT02867592|66463624|FG000|Overall Study|Protocol Violation|0|||
23824605|NCT01750190|66737918|FG000|Overall Study|Withdrawal by Subject|83|||
23556204|NCT02390531|65762494|FG003|Overall Study|Protocol Violation|0|||
23556205|NCT02390531|65762495|FG004|Overall Study|Protocol Violation|1|||
23824606|NCT01750190|66737919|FG001|Overall Study|Withdrawal by Subject|89|||
23824607|NCT01750190|66737918|FG000|Overall Study|Kidney Transplant|8|||
23556206|NCT02390531|65762496|FG005|Overall Study|Protocol Violation|0|||
23556207|NCT02390531|65762497|FG006|Overall Study|Protocol Violation|2|||
23623436|NCT01231464|66008424|FG001|Overall Study|Lost to Follow-up|2|||
23623437|NCT01231464|66008423|FG000|Overall Study|Withdrawal by Subject|3|||
23750309|NCT02867592|66463625|FG001|Overall Study|Protocol Violation|0|||
23750310|NCT02867592|66463626|FG002|Overall Study|Protocol Violation|0|||
23750311|NCT02867592|66463627|FG003|Overall Study|Protocol Violation|0|||
23623438|NCT01231464|66008424|FG001|Overall Study|Withdrawal by Subject|2|||
23750312|NCT02867592|66463628|FG004|Overall Study|Protocol Violation|1|||
23750313|NCT02867592|66463629|FG005|Overall Study|Protocol Violation|1|||
23750314|NCT02867592|66463624|FG000|Overall Study|Withdrawal by Subject|0|||
23750315|NCT02867592|66463625|FG001|Overall Study|Withdrawal by Subject|1|||
23750316|NCT02867592|66463626|FG002|Overall Study|Withdrawal by Subject|0|||
23750317|NCT02867592|66463627|FG003|Overall Study|Withdrawal by Subject|1|||
23750318|NCT02867592|66463628|FG004|Overall Study|Withdrawal by Subject|3|||
23750319|NCT02867592|66463629|FG005|Overall Study|Withdrawal by Subject|3|||
23750320|NCT02867592|66463624|FG000|Overall Study|Ineligible|1|||
23750321|NCT02867592|66463625|FG001|Overall Study|Ineligible|1|||
23750322|NCT02867592|66463626|FG002|Overall Study|Ineligible|0|||
23750323|NCT02867592|66463627|FG003|Overall Study|Ineligible|0|||
23750324|NCT02867592|66463628|FG004|Overall Study|Ineligible|2|||
23750325|NCT02867592|66463629|FG005|Overall Study|Ineligible|0|||
23750326|NCT02867592|66463624|FG000|Overall Study|No Treatment|1|||
23750327|NCT02867592|66463625|FG001|Overall Study|No Treatment|0|||
23750328|NCT02867592|66463626|FG002|Overall Study|No Treatment|0|||
23750329|NCT02867592|66463627|FG003|Overall Study|No Treatment|0|||
23750330|NCT02867592|66463628|FG004|Overall Study|No Treatment|0|||
23750331|NCT02867592|66463629|FG005|Overall Study|No Treatment|0|||
23750332|NCT02867592|66463624|FG000|Overall Study|Still on Therapy|0|||
23750333|NCT02867592|66463625|FG001|Overall Study|Still on Therapy|0|||
23750334|NCT02867592|66463626|FG002|Overall Study|Still on Therapy|0|||
23750335|NCT02867592|66463627|FG003|Overall Study|Still on Therapy|0|||
23750336|NCT02867592|66463628|FG004|Overall Study|Still on Therapy|1|||
23750337|NCT02867592|66463629|FG005|Overall Study|Still on Therapy|0|||
23750338|NCT02867592|66463624|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23433726|NCT00772109|65330554|FG002|Overall Study|Serious adverse event|1|||
23433727|NCT00772109|65330555|FG003|Overall Study|Serious adverse event|0|||
23433728|NCT00772109|65330552|FG000|Overall Study|Protocol Violation|5|||
23433729|NCT00772109|65330553|FG001|Overall Study|Protocol Violation|8|||
23433730|NCT00772109|65330554|FG002|Overall Study|Protocol Violation|7|||
23433731|NCT00772109|65330555|FG003|Overall Study|Protocol Violation|6|||
23433732|NCT00772109|65330552|FG000|Overall Study|Lost to Follow-up|7|||
23433733|NCT00772109|65330553|FG001|Overall Study|Lost to Follow-up|3|||
23433734|NCT00772109|65330554|FG002|Overall Study|Lost to Follow-up|5|||
23433735|NCT00772109|65330555|FG003|Overall Study|Lost to Follow-up|9|||
23433736|NCT00772109|65330552|FG000|Overall Study|Withdrawal by Subject|8|||
23433737|NCT00772109|65330553|FG001|Overall Study|Withdrawal by Subject|8|||
23433738|NCT00772109|65330554|FG002|Overall Study|Withdrawal by Subject|6|||
23433739|NCT00772109|65330555|FG003|Overall Study|Withdrawal by Subject|16|||
23433740|NCT01075984|65330556|FG000|Treatment Phase|Adverse Event|0|||
23433741|NCT01075984|65330557|FG001|Treatment Phase|Adverse Event|1|||
23433742|NCT01075984|65330558|FG002|Treatment Phase|Adverse Event|3|||
23433743|NCT01075984|65330559|FG003|Treatment Phase|Adverse Event|7|||
23433744|NCT01075984|65330560|FG004|Treatment Phase|Adverse Event|35|||
23433745|NCT01075984|65330556|FG000|Treatment Phase|Protocol Violation|0|||
23433746|NCT01075984|65330557|FG001|Treatment Phase|Protocol Violation|0|||
23433747|NCT01075984|65330558|FG002|Treatment Phase|Protocol Violation|1|||
23433748|NCT01075984|65330559|FG003|Treatment Phase|Protocol Violation|0|||
23433749|NCT01075984|65330560|FG004|Treatment Phase|Protocol Violation|3|||
23433750|NCT01075984|65330556|FG000|Treatment Phase|Withdrawal by Subject|0|||
23556208|NCT02390531|65762498|FG007|Overall Study|Protocol Violation|0|||
23556209|NCT00542880|65762499|FG000|Period 1|Eligibility criteria not fulfilled|2|||
23556210|NCT00542880|65762500|FG001|Period 1|Eligibility criteria not fulfilled|6|||
23556211|NCT00542880|65762499|FG000|Period 1|Adverse Event|2|||
23556212|NCT00542880|65762500|FG001|Period 1|Adverse Event|2|||
23556213|NCT00542880|65762499|FG000|Period 1|Development of study-specific criteria|1|||
23750339|NCT02867592|66463625|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23433751|NCT01075984|65330557|FG001|Treatment Phase|Withdrawal by Subject|0|||
23433752|NCT01075984|65330558|FG002|Treatment Phase|Withdrawal by Subject|2|||
23433753|NCT01075984|65330559|FG003|Treatment Phase|Withdrawal by Subject|0|||
23433754|NCT01075984|65330560|FG004|Treatment Phase|Withdrawal by Subject|15|||
23433755|NCT01075984|65330556|FG000|Treatment Phase|Treatment Failure|0|||
23556214|NCT00542880|65762500|FG001|Period 1|Development of study-specific criteria|2|||
23750340|NCT02867592|66463626|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23750341|NCT02867592|66463627|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23750342|NCT02867592|66463628|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23750343|NCT02867592|66463629|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
23750344|NCT02867592|66463624|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
23750345|NCT02867592|66463625|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23433756|NCT01075984|65330557|FG001|Treatment Phase|Treatment Failure|0|||
23433757|NCT01075984|65330558|FG002|Treatment Phase|Treatment Failure|1|||
23433758|NCT01075984|65330559|FG003|Treatment Phase|Treatment Failure|0|||
23433759|NCT01075984|65330560|FG004|Treatment Phase|Treatment Failure|5|||
23433760|NCT01075984|65330556|FG000|Treatment Phase|Progression of disease|0|||
23750346|NCT02867592|66463626|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
23750347|NCT02867592|66463627|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
23750348|NCT02867592|66463628|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23750349|NCT02867592|66463629|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23750350|NCT04512976|66466495|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23750351|NCT04512976|66466496|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23750352|NCT04512976|66466497|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23750353|NCT04512976|66466498|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23750354|NCT04512976|66466499|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23750355|NCT04512976|66466500|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
23750364|NCT01371981|66466505|FG000|Overall Study|Adverse Event|12|||
23750365|NCT01371981|66466506|FG001|Overall Study|Adverse Event|17|||
23750366|NCT01371981|66466507|FG002|Overall Study|Adverse Event|0|||
23750367|NCT01371981|66466508|FG003|Overall Study|Adverse Event|4|||
23750368|NCT01371981|66466509|FG004|Overall Study|Adverse Event|1|||
23750369|NCT01371981|66466510|FG005|Overall Study|Adverse Event|0|||
23750370|NCT01371981|66466505|FG000|Overall Study|Death|22|||
23750371|NCT01371981|66466506|FG001|Overall Study|Death|16|||
23750372|NCT01371981|66466507|FG002|Overall Study|Death|0|||
23750373|NCT01371981|66466508|FG003|Overall Study|Death|0|||
23750374|NCT01371981|66466509|FG004|Overall Study|Death|2|||
23750375|NCT01371981|66466510|FG005|Overall Study|Death|2|||
23750376|NCT01371981|66466505|FG000|Overall Study|Lack of Efficacy|69|||
23750377|NCT01371981|66466506|FG001|Overall Study|Lack of Efficacy|61|||
23750378|NCT01371981|66466507|FG002|Overall Study|Lack of Efficacy|4|||
23750379|NCT01371981|66466508|FG003|Overall Study|Lack of Efficacy|8|||
23750380|NCT01371981|66466509|FG004|Overall Study|Lack of Efficacy|5|||
23750381|NCT01371981|66466510|FG005|Overall Study|Lack of Efficacy|0|||
23750382|NCT01371981|66466505|FG000|Overall Study|Physician Decision|48|||
23750383|NCT01371981|66466506|FG001|Overall Study|Physician Decision|63|||
23750384|NCT01371981|66466507|FG002|Overall Study|Physician Decision|1|||
23750385|NCT01371981|66466508|FG003|Overall Study|Physician Decision|7|||
23750386|NCT01371981|66466509|FG004|Overall Study|Physician Decision|14|||
23750387|NCT01371981|66466510|FG005|Overall Study|Physician Decision|3|||
23824608|NCT01750190|66737919|FG001|Overall Study|Kidney Transplant|4|||
23824609|NCT01750190|66737918|FG000|Overall Study|Dialysis|22|||
23824610|NCT01750190|66737919|FG001|Overall Study|Dialysis|8|||
23824611|NCT01750190|66737918|FG000|Overall Study|Other than Specified|13|||
23824612|NCT01750190|66737919|FG001|Overall Study|Other than Specified|4|||
23824613|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
23824614|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
23824615|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824616|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824617|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824618|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824619|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824620|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824621|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824622|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23824623|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23556215|NCT00542880|65762499|FG000|Period 1|Withdrawal by Subject|1|||
23750388|NCT01371981|66466505|FG000|Overall Study|Withdrawal by Subject|12|||
23750389|NCT01371981|66466506|FG001|Overall Study|Withdrawal by Subject|19|||
23750390|NCT01371981|66466507|FG002|Overall Study|Withdrawal by Subject|1|||
23750391|NCT01371981|66466508|FG003|Overall Study|Withdrawal by Subject|2|||
23750392|NCT01371981|66466509|FG004|Overall Study|Withdrawal by Subject|10|||
23750393|NCT01371981|66466510|FG005|Overall Study|Withdrawal by Subject|3|||
23750394|NCT01371981|66466505|FG000|Overall Study|Ineligible|19|||
23750395|NCT01371981|66466506|FG001|Overall Study|Ineligible|13|||
23750396|NCT01371981|66466507|FG002|Overall Study|Ineligible|0|||
23750397|NCT01371981|66466508|FG003|Overall Study|Ineligible|0|||
23750398|NCT01371981|66466509|FG004|Overall Study|Ineligible|0|||
23750399|NCT01371981|66466510|FG005|Overall Study|Ineligible|4|||
23750400|NCT01371981|66466505|FG000|Overall Study|Did not start treatment|2|||
23750401|NCT01371981|66466506|FG001|Overall Study|Did not start treatment|3|||
23750402|NCT01371981|66466507|FG002|Overall Study|Did not start treatment|0|||
23750403|NCT01371981|66466508|FG003|Overall Study|Did not start treatment|0|||
23433761|NCT01075984|65330557|FG001|Treatment Phase|Progression of disease|0|||
23433762|NCT01075984|65330558|FG002|Treatment Phase|Progression of disease|0|||
23433763|NCT01075984|65330559|FG003|Treatment Phase|Progression of disease|0|||
23433764|NCT01075984|65330560|FG004|Treatment Phase|Progression of disease|2|||
23433765|NCT01075984|65330556|FG000|Follow-up Phase|Protocol Violation|0|||
23433766|NCT01075984|65330557|FG001|Follow-up Phase|Protocol Violation|0|||
23750404|NCT01371981|66466509|FG004|Overall Study|Did not start treatment|0|||
23750405|NCT01371981|66466510|FG005|Overall Study|Did not start treatment|2|||
23750406|NCT05146999|66466511|FG000|Overall Study|Withdrew consent|6|||
23750407|NCT05146999|66466512|FG001|Overall Study|Withdrew consent|1|||
23824624|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23750408|NCT05146999|66466511|FG000|Overall Study|Lost to Follow-up|3|||
23750409|NCT05146999|66466512|FG001|Overall Study|Lost to Follow-up|2|||
23824625|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824626|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
23824627|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824628|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824629|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824630|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824631|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824632|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824633|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824634|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824635|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824636|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23824637|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
23824638|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
23824639|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824640|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824641|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824642|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23433767|NCT01075984|65330558|FG002|Follow-up Phase|Protocol Violation|1|||
23433768|NCT01075984|65330559|FG003|Follow-up Phase|Protocol Violation|0|||
23750410|NCT05146999|66466511|FG000|Overall Study|Other|1|||
23750411|NCT05146999|66466512|FG001|Overall Study|Other|3|||
23750412|NCT01728376|66466513|FG000|Overall Study|Adverse Event|1|||
23750413|NCT01728376|66466514|FG001|Overall Study|Adverse Event|1|||
23750414|NCT01728376|66466515|FG002|Overall Study|Adverse Event|1|||
23824643|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23433769|NCT01075984|65330560|FG004|Follow-up Phase|Protocol Violation|3|||
23433770|NCT01075984|65330556|FG000|Follow-up Phase|Adverse Event|0|||
23750415|NCT01728376|66466516|FG003|Overall Study|Adverse Event|1|||
23750416|NCT01728376|66466517|FG004|Overall Study|Adverse Event|1|||
23750417|NCT01728376|66466518|FG005|Overall Study|Adverse Event|0|||
23750418|NCT01728376|66466513|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
23750419|NCT01728376|66466514|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
23750420|NCT01728376|66466515|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
23433771|NCT01075984|65330557|FG001|Follow-up Phase|Adverse Event|0|||
23750421|NCT01728376|66466516|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
23750422|NCT01728376|66466517|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
23750423|NCT01728376|66466518|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
23750424|NCT01728376|66466513|FG000|Overall Study|No relevant bacteria|2|||
23433772|NCT01075984|65330558|FG002|Follow-up Phase|Adverse Event|0|||
23433773|NCT01075984|65330559|FG003|Follow-up Phase|Adverse Event|2|||
23433774|NCT01075984|65330560|FG004|Follow-up Phase|Adverse Event|27|||
23433775|NCT01075984|65330556|FG000|Follow-up Phase|Administrative|0|||
23433776|NCT01075984|65330557|FG001|Follow-up Phase|Administrative|0|||
23433777|NCT01075984|65330558|FG002|Follow-up Phase|Administrative|0|||
23433778|NCT01075984|65330559|FG003|Follow-up Phase|Administrative|0|||
23433779|NCT01075984|65330560|FG004|Follow-up Phase|Administrative|1|||
23433780|NCT01075984|65330556|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23433781|NCT01075984|65330557|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23433782|NCT01075984|65330558|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23433783|NCT01075984|65330559|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23433784|NCT01075984|65330560|FG004|Follow-up Phase|Withdrawal by Subject|10|||
23433785|NCT01075984|65330556|FG000|Follow-up Phase|Progression of disease|0|||
23433786|NCT01075984|65330557|FG001|Follow-up Phase|Progression of disease|0|||
23433787|NCT01075984|65330558|FG002|Follow-up Phase|Progression of disease|0|||
23433788|NCT01075984|65330559|FG003|Follow-up Phase|Progression of disease|0|||
23433789|NCT01075984|65330560|FG004|Follow-up Phase|Progression of disease|2|||
23433790|NCT01075984|65330556|FG000|Follow-up Phase|Treatment failure|0|||
23433791|NCT01075984|65330557|FG001|Follow-up Phase|Treatment failure|0|||
23433792|NCT01075984|65330558|FG002|Follow-up Phase|Treatment failure|0|||
23433793|NCT01075984|65330559|FG003|Follow-up Phase|Treatment failure|0|||
23433794|NCT01075984|65330560|FG004|Follow-up Phase|Treatment failure|4|||
23433795|NCT04699461|65330561|FG000|Overall Study|Withdrawal by Subject|1|||
23556216|NCT00542880|65762500|FG001|Period 1|Withdrawal by Subject|1|||
23556217|NCT00542880|65762499|FG000|Period 1|Protocol Violation|0|||
23556218|NCT00542880|65762500|FG001|Period 1|Protocol Violation|1|||
23556219|NCT00542880|65762499|FG000|Period 2|Adverse Event|5|||
23556220|NCT00542880|65762500|FG001|Period 2|Adverse Event|7|||
23556221|NCT00542880|65762499|FG000|Period 2|Eligibility not fulfilled|0|||
23556222|NCT00542880|65762500|FG001|Period 2|Eligibility not fulfilled|1|||
23556223|NCT00542880|65762499|FG000|Period 2|Discontinuation criteria|2|||
23433796|NCT04699461|65330562|FG001|Overall Study|Withdrawal by Subject|0|||
23433797|NCT04699461|65330561|FG000|Overall Study|Study termination by sponsor|2|||
23433798|NCT04699461|65330562|FG001|Overall Study|Study termination by sponsor|1|||
23433799|NCT04699461|65330561|FG000|Overall Study|Death|1|||
23556224|NCT00542880|65762500|FG001|Period 2|Discontinuation criteria|0|||
23750425|NCT01728376|66466514|FG001|Overall Study|No relevant bacteria|0|||
23750426|NCT01728376|66466515|FG002|Overall Study|No relevant bacteria|0|||
23750427|NCT01728376|66466516|FG003|Overall Study|No relevant bacteria|0|||
23750428|NCT01728376|66466517|FG004|Overall Study|No relevant bacteria|1|||
23750429|NCT01728376|66466518|FG005|Overall Study|No relevant bacteria|1|||
23750430|NCT01728376|66466513|FG000|Overall Study|Did not receive treatment|0|||
23750431|NCT01728376|66466514|FG001|Overall Study|Did not receive treatment|1|||
23750432|NCT01728376|66466515|FG002|Overall Study|Did not receive treatment|0|||
23750433|NCT01728376|66466516|FG003|Overall Study|Did not receive treatment|0|||
23750434|NCT01728376|66466517|FG004|Overall Study|Did not receive treatment|0|||
23750435|NCT01728376|66466518|FG005|Overall Study|Did not receive treatment|0|||
23750436|NCT01728376|66466513|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23750437|NCT01728376|66466514|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23750438|NCT01728376|66466515|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23750439|NCT01728376|66466516|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
23750440|NCT01728376|66466517|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23750441|NCT01728376|66466518|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
23750442|NCT03901352|66466519|FG000|Double-blind Phase|Adverse Event|6|||
23750443|NCT03901352|66466520|FG001|Double-blind Phase|Adverse Event|4|||
23750444|NCT03901352|66466519|FG000|Double-blind Phase|Death|1|||
23750445|NCT03901352|66466520|FG001|Double-blind Phase|Death|0|||
23750446|NCT03901352|66466519|FG000|Double-blind Phase|Lack of Efficacy|0|||
23750447|NCT03901352|66466520|FG001|Double-blind Phase|Lack of Efficacy|1|||
23824644|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23433800|NCT04699461|65330562|FG001|Overall Study|Death|0|||
23433801|NCT04699461|65330561|FG000|Overall Study|Radiographic progression|0|||
23433802|NCT04699461|65330562|FG001|Overall Study|Radiographic progression|1|||
23433803|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Adverse Event|2|||
23556225|NCT00542880|65762499|FG000|Period 2|Severe non-compliance|0|||
23556226|NCT00542880|65762500|FG001|Period 2|Severe non-compliance|1|||
23750448|NCT03901352|66466519|FG000|Double-blind Phase|Protocol Violation|0|||
23433804|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Adverse Event|4|||
23433805|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Adverse Event|4|||
23433806|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
23433807|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
23433808|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
23433809|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
23433810|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
23433811|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
23433812|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
23433813|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
23433814|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
23433815|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
23433816|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
23623439|NCT00927901|66008426|FG000|Treatment Period 1|Subject withdrew consent|0|||
23623440|NCT00927901|66008427|FG001|Treatment Period 1|Subject withdrew consent|0|||
23623441|NCT00927901|66008428|FG002|Treatment Period 1|Subject withdrew consent|1|||
23433817|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
23433818|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
23433819|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
23433820|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
23433821|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
23433822|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
23433823|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
23433824|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
23433825|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
23433826|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
23433827|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
23433828|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
23433829|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
23433830|NCT01455194|65330571|FG000|Overall Study|Screen Failure|20|||
23433831|NCT01455194|65330572|FG001|Overall Study|Screen Failure|0|||
23433832|NCT01455194|65330573|FG002|Overall Study|Screen Failure|0|||
23750449|NCT03901352|66466520|FG001|Double-blind Phase|Protocol Violation|1|||
23750450|NCT03901352|66466519|FG000|Double-blind Phase|Withdrawal by Subject|10|||
23750451|NCT03901352|66466520|FG001|Double-blind Phase|Withdrawal by Subject|8|||
23750452|NCT03901352|66466519|FG000|Open-label Extension Phase|Adverse Event|24|||
23750453|NCT03901352|66466520|FG001|Open-label Extension Phase|Adverse Event|0|||
23750454|NCT03901352|66466519|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
23750455|NCT03901352|66466520|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23750456|NCT03901352|66466519|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
23750457|NCT03901352|66466520|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23750458|NCT03901352|66466519|FG000|Open-label Extension Phase|Other|1|||
23750459|NCT03901352|66466520|FG001|Open-label Extension Phase|Other|0|||
23750460|NCT05279807|66466521|FG000|Overall Study|Withdrawal by Subject|1|||
23750461|NCT05279807|66466522|FG001|Overall Study|Withdrawal by Subject|0|||
23623442|NCT00927901|66008429|FG003|Treatment Period 1|Subject withdrew consent|0|||
23623443|NCT00927901|66008426|FG000|Treatment Period 4|Adverse Event|0|||
23623444|NCT00927901|66008427|FG001|Treatment Period 4|Adverse Event|0|||
23623445|NCT00927901|66008428|FG002|Treatment Period 4|Adverse Event|0|||
23623446|NCT00927901|66008429|FG003|Treatment Period 4|Adverse Event|1|||
23623447|NCT00927901|66008426|FG000|Treatment Period 4|Subject withdrew consent|0|||
23623448|NCT00927901|66008427|FG001|Treatment Period 4|Subject withdrew consent|0|||
23623449|NCT00927901|66008428|FG002|Treatment Period 4|Subject withdrew consent|1|||
23623450|NCT00927901|66008429|FG003|Treatment Period 4|Subject withdrew consent|0|||
23623451|NCT01841697|66008430|FG000|Overall Study|Death|0|||
23623452|NCT01841697|66008431|FG001|Overall Study|Death|1|||
23623453|NCT01841697|66008430|FG000|Overall Study|Lost to Follow-up|4|||
23750462|NCT05279807|66466521|FG000|Overall Study|Adverse Event|0|||
23750463|NCT05279807|66466522|FG001|Overall Study|Adverse Event|1|||
23433833|NCT01455194|65330574|FG003|Overall Study|Screen Failure|0|||
23433834|NCT01455194|65330571|FG000|Overall Study|Randomisation Failure|90|||
23433835|NCT01455194|65330572|FG001|Overall Study|Randomisation Failure|0|||
23433836|NCT01455194|65330573|FG002|Overall Study|Randomisation Failure|0|||
23433837|NCT01455194|65330574|FG003|Overall Study|Randomisation Failure|0|||
23433838|NCT01455194|65330571|FG000|Overall Study|Deterioration in asthma|12|||
23433839|NCT01455194|65330572|FG001|Overall Study|Deterioration in asthma|6|||
23433840|NCT01455194|65330573|FG002|Overall Study|Deterioration in asthma|14|||
23433841|NCT01455194|65330574|FG003|Overall Study|Deterioration in asthma|9|||
23623454|NCT01841697|66008431|FG001|Overall Study|Lost to Follow-up|1|||
23623455|NCT01841697|66008430|FG000|Overall Study|Withdrawal by Subject|16|||
23433842|NCT01455194|65330571|FG000|Overall Study|Adverse Event|1|||
23433843|NCT01455194|65330572|FG001|Overall Study|Adverse Event|1|||
23623456|NCT01841697|66008431|FG001|Overall Study|Withdrawal by Subject|16|||
23623457|NCT01006889|66008432|FG000|Overall Study|Withdrawal by Subject|3|||
23623458|NCT00365547|66008433|FG000|Overall Study|Insurance did not cover Avastin|1|||
23750464|NCT05279807|66466521|FG000|Overall Study|Laboratory Abnormal Results|1|||
23623459|NCT00365547|66008433|FG000|Overall Study|Screen failure|1|||
23623460|NCT00365547|66008433|FG000|Overall Study|Withdrawal by Subject|1|||
23433844|NCT01455194|65330573|FG002|Overall Study|Adverse Event|1|||
23433845|NCT01455194|65330574|FG003|Overall Study|Adverse Event|3|||
23556227|NCT00542880|65762499|FG000|Period 2|Other|0|||
23623461|NCT00644878|66008434|FG000|Overall Study|Adverse Event|2|||
23623462|NCT00644878|66008434|FG000|Overall Study|Abnormal laboratory value|3|||
23623463|NCT00644878|66008434|FG000|Overall Study|Protocol deviation|2|||
23623464|NCT00644878|66008434|FG000|Overall Study|Treatment duration completed as per protocol|11|||
23623465|NCT03765164|66008437|FG000|Pre-intervention|Withdrawal by Subject|5|||
23623466|NCT03765164|66008438|FG001|Pre-intervention|Withdrawal by Subject|6|||
23623467|NCT04599907|66008439|FG000|Overall Study|Withdrawal by Subject|1|||
23556228|NCT00542880|65762500|FG001|Period 2|Other|1|||
23556229|NCT00542880|65762499|FG000|Period 3|Adverse Event|0|||
23556230|NCT00542880|65762500|FG001|Period 3|Adverse Event|2|||
23556231|NCT01833143|65762501|FG000|Overall Study|Not Treated|1|||
23556232|NCT02612064|65762502|FG000|Overall Study|Withdrawal by Subject|1|||
23556233|NCT02612064|65762503|FG001|Overall Study|Withdrawal by Subject|1|||
23556234|NCT02612064|65762502|FG000|Overall Study|Other|0|||
23556235|NCT02612064|65762503|FG001|Overall Study|Other|2|||
23556236|NCT00633464|65762506|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
23556237|NCT00633464|65762507|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
23556238|NCT00633464|65762506|FG000|Overall Study|Never Treated (Randomized in error)|0|||
23556239|NCT00633464|65762507|FG001|Overall Study|Never Treated (Randomized in error)|1|||
23556240|NCT01266850|65762508|FG000|Overall Study|Lost to Follow-up|19|||
23556241|NCT01266850|65762509|FG001|Overall Study|Lost to Follow-up|19|||
23556242|NCT01266850|65762510|FG002|Overall Study|Lost to Follow-up|13|||
23556243|NCT01266850|65762511|FG003|Overall Study|Lost to Follow-up|13|||
23556244|NCT01266850|65762512|FG004|Overall Study|Lost to Follow-up|12|||
23556245|NCT01266850|65762508|FG000|Overall Study|Withdrawal by Subject|8|||
23556246|NCT01266850|65762509|FG001|Overall Study|Withdrawal by Subject|9|||
23556247|NCT01266850|65762510|FG002|Overall Study|Withdrawal by Subject|6|||
23556248|NCT01266850|65762511|FG003|Overall Study|Withdrawal by Subject|9|||
23556249|NCT01266850|65762512|FG004|Overall Study|Withdrawal by Subject|12|||
23556250|NCT01266850|65762508|FG000|Overall Study|Physician Decision|3|||
23556251|NCT01266850|65762509|FG001|Overall Study|Physician Decision|6|||
23556252|NCT01266850|65762510|FG002|Overall Study|Physician Decision|4|||
23556253|NCT01266850|65762511|FG003|Overall Study|Physician Decision|4|||
23556254|NCT01266850|65762512|FG004|Overall Study|Physician Decision|3|||
23556255|NCT01266850|65762508|FG000|Overall Study|Protocol Violation|0|||
23556256|NCT01266850|65762509|FG001|Overall Study|Protocol Violation|1|||
23556257|NCT01266850|65762510|FG002|Overall Study|Protocol Violation|0|||
23556258|NCT01266850|65762511|FG003|Overall Study|Protocol Violation|1|||
23556259|NCT01266850|65762512|FG004|Overall Study|Protocol Violation|2|||
23556260|NCT01266850|65762508|FG000|Overall Study|Adverse Event|0|||
23556261|NCT01266850|65762509|FG001|Overall Study|Adverse Event|0|||
23623468|NCT04599907|66008440|FG001|Overall Study|Withdrawal by Subject|7|||
23623469|NCT04599907|66008441|FG002|Overall Study|Withdrawal by Subject|6|||
23556262|NCT01266850|65762510|FG002|Overall Study|Adverse Event|0|||
23556263|NCT01266850|65762511|FG003|Overall Study|Adverse Event|0|||
23556264|NCT01266850|65762512|FG004|Overall Study|Adverse Event|1|||
23556265|NCT01266850|65762508|FG000|Overall Study|Site Closure|0|||
23556266|NCT01266850|65762509|FG001|Overall Study|Site Closure|1|||
23556267|NCT01266850|65762510|FG002|Overall Study|Site Closure|1|||
23556268|NCT01266850|65762511|FG003|Overall Study|Site Closure|1|||
23556269|NCT01266850|65762512|FG004|Overall Study|Site Closure|0|||
23556270|NCT00553696|65762515|FG000|Overall Study|Adverse Event|2|||
23556271|NCT00553696|65762516|FG001|Overall Study|Adverse Event|4|||
23556272|NCT00553696|65762517|FG002|Overall Study|Adverse Event|0|||
23556273|NCT00553696|65762518|FG003|Overall Study|Adverse Event|1|||
23556274|NCT00553696|65762515|FG000|Overall Study|Global deterioration of health status|0|||
23556275|NCT00553696|65762516|FG001|Overall Study|Global deterioration of health status|2|||
23556276|NCT00553696|65762517|FG002|Overall Study|Global deterioration of health status|0|||
23556277|NCT00553696|65762518|FG003|Overall Study|Global deterioration of health status|0|||
23433846|NCT01455194|65330571|FG000|Overall Study|Withdrawal by Subject|21|||
23433847|NCT01455194|65330572|FG001|Overall Study|Withdrawal by Subject|16|||
23556278|NCT00553696|65762515|FG000|Overall Study|Objective progression or relapse|2|||
23556279|NCT00553696|65762516|FG001|Overall Study|Objective progression or relapse|9|||
23556280|NCT00553696|65762517|FG002|Overall Study|Objective progression or relapse|6|||
23556281|NCT00553696|65762518|FG003|Overall Study|Objective progression or relapse|0|||
23556282|NCT00553696|65762515|FG000|Overall Study|Withdrawal by Subject|0|||
23556283|NCT00553696|65762516|FG001|Overall Study|Withdrawal by Subject|1|||
23556284|NCT00553696|65762517|FG002|Overall Study|Withdrawal by Subject|0|||
23556285|NCT00553696|65762518|FG003|Overall Study|Withdrawal by Subject|0|||
23623470|NCT04599907|66008439|FG000|Overall Study|Lost to Follow-up|0|||
23623471|NCT04599907|66008440|FG001|Overall Study|Lost to Follow-up|1|||
23556286|NCT00238433|65762519|FG000|Overall Study|Screen failure|1|||
23623472|NCT04599907|66008441|FG002|Overall Study|Lost to Follow-up|0|||
23623473|NCT01426113|66008442|FG000|Overall Study|Study Discontinued|1|||
23556287|NCT00238433|65762519|FG000|Overall Study|Lost to Follow-up|1|||
23556288|NCT00238433|65762519|FG000|Overall Study|Death|1|||
23556289|NCT02657317|65762521|FG000|Overall Study|Withdrawal by Subject|2|||
23556290|NCT02657317|65762522|FG001|Overall Study|Withdrawal by Subject|0|||
23556291|NCT02657317|65762521|FG000|Overall Study|Lost to Follow-up|3|||
23556292|NCT02657317|65762522|FG001|Overall Study|Lost to Follow-up|3|||
23556293|NCT02216773|65762524|FG000|Overall Study|Disease progression|4|||
23556294|NCT02216773|65762525|FG001|Overall Study|Disease progression|2|||
23556295|NCT02216773|65762524|FG000|Overall Study|Insufficient FLRV|4|||
23623474|NCT01426113|66008443|FG001|Overall Study|Study Discontinued|1|||
23623475|NCT01426113|66008442|FG000|Overall Study|Adverse Event|0|||
23623476|NCT01426113|66008443|FG001|Overall Study|Adverse Event|1|||
23750465|NCT05279807|66466522|FG001|Overall Study|Laboratory Abnormal Results|0|||
23750466|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750467|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750468|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750469|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23556296|NCT02216773|65762525|FG001|Overall Study|Insufficient FLRV|0|||
23623477|NCT00809341|66008444|FG000|Overall Study|Physician Decision|0|||
23623478|NCT00809341|66008445|FG001|Overall Study|Physician Decision|1|||
23750470|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23750471|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750472|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750473|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750474|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750475|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23750476|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750477|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750478|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23750479|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
23750480|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23750481|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
23750482|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
23750483|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
23623479|NCT00329550|66008446|FG000|Overall Study|Adverse Event|3|||
23623480|NCT00329550|66008447|FG001|Overall Study|Adverse Event|4|||
23623481|NCT00329550|66008448|FG002|Overall Study|Adverse Event|2|||
23750484|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23750485|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750486|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750487|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750488|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750489|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750490|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23750491|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750492|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750493|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750494|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23750495|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750496|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23433848|NCT01455194|65330573|FG002|Overall Study|Withdrawal by Subject|12|||
23556297|NCT02216773|65762524|FG000|Overall Study|Abandoned|4|||
23556298|NCT02216773|65762525|FG001|Overall Study|Abandoned|3|||
23556299|NCT02173548|65762533|FG000|Overall Study|Lost to Follow-up|0|||
23556300|NCT02173548|65762534|FG001|Overall Study|Lost to Follow-up|2|||
23750497|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750498|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23750499|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23750500|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23750501|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23750502|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23750503|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23750504|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23750505|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750506|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750507|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23556301|NCT02173548|65762533|FG000|Overall Study|Withdrawal by Subject|1|||
23556302|NCT02173548|65762534|FG001|Overall Study|Withdrawal by Subject|0|||
23556303|NCT00785291|65762535|FG000|Overall Study|Never began treatment|8|||
23556304|NCT00785291|65762536|FG001|Overall Study|Never began treatment|4|||
23556305|NCT00785291|65762537|FG002|Overall Study|Never began treatment|4|||
23556306|NCT00785291|65762535|FG000|Overall Study|Adverse Event|39|||
23556307|NCT00785291|65762536|FG001|Overall Study|Adverse Event|70|||
23556308|NCT00785291|65762537|FG002|Overall Study|Adverse Event|56|||
23556309|NCT00785291|65762535|FG000|Overall Study|Death|7|||
23556310|NCT00785291|65762536|FG001|Overall Study|Death|4|||
23556311|NCT00785291|65762537|FG002|Overall Study|Death|3|||
23556312|NCT00785291|65762535|FG000|Overall Study|Withdrawal by Subject|35|||
23556313|NCT00785291|65762536|FG001|Overall Study|Withdrawal by Subject|36|||
23556314|NCT00785291|65762537|FG002|Overall Study|Withdrawal by Subject|17|||
23556315|NCT00785291|65762535|FG000|Overall Study|Alternative Therapy|12|||
23556316|NCT00785291|65762536|FG001|Overall Study|Alternative Therapy|6|||
23556317|NCT00785291|65762537|FG002|Overall Study|Alternative Therapy|7|||
23556318|NCT00785291|65762535|FG000|Overall Study|Complicating illness|6|||
23623482|NCT00329550|66008446|FG000|Overall Study|Withdrawal of Consent|1|||
23623483|NCT00329550|66008447|FG001|Overall Study|Withdrawal of Consent|0|||
23556319|NCT00785291|65762536|FG001|Overall Study|Complicating illness|4|||
23556320|NCT00785291|65762537|FG002|Overall Study|Complicating illness|4|||
23556321|NCT00785291|65762535|FG000|Overall Study|Other Medical Reasons|29|||
23623484|NCT00329550|66008448|FG002|Overall Study|Withdrawal of Consent|1|||
23433849|NCT01455194|65330574|FG003|Overall Study|Withdrawal by Subject|9|||
23433850|NCT01455194|65330571|FG000|Overall Study|Lost to Follow-up|2|||
23623485|NCT00329550|66008446|FG000|Overall Study|Due to Relocation|0|||
23623486|NCT00329550|66008447|FG001|Overall Study|Due to Relocation|0|||
23623487|NCT00329550|66008448|FG002|Overall Study|Due to Relocation|1|||
23623488|NCT02669407|66008449|FG000|Overall Study|Physician Decision|3|||
23623489|NCT02918292|66008450|FG000|Study Enrollment Prior to Transplant|Death|1|||
23623490|NCT02918292|66008450|FG000|Study Follow up After Transplant|Death|6|||
23623491|NCT02835092|66008451|FG000|Overall Study|Withdrawal by Subject|3|||
23623492|NCT02835092|66008452|FG001|Overall Study|Withdrawal by Subject|6|||
23623493|NCT02835092|66008453|FG002|Overall Study|Withdrawal by Subject|3|||
23623494|NCT02835092|66008451|FG000|Overall Study|Lost to Follow-up|0|||
23623495|NCT02835092|66008452|FG001|Overall Study|Lost to Follow-up|2|||
23623496|NCT02835092|66008453|FG002|Overall Study|Lost to Follow-up|0|||
23623497|NCT00350298|66008462|FG000|Overall Study|Death|7|||
23623498|NCT00350298|66008463|FG001|Overall Study|Death|8|||
23623499|NCT00350298|66008462|FG000|Overall Study|Lost to Follow-up|1|||
23623500|NCT00350298|66008463|FG001|Overall Study|Lost to Follow-up|2|||
23623501|NCT00350298|66008462|FG000|Overall Study|Withdrawal by Subject|1|||
23623502|NCT00350298|66008463|FG001|Overall Study|Withdrawal by Subject|3|||
23433851|NCT01455194|65330572|FG001|Overall Study|Lost to Follow-up|0|||
23433852|NCT01455194|65330573|FG002|Overall Study|Lost to Follow-up|1|||
23433853|NCT01455194|65330574|FG003|Overall Study|Lost to Follow-up|1|||
23433854|NCT01455194|65330571|FG000|Overall Study|Pregnancy|0|||
23433855|NCT01455194|65330572|FG001|Overall Study|Pregnancy|1|||
23433856|NCT01455194|65330573|FG002|Overall Study|Pregnancy|1|||
23750508|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750509|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23750510|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750511|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750512|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750513|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750514|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23433857|NCT01455194|65330574|FG003|Overall Study|Pregnancy|0|||
23433858|NCT01455194|65330571|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
23623503|NCT00684203|66008468|FG000|Overall Study|Adverse Event|6|||
23750515|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750516|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750517|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23824645|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824646|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824647|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824648|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23824649|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824650|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
23824651|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23750518|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23750519|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750520|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750521|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
23750522|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23750523|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750524|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750525|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23782257|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23824652|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824653|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824654|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23433859|NCT01455194|65330572|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
23433860|NCT01455194|65330573|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
23623504|NCT00684203|66008469|FG001|Overall Study|Adverse Event|4|||
23623505|NCT00684203|66008470|FG002|Overall Study|Adverse Event|8|||
23623506|NCT00684203|66008471|FG003|Overall Study|Adverse Event|0|||
23623507|NCT00684203|66008472|FG004|Overall Study|Adverse Event|0|||
23433861|NCT01455194|65330574|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
23623508|NCT00684203|66008473|FG005|Overall Study|Adverse Event|0|||
23824655|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824656|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824657|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824658|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824659|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824660|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23824661|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824662|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
23824663|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824664|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824665|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824666|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824667|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824668|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824669|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824670|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824671|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824672|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23824673|NCT03536884|66737920|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824674|NCT03536884|66737921|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
23824675|NCT03536884|66737922|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824676|NCT03536884|66737923|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824677|NCT03536884|66737924|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23750526|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750527|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750528|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750529|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750530|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750531|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750532|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750533|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23750534|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750535|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750536|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23750537|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750538|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750539|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23750540|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23750541|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23750542|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23750543|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23750544|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750545|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23750546|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750547|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750548|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23824678|NCT03536884|66737925|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23433862|NCT01455194|65330571|FG000|Overall Study|Miscellaneous|4|||
23750549|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750550|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750551|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750552|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23750553|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23750554|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23750555|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
23750556|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
23750557|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23433863|NCT01455194|65330572|FG001|Overall Study|Miscellaneous|5|||
23433864|NCT01455194|65330573|FG002|Overall Study|Miscellaneous|1|||
23433865|NCT01455194|65330574|FG003|Overall Study|Miscellaneous|4|||
23433866|NCT00267150|65330575|FG000|Overall Study|Adverse Event|1|||
23433867|NCT02951429|65330576|FG000|Overall Study|Adverse Event|3|||
23433868|NCT02951429|65330577|FG001|Overall Study|Adverse Event|7|||
23433869|NCT02951429|65330576|FG000|Overall Study|Death|28|||
23433870|NCT02951429|65330577|FG001|Overall Study|Death|36|||
23750558|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23750559|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
23750560|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23433871|NCT02951429|65330576|FG000|Overall Study|Lack of Efficacy|0|||
23750561|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750562|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750563|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
23750564|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750565|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23433872|NCT02951429|65330577|FG001|Overall Study|Lack of Efficacy|1|||
23433873|NCT02951429|65330576|FG000|Overall Study|Lost to Follow-up|0|||
23433874|NCT02951429|65330577|FG001|Overall Study|Lost to Follow-up|1|||
23433875|NCT02951429|65330576|FG000|Overall Study|Lung Transplantation|9|||
23433876|NCT02951429|65330577|FG001|Overall Study|Lung Transplantation|6|||
23433877|NCT02951429|65330576|FG000|Overall Study|Other|1|||
23433878|NCT02951429|65330577|FG001|Overall Study|Other|3|||
23433879|NCT02951429|65330576|FG000|Overall Study|Progressive Disease|1|||
23433880|NCT02951429|65330577|FG001|Overall Study|Progressive Disease|1|||
23433881|NCT02951429|65330576|FG000|Overall Study|Withdrawal by Subject|7|||
23433882|NCT02951429|65330577|FG001|Overall Study|Withdrawal by Subject|11|||
23433883|NCT02951429|65330576|FG000|Overall Study|Participant ongoing in the study|23|||
23433884|NCT02951429|65330577|FG001|Overall Study|Participant ongoing in the study|17|||
23433885|NCT00931801|65330578|FG000|Overall Study|Adverse Event|0|||
23433886|NCT00931801|65330579|FG001|Overall Study|Adverse Event|0|||
23433887|NCT00931801|65330580|FG002|Overall Study|Adverse Event|1|||
23433888|NCT00931801|65330578|FG000|Overall Study|Lost to Follow-up|0|||
23433889|NCT00931801|65330579|FG001|Overall Study|Lost to Follow-up|1|||
23433890|NCT00931801|65330580|FG002|Overall Study|Lost to Follow-up|0|||
23433891|NCT00931801|65330578|FG000|Overall Study|Withdrawal by Subject|1|||
23433892|NCT00931801|65330579|FG001|Overall Study|Withdrawal by Subject|0|||
23556322|NCT00785291|65762536|FG001|Overall Study|Other Medical Reasons|25|||
23750566|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23433893|NCT00931801|65330580|FG002|Overall Study|Withdrawal by Subject|0|||
23433894|NCT00931801|65330578|FG000|Overall Study|Confirmed Virologic Failure|0|||
23433895|NCT00931801|65330579|FG001|Overall Study|Confirmed Virologic Failure|0|||
23433896|NCT00931801|65330580|FG002|Overall Study|Confirmed Virologic Failure|3|||
23433897|NCT01090063|65330582|FG000|Screen|Screen Failed|4|||
23433898|NCT01090063|65330582|FG000|Treatment|Withdrawal by Subject|4|||
23433899|NCT02925728|65330583|FG000|Overall Study|Death|3|||
23433900|NCT02925728|65330584|FG001|Overall Study|Death|5|||
23433901|NCT02925728|65330583|FG000|Overall Study|Physician Decision|1|||
23433902|NCT02925728|65330584|FG001|Overall Study|Physician Decision|0|||
23433903|NCT02925728|65330583|FG000|Overall Study|Withdrawal by Subject|1|||
23433904|NCT02925728|65330584|FG001|Overall Study|Withdrawal by Subject|0|||
23433905|NCT01266317|65330585|FG000|Overall Study|Withdrawal by Subject|2|||
23750567|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23433906|NCT04356040|65330610|FG000|Overall Study|Death|2|||
23433907|NCT04356040|65330611|FG001|Overall Study|Death|0|||
23433908|NCT04356040|65330610|FG000|Overall Study|Lost to Follow-up|1|||
23433909|NCT04356040|65330611|FG001|Overall Study|Lost to Follow-up|0|||
23433910|NCT04356040|65330610|FG000|Overall Study|Physician Decision|0|||
23433911|NCT04356040|65330611|FG001|Overall Study|Physician Decision|1|||
23433912|NCT04356040|65330610|FG000|Overall Study|Withdrawal by Subject|13|||
23433913|NCT04356040|65330611|FG001|Overall Study|Withdrawal by Subject|1|||
23433914|NCT04356040|65330610|FG000|Overall Study|Enrollment Pause|10|||
23433915|NCT04356040|65330611|FG001|Overall Study|Enrollment Pause|0|||
23433916|NCT04356040|65330610|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
23433917|NCT04356040|65330611|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
23433918|NCT04356040|65330610|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
23433919|NCT04356040|65330611|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
23433920|NCT04356040|65330610|FG000|Overall Study|PI left institution|3|||
23433921|NCT04356040|65330611|FG001|Overall Study|PI left institution|0|||
23433922|NCT00566254|65330612|FG000|Overall Study|Adverse Event|3|||
23433923|NCT00566254|65330613|FG001|Overall Study|Adverse Event|1|||
23433924|NCT00566254|65330612|FG000|Overall Study|Protocol Violation|1|||
23433925|NCT00566254|65330613|FG001|Overall Study|Protocol Violation|3|||
23433926|NCT00566254|65330612|FG000|Overall Study|Withdrawal by Subject|1|||
23433927|NCT00566254|65330613|FG001|Overall Study|Withdrawal by Subject|2|||
23433928|NCT00566254|65330612|FG000|Overall Study|Lack of Efficacy|5|||
23433929|NCT00566254|65330613|FG001|Overall Study|Lack of Efficacy|6|||
23433930|NCT00566254|65330612|FG000|Overall Study|Other|0|||
23433931|NCT00566254|65330613|FG001|Overall Study|Other|2|||
23433932|NCT01818284|65330615|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
23433933|NCT01818284|65330616|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
23433934|NCT01818284|65330615|FG000|Overall Study|Death|0|||
23433935|NCT01818284|65330616|FG001|Overall Study|Death|2|||
23433936|NCT03755661|65330619|FG000|Overall Study|Lost to Follow-up|1|||
23433937|NCT03755661|65330620|FG001|Overall Study|Lost to Follow-up|0|||
23433938|NCT01620944|65330621|FG000|Overall Study|Early termination of Study|2|||
23433939|NCT01620944|65330622|FG001|Overall Study|Early termination of Study|1|||
23433940|NCT01746173|65330623|FG000|Overall Study|Disease Progression|2|||
23433941|NCT02974842|65330624|FG000|Overall Study|Withdrawal by Subject|4|||
23433942|NCT02974842|65330624|FG000|Overall Study|Screen failures|4|||
23433943|NCT01939366|65330625|FG000|Overall Study|Adverse Event|8|||
23433944|NCT01939366|65330626|FG001|Overall Study|Adverse Event|17|||
23433945|NCT01939366|65330627|FG002|Overall Study|Adverse Event|30|||
23433946|NCT01939366|65330628|FG003|Overall Study|Adverse Event|8|||
23433947|NCT01939366|65330629|FG004|Overall Study|Adverse Event|5|||
23750568|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750569|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23433948|NCT01939366|65330625|FG000|Overall Study|Lack of Efficacy|2|||
23433949|NCT01939366|65330626|FG001|Overall Study|Lack of Efficacy|1|||
23433950|NCT01939366|65330627|FG002|Overall Study|Lack of Efficacy|1|||
23433951|NCT01939366|65330628|FG003|Overall Study|Lack of Efficacy|1|||
23433952|NCT01939366|65330629|FG004|Overall Study|Lack of Efficacy|3|||
23433953|NCT01939366|65330625|FG000|Overall Study|Lost to Follow-up|1|||
23433954|NCT01939366|65330626|FG001|Overall Study|Lost to Follow-up|1|||
23433955|NCT01939366|65330627|FG002|Overall Study|Lost to Follow-up|0|||
23433956|NCT01939366|65330628|FG003|Overall Study|Lost to Follow-up|0|||
23433957|NCT01939366|65330629|FG004|Overall Study|Lost to Follow-up|0|||
23433958|NCT01939366|65330625|FG000|Overall Study|Withdrawal by Subject|1|||
23433959|NCT01939366|65330626|FG001|Overall Study|Withdrawal by Subject|0|||
23433960|NCT01939366|65330627|FG002|Overall Study|Withdrawal by Subject|2|||
23433961|NCT01939366|65330628|FG003|Overall Study|Withdrawal by Subject|2|||
23433962|NCT01939366|65330629|FG004|Overall Study|Withdrawal by Subject|3|||
23556323|NCT00785291|65762537|FG002|Overall Study|Other Medical Reasons|15|||
23433963|NCT01939366|65330625|FG000|Overall Study|Inclusion criteria not met|0|||
23433964|NCT01939366|65330626|FG001|Overall Study|Inclusion criteria not met|1|||
23433965|NCT01939366|65330627|FG002|Overall Study|Inclusion criteria not met|1|||
23556324|NCT01059630|65762538|FG000|Overall Study|Death|100|||
23556325|NCT01059630|65762539|FG001|Overall Study|Death|84|||
23433966|NCT01939366|65330628|FG003|Overall Study|Inclusion criteria not met|0|||
23433967|NCT01939366|65330629|FG004|Overall Study|Inclusion criteria not met|1|||
23556326|NCT01059630|65762538|FG000|Overall Study|Lost to Follow-up|4|||
23750570|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750571|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750572|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750573|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750574|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750575|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750576|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23750577|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
23750578|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
23750579|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23750580|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23556327|NCT01059630|65762539|FG001|Overall Study|Lost to Follow-up|1|||
23556328|NCT01059630|65762538|FG000|Overall Study|Physician Decision|2|||
23556329|NCT01059630|65762539|FG001|Overall Study|Physician Decision|4|||
23750581|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750582|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23556330|NCT01059630|65762538|FG000|Overall Study|Withdrawal by Subject|21|||
23556331|NCT01059630|65762539|FG001|Overall Study|Withdrawal by Subject|14|||
23556332|NCT01843192|65762543|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
23556333|NCT01843192|65762544|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
23750583|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750584|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
23750585|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750586|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750587|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750588|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750589|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
23750590|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750591|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750592|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750593|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750594|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750595|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23623509|NCT00684203|66008468|FG000|Overall Study|Protocol-defined clinical event|3|||
23556334|NCT01843192|65762545|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
23556335|NCT01123382|65762548|FG000|Overall Study|Withdrawal by Subject|1|||
23556336|NCT01123382|65762549|FG001|Overall Study|Withdrawal by Subject|4|||
23556337|NCT01123382|65762548|FG000|Overall Study|Lost to Follow-up|1|||
23556338|NCT01123382|65762549|FG001|Overall Study|Lost to Follow-up|2|||
23556339|NCT02114151|65762552|FG000|Overall Study|Death|1|||
23556340|NCT02114151|65762552|FG000|Overall Study|Lost to Follow-up|1|||
23556341|NCT02114151|65762552|FG000|Overall Study|Withdrawal by Subject|5|||
23556342|NCT01844284|65762553|FG000|Overall Study|Lost to Follow-up|12|||
23623510|NCT00684203|66008469|FG001|Overall Study|Protocol-defined clinical event|1|||
23623511|NCT00684203|66008470|FG002|Overall Study|Protocol-defined clinical event|0|||
23623512|NCT00684203|66008471|FG003|Overall Study|Protocol-defined clinical event|0|||
23623513|NCT00684203|66008472|FG004|Overall Study|Protocol-defined clinical event|0|||
23623514|NCT00684203|66008473|FG005|Overall Study|Protocol-defined clinical event|0|||
23433968|NCT01939366|65330625|FG000|Overall Study|Other|0|||
23623515|NCT00684203|66008468|FG000|Overall Study|Withdrawal by Subject|0|||
23433969|NCT01939366|65330626|FG001|Overall Study|Other|0|||
23433970|NCT01939366|65330627|FG002|Overall Study|Other|2|||
23556343|NCT01844284|65762554|FG001|Overall Study|Lost to Follow-up|7|||
23556344|NCT01687257|65762555|FG000|Overall Study|Efficacy Failure|6|||
23556345|NCT01687257|65762556|FG001|Overall Study|Efficacy Failure|0|||
23623516|NCT00684203|66008469|FG001|Overall Study|Withdrawal by Subject|2|||
23623517|NCT00684203|66008470|FG002|Overall Study|Withdrawal by Subject|1|||
23556346|NCT01687257|65762557|FG002|Overall Study|Efficacy Failure|5|||
23556347|NCT01687257|65762555|FG000|Overall Study|Subject Withdrew Consent|1|||
23433971|NCT01939366|65330628|FG003|Overall Study|Other|2|||
23433972|NCT01939366|65330629|FG004|Overall Study|Other|1|||
23433973|NCT01939366|65330625|FG000|Overall Study|Protocol Violation|0|||
23433974|NCT01939366|65330626|FG001|Overall Study|Protocol Violation|0|||
23750596|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750597|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750598|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23750599|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23750600|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23433975|NCT01939366|65330627|FG002|Overall Study|Protocol Violation|0|||
23556348|NCT01687257|65762556|FG001|Overall Study|Subject Withdrew Consent|1|||
23556349|NCT01687257|65762557|FG002|Overall Study|Subject Withdrew Consent|1|||
23556350|NCT01687257|65762555|FG000|Overall Study|Adverse Event|1|||
23556351|NCT01687257|65762556|FG001|Overall Study|Adverse Event|0|||
23433976|NCT01939366|65330628|FG003|Overall Study|Protocol Violation|1|||
23750601|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23824679|NCT03536884|66737926|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824680|NCT03536884|66737927|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824681|NCT03536884|66737928|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23750602|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23750603|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23750604|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23750605|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23433977|NCT01939366|65330629|FG004|Overall Study|Protocol Violation|0|||
23433978|NCT01939366|65330625|FG000|Overall Study|Sponsor decision|0|||
23750606|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23750607|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23433979|NCT01939366|65330626|FG001|Overall Study|Sponsor decision|0|||
23433980|NCT01939366|65330627|FG002|Overall Study|Sponsor decision|0|||
23556352|NCT01687257|65762557|FG002|Overall Study|Adverse Event|0|||
23556353|NCT01687257|65762555|FG000|Overall Study|Investigator's Discretion|0|||
23556354|NCT01687257|65762556|FG001|Overall Study|Investigator's Discretion|3|||
23556355|NCT01687257|65762557|FG002|Overall Study|Investigator's Discretion|0|||
23556356|NCT00500903|65762558|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
23556357|NCT00500903|65762559|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
23750608|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23750609|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23750610|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23750611|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23433981|NCT01939366|65330628|FG003|Overall Study|Sponsor decision|0|||
23433982|NCT01939366|65330629|FG004|Overall Study|Sponsor decision|2|||
23556358|NCT00500903|65762560|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
23750612|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
23750613|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23750614|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
23750615|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
23750616|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
23750617|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23750618|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750619|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750620|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750621|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750622|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750623|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750624|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750625|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750626|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750627|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750628|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
23750629|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750630|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750631|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750632|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750633|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750634|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23433983|NCT01939366|65330625|FG000|Overall Study|GCP non-compliance at site|2|||
23433984|NCT01939366|65330626|FG001|Overall Study|GCP non-compliance at site|3|||
23433985|NCT01939366|65330627|FG002|Overall Study|GCP non-compliance at site|2|||
23433986|NCT01939366|65330628|FG003|Overall Study|GCP non-compliance at site|3|||
23433987|NCT01939366|65330629|FG004|Overall Study|GCP non-compliance at site|3|||
23433988|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
23433989|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
23433990|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
23433991|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
23433992|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
23433993|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
23433994|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
23433995|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
23433996|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
23433997|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
23433998|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
23433999|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
23434000|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
23434001|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
23434002|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
23434003|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
23434004|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
23434005|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
23434006|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
23434007|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
23434008|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
23434009|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
23434010|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
23434011|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
23434012|NCT01972789|65330632|FG000|Overall Study|Adverse Event|11|||
23434013|NCT01972789|65330633|FG001|Overall Study|Adverse Event|4|||
23434014|NCT01972789|65330632|FG000|Overall Study|Subject withdrew consent|14|||
23434015|NCT01972789|65330633|FG001|Overall Study|Subject withdrew consent|12|||
23434016|NCT01972789|65330632|FG000|Overall Study|Lost to Follow-up|4|||
23434017|NCT01972789|65330633|FG001|Overall Study|Lost to Follow-up|7|||
23434018|NCT01972789|65330632|FG000|Overall Study|Death|7|||
23434019|NCT01972789|65330633|FG001|Overall Study|Death|5|||
23434020|NCT01972789|65330632|FG000|Overall Study|Protocol deviation|1|||
23434021|NCT01972789|65330633|FG001|Overall Study|Protocol deviation|0|||
23434022|NCT01972789|65330632|FG000|Overall Study|Physician Decision|3|||
23750635|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23434023|NCT01972789|65330633|FG001|Overall Study|Physician Decision|2|||
23434024|NCT02708485|65330634|FG000|Overall Study|Withdrawal by Subject|3|||
23434025|NCT02708485|65330635|FG001|Overall Study|Withdrawal by Subject|2|||
23623518|NCT00684203|66008471|FG003|Overall Study|Withdrawal by Subject|0|||
23623519|NCT00684203|66008472|FG004|Overall Study|Withdrawal by Subject|0|||
23434026|NCT02301624|65330636|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
23434027|NCT02301624|65330637|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
23750636|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23750637|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23750638|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23750639|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750640|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750641|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23750642|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23434028|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
23434029|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
23434030|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Adverse Event|2|||
23434031|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Adverse Event|5|||
23434032|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Physician Decision|3|||
23434033|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Physician Decision|3|||
23434034|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Death|2|||
23434035|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Death|1|||
23434036|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
23434037|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
23434038|NCT00279812|65330638|FG000|Overall Study|Protocol Violation|1|||
23434039|NCT00279812|65330639|FG001|Overall Study|Protocol Violation|1|||
23434040|NCT00279812|65330640|FG002|Overall Study|Protocol Violation|0|||
23434041|NCT00279812|65330641|FG003|Overall Study|Protocol Violation|0|||
23434042|NCT00279812|65330642|FG004|Overall Study|Protocol Violation|1|||
23434043|NCT00279812|65330643|FG005|Overall Study|Protocol Violation|0|||
23434044|NCT00279812|65330638|FG000|Overall Study|Withdrawal by Subject|0|||
23434045|NCT00279812|65330639|FG001|Overall Study|Withdrawal by Subject|4|||
23434046|NCT00279812|65330640|FG002|Overall Study|Withdrawal by Subject|2|||
23434047|NCT00279812|65330641|FG003|Overall Study|Withdrawal by Subject|0|||
23434048|NCT00279812|65330642|FG004|Overall Study|Withdrawal by Subject|0|||
23434049|NCT00279812|65330643|FG005|Overall Study|Withdrawal by Subject|0|||
23434050|NCT00279812|65330638|FG000|Overall Study|Adverse Event|0|||
23434051|NCT00279812|65330639|FG001|Overall Study|Adverse Event|1|||
23434052|NCT00279812|65330640|FG002|Overall Study|Adverse Event|1|||
23434053|NCT00279812|65330641|FG003|Overall Study|Adverse Event|0|||
23434054|NCT00279812|65330642|FG004|Overall Study|Adverse Event|2|||
23434055|NCT00279812|65330643|FG005|Overall Study|Adverse Event|1|||
23434056|NCT01895309|65330645|FG000|Overall Study|Adverse Event|13|||
23434057|NCT01895309|65330646|FG001|Overall Study|Adverse Event|17|||
23434058|NCT01895309|65330645|FG000|Overall Study|Protocol Violation|1|||
23434059|NCT01895309|65330646|FG001|Overall Study|Protocol Violation|0|||
23434060|NCT01895309|65330645|FG000|Overall Study|Lack of Efficacy|1|||
23434061|NCT01895309|65330646|FG001|Overall Study|Lack of Efficacy|3|||
23434062|NCT01895309|65330645|FG000|Overall Study|Lost to Follow-up|1|||
23434063|NCT01895309|65330646|FG001|Overall Study|Lost to Follow-up|3|||
23434064|NCT01895309|65330645|FG000|Overall Study|Physician Decision|15|||
23434065|NCT01895309|65330646|FG001|Overall Study|Physician Decision|10|||
23434066|NCT01895309|65330645|FG000|Overall Study|Withdrawal by Subject|9|||
23434067|NCT01895309|65330646|FG001|Overall Study|Withdrawal by Subject|18|||
23434068|NCT03263780|65330654|FG000|Overall Study|Withdrawal by Subject|3|||
23434069|NCT03263780|65330654|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
23434070|NCT02678923|65330657|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
23434071|NCT02678923|65330658|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
23434072|NCT02678923|65330657|FG000|Overall Study|Withdrawal by Subject|3|||
23434073|NCT02678923|65330658|FG001|Overall Study|Withdrawal by Subject|2|||
23434074|NCT02678923|65330657|FG000|Overall Study|Lost to Follow-up|1|||
23434075|NCT02678923|65330658|FG001|Overall Study|Lost to Follow-up|0|||
23434076|NCT02678923|65330657|FG000|Overall Study|Did Not Return for Study Visits|1|||
23434077|NCT02678923|65330658|FG001|Overall Study|Did Not Return for Study Visits|0|||
23434078|NCT03597061|65330659|FG000|Overall Study|Lost to Follow-up|1|||
23434079|NCT03597061|65330660|FG001|Overall Study|Lost to Follow-up|0|||
23434080|NCT03597061|65330659|FG000|Overall Study|Protocol Violation|0|||
23434081|NCT03597061|65330660|FG001|Overall Study|Protocol Violation|1|||
23434082|NCT00849108|65330662|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
23556359|NCT00500903|65762558|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
23750643|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23824682|NCT03536884|66737929|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23434083|NCT00849108|65330663|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
23434084|NCT00849108|65330662|FG000|Cohort 2 Efficacy|Adverse Event|0|||
23434085|NCT00849108|65330663|FG001|Cohort 2 Efficacy|Adverse Event|1|||
23434086|NCT00849108|65330662|FG000|Cohort 2 Efficacy|Other|0|||
23434087|NCT00849108|65330663|FG001|Cohort 2 Efficacy|Other|9|||
23434088|NCT04046250|65333987|FG000|Overall Study|Death|0|||
23434089|NCT04046250|65333988|FG001|Overall Study|Death|1|||
23434090|NCT04046250|65333987|FG000|Overall Study|Withdrawal by Subject|3|||
23434091|NCT04046250|65333988|FG001|Overall Study|Withdrawal by Subject|3|||
23434092|NCT02708355|65333989|FG000|Overall Study|Adverse Event|1|||
23434093|NCT02708355|65333990|FG001|Overall Study|Adverse Event|0|||
23434094|NCT02708355|65333991|FG002|Overall Study|Adverse Event|0|||
23434095|NCT00902174|65333992|FG000|Overall Study|Adverse Event|27|||
23434096|NCT00902174|65333993|FG001|Overall Study|Adverse Event|7|||
23434097|NCT00902174|65333992|FG000|Overall Study|Lack of Efficacy|1|||
23434098|NCT00902174|65333993|FG001|Overall Study|Lack of Efficacy|5|||
23434099|NCT00902174|65333992|FG000|Overall Study|Death|2|||
23434100|NCT00902174|65333993|FG001|Overall Study|Death|2|||
23434101|NCT00902174|65333992|FG000|Overall Study|Withdrawal by Subject|2|||
23434102|NCT00902174|65333993|FG001|Overall Study|Withdrawal by Subject|1|||
23434103|NCT00902174|65333992|FG000|Overall Study|Abnormal labs|1|||
23434104|NCT00902174|65333993|FG001|Overall Study|Abnormal labs|1|||
23434105|NCT00902174|65333992|FG000|Overall Study|Protocol Violation|1|||
23434106|NCT00902174|65333993|FG001|Overall Study|Protocol Violation|1|||
23434107|NCT00902174|65333992|FG000|Overall Study|Administration problem|0|||
23434108|NCT00902174|65333993|FG001|Overall Study|Administration problem|1|||
23434109|NCT01639755|65333999|FG000|Overall Study|Study Ongoing|15|||
23434110|NCT01639755|65333999|FG000|Overall Study|Patient had device explantation|4|||
23434111|NCT02262754|65334000|FG000|Overall Study|Adverse Event|3|||
23434112|NCT02262754|65334001|FG001|Overall Study|Adverse Event|4|||
23434113|NCT02262754|65334002|FG002|Overall Study|Adverse Event|0|||
23434114|NCT02262754|65334000|FG000|Overall Study|Lack of Efficacy|2|||
23434115|NCT02262754|65334001|FG001|Overall Study|Lack of Efficacy|0|||
23434116|NCT02262754|65334002|FG002|Overall Study|Lack of Efficacy|1|||
23434117|NCT02262754|65334000|FG000|Overall Study|Lost to Follow-up|0|||
23434118|NCT02262754|65334001|FG001|Overall Study|Lost to Follow-up|0|||
23434119|NCT02262754|65334002|FG002|Overall Study|Lost to Follow-up|1|||
23434120|NCT02262754|65334000|FG000|Overall Study|No longer meets eligibility criteria|0|||
23434121|NCT02262754|65334001|FG001|Overall Study|No longer meets eligibility criteria|1|||
23434122|NCT02262754|65334002|FG002|Overall Study|No longer meets eligibility criteria|0|||
23434123|NCT02262754|65334000|FG000|Overall Study|Study terminated by sponsor|5|||
23434124|NCT02262754|65334001|FG001|Overall Study|Study terminated by sponsor|4|||
23434125|NCT02262754|65334002|FG002|Overall Study|Study terminated by sponsor|4|||
23434126|NCT02262754|65334000|FG000|Overall Study|Protocol Violation|1|||
23434127|NCT02262754|65334001|FG001|Overall Study|Protocol Violation|0|||
23434128|NCT02262754|65334002|FG002|Overall Study|Protocol Violation|0|||
23434129|NCT02262754|65334000|FG000|Overall Study|Withdrawal by Subject|1|||
23434130|NCT02262754|65334001|FG001|Overall Study|Withdrawal by Subject|0|||
23434131|NCT02262754|65334002|FG002|Overall Study|Withdrawal by Subject|1|||
23434132|NCT02262754|65334000|FG000|Overall Study|Other|4|||
23434133|NCT02262754|65334001|FG001|Overall Study|Other|0|||
23434134|NCT02262754|65334002|FG002|Overall Study|Other|2|||
23434135|NCT01990859|65334005|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
23434136|NCT01990859|65334005|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
23434137|NCT01299116|65334006|FG000|Overall Study|Lost to Follow-up|65|||
23434138|NCT01299116|65334007|FG001|Overall Study|Lost to Follow-up|9|||
23434139|NCT01299116|65334008|FG002|Overall Study|Lost to Follow-up|11|||
23434140|NCT03664765|65334009|FG000|Overall Study|Withdrawal by Subject|4|||
23434141|NCT03664765|65334010|FG001|Overall Study|Withdrawal by Subject|1|||
23434142|NCT03664765|65334009|FG000|Overall Study|Lost to Follow-up|0|||
23434143|NCT03664765|65334010|FG001|Overall Study|Lost to Follow-up|1|||
23434144|NCT00545103|65334015|FG000|Overall Study|Lack of Efficacy|48|||
23434145|NCT00545103|65334016|FG001|Overall Study|Lack of Efficacy|45|||
23434146|NCT00545103|65334017|FG002|Overall Study|Lack of Efficacy|31|||
23434147|NCT00545103|65334018|FG003|Overall Study|Lack of Efficacy|27|||
23434148|NCT00545103|65334015|FG000|Overall Study|Withdrawal by Subject|6|||
23434149|NCT00545103|65334016|FG001|Overall Study|Withdrawal by Subject|10|||
23434150|NCT00545103|65334017|FG002|Overall Study|Withdrawal by Subject|18|||
23434151|NCT00545103|65334018|FG003|Overall Study|Withdrawal by Subject|22|||
23434152|NCT00545103|65334015|FG000|Overall Study|Adverse Event|11|||
23434153|NCT00545103|65334016|FG001|Overall Study|Adverse Event|12|||
23434154|NCT00545103|65334017|FG002|Overall Study|Adverse Event|17|||
23434155|NCT00545103|65334018|FG003|Overall Study|Adverse Event|10|||
23434156|NCT00545103|65334015|FG000|Overall Study|Lost to Follow-up|4|||
23434157|NCT00545103|65334016|FG001|Overall Study|Lost to Follow-up|6|||
23434158|NCT00545103|65334017|FG002|Overall Study|Lost to Follow-up|3|||
23434159|NCT00545103|65334018|FG003|Overall Study|Lost to Follow-up|4|||
23434160|NCT00545103|65334015|FG000|Overall Study|Protocol Violation|1|||
23434161|NCT00545103|65334016|FG001|Overall Study|Protocol Violation|2|||
23434162|NCT00545103|65334017|FG002|Overall Study|Protocol Violation|3|||
23434163|NCT00545103|65334018|FG003|Overall Study|Protocol Violation|0|||
23434164|NCT00545103|65334015|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
23434165|NCT00545103|65334016|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
23434166|NCT00545103|65334017|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
23434167|NCT00545103|65334018|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
23434168|NCT00545103|65334015|FG000|Overall Study|Difficult to open package|0|||
23434169|NCT00545103|65334016|FG001|Overall Study|Difficult to open package|0|||
23434170|NCT00545103|65334017|FG002|Overall Study|Difficult to open package|0|||
23434171|NCT00545103|65334018|FG003|Overall Study|Difficult to open package|1|||
23434172|NCT00545103|65334015|FG000|Overall Study|Investigational product not taken|1|||
23434173|NCT00545103|65334016|FG001|Overall Study|Investigational product not taken|0|||
23434174|NCT00545103|65334017|FG002|Overall Study|Investigational product not taken|0|||
23434175|NCT00545103|65334018|FG003|Overall Study|Investigational product not taken|1|||
23434176|NCT00545103|65334015|FG000|Overall Study|Wish to start a family|0|||
23434177|NCT00545103|65334016|FG001|Overall Study|Wish to start a family|0|||
23434178|NCT00545103|65334017|FG002|Overall Study|Wish to start a family|0|||
23434179|NCT00545103|65334018|FG003|Overall Study|Wish to start a family|1|||
23434180|NCT00545103|65334015|FG000|Overall Study|Diverticulitis crisis|0|||
23434181|NCT00545103|65334016|FG001|Overall Study|Diverticulitis crisis|0|||
23434182|NCT00545103|65334017|FG002|Overall Study|Diverticulitis crisis|0|||
23434183|NCT00545103|65334018|FG003|Overall Study|Diverticulitis crisis|1|||
23434184|NCT00545103|65334015|FG000|Overall Study|Personal reasons|1|||
23434185|NCT00545103|65334016|FG001|Overall Study|Personal reasons|0|||
23434186|NCT00545103|65334017|FG002|Overall Study|Personal reasons|0|||
23556360|NCT00500903|65762559|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23556361|NCT00500903|65762560|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23556362|NCT00500903|65762558|FG000|Overall Study|Progressive Disease|41|||
23556363|NCT00500903|65762559|FG001|Overall Study|Progressive Disease|2|||
23556364|NCT00500903|65762560|FG002|Overall Study|Progressive Disease|15|||
23434187|NCT00545103|65334018|FG003|Overall Study|Personal reasons|0|||
23434188|NCT00545103|65334015|FG000|Overall Study|Subject's decision|1|||
23434189|NCT00545103|65334016|FG001|Overall Study|Subject's decision|0|||
23434190|NCT00545103|65334017|FG002|Overall Study|Subject's decision|0|||
23434191|NCT00545103|65334018|FG003|Overall Study|Subject's decision|0|||
23434192|NCT00545103|65334015|FG000|Overall Study|Noncompliance|0|||
23434193|NCT00545103|65334016|FG001|Overall Study|Noncompliance|1|||
23434194|NCT00545103|65334017|FG002|Overall Study|Noncompliance|0|||
23434195|NCT00545103|65334018|FG003|Overall Study|Noncompliance|0|||
23434196|NCT00545103|65334015|FG000|Overall Study|Investigator decision|0|||
23434197|NCT00545103|65334016|FG001|Overall Study|Investigator decision|0|||
23434198|NCT00545103|65334017|FG002|Overall Study|Investigator decision|1|||
23434199|NCT00545103|65334018|FG003|Overall Study|Investigator decision|0|||
23434200|NCT00545103|65334015|FG000|Overall Study|Subject moved|0|||
23434201|NCT00545103|65334016|FG001|Overall Study|Subject moved|1|||
23434202|NCT00545103|65334017|FG002|Overall Study|Subject moved|0|||
23434203|NCT00545103|65334018|FG003|Overall Study|Subject moved|0|||
23434204|NCT00545103|65334015|FG000|Overall Study|Use of prohibited medication|0|||
23434205|NCT00545103|65334016|FG001|Overall Study|Use of prohibited medication|0|||
23434206|NCT00545103|65334017|FG002|Overall Study|Use of prohibited medication|1|||
23434207|NCT00545103|65334018|FG003|Overall Study|Use of prohibited medication|0|||
23434208|NCT00545103|65334015|FG000|Overall Study|Does not want to take study drug anymore|1|||
23434209|NCT00545103|65334016|FG001|Overall Study|Does not want to take study drug anymore|0|||
23434210|NCT00545103|65334017|FG002|Overall Study|Does not want to take study drug anymore|1|||
23434211|NCT00545103|65334018|FG003|Overall Study|Does not want to take study drug anymore|0|||
23434212|NCT00545103|65334015|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434213|NCT00545103|65334016|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434214|NCT00545103|65334017|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
23434215|NCT00545103|65334018|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434216|NCT00545103|65334015|FG000|Overall Study|Death|0|||
23434217|NCT00545103|65334016|FG001|Overall Study|Death|1|||
23750644|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23750645|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750646|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23750647|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750648|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750649|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23750650|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23750651|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23750652|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23750653|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23750654|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
23750655|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23750656|NCT01915498|66466523|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
23750657|NCT01915498|66466524|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23750658|NCT01915498|66466525|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23750659|NCT01915498|66466526|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
23750660|NCT01915498|66466527|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
23750661|NCT01915498|66466528|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
23750662|NCT01915498|66466529|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
23750663|NCT01915498|66466530|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
23750664|NCT01915498|66466531|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
23750665|NCT01915498|66466532|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
23750666|NCT01915498|66466533|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23750667|NCT01915498|66466534|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
23750668|NCT01915498|66466535|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23750669|NCT01915498|66466536|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
23434218|NCT00545103|65334017|FG002|Overall Study|Death|0|||
23434219|NCT00545103|65334018|FG003|Overall Study|Death|0|||
23434220|NCT04268745|65334020|FG000|Overall Study|Lost to Follow-up|2|||
23434221|NCT04268745|65334021|FG001|Overall Study|Lost to Follow-up|3|||
23434222|NCT04268745|65334020|FG000|Overall Study|Withdrawal by Subject|4|||
23434223|NCT04268745|65334021|FG001|Overall Study|Withdrawal by Subject|2|||
23434224|NCT04268745|65334020|FG000|Overall Study|Death in the family|1|||
23434225|NCT04268745|65334021|FG001|Overall Study|Death in the family|0|||
23434226|NCT03688100|65334022|FG000|Overall Study|Lost to Follow-up|21|||
23434227|NCT03688100|65334023|FG001|Overall Study|Lost to Follow-up|15|||
23434228|NCT03688100|65334024|FG002|Overall Study|Lost to Follow-up|15|||
23434229|NCT03688100|65334025|FG003|Overall Study|Lost to Follow-up|18|||
23434230|NCT03688100|65334022|FG000|Overall Study|Withdrawal by Subject|19|||
23434231|NCT03688100|65334023|FG001|Overall Study|Withdrawal by Subject|16|||
23434232|NCT03688100|65334024|FG002|Overall Study|Withdrawal by Subject|0|||
23434233|NCT03688100|65334025|FG003|Overall Study|Withdrawal by Subject|0|||
23434234|NCT03688100|65334022|FG000|Overall Study|Death|36|||
23434235|NCT03688100|65334023|FG001|Overall Study|Death|27|||
23434236|NCT03688100|65334024|FG002|Overall Study|Death|0|||
23434237|NCT03688100|65334025|FG003|Overall Study|Death|0|||
23434238|NCT01270256|65334031|FG000|Overall Study|Withdrawal by Subject|1|||
23434239|NCT01270256|65334032|FG001|Overall Study|Withdrawal by Subject|0|||
23434240|NCT02607228|65334033|FG000|Overall Study|Progressive Disease|4|||
23434241|NCT02607228|65334034|FG001|Overall Study|Progressive Disease|3|||
23434242|NCT02607228|65334035|FG002|Overall Study|Progressive Disease|1|||
23434243|NCT02607228|65334036|FG003|Overall Study|Progressive Disease|5|||
23434244|NCT02607228|65334037|FG004|Overall Study|Progressive Disease|4|||
23434245|NCT02607228|65334038|FG005|Overall Study|Progressive Disease|3|||
23434246|NCT02607228|65334039|FG006|Overall Study|Progressive Disease|1|||
23434247|NCT02607228|65334033|FG000|Overall Study|Adverse Event|1|||
23434248|NCT02607228|65334034|FG001|Overall Study|Adverse Event|0|||
23434249|NCT02607228|65334035|FG002|Overall Study|Adverse Event|1|||
23434250|NCT02607228|65334036|FG003|Overall Study|Adverse Event|0|||
23434251|NCT02607228|65334037|FG004|Overall Study|Adverse Event|1|||
23434252|NCT02607228|65334038|FG005|Overall Study|Adverse Event|1|||
23434253|NCT02607228|65334039|FG006|Overall Study|Adverse Event|1|||
23434254|NCT02607228|65334033|FG000|Overall Study|Investigator's Discretion|0|||
23434255|NCT02607228|65334034|FG001|Overall Study|Investigator's Discretion|0|||
23434256|NCT02607228|65334035|FG002|Overall Study|Investigator's Discretion|1|||
23434257|NCT02607228|65334036|FG003|Overall Study|Investigator's Discretion|0|||
23434258|NCT02607228|65334037|FG004|Overall Study|Investigator's Discretion|0|||
23434259|NCT02607228|65334038|FG005|Overall Study|Investigator's Discretion|1|||
23434260|NCT02607228|65334039|FG006|Overall Study|Investigator's Discretion|0|||
23434261|NCT02607228|65334033|FG000|Overall Study|Withdrew Consent|0|||
23434262|NCT02607228|65334034|FG001|Overall Study|Withdrew Consent|1|||
23750670|NCT01915498|66466537|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
23750671|NCT01915498|66466538|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
23750672|NCT01915498|66466539|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
23434263|NCT02607228|65334035|FG002|Overall Study|Withdrew Consent|0|||
23434264|NCT02607228|65334036|FG003|Overall Study|Withdrew Consent|0|||
23434265|NCT02607228|65334037|FG004|Overall Study|Withdrew Consent|0|||
23434266|NCT02607228|65334038|FG005|Overall Study|Withdrew Consent|1|||
23434267|NCT02607228|65334039|FG006|Overall Study|Withdrew Consent|0|||
23434268|NCT02607228|65334033|FG000|Overall Study|Study Terminated by Sponsor|0|||
23434269|NCT02607228|65334034|FG001|Overall Study|Study Terminated by Sponsor|0|||
23434270|NCT02607228|65334035|FG002|Overall Study|Study Terminated by Sponsor|0|||
23434271|NCT02607228|65334036|FG003|Overall Study|Study Terminated by Sponsor|1|||
23434272|NCT02607228|65334037|FG004|Overall Study|Study Terminated by Sponsor|0|||
23434273|NCT02607228|65334038|FG005|Overall Study|Study Terminated by Sponsor|0|||
23434274|NCT02607228|65334039|FG006|Overall Study|Study Terminated by Sponsor|0|||
23434275|NCT01729208|65334047|FG000|Baseline|Physician Decision|5|||
23434276|NCT01729208|65334048|FG001|Baseline|Physician Decision|4|||
23434277|NCT01729208|65334047|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
23434278|NCT01729208|65334048|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
23434279|NCT01729208|65334047|FG000|12 Months Follow-up|Lost to Follow-up|3|||
23434280|NCT01729208|65334048|FG001|12 Months Follow-up|Lost to Follow-up|3|||
23434281|NCT01729208|65334047|FG000|24 Months Follow-up|Lost to Follow-up|3|||
23434282|NCT01729208|65334048|FG001|24 Months Follow-up|Lost to Follow-up|0|||
23434283|NCT01729208|65334047|FG000|36 Months Follow-up|Physician Decision|1|||
23434284|NCT01729208|65334048|FG001|36 Months Follow-up|Physician Decision|0|||
23434285|NCT01729208|65334047|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
23434286|NCT01729208|65334048|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
23434287|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434288|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434289|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434290|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434291|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
23434292|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434293|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
23434294|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434295|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
23434296|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434297|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434298|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434299|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434300|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434301|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434302|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434303|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
23556365|NCT00500903|65762558|FG000|Overall Study|Patient Declined Further Treatment|0|||
23434304|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434305|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434306|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434307|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
23434308|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434309|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434310|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23556366|NCT00500903|65762559|FG001|Overall Study|Patient Declined Further Treatment|0|||
23434311|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434312|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434313|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434314|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
23434315|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434316|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434317|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
23434318|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434319|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434320|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434321|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434322|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434323|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434324|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434325|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434326|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434327|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434328|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434329|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434330|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434331|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434332|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434333|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434334|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
23434335|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434336|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434337|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434338|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434339|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434340|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434341|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434342|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434343|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434344|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
23434345|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434346|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
23434347|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434348|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434349|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434350|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434351|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434352|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434353|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434354|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434355|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434356|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
23434357|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434358|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434359|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434360|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434361|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434362|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434363|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23750673|NCT01915498|66466540|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
23750674|NCT01915498|66466541|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
23750675|NCT01915498|66466523|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23434364|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434365|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434366|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434367|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23623520|NCT00684203|66008473|FG005|Overall Study|Withdrawal by Subject|0|||
23623521|NCT00684203|66008468|FG000|Overall Study|Did not meet protocol eligibility|0|||
23434368|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434369|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
23434370|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434371|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434372|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434373|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434374|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434375|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434376|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23556367|NCT00500903|65762560|FG002|Overall Study|Patient Declined Further Treatment|3|||
23556368|NCT00500903|65762558|FG000|Overall Study|Symptomatic Deterioration|2|||
23556369|NCT00500903|65762559|FG001|Overall Study|Symptomatic Deterioration|0|||
23556370|NCT00500903|65762560|FG002|Overall Study|Symptomatic Deterioration|0|||
23750676|NCT01915498|66466524|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750677|NCT01915498|66466525|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750678|NCT01915498|66466526|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23824683|NCT03536884|66737930|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23556371|NCT00500903|65762558|FG000|Overall Study|Reason Not Specified|10|||
23556372|NCT00500903|65762559|FG001|Overall Study|Reason Not Specified|0|||
23556373|NCT00500903|65762560|FG002|Overall Study|Reason Not Specified|2|||
23556374|NCT03802123|65762568|FG000|Overall Study|Withdrawal by Subject|3|||
23556375|NCT03802123|65762568|FG000|Overall Study|Physician Decision|1|||
23556376|NCT03802123|65762568|FG000|Overall Study|Subject moved to hospice care|1|||
23556377|NCT03802123|65762568|FG000|Overall Study|technician error|1|||
23556378|NCT03802123|65762568|FG000|Overall Study|Death|3|||
23623522|NCT00684203|66008469|FG001|Overall Study|Did not meet protocol eligibility|1|||
23750679|NCT01915498|66466527|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750680|NCT01915498|66466528|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750681|NCT01915498|66466529|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750682|NCT01915498|66466530|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750683|NCT01915498|66466531|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750684|NCT01915498|66466532|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750685|NCT01915498|66466533|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750686|NCT01915498|66466534|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750687|NCT01915498|66466535|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750688|NCT01915498|66466536|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750689|NCT01915498|66466537|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750690|NCT01915498|66466538|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750691|NCT01915498|66466539|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750692|NCT01915498|66466540|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23750693|NCT01915498|66466541|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
23750694|NCT01915498|66466523|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750695|NCT01915498|66466524|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750696|NCT01915498|66466525|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750697|NCT01915498|66466526|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750698|NCT01915498|66466527|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750699|NCT01915498|66466528|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750700|NCT01915498|66466529|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750701|NCT01915498|66466530|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750702|NCT01915498|66466531|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750703|NCT01915498|66466532|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750704|NCT01915498|66466533|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750705|NCT01915498|66466534|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750706|NCT01915498|66466535|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750707|NCT01915498|66466536|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750708|NCT01915498|66466537|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750709|NCT01915498|66466538|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750710|NCT01915498|66466539|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750711|NCT01915498|66466540|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23750712|NCT01915498|66466541|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
23750713|NCT01915498|66466523|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750714|NCT01915498|66466524|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750715|NCT01915498|66466525|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750716|NCT01915498|66466526|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750717|NCT01915498|66466527|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750718|NCT01915498|66466528|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23434377|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434378|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434379|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434380|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
23434381|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434382|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434383|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434384|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434385|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434386|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434387|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434388|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434389|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434390|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434391|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434392|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23824684|NCT03536884|66737931|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23824685|NCT03536884|66737920|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824686|NCT03536884|66737921|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824687|NCT03536884|66737922|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
23824688|NCT03536884|66737923|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824689|NCT03536884|66737924|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
23824690|NCT03536884|66737925|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824691|NCT03536884|66737926|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824692|NCT03536884|66737927|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824693|NCT03536884|66737928|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824694|NCT03536884|66737929|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824695|NCT03536884|66737930|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
23434393|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
23434394|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434395|NCT01113580|65334061|FG000|Overall Study|Protocol Violation|1|||
23434396|NCT01113580|65334062|FG001|Overall Study|Protocol Violation|0|||
23434397|NCT01624090|65334065|FG000|Overall Study|DLT, taken off therapy|0|||
23434398|NCT01624090|65334066|FG001|Overall Study|DLT, taken off therapy|1|||
23434399|NCT01624090|65334067|FG002|Overall Study|DLT, taken off therapy|0|||
23434400|NCT01624090|65334068|FG003|Overall Study|DLT, taken off therapy|0|||
23434401|NCT01624090|65334065|FG000|Overall Study|Withdrew prior to treatment|0|||
23434402|NCT01624090|65334066|FG001|Overall Study|Withdrew prior to treatment|1|||
23434403|NCT01624090|65334067|FG002|Overall Study|Withdrew prior to treatment|0|||
23434404|NCT01624090|65334068|FG003|Overall Study|Withdrew prior to treatment|0|||
23434405|NCT01624090|65334065|FG000|Overall Study|Died on study|0|||
23434406|NCT01624090|65334066|FG001|Overall Study|Died on study|0|||
23434407|NCT01624090|65334067|FG002|Overall Study|Died on study|2|||
23824696|NCT03536884|66737931|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
23824697|NCT03536884|66737920|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824698|NCT03536884|66737921|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824699|NCT03536884|66737922|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
23434408|NCT01624090|65334068|FG003|Overall Study|Died on study|0|||
23434409|NCT01624090|65334065|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
23556379|NCT00082173|65762569|FG000|Overall Study|Withdrawal by Subject|3|||
23750719|NCT01915498|66466529|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750720|NCT01915498|66466530|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750721|NCT01915498|66466531|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750722|NCT01915498|66466532|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750723|NCT01915498|66466533|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750724|NCT01915498|66466534|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750725|NCT01915498|66466535|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750726|NCT01915498|66466536|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23824700|NCT03536884|66737923|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
23824701|NCT03536884|66737924|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
23824702|NCT03536884|66737925|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824703|NCT03536884|66737926|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824704|NCT03536884|66737927|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23434410|NCT01624090|65334066|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
23434411|NCT01624090|65334067|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
23434412|NCT01624090|65334068|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
23434413|NCT01624090|65334065|FG000|Overall Study|Dose escalated|0|||
23434414|NCT01624090|65334066|FG001|Overall Study|Dose escalated|0|||
23434415|NCT01624090|65334067|FG002|Overall Study|Dose escalated|3|||
23434416|NCT01624090|65334068|FG003|Overall Study|Dose escalated|0|||
23434417|NCT02212678|65334069|FG000|Overall Study|Adverse Event|1|||
23434418|NCT00454181|65334072|FG000|Overall Study|Adverse Event|1|||
23750727|NCT01915498|66466537|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750728|NCT01915498|66466538|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23434419|NCT00454181|65334073|FG001|Overall Study|Adverse Event|1|||
23434420|NCT00454181|65334072|FG000|Overall Study|Lost to Follow-up|11|||
23434421|NCT00454181|65334073|FG001|Overall Study|Lost to Follow-up|1|||
23434422|NCT00454181|65334072|FG000|Overall Study|Protocol Violation|1|||
23434423|NCT00454181|65334073|FG001|Overall Study|Protocol Violation|1|||
23434424|NCT00454181|65334072|FG000|Overall Study|Withdrawal by Subject|2|||
23434425|NCT00454181|65334073|FG001|Overall Study|Withdrawal by Subject|0|||
23434426|NCT01026220|65334075|FG000|Induction|Death|1|||
23434427|NCT01026220|65334076|FG001|Induction|Death|0|||
23434428|NCT01026220|65334077|FG002|Induction|Death|0|||
23434429|NCT01026220|65334075|FG000|Induction|Lack of Efficacy|2|||
23434430|NCT01026220|65334076|FG001|Induction|Lack of Efficacy|0|||
23434431|NCT01026220|65334077|FG002|Induction|Lack of Efficacy|0|||
23434432|NCT01026220|65334075|FG000|Induction|Physician Decision|12|||
23434433|NCT01026220|65334076|FG001|Induction|Physician Decision|0|||
23434434|NCT01026220|65334077|FG002|Induction|Physician Decision|0|||
23434435|NCT01026220|65334075|FG000|Induction|Withdrawal by Subject|9|||
23434436|NCT01026220|65334076|FG001|Induction|Withdrawal by Subject|0|||
23434437|NCT01026220|65334077|FG002|Induction|Withdrawal by Subject|0|||
23434438|NCT01026220|65334075|FG000|Induction|Ineligible|1|||
23434439|NCT01026220|65334076|FG001|Induction|Ineligible|0|||
23434440|NCT01026220|65334077|FG002|Induction|Ineligible|0|||
23434441|NCT01026220|65334075|FG000|Consolidation Maintenance|Death|0|||
23750729|NCT01915498|66466539|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750730|NCT01915498|66466540|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23750731|NCT01915498|66466541|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
23750732|NCT04633434|66466542|FG000|Overall Study|Lost to Follow-up|32|||
23750733|NCT04633434|66466543|FG001|Overall Study|Lost to Follow-up|32|||
23750734|NCT02252172|66466544|FG000|Overall Study|Lost to Follow-up|3|||
23750735|NCT02252172|66466545|FG001|Overall Study|Lost to Follow-up|1|||
23750736|NCT02252172|66466544|FG000|Overall Study|Ongoing|276|||
23750737|NCT02252172|66466545|FG001|Overall Study|Ongoing|298|||
23750738|NCT02965716|66466546|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23750739|NCT02965716|66466547|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
23750740|NCT02965716|66466546|FG000|Overall Study|Progression/Relapse|8|||
23750741|NCT02965716|66466547|FG001|Overall Study|Progression/Relapse|16|||
23750742|NCT02965716|66466546|FG000|Overall Study|Death|1|||
23750743|NCT02965716|66466547|FG001|Overall Study|Death|0|||
23750744|NCT02965716|66466546|FG000|Overall Study|Not Protocol Specified|1|||
23750745|NCT02965716|66466547|FG001|Overall Study|Not Protocol Specified|3|||
23434442|NCT01026220|65334076|FG001|Consolidation Maintenance|Death|1|||
23434443|NCT01026220|65334077|FG002|Consolidation Maintenance|Death|0|||
23434444|NCT01026220|65334075|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
23434445|NCT01026220|65334076|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
23434446|NCT01026220|65334077|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
23556380|NCT00082173|65762570|FG001|Overall Study|Withdrawal by Subject|5|||
23556381|NCT00082173|65762569|FG000|Overall Study|Lost to Follow-up|1|||
23556382|NCT00082173|65762570|FG001|Overall Study|Lost to Follow-up|0|||
23750746|NCT04469465|66466550|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
23750747|NCT04469465|66466551|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
23556383|NCT00082173|65762569|FG000|Overall Study|Adverse Event|1|||
23824705|NCT03536884|66737928|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23434447|NCT01026220|65334075|FG000|Consolidation Maintenance|Physician Decision|0|||
23556384|NCT00082173|65762570|FG001|Overall Study|Adverse Event|0|||
23556385|NCT00082173|65762569|FG000|Overall Study|Culture negative or resistant at baselin|5|||
23556386|NCT00082173|65762570|FG001|Overall Study|Culture negative or resistant at baselin|6|||
23556387|NCT04259450|65762574|FG000|Overall Study|Adverse event/ Toxicity|0|||
23556388|NCT04259450|65762575|FG001|Overall Study|Adverse event/ Toxicity|3|||
23556389|NCT04259450|65762576|FG002|Overall Study|Adverse event/ Toxicity|0|||
23556390|NCT04259450|65762577|FG003|Overall Study|Adverse event/ Toxicity|1|||
23556391|NCT04259450|65762578|FG004|Overall Study|Adverse event/ Toxicity|0|||
23556392|NCT04259450|65762579|FG005|Overall Study|Adverse event/ Toxicity|0|||
23434448|NCT01026220|65334076|FG001|Consolidation Maintenance|Physician Decision|2|||
23434449|NCT01026220|65334077|FG002|Consolidation Maintenance|Physician Decision|7|||
23434450|NCT01026220|65334075|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
23556393|NCT04259450|65762580|FG006|Overall Study|Adverse event/ Toxicity|0|||
23434451|NCT01026220|65334076|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
23434452|NCT01026220|65334077|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
23556394|NCT04259450|65762581|FG007|Overall Study|Adverse event/ Toxicity|1|||
23556395|NCT04259450|65762582|FG008|Overall Study|Adverse event/ Toxicity|0|||
23556396|NCT04259450|65762583|FG009|Overall Study|Adverse event/ Toxicity|3|||
23556397|NCT04259450|65762574|FG000|Overall Study|Disease progression|2|||
23434453|NCT01196416|65334078|FG000|Overall Study|Withdrawal by Subject|2|||
23434454|NCT01079936|65334079|FG000|Phase I: MTD|First Remission Status|2|||
23434455|NCT01079936|65334080|FG001|Phase I: MTD|First Remission Status|0|||
23434456|NCT01079936|65334081|FG002|Phase I: MTD|First Remission Status|0|||
23434457|NCT01079936|65334082|FG003|Phase I: MTD|First Remission Status|0|||
23434458|NCT01079936|65334083|FG004|Phase I: MTD|First Remission Status|0|||
23434459|NCT01079936|65334079|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
23434460|NCT01079936|65334080|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
23434461|NCT01079936|65334081|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
23434462|NCT01079936|65334082|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
23434463|NCT01079936|65334083|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
23434464|NCT01079936|65334079|FG000|Phase II|Adverse Event|0|||
23434465|NCT01079936|65334080|FG001|Phase II|Adverse Event|0|||
23556398|NCT04259450|65762575|FG001|Overall Study|Disease progression|3|||
23556399|NCT04259450|65762576|FG002|Overall Study|Disease progression|4|||
23556400|NCT04259450|65762577|FG003|Overall Study|Disease progression|4|||
23623523|NCT00684203|66008470|FG002|Overall Study|Did not meet protocol eligibility|0|||
23623524|NCT00684203|66008471|FG003|Overall Study|Did not meet protocol eligibility|0|||
23556401|NCT04259450|65762578|FG004|Overall Study|Disease progression|6|||
23556402|NCT04259450|65762579|FG005|Overall Study|Disease progression|6|||
23556403|NCT04259450|65762580|FG006|Overall Study|Disease progression|5|||
23556404|NCT04259450|65762581|FG007|Overall Study|Disease progression|15|||
23556405|NCT04259450|65762582|FG008|Overall Study|Disease progression|6|||
23556406|NCT04259450|65762583|FG009|Overall Study|Disease progression|17|||
23556407|NCT04259450|65762574|FG000|Overall Study|Death|0|||
23556408|NCT04259450|65762575|FG001|Overall Study|Death|0|||
23556409|NCT04259450|65762576|FG002|Overall Study|Death|0|||
23556410|NCT04259450|65762577|FG003|Overall Study|Death|0|||
23556411|NCT04259450|65762578|FG004|Overall Study|Death|0|||
23556412|NCT04259450|65762579|FG005|Overall Study|Death|0|||
23556413|NCT04259450|65762580|FG006|Overall Study|Death|0|||
23556414|NCT04259450|65762581|FG007|Overall Study|Death|1|||
23556415|NCT04259450|65762582|FG008|Overall Study|Death|1|||
23556416|NCT04259450|65762583|FG009|Overall Study|Death|0|||
23556417|NCT04259450|65762574|FG000|Overall Study|Withdrawal by Subject|0|||
23556418|NCT04259450|65762575|FG001|Overall Study|Withdrawal by Subject|0|||
23556419|NCT04259450|65762576|FG002|Overall Study|Withdrawal by Subject|0|||
23556420|NCT04259450|65762577|FG003|Overall Study|Withdrawal by Subject|0|||
23556421|NCT04259450|65762578|FG004|Overall Study|Withdrawal by Subject|0|||
23556422|NCT04259450|65762579|FG005|Overall Study|Withdrawal by Subject|0|||
23556423|NCT04259450|65762580|FG006|Overall Study|Withdrawal by Subject|0|||
23556424|NCT04259450|65762581|FG007|Overall Study|Withdrawal by Subject|1|||
23556425|NCT04259450|65762582|FG008|Overall Study|Withdrawal by Subject|0|||
23556426|NCT04259450|65762583|FG009|Overall Study|Withdrawal by Subject|0|||
23556427|NCT04259450|65762574|FG000|Overall Study|Long Term Adverse Event|0|||
23556428|NCT04259450|65762575|FG001|Overall Study|Long Term Adverse Event|0|||
23556429|NCT04259450|65762576|FG002|Overall Study|Long Term Adverse Event|0|||
23556430|NCT04259450|65762577|FG003|Overall Study|Long Term Adverse Event|0|||
23556431|NCT04259450|65762578|FG004|Overall Study|Long Term Adverse Event|0|||
23556432|NCT04259450|65762579|FG005|Overall Study|Long Term Adverse Event|0|||
23556433|NCT04259450|65762580|FG006|Overall Study|Long Term Adverse Event|0|||
23623525|NCT00684203|66008472|FG004|Overall Study|Did not meet protocol eligibility|0|||
23750748|NCT04469465|66466550|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
23750749|NCT04469465|66466551|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
23750750|NCT04469465|66466550|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
23750751|NCT04469465|66466551|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
23750752|NCT04469465|66466550|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
23750753|NCT04469465|66466551|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
23750754|NCT04469465|66466550|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
23750755|NCT04469465|66466551|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
23750756|NCT04469465|66466550|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
23750757|NCT04469465|66466551|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
23750758|NCT04469465|66466550|FG000|Long-Term Extension (LTE)|Death|0|||
23750759|NCT04469465|66466551|FG001|Long-Term Extension (LTE)|Death|1|||
23750760|NCT04469465|66466550|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
23750761|NCT04469465|66466551|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
23750762|NCT01286272|66466558|FG000|Overall Study|Ineligible after beginning treatment|1|||
23750763|NCT01286272|66466559|FG001|Overall Study|Ineligible after beginning treatment|3|||
23750764|NCT00449761|66466561|FG000|Overall Study|Disease progression|12|||
23750765|NCT00449761|66466561|FG000|Overall Study|Death|5|||
23750766|NCT00449761|66466561|FG000|Overall Study|New cancer therapy|1|||
23556434|NCT04259450|65762581|FG007|Overall Study|Long Term Adverse Event|0|||
23556435|NCT04259450|65762582|FG008|Overall Study|Long Term Adverse Event|0|||
23556436|NCT04259450|65762583|FG009|Overall Study|Long Term Adverse Event|1|||
23556437|NCT03280121|65762586|FG000|Overall Study|Physician Decision|1|||
23556438|NCT03280121|65762586|FG000|Overall Study|Lost to Follow-up|1|||
23556439|NCT03280121|65762586|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
23556440|NCT01559454|65765894|FG000|Overall Study|Lost to Follow-up|3|||
23556441|NCT01559454|65765895|FG001|Overall Study|Lost to Follow-up|2|||
23556442|NCT01559454|65765894|FG000|Overall Study|Withdrawal by Subject|0|||
23556443|NCT01559454|65765895|FG001|Overall Study|Withdrawal by Subject|1|||
23750767|NCT02180867|66466569|FG000|Overall Study|Adverse Event|3|||
23750768|NCT02180867|66466570|FG001|Overall Study|Adverse Event|4|||
23750769|NCT02180867|66466571|FG002|Overall Study|Adverse Event|1|||
23750770|NCT02180867|66466572|FG003|Overall Study|Adverse Event|5|||
23750771|NCT02180867|66466573|FG004|Overall Study|Adverse Event|0|||
23750772|NCT02180867|66466574|FG005|Overall Study|Adverse Event|0|||
23750773|NCT02180867|66466575|FG006|Overall Study|Adverse Event|0|||
23750774|NCT02180867|66466569|FG000|Overall Study|Death|0|||
23750775|NCT02180867|66466570|FG001|Overall Study|Death|0|||
23750776|NCT02180867|66466571|FG002|Overall Study|Death|0|||
23434466|NCT01079936|65334081|FG002|Phase II|Adverse Event|1|||
23434467|NCT01079936|65334082|FG003|Phase II|Adverse Event|0|||
23434468|NCT01079936|65334083|FG004|Phase II|Adverse Event|0|||
23434469|NCT01079936|65334079|FG000|Phase II|Insurance Issue|0|||
23434470|NCT01079936|65334080|FG001|Phase II|Insurance Issue|0|||
23750777|NCT02180867|66466572|FG003|Overall Study|Death|0|||
23750778|NCT02180867|66466573|FG004|Overall Study|Death|1|||
23750779|NCT02180867|66466574|FG005|Overall Study|Death|0|||
23750780|NCT02180867|66466575|FG006|Overall Study|Death|0|||
23750781|NCT02180867|66466569|FG000|Overall Study|Lack of Efficacy|0|||
23750782|NCT02180867|66466570|FG001|Overall Study|Lack of Efficacy|2|||
23750783|NCT02180867|66466571|FG002|Overall Study|Lack of Efficacy|0|||
23750784|NCT02180867|66466572|FG003|Overall Study|Lack of Efficacy|1|||
23750785|NCT02180867|66466573|FG004|Overall Study|Lack of Efficacy|6|||
23750786|NCT02180867|66466574|FG005|Overall Study|Lack of Efficacy|0|||
23750787|NCT02180867|66466575|FG006|Overall Study|Lack of Efficacy|1|||
23824706|NCT03536884|66737929|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23556444|NCT01559454|65765894|FG000|Overall Study|Physician Decision|0|||
23556445|NCT01559454|65765895|FG001|Overall Study|Physician Decision|1|||
23556446|NCT01559454|65765894|FG000|Overall Study|Protocol Violation|0|||
23556447|NCT01559454|65765895|FG001|Overall Study|Protocol Violation|1|||
23556448|NCT01559454|65765894|FG000|Overall Study|Lack of Efficacy|0|||
23750788|NCT02180867|66466569|FG000|Overall Study|Physician Decision|1|||
23434471|NCT01079936|65334081|FG002|Phase II|Insurance Issue|0|||
23434472|NCT01079936|65334082|FG003|Phase II|Insurance Issue|0|||
23434473|NCT01079936|65334083|FG004|Phase II|Insurance Issue|1|||
23434474|NCT03667690|65334086|FG000|Overall Study|Adverse Event|0|||
23434475|NCT03667690|65334087|FG001|Overall Study|Adverse Event|3|||
23434476|NCT03667690|65334086|FG000|Overall Study|Death|22|||
23434477|NCT03667690|65334087|FG001|Overall Study|Death|21|||
23556449|NCT01559454|65765895|FG001|Overall Study|Lack of Efficacy|1|||
23750789|NCT02180867|66466570|FG001|Overall Study|Physician Decision|3|||
23750790|NCT02180867|66466571|FG002|Overall Study|Physician Decision|1|||
23750791|NCT02180867|66466572|FG003|Overall Study|Physician Decision|10|||
23750792|NCT02180867|66466573|FG004|Overall Study|Physician Decision|9|||
23434478|NCT03667690|65334086|FG000|Overall Study|Lost to Follow-up|4|||
23434479|NCT03667690|65334087|FG001|Overall Study|Lost to Follow-up|5|||
23434480|NCT03667690|65334086|FG000|Overall Study|Withdrawal by Subject|7|||
23556450|NCT00733499|65765896|FG000|Pre-operative|Protocol Violation|0|||
23750793|NCT02180867|66466574|FG005|Overall Study|Physician Decision|3|||
23750794|NCT02180867|66466575|FG006|Overall Study|Physician Decision|4|||
23556451|NCT00733499|65765897|FG001|Pre-operative|Protocol Violation|1|||
23824707|NCT03536884|66737930|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824708|NCT03536884|66737931|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23824709|NCT03536884|66737920|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824710|NCT03536884|66737921|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824711|NCT03536884|66737922|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824712|NCT03536884|66737923|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
23824713|NCT03536884|66737924|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
23824714|NCT03536884|66737925|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824715|NCT03536884|66737926|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824716|NCT03536884|66737927|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824717|NCT03536884|66737928|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23434481|NCT03667690|65334087|FG001|Overall Study|Withdrawal by Subject|8|||
23824718|NCT03536884|66737929|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824719|NCT03536884|66737930|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824720|NCT03536884|66737931|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23824721|NCT03536884|66737920|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824722|NCT03536884|66737921|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824723|NCT03536884|66737922|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
23824724|NCT03536884|66737923|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
23824725|NCT03536884|66737924|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
23824726|NCT03536884|66737925|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824727|NCT03536884|66737926|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824728|NCT03536884|66737927|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824729|NCT03536884|66737928|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824730|NCT03536884|66737929|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824731|NCT03536884|66737930|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824732|NCT03536884|66737931|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23824733|NCT03536884|66737920|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824734|NCT03536884|66737921|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824735|NCT03536884|66737922|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
23824736|NCT03536884|66737923|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
23824737|NCT03536884|66737924|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
23824738|NCT03536884|66737925|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824739|NCT03536884|66737926|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824740|NCT03536884|66737927|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824741|NCT03536884|66737928|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824742|NCT03536884|66737929|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824743|NCT03536884|66737930|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23824744|NCT03536884|66737931|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23434482|NCT03667690|65334086|FG000|Overall Study|Subject could not return for additional investigational product|1|||
23434483|NCT03667690|65334087|FG001|Overall Study|Subject could not return for additional investigational product|0|||
23434484|NCT03667690|65334086|FG000|Overall Study|Subject discharged to hospice care|2|||
23434485|NCT03667690|65334087|FG001|Overall Study|Subject discharged to hospice care|0|||
23434486|NCT03667690|65334086|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
23434487|NCT03667690|65334087|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
23434488|NCT03667690|65334086|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
23434489|NCT03667690|65334087|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
23434490|NCT03667690|65334086|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
23556452|NCT00733499|65765896|FG000|3 Months Follow-up|Death|1|||
23434491|NCT03667690|65334087|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
23434492|NCT03667690|65334086|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
23434493|NCT03667690|65334087|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
23434494|NCT03667690|65334086|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
23434495|NCT03667690|65334087|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
23434496|NCT03761810|65334094|FG000|Overall Study|Adverse Event|12|||
23434497|NCT03761810|65334095|FG001|Overall Study|Adverse Event|0|||
23434498|NCT03761810|65334094|FG000|Overall Study|Lost to Follow-up|15|||
23434499|NCT03761810|65334095|FG001|Overall Study|Lost to Follow-up|7|||
23434500|NCT03761810|65334094|FG000|Overall Study|Pregnancy|1|||
23434501|NCT03761810|65334095|FG001|Overall Study|Pregnancy|0|||
23434502|NCT03761810|65334094|FG000|Overall Study|Withdrawal by Subject|14|||
23434503|NCT03761810|65334095|FG001|Overall Study|Withdrawal by Subject|5|||
23434504|NCT03761810|65334094|FG000|Overall Study|Physician Decision|1|||
23434505|NCT03761810|65334095|FG001|Overall Study|Physician Decision|0|||
23434506|NCT03761810|65334094|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
23434507|NCT03761810|65334095|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23434508|NCT03761810|65334094|FG000|Overall Study|Other Than Specified|1|||
23434509|NCT03761810|65334095|FG001|Overall Study|Other Than Specified|0|||
23434510|NCT03160885|65334096|FG000|Initial Treatment Period|Not dosed|2|||
23434511|NCT03160885|65334097|FG001|Initial Treatment Period|Not dosed|0|||
23434512|NCT03160885|65334098|FG002|Initial Treatment Period|Not dosed|0|||
23434513|NCT03160885|65334099|FG003|Initial Treatment Period|Not dosed|0|||
23434514|NCT03160885|65334100|FG004|Initial Treatment Period|Not dosed|0|||
23434515|NCT03160885|65334101|FG005|Initial Treatment Period|Not dosed|0|||
23556453|NCT00733499|65765897|FG001|3 Months Follow-up|Death|2|||
23434516|NCT03160885|65334102|FG006|Initial Treatment Period|Not dosed|0|||
23434517|NCT03160885|65334096|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
23556454|NCT00733499|65765896|FG000|6 Months Follow-up|Death|0|||
23750795|NCT02180867|66466569|FG000|Overall Study|Withdrawal by Subject|0|||
23750796|NCT02180867|66466570|FG001|Overall Study|Withdrawal by Subject|0|||
23750797|NCT02180867|66466571|FG002|Overall Study|Withdrawal by Subject|0|||
23750798|NCT02180867|66466572|FG003|Overall Study|Withdrawal by Subject|1|||
23750799|NCT02180867|66466573|FG004|Overall Study|Withdrawal by Subject|1|||
23824745|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824746|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824747|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824748|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824749|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824750|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
23824751|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
23824752|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
23556455|NCT00733499|65765897|FG001|6 Months Follow-up|Death|2|||
23556456|NCT00733499|65765896|FG000|6 Months Follow-up|Adverse Event|0|||
23556457|NCT00733499|65765897|FG001|6 Months Follow-up|Adverse Event|1|||
23556458|NCT00733499|65765896|FG000|12 Months Follow-up|Death|2|||
23556459|NCT00733499|65765897|FG001|12 Months Follow-up|Death|1|||
23556460|NCT00733499|65765896|FG000|24 Months Follow-up|Death|0|||
23556461|NCT00733499|65765897|FG001|24 Months Follow-up|Death|1|||
23556462|NCT00733499|65765896|FG000|5 Year Followup|Adverse Event|2|||
23556463|NCT00733499|65765897|FG001|5 Year Followup|Adverse Event|2|||
23556464|NCT00733499|65765896|FG000|5 Year Followup|Non device related AE|0|||
23556465|NCT00733499|65765897|FG001|5 Year Followup|Non device related AE|1|||
23556466|NCT00733499|65765896|FG000|5 Year Followup|Revision of Study Implant|0|||
23556467|NCT00733499|65765897|FG001|5 Year Followup|Revision of Study Implant|1|||
23556468|NCT00733499|65765896|FG000|5 Year Followup|Lost to Follow-up|2|||
23556469|NCT00733499|65765897|FG001|5 Year Followup|Lost to Follow-up|0|||
23556470|NCT00733499|65765896|FG000|5 Year Followup|Death|13|||
23556471|NCT00733499|65765897|FG001|5 Year Followup|Death|19|||
23556472|NCT00733499|65765896|FG000|5 Year Followup|missing, unable to locate|0|||
23556473|NCT00733499|65765897|FG001|5 Year Followup|missing, unable to locate|1|||
23556474|NCT00733499|65765896|FG000|5 Year Followup|Withdrawal by Subject|4|||
23556475|NCT00733499|65765897|FG001|5 Year Followup|Withdrawal by Subject|1|||
23556476|NCT00733499|65765896|FG000|10 Year Followup|Death|9|||
23556477|NCT00733499|65765897|FG001|10 Year Followup|Death|7|||
23556478|NCT00733499|65765896|FG000|10 Year Followup|Adverse Event|3|||
23824753|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
23824754|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824755|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824756|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
23824757|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824758|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824759|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824760|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824761|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824762|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23824763|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23824764|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23824765|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
23824766|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824767|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824768|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23824769|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824770|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824771|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824772|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824773|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824774|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
23824775|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824776|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
23824777|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824778|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824779|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824780|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23824781|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824782|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824783|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824784|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824785|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824786|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
23824787|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824788|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
23824789|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
23824790|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824791|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824792|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23824793|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824794|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824795|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824796|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824797|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824798|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
23824799|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
23824800|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
23824801|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
23824802|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824803|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824804|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23824805|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824806|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824807|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23556479|NCT00733499|65765897|FG001|10 Year Followup|Adverse Event|3|||
23824808|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824809|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824810|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
23556480|NCT00733499|65765896|FG000|10 Year Followup|Lost to Follow-up|3|||
23824811|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23556481|NCT00733499|65765897|FG001|10 Year Followup|Lost to Follow-up|2|||
23556482|NCT00733499|65765896|FG000|10 Year Followup|Withdrawal by Subject|5|||
23750800|NCT02180867|66466574|FG005|Overall Study|Withdrawal by Subject|0|||
23750801|NCT02180867|66466575|FG006|Overall Study|Withdrawal by Subject|0|||
23750802|NCT02180867|66466569|FG000|Overall Study|Ineligible|1|||
23750803|NCT02180867|66466570|FG001|Overall Study|Ineligible|2|||
23750804|NCT02180867|66466571|FG002|Overall Study|Ineligible|0|||
23750805|NCT02180867|66466572|FG003|Overall Study|Ineligible|3|||
23750806|NCT02180867|66466573|FG004|Overall Study|Ineligible|5|||
23750807|NCT02180867|66466574|FG005|Overall Study|Ineligible|0|||
23750808|NCT02180867|66466575|FG006|Overall Study|Ineligible|0|||
23750809|NCT02180867|66466569|FG000|Overall Study|Repeat Eligibility Studies|0|||
23750810|NCT02180867|66466570|FG001|Overall Study|Repeat Eligibility Studies|0|||
23750811|NCT02180867|66466571|FG002|Overall Study|Repeat Eligibility Studies|0|||
23750812|NCT02180867|66466572|FG003|Overall Study|Repeat Eligibility Studies|0|||
23750813|NCT02180867|66466573|FG004|Overall Study|Repeat Eligibility Studies|1|||
23750814|NCT02180867|66466574|FG005|Overall Study|Repeat Eligibility Studies|0|||
23750815|NCT02180867|66466575|FG006|Overall Study|Repeat Eligibility Studies|0|||
23750816|NCT02180867|66466569|FG000|Overall Study|Refusal of further protocol therapy|1|||
23750817|NCT02180867|66466570|FG001|Overall Study|Refusal of further protocol therapy|0|||
23750818|NCT02180867|66466571|FG002|Overall Study|Refusal of further protocol therapy|2|||
23750819|NCT02180867|66466572|FG003|Overall Study|Refusal of further protocol therapy|6|||
23750820|NCT02180867|66466573|FG004|Overall Study|Refusal of further protocol therapy|4|||
23750821|NCT02180867|66466574|FG005|Overall Study|Refusal of further protocol therapy|0|||
23750822|NCT02180867|66466575|FG006|Overall Study|Refusal of further protocol therapy|0|||
23750823|NCT00980460|66466576|FG000|Overall Study|Death|0|||
23750824|NCT00980460|66466577|FG001|Overall Study|Death|0|||
23750825|NCT00980460|66466578|FG002|Overall Study|Death|1|||
23750826|NCT00980460|66466579|FG003|Overall Study|Death|2|||
23750827|NCT00980460|66466580|FG004|Overall Study|Death|1|||
23750828|NCT00980460|66466576|FG000|Overall Study|Lack of Efficacy|0|||
23750829|NCT00980460|66466577|FG001|Overall Study|Lack of Efficacy|0|||
23750830|NCT00980460|66466578|FG002|Overall Study|Lack of Efficacy|10|||
23750831|NCT00980460|66466579|FG003|Overall Study|Lack of Efficacy|6|||
23750832|NCT00980460|66466580|FG004|Overall Study|Lack of Efficacy|8|||
23750833|NCT00980460|66466576|FG000|Overall Study|Lost to Follow-up|0|||
23824812|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23750834|NCT00980460|66466577|FG001|Overall Study|Lost to Follow-up|0|||
23750835|NCT00980460|66466578|FG002|Overall Study|Lost to Follow-up|0|||
23750836|NCT00980460|66466579|FG003|Overall Study|Lost to Follow-up|1|||
23434518|NCT03160885|65334097|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
23434519|NCT03160885|65334098|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23623526|NCT00684203|66008473|FG005|Overall Study|Did not meet protocol eligibility|0|||
23623527|NCT01157351|66008474|FG000|Overall Study|Adverse Event|5|||
23623528|NCT01157351|66008475|FG001|Overall Study|Adverse Event|4|||
23824813|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824814|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23434520|NCT03160885|65334099|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434521|NCT03160885|65334100|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434522|NCT03160885|65334101|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23623529|NCT01157351|66008474|FG000|Overall Study|Death|1|||
23623530|NCT01157351|66008475|FG001|Overall Study|Death|0|||
23623531|NCT01157351|66008474|FG000|Overall Study|Lost to Follow-up|53|||
23623532|NCT01157351|66008475|FG001|Overall Study|Lost to Follow-up|55|||
23623533|NCT01157351|66008474|FG000|Overall Study|Withdrawal by Subject|37|||
23623534|NCT01157351|66008475|FG001|Overall Study|Withdrawal by Subject|27|||
23623535|NCT01157351|66008474|FG000|Overall Study|Physician Decision|5|||
23623536|NCT01157351|66008475|FG001|Overall Study|Physician Decision|4|||
23623537|NCT01157351|66008474|FG000|Overall Study|Protocol Violation|0|||
23623538|NCT01157351|66008475|FG001|Overall Study|Protocol Violation|1|||
23623539|NCT01157351|66008474|FG000|Overall Study|Other|32|||
23750837|NCT00980460|66466580|FG004|Overall Study|Lost to Follow-up|0|||
23750838|NCT00980460|66466576|FG000|Overall Study|Physician Decision|0|||
23750839|NCT00980460|66466577|FG001|Overall Study|Physician Decision|0|||
23750840|NCT00980460|66466578|FG002|Overall Study|Physician Decision|11|||
23434523|NCT03160885|65334102|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434524|NCT03160885|65334096|FG000|Open-label Treatment|Not dosed|0|||
23434525|NCT03160885|65334097|FG001|Open-label Treatment|Not dosed|0|||
23434526|NCT03160885|65334098|FG002|Open-label Treatment|Not dosed|0|||
23434527|NCT03160885|65334099|FG003|Open-label Treatment|Not dosed|0|||
23434528|NCT03160885|65334100|FG004|Open-label Treatment|Not dosed|0|||
23434529|NCT03160885|65334101|FG005|Open-label Treatment|Not dosed|0|||
23434530|NCT03160885|65334102|FG006|Open-label Treatment|Not dosed|2|||
23434531|NCT03160885|65334096|FG000|Open-label Treatment|Discontinued IMP|0|||
23434532|NCT03160885|65334097|FG001|Open-label Treatment|Discontinued IMP|0|||
23750841|NCT00980460|66466579|FG003|Overall Study|Physician Decision|5|||
23750842|NCT00980460|66466580|FG004|Overall Study|Physician Decision|3|||
23750843|NCT00980460|66466576|FG000|Overall Study|Withdrawal by Subject|0|||
23750844|NCT00980460|66466577|FG001|Overall Study|Withdrawal by Subject|0|||
23750845|NCT00980460|66466578|FG002|Overall Study|Withdrawal by Subject|1|||
23750846|NCT00980460|66466579|FG003|Overall Study|Withdrawal by Subject|0|||
23750847|NCT00980460|66466580|FG004|Overall Study|Withdrawal by Subject|0|||
23750848|NCT00980460|66466576|FG000|Overall Study|Ineligible|0|||
23750849|NCT00980460|66466577|FG001|Overall Study|Ineligible|2|||
23750850|NCT00980460|66466578|FG002|Overall Study|Ineligible|3|||
23750851|NCT00980460|66466579|FG003|Overall Study|Ineligible|1|||
23750852|NCT00980460|66466580|FG004|Overall Study|Ineligible|4|||
23750853|NCT00980460|66466576|FG000|Overall Study|Refusal of further therapy|0|||
23750854|NCT00980460|66466577|FG001|Overall Study|Refusal of further therapy|2|||
23750855|NCT00980460|66466578|FG002|Overall Study|Refusal of further therapy|3|||
23750856|NCT00980460|66466579|FG003|Overall Study|Refusal of further therapy|2|||
23750857|NCT00980460|66466580|FG004|Overall Study|Refusal of further therapy|0|||
23750858|NCT00980460|66466576|FG000|Overall Study|No therapy within 42 days of resection|0|||
23750859|NCT00980460|66466577|FG001|Overall Study|No therapy within 42 days of resection|0|||
23750860|NCT00980460|66466578|FG002|Overall Study|No therapy within 42 days of resection|3|||
23750861|NCT00980460|66466579|FG003|Overall Study|No therapy within 42 days of resection|1|||
23750862|NCT00980460|66466580|FG004|Overall Study|No therapy within 42 days of resection|0|||
23750863|NCT00980460|66466576|FG000|Overall Study|No transplant by protocol timepoints|0|||
23750864|NCT00980460|66466577|FG001|Overall Study|No transplant by protocol timepoints|0|||
23750865|NCT00980460|66466578|FG002|Overall Study|No transplant by protocol timepoints|3|||
23750866|NCT00980460|66466579|FG003|Overall Study|No transplant by protocol timepoints|0|||
23750867|NCT00980460|66466580|FG004|Overall Study|No transplant by protocol timepoints|0|||
23750868|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23750869|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
23750870|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23750871|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23750872|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
23434533|NCT03160885|65334098|FG002|Open-label Treatment|Discontinued IMP|0|||
23623540|NCT01157351|66008475|FG001|Overall Study|Other|36|||
23623541|NCT01157351|66008474|FG000|Overall Study|Noncompliance with Study Drug|0|||
23623542|NCT01157351|66008475|FG001|Overall Study|Noncompliance with Study Drug|3|||
23623543|NCT01157351|66008474|FG000|Overall Study|Randomized but not Treated|4|||
23750873|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
23750874|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
23434534|NCT03160885|65334099|FG003|Open-label Treatment|Discontinued IMP|0|||
23434535|NCT03160885|65334100|FG004|Open-label Treatment|Discontinued IMP|0|||
23434536|NCT03160885|65334101|FG005|Open-label Treatment|Discontinued IMP|0|||
23434537|NCT03160885|65334102|FG006|Open-label Treatment|Discontinued IMP|131|||
23434538|NCT03160885|65334096|FG000|Open-label Treatment|Completed Week 50|0|||
23750875|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
23750876|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23750877|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
23434539|NCT03160885|65334097|FG001|Open-label Treatment|Completed Week 50|0|||
23434540|NCT03160885|65334098|FG002|Open-label Treatment|Completed Week 50|0|||
23434541|NCT03160885|65334099|FG003|Open-label Treatment|Completed Week 50|0|||
23434542|NCT03160885|65334100|FG004|Open-label Treatment|Completed Week 50|0|||
23434543|NCT03160885|65334101|FG005|Open-label Treatment|Completed Week 50|0|||
23434544|NCT03160885|65334102|FG006|Open-label Treatment|Completed Week 50|4|||
23434545|NCT03160885|65334096|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434546|NCT03160885|65334097|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434547|NCT03160885|65334098|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434548|NCT03160885|65334099|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
23434549|NCT03160885|65334100|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434550|NCT03160885|65334101|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434551|NCT03160885|65334102|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434552|NCT03160885|65334096|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
23434553|NCT03160885|65334097|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
23434554|NCT03160885|65334098|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
23434555|NCT03160885|65334099|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
23434556|NCT03160885|65334100|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
23434557|NCT03160885|65334101|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
23434558|NCT03160885|65334102|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
23434559|NCT03160885|65334096|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434560|NCT03160885|65334097|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434561|NCT03160885|65334098|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
23434562|NCT03160885|65334099|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
23434563|NCT03160885|65334100|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
23434564|NCT03160885|65334101|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
23434565|NCT03160885|65334102|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434566|NCT03160885|65334096|FG000|Maintenance Treatment Period|Completed Week 50|0|||
23434567|NCT03160885|65334097|FG001|Maintenance Treatment Period|Completed Week 50|0|||
23434568|NCT03160885|65334098|FG002|Maintenance Treatment Period|Completed Week 50|1|||
23434569|NCT03160885|65334099|FG003|Maintenance Treatment Period|Completed Week 50|0|||
23434570|NCT03160885|65334100|FG004|Maintenance Treatment Period|Completed Week 50|0|||
23434571|NCT03160885|65334101|FG005|Maintenance Treatment Period|Completed Week 50|0|||
23434572|NCT03160885|65334102|FG006|Maintenance Treatment Period|Completed Week 50|0|||
23434573|NCT00084487|65334103|FG000|Overall Study|Death|1|||
23434574|NCT01229449|65334107|FG000|Overall Study|Withdrawal by Subject|0|||
23434575|NCT01229449|65334108|FG001|Overall Study|Withdrawal by Subject|3|||
23434576|NCT01229449|65334109|FG002|Overall Study|Withdrawal by Subject|0|||
23434577|NCT01229449|65334110|FG003|Overall Study|Withdrawal by Subject|1|||
23434578|NCT01229449|65334111|FG004|Overall Study|Withdrawal by Subject|1|||
23434579|NCT01229449|65334107|FG000|Overall Study|Lost to Follow-up|1|||
23434580|NCT01229449|65334108|FG001|Overall Study|Lost to Follow-up|1|||
23434581|NCT01229449|65334109|FG002|Overall Study|Lost to Follow-up|1|||
23434582|NCT01229449|65334110|FG003|Overall Study|Lost to Follow-up|0|||
23434583|NCT01229449|65334111|FG004|Overall Study|Lost to Follow-up|0|||
23434584|NCT01229449|65334107|FG000|Overall Study|Physician Decision|0|||
23434585|NCT01229449|65334108|FG001|Overall Study|Physician Decision|0|||
23434586|NCT01229449|65334109|FG002|Overall Study|Physician Decision|1|||
23434587|NCT01229449|65334110|FG003|Overall Study|Physician Decision|0|||
23434588|NCT01229449|65334111|FG004|Overall Study|Physician Decision|0|||
23434589|NCT01953913|65334114|FG000|Overall Study|Disease Progression|349|||
23434590|NCT01953913|65334114|FG000|Overall Study|Worsening of underlying cancer|22|||
23434591|NCT01953913|65334114|FG000|Overall Study|Adverse Event|20|||
23434592|NCT01953913|65334114|FG000|Overall Study|Protocol Violation|6|||
23434593|NCT01953913|65334114|FG000|Overall Study|Lost to Follow-up|4|||
23434594|NCT01953913|65334114|FG000|Overall Study|Withdrawal by Subject|32|||
23434595|NCT01953913|65334114|FG000|Overall Study|Other than listed|108|||
23434596|NCT01953913|65334114|FG000|Overall Study|Not Treated|1|||
23434597|NCT00847015|65334115|FG000|Overall Study|Withdrawal by Subject|1|||
23434598|NCT00847015|65334115|FG000|Overall Study|declined any surgery|1|||
23750878|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23434599|NCT00847015|65334115|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
23434600|NCT02175368|65334118|FG000|Overall Study|Lost to Follow-up|1|||
23434601|NCT01571453|65334120|FG000|Overall Study|Adverse Event|14|||
23434602|NCT01571453|65334121|FG001|Overall Study|Adverse Event|32|||
23434603|NCT01571453|65334120|FG000|Overall Study|Lack of Efficacy|8|||
23434604|NCT01571453|65334121|FG001|Overall Study|Lack of Efficacy|3|||
23434605|NCT01571453|65334120|FG000|Overall Study|Non-compliance|2|||
23434606|NCT01571453|65334121|FG001|Overall Study|Non-compliance|4|||
23434607|NCT01571453|65334120|FG000|Overall Study|Protocol Violation|1|||
23434608|NCT01571453|65334121|FG001|Overall Study|Protocol Violation|5|||
23434609|NCT01571453|65334120|FG000|Overall Study|Withdrawal of consent|5|||
23434610|NCT01571453|65334121|FG001|Overall Study|Withdrawal of consent|13|||
23434611|NCT01571453|65334120|FG000|Overall Study|Lost to Follow-up|4|||
23434612|NCT01571453|65334121|FG001|Overall Study|Lost to Follow-up|2|||
23434613|NCT01571453|65334120|FG000|Overall Study|Administrative or other reason(s)|4|||
23434614|NCT01571453|65334121|FG001|Overall Study|Administrative or other reason(s)|3|||
23434615|NCT00504894|65334122|FG000|Overall Study|fMRI technical problems|1|||
23434616|NCT00504894|65334123|FG001|Overall Study|fMRI technical problems|1|||
23434617|NCT00504894|65334124|FG002|Overall Study|fMRI technical problems|0|||
23434618|NCT00504894|65334122|FG000|Overall Study|Withdrawal by Subject|0|||
23434619|NCT00504894|65334123|FG001|Overall Study|Withdrawal by Subject|1|||
23434620|NCT00504894|65334124|FG002|Overall Study|Withdrawal by Subject|0|||
23434621|NCT00504894|65334122|FG000|Overall Study|Infusion technical problems|0|||
23434622|NCT00504894|65334123|FG001|Overall Study|Infusion technical problems|1|||
23434623|NCT00504894|65334124|FG002|Overall Study|Infusion technical problems|0|||
23434624|NCT00504894|65334122|FG000|Overall Study|poor subject data|2|||
23434625|NCT00504894|65334123|FG001|Overall Study|poor subject data|0|||
23434626|NCT00504894|65334124|FG002|Overall Study|poor subject data|0|||
23434627|NCT02905006|65334125|FG000|Overall Study|Adverse Event|1|||
23434628|NCT02905006|65334126|FG001|Overall Study|Adverse Event|1|||
23434629|NCT02905006|65334127|FG002|Overall Study|Adverse Event|1|||
23434630|NCT02905006|65334128|FG003|Overall Study|Adverse Event|1|||
23434631|NCT02905006|65334129|FG004|Overall Study|Adverse Event|0|||
23434632|NCT02905006|65334130|FG005|Overall Study|Adverse Event|1|||
23434633|NCT02905006|65334125|FG000|Overall Study|Lack of Efficacy|1|||
23434634|NCT02905006|65334126|FG001|Overall Study|Lack of Efficacy|0|||
23434635|NCT02905006|65334127|FG002|Overall Study|Lack of Efficacy|0|||
23434636|NCT02905006|65334128|FG003|Overall Study|Lack of Efficacy|0|||
23434637|NCT02905006|65334129|FG004|Overall Study|Lack of Efficacy|0|||
23434638|NCT02905006|65334130|FG005|Overall Study|Lack of Efficacy|0|||
23434639|NCT02905006|65334125|FG000|Overall Study|Protocol Violation|2|||
23434640|NCT02905006|65334126|FG001|Overall Study|Protocol Violation|0|||
23434641|NCT02905006|65334127|FG002|Overall Study|Protocol Violation|0|||
23434642|NCT02905006|65334128|FG003|Overall Study|Protocol Violation|0|||
23434643|NCT02905006|65334129|FG004|Overall Study|Protocol Violation|0|||
23434644|NCT02905006|65334130|FG005|Overall Study|Protocol Violation|0|||
23434645|NCT02905006|65334125|FG000|Overall Study|Lost to Follow-up|0|||
23434646|NCT02905006|65334126|FG001|Overall Study|Lost to Follow-up|0|||
23434647|NCT02905006|65334127|FG002|Overall Study|Lost to Follow-up|0|||
23434648|NCT02905006|65334128|FG003|Overall Study|Lost to Follow-up|1|||
23434649|NCT02905006|65334129|FG004|Overall Study|Lost to Follow-up|1|||
23434650|NCT02905006|65334130|FG005|Overall Study|Lost to Follow-up|0|||
23434651|NCT02905006|65334125|FG000|Overall Study|Withdrawal by Subject|0|||
23434652|NCT02905006|65334126|FG001|Overall Study|Withdrawal by Subject|0|||
23434653|NCT02905006|65334127|FG002|Overall Study|Withdrawal by Subject|1|||
23434654|NCT02905006|65334128|FG003|Overall Study|Withdrawal by Subject|1|||
23556483|NCT00733499|65765897|FG001|10 Year Followup|Withdrawal by Subject|5|||
23556484|NCT00733499|65765896|FG000|10 Year Followup|missing, unable to locate|0|||
23556485|NCT00733499|65765897|FG001|10 Year Followup|missing, unable to locate|2|||
23556486|NCT00567190|65765898|FG000|Overall Study|Death|235|||
23556487|NCT00567190|65765899|FG001|Overall Study|Death|280|||
23556488|NCT00567190|65765898|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
23556489|NCT00567190|65765899|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
23556490|NCT03751631|65765900|FG000|Overall Study|Withdrawal by Subject|0|||
23434655|NCT02905006|65334129|FG004|Overall Study|Withdrawal by Subject|0|||
23434656|NCT02905006|65334130|FG005|Overall Study|Withdrawal by Subject|1|||
23434657|NCT02905006|65334125|FG000|Overall Study|Screening exclusion criteria met|1|||
23434658|NCT02905006|65334126|FG001|Overall Study|Screening exclusion criteria met|0|||
23434659|NCT02905006|65334127|FG002|Overall Study|Screening exclusion criteria met|0|||
23434660|NCT02905006|65334128|FG003|Overall Study|Screening exclusion criteria met|0|||
23434661|NCT02905006|65334129|FG004|Overall Study|Screening exclusion criteria met|0|||
23434662|NCT02905006|65334130|FG005|Overall Study|Screening exclusion criteria met|0|||
23556491|NCT03751631|65765901|FG001|Overall Study|Withdrawal by Subject|0|||
23623544|NCT01157351|66008475|FG001|Overall Study|Randomized but not Treated|2|||
23434663|NCT02905006|65334125|FG000|Overall Study|Lab withdrawal criterion met|0|||
23556492|NCT03751631|65765902|FG002|Overall Study|Withdrawal by Subject|1|||
23434664|NCT02905006|65334126|FG001|Overall Study|Lab withdrawal criterion met|1|||
23434665|NCT02905006|65334127|FG002|Overall Study|Lab withdrawal criterion met|2|||
23434666|NCT02905006|65334128|FG003|Overall Study|Lab withdrawal criterion met|2|||
23434667|NCT02905006|65334129|FG004|Overall Study|Lab withdrawal criterion met|2|||
23434668|NCT02905006|65334130|FG005|Overall Study|Lab withdrawal criterion met|1|||
23434669|NCT02905006|65334125|FG000|Overall Study|Positive for Tuberculosis|0|||
23556493|NCT03751631|65765903|FG003|Overall Study|Withdrawal by Subject|1|||
23434670|NCT02905006|65334126|FG001|Overall Study|Positive for Tuberculosis|1|||
23434671|NCT02905006|65334127|FG002|Overall Study|Positive for Tuberculosis|0|||
23434672|NCT02905006|65334128|FG003|Overall Study|Positive for Tuberculosis|0|||
23434673|NCT02905006|65334129|FG004|Overall Study|Positive for Tuberculosis|0|||
23434674|NCT02905006|65334130|FG005|Overall Study|Positive for Tuberculosis|0|||
23434675|NCT02905006|65334125|FG000|Overall Study|Subject positive for Hep B|0|||
23434676|NCT02905006|65334126|FG001|Overall Study|Subject positive for Hep B|0|||
23434677|NCT02905006|65334127|FG002|Overall Study|Subject positive for Hep B|1|||
23434678|NCT02905006|65334128|FG003|Overall Study|Subject positive for Hep B|0|||
23434679|NCT02905006|65334129|FG004|Overall Study|Subject positive for Hep B|0|||
23434680|NCT02905006|65334130|FG005|Overall Study|Subject positive for Hep B|0|||
23434681|NCT02905006|65334125|FG000|Overall Study|Patient moved abroad|0|||
23434682|NCT02905006|65334126|FG001|Overall Study|Patient moved abroad|0|||
23434683|NCT02905006|65334127|FG002|Overall Study|Patient moved abroad|0|||
23434684|NCT02905006|65334128|FG003|Overall Study|Patient moved abroad|1|||
23434685|NCT02905006|65334129|FG004|Overall Study|Patient moved abroad|0|||
23434686|NCT02905006|65334130|FG005|Overall Study|Patient moved abroad|0|||
23434687|NCT02905006|65334125|FG000|Overall Study|Patient randomized by mistake|0|||
23434688|NCT02905006|65334126|FG001|Overall Study|Patient randomized by mistake|0|||
23434689|NCT02905006|65334127|FG002|Overall Study|Patient randomized by mistake|0|||
23434690|NCT02905006|65334128|FG003|Overall Study|Patient randomized by mistake|0|||
23434691|NCT02905006|65334129|FG004|Overall Study|Patient randomized by mistake|0|||
23434692|NCT02905006|65334130|FG005|Overall Study|Patient randomized by mistake|1|||
23434693|NCT02409719|65334135|FG000|Overall Study|Lost to Follow-up|3|||
23434694|NCT02409719|65334136|FG001|Overall Study|Lost to Follow-up|3|||
23434695|NCT00737633|65334137|FG000|Overall Study|Study terminated by sponsor|44|||
23434696|NCT00737633|65334138|FG001|Overall Study|Study terminated by sponsor|55|||
23434697|NCT00737633|65334137|FG000|Overall Study|Lost to Follow-up|0|||
23434698|NCT00737633|65334138|FG001|Overall Study|Lost to Follow-up|1|||
23434699|NCT00737633|65334137|FG000|Overall Study|protocol non-compliance|0|||
23434700|NCT00737633|65334138|FG001|Overall Study|protocol non-compliance|1|||
23434701|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
23434702|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
23434703|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
23434704|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
23434705|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
23434706|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
23434707|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
23434708|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
23434709|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
23434710|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
23750879|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23434711|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
23434712|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
23556494|NCT03751631|65765904|FG004|Overall Study|Withdrawal by Subject|0|||
23556495|NCT03751631|65765905|FG005|Overall Study|Withdrawal by Subject|0|||
23556496|NCT02856113|65765906|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23556497|NCT02856113|65765907|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23556498|NCT02856113|65765906|FG000|Overall Study|Significant Protocol Deviation|1|||
23556499|NCT02856113|65765907|FG001|Overall Study|Significant Protocol Deviation|0|||
23556500|NCT02856113|65765906|FG000|Overall Study|Lost to Follow-up|3|||
23623545|NCT00591591|66008482|FG000|Overall Study|Withdrawal by Subject|1|||
23434713|NCT00330681|65334145|FG000|Overall Study|Adverse Event|3|||
23434714|NCT00330681|65334146|FG001|Overall Study|Adverse Event|6|||
23434715|NCT00330681|65334145|FG000|Overall Study|Protocol Violation|0|||
23434716|NCT00330681|65334146|FG001|Overall Study|Protocol Violation|1|||
23434717|NCT00330681|65334145|FG000|Overall Study|Withdrawal by Subject|5|||
23434718|NCT00330681|65334146|FG001|Overall Study|Withdrawal by Subject|5|||
23750880|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
23434719|NCT00330681|65334145|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
23434720|NCT00330681|65334146|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
23434721|NCT02322190|65334150|FG000|Overall Study|Death on study|1|||
23434722|NCT02322190|65334151|FG001|Overall Study|Death on study|0|||
23434723|NCT00629798|65334160|FG000|Overall Study|Not Treated|4|||
23434724|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
23434725|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
23434726|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
23434727|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
23434728|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
23434729|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
23434730|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
23434731|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434732|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434733|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434734|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434735|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434736|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
23434737|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
23434738|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434739|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434740|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434741|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434742|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
23434743|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
23434744|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
23434745|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
23434746|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
23434747|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
23434748|NCT02453555|65334161|FG000|Extension Period|Adverse Event|0|||
23434749|NCT02453555|65334162|FG001|Extension Period|Adverse Event|0|||
23434750|NCT02453555|65334163|FG002|Extension Period|Adverse Event|1|||
23434751|NCT02453555|65334164|FG003|Extension Period|Adverse Event|2|||
23434752|NCT02453555|65334165|FG004|Extension Period|Adverse Event|1|||
23434753|NCT02453555|65334166|FG005|Extension Period|Adverse Event|1|||
23434754|NCT02453555|65334161|FG000|Extension Period|Protocol Violation|0|||
23434755|NCT02453555|65334162|FG001|Extension Period|Protocol Violation|0|||
23434756|NCT02453555|65334163|FG002|Extension Period|Protocol Violation|1|||
23434757|NCT02453555|65334164|FG003|Extension Period|Protocol Violation|0|||
23434758|NCT02453555|65334165|FG004|Extension Period|Protocol Violation|0|||
23434759|NCT02453555|65334166|FG005|Extension Period|Protocol Violation|0|||
23434760|NCT02453555|65334161|FG000|Extension Period|Withdrawal by Subject|0|||
23434761|NCT02453555|65334162|FG001|Extension Period|Withdrawal by Subject|0|||
23434762|NCT02453555|65334163|FG002|Extension Period|Withdrawal by Subject|1|||
23434763|NCT02453555|65334164|FG003|Extension Period|Withdrawal by Subject|0|||
23556501|NCT02856113|65765907|FG001|Overall Study|Lost to Follow-up|5|||
23556502|NCT02856113|65765906|FG000|Overall Study|Voluntary Withdrawal|3|||
23556503|NCT02856113|65765907|FG001|Overall Study|Voluntary Withdrawal|5|||
23556504|NCT02856113|65765906|FG000|Overall Study|Pregnancy|0|||
23556505|NCT02856113|65765907|FG001|Overall Study|Pregnancy|1|||
23556506|NCT02856113|65765906|FG000|Overall Study|Principal Investigator Discretion|2|||
23556507|NCT02856113|65765907|FG001|Overall Study|Principal Investigator Discretion|1|||
23556508|NCT02856113|65765906|FG000|Overall Study|Randomized but not Treated|1|||
23556509|NCT02856113|65765907|FG001|Overall Study|Randomized but not Treated|0|||
23556510|NCT02856113|65765906|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
23750881|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
23750882|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
23750883|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
23750884|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
23750885|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
23750886|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
23750887|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
23750888|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23750889|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
23750890|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23750891|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23824815|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23556511|NCT02856113|65765907|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
23623546|NCT00591591|66008483|FG001|Overall Study|Withdrawal by Subject|37|||
23750892|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
23750893|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23434764|NCT02453555|65334165|FG004|Extension Period|Withdrawal by Subject|0|||
23434765|NCT02453555|65334166|FG005|Extension Period|Withdrawal by Subject|0|||
23434766|NCT04349033|65334167|FG000|Overall Study|Lost to Follow-up|3|||
23434767|NCT04349033|65334168|FG001|Overall Study|Lost to Follow-up|1|||
23434768|NCT04349033|65334169|FG002|Overall Study|Lost to Follow-up|1|||
23434769|NCT01563185|65334170|FG000|Overall Study|Withdrawal by Subject|1|||
23434770|NCT01563185|65334170|FG000|Overall Study|Non-Compliance with study drug|1|||
23434771|NCT00471887|65334171|FG000|Overall Study|Adverse Event|9|||
23434772|NCT01792518|65334172|FG000|Overall Study|Adverse Event|3|||
23434773|NCT01792518|65334173|FG001|Overall Study|Adverse Event|4|||
23434774|NCT01792518|65334172|FG000|Overall Study|Protocol Violation|0|||
23434775|NCT01792518|65334173|FG001|Overall Study|Protocol Violation|1|||
23434776|NCT01792518|65334172|FG000|Overall Study|Lost to Follow-up|3|||
23434777|NCT01792518|65334173|FG001|Overall Study|Lost to Follow-up|1|||
23434778|NCT01792518|65334172|FG000|Overall Study|Withdrawal by Subject|2|||
23434779|NCT01792518|65334173|FG001|Overall Study|Withdrawal by Subject|0|||
23434780|NCT01792518|65334172|FG000|Overall Study|Other Reason|0|||
23434781|NCT01792518|65334173|FG001|Overall Study|Other Reason|1|||
23434782|NCT00932165|65334174|FG000|Overall Study|Lost to Follow-up|1|||
23434783|NCT03657095|65334175|FG000|Overall Study|Withdrawal by Subject|1|||
23434784|NCT03657095|65334176|FG001|Overall Study|Withdrawal by Subject|1|||
23434785|NCT03657095|65334175|FG000|Overall Study|Adverse Event|0|||
23434786|NCT03657095|65334176|FG001|Overall Study|Adverse Event|3|||
23434787|NCT03657095|65334175|FG000|Overall Study|Study Terminated by Sponsor|58|||
23434788|NCT03657095|65334176|FG001|Overall Study|Study Terminated by Sponsor|49|||
23434789|NCT03180307|65334178|FG000|Overall Study|Lost to Follow-up|2|||
23434790|NCT03180307|65334179|FG001|Overall Study|Lost to Follow-up|0|||
23434791|NCT03180307|65334178|FG000|Overall Study|Death|1|||
23434792|NCT03180307|65334179|FG001|Overall Study|Death|0|||
23434793|NCT03180307|65334178|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
23434794|NCT03180307|65334179|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
23434795|NCT05079477|65334180|FG000|Overall Study|Lost to Follow-up|2|||
23434796|NCT05079477|65334181|FG001|Overall Study|Lost to Follow-up|0|||
23434797|NCT05079477|65334180|FG000|Overall Study|Withdrawal by Subject|1|||
23434798|NCT05079477|65334181|FG001|Overall Study|Withdrawal by Subject|0|||
23434799|NCT05079477|65334180|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
23434800|NCT05079477|65334181|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
23434801|NCT05079477|65334180|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
23434802|NCT05079477|65334181|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
23434803|NCT01772576|65334182|FG000|Overall Study|Death|15|||
23434804|NCT01772576|65334182|FG000|Overall Study|Protocol Violation|1|||
23434805|NCT01772576|65334182|FG000|Overall Study|Lost to Follow-up|3|||
23434806|NCT01772576|65334182|FG000|Overall Study|Study device not used|3|||
23434807|NCT01772576|65334182|FG000|Overall Study|Adverse Event|6|||
23434808|NCT01772576|65334182|FG000|Overall Study|Withdrawal by Subject|6|||
23434809|NCT03684694|65334183|FG000|Phase 1|Withdrawal by Subject|1|||
23434810|NCT03684694|65334184|FG001|Phase 1|Withdrawal by Subject|0|||
23434811|NCT03684694|65334185|FG002|Phase 1|Withdrawal by Subject|0|||
23434812|NCT03684694|65334186|FG003|Phase 1|Withdrawal by Subject|0|||
23434813|NCT03684694|65334187|FG004|Phase 1|Withdrawal by Subject|0|||
23750894|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23750895|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23750896|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
23750897|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
23750898|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
23750899|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
23750900|NCT03747939|66466581|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23750901|NCT03747939|66466582|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
23750902|NCT03747939|66466583|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23750903|NCT03747939|66466584|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23750904|NCT03747939|66466581|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
23750905|NCT03747939|66466582|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
23434814|NCT03684694|65334188|FG005|Phase 1|Withdrawal by Subject|0|||
23434815|NCT03684694|65334183|FG000|Phase 1|Investigator/Sponsor Decision|12|||
23434816|NCT03684694|65334184|FG001|Phase 1|Investigator/Sponsor Decision|2|||
23434817|NCT03684694|65334185|FG002|Phase 1|Investigator/Sponsor Decision|1|||
23434818|NCT03684694|65334186|FG003|Phase 1|Investigator/Sponsor Decision|0|||
23434819|NCT03684694|65334187|FG004|Phase 1|Investigator/Sponsor Decision|0|||
23434820|NCT03684694|65334188|FG005|Phase 1|Investigator/Sponsor Decision|0|||
23434821|NCT03684694|65334183|FG000|Phase 1|Death|24|||
23434822|NCT03684694|65334184|FG001|Phase 1|Death|0|||
23434823|NCT03684694|65334185|FG002|Phase 1|Death|3|||
23434824|NCT03684694|65334186|FG003|Phase 1|Death|0|||
23434825|NCT03684694|65334187|FG004|Phase 1|Death|0|||
23434826|NCT03684694|65334188|FG005|Phase 1|Death|0|||
23434827|NCT03684694|65334183|FG000|Phase 1|Lost to Follow-up|0|||
23434828|NCT03684694|65334184|FG001|Phase 1|Lost to Follow-up|0|||
23434829|NCT03684694|65334185|FG002|Phase 1|Lost to Follow-up|1|||
23434830|NCT03684694|65334186|FG003|Phase 1|Lost to Follow-up|0|||
23434831|NCT03684694|65334187|FG004|Phase 1|Lost to Follow-up|0|||
23434832|NCT03684694|65334188|FG005|Phase 1|Lost to Follow-up|0|||
23434833|NCT03684694|65334183|FG000|Phase 1|Miscellaneous|0|||
23434834|NCT03684694|65334184|FG001|Phase 1|Miscellaneous|1|||
23434835|NCT03684694|65334185|FG002|Phase 1|Miscellaneous|0|||
23434836|NCT03684694|65334186|FG003|Phase 1|Miscellaneous|0|||
23434837|NCT03684694|65334187|FG004|Phase 1|Miscellaneous|0|||
23434838|NCT03684694|65334188|FG005|Phase 1|Miscellaneous|0|||
23434839|NCT03684694|65334183|FG000|Phase 2|Withdrawal by Subject|0|||
23434840|NCT03684694|65334184|FG001|Phase 2|Withdrawal by Subject|0|||
23434841|NCT03684694|65334185|FG002|Phase 2|Withdrawal by Subject|0|||
23434842|NCT03684694|65334186|FG003|Phase 2|Withdrawal by Subject|0|||
23434843|NCT03684694|65334187|FG004|Phase 2|Withdrawal by Subject|0|||
23434844|NCT03684694|65334188|FG005|Phase 2|Withdrawal by Subject|1|||
23434845|NCT03684694|65334183|FG000|Phase 2|Investigator/Sponsor Decision|0|||
23434846|NCT03684694|65334184|FG001|Phase 2|Investigator/Sponsor Decision|0|||
23434847|NCT03684694|65334185|FG002|Phase 2|Investigator/Sponsor Decision|0|||
23434848|NCT03684694|65334186|FG003|Phase 2|Investigator/Sponsor Decision|17|||
23434849|NCT03684694|65334187|FG004|Phase 2|Investigator/Sponsor Decision|16|||
23434850|NCT03684694|65334188|FG005|Phase 2|Investigator/Sponsor Decision|6|||
23434851|NCT03684694|65334183|FG000|Phase 2|Death|0|||
23434852|NCT03684694|65334184|FG001|Phase 2|Death|0|||
23434853|NCT03684694|65334185|FG002|Phase 2|Death|0|||
23434854|NCT03684694|65334186|FG003|Phase 2|Death|28|||
23434855|NCT03684694|65334187|FG004|Phase 2|Death|14|||
23434856|NCT03684694|65334188|FG005|Phase 2|Death|3|||
23434857|NCT03684694|65334183|FG000|Phase 2|Lost to Follow-up|0|||
23434858|NCT03684694|65334184|FG001|Phase 2|Lost to Follow-up|0|||
23434859|NCT03684694|65334185|FG002|Phase 2|Lost to Follow-up|0|||
23434860|NCT03684694|65334186|FG003|Phase 2|Lost to Follow-up|1|||
23434861|NCT03684694|65334187|FG004|Phase 2|Lost to Follow-up|0|||
23434862|NCT03684694|65334188|FG005|Phase 2|Lost to Follow-up|0|||
23434863|NCT03684694|65334183|FG000|Phase 2|Miscellaneous|0|||
23434864|NCT03684694|65334184|FG001|Phase 2|Miscellaneous|0|||
23434865|NCT03684694|65334185|FG002|Phase 2|Miscellaneous|0|||
23434866|NCT03684694|65334186|FG003|Phase 2|Miscellaneous|3|||
23434867|NCT03684694|65334187|FG004|Phase 2|Miscellaneous|0|||
23434868|NCT03684694|65334188|FG005|Phase 2|Miscellaneous|0|||
23434869|NCT01717326|65334189|FG000|Overall Study|Death|0|||
23434870|NCT01717326|65334190|FG001|Overall Study|Death|0|||
23434871|NCT01717326|65334191|FG002|Overall Study|Death|0|||
23434872|NCT01717326|65334192|FG003|Overall Study|Death|0|||
23434873|NCT01717326|65334193|FG004|Overall Study|Death|0|||
23434874|NCT01717326|65334194|FG005|Overall Study|Death|0|||
23434875|NCT01717326|65334195|FG006|Overall Study|Death|0|||
23434876|NCT01717326|65334196|FG007|Overall Study|Death|0|||
23434877|NCT01717326|65334197|FG008|Overall Study|Death|0|||
23434878|NCT01717326|65334198|FG009|Overall Study|Death|0|||
23434879|NCT01717326|65334199|FG010|Overall Study|Death|1|||
23434880|NCT01717326|65334200|FG011|Overall Study|Death|0|||
23434881|NCT01717326|65334201|FG012|Overall Study|Death|0|||
23434882|NCT01717326|65334202|FG013|Overall Study|Death|0|||
23434883|NCT01717326|65334203|FG014|Overall Study|Death|0|||
23434884|NCT01717326|65334204|FG015|Overall Study|Death|0|||
23434885|NCT01717326|65334205|FG016|Overall Study|Death|0|||
23434886|NCT01717326|65334206|FG017|Overall Study|Death|0|||
23434887|NCT01717326|65334207|FG018|Overall Study|Death|0|||
23434888|NCT01717326|65334208|FG019|Overall Study|Death|0|||
23434889|NCT01717326|65334189|FG000|Overall Study|Lost to Follow-up|3|||
23434890|NCT01717326|65334190|FG001|Overall Study|Lost to Follow-up|0|||
23434891|NCT01717326|65334191|FG002|Overall Study|Lost to Follow-up|0|||
23434892|NCT01717326|65334192|FG003|Overall Study|Lost to Follow-up|2|||
23623547|NCT00591591|66008482|FG000|Overall Study|Lack of Efficacy|10|||
23434893|NCT01717326|65334193|FG004|Overall Study|Lost to Follow-up|1|||
23434894|NCT01717326|65334194|FG005|Overall Study|Lost to Follow-up|0|||
23434895|NCT01717326|65334195|FG006|Overall Study|Lost to Follow-up|1|||
23750906|NCT03747939|66466583|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
23434896|NCT01717326|65334196|FG007|Overall Study|Lost to Follow-up|0|||
23434897|NCT01717326|65334197|FG008|Overall Study|Lost to Follow-up|0|||
23434898|NCT01717326|65334198|FG009|Overall Study|Lost to Follow-up|0|||
23434899|NCT01717326|65334199|FG010|Overall Study|Lost to Follow-up|1|||
23434900|NCT01717326|65334200|FG011|Overall Study|Lost to Follow-up|0|||
23434901|NCT01717326|65334201|FG012|Overall Study|Lost to Follow-up|0|||
23434902|NCT01717326|65334202|FG013|Overall Study|Lost to Follow-up|0|||
23434903|NCT01717326|65334203|FG014|Overall Study|Lost to Follow-up|0|||
23434904|NCT01717326|65334204|FG015|Overall Study|Lost to Follow-up|2|||
23434905|NCT01717326|65334205|FG016|Overall Study|Lost to Follow-up|1|||
23434906|NCT01717326|65334206|FG017|Overall Study|Lost to Follow-up|0|||
23434907|NCT01717326|65334207|FG018|Overall Study|Lost to Follow-up|2|||
23434908|NCT01717326|65334208|FG019|Overall Study|Lost to Follow-up|3|||
23434909|NCT01717326|65334189|FG000|Overall Study|Physician Decision|0|||
23434910|NCT01717326|65334190|FG001|Overall Study|Physician Decision|0|||
23434911|NCT01717326|65334191|FG002|Overall Study|Physician Decision|0|||
23434912|NCT01717326|65334192|FG003|Overall Study|Physician Decision|0|||
23434913|NCT01717326|65334193|FG004|Overall Study|Physician Decision|0|||
23434914|NCT01717326|65334194|FG005|Overall Study|Physician Decision|0|||
23434915|NCT01717326|65334195|FG006|Overall Study|Physician Decision|0|||
23434916|NCT01717326|65334196|FG007|Overall Study|Physician Decision|0|||
23434917|NCT01717326|65334197|FG008|Overall Study|Physician Decision|0|||
23434918|NCT01717326|65334198|FG009|Overall Study|Physician Decision|1|||
23434919|NCT01717326|65334199|FG010|Overall Study|Physician Decision|0|||
23434920|NCT01717326|65334200|FG011|Overall Study|Physician Decision|0|||
23434921|NCT01717326|65334201|FG012|Overall Study|Physician Decision|0|||
23434922|NCT01717326|65334202|FG013|Overall Study|Physician Decision|0|||
23434923|NCT01717326|65334203|FG014|Overall Study|Physician Decision|0|||
23434924|NCT01717326|65334204|FG015|Overall Study|Physician Decision|0|||
23434925|NCT01717326|65334205|FG016|Overall Study|Physician Decision|0|||
23434926|NCT01717326|65334206|FG017|Overall Study|Physician Decision|0|||
23434927|NCT01717326|65334207|FG018|Overall Study|Physician Decision|0|||
23434928|NCT01717326|65334208|FG019|Overall Study|Physician Decision|0|||
23434929|NCT01717326|65334189|FG000|Overall Study|Protocol Violation|0|||
23434930|NCT01717326|65334190|FG001|Overall Study|Protocol Violation|0|||
23434931|NCT01717326|65334191|FG002|Overall Study|Protocol Violation|0|||
23434932|NCT01717326|65334192|FG003|Overall Study|Protocol Violation|0|||
23434933|NCT01717326|65334193|FG004|Overall Study|Protocol Violation|1|||
23434934|NCT01717326|65334194|FG005|Overall Study|Protocol Violation|0|||
23434935|NCT01717326|65334195|FG006|Overall Study|Protocol Violation|0|||
23434936|NCT01717326|65334196|FG007|Overall Study|Protocol Violation|0|||
23434937|NCT01717326|65334197|FG008|Overall Study|Protocol Violation|0|||
23434938|NCT01717326|65334198|FG009|Overall Study|Protocol Violation|0|||
23434939|NCT01717326|65334199|FG010|Overall Study|Protocol Violation|0|||
23556512|NCT01949311|65765914|FG000|Overall Study|Lost to Follow-up|73|||
23556513|NCT01949311|65765914|FG000|Overall Study|Terminated by Sponsor|708|||
23556514|NCT01949311|65765914|FG000|Overall Study|Withdrawal by Subject|375|||
23556515|NCT01949311|65765914|FG000|Overall Study|Lack of Efficacy|50|||
23556516|NCT01949311|65765914|FG000|Overall Study|Protocol Deviation|34|||
23556517|NCT01949311|65765914|FG000|Overall Study|Pregnancy|20|||
23556518|NCT01949311|65765914|FG000|Overall Study|Physician Decision|9|||
23556519|NCT01949311|65765914|FG000|Overall Study|Other|4|||
23556520|NCT01949311|65765914|FG000|Overall Study|Adverse Event|107|||
23556521|NCT02151266|65765915|FG000|Overall Study|Lost to Follow-up|1|||
23556522|NCT02151266|65765916|FG001|Overall Study|Lost to Follow-up|4|||
23556523|NCT02151266|65765917|FG002|Overall Study|Lost to Follow-up|1|||
23556524|NCT02151266|65765915|FG000|Overall Study|Did NOT receive intervention|3|||
23556525|NCT02151266|65765916|FG001|Overall Study|Did NOT receive intervention|6|||
23556526|NCT02151266|65765917|FG002|Overall Study|Did NOT receive intervention|2|||
23556527|NCT02151266|65765915|FG000|Overall Study|Not able to exercise|4|||
23556528|NCT02151266|65765916|FG001|Overall Study|Not able to exercise|5|||
23556529|NCT02151266|65765917|FG002|Overall Study|Not able to exercise|4|||
23556530|NCT02338154|65765921|FG000|Overall Study|Death|46|||
23556531|NCT02338154|65765921|FG000|Overall Study|Valve Implant Failure|17|||
23556532|NCT02338154|65765921|FG000|Overall Study|Valve Explant|11|||
23556533|NCT02338154|65765921|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
23556534|NCT02338154|65765921|FG000|Overall Study|Lost to Follow-up|8|||
23556535|NCT02338154|65765921|FG000|Overall Study|Other Reason|3|||
23623548|NCT00591591|66008483|FG001|Overall Study|Lack of Efficacy|2|||
23623549|NCT02970305|66008484|FG000|Overall Study|Adverse Event|10|||
23434940|NCT01717326|65334200|FG011|Overall Study|Protocol Violation|0|||
23434941|NCT01717326|65334201|FG012|Overall Study|Protocol Violation|0|||
23434942|NCT01717326|65334202|FG013|Overall Study|Protocol Violation|0|||
23434943|NCT01717326|65334203|FG014|Overall Study|Protocol Violation|0|||
23434944|NCT01717326|65334204|FG015|Overall Study|Protocol Violation|0|||
23434945|NCT01717326|65334205|FG016|Overall Study|Protocol Violation|0|||
23434946|NCT01717326|65334206|FG017|Overall Study|Protocol Violation|0|||
23434947|NCT01717326|65334207|FG018|Overall Study|Protocol Violation|0|||
23434948|NCT01717326|65334208|FG019|Overall Study|Protocol Violation|0|||
23556536|NCT02338154|65765921|FG000|Overall Study|Patients Without Exit Form|47|||
23556537|NCT02338154|65765921|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
23556538|NCT00316082|65765924|FG000|Overall Study|Lack of Efficacy|2|||
23556539|NCT00316082|65765925|FG001|Overall Study|Lack of Efficacy|3|||
23556540|NCT00316082|65765926|FG002|Overall Study|Lack of Efficacy|3|||
23556541|NCT00316082|65765927|FG003|Overall Study|Lack of Efficacy|4|||
23434949|NCT01717326|65334189|FG000|Overall Study|Withdrawal by Subject|0|||
23434950|NCT01717326|65334190|FG001|Overall Study|Withdrawal by Subject|1|||
23434951|NCT01717326|65334191|FG002|Overall Study|Withdrawal by Subject|0|||
23434952|NCT01717326|65334192|FG003|Overall Study|Withdrawal by Subject|0|||
23434953|NCT01717326|65334193|FG004|Overall Study|Withdrawal by Subject|0|||
23434954|NCT01717326|65334194|FG005|Overall Study|Withdrawal by Subject|0|||
23434955|NCT01717326|65334195|FG006|Overall Study|Withdrawal by Subject|0|||
23434956|NCT01717326|65334196|FG007|Overall Study|Withdrawal by Subject|0|||
23434957|NCT01717326|65334197|FG008|Overall Study|Withdrawal by Subject|0|||
23434958|NCT01717326|65334198|FG009|Overall Study|Withdrawal by Subject|1|||
23434959|NCT01717326|65334199|FG010|Overall Study|Withdrawal by Subject|0|||
23434960|NCT01717326|65334200|FG011|Overall Study|Withdrawal by Subject|0|||
23434961|NCT01717326|65334201|FG012|Overall Study|Withdrawal by Subject|1|||
23434962|NCT01717326|65334202|FG013|Overall Study|Withdrawal by Subject|0|||
23434963|NCT01717326|65334203|FG014|Overall Study|Withdrawal by Subject|0|||
23434964|NCT01717326|65334204|FG015|Overall Study|Withdrawal by Subject|1|||
23434965|NCT01717326|65334205|FG016|Overall Study|Withdrawal by Subject|0|||
23434966|NCT01717326|65334206|FG017|Overall Study|Withdrawal by Subject|0|||
23434967|NCT01717326|65334207|FG018|Overall Study|Withdrawal by Subject|2|||
23556542|NCT00316082|65765928|FG004|Overall Study|Lack of Efficacy|6|||
23556543|NCT00316082|65765924|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
23556544|NCT00316082|65765925|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
23556545|NCT00316082|65765926|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
23556546|NCT00316082|65765927|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
23623550|NCT02970305|66008485|FG001|Overall Study|Adverse Event|6|||
23623551|NCT02970305|66008484|FG000|Overall Study|Lack of Efficacy|1|||
23556547|NCT00316082|65765928|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
23556548|NCT00316082|65765924|FG000|Overall Study|Lost to Follow-up|7|||
23556549|NCT00316082|65765925|FG001|Overall Study|Lost to Follow-up|6|||
23556550|NCT00316082|65765926|FG002|Overall Study|Lost to Follow-up|7|||
23556551|NCT00316082|65765927|FG003|Overall Study|Lost to Follow-up|8|||
23556552|NCT00316082|65765928|FG004|Overall Study|Lost to Follow-up|6|||
23556553|NCT00316082|65765924|FG000|Overall Study|Poor/noncompliance|6|||
23556554|NCT00316082|65765925|FG001|Overall Study|Poor/noncompliance|1|||
23556555|NCT00316082|65765926|FG002|Overall Study|Poor/noncompliance|4|||
23556556|NCT00316082|65765927|FG003|Overall Study|Poor/noncompliance|1|||
23556557|NCT00316082|65765928|FG004|Overall Study|Poor/noncompliance|4|||
23556558|NCT00316082|65765924|FG000|Overall Study|Adverse Event|4|||
23556559|NCT00316082|65765925|FG001|Overall Study|Adverse Event|2|||
23556560|NCT00316082|65765926|FG002|Overall Study|Adverse Event|5|||
23556561|NCT00316082|65765927|FG003|Overall Study|Adverse Event|1|||
23556562|NCT00316082|65765928|FG004|Overall Study|Adverse Event|3|||
23556563|NCT00316082|65765924|FG000|Overall Study|Subject no longer meets study criteria|3|||
23556564|NCT00316082|65765925|FG001|Overall Study|Subject no longer meets study criteria|1|||
23556565|NCT00316082|65765926|FG002|Overall Study|Subject no longer meets study criteria|2|||
23556566|NCT00316082|65765927|FG003|Overall Study|Subject no longer meets study criteria|2|||
23556567|NCT00316082|65765928|FG004|Overall Study|Subject no longer meets study criteria|1|||
23556568|NCT00316082|65765924|FG000|Overall Study|Physician Decision|1|||
23556569|NCT00316082|65765925|FG001|Overall Study|Physician Decision|1|||
23556570|NCT00316082|65765926|FG002|Overall Study|Physician Decision|2|||
23556571|NCT00316082|65765927|FG003|Overall Study|Physician Decision|1|||
23556572|NCT00316082|65765928|FG004|Overall Study|Physician Decision|1|||
23556573|NCT00316082|65765924|FG000|Overall Study|Death|0|||
23556574|NCT00316082|65765925|FG001|Overall Study|Death|0|||
23556575|NCT00316082|65765926|FG002|Overall Study|Death|1|||
23556576|NCT00316082|65765927|FG003|Overall Study|Death|0|||
23623552|NCT02970305|66008485|FG001|Overall Study|Lack of Efficacy|1|||
23623553|NCT02970305|66008484|FG000|Overall Study|Noncompliance with study drug|2|||
23623554|NCT02970305|66008485|FG001|Overall Study|Noncompliance with study drug|4|||
23623555|NCT02970305|66008484|FG000|Overall Study|Protocol Violation|2|||
23623556|NCT02970305|66008485|FG001|Overall Study|Protocol Violation|2|||
23434968|NCT01717326|65334208|FG019|Overall Study|Withdrawal by Subject|3|||
23434969|NCT01092663|65334211|FG000|Overall Study|Withdrawal by Subject|3|||
23434970|NCT01092663|65334212|FG001|Overall Study|Withdrawal by Subject|2|||
23434971|NCT01092663|65334211|FG000|Overall Study|Glucose >300mg/dL|1|||
23434972|NCT01092663|65334212|FG001|Overall Study|Glucose >300mg/dL|0|||
23434973|NCT01092663|65334211|FG000|Overall Study|High fasting triglyceride|2|||
23556577|NCT00316082|65765928|FG004|Overall Study|Death|0|||
23556578|NCT00316082|65765924|FG000|Overall Study|Administrative reason by sponsor|0|||
23556579|NCT00316082|65765925|FG001|Overall Study|Administrative reason by sponsor|0|||
23556580|NCT00316082|65765926|FG002|Overall Study|Administrative reason by sponsor|1|||
23556581|NCT00316082|65765927|FG003|Overall Study|Administrative reason by sponsor|0|||
23556582|NCT00316082|65765928|FG004|Overall Study|Administrative reason by sponsor|0|||
23556583|NCT00031486|65765929|FG000|Overall Study|Adverse Event|1|||
23556584|NCT00031486|65765930|FG001|Overall Study|Adverse Event|0|||
23556585|NCT00031486|65765929|FG000|Overall Study|Lost to Follow-up|0|||
23556586|NCT00031486|65765930|FG001|Overall Study|Lost to Follow-up|1|||
23434974|NCT01092663|65334212|FG001|Overall Study|High fasting triglyceride|0|||
23434975|NCT01092663|65334211|FG000|Overall Study|Adverse Event|1|||
23556587|NCT00031486|65765929|FG000|Overall Study|Withdrawal by Subject|3|||
23556588|NCT00031486|65765930|FG001|Overall Study|Withdrawal by Subject|2|||
23556589|NCT00031486|65765929|FG000|Overall Study|Death|0|||
23556590|NCT00031486|65765930|FG001|Overall Study|Death|3|||
23556591|NCT00031486|65765929|FG000|Overall Study|Non-compliant|0|||
23556592|NCT00031486|65765930|FG001|Overall Study|Non-compliant|4|||
23556593|NCT00031486|65765929|FG000|Overall Study|Did not meet eligibility requirement|2|||
23556594|NCT00031486|65765930|FG001|Overall Study|Did not meet eligibility requirement|1|||
23556595|NCT00031486|65765929|FG000|Overall Study|Other|1|||
23556596|NCT00031486|65765930|FG001|Overall Study|Other|1|||
23556597|NCT01972529|65765937|FG000|Overall Study|Adverse Event|0|||
23556598|NCT01972529|65765938|FG001|Overall Study|Adverse Event|1|||
23824816|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23824817|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824818|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824819|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824820|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824821|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824822|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824823|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
23824824|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824825|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824826|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824827|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824828|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23824829|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824830|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824831|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824832|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824833|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824834|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824835|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
23824836|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824837|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824838|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824839|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824840|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23824841|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824842|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824843|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824844|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824845|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824846|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
23824847|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824848|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824849|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824850|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824851|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824852|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
23824853|NCT03536884|66737920|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824854|NCT03536884|66737921|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824855|NCT03536884|66737922|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824856|NCT03536884|66737923|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824857|NCT03536884|66737924|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824858|NCT03536884|66737925|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824859|NCT03536884|66737926|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23434976|NCT01092663|65334212|FG001|Overall Study|Adverse Event|1|||
23556599|NCT01972529|65765939|FG002|Overall Study|Adverse Event|0|||
23556600|NCT01972529|65765940|FG003|Overall Study|Adverse Event|0|||
23434977|NCT01092663|65334211|FG000|Overall Study|Protocol Violation|0|||
23750907|NCT03747939|66466584|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
23750908|NCT03747939|66466581|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
23750909|NCT03747939|66466582|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
23750910|NCT03747939|66466583|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
23750911|NCT03747939|66466584|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
23750912|NCT03747939|66466581|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
23750913|NCT03747939|66466582|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
23750914|NCT03747939|66466583|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
23750915|NCT03747939|66466584|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
23750916|NCT03747939|66466581|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
23750917|NCT03747939|66466582|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
23750918|NCT03747939|66466583|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
23750919|NCT03747939|66466584|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
23750920|NCT03747939|66466581|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23750921|NCT03747939|66466582|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23750922|NCT03747939|66466583|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23750923|NCT03747939|66466584|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
23750924|NCT03737994|66466587|FG000|Overall Study|Withdrawal by Subject|0|||
23750925|NCT03737994|66466588|FG001|Overall Study|Withdrawal by Subject|0|||
23750926|NCT03737994|66466589|FG002|Overall Study|Withdrawal by Subject|0|||
23750927|NCT03737994|66466590|FG003|Overall Study|Withdrawal by Subject|0|||
23750928|NCT03737994|66466591|FG004|Overall Study|Withdrawal by Subject|0|||
23750929|NCT03737994|66466592|FG005|Overall Study|Withdrawal by Subject|0|||
23750930|NCT03737994|66466593|FG006|Overall Study|Withdrawal by Subject|1|||
23750931|NCT05637515|66466594|FG000|Overall Study|Withdrawal by Subject|17|||
23750932|NCT05637515|66466595|FG001|Overall Study|Withdrawal by Subject|17|||
23750933|NCT04969263|66466597|FG000|Overall Study|Death|1|||
23750934|NCT04969263|66466597|FG000|Overall Study|Lost to Follow-up|2|||
23750935|NCT04969263|66466597|FG000|Overall Study|Withdrawal by Subject|5|||
23750936|NCT04969263|66466597|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
23750937|NCT04484805|66466598|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
23750938|NCT04484805|66466599|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
23750939|NCT04484805|66466598|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
23750940|NCT04484805|66466599|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
23750941|NCT00474994|66466602|FG000|Overall Study|Patient Not treated|1|||
23750942|NCT00474994|66466602|FG000|Overall Study|Patient evaluable for toxicity only|3|||
23750943|NCT00474994|66466602|FG000|Overall Study|Patient found to be ineligible|1|||
23750944|NCT00326118|66466603|FG000|Active Phase|Withdrawal by Subject|4|||
23750945|NCT00326118|66466604|FG001|Active Phase|Withdrawal by Subject|1|||
23750946|NCT02575807|66466605|FG000|Overall Study|Death|8|||
23750947|NCT02575807|66466606|FG001|Overall Study|Death|3|||
23750948|NCT02575807|66466607|FG002|Overall Study|Death|7|||
23750949|NCT02575807|66466608|FG003|Overall Study|Death|0|||
23750950|NCT02575807|66466609|FG004|Overall Study|Death|1|||
23750951|NCT02575807|66466605|FG000|Overall Study|Study terminated by Sponsor|0|||
23750952|NCT02575807|66466606|FG001|Overall Study|Study terminated by Sponsor|1|||
23750953|NCT02575807|66466607|FG002|Overall Study|Study terminated by Sponsor|7|||
23750954|NCT02575807|66466608|FG003|Overall Study|Study terminated by Sponsor|0|||
23750955|NCT02575807|66466609|FG004|Overall Study|Study terminated by Sponsor|1|||
23750956|NCT02575807|66466605|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
23750957|NCT02575807|66466606|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
23750958|NCT02575807|66466607|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
23750959|NCT02575807|66466608|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
23750960|NCT02575807|66466609|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
23750961|NCT02575807|66466605|FG000|Overall Study|Terminated due to physician decision|0|||
23750962|NCT02575807|66466606|FG001|Overall Study|Terminated due to physician decision|0|||
23750963|NCT02575807|66466607|FG002|Overall Study|Terminated due to physician decision|1|||
23750964|NCT02575807|66466608|FG003|Overall Study|Terminated due to physician decision|0|||
23750965|NCT02575807|66466609|FG004|Overall Study|Terminated due to physician decision|0|||
23434978|NCT01092663|65334212|FG001|Overall Study|Protocol Violation|1|||
23623557|NCT02970305|66008484|FG000|Overall Study|Withdrawal by Subject|12|||
23623558|NCT02970305|66008485|FG001|Overall Study|Withdrawal by Subject|11|||
23623559|NCT02970305|66008484|FG000|Overall Study|Not further specified|1|||
23623560|NCT02970305|66008485|FG001|Overall Study|Not further specified|2|||
23623561|NCT02970305|66008484|FG000|Overall Study|Lost to Follow-up|1|||
23623562|NCT02970305|66008485|FG001|Overall Study|Lost to Follow-up|2|||
23623563|NCT00816556|66008486|FG000|Overall Study|Adverse Event|1|||
23623564|NCT00816556|66008487|FG001|Overall Study|Adverse Event|1|||
23623565|NCT00816556|66008488|FG002|Overall Study|Adverse Event|1|||
23623566|NCT00816556|66008486|FG000|Overall Study|Withdrawal by Subject|1|||
23556601|NCT01972529|65765937|FG000|Overall Study|Lost to Follow-up|1|||
23556602|NCT01972529|65765938|FG001|Overall Study|Lost to Follow-up|0|||
23556603|NCT01972529|65765939|FG002|Overall Study|Lost to Follow-up|0|||
23556604|NCT01972529|65765940|FG003|Overall Study|Lost to Follow-up|0|||
23556605|NCT01972529|65765937|FG000|Overall Study|Participant Choice|0|||
23556606|NCT01972529|65765938|FG001|Overall Study|Participant Choice|1|||
23556607|NCT01972529|65765939|FG002|Overall Study|Participant Choice|0|||
23556608|NCT01972529|65765940|FG003|Overall Study|Participant Choice|0|||
23556609|NCT01972529|65765937|FG000|Overall Study|Withdrawl of Consent|1|||
23556610|NCT01972529|65765938|FG001|Overall Study|Withdrawl of Consent|2|||
23556611|NCT01972529|65765939|FG002|Overall Study|Withdrawl of Consent|0|||
23556612|NCT01972529|65765940|FG003|Overall Study|Withdrawl of Consent|1|||
23750966|NCT02575807|66466605|FG000|Overall Study|Subject ineligible - medical implant|0|||
23556613|NCT01972529|65765937|FG000|Overall Study|Other|0|||
23556614|NCT01972529|65765938|FG001|Overall Study|Other|0|||
23556615|NCT01972529|65765939|FG002|Overall Study|Other|0|||
23556616|NCT01972529|65765940|FG003|Overall Study|Other|2|||
23556617|NCT01972529|65765937|FG000|Overall Study|Not treated|0|||
23556618|NCT01972529|65765938|FG001|Overall Study|Not treated|1|||
23556619|NCT01972529|65765939|FG002|Overall Study|Not treated|2|||
23556620|NCT01972529|65765940|FG003|Overall Study|Not treated|1|||
23556621|NCT03260868|65765941|FG000|Overall Study|Poor Compliance to Protocol|0|||
23556622|NCT03260868|65765942|FG001|Overall Study|Poor Compliance to Protocol|2|||
23556623|NCT03260868|65765941|FG000|Overall Study|Study Terminated By Sponsor|2|||
23556624|NCT03260868|65765942|FG001|Overall Study|Study Terminated By Sponsor|1|||
23556625|NCT03260868|65765941|FG000|Overall Study|Other than specified above|1|||
23556626|NCT03260868|65765942|FG001|Overall Study|Other than specified above|0|||
23750967|NCT02575807|66466606|FG001|Overall Study|Subject ineligible - medical implant|0|||
23750968|NCT02575807|66466607|FG002|Overall Study|Subject ineligible - medical implant|0|||
23750969|NCT02575807|66466608|FG003|Overall Study|Subject ineligible - medical implant|1|||
23750970|NCT02575807|66466609|FG004|Overall Study|Subject ineligible - medical implant|0|||
23750971|NCT02575807|66466605|FG000|Overall Study|Withdrawal by Subject|0|||
23750972|NCT02575807|66466606|FG001|Overall Study|Withdrawal by Subject|0|||
23750973|NCT02575807|66466607|FG002|Overall Study|Withdrawal by Subject|1|||
23750974|NCT02575807|66466608|FG003|Overall Study|Withdrawal by Subject|1|||
23750975|NCT02575807|66466609|FG004|Overall Study|Withdrawal by Subject|2|||
23750976|NCT00962013|66466612|FG000|Overall Study|Did not have surgery|1|||
23750977|NCT00962013|66466612|FG000|Overall Study|Death|8|||
23750978|NCT00962013|66466612|FG000|Overall Study|Lost to Follow-up|12|||
23750979|NCT00962013|66466612|FG000|Overall Study|Unable/Unwilling to return|6|||
23750980|NCT00962013|66466612|FG000|Overall Study|Withdrawal by Subject|8|||
23750981|NCT00962013|66466612|FG000|Overall Study|Removal of study device|3|||
23750982|NCT00962013|66466612|FG000|Overall Study|Site Termination|24|||
23750983|NCT00962013|66466612|FG000|Overall Study|No 5 year evaluation|6|||
23750984|NCT01432600|66466618|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
23750985|NCT01432600|66466619|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
23750986|NCT01432600|66466620|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
23750987|NCT03280628|66466621|FG000|Overall Study|Lost to Follow-up|8|||
23750988|NCT03280628|66466622|FG001|Overall Study|Lost to Follow-up|6|||
23750989|NCT03280628|66466623|FG002|Overall Study|Lost to Follow-up|11|||
23750990|NCT02873195|66466626|FG000|Overall Study|Ineligible|5|||
23750991|NCT02873195|66466627|FG001|Overall Study|Ineligible|0|||
23556627|NCT04721925|65765943|FG000|2-Month Assessment|Lost to Follow-up|5|||
23556628|NCT04721925|65765944|FG001|2-Month Assessment|Lost to Follow-up|3|||
23556629|NCT04721925|65765943|FG000|4-Month Assessment|Lost to Follow-up|3|||
23623567|NCT00816556|66008487|FG001|Overall Study|Withdrawal by Subject|1|||
23623568|NCT00816556|66008488|FG002|Overall Study|Withdrawal by Subject|1|||
23623569|NCT00816556|66008486|FG000|Overall Study|Lost to Follow-up|0|||
23623570|NCT00816556|66008487|FG001|Overall Study|Lost to Follow-up|0|||
23623571|NCT00816556|66008488|FG002|Overall Study|Lost to Follow-up|1|||
23623572|NCT00488319|66008489|FG000|Overall Study|Adverse Event|1|||
23750992|NCT04798027|66466629|FG000|Overall Study|Protocol Violation|0|||
23556630|NCT04721925|65765944|FG001|4-Month Assessment|Lost to Follow-up|6|||
23556631|NCT03232983|65765945|FG000|Period 1|Physician Decision|0|||
23556632|NCT03232983|65765946|FG001|Period 1|Physician Decision|0|||
23556633|NCT03232983|65765947|FG002|Period 1|Physician Decision|1|||
23556634|NCT03232983|65765948|FG003|Period 1|Physician Decision|0|||
23556635|NCT03232983|65765945|FG000|Washout Period 2|Physician Decision|0|||
23434979|NCT03688620|65334213|FG000|Overall Study|Other|0|||
23556636|NCT03232983|65765946|FG001|Washout Period 2|Physician Decision|0|||
23556637|NCT03232983|65765947|FG002|Washout Period 2|Physician Decision|1|||
23556638|NCT03232983|65765948|FG003|Washout Period 2|Physician Decision|0|||
23556639|NCT03232983|65765945|FG000|Washout Period 2|Withdrawal by Subject|0|||
23556640|NCT03232983|65765946|FG001|Washout Period 2|Withdrawal by Subject|0|||
23556641|NCT03232983|65765947|FG002|Washout Period 2|Withdrawal by Subject|0|||
23556642|NCT03232983|65765948|FG003|Washout Period 2|Withdrawal by Subject|1|||
23556643|NCT03232983|65765945|FG000|Period 4|Withdrawal by Subject|1|||
23556644|NCT03232983|65765946|FG001|Period 4|Withdrawal by Subject|0|||
23556645|NCT03232983|65765947|FG002|Period 4|Withdrawal by Subject|0|||
23556646|NCT03232983|65765948|FG003|Period 4|Withdrawal by Subject|0|||
23556647|NCT01169675|65765949|FG000|Overall Study|Progressive disease|13|||
23556648|NCT01169675|65765950|FG001|Overall Study|Progressive disease|2|||
23556649|NCT01169675|65765951|FG002|Overall Study|Progressive disease|5|||
23556650|NCT01169675|65765952|FG003|Overall Study|Progressive disease|15|||
23556651|NCT01169675|65765953|FG004|Overall Study|Progressive disease|1|||
23556652|NCT01169675|65765949|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23556653|NCT01169675|65765950|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556654|NCT01169675|65765951|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556655|NCT01169675|65765952|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556656|NCT01169675|65765953|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23556657|NCT01169675|65765949|FG000|Overall Study|Adverse Event|5|||
23556658|NCT01169675|65765950|FG001|Overall Study|Adverse Event|1|||
23556659|NCT01169675|65765951|FG002|Overall Study|Adverse Event|2|||
23556660|NCT01169675|65765952|FG003|Overall Study|Adverse Event|0|||
23556661|NCT01169675|65765953|FG004|Overall Study|Adverse Event|0|||
23556662|NCT01169675|65765949|FG000|Overall Study|Withdrawal by Subject|1|||
23750993|NCT04798027|66466630|FG001|Overall Study|Protocol Violation|0|||
23750994|NCT04798027|66466631|FG002|Overall Study|Protocol Violation|0|||
23750995|NCT04798027|66466632|FG003|Overall Study|Protocol Violation|0|||
23750996|NCT04798027|66466633|FG004|Overall Study|Protocol Violation|1|||
23750997|NCT04798027|66466634|FG005|Overall Study|Protocol Violation|0|||
23750998|NCT04798027|66466635|FG006|Overall Study|Protocol Violation|0|||
23750999|NCT04798027|66466636|FG007|Overall Study|Protocol Violation|1|||
23751000|NCT04798027|66466637|FG008|Overall Study|Protocol Violation|0|||
23751001|NCT04798027|66466629|FG000|Overall Study|Withdrawal by Subject|1|||
23751002|NCT04798027|66466630|FG001|Overall Study|Withdrawal by Subject|0|||
23751003|NCT04798027|66466631|FG002|Overall Study|Withdrawal by Subject|1|||
23751004|NCT04798027|66466632|FG003|Overall Study|Withdrawal by Subject|1|||
23751005|NCT04798027|66466633|FG004|Overall Study|Withdrawal by Subject|1|||
23751006|NCT04798027|66466634|FG005|Overall Study|Withdrawal by Subject|1|||
23751007|NCT04798027|66466635|FG006|Overall Study|Withdrawal by Subject|3|||
23751008|NCT04798027|66466636|FG007|Overall Study|Withdrawal by Subject|2|||
23751009|NCT04798027|66466637|FG008|Overall Study|Withdrawal by Subject|2|||
23751010|NCT04798027|66466629|FG000|Overall Study|Lost to Follow-up|1|||
23751011|NCT04798027|66466630|FG001|Overall Study|Lost to Follow-up|3|||
23751012|NCT04798027|66466631|FG002|Overall Study|Lost to Follow-up|0|||
23751013|NCT04798027|66466632|FG003|Overall Study|Lost to Follow-up|0|||
23751014|NCT04798027|66466633|FG004|Overall Study|Lost to Follow-up|0|||
23751015|NCT04798027|66466634|FG005|Overall Study|Lost to Follow-up|1|||
23751016|NCT04798027|66466635|FG006|Overall Study|Lost to Follow-up|0|||
23751017|NCT04798027|66466636|FG007|Overall Study|Lost to Follow-up|0|||
23751018|NCT04798027|66466637|FG008|Overall Study|Lost to Follow-up|1|||
23751019|NCT04798027|66466629|FG000|Overall Study|Withdrawal by Sponsor|8|||
23751020|NCT04798027|66466630|FG001|Overall Study|Withdrawal by Sponsor|22|||
23751021|NCT04798027|66466631|FG002|Overall Study|Withdrawal by Sponsor|9|||
23434980|NCT03688620|65334214|FG001|Overall Study|Other|0|||
23751022|NCT04798027|66466632|FG003|Overall Study|Withdrawal by Sponsor|26|||
23751023|NCT04798027|66466633|FG004|Overall Study|Withdrawal by Sponsor|24|||
23751024|NCT04798027|66466634|FG005|Overall Study|Withdrawal by Sponsor|11|||
23751025|NCT04798027|66466635|FG006|Overall Study|Withdrawal by Sponsor|25|||
23434981|NCT03688620|65334215|FG002|Overall Study|Other|1|||
23556663|NCT01169675|65765950|FG001|Overall Study|Withdrawal by Subject|0|||
23556664|NCT01169675|65765951|FG002|Overall Study|Withdrawal by Subject|0|||
23556665|NCT01169675|65765952|FG003|Overall Study|Withdrawal by Subject|1|||
23556666|NCT01169675|65765953|FG004|Overall Study|Withdrawal by Subject|2|||
23556667|NCT01169675|65765949|FG000|Overall Study|Other Reason Not Defined Above|0|||
23556668|NCT01169675|65765950|FG001|Overall Study|Other Reason Not Defined Above|0|||
23556669|NCT01169675|65765951|FG002|Overall Study|Other Reason Not Defined Above|0|||
23751026|NCT04798027|66466636|FG007|Overall Study|Withdrawal by Sponsor|26|||
23751027|NCT04798027|66466637|FG008|Overall Study|Withdrawal by Sponsor|11|||
23751028|NCT00398632|66466638|FG000|Overall Study|Withdrawal by Subject|1|||
23623573|NCT00488319|66008490|FG001|Overall Study|Adverse Event|2|||
23434982|NCT03688620|65334213|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
23434983|NCT03688620|65334214|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
23556670|NCT01169675|65765952|FG003|Overall Study|Other Reason Not Defined Above|1|||
23556671|NCT01169675|65765953|FG004|Overall Study|Other Reason Not Defined Above|1|||
23556672|NCT00515502|65765954|FG000|Treatment Period 1|Adverse Event|0|||
23556673|NCT00515502|65765955|FG001|Treatment Period 1|Adverse Event|0|||
23556674|NCT00515502|65765956|FG002|Treatment Period 1|Adverse Event|0|||
23556675|NCT00515502|65765957|FG003|Treatment Period 1|Adverse Event|0|||
23556676|NCT00515502|65765958|FG004|Treatment Period 1|Adverse Event|0|||
23556677|NCT00515502|65765959|FG005|Treatment Period 1|Adverse Event|0|||
23556678|NCT00515502|65765960|FG006|Treatment Period 1|Adverse Event|1|||
23556679|NCT00515502|65765961|FG007|Treatment Period 1|Adverse Event|0|||
23556680|NCT00515502|65765962|FG008|Treatment Period 1|Adverse Event|1|||
23623574|NCT00488319|66008491|FG002|Overall Study|Adverse Event|23|||
23623575|NCT00488319|66008489|FG000|Overall Study|Lack of Efficacy|6|||
23434984|NCT03688620|65334215|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
23556681|NCT00515502|65765963|FG009|Treatment Period 1|Adverse Event|0|||
23556682|NCT00515502|65765964|FG010|Treatment Period 1|Adverse Event|0|||
23556683|NCT00515502|65765965|FG011|Treatment Period 1|Adverse Event|1|||
23556684|NCT00515502|65765954|FG000|Treatment Period 2|Adverse Event|0|||
23623576|NCT00488319|66008490|FG001|Overall Study|Lack of Efficacy|12|||
23623577|NCT00488319|66008491|FG002|Overall Study|Lack of Efficacy|27|||
23751029|NCT00398632|66466638|FG000|Overall Study|Lack of Efficacy|1|||
23751030|NCT04101721|66466642|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
23751031|NCT04101721|66466643|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23751032|NCT04101721|66466642|FG000|Overall Study|Death|0|||
23751033|NCT04101721|66466643|FG001|Overall Study|Death|1|||
23751034|NCT04101721|66466642|FG000|Overall Study|Lost to Follow-up|0|||
23751035|NCT04101721|66466643|FG001|Overall Study|Lost to Follow-up|3|||
23751036|NCT01615822|66466646|FG000|Period 1|Withdrawal by Subject|0|||
23751037|NCT01615822|66466647|FG001|Period 1|Withdrawal by Subject|1|||
23434985|NCT03688620|65334213|FG000|Overall Study|Lost to Follow-up|16|||
23751038|NCT01615822|66466648|FG002|Period 1|Withdrawal by Subject|0|||
23751039|NCT01615822|66466646|FG000|Period 1|Adverse Event|1|||
23751040|NCT01615822|66466647|FG001|Period 1|Adverse Event|1|||
23751041|NCT01615822|66466648|FG002|Period 1|Adverse Event|0|||
23751042|NCT01615822|66466646|FG000|Period 2|Lost to Follow-up|0|||
23556685|NCT00515502|65765955|FG001|Treatment Period 2|Adverse Event|1|||
23556686|NCT00515502|65765956|FG002|Treatment Period 2|Adverse Event|0|||
23556687|NCT00515502|65765957|FG003|Treatment Period 2|Adverse Event|0|||
23751043|NCT01615822|66466647|FG001|Period 2|Lost to Follow-up|1|||
23751044|NCT01615822|66466648|FG002|Period 2|Lost to Follow-up|2|||
23556688|NCT00515502|65765958|FG004|Treatment Period 2|Adverse Event|0|||
23556689|NCT00515502|65765959|FG005|Treatment Period 2|Adverse Event|0|||
23556690|NCT00515502|65765960|FG006|Treatment Period 2|Adverse Event|0|||
23556691|NCT00515502|65765961|FG007|Treatment Period 2|Adverse Event|0|||
23556692|NCT00515502|65765962|FG008|Treatment Period 2|Adverse Event|0|||
23556693|NCT00515502|65765963|FG009|Treatment Period 2|Adverse Event|0|||
23556694|NCT00515502|65765964|FG010|Treatment Period 2|Adverse Event|0|||
23556695|NCT00515502|65765965|FG011|Treatment Period 2|Adverse Event|0|||
23556696|NCT00338884|65765966|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
23556697|NCT00338884|65765966|FG000|Overall Study|Adverse Event|14|||
23556698|NCT00338884|65765966|FG000|Overall Study|Death|8|||
23556699|NCT00338884|65765966|FG000|Overall Study|Other|4|||
23556700|NCT00338884|65765966|FG000|Overall Study|Global Deterioration of Health Status|3|||
23556701|NCT00338884|65765966|FG000|Overall Study|Withdrawal by Subject|3|||
23556702|NCT00338884|65765966|FG000|Overall Study|Lost to Follow-up|1|||
23556703|NCT00338884|65765966|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
23556704|NCT00316173|65765968|FG000|Run-in Phase|Adverse Event|1|||
23556705|NCT00316173|65765969|FG001|Run-in Phase|Adverse Event|0|||
23556706|NCT00316173|65765968|FG000|Run-in Phase|Protocol Violation|1|||
23556707|NCT00316173|65765969|FG001|Run-in Phase|Protocol Violation|0|||
23556708|NCT00316173|65765968|FG000|Run-in Phase|Study Follow-up Stopped|5|||
23556709|NCT00316173|65765969|FG001|Run-in Phase|Study Follow-up Stopped|0|||
23751045|NCT00491322|66466649|FG000|Overall Study|Protocol Violation|1|||
23751046|NCT00491322|66466650|FG001|Overall Study|Protocol Violation|0|||
23751047|NCT00491322|66466649|FG000|Overall Study|Pregnancy|0|||
23751048|NCT00491322|66466650|FG001|Overall Study|Pregnancy|1|||
23751049|NCT04057118|66466651|FG000|Overall Study|Adverse Event|1|||
23751050|NCT04057118|66466652|FG001|Overall Study|Adverse Event|0|||
23751051|NCT04057118|66466653|FG002|Overall Study|Adverse Event|1|||
23751052|NCT04057118|66466654|FG003|Overall Study|Adverse Event|1|||
23751053|NCT04057118|66466651|FG000|Overall Study|Physician Decision|0|||
23751054|NCT04057118|66466652|FG001|Overall Study|Physician Decision|0|||
23751055|NCT04057118|66466653|FG002|Overall Study|Physician Decision|1|||
23751056|NCT04057118|66466654|FG003|Overall Study|Physician Decision|1|||
23751057|NCT04057118|66466651|FG000|Overall Study|Withdrawal by Subject|2|||
23751058|NCT04057118|66466652|FG001|Overall Study|Withdrawal by Subject|2|||
23751059|NCT04057118|66466653|FG002|Overall Study|Withdrawal by Subject|0|||
23751060|NCT04057118|66466654|FG003|Overall Study|Withdrawal by Subject|2|||
23751061|NCT04057118|66466651|FG000|Overall Study|Not Specific|0|||
23751062|NCT04057118|66466652|FG001|Overall Study|Not Specific|0|||
23751063|NCT04057118|66466653|FG002|Overall Study|Not Specific|1|||
23751064|NCT04057118|66466654|FG003|Overall Study|Not Specific|1|||
23751065|NCT01500434|66466655|FG000|Overall Study|Death|1|||
23824860|NCT03536884|66737927|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824861|NCT03536884|66737928|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
23824862|NCT03536884|66737929|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824863|NCT03536884|66737930|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824864|NCT03536884|66737931|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23824865|NCT03536884|66737920|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824866|NCT03536884|66737921|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824867|NCT03536884|66737922|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824868|NCT03536884|66737923|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824869|NCT03536884|66737924|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824870|NCT03536884|66737925|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824871|NCT03536884|66737926|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824872|NCT03536884|66737927|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23556710|NCT00316173|65765968|FG000|Treatment Phase|Adverse Event|0|||
23623578|NCT00488319|66008489|FG000|Overall Study|Lost to Follow-up|3|||
23556711|NCT00316173|65765969|FG001|Treatment Phase|Adverse Event|1|||
23556712|NCT00316173|65765968|FG000|Treatment Phase|Lack of Efficacy|0|||
23556713|NCT00316173|65765969|FG001|Treatment Phase|Lack of Efficacy|3|||
23556714|NCT00316173|65765968|FG000|Treatment Phase|Lost to Follow-up|0|||
23556715|NCT00316173|65765969|FG001|Treatment Phase|Lost to Follow-up|3|||
23556716|NCT00316173|65765968|FG000|Treatment Phase|Withdrawal by Subject|0|||
23556717|NCT00316173|65765969|FG001|Treatment Phase|Withdrawal by Subject|1|||
23751066|NCT01500434|66466655|FG000|Overall Study|Withdrawal by Subject|1|||
23751067|NCT01500434|66466655|FG000|Overall Study|Missed 12-month follow-up|5|||
23751068|NCT00819091|66466662|FG000|Overall Study|Adverse Event|3|||
23751069|NCT00819091|66466663|FG001|Overall Study|Adverse Event|5|||
23751070|NCT00819091|66466662|FG000|Overall Study|Protocol Violation|0|||
23751071|NCT00819091|66466663|FG001|Overall Study|Protocol Violation|1|||
23556718|NCT00316173|65765968|FG000|Treatment Phase|Study Follow-up Stopped|0|||
23556719|NCT00316173|65765969|FG001|Treatment Phase|Study Follow-up Stopped|34|||
23556720|NCT00765843|65765971|FG000|Overall Study|Lost to Follow-up|1|||
23556721|NCT00765843|65765972|FG001|Overall Study|Lost to Follow-up|3|||
23556722|NCT00765843|65765973|FG002|Overall Study|Lost to Follow-up|2|||
23556723|NCT00765843|65765971|FG000|Overall Study|did not return to receive intervention|0|||
23556724|NCT00765843|65765972|FG001|Overall Study|did not return to receive intervention|1|||
23556725|NCT00765843|65765973|FG002|Overall Study|did not return to receive intervention|0|||
23556726|NCT00765843|65765971|FG000|Overall Study|Adverse Event|0|||
23556727|NCT00765843|65765972|FG001|Overall Study|Adverse Event|0|||
23556728|NCT00765843|65765973|FG002|Overall Study|Adverse Event|1|||
23556729|NCT04102579|65765974|FG000|Overall Study|Withdrawal by Subject|3|||
23556730|NCT04102579|65765975|FG001|Overall Study|Withdrawal by Subject|4|||
23556731|NCT04102579|65765974|FG000|Overall Study|Lost to Follow-up|0|||
23556732|NCT04102579|65765975|FG001|Overall Study|Lost to Follow-up|1|||
23556733|NCT04102579|65765974|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
23556734|NCT04102579|65765975|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
23556735|NCT04102579|65765974|FG000|Overall Study|Other than Specified|1|||
23556736|NCT04102579|65765975|FG001|Overall Study|Other than Specified|0|||
23556737|NCT04102579|65765974|FG000|Overall Study|Not Dosed with Study Drug|0|||
23556738|NCT04102579|65765975|FG001|Overall Study|Not Dosed with Study Drug|1|||
23556739|NCT02701985|65765976|FG000|Overall Study|Withdrawal by Subject|1|||
23556740|NCT02701985|65765977|FG001|Overall Study|Withdrawal by Subject|1|||
23556741|NCT02701985|65765976|FG000|Overall Study|Lost to Follow-up|1|||
23556742|NCT02701985|65765977|FG001|Overall Study|Lost to Follow-up|0|||
23556743|NCT02701985|65765976|FG000|Overall Study|Death|1|||
23556744|NCT02701985|65765977|FG001|Overall Study|Death|0|||
23751072|NCT00819091|66466662|FG000|Overall Study|Lost to Follow-up|2|||
23751073|NCT00819091|66466663|FG001|Overall Study|Lost to Follow-up|0|||
23751074|NCT00819091|66466662|FG000|Overall Study|Withdrawal by Subject|1|||
23751075|NCT00819091|66466663|FG001|Overall Study|Withdrawal by Subject|2|||
23751076|NCT00819091|66466662|FG000|Overall Study|Other|1|||
23751077|NCT00819091|66466663|FG001|Overall Study|Other|2|||
23751078|NCT02181634|66466669|FG000|Overall Study|Lack of Efficacy|33|||
23751079|NCT02181634|66466669|FG000|Overall Study|Adverse Event|17|||
23751080|NCT02181634|66466669|FG000|Overall Study|Physician Decision|8|||
23751081|NCT02181634|66466669|FG000|Overall Study|Withdrawal by Subject|5|||
23751082|NCT02181634|66466669|FG000|Overall Study|Death|2|||
23751083|NCT02181634|66466669|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
23751084|NCT02181634|66466669|FG000|Overall Study|Ineligible|1|||
23751085|NCT02181634|66466669|FG000|Overall Study|Max number of dose reduction|1|||
23751086|NCT02181634|66466669|FG000|Overall Study|Symptomatic progression|1|||
23751087|NCT02181634|66466669|FG000|Overall Study|Patient opted to proceed to surgery|1|||
23751088|NCT04163991|66466672|FG000|Overall Study|Adverse Event|0|||
23751089|NCT04163991|66466673|FG001|Overall Study|Adverse Event|0|||
23751090|NCT04163991|66466674|FG002|Overall Study|Adverse Event|0|||
23751091|NCT04163991|66466675|FG003|Overall Study|Adverse Event|1|||
23751092|NCT04163991|66466676|FG004|Overall Study|Adverse Event|0|||
23751093|NCT04163991|66466672|FG000|Overall Study|Death|0|||
23751094|NCT04163991|66466673|FG001|Overall Study|Death|0|||
23751095|NCT04163991|66466674|FG002|Overall Study|Death|1|||
23751096|NCT04163991|66466675|FG003|Overall Study|Death|0|||
23751097|NCT04163991|66466676|FG004|Overall Study|Death|0|||
23751098|NCT04163991|66466672|FG000|Overall Study|Lost to Follow-up|0|||
23751099|NCT04163991|66466673|FG001|Overall Study|Lost to Follow-up|1|||
23751100|NCT04163991|66466674|FG002|Overall Study|Lost to Follow-up|0|||
23751101|NCT04163991|66466675|FG003|Overall Study|Lost to Follow-up|0|||
23751102|NCT04163991|66466676|FG004|Overall Study|Lost to Follow-up|0|||
23751103|NCT04163991|66466672|FG000|Overall Study|Withdrawal by Subject|1|||
23751104|NCT04163991|66466673|FG001|Overall Study|Withdrawal by Subject|1|||
23751105|NCT04163991|66466674|FG002|Overall Study|Withdrawal by Subject|3|||
23751106|NCT04163991|66466675|FG003|Overall Study|Withdrawal by Subject|1|||
23556745|NCT02701985|65765976|FG000|Overall Study|Adverse Event|0|||
23556746|NCT02701985|65765977|FG001|Overall Study|Adverse Event|5|||
23556747|NCT02001194|65765980|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
23556748|NCT02001194|65765981|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
23556749|NCT02001194|65765982|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
23556750|NCT02001194|65765983|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
23556751|NCT02001194|65765980|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
23751107|NCT04163991|66466676|FG004|Overall Study|Withdrawal by Subject|1|||
23751108|NCT04163991|66466672|FG000|Overall Study|Other, Not Specified|0|||
23751109|NCT04163991|66466673|FG001|Overall Study|Other, Not Specified|1|||
23751110|NCT04163991|66466674|FG002|Overall Study|Other, Not Specified|1|||
23751111|NCT04163991|66466675|FG003|Overall Study|Other, Not Specified|1|||
23751112|NCT04163991|66466676|FG004|Overall Study|Other, Not Specified|0|||
23751113|NCT03039686|66466677|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
23751114|NCT03039686|66466678|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
23751115|NCT03039686|66466679|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
23824873|NCT03536884|66737928|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23824874|NCT03536884|66737929|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
23824875|NCT03536884|66737930|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
23824876|NCT03536884|66737931|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
23434986|NCT03688620|65334214|FG001|Overall Study|Lost to Follow-up|0|||
23556752|NCT02001194|65765981|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
23556753|NCT02001194|65765982|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
23556754|NCT02001194|65765983|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
23556755|NCT01132326|65765985|FG000|Overall Study|Lack of Efficacy|25|||
23556756|NCT01132326|65765985|FG000|Overall Study|Adverse Event|37|||
23556757|NCT01132326|65765985|FG000|Overall Study|Protocol Violation|1|||
23751116|NCT03039686|66466677|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
23751117|NCT03039686|66466678|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
23751118|NCT03039686|66466679|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
23751119|NCT03039686|66466677|FG000|Double-blind Period|Withdrawal by Subject|2|||
23556758|NCT01132326|65765985|FG000|Overall Study|Lost to Follow-up|16|||
23556759|NCT01132326|65765985|FG000|Overall Study|Withdrawal by Subject|40|||
23556760|NCT01132326|65765985|FG000|Overall Study|Physician Decision|10|||
23556761|NCT01132326|65765985|FG000|Overall Study|Study Termination|80|||
23556762|NCT01132326|65765985|FG000|Overall Study|Declining Health|1|||
23556763|NCT01132326|65765985|FG000|Overall Study|Pregnancy|1|||
23556764|NCT01132326|65765985|FG000|Overall Study|Caregiver Withdrew Consent|1|||
23556765|NCT01132326|65765985|FG000|Overall Study|Death|5|||
23556766|NCT01132326|65765985|FG000|Overall Study|Subject Unable to Come To Visits|1|||
23556767|NCT01111838|65765986|FG000|Overall Study|Patient Ineligible|2|||
23556768|NCT01111838|65765986|FG000|Overall Study|Not Treated|3|||
23556769|NCT01111838|65765986|FG000|Overall Study|Clinical deterioration|1|||
23556770|NCT01111838|65765986|FG000|Overall Study|Other Complicating Disease|1|||
23556771|NCT00716092|65765987|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
23556772|NCT00716092|65765988|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
23556773|NCT00716092|65765989|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
23556774|NCT00168038|65765990|FG000|Overall Study|Adverse Event|1|||
23623579|NCT00488319|66008490|FG001|Overall Study|Lost to Follow-up|5|||
23751120|NCT03039686|66466678|FG001|Double-blind Period|Withdrawal by Subject|2|||
23751121|NCT03039686|66466679|FG002|Double-blind Period|Withdrawal by Subject|1|||
23751122|NCT03039686|66466677|FG000|Double-blind Period|Death|0|||
23751123|NCT03039686|66466678|FG001|Double-blind Period|Death|0|||
23751124|NCT03039686|66466679|FG002|Double-blind Period|Death|1|||
23751125|NCT03039686|66466677|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
23751126|NCT03039686|66466678|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
23751127|NCT03039686|66466679|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
23751128|NCT03039686|66466677|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
23751129|NCT03039686|66466678|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
23751130|NCT03039686|66466679|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
23751131|NCT03039686|66466677|FG000|Open Label Period|Withdrawal by Subject|0|||
23824877|NCT03536884|66737920|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23556775|NCT00168038|65765990|FG000|Overall Study|Therapy failure|1|||
23556776|NCT00387894|65765991|FG000|Overall Study|Withdrawal by Subject|1|||
23556777|NCT04839965|65765992|FG000|Overall Study|Death|6|||
23556778|NCT04839965|65765993|FG001|Overall Study|Death|6|||
23751132|NCT03039686|66466678|FG001|Open Label Period|Withdrawal by Subject|3|||
23556779|NCT04839965|65765992|FG000|Overall Study|Lost to Follow-up|1|||
23751133|NCT03039686|66466679|FG002|Open Label Period|Withdrawal by Subject|1|||
23751134|NCT01071083|66466680|FG000|Overall Study|Adverse Event|1|||
23751135|NCT01071083|66466681|FG001|Overall Study|Adverse Event|0|||
23751136|NCT01071083|66466682|FG002|Overall Study|Adverse Event|1|||
23751137|NCT01071083|66466683|FG003|Overall Study|Adverse Event|0|||
23751138|NCT01071083|66466684|FG004|Overall Study|Adverse Event|1|||
23751139|NCT01071083|66466680|FG000|Overall Study|Withdrawal by Subject|3|||
23751140|NCT01071083|66466681|FG001|Overall Study|Withdrawal by Subject|0|||
23751141|NCT01071083|66466682|FG002|Overall Study|Withdrawal by Subject|2|||
23751142|NCT01071083|66466683|FG003|Overall Study|Withdrawal by Subject|0|||
23751143|NCT01071083|66466684|FG004|Overall Study|Withdrawal by Subject|3|||
23751144|NCT01071083|66466680|FG000|Overall Study|Physician Decision|1|||
23751145|NCT01071083|66466681|FG001|Overall Study|Physician Decision|0|||
23751146|NCT01071083|66466682|FG002|Overall Study|Physician Decision|0|||
23751147|NCT01071083|66466683|FG003|Overall Study|Physician Decision|1|||
23751148|NCT01071083|66466684|FG004|Overall Study|Physician Decision|1|||
23751149|NCT01071083|66466680|FG000|Overall Study|Early Rescue|1|||
23751150|NCT01071083|66466681|FG001|Overall Study|Early Rescue|0|||
23751151|NCT01071083|66466682|FG002|Overall Study|Early Rescue|0|||
23751152|NCT01071083|66466683|FG003|Overall Study|Early Rescue|0|||
23751153|NCT01071083|66466684|FG004|Overall Study|Early Rescue|1|||
23751154|NCT01071083|66466680|FG000|Overall Study|Subject Moved|0|||
23751155|NCT01071083|66466681|FG001|Overall Study|Subject Moved|1|||
23751156|NCT01071083|66466682|FG002|Overall Study|Subject Moved|0|||
23751157|NCT01071083|66466683|FG003|Overall Study|Subject Moved|0|||
23751158|NCT01071083|66466684|FG004|Overall Study|Subject Moved|0|||
23751159|NCT01071083|66466680|FG000|Overall Study|Images Not Usable (Motion)|0|||
23751160|NCT01071083|66466681|FG001|Overall Study|Images Not Usable (Motion)|1|||
23751161|NCT01071083|66466682|FG002|Overall Study|Images Not Usable (Motion)|0|||
23751162|NCT01071083|66466683|FG003|Overall Study|Images Not Usable (Motion)|0|||
23751163|NCT01071083|66466684|FG004|Overall Study|Images Not Usable (Motion)|0|||
23751164|NCT01071083|66466680|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23751165|NCT01071083|66466681|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23751166|NCT01071083|66466682|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
23751167|NCT01071083|66466683|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
23751168|NCT01071083|66466684|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
23751169|NCT01071083|66466680|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
23751170|NCT01071083|66466681|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
23751171|NCT01071083|66466682|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
23751172|NCT01071083|66466683|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
23751173|NCT01071083|66466684|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
23751174|NCT01071083|66466680|FG000|Overall Study|Subject Refused to Continue|1|||
23751175|NCT01071083|66466681|FG001|Overall Study|Subject Refused to Continue|0|||
23751176|NCT01071083|66466682|FG002|Overall Study|Subject Refused to Continue|0|||
23751177|NCT01071083|66466683|FG003|Overall Study|Subject Refused to Continue|0|||
23751178|NCT01071083|66466684|FG004|Overall Study|Subject Refused to Continue|0|||
23751179|NCT01876082|66466685|FG000|Overall Study|Withdrawal by Subject|0|||
23751180|NCT01876082|66466686|FG001|Overall Study|Withdrawal by Subject|2|||
23751181|NCT01876082|66466685|FG000|Overall Study|Protocol Violation|1|||
23751182|NCT01876082|66466686|FG001|Overall Study|Protocol Violation|0|||
23751183|NCT01876082|66466685|FG000|Overall Study|Adverse Event|1|||
23751184|NCT01876082|66466686|FG001|Overall Study|Adverse Event|1|||
23751185|NCT01876082|66466685|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
23751186|NCT01876082|66466686|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
23751187|NCT01591499|66466687|FG000|Baseline Visit|Withdrawal by Subject|0|||
23751188|NCT01591499|66466688|FG001|Baseline Visit|Withdrawal by Subject|2|||
23751189|NCT01591499|66466689|FG002|Baseline Visit|Withdrawal by Subject|0|||
23824878|NCT03536884|66737921|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23751190|NCT01591499|66466690|FG003|Baseline Visit|Withdrawal by Subject|2|||
23751191|NCT01591499|66466687|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
23751192|NCT01591499|66466688|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
23751193|NCT01591499|66466689|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
23751194|NCT01591499|66466690|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
23824879|NCT03536884|66737922|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23751195|NCT01591499|66466687|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
23751196|NCT01591499|66466688|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
23751197|NCT01591499|66466689|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
23751198|NCT01591499|66466690|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
23751199|NCT03992456|66466691|FG000|Overall Study|Withdrawal by Subject|1|||
23751200|NCT03992456|66466692|FG001|Overall Study|Withdrawal by Subject|0|||
23751201|NCT03992456|66466691|FG000|Overall Study|Disease progression|4|||
23751202|NCT03992456|66466692|FG001|Overall Study|Disease progression|5|||
23556780|NCT04839965|65765993|FG001|Overall Study|Lost to Follow-up|0|||
23751203|NCT03992456|66466691|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
23751204|NCT03992456|66466692|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
23751205|NCT03425331|66466693|FG000|Overall Study|Withdrawal by Subject|1|||
23751206|NCT03425331|66466693|FG000|Overall Study|Death|1|||
23751207|NCT03425331|66466693|FG000|Overall Study|Adverse Event|1|||
23751208|NCT03425331|66466693|FG000|Overall Study|Disease Progression|2|||
23751209|NCT00761761|66466694|FG000|Overall Study|Lost to Follow-up|3|||
23751210|NCT00761761|66466695|FG001|Overall Study|Lost to Follow-up|1|||
23751211|NCT00761761|66466694|FG000|Overall Study|Withdrawal by Subject|3|||
23751212|NCT00761761|66466695|FG001|Overall Study|Withdrawal by Subject|0|||
23751213|NCT01414062|66466696|FG000|Overall Study|Lost to Follow-up|3|||
23751214|NCT01414062|66466697|FG001|Overall Study|Lost to Follow-up|2|||
23751215|NCT01414062|66466696|FG000|Overall Study|Left Country|1|||
23751216|NCT01414062|66466697|FG001|Overall Study|Left Country|1|||
23751217|NCT01414062|66466696|FG000|Overall Study|Family Disapproval|1|||
23751218|NCT01414062|66466697|FG001|Overall Study|Family Disapproval|0|||
23751219|NCT01414062|66466696|FG000|Overall Study|Withdrawal by Subject|0|||
23751220|NCT01414062|66466697|FG001|Overall Study|Withdrawal by Subject|1|||
23751221|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
23751222|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
23751223|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
23751224|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
23751225|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
23751226|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
23751227|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
23751228|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
23751229|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
23751230|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
23751231|NCT01777191|66466698|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
23751232|NCT01777191|66466699|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
23751233|NCT01777191|66466698|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
23751234|NCT01777191|66466699|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
23751235|NCT01777191|66466698|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
23751236|NCT01777191|66466699|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
23751237|NCT01777191|66466698|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
23751238|NCT01777191|66466699|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
23751239|NCT01777191|66466698|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
23751240|NCT01777191|66466699|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
23751241|NCT01777191|66466698|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
23751242|NCT01777191|66466699|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
23751243|NCT04881448|66466700|FG000|Overall Study|Study cancelled by sponsor|220|||
23751244|NCT04881448|66466700|FG000|Overall Study|Withdrawal by Subject|2|||
23751245|NCT04881448|66466700|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
23751246|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
23751247|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23751248|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
23751249|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23751250|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23751251|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23751252|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23751253|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23751254|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23751255|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23751256|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
23751257|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23751258|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23751259|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23751260|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23751261|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23751262|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
23751263|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23751264|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23751265|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23751266|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
23751267|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23751268|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23751269|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23751270|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23751271|NCT04682639|66466701|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23751272|NCT04682639|66466702|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23751273|NCT04682639|66466703|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23751274|NCT04682639|66466704|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23751275|NCT04682639|66466705|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23751276|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
23751277|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
23751278|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
23751279|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
23751280|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
23751281|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Other|1|||
23751282|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Other|2|||
23751283|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Other|0|||
23751284|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Other|0|||
23751285|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Other|1|||
23751286|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
23751287|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
23751288|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23751289|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23751290|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23751291|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
23824880|NCT03536884|66737923|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824881|NCT03536884|66737924|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824882|NCT03536884|66737925|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824883|NCT03536884|66737926|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824884|NCT03536884|66737927|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824885|NCT03536884|66737928|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23824886|NCT03536884|66737929|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23824887|NCT03536884|66737930|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23824888|NCT03536884|66737931|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23824889|NCT03536884|66737920|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824890|NCT03536884|66737921|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824891|NCT03536884|66737922|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824892|NCT03536884|66737923|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824893|NCT03536884|66737924|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824894|NCT03536884|66737925|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824895|NCT03536884|66737926|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824896|NCT03536884|66737927|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824897|NCT03536884|66737928|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824898|NCT03536884|66737929|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824899|NCT03536884|66737930|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
23824900|NCT03536884|66737931|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23824901|NCT03536884|66737920|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824902|NCT03536884|66737921|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824903|NCT03536884|66737922|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824904|NCT03536884|66737923|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824905|NCT03536884|66737924|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824906|NCT03536884|66737925|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824907|NCT03536884|66737926|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23434987|NCT03688620|65334215|FG002|Overall Study|Lost to Follow-up|1|||
23434988|NCT03688620|65334213|FG000|Overall Study|Withdrawal by Subject|0|||
23434989|NCT03688620|65334214|FG001|Overall Study|Withdrawal by Subject|0|||
23434990|NCT03688620|65334215|FG002|Overall Study|Withdrawal by Subject|6|||
23434991|NCT00895453|65334216|FG000|Overall Study|Lost to Follow-up|25|||
23434992|NCT00895453|65334217|FG001|Overall Study|Lost to Follow-up|25|||
23434993|NCT00895453|65334218|FG002|Overall Study|Lost to Follow-up|23|||
23434994|NCT04891107|65334221|FG000|Overall Study|Physician Decision|1|||
23623580|NCT00488319|66008491|FG002|Overall Study|Lost to Follow-up|16|||
23751292|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
23434995|NCT04891107|65334221|FG000|Overall Study|Withdrawal by Subject|1|||
23434996|NCT04891107|65334221|FG000|Overall Study|Screen failure after consent|1|||
23751293|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23751294|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23751295|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23434997|NCT02900170|65334223|FG000|Overall Study|Lost to Follow-up|8|||
23434998|NCT00551291|65334224|FG000|Overall Study|Physician Decision|1|||
23751296|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23751297|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
23751298|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23751299|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23751300|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23751301|NCT04682639|66466701|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
23751302|NCT04682639|66466702|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
23751303|NCT04682639|66466703|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
23751304|NCT04682639|66466704|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
23751305|NCT04682639|66466705|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
23751306|NCT02362646|66466706|FG000|Overall Study|Death|15|||
23751307|NCT02362646|66466707|FG001|Overall Study|Death|8|||
23751308|NCT02362646|66466706|FG000|Overall Study|Withdrawal by Subject|2|||
23751309|NCT02362646|66466707|FG001|Overall Study|Withdrawal by Subject|2|||
23751310|NCT02362646|66466706|FG000|Overall Study|received transplant|21|||
23751311|NCT02362646|66466707|FG001|Overall Study|received transplant|14|||
23751312|NCT03224234|66466708|FG000|Main Study|Lost to Follow-up|5|||
23751313|NCT03224234|66466709|FG001|Main Study|Lost to Follow-up|5|||
23751314|NCT03972709|66466710|FG000|Overall Study|Withdrawal by Subject|18|||
23751315|NCT03972709|66466711|FG001|Overall Study|Withdrawal by Subject|7|||
23751316|NCT03972709|66466712|FG002|Overall Study|Withdrawal by Subject|14|||
23751317|NCT03972709|66466710|FG000|Overall Study|Study Terminated by Sponsor|48|||
23751318|NCT03972709|66466711|FG001|Overall Study|Study Terminated by Sponsor|25|||
23751319|NCT03972709|66466712|FG002|Overall Study|Study Terminated by Sponsor|50|||
23751320|NCT03972709|66466710|FG000|Overall Study|Physician Decision|1|||
23751321|NCT03972709|66466711|FG001|Overall Study|Physician Decision|0|||
23751322|NCT03972709|66466712|FG002|Overall Study|Physician Decision|0|||
23751323|NCT03972709|66466710|FG000|Overall Study|COVID-19|0|||
23751324|NCT03972709|66466711|FG001|Overall Study|COVID-19|1|||
23751325|NCT03972709|66466712|FG002|Overall Study|COVID-19|1|||
23751326|NCT03972709|66466710|FG000|Overall Study|Lost to Follow-up|6|||
23751327|NCT03972709|66466711|FG001|Overall Study|Lost to Follow-up|1|||
23751328|NCT03972709|66466712|FG002|Overall Study|Lost to Follow-up|2|||
23751329|NCT03972709|66466710|FG000|Overall Study|Death|5|||
23751330|NCT03972709|66466711|FG001|Overall Study|Death|1|||
23751331|NCT03972709|66466712|FG002|Overall Study|Death|4|||
23751332|NCT03972709|66466710|FG000|Overall Study|Adverse Event|3|||
23751333|NCT03972709|66466711|FG001|Overall Study|Adverse Event|1|||
23751334|NCT03972709|66466712|FG002|Overall Study|Adverse Event|4|||
23751335|NCT03972709|66466710|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
23751336|NCT03972709|66466711|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
23751337|NCT03972709|66466712|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
23751338|NCT03972709|66466710|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
23751339|NCT03972709|66466711|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
23751340|NCT03972709|66466712|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
23751341|NCT03972709|66466710|FG000|Overall Study|Subject Unable to be Contacted|0|||
23751342|NCT03972709|66466711|FG001|Overall Study|Subject Unable to be Contacted|1|||
23751343|NCT03972709|66466712|FG002|Overall Study|Subject Unable to be Contacted|0|||
23751344|NCT03972709|66466710|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
23751345|NCT03972709|66466711|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
23751346|NCT03972709|66466712|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
23751347|NCT03972709|66466710|FG000|Overall Study|Subject Moved|0|||
23751348|NCT03972709|66466711|FG001|Overall Study|Subject Moved|1|||
23751349|NCT03972709|66466712|FG002|Overall Study|Subject Moved|0|||
23751350|NCT03972709|66466710|FG000|Overall Study|Missed Study Visits|1|||
23751351|NCT03972709|66466711|FG001|Overall Study|Missed Study Visits|0|||
23751352|NCT03972709|66466712|FG002|Overall Study|Missed Study Visits|0|||
23751353|NCT01856257|66466715|FG000|Overall Study|Death|2|||
23751354|NCT01856257|66466716|FG001|Overall Study|Death|0|||
23751355|NCT01856257|66466717|FG002|Overall Study|Death|0|||
23751356|NCT01856257|66466718|FG003|Overall Study|Death|0|||
23751357|NCT01856257|66466715|FG000|Overall Study|Physician Decision|0|||
23751358|NCT01856257|66466716|FG001|Overall Study|Physician Decision|0|||
23623581|NCT00488319|66008489|FG000|Overall Study|Withdrawal by Subject|5|||
23751359|NCT01856257|66466717|FG002|Overall Study|Physician Decision|0|||
23751360|NCT01856257|66466718|FG003|Overall Study|Physician Decision|1|||
23751361|NCT01856257|66466715|FG000|Overall Study|Withdrawal by Subject|1|||
23751362|NCT01856257|66466716|FG001|Overall Study|Withdrawal by Subject|1|||
23751363|NCT01856257|66466717|FG002|Overall Study|Withdrawal by Subject|0|||
23751364|NCT01856257|66466718|FG003|Overall Study|Withdrawal by Subject|0|||
23751365|NCT01856257|66466715|FG000|Overall Study|Donor complication|0|||
23751366|NCT01856257|66466716|FG001|Overall Study|Donor complication|0|||
23751367|NCT01856257|66466717|FG002|Overall Study|Donor complication|0|||
23751368|NCT01856257|66466718|FG003|Overall Study|Donor complication|1|||
23751369|NCT00605839|66466719|FG000|Overall Study|Protocol Violation|1|||
23751370|NCT00605839|66466720|FG001|Overall Study|Protocol Violation|0|||
23751371|NCT00605839|66466721|FG002|Overall Study|Protocol Violation|0|||
23751372|NCT02998645|66466729|FG000|Treatment Period 1|Adverse Event|6|||
23751373|NCT02998645|66466729|FG000|Treatment Period 1|Death|5|||
23751374|NCT02998645|66466729|FG000|Treatment Period 1|Technical Problems|4|||
23751375|NCT02998645|66466729|FG000|Treatment Period 1|Lack of Efficacy|2|||
23751376|NCT02998645|66466729|FG000|Treatment Period 1|Progressive disease|1|||
23751377|NCT02998645|66466729|FG000|Treatment Period 1|Subject/guardian decision|1|||
23751378|NCT02998645|66466729|FG000|Treatment Period 2|Lack of Efficacy|5|||
23751379|NCT02998645|66466729|FG000|Treatment Period 2|Adverse Event|2|||
23751380|NCT02998645|66466729|FG000|Treatment Period 2|Progressive disease|2|||
23751381|NCT02998645|66466729|FG000|Treatment Period 2|Physician Decision|1|||
23751382|NCT01100073|66466736|FG000|Overall Study|Lack of Efficacy|4|||
23751383|NCT01100073|66466736|FG000|Overall Study|Insufficient Tolerability|21|||
23751384|NCT01100073|66466736|FG000|Overall Study|Withdrawal by Subject|13|||
23751385|NCT01100073|66466736|FG000|Overall Study|Lost to Follow-up|39|||
23751386|NCT01100073|66466736|FG000|Overall Study|Lack of effect + patient's wish|2|||
23751387|NCT01100073|66466736|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
23751388|NCT01100073|66466736|FG000|Overall Study|Other|8|||
23751389|NCT01100073|66466736|FG000|Overall Study|Missing|5|||
23751390|NCT04341727|66466739|FG000|Overall Study|Withdrawal by Subject|0|||
23751391|NCT04341727|66466740|FG001|Overall Study|Withdrawal by Subject|0|||
23751392|NCT04341727|66466741|FG002|Overall Study|Withdrawal by Subject|1|||
23751393|NCT04341727|66466742|FG003|Overall Study|Withdrawal by Subject|0|||
23751394|NCT04341727|66466739|FG000|Overall Study|Lost to Follow-up|0|||
23751395|NCT04341727|66466740|FG001|Overall Study|Lost to Follow-up|0|||
23751396|NCT04341727|66466741|FG002|Overall Study|Lost to Follow-up|0|||
23751397|NCT04341727|66466742|FG003|Overall Study|Lost to Follow-up|1|||
23751398|NCT02900976|66466743|FG000|Overall Study|Adverse Event|0|||
23556781|NCT02158884|65765996|FG000|Baseline Assessment|Missed performance assessment|3|||
23556782|NCT02158884|65765996|FG000|Baseline Assessment|Missed SMFA|1|||
23556783|NCT02158884|65765996|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
23556784|NCT02158884|65765996|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
23556785|NCT02158884|65765996|FG000|6 Month Assessment|Missed SMFA|20|||
23751399|NCT02900976|66466744|FG001|Overall Study|Adverse Event|1|||
23434999|NCT01067469|65334225|FG000|Overall Study|Withdrawal by Subject|0|||
23435000|NCT01067469|65334226|FG001|Overall Study|Withdrawal by Subject|1|||
23435001|NCT01067469|65334225|FG000|Overall Study|Disease Progression|0|||
23435002|NCT01067469|65334226|FG001|Overall Study|Disease Progression|1|||
23435003|NCT00950742|65334230|FG000|Overall Study|Other Adverse Event|1|||
23435004|NCT00950742|65334231|FG001|Overall Study|Other Adverse Event|0|||
23435005|NCT00950742|65334230|FG000|Overall Study|Withdrawal by Subject|3|||
23435006|NCT00950742|65334231|FG001|Overall Study|Withdrawal by Subject|0|||
23435007|NCT00950742|65334230|FG000|Overall Study|Progressive Disease|6|||
23435008|NCT00950742|65334231|FG001|Overall Study|Progressive Disease|2|||
23435009|NCT00950742|65334230|FG000|Overall Study|Dose limiting toxicity|6|||
23435010|NCT00950742|65334231|FG001|Overall Study|Dose limiting toxicity|0|||
23435011|NCT04038567|65334232|FG000|Overall Study|Lost to Follow-up|6|||
23435012|NCT04038567|65334233|FG001|Overall Study|Lost to Follow-up|4|||
23435013|NCT04038567|65334234|FG002|Overall Study|Lost to Follow-up|5|||
23435014|NCT04038567|65334235|FG003|Overall Study|Lost to Follow-up|4|||
23435015|NCT04038567|65334236|FG004|Overall Study|Lost to Follow-up|6|||
23435016|NCT04038567|65334237|FG005|Overall Study|Lost to Follow-up|4|||
23435017|NCT04038567|65334238|FG006|Overall Study|Lost to Follow-up|4|||
23435018|NCT04038567|65334239|FG007|Overall Study|Lost to Follow-up|1|||
23435019|NCT04038567|65334232|FG000|Overall Study|Withdrawal by Subject|2|||
23435020|NCT04038567|65334233|FG001|Overall Study|Withdrawal by Subject|1|||
23435021|NCT04038567|65334234|FG002|Overall Study|Withdrawal by Subject|1|||
23435022|NCT04038567|65334235|FG003|Overall Study|Withdrawal by Subject|1|||
23435023|NCT04038567|65334236|FG004|Overall Study|Withdrawal by Subject|4|||
23435024|NCT04038567|65334237|FG005|Overall Study|Withdrawal by Subject|1|||
23435025|NCT04038567|65334238|FG006|Overall Study|Withdrawal by Subject|1|||
23556786|NCT02158884|65765996|FG000|12 Month Assessment|Missed SMFA|17|||
23751400|NCT02900976|66466743|FG000|Overall Study|Physician Decision|0|||
23751401|NCT02900976|66466744|FG001|Overall Study|Physician Decision|2|||
23435026|NCT04038567|65334239|FG007|Overall Study|Withdrawal by Subject|1|||
23435027|NCT04038567|65334232|FG000|Overall Study|missed survey window|1|||
23435028|NCT04038567|65334233|FG001|Overall Study|missed survey window|2|||
23435029|NCT04038567|65334234|FG002|Overall Study|missed survey window|0|||
23435030|NCT04038567|65334235|FG003|Overall Study|missed survey window|0|||
23435031|NCT04038567|65334236|FG004|Overall Study|missed survey window|1|||
23751402|NCT02900976|66466743|FG000|Overall Study|Progressive disease|0|||
23751403|NCT02900976|66466744|FG001|Overall Study|Progressive disease|6|||
23751404|NCT01067339|66466745|FG000|Overall Study|Withdrawal by Subject|6|||
23435032|NCT04038567|65334237|FG005|Overall Study|missed survey window|1|||
23435033|NCT04038567|65334238|FG006|Overall Study|missed survey window|2|||
23556787|NCT01281202|65765997|FG000|Overall Study|Adverse Event|2|||
23623582|NCT00488319|66008490|FG001|Overall Study|Withdrawal by Subject|20|||
23751405|NCT01067339|66466746|FG001|Overall Study|Withdrawal by Subject|5|||
23751406|NCT05037409|66466747|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
23751407|NCT05037409|66466748|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
23751408|NCT05037409|66466749|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
23751409|NCT04797637|66466750|FG000|Overall Study|Lost to Follow-up|23|||
23751410|NCT04797637|66466751|FG001|Overall Study|Lost to Follow-up|32|||
23751411|NCT04797637|66466750|FG000|Overall Study|Withdrawal by Subject|0|||
23751412|NCT04797637|66466751|FG001|Overall Study|Withdrawal by Subject|1|||
23751413|NCT04285983|66466753|FG000|Overall Study|Protocol Violation|6|||
23751414|NCT01371006|66466754|FG000|Overall Study|Adverse Event|1|||
23751415|NCT01371006|66466755|FG001|Overall Study|Adverse Event|0|||
23751416|NCT03976076|66470076|FG000|Overall Study|Withdrawal by Subject|2|||
23751417|NCT02866695|66470079|FG000|Overall Study|Adverse Event|1|||
23751418|NCT02866695|66470079|FG000|Overall Study|Lost to Follow-up|1|||
23751419|NCT00713830|66470080|FG000|Overall Study|Adverse Event|23|||
23751420|NCT00713830|66470081|FG001|Overall Study|Adverse Event|71|||
23751421|NCT00713830|66470080|FG000|Overall Study|Lack of Efficacy|24|||
23751422|NCT00713830|66470081|FG001|Overall Study|Lack of Efficacy|16|||
23751423|NCT00713830|66470080|FG000|Overall Study|Lost to Follow-up|2|||
23751424|NCT00713830|66470081|FG001|Overall Study|Lost to Follow-up|9|||
23751425|NCT00713830|66470080|FG000|Overall Study|Withdrawal by Subject|13|||
23751426|NCT00713830|66470081|FG001|Overall Study|Withdrawal by Subject|23|||
23751427|NCT00713830|66470080|FG000|Overall Study|Poor Compliance to Protocol|7|||
23751428|NCT00713830|66470081|FG001|Overall Study|Poor Compliance to Protocol|14|||
23751429|NCT00713830|66470080|FG000|Overall Study|Familial and Personal Reasons|9|||
23751430|NCT00713830|66470081|FG001|Overall Study|Familial and Personal Reasons|34|||
23751431|NCT00713830|66470080|FG000|Overall Study|Sponsor Decision|4|||
23751432|NCT00713830|66470081|FG001|Overall Study|Sponsor Decision|10|||
23751433|NCT01721200|66470082|FG000|Overall Study|Lost to Follow-up|3|||
23751434|NCT01721200|66470083|FG001|Overall Study|Lost to Follow-up|5|||
23751435|NCT01257737|66470084|FG000|Overall Study|Lost to Follow-up|1|||
23751436|NCT01257737|66470085|FG001|Overall Study|Lost to Follow-up|2|||
23751437|NCT01257737|66470084|FG000|Overall Study|Liver transplant|1|||
23751438|NCT01257737|66470085|FG001|Overall Study|Liver transplant|0|||
23751439|NCT01257737|66470084|FG000|Overall Study|Relocation out of the country|0|||
23751440|NCT01257737|66470085|FG001|Overall Study|Relocation out of the country|1|||
23751441|NCT01257737|66470084|FG000|Overall Study|Withdrew from study|0|||
23435034|NCT04038567|65334239|FG007|Overall Study|missed survey window|2|||
23751442|NCT01257737|66470085|FG001|Overall Study|Withdrew from study|1|||
23751443|NCT00390572|66470086|FG000|Overall Study|Lost to Follow-up|8|||
23751444|NCT00390572|66470087|FG001|Overall Study|Lost to Follow-up|4|||
23751445|NCT00390572|66470086|FG000|Overall Study|health condition|0|||
23751446|NCT00390572|66470087|FG001|Overall Study|health condition|1|||
23751447|NCT02704130|66470090|FG000|Overall Study|Physician Decision|5|||
23751448|NCT02704130|66470091|FG001|Overall Study|Physician Decision|3|||
23435035|NCT04038567|65334232|FG000|Overall Study|technical issues|0|||
23435036|NCT04038567|65334233|FG001|Overall Study|technical issues|0|||
23435037|NCT04038567|65334234|FG002|Overall Study|technical issues|0|||
23435038|NCT04038567|65334235|FG003|Overall Study|technical issues|0|||
23435039|NCT04038567|65334236|FG004|Overall Study|technical issues|0|||
23435040|NCT04038567|65334237|FG005|Overall Study|technical issues|0|||
23435041|NCT04038567|65334238|FG006|Overall Study|technical issues|1|||
23435042|NCT04038567|65334239|FG007|Overall Study|technical issues|0|||
23435043|NCT04038567|65334232|FG000|Overall Study|Medical issues (i.e., illness)|0|||
23435044|NCT04038567|65334233|FG001|Overall Study|Medical issues (i.e., illness)|1|||
23435045|NCT04038567|65334234|FG002|Overall Study|Medical issues (i.e., illness)|2|||
23435046|NCT04038567|65334235|FG003|Overall Study|Medical issues (i.e., illness)|1|||
23435047|NCT04038567|65334236|FG004|Overall Study|Medical issues (i.e., illness)|1|||
23435048|NCT04038567|65334237|FG005|Overall Study|Medical issues (i.e., illness)|1|||
23435049|NCT04038567|65334238|FG006|Overall Study|Medical issues (i.e., illness)|0|||
23435050|NCT04038567|65334239|FG007|Overall Study|Medical issues (i.e., illness)|0|||
23435051|NCT04038567|65334232|FG000|Overall Study|Death|0|||
23435052|NCT04038567|65334233|FG001|Overall Study|Death|0|||
23435053|NCT04038567|65334234|FG002|Overall Study|Death|0|||
23435054|NCT04038567|65334235|FG003|Overall Study|Death|1|||
23435055|NCT04038567|65334236|FG004|Overall Study|Death|1|||
23435056|NCT04038567|65334237|FG005|Overall Study|Death|0|||
23435057|NCT04038567|65334238|FG006|Overall Study|Death|0|||
23435058|NCT04038567|65334239|FG007|Overall Study|Death|1|||
23435059|NCT01555125|65334240|FG000|Induction Period|Lost to Follow-up|0|||
23435060|NCT01555125|65334241|FG001|Induction Period|Lost to Follow-up|2|||
23435061|NCT01555125|65334242|FG002|Induction Period|Lost to Follow-up|0|||
23435062|NCT01555125|65334243|FG003|Induction Period|Lost to Follow-up|0|||
23435063|NCT01555125|65334244|FG004|Induction Period|Lost to Follow-up|0|||
23435064|NCT01555125|65334240|FG000|Induction Period|Adverse Event|0|||
23435065|NCT01555125|65334241|FG001|Induction Period|Adverse Event|1|||
23435066|NCT01555125|65334242|FG002|Induction Period|Adverse Event|0|||
23435067|NCT01555125|65334243|FG003|Induction Period|Adverse Event|0|||
23435068|NCT01555125|65334244|FG004|Induction Period|Adverse Event|1|||
23435069|NCT01555125|65334240|FG000|Induction Period|Subject / guardian decision|0|||
23435070|NCT01555125|65334241|FG001|Induction Period|Subject / guardian decision|0|||
23435071|NCT01555125|65334242|FG002|Induction Period|Subject / guardian decision|0|||
23435072|NCT01555125|65334243|FG003|Induction Period|Subject / guardian decision|0|||
23435073|NCT01555125|65334244|FG004|Induction Period|Subject / guardian decision|2|||
23435074|NCT01555125|65334240|FG000|Induction Period|Death|1|||
23435075|NCT01555125|65334241|FG001|Induction Period|Death|0|||
23435076|NCT01555125|65334242|FG002|Induction Period|Death|0|||
23435077|NCT01555125|65334243|FG003|Induction Period|Death|0|||
23435078|NCT01555125|65334244|FG004|Induction Period|Death|0|||
23435079|NCT01555125|65334240|FG000|Maintenance Period|Adverse Event|1|||
23435080|NCT01555125|65334241|FG001|Maintenance Period|Adverse Event|1|||
23435081|NCT01555125|65334242|FG002|Maintenance Period|Adverse Event|0|||
23435082|NCT01555125|65334243|FG003|Maintenance Period|Adverse Event|0|||
23435083|NCT01555125|65334244|FG004|Maintenance Period|Adverse Event|0|||
23435084|NCT01555125|65334240|FG000|Maintenance Period|Subject / guardian decision|1|||
23435085|NCT01555125|65334241|FG001|Maintenance Period|Subject / guardian decision|2|||
23435086|NCT01555125|65334242|FG002|Maintenance Period|Subject / guardian decision|0|||
23435087|NCT01555125|65334243|FG003|Maintenance Period|Subject / guardian decision|0|||
23435088|NCT01555125|65334244|FG004|Maintenance Period|Subject / guardian decision|0|||
23435089|NCT01555125|65334240|FG000|Maintenance Period|Lost to Follow-up|2|||
23435090|NCT01555125|65334241|FG001|Maintenance Period|Lost to Follow-up|0|||
23435091|NCT01555125|65334242|FG002|Maintenance Period|Lost to Follow-up|0|||
23435092|NCT01555125|65334243|FG003|Maintenance Period|Lost to Follow-up|1|||
23435093|NCT01555125|65334244|FG004|Maintenance Period|Lost to Follow-up|0|||
23435094|NCT01555125|65334240|FG000|Maintenance Period|Lack of Efficacy|6|||
23435095|NCT01555125|65334241|FG001|Maintenance Period|Lack of Efficacy|1|||
23435096|NCT01555125|65334242|FG002|Maintenance Period|Lack of Efficacy|3|||
23435097|NCT01555125|65334243|FG003|Maintenance Period|Lack of Efficacy|0|||
23435098|NCT01555125|65334244|FG004|Maintenance Period|Lack of Efficacy|0|||
23435099|NCT01555125|65334240|FG000|Maintenance Period|Physician Decision|0|||
23435100|NCT01555125|65334241|FG001|Maintenance Period|Physician Decision|0|||
23435101|NCT01555125|65334242|FG002|Maintenance Period|Physician Decision|1|||
23435102|NCT01555125|65334243|FG003|Maintenance Period|Physician Decision|0|||
23435103|NCT01555125|65334244|FG004|Maintenance Period|Physician Decision|0|||
23435104|NCT01555125|65334240|FG000|Maintenance Period|Death|0|||
23435105|NCT01555125|65334241|FG001|Maintenance Period|Death|0|||
23435106|NCT01555125|65334242|FG002|Maintenance Period|Death|0|||
23435107|NCT01555125|65334243|FG003|Maintenance Period|Death|1|||
23435108|NCT01555125|65334244|FG004|Maintenance Period|Death|0|||
23435109|NCT01555125|65334240|FG000|Extension|Adverse Event|1|||
23435110|NCT01555125|65334241|FG001|Extension|Adverse Event|2|||
23435111|NCT01555125|65334242|FG002|Extension|Adverse Event|1|||
23435112|NCT01555125|65334243|FG003|Extension|Adverse Event|1|||
23435113|NCT01555125|65334244|FG004|Extension|Adverse Event|0|||
23435114|NCT01555125|65334240|FG000|Extension|Protocol deviation|1|||
23435115|NCT01555125|65334241|FG001|Extension|Protocol deviation|0|||
23435116|NCT01555125|65334242|FG002|Extension|Protocol deviation|0|||
23435117|NCT01555125|65334243|FG003|Extension|Protocol deviation|0|||
23435118|NCT01555125|65334244|FG004|Extension|Protocol deviation|0|||
23435119|NCT01555125|65334240|FG000|Extension|Lack of Efficacy|7|||
23435120|NCT01555125|65334241|FG001|Extension|Lack of Efficacy|6|||
23435121|NCT01555125|65334242|FG002|Extension|Lack of Efficacy|3|||
23435122|NCT01555125|65334243|FG003|Extension|Lack of Efficacy|0|||
23751449|NCT03252756|66470093|FG000|Overall Study|Protocol Violation|2|||
23751450|NCT03252756|66470094|FG001|Overall Study|Protocol Violation|4|||
23751451|NCT03252756|66470093|FG000|Overall Study|COVID-19 Pandemic|1|||
23751452|NCT03252756|66470094|FG001|Overall Study|COVID-19 Pandemic|1|||
23751453|NCT03252756|66470093|FG000|Overall Study|Study Drug Expiration|0|||
23751454|NCT03252756|66470094|FG001|Overall Study|Study Drug Expiration|1|||
23435123|NCT01555125|65334244|FG004|Extension|Lack of Efficacy|0|||
23435124|NCT01555125|65334240|FG000|Extension|Lost to Follow-up|2|||
23435125|NCT01555125|65334241|FG001|Extension|Lost to Follow-up|1|||
23435126|NCT01555125|65334242|FG002|Extension|Lost to Follow-up|2|||
23435127|NCT01555125|65334243|FG003|Extension|Lost to Follow-up|0|||
23435128|NCT01555125|65334244|FG004|Extension|Lost to Follow-up|0|||
23435129|NCT01555125|65334240|FG000|Extension|Study terminated by sponsor|32|||
23435130|NCT01555125|65334241|FG001|Extension|Study terminated by sponsor|33|||
23435131|NCT01555125|65334242|FG002|Extension|Study terminated by sponsor|16|||
23435132|NCT01555125|65334243|FG003|Extension|Study terminated by sponsor|20|||
23435133|NCT01555125|65334244|FG004|Extension|Study terminated by sponsor|0|||
23435134|NCT01555125|65334240|FG000|Extension|Subject/guardian decision|1|||
23435135|NCT01555125|65334241|FG001|Extension|Subject/guardian decision|9|||
23435136|NCT01555125|65334242|FG002|Extension|Subject/guardian decision|1|||
23435137|NCT01555125|65334243|FG003|Extension|Subject/guardian decision|0|||
23435138|NCT01555125|65334244|FG004|Extension|Subject/guardian decision|0|||
23435139|NCT01555125|65334240|FG000|Extension|Technical Problems|1|||
23435140|NCT01555125|65334241|FG001|Extension|Technical Problems|0|||
23435141|NCT01555125|65334242|FG002|Extension|Technical Problems|0|||
23435142|NCT01555125|65334243|FG003|Extension|Technical Problems|1|||
23435143|NCT01555125|65334244|FG004|Extension|Technical Problems|0|||
23435144|NCT01555125|65334240|FG000|Follow-Up Period|Lost to Follow-up|1|||
23435145|NCT01555125|65334241|FG001|Follow-Up Period|Lost to Follow-up|0|||
23435146|NCT01555125|65334242|FG002|Follow-Up Period|Lost to Follow-up|0|||
23435147|NCT01555125|65334243|FG003|Follow-Up Period|Lost to Follow-up|0|||
23435148|NCT01555125|65334244|FG004|Follow-Up Period|Lost to Follow-up|0|||
23435149|NCT01555125|65334240|FG000|Follow-Up Period|Subject / guardian decision|3|||
23435150|NCT01555125|65334241|FG001|Follow-Up Period|Subject / guardian decision|1|||
23435151|NCT01555125|65334242|FG002|Follow-Up Period|Subject / guardian decision|1|||
23435152|NCT01555125|65334243|FG003|Follow-Up Period|Subject / guardian decision|1|||
23435153|NCT01555125|65334244|FG004|Follow-Up Period|Subject / guardian decision|0|||
23435154|NCT01457846|65334245|FG000|Overall Study|Death before treatment|1|||
23435155|NCT01457846|65334246|FG001|Overall Study|Death before treatment|2|||
23435156|NCT01457846|65334245|FG000|Overall Study|Did not receive treatment|0|||
23435157|NCT01457846|65334246|FG001|Overall Study|Did not receive treatment|1|||
23435158|NCT01457846|65334245|FG000|Overall Study|Death|27|||
23435159|NCT01457846|65334246|FG001|Overall Study|Death|16|||
23435160|NCT01457846|65334245|FG000|Overall Study|Unclassified reason for not completed|11|||
23435161|NCT01457846|65334246|FG001|Overall Study|Unclassified reason for not completed|10|||
23435162|NCT01457846|65334245|FG000|Overall Study|Withdrawal by Subject|1|||
23435163|NCT01457846|65334246|FG001|Overall Study|Withdrawal by Subject|1|||
23435164|NCT01457846|65334245|FG000|Overall Study|Lost to Follow-up|1|||
23435165|NCT01457846|65334246|FG001|Overall Study|Lost to Follow-up|0|||
23435166|NCT03629912|65334247|FG000|Overall Study|Lost to Follow-up|19|||
23435167|NCT03629912|65334248|FG001|Overall Study|Lost to Follow-up|7|||
23435168|NCT03629912|65334249|FG002|Overall Study|Lost to Follow-up|5|||
23435169|NCT03629912|65334250|FG003|Overall Study|Lost to Follow-up|1|||
23435170|NCT03629912|65334247|FG000|Overall Study|Withdrawal by Subject|6|||
23435171|NCT03629912|65334248|FG001|Overall Study|Withdrawal by Subject|0|||
23435172|NCT03629912|65334249|FG002|Overall Study|Withdrawal by Subject|1|||
23435173|NCT03629912|65334250|FG003|Overall Study|Withdrawal by Subject|2|||
23435174|NCT03629912|65334247|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
23435175|NCT03629912|65334248|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
23435176|NCT03629912|65334249|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
23435177|NCT03629912|65334250|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
23435178|NCT03629912|65334247|FG000|Overall Study|Death|1|||
23435179|NCT03629912|65334248|FG001|Overall Study|Death|0|||
23751455|NCT02086968|66470095|FG000|Overall Study|Adverse Event|1|||
23751456|NCT02086968|66470096|FG001|Overall Study|Adverse Event|5|||
23435180|NCT03629912|65334249|FG002|Overall Study|Death|0|||
23435181|NCT03629912|65334250|FG003|Overall Study|Death|0|||
23435182|NCT02895945|65334252|FG000|Overall Study|Physician Decision|2|||
23435183|NCT02895945|65334253|FG001|Overall Study|Physician Decision|1|||
23435184|NCT02540291|65336991|FG000|Overall Study|Death|7|||
23435185|NCT02540291|65336992|FG001|Overall Study|Death|7|||
23435186|NCT02540291|65336993|FG002|Overall Study|Death|5|||
23435187|NCT02540291|65336994|FG003|Overall Study|Death|7|||
23435188|NCT02540291|65336991|FG000|Overall Study|Lost to Follow-up|0|||
23435189|NCT02540291|65336992|FG001|Overall Study|Lost to Follow-up|0|||
23435190|NCT02540291|65336993|FG002|Overall Study|Lost to Follow-up|1|||
23435191|NCT02540291|65336994|FG003|Overall Study|Lost to Follow-up|0|||
23435192|NCT02540291|65336991|FG000|Overall Study|Withdrawal Of Consent|0|||
23435193|NCT02540291|65336992|FG001|Overall Study|Withdrawal Of Consent|1|||
23435194|NCT02540291|65336993|FG002|Overall Study|Withdrawal Of Consent|0|||
23435195|NCT02540291|65336994|FG003|Overall Study|Withdrawal Of Consent|0|||
23435196|NCT02540291|65336991|FG000|Overall Study|Study Terminated By Sponsor|1|||
23435197|NCT02540291|65336992|FG001|Overall Study|Study Terminated By Sponsor|0|||
23435198|NCT02540291|65336993|FG002|Overall Study|Study Terminated By Sponsor|0|||
23435199|NCT02540291|65336994|FG003|Overall Study|Study Terminated By Sponsor|0|||
23435200|NCT02540291|65336991|FG000|Overall Study|Other|0|||
23435201|NCT02540291|65336992|FG001|Overall Study|Other|0|||
23435202|NCT02540291|65336993|FG002|Overall Study|Other|1|||
23435203|NCT02540291|65336994|FG003|Overall Study|Other|0|||
23435204|NCT01147848|65336995|FG000|Run-in Period|Screen Failure|623|||
23751457|NCT02086968|66470095|FG000|Overall Study|Lost to Follow-up|2|||
23751458|NCT02086968|66470096|FG001|Overall Study|Lost to Follow-up|3|||
23435205|NCT01147848|65336996|FG001|Run-in Period|Screen Failure|0|||
23435206|NCT01147848|65336997|FG002|Run-in Period|Screen Failure|0|||
23435207|NCT01147848|65336995|FG000|Run-in Period|Run-in Failure|135|||
23435208|NCT01147848|65336996|FG001|Run-in Period|Run-in Failure|0|||
23435209|NCT01147848|65336997|FG002|Run-in Period|Run-in Failure|0|||
23435210|NCT01147848|65336995|FG000|Randomized Phase|Adverse Event|0|||
23435211|NCT01147848|65336996|FG001|Randomized Phase|Adverse Event|6|||
23435212|NCT01147848|65336997|FG002|Randomized Phase|Adverse Event|8|||
23435213|NCT01147848|65336995|FG000|Randomized Phase|Lack of Efficacy|0|||
23435214|NCT01147848|65336996|FG001|Randomized Phase|Lack of Efficacy|20|||
23435215|NCT01147848|65336997|FG002|Randomized Phase|Lack of Efficacy|11|||
23435216|NCT01147848|65336995|FG000|Randomized Phase|Protocol Violation|0|||
23435217|NCT01147848|65336996|FG001|Randomized Phase|Protocol Violation|7|||
23435218|NCT01147848|65336997|FG002|Randomized Phase|Protocol Violation|10|||
23435219|NCT01147848|65336995|FG000|Randomized Phase|Lost to Follow-up|0|||
23751459|NCT02086968|66470095|FG000|Overall Study|Study drug received outside protocol|0|||
23751460|NCT02086968|66470096|FG001|Overall Study|Study drug received outside protocol|1|||
23751461|NCT02086968|66470095|FG000|Overall Study|Physician Decision|4|||
23751462|NCT02086968|66470096|FG001|Overall Study|Physician Decision|0|||
23751463|NCT02086968|66470095|FG000|Overall Study|Withdrawal by Subject|1|||
23751464|NCT02086968|66470096|FG001|Overall Study|Withdrawal by Subject|4|||
23751465|NCT03359473|66470097|FG000|Overall Study|Adverse Event|0|||
23751466|NCT03359473|66470098|FG001|Overall Study|Adverse Event|2|||
23751467|NCT03359473|66470099|FG002|Overall Study|Adverse Event|5|||
23751468|NCT03359473|66470100|FG003|Overall Study|Adverse Event|3|||
23751469|NCT03359473|66470097|FG000|Overall Study|Lost to Follow-up|0|||
23751470|NCT03359473|66470098|FG001|Overall Study|Lost to Follow-up|1|||
23751471|NCT03359473|66470099|FG002|Overall Study|Lost to Follow-up|0|||
23751472|NCT03359473|66470100|FG003|Overall Study|Lost to Follow-up|0|||
23751473|NCT03359473|66470097|FG000|Overall Study|Physician Decision|0|||
23751474|NCT03359473|66470098|FG001|Overall Study|Physician Decision|1|||
23751475|NCT03359473|66470099|FG002|Overall Study|Physician Decision|0|||
23751476|NCT03359473|66470100|FG003|Overall Study|Physician Decision|1|||
23751477|NCT03359473|66470097|FG000|Overall Study|Withdrawal by Subject|1|||
23751478|NCT03359473|66470098|FG001|Overall Study|Withdrawal by Subject|2|||
23751479|NCT03359473|66470099|FG002|Overall Study|Withdrawal by Subject|1|||
23751480|NCT03359473|66470100|FG003|Overall Study|Withdrawal by Subject|0|||
23751481|NCT03359473|66470097|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23751482|NCT03359473|66470098|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23751483|NCT03359473|66470099|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23435220|NCT01147848|65336996|FG001|Randomized Phase|Lost to Follow-up|5|||
23435221|NCT01147848|65336997|FG002|Randomized Phase|Lost to Follow-up|7|||
23435222|NCT01147848|65336995|FG000|Randomized Phase|Physician Decision|0|||
23751484|NCT03359473|66470100|FG003|Overall Study|Protocol-defined stopping criteria|1|||
23751485|NCT01125358|66470101|FG000|Overall Study|Adverse Event|3|||
23435223|NCT01147848|65336996|FG001|Randomized Phase|Physician Decision|0|||
23435224|NCT01147848|65336997|FG002|Randomized Phase|Physician Decision|1|||
23435225|NCT01147848|65336995|FG000|Randomized Phase|Withdrawal by Subject|0|||
23751486|NCT01125358|66470102|FG001|Overall Study|Adverse Event|0|||
23751487|NCT01125358|66470103|FG002|Overall Study|Adverse Event|0|||
23751488|NCT01125358|66470104|FG003|Overall Study|Adverse Event|2|||
23751489|NCT01125358|66470101|FG000|Overall Study|Perceived Lack of Efficacy|6|||
23751490|NCT01125358|66470102|FG001|Overall Study|Perceived Lack of Efficacy|3|||
23751491|NCT01125358|66470103|FG002|Overall Study|Perceived Lack of Efficacy|7|||
23751492|NCT01125358|66470104|FG003|Overall Study|Perceived Lack of Efficacy|4|||
23751493|NCT01125358|66470101|FG000|Overall Study|Protocol Violation|1|||
23751494|NCT01125358|66470102|FG001|Overall Study|Protocol Violation|0|||
23751495|NCT01125358|66470103|FG002|Overall Study|Protocol Violation|0|||
23751496|NCT01125358|66470104|FG003|Overall Study|Protocol Violation|0|||
23751497|NCT01125358|66470101|FG000|Overall Study|Sponsor Decision|0|||
23751498|NCT01125358|66470102|FG001|Overall Study|Sponsor Decision|0|||
23751499|NCT01125358|66470103|FG002|Overall Study|Sponsor Decision|1|||
23751500|NCT01125358|66470104|FG003|Overall Study|Sponsor Decision|1|||
23751501|NCT01125358|66470101|FG000|Overall Study|Withdrawal by Subject|2|||
23751502|NCT01125358|66470102|FG001|Overall Study|Withdrawal by Subject|1|||
23751503|NCT01125358|66470103|FG002|Overall Study|Withdrawal by Subject|1|||
23751504|NCT01125358|66470104|FG003|Overall Study|Withdrawal by Subject|1|||
23751505|NCT04362761|66470105|FG000|Part A (48 Weeks)|Adverse Event|2|||
23751506|NCT04362761|66470105|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
23751507|NCT04362761|66470105|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
23751508|NCT04362761|66470105|FG000|Part A (48 Weeks)|Other|5|||
23751509|NCT04362761|66470105|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
23751510|NCT04362761|66470105|FG000|Part B (86 Weeks)|Other|4|||
23751511|NCT03996694|66470106|FG000|First Washout (7 Days)|positive urine drug screen|0|||
23751512|NCT03996694|66470107|FG001|First Washout (7 Days)|positive urine drug screen|0|||
23435226|NCT01147848|65336996|FG001|Randomized Phase|Withdrawal by Subject|7|||
23435227|NCT01147848|65336997|FG002|Randomized Phase|Withdrawal by Subject|9|||
23435228|NCT02479139|65336998|FG000|Overall Study|Lost to Follow-up|2|||
23435229|NCT02479139|65336999|FG001|Overall Study|Lost to Follow-up|4|||
23435230|NCT02479139|65337000|FG002|Overall Study|Lost to Follow-up|4|||
23435231|NCT02479139|65337001|FG003|Overall Study|Lost to Follow-up|2|||
23435232|NCT02479139|65337002|FG004|Overall Study|Lost to Follow-up|3|||
23435233|NCT02479139|65337003|FG005|Overall Study|Lost to Follow-up|5|||
23751513|NCT03996694|66470108|FG002|First Washout (7 Days)|positive urine drug screen|1|||
23435234|NCT02479139|65336998|FG000|Overall Study|Withdrew Consent|5|||
23435235|NCT02479139|65336999|FG001|Overall Study|Withdrew Consent|6|||
23435236|NCT02479139|65337000|FG002|Overall Study|Withdrew Consent|1|||
23435237|NCT02479139|65337001|FG003|Overall Study|Withdrew Consent|4|||
23435238|NCT02479139|65337002|FG004|Overall Study|Withdrew Consent|1|||
23435239|NCT02479139|65337003|FG005|Overall Study|Withdrew Consent|1|||
23435240|NCT02479139|65336998|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435241|NCT02479139|65336999|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435242|NCT02479139|65337000|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
23435243|NCT02479139|65337001|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435244|NCT02479139|65337002|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435245|NCT02479139|65337003|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435246|NCT02479139|65336998|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23435247|NCT02479139|65336999|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23435248|NCT02479139|65337000|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23435249|NCT02479139|65337001|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23435250|NCT02479139|65337002|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23435251|NCT02479139|65337003|FG005|Overall Study|Other Miscellaneous Reasons|0|||
23435252|NCT03995355|65337004|FG000|Overall Study|Adverse Event|1|||
23435253|NCT03995355|65337005|FG001|Overall Study|Adverse Event|0|||
23435254|NCT03995355|65337004|FG000|Overall Study|Withdrawal by Subject|1|||
23435255|NCT03995355|65337005|FG001|Overall Study|Withdrawal by Subject|0|||
23751514|NCT03996694|66470109|FG003|First Washout (7 Days)|positive urine drug screen|0|||
23751515|NCT03996694|66470110|FG004|First Washout (7 Days)|positive urine drug screen|0|||
23751516|NCT03996694|66470111|FG005|First Washout (7 Days)|positive urine drug screen|0|||
23751517|NCT03996694|66470106|FG000|First Washout (7 Days)|Adverse Event|0|||
23751518|NCT03996694|66470107|FG001|First Washout (7 Days)|Adverse Event|1|||
23751519|NCT03996694|66470108|FG002|First Washout (7 Days)|Adverse Event|0|||
23751520|NCT03996694|66470109|FG003|First Washout (7 Days)|Adverse Event|0|||
23751521|NCT03996694|66470110|FG004|First Washout (7 Days)|Adverse Event|0|||
23751522|NCT03996694|66470111|FG005|First Washout (7 Days)|Adverse Event|0|||
23751523|NCT03996694|66470106|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
23751524|NCT03996694|66470107|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
23751525|NCT03996694|66470108|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
23435256|NCT03995355|65337004|FG000|Overall Study|Scheduling Issues|0|||
23556788|NCT01281202|65765998|FG001|Overall Study|Adverse Event|0|||
23751526|NCT03996694|66470109|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
23751527|NCT03996694|66470110|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
23751528|NCT03996694|66470111|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
23751529|NCT03996694|66470106|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
23751530|NCT03996694|66470107|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
23435257|NCT03995355|65337005|FG001|Overall Study|Scheduling Issues|1|||
23435258|NCT01174173|65337006|FG000|Overall Study|drug-drug interaction|1|||
23435259|NCT01918332|65337009|FG000|Overall Study|Adverse Event|0|||
23751531|NCT03996694|66470108|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
23751532|NCT03996694|66470109|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
23751533|NCT03996694|66470110|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
23751534|NCT03996694|66470111|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
23751535|NCT01306968|66470119|FG000|Overall Study|Lost to Follow-up|1|||
23751536|NCT01306968|66470120|FG001|Overall Study|Lost to Follow-up|1|||
23751537|NCT01306968|66470121|FG002|Overall Study|Lost to Follow-up|0|||
23751538|NCT01306968|66470122|FG003|Overall Study|Lost to Follow-up|0|||
23751539|NCT01306968|66470119|FG000|Overall Study|Physician Decision|0|||
23751540|NCT01306968|66470120|FG001|Overall Study|Physician Decision|1|||
23751541|NCT01306968|66470121|FG002|Overall Study|Physician Decision|0|||
23751542|NCT01306968|66470122|FG003|Overall Study|Physician Decision|0|||
23751543|NCT01306968|66470119|FG000|Overall Study|Relocated and left active duty|0|||
23751544|NCT01306968|66470120|FG001|Overall Study|Relocated and left active duty|1|||
23751545|NCT01306968|66470121|FG002|Overall Study|Relocated and left active duty|1|||
23751546|NCT01306968|66470122|FG003|Overall Study|Relocated and left active duty|1|||
23751547|NCT01306968|66470119|FG000|Overall Study|Withdrew - time commitment|0|||
23751548|NCT01306968|66470120|FG001|Overall Study|Withdrew - time commitment|0|||
23751549|NCT01306968|66470121|FG002|Overall Study|Withdrew - time commitment|0|||
23751550|NCT01306968|66470122|FG003|Overall Study|Withdrew - time commitment|2|||
23751551|NCT01306968|66470119|FG000|Overall Study|Withdrew over privacy concerns|0|||
23751552|NCT01306968|66470120|FG001|Overall Study|Withdrew over privacy concerns|0|||
23751553|NCT01306968|66470121|FG002|Overall Study|Withdrew over privacy concerns|0|||
23751554|NCT01306968|66470122|FG003|Overall Study|Withdrew over privacy concerns|1|||
23751555|NCT02610842|66470123|FG000|Overall Study|Lost to Follow-up|5|||
23751556|NCT00463385|66470128|FG000|Overall Study|Other|4|||
23751557|NCT00463385|66470129|FG001|Overall Study|Other|3|||
23751558|NCT00463385|66470130|FG002|Overall Study|Other|6|||
23751559|NCT00463385|66470131|FG003|Overall Study|Other|4|||
23751560|NCT00463385|66470128|FG000|Overall Study|Adverse Event|5|||
23751561|NCT00463385|66470129|FG001|Overall Study|Adverse Event|8|||
23751562|NCT00463385|66470130|FG002|Overall Study|Adverse Event|4|||
23435260|NCT01918332|65337010|FG001|Overall Study|Adverse Event|0|||
23435261|NCT01918332|65337011|FG002|Overall Study|Adverse Event|0|||
23435262|NCT01918332|65337012|FG003|Overall Study|Adverse Event|1|||
23435263|NCT01918332|65337009|FG000|Overall Study|Withdrawal by Subject|2|||
23435264|NCT01918332|65337010|FG001|Overall Study|Withdrawal by Subject|3|||
23435265|NCT01918332|65337011|FG002|Overall Study|Withdrawal by Subject|2|||
23435266|NCT01918332|65337012|FG003|Overall Study|Withdrawal by Subject|3|||
23435267|NCT01918332|65337009|FG000|Overall Study|Protocol Violation|6|||
23435268|NCT01918332|65337010|FG001|Overall Study|Protocol Violation|2|||
23435269|NCT01918332|65337011|FG002|Overall Study|Protocol Violation|6|||
23435270|NCT01918332|65337012|FG003|Overall Study|Protocol Violation|3|||
23435271|NCT01918332|65337009|FG000|Overall Study|lipid result by central lab did not meet|0|||
23435272|NCT01918332|65337010|FG001|Overall Study|lipid result by central lab did not meet|0|||
23435273|NCT01918332|65337011|FG002|Overall Study|lipid result by central lab did not meet|1|||
23435274|NCT01918332|65337012|FG003|Overall Study|lipid result by central lab did not meet|0|||
23435275|NCT00498355|65337013|FG000|Overall Study|Lost to Follow-up|1|||
23435276|NCT00991406|65337014|FG000|Overall Study|One participant did not respond to FES.|1|||
23435277|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435278|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435279|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435280|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435281|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435282|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435283|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435284|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435285|NCT03615066|65337016|FG000|Main Study|Withdrew Consent|0|||
23435286|NCT03615066|65337017|FG001|Main Study|Withdrew Consent|1|||
23435287|NCT03615066|65337018|FG002|Main Study|Withdrew Consent|1|||
23435288|NCT03615066|65337016|FG000|Main Study|Lost to Follow-up|0|||
23435289|NCT03615066|65337017|FG001|Main Study|Lost to Follow-up|0|||
23556789|NCT01281202|65765997|FG000|Overall Study|Withdrawal by Subject|2|||
23556790|NCT01281202|65765998|FG001|Overall Study|Withdrawal by Subject|2|||
23435290|NCT03615066|65337018|FG002|Main Study|Lost to Follow-up|1|||
23751563|NCT00463385|66470131|FG003|Overall Study|Adverse Event|2|||
23751564|NCT00463385|66470128|FG000|Overall Study|Lack of Efficacy|6|||
23751565|NCT00463385|66470129|FG001|Overall Study|Lack of Efficacy|6|||
23751566|NCT00463385|66470130|FG002|Overall Study|Lack of Efficacy|7|||
23751567|NCT00463385|66470131|FG003|Overall Study|Lack of Efficacy|9|||
23435291|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
23435292|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
23435293|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
23556791|NCT01281202|65765997|FG000|Overall Study|Protocol Violation|11|||
23435294|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
23435295|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
23435296|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
23435297|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
23435298|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
23435299|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
23435300|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
23435301|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435302|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435303|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435304|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435305|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435306|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
23435307|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435308|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435309|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435310|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435311|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435312|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
23435313|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435314|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435315|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435316|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435317|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435318|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
23435319|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
23435320|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
23435321|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
23435322|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
23435323|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
23435324|NCT00095173|65337027|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435325|NCT00095173|65337028|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
23435326|NCT00095173|65337029|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
23435327|NCT00095173|65337030|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435328|NCT00095173|65337031|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435329|NCT00095173|65337032|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435330|NCT00095173|65337027|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435331|NCT00095173|65337028|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
23435332|NCT00095173|65337029|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435333|NCT00095173|65337030|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435334|NCT00095173|65337031|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435335|NCT00095173|65337032|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435336|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Death|0|||
23435337|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Death|0|||
23435338|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Death|0|||
23435339|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Death|0|||
23435340|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Death|0|||
23435341|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Death|1|||
23435342|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435343|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435344|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435345|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
23435346|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
23435347|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
23435348|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435349|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435350|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435351|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
23435352|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
23435353|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
23435354|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435355|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435356|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435357|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
23435358|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
23435359|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
23435360|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435361|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435362|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435363|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
23435364|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
23435365|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435366|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435367|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435368|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435369|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435370|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
23435371|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
23435372|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435373|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435374|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435375|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435376|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
23435377|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
23435378|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435379|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435380|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435381|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
23435382|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
23435383|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
23435384|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Other|0|||
23435385|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Other|0|||
23435386|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Other|0|||
23435387|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Other|4|||
23435388|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Other|6|||
23435389|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Other|8|||
23435390|NCT03216746|65337035|FG000|Overall Study|Lost to Follow-up|6|||
23435391|NCT03216746|65337036|FG001|Overall Study|Lost to Follow-up|8|||
23435392|NCT03216746|65337037|FG002|Overall Study|Lost to Follow-up|5|||
23435393|NCT03216746|65337038|FG003|Overall Study|Lost to Follow-up|6|||
23435394|NCT00764673|65337039|FG000|Overall Study|Death|1|||
23435395|NCT00764673|65337039|FG000|Overall Study|Lost to Follow-up|3|||
23435396|NCT00764673|65337039|FG000|Overall Study|Withdrawal by Subject|6|||
23435397|NCT00764673|65337039|FG000|Overall Study|Revision of Device|2|||
23435398|NCT00391625|65337040|FG000|Month 14|Withdrawal by Subject|1|||
23435399|NCT00391625|65337040|FG000|Month 50|Physician Decision|1|||
23435400|NCT04167137|65337042|FG000|Overall Study|Disease progression|1|||
23435401|NCT04167137|65337043|FG001|Overall Study|Disease progression|1|||
23435402|NCT04167137|65337044|FG002|Overall Study|Disease progression|3|||
23435403|NCT04167137|65337045|FG003|Overall Study|Disease progression|3|||
23435404|NCT04167137|65337046|FG004|Overall Study|Disease progression|2|||
23435405|NCT04167137|65337047|FG005|Overall Study|Disease progression|3|||
23435406|NCT04167137|65337048|FG006|Overall Study|Disease progression|2|||
23435407|NCT04167137|65337049|FG007|Overall Study|Disease progression|2|||
23435408|NCT04167137|65337042|FG000|Overall Study|Withdrawal by Subject|1|||
23435409|NCT04167137|65337043|FG001|Overall Study|Withdrawal by Subject|0|||
23435410|NCT04167137|65337044|FG002|Overall Study|Withdrawal by Subject|0|||
23435411|NCT04167137|65337045|FG003|Overall Study|Withdrawal by Subject|1|||
23435412|NCT04167137|65337046|FG004|Overall Study|Withdrawal by Subject|0|||
23435413|NCT04167137|65337047|FG005|Overall Study|Withdrawal by Subject|2|||
23435414|NCT04167137|65337048|FG006|Overall Study|Withdrawal by Subject|1|||
23435415|NCT04167137|65337049|FG007|Overall Study|Withdrawal by Subject|0|||
23435416|NCT04167137|65337042|FG000|Overall Study|Adverse Event|0|||
23435417|NCT04167137|65337043|FG001|Overall Study|Adverse Event|0|||
23435418|NCT04167137|65337044|FG002|Overall Study|Adverse Event|0|||
23435419|NCT04167137|65337045|FG003|Overall Study|Adverse Event|0|||
23435420|NCT04167137|65337046|FG004|Overall Study|Adverse Event|0|||
23435421|NCT04167137|65337047|FG005|Overall Study|Adverse Event|1|||
23435422|NCT04167137|65337048|FG006|Overall Study|Adverse Event|0|||
23435423|NCT04167137|65337049|FG007|Overall Study|Adverse Event|1|||
23435424|NCT04167137|65337042|FG000|Overall Study|Physician Decision|0|||
23435425|NCT04167137|65337043|FG001|Overall Study|Physician Decision|0|||
23435426|NCT04167137|65337044|FG002|Overall Study|Physician Decision|0|||
23435427|NCT04167137|65337045|FG003|Overall Study|Physician Decision|1|||
23435428|NCT04167137|65337046|FG004|Overall Study|Physician Decision|0|||
23435429|NCT04167137|65337047|FG005|Overall Study|Physician Decision|0|||
23435430|NCT04167137|65337048|FG006|Overall Study|Physician Decision|1|||
23435431|NCT04167137|65337049|FG007|Overall Study|Physician Decision|0|||
23435432|NCT04167137|65337042|FG000|Overall Study|Death|0|||
23435433|NCT04167137|65337043|FG001|Overall Study|Death|1|||
23435434|NCT04167137|65337044|FG002|Overall Study|Death|0|||
23435435|NCT04167137|65337045|FG003|Overall Study|Death|0|||
23435436|NCT04167137|65337046|FG004|Overall Study|Death|0|||
23435437|NCT04167137|65337047|FG005|Overall Study|Death|0|||
23435438|NCT04167137|65337048|FG006|Overall Study|Death|0|||
23435439|NCT04167137|65337049|FG007|Overall Study|Death|0|||
23435440|NCT04167137|65337042|FG000|Overall Study|Study terminated by Sponsor|0|||
23435441|NCT04167137|65337043|FG001|Overall Study|Study terminated by Sponsor|0|||
23435442|NCT04167137|65337044|FG002|Overall Study|Study terminated by Sponsor|0|||
23435443|NCT04167137|65337045|FG003|Overall Study|Study terminated by Sponsor|0|||
23435444|NCT04167137|65337046|FG004|Overall Study|Study terminated by Sponsor|0|||
23435445|NCT04167137|65337047|FG005|Overall Study|Study terminated by Sponsor|0|||
23435446|NCT04167137|65337048|FG006|Overall Study|Study terminated by Sponsor|0|||
23435447|NCT04167137|65337049|FG007|Overall Study|Study terminated by Sponsor|1|||
23435448|NCT00866814|65337052|FG000|Overall Study|Lost to Follow-up|12|||
23435449|NCT00866814|65337052|FG000|Overall Study|Adverse Event|2|||
23435450|NCT00866814|65337052|FG000|Overall Study|Physician Decision|1|||
23435451|NCT00866814|65337052|FG000|Overall Study|Death|1|||
23435452|NCT00866814|65337052|FG000|Overall Study|No longer wished to participate|1|||
23435453|NCT00866814|65337052|FG000|Overall Study|Unable to meet follow-up requirements|2|||
23435454|NCT00866814|65337052|FG000|Overall Study|Moved to area without study site|1|||
23435455|NCT00559988|65337058|FG000|Overall Study|Death|147|||
23435456|NCT00559988|65337059|FG001|Overall Study|Death|140|||
23435457|NCT00559988|65337058|FG000|Overall Study|Withdrawal by Subject|152|||
23435458|NCT00559988|65337059|FG001|Overall Study|Withdrawal by Subject|139|||
23435459|NCT00559988|65337058|FG000|Overall Study|Lost to Follow-up|42|||
23435460|NCT00559988|65337059|FG001|Overall Study|Lost to Follow-up|56|||
23435461|NCT00559988|65337058|FG000|Overall Study|ICD device explanted|10|||
23435462|NCT00559988|65337059|FG001|Overall Study|ICD device explanted|17|||
23435463|NCT01008449|65337060|FG000|Overall Study|Lost to Follow-up|29|||
23435464|NCT01008449|65337061|FG001|Overall Study|Lost to Follow-up|19|||
23435465|NCT00470418|65337062|FG000|Overall Study|Withdrawal by Subject|1|||
23435466|NCT00470418|65337063|FG001|Overall Study|Withdrawal by Subject|0|||
23435467|NCT03576716|65337064|FG000|Overall Study|Withdrawal by Subject|0|||
23435468|NCT03576716|65337065|FG001|Overall Study|Withdrawal by Subject|1|||
23435469|NCT00727558|65337066|FG000|Overall Study|Lens issue|0|||
23435470|NCT00727558|65337067|FG001|Overall Study|Lens issue|1|||
23435471|NCT00727558|65337066|FG000|Overall Study|Adverse Event|0|||
23435472|NCT00727558|65337067|FG001|Overall Study|Adverse Event|1|||
23435473|NCT00727558|65337066|FG000|Overall Study|Subject unable to return for follow-up|1|||
23435474|NCT00727558|65337067|FG001|Overall Study|Subject unable to return for follow-up|1|||
23435475|NCT00727558|65337066|FG000|Overall Study|Lost to Follow-up|1|||
23751568|NCT00463385|66470128|FG000|Overall Study|Withdrawal by Subject|3|||
23751569|NCT00463385|66470129|FG001|Overall Study|Withdrawal by Subject|3|||
23751570|NCT00463385|66470130|FG002|Overall Study|Withdrawal by Subject|3|||
23751571|NCT00463385|66470131|FG003|Overall Study|Withdrawal by Subject|4|||
23751572|NCT00463385|66470128|FG000|Overall Study|Lost to Follow-up|0|||
23751573|NCT00463385|66470129|FG001|Overall Study|Lost to Follow-up|0|||
23751574|NCT00463385|66470130|FG002|Overall Study|Lost to Follow-up|0|||
23435476|NCT00727558|65337067|FG001|Overall Study|Lost to Follow-up|0|||
23435477|NCT01959243|65337068|FG000|Overall Study|Investigator Decision|3|||
23435478|NCT01959243|65337069|FG001|Overall Study|Investigator Decision|0|||
23435479|NCT01959243|65337068|FG000|Overall Study|Adverse Event|5|||
23435480|NCT01959243|65337069|FG001|Overall Study|Adverse Event|2|||
23435481|NCT01959243|65337068|FG000|Overall Study|Administrative reasons|2|||
23435482|NCT01959243|65337069|FG001|Overall Study|Administrative reasons|1|||
23435483|NCT01959243|65337068|FG000|Overall Study|Lost to Follow-up|3|||
23435484|NCT01959243|65337069|FG001|Overall Study|Lost to Follow-up|1|||
23435485|NCT03652675|65337070|FG000|Overall Study|Lost to Follow-up|4|||
23435486|NCT03652675|65337071|FG001|Overall Study|Lost to Follow-up|4|||
23435487|NCT04544683|65337074|FG000|Overall Study|Lost to Follow-up|2|||
23435488|NCT04544683|65337074|FG000|Overall Study|Underwent cervical spine surgery|6|||
23435489|NCT03848949|65337075|FG000|Overall Study|Lost to Follow-up|5|||
23435490|NCT03848949|65337076|FG001|Overall Study|Lost to Follow-up|7|||
23435491|NCT00527982|65337078|FG000|Overall Study|Physician Decision|1|||
23435492|NCT00527982|65337079|FG001|Overall Study|Physician Decision|0|||
23435493|NCT02516228|65337084|FG000|Overall Study|Lost to Follow-up|1|||
23435494|NCT02516228|65337084|FG000|Overall Study|Withdrawal by Subject|1|||
23435495|NCT02516228|65337084|FG000|Overall Study|Physician Decision|1|||
23435496|NCT02666105|65337085|FG000|Overall Study|Death|1|||
23435497|NCT03565237|65337086|FG000|Overall Study|Non-compliance of Investigational Product|1|||
23435498|NCT03565237|65337086|FG000|Overall Study|Physician Decision|1|||
23751575|NCT00463385|66470131|FG003|Overall Study|Lost to Follow-up|1|||
23751576|NCT00463385|66470128|FG000|Overall Study|Death|2|||
23751577|NCT00463385|66470129|FG001|Overall Study|Death|1|||
23751578|NCT00463385|66470130|FG002|Overall Study|Death|2|||
23751579|NCT00463385|66470131|FG003|Overall Study|Death|0|||
23751580|NCT00463385|66470128|FG000|Overall Study|Missing|2|||
23751581|NCT00463385|66470129|FG001|Overall Study|Missing|0|||
23435499|NCT02726022|65337087|FG000|Overall Study|Adverse Event|14|||
23435500|NCT02726022|65337087|FG000|Overall Study|Treatment Failure|8|||
23435501|NCT02726022|65337087|FG000|Overall Study|Poor Compliance|13|||
23435502|NCT02726022|65337087|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
23435503|NCT03824587|65337088|FG000|Run-in Period|Screen Failure|0|||
23435504|NCT03824587|65337089|FG001|Run-in Period|Screen Failure|275|||
23435505|NCT03824587|65337088|FG000|Treatment Period|Adverse Event|4|||
23435506|NCT03824587|65337089|FG001|Treatment Period|Adverse Event|1|||
23435507|NCT03824587|65337088|FG000|Treatment Period|Withdrawal by Subject|0|||
23435508|NCT03824587|65337089|FG001|Treatment Period|Withdrawal by Subject|1|||
23435509|NCT03824587|65337088|FG000|Treatment Period|Kidney Transplant|1|||
23435510|NCT03824587|65337089|FG001|Treatment Period|Kidney Transplant|1|||
23435511|NCT00812565|65337092|FG000|Overall Study|Did Not Receive Study Medication|1|||
23435512|NCT00812565|65337093|FG001|Overall Study|Did Not Receive Study Medication|1|||
23435513|NCT00812565|65337094|FG002|Overall Study|Did Not Receive Study Medication|0|||
23435514|NCT00812565|65337095|FG003|Overall Study|Did Not Receive Study Medication|0|||
23435515|NCT00812565|65337096|FG004|Overall Study|Did Not Receive Study Medication|0|||
23435516|NCT00812565|65337097|FG005|Overall Study|Did Not Receive Study Medication|0|||
23435517|NCT00812565|65337098|FG006|Overall Study|Did Not Receive Study Medication|0|||
23435518|NCT00812565|65337099|FG007|Overall Study|Did Not Receive Study Medication|0|||
23435519|NCT00812565|65337092|FG000|Overall Study|Adverse Event|0|||
23435520|NCT00812565|65337093|FG001|Overall Study|Adverse Event|0|||
23435521|NCT00812565|65337094|FG002|Overall Study|Adverse Event|0|||
23435522|NCT00812565|65337095|FG003|Overall Study|Adverse Event|2|||
23435523|NCT00812565|65337096|FG004|Overall Study|Adverse Event|0|||
23435524|NCT00812565|65337097|FG005|Overall Study|Adverse Event|0|||
23435525|NCT00812565|65337098|FG006|Overall Study|Adverse Event|0|||
23435526|NCT00812565|65337099|FG007|Overall Study|Adverse Event|1|||
23435527|NCT00812565|65337092|FG000|Overall Study|Did Not Come to Study Visit|1|||
23435528|NCT00812565|65337093|FG001|Overall Study|Did Not Come to Study Visit|0|||
23435529|NCT00812565|65337094|FG002|Overall Study|Did Not Come to Study Visit|0|||
23435530|NCT00812565|65337095|FG003|Overall Study|Did Not Come to Study Visit|0|||
23435531|NCT00812565|65337096|FG004|Overall Study|Did Not Come to Study Visit|0|||
23435532|NCT00812565|65337097|FG005|Overall Study|Did Not Come to Study Visit|0|||
23435533|NCT00812565|65337098|FG006|Overall Study|Did Not Come to Study Visit|0|||
23435534|NCT00812565|65337099|FG007|Overall Study|Did Not Come to Study Visit|0|||
23435535|NCT00812565|65337092|FG000|Overall Study|Withdrawal of Consent|1|||
23435536|NCT00812565|65337093|FG001|Overall Study|Withdrawal of Consent|0|||
23435537|NCT00812565|65337094|FG002|Overall Study|Withdrawal of Consent|0|||
23435538|NCT00812565|65337095|FG003|Overall Study|Withdrawal of Consent|0|||
23435539|NCT00812565|65337096|FG004|Overall Study|Withdrawal of Consent|1|||
23435540|NCT00812565|65337097|FG005|Overall Study|Withdrawal of Consent|0|||
23435541|NCT00812565|65337098|FG006|Overall Study|Withdrawal of Consent|0|||
23435542|NCT00812565|65337099|FG007|Overall Study|Withdrawal of Consent|0|||
23435543|NCT00812565|65337092|FG000|Overall Study|Reason Not Specified|0|||
23824908|NCT03536884|66737927|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824909|NCT03536884|66737928|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824910|NCT03536884|66737929|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824911|NCT03536884|66737930|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23824912|NCT03536884|66737931|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
23824913|NCT03536884|66737920|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824914|NCT03536884|66737921|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824915|NCT03536884|66737922|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824916|NCT03536884|66737923|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824917|NCT03536884|66737924|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23843099|NCT01738503|66805582|FG001|Treatment Period|Protocol Violation|3|||
23435544|NCT00812565|65337093|FG001|Overall Study|Reason Not Specified|0|||
23435545|NCT00812565|65337094|FG002|Overall Study|Reason Not Specified|0|||
23435546|NCT00812565|65337095|FG003|Overall Study|Reason Not Specified|0|||
23435547|NCT00812565|65337096|FG004|Overall Study|Reason Not Specified|0|||
23435548|NCT00812565|65337097|FG005|Overall Study|Reason Not Specified|1|||
23435549|NCT00812565|65337098|FG006|Overall Study|Reason Not Specified|0|||
23435550|NCT00812565|65337099|FG007|Overall Study|Reason Not Specified|0|||
23435551|NCT03244826|65337100|FG000|Overall Study|Withdrawal by Subject|2|||
23435552|NCT03244826|65337101|FG001|Overall Study|Withdrawal by Subject|0|||
23435553|NCT03244826|65337100|FG000|Overall Study|Transplant delayed or withdrawn|12|||
23435554|NCT03244826|65337101|FG001|Overall Study|Transplant delayed or withdrawn|10|||
23435555|NCT00186901|65337102|FG000|Overall Study|Pregnancy|6|||
23435556|NCT00186901|65337103|FG001|Overall Study|Pregnancy|3|||
23435557|NCT00186901|65337104|FG002|Overall Study|Pregnancy|0|||
23435558|NCT00186901|65337102|FG000|Overall Study|Lost to Follow-up|6|||
23435559|NCT00186901|65337103|FG001|Overall Study|Lost to Follow-up|3|||
23435560|NCT00186901|65337104|FG002|Overall Study|Lost to Follow-up|0|||
23435561|NCT00186901|65337102|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
23435562|NCT00186901|65337103|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
23435563|NCT00186901|65337104|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
23435564|NCT00186901|65337102|FG000|Overall Study|ALL relapse or second malignancy|1|||
23435565|NCT00186901|65337103|FG001|Overall Study|ALL relapse or second malignancy|2|||
23435566|NCT00186901|65337104|FG002|Overall Study|ALL relapse or second malignancy|0|||
23435567|NCT00186901|65337102|FG000|Overall Study|Withdrawal by Subject|4|||
23435568|NCT00186901|65337103|FG001|Overall Study|Withdrawal by Subject|5|||
23435569|NCT00186901|65337104|FG002|Overall Study|Withdrawal by Subject|0|||
23435570|NCT00186901|65337102|FG000|Overall Study|Open label|3|||
23435571|NCT00186901|65337103|FG001|Overall Study|Open label|2|||
23435572|NCT00186901|65337104|FG002|Overall Study|Open label|0|||
23435573|NCT00186901|65337102|FG000|Overall Study|Limited adherence to study requirements|20|||
23435574|NCT00186901|65337103|FG001|Overall Study|Limited adherence to study requirements|23|||
23556792|NCT01281202|65765998|FG001|Overall Study|Protocol Violation|10|||
23435575|NCT00186901|65337104|FG002|Overall Study|Limited adherence to study requirements|0|||
23435576|NCT00186901|65337102|FG000|Overall Study|Bone Mineral Density > 0|0|||
23435577|NCT00186901|65337103|FG001|Overall Study|Bone Mineral Density > 0|0|||
23435578|NCT00186901|65337104|FG002|Overall Study|Bone Mineral Density > 0|149|||
23435579|NCT02554981|65337105|FG000|Overall Study|Adverse Event|1|||
23435580|NCT02554981|65337105|FG000|Overall Study|Administrative Reasons|1|||
23435581|NCT02554981|65337105|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23435582|NCT03459365|65337106|FG000|Overall Study|Withdrawal by Subject|6|||
23435583|NCT03459365|65337106|FG000|Overall Study|Protocol Violation|8|||
23435584|NCT00528996|65337107|FG000|Overall Study|Other reasons than listing|6|||
23435585|NCT00528996|65337108|FG001|Overall Study|Other reasons than listing|7|||
23435586|NCT00528996|65337109|FG002|Overall Study|Other reasons than listing|14|||
23435587|NCT00528996|65337110|FG003|Overall Study|Other reasons than listing|11|||
23435588|NCT00528996|65337111|FG004|Overall Study|Other reasons than listing|5|||
23435589|NCT00528996|65337107|FG000|Overall Study|Refused continue medication|16|||
23435590|NCT00528996|65337108|FG001|Overall Study|Refused continue medication|0|||
23435591|NCT00528996|65337109|FG002|Overall Study|Refused continue medication|3|||
23435592|NCT00528996|65337110|FG003|Overall Study|Refused continue medication|3|||
23435593|NCT00528996|65337111|FG004|Overall Study|Refused continue medication|6|||
23435594|NCT00528996|65337107|FG000|Overall Study|Lost to Follow-up|2|||
23435595|NCT00528996|65337108|FG001|Overall Study|Lost to Follow-up|0|||
23556793|NCT01281202|65765997|FG000|Overall Study|Administrative|2|||
23556794|NCT01281202|65765998|FG001|Overall Study|Administrative|8|||
23556795|NCT01281202|65765997|FG000|Overall Study|Lost to Follow-up|11|||
23556796|NCT01281202|65765998|FG001|Overall Study|Lost to Follow-up|13|||
23556797|NCT01281202|65765997|FG000|Overall Study|Incarceration|0|||
23556798|NCT01281202|65765998|FG001|Overall Study|Incarceration|3|||
23556799|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
23556800|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
23556801|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
23623583|NCT00488319|66008491|FG002|Overall Study|Withdrawal by Subject|44|||
23435596|NCT00528996|65337109|FG002|Overall Study|Lost to Follow-up|4|||
23435597|NCT00528996|65337110|FG003|Overall Study|Lost to Follow-up|1|||
23435598|NCT00528996|65337111|FG004|Overall Study|Lost to Follow-up|3|||
23435599|NCT00528996|65337107|FG000|Overall Study|Protocol Violation|1|||
23435600|NCT00528996|65337108|FG001|Overall Study|Protocol Violation|2|||
23435601|NCT00528996|65337109|FG002|Overall Study|Protocol Violation|3|||
23435602|NCT00528996|65337110|FG003|Overall Study|Protocol Violation|3|||
23556802|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
23556803|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
23435603|NCT00528996|65337111|FG004|Overall Study|Protocol Violation|2|||
23435604|NCT00528996|65337107|FG000|Overall Study|Lack of Efficacy|7|||
23435605|NCT00528996|65337108|FG001|Overall Study|Lack of Efficacy|2|||
23435606|NCT00528996|65337109|FG002|Overall Study|Lack of Efficacy|1|||
23435607|NCT00528996|65337110|FG003|Overall Study|Lack of Efficacy|3|||
23435608|NCT00528996|65337111|FG004|Overall Study|Lack of Efficacy|3|||
23435609|NCT00528996|65337107|FG000|Overall Study|Adverse Event|32|||
23751582|NCT00463385|66470130|FG002|Overall Study|Missing|0|||
23751583|NCT00463385|66470131|FG003|Overall Study|Missing|2|||
23824918|NCT03536884|66737925|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824919|NCT03536884|66737926|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824920|NCT03536884|66737927|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824921|NCT03536884|66737928|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23435610|NCT00528996|65337108|FG001|Overall Study|Adverse Event|13|||
23751584|NCT00463385|66470128|FG000|Overall Study|1 participant received commercial drug|0|||
23751585|NCT00463385|66470129|FG001|Overall Study|1 participant received commercial drug|1|||
23751586|NCT00463385|66470130|FG002|Overall Study|1 participant received commercial drug|0|||
23751587|NCT00463385|66470131|FG003|Overall Study|1 participant received commercial drug|0|||
23751588|NCT00530621|66470134|FG000|Overall Study|Adverse Event|11|||
23751589|NCT00530621|66470135|FG001|Overall Study|Adverse Event|8|||
23751590|NCT00530621|66470134|FG000|Overall Study|Physician Decision|2|||
23751591|NCT00530621|66470135|FG001|Overall Study|Physician Decision|4|||
23751592|NCT00530621|66470134|FG000|Overall Study|Progressive Disease (PD)|47|||
23751593|NCT00530621|66470135|FG001|Overall Study|Progressive Disease (PD)|40|||
23751594|NCT00530621|66470134|FG000|Overall Study|Sponsor Decision|12|||
23751595|NCT00530621|66470135|FG001|Overall Study|Sponsor Decision|15|||
23751596|NCT00530621|66470134|FG000|Overall Study|Subject Decision|4|||
23751597|NCT00530621|66470135|FG001|Overall Study|Subject Decision|7|||
23751598|NCT00530621|66470134|FG000|Overall Study|Death|3|||
23751599|NCT00530621|66470135|FG001|Overall Study|Death|6|||
23751600|NCT00530621|66470134|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
23751601|NCT00530621|66470135|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
23751602|NCT01211613|66470136|FG000|Overall Study|Lost to Follow-up|2|||
23751603|NCT01211613|66470137|FG001|Overall Study|Lost to Follow-up|2|||
23751604|NCT01211613|66470138|FG002|Overall Study|Lost to Follow-up|2|||
23751605|NCT01211613|66470136|FG000|Overall Study|Withdrawal by Subject|1|||
23751606|NCT01211613|66470137|FG001|Overall Study|Withdrawal by Subject|0|||
23751607|NCT01211613|66470138|FG002|Overall Study|Withdrawal by Subject|0|||
23751608|NCT01023815|66470139|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
23751609|NCT01023815|66470140|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23751610|NCT01023815|66470141|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23751611|NCT01023815|66470142|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23751612|NCT01023815|66470139|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
23751613|NCT01023815|66470140|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
23751614|NCT01023815|66470141|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
23751615|NCT01023815|66470142|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
23751616|NCT01023815|66470139|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
23751617|NCT01023815|66470140|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
23751618|NCT01023815|66470141|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
23751619|NCT01023815|66470142|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
23751620|NCT01023815|66470139|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
23751621|NCT01023815|66470140|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
23751622|NCT01023815|66470141|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
23751623|NCT01023815|66470142|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
23751624|NCT01023815|66470139|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23751625|NCT01023815|66470140|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
23751626|NCT01023815|66470141|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23751627|NCT01023815|66470142|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23751628|NCT00518531|66470143|FG000|Treatment Period 1|Adverse Event|5|||
23751629|NCT00518531|66470144|FG001|Treatment Period 1|Adverse Event|0|||
23751630|NCT00518531|66470143|FG000|Treatment Period 1|Lost to Follow-up|5|||
23751631|NCT00518531|66470144|FG001|Treatment Period 1|Lost to Follow-up|3|||
23751632|NCT00518531|66470143|FG000|Treatment Period 1|Physician Decision|1|||
23751633|NCT00518531|66470144|FG001|Treatment Period 1|Physician Decision|0|||
23751634|NCT00518531|66470143|FG000|Treatment Period 1|Protocol Violation|2|||
23751635|NCT00518531|66470144|FG001|Treatment Period 1|Protocol Violation|0|||
23435611|NCT00528996|65337109|FG002|Overall Study|Adverse Event|18|||
23435612|NCT00528996|65337110|FG003|Overall Study|Adverse Event|29|||
23751636|NCT00518531|66470143|FG000|Treatment Period 1|Withdrawal by Subject|4|||
23751637|NCT00518531|66470144|FG001|Treatment Period 1|Withdrawal by Subject|6|||
23751638|NCT00518531|66470143|FG000|Treatment Period 1|Early crossover|1|||
23435613|NCT00528996|65337111|FG004|Overall Study|Adverse Event|18|||
23435614|NCT03908970|65337112|FG000|Overall Study|Adverse Event|7|||
23435615|NCT03908970|65337113|FG001|Overall Study|Adverse Event|21|||
23435616|NCT03908970|65337112|FG000|Overall Study|Physician Decision|1|||
23435617|NCT03908970|65337113|FG001|Overall Study|Physician Decision|4|||
23435618|NCT03908970|65337112|FG000|Overall Study|Withdrawal by Subject|9|||
23435619|NCT03908970|65337113|FG001|Overall Study|Withdrawal by Subject|22|||
23435620|NCT00400569|65337114|FG000|Overall Study|Death|1|||
23435621|NCT03235089|65337116|FG000|Overall Study|Lost to Follow-up|1|||
23435622|NCT03235089|65337117|FG001|Overall Study|Lost to Follow-up|1|||
23435623|NCT03235089|65337116|FG000|Overall Study|Physician Decision|2|||
23435624|NCT03235089|65337117|FG001|Overall Study|Physician Decision|2|||
23435625|NCT02540993|65337121|FG000|Overall Study|Lost to Follow-up|5|||
23435626|NCT02540993|65337122|FG001|Overall Study|Lost to Follow-up|3|||
23435627|NCT02540993|65337121|FG000|Overall Study|Withdrawal by Subject|4|||
23435628|NCT02540993|65337122|FG001|Overall Study|Withdrawal by Subject|6|||
23435629|NCT02540993|65337121|FG000|Overall Study|GCP violations|33|||
23435630|NCT02540993|65337122|FG001|Overall Study|GCP violations|27|||
23435631|NCT04356352|65337123|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
23435632|NCT04356352|65337124|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
23435633|NCT04356352|65337125|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
23435634|NCT04356352|65337123|FG000|Overall Study|Protocol Violation|0|||
23435635|NCT04356352|65337124|FG001|Overall Study|Protocol Violation|3|||
23435636|NCT04356352|65337125|FG002|Overall Study|Protocol Violation|1|||
23751639|NCT00518531|66470144|FG001|Treatment Period 1|Early crossover|3|||
23751640|NCT00518531|66470143|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23751641|NCT00518531|66470144|FG001|Treatment Period 2|Withdrawal by Subject|8|||
23751642|NCT00518531|66470143|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
23751643|NCT00518531|66470144|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
23751644|NCT00518531|66470143|FG000|Treatment Period 2|Adverse Event|1|||
23751645|NCT00518531|66470144|FG001|Treatment Period 2|Adverse Event|7|||
23751646|NCT00518531|66470143|FG000|Treatment Period 2|Protocol-specified criteria|0|||
23751647|NCT00518531|66470144|FG001|Treatment Period 2|Protocol-specified criteria|1|||
23751648|NCT00518531|66470143|FG000|Treatment Period 2|Non-compliance|1|||
23751649|NCT00518531|66470144|FG001|Treatment Period 2|Non-compliance|2|||
23751650|NCT02815540|66470145|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
23751651|NCT01689649|66470146|FG000|Overall Study|Lack of Efficacy|3|||
23751652|NCT01689649|66470146|FG000|Overall Study|Non-compliance|11|||
23751653|NCT01689649|66470146|FG000|Overall Study|Protocol Violation|3|||
23751654|NCT01689649|66470146|FG000|Overall Study|Lost to Follow-up|5|||
23751655|NCT00769132|66470147|FG000|Period 1|Adverse Event|1|||
23751656|NCT00769132|66470148|FG001|Period 1|Adverse Event|0|||
23751657|NCT00769132|66470149|FG002|Period 1|Adverse Event|0|||
23751658|NCT00769132|66470150|FG003|Period 1|Adverse Event|1|||
23751659|NCT00769132|66470147|FG000|Period 2|Withdrawal by Subject|0|||
23751660|NCT00769132|66470148|FG001|Period 2|Withdrawal by Subject|0|||
23751661|NCT00769132|66470149|FG002|Period 2|Withdrawal by Subject|0|||
23751662|NCT00769132|66470150|FG003|Period 2|Withdrawal by Subject|1|||
23751663|NCT00769132|66470147|FG000|Period 3|Withdrawal by Subject|1|||
23751664|NCT00769132|66470148|FG001|Period 3|Withdrawal by Subject|0|||
23751665|NCT00769132|66470149|FG002|Period 3|Withdrawal by Subject|0|||
23751666|NCT00769132|66470150|FG003|Period 3|Withdrawal by Subject|0|||
23824922|NCT03536884|66737929|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824923|NCT03536884|66737930|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23824924|NCT03536884|66737931|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
23824925|NCT02443740|66737935|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824926|NCT02443740|66737936|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824927|NCT02443740|66737937|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824928|NCT02443740|66737938|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824929|NCT02443740|66737939|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824930|NCT02443740|66737940|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
23824931|NCT02443740|66737941|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824932|NCT02443740|66737942|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824933|NCT02443740|66737943|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
23435637|NCT01549873|65337128|FG000|Overall Study|Physician Decision|0|||
23435638|NCT01549873|65337129|FG001|Overall Study|Physician Decision|1|||
23435639|NCT03040986|65337132|FG000|Overall Study|Hospice|1|||
23435640|NCT03040986|65337133|FG001|Overall Study|Hospice|0|||
23435641|NCT03040986|65337132|FG000|Overall Study|Adverse Event|2|||
23435642|NCT03040986|65337133|FG001|Overall Study|Adverse Event|1|||
23751667|NCT00769132|66470147|FG000|Period 4|Withdrawal by Subject|0|||
23751668|NCT00769132|66470148|FG001|Period 4|Withdrawal by Subject|1|||
23751669|NCT00769132|66470149|FG002|Period 4|Withdrawal by Subject|0|||
23751670|NCT00769132|66470150|FG003|Period 4|Withdrawal by Subject|0|||
23751671|NCT02628418|66470151|FG000|Overall Study|Lost to Follow-up|1|||
23751672|NCT02628418|66470152|FG001|Overall Study|Lost to Follow-up|2|||
23751673|NCT03751124|66470165|FG000|Overall Study|Adverse Event|4|||
23751674|NCT03751124|66470166|FG001|Overall Study|Adverse Event|3|||
23751675|NCT03751124|66470165|FG000|Overall Study|Protocol Deviation|0|||
23751676|NCT03751124|66470166|FG001|Overall Study|Protocol Deviation|1|||
23751677|NCT03751124|66470165|FG000|Overall Study|Lost to Follow-up|6|||
23435643|NCT03040986|65337132|FG000|Overall Study|Disease progression on study|3|||
23435644|NCT03040986|65337133|FG001|Overall Study|Disease progression on study|1|||
23556804|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
23556805|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
23556806|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
23556807|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
23556808|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
23556809|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
23751678|NCT03751124|66470166|FG001|Overall Study|Lost to Follow-up|4|||
23751679|NCT03751124|66470165|FG000|Overall Study|Withdrawal by Subject|6|||
23751680|NCT03751124|66470166|FG001|Overall Study|Withdrawal by Subject|8|||
23751681|NCT03751124|66470165|FG000|Overall Study|Lack of Efficacy|1|||
23751682|NCT03751124|66470166|FG001|Overall Study|Lack of Efficacy|1|||
23751683|NCT03751124|66470165|FG000|Overall Study|Pregnancy|0|||
23751684|NCT03751124|66470166|FG001|Overall Study|Pregnancy|1|||
23751685|NCT03751124|66470165|FG000|Overall Study|Other|9|||
23751686|NCT03751124|66470166|FG001|Overall Study|Other|9|||
23751687|NCT03751124|66470165|FG000|Overall Study|Participants who did not receive any study drug|0|||
23751688|NCT03751124|66470166|FG001|Overall Study|Participants who did not receive any study drug|1|||
23751689|NCT04935931|66470167|FG000|Overall Study|Withdrawal by Subject|1|||
23751690|NCT00299546|66470168|FG000|Overall Study|Death|3|||
23751691|NCT00299546|66470169|FG001|Overall Study|Death|2|||
23751692|NCT00299546|66470170|FG002|Overall Study|Death|0|||
23751693|NCT00299546|66470168|FG000|Overall Study|Lost to Follow-up|2|||
23751694|NCT00299546|66470169|FG001|Overall Study|Lost to Follow-up|2|||
23751695|NCT00299546|66470170|FG002|Overall Study|Lost to Follow-up|5|||
23751696|NCT00299546|66470168|FG000|Overall Study|Adverse Event|37|||
23751697|NCT00299546|66470169|FG001|Overall Study|Adverse Event|22|||
23751698|NCT00299546|66470170|FG002|Overall Study|Adverse Event|27|||
23751699|NCT00299546|66470168|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
23751700|NCT00299546|66470169|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
23751701|NCT00299546|66470170|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
23751702|NCT00299546|66470168|FG000|Overall Study|Other|24|||
23751703|NCT00299546|66470169|FG001|Overall Study|Other|26|||
23751704|NCT00299546|66470170|FG002|Overall Study|Other|19|||
23751705|NCT00299546|66470168|FG000|Overall Study|Not treated|0|||
23751706|NCT00299546|66470169|FG001|Overall Study|Not treated|1|||
23751707|NCT00299546|66470170|FG002|Overall Study|Not treated|1|||
23751708|NCT00689273|66470175|FG000|Overall Study|Adverse Event|3|||
23751709|NCT00689273|66470176|FG001|Overall Study|Adverse Event|1|||
23751710|NCT00689273|66470175|FG000|Overall Study|Lack of Efficacy|3|||
23751711|NCT00689273|66470176|FG001|Overall Study|Lack of Efficacy|0|||
23751712|NCT00689273|66470175|FG000|Overall Study|Lost to Follow-up|0|||
23751713|NCT00689273|66470176|FG001|Overall Study|Lost to Follow-up|2|||
23751714|NCT00689273|66470175|FG000|Overall Study|Other|6|||
23751715|NCT00689273|66470176|FG001|Overall Study|Other|2|||
23751716|NCT00689273|66470175|FG000|Overall Study|Randomized but not Treated|1|||
23751717|NCT00689273|66470176|FG001|Overall Study|Randomized but not Treated|0|||
23751718|NCT00903409|66470180|FG000|Overall Study|Adverse Event|11|||
23751719|NCT00903409|66470181|FG001|Overall Study|Adverse Event|9|||
23751720|NCT00903409|66470180|FG000|Overall Study|Non-compliance with Protocol|1|||
23751721|NCT00903409|66470181|FG001|Overall Study|Non-compliance with Protocol|1|||
23751722|NCT00903409|66470180|FG000|Overall Study|Laboratory Abnormality|2|||
23751723|NCT00903409|66470181|FG001|Overall Study|Laboratory Abnormality|0|||
23751724|NCT00903409|66470180|FG000|Overall Study|Withdrawal by Subject|8|||
23435645|NCT01844778|65337134|FG000|Overall Study|Protocol deviation|0|||
23751725|NCT00903409|66470181|FG001|Overall Study|Withdrawal by Subject|8|||
23751726|NCT00903409|66470180|FG000|Overall Study|Other|2|||
23751727|NCT00903409|66470181|FG001|Overall Study|Other|3|||
23751728|NCT00903409|66470180|FG000|Overall Study|Lost to Follow-up|2|||
23751729|NCT00903409|66470181|FG001|Overall Study|Lost to Follow-up|6|||
23751730|NCT01473589|66470182|FG000|Overall Study|Adverse Event|1|||
23751731|NCT01473589|66470183|FG001|Overall Study|Adverse Event|1|||
23556810|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
23556811|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
23556812|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
23556813|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
23556814|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
23556815|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
23556816|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
23556817|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
23556818|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
23556819|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Other|0|||
23556820|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Other|1|||
23556821|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Other|1|||
23556822|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Other|0|||
23556823|NCT04162769|65765999|FG000|OLE Period (52-Week)|Adverse Event|0|||
23556824|NCT04162769|65766000|FG001|OLE Period (52-Week)|Adverse Event|0|||
23556825|NCT04162769|65766001|FG002|OLE Period (52-Week)|Adverse Event|0|||
23556826|NCT04162769|65766002|FG003|OLE Period (52-Week)|Adverse Event|5|||
23556827|NCT04162769|65765999|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556828|NCT04162769|65766000|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556829|NCT04162769|65766001|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556830|NCT04162769|65766002|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
23556831|NCT04162769|65765999|FG000|OLE Period (52-Week)|Physician Decision|0|||
23556832|NCT04162769|65766000|FG001|OLE Period (52-Week)|Physician Decision|0|||
23556833|NCT04162769|65766001|FG002|OLE Period (52-Week)|Physician Decision|0|||
23556834|NCT04162769|65766002|FG003|OLE Period (52-Week)|Physician Decision|1|||
23556835|NCT04162769|65765999|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
23556836|NCT04162769|65766000|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
23556837|NCT04162769|65766001|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
23556838|NCT04162769|65766002|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
23556839|NCT04162769|65765999|FG000|OLE Period (52-Week)|Protocol deviation|0|||
23556840|NCT04162769|65766000|FG001|OLE Period (52-Week)|Protocol deviation|0|||
23556841|NCT04162769|65766001|FG002|OLE Period (52-Week)|Protocol deviation|0|||
23556842|NCT04162769|65766002|FG003|OLE Period (52-Week)|Protocol deviation|2|||
23623584|NCT00488319|66008489|FG000|Overall Study|Other reasons for withdrawal|0|||
23623585|NCT00488319|66008490|FG001|Overall Study|Other reasons for withdrawal|4|||
23623586|NCT00488319|66008491|FG002|Overall Study|Other reasons for withdrawal|12|||
23623587|NCT00944229|66008492|FG000|Overall Study|Withdrawal by Subject|11|||
23623588|NCT00944229|66008492|FG000|Overall Study|Physician Decision|14|||
23623589|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
23751732|NCT01473589|66470182|FG000|Overall Study|Death|2|||
23751733|NCT01473589|66470183|FG001|Overall Study|Death|0|||
23751734|NCT01473589|66470182|FG000|Overall Study|Lost to Follow-up|2|||
23751735|NCT01473589|66470183|FG001|Overall Study|Lost to Follow-up|2|||
23751736|NCT01473589|66470182|FG000|Overall Study|Protocol Violation|1|||
23751737|NCT01473589|66470183|FG001|Overall Study|Protocol Violation|0|||
23751738|NCT01473589|66470182|FG000|Overall Study|Withdrawal by Subject|5|||
23751739|NCT01473589|66470183|FG001|Overall Study|Withdrawal by Subject|11|||
23751740|NCT01473589|66470182|FG000|Overall Study|Physician Decision|0|||
23751741|NCT01473589|66470183|FG001|Overall Study|Physician Decision|1|||
23751742|NCT01473589|66470182|FG000|Overall Study|Entry criteria not met|0|||
23751743|NCT01473589|66470183|FG001|Overall Study|Entry criteria not met|1|||
23751744|NCT03022799|66470184|FG000|Overall Study|Adverse Event|0|||
23751745|NCT03022799|66470185|FG001|Overall Study|Adverse Event|0|||
23751746|NCT03022799|66470186|FG002|Overall Study|Adverse Event|0|||
23751747|NCT03022799|66470187|FG003|Overall Study|Adverse Event|0|||
23751748|NCT03022799|66470188|FG004|Overall Study|Adverse Event|0|||
23751749|NCT03022799|66470189|FG005|Overall Study|Adverse Event|0|||
23751750|NCT03022799|66470190|FG006|Overall Study|Adverse Event|0|||
23751751|NCT03022799|66470191|FG007|Overall Study|Adverse Event|0|||
23751752|NCT03022799|66470192|FG008|Overall Study|Adverse Event|0|||
23751753|NCT03022799|66470193|FG009|Overall Study|Adverse Event|1|||
23751754|NCT03022799|66470194|FG010|Overall Study|Adverse Event|1|||
23751755|NCT03022799|66470195|FG011|Overall Study|Adverse Event|0|||
23556843|NCT04530448|65766003|FG000|Overall Study|Physician Decision|3|||
23751756|NCT03022799|66470196|FG012|Overall Study|Adverse Event|0|||
23751757|NCT03862807|66470203|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
23751758|NCT02780115|66470204|FG000|Overall Study|Withdrawal by Subject|0|||
23435646|NCT01844778|65337135|FG001|Overall Study|Protocol deviation|1|||
23435647|NCT01844778|65337136|FG002|Overall Study|Protocol deviation|2|||
23556844|NCT04530448|65766004|FG001|Overall Study|Physician Decision|0|||
23556845|NCT03496662|65766007|FG000|Overall Study|Adverse Event|1|||
23556846|NCT03496662|65766008|FG001|Overall Study|Adverse Event|0|||
23623590|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
23751759|NCT02780115|66470205|FG001|Overall Study|Withdrawal by Subject|1|||
23751760|NCT02780115|66470206|FG002|Overall Study|Withdrawal by Subject|1|||
23623591|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23623592|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
23623593|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
23623594|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
23623595|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23623596|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23623597|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23623598|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23623599|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23623600|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23623601|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
23623602|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
23556847|NCT03496662|65766009|FG002|Overall Study|Adverse Event|1|||
23556848|NCT03496662|65766007|FG000|Overall Study|Physician Decision|1|||
23556849|NCT03496662|65766008|FG001|Overall Study|Physician Decision|0|||
23556850|NCT03496662|65766009|FG002|Overall Study|Physician Decision|3|||
23556851|NCT03496662|65766007|FG000|Overall Study|Withdrawal by Subject|0|||
23556852|NCT03496662|65766008|FG001|Overall Study|Withdrawal by Subject|0|||
23556853|NCT03496662|65766009|FG002|Overall Study|Withdrawal by Subject|2|||
23556854|NCT03496662|65766007|FG000|Overall Study|Death|0|||
23556855|NCT03496662|65766008|FG001|Overall Study|Death|0|||
23556856|NCT03496662|65766009|FG002|Overall Study|Death|2|||
23556857|NCT03496662|65766007|FG000|Overall Study|Noncompliance|0|||
23556858|NCT03496662|65766008|FG001|Overall Study|Noncompliance|0|||
23556859|NCT03496662|65766009|FG002|Overall Study|Noncompliance|1|||
23556860|NCT04398537|65766010|FG000|Overall Study|Physician Decision|10|||
23556861|NCT04398537|65766011|FG001|Overall Study|Physician Decision|15|||
23556862|NCT04843930|65766017|FG000|Randomization|Withdrawal by Subject|6|||
23556863|NCT04843930|65766018|FG001|Randomization|Withdrawal by Subject|6|||
23556864|NCT04843930|65766019|FG002|Randomization|Withdrawal by Subject|0|||
23556865|NCT04843930|65766020|FG003|Randomization|Withdrawal by Subject|0|||
23556866|NCT04843930|65766017|FG000|Week 6 Assessment|Adverse Event|3|||
23556867|NCT04843930|65766018|FG001|Week 6 Assessment|Adverse Event|0|||
23556868|NCT04843930|65766019|FG002|Week 6 Assessment|Adverse Event|0|||
23556869|NCT04843930|65766020|FG003|Week 6 Assessment|Adverse Event|0|||
23556870|NCT04843930|65766017|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
23556871|NCT04843930|65766018|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
23556872|NCT04843930|65766019|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
23556873|NCT04843930|65766020|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
23556874|NCT04843930|65766017|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
23556875|NCT04843930|65766018|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
23556876|NCT04843930|65766019|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
23556877|NCT04843930|65766020|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
23556878|NCT03879408|65766021|FG000|Overall Study|Lost to Follow-up|0|||
23556879|NCT03879408|65766022|FG001|Overall Study|Lost to Follow-up|3|||
23556880|NCT03879408|65766023|FG002|Overall Study|Lost to Follow-up|2|||
23556881|NCT03879408|65766024|FG003|Overall Study|Lost to Follow-up|1|||
23556882|NCT03879408|65766025|FG004|Overall Study|Lost to Follow-up|0|||
23556883|NCT03879408|65766021|FG000|Overall Study|Withdrawal by Subject|2|||
23556884|NCT03879408|65766022|FG001|Overall Study|Withdrawal by Subject|1|||
23556885|NCT03879408|65766023|FG002|Overall Study|Withdrawal by Subject|1|||
23556886|NCT03879408|65766024|FG003|Overall Study|Withdrawal by Subject|0|||
23556887|NCT03879408|65766025|FG004|Overall Study|Withdrawal by Subject|1|||
23556888|NCT00089141|65766028|FG000|Overall Study|Termination of trial|18|||
23556889|NCT00089141|65766029|FG001|Overall Study|Termination of trial|24|||
23623603|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
23623604|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
23556890|NCT04535947|65766036|FG000|Overall Study|Adverse Event|1|||
23556891|NCT04535947|65766037|FG001|Overall Study|Adverse Event|4|||
23556892|NCT04535947|65766036|FG000|Overall Study|Other reasons not specified|2|||
23556893|NCT04535947|65766037|FG001|Overall Study|Other reasons not specified|0|||
23556894|NCT04535947|65766036|FG000|Overall Study|Withdrawal by Subject|1|||
23556895|NCT04535947|65766037|FG001|Overall Study|Withdrawal by Subject|1|||
23556896|NCT01357616|65766038|FG000|Overall Study|Adverse Event|1|||
23556897|NCT01357616|65766039|FG001|Overall Study|Adverse Event|1|||
23623605|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
23623606|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
23623607|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
23556898|NCT01357616|65766038|FG000|Overall Study|Lost to Follow-up|4|||
23556899|NCT01357616|65766039|FG001|Overall Study|Lost to Follow-up|3|||
23556900|NCT01357616|65766038|FG000|Overall Study|Protocol Violation|0|||
23556901|NCT01357616|65766039|FG001|Overall Study|Protocol Violation|2|||
23556902|NCT01357616|65766038|FG000|Overall Study|Inadequate Control of IOP|1|||
23556903|NCT01357616|65766039|FG001|Overall Study|Inadequate Control of IOP|2|||
23556904|NCT01357616|65766038|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
23556905|NCT01357616|65766039|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
23824934|NCT02443740|66737944|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
23824935|NCT02443740|66737945|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
23556906|NCT01357616|65766038|FG000|Overall Study|Withdrawal by Subject|1|||
23556907|NCT01357616|65766039|FG001|Overall Study|Withdrawal by Subject|0|||
23751761|NCT02780115|66470207|FG003|Overall Study|Withdrawal by Subject|0|||
23751762|NCT02780115|66470208|FG004|Overall Study|Withdrawal by Subject|0|||
23751763|NCT02780115|66470204|FG000|Overall Study|Adverse Event|0|||
23623608|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
23556908|NCT00558064|65766040|FG000|Overall Study|Adverse Event|3|||
23556909|NCT00558064|65766041|FG001|Overall Study|Adverse Event|2|||
23556910|NCT00558064|65766040|FG000|Overall Study|Lack of Efficacy|0|||
23556911|NCT00558064|65766041|FG001|Overall Study|Lack of Efficacy|1|||
23556912|NCT00558064|65766040|FG000|Overall Study|Protocol Violation|1|||
23556913|NCT00558064|65766041|FG001|Overall Study|Protocol Violation|0|||
23556914|NCT00558064|65766040|FG000|Overall Study|Lost to Follow-up|0|||
23556915|NCT00558064|65766041|FG001|Overall Study|Lost to Follow-up|1|||
23556916|NCT00558064|65766040|FG000|Overall Study|Withdrawal by Subject|0|||
23556917|NCT00558064|65766041|FG001|Overall Study|Withdrawal by Subject|1|||
23556918|NCT00558064|65766040|FG000|Overall Study|No visit within allowance period|1|||
23556919|NCT00558064|65766041|FG001|Overall Study|No visit within allowance period|0|||
23556920|NCT00119405|65766048|FG000|Overall Study|Withdrawal by Subject|1|||
23556921|NCT02658630|65766049|FG000|Overall Study|Withdrawal by Subject|4|||
23556922|NCT01433354|65766072|FG000|Overall Study|Adverse Event|6|||
23556923|NCT01433354|65766072|FG000|Overall Study|Lost to Follow-up|1|||
23556924|NCT01433354|65766072|FG000|Overall Study|Administrative problems|90|||
23623609|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
23623610|NCT02647645|66008503|FG000|Overall Study|Lost to Follow-up|2|||
23623611|NCT02647645|66008504|FG001|Overall Study|Lost to Follow-up|1|||
23623612|NCT00611715|66008505|FG000|Overall Study|Disease Progression|24|||
23623613|NCT00611715|66008506|FG001|Overall Study|Disease Progression|4|||
23623614|NCT00611715|66008505|FG000|Overall Study|Withdrawal by Subject|5|||
23623615|NCT00611715|66008506|FG001|Overall Study|Withdrawal by Subject|1|||
23623616|NCT00611715|66008505|FG000|Overall Study|Adverse Event|9|||
23623617|NCT00611715|66008506|FG001|Overall Study|Adverse Event|1|||
23623618|NCT00611715|66008505|FG000|Overall Study|Death|1|||
23751764|NCT02780115|66470205|FG001|Overall Study|Adverse Event|0|||
23751765|NCT02780115|66470206|FG002|Overall Study|Adverse Event|0|||
23751766|NCT02780115|66470207|FG003|Overall Study|Adverse Event|1|||
23751767|NCT02780115|66470208|FG004|Overall Study|Adverse Event|1|||
23751768|NCT03099161|66470209|FG000|Overall Study|Adverse Event|0|||
23751769|NCT03099161|66470210|FG001|Overall Study|Adverse Event|0|||
23751770|NCT03099161|66470211|FG002|Overall Study|Adverse Event|2|||
23751771|NCT03099161|66470209|FG000|Overall Study|Physician Decision|2|||
23751772|NCT03099161|66470210|FG001|Overall Study|Physician Decision|0|||
23751773|NCT03099161|66470211|FG002|Overall Study|Physician Decision|0|||
23751774|NCT03099161|66470209|FG000|Overall Study|Progressive Disease|1|||
23751775|NCT03099161|66470210|FG001|Overall Study|Progressive Disease|4|||
23751776|NCT03099161|66470211|FG002|Overall Study|Progressive Disease|1|||
23751777|NCT03867500|66470212|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
23751778|NCT00391118|66470216|FG000|Overall Study|Adverse Event|3|||
23751779|NCT00391118|66470217|FG001|Overall Study|Adverse Event|10|||
23751780|NCT00391118|66470218|FG002|Overall Study|Adverse Event|7|||
23751781|NCT00391118|66470216|FG000|Overall Study|Lost to Follow-up|0|||
23751782|NCT00391118|66470217|FG001|Overall Study|Lost to Follow-up|2|||
23751783|NCT00391118|66470218|FG002|Overall Study|Lost to Follow-up|3|||
23751784|NCT00391118|66470216|FG000|Overall Study|Withdrawal by Subject|0|||
23751785|NCT00391118|66470217|FG001|Overall Study|Withdrawal by Subject|9|||
23751786|NCT00391118|66470218|FG002|Overall Study|Withdrawal by Subject|1|||
23751787|NCT00391118|66470216|FG000|Overall Study|Death|0|||
23751788|NCT00391118|66470217|FG001|Overall Study|Death|1|||
23556925|NCT01433354|65766072|FG000|Overall Study|Protocol Violation|2|||
23556926|NCT01433354|65766072|FG000|Overall Study|Lack of Efficacy|17|||
23556927|NCT01433354|65766072|FG000|Overall Study|Subject Withdrew Consent|3|||
23623619|NCT00611715|66008506|FG001|Overall Study|Death|0|||
23623620|NCT00611715|66008505|FG000|Overall Study|two patients are still on treatment|2|||
23751789|NCT00391118|66470218|FG002|Overall Study|Death|0|||
23751790|NCT00391118|66470216|FG000|Overall Study|Physician Decision|0|||
23751791|NCT00391118|66470217|FG001|Overall Study|Physician Decision|3|||
23556928|NCT02089230|65766080|FG000|Overall Study|Death|0|||
23556929|NCT02089230|65766081|FG001|Overall Study|Death|0|||
23556930|NCT02089230|65766082|FG002|Overall Study|Death|2|||
23556931|NCT02089230|65766080|FG000|Overall Study|Seeking Alternative Therapy|0|||
23556932|NCT02089230|65766081|FG001|Overall Study|Seeking Alternative Therapy|0|||
23751792|NCT00391118|66470218|FG002|Overall Study|Physician Decision|0|||
23751793|NCT00391118|66470216|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
23751794|NCT00391118|66470217|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
23751795|NCT00391118|66470218|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
23751796|NCT00391118|66470216|FG000|Overall Study|Progressive Disease|7|||
23556933|NCT02089230|65766082|FG002|Overall Study|Seeking Alternative Therapy|4|||
23556934|NCT04465357|65766083|FG000|Overall Study|Adverse Event|2|||
23556935|NCT04465357|65766083|FG000|Overall Study|Lack of Efficacy|1|||
23556936|NCT04465357|65766083|FG000|Overall Study|Lost to Follow-up|2|||
23556937|NCT04465357|65766083|FG000|Overall Study|Withdrawal by Subject|6|||
23556938|NCT04465357|65766083|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
23556939|NCT00441701|65766084|FG000|Overall Study|Adverse Event|3|||
23556940|NCT00441701|65766085|FG001|Overall Study|Adverse Event|2|||
23556941|NCT00441701|65766086|FG002|Overall Study|Adverse Event|1|||
23556942|NCT00441701|65766087|FG003|Overall Study|Adverse Event|0|||
23556943|NCT00441701|65766088|FG004|Overall Study|Adverse Event|2|||
23556944|NCT00441701|65766089|FG005|Overall Study|Adverse Event|2|||
23556945|NCT00441701|65766090|FG006|Overall Study|Adverse Event|0|||
23556946|NCT00441701|65766091|FG007|Overall Study|Adverse Event|0|||
23556947|NCT00441701|65766092|FG008|Overall Study|Adverse Event|0|||
23556948|NCT00441701|65766093|FG009|Overall Study|Adverse Event|0|||
23556949|NCT00441701|65766084|FG000|Overall Study|Lack of Efficacy|2|||
23556950|NCT00441701|65766085|FG001|Overall Study|Lack of Efficacy|0|||
23556951|NCT00441701|65766086|FG002|Overall Study|Lack of Efficacy|2|||
23556952|NCT00441701|65766087|FG003|Overall Study|Lack of Efficacy|2|||
23556953|NCT00441701|65766088|FG004|Overall Study|Lack of Efficacy|0|||
23556954|NCT00441701|65766089|FG005|Overall Study|Lack of Efficacy|1|||
23556955|NCT00441701|65766090|FG006|Overall Study|Lack of Efficacy|0|||
23556956|NCT00441701|65766091|FG007|Overall Study|Lack of Efficacy|0|||
23556957|NCT00441701|65766092|FG008|Overall Study|Lack of Efficacy|0|||
23556958|NCT00441701|65766093|FG009|Overall Study|Lack of Efficacy|0|||
23556959|NCT00441701|65766084|FG000|Overall Study|Withdrawal by Subject|0|||
23556960|NCT00441701|65766085|FG001|Overall Study|Withdrawal by Subject|2|||
23556961|NCT00441701|65766086|FG002|Overall Study|Withdrawal by Subject|1|||
23556962|NCT00441701|65766087|FG003|Overall Study|Withdrawal by Subject|1|||
23623621|NCT00611715|66008506|FG001|Overall Study|two patients are still on treatment|0|||
23623622|NCT01841112|66008507|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
23623623|NCT01841112|66008508|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
23623624|NCT01841112|66008509|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
23623625|NCT01841112|66008510|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
23623626|NCT01841112|66008511|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
23623627|NCT03561597|66008512|FG000|Overall Study|Lost to Follow-up|20|||
23623628|NCT02250534|66008513|FG000|Overall Study|Lost to Follow-up|18|||
23623629|NCT02250534|66008514|FG001|Overall Study|Lost to Follow-up|28|||
23623630|NCT02250534|66008515|FG002|Overall Study|Lost to Follow-up|33|||
23623631|NCT02250534|66008513|FG000|Overall Study|Personal reasons|7|||
23623632|NCT02250534|66008514|FG001|Overall Study|Personal reasons|8|||
23623633|NCT02250534|66008515|FG002|Overall Study|Personal reasons|14|||
23623634|NCT02250534|66008513|FG000|Overall Study|Adverse Event|6|||
23623635|NCT02250534|66008514|FG001|Overall Study|Adverse Event|3|||
23623636|NCT02250534|66008515|FG002|Overall Study|Adverse Event|8|||
23623637|NCT02250534|66008513|FG000|Overall Study|incarcerated|2|||
23623638|NCT02250534|66008514|FG001|Overall Study|incarcerated|1|||
23623639|NCT02250534|66008515|FG002|Overall Study|incarcerated|2|||
23623640|NCT02250534|66008513|FG000|Overall Study|Withdrawal by Subject|0|||
23623641|NCT02250534|66008514|FG001|Overall Study|Withdrawal by Subject|1|||
23623642|NCT02250534|66008515|FG002|Overall Study|Withdrawal by Subject|2|||
23623643|NCT02250534|66008513|FG000|Overall Study|Death|0|||
23623644|NCT02250534|66008514|FG001|Overall Study|Death|1|||
23623645|NCT02250534|66008515|FG002|Overall Study|Death|1|||
23623646|NCT02250534|66008513|FG000|Overall Study|Physician Decision|1|||
23623647|NCT02250534|66008514|FG001|Overall Study|Physician Decision|3|||
23623648|NCT02250534|66008515|FG002|Overall Study|Physician Decision|1|||
23623649|NCT02250534|66008513|FG000|Overall Study|Protocol Violation|1|||
23824936|NCT02443740|66737935|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
23824937|NCT02443740|66737936|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824938|NCT02443740|66737937|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824939|NCT02443740|66737938|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824940|NCT02443740|66737939|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824941|NCT02443740|66737940|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824942|NCT02443740|66737941|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
23623650|NCT02250534|66008514|FG001|Overall Study|Protocol Violation|0|||
23623651|NCT02250534|66008515|FG002|Overall Study|Protocol Violation|1|||
23623652|NCT02250534|66008513|FG000|Overall Study|Reason unknown|1|||
23824943|NCT02443740|66737942|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23556963|NCT00441701|65766088|FG004|Overall Study|Withdrawal by Subject|0|||
23556964|NCT00441701|65766089|FG005|Overall Study|Withdrawal by Subject|0|||
23556965|NCT00441701|65766090|FG006|Overall Study|Withdrawal by Subject|0|||
23556966|NCT00441701|65766091|FG007|Overall Study|Withdrawal by Subject|0|||
23556967|NCT00441701|65766092|FG008|Overall Study|Withdrawal by Subject|0|||
23556968|NCT00441701|65766093|FG009|Overall Study|Withdrawal by Subject|0|||
23556969|NCT02279043|65766094|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
23556970|NCT02279043|65766095|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
23824944|NCT02443740|66737943|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824945|NCT02443740|66737944|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824946|NCT02443740|66737945|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23824947|NCT02443740|66737935|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824948|NCT02443740|66737936|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824949|NCT02443740|66737937|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824950|NCT02443740|66737938|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824951|NCT02443740|66737939|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824952|NCT02443740|66737940|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
23824953|NCT02443740|66737941|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824954|NCT02443740|66737942|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824955|NCT02443740|66737943|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824956|NCT02443740|66737944|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824957|NCT02443740|66737945|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23824958|NCT02723344|66741377|FG000|Overall Study|Lost to Follow-up|0|||
23824959|NCT02723344|66741378|FG001|Overall Study|Lost to Follow-up|4|||
23824960|NCT01807065|66741379|FG000|Overall Study|Receive no sip-T due to IV access|1|||
23824961|NCT01807065|66741380|FG001|Overall Study|Receive no sip-T due to IV access|1|||
23824962|NCT01228019|66741382|FG000|Overall Study|Dose Violation|70|||
23824963|NCT01228019|66741382|FG000|Overall Study|Duplicate enrollment|1|||
23824964|NCT01228019|66741382|FG000|Overall Study|Missing pre-treatment data|72|||
23824965|NCT01228019|66741382|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
23824966|NCT01228019|66741382|FG000|Overall Study|Violation of Entry Criterion|9|||
23824967|NCT03203473|66741384|FG000|Induction Phase|Never started primary treatment|2|||
23824968|NCT03203473|66741385|FG001|Induction Phase|Never started primary treatment|0|||
23824969|NCT03203473|66741386|FG002|Induction Phase|Never started primary treatment|0|||
23824970|NCT03203473|66741384|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
23824971|NCT03203473|66741385|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
23824972|NCT03203473|66741386|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
23824973|NCT03203473|66741384|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
23824974|NCT03203473|66741385|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
23824975|NCT03203473|66741386|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
23824976|NCT03203473|66741384|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
23824977|NCT03203473|66741385|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
23824978|NCT03203473|66741386|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
23824979|NCT03203473|66741384|FG000|Arm Allocation Phase|started salvage therapy|0|||
23824980|NCT03203473|66741385|FG001|Arm Allocation Phase|started salvage therapy|5|||
23824981|NCT03203473|66741386|FG002|Arm Allocation Phase|started salvage therapy|0|||
23824982|NCT03203473|66741384|FG000|Arm Allocation Phase|Disease progression|0|||
23824983|NCT03203473|66741385|FG001|Arm Allocation Phase|Disease progression|0|||
23824984|NCT03203473|66741386|FG002|Arm Allocation Phase|Disease progression|37|||
23824985|NCT03203473|66741384|FG000|Arm Allocation Phase|Adverse Event|0|||
23824986|NCT03203473|66741385|FG001|Arm Allocation Phase|Adverse Event|0|||
23824987|NCT03203473|66741386|FG002|Arm Allocation Phase|Adverse Event|11|||
23824988|NCT03203473|66741384|FG000|Arm Allocation Phase|Physician Decision|0|||
23824989|NCT03203473|66741385|FG001|Arm Allocation Phase|Physician Decision|0|||
23824990|NCT03203473|66741386|FG002|Arm Allocation Phase|Physician Decision|3|||
23824991|NCT03203473|66741384|FG000|Arm Allocation Phase|Death|0|||
23824992|NCT03203473|66741385|FG001|Arm Allocation Phase|Death|0|||
23824993|NCT03203473|66741386|FG002|Arm Allocation Phase|Death|1|||
23824994|NCT03203473|66741384|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
23824995|NCT03203473|66741385|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
23824996|NCT03203473|66741386|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
23824997|NCT03203473|66741384|FG000|Arm Allocation Phase|Intercurrent illness|0|||
23824998|NCT03203473|66741385|FG001|Arm Allocation Phase|Intercurrent illness|0|||
23824999|NCT03203473|66741386|FG002|Arm Allocation Phase|Intercurrent illness|1|||
23825000|NCT03203473|66741384|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
23825001|NCT03203473|66741385|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
23825002|NCT03203473|66741386|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
23825003|NCT01275729|66741387|FG000|Overall Study|Death|3|||
23825004|NCT01275729|66741387|FG000|Overall Study|Withdrawal by Subject|1|||
23825005|NCT01610492|66741388|FG000|Overall Study|Adverse Event|1|||
23825006|NCT01610492|66741388|FG000|Overall Study|Lack of Efficacy|3|||
23825007|NCT01610492|66741388|FG000|Overall Study|Other: Reached stopping criteria|1|||
23825008|NCT01610492|66741388|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
23825009|NCT02508935|66741390|FG000|Overall Study|Withdrawal by Subject|1|||
23825010|NCT02508935|66741390|FG000|Overall Study|Withdrawal by Caregiver|8|||
23825011|NCT02508935|66741390|FG000|Overall Study|Pain Score <4|1|||
23825012|NCT02508935|66741390|FG000|Overall Study|Emesis|3|||
23825013|NCT02508935|66741390|FG000|Overall Study|Adverse Event|3|||
23825014|NCT02508935|66741390|FG000|Overall Study|Protocol Violation|1|||
23825015|NCT02508935|66741390|FG000|Overall Study|Physician Decision|1|||
23435648|NCT01844778|65337134|FG000|Overall Study|Withdrawal by Subject|2|||
23435649|NCT01844778|65337135|FG001|Overall Study|Withdrawal by Subject|0|||
23556971|NCT02279043|65766096|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
23556972|NCT02279043|65766094|FG000|Overall Study|Lost to Follow-up|46|||
23556973|NCT02279043|65766095|FG001|Overall Study|Lost to Follow-up|88|||
23556974|NCT02279043|65766096|FG002|Overall Study|Lost to Follow-up|0|||
23556975|NCT00003508|65766097|FG000|Overall Study|Not evaluable|5|||
23556976|NCT05899686|65766098|FG000|Overall Study|Protocol Violation|1|||
23556977|NCT02709005|65766099|FG000|Overall Study|Lost to Follow-up|1|||
23556978|NCT02709005|65766100|FG001|Overall Study|Lost to Follow-up|1|||
23556979|NCT02709005|65766099|FG000|Overall Study|Withdrawal by Subject|3|||
23556980|NCT02709005|65766100|FG001|Overall Study|Withdrawal by Subject|0|||
23556981|NCT04477187|65766101|FG000|Overall Study|Lost to Follow-up|2|||
23556982|NCT00445679|65766104|FG000|Overall Study|Adverse Event|22|||
23623653|NCT02250534|66008514|FG001|Overall Study|Reason unknown|0|||
23623654|NCT02250534|66008515|FG002|Overall Study|Reason unknown|0|||
23751797|NCT00391118|66470217|FG001|Overall Study|Progressive Disease|26|||
23751798|NCT00391118|66470218|FG002|Overall Study|Progressive Disease|43|||
23751799|NCT00391118|66470216|FG000|Overall Study|Sponsor Decision|0|||
23751800|NCT00391118|66470217|FG001|Overall Study|Sponsor Decision|1|||
23751801|NCT00391118|66470218|FG002|Overall Study|Sponsor Decision|3|||
23751802|NCT00391118|66470216|FG000|Overall Study|Protocol Violation|1|||
23751803|NCT00391118|66470217|FG001|Overall Study|Protocol Violation|0|||
23751804|NCT00391118|66470218|FG002|Overall Study|Protocol Violation|0|||
23751805|NCT00916617|66470219|FG000|Overall Study|Adverse Event|3|||
23751806|NCT00916617|66470220|FG001|Overall Study|Adverse Event|2|||
23751807|NCT00916617|66470221|FG002|Overall Study|Adverse Event|6|||
23751808|NCT00916617|66470222|FG003|Overall Study|Adverse Event|3|||
23751809|NCT00916617|66470219|FG000|Overall Study|Withdrawal by Subject|3|||
23751810|NCT00916617|66470220|FG001|Overall Study|Withdrawal by Subject|2|||
23751811|NCT00916617|66470221|FG002|Overall Study|Withdrawal by Subject|0|||
23751812|NCT00916617|66470222|FG003|Overall Study|Withdrawal by Subject|1|||
23751813|NCT00916617|66470219|FG000|Overall Study|Caregiver Request|3|||
23751814|NCT00916617|66470220|FG001|Overall Study|Caregiver Request|2|||
23751815|NCT00916617|66470221|FG002|Overall Study|Caregiver Request|1|||
23751816|NCT00916617|66470222|FG003|Overall Study|Caregiver Request|0|||
23751817|NCT00916617|66470219|FG000|Overall Study|Physician Decision|1|||
23751818|NCT00916617|66470220|FG001|Overall Study|Physician Decision|1|||
23751819|NCT00916617|66470221|FG002|Overall Study|Physician Decision|0|||
23751820|NCT00916617|66470222|FG003|Overall Study|Physician Decision|0|||
23751821|NCT00916617|66470219|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
23751822|NCT00916617|66470220|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
23751823|NCT00916617|66470221|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
23751824|NCT00916617|66470222|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
23751825|NCT00916617|66470219|FG000|Overall Study|Lost to Follow-up|2|||
23751826|NCT00916617|66470220|FG001|Overall Study|Lost to Follow-up|1|||
23751827|NCT00916617|66470221|FG002|Overall Study|Lost to Follow-up|0|||
23751828|NCT00916617|66470222|FG003|Overall Study|Lost to Follow-up|0|||
23751829|NCT00916617|66470219|FG000|Overall Study|Lack of Efficacy|1|||
23751830|NCT00916617|66470220|FG001|Overall Study|Lack of Efficacy|0|||
23751831|NCT00916617|66470221|FG002|Overall Study|Lack of Efficacy|0|||
23751832|NCT00916617|66470222|FG003|Overall Study|Lack of Efficacy|0|||
23751833|NCT00916617|66470219|FG000|Overall Study|Other|2|||
23751834|NCT00916617|66470220|FG001|Overall Study|Other|0|||
23751835|NCT00916617|66470221|FG002|Overall Study|Other|0|||
23751836|NCT00916617|66470222|FG003|Overall Study|Other|2|||
23751837|NCT02803138|66470223|FG000|Overall Study|Failure to return|38|||
23751838|NCT02803138|66470223|FG000|Overall Study|Insufficient virological response|2|||
23751839|NCT02803138|66470223|FG000|Overall Study|Withdrawn consent|1|||
23751840|NCT02803138|66470223|FG000|Overall Study|Death|1|||
23751841|NCT02803138|66470223|FG000|Overall Study|Other, not specified|28|||
23751842|NCT00038467|66470225|FG000|Overall Study|Adverse Event|170|||
23751843|NCT00038467|66470226|FG001|Overall Study|Adverse Event|145|||
23751844|NCT00038467|66470225|FG000|Overall Study|Withdrawal by Subject|150|||
23751845|NCT00038467|66470226|FG001|Overall Study|Withdrawal by Subject|107|||
23751846|NCT00038467|66470225|FG000|Overall Study|Protocol Violation|19|||
23751847|NCT00038467|66470226|FG001|Overall Study|Protocol Violation|22|||
23751848|NCT00038467|66470225|FG000|Overall Study|Death|22|||
23751849|NCT00038467|66470226|FG001|Overall Study|Death|16|||
23751850|NCT00038467|66470225|FG000|Overall Study|Lost to Follow-up|15|||
23825016|NCT02508935|66741390|FG000|Overall Study|Trial terminated by sponsor|5|||
23556983|NCT00445679|65766105|FG001|Overall Study|Adverse Event|12|||
23556984|NCT00445679|65766106|FG002|Overall Study|Adverse Event|30|||
23556985|NCT00445679|65766107|FG003|Overall Study|Adverse Event|19|||
23751851|NCT00038467|66470226|FG001|Overall Study|Lost to Follow-up|10|||
23751852|NCT00038467|66470225|FG000|Overall Study|Recurrence|109|||
23751853|NCT00038467|66470226|FG001|Overall Study|Recurrence|179|||
23751854|NCT00038467|66470225|FG000|Overall Study|Randomized, but not treated|31|||
23751855|NCT00038467|66470226|FG001|Overall Study|Randomized, but not treated|35|||
23751856|NCT00038467|66470225|FG000|Overall Study|Other|26|||
23751857|NCT00038467|66470226|FG001|Overall Study|Other|28|||
23751858|NCT01017731|66470229|FG000|Overall Study|Lost to Follow-up|2|||
23751859|NCT01017731|66470229|FG000|Overall Study|Withdrawal by Subject|3|||
23751860|NCT01017731|66470229|FG000|Overall Study|Physician Decision|2|||
23751861|NCT01017731|66470229|FG000|Overall Study|Adverse Event|1|||
23751862|NCT00530088|66470231|FG000|Overall Study|Disease Progression|4|||
23751863|NCT00530088|66470231|FG000|Overall Study|Physician Decision|4|||
23751864|NCT00530088|66470231|FG000|Overall Study|Other Not Specified|2|||
23556986|NCT00445679|65766104|FG000|Overall Study|Failed to return|1|||
23556987|NCT00445679|65766105|FG001|Overall Study|Failed to return|3|||
23435650|NCT01844778|65337136|FG002|Overall Study|Withdrawal by Subject|0|||
23556988|NCT00445679|65766106|FG002|Overall Study|Failed to return|2|||
23556989|NCT00445679|65766107|FG003|Overall Study|Failed to return|2|||
23556990|NCT00445679|65766104|FG000|Overall Study|Physician Decision|0|||
23556991|NCT00445679|65766105|FG001|Overall Study|Physician Decision|0|||
23751865|NCT01266642|66470232|FG000|Overall Study|Protocol Violation|0|||
23751866|NCT01266642|66470233|FG001|Overall Study|Protocol Violation|1|||
23751867|NCT02204449|66470234|FG000|Overall Study|Lost to Follow-up|7|||
23751868|NCT02204449|66470235|FG001|Overall Study|Lost to Follow-up|9|||
23751869|NCT02204449|66470234|FG000|Overall Study|Death|0|||
23751870|NCT02204449|66470235|FG001|Overall Study|Death|1|||
23751871|NCT02204449|66470234|FG000|Overall Study|Withdrawal by Subject|0|||
23825017|NCT03905694|66741391|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
23825018|NCT01245283|66741392|FG000|Overall Study|Lost to Follow-up|14|||
23825019|NCT01245283|66741393|FG001|Overall Study|Lost to Follow-up|11|||
23825020|NCT01245283|66741394|FG002|Overall Study|Lost to Follow-up|11|||
23825021|NCT01133067|66741395|FG000|Overall Study|Death|136|||
23825022|NCT01133067|66741395|FG000|Overall Study|Lost to Follow-up|3|||
23825023|NCT02245412|66741396|FG000|Treatment Period|Death|1|||
23825024|NCT02245412|66741397|FG001|Treatment Period|Death|1|||
23825025|NCT02245412|66741398|FG002|Treatment Period|Death|0|||
23825026|NCT02245412|66741396|FG000|Treatment Period|Physician Decision|1|||
23825027|NCT02245412|66741397|FG001|Treatment Period|Physician Decision|1|||
23825028|NCT02245412|66741398|FG002|Treatment Period|Physician Decision|0|||
23825029|NCT02245412|66741396|FG000|Treatment Period|Withdrawal by Subject|2|||
23825030|NCT02245412|66741397|FG001|Treatment Period|Withdrawal by Subject|1|||
23825031|NCT02245412|66741398|FG002|Treatment Period|Withdrawal by Subject|0|||
23825032|NCT02245412|66741396|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
23825033|NCT02245412|66741397|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
23825034|NCT02245412|66741398|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
23825035|NCT02245412|66741396|FG000|Follow-Up Period|Death|4|||
23825036|NCT02245412|66741397|FG001|Follow-Up Period|Death|2|||
23825037|NCT02245412|66741398|FG002|Follow-Up Period|Death|1|||
23825038|NCT02245412|66741396|FG000|Follow-Up Period|Physician Decision|1|||
23825039|NCT02245412|66741397|FG001|Follow-Up Period|Physician Decision|0|||
23825040|NCT02245412|66741398|FG002|Follow-Up Period|Physician Decision|0|||
23825041|NCT02245412|66741396|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
23825042|NCT02245412|66741397|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
23825043|NCT02245412|66741398|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
23825044|NCT03908437|66741399|FG000|Overall Study|Death|0|||
23825045|NCT03908437|66741400|FG001|Overall Study|Death|1|||
23825046|NCT03908437|66741399|FG000|Overall Study|Lost to Follow-up|31|||
23825047|NCT03908437|66741400|FG001|Overall Study|Lost to Follow-up|24|||
23825048|NCT04841577|66741401|FG000|Overall Study|Adverse Event|5|||
23825049|NCT04841577|66741402|FG001|Overall Study|Adverse Event|10|||
23825050|NCT04841577|66741401|FG000|Overall Study|Lost to Follow-up|8|||
23825051|NCT04841577|66741402|FG001|Overall Study|Lost to Follow-up|7|||
23825052|NCT04841577|66741401|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23825053|NCT04841577|66741402|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
23825054|NCT04841577|66741401|FG000|Overall Study|Other|0|||
23825055|NCT04841577|66741402|FG001|Overall Study|Other|1|||
23435651|NCT01844778|65337134|FG000|Overall Study|Adverse Event|0|||
23435652|NCT01844778|65337135|FG001|Overall Study|Adverse Event|2|||
23435653|NCT01844778|65337136|FG002|Overall Study|Adverse Event|2|||
23556992|NCT00445679|65766106|FG002|Overall Study|Physician Decision|1|||
23556993|NCT00445679|65766107|FG003|Overall Study|Physician Decision|0|||
23556994|NCT00445679|65766104|FG000|Overall Study|Lost to Follow-up|10|||
23556995|NCT00445679|65766105|FG001|Overall Study|Lost to Follow-up|6|||
23556996|NCT00445679|65766106|FG002|Overall Study|Lost to Follow-up|6|||
23556997|NCT00445679|65766107|FG003|Overall Study|Lost to Follow-up|5|||
23556998|NCT00445679|65766104|FG000|Overall Study|Compliance|3|||
23556999|NCT00445679|65766105|FG001|Overall Study|Compliance|2|||
23557000|NCT00445679|65766106|FG002|Overall Study|Compliance|1|||
23557001|NCT00445679|65766107|FG003|Overall Study|Compliance|2|||
23557002|NCT00445679|65766104|FG000|Overall Study|Withdrawal of Informed Consent|0|||
23557003|NCT00445679|65766105|FG001|Overall Study|Withdrawal of Informed Consent|0|||
23557004|NCT00445679|65766106|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23825056|NCT01197911|66741405|FG000|Overall Study|Adverse Event|0|||
23825057|NCT01197911|66741406|FG001|Overall Study|Adverse Event|0|||
23825058|NCT01197911|66741407|FG002|Overall Study|Adverse Event|1|||
23825059|NCT00098774|66741408|FG000|Overall Study|Adverse Event|2|||
23751872|NCT02204449|66470235|FG001|Overall Study|Withdrawal by Subject|1|||
23751873|NCT00297882|66470236|FG000|Day 14|Lack of Efficacy|12|||
23751874|NCT00297882|66470237|FG001|Day 14|Lack of Efficacy|49|||
23751875|NCT00297882|66470236|FG000|Day 28|Lost to Follow-up|13|||
23751876|NCT00297882|66470237|FG001|Day 28|Lost to Follow-up|23|||
23751877|NCT00297882|66470236|FG000|Day 28|Lack of Efficacy|3|||
23751878|NCT00297882|66470237|FG001|Day 28|Lack of Efficacy|0|||
23751879|NCT00320801|66470240|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
23751880|NCT00320801|66470241|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23751881|NCT00320801|66470242|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23751882|NCT00320801|66470243|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
23751883|NCT00320801|66470240|FG000|Open-label Run-in Period|Adverse Event|33|||
23751884|NCT00320801|66470241|FG001|Open-label Run-in Period|Adverse Event|0|||
23751885|NCT00320801|66470242|FG002|Open-label Run-in Period|Adverse Event|0|||
23751886|NCT00320801|66470243|FG003|Open-label Run-in Period|Adverse Event|0|||
23751887|NCT00320801|66470240|FG000|Open-label Run-in Period|Administrative|10|||
23751888|NCT00320801|66470241|FG001|Open-label Run-in Period|Administrative|0|||
23825060|NCT00098774|66741408|FG000|Overall Study|Disease Progression|9|||
23825061|NCT00098774|66741408|FG000|Overall Study|Withdrawal by Subject|1|||
23751889|NCT00320801|66470242|FG002|Open-label Run-in Period|Administrative|0|||
23751890|NCT00320801|66470243|FG003|Open-label Run-in Period|Administrative|0|||
23751891|NCT00320801|66470240|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
23751892|NCT00320801|66470241|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23751893|NCT00320801|66470242|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23751894|NCT00320801|66470243|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
23825062|NCT00098774|66741408|FG000|Overall Study|Failed (to respond) during induction|4|||
23825063|NCT00098774|66741408|FG000|Overall Study|Physician Decision|2|||
23825064|NCT00100828|66741409|FG000|Overall Study|Physician Decision|6|||
23825065|NCT04113018|66741410|FG000|Overall Study|Death|2|||
23825066|NCT04113018|66741410|FG000|Overall Study|Lost to Follow-up|1|||
23825067|NCT04113018|66741410|FG000|Overall Study|Still On Study (on study treatment)|24|||
23825068|NCT04113018|66741410|FG000|Overall Study|Still On Study (in follow up)|12|||
23825069|NCT02533180|66741411|FG000|Overall Study|Death|0|||
23825070|NCT02533180|66741412|FG001|Overall Study|Death|2|||
23825071|NCT02533180|66741411|FG000|Overall Study|Lost to Follow-up|0|||
23825072|NCT02533180|66741412|FG001|Overall Study|Lost to Follow-up|1|||
23557005|NCT00445679|65766107|FG003|Overall Study|Withdrawal of Informed Consent|0|||
23623655|NCT02506881|66008517|FG000|First Intervention (Day 1)|Protocol Violation|0|||
23623656|NCT02506881|66008518|FG001|First Intervention (Day 1)|Protocol Violation|0|||
23623657|NCT02506881|66008519|FG002|First Intervention (Day 1)|Protocol Violation|1|||
23623658|NCT02506881|66008520|FG003|First Intervention (Day 1)|Protocol Violation|0|||
23623659|NCT02506881|66008517|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23623660|NCT02506881|66008518|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623661|NCT02506881|66008519|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623662|NCT02506881|66008520|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623663|NCT02506881|66008517|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
23623664|NCT02506881|66008518|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
23751895|NCT00320801|66470240|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
23751896|NCT00320801|66470241|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23751897|NCT00320801|66470242|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23825073|NCT02533180|66741411|FG000|Overall Study|Physician Decision|0|||
23825074|NCT02533180|66741412|FG001|Overall Study|Physician Decision|1|||
23557006|NCT00445679|65766104|FG000|Overall Study|Protocol Violation|2|||
23557007|NCT00445679|65766105|FG001|Overall Study|Protocol Violation|3|||
23557008|NCT00445679|65766106|FG002|Overall Study|Protocol Violation|3|||
23557009|NCT00445679|65766107|FG003|Overall Study|Protocol Violation|1|||
23557010|NCT00445679|65766104|FG000|Overall Study|Withdrawal by Subject|8|||
23557011|NCT00445679|65766105|FG001|Overall Study|Withdrawal by Subject|14|||
23557012|NCT00445679|65766106|FG002|Overall Study|Withdrawal by Subject|20|||
23557013|NCT00445679|65766107|FG003|Overall Study|Withdrawal by Subject|18|||
23623665|NCT02506881|66008519|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
23825075|NCT02533180|66741411|FG000|Overall Study|Withdrawal by Subject|2|||
23825076|NCT02533180|66741412|FG001|Overall Study|Withdrawal by Subject|5|||
23825077|NCT02533180|66741411|FG000|Overall Study|Screen Failure|37|||
23825078|NCT02533180|66741412|FG001|Overall Study|Screen Failure|0|||
23623666|NCT02506881|66008520|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
23751898|NCT00320801|66470243|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
23825079|NCT02533180|66741411|FG000|Overall Study|Protocol Deviation|0|||
23825080|NCT02533180|66741412|FG001|Overall Study|Protocol Deviation|1|||
23825081|NCT02533180|66741411|FG000|Overall Study|Non-compliance|0|||
23557014|NCT00445679|65766104|FG000|Overall Study|Lack of Efficacy|2|||
23557015|NCT00445679|65766105|FG001|Overall Study|Lack of Efficacy|6|||
23751899|NCT00320801|66470240|FG000|Open-label Run-in Period|Did not qualify|1|||
23751900|NCT00320801|66470241|FG001|Open-label Run-in Period|Did not qualify|0|||
23751901|NCT00320801|66470242|FG002|Open-label Run-in Period|Did not qualify|0|||
23751902|NCT00320801|66470243|FG003|Open-label Run-in Period|Did not qualify|0|||
23751903|NCT00320801|66470240|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23751904|NCT00320801|66470241|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23751905|NCT00320801|66470242|FG002|Double-blind Phase|Withdrawal by Subject|1|||
23751906|NCT00320801|66470243|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23751907|NCT00320801|66470240|FG000|Double-blind Phase|Adverse Event|0|||
23751908|NCT00320801|66470241|FG001|Double-blind Phase|Adverse Event|2|||
23751909|NCT00320801|66470242|FG002|Double-blind Phase|Adverse Event|8|||
23751910|NCT00320801|66470243|FG003|Double-blind Phase|Adverse Event|0|||
23751911|NCT00320801|66470240|FG000|Double-blind Phase|Administrative|0|||
23751912|NCT00320801|66470241|FG001|Double-blind Phase|Administrative|0|||
23751913|NCT00320801|66470242|FG002|Double-blind Phase|Administrative|4|||
23751914|NCT00320801|66470243|FG003|Double-blind Phase|Administrative|0|||
23751915|NCT00320801|66470240|FG000|Double-blind Phase|Lack of Efficacy|0|||
23751916|NCT00320801|66470241|FG001|Double-blind Phase|Lack of Efficacy|9|||
23751917|NCT00320801|66470242|FG002|Double-blind Phase|Lack of Efficacy|1|||
23751918|NCT00320801|66470243|FG003|Double-blind Phase|Lack of Efficacy|0|||
23751919|NCT00320801|66470240|FG000|Extension Phase|Withdrawal by Subject|0|||
23751920|NCT00320801|66470241|FG001|Extension Phase|Withdrawal by Subject|0|||
23751921|NCT00320801|66470242|FG002|Extension Phase|Withdrawal by Subject|0|||
23557016|NCT00445679|65766106|FG002|Overall Study|Lack of Efficacy|2|||
23557017|NCT00445679|65766107|FG003|Overall Study|Lack of Efficacy|0|||
23557018|NCT01984697|65766108|FG000|Overall Study|Adverse Event|0|||
23557019|NCT01984697|65766109|FG001|Overall Study|Adverse Event|0|||
23557020|NCT01984697|65766110|FG002|Overall Study|Adverse Event|2|||
23557021|NCT01984697|65766111|FG003|Overall Study|Adverse Event|0|||
23557022|NCT01984697|65766112|FG004|Overall Study|Adverse Event|0|||
23557023|NCT01984697|65766108|FG000|Overall Study|Lost to Follow-up|14|||
23557024|NCT01984697|65766109|FG001|Overall Study|Lost to Follow-up|5|||
23557025|NCT01984697|65766110|FG002|Overall Study|Lost to Follow-up|10|||
23557026|NCT01984697|65766111|FG003|Overall Study|Lost to Follow-up|6|||
23557027|NCT01984697|65766112|FG004|Overall Study|Lost to Follow-up|21|||
23557028|NCT01984697|65766108|FG000|Overall Study|Physician Decision|3|||
23557029|NCT01984697|65766109|FG001|Overall Study|Physician Decision|0|||
23557030|NCT01984697|65766110|FG002|Overall Study|Physician Decision|0|||
23557031|NCT01984697|65766111|FG003|Overall Study|Physician Decision|1|||
23557032|NCT01984697|65766112|FG004|Overall Study|Physician Decision|0|||
23557033|NCT01984697|65766108|FG000|Overall Study|Protocol Violation|8|||
23751922|NCT00320801|66470243|FG003|Extension Phase|Withdrawal by Subject|6|||
23751923|NCT00320801|66470240|FG000|Extension Phase|Adverse Event|0|||
23751924|NCT00320801|66470241|FG001|Extension Phase|Adverse Event|0|||
23751925|NCT00320801|66470242|FG002|Extension Phase|Adverse Event|0|||
23557034|NCT01984697|65766109|FG001|Overall Study|Protocol Violation|5|||
23557035|NCT01984697|65766110|FG002|Overall Study|Protocol Violation|3|||
23557036|NCT01984697|65766111|FG003|Overall Study|Protocol Violation|2|||
23557037|NCT01984697|65766112|FG004|Overall Study|Protocol Violation|0|||
23557038|NCT01984697|65766108|FG000|Overall Study|Withdrawal by Subject|15|||
23751926|NCT00320801|66470243|FG003|Extension Phase|Adverse Event|8|||
23435654|NCT00915551|65337142|FG000|Overall Study|Withdrawal by Subject|0|||
23435655|NCT00915551|65337143|FG001|Overall Study|Withdrawal by Subject|1|||
23435656|NCT02437084|65337146|FG000|Overall Study|Withdrawal by Subject|2|||
23435657|NCT02437084|65337146|FG000|Overall Study|Physician Decision|1|||
23435658|NCT01276223|65337147|FG000|Overall Study|Adverse Event|7|||
23435659|NCT01276223|65337148|FG001|Overall Study|Adverse Event|4|||
23435660|NCT01276223|65337149|FG002|Overall Study|Adverse Event|1|||
23435661|NCT01276223|65337147|FG000|Overall Study|Lost to Follow-up|0|||
23435662|NCT01276223|65337148|FG001|Overall Study|Lost to Follow-up|0|||
23435663|NCT01276223|65337149|FG002|Overall Study|Lost to Follow-up|1|||
23435664|NCT01276223|65337147|FG000|Overall Study|Other|0|||
23435665|NCT01276223|65337148|FG001|Overall Study|Other|0|||
23435666|NCT01276223|65337149|FG002|Overall Study|Other|1|||
23435667|NCT01276223|65337147|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
23435668|NCT01276223|65337148|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
23435669|NCT01276223|65337149|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
23435670|NCT01276223|65337147|FG000|Overall Study|Protocol Violation|1|||
23435671|NCT01276223|65337148|FG001|Overall Study|Protocol Violation|0|||
23435672|NCT01276223|65337149|FG002|Overall Study|Protocol Violation|0|||
23435673|NCT01600092|65337150|FG000|Overall Study|Adverse Event|2|||
23435674|NCT01600092|65337151|FG001|Overall Study|Adverse Event|0|||
23435675|NCT01600092|65337150|FG000|Overall Study|Lost to Follow-up|4|||
23435676|NCT01600092|65337151|FG001|Overall Study|Lost to Follow-up|6|||
23435677|NCT01600092|65337150|FG000|Overall Study|Withdrawal by parent/guardian|8|||
23435678|NCT01600092|65337151|FG001|Overall Study|Withdrawal by parent/guardian|6|||
23435679|NCT01600092|65337150|FG000|Overall Study|Physician Decision|1|||
23435680|NCT01600092|65337151|FG001|Overall Study|Physician Decision|1|||
23435681|NCT01600092|65337150|FG000|Overall Study|Randomized but not vaccinated|3|||
23435682|NCT01600092|65337151|FG001|Overall Study|Randomized but not vaccinated|3|||
23435683|NCT00490776|65337153|FG000|Overall Study|Withdrawal by Subject|1|||
23435684|NCT00490776|65337153|FG000|Overall Study|Administrative Problems|1|||
23435685|NCT00490776|65337153|FG000|Overall Study|Death|1|||
23435686|NCT00490776|65337153|FG000|Overall Study|New Cancer Therapy|1|||
23435687|NCT00490776|65337153|FG000|Overall Study|Disease Progression|5|||
23435688|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
23435689|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
23435690|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
23435691|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435692|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435693|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435694|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435695|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435696|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435697|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Physician Decision|1|||
23435698|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Physician Decision|2|||
23435699|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Physician Decision|0|||
23435700|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Physician Decision|0|||
23435701|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Physician Decision|0|||
23435702|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Physician Decision|0|||
23435703|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Physician Decision|0|||
23435704|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Physician Decision|0|||
23435705|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Physician Decision|0|||
23435706|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
23435707|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
23435708|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
23435709|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
23435710|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
23435711|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
23435712|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
23435713|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
23435714|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
23435715|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
23435716|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435717|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435718|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435719|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435720|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435721|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435722|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435723|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435724|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
23435725|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
23435726|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435727|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435728|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435729|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435730|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435731|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435732|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435733|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Other than Specified|0|||
23435734|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Other than Specified|0|||
23435735|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Other than Specified|3|||
23435736|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Other than Specified|0|||
23435737|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Other than Specified|0|||
23557039|NCT01984697|65766109|FG001|Overall Study|Withdrawal by Subject|21|||
23557040|NCT01984697|65766110|FG002|Overall Study|Withdrawal by Subject|13|||
23435738|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Other than Specified|0|||
23435739|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Other than Specified|0|||
23435740|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Other than Specified|0|||
23435741|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Other than Specified|0|||
23435742|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435743|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435744|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435745|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
23435746|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
23435747|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
23435748|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435749|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435750|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435751|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435752|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435753|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435754|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435755|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
23435756|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435757|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435758|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435759|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435760|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435761|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435762|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435763|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
23435764|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
23435765|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
23435766|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435767|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435768|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435769|NCT04405076|65337156|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435770|NCT04405076|65337157|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435771|NCT04405076|65337158|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435772|NCT04405076|65337159|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435773|NCT04405076|65337160|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435774|NCT04405076|65337161|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435775|NCT04405076|65337162|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23557041|NCT01984697|65766111|FG003|Overall Study|Withdrawal by Subject|11|||
23557042|NCT01984697|65766112|FG004|Overall Study|Withdrawal by Subject|13|||
23557043|NCT01984697|65766108|FG000|Overall Study|Missed last follow-up visit|1|||
23557044|NCT01984697|65766109|FG001|Overall Study|Missed last follow-up visit|0|||
23557045|NCT01984697|65766110|FG002|Overall Study|Missed last follow-up visit|0|||
23557046|NCT01984697|65766111|FG003|Overall Study|Missed last follow-up visit|0|||
23557047|NCT01984697|65766112|FG004|Overall Study|Missed last follow-up visit|0|||
23557048|NCT01984697|65766108|FG000|Overall Study|Death|0|||
23557049|NCT01984697|65766109|FG001|Overall Study|Death|0|||
23557050|NCT01984697|65766110|FG002|Overall Study|Death|0|||
23435776|NCT04405076|65337163|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
23557051|NCT01984697|65766111|FG003|Overall Study|Death|1|||
23557052|NCT01984697|65766112|FG004|Overall Study|Death|0|||
23557053|NCT01984697|65766108|FG000|Overall Study|Pregnancy|2|||
23557054|NCT01984697|65766109|FG001|Overall Study|Pregnancy|0|||
23557055|NCT01984697|65766110|FG002|Overall Study|Pregnancy|1|||
23435777|NCT04405076|65337164|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
23435778|NCT04405076|65337156|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435779|NCT04405076|65337157|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435780|NCT04405076|65337158|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435781|NCT04405076|65337159|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435782|NCT04405076|65337160|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435783|NCT04405076|65337161|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435784|NCT04405076|65337162|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
23435785|NCT04405076|65337163|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435786|NCT04405076|65337164|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435787|NCT04856904|65337166|FG000|Overall Study|Physician Decision|1|||
23435788|NCT04856904|65337167|FG001|Overall Study|Physician Decision|1|||
23435789|NCT04856904|65337166|FG000|Overall Study|Withdrawal by Subject|13|||
23435790|NCT04856904|65337167|FG001|Overall Study|Withdrawal by Subject|13|||
23435791|NCT04856904|65337166|FG000|Overall Study|Adverse Event|1|||
23435792|NCT04856904|65337167|FG001|Overall Study|Adverse Event|1|||
23435793|NCT04856904|65337166|FG000|Overall Study|Non-compliance with study drug|1|||
23435794|NCT04856904|65337167|FG001|Overall Study|Non-compliance with study drug|1|||
23435795|NCT04856904|65337166|FG000|Overall Study|Lost to Follow-up|4|||
23435796|NCT04856904|65337167|FG001|Overall Study|Lost to Follow-up|4|||
23435797|NCT04856904|65337166|FG000|Overall Study|Withdrawal by Subject|1|||
23435798|NCT04856904|65337167|FG001|Overall Study|Withdrawal by Subject|1|||
23435799|NCT04856904|65337166|FG000|Overall Study|Protocol Violation|1|||
23435800|NCT04856904|65337167|FG001|Overall Study|Protocol Violation|1|||
23435801|NCT01438177|65337168|FG000|Overall Study|Withdrawal by Subject|1|||
23435802|NCT01438177|65337168|FG000|Overall Study|Initiation of new therapy|1|||
23435803|NCT05327361|65337172|FG000|Overall Study|Lost to Follow-up|4|||
23435804|NCT02305238|65337176|FG000|Overall Study|Death|2|||
23435805|NCT02305238|65337177|FG001|Overall Study|Death|1|||
23435806|NCT02305238|65337178|FG002|Overall Study|Death|0|||
23435807|NCT02305238|65337176|FG000|Overall Study|Progressive disease|4|||
23435808|NCT02305238|65337177|FG001|Overall Study|Progressive disease|4|||
23435809|NCT02305238|65337178|FG002|Overall Study|Progressive disease|0|||
23435810|NCT02305238|65337176|FG000|Overall Study|Logistical difficulties|1|||
23435811|NCT02305238|65337177|FG001|Overall Study|Logistical difficulties|3|||
23435812|NCT02305238|65337178|FG002|Overall Study|Logistical difficulties|0|||
23435813|NCT02305238|65337176|FG000|Overall Study|Protocol Violation|0|||
23435814|NCT02305238|65337177|FG001|Overall Study|Protocol Violation|3|||
23435815|NCT02305238|65337178|FG002|Overall Study|Protocol Violation|0|||
23435816|NCT02305238|65337176|FG000|Overall Study|Physician Decision|2|||
23435817|NCT02305238|65337177|FG001|Overall Study|Physician Decision|1|||
23435818|NCT02305238|65337178|FG002|Overall Study|Physician Decision|0|||
23435819|NCT02305238|65337176|FG000|Overall Study|Adverse Event|4|||
23435820|NCT02305238|65337177|FG001|Overall Study|Adverse Event|2|||
23435821|NCT02305238|65337178|FG002|Overall Study|Adverse Event|0|||
23435822|NCT02305238|65337176|FG000|Overall Study|Withdrawal by Subject|3|||
23435823|NCT02305238|65337177|FG001|Overall Study|Withdrawal by Subject|4|||
23435824|NCT02305238|65337178|FG002|Overall Study|Withdrawal by Subject|0|||
23435825|NCT02305238|65337176|FG000|Overall Study|Randomized failure|0|||
23435826|NCT02305238|65337177|FG001|Overall Study|Randomized failure|0|||
23435827|NCT02305238|65337178|FG002|Overall Study|Randomized failure|8|||
23751927|NCT00320801|66470240|FG000|Extension Phase|Administrative|0|||
23751928|NCT00320801|66470241|FG001|Extension Phase|Administrative|0|||
23751929|NCT00320801|66470242|FG002|Extension Phase|Administrative|0|||
23751930|NCT00320801|66470243|FG003|Extension Phase|Administrative|29|||
23751931|NCT00320801|66470240|FG000|Extension Phase|Lack of Efficacy|0|||
23751932|NCT00320801|66470241|FG001|Extension Phase|Lack of Efficacy|0|||
23751933|NCT00320801|66470242|FG002|Extension Phase|Lack of Efficacy|0|||
23751934|NCT00320801|66470243|FG003|Extension Phase|Lack of Efficacy|2|||
23751935|NCT00320801|66470240|FG000|Extension Phase|Lost to Follow-up|0|||
23751936|NCT00320801|66470241|FG001|Extension Phase|Lost to Follow-up|0|||
23751937|NCT00320801|66470242|FG002|Extension Phase|Lost to Follow-up|0|||
23751938|NCT00320801|66470243|FG003|Extension Phase|Lost to Follow-up|3|||
23751939|NCT04854421|66470244|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
23751940|NCT04854421|66470245|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
23751941|NCT01843660|66470248|FG000|Overall Study|Other|30|||
23751942|NCT01035229|66470255|FG000|Overall Study|Adverse Event|61|||
23751943|NCT01035229|66470256|FG001|Overall Study|Adverse Event|14|||
23435828|NCT02305238|65337176|FG000|Overall Study|Required procedure failed|0|||
23435829|NCT02305238|65337177|FG001|Overall Study|Required procedure failed|1|||
23435830|NCT02305238|65337178|FG002|Overall Study|Required procedure failed|0|||
23435831|NCT02540668|65337179|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
23435832|NCT02540668|65337180|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
23435833|NCT00293020|65337187|FG000|Overall Study|Withdrawal by Subject|34|||
23435834|NCT00293020|65337187|FG000|Overall Study|Adverse Event|30|||
23435835|NCT00293020|65337187|FG000|Overall Study|Death|32|||
23751944|NCT01035229|66470255|FG000|Overall Study|Withdrawal by Subject|20|||
23751945|NCT01035229|66470256|FG001|Overall Study|Withdrawal by Subject|7|||
23751946|NCT01035229|66470255|FG000|Overall Study|Lost to Follow-up|1|||
23751947|NCT01035229|66470256|FG001|Overall Study|Lost to Follow-up|0|||
23751948|NCT01035229|66470255|FG000|Overall Study|Administrative problems|1|||
23751949|NCT01035229|66470256|FG001|Overall Study|Administrative problems|1|||
23751950|NCT01035229|66470255|FG000|Overall Study|Death|13|||
23751951|NCT01035229|66470256|FG001|Overall Study|Death|5|||
23751952|NCT01035229|66470255|FG000|Overall Study|New cancer therapy|2|||
23751953|NCT01035229|66470256|FG001|Overall Study|New cancer therapy|0|||
23751954|NCT01035229|66470255|FG000|Overall Study|Protocol Violation|0|||
23751955|NCT01035229|66470256|FG001|Overall Study|Protocol Violation|2|||
23751956|NCT01035229|66470255|FG000|Overall Study|Sponsor's decision to end study|3|||
23751957|NCT01035229|66470256|FG001|Overall Study|Sponsor's decision to end study|3|||
23751958|NCT01035229|66470255|FG000|Overall Study|Disease Progression|261|||
23751959|NCT01035229|66470256|FG001|Overall Study|Disease Progression|152|||
23751960|NCT00057330|66470257|FG000|Overall Study|Adverse Event|9|||
23751961|NCT00057330|66470258|FG001|Overall Study|Adverse Event|12|||
23751962|NCT00057330|66470257|FG000|Overall Study|Death|1|||
23751963|NCT00057330|66470258|FG001|Overall Study|Death|0|||
23751964|NCT00057330|66470257|FG000|Overall Study|Protocol Violation|1|||
23751965|NCT00057330|66470258|FG001|Overall Study|Protocol Violation|1|||
23751966|NCT00057330|66470257|FG000|Overall Study|Withdrawal by Subject|115|||
23751967|NCT00057330|66470258|FG001|Overall Study|Withdrawal by Subject|84|||
23751968|NCT00057330|66470257|FG000|Overall Study|Lost to Follow-up|745|||
23751969|NCT00057330|66470258|FG001|Overall Study|Lost to Follow-up|617|||
23435836|NCT00293020|65337187|FG000|Overall Study|Lack of Efficacy|12|||
23435837|NCT00293020|65337187|FG000|Overall Study|Lost to Follow-up|4|||
23435838|NCT00293020|65337187|FG000|Overall Study|Protocol Violation|6|||
23435839|NCT00293020|65337187|FG000|Overall Study|Physician Decision|21|||
23435840|NCT00293020|65337187|FG000|Overall Study|Other Reason|22|||
23435841|NCT00293020|65337187|FG000|Overall Study|No dose taken|1|||
23435842|NCT01264770|65337189|FG000|Overall Study|Not reported|0|||
23435843|NCT01264770|65337190|FG001|Overall Study|Not reported|0|||
23435844|NCT01264770|65337191|FG002|Overall Study|Not reported|1|||
23751970|NCT00057330|66470257|FG000|Overall Study|Physician Decision|1|||
23751971|NCT00057330|66470258|FG001|Overall Study|Physician Decision|0|||
23435845|NCT01264770|65337192|FG003|Overall Study|Not reported|0|||
23435846|NCT01264770|65337193|FG004|Overall Study|Not reported|0|||
23435847|NCT01264770|65337194|FG005|Overall Study|Not reported|0|||
23435848|NCT01264770|65337189|FG000|Overall Study|e.g., change in circumstances|8|||
23435849|NCT01264770|65337190|FG001|Overall Study|e.g., change in circumstances|3|||
23435850|NCT01264770|65337191|FG002|Overall Study|e.g., change in circumstances|3|||
23435851|NCT01264770|65337192|FG003|Overall Study|e.g., change in circumstances|3|||
23435852|NCT01264770|65337193|FG004|Overall Study|e.g., change in circumstances|4|||
23435853|NCT01264770|65337194|FG005|Overall Study|e.g., change in circumstances|4|||
23435854|NCT01264770|65337189|FG000|Overall Study|Severe non-compliance to protocol|0|||
23435855|NCT01264770|65337190|FG001|Overall Study|Severe non-compliance to protocol|0|||
23435856|NCT01264770|65337191|FG002|Overall Study|Severe non-compliance to protocol|1|||
23435857|NCT01264770|65337192|FG003|Overall Study|Severe non-compliance to protocol|1|||
23435858|NCT01264770|65337193|FG004|Overall Study|Severe non-compliance to protocol|0|||
23751972|NCT00057330|66470257|FG000|Overall Study|Other|260|||
23751973|NCT00057330|66470258|FG001|Overall Study|Other|206|||
23751974|NCT02861534|66470259|FG000|Overall Study|Death|541|||
23751975|NCT02861534|66470260|FG001|Overall Study|Death|552|||
23751976|NCT02861534|66470259|FG000|Overall Study|Lost to Follow-up|14|||
23751977|NCT02861534|66470260|FG001|Overall Study|Lost to Follow-up|14|||
23435859|NCT01264770|65337194|FG005|Overall Study|Severe non-compliance to protocol|0|||
23435860|NCT01264770|65337189|FG000|Overall Study|Lack of therapeutic response|1|||
23435861|NCT01264770|65337190|FG001|Overall Study|Lack of therapeutic response|0|||
23435862|NCT01264770|65337191|FG002|Overall Study|Lack of therapeutic response|2|||
23435863|NCT01264770|65337192|FG003|Overall Study|Lack of therapeutic response|1|||
23435864|NCT01264770|65337193|FG004|Overall Study|Lack of therapeutic response|1|||
23435865|NCT01264770|65337194|FG005|Overall Study|Lack of therapeutic response|0|||
23435866|NCT01264770|65337189|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
23435867|NCT01264770|65337190|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23557056|NCT01984697|65766111|FG003|Overall Study|Pregnancy|0|||
23557057|NCT01984697|65766112|FG004|Overall Study|Pregnancy|1|||
23751978|NCT02861534|66470259|FG000|Overall Study|Site Terminated by Sponsor|4|||
23751979|NCT02861534|66470260|FG001|Overall Study|Site Terminated by Sponsor|3|||
23751980|NCT02861534|66470259|FG000|Overall Study|Withdrawal by Subject|15|||
23557058|NCT00855062|65766114|FG000|Step1|Early Study Closure|5|||
23435868|NCT01264770|65337191|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
23435869|NCT01264770|65337192|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
23751981|NCT02861534|66470260|FG001|Overall Study|Withdrawal by Subject|18|||
23435870|NCT01264770|65337193|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
23557059|NCT00855062|65766115|FG001|Step1|Early Study Closure|7|||
23435871|NCT01264770|65337194|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
23435872|NCT01264770|65337189|FG000|Overall Study|Lost to Follow-up|0|||
23435873|NCT01264770|65337190|FG001|Overall Study|Lost to Follow-up|0|||
23435874|NCT01264770|65337191|FG002|Overall Study|Lost to Follow-up|1|||
23435875|NCT01264770|65337192|FG003|Overall Study|Lost to Follow-up|1|||
23435876|NCT01264770|65337193|FG004|Overall Study|Lost to Follow-up|0|||
23435877|NCT01264770|65337194|FG005|Overall Study|Lost to Follow-up|0|||
23435878|NCT01264770|65337189|FG000|Overall Study|Adverse Event|7|||
23435879|NCT01264770|65337190|FG001|Overall Study|Adverse Event|7|||
23435880|NCT01264770|65337191|FG002|Overall Study|Adverse Event|8|||
23435881|NCT01264770|65337192|FG003|Overall Study|Adverse Event|0|||
23435882|NCT01264770|65337193|FG004|Overall Study|Adverse Event|2|||
23435883|NCT01264770|65337194|FG005|Overall Study|Adverse Event|1|||
23435884|NCT00377364|65337195|FG000|Overall Study|Lost to Follow-up|1|||
23435885|NCT00377364|65337196|FG001|Overall Study|Lost to Follow-up|0|||
23435886|NCT00377364|65337195|FG000|Overall Study|Withdrawal by Subject|1|||
23435887|NCT00377364|65337196|FG001|Overall Study|Withdrawal by Subject|0|||
23435888|NCT01439373|65337200|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
23435889|NCT01439373|65337201|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
23435890|NCT01439373|65337200|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
23435891|NCT01439373|65337201|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
23435892|NCT01008904|65337213|FG000|Overall Study|Lost to Follow-up|1|||
23435893|NCT01008904|65337213|FG000|Overall Study|Adverse Event|2|||
23435894|NCT01008904|65337213|FG000|Overall Study|unexpected unrelated surgery|1|||
23435895|NCT03508609|65337215|FG000|Overall Study|Withdrawal by Subject|1|||
23435896|NCT00837759|65337216|FG000|Overall Study|Protocol Violation|3|||
23435897|NCT00837759|65337216|FG000|Overall Study|Lost to Follow-up|1|||
23435898|NCT02277119|65337219|FG000|Overall Study|Lack of Efficacy|1|||
23435899|NCT02277119|65337220|FG001|Overall Study|Lack of Efficacy|1|||
23435900|NCT02277119|65337221|FG002|Overall Study|Lack of Efficacy|1|||
23435901|NCT02277119|65337219|FG000|Overall Study|Protocol Violation|2|||
23435902|NCT02277119|65337220|FG001|Overall Study|Protocol Violation|3|||
23435903|NCT02277119|65337221|FG002|Overall Study|Protocol Violation|7|||
23435904|NCT02353728|65337222|FG000|Overall Study|Subject non-compliance|1|||
23435905|NCT02428205|65337227|FG000|Overall Study|Lack of Efficacy|1|||
23435906|NCT02428205|65337228|FG001|Overall Study|Lack of Efficacy|0|||
23435907|NCT02428205|65337227|FG000|Overall Study|Lost to Follow-up|1|||
23435908|NCT02428205|65337228|FG001|Overall Study|Lost to Follow-up|1|||
23435909|NCT02428205|65337227|FG000|Overall Study|Worse behavior|0|||
23435910|NCT02428205|65337228|FG001|Overall Study|Worse behavior|1|||
23435911|NCT03369236|65337231|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
23435912|NCT03369236|65337232|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
23435913|NCT03369236|65337231|FG000|Open-label Extension Period|Lack of Efficacy|2|||
23435914|NCT03369236|65337232|FG001|Open-label Extension Period|Lack of Efficacy|1|||
23435915|NCT03369236|65337231|FG000|Open-label Extension Period|Adverse Event|0|||
23435916|NCT03369236|65337232|FG001|Open-label Extension Period|Adverse Event|1|||
23435917|NCT03369236|65337231|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
23435918|NCT03369236|65337232|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
23435919|NCT02252965|65337235|FG000|Overall Study|Adverse Event|9|||
23435920|NCT02252965|65337236|FG001|Overall Study|Adverse Event|14|||
23435921|NCT02252965|65337235|FG000|Overall Study|Lost to Follow-up|16|||
23435922|NCT02252965|65337236|FG001|Overall Study|Lost to Follow-up|8|||
23435923|NCT02252965|65337235|FG000|Overall Study|Protocol Violation|4|||
23435924|NCT02252965|65337236|FG001|Overall Study|Protocol Violation|5|||
23435925|NCT02252965|65337235|FG000|Overall Study|Lack of Efficacy|0|||
23435926|NCT02252965|65337236|FG001|Overall Study|Lack of Efficacy|2|||
23435927|NCT02252965|65337235|FG000|Overall Study|Withdrawal by Subject|7|||
23435928|NCT02252965|65337236|FG001|Overall Study|Withdrawal by Subject|9|||
23435929|NCT02252965|65337235|FG000|Overall Study|Other|4|||
23435930|NCT02252965|65337236|FG001|Overall Study|Other|5|||
23435931|NCT01403116|65337237|FG000|Overall Study|Adverse Event|7|||
23435932|NCT01403116|65337238|FG001|Overall Study|Adverse Event|4|||
23435933|NCT01403116|65337237|FG000|Overall Study|Lost to Follow-up|7|||
23435934|NCT01403116|65337238|FG001|Overall Study|Lost to Follow-up|5|||
23557060|NCT00855062|65766114|FG000|Step1|Adverse Event|1|||
23435935|NCT01403116|65337237|FG000|Overall Study|Withdrawal by Subject|12|||
23435936|NCT01403116|65337238|FG001|Overall Study|Withdrawal by Subject|15|||
23435937|NCT01403116|65337237|FG000|Overall Study|Non-compliance of study drug|3|||
23557061|NCT00855062|65766115|FG001|Step1|Adverse Event|1|||
23557062|NCT00855062|65766114|FG000|Step1|Protocol Violation|1|||
23435938|NCT01403116|65337238|FG001|Overall Study|Non-compliance of study drug|0|||
23435939|NCT01403116|65337237|FG000|Overall Study|Protocol Violation|0|||
23435940|NCT01403116|65337238|FG001|Overall Study|Protocol Violation|1|||
23435941|NCT01403116|65337237|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
23435942|NCT01403116|65337238|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
23435943|NCT01403116|65337237|FG000|Overall Study|Hct >54%|2|||
23435944|NCT01403116|65337238|FG001|Overall Study|Hct >54%|0|||
23435945|NCT01403116|65337237|FG000|Overall Study|unable to keep appointments|0|||
23435946|NCT01403116|65337238|FG001|Overall Study|unable to keep appointments|2|||
23435947|NCT01620528|65337242|FG000|Treatment Period|Did Not Receive Study Drug|0|||
23435948|NCT01620528|65337243|FG001|Treatment Period|Did Not Receive Study Drug|0|||
23435949|NCT01620528|65337244|FG002|Treatment Period|Did Not Receive Study Drug|1|||
23435950|NCT01620528|65337242|FG000|Treatment Period|Withdrawal by Subject|35|||
23435951|NCT01620528|65337243|FG001|Treatment Period|Withdrawal by Subject|21|||
23435952|NCT01620528|65337244|FG002|Treatment Period|Withdrawal by Subject|16|||
23435953|NCT01620528|65337242|FG000|Treatment Period|Adverse Event|17|||
23435954|NCT01620528|65337243|FG001|Treatment Period|Adverse Event|13|||
23435955|NCT01620528|65337244|FG002|Treatment Period|Adverse Event|21|||
23435956|NCT01620528|65337242|FG000|Treatment Period|Lost to Follow-up|16|||
23435957|NCT01620528|65337243|FG001|Treatment Period|Lost to Follow-up|8|||
23435958|NCT01620528|65337244|FG002|Treatment Period|Lost to Follow-up|14|||
23435959|NCT01620528|65337242|FG000|Treatment Period|Other|9|||
23435960|NCT01620528|65337243|FG001|Treatment Period|Other|5|||
23435961|NCT01620528|65337244|FG002|Treatment Period|Other|7|||
23435962|NCT01620528|65337242|FG000|Treatment Period|Subject Noncompliant|11|||
23435963|NCT01620528|65337243|FG001|Treatment Period|Subject Noncompliant|2|||
23435964|NCT01620528|65337244|FG002|Treatment Period|Subject Noncompliant|2|||
23435965|NCT01620528|65337242|FG000|Treatment Period|Pregnancy|7|||
23435966|NCT01620528|65337243|FG001|Treatment Period|Pregnancy|2|||
23435967|NCT01620528|65337244|FG002|Treatment Period|Pregnancy|2|||
23435968|NCT01620528|65337242|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
23435969|NCT01620528|65337243|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
23435970|NCT01620528|65337244|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
23435971|NCT01620528|65337242|FG000|Treatment Period|Exclusionary Medication Received|0|||
23435972|NCT01620528|65337243|FG001|Treatment Period|Exclusionary Medication Received|1|||
23435973|NCT01620528|65337244|FG002|Treatment Period|Exclusionary Medication Received|0|||
23435974|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23435975|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
23435976|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23435977|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23435978|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23435979|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23435980|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
23435981|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
23435982|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
23435983|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
23435984|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
23435985|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
23435986|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Other|6|||
23435987|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Other|4|||
23435988|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Other|2|||
23435989|NCT00527332|65337245|FG000|Overall Study|Protocol Violation|4|||
23435990|NCT00527332|65337246|FG001|Overall Study|Protocol Violation|8|||
23435991|NCT00527332|65337245|FG000|Overall Study|Withdrew consent|5|||
23435992|NCT00527332|65337246|FG001|Overall Study|Withdrew consent|1|||
23435993|NCT02936284|65337252|FG000|Overall Study|Withdrawal by Subject|3|||
23623667|NCT00275301|66008532|FG000|Overall Study|Adverse Event|5|||
23623668|NCT02171130|66008534|FG000|Overall Study|Death|1|||
23623669|NCT02171130|66008534|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
23623670|NCT02171130|66008534|FG000|Overall Study|Discontinued; Site Termination|5|||
23751982|NCT03683719|66470261|FG000|Overall Study|Lack of Efficacy|1|||
23751983|NCT03683719|66470262|FG001|Overall Study|Lack of Efficacy|3|||
23435994|NCT02936284|65337253|FG001|Overall Study|Withdrawal by Subject|1|||
23435995|NCT02936284|65337252|FG000|Overall Study|Lost to Follow-up|7|||
23435996|NCT02936284|65337253|FG001|Overall Study|Lost to Follow-up|8|||
23435997|NCT02999633|65337254|FG000|Overall Study|Adverse Event|2|||
23557063|NCT00855062|65766115|FG001|Step1|Protocol Violation|0|||
23557064|NCT00855062|65766114|FG000|Step1|Pregnancy|1|||
23557065|NCT00855062|65766115|FG001|Step1|Pregnancy|0|||
23557066|NCT00855062|65766114|FG000|Step1|Withdrawal by Subject|2|||
23557067|NCT00855062|65766115|FG001|Step1|Withdrawal by Subject|3|||
23557068|NCT00855062|65766114|FG000|Step2|Early Study Closure|6|||
23557069|NCT00855062|65766115|FG001|Step2|Early Study Closure|2|||
23557070|NCT00855062|65766114|FG000|Step2|Adverse Event|0|||
23557071|NCT00855062|65766115|FG001|Step2|Adverse Event|3|||
23557072|NCT00855062|65766114|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
23557073|NCT00855062|65766115|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
23557074|NCT02120027|65766119|FG000|Overall Study|Adverse Event|4|||
23435998|NCT02999633|65337254|FG000|Overall Study|Progressive disease|12|||
23557075|NCT02120027|65766120|FG001|Overall Study|Adverse Event|5|||
23557076|NCT02120027|65766119|FG000|Overall Study|Lack of Efficacy|3|||
23751984|NCT03683719|66470263|FG002|Overall Study|Lack of Efficacy|4|||
23435999|NCT00705146|65337257|FG000|Overall Study|Lost to Follow-up|1|||
23436000|NCT00705146|65337258|FG001|Overall Study|Lost to Follow-up|1|||
23436001|NCT03689855|65337267|FG000|Overall Study|Adverse Event|3|||
23436002|NCT03689855|65337267|FG000|Overall Study|Withdrawal by Subject|1|||
23436003|NCT03922620|65340559|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
23436004|NCT03922620|65340560|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
23436005|NCT02873338|65340561|FG000|Overall Study|Adverse Event|0|||
23436006|NCT02873338|65340562|FG001|Overall Study|Adverse Event|2|||
23436007|NCT02873338|65340563|FG002|Overall Study|Adverse Event|1|||
23436008|NCT02873338|65340561|FG000|Overall Study|Death|2|||
23436009|NCT02873338|65340562|FG001|Overall Study|Death|1|||
23436010|NCT02873338|65340563|FG002|Overall Study|Death|1|||
23436011|NCT02873338|65340561|FG000|Overall Study|Withdrawal by Subject|2|||
23436012|NCT02873338|65340562|FG001|Overall Study|Withdrawal by Subject|1|||
23436013|NCT02873338|65340563|FG002|Overall Study|Withdrawal by Subject|3|||
23436014|NCT02873338|65340561|FG000|Overall Study|Lack of Efficacy|0|||
23436015|NCT02873338|65340562|FG001|Overall Study|Lack of Efficacy|2|||
23436016|NCT02873338|65340563|FG002|Overall Study|Lack of Efficacy|0|||
23436017|NCT02873338|65340561|FG000|Overall Study|Other or Missing|14|||
23436018|NCT02873338|65340562|FG001|Overall Study|Other or Missing|15|||
23436019|NCT02873338|65340563|FG002|Overall Study|Other or Missing|13|||
23436020|NCT00428389|65340571|FG000|Core Phase|Adverse Event|6|||
23436021|NCT00428389|65340572|FG001|Core Phase|Adverse Event|4|||
23436022|NCT00428389|65340571|FG000|Core Phase|Lack of Efficacy|2|||
23436023|NCT00428389|65340572|FG001|Core Phase|Lack of Efficacy|0|||
23436024|NCT00428389|65340571|FG000|Core Phase|Abnormal test procedure result(s)|0|||
23436025|NCT00428389|65340572|FG001|Core Phase|Abnormal test procedure result(s)|1|||
23436026|NCT00428389|65340571|FG000|Core Phase|Withdrawal by Subject|3|||
23436027|NCT00428389|65340572|FG001|Core Phase|Withdrawal by Subject|4|||
23436028|NCT00428389|65340571|FG000|Core Phase|Protocol deviation|0|||
23436029|NCT00428389|65340572|FG001|Core Phase|Protocol deviation|2|||
23436030|NCT00428389|65340571|FG000|Extension Phase|Adverse Event|17|||
23436031|NCT00428389|65340572|FG001|Extension Phase|Adverse Event|11|||
23436032|NCT00428389|65340571|FG000|Extension Phase|Lack of Efficacy|4|||
23436033|NCT00428389|65340572|FG001|Extension Phase|Lack of Efficacy|3|||
23436034|NCT00428389|65340571|FG000|Extension Phase|Withdrawal by Subject|6|||
23436035|NCT00428389|65340572|FG001|Extension Phase|Withdrawal by Subject|6|||
23436036|NCT00428389|65340571|FG000|Extension Phase|Lost to Follow-up|0|||
23436037|NCT00428389|65340572|FG001|Extension Phase|Lost to Follow-up|3|||
23436038|NCT00428389|65340571|FG000|Extension Phase|Death|1|||
23436039|NCT00428389|65340572|FG001|Extension Phase|Death|0|||
23436040|NCT00428389|65340571|FG000|Extension Phase|Protocol Violation|3|||
23436041|NCT00428389|65340572|FG001|Extension Phase|Protocol Violation|2|||
23436042|NCT00428389|65340571|FG000|Extension Phase|Administrative problems|1|||
23436043|NCT00428389|65340572|FG001|Extension Phase|Administrative problems|1|||
23436044|NCT01870726|65340573|FG000|Overall Study|Withdrawal of informed consent|0|||
23436045|NCT01870726|65340574|FG001|Overall Study|Withdrawal of informed consent|0|||
23436046|NCT01870726|65340575|FG002|Overall Study|Withdrawal of informed consent|0|||
23436047|NCT01870726|65340576|FG003|Overall Study|Withdrawal of informed consent|1|||
23436048|NCT01870726|65340577|FG004|Overall Study|Withdrawal of informed consent|0|||
23436049|NCT01870726|65340578|FG005|Overall Study|Withdrawal of informed consent|0|||
23436050|NCT01870726|65340579|FG006|Overall Study|Withdrawal of informed consent|0|||
23436051|NCT01870726|65340573|FG000|Overall Study|Withdrawal by Subject|0|||
23436052|NCT01870726|65340574|FG001|Overall Study|Withdrawal by Subject|1|||
23436053|NCT01870726|65340575|FG002|Overall Study|Withdrawal by Subject|0|||
23436054|NCT01870726|65340576|FG003|Overall Study|Withdrawal by Subject|0|||
23751985|NCT03683719|66470264|FG003|Overall Study|Lack of Efficacy|0|||
23751986|NCT03683719|66470265|FG004|Overall Study|Lack of Efficacy|4|||
23751987|NCT03683719|66470261|FG000|Overall Study|Adverse Event|6|||
23751988|NCT03683719|66470262|FG001|Overall Study|Adverse Event|6|||
23751989|NCT03683719|66470263|FG002|Overall Study|Adverse Event|0|||
23751990|NCT03683719|66470264|FG003|Overall Study|Adverse Event|1|||
23751991|NCT03683719|66470265|FG004|Overall Study|Adverse Event|3|||
23751992|NCT03683719|66470261|FG000|Overall Study|Withdrawal by Subject|4|||
23751993|NCT03683719|66470262|FG001|Overall Study|Withdrawal by Subject|4|||
23751994|NCT03683719|66470263|FG002|Overall Study|Withdrawal by Subject|3|||
23751995|NCT03683719|66470264|FG003|Overall Study|Withdrawal by Subject|5|||
23436055|NCT01870726|65340577|FG004|Overall Study|Withdrawal by Subject|0|||
23557077|NCT02120027|65766120|FG001|Overall Study|Lack of Efficacy|5|||
23751996|NCT03683719|66470265|FG004|Overall Study|Withdrawal by Subject|5|||
23751997|NCT03683719|66470261|FG000|Overall Study|Lost to Follow-up|1|||
23436056|NCT01870726|65340578|FG005|Overall Study|Withdrawal by Subject|0|||
23436057|NCT01870726|65340579|FG006|Overall Study|Withdrawal by Subject|0|||
23436058|NCT01870726|65340573|FG000|Overall Study|Adverse Event|0|||
23436059|NCT01870726|65340574|FG001|Overall Study|Adverse Event|0|||
23436060|NCT01870726|65340575|FG002|Overall Study|Adverse Event|0|||
23436061|NCT01870726|65340576|FG003|Overall Study|Adverse Event|0|||
23751998|NCT03683719|66470262|FG001|Overall Study|Lost to Follow-up|0|||
23751999|NCT03683719|66470263|FG002|Overall Study|Lost to Follow-up|0|||
23752000|NCT03683719|66470264|FG003|Overall Study|Lost to Follow-up|1|||
23752001|NCT03683719|66470265|FG004|Overall Study|Lost to Follow-up|1|||
23752002|NCT03683719|66470261|FG000|Overall Study|Other personal reasons|0|||
23752003|NCT03683719|66470262|FG001|Overall Study|Other personal reasons|0|||
23752004|NCT03683719|66470263|FG002|Overall Study|Other personal reasons|1|||
23752005|NCT03683719|66470264|FG003|Overall Study|Other personal reasons|0|||
23752006|NCT03683719|66470265|FG004|Overall Study|Other personal reasons|1|||
23752007|NCT02723786|66470266|FG000|Overall Study|Lost to Follow-up|1|||
23436062|NCT01870726|65340577|FG004|Overall Study|Adverse Event|1|||
23436063|NCT01870726|65340578|FG005|Overall Study|Adverse Event|1|||
23436064|NCT01870726|65340579|FG006|Overall Study|Adverse Event|0|||
23436065|NCT01870726|65340573|FG000|Overall Study|Progressive disease|5|||
23436066|NCT01870726|65340574|FG001|Overall Study|Progressive disease|5|||
23436067|NCT01870726|65340575|FG002|Overall Study|Progressive disease|4|||
23436068|NCT01870726|65340576|FG003|Overall Study|Progressive disease|5|||
23436069|NCT01870726|65340577|FG004|Overall Study|Progressive disease|6|||
23436070|NCT01870726|65340578|FG005|Overall Study|Progressive disease|4|||
23436071|NCT01870726|65340579|FG006|Overall Study|Progressive disease|10|||
23436072|NCT03178669|65340580|FG000|Overall Study|Adverse Event|4|||
23436073|NCT03178669|65340581|FG001|Overall Study|Adverse Event|1|||
23436074|NCT03178669|65340582|FG002|Overall Study|Adverse Event|4|||
23436075|NCT03178669|65340583|FG003|Overall Study|Adverse Event|2|||
23436076|NCT03178669|65340584|FG004|Overall Study|Adverse Event|2|||
23436077|NCT03178669|65340580|FG000|Overall Study|Lack of Efficacy|0|||
23436078|NCT03178669|65340581|FG001|Overall Study|Lack of Efficacy|0|||
23436079|NCT03178669|65340582|FG002|Overall Study|Lack of Efficacy|2|||
23436080|NCT03178669|65340583|FG003|Overall Study|Lack of Efficacy|0|||
23436081|NCT03178669|65340584|FG004|Overall Study|Lack of Efficacy|1|||
23436082|NCT03178669|65340580|FG000|Overall Study|Physician Decision|0|||
23436083|NCT03178669|65340581|FG001|Overall Study|Physician Decision|0|||
23436084|NCT03178669|65340582|FG002|Overall Study|Physician Decision|0|||
23436085|NCT03178669|65340583|FG003|Overall Study|Physician Decision|0|||
23436086|NCT03178669|65340584|FG004|Overall Study|Physician Decision|1|||
23436087|NCT03178669|65340580|FG000|Overall Study|Withdrawal by Subject|1|||
23436088|NCT03178669|65340581|FG001|Overall Study|Withdrawal by Subject|0|||
23436089|NCT03178669|65340582|FG002|Overall Study|Withdrawal by Subject|1|||
23557078|NCT02120027|65766119|FG000|Overall Study|Lost to Follow-up|5|||
23557079|NCT02120027|65766120|FG001|Overall Study|Lost to Follow-up|13|||
23557080|NCT02120027|65766119|FG000|Overall Study|Other|4|||
23557081|NCT02120027|65766120|FG001|Overall Study|Other|0|||
23557082|NCT02120027|65766119|FG000|Overall Study|Physician Decision|4|||
23752008|NCT00902486|66470269|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23752009|NCT00902486|66470270|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
23752010|NCT00902486|66470271|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
23752011|NCT00902486|66470272|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23752012|NCT00902486|66470273|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23752013|NCT00902486|66470274|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
23752014|NCT00902486|66470269|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
23752015|NCT00902486|66470270|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23752016|NCT00902486|66470271|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23752017|NCT00902486|66470272|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23752018|NCT00902486|66470273|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23752019|NCT00902486|66470274|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
23752020|NCT00902486|66470269|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23752021|NCT00902486|66470270|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23752022|NCT00902486|66470271|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23557083|NCT02120027|65766120|FG001|Overall Study|Physician Decision|3|||
23557084|NCT02120027|65766119|FG000|Overall Study|Protocol Violation|18|||
23557085|NCT02120027|65766120|FG001|Overall Study|Protocol Violation|21|||
23557086|NCT02120027|65766119|FG000|Overall Study|Study terminated by Sponsor|45|||
23752023|NCT00902486|66470272|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23752024|NCT00902486|66470273|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
23825082|NCT02533180|66741412|FG001|Overall Study|Non-compliance|1|||
23436090|NCT03178669|65340583|FG003|Overall Study|Withdrawal by Subject|1|||
23436091|NCT03178669|65340584|FG004|Overall Study|Withdrawal by Subject|0|||
23436092|NCT03178669|65340580|FG000|Overall Study|Lost to Follow-up|0|||
23436093|NCT03178669|65340581|FG001|Overall Study|Lost to Follow-up|0|||
23436094|NCT03178669|65340582|FG002|Overall Study|Lost to Follow-up|0|||
23436095|NCT03178669|65340583|FG003|Overall Study|Lost to Follow-up|1|||
23436096|NCT03178669|65340584|FG004|Overall Study|Lost to Follow-up|0|||
23752025|NCT00902486|66470274|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
23752026|NCT00902486|66470269|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23436097|NCT02798471|65340585|FG000|Overall Study|Adverse Event|7|||
23557087|NCT02120027|65766120|FG001|Overall Study|Study terminated by Sponsor|47|||
23557088|NCT02120027|65766119|FG000|Overall Study|Withdrawal by Subject|33|||
23557089|NCT02120027|65766120|FG001|Overall Study|Withdrawal by Subject|25|||
23557090|NCT01559844|65766121|FG000|Overall Study|Consent Withdrawn|7|||
23557091|NCT01559844|65766121|FG000|Overall Study|Death|5|||
23557092|NCT01559844|65766121|FG000|Overall Study|Efficacy Failure|10|||
23557093|NCT01559844|65766121|FG000|Overall Study|No Longer A Transplant Candidate|3|||
23557094|NCT01951625|65766122|FG000|Treatment Period|Protocol Violation|2|||
23557095|NCT01951625|65766123|FG001|Treatment Period|Protocol Violation|0|||
23557096|NCT01951625|65766124|FG002|Treatment Period|Protocol Violation|1|||
23557097|NCT01951625|65766125|FG003|Treatment Period|Protocol Violation|3|||
23623671|NCT02171130|66008534|FG000|Overall Study|Withdrawal by Subject|3|||
23623672|NCT02171130|66008534|FG000|Overall Study|Physician Decision|1|||
23623673|NCT02171130|66008534|FG000|Overall Study|Lost to Follow-up|1|||
23623674|NCT02171130|66008534|FG000|Overall Study|Met Exclusion Criteria|1|||
23623675|NCT02517528|66008535|FG000|Overall Study|Withdrawal by Subject|1|||
23623676|NCT00951171|66008536|FG000|Overall Study|Adverse Event|2|||
23623677|NCT00951171|66008537|FG001|Overall Study|Adverse Event|0|||
23623678|NCT01503164|66008540|FG000|Overall Study|Withdrawal by Subject|2|||
23623679|NCT01503164|66008541|FG001|Overall Study|Withdrawal by Subject|1|||
23623680|NCT02859064|66008547|FG000|Overall Study|Progressive Disease|3|||
23623681|NCT02859064|66008547|FG000|Overall Study|Physician Decision|1|||
23623682|NCT02859064|66008547|FG000|Overall Study|Withdrawal by Subject|1|||
23623683|NCT02859064|66008547|FG000|Overall Study|Death|1|||
23623684|NCT01751165|66008553|FG000|Overall Study|Adverse event, serious fatal|1|||
23623685|NCT01751165|66008554|FG001|Overall Study|Adverse event, serious fatal|0|||
23623686|NCT01751165|66008555|FG002|Overall Study|Adverse event, serious fatal|1|||
23623687|NCT01751165|66008553|FG000|Overall Study|Withdrawal by Subject|0|||
23623688|NCT01751165|66008554|FG001|Overall Study|Withdrawal by Subject|0|||
23623689|NCT01751165|66008555|FG002|Overall Study|Withdrawal by Subject|1|||
23623690|NCT01751165|66008553|FG000|Overall Study|Serious adverse event|0|||
23623691|NCT01751165|66008554|FG001|Overall Study|Serious adverse event|2|||
23623692|NCT01751165|66008555|FG002|Overall Study|Serious adverse event|0|||
23623693|NCT01751165|66008553|FG000|Overall Study|Lost to Follow-up|1|||
23623694|NCT01751165|66008554|FG001|Overall Study|Lost to Follow-up|1|||
23623695|NCT01751165|66008555|FG002|Overall Study|Lost to Follow-up|1|||
23623696|NCT01721746|66008556|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
23623697|NCT01721746|66008557|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
23623698|NCT01721746|66008556|FG000|Pre-Treatment|Withdrawal by Subject|1|||
23623699|NCT01721746|66008557|FG001|Pre-Treatment|Withdrawal by Subject|16|||
23623700|NCT01721746|66008556|FG000|Pre-Treatment|Poor/Non-compliance|1|||
23623701|NCT01721746|66008557|FG001|Pre-Treatment|Poor/Non-compliance|0|||
23623702|NCT01721746|66008556|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
23623703|NCT01721746|66008557|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
23623704|NCT01721746|66008556|FG000|Treatment|Disease Progression|192|||
23623705|NCT01721746|66008557|FG001|Treatment|Disease Progression|74|||
23623706|NCT01721746|66008556|FG000|Treatment|Study Drug Toxicity|19|||
23623707|NCT01721746|66008557|FG001|Treatment|Study Drug Toxicity|11|||
23623708|NCT01721746|66008556|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
23623709|NCT01721746|66008557|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
23623710|NCT01721746|66008556|FG000|Treatment|Participant request to discontinue Study treatment|26|||
23623711|NCT01721746|66008557|FG001|Treatment|Participant request to discontinue Study treatment|7|||
23623712|NCT01721746|66008556|FG000|Treatment|Participant withdrew consent|4|||
23623713|NCT01721746|66008557|FG001|Treatment|Participant withdrew consent|2|||
23623714|NCT01721746|66008556|FG000|Treatment|Maximum Clinical Benefit|9|||
23623715|NCT01721746|66008557|FG001|Treatment|Maximum Clinical Benefit|3|||
23623716|NCT01721746|66008556|FG000|Treatment|Poor/Non-compliance|2|||
23623717|NCT01721746|66008557|FG001|Treatment|Poor/Non-compliance|0|||
23623718|NCT01721746|66008556|FG000|Treatment|Participant no longer met Study criteria|4|||
23623719|NCT01721746|66008557|FG001|Treatment|Participant no longer met Study criteria|0|||
23623720|NCT01721746|66008556|FG000|Treatment|Other reasons|6|||
23623721|NCT01721746|66008557|FG001|Treatment|Other reasons|2|||
23752027|NCT00902486|66470270|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23623722|NCT03517111|66008561|FG000|Enrolled|Withdrawal by Subject|0|||
23623723|NCT03517111|66008562|FG001|Enrolled|Withdrawal by Subject|1|||
23623724|NCT03517111|66008563|FG002|Enrolled|Withdrawal by Subject|0|||
23623725|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
23623726|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
23623727|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
23752028|NCT00902486|66470271|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23557098|NCT01951625|65766126|FG004|Treatment Period|Protocol Violation|2|||
23557099|NCT01951625|65766122|FG000|Treatment Period|Physician Decision|0|||
23557100|NCT01951625|65766123|FG001|Treatment Period|Physician Decision|0|||
23623728|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
23623729|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
23623730|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
23623731|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
23623732|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
23623733|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
23623734|NCT03517111|66008561|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
23752029|NCT00902486|66470272|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
23752030|NCT00902486|66470273|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23436098|NCT02798471|65340586|FG001|Overall Study|Adverse Event|2|||
23436099|NCT02798471|65340585|FG000|Overall Study|Physician Decision|3|||
23436100|NCT02798471|65340586|FG001|Overall Study|Physician Decision|7|||
23436101|NCT02798471|65340585|FG000|Overall Study|Death|2|||
23436102|NCT02798471|65340586|FG001|Overall Study|Death|3|||
23436103|NCT02798471|65340585|FG000|Overall Study|Lost to Follow-up|0|||
23436104|NCT02798471|65340586|FG001|Overall Study|Lost to Follow-up|1|||
23436105|NCT02798471|65340585|FG000|Overall Study|Other|5|||
23752031|NCT00902486|66470274|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23825083|NCT02548832|66741413|FG000|Overall Study|Lost to Follow-up|2|||
23825084|NCT02548832|66741414|FG001|Overall Study|Lost to Follow-up|2|||
23825085|NCT02548832|66741415|FG002|Overall Study|Lost to Follow-up|2|||
23557101|NCT01951625|65766124|FG002|Treatment Period|Physician Decision|0|||
23557102|NCT01951625|65766125|FG003|Treatment Period|Physician Decision|0|||
23557103|NCT01951625|65766126|FG004|Treatment Period|Physician Decision|1|||
23557104|NCT01951625|65766122|FG000|Treatment Period|Protocol driven decision point|0|||
23557105|NCT01951625|65766123|FG001|Treatment Period|Protocol driven decision point|5|||
23557106|NCT01951625|65766124|FG002|Treatment Period|Protocol driven decision point|0|||
23557107|NCT01951625|65766125|FG003|Treatment Period|Protocol driven decision point|2|||
23623735|NCT03517111|66008562|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
23623736|NCT03517111|66008563|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
23825086|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
23752032|NCT00902486|66470269|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23752033|NCT00902486|66470270|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23752034|NCT00902486|66470271|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23752035|NCT00902486|66470272|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
23752036|NCT00902486|66470273|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23752037|NCT00902486|66470274|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23752038|NCT00902486|66470269|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23752039|NCT00902486|66470270|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23752040|NCT00902486|66470271|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23752041|NCT00902486|66470272|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23752042|NCT00902486|66470273|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
23752043|NCT00902486|66470274|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
23752044|NCT00902486|66470269|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23752045|NCT00902486|66470270|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23752046|NCT00902486|66470271|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
23752047|NCT00902486|66470272|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
23752048|NCT00902486|66470273|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23752049|NCT00902486|66470274|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23752050|NCT00902486|66470269|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23752051|NCT00902486|66470270|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23752052|NCT00902486|66470271|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23752053|NCT00902486|66470272|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23752054|NCT00902486|66470273|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23752055|NCT00902486|66470274|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
23825087|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
23825088|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
23825089|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
23825090|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
23825091|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
23825092|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23623737|NCT00695136|66008564|FG000|Overall Study|Withdrawal by Subject|1|||
23623738|NCT00695136|66008564|FG000|Overall Study|unrelated adverse event|1|||
23436106|NCT02798471|65340586|FG001|Overall Study|Other|3|||
23436107|NCT02798471|65340585|FG000|Overall Study|Subject withdrew consent|0|||
23436108|NCT02798471|65340586|FG001|Overall Study|Subject withdrew consent|6|||
23436109|NCT02798471|65340585|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
23557108|NCT01951625|65766126|FG004|Treatment Period|Protocol driven decision point|1|||
23436110|NCT02798471|65340586|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
23752056|NCT00902486|66470269|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23752057|NCT00902486|66470270|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23752058|NCT00902486|66470271|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23752059|NCT00902486|66470272|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
23752060|NCT00902486|66470273|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23752061|NCT00902486|66470274|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23752062|NCT00902486|66470269|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23752063|NCT00902486|66470270|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23752064|NCT00902486|66470271|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
23752065|NCT00902486|66470272|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23752066|NCT00902486|66470273|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23752067|NCT00902486|66470274|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23752068|NCT00902486|66470269|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
23436111|NCT02798471|65340585|FG000|Overall Study|Randomized, but not treated|0|||
23436112|NCT02798471|65340586|FG001|Overall Study|Randomized, but not treated|2|||
23436113|NCT01673620|65340587|FG000|Overall Study|Adverse Event|1|||
23436114|NCT01673620|65340588|FG001|Overall Study|Adverse Event|0|||
23557109|NCT01951625|65766122|FG000|Treatment Period|Non compliance with study drug|1|||
23557110|NCT01951625|65766123|FG001|Treatment Period|Non compliance with study drug|2|||
23557111|NCT01951625|65766124|FG002|Treatment Period|Non compliance with study drug|2|||
23557112|NCT01951625|65766125|FG003|Treatment Period|Non compliance with study drug|0|||
23557113|NCT01951625|65766126|FG004|Treatment Period|Non compliance with study drug|0|||
23557114|NCT01951625|65766122|FG000|Treatment Period|Death|3|||
23557115|NCT01951625|65766123|FG001|Treatment Period|Death|2|||
23557116|NCT01951625|65766124|FG002|Treatment Period|Death|2|||
23557117|NCT01951625|65766125|FG003|Treatment Period|Death|1|||
23557118|NCT01951625|65766126|FG004|Treatment Period|Death|2|||
23557119|NCT01951625|65766122|FG000|Treatment Period|Adverse Event|7|||
23557120|NCT01951625|65766123|FG001|Treatment Period|Adverse Event|10|||
23557121|NCT01951625|65766124|FG002|Treatment Period|Adverse Event|9|||
23557122|NCT01951625|65766125|FG003|Treatment Period|Adverse Event|8|||
23557123|NCT01951625|65766126|FG004|Treatment Period|Adverse Event|8|||
23557124|NCT01951625|65766122|FG000|Treatment Period|Withdrawal by Subject|5|||
23557125|NCT01951625|65766123|FG001|Treatment Period|Withdrawal by Subject|2|||
23557126|NCT01951625|65766124|FG002|Treatment Period|Withdrawal by Subject|1|||
23557127|NCT01951625|65766125|FG003|Treatment Period|Withdrawal by Subject|7|||
23557128|NCT01951625|65766126|FG004|Treatment Period|Withdrawal by Subject|3|||
23557129|NCT01951625|65766122|FG000|Treatment Period|Lost to Follow-up|1|||
23557130|NCT01951625|65766123|FG001|Treatment Period|Lost to Follow-up|0|||
23557131|NCT01951625|65766124|FG002|Treatment Period|Lost to Follow-up|0|||
23557132|NCT01951625|65766125|FG003|Treatment Period|Lost to Follow-up|1|||
23557133|NCT01951625|65766126|FG004|Treatment Period|Lost to Follow-up|0|||
23557134|NCT01951625|65766122|FG000|Follow Up Period|Non-compliance with study drug|1|||
23557135|NCT01951625|65766123|FG001|Follow Up Period|Non-compliance with study drug|0|||
23557136|NCT01951625|65766124|FG002|Follow Up Period|Non-compliance with study drug|0|||
23557137|NCT01951625|65766125|FG003|Follow Up Period|Non-compliance with study drug|0|||
23557138|NCT01951625|65766126|FG004|Follow Up Period|Non-compliance with study drug|0|||
23557139|NCT01951625|65766122|FG000|Follow Up Period|Death|1|||
23557140|NCT01951625|65766123|FG001|Follow Up Period|Death|3|||
23557141|NCT01951625|65766124|FG002|Follow Up Period|Death|2|||
23557142|NCT01951625|65766125|FG003|Follow Up Period|Death|2|||
23557143|NCT01951625|65766126|FG004|Follow Up Period|Death|1|||
23557144|NCT01951625|65766122|FG000|Follow Up Period|Logistical difficulties|1|||
23557145|NCT01951625|65766123|FG001|Follow Up Period|Logistical difficulties|2|||
23623739|NCT02916706|66008565|FG000|Overall Study|Adverse Event|0|||
23623740|NCT02916706|66008566|FG001|Overall Study|Adverse Event|1|||
23623741|NCT02916706|66008565|FG000|Overall Study|Lost to Follow-up|0|||
23623742|NCT02916706|66008566|FG001|Overall Study|Lost to Follow-up|1|||
23436115|NCT00994643|65340589|FG000|Overall Study|Withdrawal by Subject|1|||
23436116|NCT02123576|65340592|FG000|Overall Study|Adverse Event|1|||
23436117|NCT02123576|65340593|FG001|Overall Study|Adverse Event|0|||
23752069|NCT00902486|66470270|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
23436118|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
23557146|NCT01951625|65766124|FG002|Follow Up Period|Logistical difficulties|0|||
23557147|NCT01951625|65766125|FG003|Follow Up Period|Logistical difficulties|0|||
23557148|NCT01951625|65766126|FG004|Follow Up Period|Logistical difficulties|0|||
23557149|NCT01951625|65766122|FG000|Follow Up Period|Adverse Event|0|||
23557150|NCT01951625|65766123|FG001|Follow Up Period|Adverse Event|3|||
23557151|NCT01951625|65766124|FG002|Follow Up Period|Adverse Event|2|||
23557152|NCT01951625|65766125|FG003|Follow Up Period|Adverse Event|3|||
23557153|NCT01951625|65766126|FG004|Follow Up Period|Adverse Event|5|||
23557154|NCT01951625|65766122|FG000|Follow Up Period|Withdrawal by Subject|4|||
23557155|NCT01951625|65766123|FG001|Follow Up Period|Withdrawal by Subject|1|||
23557156|NCT01951625|65766124|FG002|Follow Up Period|Withdrawal by Subject|0|||
23557157|NCT01951625|65766125|FG003|Follow Up Period|Withdrawal by Subject|5|||
23557158|NCT01951625|65766126|FG004|Follow Up Period|Withdrawal by Subject|3|||
23557159|NCT01951625|65766122|FG000|Follow Up Period|Lost to Follow-up|1|||
23557160|NCT01951625|65766123|FG001|Follow Up Period|Lost to Follow-up|0|||
23557161|NCT01951625|65766124|FG002|Follow Up Period|Lost to Follow-up|0|||
23557162|NCT01951625|65766125|FG003|Follow Up Period|Lost to Follow-up|1|||
23557163|NCT01951625|65766126|FG004|Follow Up Period|Lost to Follow-up|1|||
23557164|NCT01281644|65766127|FG000|Overall Study|Lost to Follow-up|3|||
23557165|NCT01281644|65766127|FG000|Overall Study|Withdrawal by Subject|2|||
23557166|NCT00409682|65766128|FG000|Open-label Induction Period|Adverse Event|1|||
23557167|NCT00409682|65766129|FG001|Open-label Induction Period|Adverse Event|0|||
23557168|NCT00409682|65766130|FG002|Open-label Induction Period|Adverse Event|0|||
23557169|NCT00409682|65766128|FG000|Open-label Induction Period|Lack of Efficacy|1|||
23557170|NCT00409682|65766129|FG001|Open-label Induction Period|Lack of Efficacy|0|||
23557171|NCT00409682|65766130|FG002|Open-label Induction Period|Lack of Efficacy|0|||
23557172|NCT00409682|65766128|FG000|Open-label Induction Period|Protocol Violation|1|||
23557173|NCT00409682|65766129|FG001|Open-label Induction Period|Protocol Violation|0|||
23557174|NCT00409682|65766130|FG002|Open-label Induction Period|Protocol Violation|0|||
23557175|NCT00409682|65766128|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
23557176|NCT00409682|65766129|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
23557177|NCT00409682|65766130|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
23557178|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
23557179|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
23557180|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
23557181|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
23557182|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
23557183|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
23557184|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
23557185|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
23557186|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
23557187|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
23557188|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
23557189|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
23557190|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
23557191|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
23557192|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
23557193|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
23557194|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
23557195|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
23557196|NCT05232864|65766131|FG000|Overall Study|Adverse Event|0|||
23557197|NCT05232864|65766132|FG001|Overall Study|Adverse Event|1|||
23752070|NCT00902486|66470271|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
23752071|NCT00902486|66470272|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
23752072|NCT00902486|66470273|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
23752073|NCT00902486|66470274|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
23557198|NCT05232864|65766131|FG000|Overall Study|Study terminated by sponsor|16|||
23557199|NCT05232864|65766132|FG001|Overall Study|Study terminated by sponsor|14|||
23557200|NCT02365519|65766133|FG000|Randomized and Treated|Adverse Event|0|||
23623743|NCT02916706|66008565|FG000|Overall Study|Physician Decision|1|||
23623744|NCT02916706|66008566|FG001|Overall Study|Physician Decision|0|||
23623745|NCT02916706|66008565|FG000|Overall Study|Protocol Violation|3|||
23752074|NCT00447265|66470275|FG000|Overall Study|Physician Decision|1|||
23752075|NCT00447265|66470276|FG001|Overall Study|Physician Decision|0|||
23752076|NCT00138658|66470280|FG000|Overall Study|Adverse Event|23|||
23752077|NCT00138658|66470280|FG000|Overall Study|Death|1|||
23752078|NCT00138658|66470280|FG000|Overall Study|Disease Progression|21|||
23752079|NCT00138658|66470280|FG000|Overall Study|Physician Decision|11|||
23752080|NCT00138658|66470280|FG000|Overall Study|Withdrawal by Subject|5|||
23752081|NCT00503035|66470281|FG000|Overall Study|Lost to Follow-up|2|||
23752082|NCT00503035|66470281|FG000|Overall Study|Physician Decision|3|||
23752083|NCT00503035|66470281|FG000|Overall Study|Ineligible|15|||
23752084|NCT00244881|66470282|FG000|Overall Study|Withdrawal by Subject|3|||
23752085|NCT03519386|66470285|FG000|Overall Study|Withdrawal by Subject|4|||
23752086|NCT03519386|66470286|FG001|Overall Study|Withdrawal by Subject|1|||
23752087|NCT03519386|66470287|FG002|Overall Study|Withdrawal by Subject|2|||
23752088|NCT03519386|66470285|FG000|Overall Study|Physician Decision|1|||
23752089|NCT03519386|66470286|FG001|Overall Study|Physician Decision|1|||
23752090|NCT03519386|66470287|FG002|Overall Study|Physician Decision|1|||
23752091|NCT03519386|66470285|FG000|Overall Study|Lost to Follow-up|0|||
23752092|NCT03519386|66470286|FG001|Overall Study|Lost to Follow-up|1|||
23557201|NCT02365519|65766134|FG001|Randomized and Treated|Adverse Event|1|||
23557202|NCT02365519|65766135|FG002|Randomized and Treated|Adverse Event|0|||
23557203|NCT02365519|65766133|FG000|Randomized and Treated|Withdrawal by Subject|0|||
23557204|NCT02365519|65766134|FG001|Randomized and Treated|Withdrawal by Subject|1|||
23557205|NCT02365519|65766135|FG002|Randomized and Treated|Withdrawal by Subject|1|||
23557206|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
23557207|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
23557208|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
23557209|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
23557210|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
23557211|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
23557212|NCT00337272|65766136|FG000|Treatment Period|Non-compliance|1|||
23557213|NCT00337272|65766137|FG001|Treatment Period|Non-compliance|1|||
23557214|NCT00337272|65766136|FG000|Treatment Period|Withdrawal by Subject|0|||
23557215|NCT00337272|65766137|FG001|Treatment Period|Withdrawal by Subject|1|||
23557216|NCT00337272|65766136|FG000|Withdrawal Period|Non-compliance|0|||
23557217|NCT00337272|65766137|FG001|Withdrawal Period|Non-compliance|1|||
23557218|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
23557219|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
23557220|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
23557221|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
23557222|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
23557223|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
23557224|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Death|1|||
23557225|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Death|0|||
23557226|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Adverse Event|1|||
23557227|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Adverse Event|0|||
23557228|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Physician Decision|2|||
23557229|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Physician Decision|1|||
23557230|NCT02586025|65766138|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
23557231|NCT02586025|65766139|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
23557232|NCT02586025|65766138|FG000|Adjuvant Treatment|Recurrent Disease|4|||
23557233|NCT02586025|65766139|FG001|Adjuvant Treatment|Recurrent Disease|5|||
23557234|NCT02586025|65766138|FG000|Adjuvant Treatment|Physician Decision|0|||
23557235|NCT02586025|65766139|FG001|Adjuvant Treatment|Physician Decision|1|||
23557236|NCT02586025|65766138|FG000|Adjuvant Treatment|Pregnancy|1|||
23557237|NCT02586025|65766139|FG001|Adjuvant Treatment|Pregnancy|0|||
23557238|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Death|11|||
23557239|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Death|11|||
23557240|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
23557241|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
23557242|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
23557243|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
23557244|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
23557245|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
23557246|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
23557247|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
23557248|NCT01877408|65766141|FG000|Overall Study|Lost to Follow-up|0|||
23557249|NCT01877408|65766142|FG001|Overall Study|Lost to Follow-up|2|||
23557250|NCT01552954|65766143|FG000|Overall Study|Adverse Event|1|||
23557251|NCT01552954|65766144|FG001|Overall Study|Adverse Event|2|||
23557252|NCT01552954|65766143|FG000|Overall Study|Lost to Follow-up|1|||
23557253|NCT01552954|65766144|FG001|Overall Study|Lost to Follow-up|1|||
23557254|NCT01552954|65766143|FG000|Overall Study|Withdrawal by Subject|1|||
23557255|NCT01552954|65766144|FG001|Overall Study|Withdrawal by Subject|1|||
23557256|NCT01552954|65766143|FG000|Overall Study|Protocol Violation|1|||
23557257|NCT01552954|65766144|FG001|Overall Study|Protocol Violation|2|||
23557258|NCT01552954|65766143|FG000|Overall Study|diagnosed DM|1|||
23557259|NCT01552954|65766144|FG001|Overall Study|diagnosed DM|0|||
23557260|NCT01362439|65766145|FG000|Overall Study|Adverse Event|1|||
23557261|NCT01362439|65766145|FG000|Overall Study|Lack of Efficacy|3|||
23557262|NCT01362439|65766145|FG000|Overall Study|Lost to Follow-up|2|||
23557263|NCT01362439|65766145|FG000|Overall Study|Study medication non-compliant|1|||
23752093|NCT03519386|66470287|FG002|Overall Study|Lost to Follow-up|1|||
23752094|NCT03519386|66470285|FG000|Overall Study|Death|1|||
23752095|NCT03519386|66470286|FG001|Overall Study|Death|0|||
23557264|NCT01362439|65766145|FG000|Overall Study|Participant who withdrew consent|8|||
23752096|NCT03519386|66470287|FG002|Overall Study|Death|4|||
23557265|NCT01648348|65766154|FG000|Overall Study|Cancel|1|||
23557266|NCT01648348|65766155|FG001|Overall Study|Cancel|0|||
23557267|NCT01648348|65766156|FG002|Overall Study|Cancel|0|||
23557268|NCT01648348|65766157|FG003|Overall Study|Cancel|0|||
23557269|NCT01648348|65766158|FG004|Overall Study|Cancel|3|||
23557270|NCT01648348|65766159|FG005|Overall Study|Cancel|6|||
23557271|NCT01648348|65766154|FG000|Overall Study|Replaced for MTD analysis|1|||
23557272|NCT01648348|65766155|FG001|Overall Study|Replaced for MTD analysis|0|||
23557273|NCT01648348|65766156|FG002|Overall Study|Replaced for MTD analysis|1|||
23557274|NCT01648348|65766157|FG003|Overall Study|Replaced for MTD analysis|0|||
23557275|NCT01648348|65766158|FG004|Overall Study|Replaced for MTD analysis|0|||
23557276|NCT01648348|65766159|FG005|Overall Study|Replaced for MTD analysis|0|||
23557277|NCT02690974|65766168|FG000|Overall Study|Adverse Event|16|||
23557278|NCT02690974|65766168|FG000|Overall Study|Death|9|||
23557279|NCT02690974|65766168|FG000|Overall Study|Subject/guardian decision|4|||
23557280|NCT02690974|65766168|FG000|Overall Study|Lost to Follow-up|3|||
23557281|NCT02690974|65766168|FG000|Overall Study|Withdrawal of Informed Consent|3|||
23557282|NCT02690974|65766168|FG000|Overall Study|Physician Decision|2|||
23557283|NCT02690974|65766168|FG000|Overall Study|Non-compliance with study treatment|1|||
23557284|NCT02690974|65766168|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23557285|NCT02690974|65766168|FG000|Overall Study|Protocol Deviation|1|||
23557286|NCT01875185|65766169|FG000|Overall Study|study was terminated|52|||
23557287|NCT01875185|65766170|FG001|Overall Study|study was terminated|48|||
23557288|NCT02048072|65766171|FG000|Overall Study|Adverse Event|3|||
23557289|NCT02048072|65766171|FG000|Overall Study|Lost to Follow-up|1|||
23557290|NCT00526630|65766174|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
23557291|NCT00526630|65766175|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
23557292|NCT00526630|65766174|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
23557293|NCT00526630|65766175|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
23557294|NCT02219048|65766176|FG000|Overall Study|Adverse Event|2|||
23557295|NCT02219048|65766177|FG001|Overall Study|Adverse Event|5|||
23557296|NCT02219048|65766176|FG000|Overall Study|No longer meets eligibility criteria|1|||
23557297|NCT02219048|65766177|FG001|Overall Study|No longer meets eligibility criteria|0|||
23557298|NCT02219048|65766176|FG000|Overall Study|Study terminated by sponsor|16|||
23557299|NCT02219048|65766177|FG001|Overall Study|Study terminated by sponsor|15|||
23557300|NCT02219048|65766176|FG000|Overall Study|Withdrawal by Subject|2|||
23557301|NCT02219048|65766177|FG001|Overall Study|Withdrawal by Subject|0|||
23557302|NCT02219048|65766176|FG000|Overall Study|Other|0|||
23557303|NCT02219048|65766177|FG001|Overall Study|Other|1|||
23557304|NCT02623322|65766181|FG000|Overall Study|Lost to Follow-up|2|||
23557305|NCT02623322|65766182|FG001|Overall Study|Lost to Follow-up|1|||
23557306|NCT02623322|65766183|FG002|Overall Study|Lost to Follow-up|0|||
23557307|NCT04918784|65766184|FG000|Overall Study|Amputation - no longer eligible|1|||
23557308|NCT04918784|65766185|FG001|Overall Study|Amputation - no longer eligible|2|||
23557309|NCT04918784|65766184|FG000|Overall Study|Death|1|||
23557310|NCT04918784|65766185|FG001|Overall Study|Death|0|||
23557311|NCT04918784|65766184|FG000|Overall Study|patient non-compliance|3|||
23557312|NCT04918784|65766185|FG001|Overall Study|patient non-compliance|1|||
23557313|NCT04918784|65766184|FG000|Overall Study|Adverse Event|1|||
23557314|NCT04918784|65766185|FG001|Overall Study|Adverse Event|0|||
23557315|NCT02276222|65766186|FG000|Overall Study|Adverse Event|62|||
23557316|NCT02276222|65766187|FG001|Overall Study|Adverse Event|11|||
23557317|NCT02276222|65766186|FG000|Overall Study|Death|3|||
23557318|NCT02276222|65766187|FG001|Overall Study|Death|4|||
23557319|NCT02276222|65766186|FG000|Overall Study|Lack of Efficacy|13|||
23557320|NCT02276222|65766187|FG001|Overall Study|Lack of Efficacy|3|||
23557321|NCT02276222|65766186|FG000|Overall Study|Protocol Violation|3|||
23557322|NCT02276222|65766187|FG001|Overall Study|Protocol Violation|2|||
23557323|NCT02276222|65766186|FG000|Overall Study|Withdrawal by Subject|79|||
23557324|NCT02276222|65766187|FG001|Overall Study|Withdrawal by Subject|33|||
23557325|NCT02276222|65766186|FG000|Overall Study|non compliance with study medication|6|||
23557326|NCT02276222|65766187|FG001|Overall Study|non compliance with study medication|2|||
23557327|NCT02276222|65766186|FG000|Overall Study|sponsor decision|0|||
23557328|NCT02276222|65766187|FG001|Overall Study|sponsor decision|3|||
23752097|NCT03519386|66470285|FG000|Overall Study|Adverse Event|2|||
23752098|NCT03519386|66470286|FG001|Overall Study|Adverse Event|1|||
23752099|NCT03519386|66470287|FG002|Overall Study|Adverse Event|2|||
23752100|NCT03519386|66470285|FG000|Overall Study|Explanted|2|||
23752101|NCT03519386|66470286|FG001|Overall Study|Explanted|1|||
23752102|NCT03519386|66470287|FG002|Overall Study|Explanted|0|||
23752103|NCT03519386|66470285|FG000|Overall Study|Ongoing in study|190|||
23752104|NCT03519386|66470286|FG001|Overall Study|Ongoing in study|192|||
23752105|NCT03519386|66470287|FG002|Overall Study|Ongoing in study|183|||
23752106|NCT00455923|66470288|FG000|Overall Study|Pregnancy|0|||
23752107|NCT00455923|66470289|FG001|Overall Study|Pregnancy|2|||
23557329|NCT02276222|65766186|FG000|Overall Study|Lost to Follow-up|15|||
23557330|NCT02276222|65766187|FG001|Overall Study|Lost to Follow-up|5|||
23557331|NCT02276222|65766186|FG000|Overall Study|Physician Decision|2|||
23557332|NCT02276222|65766187|FG001|Overall Study|Physician Decision|1|||
23557333|NCT02276222|65766186|FG000|Overall Study|sheduling conflict|1|||
23557334|NCT02276222|65766187|FG001|Overall Study|sheduling conflict|0|||
23557335|NCT02276222|65766186|FG000|Overall Study|subject withdrew after randomization|1|||
23557336|NCT02276222|65766187|FG001|Overall Study|subject withdrew after randomization|0|||
23752108|NCT00455923|66470288|FG000|Overall Study|Other|3|||
23752109|NCT00455923|66470289|FG001|Overall Study|Other|1|||
23623746|NCT02916706|66008566|FG001|Overall Study|Protocol Violation|1|||
23752110|NCT04980391|66470290|FG000|Overall Study|Death|0|||
23752111|NCT04980391|66470291|FG001|Overall Study|Death|0|||
23752112|NCT04980391|66470292|FG002|Overall Study|Death|1|||
23752113|NCT04980391|66470293|FG003|Overall Study|Death|1|||
23752114|NCT04980391|66470290|FG000|Overall Study|Lost to Follow-up|3|||
23752115|NCT04980391|66470291|FG001|Overall Study|Lost to Follow-up|3|||
23752116|NCT04980391|66470292|FG002|Overall Study|Lost to Follow-up|2|||
23752117|NCT04980391|66470293|FG003|Overall Study|Lost to Follow-up|3|||
23752118|NCT04980391|66470290|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
23752119|NCT04980391|66470291|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23752120|NCT04980391|66470292|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23436119|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
23557337|NCT04493931|65766188|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
23557338|NCT04493931|65766189|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557339|NCT04493931|65766190|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557340|NCT04493931|65766191|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557341|NCT04493931|65766192|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557342|NCT04493931|65766193|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557343|NCT04493931|65766194|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557344|NCT04493931|65766188|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557345|NCT04493931|65766189|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
23557346|NCT04493931|65766190|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557347|NCT04493931|65766191|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557348|NCT04493931|65766192|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557349|NCT04493931|65766193|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557350|NCT04493931|65766194|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557351|NCT04493931|65766188|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557352|NCT04493931|65766189|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
23557353|NCT04493931|65766190|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557354|NCT04493931|65766191|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557355|NCT04493931|65766192|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557356|NCT04493931|65766193|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557357|NCT04493931|65766194|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557358|NCT04493931|65766188|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557359|NCT04493931|65766189|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557360|NCT04493931|65766190|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
23557361|NCT04493931|65766191|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557362|NCT04493931|65766192|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557363|NCT04493931|65766193|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557364|NCT04493931|65766194|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557365|NCT01533493|65766195|FG000|Overall Study|Adverse Event|2|||
23557366|NCT01533493|65766196|FG001|Overall Study|Adverse Event|1|||
23557367|NCT01533493|65766195|FG000|Overall Study|Withdrawal by Subject|1|||
23557368|NCT01533493|65766196|FG001|Overall Study|Withdrawal by Subject|2|||
23557369|NCT01533493|65766195|FG000|Overall Study|Lost to Follow-up|2|||
23557370|NCT01533493|65766196|FG001|Overall Study|Lost to Follow-up|0|||
23557371|NCT00266825|65766197|FG000|Completed Follow-Up|Lost to Follow-up|14|||
23557372|NCT00266825|65766198|FG001|Completed Follow-Up|Lost to Follow-up|19|||
23557373|NCT00266825|65766197|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
23557374|NCT00266825|65766198|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
23557375|NCT02543658|65766202|FG000|Overall Study|Lack of Efficacy|0|||
23557376|NCT02543658|65766203|FG001|Overall Study|Lack of Efficacy|4|||
23557377|NCT01621126|65766206|FG000|Overall Study|Physician Decision|6|||
23557378|NCT04241094|65766207|FG000|Overall Study|Dropped out of treatment|4|||
23557379|NCT04241094|65766207|FG000|Overall Study|Ineligible after clinical assessment|2|||
23557380|NCT04241094|65766207|FG000|Overall Study|Lost to Follow-up|2|||
23557381|NCT00766675|65769304|FG000|Overall Study|Adverse Event|16|||
23557382|NCT00766675|65769304|FG000|Overall Study|Lost to Follow-up|2|||
23557383|NCT00766675|65769304|FG000|Overall Study|Withdrawal by Subject|11|||
23557384|NCT00766675|65769304|FG000|Overall Study|Protocol Violation|8|||
23557385|NCT00766675|65769304|FG000|Overall Study|Participant took prohibited medication|1|||
23557386|NCT00766675|65769304|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
23557387|NCT00766675|65769304|FG000|Overall Study|Insufficient therapy|1|||
23752121|NCT04980391|66470293|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23436120|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
23557388|NCT00522301|65769305|FG000|Overall Study|Withdrawal by Subject|1|||
23557389|NCT00522301|65769305|FG000|Overall Study|Adverse Event|5|||
23557390|NCT03466086|65769306|FG000|Period 1|Sponsor decision due to study timeline|1|||
23752122|NCT04980391|66470290|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23623747|NCT02916706|66008565|FG000|Overall Study|Withdrawal by Subject|6|||
23623748|NCT02916706|66008566|FG001|Overall Study|Withdrawal by Subject|9|||
23623749|NCT02916706|66008565|FG000|Overall Study|Other|5|||
23623750|NCT02916706|66008566|FG001|Overall Study|Other|19|||
23623751|NCT00719212|66008567|FG000|Overall Study|Death|41|||
23752123|NCT04980391|66470291|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23752124|NCT04980391|66470292|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23752125|NCT04980391|66470293|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23752126|NCT04980391|66470290|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23752127|NCT04980391|66470291|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23752128|NCT04980391|66470292|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
23825093|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23825094|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
23752129|NCT04980391|66470293|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23752130|NCT00424632|66470294|FG000|Overall Study|Death|0|||
23752131|NCT00424632|66470295|FG001|Overall Study|Death|0|||
23752132|NCT00424632|66470296|FG002|Overall Study|Death|0|||
23752133|NCT00424632|66470297|FG003|Overall Study|Death|0|||
23752134|NCT00424632|66470298|FG004|Overall Study|Death|0|||
23752135|NCT00424632|66470299|FG005|Overall Study|Death|2|||
23752136|NCT00424632|66470300|FG006|Overall Study|Death|0|||
23752137|NCT00424632|66470301|FG007|Overall Study|Death|0|||
23752138|NCT00424632|66470302|FG008|Overall Study|Death|0|||
23752139|NCT00424632|66470303|FG009|Overall Study|Death|0|||
23752140|NCT00424632|66470294|FG000|Overall Study|Adverse Event|0|||
23752141|NCT00424632|66470295|FG001|Overall Study|Adverse Event|0|||
23752142|NCT00424632|66470296|FG002|Overall Study|Adverse Event|0|||
23752143|NCT00424632|66470297|FG003|Overall Study|Adverse Event|0|||
23752144|NCT00424632|66470298|FG004|Overall Study|Adverse Event|0|||
23752145|NCT00424632|66470299|FG005|Overall Study|Adverse Event|0|||
23752146|NCT00424632|66470300|FG006|Overall Study|Adverse Event|0|||
23752147|NCT00424632|66470301|FG007|Overall Study|Adverse Event|0|||
23752148|NCT00424632|66470302|FG008|Overall Study|Adverse Event|3|||
23752149|NCT00424632|66470303|FG009|Overall Study|Adverse Event|2|||
23752150|NCT00424632|66470294|FG000|Overall Study|Global deterioration of health status|0|||
23752151|NCT00424632|66470295|FG001|Overall Study|Global deterioration of health status|0|||
23752152|NCT00424632|66470296|FG002|Overall Study|Global deterioration of health status|0|||
23752153|NCT00424632|66470297|FG003|Overall Study|Global deterioration of health status|1|||
23752154|NCT00424632|66470298|FG004|Overall Study|Global deterioration of health status|1|||
23752155|NCT00424632|66470299|FG005|Overall Study|Global deterioration of health status|0|||
23752156|NCT00424632|66470300|FG006|Overall Study|Global deterioration of health status|0|||
23752157|NCT00424632|66470301|FG007|Overall Study|Global deterioration of health status|0|||
23752158|NCT00424632|66470302|FG008|Overall Study|Global deterioration of health status|0|||
23752159|NCT00424632|66470303|FG009|Overall Study|Global deterioration of health status|0|||
23752160|NCT00424632|66470294|FG000|Overall Study|Objective progression or relapse|1|||
23752161|NCT00424632|66470295|FG001|Overall Study|Objective progression or relapse|1|||
23752162|NCT00424632|66470296|FG002|Overall Study|Objective progression or relapse|1|||
23752163|NCT00424632|66470297|FG003|Overall Study|Objective progression or relapse|2|||
23752164|NCT00424632|66470298|FG004|Overall Study|Objective progression or relapse|2|||
23752165|NCT00424632|66470299|FG005|Overall Study|Objective progression or relapse|13|||
23752166|NCT00424632|66470300|FG006|Overall Study|Objective progression or relapse|7|||
23752167|NCT00424632|66470301|FG007|Overall Study|Objective progression or relapse|3|||
23752168|NCT00424632|66470302|FG008|Overall Study|Objective progression or relapse|12|||
23752169|NCT00424632|66470303|FG009|Overall Study|Objective progression or relapse|4|||
23752170|NCT00424632|66470294|FG000|Overall Study|Other|0|||
23752171|NCT00424632|66470295|FG001|Overall Study|Other|0|||
23752172|NCT00424632|66470296|FG002|Overall Study|Other|0|||
23752173|NCT00424632|66470297|FG003|Overall Study|Other|1|||
23825095|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
23825096|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
23825097|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
23825098|NCT02422797|66741416|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
23825099|NCT02422797|66741417|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
23752174|NCT00424632|66470298|FG004|Overall Study|Other|0|||
23752175|NCT00424632|66470299|FG005|Overall Study|Other|0|||
23752176|NCT00424632|66470300|FG006|Overall Study|Other|0|||
23752177|NCT00424632|66470301|FG007|Overall Study|Other|0|||
23752178|NCT00424632|66470302|FG008|Overall Study|Other|1|||
23752179|NCT00424632|66470303|FG009|Overall Study|Other|0|||
23752180|NCT04764669|66470304|FG000|Overall Study|Adverse Event|1|||
23752181|NCT04764669|66470305|FG001|Overall Study|Adverse Event|0|||
23752182|NCT04764669|66470306|FG002|Overall Study|Adverse Event|1|||
23752183|NCT04764669|66470307|FG003|Overall Study|Adverse Event|0|||
23752184|NCT04764669|66470304|FG000|Overall Study|Subject Choice|0|||
23623752|NCT00719212|66008567|FG000|Overall Study|Lost to Follow-up|2|||
23557391|NCT03466086|65769307|FG001|Period 1|Sponsor decision due to study timeline|0|||
23557392|NCT03466086|65769306|FG000|Period 1|Withdrawal by Subject|1|||
23557393|NCT03466086|65769307|FG001|Period 1|Withdrawal by Subject|0|||
23557394|NCT03576768|65769308|FG000|Overall Study|Lost to Follow-up|3|||
23557395|NCT03576768|65769309|FG001|Overall Study|Lost to Follow-up|3|||
23557396|NCT03576768|65769310|FG002|Overall Study|Lost to Follow-up|0|||
23557397|NCT03576768|65769311|FG003|Overall Study|Lost to Follow-up|0|||
23557398|NCT04123067|65769312|FG000|Overall Study|Lost to Follow-up|0|||
23557399|NCT04123067|65769313|FG001|Overall Study|Lost to Follow-up|1|||
23557400|NCT01806584|65769314|FG000|Overall Study|Adverse Event|2|||
23557401|NCT01806584|65769315|FG001|Overall Study|Adverse Event|1|||
23557402|NCT01806584|65769314|FG000|Overall Study|Death|1|||
23557403|NCT01806584|65769315|FG001|Overall Study|Death|0|||
23557404|NCT01806584|65769314|FG000|Overall Study|Lost to Follow-up|0|||
23557405|NCT01806584|65769315|FG001|Overall Study|Lost to Follow-up|2|||
23557406|NCT01806584|65769314|FG000|Overall Study|Study terminated by sponsor|9|||
23557407|NCT01806584|65769315|FG001|Overall Study|Study terminated by sponsor|14|||
23557408|NCT01806584|65769314|FG000|Overall Study|Withdrawal by Subject|1|||
23557409|NCT01806584|65769315|FG001|Overall Study|Withdrawal by Subject|1|||
23557410|NCT01806584|65769314|FG000|Overall Study|Other unspecified|1|||
23557411|NCT01806584|65769315|FG001|Overall Study|Other unspecified|0|||
23557412|NCT01235403|65769316|FG000|Overall Study|Adverse Event|14|||
23557413|NCT01235403|65769316|FG000|Overall Study|Lost to Follow-up|2|||
23557414|NCT01235403|65769316|FG000|Overall Study|Withdrawal by Subject|4|||
23557415|NCT01235403|65769316|FG000|Overall Study|Lack of Efficacy|2|||
23752185|NCT04764669|66470305|FG001|Overall Study|Subject Choice|0|||
23752186|NCT04764669|66470306|FG002|Overall Study|Subject Choice|1|||
23752187|NCT04764669|66470307|FG003|Overall Study|Subject Choice|0|||
23752188|NCT04764669|66470304|FG000|Overall Study|Withdrawal by Subject|2|||
23752189|NCT04764669|66470305|FG001|Overall Study|Withdrawal by Subject|0|||
23752190|NCT04764669|66470306|FG002|Overall Study|Withdrawal by Subject|0|||
23752191|NCT04764669|66470307|FG003|Overall Study|Withdrawal by Subject|0|||
23752192|NCT01525407|66470308|FG000|Overall Study|Change in recipient treatment plan|2|||
23752193|NCT01525407|66470309|FG001|Overall Study|Change in recipient treatment plan|2|||
23752194|NCT01525407|66470308|FG000|Overall Study|Withdrawal by Subject|0|||
23752195|NCT01525407|66470309|FG001|Overall Study|Withdrawal by Subject|1|||
23752196|NCT01525407|66470308|FG000|Overall Study|Transplant was delayed|0|||
23752197|NCT01525407|66470309|FG001|Overall Study|Transplant was delayed|1|||
23752198|NCT01525407|66470308|FG000|Overall Study|Delay in Transplant|1|||
23752199|NCT01525407|66470309|FG001|Overall Study|Delay in Transplant|0|||
23752200|NCT01612780|66470318|FG000|Overall Study|Treatment not completed|1|||
23752201|NCT01612780|66470318|FG000|Overall Study|Withdrawal by Subject|5|||
23752202|NCT01861717|66470319|FG000|Overall Study|Lost to Follow-up|1|||
23752203|NCT01861717|66470319|FG000|Overall Study|Withdrawal by Subject|1|||
23752204|NCT01976663|66470320|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
23752205|NCT01976663|66470320|FG000|Overall Study|Personal Reasons|6|||
23752206|NCT01976663|66470320|FG000|Overall Study|Withdrawal by Subject|4|||
23752207|NCT01976663|66470320|FG000|Overall Study|Screen Failure|3|||
23752208|NCT01976663|66470320|FG000|Overall Study|Adverse Event|2|||
23752209|NCT01976663|66470320|FG000|Overall Study|Lost to Follow-up|3|||
23752210|NCT00555399|66470321|FG000|Overall Study|Withdrawal by Subject|0|||
23752211|NCT00555399|66470322|FG001|Overall Study|Withdrawal by Subject|0|||
23752212|NCT00555399|66470323|FG002|Overall Study|Withdrawal by Subject|1|||
23752213|NCT00555399|66470324|FG003|Overall Study|Withdrawal by Subject|0|||
23752214|NCT00555399|66470325|FG004|Overall Study|Withdrawal by Subject|0|||
23752215|NCT00555399|66470326|FG005|Overall Study|Withdrawal by Subject|0|||
23752216|NCT00555399|66470327|FG006|Overall Study|Withdrawal by Subject|0|||
23752217|NCT00555399|66470328|FG007|Overall Study|Withdrawal by Subject|0|||
23752218|NCT00555399|66470329|FG008|Overall Study|Withdrawal by Subject|0|||
23752219|NCT00555399|66470330|FG009|Overall Study|Withdrawal by Subject|0|||
23752220|NCT00555399|66470331|FG010|Overall Study|Withdrawal by Subject|0|||
23752221|NCT00555399|66470332|FG011|Overall Study|Withdrawal by Subject|1|||
23752222|NCT00555399|66470321|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
23752223|NCT00555399|66470322|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
23752224|NCT00555399|66470323|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
23752225|NCT00555399|66470324|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
23752226|NCT00555399|66470325|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
23752227|NCT00555399|66470326|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
23752228|NCT00555399|66470327|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
23557416|NCT01235403|65769316|FG000|Overall Study|Other reasons for premature termination|4|||
23557417|NCT01678131|65769323|FG000|Overall Study|Adverse Event|0|||
23557418|NCT01678131|65769324|FG001|Overall Study|Adverse Event|1|||
23557419|NCT01678131|65769325|FG002|Overall Study|Adverse Event|0|||
23557420|NCT01678131|65769323|FG000|Overall Study|Withdrawal by Subject|0|||
23825100|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
23752229|NCT00555399|66470328|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
23752230|NCT00555399|66470329|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
23752231|NCT00555399|66470330|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
23752232|NCT00555399|66470331|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
23752233|NCT00555399|66470332|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
23752234|NCT03875235|66470333|FG000|Overall Study|Ongoing study treatment|63|||
23752235|NCT03875235|66470334|FG001|Overall Study|Ongoing study treatment|20|||
23752236|NCT03875235|66470333|FG000|Overall Study|Off treatment|77|||
23752237|NCT03875235|66470334|FG001|Overall Study|Off treatment|91|||
23752238|NCT03875235|66470333|FG000|Overall Study|Withdrawal by Subject|3|||
23752239|NCT03875235|66470334|FG001|Overall Study|Withdrawal by Subject|10|||
23752240|NCT03875235|66470333|FG000|Overall Study|Death|198|||
23752241|NCT03875235|66470334|FG001|Overall Study|Death|223|||
23752242|NCT02787785|66470335|FG000|Overall Study|Death|3|||
23752243|NCT02787785|66470336|FG001|Overall Study|Death|4|||
23752244|NCT02787785|66470335|FG000|Overall Study|Lost to Follow-up|1|||
23752245|NCT02787785|66470336|FG001|Overall Study|Lost to Follow-up|1|||
23752246|NCT02787785|66470335|FG000|Overall Study|Withdrawal by Subject|0|||
23752247|NCT02787785|66470336|FG001|Overall Study|Withdrawal by Subject|5|||
23752248|NCT00806416|66470342|FG000|Period 1 - Part I|Adverse Event|0|||
23752249|NCT00806416|66470343|FG001|Period 1 - Part I|Adverse Event|1|||
23752250|NCT00806416|66470344|FG002|Period 1 - Part I|Adverse Event|0|||
23752251|NCT00806416|66470345|FG003|Period 1 - Part I|Adverse Event|0|||
23752252|NCT00806416|66470342|FG000|Period 1 - Part I|Lost to Follow-up|0|||
23752253|NCT00806416|66470343|FG001|Period 1 - Part I|Lost to Follow-up|2|||
23752254|NCT00806416|66470344|FG002|Period 1 - Part I|Lost to Follow-up|0|||
23752255|NCT00806416|66470345|FG003|Period 1 - Part I|Lost to Follow-up|0|||
23752256|NCT00806416|66470342|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
23752257|NCT00806416|66470343|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
23752258|NCT00806416|66470344|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
23752259|NCT00806416|66470345|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
23752260|NCT00806416|66470342|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
23752261|NCT00806416|66470343|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
23752262|NCT00806416|66470344|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
23752263|NCT00806416|66470345|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
23557421|NCT01678131|65769324|FG001|Overall Study|Withdrawal by Subject|0|||
23557422|NCT01678131|65769325|FG002|Overall Study|Withdrawal by Subject|2|||
23557423|NCT00676130|65769326|FG000|Overall Study|Lost to Follow-up|0|||
23557424|NCT00676130|65769327|FG001|Overall Study|Lost to Follow-up|1|||
23557425|NCT00676130|65769326|FG000|Overall Study|Found ineligible|3|||
23557426|NCT00676130|65769327|FG001|Overall Study|Found ineligible|2|||
23557427|NCT00676130|65769326|FG000|Overall Study|Withdrawal by Subject|0|||
23557428|NCT00676130|65769327|FG001|Overall Study|Withdrawal by Subject|1|||
23557429|NCT00077064|65769328|FG000|Overall Study|Adverse Event|0|||
23557430|NCT00077064|65769329|FG001|Overall Study|Adverse Event|4|||
23557431|NCT00077064|65769328|FG000|Overall Study|Patient refusal|0|||
23557432|NCT00077064|65769329|FG001|Overall Study|Patient refusal|2|||
23557433|NCT01959425|65769331|FG000|Overall Study|Withdrawal by Subject|5|||
23557434|NCT01959425|65769332|FG001|Overall Study|Withdrawal by Subject|4|||
23557435|NCT01959425|65769331|FG000|Overall Study|Lost to Follow-up|1|||
23557436|NCT01959425|65769332|FG001|Overall Study|Lost to Follow-up|0|||
23557437|NCT01959425|65769331|FG000|Overall Study|Discontinued Subjects|6|||
23557438|NCT01959425|65769332|FG001|Overall Study|Discontinued Subjects|4|||
23557439|NCT02807636|65769335|FG000|Overall Study|Lost to Follow-up|9|||
23557440|NCT02807636|65769336|FG001|Overall Study|Lost to Follow-up|12|||
23557441|NCT02807636|65769337|FG002|Overall Study|Lost to Follow-up|6|||
23557442|NCT02807636|65769335|FG000|Overall Study|Protocol Deviation|2|||
23557443|NCT02807636|65769336|FG001|Overall Study|Protocol Deviation|0|||
23557444|NCT02807636|65769337|FG002|Overall Study|Protocol Deviation|0|||
23557445|NCT02807636|65769335|FG000|Overall Study|Symptomatic Deterioration|0|||
23557446|NCT02807636|65769336|FG001|Overall Study|Symptomatic Deterioration|1|||
23557447|NCT02807636|65769337|FG002|Overall Study|Symptomatic Deterioration|0|||
23557448|NCT02807636|65769335|FG000|Overall Study|Withdrawal by Subject|39|||
23557449|NCT02807636|65769336|FG001|Overall Study|Withdrawal by Subject|27|||
23557450|NCT02807636|65769337|FG002|Overall Study|Withdrawal by Subject|23|||
23557451|NCT02807636|65769335|FG000|Overall Study|Death|298|||
23752264|NCT02703454|66470346|FG000|Overall Study|Not treated|1|||
23752265|NCT02703454|66470347|FG001|Overall Study|Not treated|3|||
23752266|NCT02703454|66470346|FG000|Overall Study|Withdrawal by Subject|4|||
23752267|NCT02703454|66470347|FG001|Overall Study|Withdrawal by Subject|3|||
23752268|NCT02703454|66470346|FG000|Overall Study|Lost to Follow-up|1|||
23557452|NCT02807636|65769336|FG001|Overall Study|Death|327|||
23557453|NCT02807636|65769337|FG002|Overall Study|Death|266|||
23752269|NCT02703454|66470347|FG001|Overall Study|Lost to Follow-up|2|||
23752270|NCT02703454|66470346|FG000|Overall Study|Study discontinuation|5|||
23557454|NCT02807636|65769335|FG000|Overall Study|Ongoing in Study|52|||
23557455|NCT02807636|65769336|FG001|Overall Study|Ongoing in Study|84|||
23557456|NCT02807636|65769337|FG002|Overall Study|Ongoing in Study|67|||
23557457|NCT03703466|65769338|FG000|Overall Study|Death|2|||
23557458|NCT03703466|65769339|FG001|Overall Study|Death|1|||
23557459|NCT03703466|65769340|FG002|Overall Study|Death|0|||
23557460|NCT03703466|65769338|FG000|Overall Study|Withdrawal by Subject|0|||
23557461|NCT03703466|65769339|FG001|Overall Study|Withdrawal by Subject|3|||
23557462|NCT03703466|65769340|FG002|Overall Study|Withdrawal by Subject|0|||
23557463|NCT03703466|65769338|FG000|Overall Study|Completed < 3 Cycles|2|||
23557464|NCT03703466|65769339|FG001|Overall Study|Completed < 3 Cycles|2|||
23557465|NCT03703466|65769340|FG002|Overall Study|Completed < 3 Cycles|2|||
23557466|NCT00677235|65769343|FG000|Overall Study|Withdrawal by Subject|1|||
23557467|NCT00677235|65769344|FG001|Overall Study|Withdrawal by Subject|1|||
23557468|NCT00677235|65769343|FG000|Overall Study|Lost to Follow-up|2|||
23557469|NCT00677235|65769344|FG001|Overall Study|Lost to Follow-up|1|||
23557470|NCT00677235|65769343|FG000|Overall Study|Death|37|||
23557471|NCT00677235|65769344|FG001|Overall Study|Death|36|||
23557472|NCT00677235|65769343|FG000|Overall Study|Adverse Experience|1|||
23557473|NCT00677235|65769344|FG001|Overall Study|Adverse Experience|0|||
23557474|NCT00827541|65769349|FG000|Overall Study|Exitus|1|||
23557475|NCT00827541|65769350|FG001|Overall Study|Exitus|8|||
23557476|NCT00827541|65769349|FG000|Overall Study|Other|1|||
23557477|NCT00827541|65769350|FG001|Overall Study|Other|3|||
23557478|NCT00827541|65769349|FG000|Overall Study|Pathogen not susceptible|1|||
23557479|NCT00827541|65769350|FG001|Overall Study|Pathogen not susceptible|0|||
23557480|NCT00827541|65769349|FG000|Overall Study|Lack of effectiveness|1|||
23557481|NCT00827541|65769350|FG001|Overall Study|Lack of effectiveness|0|||
23557482|NCT03248375|65769351|FG000|Overall Study|Lost to Follow-up|5|||
23557483|NCT03520400|65769356|FG000|Overall Study|Physician Decision|15|||
23557484|NCT03520400|65769357|FG001|Overall Study|Physician Decision|7|||
23557485|NCT02191267|65769358|FG000|Overall Study|Withdrawal by Subject|1|||
23557486|NCT02191267|65769359|FG001|Overall Study|Withdrawal by Subject|0|||
23557487|NCT02191267|65769360|FG002|Overall Study|Withdrawal by Subject|0|||
23557488|NCT01693692|65769367|FG000|Overall Study|Withdrawal by Subject|12|||
23557489|NCT01693692|65769368|FG001|Overall Study|Withdrawal by Subject|10|||
23557490|NCT01693692|65769369|FG002|Overall Study|Withdrawal by Subject|11|||
23557491|NCT01693692|65769367|FG000|Overall Study|Adverse Event|7|||
23557492|NCT01693692|65769368|FG001|Overall Study|Adverse Event|14|||
23557493|NCT01693692|65769369|FG002|Overall Study|Adverse Event|9|||
23557494|NCT01693692|65769367|FG000|Overall Study|Physician Decision|0|||
23752271|NCT02703454|66470347|FG001|Overall Study|Study discontinuation|8|||
23752272|NCT02940392|66470348|FG000|Overall Study|Lost to Follow-up|3|||
23752273|NCT02940392|66470348|FG000|Overall Study|Retreatment|3|||
23752274|NCT02940392|66470348|FG000|Overall Study|Death|2|||
23752275|NCT00602927|66470350|FG000|Period 1: 13 Days|Protocol Violation|2|||
23752276|NCT00602927|66470351|FG001|Period 1: 13 Days|Protocol Violation|4|||
23752277|NCT00602927|66470350|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
23752278|NCT00602927|66470351|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
23752279|NCT00602927|66470350|FG000|Period 1: 13 Days|Time|1|||
23752280|NCT00602927|66470351|FG001|Period 1: 13 Days|Time|0|||
23752281|NCT00602927|66470350|FG000|Period 1: 13 Days|Claustrophobia|0|||
23752282|NCT00602927|66470351|FG001|Period 1: 13 Days|Claustrophobia|1|||
23752283|NCT00602927|66470350|FG000|Period 2: 14 Days|Protocol Violation|0|||
23752284|NCT00602927|66470351|FG001|Period 2: 14 Days|Protocol Violation|2|||
23752285|NCT00602927|66470350|FG000|Period 3: 13 Days|Protocol Violation|0|||
23752286|NCT00602927|66470351|FG001|Period 3: 13 Days|Protocol Violation|1|||
23752287|NCT00602927|66470350|FG000|Period 3: 13 Days|MRI data quality|2|||
23752288|NCT00602927|66470351|FG001|Period 3: 13 Days|MRI data quality|2|||
23752289|NCT01447628|66470357|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23752290|NCT01447628|66470358|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23752291|NCT01447628|66470359|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23752292|NCT01447628|66470360|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
23752293|NCT03130777|66470362|FG000|Overall Study|Death|0|||
23752294|NCT03130777|66470363|FG001|Overall Study|Death|1|||
23752295|NCT03130777|66470362|FG000|Overall Study|Did not meet eligibility criteria|1|||
23557495|NCT01693692|65769368|FG001|Overall Study|Physician Decision|0|||
23557496|NCT01693692|65769369|FG002|Overall Study|Physician Decision|1|||
23557497|NCT01693692|65769367|FG000|Overall Study|Protocol Violation|5|||
23557498|NCT01693692|65769368|FG001|Overall Study|Protocol Violation|4|||
23557499|NCT01693692|65769369|FG002|Overall Study|Protocol Violation|6|||
23557500|NCT01693692|65769367|FG000|Overall Study|Lost to Follow-up|2|||
23557501|NCT01693692|65769368|FG001|Overall Study|Lost to Follow-up|2|||
23557502|NCT01693692|65769369|FG002|Overall Study|Lost to Follow-up|3|||
23557503|NCT01693692|65769367|FG000|Overall Study|Other|4|||
23752296|NCT03130777|66470363|FG001|Overall Study|Did not meet eligibility criteria|0|||
23752297|NCT01833897|66470366|FG000|Overall Study|Lack of Efficacy|1|||
23752298|NCT00440193|66470367|FG000|Treatment Period|Adverse Event|74|||
23752299|NCT00440193|66470368|FG001|Treatment Period|Adverse Event|67|||
23752300|NCT00440193|66470367|FG000|Treatment Period|Death|19|||
23752301|NCT00440193|66470368|FG001|Treatment Period|Death|22|||
23752302|NCT00440193|66470367|FG000|Treatment Period|Lack of Efficacy|0|||
23752303|NCT00440193|66470368|FG001|Treatment Period|Lack of Efficacy|1|||
23752304|NCT00440193|66470367|FG000|Treatment Period|Lost to Follow-up|12|||
23752305|NCT00440193|66470368|FG001|Treatment Period|Lost to Follow-up|18|||
23752306|NCT00440193|66470367|FG000|Treatment Period|Physician Decision|3|||
23752307|NCT00440193|66470368|FG001|Treatment Period|Physician Decision|6|||
23752308|NCT00440193|66470367|FG000|Treatment Period|Protocol Violation|16|||
23752309|NCT00440193|66470368|FG001|Treatment Period|Protocol Violation|19|||
23752310|NCT00440193|66470367|FG000|Treatment Period|Withdrawal by Subject|36|||
23752311|NCT00440193|66470368|FG001|Treatment Period|Withdrawal by Subject|77|||
23752312|NCT00440193|66470367|FG000|Treatment Period|Clinical endpoint reached|28|||
23752313|NCT00440193|66470368|FG001|Treatment Period|Clinical endpoint reached|25|||
23752314|NCT00440193|66470367|FG000|Treatment Period|Study terminated by sponsor|102|||
23752315|NCT00440193|66470368|FG001|Treatment Period|Study terminated by sponsor|94|||
23752316|NCT00440193|66470367|FG000|Treatment Period|Protocol driven decision point|2|||
23752317|NCT00440193|66470368|FG001|Treatment Period|Protocol driven decision point|2|||
23752318|NCT00440193|66470367|FG000|Treatment Period|Switch to commercial drug|0|||
23752319|NCT00440193|66470368|FG001|Treatment Period|Switch to commercial drug|2|||
23752320|NCT00440193|66470367|FG000|Treatment Period|Technical problems|1|||
23752321|NCT00440193|66470368|FG001|Treatment Period|Technical problems|1|||
23752322|NCT00440193|66470367|FG000|Treatment Period|Participant convenience|5|||
23752323|NCT00440193|66470368|FG001|Treatment Period|Participant convenience|2|||
23752324|NCT00440193|66470367|FG000|Treatment Period|Participant did not receive treatment|7|||
23752325|NCT00440193|66470368|FG001|Treatment Period|Participant did not receive treatment|13|||
23752326|NCT00440193|66470367|FG000|Treatment Period|Site closed by investigator|0|||
23752327|NCT00440193|66470368|FG001|Treatment Period|Site closed by investigator|2|||
23752328|NCT00440193|66470367|FG000|Observational Period|Adverse Event|2|||
23752329|NCT00440193|66470368|FG001|Observational Period|Adverse Event|2|||
23752330|NCT00440193|66470367|FG000|Observational Period|Death|15|||
23752331|NCT00440193|66470368|FG001|Observational Period|Death|20|||
23752332|NCT00440193|66470367|FG000|Observational Period|Lost to Follow-up|12|||
23752333|NCT00440193|66470368|FG001|Observational Period|Lost to Follow-up|8|||
23752334|NCT00440193|66470367|FG000|Observational Period|Protocol Violation|1|||
23752335|NCT00440193|66470368|FG001|Observational Period|Protocol Violation|0|||
23752336|NCT00440193|66470367|FG000|Observational Period|Withdrawal by Subject|11|||
23752337|NCT00440193|66470368|FG001|Observational Period|Withdrawal by Subject|8|||
23752338|NCT00440193|66470367|FG000|Observational Period|Physician Decision|1|||
23752339|NCT00440193|66470368|FG001|Observational Period|Physician Decision|0|||
23752340|NCT00440193|66470367|FG000|Observational Period|Clinical endpoint reached|1|||
23752341|NCT00440193|66470368|FG001|Observational Period|Clinical endpoint reached|0|||
23752342|NCT00440193|66470367|FG000|Observational Period|Participant convenience|2|||
23752343|NCT00440193|66470368|FG001|Observational Period|Participant convenience|0|||
23752344|NCT00359073|66470369|FG000|Overall Study|Withdrawal by Subject|1|||
23752345|NCT00359073|66470370|FG001|Overall Study|Withdrawal by Subject|1|||
23752346|NCT00359073|66470369|FG000|Overall Study|Eligibility criteria no longer met|3|||
23752347|NCT00359073|66470370|FG001|Overall Study|Eligibility criteria no longer met|0|||
23752348|NCT00359073|66470369|FG000|Overall Study|developed RV16 antibody|0|||
23752349|NCT00359073|66470370|FG001|Overall Study|developed RV16 antibody|1|||
23752350|NCT00558831|66470373|FG000|Overall Study|Lost to Follow-up|1|||
23752351|NCT01977482|66470377|FG000|Overall Study|Adverse Event|0|||
23752352|NCT01977482|66470378|FG001|Overall Study|Adverse Event|1|||
23752353|NCT01977482|66470379|FG002|Overall Study|Adverse Event|1|||
23752354|NCT01977482|66470380|FG003|Overall Study|Adverse Event|0|||
23752355|NCT01977482|66470381|FG004|Overall Study|Adverse Event|2|||
23752356|NCT01977482|66470382|FG005|Overall Study|Adverse Event|0|||
23752357|NCT01977482|66470377|FG000|Overall Study|Lost to Follow-up|1|||
23752358|NCT01977482|66470378|FG001|Overall Study|Lost to Follow-up|0|||
23752359|NCT01977482|66470379|FG002|Overall Study|Lost to Follow-up|0|||
23752360|NCT01977482|66470380|FG003|Overall Study|Lost to Follow-up|0|||
23752361|NCT01977482|66470381|FG004|Overall Study|Lost to Follow-up|0|||
23752362|NCT01977482|66470382|FG005|Overall Study|Lost to Follow-up|0|||
23752363|NCT01977482|66470377|FG000|Overall Study|Physician Decision|0|||
23752364|NCT01977482|66470378|FG001|Overall Study|Physician Decision|1|||
23752365|NCT01977482|66470379|FG002|Overall Study|Physician Decision|0|||
23752366|NCT01977482|66470380|FG003|Overall Study|Physician Decision|0|||
23752367|NCT01977482|66470381|FG004|Overall Study|Physician Decision|0|||
23752368|NCT01977482|66470382|FG005|Overall Study|Physician Decision|0|||
23752369|NCT01977482|66470377|FG000|Overall Study|Protocol Violation|0|||
23752370|NCT01977482|66470378|FG001|Overall Study|Protocol Violation|0|||
23752371|NCT01977482|66470379|FG002|Overall Study|Protocol Violation|1|||
23752372|NCT01977482|66470380|FG003|Overall Study|Protocol Violation|0|||
23752373|NCT01977482|66470381|FG004|Overall Study|Protocol Violation|0|||
23752374|NCT01977482|66470382|FG005|Overall Study|Protocol Violation|0|||
23752375|NCT01977482|66470377|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23752376|NCT01977482|66470378|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
23752377|NCT01977482|66470379|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
23752378|NCT01977482|66470380|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
23752379|NCT01977482|66470381|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23752380|NCT01977482|66470382|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23752381|NCT01977482|66470377|FG000|Overall Study|Withdrawal by Subject|2|||
23752382|NCT01977482|66470378|FG001|Overall Study|Withdrawal by Subject|4|||
23752383|NCT01977482|66470379|FG002|Overall Study|Withdrawal by Subject|1|||
23752384|NCT01977482|66470380|FG003|Overall Study|Withdrawal by Subject|3|||
23752385|NCT01977482|66470381|FG004|Overall Study|Withdrawal by Subject|1|||
23752386|NCT01977482|66470382|FG005|Overall Study|Withdrawal by Subject|5|||
23752387|NCT04278872|66470384|FG000|Overall Study|Adverse Event|1|||
23752388|NCT04278872|66470385|FG001|Overall Study|Adverse Event|0|||
23623753|NCT00719212|66008567|FG000|Overall Study|Withdrawal by Subject|1|||
23623754|NCT03023423|66008568|FG000|Overall Study|Death|5|||
23623755|NCT03023423|66008569|FG001|Overall Study|Death|12|||
23623756|NCT03023423|66008570|FG002|Overall Study|Death|20|||
23623757|NCT03023423|66008568|FG000|Overall Study|Other|0|||
23623758|NCT03023423|66008569|FG001|Overall Study|Other|2|||
23623759|NCT03023423|66008570|FG002|Overall Study|Other|2|||
23623760|NCT03023423|66008568|FG000|Overall Study|Ongoing|2|||
23623761|NCT03023423|66008569|FG001|Overall Study|Ongoing|32|||
23623762|NCT03023423|66008570|FG002|Overall Study|Ongoing|24|||
23623763|NCT03991988|66008571|FG000|Overall Study|Withdrawal by Subject|2|||
23623764|NCT03991988|66008572|FG001|Overall Study|Withdrawal by Subject|2|||
23623765|NCT02196077|66008573|FG000|Overall Study|Adverse Event|4|||
23623766|NCT02196077|66008573|FG000|Overall Study|Lack of Efficacy|1|||
23623767|NCT02196077|66008573|FG000|Overall Study|Withdrawal by Subject|14|||
23623768|NCT02196077|66008573|FG000|Overall Study|Physician Decision|1|||
23623769|NCT02196077|66008573|FG000|Overall Study|Lost to Follow-up|3|||
23623770|NCT02196077|66008573|FG000|Overall Study|Protocol Violation|24|||
23623771|NCT00371462|66008574|FG000|Overall Study|Withdrawal by Subject|1|||
23623772|NCT00371462|66008575|FG001|Overall Study|Withdrawal by Subject|0|||
23623773|NCT00371462|66008574|FG000|Overall Study|Other|7|||
23623774|NCT00371462|66008575|FG001|Overall Study|Other|8|||
23623775|NCT01776008|66008576|FG000|Overall Study|ineligible|2|||
23623776|NCT02447432|66008577|FG000|Epoch 001|Adverse Event|1|||
23623777|NCT02447432|66008578|FG001|Epoch 001|Adverse Event|1|||
23623778|NCT02447432|66008577|FG000|Epoch 001|Withdrawal by Subject|0|||
23623779|NCT02447432|66008578|FG001|Epoch 001|Withdrawal by Subject|4|||
23623780|NCT02447432|66008577|FG000|Epoch 001|Migrated/moved from study area|3|||
23623781|NCT02447432|66008578|FG001|Epoch 001|Migrated/moved from study area|5|||
23623782|NCT02447432|66008577|FG000|Epoch 001|Lost to Follow-up|1|||
23623783|NCT02447432|66008578|FG001|Epoch 001|Lost to Follow-up|3|||
23623784|NCT00510146|66008581|FG000|Double-Blind Treatment|Adverse Event|30|||
23623785|NCT00510146|66008582|FG001|Double-Blind Treatment|Adverse Event|13|||
23623786|NCT00510146|66008581|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
23623787|NCT00510146|66008582|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
23623788|NCT00510146|66008581|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
23623789|NCT00510146|66008582|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
23623790|NCT00510146|66008581|FG000|Double-Blind Treatment|Physician Decision|6|||
23623791|NCT00510146|66008582|FG001|Double-Blind Treatment|Physician Decision|0|||
23623792|NCT00510146|66008581|FG000|Double-Blind Treatment|Protocol Violation|1|||
23623793|NCT00510146|66008582|FG001|Double-Blind Treatment|Protocol Violation|2|||
23623794|NCT00510146|66008581|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
23623795|NCT00510146|66008582|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
23623796|NCT00510146|66008581|FG000|Double-Blind Treatment|Clinical Relapse|0|||
23623797|NCT00510146|66008582|FG001|Double-Blind Treatment|Clinical Relapse|1|||
23623798|NCT00510146|66008581|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
23623799|NCT00510146|66008582|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
23623800|NCT00510146|66008581|FG000|Open-Label Treatment|Adverse Event|22|||
23623801|NCT00510146|66008582|FG001|Open-Label Treatment|Adverse Event|8|||
23623802|NCT00510146|66008581|FG000|Open-Label Treatment|Death|1|||
23623803|NCT00510146|66008582|FG001|Open-Label Treatment|Death|1|||
23623804|NCT00510146|66008581|FG000|Open-Label Treatment|Lack of Efficacy|4|||
23752389|NCT04278872|66470384|FG000|Overall Study|Protocol Violation|0|||
23752390|NCT04278872|66470385|FG001|Overall Study|Protocol Violation|1|||
23623805|NCT00510146|66008582|FG001|Open-Label Treatment|Lack of Efficacy|0|||
23623806|NCT00510146|66008581|FG000|Open-Label Treatment|Lost to Follow-up|10|||
23623807|NCT00510146|66008582|FG001|Open-Label Treatment|Lost to Follow-up|1|||
23623808|NCT00510146|66008581|FG000|Open-Label Treatment|Physician Decision|3|||
23623809|NCT00510146|66008582|FG001|Open-Label Treatment|Physician Decision|1|||
23623810|NCT00510146|66008581|FG000|Open-Label Treatment|Protocol Violation|4|||
23623811|NCT00510146|66008582|FG001|Open-Label Treatment|Protocol Violation|2|||
23623812|NCT00510146|66008581|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
23623813|NCT00510146|66008582|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
23623814|NCT00510146|66008581|FG000|Open-Label Treatment|Clinical Relapse|1|||
23752391|NCT04278872|66470384|FG000|Overall Study|Study Termination|2|||
23752392|NCT04278872|66470385|FG001|Overall Study|Study Termination|0|||
23752393|NCT00433771|66470386|FG000|Overall Study|screen fail|14|||
23752394|NCT00433771|66470386|FG000|Overall Study|Treated and later found to be ineligible|2|||
23752395|NCT00433771|66470386|FG000|Overall Study|Death|2|||
23752396|NCT00433771|66470386|FG000|Overall Study|Failure to deploy stent|1|||
23752397|NCT03252015|66470387|FG000|Overall Study|Withdrawal by Subject|0|||
23752398|NCT03252015|66470388|FG001|Overall Study|Withdrawal by Subject|1|||
23752399|NCT03252015|66470389|FG002|Overall Study|Withdrawal by Subject|1|||
23752400|NCT03252015|66470390|FG003|Overall Study|Withdrawal by Subject|0|||
23752401|NCT03252015|66470387|FG000|Overall Study|Adverse Event|1|||
23752402|NCT03252015|66470388|FG001|Overall Study|Adverse Event|0|||
23752403|NCT03252015|66470389|FG002|Overall Study|Adverse Event|0|||
23752404|NCT03252015|66470390|FG003|Overall Study|Adverse Event|1|||
23752405|NCT04635631|66470397|FG000|Overall Study|Adverse Event|1|||
23752406|NCT04635631|66470397|FG000|Overall Study|Progressive disease|13|||
23752407|NCT04635631|66470397|FG000|Overall Study|Withdrawal by Subject|1|||
23752408|NCT00518011|66470398|FG000|Overall Study|Death|1|||
23752409|NCT00518011|66470399|FG001|Overall Study|Death|1|||
23752410|NCT00518011|66470398|FG000|Overall Study|Adverse Event|2|||
23752411|NCT00518011|66470399|FG001|Overall Study|Adverse Event|3|||
23752412|NCT00518011|66470398|FG000|Overall Study|Disease Progression|2|||
23752413|NCT00518011|66470399|FG001|Overall Study|Disease Progression|2|||
23752414|NCT00518011|66470398|FG000|Overall Study|Other Reasons|3|||
23752415|NCT00518011|66470399|FG001|Overall Study|Other Reasons|2|||
23752416|NCT00518011|66470398|FG000|Overall Study|Withdrawal by Subject|1|||
23752417|NCT00518011|66470399|FG001|Overall Study|Withdrawal by Subject|0|||
23752418|NCT00782275|66470400|FG000|Overall Study|Adverse Event|11|||
23752419|NCT00782275|66470400|FG000|Overall Study|Withdrawal by Subject|1|||
23752420|NCT00782275|66470400|FG000|Overall Study|Progressive Disease|21|||
23752421|NCT00782275|66470400|FG000|Overall Study|Physician Decision|4|||
23752422|NCT00782275|66470400|FG000|Overall Study|Not started treatment|1|||
23752423|NCT00782275|66470400|FG000|Overall Study|Other|3|||
23752424|NCT00391092|66473979|FG000|Overall Study|Death|78|||
23752425|NCT00391092|66473980|FG001|Overall Study|Death|81|||
23752426|NCT00391092|66473979|FG000|Overall Study|Lost to Follow-up|13|||
23752427|NCT00391092|66473980|FG001|Overall Study|Lost to Follow-up|18|||
23752428|NCT00391092|66473979|FG000|Overall Study|Alive on treatment|29|||
23752429|NCT00391092|66473980|FG001|Overall Study|Alive on treatment|33|||
23752430|NCT00391092|66473979|FG000|Overall Study|Alive in follow-up|88|||
23752431|NCT00391092|66473980|FG001|Overall Study|Alive in follow-up|84|||
23752432|NCT01102972|66473983|FG000|Overall Study|Adverse Event|8|||
23752433|NCT01102972|66473984|FG001|Overall Study|Adverse Event|2|||
23752434|NCT01102972|66473983|FG000|Overall Study|Lack of Efficacy|2|||
23752435|NCT01102972|66473984|FG001|Overall Study|Lack of Efficacy|1|||
23752436|NCT01102972|66473983|FG000|Overall Study|Protocol Violation|1|||
23752437|NCT01102972|66473984|FG001|Overall Study|Protocol Violation|0|||
23752438|NCT01102972|66473983|FG000|Overall Study|Lost to Follow-up|10|||
23752439|NCT01102972|66473984|FG001|Overall Study|Lost to Follow-up|5|||
23752440|NCT01102972|66473983|FG000|Overall Study|Investigator Discretion|2|||
23752441|NCT01102972|66473984|FG001|Overall Study|Investigator Discretion|0|||
23752442|NCT01102972|66473983|FG000|Overall Study|Withdrawal by Subject|6|||
23752443|NCT01102972|66473984|FG001|Overall Study|Withdrawal by Subject|6|||
23752444|NCT02284373|66473985|FG000|Overall Study|Withdrawal by Subject|0|||
23752445|NCT02284373|66473986|FG001|Overall Study|Withdrawal by Subject|1|||
23752446|NCT02284373|66473987|FG002|Overall Study|Withdrawal by Subject|0|||
23752447|NCT02284373|66473985|FG000|Overall Study|Other|0|||
23752448|NCT02284373|66473986|FG001|Overall Study|Other|1|||
23752449|NCT02284373|66473987|FG002|Overall Study|Other|0|||
23752450|NCT02284373|66473985|FG000|Overall Study|Lost to Follow-up|0|||
23752451|NCT02284373|66473986|FG001|Overall Study|Lost to Follow-up|1|||
23557504|NCT01693692|65769368|FG001|Overall Study|Other|4|||
23752452|NCT02284373|66473987|FG002|Overall Study|Lost to Follow-up|0|||
23752453|NCT00630994|66473988|FG000|Overall Study|Adverse Event|1|||
23752454|NCT00630994|66473988|FG000|Overall Study|Disease Progression|1|||
23752455|NCT00630994|66473988|FG000|Overall Study|Lack of Efficacy|1|||
23752456|NCT00630994|66473988|FG000|Overall Study|Other|1|||
23752457|NCT00798707|66473989|FG000|Overall Study|Adverse Event|6|||
23752458|NCT00798707|66473990|FG001|Overall Study|Adverse Event|8|||
23752459|NCT00798707|66473991|FG002|Overall Study|Adverse Event|8|||
23752460|NCT00798707|66473989|FG000|Overall Study|Failed to return|2|||
23752461|NCT00798707|66473990|FG001|Overall Study|Failed to return|2|||
23752462|NCT00798707|66473991|FG002|Overall Study|Failed to return|0|||
23752463|NCT00798707|66473989|FG000|Overall Study|Investigator|0|||
23752464|NCT00798707|66473990|FG001|Overall Study|Investigator|1|||
23752465|NCT00798707|66473991|FG002|Overall Study|Investigator|2|||
23752466|NCT00798707|66473989|FG000|Overall Study|Lack of Efficacy|2|||
23752467|NCT00798707|66473990|FG001|Overall Study|Lack of Efficacy|2|||
23752468|NCT00798707|66473991|FG002|Overall Study|Lack of Efficacy|1|||
23752469|NCT00798707|66473989|FG000|Overall Study|Lost to Follow-up|5|||
23752470|NCT00798707|66473990|FG001|Overall Study|Lost to Follow-up|6|||
23436121|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
23436122|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
23436123|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
23436124|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
23436125|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
23436126|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
23436127|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
23436128|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
23436129|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
23436130|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
23436131|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
23436132|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
23436133|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
23825101|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
23825102|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
23825103|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
23825104|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
23825105|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
23825106|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
23825107|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
23825108|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
23825109|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
23825110|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
23825111|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
23825112|NCT02422797|66741416|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23825113|NCT02422797|66741417|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
23825114|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
23825115|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
23825116|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
23825117|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
23436134|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
23436135|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
23436136|NCT04079114|65340605|FG000|Overall Study|Study prematuely terminated.|166|||
23436137|NCT00488826|65340608|FG000|Overall Study|Withdrawal by Subject|40|||
23436138|NCT00488826|65340609|FG001|Overall Study|Withdrawal by Subject|35|||
23436139|NCT00488826|65340610|FG002|Overall Study|Withdrawal by Subject|19|||
23436140|NCT00488826|65340608|FG000|Overall Study|Protocol Violation|0|||
23436141|NCT00488826|65340609|FG001|Overall Study|Protocol Violation|0|||
23436142|NCT00488826|65340610|FG002|Overall Study|Protocol Violation|2|||
23436143|NCT00488826|65340608|FG000|Overall Study|Adverse Event|9|||
23436144|NCT00488826|65340609|FG001|Overall Study|Adverse Event|15|||
23752471|NCT00798707|66473991|FG002|Overall Study|Lost to Follow-up|6|||
23752472|NCT00798707|66473989|FG000|Overall Study|Other|0|||
23752473|NCT00798707|66473990|FG001|Overall Study|Other|1|||
23752474|NCT00798707|66473991|FG002|Overall Study|Other|0|||
23752475|NCT00798707|66473989|FG000|Overall Study|Protocol Violation|4|||
23752476|NCT00798707|66473990|FG001|Overall Study|Protocol Violation|0|||
23436145|NCT00488826|65340610|FG002|Overall Study|Adverse Event|4|||
23436146|NCT00488826|65340608|FG000|Overall Study|Lost to Follow-up|5|||
23436147|NCT00488826|65340609|FG001|Overall Study|Lost to Follow-up|1|||
23436148|NCT00488826|65340610|FG002|Overall Study|Lost to Follow-up|0|||
23436149|NCT00488826|65340608|FG000|Overall Study|Protocol Deviations|2|||
23436150|NCT00488826|65340609|FG001|Overall Study|Protocol Deviations|1|||
23436151|NCT00488826|65340610|FG002|Overall Study|Protocol Deviations|1|||
23436152|NCT00118430|65340613|FG000|Overall Study|Withdrawal by Subject|6|||
23436153|NCT00118430|65340614|FG001|Overall Study|Withdrawal by Subject|2|||
23436154|NCT00118430|65340615|FG002|Overall Study|Withdrawal by Subject|0|||
23436155|NCT00118430|65340613|FG000|Overall Study|Lost to Follow-up|15|||
23436156|NCT00118430|65340614|FG001|Overall Study|Lost to Follow-up|22|||
23436157|NCT00118430|65340615|FG002|Overall Study|Lost to Follow-up|28|||
23436158|NCT02508428|65340616|FG000|Overall Study|Death|32|||
23436159|NCT02508428|65340617|FG001|Overall Study|Death|33|||
23436160|NCT02508428|65340616|FG000|Overall Study|Liner revised|3|||
23436161|NCT02508428|65340617|FG001|Overall Study|Liner revised|19|||
23436162|NCT02508428|65340616|FG000|Overall Study|Incomplete follow-up|17|||
23436163|NCT02508428|65340617|FG001|Overall Study|Incomplete follow-up|15|||
23436164|NCT02478255|65340618|FG000|Overall Study|Physician Decision|6|||
23436165|NCT02478255|65340619|FG001|Overall Study|Physician Decision|0|||
23436166|NCT02478255|65340618|FG000|Overall Study|Withdrawal by Subject|2|||
23436167|NCT02478255|65340619|FG001|Overall Study|Withdrawal by Subject|0|||
23436168|NCT00398320|65340620|FG000|Overall Study|Death|1|||
23436169|NCT00398320|65340620|FG000|Overall Study|Adverse Event|4|||
23436170|NCT00398320|65340620|FG000|Overall Study|Physician Decision|1|||
23436171|NCT02828020|65340623|FG000|Treatment Period|Adverse Event|3|||
23436172|NCT02828020|65340624|FG001|Treatment Period|Adverse Event|1|||
23436173|NCT02828020|65340625|FG002|Treatment Period|Adverse Event|1|||
23436174|NCT02828020|65340623|FG000|Treatment Period|Withdrawal of Consent|10|||
23436175|NCT02828020|65340624|FG001|Treatment Period|Withdrawal of Consent|14|||
23436176|NCT02828020|65340625|FG002|Treatment Period|Withdrawal of Consent|9|||
23436177|NCT02828020|65340623|FG000|Treatment Period|Lost to Follow-up|21|||
23436178|NCT02828020|65340624|FG001|Treatment Period|Lost to Follow-up|24|||
23436179|NCT02828020|65340625|FG002|Treatment Period|Lost to Follow-up|18|||
23752477|NCT00798707|66473991|FG002|Overall Study|Protocol Violation|2|||
23752478|NCT00798707|66473989|FG000|Overall Study|Withdrawal by Subject|3|||
23752479|NCT00798707|66473990|FG001|Overall Study|Withdrawal by Subject|8|||
23752480|NCT00798707|66473991|FG002|Overall Study|Withdrawal by Subject|2|||
23752481|NCT00798707|66473989|FG000|Overall Study|Randomized not treated|4|||
23752482|NCT00798707|66473990|FG001|Overall Study|Randomized not treated|5|||
23752483|NCT00798707|66473991|FG002|Overall Study|Randomized not treated|1|||
23752484|NCT00883740|66473996|FG000|First Intervention|Lost to Follow-up|1|||
23752485|NCT00883740|66473997|FG001|First Intervention|Lost to Follow-up|0|||
23752486|NCT00883740|66473996|FG000|First Intervention|No longer willing to participate|2|||
23752487|NCT00883740|66473997|FG001|First Intervention|No longer willing to participate|0|||
23752488|NCT00883740|66473996|FG000|First Intervention|Protocol Violation|3|||
23752489|NCT00883740|66473997|FG001|First Intervention|Protocol Violation|6|||
23436180|NCT02828020|65340623|FG000|Treatment Period|Lack of Qualifying Event|44|||
23436181|NCT02828020|65340624|FG001|Treatment Period|Lack of Qualifying Event|53|||
23436182|NCT02828020|65340625|FG002|Treatment Period|Lack of Qualifying Event|43|||
23436183|NCT02828020|65340623|FG000|Treatment Period|Pregnancy|0|||
23436184|NCT02828020|65340624|FG001|Treatment Period|Pregnancy|2|||
23436185|NCT02828020|65340625|FG002|Treatment Period|Pregnancy|0|||
23436186|NCT02828020|65340623|FG000|Treatment Period|Protocol Violation|2|||
23436187|NCT02828020|65340624|FG001|Treatment Period|Protocol Violation|4|||
23436188|NCT02828020|65340625|FG002|Treatment Period|Protocol Violation|7|||
23436189|NCT02828020|65340623|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23436190|NCT02828020|65340624|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
23436191|NCT02828020|65340625|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
23436192|NCT02828020|65340623|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
23436193|NCT02828020|65340624|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
23436194|NCT02828020|65340625|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
23436195|NCT02828020|65340623|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
23436196|NCT02828020|65340624|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
23436197|NCT02828020|65340625|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
23436198|NCT02828020|65340623|FG000|Safety Follow-up Period|Protocol Violation|0|||
23436199|NCT02828020|65340624|FG001|Safety Follow-up Period|Protocol Violation|2|||
23436200|NCT02828020|65340625|FG002|Safety Follow-up Period|Protocol Violation|1|||
23436201|NCT02828020|65340623|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
23436202|NCT02828020|65340624|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23436203|NCT02828020|65340625|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23436204|NCT00679172|65340627|FG000|Overall Study|Non-compliance|1|||
23436205|NCT00679172|65340628|FG001|Overall Study|Non-compliance|1|||
23436206|NCT00679172|65340629|FG002|Overall Study|Non-compliance|0|||
23436207|NCT00679172|65340630|FG003|Overall Study|Non-compliance|1|||
23436208|NCT00679172|65340631|FG004|Overall Study|Non-compliance|0|||
23436209|NCT00679172|65340627|FG000|Overall Study|Other not specified|0|||
23436210|NCT00679172|65340628|FG001|Overall Study|Other not specified|0|||
23436211|NCT00679172|65340629|FG002|Overall Study|Other not specified|1|||
23436212|NCT00679172|65340630|FG003|Overall Study|Other not specified|0|||
23436213|NCT00679172|65340631|FG004|Overall Study|Other not specified|0|||
23436214|NCT01789606|65340633|FG000|Overall Study|Participant not Purchased the Product|0|||
23436215|NCT01789606|65340634|FG001|Overall Study|Participant not Purchased the Product|20|||
23436216|NCT01789606|65340633|FG000|Overall Study|Withdrawal by Subject|0|||
23436217|NCT01789606|65340634|FG001|Overall Study|Withdrawal by Subject|1|||
23436218|NCT01789606|65340633|FG000|Overall Study|Ineligible|6|||
23436219|NCT01789606|65340634|FG001|Overall Study|Ineligible|2|||
23436220|NCT01789606|65340633|FG000|Overall Study|Administrative Reasons|17|||
23436221|NCT01789606|65340634|FG001|Overall Study|Administrative Reasons|6|||
23436222|NCT01789606|65340633|FG000|Overall Study|No Study Medication Taken|0|||
23436223|NCT01789606|65340634|FG001|Overall Study|No Study Medication Taken|1|||
23436224|NCT01789606|65340633|FG000|Overall Study|Protocol Violation|0|||
23436225|NCT01789606|65340634|FG001|Overall Study|Protocol Violation|55|||
23436226|NCT01789606|65340633|FG000|Overall Study|Adverse Event|0|||
23436227|NCT01789606|65340634|FG001|Overall Study|Adverse Event|3|||
23436228|NCT01789606|65340633|FG000|Overall Study|Lost to Follow-up|0|||
23436229|NCT01789606|65340634|FG001|Overall Study|Lost to Follow-up|14|||
23436230|NCT01789606|65340633|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
23436231|NCT01789606|65340634|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
23752490|NCT00883740|66473996|FG000|First Intervention|Adverse Event|1|||
23752491|NCT00883740|66473997|FG001|First Intervention|Adverse Event|2|||
23752492|NCT00883740|66473996|FG000|Second Intervention|Protocol Violation|1|||
23752493|NCT00883740|66473997|FG001|Second Intervention|Protocol Violation|0|||
23752494|NCT00883740|66473996|FG000|Second Intervention|No longer willing to participate|0|||
23752495|NCT00883740|66473997|FG001|Second Intervention|No longer willing to participate|1|||
23752496|NCT03087773|66474009|FG000|Overall Study|Withdrawal by Subject|8|||
23752497|NCT03087773|66474010|FG001|Overall Study|Withdrawal by Subject|4|||
23752498|NCT03087773|66474009|FG000|Overall Study|Lost to Follow-up|12|||
23752499|NCT03087773|66474010|FG001|Overall Study|Lost to Follow-up|8|||
23752500|NCT03332212|66474011|FG000|Overall Study|Not treated|0|||
23752501|NCT03332212|66474012|FG001|Overall Study|Not treated|1|||
23752502|NCT03332212|66474013|FG002|Overall Study|Not treated|0|||
23752503|NCT03332212|66474014|FG003|Overall Study|Not treated|0|||
23752504|NCT03332212|66474011|FG000|Overall Study|Adverse Event|0|||
23752505|NCT03332212|66474012|FG001|Overall Study|Adverse Event|0|||
23752506|NCT03332212|66474013|FG002|Overall Study|Adverse Event|0|||
23752507|NCT03332212|66474014|FG003|Overall Study|Adverse Event|1|||
23752508|NCT03332212|66474011|FG000|Overall Study|worsening of disease under study|1|||
23752509|NCT03332212|66474012|FG001|Overall Study|worsening of disease under study|1|||
23752510|NCT03332212|66474013|FG002|Overall Study|worsening of disease under study|0|||
23752511|NCT03332212|66474014|FG003|Overall Study|worsening of disease under study|0|||
23752512|NCT01126359|66474016|FG000|First Intervention (20-minutes)|Physician Decision|0|||
23752513|NCT01126359|66474017|FG001|First Intervention (20-minutes)|Physician Decision|1|||
23752514|NCT01643928|66474018|FG000|Overall Study|Lost to Follow-up|1|||
23752515|NCT01643928|66474019|FG001|Overall Study|Lost to Follow-up|0|||
23752516|NCT01643928|66474020|FG002|Overall Study|Lost to Follow-up|2|||
23436232|NCT02039856|65340635|FG000|Overall Study|Death|5|||
23752517|NCT01643928|66474021|FG003|Overall Study|Lost to Follow-up|0|||
23752518|NCT01643928|66474022|FG004|Overall Study|Lost to Follow-up|0|||
23436233|NCT02039856|65340636|FG001|Overall Study|Death|3|||
23436234|NCT02039856|65340635|FG000|Overall Study|Partial survey completion|61|||
23436235|NCT02039856|65340636|FG001|Overall Study|Partial survey completion|26|||
23752519|NCT01643928|66474018|FG000|Overall Study|Withdrawal by Subject|2|||
23557505|NCT01693692|65769369|FG002|Overall Study|Other|6|||
23557506|NCT02272725|65769372|FG000|Overall Study|equipment malfunction|2|||
23557507|NCT02272725|65769373|FG001|Overall Study|equipment malfunction|0|||
23557508|NCT00696410|65769374|FG000|Overall Study|Lost to Follow-up|2|||
23557509|NCT00696410|65769375|FG001|Overall Study|Lost to Follow-up|0|||
23752520|NCT01643928|66474019|FG001|Overall Study|Withdrawal by Subject|0|||
23752521|NCT01643928|66474020|FG002|Overall Study|Withdrawal by Subject|0|||
23752522|NCT01643928|66474021|FG003|Overall Study|Withdrawal by Subject|1|||
23752523|NCT01643928|66474022|FG004|Overall Study|Withdrawal by Subject|0|||
23752524|NCT01643928|66474018|FG000|Overall Study|Pregnancy|0|||
23752525|NCT01643928|66474019|FG001|Overall Study|Pregnancy|0|||
23752526|NCT01643928|66474020|FG002|Overall Study|Pregnancy|0|||
23752527|NCT01643928|66474021|FG003|Overall Study|Pregnancy|1|||
23752528|NCT01643928|66474022|FG004|Overall Study|Pregnancy|0|||
23752529|NCT01643928|66474018|FG000|Overall Study|Other|5|||
23752530|NCT01643928|66474019|FG001|Overall Study|Other|1|||
23752531|NCT01643928|66474020|FG002|Overall Study|Other|1|||
23752532|NCT01643928|66474021|FG003|Overall Study|Other|0|||
23752533|NCT01643928|66474022|FG004|Overall Study|Other|0|||
23825118|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
23825119|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
23825120|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
23825121|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
23825122|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
23825123|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
23825124|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
23825125|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
23825126|NCT02422797|66741416|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
23557510|NCT00696410|65769374|FG000|Overall Study|Withdrawal by Subject|8|||
23752534|NCT01643928|66474018|FG000|Overall Study|Adverse Event|2|||
23752535|NCT01643928|66474019|FG001|Overall Study|Adverse Event|1|||
23752536|NCT01643928|66474020|FG002|Overall Study|Adverse Event|0|||
23557511|NCT00696410|65769375|FG001|Overall Study|Withdrawal by Subject|0|||
23557512|NCT00696410|65769374|FG000|Overall Study|Physician Decision|3|||
23557513|NCT00696410|65769375|FG001|Overall Study|Physician Decision|0|||
23623815|NCT00510146|66008582|FG001|Open-Label Treatment|Clinical Relapse|1|||
23623816|NCT00510146|66008581|FG000|Open-Label Treatment|Sponsor Decision|2|||
23752537|NCT01643928|66474021|FG003|Overall Study|Adverse Event|1|||
23752538|NCT01643928|66474022|FG004|Overall Study|Adverse Event|2|||
23752539|NCT00203892|66474023|FG000|Overall Study|Physician Decision|1|||
23752540|NCT00203892|66474024|FG001|Overall Study|Physician Decision|2|||
23752541|NCT00203892|66474025|FG002|Overall Study|Physician Decision|0|||
23752542|NCT00203892|66474023|FG000|Overall Study|Death|1|||
23752543|NCT00203892|66474024|FG001|Overall Study|Death|0|||
23752544|NCT00203892|66474025|FG002|Overall Study|Death|0|||
23752545|NCT01652872|66474026|FG000|Overall Study|Death|36|||
23752546|NCT01652872|66474027|FG001|Overall Study|Death|39|||
23752547|NCT01652872|66474026|FG000|Overall Study|Lost to Follow-up|28|||
23752548|NCT01652872|66474027|FG001|Overall Study|Lost to Follow-up|23|||
23752549|NCT01652872|66474026|FG000|Overall Study|Decision by sponsor|5|||
23752550|NCT01652872|66474027|FG001|Overall Study|Decision by sponsor|7|||
23436236|NCT02039856|65340635|FG000|Overall Study|Lost to Follow-up|388|||
23436237|NCT02039856|65340636|FG001|Overall Study|Lost to Follow-up|206|||
23436238|NCT02039856|65340635|FG000|Overall Study|Withdrawal by Subject|1573|||
23436239|NCT02039856|65340636|FG001|Overall Study|Withdrawal by Subject|618|||
23436240|NCT03675737|65340637|FG000|Overall Study|Death|593|||
23436241|NCT03675737|65340638|FG001|Overall Study|Death|660|||
23436242|NCT03675737|65340637|FG000|Overall Study|Lost to Follow-up|1|||
23436243|NCT03675737|65340638|FG001|Overall Study|Lost to Follow-up|5|||
23436244|NCT03675737|65340637|FG000|Overall Study|Physician Decision|1|||
23436245|NCT03675737|65340638|FG001|Overall Study|Physician Decision|0|||
23436246|NCT03675737|65340637|FG000|Overall Study|Withdrawal by Subject|14|||
23436247|NCT03675737|65340638|FG001|Overall Study|Withdrawal by Subject|12|||
23436248|NCT03675737|65340637|FG000|Overall Study|Ongoing in Study|181|||
23436249|NCT03675737|65340638|FG001|Overall Study|Ongoing in Study|112|||
23436250|NCT01374178|65340645|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
23436251|NCT01374178|65340646|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
23436252|NCT01374178|65340645|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
23436253|NCT01374178|65340646|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
23436254|NCT01736618|65340649|FG000|Overall Study|Death|294|||
23436255|NCT01736618|65340649|FG000|Overall Study|Lost to Follow-up|193|||
23436256|NCT01736618|65340649|FG000|Overall Study|Withdrawal by Subject|54|||
23436257|NCT01736618|65340649|FG000|Overall Study|Subject unable to be followed at study location|223|||
23436258|NCT01736618|65340649|FG000|Overall Study|Physician Decision|33|||
23436259|NCT01736618|65340649|FG000|Overall Study|Transplant or removal of target organ|19|||
23436260|NCT01736618|65340649|FG000|Overall Study|Change in indication or condition|78|||
23436261|NCT01736618|65340649|FG000|Overall Study|Study device explant|103|||
23436262|NCT01736618|65340649|FG000|Overall Study|Unable to complete implant|2|||
23436263|NCT03101085|65340651|FG000|Overall Study|Lost to Follow-up|0|||
23752551|NCT01652872|66474026|FG000|Overall Study|Withdrawal by Subject|76|||
23752552|NCT01652872|66474027|FG001|Overall Study|Withdrawal by Subject|84|||
23752553|NCT04578548|66474034|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23752554|NCT04578548|66474035|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23752555|NCT04578548|66474034|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
23752556|NCT04578548|66474035|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
23752557|NCT04578548|66474034|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
23752558|NCT04578548|66474035|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23752559|NCT04578548|66474034|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
23752560|NCT04578548|66474035|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
23752561|NCT04578548|66474034|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
23752562|NCT04578548|66474035|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23752563|NCT04578548|66474034|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
23752564|NCT04578548|66474035|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
23752565|NCT03256526|66474038|FG000|Overall Study|Adverse Event|1|||
23752566|NCT03256526|66474039|FG001|Overall Study|Adverse Event|0|||
23752567|NCT03256526|66474040|FG002|Overall Study|Adverse Event|1|||
23752568|NCT03256526|66474038|FG000|Overall Study|Lost to Follow-up|1|||
23752569|NCT03256526|66474039|FG001|Overall Study|Lost to Follow-up|0|||
23752570|NCT03256526|66474040|FG002|Overall Study|Lost to Follow-up|2|||
23752571|NCT01523301|66474041|FG000|Overall Study|Adverse Event|25|||
23752572|NCT01523301|66474042|FG001|Overall Study|Adverse Event|16|||
23752573|NCT01523301|66474041|FG000|Overall Study|Lack of Efficacy|0|||
23752574|NCT01523301|66474042|FG001|Overall Study|Lack of Efficacy|2|||
23752575|NCT01523301|66474041|FG000|Overall Study|Protocol Violation|3|||
23752576|NCT01523301|66474042|FG001|Overall Study|Protocol Violation|4|||
23752577|NCT01523301|66474041|FG000|Overall Study|Lost to Follow-up|1|||
23752578|NCT01523301|66474042|FG001|Overall Study|Lost to Follow-up|0|||
23752579|NCT01523301|66474041|FG000|Overall Study|Withdrawal by Subject|6|||
23752580|NCT01523301|66474042|FG001|Overall Study|Withdrawal by Subject|8|||
23752581|NCT01523301|66474041|FG000|Overall Study|Other Reason|0|||
23752582|NCT01523301|66474042|FG001|Overall Study|Other Reason|2|||
23752583|NCT00499252|66474043|FG000|Overall Study|Adverse Event|3|||
23752584|NCT00499252|66474043|FG000|Overall Study|Refused further treatment|2|||
23436264|NCT03101085|65340652|FG001|Overall Study|Lost to Follow-up|1|||
23436265|NCT02986854|65340654|FG000|Overall Study|Withdrawal by Subject|0|||
23752585|NCT00499252|66474043|FG000|Overall Study|Ineligible|4|||
23752586|NCT00499252|66474043|FG000|Overall Study|<no further label>|3|||
23752587|NCT04527549|66474044|FG000|Overall Study|Withdrawal by Subject|1|||
23752588|NCT04527549|66474045|FG001|Overall Study|Withdrawal by Subject|1|||
23752589|NCT01215955|66474052|FG000|Overall Study|Adverse Event|1|||
23436266|NCT02986854|65340655|FG001|Overall Study|Withdrawal by Subject|1|||
23752590|NCT01215955|66474053|FG001|Overall Study|Adverse Event|4|||
23752591|NCT01215955|66474054|FG002|Overall Study|Adverse Event|2|||
23752592|NCT01215955|66474055|FG003|Overall Study|Adverse Event|3|||
23752593|NCT01215955|66474052|FG000|Overall Study|Death|2|||
23752594|NCT01215955|66474053|FG001|Overall Study|Death|0|||
23752595|NCT01215955|66474054|FG002|Overall Study|Death|1|||
23752596|NCT01215955|66474055|FG003|Overall Study|Death|3|||
23752597|NCT01215955|66474052|FG000|Overall Study|Entry Criteria Not Met|1|||
23752598|NCT01215955|66474053|FG001|Overall Study|Entry Criteria Not Met|3|||
23752599|NCT01215955|66474054|FG002|Overall Study|Entry Criteria Not Met|4|||
23752600|NCT01215955|66474055|FG003|Overall Study|Entry Criteria Not Met|7|||
23752601|NCT01215955|66474052|FG000|Overall Study|Lack of Efficacy|1|||
23752602|NCT01215955|66474053|FG001|Overall Study|Lack of Efficacy|2|||
23752603|NCT01215955|66474054|FG002|Overall Study|Lack of Efficacy|1|||
23752604|NCT01215955|66474055|FG003|Overall Study|Lack of Efficacy|0|||
23752605|NCT01215955|66474052|FG000|Overall Study|Lost to Follow-up|4|||
23752606|NCT01215955|66474053|FG001|Overall Study|Lost to Follow-up|4|||
23752607|NCT01215955|66474054|FG002|Overall Study|Lost to Follow-up|8|||
23752608|NCT01215955|66474055|FG003|Overall Study|Lost to Follow-up|9|||
23752609|NCT01215955|66474052|FG000|Overall Study|Physician Decision|4|||
23752610|NCT01215955|66474053|FG001|Overall Study|Physician Decision|10|||
23752611|NCT01215955|66474054|FG002|Overall Study|Physician Decision|8|||
23752612|NCT01215955|66474055|FG003|Overall Study|Physician Decision|11|||
23752613|NCT01215955|66474052|FG000|Overall Study|Protocol Violation|17|||
23752614|NCT01215955|66474053|FG001|Overall Study|Protocol Violation|13|||
23752615|NCT01215955|66474054|FG002|Overall Study|Protocol Violation|8|||
23752616|NCT01215955|66474055|FG003|Overall Study|Protocol Violation|8|||
23752617|NCT01215955|66474052|FG000|Overall Study|Sponsor Decision|1|||
23436267|NCT02986854|65340656|FG002|Overall Study|Withdrawal by Subject|1|||
23436268|NCT02986854|65340654|FG000|Overall Study|Lost to Follow-up|3|||
23436269|NCT02986854|65340655|FG001|Overall Study|Lost to Follow-up|11|||
23436270|NCT02986854|65340656|FG002|Overall Study|Lost to Follow-up|2|||
23436271|NCT01078168|65340666|FG000|Overall Study|Physician Decision|0|||
23557514|NCT00512148|65769379|FG000|Primay Study Period|Withdrawal by Subject|1|||
23557515|NCT00136955|65769381|FG000|Overall Study|Adverse Event|8|||
23557516|NCT00136955|65769381|FG000|Overall Study|Lost to Follow-up|1|||
23557517|NCT00136955|65769381|FG000|Overall Study|Withdrawal by Subject|2|||
23752618|NCT01215955|66474053|FG001|Overall Study|Sponsor Decision|2|||
23752619|NCT01215955|66474054|FG002|Overall Study|Sponsor Decision|0|||
23557518|NCT00136955|65769381|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
23557519|NCT00522626|65769382|FG000|Overall Study|Lost to Follow-up|7|||
23557520|NCT03409666|65769390|FG000|Overall Study|Physician Decision|0|||
23557521|NCT03409666|65769391|FG001|Overall Study|Physician Decision|1|||
23557522|NCT03409666|65769390|FG000|Overall Study|Protocol Violation|0|||
23557523|NCT03409666|65769391|FG001|Overall Study|Protocol Violation|3|||
23557524|NCT00295022|65769392|FG000|Overall Study|Adverse Event|1|||
23557525|NCT00295022|65769393|FG001|Overall Study|Adverse Event|1|||
23557526|NCT00295022|65769394|FG002|Overall Study|Adverse Event|2|||
23557527|NCT00295022|65769392|FG000|Overall Study|Lost to Follow-up|0|||
23557528|NCT00295022|65769393|FG001|Overall Study|Lost to Follow-up|0|||
23557529|NCT00295022|65769394|FG002|Overall Study|Lost to Follow-up|1|||
23557530|NCT00295022|65769392|FG000|Overall Study|Withdrawal by Subject|0|||
23623817|NCT00510146|66008582|FG001|Open-Label Treatment|Sponsor Decision|0|||
23752620|NCT01215955|66474055|FG003|Overall Study|Sponsor Decision|1|||
23752621|NCT01215955|66474052|FG000|Overall Study|Withdrawal by Subject|14|||
23752622|NCT01215955|66474053|FG001|Overall Study|Withdrawal by Subject|15|||
23752623|NCT01215955|66474054|FG002|Overall Study|Withdrawal by Subject|13|||
23752624|NCT01215955|66474055|FG003|Overall Study|Withdrawal by Subject|9|||
23752625|NCT01215955|66474052|FG000|Overall Study|Quality Issues|0|||
23752626|NCT01215955|66474053|FG001|Overall Study|Quality Issues|0|||
23752627|NCT01215955|66474054|FG002|Overall Study|Quality Issues|3|||
23752628|NCT01215955|66474055|FG003|Overall Study|Quality Issues|2|||
23752629|NCT00826176|66474059|FG000|Overall Study|Lost to Follow-up|1|||
23752630|NCT00826176|66474060|FG001|Overall Study|Lost to Follow-up|0|||
23752631|NCT00826176|66474059|FG000|Overall Study|Subject Withdrew Consent|3|||
23752632|NCT00826176|66474060|FG001|Overall Study|Subject Withdrew Consent|0|||
23557531|NCT00295022|65769393|FG001|Overall Study|Withdrawal by Subject|0|||
23623818|NCT01703845|66008583|FG000|Overall Study|Adverse Event|1|||
23752633|NCT00826176|66474059|FG000|Overall Study|Administrative|9|||
23752634|NCT00826176|66474060|FG001|Overall Study|Administrative|0|||
23752635|NCT04639310|66474061|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
23557532|NCT00295022|65769394|FG002|Overall Study|Withdrawal by Subject|2|||
23557533|NCT01113502|65769405|FG000|Overall Study|Withdrawal by Subject|1|||
23623819|NCT01703845|66008584|FG001|Overall Study|Adverse Event|0|||
23752636|NCT04639310|66474062|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
23436272|NCT01078168|65340667|FG001|Overall Study|Physician Decision|1|||
23557534|NCT01113502|65769406|FG001|Overall Study|Withdrawal by Subject|0|||
23557535|NCT01113502|65769407|FG002|Overall Study|Withdrawal by Subject|1|||
23557536|NCT01113502|65769408|FG003|Overall Study|Withdrawal by Subject|1|||
23557537|NCT01113502|65769409|FG004|Overall Study|Withdrawal by Subject|0|||
23557538|NCT01113502|65769405|FG000|Overall Study|Adverse Event|0|||
23557539|NCT01113502|65769406|FG001|Overall Study|Adverse Event|0|||
23557540|NCT01113502|65769407|FG002|Overall Study|Adverse Event|3|||
23752637|NCT03606109|66474063|FG000|Overall Study|Lost to Follow-up|2|||
23752638|NCT03606109|66474064|FG001|Overall Study|Lost to Follow-up|1|||
23825127|NCT02422797|66741417|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
23825128|NCT03772717|66741420|FG000|Overall Study|Withdrawal by Subject|2|||
23825129|NCT01401452|66741421|FG000|Overall Study|Adverse reaction|9|||
23825130|NCT01401452|66741421|FG000|Overall Study|Lost to Follow-up|12|||
23825131|NCT01401452|66741421|FG000|Overall Study|Lack of Efficacy|30|||
23825132|NCT01401452|66741421|FG000|Overall Study|Participant developed breast cancer|1|||
23825133|NCT01401452|66741421|FG000|Overall Study|Tx stopped due to financial reasons|1|||
23825134|NCT01401452|66741421|FG000|Overall Study|Tx stopped by psychiatrist|1|||
23825135|NCT01401452|66741421|FG000|Overall Study|No more visits within the 36 wk followup|4|||
23825136|NCT01401452|66741421|FG000|Overall Study|Subject did not come to follow up visits|2|||
23825137|NCT01401452|66741421|FG000|Overall Study|Subject didn't return for routine visits|1|||
23825138|NCT01401452|66741421|FG000|Overall Study|Subject moved to another city|1|||
23825139|NCT01401452|66741421|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
23825140|NCT01401452|66741421|FG000|Overall Study|Psoriatic arthritis|1|||
23825141|NCT01401452|66741421|FG000|Overall Study|Participant stopped Tx|2|||
23825142|NCT01401452|66741421|FG000|Overall Study|Discontinuation for personal reasons|1|||
23825143|NCT01401452|66741421|FG000|Overall Study|Treatment failure|1|||
23825144|NCT01401452|66741421|FG000|Overall Study|Unsatisfactory output|1|||
23825145|NCT01401452|66741421|FG000|Overall Study|Subject withdrew because of Tx success|1|||
23825146|NCT01401452|66741421|FG000|Overall Study|Subject chose to discontinue treatment|1|||
23825147|NCT01401452|66741421|FG000|Overall Study|Participant withdrew consent|1|||
23825148|NCT00606632|66741422|FG000|Overall Study|Withdrawal by Subject|13|||
23825149|NCT00606632|66741422|FG000|Overall Study|Miscellaneous reasons|9|||
23825150|NCT01626690|66741423|FG000|Overall Study|Protocol Violation|1|||
23825151|NCT01626690|66741424|FG001|Overall Study|Protocol Violation|0|||
23825152|NCT01626690|66741423|FG000|Overall Study|Adverse Event|1|||
23825153|NCT01626690|66741424|FG001|Overall Study|Adverse Event|0|||
23825154|NCT01821807|66741427|FG000|Overall Study|Lost to Follow-up|3|||
23825155|NCT01821807|66741428|FG001|Overall Study|Lost to Follow-up|1|||
23825156|NCT02269098|66741430|FG000|Overall Study|Lost to Follow-up|14|||
23825157|NCT02269098|66741431|FG001|Overall Study|Lost to Follow-up|9|||
23825158|NCT00356525|66741439|FG000|Overall Study|Progressive Disease|8|||
23825159|NCT00356525|66741440|FG001|Overall Study|Progressive Disease|5|||
23436273|NCT01730586|65340669|FG000|Overall Study|Progressive Disease|2|||
23557541|NCT01113502|65769408|FG003|Overall Study|Adverse Event|2|||
23557542|NCT01113502|65769409|FG004|Overall Study|Adverse Event|0|||
23557543|NCT00662857|65769410|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
23557544|NCT00662857|65769411|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
23557545|NCT00662857|65769410|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
23557546|NCT00662857|65769411|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
23557547|NCT00662857|65769410|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
23557548|NCT00662857|65769411|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
23557549|NCT02432105|65769412|FG000|Overall Study|Lost to Follow-up|1|||
23752639|NCT05083559|66474065|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
23752640|NCT05083559|66474066|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
23752641|NCT05083559|66474065|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
23752642|NCT05083559|66474066|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
23752643|NCT05083559|66474065|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
23752644|NCT05083559|66474066|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
23752645|NCT05144477|66474067|FG000|Overall Study|Withdrawal by Subject|1|||
23752646|NCT05144477|66474068|FG001|Overall Study|Withdrawal by Subject|1|||
23752647|NCT02058368|66474069|FG000|Overall Study|Adverse Event|15|||
23752648|NCT02058368|66474070|FG001|Overall Study|Adverse Event|20|||
23752649|NCT02058368|66474069|FG000|Overall Study|Lack of Efficacy|0|||
23752650|NCT02058368|66474070|FG001|Overall Study|Lack of Efficacy|1|||
23752651|NCT02058368|66474069|FG000|Overall Study|Protocol Violation|0|||
23752652|NCT02058368|66474070|FG001|Overall Study|Protocol Violation|4|||
23752653|NCT02058368|66474069|FG000|Overall Study|Lost to Follow-up|2|||
23752654|NCT02058368|66474070|FG001|Overall Study|Lost to Follow-up|0|||
23752655|NCT02058368|66474069|FG000|Overall Study|Physician Decision|2|||
23557550|NCT02432105|65769413|FG001|Overall Study|Lost to Follow-up|1|||
23557551|NCT02432105|65769414|FG002|Overall Study|Lost to Follow-up|0|||
23752656|NCT02058368|66474070|FG001|Overall Study|Physician Decision|3|||
23752657|NCT02058368|66474069|FG000|Overall Study|Withdrawal by Subject|22|||
23752658|NCT02058368|66474070|FG001|Overall Study|Withdrawal by Subject|26|||
23752659|NCT03725722|66474071|FG000|Overall Study|Lack of Efficacy|2|||
23752660|NCT03725722|66474072|FG001|Overall Study|Lack of Efficacy|1|||
23752661|NCT03725722|66474073|FG002|Overall Study|Lack of Efficacy|2|||
23752662|NCT03725722|66474074|FG003|Overall Study|Lack of Efficacy|0|||
23752663|NCT03725722|66474075|FG004|Overall Study|Lack of Efficacy|2|||
23752664|NCT03725722|66474071|FG000|Overall Study|Adverse Event|2|||
23752665|NCT03725722|66474072|FG001|Overall Study|Adverse Event|2|||
23752666|NCT03725722|66474073|FG002|Overall Study|Adverse Event|1|||
23752667|NCT03725722|66474074|FG003|Overall Study|Adverse Event|0|||
23752668|NCT03725722|66474075|FG004|Overall Study|Adverse Event|6|||
23752669|NCT03725722|66474071|FG000|Overall Study|Withdrawal by Subject|4|||
23752670|NCT03725722|66474072|FG001|Overall Study|Withdrawal by Subject|1|||
23752671|NCT03725722|66474073|FG002|Overall Study|Withdrawal by Subject|0|||
23752672|NCT03725722|66474074|FG003|Overall Study|Withdrawal by Subject|4|||
23752673|NCT03725722|66474075|FG004|Overall Study|Withdrawal by Subject|4|||
23752674|NCT03725722|66474071|FG000|Overall Study|Lost to Follow-up|3|||
23752675|NCT03725722|66474072|FG001|Overall Study|Lost to Follow-up|1|||
23825160|NCT00356525|66741441|FG002|Overall Study|Progressive Disease|4|||
23825161|NCT00356525|66741442|FG003|Overall Study|Progressive Disease|2|||
23825162|NCT00356525|66741439|FG000|Overall Study|Adverse Event|1|||
23825163|NCT00356525|66741440|FG001|Overall Study|Adverse Event|3|||
23825164|NCT00356525|66741441|FG002|Overall Study|Adverse Event|1|||
23825165|NCT00356525|66741442|FG003|Overall Study|Adverse Event|1|||
23436274|NCT01730586|65340669|FG000|Overall Study|Inadequate Trial|8|||
23825166|NCT00356525|66741439|FG000|Overall Study|Lost to Follow-up|1|||
23825167|NCT00356525|66741440|FG001|Overall Study|Lost to Follow-up|0|||
23825168|NCT00356525|66741441|FG002|Overall Study|Lost to Follow-up|0|||
23825169|NCT00356525|66741442|FG003|Overall Study|Lost to Follow-up|0|||
23436275|NCT01730586|65340669|FG000|Overall Study|Adverse Event|2|||
23436276|NCT01730586|65340669|FG000|Overall Study|Hospice|1|||
23436277|NCT00830180|65340670|FG000|Overall Study|Adverse Event|6|||
23436278|NCT00830180|65340670|FG000|Overall Study|Death|11|||
23436279|NCT00830180|65340670|FG000|Overall Study|Insufficient clinical response|1|||
23436280|NCT00830180|65340670|FG000|Overall Study|Withdrawal by Subject|5|||
23436281|NCT00830180|65340670|FG000|Overall Study|Progressive disease|2|||
23436282|NCT00830180|65340670|FG000|Overall Study|Other - Unspecified|1|||
23436283|NCT03916484|65340671|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436284|NCT03916484|65340672|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
23436285|NCT03916484|65340673|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436286|NCT03916484|65340674|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436287|NCT03916484|65340671|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
23557552|NCT02432105|65769412|FG000|Overall Study|Withdrawal by Subject|1|||
23557553|NCT02432105|65769413|FG001|Overall Study|Withdrawal by Subject|0|||
23825170|NCT00356525|66741439|FG000|Overall Study|Physician Decision|2|||
23825171|NCT00356525|66741440|FG001|Overall Study|Physician Decision|2|||
23825172|NCT00356525|66741441|FG002|Overall Study|Physician Decision|2|||
23825173|NCT00356525|66741442|FG003|Overall Study|Physician Decision|1|||
23825174|NCT00356525|66741439|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
23825175|NCT00356525|66741440|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
23825176|NCT00356525|66741441|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
23825177|NCT00356525|66741442|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
23825178|NCT00356525|66741439|FG000|Overall Study|Withdrawal by Subject|1|||
23825179|NCT00356525|66741440|FG001|Overall Study|Withdrawal by Subject|1|||
23825180|NCT00356525|66741441|FG002|Overall Study|Withdrawal by Subject|0|||
23825181|NCT00356525|66741442|FG003|Overall Study|Withdrawal by Subject|3|||
23825182|NCT00356525|66741439|FG000|Overall Study|Death|0|||
23825183|NCT00356525|66741440|FG001|Overall Study|Death|0|||
23825184|NCT00356525|66741441|FG002|Overall Study|Death|0|||
23557554|NCT02432105|65769414|FG002|Overall Study|Withdrawal by Subject|1|||
23557555|NCT02432105|65769412|FG000|Overall Study|Culture positive for yeast|0|||
23557556|NCT02432105|65769413|FG001|Overall Study|Culture positive for yeast|1|||
23557557|NCT02432105|65769414|FG002|Overall Study|Culture positive for yeast|0|||
23557558|NCT02432105|65769412|FG000|Overall Study|Randomized in error|0|||
23557559|NCT02432105|65769413|FG001|Overall Study|Randomized in error|0|||
23557560|NCT02432105|65769414|FG002|Overall Study|Randomized in error|2|||
23825185|NCT00356525|66741442|FG003|Overall Study|Death|1|||
23825186|NCT00356525|66741439|FG000|Overall Study|Sponsor Decision|0|||
23825187|NCT00356525|66741440|FG001|Overall Study|Sponsor Decision|0|||
23436288|NCT03916484|65340672|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
23557561|NCT00621543|65769415|FG000|Overall Study|Lost to Follow-up|23|||
23557562|NCT02274857|65769420|FG000|Overall Study|Adverse Event|1|||
23557563|NCT02274857|65769421|FG001|Overall Study|Adverse Event|0|||
23752676|NCT03725722|66474073|FG002|Overall Study|Lost to Follow-up|2|||
23752677|NCT03725722|66474074|FG003|Overall Study|Lost to Follow-up|2|||
23752678|NCT03725722|66474075|FG004|Overall Study|Lost to Follow-up|1|||
23825188|NCT00356525|66741441|FG002|Overall Study|Sponsor Decision|0|||
23825189|NCT00356525|66741442|FG003|Overall Study|Sponsor Decision|1|||
23825190|NCT01060072|66741443|FG000|Overall Study|Adverse Event|1|||
23825191|NCT01060072|66741444|FG001|Overall Study|Adverse Event|1|||
23825192|NCT01060072|66741443|FG000|Overall Study|Physician Decision|0|||
23825193|NCT01060072|66741444|FG001|Overall Study|Physician Decision|2|||
23825194|NCT01060072|66741443|FG000|Overall Study|Protocol Violation|0|||
23825195|NCT01060072|66741444|FG001|Overall Study|Protocol Violation|1|||
23825196|NCT01060072|66741443|FG000|Overall Study|Acute cholecystitis|1|||
23825197|NCT01060072|66741444|FG001|Overall Study|Acute cholecystitis|0|||
23825198|NCT01060072|66741443|FG000|Overall Study|Excluded Medications|0|||
23825199|NCT01060072|66741444|FG001|Overall Study|Excluded Medications|1|||
23825200|NCT04289363|66741448|FG000|Overall Study|Lost to Follow-up|14|||
23825201|NCT04289363|66741449|FG001|Overall Study|Lost to Follow-up|0|||
23825202|NCT03404674|66741450|FG000|Overall Study|Inability to Attend Future Visits|0|||
23825203|NCT03404674|66741451|FG001|Overall Study|Inability to Attend Future Visits|1|||
23825204|NCT03404674|66741452|FG002|Overall Study|Inability to Attend Future Visits|1|||
23825205|NCT03404674|66741453|FG003|Overall Study|Inability to Attend Future Visits|0|||
23825206|NCT03404674|66741454|FG004|Overall Study|Inability to Attend Future Visits|0|||
23825207|NCT03404674|66741455|FG005|Overall Study|Inability to Attend Future Visits|0|||
23436289|NCT03916484|65340673|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
23436290|NCT03916484|65340674|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
23436291|NCT02777827|65340675|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436292|NCT02777827|65340676|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
23752679|NCT03725722|66474071|FG000|Overall Study|Personal reasons|0|||
23436293|NCT02777827|65340677|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
23557564|NCT02274857|65769420|FG000|Overall Study|Death|1|||
23557565|NCT02274857|65769421|FG001|Overall Study|Death|2|||
23557566|NCT02274857|65769420|FG000|Overall Study|Lost to Follow-up|3|||
23557567|NCT02274857|65769421|FG001|Overall Study|Lost to Follow-up|0|||
23557568|NCT02274857|65769420|FG000|Overall Study|Physician Decision|2|||
23557569|NCT02274857|65769421|FG001|Overall Study|Physician Decision|0|||
23557570|NCT02274857|65769420|FG000|Overall Study|Trial screen failure|0|||
23557571|NCT02274857|65769421|FG001|Overall Study|Trial screen failure|2|||
23557572|NCT02274857|65769420|FG000|Overall Study|Withdrawal by Subject|11|||
23557573|NCT02274857|65769421|FG001|Overall Study|Withdrawal by Subject|2|||
23557574|NCT02274857|65769420|FG000|Overall Study|Other|2|||
23557575|NCT02274857|65769421|FG001|Overall Study|Other|0|||
23557576|NCT03284788|65769428|FG000|Overall Study|Withdrawal by Subject|2|||
23557577|NCT03017079|65769429|FG000|Overall Study|Physician Decision|1|||
23557578|NCT03017079|65769430|FG001|Overall Study|Physician Decision|1|||
23557579|NCT03017079|65769429|FG000|Overall Study|Death|3|||
23557580|NCT03017079|65769430|FG001|Overall Study|Death|2|||
23557581|NCT03017079|65769429|FG000|Overall Study|Lack of Efficacy|2|||
23557582|NCT03017079|65769430|FG001|Overall Study|Lack of Efficacy|2|||
23752680|NCT03725722|66474072|FG001|Overall Study|Personal reasons|0|||
23557583|NCT03017079|65769429|FG000|Overall Study|Protocol Violation|0|||
23752681|NCT03725722|66474073|FG002|Overall Study|Personal reasons|1|||
23752682|NCT03725722|66474074|FG003|Overall Study|Personal reasons|0|||
23752683|NCT03725722|66474075|FG004|Overall Study|Personal reasons|1|||
23752684|NCT03725722|66474071|FG000|Overall Study|COVID-19 situation|0|||
23752685|NCT03725722|66474072|FG001|Overall Study|COVID-19 situation|1|||
23752686|NCT03725722|66474073|FG002|Overall Study|COVID-19 situation|0|||
23752687|NCT03725722|66474074|FG003|Overall Study|COVID-19 situation|0|||
23752688|NCT03725722|66474075|FG004|Overall Study|COVID-19 situation|0|||
23752689|NCT00396318|66474076|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
23752690|NCT02856282|66474077|FG000|Overall Study|Withdrawal by Subject|1|||
23752691|NCT03911960|66474078|FG000|Overall Study|Lost to Follow-up|5|||
23752692|NCT03911960|66474079|FG001|Overall Study|Lost to Follow-up|3|||
23752693|NCT02076113|66474080|FG000|Overall Study|Lost to Follow-up|4|||
23752694|NCT02076113|66474081|FG001|Overall Study|Lost to Follow-up|1|||
23752695|NCT02076113|66474080|FG000|Overall Study|Withdrawal by Subject|2|||
23752696|NCT02076113|66474081|FG001|Overall Study|Withdrawal by Subject|3|||
23825208|NCT03404674|66741450|FG000|Overall Study|Behavioral Problems|0|||
23825209|NCT03404674|66741451|FG001|Overall Study|Behavioral Problems|0|||
23825210|NCT03404674|66741452|FG002|Overall Study|Behavioral Problems|1|||
23825211|NCT03404674|66741453|FG003|Overall Study|Behavioral Problems|0|||
23436294|NCT02777827|65340678|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436295|NCT02777827|65340679|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
23825212|NCT03404674|66741454|FG004|Overall Study|Behavioral Problems|0|||
23557584|NCT03017079|65769430|FG001|Overall Study|Protocol Violation|1|||
23825213|NCT03404674|66741455|FG005|Overall Study|Behavioral Problems|0|||
23557585|NCT04082884|65769432|FG000|Overall Study|Withdrawal by Subject|1|||
23825214|NCT03404674|66741450|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
23557586|NCT00789815|65769433|FG000|Overall Study|Protocol Violation|6|||
23557587|NCT00789815|65769434|FG001|Overall Study|Protocol Violation|1|||
23557588|NCT00789815|65769433|FG000|Overall Study|Intubation due to massive bleeding|1|||
23752697|NCT02076113|66474080|FG000|Overall Study|Death|1|||
23752698|NCT02076113|66474081|FG001|Overall Study|Death|3|||
23752699|NCT03981614|66474082|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
23752700|NCT03981614|66474083|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
23752701|NCT03981614|66474084|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
23752702|NCT00358670|66474089|FG000|Overall Study|Adverse Event|26|||
23752703|NCT00358670|66474090|FG001|Overall Study|Adverse Event|29|||
23436296|NCT02777827|65340680|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436297|NCT01183468|65340684|FG000|Overall Study|Lost to Follow-up|2|||
23436298|NCT01183468|65340685|FG001|Overall Study|Lost to Follow-up|1|||
23436299|NCT01183468|65340686|FG002|Overall Study|Lost to Follow-up|0|||
23436300|NCT01183468|65340687|FG003|Overall Study|Lost to Follow-up|0|||
23436301|NCT01183468|65340684|FG000|Overall Study|Physician Decision|1|||
23557589|NCT00789815|65769434|FG001|Overall Study|Intubation due to massive bleeding|0|||
23557590|NCT00490282|65769439|FG000|Overall Study|Withdrawal by Subject|3|||
23557591|NCT00539279|65769440|FG000|Treatment|Withdrawal by Subject|10|||
23752704|NCT00358670|66474089|FG000|Overall Study|Lack of Efficacy|20|||
23557592|NCT00539279|65769441|FG001|Treatment|Withdrawal by Subject|8|||
23825215|NCT03404674|66741451|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
23825216|NCT03404674|66741452|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
23825217|NCT03404674|66741453|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
23825218|NCT03404674|66741454|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
23825219|NCT03404674|66741455|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
23825220|NCT03348163|66741457|FG000|Overall Study|Withdrawal by Subject|2|||
23825221|NCT03348163|66741458|FG001|Overall Study|Withdrawal by Subject|0|||
23825222|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
23825223|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
23557593|NCT00539279|65769440|FG000|Treatment|Death|1|||
23825224|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
23825225|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
23825226|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
23825227|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
23825228|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
23825229|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
23825230|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
23825231|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
23825232|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
23825233|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
23825234|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
23825235|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
23825236|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
23825237|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
23843100|NCT01738503|66805583|FG002|Treatment Period|Protocol Violation|1|||
23436302|NCT01183468|65340685|FG001|Overall Study|Physician Decision|0|||
23557594|NCT00539279|65769441|FG001|Treatment|Death|0|||
23557595|NCT00539279|65769440|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
23557596|NCT00539279|65769441|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
23557597|NCT00539279|65769440|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
23752705|NCT00358670|66474090|FG001|Overall Study|Lack of Efficacy|23|||
23752706|NCT00358670|66474089|FG000|Overall Study|Protocol Violation|6|||
23557598|NCT00539279|65769441|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
23557599|NCT01120249|65769442|FG000|Overall Study|No protocol treatment received|21|||
23557600|NCT01120249|65769443|FG001|Overall Study|No protocol treatment received|15|||
23557601|NCT01120249|65769442|FG000|Overall Study|Disease recurrence|107|||
23557602|NCT01120249|65769443|FG001|Overall Study|Disease recurrence|57|||
23557603|NCT01120249|65769442|FG000|Overall Study|Death|1|||
23557604|NCT01120249|65769443|FG001|Overall Study|Death|0|||
23623820|NCT01703845|66008583|FG000|Overall Study|Protocol Violation|1|||
23623821|NCT01703845|66008584|FG001|Overall Study|Protocol Violation|0|||
23752707|NCT00358670|66474090|FG001|Overall Study|Protocol Violation|9|||
23752708|NCT00358670|66474089|FG000|Overall Study|Lost to Follow-up|4|||
23752709|NCT00358670|66474090|FG001|Overall Study|Lost to Follow-up|5|||
23436303|NCT01183468|65340686|FG002|Overall Study|Physician Decision|0|||
23436304|NCT01183468|65340687|FG003|Overall Study|Physician Decision|0|||
23752710|NCT00358670|66474089|FG000|Overall Study|Withdrawal by Subject|13|||
23557605|NCT01120249|65769442|FG000|Overall Study|Adverse Event|40|||
23557606|NCT01120249|65769443|FG001|Overall Study|Adverse Event|276|||
23557607|NCT01120249|65769442|FG000|Overall Study|Participant refusal|34|||
23623822|NCT01703845|66008583|FG000|Overall Study|other than stated above|1|||
23752711|NCT00358670|66474090|FG001|Overall Study|Withdrawal by Subject|24|||
23752712|NCT00358670|66474089|FG000|Overall Study|Protocol Defined Clinical Event|0|||
23752713|NCT00358670|66474090|FG001|Overall Study|Protocol Defined Clinical Event|1|||
23752714|NCT00358670|66474089|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23752715|NCT00358670|66474090|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
23752716|NCT00358670|66474089|FG000|Overall Study|Administrative|153|||
23752717|NCT00358670|66474090|FG001|Overall Study|Administrative|125|||
23752718|NCT02787746|66474091|FG000|Overall Study|Adverse Event|42|||
23752719|NCT02787746|66474091|FG000|Overall Study|Withdrawal by Subject|65|||
23752720|NCT02787746|66474091|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
23825238|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
23825239|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
23752721|NCT02662556|66474096|FG000|Overall Study|Adverse Event|4|||
23752722|NCT02662556|66474096|FG000|Overall Study|Lack of Efficacy|4|||
23825240|NCT00261443|66741459|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
23825241|NCT00261443|66741460|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
23825242|NCT00261443|66741461|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
23825243|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
23825244|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
23752723|NCT04342390|66474102|FG000|Overall Study|Lost to Follow-up|3|||
23752724|NCT04342390|66474103|FG001|Overall Study|Lost to Follow-up|0|||
23436305|NCT01183468|65340684|FG000|Overall Study|Withdrawal by Subject|0|||
23436306|NCT01183468|65340685|FG001|Overall Study|Withdrawal by Subject|1|||
23436307|NCT01183468|65340686|FG002|Overall Study|Withdrawal by Subject|0|||
23436308|NCT01183468|65340687|FG003|Overall Study|Withdrawal by Subject|0|||
23436309|NCT02915978|65340688|FG000|Overall Study|Adverse Event|2|||
23436310|NCT02915978|65340689|FG001|Overall Study|Adverse Event|1|||
23436311|NCT02915978|65340690|FG002|Overall Study|Adverse Event|0|||
23436312|NCT01153698|65340691|FG000|Overall Study|Adverse Event|12|||
23436313|NCT01153698|65340691|FG000|Overall Study|Lost to Follow-up|4|||
23436314|NCT01153698|65340691|FG000|Overall Study|Withdrawal by Subject|2|||
23436315|NCT01153698|65340691|FG000|Overall Study|Switch to other anticoagulants|4|||
23436316|NCT01153698|65340691|FG000|Overall Study|Other|2|||
23436317|NCT01153698|65340691|FG000|Overall Study|Not treated with Pradaxa|5|||
23436318|NCT03129360|65340692|FG000|Overall Study|Did not meet entry criteria|0|||
23436319|NCT03129360|65340693|FG001|Overall Study|Did not meet entry criteria|2|||
23436320|NCT03129360|65340694|FG002|Overall Study|Did not meet entry criteria|1|||
23436321|NCT03129360|65340692|FG000|Overall Study|Excluded due to motion in scanner|1|||
23436322|NCT03129360|65340693|FG001|Overall Study|Excluded due to motion in scanner|0|||
23557608|NCT01120249|65769443|FG001|Overall Study|Participant refusal|42|||
23557609|NCT01120249|65769442|FG000|Overall Study|Other reasons, not protocol specified|29|||
23557610|NCT01120249|65769443|FG001|Overall Study|Other reasons, not protocol specified|22|||
23557611|NCT01089374|65769451|FG000|Overall Study|Lost to Follow-up|3|||
23557612|NCT01089374|65769452|FG001|Overall Study|Lost to Follow-up|0|||
23557613|NCT01089374|65769451|FG000|Overall Study|Withdrawal by Subject|1|||
23557614|NCT01089374|65769452|FG001|Overall Study|Withdrawal by Subject|0|||
23557615|NCT01089374|65769451|FG000|Overall Study|Study closed early - low accrual|6|||
23557616|NCT01089374|65769452|FG001|Overall Study|Study closed early - low accrual|0|||
23557617|NCT01696981|65769459|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
23557618|NCT01696981|65769460|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
23557619|NCT01696981|65769459|FG000|Overall Study|Died Before Randomization|3|||
23557620|NCT01696981|65769460|FG001|Overall Study|Died Before Randomization|8|||
23557621|NCT01696981|65769459|FG000|Overall Study|Died Before ASU (Control)|278|||
23557622|NCT01696981|65769460|FG001|Overall Study|Died Before ASU (Control)|0|||
23557623|NCT01696981|65769459|FG000|Overall Study|Refused ASU (Control)|920|||
23557624|NCT01696981|65769460|FG001|Overall Study|Refused ASU (Control)|0|||
23557625|NCT01696981|65769459|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
23557626|NCT01696981|65769460|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
23557627|NCT03298451|65769461|FG000|Overall Study|Death|275|||
23557628|NCT03298451|65769462|FG001|Overall Study|Death|260|||
23557629|NCT03298451|65769463|FG002|Overall Study|Death|122|||
23557630|NCT03298451|65769464|FG003|Overall Study|Death|280|||
23557631|NCT03298451|65769461|FG000|Overall Study|Lost to Follow-up|1|||
23557632|NCT03298451|65769462|FG001|Overall Study|Lost to Follow-up|1|||
23557633|NCT03298451|65769463|FG002|Overall Study|Lost to Follow-up|0|||
23557634|NCT03298451|65769464|FG003|Overall Study|Lost to Follow-up|7|||
23557635|NCT03298451|65769461|FG000|Overall Study|Withdrawal by Subject|9|||
23557636|NCT03298451|65769462|FG001|Overall Study|Withdrawal by Subject|7|||
23557637|NCT03298451|65769463|FG002|Overall Study|Withdrawal by Subject|1|||
23557638|NCT03298451|65769464|FG003|Overall Study|Withdrawal by Subject|20|||
23557639|NCT00620750|65769465|FG000|Overall Study|Lost to Follow-up|25|||
23557640|NCT02057874|65769472|FG000|Overall Study|participant did not return for scan|1|||
23557641|NCT00180479|65769473|FG000|Overall Study|Death|4|||
23557642|NCT00180479|65769474|FG001|Overall Study|Death|2|||
23557643|NCT00180479|65769473|FG000|Overall Study|Lost to Follow-up|9|||
23557644|NCT00180479|65769474|FG001|Overall Study|Lost to Follow-up|7|||
23557645|NCT00180479|65769473|FG000|Overall Study|Withdrawal by Subject|3|||
23557646|NCT00180479|65769474|FG001|Overall Study|Withdrawal by Subject|3|||
23557647|NCT00180479|65769473|FG000|Overall Study|Informed consent not signed|0|||
23557648|NCT00180479|65769474|FG001|Overall Study|Informed consent not signed|1|||
23557649|NCT02954354|65769475|FG000|Overall Study|Adverse Event|2|||
23557650|NCT02954354|65769476|FG001|Overall Study|Adverse Event|2|||
23557651|NCT02954354|65769477|FG002|Overall Study|Adverse Event|4|||
23557652|NCT02954354|65769475|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
23557653|NCT02954354|65769476|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
23557654|NCT02954354|65769477|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
23436323|NCT03129360|65340694|FG002|Overall Study|Excluded due to motion in scanner|0|||
23557655|NCT02954354|65769475|FG000|Overall Study|Lack of Efficacy|0|||
23557656|NCT02954354|65769476|FG001|Overall Study|Lack of Efficacy|2|||
23752725|NCT03099265|66474105|FG000|Overall Study|Adverse Event|1|||
23436324|NCT04576897|65340695|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
23436325|NCT03197376|65340696|FG000|Primary and Booster Phase|Adverse Event|0|||
23557657|NCT02954354|65769477|FG002|Overall Study|Lack of Efficacy|0|||
23557658|NCT02954354|65769475|FG000|Overall Study|Withdrawal by Subject|17|||
23557659|NCT02954354|65769476|FG001|Overall Study|Withdrawal by Subject|9|||
23557660|NCT02954354|65769477|FG002|Overall Study|Withdrawal by Subject|11|||
23557661|NCT02954354|65769475|FG000|Overall Study|Lost to Follow-up|12|||
23436326|NCT03197376|65340697|FG001|Primary and Booster Phase|Adverse Event|0|||
23436327|NCT03197376|65340698|FG002|Primary and Booster Phase|Adverse Event|0|||
23436328|NCT03197376|65340699|FG003|Primary and Booster Phase|Adverse Event|1|||
23436329|NCT03197376|65340696|FG000|Primary and Booster Phase|Death|1|||
23436330|NCT03197376|65340697|FG001|Primary and Booster Phase|Death|0|||
23436331|NCT03197376|65340698|FG002|Primary and Booster Phase|Death|0|||
23436332|NCT03197376|65340699|FG003|Primary and Booster Phase|Death|2|||
23436333|NCT03197376|65340696|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
23436334|NCT03197376|65340697|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
23436335|NCT03197376|65340698|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
23436336|NCT03197376|65340699|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
23436337|NCT03197376|65340696|FG000|Primary and Booster Phase|Physician Decision|1|||
23436338|NCT03197376|65340697|FG001|Primary and Booster Phase|Physician Decision|0|||
23436339|NCT03197376|65340698|FG002|Primary and Booster Phase|Physician Decision|1|||
23752726|NCT04854707|66474108|FG000|Overall Study|Lack of Efficacy|78|||
23752727|NCT04854707|66474109|FG001|Overall Study|Lack of Efficacy|59|||
23752728|NCT04854707|66474110|FG002|Overall Study|Lack of Efficacy|30|||
23752729|NCT03020966|66474114|FG000|Overall Study|Withdrawal by Subject|2|||
23752730|NCT03020966|66474115|FG001|Overall Study|Withdrawal by Subject|0|||
23752731|NCT03914469|66474116|FG000|Overall Study|Lost to Follow-up|1|||
23752732|NCT03914469|66474117|FG001|Overall Study|Lost to Follow-up|4|||
23752733|NCT02426125|66474118|FG000|Overall Study|Lost to Follow-up|14|||
23752734|NCT02426125|66474119|FG001|Overall Study|Lost to Follow-up|12|||
23752735|NCT02426125|66474118|FG000|Overall Study|Withdrawal by Subject|13|||
23752736|NCT02426125|66474119|FG001|Overall Study|Withdrawal by Subject|14|||
23752737|NCT02426125|66474118|FG000|Overall Study|Death|185|||
23752738|NCT02426125|66474119|FG001|Overall Study|Death|200|||
23752739|NCT02426125|66474118|FG000|Overall Study|Randomized, But Never Treated|5|||
23752740|NCT02426125|66474119|FG001|Overall Study|Randomized, But Never Treated|2|||
23752741|NCT02395536|66474120|FG000|Overall Study|Lost to Follow-up|4|||
23752742|NCT02395536|66474121|FG001|Overall Study|Lost to Follow-up|4|||
23752743|NCT02395536|66474120|FG000|Overall Study|Death|2|||
23752744|NCT02395536|66474121|FG001|Overall Study|Death|0|||
23752745|NCT02395536|66474120|FG000|Overall Study|Physician Decision|4|||
23436340|NCT03197376|65340699|FG003|Primary and Booster Phase|Physician Decision|3|||
23436341|NCT03197376|65340696|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
23436342|NCT03197376|65340697|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
23436343|NCT03197376|65340698|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
23436344|NCT03197376|65340699|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
23436345|NCT03197376|65340696|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
23436346|NCT03197376|65340697|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
23436347|NCT03197376|65340698|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
23436348|NCT03197376|65340699|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
23436349|NCT03197376|65340696|FG000|Primary and Booster Phase|Not vaccine related|1|||
23436350|NCT03197376|65340697|FG001|Primary and Booster Phase|Not vaccine related|2|||
23436351|NCT03197376|65340698|FG002|Primary and Booster Phase|Not vaccine related|0|||
23436352|NCT03197376|65340699|FG003|Primary and Booster Phase|Not vaccine related|6|||
23436353|NCT03197376|65340696|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
23436354|NCT03197376|65340697|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
23436355|NCT03197376|65340698|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
23436356|NCT03197376|65340699|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
23436357|NCT03197376|65340696|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
23436358|NCT03197376|65340697|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
23436359|NCT03197376|65340698|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
23436360|NCT03197376|65340699|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
23436361|NCT03197376|65340696|FG000|Immune Persistence Phase|Not vaccine related|1|||
23436362|NCT03197376|65340697|FG001|Immune Persistence Phase|Not vaccine related|0|||
23436363|NCT03197376|65340698|FG002|Immune Persistence Phase|Not vaccine related|1|||
23436364|NCT03197376|65340699|FG003|Immune Persistence Phase|Not vaccine related|1|||
23436365|NCT05096312|65340700|FG000|Overall Study|Lost to Follow-up|2|||
23436366|NCT05096312|65340701|FG001|Overall Study|Lost to Follow-up|4|||
23436367|NCT05096312|65340700|FG000|Overall Study|Adverse Event|1|||
23436368|NCT05096312|65340701|FG001|Overall Study|Adverse Event|0|||
23436369|NCT02104947|65340707|FG000|Overall Study|Withdrawal by Subject|10|||
23436370|NCT02104947|65340708|FG001|Overall Study|Withdrawal by Subject|3|||
23752746|NCT02395536|66474121|FG001|Overall Study|Physician Decision|6|||
23752747|NCT02395536|66474120|FG000|Overall Study|Withdrawal by Subject|9|||
23752748|NCT02395536|66474121|FG001|Overall Study|Withdrawal by Subject|17|||
23752749|NCT02395536|66474120|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
23436371|NCT02104947|65340707|FG000|Overall Study|Lost to Follow-up|4|||
23436372|NCT02104947|65340708|FG001|Overall Study|Lost to Follow-up|4|||
23752750|NCT02395536|66474121|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
23752751|NCT02395536|66474120|FG000|Overall Study|Insurance issue|0|||
23752752|NCT02395536|66474121|FG001|Overall Study|Insurance issue|1|||
23557662|NCT02954354|65769476|FG001|Overall Study|Lost to Follow-up|5|||
23825245|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
23436373|NCT02104947|65340707|FG000|Overall Study|Protocol Violation|6|||
23436374|NCT02104947|65340708|FG001|Overall Study|Protocol Violation|8|||
23436375|NCT02104947|65340707|FG000|Overall Study|Adverse Event|57|||
23436376|NCT02104947|65340708|FG001|Overall Study|Adverse Event|38|||
23436377|NCT02104947|65340707|FG000|Overall Study|Other than stated above|2|||
23436378|NCT02104947|65340708|FG001|Overall Study|Other than stated above|3|||
23436379|NCT02220712|65340709|FG000|Overall Study|Adverse Event|1|||
23436380|NCT02220712|65340709|FG000|Overall Study|Withdrawal by Subject|2|||
23436381|NCT02220712|65340709|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
23436382|NCT04023682|65340710|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
23436383|NCT03624127|65340711|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
23436384|NCT03624127|65340712|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
23436385|NCT03624127|65340713|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
23436386|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
23436387|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
23436388|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
23436389|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Death|0|||
23436390|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Death|1|||
23436391|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Death|0|||
23436392|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
23436393|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
23436394|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
23436395|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
23436396|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
23436397|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
23436398|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
23436399|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
23436400|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
23436401|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
23436402|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
23436403|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
23436404|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
23436405|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
23436406|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
23436407|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
23436408|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
23436409|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
23436410|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
23436411|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23436412|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23436413|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23436414|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23436415|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
23436416|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
23436417|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
23436418|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
23436419|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
23436420|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
23436421|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
23436422|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
23436423|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
23436424|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
23436425|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
23436426|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
23436427|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
23436428|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
23436429|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23436430|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23436431|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
23436432|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
23436433|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
23436434|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
23436435|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
23436436|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
23436437|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
23436438|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
23436439|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
23436440|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
23436441|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23436442|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23436443|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
23752753|NCT02531698|66474122|FG000|Overall Study|Adverse Event|2|||
23752754|NCT02531698|66474123|FG001|Overall Study|Adverse Event|1|||
23752755|NCT02531698|66474122|FG000|Overall Study|Withdrawal by Subject|6|||
23752756|NCT02531698|66474123|FG001|Overall Study|Withdrawal by Subject|1|||
23752757|NCT02531698|66474122|FG000|Overall Study|Protocol Violation|2|||
23825246|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
23825247|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
23825248|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
23825249|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
23825250|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
23825251|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
23825252|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
23825253|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
23825254|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
23825255|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
23825256|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
23825257|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
23752758|NCT02531698|66474123|FG001|Overall Study|Protocol Violation|0|||
23752759|NCT02531698|66474122|FG000|Overall Study|Lost to Follow-up|1|||
23752760|NCT02531698|66474123|FG001|Overall Study|Lost to Follow-up|0|||
23752761|NCT03993288|66474126|FG000|Overall Study|Lost to Follow-up|2|||
23752762|NCT03993288|66474127|FG001|Overall Study|Lost to Follow-up|1|||
23752763|NCT03993288|66474126|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
23752764|NCT03993288|66474127|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
23436444|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
23436445|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
23436446|NCT02294734|65340714|FG000|Overall Study|Adverse Event|5|||
23752765|NCT03993288|66474126|FG000|Overall Study|wrong randomization|0|||
23752766|NCT03993288|66474127|FG001|Overall Study|wrong randomization|1|||
23752767|NCT03993288|66474126|FG000|Overall Study|improper enrollment|0|||
23752768|NCT03993288|66474127|FG001|Overall Study|improper enrollment|1|||
23752769|NCT03993288|66474126|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
23752770|NCT03993288|66474127|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
23752771|NCT03993288|66474126|FG000|Overall Study|developed SAE|2|||
23752772|NCT03993288|66474127|FG001|Overall Study|developed SAE|0|||
23752773|NCT03993288|66474126|FG000|Overall Study|consent withdrawal|1|||
23752774|NCT03993288|66474127|FG001|Overall Study|consent withdrawal|0|||
23752775|NCT03993288|66474126|FG000|Overall Study|did not follow the treatment schedule|1|||
23752776|NCT03993288|66474127|FG001|Overall Study|did not follow the treatment schedule|0|||
23752777|NCT03993288|66474126|FG000|Overall Study|did not follow the treatment regimen|1|||
23825258|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
23825259|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
23436447|NCT02294734|65340715|FG001|Overall Study|Adverse Event|5|||
23436448|NCT02294734|65340714|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
23436449|NCT02294734|65340715|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
23752778|NCT03993288|66474127|FG001|Overall Study|did not follow the treatment regimen|0|||
23752779|NCT03993288|66474126|FG000|Overall Study|Adverse Event|1|||
23436450|NCT02294734|65340714|FG000|Overall Study|Lost to Follow-up|2|||
23752780|NCT03993288|66474127|FG001|Overall Study|Adverse Event|0|||
23436451|NCT02294734|65340715|FG001|Overall Study|Lost to Follow-up|0|||
23436452|NCT02294734|65340714|FG000|Overall Study|Physician Decision|2|||
23436453|NCT02294734|65340715|FG001|Overall Study|Physician Decision|1|||
23436454|NCT02294734|65340714|FG000|Overall Study|Withdrawal by Subject|4|||
23436455|NCT02294734|65340715|FG001|Overall Study|Withdrawal by Subject|2|||
23436456|NCT03052816|65340716|FG000|Overall Study|Withdrawal by Subject|1|||
23436457|NCT03052816|65340717|FG001|Overall Study|Withdrawal by Subject|0|||
23436458|NCT03052816|65340716|FG000|Overall Study|Desired opioids|2|||
23436459|NCT03052816|65340717|FG001|Overall Study|Desired opioids|0|||
23752781|NCT03993288|66474126|FG000|Overall Study|Withdrawal by Subject|1|||
23752782|NCT03993288|66474127|FG001|Overall Study|Withdrawal by Subject|1|||
23752783|NCT00595127|66474129|FG000|Overall Study|Death|6|||
23752784|NCT00595127|66474129|FG000|Overall Study|Relapsed|3|||
23752785|NCT00595127|66474129|FG000|Overall Study|joined another trial|1|||
23752786|NCT01260194|66474130|FG000|Overall Study|Withdrawal of Consent|1|||
23752787|NCT00537056|66474131|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
23752788|NCT04993339|66474137|FG000|Overall Study|Lost to Follow-up|0|||
23752789|NCT04993339|66474138|FG001|Overall Study|Lost to Follow-up|1|||
23436460|NCT01630889|65340718|FG000|Overall Study|Death|2|||
23436461|NCT01630889|65340718|FG000|Overall Study|Withdrawal by Subject|1|||
23436462|NCT01630889|65340718|FG000|Overall Study|Other than Specified|2|||
23436463|NCT01630889|65340718|FG000|Overall Study|Lost to Follow-up|4|||
23436464|NCT01630889|65340718|FG000|Overall Study|Other|1|||
23436465|NCT02669121|65340719|FG000|Overall Study|Adverse Event|4|||
23436466|NCT02669121|65340720|FG001|Overall Study|Adverse Event|5|||
23436467|NCT02669121|65340719|FG000|Overall Study|Lost to Follow-up|15|||
23436468|NCT02669121|65340720|FG001|Overall Study|Lost to Follow-up|27|||
23436469|NCT02669121|65340719|FG000|Overall Study|Withdrawal by Subject|132|||
23436470|NCT02669121|65340720|FG001|Overall Study|Withdrawal by Subject|140|||
23436471|NCT02669121|65340719|FG000|Overall Study|Pregnancy|0|||
23436472|NCT02669121|65340720|FG001|Overall Study|Pregnancy|1|||
23436473|NCT02669121|65340719|FG000|Overall Study|Discharged from US Military Active Service|117|||
23436474|NCT02669121|65340720|FG001|Overall Study|Discharged from US Military Active Service|91|||
23436475|NCT02669121|65340719|FG000|Overall Study|Reason not Specified|22|||
23436476|NCT02669121|65340720|FG001|Overall Study|Reason not Specified|18|||
23436477|NCT01300572|65340721|FG000|Overall Study|HAMA + post dosimetry|1|||
23436478|NCT03834220|65340722|FG000|Overall Study|Adverse Event|1|||
23436479|NCT03834220|65340723|FG001|Overall Study|Adverse Event|0|||
23436480|NCT03834220|65340724|FG002|Overall Study|Adverse Event|0|||
23436481|NCT03834220|65340722|FG000|Overall Study|Death|8|||
23436482|NCT03834220|65340723|FG001|Overall Study|Death|1|||
23436483|NCT03834220|65340724|FG002|Overall Study|Death|17|||
23436484|NCT03834220|65340722|FG000|Overall Study|Reason not Specified|9|||
23436485|NCT03834220|65340723|FG001|Overall Study|Reason not Specified|0|||
23436486|NCT03834220|65340724|FG002|Overall Study|Reason not Specified|6|||
23436487|NCT03834220|65340722|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
23436488|NCT03834220|65340723|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
23436489|NCT03834220|65340724|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
23436490|NCT03834220|65340722|FG000|Overall Study|Withdrawal of Consent|2|||
23436491|NCT03834220|65340723|FG001|Overall Study|Withdrawal of Consent|2|||
23436492|NCT03834220|65340724|FG002|Overall Study|Withdrawal of Consent|2|||
23436493|NCT01192412|65340725|FG000|Overall Study|Lost to Follow-up|2|||
23436494|NCT01192412|65340726|FG001|Overall Study|Lost to Follow-up|1|||
23436495|NCT01192412|65340725|FG000|Overall Study|Withdrawal by Subject|2|||
23436496|NCT01192412|65340726|FG001|Overall Study|Withdrawal by Subject|1|||
23436497|NCT01019369|65340727|FG000|Overall Study|Lost to Follow-up|10|||
23436498|NCT01019369|65340728|FG001|Overall Study|Lost to Follow-up|6|||
23436499|NCT01019369|65340727|FG000|Overall Study|Withdrawal by Subject|0|||
23436500|NCT01019369|65340728|FG001|Overall Study|Withdrawal by Subject|1|||
23436501|NCT02337634|65340735|FG000|Overall Study|Protocol Violation|3|||
23436502|NCT02337634|65340736|FG001|Overall Study|Protocol Violation|1|||
23436503|NCT02337634|65340735|FG000|Overall Study|Lost to Follow-up|1|||
23436504|NCT02337634|65340736|FG001|Overall Study|Lost to Follow-up|0|||
23436505|NCT01329939|65340737|FG000|Overall Study|Lost to Follow-up|3|||
23436506|NCT01329939|65340738|FG001|Overall Study|Lost to Follow-up|0|||
23436507|NCT01329939|65340739|FG002|Overall Study|Lost to Follow-up|1|||
23436508|NCT01329939|65340740|FG003|Overall Study|Lost to Follow-up|2|||
23436509|NCT01329939|65340737|FG000|Overall Study|Withdrawal by Subject|0|||
23436510|NCT01329939|65340738|FG001|Overall Study|Withdrawal by Subject|1|||
23752790|NCT04993339|66474137|FG000|Overall Study|no MRI scan|3|||
23752791|NCT04993339|66474138|FG001|Overall Study|no MRI scan|1|||
23752792|NCT04611152|66474141|FG000|Overall Study|Adverse Event|9|||
23752793|NCT04611152|66474142|FG001|Overall Study|Adverse Event|8|||
23436511|NCT01329939|65340739|FG002|Overall Study|Withdrawal by Subject|0|||
23436512|NCT01329939|65340740|FG003|Overall Study|Withdrawal by Subject|0|||
23752794|NCT04611152|66474141|FG000|Overall Study|Non-compliance with study schedule|1|||
23436513|NCT01329939|65340737|FG000|Overall Study|Adverse Event|0|||
23436514|NCT01329939|65340738|FG001|Overall Study|Adverse Event|0|||
23436515|NCT01329939|65340739|FG002|Overall Study|Adverse Event|0|||
23436516|NCT01329939|65340740|FG003|Overall Study|Adverse Event|3|||
23436517|NCT02879578|65340743|FG000|Overall Study|Adverse Event|1|||
23825260|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
23825261|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
23825262|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
23752795|NCT04611152|66474142|FG001|Overall Study|Non-compliance with study schedule|3|||
23752796|NCT04611152|66474141|FG000|Overall Study|Withdrawal by Subject|5|||
23752797|NCT04611152|66474142|FG001|Overall Study|Withdrawal by Subject|6|||
23752798|NCT04611152|66474141|FG000|Overall Study|Lost to Follow-up|11|||
23752799|NCT04611152|66474142|FG001|Overall Study|Lost to Follow-up|2|||
23752800|NCT02032823|66474143|FG000|Overall Study|Death|75|||
23752801|NCT02032823|66474144|FG001|Overall Study|Death|109|||
23752802|NCT02032823|66474143|FG000|Overall Study|Lost to Follow-up|18|||
23752803|NCT02032823|66474144|FG001|Overall Study|Lost to Follow-up|17|||
23752804|NCT02032823|66474143|FG000|Overall Study|Withdrawal by Subject|70|||
23752805|NCT02032823|66474144|FG001|Overall Study|Withdrawal by Subject|53|||
23752806|NCT02032823|66474143|FG000|Overall Study|Ongoing study at data cut-off|755|||
23557663|NCT02954354|65769477|FG002|Overall Study|Lost to Follow-up|0|||
23557664|NCT02954354|65769475|FG000|Overall Study|Miscellaneous|2|||
23752807|NCT02032823|66474144|FG001|Overall Study|Ongoing study at data cut-off|731|||
23752808|NCT02032823|66474143|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
23752809|NCT02032823|66474144|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
23825263|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
23825264|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
23825265|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
23436518|NCT02879578|65340744|FG001|Overall Study|Adverse Event|2|||
23436519|NCT02879578|65340745|FG002|Overall Study|Adverse Event|14|||
23436520|NCT02879578|65340743|FG000|Overall Study|Protocol Violation|0|||
23436521|NCT02879578|65340744|FG001|Overall Study|Protocol Violation|1|||
23436522|NCT02879578|65340745|FG002|Overall Study|Protocol Violation|1|||
23436523|NCT02879578|65340743|FG000|Overall Study|Withdrawal by Subject|8|||
23436524|NCT02879578|65340744|FG001|Overall Study|Withdrawal by Subject|6|||
23436525|NCT02879578|65340745|FG002|Overall Study|Withdrawal by Subject|9|||
23436526|NCT02879578|65340743|FG000|Overall Study|Lost to Follow-up|1|||
23436527|NCT02879578|65340744|FG001|Overall Study|Lost to Follow-up|0|||
23436528|NCT02879578|65340745|FG002|Overall Study|Lost to Follow-up|4|||
23436529|NCT02879578|65340743|FG000|Overall Study|Physician Decision|0|||
23436530|NCT02879578|65340744|FG001|Overall Study|Physician Decision|0|||
23436531|NCT02879578|65340745|FG002|Overall Study|Physician Decision|4|||
23436532|NCT00167310|65340749|FG000|Overall Study|Protocol Violation|5|||
23436533|NCT00167310|65340750|FG001|Overall Study|Protocol Violation|3|||
23436534|NCT00167310|65340749|FG000|Overall Study|Withdrawal by Subject|3|||
23436535|NCT00167310|65340750|FG001|Overall Study|Withdrawal by Subject|7|||
23436536|NCT01431963|65340751|FG000|Overall Study|Adverse Event|18|||
23436537|NCT01431963|65340751|FG000|Overall Study|Lack of Efficacy|7|||
23436538|NCT01431963|65340751|FG000|Overall Study|Protocol Violation|1|||
23436539|NCT01431963|65340751|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
23436540|NCT01431963|65340751|FG000|Overall Study|Physician Decision|4|||
23825266|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
23825267|NCT00261443|66741459|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
23825268|NCT00261443|66741460|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
23825269|NCT00261443|66741461|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
23825270|NCT00261443|66741459|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
23825271|NCT00261443|66741460|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
23825272|NCT00261443|66741461|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
23825273|NCT00261443|66741459|FG000|3: Assessment of Relapse|Adverse Event|0|||
23825274|NCT00261443|66741460|FG001|3: Assessment of Relapse|Adverse Event|15|||
23825275|NCT00261443|66741461|FG002|3: Assessment of Relapse|Adverse Event|19|||
23825276|NCT00261443|66741459|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
23436541|NCT01431963|65340751|FG000|Overall Study|Withdrawal by Subject|3|||
23436542|NCT00148941|65340759|FG000|Overall Study|Lost to Follow-up|17|||
23436543|NCT00148941|65340760|FG001|Overall Study|Lost to Follow-up|24|||
23436544|NCT00148941|65340761|FG002|Overall Study|Lost to Follow-up|18|||
23825277|NCT00261443|66741460|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
23436545|NCT00148941|65340762|FG003|Overall Study|Lost to Follow-up|22|||
23436546|NCT00148941|65340759|FG000|Overall Study|Withdrawal by Subject|1|||
23436547|NCT00148941|65340760|FG001|Overall Study|Withdrawal by Subject|0|||
23436548|NCT00148941|65340761|FG002|Overall Study|Withdrawal by Subject|1|||
23436549|NCT00148941|65340762|FG003|Overall Study|Withdrawal by Subject|0|||
23436550|NCT00148941|65340759|FG000|Overall Study|Other|0|||
23436551|NCT00148941|65340760|FG001|Overall Study|Other|0|||
23825278|NCT00261443|66741461|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
23825279|NCT00261443|66741459|FG000|3: Assessment of Relapse|Death|0|||
23825280|NCT00261443|66741460|FG001|3: Assessment of Relapse|Death|0|||
23825281|NCT00261443|66741461|FG002|3: Assessment of Relapse|Death|1|||
23825282|NCT00261443|66741459|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
23825283|NCT00261443|66741460|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
23825284|NCT00261443|66741461|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
23825285|NCT00261443|66741459|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
23825286|NCT00261443|66741460|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
23825287|NCT00261443|66741461|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
23825288|NCT00261443|66741459|FG000|3: Assessment of Relapse|Pregnancy|0|||
23825289|NCT00261443|66741460|FG001|3: Assessment of Relapse|Pregnancy|2|||
23825290|NCT00261443|66741461|FG002|3: Assessment of Relapse|Pregnancy|1|||
23825291|NCT00261443|66741459|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
23825292|NCT00261443|66741460|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
23825293|NCT00261443|66741461|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
23825294|NCT00261443|66741459|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
23825295|NCT00261443|66741460|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
23825296|NCT00261443|66741461|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
23825297|NCT00261443|66741459|FG000|3: Assessment of Relapse|Other Reasons|0|||
23825298|NCT00261443|66741460|FG001|3: Assessment of Relapse|Other Reasons|4|||
23825299|NCT00261443|66741461|FG002|3: Assessment of Relapse|Other Reasons|3|||
23825300|NCT00261443|66741459|FG000|4: Extension Phase|Adverse Event|0|||
23825301|NCT00261443|66741460|FG001|4: Extension Phase|Adverse Event|1|||
23436552|NCT00148941|65340761|FG002|Overall Study|Other|1|||
23436553|NCT00148941|65340762|FG003|Overall Study|Other|2|||
23436554|NCT01073930|65340765|FG000|Overall Study|Withdrawal by Subject|3|||
23436555|NCT01073930|65340766|FG001|Overall Study|Withdrawal by Subject|2|||
23557665|NCT02954354|65769476|FG001|Overall Study|Miscellaneous|2|||
23557666|NCT02954354|65769477|FG002|Overall Study|Miscellaneous|1|||
23752810|NCT01610284|66474147|FG000|Randomization Phase|Adverse Event|1|||
23752811|NCT01610284|66474148|FG001|Randomization Phase|Adverse Event|0|||
23436556|NCT01073930|65340765|FG000|Overall Study|Lost to Follow-up|0|||
23436557|NCT01073930|65340766|FG001|Overall Study|Lost to Follow-up|1|||
23436558|NCT01073930|65340765|FG000|Overall Study|Adverse Event|0|||
23436559|NCT01073930|65340766|FG001|Overall Study|Adverse Event|1|||
23436560|NCT01073930|65340765|FG000|Overall Study|Noncompliance with study drug|0|||
23436561|NCT01073930|65340766|FG001|Overall Study|Noncompliance with study drug|1|||
23557667|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
23557668|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
23557669|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
23557670|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
23557671|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
23752812|NCT01610284|66474147|FG000|Randomization Phase|Physician Decision|1|||
23752813|NCT01610284|66474148|FG001|Randomization Phase|Physician Decision|1|||
23825302|NCT00261443|66741461|FG002|4: Extension Phase|Adverse Event|0|||
23825303|NCT00261443|66741459|FG000|4: Extension Phase|Withdrawal by Subject|0|||
23825304|NCT00261443|66741460|FG001|4: Extension Phase|Withdrawal by Subject|1|||
23825305|NCT00261443|66741461|FG002|4: Extension Phase|Withdrawal by Subject|2|||
23825306|NCT00261443|66741459|FG000|4: Extension Phase|Lost to Follow-up|0|||
23825307|NCT00261443|66741460|FG001|4: Extension Phase|Lost to Follow-up|1|||
23825308|NCT00261443|66741461|FG002|4: Extension Phase|Lost to Follow-up|0|||
23752814|NCT01610284|66474147|FG000|Randomization Phase|Death|0|||
23752815|NCT01610284|66474148|FG001|Randomization Phase|Death|1|||
23752816|NCT01610284|66474147|FG000|Treatment Phase|Adverse Event|80|||
23752817|NCT01610284|66474148|FG001|Treatment Phase|Adverse Event|12|||
23752818|NCT01610284|66474147|FG000|Treatment Phase|Lost to Follow-up|1|||
23752819|NCT01610284|66474148|FG001|Treatment Phase|Lost to Follow-up|0|||
23752820|NCT01610284|66474147|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
23752821|NCT01610284|66474148|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
23436562|NCT01073930|65340765|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
23436563|NCT01073930|65340766|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
23436564|NCT02651220|65340767|FG000|Overall Study|Adverse Event|1|||
23557672|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
23752822|NCT01610284|66474147|FG000|Treatment Phase|Physician Decision|27|||
23825309|NCT02301390|66741462|FG000|Overall Study|Withdrawal by Subject|3|||
23436565|NCT02651220|65340768|FG001|Overall Study|Adverse Event|5|||
23436566|NCT02651220|65340769|FG002|Overall Study|Adverse Event|1|||
23557673|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
23557674|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23752823|NCT01610284|66474148|FG001|Treatment Phase|Physician Decision|24|||
23825310|NCT02301390|66741463|FG001|Overall Study|Withdrawal by Subject|5|||
23825311|NCT02301390|66741462|FG000|Overall Study|Protocol Violation|1|||
23825312|NCT02301390|66741463|FG001|Overall Study|Protocol Violation|0|||
23825313|NCT02301390|66741462|FG000|Overall Study|Physician Decision|1|||
23825314|NCT02301390|66741463|FG001|Overall Study|Physician Decision|0|||
23825315|NCT02301390|66741462|FG000|Overall Study|Lost to Follow-up|0|||
23825316|NCT02301390|66741463|FG001|Overall Study|Lost to Follow-up|1|||
23825317|NCT02301390|66741462|FG000|Overall Study|Death|2|||
23825318|NCT02301390|66741463|FG001|Overall Study|Death|2|||
23825319|NCT02301390|66741462|FG000|Overall Study|Procedure not completed|0|||
23825320|NCT02301390|66741463|FG001|Overall Study|Procedure not completed|4|||
23825321|NCT02301390|66741462|FG000|Overall Study|Missed multiple visits|1|||
23825322|NCT02301390|66741463|FG001|Overall Study|Missed multiple visits|1|||
23825323|NCT02301390|66741462|FG000|Overall Study|study terminated|2|||
23825324|NCT02301390|66741463|FG001|Overall Study|study terminated|0|||
23557675|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23557676|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23557677|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
23557678|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
23557679|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
23557680|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
23557681|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
23557682|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
23557683|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
23557684|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
23557685|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
23557686|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
23557687|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
23557688|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
23557689|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
23557690|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
23557691|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
23557692|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
23557693|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
23557694|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
23557695|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
23557696|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
23557697|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
23557698|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557699|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
23557700|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557701|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557702|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
23752824|NCT01610284|66474147|FG000|Treatment Phase|Progressive Disease|377|||
23825325|NCT00280735|66741464|FG000|Overall Study|Adverse Event|5|||
23825326|NCT00280735|66741464|FG000|Overall Study|Lack of Efficacy|3|||
23825327|NCT00280735|66741464|FG000|Overall Study|Withdrawal by Subject|8|||
23752825|NCT01610284|66474148|FG001|Treatment Phase|Progressive Disease|486|||
23752826|NCT01610284|66474147|FG000|Treatment Phase|Protocol Deviation|2|||
23752827|NCT01610284|66474148|FG001|Treatment Phase|Protocol Deviation|3|||
23752828|NCT01610284|66474147|FG000|Treatment Phase|Study terminated by Sponsor|18|||
23752829|NCT01610284|66474148|FG001|Treatment Phase|Study terminated by Sponsor|15|||
23752830|NCT01610284|66474147|FG000|Treatment Phase|Subject/Guardian Decision|55|||
23752831|NCT01610284|66474148|FG001|Treatment Phase|Subject/Guardian Decision|23|||
23752832|NCT01610284|66474147|FG000|Treatment Phase|Death|6|||
23752833|NCT01610284|66474148|FG001|Treatment Phase|Death|5|||
23752834|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
23752835|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23825328|NCT00280735|66741464|FG000|Overall Study|Intercurrent Illness|2|||
23825329|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #1|24|||
23825330|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #1|0|||
23825331|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
23825332|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
23825333|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825334|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825335|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
23825336|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
23825337|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
23752836|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
23752837|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
23825338|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
23436567|NCT02651220|65340767|FG000|Overall Study|Lost to Follow-up|8|||
23825339|NCT03888066|66741465|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825340|NCT03888066|66741466|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23436568|NCT02651220|65340768|FG001|Overall Study|Lost to Follow-up|14|||
23436569|NCT02651220|65340769|FG002|Overall Study|Lost to Follow-up|14|||
23436570|NCT02651220|65340767|FG000|Overall Study|Non-Compliance with Study Drug|4|||
23436571|NCT02651220|65340768|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23436572|NCT02651220|65340769|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23436573|NCT02651220|65340767|FG000|Overall Study|Pregnancy|1|||
23825341|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825342|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825343|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
23825344|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
23436574|NCT02651220|65340768|FG001|Overall Study|Pregnancy|0|||
23436575|NCT02651220|65340769|FG002|Overall Study|Pregnancy|1|||
23436576|NCT02651220|65340767|FG000|Overall Study|Protocol Violation|0|||
23436577|NCT02651220|65340768|FG001|Overall Study|Protocol Violation|0|||
23436578|NCT02651220|65340769|FG002|Overall Study|Protocol Violation|1|||
23436579|NCT02651220|65340767|FG000|Overall Study|Withdrawal by Subject|5|||
23436580|NCT02651220|65340768|FG001|Overall Study|Withdrawal by Subject|6|||
23436581|NCT02651220|65340769|FG002|Overall Study|Withdrawal by Subject|8|||
23436582|NCT02651220|65340767|FG000|Overall Study|Miscellaneous|4|||
23436583|NCT02651220|65340768|FG001|Overall Study|Miscellaneous|1|||
23436584|NCT02651220|65340769|FG002|Overall Study|Miscellaneous|2|||
23436585|NCT02651220|65340767|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23436586|NCT02651220|65340768|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23436587|NCT02651220|65340769|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
23436588|NCT00494507|65340772|FG000|Double-Blind Phase|Adverse Event|2|||
23436589|NCT00494507|65340773|FG001|Double-Blind Phase|Adverse Event|0|||
23436590|NCT00494507|65340774|FG002|Double-Blind Phase|Adverse Event|1|||
23436591|NCT00494507|65340775|FG003|Double-Blind Phase|Adverse Event|0|||
23436592|NCT00494507|65340772|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
23436593|NCT00494507|65340773|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
23436594|NCT00494507|65340774|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23436595|NCT00494507|65340775|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23436596|NCT00494507|65340772|FG000|Double-Blind Phase|Subject Non-compliance|0|||
23436597|NCT00494507|65340773|FG001|Double-Blind Phase|Subject Non-compliance|0|||
23436598|NCT00494507|65340774|FG002|Double-Blind Phase|Subject Non-compliance|1|||
23436599|NCT00494507|65340775|FG003|Double-Blind Phase|Subject Non-compliance|0|||
23752838|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
23752839|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
23752840|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
23752841|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23752842|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
23752843|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
23752844|NCT01610284|66474147|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
23752845|NCT01610284|66474148|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
23752846|NCT01289990|66474149|FG000|Overall Study|Death|0|||
23752847|NCT01289990|66474150|FG001|Overall Study|Death|0|||
23752848|NCT01289990|66474151|FG002|Overall Study|Death|0|||
23752849|NCT01289990|66474152|FG003|Overall Study|Death|1|||
23752850|NCT01289990|66474153|FG004|Overall Study|Death|2|||
23752851|NCT01289990|66474154|FG005|Overall Study|Death|1|||
23752852|NCT01289990|66474155|FG006|Overall Study|Death|0|||
23752853|NCT01289990|66474156|FG007|Overall Study|Death|0|||
23752854|NCT01289990|66474157|FG008|Overall Study|Death|0|||
23752855|NCT01289990|66474158|FG009|Overall Study|Death|0|||
23752856|NCT01289990|66474159|FG010|Overall Study|Death|0|||
23752857|NCT01289990|66474160|FG011|Overall Study|Death|1|||
23752858|NCT01289990|66474161|FG012|Overall Study|Death|0|||
23752859|NCT01289990|66474149|FG000|Overall Study|Lost to Follow-up|3|||
23752860|NCT01289990|66474150|FG001|Overall Study|Lost to Follow-up|2|||
23752861|NCT01289990|66474151|FG002|Overall Study|Lost to Follow-up|5|||
23752862|NCT01289990|66474152|FG003|Overall Study|Lost to Follow-up|5|||
23752863|NCT01289990|66474153|FG004|Overall Study|Lost to Follow-up|3|||
23752864|NCT01289990|66474154|FG005|Overall Study|Lost to Follow-up|4|||
23436600|NCT00494507|65340772|FG000|Double-Blind Phase|Negative DNA test|0|||
23436601|NCT00494507|65340773|FG001|Double-Blind Phase|Negative DNA test|0|||
23436602|NCT00494507|65340774|FG002|Double-Blind Phase|Negative DNA test|0|||
23436603|NCT00494507|65340775|FG003|Double-Blind Phase|Negative DNA test|1|||
23436604|NCT00494507|65340772|FG000|Open-Label Phase|Adverse Event|0|||
23436605|NCT00494507|65340773|FG001|Open-Label Phase|Adverse Event|1|||
23752865|NCT01289990|66474155|FG006|Overall Study|Lost to Follow-up|2|||
23436606|NCT00494507|65340774|FG002|Open-Label Phase|Adverse Event|5|||
23436607|NCT00494507|65340775|FG003|Open-Label Phase|Adverse Event|3|||
23436608|NCT00494507|65340772|FG000|Open-Label Phase|Worsening Disease|0|||
23436609|NCT00494507|65340773|FG001|Open-Label Phase|Worsening Disease|0|||
23436610|NCT00494507|65340774|FG002|Open-Label Phase|Worsening Disease|0|||
23436611|NCT00494507|65340775|FG003|Open-Label Phase|Worsening Disease|2|||
23436612|NCT00172042|65340776|FG000|Overall Study|Adverse Event|27|||
23436613|NCT00172042|65340777|FG001|Overall Study|Adverse Event|13|||
23436614|NCT00172042|65340776|FG000|Overall Study|Abnormal laboratory value(s)|5|||
23436615|NCT00172042|65340777|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23557703|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
23557704|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
23623823|NCT01703845|66008584|FG001|Overall Study|other than stated above|0|||
23623824|NCT01427738|66008585|FG000|Overall Study|Death|12|||
23623825|NCT01427738|66008586|FG001|Overall Study|Death|9|||
23623826|NCT01427738|66008585|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23623827|NCT01427738|66008586|FG001|Overall Study|Severe debilitation, unable to continue|1|||
23557705|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
23557706|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
23623828|NCT01427738|66008585|FG000|Overall Study|Subject unable to get to clinic|5|||
23752866|NCT01289990|66474156|FG007|Overall Study|Lost to Follow-up|2|||
23752867|NCT01289990|66474157|FG008|Overall Study|Lost to Follow-up|1|||
23752868|NCT01289990|66474158|FG009|Overall Study|Lost to Follow-up|4|||
23752869|NCT01289990|66474159|FG010|Overall Study|Lost to Follow-up|2|||
23752870|NCT01289990|66474160|FG011|Overall Study|Lost to Follow-up|1|||
23557707|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
23557708|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
23557709|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
23752871|NCT01289990|66474161|FG012|Overall Study|Lost to Follow-up|2|||
23752872|NCT01289990|66474149|FG000|Overall Study|Withdrawal by Subject|15|||
23752873|NCT01289990|66474150|FG001|Overall Study|Withdrawal by Subject|14|||
23752874|NCT01289990|66474151|FG002|Overall Study|Withdrawal by Subject|12|||
23752875|NCT01289990|66474152|FG003|Overall Study|Withdrawal by Subject|13|||
23752876|NCT01289990|66474153|FG004|Overall Study|Withdrawal by Subject|8|||
23752877|NCT01289990|66474154|FG005|Overall Study|Withdrawal by Subject|7|||
23752878|NCT01289990|66474155|FG006|Overall Study|Withdrawal by Subject|13|||
23752879|NCT01289990|66474156|FG007|Overall Study|Withdrawal by Subject|9|||
23752880|NCT01289990|66474157|FG008|Overall Study|Withdrawal by Subject|12|||
23752881|NCT01289990|66474158|FG009|Overall Study|Withdrawal by Subject|13|||
23752882|NCT01289990|66474159|FG010|Overall Study|Withdrawal by Subject|11|||
23752883|NCT01289990|66474160|FG011|Overall Study|Withdrawal by Subject|13|||
23752884|NCT01289990|66474161|FG012|Overall Study|Withdrawal by Subject|16|||
23752885|NCT01289990|66474149|FG000|Overall Study|discontinued in preceding trial|18|||
23752886|NCT01289990|66474150|FG001|Overall Study|discontinued in preceding trial|20|||
23752887|NCT01289990|66474151|FG002|Overall Study|discontinued in preceding trial|41|||
23752888|NCT01289990|66474152|FG003|Overall Study|discontinued in preceding trial|17|||
23436616|NCT00172042|65340776|FG000|Overall Study|Abnormal test procedure(s)|0|||
23557710|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
23623829|NCT01427738|66008586|FG001|Overall Study|Subject unable to get to clinic|2|||
23623830|NCT01427738|66008585|FG000|Overall Study|Withdrawal by Subject|0|||
23436617|NCT00172042|65340777|FG001|Overall Study|Abnormal test procedure(s)|3|||
23623831|NCT01427738|66008586|FG001|Overall Study|Withdrawal by Subject|2|||
23752889|NCT01289990|66474153|FG004|Overall Study|discontinued in preceding trial|11|||
23752890|NCT01289990|66474154|FG005|Overall Study|discontinued in preceding trial|12|||
23752891|NCT01289990|66474155|FG006|Overall Study|discontinued in preceding trial|18|||
23436618|NCT00172042|65340776|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
23623832|NCT01427738|66008585|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
23557711|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
23557712|NCT02070484|65769483|FG000|Overall Study|Withdrawal by Subject|1|||
23557713|NCT02070484|65769484|FG001|Overall Study|Withdrawal by Subject|0|||
23557714|NCT02044848|65769492|FG000|Overall Study|Administrative Problems|2|||
23557715|NCT02044848|65769493|FG001|Overall Study|Administrative Problems|3|||
23557716|NCT02969525|65769494|FG000|Double-Blind Period|Adverse Event|0|||
23752892|NCT01289990|66474156|FG007|Overall Study|discontinued in preceding trial|8|||
23752893|NCT01289990|66474157|FG008|Overall Study|discontinued in preceding trial|17|||
23752894|NCT01289990|66474158|FG009|Overall Study|discontinued in preceding trial|21|||
23752895|NCT01289990|66474159|FG010|Overall Study|discontinued in preceding trial|17|||
23752896|NCT01289990|66474160|FG011|Overall Study|discontinued in preceding trial|17|||
23752897|NCT01289990|66474161|FG012|Overall Study|discontinued in preceding trial|24|||
23752898|NCT01289990|66474149|FG000|Overall Study|did not continue in extension|41|||
23752899|NCT01289990|66474150|FG001|Overall Study|did not continue in extension|45|||
23752900|NCT01289990|66474151|FG002|Overall Study|did not continue in extension|51|||
23752901|NCT01289990|66474152|FG003|Overall Study|did not continue in extension|51|||
23752902|NCT01289990|66474153|FG004|Overall Study|did not continue in extension|48|||
23752903|NCT01289990|66474154|FG005|Overall Study|did not continue in extension|50|||
23752904|NCT01289990|66474155|FG006|Overall Study|did not continue in extension|54|||
23752905|NCT01289990|66474156|FG007|Overall Study|did not continue in extension|36|||
23752906|NCT01289990|66474157|FG008|Overall Study|did not continue in extension|44|||
23752907|NCT01289990|66474158|FG009|Overall Study|did not continue in extension|48|||
23752908|NCT01289990|66474159|FG010|Overall Study|did not continue in extension|45|||
23752909|NCT01289990|66474160|FG011|Overall Study|did not continue in extension|34|||
23752910|NCT01289990|66474161|FG012|Overall Study|did not continue in extension|56|||
23752911|NCT01289990|66474149|FG000|Overall Study|Not treated|0|||
23752912|NCT01289990|66474150|FG001|Overall Study|Not treated|0|||
23752913|NCT01289990|66474151|FG002|Overall Study|Not treated|0|||
23752914|NCT01289990|66474152|FG003|Overall Study|Not treated|0|||
23752915|NCT01289990|66474153|FG004|Overall Study|Not treated|0|||
23752916|NCT01289990|66474154|FG005|Overall Study|Not treated|0|||
23752917|NCT01289990|66474155|FG006|Overall Study|Not treated|1|||
23752918|NCT01289990|66474156|FG007|Overall Study|Not treated|0|||
23752919|NCT01289990|66474157|FG008|Overall Study|Not treated|1|||
23752920|NCT01289990|66474158|FG009|Overall Study|Not treated|0|||
23752921|NCT01289990|66474159|FG010|Overall Study|Not treated|1|||
23752922|NCT01289990|66474160|FG011|Overall Study|Not treated|2|||
23752923|NCT01289990|66474161|FG012|Overall Study|Not treated|0|||
23752924|NCT02163694|66474162|FG000|Overall Study|Adverse event- related to progression|3|||
23752925|NCT02163694|66474163|FG001|Overall Study|Adverse event- related to progression|8|||
23752926|NCT02163694|66474162|FG000|Overall Study|Adverse event- not related to progression|7|||
23752927|NCT02163694|66474163|FG001|Overall Study|Adverse event- not related to progression|17|||
23752928|NCT02163694|66474162|FG000|Overall Study|Withdrew consent|8|||
23752929|NCT02163694|66474163|FG001|Overall Study|Withdrew consent|21|||
23752930|NCT02163694|66474162|FG000|Overall Study|Lost to Follow-up|1|||
23752931|NCT02163694|66474163|FG001|Overall Study|Lost to Follow-up|2|||
23752932|NCT02163694|66474162|FG000|Overall Study|Progressive disease per protocol|122|||
23752933|NCT02163694|66474163|FG001|Overall Study|Progressive disease per protocol|197|||
23752934|NCT02163694|66474162|FG000|Overall Study|Other, not specified|13|||
23752935|NCT02163694|66474163|FG001|Overall Study|Other, not specified|22|||
23752936|NCT00414011|66474164|FG000|Overall Study|Physician Decision|3|||
23752937|NCT00414011|66474164|FG000|Overall Study|Withdrawal by Subject|2|||
23752938|NCT01333475|66474165|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
23752939|NCT01333475|66474166|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
23752940|NCT01333475|66474165|FG000|Overall Study|Toxicity|1|||
23752941|NCT01333475|66474166|FG001|Overall Study|Toxicity|3|||
23752942|NCT03123120|66474169|FG000|Overall Study|Lost to Follow-up|0|||
23436619|NCT00172042|65340777|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
23557717|NCT02969525|65769495|FG001|Double-Blind Period|Adverse Event|0|||
23557718|NCT02969525|65769496|FG002|Double-Blind Period|Adverse Event|1|||
23752943|NCT03123120|66474170|FG001|Overall Study|Lost to Follow-up|1|||
23752944|NCT03123120|66474169|FG000|Overall Study|Withdrawal by Subject|0|||
23752945|NCT03123120|66474170|FG001|Overall Study|Withdrawal by Subject|1|||
23752946|NCT00242567|66474173|FG000|Overall Study|Adverse Event|70|||
23752947|NCT00242567|66474174|FG001|Overall Study|Adverse Event|43|||
23752948|NCT00242567|66474173|FG000|Overall Study|Disease Progression|17|||
23752949|NCT00242567|66474174|FG001|Overall Study|Disease Progression|22|||
23752950|NCT00242567|66474173|FG000|Overall Study|Symptomatic deterioration|9|||
23752951|NCT00242567|66474174|FG001|Overall Study|Symptomatic deterioration|3|||
23752952|NCT00242567|66474173|FG000|Overall Study|Lack of Efficacy|2|||
23752953|NCT00242567|66474174|FG001|Overall Study|Lack of Efficacy|2|||
23752954|NCT00242567|66474173|FG000|Overall Study|Lost to Follow-up|9|||
23752955|NCT00242567|66474174|FG001|Overall Study|Lost to Follow-up|19|||
23752956|NCT00242567|66474173|FG000|Overall Study|Withdrawal by Subject|33|||
23557719|NCT02969525|65769497|FG003|Double-Blind Period|Adverse Event|1|||
23557720|NCT02969525|65769498|FG004|Double-Blind Period|Adverse Event|0|||
23557721|NCT02969525|65769499|FG005|Double-Blind Period|Adverse Event|0|||
23557722|NCT02969525|65769500|FG006|Double-Blind Period|Adverse Event|0|||
23557723|NCT02969525|65769501|FG007|Double-Blind Period|Adverse Event|0|||
23557724|NCT02969525|65769502|FG008|Double-Blind Period|Adverse Event|0|||
23752957|NCT00242567|66474174|FG001|Overall Study|Withdrawal by Subject|28|||
23752958|NCT00242567|66474173|FG000|Overall Study|Protocol Violation|12|||
23752959|NCT00242567|66474174|FG001|Overall Study|Protocol Violation|12|||
23752960|NCT00242567|66474173|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
23752961|NCT00242567|66474174|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
23752962|NCT00242567|66474173|FG000|Overall Study|Other|14|||
23752963|NCT00242567|66474174|FG001|Overall Study|Other|9|||
23752964|NCT01548573|66474175|FG000|Overall Study|Death|3|||
23752965|NCT01548573|66474175|FG000|Overall Study|Withdrawal by Subject|2|||
23752966|NCT00445458|66474176|FG000|Overall Study|Disease Progression|3|||
23752967|NCT00445458|66474177|FG001|Overall Study|Disease Progression|4|||
23752968|NCT00445458|66474178|FG002|Overall Study|Disease Progression|54|||
23752969|NCT00445458|66474179|FG003|Overall Study|Disease Progression|27|||
23752970|NCT00445458|66474176|FG000|Overall Study|Withdrawal by Subject|0|||
23752971|NCT00445458|66474177|FG001|Overall Study|Withdrawal by Subject|0|||
23752972|NCT00445458|66474178|FG002|Overall Study|Withdrawal by Subject|7|||
23752973|NCT00445458|66474179|FG003|Overall Study|Withdrawal by Subject|0|||
23752974|NCT00445458|66474176|FG000|Overall Study|Adverse Event|0|||
23752975|NCT00445458|66474177|FG001|Overall Study|Adverse Event|0|||
23752976|NCT00445458|66474178|FG002|Overall Study|Adverse Event|3|||
23752977|NCT00445458|66474179|FG003|Overall Study|Adverse Event|0|||
23752978|NCT00445458|66474176|FG000|Overall Study|Death|0|||
23752979|NCT00445458|66474177|FG001|Overall Study|Death|1|||
23752980|NCT00445458|66474178|FG002|Overall Study|Death|2|||
23752981|NCT00445458|66474179|FG003|Overall Study|Death|0|||
23752982|NCT00445458|66474176|FG000|Overall Study|Physician Decision|0|||
23752983|NCT00445458|66474177|FG001|Overall Study|Physician Decision|0|||
23752984|NCT00445458|66474178|FG002|Overall Study|Physician Decision|1|||
23752985|NCT00445458|66474179|FG003|Overall Study|Physician Decision|1|||
23752986|NCT00445458|66474176|FG000|Overall Study|Surgery|0|||
23752987|NCT00445458|66474177|FG001|Overall Study|Surgery|0|||
23752988|NCT00445458|66474178|FG002|Overall Study|Surgery|1|||
23752989|NCT00445458|66474179|FG003|Overall Study|Surgery|0|||
23752990|NCT02594384|66474180|FG000|Overall Study|Disease Progression|3|||
23557725|NCT02969525|65769503|FG009|Double-Blind Period|Adverse Event|0|||
23752991|NCT02594384|66474181|FG001|Overall Study|Disease Progression|7|||
23752992|NCT02594384|66474182|FG002|Overall Study|Disease Progression|0|||
23752993|NCT02594384|66474183|FG003|Overall Study|Disease Progression|2|||
23557726|NCT02969525|65769504|FG010|Double-Blind Period|Adverse Event|0|||
23557727|NCT02969525|65769505|FG011|Double-Blind Period|Adverse Event|0|||
23752994|NCT02594384|66474184|FG004|Overall Study|Disease Progression|2|||
23752995|NCT02594384|66474185|FG005|Overall Study|Disease Progression|12|||
23752996|NCT02594384|66474186|FG006|Overall Study|Disease Progression|5|||
23752997|NCT02594384|66474187|FG007|Overall Study|Disease Progression|5|||
23752998|NCT02594384|66474180|FG000|Overall Study|Adverse Event|0|||
23752999|NCT02594384|66474181|FG001|Overall Study|Adverse Event|1|||
23436620|NCT00172042|65340776|FG000|Overall Study|Patient no longer requires study drug|10|||
23436621|NCT00172042|65340777|FG001|Overall Study|Patient no longer requires study drug|8|||
23436622|NCT00172042|65340776|FG000|Overall Study|Protocol Violation|8|||
23436623|NCT00172042|65340777|FG001|Overall Study|Protocol Violation|7|||
23436624|NCT00172042|65340776|FG000|Overall Study|Withdrawal by Subject|37|||
23436625|NCT00172042|65340777|FG001|Overall Study|Withdrawal by Subject|25|||
23557728|NCT02969525|65769494|FG000|Double-Blind Period|LOW EGFR|0|||
23825345|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23436626|NCT00172042|65340776|FG000|Overall Study|Lost to Follow-up|3|||
23436627|NCT00172042|65340777|FG001|Overall Study|Lost to Follow-up|5|||
23436628|NCT00172042|65340776|FG000|Overall Study|Administrative problems|13|||
23436629|NCT00172042|65340777|FG001|Overall Study|Administrative problems|10|||
23436630|NCT00172042|65340776|FG000|Overall Study|Death|42|||
23436631|NCT00172042|65340777|FG001|Overall Study|Death|42|||
23436632|NCT03188510|65340779|FG000|Overall Study|Inappropriate behavior with site staff|0|||
23436633|NCT03188510|65340780|FG001|Overall Study|Inappropriate behavior with site staff|1|||
23436634|NCT03188510|65340781|FG002|Overall Study|Inappropriate behavior with site staff|0|||
23436635|NCT02461745|65340782|FG000|Overall Study|Lack of Efficacy|9|||
23436636|NCT02461745|65340783|FG001|Overall Study|Lack of Efficacy|1|||
23436637|NCT02461745|65340782|FG000|Overall Study|Lost to Follow-up|2|||
23436638|NCT02461745|65340783|FG001|Overall Study|Lost to Follow-up|2|||
23436639|NCT02461745|65340782|FG000|Overall Study|Withdrawal by Subject|3|||
23436640|NCT02461745|65340783|FG001|Overall Study|Withdrawal by Subject|1|||
23436641|NCT00367835|65340784|FG000|Overall Study|Adverse Event|14|||
23436642|NCT00367835|65340785|FG001|Overall Study|Adverse Event|1|||
23825346|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23436643|NCT00367835|65340784|FG000|Overall Study|Protocol Violation|1|||
23436644|NCT00367835|65340785|FG001|Overall Study|Protocol Violation|7|||
23436645|NCT00367835|65340784|FG000|Overall Study|Withdrawal by Subject|7|||
23436646|NCT00367835|65340785|FG001|Overall Study|Withdrawal by Subject|6|||
23436647|NCT00367835|65340784|FG000|Overall Study|Lost to Follow-up|1|||
23436648|NCT00367835|65340785|FG001|Overall Study|Lost to Follow-up|4|||
23436649|NCT00367835|65340784|FG000|Overall Study|Lack of Efficacy|3|||
23436650|NCT00367835|65340785|FG001|Overall Study|Lack of Efficacy|12|||
23436651|NCT00367835|65340784|FG000|Overall Study|Subject in juvenile detention center|1|||
23436652|NCT00367835|65340785|FG001|Overall Study|Subject in juvenile detention center|0|||
23436653|NCT00367835|65340784|FG000|Overall Study|refused blood collection|1|||
23436654|NCT00367835|65340785|FG001|Overall Study|refused blood collection|0|||
23436655|NCT00367835|65340784|FG000|Overall Study|Did not respond to calls|1|||
23436656|NCT00367835|65340785|FG001|Overall Study|Did not respond to calls|0|||
23436657|NCT00367835|65340784|FG000|Overall Study|History of lead poisoning|0|||
23436658|NCT00367835|65340785|FG001|Overall Study|History of lead poisoning|1|||
23436659|NCT00079677|65340790|FG000|Overall Study|Adverse Event|5|||
23436660|NCT00079677|65340791|FG001|Overall Study|Adverse Event|6|||
23436661|NCT00079677|65340790|FG000|Overall Study|Lack of Efficacy|1|||
23436662|NCT00079677|65340791|FG001|Overall Study|Lack of Efficacy|0|||
23436663|NCT00079677|65340790|FG000|Overall Study|Lost to Follow-up|2|||
23436664|NCT00079677|65340791|FG001|Overall Study|Lost to Follow-up|2|||
23436665|NCT00079677|65340790|FG000|Overall Study|Physician Decision|3|||
23436666|NCT00079677|65340791|FG001|Overall Study|Physician Decision|0|||
23436667|NCT00079677|65340790|FG000|Overall Study|Protocol Violation|2|||
23436668|NCT00079677|65340791|FG001|Overall Study|Protocol Violation|3|||
23436669|NCT00079677|65340790|FG000|Overall Study|Withdrawal by Subject|5|||
23436670|NCT00079677|65340791|FG001|Overall Study|Withdrawal by Subject|3|||
23436671|NCT00079677|65340790|FG000|Overall Study|Miscellaneous|2|||
23436672|NCT00079677|65340791|FG001|Overall Study|Miscellaneous|0|||
23436673|NCT01563172|65340796|FG000|Overall Study|Adverse Event|5|||
23436674|NCT01563172|65340796|FG000|Overall Study|Lost to Follow-up|2|||
23436675|NCT01563172|65340796|FG000|Overall Study|Other (Protocol deviation)|5|||
23436676|NCT01563172|65340796|FG000|Overall Study|Other (Not specified)|1|||
23436677|NCT00447122|65340797|FG000|Overall Study|worsening medical condition -came off|0|||
23436678|NCT00447122|65340798|FG001|Overall Study|worsening medical condition -came off|1|||
23436679|NCT00447122|65340799|FG002|Overall Study|worsening medical condition -came off|0|||
23436680|NCT00447122|65340800|FG003|Overall Study|worsening medical condition -came off|0|||
23436681|NCT01371305|65340801|FG000|Overall Study|Adverse Event|0|||
23436682|NCT01371305|65340802|FG001|Overall Study|Adverse Event|0|||
23436683|NCT01371305|65340803|FG002|Overall Study|Adverse Event|0|||
23436684|NCT01371305|65340804|FG003|Overall Study|Adverse Event|2|||
23436685|NCT01371305|65340805|FG004|Overall Study|Adverse Event|1|||
23436686|NCT01371305|65340806|FG005|Overall Study|Adverse Event|0|||
23436687|NCT01371305|65340801|FG000|Overall Study|Study terminated by sponsor|0|||
23436688|NCT01371305|65340802|FG001|Overall Study|Study terminated by sponsor|0|||
23436689|NCT01371305|65340803|FG002|Overall Study|Study terminated by sponsor|0|||
23557729|NCT02969525|65769495|FG001|Double-Blind Period|LOW EGFR|0|||
23557730|NCT02969525|65769496|FG002|Double-Blind Period|LOW EGFR|0|||
23557731|NCT02969525|65769497|FG003|Double-Blind Period|LOW EGFR|1|||
23436690|NCT01371305|65340804|FG003|Overall Study|Study terminated by sponsor|0|||
23436691|NCT01371305|65340805|FG004|Overall Study|Study terminated by sponsor|3|||
23436692|NCT01371305|65340806|FG005|Overall Study|Study terminated by sponsor|1|||
23436693|NCT01371305|65340801|FG000|Overall Study|Subject request|0|||
23436694|NCT01371305|65340802|FG001|Overall Study|Subject request|0|||
23436695|NCT01371305|65340803|FG002|Overall Study|Subject request|0|||
23436696|NCT01371305|65340804|FG003|Overall Study|Subject request|0|||
23436697|NCT01371305|65340805|FG004|Overall Study|Subject request|0|||
23436698|NCT01371305|65340806|FG005|Overall Study|Subject request|1|||
23436699|NCT01793883|65340807|FG000|Overall Study|Withdrawal by Subject|3|||
23436700|NCT01793883|65340808|FG001|Overall Study|Withdrawal by Subject|7|||
23436701|NCT01793883|65340809|FG002|Overall Study|Withdrawal by Subject|3|||
23436702|NCT01793883|65340807|FG000|Overall Study|Subject noncompliance|0|||
23436703|NCT01793883|65340808|FG001|Overall Study|Subject noncompliance|1|||
23436704|NCT01793883|65340809|FG002|Overall Study|Subject noncompliance|1|||
23436705|NCT01793883|65340807|FG000|Overall Study|Lost to Follow-up|5|||
23436706|NCT01793883|65340808|FG001|Overall Study|Lost to Follow-up|1|||
23436707|NCT01793883|65340809|FG002|Overall Study|Lost to Follow-up|3|||
23436708|NCT01793883|65340807|FG000|Overall Study|Randomized in error|1|||
23436709|NCT01793883|65340808|FG001|Overall Study|Randomized in error|0|||
23436710|NCT01793883|65340809|FG002|Overall Study|Randomized in error|0|||
23436711|NCT01793883|65340807|FG000|Overall Study|Unable to complete spriometry|1|||
23436712|NCT01793883|65340808|FG001|Overall Study|Unable to complete spriometry|0|||
23436713|NCT01793883|65340809|FG002|Overall Study|Unable to complete spriometry|0|||
23436714|NCT01793883|65340807|FG000|Overall Study|Unable to complete measurements|1|||
23436715|NCT01793883|65340808|FG001|Overall Study|Unable to complete measurements|0|||
23436716|NCT01793883|65340809|FG002|Overall Study|Unable to complete measurements|0|||
23436717|NCT01793883|65340807|FG000|Overall Study|Met exclusion criteria|1|||
23436718|NCT01793883|65340808|FG001|Overall Study|Met exclusion criteria|0|||
23436719|NCT01793883|65340809|FG002|Overall Study|Met exclusion criteria|0|||
23436720|NCT01793883|65340807|FG000|Overall Study|Dosing error|0|||
23436721|NCT01793883|65340808|FG001|Overall Study|Dosing error|1|||
23436722|NCT01793883|65340809|FG002|Overall Study|Dosing error|0|||
23436723|NCT01793883|65340807|FG000|Overall Study|Respiratory distress during spirometry|0|||
23436724|NCT01793883|65340808|FG001|Overall Study|Respiratory distress during spirometry|0|||
23436725|NCT01793883|65340809|FG002|Overall Study|Respiratory distress during spirometry|1|||
23436726|NCT03262441|65340810|FG000|Overall Study|Withdrawal by Subject|1|||
23436727|NCT01846741|65340811|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
23436728|NCT01052077|65340816|FG000|Phase A|Lost to Follow-up|22|||
23436729|NCT01052077|65340817|FG001|Phase A|Lost to Follow-up|0|||
23436730|NCT01052077|65340818|FG002|Phase A|Lost to Follow-up|0|||
23436731|NCT01052077|65340819|FG003|Phase A|Lost to Follow-up|0|||
23436732|NCT01052077|65340816|FG000|Phase A|Adverse Event|32|||
23436733|NCT01052077|65340817|FG001|Phase A|Adverse Event|0|||
23436734|NCT01052077|65340818|FG002|Phase A|Adverse Event|0|||
23436735|NCT01052077|65340819|FG003|Phase A|Adverse Event|0|||
23436736|NCT01052077|65340816|FG000|Phase A|Met Withdrawal Criteria|26|||
23436737|NCT01052077|65340817|FG001|Phase A|Met Withdrawal Criteria|0|||
23436738|NCT01052077|65340818|FG002|Phase A|Met Withdrawal Criteria|0|||
23436739|NCT01052077|65340819|FG003|Phase A|Met Withdrawal Criteria|0|||
23436740|NCT01052077|65340816|FG000|Phase A|Physician Decision|10|||
23436741|NCT01052077|65340817|FG001|Phase A|Physician Decision|0|||
23436742|NCT01052077|65340818|FG002|Phase A|Physician Decision|0|||
23436743|NCT01052077|65340819|FG003|Phase A|Physician Decision|0|||
23436744|NCT01052077|65340816|FG000|Phase A|Withdrawal by Subject|29|||
23436745|NCT01052077|65340817|FG001|Phase A|Withdrawal by Subject|0|||
23436746|NCT01052077|65340818|FG002|Phase A|Withdrawal by Subject|0|||
23436747|NCT01052077|65340819|FG003|Phase A|Withdrawal by Subject|0|||
23436748|NCT01052077|65340816|FG000|Phase A|Protocol Deviation|27|||
23557732|NCT02969525|65769498|FG004|Double-Blind Period|LOW EGFR|0|||
23557733|NCT02969525|65769499|FG005|Double-Blind Period|LOW EGFR|0|||
23557734|NCT02969525|65769500|FG006|Double-Blind Period|LOW EGFR|0|||
23557735|NCT02969525|65769501|FG007|Double-Blind Period|LOW EGFR|0|||
23825347|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
23436749|NCT01052077|65340817|FG001|Phase A|Protocol Deviation|0|||
23436750|NCT01052077|65340818|FG002|Phase A|Protocol Deviation|0|||
23436751|NCT01052077|65340819|FG003|Phase A|Protocol Deviation|0|||
23436752|NCT01052077|65340816|FG000|Phase B|Lost to Follow-up|0|||
23436753|NCT01052077|65340817|FG001|Phase B|Lost to Follow-up|2|||
23436754|NCT01052077|65340818|FG002|Phase B|Lost to Follow-up|3|||
23436755|NCT01052077|65340819|FG003|Phase B|Lost to Follow-up|0|||
23436756|NCT01052077|65340816|FG000|Phase B|Adverse Event|0|||
23436757|NCT01052077|65340817|FG001|Phase B|Adverse Event|9|||
23436758|NCT01052077|65340818|FG002|Phase B|Adverse Event|2|||
23436759|NCT01052077|65340819|FG003|Phase B|Adverse Event|0|||
23436760|NCT01052077|65340816|FG000|Phase B|Met Withdrawal Criteria|0|||
23436761|NCT01052077|65340817|FG001|Phase B|Met Withdrawal Criteria|2|||
23557736|NCT02969525|65769502|FG008|Double-Blind Period|LOW EGFR|0|||
23753000|NCT02594384|66474182|FG002|Overall Study|Adverse Event|4|||
23753001|NCT02594384|66474183|FG003|Overall Study|Adverse Event|1|||
23753002|NCT02594384|66474184|FG004|Overall Study|Adverse Event|0|||
23753003|NCT02594384|66474185|FG005|Overall Study|Adverse Event|6|||
23753004|NCT02594384|66474186|FG006|Overall Study|Adverse Event|1|||
23753005|NCT02594384|66474187|FG007|Overall Study|Adverse Event|1|||
23753006|NCT02594384|66474180|FG000|Overall Study|Withdrawal by Subject|0|||
23753007|NCT02594384|66474181|FG001|Overall Study|Withdrawal by Subject|0|||
23753008|NCT02594384|66474182|FG002|Overall Study|Withdrawal by Subject|0|||
23753009|NCT02594384|66474183|FG003|Overall Study|Withdrawal by Subject|1|||
23753010|NCT02594384|66474184|FG004|Overall Study|Withdrawal by Subject|0|||
23753011|NCT02594384|66474185|FG005|Overall Study|Withdrawal by Subject|0|||
23753012|NCT02594384|66474186|FG006|Overall Study|Withdrawal by Subject|0|||
23753013|NCT02594384|66474187|FG007|Overall Study|Withdrawal by Subject|1|||
23753014|NCT02594384|66474180|FG000|Overall Study|Physician Decision|0|||
23753015|NCT02594384|66474181|FG001|Overall Study|Physician Decision|0|||
23753016|NCT02594384|66474182|FG002|Overall Study|Physician Decision|0|||
23753017|NCT02594384|66474183|FG003|Overall Study|Physician Decision|0|||
23753018|NCT02594384|66474184|FG004|Overall Study|Physician Decision|0|||
23753019|NCT02594384|66474185|FG005|Overall Study|Physician Decision|1|||
23753020|NCT02594384|66474186|FG006|Overall Study|Physician Decision|2|||
23753021|NCT02594384|66474187|FG007|Overall Study|Physician Decision|0|||
23753022|NCT02594384|66474180|FG000|Overall Study|Progressive Leukocytosis|0|||
23557737|NCT02969525|65769503|FG009|Double-Blind Period|LOW EGFR|0|||
23557738|NCT02969525|65769504|FG010|Double-Blind Period|LOW EGFR|0|||
23557739|NCT02969525|65769505|FG011|Double-Blind Period|LOW EGFR|0|||
23557740|NCT02969525|65769494|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
23557741|NCT02969525|65769495|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557742|NCT02969525|65769496|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557743|NCT02969525|65769497|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
23557744|NCT02969525|65769498|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557745|NCT02969525|65769499|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23753023|NCT02594384|66474181|FG001|Overall Study|Progressive Leukocytosis|0|||
23753024|NCT02594384|66474182|FG002|Overall Study|Progressive Leukocytosis|1|||
23753025|NCT02594384|66474183|FG003|Overall Study|Progressive Leukocytosis|0|||
23753026|NCT02594384|66474184|FG004|Overall Study|Progressive Leukocytosis|0|||
23753027|NCT02594384|66474185|FG005|Overall Study|Progressive Leukocytosis|0|||
23753028|NCT02594384|66474186|FG006|Overall Study|Progressive Leukocytosis|0|||
23753029|NCT02594384|66474187|FG007|Overall Study|Progressive Leukocytosis|0|||
23753030|NCT02594384|66474180|FG000|Overall Study|Lack of Efficacy|0|||
23753031|NCT02594384|66474181|FG001|Overall Study|Lack of Efficacy|0|||
23753032|NCT02594384|66474182|FG002|Overall Study|Lack of Efficacy|0|||
23753033|NCT02594384|66474183|FG003|Overall Study|Lack of Efficacy|0|||
23753034|NCT02594384|66474184|FG004|Overall Study|Lack of Efficacy|1|||
23753035|NCT02594384|66474185|FG005|Overall Study|Lack of Efficacy|0|||
23753036|NCT02594384|66474186|FG006|Overall Study|Lack of Efficacy|0|||
23753037|NCT02594384|66474187|FG007|Overall Study|Lack of Efficacy|0|||
23753038|NCT02594384|66474180|FG000|Overall Study|Substantial noncompliance|0|||
23753039|NCT02594384|66474181|FG001|Overall Study|Substantial noncompliance|0|||
23753040|NCT02594384|66474182|FG002|Overall Study|Substantial noncompliance|0|||
23753041|NCT02594384|66474183|FG003|Overall Study|Substantial noncompliance|0|||
23753042|NCT02594384|66474184|FG004|Overall Study|Substantial noncompliance|0|||
23753043|NCT02594384|66474185|FG005|Overall Study|Substantial noncompliance|0|||
23825348|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825349|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #2|5|||
23825350|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #2|0|||
23557746|NCT02969525|65769500|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557747|NCT02969525|65769501|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557748|NCT02969525|65769502|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557749|NCT02969525|65769503|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557750|NCT02969525|65769504|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557751|NCT02969525|65769505|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557752|NCT02969525|65769494|FG000|Dose-Blind Period|Adverse Event|0|||
23557753|NCT02969525|65769495|FG001|Dose-Blind Period|Adverse Event|0|||
23557754|NCT02969525|65769496|FG002|Dose-Blind Period|Adverse Event|0|||
23557755|NCT02969525|65769497|FG003|Dose-Blind Period|Adverse Event|0|||
23557756|NCT02969525|65769498|FG004|Dose-Blind Period|Adverse Event|0|||
23557757|NCT02969525|65769499|FG005|Dose-Blind Period|Adverse Event|0|||
23557758|NCT02969525|65769500|FG006|Dose-Blind Period|Adverse Event|0|||
23557759|NCT02969525|65769501|FG007|Dose-Blind Period|Adverse Event|0|||
23557760|NCT02969525|65769502|FG008|Dose-Blind Period|Adverse Event|0|||
23753044|NCT02594384|66474186|FG006|Overall Study|Substantial noncompliance|1|||
23753045|NCT02594384|66474187|FG007|Overall Study|Substantial noncompliance|0|||
23753046|NCT00915473|66474188|FG000|Screening|Withdrawal by Subject|1|||
23557761|NCT02969525|65769503|FG009|Dose-Blind Period|Adverse Event|1|||
23557762|NCT02969525|65769504|FG010|Dose-Blind Period|Adverse Event|1|||
23557763|NCT02969525|65769505|FG011|Dose-Blind Period|Adverse Event|1|||
23557764|NCT02969525|65769494|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
23557765|NCT02969525|65769495|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
23557766|NCT02969525|65769496|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
23557767|NCT02969525|65769497|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
23557768|NCT02969525|65769498|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
23557769|NCT02969525|65769499|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
23557770|NCT02969525|65769500|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
23557771|NCT02969525|65769501|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
23557772|NCT02969525|65769502|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
23557773|NCT02969525|65769503|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
23557774|NCT02969525|65769504|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
23557775|NCT02969525|65769505|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
23557776|NCT02969525|65769494|FG000|Dose-Blind Period|Non-cooperating patient|0|||
23557777|NCT02969525|65769495|FG001|Dose-Blind Period|Non-cooperating patient|0|||
23557778|NCT02969525|65769496|FG002|Dose-Blind Period|Non-cooperating patient|0|||
23557779|NCT02969525|65769497|FG003|Dose-Blind Period|Non-cooperating patient|0|||
23557780|NCT02969525|65769498|FG004|Dose-Blind Period|Non-cooperating patient|0|||
23557781|NCT02969525|65769499|FG005|Dose-Blind Period|Non-cooperating patient|0|||
23557782|NCT02969525|65769500|FG006|Dose-Blind Period|Non-cooperating patient|0|||
23557783|NCT02969525|65769501|FG007|Dose-Blind Period|Non-cooperating patient|0|||
23557784|NCT02969525|65769502|FG008|Dose-Blind Period|Non-cooperating patient|0|||
23557785|NCT02969525|65769503|FG009|Dose-Blind Period|Non-cooperating patient|0|||
23557786|NCT02969525|65769504|FG010|Dose-Blind Period|Non-cooperating patient|0|||
23557787|NCT02969525|65769505|FG011|Dose-Blind Period|Non-cooperating patient|1|||
23557788|NCT02969525|65769494|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557789|NCT02969525|65769495|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557790|NCT02969525|65769496|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557791|NCT02969525|65769497|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557792|NCT02969525|65769498|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557793|NCT02969525|65769499|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23753047|NCT00915473|66474189|FG001|Screening|Withdrawal by Subject|0|||
23753048|NCT00915473|66474188|FG000|4-week Follow Up|Lost to Follow-up|1|||
23557794|NCT02969525|65769500|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557795|NCT02969525|65769501|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557796|NCT02969525|65769502|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23436762|NCT01052077|65340818|FG002|Phase B|Met Withdrawal Criteria|1|||
23436763|NCT01052077|65340819|FG003|Phase B|Met Withdrawal Criteria|0|||
23436764|NCT01052077|65340816|FG000|Phase B|Physician Decision|0|||
23436765|NCT01052077|65340817|FG001|Phase B|Physician Decision|1|||
23436766|NCT01052077|65340818|FG002|Phase B|Physician Decision|1|||
23436767|NCT01052077|65340819|FG003|Phase B|Physician Decision|0|||
23436768|NCT01052077|65340816|FG000|Phase B|Withdrawal by Subject|0|||
23436769|NCT01052077|65340817|FG001|Phase B|Withdrawal by Subject|0|||
23436770|NCT01052077|65340818|FG002|Phase B|Withdrawal by Subject|5|||
23436771|NCT01052077|65340819|FG003|Phase B|Withdrawal by Subject|0|||
23436772|NCT01052077|65340816|FG000|Phase B|Protocol Deviation|0|||
23436773|NCT01052077|65340817|FG001|Phase B|Protocol Deviation|3|||
23436774|NCT01052077|65340818|FG002|Phase B|Protocol Deviation|4|||
23436775|NCT01052077|65340819|FG003|Phase B|Protocol Deviation|0|||
23436776|NCT01052077|65340816|FG000|Phase B|Lack of Efficacy|0|||
23436777|NCT01052077|65340817|FG001|Phase B|Lack of Efficacy|1|||
23436778|NCT01052077|65340818|FG002|Phase B|Lack of Efficacy|0|||
23436779|NCT01052077|65340819|FG003|Phase B|Lack of Efficacy|0|||
23436780|NCT01052077|65340816|FG000|Phase A+|Lost to Follow-up|0|||
23436781|NCT01052077|65340817|FG001|Phase A+|Lost to Follow-up|0|||
23436782|NCT01052077|65340818|FG002|Phase A+|Lost to Follow-up|0|||
23436783|NCT01052077|65340819|FG003|Phase A+|Lost to Follow-up|8|||
23436784|NCT01052077|65340816|FG000|Phase A+|Adverse Event|0|||
23436785|NCT01052077|65340817|FG001|Phase A+|Adverse Event|0|||
23436786|NCT01052077|65340818|FG002|Phase A+|Adverse Event|0|||
23436787|NCT01052077|65340819|FG003|Phase A+|Adverse Event|4|||
23436788|NCT01052077|65340816|FG000|Phase A+|Met Withdrawal Criteria|0|||
23436789|NCT01052077|65340817|FG001|Phase A+|Met Withdrawal Criteria|0|||
23436790|NCT01052077|65340818|FG002|Phase A+|Met Withdrawal Criteria|0|||
23436791|NCT01052077|65340819|FG003|Phase A+|Met Withdrawal Criteria|2|||
23436792|NCT01052077|65340816|FG000|Phase A+|Withdrawal by Subject|0|||
23436793|NCT01052077|65340817|FG001|Phase A+|Withdrawal by Subject|0|||
23436794|NCT01052077|65340818|FG002|Phase A+|Withdrawal by Subject|0|||
23436795|NCT01052077|65340819|FG003|Phase A+|Withdrawal by Subject|7|||
23436796|NCT01368081|65340820|FG000|Overall Study|Adverse Event|4|||
23436797|NCT01368081|65340821|FG001|Overall Study|Adverse Event|4|||
23557797|NCT02969525|65769503|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557798|NCT02969525|65769504|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
23557799|NCT02969525|65769505|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557800|NCT01649232|65769506|FG000|Overall Study|Physician Decision|2|||
23557801|NCT01649232|65769507|FG001|Overall Study|Physician Decision|0|||
23557802|NCT00415610|65769510|FG000|Overall Study|Death|3|||
23557803|NCT00415610|65769511|FG001|Overall Study|Death|2|||
23557804|NCT00415610|65769512|FG002|Overall Study|Death|5|||
23436798|NCT01368081|65340822|FG002|Overall Study|Adverse Event|3|||
23436799|NCT01368081|65340823|FG003|Overall Study|Adverse Event|2|||
23436800|NCT01368081|65340824|FG004|Overall Study|Adverse Event|2|||
23436801|NCT01368081|65340825|FG005|Overall Study|Adverse Event|5|||
23436802|NCT01368081|65340826|FG006|Overall Study|Adverse Event|6|||
23436803|NCT01368081|65340827|FG007|Overall Study|Adverse Event|2|||
23436804|NCT01368081|65340828|FG008|Overall Study|Adverse Event|3|||
23436805|NCT01368081|65340829|FG009|Overall Study|Adverse Event|5|||
23436806|NCT01368081|65340830|FG010|Overall Study|Adverse Event|6|||
23436807|NCT01368081|65340831|FG011|Overall Study|Adverse Event|1|||
23436808|NCT01368081|65340832|FG012|Overall Study|Adverse Event|3|||
23436809|NCT01368081|65340820|FG000|Overall Study|Lack of Efficacy|0|||
23436810|NCT01368081|65340821|FG001|Overall Study|Lack of Efficacy|1|||
23436811|NCT01368081|65340822|FG002|Overall Study|Lack of Efficacy|0|||
23436812|NCT01368081|65340823|FG003|Overall Study|Lack of Efficacy|1|||
23436813|NCT01368081|65340824|FG004|Overall Study|Lack of Efficacy|0|||
23436814|NCT01368081|65340825|FG005|Overall Study|Lack of Efficacy|0|||
23436815|NCT01368081|65340826|FG006|Overall Study|Lack of Efficacy|0|||
23436816|NCT01368081|65340827|FG007|Overall Study|Lack of Efficacy|2|||
23436817|NCT01368081|65340828|FG008|Overall Study|Lack of Efficacy|0|||
23436818|NCT01368081|65340829|FG009|Overall Study|Lack of Efficacy|0|||
23436819|NCT01368081|65340830|FG010|Overall Study|Lack of Efficacy|0|||
23436820|NCT01368081|65340831|FG011|Overall Study|Lack of Efficacy|0|||
23436821|NCT01368081|65340832|FG012|Overall Study|Lack of Efficacy|0|||
23436822|NCT01368081|65340820|FG000|Overall Study|Protocol Violation|0|||
23436823|NCT01368081|65340821|FG001|Overall Study|Protocol Violation|0|||
23436824|NCT01368081|65340822|FG002|Overall Study|Protocol Violation|0|||
23436825|NCT01368081|65340823|FG003|Overall Study|Protocol Violation|0|||
23436826|NCT01368081|65340824|FG004|Overall Study|Protocol Violation|0|||
23436827|NCT01368081|65340825|FG005|Overall Study|Protocol Violation|1|||
23436828|NCT01368081|65340826|FG006|Overall Study|Protocol Violation|0|||
23436829|NCT01368081|65340827|FG007|Overall Study|Protocol Violation|1|||
23436830|NCT01368081|65340828|FG008|Overall Study|Protocol Violation|0|||
23436831|NCT01368081|65340829|FG009|Overall Study|Protocol Violation|0|||
23436832|NCT01368081|65340830|FG010|Overall Study|Protocol Violation|0|||
23557805|NCT00394355|65769516|FG000|Overall Study|Adverse Event|10|||
23557806|NCT00394355|65769517|FG001|Overall Study|Adverse Event|6|||
23436833|NCT01368081|65340831|FG011|Overall Study|Protocol Violation|0|||
23436834|NCT01368081|65340832|FG012|Overall Study|Protocol Violation|0|||
23436835|NCT01368081|65340820|FG000|Overall Study|Lost to Follow-up|0|||
23436836|NCT01368081|65340821|FG001|Overall Study|Lost to Follow-up|0|||
23436837|NCT01368081|65340822|FG002|Overall Study|Lost to Follow-up|0|||
23436838|NCT01368081|65340823|FG003|Overall Study|Lost to Follow-up|0|||
23436839|NCT01368081|65340824|FG004|Overall Study|Lost to Follow-up|0|||
23436840|NCT01368081|65340825|FG005|Overall Study|Lost to Follow-up|0|||
23436841|NCT01368081|65340826|FG006|Overall Study|Lost to Follow-up|0|||
23436842|NCT01368081|65340827|FG007|Overall Study|Lost to Follow-up|0|||
23436843|NCT01368081|65340828|FG008|Overall Study|Lost to Follow-up|0|||
23436844|NCT01368081|65340829|FG009|Overall Study|Lost to Follow-up|0|||
23436845|NCT01368081|65340830|FG010|Overall Study|Lost to Follow-up|0|||
23436846|NCT01368081|65340831|FG011|Overall Study|Lost to Follow-up|0|||
23436847|NCT01368081|65340832|FG012|Overall Study|Lost to Follow-up|1|||
23436848|NCT01368081|65340820|FG000|Overall Study|Withdrawal by Subject|4|||
23436849|NCT01368081|65340821|FG001|Overall Study|Withdrawal by Subject|4|||
23436850|NCT01368081|65340822|FG002|Overall Study|Withdrawal by Subject|1|||
23436851|NCT01368081|65340823|FG003|Overall Study|Withdrawal by Subject|1|||
23436852|NCT01368081|65340824|FG004|Overall Study|Withdrawal by Subject|0|||
23436853|NCT01368081|65340825|FG005|Overall Study|Withdrawal by Subject|3|||
23436854|NCT01368081|65340826|FG006|Overall Study|Withdrawal by Subject|4|||
23436855|NCT01368081|65340827|FG007|Overall Study|Withdrawal by Subject|2|||
23436856|NCT01368081|65340828|FG008|Overall Study|Withdrawal by Subject|5|||
23436857|NCT01368081|65340829|FG009|Overall Study|Withdrawal by Subject|4|||
23436858|NCT01368081|65340830|FG010|Overall Study|Withdrawal by Subject|3|||
23436859|NCT01368081|65340831|FG011|Overall Study|Withdrawal by Subject|2|||
23436860|NCT01368081|65340832|FG012|Overall Study|Withdrawal by Subject|0|||
23436861|NCT01368081|65340820|FG000|Overall Study|Other reason not defined above|2|||
23436862|NCT01368081|65340821|FG001|Overall Study|Other reason not defined above|0|||
23436863|NCT01368081|65340822|FG002|Overall Study|Other reason not defined above|0|||
23436864|NCT01368081|65340823|FG003|Overall Study|Other reason not defined above|1|||
23436865|NCT01368081|65340824|FG004|Overall Study|Other reason not defined above|0|||
23436866|NCT01368081|65340825|FG005|Overall Study|Other reason not defined above|1|||
23436867|NCT01368081|65340826|FG006|Overall Study|Other reason not defined above|2|||
23436868|NCT01368081|65340827|FG007|Overall Study|Other reason not defined above|0|||
23436869|NCT01368081|65340828|FG008|Overall Study|Other reason not defined above|0|||
23436870|NCT01368081|65340829|FG009|Overall Study|Other reason not defined above|1|||
23436871|NCT01368081|65340830|FG010|Overall Study|Other reason not defined above|0|||
23436872|NCT01368081|65340831|FG011|Overall Study|Other reason not defined above|0|||
23436873|NCT01368081|65340832|FG012|Overall Study|Other reason not defined above|3|||
23436874|NCT02476006|65340833|FG000|Overall Study|Death|4|||
23436875|NCT02476006|65340833|FG000|Overall Study|Lack of treatment efficacy|2|||
23436876|NCT02476006|65340833|FG000|Overall Study|Pregnancy|1|||
23436877|NCT02476006|65340833|FG000|Overall Study|Participant did not wish to continue|39|||
23436878|NCT02476006|65340833|FG000|Overall Study|Adverse Event|41|||
23436879|NCT02476006|65340833|FG000|Overall Study|Poor compliance to study protocol|3|||
23436880|NCT02476006|65340833|FG000|Overall Study|Sponsor decision|6|||
23436881|NCT02476006|65340833|FG000|Overall Study|Lost to Follow-up|5|||
23436882|NCT02476006|65340833|FG000|Overall Study|Physician Decision|5|||
23436883|NCT02476006|65340833|FG000|Overall Study|Study ended treatment not available|4|||
23436884|NCT02476006|65340833|FG000|Overall Study|Switched to commercial drug|4|||
23436885|NCT02476006|65340833|FG000|Overall Study|Excluded from study|1|||
23436886|NCT02476006|65340833|FG000|Overall Study|Protocol Violation|1|||
23436887|NCT02476006|65340833|FG000|Overall Study|Enrolled but not treated|4|||
23436888|NCT00410605|65340835|FG000|Overall Study|Adverse Event|12|||
23436889|NCT00410605|65340835|FG000|Overall Study|Physician Decision|3|||
23436890|NCT00410605|65340835|FG000|Overall Study|Withdrawal by Subject|5|||
23436891|NCT00410605|65340835|FG000|Overall Study|Started Non-Protocol Therapy|3|||
23436892|NCT00410605|65340835|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
23436893|NCT00410605|65340835|FG000|Overall Study|Transferred to another Institution|1|||
23436894|NCT03890367|65340836|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23436895|NCT03890367|65340837|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23557807|NCT00394355|65769518|FG002|Overall Study|Adverse Event|7|||
23825351|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
23436896|NCT03890367|65340838|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23436897|NCT03890367|65340836|FG000|Overall Study|Protocol deviation|2|||
23436898|NCT03890367|65340837|FG001|Overall Study|Protocol deviation|2|||
23436899|NCT03890367|65340838|FG002|Overall Study|Protocol deviation|1|||
23557808|NCT00394355|65769519|FG003|Overall Study|Adverse Event|8|||
23436900|NCT03890367|65340836|FG000|Overall Study|Lost to Follow-up|1|||
23436901|NCT03890367|65340837|FG001|Overall Study|Lost to Follow-up|1|||
23436902|NCT03890367|65340838|FG002|Overall Study|Lost to Follow-up|0|||
23436903|NCT00626405|65340839|FG000|Overall Study|Deemed Ineligible|1|||
23436904|NCT00626405|65340840|FG001|Overall Study|Deemed Ineligible|0|||
23436905|NCT00626405|65340839|FG000|Overall Study|Withdrawal by Subject|0|||
23436906|NCT00626405|65340840|FG001|Overall Study|Withdrawal by Subject|1|||
23436907|NCT00699335|65340843|FG000|Overall Study|Combination of multiple reasons|176|||
23436908|NCT00699335|65340843|FG000|Overall Study|Missing data|52|||
23436909|NCT02421588|65340846|FG000|Overall Study|Non-treatment-related AE|8|||
23825352|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
23436910|NCT02421588|65340847|FG001|Overall Study|Non-treatment-related AE|8|||
23436911|NCT02421588|65340846|FG000|Overall Study|Progressive disease|152|||
23436912|NCT02421588|65340847|FG001|Overall Study|Progressive disease|135|||
23753049|NCT00915473|66474189|FG001|4-week Follow Up|Lost to Follow-up|5|||
23753050|NCT02487979|66474193|FG000|Overall Study|Physician Decision|2|||
23753051|NCT02487979|66474193|FG000|Overall Study|Withdrawal by Subject|2|||
23753052|NCT02487979|66474193|FG000|Overall Study|Progressive Disease|17|||
23753053|NCT00557830|66474194|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
23753054|NCT00557830|66474195|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
23753055|NCT00557830|66474196|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
23753056|NCT00557830|66474194|FG000|Screening Treatment Phase|Adverse Event|2|||
23753057|NCT00557830|66474195|FG001|Screening Treatment Phase|Adverse Event|0|||
23753058|NCT00557830|66474196|FG002|Screening Treatment Phase|Adverse Event|0|||
23753059|NCT00557830|66474194|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
23753060|NCT00557830|66474195|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
23753061|NCT00557830|66474196|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
23753062|NCT02545868|66474197|FG000|Overall Study|Lack of Efficacy|1|||
23753063|NCT02545868|66474198|FG001|Overall Study|Lack of Efficacy|1|||
23753064|NCT02545868|66474199|FG002|Overall Study|Lack of Efficacy|0|||
23753065|NCT02545868|66474197|FG000|Overall Study|Lost to Follow-up|1|||
23753066|NCT02545868|66474198|FG001|Overall Study|Lost to Follow-up|5|||
23753067|NCT02545868|66474199|FG002|Overall Study|Lost to Follow-up|1|||
23753068|NCT02545868|66474197|FG000|Overall Study|Non-compliance|1|||
23753069|NCT02545868|66474198|FG001|Overall Study|Non-compliance|1|||
23753070|NCT02545868|66474199|FG002|Overall Study|Non-compliance|1|||
23753071|NCT02545868|66474197|FG000|Overall Study|Treatment change|21|||
23753072|NCT02545868|66474198|FG001|Overall Study|Treatment change|19|||
23753073|NCT02545868|66474199|FG002|Overall Study|Treatment change|22|||
23753074|NCT02545868|66474197|FG000|Overall Study|Physician Decision|1|||
23753075|NCT02545868|66474198|FG001|Overall Study|Physician Decision|1|||
23753076|NCT02545868|66474199|FG002|Overall Study|Physician Decision|1|||
23753077|NCT02545868|66474197|FG000|Overall Study|Withdrawal by Subject|6|||
23753078|NCT02545868|66474198|FG001|Overall Study|Withdrawal by Subject|7|||
23753079|NCT02545868|66474199|FG002|Overall Study|Withdrawal by Subject|9|||
23753080|NCT00567996|66474200|FG000|Overall Study|Adverse Event|18|||
23753081|NCT00567996|66474201|FG001|Overall Study|Adverse Event|16|||
23753082|NCT00567996|66474202|FG002|Overall Study|Adverse Event|13|||
23753083|NCT00567996|66474200|FG000|Overall Study|Protocol Deviation|9|||
23753084|NCT00567996|66474201|FG001|Overall Study|Protocol Deviation|11|||
23557809|NCT00394355|65769516|FG000|Overall Study|Did not meet protocol eligibility|1|||
23753085|NCT00567996|66474202|FG002|Overall Study|Protocol Deviation|13|||
23753086|NCT00567996|66474200|FG000|Overall Study|Withdrawal by Subject|8|||
23753087|NCT00567996|66474201|FG001|Overall Study|Withdrawal by Subject|12|||
23753088|NCT00567996|66474202|FG002|Overall Study|Withdrawal by Subject|22|||
23753089|NCT00567996|66474200|FG000|Overall Study|Abnormal Lab value(s)|2|||
23753090|NCT00567996|66474201|FG001|Overall Study|Abnormal Lab value(s)|1|||
23557810|NCT00394355|65769517|FG001|Overall Study|Did not meet protocol eligibility|5|||
23557811|NCT00394355|65769518|FG002|Overall Study|Did not meet protocol eligibility|4|||
23557812|NCT00394355|65769519|FG003|Overall Study|Did not meet protocol eligibility|2|||
23557813|NCT00394355|65769516|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
23557814|NCT00394355|65769517|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
23557815|NCT00394355|65769518|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
23557816|NCT00394355|65769519|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
23557817|NCT00394355|65769516|FG000|Overall Study|Subject withdrawal - related to drug|1|||
23557818|NCT00394355|65769517|FG001|Overall Study|Subject withdrawal - related to drug|0|||
23557819|NCT00394355|65769518|FG002|Overall Study|Subject withdrawal - related to drug|0|||
23557820|NCT00394355|65769519|FG003|Overall Study|Subject withdrawal - related to drug|0|||
23557821|NCT00394355|65769516|FG000|Overall Study|Lost to Follow-up|7|||
23753091|NCT00567996|66474202|FG002|Overall Study|Abnormal Lab value(s)|2|||
23753092|NCT00567996|66474200|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23753093|NCT00567996|66474201|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23753094|NCT00567996|66474202|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23753095|NCT00567996|66474200|FG000|Overall Study|Lost to Follow-up|2|||
23753096|NCT00567996|66474201|FG001|Overall Study|Lost to Follow-up|5|||
23557822|NCT00394355|65769517|FG001|Overall Study|Lost to Follow-up|5|||
23557823|NCT00394355|65769518|FG002|Overall Study|Lost to Follow-up|4|||
23557824|NCT00394355|65769519|FG003|Overall Study|Lost to Follow-up|3|||
23557825|NCT00394355|65769516|FG000|Overall Study|Noncompliance with protocol|4|||
23753097|NCT00567996|66474202|FG002|Overall Study|Lost to Follow-up|2|||
23753098|NCT00567996|66474200|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23753099|NCT00567996|66474201|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23753100|NCT00567996|66474202|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
23753101|NCT00567996|66474200|FG000|Overall Study|Administrative problems|1|||
23753102|NCT00567996|66474201|FG001|Overall Study|Administrative problems|1|||
23753103|NCT00567996|66474202|FG002|Overall Study|Administrative problems|0|||
23753104|NCT00567996|66474200|FG000|Overall Study|Death|1|||
23753105|NCT00567996|66474201|FG001|Overall Study|Death|0|||
23753106|NCT00567996|66474202|FG002|Overall Study|Death|2|||
23436913|NCT02421588|65340846|FG000|Overall Study|Death|11|||
23436914|NCT02421588|65340847|FG001|Overall Study|Death|3|||
23436915|NCT02421588|65340846|FG000|Overall Study|Physician Decision|8|||
23436916|NCT02421588|65340847|FG001|Overall Study|Physician Decision|17|||
23557826|NCT00394355|65769517|FG001|Overall Study|Noncompliance with protocol|3|||
23557827|NCT00394355|65769518|FG002|Overall Study|Noncompliance with protocol|10|||
23557828|NCT00394355|65769519|FG003|Overall Study|Noncompliance with protocol|8|||
23557829|NCT00394355|65769516|FG000|Overall Study|Administrative|0|||
23557830|NCT00394355|65769517|FG001|Overall Study|Administrative|1|||
23557831|NCT00394355|65769518|FG002|Overall Study|Administrative|1|||
23557832|NCT00394355|65769519|FG003|Overall Study|Administrative|1|||
23557833|NCT00394355|65769516|FG000|Overall Study|Lack of Efficacy|0|||
23753107|NCT00567996|66474200|FG000|Overall Study|Patient's inability to use the device|0|||
23753108|NCT00567996|66474201|FG001|Overall Study|Patient's inability to use the device|1|||
23753109|NCT00567996|66474202|FG002|Overall Study|Patient's inability to use the device|0|||
23753110|NCT00981019|66474206|FG000|Overall Study|Did not respond|65|||
23753111|NCT00981019|66474206|FG000|Overall Study|Did not match target population|94|||
23753112|NCT00981019|66474206|FG000|Overall Study|Inadvertent exclusion|239|||
23753113|NCT00981019|66474206|FG000|Overall Study|Hit the survey after closure|79|||
23753114|NCT02886494|66474207|FG000|Overall Study|Adverse Event|1|||
23753115|NCT02886494|66474208|FG001|Overall Study|Adverse Event|0|||
23753116|NCT02886494|66474207|FG000|Overall Study|Withdrawal by Subject|12|||
23557834|NCT00394355|65769517|FG001|Overall Study|Lack of Efficacy|0|||
23557835|NCT00394355|65769518|FG002|Overall Study|Lack of Efficacy|2|||
23557836|NCT00394355|65769519|FG003|Overall Study|Lack of Efficacy|3|||
23557837|NCT02548455|65769521|FG000|Overall Study|Withdrawal by Subject|27|||
23557838|NCT02548455|65769521|FG000|Overall Study|Death|26|||
23557839|NCT02548455|65769521|FG000|Overall Study|Lost to Follow-up|14|||
23557840|NCT02548455|65769521|FG000|Overall Study|Visit not completed|173|||
23557841|NCT00508261|65769522|FG000|Overall Study|Other|0|||
23557842|NCT00508261|65769523|FG001|Overall Study|Other|1|||
23557843|NCT00508261|65769524|FG002|Overall Study|Other|1|||
23557844|NCT00508261|65769525|FG003|Overall Study|Other|0|||
23557845|NCT00508261|65769522|FG000|Overall Study|Serious Adverse Event|0|||
23557846|NCT00508261|65769523|FG001|Overall Study|Serious Adverse Event|1|||
23557847|NCT00508261|65769524|FG002|Overall Study|Serious Adverse Event|0|||
23557848|NCT00508261|65769525|FG003|Overall Study|Serious Adverse Event|0|||
23557849|NCT00508261|65769522|FG000|Overall Study|Withdrawal by Subject|3|||
23557850|NCT00508261|65769523|FG001|Overall Study|Withdrawal by Subject|4|||
23557851|NCT00508261|65769524|FG002|Overall Study|Withdrawal by Subject|4|||
23557852|NCT00508261|65769525|FG003|Overall Study|Withdrawal by Subject|0|||
23436917|NCT02421588|65340846|FG000|Overall Study|Other reason not specified|3|||
23557853|NCT00508261|65769522|FG000|Overall Study|Migrated/ moved from study area|0|||
23557854|NCT00508261|65769523|FG001|Overall Study|Migrated/ moved from study area|1|||
23557855|NCT00508261|65769524|FG002|Overall Study|Migrated/ moved from study area|0|||
23753117|NCT02886494|66474208|FG001|Overall Study|Withdrawal by Subject|3|||
23753118|NCT02886494|66474207|FG000|Overall Study|Protocol Violation|4|||
23753119|NCT02886494|66474208|FG001|Overall Study|Protocol Violation|1|||
23753120|NCT00960687|66474209|FG000|Washout Period of 7 Days|Adverse Event|3|||
23753121|NCT00960687|66474210|FG001|Washout Period of 7 Days|Adverse Event|2|||
23753122|NCT00960687|66474209|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23753123|NCT00960687|66474210|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23753124|NCT03387735|66474211|FG000|Overall Study|Lost to Follow-up|4|||
23753125|NCT03387735|66474212|FG001|Overall Study|Lost to Follow-up|8|||
23753126|NCT03387735|66474211|FG000|Overall Study|Death|4|||
23753127|NCT03387735|66474212|FG001|Overall Study|Death|8|||
23753128|NCT03869684|66474213|FG000|Overall Study|Adverse Event|0|||
23753129|NCT03869684|66474214|FG001|Overall Study|Adverse Event|3|||
23753130|NCT03869684|66474215|FG002|Overall Study|Adverse Event|1|||
23753131|NCT03869684|66474213|FG000|Overall Study|Withdrawal by Subject|1|||
23753132|NCT03869684|66474214|FG001|Overall Study|Withdrawal by Subject|0|||
23557856|NCT00508261|65769525|FG003|Overall Study|Migrated/ moved from study area|0|||
23557857|NCT00508261|65769522|FG000|Overall Study|Lost to Follow-up|0|||
23557858|NCT00508261|65769523|FG001|Overall Study|Lost to Follow-up|1|||
23557859|NCT00508261|65769524|FG002|Overall Study|Lost to Follow-up|1|||
23557860|NCT00508261|65769525|FG003|Overall Study|Lost to Follow-up|1|||
23557861|NCT01505387|65769526|FG000|Overall Study|Protocol Violation|1|||
23753133|NCT03869684|66474215|FG002|Overall Study|Withdrawal by Subject|0|||
23753134|NCT03869684|66474213|FG000|Overall Study|Lost to Follow-up|1|||
23825353|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
23436918|NCT02421588|65340847|FG001|Overall Study|Other reason not specified|1|||
23557862|NCT01505387|65769527|FG001|Overall Study|Protocol Violation|0|||
23557863|NCT01505387|65769526|FG000|Overall Study|Withdrawal by Subject|1|||
23557864|NCT01505387|65769527|FG001|Overall Study|Withdrawal by Subject|1|||
23753135|NCT03869684|66474214|FG001|Overall Study|Lost to Follow-up|0|||
23753136|NCT03869684|66474215|FG002|Overall Study|Lost to Follow-up|0|||
23753137|NCT03869684|66474213|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
23557865|NCT00710606|65769528|FG000|Overall Study|Adverse Event|0|||
23557866|NCT00710606|65769529|FG001|Overall Study|Adverse Event|2|||
23557867|NCT03395405|65769530|FG000|Overall Study|Death|0|||
23557868|NCT03395405|65769531|FG001|Overall Study|Death|2|||
23557869|NCT03395405|65769530|FG000|Overall Study|Lost to Follow-up|0|||
23557870|NCT03395405|65769531|FG001|Overall Study|Lost to Follow-up|1|||
23557871|NCT03395405|65769530|FG000|Overall Study|Protocol Violation|0|||
23557872|NCT03395405|65769531|FG001|Overall Study|Protocol Violation|1|||
23557873|NCT03395405|65769530|FG000|Overall Study|Withdrawal by Subject|3|||
23557874|NCT03395405|65769531|FG001|Overall Study|Withdrawal by Subject|1|||
23557875|NCT03395405|65769530|FG000|Overall Study|COVID-19 Pandemic|1|||
23557876|NCT03395405|65769531|FG001|Overall Study|COVID-19 Pandemic|0|||
23557877|NCT02007434|65769532|FG000|Overall Study|Lost to Follow-up|0|||
23557878|NCT02007434|65769533|FG001|Overall Study|Lost to Follow-up|1|||
23557879|NCT02007434|65769534|FG002|Overall Study|Lost to Follow-up|0|||
23557880|NCT02007434|65769535|FG003|Overall Study|Lost to Follow-up|0|||
23557881|NCT02007434|65769536|FG004|Overall Study|Lost to Follow-up|0|||
23557882|NCT02007434|65769537|FG005|Overall Study|Lost to Follow-up|0|||
23557883|NCT02007434|65769538|FG006|Overall Study|Lost to Follow-up|0|||
23557884|NCT02007434|65769539|FG007|Overall Study|Lost to Follow-up|0|||
23557885|NCT02007434|65769532|FG000|Overall Study|Non-compliance|1|||
23557886|NCT02007434|65769533|FG001|Overall Study|Non-compliance|0|||
23557887|NCT02007434|65769534|FG002|Overall Study|Non-compliance|1|||
23557888|NCT02007434|65769535|FG003|Overall Study|Non-compliance|0|||
23557889|NCT02007434|65769536|FG004|Overall Study|Non-compliance|0|||
23557890|NCT02007434|65769537|FG005|Overall Study|Non-compliance|0|||
23557891|NCT02007434|65769538|FG006|Overall Study|Non-compliance|0|||
23557892|NCT02007434|65769539|FG007|Overall Study|Non-compliance|0|||
23557893|NCT01287611|65769540|FG000|Overall Study|Lost to Follow-up|29|||
23557894|NCT01287611|65769541|FG001|Overall Study|Lost to Follow-up|16|||
23557895|NCT01287611|65769540|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
23557896|NCT01287611|65769541|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
23557897|NCT02857426|65769557|FG000|Overall Study|Disease progression|34|||
23557898|NCT02857426|65769558|FG001|Overall Study|Disease progression|13|||
23753138|NCT03869684|66474214|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
23753139|NCT03869684|66474215|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
23753140|NCT03069365|66474216|FG000|Overall Study|Adverse Event|1|||
23557899|NCT02857426|65769557|FG000|Overall Study|Study drug toxicity|4|||
23557900|NCT02857426|65769558|FG001|Overall Study|Study drug toxicity|1|||
23753141|NCT01186744|66474219|FG000|Overall Study|Lack of Efficacy|156|||
23753142|NCT01186744|66474220|FG001|Overall Study|Lack of Efficacy|99|||
23753143|NCT01186744|66474221|FG002|Overall Study|Lack of Efficacy|0|||
23753144|NCT01186744|66474222|FG003|Overall Study|Lack of Efficacy|2|||
23753145|NCT01186744|66474223|FG004|Overall Study|Lack of Efficacy|2|||
23753146|NCT01186744|66474224|FG005|Overall Study|Lack of Efficacy|5|||
23753147|NCT01186744|66474219|FG000|Overall Study|Protocol Violation|1|||
23753148|NCT01186744|66474220|FG001|Overall Study|Protocol Violation|2|||
23557901|NCT02857426|65769557|FG000|Overall Study|Death|1|||
23753149|NCT01186744|66474221|FG002|Overall Study|Protocol Violation|0|||
23753150|NCT01186744|66474222|FG003|Overall Study|Protocol Violation|1|||
23753151|NCT01186744|66474223|FG004|Overall Study|Protocol Violation|1|||
23753152|NCT01186744|66474224|FG005|Overall Study|Protocol Violation|2|||
23753153|NCT01186744|66474219|FG000|Overall Study|Lost to Follow-up|15|||
23753154|NCT01186744|66474220|FG001|Overall Study|Lost to Follow-up|16|||
23753155|NCT01186744|66474221|FG002|Overall Study|Lost to Follow-up|2|||
23753156|NCT01186744|66474222|FG003|Overall Study|Lost to Follow-up|1|||
23753157|NCT01186744|66474223|FG004|Overall Study|Lost to Follow-up|1|||
23753158|NCT01186744|66474224|FG005|Overall Study|Lost to Follow-up|4|||
23753159|NCT01186744|66474219|FG000|Overall Study|Screen failure|1|||
23753160|NCT01186744|66474220|FG001|Overall Study|Screen failure|1|||
23753161|NCT01186744|66474221|FG002|Overall Study|Screen failure|0|||
23753162|NCT01186744|66474222|FG003|Overall Study|Screen failure|1|||
23753163|NCT01186744|66474223|FG004|Overall Study|Screen failure|0|||
23753164|NCT01186744|66474224|FG005|Overall Study|Screen failure|0|||
23753165|NCT01186744|66474219|FG000|Overall Study|Withdrawal by Subject|14|||
23557902|NCT02857426|65769558|FG001|Overall Study|Death|0|||
23753166|NCT01186744|66474220|FG001|Overall Study|Withdrawal by Subject|10|||
23753167|NCT01186744|66474221|FG002|Overall Study|Withdrawal by Subject|2|||
23753168|NCT01186744|66474222|FG003|Overall Study|Withdrawal by Subject|5|||
23753169|NCT01186744|66474223|FG004|Overall Study|Withdrawal by Subject|0|||
23753170|NCT01186744|66474224|FG005|Overall Study|Withdrawal by Subject|6|||
23753171|NCT01186744|66474219|FG000|Overall Study|Study terminated by Sponsor|1|||
23753172|NCT01186744|66474220|FG001|Overall Study|Study terminated by Sponsor|0|||
23557903|NCT02857426|65769557|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23557904|NCT02857426|65769558|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23557905|NCT02857426|65769557|FG000|Overall Study|Participant withdrew consent|1|||
23557906|NCT02857426|65769558|FG001|Overall Study|Participant withdrew consent|1|||
23557907|NCT02857426|65769557|FG000|Overall Study|Maximum clinical benefit|1|||
23557908|NCT02857426|65769558|FG001|Overall Study|Maximum clinical benefit|0|||
23557909|NCT02857426|65769557|FG000|Overall Study|Completed treatment|0|||
23557910|NCT02857426|65769558|FG001|Overall Study|Completed treatment|2|||
23557911|NCT02719990|65769559|FG000|Overall Study|Physician Decision|2|||
23557912|NCT02719990|65769559|FG000|Overall Study|Withdrawal by Subject|2|||
23557913|NCT02719990|65769559|FG000|Overall Study|Study Terminated By Sponsor|32|||
23557914|NCT02740049|65769560|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
23557915|NCT01060553|65769561|FG000|Overall Study|Lost to Follow-up|3|||
23557916|NCT01060553|65769562|FG001|Overall Study|Lost to Follow-up|5|||
23557917|NCT01060553|65769561|FG000|Overall Study|Withdrawal by Subject|5|||
23557918|NCT01060553|65769562|FG001|Overall Study|Withdrawal by Subject|5|||
23557919|NCT01060553|65769561|FG000|Overall Study|Lack of Efficacy|1|||
23557920|NCT01060553|65769562|FG001|Overall Study|Lack of Efficacy|0|||
23557921|NCT01078155|65769563|FG000|Overall Study|Adverse Event|7|||
23557922|NCT01078155|65769563|FG000|Overall Study|Lack of Efficacy|16|||
23557923|NCT01078155|65769563|FG000|Overall Study|Participant's Decision|6|||
23557924|NCT01078155|65769563|FG000|Overall Study|Lost to Follow-up|15|||
23557925|NCT00441090|65769564|FG000|Overall Study|Adverse Event|0|||
23557926|NCT00441090|65769565|FG001|Overall Study|Adverse Event|1|||
23557927|NCT00441090|65769566|FG002|Overall Study|Adverse Event|1|||
23557928|NCT00441090|65769567|FG003|Overall Study|Adverse Event|0|||
23557929|NCT00441090|65769568|FG004|Overall Study|Adverse Event|0|||
23557930|NCT00441090|65769564|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557931|NCT00441090|65769565|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557932|NCT00441090|65769566|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557933|NCT00441090|65769567|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
23557934|NCT00441090|65769568|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557935|NCT00441090|65769564|FG000|Overall Study|Withdrawal by Subject|1|||
23557936|NCT00441090|65769565|FG001|Overall Study|Withdrawal by Subject|0|||
23557937|NCT00441090|65769566|FG002|Overall Study|Withdrawal by Subject|1|||
23557938|NCT00441090|65769567|FG003|Overall Study|Withdrawal by Subject|0|||
23557939|NCT00441090|65769568|FG004|Overall Study|Withdrawal by Subject|0|||
23557940|NCT00441090|65769564|FG000|Overall Study|Lack of Efficacy|1|||
23557941|NCT00441090|65769565|FG001|Overall Study|Lack of Efficacy|0|||
23557942|NCT00441090|65769566|FG002|Overall Study|Lack of Efficacy|0|||
23557943|NCT00441090|65769567|FG003|Overall Study|Lack of Efficacy|0|||
23753173|NCT01186744|66474221|FG002|Overall Study|Study terminated by Sponsor|0|||
23753174|NCT01186744|66474222|FG003|Overall Study|Study terminated by Sponsor|0|||
23753175|NCT01186744|66474223|FG004|Overall Study|Study terminated by Sponsor|0|||
23753176|NCT01186744|66474224|FG005|Overall Study|Study terminated by Sponsor|0|||
23753177|NCT01186744|66474219|FG000|Overall Study|Other|9|||
23753178|NCT01186744|66474220|FG001|Overall Study|Other|10|||
23753179|NCT01186744|66474221|FG002|Overall Study|Other|1|||
23753180|NCT01186744|66474222|FG003|Overall Study|Other|2|||
23753181|NCT01186744|66474223|FG004|Overall Study|Other|1|||
23753182|NCT01186744|66474224|FG005|Overall Study|Other|5|||
23753183|NCT01186744|66474219|FG000|Overall Study|Adverse Event|10|||
23753184|NCT01186744|66474220|FG001|Overall Study|Adverse Event|14|||
23753185|NCT01186744|66474221|FG002|Overall Study|Adverse Event|1|||
23753186|NCT01186744|66474222|FG003|Overall Study|Adverse Event|0|||
23753187|NCT01186744|66474223|FG004|Overall Study|Adverse Event|1|||
23753188|NCT01186744|66474224|FG005|Overall Study|Adverse Event|4|||
23753189|NCT01186744|66474219|FG000|Overall Study|Death|1|||
23753190|NCT01186744|66474220|FG001|Overall Study|Death|0|||
23753191|NCT01186744|66474221|FG002|Overall Study|Death|0|||
23753192|NCT01186744|66474222|FG003|Overall Study|Death|0|||
23753193|NCT01186744|66474223|FG004|Overall Study|Death|0|||
23753194|NCT01186744|66474224|FG005|Overall Study|Death|0|||
23753195|NCT00061945|66474225|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
23753196|NCT00061945|66474226|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
23753197|NCT00061945|66474225|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
23753198|NCT00061945|66474226|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
23753199|NCT00061945|66474225|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
23753200|NCT00061945|66474226|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
23557944|NCT00441090|65769568|FG004|Overall Study|Lack of Efficacy|0|||
23557945|NCT02347657|65769569|FG000|Overall Study|Physician Decision|0|||
23557946|NCT02347657|65769570|FG001|Overall Study|Physician Decision|1|||
23557947|NCT02347657|65769569|FG000|Overall Study|Adverse Event|8|||
23557948|NCT02347657|65769570|FG001|Overall Study|Adverse Event|4|||
23557949|NCT02347657|65769569|FG000|Overall Study|Withdrawal by Subject|6|||
23557950|NCT02347657|65769570|FG001|Overall Study|Withdrawal by Subject|7|||
23753201|NCT00061945|66474225|FG000|Course IV: Alemtuzumab|Early exits|6|||
23753202|NCT00061945|66474226|FG001|Course IV: Alemtuzumab|Early exits|15|||
23753203|NCT00890409|66474229|FG000|Overall Study|Lost to Follow-up|20|||
23753204|NCT00890409|66474230|FG001|Overall Study|Lost to Follow-up|21|||
23753205|NCT04856917|66474240|FG000|Overall Study|Withdrawal by Subject|4|||
23753206|NCT04856917|66474241|FG001|Overall Study|Withdrawal by Subject|3|||
23557951|NCT02347657|65769569|FG000|Overall Study|Randomized but not treated|1|||
23557952|NCT02347657|65769570|FG001|Overall Study|Randomized but not treated|0|||
23557953|NCT02347657|65769569|FG000|Overall Study|Other|3|||
23557954|NCT02347657|65769570|FG001|Overall Study|Other|3|||
23557955|NCT00404495|65769571|FG000|Overall Study|Death|37|||
23557956|NCT00404495|65769572|FG001|Overall Study|Death|11|||
23557957|NCT00404495|65769571|FG000|Overall Study|Lost to Follow-up|5|||
23557958|NCT00404495|65769572|FG001|Overall Study|Lost to Follow-up|0|||
23557959|NCT00404495|65769571|FG000|Overall Study|Other|1|||
23557960|NCT00404495|65769572|FG001|Overall Study|Other|0|||
23557961|NCT00404495|65769571|FG000|Overall Study|Withdrawal by Subject|1|||
23753207|NCT04856917|66474242|FG002|Overall Study|Withdrawal by Subject|1|||
23753208|NCT04856917|66474240|FG000|Overall Study|Lost to Follow-up|3|||
23753209|NCT04856917|66474241|FG001|Overall Study|Lost to Follow-up|1|||
23753210|NCT04856917|66474242|FG002|Overall Study|Lost to Follow-up|1|||
23557962|NCT00404495|65769572|FG001|Overall Study|Withdrawal by Subject|0|||
23557963|NCT00725452|65769575|FG000|Overall Study|Adverse Event|3|||
23753211|NCT04856917|66474240|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
23753212|NCT04856917|66474241|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
23753213|NCT04856917|66474242|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
23753214|NCT04856917|66474240|FG000|Overall Study|Other|1|||
23753215|NCT04856917|66474241|FG001|Overall Study|Other|1|||
23753216|NCT04856917|66474242|FG002|Overall Study|Other|0|||
23753217|NCT00430638|66474243|FG000|Overall Study|Adverse Event|15|||
23753218|NCT00430638|66474244|FG001|Overall Study|Adverse Event|15|||
23753219|NCT00430638|66474243|FG000|Overall Study|Uncontrolled blood pressure|48|||
23753220|NCT00430638|66474244|FG001|Overall Study|Uncontrolled blood pressure|13|||
23753221|NCT00430638|66474243|FG000|Overall Study|Lost to Follow-up|1|||
23753222|NCT00430638|66474244|FG001|Overall Study|Lost to Follow-up|7|||
23753223|NCT00430638|66474243|FG000|Overall Study|Protocol Violation|6|||
23753224|NCT00430638|66474244|FG001|Overall Study|Protocol Violation|4|||
23753225|NCT00430638|66474243|FG000|Overall Study|Withdrawal by Subject|4|||
23753226|NCT00430638|66474244|FG001|Overall Study|Withdrawal by Subject|6|||
23753227|NCT00430638|66474243|FG000|Overall Study|Non-compliant|2|||
23753228|NCT00430638|66474244|FG001|Overall Study|Non-compliant|1|||
23753229|NCT00430638|66474243|FG000|Overall Study|Other|2|||
23753230|NCT00430638|66474244|FG001|Overall Study|Other|2|||
23753231|NCT03926728|66474245|FG000|Overall Study|Withdrawal by Subject|0|||
23753232|NCT03926728|66474246|FG001|Overall Study|Withdrawal by Subject|1|||
23753233|NCT03926728|66474247|FG002|Overall Study|Withdrawal by Subject|1|||
23753234|NCT03926728|66474248|FG003|Overall Study|Withdrawal by Subject|0|||
23753235|NCT03926728|66474249|FG004|Overall Study|Withdrawal by Subject|0|||
23753236|NCT03926728|66474250|FG005|Overall Study|Withdrawal by Subject|1|||
23753237|NCT03926728|66474251|FG006|Overall Study|Withdrawal by Subject|1|||
23753238|NCT03926728|66474252|FG007|Overall Study|Withdrawal by Subject|0|||
23753239|NCT03926728|66474253|FG008|Overall Study|Withdrawal by Subject|0|||
23753240|NCT03926728|66474254|FG009|Overall Study|Withdrawal by Subject|1|||
23753241|NCT03926728|66474255|FG010|Overall Study|Withdrawal by Subject|0|||
23753242|NCT03926728|66474256|FG011|Overall Study|Withdrawal by Subject|0|||
23753243|NCT00685763|66474257|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
23753244|NCT00685763|66474257|FG000|Overall Study|Protocol Violation|1|||
23753245|NCT01844986|66474261|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
23753246|NCT01844986|66474262|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
23753247|NCT01844986|66474261|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
23753248|NCT01844986|66474262|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
23753249|NCT01844986|66474261|FG000|Overall Study (Global Cohort)|Death|55|||
23753250|NCT01844986|66474262|FG001|Overall Study (Global Cohort)|Death|26|||
23753251|NCT01844986|66474261|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
23557964|NCT00725452|65769575|FG000|Overall Study|Lack of Efficacy|2|||
23557965|NCT00725452|65769575|FG000|Overall Study|Reason not specified|1|||
23557966|NCT00725452|65769575|FG000|Overall Study|Physician Decision|1|||
23557967|NCT00725452|65769575|FG000|Overall Study|Withdrawal by Subject|3|||
23557968|NCT00725452|65769575|FG000|Overall Study|Lost to Follow-up|1|||
23557969|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
23557970|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557971|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23753252|NCT01844986|66474262|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
23753253|NCT01844986|66474261|FG000|Overall Study (China Cohort)|Death|10|||
23753254|NCT01844986|66474262|FG001|Overall Study (China Cohort)|Death|6|||
23753255|NCT01741259|66474270|FG000|Overall Study|Protocol Violation|6|||
23753256|NCT01741259|66474271|FG001|Overall Study|Protocol Violation|4|||
23753257|NCT01741259|66474270|FG000|Overall Study|Withdrawal by Subject|0|||
23753258|NCT01741259|66474271|FG001|Overall Study|Withdrawal by Subject|2|||
23753259|NCT01311505|66474272|FG000|First Intervention Period|Protocol Violation|0|||
23753260|NCT01311505|66474273|FG001|First Intervention Period|Protocol Violation|1|||
23753261|NCT02392559|66474274|FG000|Overall Study|Withdrawal by Subject|0|||
23557972|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557973|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557974|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
23557975|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557976|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557977|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557978|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557979|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23753262|NCT02392559|66474275|FG001|Overall Study|Withdrawal by Subject|1|||
23753263|NCT01491737|66474276|FG000|Overall Study|Withdrawal by Subject|20|||
23753264|NCT01491737|66474277|FG001|Overall Study|Withdrawal by Subject|17|||
23753265|NCT01491737|66474276|FG000|Overall Study|Lost to Follow-up|2|||
23753266|NCT01491737|66474277|FG001|Overall Study|Lost to Follow-up|10|||
23753267|NCT01491737|66474276|FG000|Overall Study|Death|63|||
23753268|NCT01491737|66474277|FG001|Overall Study|Death|57|||
23557980|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
23753269|NCT01491737|66474276|FG000|Overall Study|Study Termination by Sponsor|36|||
23753270|NCT01491737|66474277|FG001|Overall Study|Study Termination by Sponsor|36|||
23753271|NCT01491737|66474276|FG000|Overall Study|Reason Not Specified|8|||
23753272|NCT01491737|66474277|FG001|Overall Study|Reason Not Specified|9|||
23753273|NCT01956123|66476890|FG000|COS Cycle 2|Protocol Violation|8|||
23753274|NCT01956123|66476891|FG001|COS Cycle 2|Protocol Violation|3|||
23753275|NCT01956123|66476892|FG002|COS Cycle 2|Protocol Violation|0|||
23753276|NCT01956123|66476893|FG003|COS Cycle 2|Protocol Violation|0|||
23753277|NCT01956123|66476890|FG000|COS Cycle 2|Adverse Event|3|||
23753278|NCT01956123|66476891|FG001|COS Cycle 2|Adverse Event|4|||
23753279|NCT01956123|66476892|FG002|COS Cycle 2|Adverse Event|0|||
23753280|NCT01956123|66476893|FG003|COS Cycle 2|Adverse Event|0|||
23753281|NCT01956123|66476890|FG000|COS Cycle 2|Personal Reasons|2|||
23753282|NCT01956123|66476891|FG001|COS Cycle 2|Personal Reasons|0|||
23753283|NCT01956123|66476892|FG002|COS Cycle 2|Personal Reasons|0|||
23753284|NCT01956123|66476893|FG003|COS Cycle 2|Personal Reasons|0|||
23753285|NCT01956123|66476890|FG000|COS Cycle 2|Withdrawal by Subject|1|||
23753286|NCT01956123|66476891|FG001|COS Cycle 2|Withdrawal by Subject|0|||
23753287|NCT01956123|66476892|FG002|COS Cycle 2|Withdrawal by Subject|0|||
23753288|NCT01956123|66476893|FG003|COS Cycle 2|Withdrawal by Subject|0|||
23753289|NCT01956123|66476890|FG000|COS Cycle 3|Protocol Violation|0|||
23753290|NCT01956123|66476891|FG001|COS Cycle 3|Protocol Violation|0|||
23753291|NCT01956123|66476892|FG002|COS Cycle 3|Protocol Violation|2|||
23753292|NCT01956123|66476893|FG003|COS Cycle 3|Protocol Violation|1|||
23753293|NCT01956123|66476890|FG000|COS Cycle 3|Adverse Event|0|||
23753294|NCT01956123|66476891|FG001|COS Cycle 3|Adverse Event|0|||
23753295|NCT01956123|66476892|FG002|COS Cycle 3|Adverse Event|3|||
23753296|NCT01956123|66476893|FG003|COS Cycle 3|Adverse Event|0|||
23753297|NCT01956123|66476890|FG000|COS Cycle 3|Personal Reasons|0|||
23753298|NCT01956123|66476891|FG001|COS Cycle 3|Personal Reasons|0|||
23753299|NCT01956123|66476892|FG002|COS Cycle 3|Personal Reasons|1|||
23753300|NCT01956123|66476893|FG003|COS Cycle 3|Personal Reasons|0|||
23753301|NCT01956123|66476890|FG000|COS Cycle 3|Withdrawal by Subject|0|||
23753302|NCT01956123|66476891|FG001|COS Cycle 3|Withdrawal by Subject|0|||
23753303|NCT01956123|66476892|FG002|COS Cycle 3|Withdrawal by Subject|0|||
23753304|NCT01956123|66476893|FG003|COS Cycle 3|Withdrawal by Subject|1|||
23753305|NCT01856686|66476901|FG000|Overall Study|Lost to Follow-up|5|||
23753306|NCT01856686|66476902|FG001|Overall Study|Lost to Follow-up|11|||
23753307|NCT00817778|66476903|FG000|Overall Study|Adverse Event|1|||
23753308|NCT00817778|66476904|FG001|Overall Study|Adverse Event|0|||
23753309|NCT00817778|66476903|FG000|Overall Study|Withdrawal by Subject|1|||
23753310|NCT00817778|66476904|FG001|Overall Study|Withdrawal by Subject|1|||
23753311|NCT00817778|66476903|FG000|Overall Study|Protocol Violation|0|||
23753312|NCT00817778|66476904|FG001|Overall Study|Protocol Violation|1|||
23753313|NCT00817778|66476903|FG000|Overall Study|Study-specific discontinuation criteria|0|||
23753314|NCT00817778|66476904|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23753315|NCT00817778|66476903|FG000|Overall Study|Poor venous access|1|||
23753316|NCT00817778|66476904|FG001|Overall Study|Poor venous access|0|||
23557981|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23753317|NCT00447694|66476907|FG000|Overall Study|Adverse Event|2|||
23753318|NCT00447694|66476907|FG000|Overall Study|Abnormal laboratory value|1|||
23753319|NCT00447694|66476907|FG000|Overall Study|Abnormal test procedure result|1|||
23753320|NCT00447694|66476907|FG000|Overall Study|Withdrawal by Subject|2|||
23753321|NCT02525627|66476909|FG000|Overall Study|Revision|1|||
23753322|NCT02525627|66476910|FG001|Overall Study|Revision|1|||
23753323|NCT02525627|66476909|FG000|Overall Study|Withdrawal by Subject|1|||
23753324|NCT02525627|66476910|FG001|Overall Study|Withdrawal by Subject|2|||
23753325|NCT02525627|66476909|FG000|Overall Study|Death|1|||
23753326|NCT02525627|66476910|FG001|Overall Study|Death|0|||
23753327|NCT02525627|66476909|FG000|Overall Study|Site terminated|11|||
23753328|NCT02525627|66476910|FG001|Overall Study|Site terminated|10|||
23436919|NCT02421588|65340846|FG000|Overall Study|Symptomatic deterioration|13|||
23753329|NCT01467570|66476913|FG000|Overall Study|Lost to Follow-up|8|||
23753330|NCT01467570|66476914|FG001|Overall Study|Lost to Follow-up|9|||
23753331|NCT03669640|66476918|FG000|Overall Study|Study Terminated by Sponsor|0|||
23557982|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23557983|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557984|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557985|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557986|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557987|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557988|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557989|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557990|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557991|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557992|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557993|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557994|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557995|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557996|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
23557997|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23557998|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23557999|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558000|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558001|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558002|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558003|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
23558004|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558005|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558006|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558007|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558008|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558009|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558010|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
23558011|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558012|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558013|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558014|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558015|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558016|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558017|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
23558018|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23753332|NCT03669640|66476919|FG001|Overall Study|Study Terminated by Sponsor|0|||
23753333|NCT03669640|66476920|FG002|Overall Study|Study Terminated by Sponsor|0|||
23753334|NCT03669640|66476921|FG003|Overall Study|Study Terminated by Sponsor|0|||
23753335|NCT03669640|66476922|FG004|Overall Study|Study Terminated by Sponsor|1|||
23753336|NCT03669640|66476923|FG005|Overall Study|Study Terminated by Sponsor|0|||
23753337|NCT03669640|66476918|FG000|Overall Study|Lost to Follow-up|0|||
23753338|NCT03669640|66476919|FG001|Overall Study|Lost to Follow-up|0|||
23753339|NCT03669640|66476920|FG002|Overall Study|Lost to Follow-up|2|||
23753340|NCT03669640|66476921|FG003|Overall Study|Lost to Follow-up|0|||
23753341|NCT03669640|66476922|FG004|Overall Study|Lost to Follow-up|0|||
23753342|NCT03669640|66476923|FG005|Overall Study|Lost to Follow-up|0|||
23753343|NCT03669640|66476918|FG000|Overall Study|Death|0|||
23753344|NCT03669640|66476919|FG001|Overall Study|Death|0|||
23753345|NCT03669640|66476920|FG002|Overall Study|Death|1|||
23753346|NCT03669640|66476921|FG003|Overall Study|Death|0|||
23753347|NCT03669640|66476922|FG004|Overall Study|Death|0|||
23753348|NCT03669640|66476923|FG005|Overall Study|Death|0|||
23753349|NCT03669640|66476918|FG000|Overall Study|Withdrawal by Subject|1|||
23753350|NCT03669640|66476919|FG001|Overall Study|Withdrawal by Subject|2|||
23753351|NCT03669640|66476920|FG002|Overall Study|Withdrawal by Subject|1|||
23753352|NCT03669640|66476921|FG003|Overall Study|Withdrawal by Subject|0|||
23753353|NCT03669640|66476922|FG004|Overall Study|Withdrawal by Subject|1|||
23753354|NCT03669640|66476923|FG005|Overall Study|Withdrawal by Subject|3|||
23753355|NCT03669640|66476918|FG000|Overall Study|Protocol Violation|1|||
23753356|NCT03669640|66476919|FG001|Overall Study|Protocol Violation|0|||
23753357|NCT03669640|66476920|FG002|Overall Study|Protocol Violation|0|||
23753358|NCT03669640|66476921|FG003|Overall Study|Protocol Violation|0|||
23753359|NCT03669640|66476922|FG004|Overall Study|Protocol Violation|0|||
23753360|NCT03669640|66476923|FG005|Overall Study|Protocol Violation|0|||
23753361|NCT03669640|66476918|FG000|Overall Study|Physician Decision|0|||
23753362|NCT03669640|66476919|FG001|Overall Study|Physician Decision|2|||
23558019|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558020|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558021|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558022|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558023|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558024|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
23753363|NCT03669640|66476920|FG002|Overall Study|Physician Decision|0|||
23753364|NCT03669640|66476921|FG003|Overall Study|Physician Decision|0|||
23558025|NCT04274894|65769584|FG000|Overall Study|Adverse Event|7|||
23558026|NCT04274894|65769584|FG000|Overall Study|Withdrew consent|5|||
23558027|NCT04274894|65769584|FG000|Overall Study|Lost to Follow-up|9|||
23558028|NCT04274894|65769584|FG000|Overall Study|COVID-19 infection|1|||
23558029|NCT04274894|65769584|FG000|Overall Study|Other, not specified|20|||
23558030|NCT01065350|65769591|FG000|Overall Study|Received incorrect drug allocation|0|||
23558031|NCT01065350|65769592|FG001|Overall Study|Received incorrect drug allocation|1|||
23558032|NCT01735201|65769593|FG000|Overall Study|Adverse Event|1|||
23558033|NCT01735201|65769594|FG001|Overall Study|Adverse Event|1|||
23558034|NCT01735201|65769595|FG002|Overall Study|Adverse Event|0|||
23558035|NCT01735201|65769596|FG003|Overall Study|Adverse Event|1|||
23753365|NCT03669640|66476922|FG004|Overall Study|Physician Decision|0|||
23753366|NCT03669640|66476923|FG005|Overall Study|Physician Decision|0|||
23753367|NCT03669640|66476918|FG000|Overall Study|Disease Relapse|1|||
23753368|NCT03669640|66476919|FG001|Overall Study|Disease Relapse|0|||
23753369|NCT03669640|66476920|FG002|Overall Study|Disease Relapse|0|||
23753370|NCT03669640|66476921|FG003|Overall Study|Disease Relapse|0|||
23753371|NCT03669640|66476922|FG004|Overall Study|Disease Relapse|0|||
23753372|NCT03669640|66476923|FG005|Overall Study|Disease Relapse|0|||
23753373|NCT03669640|66476918|FG000|Overall Study|Adverse Event|2|||
23753374|NCT03669640|66476919|FG001|Overall Study|Adverse Event|1|||
23753375|NCT03669640|66476920|FG002|Overall Study|Adverse Event|0|||
23753376|NCT03669640|66476921|FG003|Overall Study|Adverse Event|0|||
23753377|NCT03669640|66476922|FG004|Overall Study|Adverse Event|1|||
23753378|NCT03669640|66476923|FG005|Overall Study|Adverse Event|0|||
23753379|NCT03533608|66476927|FG000|Overall Study|Withdrawal by Subject|3|||
23753380|NCT03533608|66476927|FG000|Overall Study|Physician Decision|2|||
23753381|NCT00996918|66476932|FG000|Overall Study|Lack of Efficacy|1|||
23753382|NCT00996918|66476933|FG001|Overall Study|Lack of Efficacy|1|||
23753383|NCT00996918|66476934|FG002|Overall Study|Lack of Efficacy|2|||
23753384|NCT00996918|66476935|FG003|Overall Study|Lack of Efficacy|2|||
23753385|NCT00996918|66476936|FG004|Overall Study|Lack of Efficacy|0|||
23753386|NCT00996918|66476932|FG000|Overall Study|Adverse Event|2|||
23753387|NCT00996918|66476933|FG001|Overall Study|Adverse Event|5|||
23753388|NCT00996918|66476934|FG002|Overall Study|Adverse Event|2|||
23753389|NCT00996918|66476935|FG003|Overall Study|Adverse Event|6|||
23753390|NCT00996918|66476936|FG004|Overall Study|Adverse Event|0|||
23753391|NCT00996918|66476932|FG000|Overall Study|Withdrawal by Subject|1|||
23753392|NCT00996918|66476933|FG001|Overall Study|Withdrawal by Subject|4|||
23753393|NCT00996918|66476934|FG002|Overall Study|Withdrawal by Subject|3|||
23753394|NCT00996918|66476935|FG003|Overall Study|Withdrawal by Subject|3|||
23753395|NCT00996918|66476936|FG004|Overall Study|Withdrawal by Subject|2|||
23753396|NCT00996918|66476932|FG000|Overall Study|Physician Decision|1|||
23753397|NCT00996918|66476933|FG001|Overall Study|Physician Decision|0|||
23753398|NCT00996918|66476934|FG002|Overall Study|Physician Decision|0|||
23558036|NCT01735201|65769597|FG004|Overall Study|Adverse Event|1|||
23558037|NCT01735201|65769598|FG005|Overall Study|Adverse Event|3|||
23558038|NCT01735201|65769599|FG006|Overall Study|Adverse Event|2|||
23558039|NCT01735201|65769600|FG007|Overall Study|Adverse Event|1|||
23558040|NCT01735201|65769593|FG000|Overall Study|Personal Reasons|1|||
23558041|NCT01735201|65769594|FG001|Overall Study|Personal Reasons|0|||
23558042|NCT01735201|65769595|FG002|Overall Study|Personal Reasons|0|||
23558043|NCT01735201|65769596|FG003|Overall Study|Personal Reasons|0|||
23558044|NCT01735201|65769597|FG004|Overall Study|Personal Reasons|0|||
23558045|NCT01735201|65769598|FG005|Overall Study|Personal Reasons|0|||
23558046|NCT01735201|65769599|FG006|Overall Study|Personal Reasons|0|||
23558047|NCT01735201|65769600|FG007|Overall Study|Personal Reasons|0|||
23558048|NCT01735201|65769593|FG000|Overall Study|Protocol Violation|1|||
23558049|NCT01735201|65769594|FG001|Overall Study|Protocol Violation|0|||
23753399|NCT00996918|66476935|FG003|Overall Study|Physician Decision|0|||
23753400|NCT00996918|66476936|FG004|Overall Study|Physician Decision|0|||
23753401|NCT00996918|66476932|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
23753402|NCT00996918|66476933|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
23558050|NCT01735201|65769595|FG002|Overall Study|Protocol Violation|0|||
23558051|NCT01735201|65769596|FG003|Overall Study|Protocol Violation|0|||
23558052|NCT01735201|65769597|FG004|Overall Study|Protocol Violation|0|||
23753403|NCT00996918|66476934|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
23753404|NCT00996918|66476935|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
23753405|NCT00996918|66476936|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
23436920|NCT02421588|65340847|FG001|Overall Study|Symptomatic deterioration|19|||
23436921|NCT02421588|65340846|FG000|Overall Study|Treatment-related AE|10|||
23436922|NCT02421588|65340847|FG001|Overall Study|Treatment-related AE|14|||
23436923|NCT02421588|65340846|FG000|Overall Study|Withdrawal by Subject|14|||
23436924|NCT02421588|65340847|FG001|Overall Study|Withdrawal by Subject|16|||
23436925|NCT02421588|65340846|FG000|Overall Study|Not treated|2|||
23436926|NCT02421588|65340847|FG001|Overall Study|Not treated|8|||
23436927|NCT02725866|65340848|FG000|Overall Study|Failure to return|6|||
23436928|NCT02725866|65340848|FG000|Overall Study|Withdrew consent|3|||
23436929|NCT02725866|65340848|FG000|Overall Study|Insufficient virological response|1|||
23436930|NCT02725866|65340848|FG000|Overall Study|Other, not specified|4|||
23436931|NCT01123707|65340849|FG000|Overall Study|Lost to Follow-up|3|||
23436932|NCT01123707|65340850|FG001|Overall Study|Lost to Follow-up|1|||
23436933|NCT01123707|65340851|FG002|Overall Study|Lost to Follow-up|3|||
23436934|NCT01123707|65340852|FG003|Overall Study|Lost to Follow-up|2|||
23436935|NCT01123707|65340849|FG000|Overall Study|Adverse Event|5|||
23436936|NCT01123707|65340850|FG001|Overall Study|Adverse Event|7|||
23436937|NCT01123707|65340851|FG002|Overall Study|Adverse Event|5|||
23436938|NCT01123707|65340852|FG003|Overall Study|Adverse Event|3|||
23436939|NCT01123707|65340849|FG000|Overall Study|Sponsor Discontinued Study|30|||
23436940|NCT01123707|65340850|FG001|Overall Study|Sponsor Discontinued Study|24|||
23436941|NCT01123707|65340851|FG002|Overall Study|Sponsor Discontinued Study|25|||
23436942|NCT01123707|65340852|FG003|Overall Study|Sponsor Discontinued Study|40|||
23436943|NCT01123707|65340849|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23436944|NCT01123707|65340850|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23436945|NCT01123707|65340851|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
23436946|NCT01123707|65340852|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23436947|NCT01123707|65340849|FG000|Overall Study|Investigator Withdrew Participant|0|||
23436948|NCT01123707|65340850|FG001|Overall Study|Investigator Withdrew Participant|1|||
23436949|NCT01123707|65340851|FG002|Overall Study|Investigator Withdrew Participant|1|||
23436950|NCT01123707|65340852|FG003|Overall Study|Investigator Withdrew Participant|1|||
23436951|NCT01123707|65340849|FG000|Overall Study|Subject Withdrew Consent|4|||
23436952|NCT01123707|65340850|FG001|Overall Study|Subject Withdrew Consent|5|||
23436953|NCT01123707|65340851|FG002|Overall Study|Subject Withdrew Consent|1|||
23436954|NCT01123707|65340852|FG003|Overall Study|Subject Withdrew Consent|2|||
23436955|NCT01123707|65340849|FG000|Overall Study|Lack of Efficacy|1|||
23436956|NCT01123707|65340850|FG001|Overall Study|Lack of Efficacy|2|||
23436957|NCT01123707|65340851|FG002|Overall Study|Lack of Efficacy|1|||
23436958|NCT01123707|65340852|FG003|Overall Study|Lack of Efficacy|0|||
23436959|NCT01123707|65340849|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
23436960|NCT01123707|65340850|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
23436961|NCT01123707|65340851|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
23436962|NCT01123707|65340852|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
23436963|NCT04058886|65340853|FG000|Overall Study|Withdrawal by Subject|4|||
23436964|NCT04058886|65340853|FG000|Overall Study|Inadequate deafness interpreter service|1|||
23436965|NCT03194438|65340856|FG000|Overall Study|Withdrawal by Subject|2|||
23436966|NCT03722524|65340857|FG000|Overall Study|Protocol Violation|86|||
23436967|NCT03722524|65340857|FG000|Overall Study|Adverse Event|7|||
23436968|NCT03722524|65340857|FG000|Overall Study|Lost to Follow-up|1|||
23436969|NCT03722524|65340857|FG000|Overall Study|Reason is not stated|1|||
23436970|NCT03722524|65340857|FG000|Overall Study|Physician Decision|1|||
23436971|NCT03722524|65340857|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
23436972|NCT05320393|65340864|FG000|Overall Study|Withdrawal by Subject|1|||
23436973|NCT05320393|65340865|FG001|Overall Study|Withdrawal by Subject|0|||
23436974|NCT05320393|65340866|FG002|Overall Study|Withdrawal by Subject|2|||
23436975|NCT05320393|65340864|FG000|Overall Study|Lost to Follow-up|1|||
23436976|NCT05320393|65340865|FG001|Overall Study|Lost to Follow-up|2|||
23436977|NCT05320393|65340866|FG002|Overall Study|Lost to Follow-up|1|||
23436978|NCT05320393|65340864|FG000|Overall Study|Moved; too much driving|0|||
23436979|NCT05320393|65340865|FG001|Overall Study|Moved; too much driving|0|||
23436980|NCT05320393|65340866|FG002|Overall Study|Moved; too much driving|2|||
23436981|NCT05320393|65340864|FG000|Overall Study|Did not receive treatment|0|||
23436982|NCT05320393|65340865|FG001|Overall Study|Did not receive treatment|0|||
23436983|NCT05320393|65340866|FG002|Overall Study|Did not receive treatment|1|||
23436984|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
23436985|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
23436986|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
23436987|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
23436988|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
23436989|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
23623833|NCT01427738|66008586|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
23623834|NCT01427738|66008585|FG000|Overall Study|Lost to Follow-up|1|||
23436990|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
23825354|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
23753406|NCT00996918|66476932|FG000|Overall Study|Loss of Caregiver|0|||
23753407|NCT00996918|66476933|FG001|Overall Study|Loss of Caregiver|1|||
23753408|NCT00996918|66476934|FG002|Overall Study|Loss of Caregiver|0|||
23753409|NCT00996918|66476935|FG003|Overall Study|Loss of Caregiver|0|||
23753410|NCT00996918|66476936|FG004|Overall Study|Loss of Caregiver|0|||
23753411|NCT00996918|66476932|FG000|Overall Study|Other|3|||
23753412|NCT00996918|66476933|FG001|Overall Study|Other|1|||
23753413|NCT00996918|66476934|FG002|Overall Study|Other|0|||
23753414|NCT00996918|66476935|FG003|Overall Study|Other|0|||
23753415|NCT00996918|66476936|FG004|Overall Study|Other|0|||
23753416|NCT00185731|66476938|FG000|Overall Study|Withdrawal by Subject|1|||
23753417|NCT00185731|66476938|FG000|Overall Study|Not Eligible|1|||
23753418|NCT00589693|66476941|FG000|Overall Study|randomized in error|12|||
23753419|NCT00589693|66476942|FG001|Overall Study|randomized in error|6|||
23753420|NCT00589693|66476941|FG000|Overall Study|Adverse Event|4|||
23753421|NCT00589693|66476942|FG001|Overall Study|Adverse Event|4|||
23753422|NCT00589693|66476941|FG000|Overall Study|Death|26|||
23558053|NCT01735201|65769598|FG005|Overall Study|Protocol Violation|0|||
23558054|NCT01735201|65769599|FG006|Overall Study|Protocol Violation|0|||
23558055|NCT01735201|65769600|FG007|Overall Study|Protocol Violation|0|||
23753423|NCT00589693|66476942|FG001|Overall Study|Death|16|||
23753424|NCT00589693|66476941|FG000|Overall Study|Lack of Efficacy|0|||
23753425|NCT00589693|66476942|FG001|Overall Study|Lack of Efficacy|1|||
23753426|NCT00589693|66476941|FG000|Overall Study|Lost to Follow-up|1|||
23753427|NCT00589693|66476942|FG001|Overall Study|Lost to Follow-up|0|||
23753428|NCT00589693|66476941|FG000|Overall Study|Physician Decision|0|||
23753429|NCT00589693|66476942|FG001|Overall Study|Physician Decision|1|||
23753430|NCT00589693|66476941|FG000|Overall Study|Protocol Violation|1|||
23753431|NCT00589693|66476942|FG001|Overall Study|Protocol Violation|1|||
23753432|NCT00902278|66476948|FG000|Overall Study|Physician Decision|1|||
23753433|NCT00902278|66476949|FG001|Overall Study|Physician Decision|0|||
23436991|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
23436992|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
23436993|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
23436994|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
23436995|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
23436996|NCT00238238|65340869|FG000|Overall Study|Withdrawal by Subject|0|||
23436997|NCT00238238|65340870|FG001|Overall Study|Withdrawal by Subject|3|||
23436998|NCT00238238|65340871|FG002|Overall Study|Withdrawal by Subject|0|||
23436999|NCT01620762|65340872|FG000|Overall Study|Protocol Violation|1|||
23437000|NCT01620762|65340873|FG001|Overall Study|Protocol Violation|1|||
23437001|NCT01620762|65340874|FG002|Overall Study|Protocol Violation|1|||
23437002|NCT01620762|65340872|FG000|Overall Study|Adverse Event|9|||
23437003|NCT01620762|65340873|FG001|Overall Study|Adverse Event|5|||
23437004|NCT01620762|65340874|FG002|Overall Study|Adverse Event|2|||
23437005|NCT01620762|65340872|FG000|Overall Study|Withdrawal by Subject|23|||
23437006|NCT01620762|65340873|FG001|Overall Study|Withdrawal by Subject|26|||
23437007|NCT01620762|65340874|FG002|Overall Study|Withdrawal by Subject|27|||
23437008|NCT01620762|65340872|FG000|Overall Study|Lost to Follow-up|11|||
23437009|NCT01620762|65340873|FG001|Overall Study|Lost to Follow-up|17|||
23437010|NCT01620762|65340874|FG002|Overall Study|Lost to Follow-up|10|||
23437011|NCT01620762|65340872|FG000|Overall Study|Protocol deviation|1|||
23437012|NCT01620762|65340873|FG001|Overall Study|Protocol deviation|1|||
23558056|NCT01735201|65769593|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23558057|NCT01735201|65769594|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23558058|NCT01735201|65769595|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23558059|NCT01735201|65769596|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23558060|NCT01735201|65769597|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23558061|NCT01735201|65769598|FG005|Overall Study|Other Miscellaneous Reasons|2|||
23623835|NCT01427738|66008586|FG001|Overall Study|Lost to Follow-up|5|||
23623836|NCT00632931|66008589|FG000|Part 1, Period 1|Protocol Violation|1|||
23753434|NCT00902278|66476950|FG002|Overall Study|Physician Decision|2|||
23753435|NCT00902278|66476951|FG003|Overall Study|Physician Decision|0|||
23753436|NCT00902278|66476952|FG004|Overall Study|Physician Decision|1|||
23437013|NCT01620762|65340874|FG002|Overall Study|Protocol deviation|6|||
23437014|NCT01620762|65340872|FG000|Overall Study|Subject deterioration|0|||
23437015|NCT01620762|65340873|FG001|Overall Study|Subject deterioration|1|||
23437016|NCT01620762|65340874|FG002|Overall Study|Subject deterioration|1|||
23753437|NCT00902278|66476948|FG000|Overall Study|Lost to Follow-up|3|||
23753438|NCT00902278|66476949|FG001|Overall Study|Lost to Follow-up|2|||
23753439|NCT00902278|66476950|FG002|Overall Study|Lost to Follow-up|3|||
23753440|NCT00902278|66476951|FG003|Overall Study|Lost to Follow-up|0|||
23437017|NCT01620762|65340872|FG000|Overall Study|Non-specified|3|||
23437018|NCT01620762|65340873|FG001|Overall Study|Non-specified|6|||
23558062|NCT01735201|65769599|FG006|Overall Study|Other Miscellaneous Reasons|1|||
23558063|NCT01735201|65769600|FG007|Overall Study|Other Miscellaneous Reasons|1|||
23623837|NCT00632931|66008590|FG001|Part 1, Period 1|Protocol Violation|0|||
23753441|NCT00902278|66476952|FG004|Overall Study|Lost to Follow-up|1|||
23753442|NCT03125915|66476953|FG000|1 Month Follow up|Lost to Follow-up|3|||
23437019|NCT01620762|65340874|FG002|Overall Study|Non-specified|5|||
23437020|NCT01620762|65340872|FG000|Overall Study|Use of prohibted therapies|0|||
23437021|NCT01620762|65340873|FG001|Overall Study|Use of prohibted therapies|1|||
23437022|NCT01620762|65340874|FG002|Overall Study|Use of prohibted therapies|1|||
23437023|NCT00695864|65340875|FG000|Placebo|Withdrawal by Subject|1|||
23558064|NCT00696384|65769601|FG000|Open Label Phase|Adverse Event|27|||
23558065|NCT00696384|65769602|FG001|Open Label Phase|Adverse Event|0|||
23558066|NCT00696384|65769603|FG002|Open Label Phase|Adverse Event|0|||
23558067|NCT00696384|65769601|FG000|Open Label Phase|Protocol Violation|18|||
23437024|NCT00695864|65340875|FG000|Placebo|Physician Decision|4|||
23437025|NCT02161757|65340878|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
23437026|NCT02161757|65340879|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
23437027|NCT02161757|65340880|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
23437028|NCT02161757|65340878|FG000|Treatment Through Study Completion|Adverse Event|1|||
23437029|NCT02161757|65340879|FG001|Treatment Through Study Completion|Adverse Event|1|||
23437030|NCT02161757|65340880|FG002|Treatment Through Study Completion|Adverse Event|0|||
23437031|NCT02161757|65340878|FG000|Treatment Through Study Completion|Protocol Violation|0|||
23437032|NCT02161757|65340879|FG001|Treatment Through Study Completion|Protocol Violation|1|||
23437033|NCT02161757|65340880|FG002|Treatment Through Study Completion|Protocol Violation|2|||
23437034|NCT02161757|65340878|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
23437035|NCT02161757|65340879|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
23437036|NCT02161757|65340880|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
23437037|NCT02161757|65340878|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
23437038|NCT02161757|65340879|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
23437039|NCT02161757|65340880|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
23437040|NCT02161757|65340878|FG000|Treatment Through Study Completion|Other|20|||
23437041|NCT02161757|65340879|FG001|Treatment Through Study Completion|Other|19|||
23437042|NCT02161757|65340880|FG002|Treatment Through Study Completion|Other|12|||
23437043|NCT02161757|65340878|FG000|Treatment Through Study Completion|Death|2|||
23437044|NCT02161757|65340879|FG001|Treatment Through Study Completion|Death|1|||
23437045|NCT02161757|65340880|FG002|Treatment Through Study Completion|Death|1|||
23437046|NCT04384523|65340881|FG000|Overall Study|Lost to Follow-up|0|||
23437047|NCT04384523|65340882|FG001|Overall Study|Lost to Follow-up|0|||
23437048|NCT04384523|65340883|FG002|Overall Study|Lost to Follow-up|0|||
23753443|NCT03125915|66476954|FG001|1 Month Follow up|Lost to Follow-up|3|||
23753444|NCT03125915|66476955|FG002|1 Month Follow up|Lost to Follow-up|2|||
23753445|NCT03125915|66476956|FG003|1 Month Follow up|Lost to Follow-up|3|||
23753446|NCT03125915|66476953|FG000|3 Month Follow-up|Lost to Follow-up|6|||
23753447|NCT03125915|66476954|FG001|3 Month Follow-up|Lost to Follow-up|4|||
23753448|NCT03125915|66476955|FG002|3 Month Follow-up|Lost to Follow-up|4|||
23753449|NCT03125915|66476956|FG003|3 Month Follow-up|Lost to Follow-up|2|||
23753450|NCT03125915|66476953|FG000|6 Month Follow-up|Lost to Follow-up|7|||
23558068|NCT00696384|65769602|FG001|Open Label Phase|Protocol Violation|0|||
23558069|NCT00696384|65769603|FG002|Open Label Phase|Protocol Violation|0|||
23558070|NCT00696384|65769601|FG000|Open Label Phase|Lost to Follow-up|24|||
23558071|NCT00696384|65769602|FG001|Open Label Phase|Lost to Follow-up|0|||
23558072|NCT00696384|65769603|FG002|Open Label Phase|Lost to Follow-up|0|||
23753451|NCT03125915|66476954|FG001|6 Month Follow-up|Lost to Follow-up|3|||
23753452|NCT03125915|66476955|FG002|6 Month Follow-up|Lost to Follow-up|6|||
23753453|NCT03125915|66476956|FG003|6 Month Follow-up|Lost to Follow-up|3|||
23558073|NCT00696384|65769601|FG000|Open Label Phase|Withdrawal by Subject|37|||
23558074|NCT00696384|65769602|FG001|Open Label Phase|Withdrawal by Subject|0|||
23558075|NCT00696384|65769603|FG002|Open Label Phase|Withdrawal by Subject|0|||
23558076|NCT00696384|65769601|FG000|Open Label Phase|Other|6|||
23558077|NCT00696384|65769602|FG001|Open Label Phase|Other|0|||
23558078|NCT00696384|65769603|FG002|Open Label Phase|Other|0|||
23558079|NCT00696384|65769601|FG000|Open Label Phase|Lack of Efficacy|3|||
23558080|NCT00696384|65769602|FG001|Open Label Phase|Lack of Efficacy|0|||
23558081|NCT00696384|65769603|FG002|Open Label Phase|Lack of Efficacy|0|||
23558082|NCT00696384|65769601|FG000|Open Label Phase|Physician Decision|4|||
23558083|NCT00696384|65769602|FG001|Open Label Phase|Physician Decision|0|||
23558084|NCT00696384|65769603|FG002|Open Label Phase|Physician Decision|0|||
23558085|NCT00696384|65769601|FG000|Double Blind Phase|Adverse Event|0|||
23558086|NCT00696384|65769602|FG001|Double Blind Phase|Adverse Event|2|||
23558087|NCT00696384|65769603|FG002|Double Blind Phase|Adverse Event|2|||
23753454|NCT04199104|66476962|FG000|Overall Study|Death|148|||
23437049|NCT04384523|65340884|FG003|Overall Study|Lost to Follow-up|0|||
23437050|NCT04384523|65340885|FG004|Overall Study|Lost to Follow-up|0|||
23437051|NCT04384523|65340886|FG005|Overall Study|Lost to Follow-up|1|||
23437052|NCT04384523|65340881|FG000|Overall Study|Protocol Violation|0|||
23437053|NCT04384523|65340882|FG001|Overall Study|Protocol Violation|1|||
23437054|NCT04384523|65340883|FG002|Overall Study|Protocol Violation|0|||
23437055|NCT04384523|65340884|FG003|Overall Study|Protocol Violation|0|||
23753455|NCT04199104|66476963|FG001|Overall Study|Death|134|||
23753456|NCT04199104|66476962|FG000|Overall Study|Lost to Follow-up|1|||
23437056|NCT04384523|65340885|FG004|Overall Study|Protocol Violation|0|||
23437057|NCT04384523|65340886|FG005|Overall Study|Protocol Violation|0|||
23437058|NCT04384523|65340881|FG000|Overall Study|Withdrawal by Subject|1|||
23437059|NCT04384523|65340882|FG001|Overall Study|Withdrawal by Subject|0|||
23437060|NCT04384523|65340883|FG002|Overall Study|Withdrawal by Subject|0|||
23437061|NCT04384523|65340884|FG003|Overall Study|Withdrawal by Subject|0|||
23437062|NCT04384523|65340885|FG004|Overall Study|Withdrawal by Subject|0|||
23437063|NCT04384523|65340886|FG005|Overall Study|Withdrawal by Subject|0|||
23437064|NCT03659136|65340887|FG000|Overall Study|Not treated|2|||
23437065|NCT03659136|65340888|FG001|Overall Study|Not treated|0|||
23437066|NCT03659136|65340887|FG000|Overall Study|Covid-19 related|1|||
23437067|NCT03659136|65340888|FG001|Overall Study|Covid-19 related|1|||
23753457|NCT04199104|66476963|FG001|Overall Study|Lost to Follow-up|1|||
23753458|NCT04199104|66476962|FG000|Overall Study|Withdrawal by Subject|4|||
23753459|NCT04199104|66476963|FG001|Overall Study|Withdrawal by Subject|4|||
23753460|NCT04199104|66476962|FG000|Overall Study|Participants Ongoing|103|||
23753461|NCT04199104|66476963|FG001|Overall Study|Participants Ongoing|116|||
23753462|NCT02949219|66476964|FG000|Overall Study|Withdrawal by Subject|1|||
23753463|NCT03286426|66476965|FG000|Overall Study|Physician Decision|3|||
23753464|NCT03079869|66476976|FG000|Overall Study|Adverse Event|6|||
23753465|NCT03079869|66476977|FG001|Overall Study|Adverse Event|8|||
23437068|NCT03659136|65340887|FG000|Overall Study|Withdrawal by Subject|1|||
23437069|NCT03659136|65340888|FG001|Overall Study|Withdrawal by Subject|6|||
23437070|NCT03659136|65340887|FG000|Overall Study|Adverse Event|4|||
23437071|NCT03659136|65340888|FG001|Overall Study|Adverse Event|6|||
23437072|NCT03659136|65340887|FG000|Overall Study|Progressive disease|37|||
23437073|NCT03659136|65340888|FG001|Overall Study|Progressive disease|31|||
23437074|NCT03659136|65340887|FG000|Overall Study|Study closure|2|||
23437075|NCT03659136|65340888|FG001|Overall Study|Study closure|2|||
23437076|NCT03659136|65340887|FG000|Overall Study|Sponsor decision/recommendation|3|||
23623838|NCT00632931|66008591|FG002|Part 1, Period 1|Protocol Violation|0|||
23623839|NCT00632931|66008589|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
23623840|NCT00632931|66008590|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
23623841|NCT00632931|66008591|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
23623842|NCT00632931|66008589|FG000|Part 2|Adverse Event|0|||
23437077|NCT03659136|65340888|FG001|Overall Study|Sponsor decision/recommendation|2|||
23437078|NCT03659136|65340887|FG000|Overall Study|Switched to other drug/therapy|2|||
23437079|NCT03659136|65340888|FG001|Overall Study|Switched to other drug/therapy|2|||
23437080|NCT03659136|65340887|FG000|Overall Study|Lack of clinical benefit|0|||
23437081|NCT03659136|65340888|FG001|Overall Study|Lack of clinical benefit|1|||
23437082|NCT03078855|65340892|FG000|Overall Study|Lack of Efficacy|62|||
23437083|NCT03078855|65340893|FG001|Overall Study|Lack of Efficacy|31|||
23437084|NCT03078855|65340892|FG000|Overall Study|Death|1|||
23437085|NCT03078855|65340893|FG001|Overall Study|Death|0|||
23437086|NCT03078855|65340892|FG000|Overall Study|Withdrawal by Subject|12|||
23437087|NCT03078855|65340893|FG001|Overall Study|Withdrawal by Subject|6|||
23437088|NCT03078855|65340892|FG000|Overall Study|Physician Decision|3|||
23437089|NCT03078855|65340893|FG001|Overall Study|Physician Decision|2|||
23437090|NCT03078855|65340892|FG000|Overall Study|Second Malignancy|4|||
23437091|NCT03078855|65340893|FG001|Overall Study|Second Malignancy|0|||
23437092|NCT03078855|65340892|FG000|Overall Study|Ineligible|2|||
23437093|NCT03078855|65340893|FG001|Overall Study|Ineligible|0|||
23437094|NCT03078855|65340892|FG000|Overall Study|Withdrew before day 1 treatment|2|||
23437095|NCT03078855|65340893|FG001|Overall Study|Withdrew before day 1 treatment|1|||
23437096|NCT00923845|65340894|FG000|Induction Therapy|Poor performance status|0|||
23437097|NCT00923845|65340895|FG001|Induction Therapy|Poor performance status|2|||
23437098|NCT02249182|65340896|FG000|Treatment Phase|Lost to Follow-up|4|||
23437099|NCT02249182|65340897|FG001|Treatment Phase|Lost to Follow-up|0|||
23437100|NCT02249182|65340898|FG002|Treatment Phase|Lost to Follow-up|0|||
23437101|NCT02249182|65340899|FG003|Treatment Phase|Lost to Follow-up|0|||
23437102|NCT02249182|65340900|FG004|Treatment Phase|Lost to Follow-up|0|||
23437103|NCT04039217|65343986|FG000|Overall Study|Lost to Follow-up|1|||
23437104|NCT01298765|65343987|FG000|Titration Period|Adverse Event|26|||
23437105|NCT01298765|65343987|FG000|Titration Period|Death|1|||
23437106|NCT01298765|65343987|FG000|Titration Period|Lack of Efficacy|21|||
23437107|NCT01298765|65343987|FG000|Titration Period|Lost to Follow-up|9|||
23753466|NCT03079869|66476976|FG000|Overall Study|Withdrawal by Subject|4|||
23753467|NCT03079869|66476977|FG001|Overall Study|Withdrawal by Subject|1|||
23753468|NCT03079869|66476976|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
23753469|NCT03079869|66476977|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
23437108|NCT01298765|65343987|FG000|Titration Period|Physician Decision|1|||
23437109|NCT01298765|65343987|FG000|Titration Period|Withdrawal by Subject|10|||
23437110|NCT01298765|65343987|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
23437111|NCT01298765|65343987|FG000|Long-Term Treatment Period|Adverse Event|19|||
23437112|NCT01298765|65343987|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
23437113|NCT01298765|65343987|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
23623843|NCT00632931|66008590|FG001|Part 2|Adverse Event|0|||
23437114|NCT01298765|65343987|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
23437115|NCT01298765|65343987|FG000|Long-Term Treatment Period|Physician Decision|1|||
23437116|NCT01298765|65343987|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
23437117|NCT03916081|65343988|FG000|Overall Study|Adverse Event|1|||
23437118|NCT03916081|65343989|FG001|Overall Study|Adverse Event|0|||
23437119|NCT03916081|65343990|FG002|Overall Study|Adverse Event|0|||
23437120|NCT03916081|65343988|FG000|Overall Study|Physician Decision|0|||
23437121|NCT03916081|65343989|FG001|Overall Study|Physician Decision|0|||
23437122|NCT03916081|65343990|FG002|Overall Study|Physician Decision|1|||
23437123|NCT03916081|65343988|FG000|Overall Study|Lost to Follow-up|0|||
23437124|NCT03916081|65343989|FG001|Overall Study|Lost to Follow-up|1|||
23437125|NCT03916081|65343990|FG002|Overall Study|Lost to Follow-up|0|||
23437126|NCT03916081|65343988|FG000|Overall Study|Withdrawal by Subject|3|||
23437127|NCT03916081|65343989|FG001|Overall Study|Withdrawal by Subject|0|||
23437128|NCT03916081|65343990|FG002|Overall Study|Withdrawal by Subject|1|||
23437129|NCT03916081|65343988|FG000|Overall Study|Worsening of AD|0|||
23437130|NCT03916081|65343989|FG001|Overall Study|Worsening of AD|0|||
23437131|NCT03916081|65343990|FG002|Overall Study|Worsening of AD|1|||
23437132|NCT01088399|65343997|FG000|Overall Study|Adverse Event|211|||
23437133|NCT01088399|65343998|FG001|Overall Study|Adverse Event|16|||
23437134|NCT01088399|65343999|FG002|Overall Study|Adverse Event|0|||
23437135|NCT01088399|65343997|FG000|Overall Study|Death|204|||
23437136|NCT01088399|65343998|FG001|Overall Study|Death|45|||
23437137|NCT01088399|65343999|FG002|Overall Study|Death|0|||
23437138|NCT01088399|65343997|FG000|Overall Study|Lack of Efficacy|298|||
23437139|NCT01088399|65343998|FG001|Overall Study|Lack of Efficacy|7|||
23437140|NCT01088399|65343999|FG002|Overall Study|Lack of Efficacy|5|||
23437141|NCT01088399|65343997|FG000|Overall Study|Lost to Follow-up|1070|||
23437142|NCT01088399|65343998|FG001|Overall Study|Lost to Follow-up|278|||
23437143|NCT01088399|65343999|FG002|Overall Study|Lost to Follow-up|58|||
23437144|NCT01088399|65343997|FG000|Overall Study|Physician Decision|531|||
23437145|NCT01088399|65343998|FG001|Overall Study|Physician Decision|88|||
23437146|NCT01088399|65343999|FG002|Overall Study|Physician Decision|16|||
23437147|NCT01088399|65343997|FG000|Overall Study|Withdrawal by Subject|544|||
23437148|NCT01088399|65343998|FG001|Overall Study|Withdrawal by Subject|195|||
23437149|NCT01088399|65343999|FG002|Overall Study|Withdrawal by Subject|33|||
23437150|NCT01088399|65343997|FG000|Overall Study|Change to or start of somatropin therapy|234|||
23437151|NCT01088399|65343998|FG001|Overall Study|Change to or start of somatropin therapy|17|||
23437152|NCT01088399|65343999|FG002|Overall Study|Change to or start of somatropin therapy|12|||
23437153|NCT01088399|65343997|FG000|Overall Study|Sponsor decision|1573|||
23437154|NCT01088399|65343998|FG001|Overall Study|Sponsor decision|298|||
23437155|NCT01088399|65343999|FG002|Overall Study|Sponsor decision|7|||
23437156|NCT01088399|65343997|FG000|Overall Study|Protocol Violation|10|||
23437157|NCT01088399|65343998|FG001|Overall Study|Protocol Violation|1|||
23437158|NCT01088399|65343999|FG002|Overall Study|Protocol Violation|0|||
23437159|NCT01088399|65343997|FG000|Overall Study|Enrollment criteria not met|48|||
23437160|NCT01088399|65343998|FG001|Overall Study|Enrollment criteria not met|119|||
23437161|NCT01088399|65343999|FG002|Overall Study|Enrollment criteria not met|70|||
23437162|NCT01088399|65343997|FG000|Overall Study|Study summary visit not completed|2398|||
23437163|NCT01088399|65343998|FG001|Overall Study|Study summary visit not completed|283|||
23437164|NCT01088399|65343999|FG002|Overall Study|Study summary visit not completed|80|||
23437165|NCT03405818|65344013|FG000|Overall Study|Withdrawal by Subject|4|||
23437166|NCT03405818|65344013|FG000|Overall Study|Lost to Follow-up|4|||
23437167|NCT01894022|65344017|FG000|Overall Study|Death|1|||
23437168|NCT01894022|65344018|FG001|Overall Study|Death|0|||
23437169|NCT01894022|65344017|FG000|Overall Study|Adverse Event, non-fatal|1|||
23437170|NCT01894022|65344018|FG001|Overall Study|Adverse Event, non-fatal|0|||
23558088|NCT00696384|65769601|FG000|Double Blind Phase|Lost to Follow-up|0|||
23558089|NCT00696384|65769602|FG001|Double Blind Phase|Lost to Follow-up|2|||
23558090|NCT00696384|65769603|FG002|Double Blind Phase|Lost to Follow-up|1|||
23437171|NCT01894022|65344017|FG000|Overall Study|Study Closed/terminated|7|||
23437172|NCT01894022|65344018|FG001|Overall Study|Study Closed/terminated|10|||
23558091|NCT00696384|65769601|FG000|Double Blind Phase|Withdrawal by Subject|0|||
23437173|NCT01853878|65344020|FG000|Overall Study|Recurrence|2|||
23437174|NCT01853878|65344021|FG001|Overall Study|Recurrence|0|||
23437175|NCT01853878|65344020|FG000|Overall Study|Adverse Event|2|||
23437176|NCT01853878|65344021|FG001|Overall Study|Adverse Event|0|||
23437177|NCT01853878|65344020|FG000|Overall Study|Withdrawal by Subject|3|||
23437178|NCT01853878|65344021|FG001|Overall Study|Withdrawal by Subject|1|||
23437179|NCT01853878|65344020|FG000|Overall Study|Migrated/moved from the study area|1|||
23437180|NCT01853878|65344021|FG001|Overall Study|Migrated/moved from the study area|0|||
23437181|NCT01853878|65344020|FG000|Overall Study|Other|55|||
23437182|NCT01853878|65344021|FG001|Overall Study|Other|43|||
23437183|NCT01105377|65344022|FG000|Overall Study|Withdrawal by Subject|0|||
23437184|NCT01105377|65344023|FG001|Overall Study|Withdrawal by Subject|1|||
23558092|NCT00696384|65769602|FG001|Double Blind Phase|Withdrawal by Subject|4|||
23437185|NCT01068158|65344024|FG000|Overall Study|Withdrawal by Subject|1|||
23437186|NCT01068158|65344025|FG001|Overall Study|Withdrawal by Subject|2|||
23753470|NCT00742859|66476978|FG000|Overall Study|Adverse Event|5|||
23753471|NCT00742859|66476979|FG001|Overall Study|Adverse Event|6|||
23753472|NCT00742859|66476980|FG002|Overall Study|Adverse Event|3|||
23753473|NCT00742859|66476981|FG003|Overall Study|Adverse Event|1|||
23753474|NCT00742859|66476978|FG000|Overall Study|Death|1|||
23753475|NCT00742859|66476979|FG001|Overall Study|Death|0|||
23753476|NCT00742859|66476980|FG002|Overall Study|Death|0|||
23753477|NCT00742859|66476981|FG003|Overall Study|Death|1|||
23753478|NCT00742859|66476978|FG000|Overall Study|Physician Decision|1|||
23437187|NCT01068158|65344024|FG000|Overall Study|Lost to Follow-up|7|||
23437188|NCT01068158|65344025|FG001|Overall Study|Lost to Follow-up|0|||
23437189|NCT01068158|65344024|FG000|Overall Study|Protocol Violation|0|||
23437190|NCT01068158|65344025|FG001|Overall Study|Protocol Violation|2|||
23437191|NCT00687531|65344026|FG000|Overall Study|Did not meet protocol eligibility|104|||
23437192|NCT00687531|65344026|FG000|Overall Study|Adverse Event|5|||
23437193|NCT00687531|65344026|FG000|Overall Study|Lost to Follow-up|26|||
23437194|NCT01336023|65344030|FG000|Week 0 to Week 26|Adverse Event|8|||
23437195|NCT01336023|65344031|FG001|Week 0 to Week 26|Adverse Event|10|||
23437196|NCT01336023|65344032|FG002|Week 0 to Week 26|Adverse Event|24|||
23437197|NCT01336023|65344030|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
23437198|NCT01336023|65344031|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
23437199|NCT01336023|65344032|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
23437200|NCT01336023|65344030|FG000|Week 0 to Week 26|Protocol Violation|1|||
23437201|NCT01336023|65344031|FG001|Week 0 to Week 26|Protocol Violation|2|||
23437202|NCT01336023|65344032|FG002|Week 0 to Week 26|Protocol Violation|0|||
23437203|NCT01336023|65344030|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
23437204|NCT01336023|65344031|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
23437205|NCT01336023|65344032|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
23437206|NCT01336023|65344030|FG000|Week 0 to Week 26|Unclassified|5|||
23437207|NCT01336023|65344031|FG001|Week 0 to Week 26|Unclassified|16|||
23437208|NCT01336023|65344032|FG002|Week 0 to Week 26|Unclassified|9|||
23437209|NCT01336023|65344030|FG000|Week 27 to 52|Adverse Event|1|||
23753479|NCT00742859|66476979|FG001|Overall Study|Physician Decision|2|||
23753480|NCT00742859|66476980|FG002|Overall Study|Physician Decision|0|||
23753481|NCT00742859|66476981|FG003|Overall Study|Physician Decision|0|||
23753482|NCT00742859|66476978|FG000|Overall Study|Withdrawal by Subject|4|||
23753483|NCT00742859|66476979|FG001|Overall Study|Withdrawal by Subject|2|||
23753484|NCT00742859|66476980|FG002|Overall Study|Withdrawal by Subject|4|||
23753485|NCT00742859|66476981|FG003|Overall Study|Withdrawal by Subject|1|||
23753486|NCT00742859|66476978|FG000|Overall Study|Endpoint|0|||
23753487|NCT00742859|66476979|FG001|Overall Study|Endpoint|1|||
23753488|NCT00742859|66476980|FG002|Overall Study|Endpoint|1|||
23753489|NCT00742859|66476981|FG003|Overall Study|Endpoint|2|||
23753490|NCT00742859|66476978|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
23753491|NCT00742859|66476979|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
23753492|NCT00742859|66476980|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
23753493|NCT00742859|66476981|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
23437210|NCT01336023|65344031|FG001|Week 27 to 52|Adverse Event|5|||
23437211|NCT01336023|65344032|FG002|Week 27 to 52|Adverse Event|2|||
23437212|NCT01336023|65344030|FG000|Week 27 to 52|Protocol Violation|0|||
23437213|NCT01336023|65344031|FG001|Week 27 to 52|Protocol Violation|2|||
23437214|NCT01336023|65344032|FG002|Week 27 to 52|Protocol Violation|1|||
23437215|NCT01336023|65344030|FG000|Week 27 to 52|Withdrawal Criteria|14|||
23437216|NCT01336023|65344031|FG001|Week 27 to 52|Withdrawal Criteria|19|||
23437217|NCT01336023|65344032|FG002|Week 27 to 52|Withdrawal Criteria|16|||
23437218|NCT01336023|65344030|FG000|Week 27 to 52|Unclassified|13|||
23437219|NCT01336023|65344031|FG001|Week 27 to 52|Unclassified|18|||
23437220|NCT01336023|65344032|FG002|Week 27 to 52|Unclassified|9|||
23437221|NCT02596945|65344038|FG000|Overall Study|No documentation of study drug dosing|3|||
23437222|NCT02596945|65344038|FG000|Overall Study|Other|32|||
23437223|NCT02596945|65344038|FG000|Overall Study|Change to hemodialysis|15|||
23437224|NCT02596945|65344038|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
23437225|NCT02596945|65344038|FG000|Overall Study|Withdrawal by Subject|1|||
23437226|NCT02596945|65344038|FG000|Overall Study|Missing|1|||
23437227|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Adverse Event|33|||
23437228|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
23437229|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
23437230|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
23437231|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Physician Decision|6|||
23753494|NCT00742859|66476978|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
23753495|NCT00742859|66476979|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
23753496|NCT00742859|66476980|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
23437232|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
23437233|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
23437234|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
23623844|NCT00632931|66008591|FG002|Part 2|Adverse Event|3|||
23437235|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
23437236|NCT00965419|65344039|FG000|Follow-up Phase|Adverse Event|9|||
23437237|NCT00965419|65344039|FG000|Follow-up Phase|Protocol Violation|4|||
23437238|NCT00965419|65344039|FG000|Follow-up Phase|Withdrawal by Subject|8|||
23437239|NCT00965419|65344039|FG000|Follow-up Phase|Physician Decision|4|||
23437240|NCT00965419|65344039|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
23437241|NCT00965419|65344039|FG000|Follow-up Phase|Lack of Efficacy|28|||
23437242|NCT04186871|65344040|FG000|Overall Study|Lack of Efficacy|0|||
23437243|NCT04186871|65344041|FG001|Overall Study|Lack of Efficacy|1|||
23437244|NCT04186871|65344042|FG002|Overall Study|Lack of Efficacy|0|||
23437245|NCT04186871|65344043|FG003|Overall Study|Lack of Efficacy|0|||
23437246|NCT04186871|65344044|FG004|Overall Study|Lack of Efficacy|1|||
23437247|NCT04186871|65344045|FG005|Overall Study|Lack of Efficacy|1|||
23437248|NCT04186871|65344040|FG000|Overall Study|Adverse Event|1|||
23437249|NCT04186871|65344041|FG001|Overall Study|Adverse Event|1|||
23437250|NCT04186871|65344042|FG002|Overall Study|Adverse Event|0|||
23437251|NCT04186871|65344043|FG003|Overall Study|Adverse Event|0|||
23753497|NCT00742859|66476981|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
23753498|NCT00742859|66476978|FG000|Overall Study|Sponsor request patient out of town|0|||
23437252|NCT04186871|65344044|FG004|Overall Study|Adverse Event|0|||
23437253|NCT04186871|65344045|FG005|Overall Study|Adverse Event|2|||
23437254|NCT04186871|65344040|FG000|Overall Study|Study terminated by sponsor|1|||
23437255|NCT04186871|65344041|FG001|Overall Study|Study terminated by sponsor|2|||
23437256|NCT04186871|65344042|FG002|Overall Study|Study terminated by sponsor|0|||
23437257|NCT04186871|65344043|FG003|Overall Study|Study terminated by sponsor|1|||
23437258|NCT04186871|65344044|FG004|Overall Study|Study terminated by sponsor|0|||
23437259|NCT04186871|65344045|FG005|Overall Study|Study terminated by sponsor|0|||
23437260|NCT04186871|65344040|FG000|Overall Study|Other reasons|0|||
23437261|NCT04186871|65344041|FG001|Overall Study|Other reasons|0|||
23437262|NCT04186871|65344042|FG002|Overall Study|Other reasons|0|||
23437263|NCT04186871|65344043|FG003|Overall Study|Other reasons|0|||
23437264|NCT04186871|65344044|FG004|Overall Study|Other reasons|0|||
23437265|NCT04186871|65344045|FG005|Overall Study|Other reasons|1|||
23437266|NCT04186871|65344040|FG000|Overall Study|Withdrawal by Subject|0|||
23437267|NCT04186871|65344041|FG001|Overall Study|Withdrawal by Subject|0|||
23437268|NCT04186871|65344042|FG002|Overall Study|Withdrawal by Subject|0|||
23437269|NCT04186871|65344043|FG003|Overall Study|Withdrawal by Subject|0|||
23437270|NCT04186871|65344044|FG004|Overall Study|Withdrawal by Subject|0|||
23753499|NCT00742859|66476979|FG001|Overall Study|Sponsor request patient out of town|0|||
23753500|NCT00742859|66476980|FG002|Overall Study|Sponsor request patient out of town|1|||
23753501|NCT00742859|66476981|FG003|Overall Study|Sponsor request patient out of town|1|||
23753502|NCT00742859|66476978|FG000|Overall Study|Site error|0|||
23753503|NCT00742859|66476979|FG001|Overall Study|Site error|0|||
23753504|NCT00742859|66476980|FG002|Overall Study|Site error|1|||
23753505|NCT00742859|66476981|FG003|Overall Study|Site error|1|||
23753506|NCT03674827|66476982|FG000|Treatment Phase|Adverse Event|0|||
23753507|NCT03674827|66476983|FG001|Treatment Phase|Adverse Event|0|||
23753508|NCT03674827|66476984|FG002|Treatment Phase|Adverse Event|0|||
23753509|NCT03674827|66476985|FG003|Treatment Phase|Adverse Event|0|||
23753510|NCT03674827|66476986|FG004|Treatment Phase|Adverse Event|0|||
23753511|NCT03674827|66476987|FG005|Treatment Phase|Adverse Event|2|||
23753512|NCT03674827|66476982|FG000|Treatment Phase|Death|2|||
23753513|NCT03674827|66476983|FG001|Treatment Phase|Death|0|||
23753514|NCT03674827|66476984|FG002|Treatment Phase|Death|0|||
23753515|NCT03674827|66476985|FG003|Treatment Phase|Death|0|||
23753516|NCT03674827|66476986|FG004|Treatment Phase|Death|1|||
23753517|NCT03674827|66476987|FG005|Treatment Phase|Death|0|||
23753518|NCT03674827|66476982|FG000|Treatment Phase|Progressive Disease|0|||
23558093|NCT00696384|65769603|FG002|Double Blind Phase|Withdrawal by Subject|3|||
23437271|NCT04186871|65344045|FG005|Overall Study|Withdrawal by Subject|1|||
23437272|NCT04186871|65344040|FG000|Overall Study|Lost to Follow-up|0|||
23437273|NCT04186871|65344041|FG001|Overall Study|Lost to Follow-up|0|||
23437274|NCT04186871|65344042|FG002|Overall Study|Lost to Follow-up|0|||
23558094|NCT00696384|65769601|FG000|Double Blind Phase|Lack of Efficacy|0|||
23753519|NCT03674827|66476983|FG001|Treatment Phase|Progressive Disease|4|||
23753520|NCT03674827|66476984|FG002|Treatment Phase|Progressive Disease|3|||
23753521|NCT03674827|66476985|FG003|Treatment Phase|Progressive Disease|4|||
23753522|NCT03674827|66476986|FG004|Treatment Phase|Progressive Disease|4|||
23437275|NCT04186871|65344043|FG003|Overall Study|Lost to Follow-up|0|||
23437276|NCT04186871|65344044|FG004|Overall Study|Lost to Follow-up|0|||
23437277|NCT04186871|65344045|FG005|Overall Study|Lost to Follow-up|1|||
23753523|NCT03674827|66476987|FG005|Treatment Phase|Progressive Disease|9|||
23753524|NCT03674827|66476982|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
23437278|NCT02292706|65344046|FG000|Overall Study|Lost to Follow-up|20|||
23558095|NCT00696384|65769602|FG001|Double Blind Phase|Lack of Efficacy|1|||
23558096|NCT00696384|65769603|FG002|Double Blind Phase|Lack of Efficacy|0|||
23558097|NCT00696384|65769601|FG000|Double Blind Phase|Physician Decision|0|||
23558098|NCT00696384|65769602|FG001|Double Blind Phase|Physician Decision|2|||
23558099|NCT00696384|65769603|FG002|Double Blind Phase|Physician Decision|0|||
23558100|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
23558101|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
23558102|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
23558103|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
23558104|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
23558105|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
23558106|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
23558107|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558108|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558109|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558110|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
23437279|NCT02292706|65344047|FG001|Overall Study|Lost to Follow-up|44|||
23437280|NCT02292706|65344048|FG002|Overall Study|Lost to Follow-up|24|||
23437281|NCT02292706|65344049|FG003|Overall Study|Lost to Follow-up|61|||
23437282|NCT02292706|65344050|FG004|Overall Study|Lost to Follow-up|21|||
23753525|NCT03674827|66476983|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
23753526|NCT03674827|66476984|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
23753527|NCT03674827|66476985|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
23753528|NCT03674827|66476986|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
23753529|NCT03674827|66476987|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
23753530|NCT03674827|66476982|FG000|Treatment Phase|Withdrawal by Subject|0|||
23753531|NCT03674827|66476983|FG001|Treatment Phase|Withdrawal by Subject|0|||
23753532|NCT03674827|66476984|FG002|Treatment Phase|Withdrawal by Subject|0|||
23753533|NCT03674827|66476985|FG003|Treatment Phase|Withdrawal by Subject|0|||
23753534|NCT03674827|66476986|FG004|Treatment Phase|Withdrawal by Subject|0|||
23753535|NCT03674827|66476987|FG005|Treatment Phase|Withdrawal by Subject|1|||
23753536|NCT03674827|66476982|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
23753537|NCT03674827|66476983|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
23753538|NCT03674827|66476984|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
23753539|NCT03674827|66476985|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
23753540|NCT03674827|66476986|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
23753541|NCT03674827|66476987|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
23753542|NCT03674827|66476982|FG000|Treatment Phase|Other|0|||
23753543|NCT03674827|66476983|FG001|Treatment Phase|Other|1|||
23753544|NCT03674827|66476984|FG002|Treatment Phase|Other|0|||
23753545|NCT03674827|66476985|FG003|Treatment Phase|Other|0|||
23753546|NCT03674827|66476986|FG004|Treatment Phase|Other|0|||
23753547|NCT03674827|66476987|FG005|Treatment Phase|Other|1|||
23558111|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
23558112|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558113|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558114|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558115|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
23558116|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
23558117|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558118|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558119|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558120|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Death|2|||
23623845|NCT00632931|66008589|FG000|Part 2|Death|0|||
23623846|NCT00632931|66008590|FG001|Part 2|Death|0|||
23753548|NCT03674827|66476982|FG000|Long-Term Follow-up Phase|Death|2|||
23437283|NCT02292706|65344051|FG005|Overall Study|Lost to Follow-up|52|||
23558121|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Death|2|||
23558122|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Death|0|||
23437284|NCT02292706|65344052|FG006|Overall Study|Lost to Follow-up|25|||
23437285|NCT02292706|65344053|FG007|Overall Study|Lost to Follow-up|0|||
23437286|NCT02292706|65344046|FG000|Overall Study|Withdrew consent|15|||
23437287|NCT02292706|65344047|FG001|Overall Study|Withdrew consent|56|||
23437288|NCT02292706|65344048|FG002|Overall Study|Withdrew consent|43|||
23437289|NCT02292706|65344049|FG003|Overall Study|Withdrew consent|36|||
23437290|NCT02292706|65344050|FG004|Overall Study|Withdrew consent|13|||
23437291|NCT02292706|65344051|FG005|Overall Study|Withdrew consent|51|||
23753549|NCT03674827|66476983|FG001|Long-Term Follow-up Phase|Death|4|||
23437292|NCT02292706|65344052|FG006|Overall Study|Withdrew consent|20|||
23437293|NCT02292706|65344053|FG007|Overall Study|Withdrew consent|0|||
23437294|NCT02292706|65344046|FG000|Overall Study|Death|3|||
23437295|NCT02292706|65344047|FG001|Overall Study|Death|11|||
23437296|NCT02292706|65344048|FG002|Overall Study|Death|16|||
23437297|NCT02292706|65344049|FG003|Overall Study|Death|22|||
23437298|NCT02292706|65344050|FG004|Overall Study|Death|8|||
23437299|NCT02292706|65344051|FG005|Overall Study|Death|17|||
23437300|NCT02292706|65344052|FG006|Overall Study|Death|3|||
23437301|NCT02292706|65344053|FG007|Overall Study|Death|0|||
23437302|NCT02292706|65344046|FG000|Overall Study|Study terminated by sponsor|0|||
23437303|NCT02292706|65344047|FG001|Overall Study|Study terminated by sponsor|9|||
23753550|NCT03674827|66476984|FG002|Long-Term Follow-up Phase|Death|2|||
23753551|NCT03674827|66476985|FG003|Long-Term Follow-up Phase|Death|3|||
23753552|NCT03674827|66476986|FG004|Long-Term Follow-up Phase|Death|2|||
23437304|NCT02292706|65344048|FG002|Overall Study|Study terminated by sponsor|4|||
23437305|NCT02292706|65344049|FG003|Overall Study|Study terminated by sponsor|21|||
23437306|NCT02292706|65344050|FG004|Overall Study|Study terminated by sponsor|11|||
23437307|NCT02292706|65344051|FG005|Overall Study|Study terminated by sponsor|13|||
23437308|NCT02292706|65344052|FG006|Overall Study|Study terminated by sponsor|3|||
23437309|NCT02292706|65344053|FG007|Overall Study|Study terminated by sponsor|0|||
23437310|NCT02292706|65344046|FG000|Overall Study|Investigator's discretion|4|||
23558123|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Death|0|||
23558124|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Death|0|||
23623847|NCT00632931|66008591|FG002|Part 2|Death|1|||
23623848|NCT00632931|66008589|FG000|Part 2|Lack of Efficacy|0|||
23753553|NCT03674827|66476987|FG005|Long-Term Follow-up Phase|Death|6|||
23753554|NCT03674827|66476982|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
23753555|NCT03674827|66476983|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
23753556|NCT03674827|66476984|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
23753557|NCT03674827|66476985|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
23753558|NCT03674827|66476986|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
23753559|NCT03674827|66476987|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
23753560|NCT03674827|66476982|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23753561|NCT03674827|66476983|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23753562|NCT03674827|66476984|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
23753563|NCT03674827|66476985|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
23753564|NCT03674827|66476986|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23753565|NCT03674827|66476987|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
23753566|NCT03205163|66476988|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
23753567|NCT03205163|66476989|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
23753568|NCT01988337|66476990|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
23753569|NCT03853213|66476991|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
23753570|NCT03853213|66476992|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
23753571|NCT03853213|66476991|FG000|Overall Study|Other (e.g., too busy)|0|||
23753572|NCT03853213|66476992|FG001|Overall Study|Other (e.g., too busy)|2|||
23753573|NCT00981409|66476993|FG000|Overall Study|Adverse Event|4|||
23753574|NCT00981409|66476994|FG001|Overall Study|Adverse Event|0|||
23753575|NCT00981409|66476993|FG000|Overall Study|Protocol Violation|0|||
23753576|NCT00981409|66476994|FG001|Overall Study|Protocol Violation|1|||
23753577|NCT00981409|66476993|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
23753578|NCT00981409|66476994|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
23753579|NCT03047031|66476998|FG000|Overall Study|Other than listed|1|||
23753580|NCT03047031|66476999|FG001|Overall Study|Other than listed|0|||
23753581|NCT03047031|66477000|FG002|Overall Study|Other than listed|0|||
23753582|NCT03047031|66476998|FG000|Overall Study|Lost to Follow-up|4|||
23753583|NCT03047031|66476999|FG001|Overall Study|Lost to Follow-up|0|||
23753584|NCT03047031|66477000|FG002|Overall Study|Lost to Follow-up|0|||
23753585|NCT03047031|66476998|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
23753586|NCT03047031|66476999|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
23753587|NCT03047031|66477000|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
23753588|NCT03047031|66476998|FG000|Overall Study|Adverse Event|1|||
23753589|NCT03047031|66476999|FG001|Overall Study|Adverse Event|0|||
23753590|NCT03047031|66477000|FG002|Overall Study|Adverse Event|0|||
23753591|NCT03047031|66476998|FG000|Overall Study|Withdrawal by Subject|2|||
23753592|NCT03047031|66476999|FG001|Overall Study|Withdrawal by Subject|0|||
23753593|NCT03047031|66477000|FG002|Overall Study|Withdrawal by Subject|0|||
23753594|NCT03047031|66476998|FG000|Overall Study|Change to other medication|2|||
23753595|NCT03047031|66476999|FG001|Overall Study|Change to other medication|0|||
23753596|NCT03047031|66477000|FG002|Overall Study|Change to other medication|0|||
23753597|NCT03047031|66476998|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
23753598|NCT03047031|66476999|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
23753599|NCT03047031|66477000|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
23753600|NCT03033069|66477002|FG000|Overall Study|Adverse Event|6|||
23753601|NCT03033069|66477003|FG001|Overall Study|Adverse Event|7|||
23753602|NCT03033069|66477004|FG002|Overall Study|Adverse Event|4|||
23753603|NCT03033069|66477005|FG003|Overall Study|Adverse Event|6|||
23753604|NCT03033069|66477002|FG000|Overall Study|Lack of Efficacy|0|||
23753605|NCT03033069|66477003|FG001|Overall Study|Lack of Efficacy|0|||
23753606|NCT03033069|66477004|FG002|Overall Study|Lack of Efficacy|1|||
23753607|NCT03033069|66477005|FG003|Overall Study|Lack of Efficacy|0|||
23753608|NCT03033069|66477002|FG000|Overall Study|Lost to Follow-up|6|||
23753609|NCT03033069|66477003|FG001|Overall Study|Lost to Follow-up|5|||
23753610|NCT03033069|66477004|FG002|Overall Study|Lost to Follow-up|5|||
23753611|NCT03033069|66477005|FG003|Overall Study|Lost to Follow-up|6|||
23753612|NCT03033069|66477002|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23753613|NCT03033069|66477003|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23753614|NCT03033069|66477004|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23753615|NCT03033069|66477005|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23753616|NCT03033069|66477002|FG000|Overall Study|Protocol Deviation|0|||
23753617|NCT03033069|66477003|FG001|Overall Study|Protocol Deviation|1|||
23753618|NCT03033069|66477004|FG002|Overall Study|Protocol Deviation|0|||
23753619|NCT03033069|66477005|FG003|Overall Study|Protocol Deviation|0|||
23753620|NCT03033069|66477002|FG000|Overall Study|Withdrawal by Subject|10|||
23753621|NCT03033069|66477003|FG001|Overall Study|Withdrawal by Subject|10|||
23753622|NCT03033069|66477004|FG002|Overall Study|Withdrawal by Subject|11|||
23753623|NCT03033069|66477005|FG003|Overall Study|Withdrawal by Subject|6|||
23558125|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
23437311|NCT02292706|65344047|FG001|Overall Study|Investigator's discretion|9|||
23437312|NCT02292706|65344048|FG002|Overall Study|Investigator's discretion|7|||
23437313|NCT02292706|65344049|FG003|Overall Study|Investigator's discretion|11|||
23437314|NCT02292706|65344050|FG004|Overall Study|Investigator's discretion|4|||
23437315|NCT02292706|65344051|FG005|Overall Study|Investigator's discretion|10|||
23437316|NCT02292706|65344052|FG006|Overall Study|Investigator's discretion|1|||
23437317|NCT02292706|65344053|FG007|Overall Study|Investigator's discretion|0|||
23437318|NCT02292706|65344046|FG000|Overall Study|Liver transplant|1|||
23437319|NCT02292706|65344047|FG001|Overall Study|Liver transplant|1|||
23437320|NCT02292706|65344048|FG002|Overall Study|Liver transplant|11|||
23437321|NCT02292706|65344049|FG003|Overall Study|Liver transplant|16|||
23437322|NCT02292706|65344050|FG004|Overall Study|Liver transplant|5|||
23437323|NCT02292706|65344051|FG005|Overall Study|Liver transplant|6|||
23437324|NCT02292706|65344052|FG006|Overall Study|Liver transplant|5|||
23437325|NCT02292706|65344053|FG007|Overall Study|Liver transplant|0|||
23437326|NCT02292706|65344046|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
23437327|NCT02292706|65344047|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
23437328|NCT02292706|65344048|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
23437329|NCT02292706|65344049|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
23437330|NCT02292706|65344050|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
23437331|NCT02292706|65344051|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
23437332|NCT02292706|65344052|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
23437333|NCT02292706|65344053|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
23437334|NCT02292706|65344046|FG000|Overall Study|Subject terminated by sponsor|1|||
23558126|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
23558127|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
23558128|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
23558129|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
23558130|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558131|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
23558132|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23753624|NCT03033069|66477002|FG000|Overall Study|Withdrawal By Caregiver|1|||
23753625|NCT03033069|66477003|FG001|Overall Study|Withdrawal By Caregiver|0|||
23753626|NCT03033069|66477004|FG002|Overall Study|Withdrawal By Caregiver|0|||
23753627|NCT03033069|66477005|FG003|Overall Study|Withdrawal By Caregiver|0|||
23558133|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558134|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558135|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
23558136|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
23558137|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23753628|NCT03033069|66477002|FG000|Overall Study|Reason not Specified|0|||
23753629|NCT03033069|66477003|FG001|Overall Study|Reason not Specified|1|||
23753630|NCT03033069|66477004|FG002|Overall Study|Reason not Specified|0|||
23753631|NCT03033069|66477005|FG003|Overall Study|Reason not Specified|1|||
23753632|NCT02367781|66477006|FG000|Overall Study|Withdrawal by Subject|20|||
23753633|NCT02367781|66477007|FG001|Overall Study|Withdrawal by Subject|13|||
23753634|NCT02367781|66477006|FG000|Overall Study|Protocol Violation|0|||
23753635|NCT02367781|66477007|FG001|Overall Study|Protocol Violation|1|||
23753636|NCT02367781|66477006|FG000|Overall Study|Physician Decision|7|||
23753637|NCT02367781|66477007|FG001|Overall Study|Physician Decision|0|||
23753638|NCT02367781|66477006|FG000|Overall Study|Randomized in Error|5|||
23753639|NCT02367781|66477007|FG001|Overall Study|Randomized in Error|4|||
23753640|NCT02367781|66477006|FG000|Overall Study|Non-Compliance|1|||
23753641|NCT02367781|66477007|FG001|Overall Study|Non-Compliance|0|||
23558138|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23558139|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23558140|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
23558141|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23753642|NCT02367781|66477006|FG000|Overall Study|Lost to Follow-up|1|||
23753643|NCT02367781|66477007|FG001|Overall Study|Lost to Follow-up|2|||
23753644|NCT02367781|66477006|FG000|Overall Study|Death|330|||
23753645|NCT02367781|66477007|FG001|Overall Study|Death|176|||
23753646|NCT02367781|66477006|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
23437335|NCT02292706|65344047|FG001|Overall Study|Subject terminated by sponsor|0|||
23437336|NCT02292706|65344048|FG002|Overall Study|Subject terminated by sponsor|0|||
23558142|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558143|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558144|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558145|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
23558146|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558147|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558148|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23753647|NCT02367781|66477007|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
23753648|NCT02367781|66477006|FG000|Overall Study|Prolonged Hospitalization|1|||
23753649|NCT02367781|66477007|FG001|Overall Study|Prolonged Hospitalization|0|||
23753650|NCT02367781|66477006|FG000|Overall Study|Death Prior First Dose|1|||
23753651|NCT02367781|66477007|FG001|Overall Study|Death Prior First Dose|0|||
23753652|NCT02367781|66477006|FG000|Overall Study|Administrative-Change Facility|1|||
23753653|NCT02367781|66477007|FG001|Overall Study|Administrative-Change Facility|0|||
23753654|NCT02367781|66477006|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
23753655|NCT02367781|66477007|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
23753656|NCT02367781|66477006|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
23753657|NCT02367781|66477007|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
23753658|NCT02367781|66477006|FG000|Overall Study|Study Terminated by Sponsor|3|||
23753659|NCT02367781|66477007|FG001|Overall Study|Study Terminated by Sponsor|1|||
23753660|NCT02367781|66477006|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
23753661|NCT02367781|66477007|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
23753662|NCT02367781|66477006|FG000|Overall Study|Sponsor Decision|2|||
23753663|NCT02367781|66477007|FG001|Overall Study|Sponsor Decision|0|||
23753664|NCT02367781|66477006|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
23753665|NCT02367781|66477007|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
23753666|NCT01788163|66477008|FG000|Overall Study|Other|53|||
23753667|NCT01788163|66477009|FG001|Overall Study|Other|0|||
23753668|NCT01788163|66477010|FG002|Overall Study|Other|0|||
23753669|NCT01788163|66477011|FG003|Overall Study|Other|0|||
23753670|NCT01788163|66477012|FG004|Overall Study|Other|0|||
23753671|NCT01788163|66477013|FG005|Overall Study|Other|7|||
23753672|NCT01788163|66477014|FG006|Overall Study|Other|1|||
23753673|NCT01788163|66477015|FG007|Overall Study|Other|48|||
23753674|NCT01788163|66477016|FG008|Overall Study|Other|15|||
23558149|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558150|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558151|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558152|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558153|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
23558154|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558155|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558156|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558157|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558158|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558159|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
23558160|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
23558161|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
23558162|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
23558163|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
23558164|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
23558165|NCT01964326|65769615|FG000|Overall Study|Adverse Event|48|||
23558166|NCT01964326|65769615|FG000|Overall Study|Death|2|||
23558167|NCT01964326|65769615|FG000|Overall Study|Protocol Violation|4|||
23558168|NCT01964326|65769615|FG000|Overall Study|Lost to Follow-up|88|||
23558169|NCT01964326|65769615|FG000|Overall Study|Withdrawal by Subject|87|||
23558170|NCT01964326|65769615|FG000|Overall Study|Pregnancy|1|||
23558171|NCT01964326|65769615|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
23558172|NCT01964326|65769615|FG000|Overall Study|Physician Decision|55|||
23558173|NCT01964326|65769615|FG000|Overall Study|Investigator Discretion|1|||
23558174|NCT01964326|65769615|FG000|Overall Study|Other|9|||
23558175|NCT01964326|65769615|FG000|Overall Study|Did not meet eligibility criteria|1|||
23558176|NCT02686034|65769616|FG000|Run-In Period 1|Eligibility|12|||
23558177|NCT02686034|65769617|FG001|Run-In Period 1|Eligibility|10|||
23558178|NCT02686034|65769616|FG000|Run-In Period 1|Withdrawal by Subject|4|||
23558179|NCT02686034|65769617|FG001|Run-In Period 1|Withdrawal by Subject|3|||
23753675|NCT01788163|66477008|FG000|Overall Study|Withdrawal by Subject|2|||
23753676|NCT01788163|66477009|FG001|Overall Study|Withdrawal by Subject|0|||
23753677|NCT01788163|66477010|FG002|Overall Study|Withdrawal by Subject|0|||
23558180|NCT02686034|65769616|FG000|Run-In Period 1|Lost to Follow-up|4|||
23753678|NCT01788163|66477011|FG003|Overall Study|Withdrawal by Subject|0|||
23558181|NCT02686034|65769617|FG001|Run-In Period 1|Lost to Follow-up|4|||
23558182|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
23558183|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
23558184|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
23558185|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
23825355|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
23825356|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
23825357|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #3|11|||
23825358|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #3|0|||
23825359|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
23825360|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
23825361|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
23825362|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23825363|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825364|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825365|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #4|3|||
23825366|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #4|0|||
23825367|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
23825368|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
23825369|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
23825370|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
23825371|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
23825372|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23825373|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
23825374|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
23825375|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
23825376|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825377|NCT03888066|66741465|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
23825378|NCT03888066|66741466|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23825379|NCT03888066|66741465|FG000|Run-in Phase|AE (Adverse Event)|17|||
23825380|NCT03888066|66741466|FG001|Run-in Phase|AE (Adverse Event)|0|||
23825381|NCT03888066|66741465|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
23825382|NCT03888066|66741466|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
23825383|NCT03888066|66741465|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825384|NCT03888066|66741466|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825385|NCT03888066|66741465|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23825386|NCT03888066|66741466|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825387|NCT03888066|66741465|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
23825388|NCT03888066|66741466|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23825389|NCT03888066|66741465|FG000|Run-in Phase|Withdrawal by Subject|43|||
23825390|NCT03888066|66741466|FG001|Run-in Phase|Withdrawal by Subject|0|||
23825391|NCT03888066|66741465|FG000|Run-in Phase|AE; Physician Decision|1|||
23825392|NCT03888066|66741466|FG001|Run-in Phase|AE; Physician Decision|0|||
23825393|NCT03888066|66741465|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
23825394|NCT03888066|66741466|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23825395|NCT03888066|66741465|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
23825396|NCT03888066|66741466|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
23825397|NCT03888066|66741465|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
23825398|NCT03888066|66741466|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23825399|NCT03888066|66741465|FG000|Run-in Phase|Death|1|||
23825400|NCT03888066|66741466|FG001|Run-in Phase|Death|0|||
23825401|NCT03888066|66741465|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
23825402|NCT03888066|66741466|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
23825403|NCT03888066|66741465|FG000|Run-in Phase|Physician Decision|1|||
23825404|NCT03888066|66741466|FG001|Run-in Phase|Physician Decision|0|||
23825405|NCT03888066|66741465|FG000|Run-in Phase|Protocol Violation|13|||
23825406|NCT03888066|66741466|FG001|Run-in Phase|Protocol Violation|0|||
23825407|NCT03888066|66741465|FG000|Run-in Phase|Sponsor Request|34|||
23825408|NCT03888066|66741466|FG001|Run-in Phase|Sponsor Request|0|||
23825409|NCT03888066|66741465|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
23825410|NCT03888066|66741466|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
23825411|NCT03888066|66741465|FG000|Run-in Phase|Withdrawal Of Consent|1|||
23825412|NCT03888066|66741466|FG001|Run-in Phase|Withdrawal Of Consent|0|||
23825413|NCT03888066|66741465|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
23825414|NCT03888066|66741466|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
23825415|NCT03888066|66741465|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
23825416|NCT03888066|66741466|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
23825417|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
23825418|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
23558186|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Adverse Event|0|||
23558187|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Adverse Event|2|||
23558188|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
23558189|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
23558190|NCT02686034|65769616|FG000|Open Label Period 3|Lost to Follow-up|0|||
23558191|NCT02686034|65769617|FG001|Open Label Period 3|Lost to Follow-up|1|||
23558192|NCT00590902|65769623|FG000|Overall Study|Death|1|||
23558193|NCT02090634|65769626|FG000|Overall Study|Lost to Follow-up|0|||
23558194|NCT02090634|65769627|FG001|Overall Study|Lost to Follow-up|1|||
23558195|NCT02090634|65769626|FG000|Overall Study|Death|0|||
23558196|NCT02090634|65769627|FG001|Overall Study|Death|1|||
23558197|NCT02090634|65769626|FG000|Overall Study|Protocol Violation|3|||
23558198|NCT02090634|65769627|FG001|Overall Study|Protocol Violation|1|||
23558199|NCT02090634|65769626|FG000|Overall Study|Adverse Event|2|||
23558200|NCT02090634|65769627|FG001|Overall Study|Adverse Event|0|||
23558201|NCT01471054|65769628|FG000|Overall Study|Study terminated prematurely|4|||
23558202|NCT01471054|65769629|FG001|Overall Study|Study terminated prematurely|0|||
23558203|NCT02831257|65769630|FG000|Overall Study|Lack of Efficacy|3|||
23558204|NCT02831257|65769630|FG000|Overall Study|Adverse Event|2|||
23558205|NCT02831257|65769630|FG000|Overall Study|Physician Decision|1|||
23558206|NCT02831257|65769630|FG000|Overall Study|Withdrawal by Subject|6|||
23558207|NCT00742079|65769631|FG000|Overall Study|Lost to Follow-up|0|||
23558208|NCT00742079|65769632|FG001|Overall Study|Lost to Follow-up|1|||
23558209|NCT00977665|65769633|FG000|Overall Study|Withdrawal by Subject|1|||
23558210|NCT00977665|65769634|FG001|Overall Study|Withdrawal by Subject|3|||
23558211|NCT00977665|65769633|FG000|Overall Study|Physician Decision|2|||
23558212|NCT00977665|65769634|FG001|Overall Study|Physician Decision|1|||
23558213|NCT00977665|65769633|FG000|Overall Study|Sponsor requested withdrawal|0|||
23558214|NCT00977665|65769634|FG001|Overall Study|Sponsor requested withdrawal|1|||
23558215|NCT00977665|65769633|FG000|Overall Study|Lost to Follow-up|1|||
23558216|NCT00977665|65769634|FG001|Overall Study|Lost to Follow-up|0|||
23558217|NCT00977665|65769633|FG000|Overall Study|Death|3|||
23558218|NCT00977665|65769634|FG001|Overall Study|Death|2|||
23558219|NCT00977665|65769633|FG000|Overall Study|Adverse Event|14|||
23558220|NCT00977665|65769634|FG001|Overall Study|Adverse Event|7|||
23558221|NCT00977665|65769633|FG000|Overall Study|Treatment failure|0|||
23558222|NCT00977665|65769634|FG001|Overall Study|Treatment failure|1|||
23558223|NCT02027402|65769635|FG000|Overall Study|Withdrawal by Subject|4|||
23558224|NCT02027402|65769636|FG001|Overall Study|Withdrawal by Subject|1|||
23558225|NCT03315143|65769639|FG000|Overall Study|Death|240|||
23558226|NCT03315143|65769640|FG001|Overall Study|Death|246|||
23558227|NCT03315143|65769639|FG000|Overall Study|Withdrawal by Subject|57|||
23558228|NCT03315143|65769640|FG001|Overall Study|Withdrawal by Subject|68|||
23558229|NCT03315143|65769639|FG000|Overall Study|Site Terminated by Sponsor|256|||
23558230|NCT03315143|65769640|FG001|Overall Study|Site Terminated by Sponsor|282|||
23558231|NCT03315143|65769639|FG000|Overall Study|Study Terminated by Sponsor|4723|||
23558232|NCT03315143|65769640|FG001|Overall Study|Study Terminated by Sponsor|4664|||
23558233|NCT03315143|65769639|FG000|Overall Study|Reason not Specified|16|||
23558234|NCT03315143|65769640|FG001|Overall Study|Reason not Specified|32|||
23558235|NCT01666951|65769647|FG000|Overall Study|Not dosed|1|||
23558236|NCT01666951|65769648|FG001|Overall Study|Not dosed|1|||
23558237|NCT00985725|65769649|FG000|Overall Study|Adverse Event|4|||
23558238|NCT00985725|65769650|FG001|Overall Study|Adverse Event|1|||
23558239|NCT00985725|65769649|FG000|Overall Study|Protocol Violation|1|||
23558240|NCT00985725|65769650|FG001|Overall Study|Protocol Violation|3|||
23558241|NCT00985725|65769649|FG000|Overall Study|Withdrawal by Subject|4|||
23558242|NCT00985725|65769650|FG001|Overall Study|Withdrawal by Subject|4|||
23753679|NCT01788163|66477012|FG004|Overall Study|Withdrawal by Subject|0|||
23753680|NCT01788163|66477013|FG005|Overall Study|Withdrawal by Subject|0|||
23753681|NCT01788163|66477014|FG006|Overall Study|Withdrawal by Subject|0|||
23753682|NCT01788163|66477015|FG007|Overall Study|Withdrawal by Subject|0|||
23753683|NCT01788163|66477016|FG008|Overall Study|Withdrawal by Subject|1|||
23753684|NCT01870921|66477020|FG000|Overall Study|Subject decision|80|||
23753685|NCT01870921|66477020|FG000|Overall Study|Severe non-compliance to protocol|7|||
23753686|NCT01870921|66477020|FG000|Overall Study|Subject Lost to Follow up|2|||
23825419|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
23558243|NCT00985725|65769649|FG000|Overall Study|Lost to Follow-up|1|||
23558244|NCT00985725|65769650|FG001|Overall Study|Lost to Follow-up|1|||
23558245|NCT00985725|65769649|FG000|Overall Study|Lack of Efficacy|0|||
23558246|NCT00985725|65769650|FG001|Overall Study|Lack of Efficacy|1|||
23558247|NCT00985725|65769649|FG000|Overall Study|Non-compliance|1|||
23558248|NCT00985725|65769650|FG001|Overall Study|Non-compliance|2|||
23558249|NCT00985725|65769649|FG000|Overall Study|Out-of-window visits|0|||
23558250|NCT00985725|65769650|FG001|Overall Study|Out-of-window visits|1|||
23558251|NCT02487472|65769652|FG000|Overall Study|Did not complete telephonic interviews|9|||
23558252|NCT02487472|65769652|FG000|Overall Study|Other|2|||
23558253|NCT02240108|65772421|FG000|Overall Study|Other than specified|8|||
23437337|NCT02292706|65344049|FG003|Overall Study|Subject terminated by sponsor|2|||
23558254|NCT02240108|65772422|FG001|Overall Study|Other than specified|6|||
23558255|NCT02240108|65772421|FG000|Overall Study|Adverse Event|1|||
23558256|NCT02240108|65772422|FG001|Overall Study|Adverse Event|9|||
23558257|NCT02240108|65772421|FG000|Overall Study|Pregnancy|1|||
23753687|NCT01870921|66477020|FG000|Overall Study|Other|1|||
23558258|NCT02240108|65772422|FG001|Overall Study|Pregnancy|0|||
23558259|NCT02240108|65772421|FG000|Overall Study|Withdrawal by Subject|4|||
23558260|NCT02240108|65772422|FG001|Overall Study|Withdrawal by Subject|9|||
23558261|NCT02240108|65772421|FG000|Overall Study|StudyTerminated by Sponsor|0|||
23753688|NCT00725725|66477026|FG000|Overall Study|Adverse Event|1|||
23753689|NCT00725725|66477027|FG001|Overall Study|Adverse Event|3|||
23753690|NCT00725725|66477028|FG002|Overall Study|Adverse Event|2|||
23753691|NCT00725725|66477026|FG000|Overall Study|Lost to Follow-up|2|||
23753692|NCT00725725|66477027|FG001|Overall Study|Lost to Follow-up|0|||
23753693|NCT00725725|66477028|FG002|Overall Study|Lost to Follow-up|2|||
23753694|NCT00725725|66477026|FG000|Overall Study|Withdrawal by Subject|1|||
23753695|NCT00725725|66477027|FG001|Overall Study|Withdrawal by Subject|0|||
23753696|NCT00725725|66477028|FG002|Overall Study|Withdrawal by Subject|1|||
23753697|NCT00725725|66477026|FG000|Overall Study|Protocol Violation|0|||
23753698|NCT00725725|66477027|FG001|Overall Study|Protocol Violation|1|||
23753699|NCT00725725|66477028|FG002|Overall Study|Protocol Violation|0|||
23753700|NCT04723173|66477029|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
23753701|NCT03664024|66477032|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
23753702|NCT03664024|66477032|FG000|Overall Study|Lost to Follow-up|2|||
23753703|NCT03664024|66477032|FG000|Overall Study|Withdrawal by Subject|2|||
23753704|NCT03664024|66477032|FG000|Overall Study|Death|80|||
23753705|NCT00424515|66477035|FG000|Overall Study|Progressive Disease|10|||
23753706|NCT00424515|66477036|FG001|Overall Study|Progressive Disease|11|||
23753707|NCT00424515|66477035|FG000|Overall Study|Adverse Event|0|||
23753708|NCT00424515|66477036|FG001|Overall Study|Adverse Event|1|||
23753709|NCT00424515|66477035|FG000|Overall Study|Intercurrent Illness|0|||
23753710|NCT00424515|66477036|FG001|Overall Study|Intercurrent Illness|1|||
23753711|NCT00424515|66477035|FG000|Overall Study|Withdrawal by Subject|1|||
23753712|NCT00424515|66477036|FG001|Overall Study|Withdrawal by Subject|0|||
23753713|NCT03338673|66477040|FG000|Overall Study|Lost to Follow-up|1|||
23753714|NCT03338673|66477041|FG001|Overall Study|Lost to Follow-up|1|||
23753715|NCT00265239|66477043|FG000|Overall Study|Adverse Event|2|||
23753716|NCT00265239|66477044|FG001|Overall Study|Adverse Event|1|||
23753717|NCT03494816|66477046|FG000|Overall Study|Protocol Violation|2|||
23753718|NCT03494816|66477046|FG000|Overall Study|Physician Decision|2|||
23753719|NCT03494816|66477046|FG000|Overall Study|Did not start trial treatment|1|||
23753720|NCT03494816|66477046|FG000|Overall Study|Adverse Event|1|||
23753721|NCT01393626|66477053|FG000|Overall Study|Adverse Event|2|||
23753722|NCT01393626|66477054|FG001|Overall Study|Adverse Event|1|||
23753723|NCT01393626|66477055|FG002|Overall Study|Adverse Event|5|||
23753724|NCT01393626|66477056|FG003|Overall Study|Adverse Event|0|||
23437338|NCT02292706|65344050|FG004|Overall Study|Subject terminated by sponsor|1|||
23558262|NCT02240108|65772422|FG001|Overall Study|StudyTerminated by Sponsor|1|||
23558263|NCT02130284|65772423|FG000|Overall Study|Withdrawal by Subject|3|||
23753725|NCT01393626|66477053|FG000|Overall Study|Did not meet entrance criteria|1|||
23753726|NCT01393626|66477054|FG001|Overall Study|Did not meet entrance criteria|0|||
23753727|NCT01393626|66477055|FG002|Overall Study|Did not meet entrance criteria|0|||
23753728|NCT01393626|66477056|FG003|Overall Study|Did not meet entrance criteria|0|||
23753729|NCT01393626|66477053|FG000|Overall Study|Lack of Efficacy|6|||
23753730|NCT01393626|66477054|FG001|Overall Study|Lack of Efficacy|6|||
23753731|NCT01393626|66477055|FG002|Overall Study|Lack of Efficacy|4|||
23753732|NCT01393626|66477056|FG003|Overall Study|Lack of Efficacy|1|||
23753733|NCT01393626|66477053|FG000|Overall Study|Lost to Follow-up|1|||
23753734|NCT01393626|66477054|FG001|Overall Study|Lost to Follow-up|1|||
23753735|NCT01393626|66477055|FG002|Overall Study|Lost to Follow-up|1|||
23753736|NCT01393626|66477056|FG003|Overall Study|Lost to Follow-up|0|||
23753737|NCT01393626|66477053|FG000|Overall Study|Withdrawal by Subject|6|||
23753738|NCT01393626|66477054|FG001|Overall Study|Withdrawal by Subject|4|||
23753739|NCT01393626|66477055|FG002|Overall Study|Withdrawal by Subject|0|||
23437339|NCT02292706|65344051|FG005|Overall Study|Subject terminated by sponsor|0|||
23558264|NCT02130284|65772423|FG000|Overall Study|Subject Withdrew Consent|1|||
23558265|NCT02130284|65772423|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
23753740|NCT01393626|66477056|FG003|Overall Study|Withdrawal by Subject|0|||
23753741|NCT01393626|66477053|FG000|Overall Study|Other|1|||
23753742|NCT01393626|66477054|FG001|Overall Study|Other|0|||
23753743|NCT01393626|66477055|FG002|Overall Study|Other|0|||
23753744|NCT01393626|66477056|FG003|Overall Study|Other|0|||
23753745|NCT01393626|66477053|FG000|Overall Study|Protocol Violation|1|||
23753746|NCT01393626|66477054|FG001|Overall Study|Protocol Violation|0|||
23753747|NCT01393626|66477055|FG002|Overall Study|Protocol Violation|2|||
23753748|NCT01393626|66477056|FG003|Overall Study|Protocol Violation|0|||
23753749|NCT02989610|66477060|FG000|Overall Study|Withdrawal by Subject|20|||
23825420|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
23825421|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
23825422|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
23825423|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
23825424|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
23825425|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
23825426|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
23825427|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
23825428|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
23825429|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
23825430|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
23825431|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
23825432|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
23825433|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
23825434|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
23825435|NCT03888066|66741465|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
23825436|NCT03888066|66741466|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
23825437|NCT00946920|66741470|FG000|Overall Study|Withdrawal by Subject|28|||
23825438|NCT00946920|66741471|FG001|Overall Study|Withdrawal by Subject|15|||
23825439|NCT00946920|66741470|FG000|Overall Study|Lost to Follow-up|2|||
23825440|NCT00946920|66741471|FG001|Overall Study|Lost to Follow-up|2|||
23825441|NCT00946920|66741470|FG000|Overall Study|Physician Decision|5|||
23825442|NCT00946920|66741471|FG001|Overall Study|Physician Decision|2|||
23825443|NCT00946920|66741470|FG000|Overall Study|Adverse Event|41|||
23825444|NCT00946920|66741471|FG001|Overall Study|Adverse Event|14|||
23825445|NCT00946920|66741470|FG000|Overall Study|Protocol Violation|16|||
23825446|NCT00946920|66741471|FG001|Overall Study|Protocol Violation|8|||
23825447|NCT00946920|66741470|FG000|Overall Study|Miscellaneous reasons|18|||
23825448|NCT00946920|66741471|FG001|Overall Study|Miscellaneous reasons|3|||
23825449|NCT02431364|66741472|FG000|Overall Study|Adverse Event|0|||
23825450|NCT02431364|66741473|FG001|Overall Study|Adverse Event|1|||
23825451|NCT02431364|66741474|FG002|Overall Study|Adverse Event|0|||
23825452|NCT02431364|66741475|FG003|Overall Study|Adverse Event|0|||
23825453|NCT02431364|66741476|FG004|Overall Study|Adverse Event|0|||
23558266|NCT02130284|65772423|FG000|Overall Study|Subject was screened as backup for study|3|||
23558267|NCT02130284|65772423|FG000|Overall Study|Screen Failure|1|||
23558268|NCT02636270|65772424|FG000|Overall Study|Adverse Event|1|||
23558269|NCT02636270|65772425|FG001|Overall Study|Adverse Event|0|||
23558270|NCT02636270|65772426|FG002|Overall Study|Adverse Event|0|||
23558271|NCT02636270|65772424|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
23558272|NCT02636270|65772425|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
23558273|NCT02636270|65772426|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
23558274|NCT04225988|65772427|FG000|Overall Study|Withdrawal by Subject|2|||
23558275|NCT04225988|65772428|FG001|Overall Study|Withdrawal by Subject|0|||
23558276|NCT02569710|65772429|FG000|Overall Study|Adverse Event|1|||
23558277|NCT02569710|65772430|FG001|Overall Study|Adverse Event|0|||
23558278|NCT02569710|65772431|FG002|Overall Study|Adverse Event|0|||
23558279|NCT02569710|65772432|FG003|Overall Study|Adverse Event|0|||
23558280|NCT02569710|65772433|FG004|Overall Study|Adverse Event|0|||
23558281|NCT02569710|65772434|FG005|Overall Study|Adverse Event|0|||
23558282|NCT02569710|65772435|FG006|Overall Study|Adverse Event|0|||
23558283|NCT02569710|65772436|FG007|Overall Study|Adverse Event|0|||
23558284|NCT02569710|65772437|FG008|Overall Study|Adverse Event|0|||
23558285|NCT02569710|65772438|FG009|Overall Study|Adverse Event|0|||
23558286|NCT02569710|65772429|FG000|Overall Study|Lost to Follow-up|0|||
23558287|NCT02569710|65772430|FG001|Overall Study|Lost to Follow-up|0|||
23558288|NCT02569710|65772431|FG002|Overall Study|Lost to Follow-up|0|||
23558289|NCT02569710|65772432|FG003|Overall Study|Lost to Follow-up|0|||
23558290|NCT02569710|65772433|FG004|Overall Study|Lost to Follow-up|0|||
23558291|NCT02569710|65772434|FG005|Overall Study|Lost to Follow-up|0|||
23558292|NCT02569710|65772435|FG006|Overall Study|Lost to Follow-up|1|||
23558293|NCT02569710|65772436|FG007|Overall Study|Lost to Follow-up|0|||
23558294|NCT02569710|65772437|FG008|Overall Study|Lost to Follow-up|1|||
23558295|NCT02569710|65772438|FG009|Overall Study|Lost to Follow-up|0|||
23558296|NCT02569710|65772429|FG000|Overall Study|Virologic failure|0|||
23558297|NCT02569710|65772430|FG001|Overall Study|Virologic failure|0|||
23558298|NCT02569710|65772431|FG002|Overall Study|Virologic failure|0|||
23558299|NCT02569710|65772432|FG003|Overall Study|Virologic failure|0|||
23558300|NCT02569710|65772433|FG004|Overall Study|Virologic failure|1|||
23558301|NCT02569710|65772434|FG005|Overall Study|Virologic failure|0|||
23558302|NCT02569710|65772435|FG006|Overall Study|Virologic failure|1|||
23825454|NCT02431364|66741472|FG000|Overall Study|Randomized but never treated|0|||
23558303|NCT02569710|65772436|FG007|Overall Study|Virologic failure|0|||
23623849|NCT00632931|66008590|FG001|Part 2|Lack of Efficacy|0|||
23623850|NCT00632931|66008591|FG002|Part 2|Lack of Efficacy|17|||
23623851|NCT00632931|66008589|FG000|Part 2|Withdrawal by Subject|0|||
23623852|NCT00632931|66008590|FG001|Part 2|Withdrawal by Subject|0|||
23623853|NCT00632931|66008591|FG002|Part 2|Withdrawal by Subject|3|||
23623854|NCT02826798|66008592|FG000|Overall Study|Withdrawal by Subject|0|||
23623855|NCT02826798|66008593|FG001|Overall Study|Withdrawal by Subject|1|||
23623856|NCT02826798|66008594|FG002|Overall Study|Withdrawal by Subject|0|||
23623857|NCT02826798|66008595|FG003|Overall Study|Withdrawal by Subject|1|||
23623858|NCT02826798|66008596|FG004|Overall Study|Withdrawal by Subject|0|||
23623859|NCT00506922|66011464|FG000|Overall Study|Physician Decision|0|||
23623860|NCT00506922|66011465|FG001|Overall Study|Physician Decision|0|||
23623861|NCT00506922|66011466|FG002|Overall Study|Physician Decision|0|||
23623862|NCT00506922|66011467|FG003|Overall Study|Physician Decision|2|||
23623863|NCT00506922|66011468|FG004|Overall Study|Physician Decision|0|||
23623864|NCT00506922|66011464|FG000|Overall Study|Withdrawal by Subject|0|||
23623865|NCT00506922|66011465|FG001|Overall Study|Withdrawal by Subject|0|||
23623866|NCT00506922|66011466|FG002|Overall Study|Withdrawal by Subject|0|||
23623867|NCT00506922|66011467|FG003|Overall Study|Withdrawal by Subject|0|||
23623868|NCT00506922|66011468|FG004|Overall Study|Withdrawal by Subject|1|||
23623869|NCT01268098|66011476|FG000|Overall Study|Adverse Event|1|||
23623870|NCT01268098|66011477|FG001|Overall Study|Adverse Event|0|||
23623871|NCT02741713|66011478|FG000|Overall Study|Surgery type changed intra-operatively|2|||
23623872|NCT02741713|66011479|FG001|Overall Study|Surgery type changed intra-operatively|1|||
23623873|NCT00887198|66011481|FG000|Randomized Period|Ongoing|42|||
23558304|NCT02569710|65772437|FG008|Overall Study|Virologic failure|0|||
23558305|NCT02569710|65772438|FG009|Overall Study|Virologic failure|0|||
23558306|NCT02569710|65772429|FG000|Overall Study|Withdrawal by Subject|0|||
23558307|NCT02569710|65772430|FG001|Overall Study|Withdrawal by Subject|0|||
23558308|NCT02569710|65772431|FG002|Overall Study|Withdrawal by Subject|0|||
23558309|NCT02569710|65772432|FG003|Overall Study|Withdrawal by Subject|0|||
23623874|NCT00887198|66011482|FG001|Randomized Period|Ongoing|0|||
23623875|NCT00887198|66011483|FG002|Randomized Period|Ongoing|0|||
23753750|NCT02989610|66477060|FG000|Overall Study|Departure of PI from Site|8|||
23753751|NCT02989610|66477060|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
23753752|NCT02989610|66477060|FG000|Overall Study|Lost to Follow-up|3|||
23753753|NCT02989610|66477060|FG000|Overall Study|Death|3|||
23753754|NCT02989610|66477060|FG000|Overall Study|System Explant|3|||
23753755|NCT02989610|66477060|FG000|Overall Study|Subject Non-Compliance|2|||
23753756|NCT02989610|66477060|FG000|Overall Study|System Revision|2|||
23753757|NCT02989610|66477060|FG000|Overall Study|PI Left, Study Closing|1|||
23753758|NCT02989610|66477060|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
23753759|NCT02989610|66477060|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
23753760|NCT03575325|66477061|FG000|Overall Study|Death|1|||
23753761|NCT00874757|66477062|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
23753762|NCT01508325|66477063|FG000|Overall Study|Withdrawal by Subject|8|||
23558310|NCT02569710|65772433|FG004|Overall Study|Withdrawal by Subject|0|||
23623876|NCT00887198|66011481|FG000|Randomized Period|Adverse Event|50|||
23623877|NCT00887198|66011482|FG001|Randomized Period|Adverse Event|33|||
23623878|NCT00887198|66011483|FG002|Randomized Period|Adverse Event|0|||
23623879|NCT00887198|66011481|FG000|Randomized Period|Lost to Follow-up|1|||
23623880|NCT00887198|66011482|FG001|Randomized Period|Lost to Follow-up|0|||
23753763|NCT01508325|66477064|FG001|Overall Study|Withdrawal by Subject|9|||
23753764|NCT01508325|66477063|FG000|Overall Study|Protocol Violation|0|||
23753765|NCT01508325|66477064|FG001|Overall Study|Protocol Violation|3|||
23753766|NCT01508325|66477063|FG000|Overall Study|Physician Decision|2|||
23753767|NCT01508325|66477064|FG001|Overall Study|Physician Decision|1|||
23753768|NCT01508325|66477063|FG000|Overall Study|Adverse Event|1|||
23753769|NCT01508325|66477064|FG001|Overall Study|Adverse Event|0|||
23753770|NCT01508325|66477063|FG000|Overall Study|Lost to Follow-up|5|||
23558311|NCT02569710|65772434|FG005|Overall Study|Withdrawal by Subject|1|||
23558312|NCT02569710|65772435|FG006|Overall Study|Withdrawal by Subject|0|||
23558313|NCT02569710|65772436|FG007|Overall Study|Withdrawal by Subject|0|||
23558314|NCT02569710|65772437|FG008|Overall Study|Withdrawal by Subject|0|||
23558315|NCT02569710|65772438|FG009|Overall Study|Withdrawal by Subject|0|||
23558316|NCT01971723|65772439|FG000|Overall Study|Withdrawal by Subject|1|||
23558317|NCT01971723|65772440|FG001|Overall Study|Withdrawal by Subject|1|||
23558318|NCT01971723|65772439|FG000|Overall Study|Protocol Violation|1|||
23558319|NCT01971723|65772440|FG001|Overall Study|Protocol Violation|2|||
23623881|NCT00887198|66011483|FG002|Randomized Period|Lost to Follow-up|0|||
23623882|NCT00887198|66011481|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
23623883|NCT00887198|66011482|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
23623884|NCT00887198|66011483|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
23623885|NCT00887198|66011481|FG000|Randomized Period|Withdrawal by Subject|41|||
23623886|NCT00887198|66011482|FG001|Randomized Period|Withdrawal by Subject|56|||
23623887|NCT00887198|66011483|FG002|Randomized Period|Withdrawal by Subject|0|||
23558320|NCT00593567|65772443|FG000|Overall Study|Adverse Event|2|||
23558321|NCT00593567|65772444|FG001|Overall Study|Adverse Event|0|||
23558322|NCT00593567|65772443|FG000|Overall Study|Physician Decision|2|||
23558323|NCT00593567|65772444|FG001|Overall Study|Physician Decision|0|||
23558324|NCT00593567|65772443|FG000|Overall Study|Protocol Violation|13|||
23558325|NCT00593567|65772444|FG001|Overall Study|Protocol Violation|7|||
23558326|NCT00593567|65772443|FG000|Overall Study|Lack of Efficacy|2|||
23558327|NCT00593567|65772444|FG001|Overall Study|Lack of Efficacy|1|||
23558328|NCT00593567|65772443|FG000|Overall Study|Withdrawal by Subject|1|||
23558329|NCT00593567|65772444|FG001|Overall Study|Withdrawal by Subject|2|||
23558330|NCT02220894|65772445|FG000|Overall Study|Adverse Event|127|||
23558331|NCT02220894|65772446|FG001|Overall Study|Adverse Event|74|||
23558332|NCT02220894|65772445|FG000|Overall Study|Death|418|||
23558333|NCT02220894|65772446|FG001|Overall Study|Death|508|||
23558334|NCT02220894|65772445|FG000|Overall Study|Lost to Follow-up|0|||
23558335|NCT02220894|65772446|FG001|Overall Study|Lost to Follow-up|4|||
23558336|NCT02220894|65772445|FG000|Overall Study|Site Terminated by Sponsor|2|||
23558337|NCT02220894|65772446|FG001|Overall Study|Site Terminated by Sponsor|0|||
23558338|NCT02220894|65772445|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
23558339|NCT02220894|65772446|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
23558340|NCT02220894|65772445|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23558341|NCT02220894|65772446|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23558342|NCT02220894|65772445|FG000|Overall Study|Withdrawal by Subject|10|||
23558343|NCT02220894|65772446|FG001|Overall Study|Withdrawal by Subject|9|||
23558344|NCT00538590|65772448|FG000|Overall Study|Death|1|||
23558345|NCT00538590|65772449|FG001|Overall Study|Death|0|||
23753771|NCT01508325|66477064|FG001|Overall Study|Lost to Follow-up|6|||
23753772|NCT01508325|66477063|FG000|Overall Study|Other|2|||
23753773|NCT01508325|66477064|FG001|Overall Study|Other|2|||
23753774|NCT01248130|66477067|FG000|Overall Study|Protocol Violation|1|||
23753775|NCT01248130|66477068|FG001|Overall Study|Protocol Violation|0|||
23753776|NCT01248130|66477067|FG000|Overall Study|Ineligible|1|||
23558346|NCT00844857|65772453|FG000|Overall Study|Adverse Event|24|||
23558347|NCT00844857|65772454|FG001|Overall Study|Adverse Event|5|||
23558348|NCT00844857|65772453|FG000|Overall Study|Sponsor Decision|1|||
23558349|NCT00844857|65772454|FG001|Overall Study|Sponsor Decision|1|||
23753777|NCT01248130|66477068|FG001|Overall Study|Ineligible|0|||
23753778|NCT00996632|66477069|FG000|Overall Study|Physician Decision|0|||
23753779|NCT00996632|66477070|FG001|Overall Study|Physician Decision|0|||
23753780|NCT00577031|66477079|FG000|Overall Study|Adverse Event|52|||
23753781|NCT00577031|66477079|FG000|Overall Study|Progression of disease|93|||
23558350|NCT00844857|65772453|FG000|Overall Study|Physician Decision|2|||
23558351|NCT00844857|65772454|FG001|Overall Study|Physician Decision|0|||
23753782|NCT00577031|66477079|FG000|Overall Study|Protocol Violation|5|||
23753783|NCT00577031|66477079|FG000|Overall Study|Participant withdrew consent|13|||
23753784|NCT00577031|66477079|FG000|Overall Study|Participant non-compliance|5|||
23753785|NCT00577031|66477079|FG000|Overall Study|Need for surgery|17|||
23753786|NCT00577031|66477079|FG000|Overall Study|Medical decision|14|||
23753787|NCT00577031|66477079|FG000|Overall Study|Death|6|||
23753788|NCT04311411|66477080|FG000|Overall Study|Adverse Event|2|||
23753789|NCT04311411|66477081|FG001|Overall Study|Adverse Event|3|||
23753790|NCT04311411|66477082|FG002|Overall Study|Adverse Event|2|||
23558352|NCT00844857|65772453|FG000|Overall Study|Parent/Caregiver Decision|6|||
23558353|NCT00844857|65772454|FG001|Overall Study|Parent/Caregiver Decision|2|||
23753791|NCT04311411|66477080|FG000|Overall Study|Withdrawal by Subject|3|||
23558354|NCT00844857|65772453|FG000|Overall Study|Withdrawal by Subject|8|||
23558355|NCT00844857|65772454|FG001|Overall Study|Withdrawal by Subject|7|||
23558356|NCT00844857|65772453|FG000|Overall Study|Protocol Violation|6|||
23558357|NCT00844857|65772454|FG001|Overall Study|Protocol Violation|0|||
23753792|NCT04311411|66477081|FG001|Overall Study|Withdrawal by Subject|3|||
23623888|NCT00887198|66011481|FG000|Randomized Period|Progressive disease|366|||
23623889|NCT00887198|66011482|FG001|Randomized Period|Progressive disease|370|||
23623890|NCT00887198|66011483|FG002|Randomized Period|Progressive disease|0|||
23623891|NCT00887198|66011481|FG000|Randomized Period|Other|42|||
23623892|NCT00887198|66011482|FG001|Randomized Period|Other|30|||
23623893|NCT00887198|66011483|FG002|Randomized Period|Other|0|||
23623894|NCT00887198|66011481|FG000|Randomized Period|Randomized, Not treated|4|||
23623895|NCT00887198|66011482|FG001|Randomized Period|Randomized, Not treated|2|||
23623896|NCT00887198|66011483|FG002|Randomized Period|Randomized, Not treated|0|||
23623897|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
23623898|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
23623899|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
23623900|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
23623901|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
23623902|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
23623903|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
23623904|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
23623905|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
23623906|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
23623907|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
23623908|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
23623909|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
23623910|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
23623911|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
23623912|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Other|0|||
23623913|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Other|0|||
23623914|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Other|19|||
23558358|NCT00844857|65772453|FG000|Overall Study|Lack of Efficacy|5|||
23623915|NCT01588366|66011490|FG000|Overall Study|Adverse Event|0|||
23623916|NCT01588366|66011491|FG001|Overall Study|Adverse Event|1|||
23558359|NCT00844857|65772454|FG001|Overall Study|Lack of Efficacy|5|||
23558360|NCT00844857|65772453|FG000|Overall Study|Clinical Relapse|0|||
23558361|NCT00844857|65772454|FG001|Overall Study|Clinical Relapse|1|||
23558362|NCT00844857|65772453|FG000|Overall Study|Entry Criteria Not Met|0|||
23558363|NCT00844857|65772454|FG001|Overall Study|Entry Criteria Not Met|1|||
23558364|NCT00844857|65772453|FG000|Overall Study|Lost to Follow-up|2|||
23558365|NCT00844857|65772454|FG001|Overall Study|Lost to Follow-up|3|||
23558366|NCT00844857|65772453|FG000|Overall Study|Did Not Take Study Drug|3|||
23558367|NCT00844857|65772454|FG001|Overall Study|Did Not Take Study Drug|1|||
23558368|NCT00844857|65772453|FG000|Overall Study|Good Clinical Practice Violations|21|||
23558369|NCT00844857|65772454|FG001|Overall Study|Good Clinical Practice Violations|11|||
23558370|NCT02403180|65772455|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
23558371|NCT02403180|65772456|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
23558372|NCT02403180|65772455|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
23558373|NCT02403180|65772456|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
23558374|NCT00105235|65772459|FG000|Overall Study|Death|4|||
23558375|NCT00105235|65772459|FG000|Overall Study|Physician Decision|1|||
23558376|NCT00105235|65772459|FG000|Overall Study|Withdrawal by Subject|2|||
23558377|NCT03224182|65772468|FG000|Overall Study|Study Drug Not Instilled|6|||
23558378|NCT03224182|65772469|FG001|Overall Study|Study Drug Not Instilled|1|||
23558379|NCT03224182|65772468|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
23558380|NCT03224182|65772469|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
23558381|NCT03224182|65772468|FG000|Overall Study|Withdrew of Consent|4|||
23558382|NCT03224182|65772469|FG001|Overall Study|Withdrew of Consent|2|||
23558383|NCT03224182|65772468|FG000|Overall Study|Investigator Decision|3|||
23558384|NCT03224182|65772469|FG001|Overall Study|Investigator Decision|1|||
23558385|NCT03224182|65772468|FG000|Overall Study|Sponsor Decision|26|||
23558386|NCT03224182|65772469|FG001|Overall Study|Sponsor Decision|12|||
23623917|NCT01588366|66011492|FG002|Overall Study|Adverse Event|0|||
23623918|NCT01588366|66011493|FG003|Overall Study|Adverse Event|1|||
23623919|NCT01588366|66011494|FG004|Overall Study|Adverse Event|0|||
23558387|NCT03224182|65772468|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
23558388|NCT03224182|65772469|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
23558389|NCT03224182|65772468|FG000|Overall Study|Lost to Follow-up|1|||
23558390|NCT03224182|65772469|FG001|Overall Study|Lost to Follow-up|0|||
23558391|NCT03224182|65772468|FG000|Overall Study|Participant Had Recurrence|11|||
23623920|NCT01588366|66011495|FG005|Overall Study|Adverse Event|2|||
23623921|NCT02104505|66011498|FG000|First Intervention (14 Days)|Adverse Event|2|||
23623922|NCT02104505|66011499|FG001|First Intervention (14 Days)|Adverse Event|0|||
23623923|NCT02104505|66011498|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
23623924|NCT02104505|66011499|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
23623925|NCT02104505|66011498|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
23825455|NCT02431364|66741473|FG001|Overall Study|Randomized but never treated|0|||
23753793|NCT04311411|66477082|FG002|Overall Study|Withdrawal by Subject|0|||
23753794|NCT00656019|66477083|FG000|Overall Study|Not Eligible|10|||
23753795|NCT00656019|66477084|FG001|Overall Study|Not Eligible|0|||
23753796|NCT00656019|66477085|FG002|Overall Study|Not Eligible|0|||
23753797|NCT00656019|66477086|FG003|Overall Study|Not Eligible|0|||
23753798|NCT00656019|66477083|FG000|Overall Study|Withdrawal by Subject|2|||
23753799|NCT00656019|66477084|FG001|Overall Study|Withdrawal by Subject|0|||
23753800|NCT00656019|66477085|FG002|Overall Study|Withdrawal by Subject|0|||
23753801|NCT00656019|66477086|FG003|Overall Study|Withdrawal by Subject|0|||
23753802|NCT00656019|66477083|FG000|Overall Study|Lost to Follow-up|2|||
23753803|NCT00656019|66477084|FG001|Overall Study|Lost to Follow-up|1|||
23753804|NCT00656019|66477085|FG002|Overall Study|Lost to Follow-up|0|||
23753805|NCT00656019|66477086|FG003|Overall Study|Lost to Follow-up|0|||
23753806|NCT00560573|66477087|FG000|Overall Study|Death|4|||
23753807|NCT00560573|66477088|FG001|Overall Study|Death|1|||
23753808|NCT00560573|66477089|FG002|Overall Study|Death|4|||
23753809|NCT00560573|66477090|FG003|Overall Study|Death|5|||
23753810|NCT00560573|66477091|FG004|Overall Study|Death|1|||
23753811|NCT00560573|66477092|FG005|Overall Study|Death|10|||
23753812|NCT00560573|66477087|FG000|Overall Study|Lost to Follow-up|0|||
23753813|NCT00560573|66477088|FG001|Overall Study|Lost to Follow-up|0|||
23753814|NCT00560573|66477089|FG002|Overall Study|Lost to Follow-up|0|||
23753815|NCT00560573|66477090|FG003|Overall Study|Lost to Follow-up|1|||
23753816|NCT00560573|66477091|FG004|Overall Study|Lost to Follow-up|1|||
23753817|NCT00560573|66477092|FG005|Overall Study|Lost to Follow-up|0|||
23753818|NCT00560573|66477087|FG000|Overall Study|Withdrawal by Subject|0|||
23753819|NCT00560573|66477088|FG001|Overall Study|Withdrawal by Subject|0|||
23753820|NCT00560573|66477089|FG002|Overall Study|Withdrawal by Subject|0|||
23753821|NCT00560573|66477090|FG003|Overall Study|Withdrawal by Subject|1|||
23753822|NCT00560573|66477091|FG004|Overall Study|Withdrawal by Subject|1|||
23753823|NCT00560573|66477092|FG005|Overall Study|Withdrawal by Subject|0|||
23753824|NCT00560573|66477087|FG000|Overall Study|Other|2|||
23753825|NCT00560573|66477088|FG001|Overall Study|Other|2|||
23753826|NCT00560573|66477089|FG002|Overall Study|Other|2|||
23753827|NCT00560573|66477090|FG003|Overall Study|Other|3|||
23753828|NCT00560573|66477091|FG004|Overall Study|Other|3|||
23753829|NCT00560573|66477092|FG005|Overall Study|Other|3|||
23753830|NCT00560573|66477087|FG000|Overall Study|Enrolled, not treated|0|||
23753831|NCT00560573|66477088|FG001|Overall Study|Enrolled, not treated|0|||
23753832|NCT00560573|66477089|FG002|Overall Study|Enrolled, not treated|0|||
23753833|NCT00560573|66477090|FG003|Overall Study|Enrolled, not treated|0|||
23753834|NCT00560573|66477091|FG004|Overall Study|Enrolled, not treated|1|||
23753835|NCT00560573|66477092|FG005|Overall Study|Enrolled, not treated|0|||
23753836|NCT03255226|66477093|FG000|Overall Study|Adverse Event|2|||
23753837|NCT03255226|66477093|FG000|Overall Study|Physician Decision|3|||
23753838|NCT03255226|66477093|FG000|Overall Study|Withdrawal by Subject|1|||
23753839|NCT03255226|66477093|FG000|Overall Study|Serum or blood sodium increased|4|||
23753840|NCT03255226|66477093|FG000|Overall Study|Serum or blood potassium increased|4|||
23753841|NCT02453282|66477100|FG000|Overall Study|Death|275|||
23753842|NCT02453282|66477101|FG001|Overall Study|Death|277|||
23558392|NCT03224182|65772469|FG001|Overall Study|Participant Had Recurrence|5|||
23558393|NCT03224182|65772468|FG000|Overall Study|Death|0|||
23558394|NCT03224182|65772469|FG001|Overall Study|Death|1|||
23558395|NCT03224182|65772468|FG000|Overall Study|Reason not Specified|3|||
23558396|NCT03224182|65772469|FG001|Overall Study|Reason not Specified|3|||
23558397|NCT03224182|65772468|FG000|Overall Study|Other|1|||
23558398|NCT03224182|65772469|FG001|Overall Study|Other|0|||
23558399|NCT03021668|65772470|FG000|Overall Study|Physician Decision|0|||
23558400|NCT03021668|65772471|FG001|Overall Study|Physician Decision|1|||
23558401|NCT02054806|65772474|FG000|Overall Study|Sponsor Decision|31|||
23558402|NCT02054806|65772474|FG000|Overall Study|Withdrawal by Subject|43|||
23623926|NCT02104505|66011499|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
23623927|NCT02104505|66011498|FG000|First Intervention (14 Days)|exclusionary condition|0|||
23753843|NCT02453282|66477102|FG002|Overall Study|Death|296|||
23753844|NCT02453282|66477100|FG000|Overall Study|Lost to Follow-up|1|||
23753845|NCT02453282|66477101|FG001|Overall Study|Lost to Follow-up|0|||
23753846|NCT02453282|66477102|FG002|Overall Study|Lost to Follow-up|2|||
23753847|NCT02453282|66477100|FG000|Overall Study|Withdrawal by Subject|12|||
23753848|NCT02453282|66477101|FG001|Overall Study|Withdrawal by Subject|10|||
23753849|NCT02453282|66477102|FG002|Overall Study|Withdrawal by Subject|11|||
23558403|NCT02054806|65772474|FG000|Overall Study|Protocol Violation|2|||
23753850|NCT02453282|66477100|FG000|Overall Study|Participants ongoing at data cut-off|85|||
23753851|NCT02453282|66477101|FG001|Overall Study|Participants ongoing at data cut-off|84|||
23753852|NCT02453282|66477102|FG002|Overall Study|Participants ongoing at data cut-off|62|||
23753853|NCT02453282|66477100|FG000|Overall Study|Other|1|||
23753854|NCT02453282|66477101|FG001|Overall Study|Other|1|||
23753855|NCT02453282|66477102|FG002|Overall Study|Other|1|||
23558404|NCT02054806|65772474|FG000|Overall Study|Lost to Follow-up|10|||
23558405|NCT02054806|65772474|FG000|Overall Study|Death|391|||
23558406|NCT01114204|65772475|FG000|Overall Study|Adverse Event|3|||
23558407|NCT01114204|65772476|FG001|Overall Study|Adverse Event|2|||
23558408|NCT01114204|65772475|FG000|Overall Study|Lost to Follow-up|1|||
23558409|NCT01114204|65772476|FG001|Overall Study|Lost to Follow-up|0|||
23558410|NCT01114204|65772475|FG000|Overall Study|Withdrawal by Subject|10|||
23558411|NCT01114204|65772476|FG001|Overall Study|Withdrawal by Subject|6|||
23558412|NCT01114204|65772475|FG000|Overall Study|Death|1|||
23558413|NCT01114204|65772476|FG001|Overall Study|Death|0|||
23558414|NCT01114204|65772475|FG000|Overall Study|Other-Personal reasons|2|||
23558415|NCT01114204|65772476|FG001|Overall Study|Other-Personal reasons|0|||
23558416|NCT01114204|65772475|FG000|Overall Study|Other-Medical monitor request|1|||
23558417|NCT01114204|65772476|FG001|Overall Study|Other-Medical monitor request|0|||
23558418|NCT01114204|65772475|FG000|Overall Study|Other-Participant request|2|||
23558419|NCT01114204|65772476|FG001|Overall Study|Other-Participant request|0|||
23558420|NCT01114204|65772475|FG000|Overall Study|Other-Protocol Violation|1|||
23558421|NCT01114204|65772476|FG001|Overall Study|Other-Protocol Violation|0|||
23558422|NCT01445652|65772477|FG000|Overall Study|Not comfortable in lenses|5|||
23558423|NCT01445652|65772478|FG001|Overall Study|Not comfortable in lenses|0|||
23558424|NCT01445652|65772477|FG000|Overall Study|Failed to attend scheduled visit|2|||
23558425|NCT01445652|65772478|FG001|Overall Study|Failed to attend scheduled visit|3|||
23558426|NCT01445652|65772477|FG000|Overall Study|Failed teach session|2|||
23558427|NCT01445652|65772478|FG001|Overall Study|Failed teach session|0|||
23558428|NCT01445652|65772477|FG000|Overall Study|Adverse Event|1|||
23558429|NCT01445652|65772478|FG001|Overall Study|Adverse Event|0|||
23558430|NCT03286751|65772480|FG000|Washout Period 1|Withdrawal by Subject|0|||
23558431|NCT03286751|65772481|FG001|Washout Period 1|Withdrawal by Subject|0|||
23558432|NCT03286751|65772482|FG002|Washout Period 1|Withdrawal by Subject|0|||
23558433|NCT03286751|65772483|FG003|Washout Period 1|Withdrawal by Subject|0|||
23558434|NCT03286751|65772484|FG004|Washout Period 1|Withdrawal by Subject|1|||
23558435|NCT03286751|65772485|FG005|Washout Period 1|Withdrawal by Subject|0|||
23558436|NCT03286751|65772480|FG000|Washout Period 2|Personal Reasons|0|||
23558437|NCT03286751|65772481|FG001|Washout Period 2|Personal Reasons|1|||
23558438|NCT03286751|65772482|FG002|Washout Period 2|Personal Reasons|0|||
23558439|NCT03286751|65772483|FG003|Washout Period 2|Personal Reasons|0|||
23558440|NCT03286751|65772484|FG004|Washout Period 2|Personal Reasons|0|||
23558441|NCT03286751|65772485|FG005|Washout Period 2|Personal Reasons|0|||
23558442|NCT03286751|65772480|FG000|Washout Period 5|Adverse Event|0|||
23558443|NCT03286751|65772481|FG001|Washout Period 5|Adverse Event|0|||
23558444|NCT03286751|65772482|FG002|Washout Period 5|Adverse Event|0|||
23558445|NCT03286751|65772483|FG003|Washout Period 5|Adverse Event|0|||
23558446|NCT03286751|65772484|FG004|Washout Period 5|Adverse Event|1|||
23558447|NCT03286751|65772485|FG005|Washout Period 5|Adverse Event|0|||
23558448|NCT01591382|65772495|FG000|Overall Study|Discharged Prior to Study Completion|2|||
23558449|NCT01591382|65772496|FG001|Overall Study|Discharged Prior to Study Completion|1|||
23558450|NCT01591382|65772495|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
23558451|NCT01591382|65772496|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
23558452|NCT01982435|65772497|FG000|Overall Study|Adverse Event|1|||
23558453|NCT01982435|65772498|FG001|Overall Study|Adverse Event|0|||
23558454|NCT01654601|65772499|FG000|1st Administration|Withdrawal by Subject|2|||
23558455|NCT01654601|65772500|FG001|1st Administration|Withdrawal by Subject|0|||
23558456|NCT01654601|65772499|FG000|1st Administration|Protocol Violation|0|||
23753856|NCT01965431|66477103|FG000|Overall Study|Adverse Event|0|||
23558457|NCT01654601|65772500|FG001|1st Administration|Protocol Violation|2|||
23558458|NCT01654601|65772499|FG000|2nd Administration|Adverse Event|1|||
23558459|NCT01654601|65772500|FG001|2nd Administration|Adverse Event|0|||
23558460|NCT01654601|65772499|FG000|2nd Administration|Protocol Violation|0|||
23753857|NCT01965431|66477104|FG001|Overall Study|Adverse Event|1|||
23623928|NCT02104505|66011499|FG001|First Intervention (14 Days)|exclusionary condition|1|||
23623929|NCT02104505|66011498|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23623930|NCT02104505|66011499|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23623931|NCT02104505|66011498|FG000|Second Intervention (14 Days)|Adverse Event|2|||
23623932|NCT02104505|66011499|FG001|Second Intervention (14 Days)|Adverse Event|0|||
23558461|NCT01654601|65772500|FG001|2nd Administration|Protocol Violation|1|||
23558462|NCT03419364|65772501|FG000|Overall Study|Delivery due to maternal condition|2|||
23558463|NCT03419364|65772502|FG001|Overall Study|Delivery due to maternal condition|0|||
23558464|NCT03419364|65772503|FG002|Overall Study|Delivery due to maternal condition|0|||
23558465|NCT00587964|65772505|FG000|Overall Study|Withdrawal by Subject|1|||
23558466|NCT00587964|65772505|FG000|Overall Study|Lost to Follow-up|1|||
23558467|NCT00587964|65772505|FG000|Overall Study|Patient found to be ineligible|1|||
23558468|NCT00587964|65772505|FG000|Overall Study|Patient did not receive intervention|5|||
23558469|NCT00587964|65772505|FG000|Overall Study|Progression of Disease|4|||
23558470|NCT03295318|65772506|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
23558471|NCT03295318|65772507|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
23558472|NCT03295318|65772508|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
23558473|NCT03295318|65772506|FG000|Overall Study|Death|1|||
23558474|NCT03295318|65772507|FG001|Overall Study|Death|1|||
23558475|NCT03295318|65772508|FG002|Overall Study|Death|1|||
23558476|NCT03295318|65772506|FG000|Overall Study|Protocol Violation|4|||
23558477|NCT03295318|65772507|FG001|Overall Study|Protocol Violation|3|||
23558478|NCT03295318|65772508|FG002|Overall Study|Protocol Violation|3|||
23558479|NCT03295318|65772506|FG000|Overall Study|Withdrawal by Subject|0|||
23558480|NCT03295318|65772507|FG001|Overall Study|Withdrawal by Subject|0|||
23558481|NCT03295318|65772508|FG002|Overall Study|Withdrawal by Subject|1|||
23623933|NCT01797562|66011502|FG000|Overall Study|Protocol Violation|5|||
23623934|NCT00469456|66011503|FG000|Overall Study|Adverse Event|4|||
23623935|NCT00469456|66011504|FG001|Overall Study|Adverse Event|3|||
23623936|NCT00469456|66011503|FG000|Overall Study|Protocol Violation|1|||
23623937|NCT00469456|66011504|FG001|Overall Study|Protocol Violation|0|||
23623938|NCT00469456|66011503|FG000|Overall Study|Withdrawal by Subject|4|||
23623939|NCT00469456|66011504|FG001|Overall Study|Withdrawal by Subject|1|||
23623940|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
23623941|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
23623942|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
23623943|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
23623944|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
23623945|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
23623946|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
23753858|NCT01965431|66477105|FG002|Overall Study|Adverse Event|0|||
23753859|NCT01965431|66477106|FG003|Overall Study|Adverse Event|0|||
23753860|NCT01965431|66477107|FG004|Overall Study|Adverse Event|0|||
23753861|NCT01965431|66477108|FG005|Overall Study|Adverse Event|0|||
23753862|NCT01965431|66477103|FG000|Overall Study|Other than stated above|6|||
23753863|NCT01965431|66477104|FG001|Overall Study|Other than stated above|5|||
23753864|NCT01965431|66477105|FG002|Overall Study|Other than stated above|6|||
23437340|NCT02292706|65344052|FG006|Overall Study|Subject terminated by sponsor|0|||
23437341|NCT02292706|65344053|FG007|Overall Study|Subject terminated by sponsor|0|||
23437342|NCT02292706|65344046|FG000|Overall Study|Missing|0|||
23437343|NCT02292706|65344047|FG001|Overall Study|Missing|0|||
23558482|NCT03295318|65772506|FG000|Overall Study|Subject discontinued due to travel|0|||
23623947|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
23623948|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
23623949|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
23623950|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
23753865|NCT01965431|66477106|FG003|Overall Study|Other than stated above|6|||
23753866|NCT01965431|66477107|FG004|Overall Study|Other than stated above|6|||
23753867|NCT01965431|66477108|FG005|Overall Study|Other than stated above|6|||
23753868|NCT00965263|66477109|FG000|Overall Study|Physician Decision|2|||
23558483|NCT03295318|65772507|FG001|Overall Study|Subject discontinued due to travel|1|||
23558484|NCT03295318|65772508|FG002|Overall Study|Subject discontinued due to travel|0|||
23558485|NCT00118716|65772514|FG000|Overall Study|Adverse Event|2|||
23558486|NCT00118716|65772515|FG001|Overall Study|Adverse Event|7|||
23558487|NCT00118716|65772514|FG000|Overall Study|Protocol Violation|5|||
23558488|NCT00118716|65772515|FG001|Overall Study|Protocol Violation|4|||
23558489|NCT00118716|65772514|FG000|Overall Study|Withdrawal by Subject|0|||
23558490|NCT00118716|65772515|FG001|Overall Study|Withdrawal by Subject|1|||
23437344|NCT02292706|65344048|FG002|Overall Study|Missing|1|||
23437345|NCT02292706|65344049|FG003|Overall Study|Missing|1|||
23558491|NCT00118716|65772514|FG000|Overall Study|Exacerbation|2|||
23558492|NCT00118716|65772515|FG001|Overall Study|Exacerbation|2|||
23623951|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
23437346|NCT02292706|65344050|FG004|Overall Study|Missing|0|||
23753869|NCT00965263|66477110|FG001|Overall Study|Physician Decision|0|||
23753870|NCT00965263|66477109|FG000|Overall Study|Family emergency|0|||
23753871|NCT00965263|66477110|FG001|Overall Study|Family emergency|1|||
23753872|NCT00965263|66477109|FG000|Overall Study|Protocol Violation|0|||
23753873|NCT00965263|66477110|FG001|Overall Study|Protocol Violation|2|||
23753874|NCT02602080|66477111|FG000|Overall Study|Protocol Violation|6|||
23753875|NCT02602080|66477112|FG001|Overall Study|Protocol Violation|1|||
23753876|NCT02602080|66477113|FG002|Overall Study|Protocol Violation|3|||
23753877|NCT03402126|66477114|FG000|Overall Study|Lost to Follow-up|6|||
23558493|NCT00118716|65772514|FG000|Overall Study|Discontinued by sponsor|1|||
23558494|NCT00118716|65772515|FG001|Overall Study|Discontinued by sponsor|1|||
23558495|NCT00118716|65772514|FG000|Overall Study|Non-compliance|1|||
23558496|NCT00118716|65772515|FG001|Overall Study|Non-compliance|3|||
23558497|NCT00118716|65772514|FG000|Overall Study|misrandomized|1|||
23558498|NCT00118716|65772515|FG001|Overall Study|misrandomized|1|||
23558499|NCT00118716|65772514|FG000|Overall Study|Expired drug use|1|||
23558500|NCT00118716|65772515|FG001|Overall Study|Expired drug use|2|||
23558501|NCT00118716|65772514|FG000|Overall Study|Investigator discretion|0|||
23623952|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
23753878|NCT03402126|66477114|FG000|Overall Study|Protocol Violation|10|||
23753879|NCT03402126|66477114|FG000|Overall Study|Sponsor request/Study termination|29|||
23753880|NCT03402126|66477114|FG000|Overall Study|Study product no longer in use|1|||
23753881|NCT03402126|66477114|FG000|Overall Study|Technical problems|1|||
23437347|NCT02292706|65344051|FG005|Overall Study|Missing|1|||
23825456|NCT02431364|66741474|FG002|Overall Study|Randomized but never treated|0|||
23825457|NCT02431364|66741475|FG003|Overall Study|Randomized but never treated|1|||
23437348|NCT02292706|65344052|FG006|Overall Study|Missing|0|||
23437349|NCT02292706|65344053|FG007|Overall Study|Missing|0|||
23558502|NCT00118716|65772515|FG001|Overall Study|Investigator discretion|1|||
23558503|NCT01324271|65772516|FG000|Overall Study|Lost to Follow-up|3|||
23558504|NCT01324271|65772517|FG001|Overall Study|Lost to Follow-up|0|||
23558505|NCT01324271|65772516|FG000|Overall Study|Physician Decision|1|||
23558506|NCT01324271|65772517|FG001|Overall Study|Physician Decision|0|||
23558507|NCT02173054|65772536|FG000|Overall Study|lack of compliance|1|||
23558508|NCT02173054|65772537|FG001|Overall Study|lack of compliance|0|||
23558509|NCT02173054|65772538|FG002|Overall Study|lack of compliance|0|||
23558510|NCT02173054|65772536|FG000|Overall Study|Withdrawal by Subject|0|||
23558511|NCT02173054|65772537|FG001|Overall Study|Withdrawal by Subject|0|||
23558512|NCT02173054|65772538|FG002|Overall Study|Withdrawal by Subject|1|||
23558513|NCT00430248|65772539|FG000|Overall Study|Adverse Event|49|||
23558514|NCT00430248|65772540|FG001|Overall Study|Adverse Event|61|||
23558515|NCT00430248|65772541|FG002|Overall Study|Adverse Event|64|||
23558516|NCT00430248|65772539|FG000|Overall Study|Protocol Violation|10|||
23558517|NCT00430248|65772540|FG001|Overall Study|Protocol Violation|2|||
23558518|NCT00430248|65772541|FG002|Overall Study|Protocol Violation|4|||
23558519|NCT00430248|65772539|FG000|Overall Study|Personal Reasons|12|||
23558520|NCT00430248|65772540|FG001|Overall Study|Personal Reasons|24|||
23558521|NCT00430248|65772541|FG002|Overall Study|Personal Reasons|9|||
23558522|NCT00430248|65772539|FG000|Overall Study|Lost to Follow-up|28|||
23558523|NCT00430248|65772540|FG001|Overall Study|Lost to Follow-up|33|||
23558524|NCT00430248|65772541|FG002|Overall Study|Lost to Follow-up|28|||
23558525|NCT00430248|65772539|FG000|Overall Study|Therapeutic Failure|1|||
23558526|NCT00430248|65772540|FG001|Overall Study|Therapeutic Failure|1|||
23558527|NCT00430248|65772541|FG002|Overall Study|Therapeutic Failure|1|||
23623953|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
23753882|NCT03402126|66477114|FG000|Overall Study|Withdrawal by Subject|6|||
23753883|NCT03402126|66477114|FG000|Overall Study|Physician Decision|2|||
23753884|NCT03402126|66477114|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
23753885|NCT03402126|66477114|FG000|Overall Study|Death|4|||
23753886|NCT00810615|66477117|FG000|Overall Study|Withdrawal by Subject|1|||
23753887|NCT00810615|66477118|FG001|Overall Study|Withdrawal by Subject|1|||
23753888|NCT01890109|66477120|FG000|Overall Study|Withdrawal by Subject|0|||
23753889|NCT01890109|66477121|FG001|Overall Study|Withdrawal by Subject|3|||
23753890|NCT01890109|66477120|FG000|Overall Study|Lost to Follow-up|1|||
23753891|NCT01890109|66477121|FG001|Overall Study|Lost to Follow-up|2|||
23753892|NCT02332655|66477125|FG000|Overall Study|Lack of Efficacy|1|||
23753893|NCT00797316|66477126|FG000|Overall Study|Administrative problems|1|||
23753894|NCT00797316|66477127|FG001|Overall Study|Administrative problems|0|||
23753895|NCT00797316|66477126|FG000|Overall Study|Adverse Event|5|||
23753896|NCT00797316|66477127|FG001|Overall Study|Adverse Event|3|||
23753897|NCT00797316|66477126|FG000|Overall Study|Lost to Follow-up|4|||
23753898|NCT00797316|66477127|FG001|Overall Study|Lost to Follow-up|8|||
23753899|NCT00797316|66477126|FG000|Overall Study|Protocol Deviation|1|||
23753900|NCT00797316|66477127|FG001|Overall Study|Protocol Deviation|2|||
23753901|NCT00797316|66477126|FG000|Overall Study|Patient withdrew consent|12|||
23753902|NCT00797316|66477127|FG001|Overall Study|Patient withdrew consent|6|||
23753903|NCT00797316|66477126|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23753904|NCT00797316|66477127|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23753905|NCT03576131|66477128|FG000|Overall Study|Investigator decision|0|||
23753906|NCT03576131|66477129|FG001|Overall Study|Investigator decision|0|||
23753907|NCT03576131|66477130|FG002|Overall Study|Investigator decision|0|||
23753908|NCT03576131|66477131|FG003|Overall Study|Investigator decision|1|||
23753909|NCT03576131|66477132|FG004|Overall Study|Investigator decision|0|||
23753910|NCT03576131|66477133|FG005|Overall Study|Investigator decision|1|||
23753911|NCT03576131|66477134|FG006|Overall Study|Investigator decision|0|||
23753912|NCT03576131|66477135|FG007|Overall Study|Investigator decision|0|||
23753913|NCT03576131|66477128|FG000|Overall Study|Withdrawal by Subject|1|||
23753914|NCT03576131|66477129|FG001|Overall Study|Withdrawal by Subject|1|||
23753915|NCT03576131|66477130|FG002|Overall Study|Withdrawal by Subject|0|||
23753916|NCT03576131|66477131|FG003|Overall Study|Withdrawal by Subject|1|||
23437350|NCT02292706|65344046|FG000|Overall Study|Virologic relapse or reinfection|1|||
23437351|NCT02292706|65344047|FG001|Overall Study|Virologic relapse or reinfection|0|||
23558528|NCT00430248|65772539|FG000|Overall Study|Withdrawal by Subject|14|||
23558529|NCT00430248|65772540|FG001|Overall Study|Withdrawal by Subject|20|||
23623954|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
23558530|NCT00430248|65772541|FG002|Overall Study|Withdrawal by Subject|16|||
23558531|NCT00430248|65772539|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23623955|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
23753917|NCT03576131|66477132|FG004|Overall Study|Withdrawal by Subject|2|||
23753918|NCT03576131|66477133|FG005|Overall Study|Withdrawal by Subject|3|||
23753919|NCT03576131|66477134|FG006|Overall Study|Withdrawal by Subject|1|||
23753920|NCT03576131|66477135|FG007|Overall Study|Withdrawal by Subject|0|||
23753921|NCT03576131|66477128|FG000|Overall Study|Death|3|||
23753922|NCT03576131|66477129|FG001|Overall Study|Death|3|||
23753923|NCT03576131|66477130|FG002|Overall Study|Death|1|||
23753924|NCT03576131|66477131|FG003|Overall Study|Death|5|||
23753925|NCT03576131|66477132|FG004|Overall Study|Death|4|||
23753926|NCT03576131|66477133|FG005|Overall Study|Death|1|||
23753927|NCT03576131|66477134|FG006|Overall Study|Death|0|||
23753928|NCT03576131|66477135|FG007|Overall Study|Death|1|||
23753929|NCT03576131|66477128|FG000|Overall Study|New anti-cancer treatment|5|||
23753930|NCT03576131|66477129|FG001|Overall Study|New anti-cancer treatment|1|||
23753931|NCT03576131|66477130|FG002|Overall Study|New anti-cancer treatment|2|||
23825458|NCT02431364|66741476|FG004|Overall Study|Randomized but never treated|0|||
23825459|NCT00770328|66741477|FG000|Overall Study|Adverse Event|11|||
23825460|NCT00770328|66741478|FG001|Overall Study|Adverse Event|2|||
23825461|NCT00770328|66741477|FG000|Overall Study|Lost to Follow-up|2|||
23753932|NCT03576131|66477131|FG003|Overall Study|New anti-cancer treatment|3|||
23753933|NCT03576131|66477132|FG004|Overall Study|New anti-cancer treatment|0|||
23753934|NCT03576131|66477133|FG005|Overall Study|New anti-cancer treatment|0|||
23753935|NCT03576131|66477134|FG006|Overall Study|New anti-cancer treatment|0|||
23753936|NCT03576131|66477135|FG007|Overall Study|New anti-cancer treatment|0|||
23753937|NCT03576131|66477128|FG000|Overall Study|Unspecified reason|0|||
23753938|NCT03576131|66477129|FG001|Overall Study|Unspecified reason|0|||
23753939|NCT03576131|66477130|FG002|Overall Study|Unspecified reason|1|||
23753940|NCT03576131|66477131|FG003|Overall Study|Unspecified reason|1|||
23753941|NCT03576131|66477132|FG004|Overall Study|Unspecified reason|1|||
23753942|NCT03576131|66477133|FG005|Overall Study|Unspecified reason|1|||
23753943|NCT03576131|66477134|FG006|Overall Study|Unspecified reason|0|||
23753944|NCT03576131|66477135|FG007|Overall Study|Unspecified reason|0|||
23753945|NCT03576131|66477128|FG000|Overall Study|Subject non-compliance|0|||
23825462|NCT00770328|66741478|FG001|Overall Study|Lost to Follow-up|2|||
23825463|NCT00711880|66741480|FG000|Overall Study|Adverse Event|11|||
23825464|NCT00711880|66741481|FG001|Overall Study|Adverse Event|2|||
23825465|NCT00711880|66741480|FG000|Overall Study|Patient non-compliance|1|||
23825466|NCT00711880|66741481|FG001|Overall Study|Patient non-compliance|0|||
23437352|NCT02292706|65344048|FG002|Overall Study|Virologic relapse or reinfection|0|||
23753946|NCT03576131|66477129|FG001|Overall Study|Subject non-compliance|0|||
23753947|NCT03576131|66477130|FG002|Overall Study|Subject non-compliance|0|||
23753948|NCT03576131|66477131|FG003|Overall Study|Subject non-compliance|0|||
23753949|NCT03576131|66477132|FG004|Overall Study|Subject non-compliance|0|||
23753950|NCT03576131|66477133|FG005|Overall Study|Subject non-compliance|1|||
23753951|NCT03576131|66477134|FG006|Overall Study|Subject non-compliance|0|||
23753952|NCT03576131|66477135|FG007|Overall Study|Subject non-compliance|0|||
23753953|NCT02617446|66477137|FG000|Overall Study|Withdrawal by Subject|0|||
23753954|NCT02617446|66477138|FG001|Overall Study|Withdrawal by Subject|2|||
23753955|NCT02617446|66477139|FG002|Overall Study|Withdrawal by Subject|0|||
23753956|NCT02617446|66477137|FG000|Overall Study|Adverse Event|1|||
23753957|NCT02617446|66477138|FG001|Overall Study|Adverse Event|0|||
23437353|NCT02292706|65344049|FG003|Overall Study|Virologic relapse or reinfection|1|||
23437354|NCT02292706|65344050|FG004|Overall Study|Virologic relapse or reinfection|0|||
23558532|NCT00430248|65772540|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23558533|NCT00430248|65772541|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23558534|NCT00430248|65772539|FG000|Overall Study|Gout Flare|3|||
23558535|NCT00430248|65772540|FG001|Overall Study|Gout Flare|7|||
23558536|NCT00430248|65772541|FG002|Overall Study|Gout Flare|2|||
23558537|NCT00430248|65772539|FG000|Overall Study|Reason Not Specified|8|||
23558538|NCT00430248|65772540|FG001|Overall Study|Reason Not Specified|8|||
23558539|NCT00430248|65772541|FG002|Overall Study|Reason Not Specified|11|||
23558540|NCT03508843|65772542|FG000|Overall Study|Withdrawal by Subject|1|||
23558541|NCT03508843|65772542|FG000|Overall Study|technical difficulties|2|||
23558542|NCT04044456|65772547|FG000|Overall Study|Lost to Follow-up|4|||
23558543|NCT04044456|65772548|FG001|Overall Study|Lost to Follow-up|1|||
23558544|NCT04044456|65772547|FG000|Overall Study|Withdrawal by Subject|1|||
23558545|NCT04044456|65772548|FG001|Overall Study|Withdrawal by Subject|0|||
23753958|NCT02617446|66477139|FG002|Overall Study|Adverse Event|5|||
23825467|NCT00711880|66741480|FG000|Overall Study|Lack of Efficacy|1|||
23558546|NCT01330316|65772549|FG000|Overall Study|Adverse Event|2|||
23558547|NCT01330316|65772550|FG001|Overall Study|Adverse Event|2|||
23753959|NCT02617446|66477137|FG000|Overall Study|Lost to Follow-up|3|||
23753960|NCT02617446|66477138|FG001|Overall Study|Lost to Follow-up|0|||
23753961|NCT02617446|66477139|FG002|Overall Study|Lost to Follow-up|0|||
23753962|NCT02617446|66477137|FG000|Overall Study|Death|0|||
23753963|NCT02617446|66477138|FG001|Overall Study|Death|0|||
23753964|NCT02617446|66477139|FG002|Overall Study|Death|2|||
23753965|NCT00532779|66477142|FG000|Overall Study|Adverse Event|122|||
23753966|NCT00532779|66477143|FG001|Overall Study|Adverse Event|112|||
23753967|NCT00532779|66477144|FG002|Overall Study|Adverse Event|56|||
23753968|NCT00532779|66477142|FG000|Overall Study|Lost to Follow-up|76|||
23437355|NCT02292706|65344051|FG005|Overall Study|Virologic relapse or reinfection|1|||
23437356|NCT02292706|65344052|FG006|Overall Study|Virologic relapse or reinfection|0|||
23437357|NCT02292706|65344053|FG007|Overall Study|Virologic relapse or reinfection|0|||
23753969|NCT00532779|66477143|FG001|Overall Study|Lost to Follow-up|65|||
23753970|NCT00532779|66477144|FG002|Overall Study|Lost to Follow-up|66|||
23753971|NCT00532779|66477142|FG000|Overall Study|Withdrawal by Subject|63|||
23623956|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
23825468|NCT00711880|66741481|FG001|Overall Study|Lack of Efficacy|5|||
23623957|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
23623958|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
23753972|NCT00532779|66477143|FG001|Overall Study|Withdrawal by Subject|60|||
23753973|NCT00532779|66477144|FG002|Overall Study|Withdrawal by Subject|90|||
23753974|NCT00532779|66477142|FG000|Overall Study|Lack of Efficacy|12|||
23753975|NCT00532779|66477143|FG001|Overall Study|Lack of Efficacy|12|||
23753976|NCT00532779|66477144|FG002|Overall Study|Lack of Efficacy|40|||
23753977|NCT00532779|66477142|FG000|Overall Study|Protocol Violation|5|||
23753978|NCT00532779|66477143|FG001|Overall Study|Protocol Violation|9|||
23753979|NCT00532779|66477144|FG002|Overall Study|Protocol Violation|7|||
23753980|NCT00532779|66477142|FG000|Overall Study|Pregnancy|2|||
23753981|NCT00532779|66477143|FG001|Overall Study|Pregnancy|5|||
23753982|NCT00532779|66477144|FG002|Overall Study|Pregnancy|3|||
23753983|NCT00532779|66477142|FG000|Overall Study|Death|0|||
23753984|NCT00532779|66477143|FG001|Overall Study|Death|1|||
23753985|NCT00532779|66477144|FG002|Overall Study|Death|0|||
23753986|NCT00532779|66477142|FG000|Overall Study|Drug noncompliance, moved, other|14|||
23753987|NCT00532779|66477143|FG001|Overall Study|Drug noncompliance, moved, other|23|||
23558548|NCT01330316|65772549|FG000|Overall Study|Lack of Efficacy|0|||
23558549|NCT01330316|65772550|FG001|Overall Study|Lack of Efficacy|10|||
23558550|NCT01330316|65772549|FG000|Overall Study|Lost to Follow-up|0|||
23558551|NCT01330316|65772550|FG001|Overall Study|Lost to Follow-up|1|||
23558552|NCT01330316|65772549|FG000|Overall Study|Withdrawal by Subject|0|||
23558553|NCT01330316|65772550|FG001|Overall Study|Withdrawal by Subject|1|||
23558554|NCT01330316|65772549|FG000|Overall Study|other than above|0|||
23558555|NCT01330316|65772550|FG001|Overall Study|other than above|1|||
23558556|NCT01320943|65772553|FG000|Overall Study|Lost to Follow-up|1|||
23558557|NCT01320943|65772554|FG001|Overall Study|Lost to Follow-up|0|||
23558558|NCT01320943|65772553|FG000|Overall Study|Physician Decision|0|||
23558559|NCT01320943|65772554|FG001|Overall Study|Physician Decision|1|||
23558560|NCT01320943|65772553|FG000|Overall Study|Randomized but not Treated|0|||
23558561|NCT01320943|65772554|FG001|Overall Study|Randomized but not Treated|1|||
23558562|NCT03988166|65772559|FG000|Overall Study|Lost to Follow-up|2|||
23558563|NCT03988166|65772559|FG000|Overall Study|Death|1|||
23753988|NCT00532779|66477144|FG002|Overall Study|Drug noncompliance, moved, other|29|||
23753989|NCT01494649|66480739|FG000|Overall Study|Lost to Follow-up|0|||
23753990|NCT01494649|66480740|FG001|Overall Study|Lost to Follow-up|1|||
23753991|NCT00478673|66480741|FG000|30-Days Post-Procedure|Death|2|||
23753992|NCT00478673|66480741|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
23753993|NCT00478673|66480741|FG000|30-Days Post-Procedure|Missed Visit|7|||
23753994|NCT00478673|66480741|FG000|12-Months Post-Procedure|Death|23|||
23753995|NCT00478673|66480741|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
23753996|NCT00478673|66480741|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
23753997|NCT00478673|66480741|FG000|12-Months Post-Procedure|Missed Visit|25|||
23753998|NCT00478673|66480741|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
23753999|NCT01892020|66480742|FG000|Period 1|Adverse Event|1|||
23558564|NCT03954743|65772564|FG000|Overall Study|Adverse Event|1|||
23558565|NCT03954743|65772565|FG001|Overall Study|Adverse Event|0|||
23558566|NCT03954743|65772564|FG000|Overall Study|Lost to Follow-up|6|||
23558567|NCT03954743|65772565|FG001|Overall Study|Lost to Follow-up|4|||
23558568|NCT03954743|65772564|FG000|Overall Study|Protocol Violation|1|||
23623959|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
23754000|NCT01892020|66480743|FG001|Period 1|Adverse Event|1|||
23754001|NCT01892020|66480742|FG000|Period 1|Protocol Violation|2|||
23754002|NCT01892020|66480743|FG001|Period 1|Protocol Violation|4|||
23754003|NCT01892020|66480742|FG000|Period 1|Unclassified|0|||
23754004|NCT01892020|66480743|FG001|Period 1|Unclassified|1|||
23754005|NCT01892020|66480742|FG000|Period 2|Protocol Violation|1|||
23754006|NCT01892020|66480743|FG001|Period 2|Protocol Violation|0|||
23754007|NCT03343054|66480744|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
23754008|NCT03343054|66480745|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
23754009|NCT03343054|66480746|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
23754010|NCT03343054|66480744|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
23754011|NCT03343054|66480745|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
23558569|NCT03954743|65772565|FG001|Overall Study|Protocol Violation|0|||
23558570|NCT03954743|65772564|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
23558571|NCT03954743|65772565|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
23754012|NCT03343054|66480746|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
23754013|NCT03343054|66480744|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
23754014|NCT03343054|66480745|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
23754015|NCT03343054|66480746|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
23558572|NCT03954743|65772564|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23558573|NCT03954743|65772565|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23558574|NCT01337674|65772566|FG000|Treatment Period 1|Adverse Event|0|||
23558575|NCT01337674|65772567|FG001|Treatment Period 1|Adverse Event|1|||
23558576|NCT01337674|65772568|FG002|Treatment Period 1|Adverse Event|0|||
23754016|NCT03343054|66480744|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
23825469|NCT02348112|66741486|FG000|Overall Study|Withdrawal by Subject|32|||
23825470|NCT02348112|66741487|FG001|Overall Study|Withdrawal by Subject|29|||
23825471|NCT02348112|66741486|FG000|Overall Study|Lost to Follow-up|24|||
23825472|NCT02348112|66741487|FG001|Overall Study|Lost to Follow-up|20|||
23825473|NCT02348112|66741486|FG000|Overall Study|Physician Decision|17|||
23825474|NCT02348112|66741487|FG001|Overall Study|Physician Decision|15|||
23825475|NCT02348112|66741486|FG000|Overall Study|Site closed due to PI leaving|0|||
23825476|NCT02348112|66741487|FG001|Overall Study|Site closed due to PI leaving|30|||
23825477|NCT02348112|66741486|FG000|Overall Study|Sponsor withdrawal|0|||
23825478|NCT02348112|66741487|FG001|Overall Study|Sponsor withdrawal|7|||
23825479|NCT02348112|66741486|FG000|Overall Study|Death|0|||
23825480|NCT02348112|66741487|FG001|Overall Study|Death|1|||
23825481|NCT04782076|66741490|FG000|Overall Study|Family Emergency|1|||
23825482|NCT01659125|66741491|FG000|Overall Study|Withdrawal by Subject|2|||
23825483|NCT01659125|66741491|FG000|Overall Study|Lost to Follow-up|7|||
23825484|NCT01659125|66741491|FG000|Overall Study|Technical Problem|1|||
23825485|NCT01659125|66741491|FG000|Overall Study|Time Constraints|2|||
23825486|NCT01659125|66741491|FG000|Overall Study|Failed to Start Treatment|2|||
23825487|NCT02698163|66741492|FG000|Overall Study|Lost to Follow-up|0|||
23825488|NCT02698163|66741493|FG001|Overall Study|Lost to Follow-up|1|||
23825489|NCT02493660|66741496|FG000|Overall Study|Physician Decision|0|||
23825490|NCT02493660|66741497|FG001|Overall Study|Physician Decision|1|||
23825491|NCT02493660|66741496|FG000|Overall Study|Adverse Event|4|||
23825492|NCT02493660|66741497|FG001|Overall Study|Adverse Event|2|||
23825493|NCT02493660|66741496|FG000|Overall Study|Withdrawal by Subject|2|||
23825494|NCT02493660|66741497|FG001|Overall Study|Withdrawal by Subject|3|||
23825495|NCT02493660|66741496|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
23825496|NCT02493660|66741497|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
23825497|NCT02493660|66741496|FG000|Overall Study|Protocol Violation|0|||
23825498|NCT02493660|66741497|FG001|Overall Study|Protocol Violation|1|||
23825499|NCT02493660|66741496|FG000|Overall Study|Death|0|||
23825500|NCT02493660|66741497|FG001|Overall Study|Death|1|||
23825501|NCT02493660|66741496|FG000|Overall Study|Lost to Follow-up|2|||
23825502|NCT02493660|66741497|FG001|Overall Study|Lost to Follow-up|4|||
23825503|NCT00595309|66741498|FG000|Overall Study|Lost to Follow-up|1|||
23825504|NCT00595309|66741498|FG000|Overall Study|planned vaccination against yellow fever|1|||
23825505|NCT00595309|66741498|FG000|Overall Study|acute infection after V0|1|||
23825506|NCT00595309|66741498|FG000|Overall Study|personal reason|1|||
23825507|NCT02308124|66741503|FG000|Overall Study|Lost to Follow-up|6|||
23825508|NCT02308124|66741504|FG001|Overall Study|Lost to Follow-up|6|||
23825509|NCT02308124|66741505|FG002|Overall Study|Lost to Follow-up|6|||
23825510|NCT02308124|66741503|FG000|Overall Study|Adverse Event|0|||
23825511|NCT02308124|66741504|FG001|Overall Study|Adverse Event|2|||
23825512|NCT02308124|66741505|FG002|Overall Study|Adverse Event|2|||
23825513|NCT03380429|66741511|FG000|Overall Study|Physician Decision|0|||
23825514|NCT03380429|66741512|FG001|Overall Study|Physician Decision|1|||
23825515|NCT03380429|66741513|FG002|Overall Study|Physician Decision|0|||
23825516|NCT03380429|66741514|FG003|Overall Study|Physician Decision|1|||
23825517|NCT03380429|66741515|FG004|Overall Study|Physician Decision|1|||
23825518|NCT03380429|66741511|FG000|Overall Study|Withdrawal by Subject|3|||
23825519|NCT03380429|66741512|FG001|Overall Study|Withdrawal by Subject|3|||
23825520|NCT03380429|66741513|FG002|Overall Study|Withdrawal by Subject|5|||
23825521|NCT03380429|66741514|FG003|Overall Study|Withdrawal by Subject|2|||
23825522|NCT03380429|66741515|FG004|Overall Study|Withdrawal by Subject|1|||
23825523|NCT03380429|66741511|FG000|Overall Study|Lost to Follow-up|0|||
23558577|NCT01337674|65772569|FG003|Treatment Period 1|Adverse Event|0|||
23558578|NCT01337674|65772566|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
23558579|NCT01337674|65772567|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
23558580|NCT01337674|65772568|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
23558581|NCT01337674|65772569|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
23558582|NCT01337674|65772566|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23558583|NCT01337674|65772567|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23558584|NCT01337674|65772568|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23558585|NCT01337674|65772569|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23558586|NCT02641392|65772572|FG000|Overall Study|Lost to Follow-up|0|||
23558587|NCT02641392|65772573|FG001|Overall Study|Lost to Follow-up|0|||
23825524|NCT03380429|66741512|FG001|Overall Study|Lost to Follow-up|2|||
23825525|NCT03380429|66741513|FG002|Overall Study|Lost to Follow-up|4|||
23825526|NCT03380429|66741514|FG003|Overall Study|Lost to Follow-up|3|||
23825527|NCT03380429|66741515|FG004|Overall Study|Lost to Follow-up|1|||
23825528|NCT03380429|66741511|FG000|Overall Study|Protocol Violation|1|||
23825529|NCT03380429|66741512|FG001|Overall Study|Protocol Violation|0|||
23825530|NCT03380429|66741513|FG002|Overall Study|Protocol Violation|1|||
23825531|NCT03380429|66741514|FG003|Overall Study|Protocol Violation|0|||
23825532|NCT03380429|66741515|FG004|Overall Study|Protocol Violation|1|||
23825533|NCT03380429|66741511|FG000|Overall Study|Lack of Efficacy|0|||
23825534|NCT03380429|66741512|FG001|Overall Study|Lack of Efficacy|0|||
23825535|NCT03380429|66741513|FG002|Overall Study|Lack of Efficacy|0|||
23825536|NCT03380429|66741514|FG003|Overall Study|Lack of Efficacy|2|||
23825537|NCT03380429|66741515|FG004|Overall Study|Lack of Efficacy|1|||
23825538|NCT03380429|66741511|FG000|Overall Study|Adverse Event|1|||
23825539|NCT03380429|66741512|FG001|Overall Study|Adverse Event|1|||
23825540|NCT03380429|66741513|FG002|Overall Study|Adverse Event|1|||
23825541|NCT03380429|66741514|FG003|Overall Study|Adverse Event|2|||
23825542|NCT03380429|66741515|FG004|Overall Study|Adverse Event|0|||
23754017|NCT03343054|66480745|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
23754018|NCT03343054|66480746|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
23754019|NCT03237481|66480747|FG000|Overall Study|Lost to Follow-up|1|||
23754020|NCT03237481|66480748|FG001|Overall Study|Lost to Follow-up|0|||
23754021|NCT03237481|66480749|FG002|Overall Study|Lost to Follow-up|0|||
23754022|NCT03237481|66480747|FG000|Overall Study|Protocol Violation|1|||
23754023|NCT03237481|66480748|FG001|Overall Study|Protocol Violation|0|||
23754024|NCT03237481|66480749|FG002|Overall Study|Protocol Violation|0|||
23754025|NCT03237481|66480747|FG000|Overall Study|Withdrawal by Subject|3|||
23754026|NCT03237481|66480748|FG001|Overall Study|Withdrawal by Subject|2|||
23754027|NCT03237481|66480749|FG002|Overall Study|Withdrawal by Subject|1|||
23754028|NCT00759174|66480755|FG000|Overall Study|Other|0|||
23754029|NCT00759174|66480756|FG001|Overall Study|Other|2|||
23754030|NCT00411762|66480757|FG000|Overall Study|Withdrawal by Subject|5|||
23754031|NCT00743119|66480758|FG000|Overall Study|unreliable|3|||
23754032|NCT00743119|66480758|FG000|Overall Study|Withdrawal by Subject|1|||
23754033|NCT01682512|66480759|FG000|Overall Study|Adverse Event|6|||
23754034|NCT01682512|66480760|FG001|Overall Study|Adverse Event|5|||
23754035|NCT01682512|66480761|FG002|Overall Study|Adverse Event|2|||
23754036|NCT01682512|66480759|FG000|Overall Study|Withdrawal by Subject|2|||
23754037|NCT01682512|66480760|FG001|Overall Study|Withdrawal by Subject|6|||
23754038|NCT01682512|66480761|FG002|Overall Study|Withdrawal by Subject|3|||
23754039|NCT01682512|66480759|FG000|Overall Study|Physician Decision|0|||
23754040|NCT01682512|66480760|FG001|Overall Study|Physician Decision|2|||
23754041|NCT01682512|66480761|FG002|Overall Study|Physician Decision|0|||
23754042|NCT01682512|66480759|FG000|Overall Study|Study terminated by sponsor|46|||
23754043|NCT01682512|66480760|FG001|Overall Study|Study terminated by sponsor|43|||
23754044|NCT01682512|66480761|FG002|Overall Study|Study terminated by sponsor|0|||
23754045|NCT01682512|66480759|FG000|Overall Study|Lost to Follow-up|3|||
23754046|NCT01682512|66480760|FG001|Overall Study|Lost to Follow-up|0|||
23754047|NCT01682512|66480761|FG002|Overall Study|Lost to Follow-up|2|||
23754048|NCT01682512|66480759|FG000|Overall Study|Protocol Violation|2|||
23754049|NCT01682512|66480760|FG001|Overall Study|Protocol Violation|3|||
23754050|NCT01682512|66480761|FG002|Overall Study|Protocol Violation|2|||
23754051|NCT01682512|66480759|FG000|Overall Study|Primary lack of efficacy|10|||
23825543|NCT02910011|66741516|FG000|Overall Study|Physician Decision|2|||
23825544|NCT03830333|66741519|FG000|Overall Study|Death|0|||
23825545|NCT03830333|66741520|FG001|Overall Study|Death|1|||
23825546|NCT03830333|66741519|FG000|Overall Study|Withdrawal by Subject|5|||
23825547|NCT03830333|66741520|FG001|Overall Study|Withdrawal by Subject|1|||
23825548|NCT03830333|66741519|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
23825549|NCT03830333|66741520|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
23437358|NCT00360568|65344055|FG000|Overall Study|Adverse Event|1|||
23437359|NCT00360568|65344056|FG001|Overall Study|Adverse Event|2|||
23437360|NCT00360568|65344055|FG000|Overall Study|Lack of Efficacy|1|||
23437361|NCT00360568|65344056|FG001|Overall Study|Lack of Efficacy|0|||
23437362|NCT00360568|65344055|FG000|Overall Study|Withdrawal by Subject|0|||
23437363|NCT00360568|65344056|FG001|Overall Study|Withdrawal by Subject|3|||
23437364|NCT01879072|65344057|FG000|Overall Study|Withdrawal by Subject|121|||
23437365|NCT01879072|65344057|FG000|Overall Study|Not Transplanted|30|||
23437366|NCT00622388|65344058|FG000|Overall Study|Disease Progression|47|||
23437367|NCT00622388|65344058|FG000|Overall Study|Adverse Event|6|||
23754052|NCT01682512|66480760|FG001|Overall Study|Primary lack of efficacy|7|||
23825550|NCT01090414|66741523|FG000|Study 101-99|Progressive Disease|28|||
23825551|NCT01090414|66741524|FG001|Study 101-99|Progressive Disease|48|||
23437368|NCT00622388|65344058|FG000|Overall Study|Protocol Violation|3|||
23558588|NCT02641392|65772574|FG002|Overall Study|Lost to Follow-up|2|||
23558589|NCT02641392|65772572|FG000|Overall Study|Withdrawal by Subject|0|||
23754053|NCT01682512|66480761|FG002|Overall Study|Primary lack of efficacy|7|||
23825552|NCT01090414|66741525|FG002|Study 101-99|Progressive Disease|10|||
23825553|NCT01090414|66741526|FG003|Study 101-99|Progressive Disease|4|||
23825554|NCT01090414|66741523|FG000|Study 101-99|Adverse Event|10|||
23825555|NCT01090414|66741524|FG001|Study 101-99|Adverse Event|28|||
23825556|NCT01090414|66741525|FG002|Study 101-99|Adverse Event|18|||
23825557|NCT01090414|66741526|FG003|Study 101-99|Adverse Event|0|||
23437369|NCT00622388|65344058|FG000|Overall Study|Participant Refusal|1|||
23437370|NCT00622388|65344058|FG000|Overall Study|Death|3|||
23558590|NCT02641392|65772573|FG001|Overall Study|Withdrawal by Subject|0|||
23558591|NCT02641392|65772574|FG002|Overall Study|Withdrawal by Subject|17|||
23558592|NCT02641392|65772572|FG000|Overall Study|Adverse Event|0|||
23825558|NCT01090414|66741523|FG000|Study 101-99|Investigator Request|1|||
23825559|NCT01090414|66741524|FG001|Study 101-99|Investigator Request|11|||
23825560|NCT01090414|66741525|FG002|Study 101-99|Investigator Request|4|||
23558593|NCT02641392|65772573|FG001|Overall Study|Adverse Event|1|||
23754054|NCT01682512|66480759|FG000|Overall Study|Secondary lack of efficacy|1|||
23825561|NCT01090414|66741526|FG003|Study 101-99|Investigator Request|0|||
23825562|NCT01090414|66741523|FG000|Study 101-99|Death|3|||
23754055|NCT01682512|66480760|FG001|Overall Study|Secondary lack of efficacy|1|||
23754056|NCT01682512|66480761|FG002|Overall Study|Secondary lack of efficacy|0|||
23754057|NCT01682512|66480759|FG000|Overall Study|Other than stated above|2|||
23754058|NCT01682512|66480760|FG001|Overall Study|Other than stated above|4|||
23754059|NCT01682512|66480761|FG002|Overall Study|Other than stated above|2|||
23754060|NCT03443973|66480764|FG000|Double-blind Treatment Period|Adverse Event|5|||
23754061|NCT03443973|66480765|FG001|Double-blind Treatment Period|Adverse Event|19|||
23754062|NCT03443973|66480766|FG002|Double-blind Treatment Period|Adverse Event|0|||
23754063|NCT03443973|66480767|FG003|Double-blind Treatment Period|Adverse Event|0|||
23754064|NCT03443973|66480764|FG000|Double-blind Treatment Period|Death|5|||
23754065|NCT03443973|66480765|FG001|Double-blind Treatment Period|Death|7|||
23754066|NCT03443973|66480766|FG002|Double-blind Treatment Period|Death|0|||
23754067|NCT03443973|66480767|FG003|Double-blind Treatment Period|Death|0|||
23754068|NCT03443973|66480764|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23754069|NCT03443973|66480765|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23754070|NCT03443973|66480766|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23558594|NCT02641392|65772574|FG002|Overall Study|Adverse Event|25|||
23558595|NCT02641392|65772572|FG000|Overall Study|Study Terminated by Sponsor|4|||
23558596|NCT02641392|65772573|FG001|Overall Study|Study Terminated by Sponsor|12|||
23558597|NCT02641392|65772574|FG002|Overall Study|Study Terminated by Sponsor|144|||
23558598|NCT02641392|65772572|FG000|Overall Study|Lack of Efficacy|0|||
23558599|NCT02641392|65772573|FG001|Overall Study|Lack of Efficacy|0|||
23558600|NCT02641392|65772574|FG002|Overall Study|Lack of Efficacy|101|||
23558601|NCT02641392|65772572|FG000|Overall Study|Miscellaneous|0|||
23558602|NCT02641392|65772573|FG001|Overall Study|Miscellaneous|0|||
23558603|NCT02641392|65772574|FG002|Overall Study|Miscellaneous|3|||
23558604|NCT02641392|65772572|FG000|Overall Study|Death|0|||
23558605|NCT02641392|65772573|FG001|Overall Study|Death|0|||
23558606|NCT02641392|65772574|FG002|Overall Study|Death|1|||
23558607|NCT00331344|65772575|FG000|Phase I|Adverse Event|0|||
23558608|NCT00331344|65772576|FG001|Phase I|Adverse Event|0|||
23558609|NCT00331344|65772577|FG002|Phase I|Adverse Event|0|||
23558610|NCT00331344|65772578|FG003|Phase I|Adverse Event|1|||
23558611|NCT00331344|65772579|FG004|Phase I|Adverse Event|2|||
23558612|NCT00331344|65772580|FG005|Phase I|Adverse Event|2|||
23558613|NCT00331344|65772581|FG006|Phase I|Adverse Event|0|||
23558614|NCT00331344|65772582|FG007|Phase I|Adverse Event|1|||
23558615|NCT00331344|65772583|FG008|Phase I|Adverse Event|0|||
23558616|NCT00331344|65772575|FG000|Phase II|Death|0|||
23558617|NCT00331344|65772576|FG001|Phase II|Death|0|||
23558618|NCT00331344|65772577|FG002|Phase II|Death|0|||
23558619|NCT00331344|65772578|FG003|Phase II|Death|0|||
23558620|NCT00331344|65772579|FG004|Phase II|Death|0|||
23558621|NCT00331344|65772580|FG005|Phase II|Death|0|||
23558622|NCT00331344|65772581|FG006|Phase II|Death|0|||
23558623|NCT00331344|65772582|FG007|Phase II|Death|0|||
23558624|NCT00331344|65772583|FG008|Phase II|Death|4|||
23558625|NCT02068495|65772584|FG000|Overall Study|Case Report Forms Uncollected|60|||
23558626|NCT02068495|65772584|FG000|Overall Study|Protocol Deviation|49|||
23558627|NCT01119898|65772585|FG000|Overall Study|Adverse Event|4|||
23558628|NCT01119898|65772586|FG001|Overall Study|Adverse Event|5|||
23558629|NCT01119898|65772585|FG000|Overall Study|Withdrawal by Subject|1|||
23558630|NCT01119898|65772586|FG001|Overall Study|Withdrawal by Subject|4|||
23558631|NCT01119898|65772585|FG000|Overall Study|Lack of Efficacy|0|||
23558632|NCT01119898|65772586|FG001|Overall Study|Lack of Efficacy|2|||
23558633|NCT01119898|65772585|FG000|Overall Study|Protocol Violation|1|||
23558634|NCT01119898|65772586|FG001|Overall Study|Protocol Violation|1|||
23558635|NCT01119898|65772585|FG000|Overall Study|Medical procedure|1|||
23623960|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
23754071|NCT03443973|66480767|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23754072|NCT03443973|66480764|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23754073|NCT03443973|66480765|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23825563|NCT01090414|66741524|FG001|Study 101-99|Death|8|||
23825564|NCT01090414|66741525|FG002|Study 101-99|Death|1|||
23825565|NCT01090414|66741526|FG003|Study 101-99|Death|0|||
23558636|NCT01119898|65772586|FG001|Overall Study|Medical procedure|0|||
23558637|NCT01119898|65772585|FG000|Overall Study|Randomized in error did not participate|1|||
23558638|NCT01119898|65772586|FG001|Overall Study|Randomized in error did not participate|0|||
23558639|NCT02342886|65772587|FG000|Overall Study|Treatment non-compliance|1|||
23558640|NCT02342886|65772588|FG001|Overall Study|Treatment non-compliance|0|||
23558641|NCT02342886|65772589|FG002|Overall Study|Treatment non-compliance|0|||
23558642|NCT02342886|65772590|FG003|Overall Study|Treatment non-compliance|1|||
23558643|NCT02342886|65772591|FG004|Overall Study|Treatment non-compliance|0|||
23437371|NCT00622388|65344058|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
23437372|NCT00622388|65344058|FG000|Overall Study|Took Prohibited Medication|2|||
23437373|NCT00622388|65344058|FG000|Overall Study|Withdrew Consent|1|||
23437374|NCT00622388|65344058|FG000|Overall Study|Insurance Expired|1|||
23437375|NCT00802893|65344059|FG000|Overall Study|study terminated|3|||
23754074|NCT03443973|66480766|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23754075|NCT03443973|66480767|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23558644|NCT02342886|65772587|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
23558645|NCT02342886|65772588|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
23437376|NCT01983774|65344060|FG000|Overall Study|Lung Transplant|0|||
23437377|NCT01983774|65344061|FG001|Overall Study|Lung Transplant|1|||
23437378|NCT01983774|65344060|FG000|Overall Study|Lost to Follow-up|1|||
23437379|NCT01983774|65344061|FG001|Overall Study|Lost to Follow-up|0|||
23437380|NCT00408434|65344062|FG000|Overall Study|Adverse Event|0|||
23437381|NCT00408434|65344063|FG001|Overall Study|Adverse Event|0|||
23437382|NCT00408434|65344064|FG002|Overall Study|Adverse Event|1|||
23437383|NCT00408434|65344065|FG003|Overall Study|Adverse Event|0|||
23437384|NCT00408434|65344066|FG004|Overall Study|Adverse Event|0|||
23558646|NCT02342886|65772589|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
23558647|NCT02342886|65772590|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
23558648|NCT02342886|65772591|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
23558649|NCT02342886|65772587|FG000|Overall Study|Adverse event/specific toxicity|4|||
23437385|NCT00408434|65344067|FG005|Overall Study|Adverse Event|0|||
23437386|NCT00408434|65344068|FG006|Overall Study|Adverse Event|0|||
23437387|NCT00408434|65344062|FG000|Overall Study|Progressive disease|6|||
23437388|NCT00408434|65344063|FG001|Overall Study|Progressive disease|3|||
23437389|NCT00408434|65344064|FG002|Overall Study|Progressive disease|4|||
23437390|NCT00408434|65344065|FG003|Overall Study|Progressive disease|3|||
23437391|NCT00408434|65344066|FG004|Overall Study|Progressive disease|3|||
23437392|NCT00408434|65344067|FG005|Overall Study|Progressive disease|1|||
23437393|NCT00408434|65344068|FG006|Overall Study|Progressive disease|4|||
23437394|NCT00408434|65344062|FG000|Overall Study|Other|0|||
23437395|NCT00408434|65344063|FG001|Overall Study|Other|0|||
23558650|NCT02342886|65772588|FG001|Overall Study|Adverse event/specific toxicity|3|||
23558651|NCT02342886|65772589|FG002|Overall Study|Adverse event/specific toxicity|11|||
23558652|NCT02342886|65772590|FG003|Overall Study|Adverse event/specific toxicity|2|||
23558653|NCT02342886|65772591|FG004|Overall Study|Adverse event/specific toxicity|1|||
23558654|NCT02342886|65772587|FG000|Overall Study|Lost to Follow-up|1|||
23558655|NCT02342886|65772588|FG001|Overall Study|Lost to Follow-up|0|||
23558656|NCT02342886|65772589|FG002|Overall Study|Lost to Follow-up|0|||
23558657|NCT02342886|65772590|FG003|Overall Study|Lost to Follow-up|0|||
23558658|NCT02342886|65772591|FG004|Overall Study|Lost to Follow-up|0|||
23558659|NCT02342886|65772587|FG000|Overall Study|Death|1|||
23558660|NCT02342886|65772588|FG001|Overall Study|Death|2|||
23558661|NCT02342886|65772589|FG002|Overall Study|Death|1|||
23558662|NCT02342886|65772590|FG003|Overall Study|Death|0|||
23558663|NCT02342886|65772591|FG004|Overall Study|Death|1|||
23558664|NCT02342886|65772587|FG000|Overall Study|Withdrawal by Subject|0|||
23754076|NCT03443973|66480764|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
23754077|NCT03443973|66480765|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
23754078|NCT03443973|66480766|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
23754079|NCT03443973|66480767|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
23754080|NCT03443973|66480764|FG000|Double-blind Treatment Period|Physician Decision|5|||
23754081|NCT03443973|66480765|FG001|Double-blind Treatment Period|Physician Decision|6|||
23754082|NCT03443973|66480766|FG002|Double-blind Treatment Period|Physician Decision|0|||
23754083|NCT03443973|66480767|FG003|Double-blind Treatment Period|Physician Decision|0|||
23754084|NCT03443973|66480764|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
23437396|NCT00408434|65344064|FG002|Overall Study|Other|1|||
23437397|NCT00408434|65344065|FG003|Overall Study|Other|0|||
23437398|NCT00408434|65344066|FG004|Overall Study|Other|2|||
23437399|NCT00408434|65344067|FG005|Overall Study|Other|1|||
23437400|NCT00408434|65344068|FG006|Overall Study|Other|0|||
23437401|NCT00408434|65344062|FG000|Overall Study|Terminated by Investigator|0|||
23437402|NCT00408434|65344063|FG001|Overall Study|Terminated by Investigator|0|||
23437403|NCT00408434|65344064|FG002|Overall Study|Terminated by Investigator|0|||
23437404|NCT00408434|65344065|FG003|Overall Study|Terminated by Investigator|0|||
23437405|NCT00408434|65344066|FG004|Overall Study|Terminated by Investigator|1|||
23437406|NCT00408434|65344067|FG005|Overall Study|Terminated by Investigator|1|||
23437407|NCT00408434|65344068|FG006|Overall Study|Terminated by Investigator|0|||
23437408|NCT02335424|65344069|FG000|Overall Study|Withdrawal by Subject|19|||
23558665|NCT02342886|65772588|FG001|Overall Study|Withdrawal by Subject|1|||
23437409|NCT02335424|65344069|FG000|Overall Study|Adverse Event|25|||
23437410|NCT02335424|65344069|FG000|Overall Study|Death|273|||
23437411|NCT02335424|65344069|FG000|Overall Study|Lost to Follow-up|3|||
23437412|NCT02335424|65344069|FG000|Overall Study|Physician Decision|13|||
23437413|NCT02335424|65344069|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
23437414|NCT02335424|65344069|FG000|Overall Study|Protocol Violation|1|||
23437415|NCT02335424|65344069|FG000|Overall Study|Screen failure|1|||
23437416|NCT02092025|65344070|FG000|Overall Study|Case Report Forms Uncollected|44|||
23437417|NCT02092025|65344070|FG000|Overall Study|Protocol Deviation|24|||
23623961|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
23623962|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
23437418|NCT03228212|65344074|FG000|Period 1|Adverse Event|1|||
23437419|NCT03228212|65344075|FG001|Period 1|Adverse Event|0|||
23437420|NCT03228212|65344074|FG000|Period 1|no longer meets eligibility criteria|0|||
23754085|NCT03443973|66480765|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
23754086|NCT03443973|66480766|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
23754087|NCT03443973|66480767|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
23754088|NCT03443973|66480764|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
23754089|NCT03443973|66480765|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
23754090|NCT03443973|66480766|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23754091|NCT03443973|66480767|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
23754092|NCT03443973|66480764|FG000|Open-label Extension Period|Reason Not Specified|0|||
23754093|NCT03443973|66480765|FG001|Open-label Extension Period|Reason Not Specified|0|||
23754094|NCT03443973|66480766|FG002|Open-label Extension Period|Reason Not Specified|3|||
23754095|NCT03443973|66480767|FG003|Open-label Extension Period|Reason Not Specified|0|||
23754096|NCT03443973|66480764|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23754097|NCT03443973|66480765|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
23754098|NCT03443973|66480766|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
23754099|NCT03443973|66480767|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
23754100|NCT00378482|66480771|FG000|Overall Study|Lost to Follow-up|1|||
23754101|NCT00378482|66480771|FG000|Overall Study|Lack of Efficacy|8|||
23754102|NCT00378482|66480771|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
23754103|NCT00378482|66480771|FG000|Overall Study|Withdrawal by Subject|4|||
23754104|NCT00378482|66480771|FG000|Overall Study|Adverse Event|9|||
23437421|NCT03228212|65344075|FG001|Period 1|no longer meets eligibility criteria|1|||
23437422|NCT03228212|65344074|FG000|Period 2|Lost to Follow-up|1|||
23437423|NCT03228212|65344075|FG001|Period 2|Lost to Follow-up|0|||
23437424|NCT01496846|65344076|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
23437425|NCT01496846|65344077|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
23437426|NCT01496846|65344078|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23623963|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
23623964|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
23623965|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
23623966|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
23623967|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
23623968|NCT04486313|66011507|FG000|Overall Study|Lost to Follow-up|7|||
23623969|NCT04486313|66011508|FG001|Overall Study|Lost to Follow-up|9|||
23623970|NCT04486313|66011507|FG000|Overall Study|Withdrawal by Subject|8|||
23623971|NCT04486313|66011508|FG001|Overall Study|Withdrawal by Subject|6|||
23623972|NCT04486313|66011507|FG000|Overall Study|Physician Decision|1|||
23623973|NCT04486313|66011508|FG001|Overall Study|Physician Decision|1|||
23623974|NCT04486313|66011507|FG000|Overall Study|Death|2|||
23623975|NCT04486313|66011508|FG001|Overall Study|Death|0|||
23623976|NCT04486313|66011507|FG000|Overall Study|Protocol Violation|1|||
23623977|NCT04486313|66011508|FG001|Overall Study|Protocol Violation|1|||
23754105|NCT01396161|66480776|FG000|Overall Study|Withdrawal by Subject|0|||
23754106|NCT01396161|66480777|FG001|Overall Study|Withdrawal by Subject|0|||
23754107|NCT01396161|66480778|FG002|Overall Study|Withdrawal by Subject|0|||
23754108|NCT01396161|66480779|FG003|Overall Study|Withdrawal by Subject|0|||
23437427|NCT01496846|65344079|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437428|NCT01496846|65344080|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437429|NCT01496846|65344081|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437430|NCT03208088|65344082|FG000|Period 2|Withdrawal by Subject|0|||
23437431|NCT03208088|65344083|FG001|Period 2|Withdrawal by Subject|0|||
23437432|NCT03208088|65344084|FG002|Period 2|Withdrawal by Subject|0|||
23437433|NCT03208088|65344085|FG003|Period 2|Withdrawal by Subject|0|||
23437434|NCT03208088|65344086|FG004|Period 2|Withdrawal by Subject|0|||
23437435|NCT03208088|65344087|FG005|Period 2|Withdrawal by Subject|0|||
23437436|NCT03208088|65344088|FG006|Period 2|Withdrawal by Subject|0|||
23437437|NCT03208088|65344089|FG007|Period 2|Withdrawal by Subject|0|||
23437438|NCT03208088|65344090|FG008|Period 2|Withdrawal by Subject|1|||
23437439|NCT03208088|65344091|FG009|Period 2|Withdrawal by Subject|0|||
23437440|NCT03208088|65344082|FG000|Period 3|Unsatisfactory Test Article|0|||
23437441|NCT03208088|65344083|FG001|Period 3|Unsatisfactory Test Article|0|||
23437442|NCT03208088|65344084|FG002|Period 3|Unsatisfactory Test Article|0|||
23437443|NCT03208088|65344085|FG003|Period 3|Unsatisfactory Test Article|1|||
23437444|NCT03208088|65344086|FG004|Period 3|Unsatisfactory Test Article|0|||
23437445|NCT03208088|65344087|FG005|Period 3|Unsatisfactory Test Article|0|||
23437446|NCT03208088|65344088|FG006|Period 3|Unsatisfactory Test Article|0|||
23437447|NCT03208088|65344089|FG007|Period 3|Unsatisfactory Test Article|0|||
23437448|NCT03208088|65344090|FG008|Period 3|Unsatisfactory Test Article|0|||
23437449|NCT03208088|65344091|FG009|Period 3|Unsatisfactory Test Article|0|||
23437450|NCT03208088|65344082|FG000|Period 4|Unsatisfactory Test Article|0|||
23437451|NCT03208088|65344083|FG001|Period 4|Unsatisfactory Test Article|0|||
23437452|NCT03208088|65344084|FG002|Period 4|Unsatisfactory Test Article|0|||
23437453|NCT03208088|65344085|FG003|Period 4|Unsatisfactory Test Article|1|||
23437454|NCT03208088|65344086|FG004|Period 4|Unsatisfactory Test Article|0|||
23437455|NCT03208088|65344087|FG005|Period 4|Unsatisfactory Test Article|0|||
23437456|NCT03208088|65344088|FG006|Period 4|Unsatisfactory Test Article|0|||
23437457|NCT03208088|65344089|FG007|Period 4|Unsatisfactory Test Article|0|||
23437458|NCT03208088|65344090|FG008|Period 4|Unsatisfactory Test Article|0|||
23437459|NCT03208088|65344091|FG009|Period 4|Unsatisfactory Test Article|0|||
23437460|NCT00835341|65344092|FG000|Overall Study|Lost to Follow-up|3|||
23437461|NCT00835341|65344093|FG001|Overall Study|Lost to Follow-up|12|||
23437462|NCT04006392|65344094|FG000|Overall Study|Lost to Follow-up|0|||
23437463|NCT04006392|65344095|FG001|Overall Study|Lost to Follow-up|1|||
23437464|NCT04078152|65344096|FG000|Overall Study|Other|83|||
23437465|NCT04078152|65344097|FG001|Overall Study|Other|22|||
23437466|NCT04078152|65344098|FG002|Overall Study|Other|25|||
23437467|NCT04078152|65344096|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
23437468|NCT04078152|65344097|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
23437469|NCT04078152|65344098|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
23437470|NCT04078152|65344096|FG000|Overall Study|Withdrawal by Subject|5|||
23437471|NCT04078152|65344097|FG001|Overall Study|Withdrawal by Subject|0|||
23437472|NCT04078152|65344098|FG002|Overall Study|Withdrawal by Subject|1|||
23437473|NCT04078152|65344096|FG000|Overall Study|Death|10|||
23437474|NCT04078152|65344097|FG001|Overall Study|Death|2|||
23437475|NCT04078152|65344098|FG002|Overall Study|Death|12|||
23437476|NCT04078152|65344096|FG000|Overall Study|Adverse Event|1|||
23437477|NCT04078152|65344097|FG001|Overall Study|Adverse Event|0|||
23437478|NCT04078152|65344098|FG002|Overall Study|Adverse Event|0|||
23437479|NCT01811186|65344099|FG000|Overall Study|Adverse Event|54|||
23437480|NCT01811186|65344100|FG001|Overall Study|Adverse Event|38|||
23437481|NCT01811186|65344099|FG000|Overall Study|Protocol Violation|5|||
23437482|NCT01811186|65344100|FG001|Overall Study|Protocol Violation|6|||
23437483|NCT01811186|65344099|FG000|Overall Study|Withdrawal by Subject|5|||
23437484|NCT01811186|65344100|FG001|Overall Study|Withdrawal by Subject|10|||
23437485|NCT01811186|65344099|FG000|Overall Study|Lack of Efficacy|3|||
23437486|NCT01811186|65344100|FG001|Overall Study|Lack of Efficacy|6|||
23437487|NCT01811186|65344099|FG000|Overall Study|Lost to Follow-up|4|||
23437488|NCT01811186|65344100|FG001|Overall Study|Lost to Follow-up|2|||
23437489|NCT03270891|65344101|FG000|Overall Study|Lost to Follow-up|3|||
23437490|NCT03270891|65344102|FG001|Overall Study|Lost to Follow-up|6|||
23437491|NCT03270891|65344103|FG002|Overall Study|Lost to Follow-up|0|||
23437492|NCT03270891|65344101|FG000|Overall Study|Withdrawal by Subject|1|||
23437493|NCT03270891|65344102|FG001|Overall Study|Withdrawal by Subject|0|||
23437494|NCT03270891|65344103|FG002|Overall Study|Withdrawal by Subject|0|||
23437495|NCT03270891|65344101|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
23437496|NCT03270891|65344102|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
23437497|NCT03270891|65344103|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
23754109|NCT01396161|66480780|FG004|Overall Study|Withdrawal by Subject|1|||
23437498|NCT01727336|65344105|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437499|NCT01727336|65344106|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
23437500|NCT01727336|65344107|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
23437501|NCT01727336|65344108|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437502|NCT01727336|65344109|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437503|NCT01727336|65344110|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437504|NCT01727336|65344105|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
23437505|NCT01727336|65344106|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
23437506|NCT01727336|65344107|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
23437507|NCT01727336|65344108|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437508|NCT01727336|65344109|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437509|NCT01727336|65344110|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437510|NCT01727336|65344105|FG000|Part 2 Blinded|Death|0|||
23437511|NCT01727336|65344106|FG001|Part 2 Blinded|Death|0|||
23437512|NCT01727336|65344107|FG002|Part 2 Blinded|Death|0|||
23437513|NCT01727336|65344108|FG003|Part 2 Blinded|Death|0|||
23437514|NCT01727336|65344109|FG004|Part 2 Blinded|Death|20|||
23437515|NCT01727336|65344110|FG005|Part 2 Blinded|Death|16|||
23437516|NCT01727336|65344105|FG000|Part 2 Blinded|Lack of Efficacy|0|||
23437517|NCT01727336|65344106|FG001|Part 2 Blinded|Lack of Efficacy|0|||
23437518|NCT01727336|65344107|FG002|Part 2 Blinded|Lack of Efficacy|0|||
23437519|NCT01727336|65344108|FG003|Part 2 Blinded|Lack of Efficacy|0|||
23437520|NCT01727336|65344109|FG004|Part 2 Blinded|Lack of Efficacy|42|||
23437521|NCT01727336|65344110|FG005|Part 2 Blinded|Lack of Efficacy|44|||
23437522|NCT01727336|65344105|FG000|Part 2 Blinded|Lost to Follow-up|0|||
23437523|NCT01727336|65344106|FG001|Part 2 Blinded|Lost to Follow-up|0|||
23437524|NCT01727336|65344107|FG002|Part 2 Blinded|Lost to Follow-up|0|||
23437525|NCT01727336|65344108|FG003|Part 2 Blinded|Lost to Follow-up|0|||
23437526|NCT01727336|65344109|FG004|Part 2 Blinded|Lost to Follow-up|0|||
23437527|NCT01727336|65344110|FG005|Part 2 Blinded|Lost to Follow-up|1|||
23437528|NCT01727336|65344105|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
23437529|NCT01727336|65344106|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
23437530|NCT01727336|65344107|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
23437531|NCT01727336|65344108|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
23437532|NCT01727336|65344109|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
23437533|NCT01727336|65344110|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
23437534|NCT01727336|65344105|FG000|Part 2 Blinded|use of prohibited medications|0|||
23437535|NCT01727336|65344106|FG001|Part 2 Blinded|use of prohibited medications|0|||
23437536|NCT01727336|65344107|FG002|Part 2 Blinded|use of prohibited medications|0|||
23437537|NCT01727336|65344108|FG003|Part 2 Blinded|use of prohibited medications|0|||
23437538|NCT01727336|65344109|FG004|Part 2 Blinded|use of prohibited medications|1|||
23437539|NCT01727336|65344110|FG005|Part 2 Blinded|use of prohibited medications|3|||
23437540|NCT02126839|65344111|FG000|Overall Study|Adverse Event|0|||
23437541|NCT02126839|65344112|FG001|Overall Study|Adverse Event|1|||
23437542|NCT02126839|65344111|FG000|Overall Study|Withdrawal by Subject|1|||
23437543|NCT02126839|65344112|FG001|Overall Study|Withdrawal by Subject|0|||
23437544|NCT02126839|65344111|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23437545|NCT02126839|65344112|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23437546|NCT02126839|65344111|FG000|Overall Study|Protocol Violation|2|||
23437547|NCT02126839|65344112|FG001|Overall Study|Protocol Violation|3|||
23437548|NCT02126839|65344111|FG000|Overall Study|Sponsor request|0|||
23437549|NCT02126839|65344112|FG001|Overall Study|Sponsor request|1|||
23437550|NCT02126839|65344111|FG000|Overall Study|Lost to Follow-up|1|||
23437551|NCT02126839|65344112|FG001|Overall Study|Lost to Follow-up|4|||
23437552|NCT02126839|65344111|FG000|Overall Study|Other|5|||
23437553|NCT02126839|65344112|FG001|Overall Study|Other|5|||
23437554|NCT01534195|65344118|FG000|Overall Study|Withdrawal by Subject|1|||
23437555|NCT01534195|65344119|FG001|Overall Study|Withdrawal by Subject|1|||
23437556|NCT00445770|65344121|FG000|Overall Study|Adverse Event|9|||
23437557|NCT00445770|65344122|FG001|Overall Study|Adverse Event|15|||
23437558|NCT00445770|65344123|FG002|Overall Study|Adverse Event|19|||
23437559|NCT00445770|65344121|FG000|Overall Study|Lack of Efficacy|38|||
23437560|NCT00445770|65344122|FG001|Overall Study|Lack of Efficacy|13|||
23437561|NCT00445770|65344123|FG002|Overall Study|Lack of Efficacy|6|||
23623978|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
23437562|NCT00445770|65344121|FG000|Overall Study|Lost to Follow-up|0|||
23437563|NCT00445770|65344122|FG001|Overall Study|Lost to Follow-up|2|||
23437564|NCT00445770|65344123|FG002|Overall Study|Lost to Follow-up|0|||
23437565|NCT00445770|65344121|FG000|Overall Study|Other|6|||
23437566|NCT00445770|65344122|FG001|Overall Study|Other|5|||
23437567|NCT00445770|65344123|FG002|Overall Study|Other|6|||
23437568|NCT02921087|65344139|FG000|Overall Study|Withdrawal by Subject|0|||
23437569|NCT02921087|65344140|FG001|Overall Study|Withdrawal by Subject|1|||
23437570|NCT01140061|65344143|FG000|Part I|Adverse Event|1|||
23437571|NCT01140061|65344144|FG001|Part I|Adverse Event|0|||
23437572|NCT01140061|65344145|FG002|Part I|Adverse Event|0|||
23437573|NCT01140061|65344146|FG003|Part I|Adverse Event|0|||
23437574|NCT01140061|65344147|FG004|Part I|Adverse Event|0|||
23437575|NCT01140061|65344148|FG005|Part I|Adverse Event|0|||
23437576|NCT01140061|65344149|FG006|Part I|Adverse Event|0|||
23437577|NCT01140061|65344150|FG007|Part I|Adverse Event|0|||
23623979|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
23623980|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
23623981|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
23623982|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
23623983|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
23623984|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
23623985|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
23623986|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Death|6|||
23623987|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Death|2|||
23623988|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Death|2|||
23623989|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Death|9|||
23623990|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
23623991|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23623992|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23623993|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
23623994|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
23623995|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
23623996|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
23623997|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
23623998|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
23754110|NCT01396161|66480781|FG005|Overall Study|Withdrawal by Subject|0|||
23754111|NCT01396161|66480782|FG006|Overall Study|Withdrawal by Subject|0|||
23754112|NCT01396161|66480776|FG000|Overall Study|Other|0|||
23754113|NCT01396161|66480777|FG001|Overall Study|Other|0|||
23754114|NCT01396161|66480778|FG002|Overall Study|Other|0|||
23754115|NCT01396161|66480779|FG003|Overall Study|Other|0|||
23754116|NCT01396161|66480780|FG004|Overall Study|Other|0|||
23754117|NCT01396161|66480781|FG005|Overall Study|Other|0|||
23754118|NCT01396161|66480782|FG006|Overall Study|Other|1|||
23754119|NCT02237118|66480783|FG000|Overall Study|Protocol Violation|0|||
23754120|NCT02237118|66480784|FG001|Overall Study|Protocol Violation|1|||
23754121|NCT02237118|66480783|FG000|Overall Study|consent withdrawn|1|||
23754122|NCT02237118|66480784|FG001|Overall Study|consent withdrawn|0|||
23754123|NCT03722849|66480785|FG000|Overall Study|Withdrawal by Subject|1|||
23754124|NCT03722849|66480786|FG001|Overall Study|Withdrawal by Subject|1|||
23623999|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
23624000|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
23624001|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
23754125|NCT05349188|66480787|FG000|Overall Study|Withdrawal by Subject|1|||
23754126|NCT05349188|66480788|FG001|Overall Study|Withdrawal by Subject|0|||
23754127|NCT03594175|66480789|FG000|Overall Study|Not treated|8|||
23754128|NCT03594175|66480790|FG001|Overall Study|Not treated|1|||
23754129|NCT03594175|66480791|FG002|Overall Study|Not treated|5|||
23754130|NCT03594175|66480789|FG000|Overall Study|Adverse Event|3|||
23754131|NCT03594175|66480790|FG001|Overall Study|Adverse Event|0|||
23754132|NCT03594175|66480791|FG002|Overall Study|Adverse Event|0|||
23754133|NCT03594175|66480789|FG000|Overall Study|Withdrawal by Subject|3|||
23754134|NCT03594175|66480790|FG001|Overall Study|Withdrawal by Subject|0|||
23754135|NCT03594175|66480791|FG002|Overall Study|Withdrawal by Subject|0|||
23754136|NCT03594175|66480789|FG000|Overall Study|Protocol Violation|2|||
23754137|NCT03594175|66480790|FG001|Overall Study|Protocol Violation|2|||
23754138|NCT03594175|66480791|FG002|Overall Study|Protocol Violation|2|||
23754139|NCT00975884|66480801|FG000|Overall Study|Adverse Event|1|||
23754140|NCT00975884|66480802|FG001|Overall Study|Adverse Event|0|||
23754141|NCT00975884|66480801|FG000|Overall Study|Lost to Follow-up|5|||
23754142|NCT00975884|66480802|FG001|Overall Study|Lost to Follow-up|3|||
23754143|NCT00975884|66480801|FG000|Overall Study|Withdrawal by Subject|9|||
23754144|NCT00975884|66480802|FG001|Overall Study|Withdrawal by Subject|9|||
23754145|NCT00975884|66480801|FG000|Overall Study|Other|1|||
23754146|NCT00975884|66480802|FG001|Overall Study|Other|3|||
23754147|NCT01346501|66480809|FG000|Overall Study|Initiated Other Biological Agents|3|||
23754148|NCT01346501|66480810|FG001|Overall Study|Initiated Other Biological Agents|1|||
23754149|NCT01346501|66480809|FG000|Overall Study|Other|8|||
23754150|NCT01346501|66480810|FG001|Overall Study|Other|12|||
23754151|NCT00759759|66480813|FG000|Overall Study|didn't return for period 2|1|||
23754152|NCT00759759|66480814|FG001|Overall Study|didn't return for period 2|0|||
23754153|NCT00759759|66480813|FG000|Overall Study|Didn't receive drug in period 2|1|||
23754154|NCT00759759|66480814|FG001|Overall Study|Didn't receive drug in period 2|0|||
23754155|NCT00759759|66480813|FG000|Overall Study|Withdrawal by Subject|2|||
23754156|NCT00759759|66480814|FG001|Overall Study|Withdrawal by Subject|1|||
23754157|NCT04939701|66480818|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
23754158|NCT04939701|66480819|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
23754159|NCT04939701|66480820|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
23754160|NCT04939701|66480818|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
23754161|NCT04939701|66480819|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
23754162|NCT04939701|66480820|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
23754163|NCT04939701|66480818|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
23754164|NCT04939701|66480819|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
23754165|NCT04939701|66480820|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
23754166|NCT04939701|66480818|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
23754167|NCT04939701|66480819|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
23754168|NCT04939701|66480820|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
23754169|NCT04939701|66480818|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
23754170|NCT04939701|66480819|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
23754171|NCT04939701|66480820|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
23825566|NCT01090414|66741523|FG000|Study 101-99|Sponsor Discontinued Study|0|||
23825567|NCT01090414|66741524|FG001|Study 101-99|Sponsor Discontinued Study|7|||
23558666|NCT02342886|65772589|FG002|Overall Study|Withdrawal by Subject|0|||
23754172|NCT04939701|66480818|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
23754173|NCT04939701|66480819|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
23825568|NCT01090414|66741525|FG002|Study 101-99|Sponsor Discontinued Study|5|||
23825569|NCT01090414|66741526|FG003|Study 101-99|Sponsor Discontinued Study|0|||
23825570|NCT01090414|66741523|FG000|Study 101-99|Other (Unknown Reasons)|3|||
23825571|NCT01090414|66741524|FG001|Study 101-99|Other (Unknown Reasons)|3|||
23825572|NCT01090414|66741525|FG002|Study 101-99|Other (Unknown Reasons)|0|||
23825573|NCT01090414|66741526|FG003|Study 101-99|Other (Unknown Reasons)|0|||
23825574|NCT01090414|66741523|FG000|Study 101-99|Withdrew Consent|0|||
23825575|NCT01090414|66741524|FG001|Study 101-99|Withdrew Consent|2|||
23825576|NCT01090414|66741525|FG002|Study 101-99|Withdrew Consent|3|||
23825577|NCT01090414|66741526|FG003|Study 101-99|Withdrew Consent|1|||
23825578|NCT01090414|66741523|FG000|Study 101-99|Participant Request|3|||
23825579|NCT01090414|66741524|FG001|Study 101-99|Participant Request|1|||
23558667|NCT02342886|65772590|FG003|Overall Study|Withdrawal by Subject|1|||
23437578|NCT01140061|65344151|FG008|Part I|Adverse Event|0|||
23437579|NCT01140061|65344152|FG009|Part I|Adverse Event|0|||
23437580|NCT01140061|65344143|FG000|Extension|Laboratory Adverse Event|0|||
23437581|NCT01140061|65344144|FG001|Extension|Laboratory Adverse Event|0|||
23437582|NCT01140061|65344145|FG002|Extension|Laboratory Adverse Event|0|||
23437583|NCT01140061|65344146|FG003|Extension|Laboratory Adverse Event|0|||
23437584|NCT01140061|65344147|FG004|Extension|Laboratory Adverse Event|0|||
23437585|NCT01140061|65344148|FG005|Extension|Laboratory Adverse Event|0|||
23754174|NCT04939701|66480820|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
23754175|NCT04939701|66480818|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
23437586|NCT01140061|65344149|FG006|Extension|Laboratory Adverse Event|0|||
23437587|NCT01140061|65344150|FG007|Extension|Laboratory Adverse Event|0|||
23437588|NCT01140061|65344151|FG008|Extension|Laboratory Adverse Event|0|||
23437589|NCT01140061|65344152|FG009|Extension|Laboratory Adverse Event|1|||
23437590|NCT00320424|65344153|FG000|Overall Study|Adverse Event|3|||
23754176|NCT04939701|66480819|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
23437591|NCT00320424|65344153|FG000|Overall Study|Other|3|||
23437592|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Adverse Event|1|||
23437593|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Adverse Event|0|||
23825580|NCT01090414|66741525|FG002|Study 101-99|Participant Request|0|||
23825581|NCT01090414|66741526|FG003|Study 101-99|Participant Request|0|||
23825582|NCT00584454|66741527|FG000|Overall Study|Adverse Event|1|||
23825583|NCT00584454|66741527|FG000|Overall Study|Relocation|1|||
23825584|NCT00584454|66741527|FG000|Overall Study|Clinical Hold|2|||
23825585|NCT02174627|66741528|FG000|Overall Study|Missing|0|||
23825586|NCT02174627|66741529|FG001|Overall Study|Missing|1|||
23825587|NCT02174627|66741528|FG000|Overall Study|Incorrect enrolment before randomization|0|||
23825588|NCT02174627|66741529|FG001|Overall Study|Incorrect enrolment before randomization|1|||
23825589|NCT02174627|66741528|FG000|Overall Study|Participant decision|84|||
23825590|NCT02174627|66741529|FG001|Overall Study|Participant decision|128|||
23825591|NCT01811472|66741532|FG000|Overall Study|Adverse Event|1|||
23437594|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
23437595|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
23437596|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
23437597|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
23437598|NCT00547521|65344154|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
23437599|NCT00547521|65344155|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
23437600|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
23437601|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
23754177|NCT04939701|66480820|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
23754178|NCT00833976|66480821|FG000|Overall Study|Withdrawal by Subject|5|||
23754179|NCT00833976|66480821|FG000|Overall Study|Lost to Follow-up|4|||
23754180|NCT00833976|66480821|FG000|Overall Study|Did not meet eligibility criteria|41|||
23754181|NCT00833976|66480821|FG000|Overall Study|Physician Decision|1|||
23754182|NCT00755937|66480826|FG000|Recruitment|Unknown if infliximab received|164|||
23754183|NCT00755937|66480826|FG000|Observational Follow-up|Lost to Follow-up|148|||
23754184|NCT05674721|66480827|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
23754185|NCT05674721|66480828|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
23754186|NCT05674721|66480827|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
23825592|NCT01811472|66741533|FG001|Overall Study|Adverse Event|0|||
23437602|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
23437603|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
23437604|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
23437605|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
23437606|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
23437607|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
23437608|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Other|0|||
23437609|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Other|2|||
23437610|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
23437611|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
23437612|NCT01868477|65344162|FG000|Overall Study|Adverse Event|2|||
23437613|NCT01868477|65344163|FG001|Overall Study|Adverse Event|4|||
23437614|NCT01868477|65344162|FG000|Overall Study|Disease progression|1|||
23437615|NCT01868477|65344163|FG001|Overall Study|Disease progression|1|||
23825593|NCT01811472|66741534|FG002|Overall Study|Adverse Event|4|||
23825594|NCT01811472|66741532|FG000|Overall Study|Lost to Follow-up|0|||
23825595|NCT01811472|66741533|FG001|Overall Study|Lost to Follow-up|0|||
23437616|NCT01868477|65344162|FG000|Overall Study|Withdrawal by Subject|1|||
23437617|NCT01868477|65344163|FG001|Overall Study|Withdrawal by Subject|0|||
23437618|NCT02409342|65344164|FG000|Overall Study|Death|211|||
23754187|NCT05674721|66480828|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
23437619|NCT02409342|65344165|FG001|Overall Study|Death|201|||
23437620|NCT02409342|65344164|FG000|Overall Study|Withdrawal by Subject|24|||
23754188|NCT00457418|66480829|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
23754189|NCT00457418|66480829|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
23754190|NCT00457418|66480829|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
23754191|NCT00457418|66480829|FG000|Post PK Maintenance|Adverse Event|10|||
23754192|NCT00457418|66480829|FG000|Post PK Maintenance|Progression of Disease|6|||
23754193|NCT00457418|66480829|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
23754194|NCT00457418|66480829|FG000|Post PK Maintenance|Lost to Follow-up|1|||
23754195|NCT02050373|66480830|FG000|Overall Study|Adverse Event|4|||
23754196|NCT02050373|66480831|FG001|Overall Study|Adverse Event|7|||
23754197|NCT02050373|66480830|FG000|Overall Study|Death|3|||
23754198|NCT02050373|66480831|FG001|Overall Study|Death|3|||
23754199|NCT01966107|66480832|FG000|Overall Study|excluded from FAS|21|||
23754200|NCT01966107|66480833|FG001|Overall Study|excluded from FAS|20|||
23754201|NCT01966107|66480832|FG000|Overall Study|discontinued treatment|345|||
23754202|NCT01966107|66480833|FG001|Overall Study|discontinued treatment|372|||
23754203|NCT01966107|66480832|FG000|Overall Study|due to study closure|164|||
23754204|NCT01966107|66480833|FG001|Overall Study|due to study closure|186|||
23754205|NCT01966107|66480832|FG000|Overall Study|withdrew from the study|272|||
23754206|NCT01966107|66480833|FG001|Overall Study|withdrew from the study|303|||
23754207|NCT01238172|66480834|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
23754208|NCT01238172|66480835|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
23754209|NCT01238172|66480834|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
23754210|NCT01238172|66480835|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
23754211|NCT01875991|66480836|FG000|Overall Study|Withdrawal by Subject|6|||
23754212|NCT01875991|66480837|FG001|Overall Study|Withdrawal by Subject|6|||
23754213|NCT01875991|66480836|FG000|Overall Study|Sponsor Decision|1|||
23754214|NCT01875991|66480837|FG001|Overall Study|Sponsor Decision|0|||
23754215|NCT00929201|66480840|FG000|Period 1|Withdrawal by Subject|0|||
23754216|NCT00929201|66480841|FG001|Period 1|Withdrawal by Subject|1|||
23754217|NCT00953927|66480842|FG000|Overall Study|Lost to Follow-up|61|||
23754218|NCT00953927|66480843|FG001|Overall Study|Lost to Follow-up|65|||
23754219|NCT00953927|66480842|FG000|Overall Study|Withdrawal by Subject|36|||
23754220|NCT00953927|66480843|FG001|Overall Study|Withdrawal by Subject|25|||
23754221|NCT00953927|66480842|FG000|Overall Study|Death|7|||
23754222|NCT00953927|66480843|FG001|Overall Study|Death|4|||
23754223|NCT00953927|66480842|FG000|Overall Study|Other study discontinuation|1|||
23754224|NCT00953927|66480843|FG001|Overall Study|Other study discontinuation|1|||
23754225|NCT01256398|66480844|FG000|Overall Study|Withdrawal by Subject|1|||
23754226|NCT03159611|66480845|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
23754227|NCT03159611|66480846|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
23754228|NCT03159611|66480845|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
23754229|NCT03159611|66480846|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
23754230|NCT03159611|66480845|FG000|Overall Study|Protocol Violation|7|||
23754231|NCT03159611|66480846|FG001|Overall Study|Protocol Violation|4|||
23754232|NCT03159611|66480845|FG000|Overall Study|Adverse Event|1|||
23754233|NCT03159611|66480846|FG001|Overall Study|Adverse Event|0|||
23754234|NCT03159611|66480845|FG000|Overall Study|Withdrawal by Subject|1|||
23754235|NCT03159611|66480846|FG001|Overall Study|Withdrawal by Subject|1|||
23754236|NCT03159611|66480845|FG000|Overall Study|Non-compliance with protocol requirement|3|||
23754237|NCT03159611|66480846|FG001|Overall Study|Non-compliance with protocol requirement|2|||
23754238|NCT03159611|66480845|FG000|Overall Study|Inability to perform procedures|1|||
23754239|NCT03159611|66480846|FG001|Overall Study|Inability to perform procedures|0|||
23754240|NCT01466673|66480847|FG000|Overall Study|Non-compliance with study treatment|2|||
23754241|NCT01466673|66480848|FG001|Overall Study|Non-compliance with study treatment|0|||
23754242|NCT01466673|66480847|FG000|Overall Study|Lost to Follow-up|3|||
23754243|NCT01466673|66480848|FG001|Overall Study|Lost to Follow-up|5|||
23754244|NCT01466673|66480847|FG000|Overall Study|Adverse Event|2|||
23754245|NCT01466673|66480848|FG001|Overall Study|Adverse Event|1|||
23754246|NCT02996448|66480851|FG000|Overall Study|Study terminated due to adverse effects|3|||
23754247|NCT05553600|66480852|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
23754248|NCT05553600|66480853|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
23754249|NCT05553600|66480854|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
23754250|NCT05553600|66480855|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
23754251|NCT05553600|66480852|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
23754252|NCT05553600|66480853|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
23754253|NCT05553600|66480854|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
23754254|NCT05553600|66480855|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
23754255|NCT05553600|66480852|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23754256|NCT05553600|66480853|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23825596|NCT01811472|66741534|FG002|Overall Study|Lost to Follow-up|1|||
23825597|NCT01811472|66741532|FG000|Overall Study|Subject/guardian decision|1|||
23825598|NCT01811472|66741533|FG001|Overall Study|Subject/guardian decision|0|||
23754257|NCT05553600|66480854|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23754258|NCT05553600|66480855|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
23754259|NCT05553600|66480852|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
23754260|NCT05553600|66480853|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
23754261|NCT05553600|66480854|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
23754262|NCT05553600|66480855|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
23754263|NCT05553600|66480852|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
23754264|NCT05553600|66480853|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
23754265|NCT05553600|66480854|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
23754266|NCT05553600|66480855|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
23754267|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23754268|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23754269|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
23754270|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23754271|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
23754272|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
23754273|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
23754274|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
23754275|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
23754276|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
23754277|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
23754278|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
23754279|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
23754280|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
23754281|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
23754282|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
23754283|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
23754284|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
23754285|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
23754286|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
23754287|NCT05553600|66480852|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
23754288|NCT05553600|66480853|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
23754289|NCT05553600|66480854|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
23754290|NCT05553600|66480855|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
23754291|NCT05553600|66480852|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
23754292|NCT05553600|66480853|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
23754293|NCT05553600|66480854|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
23754294|NCT05553600|66480855|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
23624002|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23624003|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23624004|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23624005|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
23624006|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
23624007|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
23624008|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
23624009|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
23624010|NCT03730662|66011510|FG000|Variable Treatment Period|Adverse Event|1|||
23624011|NCT03730662|66011511|FG001|Variable Treatment Period|Adverse Event|2|||
23624012|NCT03730662|66011512|FG002|Variable Treatment Period|Adverse Event|0|||
23624013|NCT03730662|66011513|FG003|Variable Treatment Period|Adverse Event|7|||
23624014|NCT03730662|66011510|FG000|Variable Treatment Period|Death|9|||
23624015|NCT03730662|66011511|FG001|Variable Treatment Period|Death|0|||
23624016|NCT03730662|66011512|FG002|Variable Treatment Period|Death|6|||
23624017|NCT03730662|66011513|FG003|Variable Treatment Period|Death|26|||
23624018|NCT03730662|66011510|FG000|Variable Treatment Period|Lost to Follow-up|2|||
23624019|NCT03730662|66011511|FG001|Variable Treatment Period|Lost to Follow-up|1|||
23624020|NCT03730662|66011512|FG002|Variable Treatment Period|Lost to Follow-up|4|||
23624021|NCT03730662|66011513|FG003|Variable Treatment Period|Lost to Follow-up|11|||
23624022|NCT03730662|66011510|FG000|Variable Treatment Period|Personal Reason|0|||
23624023|NCT03730662|66011511|FG001|Variable Treatment Period|Personal Reason|2|||
23624024|NCT03730662|66011512|FG002|Variable Treatment Period|Personal Reason|1|||
23624025|NCT03730662|66011513|FG003|Variable Treatment Period|Personal Reason|6|||
23624026|NCT03730662|66011510|FG000|Variable Treatment Period|Physician Decision|0|||
23624027|NCT03730662|66011511|FG001|Variable Treatment Period|Physician Decision|0|||
23624028|NCT03730662|66011512|FG002|Variable Treatment Period|Physician Decision|0|||
23624029|NCT03730662|66011513|FG003|Variable Treatment Period|Physician Decision|3|||
23624030|NCT03730662|66011510|FG000|Variable Treatment Period|Protocol Violation|0|||
23624031|NCT03730662|66011511|FG001|Variable Treatment Period|Protocol Violation|1|||
23754295|NCT00530439|66480858|FG000|Overall Study|GDM|9|||
23754296|NCT00530439|66480859|FG001|Overall Study|GDM|3|||
23754297|NCT00530439|66480858|FG000|Overall Study|Withdraw|18|||
23754298|NCT00530439|66480859|FG001|Overall Study|Withdraw|14|||
23624032|NCT03730662|66011512|FG002|Variable Treatment Period|Protocol Violation|1|||
23624033|NCT03730662|66011513|FG003|Variable Treatment Period|Protocol Violation|1|||
23624034|NCT03730662|66011510|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
23624035|NCT03730662|66011511|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
23624036|NCT03730662|66011512|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
23624037|NCT03730662|66011513|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
23624038|NCT01167192|66011515|FG000|Overall Study|Adverse Event|1|||
23624039|NCT01167192|66011515|FG000|Overall Study|Death|1|||
23624040|NCT01167192|66011515|FG000|Overall Study|Withdrawal by Subject|1|||
23624041|NCT01167192|66011515|FG000|Overall Study|Insurance denial|1|||
23624042|NCT01086384|66011516|FG000|2-week Run-in Period|Adverse Event|1|||
23624043|NCT01086384|66011517|FG001|2-week Run-in Period|Adverse Event|0|||
23624044|NCT01086384|66011518|FG002|2-week Run-in Period|Adverse Event|0|||
23624045|NCT01086384|66011516|FG000|2-week Run-in Period|Protocol Violation|1|||
23624046|NCT01086384|66011517|FG001|2-week Run-in Period|Protocol Violation|0|||
23624047|NCT01086384|66011518|FG002|2-week Run-in Period|Protocol Violation|0|||
23624048|NCT01086384|66011516|FG000|2-week Run-in Period|Lost to Follow-up|1|||
23624049|NCT01086384|66011517|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23624050|NCT01086384|66011518|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23624051|NCT01086384|66011516|FG000|2-week Run-in Period|Physician Decision|6|||
23624052|NCT01086384|66011517|FG001|2-week Run-in Period|Physician Decision|0|||
23624053|NCT01086384|66011518|FG002|2-week Run-in Period|Physician Decision|0|||
23624054|NCT01086384|66011516|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
23624055|NCT01086384|66011517|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23624056|NCT01086384|66011518|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23624057|NCT01086384|66011516|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
23624058|NCT01086384|66011517|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
23624059|NCT01086384|66011518|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
23624060|NCT01086384|66011516|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
23624061|NCT01086384|66011517|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23754299|NCT00530439|66480858|FG000|Overall Study|Missed abortion|1|||
23754300|NCT00530439|66480859|FG001|Overall Study|Missed abortion|4|||
23754301|NCT00530439|66480858|FG000|Overall Study|Misclassification|2|||
23754302|NCT00530439|66480859|FG001|Overall Study|Misclassification|0|||
23754303|NCT00530439|66480858|FG000|Overall Study|Twin pregnancy|0|||
23754304|NCT00530439|66480859|FG001|Overall Study|Twin pregnancy|2|||
23754305|NCT00530439|66480858|FG000|Overall Study|Severe malformation/abortion|0|||
23754306|NCT00530439|66480859|FG001|Overall Study|Severe malformation/abortion|3|||
23754307|NCT00728988|66480867|FG000|Overall Study|Not Treated|2|||
23754308|NCT00728988|66480868|FG001|Overall Study|Not Treated|2|||
23754309|NCT00728988|66480867|FG000|Overall Study|Death|1|||
23754310|NCT00728988|66480868|FG001|Overall Study|Death|1|||
23754311|NCT00728988|66480867|FG000|Overall Study|Adverse Event|3|||
23754312|NCT00728988|66480868|FG001|Overall Study|Adverse Event|2|||
23754313|NCT00728988|66480867|FG000|Overall Study|Other|85|||
23754314|NCT00728988|66480868|FG001|Overall Study|Other|77|||
23754315|NCT00728988|66480867|FG000|Overall Study|Withdrawal by Subject|2|||
23754316|NCT00728988|66480868|FG001|Overall Study|Withdrawal by Subject|6|||
23754317|NCT03333382|66480869|FG000|Overall Study|Lost to Follow-up|1|||
23754318|NCT03333382|66480870|FG001|Overall Study|Lost to Follow-up|0|||
23754319|NCT01154673|66480871|FG000|Overall Study|Lost to Follow-up|1|||
23754320|NCT01154673|66480872|FG001|Overall Study|Lost to Follow-up|0|||
23754321|NCT01154673|66480871|FG000|Overall Study|moved out of province|1|||
23754322|NCT01154673|66480872|FG001|Overall Study|moved out of province|0|||
23754323|NCT03273712|66480873|FG000|Overall Study|Death|5|||
23754324|NCT03273712|66480873|FG000|Overall Study|Adverse Event|1|||
23754325|NCT03273712|66480873|FG000|Overall Study|Disease Progression|1|||
23754326|NCT00386100|66480874|FG000|Overall Study|Did not receive study medication|6|||
23754327|NCT00386100|66480875|FG001|Overall Study|Did not receive study medication|4|||
23754328|NCT00386100|66480874|FG000|Overall Study|Adverse Event|15|||
23754329|NCT00386100|66480875|FG001|Overall Study|Adverse Event|25|||
23754330|NCT00386100|66480874|FG000|Overall Study|Death|0|||
23437621|NCT02409342|65344165|FG001|Overall Study|Withdrawal by Subject|17|||
23437622|NCT02409342|65344164|FG000|Overall Study|Study Terminated By Sponsor|48|||
23624062|NCT01086384|66011518|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23624063|NCT01086384|66011516|FG000|2-week Run-in Period|Randomized in Error|1|||
23624064|NCT01086384|66011517|FG001|2-week Run-in Period|Randomized in Error|0|||
23624065|NCT01086384|66011518|FG002|2-week Run-in Period|Randomized in Error|0|||
23624066|NCT01086384|66011516|FG000|Treatment Period|Withdrawal by Subject|0|||
23754331|NCT00386100|66480875|FG001|Overall Study|Death|1|||
23754332|NCT00386100|66480874|FG000|Overall Study|Insufficient therapeutic effect|30|||
23754333|NCT00386100|66480875|FG001|Overall Study|Insufficient therapeutic effect|6|||
23754334|NCT00386100|66480874|FG000|Overall Study|Lost to Follow-up|29|||
23754335|NCT00386100|66480875|FG001|Overall Study|Lost to Follow-up|29|||
23754336|NCT00386100|66480874|FG000|Overall Study|Non-compliance|18|||
23754337|NCT00386100|66480875|FG001|Overall Study|Non-compliance|19|||
23754338|NCT00386100|66480874|FG000|Overall Study|Protocol Violation|5|||
23754339|NCT00386100|66480875|FG001|Overall Study|Protocol Violation|3|||
23754340|NCT00386100|66480874|FG000|Overall Study|Withdrawal by Subject|32|||
23754341|NCT00386100|66480875|FG001|Overall Study|Withdrawal by Subject|31|||
23754342|NCT00386100|66480874|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
23754343|NCT00386100|66480875|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
23754344|NCT00386100|66480874|FG000|Overall Study|BMD <2.5|1|||
23754345|NCT00386100|66480875|FG001|Overall Study|BMD <2.5|0|||
23754346|NCT00386100|66480874|FG000|Overall Study|Consecutive elevated Hba1C|1|||
23754347|NCT00386100|66480875|FG001|Overall Study|Consecutive elevated Hba1C|0|||
23754348|NCT00386100|66480874|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
23624067|NCT01086384|66011517|FG001|Treatment Period|Withdrawal by Subject|53|||
23754349|NCT00386100|66480875|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
23754350|NCT00386100|66480874|FG000|Overall Study|Laboratory findings|1|||
23754351|NCT00386100|66480875|FG001|Overall Study|Laboratory findings|0|||
23754352|NCT00386100|66480874|FG000|Overall Study|Participant's concern due to CPK levels|1|||
23754353|NCT00386100|66480875|FG001|Overall Study|Participant's concern due to CPK levels|0|||
23754354|NCT00386100|66480874|FG000|Overall Study|Participant moving out of state|2|||
23754355|NCT00386100|66480875|FG001|Overall Study|Participant moving out of state|0|||
23754356|NCT00386100|66480874|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
23754357|NCT00386100|66480875|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
23754358|NCT00386100|66480874|FG000|Overall Study|Didn't meet entry criteria|1|||
23754359|NCT00386100|66480875|FG001|Overall Study|Didn't meet entry criteria|1|||
23754360|NCT00386100|66480874|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
23754361|NCT00386100|66480875|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
23754362|NCT00386100|66480874|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
23754363|NCT00386100|66480875|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
23754364|NCT00386100|66480874|FG000|Overall Study|Bad metabolic control & patient security|1|||
23825599|NCT01811472|66741534|FG002|Overall Study|Subject/guardian decision|0|||
23754365|NCT00386100|66480875|FG001|Overall Study|Bad metabolic control & patient security|0|||
23754366|NCT00386100|66480874|FG000|Overall Study|Bone loss by DXA bone scan|1|||
23754367|NCT00386100|66480875|FG001|Overall Study|Bone loss by DXA bone scan|0|||
23754368|NCT00386100|66480874|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
23754369|NCT00386100|66480875|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
23825600|NCT00065156|66741535|FG000|Overall Study|Adverse Event|37|||
23825601|NCT00065156|66741535|FG000|Overall Study|Lack of Efficacy|52|||
23825602|NCT00065156|66741535|FG000|Overall Study|Withdrawal by Subject|8|||
23825603|NCT00065156|66741535|FG000|Overall Study|Lost to Follow-up|1|||
23825604|NCT00065156|66741535|FG000|Overall Study|Death|11|||
23825605|NCT00065156|66741535|FG000|Overall Study|Study Closed by Sponsor|2|||
23825606|NCT00065156|66741535|FG000|Overall Study|Disease Progression|7|||
23825607|NCT00065156|66741535|FG000|Overall Study|Investigator Decision|2|||
23825608|NCT00065156|66741535|FG000|Overall Study|Non-Compliance|2|||
23437623|NCT02409342|65344165|FG001|Overall Study|Study Terminated By Sponsor|59|||
23437624|NCT02409342|65344164|FG000|Overall Study|Lost to Follow-up|3|||
23754370|NCT00386100|66480874|FG000|Overall Study|7.6% bone loss|1|||
23754371|NCT00386100|66480875|FG001|Overall Study|7.6% bone loss|0|||
23825609|NCT00065156|66741535|FG000|Overall Study|Loss of Response|1|||
23825610|NCT00065156|66741535|FG000|Overall Study|Secondary Malign Disease|1|||
23558668|NCT02342886|65772591|FG004|Overall Study|Withdrawal by Subject|0|||
23437625|NCT02409342|65344165|FG001|Overall Study|Lost to Follow-up|5|||
23558669|NCT02342886|65772587|FG000|Overall Study|Investigator/sponsor decision|0|||
23558670|NCT02342886|65772588|FG001|Overall Study|Investigator/sponsor decision|2|||
23558671|NCT02342886|65772589|FG002|Overall Study|Investigator/sponsor decision|0|||
23558672|NCT02342886|65772590|FG003|Overall Study|Investigator/sponsor decision|3|||
23558673|NCT02342886|65772591|FG004|Overall Study|Investigator/sponsor decision|1|||
23558674|NCT02342886|65772587|FG000|Overall Study|Pregnancy|0|||
23558675|NCT02342886|65772588|FG001|Overall Study|Pregnancy|0|||
23558676|NCT02342886|65772589|FG002|Overall Study|Pregnancy|2|||
23558677|NCT02342886|65772590|FG003|Overall Study|Pregnancy|0|||
23558678|NCT02342886|65772591|FG004|Overall Study|Pregnancy|0|||
23558679|NCT02342886|65772587|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558680|NCT02342886|65772588|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558681|NCT02342886|65772589|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
23558682|NCT02342886|65772590|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558683|NCT02342886|65772591|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558684|NCT02342886|65772587|FG000|Overall Study|Protocol Violation|0|||
23558685|NCT02342886|65772588|FG001|Overall Study|Protocol Violation|0|||
23558686|NCT02342886|65772589|FG002|Overall Study|Protocol Violation|0|||
23558687|NCT02342886|65772590|FG003|Overall Study|Protocol Violation|2|||
23558688|NCT02342886|65772591|FG004|Overall Study|Protocol Violation|0|||
23754372|NCT00386100|66480874|FG000|Overall Study|Osteoporosis|0|||
23754373|NCT00386100|66480875|FG001|Overall Study|Osteoporosis|1|||
23754374|NCT00386100|66480874|FG000|Overall Study|Positive pregnancy test|1|||
23754375|NCT00386100|66480875|FG001|Overall Study|Positive pregnancy test|3|||
23754376|NCT00386100|66480874|FG000|Overall Study|Out of country for 5 months|1|||
23754377|NCT00386100|66480875|FG001|Overall Study|Out of country for 5 months|0|||
23754378|NCT00386100|66480874|FG000|Overall Study|Hb1Ac >8%|0|||
23754379|NCT00386100|66480875|FG001|Overall Study|Hb1Ac >8%|1|||
23754380|NCT00386100|66480874|FG000|Overall Study|Participant randomized in error|1|||
23754381|NCT00386100|66480875|FG001|Overall Study|Participant randomized in error|0|||
23754382|NCT00005879|66480880|FG000|Overall Study|Withdrawal by Subject|8|||
23754383|NCT00005879|66480881|FG001|Overall Study|Withdrawal by Subject|10|||
23754384|NCT01850108|66480882|FG000|Overall Study|Lost to Follow-up|4|||
23754385|NCT01850108|66480882|FG000|Overall Study|Not eligible|1|||
23754386|NCT01850108|66480882|FG000|Overall Study|Failed engraftment|2|||
23754387|NCT01850108|66480882|FG000|Overall Study|Physician Decision|1|||
23754388|NCT00666718|66480885|FG000|Overall Study|Adverse Event|0|||
23754389|NCT00666718|66480886|FG001|Overall Study|Adverse Event|1|||
23437626|NCT02409342|65344164|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
23558689|NCT04027348|65772592|FG000|Overall Study|Adverse Event|2|||
23558690|NCT03764072|65772598|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558691|NCT03764072|65772599|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558692|NCT03764072|65772600|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23558693|NCT03764072|65772601|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558694|NCT03764072|65772602|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558695|NCT03764072|65772603|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558696|NCT03764072|65772598|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
23558697|NCT03764072|65772599|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
23558698|NCT03764072|65772600|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
23558699|NCT03764072|65772601|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
23558700|NCT03764072|65772602|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
23558701|NCT03764072|65772603|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
23558702|NCT03764072|65772598|FG000|Overall Study|Lost to Follow-up|0|||
23558703|NCT03764072|65772599|FG001|Overall Study|Lost to Follow-up|0|||
23558704|NCT03764072|65772600|FG002|Overall Study|Lost to Follow-up|0|||
23558705|NCT03764072|65772601|FG003|Overall Study|Lost to Follow-up|0|||
23558706|NCT03764072|65772602|FG004|Overall Study|Lost to Follow-up|1|||
23558707|NCT03764072|65772603|FG005|Overall Study|Lost to Follow-up|0|||
23558708|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
23558709|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
23754390|NCT00666718|66480885|FG000|Overall Study|Death|1|||
23754391|NCT00666718|66480886|FG001|Overall Study|Death|0|||
23754392|NCT00666718|66480885|FG000|Overall Study|Lost to Follow-up|1|||
23754393|NCT00666718|66480886|FG001|Overall Study|Lost to Follow-up|0|||
23754394|NCT00666718|66480885|FG000|Overall Study|Entry Criteria Not Met|2|||
23825611|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
23754395|NCT00666718|66480886|FG001|Overall Study|Entry Criteria Not Met|0|||
23624068|NCT01086384|66011518|FG002|Treatment Period|Withdrawal by Subject|55|||
23624069|NCT01086384|66011516|FG000|Treatment Period|Protocol Violation|0|||
23624070|NCT01086384|66011517|FG001|Treatment Period|Protocol Violation|26|||
23624071|NCT01086384|66011518|FG002|Treatment Period|Protocol Violation|17|||
23624072|NCT01086384|66011516|FG000|Treatment Period|Lack of Efficacy|0|||
23624073|NCT01086384|66011517|FG001|Treatment Period|Lack of Efficacy|22|||
23624074|NCT01086384|66011518|FG002|Treatment Period|Lack of Efficacy|13|||
23624075|NCT01086384|66011516|FG000|Treatment Period|Adverse Event|0|||
23624076|NCT01086384|66011517|FG001|Treatment Period|Adverse Event|19|||
23624077|NCT01086384|66011518|FG002|Treatment Period|Adverse Event|15|||
23558710|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
23624078|NCT01086384|66011516|FG000|Treatment Period|Lost to Follow-up|0|||
23624079|NCT01086384|66011517|FG001|Treatment Period|Lost to Follow-up|11|||
23624080|NCT01086384|66011518|FG002|Treatment Period|Lost to Follow-up|9|||
23624081|NCT01086384|66011516|FG000|Treatment Period|Physician Decision|0|||
23624082|NCT01086384|66011517|FG001|Treatment Period|Physician Decision|9|||
23624083|NCT01086384|66011518|FG002|Treatment Period|Physician Decision|6|||
23624084|NCT01086384|66011516|FG000|Treatment Period|Study Closed/Terminated|0|||
23624085|NCT01086384|66011517|FG001|Treatment Period|Study Closed/Terminated|7|||
23624086|NCT01086384|66011518|FG002|Treatment Period|Study Closed/Terminated|8|||
23558711|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
23558712|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
23558713|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
23558714|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
23558715|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
23558716|NCT01572389|65772610|FG000|Overall Study|Death|1|||
23558717|NCT01572389|65772611|FG001|Overall Study|Death|3|||
23558718|NCT01572389|65772610|FG000|Overall Study|Withdrawal by Subject|14|||
23558719|NCT01572389|65772611|FG001|Overall Study|Withdrawal by Subject|2|||
23624087|NCT01086384|66011516|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
23624088|NCT01086384|66011517|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
23624089|NCT01086384|66011518|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
23624090|NCT01086384|66011516|FG000|Treatment Period|Received Treatment in Error|0|||
23624091|NCT01086384|66011517|FG001|Treatment Period|Received Treatment in Error|1|||
23624092|NCT01086384|66011518|FG002|Treatment Period|Received Treatment in Error|0|||
23624093|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
23624094|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
23624095|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
23624096|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
23624097|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
23624098|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
23624099|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
23624100|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
23624101|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
23624102|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
23624103|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
23624104|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
23624105|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
23624106|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
23624107|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
23624108|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
23624109|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
23624110|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
23624111|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
23624112|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
23624113|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
23754396|NCT00666718|66480885|FG000|Overall Study|Protocol Violation|1|||
23754397|NCT00666718|66480886|FG001|Overall Study|Protocol Violation|3|||
23754398|NCT00666718|66480885|FG000|Overall Study|Withdrawal by Subject|7|||
23754399|NCT00666718|66480886|FG001|Overall Study|Withdrawal by Subject|12|||
23754400|NCT00666718|66480885|FG000|Overall Study|Physician Decision|0|||
23754401|NCT00666718|66480886|FG001|Overall Study|Physician Decision|2|||
23754402|NCT02983227|66480887|FG000|Overall Study|Adverse Event|21|||
23558720|NCT01572389|65772610|FG000|Overall Study|Lost to Follow-up|25|||
23624114|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
23624115|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
23624116|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
23624117|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
23624118|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
23754403|NCT02983227|66480888|FG001|Overall Study|Adverse Event|3|||
23754404|NCT02983227|66480887|FG000|Overall Study|Death|3|||
23624119|NCT01726049|66011525|FG000|Overall Study|Death|1|||
23624120|NCT01726049|66011526|FG001|Overall Study|Death|1|||
23624121|NCT01726049|66011525|FG000|Overall Study|Adverse Event|4|||
23624122|NCT01726049|66011526|FG001|Overall Study|Adverse Event|1|||
23624123|NCT01726049|66011525|FG000|Overall Study|refused second HC|0|||
23624124|NCT01726049|66011526|FG001|Overall Study|refused second HC|2|||
23624125|NCT00478647|66011528|FG000|Overall Study|Adverse Event|1|||
23624126|NCT00478647|66011528|FG000|Overall Study|Withdrawal by Subject|1|||
23624127|NCT00727415|66011529|FG000|Phase I|Dose Limiting Toxicity|2|||
23624128|NCT03856047|66011532|FG000|Overall Study|Withdrawal by Subject|0|||
23624129|NCT03856047|66011533|FG001|Overall Study|Withdrawal by Subject|1|||
23624130|NCT03856047|66011534|FG002|Overall Study|Withdrawal by Subject|1|||
23624131|NCT03856047|66011535|FG003|Overall Study|Withdrawal by Subject|0|||
23624132|NCT03856047|66011536|FG004|Overall Study|Withdrawal by Subject|3|||
23624133|NCT03856047|66011537|FG005|Overall Study|Withdrawal by Subject|0|||
23624134|NCT03856047|66011538|FG006|Overall Study|Withdrawal by Subject|2|||
23624135|NCT03856047|66011532|FG000|Overall Study|Lost to Follow-up|4|||
23624136|NCT03856047|66011533|FG001|Overall Study|Lost to Follow-up|2|||
23624137|NCT03856047|66011534|FG002|Overall Study|Lost to Follow-up|3|||
23624138|NCT03856047|66011535|FG003|Overall Study|Lost to Follow-up|1|||
23624139|NCT03856047|66011536|FG004|Overall Study|Lost to Follow-up|4|||
23624140|NCT03856047|66011537|FG005|Overall Study|Lost to Follow-up|4|||
23624141|NCT03856047|66011538|FG006|Overall Study|Lost to Follow-up|4|||
23624142|NCT00585975|66011539|FG000|Overall Study|Withdrawal by Subject|3|||
23624143|NCT00585975|66011540|FG001|Overall Study|Withdrawal by Subject|3|||
23624144|NCT00585975|66011539|FG000|Overall Study|Lost to Follow-up|2|||
23624145|NCT00585975|66011540|FG001|Overall Study|Lost to Follow-up|1|||
23624146|NCT00585975|66011539|FG000|Overall Study|Enrollment met/over-enrolled|10|||
23624147|NCT00585975|66011540|FG001|Overall Study|Enrollment met/over-enrolled|9|||
23624148|NCT00607997|66011542|FG000|Overall Study|Lack of Efficacy|6|||
23754405|NCT02983227|66480888|FG001|Overall Study|Death|0|||
23754406|NCT02983227|66480887|FG000|Overall Study|Lack of Efficacy|8|||
23754407|NCT02983227|66480888|FG001|Overall Study|Lack of Efficacy|1|||
23754408|NCT02983227|66480887|FG000|Overall Study|Lost to Follow-up|3|||
23754409|NCT02983227|66480888|FG001|Overall Study|Lost to Follow-up|0|||
23754410|NCT02983227|66480887|FG000|Overall Study|Multiple Reasons|2|||
23754411|NCT02983227|66480888|FG001|Overall Study|Multiple Reasons|1|||
23754412|NCT02983227|66480887|FG000|Overall Study|Physician Decision|3|||
23754413|NCT02983227|66480888|FG001|Overall Study|Physician Decision|1|||
23754414|NCT02983227|66480887|FG000|Overall Study|Withdrawal by Subject|19|||
23754415|NCT02983227|66480888|FG001|Overall Study|Withdrawal by Subject|8|||
23624149|NCT00607997|66011543|FG001|Overall Study|Lack of Efficacy|20|||
23624150|NCT00607997|66011544|FG002|Overall Study|Lack of Efficacy|14|||
23624151|NCT00607997|66011545|FG003|Overall Study|Lack of Efficacy|10|||
23624152|NCT00607997|66011542|FG000|Overall Study|Death|8|||
23624153|NCT00607997|66011543|FG001|Overall Study|Death|5|||
23624154|NCT00607997|66011544|FG002|Overall Study|Death|2|||
23624155|NCT00607997|66011545|FG003|Overall Study|Death|5|||
23624156|NCT00607997|66011542|FG000|Overall Study|Adverse Event|3|||
23624157|NCT00607997|66011543|FG001|Overall Study|Adverse Event|1|||
23624158|NCT00607997|66011544|FG002|Overall Study|Adverse Event|2|||
23624159|NCT00607997|66011545|FG003|Overall Study|Adverse Event|0|||
23754416|NCT02499406|66480889|FG000|Overall Study|missed 3 treatment sessions|4|||
23754417|NCT01422720|66480892|FG000|Overall Study|Adverse Event|16|||
23825612|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
23825613|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
23825614|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Death|1|||
23558721|NCT01572389|65772611|FG001|Overall Study|Lost to Follow-up|14|||
23754418|NCT01422720|66480892|FG000|Overall Study|Lack of Efficacy|1|||
23754419|NCT01422720|66480892|FG000|Overall Study|Withdrawal by Subject|4|||
23754420|NCT01422720|66480892|FG000|Overall Study|Ineligibility|1|||
23754421|NCT02181842|66480893|FG000|Overall Study|Case Report Forms Uncollected|2|||
23754422|NCT01227954|66480894|FG000|Overall Study|Protocol Violation|6|||
23754423|NCT01227954|66480894|FG000|Overall Study|No protocol treatment|7|||
23754424|NCT00828516|66480895|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
23754425|NCT00765999|66480905|FG000|Overall Study|Adverse Event|203|||
23754426|NCT00765999|66480905|FG000|Overall Study|Insufficient Therapeutic Response|100|||
23754427|NCT00765999|66480905|FG000|Overall Study|Protocol Violation|95|||
23754428|NCT00765999|66480905|FG000|Overall Study|Consent Withdrawn|202|||
23754429|NCT00765999|66480905|FG000|Overall Study|Lost to Follow-up|131|||
23754430|NCT00765999|66480905|FG000|Overall Study|Study Terminated by Sponsor|2|||
23754431|NCT00765999|66480905|FG000|Overall Study|Other Miscellaneous Reasons|51|||
23754432|NCT02494583|66480906|FG000|Overall Study|Death|224|||
23754433|NCT02494583|66480907|FG001|Overall Study|Death|214|||
23754434|NCT02494583|66480908|FG002|Overall Study|Death|225|||
23754435|NCT02494583|66480906|FG000|Overall Study|Lost to Follow-up|1|||
23754436|NCT02494583|66480907|FG001|Overall Study|Lost to Follow-up|0|||
23754437|NCT02494583|66480908|FG002|Overall Study|Lost to Follow-up|0|||
23754438|NCT02494583|66480906|FG000|Overall Study|Protocol Violation|1|||
23754439|NCT02494583|66480907|FG001|Overall Study|Protocol Violation|2|||
23754440|NCT02494583|66480908|FG002|Overall Study|Protocol Violation|0|||
23754441|NCT02494583|66480906|FG000|Overall Study|Screen Failure|0|||
23754442|NCT02494583|66480907|FG001|Overall Study|Screen Failure|1|||
23754443|NCT02494583|66480908|FG002|Overall Study|Screen Failure|0|||
23754444|NCT02494583|66480906|FG000|Overall Study|Transferred to Extension Study|15|||
23754445|NCT02494583|66480907|FG001|Overall Study|Transferred to Extension Study|15|||
23754446|NCT02494583|66480908|FG002|Overall Study|Transferred to Extension Study|6|||
23754447|NCT02494583|66480906|FG000|Overall Study|Did Not Continue on Extension Study|8|||
23754448|NCT02494583|66480907|FG001|Overall Study|Did Not Continue on Extension Study|10|||
23754449|NCT02494583|66480908|FG002|Overall Study|Did Not Continue on Extension Study|4|||
23754450|NCT02494583|66480906|FG000|Overall Study|Withdrawal by Subject|7|||
23754451|NCT02494583|66480907|FG001|Overall Study|Withdrawal by Subject|15|||
23754452|NCT02494583|66480908|FG002|Overall Study|Withdrawal by Subject|15|||
23754453|NCT03457727|66480909|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23754454|NCT03457727|66480910|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23754455|NCT03457727|66480911|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23558722|NCT01572389|65772610|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
23558723|NCT01572389|65772611|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
23558724|NCT01412801|65772612|FG000|Overall Study|Death|0|||
23558725|NCT01412801|65772613|FG001|Overall Study|Death|1|||
23558726|NCT01412801|65772614|FG002|Overall Study|Death|0|||
23558727|NCT01412801|65772615|FG003|Overall Study|Death|4|||
23558728|NCT01412801|65772616|FG004|Overall Study|Death|2|||
23558729|NCT01412801|65772617|FG005|Overall Study|Death|2|||
23558730|NCT01412801|65772612|FG000|Overall Study|Lost to Follow-up|1|||
23754456|NCT03457727|66480912|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
23754457|NCT01066039|66480913|FG000|Overall Study|Adverse Event|6|||
23754458|NCT01066039|66480913|FG000|Overall Study|Withdrawal by Subject|17|||
23754459|NCT01066039|66480913|FG000|Overall Study|Protocol Violation|2|||
23754460|NCT01066039|66480913|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
23754461|NCT01066039|66480913|FG000|Overall Study|Investigator's Request|1|||
23754462|NCT01066039|66480913|FG000|Overall Study|Dropout due to Insulin Administration|1|||
23754463|NCT01066039|66480913|FG000|Overall Study|Additional Antihypertensive Required|4|||
23754464|NCT01066039|66480913|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
23754465|NCT01066039|66480913|FG000|Overall Study|Failure to Control Blood Pressure|1|||
23754466|NCT01066039|66480913|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
23754467|NCT00928135|66480914|FG000|Overall Study|Withdrawal by Subject|1|||
23754468|NCT00928135|66480915|FG001|Overall Study|Withdrawal by Subject|0|||
23754469|NCT02748616|66480916|FG000|Overall Study|Lost to Follow-up|1|||
23754470|NCT02748616|66480916|FG000|Overall Study|Withdrawal by Subject|2|||
23754471|NCT02748616|66480916|FG000|Overall Study|Physician Decision|2|||
23754472|NCT02748616|66480916|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
23754473|NCT02773446|66480917|FG000|First Admission|Withdrawal by Subject|0|||
23754474|NCT02773446|66480918|FG001|First Admission|Withdrawal by Subject|0|||
23754475|NCT02773446|66480919|FG002|First Admission|Withdrawal by Subject|0|||
23558731|NCT01412801|65772613|FG001|Overall Study|Lost to Follow-up|2|||
23558732|NCT01412801|65772614|FG002|Overall Study|Lost to Follow-up|4|||
23754476|NCT02773446|66480920|FG003|First Admission|Withdrawal by Subject|1|||
23754477|NCT02773446|66480921|FG004|First Admission|Withdrawal by Subject|0|||
23754478|NCT02773446|66480922|FG005|First Admission|Withdrawal by Subject|0|||
23754479|NCT02773446|66480917|FG000|First Admission|Lost to Follow-up|1|||
23754480|NCT02773446|66480918|FG001|First Admission|Lost to Follow-up|0|||
23754481|NCT02773446|66480919|FG002|First Admission|Lost to Follow-up|0|||
23558733|NCT01412801|65772615|FG003|Overall Study|Lost to Follow-up|0|||
23558734|NCT01412801|65772616|FG004|Overall Study|Lost to Follow-up|1|||
23558735|NCT01412801|65772617|FG005|Overall Study|Lost to Follow-up|1|||
23558736|NCT01412801|65772612|FG000|Overall Study|Withdrawal by Subject|3|||
23558737|NCT01412801|65772613|FG001|Overall Study|Withdrawal by Subject|2|||
23558738|NCT01412801|65772614|FG002|Overall Study|Withdrawal by Subject|1|||
23558739|NCT01412801|65772615|FG003|Overall Study|Withdrawal by Subject|0|||
23558740|NCT01412801|65772616|FG004|Overall Study|Withdrawal by Subject|0|||
23558741|NCT01412801|65772617|FG005|Overall Study|Withdrawal by Subject|0|||
23558742|NCT01412801|65772612|FG000|Overall Study|Relocated to another area|0|||
23558743|NCT01412801|65772613|FG001|Overall Study|Relocated to another area|0|||
23624160|NCT00607997|66011542|FG000|Overall Study|Physician Decision|4|||
23624161|NCT00607997|66011543|FG001|Overall Study|Physician Decision|1|||
23624162|NCT00607997|66011544|FG002|Overall Study|Physician Decision|0|||
23624163|NCT00607997|66011545|FG003|Overall Study|Physician Decision|0|||
23624164|NCT00607997|66011542|FG000|Overall Study|Relapse, recurrent illness|4|||
23624165|NCT00607997|66011543|FG001|Overall Study|Relapse, recurrent illness|0|||
23624166|NCT00607997|66011544|FG002|Overall Study|Relapse, recurrent illness|2|||
23624167|NCT00607997|66011545|FG003|Overall Study|Relapse, recurrent illness|0|||
23624168|NCT00607997|66011542|FG000|Overall Study|Other without explanation|2|||
23624169|NCT00607997|66011543|FG001|Overall Study|Other without explanation|0|||
23624170|NCT00607997|66011544|FG002|Overall Study|Other without explanation|4|||
23624171|NCT00607997|66011545|FG003|Overall Study|Other without explanation|1|||
23754482|NCT02773446|66480920|FG003|First Admission|Lost to Follow-up|0|||
23754483|NCT02773446|66480921|FG004|First Admission|Lost to Follow-up|0|||
23624172|NCT00494026|66011546|FG000|Overall Study|Sponsor Decision|4|||
23624173|NCT02781311|66011551|FG000|Overall Study|Adverse Event|2|||
23624174|NCT02781311|66011552|FG001|Overall Study|Adverse Event|6|||
23624175|NCT02781311|66011553|FG002|Overall Study|Adverse Event|1|||
23624176|NCT02781311|66011551|FG000|Overall Study|Withdrawal of Consent|11|||
23624177|NCT02781311|66011552|FG001|Overall Study|Withdrawal of Consent|12|||
23624178|NCT02781311|66011553|FG002|Overall Study|Withdrawal of Consent|2|||
23624179|NCT02781311|66011551|FG000|Overall Study|Lost to Follow-up|11|||
23624180|NCT02781311|66011552|FG001|Overall Study|Lost to Follow-up|8|||
23624181|NCT02781311|66011553|FG002|Overall Study|Lost to Follow-up|1|||
23624182|NCT02781311|66011551|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23624183|NCT02781311|66011552|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23624184|NCT02781311|66011553|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23624185|NCT01813305|66011554|FG000|Overall Study|Withdrawal by Subject|12|||
23624186|NCT01813305|66011555|FG001|Overall Study|Withdrawal by Subject|5|||
23624187|NCT01813305|66011554|FG000|Overall Study|Safety Concern|4|||
23624188|NCT01813305|66011555|FG001|Overall Study|Safety Concern|0|||
23624189|NCT01813305|66011554|FG000|Overall Study|Ulcer became worse|4|||
23624190|NCT01813305|66011555|FG001|Overall Study|Ulcer became worse|0|||
23624191|NCT01813305|66011554|FG000|Overall Study|Physician Decision|4|||
23624192|NCT01813305|66011555|FG001|Overall Study|Physician Decision|0|||
23754484|NCT02773446|66480922|FG005|First Admission|Lost to Follow-up|0|||
23754485|NCT00450177|66480925|FG000|Overall Study|Adverse Event|7|||
23754486|NCT00450177|66480926|FG001|Overall Study|Adverse Event|4|||
23754487|NCT00450177|66480925|FG000|Overall Study|Withdrawal by Subject|1|||
23754488|NCT00450177|66480926|FG001|Overall Study|Withdrawal by Subject|6|||
23754489|NCT00450177|66480925|FG000|Overall Study|Withdrawal by Primary Team|1|||
23754490|NCT00450177|66480926|FG001|Overall Study|Withdrawal by Primary Team|1|||
23754491|NCT01461369|66480929|FG000|Overall Study|Lack of Efficacy|2|||
23754492|NCT01461369|66480930|FG001|Overall Study|Lack of Efficacy|0|||
23754493|NCT01461369|66480931|FG002|Overall Study|Lack of Efficacy|6|||
23754494|NCT01461369|66480929|FG000|Overall Study|Lost to Follow-up|0|||
23754495|NCT01461369|66480930|FG001|Overall Study|Lost to Follow-up|0|||
23754496|NCT01461369|66480931|FG002|Overall Study|Lost to Follow-up|3|||
23754497|NCT01461369|66480929|FG000|Overall Study|Adverse Event|9|||
23754498|NCT01461369|66480930|FG001|Overall Study|Adverse Event|12|||
23754499|NCT01461369|66480931|FG002|Overall Study|Adverse Event|4|||
23754500|NCT01461369|66480929|FG000|Overall Study|Protocol Violation|1|||
23754501|NCT01461369|66480930|FG001|Overall Study|Protocol Violation|2|||
23754502|NCT01461369|66480931|FG002|Overall Study|Protocol Violation|2|||
23624193|NCT01813305|66011554|FG000|Overall Study|Lost to Follow-up|3|||
23754503|NCT01461369|66480929|FG000|Overall Study|Withdrawal by Subject|1|||
23624194|NCT01813305|66011555|FG001|Overall Study|Lost to Follow-up|1|||
23624195|NCT01813305|66011554|FG000|Overall Study|Protocol Violation|1|||
23624196|NCT01813305|66011555|FG001|Overall Study|Protocol Violation|0|||
23624197|NCT01813305|66011554|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
23624198|NCT01813305|66011555|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
23754504|NCT01461369|66480930|FG001|Overall Study|Withdrawal by Subject|3|||
23754505|NCT01461369|66480931|FG002|Overall Study|Withdrawal by Subject|2|||
23754506|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
23558744|NCT01412801|65772614|FG002|Overall Study|Relocated to another area|2|||
23624199|NCT00195442|66011558|FG000|Overall Study|Less than expected therapeutic effect|38|||
23558745|NCT01412801|65772615|FG003|Overall Study|Relocated to another area|0|||
23558746|NCT01412801|65772616|FG004|Overall Study|Relocated to another area|0|||
23558747|NCT01412801|65772617|FG005|Overall Study|Relocated to another area|0|||
23558748|NCT02428296|65772618|FG000|Overall Study|Adverse Event|7|||
23558749|NCT02428296|65772618|FG000|Overall Study|Withdrawal by Subject|2|||
23558750|NCT02110901|65772621|FG000|Overall Study|Death|6|||
23754507|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
23754508|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
23754509|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
23754510|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
23754511|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
23754512|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
23754513|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
23754514|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754515|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754516|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754517|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
23754518|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
23754519|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754520|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754521|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23754522|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
23754523|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
23754524|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
23754525|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
23754526|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
23754527|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
23754528|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
23754529|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
23754530|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
23754531|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23754532|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
23754533|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23754534|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
23754535|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23754536|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23754537|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23754538|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
23754539|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23754540|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
23754541|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
23754542|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23754543|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23754544|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
23754545|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23754546|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
23754547|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
23754548|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
23754549|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
23754550|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
23754551|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
23754552|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
23754553|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
23754554|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
23754555|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
23754556|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23754557|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
23754558|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23754559|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23754560|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23754561|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23558751|NCT02110901|65772622|FG001|Overall Study|Death|3|||
23558752|NCT02110901|65772621|FG000|Overall Study|Lost to Follow-up|12|||
23558753|NCT02110901|65772622|FG001|Overall Study|Lost to Follow-up|8|||
23558754|NCT02110901|65772621|FG000|Overall Study|Withdrawal by Subject|7|||
23558755|NCT02110901|65772622|FG001|Overall Study|Withdrawal by Subject|3|||
23825615|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Death|3|||
23437627|NCT02409342|65344165|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
23558756|NCT02110901|65772621|FG000|Overall Study|received a kidney transplant|5|||
23558757|NCT02110901|65772622|FG001|Overall Study|received a kidney transplant|0|||
23558758|NCT00118898|65772626|FG000|Overall Study|Death|6|||
23558759|NCT00118898|65772627|FG001|Overall Study|Death|11|||
23558760|NCT00118898|65772628|FG002|Overall Study|Death|6|||
23558761|NCT00118898|65772629|FG003|Overall Study|Death|8|||
23558762|NCT00118898|65772626|FG000|Overall Study|Lost to Follow-up|26|||
23558763|NCT00118898|65772627|FG001|Overall Study|Lost to Follow-up|34|||
23558764|NCT00118898|65772628|FG002|Overall Study|Lost to Follow-up|33|||
23558765|NCT00118898|65772629|FG003|Overall Study|Lost to Follow-up|33|||
23558766|NCT00118898|65772626|FG000|Overall Study|Withdrawal by Subject|10|||
23558767|NCT00118898|65772627|FG001|Overall Study|Withdrawal by Subject|5|||
23558768|NCT00118898|65772628|FG002|Overall Study|Withdrawal by Subject|8|||
23558769|NCT00118898|65772629|FG003|Overall Study|Withdrawal by Subject|8|||
23558770|NCT00118898|65772626|FG000|Overall Study|Site Closure|33|||
23558771|NCT00118898|65772627|FG001|Overall Study|Site Closure|31|||
23558772|NCT00118898|65772628|FG002|Overall Study|Site Closure|28|||
23558773|NCT00118898|65772629|FG003|Overall Study|Site Closure|37|||
23558774|NCT00118898|65772626|FG000|Overall Study|Severe debilitation|1|||
23558775|NCT00118898|65772627|FG001|Overall Study|Severe debilitation|4|||
23558776|NCT00118898|65772628|FG002|Overall Study|Severe debilitation|6|||
23558777|NCT00118898|65772629|FG003|Overall Study|Severe debilitation|4|||
23558778|NCT00118898|65772626|FG000|Overall Study|Not compliant with requirements|11|||
23558779|NCT00118898|65772627|FG001|Overall Study|Not compliant with requirements|13|||
23558780|NCT00118898|65772628|FG002|Overall Study|Not compliant with requirements|11|||
23558781|NCT00118898|65772629|FG003|Overall Study|Not compliant with requirements|11|||
23558782|NCT00118898|65772626|FG000|Overall Study|Not able to get to clinic|34|||
23558783|NCT00118898|65772627|FG001|Overall Study|Not able to get to clinic|43|||
23558784|NCT00118898|65772628|FG002|Overall Study|Not able to get to clinic|31|||
23558785|NCT00118898|65772629|FG003|Overall Study|Not able to get to clinic|40|||
23558786|NCT00989092|65772633|FG000|Overall Study|Physician Decision|9|||
23558787|NCT00989092|65772634|FG001|Overall Study|Physician Decision|6|||
23558788|NCT00989092|65772633|FG000|Overall Study|Adverse Event|20|||
23558789|NCT00989092|65772634|FG001|Overall Study|Adverse Event|1|||
23558790|NCT00989092|65772633|FG000|Overall Study|Chemotherapy initiated|12|||
23558791|NCT00989092|65772634|FG001|Overall Study|Chemotherapy initiated|4|||
23558792|NCT00989092|65772633|FG000|Overall Study|Withdrawal by Subject|17|||
23558793|NCT00989092|65772634|FG001|Overall Study|Withdrawal by Subject|9|||
23558794|NCT00989092|65772633|FG000|Overall Study|Death|14|||
23558795|NCT00989092|65772634|FG001|Overall Study|Death|2|||
23558796|NCT00989092|65772633|FG000|Overall Study|Ineligibility determined|3|||
23558797|NCT00989092|65772634|FG001|Overall Study|Ineligibility determined|3|||
23558798|NCT00989092|65772633|FG000|Overall Study|Lost to Follow-up|6|||
23558799|NCT00989092|65772634|FG001|Overall Study|Lost to Follow-up|2|||
23558800|NCT00989092|65772633|FG000|Overall Study|Other|3|||
23558801|NCT00989092|65772634|FG001|Overall Study|Other|1|||
23558802|NCT00989092|65772633|FG000|Overall Study|Protocol deviation|2|||
23558803|NCT00989092|65772634|FG001|Overall Study|Protocol deviation|0|||
23558804|NCT00989092|65772633|FG000|Overall Study|Erythropoietin therapy initiated|2|||
23558805|NCT00989092|65772634|FG001|Overall Study|Erythropoietin therapy initiated|0|||
23558806|NCT00989092|65772633|FG000|Overall Study|Did not receive study drug|2|||
23558807|NCT00989092|65772634|FG001|Overall Study|Did not receive study drug|0|||
23558808|NCT00941798|65772635|FG000|Overall Study|Withdrawal by Subject|72|||
23558809|NCT00941798|65772636|FG001|Overall Study|Withdrawal by Subject|74|||
23558810|NCT00941798|65772635|FG000|Overall Study|Adverse Event|43|||
23558811|NCT00941798|65772636|FG001|Overall Study|Adverse Event|23|||
23558812|NCT00941798|65772635|FG000|Overall Study|Lost to Follow-up|29|||
23558813|NCT00941798|65772636|FG001|Overall Study|Lost to Follow-up|23|||
23558814|NCT00941798|65772635|FG000|Overall Study|Protocol Violation|17|||
23558815|NCT00941798|65772636|FG001|Overall Study|Protocol Violation|20|||
23558816|NCT00941798|65772635|FG000|Overall Study|Administrative problems|13|||
23558817|NCT00941798|65772636|FG001|Overall Study|Administrative problems|23|||
23558818|NCT00941798|65772635|FG000|Overall Study|Lack of Efficacy|10|||
23558819|NCT00941798|65772636|FG001|Overall Study|Lack of Efficacy|17|||
23558820|NCT00941798|65772635|FG000|Overall Study|Patient's inability to use device|6|||
23558821|NCT00941798|65772636|FG001|Overall Study|Patient's inability to use device|1|||
23558822|NCT00941798|65772635|FG000|Overall Study|Abnormal test procedure results|3|||
23624200|NCT00195442|66011558|FG000|Overall Study|Lost to Follow-up|27|||
23558823|NCT00941798|65772636|FG001|Overall Study|Abnormal test procedure results|1|||
23558824|NCT00941798|65772635|FG000|Overall Study|Abnormal laboratory values|1|||
23558825|NCT00941798|65772636|FG001|Overall Study|Abnormal laboratory values|2|||
23558826|NCT00941798|65772635|FG000|Overall Study|Death|0|||
23558827|NCT00941798|65772636|FG001|Overall Study|Death|1|||
23754562|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
23754563|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
23754564|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
23754565|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
23754566|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
23754567|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
23558828|NCT01648270|65772638|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
23558829|NCT02055157|65772644|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558830|NCT02055157|65772645|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
23558831|NCT02055157|65772646|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558832|NCT02055157|65772647|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558833|NCT02055157|65772644|FG000|Initial 6 Months|Adverse Event|0|||
23558834|NCT02055157|65772645|FG001|Initial 6 Months|Adverse Event|0|||
23558835|NCT02055157|65772646|FG002|Initial 6 Months|Adverse Event|0|||
23558836|NCT02055157|65772647|FG003|Initial 6 Months|Adverse Event|1|||
23558837|NCT02055157|65772644|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
23558838|NCT02055157|65772645|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
23558839|NCT02055157|65772646|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
23558840|NCT02055157|65772647|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
23558841|NCT02055157|65772644|FG000|18-month Extension|Investigator decision|0|||
23558842|NCT02055157|65772645|FG001|18-month Extension|Investigator decision|1|||
23558843|NCT02055157|65772646|FG002|18-month Extension|Investigator decision|0|||
23558844|NCT02055157|65772647|FG003|18-month Extension|Investigator decision|0|||
23558845|NCT02055157|65772644|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
23558846|NCT02055157|65772645|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558847|NCT02055157|65772646|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558848|NCT02055157|65772647|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558849|NCT00982930|65772649|FG000|Overall Study|Adverse Event|1|||
23754568|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
23754569|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
23754570|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
23754571|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
23754572|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
23754573|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
23754574|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
23754575|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
23754576|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
23754577|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
23754578|NCT04440163|66480932|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
23754579|NCT04440163|66480933|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
23754580|NCT04440163|66480934|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
23754581|NCT04440163|66480935|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
23754582|NCT04440163|66480936|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
23754583|NCT04440163|66480937|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
23754584|NCT04440163|66480938|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
23754585|NCT04440163|66480939|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
23754586|NCT04440163|66480932|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
23754587|NCT04440163|66480933|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
23754588|NCT04440163|66480934|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23754589|NCT04440163|66480935|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23754590|NCT04440163|66480936|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
23754591|NCT04440163|66480937|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23754592|NCT04440163|66480938|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
23754593|NCT04440163|66480939|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
23754594|NCT04440163|66480932|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754595|NCT04440163|66480933|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754596|NCT04440163|66480934|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754597|NCT04440163|66480935|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
23754598|NCT04440163|66480936|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754599|NCT04440163|66480937|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23558850|NCT00982930|65772649|FG000|Overall Study|Withdrawal by Subject|1|||
23558851|NCT00982930|65772649|FG000|Overall Study|Administrative Problems|2|||
23558852|NCT01733732|65772663|FG000|Overall Study|Adverse Event|1|||
23558853|NCT01733732|65772664|FG001|Overall Study|Adverse Event|0|||
23558854|NCT01733732|65772663|FG000|Overall Study|Did not attend all study visits|1|||
23558855|NCT01733732|65772664|FG001|Overall Study|Did not attend all study visits|0|||
23558856|NCT01194570|65772665|FG000|Overall Study|Adverse Event|22|||
23558857|NCT01194570|65772666|FG001|Overall Study|Adverse Event|40|||
23558858|NCT01194570|65772665|FG000|Overall Study|Death|6|||
23558859|NCT01194570|65772666|FG001|Overall Study|Death|20|||
23558860|NCT01194570|65772665|FG000|Overall Study|Lack of Efficacy|32|||
23558861|NCT01194570|65772666|FG001|Overall Study|Lack of Efficacy|33|||
23558862|NCT01194570|65772665|FG000|Overall Study|Lost to Follow-up|4|||
23558863|NCT01194570|65772666|FG001|Overall Study|Lost to Follow-up|15|||
23558864|NCT01194570|65772665|FG000|Overall Study|Non-Compliance|2|||
23558865|NCT01194570|65772666|FG001|Overall Study|Non-Compliance|2|||
23558866|NCT01194570|65772665|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23558867|NCT01194570|65772666|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23558868|NCT01194570|65772665|FG000|Overall Study|Other|18|||
23558869|NCT01194570|65772666|FG001|Overall Study|Other|47|||
23558870|NCT01194570|65772665|FG000|Overall Study|Physician Decision|10|||
23558871|NCT01194570|65772666|FG001|Overall Study|Physician Decision|25|||
23558872|NCT01194570|65772665|FG000|Overall Study|Protocol Violation|1|||
23558873|NCT01194570|65772666|FG001|Overall Study|Protocol Violation|2|||
23558874|NCT01194570|65772665|FG000|Overall Study|Study Terminated By Sponsor|0|||
23558875|NCT01194570|65772666|FG001|Overall Study|Study Terminated By Sponsor|1|||
23558876|NCT01194570|65772665|FG000|Overall Study|Withdrawal by Subject|57|||
23558877|NCT01194570|65772666|FG001|Overall Study|Withdrawal by Subject|82|||
23558878|NCT01194570|65772665|FG000|Overall Study|Pregnancy|1|||
23558879|NCT01194570|65772666|FG001|Overall Study|Pregnancy|1|||
23558880|NCT02124265|65772667|FG000|Overall Study|Adverse Event|1|||
23558881|NCT01242748|65772670|FG000|Overall Study|Adverse Event|10|||
23558882|NCT01242748|65772671|FG001|Overall Study|Adverse Event|5|||
23558883|NCT01242748|65772670|FG000|Overall Study|Lost to Follow-up|6|||
23558884|NCT01242748|65772671|FG001|Overall Study|Lost to Follow-up|2|||
23558885|NCT01242748|65772670|FG000|Overall Study|Physician Decision|3|||
23558886|NCT01242748|65772671|FG001|Overall Study|Physician Decision|2|||
23558887|NCT01242748|65772670|FG000|Overall Study|Protocol Violation|1|||
23558888|NCT01242748|65772671|FG001|Overall Study|Protocol Violation|0|||
23825616|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Death|1|||
23825617|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
23558889|NCT01242748|65772670|FG000|Overall Study|Withdrawal by Subject|10|||
23558890|NCT01242748|65772671|FG001|Overall Study|Withdrawal by Subject|2|||
23558891|NCT01242748|65772670|FG000|Overall Study|Miscellaneous reasons|8|||
23558892|NCT01242748|65772671|FG001|Overall Study|Miscellaneous reasons|3|||
23558893|NCT00659490|65772675|FG000|Overall Study|Lost to Follow-up|2|||
23558894|NCT00659490|65772676|FG001|Overall Study|Lost to Follow-up|0|||
23558895|NCT00659490|65772677|FG002|Overall Study|Lost to Follow-up|1|||
23558896|NCT02172625|65772678|FG000|Overall Study|Adverse Event|0|||
23558897|NCT02172625|65772679|FG001|Overall Study|Adverse Event|1|||
23558898|NCT02172625|65772678|FG000|Overall Study|Pregnancy|0|||
23558899|NCT02172625|65772679|FG001|Overall Study|Pregnancy|1|||
23558900|NCT02172625|65772678|FG000|Overall Study|car accident|0|||
23558901|NCT02172625|65772679|FG001|Overall Study|car accident|1|||
23558902|NCT02839343|65772680|FG000|Overall Study|Withdrawal by Subject|3|||
23825618|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
23825619|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
23825620|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
23825621|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
23825622|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
23825623|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
23825624|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
23825625|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
23825626|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
23825627|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
23558903|NCT02839343|65772681|FG001|Overall Study|Withdrawal by Subject|1|||
23558904|NCT02839343|65772680|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
23558905|NCT02839343|65772681|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
23558906|NCT02839343|65772680|FG000|Overall Study|Adverse Event|1|||
23558907|NCT02839343|65772681|FG001|Overall Study|Adverse Event|0|||
23558908|NCT03929562|65772682|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
23558909|NCT03929562|65772683|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
23558910|NCT03929562|65772682|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
23558911|NCT03929562|65772683|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
23558912|NCT03929562|65772682|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
23558913|NCT03929562|65772683|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
23558914|NCT03988634|65772684|FG000|Double-Blind|Adverse Event|4|||
23558915|NCT03988634|65772685|FG001|Double-Blind|Adverse Event|0|||
23558916|NCT03988634|65772686|FG002|Double-Blind|Adverse Event|0|||
23558917|NCT03988634|65772684|FG000|Double-Blind|Death|18|||
23558918|NCT03988634|65772685|FG001|Double-Blind|Death|26|||
23558919|NCT03988634|65772686|FG002|Double-Blind|Death|0|||
23558920|NCT03988634|65772684|FG000|Double-Blind|Lost to Follow-up|6|||
23558921|NCT03988634|65772685|FG001|Double-Blind|Lost to Follow-up|7|||
23558922|NCT03988634|65772686|FG002|Double-Blind|Lost to Follow-up|0|||
23558923|NCT03988634|65772684|FG000|Double-Blind|Physician Decision|9|||
23558924|NCT03988634|65772685|FG001|Double-Blind|Physician Decision|5|||
23558925|NCT03988634|65772686|FG002|Double-Blind|Physician Decision|0|||
23558926|NCT03988634|65772684|FG000|Double-Blind|Subject decision|24|||
23558927|NCT03988634|65772685|FG001|Double-Blind|Subject decision|13|||
23558928|NCT03988634|65772686|FG002|Double-Blind|Subject decision|0|||
23558929|NCT03988634|65772684|FG000|Open-Label|Adverse Event|0|||
23558930|NCT03988634|65772685|FG001|Open-Label|Adverse Event|0|||
23558931|NCT03988634|65772686|FG002|Open-Label|Adverse Event|7|||
23558932|NCT03988634|65772684|FG000|Open-Label|Physician Decision|0|||
23558933|NCT03988634|65772685|FG001|Open-Label|Physician Decision|0|||
23558934|NCT03988634|65772686|FG002|Open-Label|Physician Decision|1|||
23558935|NCT03988634|65772684|FG000|Open-Label|Technical problems|0|||
23558936|NCT03988634|65772685|FG001|Open-Label|Technical problems|0|||
23558937|NCT03988634|65772686|FG002|Open-Label|Technical problems|1|||
23558938|NCT00779779|65772693|FG000|Overall Study|Adverse Event|1|||
23558939|NCT00779779|65772693|FG000|Overall Study|Protocol Violation|14|||
23558940|NCT00779779|65772693|FG000|Overall Study|Withdrawal by Subject|4|||
23558941|NCT00779779|65772693|FG000|Overall Study|Lost to Follow-up|5|||
23558942|NCT02119260|65772694|FG000|Overall Study|Adverse Event|1|||
23558943|NCT02119260|65772695|FG001|Overall Study|Adverse Event|0|||
23558944|NCT02119260|65772696|FG002|Overall Study|Adverse Event|0|||
23558945|NCT02119260|65772697|FG003|Overall Study|Adverse Event|0|||
23558946|NCT02119260|65772698|FG004|Overall Study|Adverse Event|0|||
23558947|NCT02119260|65772699|FG005|Overall Study|Adverse Event|0|||
23558948|NCT02119260|65772700|FG006|Overall Study|Adverse Event|0|||
23558949|NCT02119260|65772694|FG000|Overall Study|Withdrew consent|0|||
23558950|NCT02119260|65772695|FG001|Overall Study|Withdrew consent|1|||
23558951|NCT02119260|65772696|FG002|Overall Study|Withdrew consent|1|||
23558952|NCT02119260|65772697|FG003|Overall Study|Withdrew consent|0|||
23558953|NCT02119260|65772698|FG004|Overall Study|Withdrew consent|0|||
23558954|NCT02119260|65772699|FG005|Overall Study|Withdrew consent|0|||
23558955|NCT02119260|65772700|FG006|Overall Study|Withdrew consent|0|||
23558956|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
23558957|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
23558958|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
23558959|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
23558960|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
23558961|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
23558962|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
23558963|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
23558964|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
23558965|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
23558966|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
23754600|NCT04440163|66480938|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754601|NCT04440163|66480939|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23754602|NCT03428217|66480940|FG000|Overall Study|Death|89|||
23754603|NCT03428217|66480941|FG001|Overall Study|Death|93|||
23754604|NCT03428217|66480940|FG000|Overall Study|Withdrawal by Subject|8|||
23754605|NCT03428217|66480941|FG001|Overall Study|Withdrawal by Subject|7|||
23754606|NCT03428217|66480940|FG000|Overall Study|Lost to Follow-up|1|||
23754607|NCT03428217|66480941|FG001|Overall Study|Lost to Follow-up|3|||
23754608|NCT03428217|66480940|FG000|Overall Study|Study terminated by sponsor|124|||
23754609|NCT03428217|66480941|FG001|Overall Study|Study terminated by sponsor|118|||
23754610|NCT03428217|66480940|FG000|Overall Study|Other, Not Specified|1|||
23754611|NCT03428217|66480941|FG001|Overall Study|Other, Not Specified|0|||
23754612|NCT04701658|66480947|FG000|Overall Study|Lost to Follow-up|6|||
23754613|NCT00289731|66480954|FG000|Overall Study|Adverse Event|1|||
23754614|NCT00289731|66480955|FG001|Overall Study|Adverse Event|2|||
23754615|NCT00289731|66480956|FG002|Overall Study|Adverse Event|2|||
23754616|NCT00289731|66480954|FG000|Overall Study|Other|1|||
23754617|NCT00289731|66480955|FG001|Overall Study|Other|0|||
23754618|NCT00289731|66480956|FG002|Overall Study|Other|0|||
23558967|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
23558968|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
23558969|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
23558970|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
23754619|NCT03454672|66480961|FG000|Overall Study|Adverse Event|1|||
23754620|NCT03454672|66480962|FG001|Overall Study|Adverse Event|1|||
23558971|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
23558972|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
23558973|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
23558974|NCT03040713|65776120|FG000|Overall Study|Positive amyloid scan|3|||
23558975|NCT02979639|65776121|FG000|Overall Study|Withdrawal based on medical judgement|1|||
23558976|NCT02979639|65776121|FG000|Overall Study|Lost to Follow-up|8|||
23558977|NCT02979639|65776121|FG000|Overall Study|Withdrawal by Subject|3|||
23558978|NCT02979639|65776121|FG000|Overall Study|Adverse Event|2|||
23558979|NCT00939484|65776122|FG000|Overall Study|Progression/Relapse|8|||
23558980|NCT00939484|65776123|FG001|Overall Study|Progression/Relapse|20|||
23558981|NCT00939484|65776124|FG002|Overall Study|Progression/Relapse|3|||
23558982|NCT02243280|65776127|FG000|Treated|Adverse Event|1|||
23558983|NCT02243280|65776128|FG001|Treated|Adverse Event|0|||
23558984|NCT02243280|65776129|FG002|Treated|Adverse Event|0|||
23558985|NCT02243280|65776130|FG003|Treated|Adverse Event|0|||
23558986|NCT02243280|65776131|FG004|Treated|Adverse Event|0|||
23558987|NCT02243280|65776132|FG005|Treated|Adverse Event|0|||
23558988|NCT02243280|65776133|FG006|Treated|Adverse Event|0|||
23754621|NCT03454672|66480961|FG000|Overall Study|Lost to Follow-up|1|||
23558989|NCT02243280|65776134|FG007|Treated|Adverse Event|0|||
23558990|NCT02243280|65776135|FG008|Treated|Adverse Event|0|||
23624201|NCT00195442|66011558|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
23558991|NCT02243280|65776136|FG009|Treated|Adverse Event|0|||
23558992|NCT02243280|65776137|FG010|Treated|Adverse Event|1|||
23558993|NCT02243280|65776127|FG000|Treated|Lost to Follow-up|0|||
23558994|NCT02243280|65776128|FG001|Treated|Lost to Follow-up|0|||
23558995|NCT02243280|65776129|FG002|Treated|Lost to Follow-up|0|||
23558996|NCT02243280|65776130|FG003|Treated|Lost to Follow-up|0|||
23558997|NCT02243280|65776131|FG004|Treated|Lost to Follow-up|0|||
23558998|NCT02243280|65776132|FG005|Treated|Lost to Follow-up|0|||
23558999|NCT02243280|65776133|FG006|Treated|Lost to Follow-up|0|||
23559000|NCT02243280|65776134|FG007|Treated|Lost to Follow-up|0|||
23754622|NCT03454672|66480962|FG001|Overall Study|Lost to Follow-up|3|||
23754623|NCT03454672|66480961|FG000|Overall Study|painful|1|||
23754624|NCT03454672|66480962|FG001|Overall Study|painful|2|||
23754625|NCT03454672|66480961|FG000|Overall Study|Non-compliance|2|||
23754626|NCT03454672|66480962|FG001|Overall Study|Non-compliance|4|||
23754627|NCT03454672|66480961|FG000|Overall Study|personal reasons|3|||
23754628|NCT03454672|66480962|FG001|Overall Study|personal reasons|2|||
23754629|NCT03454672|66480961|FG000|Overall Study|Withdrawal by Subject|1|||
23754630|NCT03454672|66480962|FG001|Overall Study|Withdrawal by Subject|0|||
23754631|NCT03286400|66480963|FG000|Overall Study|Death|10|||
23754632|NCT03286400|66480963|FG000|Overall Study|Lost to Follow-up|10|||
23754633|NCT03286400|66480963|FG000|Overall Study|Physician Decision|1|||
23754634|NCT03286400|66480963|FG000|Overall Study|Scheduling difficulty|4|||
23754635|NCT00343642|66480967|FG000|Overall Study|Lost to Follow-up|0|||
23754636|NCT00343642|66480968|FG001|Overall Study|Lost to Follow-up|1|||
23754637|NCT00343642|66480969|FG002|Overall Study|Lost to Follow-up|0|||
23754638|NCT00343642|66480967|FG000|Overall Study|Pregnancy|1|||
23754639|NCT00343642|66480968|FG001|Overall Study|Pregnancy|0|||
23754640|NCT00343642|66480969|FG002|Overall Study|Pregnancy|2|||
23754641|NCT00343642|66480967|FG000|Overall Study|Withdrawal by Subject|2|||
23754642|NCT00343642|66480968|FG001|Overall Study|Withdrawal by Subject|3|||
23754643|NCT00343642|66480969|FG002|Overall Study|Withdrawal by Subject|4|||
23754644|NCT00343642|66480967|FG000|Overall Study|Adverse Event|0|||
23754645|NCT00343642|66480968|FG001|Overall Study|Adverse Event|0|||
23754646|NCT00343642|66480969|FG002|Overall Study|Adverse Event|1|||
23754647|NCT00343642|66480967|FG000|Overall Study|Flare up|6|||
23754648|NCT00343642|66480968|FG001|Overall Study|Flare up|4|||
23754649|NCT00343642|66480969|FG002|Overall Study|Flare up|0|||
23754650|NCT05180630|66480970|FG000|First Intervention|Physician Decision|0|||
23754651|NCT05180630|66480971|FG001|First Intervention|Physician Decision|0|||
23754652|NCT05180630|66480972|FG002|First Intervention|Physician Decision|3|||
23754653|NCT04347161|66480973|FG000|Overall Study|Death|0|||
23754654|NCT04347161|66480974|FG001|Overall Study|Death|2|||
23754655|NCT04347161|66480973|FG000|Overall Study|Withdrawal by Subject|1|||
23754656|NCT04347161|66480974|FG001|Overall Study|Withdrawal by Subject|0|||
23754657|NCT04347161|66480973|FG000|Overall Study|Lost to Follow-up|0|||
23754658|NCT04347161|66480974|FG001|Overall Study|Lost to Follow-up|1|||
23754659|NCT04347161|66480973|FG000|Overall Study|No longer on study medication|1|||
23754660|NCT04347161|66480974|FG001|Overall Study|No longer on study medication|1|||
23754661|NCT00865306|66480975|FG000|Controlled Trial|Lost to Follow-up|1|||
23754662|NCT00865306|66480976|FG001|Controlled Trial|Lost to Follow-up|1|||
23754663|NCT00865306|66480975|FG000|Controlled Trial|Difficulty commuting|2|||
23754664|NCT00865306|66480976|FG001|Controlled Trial|Difficulty commuting|0|||
23754665|NCT00865306|66480975|FG000|Controlled Trial|Improved btw baseline and first session|1|||
23754666|NCT00865306|66480976|FG001|Controlled Trial|Improved btw baseline and first session|0|||
23754667|NCT00865306|66480975|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
23754668|NCT00865306|66480976|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
23754669|NCT00865306|66480975|FG000|Controlled Trial|Withdrawal by Subject|0|||
23754670|NCT00865306|66480976|FG001|Controlled Trial|Withdrawal by Subject|1|||
23754671|NCT03746080|66480980|FG000|Overall Study|In follow up|2|||
23754672|NCT03746080|66480980|FG000|Overall Study|Death|15|||
23754673|NCT01999322|66480981|FG000|Overall Study|Adverse Event|1|||
23559001|NCT02243280|65776135|FG008|Treated|Lost to Follow-up|1|||
23559002|NCT02243280|65776136|FG009|Treated|Lost to Follow-up|0|||
23559003|NCT02243280|65776137|FG010|Treated|Lost to Follow-up|2|||
23754674|NCT01999322|66480982|FG001|Overall Study|Adverse Event|0|||
23754675|NCT01216319|66480987|FG000|Overall Study|Lost to Follow-up|2|||
23559004|NCT01830595|65776138|FG000|First Period|Withdrawal by Subject|1|||
23559005|NCT01830595|65776139|FG001|First Period|Withdrawal by Subject|3|||
23559006|NCT01830595|65776138|FG000|Washout|Withdrawal by Subject|2|||
23754676|NCT01216319|66480987|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
23754677|NCT05478603|66480990|FG000|Overall Study|Withdrawal by Subject|0|||
23754678|NCT05478603|66480991|FG001|Overall Study|Withdrawal by Subject|1|||
23754679|NCT05478603|66480992|FG002|Overall Study|Withdrawal by Subject|0|||
23754680|NCT05478603|66480993|FG003|Overall Study|Withdrawal by Subject|0|||
23754681|NCT01610167|66480994|FG000|Overall Study|Scheduling conflict.|0|||
23754682|NCT01610167|66480995|FG001|Overall Study|Scheduling conflict.|0|||
23754683|NCT01610167|66480996|FG002|Overall Study|Scheduling conflict.|2|||
23754684|NCT01342367|66480997|FG000|Overall Study|Death|1|||
23754685|NCT01342367|66480998|FG001|Overall Study|Death|0|||
23754686|NCT01342367|66480997|FG000|Overall Study|Withdrawal by Subject|1|||
23559007|NCT01830595|65776139|FG001|Washout|Withdrawal by Subject|2|||
23559008|NCT00641719|65776142|FG000|Overall Study|Lack of Efficacy|1|||
23559009|NCT00641719|65776143|FG001|Overall Study|Lack of Efficacy|2|||
23559010|NCT00641719|65776142|FG000|Overall Study|Adverse Event|24|||
23559011|NCT00641719|65776143|FG001|Overall Study|Adverse Event|29|||
23559012|NCT00641719|65776142|FG000|Overall Study|Withdrawal by Subject|4|||
23559013|NCT00641719|65776143|FG001|Overall Study|Withdrawal by Subject|4|||
23559014|NCT00641719|65776142|FG000|Overall Study|Reason Not Specified|1|||
23559015|NCT00641719|65776143|FG001|Overall Study|Reason Not Specified|2|||
23559016|NCT00045708|65776144|FG000|Phase 1|early progressive disease|0|||
23825628|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
23825629|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
23825630|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
23825631|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
23825632|NCT00299130|66741536|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
23825633|NCT00299130|66741537|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
23825634|NCT00299130|66741538|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
23825635|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
23825636|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
23825637|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
23825638|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
23825639|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
23825640|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
23825641|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
23825642|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
23825643|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
23559017|NCT00045708|65776145|FG001|Phase 1|early progressive disease|1|||
23624202|NCT00195442|66011558|FG000|Overall Study|Intermittent product shortage|21|||
23754687|NCT01342367|66480998|FG001|Overall Study|Withdrawal by Subject|2|||
23754688|NCT00929864|66481001|FG000|Overall Study|Death|1|||
23754689|NCT00929864|66481002|FG001|Overall Study|Death|1|||
23754690|NCT00929864|66481001|FG000|Overall Study|Adverse Event|11|||
23754691|NCT00929864|66481002|FG001|Overall Study|Adverse Event|30|||
23754692|NCT00929864|66481001|FG000|Overall Study|Lack of Efficacy|19|||
23754693|NCT00929864|66481002|FG001|Overall Study|Lack of Efficacy|16|||
23754694|NCT00929864|66481001|FG000|Overall Study|Lost to Follow-up|7|||
23754695|NCT00929864|66481002|FG001|Overall Study|Lost to Follow-up|12|||
23754696|NCT00929864|66481001|FG000|Overall Study|Withdrawal by Subject|20|||
23754697|NCT00929864|66481002|FG001|Overall Study|Withdrawal by Subject|9|||
23754698|NCT00929864|66481001|FG000|Overall Study|No longer met criteria|2|||
23754699|NCT00929864|66481002|FG001|Overall Study|No longer met criteria|1|||
23754700|NCT00929864|66481001|FG000|Overall Study|Poor or non-compliance|3|||
23754701|NCT00929864|66481002|FG001|Overall Study|Poor or non-compliance|3|||
23754702|NCT00929864|66481001|FG000|Overall Study|Pregnancy|0|||
23754703|NCT00929864|66481002|FG001|Overall Study|Pregnancy|3|||
23754704|NCT00929864|66481001|FG000|Overall Study|Administrative reason by Sponsor|1|||
23754705|NCT00929864|66481002|FG001|Overall Study|Administrative reason by Sponsor|1|||
23754706|NCT00929864|66481001|FG000|Overall Study|Non-specified|2|||
23754707|NCT00929864|66481002|FG001|Overall Study|Non-specified|7|||
23754708|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
23754709|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
23754710|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
23754711|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
23754712|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
23754713|NCT01179191|66481003|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
23754714|NCT01179191|66481003|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
23754715|NCT01179191|66481003|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
23754716|NCT01179191|66481003|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
23754717|NCT01179191|66481003|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
23754718|NCT01179191|66481003|FG000|Maintenance Phase (8 Weeks)|Other|66|||
23754719|NCT03543046|66481008|FG000|Overall Study|Adverse Event|1|||
23754720|NCT03543046|66481009|FG001|Overall Study|Adverse Event|1|||
23754721|NCT03543046|66481008|FG000|Overall Study|Physician Decision|1|||
23559018|NCT00045708|65776146|FG002|Phase 1|early progressive disease|0|||
23559019|NCT02157779|65776147|FG000|Overall Study|Logistical|9|||
23559020|NCT02157779|65776148|FG001|Overall Study|Logistical|3|||
23559021|NCT02157779|65776147|FG000|Overall Study|Stopped attending, reason unknown|11|||
23559022|NCT02157779|65776148|FG001|Overall Study|Stopped attending, reason unknown|7|||
23559023|NCT02157779|65776147|FG000|Overall Study|No response to outreach after Baseline|1|||
23559024|NCT02157779|65776148|FG001|Overall Study|No response to outreach after Baseline|1|||
23559025|NCT02157779|65776147|FG000|Overall Study|Moved|1|||
23559026|NCT02157779|65776148|FG001|Overall Study|Moved|0|||
23559027|NCT02157779|65776147|FG000|Overall Study|Medical|1|||
23559028|NCT02157779|65776148|FG001|Overall Study|Medical|0|||
23559029|NCT02157779|65776147|FG000|Overall Study|Legal issue|1|||
23559030|NCT02157779|65776148|FG001|Overall Study|Legal issue|0|||
23559031|NCT01059643|65776153|FG000|Overall Study|Adverse Event|3|||
23559032|NCT01059643|65776153|FG000|Overall Study|Withdrawal by Subject|2|||
23559033|NCT01059643|65776153|FG000|Overall Study|Physician Decision|1|||
23559034|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
23559035|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
23559036|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
23559037|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
23754722|NCT03543046|66481009|FG001|Overall Study|Physician Decision|1|||
23754723|NCT03543046|66481008|FG000|Overall Study|Protocol Violation|1|||
23754724|NCT03543046|66481009|FG001|Overall Study|Protocol Violation|0|||
23754725|NCT01220128|66481010|FG000|Overall Study|Progressive disease|0|||
23754726|NCT01220128|66481011|FG001|Overall Study|Progressive disease|0|||
23754727|NCT01220128|66481012|FG002|Overall Study|Progressive disease|2|||
23754728|NCT01220128|66481013|FG003|Overall Study|Progressive disease|0|||
23754729|NCT01220128|66481014|FG004|Overall Study|Progressive disease|0|||
23754730|NCT01220128|66481015|FG005|Overall Study|Progressive disease|0|||
23754731|NCT01220128|66481016|FG006|Overall Study|Progressive disease|0|||
23754732|NCT01220128|66481010|FG000|Overall Study|Sponsor study termination|0|||
23754733|NCT01220128|66481011|FG001|Overall Study|Sponsor study termination|1|||
23754734|NCT01220128|66481012|FG002|Overall Study|Sponsor study termination|0|||
23754735|NCT01220128|66481013|FG003|Overall Study|Sponsor study termination|0|||
23754736|NCT01220128|66481014|FG004|Overall Study|Sponsor study termination|0|||
23754737|NCT01220128|66481015|FG005|Overall Study|Sponsor study termination|0|||
23754738|NCT01220128|66481016|FG006|Overall Study|Sponsor study termination|1|||
23754739|NCT01220128|66481010|FG000|Overall Study|Adverse event, serious fatal|2|||
23754740|NCT01220128|66481011|FG001|Overall Study|Adverse event, serious fatal|0|||
23754741|NCT01220128|66481012|FG002|Overall Study|Adverse event, serious fatal|0|||
23825644|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
23825645|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
23825646|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
23825647|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
23825648|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
23825649|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
23825650|NCT00299130|66741536|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
23825651|NCT00299130|66741537|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
23825652|NCT00299130|66741538|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
23825653|NCT00299130|66741536|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
23825654|NCT00299130|66741537|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
23825655|NCT00299130|66741538|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
23825656|NCT00299130|66741536|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
23825657|NCT00299130|66741537|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
23825658|NCT00299130|66741538|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
23825659|NCT00299130|66741536|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
23825660|NCT00299130|66741537|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
23754742|NCT01220128|66481013|FG003|Overall Study|Adverse event, serious fatal|0|||
23754743|NCT01220128|66481014|FG004|Overall Study|Adverse event, serious fatal|0|||
23754744|NCT01220128|66481015|FG005|Overall Study|Adverse event, serious fatal|0|||
23559038|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
23559039|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
23559040|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
23559041|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
23754745|NCT01220128|66481016|FG006|Overall Study|Adverse event, serious fatal|1|||
23754746|NCT01220128|66481010|FG000|Overall Study|Adverse event, non-fatal|1|||
23754747|NCT01220128|66481011|FG001|Overall Study|Adverse event, non-fatal|0|||
23754748|NCT01220128|66481012|FG002|Overall Study|Adverse event, non-fatal|0|||
23754749|NCT01220128|66481013|FG003|Overall Study|Adverse event, non-fatal|0|||
23754750|NCT01220128|66481014|FG004|Overall Study|Adverse event, non-fatal|0|||
23754751|NCT01220128|66481015|FG005|Overall Study|Adverse event, non-fatal|0|||
23559042|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
23754752|NCT01220128|66481016|FG006|Overall Study|Adverse event, non-fatal|3|||
23754753|NCT01220128|66481010|FG000|Overall Study|Other|0|||
23754754|NCT01220128|66481011|FG001|Overall Study|Other|0|||
23754755|NCT01220128|66481012|FG002|Overall Study|Other|1|||
23754756|NCT01220128|66481013|FG003|Overall Study|Other|0|||
23754757|NCT01220128|66481014|FG004|Overall Study|Other|0|||
23754758|NCT01220128|66481015|FG005|Overall Study|Other|0|||
23754759|NCT01220128|66481016|FG006|Overall Study|Other|0|||
23754760|NCT01220128|66481010|FG000|Overall Study|Consent withdrawn by subject|1|||
23825661|NCT00299130|66741538|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
23754761|NCT01220128|66481011|FG001|Overall Study|Consent withdrawn by subject|0|||
23754762|NCT01220128|66481012|FG002|Overall Study|Consent withdrawn by subject|0|||
23825662|NCT01042093|66741539|FG000|Overall Study|Protocol Violation|2|||
23825663|NCT01042093|66741540|FG001|Overall Study|Protocol Violation|2|||
23825664|NCT01042093|66741541|FG002|Overall Study|Protocol Violation|2|||
23825665|NCT01042093|66741542|FG003|Overall Study|Protocol Violation|3|||
23825666|NCT01042093|66741539|FG000|Overall Study|Withdrawal by Subject|0|||
23825667|NCT01042093|66741540|FG001|Overall Study|Withdrawal by Subject|0|||
23825668|NCT01042093|66741541|FG002|Overall Study|Withdrawal by Subject|0|||
23754763|NCT01220128|66481013|FG003|Overall Study|Consent withdrawn by subject|0|||
23754764|NCT01220128|66481014|FG004|Overall Study|Consent withdrawn by subject|0|||
23754765|NCT01220128|66481015|FG005|Overall Study|Consent withdrawn by subject|0|||
23754766|NCT01220128|66481016|FG006|Overall Study|Consent withdrawn by subject|0|||
23825669|NCT01042093|66741542|FG003|Overall Study|Withdrawal by Subject|1|||
23624203|NCT00195442|66011558|FG000|Overall Study|Death|7|||
23754767|NCT00550420|66481017|FG000|Overall Study|Adverse Event|28|||
23754768|NCT00550420|66481017|FG000|Overall Study|Lost to Follow-up|8|||
23754769|NCT00550420|66481017|FG000|Overall Study|Protocol Violation|11|||
23754770|NCT00550420|66481017|FG000|Overall Study|Withdrawal by Subject|30|||
23754771|NCT00550420|66481017|FG000|Overall Study|Still in study at termination|206|||
23754772|NCT00550420|66481017|FG000|Overall Study|Missing|2|||
23754773|NCT00550420|66481017|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
23754774|NCT00550420|66481017|FG000|Overall Study|Investigators opinion|1|||
23754775|NCT00550420|66481017|FG000|Overall Study|Lack of curative effect|1|||
23754776|NCT00550420|66481017|FG000|Overall Study|Unethical stop of enrollment|2|||
23754777|NCT00550420|66481017|FG000|Overall Study|Caregiver's decision to withdraw|1|||
23754778|NCT00550420|66481017|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
23754779|NCT00550420|66481017|FG000|Overall Study|Exclusion criteria|1|||
23754780|NCT00550420|66481017|FG000|Overall Study|Prohibited medicine|1|||
23754781|NCT00434148|66481018|FG000|Overall Study|Adverse Event|18|||
23754782|NCT00434148|66481019|FG001|Overall Study|Adverse Event|18|||
23754783|NCT00434148|66481018|FG000|Overall Study|Lack of Efficacy|25|||
23754784|NCT00434148|66481019|FG001|Overall Study|Lack of Efficacy|28|||
23754785|NCT00434148|66481018|FG000|Overall Study|Withdrawal by Subject|15|||
23754786|NCT00434148|66481019|FG001|Overall Study|Withdrawal by Subject|15|||
23825670|NCT04583735|66741543|FG000|Double-masked Treatment Period|Adverse Event|0|||
23825671|NCT04583735|66741544|FG001|Double-masked Treatment Period|Adverse Event|1|||
23825672|NCT04583735|66741543|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
23825673|NCT04583735|66741544|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
23825674|NCT04583735|66741543|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
23825675|NCT04583735|66741544|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
23825676|NCT04583735|66741543|FG000|Open-label Treatment Period|Adverse Event|1|||
23825677|NCT04583735|66741544|FG001|Open-label Treatment Period|Adverse Event|1|||
23825678|NCT04583735|66741543|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
23825679|NCT04583735|66741544|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23825680|NCT04583735|66741543|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23825681|NCT04583735|66741544|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
23825682|NCT03717012|66741547|FG000|Overall Study|Due to trial termination|1|||
23825683|NCT03717012|66741548|FG001|Overall Study|Due to trial termination|2|||
23825684|NCT03717012|66741547|FG000|Overall Study|Protocol Violation|0|||
23825685|NCT03717012|66741548|FG001|Overall Study|Protocol Violation|2|||
23825686|NCT03717012|66741547|FG000|Overall Study|Adverse Event|0|||
23825687|NCT03717012|66741548|FG001|Overall Study|Adverse Event|1|||
23825688|NCT03717012|66741547|FG000|Overall Study|Lung transplant|0|||
23825689|NCT03717012|66741548|FG001|Overall Study|Lung transplant|1|||
23825690|NCT01168427|66741549|FG000|Overall Study|Patient exited prior to implant|1|||
23825691|NCT02864992|66741550|FG000|Overall Study|still on treatment|15|||
23825692|NCT02864992|66741551|FG001|Overall Study|still on treatment|1|||
23825693|NCT02864992|66741552|FG002|Overall Study|still on treatment|33|||
23825694|NCT01870778|66741553|FG000|Overall Study|Withdrawal by Subject|8|||
23825695|NCT01870778|66741554|FG001|Overall Study|Withdrawal by Subject|7|||
23825696|NCT01870778|66741553|FG000|Overall Study|Lost to Follow-up|0|||
23825697|NCT01870778|66741554|FG001|Overall Study|Lost to Follow-up|2|||
23825698|NCT02797171|66741558|FG000|Overall Study|Lost to Follow-up|2|||
23825699|NCT02797171|66741559|FG001|Overall Study|Lost to Follow-up|0|||
23825700|NCT02797171|66741560|FG002|Overall Study|Lost to Follow-up|2|||
23825701|NCT02797171|66741561|FG003|Overall Study|Lost to Follow-up|1|||
23825702|NCT02797171|66741562|FG004|Overall Study|Lost to Follow-up|2|||
23825703|NCT02797171|66741563|FG005|Overall Study|Lost to Follow-up|0|||
23825704|NCT02797171|66741558|FG000|Overall Study|Withdrawal by Subject|1|||
23825705|NCT02797171|66741559|FG001|Overall Study|Withdrawal by Subject|1|||
23825706|NCT02797171|66741560|FG002|Overall Study|Withdrawal by Subject|0|||
23825707|NCT02797171|66741561|FG003|Overall Study|Withdrawal by Subject|0|||
23624204|NCT00195442|66011558|FG000|Overall Study|No reason specified|4|||
23754787|NCT00434148|66481018|FG000|Overall Study|Protocol Violation|4|||
23754788|NCT00434148|66481019|FG001|Overall Study|Protocol Violation|0|||
23754789|NCT00434148|66481018|FG000|Overall Study|Administrative problems|6|||
23754790|NCT00434148|66481019|FG001|Overall Study|Administrative problems|10|||
23825708|NCT02797171|66741562|FG004|Overall Study|Withdrawal by Subject|0|||
23825709|NCT02797171|66741563|FG005|Overall Study|Withdrawal by Subject|0|||
23825710|NCT02797171|66741558|FG000|Overall Study|Protocol Violation|1|||
23754791|NCT00434148|66481018|FG000|Overall Study|Lost to Follow-up|0|||
23754792|NCT00434148|66481019|FG001|Overall Study|Lost to Follow-up|1|||
23754793|NCT00434148|66481018|FG000|Overall Study|Condition no longer requires study drug|1|||
23754794|NCT00434148|66481019|FG001|Overall Study|Condition no longer requires study drug|0|||
23825711|NCT02797171|66741559|FG001|Overall Study|Protocol Violation|0|||
23825712|NCT02797171|66741560|FG002|Overall Study|Protocol Violation|0|||
23825713|NCT02797171|66741561|FG003|Overall Study|Protocol Violation|0|||
23825714|NCT02797171|66741562|FG004|Overall Study|Protocol Violation|0|||
23825715|NCT02797171|66741563|FG005|Overall Study|Protocol Violation|0|||
23825716|NCT02797171|66741558|FG000|Overall Study|Participant unable to adhere|0|||
23754795|NCT00434148|66481018|FG000|Overall Study|Abnormal test procedure result|0|||
23754796|NCT00434148|66481019|FG001|Overall Study|Abnormal test procedure result|1|||
23754797|NCT00791154|66481020|FG000|Overall Study|Noncompliance|0|||
23754798|NCT00791154|66481021|FG001|Overall Study|Noncompliance|1|||
23754799|NCT00791154|66481022|FG002|Overall Study|Noncompliance|0|||
23754800|NCT00791154|66481023|FG003|Overall Study|Noncompliance|0|||
23754801|NCT00791154|66481024|FG004|Overall Study|Noncompliance|1|||
23754802|NCT00791154|66481025|FG005|Overall Study|Noncompliance|1|||
23754803|NCT00791154|66481026|FG006|Overall Study|Noncompliance|1|||
23754804|NCT00791154|66481020|FG000|Overall Study|Adverse Event|0|||
23754805|NCT00791154|66481021|FG001|Overall Study|Adverse Event|0|||
23754806|NCT00791154|66481022|FG002|Overall Study|Adverse Event|0|||
23754807|NCT00791154|66481023|FG003|Overall Study|Adverse Event|0|||
23754808|NCT00791154|66481024|FG004|Overall Study|Adverse Event|2|||
23559043|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
23559044|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
23754809|NCT00791154|66481025|FG005|Overall Study|Adverse Event|0|||
23754810|NCT00791154|66481026|FG006|Overall Study|Adverse Event|1|||
23754811|NCT00791154|66481020|FG000|Overall Study|Full Consent withdrawn|1|||
23754812|NCT00791154|66481021|FG001|Overall Study|Full Consent withdrawn|3|||
23754813|NCT00791154|66481022|FG002|Overall Study|Full Consent withdrawn|0|||
23754814|NCT00791154|66481023|FG003|Overall Study|Full Consent withdrawn|0|||
23754815|NCT00791154|66481024|FG004|Overall Study|Full Consent withdrawn|1|||
23754816|NCT00791154|66481025|FG005|Overall Study|Full Consent withdrawn|3|||
23754817|NCT00791154|66481026|FG006|Overall Study|Full Consent withdrawn|1|||
23754818|NCT00791154|66481020|FG000|Overall Study|Lost to Follow-up|0|||
23754819|NCT00791154|66481021|FG001|Overall Study|Lost to Follow-up|0|||
23754820|NCT00791154|66481022|FG002|Overall Study|Lost to Follow-up|0|||
23754821|NCT00791154|66481023|FG003|Overall Study|Lost to Follow-up|1|||
23754822|NCT00791154|66481024|FG004|Overall Study|Lost to Follow-up|2|||
23754823|NCT00791154|66481025|FG005|Overall Study|Lost to Follow-up|0|||
23754824|NCT00791154|66481026|FG006|Overall Study|Lost to Follow-up|4|||
23754825|NCT00791154|66481020|FG000|Overall Study|Death|5|||
23754826|NCT00791154|66481021|FG001|Overall Study|Death|4|||
23754827|NCT00791154|66481022|FG002|Overall Study|Death|4|||
23754828|NCT00791154|66481023|FG003|Overall Study|Death|7|||
23754829|NCT00791154|66481024|FG004|Overall Study|Death|54|||
23754830|NCT00791154|66481025|FG005|Overall Study|Death|54|||
23754831|NCT00791154|66481026|FG006|Overall Study|Death|52|||
23754832|NCT00791154|66481020|FG000|Overall Study|Other event|0|||
23754833|NCT00791154|66481021|FG001|Overall Study|Other event|0|||
23754834|NCT00791154|66481022|FG002|Overall Study|Other event|2|||
23754835|NCT00791154|66481023|FG003|Overall Study|Other event|0|||
23754836|NCT00791154|66481024|FG004|Overall Study|Other event|2|||
23754837|NCT00791154|66481025|FG005|Overall Study|Other event|4|||
23754838|NCT00791154|66481026|FG006|Overall Study|Other event|2|||
23754839|NCT01286207|66481029|FG000|Overall Study|Adverse Event|27|||
23754840|NCT01286207|66481030|FG001|Overall Study|Adverse Event|41|||
23754841|NCT01286207|66481031|FG002|Overall Study|Adverse Event|8|||
23754842|NCT01286207|66481029|FG000|Overall Study|Lost to Follow-up|49|||
23754843|NCT01286207|66481030|FG001|Overall Study|Lost to Follow-up|43|||
23754844|NCT01286207|66481031|FG002|Overall Study|Lost to Follow-up|20|||
23754845|NCT01286207|66481029|FG000|Overall Study|Withdrawal by Subject|93|||
23754846|NCT01286207|66481030|FG001|Overall Study|Withdrawal by Subject|79|||
23559045|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
23559046|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
23559047|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
23559048|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
23559049|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
23559050|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
23559051|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
23559052|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
23624205|NCT00195442|66011558|FG000|Overall Study|Poor cooperation|2|||
23754847|NCT01286207|66481031|FG002|Overall Study|Withdrawal by Subject|41|||
23754848|NCT01286207|66481029|FG000|Overall Study|Lack of Response|92|||
23754849|NCT01286207|66481030|FG001|Overall Study|Lack of Response|38|||
23754850|NCT01286207|66481031|FG002|Overall Study|Lack of Response|8|||
23754851|NCT01286207|66481029|FG000|Overall Study|Other|37|||
23754852|NCT01286207|66481030|FG001|Overall Study|Other|47|||
23754853|NCT01286207|66481031|FG002|Overall Study|Other|13|||
23754854|NCT01817764|66481032|FG000|Overall Study|Adverse Event|7|||
23754855|NCT01817764|66481033|FG001|Overall Study|Adverse Event|10|||
23754856|NCT01817764|66481032|FG000|Overall Study|Lack of Efficacy|9|||
23754857|NCT01817764|66481033|FG001|Overall Study|Lack of Efficacy|7|||
23754858|NCT01817764|66481032|FG000|Overall Study|Protocol Violation|7|||
23754859|NCT01817764|66481033|FG001|Overall Study|Protocol Violation|5|||
23754860|NCT01817764|66481032|FG000|Overall Study|Lost to Follow-up|1|||
23754861|NCT01817764|66481033|FG001|Overall Study|Lost to Follow-up|4|||
23754862|NCT01817764|66481032|FG000|Overall Study|Withdrawal by Subject|10|||
23754863|NCT01817764|66481033|FG001|Overall Study|Withdrawal by Subject|12|||
23559053|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
23559054|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
23559055|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
23559056|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
23559057|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
23559058|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
23559059|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
23559060|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
23559061|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
23559062|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
23559063|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
23559064|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
23559065|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
23559066|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
23754864|NCT00572156|66481035|FG000|Overall Study|Adverse Event|3|||
23754865|NCT00572156|66481036|FG001|Overall Study|Adverse Event|1|||
23754866|NCT00572156|66481037|FG002|Overall Study|Adverse Event|5|||
23754867|NCT00572156|66481038|FG003|Overall Study|Adverse Event|1|||
23754868|NCT00572156|66481035|FG000|Overall Study|Lost to Follow-up|1|||
23754869|NCT00572156|66481036|FG001|Overall Study|Lost to Follow-up|1|||
23754870|NCT00572156|66481037|FG002|Overall Study|Lost to Follow-up|1|||
23754871|NCT00572156|66481038|FG003|Overall Study|Lost to Follow-up|0|||
23754872|NCT00572156|66481035|FG000|Overall Study|Protocol Violation|1|||
23754873|NCT00572156|66481036|FG001|Overall Study|Protocol Violation|2|||
23754874|NCT00572156|66481037|FG002|Overall Study|Protocol Violation|0|||
23754875|NCT00572156|66481038|FG003|Overall Study|Protocol Violation|2|||
23754876|NCT00572156|66481035|FG000|Overall Study|Patient/Parent Decision|1|||
23754877|NCT00572156|66481036|FG001|Overall Study|Patient/Parent Decision|6|||
23754878|NCT00572156|66481037|FG002|Overall Study|Patient/Parent Decision|4|||
23754879|NCT00572156|66481038|FG003|Overall Study|Patient/Parent Decision|3|||
23754880|NCT00572156|66481035|FG000|Overall Study|Sponsor Decision|20|||
23754881|NCT00572156|66481036|FG001|Overall Study|Sponsor Decision|16|||
23754882|NCT00572156|66481037|FG002|Overall Study|Sponsor Decision|17|||
23754883|NCT00572156|66481038|FG003|Overall Study|Sponsor Decision|19|||
23782258|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782259|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782260|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782261|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782262|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782263|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782264|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782265|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782266|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782267|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782268|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782269|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782270|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
23782271|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782272|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782273|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
23782274|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23782275|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782276|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782277|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782278|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782279|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782280|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782281|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782282|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23559067|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23559068|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23782283|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782284|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782285|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782286|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782287|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23559069|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
23754884|NCT01988493|66484378|FG000|Overall Study|Randomized but not treated|0|||
23754885|NCT01988493|66484379|FG001|Overall Study|Randomized but not treated|0|||
23754886|NCT01988493|66484380|FG002|Overall Study|Randomized but not treated|0|||
23754887|NCT01988493|66484381|FG003|Overall Study|Randomized but not treated|0|||
23754888|NCT01988493|66484382|FG004|Overall Study|Randomized but not treated|1|||
23754889|NCT03506425|66484389|FG000|Overall Study|Adverse Event|1|||
23754890|NCT03506425|66484390|FG001|Overall Study|Adverse Event|3|||
23754891|NCT03506425|66484391|FG002|Overall Study|Adverse Event|0|||
23754892|NCT03506425|66484389|FG000|Overall Study|Death|1|||
23754893|NCT03506425|66484390|FG001|Overall Study|Death|0|||
23754894|NCT03506425|66484391|FG002|Overall Study|Death|0|||
23754895|NCT03506425|66484389|FG000|Overall Study|Withdrawal by Subject|0|||
23754896|NCT03506425|66484390|FG001|Overall Study|Withdrawal by Subject|0|||
23754897|NCT03506425|66484391|FG002|Overall Study|Withdrawal by Subject|1|||
23754898|NCT00990093|66484395|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
23754899|NCT00990093|66484396|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
23754900|NCT00990093|66484395|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
23754901|NCT00990093|66484396|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
23754902|NCT00990093|66484395|FG000|Test Period 1 (1-14 Days)|Other|1|||
23754903|NCT00990093|66484396|FG001|Test Period 1 (1-14 Days)|Other|0|||
23754904|NCT00990093|66484395|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
23754905|NCT00990093|66484396|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
23437628|NCT02409342|65344164|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
23437629|NCT02409342|65344165|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
23437630|NCT02409342|65344164|FG000|Overall Study|Sponsor Decision|1|||
23437631|NCT02409342|65344165|FG001|Overall Study|Sponsor Decision|0|||
23437632|NCT04667104|65344166|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
23437633|NCT04667104|65344167|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
23437634|NCT04667104|65344168|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
23437635|NCT01192568|65344174|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
23437636|NCT01192568|65344175|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
23437637|NCT01192568|65344176|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
23437638|NCT01192568|65344177|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
23437639|NCT01192568|65344174|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
23437640|NCT01192568|65344175|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
23437641|NCT01192568|65344176|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
23437642|NCT01192568|65344177|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
23437643|NCT01114438|65344178|FG000|Overall Study|Adverse Event|10|||
23437644|NCT01114438|65344178|FG000|Overall Study|concomitant medication|1|||
23437645|NCT01114438|65344178|FG000|Overall Study|Physician Decision|1|||
23754906|NCT00990093|66484395|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
23754907|NCT00990093|66484396|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
23754908|NCT00990093|66484395|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
23754909|NCT00990093|66484396|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
23437646|NCT01114438|65344178|FG000|Overall Study|Withdrawal by Subject|2|||
23437647|NCT01209078|65344179|FG000|Overall Study|Adverse Event|5|||
23754910|NCT00990093|66484395|FG000|Test Period 2 (15-28 Days)|Other|0|||
23754911|NCT00990093|66484396|FG001|Test Period 2 (15-28 Days)|Other|1|||
23754912|NCT04333199|66484398|FG000|Evaluated Patients|Lost to Follow-up|0|||
23437648|NCT01209078|65344180|FG001|Overall Study|Adverse Event|0|||
23437649|NCT01209078|65344179|FG000|Overall Study|Lost to Follow-up|4|||
23437650|NCT01209078|65344180|FG001|Overall Study|Lost to Follow-up|0|||
23437651|NCT01209078|65344179|FG000|Overall Study|Physician Decision|5|||
23559070|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23559071|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23559072|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
23559073|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
23559074|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
23559075|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23559076|NCT00674570|65776161|FG000|Overall Study|Withdrawal by Subject|0|||
23437652|NCT01209078|65344180|FG001|Overall Study|Physician Decision|2|||
23437653|NCT01209078|65344179|FG000|Overall Study|Withdrawal by Subject|2|||
23559077|NCT00674570|65776162|FG001|Overall Study|Withdrawal by Subject|2|||
23559078|NCT00674570|65776163|FG002|Overall Study|Withdrawal by Subject|0|||
23559079|NCT01424930|65776164|FG000|Overall Study|Adverse Event|0|||
23559080|NCT01424930|65776165|FG001|Overall Study|Adverse Event|1|||
23559081|NCT01424930|65776164|FG000|Overall Study|Death|1|||
23559082|NCT01424930|65776165|FG001|Overall Study|Death|0|||
23559083|NCT01424930|65776164|FG000|Overall Study|Progressive Disease|3|||
23559084|NCT01424930|65776165|FG001|Overall Study|Progressive Disease|6|||
23559085|NCT01424930|65776164|FG000|Overall Study|Screen Failure|0|||
23559086|NCT01424930|65776165|FG001|Overall Study|Screen Failure|1|||
23559087|NCT01424930|65776164|FG000|Overall Study|Reason not specified|0|||
23559088|NCT01424930|65776165|FG001|Overall Study|Reason not specified|6|||
23559089|NCT00464815|65776166|FG000|Overall Study|Withdrawal by Subject|6|||
23559090|NCT00464815|65776167|FG001|Overall Study|Withdrawal by Subject|3|||
23559091|NCT03172702|65776170|FG000|Overall Study|Adverse Event|9|||
23559092|NCT03172702|65776170|FG000|Overall Study|Death|2|||
23559093|NCT03172702|65776170|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
23559094|NCT03172702|65776170|FG000|Overall Study|Withdrawal by Subject|5|||
23559095|NCT03172702|65776170|FG000|Overall Study|Other|2|||
23559096|NCT00420199|65776171|FG000|Overall Study|Participant no longer met study criteria|1|||
23559097|NCT00420199|65776172|FG001|Overall Study|Participant no longer met study criteria|0|||
23559098|NCT02436811|65776173|FG000|Overall Study|Lost to Follow-up|2|||
23559099|NCT02436811|65776174|FG001|Overall Study|Lost to Follow-up|9|||
23559100|NCT02436811|65776175|FG002|Overall Study|Lost to Follow-up|7|||
23559101|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
23559102|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
23559103|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
23559104|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23559105|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23559106|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
23559107|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23624206|NCT00195442|66011558|FG000|Overall Study|Other|14|||
23624207|NCT00975676|66011559|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
23624208|NCT00975676|66011560|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
23624209|NCT01185171|66011566|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
23624210|NCT01185171|66011566|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
23624211|NCT01185171|66011566|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
23624212|NCT01185171|66011566|FG000|Maintenance|Elevated liver transaminases|3|||
23754913|NCT04333199|66484399|FG001|Evaluated Patients|Lost to Follow-up|1|||
23754914|NCT04333199|66484400|FG002|Evaluated Patients|Lost to Follow-up|2|||
23754915|NCT02094573|66484401|FG000|Overall Study|Adverse Event|4|||
23754916|NCT02094573|66484402|FG001|Overall Study|Adverse Event|14|||
23754917|NCT02094573|66484401|FG000|Overall Study|Clinical Progressive Disease|9|||
23754918|NCT02094573|66484402|FG001|Overall Study|Clinical Progressive Disease|13|||
23754919|NCT02094573|66484401|FG000|Overall Study|Death|11|||
23754920|NCT02094573|66484402|FG001|Overall Study|Death|3|||
23754921|NCT02094573|66484401|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
23754922|NCT02094573|66484402|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
23754923|NCT02094573|66484401|FG000|Overall Study|Non-compliance with Study Drug|1|||
23754924|NCT02094573|66484402|FG001|Overall Study|Non-compliance with Study Drug|1|||
23754925|NCT02094573|66484401|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
23754926|NCT02094573|66484402|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
23754927|NCT02094573|66484401|FG000|Overall Study|Physician Decision|4|||
23754928|NCT02094573|66484402|FG001|Overall Study|Physician Decision|4|||
23754929|NCT02094573|66484401|FG000|Overall Study|Site Terminated by Sponsor|10|||
23754930|NCT02094573|66484402|FG001|Overall Study|Site Terminated by Sponsor|17|||
23754931|NCT02094573|66484401|FG000|Overall Study|Withdrawal by Subject|6|||
23754932|NCT02094573|66484402|FG001|Overall Study|Withdrawal by Subject|8|||
23754933|NCT02094573|66484401|FG000|Overall Study|Randomized but not Treated|3|||
23754934|NCT02094573|66484402|FG001|Overall Study|Randomized but not Treated|0|||
23754935|NCT03496207|66484403|FG000|Base Study|Adverse Event|0|||
23754936|NCT03496207|66484404|FG001|Base Study|Adverse Event|0|||
23754937|NCT03496207|66484405|FG002|Base Study|Adverse Event|1|||
23754938|NCT03496207|66484406|FG003|Base Study|Adverse Event|1|||
23754939|NCT03496207|66484407|FG004|Base Study|Adverse Event|4|||
23754940|NCT03496207|66484403|FG000|Base Study|Death|0|||
23754941|NCT03496207|66484404|FG001|Base Study|Death|0|||
23559108|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
23559109|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23559110|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
23559111|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23559112|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23559113|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23559114|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
23559115|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23559116|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
23624213|NCT01185171|66011566|FG000|Maintenance|Rush|2|||
23624214|NCT01185171|66011566|FG000|Maintenance|Diarrhea|1|||
23754942|NCT03496207|66484405|FG002|Base Study|Death|0|||
23754943|NCT03496207|66484406|FG003|Base Study|Death|0|||
23754944|NCT03496207|66484407|FG004|Base Study|Death|1|||
23754945|NCT03496207|66484403|FG000|Base Study|Withdrawal by Subject|0|||
23754946|NCT03496207|66484404|FG001|Base Study|Withdrawal by Subject|0|||
23754947|NCT03496207|66484405|FG002|Base Study|Withdrawal by Subject|1|||
23754948|NCT03496207|66484406|FG003|Base Study|Withdrawal by Subject|0|||
23754949|NCT03496207|66484407|FG004|Base Study|Withdrawal by Subject|1|||
23437654|NCT01209078|65344180|FG001|Overall Study|Withdrawal by Subject|1|||
23754950|NCT03496207|66484403|FG000|Extension Period|Adverse Event|0|||
23754951|NCT03496207|66484404|FG001|Extension Period|Adverse Event|0|||
23754952|NCT03496207|66484405|FG002|Extension Period|Adverse Event|0|||
23754953|NCT03496207|66484406|FG003|Extension Period|Adverse Event|1|||
23437655|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Death|113|||
23437656|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Death|189|||
23437657|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
23437658|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
23437659|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
23437660|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
23437661|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
23437662|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
23437663|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
23437664|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
23437665|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
23437666|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
23437667|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
23437668|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
23437669|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
23437670|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
23437671|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
23437672|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
23437673|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
23437674|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
23437675|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
23437676|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
23437677|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
23437678|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
23437679|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
23437680|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
23437681|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
23437682|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
23437683|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
23437684|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
23437685|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
23437686|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
23437687|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
23559117|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
23559118|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
23559119|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
23559120|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
23754954|NCT03496207|66484407|FG004|Extension Period|Adverse Event|1|||
23754955|NCT03496207|66484403|FG000|Extension Period|Death|1|||
23559121|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
23559122|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
23559123|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
23559124|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
23559125|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
23559126|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
23559127|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
23559128|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
23559129|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
23559130|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
23559131|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Other|2|||
23559132|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Other|2|||
23754956|NCT03496207|66484404|FG001|Extension Period|Death|0|||
23754957|NCT03496207|66484405|FG002|Extension Period|Death|0|||
23754958|NCT03496207|66484406|FG003|Extension Period|Death|1|||
23754959|NCT03496207|66484407|FG004|Extension Period|Death|2|||
23754960|NCT03496207|66484403|FG000|Extension Period|Withdrawal by Subject|1|||
23754961|NCT03496207|66484404|FG001|Extension Period|Withdrawal by Subject|0|||
23754962|NCT03496207|66484405|FG002|Extension Period|Withdrawal by Subject|0|||
23754963|NCT03496207|66484406|FG003|Extension Period|Withdrawal by Subject|1|||
23754964|NCT03496207|66484407|FG004|Extension Period|Withdrawal by Subject|1|||
23754965|NCT03496207|66484403|FG000|Extension Period|Elevated hemoglobin levels|0|||
23754966|NCT03496207|66484404|FG001|Extension Period|Elevated hemoglobin levels|0|||
23754967|NCT03496207|66484405|FG002|Extension Period|Elevated hemoglobin levels|0|||
23754968|NCT03496207|66484406|FG003|Extension Period|Elevated hemoglobin levels|0|||
23754969|NCT03496207|66484407|FG004|Extension Period|Elevated hemoglobin levels|1|||
23754970|NCT00808015|66484410|FG000|Overall Study|Death|1|||
23559133|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Other|3|||
23559134|NCT03255824|65776185|FG000|Overall Study|Under-sedation|2|||
23559135|NCT03255824|65776186|FG001|Overall Study|Under-sedation|1|||
23559136|NCT01256567|65776191|FG000|Overall Study|Withdrawal by Subject|1|||
23559137|NCT03214367|65776193|FG000|Lead-in Period|Withdrawal by Subject|50|||
23559138|NCT03214367|65776194|FG001|Lead-in Period|Withdrawal by Subject|0|||
23754971|NCT00808015|66484410|FG000|Overall Study|Lack of Efficacy|58|||
23754972|NCT00808015|66484410|FG000|Overall Study|Lost to Follow-up|76|||
23825717|NCT02797171|66741559|FG001|Overall Study|Participant unable to adhere|1|||
23825718|NCT02797171|66741560|FG002|Overall Study|Participant unable to adhere|0|||
23825719|NCT02797171|66741561|FG003|Overall Study|Participant unable to adhere|0|||
23825720|NCT02797171|66741562|FG004|Overall Study|Participant unable to adhere|0|||
23825721|NCT02797171|66741563|FG005|Overall Study|Participant unable to adhere|0|||
23825722|NCT02797171|66741558|FG000|Overall Study|Not Randomized|0|||
23825723|NCT02797171|66741559|FG001|Overall Study|Not Randomized|0|||
23825724|NCT02797171|66741560|FG002|Overall Study|Not Randomized|0|||
23825725|NCT02797171|66741561|FG003|Overall Study|Not Randomized|0|||
23825726|NCT02797171|66741562|FG004|Overall Study|Not Randomized|0|||
23825727|NCT02797171|66741563|FG005|Overall Study|Not Randomized|1|||
23825728|NCT03875508|66741566|FG000|Overall Study|Adverse Event|1|||
23825729|NCT03875508|66741566|FG000|Overall Study|Lost to Follow-up|8|||
23825730|NCT03875508|66741566|FG000|Overall Study|Lack of Efficacy|1|||
23825731|NCT03875508|66741566|FG000|Overall Study|Other, not specified|2|||
23825732|NCT04342819|66741567|FG000|Overall Study|Declined|4|||
23825733|NCT04342819|66741567|FG000|Overall Study|Not meeeting selection criteria|1|||
23825734|NCT03594071|66741575|FG000|Overall Study|Re-operation|3|||
23825735|NCT03594071|66741575|FG000|Overall Study|Missed visit|2|||
23825736|NCT03122886|66741576|FG000|Overall Study|Withdrawal by Subject|1|||
23825737|NCT03122886|66741577|FG001|Overall Study|Withdrawal by Subject|2|||
23754973|NCT00808015|66484410|FG000|Overall Study|Participants not willing to participate|158|||
23754974|NCT00808015|66484410|FG000|Overall Study|Adverse Event|22|||
23754975|NCT00808015|66484410|FG000|Overall Study|Other|25|||
23754976|NCT00808015|66484410|FG000|Overall Study|Enrolled but not treated|4|||
23754977|NCT01954082|66484411|FG000|Overall Study|Study Suspension|42|||
23754978|NCT01954082|66484412|FG001|Overall Study|Study Suspension|36|||
23754979|NCT01954082|66484411|FG000|Overall Study|Adverse Event|10|||
23754980|NCT01954082|66484412|FG001|Overall Study|Adverse Event|4|||
23754981|NCT01954082|66484411|FG000|Overall Study|Intolerance|0|||
23754982|NCT01954082|66484412|FG001|Overall Study|Intolerance|1|||
23559139|NCT03214367|65776195|FG002|Lead-in Period|Withdrawal by Subject|0|||
23559140|NCT03214367|65776196|FG003|Lead-in Period|Withdrawal by Subject|0|||
23559141|NCT03214367|65776197|FG004|Lead-in Period|Withdrawal by Subject|2|||
23754983|NCT01954082|66484411|FG000|Overall Study|Non-compliance|6|||
23754984|NCT01954082|66484412|FG001|Overall Study|Non-compliance|4|||
23754985|NCT01954082|66484411|FG000|Overall Study|Physician Decision|2|||
23754986|NCT01954082|66484412|FG001|Overall Study|Physician Decision|0|||
23825738|NCT03052751|66741578|FG000|Dosing Period 1|Adverse Event|0|||
23825739|NCT03052751|66741579|FG001|Dosing Period 1|Adverse Event|1|||
23825740|NCT03052751|66741580|FG002|Dosing Period 1|Adverse Event|0|||
23825741|NCT03052751|66741581|FG003|Dosing Period 1|Adverse Event|0|||
23825742|NCT03052751|66741582|FG004|Dosing Period 1|Adverse Event|0|||
23825743|NCT03052751|66741583|FG005|Dosing Period 1|Adverse Event|0|||
23825744|NCT03052751|66741578|FG000|Dosing Period 2|Adverse Event|0|||
23825745|NCT03052751|66741579|FG001|Dosing Period 2|Adverse Event|0|||
23825746|NCT03052751|66741580|FG002|Dosing Period 2|Adverse Event|3|||
23754987|NCT01954082|66484411|FG000|Overall Study|Parent Decision|1|||
23754988|NCT01954082|66484412|FG001|Overall Study|Parent Decision|0|||
23754989|NCT01954082|66484411|FG000|Overall Study|Withdrawal by Subject|0|||
23754990|NCT01954082|66484412|FG001|Overall Study|Withdrawal by Subject|1|||
23754991|NCT01954082|66484411|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
23754992|NCT01954082|66484412|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
23754993|NCT01954082|66484411|FG000|Overall Study|Redirection of Care|0|||
23754994|NCT01954082|66484412|FG001|Overall Study|Redirection of Care|2|||
23754995|NCT01954082|66484411|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
23754996|NCT01954082|66484412|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
23754997|NCT01954082|66484411|FG000|Overall Study|Comfort Care|0|||
23754998|NCT01954082|66484412|FG001|Overall Study|Comfort Care|1|||
23754999|NCT01954082|66484411|FG000|Overall Study|Infant Moved|0|||
23755000|NCT01954082|66484412|FG001|Overall Study|Infant Moved|1|||
23755001|NCT01954082|66484411|FG000|Overall Study|Randomized not Treated|4|||
23755002|NCT01954082|66484412|FG001|Overall Study|Randomized not Treated|2|||
23559142|NCT03214367|65776198|FG005|Lead-in Period|Withdrawal by Subject|0|||
23559143|NCT03214367|65776199|FG006|Lead-in Period|Withdrawal by Subject|0|||
23755003|NCT04388527|66484413|FG000|Overall Study|Death|14|||
23755004|NCT04388527|66484413|FG000|Overall Study|Withdrawal by Subject|2|||
23755005|NCT04388527|66484413|FG000|Overall Study|Lost to Follow-up|1|||
23755006|NCT00545441|66484416|FG000|Overall Study|Fistula draining at 6 months|2|||
23755007|NCT00545441|66484417|FG001|Overall Study|Fistula draining at 6 months|4|||
23755008|NCT00545441|66484416|FG000|Overall Study|Lost to Follow-up|9|||
23755009|NCT00545441|66484417|FG001|Overall Study|Lost to Follow-up|5|||
23755010|NCT00545441|66484416|FG000|Overall Study|Technical failure|0|||
23755011|NCT00545441|66484417|FG001|Overall Study|Technical failure|1|||
23755012|NCT00545441|66484416|FG000|Overall Study|Withdrawal by Subject|1|||
23755013|NCT00545441|66484417|FG001|Overall Study|Withdrawal by Subject|1|||
23755014|NCT00545441|66484416|FG000|Overall Study|Persistence or recurrence of fistula|5|||
23755015|NCT00545441|66484417|FG001|Overall Study|Persistence or recurrence of fistula|2|||
23755016|NCT00545441|66484416|FG000|Overall Study|Patients were not treated|1|||
23755017|NCT00545441|66484417|FG001|Overall Study|Patients were not treated|3|||
23755018|NCT03349437|66484418|FG000|Screening|Screen Fail|4|||
23755019|NCT03349437|66484419|FG001|Screening|Screen Fail|0|||
23755020|NCT03349437|66484420|FG002|Screening|Screen Fail|0|||
23755021|NCT03349437|66484418|FG000|Screening|Withdrawn|1|||
23755022|NCT03349437|66484419|FG001|Screening|Withdrawn|0|||
23755023|NCT03349437|66484420|FG002|Screening|Withdrawn|0|||
23755024|NCT03276962|66484421|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
23755025|NCT03276962|66484422|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
23755026|NCT03276962|66484423|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
23755027|NCT03276962|66484424|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
23755028|NCT03276962|66484425|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
23559144|NCT03214367|65776200|FG007|Lead-in Period|Withdrawal by Subject|0|||
23559145|NCT03214367|65776193|FG000|Lead-in Period|Adverse Event|3|||
23559146|NCT03214367|65776194|FG001|Lead-in Period|Adverse Event|0|||
23559147|NCT03214367|65776195|FG002|Lead-in Period|Adverse Event|0|||
23755029|NCT03276962|66484421|FG000|Overall Study|Protocol Deviation|2|||
23755030|NCT03276962|66484422|FG001|Overall Study|Protocol Deviation|0|||
23755031|NCT03276962|66484423|FG002|Overall Study|Protocol Deviation|1|||
23755032|NCT03276962|66484424|FG003|Overall Study|Protocol Deviation|2|||
23559148|NCT03214367|65776196|FG003|Lead-in Period|Adverse Event|0|||
23559149|NCT03214367|65776197|FG004|Lead-in Period|Adverse Event|0|||
23755033|NCT03276962|66484425|FG004|Overall Study|Protocol Deviation|1|||
23559150|NCT03214367|65776198|FG005|Lead-in Period|Adverse Event|0|||
23559151|NCT03214367|65776199|FG006|Lead-in Period|Adverse Event|0|||
23559152|NCT03214367|65776200|FG007|Lead-in Period|Adverse Event|0|||
23559153|NCT03214367|65776193|FG000|Lead-in Period|Lost to Follow-up|12|||
23755034|NCT03276962|66484421|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
23755035|NCT03276962|66484422|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
23755036|NCT03276962|66484423|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
23755037|NCT03276962|66484424|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
23755038|NCT03276962|66484425|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
23825747|NCT03052751|66741581|FG003|Dosing Period 2|Adverse Event|0|||
23559154|NCT03214367|65776194|FG001|Lead-in Period|Lost to Follow-up|0|||
23755039|NCT03276962|66484421|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
23755040|NCT03276962|66484422|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
23755041|NCT03276962|66484423|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
23755042|NCT03276962|66484424|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
23755043|NCT03276962|66484425|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
23755044|NCT03276962|66484421|FG000|Overall Study|Lost to Follow-up|10|||
23755045|NCT03276962|66484422|FG001|Overall Study|Lost to Follow-up|10|||
23755046|NCT03276962|66484423|FG002|Overall Study|Lost to Follow-up|4|||
23755047|NCT03276962|66484424|FG003|Overall Study|Lost to Follow-up|6|||
23755048|NCT03276962|66484425|FG004|Overall Study|Lost to Follow-up|10|||
23755049|NCT03276962|66484421|FG000|Overall Study|Other|0|||
23755050|NCT03276962|66484422|FG001|Overall Study|Other|2|||
23825748|NCT03052751|66741582|FG004|Dosing Period 2|Adverse Event|0|||
23825749|NCT03052751|66741583|FG005|Dosing Period 2|Adverse Event|0|||
23825750|NCT03052751|66741578|FG000|Observation Period|Adverse Event|0|||
23825751|NCT03052751|66741579|FG001|Observation Period|Adverse Event|0|||
23437688|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
23559155|NCT03214367|65776195|FG002|Lead-in Period|Lost to Follow-up|0|||
23559156|NCT03214367|65776196|FG003|Lead-in Period|Lost to Follow-up|0|||
23437689|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
23437690|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
23437691|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
23437692|NCT04230213|65344188|FG000|TP2: Week 10 to Week 16|Other|0|||
23755051|NCT03276962|66484423|FG002|Overall Study|Other|0|||
23755052|NCT03276962|66484424|FG003|Overall Study|Other|2|||
23755053|NCT03276962|66484425|FG004|Overall Study|Other|1|||
23755054|NCT04440007|66484426|FG000|Overall Study|Adverse Event|0|||
23755055|NCT04440007|66484427|FG001|Overall Study|Adverse Event|1|||
23755056|NCT04440007|66484426|FG000|Overall Study|Lost to Follow-up|1|||
23755057|NCT04440007|66484427|FG001|Overall Study|Lost to Follow-up|3|||
23755058|NCT04440007|66484426|FG000|Overall Study|Death|7|||
23755059|NCT04440007|66484427|FG001|Overall Study|Death|2|||
23755060|NCT04440007|66484426|FG000|Overall Study|Physician Decision|1|||
23755061|NCT04440007|66484427|FG001|Overall Study|Physician Decision|1|||
23755062|NCT04440007|66484426|FG000|Overall Study|Withdrawal by Subject|2|||
23437693|NCT04230213|65344189|FG001|TP2: Week 10 to Week 16|Other|2|||
23437694|NCT04230213|65344190|FG002|TP2: Week 10 to Week 16|Other|1|||
23437695|NCT04230213|65344188|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
23437696|NCT04230213|65344189|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
23437697|NCT04230213|65344190|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
23437698|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
23437699|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
23437700|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
23437701|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
23437702|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
23437703|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
23437704|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
23437705|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
23437706|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
23559157|NCT03214367|65776197|FG004|Lead-in Period|Lost to Follow-up|0|||
23559158|NCT03214367|65776198|FG005|Lead-in Period|Lost to Follow-up|0|||
23559159|NCT03214367|65776199|FG006|Lead-in Period|Lost to Follow-up|0|||
23559160|NCT03214367|65776200|FG007|Lead-in Period|Lost to Follow-up|0|||
23755063|NCT04440007|66484427|FG001|Overall Study|Withdrawal by Subject|1|||
23755064|NCT04440007|66484426|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
23755065|NCT04440007|66484427|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
23755066|NCT04440007|66484426|FG000|Overall Study|Discontinued prior to dosing|0|||
23755067|NCT04440007|66484427|FG001|Overall Study|Discontinued prior to dosing|2|||
23755068|NCT02858076|66484429|FG000|Overall Study|Death|6|||
23755069|NCT02858076|66484430|FG001|Overall Study|Death|3|||
23755070|NCT02858076|66484429|FG000|Overall Study|Withdrawal by Subject|1|||
23755071|NCT02858076|66484430|FG001|Overall Study|Withdrawal by Subject|5|||
23755072|NCT02858076|66484429|FG000|Overall Study|Lost to Follow-up|2|||
23755073|NCT02858076|66484430|FG001|Overall Study|Lost to Follow-up|7|||
23825752|NCT03052751|66741580|FG002|Observation Period|Adverse Event|0|||
23437707|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Other|0|||
23559161|NCT03214367|65776193|FG000|Lead-in Period|Sponsor Decision|11|||
23437708|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Other|1|||
23559162|NCT03214367|65776194|FG001|Lead-in Period|Sponsor Decision|0|||
23755074|NCT02858076|66484429|FG000|Overall Study|Completed Out of Window|1|||
23755075|NCT02858076|66484430|FG001|Overall Study|Completed Out of Window|3|||
23755076|NCT04476017|66484431|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
23755077|NCT04476017|66484432|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
23825753|NCT03052751|66741581|FG003|Observation Period|Adverse Event|0|||
23755078|NCT01977625|66484433|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
23825754|NCT03052751|66741582|FG004|Observation Period|Adverse Event|1|||
23755079|NCT01977625|66484434|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23755080|NCT01977625|66484433|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23755081|NCT01977625|66484434|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23755082|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
23755083|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
23755084|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
23755085|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Death|1|||
23755086|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
23755087|NCT00529802|66484437|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
23755088|NCT00529802|66484437|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
23755089|NCT00683904|66484438|FG000|Dose Level 1|Disease progression|2|||
23755090|NCT00683904|66484439|FG001|Dose Level 1|Disease progression|0|||
23755091|NCT00683904|66484438|FG000|Dose Level 1|Adverse Event|1|||
23755092|NCT00683904|66484439|FG001|Dose Level 1|Adverse Event|0|||
23755093|NCT00683904|66484438|FG000|Dose Level 2|Adverse Event|0|||
23755094|NCT00683904|66484439|FG001|Dose Level 2|Adverse Event|2|||
23755095|NCT01020773|66484444|FG000|Overall Study|Withdrawal by Subject|4|||
23755096|NCT01020773|66484445|FG001|Overall Study|Withdrawal by Subject|3|||
23755097|NCT01791127|66484450|FG000|Overall Study|Death|356|||
23755098|NCT01791127|66484450|FG000|Overall Study|Patient has withdrawn from study|293|||
23755099|NCT01791127|66484450|FG000|Overall Study|Lost to Follow-up|42|||
23755100|NCT01791127|66484450|FG000|Overall Study|All Siello leads are explanted|31|||
23755101|NCT01791127|66484450|FG000|Overall Study|Completion of 30 day safety registry|1|||
23755102|NCT01791127|66484450|FG000|Overall Study|Study terminated for EP Passion|749|||
23755103|NCT00306852|66484451|FG000|Overall Study|Death|14|||
23755104|NCT00306852|66484452|FG001|Overall Study|Death|14|||
23755105|NCT00306852|66484451|FG000|Overall Study|Lost to Follow-up|15|||
23755106|NCT00306852|66484452|FG001|Overall Study|Lost to Follow-up|24|||
23755107|NCT02756078|66484459|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
23755108|NCT02756078|66484460|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
23755109|NCT02756078|66484459|FG000|Period 1|Lost to Follow-up|0|||
23755110|NCT02756078|66484460|FG001|Period 1|Lost to Follow-up|2|||
23437709|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Other|3|||
23437710|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Other|0|||
23437711|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Other|5|||
23437712|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Other|5|||
23437713|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
23437714|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
23437715|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
23437716|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
23437717|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
23437718|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
23437719|NCT04230213|65344188|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
23437720|NCT04230213|65344189|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
23437721|NCT04230213|65344190|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
23755111|NCT02756078|66484459|FG000|Period 1|Protocol Violation|0|||
23755112|NCT02756078|66484460|FG001|Period 1|Protocol Violation|1|||
23437722|NCT04230213|65344188|FG000|Follow up: Week 32 to Week 36|Other|0|||
23437723|NCT04230213|65344189|FG001|Follow up: Week 32 to Week 36|Other|1|||
23755113|NCT02756078|66484459|FG000|Period 1|Adverse Event|1|||
23437724|NCT04230213|65344190|FG002|Follow up: Week 32 to Week 36|Other|1|||
23437725|NCT00788710|65344191|FG000|Overall Study|Adverse Event|1|||
23437726|NCT00788710|65344192|FG001|Overall Study|Adverse Event|3|||
23437727|NCT00788710|65344193|FG002|Overall Study|Adverse Event|4|||
23437728|NCT00788710|65344191|FG000|Overall Study|Lack of Efficacy|0|||
23437729|NCT00788710|65344192|FG001|Overall Study|Lack of Efficacy|0|||
23437730|NCT00788710|65344193|FG002|Overall Study|Lack of Efficacy|1|||
23437731|NCT00788710|65344191|FG000|Overall Study|Lost to Follow-up|0|||
23437732|NCT00788710|65344192|FG001|Overall Study|Lost to Follow-up|1|||
23437733|NCT00788710|65344193|FG002|Overall Study|Lost to Follow-up|0|||
23437734|NCT00788710|65344191|FG000|Overall Study|Physician Decision|2|||
23437735|NCT00788710|65344192|FG001|Overall Study|Physician Decision|1|||
23437736|NCT00788710|65344193|FG002|Overall Study|Physician Decision|0|||
23437737|NCT00788710|65344191|FG000|Overall Study|Protocol Violation|0|||
23559163|NCT03214367|65776195|FG002|Lead-in Period|Sponsor Decision|0|||
23755114|NCT02756078|66484460|FG001|Period 1|Adverse Event|10|||
23559164|NCT03214367|65776196|FG003|Lead-in Period|Sponsor Decision|0|||
23755115|NCT02756078|66484459|FG000|Period 1|Withdrawal by Subject|6|||
23755116|NCT02756078|66484460|FG001|Period 1|Withdrawal by Subject|6|||
23437738|NCT00788710|65344192|FG001|Overall Study|Protocol Violation|1|||
23437739|NCT00788710|65344193|FG002|Overall Study|Protocol Violation|1|||
23559165|NCT03214367|65776197|FG004|Lead-in Period|Sponsor Decision|0|||
23559166|NCT03214367|65776198|FG005|Lead-in Period|Sponsor Decision|0|||
23559167|NCT03214367|65776199|FG006|Lead-in Period|Sponsor Decision|0|||
23559168|NCT03214367|65776200|FG007|Lead-in Period|Sponsor Decision|0|||
23755117|NCT02756078|66484459|FG000|Period 1|Lens Discomfort|2|||
23755118|NCT02756078|66484460|FG001|Period 1|Lens Discomfort|2|||
23437740|NCT00788710|65344191|FG000|Overall Study|Withdrawal by Subject|2|||
23437741|NCT00788710|65344192|FG001|Overall Study|Withdrawal by Subject|2|||
23437742|NCT00788710|65344193|FG002|Overall Study|Withdrawal by Subject|0|||
23437743|NCT02487030|65344194|FG000|Overall Study|Lack of Efficacy|2|||
23825755|NCT03052751|66741583|FG005|Observation Period|Adverse Event|0|||
23825756|NCT00545714|66741584|FG000|Induction Phase (6 Months)|Physician Decision|3|||
23437744|NCT02487030|65344195|FG001|Overall Study|Lack of Efficacy|4|||
23437745|NCT02487030|65344196|FG002|Overall Study|Lack of Efficacy|1|||
23437746|NCT02487030|65344197|FG003|Overall Study|Lack of Efficacy|0|||
23437747|NCT02487030|65344198|FG004|Overall Study|Lack of Efficacy|1|||
23437748|NCT02487030|65344199|FG005|Overall Study|Lack of Efficacy|0|||
23437749|NCT02487030|65344200|FG006|Overall Study|Lack of Efficacy|0|||
23437750|NCT02487030|65344194|FG000|Overall Study|Lost to Follow-up|0|||
23437751|NCT02487030|65344195|FG001|Overall Study|Lost to Follow-up|0|||
23437752|NCT02487030|65344196|FG002|Overall Study|Lost to Follow-up|1|||
23437753|NCT02487030|65344197|FG003|Overall Study|Lost to Follow-up|1|||
23437754|NCT02487030|65344198|FG004|Overall Study|Lost to Follow-up|0|||
23437755|NCT02487030|65344199|FG005|Overall Study|Lost to Follow-up|1|||
23437756|NCT02487030|65344200|FG006|Overall Study|Lost to Follow-up|0|||
23437757|NCT02487030|65344194|FG000|Overall Study|Adverse Event|0|||
23559169|NCT03214367|65776193|FG000|Lead-in Period|Physician Decision|12|||
23559170|NCT03214367|65776194|FG001|Lead-in Period|Physician Decision|0|||
23559171|NCT03214367|65776195|FG002|Lead-in Period|Physician Decision|0|||
23559172|NCT03214367|65776196|FG003|Lead-in Period|Physician Decision|0|||
23559173|NCT03214367|65776197|FG004|Lead-in Period|Physician Decision|0|||
23825757|NCT00545714|66741584|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
23825758|NCT00545714|66741584|FG000|Induction Phase (6 Months)|Disease Progression|1|||
23825759|NCT00545714|66741584|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
23825760|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
23825761|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
23825762|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
23825763|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
23825764|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
23825765|NCT00545714|66741584|FG000|Maintenance Phase (36 Months)|Death|2|||
23825766|NCT02756208|66741585|FG000|Overall Study|Withdrawal by Subject|1|||
23825767|NCT02756208|66741586|FG001|Overall Study|Withdrawal by Subject|0|||
23825768|NCT02756208|66741587|FG002|Overall Study|Withdrawal by Subject|1|||
23825769|NCT02756208|66741588|FG003|Overall Study|Withdrawal by Subject|3|||
23825770|NCT02756208|66741585|FG000|Overall Study|Lost to Follow-up|3|||
23825771|NCT02756208|66741586|FG001|Overall Study|Lost to Follow-up|1|||
23825772|NCT02756208|66741587|FG002|Overall Study|Lost to Follow-up|1|||
23825773|NCT02756208|66741588|FG003|Overall Study|Lost to Follow-up|1|||
23825774|NCT02756208|66741585|FG000|Overall Study|Physician Decision|1|||
23825775|NCT02756208|66741586|FG001|Overall Study|Physician Decision|0|||
23825776|NCT02756208|66741587|FG002|Overall Study|Physician Decision|0|||
23825777|NCT02756208|66741588|FG003|Overall Study|Physician Decision|0|||
23825778|NCT02756208|66741585|FG000|Overall Study|Protocol Violation|0|||
23825779|NCT02756208|66741586|FG001|Overall Study|Protocol Violation|1|||
23825780|NCT02756208|66741587|FG002|Overall Study|Protocol Violation|0|||
23825781|NCT02756208|66741588|FG003|Overall Study|Protocol Violation|0|||
23825782|NCT01957397|66741592|FG000|Test Period 1|sudden leakage/small bag|1|||
23825783|NCT01957397|66741593|FG001|Test Period 1|sudden leakage/small bag|1|||
23825784|NCT01957397|66741592|FG000|Test Period 1|Withdrawal by Subject|1|||
23437758|NCT02487030|65344195|FG001|Overall Study|Adverse Event|0|||
23559174|NCT03214367|65776198|FG005|Lead-in Period|Physician Decision|0|||
23559175|NCT03214367|65776199|FG006|Lead-in Period|Physician Decision|0|||
23559176|NCT03214367|65776200|FG007|Lead-in Period|Physician Decision|0|||
23559177|NCT03214367|65776193|FG000|Lead-in Period|Protocol Violation|5|||
23559178|NCT03214367|65776194|FG001|Lead-in Period|Protocol Violation|0|||
23559179|NCT03214367|65776195|FG002|Lead-in Period|Protocol Violation|0|||
23559180|NCT03214367|65776196|FG003|Lead-in Period|Protocol Violation|0|||
23559181|NCT03214367|65776197|FG004|Lead-in Period|Protocol Violation|0|||
23559182|NCT03214367|65776198|FG005|Lead-in Period|Protocol Violation|0|||
23559183|NCT03214367|65776199|FG006|Lead-in Period|Protocol Violation|0|||
23559184|NCT03214367|65776200|FG007|Lead-in Period|Protocol Violation|0|||
23559185|NCT03214367|65776193|FG000|Lead-in Period|Treatment Interruption|1|||
23825785|NCT01957397|66741593|FG001|Test Period 1|Withdrawal by Subject|0|||
23825786|NCT01957397|66741592|FG000|Test Period 2|Adverse Event|0|||
23825787|NCT01957397|66741593|FG001|Test Period 2|Adverse Event|1|||
23825788|NCT01957397|66741592|FG000|Test Period 3|Adverse Event|1|||
23825789|NCT01957397|66741593|FG001|Test Period 3|Adverse Event|2|||
23437759|NCT02487030|65344196|FG002|Overall Study|Adverse Event|0|||
23437760|NCT02487030|65344197|FG003|Overall Study|Adverse Event|1|||
23437761|NCT02487030|65344198|FG004|Overall Study|Adverse Event|0|||
23825790|NCT01957397|66741592|FG000|Test Period 3|the adhesive did not work|1|||
23559186|NCT03214367|65776194|FG001|Lead-in Period|Treatment Interruption|0|||
23559187|NCT03214367|65776195|FG002|Lead-in Period|Treatment Interruption|0|||
23559188|NCT03214367|65776196|FG003|Lead-in Period|Treatment Interruption|0|||
23559189|NCT03214367|65776197|FG004|Lead-in Period|Treatment Interruption|0|||
23559190|NCT03214367|65776198|FG005|Lead-in Period|Treatment Interruption|0|||
23559191|NCT03214367|65776199|FG006|Lead-in Period|Treatment Interruption|0|||
23559192|NCT03214367|65776200|FG007|Lead-in Period|Treatment Interruption|0|||
23559193|NCT03214367|65776193|FG000|Treatment Period|Adverse Event|0|||
23559194|NCT03214367|65776194|FG001|Treatment Period|Adverse Event|1|||
23559195|NCT03214367|65776195|FG002|Treatment Period|Adverse Event|4|||
23559196|NCT03214367|65776196|FG003|Treatment Period|Adverse Event|2|||
23559197|NCT03214367|65776197|FG004|Treatment Period|Adverse Event|0|||
23559198|NCT03214367|65776198|FG005|Treatment Period|Adverse Event|0|||
23559199|NCT03214367|65776199|FG006|Treatment Period|Adverse Event|0|||
23559200|NCT03214367|65776200|FG007|Treatment Period|Adverse Event|0|||
23559201|NCT03214367|65776193|FG000|Treatment Period|Death|0|||
23755119|NCT02756078|66484459|FG000|Period 2|Adverse Event|3|||
23559202|NCT03214367|65776194|FG001|Treatment Period|Death|1|||
23559203|NCT03214367|65776195|FG002|Treatment Period|Death|1|||
23559204|NCT03214367|65776196|FG003|Treatment Period|Death|1|||
23559205|NCT03214367|65776197|FG004|Treatment Period|Death|0|||
23559206|NCT03214367|65776198|FG005|Treatment Period|Death|0|||
23755120|NCT02756078|66484460|FG001|Period 2|Adverse Event|5|||
23559207|NCT03214367|65776199|FG006|Treatment Period|Death|0|||
23559208|NCT03214367|65776200|FG007|Treatment Period|Death|0|||
23559209|NCT03214367|65776193|FG000|Treatment Period|Lost to Follow-up|0|||
23559210|NCT03214367|65776194|FG001|Treatment Period|Lost to Follow-up|5|||
23559211|NCT03214367|65776195|FG002|Treatment Period|Lost to Follow-up|3|||
23559212|NCT03214367|65776196|FG003|Treatment Period|Lost to Follow-up|2|||
23559213|NCT03214367|65776197|FG004|Treatment Period|Lost to Follow-up|0|||
23624215|NCT01185171|66011566|FG000|Maintenance|Xerostomia|1|||
23624216|NCT01185171|66011566|FG000|Maintenance|Nausea|1|||
23624217|NCT01185171|66011566|FG000|Maintenance|Comorbid Illness|2|||
23624218|NCT01185171|66011566|FG000|Maintenance|Withdrawal by Subject|1|||
23624219|NCT01185171|66011566|FG000|Maintenance|Disease Recurrence|1|||
23624220|NCT00511836|66011572|FG000|Double-blind Period|Lost to Follow-up|1|||
23624221|NCT00511836|66011573|FG001|Double-blind Period|Lost to Follow-up|0|||
23624222|NCT00908349|66011589|FG000|Overall Study|Adverse Event|10|||
23624223|NCT00908349|66011589|FG000|Overall Study|Withdrawal by Subject|9|||
23624224|NCT00908349|66011589|FG000|Overall Study|Physician Decision|5|||
23624225|NCT00908349|66011589|FG000|Overall Study|Lost to Follow-up|5|||
23624226|NCT00908349|66011589|FG000|Overall Study|Various|6|||
23624227|NCT01434680|66011592|FG000|Overall Study|Withdrawal by Subject|1|||
23624228|NCT01434680|66011593|FG001|Overall Study|Withdrawal by Subject|0|||
23624229|NCT01434680|66011594|FG002|Overall Study|Withdrawal by Subject|2|||
23624230|NCT01434680|66011595|FG003|Overall Study|Withdrawal by Subject|0|||
23624231|NCT01434680|66011592|FG000|Overall Study|Lost to Follow-up|1|||
23624232|NCT01434680|66011593|FG001|Overall Study|Lost to Follow-up|1|||
23624233|NCT01434680|66011594|FG002|Overall Study|Lost to Follow-up|0|||
23624234|NCT01434680|66011595|FG003|Overall Study|Lost to Follow-up|0|||
23624235|NCT01434680|66011592|FG000|Overall Study|Protocol Violation|1|||
23624236|NCT01434680|66011593|FG001|Overall Study|Protocol Violation|1|||
23624237|NCT01434680|66011594|FG002|Overall Study|Protocol Violation|0|||
23624238|NCT01434680|66011595|FG003|Overall Study|Protocol Violation|0|||
23624239|NCT02635386|66011599|FG000|Overall Study|Pregnancy|2|||
23624240|NCT02635386|66011600|FG001|Overall Study|Pregnancy|0|||
23624241|NCT02635386|66011601|FG002|Overall Study|Pregnancy|0|||
23624242|NCT02635386|66011602|FG003|Overall Study|Pregnancy|0|||
23624243|NCT02635386|66011603|FG004|Overall Study|Pregnancy|2|||
23624244|NCT02635386|66011599|FG000|Overall Study|Withdrawal by Subject|1|||
23624245|NCT02635386|66011600|FG001|Overall Study|Withdrawal by Subject|1|||
23624246|NCT02635386|66011601|FG002|Overall Study|Withdrawal by Subject|0|||
23624247|NCT02635386|66011602|FG003|Overall Study|Withdrawal by Subject|1|||
23624248|NCT02635386|66011603|FG004|Overall Study|Withdrawal by Subject|0|||
23624249|NCT02635386|66011599|FG000|Overall Study|Physician Decision|0|||
23624250|NCT02635386|66011600|FG001|Overall Study|Physician Decision|1|||
23624251|NCT02635386|66011601|FG002|Overall Study|Physician Decision|0|||
23624252|NCT02635386|66011602|FG003|Overall Study|Physician Decision|0|||
23624253|NCT02635386|66011603|FG004|Overall Study|Physician Decision|0|||
23624254|NCT02635386|66011599|FG000|Overall Study|Moved Out of State|0|||
23624255|NCT02635386|66011600|FG001|Overall Study|Moved Out of State|1|||
23755121|NCT02756078|66484459|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
23755122|NCT02756078|66484460|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
23437762|NCT02487030|65344199|FG005|Overall Study|Adverse Event|0|||
23437763|NCT02487030|65344200|FG006|Overall Study|Adverse Event|0|||
23437764|NCT02487030|65344194|FG000|Overall Study|Death|0|||
23437765|NCT02487030|65344195|FG001|Overall Study|Death|0|||
23559214|NCT03214367|65776198|FG005|Treatment Period|Lost to Follow-up|2|||
23559215|NCT03214367|65776199|FG006|Treatment Period|Lost to Follow-up|1|||
23559216|NCT03214367|65776200|FG007|Treatment Period|Lost to Follow-up|0|||
23755123|NCT02756078|66484459|FG000|Period 2|Withdrawal by Subject|3|||
23755124|NCT02756078|66484460|FG001|Period 2|Withdrawal by Subject|1|||
23755125|NCT02038959|66484463|FG000|Overall Study|Withdrawal by Subject|6|||
23755126|NCT02038959|66484464|FG001|Overall Study|Withdrawal by Subject|8|||
23755127|NCT01614925|66484465|FG000|Overall Study|Withdrawal by Subject|1|||
23437766|NCT02487030|65344196|FG002|Overall Study|Death|0|||
23624256|NCT02635386|66011601|FG002|Overall Study|Moved Out of State|0|||
23624257|NCT02635386|66011602|FG003|Overall Study|Moved Out of State|0|||
23559217|NCT03214367|65776193|FG000|Treatment Period|Sponsor Decision|0|||
23624258|NCT02635386|66011603|FG004|Overall Study|Moved Out of State|0|||
23624259|NCT02635386|66011599|FG000|Overall Study|Noncompliant|0|||
23755128|NCT01614925|66484466|FG001|Overall Study|Withdrawal by Subject|0|||
23437767|NCT02487030|65344197|FG003|Overall Study|Death|0|||
23559218|NCT03214367|65776194|FG001|Treatment Period|Sponsor Decision|3|||
23624260|NCT02635386|66011600|FG001|Overall Study|Noncompliant|2|||
23624261|NCT02635386|66011601|FG002|Overall Study|Noncompliant|1|||
23624262|NCT02635386|66011602|FG003|Overall Study|Noncompliant|1|||
23755129|NCT01614925|66484465|FG000|Overall Study|Protocol Violation|3|||
23755130|NCT01614925|66484466|FG001|Overall Study|Protocol Violation|2|||
23559219|NCT03214367|65776195|FG002|Treatment Period|Sponsor Decision|0|||
23559220|NCT03214367|65776196|FG003|Treatment Period|Sponsor Decision|0|||
23624263|NCT02635386|66011603|FG004|Overall Study|Noncompliant|1|||
23624264|NCT02635386|66011599|FG000|Overall Study|side effects|0|||
23624265|NCT02635386|66011600|FG001|Overall Study|side effects|0|||
23624266|NCT02635386|66011601|FG002|Overall Study|side effects|1|||
23559221|NCT03214367|65776197|FG004|Treatment Period|Sponsor Decision|0|||
23559222|NCT03214367|65776198|FG005|Treatment Period|Sponsor Decision|0|||
23559223|NCT03214367|65776199|FG006|Treatment Period|Sponsor Decision|0|||
23559224|NCT03214367|65776200|FG007|Treatment Period|Sponsor Decision|0|||
23559225|NCT03214367|65776193|FG000|Treatment Period|Physician Decision|0|||
23559226|NCT03214367|65776194|FG001|Treatment Period|Physician Decision|1|||
23559227|NCT03214367|65776195|FG002|Treatment Period|Physician Decision|2|||
23559228|NCT03214367|65776196|FG003|Treatment Period|Physician Decision|0|||
23559229|NCT03214367|65776197|FG004|Treatment Period|Physician Decision|0|||
23559230|NCT03214367|65776198|FG005|Treatment Period|Physician Decision|0|||
23559231|NCT03214367|65776199|FG006|Treatment Period|Physician Decision|0|||
23559232|NCT03214367|65776200|FG007|Treatment Period|Physician Decision|0|||
23559233|NCT03214367|65776193|FG000|Treatment Period|Protocol Violation|0|||
23559234|NCT03214367|65776194|FG001|Treatment Period|Protocol Violation|3|||
23559235|NCT03214367|65776195|FG002|Treatment Period|Protocol Violation|0|||
23559236|NCT03214367|65776196|FG003|Treatment Period|Protocol Violation|0|||
23559237|NCT03214367|65776197|FG004|Treatment Period|Protocol Violation|0|||
23559238|NCT03214367|65776198|FG005|Treatment Period|Protocol Violation|0|||
23559239|NCT03214367|65776199|FG006|Treatment Period|Protocol Violation|0|||
23559240|NCT03214367|65776200|FG007|Treatment Period|Protocol Violation|0|||
23559241|NCT03214367|65776193|FG000|Treatment Period|Withdrawal by Subject|0|||
23624267|NCT02635386|66011602|FG003|Overall Study|side effects|4|||
23624268|NCT02635386|66011603|FG004|Overall Study|side effects|6|||
23624269|NCT02635386|66011599|FG000|Overall Study|needed other major surgery|0|||
23624270|NCT02635386|66011600|FG001|Overall Study|needed other major surgery|1|||
23624271|NCT02635386|66011601|FG002|Overall Study|needed other major surgery|0|||
23624272|NCT02635386|66011602|FG003|Overall Study|needed other major surgery|0|||
23624273|NCT02635386|66011603|FG004|Overall Study|needed other major surgery|0|||
23624274|NCT02635386|66011599|FG000|Overall Study|Other medical problems not drug related|0|||
23624275|NCT02635386|66011600|FG001|Overall Study|Other medical problems not drug related|0|||
23624276|NCT02635386|66011601|FG002|Overall Study|Other medical problems not drug related|0|||
23624277|NCT02635386|66011602|FG003|Overall Study|Other medical problems not drug related|1|||
23624278|NCT02635386|66011603|FG004|Overall Study|Other medical problems not drug related|0|||
23624279|NCT00808899|66011606|FG000|Overall Study|Death|1|||
23624280|NCT00808899|66011606|FG000|Overall Study|Physician Decision|3|||
23624281|NCT02654132|66011611|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
23624282|NCT02654132|66011612|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
23624283|NCT02654132|66011611|FG000|Treatment Period|Disease progression|43|||
23624284|NCT02654132|66011612|FG001|Treatment Period|Disease progression|38|||
23624285|NCT02654132|66011611|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
23755131|NCT04529096|66484467|FG000|Overall Study|Adverse Event|6|||
23559242|NCT03214367|65776194|FG001|Treatment Period|Withdrawal by Subject|20|||
23559243|NCT03214367|65776195|FG002|Treatment Period|Withdrawal by Subject|23|||
23559244|NCT03214367|65776196|FG003|Treatment Period|Withdrawal by Subject|14|||
23559245|NCT03214367|65776197|FG004|Treatment Period|Withdrawal by Subject|0|||
23559246|NCT03214367|65776198|FG005|Treatment Period|Withdrawal by Subject|1|||
23559247|NCT03214367|65776199|FG006|Treatment Period|Withdrawal by Subject|1|||
23755132|NCT04529096|66484468|FG001|Overall Study|Adverse Event|1|||
23559248|NCT03214367|65776200|FG007|Treatment Period|Withdrawal by Subject|1|||
23559249|NCT04124926|65776201|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
23559250|NCT04124926|65776202|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
23559251|NCT04124926|65776203|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559252|NCT04124926|65776204|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559253|NCT04124926|65776205|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559254|NCT04124926|65776201|FG000|Healing Phase|Protocol Violation|0|||
23559255|NCT04124926|65776202|FG001|Healing Phase|Protocol Violation|1|||
23755133|NCT04529096|66484467|FG000|Overall Study|Lack of Efficacy|1|||
23437768|NCT02487030|65344198|FG004|Overall Study|Death|1|||
23437769|NCT02487030|65344199|FG005|Overall Study|Death|0|||
23437770|NCT02487030|65344200|FG006|Overall Study|Death|0|||
23437771|NCT01099397|65344201|FG000|Overall Study|Lost to Follow-up|4|||
23437772|NCT01099397|65344201|FG000|Overall Study|Protocol Violation|4|||
23559256|NCT04124926|65776203|FG002|Healing Phase|Protocol Violation|0|||
23559257|NCT04124926|65776204|FG003|Healing Phase|Protocol Violation|0|||
23559258|NCT04124926|65776205|FG004|Healing Phase|Protocol Violation|0|||
23559259|NCT04124926|65776201|FG000|Healing Phase|Lost to Follow-up|5|||
23624286|NCT02654132|66011612|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
23624287|NCT02654132|66011611|FG000|Treatment Period|Other reasons|4|||
23624288|NCT02654132|66011612|FG001|Treatment Period|Other reasons|2|||
23755134|NCT04529096|66484468|FG001|Overall Study|Lack of Efficacy|0|||
23437773|NCT01099397|65344201|FG000|Overall Study|Withdrawal by Subject|5|||
23437774|NCT02927938|65344202|FG000|Overall Study|Death|0|||
23559260|NCT04124926|65776202|FG001|Healing Phase|Lost to Follow-up|4|||
23559261|NCT04124926|65776203|FG002|Healing Phase|Lost to Follow-up|0|||
23559262|NCT04124926|65776204|FG003|Healing Phase|Lost to Follow-up|0|||
23559263|NCT04124926|65776205|FG004|Healing Phase|Lost to Follow-up|0|||
23559264|NCT04124926|65776201|FG000|Healing Phase|Voluntary Withdrawal|10|||
23559265|NCT04124926|65776202|FG001|Healing Phase|Voluntary Withdrawal|7|||
23559266|NCT04124926|65776203|FG002|Healing Phase|Voluntary Withdrawal|0|||
23559267|NCT04124926|65776204|FG003|Healing Phase|Voluntary Withdrawal|0|||
23559268|NCT04124926|65776205|FG004|Healing Phase|Voluntary Withdrawal|0|||
23559269|NCT04124926|65776201|FG000|Healing Phase|Withdrawal of Consent|5|||
23559270|NCT04124926|65776202|FG001|Healing Phase|Withdrawal of Consent|3|||
23559271|NCT04124926|65776203|FG002|Healing Phase|Withdrawal of Consent|0|||
23559272|NCT04124926|65776204|FG003|Healing Phase|Withdrawal of Consent|0|||
23559273|NCT04124926|65776205|FG004|Healing Phase|Withdrawal of Consent|0|||
23559274|NCT04124926|65776201|FG000|Healing Phase|Miscellaneous|8|||
23559275|NCT04124926|65776202|FG001|Healing Phase|Miscellaneous|7|||
23559276|NCT04124926|65776203|FG002|Healing Phase|Miscellaneous|0|||
23559277|NCT04124926|65776204|FG003|Healing Phase|Miscellaneous|0|||
23559278|NCT04124926|65776205|FG004|Healing Phase|Miscellaneous|0|||
23559279|NCT04124926|65776201|FG000|Healing Phase|Randomized but not Treated|0|||
23559280|NCT04124926|65776202|FG001|Healing Phase|Randomized but not Treated|3|||
23559281|NCT04124926|65776203|FG002|Healing Phase|Randomized but not Treated|0|||
23559282|NCT04124926|65776204|FG003|Healing Phase|Randomized but not Treated|0|||
23559283|NCT04124926|65776205|FG004|Healing Phase|Randomized but not Treated|0|||
23559284|NCT04124926|65776201|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
23559285|NCT04124926|65776202|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
23559286|NCT04124926|65776203|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
23559287|NCT04124926|65776204|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
23559288|NCT04124926|65776205|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
23559289|NCT04124926|65776201|FG000|Maintenance Phase|Protocol Violation|0|||
23559290|NCT04124926|65776202|FG001|Maintenance Phase|Protocol Violation|0|||
23559291|NCT04124926|65776203|FG002|Maintenance Phase|Protocol Violation|3|||
23559292|NCT04124926|65776204|FG003|Maintenance Phase|Protocol Violation|0|||
23559293|NCT04124926|65776205|FG004|Maintenance Phase|Protocol Violation|0|||
23624289|NCT02654132|66011611|FG000|Treatment Period|Study drug toxicity|2|||
23624290|NCT02654132|66011612|FG001|Treatment Period|Study drug toxicity|2|||
23624291|NCT02654132|66011611|FG000|Treatment Period|Withdrawal by Subject|2|||
23624292|NCT02654132|66011612|FG001|Treatment Period|Withdrawal by Subject|1|||
23624293|NCT02654132|66011611|FG000|Treatment Period|Maximum Clinical Benefit|0|||
23624294|NCT02654132|66011612|FG001|Treatment Period|Maximum Clinical Benefit|2|||
23624295|NCT02654132|66011611|FG000|Treatment Period|Participant request to discontinue|2|||
23624296|NCT02654132|66011612|FG001|Treatment Period|Participant request to discontinue|0|||
23624297|NCT02654132|66011611|FG000|Treatment Period|Administrative reasons by sponsor|0|||
23624298|NCT02654132|66011612|FG001|Treatment Period|Administrative reasons by sponsor|1|||
23624299|NCT02654132|66011611|FG000|Treatment Period|Death|1|||
23624300|NCT02654132|66011612|FG001|Treatment Period|Death|0|||
23624301|NCT03296566|66011615|FG000|Overall Study|Lost to Follow-up|19|||
23624302|NCT03296566|66011616|FG001|Overall Study|Lost to Follow-up|46|||
23624303|NCT03296566|66011615|FG000|Overall Study|Withdrawal by Subject|0|||
23624304|NCT03296566|66011616|FG001|Overall Study|Withdrawal by Subject|3|||
23624305|NCT01036165|66011617|FG000|Overall Study|Adverse Event|6|||
23624306|NCT01036165|66011617|FG000|Overall Study|Lost to Follow-up|2|||
23624307|NCT01036165|66011617|FG000|Overall Study|Withdrawal by Subject|3|||
23624308|NCT01036165|66011617|FG000|Overall Study|Device Related Issues|3|||
23624309|NCT01036165|66011617|FG000|Overall Study|Problems finding proper area to inject|1|||
23624310|NCT03927690|66011618|FG000|Overall Study|Withdrawal by Subject|3|||
23624311|NCT03927690|66011619|FG001|Overall Study|Withdrawal by Subject|1|||
23624312|NCT03927690|66011620|FG002|Overall Study|Withdrawal by Subject|1|||
23624313|NCT03927690|66011618|FG000|Overall Study|Adverse Event|1|||
23755135|NCT04529096|66484467|FG000|Overall Study|Lost to Follow-up|1|||
23559294|NCT04124926|65776201|FG000|Maintenance Phase|Lost to Follow-up|0|||
23559295|NCT04124926|65776202|FG001|Maintenance Phase|Lost to Follow-up|0|||
23559296|NCT04124926|65776203|FG002|Maintenance Phase|Lost to Follow-up|7|||
23559297|NCT04124926|65776204|FG003|Maintenance Phase|Lost to Follow-up|8|||
23624314|NCT03927690|66011619|FG001|Overall Study|Adverse Event|0|||
23624315|NCT03927690|66011620|FG002|Overall Study|Adverse Event|0|||
23755136|NCT04529096|66484468|FG001|Overall Study|Lost to Follow-up|1|||
23624316|NCT03927690|66011618|FG000|Overall Study|Death|1|||
23624317|NCT03927690|66011619|FG001|Overall Study|Death|0|||
23624318|NCT03927690|66011620|FG002|Overall Study|Death|0|||
23624319|NCT03927690|66011618|FG000|Overall Study|Lost to Follow-up|2|||
23624320|NCT03927690|66011619|FG001|Overall Study|Lost to Follow-up|2|||
23559298|NCT04124926|65776205|FG004|Maintenance Phase|Lost to Follow-up|9|||
23559299|NCT04124926|65776201|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
23559300|NCT04124926|65776202|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
23559301|NCT04124926|65776203|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
23559302|NCT04124926|65776204|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
23559303|NCT04124926|65776205|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
23559304|NCT04124926|65776201|FG000|Maintenance Phase|Pregnancy|0|||
23559305|NCT04124926|65776202|FG001|Maintenance Phase|Pregnancy|0|||
23559306|NCT04124926|65776203|FG002|Maintenance Phase|Pregnancy|0|||
23559307|NCT04124926|65776204|FG003|Maintenance Phase|Pregnancy|1|||
23559308|NCT04124926|65776205|FG004|Maintenance Phase|Pregnancy|0|||
23559309|NCT04124926|65776201|FG000|Maintenance Phase|Lack of Efficacy|0|||
23559310|NCT04124926|65776202|FG001|Maintenance Phase|Lack of Efficacy|0|||
23559311|NCT04124926|65776203|FG002|Maintenance Phase|Lack of Efficacy|0|||
23559312|NCT04124926|65776204|FG003|Maintenance Phase|Lack of Efficacy|0|||
23559313|NCT04124926|65776205|FG004|Maintenance Phase|Lack of Efficacy|1|||
23559314|NCT04124926|65776201|FG000|Maintenance Phase|Withdrawal of Consent|0|||
23559315|NCT04124926|65776202|FG001|Maintenance Phase|Withdrawal of Consent|0|||
23559316|NCT04124926|65776203|FG002|Maintenance Phase|Withdrawal of Consent|5|||
23559317|NCT04124926|65776204|FG003|Maintenance Phase|Withdrawal of Consent|5|||
23559318|NCT04124926|65776205|FG004|Maintenance Phase|Withdrawal of Consent|5|||
23559319|NCT04124926|65776201|FG000|Maintenance Phase|Miscellaneous|0|||
23559320|NCT04124926|65776202|FG001|Maintenance Phase|Miscellaneous|0|||
23437775|NCT02927938|65344203|FG001|Overall Study|Death|1|||
23559321|NCT04124926|65776203|FG002|Maintenance Phase|Miscellaneous|1|||
23624321|NCT03927690|66011620|FG002|Overall Study|Lost to Follow-up|1|||
23624322|NCT00719043|66011621|FG000|Overall Study|Adverse Event|5|||
23624323|NCT00719043|66011622|FG001|Overall Study|Adverse Event|1|||
23624324|NCT00719043|66011623|FG002|Overall Study|Adverse Event|2|||
23624325|NCT00719043|66011624|FG003|Overall Study|Adverse Event|2|||
23624326|NCT00719043|66011625|FG004|Overall Study|Adverse Event|1|||
23624327|NCT00719043|66011626|FG005|Overall Study|Adverse Event|4|||
23624328|NCT00719043|66011627|FG006|Overall Study|Adverse Event|4|||
23624329|NCT00719043|66011621|FG000|Overall Study|Lost to Follow-up|14|||
23559322|NCT04124926|65776204|FG003|Maintenance Phase|Miscellaneous|2|||
23559323|NCT04124926|65776205|FG004|Maintenance Phase|Miscellaneous|4|||
23559324|NCT04124926|65776201|FG000|Maintenance Phase|Randomized but not Treated|0|||
23559325|NCT04124926|65776202|FG001|Maintenance Phase|Randomized but not Treated|0|||
23559326|NCT04124926|65776203|FG002|Maintenance Phase|Randomized but not Treated|2|||
23559327|NCT04124926|65776204|FG003|Maintenance Phase|Randomized but not Treated|2|||
23559328|NCT04124926|65776205|FG004|Maintenance Phase|Randomized but not Treated|0|||
23559329|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
23559330|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
23559331|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
23559332|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
23559333|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
23624330|NCT00719043|66011622|FG001|Overall Study|Lost to Follow-up|10|||
23624331|NCT00719043|66011623|FG002|Overall Study|Lost to Follow-up|8|||
23624332|NCT00719043|66011624|FG003|Overall Study|Lost to Follow-up|9|||
23624333|NCT00719043|66011625|FG004|Overall Study|Lost to Follow-up|10|||
23624334|NCT00719043|66011626|FG005|Overall Study|Lost to Follow-up|9|||
23755137|NCT04529096|66484467|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23755138|NCT04529096|66484468|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23559334|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
23559335|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
23559336|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
23559337|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
23559338|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
23559339|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
23559340|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
23559341|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
23559342|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
23559343|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
23559344|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
23559345|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
23559346|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
23559347|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
23559348|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
23559349|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
23559350|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
23559351|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Death|143|||
23559352|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Death|136|||
23559353|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
23559354|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
23559355|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
23559356|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
23559357|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
23559358|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
23559359|NCT00863655|65776208|FG000|Overall Study|Protocol Violation|4|||
23559360|NCT00863655|65776209|FG001|Overall Study|Protocol Violation|0|||
23559361|NCT00863655|65776208|FG000|Overall Study|Adverse Event|52|||
23559362|NCT00863655|65776209|FG001|Overall Study|Adverse Event|8|||
23559363|NCT00863655|65776208|FG000|Overall Study|Withdrawal by Subject|47|||
23559364|NCT00863655|65776209|FG001|Overall Study|Withdrawal by Subject|7|||
23559365|NCT00863655|65776208|FG000|Overall Study|Administrative problems|1|||
23559366|NCT00863655|65776209|FG001|Overall Study|Administrative problems|0|||
23559367|NCT00863655|65776208|FG000|Overall Study|Death|7|||
23559368|NCT00863655|65776209|FG001|Overall Study|Death|1|||
23559369|NCT00863655|65776208|FG000|Overall Study|New cancer therapy|5|||
23559370|NCT00863655|65776209|FG001|Overall Study|New cancer therapy|1|||
23559371|NCT00863655|65776208|FG000|Overall Study|Disease progression|364|||
23559372|NCT00863655|65776209|FG001|Overall Study|Disease progression|221|||
23559373|NCT00863655|65776208|FG000|Overall Study|Treatment completed as per protocol|5|||
23559374|NCT00863655|65776209|FG001|Overall Study|Treatment completed as per protocol|1|||
23559375|NCT00572195|65776210|FG000|Overall Study|Withdrawal by Subject|50|||
23559376|NCT00572195|65776210|FG000|Overall Study|Death|9|||
23559377|NCT00572195|65776210|FG000|Overall Study|Adverse Event|4|||
23559378|NCT00572195|65776210|FG000|Overall Study|Lost to Follow-up|5|||
23559379|NCT02170025|65776211|FG000|Overall Study|Adverse Event|2|||
23755139|NCT04529096|66484467|FG000|Overall Study|Physician Decision|1|||
23755140|NCT04529096|66484468|FG001|Overall Study|Physician Decision|3|||
23559380|NCT02170025|65776212|FG001|Overall Study|Adverse Event|0|||
23559381|NCT00002558|65776213|FG000|Overall Study|Withdrawal by Subject|0|||
23559382|NCT00002558|65776214|FG001|Overall Study|Withdrawal by Subject|1|||
23559383|NCT03595332|65776215|FG000|Overall Study|Lost to Follow-up|16|||
23559384|NCT03595332|65776216|FG001|Overall Study|Lost to Follow-up|22|||
23559385|NCT03595332|65776215|FG000|Overall Study|Unable to retrieve ID from school|0|||
23559386|NCT03595332|65776216|FG001|Overall Study|Unable to retrieve ID from school|2|||
23559387|NCT03445065|65776219|FG000|Overall Study|Withdrawal by Subject|3|||
23755141|NCT04529096|66484467|FG000|Overall Study|Withdrawal by Subject|5|||
23755142|NCT04529096|66484468|FG001|Overall Study|Withdrawal by Subject|0|||
23755143|NCT03940586|66484469|FG000|Overall Study|Death|3|||
23559388|NCT03445065|65776220|FG001|Overall Study|Withdrawal by Subject|6|||
23755144|NCT03940586|66484470|FG001|Overall Study|Death|2|||
23559389|NCT03445065|65776221|FG002|Overall Study|Withdrawal by Subject|2|||
23559390|NCT03445065|65776222|FG003|Overall Study|Withdrawal by Subject|2|||
23559391|NCT03445065|65776219|FG000|Overall Study|Other|4|||
23559392|NCT03445065|65776220|FG001|Overall Study|Other|3|||
23559393|NCT03445065|65776221|FG002|Overall Study|Other|3|||
23559394|NCT03445065|65776222|FG003|Overall Study|Other|1|||
23559395|NCT01122381|65776225|FG000|Overall Study|study terminated early|0|||
23559396|NCT01122381|65776226|FG001|Overall Study|study terminated early|1|||
23624335|NCT00719043|66011627|FG006|Overall Study|Lost to Follow-up|9|||
23624336|NCT00719043|66011621|FG000|Overall Study|Protocol Violation|0|||
23624337|NCT00719043|66011622|FG001|Overall Study|Protocol Violation|0|||
23624338|NCT00719043|66011623|FG002|Overall Study|Protocol Violation|0|||
23624339|NCT00719043|66011624|FG003|Overall Study|Protocol Violation|0|||
23825791|NCT01957397|66741593|FG001|Test Period 3|the adhesive did not work|0|||
23624340|NCT00719043|66011625|FG004|Overall Study|Protocol Violation|0|||
23624341|NCT00719043|66011626|FG005|Overall Study|Protocol Violation|1|||
23624342|NCT00719043|66011627|FG006|Overall Study|Protocol Violation|0|||
23624343|NCT00719043|66011621|FG000|Overall Study|Other|1|||
23624344|NCT00719043|66011622|FG001|Overall Study|Other|0|||
23624345|NCT00719043|66011623|FG002|Overall Study|Other|1|||
23624346|NCT00719043|66011624|FG003|Overall Study|Other|2|||
23624347|NCT00719043|66011625|FG004|Overall Study|Other|0|||
23624348|NCT00719043|66011626|FG005|Overall Study|Other|2|||
23624349|NCT00719043|66011627|FG006|Overall Study|Other|1|||
23624350|NCT00719043|66011621|FG000|Overall Study|Withdrawal by Subject|12|||
23624351|NCT00719043|66011622|FG001|Overall Study|Withdrawal by Subject|14|||
23624352|NCT00719043|66011623|FG002|Overall Study|Withdrawal by Subject|9|||
23624353|NCT00719043|66011624|FG003|Overall Study|Withdrawal by Subject|10|||
23825792|NCT02094417|66741594|FG000|Overall Study|Adverse Event|0|||
23825793|NCT02094417|66741595|FG001|Overall Study|Adverse Event|0|||
23825794|NCT02094417|66741596|FG002|Overall Study|Adverse Event|0|||
23825795|NCT02094417|66741597|FG003|Overall Study|Adverse Event|1|||
23825796|NCT02094417|66741594|FG000|Overall Study|Eligibility criteria|0|||
23825797|NCT02094417|66741595|FG001|Overall Study|Eligibility criteria|1|||
23825798|NCT02094417|66741596|FG002|Overall Study|Eligibility criteria|0|||
23825799|NCT02094417|66741597|FG003|Overall Study|Eligibility criteria|0|||
23825800|NCT02094417|66741594|FG000|Overall Study|No responder|4|||
23825801|NCT02094417|66741595|FG001|Overall Study|No responder|4|||
23825802|NCT02094417|66741596|FG002|Overall Study|No responder|4|||
23825803|NCT02094417|66741597|FG003|Overall Study|No responder|3|||
23825804|NCT02094417|66741594|FG000|Overall Study|Unable to conduct observations or assess|0|||
23825805|NCT02094417|66741595|FG001|Overall Study|Unable to conduct observations or assess|1|||
23825806|NCT02094417|66741596|FG002|Overall Study|Unable to conduct observations or assess|0|||
23755145|NCT03940586|66484471|FG002|Overall Study|Death|0|||
23755146|NCT03940586|66484469|FG000|Overall Study|Physician Decision|1|||
23755147|NCT03940586|66484470|FG001|Overall Study|Physician Decision|0|||
23755148|NCT03940586|66484471|FG002|Overall Study|Physician Decision|1|||
23755149|NCT03940586|66484469|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
23755150|NCT03940586|66484470|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
23755151|NCT03940586|66484471|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23755152|NCT03940586|66484469|FG000|Overall Study|Not Treated|0|||
23755153|NCT03940586|66484470|FG001|Overall Study|Not Treated|2|||
23755154|NCT03940586|66484471|FG002|Overall Study|Not Treated|0|||
23755155|NCT00720304|66484476|FG000|Overall Study|Withdrawal by Subject|14|||
23755156|NCT00720304|66484477|FG001|Overall Study|Withdrawal by Subject|1|||
23755157|NCT00720304|66484476|FG000|Overall Study|Death|1|||
23825807|NCT02094417|66741597|FG003|Overall Study|Unable to conduct observations or assess|0|||
23825808|NCT02094417|66741594|FG000|Overall Study|Withdrawal by Subject|1|||
23825809|NCT02094417|66741595|FG001|Overall Study|Withdrawal by Subject|2|||
23825810|NCT02094417|66741596|FG002|Overall Study|Withdrawal by Subject|1|||
23825811|NCT02094417|66741597|FG003|Overall Study|Withdrawal by Subject|3|||
23825812|NCT00633243|66741598|FG000|Overall Study|Withdrawal by Subject|0|||
23825813|NCT00633243|66741599|FG001|Overall Study|Withdrawal by Subject|1|||
23559397|NCT04605978|65776227|FG000|Overall Study|Adverse Event|2|||
23559398|NCT04605978|65776228|FG001|Overall Study|Adverse Event|1|||
23624354|NCT00719043|66011625|FG004|Overall Study|Withdrawal by Subject|16|||
23825814|NCT00633243|66741598|FG000|Overall Study|incarceration|0|||
23825815|NCT00633243|66741599|FG001|Overall Study|incarceration|2|||
23825816|NCT00633243|66741598|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
23559399|NCT04605978|65776227|FG000|Overall Study|Withdrawal nonmedical reason|1|||
23624355|NCT00719043|66011626|FG005|Overall Study|Withdrawal by Subject|18|||
23755158|NCT00720304|66484477|FG001|Overall Study|Death|0|||
23755159|NCT00720304|66484476|FG000|Overall Study|Physician Decision|5|||
23825817|NCT00633243|66741599|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
23624356|NCT00719043|66011627|FG006|Overall Study|Withdrawal by Subject|14|||
23624357|NCT00878553|66011629|FG000|Sleep Study|Withdrawal by Subject|2|||
23624358|NCT00878553|66011630|FG001|Sleep Study|Withdrawal by Subject|0|||
23755160|NCT00720304|66484477|FG001|Overall Study|Physician Decision|2|||
23755161|NCT00720304|66484476|FG000|Overall Study|Adverse Event|3|||
23755162|NCT00720304|66484477|FG001|Overall Study|Adverse Event|1|||
23755163|NCT00720304|66484476|FG000|Overall Study|Disease progression|6|||
23624359|NCT00878553|66011631|FG002|Sleep Study|Withdrawal by Subject|0|||
23624360|NCT00878553|66011632|FG003|Sleep Study|Withdrawal by Subject|0|||
23624361|NCT00878553|66011633|FG004|Sleep Study|Withdrawal by Subject|0|||
23624362|NCT00878553|66011629|FG000|Sleep Study|Lost to Follow-up|1|||
23624363|NCT00878553|66011630|FG001|Sleep Study|Lost to Follow-up|0|||
23624364|NCT00878553|66011631|FG002|Sleep Study|Lost to Follow-up|0|||
23624365|NCT00878553|66011632|FG003|Sleep Study|Lost to Follow-up|0|||
23624366|NCT00878553|66011633|FG004|Sleep Study|Lost to Follow-up|0|||
23559400|NCT04605978|65776228|FG001|Overall Study|Withdrawal nonmedical reason|1|||
23559401|NCT00733980|65776229|FG000|Overall Study|Adverse Event|5|||
23559402|NCT00733980|65776230|FG001|Overall Study|Adverse Event|2|||
23559403|NCT00733980|65776229|FG000|Overall Study|Lack of Efficacy|0|||
23559404|NCT00733980|65776230|FG001|Overall Study|Lack of Efficacy|1|||
23559405|NCT00733980|65776229|FG000|Overall Study|Protocol Violation|2|||
23559406|NCT00733980|65776230|FG001|Overall Study|Protocol Violation|1|||
23559407|NCT00733980|65776229|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
23559408|NCT00733980|65776230|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
23559409|NCT00733980|65776229|FG000|Overall Study|Lost to Follow-up|6|||
23559410|NCT00733980|65776230|FG001|Overall Study|Lost to Follow-up|11|||
23559411|NCT00733980|65776229|FG000|Overall Study|Physician Decision|2|||
23559412|NCT00733980|65776230|FG001|Overall Study|Physician Decision|3|||
23559413|NCT00733980|65776229|FG000|Overall Study|Withdrawal by Subject|6|||
23559414|NCT00733980|65776230|FG001|Overall Study|Withdrawal by Subject|2|||
23559415|NCT02230956|65776231|FG000|Overall Study|Adverse Event|1|||
23559416|NCT02230956|65776232|FG001|Overall Study|Adverse Event|1|||
23559417|NCT02230956|65776233|FG002|Overall Study|Adverse Event|0|||
23559418|NCT02230956|65776231|FG000|Overall Study|Lack of Efficacy|1|||
23559419|NCT02230956|65776232|FG001|Overall Study|Lack of Efficacy|1|||
23559420|NCT02230956|65776233|FG002|Overall Study|Lack of Efficacy|1|||
23559421|NCT02230956|65776231|FG000|Overall Study|Lost to Follow-up|1|||
23559422|NCT02230956|65776232|FG001|Overall Study|Lost to Follow-up|1|||
23559423|NCT02230956|65776233|FG002|Overall Study|Lost to Follow-up|2|||
23559424|NCT02230956|65776231|FG000|Overall Study|Personal Reasons|2|||
23559425|NCT02230956|65776232|FG001|Overall Study|Personal Reasons|1|||
23559426|NCT02230956|65776233|FG002|Overall Study|Personal Reasons|1|||
23559427|NCT02230956|65776231|FG000|Overall Study|Protocol Violation|0|||
23559428|NCT02230956|65776232|FG001|Overall Study|Protocol Violation|1|||
23559429|NCT02230956|65776233|FG002|Overall Study|Protocol Violation|1|||
23624367|NCT00878553|66011629|FG000|Sleep Study|car accident|1|||
23624368|NCT00878553|66011630|FG001|Sleep Study|car accident|0|||
23755164|NCT00720304|66484477|FG001|Overall Study|Disease progression|1|||
23755165|NCT00563524|66484478|FG000|Overall Study|Adverse Event|0|||
23755166|NCT00563524|66484479|FG001|Overall Study|Adverse Event|1|||
23755167|NCT00563524|66484480|FG002|Overall Study|Adverse Event|0|||
23755168|NCT00563524|66484481|FG003|Overall Study|Adverse Event|0|||
23755169|NCT00563524|66484482|FG004|Overall Study|Adverse Event|2|||
23755170|NCT00563524|66484483|FG005|Overall Study|Adverse Event|0|||
23755171|NCT00563524|66484478|FG000|Overall Study|Lost to Follow-up|1|||
23755172|NCT00563524|66484479|FG001|Overall Study|Lost to Follow-up|0|||
23825818|NCT00633243|66741598|FG000|Overall Study|Not comfortable with self-injecting|0|||
23825819|NCT00633243|66741599|FG001|Overall Study|Not comfortable with self-injecting|1|||
23755173|NCT00563524|66484480|FG002|Overall Study|Lost to Follow-up|0|||
23755174|NCT00563524|66484481|FG003|Overall Study|Lost to Follow-up|0|||
23755175|NCT00563524|66484482|FG004|Overall Study|Lost to Follow-up|0|||
23755176|NCT00563524|66484483|FG005|Overall Study|Lost to Follow-up|0|||
23755177|NCT00563524|66484478|FG000|Overall Study|Protocol Violation|0|||
23825820|NCT00633243|66741598|FG000|Overall Study|Mental Health--Depression|0|||
23825821|NCT00633243|66741599|FG001|Overall Study|Mental Health--Depression|1|||
23825822|NCT00633243|66741598|FG000|Overall Study|Couldn't tolerate side-effects|1|||
23825823|NCT00633243|66741599|FG001|Overall Study|Couldn't tolerate side-effects|1|||
23825824|NCT01762800|66741608|FG000|Overall Study|Adverse Event|8|||
23559430|NCT02230956|65776231|FG000|Overall Study|Other Miscellaneous Reason|0|||
23559431|NCT02230956|65776232|FG001|Overall Study|Other Miscellaneous Reason|1|||
23559432|NCT02230956|65776233|FG002|Overall Study|Other Miscellaneous Reason|2|||
23624369|NCT00878553|66011631|FG002|Sleep Study|car accident|0|||
23624370|NCT00878553|66011632|FG003|Sleep Study|car accident|0|||
23755178|NCT00563524|66484479|FG001|Overall Study|Protocol Violation|1|||
23624371|NCT00878553|66011633|FG004|Sleep Study|car accident|0|||
23624372|NCT00878553|66011629|FG000|Sleep Study|family emergency|1|||
23755179|NCT00563524|66484480|FG002|Overall Study|Protocol Violation|0|||
23755180|NCT00563524|66484481|FG003|Overall Study|Protocol Violation|0|||
23755181|NCT00563524|66484482|FG004|Overall Study|Protocol Violation|0|||
23559433|NCT04247282|65776243|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
23559434|NCT04247282|65776244|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
23755182|NCT00563524|66484483|FG005|Overall Study|Protocol Violation|0|||
23755183|NCT00563524|66484478|FG000|Overall Study|Withdrawal by Subject|1|||
23755184|NCT00563524|66484479|FG001|Overall Study|Withdrawal by Subject|1|||
23624373|NCT00878553|66011630|FG001|Sleep Study|family emergency|0|||
23624374|NCT00878553|66011631|FG002|Sleep Study|family emergency|0|||
23624375|NCT00878553|66011632|FG003|Sleep Study|family emergency|0|||
23624376|NCT00878553|66011633|FG004|Sleep Study|family emergency|0|||
23624377|NCT00878553|66011629|FG000|PK Study|Withdrawal by Subject|0|||
23624378|NCT00878553|66011630|FG001|PK Study|Withdrawal by Subject|0|||
23624379|NCT00878553|66011631|FG002|PK Study|Withdrawal by Subject|0|||
23624380|NCT00878553|66011632|FG003|PK Study|Withdrawal by Subject|1|||
23624381|NCT00878553|66011633|FG004|PK Study|Withdrawal by Subject|0|||
23624382|NCT00598871|66011634|FG000|Overall Study|Adverse Event|0|||
23624383|NCT00598871|66011635|FG001|Overall Study|Adverse Event|1|||
23624384|NCT03834623|66011636|FG000|Overall Study|Progression|0|||
23624385|NCT03834623|66011637|FG001|Overall Study|Progression|1|||
23559435|NCT04247282|65776245|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
23559436|NCT04247282|65776246|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
23559437|NCT04247282|65776243|FG000|Overall Study|Refused further treatment|0|||
23559438|NCT04247282|65776244|FG001|Overall Study|Refused further treatment|1|||
23624386|NCT00776659|66011638|FG000|Overall Study|Lost to Follow-up|15|||
23624387|NCT00776659|66011638|FG000|Overall Study|Withdrawal by Subject|10|||
23624388|NCT00776659|66011638|FG000|Overall Study|Study Terminated by Sponsor|1|||
23624389|NCT04081389|66011639|FG000|Overall Study|Withdrawal by Subject|0|||
23624390|NCT04081389|66011640|FG001|Overall Study|Withdrawal by Subject|0|||
23624391|NCT04081389|66011641|FG002|Overall Study|Withdrawal by Subject|1|||
23624392|NCT04081389|66011642|FG003|Overall Study|Withdrawal by Subject|0|||
23755185|NCT00563524|66484480|FG002|Overall Study|Withdrawal by Subject|3|||
23755186|NCT00563524|66484481|FG003|Overall Study|Withdrawal by Subject|0|||
23755187|NCT00563524|66484482|FG004|Overall Study|Withdrawal by Subject|0|||
23755188|NCT00563524|66484483|FG005|Overall Study|Withdrawal by Subject|1|||
23755189|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Adverse Event|2|||
23755190|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Adverse Event|0|||
23755191|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Adverse Event|0|||
23755192|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Adverse Event|0|||
23755193|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
23755194|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
23755195|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
23755196|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
23755197|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
23755198|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
23559439|NCT04247282|65776245|FG002|Overall Study|Refused further treatment|0|||
23559440|NCT04247282|65776246|FG003|Overall Study|Refused further treatment|0|||
23559441|NCT03300570|65776253|FG000|Overall Study|Adverse Event|0|||
23559442|NCT03300570|65776254|FG001|Overall Study|Adverse Event|1|||
23559443|NCT03300570|65776253|FG000|Overall Study|Withdrawal by Subject|1|||
23559444|NCT03300570|65776254|FG001|Overall Study|Withdrawal by Subject|0|||
23559445|NCT03300570|65776253|FG000|Overall Study|Inadequate bowel prep|1|||
23559446|NCT03300570|65776254|FG001|Overall Study|Inadequate bowel prep|0|||
23559447|NCT00658567|65776258|FG000|Overall Study|Adverse Event|5|||
23559448|NCT00658567|65776259|FG001|Overall Study|Adverse Event|2|||
23559449|NCT00658567|65776260|FG002|Overall Study|Adverse Event|3|||
23559450|NCT00658567|65776258|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
23559451|NCT00658567|65776259|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
23559452|NCT00658567|65776260|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
23559453|NCT00658567|65776258|FG000|Overall Study|Physician Decision|0|||
23559454|NCT00658567|65776259|FG001|Overall Study|Physician Decision|1|||
23559455|NCT00658567|65776260|FG002|Overall Study|Physician Decision|0|||
23559456|NCT00658567|65776258|FG000|Overall Study|At Discretion of Sponsor|1|||
23559457|NCT00658567|65776259|FG001|Overall Study|At Discretion of Sponsor|1|||
23559458|NCT00658567|65776260|FG002|Overall Study|At Discretion of Sponsor|1|||
23559459|NCT00685945|65776269|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
23559460|NCT01553318|65776270|FG000|Overall Study|Protocol Violation|3|||
23755199|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
23559461|NCT01553318|65776271|FG001|Overall Study|Protocol Violation|2|||
23559462|NCT01435655|65776272|FG000|Overall Study|Death|2|||
23559463|NCT01435655|65776272|FG000|Overall Study|Other|1|||
23624393|NCT01124838|66011646|FG000|Overall Study|Miscellaneous|4|||
23624394|NCT01124838|66011647|FG001|Overall Study|Miscellaneous|2|||
23624395|NCT01124838|66011646|FG000|Overall Study|Adverse Event|7|||
23624396|NCT01124838|66011647|FG001|Overall Study|Adverse Event|11|||
23624397|NCT01124838|66011646|FG000|Overall Study|Lack of Efficacy|2|||
23624398|NCT01124838|66011647|FG001|Overall Study|Lack of Efficacy|0|||
23624399|NCT01124838|66011646|FG000|Overall Study|Withdrawal by Subject|3|||
23624400|NCT01124838|66011647|FG001|Overall Study|Withdrawal by Subject|2|||
23755200|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23755201|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Physician Decision|1|||
23755202|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Physician Decision|0|||
23755203|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Physician Decision|0|||
23755204|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Physician Decision|0|||
23755205|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Pregnancy|1|||
23755206|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Pregnancy|0|||
23755207|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Pregnancy|0|||
23755208|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Pregnancy|0|||
23755209|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
23755210|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
23755211|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23755212|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23755213|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
23755214|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
23755215|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
23755216|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
23755217|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
23755218|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23755219|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23755220|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23755221|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23755222|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
23755223|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23755224|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23755225|NCT04057573|66484484|FG000|24-Week Double-Blind Period|Not Treated|1|||
23755226|NCT04057573|66484485|FG001|24-Week Double-Blind Period|Not Treated|0|||
23755227|NCT04057573|66484486|FG002|24-Week Double-Blind Period|Not Treated|0|||
23755228|NCT04057573|66484487|FG003|24-Week Double-Blind Period|Not Treated|0|||
23755229|NCT04057573|66484484|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
23755230|NCT04057573|66484485|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
23755231|NCT04057573|66484486|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
23755232|NCT04057573|66484487|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
23755233|NCT04057573|66484484|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23755234|NCT04057573|66484485|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23755235|NCT04057573|66484486|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
23755236|NCT04057573|66484487|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23755237|NCT04057573|66484484|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
23755238|NCT04057573|66484485|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
23755239|NCT04057573|66484486|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
23755240|NCT04057573|66484487|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
23755241|NCT04057573|66484484|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
23755242|NCT04057573|66484485|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
23755243|NCT04057573|66484486|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
23755244|NCT04057573|66484487|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
23755245|NCT04057573|66484484|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23755246|NCT04057573|66484485|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23624401|NCT01124838|66011646|FG000|Overall Study|Lost to Follow-up|2|||
23624402|NCT01124838|66011647|FG001|Overall Study|Lost to Follow-up|0|||
23624403|NCT00004445|66011648|FG000|Overall Study|Physician Decision|2|||
23624404|NCT00004445|66011648|FG000|Overall Study|Withdrawal by Subject|1|||
23624405|NCT00548847|66011649|FG000|Overall Study|Disease progression|7|||
23624406|NCT00761956|66011650|FG000|Overall Study|Lost to Follow-up|6|||
23624407|NCT00761956|66011651|FG001|Overall Study|Lost to Follow-up|11|||
23624408|NCT00761956|66011650|FG000|Overall Study|Withdrawal by Subject|3|||
23624409|NCT00761956|66011651|FG001|Overall Study|Withdrawal by Subject|8|||
23755247|NCT04057573|66484486|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
23755248|NCT04057573|66484487|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23624410|NCT00761956|66011650|FG000|Overall Study|Death|0|||
23624411|NCT00761956|66011651|FG001|Overall Study|Death|1|||
23624412|NCT00761956|66011650|FG000|Overall Study|Adverse Event|26|||
23624413|NCT00761956|66011651|FG001|Overall Study|Adverse Event|34|||
23755249|NCT01052038|66484488|FG000|Overall Study|Lost to Follow-up|2|||
23755250|NCT01052038|66484489|FG001|Overall Study|Lost to Follow-up|3|||
23755251|NCT01052038|66484490|FG002|Overall Study|Lost to Follow-up|1|||
23755252|NCT01052038|66484488|FG000|Overall Study|Protocol Violation|2|||
23559464|NCT01499082|65776275|FG000|Overall Study|Randomized but not Treated|0|||
23559465|NCT01499082|65776276|FG001|Overall Study|Randomized but not Treated|1|||
23559466|NCT01499082|65776275|FG000|Overall Study|Adverse Event|12|||
23559467|NCT01499082|65776276|FG001|Overall Study|Adverse Event|16|||
23559468|NCT01499082|65776275|FG000|Overall Study|Lack of Efficacy|1|||
23559469|NCT01499082|65776276|FG001|Overall Study|Lack of Efficacy|1|||
23559470|NCT01499082|65776275|FG000|Overall Study|Protocol Violation|6|||
23559471|NCT01499082|65776276|FG001|Overall Study|Protocol Violation|8|||
23559472|NCT01499082|65776275|FG000|Overall Study|Diverse Reasons|18|||
23559473|NCT01499082|65776276|FG001|Overall Study|Diverse Reasons|14|||
23559474|NCT01499082|65776275|FG000|Overall Study|Site Closure for Noncompliance|5|||
23559475|NCT01499082|65776276|FG001|Overall Study|Site Closure for Noncompliance|2|||
23559476|NCT01499082|65776275|FG000|Overall Study|Hypoglycemia|2|||
23559477|NCT01499082|65776276|FG001|Overall Study|Hypoglycemia|3|||
23755253|NCT01052038|66484489|FG001|Overall Study|Protocol Violation|3|||
23755254|NCT01052038|66484490|FG002|Overall Study|Protocol Violation|3|||
23755255|NCT01383954|66484503|FG000|Overall Study|Lack of Efficacy|2|||
23755256|NCT01383954|66484503|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
23559478|NCT01499082|65776275|FG000|Overall Study|Lost to Follow-up|1|||
23559479|NCT01499082|65776276|FG001|Overall Study|Lost to Follow-up|3|||
23559480|NCT00790452|65776277|FG000|Overall Study|Drug supply issue|1|||
23559481|NCT00790452|65776278|FG001|Overall Study|Drug supply issue|0|||
23559482|NCT03649230|65776279|FG000|Overall Study|Adverse Event|12|||
23559483|NCT03649230|65776279|FG000|Overall Study|Death|8|||
23559484|NCT03649230|65776279|FG000|Overall Study|Withdrawal by Subject|6|||
23559485|NCT03649230|65776279|FG000|Overall Study|Physician Decision|5|||
23559486|NCT03649230|65776279|FG000|Overall Study|Disease progression|5|||
23559487|NCT03649230|65776279|FG000|Overall Study|Switched to non-HEC|5|||
23559488|NCT03649230|65776279|FG000|Overall Study|Chemotherapy discontinued|4|||
23559489|NCT03649230|65776279|FG000|Overall Study|Received only 3 HEC cycles|4|||
23559490|NCT03649230|65776279|FG000|Overall Study|Screen Failure|3|||
23559491|NCT03649230|65776279|FG000|Overall Study|Patient stopped treatment|2|||
23559492|NCT03649230|65776279|FG000|Overall Study|Protocol Violation|1|||
23559493|NCT03649230|65776279|FG000|Overall Study|Non-compliance|1|||
23559494|NCT03649230|65776279|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
23559495|NCT01490125|65776280|FG000|Period I|Adverse Event|4|||
23559496|NCT01490125|65776281|FG001|Period I|Adverse Event|1|||
23559497|NCT01490125|65776282|FG002|Period I|Adverse Event|1|||
23559498|NCT01490125|65776283|FG003|Period I|Adverse Event|3|||
23559499|NCT01490125|65776284|FG004|Period I|Adverse Event|2|||
23559500|NCT01490125|65776285|FG005|Period I|Adverse Event|4|||
23559501|NCT01490125|65776280|FG000|Period I|Protocol Violation|1|||
23559502|NCT01490125|65776281|FG001|Period I|Protocol Violation|1|||
23559503|NCT01490125|65776282|FG002|Period I|Protocol Violation|1|||
23559504|NCT01490125|65776283|FG003|Period I|Protocol Violation|1|||
23559505|NCT01490125|65776284|FG004|Period I|Protocol Violation|0|||
23559506|NCT01490125|65776285|FG005|Period I|Protocol Violation|0|||
23559507|NCT01490125|65776280|FG000|Period I|Withdrawal by Subject|1|||
23559508|NCT01490125|65776281|FG001|Period I|Withdrawal by Subject|3|||
23559509|NCT01490125|65776282|FG002|Period I|Withdrawal by Subject|2|||
23559510|NCT01490125|65776283|FG003|Period I|Withdrawal by Subject|1|||
23559511|NCT01490125|65776284|FG004|Period I|Withdrawal by Subject|2|||
23755257|NCT01383954|66484503|FG000|Overall Study|Adverse Event|1|||
23755258|NCT01383954|66484503|FG000|Overall Study|Reason Not Specified|9|||
23825825|NCT01762800|66741609|FG001|Overall Study|Adverse Event|13|||
23825826|NCT01762800|66741608|FG000|Overall Study|Lack of Efficacy|3|||
23559512|NCT01490125|65776285|FG005|Period I|Withdrawal by Subject|1|||
23755259|NCT00792948|66484504|FG000|Overall Study|Adverse Event|6|||
23755260|NCT00792948|66484504|FG000|Overall Study|Death|4|||
23755261|NCT00792948|66484504|FG000|Overall Study|Withdrawal by Subject|3|||
23755262|NCT00792948|66484504|FG000|Overall Study|Ineligible|2|||
23559513|NCT01490125|65776280|FG000|Period II|Adverse Event|2|||
23559514|NCT01490125|65776281|FG001|Period II|Adverse Event|3|||
23559515|NCT01490125|65776282|FG002|Period II|Adverse Event|2|||
23559516|NCT01490125|65776283|FG003|Period II|Adverse Event|2|||
23559517|NCT01490125|65776284|FG004|Period II|Adverse Event|4|||
23559518|NCT01490125|65776285|FG005|Period II|Adverse Event|2|||
23559519|NCT01490125|65776280|FG000|Period II|Protocol Violation|0|||
23559520|NCT01490125|65776281|FG001|Period II|Protocol Violation|0|||
23559521|NCT01490125|65776282|FG002|Period II|Protocol Violation|1|||
23559522|NCT01490125|65776283|FG003|Period II|Protocol Violation|1|||
23559523|NCT01490125|65776284|FG004|Period II|Protocol Violation|0|||
23559524|NCT01490125|65776285|FG005|Period II|Protocol Violation|0|||
23559525|NCT01490125|65776280|FG000|Period II|Lost to Follow-up|0|||
23559526|NCT01490125|65776281|FG001|Period II|Lost to Follow-up|1|||
23755263|NCT00792948|66484504|FG000|Overall Study|Insurance denial - not treated|1|||
23755264|NCT00792948|66484504|FG000|Overall Study|Physician Decision|11|||
23559527|NCT01490125|65776282|FG002|Period II|Lost to Follow-up|0|||
23559528|NCT01490125|65776283|FG003|Period II|Lost to Follow-up|0|||
23559529|NCT01490125|65776284|FG004|Period II|Lost to Follow-up|0|||
23559530|NCT01490125|65776285|FG005|Period II|Lost to Follow-up|0|||
23559531|NCT01490125|65776280|FG000|Period II|Withdrawal by Subject|1|||
23559532|NCT01490125|65776281|FG001|Period II|Withdrawal by Subject|0|||
23559533|NCT01490125|65776282|FG002|Period II|Withdrawal by Subject|0|||
23559534|NCT01490125|65776283|FG003|Period II|Withdrawal by Subject|0|||
23559535|NCT01490125|65776284|FG004|Period II|Withdrawal by Subject|0|||
23559536|NCT01490125|65776285|FG005|Period II|Withdrawal by Subject|0|||
23559537|NCT01490125|65776280|FG000|Period III|Adverse Event|3|||
23559538|NCT01490125|65776281|FG001|Period III|Adverse Event|1|||
23559539|NCT01490125|65776282|FG002|Period III|Adverse Event|0|||
23559540|NCT01490125|65776283|FG003|Period III|Adverse Event|1|||
23559541|NCT01490125|65776284|FG004|Period III|Adverse Event|0|||
23559542|NCT01490125|65776285|FG005|Period III|Adverse Event|0|||
23559543|NCT01490125|65776280|FG000|Period III|Death|0|||
23559544|NCT01490125|65776281|FG001|Period III|Death|0|||
23559545|NCT01490125|65776282|FG002|Period III|Death|0|||
23559546|NCT01490125|65776283|FG003|Period III|Death|1|||
23559547|NCT01490125|65776284|FG004|Period III|Death|0|||
23559548|NCT01490125|65776285|FG005|Period III|Death|0|||
23559549|NCT01490125|65776280|FG000|Period III|Lack of Efficacy|0|||
23559550|NCT01490125|65776281|FG001|Period III|Lack of Efficacy|0|||
23559551|NCT01490125|65776282|FG002|Period III|Lack of Efficacy|0|||
23559552|NCT01490125|65776283|FG003|Period III|Lack of Efficacy|0|||
23559553|NCT01490125|65776284|FG004|Period III|Lack of Efficacy|1|||
23559554|NCT01490125|65776285|FG005|Period III|Lack of Efficacy|0|||
23559555|NCT04179721|65776286|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
23559556|NCT04179721|65776287|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
23559557|NCT04179721|65776286|FG000|Overall Study|Lost to Follow-up|0|||
23559558|NCT04179721|65776287|FG001|Overall Study|Lost to Follow-up|1|||
23559559|NCT01061333|65776289|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
23559560|NCT01061333|65776290|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
23559561|NCT04425902|65776291|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
23559562|NCT01353222|65776297|FG000|Overall Study|Death|30|||
23559563|NCT01353222|65776298|FG001|Overall Study|Death|30|||
23559564|NCT01353222|65776297|FG000|Overall Study|Withdrawal by Subject|8|||
23559565|NCT01353222|65776298|FG001|Overall Study|Withdrawal by Subject|5|||
23559566|NCT01353222|65776297|FG000|Overall Study|Study Terminated|31|||
23559567|NCT01353222|65776298|FG001|Overall Study|Study Terminated|37|||
23559568|NCT01353222|65776297|FG000|Overall Study|Site closed research department|1|||
23559569|NCT01353222|65776298|FG001|Overall Study|Site closed research department|0|||
23559570|NCT00570674|65776300|FG000|Overall Study|Withdrawal by Subject|0|||
23755265|NCT00792948|66484504|FG000|Overall Study|Protocol Violation|1|||
23755266|NCT00849524|66484507|FG000|Overall Study|Lack of Efficacy|3|||
23755267|NCT01678924|66484508|FG000|Overall Study|Adverse Event|1|||
23755268|NCT01678924|66484509|FG001|Overall Study|Adverse Event|1|||
23559571|NCT00570674|65776301|FG001|Overall Study|Withdrawal by Subject|0|||
23559572|NCT00570674|65776302|FG002|Overall Study|Withdrawal by Subject|1|||
23559573|NCT00570674|65776303|FG003|Overall Study|Withdrawal by Subject|0|||
23755269|NCT01678924|66484510|FG002|Overall Study|Adverse Event|0|||
23755270|NCT01678924|66484511|FG003|Overall Study|Adverse Event|1|||
23559574|NCT00570674|65776304|FG004|Overall Study|Withdrawal by Subject|0|||
23755271|NCT01678924|66484508|FG000|Overall Study|Lack of Efficacy|7|||
23559575|NCT00570674|65776305|FG005|Overall Study|Withdrawal by Subject|0|||
23755272|NCT01678924|66484509|FG001|Overall Study|Lack of Efficacy|2|||
23559576|NCT00570674|65776306|FG006|Overall Study|Withdrawal by Subject|0|||
23559577|NCT05168579|65776307|FG000|Overall Study|Lack of Consent|1|||
23559578|NCT05168579|65776308|FG001|Overall Study|Lack of Consent|0|||
23559579|NCT05168579|65776307|FG000|Overall Study|Conflicts with time|2|||
23559580|NCT05168579|65776308|FG001|Overall Study|Conflicts with time|0|||
23755273|NCT01678924|66484510|FG002|Overall Study|Lack of Efficacy|0|||
23755274|NCT01678924|66484511|FG003|Overall Study|Lack of Efficacy|5|||
23755275|NCT01678924|66484508|FG000|Overall Study|Lost to Follow-up|0|||
23755276|NCT01678924|66484509|FG001|Overall Study|Lost to Follow-up|4|||
23755277|NCT01678924|66484510|FG002|Overall Study|Lost to Follow-up|0|||
23755278|NCT01678924|66484511|FG003|Overall Study|Lost to Follow-up|2|||
23755279|NCT01678924|66484508|FG000|Overall Study|Personal Reasons|2|||
23755280|NCT01678924|66484509|FG001|Overall Study|Personal Reasons|2|||
23559581|NCT05168579|65776307|FG000|Overall Study|Time slots were full|3|||
23559582|NCT05168579|65776308|FG001|Overall Study|Time slots were full|0|||
23559583|NCT05168579|65776307|FG000|Overall Study|Lost to Follow-up|0|||
23559584|NCT05168579|65776308|FG001|Overall Study|Lost to Follow-up|15|||
23559585|NCT02606279|65776309|FG000|Overall Study|Lost to Follow-up|0|||
23559586|NCT02606279|65776310|FG001|Overall Study|Lost to Follow-up|1|||
23559587|NCT04710927|65776311|FG000|Overall Study|Lost to Follow-up|7|||
23559588|NCT04710927|65776312|FG001|Overall Study|Lost to Follow-up|6|||
23559589|NCT04710927|65776313|FG002|Overall Study|Lost to Follow-up|5|||
23559590|NCT03320018|65776314|FG000|Treatment Period|Withdrawal by Subject|1|||
23559591|NCT03320018|65776315|FG001|Treatment Period|Withdrawal by Subject|0|||
23559592|NCT03320018|65776314|FG000|Day 90 Follow up|Death|0|||
23559593|NCT03320018|65776315|FG001|Day 90 Follow up|Death|1|||
23559594|NCT00943306|65776317|FG000|Overall Study|Physician Decision|1|||
23559595|NCT00943306|65776317|FG000|Overall Study|Death|1|||
23559596|NCT00943306|65776317|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
23559597|NCT02691182|65776319|FG000|Overall Study|Withdrawal by Subject|4|||
23559598|NCT02691182|65776320|FG001|Overall Study|Withdrawal by Subject|7|||
23559599|NCT02691182|65776321|FG002|Overall Study|Withdrawal by Subject|6|||
23559600|NCT02691182|65776322|FG003|Overall Study|Withdrawal by Subject|8|||
23559601|NCT02691182|65776319|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
23559602|NCT02691182|65776320|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
23559603|NCT02691182|65776321|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
23559604|NCT02691182|65776322|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
23559605|NCT02691182|65776319|FG000|Overall Study|Lost to Follow-up|8|||
23559606|NCT02691182|65776320|FG001|Overall Study|Lost to Follow-up|33|||
23559607|NCT02691182|65776321|FG002|Overall Study|Lost to Follow-up|19|||
23559608|NCT02691182|65776322|FG003|Overall Study|Lost to Follow-up|22|||
23559609|NCT02691182|65776319|FG000|Overall Study|Adverse Event|3|||
23559610|NCT02691182|65776320|FG001|Overall Study|Adverse Event|10|||
23559611|NCT02691182|65776321|FG002|Overall Study|Adverse Event|10|||
23559612|NCT02691182|65776322|FG003|Overall Study|Adverse Event|11|||
23755281|NCT01678924|66484510|FG002|Overall Study|Personal Reasons|2|||
23755282|NCT01678924|66484511|FG003|Overall Study|Personal Reasons|7|||
23755283|NCT01678924|66484508|FG000|Overall Study|Withdrawal by Subject|0|||
23755284|NCT01678924|66484509|FG001|Overall Study|Withdrawal by Subject|3|||
23755285|NCT01678924|66484510|FG002|Overall Study|Withdrawal by Subject|0|||
23755286|NCT01678924|66484511|FG003|Overall Study|Withdrawal by Subject|2|||
23755287|NCT01678924|66484508|FG000|Overall Study|Unable to attend scheduled visits|0|||
23755288|NCT01678924|66484509|FG001|Overall Study|Unable to attend scheduled visits|0|||
23755289|NCT01678924|66484510|FG002|Overall Study|Unable to attend scheduled visits|0|||
23755290|NCT01678924|66484511|FG003|Overall Study|Unable to attend scheduled visits|1|||
23755291|NCT01238211|66484514|FG000|Overall Study|Continues active treatment|31|||
23755292|NCT01238211|66484514|FG000|Overall Study|Adverse Event|7|||
23755293|NCT01238211|66484514|FG000|Overall Study|Death|4|||
23437776|NCT02927938|65344204|FG002|Overall Study|Death|0|||
23559613|NCT02691182|65776319|FG000|Overall Study|Physician Decision|3|||
23559614|NCT02691182|65776320|FG001|Overall Study|Physician Decision|7|||
23559615|NCT02691182|65776321|FG002|Overall Study|Physician Decision|14|||
23559616|NCT02691182|65776322|FG003|Overall Study|Physician Decision|8|||
23559617|NCT02691182|65776319|FG000|Overall Study|Lack of Efficacy|0|||
23755294|NCT01238211|66484514|FG000|Overall Study|Relapse/Progression|2|||
23755295|NCT01238211|66484514|FG000|Overall Study|Withdrawal by Subject|7|||
23755296|NCT01238211|66484514|FG000|Overall Study|Non-protocol treatment|4|||
23755297|NCT01238211|66484514|FG000|Overall Study|Investigator/Patient Decision|3|||
23755298|NCT03634488|66484517|FG000|Overall Study|Death|1|||
23437777|NCT02927938|65344205|FG003|Overall Study|Death|4|||
23559618|NCT02691182|65776320|FG001|Overall Study|Lack of Efficacy|0|||
23559619|NCT02691182|65776321|FG002|Overall Study|Lack of Efficacy|0|||
23559620|NCT02691182|65776322|FG003|Overall Study|Lack of Efficacy|4|||
23559621|NCT02691182|65776319|FG000|Overall Study|Protocol Violation|2|||
23559622|NCT02691182|65776320|FG001|Overall Study|Protocol Violation|6|||
23559623|NCT02691182|65776321|FG002|Overall Study|Protocol Violation|6|||
23559624|NCT02691182|65776322|FG003|Overall Study|Protocol Violation|8|||
23755299|NCT03634488|66484518|FG001|Overall Study|Death|0|||
23755300|NCT03634488|66484519|FG002|Overall Study|Death|0|||
23755301|NCT03634488|66484517|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
23755302|NCT03634488|66484518|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
23755303|NCT03634488|66484519|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
23559625|NCT02691182|65776319|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
23559626|NCT02691182|65776320|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
23559627|NCT02691182|65776321|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
23559628|NCT02691182|65776322|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
23559629|NCT02691182|65776319|FG000|Overall Study|Missing|0|||
23559630|NCT02691182|65776320|FG001|Overall Study|Missing|5|||
23559631|NCT02691182|65776321|FG002|Overall Study|Missing|1|||
23559632|NCT02691182|65776322|FG003|Overall Study|Missing|5|||
23559633|NCT01807650|65776323|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
23559634|NCT01807650|65776323|FG000|Overall Study|Adverse Event|5|||
23559635|NCT01807650|65776323|FG000|Overall Study|Other|2|||
23559636|NCT00691938|65776328|FG000|Overall Study|QTc prolongation|1|||
23559637|NCT00691938|65776329|FG001|Overall Study|QTc prolongation|0|||
23559638|NCT00691938|65776330|FG002|Overall Study|QTc prolongation|0|||
23755304|NCT00963599|66484520|FG000|Overall Study|Adverse Event|2|||
23755305|NCT00963599|66484521|FG001|Overall Study|Adverse Event|0|||
23755306|NCT00963599|66484522|FG002|Overall Study|Adverse Event|1|||
23755307|NCT00963599|66484523|FG003|Overall Study|Adverse Event|2|||
23755308|NCT00963599|66484520|FG000|Overall Study|Lack of Efficacy|0|||
23755309|NCT00963599|66484521|FG001|Overall Study|Lack of Efficacy|2|||
23755310|NCT00963599|66484522|FG002|Overall Study|Lack of Efficacy|1|||
23755311|NCT00963599|66484523|FG003|Overall Study|Lack of Efficacy|4|||
23755312|NCT00963599|66484520|FG000|Overall Study|Lost to Follow-up|0|||
23755313|NCT00963599|66484521|FG001|Overall Study|Lost to Follow-up|1|||
23755314|NCT00963599|66484522|FG002|Overall Study|Lost to Follow-up|1|||
23755315|NCT00963599|66484523|FG003|Overall Study|Lost to Follow-up|1|||
23755316|NCT00963599|66484520|FG000|Overall Study|Protocol Violation|2|||
23755317|NCT00963599|66484521|FG001|Overall Study|Protocol Violation|2|||
23755318|NCT00963599|66484522|FG002|Overall Study|Protocol Violation|3|||
23755319|NCT00963599|66484523|FG003|Overall Study|Protocol Violation|4|||
23755320|NCT00963599|66484520|FG000|Overall Study|Withdrawal by Subject|2|||
23755321|NCT00963599|66484521|FG001|Overall Study|Withdrawal by Subject|1|||
23755322|NCT00963599|66484522|FG002|Overall Study|Withdrawal by Subject|3|||
23755323|NCT00963599|66484523|FG003|Overall Study|Withdrawal by Subject|3|||
23755324|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
23755325|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
23559639|NCT00691938|65776331|FG003|Overall Study|QTc prolongation|0|||
23559640|NCT00691938|65776332|FG004|Overall Study|QTc prolongation|0|||
23559641|NCT00691938|65776333|FG005|Overall Study|QTc prolongation|0|||
23559642|NCT00691938|65776334|FG006|Overall Study|QTc prolongation|0|||
23755326|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
23755327|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
23755328|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
23755329|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
23755330|NCT00566631|66484526|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
23755331|NCT00566631|66484526|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
23755332|NCT00566631|66484526|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
23755333|NCT00566631|66484526|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
23825827|NCT01762800|66741609|FG001|Overall Study|Lack of Efficacy|2|||
23559643|NCT04080752|65776335|FG000|Overall Study|Adverse Event|2|||
23559644|NCT04080752|65776336|FG001|Overall Study|Adverse Event|3|||
23559645|NCT04080752|65776335|FG000|Overall Study|Lack of Efficacy|1|||
23559646|NCT04080752|65776336|FG001|Overall Study|Lack of Efficacy|0|||
23559647|NCT04080752|65776335|FG000|Overall Study|Lost to Follow-up|1|||
23559648|NCT04080752|65776336|FG001|Overall Study|Lost to Follow-up|0|||
23559649|NCT04080752|65776335|FG000|Overall Study|Pregnancy|0|||
23559650|NCT04080752|65776336|FG001|Overall Study|Pregnancy|1|||
23559651|NCT04080752|65776335|FG000|Overall Study|Withdrawal by Subject|7|||
23559652|NCT04080752|65776336|FG001|Overall Study|Withdrawal by Subject|0|||
23559653|NCT04080752|65776335|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23755334|NCT00566631|66484526|FG000|Part 2: Extension Phase|Adverse Event|11|||
23755335|NCT00566631|66484526|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
23825828|NCT01762800|66741608|FG000|Overall Study|Study Closed/Terminated|0|||
23825829|NCT01762800|66741609|FG001|Overall Study|Study Closed/Terminated|1|||
23559654|NCT04080752|65776336|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23559655|NCT04080752|65776335|FG000|Overall Study|Other|2|||
23624414|NCT01181609|66011652|FG000|Overall Study|Adverse Event|1|||
23559656|NCT04080752|65776336|FG001|Overall Study|Other|1|||
23559657|NCT01657266|65776337|FG000|Overall Study|Lost to Follow-up|2|||
23755336|NCT00566631|66484526|FG000|Part 2: Extension Phase|Death|1|||
23755337|NCT00566631|66484526|FG000|Part 2: Extension Phase|Other|5|||
23755338|NCT00701558|66484527|FG000|Overall Study|Death|7|||
23755339|NCT00701558|66484527|FG000|Overall Study|Lost to Follow-up|8|||
23755340|NCT04098068|66484528|FG000|Overall Study|Disease Progression|7|||
23755341|NCT04098068|66484528|FG000|Overall Study|Withdrawal by Subject|2|||
23559658|NCT01657266|65776338|FG001|Overall Study|Lost to Follow-up|2|||
23755342|NCT04098068|66484528|FG000|Overall Study|New Cancer Diagnosis|1|||
23559659|NCT01657266|65776337|FG000|Overall Study|Adverse Event|2|||
23559660|NCT01657266|65776338|FG001|Overall Study|Adverse Event|3|||
23559661|NCT04098406|65776339|FG000|Overall Study|Adverse Event|2|||
23559662|NCT04098406|65776340|FG001|Overall Study|Adverse Event|1|||
23559663|NCT04098406|65776339|FG000|Overall Study|Withdrawal by Subject|1|||
23559664|NCT04098406|65776340|FG001|Overall Study|Withdrawal by Subject|0|||
23559665|NCT00985985|65776344|FG000|Overall Study|Adverse Event|4|||
23559666|NCT00985985|65776345|FG001|Overall Study|Adverse Event|2|||
23559667|NCT00985985|65776346|FG002|Overall Study|Adverse Event|2|||
23559668|NCT00985985|65776347|FG003|Overall Study|Adverse Event|2|||
23559669|NCT00985985|65776344|FG000|Overall Study|Lost to Follow-up|4|||
23559670|NCT00985985|65776345|FG001|Overall Study|Lost to Follow-up|11|||
23559671|NCT00985985|65776346|FG002|Overall Study|Lost to Follow-up|2|||
23559672|NCT00985985|65776347|FG003|Overall Study|Lost to Follow-up|3|||
23559673|NCT00985985|65776344|FG000|Overall Study|Protocol Violation|1|||
23559674|NCT00985985|65776345|FG001|Overall Study|Protocol Violation|2|||
23559675|NCT00985985|65776346|FG002|Overall Study|Protocol Violation|0|||
23559676|NCT00985985|65776347|FG003|Overall Study|Protocol Violation|1|||
23559677|NCT00985985|65776344|FG000|Overall Study|Lack of Efficacy|5|||
23559678|NCT00985985|65776345|FG001|Overall Study|Lack of Efficacy|6|||
23559679|NCT00985985|65776346|FG002|Overall Study|Lack of Efficacy|1|||
23559680|NCT00985985|65776347|FG003|Overall Study|Lack of Efficacy|3|||
23559681|NCT00985985|65776344|FG000|Overall Study|Withdrawal by Subject|4|||
23559682|NCT00985985|65776345|FG001|Overall Study|Withdrawal by Subject|2|||
23559683|NCT00985985|65776346|FG002|Overall Study|Withdrawal by Subject|2|||
23755343|NCT02411110|66484529|FG000|Treatment Period 1|Adverse Event|4|||
23825830|NCT01762800|66741608|FG000|Overall Study|Physician Decision|1|||
23825831|NCT01762800|66741609|FG001|Overall Study|Physician Decision|1|||
23825832|NCT01762800|66741608|FG000|Overall Study|Withdrawal by Subject|7|||
23825833|NCT01762800|66741609|FG001|Overall Study|Withdrawal by Subject|4|||
23825834|NCT02201784|66741610|FG000|Overall Study|Failure to achieve adequate block|2|||
23437778|NCT02927938|65344202|FG000|Overall Study|Early Study Termination|1|||
23755344|NCT02411110|66484530|FG001|Treatment Period 1|Adverse Event|2|||
23755345|NCT02411110|66484529|FG000|Treatment Period 1|Lost to Follow-up|1|||
23755346|NCT02411110|66484530|FG001|Treatment Period 1|Lost to Follow-up|0|||
23755347|NCT02411110|66484529|FG000|Treatment Period 1|Personal Reasons|2|||
23755348|NCT02411110|66484530|FG001|Treatment Period 1|Personal Reasons|5|||
23755349|NCT02411110|66484529|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
23755350|NCT02411110|66484530|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
23755351|NCT02411110|66484529|FG000|Treatment Period 2|Adverse Event|1|||
23755352|NCT02411110|66484530|FG001|Treatment Period 2|Adverse Event|0|||
23755353|NCT02411110|66484529|FG000|Treatment Period 2|Lost to Follow-up|0|||
23755354|NCT02411110|66484530|FG001|Treatment Period 2|Lost to Follow-up|2|||
23755355|NCT02411110|66484529|FG000|Treatment Period 2|Personal Reasons|0|||
23755356|NCT02411110|66484530|FG001|Treatment Period 2|Personal Reasons|2|||
23755357|NCT01205529|66484531|FG000|Overall Study|Procedure Cancelled|4|||
23755358|NCT01205529|66484531|FG000|Overall Study|Withdrawal by Subject|2|||
23755359|NCT01205529|66484531|FG000|Overall Study|Physician Decision|4|||
23755360|NCT01205529|66484531|FG000|Overall Study|Unstable post op|15|||
23755361|NCT01205529|66484531|FG000|Overall Study|No longer met criteria|30|||
23755362|NCT00665626|66484532|FG000|Overall Study|Lack of Efficacy|8|||
23825835|NCT02201784|66741611|FG001|Overall Study|Failure to achieve adequate block|0|||
23437779|NCT02927938|65344203|FG001|Overall Study|Early Study Termination|5|||
23437780|NCT02927938|65344204|FG002|Overall Study|Early Study Termination|4|||
23437781|NCT02927938|65344205|FG003|Overall Study|Early Study Termination|3|||
23437782|NCT01380834|65344206|FG000|Overall Study|Physician Decision|1|||
23437783|NCT01380834|65344207|FG001|Overall Study|Physician Decision|0|||
23437784|NCT00455143|65344212|FG000|Overall Study|Physician Decision|1|||
23437785|NCT00455143|65344212|FG000|Overall Study|Withdrawal by Subject|1|||
23437786|NCT00455143|65344212|FG000|Overall Study|Staff was not avail to follow patient|2|||
23437787|NCT00455143|65344212|FG000|Overall Study|No longer met Inclusion Criteria|1|||
23437788|NCT00455143|65344212|FG000|Overall Study|Surgical time, staff not available|1|||
23559684|NCT00985985|65776347|FG003|Overall Study|Withdrawal by Subject|2|||
23437789|NCT01543776|65344215|FG000|Overall Study|Withdrawal by Subject|2|||
23559685|NCT00985985|65776344|FG000|Overall Study|Other Reason|6|||
23559686|NCT00985985|65776345|FG001|Overall Study|Other Reason|1|||
23559687|NCT00985985|65776346|FG002|Overall Study|Other Reason|4|||
23559688|NCT00985985|65776347|FG003|Overall Study|Other Reason|2|||
23559689|NCT01750879|65776350|FG000|Overall Study|Adverse Event|8|||
23559690|NCT01750879|65776351|FG001|Overall Study|Adverse Event|0|||
23559691|NCT01750879|65776350|FG000|Overall Study|Lack of Efficacy|1|||
23755363|NCT00665626|66484533|FG001|Overall Study|Lack of Efficacy|5|||
23755364|NCT00665626|66484532|FG000|Overall Study|Lost to Follow-up|0|||
23755365|NCT00665626|66484533|FG001|Overall Study|Lost to Follow-up|2|||
23755366|NCT00665626|66484532|FG000|Overall Study|Withdrawal by Subject|0|||
23755367|NCT00665626|66484533|FG001|Overall Study|Withdrawal by Subject|1|||
23437790|NCT01543776|65344216|FG001|Overall Study|Withdrawal by Subject|2|||
23437791|NCT00392990|65344217|FG000|Treatment on Study|Adverse Event|3|||
23437792|NCT00392990|65344218|FG001|Treatment on Study|Adverse Event|1|||
23437793|NCT00392990|65344217|FG000|Follow up for 2 Years|Death|4|||
23624415|NCT01181609|66011652|FG000|Overall Study|Withdrawal by Subject|1|||
23624416|NCT01181609|66011652|FG000|Overall Study|Lost to Follow-up|1|||
23624417|NCT01181609|66011652|FG000|Overall Study|Death|50|||
23624418|NCT00344032|66011653|FG000|Overall Study|Adverse Event|0|||
23624419|NCT00344032|66011654|FG001|Overall Study|Adverse Event|1|||
23624420|NCT00344032|66011653|FG000|Overall Study|Withdrawal by Subject|6|||
23624421|NCT00344032|66011654|FG001|Overall Study|Withdrawal by Subject|2|||
23624422|NCT00344032|66011653|FG000|Overall Study|Lost to Follow-up|4|||
23624423|NCT00344032|66011654|FG001|Overall Study|Lost to Follow-up|6|||
23624424|NCT00344032|66011653|FG000|Overall Study|Physician Decision|4|||
23624425|NCT00344032|66011654|FG001|Overall Study|Physician Decision|1|||
23624426|NCT03246347|66011657|FG000|Overall Study|On Study|23|||
23624427|NCT01340014|66011658|FG000|Period 1, First 7 Days|Adverse Event|1|||
23624428|NCT01340014|66011659|FG001|Period 1, First 7 Days|Adverse Event|0|||
23624429|NCT01340014|66011658|FG000|Period 1, First 7 Days|Personal Reasons|1|||
23624430|NCT01340014|66011659|FG001|Period 1, First 7 Days|Personal Reasons|0|||
23624431|NCT01340014|66011658|FG000|Period 2, Second 7 Days|Adverse Event|0|||
23624432|NCT01340014|66011659|FG001|Period 2, Second 7 Days|Adverse Event|1|||
23624433|NCT00320398|66011667|FG000|Overall Study|Adverse Event|1|||
23624434|NCT00320398|66011668|FG001|Overall Study|Adverse Event|4|||
23624435|NCT00320398|66011667|FG000|Overall Study|Other|1|||
23624436|NCT00320398|66011668|FG001|Overall Study|Other|0|||
23624437|NCT01777490|66011669|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
23624438|NCT01777490|66011670|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
23624439|NCT01777490|66011671|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
23624440|NCT01777490|66011672|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
23624441|NCT00983905|66011676|FG000|Theophylline Alone|Adverse Event|1|||
23624442|NCT00983905|66011676|FG000|Colchicine Alone|Adverse Event|2|||
23624443|NCT00846768|66011686|FG000|Overall Study|Adverse Event|0|||
23624444|NCT00846768|66011687|FG001|Overall Study|Adverse Event|1|||
23624445|NCT00846768|66011688|FG002|Overall Study|Adverse Event|0|||
23624446|NCT00846768|66011689|FG003|Overall Study|Adverse Event|0|||
23624447|NCT01375114|66011690|FG000|Overall Study|Lost to Follow-up|1|||
23624448|NCT01375114|66011691|FG001|Overall Study|Lost to Follow-up|0|||
23624449|NCT01375114|66011692|FG002|Overall Study|Lost to Follow-up|1|||
23624450|NCT01375114|66011690|FG000|Overall Study|Disease Progression|3|||
23624451|NCT01375114|66011691|FG001|Overall Study|Disease Progression|2|||
23624452|NCT01375114|66011692|FG002|Overall Study|Disease Progression|2|||
23624453|NCT01375114|66011690|FG000|Overall Study|Patient Changed Mind|0|||
23624454|NCT01375114|66011691|FG001|Overall Study|Patient Changed Mind|0|||
23624455|NCT01375114|66011692|FG002|Overall Study|Patient Changed Mind|2|||
23624456|NCT01375114|66011690|FG000|Overall Study|Pruritus|0|||
23624457|NCT01375114|66011691|FG001|Overall Study|Pruritus|0|||
23624458|NCT01375114|66011692|FG002|Overall Study|Pruritus|1|||
23624459|NCT01375114|66011690|FG000|Overall Study|Restlessness|0|||
23624460|NCT01375114|66011691|FG001|Overall Study|Restlessness|0|||
23624461|NCT01375114|66011692|FG002|Overall Study|Restlessness|1|||
23437794|NCT00392990|65344218|FG001|Follow up for 2 Years|Death|0|||
23437795|NCT00666965|65344219|FG000|Overall Study|Adverse Event|0|||
23437796|NCT00666965|65344220|FG001|Overall Study|Adverse Event|2|||
23437797|NCT00666965|65344221|FG002|Overall Study|Adverse Event|1|||
23437798|NCT00666965|65344222|FG003|Overall Study|Adverse Event|9|||
23437799|NCT00666965|65344219|FG000|Overall Study|Lack of Efficacy|1|||
23437800|NCT00666965|65344220|FG001|Overall Study|Lack of Efficacy|1|||
23624462|NCT01375114|66011690|FG000|Overall Study|Diarrhea|0|||
23624463|NCT01375114|66011691|FG001|Overall Study|Diarrhea|0|||
23624464|NCT01375114|66011692|FG002|Overall Study|Diarrhea|1|||
23624465|NCT01375114|66011690|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
23624466|NCT01375114|66011691|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
23624467|NCT01375114|66011692|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
23624468|NCT01375114|66011690|FG000|Overall Study|Nausea|0|||
23624469|NCT01375114|66011691|FG001|Overall Study|Nausea|1|||
23755368|NCT00665626|66484532|FG000|Overall Study|Protocol Violation|0|||
23755369|NCT00665626|66484533|FG001|Overall Study|Protocol Violation|2|||
23755370|NCT00665626|66484532|FG000|Overall Study|Adverse Event|1|||
23755371|NCT00665626|66484533|FG001|Overall Study|Adverse Event|9|||
23755372|NCT00665626|66484532|FG000|Overall Study|Due to exclusion criteria|0|||
23755373|NCT00665626|66484533|FG001|Overall Study|Due to exclusion criteria|1|||
23755374|NCT00665626|66484532|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
23755375|NCT00665626|66484533|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
23755376|NCT00665626|66484532|FG000|Overall Study|Unably to comply with dosing regimen|0|||
23755377|NCT00665626|66484533|FG001|Overall Study|Unably to comply with dosing regimen|1|||
23755378|NCT00665626|66484532|FG000|Overall Study|Death|1|||
23755379|NCT00665626|66484533|FG001|Overall Study|Death|0|||
23755380|NCT00297492|66484534|FG000|Set Quit Date|Lost to Follow-up|7|||
23825836|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
23825837|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
23825838|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
23825839|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
23825840|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
23825841|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
23825842|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
23825843|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
23825844|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
23825845|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
23825846|NCT00451178|66741612|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
23825847|NCT00451178|66741613|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
23825848|NCT00451178|66741612|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
23825849|NCT00451178|66741613|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
23825850|NCT00451178|66741612|FG000|Prior to Maintenance Therapy|PD|2|||
23825851|NCT00451178|66741613|FG001|Prior to Maintenance Therapy|PD|0|||
23825852|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
23825853|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
23825854|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
23825855|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
23825856|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
23825857|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
23825858|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
23825859|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
23825860|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
23825861|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
23825862|NCT00451178|66741612|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
23825863|NCT00451178|66741613|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
23825864|NCT00451178|66741612|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
23825865|NCT00451178|66741613|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
23825866|NCT03682107|66741616|FG000|Overall Study|Withdrawal by Subject|0|||
23624470|NCT01375114|66011692|FG002|Overall Study|Nausea|0|||
23624471|NCT01375114|66011690|FG000|Overall Study|Increased AST/ALT|0|||
23624472|NCT01375114|66011691|FG001|Overall Study|Increased AST/ALT|1|||
23624473|NCT01375114|66011692|FG002|Overall Study|Increased AST/ALT|0|||
23624474|NCT01375114|66011690|FG000|Overall Study|Vaginal Hemorrhage|0|||
23825867|NCT03682107|66741617|FG001|Overall Study|Withdrawal by Subject|1|||
23825868|NCT03682107|66741618|FG002|Overall Study|Withdrawal by Subject|0|||
23825869|NCT03682107|66741619|FG003|Overall Study|Withdrawal by Subject|0|||
23825870|NCT03682107|66741620|FG004|Overall Study|Withdrawal by Subject|0|||
23825871|NCT03267212|66741621|FG000|First Intervention|Lost to Follow-up|0|||
23825872|NCT03267212|66741622|FG001|First Intervention|Lost to Follow-up|2|||
23825873|NCT03267212|66741621|FG000|First Intervention|Withdrawal by Subject|1|||
23825874|NCT03267212|66741622|FG001|First Intervention|Withdrawal by Subject|1|||
23825875|NCT03267212|66741621|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
23825876|NCT03267212|66741622|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
23437801|NCT00666965|65344221|FG002|Overall Study|Lack of Efficacy|0|||
23437802|NCT00666965|65344222|FG003|Overall Study|Lack of Efficacy|0|||
23437803|NCT00666965|65344219|FG000|Overall Study|Protocol Violation|0|||
23437804|NCT00666965|65344220|FG001|Overall Study|Protocol Violation|0|||
23437805|NCT00666965|65344221|FG002|Overall Study|Protocol Violation|0|||
23437806|NCT00666965|65344222|FG003|Overall Study|Protocol Violation|2|||
23437807|NCT00666965|65344219|FG000|Overall Study|Discontinuation criteria|2|||
23437808|NCT00666965|65344220|FG001|Overall Study|Discontinuation criteria|1|||
23437809|NCT00666965|65344221|FG002|Overall Study|Discontinuation criteria|1|||
23437810|NCT00666965|65344222|FG003|Overall Study|Discontinuation criteria|2|||
23437811|NCT00666965|65344219|FG000|Overall Study|Withdrawal by Subject|0|||
23437812|NCT00666965|65344220|FG001|Overall Study|Withdrawal by Subject|0|||
23437813|NCT00666965|65344221|FG002|Overall Study|Withdrawal by Subject|0|||
23437814|NCT00666965|65344222|FG003|Overall Study|Withdrawal by Subject|2|||
23437815|NCT02516592|65344223|FG000|Overall Study|Patient withdrew consent|5|||
23437816|NCT02516592|65344224|FG001|Overall Study|Patient withdrew consent|2|||
23437817|NCT02516592|65344223|FG000|Overall Study|Protocol deviation|4|||
23437818|NCT02516592|65344224|FG001|Overall Study|Protocol deviation|4|||
23437819|NCT02516592|65344223|FG000|Overall Study|Lost to Follow-up|2|||
23437820|NCT02516592|65344224|FG001|Overall Study|Lost to Follow-up|3|||
23624475|NCT01375114|66011691|FG001|Overall Study|Vaginal Hemorrhage|1|||
23825877|NCT03910673|66741623|FG000|Overall Study|Adverse Event|0|||
23825878|NCT03910673|66741624|FG001|Overall Study|Adverse Event|0|||
23437821|NCT02516592|65344223|FG000|Overall Study|Patient/guardian decision|2|||
23825879|NCT03910673|66741625|FG002|Overall Study|Adverse Event|0|||
23624476|NCT01375114|66011692|FG002|Overall Study|Vaginal Hemorrhage|0|||
23624477|NCT01375114|66011690|FG000|Overall Study|Family problem|0|||
23825880|NCT03910673|66741626|FG003|Overall Study|Adverse Event|2|||
23825881|NCT03910673|66741627|FG004|Overall Study|Adverse Event|0|||
23825882|NCT03953612|66741628|FG000|Overall Study|Randomized but did not start|1|||
23825883|NCT03953612|66741629|FG001|Overall Study|Randomized but did not start|1|||
23559692|NCT01750879|65776351|FG001|Overall Study|Lack of Efficacy|0|||
23559693|NCT01750879|65776350|FG000|Overall Study|Withdrawal by Subject|1|||
23559694|NCT01750879|65776351|FG001|Overall Study|Withdrawal by Subject|0|||
23559695|NCT01750879|65776350|FG000|Overall Study|Did not complete per protocol|0|||
23559696|NCT01750879|65776351|FG001|Overall Study|Did not complete per protocol|3|||
23559697|NCT03813238|65776369|FG000|Overall Study|Adverse Event|0|||
23559698|NCT03813238|65776370|FG001|Overall Study|Adverse Event|6|||
23559699|NCT03813238|65776369|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23559700|NCT03813238|65776370|FG001|Overall Study|Withdrawal by parent/guardian|2|||
23559701|NCT03813238|65776369|FG000|Overall Study|Lost to Follow-up|0|||
23559702|NCT03813238|65776370|FG001|Overall Study|Lost to Follow-up|1|||
23559703|NCT03813238|65776369|FG000|Overall Study|Other than specified|1|||
23559704|NCT03813238|65776370|FG001|Overall Study|Other than specified|2|||
23559705|NCT01201811|65776371|FG000|Overall Study|Adverse Event|6|||
23559706|NCT01201811|65776371|FG000|Overall Study|Disease progression|3|||
23559707|NCT01201811|65776371|FG000|Overall Study|Withdrawal by Subject|3|||
23559708|NCT01201811|65776371|FG000|Overall Study|Death|4|||
23559709|NCT01201811|65776371|FG000|Overall Study|Treatment Failure|2|||
23559710|NCT01201811|65776371|FG000|Overall Study|Physician Decision|1|||
23559711|NCT02277743|65776372|FG000|Overall Study|Protocol Violation|1|||
23559712|NCT02277743|65776373|FG001|Overall Study|Protocol Violation|1|||
23559713|NCT02277743|65776374|FG002|Overall Study|Protocol Violation|1|||
23559714|NCT02277743|65776372|FG000|Overall Study|Adverse Event|10|||
23559715|NCT02277743|65776373|FG001|Overall Study|Adverse Event|6|||
23559716|NCT02277743|65776374|FG002|Overall Study|Adverse Event|6|||
23559717|NCT02277743|65776372|FG000|Overall Study|Lack of Efficacy|11|||
23559718|NCT02277743|65776373|FG001|Overall Study|Lack of Efficacy|4|||
23559719|NCT02277743|65776374|FG002|Overall Study|Lack of Efficacy|3|||
23559720|NCT02277743|65776372|FG000|Overall Study|Other than specified above|18|||
23559721|NCT02277743|65776373|FG001|Overall Study|Other than specified above|5|||
23825884|NCT03953612|66741630|FG002|Overall Study|Randomized but did not start|1|||
23825885|NCT03953612|66741628|FG000|Overall Study|Withdrawal by Subject|2|||
23559722|NCT02277743|65776374|FG002|Overall Study|Other than specified above|16|||
23559723|NCT02634788|65776375|FG000|Overall Study|Adverse Event|0|||
23559724|NCT02634788|65776376|FG001|Overall Study|Adverse Event|8|||
23559725|NCT02634788|65776377|FG002|Overall Study|Adverse Event|3|||
23559726|NCT02634788|65776378|FG003|Overall Study|Adverse Event|1|||
23559727|NCT02634788|65776375|FG000|Overall Study|Lack of Efficacy|4|||
23559728|NCT02634788|65776376|FG001|Overall Study|Lack of Efficacy|0|||
23559729|NCT02634788|65776377|FG002|Overall Study|Lack of Efficacy|1|||
23559730|NCT02634788|65776378|FG003|Overall Study|Lack of Efficacy|4|||
23559731|NCT02634788|65776375|FG000|Overall Study|Lost to Follow-up|0|||
23559732|NCT02634788|65776376|FG001|Overall Study|Lost to Follow-up|1|||
23559733|NCT02634788|65776377|FG002|Overall Study|Lost to Follow-up|0|||
23559734|NCT02634788|65776378|FG003|Overall Study|Lost to Follow-up|0|||
23559735|NCT02634788|65776375|FG000|Overall Study|Withdrawal by Subject|0|||
23559736|NCT02634788|65776376|FG001|Overall Study|Withdrawal by Subject|1|||
23559737|NCT02634788|65776377|FG002|Overall Study|Withdrawal by Subject|1|||
23559738|NCT02634788|65776378|FG003|Overall Study|Withdrawal by Subject|0|||
23559739|NCT00754338|65776379|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559740|NCT00754338|65776380|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
23559741|NCT00754338|65776381|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
23559742|NCT00754338|65776382|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559743|NCT00754338|65776379|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559744|NCT00754338|65776380|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
23559745|NCT00754338|65776381|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559746|NCT00754338|65776382|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
23559747|NCT00755222|65776383|FG000|Overall Study|Withdrawal by Subject|4|||
23825886|NCT03953612|66741629|FG001|Overall Study|Withdrawal by Subject|1|||
23825887|NCT03953612|66741630|FG002|Overall Study|Withdrawal by Subject|0|||
23559748|NCT00755222|65776384|FG001|Overall Study|Withdrawal by Subject|2|||
23825888|NCT02413229|66741636|FG000|Overall Study|Adverse Event|0|||
23825889|NCT02413229|66741637|FG001|Overall Study|Adverse Event|0|||
23825890|NCT02413229|66741638|FG002|Overall Study|Adverse Event|0|||
23825891|NCT02413229|66741639|FG003|Overall Study|Adverse Event|1|||
23559749|NCT00755222|65776383|FG000|Overall Study|Adverse Event|2|||
23559750|NCT00755222|65776384|FG001|Overall Study|Adverse Event|0|||
23559751|NCT00755222|65776383|FG000|Overall Study|Protocol Violation|2|||
23559752|NCT00755222|65776384|FG001|Overall Study|Protocol Violation|0|||
23559753|NCT04349280|65776386|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
23559754|NCT04349280|65776387|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
23825892|NCT02413229|66741640|FG004|Overall Study|Adverse Event|0|||
23755381|NCT00297492|66484535|FG001|Set Quit Date|Lost to Follow-up|13|||
23755382|NCT00297492|66484536|FG002|Set Quit Date|Lost to Follow-up|5|||
23755383|NCT00297492|66484534|FG000|6 Month Follow-up|Lost to Follow-up|63|||
23755384|NCT00297492|66484535|FG001|6 Month Follow-up|Lost to Follow-up|49|||
23755385|NCT00297492|66484536|FG002|6 Month Follow-up|Lost to Follow-up|27|||
23755386|NCT04651218|66484537|FG000|Overall Study|Withdrawal by Subject|0|||
23755387|NCT04651218|66484538|FG001|Overall Study|Withdrawal by Subject|2|||
23825893|NCT02413229|66741641|FG005|Overall Study|Adverse Event|0|||
23825894|NCT02413229|66741642|FG006|Overall Study|Adverse Event|0|||
23825895|NCT02413229|66741643|FG007|Overall Study|Adverse Event|1|||
23825896|NCT02413229|66741636|FG000|Overall Study|Lost to Follow-up|0|||
23825897|NCT02413229|66741637|FG001|Overall Study|Lost to Follow-up|0|||
23825898|NCT02413229|66741638|FG002|Overall Study|Lost to Follow-up|1|||
23825899|NCT02413229|66741639|FG003|Overall Study|Lost to Follow-up|0|||
23437822|NCT02516592|65344224|FG001|Overall Study|Patient/guardian decision|1|||
23437823|NCT02516592|65344223|FG000|Overall Study|Adverse Event|1|||
23437824|NCT02516592|65344224|FG001|Overall Study|Adverse Event|2|||
23437825|NCT02516592|65344223|FG000|Overall Study|Abnormal test procedure result|1|||
23437826|NCT02516592|65344224|FG001|Overall Study|Abnormal test procedure result|0|||
23437827|NCT02516592|65344223|FG000|Overall Study|Death|1|||
23437828|NCT02516592|65344224|FG001|Overall Study|Death|1|||
23437829|NCT01320202|65344225|FG000|Overall Study|Adverse Event|5|||
23437830|NCT01320202|65344226|FG001|Overall Study|Adverse Event|5|||
23437831|NCT01320202|65344225|FG000|Overall Study|Death|5|||
23437832|NCT01320202|65344226|FG001|Overall Study|Death|3|||
23437833|NCT01320202|65344225|FG000|Overall Study|Lost to Follow-up|1|||
23437834|NCT01320202|65344226|FG001|Overall Study|Lost to Follow-up|0|||
23437835|NCT01320202|65344225|FG000|Overall Study|Physician Decision|3|||
23437836|NCT01320202|65344226|FG001|Overall Study|Physician Decision|1|||
23559755|NCT04349280|65776386|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
23559756|NCT04349280|65776387|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
23559757|NCT04349280|65776386|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
23559758|NCT04349280|65776387|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
23559759|NCT02052310|65776391|FG000|Overall Study|Death|64|||
23559760|NCT02052310|65776392|FG001|Overall Study|Death|54|||
23559761|NCT02052310|65776391|FG000|Overall Study|Withdrawal by Subject|37|||
23559762|NCT02052310|65776392|FG001|Overall Study|Withdrawal by Subject|49|||
23559763|NCT02052310|65776391|FG000|Overall Study|Other than specified|32|||
23559764|NCT02052310|65776392|FG001|Overall Study|Other than specified|29|||
23559765|NCT02052310|65776391|FG000|Overall Study|Adverse Event|29|||
23755388|NCT01785472|66484539|FG000|Overall Study|Adverse Event|5|||
23755389|NCT01785472|66484540|FG001|Overall Study|Adverse Event|4|||
23755390|NCT01785472|66484541|FG002|Overall Study|Adverse Event|6|||
23755391|NCT01785472|66484539|FG000|Overall Study|Lack of Efficacy|2|||
23755392|NCT01785472|66484540|FG001|Overall Study|Lack of Efficacy|0|||
23755393|NCT01785472|66484541|FG002|Overall Study|Lack of Efficacy|1|||
23755394|NCT01785472|66484539|FG000|Overall Study|Lost to Follow-up|1|||
23755395|NCT01785472|66484540|FG001|Overall Study|Lost to Follow-up|2|||
23755396|NCT01785472|66484541|FG002|Overall Study|Lost to Follow-up|0|||
23755397|NCT01785472|66484539|FG000|Overall Study|Physician Decision|1|||
23755398|NCT01785472|66484540|FG001|Overall Study|Physician Decision|1|||
23755399|NCT01785472|66484541|FG002|Overall Study|Physician Decision|1|||
23755400|NCT01785472|66484539|FG000|Overall Study|Protocol deviation|0|||
23755401|NCT01785472|66484540|FG001|Overall Study|Protocol deviation|2|||
23755402|NCT01785472|66484541|FG002|Overall Study|Protocol deviation|2|||
23755403|NCT01785472|66484539|FG000|Overall Study|Subject/guardian decision|15|||
23755404|NCT01785472|66484540|FG001|Overall Study|Subject/guardian decision|10|||
23755405|NCT01785472|66484541|FG002|Overall Study|Subject/guardian decision|11|||
23755406|NCT01785472|66484539|FG000|Overall Study|Technical problems|0|||
23755407|NCT01785472|66484540|FG001|Overall Study|Technical problems|0|||
23755408|NCT01785472|66484541|FG002|Overall Study|Technical problems|1|||
23755409|NCT02702271|66484542|FG000|Overall Study|Death|36|||
23755410|NCT02702271|66484543|FG001|Overall Study|Death|7|||
23755411|NCT02702271|66484542|FG000|Overall Study|Lost to Follow-up|12|||
23755412|NCT02702271|66484543|FG001|Overall Study|Lost to Follow-up|0|||
23755413|NCT02702271|66484542|FG000|Overall Study|Withdrawal by Subject|8|||
23755414|NCT02702271|66484543|FG001|Overall Study|Withdrawal by Subject|1|||
23755415|NCT02702271|66484542|FG000|Overall Study|Physician Decision|2|||
23755416|NCT02702271|66484543|FG001|Overall Study|Physician Decision|0|||
23755417|NCT02702271|66484542|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
23755418|NCT02702271|66484543|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
23755419|NCT03701516|66484544|FG000|Period 1|Lost to Follow-up|0|||
23755420|NCT03701516|66484545|FG001|Period 1|Lost to Follow-up|1|||
23755421|NCT03701516|66484544|FG000|Period 1|Adverse Event|0|||
23755422|NCT03701516|66484545|FG001|Period 1|Adverse Event|2|||
23755423|NCT03701516|66484544|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
23755424|NCT03701516|66484545|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
23755425|NCT03701516|66484544|FG000|Period 1|Non Compliance to Protocol|2|||
23755426|NCT03701516|66484545|FG001|Period 1|Non Compliance to Protocol|1|||
23624478|NCT01375114|66011691|FG001|Overall Study|Family problem|1|||
23624479|NCT01375114|66011692|FG002|Overall Study|Family problem|0|||
23624480|NCT01375114|66011690|FG000|Overall Study|Protocol Violation|2|||
23559766|NCT02052310|65776392|FG001|Overall Study|Adverse Event|22|||
23559767|NCT02052310|65776391|FG000|Overall Study|Kidney Transplant|23|||
23559768|NCT02052310|65776392|FG001|Overall Study|Kidney Transplant|29|||
23559769|NCT02052310|65776391|FG000|Overall Study|Physician Decision|14|||
23559770|NCT02052310|65776392|FG001|Overall Study|Physician Decision|7|||
23559771|NCT02052310|65776391|FG000|Overall Study|Lack of Efficacy|6|||
23559772|NCT02052310|65776392|FG001|Overall Study|Lack of Efficacy|1|||
23559773|NCT02052310|65776391|FG000|Overall Study|Site Terminated by Sponsor|5|||
23559774|NCT02052310|65776392|FG001|Overall Study|Site Terminated by Sponsor|13|||
23559775|NCT02052310|65776391|FG000|Overall Study|Lost to Follow-up|4|||
23559776|NCT02052310|65776392|FG001|Overall Study|Lost to Follow-up|2|||
23559777|NCT02052310|65776391|FG000|Overall Study|Protocol Violation|1|||
23559778|NCT02052310|65776392|FG001|Overall Study|Protocol Violation|6|||
23559779|NCT01301391|65776393|FG000|Overall Study|Death|13|||
23559780|NCT01301391|65776393|FG000|Overall Study|Lost to Follow-up|3|||
23559781|NCT01301391|65776393|FG000|Overall Study|Physician Decision|2|||
23559782|NCT01301391|65776393|FG000|Overall Study|Sponsor's decision|8|||
23559783|NCT01666808|65776394|FG000|Overall Study|Lost to Follow-up|9|||
23437837|NCT01320202|65344225|FG000|Overall Study|Protocol Violation|2|||
23559784|NCT01666808|65776395|FG001|Overall Study|Lost to Follow-up|15|||
23559785|NCT01666808|65776394|FG000|Overall Study|Withdrawal by Subject|3|||
23437838|NCT01320202|65344226|FG001|Overall Study|Protocol Violation|1|||
23559786|NCT01666808|65776395|FG001|Overall Study|Withdrawal by Subject|1|||
23559787|NCT01666808|65776394|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
23559788|NCT01666808|65776395|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
23559789|NCT01995539|65776398|FG000|Overall Study|Screening Failure|1|||
23559790|NCT01995539|65776398|FG000|Overall Study|Withdrawal by Investigator|15|||
23559791|NCT01995539|65776398|FG000|Overall Study|Withdrawal by Subject|11|||
23559792|NCT01995539|65776398|FG000|Overall Study|Lost to Follow-up|5|||
23559793|NCT01995539|65776398|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
23559794|NCT04493216|65776402|FG000|Overall Study|Study terminated by sponsor|30|||
23559795|NCT04493216|65776403|FG001|Overall Study|Study terminated by sponsor|33|||
23559796|NCT04493216|65776404|FG002|Overall Study|Study terminated by sponsor|28|||
23559797|NCT04493216|65776405|FG003|Overall Study|Study terminated by sponsor|27|||
23559798|NCT04493216|65776402|FG000|Overall Study|Withdrawal by Subject|2|||
23559799|NCT04493216|65776403|FG001|Overall Study|Withdrawal by Subject|1|||
23559800|NCT04493216|65776404|FG002|Overall Study|Withdrawal by Subject|1|||
23559801|NCT04493216|65776405|FG003|Overall Study|Withdrawal by Subject|2|||
23559802|NCT04493216|65776402|FG000|Overall Study|Protocol Violation|1|||
23559803|NCT04493216|65776403|FG001|Overall Study|Protocol Violation|2|||
23559804|NCT04493216|65776404|FG002|Overall Study|Protocol Violation|0|||
23559805|NCT04493216|65776405|FG003|Overall Study|Protocol Violation|2|||
23559806|NCT04493216|65776402|FG000|Overall Study|Physician Decision|0|||
23559807|NCT04493216|65776403|FG001|Overall Study|Physician Decision|0|||
23559808|NCT04493216|65776404|FG002|Overall Study|Physician Decision|1|||
23559809|NCT04493216|65776405|FG003|Overall Study|Physician Decision|0|||
23559810|NCT04493216|65776402|FG000|Overall Study|Lost to Follow-up|2|||
23559811|NCT04493216|65776403|FG001|Overall Study|Lost to Follow-up|1|||
23559812|NCT04493216|65776404|FG002|Overall Study|Lost to Follow-up|0|||
23559813|NCT04493216|65776405|FG003|Overall Study|Lost to Follow-up|1|||
23559814|NCT04493216|65776402|FG000|Overall Study|Adverse Event|1|||
23559815|NCT04493216|65776403|FG001|Overall Study|Adverse Event|4|||
23559816|NCT04493216|65776404|FG002|Overall Study|Adverse Event|5|||
23559817|NCT04493216|65776405|FG003|Overall Study|Adverse Event|2|||
23559818|NCT04493216|65776402|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
23559819|NCT04493216|65776403|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
23559820|NCT04493216|65776404|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
23559821|NCT04493216|65776405|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
23559822|NCT00682643|65776406|FG000|Overall Study|Adverse Event|12|||
23559823|NCT00682643|65776407|FG001|Overall Study|Adverse Event|23|||
23559824|NCT00682643|65776406|FG000|Overall Study|Lack of Efficacy|2|||
23559825|NCT00682643|65776407|FG001|Overall Study|Lack of Efficacy|0|||
23559826|NCT00682643|65776406|FG000|Overall Study|Protocol Violation|38|||
23559827|NCT00682643|65776407|FG001|Overall Study|Protocol Violation|76|||
23559828|NCT00682643|65776406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23559829|NCT00682643|65776407|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23559830|NCT00682643|65776406|FG000|Overall Study|Lost to Follow-up|1|||
23559831|NCT00682643|65776407|FG001|Overall Study|Lost to Follow-up|6|||
23559832|NCT00682643|65776406|FG000|Overall Study|Physician Decision|2|||
23559833|NCT00682643|65776407|FG001|Overall Study|Physician Decision|6|||
23559834|NCT00682643|65776406|FG000|Overall Study|Withdrawal by Subject|19|||
23559835|NCT00682643|65776407|FG001|Overall Study|Withdrawal by Subject|53|||
23559836|NCT00682643|65776406|FG000|Overall Study|Did Not Receive Study Drug|1|||
23559837|NCT00682643|65776407|FG001|Overall Study|Did Not Receive Study Drug|1|||
23559838|NCT00949715|65776412|FG000|Overall Study|Physician Decision|1|||
23559839|NCT00949715|65776413|FG001|Overall Study|Physician Decision|0|||
23559840|NCT00949715|65776412|FG000|Overall Study|Lost to Follow-up|1|||
23559841|NCT00949715|65776413|FG001|Overall Study|Lost to Follow-up|0|||
23559842|NCT00949715|65776412|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
23559843|NCT00949715|65776413|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
23755427|NCT03701516|66484544|FG000|Period 1|Withdrawal by Subject|0|||
23755428|NCT03701516|66484545|FG001|Period 1|Withdrawal by Subject|1|||
23755429|NCT03701516|66484544|FG000|Period 2|failed to meet all eligibility creiteria|1|||
23755430|NCT03701516|66484545|FG001|Period 2|failed to meet all eligibility creiteria|0|||
23755431|NCT03701516|66484544|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
23755432|NCT03701516|66484545|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
23755433|NCT01246986|66484546|FG000|Overall Study|Lost to Follow-up|0|||
23755434|NCT01246986|66484547|FG001|Overall Study|Lost to Follow-up|1|||
23755435|NCT01246986|66484548|FG002|Overall Study|Lost to Follow-up|3|||
23755436|NCT01246986|66484549|FG003|Overall Study|Lost to Follow-up|0|||
23755437|NCT01246986|66484550|FG004|Overall Study|Lost to Follow-up|0|||
23755438|NCT01246986|66484551|FG005|Overall Study|Lost to Follow-up|1|||
23755439|NCT01246986|66484552|FG006|Overall Study|Lost to Follow-up|0|||
23559844|NCT01453348|65779471|FG000|Overall Study|Death|0|||
23559845|NCT01453348|65779472|FG001|Overall Study|Death|0|||
23559846|NCT01453348|65779473|FG002|Overall Study|Death|1|||
23559847|NCT01453348|65779471|FG000|Overall Study|Withdrawal by Subject|0|||
23559848|NCT01453348|65779472|FG001|Overall Study|Withdrawal by Subject|1|||
23559849|NCT01453348|65779473|FG002|Overall Study|Withdrawal by Subject|0|||
23559850|NCT01453348|65779471|FG000|Overall Study|Protocol Violation|1|||
23559851|NCT01453348|65779472|FG001|Overall Study|Protocol Violation|0|||
23559852|NCT01453348|65779473|FG002|Overall Study|Protocol Violation|0|||
23559853|NCT01224158|65779474|FG000|Overall Study|Withdrawal by Subject|1|||
23559854|NCT01224158|65779475|FG001|Overall Study|Withdrawal by Subject|0|||
23559855|NCT01494584|65779478|FG000|Overall Study|Study Closed/Terminated|1|||
23559856|NCT03010462|65779484|FG000|Overall Study|Withdrawal by Subject|3|||
23559857|NCT03010462|65779485|FG001|Overall Study|Withdrawal by Subject|1|||
23624481|NCT01375114|66011691|FG001|Overall Study|Protocol Violation|0|||
23559858|NCT00524030|65779488|FG000|Overall Study|Lack of Efficacy|10|||
23559859|NCT00524030|65779489|FG001|Overall Study|Lack of Efficacy|24|||
23559860|NCT00524030|65779488|FG000|Overall Study|Lost to Follow-up|0|||
23559861|NCT00524030|65779489|FG001|Overall Study|Lost to Follow-up|2|||
23559862|NCT00524030|65779488|FG000|Overall Study|Withdrawal by Subject|3|||
23559863|NCT00524030|65779489|FG001|Overall Study|Withdrawal by Subject|8|||
23559864|NCT00524030|65779488|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
23559865|NCT00524030|65779489|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
23559866|NCT00524030|65779488|FG000|Overall Study|Protocol Violation|0|||
23559867|NCT00524030|65779489|FG001|Overall Study|Protocol Violation|1|||
23559868|NCT00524030|65779488|FG000|Overall Study|Pregnancy|1|||
23559869|NCT00524030|65779489|FG001|Overall Study|Pregnancy|0|||
23559870|NCT00524030|65779488|FG000|Overall Study|Adverse Event|3|||
23559871|NCT00524030|65779489|FG001|Overall Study|Adverse Event|21|||
23559872|NCT00524030|65779488|FG000|Overall Study|Death|0|||
23559873|NCT00524030|65779489|FG001|Overall Study|Death|1|||
23559874|NCT02472652|65779490|FG000|Overall Study|Lost to Follow-up|1|||
23559875|NCT02192970|65779498|FG000|Overall Study|Lost to Follow-up|6|||
23559876|NCT02192970|65779499|FG001|Overall Study|Lost to Follow-up|0|||
23559877|NCT03587142|65779500|FG000|Overall Study|Lost to Follow-up|5|||
23559878|NCT03587142|65779501|FG001|Overall Study|Lost to Follow-up|3|||
23624482|NCT01375114|66011692|FG002|Overall Study|Protocol Violation|0|||
23437839|NCT01320202|65344225|FG000|Overall Study|Withdrawal by Subject|10|||
23437840|NCT01320202|65344226|FG001|Overall Study|Withdrawal by Subject|3|||
23559879|NCT03587142|65779500|FG000|Overall Study|Did not complete the f4 visit|3|||
23559880|NCT03587142|65779501|FG001|Overall Study|Did not complete the f4 visit|7|||
23559881|NCT01337986|65779502|FG000|Overall Study|Adverse Event|2|||
23559882|NCT01337986|65779503|FG001|Overall Study|Adverse Event|2|||
23755440|NCT01246986|66484546|FG000|Overall Study|Withdrawal by Subject|3|||
23755441|NCT01246986|66484547|FG001|Overall Study|Withdrawal by Subject|4|||
23755442|NCT01246986|66484548|FG002|Overall Study|Withdrawal by Subject|3|||
23755443|NCT01246986|66484549|FG003|Overall Study|Withdrawal by Subject|0|||
23755444|NCT01246986|66484550|FG004|Overall Study|Withdrawal by Subject|4|||
23755445|NCT01246986|66484551|FG005|Overall Study|Withdrawal by Subject|0|||
23755446|NCT01246986|66484552|FG006|Overall Study|Withdrawal by Subject|0|||
23755447|NCT00435825|66484555|FG000|Overall Study|Abnormality of Laboratory Test|0|||
23755448|NCT00435825|66484556|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23755449|NCT00435825|66484557|FG002|Overall Study|Abnormality of Laboratory Test|0|||
23755450|NCT00435825|66484558|FG003|Overall Study|Abnormality of Laboratory Test|0|||
23755451|NCT00435825|66484555|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23755452|NCT00435825|66484556|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23755453|NCT00435825|66484557|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23755454|NCT00435825|66484558|FG003|Overall Study|Insufficient Therapeutic Response|3|||
23755455|NCT00435825|66484555|FG000|Overall Study|Other Protocol Violation|1|||
23755456|NCT00435825|66484556|FG001|Overall Study|Other Protocol Violation|0|||
23755457|NCT00435825|66484557|FG002|Overall Study|Other Protocol Violation|0|||
23755458|NCT00435825|66484558|FG003|Overall Study|Other Protocol Violation|0|||
23755459|NCT00435825|66484555|FG000|Overall Study|Refused treatment|2|||
23755460|NCT00435825|66484556|FG001|Overall Study|Refused treatment|0|||
23755461|NCT00435825|66484557|FG002|Overall Study|Refused treatment|0|||
23755462|NCT00435825|66484558|FG003|Overall Study|Refused treatment|5|||
23755463|NCT00435825|66484555|FG000|Overall Study|Failure to return|5|||
23755464|NCT00435825|66484556|FG001|Overall Study|Failure to return|0|||
23755465|NCT00435825|66484557|FG002|Overall Study|Failure to return|4|||
23755466|NCT00435825|66484558|FG003|Overall Study|Failure to return|0|||
23755467|NCT00435825|66484555|FG000|Overall Study|Did not receive study drug|1|||
23755468|NCT00435825|66484556|FG001|Overall Study|Did not receive study drug|0|||
23755469|NCT00435825|66484557|FG002|Overall Study|Did not receive study drug|2|||
23755470|NCT00435825|66484558|FG003|Overall Study|Did not receive study drug|0|||
23755471|NCT00435825|66484555|FG000|Overall Study|Did not enter follow-up|0|||
23755472|NCT00435825|66484556|FG001|Overall Study|Did not enter follow-up|4|||
23755473|NCT00435825|66484557|FG002|Overall Study|Did not enter follow-up|1|||
23559883|NCT01337986|65779502|FG000|Overall Study|Lost to Follow-up|1|||
23559884|NCT01337986|65779503|FG001|Overall Study|Lost to Follow-up|0|||
23559885|NCT01337986|65779502|FG000|Overall Study|Protocol Violation|0|||
23559886|NCT01337986|65779503|FG001|Overall Study|Protocol Violation|3|||
23559887|NCT02487498|65779509|FG000|Period: Period 1|Adverse Event|2|||
23559888|NCT02487498|65779510|FG001|Period: Period 1|Adverse Event|4|||
23559889|NCT02487498|65779509|FG000|Period: Period 1|Subject/guardian decision|2|||
23559890|NCT02487498|65779510|FG001|Period: Period 1|Subject/guardian decision|4|||
23559891|NCT02487498|65779509|FG000|Period: Period 1|Lost to Follow-up|0|||
23559892|NCT02487498|65779510|FG001|Period: Period 1|Lost to Follow-up|2|||
23559893|NCT02487498|65779509|FG000|Period: Period 1|Lack of Efficacy|1|||
23559894|NCT02487498|65779510|FG001|Period: Period 1|Lack of Efficacy|0|||
23559895|NCT02487498|65779509|FG000|Period: Period 1|Physician Decision|0|||
23559896|NCT02487498|65779510|FG001|Period: Period 1|Physician Decision|1|||
23559897|NCT02487498|65779509|FG000|Period: Period 1|Protocol deviation|1|||
23559898|NCT02487498|65779510|FG001|Period: Period 1|Protocol deviation|0|||
23559899|NCT02487498|65779509|FG000|Period: Washout|Subject/guardian decision|0|||
23559900|NCT02487498|65779510|FG001|Period: Washout|Subject/guardian decision|5|||
23559901|NCT02487498|65779509|FG000|Period: Washout|Lack of Efficacy|1|||
23559902|NCT02487498|65779510|FG001|Period: Washout|Lack of Efficacy|1|||
23559903|NCT02487498|65779509|FG000|Period: Washout|Physician Decision|1|||
23559904|NCT02487498|65779510|FG001|Period: Washout|Physician Decision|0|||
23559905|NCT02487498|65779509|FG000|Period: Washout|Non-compliance with study treatment|0|||
23559906|NCT02487498|65779510|FG001|Period: Washout|Non-compliance with study treatment|1|||
23559907|NCT02487498|65779509|FG000|Period: Period 2|Adverse Event|2|||
23559908|NCT02487498|65779510|FG001|Period: Period 2|Adverse Event|2|||
23559909|NCT02487498|65779509|FG000|Period: Period 2|Subject/guardian decision|2|||
23755474|NCT00435825|66484558|FG003|Overall Study|Did not enter follow-up|3|||
23559910|NCT02487498|65779510|FG001|Period: Period 2|Subject/guardian decision|1|||
23559911|NCT02487498|65779509|FG000|Period: Period 2|Lost to Follow-up|1|||
23755475|NCT00435825|66484555|FG000|Overall Study|Did not complete full follow-up period|6|||
23755476|NCT00435825|66484556|FG001|Overall Study|Did not complete full follow-up period|6|||
23559912|NCT02487498|65779510|FG001|Period: Period 2|Lost to Follow-up|1|||
23559913|NCT02487498|65779509|FG000|Period: Period 2|Death|0|||
23755477|NCT00435825|66484557|FG002|Overall Study|Did not complete full follow-up period|4|||
23755478|NCT00435825|66484558|FG003|Overall Study|Did not complete full follow-up period|5|||
23755479|NCT02367729|66484563|FG000|Overall Study|Organic disorder diagnosed|2|||
23755480|NCT02367729|66484564|FG001|Overall Study|Organic disorder diagnosed|1|||
23755481|NCT02367729|66484563|FG000|Overall Study|Adverse Event|1|||
23755482|NCT02367729|66484564|FG001|Overall Study|Adverse Event|2|||
23755483|NCT02367729|66484563|FG000|Overall Study|Withdrawal by Subject|0|||
23755484|NCT02367729|66484564|FG001|Overall Study|Withdrawal by Subject|5|||
23755485|NCT02729545|66484569|FG000|Overall Study|Pregnancy|1|||
23755486|NCT02729545|66484570|FG001|Overall Study|Pregnancy|1|||
23755487|NCT02729545|66484569|FG000|Overall Study|Lost to Follow-up|0|||
23755488|NCT02729545|66484570|FG001|Overall Study|Lost to Follow-up|1|||
23755489|NCT02729545|66484569|FG000|Overall Study|Withdrawal by Subject|2|||
23755490|NCT02729545|66484570|FG001|Overall Study|Withdrawal by Subject|3|||
23755491|NCT03151226|66484571|FG000|Overall Study|Withdrawal by Subject|2|||
23755492|NCT03151226|66484571|FG000|Overall Study|not wear device correctly|1|||
23755493|NCT00734617|66484572|FG000|Overall Study|Adverse Event|4|||
23755494|NCT00734617|66484573|FG001|Overall Study|Adverse Event|7|||
23755495|NCT00734617|66484572|FG000|Overall Study|Withdrawal by Subject|103|||
23755496|NCT00734617|66484573|FG001|Overall Study|Withdrawal by Subject|95|||
23755497|NCT01652573|66484578|FG000|Overall Study|Adverse Event|0|||
23755498|NCT01652573|66484579|FG001|Overall Study|Adverse Event|1|||
23755499|NCT02643394|66484580|FG000|Overall Study|Protocol Violation|4|||
23755500|NCT02643394|66484581|FG001|Overall Study|Protocol Violation|5|||
23755501|NCT03091400|66484592|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
23755502|NCT03091400|66484593|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
23755503|NCT00190684|66484594|FG000|Overall Study|Adverse Event|86|||
23755504|NCT00190684|66484594|FG000|Overall Study|Satisfactory response|80|||
23755505|NCT00190684|66484594|FG000|Overall Study|Lack of efficacy|204|||
23755506|NCT00190684|66484594|FG000|Overall Study|Lost to Follow-up|232|||
23755507|NCT00190684|66484594|FG000|Overall Study|Patient moved|60|||
23755508|NCT00190684|66484594|FG000|Overall Study|Patient Decision|432|||
23755509|NCT00190684|66484594|FG000|Overall Study|Clinical relapse|67|||
23755510|NCT00190684|66484594|FG000|Overall Study|Sponsor's decision|17|||
23755511|NCT00190684|66484594|FG000|Overall Study|Physician Decision|84|||
23755512|NCT00190684|66484594|FG000|Overall Study|Protocol Violation|123|||
23755513|NCT00190684|66484594|FG000|Overall Study|Study Period III Completed|103|||
23559914|NCT02487498|65779510|FG001|Period: Period 2|Death|1|||
23559915|NCT02487498|65779509|FG000|Period: Period 2|Physician Decision|1|||
23559916|NCT02487498|65779510|FG001|Period: Period 2|Physician Decision|0|||
23559917|NCT02238379|65779511|FG000|Overall Study|Lost to Follow-up|1|||
23559918|NCT02238379|65779512|FG001|Overall Study|Lost to Follow-up|0|||
23559919|NCT03645759|65779513|FG000|Overall Study|Lost to Follow-up|3|||
23559920|NCT03645759|65779514|FG001|Overall Study|Lost to Follow-up|2|||
23559921|NCT01127646|65779517|FG000|Overall Study|Entry Criteria Not Met|1|||
23559922|NCT01127646|65779518|FG001|Overall Study|Entry Criteria Not Met|0|||
23559923|NCT01127646|65779517|FG000|Overall Study|Protocol Violation|0|||
23559924|NCT01127646|65779518|FG001|Overall Study|Protocol Violation|1|||
23559925|NCT01564368|65779524|FG000|Overall Study|Ineligible|18|||
23559926|NCT01564368|65779524|FG000|Overall Study|Not Randomized in Parent study|116|||
23559927|NCT01564368|65779524|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
23559928|NCT01564368|65779524|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
23559929|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559930|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559931|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
23559932|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559933|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
23559934|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
23559935|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
23559936|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
23559937|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
23559938|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
23559939|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
23559940|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
23559941|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
23755514|NCT00190684|66484594|FG000|Overall Study|Study Period V Completed|1|||
23755515|NCT04380701|66484595|FG000|Overall Study|Pregnancy|0|||
23755516|NCT04380701|66484596|FG001|Overall Study|Pregnancy|0|||
23755517|NCT04380701|66484597|FG002|Overall Study|Pregnancy|0|||
23755518|NCT04380701|66484598|FG003|Overall Study|Pregnancy|0|||
23755519|NCT04380701|66484599|FG004|Overall Study|Pregnancy|0|||
23755520|NCT04380701|66484600|FG005|Overall Study|Pregnancy|0|||
23755521|NCT04380701|66484601|FG006|Overall Study|Pregnancy|0|||
23559942|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
23559943|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
23559944|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
23559945|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559946|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559947|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559948|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
23559949|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
23559950|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559951|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559952|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
23559953|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559954|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
23559955|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
23559956|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
23559957|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
23559958|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
23559959|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559960|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559961|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559962|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
23559963|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
23559964|NCT03002610|65779538|FG000|Overall Study|Withdrawal by Subject|6|||
23559965|NCT03002610|65779539|FG001|Overall Study|Withdrawal by Subject|25|||
23559966|NCT03002610|65779540|FG002|Overall Study|Withdrawal by Subject|13|||
23559967|NCT02160314|65779544|FG000|Overall Study|Adverse Event|0|||
23559968|NCT02160314|65779545|FG001|Overall Study|Adverse Event|6|||
23559969|NCT02160314|65779544|FG000|Overall Study|Protocol Violation|0|||
23559970|NCT02160314|65779545|FG001|Overall Study|Protocol Violation|4|||
23559971|NCT02160314|65779544|FG000|Overall Study|Withdrawal by Subject|1|||
23559972|NCT02160314|65779545|FG001|Overall Study|Withdrawal by Subject|2|||
23559973|NCT02160314|65779544|FG000|Overall Study|Lost to Follow-up|0|||
23559974|NCT02160314|65779545|FG001|Overall Study|Lost to Follow-up|1|||
23559975|NCT01820559|65779546|FG000|Overall Study|Adverse Event|4|||
23559976|NCT01820559|65779547|FG001|Overall Study|Adverse Event|6|||
23559977|NCT01820559|65779548|FG002|Overall Study|Adverse Event|13|||
23559978|NCT01820559|65779546|FG000|Overall Study|Withdrawal by Subject|1|||
23559979|NCT01820559|65779547|FG001|Overall Study|Withdrawal by Subject|2|||
23559980|NCT01820559|65779548|FG002|Overall Study|Withdrawal by Subject|5|||
23559981|NCT01820559|65779546|FG000|Overall Study|Protocol Violation|2|||
23559982|NCT01820559|65779547|FG001|Overall Study|Protocol Violation|1|||
23559983|NCT01820559|65779548|FG002|Overall Study|Protocol Violation|3|||
23559984|NCT01820559|65779546|FG000|Overall Study|Subject's non-compliance|1|||
23559985|NCT01820559|65779547|FG001|Overall Study|Subject's non-compliance|0|||
23559986|NCT01820559|65779548|FG002|Overall Study|Subject's non-compliance|2|||
23624483|NCT00983892|66011694|FG000|Overall Study|Withdrawal by Subject|10|||
23624484|NCT00983892|66011695|FG001|Overall Study|Withdrawal by Subject|12|||
23624485|NCT00934700|66011696|FG000|Overall Study|missing scan|5|||
23624486|NCT00934700|66011697|FG001|Overall Study|missing scan|9|||
23755522|NCT04380701|66484602|FG007|Overall Study|Pregnancy|0|||
23755523|NCT04380701|66484603|FG008|Overall Study|Pregnancy|0|||
23755524|NCT04380701|66484604|FG009|Overall Study|Pregnancy|0|||
23755525|NCT04380701|66484605|FG010|Overall Study|Pregnancy|0|||
23755526|NCT04380701|66484606|FG011|Overall Study|Pregnancy|0|||
23755527|NCT04380701|66484607|FG012|Overall Study|Pregnancy|0|||
23755528|NCT04380701|66484608|FG013|Overall Study|Pregnancy|0|||
23755529|NCT04380701|66484609|FG014|Overall Study|Pregnancy|0|||
23755530|NCT04380701|66484610|FG015|Overall Study|Pregnancy|0|||
23755531|NCT04380701|66484611|FG016|Overall Study|Pregnancy|0|||
23755532|NCT04380701|66484612|FG017|Overall Study|Pregnancy|0|||
23755533|NCT04380701|66484613|FG018|Overall Study|Pregnancy|0|||
23755534|NCT04380701|66484614|FG019|Overall Study|Pregnancy|0|||
23825900|NCT02413229|66741640|FG004|Overall Study|Lost to Follow-up|2|||
23825901|NCT02413229|66741641|FG005|Overall Study|Lost to Follow-up|0|||
23825902|NCT02413229|66741642|FG006|Overall Study|Lost to Follow-up|0|||
23825903|NCT02413229|66741643|FG007|Overall Study|Lost to Follow-up|0|||
23825904|NCT02413229|66741636|FG000|Overall Study|Withdrawal by Subject|1|||
23624487|NCT00934700|66011696|FG000|Overall Study|Death|8|||
23624488|NCT00934700|66011697|FG001|Overall Study|Death|3|||
23755535|NCT04380701|66484615|FG020|Overall Study|Pregnancy|0|||
23755536|NCT04380701|66484616|FG021|Overall Study|Pregnancy|0|||
23755537|NCT04380701|66484617|FG022|Overall Study|Pregnancy|0|||
23755538|NCT04380701|66484618|FG023|Overall Study|Pregnancy|0|||
23825905|NCT02413229|66741637|FG001|Overall Study|Withdrawal by Subject|1|||
23559987|NCT01820559|65779546|FG000|Overall Study|Lost to Follow-up|3|||
23559988|NCT01820559|65779547|FG001|Overall Study|Lost to Follow-up|2|||
23559989|NCT01820559|65779548|FG002|Overall Study|Lost to Follow-up|2|||
23559990|NCT01820559|65779546|FG000|Overall Study|At sponsor request|0|||
23559991|NCT01820559|65779547|FG001|Overall Study|At sponsor request|0|||
23559992|NCT01820559|65779548|FG002|Overall Study|At sponsor request|1|||
23559993|NCT01820559|65779546|FG000|Overall Study|Lack of Efficacy|3|||
23559994|NCT01820559|65779547|FG001|Overall Study|Lack of Efficacy|2|||
23559995|NCT01820559|65779548|FG002|Overall Study|Lack of Efficacy|3|||
23559996|NCT00437645|65779551|FG000|Overall Study|Adverse Event|15|||
23559997|NCT00437645|65779552|FG001|Overall Study|Adverse Event|84|||
23559998|NCT00437645|65779551|FG000|Overall Study|Withdrawal by Subject|10|||
23559999|NCT00437645|65779552|FG001|Overall Study|Withdrawal by Subject|22|||
23825906|NCT02413229|66741638|FG002|Overall Study|Withdrawal by Subject|0|||
23560000|NCT00437645|65779551|FG000|Overall Study|Protocol Violation|3|||
23560001|NCT00437645|65779552|FG001|Overall Study|Protocol Violation|3|||
23560002|NCT00437645|65779551|FG000|Overall Study|Lost to Follow-up|2|||
23560003|NCT00437645|65779552|FG001|Overall Study|Lost to Follow-up|3|||
23560004|NCT00437645|65779551|FG000|Overall Study|Administrative problems|2|||
23560005|NCT00437645|65779552|FG001|Overall Study|Administrative problems|1|||
23560006|NCT00437645|65779551|FG000|Overall Study|Lack of Efficacy|2|||
23560007|NCT00437645|65779552|FG001|Overall Study|Lack of Efficacy|1|||
23560008|NCT00437645|65779551|FG000|Overall Study|Condition no longer requires study drug|1|||
23825907|NCT02413229|66741639|FG003|Overall Study|Withdrawal by Subject|0|||
23825908|NCT02413229|66741640|FG004|Overall Study|Withdrawal by Subject|1|||
23825909|NCT02413229|66741641|FG005|Overall Study|Withdrawal by Subject|0|||
23825910|NCT02413229|66741642|FG006|Overall Study|Withdrawal by Subject|0|||
23825911|NCT02413229|66741643|FG007|Overall Study|Withdrawal by Subject|2|||
23825912|NCT02413229|66741636|FG000|Overall Study|Progressive Disease|0|||
23825913|NCT02413229|66741637|FG001|Overall Study|Progressive Disease|0|||
23825914|NCT02413229|66741638|FG002|Overall Study|Progressive Disease|0|||
23825915|NCT02413229|66741639|FG003|Overall Study|Progressive Disease|0|||
23825916|NCT02413229|66741640|FG004|Overall Study|Progressive Disease|0|||
23825917|NCT02413229|66741641|FG005|Overall Study|Progressive Disease|0|||
23825918|NCT02413229|66741642|FG006|Overall Study|Progressive Disease|0|||
23825919|NCT02413229|66741643|FG007|Overall Study|Progressive Disease|1|||
23825920|NCT03345420|66741648|FG000|Overall Study|Withdrawal by Subject|1|||
23825921|NCT03126435|66741649|FG000|Overall Study|Death|90|||
23825922|NCT03126435|66741650|FG001|Overall Study|Death|84|||
23825923|NCT03126435|66741649|FG000|Overall Study|Lost to Follow-up|4|||
23825924|NCT03126435|66741650|FG001|Overall Study|Lost to Follow-up|3|||
23825925|NCT03126435|66741649|FG000|Overall Study|Physician Decision|0|||
23825926|NCT03126435|66741650|FG001|Overall Study|Physician Decision|1|||
23825927|NCT03126435|66741649|FG000|Overall Study|Withdrawal by Subject|6|||
23825928|NCT03126435|66741650|FG001|Overall Study|Withdrawal by Subject|12|||
23825929|NCT03126435|66741649|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
23825930|NCT03126435|66741650|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
23825931|NCT00444587|66741651|FG000|Overall Study|Death|2|||
23825932|NCT00444587|66741652|FG001|Overall Study|Death|1|||
23825933|NCT00444587|66741651|FG000|Overall Study|Progression of the disease|73|||
23825934|NCT00444587|66741652|FG001|Overall Study|Progression of the disease|8|||
23825935|NCT00444587|66741651|FG000|Overall Study|Refused treatment/did not cooperate|4|||
23825936|NCT00444587|66741652|FG001|Overall Study|Refused treatment/did not cooperate|1|||
23825937|NCT00444587|66741651|FG000|Overall Study|Investigator decision|3|||
23560009|NCT00437645|65779552|FG001|Overall Study|Condition no longer requires study drug|1|||
23560010|NCT00508404|65779555|FG000|Overall Study|Ongoing at Data Cut-off|12|||
23560011|NCT00508404|65779555|FG000|Overall Study|Adverse Event|2|||
23825938|NCT00444587|66741652|FG001|Overall Study|Investigator decision|0|||
23825939|NCT00444587|66741651|FG000|Overall Study|Protocol Violation|1|||
23825940|NCT00444587|66741652|FG001|Overall Study|Protocol Violation|0|||
23560012|NCT00508404|65779555|FG000|Overall Study|Death|16|||
23825941|NCT00444587|66741651|FG000|Overall Study|Missing|0|||
23825942|NCT00444587|66741652|FG001|Overall Study|Missing|5|||
23825943|NCT01565707|66741653|FG000|Overall Study|Adverse Event|1|||
23825944|NCT01565707|66741654|FG001|Overall Study|Adverse Event|6|||
23825945|NCT01565707|66741655|FG002|Overall Study|Adverse Event|2|||
23825946|NCT01565707|66741656|FG003|Overall Study|Adverse Event|1|||
23825947|NCT01565707|66741653|FG000|Overall Study|Lost to Follow-up|1|||
23825948|NCT01565707|66741654|FG001|Overall Study|Lost to Follow-up|0|||
23825949|NCT01565707|66741655|FG002|Overall Study|Lost to Follow-up|0|||
23825950|NCT01565707|66741656|FG003|Overall Study|Lost to Follow-up|0|||
23825951|NCT01565707|66741653|FG000|Overall Study|Protocol Violation|1|||
23825952|NCT01565707|66741654|FG001|Overall Study|Protocol Violation|0|||
23825953|NCT01565707|66741655|FG002|Overall Study|Protocol Violation|0|||
23825954|NCT01565707|66741656|FG003|Overall Study|Protocol Violation|1|||
23825955|NCT01565707|66741653|FG000|Overall Study|Withdrawal by Subject|3|||
23825956|NCT01565707|66741654|FG001|Overall Study|Withdrawal by Subject|1|||
23825957|NCT01565707|66741655|FG002|Overall Study|Withdrawal by Subject|1|||
23825958|NCT01565707|66741656|FG003|Overall Study|Withdrawal by Subject|1|||
23825959|NCT01565707|66741653|FG000|Overall Study|Randomized but not evaluable|2|||
23825960|NCT01565707|66741654|FG001|Overall Study|Randomized but not evaluable|0|||
23825961|NCT01565707|66741655|FG002|Overall Study|Randomized but not evaluable|0|||
23825962|NCT01565707|66741656|FG003|Overall Study|Randomized but not evaluable|0|||
23825963|NCT01565707|66741653|FG000|Overall Study|Miscellaneous|1|||
23825964|NCT01565707|66741654|FG001|Overall Study|Miscellaneous|1|||
23825965|NCT01565707|66741655|FG002|Overall Study|Miscellaneous|0|||
23560013|NCT00508404|65779555|FG000|Overall Study|Physician Decision|2|||
23560014|NCT00508404|65779555|FG000|Overall Study|Withdrawal by Subject|3|||
23560015|NCT00508404|65779555|FG000|Overall Study|Protocol-specified Criteria|2|||
23560016|NCT00508404|65779555|FG000|Overall Study|Lost to Follow-up|2|||
23560017|NCT00508404|65779555|FG000|Overall Study|Other - Not Specified|3|||
23560018|NCT00840801|65779556|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
23560019|NCT00840801|65779557|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
23560020|NCT00840801|65779558|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
23825966|NCT01565707|66741656|FG003|Overall Study|Miscellaneous|2|||
23560021|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
23825967|NCT04542057|66741657|FG000|Overall Study|Death|3|||
23825968|NCT04542057|66741658|FG001|Overall Study|Death|1|||
23825969|NCT04542057|66741657|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
23825970|NCT04542057|66741658|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
23825971|NCT04542057|66741657|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
23825972|NCT04542057|66741658|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
23825973|NCT04542057|66741657|FG000|Overall Study|Adverse Event|15|||
23825974|NCT04542057|66741658|FG001|Overall Study|Adverse Event|6|||
23825975|NCT04542057|66741657|FG000|Overall Study|COVID-19 adverse event|6|||
23825976|NCT04542057|66741658|FG001|Overall Study|COVID-19 adverse event|4|||
23825977|NCT04542057|66741657|FG000|Overall Study|Lack of Efficacy|2|||
23825978|NCT04542057|66741658|FG001|Overall Study|Lack of Efficacy|5|||
23825979|NCT04542057|66741657|FG000|Overall Study|Study terminated by sponsor|1|||
23825980|NCT04542057|66741658|FG001|Overall Study|Study terminated by sponsor|0|||
23825981|NCT04542057|66741657|FG000|Overall Study|Investigator discretion|2|||
23825982|NCT04542057|66741658|FG001|Overall Study|Investigator discretion|1|||
23825983|NCT04542057|66741657|FG000|Overall Study|Withdrawal by Subject|52|||
23825984|NCT04542057|66741658|FG001|Overall Study|Withdrawal by Subject|30|||
23825985|NCT04542057|66741657|FG000|Overall Study|Lost to Follow-up|8|||
23825986|NCT04542057|66741658|FG001|Overall Study|Lost to Follow-up|11|||
23825987|NCT04542057|66741657|FG000|Overall Study|Other|2|||
23825988|NCT04542057|66741658|FG001|Overall Study|Other|2|||
23825989|NCT03410056|66741661|FG000|Overall Study|Decision by Sponsor|0|||
23825990|NCT03410056|66741662|FG001|Overall Study|Decision by Sponsor|0|||
23825991|NCT03410056|66741663|FG002|Overall Study|Decision by Sponsor|3|||
23825992|NCT03410056|66741664|FG003|Overall Study|Decision by Sponsor|0|||
23560022|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
23624489|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
23624490|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
23825993|NCT03410056|66741665|FG004|Overall Study|Decision by Sponsor|0|||
23825994|NCT03410056|66741666|FG005|Overall Study|Decision by Sponsor|0|||
23825995|NCT03410056|66741667|FG006|Overall Study|Decision by Sponsor|0|||
23825996|NCT03410056|66741661|FG000|Overall Study|Withdrawal by Subject|0|||
23825997|NCT03410056|66741662|FG001|Overall Study|Withdrawal by Subject|2|||
23825998|NCT03410056|66741663|FG002|Overall Study|Withdrawal by Subject|5|||
23825999|NCT03410056|66741664|FG003|Overall Study|Withdrawal by Subject|5|||
23826000|NCT03410056|66741665|FG004|Overall Study|Withdrawal by Subject|0|||
23826001|NCT03410056|66741666|FG005|Overall Study|Withdrawal by Subject|0|||
23826002|NCT03410056|66741667|FG006|Overall Study|Withdrawal by Subject|0|||
23826003|NCT02755649|66741671|FG000|Overall Study|Transitioned into OLE study|99|||
23826004|NCT02755649|66741672|FG001|Overall Study|Transitioned into OLE study|98|||
23826005|NCT02755649|66741673|FG002|Overall Study|Transitioned into OLE study|100|||
23826006|NCT02755649|66741671|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
23826007|NCT02755649|66741672|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
23826008|NCT02755649|66741673|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
23826009|NCT02755649|66741671|FG000|Overall Study|Physician Decision|0|||
23826010|NCT02755649|66741672|FG001|Overall Study|Physician Decision|0|||
23826011|NCT02755649|66741673|FG002|Overall Study|Physician Decision|2|||
23826012|NCT02755649|66741671|FG000|Overall Study|Withdrawal by Subject|0|||
23826013|NCT02755649|66741672|FG001|Overall Study|Withdrawal by Subject|1|||
23826014|NCT02755649|66741673|FG002|Overall Study|Withdrawal by Subject|0|||
23826015|NCT02755649|66741671|FG000|Overall Study|Undecided|1|||
23826016|NCT02755649|66741672|FG001|Overall Study|Undecided|0|||
23826017|NCT02755649|66741673|FG002|Overall Study|Undecided|0|||
23826018|NCT00378573|66741674|FG000|Treatment Period|Adverse Event|9|||
23826019|NCT00378573|66741674|FG000|Treatment Period|Physician Decision|1|||
23826020|NCT00378573|66741674|FG000|Treatment Period|Withdrawal by Subject|2|||
23826021|NCT00378573|66741674|FG000|Treatment Period|Disease Progression|4|||
23826022|NCT00378573|66741674|FG000|Treatment Period|Sponsor decision to close study|1|||
23826023|NCT00378573|66741674|FG000|Follow-up|Death|12|||
23826024|NCT00378573|66741674|FG000|Follow-up|Lost to Follow-up|1|||
23755539|NCT04380701|66484619|FG024|Overall Study|Pregnancy|0|||
23755540|NCT04380701|66484620|FG025|Overall Study|Pregnancy|0|||
23755541|NCT04380701|66484621|FG026|Overall Study|Pregnancy|0|||
23755542|NCT04380701|66484622|FG027|Overall Study|Pregnancy|0|||
23755543|NCT04380701|66484623|FG028|Overall Study|Pregnancy|0|||
23755544|NCT04380701|66484624|FG029|Overall Study|Pregnancy|0|||
23755545|NCT04380701|66484625|FG030|Overall Study|Pregnancy|0|||
23755546|NCT04380701|66484626|FG031|Overall Study|Pregnancy|0|||
23755547|NCT04380701|66484627|FG032|Overall Study|Pregnancy|1|||
23755548|NCT04380701|66484628|FG033|Overall Study|Pregnancy|0|||
23755549|NCT04380701|66484595|FG000|Overall Study|Lost to Follow-up|0|||
23755550|NCT04380701|66484596|FG001|Overall Study|Lost to Follow-up|0|||
23755551|NCT04380701|66484597|FG002|Overall Study|Lost to Follow-up|0|||
23755552|NCT04380701|66484598|FG003|Overall Study|Lost to Follow-up|0|||
23755553|NCT04380701|66484599|FG004|Overall Study|Lost to Follow-up|0|||
23755554|NCT04380701|66484600|FG005|Overall Study|Lost to Follow-up|0|||
23755555|NCT04380701|66484601|FG006|Overall Study|Lost to Follow-up|0|||
23755556|NCT04380701|66484602|FG007|Overall Study|Lost to Follow-up|0|||
23755557|NCT04380701|66484603|FG008|Overall Study|Lost to Follow-up|0|||
23755558|NCT04380701|66484604|FG009|Overall Study|Lost to Follow-up|0|||
23755559|NCT04380701|66484605|FG010|Overall Study|Lost to Follow-up|0|||
23755560|NCT04380701|66484606|FG011|Overall Study|Lost to Follow-up|0|||
23755561|NCT04380701|66484607|FG012|Overall Study|Lost to Follow-up|0|||
23755562|NCT04380701|66484608|FG013|Overall Study|Lost to Follow-up|0|||
23755563|NCT04380701|66484609|FG014|Overall Study|Lost to Follow-up|0|||
23755564|NCT04380701|66484610|FG015|Overall Study|Lost to Follow-up|0|||
23755565|NCT04380701|66484611|FG016|Overall Study|Lost to Follow-up|0|||
23755566|NCT04380701|66484612|FG017|Overall Study|Lost to Follow-up|0|||
23755567|NCT04380701|66484613|FG018|Overall Study|Lost to Follow-up|0|||
23755568|NCT04380701|66484614|FG019|Overall Study|Lost to Follow-up|0|||
23755569|NCT04380701|66484615|FG020|Overall Study|Lost to Follow-up|1|||
23755570|NCT04380701|66484616|FG021|Overall Study|Lost to Follow-up|0|||
23755571|NCT04380701|66484617|FG022|Overall Study|Lost to Follow-up|0|||
23560023|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
23560024|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
23560025|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
23560026|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
23560027|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
23560028|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
23560029|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
23560030|NCT05056870|65779559|FG000|Period 1|Site COVID-19 Related|3|||
23560031|NCT05056870|65779560|FG001|Period 1|Site COVID-19 Related|3|||
23560032|NCT05056870|65779559|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
23560033|NCT05056870|65779560|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
23560034|NCT05056870|65779559|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
23560035|NCT05056870|65779560|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
23560036|NCT05056870|65779559|FG000|Period 2|COVID-19 Related|1|||
23560037|NCT05056870|65779560|FG001|Period 2|COVID-19 Related|0|||
23560038|NCT05056870|65779559|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23560039|NCT05056870|65779560|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23560040|NCT01699022|65779561|FG000|Overall Study|Early discontinuation from the study|3|||
23560041|NCT00736489|65779562|FG000|Period 1|Lost to Follow-up|1|||
23560042|NCT00736489|65779563|FG001|Period 1|Lost to Follow-up|0|||
23560043|NCT00736489|65779564|FG002|Period 1|Lost to Follow-up|0|||
23560044|NCT00736489|65779565|FG003|Period 1|Lost to Follow-up|0|||
23560045|NCT00736489|65779566|FG004|Period 1|Lost to Follow-up|0|||
23560046|NCT00736489|65779567|FG005|Period 1|Lost to Follow-up|0|||
23560047|NCT00736489|65779562|FG000|Period 1|Withdrawal by Subject|0|||
23560048|NCT00736489|65779563|FG001|Period 1|Withdrawal by Subject|0|||
23560049|NCT00736489|65779564|FG002|Period 1|Withdrawal by Subject|0|||
23560050|NCT00736489|65779565|FG003|Period 1|Withdrawal by Subject|0|||
23560051|NCT00736489|65779566|FG004|Period 1|Withdrawal by Subject|0|||
23560052|NCT00736489|65779567|FG005|Period 1|Withdrawal by Subject|1|||
23560053|NCT00509236|65779568|FG000|Overall Study|Adverse Event|7|||
23560054|NCT00509236|65779569|FG001|Overall Study|Adverse Event|9|||
23560055|NCT00509236|65779568|FG000|Overall Study|Withdrawal by Subject|5|||
23560056|NCT00509236|65779569|FG001|Overall Study|Withdrawal by Subject|10|||
23560057|NCT00509236|65779568|FG000|Overall Study|Protocol Violation|3|||
23560058|NCT00509236|65779569|FG001|Overall Study|Protocol Violation|0|||
23755572|NCT04380701|66484618|FG023|Overall Study|Lost to Follow-up|1|||
23755573|NCT04380701|66484619|FG024|Overall Study|Lost to Follow-up|0|||
23755574|NCT04380701|66484620|FG025|Overall Study|Lost to Follow-up|0|||
23755575|NCT04380701|66484621|FG026|Overall Study|Lost to Follow-up|0|||
23755576|NCT04380701|66484622|FG027|Overall Study|Lost to Follow-up|0|||
23755577|NCT04380701|66484623|FG028|Overall Study|Lost to Follow-up|0|||
23755578|NCT04380701|66484624|FG029|Overall Study|Lost to Follow-up|1|||
23755579|NCT04380701|66484625|FG030|Overall Study|Lost to Follow-up|0|||
23755580|NCT04380701|66484626|FG031|Overall Study|Lost to Follow-up|0|||
23560059|NCT00509236|65779568|FG000|Overall Study|Excluded Medication|1|||
23560060|NCT00509236|65779569|FG001|Overall Study|Excluded Medication|1|||
23560061|NCT00509236|65779568|FG000|Overall Study|Scheduled Kidney Transplant|1|||
23560062|NCT00509236|65779569|FG001|Overall Study|Scheduled Kidney Transplant|0|||
23560063|NCT01778556|65779570|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
23560064|NCT01778556|65779571|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
23560065|NCT01778556|65779570|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23560066|NCT01778556|65779571|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
23560067|NCT01778556|65779570|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
23560068|NCT01778556|65779571|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
23560069|NCT01778556|65779570|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
23560070|NCT01778556|65779571|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
23560071|NCT03108157|65779572|FG000|Overall Study|Protocol Violation|15|||
23755581|NCT04380701|66484627|FG032|Overall Study|Lost to Follow-up|0|||
23755582|NCT04380701|66484628|FG033|Overall Study|Lost to Follow-up|1|||
23755583|NCT04380701|66484595|FG000|Overall Study|Private reason(s)|0|||
23755584|NCT04380701|66484596|FG001|Overall Study|Private reason(s)|0|||
23826025|NCT00378573|66741674|FG000|Follow-up|Withdrawal by Subject|1|||
23826026|NCT03066258|66741675|FG000|Overall Study|Death|1|||
23826027|NCT03066258|66741676|FG001|Overall Study|Death|0|||
23826028|NCT03066258|66741677|FG002|Overall Study|Death|0|||
23826029|NCT03066258|66741678|FG003|Overall Study|Death|0|||
23826030|NCT03066258|66741679|FG004|Overall Study|Death|1|||
23826031|NCT02635984|66741680|FG000|Overall Study|Lost to Follow-up|2|||
23826032|NCT02635984|66741681|FG001|Overall Study|Lost to Follow-up|4|||
23826033|NCT02635984|66741680|FG000|Overall Study|Study Arm Closed|1|||
23826034|NCT02635984|66741681|FG001|Overall Study|Study Arm Closed|0|||
23755585|NCT04380701|66484597|FG002|Overall Study|Private reason(s)|0|||
23755586|NCT04380701|66484598|FG003|Overall Study|Private reason(s)|0|||
23755587|NCT04380701|66484599|FG004|Overall Study|Private reason(s)|0|||
23755588|NCT04380701|66484600|FG005|Overall Study|Private reason(s)|0|||
23755589|NCT04380701|66484601|FG006|Overall Study|Private reason(s)|1|||
23755590|NCT04380701|66484602|FG007|Overall Study|Private reason(s)|0|||
23560072|NCT03108157|65779573|FG001|Overall Study|Protocol Violation|4|||
23826035|NCT02286843|66745015|FG000|Overall Study|Not Treated|4|||
23560073|NCT01965938|65779587|FG000|Overall Study|Withdrawal by Subject|1|||
23560074|NCT01965938|65779588|FG001|Overall Study|Withdrawal by Subject|0|||
23560075|NCT05050578|65779590|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
23560076|NCT05050578|65779591|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
23755591|NCT04380701|66484603|FG008|Overall Study|Private reason(s)|1|||
23755592|NCT04380701|66484604|FG009|Overall Study|Private reason(s)|1|||
23755593|NCT04380701|66484605|FG010|Overall Study|Private reason(s)|0|||
23755594|NCT04380701|66484606|FG011|Overall Study|Private reason(s)|0|||
23755595|NCT04380701|66484607|FG012|Overall Study|Private reason(s)|0|||
23755596|NCT04380701|66484608|FG013|Overall Study|Private reason(s)|0|||
23755597|NCT04380701|66484609|FG014|Overall Study|Private reason(s)|0|||
23755598|NCT04380701|66484610|FG015|Overall Study|Private reason(s)|0|||
23755599|NCT04380701|66484611|FG016|Overall Study|Private reason(s)|0|||
23755600|NCT04380701|66484612|FG017|Overall Study|Private reason(s)|0|||
23826036|NCT02286843|66745015|FG000|Overall Study|Protocol Violation|1|||
23826037|NCT02286843|66745015|FG000|Overall Study|Withdrawal by Subject|1|||
23560077|NCT05050578|65779590|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
23560078|NCT05050578|65779591|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
23560079|NCT05050578|65779590|FG000|Period 2, 30 Days|Protocol Violation|0|||
23560080|NCT05050578|65779591|FG001|Period 2, 30 Days|Protocol Violation|1|||
23826038|NCT00711243|66745018|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
23826039|NCT00711243|66745019|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
23560081|NCT00800202|65779592|FG000|Overall Study|Adverse Event|7|||
23560082|NCT00800202|65779593|FG001|Overall Study|Adverse Event|6|||
23560083|NCT00800202|65779592|FG000|Overall Study|Death|1|||
23560084|NCT00800202|65779593|FG001|Overall Study|Death|0|||
23560085|NCT00800202|65779592|FG000|Overall Study|Other|5|||
23560086|NCT00800202|65779593|FG001|Overall Study|Other|0|||
23560087|NCT00800202|65779592|FG000|Overall Study|Disease Progression|54|||
23826040|NCT00711243|66745020|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
23826041|NCT00711243|66745021|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
23826042|NCT00711243|66745022|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
23826043|NCT00711243|66745023|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
23826044|NCT00711243|66745018|FG000|Reached First Response/4 Cycles|Death|0|||
23826045|NCT00711243|66745019|FG001|Reached First Response/4 Cycles|Death|0|||
23826046|NCT00711243|66745020|FG002|Reached First Response/4 Cycles|Death|0|||
23437841|NCT01320202|65344225|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
23560088|NCT00800202|65779593|FG001|Overall Study|Disease Progression|18|||
23755601|NCT04380701|66484613|FG018|Overall Study|Private reason(s)|0|||
23755602|NCT04380701|66484614|FG019|Overall Study|Private reason(s)|0|||
23755603|NCT04380701|66484615|FG020|Overall Study|Private reason(s)|0|||
23755604|NCT04380701|66484616|FG021|Overall Study|Private reason(s)|0|||
23755605|NCT04380701|66484617|FG022|Overall Study|Private reason(s)|0|||
23755606|NCT04380701|66484618|FG023|Overall Study|Private reason(s)|1|||
23437842|NCT01320202|65344226|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
23437843|NCT01320202|65344225|FG000|Overall Study|kidney transplant|1|||
23437844|NCT01320202|65344226|FG001|Overall Study|kidney transplant|2|||
23437845|NCT01320202|65344225|FG000|Overall Study|blood transfusion|1|||
23437846|NCT01320202|65344226|FG001|Overall Study|blood transfusion|7|||
23437847|NCT01320202|65344225|FG000|Overall Study|moved/changed dialysis|5|||
23437848|NCT01320202|65344226|FG001|Overall Study|moved/changed dialysis|2|||
23437849|NCT01320202|65344225|FG000|Overall Study|sponsor request|2|||
23437850|NCT01320202|65344226|FG001|Overall Study|sponsor request|0|||
23437851|NCT01320202|65344225|FG000|Overall Study|ineligible|3|||
23437852|NCT01320202|65344226|FG001|Overall Study|ineligible|0|||
23437853|NCT01320202|65344225|FG000|Overall Study|regained renal function|1|||
23437854|NCT01320202|65344226|FG001|Overall Study|regained renal function|0|||
23560089|NCT00991341|65779597|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
23560090|NCT00991341|65779598|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
23560091|NCT00991341|65779597|FG000|Overall Study|Death|3|||
23560092|NCT00991341|65779598|FG001|Overall Study|Death|0|||
23560093|NCT00991341|65779597|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
23560094|NCT00991341|65779598|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
23560095|NCT00991341|65779597|FG000|Overall Study|Physician Decision|1|||
23755607|NCT04380701|66484619|FG024|Overall Study|Private reason(s)|0|||
23755608|NCT04380701|66484620|FG025|Overall Study|Private reason(s)|0|||
23755609|NCT04380701|66484621|FG026|Overall Study|Private reason(s)|0|||
23755610|NCT04380701|66484622|FG027|Overall Study|Private reason(s)|0|||
23755611|NCT04380701|66484623|FG028|Overall Study|Private reason(s)|0|||
23755612|NCT04380701|66484624|FG029|Overall Study|Private reason(s)|1|||
23755613|NCT04380701|66484625|FG030|Overall Study|Private reason(s)|0|||
23755614|NCT04380701|66484626|FG031|Overall Study|Private reason(s)|0|||
23755615|NCT04380701|66484627|FG032|Overall Study|Private reason(s)|0|||
23755616|NCT04380701|66484628|FG033|Overall Study|Private reason(s)|0|||
23755617|NCT04380701|66484595|FG000|Overall Study|Withdrawal by Subject|0|||
23755618|NCT04380701|66484596|FG001|Overall Study|Withdrawal by Subject|0|||
23755619|NCT04380701|66484597|FG002|Overall Study|Withdrawal by Subject|0|||
23755620|NCT04380701|66484598|FG003|Overall Study|Withdrawal by Subject|0|||
23755621|NCT04380701|66484599|FG004|Overall Study|Withdrawal by Subject|0|||
23755622|NCT04380701|66484600|FG005|Overall Study|Withdrawal by Subject|0|||
23755623|NCT04380701|66484601|FG006|Overall Study|Withdrawal by Subject|1|||
23755624|NCT04380701|66484602|FG007|Overall Study|Withdrawal by Subject|1|||
23755625|NCT04380701|66484603|FG008|Overall Study|Withdrawal by Subject|0|||
23755626|NCT04380701|66484604|FG009|Overall Study|Withdrawal by Subject|0|||
23755627|NCT04380701|66484605|FG010|Overall Study|Withdrawal by Subject|0|||
23755628|NCT04380701|66484606|FG011|Overall Study|Withdrawal by Subject|1|||
23755629|NCT04380701|66484607|FG012|Overall Study|Withdrawal by Subject|0|||
23755630|NCT04380701|66484608|FG013|Overall Study|Withdrawal by Subject|1|||
23755631|NCT04380701|66484609|FG014|Overall Study|Withdrawal by Subject|0|||
23755632|NCT04380701|66484610|FG015|Overall Study|Withdrawal by Subject|0|||
23826047|NCT00711243|66745021|FG003|Reached First Response/4 Cycles|Death|0|||
23437855|NCT03088813|65344232|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437856|NCT03088813|65344233|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
23437857|NCT03088813|65344234|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437858|NCT03088813|65344235|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437859|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23437860|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23437861|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
23437862|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23560096|NCT00991341|65779598|FG001|Overall Study|Physician Decision|2|||
23560097|NCT00991341|65779597|FG000|Overall Study|Withdrawal by Subject|3|||
23560098|NCT00991341|65779598|FG001|Overall Study|Withdrawal by Subject|4|||
23560099|NCT00514683|65779599|FG000|Overall Study|Not treated|2|||
23560100|NCT00514683|65779600|FG001|Overall Study|Not treated|1|||
23560101|NCT00514683|65779601|FG002|Overall Study|Not treated|0|||
23560102|NCT00514683|65779602|FG003|Overall Study|Not treated|0|||
23437863|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
23560103|NCT00514683|65779603|FG004|Overall Study|Not treated|1|||
23755633|NCT04380701|66484611|FG016|Overall Study|Withdrawal by Subject|1|||
23755634|NCT04380701|66484612|FG017|Overall Study|Withdrawal by Subject|0|||
23437864|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
23560104|NCT00514683|65779599|FG000|Overall Study|Adverse Event|21|||
23560105|NCT00514683|65779600|FG001|Overall Study|Adverse Event|20|||
23560106|NCT00514683|65779601|FG002|Overall Study|Adverse Event|15|||
23755635|NCT04380701|66484613|FG018|Overall Study|Withdrawal by Subject|0|||
23755636|NCT04380701|66484614|FG019|Overall Study|Withdrawal by Subject|0|||
23755637|NCT04380701|66484615|FG020|Overall Study|Withdrawal by Subject|0|||
23755638|NCT04380701|66484616|FG021|Overall Study|Withdrawal by Subject|0|||
23437865|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
23437866|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
23437867|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
23437868|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
23755639|NCT04380701|66484617|FG022|Overall Study|Withdrawal by Subject|2|||
23755640|NCT04380701|66484618|FG023|Overall Study|Withdrawal by Subject|2|||
23755641|NCT04380701|66484619|FG024|Overall Study|Withdrawal by Subject|1|||
23755642|NCT04380701|66484620|FG025|Overall Study|Withdrawal by Subject|1|||
23755643|NCT04380701|66484621|FG026|Overall Study|Withdrawal by Subject|0|||
23755644|NCT04380701|66484622|FG027|Overall Study|Withdrawal by Subject|0|||
23755645|NCT04380701|66484623|FG028|Overall Study|Withdrawal by Subject|0|||
23755646|NCT04380701|66484624|FG029|Overall Study|Withdrawal by Subject|0|||
23437869|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
23437870|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
23437871|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
23437872|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
23437873|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
23437874|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
23437875|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23437876|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23755647|NCT04380701|66484625|FG030|Overall Study|Withdrawal by Subject|0|||
23755648|NCT04380701|66484626|FG031|Overall Study|Withdrawal by Subject|0|||
23755649|NCT04380701|66484627|FG032|Overall Study|Withdrawal by Subject|0|||
23755650|NCT04380701|66484628|FG033|Overall Study|Withdrawal by Subject|0|||
23755651|NCT04380701|66484595|FG000|Overall Study|Adverse Event|0|||
23755652|NCT04380701|66484596|FG001|Overall Study|Adverse Event|0|||
23755653|NCT04380701|66484597|FG002|Overall Study|Adverse Event|0|||
23755654|NCT04380701|66484598|FG003|Overall Study|Adverse Event|0|||
23755655|NCT04380701|66484599|FG004|Overall Study|Adverse Event|0|||
23755656|NCT04380701|66484600|FG005|Overall Study|Adverse Event|1|||
23755657|NCT04380701|66484601|FG006|Overall Study|Adverse Event|0|||
23755658|NCT04380701|66484602|FG007|Overall Study|Adverse Event|0|||
23755659|NCT04380701|66484603|FG008|Overall Study|Adverse Event|0|||
23755660|NCT04380701|66484604|FG009|Overall Study|Adverse Event|0|||
23755661|NCT04380701|66484605|FG010|Overall Study|Adverse Event|0|||
23755662|NCT04380701|66484606|FG011|Overall Study|Adverse Event|0|||
23755663|NCT04380701|66484607|FG012|Overall Study|Adverse Event|0|||
23755664|NCT04380701|66484608|FG013|Overall Study|Adverse Event|0|||
23437877|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23437878|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
23437879|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437880|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437881|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
23437882|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437883|NCT03172130|65344238|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
23437884|NCT03172130|65344239|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
23437885|NCT03997825|65344241|FG000|Overall Study|Death|3|||
23437886|NCT03997825|65344241|FG000|Overall Study|Lost to Follow-up|10|||
23437887|NCT03997825|65344241|FG000|Overall Study|Withdrawal by Subject|3|||
23437888|NCT03997825|65344241|FG000|Overall Study|Refused participation|1|||
23437889|NCT01123395|65344242|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
23437890|NCT01123395|65344243|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
23437891|NCT04407234|65344244|FG000|Overall Study|Adverse Event|3|||
23437892|NCT04407234|65344245|FG001|Overall Study|Adverse Event|3|||
23437893|NCT00861471|65344249|FG000|Overall Study|Withdrawal by Subject|1|||
23437894|NCT00861471|65344249|FG000|Overall Study|Adverse Event|2|||
23437895|NCT00861471|65344249|FG000|Overall Study|Lack of Efficacy|3|||
23437896|NCT00861471|65344249|FG000|Overall Study|treatment for lumbar laminectomy|1|||
23437897|NCT00861471|65344249|FG000|Overall Study|Physician Decision|2|||
23437898|NCT00828750|65344250|FG000|Overall Study|Lack of Efficacy|3|||
23437899|NCT00828750|65344250|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
23437900|NCT00064792|65344251|FG000|Overall Study|Withdrawal by Subject|2|||
23437901|NCT00064792|65344252|FG001|Overall Study|Withdrawal by Subject|0|||
23560107|NCT00514683|65779602|FG003|Overall Study|Adverse Event|13|||
23755665|NCT04380701|66484609|FG014|Overall Study|Adverse Event|0|||
23437902|NCT00064792|65344251|FG000|Overall Study|Adverse Event|3|||
23755666|NCT04380701|66484610|FG015|Overall Study|Adverse Event|1|||
23755667|NCT04380701|66484611|FG016|Overall Study|Adverse Event|0|||
23755668|NCT04380701|66484612|FG017|Overall Study|Adverse Event|0|||
23755669|NCT04380701|66484613|FG018|Overall Study|Adverse Event|0|||
23755670|NCT04380701|66484614|FG019|Overall Study|Adverse Event|1|||
23437903|NCT00064792|65344252|FG001|Overall Study|Adverse Event|0|||
23437904|NCT00250276|65344253|FG000|Overall Study|Serious Adverse Event|0|||
23755671|NCT04380701|66484615|FG020|Overall Study|Adverse Event|0|||
23755672|NCT04380701|66484616|FG021|Overall Study|Adverse Event|0|||
23437905|NCT00250276|65344254|FG001|Overall Study|Serious Adverse Event|0|||
23437906|NCT00250276|65344255|FG002|Overall Study|Serious Adverse Event|1|||
23437907|NCT00250276|65344256|FG003|Overall Study|Serious Adverse Event|0|||
23437908|NCT00250276|65344253|FG000|Overall Study|Non-serious Adverse Event|2|||
23437909|NCT00250276|65344254|FG001|Overall Study|Non-serious Adverse Event|0|||
23437910|NCT00250276|65344255|FG002|Overall Study|Non-serious Adverse Event|0|||
23437911|NCT00250276|65344256|FG003|Overall Study|Non-serious Adverse Event|2|||
23437912|NCT00250276|65344253|FG000|Overall Study|Protocol Violation|0|||
23437913|NCT00250276|65344254|FG001|Overall Study|Protocol Violation|1|||
23437914|NCT00250276|65344255|FG002|Overall Study|Protocol Violation|0|||
23437915|NCT00250276|65344256|FG003|Overall Study|Protocol Violation|0|||
23437916|NCT00250276|65344253|FG000|Overall Study|Withdrawal by Subject|1|||
23437917|NCT00250276|65344254|FG001|Overall Study|Withdrawal by Subject|2|||
23437918|NCT00250276|65344255|FG002|Overall Study|Withdrawal by Subject|3|||
23437919|NCT00250276|65344256|FG003|Overall Study|Withdrawal by Subject|2|||
23437920|NCT00250276|65344253|FG000|Overall Study|Migrated/moved from study area|3|||
23437921|NCT00250276|65344254|FG001|Overall Study|Migrated/moved from study area|0|||
23437922|NCT00250276|65344255|FG002|Overall Study|Migrated/moved from study area|2|||
23437923|NCT00250276|65344256|FG003|Overall Study|Migrated/moved from study area|7|||
23437924|NCT00250276|65344253|FG000|Overall Study|Lost to Follow-up|11|||
23437925|NCT00250276|65344254|FG001|Overall Study|Lost to Follow-up|18|||
23437926|NCT00250276|65344255|FG002|Overall Study|Lost to Follow-up|13|||
23437927|NCT00250276|65344256|FG003|Overall Study|Lost to Follow-up|8|||
23437928|NCT01832532|65344258|FG000|Overall Study|Withdrawal by Subject|5|||
23437929|NCT01832532|65344259|FG001|Overall Study|Withdrawal by Subject|2|||
23437930|NCT00999518|65344265|FG000|Overall Study|Adverse Event|1|||
23437931|NCT00999518|65344266|FG001|Overall Study|Adverse Event|6|||
23437932|NCT00999518|65344267|FG002|Overall Study|Adverse Event|3|||
23437933|NCT00999518|65344268|FG003|Overall Study|Adverse Event|1|||
23437934|NCT00999518|65344269|FG004|Overall Study|Adverse Event|2|||
23437935|NCT00999518|65344265|FG000|Overall Study|Lack of Efficacy|2|||
23437936|NCT00999518|65344266|FG001|Overall Study|Lack of Efficacy|0|||
23437937|NCT00999518|65344267|FG002|Overall Study|Lack of Efficacy|0|||
23437938|NCT00999518|65344268|FG003|Overall Study|Lack of Efficacy|2|||
23437939|NCT00999518|65344269|FG004|Overall Study|Lack of Efficacy|2|||
23437940|NCT00999518|65344265|FG000|Overall Study|Lost to Follow-up|0|||
23437941|NCT00999518|65344266|FG001|Overall Study|Lost to Follow-up|0|||
23437942|NCT00999518|65344267|FG002|Overall Study|Lost to Follow-up|0|||
23437943|NCT00999518|65344268|FG003|Overall Study|Lost to Follow-up|4|||
23437944|NCT00999518|65344269|FG004|Overall Study|Lost to Follow-up|1|||
23437945|NCT00999518|65344265|FG000|Overall Study|Did not meet entrance criteria|0|||
23437946|NCT00999518|65344266|FG001|Overall Study|Did not meet entrance criteria|0|||
23560108|NCT00514683|65779603|FG004|Overall Study|Adverse Event|27|||
23560109|NCT00514683|65779599|FG000|Overall Study|Protocol Violation|1|||
23560110|NCT00514683|65779600|FG001|Overall Study|Protocol Violation|1|||
23560111|NCT00514683|65779601|FG002|Overall Study|Protocol Violation|0|||
23755673|NCT04380701|66484617|FG022|Overall Study|Adverse Event|0|||
23755674|NCT04380701|66484618|FG023|Overall Study|Adverse Event|0|||
23755675|NCT04380701|66484619|FG024|Overall Study|Adverse Event|0|||
23755676|NCT04380701|66484620|FG025|Overall Study|Adverse Event|0|||
23437947|NCT00999518|65344267|FG002|Overall Study|Did not meet entrance criteria|0|||
23437948|NCT00999518|65344268|FG003|Overall Study|Did not meet entrance criteria|0|||
23437949|NCT00999518|65344269|FG004|Overall Study|Did not meet entrance criteria|1|||
23437950|NCT00999518|65344265|FG000|Overall Study|Study terminated by sponsor|10|||
23560112|NCT00514683|65779602|FG003|Overall Study|Protocol Violation|1|||
23560113|NCT00514683|65779603|FG004|Overall Study|Protocol Violation|0|||
23560114|NCT00514683|65779599|FG000|Overall Study|Withdrawal by Subject|2|||
23560115|NCT00514683|65779600|FG001|Overall Study|Withdrawal by Subject|2|||
23560116|NCT00514683|65779601|FG002|Overall Study|Withdrawal by Subject|1|||
23560117|NCT00514683|65779602|FG003|Overall Study|Withdrawal by Subject|0|||
23560118|NCT00514683|65779603|FG004|Overall Study|Withdrawal by Subject|4|||
23560119|NCT00514683|65779599|FG000|Overall Study|Reason other than listed above|0|||
23560120|NCT00514683|65779600|FG001|Overall Study|Reason other than listed above|1|||
23560121|NCT00514683|65779601|FG002|Overall Study|Reason other than listed above|2|||
23560122|NCT00514683|65779602|FG003|Overall Study|Reason other than listed above|0|||
23560123|NCT00514683|65779603|FG004|Overall Study|Reason other than listed above|1|||
23560124|NCT04382924|65779604|FG000|Overall Study|Death|2|||
23437951|NCT00999518|65344266|FG001|Overall Study|Study terminated by sponsor|6|||
23437952|NCT00999518|65344267|FG002|Overall Study|Study terminated by sponsor|5|||
23437953|NCT00999518|65344268|FG003|Overall Study|Study terminated by sponsor|5|||
23755677|NCT04380701|66484621|FG026|Overall Study|Adverse Event|0|||
23437954|NCT00999518|65344269|FG004|Overall Study|Study terminated by sponsor|9|||
23560125|NCT04382924|65779605|FG001|Overall Study|Death|5|||
23560126|NCT04382924|65779606|FG002|Overall Study|Death|4|||
23560127|NCT04382924|65779604|FG000|Overall Study|Protocol Violation|0|||
23560128|NCT04382924|65779605|FG001|Overall Study|Protocol Violation|1|||
23826048|NCT00711243|66745022|FG004|Reached First Response/4 Cycles|Death|0|||
23826049|NCT00711243|66745023|FG005|Reached First Response/4 Cycles|Death|2|||
23826050|NCT00711243|66745018|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
23826051|NCT00711243|66745019|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
23437955|NCT00999518|65344265|FG000|Overall Study|Pregnancy|0|||
23437956|NCT00999518|65344266|FG001|Overall Study|Pregnancy|0|||
23437957|NCT00999518|65344267|FG002|Overall Study|Pregnancy|1|||
23624491|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
23624492|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
23624493|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Death|0|||
23624494|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Death|1|||
23624495|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
23624496|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
23624497|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
23624498|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
23624499|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
23624500|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
23624501|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
23624502|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
23624503|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
23624504|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
23624505|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
23624506|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
23624507|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
23624508|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
23624509|NCT01309243|66011701|FG000|Extension Phase|Lost to Follow-up|6|||
23624510|NCT01309243|66011702|FG001|Extension Phase|Lost to Follow-up|0|||
23624511|NCT02215954|66011703|FG000|Overall Study|Adverse Event|0|||
23624512|NCT02215954|66011704|FG001|Overall Study|Adverse Event|0|||
23437958|NCT00999518|65344268|FG003|Overall Study|Pregnancy|0|||
23437959|NCT00999518|65344269|FG004|Overall Study|Pregnancy|0|||
23437960|NCT00999518|65344265|FG000|Overall Study|Protocol Violation|0|||
23437961|NCT00999518|65344266|FG001|Overall Study|Protocol Violation|1|||
23437962|NCT00999518|65344267|FG002|Overall Study|Protocol Violation|0|||
23437963|NCT00999518|65344268|FG003|Overall Study|Protocol Violation|0|||
23437964|NCT00999518|65344269|FG004|Overall Study|Protocol Violation|2|||
23437965|NCT00999518|65344265|FG000|Overall Study|Withdrawal by Subject|5|||
23437966|NCT00999518|65344266|FG001|Overall Study|Withdrawal by Subject|4|||
23437967|NCT00999518|65344267|FG002|Overall Study|Withdrawal by Subject|10|||
23624513|NCT02215954|66011705|FG002|Overall Study|Adverse Event|1|||
23624514|NCT02215954|66011703|FG000|Overall Study|Withdrawal by Subject|0|||
23624515|NCT02215954|66011704|FG001|Overall Study|Withdrawal by Subject|0|||
23437968|NCT00999518|65344268|FG003|Overall Study|Withdrawal by Subject|6|||
23437969|NCT00999518|65344269|FG004|Overall Study|Withdrawal by Subject|1|||
23437970|NCT00999518|65344265|FG000|Overall Study|Other|5|||
23560129|NCT04382924|65779606|FG002|Overall Study|Protocol Violation|1|||
23560130|NCT04382924|65779604|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
23560131|NCT04382924|65779605|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
23560132|NCT04382924|65779606|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
23560133|NCT04382924|65779604|FG000|Overall Study|Withdrawal by Subject|6|||
23560134|NCT04382924|65779605|FG001|Overall Study|Withdrawal by Subject|3|||
23560135|NCT04382924|65779606|FG002|Overall Study|Withdrawal by Subject|6|||
23560136|NCT05292534|65779607|FG000|Overall Study|Protocol Violation|3|||
23560137|NCT05292534|65779608|FG001|Overall Study|Protocol Violation|4|||
23560138|NCT05292534|65779607|FG000|Overall Study|Withdrawal by Subject|0|||
23560139|NCT05292534|65779608|FG001|Overall Study|Withdrawal by Subject|1|||
23560140|NCT03633929|65779609|FG000|Overall Study|Lost to Follow-up|1|||
23624516|NCT02215954|66011705|FG002|Overall Study|Withdrawal by Subject|2|||
23624517|NCT02215954|66011703|FG000|Overall Study|Not exposed|1|||
23437971|NCT00999518|65344266|FG001|Overall Study|Other|7|||
23437972|NCT00999518|65344267|FG002|Overall Study|Other|1|||
23437973|NCT00999518|65344268|FG003|Overall Study|Other|4|||
23560141|NCT03633929|65779609|FG000|Overall Study|Did not login to software. Did not participate|3|||
23560142|NCT01125722|65779620|FG000|Overall Study|Withdrawal by Subject|2|||
23560143|NCT01125722|65779621|FG001|Overall Study|Withdrawal by Subject|1|||
23624518|NCT02215954|66011704|FG001|Overall Study|Not exposed|1|||
23624519|NCT02215954|66011705|FG002|Overall Study|Not exposed|3|||
23755678|NCT04380701|66484622|FG027|Overall Study|Adverse Event|0|||
23437974|NCT00999518|65344269|FG004|Overall Study|Other|5|||
23437975|NCT00999518|65344265|FG000|Overall Study|Randomized but not Treated|1|||
23437976|NCT00999518|65344266|FG001|Overall Study|Randomized but not Treated|1|||
23437977|NCT00999518|65344267|FG002|Overall Study|Randomized but not Treated|2|||
23437978|NCT00999518|65344268|FG003|Overall Study|Randomized but not Treated|0|||
23560144|NCT01125722|65779620|FG000|Overall Study|Lost to Follow-up|1|||
23560145|NCT01125722|65779621|FG001|Overall Study|Lost to Follow-up|0|||
23437979|NCT00999518|65344269|FG004|Overall Study|Randomized but not Treated|1|||
23437980|NCT02396589|65344272|FG000|Intervention|Lost to Follow-up|1|||
23437981|NCT02396589|65344273|FG001|Intervention|Lost to Follow-up|0|||
23437982|NCT02396589|65344272|FG000|6 Month Follow-up|change in health status|0|||
23560146|NCT01690130|65779625|FG000|Overall Study|Subject have cancelled visit.|1|||
23560147|NCT01690130|65779626|FG001|Overall Study|Subject have cancelled visit.|0|||
23560148|NCT04510675|65779627|FG000|Overall Study|Withdrawal by Subject|5|||
23560149|NCT00552084|65779630|FG000|Overall Study|Adverse Event|2|||
23560150|NCT00552084|65779631|FG001|Overall Study|Adverse Event|3|||
23560151|NCT00552084|65779630|FG000|Overall Study|Withdrawal by Subject|4|||
23560152|NCT00552084|65779631|FG001|Overall Study|Withdrawal by Subject|5|||
23560153|NCT00552084|65779630|FG000|Overall Study|Protocol Violation|1|||
23560154|NCT00552084|65779631|FG001|Overall Study|Protocol Violation|0|||
23560155|NCT00552084|65779630|FG000|Overall Study|change in anti-arrythmic drug|1|||
23560156|NCT00552084|65779631|FG001|Overall Study|change in anti-arrythmic drug|1|||
23560157|NCT00321048|65779632|FG000|Overall Study|Withdrawal by Subject|6|||
23560158|NCT00321048|65779633|FG001|Overall Study|Withdrawal by Subject|8|||
23560159|NCT01197508|65779634|FG000|Overall Study|Withdrawal by Subject|8|||
23560160|NCT01197508|65779635|FG001|Overall Study|Withdrawal by Subject|7|||
23560161|NCT01197508|65779636|FG002|Overall Study|Withdrawal by Subject|15|||
23560162|NCT01197508|65779637|FG003|Overall Study|Withdrawal by Subject|4|||
23560163|NCT01197508|65779634|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
23755679|NCT04380701|66484623|FG028|Overall Study|Adverse Event|0|||
23755680|NCT04380701|66484624|FG029|Overall Study|Adverse Event|0|||
23755681|NCT04380701|66484625|FG030|Overall Study|Adverse Event|0|||
23755682|NCT04380701|66484626|FG031|Overall Study|Adverse Event|0|||
23755683|NCT04380701|66484627|FG032|Overall Study|Adverse Event|0|||
23755684|NCT04380701|66484628|FG033|Overall Study|Adverse Event|0|||
23755685|NCT04380701|66484595|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
23755686|NCT04380701|66484596|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
23826052|NCT00711243|66745020|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
23437983|NCT02396589|65344273|FG001|6 Month Follow-up|change in health status|1|||
23437984|NCT02396589|65344272|FG000|9 Month Follow-up|Death|0|||
23437985|NCT02396589|65344273|FG001|9 Month Follow-up|Death|1|||
23560164|NCT01197508|65779635|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
23560165|NCT01197508|65779636|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
23560166|NCT01197508|65779637|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
23826053|NCT00711243|66745021|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
23826054|NCT00711243|66745022|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
23826055|NCT00711243|66745023|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
23826056|NCT00711243|66745018|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
23826057|NCT00711243|66745019|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
23826058|NCT00711243|66745020|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
23826059|NCT00711243|66745021|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
23826060|NCT00711243|66745022|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
23826061|NCT00711243|66745023|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
23826062|NCT00711243|66745018|FG000|Treated Cycle 5 After First Response|Death|0|||
23826063|NCT00711243|66745019|FG001|Treated Cycle 5 After First Response|Death|0|||
23826064|NCT00711243|66745020|FG002|Treated Cycle 5 After First Response|Death|0|||
23826065|NCT00711243|66745021|FG003|Treated Cycle 5 After First Response|Death|0|||
23826066|NCT00711243|66745022|FG004|Treated Cycle 5 After First Response|Death|0|||
23560167|NCT01197508|65779634|FG000|Overall Study|Adverse Event|10|||
23560168|NCT01197508|65779635|FG001|Overall Study|Adverse Event|13|||
23560169|NCT01197508|65779636|FG002|Overall Study|Adverse Event|23|||
23560170|NCT01197508|65779637|FG003|Overall Study|Adverse Event|3|||
23560171|NCT01197508|65779634|FG000|Overall Study|Severe non-compliance to protocol|0|||
23560172|NCT01197508|65779635|FG001|Overall Study|Severe non-compliance to protocol|3|||
23560173|NCT01197508|65779636|FG002|Overall Study|Severe non-compliance to protocol|1|||
23826067|NCT00711243|66745023|FG005|Treated Cycle 5 After First Response|Death|2|||
23560174|NCT01197508|65779637|FG003|Overall Study|Severe non-compliance to protocol|3|||
23560175|NCT01197508|65779634|FG000|Overall Study|Condition under investigation worsened|1|||
23560176|NCT01197508|65779635|FG001|Overall Study|Condition under investigation worsened|1|||
23560177|NCT01197508|65779636|FG002|Overall Study|Condition under investigation worsened|1|||
23560178|NCT01197508|65779637|FG003|Overall Study|Condition under investigation worsened|1|||
23560179|NCT01197508|65779634|FG000|Overall Study|Lack of Efficacy|1|||
23560180|NCT01197508|65779635|FG001|Overall Study|Lack of Efficacy|2|||
23560181|NCT01197508|65779636|FG002|Overall Study|Lack of Efficacy|2|||
23560182|NCT01197508|65779637|FG003|Overall Study|Lack of Efficacy|1|||
23624520|NCT01200485|66011706|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
23755687|NCT04380701|66484597|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
23826068|NCT00711243|66745018|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
23437986|NCT02396589|65344272|FG000|12 Month Follow up|Lost to Follow-up|0|||
23437987|NCT02396589|65344273|FG001|12 Month Follow up|Lost to Follow-up|2|||
23437988|NCT01041287|65344274|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
23437989|NCT01041287|65344275|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
23437990|NCT01041287|65344274|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
23437991|NCT01041287|65344275|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
23437992|NCT00659230|65344276|FG000|Overall Study|Lost to Follow-up|2|||
23437993|NCT00659230|65344277|FG001|Overall Study|Lost to Follow-up|5|||
23437994|NCT00659230|65344276|FG000|Overall Study|Lost source documentation|5|||
23437995|NCT00659230|65344277|FG001|Overall Study|Lost source documentation|4|||
23624521|NCT01200485|66011707|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
23624522|NCT01200485|66011708|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
23437996|NCT00659230|65344276|FG000|Overall Study|Did not return post-randomization|2|||
23560183|NCT01197508|65779634|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23624523|NCT01200485|66011706|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
23624524|NCT01200485|66011707|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
23624525|NCT01200485|66011708|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
23624526|NCT03187353|66011712|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
23624527|NCT03187353|66011713|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
23624528|NCT03187353|66011712|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23624529|NCT03187353|66011713|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23624530|NCT03187353|66011712|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
23624531|NCT03187353|66011713|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
23624532|NCT03187353|66011712|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23624533|NCT03187353|66011713|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
23624534|NCT03187353|66011712|FG000|Washout (2 Weeks)|Adverse Event|2|||
23624535|NCT03187353|66011713|FG001|Washout (2 Weeks)|Adverse Event|0|||
23560184|NCT01197508|65779635|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23560185|NCT01197508|65779636|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23560186|NCT01197508|65779637|FG003|Overall Study|Study-specific withdrawal criteria|2|||
23560187|NCT01197508|65779634|FG000|Overall Study|Lost to Follow-up|1|||
23560188|NCT01197508|65779635|FG001|Overall Study|Lost to Follow-up|1|||
23560189|NCT01197508|65779636|FG002|Overall Study|Lost to Follow-up|2|||
23560190|NCT01197508|65779637|FG003|Overall Study|Lost to Follow-up|0|||
23560191|NCT01197508|65779634|FG000|Overall Study|Other|2|||
23560192|NCT01197508|65779635|FG001|Overall Study|Other|3|||
23560193|NCT01197508|65779636|FG002|Overall Study|Other|2|||
23560194|NCT01197508|65779637|FG003|Overall Study|Other|2|||
23560195|NCT01712009|65779638|FG000|Overall Study|Withdrawal by Subject|24|||
23560196|NCT01712009|65779639|FG001|Overall Study|Withdrawal by Subject|15|||
23560197|NCT01712009|65779640|FG002|Overall Study|Withdrawal by Subject|8|||
23560198|NCT01712009|65779638|FG000|Overall Study|Lost to Follow-up|2|||
23560199|NCT01712009|65779639|FG001|Overall Study|Lost to Follow-up|0|||
23560200|NCT01712009|65779640|FG002|Overall Study|Lost to Follow-up|1|||
23560201|NCT01712009|65779638|FG000|Overall Study|Decision by Sponsor|12|||
23560202|NCT01712009|65779639|FG001|Overall Study|Decision by Sponsor|14|||
23560203|NCT01712009|65779640|FG002|Overall Study|Decision by Sponsor|12|||
23560204|NCT02901626|65779646|FG000|Overall Study|Lost to Follow-up|1|||
23560205|NCT02901626|65779647|FG001|Overall Study|Lost to Follow-up|1|||
23560206|NCT04524598|65779648|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
23560207|NCT04524598|65779649|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
23560208|NCT04524598|65779650|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
23560209|NCT04524598|65779651|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
23560210|NCT04524598|65779652|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
23560211|NCT04524598|65779648|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
23560212|NCT04524598|65779649|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
23560213|NCT04524598|65779650|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560214|NCT04524598|65779651|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560215|NCT04524598|65779652|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560216|NCT04524598|65779648|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
23560217|NCT04524598|65779649|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
23560218|NCT04524598|65779650|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
23560219|NCT04524598|65779651|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
23560220|NCT04524598|65779652|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
23560221|NCT04524598|65779648|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
23560222|NCT04524598|65779649|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
23560223|NCT04524598|65779650|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
23560224|NCT04524598|65779651|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
23560225|NCT04524598|65779652|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
23560226|NCT04524598|65779648|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560227|NCT04524598|65779649|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560228|NCT04524598|65779650|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
23560229|NCT04524598|65779651|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
23560230|NCT04524598|65779652|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560231|NCT04524598|65779648|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
23560232|NCT04524598|65779649|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
23560233|NCT04524598|65779650|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
23560234|NCT04524598|65779651|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
23560235|NCT04524598|65779652|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
23560236|NCT04524598|65779648|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560237|NCT04524598|65779649|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560238|NCT04524598|65779650|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560239|NCT04524598|65779651|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560240|NCT04524598|65779652|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
23560241|NCT00454571|65779653|FG000|Overall Study|Adverse Event|2|||
23560242|NCT00454571|65779654|FG001|Overall Study|Adverse Event|0|||
23560243|NCT00454571|65779653|FG000|Overall Study|Physician Decision|0|||
23560244|NCT00454571|65779654|FG001|Overall Study|Physician Decision|1|||
23560245|NCT00454571|65779653|FG000|Overall Study|Protocol Violation|1|||
23560246|NCT00454571|65779654|FG001|Overall Study|Protocol Violation|0|||
23755688|NCT04380701|66484598|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
23755689|NCT04380701|66484599|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
23755690|NCT04380701|66484600|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
23755691|NCT04380701|66484601|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
23755692|NCT04380701|66484602|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
23755693|NCT04380701|66484603|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
23755694|NCT04380701|66484604|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
23755695|NCT04380701|66484605|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
23755696|NCT04380701|66484606|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
23755697|NCT04380701|66484607|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
23755698|NCT04380701|66484608|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
23755699|NCT04380701|66484609|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
23755700|NCT04380701|66484610|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
23755701|NCT04380701|66484611|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
23755702|NCT04380701|66484612|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
23755703|NCT04380701|66484613|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
23755704|NCT04380701|66484614|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
23755705|NCT04380701|66484615|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
23755706|NCT04380701|66484616|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
23755707|NCT04380701|66484617|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
23755708|NCT04380701|66484618|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
23755709|NCT04380701|66484619|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
23755710|NCT04380701|66484620|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
23755711|NCT04380701|66484621|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
23755712|NCT04380701|66484622|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
23755713|NCT04380701|66484623|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
23755714|NCT04380701|66484624|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
23755715|NCT04380701|66484625|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
23755716|NCT04380701|66484626|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
23755717|NCT04380701|66484627|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
23755718|NCT04380701|66484628|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
23755719|NCT04380701|66484595|FG000|Overall Study|Physician Decision|0|||
23755720|NCT04380701|66484596|FG001|Overall Study|Physician Decision|0|||
23755721|NCT04380701|66484597|FG002|Overall Study|Physician Decision|0|||
23755722|NCT04380701|66484598|FG003|Overall Study|Physician Decision|0|||
23826069|NCT00711243|66745019|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
23826070|NCT00711243|66745020|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
23826071|NCT00711243|66745021|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
23826072|NCT00711243|66745022|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
23826073|NCT00711243|66745023|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
23826074|NCT00711243|66745018|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23826075|NCT00711243|66745019|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23560247|NCT00454571|65779653|FG000|Overall Study|Withdrawal by Subject|10|||
23624536|NCT03187353|66011712|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
23560248|NCT00454571|65779654|FG001|Overall Study|Withdrawal by Subject|5|||
23560249|NCT04934722|65779655|FG000|Overall Study|Death|4|||
23755723|NCT04380701|66484599|FG004|Overall Study|Physician Decision|0|||
23755724|NCT04380701|66484600|FG005|Overall Study|Physician Decision|0|||
23755725|NCT04380701|66484601|FG006|Overall Study|Physician Decision|0|||
23755726|NCT04380701|66484602|FG007|Overall Study|Physician Decision|0|||
23755727|NCT04380701|66484603|FG008|Overall Study|Physician Decision|0|||
23755728|NCT04380701|66484604|FG009|Overall Study|Physician Decision|0|||
23755729|NCT04380701|66484605|FG010|Overall Study|Physician Decision|0|||
23755730|NCT04380701|66484606|FG011|Overall Study|Physician Decision|0|||
23755731|NCT04380701|66484607|FG012|Overall Study|Physician Decision|0|||
23755732|NCT04380701|66484608|FG013|Overall Study|Physician Decision|0|||
23755733|NCT04380701|66484609|FG014|Overall Study|Physician Decision|0|||
23755734|NCT04380701|66484610|FG015|Overall Study|Physician Decision|0|||
23755735|NCT04380701|66484611|FG016|Overall Study|Physician Decision|0|||
23755736|NCT04380701|66484612|FG017|Overall Study|Physician Decision|0|||
23755737|NCT04380701|66484613|FG018|Overall Study|Physician Decision|0|||
23755738|NCT04380701|66484614|FG019|Overall Study|Physician Decision|0|||
23755739|NCT04380701|66484615|FG020|Overall Study|Physician Decision|0|||
23560250|NCT04934722|65779656|FG001|Overall Study|Death|3|||
23560251|NCT04934722|65779655|FG000|Overall Study|Participants Ongoing|88|||
23560252|NCT04934722|65779656|FG001|Overall Study|Participants Ongoing|91|||
23437997|NCT00659230|65344277|FG001|Overall Study|Did not return post-randomization|3|||
23437998|NCT00859937|65344278|FG000|Overall Study|Protocol Violation|1|||
23437999|NCT00859937|65344279|FG001|Overall Study|Protocol Violation|0|||
23438000|NCT00620113|65344280|FG000|Overall Study|Adverse Event|3|||
23438001|NCT00620113|65344281|FG001|Overall Study|Adverse Event|2|||
23438002|NCT00620113|65344282|FG002|Overall Study|Adverse Event|2|||
23438003|NCT00620113|65344283|FG003|Overall Study|Adverse Event|1|||
23438004|NCT00620113|65344280|FG000|Overall Study|Lack of Efficacy|2|||
23438005|NCT00620113|65344281|FG001|Overall Study|Lack of Efficacy|3|||
23438006|NCT00620113|65344282|FG002|Overall Study|Lack of Efficacy|0|||
23438007|NCT00620113|65344283|FG003|Overall Study|Lack of Efficacy|2|||
23560253|NCT01786330|65779659|FG000|Overall Study|Withdrawal by Subject|0|||
23560254|NCT01786330|65779660|FG001|Overall Study|Withdrawal by Subject|1|||
23560255|NCT01786330|65779659|FG000|Overall Study|Lost to Follow-up|0|||
23560256|NCT01786330|65779660|FG001|Overall Study|Lost to Follow-up|1|||
23560257|NCT01786330|65779659|FG000|Overall Study|Excluded intraoperatively|0|||
23560258|NCT01786330|65779660|FG001|Overall Study|Excluded intraoperatively|1|||
23755740|NCT04380701|66484616|FG021|Overall Study|Physician Decision|0|||
23560259|NCT01786330|65779659|FG000|Overall Study|Protocol Violation|1|||
23560260|NCT01786330|65779660|FG001|Overall Study|Protocol Violation|0|||
23826076|NCT00711243|66745020|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23826077|NCT00711243|66745021|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23826078|NCT00711243|66745022|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23826079|NCT00711243|66745023|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
23826080|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
23843101|NCT01738503|66805584|FG003|Treatment Period|Protocol Violation|0|||
23438008|NCT00620113|65344280|FG000|Overall Study|Physician Decision|1|||
23438009|NCT00620113|65344281|FG001|Overall Study|Physician Decision|0|||
23438010|NCT00620113|65344282|FG002|Overall Study|Physician Decision|0|||
23560261|NCT00615264|65779668|FG000|Overall Study|Withdrawal by Subject|17|||
23755741|NCT04380701|66484617|FG022|Overall Study|Physician Decision|0|||
23755742|NCT04380701|66484618|FG023|Overall Study|Physician Decision|0|||
23560262|NCT00615264|65779669|FG001|Overall Study|Withdrawal by Subject|19|||
23560263|NCT00615264|65779668|FG000|Overall Study|Lost to Follow-up|6|||
23560264|NCT00615264|65779669|FG001|Overall Study|Lost to Follow-up|13|||
23438011|NCT00620113|65344283|FG003|Overall Study|Physician Decision|2|||
23438012|NCT00620113|65344280|FG000|Overall Study|Protocol Violation|2|||
23438013|NCT00620113|65344281|FG001|Overall Study|Protocol Violation|1|||
23438014|NCT00620113|65344282|FG002|Overall Study|Protocol Violation|0|||
23438015|NCT00620113|65344283|FG003|Overall Study|Protocol Violation|0|||
23560265|NCT00615264|65779668|FG000|Overall Study|Adverse Event|8|||
23560266|NCT00615264|65779669|FG001|Overall Study|Adverse Event|5|||
23624537|NCT03187353|66011713|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
23560267|NCT00615264|65779668|FG000|Overall Study|Death|1|||
23560268|NCT00615264|65779669|FG001|Overall Study|Death|1|||
23560269|NCT00615264|65779668|FG000|Overall Study|Protocol Violation|11|||
23560270|NCT00615264|65779669|FG001|Overall Study|Protocol Violation|7|||
23560271|NCT00615264|65779668|FG000|Overall Study|Not defined|7|||
23560272|NCT00615264|65779669|FG001|Overall Study|Not defined|4|||
23560273|NCT00615264|65779668|FG000|Overall Study|Dermal Hypersensitivity|0|||
23560274|NCT00615264|65779669|FG001|Overall Study|Dermal Hypersensitivity|3|||
23560275|NCT01984684|65779671|FG000|Overall Study|Lost to Follow-up|25|||
23560276|NCT01984684|65779672|FG001|Overall Study|Lost to Follow-up|24|||
23560277|NCT01984684|65779671|FG000|Overall Study|Adverse Event|8|||
23560278|NCT01984684|65779672|FG001|Overall Study|Adverse Event|12|||
23560279|NCT01984684|65779671|FG000|Overall Study|Withdrawal by Subject|9|||
23624538|NCT04014790|66011714|FG000|Overall Study|Death|4|||
23624539|NCT04014790|66011714|FG000|Overall Study|Adverse Event|1|||
23624540|NCT04014790|66011714|FG000|Overall Study|Withdrawal by Subject|1|||
23624541|NCT03128671|66011717|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
23624542|NCT03128671|66011718|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
23624543|NCT03128671|66011717|FG000|Allocation|Death|1|||
23624544|NCT03128671|66011718|FG001|Allocation|Death|0|||
23624545|NCT03128671|66011717|FG000|Allocation|Withdrawal by Subject|4|||
23624546|NCT03128671|66011718|FG001|Allocation|Withdrawal by Subject|0|||
23624547|NCT03128671|66011717|FG000|Intervention|Withdrawal by Subject|11|||
23624548|NCT03128671|66011718|FG001|Intervention|Withdrawal by Subject|10|||
23624549|NCT03128671|66011717|FG000|Intervention|Palliative/hospice care initiated|9|||
23624550|NCT03128671|66011718|FG001|Intervention|Palliative/hospice care initiated|10|||
23624551|NCT03128671|66011717|FG000|Intervention|Death|13|||
23624552|NCT03128671|66011718|FG001|Intervention|Death|11|||
23624553|NCT03128671|66011717|FG000|Intervention|Interrupted by hurricane|1|||
23624554|NCT03128671|66011718|FG001|Intervention|Interrupted by hurricane|0|||
23624555|NCT03128671|66011717|FG000|Intervention|Physician Decision|2|||
23624556|NCT03128671|66011718|FG001|Intervention|Physician Decision|3|||
23560280|NCT01984684|65779672|FG001|Overall Study|Withdrawal by Subject|9|||
23624557|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
23438016|NCT00620113|65344280|FG000|Overall Study|Withdrawal by Subject|5|||
23438017|NCT00620113|65344281|FG001|Overall Study|Withdrawal by Subject|1|||
23624558|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
23560281|NCT01984684|65779671|FG000|Overall Study|Lack of Efficacy|3|||
23560282|NCT01984684|65779672|FG001|Overall Study|Lack of Efficacy|6|||
23560283|NCT01984684|65779671|FG000|Overall Study|Physician Decision|4|||
23624559|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
23624560|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
23560284|NCT01984684|65779672|FG001|Overall Study|Physician Decision|2|||
23560285|NCT01984684|65779671|FG000|Overall Study|Protocol Violation|4|||
23560286|NCT01984684|65779672|FG001|Overall Study|Protocol Violation|2|||
23560287|NCT01984684|65779671|FG000|Overall Study|Death|0|||
23560288|NCT01984684|65779672|FG001|Overall Study|Death|1|||
23560289|NCT01984684|65779671|FG000|Overall Study|Noncompliance with study drug|2|||
23560290|NCT01984684|65779672|FG001|Overall Study|Noncompliance with study drug|1|||
23560291|NCT01984684|65779671|FG000|Overall Study|Subject incarcerated|1|||
23560292|NCT01984684|65779672|FG001|Overall Study|Subject incarcerated|0|||
23560293|NCT01984684|65779671|FG000|Overall Study|Study drug not available at site|1|||
23560294|NCT01984684|65779672|FG001|Overall Study|Study drug not available at site|1|||
23560295|NCT01984684|65779671|FG000|Overall Study|Subject had inadequate IV access|0|||
23624561|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
23624562|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
23624563|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
23438018|NCT00620113|65344282|FG002|Overall Study|Withdrawal by Subject|3|||
23438019|NCT00620113|65344283|FG003|Overall Study|Withdrawal by Subject|5|||
23560296|NCT01984684|65779672|FG001|Overall Study|Subject had inadequate IV access|1|||
23560297|NCT00855595|65779674|FG000|Overall Study|Withdrawal by Subject|1|||
23755743|NCT04380701|66484619|FG024|Overall Study|Physician Decision|2|||
23755744|NCT04380701|66484620|FG025|Overall Study|Physician Decision|0|||
23755745|NCT04380701|66484621|FG026|Overall Study|Physician Decision|0|||
23755746|NCT04380701|66484622|FG027|Overall Study|Physician Decision|0|||
23755747|NCT04380701|66484623|FG028|Overall Study|Physician Decision|0|||
23755748|NCT04380701|66484624|FG029|Overall Study|Physician Decision|0|||
23755749|NCT04380701|66484625|FG030|Overall Study|Physician Decision|0|||
23755750|NCT04380701|66484626|FG031|Overall Study|Physician Decision|0|||
23755751|NCT04380701|66484627|FG032|Overall Study|Physician Decision|0|||
23755752|NCT04380701|66484628|FG033|Overall Study|Physician Decision|0|||
23755753|NCT04380701|66484595|FG000|Overall Study|Death|0|||
23755754|NCT04380701|66484596|FG001|Overall Study|Death|0|||
23755755|NCT04380701|66484597|FG002|Overall Study|Death|0|||
23755756|NCT04380701|66484598|FG003|Overall Study|Death|0|||
23755757|NCT04380701|66484599|FG004|Overall Study|Death|0|||
23755758|NCT04380701|66484600|FG005|Overall Study|Death|0|||
23755759|NCT04380701|66484601|FG006|Overall Study|Death|0|||
23755760|NCT04380701|66484602|FG007|Overall Study|Death|0|||
23755761|NCT04380701|66484603|FG008|Overall Study|Death|0|||
23755762|NCT04380701|66484604|FG009|Overall Study|Death|0|||
23755763|NCT04380701|66484605|FG010|Overall Study|Death|0|||
23755764|NCT04380701|66484606|FG011|Overall Study|Death|0|||
23755765|NCT04380701|66484607|FG012|Overall Study|Death|0|||
23755766|NCT04380701|66484608|FG013|Overall Study|Death|0|||
23755767|NCT04380701|66484609|FG014|Overall Study|Death|0|||
23755768|NCT04380701|66484610|FG015|Overall Study|Death|0|||
23755769|NCT04380701|66484611|FG016|Overall Study|Death|0|||
23755770|NCT04380701|66484612|FG017|Overall Study|Death|0|||
23624564|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
23624565|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
23624566|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
23624567|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
23624568|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
23624569|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
23624570|NCT01214421|66011720|FG000|Overall Study|Lost to Follow-up|7|||
23624571|NCT01214421|66011721|FG001|Overall Study|Lost to Follow-up|3|||
23624572|NCT01214421|66011722|FG002|Overall Study|Lost to Follow-up|7|||
23624573|NCT01214421|66011723|FG003|Overall Study|Lost to Follow-up|3|||
23624574|NCT01214421|66011720|FG000|Overall Study|Adverse Event|16|||
23624575|NCT01214421|66011721|FG001|Overall Study|Adverse Event|35|||
23624576|NCT01214421|66011722|FG002|Overall Study|Adverse Event|14|||
23624577|NCT01214421|66011723|FG003|Overall Study|Adverse Event|3|||
23624578|NCT01214421|66011720|FG000|Overall Study|Sponsor Discontinued Site|1|||
23624579|NCT01214421|66011721|FG001|Overall Study|Sponsor Discontinued Site|2|||
23624580|NCT01214421|66011722|FG002|Overall Study|Sponsor Discontinued Site|0|||
23624581|NCT01214421|66011723|FG003|Overall Study|Sponsor Discontinued Site|0|||
23624582|NCT01214421|66011720|FG000|Overall Study|Withdrawal Criteria Met|3|||
23624583|NCT01214421|66011721|FG001|Overall Study|Withdrawal Criteria Met|0|||
23624584|NCT01214421|66011722|FG002|Overall Study|Withdrawal Criteria Met|2|||
23624585|NCT01214421|66011723|FG003|Overall Study|Withdrawal Criteria Met|1|||
23624586|NCT01214421|66011720|FG000|Overall Study|Physician Decision|2|||
23624587|NCT01214421|66011721|FG001|Overall Study|Physician Decision|0|||
23624588|NCT01214421|66011722|FG002|Overall Study|Physician Decision|4|||
23624589|NCT01214421|66011723|FG003|Overall Study|Physician Decision|0|||
23624590|NCT01214421|66011720|FG000|Overall Study|Withdrawal by Subject|21|||
23624591|NCT01214421|66011721|FG001|Overall Study|Withdrawal by Subject|18|||
23624592|NCT01214421|66011722|FG002|Overall Study|Withdrawal by Subject|11|||
23560298|NCT00855595|65779675|FG001|Overall Study|Withdrawal by Subject|2|||
23755771|NCT04380701|66484613|FG018|Overall Study|Death|0|||
23755772|NCT04380701|66484614|FG019|Overall Study|Death|0|||
23755773|NCT04380701|66484615|FG020|Overall Study|Death|0|||
23755774|NCT04380701|66484616|FG021|Overall Study|Death|0|||
23755775|NCT04380701|66484617|FG022|Overall Study|Death|0|||
23755776|NCT04380701|66484618|FG023|Overall Study|Death|0|||
23755777|NCT04380701|66484619|FG024|Overall Study|Death|1|||
23755778|NCT04380701|66484620|FG025|Overall Study|Death|0|||
23755779|NCT04380701|66484621|FG026|Overall Study|Death|0|||
23755780|NCT04380701|66484622|FG027|Overall Study|Death|0|||
23755781|NCT04380701|66484623|FG028|Overall Study|Death|0|||
23755782|NCT04380701|66484624|FG029|Overall Study|Death|0|||
23755783|NCT04380701|66484625|FG030|Overall Study|Death|0|||
23755784|NCT04380701|66484626|FG031|Overall Study|Death|0|||
23755785|NCT04380701|66484627|FG032|Overall Study|Death|0|||
23755786|NCT04380701|66484628|FG033|Overall Study|Death|0|||
23755787|NCT04380701|66484595|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755788|NCT04380701|66484596|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755789|NCT04380701|66484597|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755790|NCT04380701|66484598|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755791|NCT04380701|66484599|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755792|NCT04380701|66484600|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755793|NCT04380701|66484601|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755794|NCT04380701|66484602|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755795|NCT04380701|66484603|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755796|NCT04380701|66484604|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755797|NCT04380701|66484605|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755798|NCT04380701|66484606|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755799|NCT04380701|66484607|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755800|NCT04380701|66484608|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755801|NCT04380701|66484609|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755802|NCT04380701|66484610|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755803|NCT04380701|66484611|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755804|NCT04380701|66484612|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755805|NCT04380701|66484613|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755806|NCT04380701|66484614|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755807|NCT04380701|66484615|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755808|NCT04380701|66484616|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
23755809|NCT04380701|66484617|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
23755810|NCT04380701|66484618|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
23755811|NCT04380701|66484619|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
23755812|NCT04380701|66484620|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755813|NCT04380701|66484621|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755814|NCT04380701|66484622|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755815|NCT04380701|66484623|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23560299|NCT00855595|65779674|FG000|Overall Study|Lost to Follow-up|3|||
23560300|NCT00855595|65779675|FG001|Overall Study|Lost to Follow-up|3|||
23560301|NCT00855595|65779674|FG000|Overall Study|Adverse Event|1|||
23560302|NCT00855595|65779675|FG001|Overall Study|Adverse Event|1|||
23560303|NCT00855595|65779674|FG000|Overall Study|patient moved out of state|1|||
23560304|NCT00855595|65779675|FG001|Overall Study|patient moved out of state|0|||
23560305|NCT00855595|65779674|FG000|Overall Study|patient left country|0|||
23560306|NCT00855595|65779675|FG001|Overall Study|patient left country|1|||
23560307|NCT02940574|65779676|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
23560308|NCT02940574|65779677|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
23560309|NCT02940574|65779676|FG000|1-year Follow-up|Lost to Follow-up|3|||
23560310|NCT02940574|65779677|FG001|1-year Follow-up|Lost to Follow-up|4|||
23560311|NCT00152464|65779678|FG000|Overall Study|Adverse Event|3|||
23755816|NCT04380701|66484624|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755817|NCT04380701|66484625|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755818|NCT04380701|66484626|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755819|NCT04380701|66484627|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23560312|NCT00152464|65779679|FG001|Overall Study|Adverse Event|6|||
23560313|NCT00152464|65779678|FG000|Overall Study|Lost to Follow-up|8|||
23560314|NCT00152464|65779679|FG001|Overall Study|Lost to Follow-up|4|||
23560315|NCT00152464|65779678|FG000|Overall Study|Protocol Violation|3|||
23560316|NCT00152464|65779679|FG001|Overall Study|Protocol Violation|1|||
23560317|NCT00152464|65779678|FG000|Overall Study|Withdrawal by Subject|21|||
23560318|NCT00152464|65779679|FG001|Overall Study|Withdrawal by Subject|22|||
23560319|NCT00152464|65779678|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
23624593|NCT01214421|66011723|FG003|Overall Study|Withdrawal by Subject|2|||
23624594|NCT00732992|66011724|FG000|Overall Study|Adverse Event|1|||
23624595|NCT00732992|66011725|FG001|Overall Study|Adverse Event|1|||
23624596|NCT00732992|66011724|FG000|Overall Study|Objective Progression or Relapse|3|||
23624597|NCT00732992|66011725|FG001|Overall Study|Objective Progression or Relapse|5|||
23624598|NCT00732992|66011724|FG000|Overall Study|Global Deterioration of Health Status|1|||
23624599|NCT00732992|66011725|FG001|Overall Study|Global Deterioration of Health Status|0|||
23624600|NCT00732992|66011724|FG000|Overall Study|Withdrawal by Subject|1|||
23624601|NCT00732992|66011725|FG001|Overall Study|Withdrawal by Subject|0|||
23624602|NCT02202109|66011727|FG000|Overall Study|Lost to Follow-up|88|||
23624603|NCT02202109|66011728|FG001|Overall Study|Lost to Follow-up|87|||
23624604|NCT02202109|66011727|FG000|Overall Study|Withdrawal by Subject|2|||
23624605|NCT02202109|66011728|FG001|Overall Study|Withdrawal by Subject|0|||
23624606|NCT03635086|66011729|FG000|Overall Study|Withdrawal of consent|0|||
23624607|NCT03635086|66011730|FG001|Overall Study|Withdrawal of consent|0|||
23624608|NCT03635086|66011731|FG002|Overall Study|Withdrawal of consent|1|||
23624609|NCT03635086|66011732|FG003|Overall Study|Withdrawal of consent|0|||
23624610|NCT03635086|66011733|FG004|Overall Study|Withdrawal of consent|0|||
23624611|NCT03635086|66011729|FG000|Overall Study|Adverse Event|0|||
23624612|NCT03635086|66011730|FG001|Overall Study|Adverse Event|1|||
23624613|NCT03635086|66011731|FG002|Overall Study|Adverse Event|0|||
23624614|NCT03635086|66011732|FG003|Overall Study|Adverse Event|0|||
23624615|NCT03635086|66011733|FG004|Overall Study|Adverse Event|0|||
23624616|NCT03635086|66011729|FG000|Overall Study|Lost to Follow-up|1|||
23624617|NCT03635086|66011730|FG001|Overall Study|Lost to Follow-up|0|||
23624618|NCT03635086|66011731|FG002|Overall Study|Lost to Follow-up|0|||
23624619|NCT03635086|66011732|FG003|Overall Study|Lost to Follow-up|0|||
23624620|NCT03635086|66011733|FG004|Overall Study|Lost to Follow-up|0|||
23624621|NCT03188536|66011734|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
23624622|NCT03188536|66011734|FG000|Overall Study|Not participated/met inclusion criteria|1|||
23624623|NCT04245345|66011735|FG000|Overall Study|Death|1|||
23624624|NCT04245345|66011735|FG000|Overall Study|Exited prior to implant|5|||
23560320|NCT00152464|65779679|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
23560321|NCT00152464|65779678|FG000|Overall Study|Eczema deterioration|0|||
23560322|NCT00152464|65779679|FG001|Overall Study|Eczema deterioration|1|||
23624625|NCT04245345|66011735|FG000|Overall Study|Exited prior to 1-month|9|||
23624626|NCT04245345|66011735|FG000|Overall Study|Missed 1-month visit|3|||
23624627|NCT04245345|66011735|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
23624628|NCT04245345|66011735|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
23624629|NCT02872311|66011736|FG000|Overall Study|Death|2|||
23560323|NCT00152464|65779678|FG000|Overall Study|Parent decision|1|||
23560324|NCT00152464|65779679|FG001|Overall Study|Parent decision|1|||
23560325|NCT00152464|65779678|FG000|Overall Study|Investigator decision|1|||
23560326|NCT00152464|65779679|FG001|Overall Study|Investigator decision|0|||
23560327|NCT00152464|65779678|FG000|Overall Study|Lack of Efficacy|1|||
23560328|NCT00152464|65779679|FG001|Overall Study|Lack of Efficacy|0|||
23560329|NCT00152464|65779678|FG000|Overall Study|Eczema poorly controlled|1|||
23560330|NCT00152464|65779679|FG001|Overall Study|Eczema poorly controlled|0|||
23560331|NCT00152464|65779678|FG000|Overall Study|Patient relocated|1|||
23560332|NCT00152464|65779679|FG001|Overall Study|Patient relocated|0|||
23560333|NCT00499863|65779680|FG000|Overall Study|Lack of Efficacy|21|||
23560334|NCT00499863|65779681|FG001|Overall Study|Lack of Efficacy|27|||
23560335|NCT00499863|65779680|FG000|Overall Study|Protocol Violation|12|||
23560336|NCT00499863|65779681|FG001|Overall Study|Protocol Violation|7|||
23560337|NCT00499863|65779680|FG000|Overall Study|Withdrawal by Subject|6|||
23624630|NCT02872311|66011737|FG001|Overall Study|Death|0|||
23624631|NCT02872311|66011738|FG002|Overall Study|Death|0|||
23624632|NCT02872311|66011739|FG003|Overall Study|Death|0|||
23624633|NCT02872311|66011740|FG004|Overall Study|Death|0|||
23560338|NCT00499863|65779681|FG001|Overall Study|Withdrawal by Subject|4|||
23560339|NCT00499863|65779680|FG000|Overall Study|Adverse Event|8|||
23560340|NCT00499863|65779681|FG001|Overall Study|Adverse Event|2|||
23560341|NCT00499863|65779680|FG000|Overall Study|Sponsor decision|2|||
23560342|NCT00499863|65779681|FG001|Overall Study|Sponsor decision|2|||
23624634|NCT02872311|66011736|FG000|Overall Study|Lost to Follow-up|2|||
23624635|NCT02872311|66011737|FG001|Overall Study|Lost to Follow-up|0|||
23560343|NCT00499863|65779680|FG000|Overall Study|Lost to Follow-up|1|||
23560344|NCT00499863|65779681|FG001|Overall Study|Lost to Follow-up|1|||
23624636|NCT02872311|66011738|FG002|Overall Study|Lost to Follow-up|0|||
23624637|NCT02872311|66011739|FG003|Overall Study|Lost to Follow-up|0|||
23624638|NCT02872311|66011740|FG004|Overall Study|Lost to Follow-up|0|||
23755820|NCT04380701|66484628|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23755821|NCT03284424|66484629|FG000|Overall Study|Death|70|||
23755822|NCT03284424|66484630|FG001|Overall Study|Death|24|||
23755823|NCT03284424|66484629|FG000|Overall Study|Lost to Follow-up|3|||
23755824|NCT03284424|66484630|FG001|Overall Study|Lost to Follow-up|1|||
23755825|NCT03284424|66484629|FG000|Overall Study|Physician Decision|1|||
23755826|NCT03284424|66484630|FG001|Overall Study|Physician Decision|2|||
23755827|NCT03284424|66484629|FG000|Overall Study|Withdrawal by Subject|4|||
23755828|NCT03284424|66484630|FG001|Overall Study|Withdrawal by Subject|5|||
23755829|NCT03284424|66484629|FG000|Overall Study|Sponsor's decision|27|||
23755830|NCT03284424|66484630|FG001|Overall Study|Sponsor's decision|22|||
23755831|NCT02595528|66484635|FG000|Overall Study|Withdrawal by Subject|1|||
23755832|NCT02595528|66484636|FG001|Overall Study|Withdrawal by Subject|2|||
23755833|NCT02595528|66484637|FG002|Overall Study|Withdrawal by Subject|1|||
23755834|NCT02595528|66484638|FG003|Overall Study|Withdrawal by Subject|3|||
23755835|NCT02595528|66484635|FG000|Overall Study|Lost to Follow-up|1|||
23755836|NCT02595528|66484636|FG001|Overall Study|Lost to Follow-up|1|||
23755837|NCT02595528|66484637|FG002|Overall Study|Lost to Follow-up|0|||
23755838|NCT02595528|66484638|FG003|Overall Study|Lost to Follow-up|1|||
23755839|NCT03959423|66484640|FG000|Overall Study|Withdrawal by Subject|2|||
23755840|NCT03959423|66484641|FG001|Overall Study|Withdrawal by Subject|3|||
23755841|NCT03959423|66484640|FG000|Overall Study|Physician Decision|0|||
23755842|NCT03959423|66484641|FG001|Overall Study|Physician Decision|1|||
23755843|NCT03959423|66484640|FG000|Overall Study|Lost to Follow-up|1|||
23755844|NCT03959423|66484641|FG001|Overall Study|Lost to Follow-up|0|||
23755845|NCT03959423|66484640|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
23755846|NCT03959423|66484641|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23755847|NCT04465916|66484642|FG000|Overall Study|Withdrawal by Subject|0|||
23755848|NCT04465916|66484643|FG001|Overall Study|Withdrawal by Subject|1|||
23755849|NCT00858234|66484646|FG000|Overall Study|Adverse Event|6|||
23755850|NCT00858234|66484646|FG000|Overall Study|Progressive disease|2|||
23755851|NCT00858234|66484646|FG000|Overall Study|Status unknown|1|||
23755852|NCT00479765|66484647|FG000|Overall Study|study terminated|4|||
23755853|NCT00291330|66484648|FG000|Overall Study|Adverse Event|47|||
23755854|NCT00291330|66484649|FG001|Overall Study|Adverse Event|40|||
23755855|NCT00291330|66484648|FG000|Overall Study|Protocol Violation|13|||
23755856|NCT00291330|66484649|FG001|Overall Study|Protocol Violation|20|||
23755857|NCT00291330|66484648|FG000|Overall Study|Lost to Follow-up|16|||
23755858|NCT00291330|66484649|FG001|Overall Study|Lost to Follow-up|11|||
23755859|NCT00291330|66484648|FG000|Overall Study|Withdrawal by Subject|22|||
23755860|NCT00291330|66484649|FG001|Overall Study|Withdrawal by Subject|25|||
23755861|NCT00291330|66484648|FG000|Overall Study|Other|3|||
23755862|NCT00291330|66484649|FG001|Overall Study|Other|1|||
23755863|NCT03591107|66484650|FG000|Overall Study|Same patient in both arms|1|||
23755864|NCT03591107|66484651|FG001|Overall Study|Same patient in both arms|1|||
23755865|NCT03591107|66484650|FG000|Overall Study|Sought care at other clinics|0|||
23755866|NCT03591107|66484651|FG001|Overall Study|Sought care at other clinics|2|||
23755867|NCT03591107|66484650|FG000|Overall Study|Discharged from clinic|0|||
23755868|NCT03591107|66484651|FG001|Overall Study|Discharged from clinic|1|||
23755869|NCT03591107|66484650|FG000|Overall Study|Withdrawal by Subject|0|||
23755870|NCT03591107|66484651|FG001|Overall Study|Withdrawal by Subject|1|||
23755871|NCT01556165|66484652|FG000|Overall Study|Adverse Event|5|||
23755872|NCT01556165|66484653|FG001|Overall Study|Adverse Event|3|||
23755873|NCT01556165|66484652|FG000|Overall Study|Protocol Violation|0|||
23755874|NCT01556165|66484653|FG001|Overall Study|Protocol Violation|3|||
23755875|NCT01556165|66484652|FG000|Overall Study|Withdrawal of Consent|7|||
23755876|NCT01556165|66484653|FG001|Overall Study|Withdrawal of Consent|1|||
23755877|NCT01328054|66484654|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
23755878|NCT01328054|66484655|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
23755879|NCT01328054|66484654|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
23755880|NCT01328054|66484655|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
23755881|NCT01328054|66484654|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
23755882|NCT01328054|66484655|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
23755883|NCT01244516|66484656|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
23624639|NCT02872311|66011736|FG000|Overall Study|Protocol Violation|0|||
23755884|NCT01244516|66484657|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
23755885|NCT01244516|66484658|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
23755886|NCT01244516|66484656|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
23755887|NCT01244516|66484657|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
23755888|NCT01244516|66484658|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
23755889|NCT01244516|66484656|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
23755890|NCT01244516|66484657|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
23755891|NCT01244516|66484658|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
23755892|NCT01244516|66484656|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
23755893|NCT01244516|66484657|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
23755894|NCT01244516|66484658|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
23755895|NCT01244516|66484656|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
23755896|NCT01244516|66484657|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
23755897|NCT01244516|66484658|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
23755898|NCT01244516|66484656|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
23755899|NCT01244516|66484657|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
23755900|NCT01244516|66484658|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
23755901|NCT01244516|66484656|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
23755902|NCT01244516|66484657|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
23755903|NCT01244516|66484658|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
23755904|NCT02428231|66484659|FG000|Overall Study|Other|10|||
23755905|NCT02428231|66484660|FG001|Overall Study|Other|16|||
23755906|NCT02428231|66484659|FG000|Overall Study|Required Symptomatic Therapy|0|||
23755907|NCT02428231|66484660|FG001|Overall Study|Required Symptomatic Therapy|1|||
23755908|NCT02428231|66484659|FG000|Overall Study|Adverse Event|3|||
23755909|NCT02428231|66484660|FG001|Overall Study|Adverse Event|0|||
23755910|NCT02525562|66484662|FG000|Overall Study|Death|9|||
23755911|NCT02525562|66484663|FG001|Overall Study|Death|0|||
23755912|NCT02525562|66484664|FG002|Overall Study|Death|0|||
23755913|NCT02525562|66484662|FG000|Overall Study|Lost to Follow-up|19|||
23755914|NCT02525562|66484663|FG001|Overall Study|Lost to Follow-up|0|||
23755915|NCT02525562|66484664|FG002|Overall Study|Lost to Follow-up|0|||
23755916|NCT02525562|66484662|FG000|Overall Study|Withdrawal by Subject|37|||
23755917|NCT02525562|66484663|FG001|Overall Study|Withdrawal by Subject|0|||
23755918|NCT02525562|66484664|FG002|Overall Study|Withdrawal by Subject|0|||
23755919|NCT02525562|66484662|FG000|Overall Study|Revision/Removal of Study Device|4|||
23755920|NCT02525562|66484663|FG001|Overall Study|Revision/Removal of Study Device|0|||
23755921|NCT02525562|66484664|FG002|Overall Study|Revision/Removal of Study Device|0|||
23755922|NCT02525562|66484662|FG000|Overall Study|Study Closed by Sponsor|154|||
23755923|NCT02525562|66484663|FG001|Overall Study|Study Closed by Sponsor|0|||
23755924|NCT02525562|66484664|FG002|Overall Study|Study Closed by Sponsor|0|||
23755925|NCT01784419|66484668|FG000|Overall Study|Adverse Event|3|||
23755926|NCT02162511|66484669|FG000|Overall Study|Lack of Efficacy|0|||
23755927|NCT02162511|66484670|FG001|Overall Study|Lack of Efficacy|0|||
23755928|NCT02162511|66484671|FG002|Overall Study|Lack of Efficacy|2|||
23755929|NCT02406742|66484689|FG000|Overall Study|Progression of Disease|5|||
23755930|NCT02406742|66484690|FG001|Overall Study|Progression of Disease|1|||
23755931|NCT02406742|66484691|FG002|Overall Study|Progression of Disease|6|||
23755932|NCT02406742|66484689|FG000|Overall Study|Adverse Event|3|||
23755933|NCT02406742|66484690|FG001|Overall Study|Adverse Event|0|||
23755934|NCT02406742|66484691|FG002|Overall Study|Adverse Event|2|||
23755935|NCT02406742|66484689|FG000|Overall Study|Death|1|||
23755936|NCT02406742|66484690|FG001|Overall Study|Death|0|||
23755937|NCT02406742|66484691|FG002|Overall Study|Death|0|||
23755938|NCT02406742|66484689|FG000|Overall Study|Lack of Efficacy|0|||
23755939|NCT02406742|66484690|FG001|Overall Study|Lack of Efficacy|0|||
23755940|NCT02406742|66484691|FG002|Overall Study|Lack of Efficacy|1|||
23560345|NCT02710292|65779682|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
23755941|NCT02406742|66484689|FG000|Overall Study|Withdrawal by Participant|1|||
23755942|NCT02406742|66484690|FG001|Overall Study|Withdrawal by Participant|2|||
23755943|NCT02406742|66484691|FG002|Overall Study|Withdrawal by Participant|0|||
23755944|NCT02406742|66484689|FG000|Overall Study|Physician Decision|1|||
23755945|NCT02406742|66484690|FG001|Overall Study|Physician Decision|2|||
23755946|NCT02406742|66484691|FG002|Overall Study|Physician Decision|1|||
23755947|NCT02406742|66484689|FG000|Overall Study|Transition to other treatment|2|||
23755948|NCT02406742|66484690|FG001|Overall Study|Transition to other treatment|0|||
23755949|NCT02406742|66484691|FG002|Overall Study|Transition to other treatment|1|||
23755950|NCT02406742|66484689|FG000|Overall Study|Other Reasons|1|||
23755951|NCT02406742|66484690|FG001|Overall Study|Other Reasons|11|||
23755952|NCT02406742|66484691|FG002|Overall Study|Other Reasons|5|||
23755953|NCT02441179|66484692|FG000|Overall Study|Withdrawal by Subject|1|||
23755954|NCT02441179|66484693|FG001|Overall Study|Withdrawal by Subject|1|||
23560346|NCT02710292|65779683|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
23560347|NCT02710292|65779682|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
23755955|NCT02564952|66484696|FG000|Overall Study|Adverse Event|6|||
23755956|NCT02564952|66484696|FG000|Overall Study|Lost to Follow-up|1|||
23755957|NCT02564952|66484696|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
23755958|NCT02564952|66484696|FG000|Overall Study|Withdrawal by Subject|1|||
23755959|NCT02564952|66484696|FG000|Overall Study|Low Efficacy|1|||
23755960|NCT02564952|66484696|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23755961|NCT04523831|66484697|FG000|Overall Study|Lost to Follow-up|15|||
23755962|NCT04523831|66484698|FG001|Overall Study|Lost to Follow-up|17|||
23755963|NCT04523831|66484697|FG000|Overall Study|Death|0|||
23755964|NCT04523831|66484698|FG001|Overall Study|Death|3|||
23560348|NCT02710292|65779683|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
23560349|NCT01373931|65779686|FG000|Lead-in Period|Adverse Event|2|||
23560350|NCT01373931|65779687|FG001|Lead-in Period|Adverse Event|0|||
23560351|NCT01373931|65779686|FG000|Period 1|Adverse Event|2|||
23560352|NCT01373931|65779687|FG001|Period 1|Adverse Event|0|||
23560353|NCT01373931|65779686|FG000|Period 1|Withdrawal by Subject|0|||
23560354|NCT01373931|65779687|FG001|Period 1|Withdrawal by Subject|2|||
23560355|NCT03324880|65779688|FG000|Overall Study|Adverse Event|0|||
23560356|NCT03324880|65779689|FG001|Overall Study|Adverse Event|2|||
23560357|NCT03324880|65779688|FG000|Overall Study|Withdrawal by Subject|2|||
23560358|NCT03324880|65779689|FG001|Overall Study|Withdrawal by Subject|2|||
23560359|NCT03324880|65779688|FG000|Overall Study|Lost to Follow-up|0|||
23560360|NCT03324880|65779689|FG001|Overall Study|Lost to Follow-up|1|||
23560361|NCT03324880|65779688|FG000|Overall Study|Product Recall|0|||
23560362|NCT03324880|65779689|FG001|Overall Study|Product Recall|1|||
23560363|NCT04209725|65779690|FG000|Overall Study|Adverse Event|1|||
23560364|NCT01538472|65779701|FG000|Overall Study|Disease Progression|3|||
23560365|NCT01538472|65779701|FG000|Overall Study|Death|1|||
23560366|NCT01489189|65779702|FG000|Overall Study|Withdrawal by Subject|20|||
23560367|NCT01489189|65779703|FG001|Overall Study|Withdrawal by Subject|23|||
23560368|NCT01489189|65779702|FG000|Overall Study|Death|10|||
23560369|NCT01489189|65779703|FG001|Overall Study|Death|8|||
23560370|NCT01489189|65779702|FG000|Overall Study|Missed Visit|1|||
23560371|NCT01489189|65779703|FG001|Overall Study|Missed Visit|4|||
23560372|NCT03308825|65779705|FG000|Overall Study|Lost to Follow-up|2|||
23560373|NCT03308825|65779706|FG001|Overall Study|Lost to Follow-up|2|||
23560374|NCT03308825|65779707|FG002|Overall Study|Lost to Follow-up|1|||
23560375|NCT03308825|65779708|FG003|Overall Study|Lost to Follow-up|0|||
23560376|NCT03308825|65779705|FG000|Overall Study|Protocol Violation|0|||
23560377|NCT03308825|65779706|FG001|Overall Study|Protocol Violation|2|||
23624640|NCT02872311|66011737|FG001|Overall Study|Protocol Violation|2|||
23624641|NCT02872311|66011738|FG002|Overall Study|Protocol Violation|1|||
23624642|NCT02872311|66011739|FG003|Overall Study|Protocol Violation|0|||
23624643|NCT02872311|66011740|FG004|Overall Study|Protocol Violation|0|||
23624644|NCT04706793|66011741|FG000|Treatment|Disease worsening|10|||
23624645|NCT04706793|66011742|FG001|Treatment|Disease worsening|10|||
23624646|NCT04706793|66011741|FG000|Follow-up|Lack of Efficacy|1|||
23624647|NCT04706793|66011742|FG001|Follow-up|Lack of Efficacy|0|||
23624648|NCT04706793|66011741|FG000|Follow-up|Disease worsening|8|||
23624649|NCT04706793|66011742|FG001|Follow-up|Disease worsening|10|||
23624650|NCT04706793|66011741|FG000|Follow-up|Adverse Event|1|||
23624651|NCT04706793|66011742|FG001|Follow-up|Adverse Event|0|||
23624652|NCT00917462|66011743|FG000|Overall Study|Clinical Deterioration|1|||
23624653|NCT00805285|66011746|FG000|Overall Study|Lack of Efficacy|1|||
23624654|NCT03458728|66011747|FG000|Overall Study|Adverse Event|1|||
23624655|NCT03458728|66011748|FG001|Overall Study|Adverse Event|0|||
23624656|NCT03458728|66011747|FG000|Overall Study|Physician Decision|1|||
23624657|NCT03458728|66011748|FG001|Overall Study|Physician Decision|0|||
23624658|NCT03458728|66011747|FG000|Overall Study|Progressive disease - clinical assessment|1|||
23624659|NCT03458728|66011748|FG001|Overall Study|Progressive disease - clinical assessment|0|||
23624660|NCT03458728|66011747|FG000|Overall Study|Progressive disease - radiological progression|21|||
23624661|NCT03458728|66011748|FG001|Overall Study|Progressive disease - radiological progression|6|||
23624662|NCT03458728|66011747|FG000|Overall Study|Withdrawal by Subject|0|||
23624663|NCT03458728|66011748|FG001|Overall Study|Withdrawal by Subject|1|||
23624664|NCT01461005|66011753|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
23624665|NCT00704171|66011754|FG000|Overall Study|Withdrawal by Subject|1|||
23624666|NCT00704171|66011755|FG001|Overall Study|Withdrawal by Subject|0|||
23755965|NCT04523831|66484697|FG000|Overall Study|Adverse Event|2|||
23755966|NCT04523831|66484698|FG001|Overall Study|Adverse Event|0|||
23560378|NCT03308825|65779707|FG002|Overall Study|Protocol Violation|0|||
23560379|NCT03308825|65779708|FG003|Overall Study|Protocol Violation|0|||
23624667|NCT01919398|66011756|FG000|Overall Study|Progressive Disease|0|||
23624668|NCT01919398|66011757|FG001|Overall Study|Progressive Disease|0|||
23624669|NCT01919398|66011758|FG002|Overall Study|Progressive Disease|4|||
23624670|NCT01710800|66011759|FG000|Overall Study|Withdrawal by Subject|21|||
23624671|NCT01710800|66011759|FG000|Overall Study|Protocol Violation|1|||
23560380|NCT03573908|65779709|FG000|Treatment Period|Adverse Event|4|||
23624672|NCT01801982|66011760|FG000|Overall Study|Lost to Follow-up|1|||
23624673|NCT00745498|66011761|FG000|Overall Study|Lost to Follow-up|1|||
23624674|NCT00745498|66011762|FG001|Overall Study|Lost to Follow-up|1|||
23560381|NCT03573908|65779710|FG001|Treatment Period|Adverse Event|9|||
23560382|NCT03573908|65779711|FG002|Treatment Period|Adverse Event|0|||
23560383|NCT03573908|65779712|FG003|Treatment Period|Adverse Event|0|||
23560384|NCT03573908|65779713|FG004|Treatment Period|Adverse Event|0|||
23624675|NCT00745498|66011763|FG002|Overall Study|Lost to Follow-up|3|||
23624676|NCT00745498|66011761|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
23755967|NCT00068445|66484701|FG000|Randomization|Cancel|1|||
23560385|NCT03573908|65779709|FG000|Treatment Period|Protocol Violation|1|||
23560386|NCT03573908|65779710|FG001|Treatment Period|Protocol Violation|0|||
23755968|NCT00068445|66484702|FG001|Randomization|Cancel|3|||
23755969|NCT00068445|66484701|FG000|Randomization|Ineligible|1|||
23755970|NCT00068445|66484702|FG001|Randomization|Ineligible|1|||
23755971|NCT00068445|66484701|FG000|Treatment|Refused Further Treatment|13|||
23755972|NCT00068445|66484702|FG001|Treatment|Refused Further Treatment|10|||
23755973|NCT00068445|66484701|FG000|Treatment|Adverse Event|7|||
23755974|NCT00068445|66484702|FG001|Treatment|Adverse Event|1|||
23755975|NCT00068445|66484701|FG000|Treatment|Other (Specifics not available)|9|||
23755976|NCT00068445|66484702|FG001|Treatment|Other (Specifics not available)|5|||
23755977|NCT02524665|66484703|FG000|Overall Study|Lost to Follow-up|1|||
23755978|NCT01010230|66484704|FG000|Overall Study|Withdrawal by Subject|6|||
23755979|NCT01010230|66484705|FG001|Overall Study|Withdrawal by Subject|5|||
23755980|NCT01010230|66484704|FG000|Overall Study|Lost to Follow-up|4|||
23755981|NCT01010230|66484705|FG001|Overall Study|Lost to Follow-up|2|||
23755982|NCT02149199|66484716|FG000|Overall Study|Study specific withdrawal criteria|4|||
23755983|NCT02149199|66484717|FG001|Overall Study|Study specific withdrawal criteria|21|||
23340858|NCT01936181|64992871|FG001|Randomised, Double-blind|Pregnancy|1|||
23340859|NCT01936181|64992872|FG002|Randomised, Double-blind|Pregnancy|0|||
23340860|NCT01936181|64992873|FG003|Randomised, Double-blind|Pregnancy|0|||
23340861|NCT01936181|64992870|FG000|Randomised, Double-blind|Physician Decision|4|||
23340862|NCT01936181|64992871|FG001|Randomised, Double-blind|Physician Decision|4|||
23340863|NCT01936181|64992872|FG002|Randomised, Double-blind|Physician Decision|0|||
23340864|NCT01936181|64992873|FG003|Randomised, Double-blind|Physician Decision|0|||
23340865|NCT01936181|64992870|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
23438020|NCT01564732|65344291|FG000|Overall Study|Early termination by the study sponsor|6|||
23438021|NCT01564732|65344292|FG001|Overall Study|Early termination by the study sponsor|5|||
23755984|NCT02149199|66484718|FG002|Overall Study|Study specific withdrawal criteria|6|||
23755985|NCT02149199|66484716|FG000|Overall Study|Other|20|||
23755986|NCT02149199|66484717|FG001|Overall Study|Other|25|||
23755987|NCT02149199|66484718|FG002|Overall Study|Other|20|||
23624677|NCT00745498|66011762|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
23624678|NCT00745498|66011763|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
23624679|NCT00745498|66011761|FG000|Overall Study|Non-PDR related VH|0|||
23624680|NCT00745498|66011762|FG001|Overall Study|Non-PDR related VH|1|||
23624681|NCT00745498|66011763|FG002|Overall Study|Non-PDR related VH|1|||
23624682|NCT00745498|66011761|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
23624683|NCT00745498|66011762|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
23624684|NCT00745498|66011763|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
23560387|NCT03573908|65779711|FG002|Treatment Period|Protocol Violation|0|||
23560388|NCT03573908|65779712|FG003|Treatment Period|Protocol Violation|0|||
23560389|NCT03573908|65779713|FG004|Treatment Period|Protocol Violation|0|||
23560390|NCT03573908|65779709|FG000|Treatment Period|Withdrawal by Subject|7|||
23560391|NCT03573908|65779710|FG001|Treatment Period|Withdrawal by Subject|5|||
23560392|NCT03573908|65779711|FG002|Treatment Period|Withdrawal by Subject|0|||
23560393|NCT03573908|65779712|FG003|Treatment Period|Withdrawal by Subject|0|||
23560394|NCT03573908|65779713|FG004|Treatment Period|Withdrawal by Subject|0|||
23560395|NCT03573908|65779709|FG000|Treatment Period|Lost to Follow-up|7|||
23560396|NCT03573908|65779710|FG001|Treatment Period|Lost to Follow-up|6|||
23560397|NCT03573908|65779711|FG002|Treatment Period|Lost to Follow-up|0|||
23560398|NCT03573908|65779712|FG003|Treatment Period|Lost to Follow-up|0|||
23560399|NCT03573908|65779713|FG004|Treatment Period|Lost to Follow-up|0|||
23560400|NCT03573908|65779709|FG000|Treatment Period|Pregnancy|1|||
23560401|NCT03573908|65779710|FG001|Treatment Period|Pregnancy|0|||
23560402|NCT03573908|65779711|FG002|Treatment Period|Pregnancy|0|||
23560403|NCT03573908|65779712|FG003|Treatment Period|Pregnancy|0|||
23560404|NCT03573908|65779713|FG004|Treatment Period|Pregnancy|0|||
23560405|NCT03573908|65779709|FG000|Treatment Period|Other, Not Specified|4|||
23560406|NCT03573908|65779710|FG001|Treatment Period|Other, Not Specified|6|||
23560407|NCT03573908|65779711|FG002|Treatment Period|Other, Not Specified|0|||
23560408|NCT03573908|65779712|FG003|Treatment Period|Other, Not Specified|0|||
23560409|NCT03573908|65779713|FG004|Treatment Period|Other, Not Specified|0|||
23560410|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23560411|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Adverse Event|0|||
23560412|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Adverse Event|3|||
23560413|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Adverse Event|0|||
23560414|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Adverse Event|0|||
23560415|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560416|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560417|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560418|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560419|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
23560420|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560421|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560422|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
23560423|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560424|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560425|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
23560426|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
23560427|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
23560428|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
23560429|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
23560430|NCT00847405|65779714|FG000|First Intervention|Adverse Event|0|||
23560431|NCT00847405|65779715|FG001|First Intervention|Adverse Event|1|||
23560432|NCT00847405|65779714|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23624685|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
23624686|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
23624687|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
23624688|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Death|0|||
23624689|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Death|0|||
23560433|NCT00847405|65779715|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23560434|NCT03585296|65779718|FG000|Overall Study|Adverse Event|1|||
23560435|NCT03585296|65779718|FG000|Overall Study|Lost to Follow-up|2|||
23560436|NCT03585296|65779718|FG000|Overall Study|Withdrawal by Subject|2|||
23560437|NCT03928028|65779719|FG000|Overall Study|Physician Decision|9|||
23560438|NCT03928028|65779720|FG001|Overall Study|Physician Decision|6|||
23624690|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Death|1|||
23624691|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
23624692|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
23560439|NCT03928028|65779721|FG002|Overall Study|Physician Decision|3|||
23755988|NCT02149199|66484716|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
23755989|NCT02149199|66484717|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
23755990|NCT02149199|66484718|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
23755991|NCT02149199|66484716|FG000|Overall Study|Withdrawal by Subject|75|||
23755992|NCT02149199|66484717|FG001|Overall Study|Withdrawal by Subject|93|||
23755993|NCT02149199|66484718|FG002|Overall Study|Withdrawal by Subject|77|||
23755994|NCT02149199|66484716|FG000|Overall Study|Protocol Violation|16|||
23755995|NCT02149199|66484717|FG001|Overall Study|Protocol Violation|13|||
23755996|NCT02149199|66484718|FG002|Overall Study|Protocol Violation|15|||
23755997|NCT02149199|66484716|FG000|Overall Study|Lost to Follow-up|3|||
23755998|NCT02149199|66484717|FG001|Overall Study|Lost to Follow-up|12|||
23755999|NCT02149199|66484718|FG002|Overall Study|Lost to Follow-up|11|||
23756000|NCT02149199|66484716|FG000|Overall Study|Death|0|||
23756001|NCT02149199|66484717|FG001|Overall Study|Death|0|||
23756002|NCT02149199|66484718|FG002|Overall Study|Death|1|||
23756003|NCT02149199|66484716|FG000|Overall Study|Adverse Event|6|||
23756004|NCT02149199|66484717|FG001|Overall Study|Adverse Event|15|||
23756005|NCT02149199|66484718|FG002|Overall Study|Adverse Event|9|||
23756006|NCT04508621|66484719|FG000|Overall Study|Adverse Event|39|||
23756007|NCT04508621|66484720|FG001|Overall Study|Adverse Event|16|||
23756008|NCT04508621|66484719|FG000|Overall Study|Lack of Efficacy|2|||
23756009|NCT04508621|66484720|FG001|Overall Study|Lack of Efficacy|8|||
23756010|NCT04508621|66484719|FG000|Overall Study|Physician Decision|0|||
23756011|NCT04508621|66484720|FG001|Overall Study|Physician Decision|1|||
23756012|NCT04508621|66484719|FG000|Overall Study|Withdrawal by Subject|10|||
23756013|NCT04508621|66484720|FG001|Overall Study|Withdrawal by Subject|14|||
23756014|NCT04508621|66484719|FG000|Overall Study|Lost to Follow-up|12|||
23756015|NCT04508621|66484720|FG001|Overall Study|Lost to Follow-up|9|||
23756016|NCT04508621|66484719|FG000|Overall Study|COVID-19 related crisis|3|||
23756017|NCT04508621|66484720|FG001|Overall Study|COVID-19 related crisis|0|||
23756018|NCT04508621|66484719|FG000|Overall Study|Subject non-compliance|1|||
23756019|NCT04508621|66484720|FG001|Overall Study|Subject non-compliance|0|||
23756020|NCT02173301|66484729|FG000|Overall Study|Adverse Event|7|||
23756021|NCT02173301|66484730|FG001|Overall Study|Adverse Event|8|||
23756022|NCT02173301|66484731|FG002|Overall Study|Adverse Event|13|||
23560440|NCT03928028|65779719|FG000|Overall Study|Withdrawal by Subject|12|||
23560441|NCT03928028|65779720|FG001|Overall Study|Withdrawal by Subject|3|||
23560442|NCT03928028|65779721|FG002|Overall Study|Withdrawal by Subject|3|||
23560443|NCT02296190|65779724|FG000|Overall Study|Lost to Follow-up|0|||
23756023|NCT02173301|66484732|FG003|Overall Study|Adverse Event|5|||
23756024|NCT02173301|66484729|FG000|Overall Study|Withdrawal by Subject|8|||
23756025|NCT02173301|66484730|FG001|Overall Study|Withdrawal by Subject|10|||
23756026|NCT02173301|66484731|FG002|Overall Study|Withdrawal by Subject|4|||
23756027|NCT02173301|66484732|FG003|Overall Study|Withdrawal by Subject|8|||
23756028|NCT02173301|66484729|FG000|Overall Study|Lost to Follow-up|4|||
23756029|NCT02173301|66484730|FG001|Overall Study|Lost to Follow-up|4|||
23756030|NCT02173301|66484731|FG002|Overall Study|Lost to Follow-up|2|||
23756031|NCT02173301|66484732|FG003|Overall Study|Lost to Follow-up|2|||
23756032|NCT02173301|66484729|FG000|Overall Study|Protocol Violation|0|||
23756033|NCT02173301|66484730|FG001|Overall Study|Protocol Violation|1|||
23756034|NCT02173301|66484731|FG002|Overall Study|Protocol Violation|0|||
23756035|NCT02173301|66484732|FG003|Overall Study|Protocol Violation|0|||
23756036|NCT02173301|66484729|FG000|Overall Study|Physician Decision|0|||
23756037|NCT02173301|66484730|FG001|Overall Study|Physician Decision|0|||
23560444|NCT02296190|65779725|FG001|Overall Study|Lost to Follow-up|0|||
23560445|NCT02296190|65779726|FG002|Overall Study|Lost to Follow-up|0|||
23756038|NCT02173301|66484731|FG002|Overall Study|Physician Decision|1|||
23756039|NCT02173301|66484732|FG003|Overall Study|Physician Decision|0|||
23756040|NCT02173301|66484729|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
23438022|NCT02697435|65344293|FG000|Overall Study|Withdrawal by Subject|1|||
23438023|NCT02697435|65344294|FG001|Overall Study|Withdrawal by Subject|0|||
23624693|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
23624694|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
23624695|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
23624696|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
23624697|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
23624698|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
23624699|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
23624700|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
23624701|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
23624702|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
23624703|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Death|0|||
23624704|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Death|1|||
23624705|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Death|0|||
23624706|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
23624707|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
23624708|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
23624709|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
23624710|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
23624711|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
23624712|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
23624713|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
23624714|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
23624715|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
23756041|NCT02173301|66484730|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23756042|NCT02173301|66484731|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23756043|NCT02173301|66484732|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23756044|NCT03876873|66484733|FG000|Overall Study|Physician Decision|0|||
23756045|NCT03876873|66484734|FG001|Overall Study|Physician Decision|1|||
23756046|NCT02200614|66484737|FG000|Double Blind Treatment|Adverse Event|86|||
23756047|NCT02200614|66484738|FG001|Double Blind Treatment|Adverse Event|48|||
23560446|NCT02296190|65779727|FG003|Overall Study|Lost to Follow-up|0|||
23560447|NCT02296190|65779728|FG004|Overall Study|Lost to Follow-up|1|||
23560448|NCT02296190|65779729|FG005|Overall Study|Lost to Follow-up|0|||
23560449|NCT02296190|65779724|FG000|Overall Study|Failure to induce PSVT|6|||
23560450|NCT02296190|65779725|FG001|Overall Study|Failure to induce PSVT|10|||
23560451|NCT02296190|65779726|FG002|Overall Study|Failure to induce PSVT|5|||
23560452|NCT02296190|65779727|FG003|Overall Study|Failure to induce PSVT|13|||
23560453|NCT02296190|65779728|FG004|Overall Study|Failure to induce PSVT|8|||
23560454|NCT02296190|65779729|FG005|Overall Study|Failure to induce PSVT|0|||
23560455|NCT02296190|65779724|FG000|Overall Study|Physician Decision|1|||
23560456|NCT02296190|65779725|FG001|Overall Study|Physician Decision|1|||
23560457|NCT02296190|65779726|FG002|Overall Study|Physician Decision|0|||
23560458|NCT02296190|65779727|FG003|Overall Study|Physician Decision|1|||
23560459|NCT02296190|65779728|FG004|Overall Study|Physician Decision|2|||
23560460|NCT02296190|65779729|FG005|Overall Study|Physician Decision|0|||
23560461|NCT02296190|65779724|FG000|Overall Study|Withdrawal by Subject|0|||
23560462|NCT02296190|65779725|FG001|Overall Study|Withdrawal by Subject|1|||
23560463|NCT02296190|65779726|FG002|Overall Study|Withdrawal by Subject|0|||
23560464|NCT02296190|65779727|FG003|Overall Study|Withdrawal by Subject|0|||
23560465|NCT02296190|65779728|FG004|Overall Study|Withdrawal by Subject|0|||
23560466|NCT02296190|65779729|FG005|Overall Study|Withdrawal by Subject|0|||
23560467|NCT02296190|65779724|FG000|Overall Study|PSVT < 5 minutes|5|||
23560468|NCT02296190|65779725|FG001|Overall Study|PSVT < 5 minutes|6|||
23560469|NCT02296190|65779726|FG002|Overall Study|PSVT < 5 minutes|6|||
23560470|NCT02296190|65779727|FG003|Overall Study|PSVT < 5 minutes|6|||
23560471|NCT02296190|65779728|FG004|Overall Study|PSVT < 5 minutes|5|||
23560472|NCT02296190|65779729|FG005|Overall Study|PSVT < 5 minutes|0|||
23560473|NCT02296190|65779724|FG000|Overall Study|Patient was given Propofol|0|||
23560474|NCT02296190|65779725|FG001|Overall Study|Patient was given Propofol|1|||
23560475|NCT02296190|65779726|FG002|Overall Study|Patient was given Propofol|0|||
23560476|NCT02296190|65779727|FG003|Overall Study|Patient was given Propofol|1|||
23560477|NCT02296190|65779728|FG004|Overall Study|Patient was given Propofol|0|||
23560478|NCT02296190|65779729|FG005|Overall Study|Patient was given Propofol|0|||
23560479|NCT02296190|65779724|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
23560480|NCT02296190|65779725|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
23560481|NCT02296190|65779726|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
23560482|NCT02296190|65779727|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
23560483|NCT02296190|65779728|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
23560484|NCT02296190|65779729|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
23560485|NCT02296190|65779724|FG000|Overall Study|Blood pressure <100 after sedation|0|||
23756048|NCT02200614|66484737|FG000|Double Blind Treatment|Confirmed metastasis|120|||
23756049|NCT02200614|66484738|FG001|Double Blind Treatment|Confirmed metastasis|140|||
23756050|NCT02200614|66484737|FG000|Double Blind Treatment|Judgment of the investigator|59|||
23756051|NCT02200614|66484738|FG001|Double Blind Treatment|Judgment of the investigator|99|||
23756052|NCT02200614|66484737|FG000|Double Blind Treatment|Metastasis by local reading|1|||
23756053|NCT02200614|66484738|FG001|Double Blind Treatment|Metastasis by local reading|3|||
23756054|NCT02200614|66484737|FG000|Double Blind Treatment|Other reason|6|||
23560486|NCT02296190|65779725|FG001|Overall Study|Blood pressure <100 after sedation|0|||
23560487|NCT02296190|65779726|FG002|Overall Study|Blood pressure <100 after sedation|0|||
23560488|NCT02296190|65779727|FG003|Overall Study|Blood pressure <100 after sedation|1|||
23560489|NCT02296190|65779728|FG004|Overall Study|Blood pressure <100 after sedation|0|||
23560490|NCT02296190|65779729|FG005|Overall Study|Blood pressure <100 after sedation|0|||
23560491|NCT02296190|65779724|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560492|NCT02296190|65779725|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
23560493|NCT02296190|65779726|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
23756055|NCT02200614|66484738|FG001|Double Blind Treatment|Other reason|2|||
23756056|NCT02200614|66484737|FG000|Double Blind Treatment|Personal reason|77|||
23756057|NCT02200614|66484738|FG001|Double Blind Treatment|Personal reason|85|||
23756058|NCT02200614|66484737|FG000|Double Blind Treatment|Protocol deviation|14|||
23756059|NCT02200614|66484738|FG001|Double Blind Treatment|Protocol deviation|7|||
23756060|NCT02200614|66484737|FG000|Double Blind Treatment|Not treated|1|||
23560494|NCT02296190|65779727|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560495|NCT02296190|65779728|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560496|NCT02296190|65779729|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23756061|NCT02200614|66484738|FG001|Double Blind Treatment|Not treated|0|||
23756062|NCT02200614|66484737|FG000|Open Label|Adverse Event|41|||
23756063|NCT02200614|66484738|FG001|Open Label|Adverse Event|11|||
23756064|NCT02200614|66484737|FG000|Open Label|Confirmed metastasis|1|||
23756065|NCT02200614|66484738|FG001|Open Label|Confirmed metastasis|0|||
23756066|NCT02200614|66484737|FG000|Open Label|Judgment of the investigator|29|||
23756067|NCT02200614|66484738|FG001|Open Label|Judgment of the investigator|2|||
23756068|NCT02200614|66484737|FG000|Open Label|Metastasis by local reading|138|||
23756069|NCT02200614|66484738|FG001|Open Label|Metastasis by local reading|27|||
23756070|NCT02200614|66484737|FG000|Open Label|Other reason|22|||
23756071|NCT02200614|66484738|FG001|Open Label|Other reason|4|||
23756072|NCT02200614|66484737|FG000|Open Label|Personal reason|60|||
23756073|NCT02200614|66484738|FG001|Open Label|Personal reason|8|||
23756074|NCT02200614|66484737|FG000|Open Label|Protocol deviation|3|||
23756075|NCT02200614|66484738|FG001|Open Label|Protocol deviation|2|||
23756076|NCT02200614|66484737|FG000|Open Label|Missing|2|||
23756077|NCT02200614|66484738|FG001|Open Label|Missing|2|||
23756078|NCT02125734|66484739|FG000|Period 2|Adverse Event|0|||
23826081|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
23624716|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
23756079|NCT02125734|66484740|FG001|Period 2|Adverse Event|1|||
23756080|NCT00943384|66484741|FG000|Overall Study|Dispositioned prior to treatment|23|||
23756081|NCT00943384|66484741|FG000|Overall Study|Treated off protocol-protocol violation|5|||
23756082|NCT00943384|66484741|FG000|Overall Study|Lost to Follow-up|16|||
23756083|NCT00943384|66484741|FG000|Overall Study|Withdrawal by Subject|5|||
23826082|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
23843102|NCT01738503|66805585|FG004|Treatment Period|Protocol Violation|4|||
23560497|NCT02296190|65779724|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
23560498|NCT02296190|65779725|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
23756084|NCT01339000|66487132|FG000|Overall Study|study closed due to lack of drug supply|1|||
23756085|NCT01339000|66487133|FG001|Overall Study|study closed due to lack of drug supply|0|||
23756086|NCT00827359|66487134|FG000|Overall Study|Progressive Diseas|19|||
23756087|NCT00827359|66487134|FG000|Overall Study|Unacceptable Toxicity|5|||
23756088|NCT00827359|66487134|FG000|Overall Study|Ineligible|1|||
23756089|NCT00585039|66487141|FG000|Overall Study|medication spilled|2|||
23756090|NCT00585039|66487142|FG001|Overall Study|medication spilled|0|||
23756091|NCT01345058|66487143|FG000|Overall Study|Withdrawal by Subject|1|||
23756092|NCT01345058|66487144|FG001|Overall Study|Withdrawal by Subject|0|||
23756093|NCT01345058|66487143|FG000|Overall Study|Participant Reported Increase in Events|1|||
23756094|NCT01345058|66487144|FG001|Overall Study|Participant Reported Increase in Events|0|||
23756095|NCT01345058|66487143|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
23756096|NCT01345058|66487144|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
23756097|NCT01345058|66487143|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
23756098|NCT01345058|66487144|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
23756099|NCT01345058|66487143|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
23756100|NCT01345058|66487144|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
23756101|NCT02956005|66487148|FG000|Overall Study|Not eligible|1|||
23756102|NCT02956005|66487148|FG000|Overall Study|Withdrawal by Subject|3|||
23756103|NCT02956005|66487148|FG000|Overall Study|Physician Decision|12|||
23756104|NCT01005680|66487157|FG000|Overall Study|Lost to Follow-up|4|||
23756105|NCT01005680|66487158|FG001|Overall Study|Lost to Follow-up|6|||
23756106|NCT01005680|66487157|FG000|Overall Study|Withdrawal by Subject|1|||
23756107|NCT01005680|66487158|FG001|Overall Study|Withdrawal by Subject|4|||
23756108|NCT01005680|66487157|FG000|Overall Study|Physician Decision|1|||
23756109|NCT01005680|66487158|FG001|Overall Study|Physician Decision|1|||
23756110|NCT01896700|66487159|FG000|Overall Study|Adverse Event|4|||
23756111|NCT01896700|66487160|FG001|Overall Study|Adverse Event|5|||
23756112|NCT01896700|66487159|FG000|Overall Study|Withdrawal by Subject|0|||
23756113|NCT01896700|66487160|FG001|Overall Study|Withdrawal by Subject|1|||
23756114|NCT02574260|66487161|FG000|Overall Study|Disease Progression|1|||
23756115|NCT02962739|66487162|FG000|Overall Study|Withdrawal by Subject|0|||
23756116|NCT02962739|66487163|FG001|Overall Study|Withdrawal by Subject|1|||
23756117|NCT02962739|66487164|FG002|Overall Study|Withdrawal by Subject|0|||
23756118|NCT02962739|66487165|FG003|Overall Study|Withdrawal by Subject|0|||
23756119|NCT02962739|66487166|FG004|Overall Study|Withdrawal by Subject|0|||
23756120|NCT02962739|66487167|FG005|Overall Study|Withdrawal by Subject|0|||
23756121|NCT02962739|66487162|FG000|Overall Study|Protocol Violation|0|||
23756122|NCT02962739|66487163|FG001|Overall Study|Protocol Violation|0|||
23756123|NCT02962739|66487164|FG002|Overall Study|Protocol Violation|1|||
23756124|NCT02962739|66487165|FG003|Overall Study|Protocol Violation|0|||
23756125|NCT02962739|66487166|FG004|Overall Study|Protocol Violation|1|||
23756126|NCT02962739|66487167|FG005|Overall Study|Protocol Violation|0|||
23756127|NCT02766088|66487168|FG000|Overall Study|Sponsor study termination|498|||
23756128|NCT02766088|66487168|FG000|Overall Study|Migrated/moved from the study area|1|||
23756129|NCT02766088|66487168|FG000|Overall Study|Lost to Follow-up|5|||
23756130|NCT02766088|66487168|FG000|Overall Study|Other|1|||
23756131|NCT02766088|66487168|FG000|Overall Study|Death|1|||
23756132|NCT03547531|66487169|FG000|Overall Study|not coming in data collection : sick|2|||
23756133|NCT03547531|66487170|FG001|Overall Study|not coming in data collection : sick|2|||
23756134|NCT03547531|66487169|FG000|Overall Study|having family occasion|0|||
23756135|NCT03547531|66487170|FG001|Overall Study|having family occasion|2|||
23756136|NCT00835068|66487171|FG000|Overall Study|Death|1|||
23756137|NCT00835068|66487172|FG001|Overall Study|Death|0|||
23756138|NCT00835068|66487171|FG000|Overall Study|Adverse Event|0|||
23756139|NCT00835068|66487172|FG001|Overall Study|Adverse Event|1|||
23756140|NCT00835068|66487171|FG000|Overall Study|Other|8|||
23756141|NCT00835068|66487172|FG001|Overall Study|Other|0|||
23756142|NCT00835068|66487171|FG000|Overall Study|Withdrawal by Subject|1|||
23756143|NCT00835068|66487172|FG001|Overall Study|Withdrawal by Subject|0|||
23756144|NCT00420290|66487175|FG000|Overall Study|Adverse Event|3|||
23756145|NCT00420290|66487176|FG001|Overall Study|Adverse Event|1|||
23756146|NCT00420290|66487175|FG000|Overall Study|Withdrawal by Subject|0|||
23756147|NCT00420290|66487176|FG001|Overall Study|Withdrawal by Subject|2|||
23560499|NCT02296190|65779726|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
23756148|NCT00420290|66487175|FG000|Overall Study|did not meet inclusion/exclusion|1|||
23756149|NCT00420290|66487176|FG001|Overall Study|did not meet inclusion/exclusion|1|||
23756150|NCT01123980|66487179|FG000|Overall Study|Adverse Event|1|||
23756151|NCT01123980|66487180|FG001|Overall Study|Adverse Event|1|||
23756152|NCT01123980|66487179|FG000|Overall Study|Lack of Efficacy|1|||
23756153|NCT01123980|66487180|FG001|Overall Study|Lack of Efficacy|0|||
23756154|NCT01123980|66487179|FG000|Overall Study|Physician Decision|0|||
23756155|NCT01123980|66487180|FG001|Overall Study|Physician Decision|1|||
23756156|NCT01123980|66487179|FG000|Overall Study|Lost to Follow-up|0|||
23756157|NCT01123980|66487180|FG001|Overall Study|Lost to Follow-up|6|||
23756158|NCT01123980|66487179|FG000|Overall Study|Protocol Violation|6|||
23560500|NCT02296190|65779727|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
23560501|NCT02296190|65779728|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
23560502|NCT02296190|65779729|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
23624717|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
23624718|NCT04582669|66011767|FG000|Overall Study|Subject missed appointment(s).|1|||
23624719|NCT04582669|66011768|FG001|Overall Study|Subject missed appointment(s).|0|||
23624720|NCT04582669|66011769|FG002|Overall Study|Subject missed appointment(s).|1|||
23624721|NCT04582669|66011770|FG003|Overall Study|Subject missed appointment(s).|2|||
23624722|NCT04582669|66011767|FG000|Overall Study|Protocol Violation|0|||
23624723|NCT04582669|66011768|FG001|Overall Study|Protocol Violation|1|||
23624724|NCT04582669|66011769|FG002|Overall Study|Protocol Violation|1|||
23624725|NCT04582669|66011770|FG003|Overall Study|Protocol Violation|0|||
23624726|NCT02418845|66011771|FG000|Overall Study|Lost to Follow-up|7|||
23624727|NCT02418845|66011772|FG001|Overall Study|Lost to Follow-up|2|||
23624728|NCT02418845|66011771|FG000|Overall Study|Lack of Efficacy|0|||
23624729|NCT02418845|66011772|FG001|Overall Study|Lack of Efficacy|3|||
23624730|NCT02418845|66011771|FG000|Overall Study|Physician Decision|5|||
23624731|NCT02418845|66011772|FG001|Overall Study|Physician Decision|5|||
23624732|NCT02418845|66011771|FG000|Overall Study|Protocol Violation|1|||
23624733|NCT02418845|66011772|FG001|Overall Study|Protocol Violation|0|||
23624734|NCT02418845|66011771|FG000|Overall Study|Withdrawal by Subject|3|||
23624735|NCT02418845|66011772|FG001|Overall Study|Withdrawal by Subject|2|||
23624736|NCT00508274|66011773|FG000|Overall Study|Adverse Event|5|||
23624737|NCT00508274|66011773|FG000|Overall Study|Death|7|||
23624738|NCT00508274|66011773|FG000|Overall Study|Disease progression|32|||
23624739|NCT00508274|66011773|FG000|Overall Study|Withdrawal by Subject|1|||
23624740|NCT00508274|66011773|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
23624741|NCT00508274|66011773|FG000|Overall Study|Missing|3|||
23624742|NCT00715117|66011774|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
23624743|NCT00715117|66011775|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
23756159|NCT01123980|66487180|FG001|Overall Study|Protocol Violation|6|||
23560503|NCT02296190|65779724|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560504|NCT02296190|65779725|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
23560505|NCT02296190|65779726|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560506|NCT02296190|65779727|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560507|NCT02296190|65779728|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560508|NCT02296190|65779729|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560509|NCT02296190|65779724|FG000|Overall Study|Lab result not available in time|1|||
23560510|NCT02296190|65779725|FG001|Overall Study|Lab result not available in time|0|||
23560511|NCT02296190|65779726|FG002|Overall Study|Lab result not available in time|0|||
23560512|NCT02296190|65779727|FG003|Overall Study|Lab result not available in time|0|||
23560513|NCT02296190|65779728|FG004|Overall Study|Lab result not available in time|0|||
23560514|NCT02296190|65779729|FG005|Overall Study|Lab result not available in time|0|||
23560515|NCT03642938|65779731|FG000|Overall Study|Withdrawal by Subject|0|||
23560516|NCT03642938|65779732|FG001|Overall Study|Withdrawal by Subject|0|||
23756160|NCT01123980|66487179|FG000|Overall Study|Withdrawal by Subject|5|||
23756161|NCT01123980|66487180|FG001|Overall Study|Withdrawal by Subject|3|||
23756162|NCT01123980|66487179|FG000|Overall Study|Unclassified|6|||
23756163|NCT01123980|66487180|FG001|Overall Study|Unclassified|7|||
23756164|NCT00829439|66487183|FG000|Overall Study|Adverse Event|0|||
23756165|NCT00829439|66487184|FG001|Overall Study|Adverse Event|0|||
23756166|NCT00829439|66487185|FG002|Overall Study|Adverse Event|1|||
23756167|NCT00829439|66487186|FG003|Overall Study|Adverse Event|0|||
23756168|NCT00640614|66487189|FG000|Overall Study|Lost to Follow-up|1|||
23756169|NCT00640614|66487190|FG001|Overall Study|Lost to Follow-up|0|||
23560517|NCT03642938|65779733|FG002|Overall Study|Withdrawal by Subject|0|||
23756170|NCT01625286|66487192|FG000|Overall Study|Adverse Event|0|||
23560518|NCT03642938|65779734|FG003|Overall Study|Withdrawal by Subject|1|||
23560519|NCT03078816|65779745|FG000|Overall Study|Withdrawal by Subject|1|||
23560520|NCT01966003|65779752|FG000|Overall Study|Death|43|||
23560521|NCT01966003|65779753|FG001|Overall Study|Death|36|||
23560522|NCT01966003|65779752|FG000|Overall Study|Protocol Violation|6|||
23560523|NCT01966003|65779753|FG001|Overall Study|Protocol Violation|4|||
23560524|NCT01966003|65779752|FG000|Overall Study|Lost to Follow-up|4|||
23560525|NCT01966003|65779753|FG001|Overall Study|Lost to Follow-up|3|||
23560526|NCT01966003|65779752|FG000|Overall Study|Physician Decision|12|||
23560527|NCT01966003|65779753|FG001|Overall Study|Physician Decision|13|||
23560528|NCT01966003|65779752|FG000|Overall Study|Withdrawal by Subject|29|||
23560529|NCT01966003|65779753|FG001|Overall Study|Withdrawal by Subject|19|||
23560530|NCT01966003|65779752|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
23560531|NCT01966003|65779753|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
23560532|NCT01966003|65779752|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
23560533|NCT01966003|65779753|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
23560534|NCT01966003|65779752|FG000|Overall Study|Other|1|||
23560535|NCT01966003|65779753|FG001|Overall Study|Other|1|||
23560536|NCT01644734|65779756|FG000|Overall Study|Adverse Event|4|||
23560537|NCT01644734|65779756|FG000|Overall Study|Lost to Follow-up|17|||
23560538|NCT01644734|65779756|FG000|Overall Study|Reasons other than stated above|7|||
23560539|NCT01644734|65779756|FG000|Overall Study|Missing documentation|238|||
23560540|NCT01226511|65779762|FG000|Acute Treatment Period|Adverse Event|7|||
23560541|NCT01226511|65779763|FG001|Acute Treatment Period|Adverse Event|6|||
23560542|NCT01226511|65779762|FG000|Acute Treatment Period|Lack of Efficacy|2|||
23560543|NCT01226511|65779763|FG001|Acute Treatment Period|Lack of Efficacy|1|||
23560544|NCT01226511|65779762|FG000|Acute Treatment Period|Lost to Follow-up|3|||
23560545|NCT01226511|65779763|FG001|Acute Treatment Period|Lost to Follow-up|6|||
23560546|NCT01226511|65779762|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
23560547|NCT01226511|65779763|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
23560548|NCT01226511|65779762|FG000|Acute Treatment Period|Protocol Violation|5|||
23560549|NCT01226511|65779763|FG001|Acute Treatment Period|Protocol Violation|5|||
23560550|NCT01226511|65779762|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
23560551|NCT01226511|65779763|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
23560552|NCT01226511|65779762|FG000|Extension Treatment Period|Adverse Event|8|||
23560553|NCT01226511|65779763|FG001|Extension Treatment Period|Adverse Event|8|||
23560554|NCT01226511|65779762|FG000|Extension Treatment Period|Lack of Efficacy|3|||
23560555|NCT01226511|65779763|FG001|Extension Treatment Period|Lack of Efficacy|2|||
23560556|NCT01226511|65779762|FG000|Extension Treatment Period|Lost to Follow-up|4|||
23560557|NCT01226511|65779763|FG001|Extension Treatment Period|Lost to Follow-up|3|||
23560558|NCT01226511|65779762|FG000|Extension Treatment Period|Protocol Violation|2|||
23560559|NCT01226511|65779763|FG001|Extension Treatment Period|Protocol Violation|2|||
23560560|NCT01226511|65779762|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
23560561|NCT01226511|65779763|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
23560562|NCT01226511|65779762|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
23560563|NCT01226511|65779763|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
23560564|NCT01226511|65779762|FG000|Extension Treatment Period|Sponsor Decision|1|||
23560565|NCT01226511|65779763|FG001|Extension Treatment Period|Sponsor Decision|1|||
23560566|NCT01226511|65779762|FG000|Taper Period|Adverse Event|1|||
23560567|NCT01226511|65779763|FG001|Taper Period|Adverse Event|0|||
23560568|NCT01226511|65779762|FG000|Taper Period|Lost to Follow-up|2|||
23560569|NCT01226511|65779763|FG001|Taper Period|Lost to Follow-up|2|||
23560570|NCT01226511|65779762|FG000|Taper Period|Protocol Violation|1|||
23560571|NCT01226511|65779763|FG001|Taper Period|Protocol Violation|0|||
23560572|NCT01226511|65779762|FG000|Taper Period|Parent/Caregiver Decision|1|||
23560573|NCT01226511|65779763|FG001|Taper Period|Parent/Caregiver Decision|1|||
23560574|NCT01987817|65779764|FG000|Overall Study|Adverse Event|4|||
23560575|NCT01987817|65779765|FG001|Overall Study|Adverse Event|0|||
23560576|NCT01987817|65779764|FG000|Overall Study|Withdrawal by Subject|1|||
23560577|NCT01987817|65779765|FG001|Overall Study|Withdrawal by Subject|1|||
23560578|NCT01987817|65779764|FG000|Overall Study|Physician Decision|1|||
23756171|NCT01625286|66487193|FG001|Overall Study|Adverse Event|0|||
23756172|NCT01625286|66487194|FG002|Overall Study|Adverse Event|0|||
23756173|NCT01625286|66487195|FG003|Overall Study|Adverse Event|0|||
23756174|NCT01625286|66487196|FG004|Overall Study|Adverse Event|1|||
23756175|NCT01625286|66487197|FG005|Overall Study|Adverse Event|2|||
23756176|NCT01625286|66487198|FG006|Overall Study|Adverse Event|1|||
23560579|NCT01987817|65779765|FG001|Overall Study|Physician Decision|0|||
23560580|NCT00909428|65779782|FG000|Overall Study|Lost to Follow-up|13|||
23560581|NCT00909428|65779783|FG001|Overall Study|Lost to Follow-up|10|||
23560582|NCT00909428|65779784|FG002|Overall Study|Lost to Follow-up|9|||
23560583|NCT00652938|65779785|FG000|Overall Study|Adverse Event|1|||
23756177|NCT01625286|66487192|FG000|Overall Study|Death|0|||
23560584|NCT00652938|65779786|FG001|Overall Study|Adverse Event|0|||
23560585|NCT00652938|65779787|FG002|Overall Study|Adverse Event|2|||
23560586|NCT00652938|65779785|FG000|Overall Study|Withdrawal by Subject|0|||
23560587|NCT00652938|65779786|FG001|Overall Study|Withdrawal by Subject|6|||
23560588|NCT00652938|65779787|FG002|Overall Study|Withdrawal by Subject|1|||
23560589|NCT00652938|65779785|FG000|Overall Study|Lost to Follow-up|0|||
23560590|NCT00652938|65779786|FG001|Overall Study|Lost to Follow-up|0|||
23560591|NCT00652938|65779787|FG002|Overall Study|Lost to Follow-up|2|||
23560592|NCT00652938|65779785|FG000|Overall Study|fear of blood sampling|0|||
23560593|NCT00652938|65779786|FG001|Overall Study|fear of blood sampling|1|||
23560594|NCT00652938|65779787|FG002|Overall Study|fear of blood sampling|0|||
23560595|NCT00903786|65779790|FG000|Overall Study|Physician Decision|6|||
23560596|NCT00903786|65779790|FG000|Overall Study|Lack of Efficacy|5|||
23560597|NCT00903786|65779790|FG000|Overall Study|Reason other than lack of efficacy|4|||
23560598|NCT01949870|65782343|FG000|Overall Study|Lack of Efficacy|2|||
23560599|NCT01949870|65782343|FG000|Overall Study|Adverse Event|1|||
23560600|NCT01949870|65782343|FG000|Overall Study|Study termination|1|||
23560601|NCT01949870|65782343|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
23756178|NCT01625286|66487193|FG001|Overall Study|Death|0|||
23756179|NCT01625286|66487194|FG002|Overall Study|Death|1|||
23756180|NCT01625286|66487195|FG003|Overall Study|Death|1|||
23756181|NCT01625286|66487196|FG004|Overall Study|Death|0|||
23756182|NCT01625286|66487197|FG005|Overall Study|Death|11|||
23756183|NCT01625286|66487198|FG006|Overall Study|Death|16|||
23756184|NCT01625286|66487192|FG000|Overall Study|Withdrawal by Subject|0|||
23756185|NCT01625286|66487193|FG001|Overall Study|Withdrawal by Subject|1|||
23756186|NCT01625286|66487194|FG002|Overall Study|Withdrawal by Subject|0|||
23756187|NCT01625286|66487195|FG003|Overall Study|Withdrawal by Subject|1|||
23756188|NCT01625286|66487196|FG004|Overall Study|Withdrawal by Subject|0|||
23756189|NCT01625286|66487197|FG005|Overall Study|Withdrawal by Subject|0|||
23756190|NCT01625286|66487198|FG006|Overall Study|Withdrawal by Subject|1|||
23756191|NCT01625286|66487192|FG000|Overall Study|Any reason not specifically recorded|0|||
23756192|NCT01625286|66487193|FG001|Overall Study|Any reason not specifically recorded|0|||
23756193|NCT01625286|66487194|FG002|Overall Study|Any reason not specifically recorded|0|||
23756194|NCT01625286|66487195|FG003|Overall Study|Any reason not specifically recorded|0|||
23756195|NCT01625286|66487196|FG004|Overall Study|Any reason not specifically recorded|0|||
23756196|NCT01625286|66487197|FG005|Overall Study|Any reason not specifically recorded|1|||
23756197|NCT01625286|66487198|FG006|Overall Study|Any reason not specifically recorded|0|||
23756198|NCT01625286|66487192|FG000|Overall Study|Progressive disease|6|||
23756199|NCT01625286|66487193|FG001|Overall Study|Progressive disease|3|||
23756200|NCT01625286|66487194|FG002|Overall Study|Progressive disease|4|||
23756201|NCT01625286|66487195|FG003|Overall Study|Progressive disease|5|||
23756202|NCT01625286|66487196|FG004|Overall Study|Progressive disease|5|||
23756203|NCT01625286|66487197|FG005|Overall Study|Progressive disease|0|||
23756204|NCT01625286|66487198|FG006|Overall Study|Progressive disease|0|||
23438024|NCT02697435|65344293|FG000|Overall Study|Physician Decision|0|||
23438025|NCT02697435|65344294|FG001|Overall Study|Physician Decision|4|||
23438026|NCT02038075|65344295|FG000|Overall Study|Withdrawal by Subject|3|||
23438027|NCT02038075|65344296|FG001|Overall Study|Withdrawal by Subject|0|||
23438028|NCT00319254|65348453|FG000|Overall Study|Withdrawal by Subject|4|||
23438029|NCT00319254|65348453|FG000|Overall Study|Death|46|||
23756205|NCT01625286|66487192|FG000|Overall Study|Lost to Follow-up|0|||
23756206|NCT01625286|66487193|FG001|Overall Study|Lost to Follow-up|0|||
23756207|NCT01625286|66487194|FG002|Overall Study|Lost to Follow-up|0|||
23756208|NCT01625286|66487195|FG003|Overall Study|Lost to Follow-up|0|||
23438030|NCT00319254|65348453|FG000|Overall Study|Lost to Follow-up|2|||
23438031|NCT00319254|65348453|FG000|Overall Study|Enrolled, Not Treated|2|||
23560602|NCT05158296|65782344|FG000|Overall Study|Sponsor Decision|2|||
23756209|NCT01625286|66487196|FG004|Overall Study|Lost to Follow-up|0|||
23756210|NCT01625286|66487197|FG005|Overall Study|Lost to Follow-up|0|||
23756211|NCT01625286|66487198|FG006|Overall Study|Lost to Follow-up|1|||
23438032|NCT05513053|65348454|FG000|Overall Study|Lost to Follow-up|9|||
23560603|NCT05158296|65782345|FG001|Overall Study|Sponsor Decision|3|||
23756212|NCT04128696|66487199|FG000|Overall Study|Lost to Follow-up|3|||
23756213|NCT04128696|66487200|FG001|Overall Study|Lost to Follow-up|7|||
23826083|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
23826084|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
23826085|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826086|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826087|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826088|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826089|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826090|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826091|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826092|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23756214|NCT04128696|66487199|FG000|Overall Study|Withdrawal by Subject|12|||
23438033|NCT05513053|65348455|FG001|Overall Study|Lost to Follow-up|11|||
23438034|NCT05513053|65348454|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23756215|NCT04128696|66487200|FG001|Overall Study|Withdrawal by Subject|11|||
23756216|NCT04128696|66487199|FG000|Overall Study|Study Closed/Terminated|26|||
23756217|NCT04128696|66487200|FG001|Overall Study|Study Closed/Terminated|38|||
23756218|NCT04128696|66487199|FG000|Overall Study|Physician Decision|2|||
23756219|NCT04128696|66487200|FG001|Overall Study|Physician Decision|3|||
23756220|NCT00934622|66487202|FG000|Overall Study|Lost to Follow-up|7|||
23756221|NCT00934622|66487202|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
23756222|NCT02475980|66487207|FG000|Overall Study|Lost to Follow-up|4|||
23756223|NCT02475980|66487207|FG000|Overall Study|Withdrawal by Subject|1|||
23756224|NCT03174925|66487210|FG000|Overall Study|Elastographic images not retrievable|2|||
23756225|NCT03174925|66487210|FG000|Overall Study|Elastography image not interpretable|1|||
23756226|NCT00337129|66487214|FG000|Overall Study|Adverse Event|4|||
23756227|NCT00337129|66487214|FG000|Overall Study|Withdrawal by Subject|1|||
23756228|NCT00337129|66487214|FG000|Overall Study|Lack of Efficacy|32|||
23756229|NCT00337129|66487214|FG000|Overall Study|Death|2|||
23756230|NCT00337129|66487214|FG000|Overall Study|not protocol specified|1|||
23756231|NCT01825876|66487215|FG000|Period 2|Withdrawal by Subject|0|||
23756232|NCT01825876|66487216|FG001|Period 2|Withdrawal by Subject|1|||
23756233|NCT00423488|66487217|FG000|Overall Study|No evidence of study drug intake|2|||
23756234|NCT00423488|66487218|FG001|Overall Study|No evidence of study drug intake|1|||
23756235|NCT00423488|66487217|FG000|Overall Study|No post baseline data|3|||
23756236|NCT00423488|66487218|FG001|Overall Study|No post baseline data|0|||
23756237|NCT00000135|66487219|FG000|Overall Study|Death|27|||
23438035|NCT05513053|65348455|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23438036|NCT05513053|65348454|FG000|Overall Study|Withdrawal by Subject|2|||
23756238|NCT00000135|66487220|FG001|Overall Study|Death|14|||
23756239|NCT03891875|66487223|FG000|Overall Study|Withdrawal by Subject|20|||
23756240|NCT03891875|66487224|FG001|Overall Study|Withdrawal by Subject|3|||
23756241|NCT03891875|66487223|FG000|Overall Study|Adverse Event|10|||
23438037|NCT05513053|65348455|FG001|Overall Study|Withdrawal by Subject|9|||
23438038|NCT05513053|65348454|FG000|Overall Study|Protocol Violation|6|||
23756242|NCT03891875|66487224|FG001|Overall Study|Adverse Event|4|||
23756243|NCT03891875|66487223|FG000|Overall Study|Physician Decision|1|||
23756244|NCT03891875|66487224|FG001|Overall Study|Physician Decision|1|||
23756245|NCT03891875|66487223|FG000|Overall Study|Protocol Violation|1|||
23756246|NCT03891875|66487224|FG001|Overall Study|Protocol Violation|0|||
23756247|NCT03891875|66487223|FG000|Overall Study|Lost to Follow-up|1|||
23756248|NCT03891875|66487224|FG001|Overall Study|Lost to Follow-up|0|||
23756249|NCT03891875|66487223|FG000|Overall Study|COVID-19 infection|1|||
23756250|NCT03891875|66487224|FG001|Overall Study|COVID-19 infection|0|||
23756251|NCT02609178|66487231|FG000|First Crown|Withdrawal by Subject|0|||
23756252|NCT02609178|66487232|FG001|First Crown|Withdrawal by Subject|0|||
23560604|NCT05158296|65782346|FG002|Overall Study|Sponsor Decision|2|||
23624744|NCT01169636|66015332|FG000|Overall Study|Adverse Event|0|||
23624745|NCT01169636|66015333|FG001|Overall Study|Adverse Event|0|||
23624746|NCT01169636|66015334|FG002|Overall Study|Adverse Event|1|||
23624747|NCT01169636|66015335|FG003|Overall Study|Adverse Event|1|||
23624748|NCT01169636|66015336|FG004|Overall Study|Adverse Event|0|||
23624749|NCT01169636|66015332|FG000|Overall Study|Screen failure|0|||
23624750|NCT01169636|66015333|FG001|Overall Study|Screen failure|0|||
23624751|NCT01169636|66015334|FG002|Overall Study|Screen failure|2|||
23624752|NCT01169636|66015335|FG003|Overall Study|Screen failure|0|||
23624753|NCT01169636|66015336|FG004|Overall Study|Screen failure|0|||
23756253|NCT02609178|66487233|FG002|First Crown|Withdrawal by Subject|1|||
23756254|NCT02609178|66487234|FG003|First Crown|Withdrawal by Subject|1|||
23756255|NCT02609178|66487235|FG004|First Crown|Withdrawal by Subject|0|||
23560605|NCT05076149|65782347|FG000|Overall Study|Adverse Event|3|||
23560606|NCT05076149|65782348|FG001|Overall Study|Adverse Event|9|||
23560607|NCT05076149|65782347|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23560608|NCT05076149|65782348|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
23560609|NCT05076149|65782347|FG000|Overall Study|Lost to Follow-up|0|||
23560610|NCT05076149|65782348|FG001|Overall Study|Lost to Follow-up|1|||
23560611|NCT05076149|65782347|FG000|Overall Study|Commercial drug is available for participant|0|||
23560612|NCT05076149|65782348|FG001|Overall Study|Commercial drug is available for participant|1|||
23560613|NCT05076149|65782347|FG000|Overall Study|Other non compliance|1|||
23560614|NCT05076149|65782348|FG001|Overall Study|Other non compliance|1|||
23560615|NCT05076149|65782347|FG000|Overall Study|Physician Decision|0|||
23560616|NCT05076149|65782348|FG001|Overall Study|Physician Decision|1|||
23560617|NCT05076149|65782347|FG000|Overall Study|Other|5|||
23560618|NCT05076149|65782348|FG001|Overall Study|Other|4|||
23560619|NCT00116272|65782349|FG000|Overall Study|Lost to Follow-up|11|||
23560620|NCT00116272|65782350|FG001|Overall Study|Lost to Follow-up|6|||
23560621|NCT00118092|65782355|FG000|Overall Study|Withdrawal by Subject|1|||
23560622|NCT00118092|65782355|FG000|Overall Study|Protocol Violation|1|||
23560623|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
23624754|NCT01169636|66015332|FG000|Overall Study|Withdrawal by Subject|0|||
23624755|NCT01169636|66015333|FG001|Overall Study|Withdrawal by Subject|0|||
23624756|NCT01169636|66015334|FG002|Overall Study|Withdrawal by Subject|0|||
23624757|NCT01169636|66015335|FG003|Overall Study|Withdrawal by Subject|0|||
23624758|NCT01169636|66015336|FG004|Overall Study|Withdrawal by Subject|3|||
23624759|NCT03119688|66015341|FG000|Overall Study|Adverse Event|4|||
23624760|NCT01834586|66015342|FG000|Overall Study|Adverse Event|1|||
23624761|NCT00621192|66015356|FG000|Overall Study|Withdrawal by Subject|0|||
23624762|NCT00621192|66015357|FG001|Overall Study|Withdrawal by Subject|0|||
23624763|NCT00621192|66015358|FG002|Overall Study|Withdrawal by Subject|2|||
23624764|NCT00621192|66015359|FG003|Overall Study|Withdrawal by Subject|0|||
23624765|NCT00621192|66015356|FG000|Overall Study|Physician Decision|1|||
23624766|NCT00621192|66015357|FG001|Overall Study|Physician Decision|3|||
23624767|NCT00621192|66015358|FG002|Overall Study|Physician Decision|0|||
23624768|NCT00621192|66015359|FG003|Overall Study|Physician Decision|0|||
23624769|NCT00621192|66015356|FG000|Overall Study|Protocol Violation|1|||
23624770|NCT00621192|66015357|FG001|Overall Study|Protocol Violation|0|||
23624771|NCT00621192|66015358|FG002|Overall Study|Protocol Violation|0|||
23624772|NCT00621192|66015359|FG003|Overall Study|Protocol Violation|1|||
23624773|NCT00621192|66015356|FG000|Overall Study|Adverse Event|0|||
23624774|NCT00621192|66015357|FG001|Overall Study|Adverse Event|1|||
23624775|NCT00621192|66015358|FG002|Overall Study|Adverse Event|0|||
23624776|NCT00621192|66015359|FG003|Overall Study|Adverse Event|1|||
23624777|NCT00621192|66015356|FG000|Overall Study|Death|2|||
23624778|NCT00621192|66015357|FG001|Overall Study|Death|5|||
23624779|NCT00621192|66015358|FG002|Overall Study|Death|0|||
23624780|NCT00621192|66015359|FG003|Overall Study|Death|0|||
23624781|NCT00621192|66015356|FG000|Overall Study|Final Assessments not Completed|0|||
23624782|NCT00621192|66015357|FG001|Overall Study|Final Assessments not Completed|0|||
23624783|NCT00621192|66015358|FG002|Overall Study|Final Assessments not Completed|3|||
23624784|NCT00621192|66015359|FG003|Overall Study|Final Assessments not Completed|1|||
23756256|NCT02609178|66487236|FG005|First Crown|Withdrawal by Subject|0|||
23560624|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
23560625|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
23560626|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
23560627|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
23560628|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
23624785|NCT00988533|66015362|FG000|Overall Study|Lost to Follow-up|3|||
23624786|NCT00740870|66015363|FG000|Overall Study|Not Catheterized|4|||
23624787|NCT00740870|66015363|FG000|Overall Study|Further testing contraindicated implant|17|||
23624788|NCT04629443|66015365|FG000|Overall Study|Adverse Event|2|||
23756257|NCT00366678|66487237|FG000|Infant Series|Withdrawal by Subject|8|||
23624789|NCT04629443|66015366|FG001|Overall Study|Adverse Event|1|||
23624790|NCT04629443|66015367|FG002|Overall Study|Adverse Event|2|||
23624791|NCT04629443|66015365|FG000|Overall Study|Progressive Disease|2|||
23624792|NCT04629443|66015366|FG001|Overall Study|Progressive Disease|3|||
23624793|NCT04629443|66015367|FG002|Overall Study|Progressive Disease|3|||
23624794|NCT04629443|66015365|FG000|Overall Study|Physician Decision|1|||
23624795|NCT04629443|66015366|FG001|Overall Study|Physician Decision|3|||
23624796|NCT04629443|66015367|FG002|Overall Study|Physician Decision|0|||
23624797|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
23624798|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
23826093|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826094|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23826095|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
23826096|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
23826097|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
23826098|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
23826099|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
23826100|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826101|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826102|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826103|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826104|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826105|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826106|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826107|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826108|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23826109|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23560629|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
23560630|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
23560631|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
23560632|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
23560633|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
23560634|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23560635|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
23560636|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
23560637|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
23560638|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
23560639|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
23560640|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
23560641|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
23560642|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
23560643|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
23560644|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
23560645|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
23560646|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
23560647|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
23560648|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
23624799|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
23624800|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
23624801|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
23624802|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
23624803|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
23826110|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
23826111|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
23826112|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
23826113|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
23826114|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
23826115|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23438039|NCT05513053|65348455|FG001|Overall Study|Protocol Violation|3|||
23438040|NCT05513053|65348454|FG000|Overall Study|Adverse Event|0|||
23438041|NCT05513053|65348455|FG001|Overall Study|Adverse Event|2|||
23438042|NCT01223183|65348456|FG000|Imaging Day 1|Physician Decision|0|||
23438043|NCT01223183|65348457|FG001|Imaging Day 1|Physician Decision|1|||
23438044|NCT01223183|65348456|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
23624804|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
23624805|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
23756258|NCT00366678|66487238|FG001|Infant Series|Withdrawal by Subject|6|||
23756259|NCT00366678|66487239|FG002|Infant Series|Withdrawal by Subject|0|||
23756260|NCT00366678|66487237|FG000|Infant Series|Protocol Violation|4|||
23756261|NCT00366678|66487238|FG001|Infant Series|Protocol Violation|3|||
23756262|NCT00366678|66487239|FG002|Infant Series|Protocol Violation|0|||
23756263|NCT00366678|66487237|FG000|Infant Series|Failed to return|1|||
23756264|NCT00366678|66487238|FG001|Infant Series|Failed to return|1|||
23756265|NCT00366678|66487239|FG002|Infant Series|Failed to return|0|||
23756266|NCT00366678|66487237|FG000|Infant Series|Adverse Event|1|||
23756267|NCT00366678|66487238|FG001|Infant Series|Adverse Event|0|||
23756268|NCT00366678|66487239|FG002|Infant Series|Adverse Event|0|||
23756269|NCT00366678|66487237|FG000|After Infant|Withdrawal by Subject|8|||
23756270|NCT00366678|66487238|FG001|After Infant|Withdrawal by Subject|4|||
23756271|NCT00366678|66487239|FG002|After Infant|Withdrawal by Subject|0|||
23756272|NCT00366678|66487237|FG000|After Infant|Lost to Follow-up|2|||
23438045|NCT01223183|65348457|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
23438046|NCT01223183|65348456|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
23438047|NCT01223183|65348457|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
23438048|NCT00847197|65348462|FG000|Overall Study|Adverse Event|21|||
23438049|NCT00847197|65348463|FG001|Overall Study|Adverse Event|3|||
23438050|NCT00847197|65348462|FG000|Overall Study|Protocol Violation|0|||
23438051|NCT00847197|65348463|FG001|Overall Study|Protocol Violation|1|||
23438052|NCT00847197|65348462|FG000|Overall Study|Withdrawal by Subject|3|||
23438053|NCT00847197|65348463|FG001|Overall Study|Withdrawal by Subject|1|||
23438054|NCT00465647|65348464|FG000|Overall Study|Administrative|2|||
23438055|NCT00465647|65348465|FG001|Overall Study|Administrative|2|||
23438056|NCT00465647|65348466|FG002|Overall Study|Administrative|3|||
23438057|NCT00465647|65348467|FG003|Overall Study|Administrative|2|||
23438058|NCT00465647|65348464|FG000|Overall Study|Adverse Event|2|||
23438059|NCT00465647|65348465|FG001|Overall Study|Adverse Event|0|||
23438060|NCT00465647|65348466|FG002|Overall Study|Adverse Event|3|||
23438061|NCT00465647|65348467|FG003|Overall Study|Adverse Event|2|||
23438062|NCT00465647|65348464|FG000|Overall Study|Withdrawal by Subject|1|||
23438063|NCT00465647|65348465|FG001|Overall Study|Withdrawal by Subject|2|||
23438064|NCT00465647|65348466|FG002|Overall Study|Withdrawal by Subject|2|||
23438065|NCT00465647|65348467|FG003|Overall Study|Withdrawal by Subject|7|||
23438066|NCT00465647|65348464|FG000|Overall Study|"The other reasons included loss of IV"|8|||
23438067|NCT00465647|65348465|FG001|Overall Study|"The other reasons included loss of IV"|4|||
23438068|NCT00465647|65348466|FG002|Overall Study|"The other reasons included loss of IV"|3|||
23438069|NCT00465647|65348467|FG003|Overall Study|"The other reasons included loss of IV"|2|||
23438070|NCT02578186|65348468|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
23438071|NCT02578186|65348469|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
23438072|NCT02578186|65348468|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
23438073|NCT02578186|65348469|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
23438074|NCT00106353|65348470|FG000|Part 1|Disease progression|3|||
23438075|NCT00106353|65348471|FG001|Part 1|Disease progression|4|||
23438076|NCT00106353|65348472|FG002|Part 1|Disease progression|1|||
23438077|NCT00106353|65348473|FG003|Part 1|Disease progression|3|||
23438078|NCT00106353|65348474|FG004|Part 1|Disease progression|0|||
23438079|NCT00106353|65348475|FG005|Part 1|Disease progression|0|||
23438080|NCT00106353|65348476|FG006|Part 1|Disease progression|0|||
23756273|NCT00366678|66487238|FG001|After Infant|Lost to Follow-up|1|||
23756274|NCT00366678|66487239|FG002|After Infant|Lost to Follow-up|0|||
23438081|NCT00106353|65348470|FG000|Part 1|Withdrawal by Subject|0|||
23438082|NCT00106353|65348471|FG001|Part 1|Withdrawal by Subject|0|||
23438083|NCT00106353|65348472|FG002|Part 1|Withdrawal by Subject|1|||
23438084|NCT00106353|65348473|FG003|Part 1|Withdrawal by Subject|2|||
23756275|NCT00366678|66487237|FG000|After Infant|Failed to return|5|||
23756276|NCT00366678|66487238|FG001|After Infant|Failed to return|5|||
23438085|NCT00106353|65348474|FG004|Part 1|Withdrawal by Subject|0|||
23438086|NCT00106353|65348475|FG005|Part 1|Withdrawal by Subject|0|||
23438087|NCT00106353|65348476|FG006|Part 1|Withdrawal by Subject|0|||
23438088|NCT00106353|65348470|FG000|Part 1|Symptomatic deterioration|0|||
23438089|NCT00106353|65348471|FG001|Part 1|Symptomatic deterioration|0|||
23438090|NCT00106353|65348472|FG002|Part 1|Symptomatic deterioration|1|||
23438091|NCT00106353|65348473|FG003|Part 1|Symptomatic deterioration|0|||
23438092|NCT00106353|65348474|FG004|Part 1|Symptomatic deterioration|0|||
23438093|NCT00106353|65348475|FG005|Part 1|Symptomatic deterioration|0|||
23438094|NCT00106353|65348476|FG006|Part 1|Symptomatic deterioration|0|||
23756277|NCT00366678|66487239|FG002|After Infant|Failed to return|0|||
23756278|NCT00366678|66487237|FG000|After Infant|Adverse Event|1|||
23756279|NCT00366678|66487238|FG001|After Infant|Adverse Event|0|||
23756280|NCT00366678|66487239|FG002|After Infant|Adverse Event|0|||
23756281|NCT00366678|66487237|FG000|After Infant|Protocol Violation|1|||
23756282|NCT00366678|66487238|FG001|After Infant|Protocol Violation|0|||
23756283|NCT00366678|66487239|FG002|After Infant|Protocol Violation|0|||
23756284|NCT00366678|66487237|FG000|Toddler Dose|Protocol Violation|2|||
23756285|NCT00366678|66487238|FG001|Toddler Dose|Protocol Violation|1|||
23756286|NCT00366678|66487239|FG002|Toddler Dose|Protocol Violation|0|||
23756287|NCT00366678|66487237|FG000|Toddler Dose|Failed to return|1|||
23756288|NCT00366678|66487238|FG001|Toddler Dose|Failed to return|0|||
23756289|NCT00366678|66487239|FG002|Toddler Dose|Failed to return|0|||
23756290|NCT00366678|66487237|FG000|Toddler Dose|Withdrawal by Subject|1|||
23756291|NCT00366678|66487238|FG001|Toddler Dose|Withdrawal by Subject|0|||
23756292|NCT00366678|66487239|FG002|Toddler Dose|Withdrawal by Subject|0|||
23756293|NCT00366678|66487237|FG000|Toddler Dose|protocol deviation|1|||
23756294|NCT00366678|66487238|FG001|Toddler Dose|protocol deviation|0|||
23756295|NCT00366678|66487239|FG002|Toddler Dose|protocol deviation|0|||
23756296|NCT00854607|66487242|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
23756297|NCT01418352|66487248|FG000|Overall Study|Lost to Follow-up|2|||
23756298|NCT01418352|66487249|FG001|Overall Study|Lost to Follow-up|0|||
23756299|NCT01418352|66487250|FG002|Overall Study|Lost to Follow-up|0|||
23756300|NCT01418352|66487251|FG003|Overall Study|Lost to Follow-up|0|||
23756301|NCT01418352|66487248|FG000|Overall Study|Adverse Event|0|||
23756302|NCT01418352|66487249|FG001|Overall Study|Adverse Event|1|||
23756303|NCT01418352|66487250|FG002|Overall Study|Adverse Event|0|||
23756304|NCT01418352|66487251|FG003|Overall Study|Adverse Event|0|||
23756305|NCT01418352|66487248|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
23756306|NCT01418352|66487249|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
23756307|NCT01418352|66487250|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
23756308|NCT01418352|66487251|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
23756309|NCT01418352|66487248|FG000|Overall Study|Subject Withdrew Consent|0|||
23756310|NCT01418352|66487249|FG001|Overall Study|Subject Withdrew Consent|1|||
23756311|NCT01418352|66487250|FG002|Overall Study|Subject Withdrew Consent|2|||
23756312|NCT01418352|66487251|FG003|Overall Study|Subject Withdrew Consent|1|||
23756313|NCT01418352|66487248|FG000|Overall Study|Protocol Deviation|0|||
23756314|NCT01418352|66487249|FG001|Overall Study|Protocol Deviation|0|||
23756315|NCT01418352|66487250|FG002|Overall Study|Protocol Deviation|1|||
23756316|NCT01418352|66487251|FG003|Overall Study|Protocol Deviation|0|||
23756317|NCT01418352|66487248|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
23756318|NCT01418352|66487249|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23756319|NCT01418352|66487250|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23756320|NCT01418352|66487251|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23756321|NCT03120520|66487252|FG000|Overall Study|Lost to Follow-up|1|||
23756322|NCT03120520|66487253|FG001|Overall Study|Lost to Follow-up|1|||
23756323|NCT03120520|66487254|FG002|Overall Study|Lost to Follow-up|1|||
23756324|NCT03120520|66487255|FG003|Overall Study|Lost to Follow-up|1|||
23756325|NCT03120520|66487252|FG000|Overall Study|Withdrawal by Subject|3|||
23756326|NCT03120520|66487253|FG001|Overall Study|Withdrawal by Subject|2|||
23756327|NCT03120520|66487254|FG002|Overall Study|Withdrawal by Subject|3|||
23756328|NCT03120520|66487255|FG003|Overall Study|Withdrawal by Subject|2|||
23756329|NCT03120520|66487252|FG000|Overall Study|Other|0|||
23438095|NCT00106353|65348470|FG000|Part 1|Entered follow-up phase|1|||
23438096|NCT00106353|65348471|FG001|Part 1|Entered follow-up phase|1|||
23438097|NCT00106353|65348472|FG002|Part 1|Entered follow-up phase|0|||
23756330|NCT03120520|66487253|FG001|Overall Study|Other|1|||
23756331|NCT03120520|66487254|FG002|Overall Study|Other|0|||
23756332|NCT03120520|66487255|FG003|Overall Study|Other|0|||
23756333|NCT01174368|66487256|FG000|Overall Study|Withdrawal by Subject|1|||
23756334|NCT02913261|66487259|FG000|Overall Study|Technical problems|0|||
23756335|NCT02913261|66487260|FG001|Overall Study|Technical problems|1|||
23756336|NCT02913261|66487259|FG000|Overall Study|Lack of Efficacy|32|||
23756337|NCT02913261|66487260|FG001|Overall Study|Lack of Efficacy|69|||
23756338|NCT02913261|66487259|FG000|Overall Study|Adverse Event|27|||
23438098|NCT00106353|65348473|FG003|Part 1|Entered follow-up phase|1|||
23438099|NCT00106353|65348474|FG004|Part 1|Entered follow-up phase|0|||
23756339|NCT02913261|66487260|FG001|Overall Study|Adverse Event|5|||
23624806|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
23438100|NCT00106353|65348475|FG005|Part 1|Entered follow-up phase|0|||
23438101|NCT00106353|65348476|FG006|Part 1|Entered follow-up phase|0|||
23438102|NCT00106353|65348470|FG000|Part 1|Adverse Event|0|||
23756340|NCT02913261|66487259|FG000|Overall Study|Death|25|||
23756341|NCT02913261|66487260|FG001|Overall Study|Death|22|||
23756342|NCT02913261|66487259|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
23756343|NCT02913261|66487260|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
23756344|NCT02913261|66487259|FG000|Overall Study|Disease relapse|8|||
23756345|NCT02913261|66487260|FG001|Overall Study|Disease relapse|13|||
23756346|NCT02913261|66487259|FG000|Overall Study|Physician Decision|8|||
23756347|NCT02913261|66487260|FG001|Overall Study|Physician Decision|9|||
23756348|NCT02913261|66487259|FG000|Overall Study|Subject/guardian decision|4|||
23756349|NCT02913261|66487260|FG001|Overall Study|Subject/guardian decision|6|||
23756350|NCT02913261|66487259|FG000|Overall Study|Graft loss|2|||
23756351|NCT02913261|66487260|FG001|Overall Study|Graft loss|0|||
23756352|NCT01563029|66487263|FG000|Overall Study|Adverse Event|1|||
23756353|NCT01563029|66487264|FG001|Overall Study|Adverse Event|0|||
23756354|NCT01563029|66487265|FG002|Overall Study|Adverse Event|1|||
23756355|NCT01563029|66487266|FG003|Overall Study|Adverse Event|2|||
23756356|NCT01563029|66487267|FG004|Overall Study|Adverse Event|1|||
23756357|NCT01563029|66487263|FG000|Overall Study|Lack of Efficacy|42|||
23756358|NCT01563029|66487264|FG001|Overall Study|Lack of Efficacy|16|||
23756359|NCT01563029|66487265|FG002|Overall Study|Lack of Efficacy|23|||
23756360|NCT01563029|66487266|FG003|Overall Study|Lack of Efficacy|21|||
23756361|NCT01563029|66487267|FG004|Overall Study|Lack of Efficacy|19|||
23756362|NCT01563029|66487263|FG000|Overall Study|Protocol Violation|1|||
23756363|NCT01563029|66487264|FG001|Overall Study|Protocol Violation|2|||
23756364|NCT01563029|66487265|FG002|Overall Study|Protocol Violation|3|||
23756365|NCT01563029|66487266|FG003|Overall Study|Protocol Violation|1|||
23756366|NCT01563029|66487267|FG004|Overall Study|Protocol Violation|3|||
23756367|NCT01563029|66487263|FG000|Overall Study|Protocol defined stopping criteria|1|||
23756368|NCT01563029|66487264|FG001|Overall Study|Protocol defined stopping criteria|0|||
23756369|NCT01563029|66487265|FG002|Overall Study|Protocol defined stopping criteria|0|||
23756370|NCT01563029|66487266|FG003|Overall Study|Protocol defined stopping criteria|0|||
23756371|NCT01563029|66487267|FG004|Overall Study|Protocol defined stopping criteria|0|||
23756372|NCT01563029|66487263|FG000|Overall Study|Lost to Follow-up|1|||
23756373|NCT01563029|66487264|FG001|Overall Study|Lost to Follow-up|0|||
23756374|NCT01563029|66487265|FG002|Overall Study|Lost to Follow-up|1|||
23756375|NCT01563029|66487266|FG003|Overall Study|Lost to Follow-up|1|||
23756376|NCT01563029|66487267|FG004|Overall Study|Lost to Follow-up|1|||
23756377|NCT01563029|66487263|FG000|Overall Study|Physician Decision|3|||
23756378|NCT01563029|66487264|FG001|Overall Study|Physician Decision|5|||
23756379|NCT01563029|66487265|FG002|Overall Study|Physician Decision|2|||
23756380|NCT01563029|66487266|FG003|Overall Study|Physician Decision|4|||
23756381|NCT01563029|66487267|FG004|Overall Study|Physician Decision|2|||
23756382|NCT01563029|66487263|FG000|Overall Study|Withdrawal by Subject|4|||
23756383|NCT01563029|66487264|FG001|Overall Study|Withdrawal by Subject|1|||
23756384|NCT01563029|66487265|FG002|Overall Study|Withdrawal by Subject|3|||
23560649|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
23756385|NCT01563029|66487266|FG003|Overall Study|Withdrawal by Subject|4|||
23756386|NCT01563029|66487267|FG004|Overall Study|Withdrawal by Subject|3|||
23756387|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
23756388|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23756389|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23438103|NCT00106353|65348471|FG001|Part 1|Adverse Event|0|||
23438104|NCT00106353|65348472|FG002|Part 1|Adverse Event|0|||
23438105|NCT00106353|65348473|FG003|Part 1|Adverse Event|1|||
23560650|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
23560651|NCT01493687|65782360|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
23560652|NCT01493687|65782361|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
23438106|NCT00106353|65348474|FG004|Part 1|Adverse Event|0|||
23438107|NCT00106353|65348475|FG005|Part 1|Adverse Event|0|||
23438108|NCT00106353|65348476|FG006|Part 1|Adverse Event|0|||
23438109|NCT00106353|65348470|FG000|Part 2|Disease progression|0|||
23438110|NCT00106353|65348471|FG001|Part 2|Disease progression|0|||
23438111|NCT00106353|65348472|FG002|Part 2|Disease progression|0|||
23438112|NCT00106353|65348473|FG003|Part 2|Disease progression|0|||
23438113|NCT00106353|65348474|FG004|Part 2|Disease progression|8|||
23438114|NCT00106353|65348475|FG005|Part 2|Disease progression|14|||
23560653|NCT01376323|65782362|FG000|Overall Study|Adverse Event|1|||
23560654|NCT01376323|65782363|FG001|Overall Study|Adverse Event|0|||
23560655|NCT01376323|65782364|FG002|Overall Study|Adverse Event|0|||
23560656|NCT01376323|65782365|FG003|Overall Study|Adverse Event|2|||
23560657|NCT01376323|65782366|FG004|Overall Study|Adverse Event|0|||
23560658|NCT01376323|65782362|FG000|Overall Study|Lost to Follow-up|0|||
23560659|NCT01376323|65782363|FG001|Overall Study|Lost to Follow-up|0|||
23756390|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23756391|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
23756392|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
23756393|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
23756394|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
23756395|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
23756396|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23756397|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23756398|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23756399|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
23756400|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
23756401|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
23756402|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
23438115|NCT00106353|65348476|FG006|Part 2|Disease progression|13|||
23438116|NCT00106353|65348470|FG000|Part 2|Death|0|||
23438117|NCT00106353|65348471|FG001|Part 2|Death|0|||
23438118|NCT00106353|65348472|FG002|Part 2|Death|0|||
23438119|NCT00106353|65348473|FG003|Part 2|Death|0|||
23438120|NCT00106353|65348474|FG004|Part 2|Death|3|||
23438121|NCT00106353|65348475|FG005|Part 2|Death|0|||
23560660|NCT01376323|65782364|FG002|Overall Study|Lost to Follow-up|0|||
23560661|NCT01376323|65782365|FG003|Overall Study|Lost to Follow-up|2|||
23756403|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
23756404|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23826116|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826117|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826118|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826119|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826120|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826121|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826122|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826123|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826124|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23826125|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
23826126|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
23756405|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23756406|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23756407|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
23756408|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
23756409|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
23756410|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
23756411|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
23756412|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23756413|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23756414|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23756415|NCT01299272|66487268|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
23756416|NCT01299272|66487269|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
23756417|NCT01299272|66487270|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
23756418|NCT01299272|66487271|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
23756419|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23756420|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
23756421|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23756422|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23756423|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23756424|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
23756425|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23756426|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23756427|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
23756428|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
23756429|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
23756430|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
23756431|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23756432|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
23756433|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23756434|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23756435|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23756436|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
23624807|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
23756437|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23756438|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23826127|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
23624808|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
23438122|NCT00106353|65348476|FG006|Part 2|Death|1|||
23438123|NCT00106353|65348470|FG000|Part 2|Symptomatic deterioration|0|||
23438124|NCT00106353|65348471|FG001|Part 2|Symptomatic deterioration|0|||
23438125|NCT00106353|65348472|FG002|Part 2|Symptomatic deterioration|0|||
23438126|NCT00106353|65348473|FG003|Part 2|Symptomatic deterioration|0|||
23438127|NCT00106353|65348474|FG004|Part 2|Symptomatic deterioration|3|||
23438128|NCT00106353|65348475|FG005|Part 2|Symptomatic deterioration|0|||
23438129|NCT00106353|65348476|FG006|Part 2|Symptomatic deterioration|0|||
23438130|NCT00106353|65348470|FG000|Part 2|Adverse Event|0|||
23438131|NCT00106353|65348471|FG001|Part 2|Adverse Event|0|||
23756439|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23756440|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
23756441|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23756442|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23756443|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23756444|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
23438132|NCT00106353|65348472|FG002|Part 2|Adverse Event|0|||
23438133|NCT00106353|65348473|FG003|Part 2|Adverse Event|0|||
23438134|NCT00106353|65348474|FG004|Part 2|Adverse Event|0|||
23438135|NCT00106353|65348475|FG005|Part 2|Adverse Event|2|||
23438136|NCT00106353|65348476|FG006|Part 2|Adverse Event|1|||
23756445|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23756446|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23756447|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23756448|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
23756449|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23756450|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23756451|NCT01299272|66487268|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
23756452|NCT01299272|66487269|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
23756453|NCT01299272|66487270|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
23756454|NCT01299272|66487271|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
23756455|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
23756456|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
23756457|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
23756458|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
23826128|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
23826129|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
23826130|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826131|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826132|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826133|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826134|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826135|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826136|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826137|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826138|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826139|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23826140|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
23826141|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826142|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
23826143|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
23826144|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
23826145|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826146|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826147|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826148|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826149|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826150|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826151|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826152|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23756459|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
23438137|NCT00106353|65348470|FG000|Part 2|Other|0|||
23438138|NCT00106353|65348471|FG001|Part 2|Other|0|||
23438139|NCT00106353|65348472|FG002|Part 2|Other|0|||
23438140|NCT00106353|65348473|FG003|Part 2|Other|0|||
23438141|NCT00106353|65348474|FG004|Part 2|Other|1|||
23438142|NCT00106353|65348475|FG005|Part 2|Other|1|||
23438143|NCT00106353|65348476|FG006|Part 2|Other|1|||
23438144|NCT00106353|65348470|FG000|Part 2|Withdrawal by Subject|0|||
23438145|NCT00106353|65348471|FG001|Part 2|Withdrawal by Subject|0|||
23438146|NCT00106353|65348472|FG002|Part 2|Withdrawal by Subject|0|||
23826153|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23826154|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23438147|NCT00106353|65348473|FG003|Part 2|Withdrawal by Subject|0|||
23438148|NCT00106353|65348474|FG004|Part 2|Withdrawal by Subject|1|||
23438149|NCT00106353|65348475|FG005|Part 2|Withdrawal by Subject|0|||
23438150|NCT00106353|65348476|FG006|Part 2|Withdrawal by Subject|0|||
23560662|NCT01376323|65782366|FG004|Overall Study|Lost to Follow-up|0|||
23560663|NCT01376323|65782362|FG000|Overall Study|Physician Decision|1|||
23560664|NCT01376323|65782363|FG001|Overall Study|Physician Decision|0|||
23560665|NCT01376323|65782364|FG002|Overall Study|Physician Decision|2|||
23560666|NCT01376323|65782365|FG003|Overall Study|Physician Decision|1|||
23560667|NCT01376323|65782366|FG004|Overall Study|Physician Decision|1|||
23560668|NCT01376323|65782362|FG000|Overall Study|Withdrawal by Subject|0|||
23826155|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826156|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
23438151|NCT00106353|65348470|FG000|Part 2|Physician Decision|0|||
23438152|NCT00106353|65348471|FG001|Part 2|Physician Decision|0|||
23438153|NCT00106353|65348472|FG002|Part 2|Physician Decision|0|||
23438154|NCT00106353|65348473|FG003|Part 2|Physician Decision|0|||
23438155|NCT00106353|65348474|FG004|Part 2|Physician Decision|0|||
23438156|NCT00106353|65348475|FG005|Part 2|Physician Decision|1|||
23438157|NCT00106353|65348476|FG006|Part 2|Physician Decision|0|||
23438158|NCT00477152|65348478|FG000|Overall Study|Parent withdrew consent|2|||
23826157|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826158|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
23826159|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826160|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826161|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826162|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826163|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826164|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826165|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826166|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826167|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826168|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
23826169|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
23438159|NCT00477152|65348478|FG000|Overall Study|Adverse Event|1|||
23438160|NCT01138501|65348482|FG000|Overall Study|Protocol Violation|2|||
23438161|NCT01138501|65348482|FG000|Overall Study|Withdrawal by Subject|3|||
23438162|NCT00077649|65348483|FG000|Overall Study|Adverse Event|5|||
23438163|NCT00077649|65348484|FG001|Overall Study|Adverse Event|1|||
23438164|NCT00077649|65348485|FG002|Overall Study|Adverse Event|7|||
23438165|NCT00077649|65348486|FG003|Overall Study|Adverse Event|9|||
23438166|NCT00077649|65348483|FG000|Overall Study|Lack of Efficacy|5|||
23438167|NCT00077649|65348484|FG001|Overall Study|Lack of Efficacy|3|||
23438168|NCT00077649|65348485|FG002|Overall Study|Lack of Efficacy|3|||
23438169|NCT00077649|65348486|FG003|Overall Study|Lack of Efficacy|2|||
23438170|NCT00077649|65348483|FG000|Overall Study|Withdrawal by Subject|0|||
23438171|NCT00077649|65348484|FG001|Overall Study|Withdrawal by Subject|1|||
23438172|NCT00077649|65348485|FG002|Overall Study|Withdrawal by Subject|1|||
23438173|NCT00077649|65348486|FG003|Overall Study|Withdrawal by Subject|2|||
23438174|NCT00077649|65348483|FG000|Overall Study|Lost to Follow-up|2|||
23438175|NCT00077649|65348484|FG001|Overall Study|Lost to Follow-up|2|||
23438176|NCT00077649|65348485|FG002|Overall Study|Lost to Follow-up|3|||
23438177|NCT00077649|65348486|FG003|Overall Study|Lost to Follow-up|2|||
23438178|NCT00077649|65348483|FG000|Overall Study|Abnormality of Laboratory Test|1|||
23438179|NCT00077649|65348484|FG001|Overall Study|Abnormality of Laboratory Test|2|||
23438180|NCT00077649|65348485|FG002|Overall Study|Abnormality of Laboratory Test|1|||
23438181|NCT00077649|65348486|FG003|Overall Study|Abnormality of Laboratory Test|2|||
23826170|NCT03334435|66745024|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826171|NCT03334435|66745025|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
23438182|NCT00077649|65348483|FG000|Overall Study|Randomized but never dosed|1|||
23438183|NCT00077649|65348484|FG001|Overall Study|Randomized but never dosed|0|||
23438184|NCT00077649|65348485|FG002|Overall Study|Randomized but never dosed|0|||
23438185|NCT00077649|65348486|FG003|Overall Study|Randomized but never dosed|0|||
23560669|NCT01376323|65782363|FG001|Overall Study|Withdrawal by Subject|1|||
23560670|NCT01376323|65782364|FG002|Overall Study|Withdrawal by Subject|1|||
23438186|NCT04541628|65348487|FG000|Overall Study|Study Terminated|1|||
23438187|NCT04541628|65348488|FG001|Overall Study|Study Terminated|1|||
23438188|NCT04541628|65348489|FG002|Overall Study|Study Terminated|1|||
23438189|NCT03422536|65348495|FG000|Randomized|Physician Decision|1|||
23438190|NCT03422536|65348496|FG001|Randomized|Physician Decision|1|||
23438191|NCT03422536|65348495|FG000|Allocation - Received Intervention|Disease progression|19|||
23438192|NCT03422536|65348496|FG001|Allocation - Received Intervention|Disease progression|25|||
23438193|NCT03422536|65348495|FG000|Allocation - Received Intervention|Death|1|||
23438194|NCT03422536|65348496|FG001|Allocation - Received Intervention|Death|3|||
23438195|NCT03422536|65348495|FG000|Allocation - Received Intervention|Adverse Event|1|||
23438196|NCT03422536|65348496|FG001|Allocation - Received Intervention|Adverse Event|0|||
23438197|NCT03422536|65348495|FG000|Allocation - Received Intervention|Physician Decision|1|||
23438198|NCT03422536|65348496|FG001|Allocation - Received Intervention|Physician Decision|1|||
23438199|NCT03422536|65348495|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
23438200|NCT03422536|65348496|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
23624809|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
23624810|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
23624811|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
23624812|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
23624813|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
23438201|NCT03422536|65348495|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
23438202|NCT03422536|65348496|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
23438203|NCT00766051|65348497|FG000|Overall Study|Withdrawal by Subject|2|||
23438204|NCT00766051|65348498|FG001|Overall Study|Withdrawal by Subject|0|||
23438205|NCT01743040|65348499|FG000|Overall Study|Death|1|||
23438206|NCT01743040|65348499|FG000|Overall Study|Lost to Follow-up|66|||
23438207|NCT01743040|65348499|FG000|Overall Study|Physician Decision|40|||
23438208|NCT01743040|65348499|FG000|Overall Study|Protocol Violation|1|||
23438209|NCT01743040|65348499|FG000|Overall Study|Withdrawal by Subject|121|||
23438210|NCT02687581|65348500|FG000|Overall Study|Withdrawal by Subject|1|||
23438211|NCT02687581|65348501|FG001|Overall Study|Withdrawal by Subject|0|||
23438212|NCT02687581|65348502|FG002|Overall Study|Withdrawal by Subject|0|||
23438213|NCT02687581|65348503|FG003|Overall Study|Withdrawal by Subject|1|||
23438214|NCT02687581|65348500|FG000|Overall Study|Lost to Follow-up|2|||
23438215|NCT02687581|65348501|FG001|Overall Study|Lost to Follow-up|2|||
23438216|NCT02687581|65348502|FG002|Overall Study|Lost to Follow-up|0|||
23438217|NCT02687581|65348503|FG003|Overall Study|Lost to Follow-up|0|||
23438218|NCT02687581|65348500|FG000|Overall Study|the device is too small for the patient.|1|||
23438219|NCT02687581|65348501|FG001|Overall Study|the device is too small for the patient.|0|||
23438220|NCT02687581|65348502|FG002|Overall Study|the device is too small for the patient.|0|||
23438221|NCT02687581|65348503|FG003|Overall Study|the device is too small for the patient.|0|||
23438222|NCT04302545|65348504|FG000|Overall Study|Lost to Follow-up|3|||
23438223|NCT04302545|65348505|FG001|Overall Study|Lost to Follow-up|4|||
23438224|NCT00429169|65348506|FG000|Overall Study|Lost to Follow-up|0|||
23438225|NCT00429169|65348507|FG001|Overall Study|Lost to Follow-up|1|||
23438226|NCT00429169|65348506|FG000|Overall Study|Ineligibility discovered after entry|2|||
23438227|NCT00429169|65348507|FG001|Overall Study|Ineligibility discovered after entry|1|||
23438228|NCT04090242|65348508|FG000|Overall Study|Withdrawal by Subject|1|||
23438229|NCT04090242|65348509|FG001|Overall Study|Withdrawal by Subject|0|||
23756460|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
23756461|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
23756462|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
23756463|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
23756464|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
23756465|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
23756466|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
23438230|NCT02673684|65348510|FG000|Overall Study|Study not completed d/t loss of funding|9|||
23624814|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
23624815|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Missing|2|||
23624816|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Missing|1|||
23624817|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
23624818|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
23624819|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
23624820|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
23624821|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
23624822|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
23624823|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
23624824|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
23624825|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
23438231|NCT02673684|65348511|FG001|Overall Study|Study not completed d/t loss of funding|8|||
23438232|NCT02853435|65348524|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438233|NCT02853435|65348525|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438234|NCT02853435|65348526|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23624826|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
23624827|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
23624828|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
23624829|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
23624830|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
23438235|NCT02853435|65348527|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438236|NCT02853435|65348528|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
23624831|NCT01190644|66015381|FG000|Overall Study|Death|2|||
23624832|NCT01190644|66015381|FG000|Overall Study|Disease progression|1|||
23624833|NCT01390441|66015382|FG000|Treatment Period|Protocol Violation|0|||
23624834|NCT01390441|66015383|FG001|Treatment Period|Protocol Violation|1|||
23624835|NCT01390441|66015384|FG002|Treatment Period|Protocol Violation|0|||
23624836|NCT01390441|66015385|FG003|Treatment Period|Protocol Violation|0|||
23438237|NCT02853435|65348529|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438238|NCT00042991|65348530|FG000|Overall Study|Adverse Event|1|||
23438239|NCT00042991|65348531|FG001|Overall Study|Adverse Event|4|||
23438240|NCT00042991|65348532|FG002|Overall Study|Adverse Event|2|||
23438241|NCT00042991|65348533|FG003|Overall Study|Adverse Event|0|||
23438242|NCT00042991|65348534|FG004|Overall Study|Adverse Event|0|||
23438243|NCT00042991|65348535|FG005|Overall Study|Adverse Event|1|||
23438244|NCT00042991|65348536|FG006|Overall Study|Adverse Event|0|||
23624837|NCT01390441|66015386|FG004|Treatment Period|Protocol Violation|0|||
23624838|NCT01390441|66015382|FG000|Treatment Period|Physician Decision|0|||
23624839|NCT01390441|66015383|FG001|Treatment Period|Physician Decision|0|||
23624840|NCT01390441|66015384|FG002|Treatment Period|Physician Decision|0|||
23438245|NCT00042991|65348530|FG000|Overall Study|Withdrawal by Subject|0|||
23438246|NCT00042991|65348531|FG001|Overall Study|Withdrawal by Subject|7|||
23438247|NCT00042991|65348532|FG002|Overall Study|Withdrawal by Subject|2|||
23438248|NCT00042991|65348533|FG003|Overall Study|Withdrawal by Subject|0|||
23438249|NCT00042991|65348534|FG004|Overall Study|Withdrawal by Subject|1|||
23438250|NCT00042991|65348535|FG005|Overall Study|Withdrawal by Subject|0|||
23438251|NCT00042991|65348536|FG006|Overall Study|Withdrawal by Subject|0|||
23438252|NCT00042991|65348530|FG000|Overall Study|Disease Progression|5|||
23438253|NCT00042991|65348531|FG001|Overall Study|Disease Progression|29|||
23438254|NCT00042991|65348532|FG002|Overall Study|Disease Progression|2|||
23438255|NCT00042991|65348533|FG003|Overall Study|Disease Progression|2|||
23438256|NCT00042991|65348534|FG004|Overall Study|Disease Progression|1|||
23438257|NCT00042991|65348535|FG005|Overall Study|Disease Progression|4|||
23438258|NCT00042991|65348536|FG006|Overall Study|Disease Progression|2|||
23438259|NCT00042991|65348530|FG000|Overall Study|Alternative Therapy|0|||
23438260|NCT00042991|65348531|FG001|Overall Study|Alternative Therapy|0|||
23438261|NCT00042991|65348532|FG002|Overall Study|Alternative Therapy|0|||
23438262|NCT00042991|65348533|FG003|Overall Study|Alternative Therapy|0|||
23438263|NCT00042991|65348534|FG004|Overall Study|Alternative Therapy|1|||
23438264|NCT00042991|65348535|FG005|Overall Study|Alternative Therapy|0|||
23438265|NCT00042991|65348536|FG006|Overall Study|Alternative Therapy|0|||
23438266|NCT04725500|65348541|FG000|Screening|Screen Failure|26|||
23438267|NCT04725500|65348541|FG000|Screening|Withdrawal by Subject|1|||
23438268|NCT04725500|65348541|FG000|2 Week Take Home|Screen Fail|5|||
23438269|NCT02980133|65348542|FG000|Overall Study|Other than specified|1|||
23438270|NCT02980133|65348543|FG001|Overall Study|Other than specified|1|||
23438271|NCT02980133|65348544|FG002|Overall Study|Other than specified|2|||
23438272|NCT02980133|65348545|FG003|Overall Study|Other than specified|2|||
23438273|NCT02980133|65348542|FG000|Overall Study|Lost to Follow-up|0|||
23438274|NCT02980133|65348543|FG001|Overall Study|Lost to Follow-up|0|||
23438275|NCT02980133|65348544|FG002|Overall Study|Lost to Follow-up|1|||
23438276|NCT02980133|65348545|FG003|Overall Study|Lost to Follow-up|3|||
23438277|NCT02980133|65348542|FG000|Overall Study|Protocol Violation|0|||
23438278|NCT02980133|65348543|FG001|Overall Study|Protocol Violation|1|||
23438279|NCT02980133|65348544|FG002|Overall Study|Protocol Violation|0|||
23438280|NCT02980133|65348545|FG003|Overall Study|Protocol Violation|0|||
23624841|NCT01390441|66015385|FG003|Treatment Period|Physician Decision|1|||
23624842|NCT01390441|66015386|FG004|Treatment Period|Physician Decision|0|||
23624843|NCT01390441|66015382|FG000|Treatment Period|Lack of Efficacy|0|||
23624844|NCT01390441|66015383|FG001|Treatment Period|Lack of Efficacy|0|||
23624845|NCT01390441|66015384|FG002|Treatment Period|Lack of Efficacy|0|||
23624846|NCT01390441|66015385|FG003|Treatment Period|Lack of Efficacy|0|||
23624847|NCT01390441|66015386|FG004|Treatment Period|Lack of Efficacy|1|||
23624848|NCT01390441|66015382|FG000|Treatment Period|Unknown due to early stopping of study|0|||
23624849|NCT01390441|66015383|FG001|Treatment Period|Unknown due to early stopping of study|0|||
23624850|NCT01390441|66015384|FG002|Treatment Period|Unknown due to early stopping of study|8|||
23624851|NCT01390441|66015385|FG003|Treatment Period|Unknown due to early stopping of study|11|||
23624852|NCT01390441|66015386|FG004|Treatment Period|Unknown due to early stopping of study|7|||
23438281|NCT02980133|65348542|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23438282|NCT02980133|65348543|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23438283|NCT02980133|65348544|FG002|Overall Study|Withdrawal by parent/guardian|3|||
23438284|NCT02980133|65348545|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23438285|NCT02980133|65348542|FG000|Overall Study|Withdrawal by Subject|0|||
23438286|NCT02980133|65348543|FG001|Overall Study|Withdrawal by Subject|0|||
23438287|NCT02980133|65348544|FG002|Overall Study|Withdrawal by Subject|1|||
23438288|NCT02980133|65348545|FG003|Overall Study|Withdrawal by Subject|0|||
23438289|NCT01240135|65348550|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
23438290|NCT01240135|65348551|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
23438291|NCT01240135|65348550|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
23438292|NCT01240135|65348551|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
23438293|NCT03319212|65348554|FG000|Overall Study|Discontinued as moving out of local area|0|||
23438294|NCT03319212|65348555|FG001|Overall Study|Discontinued as moving out of local area|1|||
23438295|NCT03319212|65348554|FG000|Overall Study|Adverse Event|2|||
23438296|NCT03319212|65348555|FG001|Overall Study|Adverse Event|2|||
23438297|NCT03319212|65348554|FG000|Overall Study|Withdrawal by Subject|0|||
23438298|NCT03319212|65348555|FG001|Overall Study|Withdrawal by Subject|1|||
23438299|NCT03319212|65348554|FG000|Overall Study|Lost to Follow-up|0|||
23438300|NCT03319212|65348555|FG001|Overall Study|Lost to Follow-up|1|||
23438301|NCT03319212|65348554|FG000|Overall Study|Physician Decision|1|||
23438302|NCT03319212|65348555|FG001|Overall Study|Physician Decision|0|||
23438303|NCT03170193|65348556|FG000|Overall Study|Withdrawal by Subject|0|||
23438304|NCT03170193|65348557|FG001|Overall Study|Withdrawal by Subject|0|||
23438305|NCT03170193|65348558|FG002|Overall Study|Withdrawal by Subject|0|||
23624853|NCT01390441|66015382|FG000|Treatment Period|Adverse Event|0|||
23624854|NCT01390441|66015383|FG001|Treatment Period|Adverse Event|0|||
23624855|NCT01390441|66015384|FG002|Treatment Period|Adverse Event|1|||
23438306|NCT03170193|65348559|FG003|Overall Study|Withdrawal by Subject|1|||
23438307|NCT03170193|65348560|FG004|Overall Study|Withdrawal by Subject|0|||
23438308|NCT03170193|65348561|FG005|Overall Study|Withdrawal by Subject|0|||
23438309|NCT03170193|65348562|FG006|Overall Study|Withdrawal by Subject|0|||
23438310|NCT03170193|65348556|FG000|Overall Study|Lost to Follow-up|1|||
23438311|NCT03170193|65348557|FG001|Overall Study|Lost to Follow-up|1|||
23438312|NCT03170193|65348558|FG002|Overall Study|Lost to Follow-up|0|||
23438313|NCT03170193|65348559|FG003|Overall Study|Lost to Follow-up|0|||
23438314|NCT03170193|65348560|FG004|Overall Study|Lost to Follow-up|0|||
23438315|NCT03170193|65348561|FG005|Overall Study|Lost to Follow-up|0|||
23438316|NCT03170193|65348562|FG006|Overall Study|Lost to Follow-up|0|||
23438317|NCT02160145|65348563|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
23438318|NCT02160145|65348564|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
23624856|NCT01390441|66015385|FG003|Treatment Period|Adverse Event|1|||
23624857|NCT01390441|66015386|FG004|Treatment Period|Adverse Event|2|||
23624858|NCT01390441|66015382|FG000|Treatment Period|Withdrawal by Subject|0|||
23826172|NCT03334435|66745026|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
23438319|NCT02160145|65348565|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
23438320|NCT02160145|65348563|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
23438321|NCT02160145|65348564|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
23438322|NCT02160145|65348565|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
23438323|NCT02160145|65348563|FG000|Randomized Double-blind Period|Subject decision|0|||
23438324|NCT02160145|65348564|FG001|Randomized Double-blind Period|Subject decision|21|||
23438325|NCT02160145|65348565|FG002|Randomized Double-blind Period|Subject decision|20|||
23438326|NCT02160145|65348563|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
23438327|NCT02160145|65348564|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
23438328|NCT02160145|65348565|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
23438329|NCT02160145|65348563|FG000|Randomized Double-blind Period|Physician Decision|0|||
23438330|NCT02160145|65348564|FG001|Randomized Double-blind Period|Physician Decision|7|||
23438331|NCT02160145|65348565|FG002|Randomized Double-blind Period|Physician Decision|5|||
23438332|NCT03068767|65348566|FG000|Overall Study|Lost to Follow-up|7|||
23438333|NCT03068767|65348567|FG001|Overall Study|Lost to Follow-up|3|||
23438334|NCT03068767|65348566|FG000|Overall Study|Protocol Violation|3|||
23438335|NCT03068767|65348567|FG001|Overall Study|Protocol Violation|0|||
23438336|NCT00231413|65348568|FG000|Overall Study|Non-serious AE|0|||
23438337|NCT00231413|65348569|FG001|Overall Study|Non-serious AE|0|||
23438338|NCT00231413|65348570|FG002|Overall Study|Non-serious AE|1|||
23438339|NCT00231413|65348571|FG003|Overall Study|Non-serious AE|0|||
23438340|NCT00231413|65348572|FG004|Overall Study|Non-serious AE|0|||
23438341|NCT00231413|65348573|FG005|Overall Study|Non-serious AE|0|||
23438342|NCT00231413|65348574|FG006|Overall Study|Non-serious AE|1|||
23438343|NCT00231413|65348568|FG000|Overall Study|Withdrawal by Subject|3|||
23438344|NCT00231413|65348569|FG001|Overall Study|Withdrawal by Subject|1|||
23438345|NCT00231413|65348570|FG002|Overall Study|Withdrawal by Subject|4|||
23438346|NCT00231413|65348571|FG003|Overall Study|Withdrawal by Subject|2|||
23438347|NCT00231413|65348572|FG004|Overall Study|Withdrawal by Subject|2|||
23438348|NCT00231413|65348573|FG005|Overall Study|Withdrawal by Subject|0|||
23624859|NCT01390441|66015383|FG001|Treatment Period|Withdrawal by Subject|0|||
23438349|NCT00231413|65348574|FG006|Overall Study|Withdrawal by Subject|3|||
23624860|NCT01390441|66015384|FG002|Treatment Period|Withdrawal by Subject|1|||
23624861|NCT01390441|66015385|FG003|Treatment Period|Withdrawal by Subject|0|||
23624862|NCT01390441|66015386|FG004|Treatment Period|Withdrawal by Subject|1|||
23624863|NCT01390441|66015382|FG000|Treatment Period|Lost to Follow-up|1|||
23624864|NCT01390441|66015383|FG001|Treatment Period|Lost to Follow-up|0|||
23624865|NCT01390441|66015384|FG002|Treatment Period|Lost to Follow-up|0|||
23624866|NCT01390441|66015385|FG003|Treatment Period|Lost to Follow-up|0|||
23624867|NCT01390441|66015386|FG004|Treatment Period|Lost to Follow-up|0|||
23624868|NCT01390441|66015382|FG000|Extension Period|Protocol Violation|3|||
23624869|NCT01390441|66015383|FG001|Extension Period|Protocol Violation|1|||
23624870|NCT01390441|66015384|FG002|Extension Period|Protocol Violation|0|||
23624871|NCT01390441|66015385|FG003|Extension Period|Protocol Violation|1|||
23624872|NCT01390441|66015386|FG004|Extension Period|Protocol Violation|0|||
23624873|NCT00129649|66015388|FG000|Overall Study|Withdrawal by Subject|76|||
23624874|NCT00129649|66015389|FG001|Overall Study|Withdrawal by Subject|65|||
23624875|NCT00905034|66015391|FG000|Overall Study|Withdrawal by Subject|1|||
23624876|NCT01296555|66015392|FG000|Overall Study|Adverse Event|0|||
23624877|NCT01296555|66015393|FG001|Overall Study|Adverse Event|0|||
23624878|NCT01296555|66015394|FG002|Overall Study|Adverse Event|1|||
23624879|NCT01296555|66015395|FG003|Overall Study|Adverse Event|1|||
23624880|NCT01296555|66015396|FG004|Overall Study|Adverse Event|2|||
23624881|NCT01296555|66015397|FG005|Overall Study|Adverse Event|4|||
23624882|NCT01296555|66015398|FG006|Overall Study|Adverse Event|1|||
23624883|NCT01296555|66015399|FG007|Overall Study|Adverse Event|4|||
23624884|NCT01296555|66015400|FG008|Overall Study|Adverse Event|3|||
23624885|NCT01296555|66015401|FG009|Overall Study|Adverse Event|1|||
23624886|NCT01296555|66015402|FG010|Overall Study|Adverse Event|0|||
23624887|NCT01296555|66015403|FG011|Overall Study|Adverse Event|4|||
23624888|NCT01296555|66015404|FG012|Overall Study|Adverse Event|1|||
23624889|NCT01296555|66015405|FG013|Overall Study|Adverse Event|4|||
23438350|NCT00231413|65348568|FG000|Overall Study|Migrated/moved from study area|0|||
23438351|NCT00231413|65348569|FG001|Overall Study|Migrated/moved from study area|0|||
23438352|NCT00231413|65348570|FG002|Overall Study|Migrated/moved from study area|1|||
23624890|NCT01296555|66015406|FG014|Overall Study|Adverse Event|0|||
23624891|NCT01296555|66015407|FG015|Overall Study|Adverse Event|0|||
23624892|NCT01296555|66015408|FG016|Overall Study|Adverse Event|0|||
23624893|NCT01296555|66015409|FG017|Overall Study|Adverse Event|0|||
23624894|NCT01296555|66015410|FG018|Overall Study|Adverse Event|0|||
23438353|NCT00231413|65348571|FG003|Overall Study|Migrated/moved from study area|0|||
23624895|NCT01296555|66015411|FG019|Overall Study|Adverse Event|1|||
23756467|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
23756468|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
23756469|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
23756470|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
23756471|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
23756472|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
23756473|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
23756474|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
23756475|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
23756476|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
23756477|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
23756478|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
23756479|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
23756480|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
23756481|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
23756482|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
23756483|NCT01299272|66487268|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
23756484|NCT01299272|66487269|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
23756485|NCT01299272|66487270|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
23756486|NCT01299272|66487271|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
23756487|NCT04247594|66487272|FG000|Overall Study|Withdrawal by Subject|4|||
23756488|NCT02156466|66487274|FG000|Overall Study|Adverse Event|0|||
23756489|NCT02156466|66487275|FG001|Overall Study|Adverse Event|0|||
23756490|NCT02156466|66487276|FG002|Overall Study|Adverse Event|1|||
23756491|NCT02156466|66487277|FG003|Overall Study|Adverse Event|1|||
23756492|NCT02156466|66487278|FG004|Overall Study|Adverse Event|0|||
23756493|NCT02156466|66487274|FG000|Overall Study|Quantiferon Positivity|0|||
23756494|NCT02156466|66487275|FG001|Overall Study|Quantiferon Positivity|0|||
23756495|NCT02156466|66487276|FG002|Overall Study|Quantiferon Positivity|0|||
23756496|NCT02156466|66487277|FG003|Overall Study|Quantiferon Positivity|1|||
23756497|NCT02156466|66487278|FG004|Overall Study|Quantiferon Positivity|0|||
23756498|NCT01959230|66487279|FG000|Overall Study|Failure to follow study procedures|0|||
23756499|NCT01959230|66487280|FG001|Overall Study|Failure to follow study procedures|1|||
23756500|NCT01959230|66487279|FG000|Overall Study|Administrative reasons|2|||
23756501|NCT01959230|66487280|FG001|Overall Study|Administrative reasons|0|||
23826173|NCT03334435|66745027|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
23826174|NCT03334435|66745028|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
23826175|NCT03334435|66745029|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826176|NCT03334435|66745030|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826177|NCT03334435|66745031|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826178|NCT03334435|66745032|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826179|NCT03334435|66745033|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826180|NCT03334435|66745034|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826181|NCT03334435|66745035|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826182|NCT03334435|66745036|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826183|NCT03334435|66745037|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826184|NCT03334435|66745038|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
23826185|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23826186|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23826187|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23826188|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23826189|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23826190|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23826191|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
23826192|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23826193|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
23826194|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
23826195|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23826196|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
23826197|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
23826198|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
23826199|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
23826200|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23826201|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23826202|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23826203|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23826204|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23756502|NCT01959230|66487279|FG000|Overall Study|Withdrawal by Subject|2|||
23756503|NCT01959230|66487280|FG001|Overall Study|Withdrawal by Subject|0|||
23756504|NCT00468312|66487281|FG000|Overall Study|Adverse Event|2|||
23756505|NCT00468312|66487282|FG001|Overall Study|Adverse Event|1|||
23756506|NCT00468312|66487281|FG000|Overall Study|Lack of Efficacy|0|||
23756507|NCT00468312|66487282|FG001|Overall Study|Lack of Efficacy|1|||
23756508|NCT00468312|66487281|FG000|Overall Study|Withdrawal by Subject|0|||
23756509|NCT00468312|66487282|FG001|Overall Study|Withdrawal by Subject|1|||
23756510|NCT00468312|66487281|FG000|Overall Study|Protocol Violation|2|||
23756511|NCT00468312|66487282|FG001|Overall Study|Protocol Violation|1|||
23756512|NCT00468312|66487281|FG000|Overall Study|Did not meet protocol eligibility|0|||
23756513|NCT00468312|66487282|FG001|Overall Study|Did not meet protocol eligibility|1|||
23756514|NCT00068406|66487287|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
23756515|NCT00068406|66487287|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
23756516|NCT00602979|66487290|FG000|Overall Study|Lost to Follow-up|3|||
23756517|NCT00602979|66487291|FG001|Overall Study|Lost to Follow-up|2|||
23826205|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
23756518|NCT00602979|66487292|FG002|Overall Study|Lost to Follow-up|3|||
23756519|NCT00602979|66487293|FG003|Overall Study|Lost to Follow-up|2|||
23756520|NCT00602979|66487294|FG004|Overall Study|Lost to Follow-up|3|||
23756521|NCT00602979|66487290|FG000|Overall Study|Failed Intubation|0|||
23756522|NCT00602979|66487291|FG001|Overall Study|Failed Intubation|1|||
23756523|NCT00602979|66487292|FG002|Overall Study|Failed Intubation|0|||
23756524|NCT00602979|66487293|FG003|Overall Study|Failed Intubation|1|||
23756525|NCT00602979|66487294|FG004|Overall Study|Failed Intubation|0|||
23756526|NCT04288115|66487295|FG000|Overall Study|Withdrawal by Subject|0|||
23756527|NCT04288115|66487296|FG001|Overall Study|Withdrawal by Subject|1|||
23756528|NCT04288115|66487295|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
23756529|NCT04288115|66487296|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
23756530|NCT00449930|66487297|FG000|Overall Study|Adverse Event|9|||
23756531|NCT00449930|66487298|FG001|Overall Study|Adverse Event|19|||
23826206|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
23826207|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
23826208|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
23826209|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
23826210|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
23826211|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
23826212|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
23826213|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
23826214|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
23826215|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826216|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826217|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826218|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826219|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826220|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
23826221|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
23826222|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
23826223|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
23826224|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
23826225|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
23826226|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
23826227|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23826228|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
23826229|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
23826230|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23826231|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23826232|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23826233|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23826234|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23826235|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
23756532|NCT00449930|66487297|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
23756533|NCT00449930|66487298|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
23756534|NCT00449930|66487297|FG000|Overall Study|Lack of Efficacy|10|||
23756535|NCT00449930|66487298|FG001|Overall Study|Lack of Efficacy|1|||
23756536|NCT00449930|66487297|FG000|Overall Study|Lost to Follow-up|9|||
23756537|NCT00449930|66487298|FG001|Overall Study|Lost to Follow-up|14|||
23756538|NCT00449930|66487297|FG000|Overall Study|Physician Decision|1|||
23756539|NCT00449930|66487298|FG001|Overall Study|Physician Decision|2|||
23756540|NCT00449930|66487297|FG000|Overall Study|Protocol Violation|14|||
23756541|NCT00449930|66487298|FG001|Overall Study|Protocol Violation|15|||
23756542|NCT00449930|66487297|FG000|Overall Study|Withdrawal by Subject|16|||
23756543|NCT00449930|66487298|FG001|Overall Study|Withdrawal by Subject|23|||
23756544|NCT00449930|66487297|FG000|Overall Study|Glycemic discontinuation criteria|1|||
23756545|NCT00449930|66487298|FG001|Overall Study|Glycemic discontinuation criteria|1|||
23756546|NCT02742818|66487299|FG000|Overall Study|Adverse Event|0|||
23756547|NCT02742818|66487300|FG001|Overall Study|Adverse Event|1|||
23756548|NCT02742818|66487299|FG000|Overall Study|Protocol Violation|0|||
23756549|NCT02742818|66487300|FG001|Overall Study|Protocol Violation|1|||
23756550|NCT02862535|66487309|FG000|Overall Study|Death|7|||
23756551|NCT02862535|66487310|FG001|Overall Study|Death|3|||
23756552|NCT02862535|66487311|FG002|Overall Study|Death|2|||
23756553|NCT02862535|66487312|FG003|Overall Study|Death|5|||
23756554|NCT02862535|66487309|FG000|Overall Study|Study Terminated by Sponsor|1|||
23756555|NCT02862535|66487310|FG001|Overall Study|Study Terminated by Sponsor|3|||
23756556|NCT02862535|66487311|FG002|Overall Study|Study Terminated by Sponsor|8|||
23756557|NCT02862535|66487312|FG003|Overall Study|Study Terminated by Sponsor|5|||
23756558|NCT02862535|66487309|FG000|Overall Study|Enrolled, not Treated|1|||
23756559|NCT02862535|66487310|FG001|Overall Study|Enrolled, not Treated|0|||
23756560|NCT02862535|66487311|FG002|Overall Study|Enrolled, not Treated|0|||
23560671|NCT01376323|65782365|FG003|Overall Study|Withdrawal by Subject|0|||
23560672|NCT01376323|65782366|FG004|Overall Study|Withdrawal by Subject|0|||
23560673|NCT01224925|65782367|FG000|Overall Study|Lost to Follow-up|3|||
23560674|NCT01224925|65782368|FG001|Overall Study|Lost to Follow-up|2|||
23560675|NCT01520402|65782372|FG000|Overall Study|Withdrawal by Subject|2|||
23560676|NCT01520402|65782372|FG000|Overall Study|Physician Decision|3|||
23560677|NCT01279343|65782373|FG000|Overall Study|Did not receive treatment|2|||
23560678|NCT01279343|65782374|FG001|Overall Study|Did not receive treatment|6|||
23560679|NCT00571701|65782377|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
23560680|NCT00571701|65782378|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
23560681|NCT00571701|65782377|FG000|First Intervention 12 Months|Death|1|||
23756561|NCT02862535|66487312|FG003|Overall Study|Enrolled, not Treated|1|||
23756562|NCT03056001|66487314|FG000|Overall Study|Death|24|||
23756563|NCT00763269|66487315|FG000|Overall Study|Lost to Follow-up|12|||
23756564|NCT00763269|66487316|FG001|Overall Study|Lost to Follow-up|13|||
23756565|NCT01374906|66487317|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23756566|NCT01374906|66487318|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23756567|NCT01374906|66487317|FG000|Overall Study|Administrative problems|2|||
23756568|NCT01374906|66487318|FG001|Overall Study|Administrative problems|2|||
23560682|NCT00571701|65782378|FG001|First Intervention 12 Months|Death|0|||
23560683|NCT00571701|65782377|FG000|Second Intervention 12 Months|Adverse Event|0|||
23756569|NCT01374906|66487317|FG000|Overall Study|Adverse Event|10|||
23560684|NCT00571701|65782378|FG001|Second Intervention 12 Months|Adverse Event|1|||
23560685|NCT00571701|65782377|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
23756570|NCT01374906|66487318|FG001|Overall Study|Adverse Event|11|||
23438354|NCT00231413|65348572|FG004|Overall Study|Migrated/moved from study area|0|||
23438355|NCT00231413|65348573|FG005|Overall Study|Migrated/moved from study area|1|||
23438356|NCT00231413|65348574|FG006|Overall Study|Migrated/moved from study area|0|||
23438357|NCT00231413|65348568|FG000|Overall Study|Lost to Follow-up|4|||
23438358|NCT00231413|65348569|FG001|Overall Study|Lost to Follow-up|4|||
23438359|NCT00231413|65348570|FG002|Overall Study|Lost to Follow-up|1|||
23438360|NCT00231413|65348571|FG003|Overall Study|Lost to Follow-up|1|||
23438361|NCT00231413|65348572|FG004|Overall Study|Lost to Follow-up|1|||
23438362|NCT00231413|65348573|FG005|Overall Study|Lost to Follow-up|4|||
23438363|NCT00231413|65348574|FG006|Overall Study|Lost to Follow-up|0|||
23624896|NCT01296555|66015412|FG020|Overall Study|Adverse Event|0|||
23624897|NCT01296555|66015413|FG021|Overall Study|Adverse Event|0|||
23624898|NCT01296555|66015414|FG022|Overall Study|Adverse Event|0|||
23624899|NCT01296555|66015415|FG023|Overall Study|Adverse Event|0|||
23756571|NCT01374906|66487317|FG000|Overall Study|Death|0|||
23756572|NCT01374906|66487318|FG001|Overall Study|Death|2|||
23756573|NCT01374906|66487317|FG000|Overall Study|Protocol Violation|2|||
23756574|NCT01374906|66487318|FG001|Overall Study|Protocol Violation|2|||
23756575|NCT01374906|66487317|FG000|Overall Study|Withdrawal by Subject|15|||
23756576|NCT01374906|66487318|FG001|Overall Study|Withdrawal by Subject|9|||
23756577|NCT01374906|66487317|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
23756578|NCT01374906|66487318|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
23756579|NCT00331773|66487323|FG000|Overall Study|Withdrawal by Subject|6|||
23756580|NCT00331773|66487324|FG001|Overall Study|Withdrawal by Subject|4|||
23756581|NCT00331773|66487323|FG000|Overall Study|Protocol Violation|10|||
23826236|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
23826237|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23826238|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23826239|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
23826240|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
23826241|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
23826242|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23826243|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
23826244|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
23826245|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826246|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826247|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826248|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826249|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826250|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826251|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
23826252|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
23826253|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
23826254|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23826255|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23826256|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23826257|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23826258|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
23438364|NCT00231413|65348568|FG000|Overall Study|Pregnancy|1|||
23756582|NCT00331773|66487324|FG001|Overall Study|Protocol Violation|3|||
23756583|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
23826259|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
23624900|NCT01296555|66015416|FG024|Overall Study|Adverse Event|0|||
23624901|NCT01296555|66015417|FG025|Overall Study|Adverse Event|0|||
23756584|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
23438365|NCT00231413|65348569|FG001|Overall Study|Pregnancy|0|||
23560686|NCT00571701|65782378|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
23560687|NCT00069784|65782381|FG000|Overall Study|Adverse Event|105|||
23560688|NCT00069784|65782382|FG001|Overall Study|Adverse Event|0|||
23756585|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
23756586|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
23756587|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
23756588|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
23756589|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
23756590|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
23756591|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
23756592|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
23756593|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
23756594|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
23756595|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
23756596|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
23756597|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
23756598|NCT00529568|66487327|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
23826260|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826261|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826262|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826263|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826264|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826265|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826266|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23756599|NCT00529568|66487328|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
23756600|NCT00529568|66487329|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
23560689|NCT00069784|65782381|FG000|Overall Study|Withdrawal by Subject|1090|||
23560690|NCT00069784|65782382|FG001|Overall Study|Withdrawal by Subject|0|||
23560691|NCT00069784|65782381|FG000|Overall Study|Other|17|||
23560692|NCT00069784|65782382|FG001|Overall Study|Other|0|||
23560693|NCT02010632|65782384|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
23560694|NCT02010632|65782385|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
23560695|NCT02736825|65782386|FG000|Overall Study|Lost to Follow-up|10|||
23560696|NCT02736825|65782387|FG001|Overall Study|Lost to Follow-up|11|||
23560697|NCT02736825|65782386|FG000|Overall Study|Early Termination|0|||
23560698|NCT02736825|65782387|FG001|Overall Study|Early Termination|1|||
23560699|NCT03541044|65782388|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
23756601|NCT00529568|66487327|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
23756602|NCT00529568|66487328|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
23756603|NCT00529568|66487329|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
23756604|NCT00529568|66487327|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
23756605|NCT00529568|66487328|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
23756606|NCT00529568|66487329|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
23560700|NCT03541044|65782389|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
23560701|NCT03541044|65782388|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
23560702|NCT03541044|65782389|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
23560703|NCT00094328|65782390|FG000|Overall Study|Lost to Follow-up|1|||
23560704|NCT05597722|65782391|FG000|Overall Study|Study was terminated|6|||
23560705|NCT05597722|65782392|FG001|Overall Study|Study was terminated|1|||
23560706|NCT00106184|65782394|FG000|Overall Study|Withdrawal by Subject|3|||
23560707|NCT00106184|65782395|FG001|Overall Study|Withdrawal by Subject|2|||
23560708|NCT03188120|65782397|FG000|Overall Study|Adverse Event|4|||
23560709|NCT03188120|65782397|FG000|Overall Study|Insufficient Effectiveness|8|||
23560710|NCT03188120|65782397|FG000|Overall Study|Improved|12|||
23624902|NCT01296555|66015418|FG026|Overall Study|Adverse Event|0|||
23560711|NCT03188120|65782397|FG000|Overall Study|Lost to Follow-up|7|||
23560712|NCT03188120|65782397|FG000|Overall Study|Other than specified|3|||
23560713|NCT03188120|65782397|FG000|Overall Study|No visit after the first visit|13|||
23560714|NCT01960725|65782401|FG000|Overall Study|Lost to Follow-up|4|||
23560715|NCT01960725|65782402|FG001|Overall Study|Lost to Follow-up|3|||
23560716|NCT01960725|65782401|FG000|Overall Study|Withdrawal by Subject|1|||
23560717|NCT01960725|65782402|FG001|Overall Study|Withdrawal by Subject|0|||
23624903|NCT01296555|66015419|FG027|Overall Study|Adverse Event|0|||
23756607|NCT00529568|66487327|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
23756608|NCT00529568|66487328|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
23756609|NCT00529568|66487329|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
23756610|NCT00529568|66487327|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
23756611|NCT00529568|66487328|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
23756612|NCT00529568|66487329|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
23756613|NCT00529568|66487327|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
23438366|NCT00231413|65348570|FG002|Overall Study|Pregnancy|0|||
23438367|NCT00231413|65348571|FG003|Overall Study|Pregnancy|0|||
23438368|NCT00231413|65348572|FG004|Overall Study|Pregnancy|0|||
23438369|NCT00231413|65348573|FG005|Overall Study|Pregnancy|0|||
23438370|NCT00231413|65348574|FG006|Overall Study|Pregnancy|0|||
23438371|NCT00983385|65348575|FG000|Observation Period|Not eligible to be dosed|20|||
23438372|NCT00983385|65348575|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
23438373|NCT01894243|65348576|FG000|Overall Study|Adverse Event|0|||
23438374|NCT01894243|65348577|FG001|Overall Study|Adverse Event|1|||
23438375|NCT01894243|65348578|FG002|Overall Study|Adverse Event|2|||
23438376|NCT01894243|65348576|FG000|Overall Study|Death|0|||
23438377|NCT01894243|65348577|FG001|Overall Study|Death|0|||
23560718|NCT01960725|65782401|FG000|Overall Study|unable to obtain blood sample|1|||
23560719|NCT01960725|65782402|FG001|Overall Study|unable to obtain blood sample|2|||
23560720|NCT01058304|65782403|FG000|Overall Study|Withdrawal by Subject|8|||
23560721|NCT01058304|65782404|FG001|Overall Study|Withdrawal by Subject|5|||
23560722|NCT01058304|65782403|FG000|Overall Study|Lost to Follow-up|13|||
23560723|NCT01058304|65782404|FG001|Overall Study|Lost to Follow-up|16|||
23560724|NCT01058304|65782403|FG000|Overall Study|Developed exclusion criterion|6|||
23560725|NCT01058304|65782404|FG001|Overall Study|Developed exclusion criterion|12|||
23756614|NCT00529568|66487328|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
23560726|NCT00946296|65782405|FG000|Overall Study|Physician Decision|3|||
23560727|NCT00946296|65782406|FG001|Overall Study|Physician Decision|0|||
23756615|NCT00529568|66487329|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
23756616|NCT02380248|66487330|FG000|Overall Study|Lost to Follow-up|11|||
23756617|NCT02380248|66487330|FG000|Overall Study|Withdrawal by Subject|3|||
23756618|NCT01162135|66487331|FG000|Overall Study|Withdrawal by Subject|1|||
23756619|NCT01162135|66487331|FG000|Overall Study|Severe back pain|1|||
23756620|NCT01162135|66487331|FG000|Overall Study|Ineligible|1|||
23756621|NCT00267007|66487332|FG000|Overall Study|Withdrawal by Subject|6|||
23756622|NCT00267007|66487333|FG001|Overall Study|Withdrawal by Subject|0|||
23756623|NCT00267007|66487332|FG000|Overall Study|Lost to Follow-up|1|||
23756624|NCT00267007|66487333|FG001|Overall Study|Lost to Follow-up|0|||
23756625|NCT00267007|66487332|FG000|Overall Study|Non-compliance|0|||
23756626|NCT00267007|66487333|FG001|Overall Study|Non-compliance|1|||
23756627|NCT00267007|66487332|FG000|Overall Study|Adverse Event|1|||
23756628|NCT00267007|66487333|FG001|Overall Study|Adverse Event|0|||
23756629|NCT01325701|66487335|FG000|Overall Study|Adverse Event|12|||
23756630|NCT01325701|66487336|FG001|Overall Study|Adverse Event|0|||
23756631|NCT01325701|66487335|FG000|Overall Study|Protocol Violation|1|||
23756632|NCT01325701|66487336|FG001|Overall Study|Protocol Violation|0|||
23756633|NCT01325701|66487335|FG000|Overall Study|Physician Decision|2|||
23756634|NCT01325701|66487336|FG001|Overall Study|Physician Decision|2|||
23756635|NCT01325701|66487335|FG000|Overall Study|Withdrawal by Subject|2|||
23756636|NCT01325701|66487336|FG001|Overall Study|Withdrawal by Subject|1|||
23756637|NCT01325701|66487335|FG000|Overall Study|Rollerover Extension Study|4|||
23756638|NCT01325701|66487336|FG001|Overall Study|Rollerover Extension Study|0|||
23826267|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826268|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23560728|NCT04176939|65782407|FG000|Overall Study|Adverse Event|7|||
23560729|NCT04176939|65782407|FG000|Overall Study|Unspecified reason|2|||
23826269|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23438378|NCT01894243|65348578|FG002|Overall Study|Death|3|||
23438379|NCT01894243|65348576|FG000|Overall Study|Lack of Efficacy|3|||
23438380|NCT01894243|65348577|FG001|Overall Study|Lack of Efficacy|3|||
23560730|NCT04176939|65782407|FG000|Overall Study|Migrated/Moved from the study area|1|||
23756639|NCT00995930|66487337|FG000|Overall Study|Protocol deviation|2|||
23756640|NCT00995930|66487338|FG001|Overall Study|Protocol deviation|5|||
23756641|NCT00995930|66487337|FG000|Overall Study|Death|0|||
23756642|NCT00995930|66487338|FG001|Overall Study|Death|1|||
23756643|NCT00995930|66487337|FG000|Overall Study|Administrative problems|4|||
23756644|NCT00995930|66487338|FG001|Overall Study|Administrative problems|2|||
23438381|NCT01894243|65348578|FG002|Overall Study|Lack of Efficacy|1|||
23560731|NCT04176939|65782407|FG000|Overall Study|Withdrawal by Subject|4|||
23560732|NCT04176939|65782407|FG000|Overall Study|In follow-up|54|||
23756645|NCT00995930|66487337|FG000|Overall Study|Lost to Follow-up|1|||
23560733|NCT00110890|65782408|FG000|Overall Study|Adverse Event|30|||
23756646|NCT00995930|66487338|FG001|Overall Study|Lost to Follow-up|2|||
23756647|NCT00995930|66487337|FG000|Overall Study|Withdrawal by Subject|3|||
23756648|NCT00995930|66487338|FG001|Overall Study|Withdrawal by Subject|4|||
23756649|NCT00995930|66487337|FG000|Overall Study|Adverse Event|11|||
23756650|NCT00995930|66487338|FG001|Overall Study|Adverse Event|14|||
23756651|NCT00402779|66487339|FG000|Overall Study|Screen Failure|77|||
23756652|NCT00402779|66487340|FG001|Overall Study|Screen Failure|76|||
23756653|NCT02476851|66487341|FG000|Overall Study|Protocol Violation|1|||
23756654|NCT02476851|66487342|FG001|Overall Study|Protocol Violation|1|||
23756655|NCT01271933|66487343|FG000|Single-Blind Phase|Lack of Efficacy|37|||
23826270|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826271|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
23826272|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826273|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
23826274|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23826275|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826276|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826277|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
23756656|NCT01271933|66487344|FG001|Single-Blind Phase|Lack of Efficacy|0|||
23756657|NCT01271933|66487345|FG002|Single-Blind Phase|Lack of Efficacy|0|||
23756658|NCT01271933|66487343|FG000|Single-Blind Phase|Lost to Follow-up|10|||
23756659|NCT01271933|66487344|FG001|Single-Blind Phase|Lost to Follow-up|0|||
23756660|NCT01271933|66487345|FG002|Single-Blind Phase|Lost to Follow-up|0|||
23756661|NCT01271933|66487343|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
23756662|NCT01271933|66487344|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
23438382|NCT01894243|65348576|FG000|Overall Study|Condition under investigation worsened|8|||
23438383|NCT01894243|65348577|FG001|Overall Study|Condition under investigation worsened|6|||
23438384|NCT01894243|65348578|FG002|Overall Study|Condition under investigation worsened|2|||
23438385|NCT01894243|65348576|FG000|Overall Study|Subject decision|1|||
23438386|NCT01894243|65348577|FG001|Overall Study|Subject decision|0|||
23438387|NCT01894243|65348578|FG002|Overall Study|Subject decision|0|||
23438388|NCT01894243|65348576|FG000|Overall Study|Other|1|||
23438389|NCT01894243|65348577|FG001|Overall Study|Other|0|||
23438390|NCT01894243|65348578|FG002|Overall Study|Other|0|||
23438391|NCT04000581|65348583|FG000|Overall Study|Withdrawal by Subject|0|||
23438392|NCT04000581|65348584|FG001|Overall Study|Withdrawal by Subject|1|||
23438393|NCT00767819|65348590|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23438394|NCT00767819|65348591|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
23438395|NCT00767819|65348592|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23438396|NCT00767819|65348590|FG000|Overall Study|Withdrawal by Subject|1|||
23438397|NCT00767819|65348591|FG001|Overall Study|Withdrawal by Subject|1|||
23438398|NCT00767819|65348592|FG002|Overall Study|Withdrawal by Subject|0|||
23438399|NCT00767819|65348590|FG000|Overall Study|Administrative problems|0|||
23438400|NCT00767819|65348591|FG001|Overall Study|Administrative problems|1|||
23438401|NCT00767819|65348592|FG002|Overall Study|Administrative problems|0|||
23438402|NCT00767819|65348590|FG000|Overall Study|Death|2|||
23438403|NCT00767819|65348591|FG001|Overall Study|Death|3|||
23438404|NCT00767819|65348592|FG002|Overall Study|Death|0|||
23438405|NCT00767819|65348590|FG000|Overall Study|Adverse Event|2|||
23438406|NCT00767819|65348591|FG001|Overall Study|Adverse Event|0|||
23560734|NCT00110890|65782409|FG001|Overall Study|Adverse Event|7|||
23560735|NCT00110890|65782408|FG000|Overall Study|Death|16|||
23560736|NCT00110890|65782409|FG001|Overall Study|Death|9|||
23560737|NCT00110890|65782408|FG000|Overall Study|Lost to Follow-up|3|||
23560738|NCT00110890|65782409|FG001|Overall Study|Lost to Follow-up|1|||
23560739|NCT00110890|65782408|FG000|Overall Study|Physician Decision|4|||
23560740|NCT00110890|65782409|FG001|Overall Study|Physician Decision|5|||
23756663|NCT01271933|66487345|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
23826278|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826279|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826280|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
23826281|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
23438407|NCT00767819|65348592|FG002|Overall Study|Adverse Event|0|||
23438408|NCT00767819|65348590|FG000|Overall Study|Abnormal lab values|1|||
23438409|NCT00767819|65348591|FG001|Overall Study|Abnormal lab values|0|||
23438410|NCT00767819|65348592|FG002|Overall Study|Abnormal lab values|0|||
23438411|NCT00767819|65348590|FG000|Overall Study|Lost to Follow-up|1|||
23438412|NCT00767819|65348591|FG001|Overall Study|Lost to Follow-up|0|||
23756664|NCT01271933|66487343|FG000|Single-Blind Phase|Protocol Violation|3|||
23756665|NCT01271933|66487344|FG001|Single-Blind Phase|Protocol Violation|0|||
23560741|NCT00110890|65782408|FG000|Overall Study|Withdrawal by Subject|17|||
23560742|NCT00110890|65782409|FG001|Overall Study|Withdrawal by Subject|5|||
23560743|NCT00110890|65782408|FG000|Overall Study|Protocol Deviation|1|||
23438413|NCT00767819|65348592|FG002|Overall Study|Lost to Follow-up|0|||
23438414|NCT00900029|65348593|FG000|Overall Study|Lost to Follow-up|0|||
23438415|NCT00900029|65348594|FG001|Overall Study|Lost to Follow-up|2|||
23438416|NCT00900029|65348595|FG002|Overall Study|Lost to Follow-up|1|||
23438417|NCT00900029|65348596|FG003|Overall Study|Lost to Follow-up|4|||
23438418|NCT00900029|65348597|FG004|Overall Study|Lost to Follow-up|4|||
23438419|NCT00900029|65348593|FG000|Overall Study|Withdrawal by Subject|2|||
23438420|NCT00900029|65348594|FG001|Overall Study|Withdrawal by Subject|2|||
23438421|NCT00900029|65348595|FG002|Overall Study|Withdrawal by Subject|1|||
23438422|NCT00900029|65348596|FG003|Overall Study|Withdrawal by Subject|1|||
23438423|NCT00900029|65348597|FG004|Overall Study|Withdrawal by Subject|1|||
23438424|NCT00900029|65348593|FG000|Overall Study|Adverse Event|0|||
23438425|NCT00900029|65348594|FG001|Overall Study|Adverse Event|0|||
23438426|NCT00900029|65348595|FG002|Overall Study|Adverse Event|1|||
23438427|NCT00900029|65348596|FG003|Overall Study|Adverse Event|1|||
23438428|NCT00900029|65348597|FG004|Overall Study|Adverse Event|1|||
23438429|NCT00900029|65348593|FG000|Overall Study|Death|1|||
23438430|NCT00900029|65348594|FG001|Overall Study|Death|0|||
23438431|NCT00900029|65348595|FG002|Overall Study|Death|0|||
23438432|NCT00900029|65348596|FG003|Overall Study|Death|1|||
23438433|NCT00900029|65348597|FG004|Overall Study|Death|0|||
23438434|NCT02713828|65348598|FG000|Overall Study|Death|2|||
23438435|NCT02713828|65348599|FG001|Overall Study|Death|0|||
23438436|NCT02713828|65348598|FG000|Overall Study|Withdrawal by Subject|1|||
23438437|NCT02713828|65348599|FG001|Overall Study|Withdrawal by Subject|0|||
23438438|NCT02713828|65348598|FG000|Overall Study|study terminated but patient allowed to|2|||
23438439|NCT02713828|65348599|FG001|Overall Study|study terminated but patient allowed to|0|||
23438440|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438441|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438442|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
23438443|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
23438444|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
23438445|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438446|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
23438447|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
23438448|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
23438449|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438450|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438451|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438452|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438453|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
23438454|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438455|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
23438456|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438457|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438458|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438459|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438460|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438461|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
23438462|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438463|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438464|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438465|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438466|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23756666|NCT01271933|66487345|FG002|Single-Blind Phase|Protocol Violation|0|||
23756667|NCT01271933|66487343|FG000|Single-Blind Phase|Adverse Event|52|||
23756668|NCT01271933|66487344|FG001|Single-Blind Phase|Adverse Event|0|||
23756669|NCT01271933|66487345|FG002|Single-Blind Phase|Adverse Event|0|||
23756670|NCT01271933|66487343|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
23756671|NCT01271933|66487344|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
23756672|NCT01271933|66487345|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
23756673|NCT01271933|66487343|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
23756674|NCT01271933|66487344|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
23438467|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438468|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438469|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438470|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438471|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438472|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438473|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23453637|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23438474|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438475|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438476|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438477|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438478|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438479|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438480|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438481|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438482|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438483|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438484|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438485|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438486|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438487|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438488|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438489|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438490|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438491|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438492|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438493|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438494|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438495|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
23438496|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438497|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438498|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438499|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
23438500|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438501|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438502|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438503|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438504|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438505|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438506|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438507|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438508|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
23438509|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438510|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438511|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
23438512|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438513|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438514|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438515|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438516|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438517|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438518|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438519|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
23438520|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438521|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438522|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438523|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438524|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438525|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438526|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438527|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438528|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23826282|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
23438529|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438530|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438531|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
23756675|NCT01271933|66487345|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
23756676|NCT01271933|66487343|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
23756677|NCT01271933|66487344|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
23756678|NCT01271933|66487345|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
23756679|NCT01271933|66487343|FG000|Double-Blind Phase|Randomized but not treated|0|||
23756680|NCT01271933|66487344|FG001|Double-Blind Phase|Randomized but not treated|0|||
23756681|NCT01271933|66487345|FG002|Double-Blind Phase|Randomized but not treated|1|||
23756682|NCT01271933|66487343|FG000|Double-Blind Phase|Lack of Efficacy|0|||
23756683|NCT01271933|66487344|FG001|Double-Blind Phase|Lack of Efficacy|6|||
23438532|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438533|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438534|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438535|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438536|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438537|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438538|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438539|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438540|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438541|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438542|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438543|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438544|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438545|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438546|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23756684|NCT01271933|66487345|FG002|Double-Blind Phase|Lack of Efficacy|9|||
23438547|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438548|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438549|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438550|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
23438551|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438552|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438553|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438554|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438555|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438556|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438557|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438558|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438559|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560744|NCT00110890|65782409|FG001|Overall Study|Protocol Deviation|0|||
23560745|NCT00110890|65782408|FG000|Overall Study|Noncompliance|10|||
23560746|NCT00110890|65782409|FG001|Overall Study|Noncompliance|0|||
23560747|NCT00110890|65782408|FG000|Overall Study|Kidney Transplant|16|||
23560748|NCT00110890|65782409|FG001|Overall Study|Kidney Transplant|12|||
23560749|NCT00110890|65782408|FG000|Overall Study|Invest. Product Commercially Available|217|||
23560750|NCT00110890|65782409|FG001|Overall Study|Invest. Product Commercially Available|110|||
23560751|NCT00110890|65782408|FG000|Overall Study|Other|34|||
23560752|NCT00110890|65782409|FG001|Overall Study|Other|23|||
23560753|NCT00110890|65782408|FG000|Overall Study|Ineligibility determined|3|||
23560754|NCT00110890|65782409|FG001|Overall Study|Ineligibility determined|0|||
23560755|NCT00110890|65782408|FG000|Overall Study|Requirement for alternative therapy|0|||
23560756|NCT00110890|65782409|FG001|Overall Study|Requirement for alternative therapy|1|||
23560757|NCT00110890|65782408|FG000|Overall Study|Disease progression|0|||
23560758|NCT00110890|65782409|FG001|Overall Study|Disease progression|1|||
23560759|NCT00110890|65782408|FG000|Overall Study|Parathyroidectomy|0|||
23560760|NCT00110890|65782409|FG001|Overall Study|Parathyroidectomy|1|||
23560761|NCT00110890|65782408|FG000|Overall Study|Did not enter follow-up phase|10|||
23560762|NCT00110890|65782409|FG001|Overall Study|Did not enter follow-up phase|4|||
23560763|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
23560764|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
23560765|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
23560766|NCT02535364|65782414|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
23560767|NCT02535364|65782414|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
23560768|NCT02535364|65782414|FG000|Part B Screening|Death|2|||
23560769|NCT02535364|65782414|FG000|Part B Screening|Physician Decision|1|||
23560770|NCT02535364|65782414|FG000|Part B Screening|Withdrawal by Subject|1|||
23560771|NCT02535364|65782414|FG000|Part B Screening|Adverse Event|1|||
23560772|NCT02535364|65782414|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
23560773|NCT02535364|65782414|FG000|Study Treatment|Death|1|||
23560774|NCT02535364|65782414|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
23560775|NCT02535364|65782414|FG000|12-Month Follow-up Period|Disease progression|22|||
23560776|NCT02535364|65782414|FG000|12-Month Follow-up Period|Death|5|||
23756685|NCT01271933|66487343|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23438560|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438561|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438562|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560777|NCT02535364|65782414|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
23560778|NCT02535364|65782414|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
23560779|NCT02535364|65782414|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
23582243|NCT00567879|65862410|FG000|Overall Study|Abnormal test procedure(s)|0|||
23438563|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23624904|NCT01296555|66015420|FG028|Overall Study|Adverse Event|0|||
23624905|NCT01296555|66015392|FG000|Overall Study|Reason Not Specified|0|||
23624906|NCT01296555|66015393|FG001|Overall Study|Reason Not Specified|0|||
23624907|NCT01296555|66015394|FG002|Overall Study|Reason Not Specified|0|||
23624908|NCT01296555|66015395|FG003|Overall Study|Reason Not Specified|0|||
23624909|NCT01296555|66015396|FG004|Overall Study|Reason Not Specified|0|||
23624910|NCT01296555|66015397|FG005|Overall Study|Reason Not Specified|0|||
23624911|NCT01296555|66015398|FG006|Overall Study|Reason Not Specified|0|||
23624912|NCT01296555|66015399|FG007|Overall Study|Reason Not Specified|0|||
23624913|NCT01296555|66015400|FG008|Overall Study|Reason Not Specified|0|||
23624914|NCT01296555|66015401|FG009|Overall Study|Reason Not Specified|0|||
23624915|NCT01296555|66015402|FG010|Overall Study|Reason Not Specified|0|||
23624916|NCT01296555|66015403|FG011|Overall Study|Reason Not Specified|0|||
23624917|NCT01296555|66015404|FG012|Overall Study|Reason Not Specified|0|||
23624918|NCT01296555|66015405|FG013|Overall Study|Reason Not Specified|1|||
23624919|NCT01296555|66015406|FG014|Overall Study|Reason Not Specified|2|||
23624920|NCT01296555|66015407|FG015|Overall Study|Reason Not Specified|3|||
23624921|NCT01296555|66015408|FG016|Overall Study|Reason Not Specified|7|||
23560780|NCT03995784|65782415|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
23560781|NCT02801669|65782416|FG000|Overall Study|Death|66|||
23560782|NCT02801669|65782417|FG001|Overall Study|Death|69|||
23560783|NCT02801669|65782416|FG000|Overall Study|Withdrawal by Subject|81|||
23560784|NCT02801669|65782417|FG001|Overall Study|Withdrawal by Subject|77|||
23560785|NCT02801669|65782416|FG000|Overall Study|Other|4|||
23560786|NCT02801669|65782417|FG001|Overall Study|Other|6|||
23560787|NCT02739347|65782418|FG000|Overall Study|Adverse Event|3|||
23560788|NCT02739347|65782419|FG001|Overall Study|Adverse Event|0|||
23560789|NCT02739347|65782418|FG000|Overall Study|Protocol Violation|0|||
23624922|NCT01296555|66015409|FG017|Overall Study|Reason Not Specified|4|||
23560790|NCT02739347|65782419|FG001|Overall Study|Protocol Violation|1|||
23560791|NCT02739347|65782418|FG000|Overall Study|Lost to Follow-up|0|||
23560792|NCT02739347|65782419|FG001|Overall Study|Lost to Follow-up|2|||
23560793|NCT02217280|65782422|FG000|Overall Study|Withdrawal by Subject|2|||
23560794|NCT02217280|65782422|FG000|Overall Study|Post-consent sceen fail|2|||
23560795|NCT00643123|65782426|FG000|Overall Study|Lost to Follow-up|4|||
23560796|NCT00643123|65782427|FG001|Overall Study|Lost to Follow-up|0|||
23560797|NCT00643123|65782426|FG000|Overall Study|Withdrawal by Subject|1|||
23560798|NCT00643123|65782427|FG001|Overall Study|Withdrawal by Subject|1|||
23560799|NCT04062448|65782429|FG000|Overall Study|Lost to Follow-up|1|||
23560800|NCT04062448|65782429|FG000|Overall Study|Withdrawal by Subject|2|||
23560801|NCT00962247|65782430|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
23560802|NCT00962247|65782430|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
23560803|NCT04209855|65782431|FG000|Overall Study|Adverse Event|20|||
23560804|NCT04209855|65782432|FG001|Overall Study|Adverse Event|28|||
23560805|NCT04209855|65782431|FG000|Overall Study|Death|3|||
23560806|NCT04209855|65782432|FG001|Overall Study|Death|1|||
23560807|NCT04209855|65782431|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
23560808|NCT04209855|65782432|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
23624923|NCT01296555|66015410|FG018|Overall Study|Reason Not Specified|3|||
23624924|NCT01296555|66015411|FG019|Overall Study|Reason Not Specified|7|||
23624925|NCT01296555|66015412|FG020|Overall Study|Reason Not Specified|11|||
23560809|NCT04209855|65782431|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
23560810|NCT04209855|65782432|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
23560811|NCT04209855|65782431|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
23560812|NCT04209855|65782432|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
23560813|NCT04209855|65782431|FG000|Overall Study|Progressive Disease|154|||
23560814|NCT04209855|65782432|FG001|Overall Study|Progressive Disease|145|||
23560815|NCT04209855|65782431|FG000|Overall Study|Protocol Deviation|1|||
23560816|NCT04209855|65782432|FG001|Overall Study|Protocol Deviation|1|||
23624926|NCT01296555|66015413|FG021|Overall Study|Reason Not Specified|5|||
23624927|NCT01296555|66015414|FG022|Overall Study|Reason Not Specified|5|||
23624928|NCT01296555|66015415|FG023|Overall Study|Reason Not Specified|7|||
23560817|NCT04209855|65782431|FG000|Overall Study|Other Than Specified|5|||
23560818|NCT04209855|65782432|FG001|Overall Study|Other Than Specified|10|||
23560819|NCT02532179|65782433|FG000|Overall Study|Lost to Follow-up|1|||
23560820|NCT02532179|65782433|FG000|Overall Study|Pregnancy|1|||
23560821|NCT02532179|65782433|FG000|Overall Study|Subject received depot steroid injection|1|||
23560822|NCT00312702|65782434|FG000|Immunization Phase|Lost to Follow-up|0|||
23560823|NCT00312702|65782435|FG001|Immunization Phase|Lost to Follow-up|1|||
23560824|NCT00312702|65782436|FG002|Immunization Phase|Lost to Follow-up|0|||
23560825|NCT02395133|65782443|FG000|Overall Study|Adverse Event|4|||
23560826|NCT02395133|65782444|FG001|Overall Study|Adverse Event|1|||
23560827|NCT02395133|65782445|FG002|Overall Study|Adverse Event|3|||
23560828|NCT02395133|65782446|FG003|Overall Study|Adverse Event|0|||
23560829|NCT02395133|65782443|FG000|Overall Study|Lack of Efficacy|1|||
23560830|NCT02395133|65782444|FG001|Overall Study|Lack of Efficacy|0|||
23560831|NCT02395133|65782445|FG002|Overall Study|Lack of Efficacy|1|||
23560832|NCT02395133|65782446|FG003|Overall Study|Lack of Efficacy|1|||
23560833|NCT02395133|65782443|FG000|Overall Study|Protocol Violation|1|||
23560834|NCT02395133|65782444|FG001|Overall Study|Protocol Violation|1|||
23560835|NCT02395133|65782445|FG002|Overall Study|Protocol Violation|0|||
23560836|NCT02395133|65782446|FG003|Overall Study|Protocol Violation|3|||
23560837|NCT02395133|65782443|FG000|Overall Study|Lost to Follow-up|0|||
23560838|NCT02395133|65782444|FG001|Overall Study|Lost to Follow-up|1|||
23560839|NCT02395133|65782445|FG002|Overall Study|Lost to Follow-up|1|||
23560840|NCT02395133|65782446|FG003|Overall Study|Lost to Follow-up|0|||
23560841|NCT02395133|65782443|FG000|Overall Study|Pregnancy|0|||
23560842|NCT02395133|65782444|FG001|Overall Study|Pregnancy|0|||
23560843|NCT02395133|65782445|FG002|Overall Study|Pregnancy|3|||
23560844|NCT02395133|65782446|FG003|Overall Study|Pregnancy|0|||
23560845|NCT02395133|65782443|FG000|Overall Study|Consent withdrawn with no reason given|1|||
23560846|NCT02395133|65782444|FG001|Overall Study|Consent withdrawn with no reason given|3|||
23560847|NCT02395133|65782445|FG002|Overall Study|Consent withdrawn with no reason given|0|||
23624929|NCT01296555|66015416|FG024|Overall Study|Reason Not Specified|2|||
23624930|NCT01296555|66015417|FG025|Overall Study|Reason Not Specified|2|||
23624931|NCT01296555|66015418|FG026|Overall Study|Reason Not Specified|19|||
23624932|NCT01296555|66015419|FG027|Overall Study|Reason Not Specified|11|||
23560848|NCT02395133|65782446|FG003|Overall Study|Consent withdrawn with no reason given|2|||
23560849|NCT02395133|65782443|FG000|Overall Study|Consent withdrawn with personal reason|0|||
23560850|NCT02395133|65782444|FG001|Overall Study|Consent withdrawn with personal reason|1|||
23560851|NCT02395133|65782445|FG002|Overall Study|Consent withdrawn with personal reason|0|||
23560852|NCT02395133|65782446|FG003|Overall Study|Consent withdrawn with personal reason|3|||
23560853|NCT02395133|65782443|FG000|Overall Study|Sponsor decision|2|||
23560854|NCT02395133|65782444|FG001|Overall Study|Sponsor decision|0|||
23560855|NCT02395133|65782445|FG002|Overall Study|Sponsor decision|0|||
23560856|NCT02395133|65782446|FG003|Overall Study|Sponsor decision|1|||
23560857|NCT02395133|65782443|FG000|Overall Study|Other than specified above|5|||
23560858|NCT02395133|65782444|FG001|Overall Study|Other than specified above|2|||
23560859|NCT02395133|65782445|FG002|Overall Study|Other than specified above|2|||
23560860|NCT02395133|65782446|FG003|Overall Study|Other than specified above|4|||
23560861|NCT02991482|65782450|FG000|Overall Study|Disease progression|56|||
23560862|NCT02991482|65782451|FG001|Overall Study|Disease progression|47|||
23560863|NCT02991482|65782450|FG000|Overall Study|Death|4|||
23560864|NCT02991482|65782451|FG001|Overall Study|Death|4|||
23560865|NCT02991482|65782450|FG000|Overall Study|Adverse Event|1|||
23560866|NCT02991482|65782451|FG001|Overall Study|Adverse Event|6|||
23560867|NCT02991482|65782450|FG000|Overall Study|Patient decision|1|||
23560868|NCT02991482|65782451|FG001|Overall Study|Patient decision|1|||
23560869|NCT02991482|65782450|FG000|Overall Study|Physician Decision|0|||
23560870|NCT02991482|65782451|FG001|Overall Study|Physician Decision|6|||
23560871|NCT02991482|65782450|FG000|Overall Study|Clinical deterioration|1|||
23560872|NCT02991482|65782451|FG001|Overall Study|Clinical deterioration|0|||
23560873|NCT02991482|65782450|FG000|Overall Study|Patient feeling too unwell|1|||
23560874|NCT02991482|65782451|FG001|Overall Study|Patient feeling too unwell|0|||
23560875|NCT02991482|65782450|FG000|Overall Study|Worsening of performance status|0|||
23624933|NCT01296555|66015420|FG028|Overall Study|Reason Not Specified|9|||
23624934|NCT01296555|66015392|FG000|Overall Study|Physician Decision|0|||
23624935|NCT01296555|66015393|FG001|Overall Study|Physician Decision|0|||
23560876|NCT02991482|65782451|FG001|Overall Study|Worsening of performance status|1|||
23560877|NCT02991482|65782450|FG000|Overall Study|Death prior to study drug initiation|1|||
23560878|NCT02991482|65782451|FG001|Overall Study|Death prior to study drug initiation|0|||
23624936|NCT01296555|66015394|FG002|Overall Study|Physician Decision|0|||
23560879|NCT02991482|65782450|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
23560880|NCT02991482|65782451|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
23560881|NCT03980184|65782452|FG000|Overall Study|Dropped out before treatment|2|||
23560882|NCT03980184|65782453|FG001|Overall Study|Dropped out before treatment|2|||
23560883|NCT03980184|65782452|FG000|Overall Study|Lost to Follow-up|11|||
23560884|NCT03980184|65782453|FG001|Overall Study|Lost to Follow-up|13|||
23756686|NCT01271933|66487344|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23756687|NCT01271933|66487345|FG002|Double-Blind Phase|Lost to Follow-up|1|||
23756688|NCT01271933|66487343|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23756689|NCT01271933|66487344|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23756690|NCT01271933|66487345|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
23756691|NCT01271933|66487343|FG000|Double-Blind Phase|Adverse Event|0|||
23756692|NCT01271933|66487344|FG001|Double-Blind Phase|Adverse Event|3|||
23756693|NCT01271933|66487345|FG002|Double-Blind Phase|Adverse Event|0|||
23756694|NCT01271933|66487343|FG000|Double-Blind Phase|Participant request-personal reason|0|||
23756695|NCT01271933|66487344|FG001|Double-Blind Phase|Participant request-personal reason|1|||
23756696|NCT01271933|66487345|FG002|Double-Blind Phase|Participant request-personal reason|0|||
23756697|NCT01858558|66487346|FG000|Overall Study|Death|1|||
23756698|NCT01858558|66487347|FG001|Overall Study|Death|1|||
23756699|NCT01858558|66487346|FG000|Overall Study|Lost to Follow-up|1|||
23756700|NCT01858558|66487347|FG001|Overall Study|Lost to Follow-up|0|||
23756701|NCT01858558|66487346|FG000|Overall Study|Disease progression|3|||
23756702|NCT01858558|66487347|FG001|Overall Study|Disease progression|1|||
23756703|NCT01858558|66487346|FG000|Overall Study|Product contamination|2|||
23756704|NCT01858558|66487347|FG001|Overall Study|Product contamination|0|||
23756705|NCT01858558|66487346|FG000|Overall Study|Failed expansion of cell product|2|||
23756706|NCT01858558|66487347|FG001|Overall Study|Failed expansion of cell product|0|||
23756707|NCT02875067|66487348|FG000|Overall Study|Withdrawal by Subject|1|||
23756708|NCT02875067|66487348|FG000|Overall Study|Withdrawal by Termination of Study|5|||
23756709|NCT01458132|66487349|FG000|Overall Study|Other|15|||
23756710|NCT01458132|66487350|FG001|Overall Study|Other|3|||
23756711|NCT03044431|66487351|FG000|Overall Study|Lost to Follow-up|59|||
23756712|NCT00837577|66487356|FG000|Double-blind Period|Clinical Adverse Event|1|||
23756713|NCT00837577|66487357|FG001|Double-blind Period|Clinical Adverse Event|0|||
23756714|NCT00837577|66487356|FG000|Double-blind Period|Withdrawal by Subject|1|||
23756715|NCT00837577|66487357|FG001|Double-blind Period|Withdrawal by Subject|0|||
23756716|NCT00837577|66487356|FG000|Open-label Period|Clinical Adverse Event|2|||
23756717|NCT00837577|66487357|FG001|Open-label Period|Clinical Adverse Event|2|||
23756718|NCT00837577|66487356|FG000|Open-label Period|Laboratory Adverse Event|0|||
23756719|NCT00837577|66487357|FG001|Open-label Period|Laboratory Adverse Event|1|||
23756720|NCT00837577|66487356|FG000|Open-label Period|Lack of Efficacy|4|||
23756721|NCT00837577|66487357|FG001|Open-label Period|Lack of Efficacy|3|||
23756722|NCT00837577|66487356|FG000|Open-label Period|Withdrawal by Subject|1|||
23756723|NCT00837577|66487357|FG001|Open-label Period|Withdrawal by Subject|2|||
23756724|NCT00837577|66487356|FG000|Open-label Period|Other Reason|1|||
23756725|NCT00837577|66487357|FG001|Open-label Period|Other Reason|1|||
23756726|NCT00627458|66487361|FG000|Overall Study|Migrated from study area|1|||
23756727|NCT00627458|66487362|FG001|Overall Study|Migrated from study area|0|||
23756728|NCT00627458|66487363|FG002|Overall Study|Migrated from study area|1|||
23756729|NCT00627458|66487361|FG000|Overall Study|Withdrawal by Subject|2|||
23756730|NCT00627458|66487362|FG001|Overall Study|Withdrawal by Subject|6|||
23756731|NCT00627458|66487363|FG002|Overall Study|Withdrawal by Subject|5|||
23756732|NCT00627458|66487361|FG000|Overall Study|Lost to Follow-up|1|||
23756733|NCT00627458|66487362|FG001|Overall Study|Lost to Follow-up|1|||
23756734|NCT00627458|66487363|FG002|Overall Study|Lost to Follow-up|0|||
23756735|NCT01529749|66487364|FG000|Overall Study|Lost to Follow-up|0|||
23756736|NCT01529749|66487365|FG001|Overall Study|Lost to Follow-up|1|||
23756737|NCT01529749|66487366|FG002|Overall Study|Lost to Follow-up|1|||
23560885|NCT02227875|65782455|FG000|Overall Study|Protocol Violation|10|||
23560886|NCT02227875|65782456|FG001|Overall Study|Protocol Violation|7|||
23560887|NCT02227875|65782455|FG000|Overall Study|Other|1|||
23560888|NCT02227875|65782456|FG001|Overall Study|Other|3|||
23560889|NCT02227875|65782455|FG000|Overall Study|Physician Decision|1|||
23560890|NCT02227875|65782456|FG001|Overall Study|Physician Decision|0|||
23560891|NCT02227875|65782455|FG000|Overall Study|Adverse Event|3|||
23560892|NCT02227875|65782456|FG001|Overall Study|Adverse Event|0|||
23560893|NCT02227875|65782455|FG000|Overall Study|Withdrawal by Subject|12|||
23560894|NCT02227875|65782456|FG001|Overall Study|Withdrawal by Subject|13|||
23560895|NCT02227875|65782455|FG000|Overall Study|Lost to Follow-up|10|||
23560896|NCT02227875|65782456|FG001|Overall Study|Lost to Follow-up|10|||
23560897|NCT00895622|65782457|FG000|Overall Study|Protocol Violation|5|||
23560898|NCT00895622|65782458|FG001|Overall Study|Protocol Violation|4|||
23560899|NCT00895622|65782459|FG002|Overall Study|Protocol Violation|4|||
23560900|NCT03757234|65782461|FG000|Overall Study|Adverse Event|0|||
23560901|NCT03757234|65782462|FG001|Overall Study|Adverse Event|0|||
23624937|NCT01296555|66015395|FG003|Overall Study|Physician Decision|0|||
23624938|NCT01296555|66015396|FG004|Overall Study|Physician Decision|1|||
23624939|NCT01296555|66015397|FG005|Overall Study|Physician Decision|0|||
23624940|NCT01296555|66015398|FG006|Overall Study|Physician Decision|0|||
23624941|NCT01296555|66015399|FG007|Overall Study|Physician Decision|0|||
23624942|NCT01296555|66015400|FG008|Overall Study|Physician Decision|0|||
23624943|NCT01296555|66015401|FG009|Overall Study|Physician Decision|0|||
23624944|NCT01296555|66015402|FG010|Overall Study|Physician Decision|0|||
23624945|NCT01296555|66015403|FG011|Overall Study|Physician Decision|0|||
23560902|NCT03757234|65782463|FG002|Overall Study|Adverse Event|0|||
23560903|NCT03757234|65782464|FG003|Overall Study|Adverse Event|0|||
23560904|NCT03757234|65782465|FG004|Overall Study|Adverse Event|1|||
23560905|NCT03757234|65782461|FG000|Overall Study|Lost to Follow-up|1|||
23560906|NCT03757234|65782462|FG001|Overall Study|Lost to Follow-up|0|||
23560907|NCT03757234|65782463|FG002|Overall Study|Lost to Follow-up|0|||
23560908|NCT03757234|65782464|FG003|Overall Study|Lost to Follow-up|0|||
23624946|NCT01296555|66015404|FG012|Overall Study|Physician Decision|0|||
23624947|NCT01296555|66015405|FG013|Overall Study|Physician Decision|1|||
23624948|NCT01296555|66015406|FG014|Overall Study|Physician Decision|0|||
23624949|NCT01296555|66015407|FG015|Overall Study|Physician Decision|0|||
23624950|NCT01296555|66015408|FG016|Overall Study|Physician Decision|0|||
23624951|NCT01296555|66015409|FG017|Overall Study|Physician Decision|0|||
23624952|NCT01296555|66015410|FG018|Overall Study|Physician Decision|0|||
23624953|NCT01296555|66015411|FG019|Overall Study|Physician Decision|1|||
23624954|NCT01296555|66015412|FG020|Overall Study|Physician Decision|0|||
23624955|NCT01296555|66015413|FG021|Overall Study|Physician Decision|0|||
23624956|NCT01296555|66015414|FG022|Overall Study|Physician Decision|0|||
23624957|NCT01296555|66015415|FG023|Overall Study|Physician Decision|0|||
23756738|NCT01529749|66487367|FG003|Overall Study|Lost to Follow-up|0|||
23624958|NCT01296555|66015416|FG024|Overall Study|Physician Decision|0|||
23624959|NCT01296555|66015417|FG025|Overall Study|Physician Decision|0|||
23624960|NCT01296555|66015418|FG026|Overall Study|Physician Decision|0|||
23624961|NCT01296555|66015419|FG027|Overall Study|Physician Decision|0|||
23756739|NCT01529749|66487364|FG000|Overall Study|Physician Decision|0|||
23756740|NCT01529749|66487365|FG001|Overall Study|Physician Decision|0|||
23756741|NCT01529749|66487366|FG002|Overall Study|Physician Decision|0|||
23756742|NCT01529749|66487367|FG003|Overall Study|Physician Decision|1|||
23756743|NCT01529749|66487364|FG000|Overall Study|Withdrawal by Subject|0|||
23756744|NCT01529749|66487365|FG001|Overall Study|Withdrawal by Subject|1|||
23756745|NCT01529749|66487366|FG002|Overall Study|Withdrawal by Subject|1|||
23756746|NCT01529749|66487367|FG003|Overall Study|Withdrawal by Subject|0|||
23756747|NCT01529749|66487364|FG000|Overall Study|Protocol Violation|0|||
23756748|NCT01529749|66487365|FG001|Overall Study|Protocol Violation|0|||
23756749|NCT01529749|66487366|FG002|Overall Study|Protocol Violation|0|||
23756750|NCT01529749|66487367|FG003|Overall Study|Protocol Violation|1|||
23756751|NCT01984229|66489488|FG000|Safety Follow-up Period|Adverse Event|1|||
23438564|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560909|NCT03757234|65782465|FG004|Overall Study|Lost to Follow-up|1|||
23624962|NCT01296555|66015420|FG028|Overall Study|Physician Decision|0|||
23624963|NCT01296555|66015392|FG000|Overall Study|Progressive Disease|6|||
23624964|NCT01296555|66015393|FG001|Overall Study|Progressive Disease|3|||
23624965|NCT01296555|66015394|FG002|Overall Study|Progressive Disease|3|||
23624966|NCT01296555|66015395|FG003|Overall Study|Progressive Disease|7|||
23624967|NCT01296555|66015396|FG004|Overall Study|Progressive Disease|6|||
23756752|NCT01984229|66489489|FG001|Safety Follow-up Period|Adverse Event|1|||
23756753|NCT01984229|66489488|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
23756754|NCT01984229|66489489|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23560910|NCT03757234|65782461|FG000|Overall Study|Withdrawal by Subject|1|||
23560911|NCT03757234|65782462|FG001|Overall Study|Withdrawal by Subject|1|||
23560912|NCT03757234|65782463|FG002|Overall Study|Withdrawal by Subject|0|||
23560913|NCT03757234|65782464|FG003|Overall Study|Withdrawal by Subject|1|||
23560914|NCT03757234|65782465|FG004|Overall Study|Withdrawal by Subject|2|||
23624968|NCT01296555|66015397|FG005|Overall Study|Progressive Disease|16|||
23756755|NCT01559818|66489490|FG000|Overall Study|Physician Decision|1|||
23756756|NCT01559818|66489490|FG000|Overall Study|Pregnancy|1|||
23756757|NCT01559818|66489490|FG000|Overall Study|Study terminated by Sponsor|4|||
23438565|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438566|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23624969|NCT01296555|66015398|FG006|Overall Study|Progressive Disease|16|||
23560915|NCT03757234|65782461|FG000|Overall Study|Other|1|||
23560916|NCT03757234|65782462|FG001|Overall Study|Other|1|||
23560917|NCT03757234|65782463|FG002|Overall Study|Other|0|||
23560918|NCT03757234|65782464|FG003|Overall Study|Other|0|||
23560919|NCT03757234|65782465|FG004|Overall Study|Other|0|||
23560920|NCT02110732|65782466|FG000|Overall Study|Physician Decision|5|||
23560921|NCT02110732|65782467|FG001|Overall Study|Physician Decision|2|||
23560922|NCT02110732|65782466|FG000|Overall Study|Lost to Follow-up|1|||
23560923|NCT02110732|65782467|FG001|Overall Study|Lost to Follow-up|1|||
23560924|NCT00429663|65782468|FG000|Overall Study|Lost to Follow-up|24|||
23560925|NCT00429663|65782469|FG001|Overall Study|Lost to Follow-up|31|||
23560926|NCT00429663|65782468|FG000|Overall Study|Physician Decision|6|||
23560927|NCT00429663|65782469|FG001|Overall Study|Physician Decision|3|||
23560928|NCT00429663|65782468|FG000|Overall Study|Withdrawal by Subject|2|||
23560929|NCT00429663|65782469|FG001|Overall Study|Withdrawal by Subject|5|||
23560930|NCT00429663|65782468|FG000|Overall Study|Death|4|||
23560931|NCT00429663|65782469|FG001|Overall Study|Death|0|||
23560932|NCT01621880|65782479|FG000|Overall Study|Adverse Event|5|||
23560933|NCT01621880|65782480|FG001|Overall Study|Adverse Event|1|||
23560934|NCT01621880|65782479|FG000|Overall Study|Withdrawal by Subject|5|||
23560935|NCT01621880|65782480|FG001|Overall Study|Withdrawal by Subject|4|||
23560936|NCT03745222|65782481|FG000|Overall Study|Withdrawal by Subject|0|||
23560937|NCT03745222|65782482|FG001|Overall Study|Withdrawal by Subject|1|||
23560938|NCT03745222|65782483|FG002|Overall Study|Withdrawal by Subject|0|||
23560939|NCT01525602|65782484|FG000|Overall Study|Adverse Event|1|||
23560940|NCT01525602|65782485|FG001|Overall Study|Adverse Event|0|||
23560941|NCT01525602|65782486|FG002|Overall Study|Adverse Event|1|||
23560942|NCT01525602|65782487|FG003|Overall Study|Adverse Event|1|||
23560943|NCT01525602|65782488|FG004|Overall Study|Adverse Event|3|||
23560944|NCT01525602|65782489|FG005|Overall Study|Adverse Event|3|||
23560945|NCT01525602|65782490|FG006|Overall Study|Adverse Event|0|||
23560946|NCT01525602|65782491|FG007|Overall Study|Adverse Event|1|||
23624970|NCT01296555|66015399|FG007|Overall Study|Progressive Disease|8|||
23624971|NCT01296555|66015400|FG008|Overall Study|Progressive Disease|7|||
23624972|NCT01296555|66015401|FG009|Overall Study|Progressive Disease|18|||
23624973|NCT01296555|66015402|FG010|Overall Study|Progressive Disease|7|||
23624974|NCT01296555|66015403|FG011|Overall Study|Progressive Disease|14|||
23624975|NCT01296555|66015404|FG012|Overall Study|Progressive Disease|5|||
23624976|NCT01296555|66015405|FG013|Overall Study|Progressive Disease|12|||
23624977|NCT01296555|66015406|FG014|Overall Study|Progressive Disease|1|||
23624978|NCT01296555|66015407|FG015|Overall Study|Progressive Disease|1|||
23624979|NCT01296555|66015408|FG016|Overall Study|Progressive Disease|0|||
23624980|NCT01296555|66015409|FG017|Overall Study|Progressive Disease|0|||
23624981|NCT01296555|66015410|FG018|Overall Study|Progressive Disease|0|||
23624982|NCT01296555|66015411|FG019|Overall Study|Progressive Disease|1|||
23624983|NCT01296555|66015412|FG020|Overall Study|Progressive Disease|0|||
23624984|NCT01296555|66015413|FG021|Overall Study|Progressive Disease|0|||
23624985|NCT01296555|66015414|FG022|Overall Study|Progressive Disease|0|||
23624986|NCT01296555|66015415|FG023|Overall Study|Progressive Disease|0|||
23624987|NCT01296555|66015416|FG024|Overall Study|Progressive Disease|1|||
23624988|NCT01296555|66015417|FG025|Overall Study|Progressive Disease|0|||
23624989|NCT01296555|66015418|FG026|Overall Study|Progressive Disease|5|||
23624990|NCT01296555|66015419|FG027|Overall Study|Progressive Disease|1|||
23624991|NCT01296555|66015420|FG028|Overall Study|Progressive Disease|0|||
23624992|NCT01296555|66015392|FG000|Overall Study|Protocol Violation|0|||
23624993|NCT01296555|66015393|FG001|Overall Study|Protocol Violation|0|||
23756758|NCT01559818|66489490|FG000|Overall Study|Withdrawal by Subject|1|||
23438567|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
23560947|NCT01525602|65782484|FG000|Overall Study|Disease progression|6|||
23560948|NCT01525602|65782485|FG001|Overall Study|Disease progression|3|||
23560949|NCT01525602|65782486|FG002|Overall Study|Disease progression|2|||
23624994|NCT01296555|66015394|FG002|Overall Study|Protocol Violation|0|||
23624995|NCT01296555|66015395|FG003|Overall Study|Protocol Violation|0|||
23624996|NCT01296555|66015396|FG004|Overall Study|Protocol Violation|0|||
23624997|NCT01296555|66015397|FG005|Overall Study|Protocol Violation|0|||
23624998|NCT01296555|66015398|FG006|Overall Study|Protocol Violation|0|||
23624999|NCT01296555|66015399|FG007|Overall Study|Protocol Violation|0|||
23625000|NCT01296555|66015400|FG008|Overall Study|Protocol Violation|0|||
23826283|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
23560950|NCT01525602|65782487|FG003|Overall Study|Disease progression|5|||
23560951|NCT01525602|65782488|FG004|Overall Study|Disease progression|22|||
23560952|NCT01525602|65782489|FG005|Overall Study|Disease progression|2|||
23560953|NCT01525602|65782490|FG006|Overall Study|Disease progression|3|||
23625001|NCT01296555|66015401|FG009|Overall Study|Protocol Violation|0|||
23625002|NCT01296555|66015402|FG010|Overall Study|Protocol Violation|0|||
23625003|NCT01296555|66015403|FG011|Overall Study|Protocol Violation|0|||
23625004|NCT01296555|66015404|FG012|Overall Study|Protocol Violation|0|||
23625005|NCT01296555|66015405|FG013|Overall Study|Protocol Violation|1|||
23625006|NCT01296555|66015406|FG014|Overall Study|Protocol Violation|0|||
23625007|NCT01296555|66015407|FG015|Overall Study|Protocol Violation|0|||
23625008|NCT01296555|66015408|FG016|Overall Study|Protocol Violation|0|||
23625009|NCT01296555|66015409|FG017|Overall Study|Protocol Violation|0|||
23625010|NCT01296555|66015410|FG018|Overall Study|Protocol Violation|0|||
23625011|NCT01296555|66015411|FG019|Overall Study|Protocol Violation|0|||
23625012|NCT01296555|66015412|FG020|Overall Study|Protocol Violation|0|||
23625013|NCT01296555|66015413|FG021|Overall Study|Protocol Violation|0|||
23625014|NCT01296555|66015414|FG022|Overall Study|Protocol Violation|0|||
23625015|NCT01296555|66015415|FG023|Overall Study|Protocol Violation|0|||
23625016|NCT01296555|66015416|FG024|Overall Study|Protocol Violation|0|||
23625017|NCT01296555|66015417|FG025|Overall Study|Protocol Violation|0|||
23625018|NCT01296555|66015418|FG026|Overall Study|Protocol Violation|0|||
23625019|NCT01296555|66015419|FG027|Overall Study|Protocol Violation|0|||
23625020|NCT01296555|66015420|FG028|Overall Study|Protocol Violation|0|||
23625021|NCT01296555|66015392|FG000|Overall Study|Study Terminated By Sponsor|0|||
23625022|NCT01296555|66015393|FG001|Overall Study|Study Terminated By Sponsor|0|||
23625023|NCT01296555|66015394|FG002|Overall Study|Study Terminated By Sponsor|0|||
23625024|NCT01296555|66015395|FG003|Overall Study|Study Terminated By Sponsor|0|||
23560954|NCT01525602|65782491|FG007|Overall Study|Disease progression|3|||
23560955|NCT01525602|65782484|FG000|Overall Study|Clinical progression|2|||
23560956|NCT01525602|65782485|FG001|Overall Study|Clinical progression|0|||
23560957|NCT01525602|65782486|FG002|Overall Study|Clinical progression|0|||
23560958|NCT01525602|65782487|FG003|Overall Study|Clinical progression|0|||
23560959|NCT01525602|65782488|FG004|Overall Study|Clinical progression|0|||
23560960|NCT01525602|65782489|FG005|Overall Study|Clinical progression|0|||
23560961|NCT01525602|65782490|FG006|Overall Study|Clinical progression|1|||
23560962|NCT01525602|65782491|FG007|Overall Study|Clinical progression|1|||
23560963|NCT01525602|65782484|FG000|Overall Study|Non-compliance|0|||
23560964|NCT01525602|65782485|FG001|Overall Study|Non-compliance|0|||
23560965|NCT01525602|65782486|FG002|Overall Study|Non-compliance|0|||
23560966|NCT01525602|65782487|FG003|Overall Study|Non-compliance|0|||
23560967|NCT01525602|65782488|FG004|Overall Study|Non-compliance|1|||
23625025|NCT01296555|66015396|FG004|Overall Study|Study Terminated By Sponsor|0|||
23625026|NCT01296555|66015397|FG005|Overall Study|Study Terminated By Sponsor|0|||
23625027|NCT01296555|66015398|FG006|Overall Study|Study Terminated By Sponsor|0|||
23625028|NCT01296555|66015399|FG007|Overall Study|Study Terminated By Sponsor|0|||
23625029|NCT01296555|66015400|FG008|Overall Study|Study Terminated By Sponsor|0|||
23625030|NCT01296555|66015401|FG009|Overall Study|Study Terminated By Sponsor|0|||
23560968|NCT01525602|65782489|FG005|Overall Study|Non-compliance|0|||
23560969|NCT01525602|65782490|FG006|Overall Study|Non-compliance|0|||
23560970|NCT01525602|65782491|FG007|Overall Study|Non-compliance|0|||
23560971|NCT01525602|65782484|FG000|Overall Study|Withdrawal by Subject|0|||
23560972|NCT01525602|65782485|FG001|Overall Study|Withdrawal by Subject|0|||
23560973|NCT01525602|65782486|FG002|Overall Study|Withdrawal by Subject|0|||
23560974|NCT01525602|65782487|FG003|Overall Study|Withdrawal by Subject|0|||
23560975|NCT01525602|65782488|FG004|Overall Study|Withdrawal by Subject|3|||
23560976|NCT01525602|65782489|FG005|Overall Study|Withdrawal by Subject|1|||
23560977|NCT01525602|65782490|FG006|Overall Study|Withdrawal by Subject|0|||
23560978|NCT01525602|65782491|FG007|Overall Study|Withdrawal by Subject|1|||
23560979|NCT01525602|65782484|FG000|Overall Study|Physician Decision|0|||
23560980|NCT01525602|65782485|FG001|Overall Study|Physician Decision|0|||
23560981|NCT01525602|65782486|FG002|Overall Study|Physician Decision|0|||
23560982|NCT01525602|65782487|FG003|Overall Study|Physician Decision|0|||
23560983|NCT01525602|65782488|FG004|Overall Study|Physician Decision|3|||
23560984|NCT01525602|65782489|FG005|Overall Study|Physician Decision|0|||
23560985|NCT01525602|65782490|FG006|Overall Study|Physician Decision|1|||
23560986|NCT01525602|65782491|FG007|Overall Study|Physician Decision|0|||
23560987|NCT01525602|65782484|FG000|Overall Study|Death|0|||
23560988|NCT01525602|65782485|FG001|Overall Study|Death|0|||
23560989|NCT01525602|65782486|FG002|Overall Study|Death|0|||
23560990|NCT01525602|65782487|FG003|Overall Study|Death|0|||
23560991|NCT01525602|65782488|FG004|Overall Study|Death|1|||
23625031|NCT01296555|66015402|FG010|Overall Study|Study Terminated By Sponsor|0|||
23625032|NCT01296555|66015403|FG011|Overall Study|Study Terminated By Sponsor|0|||
23625033|NCT01296555|66015404|FG012|Overall Study|Study Terminated By Sponsor|0|||
23625034|NCT01296555|66015405|FG013|Overall Study|Study Terminated By Sponsor|0|||
23625035|NCT01296555|66015406|FG014|Overall Study|Study Terminated By Sponsor|0|||
23756759|NCT01612702|66489493|FG000|Overall Study|Protocol Violation|11|||
23560992|NCT01525602|65782489|FG005|Overall Study|Death|1|||
23560993|NCT01525602|65782490|FG006|Overall Study|Death|0|||
23625036|NCT01296555|66015407|FG015|Overall Study|Study Terminated By Sponsor|0|||
23756760|NCT01612702|66489494|FG001|Overall Study|Protocol Violation|11|||
23756761|NCT04529499|66489495|FG000|Overall Study|Withdrawal by Subject|9|||
23756762|NCT04529499|66489496|FG001|Overall Study|Withdrawal by Subject|11|||
23756763|NCT04529499|66489495|FG000|Overall Study|Physician Decision|1|||
23756764|NCT04529499|66489496|FG001|Overall Study|Physician Decision|2|||
23756765|NCT04529499|66489495|FG000|Overall Study|Adverse Event|4|||
23756766|NCT04529499|66489496|FG001|Overall Study|Adverse Event|4|||
23756767|NCT04529499|66489495|FG000|Overall Study|Death|14|||
23756768|NCT04529499|66489496|FG001|Overall Study|Death|11|||
23756769|NCT04529499|66489495|FG000|Overall Study|Lost to Follow-up|1|||
23756770|NCT04529499|66489496|FG001|Overall Study|Lost to Follow-up|1|||
23756771|NCT04529499|66489495|FG000|Overall Study|Others|7|||
23756772|NCT04529499|66489496|FG001|Overall Study|Others|11|||
23756773|NCT01835470|66489499|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
23756774|NCT01835470|66489499|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
23756775|NCT00021229|66489500|FG000|Overall Study|Adverse Event|10|||
23756776|NCT00021229|66489501|FG001|Overall Study|Adverse Event|5|||
23756777|NCT00021229|66489502|FG002|Overall Study|Adverse Event|2|||
23756778|NCT00021229|66489500|FG000|Overall Study|Death|0|||
23756779|NCT00021229|66489501|FG001|Overall Study|Death|1|||
23560994|NCT01525602|65782491|FG007|Overall Study|Death|0|||
23560995|NCT01525602|65782484|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560996|NCT01525602|65782485|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560997|NCT01525602|65782486|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560998|NCT01525602|65782487|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560999|NCT01525602|65782488|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
23561000|NCT01525602|65782489|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
23561001|NCT01525602|65782490|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
23561002|NCT01525602|65782491|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
23561003|NCT02228967|65782492|FG000|Overall Study|Lost to Follow-up|146|||
23561004|NCT02228967|65782493|FG001|Overall Study|Lost to Follow-up|142|||
23561005|NCT02228967|65782492|FG000|Overall Study|Withdrawal by Subject|13|||
23561006|NCT02228967|65782493|FG001|Overall Study|Withdrawal by Subject|18|||
23561007|NCT02207725|65782494|FG000|Overall Study|Did Not Receive Treatment|0|||
23561008|NCT02207725|65782495|FG001|Overall Study|Did Not Receive Treatment|1|||
23561009|NCT02207725|65782496|FG002|Overall Study|Did Not Receive Treatment|1|||
23561010|NCT02207725|65782497|FG003|Overall Study|Did Not Receive Treatment|1|||
23561011|NCT04810221|65782498|FG000|Overall Study|Physician Decision|3|||
23561012|NCT01377480|65782499|FG000|Overall Study|Protocol Violation|0|||
23561013|NCT01377480|65782500|FG001|Overall Study|Protocol Violation|0|||
23561014|NCT01377480|65782501|FG002|Overall Study|Protocol Violation|0|||
23561015|NCT01377480|65782502|FG003|Overall Study|Protocol Violation|4|||
23561016|NCT01377480|65782499|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
23561017|NCT01377480|65782500|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
23561018|NCT01377480|65782501|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
23561019|NCT01377480|65782502|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
23561020|NCT01377480|65782499|FG000|Overall Study|Withdrawal by Subject|0|||
23561021|NCT01377480|65782500|FG001|Overall Study|Withdrawal by Subject|0|||
23561022|NCT01377480|65782501|FG002|Overall Study|Withdrawal by Subject|1|||
23561023|NCT01377480|65782502|FG003|Overall Study|Withdrawal by Subject|0|||
23561024|NCT01377480|65782499|FG000|Overall Study|Serious adverse event|0|||
23561025|NCT01377480|65782500|FG001|Overall Study|Serious adverse event|0|||
23561026|NCT01377480|65782501|FG002|Overall Study|Serious adverse event|1|||
23561027|NCT01377480|65782502|FG003|Overall Study|Serious adverse event|1|||
23561028|NCT01377480|65782499|FG000|Overall Study|Other|0|||
23561029|NCT01377480|65782500|FG001|Overall Study|Other|0|||
23561030|NCT01377480|65782501|FG002|Overall Study|Other|7|||
23561031|NCT01377480|65782502|FG003|Overall Study|Other|6|||
23561032|NCT05096208|65782503|FG000|Overall Study|Lost to Follow-up|3|||
23561033|NCT05096208|65782504|FG001|Overall Study|Lost to Follow-up|5|||
23561034|NCT05096208|65782505|FG002|Overall Study|Lost to Follow-up|5|||
23561035|NCT05096208|65782506|FG003|Overall Study|Lost to Follow-up|2|||
23561036|NCT05096208|65782503|FG000|Overall Study|Withdrawal by Subject|0|||
23756780|NCT00021229|66489502|FG002|Overall Study|Death|0|||
23756781|NCT00021229|66489500|FG000|Overall Study|Withdrawal by Subject|7|||
23756782|NCT00021229|66489501|FG001|Overall Study|Withdrawal by Subject|7|||
23756783|NCT00021229|66489502|FG002|Overall Study|Withdrawal by Subject|1|||
23756784|NCT00021229|66489500|FG000|Overall Study|Progressive Disease|15|||
23625037|NCT01296555|66015408|FG016|Overall Study|Study Terminated By Sponsor|0|||
23438568|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
23438569|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
23438570|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438571|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438572|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561037|NCT05096208|65782504|FG001|Overall Study|Withdrawal by Subject|1|||
23561038|NCT05096208|65782505|FG002|Overall Study|Withdrawal by Subject|2|||
23561039|NCT05096208|65782506|FG003|Overall Study|Withdrawal by Subject|3|||
23625038|NCT01296555|66015409|FG017|Overall Study|Study Terminated By Sponsor|0|||
23625039|NCT01296555|66015410|FG018|Overall Study|Study Terminated By Sponsor|0|||
23756785|NCT00021229|66489501|FG001|Overall Study|Progressive Disease|19|||
23756786|NCT00021229|66489502|FG002|Overall Study|Progressive Disease|12|||
23561040|NCT05096208|65782503|FG000|Overall Study|No longer met eligibility criteria|1|||
23561041|NCT05096208|65782504|FG001|Overall Study|No longer met eligibility criteria|0|||
23561042|NCT05096208|65782505|FG002|Overall Study|No longer met eligibility criteria|0|||
23561043|NCT05096208|65782506|FG003|Overall Study|No longer met eligibility criteria|0|||
23561044|NCT05096208|65782503|FG000|Overall Study|Other|0|||
23561045|NCT05096208|65782504|FG001|Overall Study|Other|0|||
23561046|NCT05096208|65782505|FG002|Overall Study|Other|1|||
23561047|NCT05096208|65782506|FG003|Overall Study|Other|0|||
23561048|NCT02755597|65782508|FG000|Overall Study|Withdrew consent|27|||
23561049|NCT02755597|65782509|FG001|Overall Study|Withdrew consent|11|||
23561050|NCT02755597|65782508|FG000|Overall Study|Lost to Follow-up|1|||
23561051|NCT02755597|65782509|FG001|Overall Study|Lost to Follow-up|0|||
23561052|NCT02755597|65782508|FG000|Overall Study|Death|78|||
23561053|NCT02755597|65782509|FG001|Overall Study|Death|36|||
23561054|NCT02755597|65782508|FG000|Overall Study|Study terminated by Sponsor|67|||
23561055|NCT02755597|65782509|FG001|Overall Study|Study terminated by Sponsor|47|||
23561056|NCT02755597|65782508|FG000|Overall Study|Other, not specified|20|||
23561057|NCT02755597|65782509|FG001|Overall Study|Other, not specified|3|||
23561058|NCT02755597|65782508|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
23561059|NCT02755597|65782509|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
23561060|NCT04108000|65782510|FG000|Overall Study|Death of patient|1|||
23561061|NCT04108000|65782511|FG001|Overall Study|Death of patient|0|||
23561062|NCT04108000|65782512|FG002|Overall Study|Death of patient|1|||
23561063|NCT04108000|65782513|FG003|Overall Study|Death of patient|0|||
23561064|NCT04108000|65782510|FG000|Overall Study|Withdrawal by Subject|2|||
23561065|NCT04108000|65782511|FG001|Overall Study|Withdrawal by Subject|2|||
23561066|NCT04108000|65782512|FG002|Overall Study|Withdrawal by Subject|0|||
23561067|NCT04108000|65782513|FG003|Overall Study|Withdrawal by Subject|0|||
23561068|NCT04108000|65782510|FG000|Overall Study|Death of surrogate partner|0|||
23561069|NCT04108000|65782511|FG001|Overall Study|Death of surrogate partner|1|||
23561070|NCT04108000|65782512|FG002|Overall Study|Death of surrogate partner|0|||
23561071|NCT04108000|65782513|FG003|Overall Study|Death of surrogate partner|1|||
23561072|NCT04766086|65782516|FG000|Overall Study|Lost to Follow-up|3|||
23561073|NCT04766086|65782517|FG001|Overall Study|Lost to Follow-up|5|||
23561074|NCT04766086|65782518|FG002|Overall Study|Lost to Follow-up|3|||
23756787|NCT00021229|66489500|FG000|Overall Study|Protocol Violation|1|||
23756788|NCT00021229|66489501|FG001|Overall Study|Protocol Violation|1|||
23756789|NCT00021229|66489502|FG002|Overall Study|Protocol Violation|0|||
23756790|NCT00021229|66489500|FG000|Overall Study|Physician Decision|0|||
23756791|NCT00021229|66489501|FG001|Overall Study|Physician Decision|0|||
23561075|NCT04766086|65782516|FG000|Overall Study|Withdrawal by Subject|1|||
23561076|NCT04766086|65782517|FG001|Overall Study|Withdrawal by Subject|1|||
23561077|NCT04766086|65782518|FG002|Overall Study|Withdrawal by Subject|2|||
23561078|NCT04766086|65782516|FG000|Overall Study|Other|0|||
23561079|NCT04766086|65782517|FG001|Overall Study|Other|0|||
23756792|NCT00021229|66489502|FG002|Overall Study|Physician Decision|1|||
23561080|NCT04766086|65782518|FG002|Overall Study|Other|1|||
23561081|NCT00457639|65782519|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
23561082|NCT00457639|65782520|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
23561083|NCT00457639|65782519|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
23625040|NCT01296555|66015411|FG019|Overall Study|Study Terminated By Sponsor|0|||
23756793|NCT00021229|66489500|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
23756794|NCT00021229|66489501|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
23561084|NCT00457639|65782520|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
23561085|NCT00457639|65782519|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
23561086|NCT00457639|65782520|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
23561087|NCT02404389|65782524|FG000|Overall Study|Adverse Event|1|||
23561088|NCT02404389|65782525|FG001|Overall Study|Adverse Event|0|||
23561089|NCT02404389|65782526|FG002|Overall Study|Adverse Event|1|||
23561090|NCT02404389|65782527|FG003|Overall Study|Adverse Event|0|||
23561091|NCT02404389|65782528|FG004|Overall Study|Adverse Event|2|||
23561092|NCT02404389|65782524|FG000|Overall Study|Subject/guardian decision|1|||
23561093|NCT02404389|65782525|FG001|Overall Study|Subject/guardian decision|0|||
23561094|NCT02404389|65782526|FG002|Overall Study|Subject/guardian decision|0|||
23561095|NCT02404389|65782527|FG003|Overall Study|Subject/guardian decision|1|||
23561096|NCT02404389|65782528|FG004|Overall Study|Subject/guardian decision|1|||
23561097|NCT00886639|65782529|FG000|Overall Study|acute exacerbation|14|||
23561098|NCT00886639|65782529|FG000|Overall Study|non-compliance|2|||
23561099|NCT01931735|65782530|FG000|Randomized Phase|Lost to Follow-up|2|||
23561100|NCT01931735|65782531|FG001|Randomized Phase|Lost to Follow-up|2|||
23561101|NCT01931735|65782532|FG002|Randomized Phase|Lost to Follow-up|5|||
23561102|NCT01931735|65782533|FG003|Randomized Phase|Lost to Follow-up|0|||
23561103|NCT01931735|65782530|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
23561104|NCT01931735|65782531|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
23561105|NCT01931735|65782532|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
23561106|NCT01931735|65782533|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
23561107|NCT01931735|65782530|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561108|NCT01931735|65782531|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561109|NCT01931735|65782532|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561110|NCT01931735|65782533|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
23561111|NCT01555164|65782545|FG000|Overall Study|Adverse Event|5|||
23561112|NCT01555164|65782546|FG001|Overall Study|Adverse Event|7|||
23561113|NCT01555164|65782545|FG000|Overall Study|Hyperglycemia|0|||
23561114|NCT01555164|65782546|FG001|Overall Study|Hyperglycemia|1|||
23561115|NCT01555164|65782545|FG000|Overall Study|Investigator's Discretion|2|||
23561116|NCT01555164|65782546|FG001|Overall Study|Investigator's Discretion|2|||
23561117|NCT01555164|65782545|FG000|Overall Study|Lost to Follow-up|4|||
23561118|NCT01555164|65782546|FG001|Overall Study|Lost to Follow-up|3|||
23561119|NCT01555164|65782545|FG000|Overall Study|Protocol Violation|9|||
23561120|NCT01555164|65782546|FG001|Overall Study|Protocol Violation|5|||
23561121|NCT01555164|65782545|FG000|Overall Study|Subject Non-compliance|14|||
23561122|NCT01555164|65782546|FG001|Overall Study|Subject Non-compliance|6|||
23561123|NCT01555164|65782545|FG000|Overall Study|Subject Withdrew Consent|6|||
23561124|NCT01555164|65782546|FG001|Overall Study|Subject Withdrew Consent|11|||
23561125|NCT00215540|65782547|FG000|Overall Study|Withdrew from study medication|1|||
23561126|NCT00215540|65782548|FG001|Overall Study|Withdrew from study medication|0|||
23561127|NCT00215540|65782549|FG002|Overall Study|Withdrew from study medication|0|||
23561128|NCT02234063|65782551|FG000|Overall Study|Lost to Follow-up|235|||
23561129|NCT02234063|65782552|FG001|Overall Study|Lost to Follow-up|42|||
23561130|NCT02234063|65782551|FG000|Overall Study|Withdrawal by Subject|20|||
23561131|NCT02234063|65782552|FG001|Overall Study|Withdrawal by Subject|1|||
23561132|NCT01407354|65782557|FG000|First Intervention|Withdrawal by Subject|0|||
23561133|NCT01407354|65782558|FG001|First Intervention|Withdrawal by Subject|2|||
23561134|NCT01407354|65782557|FG000|First Intervention|Adverse Event|1|||
23561135|NCT01407354|65782558|FG001|First Intervention|Adverse Event|0|||
23561136|NCT01407354|65782557|FG000|First Intervention|Physician Decision|1|||
23561137|NCT01407354|65782558|FG001|First Intervention|Physician Decision|0|||
23561138|NCT00746096|65782559|FG000|Overall Study|Adverse Event|1|||
23561139|NCT00746096|65782560|FG001|Overall Study|Adverse Event|0|||
23561140|NCT00746096|65782559|FG000|Overall Study|Withdrawal by Subject|5|||
23561141|NCT00746096|65782560|FG001|Overall Study|Withdrawal by Subject|1|||
23561142|NCT00746096|65782559|FG000|Overall Study|Lost to Follow-up|2|||
23561143|NCT00746096|65782560|FG001|Overall Study|Lost to Follow-up|1|||
23561144|NCT00746096|65782559|FG000|Overall Study|Protocol Violation|1|||
23561145|NCT00746096|65782560|FG001|Overall Study|Protocol Violation|0|||
23561146|NCT00746096|65782559|FG000|Overall Study|No study drug treatment|1|||
23756795|NCT00021229|66489502|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
23756796|NCT01571635|66489505|FG000|Overall Study|Adverse Event|3|||
23561147|NCT00746096|65782560|FG001|Overall Study|No study drug treatment|1|||
23561148|NCT04074590|65782561|FG000|Overall Study|Adverse Event|1|||
23561149|NCT04074590|65782562|FG001|Overall Study|Adverse Event|0|||
23561150|NCT04074590|65782561|FG000|Overall Study|Physician Decision|1|||
23561151|NCT04074590|65782562|FG001|Overall Study|Physician Decision|0|||
23561152|NCT04074590|65782561|FG000|Overall Study|Withdrawal by Subject|2|||
23561153|NCT04074590|65782562|FG001|Overall Study|Withdrawal by Subject|0|||
23561154|NCT03303469|65782563|FG000|Overall Study|Lost to Follow-up|2|||
23561155|NCT01682213|65782567|FG000|Overall Study|Withdrawal by Subject|2|||
23561156|NCT02944656|65782568|FG000|Overall Study|No longer eligible|3|||
23561157|NCT02944656|65782569|FG001|Overall Study|No longer eligible|0|||
23561158|NCT02944656|65782568|FG000|Overall Study|Lost to Follow-up|7|||
23561159|NCT02944656|65782569|FG001|Overall Study|Lost to Follow-up|10|||
23561160|NCT02316769|65782570|FG000|Overall Study|Physician Decision|1|||
23561161|NCT02316769|65782571|FG001|Overall Study|Physician Decision|0|||
23561162|NCT02316769|65782570|FG000|Overall Study|Withdrawal by Subject|1|||
23756797|NCT01571635|66489506|FG001|Overall Study|Adverse Event|0|||
23756798|NCT01571635|66489507|FG002|Overall Study|Adverse Event|2|||
23756799|NCT01571635|66489508|FG003|Overall Study|Adverse Event|3|||
23756800|NCT01571635|66489509|FG004|Overall Study|Adverse Event|5|||
23756801|NCT01571635|66489505|FG000|Overall Study|Other reasons|2|||
23756802|NCT01571635|66489506|FG001|Overall Study|Other reasons|1|||
23756803|NCT01571635|66489507|FG002|Overall Study|Other reasons|2|||
23756804|NCT01571635|66489508|FG003|Overall Study|Other reasons|2|||
23756805|NCT01571635|66489509|FG004|Overall Study|Other reasons|1|||
23756806|NCT01571635|66489505|FG000|Overall Study|Study terminated by sponsor|0|||
23756807|NCT01571635|66489506|FG001|Overall Study|Study terminated by sponsor|4|||
23756808|NCT01571635|66489507|FG002|Overall Study|Study terminated by sponsor|1|||
23756809|NCT01571635|66489508|FG003|Overall Study|Study terminated by sponsor|3|||
23756810|NCT01571635|66489509|FG004|Overall Study|Study terminated by sponsor|1|||
23756811|NCT01571635|66489505|FG000|Overall Study|Withdrew consent|1|||
23756812|NCT01571635|66489506|FG001|Overall Study|Withdrew consent|1|||
23756813|NCT01571635|66489507|FG002|Overall Study|Withdrew consent|2|||
23756814|NCT01571635|66489508|FG003|Overall Study|Withdrew consent|3|||
23756815|NCT01571635|66489509|FG004|Overall Study|Withdrew consent|0|||
23756816|NCT01571635|66489505|FG000|Overall Study|Lack of Efficacy|0|||
23756817|NCT01571635|66489506|FG001|Overall Study|Lack of Efficacy|2|||
23756818|NCT01571635|66489507|FG002|Overall Study|Lack of Efficacy|0|||
23756819|NCT01571635|66489508|FG003|Overall Study|Lack of Efficacy|1|||
23756820|NCT01571635|66489509|FG004|Overall Study|Lack of Efficacy|2|||
23756821|NCT01106352|66489510|FG000|Overall Study|Subjects untreated|0|||
23756822|NCT01106352|66489511|FG001|Overall Study|Subjects untreated|0|||
23756823|NCT01106352|66489512|FG002|Overall Study|Subjects untreated|0|||
23756824|NCT01106352|66489513|FG003|Overall Study|Subjects untreated|3|||
23756825|NCT01106352|66489514|FG004|Overall Study|Subjects untreated|4|||
23756826|NCT01106352|66489510|FG000|Overall Study|Sponsor Decision|1|||
23756827|NCT01106352|66489511|FG001|Overall Study|Sponsor Decision|0|||
23756828|NCT01106352|66489512|FG002|Overall Study|Sponsor Decision|0|||
23756829|NCT01106352|66489513|FG003|Overall Study|Sponsor Decision|0|||
23756830|NCT01106352|66489514|FG004|Overall Study|Sponsor Decision|0|||
23756831|NCT01106352|66489510|FG000|Overall Study|Too ill to come in for the visit|0|||
23756832|NCT01106352|66489511|FG001|Overall Study|Too ill to come in for the visit|0|||
23756833|NCT01106352|66489512|FG002|Overall Study|Too ill to come in for the visit|1|||
23756834|NCT01106352|66489513|FG003|Overall Study|Too ill to come in for the visit|0|||
23756835|NCT01106352|66489514|FG004|Overall Study|Too ill to come in for the visit|0|||
23756836|NCT01106352|66489510|FG000|Overall Study|Lost to Follow-up|0|||
23756837|NCT01106352|66489511|FG001|Overall Study|Lost to Follow-up|0|||
23756838|NCT01106352|66489512|FG002|Overall Study|Lost to Follow-up|0|||
23756839|NCT01106352|66489513|FG003|Overall Study|Lost to Follow-up|0|||
23756840|NCT01106352|66489514|FG004|Overall Study|Lost to Follow-up|1|||
23756841|NCT01106352|66489510|FG000|Overall Study|Death|0|||
23561163|NCT02316769|65782571|FG001|Overall Study|Withdrawal by Subject|0|||
23561164|NCT00521144|65782572|FG000|Overall Study|Not Treated|0|||
23561165|NCT00521144|65782573|FG001|Overall Study|Not Treated|0|||
23561166|NCT00521144|65782574|FG002|Overall Study|Not Treated|0|||
23561167|NCT00521144|65782575|FG003|Overall Study|Not Treated|1|||
23561168|NCT00521144|65782576|FG004|Overall Study|Not Treated|0|||
23561169|NCT00521144|65782572|FG000|Overall Study|Adverse Event|0|||
23561170|NCT00521144|65782573|FG001|Overall Study|Adverse Event|1|||
23561171|NCT00521144|65782574|FG002|Overall Study|Adverse Event|0|||
23561172|NCT00521144|65782575|FG003|Overall Study|Adverse Event|0|||
23561173|NCT00521144|65782576|FG004|Overall Study|Adverse Event|1|||
23561174|NCT00521144|65782572|FG000|Overall Study|Progressive Disease|4|||
23561175|NCT00521144|65782573|FG001|Overall Study|Progressive Disease|2|||
23561176|NCT00521144|65782574|FG002|Overall Study|Progressive Disease|2|||
23561177|NCT00521144|65782575|FG003|Overall Study|Progressive Disease|0|||
23756842|NCT01106352|66489511|FG001|Overall Study|Death|0|||
23756843|NCT01106352|66489512|FG002|Overall Study|Death|1|||
23756844|NCT01106352|66489513|FG003|Overall Study|Death|3|||
23756845|NCT01106352|66489514|FG004|Overall Study|Death|1|||
23756846|NCT01106352|66489510|FG000|Overall Study|Disease progression|0|||
23756847|NCT01106352|66489511|FG001|Overall Study|Disease progression|0|||
23561178|NCT00521144|65782576|FG004|Overall Study|Progressive Disease|6|||
23756848|NCT01106352|66489512|FG002|Overall Study|Disease progression|0|||
23756849|NCT01106352|66489513|FG003|Overall Study|Disease progression|1|||
23756850|NCT01106352|66489514|FG004|Overall Study|Disease progression|0|||
23756851|NCT01106352|66489510|FG000|Overall Study|Withdrawal by Subject|0|||
23756852|NCT01106352|66489511|FG001|Overall Study|Withdrawal by Subject|0|||
23756853|NCT01106352|66489512|FG002|Overall Study|Withdrawal by Subject|0|||
23756854|NCT01106352|66489513|FG003|Overall Study|Withdrawal by Subject|3|||
23561179|NCT02768662|65782577|FG000|Overall Study|Adverse Event|1|||
23561180|NCT02768662|65782577|FG000|Overall Study|Lost to Follow-up|4|||
23561181|NCT02768662|65782577|FG000|Overall Study|Withdrawal by Subject|3|||
23561182|NCT02768662|65782577|FG000|Overall Study|Study terminated by Sponsor|78|||
23561183|NCT00246337|65782578|FG000|Overall Study|Lost to Follow-up|3|||
23561184|NCT00246337|65782579|FG001|Overall Study|Lost to Follow-up|0|||
23561185|NCT00246337|65782580|FG002|Overall Study|Lost to Follow-up|0|||
23561186|NCT00246337|65782581|FG003|Overall Study|Lost to Follow-up|0|||
23561187|NCT00246337|65782582|FG004|Overall Study|Lost to Follow-up|2|||
23561188|NCT00246337|65782583|FG005|Overall Study|Lost to Follow-up|2|||
23561189|NCT00246337|65782584|FG006|Overall Study|Lost to Follow-up|1|||
23561190|NCT00246337|65782585|FG007|Overall Study|Lost to Follow-up|2|||
23561191|NCT00246337|65782586|FG008|Overall Study|Lost to Follow-up|0|||
23561192|NCT00246337|65782578|FG000|Overall Study|Protocol Violation|1|||
23561193|NCT00246337|65782579|FG001|Overall Study|Protocol Violation|0|||
23561194|NCT00246337|65782580|FG002|Overall Study|Protocol Violation|0|||
23561195|NCT00246337|65782581|FG003|Overall Study|Protocol Violation|0|||
23561196|NCT00246337|65782582|FG004|Overall Study|Protocol Violation|1|||
23561197|NCT00246337|65782583|FG005|Overall Study|Protocol Violation|0|||
23561198|NCT00246337|65782584|FG006|Overall Study|Protocol Violation|1|||
23561199|NCT00246337|65782585|FG007|Overall Study|Protocol Violation|1|||
23561200|NCT00246337|65782586|FG008|Overall Study|Protocol Violation|0|||
23561201|NCT00246337|65782578|FG000|Overall Study|Withdrawal by Subject|2|||
23561202|NCT00246337|65782579|FG001|Overall Study|Withdrawal by Subject|0|||
23561203|NCT00246337|65782580|FG002|Overall Study|Withdrawal by Subject|0|||
23561204|NCT00246337|65782581|FG003|Overall Study|Withdrawal by Subject|0|||
23561205|NCT00246337|65782582|FG004|Overall Study|Withdrawal by Subject|0|||
23561206|NCT00246337|65782583|FG005|Overall Study|Withdrawal by Subject|0|||
23561207|NCT00246337|65782584|FG006|Overall Study|Withdrawal by Subject|1|||
23561208|NCT00246337|65782585|FG007|Overall Study|Withdrawal by Subject|1|||
23561209|NCT00246337|65782586|FG008|Overall Study|Withdrawal by Subject|0|||
23561210|NCT00246337|65782578|FG000|Overall Study|Lack of Qualifying Event|8|||
23561211|NCT00246337|65782579|FG001|Overall Study|Lack of Qualifying Event|2|||
23561212|NCT00246337|65782580|FG002|Overall Study|Lack of Qualifying Event|1|||
23561213|NCT00246337|65782581|FG003|Overall Study|Lack of Qualifying Event|1|||
23561214|NCT00246337|65782582|FG004|Overall Study|Lack of Qualifying Event|1|||
23561215|NCT00246337|65782583|FG005|Overall Study|Lack of Qualifying Event|3|||
23561216|NCT00246337|65782584|FG006|Overall Study|Lack of Qualifying Event|3|||
23561217|NCT00246337|65782585|FG007|Overall Study|Lack of Qualifying Event|2|||
23561218|NCT00246337|65782586|FG008|Overall Study|Lack of Qualifying Event|5|||
23561219|NCT00246337|65782578|FG000|Overall Study|Site Terminated|10|||
23561220|NCT00246337|65782579|FG001|Overall Study|Site Terminated|0|||
23561221|NCT00246337|65782580|FG002|Overall Study|Site Terminated|0|||
23561222|NCT00246337|65782581|FG003|Overall Study|Site Terminated|0|||
23561223|NCT00246337|65782582|FG004|Overall Study|Site Terminated|0|||
23561224|NCT00246337|65782583|FG005|Overall Study|Site Terminated|7|||
23561225|NCT00246337|65782584|FG006|Overall Study|Site Terminated|1|||
23561226|NCT00246337|65782585|FG007|Overall Study|Site Terminated|6|||
23561227|NCT00246337|65782586|FG008|Overall Study|Site Terminated|2|||
23561228|NCT00246337|65782578|FG000|Overall Study|Abnormal baseline lab values|7|||
23561229|NCT00246337|65782579|FG001|Overall Study|Abnormal baseline lab values|0|||
23561230|NCT00246337|65782580|FG002|Overall Study|Abnormal baseline lab values|2|||
23561231|NCT00246337|65782581|FG003|Overall Study|Abnormal baseline lab values|0|||
23561232|NCT00246337|65782582|FG004|Overall Study|Abnormal baseline lab values|0|||
23561233|NCT00246337|65782583|FG005|Overall Study|Abnormal baseline lab values|2|||
23561234|NCT00246337|65782584|FG006|Overall Study|Abnormal baseline lab values|2|||
23561235|NCT00246337|65782585|FG007|Overall Study|Abnormal baseline lab values|0|||
23561236|NCT00246337|65782586|FG008|Overall Study|Abnormal baseline lab values|4|||
23561237|NCT00246337|65782578|FG000|Overall Study|Overwhelmed|0|||
23561238|NCT00246337|65782579|FG001|Overall Study|Overwhelmed|0|||
23561239|NCT00246337|65782580|FG002|Overall Study|Overwhelmed|0|||
23561240|NCT00246337|65782581|FG003|Overall Study|Overwhelmed|0|||
23561241|NCT00246337|65782582|FG004|Overall Study|Overwhelmed|0|||
23561242|NCT00246337|65782583|FG005|Overall Study|Overwhelmed|1|||
23561243|NCT00246337|65782584|FG006|Overall Study|Overwhelmed|0|||
23756855|NCT01106352|66489514|FG004|Overall Study|Withdrawal by Subject|2|||
23756856|NCT01106352|66489510|FG000|Overall Study|Went on hospice|0|||
23756857|NCT01106352|66489511|FG001|Overall Study|Went on hospice|0|||
23561244|NCT00246337|65782585|FG007|Overall Study|Overwhelmed|0|||
23756858|NCT01106352|66489512|FG002|Overall Study|Went on hospice|0|||
23561245|NCT00246337|65782586|FG008|Overall Study|Overwhelmed|0|||
23561246|NCT00246337|65782578|FG000|Overall Study|Protocol Violator|1|||
23561247|NCT00246337|65782579|FG001|Overall Study|Protocol Violator|0|||
23561248|NCT00246337|65782580|FG002|Overall Study|Protocol Violator|0|||
23561249|NCT00246337|65782581|FG003|Overall Study|Protocol Violator|0|||
23561250|NCT00246337|65782582|FG004|Overall Study|Protocol Violator|0|||
23561251|NCT00246337|65782583|FG005|Overall Study|Protocol Violator|0|||
23561252|NCT00246337|65782584|FG006|Overall Study|Protocol Violator|0|||
23561253|NCT00246337|65782585|FG007|Overall Study|Protocol Violator|0|||
23561254|NCT00246337|65782586|FG008|Overall Study|Protocol Violator|0|||
23561255|NCT00246337|65782578|FG000|Overall Study|Reported as completing trial in error|0|||
23561256|NCT00246337|65782579|FG001|Overall Study|Reported as completing trial in error|0|||
23561257|NCT00246337|65782580|FG002|Overall Study|Reported as completing trial in error|0|||
23561258|NCT00246337|65782581|FG003|Overall Study|Reported as completing trial in error|0|||
23561259|NCT00246337|65782582|FG004|Overall Study|Reported as completing trial in error|0|||
23561260|NCT00246337|65782583|FG005|Overall Study|Reported as completing trial in error|0|||
23561261|NCT00246337|65782584|FG006|Overall Study|Reported as completing trial in error|0|||
23561262|NCT00246337|65782585|FG007|Overall Study|Reported as completing trial in error|1|||
23561263|NCT00246337|65782586|FG008|Overall Study|Reported as completing trial in error|0|||
23561264|NCT03518125|65782587|FG000|Overall Study|Lost to Follow-up|0|||
23561265|NCT03518125|65782588|FG001|Overall Study|Lost to Follow-up|2|||
23561266|NCT03518125|65782589|FG002|Overall Study|Lost to Follow-up|0|||
23561267|NCT03518125|65782590|FG003|Overall Study|Lost to Follow-up|0|||
23561268|NCT03518125|65782591|FG004|Overall Study|Lost to Follow-up|3|||
23561269|NCT03518125|65782592|FG005|Overall Study|Lost to Follow-up|5|||
23561270|NCT03518125|65782587|FG000|Overall Study|Physician Decision|0|||
23561271|NCT03518125|65782588|FG001|Overall Study|Physician Decision|1|||
23561272|NCT03518125|65782589|FG002|Overall Study|Physician Decision|0|||
23561273|NCT03518125|65782590|FG003|Overall Study|Physician Decision|0|||
23561274|NCT03518125|65782591|FG004|Overall Study|Physician Decision|0|||
23561275|NCT03518125|65782592|FG005|Overall Study|Physician Decision|0|||
23561276|NCT03518125|65782587|FG000|Overall Study|Withdrawal by Subject|1|||
23561277|NCT03518125|65782588|FG001|Overall Study|Withdrawal by Subject|1|||
23561278|NCT03518125|65782589|FG002|Overall Study|Withdrawal by Subject|0|||
23625041|NCT01296555|66015412|FG020|Overall Study|Study Terminated By Sponsor|0|||
23625042|NCT01296555|66015413|FG021|Overall Study|Study Terminated By Sponsor|0|||
23561279|NCT03518125|65782590|FG003|Overall Study|Withdrawal by Subject|1|||
23561280|NCT03518125|65782591|FG004|Overall Study|Withdrawal by Subject|1|||
23561281|NCT03518125|65782592|FG005|Overall Study|Withdrawal by Subject|3|||
23561282|NCT03518125|65782587|FG000|Overall Study|Missed Day 394 Visit|1|||
23561283|NCT03518125|65782588|FG001|Overall Study|Missed Day 394 Visit|0|||
23561284|NCT03518125|65782589|FG002|Overall Study|Missed Day 394 Visit|0|||
23561285|NCT03518125|65782590|FG003|Overall Study|Missed Day 394 Visit|0|||
23625043|NCT01296555|66015414|FG022|Overall Study|Study Terminated By Sponsor|0|||
23561286|NCT03518125|65782591|FG004|Overall Study|Missed Day 394 Visit|0|||
23826284|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826285|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826286|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826287|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
23561287|NCT03518125|65782592|FG005|Overall Study|Missed Day 394 Visit|0|||
23561288|NCT02178059|65782593|FG000|Washout|Physician Decision|1|||
23561289|NCT02178059|65782594|FG001|Washout|Physician Decision|0|||
23561290|NCT03205371|65782598|FG000|Overall Study|Withdrawal by Subject|4|||
23561291|NCT03205371|65782599|FG001|Overall Study|Withdrawal by Subject|1|||
23561292|NCT03205371|65782600|FG002|Overall Study|Withdrawal by Subject|0|||
23561293|NCT03205371|65782601|FG003|Overall Study|Withdrawal by Subject|0|||
23561294|NCT03205371|65782602|FG004|Overall Study|Withdrawal by Subject|0|||
23561295|NCT03205371|65782603|FG005|Overall Study|Withdrawal by Subject|0|||
23561296|NCT03205371|65782604|FG006|Overall Study|Withdrawal by Subject|4|||
23561297|NCT03205371|65782605|FG007|Overall Study|Withdrawal by Subject|0|||
23561298|NCT03205371|65782606|FG008|Overall Study|Withdrawal by Subject|2|||
23561299|NCT03205371|65782607|FG009|Overall Study|Withdrawal by Subject|0|||
23561300|NCT03205371|65782608|FG010|Overall Study|Withdrawal by Subject|0|||
23561301|NCT03205371|65782609|FG011|Overall Study|Withdrawal by Subject|1|||
23561302|NCT03205371|65782598|FG000|Overall Study|Lost to Follow-up|0|||
23561303|NCT03205371|65782599|FG001|Overall Study|Lost to Follow-up|0|||
23561304|NCT03205371|65782600|FG002|Overall Study|Lost to Follow-up|0|||
23561305|NCT03205371|65782601|FG003|Overall Study|Lost to Follow-up|0|||
23561306|NCT03205371|65782602|FG004|Overall Study|Lost to Follow-up|0|||
23561307|NCT03205371|65782603|FG005|Overall Study|Lost to Follow-up|0|||
23561308|NCT03205371|65782604|FG006|Overall Study|Lost to Follow-up|5|||
23561309|NCT03205371|65782605|FG007|Overall Study|Lost to Follow-up|2|||
23561310|NCT03205371|65782606|FG008|Overall Study|Lost to Follow-up|3|||
23561311|NCT03205371|65782607|FG009|Overall Study|Lost to Follow-up|0|||
23756859|NCT01106352|66489513|FG003|Overall Study|Went on hospice|1|||
23561312|NCT03205371|65782608|FG010|Overall Study|Lost to Follow-up|0|||
23561313|NCT03205371|65782609|FG011|Overall Study|Lost to Follow-up|0|||
23561314|NCT03205371|65782598|FG000|Overall Study|Protocol Violation|0|||
23561315|NCT03205371|65782599|FG001|Overall Study|Protocol Violation|0|||
23756860|NCT01106352|66489514|FG004|Overall Study|Went on hospice|0|||
23756861|NCT01106352|66489510|FG000|Overall Study|Subject entered hospice|0|||
23756862|NCT01106352|66489511|FG001|Overall Study|Subject entered hospice|0|||
23756863|NCT01106352|66489512|FG002|Overall Study|Subject entered hospice|0|||
23756864|NCT01106352|66489513|FG003|Overall Study|Subject entered hospice|1|||
23756865|NCT01106352|66489514|FG004|Overall Study|Subject entered hospice|0|||
23756866|NCT01106352|66489510|FG000|Overall Study|Home hospice since July 2013|0|||
23756867|NCT01106352|66489511|FG001|Overall Study|Home hospice since July 2013|0|||
23756868|NCT01106352|66489512|FG002|Overall Study|Home hospice since July 2013|0|||
23756869|NCT01106352|66489513|FG003|Overall Study|Home hospice since July 2013|1|||
23756870|NCT01106352|66489514|FG004|Overall Study|Home hospice since July 2013|0|||
23756871|NCT00078819|66489515|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23438573|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23756872|NCT00078819|66489516|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
23438574|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23756873|NCT00078819|66489517|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23756874|NCT00078819|66489518|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23756875|NCT00078819|66489515|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
23756876|NCT00078819|66489516|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23756877|NCT00078819|66489517|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23756878|NCT00078819|66489518|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23756879|NCT00078819|66489515|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
23756880|NCT00078819|66489516|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
23756881|NCT00078819|66489517|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
23756882|NCT00078819|66489518|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
23756883|NCT00078819|66489515|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
23756884|NCT00078819|66489516|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
23756885|NCT00078819|66489517|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
23438575|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438576|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438577|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438578|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561316|NCT03205371|65782600|FG002|Overall Study|Protocol Violation|0|||
23561317|NCT03205371|65782601|FG003|Overall Study|Protocol Violation|0|||
23561318|NCT03205371|65782602|FG004|Overall Study|Protocol Violation|0|||
23561319|NCT03205371|65782603|FG005|Overall Study|Protocol Violation|0|||
23561320|NCT03205371|65782604|FG006|Overall Study|Protocol Violation|1|||
23561321|NCT03205371|65782605|FG007|Overall Study|Protocol Violation|0|||
23561322|NCT03205371|65782606|FG008|Overall Study|Protocol Violation|0|||
23561323|NCT03205371|65782607|FG009|Overall Study|Protocol Violation|0|||
23561324|NCT03205371|65782608|FG010|Overall Study|Protocol Violation|0|||
23561325|NCT03205371|65782609|FG011|Overall Study|Protocol Violation|0|||
23561326|NCT03205371|65782598|FG000|Overall Study|Adverse Event|0|||
23561327|NCT03205371|65782599|FG001|Overall Study|Adverse Event|0|||
23561328|NCT03205371|65782600|FG002|Overall Study|Adverse Event|0|||
23561329|NCT03205371|65782601|FG003|Overall Study|Adverse Event|0|||
23561330|NCT03205371|65782602|FG004|Overall Study|Adverse Event|0|||
23561331|NCT03205371|65782603|FG005|Overall Study|Adverse Event|0|||
23561332|NCT03205371|65782604|FG006|Overall Study|Adverse Event|0|||
23561333|NCT03205371|65782605|FG007|Overall Study|Adverse Event|1|||
23438579|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561334|NCT03205371|65782606|FG008|Overall Study|Adverse Event|0|||
23561335|NCT03205371|65782607|FG009|Overall Study|Adverse Event|0|||
23561336|NCT03205371|65782608|FG010|Overall Study|Adverse Event|0|||
23561337|NCT03205371|65782609|FG011|Overall Study|Adverse Event|0|||
23561338|NCT00611858|65782610|FG000|Overall Study|Adverse Event|2|||
23561339|NCT00611858|65782610|FG000|Overall Study|Withdrawal by Subject|2|||
23561340|NCT03122119|65782615|FG000|Overall Study|Did not meet eligibility critria|1|||
23561341|NCT03124199|65782616|FG000|Overall Study|Lost to Follow-up|4|||
23561342|NCT03243422|65782617|FG000|Overall Study|Death|20|||
23561343|NCT03243422|65782618|FG001|Overall Study|Death|21|||
23561344|NCT03243422|65782617|FG000|Overall Study|Lost to Follow-up|9|||
23625044|NCT01296555|66015415|FG023|Overall Study|Study Terminated By Sponsor|0|||
23625045|NCT01296555|66015416|FG024|Overall Study|Study Terminated By Sponsor|0|||
23625046|NCT01296555|66015417|FG025|Overall Study|Study Terminated By Sponsor|1|||
23625047|NCT01296555|66015418|FG026|Overall Study|Study Terminated By Sponsor|0|||
23625048|NCT01296555|66015419|FG027|Overall Study|Study Terminated By Sponsor|0|||
23561345|NCT03243422|65782618|FG001|Overall Study|Lost to Follow-up|21|||
23561346|NCT03243422|65782617|FG000|Overall Study|Withdrawal by Subject|22|||
23561347|NCT03243422|65782618|FG001|Overall Study|Withdrawal by Subject|8|||
23561348|NCT01301274|65782619|FG000|Overall Study|Physician Decision|2|||
23561349|NCT01301274|65782620|FG001|Overall Study|Physician Decision|1|||
23561350|NCT02978443|65782621|FG000|Overall Study|Withdrawal by Subject|1|||
23561351|NCT02978443|65782621|FG000|Overall Study|Adverse Event|3|||
23625049|NCT01296555|66015420|FG028|Overall Study|Study Terminated By Sponsor|0|||
23625050|NCT01296555|66015392|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625051|NCT01296555|66015393|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23756886|NCT00078819|66489518|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
23756887|NCT00078819|66489515|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
23756888|NCT00078819|66489516|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
23756889|NCT00078819|66489517|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
23756890|NCT00078819|66489518|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
23756891|NCT00078819|66489515|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
23756892|NCT00078819|66489516|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
23756893|NCT00078819|66489517|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
23756894|NCT00078819|66489518|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
23756895|NCT00078819|66489515|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
23756896|NCT00078819|66489516|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
23756897|NCT00078819|66489517|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
23756898|NCT00078819|66489518|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
23438580|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
23438581|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
23438582|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438583|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438584|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438585|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438586|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438587|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438588|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438589|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438590|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438591|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438592|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
23438593|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
23438594|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438595|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
23438596|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438597|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438598|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438599|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438600|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438601|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438602|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438603|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438604|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438605|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438606|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
23438607|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438608|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438609|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438610|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438611|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438612|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438613|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438614|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438615|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438616|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438617|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438618|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438619|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438620|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23826288|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
23826289|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
23438621|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
23438622|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438623|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438624|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438625|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438626|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438627|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438628|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438629|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23625052|NCT01296555|66015394|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625053|NCT01296555|66015395|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625054|NCT01296555|66015396|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625055|NCT01296555|66015397|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625056|NCT01296555|66015398|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625057|NCT01296555|66015399|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625058|NCT01296555|66015400|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625059|NCT01296555|66015401|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625060|NCT01296555|66015402|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625061|NCT01296555|66015403|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625062|NCT01296555|66015404|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438630|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438631|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
23625063|NCT01296555|66015405|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625064|NCT01296555|66015406|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438632|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23625065|NCT01296555|66015407|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625066|NCT01296555|66015408|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625067|NCT01296555|66015409|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625068|NCT01296555|66015410|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625069|NCT01296555|66015411|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
23625070|NCT01296555|66015412|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438633|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438634|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438635|NCT02702414|65348615|FG000|Overall Study|Death|96|||
23438636|NCT02702414|65348616|FG001|Overall Study|Death|42|||
23438637|NCT02702414|65348615|FG000|Overall Study|Lost to Follow-up|0|||
23438638|NCT02702414|65348616|FG001|Overall Study|Lost to Follow-up|1|||
23438639|NCT02702414|65348615|FG000|Overall Study|Withdrawal by Subject|0|||
23438640|NCT02702414|65348616|FG001|Overall Study|Withdrawal by Subject|1|||
23438641|NCT02702414|65348615|FG000|Overall Study|Protocol Violation|1|||
23438642|NCT02702414|65348616|FG001|Overall Study|Protocol Violation|0|||
23438643|NCT02702414|65348615|FG000|Overall Study|Sponsor Decision|8|||
23438644|NCT02702414|65348616|FG001|Overall Study|Sponsor Decision|7|||
23438645|NCT04390841|65348618|FG000|Overall Study|Withdrawal by Subject|2|||
23438646|NCT00588354|65348619|FG000|Baseline to 2 Weeks|Adverse Event|1|||
23438647|NCT00588354|65348620|FG001|Baseline to 2 Weeks|Adverse Event|0|||
23438648|NCT00588354|65348619|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
23438649|NCT00588354|65348620|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
23438650|NCT00588354|65348619|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
23438651|NCT00588354|65348620|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
23438652|NCT02485704|65348623|FG000|Overall Study|Lost to Follow-up|4|||
23438653|NCT02485704|65348624|FG001|Overall Study|Lost to Follow-up|5|||
23438654|NCT02485704|65348623|FG000|Overall Study|Withdrawal by Subject|0|||
23438655|NCT02485704|65348624|FG001|Overall Study|Withdrawal by Subject|3|||
23438656|NCT02485704|65348623|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
23438657|NCT02485704|65348624|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
23438658|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
23438659|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
23438660|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
23438661|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
23438662|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
23438663|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
23438664|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23438665|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
23756899|NCT00078819|66489515|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23756900|NCT00078819|66489516|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23756901|NCT00078819|66489517|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23756902|NCT00078819|66489518|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
23756903|NCT03959137|66489520|FG000|Overall Study|Protocol Violation|6|||
23756904|NCT01358708|66489521|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23756905|NCT01358708|66489522|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23756906|NCT01358708|66489521|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23438666|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
23438667|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
23438668|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
23438669|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
23438670|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
23438671|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
23438672|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
23438673|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
23438674|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
23438675|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
23438676|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
23438677|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
23438678|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23438679|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23625071|NCT01296555|66015413|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625072|NCT01296555|66015414|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23826290|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826291|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23438680|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
23438681|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
23625073|NCT01296555|66015415|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625074|NCT01296555|66015416|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438682|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
23438683|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
23438684|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
23438685|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
23438686|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
23438687|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
23438688|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
23438689|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
23438690|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
23438691|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
23438692|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
23438693|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
23438694|NCT02008773|65348628|FG000|Overall Study|Adverse Event|3|||
23438695|NCT02008773|65348629|FG001|Overall Study|Adverse Event|3|||
23438696|NCT02008773|65348630|FG002|Overall Study|Adverse Event|1|||
23438697|NCT02008773|65348631|FG003|Overall Study|Adverse Event|2|||
23438698|NCT02008773|65348628|FG000|Overall Study|Medication Non-compliance|2|||
23438699|NCT02008773|65348629|FG001|Overall Study|Medication Non-compliance|1|||
23438700|NCT02008773|65348630|FG002|Overall Study|Medication Non-compliance|3|||
23438701|NCT02008773|65348631|FG003|Overall Study|Medication Non-compliance|2|||
23438702|NCT02008773|65348628|FG000|Overall Study|Withdrawal by Subject|8|||
23438703|NCT02008773|65348629|FG001|Overall Study|Withdrawal by Subject|4|||
23438704|NCT02008773|65348630|FG002|Overall Study|Withdrawal by Subject|7|||
23438705|NCT02008773|65348631|FG003|Overall Study|Withdrawal by Subject|6|||
23438706|NCT02008773|65348628|FG000|Overall Study|Lost to Follow-up|0|||
23438707|NCT02008773|65348629|FG001|Overall Study|Lost to Follow-up|1|||
23438708|NCT02008773|65348630|FG002|Overall Study|Lost to Follow-up|3|||
23438709|NCT02008773|65348631|FG003|Overall Study|Lost to Follow-up|2|||
23438710|NCT02834247|65348632|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
23438711|NCT02834247|65348633|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
23438712|NCT02834247|65348634|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
23438713|NCT02834247|65348635|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
23438714|NCT02834247|65348632|FG000|Dose Escalation Phase|Death|5|||
23438715|NCT02834247|65348633|FG001|Dose Escalation Phase|Death|6|||
23438716|NCT02834247|65348634|FG002|Dose Escalation Phase|Death|5|||
23438717|NCT02834247|65348635|FG003|Dose Escalation Phase|Death|0|||
23438718|NCT02834247|65348632|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
23438719|NCT02834247|65348633|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
23438720|NCT02834247|65348634|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
23438721|NCT02834247|65348635|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
23438722|NCT02834247|65348632|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
23438723|NCT02834247|65348633|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
23438724|NCT02834247|65348634|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23438725|NCT02834247|65348635|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23625075|NCT01296555|66015417|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625076|NCT01296555|66015418|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625077|NCT01296555|66015419|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625078|NCT01296555|66015420|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625079|NCT01296555|66015392|FG000|Overall Study|Death|0|||
23625080|NCT01296555|66015393|FG001|Overall Study|Death|0|||
23625081|NCT01296555|66015394|FG002|Overall Study|Death|0|||
23438726|NCT02834247|65348632|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438727|NCT02834247|65348633|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438728|NCT02834247|65348634|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438729|NCT02834247|65348635|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
23438730|NCT02834247|65348632|FG000|Dose Expansion Phase|Death|0|||
23438731|NCT02834247|65348633|FG001|Dose Expansion Phase|Death|0|||
23438732|NCT02834247|65348634|FG002|Dose Expansion Phase|Death|0|||
23438733|NCT02834247|65348635|FG003|Dose Expansion Phase|Death|8|||
23438734|NCT02834247|65348632|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
23438735|NCT02834247|65348633|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
23438736|NCT02834247|65348634|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
23438737|NCT02834247|65348635|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
23438738|NCT02834247|65348632|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
23438739|NCT02834247|65348633|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
23438740|NCT02834247|65348634|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
23625082|NCT01296555|66015395|FG003|Overall Study|Death|2|||
23438741|NCT02834247|65348635|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
23625083|NCT01296555|66015396|FG004|Overall Study|Death|1|||
23438742|NCT00417963|65348638|FG000|Overall Study|Lost to Follow-up|3|||
23438743|NCT00417963|65348638|FG000|Overall Study|Withdrawal by Subject|18|||
23438744|NCT00417963|65348638|FG000|Overall Study|Death|17|||
23625084|NCT01296555|66015397|FG005|Overall Study|Death|0|||
23625085|NCT01296555|66015398|FG006|Overall Study|Death|2|||
23625086|NCT01296555|66015399|FG007|Overall Study|Death|0|||
23625087|NCT01296555|66015400|FG008|Overall Study|Death|0|||
23625088|NCT01296555|66015401|FG009|Overall Study|Death|1|||
23625089|NCT01296555|66015402|FG010|Overall Study|Death|0|||
23625090|NCT01296555|66015403|FG011|Overall Study|Death|1|||
23438745|NCT00417963|65348638|FG000|Overall Study|Study device could not be deployed|3|||
23438746|NCT00699660|65348639|FG000|Overall Study|Lost to Follow-up|4|||
23438747|NCT00699660|65348640|FG001|Overall Study|Lost to Follow-up|2|||
23561352|NCT02978443|65782621|FG000|Overall Study|Disease Progression on study|6|||
23625091|NCT01296555|66015404|FG012|Overall Study|Death|0|||
23625092|NCT01296555|66015405|FG013|Overall Study|Death|2|||
23625093|NCT01296555|66015406|FG014|Overall Study|Death|27|||
23625094|NCT01296555|66015407|FG015|Overall Study|Death|15|||
23625095|NCT01296555|66015408|FG016|Overall Study|Death|11|||
23625096|NCT01296555|66015409|FG017|Overall Study|Death|11|||
23561353|NCT02978443|65782621|FG000|Overall Study|Death|1|||
23561354|NCT02978443|65782621|FG000|Overall Study|Physician Decision|1|||
23561355|NCT02978443|65782621|FG000|Overall Study|Switch to alternative therapy|1|||
23561356|NCT02978443|65782621|FG000|Overall Study|Refused further treatment|1|||
23561357|NCT01892345|65782624|FG000|Overall Study|Adverse Event|0|||
23561358|NCT01892345|65782625|FG001|Overall Study|Adverse Event|2|||
23561359|NCT01892345|65782624|FG000|Overall Study|Death|1|||
23561360|NCT01892345|65782625|FG001|Overall Study|Death|0|||
23561361|NCT01892345|65782624|FG000|Overall Study|Lost to Follow-up|3|||
23561362|NCT01892345|65782625|FG001|Overall Study|Lost to Follow-up|0|||
23561363|NCT01892345|65782624|FG000|Overall Study|Withdrawal by Subject|12|||
23561364|NCT01892345|65782625|FG001|Overall Study|Withdrawal by Subject|1|||
23561365|NCT00595504|65782630|FG000|Overall Study|Withdrawal by Subject|1|||
23561366|NCT00595504|65782631|FG001|Overall Study|Withdrawal by Subject|3|||
23561367|NCT00595504|65782630|FG000|Overall Study|Physician Decision|1|||
23561368|NCT00595504|65782631|FG001|Overall Study|Physician Decision|0|||
23561369|NCT01106430|65782636|FG000|Overall Study|Adverse Event|8|||
23561370|NCT01106430|65782637|FG001|Overall Study|Adverse Event|10|||
23561371|NCT01106430|65782636|FG000|Overall Study|Lack of Efficacy|2|||
23561372|NCT01106430|65782637|FG001|Overall Study|Lack of Efficacy|13|||
23561373|NCT01106430|65782636|FG000|Overall Study|Lost to Follow-up|5|||
23561374|NCT01106430|65782637|FG001|Overall Study|Lost to Follow-up|1|||
23561375|NCT01106430|65782636|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
23561376|NCT01106430|65782637|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
23561377|NCT01106430|65782636|FG000|Overall Study|Moved Out Of State|0|||
23561378|NCT01106430|65782637|FG001|Overall Study|Moved Out Of State|1|||
23561379|NCT01106430|65782636|FG000|Overall Study|Refused To Take Medication|0|||
23561380|NCT01106430|65782637|FG001|Overall Study|Refused To Take Medication|1|||
23561381|NCT01106430|65782636|FG000|Overall Study|Noncompliance|0|||
23561382|NCT01106430|65782637|FG001|Overall Study|Noncompliance|1|||
23561383|NCT01106430|65782636|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
23561384|NCT01106430|65782637|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
23561385|NCT01106430|65782636|FG000|Overall Study|Previous Use Of Marijuana|1|||
23561386|NCT01106430|65782637|FG001|Overall Study|Previous Use Of Marijuana|0|||
23561387|NCT01106430|65782636|FG000|Overall Study|Protocol Violation|7|||
23561388|NCT01106430|65782637|FG001|Overall Study|Protocol Violation|2|||
23561389|NCT01106430|65782636|FG000|Overall Study|Withdrawal by Subject|8|||
23561390|NCT01106430|65782637|FG001|Overall Study|Withdrawal by Subject|4|||
23561391|NCT01191840|65782638|FG000|Overall Study|withdrew consent|2|||
23561392|NCT01191840|65782639|FG001|Overall Study|withdrew consent|1|||
23561393|NCT01191840|65782638|FG000|Overall Study|Subject discontinued treatment|1|||
23561394|NCT01191840|65782639|FG001|Overall Study|Subject discontinued treatment|2|||
23561395|NCT01191840|65782638|FG000|Overall Study|Lost to Follow-up|4|||
23561396|NCT01191840|65782639|FG001|Overall Study|Lost to Follow-up|6|||
23625097|NCT01296555|66015410|FG018|Overall Study|Death|17|||
23625098|NCT01296555|66015411|FG019|Overall Study|Death|12|||
23625099|NCT01296555|66015412|FG020|Overall Study|Death|13|||
23625100|NCT01296555|66015413|FG021|Overall Study|Death|12|||
23625101|NCT01296555|66015414|FG022|Overall Study|Death|12|||
23625102|NCT01296555|66015415|FG023|Overall Study|Death|13|||
23625103|NCT01296555|66015416|FG024|Overall Study|Death|7|||
23625104|NCT01296555|66015417|FG025|Overall Study|Death|7|||
23625105|NCT01296555|66015418|FG026|Overall Study|Death|35|||
23625106|NCT01296555|66015419|FG027|Overall Study|Death|92|||
23561397|NCT01191840|65782638|FG000|Overall Study|Non Staph Infection|4|||
23561398|NCT01191840|65782639|FG001|Overall Study|Non Staph Infection|3|||
23561399|NCT01191840|65782638|FG000|Overall Study|ineligible at enrollment|1|||
23561400|NCT01191840|65782639|FG001|Overall Study|ineligible at enrollment|0|||
23561401|NCT01191840|65782638|FG000|Overall Study|IRB approval lapse|0|||
23561402|NCT01191840|65782639|FG001|Overall Study|IRB approval lapse|2|||
23561403|NCT01191840|65782638|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
23561404|NCT01191840|65782639|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
23561405|NCT01191840|65782638|FG000|Overall Study|Withdrawal by Subject|2|||
23625107|NCT01296555|66015420|FG028|Overall Study|Death|44|||
23625108|NCT01296555|66015392|FG000|Overall Study|Lost to Follow-up|0|||
23756907|NCT01358708|66489522|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
23561406|NCT01191840|65782639|FG001|Overall Study|Withdrawal by Subject|0|||
23561407|NCT03976466|65786142|FG000|Overall Study|Lost to Follow-up|1|||
23561408|NCT03976466|65786143|FG001|Overall Study|Lost to Follow-up|3|||
23561409|NCT00642902|65786145|FG000|Overall Study|Adverse Event|0|||
23561410|NCT00642902|65786146|FG001|Overall Study|Adverse Event|1|||
23561411|NCT00642902|65786147|FG002|Overall Study|Adverse Event|3|||
23561412|NCT00642902|65786148|FG003|Overall Study|Adverse Event|1|||
23561413|NCT00642902|65786145|FG000|Overall Study|Lost to Follow-up|1|||
23561414|NCT00642902|65786146|FG001|Overall Study|Lost to Follow-up|1|||
23561415|NCT00642902|65786147|FG002|Overall Study|Lost to Follow-up|0|||
23561416|NCT00642902|65786148|FG003|Overall Study|Lost to Follow-up|0|||
23561417|NCT00642902|65786145|FG000|Overall Study|Lack of Efficacy|0|||
23756908|NCT01977352|66489526|FG000|Overall Study|Lost to Follow-up|1|||
23756909|NCT01977352|66489527|FG001|Overall Study|Lost to Follow-up|2|||
23561418|NCT00642902|65786146|FG001|Overall Study|Lack of Efficacy|3|||
23756910|NCT00647426|66489528|FG000|Overall Study|Withdrawal by Subject|2|||
23756911|NCT02295280|66489529|FG000|Overall Study|Adverse Event|0|||
23438748|NCT00699660|65348639|FG000|Overall Study|missing reports and recording failures|10|||
23438749|NCT00699660|65348640|FG001|Overall Study|missing reports and recording failures|6|||
23438750|NCT02868229|65348641|FG000|Overall Study|Adverse Event|1|||
23438751|NCT02868229|65348642|FG001|Overall Study|Adverse Event|0|||
23438752|NCT02868229|65348643|FG002|Overall Study|Adverse Event|0|||
23438753|NCT02868229|65348644|FG003|Overall Study|Adverse Event|1|||
23438754|NCT02868229|65348641|FG000|Overall Study|Death|0|||
23438755|NCT02868229|65348642|FG001|Overall Study|Death|0|||
23438756|NCT02868229|65348643|FG002|Overall Study|Death|1|||
23438757|NCT02868229|65348644|FG003|Overall Study|Death|1|||
23438758|NCT02868229|65348641|FG000|Overall Study|Missed dose|0|||
23438759|NCT02868229|65348642|FG001|Overall Study|Missed dose|0|||
23438760|NCT02868229|65348643|FG002|Overall Study|Missed dose|0|||
23438761|NCT02868229|65348644|FG003|Overall Study|Missed dose|3|||
23438762|NCT04752358|65348646|FG000|Overall Study|Death|2|||
23438763|NCT04752358|65348647|FG001|Overall Study|Death|1|||
23438764|NCT01628965|65348648|FG000|Overall Study|Adverse Event|30|||
23438765|NCT01628965|65348648|FG000|Overall Study|Lack of Efficacy|7|||
23438766|NCT01628965|65348648|FG000|Overall Study|Withdrawal by Subject|3|||
23438767|NCT01628965|65348648|FG000|Overall Study|Lost to Follow-up|1|||
23438768|NCT01628965|65348648|FG000|Overall Study|Discontinuation criteria|8|||
23756912|NCT02295280|66489530|FG001|Overall Study|Adverse Event|1|||
23756913|NCT02713243|66489533|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
23438769|NCT00061633|65348650|FG000|Overall Study|Adverse Event|1|||
23438770|NCT00061633|65348651|FG001|Overall Study|Adverse Event|2|||
23438771|NCT00061633|65348650|FG000|Overall Study|Withdrawal by Subject|2|||
23438772|NCT00061633|65348651|FG001|Overall Study|Withdrawal by Subject|2|||
23438773|NCT00061633|65348650|FG000|Overall Study|Lost to Follow-up|1|||
23438774|NCT00061633|65348651|FG001|Overall Study|Lost to Follow-up|4|||
23561419|NCT00642902|65786147|FG002|Overall Study|Lack of Efficacy|3|||
23561420|NCT00642902|65786148|FG003|Overall Study|Lack of Efficacy|0|||
23561421|NCT00642902|65786145|FG000|Overall Study|Death|1|||
23756914|NCT02713243|66489534|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
23756915|NCT02713243|66489533|FG000|Overall Study|Administrative problems|0|||
23756916|NCT02713243|66489534|FG001|Overall Study|Administrative problems|1|||
23756917|NCT02713243|66489533|FG000|Overall Study|Protocol deviation|0|||
23756918|NCT02713243|66489534|FG001|Overall Study|Protocol deviation|1|||
23756919|NCT00350519|66489535|FG000|Overall Study|Death|0|||
23756920|NCT00350519|66489536|FG001|Overall Study|Death|1|||
23756921|NCT00350519|66489535|FG000|Overall Study|Physician Decision|0|||
23756922|NCT00350519|66489536|FG001|Overall Study|Physician Decision|1|||
23756923|NCT00350519|66489535|FG000|Overall Study|Protocol Violation|1|||
23756924|NCT00350519|66489536|FG001|Overall Study|Protocol Violation|2|||
23756925|NCT00350519|66489535|FG000|Overall Study|Withdrawal by Subject|3|||
23756926|NCT00350519|66489536|FG001|Overall Study|Withdrawal by Subject|2|||
23756927|NCT00527397|66489537|FG000|Overall Study|Adverse Event|3|||
23438775|NCT00061633|65348650|FG000|Overall Study|Other|1|||
23756928|NCT00527397|66489537|FG000|Overall Study|Lack of Efficacy|1|||
23561422|NCT00642902|65786146|FG001|Overall Study|Death|0|||
23438776|NCT00061633|65348651|FG001|Overall Study|Other|1|||
23561423|NCT00642902|65786147|FG002|Overall Study|Death|0|||
23561424|NCT00642902|65786148|FG003|Overall Study|Death|0|||
23561425|NCT00642902|65786145|FG000|Overall Study|Premature termination of clinical trial|37|||
23561426|NCT00642902|65786146|FG001|Overall Study|Premature termination of clinical trial|32|||
23561427|NCT00642902|65786147|FG002|Overall Study|Premature termination of clinical trial|35|||
23561428|NCT00642902|65786148|FG003|Overall Study|Premature termination of clinical trial|35|||
23561429|NCT00642902|65786145|FG000|Overall Study|Randomized, but not treated|0|||
23561430|NCT00642902|65786146|FG001|Overall Study|Randomized, but not treated|0|||
23561431|NCT00642902|65786147|FG002|Overall Study|Randomized, but not treated|1|||
23561432|NCT00642902|65786148|FG003|Overall Study|Randomized, but not treated|0|||
23561433|NCT00642902|65786145|FG000|Overall Study|Other|1|||
23561434|NCT00642902|65786146|FG001|Overall Study|Other|5|||
23561435|NCT00642902|65786147|FG002|Overall Study|Other|1|||
23561436|NCT00642902|65786148|FG003|Overall Study|Other|4|||
23561437|NCT02567825|65786149|FG000|Overall Study|No follow-up post-randomization|5|||
23561438|NCT02567825|65786150|FG001|Overall Study|No follow-up post-randomization|1|||
23561439|NCT02567825|65786149|FG000|Overall Study|Follow-up less than 23 months|16|||
23561440|NCT02567825|65786150|FG001|Overall Study|Follow-up less than 23 months|20|||
23561441|NCT00885352|65786151|FG000|Overall Study|Adverse Event|2|||
23561442|NCT00885352|65786152|FG001|Overall Study|Adverse Event|3|||
23561443|NCT00885352|65786151|FG000|Overall Study|Lost to Follow-up|2|||
23561444|NCT00885352|65786152|FG001|Overall Study|Lost to Follow-up|2|||
23561445|NCT00885352|65786151|FG000|Overall Study|Physician Decision|0|||
23561446|NCT00885352|65786152|FG001|Overall Study|Physician Decision|3|||
23561447|NCT00885352|65786151|FG000|Overall Study|Protocol Violation|0|||
23561448|NCT00885352|65786152|FG001|Overall Study|Protocol Violation|2|||
23561449|NCT00885352|65786151|FG000|Overall Study|Withdrawal by Subject|1|||
23561450|NCT00885352|65786152|FG001|Overall Study|Withdrawal by Subject|5|||
23561451|NCT00885352|65786151|FG000|Overall Study|Contradiction to study medication|0|||
23561452|NCT00885352|65786152|FG001|Overall Study|Contradiction to study medication|2|||
23561453|NCT00885352|65786151|FG000|Overall Study|Excluded medication|2|||
23561454|NCT00885352|65786152|FG001|Overall Study|Excluded medication|2|||
23561455|NCT00885352|65786151|FG000|Overall Study|Lab abnormalities|1|||
23561456|NCT00885352|65786152|FG001|Overall Study|Lab abnormalities|1|||
23561457|NCT04006925|65786153|FG000|Overall Study|Side effects|2|||
23561458|NCT04006925|65786154|FG001|Overall Study|Side effects|0|||
23561459|NCT03333915|65786158|FG000|Overall Study|Lost to Follow-up|0|||
23561460|NCT03333915|65786159|FG001|Overall Study|Lost to Follow-up|0|||
23561461|NCT03333915|65786160|FG002|Overall Study|Lost to Follow-up|1|||
23561462|NCT03333915|65786161|FG003|Overall Study|Lost to Follow-up|0|||
23561463|NCT03333915|65786162|FG004|Overall Study|Lost to Follow-up|0|||
23561464|NCT03333915|65786158|FG000|Overall Study|Disease Progression|0|||
23561465|NCT03333915|65786159|FG001|Overall Study|Disease Progression|1|||
23561466|NCT03333915|65786160|FG002|Overall Study|Disease Progression|0|||
23561467|NCT03333915|65786161|FG003|Overall Study|Disease Progression|0|||
23561468|NCT03333915|65786162|FG004|Overall Study|Disease Progression|0|||
23561469|NCT03333915|65786158|FG000|Overall Study|Death|0|||
23561470|NCT03333915|65786159|FG001|Overall Study|Death|0|||
23561471|NCT03333915|65786160|FG002|Overall Study|Death|0|||
23561472|NCT03333915|65786161|FG003|Overall Study|Death|37|||
23561473|NCT03333915|65786162|FG004|Overall Study|Death|18|||
23561474|NCT03333915|65786158|FG000|Overall Study|Sponsor's Decision|0|||
23756929|NCT00527397|66489537|FG000|Overall Study|Protocol Violation|1|||
23756930|NCT00527397|66489537|FG000|Overall Study|Withdrawal by Subject|6|||
23756931|NCT00527397|66489537|FG000|Overall Study|Study terminated by sponsor|13|||
23756932|NCT02561000|66489538|FG000|Overall Study|Withdrawal by Subject|2|||
23756933|NCT02561000|66489539|FG001|Overall Study|Withdrawal by Subject|3|||
23756934|NCT02561000|66489540|FG002|Overall Study|Withdrawal by Subject|0|||
23756935|NCT02561000|66489538|FG000|Overall Study|Adverse Event|0|||
23756936|NCT02561000|66489539|FG001|Overall Study|Adverse Event|1|||
23756937|NCT02561000|66489540|FG002|Overall Study|Adverse Event|0|||
23756938|NCT01011907|66489541|FG000|Overall Study|Withdrawal by Subject|13|||
23756939|NCT01011907|66489542|FG001|Overall Study|Withdrawal by Subject|11|||
23756940|NCT01011907|66489541|FG000|Overall Study|Adverse Event|1|||
23561475|NCT03333915|65786159|FG001|Overall Study|Sponsor's Decision|0|||
23561476|NCT03333915|65786160|FG002|Overall Study|Sponsor's Decision|0|||
23561477|NCT03333915|65786161|FG003|Overall Study|Sponsor's Decision|48|||
23561478|NCT03333915|65786162|FG004|Overall Study|Sponsor's Decision|4|||
23561479|NCT03333915|65786158|FG000|Overall Study|Withdrawal by Subject|0|||
23561480|NCT03333915|65786159|FG001|Overall Study|Withdrawal by Subject|0|||
23561481|NCT03333915|65786160|FG002|Overall Study|Withdrawal by Subject|0|||
23561482|NCT03333915|65786161|FG003|Overall Study|Withdrawal by Subject|5|||
23561483|NCT03333915|65786162|FG004|Overall Study|Withdrawal by Subject|1|||
23561484|NCT00768430|65786163|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
23561485|NCT00768430|65786164|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
23561486|NCT02759185|65786167|FG000|Stage 1|Adverse Event|0|||
23756941|NCT01011907|66489542|FG001|Overall Study|Adverse Event|4|||
23756942|NCT02567266|66489543|FG000|Overall Study|Withdrawal by Subject|10|||
23625109|NCT01296555|66015393|FG001|Overall Study|Lost to Follow-up|0|||
23625110|NCT01296555|66015394|FG002|Overall Study|Lost to Follow-up|0|||
23625111|NCT01296555|66015395|FG003|Overall Study|Lost to Follow-up|0|||
23625112|NCT01296555|66015396|FG004|Overall Study|Lost to Follow-up|0|||
23625113|NCT01296555|66015397|FG005|Overall Study|Lost to Follow-up|0|||
23625114|NCT01296555|66015398|FG006|Overall Study|Lost to Follow-up|0|||
23625115|NCT01296555|66015399|FG007|Overall Study|Lost to Follow-up|0|||
23625116|NCT01296555|66015400|FG008|Overall Study|Lost to Follow-up|0|||
23625117|NCT01296555|66015401|FG009|Overall Study|Lost to Follow-up|0|||
23625118|NCT01296555|66015402|FG010|Overall Study|Lost to Follow-up|0|||
23625119|NCT01296555|66015403|FG011|Overall Study|Lost to Follow-up|0|||
23625120|NCT01296555|66015404|FG012|Overall Study|Lost to Follow-up|0|||
23625121|NCT01296555|66015405|FG013|Overall Study|Lost to Follow-up|0|||
23625122|NCT01296555|66015406|FG014|Overall Study|Lost to Follow-up|2|||
23625123|NCT01296555|66015407|FG015|Overall Study|Lost to Follow-up|1|||
23625124|NCT01296555|66015408|FG016|Overall Study|Lost to Follow-up|0|||
23625125|NCT01296555|66015409|FG017|Overall Study|Lost to Follow-up|2|||
23625126|NCT01296555|66015410|FG018|Overall Study|Lost to Follow-up|0|||
23625127|NCT01296555|66015411|FG019|Overall Study|Lost to Follow-up|2|||
23625128|NCT01296555|66015412|FG020|Overall Study|Lost to Follow-up|3|||
23625129|NCT01296555|66015413|FG021|Overall Study|Lost to Follow-up|2|||
23625130|NCT01296555|66015414|FG022|Overall Study|Lost to Follow-up|0|||
23625131|NCT01296555|66015415|FG023|Overall Study|Lost to Follow-up|0|||
23625132|NCT01296555|66015416|FG024|Overall Study|Lost to Follow-up|0|||
23625133|NCT01296555|66015417|FG025|Overall Study|Lost to Follow-up|0|||
23625134|NCT01296555|66015418|FG026|Overall Study|Lost to Follow-up|3|||
23625135|NCT01296555|66015419|FG027|Overall Study|Lost to Follow-up|13|||
23625136|NCT01296555|66015420|FG028|Overall Study|Lost to Follow-up|5|||
23826292|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826293|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826294|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826295|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826296|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826297|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826298|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826299|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
23826300|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826301|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23826302|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826303|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826304|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23826305|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826306|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826307|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826308|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826309|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826310|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23826311|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23826312|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23625137|NCT01296555|66015392|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23625138|NCT01296555|66015393|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23625139|NCT01296555|66015394|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23625140|NCT01296555|66015395|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23625141|NCT01296555|66015396|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23625142|NCT01296555|66015397|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23625143|NCT01296555|66015398|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23561487|NCT02759185|65786168|FG001|Stage 1|Adverse Event|1|||
23561488|NCT02759185|65786169|FG002|Stage 1|Adverse Event|3|||
23561489|NCT02759185|65786170|FG003|Stage 1|Adverse Event|0|||
23561490|NCT02759185|65786171|FG004|Stage 1|Adverse Event|0|||
23561491|NCT02759185|65786172|FG005|Stage 1|Adverse Event|0|||
23561492|NCT02759185|65786173|FG006|Stage 1|Adverse Event|0|||
23561493|NCT02759185|65786167|FG000|Stage 1|Withdrawal by Subject|1|||
23561494|NCT02759185|65786168|FG001|Stage 1|Withdrawal by Subject|0|||
23561495|NCT02759185|65786169|FG002|Stage 1|Withdrawal by Subject|0|||
23561496|NCT02759185|65786170|FG003|Stage 1|Withdrawal by Subject|0|||
23561497|NCT02759185|65786171|FG004|Stage 1|Withdrawal by Subject|0|||
23561498|NCT02759185|65786172|FG005|Stage 1|Withdrawal by Subject|0|||
23561499|NCT02759185|65786173|FG006|Stage 1|Withdrawal by Subject|0|||
23561500|NCT02759185|65786167|FG000|Stage 2|Adverse Event|0|||
23561501|NCT02759185|65786168|FG001|Stage 2|Adverse Event|0|||
23561502|NCT02759185|65786169|FG002|Stage 2|Adverse Event|0|||
23561503|NCT02759185|65786170|FG003|Stage 2|Adverse Event|0|||
23561504|NCT02759185|65786171|FG004|Stage 2|Adverse Event|1|||
23561505|NCT02759185|65786172|FG005|Stage 2|Adverse Event|2|||
23561506|NCT02759185|65786173|FG006|Stage 2|Adverse Event|0|||
23561507|NCT02759185|65786167|FG000|Stage 2|Withdrawal by Subject|0|||
23561508|NCT02759185|65786168|FG001|Stage 2|Withdrawal by Subject|0|||
23561509|NCT02759185|65786169|FG002|Stage 2|Withdrawal by Subject|0|||
23561510|NCT02759185|65786170|FG003|Stage 2|Withdrawal by Subject|0|||
23756943|NCT02567266|66489544|FG001|Overall Study|Withdrawal by Subject|7|||
23756944|NCT02567266|66489545|FG002|Overall Study|Withdrawal by Subject|6|||
23561511|NCT02759185|65786171|FG004|Stage 2|Withdrawal by Subject|1|||
23561512|NCT02759185|65786172|FG005|Stage 2|Withdrawal by Subject|1|||
23561513|NCT02759185|65786173|FG006|Stage 2|Withdrawal by Subject|1|||
23561514|NCT04207840|65786174|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
23561515|NCT04207840|65786175|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
23561516|NCT04207840|65786176|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
23561517|NCT04207840|65786174|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
23561518|NCT04207840|65786175|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
23561519|NCT04207840|65786176|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
23561520|NCT00612534|65786177|FG000|Overall Study|Adverse Event|0|||
23561521|NCT00612534|65786178|FG001|Overall Study|Adverse Event|4|||
23561522|NCT00612534|65786179|FG002|Overall Study|Adverse Event|2|||
23561523|NCT00612534|65786180|FG003|Overall Study|Adverse Event|1|||
23561524|NCT00612534|65786177|FG000|Overall Study|Lack of Efficacy|13|||
23561525|NCT00612534|65786178|FG001|Overall Study|Lack of Efficacy|12|||
23561526|NCT00612534|65786179|FG002|Overall Study|Lack of Efficacy|5|||
23756945|NCT02567266|66489543|FG000|Overall Study|Lost to Follow-up|13|||
23756946|NCT02567266|66489544|FG001|Overall Study|Lost to Follow-up|8|||
23756947|NCT02567266|66489545|FG002|Overall Study|Lost to Follow-up|10|||
23756948|NCT03672396|66489546|FG000|Overall Study|Withdrawal by Subject|4|||
23756949|NCT03672396|66489546|FG000|Overall Study|Physician Decision|1|||
23756950|NCT03672396|66489546|FG000|Overall Study|Adverse Event|1|||
23756951|NCT02598622|66489550|FG000|Overall Study|Withdrawal by Subject|3|||
23756952|NCT02598622|66489551|FG001|Overall Study|Withdrawal by Subject|0|||
23756953|NCT02598622|66489550|FG000|Overall Study|Physician Decision|3|||
23438777|NCT00061633|65348650|FG000|Overall Study|Never received study treatment|0|||
23561527|NCT00612534|65786180|FG003|Overall Study|Lack of Efficacy|16|||
23561528|NCT00612534|65786177|FG000|Overall Study|Other Reason|0|||
23561529|NCT00612534|65786178|FG001|Overall Study|Other Reason|1|||
23561530|NCT00612534|65786179|FG002|Overall Study|Other Reason|0|||
23561531|NCT00612534|65786180|FG003|Overall Study|Other Reason|0|||
23561532|NCT03315130|65786181|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23561533|NCT03315130|65786182|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
23561534|NCT03315130|65786183|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23561535|NCT03315130|65786184|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23438778|NCT00061633|65348651|FG001|Overall Study|Never received study treatment|2|||
23561536|NCT03315130|65786181|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561537|NCT03315130|65786182|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
23561538|NCT03315130|65786183|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561539|NCT03315130|65786184|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561540|NCT03315130|65786181|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
23561541|NCT03315130|65786182|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23561542|NCT03315130|65786183|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23756954|NCT02598622|66489551|FG001|Overall Study|Physician Decision|0|||
23756955|NCT00995488|66489552|FG000|Overall Study|Withdrawal by Subject|1|||
23756956|NCT03724916|66489559|FG000|Overall Study|Withdrawal by Subject|0|||
23561543|NCT03315130|65786184|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23561544|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23561545|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
23561546|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23756957|NCT03724916|66489560|FG001|Overall Study|Withdrawal by Subject|1|||
23826313|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826314|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826315|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23826316|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23826317|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23826318|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
23826319|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
23826320|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826321|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826322|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826323|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23438779|NCT03245775|65348652|FG000|Overall Study|Lost to Follow-up|25|||
23438780|NCT03245775|65348653|FG001|Overall Study|Lost to Follow-up|26|||
23438781|NCT03245775|65348654|FG002|Overall Study|Lost to Follow-up|16|||
23438782|NCT03245775|65348655|FG003|Overall Study|Lost to Follow-up|16|||
23561547|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23561548|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561549|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
23561550|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561551|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561552|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
23561553|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
23561554|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
23561555|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
23561556|NCT03474549|65786189|FG000|Overall Study|Death|31|||
23561557|NCT03474549|65786189|FG000|Overall Study|Lost to Follow-up|4|||
23756958|NCT03724916|66489561|FG002|Overall Study|Withdrawal by Subject|1|||
23756959|NCT03724916|66489562|FG003|Overall Study|Withdrawal by Subject|2|||
23756960|NCT03724916|66489559|FG000|Overall Study|Randomized but not Treated|1|||
23756961|NCT03724916|66489560|FG001|Overall Study|Randomized but not Treated|0|||
23756962|NCT03724916|66489561|FG002|Overall Study|Randomized but not Treated|0|||
23756963|NCT03724916|66489562|FG003|Overall Study|Randomized but not Treated|0|||
23756964|NCT04603937|66489563|FG000|Overall Study|Adverse Event|9|||
23756965|NCT04603937|66489564|FG001|Overall Study|Adverse Event|10|||
23756966|NCT04603937|66489563|FG000|Overall Study|Withdrawal by Subject|7|||
23756967|NCT04603937|66489564|FG001|Overall Study|Withdrawal by Subject|6|||
23756968|NCT04603937|66489563|FG000|Overall Study|Lost to Follow-up|5|||
23756969|NCT04603937|66489564|FG001|Overall Study|Lost to Follow-up|6|||
23756970|NCT04603937|66489563|FG000|Overall Study|Physician Decision|0|||
23756971|NCT04603937|66489564|FG001|Overall Study|Physician Decision|1|||
23756972|NCT04603937|66489563|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
23756973|NCT04603937|66489564|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
23756974|NCT01864525|66489565|FG000|Overall Study|Adverse Event|1|||
23756975|NCT01864525|66489566|FG001|Overall Study|Adverse Event|0|||
23756976|NCT00738920|66489569|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
23756977|NCT00738920|66489570|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
23756978|NCT00738920|66489571|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
23756979|NCT00738920|66489569|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
23826324|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826325|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23438783|NCT02464410|65348656|FG000|Overall Study|Death|3|||
23438784|NCT02464410|65348657|FG001|Overall Study|Death|4|||
23438785|NCT02464410|65348656|FG000|Overall Study|Lost to Follow-up|7|||
23438786|NCT02464410|65348657|FG001|Overall Study|Lost to Follow-up|9|||
23438787|NCT02464410|65348656|FG000|Overall Study|Withdrawal by Subject|12|||
23438788|NCT02464410|65348657|FG001|Overall Study|Withdrawal by Subject|3|||
23438789|NCT00940498|65348658|FG000|Overall Study|Death|2|||
23438790|NCT00940498|65348659|FG001|Overall Study|Death|0|||
23561558|NCT03474549|65786189|FG000|Overall Study|Withdrawal by Subject|2|||
23561559|NCT01782742|65786190|FG000|Double-blind Treatment Phase|Adverse Event|1|||
23561560|NCT01782742|65786191|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23756980|NCT00738920|66489570|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
23756981|NCT00738920|66489571|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
23826326|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23756982|NCT00738920|66489569|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
23438791|NCT00940498|65348660|FG002|Overall Study|Death|0|||
23438792|NCT00940498|65348661|FG003|Overall Study|Death|1|||
23438793|NCT00940498|65348662|FG004|Overall Study|Death|5|||
23561561|NCT02696902|65786192|FG000|Overall Study|Lost to Follow-up|0|||
23561562|NCT02696902|65786193|FG001|Overall Study|Lost to Follow-up|1|||
23438794|NCT00940498|65348663|FG005|Overall Study|Death|0|||
23438795|NCT00940498|65348664|FG006|Overall Study|Death|1|||
23438796|NCT00940498|65348665|FG007|Overall Study|Death|0|||
23438797|NCT00940498|65348658|FG000|Overall Study|Lost to Follow-up|1|||
23438798|NCT00940498|65348659|FG001|Overall Study|Lost to Follow-up|1|||
23438799|NCT00940498|65348660|FG002|Overall Study|Lost to Follow-up|2|||
23438800|NCT00940498|65348661|FG003|Overall Study|Lost to Follow-up|0|||
23438801|NCT00940498|65348662|FG004|Overall Study|Lost to Follow-up|1|||
23438802|NCT00940498|65348663|FG005|Overall Study|Lost to Follow-up|0|||
23438803|NCT00940498|65348664|FG006|Overall Study|Lost to Follow-up|0|||
23438804|NCT00940498|65348665|FG007|Overall Study|Lost to Follow-up|1|||
23438805|NCT00940498|65348658|FG000|Overall Study|Disease Progression|0|||
23438806|NCT00940498|65348659|FG001|Overall Study|Disease Progression|0|||
23438807|NCT00940498|65348660|FG002|Overall Study|Disease Progression|1|||
23438808|NCT00940498|65348661|FG003|Overall Study|Disease Progression|1|||
23438809|NCT00940498|65348662|FG004|Overall Study|Disease Progression|0|||
23438810|NCT00940498|65348663|FG005|Overall Study|Disease Progression|1|||
23438811|NCT00940498|65348664|FG006|Overall Study|Disease Progression|0|||
23438812|NCT00940498|65348665|FG007|Overall Study|Disease Progression|0|||
23438813|NCT00940498|65348658|FG000|Overall Study|Physician Decision|0|||
23438814|NCT00940498|65348659|FG001|Overall Study|Physician Decision|0|||
23438815|NCT00940498|65348660|FG002|Overall Study|Physician Decision|0|||
23438816|NCT00940498|65348661|FG003|Overall Study|Physician Decision|0|||
23438817|NCT00940498|65348662|FG004|Overall Study|Physician Decision|2|||
23438818|NCT00940498|65348663|FG005|Overall Study|Physician Decision|0|||
23438819|NCT00940498|65348664|FG006|Overall Study|Physician Decision|0|||
23438820|NCT00940498|65348665|FG007|Overall Study|Physician Decision|0|||
23438821|NCT00940498|65348658|FG000|Overall Study|Not treated due to disease related pain|0|||
23438822|NCT00940498|65348659|FG001|Overall Study|Not treated due to disease related pain|0|||
23438823|NCT00940498|65348660|FG002|Overall Study|Not treated due to disease related pain|0|||
23438824|NCT00940498|65348661|FG003|Overall Study|Not treated due to disease related pain|0|||
23438825|NCT00940498|65348662|FG004|Overall Study|Not treated due to disease related pain|1|||
23438826|NCT00940498|65348663|FG005|Overall Study|Not treated due to disease related pain|0|||
23438827|NCT00940498|65348664|FG006|Overall Study|Not treated due to disease related pain|0|||
23438828|NCT00940498|65348665|FG007|Overall Study|Not treated due to disease related pain|0|||
23438829|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
23438830|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
23438831|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
23438832|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Death|0|||
23438833|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Death|2|||
23756983|NCT00738920|66489570|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
23756984|NCT00738920|66489571|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
23561563|NCT02696902|65786194|FG002|Overall Study|Lost to Follow-up|1|||
23756985|NCT00738920|66489569|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
23756986|NCT00738920|66489570|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
23756987|NCT00738920|66489571|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
23756988|NCT00738920|66489569|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
23756989|NCT00738920|66489570|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
23438834|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Death|0|||
23438835|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
23438836|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
23438837|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
23438838|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
23438839|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
23438840|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
23438841|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
23438842|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
23438843|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
23756990|NCT00738920|66489571|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
23756991|NCT00738920|66489569|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
23756992|NCT00738920|66489570|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
23756993|NCT00738920|66489571|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
23756994|NCT00738920|66489569|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
23756995|NCT00738920|66489570|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
23756996|NCT00738920|66489571|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
23438844|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
23561564|NCT02696902|65786192|FG000|Overall Study|Withdrawal by Subject|0|||
23756997|NCT00738920|66489569|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
23756998|NCT00738920|66489570|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
23561565|NCT02696902|65786193|FG001|Overall Study|Withdrawal by Subject|0|||
23561566|NCT02696902|65786194|FG002|Overall Study|Withdrawal by Subject|1|||
23561567|NCT02696902|65786192|FG000|Overall Study|Death|19|||
23561568|NCT02696902|65786193|FG001|Overall Study|Death|3|||
23561569|NCT02696902|65786194|FG002|Overall Study|Death|24|||
23561570|NCT02696902|65786192|FG000|Overall Study|Participant not fit post-randomization|0|||
23756999|NCT00738920|66489571|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
23438845|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
23757000|NCT00738920|66489569|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
23438846|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
23561571|NCT02696902|65786193|FG001|Overall Study|Participant not fit post-randomization|0|||
23561572|NCT02696902|65786194|FG002|Overall Study|Participant not fit post-randomization|1|||
23561573|NCT02696902|65786192|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
23561574|NCT02696902|65786193|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
23561575|NCT02696902|65786194|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
23561576|NCT02696902|65786192|FG000|Overall Study|Principal investigator's decision|1|||
23561577|NCT02696902|65786193|FG001|Overall Study|Principal investigator's decision|0|||
23561578|NCT02696902|65786194|FG002|Overall Study|Principal investigator's decision|0|||
23561579|NCT02696902|65786192|FG000|Overall Study|Sponsor's decision|1|||
23561580|NCT02696902|65786193|FG001|Overall Study|Sponsor's decision|0|||
23561581|NCT02696902|65786194|FG002|Overall Study|Sponsor's decision|0|||
23561582|NCT02696902|65786192|FG000|Overall Study|Transferred to other hospital|1|||
23561583|NCT02696902|65786193|FG001|Overall Study|Transferred to other hospital|0|||
23561584|NCT02696902|65786194|FG002|Overall Study|Transferred to other hospital|0|||
23561585|NCT01392300|65786195|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
23561586|NCT01392300|65786196|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
23625144|NCT01296555|66015399|FG007|Overall Study|Non-Compliance With Study Drug|1|||
23438847|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
23438848|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
23438849|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
23438850|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Recovery|1|||
23438851|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Recovery|0|||
23438852|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Recovery|1|||
23438853|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
23438854|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
23438855|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
23438856|NCT00195663|65348666|FG000|Open-Label Extension Period|Adverse Event|21|||
23438857|NCT00195663|65348667|FG001|Open-Label Extension Period|Adverse Event|32|||
23438858|NCT00195663|65348668|FG002|Open-Label Extension Period|Adverse Event|36|||
23438859|NCT00195663|65348666|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
23438860|NCT00195663|65348667|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
23438861|NCT00195663|65348668|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
23438862|NCT00195663|65348666|FG000|Open-Label Extension Period|Recovery|0|||
23438863|NCT00195663|65348667|FG001|Open-Label Extension Period|Recovery|2|||
23438864|NCT00195663|65348668|FG002|Open-Label Extension Period|Recovery|2|||
23438865|NCT00195663|65348666|FG000|Open-Label Extension Period|Protocol Violation|3|||
23438866|NCT00195663|65348667|FG001|Open-Label Extension Period|Protocol Violation|4|||
23438867|NCT00195663|65348668|FG002|Open-Label Extension Period|Protocol Violation|4|||
23438868|NCT00195663|65348666|FG000|Open-Label Extension Period|Death|2|||
23438869|NCT00195663|65348667|FG001|Open-Label Extension Period|Death|2|||
23438870|NCT00195663|65348668|FG002|Open-Label Extension Period|Death|2|||
23438871|NCT00195663|65348666|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
23438872|NCT00195663|65348667|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
23438873|NCT00195663|65348668|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
23438874|NCT00195663|65348666|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
23625145|NCT01296555|66015400|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23625146|NCT01296555|66015401|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23438875|NCT00195663|65348667|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
23561587|NCT01392300|65786197|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
23561588|NCT01392300|65786195|FG000|Main Period (MP)|Withdrawal by Subject|5|||
23561589|NCT01392300|65786196|FG001|Main Period (MP)|Withdrawal by Subject|1|||
23625147|NCT01296555|66015402|FG010|Overall Study|Non-Compliance With Study Drug|0|||
23438876|NCT00195663|65348668|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
23438877|NCT00195663|65348666|FG000|Open-Label Extension Period|Administrative reasons|11|||
23438878|NCT00195663|65348667|FG001|Open-Label Extension Period|Administrative reasons|11|||
23438879|NCT00195663|65348668|FG002|Open-Label Extension Period|Administrative reasons|13|||
23438880|NCT03304873|65348669|FG000|Overall Study|Lost to Follow-up|1|||
23438881|NCT03304873|65348670|FG001|Overall Study|Lost to Follow-up|8|||
23438882|NCT01817959|65348671|FG000|Overall Study|Graft loss|1|||
23438883|NCT01817959|65348672|FG001|Overall Study|Graft loss|1|||
23438884|NCT01817959|65348671|FG000|Overall Study|forbidden medication|1|||
23438885|NCT01817959|65348672|FG001|Overall Study|forbidden medication|1|||
23438886|NCT01817959|65348671|FG000|Overall Study|Adverse Event|1|||
23438887|NCT01817959|65348672|FG001|Overall Study|Adverse Event|0|||
23438888|NCT01817959|65348671|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
23438889|NCT01817959|65348672|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
23438890|NCT01912339|65348675|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
23438891|NCT01912339|65348676|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
23438892|NCT01912339|65348677|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
23438893|NCT01912339|65348675|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
23438894|NCT01912339|65348676|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
23438895|NCT01912339|65348677|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
23438896|NCT01912339|65348675|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
23438897|NCT01912339|65348676|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
23438898|NCT01912339|65348677|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
23438899|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
23438900|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
23438901|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
23438902|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
23438903|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
23438904|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
23438905|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
23438906|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
23438907|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
23438908|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
23438909|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
23438910|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
23438911|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
23438912|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
23438913|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
23438914|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
23438915|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
23438916|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
23438917|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
23438918|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
23438919|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
23438920|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
23438921|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
23438922|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
23438923|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
23438924|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
23438925|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
23438926|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
23438927|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
23438928|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
23438929|NCT03878758|65348680|FG000|Overall Study|Withdrawal by Subject|1|||
23438930|NCT03878758|65348680|FG000|Overall Study|Protocol defined|2|||
23438931|NCT03878758|65348680|FG000|Overall Study|Improper consent documentation|1|||
23438932|NCT01069705|65348681|FG000|Overall Study|Adverse Event|1|||
23438933|NCT01069705|65348681|FG000|Overall Study|Withdrawal by Subject|2|||
23438934|NCT02577016|65348682|FG000|Overall Study|Adverse Event|2|||
23438935|NCT02577016|65348683|FG001|Overall Study|Adverse Event|1|||
23826327|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826328|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826329|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23438936|NCT02577016|65348682|FG000|Overall Study|Physician Decision|0|||
23438937|NCT02577016|65348683|FG001|Overall Study|Physician Decision|1|||
23438938|NCT04294147|65348684|FG000|Overall Study|Protocol Violation|2|||
23438939|NCT04294147|65348685|FG001|Overall Study|Protocol Violation|0|||
23438940|NCT01023672|65348690|FG000|Overall Study|Worsening disease|2|||
23438941|NCT01023672|65348690|FG000|Overall Study|Death|1|||
23438942|NCT01068769|65348691|FG000|Overall Study|Ineligible|1|||
23438943|NCT02783599|65348692|FG000|Overall Study|Progressive disease|23|||
23438944|NCT02783599|65348692|FG000|Overall Study|Surgical Resection|10|||
23438945|NCT02783599|65348692|FG000|Overall Study|Adverse Event|4|||
23826330|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23826331|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826332|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826333|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23826334|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23826335|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23438946|NCT02783599|65348692|FG000|Overall Study|Physician Decision|2|||
23438947|NCT02783599|65348692|FG000|Overall Study|Death|1|||
23561590|NCT01392300|65786197|FG002|Main Period (MP)|Withdrawal by Subject|0|||
23561591|NCT01392300|65786195|FG000|Main Period (MP)|Lost to Follow-up|3|||
23561592|NCT01392300|65786196|FG001|Main Period (MP)|Lost to Follow-up|3|||
23561593|NCT01392300|65786197|FG002|Main Period (MP)|Lost to Follow-up|0|||
23438948|NCT02188849|65348693|FG000|Overall Study|Lost to Follow-up|3|||
23438949|NCT02188849|65348694|FG001|Overall Study|Lost to Follow-up|8|||
23438950|NCT00619307|65348696|FG000|Overall Study|Adverse Event|0|||
23438951|NCT00619307|65348697|FG001|Overall Study|Adverse Event|1|||
23438952|NCT00619307|65348696|FG000|Overall Study|Lost to Follow-up|0|||
23438953|NCT00619307|65348697|FG001|Overall Study|Lost to Follow-up|1|||
23438954|NCT00619307|65348696|FG000|Overall Study|Protocol Violation|3|||
23438955|NCT00619307|65348697|FG001|Overall Study|Protocol Violation|0|||
23438956|NCT00619307|65348696|FG000|Overall Study|Withdrew consent|1|||
23438957|NCT00619307|65348697|FG001|Overall Study|Withdrew consent|0|||
23438958|NCT00619307|65348696|FG000|Overall Study|Severe migraine|0|||
23438959|NCT00619307|65348697|FG001|Overall Study|Severe migraine|1|||
23438960|NCT00619307|65348696|FG000|Overall Study|MS attack plus steroids|0|||
23438961|NCT00619307|65348697|FG001|Overall Study|MS attack plus steroids|1|||
23438962|NCT01045694|65348698|FG000|Overall Study|Withdrawal by Subject|2|||
23438963|NCT01153724|65348701|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23438964|NCT01153724|65348701|FG000|Treatment Period 2|Adverse Event|1|||
23438965|NCT01153724|65348701|FG000|Treatment Period 2|Other reason not defined above|1|||
23438966|NCT02504580|65348708|FG000|Overall Study|Other|1|||
23438967|NCT02504580|65348709|FG001|Overall Study|Other|0|||
23438968|NCT02504580|65348710|FG002|Overall Study|Other|0|||
23438969|NCT02504580|65348711|FG003|Overall Study|Other|2|||
23438970|NCT02504580|65348712|FG004|Overall Study|Other|1|||
23438971|NCT02504580|65348713|FG005|Overall Study|Other|1|||
23438972|NCT02504580|65348714|FG006|Overall Study|Other|1|||
23438973|NCT02504580|65348715|FG007|Overall Study|Other|2|||
23438974|NCT02504580|65348716|FG008|Overall Study|Other|0|||
23438975|NCT02504580|65348717|FG009|Overall Study|Other|0|||
23561594|NCT01392300|65786195|FG000|Main Period (MP)|Non-compliance|1|||
23561595|NCT01392300|65786196|FG001|Main Period (MP)|Non-compliance|0|||
23561596|NCT01392300|65786197|FG002|Main Period (MP)|Non-compliance|0|||
23561597|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
23561598|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
23561599|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
23561600|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
23561601|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
23561602|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
23561603|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
23561604|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
23561605|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
23561606|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Death|0|||
23561607|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Death|0|||
23561608|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Death|4|||
23561609|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
23438976|NCT02504580|65348718|FG010|Overall Study|Other|0|||
23438977|NCT02504580|65348719|FG011|Overall Study|Other|2|||
23438978|NCT02504580|65348708|FG000|Overall Study|Subject refusal to continue|0|||
23561610|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
23561611|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
23438979|NCT02504580|65348709|FG001|Overall Study|Subject refusal to continue|1|||
23438980|NCT02504580|65348710|FG002|Overall Study|Subject refusal to continue|0|||
23438981|NCT02504580|65348711|FG003|Overall Study|Subject refusal to continue|0|||
23438982|NCT02504580|65348712|FG004|Overall Study|Subject refusal to continue|0|||
23438983|NCT02504580|65348713|FG005|Overall Study|Subject refusal to continue|0|||
23438984|NCT02504580|65348714|FG006|Overall Study|Subject refusal to continue|0|||
23438985|NCT02504580|65348715|FG007|Overall Study|Subject refusal to continue|0|||
23438986|NCT02504580|65348716|FG008|Overall Study|Subject refusal to continue|0|||
23438987|NCT02504580|65348717|FG009|Overall Study|Subject refusal to continue|0|||
23438988|NCT02504580|65348718|FG010|Overall Study|Subject refusal to continue|0|||
23438989|NCT02504580|65348719|FG011|Overall Study|Subject refusal to continue|0|||
23438990|NCT00604695|65348721|FG000|Overall Study|Did not receive first bolus.|0|||
23438991|NCT00604695|65348722|FG001|Overall Study|Did not receive first bolus.|4|||
23438992|NCT01887353|65348725|FG000|Overall Study|Study stopped early|4|||
23438993|NCT01887353|65348726|FG001|Overall Study|Study stopped early|3|||
23438994|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
23438995|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
23438996|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
23438997|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
23438998|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
23438999|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
23439000|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
23439001|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
23439002|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
23439003|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
23439004|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
23439005|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
23625148|NCT01296555|66015403|FG011|Overall Study|Non-Compliance With Study Drug|0|||
23625149|NCT01296555|66015404|FG012|Overall Study|Non-Compliance With Study Drug|0|||
23826336|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826337|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826338|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826339|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826340|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826341|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826342|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23625150|NCT01296555|66015405|FG013|Overall Study|Non-Compliance With Study Drug|0|||
23625151|NCT01296555|66015406|FG014|Overall Study|Non-Compliance With Study Drug|0|||
23625152|NCT01296555|66015407|FG015|Overall Study|Non-Compliance With Study Drug|0|||
23625153|NCT01296555|66015408|FG016|Overall Study|Non-Compliance With Study Drug|0|||
23625154|NCT01296555|66015409|FG017|Overall Study|Non-Compliance With Study Drug|0|||
23625155|NCT01296555|66015410|FG018|Overall Study|Non-Compliance With Study Drug|0|||
23625156|NCT01296555|66015411|FG019|Overall Study|Non-Compliance With Study Drug|0|||
23625157|NCT01296555|66015412|FG020|Overall Study|Non-Compliance With Study Drug|0|||
23625158|NCT01296555|66015413|FG021|Overall Study|Non-Compliance With Study Drug|0|||
23625159|NCT01296555|66015414|FG022|Overall Study|Non-Compliance With Study Drug|0|||
23625160|NCT01296555|66015415|FG023|Overall Study|Non-Compliance With Study Drug|0|||
23625161|NCT01296555|66015416|FG024|Overall Study|Non-Compliance With Study Drug|0|||
23625162|NCT01296555|66015417|FG025|Overall Study|Non-Compliance With Study Drug|0|||
23625163|NCT01296555|66015418|FG026|Overall Study|Non-Compliance With Study Drug|0|||
23625164|NCT01296555|66015419|FG027|Overall Study|Non-Compliance With Study Drug|0|||
23625165|NCT01296555|66015420|FG028|Overall Study|Non-Compliance With Study Drug|0|||
23625166|NCT01296555|66015392|FG000|Overall Study|Withdrawal by Subject|0|||
23625167|NCT01296555|66015393|FG001|Overall Study|Withdrawal by Subject|0|||
23625168|NCT01296555|66015394|FG002|Overall Study|Withdrawal by Subject|0|||
23625169|NCT01296555|66015395|FG003|Overall Study|Withdrawal by Subject|0|||
23625170|NCT01296555|66015396|FG004|Overall Study|Withdrawal by Subject|1|||
23625171|NCT01296555|66015397|FG005|Overall Study|Withdrawal by Subject|0|||
23625172|NCT01296555|66015398|FG006|Overall Study|Withdrawal by Subject|1|||
23625173|NCT01296555|66015399|FG007|Overall Study|Withdrawal by Subject|0|||
23625174|NCT01296555|66015400|FG008|Overall Study|Withdrawal by Subject|0|||
23625175|NCT01296555|66015401|FG009|Overall Study|Withdrawal by Subject|0|||
23625176|NCT01296555|66015402|FG010|Overall Study|Withdrawal by Subject|1|||
23625177|NCT01296555|66015403|FG011|Overall Study|Withdrawal by Subject|1|||
23625178|NCT01296555|66015404|FG012|Overall Study|Withdrawal by Subject|0|||
23625179|NCT01296555|66015405|FG013|Overall Study|Withdrawal by Subject|0|||
23625180|NCT01296555|66015406|FG014|Overall Study|Withdrawal by Subject|3|||
23625181|NCT01296555|66015407|FG015|Overall Study|Withdrawal by Subject|0|||
23625182|NCT01296555|66015408|FG016|Overall Study|Withdrawal by Subject|2|||
23625183|NCT01296555|66015409|FG017|Overall Study|Withdrawal by Subject|1|||
23826343|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23826344|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826345|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23826346|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
23439006|NCT01971008|65348729|FG000|Overall Study|Protocol Violation|2|||
23625184|NCT01296555|66015410|FG018|Overall Study|Withdrawal by Subject|0|||
23625185|NCT01296555|66015411|FG019|Overall Study|Withdrawal by Subject|1|||
23625186|NCT01296555|66015412|FG020|Overall Study|Withdrawal by Subject|1|||
23625187|NCT01296555|66015413|FG021|Overall Study|Withdrawal by Subject|1|||
23625188|NCT01296555|66015414|FG022|Overall Study|Withdrawal by Subject|3|||
23625189|NCT01296555|66015415|FG023|Overall Study|Withdrawal by Subject|0|||
23439007|NCT01971008|65348730|FG001|Overall Study|Protocol Violation|1|||
23439008|NCT04207060|65348731|FG000|Overall Study|Lost to Follow-up|2|||
23439009|NCT04207060|65348732|FG001|Overall Study|Lost to Follow-up|0|||
23439010|NCT04378114|65348735|FG000|Overall Study|Withdrawal by Subject|5|||
23439011|NCT00989963|65348736|FG000|Overall Study|Adverse Event|1|||
23439012|NCT00989963|65348737|FG001|Overall Study|Adverse Event|1|||
23439013|NCT00989963|65348738|FG002|Overall Study|Adverse Event|1|||
23439014|NCT02465203|65348743|FG000|Overall Study|Protocol Violation|1|||
23439015|NCT02465203|65348744|FG001|Overall Study|Protocol Violation|1|||
23439016|NCT02465203|65348745|FG002|Overall Study|Protocol Violation|1|||
23439017|NCT02465203|65348743|FG000|Overall Study|Study terminated by sponsor|50|||
23439018|NCT02465203|65348744|FG001|Overall Study|Study terminated by sponsor|34|||
23439019|NCT02465203|65348745|FG002|Overall Study|Study terminated by sponsor|11|||
23439020|NCT02465203|65348743|FG000|Overall Study|New therapy for study indication|4|||
23439021|NCT02465203|65348744|FG001|Overall Study|New therapy for study indication|0|||
23439022|NCT02465203|65348745|FG002|Overall Study|New therapy for study indication|0|||
23439023|NCT02465203|65348743|FG000|Overall Study|Patient/guardian decision|1|||
23439024|NCT02465203|65348744|FG001|Overall Study|Patient/guardian decision|1|||
23439025|NCT02465203|65348745|FG002|Overall Study|Patient/guardian decision|1|||
23439026|NCT00615992|65348751|FG000|Overall Study|Protocol Violation|67|||
23439027|NCT02560012|65348752|FG000|Overall Study|Study Terminated|2|||
23439028|NCT00151476|65348756|FG000|FAP Identified Subjects|Protocol Violation|0|||
23439029|NCT00151476|65348757|FG001|FAP Identified Subjects|Protocol Violation|1|||
23439030|NCT00151476|65348756|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
23439031|NCT00151476|65348757|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
23439032|NCT00151476|65348756|FG000|FAP Analyzed Subjects|Other study participation|0|||
23439033|NCT00151476|65348757|FG001|FAP Analyzed Subjects|Other study participation|1|||
23439034|NCT00151372|65348763|FG000|Overall Study|Death|12|||
23439035|NCT00151372|65348764|FG001|Overall Study|Death|11|||
23439036|NCT00151372|65348763|FG000|Overall Study|Lost to Follow-up|5|||
23439037|NCT00151372|65348764|FG001|Overall Study|Lost to Follow-up|5|||
23439038|NCT00151372|65348763|FG000|Overall Study|Too sick medically to continue|5|||
23439039|NCT00151372|65348764|FG001|Overall Study|Too sick medically to continue|6|||
23439040|NCT00151372|65348763|FG000|Overall Study|Withdrawal by Subject|7|||
23439041|NCT00151372|65348764|FG001|Overall Study|Withdrawal by Subject|7|||
23439042|NCT01345669|65348765|FG000|Overall Study|Primary tumour recurrence|53|||
23439043|NCT01345669|65348766|FG001|Overall Study|Primary tumour recurrence|32|||
23439044|NCT01345669|65348765|FG000|Overall Study|Second primary tumour|4|||
23439045|NCT01345669|65348766|FG001|Overall Study|Second primary tumour|3|||
23439046|NCT01345669|65348765|FG000|Overall Study|Adverse Event|63|||
23439047|NCT01345669|65348766|FG001|Overall Study|Adverse Event|9|||
23439048|NCT01345669|65348765|FG000|Overall Study|Protocol Violation|3|||
23439049|NCT01345669|65348766|FG001|Overall Study|Protocol Violation|1|||
23439050|NCT01345669|65348765|FG000|Overall Study|Lost to Follow-up|1|||
23439051|NCT01345669|65348766|FG001|Overall Study|Lost to Follow-up|1|||
23439052|NCT01345669|65348765|FG000|Overall Study|Withdrawal by Subject|52|||
23439053|NCT01345669|65348766|FG001|Overall Study|Withdrawal by Subject|13|||
23439054|NCT01345669|65348765|FG000|Overall Study|Other Reasons|111|||
23439055|NCT01345669|65348766|FG001|Overall Study|Other Reasons|60|||
23439056|NCT03364738|65348767|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
23439057|NCT03364738|65348767|FG000|Overall Study|Withdrawal by Subject|1|||
23439058|NCT03364738|65348767|FG000|Overall Study|Adverse Event|1|||
23439059|NCT01990612|65348768|FG000|Overall Study|Lost to Follow-up|2|||
23439060|NCT01990612|65348769|FG001|Overall Study|Lost to Follow-up|1|||
23439061|NCT01990612|65348768|FG000|Overall Study|Withdrawal by Subject|5|||
23439062|NCT01990612|65348769|FG001|Overall Study|Withdrawal by Subject|2|||
23439063|NCT02593825|65348774|FG000|Intervention|Lost to Follow-up|10|||
23439064|NCT02593825|65348775|FG001|Intervention|Lost to Follow-up|12|||
23439065|NCT01815840|65348779|FG000|Overall Study|Missing|1|||
23439066|NCT01815840|65348780|FG001|Overall Study|Missing|0|||
23439067|NCT01815840|65348779|FG000|Overall Study|Withdrew Consent|31|||
23439068|NCT01815840|65348780|FG001|Overall Study|Withdrew Consent|30|||
23625190|NCT01296555|66015416|FG024|Overall Study|Withdrawal by Subject|0|||
23625191|NCT01296555|66015417|FG025|Overall Study|Withdrawal by Subject|0|||
23625192|NCT01296555|66015418|FG026|Overall Study|Withdrawal by Subject|8|||
23439069|NCT01815840|65348779|FG000|Overall Study|Administrative/Other|1|||
23439070|NCT01815840|65348780|FG001|Overall Study|Administrative/Other|3|||
23439071|NCT01815840|65348779|FG000|Overall Study|Adverse Event|10|||
23439072|NCT01815840|65348780|FG001|Overall Study|Adverse Event|16|||
23439073|NCT01815840|65348779|FG000|Overall Study|Death|2|||
23439074|NCT01815840|65348780|FG001|Overall Study|Death|2|||
23439075|NCT01815840|65348779|FG000|Overall Study|Disease progression|3|||
23439076|NCT01815840|65348780|FG001|Overall Study|Disease progression|2|||
23439077|NCT01815840|65348779|FG000|Overall Study|Investigators Decision|2|||
23439078|NCT01815840|65348780|FG001|Overall Study|Investigators Decision|3|||
23439079|NCT01815840|65348779|FG000|Overall Study|Lost to Follow-up|3|||
23439080|NCT01815840|65348780|FG001|Overall Study|Lost to Follow-up|6|||
23439081|NCT01815840|65348779|FG000|Overall Study|Refused Treatment|5|||
23439082|NCT01815840|65348780|FG001|Overall Study|Refused Treatment|1|||
23439083|NCT01815840|65348779|FG000|Overall Study|Sponsor Termination Treatment|1|||
23439084|NCT01815840|65348780|FG001|Overall Study|Sponsor Termination Treatment|0|||
23439085|NCT00646399|65348781|FG000|Overall Study|Death|63|||
23439086|NCT00646399|65348782|FG001|Overall Study|Death|53|||
23439087|NCT00646399|65348781|FG000|Overall Study|Withdrawal by Subject|9|||
23439088|NCT00646399|65348782|FG001|Overall Study|Withdrawal by Subject|10|||
23439089|NCT00646399|65348781|FG000|Overall Study|Other Reason|11|||
23439090|NCT00646399|65348782|FG001|Overall Study|Other Reason|11|||
23439091|NCT04072887|65348783|FG000|Overall Study|Withdrawal by Subject|3|||
23439092|NCT04072887|65348784|FG001|Overall Study|Withdrawal by Subject|8|||
23439093|NCT04072887|65348785|FG002|Overall Study|Withdrawal by Subject|1|||
23439094|NCT04072887|65348786|FG003|Overall Study|Withdrawal by Subject|3|||
23439095|NCT04072887|65348787|FG004|Overall Study|Withdrawal by Subject|3|||
23439096|NCT04072887|65348788|FG005|Overall Study|Withdrawal by Subject|13|||
23439097|NCT04072887|65348783|FG000|Overall Study|Adverse Event|2|||
23439098|NCT04072887|65348784|FG001|Overall Study|Adverse Event|4|||
23439099|NCT04072887|65348785|FG002|Overall Study|Adverse Event|1|||
23439100|NCT04072887|65348786|FG003|Overall Study|Adverse Event|4|||
23439101|NCT04072887|65348787|FG004|Overall Study|Adverse Event|0|||
23439102|NCT04072887|65348788|FG005|Overall Study|Adverse Event|1|||
23439103|NCT04072887|65348783|FG000|Overall Study|Physician Decision|2|||
23439104|NCT04072887|65348784|FG001|Overall Study|Physician Decision|0|||
23439105|NCT04072887|65348785|FG002|Overall Study|Physician Decision|0|||
23439106|NCT04072887|65348786|FG003|Overall Study|Physician Decision|0|||
23439107|NCT04072887|65348787|FG004|Overall Study|Physician Decision|0|||
23439108|NCT04072887|65348788|FG005|Overall Study|Physician Decision|1|||
23439109|NCT04072887|65348783|FG000|Overall Study|Lost to Follow-up|1|||
23439110|NCT04072887|65348784|FG001|Overall Study|Lost to Follow-up|3|||
23439111|NCT04072887|65348785|FG002|Overall Study|Lost to Follow-up|0|||
23439112|NCT04072887|65348786|FG003|Overall Study|Lost to Follow-up|0|||
23439113|NCT04072887|65348787|FG004|Overall Study|Lost to Follow-up|0|||
23439114|NCT04072887|65348788|FG005|Overall Study|Lost to Follow-up|0|||
23439115|NCT04072887|65348783|FG000|Overall Study|Death|0|||
23439116|NCT04072887|65348784|FG001|Overall Study|Death|2|||
23439117|NCT04072887|65348785|FG002|Overall Study|Death|0|||
23439118|NCT04072887|65348786|FG003|Overall Study|Death|2|||
23439119|NCT04072887|65348787|FG004|Overall Study|Death|3|||
23439120|NCT04072887|65348788|FG005|Overall Study|Death|0|||
23439121|NCT00296140|65352311|FG000|Overall Study|Lost to Follow-up|1|||
23439122|NCT00296140|65352312|FG001|Overall Study|Lost to Follow-up|0|||
23439123|NCT00296140|65352311|FG000|Overall Study|Withdrawal by Subject|1|||
23439124|NCT00296140|65352312|FG001|Overall Study|Withdrawal by Subject|0|||
23439125|NCT00296140|65352311|FG000|Overall Study|Discharge to Nursing Home|1|||
23439126|NCT00296140|65352312|FG001|Overall Study|Discharge to Nursing Home|0|||
23439127|NCT02006979|65352313|FG000|Overall Study|Withdrawal by Subject|1|||
23439128|NCT02006979|65352314|FG001|Overall Study|Withdrawal by Subject|1|||
23439129|NCT02006979|65352313|FG000|Overall Study|Protocol Violation|0|||
23439130|NCT02006979|65352314|FG001|Overall Study|Protocol Violation|1|||
23439131|NCT00411632|65352315|FG000|Overall Study|Death|1|||
23439132|NCT00794950|65352317|FG000|BCG Induction|Withdrawal by Subject|2|||
23439133|NCT00794950|65352317|FG000|BCG Induction|ineligible|3|||
23439134|NCT00794950|65352317|FG000|BCG Induction|noncompliant w. BCG|1|||
23439135|NCT00794950|65352317|FG000|BCG Induction|Adverse Event|1|||
23439136|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
23439137|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
23439138|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
23439139|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
23757001|NCT00738920|66489570|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
23757002|NCT00738920|66489571|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
23757003|NCT00738920|66489569|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
23439140|NCT01266590|65352318|FG000|Overall Study|Adverse Event|3|||
23439141|NCT01266590|65352318|FG000|Overall Study|Lost to Follow-up|1|||
23757004|NCT00738920|66489570|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
23757005|NCT00738920|66489571|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
23439142|NCT01266590|65352318|FG000|Overall Study|Withdrawal by Subject|1|||
23439143|NCT01266590|65352318|FG000|Overall Study|Physician Decision|1|||
23439144|NCT02241343|65352319|FG000|Overall Study|Adverse Event|1|||
23439145|NCT02328027|65352320|FG000|Overall Study|Withdrawal by Subject|0|||
23439146|NCT02328027|65352321|FG001|Overall Study|Withdrawal by Subject|1|||
23439147|NCT04369950|65352323|FG000|Overall Study|Protocol Violation|2|||
23439148|NCT04369950|65352324|FG001|Overall Study|Protocol Violation|2|||
23439149|NCT03477838|65352325|FG000|Overall Study|Lost to Follow-up|14|||
23826347|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23625193|NCT01296555|66015419|FG027|Overall Study|Withdrawal by Subject|4|||
23625194|NCT01296555|66015420|FG028|Overall Study|Withdrawal by Subject|2|||
23625195|NCT02806505|66015434|FG000|Overall Study|Adverse event/intercurrent illness|1|||
23625196|NCT02806505|66015435|FG001|Overall Study|Adverse event/intercurrent illness|3|||
23826348|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23439150|NCT01546688|65352326|FG000|Overall Study|Adverse Event|0|||
23439151|NCT01546688|65352327|FG001|Overall Study|Adverse Event|4|||
23439152|NCT01546688|65352326|FG000|Overall Study|Withdrawal by Subject|2|||
23561612|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
23561613|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
23561614|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
23561615|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
23561616|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
23561617|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
23561618|NCT03916744|65786200|FG000|Overall Study|Withdrawal by Subject|0|||
23439153|NCT01546688|65352327|FG001|Overall Study|Withdrawal by Subject|1|||
23561619|NCT03916744|65786201|FG001|Overall Study|Withdrawal by Subject|1|||
23561620|NCT03916744|65786202|FG002|Overall Study|Withdrawal by Subject|2|||
23561621|NCT00058422|65786206|FG000|Overall Study|Not treated|2|||
23561622|NCT01691521|65786210|FG000|Overall Study|Adverse Event|4|||
23561623|NCT01691521|65786211|FG001|Overall Study|Adverse Event|0|||
23561624|NCT01691521|65786212|FG002|Overall Study|Adverse Event|1|||
23561625|NCT01691521|65786210|FG000|Overall Study|Lack of Efficacy|1|||
23561626|NCT01691521|65786211|FG001|Overall Study|Lack of Efficacy|1|||
23561627|NCT01691521|65786212|FG002|Overall Study|Lack of Efficacy|2|||
23561628|NCT01691521|65786210|FG000|Overall Study|Protocol Violation|0|||
23561629|NCT01691521|65786211|FG001|Overall Study|Protocol Violation|3|||
23561630|NCT01691521|65786212|FG002|Overall Study|Protocol Violation|0|||
23561631|NCT01691521|65786210|FG000|Overall Study|Lost to Follow-up|0|||
23561632|NCT01691521|65786211|FG001|Overall Study|Lost to Follow-up|2|||
23561633|NCT01691521|65786212|FG002|Overall Study|Lost to Follow-up|2|||
23561634|NCT01691521|65786210|FG000|Overall Study|Physician Decision|2|||
23561635|NCT01691521|65786211|FG001|Overall Study|Physician Decision|1|||
23561636|NCT01691521|65786212|FG002|Overall Study|Physician Decision|0|||
23561637|NCT01691521|65786210|FG000|Overall Study|Withdrawal by Subject|5|||
23561638|NCT01691521|65786211|FG001|Overall Study|Withdrawal by Subject|9|||
23561639|NCT01691521|65786212|FG002|Overall Study|Withdrawal by Subject|4|||
23561640|NCT01889186|65786213|FG000|Overall Study|Adverse event- not related to progression|18|||
23561641|NCT01889186|65786214|FG001|Overall Study|Adverse event- not related to progression|5|||
23561642|NCT01889186|65786213|FG000|Overall Study|Adverse event- related to progression|7|||
23561643|NCT01889186|65786214|FG001|Overall Study|Adverse event- related to progression|2|||
23561644|NCT01889186|65786213|FG000|Overall Study|COVID-19 logistical restrictions|1|||
23561645|NCT01889186|65786214|FG001|Overall Study|COVID-19 logistical restrictions|0|||
23561646|NCT01889186|65786213|FG000|Overall Study|Investigator request|1|||
23561647|NCT01889186|65786214|FG001|Overall Study|Investigator request|1|||
23561648|NCT01889186|65786213|FG000|Overall Study|Progressive disease- Richter's|12|||
23561649|NCT01889186|65786214|FG001|Overall Study|Progressive disease- Richter's|7|||
23561650|NCT01889186|65786213|FG000|Overall Study|Progressive disease per protocol|46|||
23561651|NCT01889186|65786214|FG001|Overall Study|Progressive disease per protocol|17|||
23561652|NCT01889186|65786213|FG000|Overall Study|Stem cell transplant|2|||
23561653|NCT01889186|65786214|FG001|Overall Study|Stem cell transplant|1|||
23561654|NCT01889186|65786213|FG000|Overall Study|Withdrew consent|2|||
23561655|NCT01889186|65786214|FG001|Overall Study|Withdrew consent|3|||
23561656|NCT01889186|65786213|FG000|Overall Study|Other, not specified|18|||
23561657|NCT01889186|65786214|FG001|Overall Study|Other, not specified|15|||
23561658|NCT03559218|65786218|FG000|Overall Study|Withdrawal by Subject|1|||
23561659|NCT03559218|65786219|FG001|Overall Study|Withdrawal by Subject|0|||
23561660|NCT01807156|65786220|FG000|Overall Study|Physician Decision|1|||
23561661|NCT04067401|65786232|FG000|Overall Study|Withdrawal by Subject|7|||
23561662|NCT04067401|65786233|FG001|Overall Study|Withdrawal by Subject|0|||
23561663|NCT04067401|65786232|FG000|Overall Study|no data provided|1|||
23561664|NCT04067401|65786233|FG001|Overall Study|no data provided|0|||
23561665|NCT03237858|65786236|FG000|Overall Study|Death|19|||
23561666|NCT03237858|65786236|FG000|Overall Study|Withdrawal by Subject|37|||
23561667|NCT03704584|65786237|FG000|Overall Study|Withdrawal by Subject|1|||
23561668|NCT03704584|65786238|FG001|Overall Study|Withdrawal by Subject|0|||
23625197|NCT02806505|66015434|FG000|Overall Study|Death|4|||
23625198|NCT02806505|66015435|FG001|Overall Study|Death|0|||
23625199|NCT02806505|66015434|FG000|Overall Study|Did not cooperate/refused treatment|3|||
23561669|NCT02832622|65786244|FG000|Overall Study|MPP not programmed|1259|||
23625200|NCT02806505|66015435|FG001|Overall Study|Did not cooperate/refused treatment|3|||
23439154|NCT01546688|65352326|FG000|Overall Study|Lack of Efficacy|1|||
23561670|NCT02832622|65786244|FG000|Overall Study|Withdrawal by Subject|123|||
23561671|NCT02832622|65786244|FG000|Overall Study|Death|119|||
23439155|NCT01546688|65352327|FG001|Overall Study|Lack of Efficacy|0|||
23439156|NCT01059318|65352328|FG000|Core Study (26 Week)|Adverse Event|3|||
23439157|NCT01059318|65352328|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
23439158|NCT01059318|65352328|FG000|Extension (36 Week)|Adverse Event|3|||
23439159|NCT00793325|65352329|FG000|Overall Study|Protocol Violation|18|||
23439160|NCT00793325|65352329|FG000|Overall Study|Lost to Follow-up|1|||
23439161|NCT00422383|65352330|FG000|Overall Study|Adverse Event|5|||
23439162|NCT00422383|65352331|FG001|Overall Study|Adverse Event|3|||
23439163|NCT00422383|65352332|FG002|Overall Study|Adverse Event|1|||
23439164|NCT00422383|65352333|FG003|Overall Study|Adverse Event|1|||
23439165|NCT00422383|65352334|FG004|Overall Study|Adverse Event|0|||
23439166|NCT00422383|65352330|FG000|Overall Study|Lack of Efficacy|4|||
23439167|NCT00422383|65352331|FG001|Overall Study|Lack of Efficacy|4|||
23439168|NCT00422383|65352332|FG002|Overall Study|Lack of Efficacy|2|||
23439169|NCT00422383|65352333|FG003|Overall Study|Lack of Efficacy|1|||
23439170|NCT00422383|65352334|FG004|Overall Study|Lack of Efficacy|1|||
23439171|NCT00422383|65352330|FG000|Overall Study|Lost to Follow-up|0|||
23439172|NCT00422383|65352331|FG001|Overall Study|Lost to Follow-up|1|||
23439173|NCT00422383|65352332|FG002|Overall Study|Lost to Follow-up|0|||
23439174|NCT00422383|65352333|FG003|Overall Study|Lost to Follow-up|0|||
23439175|NCT00422383|65352334|FG004|Overall Study|Lost to Follow-up|1|||
23439176|NCT00422383|65352330|FG000|Overall Study|Protocol Violation|1|||
23439177|NCT00422383|65352331|FG001|Overall Study|Protocol Violation|1|||
23439178|NCT00422383|65352332|FG002|Overall Study|Protocol Violation|1|||
23439179|NCT00422383|65352333|FG003|Overall Study|Protocol Violation|0|||
23439180|NCT00422383|65352334|FG004|Overall Study|Protocol Violation|0|||
23439181|NCT00422383|65352330|FG000|Overall Study|Withdrawal by Subject|5|||
23439182|NCT00422383|65352331|FG001|Overall Study|Withdrawal by Subject|5|||
23439183|NCT00422383|65352332|FG002|Overall Study|Withdrawal by Subject|0|||
23439184|NCT00422383|65352333|FG003|Overall Study|Withdrawal by Subject|0|||
23439185|NCT00422383|65352334|FG004|Overall Study|Withdrawal by Subject|1|||
23439186|NCT00761527|65352342|FG000|Overall Study|Adverse Event|3|||
23439187|NCT00761527|65352342|FG000|Overall Study|Poor Compliance|8|||
23439188|NCT00761527|65352342|FG000|Overall Study|Lost to Follow-up|9|||
23439189|NCT00761527|65352342|FG000|Overall Study|Unknown reason|2|||
23439190|NCT02283788|65352345|FG000|Overall Study|Adverse Event|1|||
23439191|NCT02283788|65352346|FG001|Overall Study|Adverse Event|3|||
23439192|NCT02283788|65352347|FG002|Overall Study|Adverse Event|5|||
23439193|NCT02283788|65352348|FG003|Overall Study|Adverse Event|1|||
23439194|NCT02283788|65352345|FG000|Overall Study|Withdrawal by Subject|0|||
23439195|NCT02283788|65352346|FG001|Overall Study|Withdrawal by Subject|1|||
23439196|NCT02283788|65352347|FG002|Overall Study|Withdrawal by Subject|0|||
23439197|NCT02283788|65352348|FG003|Overall Study|Withdrawal by Subject|1|||
23439198|NCT01371734|65352349|FG000|Overall Study|Other|2|||
23439199|NCT01371734|65352350|FG001|Overall Study|Other|1|||
23439200|NCT01371734|65352351|FG002|Overall Study|Other|2|||
23439201|NCT01371734|65352349|FG000|Overall Study|Withdrawal by Subject|3|||
23439202|NCT01371734|65352350|FG001|Overall Study|Withdrawal by Subject|4|||
23439203|NCT01371734|65352351|FG002|Overall Study|Withdrawal by Subject|9|||
23439204|NCT01371734|65352349|FG000|Overall Study|Lost to Follow-up|5|||
23439205|NCT01371734|65352350|FG001|Overall Study|Lost to Follow-up|3|||
23439206|NCT01371734|65352351|FG002|Overall Study|Lost to Follow-up|1|||
23439207|NCT01371734|65352349|FG000|Overall Study|Protocol Violation|3|||
23439208|NCT01371734|65352350|FG001|Overall Study|Protocol Violation|1|||
23439209|NCT01371734|65352351|FG002|Overall Study|Protocol Violation|2|||
23439210|NCT01371734|65352349|FG000|Overall Study|Adverse Event|8|||
23439211|NCT01371734|65352350|FG001|Overall Study|Adverse Event|8|||
23439212|NCT01371734|65352351|FG002|Overall Study|Adverse Event|3|||
23439213|NCT01371734|65352349|FG000|Overall Study|Lack of Efficacy|2|||
23439214|NCT01371734|65352350|FG001|Overall Study|Lack of Efficacy|2|||
23561672|NCT02832622|65786244|FG000|Overall Study|Unsuccessful CRT implant|93|||
23439215|NCT01371734|65352351|FG002|Overall Study|Lack of Efficacy|0|||
23439216|NCT03772665|65352352|FG000|Overall Study|Protocol Violation|1|||
23561673|NCT02832622|65786244|FG000|Overall Study|Lost to Follow-up|45|||
23439217|NCT03772665|65352353|FG001|Overall Study|Protocol Violation|0|||
23439218|NCT03193736|65352354|FG000|Overall Study|Death|2|||
23439219|NCT03193736|65352354|FG000|Overall Study|Withdrawal by Subject|1|||
23439220|NCT03193736|65352354|FG000|Overall Study|Lost to Follow-up|1|||
23439221|NCT03193736|65352354|FG000|Overall Study|implant not received|1|||
23439222|NCT00811174|65352355|FG000|Overall Study|Protocol Violation|2|||
23439223|NCT00811174|65352355|FG000|Overall Study|Sponsors Decision|1|||
23439224|NCT04439318|65352356|FG000|Overall Study|Ineligible|1|||
23439225|NCT04439318|65352356|FG000|Overall Study|Never Started Treatment|3|||
23439226|NCT04439318|65352356|FG000|Overall Study|Adverse Event|10|||
23439227|NCT04439318|65352356|FG000|Overall Study|Death|2|||
23439228|NCT04439318|65352356|FG000|Overall Study|Disease Progression|25|||
23439229|NCT04439318|65352356|FG000|Overall Study|Other Complicating Disease|2|||
23439230|NCT04439318|65352356|FG000|Overall Study|Withdrawal by Subject|4|||
23561674|NCT02832622|65786244|FG000|Overall Study|Patient non-compliance|42|||
23561675|NCT02832622|65786244|FG000|Overall Study|Withdrawal by other reasons|25|||
23625201|NCT02806505|66015434|FG000|Overall Study|Failure to return|0|||
23625202|NCT02806505|66015435|FG001|Overall Study|Failure to return|1|||
23439231|NCT04439318|65352356|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
23439232|NCT04439318|65352356|FG000|Overall Study|Non-Compliance|1|||
23439233|NCT04439318|65352356|FG000|Overall Study|Still on Treatment|1|||
23439234|NCT02503501|65352357|FG000|Overall Study|Physician Decision|1|||
23439235|NCT02503501|65352358|FG001|Overall Study|Physician Decision|0|||
23439236|NCT02503501|65352357|FG000|Overall Study|Protocol Violation|0|||
23439237|NCT02503501|65352358|FG001|Overall Study|Protocol Violation|1|||
23439238|NCT02503501|65352357|FG000|Overall Study|Withdrawal by Subject|0|||
23439239|NCT02503501|65352358|FG001|Overall Study|Withdrawal by Subject|2|||
23439240|NCT00320515|65352360|FG000|Overall Study|Death|33|||
23439241|NCT00320515|65352360|FG000|Overall Study|Lost to Follow-up|6|||
23439242|NCT00320515|65352360|FG000|Overall Study|Physician Decision|2|||
23561676|NCT02832622|65786244|FG000|Overall Study|System explant|24|||
23625203|NCT02806505|66015434|FG000|Overall Study|Insufficient therapeutic response|2|||
23625204|NCT02806505|66015435|FG001|Overall Study|Insufficient therapeutic response|4|||
23625205|NCT00839332|66015436|FG000|Phase 1|Disease Progression|38|||
23625206|NCT00839332|66015437|FG001|Phase 1|Disease Progression|0|||
23625207|NCT00839332|66015438|FG002|Phase 1|Disease Progression|0|||
23625208|NCT00839332|66015436|FG000|Phase 1|Adverse Event|6|||
23625209|NCT00839332|66015437|FG001|Phase 1|Adverse Event|0|||
23625210|NCT00839332|66015438|FG002|Phase 1|Adverse Event|0|||
23757006|NCT03471182|66489572|FG000|Overall Study|Withdrawal by Subject|1|||
23561677|NCT02832622|65786244|FG000|Overall Study|Physician Decision|6|||
23561678|NCT01287520|65786247|FG000|Overall Study|Adverse Event|2|||
23561679|NCT01287520|65786248|FG001|Overall Study|Adverse Event|2|||
23561680|NCT01287520|65786249|FG002|Overall Study|Adverse Event|2|||
23561681|NCT01287520|65786250|FG003|Overall Study|Adverse Event|1|||
23439243|NCT00320515|65352360|FG000|Overall Study|Withdrawal by Subject|8|||
23439244|NCT01180296|65352361|FG000|Overall Study|Protocol Violation|1|||
23439245|NCT01180296|65352362|FG001|Overall Study|Protocol Violation|2|||
23439246|NCT02587819|65352372|FG000|Overall Study|Adverse Event|1|||
23625211|NCT00839332|66015436|FG000|Phase 1|Withdrawal by Subject|4|||
23625212|NCT00839332|66015437|FG001|Phase 1|Withdrawal by Subject|0|||
23757007|NCT03471182|66489573|FG001|Overall Study|Withdrawal by Subject|1|||
23439247|NCT02587819|65352372|FG000|Overall Study|Lost to Follow-up|1|||
23439248|NCT01867086|65352373|FG000|Overall Study|Disease Progression|1|||
23561682|NCT01287520|65786251|FG004|Overall Study|Adverse Event|1|||
23757008|NCT03471182|66489574|FG002|Overall Study|Withdrawal by Subject|0|||
23757009|NCT03471182|66489572|FG000|Overall Study|Technical failure|2|||
23439249|NCT01393639|65352374|FG000|Overall Study|Protocol Violation|0|||
23826349|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23826350|NCT03334435|66745024|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826351|NCT03334435|66745025|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826352|NCT03334435|66745026|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826353|NCT03334435|66745027|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826354|NCT03334435|66745028|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826355|NCT03334435|66745029|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826356|NCT03334435|66745030|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826357|NCT03334435|66745031|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826358|NCT03334435|66745032|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826359|NCT03334435|66745033|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826360|NCT03334435|66745034|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826361|NCT03334435|66745035|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23826362|NCT03334435|66745036|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23826363|NCT03334435|66745037|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23826364|NCT03334435|66745038|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23826365|NCT01197534|66745039|FG000|Overall Study|Not reported|16|||
23826366|NCT01197534|66745040|FG001|Overall Study|Not reported|10|||
23826367|NCT01197534|66745041|FG002|Overall Study|Not reported|16|||
23826368|NCT01197534|66745039|FG000|Overall Study|Enrolment in long term extension|57|||
23826369|NCT01197534|66745040|FG001|Overall Study|Enrolment in long term extension|66|||
23826370|NCT01197534|66745041|FG002|Overall Study|Enrolment in long term extension|119|||
23826371|NCT01197534|66745039|FG000|Overall Study|Severe non-compliance to protocol|3|||
23826372|NCT01197534|66745040|FG001|Overall Study|Severe non-compliance to protocol|4|||
23826373|NCT01197534|66745041|FG002|Overall Study|Severe non-compliance to protocol|1|||
23826374|NCT01197534|66745039|FG000|Overall Study|Lack of therapeutic response|9|||
23826375|NCT01197534|66745040|FG001|Overall Study|Lack of therapeutic response|4|||
23826376|NCT01197534|66745041|FG002|Overall Study|Lack of therapeutic response|9|||
23826377|NCT01197534|66745039|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
23826378|NCT01197534|66745040|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
23826379|NCT01197534|66745041|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
23826380|NCT01197534|66745039|FG000|Overall Study|Lost to Follow-up|1|||
23826381|NCT01197534|66745040|FG001|Overall Study|Lost to Follow-up|4|||
23826382|NCT01197534|66745041|FG002|Overall Study|Lost to Follow-up|2|||
23826383|NCT01197534|66745039|FG000|Overall Study|Adverse Event|35|||
23826384|NCT01197534|66745040|FG001|Overall Study|Adverse Event|36|||
23826385|NCT01197534|66745041|FG002|Overall Study|Adverse Event|24|||
23826386|NCT03889886|66745042|FG000|Overall Study|Other|0|||
23826387|NCT03889886|66745043|FG001|Overall Study|Other|1|||
23826388|NCT03889886|66745044|FG002|Overall Study|Other|0|||
23826389|NCT03889886|66745045|FG003|Overall Study|Other|1|||
23826390|NCT03889886|66745042|FG000|Overall Study|Withdrawal by Subject|0|||
23826391|NCT03889886|66745043|FG001|Overall Study|Withdrawal by Subject|0|||
23826392|NCT03889886|66745044|FG002|Overall Study|Withdrawal by Subject|1|||
23826393|NCT03889886|66745045|FG003|Overall Study|Withdrawal by Subject|0|||
23826394|NCT03889886|66745042|FG000|Overall Study|Adverse Event|0|||
23826395|NCT03889886|66745043|FG001|Overall Study|Adverse Event|0|||
23826396|NCT03889886|66745044|FG002|Overall Study|Adverse Event|0|||
23826397|NCT03889886|66745045|FG003|Overall Study|Adverse Event|6|||
23826398|NCT02524847|66745046|FG000|Overall Study|Adverse Event|4|||
23826399|NCT02524847|66745046|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23826400|NCT02524847|66745046|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
23826401|NCT02524847|66745046|FG000|Overall Study|Death|1|||
23826402|NCT02524847|66745046|FG000|Overall Study|Reason not Specified|1|||
23826403|NCT03022370|66745047|FG000|Overall Study|Death|6|||
23826404|NCT03022370|66745048|FG001|Overall Study|Death|12|||
23826405|NCT03022370|66745047|FG000|Overall Study|Lost to Follow-up|174|||
23826406|NCT03022370|66745048|FG001|Overall Study|Lost to Follow-up|109|||
23826407|NCT02115607|66745049|FG000|Overall Study|Withdrawal by Subject|1|||
23826408|NCT01495702|66745055|FG000|Randomized Phase|Randomized But Not Treated|1|||
23826409|NCT01495702|66745056|FG001|Randomized Phase|Randomized But Not Treated|4|||
23826410|NCT01495702|66745055|FG000|Randomized Phase|Adverse Event|2|||
23826411|NCT01495702|66745056|FG001|Randomized Phase|Adverse Event|2|||
23561683|NCT01287520|65786252|FG005|Overall Study|Adverse Event|2|||
23826412|NCT01495702|66745055|FG000|Randomized Phase|Death|1|||
23826413|NCT01495702|66745056|FG001|Randomized Phase|Death|0|||
23826414|NCT01495702|66745055|FG000|Randomized Phase|Lack of Efficacy|2|||
23561684|NCT01287520|65786253|FG006|Overall Study|Adverse Event|0|||
23561685|NCT01287520|65786254|FG007|Overall Study|Adverse Event|2|||
23561686|NCT01287520|65786255|FG008|Overall Study|Adverse Event|0|||
23757010|NCT03471182|66489573|FG001|Overall Study|Technical failure|0|||
23757011|NCT03471182|66489574|FG002|Overall Study|Technical failure|0|||
23757012|NCT00758706|66489592|FG000|Overall Study|Adverse Event|4|||
23757013|NCT00758706|66489593|FG001|Overall Study|Adverse Event|4|||
23757014|NCT03078192|66489594|FG000|Overall Study|Withdrawal by Subject|2|||
23757015|NCT03078192|66489595|FG001|Overall Study|Withdrawal by Subject|1|||
23757016|NCT03078192|66489594|FG000|Overall Study|screen failure|0|||
23757017|NCT03078192|66489595|FG001|Overall Study|screen failure|3|||
23757018|NCT00078312|66489596|FG000|Overall Study|Adverse Event|43|||
23757019|NCT00078312|66489596|FG000|Overall Study|Lack of Efficacy|15|||
23757020|NCT00078312|66489596|FG000|Overall Study|Lost to Follow-up|41|||
23757021|NCT00078312|66489596|FG000|Overall Study|Physician Decision|9|||
23757022|NCT00078312|66489596|FG000|Overall Study|Protocol Violation|3|||
23757023|NCT00078312|66489596|FG000|Overall Study|Withdrawal by Subject|33|||
23757024|NCT00078312|66489596|FG000|Overall Study|Miscellaneous|33|||
23757025|NCT02261974|66489597|FG000|Overall Study|Withdrawal by Subject|3|||
23757026|NCT02261974|66489598|FG001|Overall Study|Withdrawal by Subject|2|||
23757027|NCT02261974|66489597|FG000|Overall Study|Pregnancy|0|||
23757028|NCT02261974|66489598|FG001|Overall Study|Pregnancy|1|||
23757029|NCT02261974|66489597|FG000|Overall Study|Missed treatment cut-off date|6|||
23757030|NCT02261974|66489598|FG001|Overall Study|Missed treatment cut-off date|3|||
23757031|NCT02261974|66489597|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
23757032|NCT02261974|66489598|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
23757033|NCT02261974|66489597|FG000|Overall Study|Lost to Follow-up|2|||
23757034|NCT02261974|66489598|FG001|Overall Study|Lost to Follow-up|0|||
23757035|NCT02261974|66489597|FG000|Overall Study|Adverse Event|1|||
23757036|NCT02261974|66489598|FG001|Overall Study|Adverse Event|0|||
23757037|NCT02164539|66489599|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
23757038|NCT02164539|66489600|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
23757039|NCT02164539|66489601|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
23757040|NCT02164539|66489602|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
23757041|NCT02164539|66489603|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
23757042|NCT02164539|66489604|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
23757043|NCT02164539|66489605|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
23757044|NCT02164539|66489599|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
23757045|NCT02164539|66489600|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
23757046|NCT02164539|66489601|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
23757047|NCT02164539|66489602|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
23757048|NCT02164539|66489603|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
23757049|NCT02164539|66489604|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
23757050|NCT02164539|66489605|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
23757051|NCT02164539|66489599|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
23757052|NCT02164539|66489600|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
23757053|NCT02164539|66489601|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
23757054|NCT02164539|66489602|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
23757055|NCT02164539|66489603|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
23757056|NCT02164539|66489604|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
23757057|NCT02164539|66489605|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
23757058|NCT02164539|66489599|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
23757059|NCT02164539|66489600|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757060|NCT02164539|66489601|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757061|NCT02164539|66489602|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757062|NCT02164539|66489603|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757063|NCT02164539|66489604|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757064|NCT02164539|66489605|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23757065|NCT02164539|66489599|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
23757066|NCT02164539|66489600|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
23757067|NCT02164539|66489601|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
23757068|NCT02164539|66489602|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
23757069|NCT02164539|66489603|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
23757070|NCT02164539|66489604|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
23757071|NCT02164539|66489605|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
23757072|NCT02164539|66489599|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
23757073|NCT02164539|66489600|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
23757074|NCT02164539|66489601|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
23757075|NCT02164539|66489602|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
23757076|NCT02164539|66489603|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
23757077|NCT02164539|66489604|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
23757078|NCT02164539|66489605|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
23757079|NCT02239601|66489606|FG000|Overall Study|Withdrawal by Subject|3|||
23757080|NCT02239601|66489607|FG001|Overall Study|Withdrawal by Subject|4|||
23561687|NCT01287520|65786247|FG000|Overall Study|Physician Decision|1|||
23561688|NCT01287520|65786248|FG001|Overall Study|Physician Decision|1|||
23561689|NCT01287520|65786249|FG002|Overall Study|Physician Decision|2|||
23625213|NCT00839332|66015438|FG002|Phase 1|Withdrawal by Subject|0|||
23625214|NCT00839332|66015436|FG000|Phase 1|Physician Decision|2|||
23625215|NCT00839332|66015437|FG001|Phase 1|Physician Decision|0|||
23625216|NCT00839332|66015438|FG002|Phase 1|Physician Decision|0|||
23625217|NCT00839332|66015436|FG000|Phase 2|Protocol Violation|0|||
23625218|NCT00839332|66015437|FG001|Phase 2|Protocol Violation|1|||
23625219|NCT00839332|66015438|FG002|Phase 2|Protocol Violation|0|||
23625220|NCT00839332|66015436|FG000|Phase 2|Disease Progression|0|||
23625221|NCT00839332|66015437|FG001|Phase 2|Disease Progression|46|||
23625222|NCT00839332|66015438|FG002|Phase 2|Disease Progression|21|||
23625223|NCT00839332|66015436|FG000|Phase 2|Adverse Event|0|||
23625224|NCT00839332|66015437|FG001|Phase 2|Adverse Event|8|||
23625225|NCT00839332|66015438|FG002|Phase 2|Adverse Event|6|||
23625226|NCT00839332|66015436|FG000|Phase 2|Death|0|||
23625227|NCT00839332|66015437|FG001|Phase 2|Death|4|||
23625228|NCT00839332|66015438|FG002|Phase 2|Death|2|||
23757081|NCT02239601|66489606|FG000|Overall Study|Protocol Violation|4|||
23757082|NCT02239601|66489607|FG001|Overall Study|Protocol Violation|2|||
23757083|NCT02482571|66489610|FG000|Overall Study|Adverse Event|1|||
23757084|NCT02482571|66489610|FG000|Overall Study|Scanner or Respiract failure|3|||
23757085|NCT02482571|66489610|FG000|Overall Study|Withdrawal by Subject|4|||
23757086|NCT02176642|66489611|FG000|Overall Study|Withdrawal by Subject|0|||
23757087|NCT02176642|66489612|FG001|Overall Study|Withdrawal by Subject|1|||
23757088|NCT02556632|66489616|FG000|Overall Study|Lost to Follow-up|1|||
23757089|NCT02556632|66489617|FG001|Overall Study|Lost to Follow-up|0|||
23757090|NCT02556632|66489618|FG002|Overall Study|Lost to Follow-up|0|||
23757091|NCT02556632|66489616|FG000|Overall Study|Disliked Intervention|1|||
23757092|NCT02556632|66489617|FG001|Overall Study|Disliked Intervention|1|||
23757093|NCT02556632|66489618|FG002|Overall Study|Disliked Intervention|1|||
23757094|NCT02556632|66489616|FG000|Overall Study|No Reason|1|||
23757095|NCT02556632|66489617|FG001|Overall Study|No Reason|0|||
23757096|NCT02556632|66489618|FG002|Overall Study|No Reason|1|||
23757097|NCT02556632|66489616|FG000|Overall Study|Personal Issues|0|||
23757098|NCT02556632|66489617|FG001|Overall Study|Personal Issues|1|||
23757099|NCT02556632|66489618|FG002|Overall Study|Personal Issues|1|||
23757100|NCT02556632|66489616|FG000|Overall Study|Changed Mind|0|||
23757101|NCT02556632|66489617|FG001|Overall Study|Changed Mind|1|||
23757102|NCT02556632|66489618|FG002|Overall Study|Changed Mind|0|||
23757103|NCT02556632|66489616|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
23757104|NCT02556632|66489617|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
23757105|NCT02556632|66489618|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
23757106|NCT02556632|66489616|FG000|Overall Study|Unrelated Adverse Event|1|||
23757107|NCT02556632|66489617|FG001|Overall Study|Unrelated Adverse Event|0|||
23757108|NCT02556632|66489618|FG002|Overall Study|Unrelated Adverse Event|3|||
23757109|NCT02556632|66489616|FG000|Overall Study|Related Adverse Event|0|||
23757110|NCT02556632|66489617|FG001|Overall Study|Related Adverse Event|1|||
23757111|NCT02556632|66489618|FG002|Overall Study|Related Adverse Event|0|||
23757112|NCT02556632|66489616|FG000|Overall Study|Possibly Related Adverse Event|0|||
23757113|NCT02556632|66489617|FG001|Overall Study|Possibly Related Adverse Event|0|||
23757114|NCT02556632|66489618|FG002|Overall Study|Possibly Related Adverse Event|1|||
23757115|NCT02556632|66489616|FG000|Overall Study|Did Not Start RT|0|||
23757116|NCT02556632|66489617|FG001|Overall Study|Did Not Start RT|1|||
23757117|NCT02556632|66489618|FG002|Overall Study|Did Not Start RT|0|||
23757118|NCT02556632|66489616|FG000|Overall Study|Ineligible|0|||
23757119|NCT02556632|66489617|FG001|Overall Study|Ineligible|1|||
23757120|NCT02556632|66489618|FG002|Overall Study|Ineligible|0|||
23757121|NCT02556632|66489616|FG000|Overall Study|Disliked Study Procedures|0|||
23757122|NCT02556632|66489617|FG001|Overall Study|Disliked Study Procedures|0|||
23757123|NCT02556632|66489618|FG002|Overall Study|Disliked Study Procedures|1|||
23757124|NCT02556632|66489616|FG000|Overall Study|Treatment or Change Delay|0|||
23757125|NCT02556632|66489617|FG001|Overall Study|Treatment or Change Delay|0|||
23757126|NCT02556632|66489618|FG002|Overall Study|Treatment or Change Delay|1|||
23757127|NCT02059187|66489621|FG000|Overall Study|Adverse Event|0|||
23757128|NCT02059187|66489622|FG001|Overall Study|Adverse Event|3|||
23757129|NCT02059187|66489621|FG000|Overall Study|Death|1|||
23625229|NCT00839332|66015436|FG000|Phase 2|Withdrawal by Subject|0|||
23757130|NCT02059187|66489622|FG001|Overall Study|Death|1|||
23757131|NCT02059187|66489621|FG000|Overall Study|Lost to Follow-up|9|||
23757132|NCT02059187|66489622|FG001|Overall Study|Lost to Follow-up|8|||
23757133|NCT02059187|66489621|FG000|Overall Study|Non-compliance with study drug|1|||
23757134|NCT02059187|66489622|FG001|Overall Study|Non-compliance with study drug|0|||
23757135|NCT02059187|66489621|FG000|Overall Study|Physician Decision|1|||
23757136|NCT02059187|66489622|FG001|Overall Study|Physician Decision|2|||
23757137|NCT02059187|66489621|FG000|Overall Study|Protocol Violation|1|||
23757138|NCT02059187|66489622|FG001|Overall Study|Protocol Violation|0|||
23757139|NCT02059187|66489621|FG000|Overall Study|Withdrawal by Subject|12|||
23625230|NCT00839332|66015437|FG001|Phase 2|Withdrawal by Subject|5|||
23625231|NCT00839332|66015438|FG002|Phase 2|Withdrawal by Subject|8|||
23625232|NCT00839332|66015436|FG000|Phase 2|Physician Decision|0|||
23757140|NCT02059187|66489622|FG001|Overall Study|Withdrawal by Subject|8|||
23625233|NCT00839332|66015437|FG001|Phase 2|Physician Decision|4|||
23625234|NCT00839332|66015438|FG002|Phase 2|Physician Decision|1|||
23625235|NCT00839332|66015436|FG000|Phase 2|Lost to Follow-up|0|||
23625236|NCT00839332|66015437|FG001|Phase 2|Lost to Follow-up|0|||
23625237|NCT00839332|66015438|FG002|Phase 2|Lost to Follow-up|1|||
23625238|NCT02509312|66015441|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
23625239|NCT02509312|66015442|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
23625240|NCT02509312|66015441|FG000|Overall Study|Obstetrician refusal|0|||
23625241|NCT02509312|66015442|FG001|Overall Study|Obstetrician refusal|1|||
23625242|NCT02509312|66015441|FG000|Overall Study|Patient elected for TOLAC|1|||
23625243|NCT02509312|66015442|FG001|Overall Study|Patient elected for TOLAC|0|||
23625244|NCT02509312|66015441|FG000|Overall Study|Cesarean deemed stat|1|||
23625245|NCT02509312|66015442|FG001|Overall Study|Cesarean deemed stat|0|||
23625246|NCT02509312|66015441|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
23625247|NCT02509312|66015442|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
23625248|NCT00727506|66015443|FG000|Overall Study|Adverse Event|0|||
23625249|NCT00727506|66015444|FG001|Overall Study|Adverse Event|0|||
23625250|NCT00727506|66015445|FG002|Overall Study|Adverse Event|4|||
23625251|NCT00727506|66015446|FG003|Overall Study|Adverse Event|4|||
23625252|NCT00727506|66015447|FG004|Overall Study|Adverse Event|1|||
23625253|NCT00727506|66015448|FG005|Overall Study|Adverse Event|8|||
23625254|NCT00727506|66015443|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23625255|NCT00727506|66015444|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625256|NCT00727506|66015445|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23625257|NCT00727506|66015446|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625258|NCT00727506|66015447|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625259|NCT00727506|66015448|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625260|NCT00727506|66015443|FG000|Overall Study|Progressive disease|4|||
23625261|NCT00727506|66015444|FG001|Overall Study|Progressive disease|7|||
23625262|NCT00727506|66015445|FG002|Overall Study|Progressive disease|9|||
23625263|NCT00727506|66015446|FG003|Overall Study|Progressive disease|28|||
23625264|NCT00727506|66015447|FG004|Overall Study|Progressive disease|38|||
23625265|NCT00727506|66015448|FG005|Overall Study|Progressive disease|28|||
23625266|NCT00727506|66015443|FG000|Overall Study|Refused to continue medication|0|||
23625267|NCT00727506|66015444|FG001|Overall Study|Refused to continue medication|1|||
23625268|NCT00727506|66015445|FG002|Overall Study|Refused to continue medication|2|||
23625269|NCT00727506|66015446|FG003|Overall Study|Refused to continue medication|3|||
23625270|NCT00727506|66015447|FG004|Overall Study|Refused to continue medication|1|||
23625271|NCT00727506|66015448|FG005|Overall Study|Refused to continue medication|2|||
23625272|NCT00727506|66015443|FG000|Overall Study|Other reason not described above|0|||
23625273|NCT00727506|66015444|FG001|Overall Study|Other reason not described above|0|||
23625274|NCT00727506|66015445|FG002|Overall Study|Other reason not described above|1|||
23625275|NCT00727506|66015446|FG003|Overall Study|Other reason not described above|4|||
23625276|NCT00727506|66015447|FG004|Overall Study|Other reason not described above|1|||
23625277|NCT00727506|66015448|FG005|Overall Study|Other reason not described above|1|||
23625278|NCT01340300|66015449|FG000|Overall Study|Lost to Follow-up|3|||
23625279|NCT01340300|66015450|FG001|Overall Study|Lost to Follow-up|0|||
23625280|NCT01340300|66015451|FG002|Overall Study|Lost to Follow-up|5|||
23625281|NCT01340300|66015452|FG003|Overall Study|Lost to Follow-up|10|||
23625282|NCT01340300|66015449|FG000|Overall Study|Withdrawal by Subject|5|||
23625283|NCT01340300|66015450|FG001|Overall Study|Withdrawal by Subject|6|||
23625284|NCT01340300|66015451|FG002|Overall Study|Withdrawal by Subject|6|||
23625285|NCT01340300|66015452|FG003|Overall Study|Withdrawal by Subject|3|||
23625286|NCT01340300|66015449|FG000|Overall Study|Adverse Event|1|||
23625287|NCT01340300|66015450|FG001|Overall Study|Adverse Event|0|||
23625288|NCT01340300|66015451|FG002|Overall Study|Adverse Event|4|||
23625289|NCT01340300|66015452|FG003|Overall Study|Adverse Event|0|||
23625290|NCT01340300|66015449|FG000|Overall Study|Physician Decision|0|||
23625291|NCT01340300|66015450|FG001|Overall Study|Physician Decision|1|||
23625292|NCT01340300|66015451|FG002|Overall Study|Physician Decision|0|||
23625293|NCT01340300|66015452|FG003|Overall Study|Physician Decision|0|||
23625294|NCT01340300|66015449|FG000|Overall Study|Unrelated sickness|0|||
23625295|NCT01340300|66015450|FG001|Overall Study|Unrelated sickness|2|||
23625296|NCT01340300|66015451|FG002|Overall Study|Unrelated sickness|0|||
23625297|NCT01340300|66015452|FG003|Overall Study|Unrelated sickness|1|||
23625298|NCT03371823|66015457|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
23625299|NCT03371823|66015458|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
23757141|NCT03726437|66489623|FG000|Overall Study|Lost to Follow-up|85|||
23757142|NCT03726437|66489624|FG001|Overall Study|Lost to Follow-up|76|||
23625300|NCT02057575|66015459|FG000|Overall Study|Adverse Event|0|||
23625301|NCT02057575|66015460|FG001|Overall Study|Adverse Event|2|||
23625302|NCT02057575|66015461|FG002|Overall Study|Adverse Event|0|||
23625303|NCT02057575|66015462|FG003|Overall Study|Adverse Event|1|||
23625304|NCT02057575|66015459|FG000|Overall Study|Withdrawal by Subject|1|||
23625305|NCT02057575|66015460|FG001|Overall Study|Withdrawal by Subject|0|||
23625306|NCT02057575|66015461|FG002|Overall Study|Withdrawal by Subject|0|||
23625307|NCT02057575|66015462|FG003|Overall Study|Withdrawal by Subject|0|||
23625308|NCT02057575|66015459|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
23625309|NCT02057575|66015460|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
23625310|NCT02057575|66015461|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
23625311|NCT02057575|66015462|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
23625312|NCT02057575|66015459|FG000|Overall Study|Protocol Violation|0|||
23757143|NCT00709735|66489627|FG000|Overall Study|Lost to Follow-up|1|||
23757144|NCT00709735|66489628|FG001|Overall Study|Lost to Follow-up|1|||
23757145|NCT00709735|66489627|FG000|Overall Study|Relapse into Opioid Abuse|0|||
23757146|NCT00709735|66489628|FG001|Overall Study|Relapse into Opioid Abuse|1|||
23757147|NCT00709735|66489627|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
23757148|NCT00709735|66489628|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
23757149|NCT04147611|66489631|FG000|Overall Study|Physician Decision|0|||
23757150|NCT04147611|66489632|FG001|Overall Study|Physician Decision|1|||
23757151|NCT04330482|66489635|FG000|Overall Study|Lost to Follow-up|2|||
23757152|NCT04330482|66489636|FG001|Overall Study|Lost to Follow-up|1|||
23757153|NCT04330482|66489635|FG000|Overall Study|Withdrawal by Subject|0|||
23757154|NCT04330482|66489636|FG001|Overall Study|Withdrawal by Subject|3|||
23757155|NCT00267020|66489637|FG000|Overall Study|Adverse Event|22|||
23757156|NCT00267020|66489638|FG001|Overall Study|Adverse Event|5|||
23757157|NCT00267020|66489637|FG000|Overall Study|Death|2|||
23757158|NCT00267020|66489638|FG001|Overall Study|Death|1|||
23757159|NCT00267020|66489637|FG000|Overall Study|Withdrawal by Subject|17|||
23757160|NCT00267020|66489638|FG001|Overall Study|Withdrawal by Subject|7|||
23757161|NCT00267020|66489637|FG000|Overall Study|Physician Decision|3|||
23757162|NCT00267020|66489638|FG001|Overall Study|Physician Decision|2|||
23826415|NCT01495702|66745056|FG001|Randomized Phase|Lack of Efficacy|0|||
23826416|NCT01495702|66745055|FG000|Randomized Phase|Investigators Discretion|2|||
23826417|NCT01495702|66745056|FG001|Randomized Phase|Investigators Discretion|0|||
23826418|NCT01495702|66745055|FG000|Randomized Phase|Withdrew Consent|10|||
23826419|NCT01495702|66745056|FG001|Randomized Phase|Withdrew Consent|18|||
23826420|NCT01495702|66745055|FG000|Randomized Phase|Lost to Follow-up|4|||
23826421|NCT01495702|66745056|FG001|Randomized Phase|Lost to Follow-up|3|||
23826422|NCT01495702|66745055|FG000|Randomized Phase|Participant Noncompliance|1|||
23826423|NCT01495702|66745056|FG001|Randomized Phase|Participant Noncompliance|0|||
23826424|NCT01495702|66745055|FG000|Randomized Phase|Protocol Violation|3|||
23826425|NCT01495702|66745056|FG001|Randomized Phase|Protocol Violation|1|||
23826426|NCT02107131|66745057|FG000|Overall Study|Lost to Follow-up|4|||
23826427|NCT02107131|66745058|FG001|Overall Study|Lost to Follow-up|4|||
23826428|NCT02107131|66745057|FG000|Overall Study|Physician Decision|1|||
23826429|NCT02107131|66745058|FG001|Overall Study|Physician Decision|0|||
23826430|NCT02107131|66745057|FG000|Overall Study|Withdrawal by Subject|2|||
23826431|NCT02107131|66745058|FG001|Overall Study|Withdrawal by Subject|0|||
23826432|NCT02107131|66745057|FG000|Overall Study|mental instability|1|||
23826433|NCT02107131|66745058|FG001|Overall Study|mental instability|0|||
23826434|NCT02107131|66745057|FG000|Overall Study|Death|0|||
23826435|NCT02107131|66745058|FG001|Overall Study|Death|1|||
23826436|NCT02107131|66745057|FG000|Overall Study|Protocol Violation|0|||
23826437|NCT02107131|66745058|FG001|Overall Study|Protocol Violation|4|||
23826438|NCT05219448|66745062|FG000|Overall Study|Lost to Follow-up|9|||
23826439|NCT05219448|66745063|FG001|Overall Study|Lost to Follow-up|0|||
23561690|NCT01287520|65786250|FG003|Overall Study|Physician Decision|0|||
23561691|NCT01287520|65786251|FG004|Overall Study|Physician Decision|1|||
23561692|NCT01287520|65786252|FG005|Overall Study|Physician Decision|1|||
23561693|NCT01287520|65786253|FG006|Overall Study|Physician Decision|0|||
23561694|NCT01287520|65786254|FG007|Overall Study|Physician Decision|1|||
23561695|NCT01287520|65786255|FG008|Overall Study|Physician Decision|0|||
23561696|NCT01287520|65786247|FG000|Overall Study|Progressive disease|0|||
23561697|NCT01287520|65786248|FG001|Overall Study|Progressive disease|4|||
23561698|NCT01287520|65786249|FG002|Overall Study|Progressive disease|1|||
23561699|NCT01287520|65786250|FG003|Overall Study|Progressive disease|6|||
23561700|NCT01287520|65786251|FG004|Overall Study|Progressive disease|1|||
23561701|NCT01287520|65786252|FG005|Overall Study|Progressive disease|0|||
23561702|NCT01287520|65786253|FG006|Overall Study|Progressive disease|2|||
23561703|NCT01287520|65786254|FG007|Overall Study|Progressive disease|2|||
23561704|NCT01287520|65786255|FG008|Overall Study|Progressive disease|4|||
23561705|NCT01287520|65786247|FG000|Overall Study|Withdrawal by Subject|0|||
23561706|NCT01287520|65786248|FG001|Overall Study|Withdrawal by Subject|0|||
23561707|NCT01287520|65786249|FG002|Overall Study|Withdrawal by Subject|0|||
23561708|NCT01287520|65786250|FG003|Overall Study|Withdrawal by Subject|0|||
23561709|NCT01287520|65786251|FG004|Overall Study|Withdrawal by Subject|0|||
23561710|NCT01287520|65786252|FG005|Overall Study|Withdrawal by Subject|1|||
23561711|NCT01287520|65786253|FG006|Overall Study|Withdrawal by Subject|0|||
23561712|NCT01287520|65786254|FG007|Overall Study|Withdrawal by Subject|0|||
23561713|NCT01287520|65786255|FG008|Overall Study|Withdrawal by Subject|1|||
23561714|NCT02924389|65786261|FG000|Overall Study|Lost to Follow-up|1|||
23561715|NCT02924389|65786262|FG001|Overall Study|Lost to Follow-up|0|||
23561716|NCT02924389|65786261|FG000|Overall Study|Physician Decision|2|||
23561717|NCT02924389|65786262|FG001|Overall Study|Physician Decision|0|||
23561718|NCT02924389|65786261|FG000|Overall Study|Withdrawal by Subject|3|||
23561719|NCT02924389|65786262|FG001|Overall Study|Withdrawal by Subject|0|||
23561720|NCT02924389|65786261|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
23561721|NCT02924389|65786262|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
23561722|NCT00782496|65786264|FG000|Overall Study|Lost to Follow-up|14|||
23561723|NCT00782496|65786265|FG001|Overall Study|Lost to Follow-up|15|||
23561724|NCT00622180|65786268|FG000|Overall Study|Lost to Follow-up|1|||
23561725|NCT00622180|65786269|FG001|Overall Study|Lost to Follow-up|2|||
23561726|NCT01669798|65786270|FG000|Overall Study|Physician Decision|5|||
23561727|NCT02259517|65786272|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
23561728|NCT02259517|65786273|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
23561729|NCT02259517|65786274|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
23561730|NCT02259517|65786272|FG000|Overall Study|Withdrawal by Subject|0|||
23561731|NCT02259517|65786273|FG001|Overall Study|Withdrawal by Subject|0|||
23561732|NCT02259517|65786274|FG002|Overall Study|Withdrawal by Subject|3|||
23561733|NCT01370525|65786275|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
23561734|NCT01370525|65786276|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
23561735|NCT01370525|65786275|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23561736|NCT01370525|65786276|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23561737|NCT01370525|65786275|FG000|Overall Study|Adverse Event|0|||
23561738|NCT01370525|65786276|FG001|Overall Study|Adverse Event|1|||
23561739|NCT01370525|65786275|FG000|Overall Study|Protocol Violation|2|||
23561740|NCT01370525|65786276|FG001|Overall Study|Protocol Violation|1|||
23561741|NCT01370525|65786275|FG000|Overall Study|Lost to follow up|2|||
23561742|NCT01370525|65786276|FG001|Overall Study|Lost to follow up|6|||
23561743|NCT02552238|65786279|FG000|Overall Study|Withdrawal by Subject|2|||
23561744|NCT02552238|65786279|FG000|Overall Study|Adverse Event|2|||
23561745|NCT02583425|65786284|FG000|Screening|Did not meet entry criteria|12|||
23561746|NCT02583425|65786284|FG000|Baseline|Did not meet continued criteria|5|||
23561747|NCT02583425|65786284|FG000|Treatment Period|Adverse Event|1|||
23561748|NCT01330433|65786285|FG000|Overall Study|Death|1|||
23561749|NCT01330433|65786286|FG001|Overall Study|Death|3|||
23561750|NCT01330433|65786285|FG000|Overall Study|Lost to Follow-up|1|||
23561751|NCT01330433|65786286|FG001|Overall Study|Lost to Follow-up|0|||
23561752|NCT02946918|65786287|FG000|Overall Study|Patient unblinded himself|1|||
23561753|NCT02946918|65786288|FG001|Overall Study|Patient unblinded himself|0|||
23561754|NCT02946918|65786287|FG000|Overall Study|Physician Decision|0|||
23561755|NCT02946918|65786288|FG001|Overall Study|Physician Decision|2|||
23561756|NCT02946918|65786287|FG000|Overall Study|Ran out of study medication|0|||
23561757|NCT02946918|65786288|FG001|Overall Study|Ran out of study medication|1|||
23561758|NCT01650519|65786289|FG000|Overall Study|Withdrawal by Subject|1|||
23561759|NCT01650519|65786290|FG001|Overall Study|Withdrawal by Subject|0|||
23561760|NCT00758459|65786291|FG000|Overall Study|Adverse Event|3|||
23561761|NCT00758459|65786292|FG001|Overall Study|Adverse Event|2|||
23561762|NCT00758459|65786291|FG000|Overall Study|Protocol Violation|0|||
23561763|NCT00758459|65786292|FG001|Overall Study|Protocol Violation|1|||
23561764|NCT00758459|65786291|FG000|Overall Study|Withdrawal by Subject|0|||
23561765|NCT00758459|65786292|FG001|Overall Study|Withdrawal by Subject|1|||
23561766|NCT00550550|65786295|FG000|Overall Study|Adverse Event|13|||
23561767|NCT00550550|65786296|FG001|Overall Study|Adverse Event|5|||
23561768|NCT00550550|65786295|FG000|Overall Study|Treatment Failure|0|||
23561769|NCT00550550|65786296|FG001|Overall Study|Treatment Failure|1|||
23625313|NCT02057575|66015460|FG001|Overall Study|Protocol Violation|1|||
23561770|NCT00550550|65786295|FG000|Overall Study|Lost to Follow-up|4|||
23561771|NCT00550550|65786296|FG001|Overall Study|Lost to Follow-up|0|||
23561772|NCT00550550|65786295|FG000|Overall Study|Withdrawal by Subject|10|||
23561773|NCT00550550|65786296|FG001|Overall Study|Withdrawal by Subject|8|||
23561774|NCT00550550|65786295|FG000|Overall Study|Protocol Violation|5|||
23561775|NCT00550550|65786296|FG001|Overall Study|Protocol Violation|14|||
23561776|NCT00550550|65786295|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23561777|NCT00550550|65786296|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23561778|NCT00550550|65786295|FG000|Overall Study|Randomized But Not Treated|1|||
23561779|NCT00550550|65786296|FG001|Overall Study|Randomized But Not Treated|0|||
23561780|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Adverse Event|0|||
23561781|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Adverse Event|0|||
23561782|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Adverse Event|0|||
23561783|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Adverse Event|0|||
23561784|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Adverse Event|0|||
23561785|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Adverse Event|1|||
23561786|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Adverse Event|0|||
23561787|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Adverse Event|1|||
23561788|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Adverse Event|0|||
23561789|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Adverse Event|0|||
23561790|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23757163|NCT00267020|66489637|FG000|Overall Study|Disease Progression|39|||
23757164|NCT00267020|66489638|FG001|Overall Study|Disease Progression|25|||
23757165|NCT00267020|66489637|FG000|Overall Study|Unrelated Complication|1|||
23757166|NCT00267020|66489638|FG001|Overall Study|Unrelated Complication|1|||
23757167|NCT00267020|66489637|FG000|Overall Study|Sponsor Request|1|||
23757168|NCT00267020|66489638|FG001|Overall Study|Sponsor Request|0|||
23757169|NCT00267020|66489637|FG000|Overall Study|Other|1|||
23757170|NCT00267020|66489638|FG001|Overall Study|Other|2|||
23826440|NCT02932462|66745064|FG000|Overall Study|Adverse Event|1|||
23826441|NCT02932462|66745065|FG001|Overall Study|Adverse Event|2|||
23826442|NCT02932462|66745064|FG000|Overall Study|Lost to Follow-up|4|||
23826443|NCT02932462|66745065|FG001|Overall Study|Lost to Follow-up|1|||
23826444|NCT02932462|66745064|FG000|Overall Study|Protocol Violation|0|||
23826445|NCT02932462|66745065|FG001|Overall Study|Protocol Violation|5|||
23826446|NCT02932462|66745064|FG000|Overall Study|Withdrawal by Subject|1|||
23826447|NCT02932462|66745065|FG001|Overall Study|Withdrawal by Subject|4|||
23561791|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561792|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561793|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561794|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561795|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561796|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561797|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23625314|NCT02057575|66015461|FG002|Overall Study|Protocol Violation|0|||
23625315|NCT02057575|66015462|FG003|Overall Study|Protocol Violation|0|||
23757171|NCT05028751|66489639|FG000|Overall Study|Study Terminated by Sponsor|3|||
23757172|NCT05028751|66489640|FG001|Overall Study|Study Terminated by Sponsor|0|||
23826448|NCT02932462|66745064|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23826449|NCT02932462|66745065|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23826450|NCT02932462|66745064|FG000|Overall Study|Progressive Disease|1|||
23826451|NCT02932462|66745065|FG001|Overall Study|Progressive Disease|0|||
23826452|NCT02163057|66745073|FG000|Overall Study|Participant Refusal to Continue|2|||
23826453|NCT02163057|66745074|FG001|Overall Study|Participant Refusal to Continue|2|||
23826454|NCT02163057|66745073|FG000|Overall Study|Participant Significant Noncompliance|0|||
23826455|NCT02163057|66745074|FG001|Overall Study|Participant Significant Noncompliance|1|||
23826456|NCT02163057|66745073|FG000|Overall Study|Progression of Disease|1|||
23826457|NCT02163057|66745074|FG001|Overall Study|Progression of Disease|2|||
23826458|NCT02860546|66745075|FG000|Overall Study|Clinical Progression|6|||
23826459|NCT02860546|66745075|FG000|Overall Study|Radiological Progression|12|||
23826460|NCT02566889|66745076|FG000|Overall Study|Withdrawal by Subject|3|||
23826461|NCT02566889|66745077|FG001|Overall Study|Withdrawal by Subject|1|||
23826462|NCT02566889|66745076|FG000|Overall Study|Adverse Event|4|||
23561798|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561799|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23757173|NCT05028751|66489641|FG002|Overall Study|Study Terminated by Sponsor|0|||
23826463|NCT02566889|66745077|FG001|Overall Study|Adverse Event|2|||
23826464|NCT02566889|66745076|FG000|Overall Study|Other|6|||
23826465|NCT02566889|66745077|FG001|Overall Study|Other|2|||
23826466|NCT03817190|66745081|FG000|Overall Study|Early Termination|13|||
23439250|NCT01393639|65352375|FG001|Overall Study|Protocol Violation|0|||
23439251|NCT01393639|65352376|FG002|Overall Study|Protocol Violation|0|||
23439252|NCT01393639|65352377|FG003|Overall Study|Protocol Violation|1|||
23439253|NCT01393639|65352378|FG004|Overall Study|Protocol Violation|0|||
23439254|NCT01393639|65352379|FG005|Overall Study|Protocol Violation|0|||
23439255|NCT01393639|65352380|FG006|Overall Study|Protocol Violation|0|||
23439256|NCT01393639|65352374|FG000|Overall Study|Other|0|||
23439257|NCT01393639|65352375|FG001|Overall Study|Other|2|||
23439258|NCT01393639|65352376|FG002|Overall Study|Other|0|||
23439259|NCT01393639|65352377|FG003|Overall Study|Other|2|||
23439260|NCT01393639|65352378|FG004|Overall Study|Other|1|||
23439261|NCT01393639|65352379|FG005|Overall Study|Other|0|||
23439262|NCT01393639|65352380|FG006|Overall Study|Other|1|||
23439263|NCT01393639|65352374|FG000|Overall Study|Withdrawal by Subject|1|||
23439264|NCT01393639|65352375|FG001|Overall Study|Withdrawal by Subject|1|||
23439265|NCT01393639|65352376|FG002|Overall Study|Withdrawal by Subject|0|||
23439266|NCT01393639|65352377|FG003|Overall Study|Withdrawal by Subject|0|||
23439267|NCT01393639|65352378|FG004|Overall Study|Withdrawal by Subject|0|||
23439268|NCT01393639|65352379|FG005|Overall Study|Withdrawal by Subject|0|||
23439269|NCT01393639|65352380|FG006|Overall Study|Withdrawal by Subject|1|||
23439270|NCT01393639|65352374|FG000|Overall Study|Medication error without associated AE|0|||
23439271|NCT01393639|65352375|FG001|Overall Study|Medication error without associated AE|0|||
23439272|NCT01393639|65352376|FG002|Overall Study|Medication error without associated AE|0|||
23439273|NCT01393639|65352377|FG003|Overall Study|Medication error without associated AE|0|||
23439274|NCT01393639|65352378|FG004|Overall Study|Medication error without associated AE|0|||
23439275|NCT01393639|65352379|FG005|Overall Study|Medication error without associated AE|0|||
23439276|NCT01393639|65352380|FG006|Overall Study|Medication error without associated AE|1|||
23439277|NCT01393639|65352374|FG000|Overall Study|Lost to Follow-up|0|||
23439278|NCT01393639|65352375|FG001|Overall Study|Lost to Follow-up|1|||
23439279|NCT01393639|65352376|FG002|Overall Study|Lost to Follow-up|0|||
23439280|NCT01393639|65352377|FG003|Overall Study|Lost to Follow-up|0|||
23439281|NCT01393639|65352378|FG004|Overall Study|Lost to Follow-up|0|||
23439282|NCT01393639|65352379|FG005|Overall Study|Lost to Follow-up|0|||
23439283|NCT01393639|65352380|FG006|Overall Study|Lost to Follow-up|1|||
23439284|NCT01393639|65352374|FG000|Overall Study|Lack of Efficacy|0|||
23439285|NCT01393639|65352375|FG001|Overall Study|Lack of Efficacy|0|||
23439286|NCT01393639|65352376|FG002|Overall Study|Lack of Efficacy|0|||
23439287|NCT01393639|65352377|FG003|Overall Study|Lack of Efficacy|0|||
23439288|NCT01393639|65352378|FG004|Overall Study|Lack of Efficacy|0|||
23439289|NCT01393639|65352379|FG005|Overall Study|Lack of Efficacy|0|||
23439290|NCT01393639|65352380|FG006|Overall Study|Lack of Efficacy|1|||
23439291|NCT01393639|65352374|FG000|Overall Study|Adverse Event|2|||
23439292|NCT01393639|65352375|FG001|Overall Study|Adverse Event|3|||
23439293|NCT01393639|65352376|FG002|Overall Study|Adverse Event|1|||
23439294|NCT01393639|65352377|FG003|Overall Study|Adverse Event|2|||
23439295|NCT01393639|65352378|FG004|Overall Study|Adverse Event|0|||
23439296|NCT01393639|65352379|FG005|Overall Study|Adverse Event|2|||
23439297|NCT01393639|65352380|FG006|Overall Study|Adverse Event|3|||
23439298|NCT03647267|65352392|FG000|Overall Study|Lost to Follow-up|1|||
23439299|NCT03647267|65352393|FG001|Overall Study|Lost to Follow-up|0|||
23561800|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Physician Decision|0|||
23561801|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Physician Decision|0|||
23561802|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Physician Decision|0|||
23561803|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Physician Decision|0|||
23561804|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Physician Decision|0|||
23561805|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Physician Decision|0|||
23561806|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Physician Decision|1|||
23561807|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Physician Decision|0|||
23561808|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Physician Decision|0|||
23561809|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Physician Decision|0|||
23757174|NCT05028751|66489642|FG003|Overall Study|Study Terminated by Sponsor|0|||
23757175|NCT05028751|66489639|FG000|Overall Study|Death|9|||
23757176|NCT05028751|66489640|FG001|Overall Study|Death|3|||
23561810|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561811|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561812|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
23439300|NCT03052049|65352395|FG000|Overall Study|Withdrawal by Subject|2|||
23439301|NCT01278797|65352396|FG000|Period 1|Adverse Event|0|||
23439302|NCT01278797|65352397|FG001|Period 1|Adverse Event|1|||
23439303|NCT01278797|65352396|FG000|Period 1|Protocol Violation|1|||
23439304|NCT01278797|65352397|FG001|Period 1|Protocol Violation|0|||
23439305|NCT02218008|65352398|FG000|Stage 1 (S1)|Adverse Event|6|||
23439306|NCT02218008|65352399|FG001|Stage 1 (S1)|Adverse Event|5|||
23439307|NCT02218008|65352400|FG002|Stage 1 (S1)|Adverse Event|11|||
23439308|NCT02218008|65352401|FG003|Stage 1 (S1)|Adverse Event|0|||
23439309|NCT02218008|65352402|FG004|Stage 1 (S1)|Adverse Event|0|||
23439310|NCT02218008|65352403|FG005|Stage 1 (S1)|Adverse Event|0|||
23757177|NCT05028751|66489641|FG002|Overall Study|Death|2|||
23439311|NCT02218008|65352398|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
23439312|NCT02218008|65352399|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
23439313|NCT02218008|65352400|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
23439314|NCT02218008|65352401|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
23439315|NCT02218008|65352402|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
23439316|NCT02218008|65352403|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
23439317|NCT02218008|65352398|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
23439318|NCT02218008|65352399|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
23439319|NCT02218008|65352400|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
23439320|NCT02218008|65352401|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
23439321|NCT02218008|65352402|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
23439322|NCT02218008|65352403|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
23439323|NCT02218008|65352398|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
23439324|NCT02218008|65352399|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
23439325|NCT02218008|65352400|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
23439326|NCT02218008|65352401|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
23439327|NCT02218008|65352402|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
23439328|NCT02218008|65352403|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
23439329|NCT02218008|65352398|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
23439330|NCT02218008|65352399|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
23439331|NCT02218008|65352400|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439332|NCT02218008|65352401|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439333|NCT02218008|65352402|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439334|NCT02218008|65352403|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439335|NCT02218008|65352398|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
23439336|NCT02218008|65352399|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
23439337|NCT02218008|65352400|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
23439338|NCT02218008|65352401|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
23439339|NCT02218008|65352402|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
23439340|NCT02218008|65352403|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
23439341|NCT02218008|65352398|FG000|Stage 1 (S1)|Pregnancy|0|||
23439342|NCT02218008|65352399|FG001|Stage 1 (S1)|Pregnancy|0|||
23439343|NCT02218008|65352400|FG002|Stage 1 (S1)|Pregnancy|1|||
23439344|NCT02218008|65352401|FG003|Stage 1 (S1)|Pregnancy|0|||
23439345|NCT02218008|65352402|FG004|Stage 1 (S1)|Pregnancy|0|||
23439346|NCT02218008|65352403|FG005|Stage 1 (S1)|Pregnancy|0|||
23439347|NCT02218008|65352398|FG000|Stage 1 (S1)|Protocol Violation|0|||
23439348|NCT02218008|65352399|FG001|Stage 1 (S1)|Protocol Violation|0|||
23439349|NCT02218008|65352400|FG002|Stage 1 (S1)|Protocol Violation|1|||
23439350|NCT02218008|65352401|FG003|Stage 1 (S1)|Protocol Violation|0|||
23439351|NCT02218008|65352402|FG004|Stage 1 (S1)|Protocol Violation|0|||
23439352|NCT02218008|65352403|FG005|Stage 1 (S1)|Protocol Violation|0|||
23561813|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561814|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561815|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561816|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561817|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561818|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561819|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561820|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Adverse Event|0|||
23561821|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Adverse Event|1|||
23561822|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Adverse Event|0|||
23561823|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Adverse Event|0|||
23561824|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Adverse Event|1|||
23561825|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Adverse Event|1|||
23561826|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Adverse Event|0|||
23561827|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Adverse Event|0|||
23561828|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Adverse Event|0|||
23561829|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Adverse Event|0|||
23561830|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Physician Decision|0|||
23561831|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Physician Decision|0|||
23561832|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Physician Decision|0|||
23439353|NCT02218008|65352398|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
23561833|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Physician Decision|0|||
23561834|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Physician Decision|0|||
23561835|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Physician Decision|1|||
23561836|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Physician Decision|0|||
23439354|NCT02218008|65352399|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439355|NCT02218008|65352400|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439356|NCT02218008|65352401|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439357|NCT02218008|65352402|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439358|NCT02218008|65352403|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439359|NCT02218008|65352398|FG000|Stage 2 (S2)|Adverse Event|0|||
23439360|NCT02218008|65352399|FG001|Stage 2 (S2)|Adverse Event|0|||
23439361|NCT02218008|65352400|FG002|Stage 2 (S2)|Adverse Event|0|||
23439362|NCT02218008|65352401|FG003|Stage 2 (S2)|Adverse Event|2|||
23439363|NCT02218008|65352402|FG004|Stage 2 (S2)|Adverse Event|3|||
23439364|NCT02218008|65352403|FG005|Stage 2 (S2)|Adverse Event|3|||
23439365|NCT02218008|65352398|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
23439366|NCT02218008|65352399|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
23439367|NCT02218008|65352400|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
23826467|NCT03817190|66745082|FG001|Overall Study|Early Termination|20|||
23826468|NCT03817190|66745081|FG000|Overall Study|Adverse Event|10|||
23439368|NCT02218008|65352401|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
23439369|NCT02218008|65352402|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
23439370|NCT02218008|65352403|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
23439371|NCT02218008|65352398|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
23439372|NCT02218008|65352399|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
23439373|NCT02218008|65352400|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
23826469|NCT03817190|66745082|FG001|Overall Study|Adverse Event|17|||
23826470|NCT03817190|66745081|FG000|Overall Study|Withdrawal by Subject|12|||
23826471|NCT03817190|66745082|FG001|Overall Study|Withdrawal by Subject|8|||
23826472|NCT03817190|66745081|FG000|Overall Study|Lost to Follow-up|11|||
23826473|NCT03817190|66745082|FG001|Overall Study|Lost to Follow-up|7|||
23826474|NCT03817190|66745081|FG000|Overall Study|Lack of Efficacy|7|||
23826475|NCT03817190|66745082|FG001|Overall Study|Lack of Efficacy|5|||
23826476|NCT03817190|66745081|FG000|Overall Study|Investigator Decision|5|||
23439374|NCT02218008|65352401|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
23439375|NCT02218008|65352402|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
23439376|NCT02218008|65352403|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
23439377|NCT02218008|65352398|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23561837|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Physician Decision|0|||
23561838|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Physician Decision|0|||
23561839|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Physician Decision|0|||
23561840|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561841|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561842|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23439378|NCT02218008|65352399|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439379|NCT02218008|65352400|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439380|NCT02218008|65352401|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
23439381|NCT02218008|65352402|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439382|NCT02218008|65352403|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439383|NCT02218008|65352398|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
23439384|NCT02218008|65352399|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
23439385|NCT02218008|65352400|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
23439386|NCT02218008|65352401|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
23439387|NCT02218008|65352402|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
23439388|NCT02218008|65352403|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
23439389|NCT01108523|65352404|FG000|Overall Study|Protocol Violation|4|||
23439390|NCT01463306|65352413|FG000|Overall Study|Adverse Event|6|||
23439391|NCT01463306|65352414|FG001|Overall Study|Adverse Event|9|||
23439392|NCT01463306|65352415|FG002|Overall Study|Adverse Event|3|||
23439393|NCT01463306|65352413|FG000|Overall Study|Death|3|||
23439394|NCT01463306|65352414|FG001|Overall Study|Death|3|||
23439395|NCT01463306|65352415|FG002|Overall Study|Death|0|||
23439396|NCT01463306|65352413|FG000|Overall Study|Lack of Efficacy|22|||
23439397|NCT01463306|65352414|FG001|Overall Study|Lack of Efficacy|16|||
23439398|NCT01463306|65352415|FG002|Overall Study|Lack of Efficacy|1|||
23439399|NCT01463306|65352413|FG000|Overall Study|Lost to Follow-up|5|||
23439400|NCT01463306|65352414|FG001|Overall Study|Lost to Follow-up|2|||
23439401|NCT01463306|65352415|FG002|Overall Study|Lost to Follow-up|0|||
23439402|NCT01463306|65352413|FG000|Overall Study|Protocol Violation|4|||
23439403|NCT01463306|65352414|FG001|Overall Study|Protocol Violation|0|||
23439404|NCT01463306|65352415|FG002|Overall Study|Protocol Violation|0|||
23439405|NCT01463306|65352413|FG000|Overall Study|Withdrawal by Subject|19|||
23439406|NCT01463306|65352414|FG001|Overall Study|Withdrawal by Subject|9|||
23439407|NCT01463306|65352415|FG002|Overall Study|Withdrawal by Subject|1|||
23439408|NCT01463306|65352413|FG000|Overall Study|Other|26|||
23439409|NCT01463306|65352414|FG001|Overall Study|Other|13|||
23561843|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
23561844|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
23826477|NCT03817190|66745082|FG001|Overall Study|Investigator Decision|1|||
23439410|NCT01463306|65352415|FG002|Overall Study|Other|0|||
23826478|NCT03817190|66745081|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
23439411|NCT01463306|65352413|FG000|Overall Study|Approval expiry at site|1|||
23439412|NCT01463306|65352414|FG001|Overall Study|Approval expiry at site|0|||
23439413|NCT01463306|65352415|FG002|Overall Study|Approval expiry at site|0|||
23439414|NCT03182907|65352416|FG000|Overall Study|Death|3|||
23439415|NCT03182907|65352417|FG001|Overall Study|Death|0|||
23439416|NCT03182907|65352416|FG000|Overall Study|Protocol Violation|4|||
23439417|NCT03182907|65352417|FG001|Overall Study|Protocol Violation|0|||
23439418|NCT03182907|65352416|FG000|Overall Study|Lost to Follow-up|1|||
23439419|NCT03182907|65352417|FG001|Overall Study|Lost to Follow-up|0|||
23439420|NCT03182907|65352416|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23439421|NCT03182907|65352417|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23439422|NCT00235716|65352424|FG000|Overall Study|Death|26|||
23439423|NCT00235716|65352425|FG001|Overall Study|Death|39|||
23439424|NCT00235716|65352426|FG002|Overall Study|Death|32|||
23439425|NCT00235716|65352427|FG003|Overall Study|Death|31|||
23439426|NCT00235716|65352424|FG000|Overall Study|Withdrawal by Subject|23|||
23439427|NCT00235716|65352425|FG001|Overall Study|Withdrawal by Subject|19|||
23439428|NCT00235716|65352426|FG002|Overall Study|Withdrawal by Subject|17|||
23439429|NCT00235716|65352427|FG003|Overall Study|Withdrawal by Subject|18|||
23439430|NCT00235716|65352424|FG000|Overall Study|Lost to Follow-up|12|||
23439431|NCT00235716|65352425|FG001|Overall Study|Lost to Follow-up|7|||
23439432|NCT00235716|65352426|FG002|Overall Study|Lost to Follow-up|14|||
23439433|NCT00235716|65352427|FG003|Overall Study|Lost to Follow-up|10|||
23439434|NCT00235716|65352424|FG000|Overall Study|Adverse Event|1|||
23439435|NCT00235716|65352425|FG001|Overall Study|Adverse Event|1|||
23439436|NCT00235716|65352426|FG002|Overall Study|Adverse Event|1|||
23439437|NCT00235716|65352427|FG003|Overall Study|Adverse Event|0|||
23439438|NCT00235716|65352424|FG000|Overall Study|Physician Decision|0|||
23439439|NCT00235716|65352425|FG001|Overall Study|Physician Decision|1|||
23439440|NCT00235716|65352426|FG002|Overall Study|Physician Decision|1|||
23439441|NCT00235716|65352427|FG003|Overall Study|Physician Decision|3|||
23439442|NCT02413489|65352428|FG000|Overall Study|Death|11|||
23439443|NCT02413489|65352429|FG001|Overall Study|Death|3|||
23439444|NCT02413489|65352430|FG002|Overall Study|Death|4|||
23561845|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561846|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561847|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561848|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561849|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561850|NCT00085202|65786307|FG000|Overall Study|Still on therapy|2|||
23561851|NCT00085202|65786308|FG001|Overall Study|Still on therapy|0|||
23561852|NCT00085202|65786307|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
23561853|NCT00085202|65786308|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
23561854|NCT00085202|65786307|FG000|Overall Study|Excessive toxicity|6|||
23561855|NCT00085202|65786308|FG001|Overall Study|Excessive toxicity|5|||
23561856|NCT00085202|65786307|FG000|Overall Study|Non-specified|3|||
23561857|NCT00085202|65786308|FG001|Overall Study|Non-specified|5|||
23561858|NCT00085202|65786307|FG000|Overall Study|Withdrawal by Subject|2|||
23561859|NCT00085202|65786308|FG001|Overall Study|Withdrawal by Subject|1|||
23561860|NCT00085202|65786307|FG000|Overall Study|Physician Decision|4|||
23561861|NCT00085202|65786308|FG001|Overall Study|Physician Decision|1|||
23561862|NCT00085202|65786307|FG000|Overall Study|Progressive disease|1|||
23561863|NCT00085202|65786308|FG001|Overall Study|Progressive disease|11|||
23561864|NCT03183388|65786316|FG000|Overall Study|Lost to Follow-up|3|||
23561865|NCT03183388|65786317|FG001|Overall Study|Lost to Follow-up|5|||
23561866|NCT03183388|65786316|FG000|Overall Study|Physician Decision|1|||
23561867|NCT03183388|65786317|FG001|Overall Study|Physician Decision|4|||
23561868|NCT03183388|65786316|FG000|Overall Study|Withdrawal by Subject|4|||
23561869|NCT03183388|65786317|FG001|Overall Study|Withdrawal by Subject|1|||
23561870|NCT03183388|65786316|FG000|Overall Study|Moved|1|||
23561871|NCT03183388|65786317|FG001|Overall Study|Moved|0|||
23561872|NCT03183388|65786316|FG000|Overall Study|Met Exclusion Criteria|2|||
23561873|NCT03183388|65786317|FG001|Overall Study|Met Exclusion Criteria|2|||
23561874|NCT03183388|65786316|FG000|Overall Study|COVID Pandemic Related|2|||
23561875|NCT03183388|65786317|FG001|Overall Study|COVID Pandemic Related|4|||
23561876|NCT03299686|65786318|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
23561877|NCT03299686|65786319|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
23561878|NCT03299686|65786318|FG000|Treatment Epoch|Physician Decision|1|||
23561879|NCT03299686|65786319|FG001|Treatment Epoch|Physician Decision|0|||
23561880|NCT03299686|65786318|FG000|Treatment Epoch|Adverse Event|8|||
23561881|NCT03299686|65786319|FG001|Treatment Epoch|Adverse Event|4|||
23561882|NCT03299686|65786318|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
23561883|NCT03299686|65786319|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
23561884|NCT03138733|65786326|FG000|Overall Study|Death|17|||
23561885|NCT03138733|65786327|FG001|Overall Study|Death|18|||
23439445|NCT02413489|65352428|FG000|Overall Study|Withdrawal by Subject|2|||
23439446|NCT02413489|65352429|FG001|Overall Study|Withdrawal by Subject|0|||
23439447|NCT02413489|65352430|FG002|Overall Study|Withdrawal by Subject|0|||
23439448|NCT02413489|65352428|FG000|Overall Study|Study Terminated By Sponsor|2|||
23561886|NCT03138733|65786326|FG000|Overall Study|Withdrawal by Subject|11|||
23561887|NCT03138733|65786327|FG001|Overall Study|Withdrawal by Subject|6|||
23561888|NCT03138733|65786326|FG000|Overall Study|Lost to Follow-up|3|||
23561889|NCT03138733|65786327|FG001|Overall Study|Lost to Follow-up|2|||
23561890|NCT03138733|65786326|FG000|Overall Study|Adverse Event|1|||
23561891|NCT03138733|65786327|FG001|Overall Study|Adverse Event|0|||
23561892|NCT03138733|65786326|FG000|Overall Study|Protocol Violation|1|||
23561893|NCT03138733|65786327|FG001|Overall Study|Protocol Violation|3|||
23561894|NCT03138733|65786326|FG000|Overall Study|Administrative or logistical reason|1|||
23561895|NCT03138733|65786327|FG001|Overall Study|Administrative or logistical reason|0|||
23561896|NCT03138733|65786326|FG000|Overall Study|The patient was transferred to another hospital|1|||
23561897|NCT03138733|65786327|FG001|Overall Study|The patient was transferred to another hospital|0|||
23561898|NCT02287584|65786328|FG000|the Double-blind Phase|Adverse Event|17|||
23561899|NCT02287584|65786329|FG001|the Double-blind Phase|Adverse Event|17|||
23561900|NCT02287584|65786330|FG002|the Double-blind Phase|Adverse Event|12|||
23561901|NCT02287584|65786331|FG003|the Double-blind Phase|Adverse Event|0|||
23561902|NCT02287584|65786332|FG004|the Double-blind Phase|Adverse Event|0|||
23561903|NCT02287584|65786333|FG005|the Double-blind Phase|Adverse Event|0|||
23561904|NCT02287584|65786328|FG000|the Double-blind Phase|Lack of Efficacy|18|||
23561905|NCT02287584|65786329|FG001|the Double-blind Phase|Lack of Efficacy|8|||
23561906|NCT02287584|65786330|FG002|the Double-blind Phase|Lack of Efficacy|8|||
23561907|NCT02287584|65786331|FG003|the Double-blind Phase|Lack of Efficacy|0|||
23561908|NCT02287584|65786332|FG004|the Double-blind Phase|Lack of Efficacy|0|||
23561909|NCT02287584|65786333|FG005|the Double-blind Phase|Lack of Efficacy|0|||
23561910|NCT02287584|65786328|FG000|the Double-blind Phase|Lost to Follow-up|0|||
23561911|NCT02287584|65786329|FG001|the Double-blind Phase|Lost to Follow-up|1|||
23561912|NCT02287584|65786330|FG002|the Double-blind Phase|Lost to Follow-up|1|||
23561913|NCT02287584|65786331|FG003|the Double-blind Phase|Lost to Follow-up|0|||
23439449|NCT02413489|65352429|FG001|Overall Study|Study Terminated By Sponsor|13|||
23439450|NCT02413489|65352430|FG002|Overall Study|Study Terminated By Sponsor|1|||
23439451|NCT00483938|65352431|FG000|Overall Study|Protocol Violation|0|||
23439452|NCT00483938|65352432|FG001|Overall Study|Protocol Violation|0|||
23561914|NCT02287584|65786332|FG004|the Double-blind Phase|Lost to Follow-up|0|||
23561915|NCT02287584|65786333|FG005|the Double-blind Phase|Lost to Follow-up|0|||
23561916|NCT02287584|65786328|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
23561917|NCT02287584|65786329|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
23561918|NCT02287584|65786330|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
23561919|NCT02287584|65786331|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
23561920|NCT02287584|65786332|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
23561921|NCT02287584|65786333|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
23561922|NCT02287584|65786328|FG000|the Double-blind Phase|Pregnancy|0|||
23561923|NCT02287584|65786329|FG001|the Double-blind Phase|Pregnancy|1|||
23561924|NCT02287584|65786330|FG002|the Double-blind Phase|Pregnancy|0|||
23561925|NCT02287584|65786331|FG003|the Double-blind Phase|Pregnancy|0|||
23561926|NCT02287584|65786332|FG004|the Double-blind Phase|Pregnancy|0|||
23561927|NCT02287584|65786333|FG005|the Double-blind Phase|Pregnancy|0|||
23561928|NCT02287584|65786328|FG000|the Double-blind Phase|Protocol Violation|0|||
23561929|NCT02287584|65786329|FG001|the Double-blind Phase|Protocol Violation|3|||
23561930|NCT02287584|65786330|FG002|the Double-blind Phase|Protocol Violation|0|||
23561931|NCT02287584|65786331|FG003|the Double-blind Phase|Protocol Violation|0|||
23561932|NCT02287584|65786332|FG004|the Double-blind Phase|Protocol Violation|0|||
23561933|NCT02287584|65786333|FG005|the Double-blind Phase|Protocol Violation|0|||
23561934|NCT02287584|65786328|FG000|the Double-blind Phase|other reasons|0|||
23561935|NCT02287584|65786329|FG001|the Double-blind Phase|other reasons|0|||
23561936|NCT02287584|65786330|FG002|the Double-blind Phase|other reasons|1|||
23561937|NCT02287584|65786331|FG003|the Double-blind Phase|other reasons|0|||
23561938|NCT02287584|65786332|FG004|the Double-blind Phase|other reasons|0|||
23561939|NCT02287584|65786333|FG005|the Double-blind Phase|other reasons|0|||
23561940|NCT02287584|65786328|FG000|the Open-label Phase|Did not receive drug|0|||
23561941|NCT02287584|65786329|FG001|the Open-label Phase|Did not receive drug|0|||
23757178|NCT05028751|66489642|FG003|Overall Study|Death|4|||
23439453|NCT00483938|65352433|FG002|Overall Study|Protocol Violation|0|||
23561942|NCT02287584|65786330|FG002|the Open-label Phase|Did not receive drug|0|||
23561943|NCT02287584|65786331|FG003|the Open-label Phase|Did not receive drug|7|||
23561944|NCT02287584|65786332|FG004|the Open-label Phase|Did not receive drug|6|||
23561945|NCT02287584|65786333|FG005|the Open-label Phase|Did not receive drug|4|||
23561946|NCT02287584|65786328|FG000|the Open-label Phase|Adverse Event|0|||
23561947|NCT02287584|65786329|FG001|the Open-label Phase|Adverse Event|0|||
23439454|NCT00483938|65352434|FG003|Overall Study|Protocol Violation|0|||
23561948|NCT02287584|65786330|FG002|the Open-label Phase|Adverse Event|0|||
23561949|NCT02287584|65786331|FG003|the Open-label Phase|Adverse Event|15|||
23561950|NCT02287584|65786332|FG004|the Open-label Phase|Adverse Event|12|||
23561951|NCT02287584|65786333|FG005|the Open-label Phase|Adverse Event|16|||
23561952|NCT02287584|65786328|FG000|the Open-label Phase|Lack of Efficacy|0|||
23561953|NCT02287584|65786329|FG001|the Open-label Phase|Lack of Efficacy|0|||
23561954|NCT02287584|65786330|FG002|the Open-label Phase|Lack of Efficacy|0|||
23561955|NCT02287584|65786331|FG003|the Open-label Phase|Lack of Efficacy|8|||
23561956|NCT02287584|65786332|FG004|the Open-label Phase|Lack of Efficacy|3|||
23561957|NCT02287584|65786333|FG005|the Open-label Phase|Lack of Efficacy|7|||
23561958|NCT02287584|65786328|FG000|the Open-label Phase|Lost to Follow-up|0|||
23561959|NCT02287584|65786329|FG001|the Open-label Phase|Lost to Follow-up|0|||
23561960|NCT02287584|65786330|FG002|the Open-label Phase|Lost to Follow-up|0|||
23561961|NCT02287584|65786331|FG003|the Open-label Phase|Lost to Follow-up|4|||
23561962|NCT02287584|65786332|FG004|the Open-label Phase|Lost to Follow-up|1|||
23561963|NCT02287584|65786333|FG005|the Open-label Phase|Lost to Follow-up|2|||
23561964|NCT02287584|65786328|FG000|the Open-label Phase|Withdrawal by Subject|0|||
23561965|NCT02287584|65786329|FG001|the Open-label Phase|Withdrawal by Subject|0|||
23561966|NCT02287584|65786330|FG002|the Open-label Phase|Withdrawal by Subject|0|||
23561967|NCT02287584|65786331|FG003|the Open-label Phase|Withdrawal by Subject|18|||
23561968|NCT02287584|65786332|FG004|the Open-label Phase|Withdrawal by Subject|29|||
23561969|NCT02287584|65786333|FG005|the Open-label Phase|Withdrawal by Subject|21|||
23561970|NCT02287584|65786328|FG000|the Open-label Phase|non-compliance|0|||
23561971|NCT02287584|65786329|FG001|the Open-label Phase|non-compliance|0|||
23561972|NCT02287584|65786330|FG002|the Open-label Phase|non-compliance|0|||
23561973|NCT02287584|65786331|FG003|the Open-label Phase|non-compliance|2|||
23561974|NCT02287584|65786332|FG004|the Open-label Phase|non-compliance|5|||
23561975|NCT02287584|65786333|FG005|the Open-label Phase|non-compliance|1|||
23561976|NCT02287584|65786328|FG000|the Open-label Phase|other reasons|0|||
23561977|NCT02287584|65786329|FG001|the Open-label Phase|other reasons|0|||
23561978|NCT02287584|65786330|FG002|the Open-label Phase|other reasons|0|||
23561979|NCT02287584|65786331|FG003|the Open-label Phase|other reasons|3|||
23561980|NCT02287584|65786332|FG004|the Open-label Phase|other reasons|6|||
23561981|NCT02287584|65786333|FG005|the Open-label Phase|other reasons|6|||
23561982|NCT01436201|65786339|FG000|Overall Study|Adverse Event|2|||
23561983|NCT01436201|65786339|FG000|Overall Study|Withdrawal by Subject|1|||
23561984|NCT01436201|65786339|FG000|Overall Study|Protocol Violation|1|||
23439455|NCT00483938|65352435|FG004|Overall Study|Protocol Violation|0|||
23439456|NCT00483938|65352436|FG005|Overall Study|Protocol Violation|0|||
23561985|NCT00117156|65786343|FG000|Overall Study|Adverse Event|9|||
23561986|NCT00117156|65786343|FG000|Overall Study|Physician Decision|1|||
23561987|NCT00117156|65786343|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
23561988|NCT02036645|65786347|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561989|NCT02036645|65786348|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561990|NCT02036645|65786349|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561991|NCT02036645|65786350|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561992|NCT02036645|65786351|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561993|NCT02036645|65786352|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561994|NCT02036645|65786353|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
23561995|NCT02036645|65786354|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561996|NCT02036645|65786355|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561997|NCT02036645|65786356|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561998|NCT02036645|65786357|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561999|NCT02036645|65786358|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23562000|NCT02036645|65786347|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562001|NCT02036645|65786348|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562002|NCT02036645|65786349|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562003|NCT02036645|65786350|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
23562004|NCT02036645|65786351|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562005|NCT02036645|65786352|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562006|NCT02036645|65786353|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562007|NCT02036645|65786354|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562008|NCT02036645|65786355|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562009|NCT02036645|65786356|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562010|NCT02036645|65786357|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562011|NCT02036645|65786358|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562012|NCT04525547|65786359|FG000|Overall Study|Not treated with Ofev|2|||
23562013|NCT04525547|65786359|FG000|Overall Study|Off-label use|2|||
23826479|NCT03817190|66745082|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
23826480|NCT03817190|66745081|FG000|Overall Study|Lack of Contact|1|||
23562014|NCT04525547|65786359|FG000|Overall Study|Lost to Follow-up|1|||
23562015|NCT01641926|65786366|FG000|Overall Study|Adverse Event|5|||
23562016|NCT01641926|65786367|FG001|Overall Study|Adverse Event|2|||
23562017|NCT01641926|65786368|FG002|Overall Study|Adverse Event|3|||
23562018|NCT01641926|65786369|FG003|Overall Study|Adverse Event|1|||
23562019|NCT01641926|65786366|FG000|Overall Study|Lost to Follow-up|2|||
23439457|NCT00483938|65352437|FG006|Overall Study|Protocol Violation|3|||
23439458|NCT00483938|65352431|FG000|Overall Study|Withdrawal by Subject|1|||
23439459|NCT00483938|65352432|FG001|Overall Study|Withdrawal by Subject|6|||
23439460|NCT00483938|65352433|FG002|Overall Study|Withdrawal by Subject|0|||
23439461|NCT00483938|65352434|FG003|Overall Study|Withdrawal by Subject|0|||
23439462|NCT00483938|65352435|FG004|Overall Study|Withdrawal by Subject|1|||
23439463|NCT00483938|65352436|FG005|Overall Study|Withdrawal by Subject|3|||
23439464|NCT00483938|65352437|FG006|Overall Study|Withdrawal by Subject|2|||
23439465|NCT00483938|65352431|FG000|Overall Study|Lost to Follow-up|1|||
23439466|NCT00483938|65352432|FG001|Overall Study|Lost to Follow-up|2|||
23439467|NCT00483938|65352433|FG002|Overall Study|Lost to Follow-up|0|||
23439468|NCT00483938|65352434|FG003|Overall Study|Lost to Follow-up|2|||
23439469|NCT00483938|65352435|FG004|Overall Study|Lost to Follow-up|1|||
23439470|NCT00483938|65352436|FG005|Overall Study|Lost to Follow-up|1|||
23439471|NCT00483938|65352437|FG006|Overall Study|Lost to Follow-up|3|||
23439472|NCT00483938|65352431|FG000|Overall Study|Death|0|||
23439473|NCT00483938|65352432|FG001|Overall Study|Death|2|||
23439474|NCT00483938|65352433|FG002|Overall Study|Death|0|||
23439475|NCT00483938|65352434|FG003|Overall Study|Death|0|||
23439476|NCT00483938|65352435|FG004|Overall Study|Death|0|||
23439477|NCT00483938|65352436|FG005|Overall Study|Death|0|||
23439478|NCT00483938|65352437|FG006|Overall Study|Death|0|||
23439479|NCT00483938|65352431|FG000|Overall Study|Other|3|||
23439480|NCT00483938|65352432|FG001|Overall Study|Other|9|||
23439481|NCT00483938|65352433|FG002|Overall Study|Other|0|||
23439482|NCT00483938|65352434|FG003|Overall Study|Other|4|||
23439483|NCT00483938|65352435|FG004|Overall Study|Other|0|||
23439484|NCT00483938|65352436|FG005|Overall Study|Other|4|||
23439485|NCT00483938|65352437|FG006|Overall Study|Other|32|||
23439486|NCT03214406|65352438|FG000|Overall Study|did not meet enrollment criteria|9|||
23439487|NCT03214406|65352439|FG001|Overall Study|did not meet enrollment criteria|13|||
23439488|NCT03214406|65352438|FG000|Overall Study|Withdrawal by Subject|1|||
23439489|NCT03214406|65352439|FG001|Overall Study|Withdrawal by Subject|0|||
23439490|NCT03214406|65352438|FG000|Overall Study|Lost to Follow-up|0|||
23439491|NCT03214406|65352439|FG001|Overall Study|Lost to Follow-up|2|||
23439492|NCT00621140|65352440|FG000|Overall Study|Adverse Event|4|||
23439493|NCT00621140|65352441|FG001|Overall Study|Adverse Event|5|||
23439494|NCT00621140|65352440|FG000|Overall Study|Lost to Follow-up|1|||
23439495|NCT00621140|65352441|FG001|Overall Study|Lost to Follow-up|2|||
23439496|NCT00621140|65352440|FG000|Overall Study|Withdrawal by Subject|4|||
23439497|NCT00621140|65352441|FG001|Overall Study|Withdrawal by Subject|6|||
23439498|NCT00621140|65352440|FG000|Overall Study|Other incl. lack of efficacy|6|||
23439499|NCT00621140|65352441|FG001|Overall Study|Other incl. lack of efficacy|5|||
23439500|NCT00635882|65352442|FG000|Overall Study|Protocol Violation|1|||
23439501|NCT00635882|65352443|FG001|Overall Study|Protocol Violation|0|||
23439502|NCT00635882|65352444|FG002|Overall Study|Protocol Violation|0|||
23439503|NCT00635882|65352445|FG003|Overall Study|Protocol Violation|0|||
23439504|NCT00635882|65352446|FG004|Overall Study|Protocol Violation|0|||
23439505|NCT00635882|65352447|FG005|Overall Study|Protocol Violation|0|||
23439506|NCT01611194|65352448|FG000|Overall Study|Lost to Follow-up|0|||
23439507|NCT01611194|65352449|FG001|Overall Study|Lost to Follow-up|1|||
23439508|NCT01611194|65352448|FG000|Overall Study|Withdrawal by Subject|0|||
23439509|NCT01611194|65352449|FG001|Overall Study|Withdrawal by Subject|1|||
23439510|NCT01611194|65352448|FG000|Overall Study|drug use|0|||
23439511|NCT01611194|65352449|FG001|Overall Study|drug use|1|||
23439512|NCT00599755|65352450|FG000|Overall Study|Adverse Event|11|||
23439513|NCT00599755|65352450|FG000|Overall Study|Withdrawal by Subject|2|||
23562020|NCT01641926|65786367|FG001|Overall Study|Lost to Follow-up|2|||
23562021|NCT01641926|65786368|FG002|Overall Study|Lost to Follow-up|1|||
23562022|NCT01641926|65786369|FG003|Overall Study|Lost to Follow-up|0|||
23826481|NCT03817190|66745082|FG001|Overall Study|Lack of Contact|0|||
23826482|NCT03817190|66745081|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
23826483|NCT03817190|66745082|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
23439514|NCT00599755|65352450|FG000|Overall Study|Progression of Disease|3|||
23439515|NCT00599755|65352450|FG000|Overall Study|Other Reason|2|||
23439516|NCT00599755|65352450|FG000|Overall Study|No data available|1|||
23439517|NCT02119663|65352451|FG000|Overall Study|Disease progression|26|||
23439518|NCT02119663|65352452|FG001|Overall Study|Disease progression|27|||
23439519|NCT02119663|65352451|FG000|Overall Study|Adverse Event|5|||
23439520|NCT02119663|65352452|FG001|Overall Study|Adverse Event|5|||
23562023|NCT01641926|65786366|FG000|Overall Study|Physician Decision|6|||
23826484|NCT02964247|66745085|FG000|Overall Study|Lost to Follow-up|2|||
23439521|NCT02119663|65352451|FG000|Overall Study|Death|3|||
23439522|NCT02119663|65352452|FG001|Overall Study|Death|2|||
23439523|NCT02119663|65352451|FG000|Overall Study|Physician Decision|1|||
23439524|NCT02119663|65352452|FG001|Overall Study|Physician Decision|2|||
23439525|NCT02119663|65352451|FG000|Overall Study|Other unspecified|2|||
23562024|NCT01641926|65786367|FG001|Overall Study|Physician Decision|5|||
23562025|NCT01641926|65786368|FG002|Overall Study|Physician Decision|0|||
23562026|NCT01641926|65786369|FG003|Overall Study|Physician Decision|1|||
23562027|NCT01641926|65786366|FG000|Overall Study|Protocol Violation|1|||
23562028|NCT01641926|65786367|FG001|Overall Study|Protocol Violation|0|||
23562029|NCT01641926|65786368|FG002|Overall Study|Protocol Violation|0|||
23562030|NCT01641926|65786369|FG003|Overall Study|Protocol Violation|1|||
23562031|NCT01641926|65786366|FG000|Overall Study|Withdrawal by Subject|13|||
23562032|NCT01641926|65786367|FG001|Overall Study|Withdrawal by Subject|5|||
23562033|NCT01641926|65786368|FG002|Overall Study|Withdrawal by Subject|6|||
23562034|NCT01641926|65786369|FG003|Overall Study|Withdrawal by Subject|1|||
23562035|NCT01641926|65786366|FG000|Overall Study|Not Treated|1|||
23562036|NCT01641926|65786367|FG001|Overall Study|Not Treated|1|||
23562037|NCT01641926|65786368|FG002|Overall Study|Not Treated|1|||
23562038|NCT01641926|65786369|FG003|Overall Study|Not Treated|0|||
23562039|NCT02799784|65786370|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
23562040|NCT02799784|65786371|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
23562041|NCT02799784|65786370|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
23562042|NCT02799784|65786371|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
23562043|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
23562044|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
23562045|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
23562046|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
23562047|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
23562048|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
23562049|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
23562050|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
23562051|NCT01800201|65786372|FG000|Overall Study|Withdrawal by Subject|2|||
23562052|NCT01800201|65786373|FG001|Overall Study|Withdrawal by Subject|0|||
23757179|NCT05028751|66489639|FG000|Overall Study|Withdrawal by Subject|0|||
23757180|NCT05028751|66489640|FG001|Overall Study|Withdrawal by Subject|0|||
23757181|NCT05028751|66489641|FG002|Overall Study|Withdrawal by Subject|1|||
23757182|NCT05028751|66489642|FG003|Overall Study|Withdrawal by Subject|0|||
23757183|NCT05028751|66489639|FG000|Overall Study|Miscellaneous|2|||
23757184|NCT05028751|66489640|FG001|Overall Study|Miscellaneous|0|||
23562053|NCT01800201|65786372|FG000|Overall Study|patient privacy concerns|1|||
23562054|NCT01800201|65786373|FG001|Overall Study|patient privacy concerns|1|||
23562055|NCT01800201|65786372|FG000|Overall Study|did not want to use device|0|||
23562056|NCT01800201|65786373|FG001|Overall Study|did not want to use device|1|||
23562057|NCT01800201|65786372|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
23562058|NCT01800201|65786373|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
23562059|NCT05674890|65786374|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
23562060|NCT05674890|65786375|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
23562061|NCT05674890|65786374|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
23562062|NCT05674890|65786375|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
23562063|NCT05674890|65786374|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
23562064|NCT05674890|65786375|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
23562065|NCT03012061|65786376|FG000|Overall Study|Withdrawal by Subject|1|||
23562066|NCT03012061|65786377|FG001|Overall Study|Withdrawal by Subject|5|||
23562067|NCT03012061|65786378|FG002|Overall Study|Withdrawal by Subject|4|||
23562068|NCT03012061|65786376|FG000|Overall Study|Investigator Site Closed|1|||
23562069|NCT03012061|65786377|FG001|Overall Study|Investigator Site Closed|2|||
23562070|NCT03012061|65786378|FG002|Overall Study|Investigator Site Closed|0|||
23562071|NCT03012061|65786376|FG000|Overall Study|Lost to Follow-up|2|||
23562072|NCT03012061|65786377|FG001|Overall Study|Lost to Follow-up|1|||
23562073|NCT03012061|65786378|FG002|Overall Study|Lost to Follow-up|0|||
23562074|NCT03012061|65786376|FG000|Overall Study|Study closed/ Terminated|0|||
23757185|NCT05028751|66489641|FG002|Overall Study|Miscellaneous|0|||
23826485|NCT02964247|66745086|FG001|Overall Study|Lost to Follow-up|0|||
23826486|NCT02964247|66745085|FG000|Overall Study|Withdrawal by Subject|1|||
23562075|NCT03012061|65786377|FG001|Overall Study|Study closed/ Terminated|0|||
23562076|NCT03012061|65786378|FG002|Overall Study|Study closed/ Terminated|1|||
23562077|NCT03012061|65786376|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
23562078|NCT03012061|65786377|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
23562079|NCT03012061|65786378|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
23562080|NCT03012061|65786376|FG000|Overall Study|Protocol Violation|0|||
23757186|NCT05028751|66489642|FG003|Overall Study|Miscellaneous|0|||
23757187|NCT01169844|66489643|FG000|Overall Study|Adverse Event|0|||
23757188|NCT01169844|66489644|FG001|Overall Study|Adverse Event|1|||
23757189|NCT01169844|66489643|FG000|Overall Study|Patient withdrew consent|4|||
23757190|NCT01169844|66489644|FG001|Overall Study|Patient withdrew consent|0|||
23757191|NCT01169844|66489643|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23757192|NCT01169844|66489644|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23757193|NCT01399125|66489645|FG000|Overall Study|Adverse Event|32|||
23757194|NCT01399125|66489646|FG001|Overall Study|Adverse Event|30|||
23757195|NCT01399125|66489645|FG000|Overall Study|Abnormal Lab values|0|||
23757196|NCT01399125|66489646|FG001|Overall Study|Abnormal Lab values|1|||
23757197|NCT01399125|66489645|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23757198|NCT01399125|66489646|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23757199|NCT01399125|66489645|FG000|Overall Study|Withdrawal by Subject|5|||
23757200|NCT01399125|66489646|FG001|Overall Study|Withdrawal by Subject|8|||
23757201|NCT01399125|66489645|FG000|Overall Study|Lost to Follow-up|2|||
23757202|NCT01399125|66489646|FG001|Overall Study|Lost to Follow-up|3|||
23757203|NCT01399125|66489645|FG000|Overall Study|Administrative Problems|7|||
23757204|NCT01399125|66489646|FG001|Overall Study|Administrative Problems|11|||
23757205|NCT01399125|66489645|FG000|Overall Study|Death|0|||
23757206|NCT01399125|66489646|FG001|Overall Study|Death|1|||
23757207|NCT01399125|66489645|FG000|Overall Study|Protocol Deviation|5|||
23757208|NCT01399125|66489646|FG001|Overall Study|Protocol Deviation|2|||
23757209|NCT00766506|66489654|FG000|Overall Study|Use rescue medication after 3 hours|3|||
23757210|NCT00766506|66489655|FG001|Overall Study|Use rescue medication after 3 hours|0|||
23757211|NCT00766506|66489654|FG000|Overall Study|Other|2|||
23757212|NCT00766506|66489655|FG001|Overall Study|Other|2|||
23757213|NCT01430104|66489659|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
23757214|NCT00096200|66489660|FG000|Overall Study|Adverse Event|0|||
23757215|NCT00096200|66489661|FG001|Overall Study|Adverse Event|4|||
23757216|NCT00096200|66489662|FG002|Overall Study|Adverse Event|0|||
23826487|NCT02964247|66745086|FG001|Overall Study|Withdrawal by Subject|2|||
23826488|NCT02370238|66745090|FG000|Overall Study|Death|42|||
23562081|NCT03012061|65786377|FG001|Overall Study|Protocol Violation|0|||
23562082|NCT03012061|65786378|FG002|Overall Study|Protocol Violation|2|||
23562083|NCT03012061|65786376|FG000|Overall Study|Lack of Efficacy|0|||
23562084|NCT03012061|65786377|FG001|Overall Study|Lack of Efficacy|1|||
23826489|NCT02370238|66745091|FG001|Overall Study|Death|35|||
23826490|NCT02370238|66745090|FG000|Overall Study|Lost to Follow-up|1|||
23826491|NCT02370238|66745091|FG001|Overall Study|Lost to Follow-up|3|||
23562085|NCT03012061|65786378|FG002|Overall Study|Lack of Efficacy|0|||
23562086|NCT03012061|65786376|FG000|Overall Study|Adverse Event|2|||
23562087|NCT03012061|65786377|FG001|Overall Study|Adverse Event|0|||
23562088|NCT03012061|65786378|FG002|Overall Study|Adverse Event|0|||
23562089|NCT03287414|65786379|FG000|Treatment Epoch|Adverse Event|0|||
23562090|NCT03287414|65786380|FG001|Treatment Epoch|Adverse Event|1|||
23562091|NCT03287414|65786379|FG000|Treatment Epoch|Study terminated by sponsor|2|||
23562092|NCT03287414|65786380|FG001|Treatment Epoch|Study terminated by sponsor|2|||
23826492|NCT02370238|66745090|FG000|Overall Study|Withdrawal by Subject|2|||
23826493|NCT02370238|66745091|FG001|Overall Study|Withdrawal by Subject|6|||
23826494|NCT02370238|66745090|FG000|Overall Study|Other|2|||
23826495|NCT02370238|66745091|FG001|Overall Study|Other|1|||
23562093|NCT03287414|65786379|FG000|Treatment Epoch|Subject/Guardian decision|4|||
23562094|NCT03287414|65786380|FG001|Treatment Epoch|Subject/Guardian decision|0|||
23562095|NCT03287414|65786379|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
23757217|NCT00096200|66489660|FG000|Overall Study|Withdrawal by Subject|1|||
23826496|NCT04607135|66745092|FG000|Overall Study|Physician Decision|1|||
23826497|NCT04607135|66745092|FG000|Overall Study|Withdrawal by Subject|1|||
23826498|NCT04607135|66745092|FG000|Overall Study|Equipment not working|3|||
23826499|NCT04728802|66745093|FG000|Overall Study|Withdrawal by Subject|4|||
23562096|NCT03287414|65786380|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
23562097|NCT03287414|65786379|FG000|Treatment Epoch|Withdrawal by Subject|1|||
23757218|NCT00096200|66489661|FG001|Overall Study|Withdrawal by Subject|2|||
23757219|NCT00096200|66489662|FG002|Overall Study|Withdrawal by Subject|0|||
23757220|NCT00096200|66489660|FG000|Overall Study|Ineligible pathology|0|||
23757221|NCT00096200|66489661|FG001|Overall Study|Ineligible pathology|1|||
23757222|NCT00096200|66489662|FG002|Overall Study|Ineligible pathology|0|||
23757223|NCT00802529|66489664|FG000|Overall Study|Lost to Follow-up|0|||
23757224|NCT00802529|66489665|FG001|Overall Study|Lost to Follow-up|1|||
23757225|NCT00370396|66489666|FG000|Overall Study|Withdrawal by Subject|0|||
23757226|NCT00370396|66489667|FG001|Overall Study|Withdrawal by Subject|0|||
23757227|NCT00370396|66489668|FG002|Overall Study|Withdrawal by Subject|1|||
23757228|NCT00370396|66489666|FG000|Overall Study|Lost to Follow-up|11|||
23757229|NCT00370396|66489667|FG001|Overall Study|Lost to Follow-up|1|||
23757230|NCT00370396|66489668|FG002|Overall Study|Lost to Follow-up|0|||
23757231|NCT01336608|66489669|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
23757232|NCT01336608|66489670|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23757233|NCT01336608|66489671|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23757234|NCT01336608|66489672|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23757235|NCT01336608|66489669|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
23757236|NCT01336608|66489670|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23757237|NCT01336608|66489671|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23562098|NCT03287414|65786380|FG001|Treatment Epoch|Withdrawal by Subject|0|||
23757238|NCT01336608|66489672|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23757239|NCT01336608|66489669|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
23757240|NCT01336608|66489670|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23757241|NCT01336608|66489671|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23757242|NCT01336608|66489672|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23757243|NCT01336608|66489669|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
23562099|NCT03287414|65786379|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
23562100|NCT03287414|65786380|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
23562101|NCT03287414|65786379|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
23562102|NCT03287414|65786380|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
23562103|NCT00638235|65786387|FG000|Overall Study|Lost to Follow-up|31|||
23562104|NCT00638235|65786388|FG001|Overall Study|Lost to Follow-up|3|||
23562105|NCT00638235|65786389|FG002|Overall Study|Lost to Follow-up|18|||
23562106|NCT00638235|65786390|FG003|Overall Study|Lost to Follow-up|10|||
23562107|NCT00638235|65786391|FG004|Overall Study|Lost to Follow-up|13|||
23562108|NCT00638235|65786392|FG005|Overall Study|Lost to Follow-up|26|||
23562109|NCT00638235|65786393|FG006|Overall Study|Lost to Follow-up|0|||
23562110|NCT00638235|65786394|FG007|Overall Study|Lost to Follow-up|1|||
23562111|NCT00638235|65786395|FG008|Overall Study|Lost to Follow-up|18|||
23562112|NCT00245102|65786397|FG000|Overall Study|Not Treated|1|||
23562113|NCT00245102|65786398|FG001|Overall Study|Not Treated|0|||
23562114|NCT00245102|65786399|FG002|Overall Study|Not Treated|1|||
23562115|NCT00245102|65786400|FG003|Overall Study|Not Treated|0|||
23562116|NCT00245102|65786401|FG004|Overall Study|Not Treated|0|||
23562117|NCT00245102|65786402|FG005|Overall Study|Not Treated|0|||
23562118|NCT00245102|65786397|FG000|Overall Study|Protocol Violation|1|||
23562119|NCT00245102|65786398|FG001|Overall Study|Protocol Violation|0|||
23562120|NCT00245102|65786399|FG002|Overall Study|Protocol Violation|0|||
23562121|NCT00245102|65786400|FG003|Overall Study|Protocol Violation|0|||
23562122|NCT00245102|65786401|FG004|Overall Study|Protocol Violation|0|||
23562123|NCT00245102|65786402|FG005|Overall Study|Protocol Violation|0|||
23562124|NCT00245102|65786397|FG000|Overall Study|Death|0|||
23562125|NCT00245102|65786398|FG001|Overall Study|Death|0|||
23562126|NCT00245102|65786399|FG002|Overall Study|Death|0|||
23562127|NCT00245102|65786400|FG003|Overall Study|Death|1|||
23562128|NCT00245102|65786401|FG004|Overall Study|Death|0|||
23562129|NCT00245102|65786402|FG005|Overall Study|Death|0|||
23562130|NCT00245102|65786397|FG000|Overall Study|Adverse Event|4|||
23562131|NCT00245102|65786398|FG001|Overall Study|Adverse Event|2|||
23562132|NCT00245102|65786399|FG002|Overall Study|Adverse Event|5|||
23562133|NCT00245102|65786400|FG003|Overall Study|Adverse Event|1|||
23562134|NCT00245102|65786401|FG004|Overall Study|Adverse Event|0|||
23562135|NCT00245102|65786402|FG005|Overall Study|Adverse Event|2|||
23562136|NCT00245102|65786397|FG000|Overall Study|Decline in performance|0|||
23562137|NCT00245102|65786398|FG001|Overall Study|Decline in performance|2|||
23562138|NCT00245102|65786399|FG002|Overall Study|Decline in performance|0|||
23562139|NCT00245102|65786400|FG003|Overall Study|Decline in performance|1|||
23562140|NCT00245102|65786401|FG004|Overall Study|Decline in performance|0|||
23826500|NCT04728802|66745094|FG001|Overall Study|Withdrawal by Subject|20|||
23826501|NCT04728802|66745093|FG000|Overall Study|Physician Decision|7|||
23562141|NCT00245102|65786402|FG005|Overall Study|Decline in performance|2|||
23562142|NCT00245102|65786397|FG000|Overall Study|Participant needed surgery|0|||
23562143|NCT00245102|65786398|FG001|Overall Study|Participant needed surgery|0|||
23562144|NCT00245102|65786399|FG002|Overall Study|Participant needed surgery|1|||
23562145|NCT00245102|65786400|FG003|Overall Study|Participant needed surgery|0|||
23562146|NCT00245102|65786401|FG004|Overall Study|Participant needed surgery|0|||
23562147|NCT00245102|65786402|FG005|Overall Study|Participant needed surgery|0|||
23562148|NCT00245102|65786397|FG000|Overall Study|Clinical progression|1|||
23562149|NCT00245102|65786398|FG001|Overall Study|Clinical progression|0|||
23757244|NCT01336608|66489670|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23757245|NCT01336608|66489671|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23757246|NCT01336608|66489672|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23757247|NCT01336608|66489669|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
23757248|NCT01336608|66489670|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23757249|NCT01336608|66489671|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23757250|NCT01336608|66489672|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23757251|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23757252|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
23757253|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
23757254|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
23757255|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23757256|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23757257|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23757258|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23757259|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23757260|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23757261|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23757262|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
23757263|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23757264|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23757265|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23757266|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23757267|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
23757268|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
23757269|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
23757270|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
23757271|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23757272|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23757273|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23757274|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23757275|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23562150|NCT00245102|65786399|FG002|Overall Study|Clinical progression|0|||
23562151|NCT00245102|65786400|FG003|Overall Study|Clinical progression|0|||
23562152|NCT00245102|65786401|FG004|Overall Study|Clinical progression|0|||
23562153|NCT00245102|65786402|FG005|Overall Study|Clinical progression|0|||
23757276|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
23757277|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23757278|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
23757279|NCT01336608|66489669|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23757280|NCT01336608|66489670|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23757281|NCT01336608|66489671|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
23757282|NCT01336608|66489672|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
23757283|NCT00869089|66489678|FG000|Overall Study|Lost to Follow-up|1|||
23757284|NCT00869089|66489678|FG000|Overall Study|Withdrawal by Subject|1|||
23757285|NCT00869089|66489678|FG000|Overall Study|Screen Fail|1|||
23757286|NCT02444182|66489679|FG000|Overall Study|non-compliance|2|||
23757287|NCT02444182|66489680|FG001|Overall Study|non-compliance|1|||
23757288|NCT02444182|66489679|FG000|Overall Study|Lost to Follow-up|0|||
23757289|NCT02444182|66489680|FG001|Overall Study|Lost to Follow-up|4|||
23757290|NCT02643966|66489681|FG000|First Screening Round|ineligible|1|||
23757291|NCT02643966|66489681|FG000|First Screening Round|excluded from analysis|2|||
23757292|NCT02643966|66489681|FG000|First Screening Round|Lost to Follow-up|56|||
23757293|NCT02643966|66489681|FG000|First Screening Round|Withdrawal by Subject|28|||
23757294|NCT02643966|66489681|FG000|First Screening Round|Death|1|||
23757295|NCT02643966|66489681|FG000|Between First and Second Screening|Lost to Follow-up|65|||
23757296|NCT02643966|66489681|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
23757297|NCT02643966|66489681|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
23562154|NCT00459342|65786403|FG000|Overall Study|Not eligible|1|||
23562155|NCT00717314|65786404|FG000|Overall Study|Adverse Event|3|||
23562156|NCT00717314|65786405|FG001|Overall Study|Adverse Event|2|||
23562157|NCT00717314|65786404|FG000|Overall Study|Protocol Violation|1|||
23562158|NCT00717314|65786405|FG001|Overall Study|Protocol Violation|0|||
23757298|NCT02643966|66489681|FG000|Second Screening Round|Withdrawal by Subject|20|||
23562159|NCT00717314|65786404|FG000|Overall Study|Lost to Follow-up|1|||
23562160|NCT00717314|65786405|FG001|Overall Study|Lost to Follow-up|5|||
23562161|NCT00717314|65786404|FG000|Overall Study|Withdrawal by Subject|1|||
23562162|NCT00717314|65786405|FG001|Overall Study|Withdrawal by Subject|3|||
23562163|NCT05178121|65786406|FG000|Overall Study|Other|4|||
23562164|NCT05178121|65786406|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
23562165|NCT03386032|65786407|FG000|Overall Study|Lack of Efficacy|6|||
23562166|NCT03386032|65786408|FG001|Overall Study|Lack of Efficacy|2|||
23562167|NCT03386032|65786409|FG002|Overall Study|Lack of Efficacy|0|||
23757299|NCT02643966|66489681|FG000|Second Screening Round|Lost to Follow-up|57|||
23625316|NCT01103232|66015463|FG000|Overall Study|Withdrawal by Subject|1|||
23625317|NCT01103232|66015464|FG001|Overall Study|Withdrawal by Subject|1|||
23625318|NCT01103232|66015463|FG000|Overall Study|Protocol Violation|0|||
23625319|NCT01103232|66015464|FG001|Overall Study|Protocol Violation|1|||
23625320|NCT00853372|66015465|FG000|Overall Study|Death|30|||
23757300|NCT02643966|66489681|FG000|Second Screening Round|Physician Decision|2|||
23757301|NCT02643966|66489681|FG000|Second Screening Round|Death|4|||
23757302|NCT02643966|66489681|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
23439526|NCT02119663|65352452|FG001|Overall Study|Other unspecified|0|||
23439527|NCT02119663|65352451|FG000|Overall Study|Subject decision|0|||
23439528|NCT02119663|65352452|FG001|Overall Study|Subject decision|1|||
23439529|NCT02119663|65352451|FG000|Overall Study|Study Terminated by the Sponsor|3|||
23439530|NCT02119663|65352452|FG001|Overall Study|Study Terminated by the Sponsor|4|||
23439531|NCT00384332|65352453|FG000|Overall Study|Lost to Follow-up|4|||
23439532|NCT00384332|65352454|FG001|Overall Study|Lost to Follow-up|0|||
23439533|NCT05198843|65352455|FG000|Overall Study|Lack of Efficacy|1|||
23439534|NCT03781778|65352456|FG000|Overall Study|Withdrawal by Subject|2|||
23439535|NCT03781778|65352457|FG001|Overall Study|Withdrawal by Subject|2|||
23439536|NCT05090852|65352458|FG000|Overall Study|Physician Decision|5|||
23757303|NCT02643966|66489681|FG000|Between Second and Third Screening|Death|1|||
23757304|NCT02643966|66489681|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
23439537|NCT01357551|65352461|FG000|Overall Study|Withdrawal by Subject|6|||
23439538|NCT01357551|65352462|FG001|Overall Study|Withdrawal by Subject|4|||
23439539|NCT01357551|65352461|FG000|Overall Study|Death|0|||
23439540|NCT01357551|65352462|FG001|Overall Study|Death|1|||
23439541|NCT01357551|65352461|FG000|Overall Study|Lost to Follow-up|16|||
23439542|NCT01357551|65352462|FG001|Overall Study|Lost to Follow-up|6|||
23439543|NCT00842543|65352463|FG000|Overall Study|Withdrawal by Subject|2|||
23439544|NCT00842543|65352464|FG001|Overall Study|Withdrawal by Subject|0|||
23439545|NCT00842543|65352465|FG002|Overall Study|Withdrawal by Subject|3|||
23439546|NCT00842543|65352466|FG003|Overall Study|Withdrawal by Subject|4|||
23439547|NCT00856297|65352472|FG000|Overall Study|Unable to classify|2|||
23439548|NCT00856297|65352473|FG001|Overall Study|Unable to classify|0|||
23439549|NCT00856297|65352474|FG002|Overall Study|Unable to classify|0|||
23439550|NCT00856297|65352475|FG003|Overall Study|Unable to classify|0|||
23439551|NCT00856297|65352476|FG004|Overall Study|Unable to classify|0|||
23439552|NCT03691571|65352477|FG000|Overall Study|Withdrawal by Subject|9|||
23439553|NCT03691571|65352478|FG001|Overall Study|Withdrawal by Subject|2|||
23439554|NCT02513472|65352489|FG000|Overall Study|Radiological Disease Progression|45|||
23439555|NCT02513472|65352490|FG001|Overall Study|Radiological Disease Progression|57|||
23439556|NCT02513472|65352489|FG000|Overall Study|Clinical Disease Progression|5|||
23439557|NCT02513472|65352490|FG001|Overall Study|Clinical Disease Progression|13|||
23439558|NCT02513472|65352489|FG000|Overall Study|Adverse Event|8|||
23439559|NCT02513472|65352490|FG001|Overall Study|Adverse Event|11|||
23439560|NCT02513472|65352489|FG000|Overall Study|Withdrawal by Subject|0|||
23439561|NCT02513472|65352490|FG001|Overall Study|Withdrawal by Subject|4|||
23439562|NCT02513472|65352489|FG000|Overall Study|Subject Choice|2|||
23439563|NCT02513472|65352490|FG001|Overall Study|Subject Choice|7|||
23439564|NCT02513472|65352489|FG000|Overall Study|Treatment Completed as per Protocol|3|||
23439565|NCT02513472|65352490|FG001|Overall Study|Treatment Completed as per Protocol|3|||
23439566|NCT02513472|65352489|FG000|Overall Study|Other|3|||
23439567|NCT02513472|65352490|FG001|Overall Study|Other|6|||
23439568|NCT00048347|65352491|FG000|Overall Study|Screen failure|2|||
23562168|NCT03386032|65786407|FG000|Overall Study|Adverse Event|2|||
23562169|NCT03386032|65786408|FG001|Overall Study|Adverse Event|2|||
23757305|NCT02643966|66489681|FG000|Third Screening Round|PI excluded|2|||
23757306|NCT02643966|66489681|FG000|Third Screening Round|Lost to Follow-up|241|||
23757307|NCT01629693|66489682|FG000|Overall Study|Lost to Follow-up|2|||
23439569|NCT00416455|65352496|FG000|Overall Study|PET / CT not done|3|||
23439570|NCT00416455|65352497|FG001|Overall Study|PET / CT not done|5|||
23439571|NCT00416455|65352496|FG000|Overall Study|PET / CT poor quality|2|||
23439572|NCT00416455|65352497|FG001|Overall Study|PET / CT poor quality|1|||
23439573|NCT00416455|65352496|FG000|Overall Study|Inadequate pathology|11|||
23439574|NCT00416455|65352497|FG001|Overall Study|Inadequate pathology|2|||
23439575|NCT03043651|65352498|FG000|Overall Study|Death|1|||
23625321|NCT00853372|66015466|FG001|Overall Study|Death|26|||
23625322|NCT00853372|66015465|FG000|Overall Study|Lost to Follow-up|1|||
23562170|NCT03386032|65786409|FG002|Overall Study|Adverse Event|0|||
23562171|NCT03386032|65786407|FG000|Overall Study|Withdrawal by Subject|1|||
23439576|NCT03043651|65352498|FG000|Overall Study|Progressive Disease|2|||
23625323|NCT00853372|66015466|FG001|Overall Study|Lost to Follow-up|2|||
23439577|NCT03043651|65352498|FG000|Overall Study|Adverse Event|2|||
23439578|NCT03043651|65352498|FG000|Overall Study|Withdrawal by Subject|4|||
23439579|NCT03043651|65352498|FG000|Overall Study|Study Terminated by Sponsor|39|||
23439580|NCT00947115|65352499|FG000|Overall Study|Missed reporting interval|3|||
23439581|NCT00947115|65352500|FG001|Overall Study|Missed reporting interval|4|||
23439582|NCT00947115|65352501|FG002|Overall Study|Missed reporting interval|2|||
23439583|NCT00947115|65352499|FG000|Overall Study|Physician Decision|0|||
23439584|NCT00947115|65352500|FG001|Overall Study|Physician Decision|2|||
23439585|NCT00947115|65352501|FG002|Overall Study|Physician Decision|0|||
23562172|NCT03386032|65786408|FG001|Overall Study|Withdrawal by Subject|0|||
23562173|NCT03386032|65786409|FG002|Overall Study|Withdrawal by Subject|0|||
23562174|NCT03386032|65786407|FG000|Overall Study|Lost to Follow-up|9|||
23562175|NCT03386032|65786408|FG001|Overall Study|Lost to Follow-up|3|||
23562176|NCT03386032|65786409|FG002|Overall Study|Lost to Follow-up|0|||
23562177|NCT00224770|65786417|FG000|Overall Study|Lost to Follow-up|4|||
23562178|NCT00224770|65786418|FG001|Overall Study|Lost to Follow-up|2|||
23562179|NCT00224770|65786419|FG002|Overall Study|Lost to Follow-up|0|||
23562180|NCT02293395|65786422|FG000|Overall Study|Lost to Follow-up|1|||
23562181|NCT02293395|65786423|FG001|Overall Study|Lost to Follow-up|0|||
23562182|NCT02293395|65786422|FG000|Overall Study|Withdrawal by Subject|8|||
23562183|NCT02293395|65786423|FG001|Overall Study|Withdrawal by Subject|7|||
23562184|NCT00838682|65786428|FG000|Overall Study|Lost to Follow-up|21|||
23562185|NCT00838682|65786429|FG001|Overall Study|Lost to Follow-up|14|||
23562186|NCT00838682|65786428|FG000|Overall Study|detection of exclusion criteria|4|||
23562187|NCT00838682|65786429|FG001|Overall Study|detection of exclusion criteria|3|||
23562188|NCT00838682|65786428|FG000|Overall Study|Protocol Violation|0|||
23562189|NCT00838682|65786429|FG001|Overall Study|Protocol Violation|1|||
23757308|NCT01629693|66489683|FG001|Overall Study|Lost to Follow-up|4|||
23757309|NCT01629693|66489682|FG000|Overall Study|Withdrawal by Subject|2|||
23757310|NCT01629693|66489683|FG001|Overall Study|Withdrawal by Subject|2|||
23757311|NCT01629693|66489682|FG000|Overall Study|Adverse Event|1|||
23562190|NCT00838682|65786428|FG000|Overall Study|Withdrawal by Subject|0|||
23562191|NCT00838682|65786429|FG001|Overall Study|Withdrawal by Subject|1|||
23562192|NCT04043962|65786431|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
23562193|NCT04043962|65786431|FG000|Post-Treatment|Withdrawal by Subject|5|||
23562194|NCT04043962|65786431|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
23562195|NCT03092375|65786432|FG000|Overall Study|Lack of Efficacy|0|||
23562196|NCT03092375|65786433|FG001|Overall Study|Lack of Efficacy|1|||
23562197|NCT03092375|65786434|FG002|Overall Study|Lack of Efficacy|1|||
23562198|NCT03092375|65786435|FG003|Overall Study|Lack of Efficacy|0|||
23562199|NCT00738101|65786437|FG000|Overall Study|Physician Decision|5|||
23562200|NCT00738101|65786437|FG000|Overall Study|Death|1|||
23757312|NCT01629693|66489683|FG001|Overall Study|Adverse Event|0|||
23439586|NCT00947115|65352499|FG000|Overall Study|Death|0|||
23439587|NCT00947115|65352500|FG001|Overall Study|Death|1|||
23439588|NCT00947115|65352501|FG002|Overall Study|Death|1|||
23439589|NCT00947115|65352499|FG000|Overall Study|Migrated from study area|2|||
23439590|NCT00947115|65352500|FG001|Overall Study|Migrated from study area|0|||
23439591|NCT00947115|65352501|FG002|Overall Study|Migrated from study area|0|||
23439592|NCT00947115|65352499|FG000|Overall Study|Withdrawal by Subject|1|||
23439593|NCT00947115|65352500|FG001|Overall Study|Withdrawal by Subject|3|||
23439594|NCT00947115|65352501|FG002|Overall Study|Withdrawal by Subject|4|||
23439595|NCT00947115|65352499|FG000|Overall Study|Lost to Follow-up|11|||
23439596|NCT00947115|65352500|FG001|Overall Study|Lost to Follow-up|12|||
23439597|NCT00947115|65352501|FG002|Overall Study|Lost to Follow-up|8|||
23439598|NCT02593318|65352502|FG000|Overall Study|Withdrawal by Subject|1|||
23439599|NCT02593318|65352503|FG001|Overall Study|Withdrawal by Subject|1|||
23439600|NCT01022424|65352510|FG000|Overall Study|Adverse Event|1|||
23439601|NCT01022424|65352510|FG000|Overall Study|Physician Decision|1|||
23439602|NCT01022424|65352510|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
23439603|NCT00662909|65352511|FG000|Overall Study|Adverse Event|17|||
23439604|NCT00662909|65352512|FG001|Overall Study|Adverse Event|18|||
23439605|NCT00662909|65352513|FG002|Overall Study|Adverse Event|19|||
23439606|NCT00662909|65352511|FG000|Overall Study|Lack of Efficacy|9|||
23757313|NCT01629693|66489682|FG000|Overall Study|Investigator decision|0|||
23757314|NCT01629693|66489683|FG001|Overall Study|Investigator decision|1|||
23439607|NCT00662909|65352512|FG001|Overall Study|Lack of Efficacy|1|||
23439608|NCT00662909|65352513|FG002|Overall Study|Lack of Efficacy|5|||
23562201|NCT00738101|65786437|FG000|Overall Study|Repeat enrollment|1|||
23562202|NCT02277990|65786440|FG000|Overall Study|Death|170|||
23562203|NCT02277990|65786441|FG001|Overall Study|Death|188|||
23562204|NCT02277990|65786440|FG000|Overall Study|Withdrawal by Subject|64|||
23562205|NCT02277990|65786441|FG001|Overall Study|Withdrawal by Subject|53|||
23757315|NCT01629693|66489682|FG000|Overall Study|Poor comfort of study lenses|0|||
23439609|NCT00662909|65352511|FG000|Overall Study|Withdrawal by Subject|29|||
23757316|NCT01629693|66489683|FG001|Overall Study|Poor comfort of study lenses|2|||
23562206|NCT02277990|65786440|FG000|Overall Study|Physician Decision|40|||
23562207|NCT02277990|65786441|FG001|Overall Study|Physician Decision|34|||
23439610|NCT00662909|65352512|FG001|Overall Study|Withdrawal by Subject|22|||
23439611|NCT00662909|65352513|FG002|Overall Study|Withdrawal by Subject|16|||
23439612|NCT00662909|65352511|FG000|Overall Study|Lost to Follow-up|2|||
23439613|NCT00662909|65352512|FG001|Overall Study|Lost to Follow-up|9|||
23439614|NCT00662909|65352513|FG002|Overall Study|Lost to Follow-up|3|||
23439615|NCT00662909|65352511|FG000|Overall Study|Protocol Violation|7|||
23439616|NCT00662909|65352512|FG001|Overall Study|Protocol Violation|4|||
23439617|NCT00662909|65352513|FG002|Overall Study|Protocol Violation|5|||
23439618|NCT00662909|65352511|FG000|Overall Study|Randomized- never received study drug|1|||
23439619|NCT00662909|65352512|FG001|Overall Study|Randomized- never received study drug|0|||
23439620|NCT00662909|65352513|FG002|Overall Study|Randomized- never received study drug|0|||
23439621|NCT00662909|65352511|FG000|Overall Study|Non-compliance with study procedures|3|||
23439622|NCT00662909|65352512|FG001|Overall Study|Non-compliance with study procedures|3|||
23439623|NCT00662909|65352513|FG002|Overall Study|Non-compliance with study procedures|2|||
23562208|NCT02277990|65786440|FG000|Overall Study|Lost to Follow-up|66|||
23757317|NCT01629693|66489682|FG000|Overall Study|Subject decision unrelated to AE|0|||
23757318|NCT01629693|66489683|FG001|Overall Study|Subject decision unrelated to AE|1|||
23757319|NCT03467971|66489684|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23757320|NCT03467971|66489685|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23757321|NCT00568776|66489686|FG000|Overall Study|Adverse Event|8|||
23757322|NCT00568776|66489687|FG001|Overall Study|Adverse Event|8|||
23439624|NCT00662909|65352511|FG000|Overall Study|Physician Decision|1|||
23439625|NCT00662909|65352512|FG001|Overall Study|Physician Decision|1|||
23562209|NCT02277990|65786441|FG001|Overall Study|Lost to Follow-up|69|||
23562210|NCT02277990|65786440|FG000|Overall Study|Had other reason|26|||
23562211|NCT02277990|65786441|FG001|Overall Study|Had other reason|32|||
23562212|NCT02127372|65786442|FG000|Overall Study|Withdrawal by Subject|1|||
23562213|NCT02127372|65786443|FG001|Overall Study|Withdrawal by Subject|0|||
23562214|NCT03131960|65786446|FG000|Overall Study|Adverse Event|0|||
23562215|NCT03131960|65786447|FG001|Overall Study|Adverse Event|1|||
23562216|NCT01395823|65786448|FG000|Overall Study|Death|4|||
23562217|NCT01395823|65786449|FG001|Overall Study|Death|4|||
23562218|NCT01395823|65786448|FG000|Overall Study|Physician Decision|3|||
23562219|NCT01395823|65786449|FG001|Overall Study|Physician Decision|1|||
23562220|NCT01395823|65786448|FG000|Overall Study|Lost to Follow-up|1|||
23439626|NCT00662909|65352513|FG002|Overall Study|Physician Decision|2|||
23439627|NCT00662909|65352511|FG000|Overall Study|Eligibility criterion not met|0|||
23439628|NCT00662909|65352512|FG001|Overall Study|Eligibility criterion not met|1|||
23439629|NCT00662909|65352513|FG002|Overall Study|Eligibility criterion not met|1|||
23439630|NCT02451124|65352514|FG000|Overall Study|Withdrawal by Subject|1|||
23439631|NCT01103063|65352521|FG000|Overall Study|Adverse Event|3|||
23439632|NCT01103063|65352522|FG001|Overall Study|Adverse Event|1|||
23439633|NCT01103063|65352521|FG000|Overall Study|Lost to Follow-up|68|||
23562221|NCT01395823|65786449|FG001|Overall Study|Lost to Follow-up|0|||
23562222|NCT01395823|65786448|FG000|Overall Study|Transplant|1|||
23562223|NCT01395823|65786449|FG001|Overall Study|Transplant|0|||
23562224|NCT01395823|65786448|FG000|Overall Study|GI symptoms|1|||
23562225|NCT01395823|65786449|FG001|Overall Study|GI symptoms|0|||
23562226|NCT01395823|65786448|FG000|Overall Study|Withdrawal by Subject|5|||
23562227|NCT01395823|65786449|FG001|Overall Study|Withdrawal by Subject|4|||
23562228|NCT02696564|65786458|FG000|Overall Study|Death|1|||
23439634|NCT01103063|65352522|FG001|Overall Study|Lost to Follow-up|51|||
23439635|NCT01103063|65352521|FG000|Overall Study|Withdrawal by Subject|60|||
23439636|NCT01103063|65352522|FG001|Overall Study|Withdrawal by Subject|15|||
23439637|NCT01103063|65352521|FG000|Overall Study|Other|16|||
23439638|NCT01103063|65352522|FG001|Overall Study|Other|11|||
23439639|NCT01103063|65352521|FG000|Overall Study|Protocol Violation|1|||
23439640|NCT01103063|65352522|FG001|Overall Study|Protocol Violation|0|||
23562229|NCT02696564|65786459|FG001|Overall Study|Death|2|||
23562230|NCT02696564|65786458|FG000|Overall Study|Withdrawal by Subject|3|||
23562231|NCT02696564|65786459|FG001|Overall Study|Withdrawal by Subject|2|||
23562232|NCT02696564|65786458|FG000|Overall Study|Lost to Follow-up|3|||
23562233|NCT02696564|65786459|FG001|Overall Study|Lost to Follow-up|3|||
23562234|NCT02696564|65786458|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
23562235|NCT02696564|65786459|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
23562236|NCT02696564|65786458|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
23562237|NCT02696564|65786459|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
23562238|NCT02696564|65786458|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
23439641|NCT01103063|65352521|FG000|Overall Study|Study terminated by Sponsor|326|||
23562239|NCT02696564|65786459|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
23625324|NCT00853372|66015465|FG000|Overall Study|Full Consent Withdrawn|1|||
23757323|NCT00568776|66489688|FG002|Overall Study|Adverse Event|10|||
23562240|NCT02696564|65786458|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
23625325|NCT00853372|66015466|FG001|Overall Study|Full Consent Withdrawn|1|||
23757324|NCT00568776|66489689|FG003|Overall Study|Adverse Event|8|||
23562241|NCT02696564|65786459|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
23562242|NCT02696564|65786458|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
23562243|NCT02696564|65786459|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
23562244|NCT04899245|65790217|FG000|Overall Study|Withdrawal by Subject|3|||
23562245|NCT04899245|65790218|FG001|Overall Study|Withdrawal by Subject|5|||
23562246|NCT04899245|65790219|FG002|Overall Study|Withdrawal by Subject|2|||
23562247|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Left staff position|0|||
23562248|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Left staff position|0|||
23562249|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Left staff position|1|||
23562250|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
23562251|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
23562252|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
23562253|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Moved away from area|2|||
23562254|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Moved away from area|2|||
23562255|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Moved away from area|0|||
23562256|NCT01164228|65790220|FG000|Overall Study|Progression|24|||
23562257|NCT01164228|65790221|FG001|Overall Study|Progression|25|||
23562258|NCT01164228|65790220|FG000|Overall Study|Adverse Event|13|||
23562259|NCT01164228|65790221|FG001|Overall Study|Adverse Event|7|||
23562260|NCT01164228|65790220|FG000|Overall Study|Death|1|||
23562261|NCT01164228|65790221|FG001|Overall Study|Death|1|||
23562262|NCT01164228|65790220|FG000|Overall Study|Withdrawal by Subject|2|||
23562263|NCT01164228|65790221|FG001|Overall Study|Withdrawal by Subject|0|||
23562264|NCT01164228|65790220|FG000|Overall Study|Physician Decision|1|||
23562265|NCT01164228|65790221|FG001|Overall Study|Physician Decision|2|||
23562266|NCT01164228|65790220|FG000|Overall Study|Symptomatic deterioration|1|||
23562267|NCT01164228|65790221|FG001|Overall Study|Symptomatic deterioration|0|||
23562268|NCT01164228|65790220|FG000|Overall Study|Never started treatment|1|||
23562269|NCT01164228|65790221|FG001|Overall Study|Never started treatment|3|||
23562270|NCT01164228|65790220|FG000|Overall Study|Ineligible|1|||
23562271|NCT01164228|65790221|FG001|Overall Study|Ineligible|0|||
23562272|NCT00708435|65790222|FG000|Overall Study|Death / Serious Adverse Event|10|||
23562273|NCT00708435|65790223|FG001|Overall Study|Death / Serious Adverse Event|5|||
23562274|NCT00708435|65790222|FG000|Overall Study|Lost to Follow-up|9|||
23562275|NCT00708435|65790223|FG001|Overall Study|Lost to Follow-up|4|||
23562276|NCT00708435|65790222|FG000|Overall Study|Withdrawal by Subject|3|||
23562277|NCT00708435|65790223|FG001|Overall Study|Withdrawal by Subject|7|||
23562278|NCT00708435|65790222|FG000|Overall Study|Adverse Event|1|||
23562279|NCT00708435|65790223|FG001|Overall Study|Adverse Event|0|||
23562280|NCT00708435|65790222|FG000|Overall Study|Protocol Violation|0|||
23562281|NCT00708435|65790223|FG001|Overall Study|Protocol Violation|1|||
23562282|NCT00708435|65790222|FG000|Overall Study|Intervention by primary care physician|1|||
23562283|NCT00708435|65790223|FG001|Overall Study|Intervention by primary care physician|0|||
23562284|NCT00708435|65790222|FG000|Overall Study|Refused hospitalization|1|||
23562285|NCT00708435|65790223|FG001|Overall Study|Refused hospitalization|0|||
23562286|NCT01121484|65790224|FG000|Overall Study|Adverse Event|12|||
23562287|NCT01121484|65790225|FG001|Overall Study|Adverse Event|5|||
23562288|NCT01121484|65790224|FG000|Overall Study|Lack of Efficacy|3|||
23562289|NCT01121484|65790225|FG001|Overall Study|Lack of Efficacy|11|||
23562290|NCT01121484|65790224|FG000|Overall Study|Lost to Follow-up|5|||
23562291|NCT01121484|65790225|FG001|Overall Study|Lost to Follow-up|9|||
23562292|NCT01121484|65790224|FG000|Overall Study|Physician Decision|0|||
23562293|NCT01121484|65790225|FG001|Overall Study|Physician Decision|3|||
23562294|NCT01121484|65790224|FG000|Overall Study|Protocol Violation|1|||
23439642|NCT01103063|65352522|FG001|Overall Study|Study terminated by Sponsor|342|||
23439643|NCT01103063|65352521|FG000|Overall Study|Death|3|||
23439644|NCT01103063|65352522|FG001|Overall Study|Death|1|||
23439645|NCT02429830|65352526|FG000|Overall Study|Lost to Follow-up|1|||
23439646|NCT02429830|65352526|FG000|Overall Study|Device Explant|2|||
23439647|NCT00605345|65352527|FG000|Overall Study|Withdrawal by Subject|1|||
23439648|NCT00605345|65352528|FG001|Overall Study|Withdrawal by Subject|0|||
23562295|NCT01121484|65790225|FG001|Overall Study|Protocol Violation|0|||
23562296|NCT01121484|65790224|FG000|Overall Study|Withdrawal by Subject|8|||
23439649|NCT00605345|65352527|FG000|Overall Study|Adverse Event|0|||
23439650|NCT00605345|65352528|FG001|Overall Study|Adverse Event|1|||
23562297|NCT01121484|65790225|FG001|Overall Study|Withdrawal by Subject|7|||
23562298|NCT01121484|65790224|FG000|Overall Study|Discontinuation of study by sponsor|0|||
23562299|NCT01121484|65790225|FG001|Overall Study|Discontinuation of study by sponsor|1|||
23562300|NCT01121484|65790224|FG000|Overall Study|Other|3|||
23562301|NCT01121484|65790225|FG001|Overall Study|Other|3|||
23562302|NCT01121484|65790224|FG000|Overall Study|Randomized, not treated|1|||
23562303|NCT01121484|65790225|FG001|Overall Study|Randomized, not treated|4|||
23439651|NCT00605345|65352527|FG000|Overall Study|Protocol Violation|0|||
23439652|NCT00605345|65352528|FG001|Overall Study|Protocol Violation|2|||
23439653|NCT01712204|65352529|FG000|Overall Study|Adverse Event|3|||
23562304|NCT01521884|65790226|FG000|Overall Study|Non Responders|10|||
23562305|NCT01521884|65790226|FG000|Overall Study|Adverse Event|5|||
23562306|NCT01521884|65790226|FG000|Overall Study|Pregnancy|1|||
23562307|NCT01521884|65790226|FG000|Overall Study|Withdrawal by Subject|1|||
23562308|NCT01521884|65790226|FG000|Overall Study|Physician Decision|2|||
23562309|NCT01521884|65790226|FG000|Overall Study|Protocol Violation|3|||
23562310|NCT01521884|65790226|FG000|Overall Study|Participant non-eligible|1|||
23562311|NCT01521884|65790226|FG000|Overall Study|Lost to Follow-up|4|||
23562312|NCT02073097|65790227|FG000|Overall Study|Adverse Event|0|||
23562313|NCT02073097|65790228|FG001|Overall Study|Adverse Event|0|||
23562314|NCT02073097|65790229|FG002|Overall Study|Adverse Event|0|||
23562315|NCT02073097|65790230|FG003|Overall Study|Adverse Event|0|||
23562316|NCT02073097|65790231|FG004|Overall Study|Adverse Event|0|||
23562317|NCT02073097|65790232|FG005|Overall Study|Adverse Event|0|||
23562318|NCT02073097|65790233|FG006|Overall Study|Adverse Event|0|||
23757325|NCT00568776|66489686|FG000|Overall Study|Death|0|||
23757326|NCT00568776|66489687|FG001|Overall Study|Death|1|||
23757327|NCT00568776|66489688|FG002|Overall Study|Death|4|||
23757328|NCT00568776|66489689|FG003|Overall Study|Death|3|||
23757329|NCT00568776|66489686|FG000|Overall Study|Physician Decision|0|||
23439654|NCT01712204|65352530|FG001|Overall Study|Adverse Event|1|||
23439655|NCT01712204|65352529|FG000|Overall Study|Withdrawal by Subject|3|||
23439656|NCT01712204|65352530|FG001|Overall Study|Withdrawal by Subject|3|||
23439657|NCT01712204|65352529|FG000|Overall Study|Lost to Follow-up|1|||
23439658|NCT01712204|65352530|FG001|Overall Study|Lost to Follow-up|0|||
23439659|NCT01712204|65352529|FG000|Overall Study|Protocol Violation|1|||
23439660|NCT01712204|65352530|FG001|Overall Study|Protocol Violation|1|||
23439661|NCT01279681|65352533|FG000|Overall Study|Disease Progression|9|||
23439662|NCT01279681|65352534|FG001|Overall Study|Disease Progression|6|||
23439663|NCT01279681|65352533|FG000|Overall Study|Withdrawal by Subject|3|||
23562319|NCT02073097|65790234|FG007|Overall Study|Adverse Event|2|||
23562320|NCT02073097|65790227|FG000|Overall Study|Withdrawal by Subject|0|||
23562321|NCT02073097|65790228|FG001|Overall Study|Withdrawal by Subject|0|||
23562322|NCT02073097|65790229|FG002|Overall Study|Withdrawal by Subject|0|||
23562323|NCT02073097|65790230|FG003|Overall Study|Withdrawal by Subject|0|||
23562324|NCT02073097|65790231|FG004|Overall Study|Withdrawal by Subject|0|||
23562325|NCT02073097|65790232|FG005|Overall Study|Withdrawal by Subject|0|||
23562326|NCT02073097|65790233|FG006|Overall Study|Withdrawal by Subject|0|||
23562327|NCT02073097|65790234|FG007|Overall Study|Withdrawal by Subject|2|||
23562328|NCT02073097|65790227|FG000|Overall Study|Death|0|||
23562329|NCT02073097|65790228|FG001|Overall Study|Death|0|||
23562330|NCT02073097|65790229|FG002|Overall Study|Death|0|||
23439664|NCT01279681|65352534|FG001|Overall Study|Withdrawal by Subject|4|||
23562331|NCT02073097|65790230|FG003|Overall Study|Death|0|||
23562332|NCT02073097|65790231|FG004|Overall Study|Death|0|||
23562333|NCT02073097|65790232|FG005|Overall Study|Death|0|||
23562334|NCT02073097|65790233|FG006|Overall Study|Death|0|||
23562335|NCT02073097|65790234|FG007|Overall Study|Death|1|||
23562336|NCT02073097|65790227|FG000|Overall Study|Physician Decision|0|||
23562337|NCT02073097|65790228|FG001|Overall Study|Physician Decision|0|||
23562338|NCT02073097|65790229|FG002|Overall Study|Physician Decision|0|||
23562339|NCT02073097|65790230|FG003|Overall Study|Physician Decision|0|||
23562340|NCT02073097|65790231|FG004|Overall Study|Physician Decision|0|||
23562341|NCT02073097|65790232|FG005|Overall Study|Physician Decision|0|||
23562342|NCT02073097|65790233|FG006|Overall Study|Physician Decision|0|||
23562343|NCT02073097|65790234|FG007|Overall Study|Physician Decision|1|||
23562344|NCT01483937|65790235|FG000|Overall Study|Withdrawal by Subject|4|||
23562345|NCT01483937|65790236|FG001|Overall Study|Withdrawal by Subject|3|||
23562346|NCT02087501|65790237|FG000|Overall Study|Death|7|||
23562347|NCT02087501|65790237|FG000|Overall Study|Open repair of aneurysm|1|||
23562348|NCT02087501|65790237|FG000|Overall Study|Lost to Follow-up|2|||
23562349|NCT03682705|65790238|FG000|Overall Study|Adverse Event|1|||
23562350|NCT03682705|65790239|FG001|Overall Study|Adverse Event|1|||
23625326|NCT01270828|66015467|FG000|Pregabalin CR SB|Reason Unspecified|0|||
23757330|NCT00568776|66489687|FG001|Overall Study|Physician Decision|2|||
23439665|NCT01279681|65352533|FG000|Overall Study|Adverse Event|2|||
23562351|NCT03682705|65790240|FG002|Overall Study|Adverse Event|1|||
23562352|NCT03682705|65790241|FG003|Overall Study|Adverse Event|0|||
23562353|NCT03682705|65790242|FG004|Overall Study|Adverse Event|1|||
23562354|NCT03682705|65790243|FG005|Overall Study|Adverse Event|1|||
23562355|NCT03682705|65790238|FG000|Overall Study|Withdrawal by Subject|1|||
23562356|NCT03682705|65790239|FG001|Overall Study|Withdrawal by Subject|3|||
23562357|NCT03682705|65790240|FG002|Overall Study|Withdrawal by Subject|2|||
23439666|NCT01279681|65352534|FG001|Overall Study|Adverse Event|3|||
23562358|NCT03682705|65790241|FG003|Overall Study|Withdrawal by Subject|4|||
23562359|NCT03682705|65790242|FG004|Overall Study|Withdrawal by Subject|0|||
23562360|NCT03682705|65790243|FG005|Overall Study|Withdrawal by Subject|1|||
23562361|NCT03682705|65790238|FG000|Overall Study|Other, not specified|0|||
23562362|NCT03682705|65790239|FG001|Overall Study|Other, not specified|0|||
23625327|NCT01270828|66015468|FG001|Pregabalin CR SB|Reason Unspecified|0|||
23562363|NCT03682705|65790240|FG002|Overall Study|Other, not specified|0|||
23562364|NCT03682705|65790241|FG003|Overall Study|Other, not specified|1|||
23562365|NCT03682705|65790242|FG004|Overall Study|Other, not specified|2|||
23562366|NCT03682705|65790243|FG005|Overall Study|Other, not specified|0|||
23562367|NCT03682705|65790238|FG000|Overall Study|Lost to Follow-up|0|||
23562368|NCT03682705|65790239|FG001|Overall Study|Lost to Follow-up|0|||
23562369|NCT03682705|65790240|FG002|Overall Study|Lost to Follow-up|0|||
23439667|NCT01279681|65352533|FG000|Overall Study|Death|0|||
23562370|NCT03682705|65790241|FG003|Overall Study|Lost to Follow-up|0|||
23562371|NCT03682705|65790242|FG004|Overall Study|Lost to Follow-up|3|||
23562372|NCT03682705|65790243|FG005|Overall Study|Lost to Follow-up|0|||
23562373|NCT02202434|65790249|FG000|Overall Study|Death|70|||
23562374|NCT02202434|65790250|FG001|Overall Study|Death|39|||
23562375|NCT02202434|65790251|FG002|Overall Study|Death|13|||
23562376|NCT02202434|65790252|FG003|Overall Study|Death|27|||
23562377|NCT02202434|65790249|FG000|Overall Study|Lost to Follow-up|1|||
23562378|NCT02202434|65790250|FG001|Overall Study|Lost to Follow-up|1|||
23562379|NCT02202434|65790251|FG002|Overall Study|Lost to Follow-up|1|||
23562380|NCT02202434|65790252|FG003|Overall Study|Lost to Follow-up|0|||
23562381|NCT02202434|65790249|FG000|Overall Study|Physician Decision|2|||
23562382|NCT02202434|65790250|FG001|Overall Study|Physician Decision|3|||
23439668|NCT01279681|65352534|FG001|Overall Study|Death|1|||
23439669|NCT01279681|65352533|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
23439670|NCT01279681|65352534|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
23439671|NCT01279681|65352533|FG000|Overall Study|Physician Decision|1|||
23439672|NCT01279681|65352534|FG001|Overall Study|Physician Decision|0|||
23439673|NCT01279681|65352533|FG000|Overall Study|Other Reason|0|||
23439674|NCT01279681|65352534|FG001|Overall Study|Other Reason|2|||
23439675|NCT00423449|65352537|FG000|Overall Study|Clinical Adverse Event|1|||
23439676|NCT00423449|65352538|FG001|Overall Study|Clinical Adverse Event|0|||
23439677|NCT00423449|65352539|FG002|Overall Study|Clinical Adverse Event|1|||
23439678|NCT00423449|65352540|FG003|Overall Study|Clinical Adverse Event|8|||
23439679|NCT00423449|65352541|FG004|Overall Study|Clinical Adverse Event|2|||
23439680|NCT00423449|65352537|FG000|Overall Study|Death|1|||
23439681|NCT00423449|65352538|FG001|Overall Study|Death|0|||
23439682|NCT00423449|65352539|FG002|Overall Study|Death|2|||
23439683|NCT00423449|65352540|FG003|Overall Study|Death|1|||
23439684|NCT00423449|65352541|FG004|Overall Study|Death|1|||
23439685|NCT00423449|65352537|FG000|Overall Study|Progressive Disease|1|||
23439686|NCT00423449|65352538|FG001|Overall Study|Progressive Disease|3|||
23439687|NCT00423449|65352539|FG002|Overall Study|Progressive Disease|8|||
23439688|NCT00423449|65352540|FG003|Overall Study|Progressive Disease|11|||
23439689|NCT00423449|65352541|FG004|Overall Study|Progressive Disease|4|||
23439690|NCT00423449|65352537|FG000|Overall Study|Laboratory Adverse Event|0|||
23439691|NCT00423449|65352538|FG001|Overall Study|Laboratory Adverse Event|1|||
23439692|NCT00423449|65352539|FG002|Overall Study|Laboratory Adverse Event|2|||
23439693|NCT00423449|65352540|FG003|Overall Study|Laboratory Adverse Event|0|||
23439694|NCT00423449|65352541|FG004|Overall Study|Laboratory Adverse Event|0|||
23439695|NCT00423449|65352537|FG000|Overall Study|Other|0|||
23439696|NCT00423449|65352538|FG001|Overall Study|Other|0|||
23439697|NCT00423449|65352539|FG002|Overall Study|Other|0|||
23439698|NCT00423449|65352540|FG003|Overall Study|Other|1|||
23439699|NCT00423449|65352541|FG004|Overall Study|Other|0|||
23439700|NCT00423449|65352537|FG000|Overall Study|Protocol Violation|0|||
23439701|NCT00423449|65352538|FG001|Overall Study|Protocol Violation|0|||
23439702|NCT00423449|65352539|FG002|Overall Study|Protocol Violation|2|||
23439703|NCT00423449|65352540|FG003|Overall Study|Protocol Violation|1|||
23439704|NCT00423449|65352541|FG004|Overall Study|Protocol Violation|0|||
23439705|NCT01629953|65352542|FG000|Overall Study|Death|3|||
23562383|NCT02202434|65790251|FG002|Overall Study|Physician Decision|0|||
23439706|NCT01629953|65352543|FG001|Overall Study|Death|1|||
23439707|NCT01629953|65352542|FG000|Overall Study|Lost to Follow-up|10|||
23562384|NCT02202434|65790252|FG003|Overall Study|Physician Decision|0|||
23625328|NCT01270828|66015469|FG002|Pregabalin CR SB|Reason Unspecified|8|||
23439708|NCT01629953|65352543|FG001|Overall Study|Lost to Follow-up|14|||
23439709|NCT00615030|65352544|FG000|Period I|Administrative problem|0|||
23439710|NCT00615030|65352545|FG001|Period I|Administrative problem|0|||
23439711|NCT00615030|65352546|FG002|Period I|Administrative problem|0|||
23439712|NCT00615030|65352547|FG003|Period I|Administrative problem|0|||
23439713|NCT00615030|65352548|FG004|Period I|Administrative problem|1|||
23439714|NCT00615030|65352549|FG005|Period I|Administrative problem|0|||
23439715|NCT00615030|65352550|FG006|Period I|Administrative problem|0|||
23562385|NCT02202434|65790249|FG000|Overall Study|Withdrawal by Subject|13|||
23562386|NCT02202434|65790250|FG001|Overall Study|Withdrawal by Subject|14|||
23562387|NCT02202434|65790251|FG002|Overall Study|Withdrawal by Subject|1|||
23562388|NCT02202434|65790252|FG003|Overall Study|Withdrawal by Subject|4|||
23439716|NCT00615030|65352551|FG007|Period I|Administrative problem|0|||
23439717|NCT00615030|65352552|FG008|Period I|Administrative problem|0|||
23562389|NCT02202434|65790249|FG000|Overall Study|Completed Study|1|||
23562390|NCT02202434|65790250|FG001|Overall Study|Completed Study|0|||
23625329|NCT01270828|66015467|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
23562391|NCT02202434|65790251|FG002|Overall Study|Completed Study|0|||
23439718|NCT00615030|65352553|FG009|Period I|Administrative problem|0|||
23439719|NCT00615030|65352554|FG010|Period I|Administrative problem|0|||
23439720|NCT00615030|65352555|FG011|Period I|Administrative problem|0|||
23439721|NCT00615030|65352544|FG000|Period I|Protocol deviation|1|||
23439722|NCT00615030|65352545|FG001|Period I|Protocol deviation|0|||
23439723|NCT00615030|65352546|FG002|Period I|Protocol deviation|0|||
23439724|NCT00615030|65352547|FG003|Period I|Protocol deviation|0|||
23439725|NCT00615030|65352548|FG004|Period I|Protocol deviation|0|||
23439726|NCT00615030|65352549|FG005|Period I|Protocol deviation|0|||
23439727|NCT00615030|65352550|FG006|Period I|Protocol deviation|0|||
23439728|NCT00615030|65352551|FG007|Period I|Protocol deviation|0|||
23439729|NCT00615030|65352552|FG008|Period I|Protocol deviation|0|||
23439730|NCT00615030|65352553|FG009|Period I|Protocol deviation|0|||
23439731|NCT00615030|65352554|FG010|Period I|Protocol deviation|0|||
23439732|NCT00615030|65352555|FG011|Period I|Protocol deviation|0|||
23562392|NCT02202434|65790252|FG003|Overall Study|Completed Study|0|||
23562393|NCT02202434|65790249|FG000|Overall Study|Visit Missed|21|||
23562394|NCT02202434|65790250|FG001|Overall Study|Visit Missed|12|||
23562395|NCT02202434|65790251|FG002|Overall Study|Visit Missed|0|||
23562396|NCT02202434|65790252|FG003|Overall Study|Visit Missed|5|||
23562397|NCT02202434|65790249|FG000|Overall Study|Other|1|||
23562398|NCT02202434|65790250|FG001|Overall Study|Other|0|||
23562399|NCT02202434|65790251|FG002|Overall Study|Other|0|||
23562400|NCT02202434|65790252|FG003|Overall Study|Other|1|||
23562401|NCT04461795|65790253|FG000|Overall Study|Lost to Follow-up|2|||
23562402|NCT04461795|65790253|FG000|Overall Study|Withdrawal by Subject|2|||
23562403|NCT04461795|65790253|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
23562404|NCT00990340|65790256|FG000|First 14-day Treatment|Not Compliant|2|||
23562405|NCT00990340|65790257|FG001|First 14-day Treatment|Not Compliant|1|||
23562406|NCT00990340|65790256|FG000|First 14-day Treatment|Lost to Follow-up|2|||
23562407|NCT00990340|65790257|FG001|First 14-day Treatment|Lost to Follow-up|1|||
23562408|NCT00990340|65790256|FG000|First 14-day Treatment|Protocol Violation|2|||
23562409|NCT00990340|65790257|FG001|First 14-day Treatment|Protocol Violation|2|||
23562410|NCT00927355|65790258|FG000|Overall Study|Adverse Event|1|||
23562411|NCT00927355|65790259|FG001|Overall Study|Adverse Event|1|||
23562412|NCT00100932|65790263|FG000|Overall Study|Adverse Event|11|||
23562413|NCT00100932|65790264|FG001|Overall Study|Adverse Event|2|||
23562414|NCT00100932|65790263|FG000|Overall Study|Withdrawal by Subject|6|||
23562415|NCT00100932|65790264|FG001|Overall Study|Withdrawal by Subject|0|||
23562416|NCT00100932|65790263|FG000|Overall Study|Progressive Disease|44|||
23562417|NCT00100932|65790264|FG001|Overall Study|Progressive Disease|18|||
23562418|NCT00100932|65790263|FG000|Overall Study|Physician Decision|7|||
23562419|NCT00100932|65790264|FG001|Overall Study|Physician Decision|5|||
23562420|NCT00100932|65790263|FG000|Overall Study|Other|5|||
23562421|NCT00100932|65790264|FG001|Overall Study|Other|2|||
23562422|NCT03673462|65790265|FG000|Overall Study|Adverse Event|11|||
23562423|NCT03673462|65790266|FG001|Overall Study|Adverse Event|1|||
23562424|NCT03673462|65790265|FG000|Overall Study|Protocol Violation|25|||
23562425|NCT03673462|65790266|FG001|Overall Study|Protocol Violation|11|||
23562426|NCT03673462|65790265|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
23562427|NCT03673462|65790266|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
23562428|NCT03673462|65790265|FG000|Overall Study|Lost to Follow-up|102|||
23562429|NCT03673462|65790266|FG001|Overall Study|Lost to Follow-up|19|||
23562430|NCT01986881|65790267|FG000|Overall Study|Death|228|||
23562431|NCT01986881|65790268|FG001|Overall Study|Death|233|||
23562432|NCT01986881|65790269|FG002|Overall Study|Death|247|||
23757331|NCT00568776|66489688|FG002|Overall Study|Physician Decision|0|||
23757332|NCT00568776|66489689|FG003|Overall Study|Physician Decision|0|||
23757333|NCT00568776|66489686|FG000|Overall Study|Lack of Efficacy|2|||
23757334|NCT00568776|66489687|FG001|Overall Study|Lack of Efficacy|2|||
23757335|NCT00568776|66489688|FG002|Overall Study|Lack of Efficacy|2|||
23757336|NCT00568776|66489689|FG003|Overall Study|Lack of Efficacy|4|||
23757337|NCT00568776|66489686|FG000|Overall Study|Lost to Follow-up|1|||
23757338|NCT00568776|66489687|FG001|Overall Study|Lost to Follow-up|1|||
23439733|NCT00615030|65352544|FG000|Period I|Subject withdrew consent|0|||
23562433|NCT01986881|65790267|FG000|Overall Study|Lost to Follow-up|51|||
23562434|NCT01986881|65790268|FG001|Overall Study|Lost to Follow-up|44|||
23625330|NCT01270828|66015468|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
23757339|NCT00568776|66489688|FG002|Overall Study|Lost to Follow-up|1|||
23439734|NCT00615030|65352545|FG001|Period I|Subject withdrew consent|0|||
23439735|NCT00615030|65352546|FG002|Period I|Subject withdrew consent|0|||
23439736|NCT00615030|65352547|FG003|Period I|Subject withdrew consent|0|||
23439737|NCT00615030|65352548|FG004|Period I|Subject withdrew consent|0|||
23439738|NCT00615030|65352549|FG005|Period I|Subject withdrew consent|0|||
23439739|NCT00615030|65352550|FG006|Period I|Subject withdrew consent|0|||
23439740|NCT00615030|65352551|FG007|Period I|Subject withdrew consent|0|||
23562435|NCT01986881|65790269|FG002|Overall Study|Lost to Follow-up|55|||
23562436|NCT01986881|65790267|FG000|Overall Study|Physician Decision|7|||
23625331|NCT01270828|66015469|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
23562437|NCT01986881|65790268|FG001|Overall Study|Physician Decision|4|||
23562438|NCT01986881|65790269|FG002|Overall Study|Physician Decision|6|||
23562439|NCT01986881|65790267|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
23562440|NCT01986881|65790268|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
23562441|NCT01986881|65790269|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
23757340|NCT00568776|66489689|FG003|Overall Study|Lost to Follow-up|1|||
23757341|NCT00568776|66489686|FG000|Overall Study|Protocol Violation|1|||
23757342|NCT00568776|66489687|FG001|Overall Study|Protocol Violation|0|||
23757343|NCT00568776|66489688|FG002|Overall Study|Protocol Violation|1|||
23757344|NCT00568776|66489689|FG003|Overall Study|Protocol Violation|1|||
23757345|NCT00568776|66489686|FG000|Overall Study|Withdrawal by Subject|13|||
23757346|NCT00568776|66489687|FG001|Overall Study|Withdrawal by Subject|15|||
23757347|NCT00568776|66489688|FG002|Overall Study|Withdrawal by Subject|13|||
23757348|NCT00568776|66489689|FG003|Overall Study|Withdrawal by Subject|7|||
23757349|NCT00568776|66489686|FG000|Overall Study|Loss of Caregiver|0|||
23757350|NCT00568776|66489687|FG001|Overall Study|Loss of Caregiver|2|||
23757351|NCT00568776|66489688|FG002|Overall Study|Loss of Caregiver|1|||
23757352|NCT00568776|66489689|FG003|Overall Study|Loss of Caregiver|2|||
23757353|NCT00568776|66489686|FG000|Overall Study|Sponsor Decision|2|||
23757354|NCT00568776|66489687|FG001|Overall Study|Sponsor Decision|2|||
23757355|NCT00568776|66489688|FG002|Overall Study|Sponsor Decision|41|||
23757356|NCT00568776|66489689|FG003|Overall Study|Sponsor Decision|42|||
23757357|NCT00568776|66489686|FG000|Overall Study|Miscellaeneous|3|||
23757358|NCT00568776|66489687|FG001|Overall Study|Miscellaeneous|3|||
23757359|NCT00568776|66489688|FG002|Overall Study|Miscellaeneous|1|||
23757360|NCT00568776|66489689|FG003|Overall Study|Miscellaeneous|4|||
23757361|NCT03734679|66489690|FG000|Overall Study|Missed Visit|1|||
23757362|NCT00972153|66489691|FG000|Overall Study|Equipment malfunction during case|0|||
23757363|NCT00972153|66489692|FG001|Overall Study|Equipment malfunction during case|1|||
23757364|NCT00972153|66489693|FG002|Overall Study|Equipment malfunction during case|0|||
23826502|NCT04728802|66745094|FG001|Overall Study|Physician Decision|7|||
23826503|NCT04728802|66745093|FG000|Overall Study|Protocol Violation|10|||
23439741|NCT00615030|65352552|FG008|Period I|Subject withdrew consent|1|||
23439742|NCT00615030|65352553|FG009|Period I|Subject withdrew consent|0|||
23439743|NCT00615030|65352554|FG010|Period I|Subject withdrew consent|1|||
23439744|NCT00615030|65352555|FG011|Period I|Subject withdrew consent|1|||
23439745|NCT00615030|65352544|FG000|Period I|Abnormal laboratory value(s)|0|||
23439746|NCT00615030|65352545|FG001|Period I|Abnormal laboratory value(s)|0|||
23439747|NCT00615030|65352546|FG002|Period I|Abnormal laboratory value(s)|0|||
23439748|NCT00615030|65352547|FG003|Period I|Abnormal laboratory value(s)|0|||
23439749|NCT00615030|65352548|FG004|Period I|Abnormal laboratory value(s)|0|||
23439750|NCT00615030|65352549|FG005|Period I|Abnormal laboratory value(s)|1|||
23439751|NCT00615030|65352550|FG006|Period I|Abnormal laboratory value(s)|0|||
23439752|NCT00615030|65352551|FG007|Period I|Abnormal laboratory value(s)|0|||
23439753|NCT00615030|65352552|FG008|Period I|Abnormal laboratory value(s)|0|||
23439754|NCT00615030|65352553|FG009|Period I|Abnormal laboratory value(s)|0|||
23439755|NCT00615030|65352554|FG010|Period I|Abnormal laboratory value(s)|0|||
23439756|NCT00615030|65352555|FG011|Period I|Abnormal laboratory value(s)|0|||
23439757|NCT00615030|65352544|FG000|Period II|Adverse Event|0|||
23439758|NCT00615030|65352545|FG001|Period II|Adverse Event|0|||
23439759|NCT00615030|65352546|FG002|Period II|Adverse Event|1|||
23439760|NCT00615030|65352547|FG003|Period II|Adverse Event|0|||
23439761|NCT00615030|65352548|FG004|Period II|Adverse Event|0|||
23439762|NCT00615030|65352549|FG005|Period II|Adverse Event|0|||
23439763|NCT00615030|65352550|FG006|Period II|Adverse Event|0|||
23439764|NCT00615030|65352551|FG007|Period II|Adverse Event|0|||
23439765|NCT00615030|65352552|FG008|Period II|Adverse Event|1|||
23439766|NCT00615030|65352553|FG009|Period II|Adverse Event|0|||
23439767|NCT00615030|65352554|FG010|Period II|Adverse Event|0|||
23439768|NCT00615030|65352555|FG011|Period II|Adverse Event|0|||
23439769|NCT00615030|65352544|FG000|Period II|Subject withdrew consent|0|||
23562442|NCT01986881|65790267|FG000|Overall Study|Withdrawal by Subject|41|||
23562443|NCT01986881|65790268|FG001|Overall Study|Withdrawal by Subject|60|||
23562444|NCT01986881|65790269|FG002|Overall Study|Withdrawal by Subject|45|||
23562445|NCT01986881|65790267|FG000|Overall Study|Subject Moved|0|||
23757365|NCT03944707|66489694|FG000|Overall Study|Adverse Event|0|||
23757366|NCT03944707|66489695|FG001|Overall Study|Adverse Event|2|||
23757367|NCT03944707|66489694|FG000|Overall Study|Study terminated by sponsor|12|||
23439770|NCT00615030|65352545|FG001|Period II|Subject withdrew consent|0|||
23439771|NCT00615030|65352546|FG002|Period II|Subject withdrew consent|0|||
23562446|NCT01986881|65790268|FG001|Overall Study|Subject Moved|1|||
23562447|NCT01986881|65790269|FG002|Overall Study|Subject Moved|0|||
23757368|NCT03944707|66489695|FG001|Overall Study|Study terminated by sponsor|7|||
23757369|NCT03944707|66489694|FG000|Overall Study|Subject decision|0|||
23826504|NCT04728802|66745094|FG001|Overall Study|Protocol Violation|4|||
23826505|NCT04728802|66745093|FG000|Overall Study|Transfer|1|||
23439772|NCT00615030|65352547|FG003|Period II|Subject withdrew consent|1|||
23562448|NCT01986881|65790267|FG000|Overall Study|Other|1|||
23439773|NCT00615030|65352548|FG004|Period II|Subject withdrew consent|0|||
23562449|NCT01986881|65790268|FG001|Overall Study|Other|2|||
23562450|NCT01986881|65790269|FG002|Overall Study|Other|2|||
23562451|NCT02002884|65790274|FG000|Main Period (MP)|Other|0|||
23562452|NCT02002884|65790275|FG001|Main Period (MP)|Other|3|||
23562453|NCT02002884|65790276|FG002|Main Period (MP)|Other|3|||
23562454|NCT02002884|65790277|FG003|Main Period (MP)|Other|0|||
23562455|NCT02002884|65790274|FG000|Main Period (MP)|Adverse Event|0|||
23439774|NCT00615030|65352549|FG005|Period II|Subject withdrew consent|0|||
23439775|NCT00615030|65352550|FG006|Period II|Subject withdrew consent|1|||
23439776|NCT00615030|65352551|FG007|Period II|Subject withdrew consent|0|||
23439777|NCT00615030|65352552|FG008|Period II|Subject withdrew consent|0|||
23439778|NCT00615030|65352553|FG009|Period II|Subject withdrew consent|0|||
23439779|NCT00615030|65352554|FG010|Period II|Subject withdrew consent|0|||
23562456|NCT02002884|65790275|FG001|Main Period (MP)|Adverse Event|1|||
23562457|NCT02002884|65790276|FG002|Main Period (MP)|Adverse Event|1|||
23562458|NCT02002884|65790277|FG003|Main Period (MP)|Adverse Event|0|||
23562459|NCT02002884|65790274|FG000|Main Period (MP)|Withdrawal by Subject|6|||
23562460|NCT02002884|65790275|FG001|Main Period (MP)|Withdrawal by Subject|2|||
23562461|NCT02002884|65790276|FG002|Main Period (MP)|Withdrawal by Subject|2|||
23562462|NCT02002884|65790277|FG003|Main Period (MP)|Withdrawal by Subject|0|||
23562463|NCT02002884|65790274|FG000|Main Period (MP)|Lost to Follow-up|0|||
23562464|NCT02002884|65790275|FG001|Main Period (MP)|Lost to Follow-up|0|||
23562465|NCT02002884|65790276|FG002|Main Period (MP)|Lost to Follow-up|2|||
23562466|NCT02002884|65790277|FG003|Main Period (MP)|Lost to Follow-up|0|||
23562467|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Other|0|||
23562468|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Other|0|||
23562469|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Other|0|||
23562470|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Other|24|||
23439780|NCT00615030|65352555|FG011|Period II|Subject withdrew consent|0|||
23439781|NCT00615030|65352544|FG000|Period III|Administrative problems|1|||
23439782|NCT00615030|65352545|FG001|Period III|Administrative problems|0|||
23439783|NCT00615030|65352546|FG002|Period III|Administrative problems|0|||
23439784|NCT00615030|65352547|FG003|Period III|Administrative problems|1|||
23562471|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562472|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562473|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562474|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
23562475|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23562476|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23562477|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23757370|NCT03944707|66489695|FG001|Overall Study|Subject decision|1|||
23757371|NCT00479401|66489696|FG000|Overall Study|Adverse Event|24|||
23439785|NCT00615030|65352548|FG004|Period III|Administrative problems|0|||
23439786|NCT00615030|65352549|FG005|Period III|Administrative problems|0|||
23439787|NCT00615030|65352550|FG006|Period III|Administrative problems|0|||
23439788|NCT00615030|65352551|FG007|Period III|Administrative problems|0|||
23439789|NCT00615030|65352552|FG008|Period III|Administrative problems|0|||
23439790|NCT00615030|65352553|FG009|Period III|Administrative problems|0|||
23439791|NCT00615030|65352554|FG010|Period III|Administrative problems|0|||
23439792|NCT00615030|65352555|FG011|Period III|Administrative problems|0|||
23439793|NCT00958165|65352556|FG000|Overall Study|Lost to Follow-up|5|||
23439794|NCT00958165|65352556|FG000|Overall Study|Not eligible|9|||
23439795|NCT01235234|65352558|FG000|Overall Study|Adverse Event|2|||
23439796|NCT01235234|65352559|FG001|Overall Study|Adverse Event|2|||
23439797|NCT01235234|65352560|FG002|Overall Study|Adverse Event|1|||
23439798|NCT02663622|65352561|FG000|Overall Study|Death|3|||
23439799|NCT02663622|65352562|FG001|Overall Study|Death|1|||
23439800|NCT02663622|65352563|FG002|Overall Study|Death|1|||
23439801|NCT02663622|65352564|FG003|Overall Study|Death|8|||
23562478|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
23562479|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562480|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562481|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562482|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
23757372|NCT00479401|66489697|FG001|Overall Study|Adverse Event|20|||
23757373|NCT00479401|66489698|FG002|Overall Study|Adverse Event|4|||
23757374|NCT00479401|66489696|FG000|Overall Study|Lack of Efficacy|2|||
23439802|NCT02663622|65352561|FG000|Overall Study|Protocol Violation|0|||
23439803|NCT02663622|65352562|FG001|Overall Study|Protocol Violation|0|||
23439804|NCT02663622|65352563|FG002|Overall Study|Protocol Violation|0|||
23439805|NCT02663622|65352564|FG003|Overall Study|Protocol Violation|1|||
23439806|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Adverse Event|3|||
23439807|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Adverse Event|0|||
23439808|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
23439809|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
23439810|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Physician Decision|1|||
23439811|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Physician Decision|0|||
23439812|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
23439813|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
23439814|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
23439815|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
23439816|NCT02081599|65352566|FG000|Period 1：Double-blind Period|stopping criteria|1|||
23439817|NCT02081599|65352567|FG001|Period 1：Double-blind Period|stopping criteria|0|||
23439818|NCT02081599|65352566|FG000|Period 2：Open-label Period|Adverse Event|1|||
23439819|NCT02081599|65352567|FG001|Period 2：Open-label Period|Adverse Event|0|||
23439820|NCT02081599|65352566|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
23439821|NCT02081599|65352567|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
23439822|NCT02081599|65352566|FG000|Period 2：Open-label Period|Physician Decision|1|||
23439823|NCT02081599|65352567|FG001|Period 2：Open-label Period|Physician Decision|0|||
23562483|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562484|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562485|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562486|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
23562487|NCT01755702|65790284|FG000|Wash Out Period I|Other Reason|3|||
23562488|NCT01755702|65790284|FG000|Washout Period II|Other Reason|5|||
23562489|NCT05340751|65790285|FG000|Overall Study|Physician Decision|3|||
23562490|NCT01396317|65790286|FG000|Overall Study|Adverse Event|1|||
23439824|NCT02081599|65352566|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
23439825|NCT02081599|65352567|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
23439826|NCT01301833|65352570|FG000|Overall Study|Adverse Event|7|||
23439827|NCT01301833|65352571|FG001|Overall Study|Adverse Event|5|||
23562491|NCT01396317|65790287|FG001|Overall Study|Adverse Event|0|||
23562492|NCT01119768|65790292|FG000|Treatment Period|Lack of Efficacy|18|||
23562493|NCT01119768|65790293|FG001|Treatment Period|Lack of Efficacy|25|||
23562494|NCT01919970|65790297|FG000|Overall Study|Withdrawal by Subject|3|||
23562495|NCT01919970|65790298|FG001|Overall Study|Withdrawal by Subject|0|||
23562496|NCT00510458|65790299|FG000|Overall Study|5 year not evaluable/missed|21|||
23562497|NCT00510458|65790299|FG000|Overall Study|Death|1|||
23562498|NCT00510458|65790299|FG000|Overall Study|Terminated|14|||
23562499|NCT00510458|65790299|FG000|Overall Study|Lost to Follow-up|6|||
23562500|NCT00510458|65790299|FG000|Overall Study|Withdrawal by Subject|3|||
23562501|NCT00510458|65790299|FG000|Overall Study|Revision|2|||
23562502|NCT02613221|65790300|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
23562503|NCT02613221|65790300|FG000|Overall Study|Adverse Event|2|||
23562504|NCT02613221|65790300|FG000|Overall Study|Voluntary Discontinuation|1|||
23562505|NCT02613221|65790300|FG000|Overall Study|Delayed Treatment|1|||
23562506|NCT02613221|65790300|FG000|Overall Study|Enrolled but Not Treated|1|||
23562507|NCT01352585|65790301|FG000|Overall Study|Adverse Event|2|||
23562508|NCT01352585|65790302|FG001|Overall Study|Adverse Event|1|||
23562509|NCT01352585|65790301|FG000|Overall Study|Lost to Follow-up|1|||
23562510|NCT01352585|65790302|FG001|Overall Study|Lost to Follow-up|0|||
23562511|NCT01352585|65790301|FG000|Overall Study|Other|5|||
23562512|NCT01352585|65790302|FG001|Overall Study|Other|2|||
23562513|NCT00041756|65790303|FG000|Overall Study|Adverse Event|4|||
23562514|NCT00041756|65790304|FG001|Overall Study|Adverse Event|10|||
23562515|NCT00041756|65790305|FG002|Overall Study|Adverse Event|6|||
23562516|NCT00041756|65790306|FG003|Overall Study|Adverse Event|11|||
23562517|NCT00041756|65790307|FG004|Overall Study|Adverse Event|34|||
23562518|NCT00041756|65790303|FG000|Overall Study|Protocol Violation|1|||
23562519|NCT00041756|65790304|FG001|Overall Study|Protocol Violation|1|||
23562520|NCT00041756|65790305|FG002|Overall Study|Protocol Violation|2|||
23562521|NCT00041756|65790306|FG003|Overall Study|Protocol Violation|2|||
23562522|NCT00041756|65790307|FG004|Overall Study|Protocol Violation|1|||
23562523|NCT00041756|65790303|FG000|Overall Study|Withdrawal by Subject|3|||
23562524|NCT00041756|65790304|FG001|Overall Study|Withdrawal by Subject|3|||
23562525|NCT00041756|65790305|FG002|Overall Study|Withdrawal by Subject|4|||
23562526|NCT00041756|65790306|FG003|Overall Study|Withdrawal by Subject|2|||
23562527|NCT00041756|65790307|FG004|Overall Study|Withdrawal by Subject|3|||
23562528|NCT00041756|65790303|FG000|Overall Study|Lost to Follow-up|0|||
23562529|NCT00041756|65790304|FG001|Overall Study|Lost to Follow-up|1|||
23562530|NCT00041756|65790305|FG002|Overall Study|Lost to Follow-up|0|||
23562531|NCT00041756|65790306|FG003|Overall Study|Lost to Follow-up|1|||
23562532|NCT00041756|65790307|FG004|Overall Study|Lost to Follow-up|0|||
23439828|NCT01301833|65352572|FG002|Overall Study|Adverse Event|5|||
23439829|NCT01301833|65352573|FG003|Overall Study|Adverse Event|5|||
23439830|NCT01301833|65352570|FG000|Overall Study|Lack of Efficacy|1|||
23439831|NCT01301833|65352571|FG001|Overall Study|Lack of Efficacy|1|||
23439832|NCT01301833|65352572|FG002|Overall Study|Lack of Efficacy|0|||
23439833|NCT01301833|65352573|FG003|Overall Study|Lack of Efficacy|0|||
23439834|NCT01301833|65352570|FG000|Overall Study|Physician Decision|3|||
23562533|NCT00041756|65790303|FG000|Overall Study|Unable to meet protocol criteria|0|||
23439835|NCT01301833|65352571|FG001|Overall Study|Physician Decision|1|||
23439836|NCT01301833|65352572|FG002|Overall Study|Physician Decision|1|||
23562534|NCT00041756|65790304|FG001|Overall Study|Unable to meet protocol criteria|0|||
23562535|NCT00041756|65790305|FG002|Overall Study|Unable to meet protocol criteria|1|||
23562536|NCT00041756|65790306|FG003|Overall Study|Unable to meet protocol criteria|0|||
23562537|NCT00041756|65790307|FG004|Overall Study|Unable to meet protocol criteria|1|||
23562538|NCT00041756|65790303|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
23562539|NCT00041756|65790304|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
23562540|NCT00041756|65790305|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
23562541|NCT00041756|65790306|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
23562542|NCT00041756|65790307|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
23562543|NCT01013792|65790308|FG000|Overall Study|Study suspended|2|||
23562544|NCT01013792|65790309|FG001|Overall Study|Study suspended|1|||
23562545|NCT01013792|65790308|FG000|Overall Study|Adverse Event|0|||
23562546|NCT01013792|65790309|FG001|Overall Study|Adverse Event|3|||
23439837|NCT01301833|65352573|FG003|Overall Study|Physician Decision|0|||
23439838|NCT01301833|65352570|FG000|Overall Study|Withdrawal by Subject|3|||
23439839|NCT01301833|65352571|FG001|Overall Study|Withdrawal by Subject|1|||
23439840|NCT01301833|65352572|FG002|Overall Study|Withdrawal by Subject|1|||
23439841|NCT01301833|65352573|FG003|Overall Study|Withdrawal by Subject|2|||
23562547|NCT01013792|65790308|FG000|Overall Study|Lost to Follow-up|0|||
23562548|NCT01013792|65790309|FG001|Overall Study|Lost to Follow-up|1|||
23562549|NCT04555096|65790312|FG000|Overall Study|Death|4|||
23562550|NCT04555096|65790313|FG001|Overall Study|Death|4|||
23562551|NCT04555096|65790312|FG000|Overall Study|Withdrawal by Subject|1|||
23562552|NCT04555096|65790313|FG001|Overall Study|Withdrawal by Subject|0|||
23562553|NCT04555096|65790312|FG000|Overall Study|Other|0|||
23562554|NCT04555096|65790313|FG001|Overall Study|Other|1|||
23562555|NCT01852058|65790314|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
23562556|NCT01852058|65790315|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562557|NCT01852058|65790316|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562558|NCT01852058|65790317|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562559|NCT01852058|65790318|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562560|NCT01852058|65790319|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562561|NCT01852058|65790320|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562562|NCT01852058|65790321|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562563|NCT01852058|65790322|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562564|NCT01852058|65790323|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23439842|NCT01301833|65352570|FG000|Overall Study|Personal matter|1|||
23439843|NCT01301833|65352571|FG001|Overall Study|Personal matter|0|||
23439844|NCT01301833|65352572|FG002|Overall Study|Personal matter|0|||
23439845|NCT01301833|65352573|FG003|Overall Study|Personal matter|0|||
23562565|NCT01852058|65790324|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562566|NCT01852058|65790325|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562567|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562568|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562569|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562570|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562571|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
23757375|NCT00479401|66489697|FG001|Overall Study|Lack of Efficacy|2|||
23439846|NCT01943591|65352574|FG000|Overall Study|Lost to Follow-up|3|||
23439847|NCT01943591|65352575|FG001|Overall Study|Lost to Follow-up|4|||
23757376|NCT00479401|66489698|FG002|Overall Study|Lack of Efficacy|4|||
23757377|NCT00479401|66489696|FG000|Overall Study|Protocol Violation|2|||
23439848|NCT01943591|65352574|FG000|Overall Study|Death|2|||
23439849|NCT01943591|65352575|FG001|Overall Study|Death|7|||
23439850|NCT00372697|65352578|FG000|Overall Study|Protocol Violation|1|||
23439851|NCT00372697|65352579|FG001|Overall Study|Protocol Violation|1|||
23439852|NCT00534976|65352584|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
23439853|NCT00534976|65352585|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
23439854|NCT00534976|65352584|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
23439855|NCT00534976|65352585|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
23439856|NCT00534976|65352584|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
23439857|NCT00534976|65352585|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
23439858|NCT01007838|65352588|FG000|Overall Study|Withdrawal by Subject|1|||
23439859|NCT01007838|65352589|FG001|Overall Study|Withdrawal by Subject|0|||
23439860|NCT01007838|65352590|FG002|Overall Study|Withdrawal by Subject|0|||
23439861|NCT01007838|65352591|FG003|Overall Study|Withdrawal by Subject|0|||
23439862|NCT01007838|65352588|FG000|Overall Study|Physician Decision|1|||
23439863|NCT01007838|65352589|FG001|Overall Study|Physician Decision|0|||
23562572|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562573|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23757378|NCT00479401|66489697|FG001|Overall Study|Protocol Violation|1|||
23439864|NCT01007838|65352590|FG002|Overall Study|Physician Decision|0|||
23439865|NCT01007838|65352591|FG003|Overall Study|Physician Decision|0|||
23439866|NCT01007838|65352588|FG000|Overall Study|Started home haemodialysis|1|||
23439867|NCT01007838|65352589|FG001|Overall Study|Started home haemodialysis|0|||
23439868|NCT01007838|65352590|FG002|Overall Study|Started home haemodialysis|0|||
23439869|NCT01007838|65352591|FG003|Overall Study|Started home haemodialysis|0|||
23439870|NCT01748825|65352592|FG000|Dose Escalation|Refused further treatment|2|||
23439871|NCT01748825|65352593|FG001|Dose Escalation|Refused further treatment|2|||
23439872|NCT01748825|65352594|FG002|Dose Escalation|Refused further treatment|0|||
23439873|NCT01748825|65352595|FG003|Dose Escalation|Refused further treatment|0|||
23439874|NCT01748825|65352596|FG004|Dose Escalation|Refused further treatment|1|||
23439875|NCT01748825|65352597|FG005|Dose Escalation|Refused further treatment|2|||
23439876|NCT01748825|65352598|FG006|Dose Escalation|Refused further treatment|0|||
23439877|NCT01748825|65352599|FG007|Dose Escalation|Refused further treatment|0|||
23439878|NCT01748825|65352600|FG008|Dose Escalation|Refused further treatment|0|||
23439879|NCT01748825|65352601|FG009|Dose Escalation|Refused further treatment|0|||
23439880|NCT01748825|65352592|FG000|Dose Escalation|Switched to alternative treatment|0|||
23439881|NCT01748825|65352593|FG001|Dose Escalation|Switched to alternative treatment|0|||
23439882|NCT01748825|65352594|FG002|Dose Escalation|Switched to alternative treatment|0|||
23439883|NCT01748825|65352595|FG003|Dose Escalation|Switched to alternative treatment|1|||
23439884|NCT01748825|65352596|FG004|Dose Escalation|Switched to alternative treatment|0|||
23439885|NCT01748825|65352597|FG005|Dose Escalation|Switched to alternative treatment|0|||
23562574|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562575|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562576|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562577|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562578|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562579|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562580|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562581|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562582|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562583|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
23562584|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
23562585|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562586|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562587|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562588|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562589|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562590|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562591|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562592|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562593|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562594|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23757379|NCT00479401|66489698|FG002|Overall Study|Protocol Violation|1|||
23757380|NCT00479401|66489696|FG000|Overall Study|Lost to Follow-up|1|||
23757381|NCT00479401|66489697|FG001|Overall Study|Lost to Follow-up|1|||
23757382|NCT00479401|66489698|FG002|Overall Study|Lost to Follow-up|1|||
23757383|NCT00479401|66489696|FG000|Overall Study|Withdrawal by Subject|16|||
23757384|NCT00479401|66489697|FG001|Overall Study|Withdrawal by Subject|10|||
23757385|NCT00479401|66489698|FG002|Overall Study|Withdrawal by Subject|2|||
23757386|NCT00479401|66489696|FG000|Overall Study|Exclusion criteria, relocation|4|||
23757387|NCT00479401|66489697|FG001|Overall Study|Exclusion criteria, relocation|3|||
23757388|NCT00479401|66489698|FG002|Overall Study|Exclusion criteria, relocation|0|||
23757389|NCT01586624|66489699|FG000|Overall Study|Adverse Event|3|||
23757390|NCT01586624|66489700|FG001|Overall Study|Adverse Event|0|||
23757391|NCT01586624|66489701|FG002|Overall Study|Adverse Event|2|||
23757392|NCT01586624|66489702|FG003|Overall Study|Adverse Event|1|||
23757393|NCT01586624|66489703|FG004|Overall Study|Adverse Event|3|||
23757394|NCT01586624|66489704|FG005|Overall Study|Adverse Event|3|||
23757395|NCT01586624|66489705|FG006|Overall Study|Adverse Event|2|||
23757396|NCT01586624|66489706|FG007|Overall Study|Adverse Event|3|||
23757397|NCT01586624|66489699|FG000|Overall Study|Physician Decision|0|||
23757398|NCT01586624|66489700|FG001|Overall Study|Physician Decision|1|||
23757399|NCT01586624|66489701|FG002|Overall Study|Physician Decision|1|||
23757400|NCT01586624|66489702|FG003|Overall Study|Physician Decision|0|||
23439886|NCT01748825|65352598|FG006|Dose Escalation|Switched to alternative treatment|0|||
23439887|NCT01748825|65352599|FG007|Dose Escalation|Switched to alternative treatment|0|||
23439888|NCT01748825|65352600|FG008|Dose Escalation|Switched to alternative treatment|0|||
23562595|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
23439889|NCT01748825|65352601|FG009|Dose Escalation|Switched to alternative treatment|0|||
23757401|NCT01586624|66489703|FG004|Overall Study|Physician Decision|2|||
23757402|NCT01586624|66489704|FG005|Overall Study|Physician Decision|0|||
23439890|NCT01748825|65352592|FG000|Dose Escalation|Adverse Event|0|||
23439891|NCT01748825|65352593|FG001|Dose Escalation|Adverse Event|0|||
23439892|NCT01748825|65352594|FG002|Dose Escalation|Adverse Event|0|||
23439893|NCT01748825|65352595|FG003|Dose Escalation|Adverse Event|0|||
23439894|NCT01748825|65352596|FG004|Dose Escalation|Adverse Event|0|||
23439895|NCT01748825|65352597|FG005|Dose Escalation|Adverse Event|0|||
23439896|NCT01748825|65352598|FG006|Dose Escalation|Adverse Event|1|||
23439897|NCT01748825|65352599|FG007|Dose Escalation|Adverse Event|0|||
23439898|NCT01748825|65352600|FG008|Dose Escalation|Adverse Event|0|||
23439899|NCT01748825|65352601|FG009|Dose Escalation|Adverse Event|0|||
23439900|NCT01748825|65352592|FG000|Dose Expansion|Refused further treatment|0|||
23439901|NCT01748825|65352593|FG001|Dose Expansion|Refused further treatment|0|||
23439902|NCT01748825|65352594|FG002|Dose Expansion|Refused further treatment|0|||
23625332|NCT01270828|66015467|FG000|Pregabalin CR SB|Related adverse event|0|||
23625333|NCT01270828|66015468|FG001|Pregabalin CR SB|Related adverse event|0|||
23625334|NCT01270828|66015469|FG002|Pregabalin CR SB|Related adverse event|46|||
23625335|NCT01270828|66015467|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
23625336|NCT01270828|66015468|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
23625337|NCT01270828|66015469|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
23625338|NCT01270828|66015467|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
23625339|NCT01270828|66015468|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
23625340|NCT01270828|66015469|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
23625341|NCT01270828|66015467|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
23625342|NCT01270828|66015468|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
23625343|NCT01270828|66015469|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
23625344|NCT01270828|66015467|FG000|Pregabalin CR SB|Unrelated AE|0|||
23625345|NCT01270828|66015468|FG001|Pregabalin CR SB|Unrelated AE|0|||
23625346|NCT01270828|66015469|FG002|Pregabalin CR SB|Unrelated AE|8|||
23625347|NCT01270828|66015467|FG000|Pregabalin CR SB|Protocol Violation|0|||
23625348|NCT01270828|66015468|FG001|Pregabalin CR SB|Protocol Violation|0|||
23625349|NCT01270828|66015469|FG002|Pregabalin CR SB|Protocol Violation|8|||
23625350|NCT01270828|66015467|FG000|Double Blind Phase|Death|0|||
23757403|NCT01586624|66489705|FG006|Overall Study|Physician Decision|1|||
23757404|NCT01586624|66489706|FG007|Overall Study|Physician Decision|1|||
23757405|NCT01586624|66489699|FG000|Overall Study|Withdrawal by Subject|0|||
23757406|NCT01586624|66489700|FG001|Overall Study|Withdrawal by Subject|0|||
23757407|NCT01586624|66489701|FG002|Overall Study|Withdrawal by Subject|0|||
23757408|NCT01586624|66489702|FG003|Overall Study|Withdrawal by Subject|1|||
23757409|NCT01586624|66489703|FG004|Overall Study|Withdrawal by Subject|0|||
23757410|NCT01586624|66489704|FG005|Overall Study|Withdrawal by Subject|0|||
23757411|NCT01586624|66489705|FG006|Overall Study|Withdrawal by Subject|0|||
23757412|NCT01586624|66489706|FG007|Overall Study|Withdrawal by Subject|0|||
23757413|NCT01586624|66489699|FG000|Overall Study|Evidence of disease progression|1|||
23625351|NCT01270828|66015468|FG001|Double Blind Phase|Death|1|||
23625352|NCT01270828|66015469|FG002|Double Blind Phase|Death|0|||
23625353|NCT01270828|66015467|FG000|Double Blind Phase|Protocol Violation|0|||
23625354|NCT01270828|66015468|FG001|Double Blind Phase|Protocol Violation|1|||
23757414|NCT01586624|66489700|FG001|Overall Study|Evidence of disease progression|3|||
23439903|NCT01748825|65352595|FG003|Dose Expansion|Refused further treatment|0|||
23439904|NCT01748825|65352596|FG004|Dose Expansion|Refused further treatment|0|||
23625355|NCT01270828|66015469|FG002|Double Blind Phase|Protocol Violation|0|||
23757415|NCT01586624|66489701|FG002|Overall Study|Evidence of disease progression|2|||
23757416|NCT01586624|66489702|FG003|Overall Study|Evidence of disease progression|5|||
23562596|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562597|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562598|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562599|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562600|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562601|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562602|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562603|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562604|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562605|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562606|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562607|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
23757417|NCT01586624|66489703|FG004|Overall Study|Evidence of disease progression|3|||
23757418|NCT01586624|66489704|FG005|Overall Study|Evidence of disease progression|5|||
23757419|NCT01586624|66489705|FG006|Overall Study|Evidence of disease progression|4|||
23757420|NCT01586624|66489706|FG007|Overall Study|Evidence of disease progression|6|||
23757421|NCT01586624|66489699|FG000|Overall Study|Screen failure (no treatment received)|0|||
23757422|NCT01586624|66489700|FG001|Overall Study|Screen failure (no treatment received)|0|||
23757423|NCT01586624|66489701|FG002|Overall Study|Screen failure (no treatment received)|0|||
23757424|NCT01586624|66489702|FG003|Overall Study|Screen failure (no treatment received)|0|||
23757425|NCT01586624|66489703|FG004|Overall Study|Screen failure (no treatment received)|0|||
23562608|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
23562609|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562610|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562611|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562612|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562613|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562614|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562615|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562616|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562617|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562618|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
23562619|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562620|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562621|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562622|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562623|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562624|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562625|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562626|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562627|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562628|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562629|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562630|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562631|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
23562632|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
23562633|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562634|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562635|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562636|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562637|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562638|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562639|NCT01852058|65790314|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562640|NCT01852058|65790315|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562641|NCT01852058|65790316|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562642|NCT01852058|65790317|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562643|NCT01852058|65790318|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562644|NCT01852058|65790319|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562645|NCT01852058|65790320|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23625356|NCT01270828|66015467|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
23757426|NCT01586624|66489704|FG005|Overall Study|Screen failure (no treatment received)|0|||
23757427|NCT01586624|66489705|FG006|Overall Study|Screen failure (no treatment received)|1|||
23757428|NCT01586624|66489706|FG007|Overall Study|Screen failure (no treatment received)|0|||
23625357|NCT01270828|66015468|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
23625358|NCT01270828|66015469|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
23625359|NCT01270828|66015467|FG000|Double Blind Phase|Reason Unspecified|7|||
23625360|NCT01270828|66015468|FG001|Double Blind Phase|Reason Unspecified|4|||
23625361|NCT01270828|66015469|FG002|Double Blind Phase|Reason Unspecified|0|||
23625362|NCT01270828|66015467|FG000|Double Blind Phase|Withdrawal by Subject|6|||
23625363|NCT01270828|66015468|FG001|Double Blind Phase|Withdrawal by Subject|15|||
23757429|NCT00552617|66489707|FG000|Overall Study|Not Treated|0|||
23439905|NCT01748825|65352597|FG005|Dose Expansion|Refused further treatment|0|||
23757430|NCT00552617|66489708|FG001|Overall Study|Not Treated|0|||
23757431|NCT00552617|66489709|FG002|Overall Study|Not Treated|1|||
23757432|NCT00552617|66489710|FG003|Overall Study|Not Treated|0|||
23757433|NCT00552617|66489711|FG004|Overall Study|Not Treated|0|||
23826506|NCT04728802|66745094|FG001|Overall Study|Transfer|0|||
23826507|NCT04728802|66745093|FG000|Overall Study|Death|4|||
23826508|NCT04728802|66745094|FG001|Overall Study|Death|5|||
23826509|NCT04728802|66745093|FG000|Overall Study|Other|3|||
23826510|NCT04728802|66745094|FG001|Overall Study|Other|0|||
23826511|NCT05024747|66745095|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
23826512|NCT05024747|66745096|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
23826513|NCT05024747|66745095|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
23826514|NCT05024747|66745096|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
23826515|NCT05024747|66745095|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
23826516|NCT05024747|66745096|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
23826517|NCT05373108|66745098|FG000|Overall Study|Withdrawal by Subject|2|||
23826518|NCT01154231|66745105|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
23826519|NCT01154231|66745105|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
23826520|NCT01459783|66745106|FG000|Baseline to 6 Months|Death|1|||
23826521|NCT01459783|66745107|FG001|Baseline to 6 Months|Death|0|||
23826522|NCT01459783|66745106|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
23826523|NCT01459783|66745107|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
23826524|NCT01459783|66745106|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
23826525|NCT01459783|66745107|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
23826526|NCT01459783|66745106|FG000|6 Months to 12 Months|Death|0|||
23826527|NCT01459783|66745107|FG001|6 Months to 12 Months|Death|1|||
23826528|NCT01459783|66745106|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
23826529|NCT01459783|66745107|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
23826530|NCT01459783|66745106|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
23826531|NCT01459783|66745107|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
23439906|NCT01748825|65352598|FG006|Dose Expansion|Refused further treatment|0|||
23757434|NCT00552617|66489712|FG005|Overall Study|Not Treated|0|||
23757435|NCT00552617|66489713|FG006|Overall Study|Not Treated|0|||
23757436|NCT00552617|66489714|FG007|Overall Study|Not Treated|0|||
23757437|NCT00552617|66489715|FG008|Overall Study|Not Treated|0|||
23757438|NCT00552617|66489716|FG009|Overall Study|Not Treated|1|||
23757439|NCT00552617|66489707|FG000|Overall Study|Lost to Follow-up|0|||
23757440|NCT00552617|66489708|FG001|Overall Study|Lost to Follow-up|0|||
23757441|NCT00552617|66489709|FG002|Overall Study|Lost to Follow-up|0|||
23757442|NCT00552617|66489710|FG003|Overall Study|Lost to Follow-up|1|||
23757443|NCT00552617|66489711|FG004|Overall Study|Lost to Follow-up|0|||
23757444|NCT00552617|66489712|FG005|Overall Study|Lost to Follow-up|2|||
23757445|NCT00552617|66489713|FG006|Overall Study|Lost to Follow-up|0|||
23757446|NCT00552617|66489714|FG007|Overall Study|Lost to Follow-up|0|||
23757447|NCT00552617|66489715|FG008|Overall Study|Lost to Follow-up|2|||
23757448|NCT00552617|66489716|FG009|Overall Study|Lost to Follow-up|0|||
23757449|NCT01364298|66489717|FG000|Overall Study|Adverse Event|3|||
23757450|NCT01364298|66489718|FG001|Overall Study|Adverse Event|4|||
23757451|NCT01364298|66489717|FG000|Overall Study|Lack of adherence to treatment|1|||
23757452|NCT01364298|66489718|FG001|Overall Study|Lack of adherence to treatment|3|||
23757453|NCT01364298|66489717|FG000|Overall Study|Lack of Efficacy|1|||
23757454|NCT01364298|66489718|FG001|Overall Study|Lack of Efficacy|0|||
23757455|NCT01364298|66489717|FG000|Overall Study|Lost to Follow-up|5|||
23757456|NCT01364298|66489718|FG001|Overall Study|Lost to Follow-up|10|||
23757457|NCT01364298|66489717|FG000|Overall Study|Withdrawal by Subject|3|||
23757458|NCT01364298|66489718|FG001|Overall Study|Withdrawal by Subject|3|||
23757459|NCT01364298|66489717|FG000|Overall Study|Other|1|||
23757460|NCT01364298|66489718|FG001|Overall Study|Other|3|||
23757461|NCT00667719|66489721|FG000|Overall Study|Adverse Event|39|||
23757462|NCT00667719|66489721|FG000|Overall Study|Abnormal Test Procedure|1|||
23757463|NCT00667719|66489721|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23757464|NCT00667719|66489721|FG000|Overall Study|Protocol Violation|3|||
23757465|NCT00667719|66489721|FG000|Overall Study|Withdrawal by Subject|17|||
23757466|NCT00667719|66489721|FG000|Overall Study|Lost to Follow-up|8|||
23757467|NCT01493531|66489722|FG000|Overall Study|Adverse Event|4|||
23757468|NCT01493531|66489723|FG001|Overall Study|Adverse Event|12|||
23757469|NCT01493531|66489724|FG002|Overall Study|Adverse Event|9|||
23757470|NCT01493531|66489722|FG000|Overall Study|Gout flare|3|||
23757471|NCT01493531|66489723|FG001|Overall Study|Gout flare|0|||
23757472|NCT01493531|66489724|FG002|Overall Study|Gout flare|2|||
23757473|NCT01493531|66489722|FG000|Overall Study|Protocol Violation|8|||
23757474|NCT01493531|66489723|FG001|Overall Study|Protocol Violation|15|||
23757475|NCT01493531|66489724|FG002|Overall Study|Protocol Violation|12|||
23757476|NCT01493531|66489722|FG000|Overall Study|Sponsor terminated study|5|||
23757477|NCT01493531|66489723|FG001|Overall Study|Sponsor terminated study|2|||
23757478|NCT01493531|66489724|FG002|Overall Study|Sponsor terminated study|3|||
23757479|NCT01493531|66489722|FG000|Overall Study|Lost to Follow-up|5|||
23757480|NCT01493531|66489723|FG001|Overall Study|Lost to Follow-up|7|||
23757481|NCT01493531|66489724|FG002|Overall Study|Lost to Follow-up|11|||
23757482|NCT01493531|66489722|FG000|Overall Study|Withdrawal by Subject|16|||
23757483|NCT01493531|66489723|FG001|Overall Study|Withdrawal by Subject|13|||
23757484|NCT01493531|66489724|FG002|Overall Study|Withdrawal by Subject|11|||
23757485|NCT01493531|66489722|FG000|Overall Study|Death|0|||
23757486|NCT01493531|66489723|FG001|Overall Study|Death|1|||
23757487|NCT01493531|66489724|FG002|Overall Study|Death|0|||
23757488|NCT04444752|66489725|FG000|Overall Study|Adverse Event|1|||
23757489|NCT04444752|66489726|FG001|Overall Study|Adverse Event|0|||
23757490|NCT04444752|66489727|FG002|Overall Study|Adverse Event|0|||
23757491|NCT04444752|66489728|FG003|Overall Study|Adverse Event|2|||
23757492|NCT04444752|66489725|FG000|Overall Study|Lost to Follow-up|2|||
23757493|NCT04444752|66489726|FG001|Overall Study|Lost to Follow-up|6|||
23757494|NCT04444752|66489727|FG002|Overall Study|Lost to Follow-up|2|||
23757495|NCT04444752|66489728|FG003|Overall Study|Lost to Follow-up|5|||
23757496|NCT04444752|66489725|FG000|Overall Study|Physician Decision|0|||
23757497|NCT04444752|66489726|FG001|Overall Study|Physician Decision|0|||
23757498|NCT04444752|66489727|FG002|Overall Study|Physician Decision|0|||
23757499|NCT04444752|66489728|FG003|Overall Study|Physician Decision|2|||
23757500|NCT04444752|66489725|FG000|Overall Study|Pregnancy|0|||
23757501|NCT04444752|66489726|FG001|Overall Study|Pregnancy|0|||
23757502|NCT04444752|66489727|FG002|Overall Study|Pregnancy|0|||
23757503|NCT04444752|66489728|FG003|Overall Study|Pregnancy|1|||
23757504|NCT04444752|66489725|FG000|Overall Study|Withdrawal by Subject|6|||
23757505|NCT04444752|66489726|FG001|Overall Study|Withdrawal by Subject|5|||
23757506|NCT04444752|66489727|FG002|Overall Study|Withdrawal by Subject|3|||
23757507|NCT04444752|66489728|FG003|Overall Study|Withdrawal by Subject|4|||
23757508|NCT04444752|66489725|FG000|Overall Study|Protocol Violation|1|||
23757509|NCT04444752|66489726|FG001|Overall Study|Protocol Violation|1|||
23757510|NCT04444752|66489727|FG002|Overall Study|Protocol Violation|0|||
23757511|NCT04444752|66489728|FG003|Overall Study|Protocol Violation|0|||
23757512|NCT04444752|66489725|FG000|Overall Study|Patient moving out of town|1|||
23757513|NCT04444752|66489726|FG001|Overall Study|Patient moving out of town|0|||
23757514|NCT04444752|66489727|FG002|Overall Study|Patient moving out of town|0|||
23757515|NCT04444752|66489728|FG003|Overall Study|Patient moving out of town|1|||
23562646|NCT01852058|65790321|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
23757516|NCT04444752|66489725|FG000|Overall Study|Lack of Efficacy|0|||
23757517|NCT04444752|66489726|FG001|Overall Study|Lack of Efficacy|0|||
23757518|NCT04444752|66489727|FG002|Overall Study|Lack of Efficacy|0|||
23757519|NCT04444752|66489728|FG003|Overall Study|Lack of Efficacy|1|||
23757520|NCT04444752|66489725|FG000|Overall Study|Death|0|||
23757521|NCT04444752|66489726|FG001|Overall Study|Death|0|||
23757522|NCT04444752|66489727|FG002|Overall Study|Death|1|||
23757523|NCT04444752|66489728|FG003|Overall Study|Death|0|||
23757524|NCT01902134|66489731|FG000|Overall Study|Adverse Event|3|||
23757525|NCT01902134|66489732|FG001|Overall Study|Adverse Event|1|||
23757526|NCT01902134|66489733|FG002|Overall Study|Adverse Event|2|||
23757527|NCT01902134|66489734|FG003|Overall Study|Adverse Event|1|||
23757528|NCT01902134|66489735|FG004|Overall Study|Adverse Event|1|||
23757529|NCT01902134|66489736|FG005|Overall Study|Adverse Event|3|||
23757530|NCT01902134|66489731|FG000|Overall Study|Lack of Efficacy|0|||
23757531|NCT01902134|66489732|FG001|Overall Study|Lack of Efficacy|0|||
23757532|NCT01902134|66489733|FG002|Overall Study|Lack of Efficacy|2|||
23757533|NCT01902134|66489734|FG003|Overall Study|Lack of Efficacy|0|||
23757534|NCT01902134|66489735|FG004|Overall Study|Lack of Efficacy|0|||
23757535|NCT01902134|66489736|FG005|Overall Study|Lack of Efficacy|1|||
23757536|NCT01902134|66489731|FG000|Overall Study|Physician Decision|0|||
23757537|NCT01902134|66489732|FG001|Overall Study|Physician Decision|1|||
23757538|NCT01902134|66489733|FG002|Overall Study|Physician Decision|0|||
23757539|NCT01902134|66489734|FG003|Overall Study|Physician Decision|0|||
23757540|NCT01902134|66489735|FG004|Overall Study|Physician Decision|0|||
23757541|NCT01902134|66489736|FG005|Overall Study|Physician Decision|0|||
23757542|NCT01902134|66489731|FG000|Overall Study|Protocol Violation|0|||
23757543|NCT01902134|66489732|FG001|Overall Study|Protocol Violation|0|||
23757544|NCT01902134|66489733|FG002|Overall Study|Protocol Violation|0|||
23757545|NCT01902134|66489734|FG003|Overall Study|Protocol Violation|0|||
23757546|NCT01902134|66489735|FG004|Overall Study|Protocol Violation|0|||
23757547|NCT01902134|66489736|FG005|Overall Study|Protocol Violation|1|||
23757548|NCT01902134|66489731|FG000|Overall Study|Withdrawal by Subject|4|||
23757549|NCT01902134|66489732|FG001|Overall Study|Withdrawal by Subject|8|||
23757550|NCT01902134|66489733|FG002|Overall Study|Withdrawal by Subject|9|||
23826532|NCT01459783|66745106|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
23826533|NCT01459783|66745107|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
23757551|NCT01902134|66489734|FG003|Overall Study|Withdrawal by Subject|1|||
23757552|NCT01902134|66489735|FG004|Overall Study|Withdrawal by Subject|5|||
23757553|NCT01902134|66489736|FG005|Overall Study|Withdrawal by Subject|4|||
23757554|NCT01902134|66489731|FG000|Overall Study|no compliance|1|||
23757555|NCT01902134|66489732|FG001|Overall Study|no compliance|0|||
23757556|NCT01902134|66489733|FG002|Overall Study|no compliance|0|||
23757557|NCT01902134|66489734|FG003|Overall Study|no compliance|0|||
23757558|NCT01902134|66489735|FG004|Overall Study|no compliance|0|||
23757559|NCT01902134|66489736|FG005|Overall Study|no compliance|0|||
23439907|NCT01748825|65352599|FG007|Dose Expansion|Refused further treatment|0|||
23439908|NCT01748825|65352600|FG008|Dose Expansion|Refused further treatment|1|||
23439909|NCT01748825|65352601|FG009|Dose Expansion|Refused further treatment|1|||
23439910|NCT01748825|65352592|FG000|Dose Expansion|Switched to alternative treatment|0|||
23439911|NCT01748825|65352593|FG001|Dose Expansion|Switched to alternative treatment|0|||
23439912|NCT01748825|65352594|FG002|Dose Expansion|Switched to alternative treatment|0|||
23757560|NCT01902134|66489731|FG000|Overall Study|Other|0|||
23757561|NCT01902134|66489732|FG001|Overall Study|Other|1|||
23757562|NCT01902134|66489733|FG002|Overall Study|Other|2|||
23757563|NCT01902134|66489734|FG003|Overall Study|Other|0|||
23757564|NCT01902134|66489735|FG004|Overall Study|Other|1|||
23757565|NCT01902134|66489736|FG005|Overall Study|Other|0|||
23757566|NCT01120600|66489737|FG000|Overall Study|Adverse Event|7|||
23757567|NCT01120600|66489738|FG001|Overall Study|Adverse Event|7|||
23757568|NCT01120600|66489737|FG000|Overall Study|Excessive Bone Loss|0|||
23757569|NCT01120600|66489738|FG001|Overall Study|Excessive Bone Loss|4|||
23757570|NCT01120600|66489737|FG000|Overall Study|Lost to Follow-up|1|||
23757571|NCT01120600|66489738|FG001|Overall Study|Lost to Follow-up|3|||
23757572|NCT01120600|66489737|FG000|Overall Study|Physician Decision|1|||
23757573|NCT01120600|66489738|FG001|Overall Study|Physician Decision|3|||
23757574|NCT01120600|66489737|FG000|Overall Study|Protocol Violation|0|||
23757575|NCT01120600|66489738|FG001|Overall Study|Protocol Violation|4|||
23757576|NCT01120600|66489737|FG000|Overall Study|Withdrawal by Subject|10|||
23757577|NCT01120600|66489738|FG001|Overall Study|Withdrawal by Subject|11|||
23757578|NCT00756652|66489739|FG000|Original Phase|Withdrawal by Subject|864|||
23757579|NCT00756652|66489740|FG001|Original Phase|Withdrawal by Subject|23|||
23757580|NCT00756652|66489739|FG000|Original Phase|Lost to Follow-up|601|||
23757581|NCT00756652|66489740|FG001|Original Phase|Lost to Follow-up|0|||
23757582|NCT00756652|66489739|FG000|Original Phase|Other Discontinuation|797|||
23757583|NCT00756652|66489740|FG001|Original Phase|Other Discontinuation|5|||
23757584|NCT00756652|66489739|FG000|Original Phase|Participant Noncompliance|18622|||
23757585|NCT00756652|66489740|FG001|Original Phase|Participant Noncompliance|424|||
23757586|NCT00756652|66489739|FG000|Original Phase|Unknown Discontinuation Reason|2|||
23757587|NCT00756652|66489740|FG001|Original Phase|Unknown Discontinuation Reason|0|||
23757588|NCT00756652|66489739|FG000|Original Phase|Participants without data|3259|||
23562647|NCT01852058|65790322|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23757589|NCT00756652|66489740|FG001|Original Phase|Participants without data|466|||
23757590|NCT00756652|66489739|FG000|Original Phase|Death|168|||
23757591|NCT00756652|66489740|FG001|Original Phase|Death|1|||
23757592|NCT00756652|66489739|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
23757593|NCT00756652|66489740|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
23757594|NCT00756652|66489739|FG000|Re-Op Phase|Withdrawal by Subject|62|||
23757595|NCT00756652|66489740|FG001|Re-Op Phase|Withdrawal by Subject|0|||
23757596|NCT00756652|66489739|FG000|Re-Op Phase|Death|6|||
23562648|NCT01852058|65790323|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562649|NCT01852058|65790324|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562650|NCT01852058|65790325|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562651|NCT01852058|65790314|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562652|NCT01852058|65790315|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562653|NCT01852058|65790316|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562654|NCT01852058|65790317|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562655|NCT01852058|65790318|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562656|NCT01852058|65790319|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562657|NCT01852058|65790320|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562658|NCT01852058|65790321|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562659|NCT01852058|65790322|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
23562660|NCT01852058|65790323|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562661|NCT01852058|65790324|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562662|NCT01852058|65790325|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562663|NCT00263328|65790326|FG000|Overall Study|Death|0|||
23562664|NCT00263328|65790327|FG001|Overall Study|Death|0|||
23562665|NCT00263328|65790328|FG002|Overall Study|Death|1|||
23562666|NCT00263328|65790326|FG000|Overall Study|Lost to Follow-up|1|||
23562667|NCT00263328|65790327|FG001|Overall Study|Lost to Follow-up|1|||
23562668|NCT00263328|65790328|FG002|Overall Study|Lost to Follow-up|0|||
23562669|NCT00263328|65790326|FG000|Overall Study|Withdrawal by Subject|3|||
23562670|NCT00263328|65790327|FG001|Overall Study|Withdrawal by Subject|0|||
23562671|NCT00263328|65790328|FG002|Overall Study|Withdrawal by Subject|1|||
23562672|NCT00263328|65790326|FG000|Overall Study|Other|3|||
23562673|NCT00263328|65790327|FG001|Overall Study|Other|0|||
23562674|NCT00263328|65790328|FG002|Overall Study|Other|1|||
23562675|NCT00263328|65790326|FG000|Overall Study|Adverse Event|1|||
23562676|NCT00263328|65790327|FG001|Overall Study|Adverse Event|1|||
23562677|NCT00263328|65790328|FG002|Overall Study|Adverse Event|4|||
23562678|NCT02323646|65790329|FG000|Treatment Course 1|Adverse Event|1|||
23562679|NCT02323646|65790330|FG001|Treatment Course 1|Adverse Event|0|||
23562680|NCT02323646|65790331|FG002|Treatment Course 1|Adverse Event|1|||
23562681|NCT02323646|65790329|FG000|Treatment Course 1|Heavy Bleeding|1|||
23562682|NCT02323646|65790330|FG001|Treatment Course 1|Heavy Bleeding|1|||
23562683|NCT02323646|65790331|FG002|Treatment Course 1|Heavy Bleeding|0|||
23562684|NCT02323646|65790329|FG000|Treatment Course 1|Lost to Follow-up|1|||
23562685|NCT02323646|65790330|FG001|Treatment Course 1|Lost to Follow-up|0|||
23562686|NCT02323646|65790331|FG002|Treatment Course 1|Lost to Follow-up|2|||
23562687|NCT02323646|65790329|FG000|Treatment Course 1|Withdrawal by Subject|0|||
23562688|NCT02323646|65790330|FG001|Treatment Course 1|Withdrawal by Subject|2|||
23562689|NCT02323646|65790331|FG002|Treatment Course 1|Withdrawal by Subject|0|||
23562690|NCT02323646|65790329|FG000|Treatment Course 2|Adverse Event|1|||
23562691|NCT02323646|65790330|FG001|Treatment Course 2|Adverse Event|0|||
23562692|NCT02323646|65790331|FG002|Treatment Course 2|Adverse Event|1|||
23562693|NCT02323646|65790329|FG000|Treatment Course 2|Lost to Follow-up|0|||
23562694|NCT02323646|65790330|FG001|Treatment Course 2|Lost to Follow-up|0|||
23562695|NCT02323646|65790331|FG002|Treatment Course 2|Lost to Follow-up|1|||
23562696|NCT02323646|65790329|FG000|Treatment Course 2|Non-compliance|0|||
23625364|NCT01270828|66015469|FG002|Double Blind Phase|Withdrawal by Subject|0|||
23625365|NCT01270828|66015467|FG000|Double Blind Phase|Lost to Follow-up|1|||
23562697|NCT02323646|65790330|FG001|Treatment Course 2|Non-compliance|1|||
23562698|NCT02323646|65790331|FG002|Treatment Course 2|Non-compliance|1|||
23562699|NCT01672853|65790332|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
23562700|NCT01672853|65790333|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
23562701|NCT01672853|65790334|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
23562702|NCT01672853|65790332|FG000|Overall Study|Pregnancy|0|||
23625366|NCT01270828|66015468|FG001|Double Blind Phase|Lost to Follow-up|2|||
23625367|NCT01270828|66015469|FG002|Double Blind Phase|Lost to Follow-up|0|||
23625368|NCT01270828|66015467|FG000|Double Blind Phase|Lack of Efficacy|2|||
23625369|NCT01270828|66015468|FG001|Double Blind Phase|Lack of Efficacy|11|||
23757597|NCT00756652|66489740|FG001|Re-Op Phase|Death|0|||
23757598|NCT00756652|66489739|FG000|Re-Op Phase|Lost to Follow-up|340|||
23757599|NCT00756652|66489740|FG001|Re-Op Phase|Lost to Follow-up|0|||
23757600|NCT00756652|66489739|FG000|Re-Op Phase|Site Closed|2454|||
23757601|NCT00756652|66489740|FG001|Re-Op Phase|Site Closed|0|||
23757602|NCT00756652|66489739|FG000|Re-Op Phase|Withdrawn after explant|14|||
23757603|NCT00756652|66489740|FG001|Re-Op Phase|Withdrawn after explant|0|||
23757604|NCT01222715|66489741|FG000|Overall Study|Adverse Event|0|||
23757605|NCT01222715|66489742|FG001|Overall Study|Adverse Event|4|||
23757606|NCT01222715|66489741|FG000|Overall Study|Death|0|||
23757607|NCT01222715|66489742|FG001|Overall Study|Death|1|||
23757608|NCT01222715|66489741|FG000|Overall Study|Lack of Efficacy|22|||
23757609|NCT01222715|66489742|FG001|Overall Study|Lack of Efficacy|14|||
23757610|NCT01222715|66489741|FG000|Overall Study|Physician Decision|12|||
23757611|NCT01222715|66489742|FG001|Overall Study|Physician Decision|2|||
23757612|NCT01222715|66489741|FG000|Overall Study|Refusal of further protocol therapy|0|||
23757613|NCT01222715|66489742|FG001|Overall Study|Refusal of further protocol therapy|4|||
23757614|NCT01222715|66489741|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
23757615|NCT01222715|66489742|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
23757616|NCT01222715|66489741|FG000|Overall Study|Ineligible|0|||
23757617|NCT01222715|66489742|FG001|Overall Study|Ineligible|1|||
23757618|NCT01222715|66489741|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
23757619|NCT01222715|66489742|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
23757620|NCT02239692|66489743|FG000|Overall Study|Incomplete colonoscopy|1|||
23757621|NCT02239692|66489744|FG001|Overall Study|Incomplete colonoscopy|2|||
23757622|NCT02239692|66489743|FG000|Overall Study|Adverse Event|0|||
23757623|NCT02239692|66489744|FG001|Overall Study|Adverse Event|1|||
23757624|NCT02239692|66489743|FG000|Overall Study|Physician Decision|0|||
23757625|NCT02239692|66489744|FG001|Overall Study|Physician Decision|1|||
23757626|NCT02239692|66489743|FG000|Overall Study|Lost to Follow-up|1|||
23757627|NCT02239692|66489744|FG001|Overall Study|Lost to Follow-up|4|||
23757628|NCT02239692|66489743|FG000|Overall Study|Withdrawal by Subject|3|||
23757629|NCT02239692|66489744|FG001|Overall Study|Withdrawal by Subject|5|||
23757630|NCT02239692|66489743|FG000|Overall Study|Other reason|1|||
23757631|NCT02239692|66489744|FG001|Overall Study|Other reason|0|||
23757632|NCT00678379|66489748|FG000|Overall Study|Injection performed after tonsillectomy|2|||
23757633|NCT00678379|66489749|FG001|Overall Study|Injection performed after tonsillectomy|0|||
23757634|NCT00678379|66489750|FG002|Overall Study|Injection performed after tonsillectomy|1|||
23757635|NCT00678379|66489748|FG000|Overall Study|Incomplete Data|4|||
23757636|NCT00678379|66489749|FG001|Overall Study|Incomplete Data|3|||
23757637|NCT00678379|66489750|FG002|Overall Study|Incomplete Data|3|||
23757638|NCT05288673|66489751|FG000|Overall Study|Consent withdrawn by subject|0|||
23757639|NCT05288673|66489752|FG001|Overall Study|Consent withdrawn by subject|0|||
23757640|NCT05288673|66489753|FG002|Overall Study|Consent withdrawn by subject|1|||
23757641|NCT01092702|66492125|FG000|Overall Study|Withdrawal by Subject|7|||
23757642|NCT01092702|66492125|FG000|Overall Study|Lost to Follow-up|2|||
23757643|NCT01715415|66492126|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
23757644|NCT01715415|66492127|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
23757645|NCT01715415|66492126|FG000|Double-blind Treatment|Adverse Event|3|||
23757646|NCT01715415|66492127|FG001|Double-blind Treatment|Adverse Event|0|||
23757647|NCT01715415|66492126|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
23757648|NCT01715415|66492127|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
23757649|NCT01715415|66492126|FG000|Double-blind Treatment|Other|1|||
23757650|NCT01715415|66492127|FG001|Double-blind Treatment|Other|0|||
23757651|NCT01715415|66492126|FG000|Open-label Treatment|Adverse Event|0|||
23757652|NCT01715415|66492127|FG001|Open-label Treatment|Adverse Event|1|||
23757653|NCT01715415|66492126|FG000|Open-label Treatment|Subject Noncompliant|0|||
23757654|NCT01715415|66492127|FG001|Open-label Treatment|Subject Noncompliant|1|||
23757655|NCT03302299|66492128|FG000|Overall Study|Protocol Violation|1|||
23757656|NCT03797222|66492129|FG000|Overall Study|Withdrawal by Subject|1|||
23562703|NCT01672853|65790333|FG001|Overall Study|Pregnancy|1|||
23562704|NCT01672853|65790334|FG002|Overall Study|Pregnancy|0|||
23562705|NCT01672853|65790332|FG000|Overall Study|Investigator's Discretion|1|||
23562706|NCT01672853|65790333|FG001|Overall Study|Investigator's Discretion|0|||
23562707|NCT01672853|65790334|FG002|Overall Study|Investigator's Discretion|0|||
23562708|NCT01672853|65790332|FG000|Overall Study|Withdrew Consent|5|||
23562709|NCT01672853|65790333|FG001|Overall Study|Withdrew Consent|5|||
23562710|NCT01672853|65790334|FG002|Overall Study|Withdrew Consent|5|||
23757657|NCT00319020|66492137|FG000|Overall Study|Death|2|||
23757658|NCT00319020|66492138|FG001|Overall Study|Death|2|||
23757659|NCT00319020|66492137|FG000|Overall Study|Withdrawal by Subject|4|||
23757660|NCT00319020|66492138|FG001|Overall Study|Withdrawal by Subject|1|||
23757661|NCT00319020|66492137|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
23757662|NCT00319020|66492138|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
23757663|NCT00319020|66492137|FG000|Overall Study|Administrative reason|0|||
23757664|NCT00319020|66492138|FG001|Overall Study|Administrative reason|5|||
23757665|NCT00319020|66492137|FG000|Overall Study|Disease progression|0|||
23757666|NCT00319020|66492138|FG001|Overall Study|Disease progression|2|||
23757667|NCT00319020|66492137|FG000|Overall Study|Transplant|0|||
23757668|NCT00319020|66492138|FG001|Overall Study|Transplant|1|||
23757669|NCT00319020|66492137|FG000|Overall Study|Treatment failure|0|||
23757670|NCT00319020|66492138|FG001|Overall Study|Treatment failure|1|||
23757671|NCT00319020|66492137|FG000|Overall Study|Adverse Event|0|||
23757672|NCT00319020|66492138|FG001|Overall Study|Adverse Event|1|||
23757673|NCT04056299|66492139|FG000|Overall Study|Sponsor discontinued study|3|||
23757674|NCT04056299|66492140|FG001|Overall Study|Sponsor discontinued study|3|||
23757675|NCT01050673|66492141|FG000|Overall Study|Physician Decision|4|||
23757676|NCT01050673|66492142|FG001|Overall Study|Physician Decision|5|||
23757677|NCT01335399|66492143|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
23757678|NCT01335399|66492144|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
23757679|NCT01335399|66492143|FG000|Pre-treatment Period|Participant request to discontinue|0|||
23757680|NCT01335399|66492144|FG001|Pre-treatment Period|Participant request to discontinue|1|||
23757681|NCT01335399|66492143|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
23757682|NCT01335399|66492144|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
23757683|NCT01335399|66492143|FG000|Pre-treatment Period|Consent withdrawal|3|||
23757684|NCT01335399|66492144|FG001|Pre-treatment Period|Consent withdrawal|0|||
23757685|NCT01335399|66492143|FG000|Treatment Period|Disease progression|117|||
23757686|NCT01335399|66492144|FG001|Treatment Period|Disease progression|145|||
23757687|NCT01335399|66492143|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
23757688|NCT01335399|66492144|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
23757689|NCT01335399|66492143|FG000|Treatment Period|Study drug toxicity|52|||
23757690|NCT01335399|66492144|FG001|Treatment Period|Study drug toxicity|64|||
23757691|NCT01335399|66492143|FG000|Treatment Period|Participant request to discontinue|30|||
23757692|NCT01335399|66492144|FG001|Treatment Period|Participant request to discontinue|22|||
23757693|NCT01335399|66492143|FG000|Treatment Period|Other reasons|30|||
23757694|NCT01335399|66492144|FG001|Treatment Period|Other reasons|30|||
23757695|NCT01335399|66492143|FG000|Treatment Period|Consent withdrawal|10|||
23757696|NCT01335399|66492144|FG001|Treatment Period|Consent withdrawal|7|||
23757697|NCT01335399|66492143|FG000|Treatment Period|Death|7|||
23757698|NCT01335399|66492144|FG001|Treatment Period|Death|6|||
23757699|NCT01335399|66492143|FG000|Treatment Period|Poor/Non-compliance|3|||
23757700|NCT01335399|66492144|FG001|Treatment Period|Poor/Non-compliance|4|||
23757701|NCT01335399|66492143|FG000|Treatment Period|Lost to Follow-up|2|||
23757702|NCT01335399|66492144|FG001|Treatment Period|Lost to Follow-up|2|||
23757703|NCT01335399|66492143|FG000|Treatment Period|Maximum clinical benefit|1|||
23757704|NCT01335399|66492144|FG001|Treatment Period|Maximum clinical benefit|1|||
23757705|NCT01335399|66492143|FG000|Treatment Period|No longer meet study criteria|1|||
23562711|NCT01672853|65790332|FG000|Overall Study|Adverse Event|4|||
23562712|NCT01672853|65790333|FG001|Overall Study|Adverse Event|6|||
23562713|NCT01672853|65790334|FG002|Overall Study|Adverse Event|8|||
23562714|NCT01672853|65790332|FG000|Overall Study|Lost to Follow-up|0|||
23757706|NCT01335399|66492144|FG001|Treatment Period|No longer meet study criteria|1|||
23757707|NCT01335399|66492143|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
23757708|NCT01335399|66492144|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
23757709|NCT01963676|66492146|FG000|Overall Study|Withdrawal by Subject|1|||
23757710|NCT01963676|66492147|FG001|Overall Study|Withdrawal by Subject|0|||
23757711|NCT03182686|66492148|FG000|Overall Study|Lost to Follow-up|2|||
23757712|NCT03182686|66492149|FG001|Overall Study|Lost to Follow-up|0|||
23757713|NCT03182686|66492148|FG000|Overall Study|Adverse Event|2|||
23757714|NCT03182686|66492149|FG001|Overall Study|Adverse Event|0|||
23757715|NCT03182686|66492148|FG000|Overall Study|Withdrawal by Subject|3|||
23757716|NCT03182686|66492149|FG001|Overall Study|Withdrawal by Subject|0|||
23757717|NCT01185639|66492150|FG000|Overall Study|Progressed and didn't receive therapy|2|||
23757718|NCT00033631|66492155|FG000|Overall Study|Protocol Violation|14|||
23757719|NCT00033631|66492156|FG001|Overall Study|Protocol Violation|11|||
23826534|NCT02553772|66745111|FG000|Overall Study|Adverse Event|2|||
23826535|NCT02553772|66745112|FG001|Overall Study|Adverse Event|3|||
23562715|NCT01672853|65790333|FG001|Overall Study|Lost to Follow-up|1|||
23562716|NCT01672853|65790334|FG002|Overall Study|Lost to Follow-up|0|||
23562717|NCT01672853|65790332|FG000|Overall Study|Randomized but Never Treated|0|||
23562718|NCT01672853|65790333|FG001|Overall Study|Randomized but Never Treated|0|||
23562719|NCT01672853|65790334|FG002|Overall Study|Randomized but Never Treated|1|||
23826536|NCT02553772|66745111|FG000|Overall Study|Lost to Follow-up|2|||
23826537|NCT02553772|66745112|FG001|Overall Study|Lost to Follow-up|1|||
23562720|NCT02966002|65790335|FG000|Overall Study|Withdrawal by Subject|2|||
23562721|NCT02966002|65790335|FG000|Overall Study|Adverse Event|1|||
23757720|NCT00033631|66492155|FG000|Overall Study|Withdrawal by Subject|4|||
23757721|NCT00033631|66492156|FG001|Overall Study|Withdrawal by Subject|4|||
23757722|NCT01406873|66492159|FG000|Overall Study|Withdrawal by Subject|1|||
23757723|NCT01406873|66492160|FG001|Overall Study|Withdrawal by Subject|1|||
23757724|NCT01440647|66492161|FG000|Overall Study|Death|2|||
23757725|NCT01440647|66492162|FG001|Overall Study|Death|3|||
23757726|NCT01726335|66492163|FG000|Overall Study|Lost to Follow-up|2|||
23826538|NCT02553772|66745111|FG000|Overall Study|Withdrawal of Consent|1|||
23757727|NCT01726335|66492163|FG000|Overall Study|Withdrawal by Subject|15|||
23757728|NCT01726335|66492163|FG000|Overall Study|Adverse Event|4|||
23757729|NCT01726335|66492163|FG000|Overall Study|Lost to Follow-up|2|||
23757730|NCT01726335|66492163|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
23757731|NCT03263819|66492164|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
23757732|NCT03263819|66492165|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
23757733|NCT01783730|66492167|FG000|Overall Study|Failed to meet inclusion criteria|6|||
23757734|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
23757735|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
23757736|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
23757737|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
23757738|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
23757739|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Adverse Event|60|||
23757740|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Adverse Event|0|||
23757741|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Adverse Event|0|||
23757742|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Adverse Event|0|||
23757743|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Adverse Event|0|||
23757744|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
23757745|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23757746|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23757747|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23757748|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23757749|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Physician Decision|10|||
23757750|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Physician Decision|0|||
23757751|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Physician Decision|0|||
23757752|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Physician Decision|0|||
23757753|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Physician Decision|0|||
23757754|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
23757755|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23757756|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23757757|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23757758|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23757759|NCT01360632|66492176|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
23757760|NCT01360632|66492177|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
23757761|NCT01360632|66492178|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
23757762|NCT01360632|66492179|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
23757763|NCT01360632|66492180|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
23757764|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
23757765|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
23757766|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
23757767|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
23757768|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
23757769|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Adverse Event|0|||
23757770|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Adverse Event|3|||
23757771|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Adverse Event|9|||
23757772|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Adverse Event|3|||
23757773|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Adverse Event|0|||
23757774|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23562722|NCT02966002|65790335|FG000|Overall Study|Lost to Follow-up|1|||
23757775|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23757776|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
23757777|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
23757778|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23826539|NCT02553772|66745112|FG001|Overall Study|Withdrawal of Consent|1|||
23757779|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Physician Decision|0|||
23757780|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Physician Decision|0|||
23757781|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Physician Decision|0|||
23757782|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Physician Decision|1|||
23757783|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Physician Decision|0|||
23757784|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23757785|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
23757786|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
23757787|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
23757788|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23757789|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
23757790|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
23757791|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
23826540|NCT02553772|66745111|FG000|Overall Study|Lack of Efficacy|1|||
23826541|NCT02553772|66745112|FG001|Overall Study|Lack of Efficacy|0|||
23439913|NCT01748825|65352595|FG003|Dose Expansion|Switched to alternative treatment|0|||
23439914|NCT01748825|65352596|FG004|Dose Expansion|Switched to alternative treatment|0|||
23439915|NCT01748825|65352597|FG005|Dose Expansion|Switched to alternative treatment|0|||
23439916|NCT01748825|65352598|FG006|Dose Expansion|Switched to alternative treatment|0|||
23439917|NCT01748825|65352599|FG007|Dose Expansion|Switched to alternative treatment|0|||
23439918|NCT01748825|65352600|FG008|Dose Expansion|Switched to alternative treatment|0|||
23439919|NCT01748825|65352601|FG009|Dose Expansion|Switched to alternative treatment|1|||
23439920|NCT01748825|65352592|FG000|Dose Expansion|Adverse Event|0|||
23439921|NCT01748825|65352593|FG001|Dose Expansion|Adverse Event|0|||
23439922|NCT01748825|65352594|FG002|Dose Expansion|Adverse Event|0|||
23439923|NCT01748825|65352595|FG003|Dose Expansion|Adverse Event|0|||
23439924|NCT01748825|65352596|FG004|Dose Expansion|Adverse Event|0|||
23439925|NCT01748825|65352597|FG005|Dose Expansion|Adverse Event|0|||
23439926|NCT01748825|65352598|FG006|Dose Expansion|Adverse Event|0|||
23439927|NCT01748825|65352599|FG007|Dose Expansion|Adverse Event|0|||
23439928|NCT01748825|65352600|FG008|Dose Expansion|Adverse Event|0|||
23439929|NCT01748825|65352601|FG009|Dose Expansion|Adverse Event|3|||
23439930|NCT01748825|65352592|FG000|Dose Expansion|Physician Decision|0|||
23439931|NCT01748825|65352593|FG001|Dose Expansion|Physician Decision|0|||
23439932|NCT01748825|65352594|FG002|Dose Expansion|Physician Decision|0|||
23439933|NCT01748825|65352595|FG003|Dose Expansion|Physician Decision|0|||
23439934|NCT01748825|65352596|FG004|Dose Expansion|Physician Decision|0|||
23439935|NCT01748825|65352597|FG005|Dose Expansion|Physician Decision|0|||
23439936|NCT01748825|65352598|FG006|Dose Expansion|Physician Decision|0|||
23439937|NCT01748825|65352599|FG007|Dose Expansion|Physician Decision|0|||
23826542|NCT02553772|66745111|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23826543|NCT02553772|66745112|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23826544|NCT04700137|66745113|FG000|Overall Study|Lost to Follow-up|1|||
23826545|NCT04700137|66745114|FG001|Overall Study|Lost to Follow-up|6|||
23826546|NCT04700137|66745115|FG002|Overall Study|Lost to Follow-up|1|||
23826547|NCT04700137|66745116|FG003|Overall Study|Lost to Follow-up|1|||
23826548|NCT04700137|66745113|FG000|Overall Study|Withdrawal by Subject|0|||
23826549|NCT04700137|66745114|FG001|Overall Study|Withdrawal by Subject|0|||
23439938|NCT01748825|65352600|FG008|Dose Expansion|Physician Decision|1|||
23439939|NCT01748825|65352601|FG009|Dose Expansion|Physician Decision|0|||
23439940|NCT03887221|65352602|FG000|Overall Study|Protocol Violation|1|||
23439941|NCT03887221|65352603|FG001|Overall Study|Protocol Violation|0|||
23439942|NCT02720692|65352604|FG000|Overall Study|Withdrawal by Subject|3|||
23439943|NCT02720692|65352605|FG001|Overall Study|Withdrawal by Subject|0|||
23439944|NCT02720692|65352604|FG000|Overall Study|Physician Decision|1|||
23439945|NCT02720692|65352605|FG001|Overall Study|Physician Decision|0|||
23439946|NCT02720692|65352604|FG000|Overall Study|Lost to Follow-up|8|||
23439947|NCT02720692|65352605|FG001|Overall Study|Lost to Follow-up|3|||
23439948|NCT02720692|65352604|FG000|Overall Study|Subject unable to return for visit|1|||
23562723|NCT00514943|65790336|FG000|Stage 1|Progressive disease|4|||
23562724|NCT00514943|65790337|FG001|Stage 1|Progressive disease|8|||
23562725|NCT00514943|65790336|FG000|Stage 1|Other Adverse Event|16|||
23562726|NCT00514943|65790337|FG001|Stage 1|Other Adverse Event|6|||
23562727|NCT00514943|65790336|FG000|Stage 1|Not treated|1|||
23562728|NCT00514943|65790337|FG001|Stage 1|Not treated|2|||
23562729|NCT00514943|65790336|FG000|Stage 1|Patient refused to continue study meds|8|||
23562730|NCT00514943|65790337|FG001|Stage 1|Patient refused to continue study meds|3|||
23562731|NCT00514943|65790336|FG000|Stage 1|Other than stated above|1|||
23562732|NCT00514943|65790337|FG001|Stage 1|Other than stated above|7|||
23826550|NCT04700137|66745115|FG002|Overall Study|Withdrawal by Subject|1|||
23826551|NCT04700137|66745116|FG003|Overall Study|Withdrawal by Subject|0|||
23439949|NCT02720692|65352605|FG001|Overall Study|Subject unable to return for visit|0|||
23439950|NCT00310817|65352606|FG000|Overall Study|AE or Death|3|||
23439951|NCT00310817|65352607|FG001|Overall Study|AE or Death|1|||
23439952|NCT00310817|65352608|FG002|Overall Study|AE or Death|0|||
23439953|NCT00310817|65352609|FG003|Overall Study|AE or Death|0|||
23439954|NCT00310817|65352606|FG000|Overall Study|Withdrawal by Subject|1|||
23439955|NCT00310817|65352607|FG001|Overall Study|Withdrawal by Subject|4|||
23562733|NCT00514943|65790336|FG000|Stage 2|Progressive disease|27|||
23439956|NCT00310817|65352608|FG002|Overall Study|Withdrawal by Subject|6|||
23757792|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
23826552|NCT04700137|66745113|FG000|Overall Study|Death|0|||
23439957|NCT00310817|65352609|FG003|Overall Study|Withdrawal by Subject|7|||
23439958|NCT00310817|65352606|FG000|Overall Study|Lost to Follow-up|2|||
23439959|NCT00310817|65352607|FG001|Overall Study|Lost to Follow-up|1|||
23439960|NCT00310817|65352608|FG002|Overall Study|Lost to Follow-up|0|||
23439961|NCT00310817|65352609|FG003|Overall Study|Lost to Follow-up|0|||
23439962|NCT00310817|65352606|FG000|Overall Study|Inappropriate Enrollment|1|||
23439963|NCT00310817|65352607|FG001|Overall Study|Inappropriate Enrollment|0|||
23439964|NCT00310817|65352608|FG002|Overall Study|Inappropriate Enrollment|1|||
23439965|NCT00310817|65352609|FG003|Overall Study|Inappropriate Enrollment|0|||
23439966|NCT00310817|65352606|FG000|Overall Study|Protocol Violation|1|||
23439967|NCT00310817|65352607|FG001|Overall Study|Protocol Violation|1|||
23439968|NCT00310817|65352608|FG002|Overall Study|Protocol Violation|1|||
23439969|NCT00310817|65352609|FG003|Overall Study|Protocol Violation|1|||
23439970|NCT00310817|65352606|FG000|Overall Study|Unable to classify|3|||
23439971|NCT00310817|65352607|FG001|Overall Study|Unable to classify|1|||
23439972|NCT00310817|65352608|FG002|Overall Study|Unable to classify|0|||
23439973|NCT00310817|65352609|FG003|Overall Study|Unable to classify|0|||
23439974|NCT00869518|65352610|FG000|Overall Study|Lost to Follow-up|1|||
23439975|NCT00869518|65352611|FG001|Overall Study|Lost to Follow-up|1|||
23439976|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
23439977|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
23439978|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Adverse Event|4|||
23439979|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Adverse Event|1|||
23439980|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
23439981|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
23439982|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Patient preference|1|||
23439983|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Patient preference|3|||
23439984|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Pain|1|||
23439985|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Pain|0|||
23439986|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Too tired|1|||
23439987|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Too tired|0|||
23439988|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
23439989|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
23439990|NCT00934128|65352612|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
23439991|NCT00934128|65352613|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
23439992|NCT04680975|65352614|FG000|Overall Study|Adverse Event|3|||
23439993|NCT04680975|65352614|FG000|Overall Study|Death|1|||
23439994|NCT04680975|65352614|FG000|Overall Study|Progressive Disease|1|||
23439995|NCT04680975|65352614|FG000|Overall Study|Withdrawal by Subject|1|||
23439996|NCT01161537|65352617|FG000|Part B|Withdrawal by Subject|2|||
23439997|NCT02227199|65352618|FG000|Overall Study|Physician Decision|0|||
23439998|NCT02227199|65352619|FG001|Overall Study|Physician Decision|0|||
23439999|NCT02227199|65352620|FG002|Overall Study|Physician Decision|1|||
23440000|NCT02227199|65352618|FG000|Overall Study|Adverse Event|0|||
23440001|NCT02227199|65352619|FG001|Overall Study|Adverse Event|0|||
23440002|NCT02227199|65352620|FG002|Overall Study|Adverse Event|3|||
23440003|NCT00528801|65352623|FG000|Overall Study|Withdrawal by Subject|1|||
23440004|NCT00528801|65352624|FG001|Overall Study|Withdrawal by Subject|1|||
23440005|NCT00528801|65352623|FG000|Overall Study|Protocol Violation|11|||
23440006|NCT00528801|65352624|FG001|Overall Study|Protocol Violation|5|||
23440007|NCT00528801|65352623|FG000|Overall Study|Lost to Follow-up|15|||
23826553|NCT04700137|66745114|FG001|Overall Study|Death|0|||
23440008|NCT00528801|65352624|FG001|Overall Study|Lost to Follow-up|4|||
23440009|NCT00528801|65352623|FG000|Overall Study|Administrative Reasons|0|||
23440010|NCT00528801|65352624|FG001|Overall Study|Administrative Reasons|1|||
23440011|NCT00856544|65352625|FG000|Overall Study|Randomized but not treated|3|||
23440012|NCT00856544|65352626|FG001|Overall Study|Randomized but not treated|0|||
23440013|NCT00856544|65352627|FG002|Overall Study|Randomized but not treated|0|||
23440014|NCT00856544|65352628|FG003|Overall Study|Randomized but not treated|0|||
23440015|NCT00856544|65352625|FG000|Overall Study|Death|0|||
23440016|NCT00856544|65352626|FG001|Overall Study|Death|2|||
23440017|NCT00856544|65352627|FG002|Overall Study|Death|0|||
23440018|NCT00856544|65352628|FG003|Overall Study|Death|0|||
23440019|NCT00856544|65352625|FG000|Overall Study|Adverse Event|20|||
23440020|NCT00856544|65352626|FG001|Overall Study|Adverse Event|29|||
23440021|NCT00856544|65352627|FG002|Overall Study|Adverse Event|2|||
23440022|NCT00856544|65352628|FG003|Overall Study|Adverse Event|3|||
23440023|NCT00856544|65352625|FG000|Overall Study|Lack of Efficacy|16|||
23625370|NCT01270828|66015469|FG002|Double Blind Phase|Lack of Efficacy|0|||
23625371|NCT01270828|66015467|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
23440024|NCT00856544|65352626|FG001|Overall Study|Lack of Efficacy|12|||
23826554|NCT04700137|66745115|FG002|Overall Study|Death|1|||
23440025|NCT00856544|65352627|FG002|Overall Study|Lack of Efficacy|3|||
23440026|NCT00856544|65352628|FG003|Overall Study|Lack of Efficacy|3|||
23440027|NCT00856544|65352625|FG000|Overall Study|Other|9|||
23440028|NCT00856544|65352626|FG001|Overall Study|Other|16|||
23440029|NCT00856544|65352627|FG002|Overall Study|Other|1|||
23440030|NCT00856544|65352628|FG003|Overall Study|Other|6|||
23562734|NCT00514943|65790337|FG001|Stage 2|Progressive disease|24|||
23562735|NCT00514943|65790336|FG000|Stage 2|Other Adverse Event|3|||
23440031|NCT00856544|65352625|FG000|Overall Study|Lost to Follow-up|1|||
23440032|NCT00856544|65352626|FG001|Overall Study|Lost to Follow-up|2|||
23440033|NCT00856544|65352627|FG002|Overall Study|Lost to Follow-up|2|||
23440034|NCT00856544|65352628|FG003|Overall Study|Lost to Follow-up|0|||
23440035|NCT00856544|65352625|FG000|Overall Study|Withdrawal by Subject|8|||
23440036|NCT00856544|65352626|FG001|Overall Study|Withdrawal by Subject|5|||
23440037|NCT00856544|65352627|FG002|Overall Study|Withdrawal by Subject|0|||
23440038|NCT00856544|65352628|FG003|Overall Study|Withdrawal by Subject|1|||
23440039|NCT00895310|65352631|FG000|Overall Study|Withdrawal by Subject|1|||
23440040|NCT00799591|65352632|FG000|Overall Study|De-escalation of doses|20|||
23440041|NCT00799591|65352632|FG000|Overall Study|Death|14|||
23440042|NCT00799591|65352632|FG000|Overall Study|Technical failure|12|||
23440043|NCT00799591|65352632|FG000|Overall Study|Resistant germ|11|||
23440044|NCT00799591|65352632|FG000|Overall Study|New infection|4|||
23440045|NCT00799591|65352632|FG000|Overall Study|Resistance germ and technical failure|2|||
23440046|NCT00799591|65352632|FG000|Overall Study|Persistance of fever undetermined origin|1|||
23440047|NCT00799591|65352632|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
23440048|NCT00799591|65352632|FG000|Overall Study|Infectious origin not probable|1|||
23440049|NCT00652951|65352633|FG000|Booster Phase|Adverse event, non-fatal|0|||
23440050|NCT00652951|65352634|FG001|Booster Phase|Adverse event, non-fatal|1|||
23440051|NCT00652951|65352635|FG002|Booster Phase|Adverse event, non-fatal|0|||
23440052|NCT00652951|65352633|FG000|Booster Phase|Other|1|||
23826555|NCT04700137|66745116|FG003|Overall Study|Death|0|||
23826556|NCT00972595|66745117|FG000|Period 1|Adverse Event|1|||
23826557|NCT00972595|66745118|FG001|Period 1|Adverse Event|0|||
23440053|NCT00652951|65352634|FG001|Booster Phase|Other|0|||
23440054|NCT00652951|65352635|FG002|Booster Phase|Other|0|||
23625372|NCT01270828|66015468|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
23625373|NCT01270828|66015469|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
23625374|NCT01270828|66015467|FG000|Double Blind Phase|Adverse event related to study drug|5|||
23757793|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
23440055|NCT02106403|65352637|FG000|Follow-Up Visit 3|Other Reason|0|||
23562736|NCT00514943|65790337|FG001|Stage 2|Other Adverse Event|10|||
23562737|NCT00514943|65790336|FG000|Stage 2|Patient refused to continue study meds|2|||
23757794|NCT01360632|66492176|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
23757795|NCT01360632|66492177|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
23757796|NCT01360632|66492178|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
23757797|NCT01360632|66492179|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
23757798|NCT01360632|66492180|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
23757799|NCT01360632|66492176|FG000|Phase A+|Lost to Follow-up|0|||
23562738|NCT00514943|65790337|FG001|Stage 2|Patient refused to continue study meds|0|||
23562739|NCT00514943|65790336|FG000|Stage 2|Other than stated above|0|||
23562740|NCT00514943|65790337|FG001|Stage 2|Other than stated above|2|||
23562741|NCT00112580|65790340|FG000|Overall Study|Adverse Event|1|||
23562742|NCT00112580|65790341|FG001|Overall Study|Adverse Event|2|||
23562743|NCT00112580|65790340|FG000|Overall Study|Disease progression|5|||
23562744|NCT00112580|65790341|FG001|Overall Study|Disease progression|16|||
23757800|NCT01360632|66492177|FG001|Phase A+|Lost to Follow-up|0|||
23757801|NCT01360632|66492178|FG002|Phase A+|Lost to Follow-up|0|||
23757802|NCT01360632|66492179|FG003|Phase A+|Lost to Follow-up|0|||
23757803|NCT01360632|66492180|FG004|Phase A+|Lost to Follow-up|2|||
23826558|NCT02618759|66745119|FG000|Overall Study|Lost to Follow-up|0|||
23826559|NCT02618759|66745120|FG001|Overall Study|Lost to Follow-up|1|||
23440056|NCT02106403|65352638|FG001|Follow-Up Visit 3|Other Reason|0|||
23562745|NCT00112580|65790340|FG000|Overall Study|Participant withdrew consent|2|||
23562746|NCT00112580|65790341|FG001|Overall Study|Participant withdrew consent|1|||
23562747|NCT04539821|65790356|FG000|Overall Study|Withdrawal by Subject|2|||
23562748|NCT04539821|65790356|FG000|Overall Study|continued care with their physician|20|||
23562749|NCT04539821|65790356|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
23562750|NCT01662063|65790357|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
23562751|NCT01662063|65790358|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
23440057|NCT02106403|65352639|FG002|Follow-Up Visit 3|Other Reason|0|||
23562752|NCT01662063|65790359|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
23562753|NCT01662063|65790357|FG000|Overall Study|Lack of Efficacy|1|||
23562754|NCT01662063|65790358|FG001|Overall Study|Lack of Efficacy|6|||
23440058|NCT02106403|65352640|FG003|Follow-Up Visit 3|Other Reason|0|||
23562755|NCT01662063|65790359|FG002|Overall Study|Lack of Efficacy|0|||
23562756|NCT01662063|65790357|FG000|Overall Study|Lost to Follow-up|0|||
23625375|NCT01270828|66015468|FG001|Double Blind Phase|Adverse event related to study drug|7|||
23757804|NCT01360632|66492176|FG000|Phase A+|Adverse Event|0|||
23757805|NCT01360632|66492177|FG001|Phase A+|Adverse Event|0|||
23440059|NCT02106403|65352641|FG004|Follow-Up Visit 3|Other Reason|0|||
23440060|NCT02106403|65352642|FG005|Follow-Up Visit 3|Other Reason|1|||
23440061|NCT00650845|65352647|FG000|Overall Study|Withdrawal by Subject|5|||
23757806|NCT01360632|66492178|FG002|Phase A+|Adverse Event|0|||
23757807|NCT01360632|66492179|FG003|Phase A+|Adverse Event|0|||
23757808|NCT01360632|66492180|FG004|Phase A+|Adverse Event|2|||
23440062|NCT00650845|65352648|FG001|Overall Study|Withdrawal by Subject|0|||
23440063|NCT00650845|65352647|FG000|Overall Study|Protocol Violation|0|||
23440064|NCT00650845|65352648|FG001|Overall Study|Protocol Violation|13|||
23440065|NCT02718716|65352649|FG000|Overall Study|Lack of Efficacy|1|||
23440066|NCT02718716|65352650|FG001|Overall Study|Lack of Efficacy|0|||
23440067|NCT02718716|65352651|FG002|Overall Study|Lack of Efficacy|0|||
23440068|NCT02718716|65352652|FG003|Overall Study|Lack of Efficacy|0|||
23440069|NCT02718716|65352653|FG004|Overall Study|Lack of Efficacy|0|||
23440070|NCT00448747|65352654|FG000|Overall Study|collapsed veins|1|||
23440071|NCT00448747|65352655|FG001|Overall Study|collapsed veins|0|||
23440072|NCT02147288|65355140|FG000|Overall Study|post-operative hematoma|1|||
23440073|NCT02147288|65355141|FG001|Overall Study|post-operative hematoma|1|||
23440074|NCT02147288|65355142|FG002|Overall Study|post-operative hematoma|0|||
23440075|NCT02147288|65355143|FG003|Overall Study|post-operative hematoma|0|||
23440076|NCT02147288|65355144|FG004|Overall Study|post-operative hematoma|0|||
23440077|NCT02147288|65355145|FG005|Overall Study|post-operative hematoma|0|||
23440078|NCT02147288|65355146|FG006|Overall Study|post-operative hematoma|0|||
23440079|NCT02147288|65355147|FG007|Overall Study|post-operative hematoma|0|||
23440080|NCT02147288|65355148|FG008|Overall Study|post-operative hematoma|0|||
23440081|NCT02147288|65355149|FG009|Overall Study|post-operative hematoma|0|||
23440082|NCT02147288|65355140|FG000|Overall Study|complications from concurrent hernia rep|0|||
23440083|NCT02147288|65355141|FG001|Overall Study|complications from concurrent hernia rep|1|||
23440084|NCT02147288|65355142|FG002|Overall Study|complications from concurrent hernia rep|0|||
23440085|NCT02147288|65355143|FG003|Overall Study|complications from concurrent hernia rep|0|||
23440086|NCT02147288|65355144|FG004|Overall Study|complications from concurrent hernia rep|0|||
23757809|NCT01360632|66492176|FG000|Phase A+|Met Withdrawal Criteria|0|||
23440087|NCT02147288|65355145|FG005|Overall Study|complications from concurrent hernia rep|0|||
23440088|NCT02147288|65355146|FG006|Overall Study|complications from concurrent hernia rep|0|||
23440089|NCT02147288|65355147|FG007|Overall Study|complications from concurrent hernia rep|0|||
23440090|NCT02147288|65355148|FG008|Overall Study|complications from concurrent hernia rep|0|||
23440091|NCT02147288|65355149|FG009|Overall Study|complications from concurrent hernia rep|0|||
23440092|NCT02161380|65355150|FG000|Overall Study|Lost to Follow-up|0|||
23440093|NCT02161380|65355151|FG001|Overall Study|Lost to Follow-up|1|||
23440094|NCT02161380|65355152|FG002|Overall Study|Lost to Follow-up|0|||
23440095|NCT02161380|65355153|FG003|Overall Study|Lost to Follow-up|0|||
23440096|NCT01433172|65355154|FG000|Overall Study|Withdrawal by Subject|0|||
23440097|NCT01433172|65355155|FG001|Overall Study|Withdrawal by Subject|1|||
23440098|NCT01433172|65355156|FG002|Overall Study|Withdrawal by Subject|0|||
23440099|NCT01433172|65355154|FG000|Overall Study|Disease Progression|0|||
23440100|NCT01433172|65355155|FG001|Overall Study|Disease Progression|0|||
23440101|NCT01433172|65355156|FG002|Overall Study|Disease Progression|1|||
23440102|NCT01433172|65355154|FG000|Overall Study|Death|0|||
23440103|NCT01433172|65355155|FG001|Overall Study|Death|2|||
23440104|NCT01433172|65355156|FG002|Overall Study|Death|0|||
23757810|NCT01360632|66492177|FG001|Phase A+|Met Withdrawal Criteria|0|||
23757811|NCT01360632|66492178|FG002|Phase A+|Met Withdrawal Criteria|0|||
23757812|NCT01360632|66492179|FG003|Phase A+|Met Withdrawal Criteria|0|||
23757813|NCT01360632|66492180|FG004|Phase A+|Met Withdrawal Criteria|7|||
23757814|NCT01360632|66492176|FG000|Phase A+|Physician Decision|0|||
23757815|NCT01360632|66492177|FG001|Phase A+|Physician Decision|0|||
23757816|NCT01360632|66492178|FG002|Phase A+|Physician Decision|0|||
23757817|NCT01360632|66492179|FG003|Phase A+|Physician Decision|0|||
23757818|NCT01360632|66492180|FG004|Phase A+|Physician Decision|3|||
23757819|NCT01360632|66492176|FG000|Phase A+|Withdrawal by Subject|0|||
23757820|NCT01360632|66492177|FG001|Phase A+|Withdrawal by Subject|0|||
23440105|NCT00350844|65355157|FG000|Overall Study|Lost to Follow-up|1|||
23440106|NCT03517228|65355164|FG000|Overall Study|Withdrawal by Subject|2|||
23440107|NCT03517228|65355164|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
23440108|NCT03517228|65355164|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
23440109|NCT03517228|65355164|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
23440110|NCT03517228|65355164|FG000|Overall Study|Canceled due to device being updated|1|||
23757821|NCT01360632|66492178|FG002|Phase A+|Withdrawal by Subject|0|||
23757822|NCT01360632|66492179|FG003|Phase A+|Withdrawal by Subject|0|||
23757823|NCT01360632|66492180|FG004|Phase A+|Withdrawal by Subject|8|||
23757824|NCT01360632|66492176|FG000|Phase A+|Protocol Deviation|0|||
23757825|NCT01360632|66492177|FG001|Phase A+|Protocol Deviation|0|||
23826560|NCT02618759|66745119|FG000|Overall Study|Withdrawal by Subject|1|||
23440111|NCT03517228|65355164|FG000|Overall Study|No V Cares in stock|1|||
23440112|NCT03517228|65355164|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
23440113|NCT03302247|65355165|FG000|Overall Study|the study has closed prematurely|2|||
23440114|NCT03302247|65355165|FG000|Overall Study|Death|1|||
23440115|NCT00986362|65355166|FG000|Overall Study|Death|2|||
23757826|NCT01360632|66492178|FG002|Phase A+|Protocol Deviation|0|||
23757827|NCT01360632|66492179|FG003|Phase A+|Protocol Deviation|0|||
23440116|NCT00986362|65355167|FG001|Overall Study|Death|0|||
23440117|NCT00986362|65355166|FG000|Overall Study|Lost to Follow-up|0|||
23440118|NCT00986362|65355167|FG001|Overall Study|Lost to Follow-up|1|||
23440119|NCT00779025|65355168|FG000|Overall Study|Withdrawal by Subject|1|||
23440120|NCT01807299|65355169|FG000|Overall Study|Protocol Violation|3|||
23440121|NCT01807299|65355170|FG001|Overall Study|Protocol Violation|1|||
23440122|NCT01807299|65355171|FG002|Overall Study|Protocol Violation|0|||
23440123|NCT01807299|65355172|FG003|Overall Study|Protocol Violation|2|||
23440124|NCT02008227|65355174|FG000|Overall Study|Lost to Follow-up|7|||
23440125|NCT02008227|65355175|FG001|Overall Study|Lost to Follow-up|9|||
23440126|NCT02008227|65355174|FG000|Overall Study|Death|494|||
23440127|NCT02008227|65355175|FG001|Overall Study|Death|485|||
23440128|NCT02008227|65355174|FG000|Overall Study|Withdrawal by Subject|67|||
23440129|NCT02008227|65355175|FG001|Overall Study|Withdrawal by Subject|36|||
23440130|NCT02008227|65355174|FG000|Overall Study|Study Terminated By Sponsor|44|||
23440131|NCT02008227|65355175|FG001|Overall Study|Study Terminated By Sponsor|83|||
23440132|NCT00555217|65355176|FG000|Overall Study|Withdrawal by Subject|35|||
23440133|NCT00555217|65355177|FG001|Overall Study|Withdrawal by Subject|31|||
23440134|NCT00555217|65355176|FG000|Overall Study|Lost to Follow-up|19|||
23440135|NCT00555217|65355177|FG001|Overall Study|Lost to Follow-up|20|||
23440136|NCT00555217|65355176|FG000|Overall Study|close out sites|21|||
23440137|NCT00555217|65355177|FG001|Overall Study|close out sites|17|||
23440138|NCT00707954|65355185|FG000|Overall Study|Physician Decision|0|||
23440139|NCT00707954|65355186|FG001|Overall Study|Physician Decision|0|||
23440140|NCT00707954|65355187|FG002|Overall Study|Physician Decision|0|||
23440141|NCT00707954|65355188|FG003|Overall Study|Physician Decision|0|||
23440142|NCT00707954|65355189|FG004|Overall Study|Physician Decision|1|||
23440143|NCT00850538|65355190|FG000|Overall Study|unable/unwilling to complete MRI|13|||
23440144|NCT00850538|65355190|FG000|Overall Study|specimen missed due to scheduling error|14|||
23440145|NCT00850538|65355190|FG000|Overall Study|specimen unusable|7|||
23440146|NCT00850538|65355190|FG000|Overall Study|Withdrawal by Subject|3|||
23440147|NCT00850538|65355190|FG000|Overall Study|radiology error|2|||
23440148|NCT00850538|65355190|FG000|Overall Study|Protocol Violation|2|||
23440149|NCT00774800|65355205|FG000|Intervention 4|Withdrawal by Subject|1|||
23440150|NCT01364389|65355206|FG000|Overall Study|Withdrawal by Subject|0|||
23440151|NCT01364389|65355207|FG001|Overall Study|Withdrawal by Subject|1|||
23440152|NCT01364389|65355208|FG002|Overall Study|Withdrawal by Subject|0|||
23440153|NCT01364389|65355206|FG000|Overall Study|Protocol deviation|0|||
23440154|NCT01364389|65355207|FG001|Overall Study|Protocol deviation|0|||
23440155|NCT01364389|65355208|FG002|Overall Study|Protocol deviation|1|||
23440156|NCT01364389|65355206|FG000|Overall Study|Administrative problems|1|||
23440157|NCT01364389|65355207|FG001|Overall Study|Administrative problems|0|||
23440158|NCT01364389|65355208|FG002|Overall Study|Administrative problems|0|||
23440159|NCT01364389|65355206|FG000|Overall Study|Adverse Event|1|||
23440160|NCT01364389|65355207|FG001|Overall Study|Adverse Event|0|||
23440161|NCT01364389|65355208|FG002|Overall Study|Adverse Event|0|||
23440162|NCT03698019|65355211|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
23440163|NCT03698019|65355212|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
23440164|NCT03698019|65355211|FG000|Step 1: Registration|Withdrawal by Subject|7|||
23440165|NCT03698019|65355212|FG001|Step 1: Registration|Withdrawal by Subject|2|||
23562757|NCT01662063|65790358|FG001|Overall Study|Lost to Follow-up|4|||
23562758|NCT01662063|65790359|FG002|Overall Study|Lost to Follow-up|0|||
23440166|NCT03698019|65355211|FG000|Step 1: Registration|Toxicity|0|||
23440167|NCT03698019|65355212|FG001|Step 1: Registration|Toxicity|1|||
23440168|NCT03698019|65355211|FG000|Step 1: Registration|Disease Progression|0|||
23440169|NCT03698019|65355212|FG001|Step 1: Registration|Disease Progression|12|||
23440170|NCT03698019|65355211|FG000|Step 1: Registration|Co-morbidities|0|||
23440171|NCT03698019|65355212|FG001|Step 1: Registration|Co-morbidities|1|||
23440172|NCT03698019|65355211|FG000|Step 1: Registration|Scheduling Issues|1|||
23440173|NCT03698019|65355212|FG001|Step 1: Registration|Scheduling Issues|0|||
23440174|NCT03698019|65355211|FG000|Step 1: Registration|Participant Refusal|0|||
23440175|NCT03698019|65355212|FG001|Step 1: Registration|Participant Refusal|1|||
23440176|NCT03698019|65355211|FG000|Step 2: Surgery|Participant Refusal|2|||
23440177|NCT03698019|65355212|FG001|Step 2: Surgery|Participant Refusal|1|||
23440178|NCT03698019|65355211|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
23562759|NCT01662063|65790357|FG000|Overall Study|Protocol Violation|1|||
23562760|NCT01662063|65790358|FG001|Overall Study|Protocol Violation|0|||
23440179|NCT03698019|65355212|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
23440180|NCT03698019|65355211|FG000|Step 2: Surgery|Metastatic Disease|16|||
23440181|NCT03698019|65355212|FG001|Step 2: Surgery|Metastatic Disease|9|||
23440182|NCT03698019|65355211|FG000|Step 2: Surgery|Residual Disease|2|||
23440183|NCT03698019|65355212|FG001|Step 2: Surgery|Residual Disease|1|||
23440184|NCT03698019|65355211|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
23440185|NCT03698019|65355212|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
23440186|NCT03698019|65355211|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
23440187|NCT03698019|65355212|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
23440188|NCT03698019|65355211|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
23440189|NCT03698019|65355212|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
23440190|NCT03698019|65355211|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
23440191|NCT03698019|65355212|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
23440192|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
23440193|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
23440194|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
23440195|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
23440196|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
23440197|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
23440198|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
23440199|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
23440200|NCT04677504|65355217|FG000|Overall Study|Death|51|||
23440201|NCT04677504|65355218|FG001|Overall Study|Death|49|||
23440202|NCT04677504|65355217|FG000|Overall Study|Progressive Disease|1|||
23440203|NCT04677504|65355218|FG001|Overall Study|Progressive Disease|0|||
23440204|NCT04677504|65355217|FG000|Overall Study|Symptomatic Deterioration|1|||
23440205|NCT04677504|65355218|FG001|Overall Study|Symptomatic Deterioration|0|||
23440206|NCT04677504|65355217|FG000|Overall Study|Withdrawal by Subject|2|||
23440207|NCT04677504|65355218|FG001|Overall Study|Withdrawal by Subject|5|||
23440208|NCT04677504|65355217|FG000|Overall Study|Study Terminated By Sponsor|28|||
23440209|NCT04677504|65355218|FG001|Overall Study|Study Terminated By Sponsor|24|||
23440210|NCT04677504|65355217|FG000|Overall Study|Adverse Event|0|||
23562761|NCT01662063|65790359|FG002|Overall Study|Protocol Violation|0|||
23562762|NCT01662063|65790357|FG000|Overall Study|Withdrawal by Subject|2|||
23562763|NCT01662063|65790358|FG001|Overall Study|Withdrawal by Subject|4|||
23562764|NCT01662063|65790359|FG002|Overall Study|Withdrawal by Subject|1|||
23562765|NCT01662063|65790357|FG000|Overall Study|Physician Decision|0|||
23562766|NCT01662063|65790358|FG001|Overall Study|Physician Decision|2|||
23757828|NCT01360632|66492180|FG004|Phase A+|Protocol Deviation|3|||
23562767|NCT01662063|65790359|FG002|Overall Study|Physician Decision|0|||
23562768|NCT01662063|65790357|FG000|Overall Study|Other|0|||
23562769|NCT01662063|65790358|FG001|Overall Study|Other|1|||
23562770|NCT01662063|65790359|FG002|Overall Study|Other|0|||
23562771|NCT01780935|65790360|FG000|Overall Study|Admin problems due to early termination|321|||
23562772|NCT01780935|65790361|FG001|Overall Study|Admin problems due to early termination|309|||
23562773|NCT01780935|65790360|FG000|Overall Study|Adverse Event|2|||
23562774|NCT01780935|65790361|FG001|Overall Study|Adverse Event|4|||
23562775|NCT01780935|65790360|FG000|Overall Study|Death|1|||
23562776|NCT01780935|65790361|FG001|Overall Study|Death|6|||
23562777|NCT01780935|65790360|FG000|Overall Study|Lost to Follow-up|2|||
23562778|NCT01780935|65790361|FG001|Overall Study|Lost to Follow-up|6|||
23562779|NCT01780935|65790360|FG000|Overall Study|Physician Decision|1|||
23562780|NCT01780935|65790361|FG001|Overall Study|Physician Decision|1|||
23562781|NCT01780935|65790360|FG000|Overall Study|Protocol deviation|0|||
23562782|NCT01780935|65790361|FG001|Overall Study|Protocol deviation|1|||
23562783|NCT01780935|65790360|FG000|Overall Study|Patient withdrew consent|8|||
23562784|NCT01780935|65790361|FG001|Overall Study|Patient withdrew consent|9|||
23562785|NCT01728792|65790367|FG000|Overall Study|Withdrawal of Consent|1|||
23562786|NCT01728792|65790368|FG001|Overall Study|Withdrawal of Consent|1|||
23562787|NCT01728792|65790369|FG002|Overall Study|Withdrawal of Consent|0|||
23562788|NCT01728792|65790370|FG003|Overall Study|Withdrawal of Consent|1|||
23562789|NCT01728792|65790371|FG004|Overall Study|Withdrawal of Consent|0|||
23562790|NCT01728792|65790367|FG000|Overall Study|Lost to Follow-up|2|||
23562791|NCT01728792|65790368|FG001|Overall Study|Lost to Follow-up|1|||
23562792|NCT01728792|65790369|FG002|Overall Study|Lost to Follow-up|4|||
23562793|NCT01728792|65790370|FG003|Overall Study|Lost to Follow-up|2|||
23562794|NCT01728792|65790371|FG004|Overall Study|Lost to Follow-up|0|||
23562795|NCT01763788|65790373|FG000|Overall Study|Lost to Follow-up|0|||
23562796|NCT01763788|65790374|FG001|Overall Study|Lost to Follow-up|0|||
23562797|NCT01763788|65790375|FG002|Overall Study|Lost to Follow-up|1|||
23757829|NCT01964898|66492182|FG000|Overall Study|ineligible post-randomization|1|||
23562798|NCT01763788|65790376|FG003|Overall Study|Lost to Follow-up|0|||
23625376|NCT01270828|66015469|FG002|Double Blind Phase|Adverse event related to study drug|0|||
23757830|NCT01964898|66492183|FG001|Overall Study|ineligible post-randomization|1|||
23440211|NCT04677504|65355218|FG001|Overall Study|Adverse Event|1|||
23440212|NCT00527904|65355219|FG000|Overall Study|Adverse Event|45|||
23440213|NCT00527904|65355219|FG000|Overall Study|Withdrawal by Subject|21|||
23440214|NCT00527904|65355219|FG000|Overall Study|Lost to Follow-up|8|||
23562799|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
23562800|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
23757831|NCT01964898|66492182|FG000|Overall Study|did not receive the allocated interventi|2|||
23440215|NCT00527904|65355219|FG000|Overall Study|misc|22|||
23562801|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
23562802|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
23562803|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
23562804|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
23562805|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
23562806|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
23562807|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
23562808|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
23562809|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
23562810|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
23562811|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562812|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562813|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562814|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562815|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
23562816|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562817|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
23562818|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562819|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562820|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562821|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562822|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
23562823|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562824|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562825|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562826|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
23562827|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
23562828|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562829|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562830|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
23562831|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562832|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
23562833|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
23562834|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562835|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
23562836|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23562837|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
23562838|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
23562839|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23562840|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23562841|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562842|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
23562843|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562844|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562845|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23625377|NCT00585078|66015472|FG000|Overall Study|Withdrawal by Subject|4|||
23826561|NCT02618759|66745120|FG001|Overall Study|Withdrawal by Subject|0|||
23562846|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562847|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
23562848|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
23562849|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
23562850|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
23562851|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
23625378|NCT00585078|66015472|FG000|Overall Study|Poor performance status|1|||
23625379|NCT00585078|66015472|FG000|Overall Study|Disease Progression|24|||
23625380|NCT00585078|66015472|FG000|Overall Study|Adverse Event|10|||
23625381|NCT00585078|66015472|FG000|Overall Study|Death|1|||
23625382|NCT01983462|66015477|FG000|Overall Study|Adverse Event|1|||
23625383|NCT01983462|66015478|FG001|Overall Study|Adverse Event|0|||
23625384|NCT01983462|66015479|FG002|Overall Study|Adverse Event|0|||
23625385|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
23625386|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
23625387|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
23625388|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
23625389|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
23625390|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
23757832|NCT01964898|66492183|FG001|Overall Study|did not receive the allocated interventi|1|||
23757833|NCT01964898|66492182|FG000|Overall Study|Lost to Follow-up|3|||
23757834|NCT01964898|66492183|FG001|Overall Study|Lost to Follow-up|5|||
23757835|NCT01964898|66492182|FG000|Overall Study|Withdrawal by Subject|1|||
23757836|NCT01964898|66492183|FG001|Overall Study|Withdrawal by Subject|0|||
23757837|NCT03550794|66492184|FG000|Overall Study|No longer met inclusion criteria|1|||
23757838|NCT03550794|66492185|FG001|Overall Study|No longer met inclusion criteria|2|||
23757839|NCT03550794|66492184|FG000|Overall Study|Goals of care changed|1|||
23757840|NCT03550794|66492185|FG001|Overall Study|Goals of care changed|0|||
23757841|NCT03550794|66492184|FG000|Overall Study|Withdrawal by Subject|2|||
23757842|NCT03550794|66492185|FG001|Overall Study|Withdrawal by Subject|0|||
23757843|NCT03550794|66492184|FG000|Overall Study|Death|0|||
23757844|NCT03550794|66492185|FG001|Overall Study|Death|1|||
23757845|NCT03611751|66492188|FG000|Pre-treatment|Randomized but not treated|1|||
23757846|NCT03611751|66492189|FG001|Pre-treatment|Randomized but not treated|1|||
23757847|NCT03611751|66492190|FG002|Pre-treatment|Randomized but not treated|0|||
23757848|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
23757849|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
23757850|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
23757851|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
23562852|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
23562853|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
23562854|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562855|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
23562856|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23625391|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
23625392|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
23757852|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
23757853|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
23757854|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
23757855|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
23625393|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
23562857|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562858|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562859|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562860|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562861|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562862|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562863|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562864|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562865|NCT01264380|65790383|FG000|Period C|Disease Progression|0|||
23562866|NCT01264380|65790384|FG001|Period C|Disease Progression|0|||
23757856|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
23757857|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
23757858|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
23757859|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
23757860|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
23757861|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
23757862|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
23757863|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
23757864|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
23757865|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
23757866|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
23757867|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
23757868|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
23757869|NCT03611751|66492188|FG000|Treatment Week 0 - Week 16|Death|0|||
23757870|NCT03611751|66492189|FG001|Treatment Week 0 - Week 16|Death|0|||
23757871|NCT03611751|66492190|FG002|Treatment Week 0 - Week 16|Death|1|||
23757872|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
23757873|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
23757874|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
23757875|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
23757876|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23757877|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
23757878|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
23757879|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23757880|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23757881|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
23757882|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
23757883|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
23757884|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
23757885|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
23757886|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
23757887|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
23757888|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
23757889|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
23757890|NCT03611751|66492188|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
23757891|NCT03611751|66492189|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
23826562|NCT02618759|66745119|FG000|Overall Study|Other Reasons|1|||
23562867|NCT01264380|65790385|FG002|Period C|Disease Progression|4|||
23625394|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
23625395|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
23625396|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
23625397|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
23625398|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
23625399|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
23625400|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
23625401|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
23625402|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
23625403|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
23625404|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
23625405|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
23757892|NCT03611751|66492190|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
23757893|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
23757894|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
23757895|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
23757896|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
23757897|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
23757898|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23757899|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
23757900|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
23757901|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
23440216|NCT00595478|65355220|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
23440217|NCT00595478|65355221|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
23440218|NCT00595478|65355220|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
23440219|NCT00595478|65355221|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
23440220|NCT03915470|65355224|FG000|Overall Study|Death|3|||
23440221|NCT03915470|65355225|FG001|Overall Study|Death|1|||
23440222|NCT03915470|65355224|FG000|Overall Study|Adverse Event|1|||
23440223|NCT03915470|65355225|FG001|Overall Study|Adverse Event|0|||
23440224|NCT03915470|65355224|FG000|Overall Study|Physician Decision|1|||
23440225|NCT03915470|65355225|FG001|Overall Study|Physician Decision|0|||
23440226|NCT03915470|65355224|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
23440227|NCT03915470|65355225|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
23440228|NCT00704288|65355226|FG000|Overall Treatment Period|Adverse Event|11|||
23440229|NCT00704288|65355227|FG001|Overall Treatment Period|Adverse Event|8|||
23440230|NCT00704288|65355228|FG002|Overall Treatment Period|Adverse Event|22|||
23440231|NCT00704288|65355226|FG000|Overall Treatment Period|Death|0|||
23440232|NCT00704288|65355227|FG001|Overall Treatment Period|Death|0|||
23440233|NCT00704288|65355228|FG002|Overall Treatment Period|Death|1|||
23440234|NCT00704288|65355226|FG000|Overall Treatment Period|Physician Decision|0|||
23440235|NCT00704288|65355227|FG001|Overall Treatment Period|Physician Decision|2|||
23440236|NCT00704288|65355228|FG002|Overall Treatment Period|Physician Decision|0|||
23440237|NCT00704288|65355226|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
23440238|NCT00704288|65355227|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
23440239|NCT00704288|65355228|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
23440240|NCT00704288|65355226|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
23440241|NCT00704288|65355227|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
23440242|NCT00704288|65355228|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
23440243|NCT00704288|65355226|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
23440244|NCT00704288|65355227|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
23440245|NCT00704288|65355228|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
23440246|NCT00704288|65355226|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
23440247|NCT00704288|65355227|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
23440248|NCT00704288|65355228|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
23440249|NCT00704288|65355226|FG000|Overall Treatment Period|Roll-over to another study|1|||
23440250|NCT00704288|65355227|FG001|Overall Treatment Period|Roll-over to another study|0|||
23440251|NCT00704288|65355228|FG002|Overall Treatment Period|Roll-over to another study|4|||
23440252|NCT00704288|65355226|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
23440253|NCT00704288|65355227|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
23440254|NCT00704288|65355228|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
23440255|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Death|41|||
23440256|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Death|50|||
23440257|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Death|93|||
23440258|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
23440259|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
23440260|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
23440261|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
23440262|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
23440263|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
23440264|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
23440265|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
23440266|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
23440267|NCT01635855|65355231|FG000|Overall Study|Withdrawal by Subject|4|||
23440268|NCT00511238|65355232|FG000|Overall Study|Adverse Event|13|||
23440269|NCT00511238|65355233|FG001|Overall Study|Adverse Event|33|||
23440270|NCT00511238|65355232|FG000|Overall Study|Withdrawal by Subject|2|||
23440271|NCT00511238|65355233|FG001|Overall Study|Withdrawal by Subject|22|||
23440272|NCT00511238|65355232|FG000|Overall Study|Progressive Disease|23|||
23440273|NCT00511238|65355233|FG001|Overall Study|Progressive Disease|157|||
23440274|NCT00511238|65355232|FG000|Overall Study|various reasons|4|||
23440275|NCT00511238|65355233|FG001|Overall Study|various reasons|14|||
23440276|NCT00924508|65355236|FG000|Overall Study|Withdrawal by Subject|3|||
23440277|NCT00434109|65355237|FG000|Overall Study|Physician Decision|9|||
23440278|NCT00434109|65355237|FG000|Overall Study|Adverse Event|5|||
23440279|NCT00434109|65355237|FG000|Overall Study|Protocol Violation|1|||
23440280|NCT00434109|65355237|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
23757902|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
23440281|NCT02799745|65355243|FG000|Overall Study|Participant moved out of state|1|||
23757903|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
23562868|NCT01264380|65790383|FG000|Period C|Death|0|||
23562869|NCT01264380|65790384|FG001|Period C|Death|0|||
23562870|NCT01264380|65790385|FG002|Period C|Death|2|||
23562871|NCT01264380|65790383|FG000|Period C|Follow-up for survival status|0|||
23562872|NCT01264380|65790384|FG001|Period C|Follow-up for survival status|0|||
23562873|NCT01264380|65790385|FG002|Period C|Follow-up for survival status|6|||
23562874|NCT01264380|65790383|FG000|Period C|Withdrawal by Subject|0|||
23562875|NCT01264380|65790384|FG001|Period C|Withdrawal by Subject|0|||
23562876|NCT01264380|65790385|FG002|Period C|Withdrawal by Subject|1|||
23440282|NCT02799745|65355244|FG001|Overall Study|Participant moved out of state|0|||
23440283|NCT02799745|65355243|FG000|Overall Study|Discontinued due to planned surgery|1|||
23440284|NCT02799745|65355244|FG001|Overall Study|Discontinued due to planned surgery|0|||
23440285|NCT02799745|65355243|FG000|Overall Study|Withdrawal by Subject|16|||
23440286|NCT02799745|65355244|FG001|Overall Study|Withdrawal by Subject|25|||
23440287|NCT02799745|65355243|FG000|Overall Study|Protocol Deviation|4|||
23440288|NCT02799745|65355244|FG001|Overall Study|Protocol Deviation|5|||
23440289|NCT02799745|65355243|FG000|Overall Study|Progressive Disease|28|||
23440290|NCT02799745|65355244|FG001|Overall Study|Progressive Disease|38|||
23440291|NCT02799745|65355243|FG000|Overall Study|Lost to Follow-up|3|||
23440292|NCT02799745|65355244|FG001|Overall Study|Lost to Follow-up|2|||
23440293|NCT02799745|65355243|FG000|Overall Study|Death|3|||
23440294|NCT02799745|65355244|FG001|Overall Study|Death|0|||
23440295|NCT02799745|65355243|FG000|Overall Study|Adverse Event|0|||
23440296|NCT02799745|65355244|FG001|Overall Study|Adverse Event|1|||
23440297|NCT00163020|65355246|FG000|Overall Study|Lost to Follow-up|0|||
23440298|NCT00163020|65355247|FG001|Overall Study|Lost to Follow-up|2|||
23440299|NCT02564978|65355250|FG000|Overall Study|Adverse Event|8|||
23440300|NCT02564978|65355250|FG000|Overall Study|Death|1|||
23440301|NCT02564978|65355250|FG000|Overall Study|Lost to Follow-up|1|||
23440302|NCT02564978|65355250|FG000|Overall Study|Withdrawal by Subject|15|||
23440303|NCT02564978|65355250|FG000|Overall Study|Early Study Closure|2|||
23440304|NCT02564978|65355250|FG000|Overall Study|Other Reason|5|||
23440305|NCT00892775|65355251|FG000|Overall Study|Protocol Violation|1|||
23440306|NCT00892775|65355252|FG001|Overall Study|Protocol Violation|0|||
23440307|NCT00892775|65355251|FG000|Overall Study|Subject difficulties with blood drawing|1|||
23440308|NCT00892775|65355252|FG001|Overall Study|Subject difficulties with blood drawing|0|||
23440309|NCT00892775|65355251|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
23440310|NCT00892775|65355252|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
23440311|NCT00892775|65355251|FG000|Overall Study|Migrated/ moved from study area|1|||
23440312|NCT00892775|65355252|FG001|Overall Study|Migrated/ moved from study area|0|||
23440313|NCT00892775|65355251|FG000|Overall Study|Withdrawal by Subject|0|||
23440314|NCT00892775|65355252|FG001|Overall Study|Withdrawal by Subject|1|||
23440315|NCT00892775|65355251|FG000|Overall Study|Lost to Follow-up|1|||
23440316|NCT00892775|65355252|FG001|Overall Study|Lost to Follow-up|0|||
23440317|NCT00782483|65355253|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
23440318|NCT01754493|65355256|FG000|Overall Study|Adverse Event|1|||
23440319|NCT01754493|65355256|FG000|Overall Study|Lost to Follow-up|3|||
23440320|NCT01754493|65355256|FG000|Overall Study|Withdrawal by Subject|1|||
23440321|NCT01754493|65355256|FG000|Overall Study|Moved out of town|1|||
23440322|NCT01754493|65355256|FG000|Overall Study|Scheduling conflict|1|||
23440323|NCT03364309|65355257|FG000|Induction Period|Adverse Event|4|||
23440324|NCT03364309|65355258|FG001|Induction Period|Adverse Event|0|||
23440325|NCT03364309|65355259|FG002|Induction Period|Adverse Event|1|||
23440326|NCT03364309|65355260|FG003|Induction Period|Adverse Event|0|||
23440327|NCT03364309|65355261|FG004|Induction Period|Adverse Event|0|||
23440328|NCT03364309|65355262|FG005|Induction Period|Adverse Event|0|||
23440329|NCT03364309|65355263|FG006|Induction Period|Adverse Event|0|||
23440330|NCT03364309|65355264|FG007|Induction Period|Adverse Event|0|||
23440331|NCT03364309|65355265|FG008|Induction Period|Adverse Event|0|||
23440332|NCT03364309|65355266|FG009|Induction Period|Adverse Event|0|||
23440333|NCT03364309|65355267|FG010|Induction Period|Adverse Event|0|||
23440334|NCT03364309|65355268|FG011|Induction Period|Adverse Event|0|||
23562877|NCT01264380|65790383|FG000|Period C|Adverse Event|0|||
23562878|NCT01264380|65790384|FG001|Period C|Adverse Event|0|||
23562879|NCT01264380|65790385|FG002|Period C|Adverse Event|1|||
23757904|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
23757905|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
23757906|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
23757907|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23757908|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
23757909|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
23757910|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
23757911|NCT03611751|66492188|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
23757912|NCT03611751|66492189|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
23757913|NCT03611751|66492190|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
23757914|NCT00597207|66492193|FG000|Overall Study|Lost to Follow-up|5|||
23440335|NCT03364309|65355269|FG012|Induction Period|Adverse Event|0|||
23440336|NCT03364309|65355270|FG013|Induction Period|Adverse Event|0|||
23440337|NCT03364309|65355271|FG014|Induction Period|Adverse Event|0|||
23440338|NCT03364309|65355272|FG015|Induction Period|Adverse Event|0|||
23440339|NCT03364309|65355273|FG016|Induction Period|Adverse Event|0|||
23440340|NCT03364309|65355274|FG017|Induction Period|Adverse Event|0|||
23440341|NCT03364309|65355275|FG018|Induction Period|Adverse Event|0|||
23440342|NCT03364309|65355257|FG000|Induction Period|Withdrawal by Subject|1|||
23440343|NCT03364309|65355258|FG001|Induction Period|Withdrawal by Subject|3|||
23440344|NCT03364309|65355259|FG002|Induction Period|Withdrawal by Subject|0|||
23440345|NCT03364309|65355260|FG003|Induction Period|Withdrawal by Subject|0|||
23562880|NCT02508532|65790391|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562881|NCT02508532|65790392|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562882|NCT02508532|65790393|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562883|NCT02508532|65790394|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562884|NCT02508532|65790395|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562885|NCT02508532|65790396|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562886|NCT02508532|65790397|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
23562887|NCT02508532|65790398|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562888|NCT02508532|65790399|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562889|NCT02508532|65790391|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562890|NCT02508532|65790392|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562891|NCT02508532|65790393|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562892|NCT02508532|65790394|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562893|NCT02508532|65790395|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562894|NCT02508532|65790396|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562895|NCT02508532|65790397|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562896|NCT02508532|65790398|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
23562897|NCT02508532|65790399|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562898|NCT02508532|65790391|FG000|Part 2 - Treatment|Disease Progression|0|||
23625406|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
23625407|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
23625408|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
23625409|NCT02658175|66015481|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
23625410|NCT02658175|66015482|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
23625411|NCT02658175|66015483|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
23625412|NCT02658175|66015481|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
23625413|NCT02658175|66015482|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
23625414|NCT02658175|66015483|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
23625415|NCT01447576|66015484|FG000|Overall Study|Lost to Follow-up|52|||
23625416|NCT01447576|66015484|FG000|Overall Study|Adverse Event|127|||
23625417|NCT01447576|66015484|FG000|Overall Study|Participant met withdrawal criteria|40|||
23625418|NCT01447576|66015484|FG000|Overall Study|Withdrawal by Subject|100|||
23625419|NCT01447576|66015484|FG000|Overall Study|Protocol deviation|83|||
23562899|NCT02508532|65790392|FG001|Part 2 - Treatment|Disease Progression|0|||
23562900|NCT02508532|65790393|FG002|Part 2 - Treatment|Disease Progression|0|||
23625420|NCT01447576|66015484|FG000|Overall Study|Lack of Efficacy|68|||
23625421|NCT01447576|66015484|FG000|Overall Study|Physician Decision|6|||
23826563|NCT02618759|66745120|FG001|Overall Study|Other Reasons|4|||
23625422|NCT01667549|66015487|FG000|Overall Study|Withdrawal by Subject|3|||
23625423|NCT01667549|66015488|FG001|Overall Study|Withdrawal by Subject|5|||
23625424|NCT01667549|66015489|FG002|Overall Study|Withdrawal by Subject|7|||
23625425|NCT01667549|66015490|FG003|Overall Study|Withdrawal by Subject|6|||
23625426|NCT01667549|66015491|FG004|Overall Study|Withdrawal by Subject|1|||
23625427|NCT03414047|66015499|FG000|Overall Study|Adverse Event|0|||
23625428|NCT03414047|66015500|FG001|Overall Study|Adverse Event|0|||
23625429|NCT03414047|66015501|FG002|Overall Study|Adverse Event|1|||
23625430|NCT03414047|66015502|FG003|Overall Study|Adverse Event|1|||
23625431|NCT03414047|66015499|FG000|Overall Study|Physician Decision|1|||
23625432|NCT03414047|66015500|FG001|Overall Study|Physician Decision|0|||
23625433|NCT03414047|66015501|FG002|Overall Study|Physician Decision|0|||
23625434|NCT03414047|66015502|FG003|Overall Study|Physician Decision|1|||
23625435|NCT03414047|66015499|FG000|Overall Study|Withdrawal by Subject|1|||
23625436|NCT03414047|66015500|FG001|Overall Study|Withdrawal by Subject|0|||
23625437|NCT03414047|66015501|FG002|Overall Study|Withdrawal by Subject|2|||
23440346|NCT03364309|65355261|FG004|Induction Period|Withdrawal by Subject|0|||
23440347|NCT03364309|65355262|FG005|Induction Period|Withdrawal by Subject|0|||
23440348|NCT03364309|65355263|FG006|Induction Period|Withdrawal by Subject|0|||
23440349|NCT03364309|65355264|FG007|Induction Period|Withdrawal by Subject|0|||
23440350|NCT03364309|65355265|FG008|Induction Period|Withdrawal by Subject|0|||
23440351|NCT03364309|65355266|FG009|Induction Period|Withdrawal by Subject|0|||
23440352|NCT03364309|65355267|FG010|Induction Period|Withdrawal by Subject|0|||
23440353|NCT03364309|65355268|FG011|Induction Period|Withdrawal by Subject|0|||
23440354|NCT03364309|65355269|FG012|Induction Period|Withdrawal by Subject|0|||
23440355|NCT03364309|65355270|FG013|Induction Period|Withdrawal by Subject|0|||
23440356|NCT03364309|65355271|FG014|Induction Period|Withdrawal by Subject|0|||
23440357|NCT03364309|65355272|FG015|Induction Period|Withdrawal by Subject|0|||
23440358|NCT03364309|65355273|FG016|Induction Period|Withdrawal by Subject|0|||
23562901|NCT02508532|65790394|FG003|Part 2 - Treatment|Disease Progression|0|||
23562902|NCT02508532|65790395|FG004|Part 2 - Treatment|Disease Progression|0|||
23562903|NCT02508532|65790396|FG005|Part 2 - Treatment|Disease Progression|0|||
23562904|NCT02508532|65790397|FG006|Part 2 - Treatment|Disease Progression|0|||
23562905|NCT02508532|65790398|FG007|Part 2 - Treatment|Disease Progression|0|||
23562906|NCT02508532|65790399|FG008|Part 2 - Treatment|Disease Progression|118|||
23562907|NCT02508532|65790391|FG000|Part 2 - Treatment|Adverse Event|0|||
23562908|NCT02508532|65790392|FG001|Part 2 - Treatment|Adverse Event|0|||
23562909|NCT02508532|65790393|FG002|Part 2 - Treatment|Adverse Event|0|||
23625438|NCT03414047|66015502|FG003|Overall Study|Withdrawal by Subject|0|||
23625439|NCT03443414|66015503|FG000|Overall Study|Adverse Event|6|||
23625440|NCT03443414|66015504|FG001|Overall Study|Adverse Event|0|||
23625441|NCT03443414|66015505|FG002|Overall Study|Adverse Event|4|||
23562910|NCT02508532|65790394|FG003|Part 2 - Treatment|Adverse Event|0|||
23562911|NCT02508532|65790395|FG004|Part 2 - Treatment|Adverse Event|0|||
23562912|NCT02508532|65790396|FG005|Part 2 - Treatment|Adverse Event|0|||
23625442|NCT03443414|66015506|FG003|Overall Study|Adverse Event|2|||
23625443|NCT03443414|66015507|FG004|Overall Study|Adverse Event|3|||
23625444|NCT03443414|66015503|FG000|Overall Study|Withdrawal by Subject|3|||
23625445|NCT03443414|66015504|FG001|Overall Study|Withdrawal by Subject|2|||
23625446|NCT03443414|66015505|FG002|Overall Study|Withdrawal by Subject|2|||
23625447|NCT03443414|66015506|FG003|Overall Study|Withdrawal by Subject|2|||
23757915|NCT00597207|66492194|FG001|Overall Study|Lost to Follow-up|7|||
23757916|NCT03001011|66492197|FG000|Overall Study|Adverse Event|9|||
23757917|NCT03001011|66492198|FG001|Overall Study|Adverse Event|3|||
23757918|NCT03001011|66492197|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
23757919|NCT03001011|66492198|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
23757920|NCT03001011|66492197|FG000|Overall Study|Other than specified above|3|||
23757921|NCT03001011|66492198|FG001|Overall Study|Other than specified above|8|||
23757922|NCT02746705|66492199|FG000|Overall Study|Physician Decision|1|||
23757923|NCT02746705|66492200|FG001|Overall Study|Physician Decision|1|||
23757924|NCT02746705|66492199|FG000|Overall Study|Lost to Follow-up|1|||
23757925|NCT02746705|66492200|FG001|Overall Study|Lost to Follow-up|0|||
23757926|NCT02746705|66492199|FG000|Overall Study|outlier scores deemed not valid|0|||
23757927|NCT02746705|66492200|FG001|Overall Study|outlier scores deemed not valid|1|||
23757928|NCT03499249|66492203|FG000|Overall Study|Physician Decision|1|||
23757929|NCT01787188|66492207|FG000|Overall Study|Adverse Event|2|||
23757930|NCT01787188|66492208|FG001|Overall Study|Adverse Event|4|||
23757931|NCT01787188|66492209|FG002|Overall Study|Adverse Event|6|||
23757932|NCT01787188|66492207|FG000|Overall Study|Lack of Efficacy|7|||
23757933|NCT01787188|66492208|FG001|Overall Study|Lack of Efficacy|3|||
23757934|NCT01787188|66492209|FG002|Overall Study|Lack of Efficacy|5|||
23757935|NCT01787188|66492207|FG000|Overall Study|Non-compliance with Study Drug|0|||
23757936|NCT01787188|66492208|FG001|Overall Study|Non-compliance with Study Drug|1|||
23757937|NCT01787188|66492209|FG002|Overall Study|Non-compliance with Study Drug|0|||
23757938|NCT01787188|66492207|FG000|Overall Study|Withdrawal by Subject|4|||
23625448|NCT03443414|66015507|FG004|Overall Study|Withdrawal by Subject|1|||
23625449|NCT03443414|66015503|FG000|Overall Study|Death|0|||
23625450|NCT03443414|66015504|FG001|Overall Study|Death|1|||
23625451|NCT03443414|66015505|FG002|Overall Study|Death|0|||
23625452|NCT03443414|66015506|FG003|Overall Study|Death|1|||
23625453|NCT03443414|66015507|FG004|Overall Study|Death|0|||
23625454|NCT03443414|66015503|FG000|Overall Study|Reason not specified|2|||
23625455|NCT03443414|66015504|FG001|Overall Study|Reason not specified|0|||
23625456|NCT03443414|66015505|FG002|Overall Study|Reason not specified|0|||
23625457|NCT03443414|66015506|FG003|Overall Study|Reason not specified|0|||
23625458|NCT03443414|66015507|FG004|Overall Study|Reason not specified|1|||
23625459|NCT00623363|66015513|FG000|Overall Study|Adverse Event|2|||
23625460|NCT00623363|66015514|FG001|Overall Study|Adverse Event|2|||
23625461|NCT01587118|66015517|FG000|Overall Study|Adverse Event|3|||
23625462|NCT01587118|66015517|FG000|Overall Study|Lost to Follow-up|2|||
23625463|NCT01587118|66015517|FG000|Overall Study|Relocation|1|||
23625464|NCT01587118|66015517|FG000|Overall Study|nonresponse|1|||
23625465|NCT01242371|66015518|FG000|Overall Study|Withdrawal by Subject|2|||
23625466|NCT01242371|66015519|FG001|Overall Study|Withdrawal by Subject|2|||
23625467|NCT01242371|66015518|FG000|Overall Study|Protocol Violation|0|||
23625468|NCT01242371|66015519|FG001|Overall Study|Protocol Violation|3|||
23625469|NCT00174447|66015520|FG000|Overall Study|Adverse Event|19|||
23625470|NCT00174447|66015520|FG000|Overall Study|Withdrawal by Subject|15|||
23625471|NCT00174447|66015520|FG000|Overall Study|Protocol Violation|1|||
23625472|NCT00174447|66015520|FG000|Overall Study|Lack of Efficacy|1|||
23625473|NCT00174447|66015520|FG000|Overall Study|Administrative reason/Other|2|||
23625474|NCT01151423|66015521|FG000|Overall Study|Study terminated by Sponsor|9|||
23625475|NCT01151423|66015522|FG001|Overall Study|Study terminated by Sponsor|10|||
23625476|NCT01151423|66015521|FG000|Overall Study|Protocol Violation|0|||
23625477|NCT01151423|66015522|FG001|Overall Study|Protocol Violation|1|||
23625478|NCT01151423|66015521|FG000|Overall Study|Physician Decision|1|||
23625479|NCT01151423|66015522|FG001|Overall Study|Physician Decision|1|||
23625480|NCT01151423|66015521|FG000|Overall Study|Pregnancy|0|||
23625481|NCT01151423|66015522|FG001|Overall Study|Pregnancy|1|||
23625482|NCT01151423|66015521|FG000|Overall Study|Death|0|||
23625483|NCT01151423|66015522|FG001|Overall Study|Death|1|||
23625484|NCT01151423|66015521|FG000|Overall Study|Adverse Event|3|||
23625485|NCT01151423|66015522|FG001|Overall Study|Adverse Event|0|||
23625486|NCT01151423|66015521|FG000|Overall Study|Withdrawal by Subject|1|||
23625487|NCT01151423|66015522|FG001|Overall Study|Withdrawal by Subject|3|||
23625488|NCT01151423|66015521|FG000|Overall Study|Lost to Follow-up|1|||
23625489|NCT01151423|66015522|FG001|Overall Study|Lost to Follow-up|0|||
23625490|NCT01151423|66015521|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
23757939|NCT01787188|66492208|FG001|Overall Study|Withdrawal by Subject|3|||
23440359|NCT03364309|65355274|FG017|Induction Period|Withdrawal by Subject|0|||
23440360|NCT03364309|65355275|FG018|Induction Period|Withdrawal by Subject|0|||
23440361|NCT03364309|65355257|FG000|Induction Period|Lost to Follow-up|1|||
23440362|NCT03364309|65355258|FG001|Induction Period|Lost to Follow-up|0|||
23440363|NCT03364309|65355259|FG002|Induction Period|Lost to Follow-up|0|||
23440364|NCT03364309|65355260|FG003|Induction Period|Lost to Follow-up|0|||
23440365|NCT03364309|65355261|FG004|Induction Period|Lost to Follow-up|0|||
23440366|NCT03364309|65355262|FG005|Induction Period|Lost to Follow-up|0|||
23440367|NCT03364309|65355263|FG006|Induction Period|Lost to Follow-up|0|||
23440368|NCT03364309|65355264|FG007|Induction Period|Lost to Follow-up|0|||
23440369|NCT03364309|65355265|FG008|Induction Period|Lost to Follow-up|0|||
23440370|NCT03364309|65355266|FG009|Induction Period|Lost to Follow-up|0|||
23440371|NCT03364309|65355267|FG010|Induction Period|Lost to Follow-up|0|||
23440372|NCT03364309|65355268|FG011|Induction Period|Lost to Follow-up|0|||
23440373|NCT03364309|65355269|FG012|Induction Period|Lost to Follow-up|0|||
23440374|NCT03364309|65355270|FG013|Induction Period|Lost to Follow-up|0|||
23440375|NCT03364309|65355271|FG014|Induction Period|Lost to Follow-up|0|||
23440376|NCT03364309|65355272|FG015|Induction Period|Lost to Follow-up|0|||
23440377|NCT03364309|65355273|FG016|Induction Period|Lost to Follow-up|0|||
23440378|NCT03364309|65355274|FG017|Induction Period|Lost to Follow-up|0|||
23440379|NCT03364309|65355275|FG018|Induction Period|Lost to Follow-up|0|||
23440380|NCT03364309|65355257|FG000|Induction Period|Physician Decision|0|||
23440381|NCT03364309|65355258|FG001|Induction Period|Physician Decision|1|||
23440382|NCT03364309|65355259|FG002|Induction Period|Physician Decision|0|||
23440383|NCT03364309|65355260|FG003|Induction Period|Physician Decision|0|||
23440384|NCT03364309|65355261|FG004|Induction Period|Physician Decision|0|||
23625491|NCT01151423|66015522|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
23625492|NCT01151423|66015521|FG000|Overall Study|Participated in other clinical trial|1|||
23625493|NCT01151423|66015522|FG001|Overall Study|Participated in other clinical trial|0|||
23625494|NCT01585298|66015524|FG000|Overall Study|Study completion was not documented.|1|||
23625495|NCT01585298|66015524|FG000|Overall Study|Protocol deviation|1|||
23625496|NCT01585298|66015524|FG000|Overall Study|Administrative problems|4|||
23625497|NCT01585298|66015524|FG000|Overall Study|Lost to Follow-up|2|||
23625498|NCT01585298|66015524|FG000|Overall Study|Withdrawal by Subject|4|||
23625499|NCT01585298|66015524|FG000|Overall Study|Abnormal test procedure results|1|||
23625500|NCT01585298|66015524|FG000|Overall Study|Adverse Event|24|||
23625501|NCT01111240|66015525|FG000|Overall Study|Adverse Event|190|||
23562913|NCT02508532|65790397|FG006|Part 2 - Treatment|Adverse Event|0|||
23562914|NCT02508532|65790398|FG007|Part 2 - Treatment|Adverse Event|0|||
23562915|NCT02508532|65790399|FG008|Part 2 - Treatment|Adverse Event|49|||
23562916|NCT02508532|65790391|FG000|Part 2 - Treatment|Physician Decision|0|||
23562917|NCT02508532|65790392|FG001|Part 2 - Treatment|Physician Decision|0|||
23562918|NCT02508532|65790393|FG002|Part 2 - Treatment|Physician Decision|0|||
23562919|NCT02508532|65790394|FG003|Part 2 - Treatment|Physician Decision|0|||
23562920|NCT02508532|65790395|FG004|Part 2 - Treatment|Physician Decision|0|||
23562921|NCT02508532|65790396|FG005|Part 2 - Treatment|Physician Decision|0|||
23562922|NCT02508532|65790397|FG006|Part 2 - Treatment|Physician Decision|0|||
23562923|NCT02508532|65790398|FG007|Part 2 - Treatment|Physician Decision|0|||
23562924|NCT02508532|65790399|FG008|Part 2 - Treatment|Physician Decision|12|||
23562925|NCT02508532|65790391|FG000|Part 2 - Treatment|Administrative|0|||
23562926|NCT02508532|65790392|FG001|Part 2 - Treatment|Administrative|0|||
23562927|NCT02508532|65790393|FG002|Part 2 - Treatment|Administrative|0|||
23562928|NCT02508532|65790394|FG003|Part 2 - Treatment|Administrative|0|||
23562929|NCT02508532|65790395|FG004|Part 2 - Treatment|Administrative|0|||
23562930|NCT02508532|65790396|FG005|Part 2 - Treatment|Administrative|0|||
23562931|NCT02508532|65790397|FG006|Part 2 - Treatment|Administrative|0|||
23562932|NCT02508532|65790398|FG007|Part 2 - Treatment|Administrative|0|||
23562933|NCT02508532|65790399|FG008|Part 2 - Treatment|Administrative|3|||
23562934|NCT02508532|65790391|FG000|Part 2 - Treatment|Sponsor Decision|0|||
23562935|NCT02508532|65790392|FG001|Part 2 - Treatment|Sponsor Decision|0|||
23562936|NCT02508532|65790393|FG002|Part 2 - Treatment|Sponsor Decision|0|||
23625502|NCT01111240|66015525|FG000|Overall Study|Lack of Efficacy|545|||
23625503|NCT01111240|66015525|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
23625504|NCT01111240|66015525|FG000|Overall Study|Other|312|||
23625505|NCT03020069|66015526|FG000|Overall Study|Lost to Follow-up|0|||
23625506|NCT03020069|66015527|FG001|Overall Study|Lost to Follow-up|1|||
23625507|NCT01438840|66015531|FG000|Core Study|Adverse Event|0|||
23625508|NCT01438840|66015532|FG001|Core Study|Adverse Event|3|||
23625509|NCT01438840|66015533|FG002|Core Study|Adverse Event|0|||
23625510|NCT01438840|66015531|FG000|Core Study|Lack of Efficacy|15|||
23757940|NCT01787188|66492209|FG002|Overall Study|Withdrawal by Subject|2|||
23757941|NCT01787188|66492207|FG000|Overall Study|Protocol Violation|3|||
23757942|NCT01787188|66492208|FG001|Overall Study|Protocol Violation|2|||
23757943|NCT01787188|66492209|FG002|Overall Study|Protocol Violation|3|||
23757944|NCT01787188|66492207|FG000|Overall Study|Lost to Follow-up|1|||
23757945|NCT01787188|66492208|FG001|Overall Study|Lost to Follow-up|2|||
23757946|NCT01787188|66492209|FG002|Overall Study|Lost to Follow-up|2|||
23757947|NCT01787188|66492207|FG000|Overall Study|Other, including patient moved|0|||
23757948|NCT01787188|66492208|FG001|Overall Study|Other, including patient moved|3|||
23757949|NCT01787188|66492209|FG002|Overall Study|Other, including patient moved|0|||
23757950|NCT00295620|66492210|FG000|Overall Study|Lost to Follow-up|9|||
23757951|NCT00295620|66492211|FG001|Overall Study|Lost to Follow-up|5|||
23757952|NCT00295620|66492210|FG000|Overall Study|Withdrawal by Subject|37|||
23757953|NCT00295620|66492211|FG001|Overall Study|Withdrawal by Subject|50|||
23757954|NCT00295620|66492210|FG000|Overall Study|Death|206|||
23757955|NCT00295620|66492211|FG001|Overall Study|Death|207|||
23757956|NCT00295620|66492210|FG000|Overall Study|Other reasons|10|||
23757957|NCT00295620|66492211|FG001|Overall Study|Other reasons|9|||
23757958|NCT00295620|66492210|FG000|Overall Study|Discontinuation by sponsor|580|||
23757959|NCT00295620|66492211|FG001|Overall Study|Discontinuation by sponsor|593|||
23757960|NCT00295620|66492210|FG000|Overall Study|Protocol Violation|30|||
23757961|NCT00295620|66492211|FG001|Overall Study|Protocol Violation|32|||
23757962|NCT01074307|66492217|FG000|Overall Study|No primary endpoint evaluation|14|||
23757963|NCT01074307|66492218|FG001|Overall Study|No primary endpoint evaluation|6|||
23757964|NCT01074307|66492217|FG000|Overall Study|Exclusion criterion|0|||
23757965|NCT01074307|66492218|FG001|Overall Study|Exclusion criterion|1|||
23757966|NCT01074307|66492217|FG000|Overall Study|Protocol Violation|8|||
23757967|NCT01074307|66492218|FG001|Overall Study|Protocol Violation|5|||
23757968|NCT01309828|66492219|FG000|Overall Study|Adverse Event|10|||
23757969|NCT01309828|66492220|FG001|Overall Study|Adverse Event|11|||
23562937|NCT02508532|65790394|FG003|Part 2 - Treatment|Sponsor Decision|0|||
23562938|NCT02508532|65790395|FG004|Part 2 - Treatment|Sponsor Decision|0|||
23562939|NCT02508532|65790396|FG005|Part 2 - Treatment|Sponsor Decision|0|||
23562940|NCT02508532|65790397|FG006|Part 2 - Treatment|Sponsor Decision|0|||
23625511|NCT01438840|66015532|FG001|Core Study|Lack of Efficacy|7|||
23757970|NCT01309828|66492219|FG000|Overall Study|Voluntary Withdrawal|5|||
23562941|NCT02508532|65790398|FG007|Part 2 - Treatment|Sponsor Decision|0|||
23562942|NCT02508532|65790399|FG008|Part 2 - Treatment|Sponsor Decision|28|||
23562943|NCT02508532|65790391|FG000|Part 2 - Treatment|Death|0|||
23562944|NCT02508532|65790392|FG001|Part 2 - Treatment|Death|0|||
23625512|NCT01438840|66015533|FG002|Core Study|Lack of Efficacy|0|||
23625513|NCT01438840|66015531|FG000|Core Study|Withdrawal of consent|1|||
23757971|NCT01309828|66492220|FG001|Overall Study|Voluntary Withdrawal|4|||
23757972|NCT01309828|66492219|FG000|Overall Study|Major Protocol Deviation|0|||
23562945|NCT02508532|65790393|FG002|Part 2 - Treatment|Death|0|||
23562946|NCT02508532|65790394|FG003|Part 2 - Treatment|Death|0|||
23562947|NCT02508532|65790395|FG004|Part 2 - Treatment|Death|0|||
23562948|NCT02508532|65790396|FG005|Part 2 - Treatment|Death|0|||
23562949|NCT02508532|65790397|FG006|Part 2 - Treatment|Death|0|||
23562950|NCT02508532|65790398|FG007|Part 2 - Treatment|Death|0|||
23562951|NCT02508532|65790399|FG008|Part 2 - Treatment|Death|1|||
23562952|NCT02508532|65790391|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
23562953|NCT02508532|65790392|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
23562954|NCT02508532|65790393|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
23562955|NCT02508532|65790394|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
23562956|NCT02508532|65790395|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
23562957|NCT02508532|65790396|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
23562958|NCT02508532|65790397|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
23562959|NCT02508532|65790398|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
23562960|NCT02508532|65790399|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
23562961|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
23562962|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562963|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
23625514|NCT01438840|66015532|FG001|Core Study|Withdrawal of consent|0|||
23625515|NCT01438840|66015533|FG002|Core Study|Withdrawal of consent|0|||
23625516|NCT01438840|66015531|FG000|Extension Phase|Adverse Event|0|||
23625517|NCT01438840|66015532|FG001|Extension Phase|Adverse Event|0|||
23625518|NCT01438840|66015533|FG002|Extension Phase|Adverse Event|3|||
23625519|NCT01438840|66015531|FG000|Extension Phase|Lost to Follow-up|0|||
23625520|NCT01438840|66015532|FG001|Extension Phase|Lost to Follow-up|0|||
23625521|NCT01438840|66015533|FG002|Extension Phase|Lost to Follow-up|1|||
23625522|NCT01438840|66015531|FG000|Extension Phase|Withdrawal by Subject|0|||
23625523|NCT01438840|66015532|FG001|Extension Phase|Withdrawal by Subject|0|||
23625524|NCT01438840|66015533|FG002|Extension Phase|Withdrawal by Subject|3|||
23625525|NCT01438840|66015531|FG000|Extension Phase|Lack of Efficacy|0|||
23625526|NCT01438840|66015532|FG001|Extension Phase|Lack of Efficacy|0|||
23625527|NCT01438840|66015533|FG002|Extension Phase|Lack of Efficacy|2|||
23625528|NCT01438840|66015531|FG000|Extension Phase|Other|0|||
23625529|NCT01438840|66015532|FG001|Extension Phase|Other|0|||
23625530|NCT01438840|66015533|FG002|Extension Phase|Other|1|||
23625531|NCT01458522|66015539|FG000|Overall Study|Withdrawal by Subject|2|||
23625532|NCT01458522|66015540|FG001|Overall Study|Withdrawal by Subject|2|||
23625533|NCT01458522|66015539|FG000|Overall Study|Physician Decision|1|||
23625534|NCT01458522|66015540|FG001|Overall Study|Physician Decision|9|||
23625535|NCT00966979|66015543|FG000|Overall Study|Death|1|||
23625536|NCT00966979|66015543|FG000|Overall Study|Lost to Follow-up|6|||
23625537|NCT00966979|66015543|FG000|Overall Study|Withdrawal by Subject|14|||
23625538|NCT00966979|66015543|FG000|Overall Study|Adverse Event|5|||
23625539|NCT00966979|66015543|FG000|Overall Study|Sponsor terminated early|49|||
23625540|NCT00966979|66015543|FG000|Overall Study|Censored because surgery not done|2|||
23625541|NCT00966979|66015543|FG000|Overall Study|Censored because study device was not implanted|14|||
23625542|NCT00966979|66015543|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
23625543|NCT03616964|66015544|FG000|Overall Study|Adverse Event|15|||
23625544|NCT03616964|66015545|FG001|Overall Study|Adverse Event|10|||
23625545|NCT03616964|66015546|FG002|Overall Study|Adverse Event|16|||
23625546|NCT03616964|66015544|FG000|Overall Study|Death|3|||
23625547|NCT03616964|66015545|FG001|Overall Study|Death|0|||
23625548|NCT03616964|66015546|FG002|Overall Study|Death|4|||
23625549|NCT03616964|66015544|FG000|Overall Study|Lack of Efficacy|4|||
23625550|NCT03616964|66015545|FG001|Overall Study|Lack of Efficacy|8|||
23625551|NCT03616964|66015546|FG002|Overall Study|Lack of Efficacy|8|||
23625552|NCT03616964|66015544|FG000|Overall Study|Lost to Follow-up|2|||
23625553|NCT03616964|66015545|FG001|Overall Study|Lost to Follow-up|1|||
23625554|NCT03616964|66015546|FG002|Overall Study|Lost to Follow-up|3|||
23625555|NCT03616964|66015544|FG000|Overall Study|Withdrawal by Subject|18|||
23757973|NCT01309828|66492220|FG001|Overall Study|Major Protocol Deviation|1|||
23562964|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562965|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562966|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562967|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562968|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
23625556|NCT03616964|66015545|FG001|Overall Study|Withdrawal by Subject|14|||
23625557|NCT03616964|66015546|FG002|Overall Study|Withdrawal by Subject|21|||
23625558|NCT03616964|66015544|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625559|NCT03616964|66015545|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625560|NCT03616964|66015546|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625561|NCT03616964|66015544|FG000|Overall Study|Sponsor's Decision|1|||
23625562|NCT03616964|66015545|FG001|Overall Study|Sponsor's Decision|0|||
23625563|NCT03616964|66015546|FG002|Overall Study|Sponsor's Decision|0|||
23625564|NCT03616964|66015544|FG000|Overall Study|Physician Decision|0|||
23562969|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
23757974|NCT01309828|66492219|FG000|Overall Study|Other|1|||
23440385|NCT03364309|65355262|FG005|Induction Period|Physician Decision|0|||
23440386|NCT03364309|65355263|FG006|Induction Period|Physician Decision|0|||
23440387|NCT03364309|65355264|FG007|Induction Period|Physician Decision|0|||
23440388|NCT03364309|65355265|FG008|Induction Period|Physician Decision|0|||
23440389|NCT03364309|65355266|FG009|Induction Period|Physician Decision|0|||
23440390|NCT03364309|65355267|FG010|Induction Period|Physician Decision|0|||
23440391|NCT03364309|65355268|FG011|Induction Period|Physician Decision|0|||
23440392|NCT03364309|65355269|FG012|Induction Period|Physician Decision|0|||
23440393|NCT03364309|65355270|FG013|Induction Period|Physician Decision|0|||
23440394|NCT03364309|65355271|FG014|Induction Period|Physician Decision|0|||
23440395|NCT03364309|65355272|FG015|Induction Period|Physician Decision|0|||
23440396|NCT03364309|65355273|FG016|Induction Period|Physician Decision|0|||
23440397|NCT03364309|65355274|FG017|Induction Period|Physician Decision|0|||
23440398|NCT03364309|65355275|FG018|Induction Period|Physician Decision|0|||
23440399|NCT03364309|65355257|FG000|Maintenance Period|Withdrawal by Subject|0|||
23440400|NCT03364309|65355258|FG001|Maintenance Period|Withdrawal by Subject|0|||
23440401|NCT03364309|65355259|FG002|Maintenance Period|Withdrawal by Subject|0|||
23440402|NCT03364309|65355260|FG003|Maintenance Period|Withdrawal by Subject|1|||
23440403|NCT03364309|65355261|FG004|Maintenance Period|Withdrawal by Subject|3|||
23440404|NCT03364309|65355262|FG005|Maintenance Period|Withdrawal by Subject|1|||
23440405|NCT03364309|65355263|FG006|Maintenance Period|Withdrawal by Subject|3|||
23440406|NCT03364309|65355264|FG007|Maintenance Period|Withdrawal by Subject|0|||
23440407|NCT03364309|65355265|FG008|Maintenance Period|Withdrawal by Subject|1|||
23440408|NCT03364309|65355266|FG009|Maintenance Period|Withdrawal by Subject|1|||
23440409|NCT03364309|65355267|FG010|Maintenance Period|Withdrawal by Subject|2|||
23440410|NCT03364309|65355268|FG011|Maintenance Period|Withdrawal by Subject|0|||
23440411|NCT03364309|65355269|FG012|Maintenance Period|Withdrawal by Subject|0|||
23440412|NCT03364309|65355270|FG013|Maintenance Period|Withdrawal by Subject|0|||
23440413|NCT03364309|65355271|FG014|Maintenance Period|Withdrawal by Subject|0|||
23440414|NCT03364309|65355272|FG015|Maintenance Period|Withdrawal by Subject|0|||
23440415|NCT03364309|65355273|FG016|Maintenance Period|Withdrawal by Subject|0|||
23440416|NCT03364309|65355274|FG017|Maintenance Period|Withdrawal by Subject|0|||
23440417|NCT03364309|65355275|FG018|Maintenance Period|Withdrawal by Subject|0|||
23440418|NCT03364309|65355257|FG000|Maintenance Period|Adverse Event|0|||
23440419|NCT03364309|65355258|FG001|Maintenance Period|Adverse Event|0|||
23440420|NCT03364309|65355259|FG002|Maintenance Period|Adverse Event|0|||
23440421|NCT03364309|65355260|FG003|Maintenance Period|Adverse Event|0|||
23440422|NCT03364309|65355261|FG004|Maintenance Period|Adverse Event|2|||
23440423|NCT03364309|65355262|FG005|Maintenance Period|Adverse Event|0|||
23440424|NCT03364309|65355263|FG006|Maintenance Period|Adverse Event|3|||
23440425|NCT03364309|65355264|FG007|Maintenance Period|Adverse Event|0|||
23440426|NCT03364309|65355265|FG008|Maintenance Period|Adverse Event|1|||
23440427|NCT03364309|65355266|FG009|Maintenance Period|Adverse Event|0|||
23440428|NCT03364309|65355267|FG010|Maintenance Period|Adverse Event|2|||
23562970|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
23562971|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
23440429|NCT03364309|65355268|FG011|Maintenance Period|Adverse Event|0|||
23440430|NCT03364309|65355269|FG012|Maintenance Period|Adverse Event|0|||
23440431|NCT03364309|65355270|FG013|Maintenance Period|Adverse Event|0|||
23440432|NCT03364309|65355271|FG014|Maintenance Period|Adverse Event|0|||
23440433|NCT03364309|65355272|FG015|Maintenance Period|Adverse Event|0|||
23440434|NCT03364309|65355273|FG016|Maintenance Period|Adverse Event|0|||
23440435|NCT03364309|65355274|FG017|Maintenance Period|Adverse Event|0|||
23440436|NCT03364309|65355275|FG018|Maintenance Period|Adverse Event|0|||
23440437|NCT03364309|65355257|FG000|Maintenance Period|Relapsed|0|||
23440438|NCT03364309|65355258|FG001|Maintenance Period|Relapsed|0|||
23440439|NCT03364309|65355259|FG002|Maintenance Period|Relapsed|0|||
23757975|NCT01309828|66492220|FG001|Overall Study|Other|0|||
23440440|NCT03364309|65355260|FG003|Maintenance Period|Relapsed|43|||
23440441|NCT03364309|65355261|FG004|Maintenance Period|Relapsed|7|||
23440442|NCT03364309|65355262|FG005|Maintenance Period|Relapsed|45|||
23440443|NCT03364309|65355263|FG006|Maintenance Period|Relapsed|10|||
23440444|NCT03364309|65355264|FG007|Maintenance Period|Relapsed|2|||
23440445|NCT03364309|65355265|FG008|Maintenance Period|Relapsed|0|||
23440446|NCT03364309|65355266|FG009|Maintenance Period|Relapsed|0|||
23440447|NCT03364309|65355267|FG010|Maintenance Period|Relapsed|0|||
23562972|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
23625565|NCT03616964|66015545|FG001|Overall Study|Physician Decision|2|||
23625566|NCT03616964|66015546|FG002|Overall Study|Physician Decision|0|||
23625567|NCT03616964|66015544|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
23757976|NCT01964105|66492224|FG000|Overall Study|Lost to Follow-up|2|||
23757977|NCT01964105|66492225|FG001|Overall Study|Lost to Follow-up|13|||
23757978|NCT01964105|66492226|FG002|Overall Study|Lost to Follow-up|0|||
23757979|NCT01766310|66492227|FG000|Overall Study|Lost to Follow-up|1|||
23826564|NCT00577863|66745129|FG000|Overall Study|Adverse Event|4|||
23826565|NCT00577863|66745130|FG001|Overall Study|Adverse Event|2|||
23757980|NCT01766310|66492228|FG001|Overall Study|Lost to Follow-up|3|||
23757981|NCT02953262|66492229|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
23757982|NCT02953262|66492230|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
23757983|NCT02953262|66492231|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
23757984|NCT02953262|66492232|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
23757985|NCT00833547|66492233|FG000|Overall Study|Withdrawal by Subject|2|||
23757986|NCT00833547|66492234|FG001|Overall Study|Withdrawal by Subject|2|||
23757987|NCT01296152|66492235|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23757988|NCT02124746|66492243|FG000|Overall Study|Adverse Event|2|||
23757989|NCT02124746|66492244|FG001|Overall Study|Adverse Event|1|||
23757990|NCT02124746|66492245|FG002|Overall Study|Adverse Event|2|||
23757991|NCT02124746|66492243|FG000|Overall Study|Death|2|||
23757992|NCT02124746|66492244|FG001|Overall Study|Death|1|||
23757993|NCT02124746|66492245|FG002|Overall Study|Death|3|||
23757994|NCT02124746|66492243|FG000|Overall Study|Lack of Efficacy|3|||
23757995|NCT02124746|66492244|FG001|Overall Study|Lack of Efficacy|2|||
23757996|NCT02124746|66492245|FG002|Overall Study|Lack of Efficacy|2|||
23757997|NCT02124746|66492243|FG000|Overall Study|Physician Decision|6|||
23757998|NCT02124746|66492244|FG001|Overall Study|Physician Decision|4|||
23757999|NCT02124746|66492245|FG002|Overall Study|Physician Decision|5|||
23758000|NCT02124746|66492243|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23758001|NCT02124746|66492244|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23758002|NCT02124746|66492245|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23758003|NCT02124746|66492243|FG000|Overall Study|Withdrawal by Subject|3|||
23758004|NCT02124746|66492244|FG001|Overall Study|Withdrawal by Subject|3|||
23826566|NCT00577863|66745129|FG000|Overall Study|Death|1|||
23826567|NCT00577863|66745130|FG001|Overall Study|Death|0|||
23826568|NCT00577863|66745129|FG000|Overall Study|Lost to Follow-up|2|||
23826569|NCT00577863|66745130|FG001|Overall Study|Lost to Follow-up|2|||
23826570|NCT00577863|66745129|FG000|Overall Study|Entry Criteria Exclusion|1|||
23826571|NCT00577863|66745130|FG001|Overall Study|Entry Criteria Exclusion|0|||
23826572|NCT00577863|66745129|FG000|Overall Study|Withdrawal by Subject|0|||
23826573|NCT00577863|66745130|FG001|Overall Study|Withdrawal by Subject|2|||
23826574|NCT00577863|66745129|FG000|Overall Study|Sponsor Decision|2|||
23826575|NCT00577863|66745130|FG001|Overall Study|Sponsor Decision|7|||
23826576|NCT00577863|66745129|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
23826577|NCT00577863|66745130|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
23826578|NCT01569295|66745131|FG000|Overall Study|Progressive Disease|75|||
23826579|NCT01569295|66745132|FG001|Overall Study|Progressive Disease|139|||
23826580|NCT01569295|66745131|FG000|Overall Study|Adverse Event|39|||
23826581|NCT01569295|66745132|FG001|Overall Study|Adverse Event|14|||
23826582|NCT01569295|66745131|FG000|Overall Study|Withdrawal by Subject|25|||
23826583|NCT01569295|66745132|FG001|Overall Study|Withdrawal by Subject|12|||
23826584|NCT01569295|66745131|FG000|Overall Study|Death|19|||
23826585|NCT01569295|66745132|FG001|Overall Study|Death|15|||
23758005|NCT02124746|66492245|FG002|Overall Study|Withdrawal by Subject|0|||
23758006|NCT02124746|66492243|FG000|Overall Study|Study Terminated by Sponsor|0|||
23826586|NCT01569295|66745131|FG000|Overall Study|Physician Decision|13|||
23758007|NCT02124746|66492244|FG001|Overall Study|Study Terminated by Sponsor|0|||
23758008|NCT02124746|66492245|FG002|Overall Study|Study Terminated by Sponsor|6|||
23826587|NCT01569295|66745132|FG001|Overall Study|Physician Decision|18|||
23826588|NCT01569295|66745131|FG000|Overall Study|Study Terminated by Sponsor|24|||
23826589|NCT01569295|66745132|FG001|Overall Study|Study Terminated by Sponsor|2|||
23826590|NCT01569295|66745131|FG000|Overall Study|Other Reason not Specified|3|||
23826591|NCT01569295|66745132|FG001|Overall Study|Other Reason not Specified|5|||
23758009|NCT02124746|66492243|FG000|Overall Study|Disease Progression|3|||
23758010|NCT02124746|66492244|FG001|Overall Study|Disease Progression|6|||
23758011|NCT02124746|66492245|FG002|Overall Study|Disease Progression|4|||
23758012|NCT01389024|66492249|FG000|Overall Study|Withdrawal by Subject|0|||
23758013|NCT01389024|66492250|FG001|Overall Study|Withdrawal by Subject|1|||
23758014|NCT01389024|66492249|FG000|Overall Study|Lost to Follow-up|1|||
23758015|NCT01389024|66492250|FG001|Overall Study|Lost to Follow-up|0|||
23758016|NCT01656967|66492251|FG000|Overall Study|faulty monitor|1|||
23758017|NCT01656967|66492252|FG001|Overall Study|faulty monitor|0|||
23758018|NCT01656967|66492251|FG000|Overall Study|unsuccessful ETT insertion|3|||
23758019|NCT01656967|66492252|FG001|Overall Study|unsuccessful ETT insertion|2|||
23758020|NCT03296553|66492254|FG000|Overall Study|Withdrawal by Subject|1|||
23758021|NCT03296553|66492255|FG001|Overall Study|Withdrawal by Subject|1|||
23758022|NCT03296553|66492254|FG000|Overall Study|Death|1|||
23758023|NCT03296553|66492255|FG001|Overall Study|Death|0|||
23758024|NCT00388674|66492258|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
23758025|NCT00388674|66492259|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
23758026|NCT00388674|66492258|FG000|Initial Treatment|Adverse Event|22|||
23758027|NCT00388674|66492259|FG001|Initial Treatment|Adverse Event|87|||
23758028|NCT00388674|66492258|FG000|Initial Treatment|Death|215|||
23758029|NCT00388674|66492259|FG001|Initial Treatment|Death|216|||
23758030|NCT00388674|66492258|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
23758031|NCT00388674|66492259|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
23758032|NCT00388674|66492258|FG000|Initial Treatment|HCC|12|||
23758033|NCT00388674|66492259|FG001|Initial Treatment|HCC|20|||
23758034|NCT00388674|66492258|FG000|Initial Treatment|Lost to Follow-up|526|||
23758035|NCT00388674|66492259|FG001|Initial Treatment|Lost to Follow-up|624|||
23758036|NCT00388674|66492258|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
23758037|NCT00388674|66492259|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
23758038|NCT00388674|66492258|FG000|Initial Treatment|Never Treated with Study Medication|1|||
23758039|NCT00388674|66492259|FG001|Initial Treatment|Never Treated with Study Medication|7|||
23758040|NCT00388674|66492258|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
23758041|NCT00388674|66492259|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
23758042|NCT00388674|66492258|FG000|Initial Treatment|Not Defined|125|||
23758043|NCT00388674|66492259|FG001|Initial Treatment|Not Defined|172|||
23758044|NCT00388674|66492258|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
23758045|NCT00388674|66492259|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
23758046|NCT00388674|66492258|FG000|Initial Treatment|Pregnancy|26|||
23758047|NCT00388674|66492259|FG001|Initial Treatment|Pregnancy|16|||
23758048|NCT00388674|66492258|FG000|Initial Treatment|Study Drug Toxicity|5|||
23826592|NCT01569295|66745131|FG000|Overall Study|Non-Compliance with Study Drug|6|||
23826593|NCT01569295|66745132|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23826594|NCT01569295|66745131|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
23826595|NCT01569295|66745132|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
23826596|NCT01569295|66745131|FG000|Overall Study|Lost to Follow-up|1|||
23826597|NCT01569295|66745132|FG001|Overall Study|Lost to Follow-up|1|||
23826598|NCT01372748|66745133|FG000|Overall Study|Lost to Follow-up|16|||
23826599|NCT01372748|66745134|FG001|Overall Study|Lost to Follow-up|34|||
23758049|NCT00388674|66492259|FG001|Initial Treatment|Study Drug Toxicity|92|||
23758050|NCT00388674|66492258|FG000|Initial Treatment|Participant Request|501|||
23758051|NCT00388674|66492259|FG001|Initial Treatment|Participant Request|673|||
23758052|NCT00388674|66492258|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
23758053|NCT00388674|66492259|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
23758054|NCT00388674|66492258|FG000|Initial Treatment|Not Reported|10|||
23826600|NCT01372748|66745133|FG000|Overall Study|Withdrawal by Subject|7|||
23826601|NCT01372748|66745134|FG001|Overall Study|Withdrawal by Subject|5|||
23826602|NCT00879086|66745135|FG000|Overall Study|Adverse Event|3|||
23826603|NCT00879086|66745136|FG001|Overall Study|Adverse Event|15|||
23826604|NCT00879086|66745135|FG000|Overall Study|Participant choice|2|||
23826605|NCT00879086|66745136|FG001|Overall Study|Participant choice|2|||
23826606|NCT00879086|66745135|FG000|Overall Study|Progression of disease|40|||
23826607|NCT00879086|66745136|FG001|Overall Study|Progression of disease|26|||
23826608|NCT00879086|66745135|FG000|Overall Study|Withdrawal of consent|2|||
23826609|NCT00879086|66745136|FG001|Overall Study|Withdrawal of consent|1|||
23826610|NCT00879086|66745135|FG000|Overall Study|Other|4|||
23826611|NCT00879086|66745136|FG001|Overall Study|Other|6|||
23826612|NCT00879086|66745135|FG000|Overall Study|Death|1|||
23826613|NCT00879086|66745136|FG001|Overall Study|Death|2|||
23826614|NCT04981717|66745138|FG000|Overall Study|Protocol Violation|0|||
23826615|NCT04981717|66745139|FG001|Overall Study|Protocol Violation|3|||
23826616|NCT04981717|66745138|FG000|Overall Study|Adverse Event|1|||
23826617|NCT04981717|66745139|FG001|Overall Study|Adverse Event|3|||
23826618|NCT04981717|66745138|FG000|Overall Study|Pregnancy|1|||
23826619|NCT04981717|66745139|FG001|Overall Study|Pregnancy|0|||
23826620|NCT04981717|66745138|FG000|Overall Study|Physician Decision|1|||
23826621|NCT04981717|66745139|FG001|Overall Study|Physician Decision|0|||
23826622|NCT04981717|66745138|FG000|Overall Study|Sponsor Request|157|||
23826623|NCT04981717|66745139|FG001|Overall Study|Sponsor Request|172|||
23826624|NCT04981717|66745138|FG000|Overall Study|Lost to Follow-up|4|||
23826625|NCT04981717|66745139|FG001|Overall Study|Lost to Follow-up|5|||
23826626|NCT04981717|66745138|FG000|Overall Study|Withdrawal by Subject|50|||
23826627|NCT04981717|66745139|FG001|Overall Study|Withdrawal by Subject|37|||
23826628|NCT00709995|66745140|FG000|Overall Study|Adverse Event|4|||
23826629|NCT00709995|66745141|FG001|Overall Study|Adverse Event|2|||
23826630|NCT00709995|66745140|FG000|Overall Study|Withdrawal by Subject|1|||
23826631|NCT00709995|66745141|FG001|Overall Study|Withdrawal by Subject|3|||
23826632|NCT03993379|66745145|FG000|Overall Study|The study was terminated early due to business decision.|0|||
23826633|NCT03993379|66745146|FG001|Overall Study|The study was terminated early due to business decision.|2|||
23826634|NCT03993379|66745147|FG002|Overall Study|The study was terminated early due to business decision.|0|||
23826635|NCT03993379|66745148|FG003|Overall Study|The study was terminated early due to business decision.|0|||
23758055|NCT00388674|66492259|FG001|Initial Treatment|Not Reported|12|||
23758056|NCT00388674|66492258|FG000|End of Study|Administrative Reason By Sponsor|299|||
23758057|NCT00388674|66492259|FG001|End of Study|Administrative Reason By Sponsor|253|||
23758058|NCT00388674|66492258|FG000|End of Study|Death|239|||
23758059|NCT00388674|66492259|FG001|End of Study|Death|262|||
23758060|NCT00388674|66492258|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
23758061|NCT00388674|66492259|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
23758062|NCT00388674|66492258|FG000|End of Study|HCC|8|||
23758063|NCT00388674|66492259|FG001|End of Study|HCC|7|||
23758064|NCT00388674|66492258|FG000|End of Study|Lost to Follow-up|587|||
23758065|NCT00388674|66492259|FG001|End of Study|Lost to Follow-up|715|||
23826636|NCT03993379|66745145|FG000|Overall Study|Withdrawal by Subject|0|||
23826637|NCT03993379|66745146|FG001|Overall Study|Withdrawal by Subject|1|||
23826638|NCT03993379|66745147|FG002|Overall Study|Withdrawal by Subject|0|||
23440448|NCT03364309|65355268|FG011|Maintenance Period|Relapsed|0|||
23625568|NCT03616964|66015545|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
23625569|NCT03616964|66015546|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
23625570|NCT03616964|66015544|FG000|Overall Study|Protocol Violation|0|||
23625571|NCT03616964|66015545|FG001|Overall Study|Protocol Violation|1|||
23625572|NCT03616964|66015546|FG002|Overall Study|Protocol Violation|0|||
23625573|NCT03616964|66015544|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
23625574|NCT03616964|66015545|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
23625575|NCT03616964|66015546|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
23625576|NCT03616964|66015544|FG000|Overall Study|Randomized but Never Treated|1|||
23758066|NCT00388674|66492258|FG000|End of Study|Malignancy (Non-HCC)|1|||
23758067|NCT00388674|66492259|FG001|End of Study|Malignancy (Non-HCC)|1|||
23826639|NCT03993379|66745148|FG003|Overall Study|Withdrawal by Subject|0|||
23826640|NCT01443728|66745149|FG000|Overall Study|Lost to Follow-up|2|||
23826641|NCT01443728|66745150|FG001|Overall Study|Lost to Follow-up|0|||
23826642|NCT01443728|66745149|FG000|Overall Study|Withdrawal by Subject|1|||
23826643|NCT01443728|66745150|FG001|Overall Study|Withdrawal by Subject|1|||
23440449|NCT03364309|65355269|FG012|Maintenance Period|Relapsed|0|||
23826644|NCT01443728|66745149|FG000|Overall Study|Adverse Event|0|||
23826645|NCT01443728|66745150|FG001|Overall Study|Adverse Event|2|||
23758068|NCT00388674|66492258|FG000|End of Study|Non-Study Related Comorbidities|3|||
23758069|NCT00388674|66492259|FG001|End of Study|Non-Study Related Comorbidities|4|||
23826646|NCT01810302|66745151|FG000|Overall Study|Death|1|||
23826647|NCT01810302|66745152|FG001|Overall Study|Death|0|||
23440450|NCT03364309|65355270|FG013|Maintenance Period|Relapsed|0|||
23440451|NCT03364309|65355271|FG014|Maintenance Period|Relapsed|0|||
23440452|NCT03364309|65355272|FG015|Maintenance Period|Relapsed|0|||
23440453|NCT03364309|65355273|FG016|Maintenance Period|Relapsed|0|||
23440454|NCT03364309|65355274|FG017|Maintenance Period|Relapsed|0|||
23440455|NCT03364309|65355275|FG018|Maintenance Period|Relapsed|0|||
23440456|NCT03364309|65355257|FG000|Maintenance Period|Lack of Efficacy|0|||
23440457|NCT03364309|65355258|FG001|Maintenance Period|Lack of Efficacy|0|||
23440458|NCT03364309|65355259|FG002|Maintenance Period|Lack of Efficacy|0|||
23440459|NCT03364309|65355260|FG003|Maintenance Period|Lack of Efficacy|0|||
23440460|NCT03364309|65355261|FG004|Maintenance Period|Lack of Efficacy|0|||
23440461|NCT03364309|65355262|FG005|Maintenance Period|Lack of Efficacy|0|||
23440462|NCT03364309|65355263|FG006|Maintenance Period|Lack of Efficacy|0|||
23440463|NCT03364309|65355264|FG007|Maintenance Period|Lack of Efficacy|0|||
23440464|NCT03364309|65355265|FG008|Maintenance Period|Lack of Efficacy|1|||
23440465|NCT03364309|65355266|FG009|Maintenance Period|Lack of Efficacy|3|||
23440466|NCT03364309|65355267|FG010|Maintenance Period|Lack of Efficacy|2|||
23440467|NCT03364309|65355268|FG011|Maintenance Period|Lack of Efficacy|0|||
23440468|NCT03364309|65355269|FG012|Maintenance Period|Lack of Efficacy|0|||
23440469|NCT03364309|65355270|FG013|Maintenance Period|Lack of Efficacy|0|||
23440470|NCT03364309|65355271|FG014|Maintenance Period|Lack of Efficacy|0|||
23440471|NCT03364309|65355272|FG015|Maintenance Period|Lack of Efficacy|0|||
23440472|NCT03364309|65355273|FG016|Maintenance Period|Lack of Efficacy|0|||
23440473|NCT03364309|65355274|FG017|Maintenance Period|Lack of Efficacy|0|||
23440474|NCT03364309|65355275|FG018|Maintenance Period|Lack of Efficacy|0|||
23440475|NCT03364309|65355257|FG000|Maintenance Period|Death|0|||
23440476|NCT03364309|65355258|FG001|Maintenance Period|Death|0|||
23440477|NCT03364309|65355259|FG002|Maintenance Period|Death|0|||
23440478|NCT03364309|65355260|FG003|Maintenance Period|Death|0|||
23440479|NCT03364309|65355261|FG004|Maintenance Period|Death|0|||
23440480|NCT03364309|65355262|FG005|Maintenance Period|Death|0|||
23440481|NCT03364309|65355263|FG006|Maintenance Period|Death|0|||
23440482|NCT03364309|65355264|FG007|Maintenance Period|Death|0|||
23440483|NCT03364309|65355265|FG008|Maintenance Period|Death|1|||
23440484|NCT03364309|65355266|FG009|Maintenance Period|Death|0|||
23440485|NCT03364309|65355267|FG010|Maintenance Period|Death|0|||
23440486|NCT03364309|65355268|FG011|Maintenance Period|Death|0|||
23440487|NCT03364309|65355269|FG012|Maintenance Period|Death|0|||
23440488|NCT03364309|65355270|FG013|Maintenance Period|Death|0|||
23440489|NCT03364309|65355271|FG014|Maintenance Period|Death|0|||
23440490|NCT03364309|65355272|FG015|Maintenance Period|Death|0|||
23440491|NCT03364309|65355273|FG016|Maintenance Period|Death|0|||
23440492|NCT03364309|65355274|FG017|Maintenance Period|Death|0|||
23440493|NCT03364309|65355275|FG018|Maintenance Period|Death|0|||
23440494|NCT03364309|65355257|FG000|Maintenance Period|Lost to Follow-up|0|||
23440495|NCT03364309|65355258|FG001|Maintenance Period|Lost to Follow-up|0|||
23440496|NCT03364309|65355259|FG002|Maintenance Period|Lost to Follow-up|0|||
23440497|NCT03364309|65355260|FG003|Maintenance Period|Lost to Follow-up|0|||
23440498|NCT03364309|65355261|FG004|Maintenance Period|Lost to Follow-up|0|||
23440499|NCT03364309|65355262|FG005|Maintenance Period|Lost to Follow-up|0|||
23440500|NCT03364309|65355263|FG006|Maintenance Period|Lost to Follow-up|0|||
23440501|NCT03364309|65355264|FG007|Maintenance Period|Lost to Follow-up|0|||
23625577|NCT03616964|66015545|FG001|Overall Study|Randomized but Never Treated|1|||
23625578|NCT03616964|66015546|FG002|Overall Study|Randomized but Never Treated|1|||
23625579|NCT04333147|66015547|FG000|Overall Study|Adverse Event|43|||
23440502|NCT03364309|65355265|FG008|Maintenance Period|Lost to Follow-up|1|||
23440503|NCT03364309|65355266|FG009|Maintenance Period|Lost to Follow-up|0|||
23625580|NCT04333147|66015548|FG001|Overall Study|Adverse Event|40|||
23625581|NCT04333147|66015547|FG000|Overall Study|Lack of Efficacy|49|||
23625582|NCT04333147|66015548|FG001|Overall Study|Lack of Efficacy|48|||
23440504|NCT03364309|65355267|FG010|Maintenance Period|Lost to Follow-up|0|||
23440505|NCT03364309|65355268|FG011|Maintenance Period|Lost to Follow-up|0|||
23440506|NCT03364309|65355269|FG012|Maintenance Period|Lost to Follow-up|0|||
23440507|NCT03364309|65355270|FG013|Maintenance Period|Lost to Follow-up|0|||
23440508|NCT03364309|65355271|FG014|Maintenance Period|Lost to Follow-up|0|||
23440509|NCT03364309|65355272|FG015|Maintenance Period|Lost to Follow-up|0|||
23440510|NCT03364309|65355273|FG016|Maintenance Period|Lost to Follow-up|0|||
23440511|NCT03364309|65355274|FG017|Maintenance Period|Lost to Follow-up|0|||
23440512|NCT03364309|65355275|FG018|Maintenance Period|Lost to Follow-up|0|||
23440513|NCT03364309|65355257|FG000|Maintenance Period|Miscellaneous|0|||
23625583|NCT04333147|66015547|FG000|Overall Study|Lost to Follow-up|19|||
23562973|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562974|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562975|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562976|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562977|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562978|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
23562979|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Death|0|||
23562980|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Death|4|||
23562981|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Death|2|||
23562982|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Death|4|||
23562983|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Death|3|||
23562984|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Death|0|||
23562985|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Death|0|||
23562986|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Death|1|||
23562987|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Death|111|||
23562988|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562989|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562990|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562991|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562992|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562993|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562994|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562995|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562996|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
23562997|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23562998|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23562999|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563000|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563001|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563002|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23758070|NCT00388674|66492258|FG000|End of Study|Not Defined|135|||
23758071|NCT00388674|66492259|FG001|End of Study|Not Defined|214|||
23758072|NCT00388674|66492258|FG000|End of Study|Participant Withdrew Consent|437|||
23758073|NCT00388674|66492259|FG001|End of Study|Participant Withdrew Consent|673|||
23758074|NCT00388674|66492258|FG000|End of Study|No Off-Treatment Status Data|22|||
23563003|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563004|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563005|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
23563006|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563007|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563008|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
23563009|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563010|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
23563011|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
23625584|NCT04333147|66015548|FG001|Overall Study|Lost to Follow-up|16|||
23625585|NCT04333147|66015547|FG000|Overall Study|Physician Decision|17|||
23625586|NCT04333147|66015548|FG001|Overall Study|Physician Decision|20|||
23625587|NCT04333147|66015547|FG000|Overall Study|Withdrawal by Subject|65|||
23625588|NCT04333147|66015548|FG001|Overall Study|Withdrawal by Subject|68|||
23625589|NCT04333147|66015547|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
23625590|NCT04333147|66015548|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
23625591|NCT04333147|66015547|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
23625592|NCT04333147|66015548|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
23563012|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563013|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563014|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
23563015|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563016|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563017|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563018|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563019|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563020|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563021|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563022|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23625593|NCT04333147|66015547|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
23625594|NCT04333147|66015548|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
23625595|NCT01093599|66015549|FG000|Overall Study|Lost to Follow-up|32|||
23625596|NCT01093599|66015550|FG001|Overall Study|Lost to Follow-up|46|||
23758075|NCT00388674|66492259|FG001|End of Study|No Off-Treatment Status Data|30|||
23758076|NCT00388674|66492258|FG000|End of Study|Not Reported|0|||
23563023|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
23563024|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563025|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563026|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563027|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563028|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563029|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
23625597|NCT01728623|66015551|FG000|Overall Study|Disease progression|26|||
23625598|NCT01728623|66015551|FG000|Overall Study|Adverse Event|1|||
23625599|NCT01728623|66015551|FG000|Overall Study|Withdrawal by Subject|1|||
23758077|NCT00388674|66492259|FG001|End of Study|Not Reported|1|||
23563030|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
23563031|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563032|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
23563033|NCT03391765|65790400|FG000|Overall Study|Adverse Event|2|||
23563034|NCT03391765|65790401|FG001|Overall Study|Adverse Event|0|||
23563035|NCT03391765|65790402|FG002|Overall Study|Adverse Event|0|||
23563036|NCT03391765|65790403|FG003|Overall Study|Adverse Event|2|||
23563037|NCT03391765|65790400|FG000|Overall Study|Withdrew consent|5|||
23563038|NCT03391765|65790401|FG001|Overall Study|Withdrew consent|7|||
23563039|NCT03391765|65790402|FG002|Overall Study|Withdrew consent|2|||
23563040|NCT03391765|65790403|FG003|Overall Study|Withdrew consent|5|||
23563041|NCT03391765|65790400|FG000|Overall Study|Other, not specified|44|||
23563042|NCT03391765|65790401|FG001|Overall Study|Other, not specified|38|||
23563043|NCT03391765|65790402|FG002|Overall Study|Other, not specified|21|||
23563044|NCT03391765|65790403|FG003|Overall Study|Other, not specified|16|||
23563045|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
23563046|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
23563047|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23563048|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
23563049|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
23563050|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
23563051|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
23563052|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
23563053|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
23563054|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
23563055|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
23563056|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
23563057|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
23563058|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
23563059|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
23563060|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
23563061|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
23563062|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
23758078|NCT00619619|66492260|FG000|Overall Study|Physician Decision|0|||
23758079|NCT00619619|66492261|FG001|Overall Study|Physician Decision|0|||
23758080|NCT00619619|66492262|FG002|Overall Study|Physician Decision|1|||
23758081|NCT00619619|66492263|FG003|Overall Study|Physician Decision|0|||
23758082|NCT00619619|66492264|FG004|Overall Study|Physician Decision|0|||
23758083|NCT00619619|66492265|FG005|Overall Study|Physician Decision|0|||
23758084|NCT00619619|66492266|FG006|Overall Study|Physician Decision|0|||
23758085|NCT00619619|66492267|FG007|Overall Study|Physician Decision|0|||
23758086|NCT00619619|66492260|FG000|Overall Study|Protocol Violation|0|||
23758087|NCT00619619|66492261|FG001|Overall Study|Protocol Violation|0|||
23758088|NCT00619619|66492262|FG002|Overall Study|Protocol Violation|0|||
23758089|NCT00619619|66492263|FG003|Overall Study|Protocol Violation|1|||
23758090|NCT00619619|66492264|FG004|Overall Study|Protocol Violation|0|||
23758091|NCT00619619|66492265|FG005|Overall Study|Protocol Violation|0|||
23758092|NCT00619619|66492266|FG006|Overall Study|Protocol Violation|1|||
23758093|NCT00619619|66492267|FG007|Overall Study|Protocol Violation|1|||
23758094|NCT00619619|66492260|FG000|Overall Study|Adverse Event|0|||
23758095|NCT00619619|66492261|FG001|Overall Study|Adverse Event|0|||
23758096|NCT00619619|66492262|FG002|Overall Study|Adverse Event|0|||
23758097|NCT00619619|66492263|FG003|Overall Study|Adverse Event|0|||
23758098|NCT00619619|66492264|FG004|Overall Study|Adverse Event|2|||
23758099|NCT00619619|66492265|FG005|Overall Study|Adverse Event|0|||
23758100|NCT00619619|66492266|FG006|Overall Study|Adverse Event|0|||
23563063|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
23563064|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
23563065|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
23563066|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
23758101|NCT00619619|66492267|FG007|Overall Study|Adverse Event|2|||
23758102|NCT01355523|66492268|FG000|Overall Study|Withdrawal by Subject|1|||
23758103|NCT01355523|66492269|FG001|Overall Study|Withdrawal by Subject|4|||
23758104|NCT01355523|66492268|FG000|Overall Study|Lost to Follow-up|0|||
23625600|NCT03277352|66015552|FG000|Overall Study|Study Terminated By Sponsor|2|||
23625601|NCT03277352|66015552|FG000|Overall Study|Withdrawal by Subject|4|||
23625602|NCT03277352|66015552|FG000|Overall Study|Death|4|||
23625603|NCT01918371|66015553|FG000|Overall Study|Missing Data|1|||
23625604|NCT01918371|66015554|FG001|Overall Study|Missing Data|1|||
23625605|NCT03470545|66015555|FG000|Overall Study|Death|0|||
23625606|NCT03470545|66015556|FG001|Overall Study|Death|1|||
23625607|NCT03470545|66015555|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
23625608|NCT03470545|66015556|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
23625609|NCT03470545|66015555|FG000|Overall Study|Adverse Event|2|||
23625610|NCT03470545|66015556|FG001|Overall Study|Adverse Event|0|||
23625611|NCT03470545|66015555|FG000|Overall Study|Withdrawal by Subject|1|||
23625612|NCT03470545|66015556|FG001|Overall Study|Withdrawal by Subject|1|||
23625613|NCT03470545|66015555|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
23625614|NCT03470545|66015556|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
23625615|NCT02725528|66015557|FG000|Overall Study|Lost to Follow-up|1|||
23625616|NCT02725528|66015558|FG001|Overall Study|Lost to Follow-up|4|||
23625617|NCT02725528|66015557|FG000|Overall Study|Withdrawal by Subject|0|||
23625618|NCT02725528|66015558|FG001|Overall Study|Withdrawal by Subject|1|||
23625619|NCT02575950|66015559|FG000|Overall Study|Withdrawal by Subject|0|||
23625620|NCT02575950|66015560|FG001|Overall Study|Withdrawal by Subject|0|||
23625621|NCT02575950|66015561|FG002|Overall Study|Withdrawal by Subject|0|||
23625622|NCT02575950|66015562|FG003|Overall Study|Withdrawal by Subject|2|||
23625623|NCT02575950|66015559|FG000|Overall Study|Lost to Follow-up|0|||
23625624|NCT02575950|66015560|FG001|Overall Study|Lost to Follow-up|1|||
23625625|NCT02575950|66015561|FG002|Overall Study|Lost to Follow-up|0|||
23625626|NCT02575950|66015562|FG003|Overall Study|Lost to Follow-up|3|||
23625627|NCT01263054|66015577|FG000|Overall Study|Death|1|||
23625628|NCT01263054|66015578|FG001|Overall Study|Death|0|||
23625629|NCT01263054|66015577|FG000|Overall Study|Lost to Follow-up|2|||
23625630|NCT01263054|66015578|FG001|Overall Study|Lost to Follow-up|2|||
23625631|NCT01263054|66015577|FG000|Overall Study|Withdrawal by Subject|1|||
23625632|NCT01263054|66015578|FG001|Overall Study|Withdrawal by Subject|3|||
23625633|NCT01263054|66015577|FG000|Overall Study|Qualification Violation|1|||
23625634|NCT01263054|66015578|FG001|Overall Study|Qualification Violation|0|||
23625635|NCT01263054|66015577|FG000|Overall Study|Other|0|||
23625636|NCT01263054|66015578|FG001|Overall Study|Other|1|||
23625637|NCT03636373|66015581|FG000|Overall Study|Study closure due to Covid-19|1|||
23625638|NCT03636373|66015582|FG001|Overall Study|Study closure due to Covid-19|0|||
23625639|NCT01017263|66015583|FG000|Overall Study|not eligible|12|||
23625640|NCT00025506|66015584|FG000|Overall Study|Ineligible: clerical error|1|||
23625641|NCT00025506|66015584|FG000|Overall Study|Ineligible: wrong cell type|5|||
23625642|NCT00025506|66015584|FG000|Overall Study|Ineligible: inadequate pathology|2|||
23625643|NCT00025506|66015584|FG000|Overall Study|Never Treated|2|||
23625644|NCT00307164|66015589|FG000|Overall Study|Death|1|||
23625645|NCT00307164|66015590|FG001|Overall Study|Death|0|||
23625646|NCT00307164|66015589|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23625647|NCT00307164|66015590|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23625648|NCT00307164|66015589|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
23625649|NCT00307164|66015590|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
23625650|NCT00307164|66015589|FG000|Overall Study|Withdrawal by Subject|1|||
23625651|NCT00307164|66015590|FG001|Overall Study|Withdrawal by Subject|8|||
23625652|NCT00307164|66015589|FG000|Overall Study|Not compliant with requirements|4|||
23625653|NCT00307164|66015590|FG001|Overall Study|Not compliant with requirements|4|||
23625654|NCT00307164|66015589|FG000|Overall Study|Lost to Follow-up|6|||
23758105|NCT01355523|66492269|FG001|Overall Study|Lost to Follow-up|2|||
23758106|NCT01355523|66492268|FG000|Overall Study|Protocol Violation|0|||
23758107|NCT01355523|66492269|FG001|Overall Study|Protocol Violation|2|||
23758108|NCT01355523|66492268|FG000|Overall Study|Adverse Event|0|||
23758109|NCT01355523|66492269|FG001|Overall Study|Adverse Event|2|||
23758110|NCT01463683|66492270|FG000|Overall Study|Adverse Event|2|||
23758111|NCT01463683|66492271|FG001|Overall Study|Adverse Event|0|||
23758112|NCT01463683|66492272|FG002|Overall Study|Adverse Event|0|||
23758113|NCT01463683|66492270|FG000|Overall Study|Lost to Follow-up|10|||
23758114|NCT01463683|66492271|FG001|Overall Study|Lost to Follow-up|9|||
23758115|NCT01463683|66492272|FG002|Overall Study|Lost to Follow-up|7|||
23625655|NCT00307164|66015590|FG001|Overall Study|Lost to Follow-up|1|||
23625656|NCT00827775|66015592|FG000|Overall Study|Withdrawal by Subject|0|||
23625657|NCT00827775|66015593|FG001|Overall Study|Withdrawal by Subject|5|||
23758116|NCT01463683|66492270|FG000|Overall Study|Physician Decision|0|||
23758117|NCT01463683|66492271|FG001|Overall Study|Physician Decision|3|||
23758118|NCT01463683|66492272|FG002|Overall Study|Physician Decision|1|||
23625658|NCT01772563|66015594|FG000|Cycle 1|Dose limiting toxicity|2|||
23625659|NCT01772563|66015594|FG000|Cycle 1|Progressive disease|2|||
23625660|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Progressive disease|17|||
23758119|NCT01463683|66492270|FG000|Overall Study|Pregnancy|2|||
23625661|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
23625662|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
23625663|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
23625664|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
23625665|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
23625666|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
23625667|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
23563067|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
23563068|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
23563069|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
23563070|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
23563071|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
23563072|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
23563073|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
23563074|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
23563075|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
23563076|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
23563077|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
23563078|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
23563079|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
23563080|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
23563081|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
23563082|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
23563083|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
23563084|NCT00365378|65790406|FG000|Extension|Adverse Event|0|||
23563085|NCT00365378|65790407|FG001|Extension|Adverse Event|0|||
23563086|NCT00365378|65790408|FG002|Extension|Adverse Event|1|||
23563087|NCT00365378|65790406|FG000|Extension|Moved|0|||
23563088|NCT00365378|65790407|FG001|Extension|Moved|0|||
23563089|NCT00365378|65790408|FG002|Extension|Moved|8|||
23563090|NCT00365378|65790406|FG000|Extension|Lost to Follow-up|0|||
23563091|NCT00365378|65790407|FG001|Extension|Lost to Follow-up|0|||
23563092|NCT00365378|65790408|FG002|Extension|Lost to Follow-up|57|||
23563093|NCT00365378|65790406|FG000|Extension|Protocol Violation|0|||
23563094|NCT00365378|65790407|FG001|Extension|Protocol Violation|0|||
23563095|NCT00365378|65790408|FG002|Extension|Protocol Violation|2|||
23563096|NCT00365378|65790406|FG000|Extension|Withdrawal by Subject|0|||
23563097|NCT00365378|65790407|FG001|Extension|Withdrawal by Subject|0|||
23563098|NCT00365378|65790408|FG002|Extension|Withdrawal by Subject|98|||
23563099|NCT00365378|65790406|FG000|Extension|Other|0|||
23563100|NCT00365378|65790407|FG001|Extension|Other|0|||
23563101|NCT00365378|65790408|FG002|Extension|Other|31|||
23563102|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
23563103|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
23758120|NCT01463683|66492271|FG001|Overall Study|Pregnancy|2|||
23758121|NCT01463683|66492272|FG002|Overall Study|Pregnancy|1|||
23758122|NCT01463683|66492270|FG000|Overall Study|Withdrawal by Subject|5|||
23758123|NCT01463683|66492271|FG001|Overall Study|Withdrawal by Subject|17|||
23758124|NCT01463683|66492272|FG002|Overall Study|Withdrawal by Subject|2|||
23758125|NCT01190098|66492273|FG000|Overall Study|Adverse Event|2|||
23758126|NCT01190098|66492274|FG001|Overall Study|Adverse Event|0|||
23758127|NCT01190098|66492273|FG000|Overall Study|Patient coomorbidity|0|||
23758128|NCT01190098|66492274|FG001|Overall Study|Patient coomorbidity|1|||
23758129|NCT01190098|66492273|FG000|Overall Study|Lack of transportation|1|||
23758130|NCT01190098|66492274|FG001|Overall Study|Lack of transportation|0|||
23758131|NCT01190098|66492273|FG000|Overall Study|Other|0|||
23758132|NCT01190098|66492274|FG001|Overall Study|Other|1|||
23758133|NCT01829295|66492277|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
23758134|NCT01829295|66492278|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
23758135|NCT01829295|66492279|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
23758136|NCT01829295|66492280|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
23758137|NCT01829295|66492277|FG000|6-12 Months|Adverse Event|0|||
23758138|NCT01829295|66492278|FG001|6-12 Months|Adverse Event|0|||
23758139|NCT01829295|66492279|FG002|6-12 Months|Adverse Event|3|||
23758140|NCT01829295|66492280|FG003|6-12 Months|Adverse Event|2|||
23758141|NCT01829295|66492277|FG000|6-12 Months|Lost to Follow-up|2|||
23758142|NCT01829295|66492278|FG001|6-12 Months|Lost to Follow-up|0|||
23758143|NCT01829295|66492279|FG002|6-12 Months|Lost to Follow-up|0|||
23758144|NCT01829295|66492280|FG003|6-12 Months|Lost to Follow-up|0|||
23758145|NCT01829295|66492277|FG000|6-12 Months|Withdrawal by Subject|2|||
23758146|NCT01829295|66492278|FG001|6-12 Months|Withdrawal by Subject|2|||
23758147|NCT01829295|66492279|FG002|6-12 Months|Withdrawal by Subject|0|||
23758148|NCT01829295|66492280|FG003|6-12 Months|Withdrawal by Subject|0|||
23758149|NCT00886782|66492281|FG000|Overall Study|Disease progression|3|||
23758150|NCT00886782|66492282|FG001|Overall Study|Disease progression|3|||
23758151|NCT00886782|66492283|FG002|Overall Study|Disease progression|3|||
23758152|NCT00886782|66492281|FG000|Overall Study|Study drug toxicity|0|||
23758153|NCT00886782|66492282|FG001|Overall Study|Study drug toxicity|0|||
23758154|NCT00886782|66492283|FG002|Overall Study|Study drug toxicity|1|||
23758155|NCT00886782|66492281|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
23758156|NCT00886782|66492282|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
23758157|NCT00886782|66492283|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
23758158|NCT05003167|66492284|FG000|Overall Study|Withdrawal by Subject|1|||
23826648|NCT01810302|66745151|FG000|Overall Study|Physician Decision|0|||
23758159|NCT01488071|66492285|FG000|Overall Study|Adverse Event|15|||
23758160|NCT01488071|66492286|FG001|Overall Study|Adverse Event|23|||
23625668|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
23625669|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
23625670|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
23625671|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
23625672|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
23625673|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
23625674|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
23625675|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
23625676|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
23625677|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
23625678|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
23625679|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
23625680|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
23625681|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
23625682|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
23625683|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
23625684|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
23625685|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
23625686|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
23625687|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
23625688|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
23625689|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
23625690|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
23625691|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
23758161|NCT01488071|66492285|FG000|Overall Study|Lack of Efficacy|11|||
23758162|NCT01488071|66492286|FG001|Overall Study|Lack of Efficacy|17|||
23758163|NCT01488071|66492285|FG000|Overall Study|Non-compliance with study drug|2|||
23758164|NCT01488071|66492286|FG001|Overall Study|Non-compliance with study drug|0|||
23758165|NCT01488071|66492285|FG000|Overall Study|Protocol Violation|5|||
23563104|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
23563105|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563106|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563107|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563108|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
23563109|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Physician Decision|4|||
23563110|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Physician Decision|1|||
23563111|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Physician Decision|3|||
23563112|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Physician Decision|0|||
23563113|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Physician Decision|0|||
23563114|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Physician Decision|1|||
23563115|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Physician Decision|0|||
23563116|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Other|0|||
23563117|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Other|1|||
23563118|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Other|0|||
23563119|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Other|0|||
23563120|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Other|0|||
23563121|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Other|0|||
23563122|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Other|0|||
23563123|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563124|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563125|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563126|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563127|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563128|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563129|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
23563130|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
23563131|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
23563132|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
23563133|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
23563134|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
23563135|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
23563136|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
23563137|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Pregnancy|0|||
23563138|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Pregnancy|0|||
23563139|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Pregnancy|1|||
23563140|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Pregnancy|0|||
23563141|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Pregnancy|0|||
23758166|NCT01488071|66492286|FG001|Overall Study|Protocol Violation|7|||
23758167|NCT01488071|66492285|FG000|Overall Study|Withdrawal of Consent|14|||
23440514|NCT03364309|65355258|FG001|Maintenance Period|Miscellaneous|0|||
23625692|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
23625693|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
23625694|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
23625695|NCT00412880|66015597|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
23625696|NCT00412880|66015597|FG000|Overall Study|Consent withdrawn|1|||
23625697|NCT00412880|66015597|FG000|Overall Study|Adverse Event|1|||
23625698|NCT00412880|66015597|FG000|Overall Study|Progressive disease|20|||
23625699|NCT02485899|66015598|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
23625700|NCT02485899|66015599|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23625701|NCT02485899|66015598|FG000|Overall Study|Withdrawal by Subject|1|||
23625702|NCT02485899|66015599|FG001|Overall Study|Withdrawal by Subject|0|||
23625703|NCT02485899|66015598|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
23625704|NCT02485899|66015599|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
23625705|NCT04035577|66015601|FG000|Overall Study|Lost to Follow-up|1|||
23625706|NCT04035577|66015601|FG000|Overall Study|Withdrawal by Subject|1|||
23625707|NCT00639769|66015606|FG000|Overall Study|Death|2|||
23625708|NCT00639769|66015606|FG000|Overall Study|Adverse Event|7|||
23625709|NCT00639769|66015606|FG000|Overall Study|Lack of Efficacy|1|||
23625710|NCT00639769|66015606|FG000|Overall Study|Disease progression|26|||
23625711|NCT00639769|66015606|FG000|Overall Study|Withdrawal by Subject|4|||
23625712|NCT01006616|66015607|FG000|Period 1 (6 Months)|Adverse Event|10|||
23625713|NCT01006616|66015608|FG001|Period 1 (6 Months)|Adverse Event|31|||
23625714|NCT01006616|66015609|FG002|Period 1 (6 Months)|Adverse Event|37|||
23625715|NCT01006616|66015610|FG003|Period 1 (6 Months)|Adverse Event|9|||
23625716|NCT01006616|66015607|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
23625717|NCT01006616|66015608|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
23625718|NCT01006616|66015609|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
23625719|NCT01006616|66015610|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
23625720|NCT01006616|66015607|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
23625721|NCT01006616|66015608|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
23826649|NCT01810302|66745152|FG001|Overall Study|Physician Decision|1|||
23826650|NCT00625820|66745153|FG000|Overall Study|Withdrawal by Subject|1|||
23826651|NCT03452943|66745158|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
23826652|NCT03452943|66745159|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
23826653|NCT03452943|66745158|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
23826654|NCT03452943|66745159|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
23826655|NCT03452943|66745158|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
23826656|NCT03452943|66745159|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
23440515|NCT03364309|65355259|FG002|Maintenance Period|Miscellaneous|0|||
23625722|NCT01006616|66015609|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
23440516|NCT03364309|65355260|FG003|Maintenance Period|Miscellaneous|0|||
23625723|NCT01006616|66015610|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
23625724|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
23625725|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
23625726|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
23826657|NCT03452943|66745158|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
23826658|NCT03452943|66745159|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
23826659|NCT03452943|66745158|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
23826660|NCT03452943|66745159|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
23826661|NCT03452943|66745158|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
23826662|NCT03452943|66745159|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
23826663|NCT01564537|66745160|FG000|Overall Study|Site Terminated by Sponsor|1|||
23826664|NCT01564537|66745161|FG001|Overall Study|Site Terminated by Sponsor|0|||
23826665|NCT01564537|66745160|FG000|Overall Study|Withdrawal by Subject|12|||
23826666|NCT01564537|66745161|FG001|Overall Study|Withdrawal by Subject|14|||
23826667|NCT01564537|66745160|FG000|Overall Study|Lost to Follow-up|7|||
23826668|NCT01564537|66745161|FG001|Overall Study|Lost to Follow-up|3|||
23826669|NCT01564537|66745160|FG000|Overall Study|Reason not specified|81|||
23563142|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Pregnancy|0|||
23563143|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Pregnancy|0|||
23758168|NCT01488071|66492286|FG001|Overall Study|Withdrawal of Consent|12|||
23563144|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563145|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563146|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
23563147|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563148|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563149|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563150|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563151|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563152|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23563153|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563154|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23758169|NCT01488071|66492285|FG000|Overall Study|Lost to Follow-up|1|||
23758170|NCT01488071|66492286|FG001|Overall Study|Lost to Follow-up|0|||
23758171|NCT01488071|66492285|FG000|Overall Study|Administrative or Other Reason(s)|5|||
23758172|NCT01488071|66492286|FG001|Overall Study|Administrative or Other Reason(s)|4|||
23563155|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23563156|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563157|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23758173|NCT03836729|66492287|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
23758174|NCT03707522|66492288|FG000|Overall Study|Lost to Follow-up|24|||
23758175|NCT03707522|66492289|FG001|Overall Study|Lost to Follow-up|27|||
23758176|NCT03707522|66492290|FG002|Overall Study|Lost to Follow-up|41|||
23758177|NCT03707522|66492291|FG003|Overall Study|Lost to Follow-up|36|||
23758178|NCT01408576|66492294|FG000|Overall Study|Lack of Efficacy|17|||
23826670|NCT01564537|66745161|FG001|Overall Study|Reason not specified|82|||
23826671|NCT00246324|66745163|FG000|Overall Study|Withdrawal by Subject|1|||
23826672|NCT03154125|66745164|FG000|Overall Study|Lost to Follow-up|11|||
23826673|NCT03154125|66745165|FG001|Overall Study|Lost to Follow-up|11|||
23563158|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Other|0|||
23563159|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Other|1|||
23758179|NCT01408576|66492295|FG001|Overall Study|Lack of Efficacy|30|||
23563160|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Other|0|||
23758180|NCT01408576|66492296|FG002|Overall Study|Lack of Efficacy|48|||
23758181|NCT01408576|66492294|FG000|Overall Study|Protocol Violation|1|||
23826674|NCT03154125|66745166|FG002|Overall Study|Lost to Follow-up|0|||
23563161|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Other|0|||
23563162|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Other|0|||
23563163|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Other|0|||
23563164|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Other|0|||
23563165|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
23563166|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563167|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
23563168|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563169|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563170|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563171|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563172|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563173|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
23563174|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563175|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
23563176|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563177|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23625727|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625728|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
23625729|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
23758182|NCT01408576|66492295|FG001|Overall Study|Protocol Violation|2|||
23758183|NCT01408576|66492296|FG002|Overall Study|Protocol Violation|2|||
23758184|NCT01408576|66492294|FG000|Overall Study|Lost to Follow-up|10|||
23758185|NCT01408576|66492295|FG001|Overall Study|Lost to Follow-up|9|||
23758186|NCT01408576|66492296|FG002|Overall Study|Lost to Follow-up|17|||
23758187|NCT01408576|66492294|FG000|Overall Study|Withdrawal by Subject|34|||
23758188|NCT01408576|66492295|FG001|Overall Study|Withdrawal by Subject|60|||
23758189|NCT01408576|66492296|FG002|Overall Study|Withdrawal by Subject|66|||
23826675|NCT03154125|66745164|FG000|Overall Study|Withdrawal by Subject|49|||
23826676|NCT03154125|66745165|FG001|Overall Study|Withdrawal by Subject|55|||
23826677|NCT03154125|66745166|FG002|Overall Study|Withdrawal by Subject|8|||
23826678|NCT03154125|66745164|FG000|Overall Study|Physician Decision|13|||
23826679|NCT03154125|66745165|FG001|Overall Study|Physician Decision|6|||
23826680|NCT03154125|66745166|FG002|Overall Study|Physician Decision|0|||
23826681|NCT03154125|66745164|FG000|Overall Study|Protocol Violation|3|||
23826682|NCT03154125|66745165|FG001|Overall Study|Protocol Violation|5|||
23826683|NCT03154125|66745166|FG002|Overall Study|Protocol Violation|0|||
23826684|NCT02126826|66745167|FG000|Overall Study|Withdrawal by Subject|0|||
23826685|NCT02126826|66745168|FG001|Overall Study|Withdrawal by Subject|0|||
23826686|NCT02126826|66745169|FG002|Overall Study|Withdrawal by Subject|0|||
23563178|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
23563179|NCT04244396|65790416|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
23625730|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
23625731|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
23625732|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625733|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625734|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625735|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
23625736|NCT01006616|66015607|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625737|NCT01006616|66015608|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
23625738|NCT01006616|66015609|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625739|NCT01006616|66015610|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625740|NCT01006616|66015607|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
23625741|NCT01006616|66015608|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
23625742|NCT01006616|66015609|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
23758190|NCT01408576|66492294|FG000|Overall Study|Sponsor terminated study|89|||
23758191|NCT01408576|66492295|FG001|Overall Study|Sponsor terminated study|333|||
23563180|NCT04244396|65790416|FG000|Overall Study|Withdrawal by Subject|2|||
23758192|NCT01408576|66492296|FG002|Overall Study|Sponsor terminated study|330|||
23826687|NCT02126826|66745170|FG003|Overall Study|Withdrawal by Subject|1|||
23826688|NCT02126826|66745171|FG004|Overall Study|Withdrawal by Subject|0|||
23563181|NCT04244396|65790416|FG000|Overall Study|Study termination|37|||
23563182|NCT03066622|65790423|FG000|Overall Study|Lost to Follow-up|24|||
23758193|NCT01408576|66492294|FG000|Overall Study|AE, serious fatal|4|||
23826689|NCT02126826|66745172|FG005|Overall Study|Withdrawal by Subject|0|||
23826690|NCT02126826|66745173|FG006|Overall Study|Withdrawal by Subject|0|||
23563183|NCT03066622|65790424|FG001|Overall Study|Lost to Follow-up|25|||
23563184|NCT03066622|65790423|FG000|Overall Study|Withdrawal by Subject|2|||
23625743|NCT01006616|66015610|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
23625744|NCT01006616|66015607|FG000|Period 1 (6 Months)|Not Treated|0|||
23625745|NCT01006616|66015608|FG001|Period 1 (6 Months)|Not Treated|0|||
23625746|NCT01006616|66015609|FG002|Period 1 (6 Months)|Not Treated|1|||
23625747|NCT01006616|66015610|FG003|Period 1 (6 Months)|Not Treated|1|||
23625748|NCT01006616|66015607|FG000|Period 2 (18 Months)|Adverse Event|6|||
23625749|NCT01006616|66015608|FG001|Period 2 (18 Months)|Adverse Event|6|||
23625750|NCT01006616|66015609|FG002|Period 2 (18 Months)|Adverse Event|6|||
23625751|NCT01006616|66015610|FG003|Period 2 (18 Months)|Adverse Event|4|||
23625752|NCT01006616|66015607|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
23625753|NCT01006616|66015608|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
23625754|NCT01006616|66015609|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
23625755|NCT01006616|66015610|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
23625756|NCT01006616|66015607|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
23625757|NCT01006616|66015608|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
23625758|NCT01006616|66015609|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
23625759|NCT01006616|66015610|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
23625760|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625761|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
23625762|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625763|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
23625764|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
23625765|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
23625766|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
23625767|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
23625768|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
23758194|NCT01408576|66492295|FG001|Overall Study|AE, serious fatal|4|||
23758195|NCT01408576|66492296|FG002|Overall Study|AE, serious fatal|1|||
23758196|NCT01408576|66492294|FG000|Overall Study|SAE, non-fatal|11|||
23758197|NCT01408576|66492295|FG001|Overall Study|SAE, non-fatal|23|||
23758198|NCT01408576|66492296|FG002|Overall Study|SAE, non-fatal|14|||
23758199|NCT01408576|66492294|FG000|Overall Study|AE, non-serious non-fatal|12|||
23758200|NCT01408576|66492295|FG001|Overall Study|AE, non-serious non-fatal|19|||
23758201|NCT01408576|66492296|FG002|Overall Study|AE, non-serious non-fatal|11|||
23758202|NCT01408576|66492294|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23758203|NCT01408576|66492295|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23758204|NCT01408576|66492296|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23758205|NCT01408576|66492294|FG000|Overall Study|AE, unknown type|0|||
23758206|NCT01408576|66492295|FG001|Overall Study|AE, unknown type|1|||
23758207|NCT01408576|66492296|FG002|Overall Study|AE, unknown type|0|||
23758208|NCT01408576|66492294|FG000|Overall Study|Other|10|||
23758209|NCT01408576|66492295|FG001|Overall Study|Other|16|||
23758210|NCT01408576|66492296|FG002|Overall Study|Other|18|||
23758211|NCT00964223|66492305|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
23758212|NCT01458119|66492306|FG000|Overall Study|Physician Decision|4|||
23758213|NCT01458119|66492306|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
23758214|NCT01458119|66492306|FG000|Overall Study|Pregnancy|1|||
23758215|NCT01458119|66492306|FG000|Overall Study|Death|2|||
23758216|NCT01458119|66492306|FG000|Overall Study|Adverse Event|1|||
23758217|NCT01458119|66492306|FG000|Overall Study|Consent Withdrawn by Participant|8|||
23758218|NCT01458119|66492306|FG000|Overall Study|Non-compliance With Study Drug|3|||
23758219|NCT01401478|66492309|FG000|Overall Study|Study drug not available|6|||
23758220|NCT01401478|66492309|FG000|Overall Study|Adverse Event|5|||
23758221|NCT01401478|66492309|FG000|Overall Study|Hyperphosphatemia|5|||
23758222|NCT01401478|66492309|FG000|Overall Study|Lost to Follow-up|5|||
23758223|NCT01401478|66492309|FG000|Overall Study|Kidney transplantation|3|||
23758224|NCT01401478|66492309|FG000|Overall Study|Withdrawal by Subject|3|||
23758225|NCT01401478|66492309|FG000|Overall Study|Blood samples not available|1|||
23758226|NCT01401478|66492309|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
23758227|NCT01401478|66492309|FG000|Overall Study|Low intact parathyroid hormone|1|||
23758228|NCT01401478|66492309|FG000|Overall Study|Serious adverse event|1|||
23758229|NCT02236754|66492310|FG000|Overall Study|Withdrawal by Subject|1|||
23758230|NCT02236754|66492311|FG001|Overall Study|Withdrawal by Subject|0|||
23758231|NCT00051636|66492312|FG000|Period 1 - Core|Adverse Event|2|||
23758232|NCT00051636|66492313|FG001|Period 1 - Core|Adverse Event|2|||
23758233|NCT00051636|66492312|FG000|Period 1 - Core|Protocol Violation|1|||
23758234|NCT00051636|66492313|FG001|Period 1 - Core|Protocol Violation|0|||
23758235|NCT00051636|66492312|FG000|Period 1 - Core|Withdrawal by Subject|1|||
23758236|NCT00051636|66492313|FG001|Period 1 - Core|Withdrawal by Subject|2|||
23758237|NCT00051636|66492312|FG000|Period 1 - Core|Lost to Follow-up|0|||
23758238|NCT00051636|66492313|FG001|Period 1 - Core|Lost to Follow-up|2|||
23758239|NCT00051636|66492312|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
23758240|NCT00051636|66492313|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
23758241|NCT00051636|66492312|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
23758242|NCT00051636|66492313|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
23758243|NCT00051636|66492312|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
23758244|NCT00051636|66492313|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
23758245|NCT00051636|66492312|FG000|Period 2- Extended Observation Period|Death|4|||
23758246|NCT00051636|66492313|FG001|Period 2- Extended Observation Period|Death|5|||
23758247|NCT00051636|66492312|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
23758248|NCT00051636|66492313|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
23758249|NCT00681824|66492314|FG000|Overall Study|withdrawn by investigator|0|||
23758250|NCT00681824|66492315|FG001|Overall Study|withdrawn by investigator|0|||
23563185|NCT03066622|65790424|FG001|Overall Study|Withdrawal by Subject|1|||
23563186|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23563187|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
23563188|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23563189|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23758251|NCT00681824|66492316|FG002|Overall Study|withdrawn by investigator|1|||
23758252|NCT00681824|66492314|FG000|Overall Study|scheduling conflict|1|||
23758253|NCT00681824|66492315|FG001|Overall Study|scheduling conflict|0|||
23758254|NCT00681824|66492316|FG002|Overall Study|scheduling conflict|0|||
23826691|NCT01924689|66745174|FG000|Overall Study|Death|0|||
23826692|NCT01924689|66745175|FG001|Overall Study|Death|1|||
23440517|NCT03364309|65355261|FG004|Maintenance Period|Miscellaneous|0|||
23563190|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
23440518|NCT03364309|65355262|FG005|Maintenance Period|Miscellaneous|0|||
23563191|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
23563192|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
23563193|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
23563194|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
23563195|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
23563196|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
23563197|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
23563198|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23563199|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
23563200|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
23563201|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23563202|NCT04534114|65790425|FG000|Main Treatment Period|Physician Decision|0|||
23563203|NCT04534114|65790426|FG001|Main Treatment Period|Physician Decision|0|||
23563204|NCT04534114|65790427|FG002|Main Treatment Period|Physician Decision|0|||
23563205|NCT04534114|65790428|FG003|Main Treatment Period|Physician Decision|1|||
23563206|NCT04534114|65790425|FG000|Main Treatment Period|Death|1|||
23563207|NCT04534114|65790426|FG001|Main Treatment Period|Death|0|||
23563208|NCT04534114|65790427|FG002|Main Treatment Period|Death|0|||
23563209|NCT04534114|65790428|FG003|Main Treatment Period|Death|1|||
23563210|NCT04534114|65790425|FG000|Main Treatment Period|Other reason|1|||
23563211|NCT04534114|65790426|FG001|Main Treatment Period|Other reason|1|||
23563212|NCT04534114|65790427|FG002|Main Treatment Period|Other reason|0|||
23563213|NCT04534114|65790428|FG003|Main Treatment Period|Other reason|0|||
23563214|NCT04534114|65790425|FG000|Main Treatment Period|Participant decision|1|||
23563215|NCT04534114|65790426|FG001|Main Treatment Period|Participant decision|3|||
23563216|NCT04534114|65790427|FG002|Main Treatment Period|Participant decision|3|||
23563217|NCT04534114|65790428|FG003|Main Treatment Period|Participant decision|1|||
23563218|NCT04534114|65790425|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
23563219|NCT04534114|65790426|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
23563220|NCT04534114|65790427|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
23563221|NCT04534114|65790428|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
23563222|NCT04534114|65790425|FG000|Main Treatment Period|Adverse Event|4|||
23563223|NCT04534114|65790426|FG001|Main Treatment Period|Adverse Event|2|||
23563224|NCT04534114|65790427|FG002|Main Treatment Period|Adverse Event|1|||
23563225|NCT04534114|65790428|FG003|Main Treatment Period|Adverse Event|2|||
23563226|NCT04534114|65790425|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23563227|NCT04534114|65790426|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23563228|NCT04534114|65790427|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23440519|NCT03364309|65355263|FG006|Maintenance Period|Miscellaneous|0|||
23440520|NCT03364309|65355264|FG007|Maintenance Period|Miscellaneous|0|||
23440521|NCT03364309|65355265|FG008|Maintenance Period|Miscellaneous|1|||
23440522|NCT03364309|65355266|FG009|Maintenance Period|Miscellaneous|0|||
23440523|NCT03364309|65355267|FG010|Maintenance Period|Miscellaneous|0|||
23440524|NCT03364309|65355268|FG011|Maintenance Period|Miscellaneous|0|||
23440525|NCT03364309|65355269|FG012|Maintenance Period|Miscellaneous|0|||
23440526|NCT03364309|65355270|FG013|Maintenance Period|Miscellaneous|0|||
23440527|NCT03364309|65355271|FG014|Maintenance Period|Miscellaneous|0|||
23440528|NCT03364309|65355272|FG015|Maintenance Period|Miscellaneous|0|||
23440529|NCT03364309|65355273|FG016|Maintenance Period|Miscellaneous|0|||
23440530|NCT03364309|65355274|FG017|Maintenance Period|Miscellaneous|0|||
23440531|NCT03364309|65355275|FG018|Maintenance Period|Miscellaneous|0|||
23440532|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440533|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440534|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440535|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440536|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440537|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440538|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440539|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440540|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440541|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440542|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440543|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440544|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440545|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23563229|NCT04534114|65790428|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
23563230|NCT04534114|65790425|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23582244|NCT00567879|65862411|FG001|Overall Study|Abnormal test procedure(s)|0|||
23625769|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
23440546|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23440547|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23563231|NCT04534114|65790426|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563232|NCT04534114|65790427|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563233|NCT04534114|65790428|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563234|NCT04534114|65790425|FG000|Extension Treatment Period|Other reason|0|||
23563235|NCT04534114|65790426|FG001|Extension Treatment Period|Other reason|1|||
23563236|NCT04534114|65790427|FG002|Extension Treatment Period|Other reason|0|||
23563237|NCT04534114|65790428|FG003|Extension Treatment Period|Other reason|0|||
23563238|NCT04534114|65790425|FG000|Extension Treatment Period|Death|0|||
23563239|NCT04534114|65790426|FG001|Extension Treatment Period|Death|0|||
23563240|NCT04534114|65790427|FG002|Extension Treatment Period|Death|1|||
23563241|NCT04534114|65790428|FG003|Extension Treatment Period|Death|2|||
23563242|NCT04534114|65790425|FG000|Extension Treatment Period|Adverse Event|0|||
23563243|NCT04534114|65790426|FG001|Extension Treatment Period|Adverse Event|1|||
23563244|NCT04534114|65790427|FG002|Extension Treatment Period|Adverse Event|0|||
23563245|NCT04534114|65790428|FG003|Extension Treatment Period|Adverse Event|1|||
23563246|NCT04534114|65790425|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
23563247|NCT04534114|65790426|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
23563248|NCT04534114|65790427|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
23563249|NCT04534114|65790428|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
23563250|NCT01498822|65790432|FG000|Overall Study|Protocol Violation|8|||
23563251|NCT01498822|65790433|FG001|Overall Study|Protocol Violation|4|||
23563252|NCT01498822|65790432|FG000|Overall Study|Other Reason|5|||
23563253|NCT01498822|65790433|FG001|Overall Study|Other Reason|2|||
23563254|NCT01498822|65790432|FG000|Overall Study|Lack of Efficacy|7|||
23563255|NCT01498822|65790433|FG001|Overall Study|Lack of Efficacy|2|||
23563256|NCT01498822|65790432|FG000|Overall Study|AE, non-serious non-fatal|8|||
23563257|NCT01498822|65790433|FG001|Overall Study|AE, non-serious non-fatal|17|||
23563258|NCT01498822|65790432|FG000|Overall Study|SAE, non-fatal|2|||
23563259|NCT01498822|65790433|FG001|Overall Study|SAE, non-fatal|2|||
23563260|NCT01498822|65790432|FG000|Overall Study|Adverse Event, serious fatal|1|||
23563261|NCT01498822|65790433|FG001|Overall Study|Adverse Event, serious fatal|1|||
23563262|NCT01498822|65790432|FG000|Overall Study|Withdrawal by Subject|15|||
23563263|NCT01498822|65790433|FG001|Overall Study|Withdrawal by Subject|25|||
23563264|NCT01498822|65790432|FG000|Overall Study|Lost to Follow-up|8|||
23563265|NCT01498822|65790433|FG001|Overall Study|Lost to Follow-up|3|||
23563266|NCT02835339|65790434|FG000|Overall Study|Did not receive allocated intervention|13|||
23563267|NCT02835339|65790435|FG001|Overall Study|Did not receive allocated intervention|16|||
23563268|NCT00553501|65790442|FG000|Overall Study|Adverse Event|2|||
23563269|NCT00553501|65790442|FG000|Overall Study|Death|1|||
23563270|NCT00553501|65790442|FG000|Overall Study|Progression|1|||
23563271|NCT02237508|65790443|FG000|Overall Study|Withdrawal by Subject|0|||
23563272|NCT02237508|65790444|FG001|Overall Study|Withdrawal by Subject|2|||
23563273|NCT02237508|65790445|FG002|Overall Study|Withdrawal by Subject|0|||
23563274|NCT02237508|65790446|FG003|Overall Study|Withdrawal by Subject|1|||
23563275|NCT02237508|65790447|FG004|Overall Study|Withdrawal by Subject|0|||
23563276|NCT02237508|65790448|FG005|Overall Study|Withdrawal by Subject|1|||
23563277|NCT02237508|65790449|FG006|Overall Study|Withdrawal by Subject|1|||
23563278|NCT02237508|65790450|FG007|Overall Study|Withdrawal by Subject|0|||
23563279|NCT02237508|65790451|FG008|Overall Study|Withdrawal by Subject|1|||
23563280|NCT02237508|65790452|FG009|Overall Study|Withdrawal by Subject|0|||
23563281|NCT02237508|65790443|FG000|Overall Study|Physician Decision|0|||
23563282|NCT02237508|65790444|FG001|Overall Study|Physician Decision|1|||
23563283|NCT02237508|65790445|FG002|Overall Study|Physician Decision|0|||
23563284|NCT02237508|65790446|FG003|Overall Study|Physician Decision|0|||
23563285|NCT02237508|65790447|FG004|Overall Study|Physician Decision|0|||
23563286|NCT02237508|65790448|FG005|Overall Study|Physician Decision|0|||
23563287|NCT02237508|65790449|FG006|Overall Study|Physician Decision|0|||
23563288|NCT02237508|65790450|FG007|Overall Study|Physician Decision|0|||
23563289|NCT02237508|65790451|FG008|Overall Study|Physician Decision|0|||
23563290|NCT02237508|65790452|FG009|Overall Study|Physician Decision|0|||
23563291|NCT02237508|65790443|FG000|Overall Study|Protocol Violation|0|||
23563292|NCT02237508|65790444|FG001|Overall Study|Protocol Violation|0|||
23563293|NCT02237508|65790445|FG002|Overall Study|Protocol Violation|1|||
23563294|NCT02237508|65790446|FG003|Overall Study|Protocol Violation|0|||
23563295|NCT02237508|65790447|FG004|Overall Study|Protocol Violation|0|||
23563296|NCT02237508|65790448|FG005|Overall Study|Protocol Violation|0|||
23758255|NCT00681824|66492314|FG000|Overall Study|Death|0|||
23563297|NCT02237508|65790449|FG006|Overall Study|Protocol Violation|0|||
23563298|NCT02237508|65790450|FG007|Overall Study|Protocol Violation|0|||
23563299|NCT02237508|65790451|FG008|Overall Study|Protocol Violation|0|||
23563300|NCT02237508|65790452|FG009|Overall Study|Protocol Violation|0|||
23563301|NCT01364922|65790456|FG000|Open-label (OL) Period|Adverse Event|7|||
23563302|NCT01364922|65790457|FG001|Open-label (OL) Period|Adverse Event|0|||
23563303|NCT01364922|65790458|FG002|Open-label (OL) Period|Adverse Event|0|||
23758256|NCT00681824|66492315|FG001|Overall Study|Death|1|||
23758257|NCT00681824|66492316|FG002|Overall Study|Death|0|||
23563304|NCT01364922|65790456|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
23563305|NCT01364922|65790457|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
23563306|NCT01364922|65790458|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
23563307|NCT01364922|65790456|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
23563308|NCT01364922|65790457|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
23563309|NCT01364922|65790458|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
23563310|NCT01364922|65790456|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
23563311|NCT01364922|65790457|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
23563312|NCT01364922|65790458|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
23563313|NCT01364922|65790456|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
23563314|NCT01364922|65790457|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
23563315|NCT01364922|65790458|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
23563316|NCT01364922|65790456|FG000|Open-label (OL) Period|Other, Unspecified|1|||
23563317|NCT01364922|65790457|FG001|Open-label (OL) Period|Other, Unspecified|0|||
23563318|NCT01364922|65790458|FG002|Open-label (OL) Period|Other, Unspecified|0|||
23563319|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
23563320|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
23563321|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
23563322|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
23563323|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
23563324|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
23563325|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Adverse Event|0|||
23563326|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Adverse Event|0|||
23563327|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Adverse Event|1|||
23563328|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
23563329|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
23563330|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
23563331|NCT05061537|65790460|FG000|Treatment Phase|Progressive disease|0|||
23563332|NCT05061537|65790461|FG001|Treatment Phase|Progressive disease|1|||
23563333|NCT05061537|65790462|FG002|Treatment Phase|Progressive disease|2|||
23563334|NCT05061537|65790463|FG003|Treatment Phase|Progressive disease|0|||
23563335|NCT05061537|65790464|FG004|Treatment Phase|Progressive disease|0|||
23563336|NCT05061537|65790460|FG000|Treatment Phase|Adverse Event|0|||
23563337|NCT05061537|65790461|FG001|Treatment Phase|Adverse Event|0|||
23563338|NCT05061537|65790462|FG002|Treatment Phase|Adverse Event|2|||
23563339|NCT05061537|65790463|FG003|Treatment Phase|Adverse Event|0|||
23563340|NCT05061537|65790464|FG004|Treatment Phase|Adverse Event|0|||
23563341|NCT05061537|65790460|FG000|Treatment Phase|Global deterioration of health status|0|||
23563342|NCT05061537|65790461|FG001|Treatment Phase|Global deterioration of health status|1|||
23563343|NCT05061537|65790462|FG002|Treatment Phase|Global deterioration of health status|0|||
23563344|NCT05061537|65790463|FG003|Treatment Phase|Global deterioration of health status|0|||
23563345|NCT05061537|65790464|FG004|Treatment Phase|Global deterioration of health status|0|||
23563346|NCT05061537|65790460|FG000|Follow up|Other|2|||
23563347|NCT05061537|65790461|FG001|Follow up|Other|0|||
23563348|NCT05061537|65790462|FG002|Follow up|Other|2|||
23563349|NCT05061537|65790463|FG003|Follow up|Other|0|||
23563350|NCT05061537|65790464|FG004|Follow up|Other|0|||
23563351|NCT05061537|65790460|FG000|Follow up|Study terminated by sponsor|0|||
23563352|NCT05061537|65790461|FG001|Follow up|Study terminated by sponsor|0|||
23625770|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
23563353|NCT05061537|65790462|FG002|Follow up|Study terminated by sponsor|2|||
23563354|NCT05061537|65790463|FG003|Follow up|Study terminated by sponsor|0|||
23563355|NCT05061537|65790464|FG004|Follow up|Study terminated by sponsor|0|||
23563356|NCT05061537|65790460|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
23563357|NCT05061537|65790461|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
23563358|NCT05061537|65790462|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
23625771|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
23625772|NCT01006616|66015607|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
23563359|NCT05061537|65790463|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
23563360|NCT05061537|65790464|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
23563361|NCT05061537|65790460|FG000|Long-term Follow-up|Death|0|||
23563362|NCT05061537|65790461|FG001|Long-term Follow-up|Death|1|||
23563363|NCT05061537|65790462|FG002|Long-term Follow-up|Death|0|||
23563364|NCT05061537|65790463|FG003|Long-term Follow-up|Death|0|||
23563365|NCT05061537|65790464|FG004|Long-term Follow-up|Death|0|||
23563366|NCT02313909|65790465|FG000|Overall Study|Consent withdrawn by participant|33|||
23563367|NCT02313909|65790466|FG001|Overall Study|Consent withdrawn by participant|33|||
23563368|NCT02313909|65790465|FG000|Overall Study|Lost to Follow-up|24|||
23563369|NCT02313909|65790466|FG001|Overall Study|Lost to Follow-up|17|||
23563370|NCT00576732|65790467|FG000|DOUBLE BLIND|Adverse Event|0|||
23563371|NCT00576732|65790468|FG001|DOUBLE BLIND|Adverse Event|0|||
23563372|NCT00576732|65790469|FG002|DOUBLE BLIND|Adverse Event|1|||
23563373|NCT00576732|65790470|FG003|DOUBLE BLIND|Adverse Event|0|||
23563374|NCT00576732|65790471|FG004|DOUBLE BLIND|Adverse Event|0|||
23563375|NCT00576732|65790472|FG005|DOUBLE BLIND|Adverse Event|0|||
23563376|NCT00576732|65790467|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
23563377|NCT00576732|65790468|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
23563378|NCT00576732|65790469|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
23563379|NCT00576732|65790470|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
23563380|NCT00576732|65790471|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
23563381|NCT00576732|65790472|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
23563382|NCT00576732|65790467|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
23563383|NCT00576732|65790468|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
23563384|NCT00576732|65790469|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
23563385|NCT00576732|65790470|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
23563386|NCT00576732|65790471|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
23563387|NCT00576732|65790472|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
23563388|NCT00576732|65790467|FG000|DOUBLE BLIND|OTHER|0|||
23563389|NCT00576732|65790468|FG001|DOUBLE BLIND|OTHER|2|||
23563390|NCT00576732|65790469|FG002|DOUBLE BLIND|OTHER|1|||
23563391|NCT00576732|65790470|FG003|DOUBLE BLIND|OTHER|0|||
23563392|NCT00576732|65790471|FG004|DOUBLE BLIND|OTHER|0|||
23563393|NCT00576732|65790472|FG005|DOUBLE BLIND|OTHER|0|||
23440548|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440549|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440550|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440551|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440552|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440553|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440554|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
23563394|NCT00576732|65790467|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
23563395|NCT00576732|65790468|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
23563396|NCT00576732|65790469|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
23625773|NCT01006616|66015608|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
23625774|NCT01006616|66015609|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
23440555|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440556|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440557|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440558|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440559|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440560|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440561|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440562|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440563|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440564|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440565|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
23440566|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440567|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440568|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440569|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440570|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
23440571|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
23440572|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
23563397|NCT00576732|65790470|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
23563398|NCT00576732|65790471|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
23563399|NCT00576732|65790472|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
23563400|NCT00576732|65790467|FG000|DOUBLE BLIND|Protocol Violation|1|||
23563401|NCT00576732|65790468|FG001|DOUBLE BLIND|Protocol Violation|0|||
23563402|NCT00576732|65790469|FG002|DOUBLE BLIND|Protocol Violation|0|||
23625775|NCT01006616|66015610|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
23440573|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
23563403|NCT00576732|65790470|FG003|DOUBLE BLIND|Protocol Violation|0|||
23563404|NCT00576732|65790471|FG004|DOUBLE BLIND|Protocol Violation|0|||
23563405|NCT00576732|65790472|FG005|DOUBLE BLIND|Protocol Violation|0|||
23440574|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
23440575|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
23440576|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
23440577|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
23440578|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
23440579|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
23440580|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
23440581|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
23440582|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
23440583|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
23440584|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
23440585|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
23440586|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
23440587|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
23440588|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
23440589|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440590|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440591|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440592|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440593|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440594|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440595|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440596|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440597|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440598|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440599|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440600|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440601|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440602|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440603|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440604|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440605|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
23440606|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
23440607|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
23440608|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Adverse Event|0|||
23440609|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Adverse Event|0|||
23440610|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Adverse Event|0|||
23440611|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Adverse Event|0|||
23440612|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Adverse Event|0|||
23440613|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Adverse Event|0|||
23440614|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Adverse Event|0|||
23440615|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Adverse Event|0|||
23440616|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Adverse Event|0|||
23440617|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Adverse Event|0|||
23440618|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Adverse Event|0|||
23440619|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Adverse Event|0|||
23440620|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Adverse Event|0|||
23440621|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Adverse Event|0|||
23440622|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Adverse Event|0|||
23440623|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Adverse Event|0|||
23440624|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Adverse Event|2|||
23440625|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Adverse Event|6|||
23440626|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Adverse Event|1|||
23440627|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440628|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440629|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440630|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440631|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440632|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440633|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440634|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440635|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440636|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440637|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440638|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440639|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440640|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440641|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440642|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440643|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440644|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
23440645|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440646|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
23440647|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
23440648|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
23440649|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
23440650|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
23440651|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
23440652|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
23440653|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
23440654|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
23440655|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
23440656|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
23440657|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
23440658|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
23440659|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
23440660|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
23440661|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
23440662|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
23440663|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
23440664|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
23440665|NCT00387725|65355276|FG000|Overall Study|Adverse Event|0|||
23440666|NCT00387725|65355277|FG001|Overall Study|Adverse Event|0|||
23440667|NCT00387725|65355278|FG002|Overall Study|Adverse Event|0|||
23440668|NCT00387725|65355279|FG003|Overall Study|Adverse Event|1|||
23440669|NCT00387725|65355276|FG000|Overall Study|Protocol Violation|0|||
23440670|NCT00387725|65355277|FG001|Overall Study|Protocol Violation|1|||
23440671|NCT00387725|65355278|FG002|Overall Study|Protocol Violation|0|||
23440672|NCT00387725|65355279|FG003|Overall Study|Protocol Violation|0|||
23440673|NCT00387725|65355276|FG000|Overall Study|Withdrawal by Subject|1|||
23440674|NCT00387725|65355277|FG001|Overall Study|Withdrawal by Subject|0|||
23440675|NCT00387725|65355278|FG002|Overall Study|Withdrawal by Subject|1|||
23563406|NCT00576732|65790467|FG000|OPEN LABEL|Adverse Event|0|||
23563407|NCT00576732|65790468|FG001|OPEN LABEL|Adverse Event|0|||
23563408|NCT00576732|65790469|FG002|OPEN LABEL|Adverse Event|0|||
23563409|NCT00576732|65790470|FG003|OPEN LABEL|Adverse Event|4|||
23563410|NCT00576732|65790471|FG004|OPEN LABEL|Adverse Event|0|||
23563411|NCT00576732|65790472|FG005|OPEN LABEL|Adverse Event|1|||
23440676|NCT00387725|65355279|FG003|Overall Study|Withdrawal by Subject|0|||
23440677|NCT00387725|65355276|FG000|Overall Study|Parent/legal guardian request|0|||
23440678|NCT00387725|65355277|FG001|Overall Study|Parent/legal guardian request|0|||
23758258|NCT03636542|66492318|FG000|Overall Study|Lost to Follow-up|1|||
23758259|NCT03636542|66492319|FG001|Overall Study|Lost to Follow-up|1|||
23440679|NCT00387725|65355278|FG002|Overall Study|Parent/legal guardian request|1|||
23440680|NCT00387725|65355279|FG003|Overall Study|Parent/legal guardian request|1|||
23440681|NCT00348309|65355280|FG000|Overall Study|Adverse Event|56|||
23440682|NCT00348309|65355281|FG001|Overall Study|Adverse Event|28|||
23440683|NCT00348309|65355282|FG002|Overall Study|Adverse Event|63|||
23440684|NCT00348309|65355280|FG000|Overall Study|Lost to Follow-up|6|||
23440685|NCT00348309|65355281|FG001|Overall Study|Lost to Follow-up|7|||
23440686|NCT00348309|65355282|FG002|Overall Study|Lost to Follow-up|4|||
23440687|NCT00348309|65355280|FG000|Overall Study|Protocol Violation|7|||
23440688|NCT00348309|65355281|FG001|Overall Study|Protocol Violation|12|||
23440689|NCT00348309|65355282|FG002|Overall Study|Protocol Violation|7|||
23440690|NCT00348309|65355280|FG000|Overall Study|Withdrawal by Subject|33|||
23563412|NCT00576732|65790467|FG000|OPEN LABEL|Lost to Follow-up|0|||
23563413|NCT00576732|65790468|FG001|OPEN LABEL|Lost to Follow-up|0|||
23563414|NCT00576732|65790469|FG002|OPEN LABEL|Lost to Follow-up|0|||
23563415|NCT00576732|65790470|FG003|OPEN LABEL|Lost to Follow-up|2|||
23563416|NCT00576732|65790471|FG004|OPEN LABEL|Lost to Follow-up|1|||
23563417|NCT00576732|65790472|FG005|OPEN LABEL|Lost to Follow-up|1|||
23563418|NCT00576732|65790467|FG000|OPEN LABEL|Withdrawal by Subject|0|||
23563419|NCT00576732|65790468|FG001|OPEN LABEL|Withdrawal by Subject|0|||
23563420|NCT00576732|65790469|FG002|OPEN LABEL|Withdrawal by Subject|0|||
23563421|NCT00576732|65790470|FG003|OPEN LABEL|Withdrawal by Subject|1|||
23563422|NCT00576732|65790471|FG004|OPEN LABEL|Withdrawal by Subject|0|||
23563423|NCT00576732|65790472|FG005|OPEN LABEL|Withdrawal by Subject|1|||
23563424|NCT00576732|65790467|FG000|OPEN LABEL|OTHER|0|||
23563425|NCT00576732|65790468|FG001|OPEN LABEL|OTHER|0|||
23563426|NCT00576732|65790469|FG002|OPEN LABEL|OTHER|0|||
23563427|NCT00576732|65790470|FG003|OPEN LABEL|OTHER|0|||
23563428|NCT00576732|65790471|FG004|OPEN LABEL|OTHER|0|||
23563429|NCT00576732|65790472|FG005|OPEN LABEL|OTHER|2|||
23563430|NCT00576732|65790467|FG000|OPEN LABEL|Lack of Efficacy|0|||
23563431|NCT00576732|65790468|FG001|OPEN LABEL|Lack of Efficacy|0|||
23563432|NCT00576732|65790469|FG002|OPEN LABEL|Lack of Efficacy|0|||
23563433|NCT00576732|65790470|FG003|OPEN LABEL|Lack of Efficacy|2|||
23563434|NCT00576732|65790471|FG004|OPEN LABEL|Lack of Efficacy|2|||
23563435|NCT00576732|65790472|FG005|OPEN LABEL|Lack of Efficacy|3|||
23563436|NCT00576732|65790467|FG000|OPEN LABEL|Protocol Violation|0|||
23563437|NCT00576732|65790468|FG001|OPEN LABEL|Protocol Violation|0|||
23563438|NCT00576732|65790469|FG002|OPEN LABEL|Protocol Violation|0|||
23563439|NCT00576732|65790470|FG003|OPEN LABEL|Protocol Violation|2|||
23563440|NCT00576732|65790471|FG004|OPEN LABEL|Protocol Violation|1|||
23563441|NCT00576732|65790472|FG005|OPEN LABEL|Protocol Violation|0|||
23563442|NCT02799472|65790473|FG000|Overall Study|Withdrawal by Subject|2|||
23563443|NCT02799472|65790474|FG001|Overall Study|Withdrawal by Subject|4|||
23563444|NCT02799472|65790473|FG000|Overall Study|Lack of Efficacy|2|||
23563445|NCT02799472|65790474|FG001|Overall Study|Lack of Efficacy|0|||
23563446|NCT02799472|65790473|FG000|Overall Study|Lost to Follow-up|0|||
23563447|NCT02799472|65790474|FG001|Overall Study|Lost to Follow-up|1|||
23758260|NCT03636542|66492318|FG000|Overall Study|Physician Decision|0|||
23440691|NCT00348309|65355281|FG001|Overall Study|Withdrawal by Subject|37|||
23563448|NCT00909480|65790475|FG000|Overall Study|Adverse Event|5|||
23563449|NCT00909480|65790476|FG001|Overall Study|Adverse Event|3|||
23563450|NCT00909480|65790475|FG000|Overall Study|Protocol Violation|6|||
23563451|NCT00909480|65790476|FG001|Overall Study|Protocol Violation|8|||
23563452|NCT00909480|65790475|FG000|Overall Study|Withdrawal criteria|9|||
23563453|NCT00909480|65790476|FG001|Overall Study|Withdrawal criteria|11|||
23563454|NCT00909480|65790475|FG000|Overall Study|Unclassified|18|||
23758261|NCT03636542|66492319|FG001|Overall Study|Physician Decision|1|||
23563455|NCT00909480|65790476|FG001|Overall Study|Unclassified|19|||
23563456|NCT02716038|65790477|FG000|Overall Study|Not evaluable|1|||
23563457|NCT02716038|65790477|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
23563458|NCT02716038|65790477|FG000|Overall Study|Unresectable|3|||
23563459|NCT00792103|65790478|FG000|Overall Study|Enrolled, not treated|15|||
23563460|NCT00792103|65790478|FG000|Overall Study|Lost to Follow-up|17|||
23563461|NCT00792103|65790478|FG000|Overall Study|Adverse Event|25|||
23563462|NCT00792103|65790478|FG000|Overall Study|Withdrawal by Subject|52|||
23758262|NCT03636542|66492318|FG000|Overall Study|Withdrawal by Subject|1|||
23758263|NCT03636542|66492319|FG001|Overall Study|Withdrawal by Subject|0|||
23758264|NCT00971204|66492321|FG000|Overall Study|Did not meet all criteria-not treated|14|||
23758265|NCT00971204|66492321|FG000|Overall Study|Lost to Follow-up|10|||
23758266|NCT03840135|66492322|FG000|Overall Study|Protocol Violation|6|||
23758267|NCT03840135|66492323|FG001|Overall Study|Protocol Violation|1|||
23758268|NCT03840135|66492322|FG000|Overall Study|Withdrawal by Subject|1|||
23758269|NCT03840135|66492323|FG001|Overall Study|Withdrawal by Subject|0|||
23758270|NCT02046369|66492324|FG000|Overall Study|Adverse Event|3|||
23758271|NCT02046369|66492325|FG001|Overall Study|Adverse Event|3|||
23758272|NCT02046369|66492324|FG000|Overall Study|Lack of Efficacy|3|||
23758273|NCT02046369|66492325|FG001|Overall Study|Lack of Efficacy|3|||
23758274|NCT02046369|66492324|FG000|Overall Study|Lost to Follow-up|3|||
23758275|NCT02046369|66492325|FG001|Overall Study|Lost to Follow-up|3|||
23758276|NCT02046369|66492324|FG000|Overall Study|Protocol Violation|1|||
23758277|NCT02046369|66492325|FG001|Overall Study|Protocol Violation|2|||
23758278|NCT02046369|66492324|FG000|Overall Study|Withdrawal by Subject|3|||
23758279|NCT02046369|66492325|FG001|Overall Study|Withdrawal by Subject|6|||
23758280|NCT02046369|66492324|FG000|Overall Study|never received study drug|0|||
23758281|NCT02046369|66492325|FG001|Overall Study|never received study drug|1|||
23758282|NCT02046369|66492324|FG000|Overall Study|non compliance|1|||
23758283|NCT02046369|66492325|FG001|Overall Study|non compliance|0|||
23758284|NCT03216954|66492326|FG000|Overall Study|Adverse Event|0|||
23758285|NCT03216954|66492327|FG001|Overall Study|Adverse Event|0|||
23758286|NCT03216954|66492328|FG002|Overall Study|Adverse Event|1|||
23758287|NCT03216954|66492329|FG003|Overall Study|Adverse Event|0|||
23758288|NCT03216954|66492330|FG004|Overall Study|Adverse Event|1|||
23758289|NCT03216954|66492326|FG000|Overall Study|Withdrawal by Subject|2|||
23758290|NCT03216954|66492327|FG001|Overall Study|Withdrawal by Subject|0|||
23758291|NCT03216954|66492328|FG002|Overall Study|Withdrawal by Subject|0|||
23758292|NCT03216954|66492329|FG003|Overall Study|Withdrawal by Subject|0|||
23758293|NCT03216954|66492330|FG004|Overall Study|Withdrawal by Subject|0|||
23758294|NCT03216954|66492326|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23758295|NCT03216954|66492327|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
23758296|NCT03216954|66492328|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23758297|NCT03216954|66492329|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23758298|NCT03216954|66492330|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23758299|NCT00383019|66492331|FG000|Overall Study|Adverse Event|5|||
23758300|NCT00383019|66492332|FG001|Overall Study|Adverse Event|1|||
23758301|NCT00383019|66492331|FG000|Overall Study|Withdrawal by Subject|0|||
23758302|NCT00383019|66492332|FG001|Overall Study|Withdrawal by Subject|1|||
23758303|NCT04060654|66492334|FG000|Overall Study|Withdrawal by Subject|1|||
23758304|NCT04060654|66492334|FG000|Overall Study|Lost to Follow-up|5|||
23758305|NCT02018042|66492337|FG000|Overall Study|Withdrawal by Subject|1|||
23758306|NCT02555618|66492338|FG000|Overall Study|Sponsor's Circumstances|1|||
23758307|NCT02555618|66492339|FG001|Overall Study|Sponsor's Circumstances|0|||
23758308|NCT00344305|66492340|FG000|Overall Study|Lost to Follow-up|2|||
23758309|NCT00344305|66492341|FG001|Overall Study|Lost to Follow-up|0|||
23758310|NCT00344305|66492340|FG000|Overall Study|Participant was not contacted in window|0|||
23758311|NCT00344305|66492341|FG001|Overall Study|Participant was not contacted in window|1|||
23758312|NCT01375010|66492344|FG000|Overall Study|Lost to Follow-up|8|||
23758313|NCT01375010|66492345|FG001|Overall Study|Lost to Follow-up|2|||
23758314|NCT01375010|66492344|FG000|Overall Study|Withdrawal by Subject|4|||
23758315|NCT01375010|66492345|FG001|Overall Study|Withdrawal by Subject|2|||
23758316|NCT04363736|66492346|FG000|Overall Study|Withdrawal by Subject|1|||
23758317|NCT04363736|66492347|FG001|Overall Study|Withdrawal by Subject|0|||
23758318|NCT04363736|66492346|FG000|Overall Study|Lost to Follow-up|10|||
23758319|NCT04363736|66492347|FG001|Overall Study|Lost to Follow-up|7|||
23758320|NCT04363736|66492346|FG000|Overall Study|Death|8|||
23758321|NCT04363736|66492347|FG001|Overall Study|Death|6|||
23758322|NCT02117479|66492350|FG000|Overall Study|Death|13|||
23758323|NCT02117479|66492351|FG001|Overall Study|Death|8|||
23758324|NCT02117479|66492350|FG000|Overall Study|Adverse Event|8|||
23758325|NCT02117479|66492351|FG001|Overall Study|Adverse Event|16|||
23758326|NCT02117479|66492350|FG000|Overall Study|Subject decision|8|||
23758327|NCT02117479|66492351|FG001|Overall Study|Subject decision|9|||
23758328|NCT02117479|66492350|FG000|Overall Study|Disease progression|104|||
23758329|NCT02117479|66492351|FG001|Overall Study|Disease progression|108|||
23758330|NCT02117479|66492350|FG000|Overall Study|Noncompliance with study treatment|1|||
23758331|NCT02117479|66492351|FG001|Overall Study|Noncompliance with study treatment|0|||
23758332|NCT02117479|66492350|FG000|Overall Study|Study terminated by the sponsor|4|||
23758333|NCT02117479|66492351|FG001|Overall Study|Study terminated by the sponsor|6|||
23758334|NCT02117479|66492350|FG000|Overall Study|Physician Decision|7|||
23758335|NCT02117479|66492351|FG001|Overall Study|Physician Decision|2|||
23758336|NCT02117479|66492350|FG000|Overall Study|Other unspecified|11|||
23758337|NCT02117479|66492351|FG001|Overall Study|Other unspecified|7|||
23625776|NCT01006616|66015607|FG000|Period 2 (18 Months)|Study Terminated|63|||
23625777|NCT01006616|66015608|FG001|Period 2 (18 Months)|Study Terminated|46|||
23625778|NCT01006616|66015609|FG002|Period 2 (18 Months)|Study Terminated|44|||
23625779|NCT01006616|66015610|FG003|Period 2 (18 Months)|Study Terminated|70|||
23625780|NCT00863798|66015611|FG000|Overall Study|Adverse Event|5|||
23625781|NCT00863798|66015612|FG001|Overall Study|Adverse Event|2|||
23625782|NCT00863798|66015613|FG002|Overall Study|Adverse Event|4|||
23625783|NCT00863798|66015611|FG000|Overall Study|Participant failed to return|2|||
23625784|NCT00863798|66015612|FG001|Overall Study|Participant failed to return|1|||
23625785|NCT00863798|66015613|FG002|Overall Study|Participant failed to return|0|||
23625786|NCT00863798|66015611|FG000|Overall Study|Investigator request|1|||
23625787|NCT00863798|66015612|FG001|Overall Study|Investigator request|2|||
23758338|NCT01392170|66492352|FG000|Overall Study|Withdrawal by Subject|1|||
23758339|NCT01392170|66492352|FG000|Overall Study|Ineligible|1|||
23758340|NCT02923115|66492353|FG000|Overall Study|Lost to Follow-up|0|||
23758341|NCT02923115|66492354|FG001|Overall Study|Lost to Follow-up|0|||
23758342|NCT02923115|66492355|FG002|Overall Study|Lost to Follow-up|0|||
23440692|NCT00348309|65355282|FG002|Overall Study|Withdrawal by Subject|40|||
23440693|NCT00348309|65355280|FG000|Overall Study|Non-compliance|8|||
23563463|NCT00792103|65790478|FG000|Overall Study|Protocol Violation|10|||
23563464|NCT00792103|65790478|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
23563465|NCT01933880|65790479|FG000|Overall Study|Withdrawal by Subject|5|||
23563466|NCT01933880|65790480|FG001|Overall Study|Withdrawal by Subject|0|||
23563467|NCT01933880|65790479|FG000|Overall Study|Lack of Efficacy|1|||
23563468|NCT01933880|65790480|FG001|Overall Study|Lack of Efficacy|0|||
23563469|NCT01933880|65790479|FG000|Overall Study|Concomitant medication Interference|0|||
23563470|NCT01933880|65790480|FG001|Overall Study|Concomitant medication Interference|1|||
23563471|NCT01933880|65790479|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
23563472|NCT01933880|65790480|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
23563473|NCT01933880|65790479|FG000|Overall Study|Other|4|||
23563474|NCT01933880|65790480|FG001|Overall Study|Other|0|||
23563475|NCT01933880|65790479|FG000|Overall Study|Protocol Violation|1|||
23563476|NCT01933880|65790480|FG001|Overall Study|Protocol Violation|0|||
23563477|NCT02923739|65790482|FG000|Overall Study|Withdrawal by Subject|2|||
23563478|NCT02923739|65790483|FG001|Overall Study|Withdrawal by Subject|0|||
23563479|NCT02923739|65790484|FG002|Overall Study|Withdrawal by Subject|0|||
23563480|NCT02923739|65790485|FG003|Overall Study|Withdrawal by Subject|0|||
23563481|NCT02923739|65790482|FG000|Overall Study|Failed Screening|3|||
23563482|NCT02923739|65790483|FG001|Overall Study|Failed Screening|0|||
23563483|NCT02923739|65790484|FG002|Overall Study|Failed Screening|0|||
23563484|NCT02923739|65790485|FG003|Overall Study|Failed Screening|0|||
23563485|NCT01529008|65790486|FG000|Bone Marrow Harvesting|Physician Decision|1|||
23563486|NCT01529008|65790487|FG001|Bone Marrow Harvesting|Physician Decision|1|||
23563487|NCT01529008|65790486|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
23563488|NCT01529008|65790487|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
23563489|NCT01529008|65790486|FG000|Treatment|Adverse Event|6|||
23563490|NCT01529008|65790487|FG001|Treatment|Adverse Event|0|||
23563491|NCT01529008|65790486|FG000|Treatment|Other|3|||
23563492|NCT01529008|65790487|FG001|Treatment|Other|1|||
23563493|NCT01529008|65790486|FG000|Efficacy Analysis|Protocol Violation|2|||
23563494|NCT01529008|65790487|FG001|Efficacy Analysis|Protocol Violation|0|||
23563495|NCT01529008|65790486|FG000|Efficacy Analysis|Physician Decision|0|||
23563496|NCT01529008|65790487|FG001|Efficacy Analysis|Physician Decision|1|||
23563497|NCT01529008|65790486|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
23563498|NCT01529008|65790487|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
23625788|NCT00863798|66015613|FG002|Overall Study|Investigator request|1|||
23625789|NCT00863798|66015611|FG000|Overall Study|Lack of Efficacy|4|||
23563499|NCT00603265|65790494|FG000|Overall Study|Adverse Event|2|||
23758343|NCT02923115|66492356|FG003|Overall Study|Lost to Follow-up|1|||
23563500|NCT00603265|65790495|FG001|Overall Study|Adverse Event|11|||
23563501|NCT00603265|65790496|FG002|Overall Study|Adverse Event|1|||
23563502|NCT00603265|65790494|FG000|Overall Study|Withdrawal by Subject|1|||
23563503|NCT00603265|65790495|FG001|Overall Study|Withdrawal by Subject|2|||
23563504|NCT00603265|65790496|FG002|Overall Study|Withdrawal by Subject|1|||
23563505|NCT00603265|65790494|FG000|Overall Study|Lack of Efficacy|3|||
23563506|NCT00603265|65790495|FG001|Overall Study|Lack of Efficacy|0|||
23625790|NCT00863798|66015612|FG001|Overall Study|Lack of Efficacy|3|||
23625791|NCT00863798|66015613|FG002|Overall Study|Lack of Efficacy|6|||
23625792|NCT00863798|66015611|FG000|Overall Study|Lost to Follow-up|6|||
23625793|NCT00863798|66015612|FG001|Overall Study|Lost to Follow-up|9|||
23625794|NCT00863798|66015613|FG002|Overall Study|Lost to Follow-up|5|||
23625795|NCT00863798|66015611|FG000|Overall Study|Other|2|||
23625796|NCT00863798|66015612|FG001|Overall Study|Other|3|||
23625797|NCT00863798|66015613|FG002|Overall Study|Other|1|||
23625798|NCT00863798|66015611|FG000|Overall Study|Protocol Violation|0|||
23625799|NCT00863798|66015612|FG001|Overall Study|Protocol Violation|1|||
23625800|NCT00863798|66015613|FG002|Overall Study|Protocol Violation|1|||
23625801|NCT00863798|66015611|FG000|Overall Study|Withdrawal by Subject|8|||
23625802|NCT00863798|66015612|FG001|Overall Study|Withdrawal by Subject|7|||
23625803|NCT00863798|66015613|FG002|Overall Study|Withdrawal by Subject|4|||
23625804|NCT00863798|66015611|FG000|Overall Study|Randomized not treated|4|||
23625805|NCT00863798|66015612|FG001|Overall Study|Randomized not treated|2|||
23625806|NCT00863798|66015613|FG002|Overall Study|Randomized not treated|3|||
23625807|NCT00443898|66015617|FG000|Overall Study|Adverse Event|0|||
23625808|NCT00443898|66015618|FG001|Overall Study|Adverse Event|0|||
23625809|NCT00443898|66015619|FG002|Overall Study|Adverse Event|1|||
23625810|NCT00443898|66015620|FG003|Overall Study|Adverse Event|1|||
23625811|NCT00443898|66015617|FG000|Overall Study|Lack of Efficacy|2|||
23625812|NCT00443898|66015618|FG001|Overall Study|Lack of Efficacy|3|||
23625813|NCT00443898|66015619|FG002|Overall Study|Lack of Efficacy|3|||
23625814|NCT00443898|66015620|FG003|Overall Study|Lack of Efficacy|1|||
23625815|NCT00443898|66015617|FG000|Overall Study|Protocol Violation|1|||
23625816|NCT00443898|66015618|FG001|Overall Study|Protocol Violation|1|||
23758344|NCT02923115|66492357|FG004|Overall Study|Lost to Follow-up|0|||
23758345|NCT02923115|66492358|FG005|Overall Study|Lost to Follow-up|0|||
23758346|NCT02923115|66492353|FG000|Overall Study|Withdrawal by Subject|0|||
23758347|NCT02923115|66492354|FG001|Overall Study|Withdrawal by Subject|1|||
23758348|NCT02923115|66492355|FG002|Overall Study|Withdrawal by Subject|0|||
23758349|NCT02923115|66492356|FG003|Overall Study|Withdrawal by Subject|0|||
23625817|NCT00443898|66015619|FG002|Overall Study|Protocol Violation|1|||
23625818|NCT00443898|66015620|FG003|Overall Study|Protocol Violation|0|||
23625819|NCT00443898|66015617|FG000|Overall Study|Withdrawal by Subject|11|||
23625820|NCT00443898|66015618|FG001|Overall Study|Withdrawal by Subject|10|||
23625821|NCT00443898|66015619|FG002|Overall Study|Withdrawal by Subject|10|||
23625822|NCT00443898|66015620|FG003|Overall Study|Withdrawal by Subject|6|||
23625823|NCT00443898|66015617|FG000|Overall Study|Lost to Follow-up|10|||
23758350|NCT02923115|66492357|FG004|Overall Study|Withdrawal by Subject|0|||
23625824|NCT00443898|66015618|FG001|Overall Study|Lost to Follow-up|10|||
23625825|NCT00443898|66015619|FG002|Overall Study|Lost to Follow-up|14|||
23625826|NCT00443898|66015620|FG003|Overall Study|Lost to Follow-up|10|||
23625827|NCT00443898|66015617|FG000|Overall Study|Death|0|||
23625828|NCT00443898|66015618|FG001|Overall Study|Death|1|||
23625829|NCT00443898|66015619|FG002|Overall Study|Death|0|||
23625830|NCT00443898|66015620|FG003|Overall Study|Death|0|||
23625831|NCT00394589|66015621|FG000|Overall Study|Adverse Event|2|||
23758351|NCT02923115|66492358|FG005|Overall Study|Withdrawal by Subject|0|||
23563507|NCT00603265|65790496|FG002|Overall Study|Lack of Efficacy|3|||
23563508|NCT00603265|65790494|FG000|Overall Study|Lost to Follow-up|0|||
23563509|NCT00603265|65790495|FG001|Overall Study|Lost to Follow-up|1|||
23563510|NCT00603265|65790496|FG002|Overall Study|Lost to Follow-up|0|||
23563511|NCT00603265|65790494|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
23563512|NCT00603265|65790495|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
23563513|NCT00603265|65790496|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
23563514|NCT00603265|65790494|FG000|Overall Study|Participant Left Country, No Responses|0|||
23563515|NCT00603265|65790495|FG001|Overall Study|Participant Left Country, No Responses|1|||
23563516|NCT00603265|65790496|FG002|Overall Study|Participant Left Country, No Responses|0|||
23563517|NCT00603265|65790494|FG000|Overall Study|Protocol Violation|1|||
23563518|NCT00603265|65790495|FG001|Overall Study|Protocol Violation|0|||
23563519|NCT00603265|65790496|FG002|Overall Study|Protocol Violation|0|||
23563520|NCT04860518|65790497|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
23563521|NCT04860518|65790498|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
23563522|NCT00462670|65790499|FG000|Overall Study|Adverse Event|3|||
23563523|NCT00462670|65790500|FG001|Overall Study|Adverse Event|5|||
23563524|NCT00462670|65790499|FG000|Overall Study|Lack of Efficacy|1|||
23758352|NCT02923115|66492353|FG000|Overall Study|Randomized, but not dosed|0|||
23758353|NCT02923115|66492354|FG001|Overall Study|Randomized, but not dosed|0|||
23563525|NCT00462670|65790500|FG001|Overall Study|Lack of Efficacy|0|||
23563526|NCT00462670|65790499|FG000|Overall Study|Protocol Violation|1|||
23563527|NCT00462670|65790500|FG001|Overall Study|Protocol Violation|0|||
23563528|NCT00462670|65790499|FG000|Overall Study|Resolution of signs and symptoms|0|||
23563529|NCT00462670|65790500|FG001|Overall Study|Resolution of signs and symptoms|2|||
23563530|NCT01364597|65790501|FG000|Overall Study|Adverse Event|4|||
23563531|NCT01364597|65790502|FG001|Overall Study|Adverse Event|5|||
23563532|NCT01364597|65790503|FG002|Overall Study|Adverse Event|16|||
23563533|NCT01364597|65790504|FG003|Overall Study|Adverse Event|7|||
23563534|NCT01364597|65790501|FG000|Overall Study|Lack of Efficacy|4|||
23563535|NCT01364597|65790502|FG001|Overall Study|Lack of Efficacy|4|||
23758354|NCT02923115|66492355|FG002|Overall Study|Randomized, but not dosed|3|||
23758355|NCT02923115|66492356|FG003|Overall Study|Randomized, but not dosed|1|||
23758356|NCT02923115|66492357|FG004|Overall Study|Randomized, but not dosed|5|||
23563536|NCT01364597|65790503|FG002|Overall Study|Lack of Efficacy|23|||
23563537|NCT01364597|65790504|FG003|Overall Study|Lack of Efficacy|8|||
23563538|NCT01364597|65790501|FG000|Overall Study|Protocol Violation|0|||
23758357|NCT02923115|66492358|FG005|Overall Study|Randomized, but not dosed|0|||
23758358|NCT03740100|66492359|FG000|Overall Study|Adverse Event|1|||
23758359|NCT03740100|66492359|FG000|Overall Study|Death|1|||
23758360|NCT02868281|66492360|FG000|Overall Study|Adverse Event|2|||
23758361|NCT02868281|66492361|FG001|Overall Study|Adverse Event|2|||
23758362|NCT02868281|66492360|FG000|Overall Study|Protocol Violation|13|||
23758363|NCT02868281|66492361|FG001|Overall Study|Protocol Violation|10|||
23758364|NCT02868281|66492360|FG000|Overall Study|Lost to Follow-up|3|||
23758365|NCT02868281|66492361|FG001|Overall Study|Lost to Follow-up|6|||
23758366|NCT02868281|66492360|FG000|Overall Study|Withdrawal by Subject|11|||
23758367|NCT02868281|66492361|FG001|Overall Study|Withdrawal by Subject|15|||
23758368|NCT02868281|66492360|FG000|Overall Study|Physician Decision|2|||
23758369|NCT02868281|66492361|FG001|Overall Study|Physician Decision|0|||
23758370|NCT02868281|66492360|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
23758371|NCT02868281|66492361|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
23758372|NCT02868281|66492360|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
23758373|NCT02868281|66492361|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
23758374|NCT02868281|66492360|FG000|Overall Study|Long journey/moving away|1|||
23758375|NCT02868281|66492361|FG001|Overall Study|Long journey/moving away|1|||
23758376|NCT02191579|66492362|FG000|Treatment 1|Multiple Reasons Specified|27|||
23758377|NCT02191579|66492363|FG001|Treatment 1|Multiple Reasons Specified|58|||
23758378|NCT02191579|66492362|FG000|Treatment 2|Multiple Reasons Specified|0|||
23758379|NCT02191579|66492363|FG001|Treatment 2|Multiple Reasons Specified|25|||
23758380|NCT01613131|66492364|FG000|Overall Study|Withdrawal by Subject|3|||
23563539|NCT01364597|65790502|FG001|Overall Study|Protocol Violation|0|||
23563540|NCT01364597|65790503|FG002|Overall Study|Protocol Violation|2|||
23563541|NCT01364597|65790504|FG003|Overall Study|Protocol Violation|0|||
23563542|NCT01364597|65790501|FG000|Overall Study|Lost to Follow-up|0|||
23563543|NCT01364597|65790502|FG001|Overall Study|Lost to Follow-up|0|||
23563544|NCT01364597|65790503|FG002|Overall Study|Lost to Follow-up|5|||
23563545|NCT01364597|65790504|FG003|Overall Study|Lost to Follow-up|3|||
23563546|NCT01364597|65790501|FG000|Overall Study|Withdrawal by Subject|4|||
23563547|NCT01364597|65790502|FG001|Overall Study|Withdrawal by Subject|1|||
23758381|NCT01613131|66492365|FG001|Overall Study|Withdrawal by Subject|5|||
23758382|NCT00606801|66494528|FG000|Intervention|Protocol Violation|3|||
23758383|NCT00606801|66494529|FG001|Intervention|Protocol Violation|3|||
23758384|NCT00515073|66494530|FG000|Overall Study|Withdrawal by Subject|1|||
23758385|NCT00515073|66494530|FG000|Overall Study|Physician Decision|1|||
23758386|NCT01160198|66494531|FG000|Overall Study|Withdrawal by Subject|2|||
23758387|NCT01160198|66494532|FG001|Overall Study|Withdrawal by Subject|1|||
23758388|NCT01160198|66494533|FG002|Overall Study|Withdrawal by Subject|0|||
23563548|NCT01364597|65790503|FG002|Overall Study|Withdrawal by Subject|18|||
23563549|NCT01364597|65790504|FG003|Overall Study|Withdrawal by Subject|6|||
23563550|NCT01364597|65790501|FG000|Overall Study|Non compliance|1|||
23563551|NCT01364597|65790502|FG001|Overall Study|Non compliance|0|||
23563552|NCT01364597|65790503|FG002|Overall Study|Non compliance|1|||
23563553|NCT01364597|65790504|FG003|Overall Study|Non compliance|0|||
23563554|NCT01364597|65790501|FG000|Overall Study|Lack of compliance|1|||
23563555|NCT01364597|65790502|FG001|Overall Study|Lack of compliance|0|||
23563556|NCT01364597|65790503|FG002|Overall Study|Lack of compliance|0|||
23563557|NCT01364597|65790504|FG003|Overall Study|Lack of compliance|0|||
23563558|NCT01364597|65790501|FG000|Overall Study|End of treatment epilepsy|1|||
23563559|NCT01364597|65790502|FG001|Overall Study|End of treatment epilepsy|0|||
23563560|NCT01364597|65790503|FG002|Overall Study|End of treatment epilepsy|0|||
23563561|NCT01364597|65790504|FG003|Overall Study|End of treatment epilepsy|0|||
23563562|NCT01364597|65790501|FG000|Overall Study|No Seizures|1|||
23563563|NCT01364597|65790502|FG001|Overall Study|No Seizures|0|||
23758389|NCT01160198|66494531|FG000|Overall Study|Adverse Event|0|||
23758390|NCT01160198|66494532|FG001|Overall Study|Adverse Event|1|||
23758391|NCT01160198|66494533|FG002|Overall Study|Adverse Event|0|||
23758392|NCT01160198|66494531|FG000|Overall Study|Lost to Follow-up|0|||
23758393|NCT01160198|66494532|FG001|Overall Study|Lost to Follow-up|1|||
23758394|NCT01160198|66494533|FG002|Overall Study|Lost to Follow-up|0|||
23758395|NCT01160198|66494531|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
23758396|NCT01160198|66494532|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
23758397|NCT01160198|66494533|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
23758398|NCT00659581|66494534|FG000|Overall Study|Adverse Event|1006|||
23758399|NCT00659581|66494534|FG000|Overall Study|Lack of Efficacy|1183|||
23758400|NCT00659581|66494534|FG000|Overall Study|Other|6393|||
23563564|NCT01364597|65790503|FG002|Overall Study|No Seizures|0|||
23563565|NCT01364597|65790504|FG003|Overall Study|No Seizures|0|||
23563566|NCT01364597|65790501|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
23563567|NCT01364597|65790502|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563568|NCT01364597|65790503|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563569|NCT01364597|65790504|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563570|NCT01364597|65790501|FG000|Overall Study|Cure|1|||
23563571|NCT01364597|65790502|FG001|Overall Study|Cure|0|||
23563572|NCT01364597|65790503|FG002|Overall Study|Cure|0|||
23563573|NCT01364597|65790504|FG003|Overall Study|Cure|0|||
23563574|NCT01364597|65790501|FG000|Overall Study|Patient was moving|0|||
23563575|NCT01364597|65790502|FG001|Overall Study|Patient was moving|1|||
23563576|NCT01364597|65790503|FG002|Overall Study|Patient was moving|0|||
23563577|NCT01364597|65790504|FG003|Overall Study|Patient was moving|0|||
23563578|NCT01364597|65790501|FG000|Overall Study|Seizures resolved|0|||
23563579|NCT01364597|65790502|FG001|Overall Study|Seizures resolved|0|||
23563580|NCT01364597|65790503|FG002|Overall Study|Seizures resolved|1|||
23563581|NCT01364597|65790504|FG003|Overall Study|Seizures resolved|0|||
23563582|NCT01364597|65790501|FG000|Overall Study|Patient became seizure-free after surgery|0|||
23563583|NCT01364597|65790502|FG001|Overall Study|Patient became seizure-free after surgery|0|||
23563584|NCT01364597|65790503|FG002|Overall Study|Patient became seizure-free after surgery|1|||
23563585|NCT01364597|65790504|FG003|Overall Study|Patient became seizure-free after surgery|0|||
23563586|NCT01364597|65790501|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
23563587|NCT01364597|65790502|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
23563588|NCT01364597|65790503|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
23563589|NCT01364597|65790504|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
23563590|NCT01364597|65790501|FG000|Overall Study|Patient cured from Epilepsy|0|||
23563591|NCT01364597|65790502|FG001|Overall Study|Patient cured from Epilepsy|0|||
23563592|NCT01364597|65790503|FG002|Overall Study|Patient cured from Epilepsy|1|||
23563593|NCT01364597|65790504|FG003|Overall Study|Patient cured from Epilepsy|0|||
23563594|NCT01364597|65790501|FG000|Overall Study|Investigator decision|0|||
23563595|NCT01364597|65790502|FG001|Overall Study|Investigator decision|0|||
23563596|NCT01364597|65790503|FG002|Overall Study|Investigator decision|1|||
23758401|NCT01946282|66494535|FG000|Year 1|Did not return FIT kit|4186|||
23563597|NCT01364597|65790504|FG003|Overall Study|Investigator decision|0|||
23563598|NCT01364597|65790501|FG000|Overall Study|Sponsor recommended discontinuation|0|||
23563599|NCT01364597|65790502|FG001|Overall Study|Sponsor recommended discontinuation|0|||
23563600|NCT01364597|65790503|FG002|Overall Study|Sponsor recommended discontinuation|0|||
23563601|NCT01364597|65790504|FG003|Overall Study|Sponsor recommended discontinuation|1|||
23563602|NCT01364597|65790501|FG000|Overall Study|Parents went abroad with the patient|0|||
23758402|NCT01946282|66494536|FG001|Year 1|Did not return FIT kit|608|||
23758403|NCT01946282|66494537|FG002|Year 1|Did not return FIT kit|654|||
23758404|NCT01946282|66494535|FG000|Year 2|Did not return FIT kit|803|||
23563603|NCT01364597|65790502|FG001|Overall Study|Parents went abroad with the patient|0|||
23563604|NCT01364597|65790503|FG002|Overall Study|Parents went abroad with the patient|1|||
23758405|NCT01946282|66494536|FG001|Year 2|Did not return FIT kit|131|||
23563605|NCT01364597|65790504|FG003|Overall Study|Parents went abroad with the patient|0|||
23563606|NCT01364597|65790501|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563607|NCT01364597|65790502|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563608|NCT01364597|65790503|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
23563609|NCT01364597|65790504|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563610|NCT01364597|65790501|FG000|Overall Study|BRV administration dropout|0|||
23563611|NCT01364597|65790502|FG001|Overall Study|BRV administration dropout|0|||
23563612|NCT01364597|65790503|FG002|Overall Study|BRV administration dropout|1|||
23563613|NCT01364597|65790504|FG003|Overall Study|BRV administration dropout|0|||
23563614|NCT01364597|65790501|FG000|Overall Study|Dropout|0|||
23563615|NCT01364597|65790502|FG001|Overall Study|Dropout|0|||
23563616|NCT01364597|65790503|FG002|Overall Study|Dropout|3|||
23563617|NCT01364597|65790504|FG003|Overall Study|Dropout|1|||
23563618|NCT01364597|65790501|FG000|Overall Study|Unreliable subject|0|||
23563619|NCT01364597|65790502|FG001|Overall Study|Unreliable subject|0|||
23563620|NCT01364597|65790503|FG002|Overall Study|Unreliable subject|0|||
23563621|NCT01364597|65790504|FG003|Overall Study|Unreliable subject|1|||
23563622|NCT01364597|65790501|FG000|Overall Study|Other|0|||
23563623|NCT01364597|65790502|FG001|Overall Study|Other|0|||
23563624|NCT01364597|65790503|FG002|Overall Study|Other|0|||
23758406|NCT01946282|66494537|FG002|Year 2|Did not return FIT kit|115|||
23758407|NCT01946282|66494535|FG000|Year 3|Did not return FIT kit|288|||
23758408|NCT01946282|66494536|FG001|Year 3|Did not return FIT kit|43|||
23758409|NCT01946282|66494537|FG002|Year 3|Did not return FIT kit|30|||
23758410|NCT01154127|66494542|FG000|Period 1 (21 Days)|Adverse Event|3|||
23758411|NCT01154127|66494543|FG001|Period 1 (21 Days)|Adverse Event|4|||
23758412|NCT01154127|66494542|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
23758413|NCT01154127|66494543|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
23758414|NCT01154127|66494542|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
23758415|NCT01154127|66494543|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
23758416|NCT01154127|66494542|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
23758417|NCT01154127|66494543|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
23758418|NCT01154127|66494542|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
23758419|NCT01154127|66494543|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
23758420|NCT00579254|66494546|FG000|Overall Study|Lost to Follow-up|39|||
23758421|NCT00579254|66494546|FG000|Overall Study|Discontinued when study terminated|73|||
23758422|NCT01749033|66494547|FG000|Overall Study|Did not receive allocated intervention|3|||
23758423|NCT01749033|66494548|FG001|Overall Study|Did not receive allocated intervention|3|||
23758424|NCT01749033|66494549|FG002|Overall Study|Did not receive allocated intervention|0|||
23758425|NCT01749033|66494547|FG000|Overall Study|Lost to Follow-up|0|||
23758426|NCT01749033|66494548|FG001|Overall Study|Lost to Follow-up|2|||
23758427|NCT01749033|66494549|FG002|Overall Study|Lost to Follow-up|1|||
23758428|NCT00936884|66494550|FG000|Double-blind|Withdrawal by Subject|6|||
23758429|NCT00936884|66494551|FG001|Double-blind|Withdrawal by Subject|4|||
23758430|NCT00936884|66494552|FG002|Double-blind|Withdrawal by Subject|0|||
23758431|NCT00936884|66494550|FG000|Double-blind|Death|2|||
23758432|NCT00936884|66494551|FG001|Double-blind|Death|1|||
23758433|NCT00936884|66494552|FG002|Double-blind|Death|0|||
23758434|NCT00936884|66494550|FG000|Double-blind|Lack of Efficacy|1|||
23758435|NCT00936884|66494551|FG001|Double-blind|Lack of Efficacy|1|||
23758436|NCT00936884|66494552|FG002|Double-blind|Lack of Efficacy|0|||
23563625|NCT01364597|65790504|FG003|Overall Study|Other|1|||
23563626|NCT00067990|65790505|FG000|Overall Study|Death|5|||
23758437|NCT00936884|66494550|FG000|Double-blind|Adverse Event|1|||
23758438|NCT00936884|66494551|FG001|Double-blind|Adverse Event|0|||
23758439|NCT00936884|66494552|FG002|Double-blind|Adverse Event|0|||
23758440|NCT00936884|66494550|FG000|Double-blind|Physician Decision|1|||
23758441|NCT00936884|66494551|FG001|Double-blind|Physician Decision|0|||
23758442|NCT00936884|66494552|FG002|Double-blind|Physician Decision|0|||
23758443|NCT00936884|66494550|FG000|Double-blind|No post baseline diary entry|1|||
23758444|NCT00936884|66494551|FG001|Double-blind|No post baseline diary entry|0|||
23758445|NCT00936884|66494552|FG002|Double-blind|No post baseline diary entry|0|||
23758446|NCT00936884|66494550|FG000|Double-blind|Did not receive study drug|0|||
23758447|NCT00936884|66494551|FG001|Double-blind|Did not receive study drug|1|||
23758448|NCT00936884|66494552|FG002|Double-blind|Did not receive study drug|0|||
23563627|NCT00067990|65790506|FG001|Overall Study|Death|7|||
23563628|NCT00067990|65790505|FG000|Overall Study|ESRD, Non IF/TA|1|||
23563629|NCT00067990|65790506|FG001|Overall Study|ESRD, Non IF/TA|3|||
23563630|NCT00067990|65790505|FG000|Overall Study|Withdrawal by Subject|4|||
23563631|NCT00067990|65790506|FG001|Overall Study|Withdrawal by Subject|12|||
23563632|NCT03035032|65790512|FG000|Overall Study|Adverse Event|2|||
23563633|NCT03035032|65790512|FG000|Overall Study|Death|9|||
23563634|NCT03035032|65790512|FG000|Overall Study|Lost to Follow-up|1|||
23758449|NCT00304954|66494553|FG000|Overall Study|Withdrawal by Subject|0|||
23758450|NCT00304954|66494554|FG001|Overall Study|Withdrawal by Subject|0|||
23758451|NCT00304954|66494555|FG002|Overall Study|Withdrawal by Subject|1|||
23563635|NCT03035032|65790512|FG000|Overall Study|Progressive Disease|22|||
23758452|NCT00304954|66494556|FG003|Overall Study|Withdrawal by Subject|0|||
23625832|NCT00394589|66015622|FG001|Overall Study|Adverse Event|1|||
23625833|NCT00394589|66015623|FG002|Overall Study|Adverse Event|2|||
23625834|NCT00394589|66015621|FG000|Overall Study|Lack of Efficacy|2|||
23625835|NCT00394589|66015622|FG001|Overall Study|Lack of Efficacy|2|||
23625836|NCT00394589|66015623|FG002|Overall Study|Lack of Efficacy|3|||
23625837|NCT00394589|66015621|FG000|Overall Study|Protocol Violation|4|||
23625838|NCT00394589|66015622|FG001|Overall Study|Protocol Violation|0|||
23625839|NCT00394589|66015623|FG002|Overall Study|Protocol Violation|2|||
23625840|NCT03409731|66015628|FG000|Overall Study|Withdrawal by Subject|17|||
23625841|NCT03409731|66015628|FG000|Overall Study|Death|4|||
23625842|NCT01407276|66015631|FG000|Overall Study|Withdrawal by Subject|0|||
23625843|NCT01407276|66015632|FG001|Overall Study|Withdrawal by Subject|0|||
23625844|NCT01407276|66015633|FG002|Overall Study|Withdrawal by Subject|0|||
23625845|NCT01407276|66015634|FG003|Overall Study|Withdrawal by Subject|0|||
23625846|NCT01407276|66015635|FG004|Overall Study|Withdrawal by Subject|0|||
23625847|NCT01407276|66015636|FG005|Overall Study|Withdrawal by Subject|0|||
23625848|NCT01407276|66015637|FG006|Overall Study|Withdrawal by Subject|0|||
23826693|NCT01924689|66745176|FG002|Overall Study|Death|0|||
23826694|NCT01924689|66745177|FG003|Overall Study|Death|1|||
23826695|NCT01924689|66745178|FG004|Overall Study|Death|0|||
23826696|NCT01924689|66745179|FG005|Overall Study|Death|0|||
23826697|NCT01924689|66745174|FG000|Overall Study|Disease progression|0|||
23826698|NCT01924689|66745175|FG001|Overall Study|Disease progression|0|||
23826699|NCT01924689|66745176|FG002|Overall Study|Disease progression|2|||
23826700|NCT01924689|66745177|FG003|Overall Study|Disease progression|0|||
23826701|NCT01924689|66745178|FG004|Overall Study|Disease progression|3|||
23826702|NCT01924689|66745179|FG005|Overall Study|Disease progression|2|||
23826703|NCT01924689|66745174|FG000|Overall Study|New therapy or study|3|||
23826704|NCT01924689|66745175|FG001|Overall Study|New therapy or study|2|||
23826705|NCT01924689|66745176|FG002|Overall Study|New therapy or study|1|||
23826706|NCT01924689|66745177|FG003|Overall Study|New therapy or study|4|||
23826707|NCT01924689|66745178|FG004|Overall Study|New therapy or study|2|||
23826708|NCT01924689|66745179|FG005|Overall Study|New therapy or study|0|||
23826709|NCT01924689|66745174|FG000|Overall Study|Withdrawal of consent|0|||
23625849|NCT01407276|66015638|FG007|Overall Study|Withdrawal by Subject|1|||
23625850|NCT01689363|66015639|FG000|Overall Study|Protocol Violation|0|||
23625851|NCT01689363|66015640|FG001|Overall Study|Protocol Violation|1|||
23758453|NCT00304954|66494553|FG000|Overall Study|Adverse Event|1|||
23758454|NCT00304954|66494554|FG001|Overall Study|Adverse Event|0|||
23758455|NCT00304954|66494555|FG002|Overall Study|Adverse Event|0|||
23758456|NCT00304954|66494556|FG003|Overall Study|Adverse Event|0|||
23758457|NCT01128153|66494558|FG000|Overall Study|Adverse Event|1|||
23758458|NCT01128153|66494559|FG001|Overall Study|Adverse Event|3|||
23758459|NCT01128153|66494558|FG000|Overall Study|Condition under investigation worsened|8|||
23758460|NCT01128153|66494559|FG001|Overall Study|Condition under investigation worsened|7|||
23758461|NCT01128153|66494558|FG000|Overall Study|Withdrawal by Subject|2|||
23758462|NCT01128153|66494559|FG001|Overall Study|Withdrawal by Subject|3|||
23758463|NCT01128153|66494558|FG000|Overall Study|Incorrect enrolment to study|2|||
23758464|NCT01128153|66494559|FG001|Overall Study|Incorrect enrolment to study|1|||
23758465|NCT01128153|66494558|FG000|Overall Study|Protocol Violation|2|||
23758466|NCT01128153|66494559|FG001|Overall Study|Protocol Violation|0|||
23758467|NCT01128153|66494558|FG000|Overall Study|Developed discontinuation criteria|1|||
23758468|NCT01128153|66494559|FG001|Overall Study|Developed discontinuation criteria|1|||
23758469|NCT00895583|66494562|FG000|Overall Study|Adverse Event|28|||
23758470|NCT00895583|66494563|FG001|Overall Study|Adverse Event|4|||
23758471|NCT00895583|66494562|FG000|Overall Study|Death|2|||
23826710|NCT01924689|66745175|FG001|Overall Study|Withdrawal of consent|0|||
23758472|NCT00895583|66494563|FG001|Overall Study|Death|1|||
23758473|NCT00895583|66494562|FG000|Overall Study|Physician Decision|3|||
23758474|NCT00895583|66494563|FG001|Overall Study|Physician Decision|1|||
23758475|NCT00895583|66494562|FG000|Overall Study|Lost to Follow-up|1|||
23826711|NCT01924689|66745176|FG002|Overall Study|Withdrawal of consent|1|||
23826712|NCT01924689|66745177|FG003|Overall Study|Withdrawal of consent|1|||
23826713|NCT01924689|66745178|FG004|Overall Study|Withdrawal of consent|0|||
23826714|NCT01924689|66745179|FG005|Overall Study|Withdrawal of consent|0|||
23625852|NCT01689363|66015641|FG002|Overall Study|Protocol Violation|0|||
23625853|NCT01689363|66015642|FG003|Overall Study|Protocol Violation|0|||
23625854|NCT01689363|66015643|FG004|Overall Study|Protocol Violation|0|||
23440694|NCT00348309|65355281|FG001|Overall Study|Non-compliance|6|||
23440695|NCT00348309|65355282|FG002|Overall Study|Non-compliance|8|||
23440696|NCT00348309|65355280|FG000|Overall Study|Death of caregiver|1|||
23440697|NCT00348309|65355281|FG001|Overall Study|Death of caregiver|0|||
23440698|NCT00348309|65355282|FG002|Overall Study|Death of caregiver|1|||
23440699|NCT00348309|65355280|FG000|Overall Study|Lack of insight, dementia|1|||
23563636|NCT03035032|65790512|FG000|Overall Study|Protocol Violation|2|||
23563637|NCT03035032|65790512|FG000|Overall Study|Withdrawal by Subject|2|||
23563638|NCT03035032|65790512|FG000|Overall Study|Physician Decision|5|||
23563639|NCT02322814|65790513|FG000|Overall Study|Death|7|||
23563640|NCT02322814|65790514|FG001|Overall Study|Death|29|||
23563641|NCT02322814|65790515|FG002|Overall Study|Death|32|||
23563642|NCT02322814|65790516|FG003|Overall Study|Death|23|||
23563643|NCT02322814|65790517|FG004|Overall Study|Death|14|||
23758476|NCT00895583|66494563|FG001|Overall Study|Lost to Follow-up|3|||
23758477|NCT00895583|66494562|FG000|Overall Study|Protocol Violation|1|||
23440700|NCT00348309|65355281|FG001|Overall Study|Lack of insight, dementia|0|||
23440701|NCT00348309|65355282|FG002|Overall Study|Lack of insight, dementia|0|||
23440702|NCT00348309|65355280|FG000|Overall Study|Wrong bottle allocated|1|||
23440703|NCT00348309|65355281|FG001|Overall Study|Wrong bottle allocated|0|||
23440704|NCT00348309|65355282|FG002|Overall Study|Wrong bottle allocated|0|||
23440705|NCT00348309|65355280|FG000|Overall Study|Caregiver sick|1|||
23440706|NCT00348309|65355281|FG001|Overall Study|Caregiver sick|0|||
23440707|NCT00348309|65355282|FG002|Overall Study|Caregiver sick|0|||
23440708|NCT00348309|65355280|FG000|Overall Study|Use of prohibited medication|5|||
23440709|NCT00348309|65355281|FG001|Overall Study|Use of prohibited medication|2|||
23440710|NCT00348309|65355282|FG002|Overall Study|Use of prohibited medication|2|||
23440711|NCT00348309|65355280|FG000|Overall Study|Caregiver withdrawal|3|||
23440712|NCT00348309|65355281|FG001|Overall Study|Caregiver withdrawal|0|||
23440713|NCT00348309|65355282|FG002|Overall Study|Caregiver withdrawal|7|||
23440714|NCT00348309|65355280|FG000|Overall Study|Unable to complete ET visit|1|||
23440715|NCT00348309|65355281|FG001|Overall Study|Unable to complete ET visit|0|||
23440716|NCT00348309|65355282|FG002|Overall Study|Unable to complete ET visit|0|||
23440717|NCT00348309|65355280|FG000|Overall Study|PI closing medical practice|1|||
23440718|NCT00348309|65355281|FG001|Overall Study|PI closing medical practice|0|||
23440719|NCT00348309|65355282|FG002|Overall Study|PI closing medical practice|0|||
23440720|NCT00348309|65355280|FG000|Overall Study|Principal investigator's decision|1|||
23440721|NCT00348309|65355281|FG001|Overall Study|Principal investigator's decision|0|||
23440722|NCT00348309|65355282|FG002|Overall Study|Principal investigator's decision|0|||
23440723|NCT00348309|65355280|FG000|Overall Study|No disponibility of medication|1|||
23440724|NCT00348309|65355281|FG001|Overall Study|No disponibility of medication|0|||
23440725|NCT00348309|65355282|FG002|Overall Study|No disponibility of medication|0|||
23440726|NCT00348309|65355280|FG000|Overall Study|Worsened neurodegenerative disease|1|||
23440727|NCT00348309|65355281|FG001|Overall Study|Worsened neurodegenerative disease|0|||
23440728|NCT00348309|65355282|FG002|Overall Study|Worsened neurodegenerative disease|0|||
23440729|NCT00348309|65355280|FG000|Overall Study|Cognitive and behaviour worsening|2|||
23440730|NCT00348309|65355281|FG001|Overall Study|Cognitive and behaviour worsening|0|||
23440731|NCT00348309|65355282|FG002|Overall Study|Cognitive and behaviour worsening|0|||
23758478|NCT00895583|66494563|FG001|Overall Study|Protocol Violation|0|||
23440732|NCT00348309|65355280|FG000|Overall Study|Worsening of alzheimer|1|||
23440733|NCT00348309|65355281|FG001|Overall Study|Worsening of alzheimer|0|||
23440734|NCT00348309|65355282|FG002|Overall Study|Worsening of alzheimer|1|||
23440735|NCT00348309|65355280|FG000|Overall Study|Did not appear in time for Visit 3|1|||
23440736|NCT00348309|65355281|FG001|Overall Study|Did not appear in time for Visit 3|0|||
23440737|NCT00348309|65355282|FG002|Overall Study|Did not appear in time for Visit 3|0|||
23758479|NCT00895583|66494562|FG000|Overall Study|Withdrawal by Subject|4|||
23758480|NCT00895583|66494563|FG001|Overall Study|Withdrawal by Subject|2|||
23758481|NCT00895583|66494562|FG000|Overall Study|Lack of Efficacy|5|||
23758482|NCT00895583|66494563|FG001|Overall Study|Lack of Efficacy|0|||
23758483|NCT00895583|66494562|FG000|Overall Study|Other|0|||
23758484|NCT00895583|66494563|FG001|Overall Study|Other|1|||
23758485|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
23563644|NCT02322814|65790513|FG000|Overall Study|Lost to Follow-up|1|||
23563645|NCT02322814|65790514|FG001|Overall Study|Lost to Follow-up|3|||
23563646|NCT02322814|65790515|FG002|Overall Study|Lost to Follow-up|3|||
23758486|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
23758487|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
23758488|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
23440738|NCT00348309|65355280|FG000|Overall Study|Participant died|2|||
23440739|NCT00348309|65355281|FG001|Overall Study|Participant died|1|||
23440740|NCT00348309|65355282|FG002|Overall Study|Participant died|1|||
23440741|NCT00348309|65355280|FG000|Overall Study|Decision of sponsor|1|||
23440742|NCT00348309|65355281|FG001|Overall Study|Decision of sponsor|0|||
23563647|NCT02322814|65790516|FG003|Overall Study|Lost to Follow-up|1|||
23758489|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
23826715|NCT01924689|66745174|FG000|Overall Study|Other|0|||
23826716|NCT01924689|66745175|FG001|Overall Study|Other|0|||
23826717|NCT01924689|66745176|FG002|Overall Study|Other|0|||
23826718|NCT01924689|66745177|FG003|Overall Study|Other|0|||
23563648|NCT02322814|65790517|FG004|Overall Study|Lost to Follow-up|0|||
23758490|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
23758491|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
23758492|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
23758493|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
23758494|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
23758495|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
23758496|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
23758497|NCT01600014|66494565|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
23758498|NCT01600014|66494566|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
23758499|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
23758500|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
23758501|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
23758502|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
23758503|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
23758504|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
23758505|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
23758506|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
23758507|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
23758508|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
23758509|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
23758510|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
23758511|NCT01600014|66494565|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
23758512|NCT01600014|66494566|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
23758513|NCT01600014|66494565|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
23758514|NCT01600014|66494566|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
23758515|NCT01600014|66494565|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
23758516|NCT01600014|66494566|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
23758517|NCT01600014|66494565|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
23758518|NCT01600014|66494566|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
23758519|NCT02477696|66494569|FG000|Overall Study|Death|89|||
23758520|NCT02477696|66494570|FG001|Overall Study|Death|106|||
23758521|NCT02477696|66494569|FG000|Overall Study|Lost to Follow-up|7|||
23758522|NCT02477696|66494570|FG001|Overall Study|Lost to Follow-up|5|||
23758523|NCT02477696|66494569|FG000|Overall Study|Withdrawal by Subject|37|||
23758524|NCT02477696|66494570|FG001|Overall Study|Withdrawal by Subject|34|||
23758525|NCT02477696|66494569|FG000|Overall Study|Physician Decision|7|||
23758526|NCT02477696|66494570|FG001|Overall Study|Physician Decision|9|||
23758527|NCT02477696|66494569|FG000|Overall Study|Study terminated by sponsor|103|||
23758528|NCT02477696|66494570|FG001|Overall Study|Study terminated by sponsor|99|||
23758529|NCT02477696|66494569|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
23758530|NCT02477696|66494570|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
23758531|NCT02477696|66494569|FG000|Overall Study|Missing/Unknown|2|||
23758532|NCT02477696|66494570|FG001|Overall Study|Missing/Unknown|0|||
23758533|NCT03724968|66494578|FG000|Overall Study|Insurance issues|0|||
23758534|NCT03724968|66494579|FG001|Overall Study|Insurance issues|1|||
23758535|NCT03724968|66494578|FG000|Overall Study|Study closed|0|||
23758536|NCT03724968|66494579|FG001|Overall Study|Study closed|1|||
23758537|NCT00457665|66494580|FG000|12 Months|Drug allergy|1|||
23758538|NCT00457665|66494581|FG001|12 Months|Drug allergy|1|||
23758539|NCT00457665|66494580|FG000|12 Months|High HIV viral load|5|||
23758540|NCT00457665|66494581|FG001|12 Months|High HIV viral load|1|||
23826719|NCT01924689|66745178|FG004|Overall Study|Other|1|||
23826720|NCT01924689|66745179|FG005|Overall Study|Other|0|||
23563649|NCT02322814|65790513|FG000|Overall Study|Various Reasons|2|||
23563650|NCT02322814|65790514|FG001|Overall Study|Various Reasons|0|||
23563651|NCT02322814|65790515|FG002|Overall Study|Various Reasons|1|||
23563652|NCT02322814|65790516|FG003|Overall Study|Various Reasons|1|||
23758541|NCT00457665|66494580|FG000|12 Months|Lipodystrophy|2|||
23826721|NCT03668808|66745184|FG000|First Intervention|Withdrawal by Subject|2|||
23563653|NCT02322814|65790517|FG004|Overall Study|Various Reasons|0|||
23563654|NCT02322814|65790513|FG000|Overall Study|Progressive Disease|0|||
23563655|NCT02322814|65790514|FG001|Overall Study|Progressive Disease|0|||
23563656|NCT02322814|65790515|FG002|Overall Study|Progressive Disease|0|||
23758542|NCT00457665|66494581|FG001|12 Months|Lipodystrophy|0|||
23758543|NCT00457665|66494580|FG000|12 Months|Withdrawal by Subject|0|||
23758544|NCT00457665|66494581|FG001|12 Months|Withdrawal by Subject|2|||
23758545|NCT00457665|66494580|FG000|12 Months|Abnormal Liver function tests|0|||
23758546|NCT00457665|66494581|FG001|12 Months|Abnormal Liver function tests|5|||
23758547|NCT00457665|66494580|FG000|24 Months|Withdrawal by Subject|3|||
23758548|NCT00457665|66494581|FG001|24 Months|Withdrawal by Subject|2|||
23758549|NCT00457665|66494580|FG000|24 Months|Lipodystrophy|1|||
23758550|NCT00457665|66494581|FG001|24 Months|Lipodystrophy|1|||
23758551|NCT00457665|66494580|FG000|24 Months|Abnormal liver function tests|1|||
23758552|NCT00457665|66494581|FG001|24 Months|Abnormal liver function tests|5|||
23758553|NCT01142466|66494582|FG000|Overall Study|Adverse Event|2|||
23758554|NCT01142466|66494583|FG001|Overall Study|Adverse Event|1|||
23758555|NCT01142466|66494582|FG000|Overall Study|Withdrawal by Subject|1|||
23758556|NCT01142466|66494583|FG001|Overall Study|Withdrawal by Subject|1|||
23758557|NCT03578276|66494589|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
23758558|NCT03578276|66494590|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
23758559|NCT01246973|66494591|FG000|Overall Study|Other|38|||
23440743|NCT00348309|65355282|FG002|Overall Study|Decision of sponsor|0|||
23440744|NCT00348309|65355280|FG000|Overall Study|Ineffectiveness of treatment|0|||
23440745|NCT00348309|65355281|FG001|Overall Study|Ineffectiveness of treatment|1|||
23758560|NCT01246973|66494592|FG001|Overall Study|Other|25|||
23440746|NCT00348309|65355282|FG002|Overall Study|Ineffectiveness of treatment|0|||
23758561|NCT01246973|66494591|FG000|Overall Study|Adverse Event|16|||
23625855|NCT01689363|66015644|FG005|Overall Study|Protocol Violation|0|||
23625856|NCT01689363|66015645|FG006|Overall Study|Protocol Violation|0|||
23625857|NCT01689363|66015646|FG007|Overall Study|Protocol Violation|0|||
23758562|NCT01246973|66494592|FG001|Overall Study|Adverse Event|9|||
23758563|NCT01246973|66494591|FG000|Overall Study|Withdrawal by Subject|7|||
23758564|NCT01246973|66494592|FG001|Overall Study|Withdrawal by Subject|13|||
23758565|NCT00103259|66494593|FG000|Overall Study|Death|3|||
23758566|NCT00103259|66494594|FG001|Overall Study|Death|2|||
23758567|NCT00103259|66494593|FG000|Overall Study|Withdrawal by Subject|2|||
23758568|NCT00103259|66494594|FG001|Overall Study|Withdrawal by Subject|3|||
23758569|NCT00103259|66494593|FG000|Overall Study|alternative therapy|1|||
23758570|NCT00103259|66494594|FG001|Overall Study|alternative therapy|0|||
23758571|NCT00103259|66494593|FG000|Overall Study|other (reasons were not specified)|2|||
23758572|NCT00103259|66494594|FG001|Overall Study|other (reasons were not specified)|1|||
23758573|NCT00103259|66494593|FG000|Overall Study|ineligible/no protocol therapy|4|||
23758574|NCT00103259|66494594|FG001|Overall Study|ineligible/no protocol therapy|6|||
23758575|NCT00272961|66494595|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
23758576|NCT00272961|66494596|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23758577|NCT00272961|66494597|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23758578|NCT00272961|66494598|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23758579|NCT00272961|66494599|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23758580|NCT00272961|66494595|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
23758581|NCT00272961|66494596|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23758582|NCT00272961|66494597|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23758583|NCT00272961|66494598|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23758584|NCT00272961|66494599|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23758585|NCT00272961|66494595|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
23758586|NCT00272961|66494596|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23758587|NCT00272961|66494597|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23758588|NCT00272961|66494598|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23758589|NCT00272961|66494599|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23758590|NCT00272961|66494595|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
23758591|NCT00272961|66494596|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23758592|NCT00272961|66494597|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23758593|NCT00272961|66494598|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23758594|NCT00272961|66494599|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23758595|NCT00272961|66494595|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
23758596|NCT00272961|66494596|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
23758597|NCT00272961|66494597|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
23758598|NCT00272961|66494598|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
23758599|NCT00272961|66494599|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
23758600|NCT00272961|66494595|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
23758601|NCT00272961|66494596|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
23758602|NCT00272961|66494597|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
23758603|NCT00272961|66494598|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
23758604|NCT00272961|66494599|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
23758605|NCT00272961|66494595|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
23758606|NCT00272961|66494596|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23625858|NCT01336205|66015647|FG000|Overall Study|Other|22|||
23440747|NCT00348309|65355280|FG000|Overall Study|A foul of exclusion criteria|0|||
23440748|NCT00348309|65355281|FG001|Overall Study|A foul of exclusion criteria|1|||
23440749|NCT00348309|65355282|FG002|Overall Study|A foul of exclusion criteria|0|||
23440750|NCT00348309|65355280|FG000|Overall Study|Participant was hospitalized|0|||
23440751|NCT00348309|65355281|FG001|Overall Study|Participant was hospitalized|1|||
23440752|NCT00348309|65355282|FG002|Overall Study|Participant was hospitalized|0|||
23440753|NCT00348309|65355280|FG000|Overall Study|Sponsor refuseal|0|||
23440754|NCT00348309|65355281|FG001|Overall Study|Sponsor refuseal|1|||
23440755|NCT00348309|65355282|FG002|Overall Study|Sponsor refuseal|1|||
23440756|NCT00348309|65355280|FG000|Overall Study|Forgot often medication|0|||
23440757|NCT00348309|65355281|FG001|Overall Study|Forgot often medication|1|||
23440758|NCT00348309|65355282|FG002|Overall Study|Forgot often medication|0|||
23440759|NCT00348309|65355280|FG000|Overall Study|Medical Monitor decision|0|||
23440760|NCT00348309|65355281|FG001|Overall Study|Medical Monitor decision|0|||
23440761|NCT00348309|65355282|FG002|Overall Study|Medical Monitor decision|1|||
23440762|NCT00348309|65355280|FG000|Overall Study|Increased dose of Aricept|0|||
23440763|NCT00348309|65355281|FG001|Overall Study|Increased dose of Aricept|0|||
23440764|NCT00348309|65355282|FG002|Overall Study|Increased dose of Aricept|1|||
23440765|NCT00348309|65355280|FG000|Overall Study|Site closure|0|||
23440766|NCT00348309|65355281|FG001|Overall Study|Site closure|0|||
23440767|NCT00348309|65355282|FG002|Overall Study|Site closure|1|||
23440768|NCT00348309|65355280|FG000|Overall Study|Adverse event not attended|0|||
23440769|NCT00348309|65355281|FG001|Overall Study|Adverse event not attended|0|||
23440770|NCT00348309|65355282|FG002|Overall Study|Adverse event not attended|1|||
23440771|NCT00348309|65355280|FG000|Overall Study|ECG abnormal|0|||
23440772|NCT00348309|65355281|FG001|Overall Study|ECG abnormal|0|||
23440773|NCT00348309|65355282|FG002|Overall Study|ECG abnormal|2|||
23440774|NCT00348309|65355280|FG000|Overall Study|Cardiologist recommendations|0|||
23440775|NCT00348309|65355281|FG001|Overall Study|Cardiologist recommendations|0|||
23440776|NCT00348309|65355282|FG002|Overall Study|Cardiologist recommendations|1|||
23440777|NCT00348309|65355280|FG000|Overall Study|HCV career|0|||
23440778|NCT00348309|65355281|FG001|Overall Study|HCV career|0|||
23440779|NCT00348309|65355282|FG002|Overall Study|HCV career|1|||
23440780|NCT04310566|65355283|FG000|Period 1|Study Termination due to COVID-19|15|||
23440781|NCT04310566|65355284|FG001|Period 1|Study Termination due to COVID-19|17|||
23440782|NCT04310566|65355283|FG000|Period 1|Protocol Violation|0|||
23440783|NCT04310566|65355284|FG001|Period 1|Protocol Violation|1|||
23440784|NCT04310566|65355283|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
23440785|NCT04310566|65355284|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
23440786|NCT04310566|65355283|FG000|Period 1|Lost to Follow-up|1|||
23440787|NCT04310566|65355284|FG001|Period 1|Lost to Follow-up|0|||
23440788|NCT04310566|65355283|FG000|Period 1|Withdrawal by Subject|0|||
23440789|NCT04310566|65355284|FG001|Period 1|Withdrawal by Subject|1|||
23440790|NCT04310566|65355283|FG000|Period 2|Study Termination|7|||
23440791|NCT04310566|65355284|FG001|Period 2|Study Termination|5|||
23440792|NCT00211887|65355287|FG000|Overall Study|Adverse Event|8|||
23440793|NCT00211887|65355288|FG001|Overall Study|Adverse Event|4|||
23440794|NCT00211887|65355289|FG002|Overall Study|Adverse Event|6|||
23758607|NCT00272961|66494597|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
23440795|NCT00211887|65355287|FG000|Overall Study|Death|1|||
23440796|NCT00211887|65355288|FG001|Overall Study|Death|1|||
23440797|NCT00211887|65355289|FG002|Overall Study|Death|1|||
23440798|NCT00211887|65355287|FG000|Overall Study|Lost to Follow-up|28|||
23440799|NCT00211887|65355288|FG001|Overall Study|Lost to Follow-up|13|||
23440800|NCT00211887|65355289|FG002|Overall Study|Lost to Follow-up|9|||
23440801|NCT00211887|65355287|FG000|Overall Study|Non-medical reason|31|||
23440802|NCT00211887|65355288|FG001|Overall Study|Non-medical reason|14|||
23440803|NCT00211887|65355289|FG002|Overall Study|Non-medical reason|8|||
23440804|NCT00211887|65355287|FG000|Overall Study|Other medical reason|15|||
23563657|NCT02322814|65790516|FG003|Overall Study|Progressive Disease|1|||
23563658|NCT02322814|65790517|FG004|Overall Study|Progressive Disease|1|||
23563659|NCT02322814|65790513|FG000|Overall Study|Protocol Violation|1|||
23563660|NCT02322814|65790514|FG001|Overall Study|Protocol Violation|0|||
23563661|NCT02322814|65790515|FG002|Overall Study|Protocol Violation|0|||
23563662|NCT02322814|65790516|FG003|Overall Study|Protocol Violation|0|||
23563663|NCT02322814|65790517|FG004|Overall Study|Protocol Violation|0|||
23563664|NCT02322814|65790513|FG000|Overall Study|Study Terminated by Sponsor|0|||
23563665|NCT02322814|65790514|FG001|Overall Study|Study Terminated by Sponsor|7|||
23563666|NCT02322814|65790515|FG002|Overall Study|Study Terminated by Sponsor|9|||
23563667|NCT02322814|65790516|FG003|Overall Study|Study Terminated by Sponsor|5|||
23563668|NCT02322814|65790517|FG004|Overall Study|Study Terminated by Sponsor|13|||
23563669|NCT02322814|65790513|FG000|Overall Study|Withdrawal by Subject|5|||
23563670|NCT02322814|65790514|FG001|Overall Study|Withdrawal by Subject|4|||
23563671|NCT02322814|65790515|FG002|Overall Study|Withdrawal by Subject|2|||
23563672|NCT02322814|65790516|FG003|Overall Study|Withdrawal by Subject|1|||
23563673|NCT02322814|65790517|FG004|Overall Study|Withdrawal by Subject|3|||
23563674|NCT04707196|65790518|FG000|Overall Study|Withdrawal by Subject|9|||
23563675|NCT04707196|65790519|FG001|Overall Study|Withdrawal by Subject|6|||
23563676|NCT04707196|65790518|FG000|Overall Study|Lost to Follow-up|1|||
23563677|NCT04707196|65790519|FG001|Overall Study|Lost to Follow-up|0|||
23563678|NCT04707196|65790518|FG000|Overall Study|Protocol Violation|4|||
23563679|NCT04707196|65790519|FG001|Overall Study|Protocol Violation|1|||
23563680|NCT04707196|65790518|FG000|Overall Study|Adverse Event|2|||
23563681|NCT04707196|65790519|FG001|Overall Study|Adverse Event|2|||
23563682|NCT04707196|65790518|FG000|Overall Study|Death|3|||
23563683|NCT04707196|65790519|FG001|Overall Study|Death|1|||
23563684|NCT04707196|65790518|FG000|Overall Study|Non-compliance with study drug|1|||
23563685|NCT04707196|65790519|FG001|Overall Study|Non-compliance with study drug|0|||
23563686|NCT04707196|65790518|FG000|Overall Study|Progressive disease|9|||
23563687|NCT04707196|65790519|FG001|Overall Study|Progressive disease|10|||
23563688|NCT01785563|65790520|FG000|Overall Study|Physician Decision|10|||
23563689|NCT01785563|65790520|FG000|Overall Study|Withdrawal by Subject|1|||
23563690|NCT01785563|65790520|FG000|Overall Study|Protocol Violation|2|||
23758608|NCT00272961|66494598|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23758609|NCT00272961|66494599|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23758610|NCT00272961|66494595|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
23758611|NCT00272961|66494596|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
23758612|NCT00272961|66494597|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
23758613|NCT00272961|66494598|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
23758614|NCT00272961|66494599|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
23563691|NCT01255592|65790521|FG000|Overall Study|Adverse Event|5|||
23563692|NCT01255592|65790522|FG001|Overall Study|Adverse Event|0|||
23563693|NCT01255592|65790521|FG000|Overall Study|Withdrawal by Subject|1|||
23563694|NCT01255592|65790522|FG001|Overall Study|Withdrawal by Subject|0|||
23563695|NCT01255592|65790521|FG000|Overall Study|Other|0|||
23758615|NCT03670537|66494601|FG000|Overall Study|Protocol Violation|1|||
23440805|NCT00211887|65355288|FG001|Overall Study|Other medical reason|11|||
23563696|NCT01255592|65790522|FG001|Overall Study|Other|1|||
23563697|NCT00661661|65790523|FG000|Overall Study|Adverse Event|99|||
23563698|NCT00661661|65790524|FG001|Overall Study|Adverse Event|24|||
23563699|NCT00661661|65790523|FG000|Overall Study|Lack of Efficacy|3|||
23563700|NCT00661661|65790524|FG001|Overall Study|Lack of Efficacy|2|||
23563701|NCT00661661|65790523|FG000|Overall Study|Lost to Follow-up|0|||
23563702|NCT00661661|65790524|FG001|Overall Study|Lost to Follow-up|1|||
23563703|NCT00661661|65790523|FG000|Overall Study|Withdrawal by Subject|15|||
23563704|NCT00661661|65790524|FG001|Overall Study|Withdrawal by Subject|5|||
23758616|NCT02072174|66494604|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
23758617|NCT02072174|66494605|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
23758618|NCT02072174|66494604|FG000|Overall Study|Protocol Violation|16|||
23758619|NCT02072174|66494605|FG001|Overall Study|Protocol Violation|23|||
23758620|NCT02072174|66494604|FG000|Overall Study|Physician Decision|0|||
23758621|NCT02072174|66494605|FG001|Overall Study|Physician Decision|1|||
23758622|NCT02072174|66494604|FG000|Overall Study|Non-compliance with protocol requirement|2|||
23758623|NCT02072174|66494605|FG001|Overall Study|Non-compliance with protocol requirement|0|||
23758624|NCT01537549|66494607|FG000|Overall Study|Lost to Follow-up|1|||
23758625|NCT01537549|66494607|FG000|Overall Study|Withdrawal by Subject|2|||
23758626|NCT03262233|66494608|FG000|Overall Study|Withdrawal by Subject|12|||
23758627|NCT03262233|66494609|FG001|Overall Study|Withdrawal by Subject|8|||
23758628|NCT03262233|66494610|FG002|Overall Study|Withdrawal by Subject|21|||
23758629|NCT03262233|66494611|FG003|Overall Study|Withdrawal by Subject|13|||
23440806|NCT00211887|65355289|FG002|Overall Study|Other medical reason|7|||
23440807|NCT00211887|65355287|FG000|Overall Study|Side effects|19|||
23440808|NCT00211887|65355288|FG001|Overall Study|Side effects|13|||
23440809|NCT00211887|65355289|FG002|Overall Study|Side effects|5|||
23440810|NCT04522141|65355290|FG000|Overall Study|Withdrawal by Subject|1|||
23440811|NCT04522141|65355291|FG001|Overall Study|Withdrawal by Subject|0|||
23440812|NCT01657292|65355292|FG000|Overall Study|Adverse Event|6|||
23440813|NCT01657292|65355292|FG000|Overall Study|Withdrawal by Subject|2|||
23440814|NCT01657292|65355292|FG000|Overall Study|Violation of eligibility criteria|1|||
23440815|NCT01657292|65355292|FG000|Overall Study|Change of therapy|1|||
23440816|NCT02775916|65355293|FG000|Overall Study|Adverse Event|1|||
23440817|NCT02775916|65355294|FG001|Overall Study|Adverse Event|0|||
23440818|NCT02775916|65355293|FG000|Overall Study|Subject/Guardian Decision|2|||
23440819|NCT02775916|65355294|FG001|Overall Study|Subject/Guardian Decision|0|||
23440820|NCT01128946|65355295|FG000|Period I|Protocol Violation|0|||
23440821|NCT01128946|65355296|FG001|Period I|Protocol Violation|1|||
23440822|NCT01128946|65355297|FG002|Period I|Protocol Violation|0|||
23440823|NCT01128946|65355298|FG003|Period I|Protocol Violation|0|||
23440824|NCT01128946|65355295|FG000|Period I|Withdrawal by Subject|0|||
23440825|NCT01128946|65355296|FG001|Period I|Withdrawal by Subject|0|||
23440826|NCT01128946|65355297|FG002|Period I|Withdrawal by Subject|1|||
23440827|NCT01128946|65355298|FG003|Period I|Withdrawal by Subject|1|||
23440828|NCT01128946|65355295|FG000|Period II|Protocol Violation|0|||
23440829|NCT01128946|65355296|FG001|Period II|Protocol Violation|1|||
23440830|NCT01128946|65355297|FG002|Period II|Protocol Violation|0|||
23440831|NCT01128946|65355298|FG003|Period II|Protocol Violation|0|||
23440832|NCT01128946|65355295|FG000|Period II|Withdrawal by Subject|0|||
23440833|NCT01128946|65355296|FG001|Period II|Withdrawal by Subject|0|||
23440834|NCT01128946|65355297|FG002|Period II|Withdrawal by Subject|0|||
23440835|NCT01128946|65355298|FG003|Period II|Withdrawal by Subject|1|||
23440836|NCT01128946|65355295|FG000|Period III|Protocol Violation|1|||
23440837|NCT01128946|65355296|FG001|Period III|Protocol Violation|0|||
23440838|NCT01128946|65355297|FG002|Period III|Protocol Violation|0|||
23440839|NCT01128946|65355298|FG003|Period III|Protocol Violation|0|||
23440840|NCT04178720|65355301|FG000|Overall Study|Withdrawal by Subject|2|||
23440841|NCT04178720|65355302|FG001|Overall Study|Withdrawal by Subject|0|||
23440842|NCT04178720|65355301|FG000|Overall Study|Relocation|0|||
23440843|NCT04178720|65355302|FG001|Overall Study|Relocation|1|||
23440844|NCT01196026|65355307|FG000|Overall Study|Withdrawal by Subject|1|||
23440845|NCT01196026|65355308|FG001|Overall Study|Withdrawal by Subject|4|||
23440846|NCT01196026|65355309|FG002|Overall Study|Withdrawal by Subject|0|||
23440847|NCT01196026|65355310|FG003|Overall Study|Withdrawal by Subject|0|||
23440848|NCT01196026|65355311|FG004|Overall Study|Withdrawal by Subject|0|||
23440849|NCT01196026|65355312|FG005|Overall Study|Withdrawal by Subject|0|||
23440850|NCT01196026|65355307|FG000|Overall Study|Lost to Follow-up|0|||
23440851|NCT01196026|65355308|FG001|Overall Study|Lost to Follow-up|3|||
23440852|NCT01196026|65355309|FG002|Overall Study|Lost to Follow-up|0|||
23440853|NCT01196026|65355310|FG003|Overall Study|Lost to Follow-up|0|||
23440854|NCT01196026|65355311|FG004|Overall Study|Lost to Follow-up|1|||
23440855|NCT01196026|65355312|FG005|Overall Study|Lost to Follow-up|0|||
23440856|NCT01196026|65355307|FG000|Overall Study|Other|0|||
23826722|NCT03668808|66745185|FG001|First Intervention|Withdrawal by Subject|2|||
23826723|NCT03499067|66745186|FG000|First Intervention|Physician Decision|2|||
23826724|NCT03499067|66745187|FG001|First Intervention|Physician Decision|1|||
23826725|NCT03499067|66745186|FG000|First Intervention|Withdrawal by Subject|3|||
23440857|NCT01196026|65355308|FG001|Overall Study|Other|1|||
23440858|NCT01196026|65355309|FG002|Overall Study|Other|0|||
23440859|NCT01196026|65355310|FG003|Overall Study|Other|0|||
23440860|NCT01196026|65355311|FG004|Overall Study|Other|0|||
23440861|NCT01196026|65355312|FG005|Overall Study|Other|0|||
23440862|NCT03790917|65355313|FG000|Overall Study|Death|1|||
23440863|NCT01114828|65355320|FG000|Overall Study|Adverse Event|1|||
23440864|NCT01114828|65355321|FG001|Overall Study|Adverse Event|1|||
23440865|NCT01114828|65355320|FG000|Overall Study|Lack of Efficacy|0|||
23440866|NCT01114828|65355321|FG001|Overall Study|Lack of Efficacy|2|||
23758630|NCT03262233|66494608|FG000|Overall Study|Declined due to shock|1|||
23625859|NCT01336205|66015648|FG001|Overall Study|Other|9|||
23625860|NCT01336205|66015647|FG000|Overall Study|Lost to Follow-up|40|||
23625861|NCT01336205|66015648|FG001|Overall Study|Lost to Follow-up|20|||
23625862|NCT01336205|66015647|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
23625863|NCT01336205|66015648|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
23625864|NCT01336205|66015647|FG000|Overall Study|Lack of Efficacy|4|||
23625865|NCT01336205|66015648|FG001|Overall Study|Lack of Efficacy|0|||
23625866|NCT01336205|66015647|FG000|Overall Study|Severe noncompliance with protocol|9|||
23625867|NCT01336205|66015648|FG001|Overall Study|Severe noncompliance with protocol|2|||
23625868|NCT01336205|66015647|FG000|Overall Study|Adverse Event|56|||
23625869|NCT01336205|66015648|FG001|Overall Study|Adverse Event|6|||
23625870|NCT01336205|66015647|FG000|Overall Study|Death|1|||
23625871|NCT01336205|66015648|FG001|Overall Study|Death|1|||
23625872|NCT01336205|66015647|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
23625873|NCT01336205|66015648|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
23625874|NCT01336205|66015647|FG000|Overall Study|Withdrawal by Subject|72|||
23625875|NCT01336205|66015648|FG001|Overall Study|Withdrawal by Subject|38|||
23625876|NCT01336205|66015647|FG000|Overall Study|Did not receive treatment|4|||
23625877|NCT01336205|66015648|FG001|Overall Study|Did not receive treatment|0|||
23625878|NCT01402063|66015649|FG000|Overall Study|Withdrawal by Subject|3|||
23625879|NCT01402063|66015650|FG001|Overall Study|Withdrawal by Subject|3|||
23625880|NCT02650466|66015651|FG000|Overall Study|Physician Decision|1|||
23625881|NCT02650466|66015651|FG000|Overall Study|Withdrawal by Subject|5|||
23625882|NCT02650466|66015651|FG000|Overall Study|Lost to Follow-up|1|||
23625883|NCT01057251|66015652|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
23625884|NCT01057251|66015653|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
23625885|NCT01057251|66015652|FG000|Overall Study|Adverse Event|4|||
23440867|NCT01114828|65355320|FG000|Overall Study|Protocol Violation|2|||
23625886|NCT01057251|66015653|FG001|Overall Study|Adverse Event|2|||
23625887|NCT01057251|66015652|FG000|Overall Study|Lack of Efficacy|2|||
23625888|NCT01057251|66015653|FG001|Overall Study|Lack of Efficacy|11|||
23625889|NCT01057251|66015652|FG000|Overall Study|Protocol Violation|6|||
23625890|NCT01057251|66015653|FG001|Overall Study|Protocol Violation|2|||
23625891|NCT01057251|66015652|FG000|Overall Study|Withdrawal by Subject|4|||
23625892|NCT01057251|66015653|FG001|Overall Study|Withdrawal by Subject|5|||
23625893|NCT01057251|66015652|FG000|Overall Study|Lost to Follow-up|7|||
23625894|NCT01057251|66015653|FG001|Overall Study|Lost to Follow-up|6|||
23758631|NCT03262233|66494609|FG001|Overall Study|Declined due to shock|2|||
23758632|NCT03262233|66494610|FG002|Overall Study|Declined due to shock|2|||
23758633|NCT03262233|66494611|FG003|Overall Study|Declined due to shock|3|||
23758634|NCT03262233|66494608|FG000|Overall Study|Protocol Violation|5|||
23758635|NCT03262233|66494609|FG001|Overall Study|Protocol Violation|10|||
23758636|NCT03262233|66494610|FG002|Overall Study|Protocol Violation|2|||
23758637|NCT03262233|66494611|FG003|Overall Study|Protocol Violation|13|||
23758638|NCT03262233|66494608|FG000|Overall Study|data collection artifact|0|||
23758639|NCT03262233|66494609|FG001|Overall Study|data collection artifact|1|||
23758640|NCT03262233|66494610|FG002|Overall Study|data collection artifact|0|||
23758641|NCT03262233|66494611|FG003|Overall Study|data collection artifact|0|||
23758642|NCT00729365|66494612|FG000|Overall Study|Physician Decision|33|||
23758643|NCT00729365|66494613|FG001|Overall Study|Physician Decision|6|||
23758644|NCT00729365|66494614|FG002|Overall Study|Physician Decision|7|||
23758645|NCT01155284|66494615|FG000|Overall Study|Withdrawal by Subject|4|||
23758646|NCT01155284|66494616|FG001|Overall Study|Withdrawal by Subject|3|||
23758647|NCT01155284|66494615|FG000|Overall Study|Lost to Follow-up|1|||
23758648|NCT01155284|66494616|FG001|Overall Study|Lost to Follow-up|2|||
23758649|NCT01155284|66494615|FG000|Overall Study|Physician Decision|1|||
23758650|NCT01155284|66494616|FG001|Overall Study|Physician Decision|0|||
23758651|NCT01155284|66494615|FG000|Overall Study|Adverse Event|1|||
23758652|NCT01155284|66494616|FG001|Overall Study|Adverse Event|0|||
23758653|NCT03012815|66494617|FG000|Overall Study|Lost to Follow-up|1|||
23758654|NCT03012815|66494618|FG001|Overall Study|Lost to Follow-up|0|||
23758655|NCT03012815|66494617|FG000|Overall Study|Physician Decision|3|||
23758656|NCT03012815|66494618|FG001|Overall Study|Physician Decision|2|||
23758657|NCT03012815|66494617|FG000|Overall Study|Adverse Event|1|||
23440868|NCT01114828|65355321|FG001|Overall Study|Protocol Violation|0|||
23625895|NCT01057251|66015652|FG000|Overall Study|Other Reason|1|||
23625896|NCT01057251|66015653|FG001|Overall Study|Other Reason|1|||
23625897|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23625898|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
23625899|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
23625900|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23758658|NCT03012815|66494618|FG001|Overall Study|Adverse Event|0|||
23758659|NCT03125629|66494625|FG000|Overall Study|Withdrawal by Subject|2|||
23758660|NCT03125629|66494625|FG000|Overall Study|Equipment malfunction|1|||
23758661|NCT03264066|66494628|FG000|Overall Study|Adverse Event|1|||
23440869|NCT01114828|65355320|FG000|Overall Study|Withdrawal by Subject|0|||
23625901|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23625902|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23625903|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
23625904|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
23625905|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
23625906|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
23625907|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
23625908|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
23625909|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625910|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625911|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625912|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625913|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625914|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625915|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
23625916|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
23625917|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
23625918|NCT03569475|66015656|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
23625919|NCT03569475|66015657|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
23625920|NCT03569475|66015658|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
23625921|NCT03569475|66015656|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
23625922|NCT03569475|66015657|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
23625923|NCT03569475|66015658|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
23625924|NCT01930214|66015659|FG000|Overall Study|Death|4|||
23625925|NCT01930214|66015660|FG001|Overall Study|Death|4|||
23625926|NCT01930214|66015661|FG002|Overall Study|Death|11|||
23625927|NCT01930214|66015659|FG000|Overall Study|Lost to Follow-up|12|||
23625928|NCT01930214|66015660|FG001|Overall Study|Lost to Follow-up|13|||
23625929|NCT01930214|66015661|FG002|Overall Study|Lost to Follow-up|12|||
23625930|NCT01930214|66015659|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
23625931|NCT01930214|66015660|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
23625932|NCT01930214|66015661|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
23625933|NCT01930214|66015659|FG000|Overall Study|Physician Decision|2|||
23625934|NCT01930214|66015660|FG001|Overall Study|Physician Decision|0|||
23625935|NCT01930214|66015661|FG002|Overall Study|Physician Decision|0|||
23625936|NCT03589300|66015662|FG000|Overall Study|Adverse Event|2|||
23625937|NCT03589300|66015662|FG000|Overall Study|Death|4|||
23625938|NCT03589300|66015662|FG000|Overall Study|Lost to Follow-up|12|||
23625939|NCT03589300|66015662|FG000|Overall Study|Withdrawal by Subject|5|||
23625940|NCT00243022|66015663|FG000|Overall Study|Withdrawal by Subject|1|||
23625941|NCT00243022|66015664|FG001|Overall Study|Withdrawal by Subject|0|||
23625942|NCT00243022|66015663|FG000|Overall Study|Death|1|||
23625943|NCT00243022|66015664|FG001|Overall Study|Death|0|||
23625944|NCT00243022|66015663|FG000|Overall Study|Difficult Travel Distance|0|||
23625945|NCT00243022|66015664|FG001|Overall Study|Difficult Travel Distance|1|||
23625946|NCT01917006|66015665|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
23625947|NCT01917006|66015666|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
23625948|NCT01917006|66015667|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
23625949|NCT01917006|66015668|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
23625950|NCT01917006|66015669|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
23625951|NCT01917006|66015670|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
23625952|NCT01917006|66015671|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
23625953|NCT01917006|66015672|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
23625954|NCT01917006|66015665|FG000|Randomized-treatment Period|Personal Reasons|0|||
23625955|NCT01917006|66015666|FG001|Randomized-treatment Period|Personal Reasons|0|||
23625956|NCT01917006|66015667|FG002|Randomized-treatment Period|Personal Reasons|0|||
23625957|NCT01917006|66015668|FG003|Randomized-treatment Period|Personal Reasons|0|||
23625958|NCT01917006|66015669|FG004|Randomized-treatment Period|Personal Reasons|0|||
23440870|NCT01114828|65355321|FG001|Overall Study|Withdrawal by Subject|1|||
23440871|NCT00206440|65355322|FG000|Overall Study|Protocol Violation|1|||
23625959|NCT01917006|66015670|FG005|Randomized-treatment Period|Personal Reasons|1|||
23625960|NCT01917006|66015671|FG006|Randomized-treatment Period|Personal Reasons|0|||
23625961|NCT01917006|66015672|FG007|Randomized-treatment Period|Personal Reasons|0|||
23625962|NCT01917006|66015665|FG000|Randomized-treatment Period|Protocol Violation|1|||
23625963|NCT01917006|66015666|FG001|Randomized-treatment Period|Protocol Violation|0|||
23625964|NCT01917006|66015667|FG002|Randomized-treatment Period|Protocol Violation|0|||
23440872|NCT00206440|65355323|FG001|Overall Study|Protocol Violation|2|||
23826726|NCT03499067|66745187|FG001|First Intervention|Withdrawal by Subject|6|||
23440873|NCT00206440|65355322|FG000|Overall Study|Adverse Event|4|||
23440874|NCT00206440|65355323|FG001|Overall Study|Adverse Event|2|||
23625965|NCT01917006|66015668|FG003|Randomized-treatment Period|Protocol Violation|0|||
23826727|NCT02661217|66745188|FG000|Overall Study|Physician Decision|12|||
23826728|NCT02661217|66745189|FG001|Overall Study|Physician Decision|15|||
23826729|NCT02661217|66745188|FG000|Overall Study|Lost to Follow-up|1|||
23826730|NCT02661217|66745189|FG001|Overall Study|Lost to Follow-up|4|||
23826731|NCT02661217|66745188|FG000|Overall Study|Protocol Deviation|0|||
23826732|NCT02661217|66745189|FG001|Overall Study|Protocol Deviation|4|||
23826733|NCT02661217|66745188|FG000|Overall Study|Non-compliance with study treatment|5|||
23826734|NCT02661217|66745189|FG001|Overall Study|Non-compliance with study treatment|5|||
23826735|NCT02661217|66745188|FG000|Overall Study|Death|21|||
23826736|NCT02661217|66745189|FG001|Overall Study|Death|15|||
23826737|NCT02661217|66745188|FG000|Overall Study|Adverse Event|10|||
23826738|NCT02661217|66745189|FG001|Overall Study|Adverse Event|8|||
23826739|NCT02661217|66745188|FG000|Overall Study|Withdrawal by Subject|15|||
23826740|NCT02661217|66745189|FG001|Overall Study|Withdrawal by Subject|19|||
23826741|NCT02661217|66745188|FG000|Overall Study|Did not enter follow-up epoch|7|||
23826742|NCT02661217|66745189|FG001|Overall Study|Did not enter follow-up epoch|10|||
23826743|NCT02661217|66745188|FG000|Overall Study|Death - no study drug received|1|||
23826744|NCT02661217|66745189|FG001|Overall Study|Death - no study drug received|2|||
23826745|NCT02661217|66745188|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
23826746|NCT02661217|66745189|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
23826747|NCT03280264|66745190|FG000|Overall Study|Adverse Event|1|||
23826748|NCT03280264|66745190|FG000|Overall Study|Physician Decision|1|||
23826749|NCT03280264|66745190|FG000|Overall Study|Withdrawal by Subject|1|||
23826750|NCT04352101|66745191|FG000|Overall Study|Physician Decision|2|||
23826751|NCT04352101|66745192|FG001|Overall Study|Physician Decision|1|||
23826752|NCT04108299|66745204|FG000|Overall Study|Not interested in participating|2|||
23625966|NCT01917006|66015669|FG004|Randomized-treatment Period|Protocol Violation|0|||
23625967|NCT01917006|66015670|FG005|Randomized-treatment Period|Protocol Violation|0|||
23625968|NCT01917006|66015671|FG006|Randomized-treatment Period|Protocol Violation|0|||
23625969|NCT01917006|66015672|FG007|Randomized-treatment Period|Protocol Violation|0|||
23625970|NCT01917006|66015665|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625971|NCT01917006|66015666|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625972|NCT01917006|66015667|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625973|NCT01917006|66015668|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625974|NCT01917006|66015669|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23826753|NCT04108299|66745205|FG001|Overall Study|Not interested in participating|1|||
23826754|NCT04108299|66745206|FG002|Overall Study|Not interested in participating|2|||
23826755|NCT04108299|66745207|FG003|Overall Study|Not interested in participating|1|||
23826756|NCT01994850|66745208|FG000|Overall Study|Physician Decision|1|||
23826757|NCT01994850|66745208|FG000|Overall Study|Withdrawal by Subject|1|||
23826758|NCT01286753|66745211|FG000|Overall Study|Adverse Event|7|||
23826759|NCT01286753|66745212|FG001|Overall Study|Adverse Event|6|||
23826760|NCT01286753|66745211|FG000|Overall Study|Progression|11|||
23826761|NCT01286753|66745212|FG001|Overall Study|Progression|13|||
23826762|NCT01286753|66745211|FG000|Overall Study|Refused Treatment|1|||
23826763|NCT01286753|66745212|FG001|Overall Study|Refused Treatment|0|||
23826764|NCT01286753|66745211|FG000|Overall Study|Withdrawal of Consent|0|||
23826765|NCT01286753|66745212|FG001|Overall Study|Withdrawal of Consent|2|||
23625975|NCT01917006|66015670|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625976|NCT01917006|66015671|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
23625977|NCT01917006|66015672|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625978|NCT01917006|66015665|FG000|Open-label Period|Adverse Event|0|||
23625979|NCT01917006|66015666|FG001|Open-label Period|Adverse Event|0|||
23625980|NCT01917006|66015667|FG002|Open-label Period|Adverse Event|0|||
23625981|NCT01917006|66015668|FG003|Open-label Period|Adverse Event|0|||
23625982|NCT01917006|66015669|FG004|Open-label Period|Adverse Event|0|||
23826766|NCT01286753|66745211|FG000|Overall Study|Discontinued to Join Extension Study|6|||
23826767|NCT01286753|66745212|FG001|Overall Study|Discontinued to Join Extension Study|4|||
23826768|NCT01286753|66745211|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
23625983|NCT01917006|66015670|FG005|Open-label Period|Adverse Event|0|||
23625984|NCT01917006|66015671|FG006|Open-label Period|Adverse Event|0|||
23625985|NCT01917006|66015672|FG007|Open-label Period|Adverse Event|1|||
23625986|NCT01917006|66015665|FG000|Open-label Period|Lost to Follow-up|0|||
23826769|NCT01286753|66745212|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
23826770|NCT00916383|66745213|FG000|Overall Study|Adverse Event|1|||
23826771|NCT00916383|66745213|FG000|Overall Study|Death|1|||
23758662|NCT03264066|66494629|FG001|Overall Study|Adverse Event|1|||
23758663|NCT03264066|66494630|FG002|Overall Study|Adverse Event|0|||
23758664|NCT03264066|66494631|FG003|Overall Study|Adverse Event|0|||
23758665|NCT03264066|66494632|FG004|Overall Study|Adverse Event|0|||
23758666|NCT03264066|66494633|FG005|Overall Study|Adverse Event|0|||
23758667|NCT03264066|66494628|FG000|Overall Study|Death|12|||
23758668|NCT03264066|66494629|FG001|Overall Study|Death|12|||
23758669|NCT03264066|66494630|FG002|Overall Study|Death|8|||
23758670|NCT03264066|66494631|FG003|Overall Study|Death|10|||
23758671|NCT03264066|66494632|FG004|Overall Study|Death|6|||
23758672|NCT03264066|66494633|FG005|Overall Study|Death|1|||
23758673|NCT03264066|66494628|FG000|Overall Study|Lost to Follow-up|1|||
23758674|NCT03264066|66494629|FG001|Overall Study|Lost to Follow-up|0|||
23758675|NCT03264066|66494630|FG002|Overall Study|Lost to Follow-up|0|||
23758676|NCT03264066|66494631|FG003|Overall Study|Lost to Follow-up|0|||
23758677|NCT03264066|66494632|FG004|Overall Study|Lost to Follow-up|0|||
23758678|NCT03264066|66494633|FG005|Overall Study|Lost to Follow-up|0|||
23758679|NCT03264066|66494628|FG000|Overall Study|Progressive Disease|0|||
23758680|NCT03264066|66494629|FG001|Overall Study|Progressive Disease|2|||
23758681|NCT03264066|66494630|FG002|Overall Study|Progressive Disease|1|||
23440875|NCT02397057|65355324|FG000|Overall Study|Withdrawal by Subject|6|||
23440876|NCT02397057|65355325|FG001|Overall Study|Withdrawal by Subject|7|||
23563705|NCT00661661|65790523|FG000|Overall Study|Other|22|||
23563706|NCT00661661|65790524|FG001|Overall Study|Other|7|||
23563707|NCT00661661|65790523|FG000|Overall Study|Not assigned treatment|1|||
23563708|NCT00661661|65790524|FG001|Overall Study|Not assigned treatment|0|||
23563709|NCT02459093|65790525|FG000|Overall Study|Protocol Violation|6|||
23563710|NCT02459093|65790526|FG001|Overall Study|Protocol Violation|11|||
23563711|NCT02459093|65790525|FG000|Overall Study|Lost to Follow-up|6|||
23563712|NCT02459093|65790526|FG001|Overall Study|Lost to Follow-up|7|||
23563713|NCT02086552|65790529|FG000|Overall Study|Withdrawal by Subject|1|||
23563714|NCT00944658|65790532|FG000|Treatment 12 Weeks|Adverse Event|0|||
23563715|NCT00944658|65790533|FG001|Treatment 12 Weeks|Adverse Event|2|||
23563716|NCT03560258|65790534|FG000|Overall Study|Lost to Follow-up|3|||
23563717|NCT03560258|65790535|FG001|Overall Study|Lost to Follow-up|0|||
23563718|NCT03560258|65790536|FG002|Overall Study|Lost to Follow-up|0|||
23563719|NCT03560258|65790534|FG000|Overall Study|Protocol Violation|0|||
23563720|NCT03560258|65790535|FG001|Overall Study|Protocol Violation|1|||
23563721|NCT03560258|65790536|FG002|Overall Study|Protocol Violation|0|||
23563722|NCT03560258|65790534|FG000|Overall Study|Withdrawal by Subject|0|||
23563723|NCT03560258|65790535|FG001|Overall Study|Withdrawal by Subject|0|||
23563724|NCT03560258|65790536|FG002|Overall Study|Withdrawal by Subject|1|||
23563725|NCT00695786|65790540|FG000|Overall Study|Adverse Event|0|||
23563726|NCT00695786|65790541|FG001|Overall Study|Adverse Event|3|||
23563727|NCT00695786|65790542|FG002|Overall Study|Adverse Event|4|||
23563728|NCT00695786|65790543|FG003|Overall Study|Adverse Event|2|||
23563729|NCT00695786|65790540|FG000|Overall Study|Lost to Follow-up|0|||
23563730|NCT00695786|65790541|FG001|Overall Study|Lost to Follow-up|5|||
23563731|NCT00695786|65790542|FG002|Overall Study|Lost to Follow-up|1|||
23758682|NCT03264066|66494631|FG003|Overall Study|Progressive Disease|0|||
23826772|NCT00916383|66745213|FG000|Overall Study|Protocol Violation|1|||
23440877|NCT02397057|65355324|FG000|Overall Study|Lost to Follow-up|4|||
23563732|NCT00695786|65790543|FG003|Overall Study|Lost to Follow-up|1|||
23758683|NCT03264066|66494632|FG004|Overall Study|Progressive Disease|0|||
23758684|NCT03264066|66494633|FG005|Overall Study|Progressive Disease|0|||
23758685|NCT03264066|66494628|FG000|Overall Study|Study Terminated by Sponsor|5|||
23758686|NCT03264066|66494629|FG001|Overall Study|Study Terminated by Sponsor|5|||
23758687|NCT03264066|66494630|FG002|Overall Study|Study Terminated by Sponsor|8|||
23758688|NCT03264066|66494631|FG003|Overall Study|Study Terminated by Sponsor|5|||
23758689|NCT03264066|66494632|FG004|Overall Study|Study Terminated by Sponsor|1|||
23758690|NCT03264066|66494633|FG005|Overall Study|Study Terminated by Sponsor|2|||
23758691|NCT03264066|66494628|FG000|Overall Study|Withdrawal by Subject|1|||
23758692|NCT03264066|66494629|FG001|Overall Study|Withdrawal by Subject|0|||
23758693|NCT03264066|66494630|FG002|Overall Study|Withdrawal by Subject|0|||
23758694|NCT03264066|66494631|FG003|Overall Study|Withdrawal by Subject|5|||
23563733|NCT00695786|65790540|FG000|Overall Study|Withdrawal by Subject|0|||
23563734|NCT00695786|65790541|FG001|Overall Study|Withdrawal by Subject|4|||
23563735|NCT00695786|65790542|FG002|Overall Study|Withdrawal by Subject|3|||
23758695|NCT03264066|66494632|FG004|Overall Study|Withdrawal by Subject|0|||
23758696|NCT03264066|66494633|FG005|Overall Study|Withdrawal by Subject|0|||
23758697|NCT03548207|66494637|FG000|Overall Study|Death|10|||
23758698|NCT03548207|66494638|FG001|Overall Study|Death|23|||
23758699|NCT03548207|66494639|FG002|Overall Study|Death|3|||
23758700|NCT03548207|66494637|FG000|Overall Study|Lost to Follow-up|0|||
23758701|NCT03548207|66494638|FG001|Overall Study|Lost to Follow-up|2|||
23758702|NCT03548207|66494639|FG002|Overall Study|Lost to Follow-up|0|||
23758703|NCT03548207|66494637|FG000|Overall Study|Withdrawal by Subject|0|||
23758704|NCT03548207|66494638|FG001|Overall Study|Withdrawal by Subject|3|||
23758705|NCT03548207|66494639|FG002|Overall Study|Withdrawal by Subject|0|||
23758706|NCT03548207|66494637|FG000|Overall Study|Sponsor decision|19|||
23758707|NCT03548207|66494638|FG001|Overall Study|Sponsor decision|40|||
23758708|NCT03548207|66494639|FG002|Overall Study|Sponsor decision|6|||
23758709|NCT03548207|66494637|FG000|Overall Study|Randomized but not treated|6|||
23758710|NCT03548207|66494638|FG001|Overall Study|Randomized but not treated|10|||
23758711|NCT03548207|66494639|FG002|Overall Study|Randomized but not treated|4|||
23758712|NCT03118765|66494640|FG000|Overall Study|Withdrawal by Subject|0|||
23758713|NCT03118765|66494641|FG001|Overall Study|Withdrawal by Subject|0|||
23758714|NCT03118765|66494642|FG002|Overall Study|Withdrawal by Subject|1|||
23758715|NCT03118765|66494643|FG003|Overall Study|Withdrawal by Subject|0|||
23758716|NCT03118765|66494644|FG004|Overall Study|Withdrawal by Subject|0|||
23758717|NCT03118765|66494640|FG000|Overall Study|Adverse Event|1|||
23758718|NCT03118765|66494641|FG001|Overall Study|Adverse Event|1|||
23758719|NCT03118765|66494642|FG002|Overall Study|Adverse Event|1|||
23758720|NCT03118765|66494643|FG003|Overall Study|Adverse Event|1|||
23758721|NCT03118765|66494644|FG004|Overall Study|Adverse Event|1|||
23758722|NCT03118765|66494640|FG000|Overall Study|Non compliance with Study Procedures|0|||
23758723|NCT03118765|66494641|FG001|Overall Study|Non compliance with Study Procedures|0|||
23758724|NCT03118765|66494642|FG002|Overall Study|Non compliance with Study Procedures|0|||
23758725|NCT03118765|66494643|FG003|Overall Study|Non compliance with Study Procedures|1|||
23758726|NCT03118765|66494644|FG004|Overall Study|Non compliance with Study Procedures|0|||
23758727|NCT03118765|66494640|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23758728|NCT03118765|66494641|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
23758729|NCT03118765|66494642|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
23758730|NCT03118765|66494643|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23758731|NCT03118765|66494644|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23758732|NCT03118765|66494640|FG000|Overall Study|COPD Exacerbation|1|||
23758733|NCT03118765|66494641|FG001|Overall Study|COPD Exacerbation|0|||
23758734|NCT03118765|66494642|FG002|Overall Study|COPD Exacerbation|0|||
23758735|NCT03118765|66494643|FG003|Overall Study|COPD Exacerbation|1|||
23758736|NCT03118765|66494644|FG004|Overall Study|COPD Exacerbation|0|||
23758737|NCT03118765|66494640|FG000|Overall Study|Lost to Follow-up|1|||
23758738|NCT03118765|66494641|FG001|Overall Study|Lost to Follow-up|0|||
23563736|NCT00695786|65790543|FG003|Overall Study|Withdrawal by Subject|1|||
23563737|NCT00695786|65790540|FG000|Overall Study|Deemed Ineligible|1|||
23563738|NCT00695786|65790541|FG001|Overall Study|Deemed Ineligible|0|||
23563739|NCT00695786|65790542|FG002|Overall Study|Deemed Ineligible|0|||
23758739|NCT03118765|66494642|FG002|Overall Study|Lost to Follow-up|1|||
23758740|NCT03118765|66494643|FG003|Overall Study|Lost to Follow-up|0|||
23758741|NCT03118765|66494644|FG004|Overall Study|Lost to Follow-up|0|||
23758742|NCT03118765|66494640|FG000|Overall Study|Sponsor Decision|1|||
23758743|NCT03118765|66494641|FG001|Overall Study|Sponsor Decision|0|||
23758744|NCT03118765|66494642|FG002|Overall Study|Sponsor Decision|1|||
23758745|NCT03118765|66494643|FG003|Overall Study|Sponsor Decision|0|||
23758746|NCT03118765|66494644|FG004|Overall Study|Sponsor Decision|1|||
23758747|NCT01585831|66494648|FG000|Overall Study|Physician Decision|0|||
23758748|NCT01585831|66494649|FG001|Overall Study|Physician Decision|1|||
23758749|NCT01585831|66494648|FG000|Overall Study|Withdrawal by Subject|2|||
23758750|NCT01585831|66494649|FG001|Overall Study|Withdrawal by Subject|1|||
23758751|NCT01169987|66494650|FG000|Overall Study|Withdrawal by Subject|3|||
23758752|NCT01169987|66494650|FG000|Overall Study|Lost to Follow-up|24|||
23758753|NCT01169987|66494650|FG000|Overall Study|Other|4|||
23758754|NCT02016755|66494651|FG000|Overall Study|Major amputation of index limb|2|||
23758755|NCT02016755|66494651|FG000|Overall Study|Adverse Event|2|||
23758756|NCT02016755|66494651|FG000|Overall Study|Physician Decision|1|||
23758757|NCT02016755|66494651|FG000|Overall Study|Death|2|||
23758758|NCT00363129|66494655|FG000|Overall Study|Withdrawal by Subject|11|||
23758759|NCT00363129|66494656|FG001|Overall Study|Withdrawal by Subject|18|||
23758760|NCT00363129|66494655|FG000|Overall Study|Adverse Event|8|||
23758761|NCT00363129|66494656|FG001|Overall Study|Adverse Event|3|||
23758762|NCT00363129|66494655|FG000|Overall Study|Alternate Treatment|2|||
23758763|NCT00363129|66494656|FG001|Overall Study|Alternate Treatment|4|||
23758764|NCT00363129|66494655|FG000|Overall Study|Other Medical Problems|2|||
23758765|NCT00363129|66494656|FG001|Overall Study|Other Medical Problems|4|||
23758766|NCT00363129|66494655|FG000|Overall Study|Death|0|||
23758767|NCT00363129|66494656|FG001|Overall Study|Death|1|||
23758768|NCT00363129|66494655|FG000|Overall Study|Other Reasons|6|||
23758769|NCT00363129|66494656|FG001|Overall Study|Other Reasons|3|||
23758770|NCT00265083|66494657|FG000|Overall Study|Adverse Event|5|||
23758771|NCT00265083|66494658|FG001|Overall Study|Adverse Event|13|||
23758772|NCT00265083|66494659|FG002|Overall Study|Adverse Event|15|||
23758773|NCT00265083|66494657|FG000|Overall Study|Lost to Follow-up|3|||
23758774|NCT00265083|66494658|FG001|Overall Study|Lost to Follow-up|4|||
23758775|NCT00265083|66494659|FG002|Overall Study|Lost to Follow-up|4|||
23440878|NCT02397057|65355325|FG001|Overall Study|Lost to Follow-up|3|||
23440879|NCT02397057|65355324|FG000|Overall Study|Death|1|||
23758776|NCT00265083|66494657|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
23758777|NCT00265083|66494658|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23758778|NCT00265083|66494659|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
23758779|NCT00265083|66494657|FG000|Overall Study|Other|1|||
23758780|NCT00265083|66494658|FG001|Overall Study|Other|12|||
23440880|NCT02397057|65355325|FG001|Overall Study|Death|0|||
23440881|NCT02397057|65355324|FG000|Overall Study|Adverse Event|0|||
23758781|NCT00265083|66494659|FG002|Overall Study|Other|9|||
23758782|NCT04088734|66494660|FG000|Overall Study|Other, Not Specified|5|||
23758783|NCT01796860|66494666|FG000|Overall Study|Withdrawal by Subject|3|||
23758784|NCT05016765|66494670|FG000|Overall Study|Lost to Follow-up|4|||
23440882|NCT02397057|65355325|FG001|Overall Study|Adverse Event|1|||
23440883|NCT02397057|65355324|FG000|Overall Study|Physician Decision|0|||
23440884|NCT02397057|65355325|FG001|Overall Study|Physician Decision|1|||
23440885|NCT02397057|65355324|FG000|Overall Study|Subject did not receive study drug|0|||
23440886|NCT02397057|65355325|FG001|Overall Study|Subject did not receive study drug|1|||
23440887|NCT00880191|65355326|FG000|Overall Study|Refused further treatment|4|||
23563740|NCT00695786|65790543|FG003|Overall Study|Deemed Ineligible|0|||
23758785|NCT00569231|66494671|FG000|Overall Study|Study unrelated surgery|1|||
23758786|NCT00569231|66494671|FG000|Overall Study|Airfare expense|2|||
23758787|NCT00569231|66494671|FG000|Overall Study|Withdrawal by Subject|1|||
23758788|NCT00569231|66494671|FG000|Overall Study|Car accident injury|1|||
23758789|NCT00569231|66494671|FG000|Overall Study|Non-compliance|2|||
23758790|NCT00379587|66494675|FG000|Overall Study|Lost to Follow-up|2|||
23758791|NCT03053622|66494676|FG000|Overall Study|Lost to Follow-up|0|||
23758792|NCT03053622|66494677|FG001|Overall Study|Lost to Follow-up|0|||
23758793|NCT03053622|66494678|FG002|Overall Study|Lost to Follow-up|0|||
23758794|NCT03053622|66494679|FG003|Overall Study|Lost to Follow-up|1|||
23758795|NCT01462695|66494680|FG000|Overall Study|Adverse Event|1|||
23758796|NCT01462695|66494681|FG001|Overall Study|Adverse Event|1|||
23758797|NCT01462695|66494680|FG000|Overall Study|Death|2|||
23758798|NCT01462695|66494681|FG001|Overall Study|Death|0|||
23758799|NCT01462695|66494680|FG000|Overall Study|Lack of Efficacy|6|||
23758800|NCT01462695|66494681|FG001|Overall Study|Lack of Efficacy|12|||
23758801|NCT01462695|66494680|FG000|Overall Study|Physician Decision|5|||
23440888|NCT00880191|65355327|FG001|Overall Study|Refused further treatment|1|||
23758802|NCT01462695|66494681|FG001|Overall Study|Physician Decision|0|||
23758803|NCT01462695|66494680|FG000|Overall Study|Withdrawal by Subject|2|||
23758804|NCT01462695|66494681|FG001|Overall Study|Withdrawal by Subject|0|||
23758805|NCT01462695|66494680|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
23758806|NCT01462695|66494681|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
23758807|NCT00481871|66494682|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
23758808|NCT00481871|66494683|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
23758809|NCT00481871|66494684|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
23758810|NCT00481871|66494685|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
23563741|NCT00695786|65790540|FG000|Overall Study|Lack of Efficacy|0|||
23563742|NCT00695786|65790541|FG001|Overall Study|Lack of Efficacy|0|||
23563743|NCT00695786|65790542|FG002|Overall Study|Lack of Efficacy|0|||
23758811|NCT00481871|66494686|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
23758812|NCT01542736|66494687|FG000|Overall Study|Death|1|||
23758813|NCT00520494|66494688|FG000|Overall Study|Withdrawal by Subject|1|||
23758814|NCT00283686|66494689|FG000|Overall Study|Death|1|||
23758815|NCT00283686|66494690|FG001|Overall Study|Death|1|||
23758816|NCT00283686|66494691|FG002|Overall Study|Death|1|||
23758817|NCT00283686|66494692|FG003|Overall Study|Death|0|||
23758818|NCT00283686|66494689|FG000|Overall Study|Lost to Follow-up|21|||
23758819|NCT00283686|66494690|FG001|Overall Study|Lost to Follow-up|31|||
23758820|NCT00283686|66494691|FG002|Overall Study|Lost to Follow-up|26|||
23758821|NCT00283686|66494692|FG003|Overall Study|Lost to Follow-up|20|||
23758822|NCT00283686|66494689|FG000|Overall Study|Less than full participation|7|||
23758823|NCT00283686|66494690|FG001|Overall Study|Less than full participation|9|||
23758824|NCT00283686|66494691|FG002|Overall Study|Less than full participation|6|||
23563744|NCT00695786|65790543|FG003|Overall Study|Lack of Efficacy|4|||
23758825|NCT00283686|66494692|FG003|Overall Study|Less than full participation|12|||
23758826|NCT04318535|66494693|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
23758827|NCT04318535|66494694|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
23758828|NCT04318535|66494695|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
23758829|NCT02209454|66494696|FG000|Second Period|Adverse Event|1|||
23758830|NCT02209454|66494697|FG001|Second Period|Adverse Event|0|||
23440889|NCT00880191|65355326|FG000|Overall Study|Adverse Event|8|||
23758831|NCT02340078|66494698|FG000|Overall Study|Protocol Violation|1|||
23758832|NCT04385199|66494701|FG000|Overall Study|Withdrawal by Subject|1|||
23563745|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
23563746|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563747|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563748|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563749|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23758833|NCT04385199|66494702|FG001|Overall Study|Withdrawal by Subject|0|||
23758834|NCT00751998|66494703|FG000|Overall Study|Lost to Follow-up|7|||
23758835|NCT00751998|66494703|FG000|Overall Study|Death|11|||
23758836|NCT00751998|66494703|FG000|Overall Study|Withdrawal by Subject|2|||
23758837|NCT02729194|66494705|FG000|Overall Study|Withdrawal by Subject|3|||
23758838|NCT01027884|66494709|FG000|Overall Study|Adverse Event|2|||
23758839|NCT01027884|66494710|FG001|Overall Study|Adverse Event|1|||
23758840|NCT01027884|66494709|FG000|Overall Study|Protocol Violation|1|||
23758841|NCT01027884|66494710|FG001|Overall Study|Protocol Violation|0|||
23758842|NCT01027884|66494709|FG000|Overall Study|Non-compliance|1|||
23758843|NCT01027884|66494710|FG001|Overall Study|Non-compliance|1|||
23758844|NCT01027884|66494709|FG000|Overall Study|Withdrawal by Subject|0|||
23758845|NCT01027884|66494710|FG001|Overall Study|Withdrawal by Subject|1|||
23758846|NCT01027884|66494709|FG000|Overall Study|Lost to Follow-up|0|||
23758847|NCT01027884|66494710|FG001|Overall Study|Lost to Follow-up|1|||
23758848|NCT01027884|66494709|FG000|Overall Study|Spinal fixation surgery|0|||
23758849|NCT01027884|66494710|FG001|Overall Study|Spinal fixation surgery|3|||
23758850|NCT04556838|66494711|FG000|Overall Study|Withdrawal by Subject|3|||
23758851|NCT04556838|66494712|FG001|Overall Study|Withdrawal by Subject|1|||
23758852|NCT04556838|66494713|FG002|Overall Study|Withdrawal by Subject|2|||
23758853|NCT04556838|66494711|FG000|Overall Study|Adverse Event|0|||
23758854|NCT04556838|66494712|FG001|Overall Study|Adverse Event|1|||
23758855|NCT04556838|66494713|FG002|Overall Study|Adverse Event|1|||
23758856|NCT04556838|66494711|FG000|Overall Study|Lost to Follow-up|0|||
23758857|NCT04556838|66494712|FG001|Overall Study|Lost to Follow-up|0|||
23758858|NCT04556838|66494713|FG002|Overall Study|Lost to Follow-up|2|||
23758859|NCT04556838|66494711|FG000|Overall Study|Subject travel|0|||
23758860|NCT04556838|66494712|FG001|Overall Study|Subject travel|1|||
23758861|NCT04556838|66494713|FG002|Overall Study|Subject travel|0|||
23758862|NCT04556838|66494711|FG000|Overall Study|Physician Decision|1|||
23758863|NCT04556838|66494712|FG001|Overall Study|Physician Decision|0|||
23758864|NCT04556838|66494713|FG002|Overall Study|Physician Decision|0|||
23758865|NCT02496221|66494716|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
23758866|NCT02496221|66494717|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
23758867|NCT02496221|66494716|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
23758868|NCT02496221|66494717|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
23758869|NCT02496221|66494716|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
23758870|NCT02496221|66494717|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
23758871|NCT00127192|66494720|FG000|Overall Study|Adverse Event|0|||
23758872|NCT00127192|66494721|FG001|Overall Study|Adverse Event|1|||
23758873|NCT00127192|66494722|FG002|Overall Study|Adverse Event|1|||
23758874|NCT00127192|66494723|FG003|Overall Study|Adverse Event|1|||
23758875|NCT00127192|66494724|FG004|Overall Study|Adverse Event|0|||
23758876|NCT00127192|66494720|FG000|Overall Study|Lack of Efficacy|2|||
23758877|NCT00127192|66494721|FG001|Overall Study|Lack of Efficacy|0|||
23758878|NCT00127192|66494722|FG002|Overall Study|Lack of Efficacy|0|||
23758879|NCT00127192|66494723|FG003|Overall Study|Lack of Efficacy|0|||
23758880|NCT00127192|66494724|FG004|Overall Study|Lack of Efficacy|2|||
23758881|NCT00127192|66494720|FG000|Overall Study|Withdrawal by Subject|0|||
23758882|NCT00127192|66494721|FG001|Overall Study|Withdrawal by Subject|0|||
23758883|NCT00127192|66494722|FG002|Overall Study|Withdrawal by Subject|1|||
23758884|NCT00127192|66494723|FG003|Overall Study|Withdrawal by Subject|0|||
23758885|NCT00127192|66494724|FG004|Overall Study|Withdrawal by Subject|3|||
23758886|NCT00127192|66494720|FG000|Overall Study|Adverse event in pre-treatment period|1|||
23758887|NCT00127192|66494721|FG001|Overall Study|Adverse event in pre-treatment period|0|||
23758888|NCT00127192|66494722|FG002|Overall Study|Adverse event in pre-treatment period|0|||
23758889|NCT00127192|66494723|FG003|Overall Study|Adverse event in pre-treatment period|0|||
23758890|NCT00127192|66494724|FG004|Overall Study|Adverse event in pre-treatment period|0|||
23563750|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
23563751|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563752|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563753|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23625987|NCT01917006|66015666|FG001|Open-label Period|Lost to Follow-up|0|||
23625988|NCT01917006|66015667|FG002|Open-label Period|Lost to Follow-up|0|||
23758891|NCT04126733|66494725|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
23758892|NCT04126733|66494725|FG000|Treatment Period|Adverse Event|8|||
23758893|NCT04126733|66494725|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
23758894|NCT04126733|66494725|FG000|Treatment Period|Physician Decision|5|||
23758895|NCT04126733|66494725|FG000|Treatment Period|Death|1|||
23758896|NCT04126733|66494725|FG000|Treatment Period|Other Reasons|2|||
23758897|NCT04126733|66494725|FG000|Active Follow-up Period|Death|13|||
23758898|NCT04126733|66494725|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
23758899|NCT04126733|66494725|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
23758900|NCT04126733|66494725|FG000|Active Follow-up Period|Other Reasons|1|||
23758901|NCT04126733|66494725|FG000|Long-term Follow-up Period|Death|22|||
23758902|NCT04126733|66494725|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
23758903|NCT04126733|66494725|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
23758904|NCT00080288|66494726|FG000|Overall Study|Adverse Event|7|||
23758905|NCT00080288|66494727|FG001|Overall Study|Adverse Event|4|||
23758906|NCT00080288|66494726|FG000|Overall Study|Lost to Follow-up|3|||
23758907|NCT00080288|66494727|FG001|Overall Study|Lost to Follow-up|5|||
23758908|NCT00080288|66494726|FG000|Overall Study|Physician Decision|6|||
23758909|NCT00080288|66494727|FG001|Overall Study|Physician Decision|2|||
23758910|NCT00080288|66494726|FG000|Overall Study|Withdrawal by Subject|3|||
23758911|NCT00080288|66494727|FG001|Overall Study|Withdrawal by Subject|16|||
23758912|NCT00080288|66494726|FG000|Overall Study|Miscellaneous|11|||
23758913|NCT00080288|66494727|FG001|Overall Study|Miscellaneous|11|||
23758914|NCT01201356|66494736|FG000|Overall Study|Adverse Event|170|||
23758915|NCT01201356|66494736|FG000|Overall Study|Abnormal laboratory value(s)|51|||
23758916|NCT01201356|66494736|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23758917|NCT01201356|66494736|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
23758918|NCT01201356|66494736|FG000|Overall Study|Condition no longer requires study drug|12|||
23758919|NCT01201356|66494736|FG000|Overall Study|Withdrawal by Subject|144|||
23758920|NCT01201356|66494736|FG000|Overall Study|Lost to Follow-up|50|||
23758921|NCT01201356|66494736|FG000|Overall Study|administrative problems|74|||
23758922|NCT01201356|66494736|FG000|Overall Study|Death|16|||
23758923|NCT01201356|66494736|FG000|Overall Study|Protocol Violation|12|||
23758924|NCT02623426|66494738|FG000|Overall Study|Lost to Follow-up|0|||
23758925|NCT02623426|66494739|FG001|Overall Study|Lost to Follow-up|0|||
23758926|NCT02623426|66494740|FG002|Overall Study|Lost to Follow-up|1|||
23826773|NCT02955212|66745214|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
23826774|NCT02955212|66745215|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
23826775|NCT02955212|66745214|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
23826776|NCT02955212|66745215|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
23826777|NCT02955212|66745214|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
23826778|NCT02955212|66745215|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
23440890|NCT00880191|65355327|FG001|Overall Study|Adverse Event|6|||
23440891|NCT00880191|65355326|FG000|Overall Study|Hospitalization/efficacy|1|||
23440892|NCT00880191|65355327|FG001|Overall Study|Hospitalization/efficacy|1|||
23440893|NCT04177212|65355332|FG000|Overall Study|Withdrawal by Subject|9|||
23440894|NCT04177212|65355333|FG001|Overall Study|Withdrawal by Subject|7|||
23440895|NCT04177212|65355332|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
23440896|NCT04177212|65355333|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
23440897|NCT04177212|65355332|FG000|Overall Study|Physician Decision|1|||
23758927|NCT02623426|66494738|FG000|Overall Study|Withdrawal by Subject|1|||
23758928|NCT02623426|66494739|FG001|Overall Study|Withdrawal by Subject|2|||
23758929|NCT02623426|66494740|FG002|Overall Study|Withdrawal by Subject|2|||
23826779|NCT02955212|66745214|FG000|Period 1: Double-blind Treatment Period|Other|3|||
23440898|NCT04177212|65355333|FG001|Overall Study|Physician Decision|0|||
23440899|NCT04177212|65355332|FG000|Overall Study|Lost to Follow-up|0|||
23440900|NCT04177212|65355333|FG001|Overall Study|Lost to Follow-up|3|||
23440901|NCT04177212|65355332|FG000|Overall Study|Adverse Event|0|||
23440902|NCT04177212|65355333|FG001|Overall Study|Adverse Event|1|||
23440903|NCT04177212|65355332|FG000|Overall Study|Other|1|||
23440904|NCT04177212|65355333|FG001|Overall Study|Other|2|||
23440905|NCT00166439|65355337|FG000|Overall Study|Ineligible|5|||
23440906|NCT01711645|65355338|FG000|Overall Study|Withdrawal by Subject|8|||
23440907|NCT01711645|65355338|FG000|Overall Study|Lost to Follow-up|6|||
23440908|NCT01711645|65355338|FG000|Overall Study|Physician Decision|5|||
23440909|NCT00269633|65355345|FG000|Overall Study|Withdrawal by Subject|1|||
23440910|NCT00269633|65355346|FG001|Overall Study|Withdrawal by Subject|0|||
23440911|NCT03857542|65355351|FG000|Overall Study|Adverse Event|1|||
23440912|NCT03857542|65355352|FG001|Overall Study|Adverse Event|3|||
23440913|NCT03857542|65355351|FG000|Overall Study|Withdrawal by Subject|2|||
23440914|NCT03857542|65355352|FG001|Overall Study|Withdrawal by Subject|1|||
23440915|NCT03857542|65355351|FG000|Overall Study|Lost to Follow-up|2|||
23440916|NCT03857542|65355352|FG001|Overall Study|Lost to Follow-up|1|||
23440917|NCT03857542|65355351|FG000|Overall Study|Reason not Specified|1|||
23440918|NCT03857542|65355352|FG001|Overall Study|Reason not Specified|0|||
23440919|NCT03679624|65355353|FG000|Overall Study|Adverse Event|1|||
23440920|NCT03679624|65355354|FG001|Overall Study|Adverse Event|0|||
23440921|NCT01063153|65355355|FG000|Overall Study|Found Ineligible During Screening|2|||
23440922|NCT01063153|65355356|FG001|Overall Study|Found Ineligible During Screening|0|||
23440923|NCT01063153|65355355|FG000|Overall Study|Lost to Follow-up|0|||
23440924|NCT01063153|65355356|FG001|Overall Study|Lost to Follow-up|7|||
23440925|NCT01063153|65355355|FG000|Overall Study|Withdrawal by Subject|0|||
23440926|NCT01063153|65355356|FG001|Overall Study|Withdrawal by Subject|1|||
23440927|NCT01063153|65355355|FG000|Overall Study|Physician Decision|0|||
23440928|NCT01063153|65355356|FG001|Overall Study|Physician Decision|4|||
23440929|NCT02942485|65355357|FG000|Overall Study|Lost to Follow-up|1|||
23440930|NCT02942485|65355358|FG001|Overall Study|Lost to Follow-up|0|||
23440931|NCT03992846|65355362|FG000|Overall Study|Adverse Event|8|||
23440932|NCT03992846|65355363|FG001|Overall Study|Adverse Event|6|||
23440933|NCT03992846|65355364|FG002|Overall Study|Adverse Event|3|||
23440934|NCT03992846|65355362|FG000|Overall Study|Lost to Follow-up|0|||
23440935|NCT03992846|65355363|FG001|Overall Study|Lost to Follow-up|1|||
23440936|NCT03992846|65355364|FG002|Overall Study|Lost to Follow-up|1|||
23440937|NCT03992846|65355362|FG000|Overall Study|Pregnancy|2|||
23440938|NCT03992846|65355363|FG001|Overall Study|Pregnancy|0|||
23440939|NCT03992846|65355364|FG002|Overall Study|Pregnancy|1|||
23440940|NCT03992846|65355362|FG000|Overall Study|Protocol Violation|1|||
23440941|NCT03992846|65355363|FG001|Overall Study|Protocol Violation|2|||
23440942|NCT03992846|65355364|FG002|Overall Study|Protocol Violation|0|||
23440943|NCT03992846|65355362|FG000|Overall Study|Withdrawal by Subject|8|||
23563754|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563755|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
23826780|NCT02955212|66745215|FG001|Period 1: Double-blind Treatment Period|Other|2|||
23826781|NCT02955212|66745214|FG000|Period 2: Open-label Extension|Adverse Event|11|||
23440944|NCT03992846|65355363|FG001|Overall Study|Withdrawal by Subject|10|||
23440945|NCT03992846|65355364|FG002|Overall Study|Withdrawal by Subject|20|||
23440946|NCT03992846|65355362|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
23440947|NCT03992846|65355363|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
23440948|NCT03992846|65355364|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
23440949|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
23440950|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
23440951|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440952|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440953|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440954|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
23440955|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
23440956|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
23440957|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
23440958|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
23440959|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
23440960|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440961|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440962|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440963|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440964|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Disease progression|0|||
23440965|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Disease progression|1|||
23440966|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Disease progression|1|||
23440967|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Disease progression|0|||
23440968|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Disease progression|0|||
23563756|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
23563757|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23563758|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23582245|NCT00567879|65862412|FG002|Overall Study|Abnormal test procedure(s)|1|||
23440969|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440970|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440971|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440972|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
23440973|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
23440974|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440975|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440976|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440977|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
23440978|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440979|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440980|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440981|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440982|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
23440983|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440984|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
23440985|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
23440986|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
23440987|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
23440988|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
23440989|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Death|0|||
23440990|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Death|0|||
23563759|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23563760|NCT02093663|65790544|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563761|NCT02093663|65790545|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563762|NCT02093663|65790546|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
23826782|NCT02955212|66745215|FG001|Period 2: Open-label Extension|Adverse Event|7|||
23826783|NCT02955212|66745214|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
23826784|NCT02955212|66745215|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
23826785|NCT02955212|66745214|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
23826786|NCT02955212|66745215|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
23563763|NCT02093663|65790547|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563764|NCT02093663|65790548|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563765|NCT02093663|65790544|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563766|NCT02093663|65790545|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563767|NCT02093663|65790546|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
23563768|NCT02093663|65790547|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563769|NCT02093663|65790548|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563770|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563771|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563772|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563773|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
23563774|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
23563775|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563776|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563777|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563778|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
23563779|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
23563780|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563781|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563782|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563783|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
23563784|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
23563785|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563786|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563787|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563788|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563789|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
23563790|NCT03321006|65790549|FG000|Overall Study|Death|1|||
23563791|NCT03321006|65790550|FG001|Overall Study|Death|0|||
23563792|NCT03321006|65790549|FG000|Overall Study|Lack of Efficacy|1|||
23563793|NCT03321006|65790550|FG001|Overall Study|Lack of Efficacy|0|||
23563794|NCT01161472|65793536|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
23563795|NCT01161472|65793537|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23826787|NCT02955212|66745214|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
23440991|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Death|0|||
23625989|NCT01917006|66015668|FG003|Open-label Period|Lost to Follow-up|0|||
23625990|NCT01917006|66015669|FG004|Open-label Period|Lost to Follow-up|0|||
23625991|NCT01917006|66015670|FG005|Open-label Period|Lost to Follow-up|0|||
23625992|NCT01917006|66015671|FG006|Open-label Period|Lost to Follow-up|0|||
23625993|NCT01917006|66015672|FG007|Open-label Period|Lost to Follow-up|1|||
23625994|NCT01947517|66015676|FG000|Overall Study|Withdrawal by Subject|1|||
23625995|NCT01947517|66015677|FG001|Overall Study|Withdrawal by Subject|1|||
23625996|NCT02561806|66015678|FG000|Induction Period|Adverse Event|0|||
23625997|NCT02561806|66015679|FG001|Induction Period|Adverse Event|2|||
23625998|NCT02561806|66015678|FG000|Induction Period|Lack of Efficacy|1|||
23625999|NCT02561806|66015679|FG001|Induction Period|Lack of Efficacy|0|||
23626000|NCT02561806|66015678|FG000|Induction Period|Withdrawal by Subject|0|||
23626001|NCT02561806|66015679|FG001|Induction Period|Withdrawal by Subject|2|||
23626002|NCT02561806|66015678|FG000|Induction Period|Site staff became unblinded|1|||
23626003|NCT02561806|66015679|FG001|Induction Period|Site staff became unblinded|0|||
23626004|NCT02561806|66015678|FG000|Induction Period|Randomized but not treated|0|||
23758930|NCT02576054|66494754|FG000|Overall Study|Withdrawal by Subject|1|||
23758931|NCT02766400|66494755|FG000|Overall Study|Death|1|||
23758932|NCT02766400|66494756|FG001|Overall Study|Death|2|||
23758933|NCT02766400|66494755|FG000|Overall Study|Withdrawal by Subject|1|||
23758934|NCT02766400|66494756|FG001|Overall Study|Withdrawal by Subject|0|||
23758935|NCT00740480|66494757|FG000|Overall Study|Adverse Event|1|||
23758936|NCT00740480|66494757|FG000|Overall Study|Physician Decision|1|||
23758937|NCT02030834|66494758|FG000|Overall Study|Death|4|||
23758938|NCT02030834|66494759|FG001|Overall Study|Death|0|||
23758939|NCT02030834|66494760|FG002|Overall Study|Death|0|||
23758940|NCT02030834|66494758|FG000|Overall Study|Manufacturing failure|2|||
23758941|NCT02030834|66494759|FG001|Overall Study|Manufacturing failure|0|||
23758942|NCT02030834|66494760|FG002|Overall Study|Manufacturing failure|1|||
23758943|NCT02030834|66494758|FG000|Overall Study|Disease progression|2|||
23758944|NCT02030834|66494759|FG001|Overall Study|Disease progression|0|||
23758945|NCT02030834|66494760|FG002|Overall Study|Disease progression|2|||
23758946|NCT02030834|66494758|FG000|Overall Study|Lost to Follow-up|1|||
23758947|NCT02030834|66494759|FG001|Overall Study|Lost to Follow-up|0|||
23758948|NCT02030834|66494760|FG002|Overall Study|Lost to Follow-up|0|||
23758949|NCT02030834|66494758|FG000|Overall Study|Withdrawal by Subject|1|||
23758950|NCT02030834|66494759|FG001|Overall Study|Withdrawal by Subject|0|||
23758951|NCT02030834|66494760|FG002|Overall Study|Withdrawal by Subject|0|||
23758952|NCT02030834|66494758|FG000|Overall Study|Lack of funding|1|||
23758953|NCT02030834|66494759|FG001|Overall Study|Lack of funding|0|||
23758954|NCT02030834|66494760|FG002|Overall Study|Lack of funding|0|||
23758955|NCT02217345|66494761|FG000|Overall Study|Lost to Follow-up|2|||
23758956|NCT02217345|66494762|FG001|Overall Study|Lost to Follow-up|1|||
23758957|NCT02217345|66494761|FG000|Overall Study|Withdrawal by Subject|3|||
23758958|NCT02217345|66494762|FG001|Overall Study|Withdrawal by Subject|2|||
23758959|NCT02217345|66494761|FG000|Overall Study|Adverse Event|2|||
23758960|NCT02217345|66494762|FG001|Overall Study|Adverse Event|1|||
23758961|NCT02217345|66494761|FG000|Overall Study|Physician Decision|0|||
23758962|NCT02217345|66494762|FG001|Overall Study|Physician Decision|1|||
23758963|NCT00328783|66494763|FG000|Overall Study|Could not tolerate ABC|21|||
23758964|NCT00328783|66494763|FG000|Overall Study|No heart in RT field|4|||
23758965|NCT00328783|66494763|FG000|Overall Study|Withdrawal by Subject|1|||
23758966|NCT03456726|66498068|FG000|Overall Study|Disease Progression|6|||
23758967|NCT03456726|66498069|FG001|Overall Study|Disease Progression|1|||
23758968|NCT03456726|66498068|FG000|Overall Study|Adverse Event|4|||
23758969|NCT03456726|66498069|FG001|Overall Study|Adverse Event|2|||
23758970|NCT03456726|66498068|FG000|Overall Study|Withdrawal by Subject|1|||
23758971|NCT03456726|66498069|FG001|Overall Study|Withdrawal by Subject|0|||
23758972|NCT03456726|66498068|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
23758973|NCT03456726|66498069|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
23758974|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758975|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758976|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758977|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
23758978|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758979|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758980|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758981|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758982|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758983|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23758984|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23758985|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23758986|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Adverse Event|1|||
23758987|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Adverse Event|1|||
23758988|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Adverse Event|1|||
23758989|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Adverse Event|1|||
23758990|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Adverse Event|0|||
23758991|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Adverse Event|0|||
23758992|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Adverse Event|0|||
23758993|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Adverse Event|0|||
23758994|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
23758995|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
23758996|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
23758997|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
23758998|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
23758999|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
23759000|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
23759001|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
23759002|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
23759003|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
23759004|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23759005|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23759006|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
23759007|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23759008|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
23759009|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
23759010|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
23759011|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
23759012|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
23759013|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
23563796|NCT01161472|65793538|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23563797|NCT01161472|65793539|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23563798|NCT04277455|65793540|FG000|Overall Study|Lost to Follow-up|1|||
23563799|NCT03882801|65793543|FG000|Period 1|Adverse Event|0|||
23759014|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23759015|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23759016|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759017|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759018|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759019|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759020|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759021|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23563800|NCT03882801|65793544|FG001|Period 1|Adverse Event|1|||
23563801|NCT03882801|65793543|FG000|Period 1|Non-compliance with study drug|1|||
23563802|NCT03882801|65793544|FG001|Period 1|Non-compliance with study drug|1|||
23563803|NCT03882801|65793543|FG000|Period 1|Never treated with study drug|1|||
23563804|NCT03882801|65793544|FG001|Period 1|Never treated with study drug|0|||
23563805|NCT03882801|65793543|FG000|Washout Period|Physician Decision|0|||
23563806|NCT03882801|65793544|FG001|Washout Period|Physician Decision|1|||
23563807|NCT03882801|65793543|FG000|Period 2|Non-compliance with study drug|0|||
23563808|NCT03882801|65793544|FG001|Period 2|Non-compliance with study drug|1|||
23563809|NCT01871558|65793545|FG000|Overall Study|Other reason|0|||
23563810|NCT01871558|65793546|FG001|Overall Study|Other reason|1|||
23563811|NCT01871558|65793545|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
23563812|NCT01871558|65793546|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
23563813|NCT01871558|65793545|FG000|Overall Study|Withdrawal by Subject|2|||
23563814|NCT01871558|65793546|FG001|Overall Study|Withdrawal by Subject|0|||
23563815|NCT02301156|65793563|FG000|Overall Study|Adverse Event|13|||
23563816|NCT02301156|65793564|FG001|Overall Study|Adverse Event|14|||
23563817|NCT02301156|65793563|FG000|Overall Study|Death|1|||
23563818|NCT02301156|65793564|FG001|Overall Study|Death|5|||
23563819|NCT02301156|65793563|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
23563820|NCT02301156|65793564|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
23563821|NCT02301156|65793563|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
23563822|NCT02301156|65793564|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
23563823|NCT02301156|65793563|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
23563824|NCT02301156|65793564|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
23563825|NCT02301156|65793563|FG000|Overall Study|Reason not Specified|6|||
23563826|NCT02301156|65793564|FG001|Overall Study|Reason not Specified|3|||
23563827|NCT04522180|65793565|FG000|Overall Study|Investigator judgement|3|||
23563828|NCT04522180|65793566|FG001|Overall Study|Investigator judgement|4|||
23759022|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759023|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23759024|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23826788|NCT02955212|66745215|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
23826789|NCT02955212|66745214|FG000|Period 2: Open-label Extension|Other|2|||
23826790|NCT02955212|66745215|FG001|Period 2: Open-label Extension|Other|4|||
23826791|NCT00262028|66745218|FG000|Overall Study|Withdrawal by Subject|6|||
23826792|NCT00262028|66745219|FG001|Overall Study|Withdrawal by Subject|3|||
23826793|NCT00262028|66745220|FG002|Overall Study|Withdrawal by Subject|6|||
23826794|NCT00262028|66745221|FG003|Overall Study|Withdrawal by Subject|5|||
23826795|NCT00262028|66745222|FG004|Overall Study|Withdrawal by Subject|2|||
23826796|NCT00262028|66745223|FG005|Overall Study|Withdrawal by Subject|3|||
23826797|NCT00262028|66745224|FG006|Overall Study|Withdrawal by Subject|5|||
23826798|NCT00262028|66745225|FG007|Overall Study|Withdrawal by Subject|7|||
23826799|NCT00262028|66745226|FG008|Overall Study|Withdrawal by Subject|2|||
23826800|NCT00262028|66745218|FG000|Overall Study|Lost to Follow-up|7|||
23826801|NCT00262028|66745219|FG001|Overall Study|Lost to Follow-up|7|||
23826802|NCT00262028|66745220|FG002|Overall Study|Lost to Follow-up|5|||
23826803|NCT00262028|66745221|FG003|Overall Study|Lost to Follow-up|5|||
23826804|NCT00262028|66745222|FG004|Overall Study|Lost to Follow-up|4|||
23826805|NCT00262028|66745223|FG005|Overall Study|Lost to Follow-up|3|||
23826806|NCT00262028|66745224|FG006|Overall Study|Lost to Follow-up|3|||
23826807|NCT00262028|66745225|FG007|Overall Study|Lost to Follow-up|5|||
23826808|NCT00262028|66745226|FG008|Overall Study|Lost to Follow-up|6|||
23826809|NCT00262028|66745218|FG000|Overall Study|Administrative Reason|11|||
23826810|NCT00262028|66745219|FG001|Overall Study|Administrative Reason|14|||
23826811|NCT00262028|66745220|FG002|Overall Study|Administrative Reason|9|||
23826812|NCT00262028|66745221|FG003|Overall Study|Administrative Reason|12|||
23826813|NCT00262028|66745222|FG004|Overall Study|Administrative Reason|6|||
23826814|NCT00262028|66745223|FG005|Overall Study|Administrative Reason|7|||
23826815|NCT00262028|66745224|FG006|Overall Study|Administrative Reason|4|||
23826816|NCT00262028|66745225|FG007|Overall Study|Administrative Reason|6|||
23826817|NCT00262028|66745226|FG008|Overall Study|Administrative Reason|10|||
23826818|NCT00262028|66745218|FG000|Overall Study|Protocol Violation|0|||
23826819|NCT00262028|66745219|FG001|Overall Study|Protocol Violation|0|||
23826820|NCT00262028|66745220|FG002|Overall Study|Protocol Violation|0|||
23826821|NCT00262028|66745221|FG003|Overall Study|Protocol Violation|1|||
23826822|NCT00262028|66745222|FG004|Overall Study|Protocol Violation|0|||
23826823|NCT00262028|66745223|FG005|Overall Study|Protocol Violation|0|||
23826824|NCT00262028|66745224|FG006|Overall Study|Protocol Violation|0|||
23826825|NCT00262028|66745225|FG007|Overall Study|Protocol Violation|0|||
23826826|NCT00262028|66745226|FG008|Overall Study|Protocol Violation|0|||
23826827|NCT00262028|66745218|FG000|Overall Study|Unable to classify|0|||
23826828|NCT00262028|66745219|FG001|Overall Study|Unable to classify|3|||
23826829|NCT00262028|66745220|FG002|Overall Study|Unable to classify|0|||
23826830|NCT00262028|66745221|FG003|Overall Study|Unable to classify|0|||
23826831|NCT00262028|66745222|FG004|Overall Study|Unable to classify|0|||
23826832|NCT00262028|66745223|FG005|Overall Study|Unable to classify|0|||
23626005|NCT02561806|66015679|FG001|Induction Period|Randomized but not treated|1|||
23626006|NCT02561806|66015678|FG000|Maintenance Period|Adverse Event|2|||
23626007|NCT02561806|66015679|FG001|Maintenance Period|Adverse Event|1|||
23626008|NCT02561806|66015678|FG000|Maintenance Period|Lack of Efficacy|3|||
23626009|NCT02561806|66015679|FG001|Maintenance Period|Lack of Efficacy|1|||
23626010|NCT02561806|66015678|FG000|Maintenance Period|Lost to Follow-up|2|||
23626011|NCT02561806|66015679|FG001|Maintenance Period|Lost to Follow-up|2|||
23626012|NCT02561806|66015678|FG000|Maintenance Period|Protocol Violation|1|||
23626013|NCT02561806|66015679|FG001|Maintenance Period|Protocol Violation|0|||
23626014|NCT02561806|66015678|FG000|Maintenance Period|Withdrawal by Subject|5|||
23626015|NCT02561806|66015679|FG001|Maintenance Period|Withdrawal by Subject|3|||
23626016|NCT02561806|66015678|FG000|Maintenance Period|Site staff became unblinded|0|||
23626017|NCT02561806|66015679|FG001|Maintenance Period|Site staff became unblinded|1|||
23626018|NCT02561806|66015678|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
23759025|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759026|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759027|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759028|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
23759029|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
23759030|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759031|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759032|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759033|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23759034|NCT00950599|66498070|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
23826833|NCT00262028|66745224|FG006|Overall Study|Unable to classify|0|||
23826834|NCT00262028|66745225|FG007|Overall Study|Unable to classify|0|||
23826835|NCT00262028|66745226|FG008|Overall Study|Unable to classify|1|||
23826836|NCT00417170|66745234|FG000|Overall Study|Adverse Event|1|||
23826837|NCT00417170|66745235|FG001|Overall Study|Adverse Event|1|||
23626019|NCT02561806|66015679|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
23626020|NCT02561806|66015678|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
23626021|NCT02561806|66015679|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
23626022|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
23626023|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
23626024|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
23626025|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
23626026|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
23626027|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
23626028|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
23626029|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
23626030|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
23626031|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
23626032|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
23626033|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
23626034|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
23626035|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
23626036|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
23626037|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626038|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626039|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626040|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
23626041|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
23626042|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
23626043|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626044|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626045|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626046|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
23626047|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
23626048|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
23626049|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
23626050|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
23626051|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
23626052|NCT02599688|66015683|FG000|Overall Study|Lack of Efficacy|1|||
23626053|NCT02599688|66015683|FG000|Overall Study|Withdrawal by Subject|1|||
23626054|NCT02599688|66015683|FG000|Overall Study|Termination by Sponsor|2|||
23626055|NCT04947436|66015684|FG000|Overall Study|Lost to Follow-up|3|||
23626056|NCT04947436|66015685|FG001|Overall Study|Lost to Follow-up|7|||
23626057|NCT04947436|66015686|FG002|Overall Study|Lost to Follow-up|5|||
23626058|NCT04947436|66015684|FG000|Overall Study|Death|1|||
23626059|NCT04947436|66015685|FG001|Overall Study|Death|1|||
23626060|NCT04947436|66015686|FG002|Overall Study|Death|1|||
23626061|NCT01233999|66015690|FG000|Overall Study|Withdrawal by Subject|1|||
23626062|NCT01233999|66015690|FG000|Overall Study|Lost to Follow-up|1|||
23626063|NCT00617929|66015691|FG000|Overall Study|Physician Decision|1|||
23626064|NCT01806389|66015692|FG000|Overall Study|Withdrawal by Subject|4|||
23626065|NCT03000348|66015693|FG000|Overall Study|Adverse Event|1|||
23626066|NCT03000348|66015694|FG001|Overall Study|Adverse Event|1|||
23626067|NCT03000348|66015695|FG002|Overall Study|Adverse Event|1|||
23626068|NCT03000348|66015696|FG003|Overall Study|Adverse Event|1|||
23626069|NCT03000348|66015697|FG004|Overall Study|Adverse Event|1|||
23626070|NCT03000348|66015698|FG005|Overall Study|Adverse Event|1|||
23626071|NCT03000348|66015693|FG000|Overall Study|Lost to Follow-up|0|||
23626072|NCT03000348|66015694|FG001|Overall Study|Lost to Follow-up|0|||
23626073|NCT03000348|66015695|FG002|Overall Study|Lost to Follow-up|1|||
23626074|NCT03000348|66015696|FG003|Overall Study|Lost to Follow-up|0|||
23626075|NCT03000348|66015697|FG004|Overall Study|Lost to Follow-up|0|||
23626076|NCT03000348|66015698|FG005|Overall Study|Lost to Follow-up|0|||
23626077|NCT03000348|66015693|FG000|Overall Study|Withdrawal by Subject|0|||
23626078|NCT03000348|66015694|FG001|Overall Study|Withdrawal by Subject|1|||
23626079|NCT03000348|66015695|FG002|Overall Study|Withdrawal by Subject|0|||
23626080|NCT03000348|66015696|FG003|Overall Study|Withdrawal by Subject|0|||
23626081|NCT03000348|66015697|FG004|Overall Study|Withdrawal by Subject|0|||
23759035|NCT00950599|66498071|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23759036|NCT00950599|66498072|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23759037|NCT00950599|66498073|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
23759038|NCT00950599|66498074|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
23626082|NCT03000348|66015698|FG005|Overall Study|Withdrawal by Subject|0|||
23626083|NCT03000348|66015693|FG000|Overall Study|Consent|0|||
23626084|NCT03000348|66015694|FG001|Overall Study|Consent|0|||
23626085|NCT03000348|66015695|FG002|Overall Study|Consent|0|||
23626086|NCT03000348|66015696|FG003|Overall Study|Consent|0|||
23626087|NCT03000348|66015697|FG004|Overall Study|Consent|1|||
23626088|NCT03000348|66015698|FG005|Overall Study|Consent|0|||
23626089|NCT03000348|66015693|FG000|Overall Study|Failure to expectorate sputum|1|||
23626090|NCT03000348|66015694|FG001|Overall Study|Failure to expectorate sputum|0|||
23626091|NCT03000348|66015695|FG002|Overall Study|Failure to expectorate sputum|1|||
23626092|NCT03000348|66015696|FG003|Overall Study|Failure to expectorate sputum|0|||
23626093|NCT03000348|66015697|FG004|Overall Study|Failure to expectorate sputum|1|||
23626094|NCT03000348|66015698|FG005|Overall Study|Failure to expectorate sputum|0|||
23826838|NCT00417170|66745234|FG000|Overall Study|Withdrawal by Subject|1|||
23826839|NCT00417170|66745235|FG001|Overall Study|Withdrawal by Subject|1|||
23826840|NCT00417170|66745234|FG000|Overall Study|Lost to Follow-up|0|||
23826841|NCT00417170|66745235|FG001|Overall Study|Lost to Follow-up|1|||
23826842|NCT00866359|66745236|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
23826843|NCT00866359|66745237|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
23826844|NCT00866359|66745238|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
23826845|NCT00866359|66745239|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
23826846|NCT00866359|66745236|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
23826847|NCT00866359|66745237|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23440992|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Death|1|||
23440993|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Death|1|||
23626095|NCT03000348|66015693|FG000|Overall Study|No gram negative|1|||
23626096|NCT03000348|66015694|FG001|Overall Study|No gram negative|2|||
23826848|NCT00866359|66745238|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23826849|NCT00866359|66745239|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23626097|NCT03000348|66015695|FG002|Overall Study|No gram negative|1|||
23626098|NCT03000348|66015696|FG003|Overall Study|No gram negative|1|||
23626099|NCT03000348|66015697|FG004|Overall Study|No gram negative|1|||
23626100|NCT03000348|66015698|FG005|Overall Study|No gram negative|1|||
23626101|NCT03000348|66015693|FG000|Overall Study|Patient had no transport|0|||
23626102|NCT03000348|66015694|FG001|Overall Study|Patient had no transport|0|||
23626103|NCT03000348|66015695|FG002|Overall Study|Patient had no transport|0|||
23626104|NCT03000348|66015696|FG003|Overall Study|Patient had no transport|1|||
23626105|NCT03000348|66015697|FG004|Overall Study|Patient had no transport|0|||
23626106|NCT03000348|66015698|FG005|Overall Study|Patient had no transport|0|||
23626107|NCT03000348|66015693|FG000|Overall Study|Dosing|0|||
23626108|NCT03000348|66015694|FG001|Overall Study|Dosing|0|||
23626109|NCT03000348|66015695|FG002|Overall Study|Dosing|0|||
23626110|NCT03000348|66015696|FG003|Overall Study|Dosing|0|||
23626111|NCT03000348|66015697|FG004|Overall Study|Dosing|1|||
23759039|NCT00950599|66498075|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
23759040|NCT00950599|66498076|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23626112|NCT03000348|66015698|FG005|Overall Study|Dosing|0|||
23626113|NCT00770588|66020197|FG000|Overall Study|Adverse Event|9|||
23626114|NCT00770588|66020198|FG001|Overall Study|Adverse Event|2|||
23626115|NCT00770588|66020197|FG000|Overall Study|Death caused by progression of disease|70|||
23626116|NCT00770588|66020198|FG001|Overall Study|Death caused by progression of disease|91|||
23626117|NCT00770588|66020197|FG000|Overall Study|Lost to Follow-up|1|||
23626118|NCT00770588|66020198|FG001|Overall Study|Lost to Follow-up|1|||
23626119|NCT00770588|66020197|FG000|Overall Study|Withdrawal by Subject|1|||
23626120|NCT00770588|66020198|FG001|Overall Study|Withdrawal by Subject|1|||
23626121|NCT04160988|66020201|FG000|Overall Study|poor image quality|28|||
23626122|NCT02153905|66020203|FG000|Overall Study|Death|1|||
23626123|NCT02153905|66020204|FG001|Overall Study|Death|0|||
23626124|NCT03634839|66020211|FG000|First Intervention (2 Hours)|Adverse Event|0|||
23626125|NCT03634839|66020212|FG001|First Intervention (2 Hours)|Adverse Event|2|||
23626126|NCT00912223|66020213|FG000|Overall Study|Withdrawal by Subject|1|||
23626127|NCT00912223|66020213|FG000|Overall Study|Not transplanted|1|||
23626128|NCT00912223|66020213|FG000|Overall Study|Transformed disease|1|||
23626129|NCT02561247|66020214|FG000|Overall Study|Protocol Violation|1|||
23626130|NCT02561247|66020214|FG000|Overall Study|Withdrawal by Subject|1|||
23626131|NCT02561247|66020214|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
23626132|NCT03512197|66020216|FG000|Overall Study|Guardian decision|1|||
23626133|NCT03512197|66020217|FG001|Overall Study|Guardian decision|1|||
23626134|NCT03512197|66020216|FG000|Overall Study|Lack of Efficacy|19|||
23626135|NCT03512197|66020217|FG001|Overall Study|Lack of Efficacy|11|||
23626136|NCT03512197|66020216|FG000|Overall Study|New Therapy for Study Indication|16|||
23626137|NCT03512197|66020217|FG001|Overall Study|New Therapy for Study Indication|16|||
23626138|NCT03512197|66020216|FG000|Overall Study|Physician Decision|60|||
23626139|NCT03512197|66020217|FG001|Overall Study|Physician Decision|60|||
23626140|NCT03512197|66020216|FG000|Overall Study|Protocol Violation|0|||
23626141|NCT03512197|66020217|FG001|Overall Study|Protocol Violation|2|||
23626142|NCT03512197|66020216|FG000|Overall Study|Terminated by Sponsored|46|||
23626143|NCT03512197|66020217|FG001|Overall Study|Terminated by Sponsored|50|||
23626144|NCT03512197|66020216|FG000|Overall Study|Subject Decision|15|||
23626145|NCT03512197|66020217|FG001|Overall Study|Subject Decision|12|||
23626146|NCT03512197|66020216|FG000|Overall Study|Withdrawal of informed consent|20|||
23626147|NCT03512197|66020217|FG001|Overall Study|Withdrawal of informed consent|14|||
23626148|NCT03512197|66020216|FG000|Overall Study|Adverse Event|30|||
23626149|NCT03512197|66020217|FG001|Overall Study|Adverse Event|34|||
23626150|NCT03512197|66020216|FG000|Overall Study|Death|14|||
23626151|NCT03512197|66020217|FG001|Overall Study|Death|9|||
23626152|NCT03512197|66020216|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
23626153|NCT03512197|66020217|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
23626154|NCT03512197|66020216|FG000|Overall Study|Missing|3|||
23626155|NCT03512197|66020217|FG001|Overall Study|Missing|13|||
23626156|NCT02804399|66020218|FG000|Period 2|Adverse Event|0|||
23626157|NCT02804399|66020219|FG001|Period 2|Adverse Event|1|||
23626158|NCT02447718|66020220|FG000|Overall Study|Lost to Follow-up|8|||
23626159|NCT02447718|66020221|FG001|Overall Study|Lost to Follow-up|0|||
23626160|NCT02447718|66020220|FG000|Overall Study|Withdrawal by Subject|3|||
23626161|NCT02447718|66020221|FG001|Overall Study|Withdrawal by Subject|0|||
23626162|NCT02447718|66020220|FG000|Overall Study|Screen Failure|1|||
23626163|NCT02447718|66020221|FG001|Overall Study|Screen Failure|0|||
23626164|NCT04042077|66020222|FG000|Overall Study|Adverse Event|0|||
23626165|NCT04042077|66020223|FG001|Overall Study|Adverse Event|1|||
23626166|NCT04042077|66020222|FG000|Overall Study|Death|2|||
23626167|NCT04042077|66020223|FG001|Overall Study|Death|1|||
23626168|NCT04042077|66020222|FG000|Overall Study|Physician Decision|2|||
23626169|NCT04042077|66020223|FG001|Overall Study|Physician Decision|0|||
23626170|NCT04042077|66020222|FG000|Overall Study|Withdrawal by Subject|3|||
23626171|NCT04042077|66020223|FG001|Overall Study|Withdrawal by Subject|2|||
23626172|NCT04042077|66020222|FG000|Overall Study|Lack of Efficacy|0|||
23626173|NCT04042077|66020223|FG001|Overall Study|Lack of Efficacy|1|||
23626174|NCT03174782|66020234|FG000|Overall Study|Protocol Violation|1|||
23626175|NCT03174782|66020235|FG001|Overall Study|Protocol Violation|0|||
23626176|NCT03174782|66020234|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
23626177|NCT03174782|66020235|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
23626178|NCT02573493|66020236|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
23626179|NCT02573493|66020237|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
23626180|NCT02573493|66020238|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
23626181|NCT02573493|66020239|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
23626182|NCT00723125|66020240|FG000|Overall Study|Met Dx|1|||
23626183|NCT00723125|66020241|FG001|Overall Study|Met Dx|0|||
23626184|NCT00723125|66020240|FG000|Overall Study|Withdrawal by Subject|15|||
23626185|NCT00723125|66020241|FG001|Overall Study|Withdrawal by Subject|6|||
23626186|NCT00723125|66020240|FG000|Overall Study|Adverse Event|2|||
23626187|NCT00723125|66020241|FG001|Overall Study|Adverse Event|0|||
23626188|NCT01018732|66020242|FG000|Overall Study|Lost to Follow-up|0|||
23626189|NCT01018732|66020243|FG001|Overall Study|Lost to Follow-up|0|||
23626190|NCT01018732|66020244|FG002|Overall Study|Lost to Follow-up|3|||
23626191|NCT01018732|66020242|FG000|Overall Study|Protocol Violation|1|||
23626192|NCT01018732|66020243|FG001|Overall Study|Protocol Violation|1|||
23626193|NCT01018732|66020244|FG002|Overall Study|Protocol Violation|0|||
23626194|NCT01018732|66020242|FG000|Overall Study|Inappropriate Enrollment|0|||
23626195|NCT01018732|66020243|FG001|Overall Study|Inappropriate Enrollment|1|||
23563829|NCT04522180|65793565|FG000|Overall Study|Voluntary withdrawal|1|||
23563830|NCT04522180|65793566|FG001|Overall Study|Voluntary withdrawal|0|||
23563831|NCT04522180|65793565|FG000|Overall Study|Pregnancy|0|||
23563832|NCT04522180|65793566|FG001|Overall Study|Pregnancy|1|||
23563833|NCT04522180|65793565|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
23563834|NCT04522180|65793566|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
23563835|NCT04522180|65793565|FG000|Overall Study|Reason not specified|8|||
23563836|NCT04522180|65793566|FG001|Overall Study|Reason not specified|5|||
23563837|NCT00988221|65793567|FG000|Part I|Adverse Event|0|||
23563838|NCT00988221|65793568|FG001|Part I|Adverse Event|1|||
23563839|NCT00988221|65793569|FG002|Part I|Adverse Event|2|||
23626196|NCT01018732|66020244|FG002|Overall Study|Inappropriate Enrollment|0|||
23626197|NCT01018732|66020242|FG000|Overall Study|Unable to Classify|0|||
23759041|NCT00950599|66498077|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23626198|NCT01018732|66020243|FG001|Overall Study|Unable to Classify|0|||
23626199|NCT01018732|66020244|FG002|Overall Study|Unable to Classify|1|||
23626200|NCT04544865|66020245|FG000|Overall Study|Death|0|||
23626201|NCT04544865|66020246|FG001|Overall Study|Death|2|||
23626202|NCT04544865|66020245|FG000|Overall Study|Lost to Follow-up|11|||
23626203|NCT04544865|66020246|FG001|Overall Study|Lost to Follow-up|7|||
23826850|NCT00866359|66745236|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
23826851|NCT00866359|66745237|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23826852|NCT00866359|66745238|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23626204|NCT04544865|66020245|FG000|Overall Study|Withdrawal by Subject|0|||
23626205|NCT04544865|66020246|FG001|Overall Study|Withdrawal by Subject|1|||
23626206|NCT04544865|66020245|FG000|Overall Study|Other|0|||
23626207|NCT04544865|66020246|FG001|Overall Study|Other|1|||
23626208|NCT00464945|66020247|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
23626209|NCT00464945|66020248|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
23626210|NCT00464945|66020247|FG000|Infant Series|Protocol Violation|1|||
23626211|NCT00464945|66020248|FG001|Infant Series|Protocol Violation|0|||
23626212|NCT00464945|66020247|FG000|Infant Series|Lost to Follow-up|1|||
23626213|NCT00464945|66020248|FG001|Infant Series|Lost to Follow-up|0|||
23626214|NCT00464945|66020247|FG000|After Infant Series|Withdrawal by Subject|0|||
23626215|NCT00464945|66020248|FG001|After Infant Series|Withdrawal by Subject|2|||
23626216|NCT00464945|66020247|FG000|Toddler Dose|Lost to Follow-up|0|||
23626217|NCT00464945|66020248|FG001|Toddler Dose|Lost to Follow-up|1|||
23626218|NCT02548078|66020251|FG000|Overall Study|Serious adverse event/Adverse event|1|||
23626219|NCT02548078|66020252|FG001|Overall Study|Serious adverse event/Adverse event|0|||
23626220|NCT02548078|66020251|FG000|Overall Study|Moved from study area|3|||
23626221|NCT02548078|66020252|FG001|Overall Study|Moved from study area|3|||
23626222|NCT02548078|66020251|FG000|Overall Study|Lost to Follow-up|1|||
23626223|NCT02548078|66020252|FG001|Overall Study|Lost to Follow-up|3|||
23626224|NCT01547117|66020253|FG000|Overall Study|Physician Decision|0|||
23626225|NCT01547117|66020254|FG001|Overall Study|Physician Decision|1|||
23759042|NCT00950599|66498078|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23759043|NCT00950599|66498079|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23759044|NCT00950599|66498070|FG000|Follow-Up Period|Adverse Event|0|||
23759045|NCT00950599|66498071|FG001|Follow-Up Period|Adverse Event|0|||
23759046|NCT00950599|66498072|FG002|Follow-Up Period|Adverse Event|0|||
23759047|NCT00950599|66498073|FG003|Follow-Up Period|Adverse Event|0|||
23759048|NCT00950599|66498074|FG004|Follow-Up Period|Adverse Event|0|||
23759049|NCT00950599|66498075|FG005|Follow-Up Period|Adverse Event|0|||
23759050|NCT00950599|66498076|FG006|Follow-Up Period|Adverse Event|0|||
23759051|NCT00950599|66498077|FG007|Follow-Up Period|Adverse Event|0|||
23759052|NCT00950599|66498078|FG008|Follow-Up Period|Adverse Event|1|||
23759053|NCT00950599|66498079|FG009|Follow-Up Period|Adverse Event|0|||
23759054|NCT00950599|66498070|FG000|Follow-Up Period|Lack of Efficacy|0|||
23759055|NCT00950599|66498071|FG001|Follow-Up Period|Lack of Efficacy|0|||
23759056|NCT00950599|66498072|FG002|Follow-Up Period|Lack of Efficacy|0|||
23759057|NCT00950599|66498073|FG003|Follow-Up Period|Lack of Efficacy|0|||
23759058|NCT00950599|66498074|FG004|Follow-Up Period|Lack of Efficacy|0|||
23826853|NCT00866359|66745239|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23563840|NCT00988221|65793570|FG003|Part I|Adverse Event|0|||
23563841|NCT00988221|65793567|FG000|Part I|Insufficient Therapeutic Response|4|||
23563842|NCT00988221|65793568|FG001|Part I|Insufficient Therapeutic Response|6|||
23563843|NCT00988221|65793569|FG002|Part I|Insufficient Therapeutic Response|5|||
23563844|NCT00988221|65793570|FG003|Part I|Insufficient Therapeutic Response|0|||
23563845|NCT00988221|65793567|FG000|Part I|Refused Treatment|0|||
23563846|NCT00988221|65793568|FG001|Part I|Refused Treatment|2|||
23563847|NCT00988221|65793569|FG002|Part I|Refused Treatment|1|||
23563848|NCT00988221|65793570|FG003|Part I|Refused Treatment|0|||
23563849|NCT00988221|65793567|FG000|Part I|Lost to Follow-up|0|||
23626226|NCT01547117|66020255|FG002|Overall Study|Physician Decision|1|||
23626227|NCT01547117|66020256|FG003|Overall Study|Physician Decision|3|||
23759059|NCT00950599|66498075|FG005|Follow-Up Period|Lack of Efficacy|0|||
23759060|NCT00950599|66498076|FG006|Follow-Up Period|Lack of Efficacy|0|||
23759061|NCT00950599|66498077|FG007|Follow-Up Period|Lack of Efficacy|0|||
23759062|NCT00950599|66498078|FG008|Follow-Up Period|Lack of Efficacy|3|||
23759063|NCT00950599|66498079|FG009|Follow-Up Period|Lack of Efficacy|0|||
23759064|NCT00950599|66498070|FG000|Follow-Up Period|Lost to Follow-up|0|||
23759065|NCT00950599|66498071|FG001|Follow-Up Period|Lost to Follow-up|0|||
23759066|NCT00950599|66498072|FG002|Follow-Up Period|Lost to Follow-up|0|||
23759067|NCT00950599|66498073|FG003|Follow-Up Period|Lost to Follow-up|0|||
23759068|NCT00950599|66498074|FG004|Follow-Up Period|Lost to Follow-up|0|||
23759069|NCT00950599|66498075|FG005|Follow-Up Period|Lost to Follow-up|0|||
23759070|NCT00950599|66498076|FG006|Follow-Up Period|Lost to Follow-up|0|||
23759071|NCT00950599|66498077|FG007|Follow-Up Period|Lost to Follow-up|0|||
23759072|NCT00950599|66498078|FG008|Follow-Up Period|Lost to Follow-up|5|||
23759073|NCT00950599|66498079|FG009|Follow-Up Period|Lost to Follow-up|1|||
23563850|NCT00988221|65793568|FG001|Part I|Lost to Follow-up|1|||
23563851|NCT00988221|65793569|FG002|Part I|Lost to Follow-up|0|||
23563852|NCT00988221|65793570|FG003|Part I|Lost to Follow-up|0|||
23563853|NCT00988221|65793567|FG000|Part II|Adverse Event|1|||
23563854|NCT00988221|65793568|FG001|Part II|Adverse Event|0|||
23563855|NCT00988221|65793569|FG002|Part II|Adverse Event|0|||
23563856|NCT00988221|65793570|FG003|Part II|Adverse Event|1|||
23563857|NCT00988221|65793567|FG000|Part II|Withdrawal by Subject|0|||
23563858|NCT00988221|65793568|FG001|Part II|Withdrawal by Subject|0|||
23563859|NCT00988221|65793569|FG002|Part II|Withdrawal by Subject|2|||
23563860|NCT00988221|65793570|FG003|Part II|Withdrawal by Subject|2|||
23563861|NCT00988221|65793567|FG000|Part II|Reason not Specified|0|||
23759074|NCT00950599|66498070|FG000|Follow-Up Period|Physician Decision|0|||
23759075|NCT00950599|66498071|FG001|Follow-Up Period|Physician Decision|0|||
23759076|NCT00950599|66498072|FG002|Follow-Up Period|Physician Decision|0|||
23440994|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440995|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440996|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440997|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440998|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
23440999|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441000|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441001|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441002|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441003|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
23441004|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441005|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441006|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441007|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
23441008|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441009|NCT00709618|65355376|FG000|Overall Study|Withdrawal by Subject|4|||
23441010|NCT00709618|65355376|FG000|Overall Study|Lost to Follow-up|1|||
23441011|NCT00709618|65355376|FG000|Overall Study|Study Closed/Terminated|25|||
23441012|NCT00264537|65355377|FG000|Overall Study|Death|0|||
23441013|NCT00264537|65355378|FG001|Overall Study|Death|3|||
23441014|NCT00264537|65355379|FG002|Overall Study|Death|3|||
23441015|NCT00264537|65355380|FG003|Overall Study|Death|2|||
23759077|NCT00950599|66498073|FG003|Follow-Up Period|Physician Decision|0|||
23441016|NCT00264537|65355377|FG000|Overall Study|Lost to Follow-up|3|||
23441017|NCT00264537|65355378|FG001|Overall Study|Lost to Follow-up|4|||
23441018|NCT00264537|65355379|FG002|Overall Study|Lost to Follow-up|7|||
23563862|NCT00988221|65793568|FG001|Part II|Reason not Specified|0|||
23563863|NCT00988221|65793569|FG002|Part II|Reason not Specified|1|||
23563864|NCT00988221|65793570|FG003|Part II|Reason not Specified|0|||
23563865|NCT00988221|65793567|FG000|Part III|Adverse Event|1|||
23563866|NCT00988221|65793568|FG001|Part III|Adverse Event|0|||
23563867|NCT00988221|65793569|FG002|Part III|Adverse Event|1|||
23563868|NCT00988221|65793570|FG003|Part III|Adverse Event|0|||
23563869|NCT00988221|65793567|FG000|Part III|Insufficient Therapeutic Response|0|||
23563870|NCT00988221|65793568|FG001|Part III|Insufficient Therapeutic Response|1|||
23563871|NCT00988221|65793569|FG002|Part III|Insufficient Therapeutic Response|1|||
23563872|NCT00988221|65793570|FG003|Part III|Insufficient Therapeutic Response|0|||
23563873|NCT00988221|65793567|FG000|Part III|Refused Treatment|0|||
23563874|NCT00988221|65793568|FG001|Part III|Refused Treatment|0|||
23563875|NCT00988221|65793569|FG002|Part III|Refused Treatment|1|||
23563876|NCT00988221|65793570|FG003|Part III|Refused Treatment|0|||
23563877|NCT02013388|65793571|FG000|Overall Study|work emergency|1|||
23563878|NCT02013388|65793572|FG001|Overall Study|work emergency|0|||
23563879|NCT02013388|65793573|FG002|Overall Study|work emergency|0|||
23626228|NCT01547117|66020253|FG000|Overall Study|Withdrawal by Subject|1|||
23626229|NCT01547117|66020254|FG001|Overall Study|Withdrawal by Subject|2|||
23626230|NCT01547117|66020255|FG002|Overall Study|Withdrawal by Subject|1|||
23441019|NCT00264537|65355380|FG003|Overall Study|Lost to Follow-up|6|||
23441020|NCT00264537|65355377|FG000|Overall Study|Adverse Event|21|||
23626231|NCT01547117|66020256|FG003|Overall Study|Withdrawal by Subject|2|||
23441021|NCT00264537|65355378|FG001|Overall Study|Adverse Event|32|||
23441022|NCT00264537|65355379|FG002|Overall Study|Adverse Event|24|||
23441023|NCT00264537|65355380|FG003|Overall Study|Adverse Event|34|||
23563880|NCT02013388|65793574|FG003|Overall Study|work emergency|0|||
23563881|NCT02013388|65793575|FG004|Overall Study|work emergency|1|||
23563882|NCT02013388|65793576|FG005|Overall Study|work emergency|0|||
23626232|NCT00810342|66020257|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
23626233|NCT00810342|66020258|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
23626234|NCT00810342|66020257|FG000|Month 1 Follow-up|Pregnancy|1|||
23626235|NCT00810342|66020258|FG001|Month 1 Follow-up|Pregnancy|0|||
23626236|NCT00810342|66020257|FG000|6-month Follow-up|Lost to Follow-up|18|||
23626237|NCT00810342|66020258|FG001|6-month Follow-up|Lost to Follow-up|6|||
23626238|NCT00810342|66020257|FG000|6-month Follow-up|Pregnancy|6|||
23626239|NCT00810342|66020258|FG001|6-month Follow-up|Pregnancy|2|||
23759078|NCT00950599|66498074|FG004|Follow-Up Period|Physician Decision|0|||
23759079|NCT00950599|66498075|FG005|Follow-Up Period|Physician Decision|0|||
23563883|NCT02013388|65793577|FG006|Overall Study|work emergency|0|||
23563884|NCT02013388|65793578|FG007|Overall Study|work emergency|0|||
23563885|NCT02066402|65793585|FG000|Overall Study|Adverse Event|1|||
23563886|NCT02066402|65793586|FG001|Overall Study|Adverse Event|2|||
23563887|NCT02066402|65793585|FG000|Overall Study|Lost to Follow-up|11|||
23626240|NCT00810342|66020257|FG000|12-month Followup|Pregnancy|9|||
23441024|NCT00264537|65355377|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23563888|NCT02066402|65793586|FG001|Overall Study|Lost to Follow-up|8|||
23441025|NCT00264537|65355378|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23441026|NCT00264537|65355379|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23441027|NCT00264537|65355380|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
23441028|NCT00264537|65355377|FG000|Overall Study|Other|21|||
23441029|NCT00264537|65355378|FG001|Overall Study|Other|11|||
23441030|NCT00264537|65355379|FG002|Overall Study|Other|10|||
23441031|NCT00264537|65355380|FG003|Overall Study|Other|11|||
23441032|NCT00264537|65355377|FG000|Overall Study|Not treated|0|||
23441033|NCT00264537|65355378|FG001|Overall Study|Not treated|2|||
23441034|NCT00264537|65355379|FG002|Overall Study|Not treated|1|||
23441035|NCT00264537|65355380|FG003|Overall Study|Not treated|0|||
23441036|NCT04698993|65355383|FG000|Overall Study|PCR results not accessible|2|||
23441037|NCT04698993|65355384|FG001|Overall Study|PCR results not accessible|7|||
23441038|NCT04698993|65355383|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
23441039|NCT04698993|65355384|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
23441040|NCT01339897|65355385|FG000|Overall Study|Adverse Event|1|||
23441041|NCT01339897|65355386|FG001|Overall Study|Adverse Event|0|||
23441042|NCT01339897|65355387|FG002|Overall Study|Adverse Event|0|||
23441043|NCT01339897|65355388|FG003|Overall Study|Adverse Event|1|||
23441044|NCT01098305|65355389|FG000|Overall Study|Lost to Follow-up|31|||
23441045|NCT01098305|65355390|FG001|Overall Study|Lost to Follow-up|33|||
23441046|NCT02207491|65355392|FG000|Overall Study|Adverse Event|20|||
23441047|NCT02207491|65355393|FG001|Overall Study|Adverse Event|4|||
23441048|NCT02207491|65355392|FG000|Overall Study|Withdrawal by Subject|3|||
23441049|NCT02207491|65355393|FG001|Overall Study|Withdrawal by Subject|2|||
23441050|NCT02207491|65355392|FG000|Overall Study|Non-compliant|0|||
23441051|NCT02207491|65355393|FG001|Overall Study|Non-compliant|1|||
23441052|NCT02207491|65355392|FG000|Overall Study|Lost to Follow-up|0|||
23441053|NCT02207491|65355393|FG001|Overall Study|Lost to Follow-up|1|||
23441054|NCT02207491|65355392|FG000|Overall Study|Lack of Efficacy|3|||
23441055|NCT02207491|65355393|FG001|Overall Study|Lack of Efficacy|0|||
23441056|NCT02207491|65355392|FG000|Overall Study|Physician Decision|2|||
23441057|NCT02207491|65355393|FG001|Overall Study|Physician Decision|0|||
23441058|NCT02207491|65355392|FG000|Overall Study|Protocol Violation|3|||
23441059|NCT02207491|65355393|FG001|Overall Study|Protocol Violation|5|||
23441060|NCT04599465|65355396|FG000|Overall Study|Physician Decision|1|||
23441061|NCT04599465|65355396|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
23441062|NCT00950248|65355401|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
23441063|NCT00950248|65355402|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
23441064|NCT00950248|65355403|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
23563889|NCT02066402|65793585|FG000|Overall Study|Withdrawal by Subject|14|||
23563890|NCT02066402|65793586|FG001|Overall Study|Withdrawal by Subject|11|||
23563891|NCT02066402|65793585|FG000|Overall Study|Progressive disease-clinical progression|0|||
23563892|NCT02066402|65793586|FG001|Overall Study|Progressive disease-clinical progression|1|||
23563893|NCT02066402|65793585|FG000|Overall Study|Protocol driven decision point|0|||
23563894|NCT02066402|65793586|FG001|Overall Study|Protocol driven decision point|1|||
23563895|NCT01203930|65793587|FG000|Overall Study|Disease Progression|0|||
23563896|NCT01203930|65793588|FG001|Overall Study|Disease Progression|4|||
23563897|NCT01203930|65793587|FG000|Overall Study|Death|3|||
23563898|NCT01203930|65793588|FG001|Overall Study|Death|1|||
23563899|NCT01203930|65793587|FG000|Overall Study|Withdrew Consent|1|||
23563900|NCT01203930|65793588|FG001|Overall Study|Withdrew Consent|10|||
23563901|NCT01203930|65793587|FG000|Overall Study|Investigator Request|0|||
23563902|NCT01203930|65793588|FG001|Overall Study|Investigator Request|8|||
23563903|NCT01203930|65793587|FG000|Overall Study|Study Terminated by Sponsor|0|||
23563904|NCT01203930|65793588|FG001|Overall Study|Study Terminated by Sponsor|12|||
23563905|NCT01203930|65793587|FG000|Overall Study|Poor tolerance of study drug|0|||
23563906|NCT01203930|65793588|FG001|Overall Study|Poor tolerance of study drug|1|||
23563907|NCT01203930|65793587|FG000|Overall Study|Adverse Event|17|||
23563908|NCT01203930|65793588|FG001|Overall Study|Adverse Event|5|||
23563909|NCT01857622|65793589|FG000|Overall Study|Adverse Event|5|||
23563910|NCT01857622|65793590|FG001|Overall Study|Adverse Event|0|||
23563911|NCT01857622|65793591|FG002|Overall Study|Adverse Event|2|||
23441065|NCT00950248|65355401|FG000|Year 1: Baseline|worsening of symptoms|2|||
23441066|NCT00950248|65355402|FG001|Year 1: Baseline|worsening of symptoms|0|||
23441067|NCT00950248|65355403|FG002|Year 1: Baseline|worsening of symptoms|0|||
23441068|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
23441069|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
23441070|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
23441071|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
23441072|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
23441073|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
23441074|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|Death|0|||
23441075|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|Death|0|||
23563912|NCT01857622|65793589|FG000|Overall Study|Physician Decision|1|||
23563913|NCT01857622|65793590|FG001|Overall Study|Physician Decision|0|||
23563914|NCT01857622|65793591|FG002|Overall Study|Physician Decision|0|||
23563915|NCT01857622|65793589|FG000|Overall Study|Protocol Violation|4|||
23563916|NCT01857622|65793590|FG001|Overall Study|Protocol Violation|1|||
23563917|NCT01857622|65793591|FG002|Overall Study|Protocol Violation|0|||
23563918|NCT01857622|65793589|FG000|Overall Study|Withdrawal by Subject|1|||
23563919|NCT01857622|65793590|FG001|Overall Study|Withdrawal by Subject|0|||
23563920|NCT01857622|65793591|FG002|Overall Study|Withdrawal by Subject|0|||
23563921|NCT03635489|65793594|FG000|Overall Study|Death|19|||
23563922|NCT03635489|65793595|FG001|Overall Study|Death|13|||
23563923|NCT03635489|65793594|FG000|Overall Study|Lost to Follow-up|1|||
23563924|NCT03635489|65793595|FG001|Overall Study|Lost to Follow-up|2|||
23563925|NCT03635489|65793594|FG000|Overall Study|Withdrawal by Subject|1|||
23563926|NCT03635489|65793595|FG001|Overall Study|Withdrawal by Subject|2|||
23563927|NCT03635489|65793594|FG000|Overall Study|Study Ended by Sponsor|28|||
23563928|NCT03635489|65793595|FG001|Overall Study|Study Ended by Sponsor|34|||
23563929|NCT01036022|65793596|FG000|Overall Study|Adverse Event|1|||
23563930|NCT01036022|65793597|FG001|Overall Study|Adverse Event|3|||
23563931|NCT01036022|65793598|FG002|Overall Study|Adverse Event|2|||
23563932|NCT01036022|65793599|FG003|Overall Study|Adverse Event|1|||
23563933|NCT01036022|65793600|FG004|Overall Study|Adverse Event|0|||
23626241|NCT00810342|66020258|FG001|12-month Followup|Pregnancy|10|||
23626242|NCT00810342|66020257|FG000|12-month Followup|Lost to Follow-up|3|||
23626243|NCT00810342|66020258|FG001|12-month Followup|Lost to Follow-up|1|||
23626244|NCT00847132|66020263|FG000|Overall Study|Death|1|||
23626245|NCT00847132|66020264|FG001|Overall Study|Death|1|||
23626246|NCT01266018|66020265|FG000|Overall Study|Physician Decision|1|||
23563934|NCT01036022|65793601|FG005|Overall Study|Adverse Event|2|||
23563935|NCT01036022|65793596|FG000|Overall Study|Lack of Efficacy|1|||
23563936|NCT01036022|65793597|FG001|Overall Study|Lack of Efficacy|1|||
23563937|NCT01036022|65793598|FG002|Overall Study|Lack of Efficacy|1|||
23563938|NCT01036022|65793599|FG003|Overall Study|Lack of Efficacy|0|||
23563939|NCT01036022|65793600|FG004|Overall Study|Lack of Efficacy|1|||
23563940|NCT01036022|65793601|FG005|Overall Study|Lack of Efficacy|1|||
23563941|NCT01036022|65793596|FG000|Overall Study|Physician Decision|0|||
23626247|NCT01266018|66020266|FG001|Overall Study|Physician Decision|0|||
23626248|NCT01266018|66020265|FG000|Overall Study|Progressive disease|0|||
23563942|NCT01036022|65793597|FG001|Overall Study|Physician Decision|0|||
23626249|NCT01266018|66020266|FG001|Overall Study|Progressive disease|1|||
23759080|NCT00950599|66498076|FG006|Follow-Up Period|Physician Decision|0|||
23563943|NCT01036022|65793598|FG002|Overall Study|Physician Decision|1|||
23626250|NCT00992992|66020267|FG000|Overall Study|Lost to Follow-up|3|||
23563944|NCT01036022|65793599|FG003|Overall Study|Physician Decision|0|||
23441076|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|Death|1|||
23563945|NCT01036022|65793600|FG004|Overall Study|Physician Decision|0|||
23826854|NCT00866359|66745236|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
23826855|NCT00866359|66745237|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
23826856|NCT00866359|66745238|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
23826857|NCT00866359|66745239|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
23826858|NCT00866359|66745236|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
23563946|NCT01036022|65793601|FG005|Overall Study|Physician Decision|0|||
23563947|NCT01036022|65793596|FG000|Overall Study|Withdrawal by Subject|0|||
23826859|NCT00866359|66745237|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
23826860|NCT00866359|66745238|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
23826861|NCT00866359|66745239|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
23626251|NCT00992992|66020267|FG000|Overall Study|Death|16|||
23626252|NCT00992992|66020267|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
23626253|NCT00992992|66020267|FG000|Overall Study|Sponsor Closed the Study|4|||
23626254|NCT04698915|66020268|FG000|Overall Study|Adverse Event|2|||
23626255|NCT04698915|66020269|FG001|Overall Study|Adverse Event|0|||
23626256|NCT04698915|66020268|FG000|Overall Study|Death|23|||
23626257|NCT04698915|66020269|FG001|Overall Study|Death|20|||
23626258|NCT04698915|66020268|FG000|Overall Study|Physician Decision|1|||
23826862|NCT00866359|66745236|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
23826863|NCT00866359|66745237|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
23826864|NCT00866359|66745238|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
23441077|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
23563948|NCT01036022|65793597|FG001|Overall Study|Withdrawal by Subject|0|||
23563949|NCT01036022|65793598|FG002|Overall Study|Withdrawal by Subject|0|||
23563950|NCT01036022|65793599|FG003|Overall Study|Withdrawal by Subject|1|||
23563951|NCT01036022|65793600|FG004|Overall Study|Withdrawal by Subject|2|||
23563952|NCT01036022|65793601|FG005|Overall Study|Withdrawal by Subject|0|||
23563953|NCT02243202|65793602|FG000|Overall Study|Adverse Event|5|||
23563954|NCT02243202|65793603|FG001|Overall Study|Adverse Event|6|||
23563955|NCT02243202|65793604|FG002|Overall Study|Adverse Event|10|||
23563956|NCT02243202|65793605|FG003|Overall Study|Adverse Event|4|||
23563957|NCT02243202|65793602|FG000|Overall Study|Lost to Follow-up|9|||
23563958|NCT02243202|65793603|FG001|Overall Study|Lost to Follow-up|9|||
23563959|NCT02243202|65793604|FG002|Overall Study|Lost to Follow-up|14|||
23563960|NCT02243202|65793605|FG003|Overall Study|Lost to Follow-up|11|||
23563961|NCT02243202|65793602|FG000|Overall Study|Protocol Violation|3|||
23563962|NCT02243202|65793603|FG001|Overall Study|Protocol Violation|1|||
23563963|NCT02243202|65793604|FG002|Overall Study|Protocol Violation|2|||
23563964|NCT02243202|65793605|FG003|Overall Study|Protocol Violation|1|||
23563965|NCT02243202|65793602|FG000|Overall Study|Withdrawal by Subject|7|||
23563966|NCT02243202|65793603|FG001|Overall Study|Withdrawal by Subject|6|||
23563967|NCT02243202|65793604|FG002|Overall Study|Withdrawal by Subject|4|||
23563968|NCT02243202|65793605|FG003|Overall Study|Withdrawal by Subject|4|||
23563969|NCT02243202|65793602|FG000|Overall Study|Other|1|||
23563970|NCT02243202|65793603|FG001|Overall Study|Other|3|||
23626259|NCT04698915|66020269|FG001|Overall Study|Physician Decision|1|||
23563971|NCT02243202|65793604|FG002|Overall Study|Other|1|||
23563972|NCT02243202|65793605|FG003|Overall Study|Other|2|||
23563973|NCT02243202|65793602|FG000|Overall Study|Randomized but not received treatment|0|||
23563974|NCT02243202|65793603|FG001|Overall Study|Randomized but not received treatment|0|||
23563975|NCT02243202|65793604|FG002|Overall Study|Randomized but not received treatment|0|||
23563976|NCT02243202|65793605|FG003|Overall Study|Randomized but not received treatment|1|||
23563977|NCT00659984|65793610|FG000|Overall Study|Adverse Event|1|||
23563978|NCT01518946|65793611|FG000|Open-label Phase|Other|4|||
23563979|NCT01518946|65793612|FG001|Open-label Phase|Other|0|||
23563980|NCT01518946|65793613|FG002|Open-label Phase|Other|0|||
23563981|NCT01518946|65793611|FG000|Randomized Phase (First Intervention)|Other|0|||
23563982|NCT01518946|65793612|FG001|Randomized Phase (First Intervention)|Other|1|||
23563983|NCT01518946|65793613|FG002|Randomized Phase (First Intervention)|Other|0|||
23563984|NCT03610737|65793615|FG000|Overall Study|Withdrawal by Subject|1|||
23563985|NCT03610737|65793616|FG001|Overall Study|Withdrawal by Subject|5|||
23563986|NCT03610737|65793615|FG000|Overall Study|Death|1|||
23626260|NCT04698915|66020268|FG000|Overall Study|Lost to Follow-up|1|||
23626261|NCT04698915|66020269|FG001|Overall Study|Lost to Follow-up|0|||
23626262|NCT04698915|66020268|FG000|Overall Study|Study Terminated by Sponsor|55|||
23626263|NCT04698915|66020269|FG001|Overall Study|Study Terminated by Sponsor|60|||
23626264|NCT04698915|66020268|FG000|Overall Study|Withdrawal by Subject|2|||
23626265|NCT04698915|66020269|FG001|Overall Study|Withdrawal by Subject|3|||
23626266|NCT00952848|66020271|FG000|Overall Study|Withdrawal by Subject|4|||
23626267|NCT00516139|66020274|FG000|Overall Study|Adverse Event|27|||
23626268|NCT00516139|66020274|FG000|Overall Study|Lost to Follow-up|1|||
23626269|NCT00516139|66020274|FG000|Overall Study|Protocol Violation|1|||
23626270|NCT00516139|66020274|FG000|Overall Study|Withdrawal by Subject|8|||
23626271|NCT00516139|66020274|FG000|Overall Study|Lack of Efficacy|1|||
23759081|NCT00950599|66498077|FG007|Follow-Up Period|Physician Decision|0|||
23759082|NCT00950599|66498078|FG008|Follow-Up Period|Physician Decision|1|||
23759083|NCT00950599|66498079|FG009|Follow-Up Period|Physician Decision|0|||
23759084|NCT00950599|66498070|FG000|Follow-Up Period|Poor/Noncompliance|0|||
23759085|NCT00950599|66498071|FG001|Follow-Up Period|Poor/Noncompliance|0|||
23759086|NCT00950599|66498072|FG002|Follow-Up Period|Poor/Noncompliance|0|||
23759087|NCT00950599|66498073|FG003|Follow-Up Period|Poor/Noncompliance|0|||
23826865|NCT00866359|66745239|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
23759088|NCT00950599|66498074|FG004|Follow-Up Period|Poor/Noncompliance|0|||
23826866|NCT00344448|66745242|FG000|Screening|Withdrawal by Subject|0|||
23563987|NCT03610737|65793616|FG001|Overall Study|Death|0|||
23563988|NCT03610737|65793615|FG000|Overall Study|Not treated|5|||
23626272|NCT01130168|66020275|FG000|Period 1|Withdrawal by Subject|0|||
23759089|NCT00950599|66498075|FG005|Follow-Up Period|Poor/Noncompliance|0|||
23563989|NCT03610737|65793616|FG001|Overall Study|Not treated|2|||
23563990|NCT03610737|65793615|FG000|Overall Study|Missed Visit|1|||
23563991|NCT03610737|65793616|FG001|Overall Study|Missed Visit|2|||
23759090|NCT00950599|66498076|FG006|Follow-Up Period|Poor/Noncompliance|0|||
23759091|NCT00950599|66498077|FG007|Follow-Up Period|Poor/Noncompliance|0|||
23759092|NCT00950599|66498078|FG008|Follow-Up Period|Poor/Noncompliance|1|||
23759093|NCT00950599|66498079|FG009|Follow-Up Period|Poor/Noncompliance|0|||
23759094|NCT00950599|66498070|FG000|Follow-Up Period|Subject withdrew Consent|0|||
23759095|NCT00950599|66498071|FG001|Follow-Up Period|Subject withdrew Consent|0|||
23826867|NCT00344448|66745243|FG001|Screening|Withdrawal by Subject|1|||
23826868|NCT00344448|66745242|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
23563992|NCT04399356|65793631|FG000|Overall Study|Lost to Follow-up|1|||
23563993|NCT04399356|65793632|FG001|Overall Study|Lost to Follow-up|1|||
23563994|NCT04399356|65793631|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
23563995|NCT04399356|65793632|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
23563996|NCT04399356|65793631|FG000|Overall Study|Withdrawal by Subject|1|||
23563997|NCT04399356|65793632|FG001|Overall Study|Withdrawal by Subject|0|||
23563998|NCT03565068|65793633|FG000|Overall Study|Protocol Violation|0|||
23563999|NCT03565068|65793634|FG001|Overall Study|Protocol Violation|0|||
23564000|NCT03565068|65793635|FG002|Overall Study|Protocol Violation|0|||
23826869|NCT00344448|66745243|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
23826870|NCT00344448|66745242|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
23759096|NCT00950599|66498072|FG002|Follow-Up Period|Subject withdrew Consent|0|||
23759097|NCT00950599|66498073|FG003|Follow-Up Period|Subject withdrew Consent|0|||
23759098|NCT00950599|66498074|FG004|Follow-Up Period|Subject withdrew Consent|0|||
23759099|NCT00950599|66498075|FG005|Follow-Up Period|Subject withdrew Consent|0|||
23759100|NCT00950599|66498076|FG006|Follow-Up Period|Subject withdrew Consent|0|||
23759101|NCT00950599|66498077|FG007|Follow-Up Period|Subject withdrew Consent|0|||
23759102|NCT00950599|66498078|FG008|Follow-Up Period|Subject withdrew Consent|2|||
23759103|NCT00950599|66498079|FG009|Follow-Up Period|Subject withdrew Consent|1|||
23759104|NCT00382291|66498080|FG000|Overall Study|Adverse Event|1|||
23564001|NCT03565068|65793636|FG003|Overall Study|Protocol Violation|0|||
23626273|NCT01130168|66020276|FG001|Period 1|Withdrawal by Subject|1|||
23626274|NCT01130168|66020277|FG002|Period 1|Withdrawal by Subject|0|||
23626275|NCT01130168|66020278|FG003|Period 1|Withdrawal by Subject|1|||
23759105|NCT00382291|66498081|FG001|Overall Study|Adverse Event|2|||
23759106|NCT00382291|66498082|FG002|Overall Study|Adverse Event|2|||
23759107|NCT00382291|66498080|FG000|Overall Study|Protocol Violation|1|||
23759108|NCT00382291|66498081|FG001|Overall Study|Protocol Violation|0|||
23759109|NCT00382291|66498082|FG002|Overall Study|Protocol Violation|0|||
23759110|NCT00382291|66498080|FG000|Overall Study|Temporary study suspension|2|||
23759111|NCT00382291|66498081|FG001|Overall Study|Temporary study suspension|2|||
23759112|NCT00382291|66498082|FG002|Overall Study|Temporary study suspension|5|||
23826871|NCT00344448|66745243|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
23826872|NCT00344448|66745242|FG000|Open Label|Withdrawal by Subject|1|||
23826873|NCT00344448|66745243|FG001|Open Label|Withdrawal by Subject|1|||
23626276|NCT01130168|66020279|FG004|Period 1|Withdrawal by Subject|0|||
23626277|NCT01130168|66020280|FG005|Period 1|Withdrawal by Subject|0|||
23626278|NCT01130168|66020275|FG000|Period 1|Discontinued For Other Reason|0|||
23626279|NCT01130168|66020276|FG001|Period 1|Discontinued For Other Reason|0|||
23626280|NCT01130168|66020277|FG002|Period 1|Discontinued For Other Reason|1|||
23626281|NCT01130168|66020278|FG003|Period 1|Discontinued For Other Reason|1|||
23626282|NCT01130168|66020279|FG004|Period 1|Discontinued For Other Reason|0|||
23626283|NCT01130168|66020280|FG005|Period 1|Discontinued For Other Reason|0|||
23626284|NCT01130168|66020275|FG000|Period 1|Adverse Event|0|||
23626285|NCT01130168|66020276|FG001|Period 1|Adverse Event|0|||
23626286|NCT01130168|66020277|FG002|Period 1|Adverse Event|0|||
23626287|NCT01130168|66020278|FG003|Period 1|Adverse Event|1|||
23626288|NCT01130168|66020279|FG004|Period 1|Adverse Event|0|||
23626289|NCT01130168|66020280|FG005|Period 1|Adverse Event|0|||
23626290|NCT03596242|66020281|FG000|Overall Study|Lost to Follow-up|2|||
23626291|NCT03596242|66020282|FG001|Overall Study|Lost to Follow-up|2|||
23759113|NCT00382291|66498080|FG000|Overall Study|Withdrawal by Subject|0|||
23759114|NCT00382291|66498081|FG001|Overall Study|Withdrawal by Subject|2|||
23759115|NCT00382291|66498082|FG002|Overall Study|Withdrawal by Subject|0|||
23759116|NCT00382291|66498080|FG000|Overall Study|Physician Decision|0|||
23759117|NCT00382291|66498081|FG001|Overall Study|Physician Decision|1|||
23826874|NCT00344448|66745242|FG000|Open Label|Study terminated|1|||
23564002|NCT03565068|65793637|FG004|Overall Study|Protocol Violation|1|||
23564003|NCT03565068|65793638|FG005|Overall Study|Protocol Violation|0|||
23626292|NCT04398368|66020293|FG000|Overall Study|Withdrawal by Subject|2|||
23626293|NCT01321723|66020296|FG000|Overall Study|Adverse Event|3|||
23626294|NCT01321723|66020297|FG001|Overall Study|Adverse Event|5|||
23626295|NCT01321723|66020298|FG002|Overall Study|Adverse Event|2|||
23626296|NCT01321723|66020296|FG000|Overall Study|Withdrawal by Subject|2|||
23626297|NCT01321723|66020297|FG001|Overall Study|Withdrawal by Subject|0|||
23759118|NCT00382291|66498082|FG002|Overall Study|Physician Decision|0|||
23759119|NCT00382291|66498080|FG000|Overall Study|Lack of Efficacy|0|||
23759120|NCT00382291|66498081|FG001|Overall Study|Lack of Efficacy|0|||
23759121|NCT00382291|66498082|FG002|Overall Study|Lack of Efficacy|1|||
23759122|NCT02683187|66498083|FG000|Overall Study|Failed IV access|3|||
23759123|NCT02683187|66498083|FG000|Overall Study|Withdrawal by Subject|5|||
23759124|NCT00660790|66498084|FG000|Baseline to 3 Months|Death|1|||
23759125|NCT00660790|66498084|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
23759126|NCT00660790|66498084|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
23759127|NCT02629965|66498089|FG000|Period 1|Adverse Event|1|||
23759128|NCT02629965|66498090|FG001|Period 1|Adverse Event|0|||
23759129|NCT02629965|66498089|FG000|Period 1|Unexpected worsening of disease|2|||
23759130|NCT02629965|66498090|FG001|Period 1|Unexpected worsening of disease|0|||
23759131|NCT02629965|66498089|FG000|Period 1|Other than listed above|1|||
23759132|NCT02629965|66498090|FG001|Period 1|Other than listed above|2|||
23759133|NCT02629965|66498089|FG000|Period 2|Adverse Event|1|||
23759134|NCT02629965|66498090|FG001|Period 2|Adverse Event|0|||
23759135|NCT04575038|66498096|FG000|Overall Study|Withdrawal by Subject|1|||
23759136|NCT04575038|66498097|FG001|Overall Study|Withdrawal by Subject|1|||
23759137|NCT01684722|66498098|FG000|Overall Study|Lost to Follow-up|78|||
23759138|NCT01684722|66498099|FG001|Overall Study|Lost to Follow-up|56|||
23759139|NCT01684722|66498100|FG002|Overall Study|Lost to Follow-up|75|||
23759140|NCT01684722|66498101|FG003|Overall Study|Lost to Follow-up|89|||
23759141|NCT01684722|66498098|FG000|Overall Study|Death|19|||
23759142|NCT01684722|66498099|FG001|Overall Study|Death|21|||
23759143|NCT01684722|66498100|FG002|Overall Study|Death|19|||
23759144|NCT01684722|66498101|FG003|Overall Study|Death|21|||
23441078|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
23441079|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
23441080|NCT04565951|65355404|FG000|Overall Study|Lost to Follow-up|66|||
23441081|NCT04565951|65355405|FG001|Overall Study|Lost to Follow-up|38|||
23441082|NCT04565951|65355404|FG000|Overall Study|Withdrawal by Subject|14|||
23441083|NCT04565951|65355405|FG001|Overall Study|Withdrawal by Subject|7|||
23441084|NCT04565951|65355404|FG000|Overall Study|Death|0|||
23441085|NCT04565951|65355405|FG001|Overall Study|Death|1|||
23441086|NCT01440816|65355407|FG000|Overall Study|Disease Progression|0|||
23441087|NCT01440816|65355408|FG001|Overall Study|Disease Progression|9|||
23441088|NCT01440816|65355407|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
23441089|NCT01440816|65355408|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
23441090|NCT00517361|65355409|FG000|Overall Study|Death|6|||
23441091|NCT00517361|65355409|FG000|Overall Study|The study was terminated|5|||
23441092|NCT03775512|65355412|FG000|Overall Study|Death|1|||
23441093|NCT03775512|65355413|FG001|Overall Study|Death|1|||
23441094|NCT03775512|65355412|FG000|Overall Study|Withdrawal by Subject|7|||
23441095|NCT03775512|65355413|FG001|Overall Study|Withdrawal by Subject|4|||
23441096|NCT03775512|65355412|FG000|Overall Study|Lost to Follow-up|5|||
23441097|NCT03775512|65355413|FG001|Overall Study|Lost to Follow-up|5|||
23441098|NCT03775512|65355412|FG000|Overall Study|Excluded before Catheter insertion|14|||
23441099|NCT03775512|65355413|FG001|Overall Study|Excluded before Catheter insertion|5|||
23441100|NCT03775512|65355412|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
23441101|NCT03775512|65355413|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
23441102|NCT03775512|65355412|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
23759145|NCT03101293|66498102|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
23759146|NCT03101293|66498103|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
23759147|NCT01764854|66498104|FG000|Overall Study|Adverse Event|0|||
23759148|NCT01764854|66498105|FG001|Overall Study|Adverse Event|0|||
23759149|NCT01764854|66498106|FG002|Overall Study|Adverse Event|2|||
23759150|NCT01764854|66498107|FG003|Overall Study|Adverse Event|0|||
23759151|NCT01764854|66498104|FG000|Overall Study|Withdrawal by Subject|0|||
23759152|NCT01764854|66498105|FG001|Overall Study|Withdrawal by Subject|0|||
23759153|NCT01764854|66498106|FG002|Overall Study|Withdrawal by Subject|1|||
23759154|NCT01764854|66498107|FG003|Overall Study|Withdrawal by Subject|0|||
23759155|NCT01764854|66498104|FG000|Overall Study|relocation|0|||
23759156|NCT01764854|66498105|FG001|Overall Study|relocation|0|||
23759157|NCT01764854|66498106|FG002|Overall Study|relocation|2|||
23759158|NCT01764854|66498107|FG003|Overall Study|relocation|0|||
23441103|NCT03775512|65355413|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
23441104|NCT01769196|65355418|FG000|Overall Study|Adverse Event|24|||
23441105|NCT01769196|65355419|FG001|Overall Study|Adverse Event|20|||
23441106|NCT01769196|65355418|FG000|Overall Study|Death|21|||
23441107|NCT01769196|65355419|FG001|Overall Study|Death|26|||
23441108|NCT01769196|65355418|FG000|Overall Study|Investigator Discretion|7|||
23441109|NCT01769196|65355419|FG001|Overall Study|Investigator Discretion|3|||
23759159|NCT01764854|66498104|FG000|Overall Study|Protocol Violation|0|||
23759160|NCT01764854|66498105|FG001|Overall Study|Protocol Violation|0|||
23759161|NCT01764854|66498106|FG002|Overall Study|Protocol Violation|1|||
23759162|NCT01764854|66498107|FG003|Overall Study|Protocol Violation|2|||
23759163|NCT04292171|66498110|FG000|Overall Study|Pharmacy error|2|||
23441110|NCT01769196|65355418|FG000|Overall Study|Lack of Efficacy|3|||
23441111|NCT01769196|65355419|FG001|Overall Study|Lack of Efficacy|2|||
23441112|NCT01769196|65355418|FG000|Overall Study|Progressive disease|11|||
23441113|NCT01769196|65355419|FG001|Overall Study|Progressive disease|6|||
23564004|NCT03565068|65793639|FG006|Overall Study|Protocol Violation|0|||
23564005|NCT03565068|65793640|FG007|Overall Study|Protocol Violation|1|||
23564006|NCT03565068|65793641|FG008|Overall Study|Protocol Violation|0|||
23564007|NCT03565068|65793633|FG000|Overall Study|Sponsor decision|0|||
23564008|NCT03565068|65793634|FG001|Overall Study|Sponsor decision|0|||
23564009|NCT03565068|65793635|FG002|Overall Study|Sponsor decision|0|||
23564010|NCT03565068|65793636|FG003|Overall Study|Sponsor decision|0|||
23564011|NCT03565068|65793637|FG004|Overall Study|Sponsor decision|1|||
23564012|NCT03565068|65793638|FG005|Overall Study|Sponsor decision|1|||
23564013|NCT03565068|65793639|FG006|Overall Study|Sponsor decision|0|||
23564014|NCT03565068|65793640|FG007|Overall Study|Sponsor decision|0|||
23564015|NCT03565068|65793641|FG008|Overall Study|Sponsor decision|0|||
23564016|NCT03565068|65793633|FG000|Overall Study|Withdrawal by Subject|0|||
23564017|NCT03565068|65793634|FG001|Overall Study|Withdrawal by Subject|0|||
23564018|NCT03565068|65793635|FG002|Overall Study|Withdrawal by Subject|1|||
23564019|NCT03565068|65793636|FG003|Overall Study|Withdrawal by Subject|0|||
23564020|NCT03565068|65793637|FG004|Overall Study|Withdrawal by Subject|2|||
23564021|NCT03565068|65793638|FG005|Overall Study|Withdrawal by Subject|0|||
23564022|NCT03565068|65793639|FG006|Overall Study|Withdrawal by Subject|1|||
23564023|NCT03565068|65793640|FG007|Overall Study|Withdrawal by Subject|5|||
23564024|NCT03565068|65793641|FG008|Overall Study|Withdrawal by Subject|1|||
23564025|NCT03565068|65793633|FG000|Overall Study|Physician Decision|0|||
23564026|NCT03565068|65793634|FG001|Overall Study|Physician Decision|0|||
23564027|NCT03565068|65793635|FG002|Overall Study|Physician Decision|0|||
23759164|NCT04292171|66498111|FG001|Overall Study|Pharmacy error|0|||
23759165|NCT04292171|66498110|FG000|Overall Study|Delivered prior to procedure|0|||
23759166|NCT04292171|66498111|FG001|Overall Study|Delivered prior to procedure|1|||
23759167|NCT00830063|66498112|FG000|Overall Study|Adverse Event|7|||
23759168|NCT00830063|66498113|FG001|Overall Study|Adverse Event|13|||
23759169|NCT00830063|66498114|FG002|Overall Study|Adverse Event|16|||
23759170|NCT00830063|66498115|FG003|Overall Study|Adverse Event|13|||
23759171|NCT00830063|66498112|FG000|Overall Study|Death|1|||
23759172|NCT00830063|66498113|FG001|Overall Study|Death|0|||
23759173|NCT00830063|66498114|FG002|Overall Study|Death|0|||
23759174|NCT00830063|66498115|FG003|Overall Study|Death|0|||
23759175|NCT00830063|66498112|FG000|Overall Study|Lost to Follow-up|0|||
23759176|NCT00830063|66498113|FG001|Overall Study|Lost to Follow-up|0|||
23759177|NCT00830063|66498114|FG002|Overall Study|Lost to Follow-up|3|||
23759178|NCT00830063|66498115|FG003|Overall Study|Lost to Follow-up|1|||
23759179|NCT00830063|66498112|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
23759180|NCT00830063|66498113|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
23759181|NCT00830063|66498114|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
23759182|NCT00830063|66498115|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
23759183|NCT00830063|66498112|FG000|Overall Study|Lack of Efficacy|51|||
23759184|NCT00830063|66498113|FG001|Overall Study|Lack of Efficacy|23|||
23759185|NCT00830063|66498114|FG002|Overall Study|Lack of Efficacy|25|||
23759186|NCT00830063|66498115|FG003|Overall Study|Lack of Efficacy|32|||
23826875|NCT00344448|66745243|FG001|Open Label|Study terminated|0|||
23826876|NCT01027702|66745244|FG000|Overall Study|Received subsequent therapy|1|||
23564028|NCT03565068|65793636|FG003|Overall Study|Physician Decision|0|||
23564029|NCT03565068|65793637|FG004|Overall Study|Physician Decision|0|||
23759187|NCT00830063|66498112|FG000|Overall Study|Other|5|||
23759188|NCT00830063|66498113|FG001|Overall Study|Other|5|||
23759189|NCT00830063|66498114|FG002|Overall Study|Other|8|||
23759190|NCT00830063|66498115|FG003|Overall Study|Other|6|||
23564030|NCT03565068|65793638|FG005|Overall Study|Physician Decision|0|||
23564031|NCT03565068|65793639|FG006|Overall Study|Physician Decision|0|||
23564032|NCT03565068|65793640|FG007|Overall Study|Physician Decision|1|||
23759191|NCT00830063|66498112|FG000|Overall Study|Withdrawal by Subject|16|||
23759192|NCT00830063|66498113|FG001|Overall Study|Withdrawal by Subject|10|||
23759193|NCT00830063|66498114|FG002|Overall Study|Withdrawal by Subject|16|||
23759194|NCT00830063|66498115|FG003|Overall Study|Withdrawal by Subject|13|||
23826877|NCT01027702|66745245|FG001|Overall Study|Received subsequent therapy|2|||
23441114|NCT01769196|65355418|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
23441115|NCT01769196|65355419|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
23441116|NCT01769196|65355418|FG000|Overall Study|Protocol Violation|0|||
23441117|NCT01769196|65355419|FG001|Overall Study|Protocol Violation|3|||
23441118|NCT01769196|65355418|FG000|Overall Study|Study terminated by sponsor|160|||
23441119|NCT01769196|65355419|FG001|Overall Study|Study terminated by sponsor|161|||
23441120|NCT01769196|65355418|FG000|Overall Study|Participant never dosed with study drug|1|||
23441121|NCT01769196|65355419|FG001|Overall Study|Participant never dosed with study drug|0|||
23441122|NCT01769196|65355418|FG000|Overall Study|Withdrew consent|36|||
23441123|NCT01769196|65355419|FG001|Overall Study|Withdrew consent|40|||
23441124|NCT00286429|65355420|FG000|Overall Study|Adverse Event|4|||
23441125|NCT00286429|65355421|FG001|Overall Study|Adverse Event|1|||
23441126|NCT00286429|65355422|FG002|Overall Study|Adverse Event|6|||
23441127|NCT00286429|65355420|FG000|Overall Study|Lack of Efficacy|52|||
23441128|NCT00286429|65355421|FG001|Overall Study|Lack of Efficacy|27|||
23441129|NCT00286429|65355422|FG002|Overall Study|Lack of Efficacy|25|||
23441130|NCT00286429|65355420|FG000|Overall Study|Lost to Follow-up|2|||
23441131|NCT00286429|65355421|FG001|Overall Study|Lost to Follow-up|4|||
23441132|NCT00286429|65355422|FG002|Overall Study|Lost to Follow-up|3|||
23441133|NCT00286429|65355420|FG000|Overall Study|Physician Decision|10|||
23441134|NCT00286429|65355421|FG001|Overall Study|Physician Decision|7|||
23441135|NCT00286429|65355422|FG002|Overall Study|Physician Decision|7|||
23441136|NCT00286429|65355420|FG000|Overall Study|Protocol Violation|3|||
23441137|NCT00286429|65355421|FG001|Overall Study|Protocol Violation|5|||
23441138|NCT00286429|65355422|FG002|Overall Study|Protocol Violation|4|||
23441139|NCT00286429|65355420|FG000|Overall Study|Withdrawal by Subject|3|||
23441140|NCT00286429|65355421|FG001|Overall Study|Withdrawal by Subject|2|||
23441141|NCT00286429|65355422|FG002|Overall Study|Withdrawal by Subject|6|||
23441142|NCT00286429|65355420|FG000|Overall Study|Administrative Error|1|||
23441143|NCT00286429|65355421|FG001|Overall Study|Administrative Error|1|||
23441144|NCT00286429|65355422|FG002|Overall Study|Administrative Error|1|||
23441145|NCT00286429|65355420|FG000|Overall Study|Administrative Decision|0|||
23441146|NCT00286429|65355421|FG001|Overall Study|Administrative Decision|1|||
23441147|NCT00286429|65355422|FG002|Overall Study|Administrative Decision|0|||
23441148|NCT01445080|65355425|FG000|Overall Study|Adverse Event|5|||
23441149|NCT01445080|65355426|FG001|Overall Study|Adverse Event|3|||
23441150|NCT01445080|65355427|FG002|Overall Study|Adverse Event|11|||
23441151|NCT01445080|65355428|FG003|Overall Study|Adverse Event|6|||
23441152|NCT01445080|65355429|FG004|Overall Study|Adverse Event|2|||
23441153|NCT01445080|65355430|FG005|Overall Study|Adverse Event|3|||
23441154|NCT01445080|65355431|FG006|Overall Study|Adverse Event|0|||
23441155|NCT01445080|65355432|FG007|Overall Study|Adverse Event|3|||
23441156|NCT01445080|65355433|FG008|Overall Study|Adverse Event|10|||
23441157|NCT01445080|65355425|FG000|Overall Study|Physician Decision|0|||
23441158|NCT01445080|65355426|FG001|Overall Study|Physician Decision|0|||
23441159|NCT01445080|65355427|FG002|Overall Study|Physician Decision|1|||
23564033|NCT03565068|65793641|FG008|Overall Study|Physician Decision|0|||
23564034|NCT03565068|65793633|FG000|Overall Study|Lost to Follow-up|0|||
23564035|NCT03565068|65793634|FG001|Overall Study|Lost to Follow-up|0|||
23564036|NCT03565068|65793635|FG002|Overall Study|Lost to Follow-up|0|||
23564037|NCT03565068|65793636|FG003|Overall Study|Lost to Follow-up|0|||
23564038|NCT03565068|65793637|FG004|Overall Study|Lost to Follow-up|0|||
23564039|NCT03565068|65793638|FG005|Overall Study|Lost to Follow-up|0|||
23564040|NCT03565068|65793639|FG006|Overall Study|Lost to Follow-up|0|||
23564041|NCT03565068|65793640|FG007|Overall Study|Lost to Follow-up|1|||
23564042|NCT03565068|65793641|FG008|Overall Study|Lost to Follow-up|0|||
23564043|NCT00691132|65793642|FG000|Overall Study|Adverse Event|2|||
23564044|NCT00691132|65793643|FG001|Overall Study|Adverse Event|3|||
23564045|NCT00691132|65793642|FG000|Overall Study|Withdrawal by Subject|10|||
23564046|NCT00691132|65793643|FG001|Overall Study|Withdrawal by Subject|10|||
23564047|NCT02204579|65793644|FG000|Overall Study|Screen failures|2|||
23564048|NCT00744263|65793654|FG000|Overall Study|Death|3006|||
23564049|NCT00744263|65793655|FG001|Overall Study|Death|3005|||
23564050|NCT00744263|65793654|FG000|Overall Study|Lost to Follow-up|2038|||
23564051|NCT00744263|65793655|FG001|Overall Study|Lost to Follow-up|2135|||
23441160|NCT01445080|65355428|FG003|Overall Study|Physician Decision|0|||
23441161|NCT01445080|65355429|FG004|Overall Study|Physician Decision|0|||
23441162|NCT01445080|65355430|FG005|Overall Study|Physician Decision|3|||
23441163|NCT01445080|65355431|FG006|Overall Study|Physician Decision|2|||
23441164|NCT01445080|65355432|FG007|Overall Study|Physician Decision|2|||
23441165|NCT01445080|65355433|FG008|Overall Study|Physician Decision|0|||
23441166|NCT01445080|65355425|FG000|Overall Study|Withdrawal by Subject|1|||
23441167|NCT01445080|65355426|FG001|Overall Study|Withdrawal by Subject|0|||
23564052|NCT00744263|65793654|FG000|Overall Study|Withdrawal by Subject|166|||
23564053|NCT00744263|65793655|FG001|Overall Study|Withdrawal by Subject|150|||
23564054|NCT00744263|65793654|FG000|Overall Study|Physician Decision|20|||
23441168|NCT01445080|65355427|FG002|Overall Study|Withdrawal by Subject|0|||
23441169|NCT01445080|65355428|FG003|Overall Study|Withdrawal by Subject|1|||
23441170|NCT01445080|65355429|FG004|Overall Study|Withdrawal by Subject|0|||
23441171|NCT01445080|65355430|FG005|Overall Study|Withdrawal by Subject|0|||
23441172|NCT01445080|65355431|FG006|Overall Study|Withdrawal by Subject|0|||
23441173|NCT01445080|65355432|FG007|Overall Study|Withdrawal by Subject|0|||
23441174|NCT01445080|65355433|FG008|Overall Study|Withdrawal by Subject|2|||
23441175|NCT01445080|65355425|FG000|Overall Study|Ineligible/Inevaluable|1|||
23441176|NCT01445080|65355426|FG001|Overall Study|Ineligible/Inevaluable|2|||
23441177|NCT01445080|65355427|FG002|Overall Study|Ineligible/Inevaluable|0|||
23441178|NCT01445080|65355428|FG003|Overall Study|Ineligible/Inevaluable|1|||
23441179|NCT01445080|65355429|FG004|Overall Study|Ineligible/Inevaluable|2|||
23441180|NCT01445080|65355430|FG005|Overall Study|Ineligible/Inevaluable|3|||
23441181|NCT01445080|65355431|FG006|Overall Study|Ineligible/Inevaluable|0|||
23441182|NCT01445080|65355432|FG007|Overall Study|Ineligible/Inevaluable|0|||
23441183|NCT01445080|65355433|FG008|Overall Study|Ineligible/Inevaluable|6|||
23441184|NCT04440813|65355438|FG000|Overall Study|Lost to Follow-up|5|||
23441185|NCT04440813|65355439|FG001|Overall Study|Lost to Follow-up|5|||
23441186|NCT04736628|65355440|FG000|Overall Study|Not treated|0|||
23441187|NCT04736628|65355441|FG001|Overall Study|Not treated|0|||
23441188|NCT04736628|65355442|FG002|Overall Study|Not treated|0|||
23441189|NCT04736628|65355443|FG003|Overall Study|Not treated|2|||
23441190|NCT04736628|65355440|FG000|Overall Study|Other reason than listed|1|||
23441191|NCT04736628|65355441|FG001|Overall Study|Other reason than listed|2|||
23441192|NCT04736628|65355442|FG002|Overall Study|Other reason than listed|2|||
23441193|NCT04736628|65355443|FG003|Overall Study|Other reason than listed|3|||
23441194|NCT04736628|65355440|FG000|Overall Study|Protocol deviation|0|||
23441195|NCT04736628|65355441|FG001|Overall Study|Protocol deviation|0|||
23441196|NCT04736628|65355442|FG002|Overall Study|Protocol deviation|0|||
23441197|NCT04736628|65355443|FG003|Overall Study|Protocol deviation|1|||
23441198|NCT04736628|65355440|FG000|Overall Study|Burden of study procedures|1|||
23441199|NCT04736628|65355441|FG001|Overall Study|Burden of study procedures|0|||
23441200|NCT04736628|65355442|FG002|Overall Study|Burden of study procedures|0|||
23441201|NCT04736628|65355443|FG003|Overall Study|Burden of study procedures|1|||
23441202|NCT04736628|65355440|FG000|Overall Study|Change of residence|0|||
23441203|NCT04736628|65355441|FG001|Overall Study|Change of residence|1|||
23441204|NCT04736628|65355442|FG002|Overall Study|Change of residence|0|||
23759195|NCT00830063|66498112|FG000|Overall Study|Protocol Violation|1|||
23759196|NCT00830063|66498113|FG001|Overall Study|Protocol Violation|0|||
23759197|NCT00830063|66498114|FG002|Overall Study|Protocol Violation|3|||
23759198|NCT00830063|66498115|FG003|Overall Study|Protocol Violation|2|||
23759199|NCT00830063|66498112|FG000|Overall Study|Randomized But Not Treated|0|||
23759200|NCT00830063|66498113|FG001|Overall Study|Randomized But Not Treated|2|||
23759201|NCT00830063|66498114|FG002|Overall Study|Randomized But Not Treated|0|||
23759202|NCT00830063|66498115|FG003|Overall Study|Randomized But Not Treated|2|||
23759203|NCT00879970|66498117|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
23759204|NCT00879970|66498118|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
23759205|NCT00879970|66498119|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
23759206|NCT00879970|66498120|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
23759207|NCT00879970|66498121|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
23759208|NCT00879970|66498117|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
23759209|NCT00879970|66498118|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
23759210|NCT00879970|66498119|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
23759211|NCT00879970|66498120|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
23759212|NCT00879970|66498121|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
23759213|NCT00879970|66498117|FG000|Period 1 TZD Randomization|Death|2|||
23759214|NCT00879970|66498118|FG001|Period 1 TZD Randomization|Death|1|||
23759215|NCT00879970|66498119|FG002|Period 1 TZD Randomization|Death|0|||
23759216|NCT00879970|66498120|FG003|Period 1 TZD Randomization|Death|0|||
23759217|NCT00879970|66498121|FG004|Period 1 TZD Randomization|Death|0|||
23759218|NCT00879970|66498117|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
23759219|NCT00879970|66498118|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23759220|NCT00879970|66498119|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
23759221|NCT00879970|66498120|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23759222|NCT00879970|66498121|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23441205|NCT04736628|65355443|FG003|Overall Study|Change of residence|0|||
23441206|NCT04736628|65355440|FG000|Overall Study|Perceived lack of efficacy|1|||
23441207|NCT04736628|65355441|FG001|Overall Study|Perceived lack of efficacy|0|||
23441208|NCT04736628|65355442|FG002|Overall Study|Perceived lack of efficacy|0|||
23759223|NCT00879970|66498117|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23759224|NCT00879970|66498118|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23441209|NCT04736628|65355443|FG003|Overall Study|Perceived lack of efficacy|1|||
23441210|NCT04736628|65355440|FG000|Overall Study|Adverse Event|3|||
23441211|NCT04736628|65355441|FG001|Overall Study|Adverse Event|2|||
23441212|NCT04736628|65355442|FG002|Overall Study|Adverse Event|4|||
23441213|NCT04736628|65355443|FG003|Overall Study|Adverse Event|3|||
23441214|NCT01900652|65355445|FG000|Overall Study|Progressive Disease|1|||
23441215|NCT01900652|65355446|FG001|Overall Study|Progressive Disease|0|||
23441216|NCT01900652|65355445|FG000|Overall Study|Consent withdrawn by subject|1|||
23441217|NCT01900652|65355446|FG001|Overall Study|Consent withdrawn by subject|1|||
23441218|NCT01900652|65355445|FG000|Overall Study|Death|3|||
23441219|NCT01900652|65355446|FG001|Overall Study|Death|0|||
23441220|NCT01900652|65355445|FG000|Overall Study|Adverse Event|2|||
23441221|NCT01900652|65355446|FG001|Overall Study|Adverse Event|1|||
23441222|NCT01900652|65355445|FG000|Overall Study|Physician Decision|1|||
23441223|NCT01900652|65355446|FG001|Overall Study|Physician Decision|1|||
23826878|NCT01027702|66745246|FG002|Overall Study|Received subsequent therapy|0|||
23826879|NCT01027702|66745247|FG003|Overall Study|Received subsequent therapy|4|||
23441224|NCT01771250|65358434|FG000|Period 1|Met exclusion criteria|1|||
23441225|NCT01771250|65358435|FG001|Period 1|Met exclusion criteria|0|||
23441226|NCT03566082|65358436|FG000|Overall Study|Death|7|||
23441227|NCT03566082|65358436|FG000|Overall Study|Failures (revision required)|2|||
23441228|NCT03566082|65358436|FG000|Overall Study|Lost to Follow-up|8|||
23441229|NCT02069392|65358437|FG000|Overall Study|Withdrawal by Subject|4|||
23441230|NCT02069392|65358438|FG001|Overall Study|Withdrawal by Subject|2|||
23441231|NCT01371552|65358439|FG000|Part 1, First 3 Days|Inconvenience|0|||
23441232|NCT01371552|65358440|FG001|Part 1, First 3 Days|Inconvenience|0|||
23441233|NCT01371552|65358441|FG002|Part 1, First 3 Days|Inconvenience|1|||
23441234|NCT01371552|65358442|FG003|Part 1, First 3 Days|Inconvenience|0|||
23441235|NCT01371552|65358443|FG004|Part 1, First 3 Days|Inconvenience|0|||
23441236|NCT01371552|65358444|FG005|Part 1, First 3 Days|Inconvenience|0|||
23441237|NCT00495625|65358448|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
23441238|NCT00781859|65358449|FG000|Overall Study|Adverse Event|2|||
23441239|NCT00781859|65358450|FG001|Overall Study|Adverse Event|2|||
23441240|NCT00781859|65358449|FG000|Overall Study|Withdrawal by Subject|8|||
23441241|NCT00781859|65358450|FG001|Overall Study|Withdrawal by Subject|4|||
23441242|NCT00781859|65358449|FG000|Overall Study|Lost to Follow-up|6|||
23441243|NCT00781859|65358450|FG001|Overall Study|Lost to Follow-up|3|||
23441244|NCT00781859|65358449|FG000|Overall Study|Death|3|||
23441245|NCT00781859|65358450|FG001|Overall Study|Death|0|||
23441246|NCT00375518|65358452|FG000|Overall Study|Withdrawal by Subject|2|||
23441247|NCT00375518|65358453|FG001|Overall Study|Withdrawal by Subject|10|||
23441248|NCT00375518|65358452|FG000|Overall Study|Patient Not Treated|6|||
23441249|NCT00375518|65358453|FG001|Overall Study|Patient Not Treated|6|||
23441250|NCT00375518|65358452|FG000|Overall Study|Death|0|||
23441251|NCT00375518|65358453|FG001|Overall Study|Death|1|||
23441252|NCT02452424|65358454|FG000|Overall Study|Death|2|||
23441253|NCT02452424|65358455|FG001|Overall Study|Death|2|||
23441254|NCT02452424|65358456|FG002|Overall Study|Death|2|||
23441255|NCT02452424|65358457|FG003|Overall Study|Death|6|||
23441256|NCT02452424|65358458|FG004|Overall Study|Death|2|||
23441257|NCT02452424|65358459|FG005|Overall Study|Death|0|||
23564055|NCT00744263|65793655|FG001|Overall Study|Physician Decision|23|||
23564056|NCT00744263|65793654|FG000|Overall Study|Protocol Violation|3|||
23564057|NCT00744263|65793655|FG001|Overall Study|Protocol Violation|5|||
23564058|NCT00744263|65793654|FG000|Overall Study|Adverse Event|1|||
23564059|NCT00744263|65793655|FG001|Overall Study|Adverse Event|0|||
23564060|NCT00744263|65793654|FG000|Overall Study|Other|2|||
23564061|NCT00744263|65793655|FG001|Overall Study|Other|2|||
23564062|NCT01861522|65793658|FG000|Overall Study|Adverse Event|1|||
23564063|NCT01861522|65793659|FG001|Overall Study|Adverse Event|0|||
23564064|NCT01861522|65793658|FG000|Overall Study|Withdrawal by Subject|2|||
23564065|NCT01861522|65793659|FG001|Overall Study|Withdrawal by Subject|0|||
23564066|NCT02668016|65793660|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
23564067|NCT02668016|65793660|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
23564068|NCT02668016|65793660|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
23564069|NCT02668016|65793660|FG000|Month 4|Withdrawal due to severe symptoms|1|||
23826880|NCT01027702|66745248|FG004|Overall Study|Received subsequent therapy|1|||
23441258|NCT02452424|65358460|FG006|Overall Study|Death|5|||
23441259|NCT02452424|65358461|FG007|Overall Study|Death|1|||
23441260|NCT02452424|65358462|FG008|Overall Study|Death|3|||
23441261|NCT02452424|65358463|FG009|Overall Study|Death|1|||
23441262|NCT02452424|65358464|FG010|Overall Study|Death|0|||
23441263|NCT02452424|65358454|FG000|Overall Study|Lost to Follow-up|0|||
23441264|NCT02452424|65358455|FG001|Overall Study|Lost to Follow-up|1|||
23441265|NCT02452424|65358456|FG002|Overall Study|Lost to Follow-up|1|||
23441266|NCT02452424|65358457|FG003|Overall Study|Lost to Follow-up|0|||
23441267|NCT02452424|65358458|FG004|Overall Study|Lost to Follow-up|0|||
23441268|NCT02452424|65358459|FG005|Overall Study|Lost to Follow-up|0|||
23441269|NCT02452424|65358460|FG006|Overall Study|Lost to Follow-up|0|||
23564070|NCT02668016|65793660|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
23564071|NCT02668016|65793660|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
23564072|NCT02668016|65793660|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
23564073|NCT02668016|65793660|FG000|Month 6|Withdrawal due to severe symptoms|2|||
23564074|NCT02668016|65793660|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
23564075|NCT02668016|65793660|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
23564076|NCT02668016|65793660|FG000|Month 8|Withdrawal due to severe symptoms|1|||
23564077|NCT02668016|65793660|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
23564078|NCT02668016|65793660|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
23564079|NCT02668016|65793660|FG000|Month 10|Withdrawal due to severe symptoms|1|||
23564080|NCT02668016|65793660|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
23564081|NCT00405639|65793667|FG000|Overall Study|Withdrawal by Subject|1|||
23564082|NCT00405639|65793668|FG001|Overall Study|Withdrawal by Subject|0|||
23564083|NCT00405639|65793667|FG000|Overall Study|Adverse Event|1|||
23564084|NCT00405639|65793668|FG001|Overall Study|Adverse Event|0|||
23564085|NCT00405639|65793667|FG000|Overall Study|Seizure prior to receiving BNP|1|||
23564086|NCT00405639|65793668|FG001|Overall Study|Seizure prior to receiving BNP|0|||
23564087|NCT03489057|65793671|FG000|Overall Study|Lost to Follow-up|16|||
23564088|NCT03489057|65793672|FG001|Overall Study|Lost to Follow-up|16|||
23564089|NCT03489057|65793673|FG002|Overall Study|Lost to Follow-up|14|||
23564090|NCT03489057|65793674|FG003|Overall Study|Lost to Follow-up|14|||
23564091|NCT03489057|65793671|FG000|Overall Study|Withdrawal by Subject|12|||
23564092|NCT03489057|65793672|FG001|Overall Study|Withdrawal by Subject|12|||
23564093|NCT03489057|65793673|FG002|Overall Study|Withdrawal by Subject|8|||
23564094|NCT03489057|65793674|FG003|Overall Study|Withdrawal by Subject|8|||
23564095|NCT03489057|65793671|FG000|Overall Study|Protocol Violation|7|||
23564096|NCT03489057|65793672|FG001|Overall Study|Protocol Violation|7|||
23564097|NCT03489057|65793673|FG002|Overall Study|Protocol Violation|2|||
23564098|NCT03489057|65793674|FG003|Overall Study|Protocol Violation|2|||
23564099|NCT00770432|65793675|FG000|Overall Study|Other|4|||
23564100|NCT00770432|65793676|FG001|Overall Study|Other|6|||
23564101|NCT00770432|65793675|FG000|Overall Study|Non-compliance|0|||
23564102|NCT00770432|65793676|FG001|Overall Study|Non-compliance|1|||
23564103|NCT02343003|65793677|FG000|Overall Study|Withdrawal by Subject|9|||
23564104|NCT02343003|65793678|FG001|Overall Study|Withdrawal by Subject|4|||
23564105|NCT02343003|65793677|FG000|Overall Study|Lost to Follow-up|5|||
23564106|NCT02343003|65793678|FG001|Overall Study|Lost to Follow-up|1|||
23564107|NCT02343003|65793677|FG000|Overall Study|Protocol Violation|1|||
23564108|NCT02343003|65793678|FG001|Overall Study|Protocol Violation|0|||
23564109|NCT02343003|65793677|FG000|Overall Study|Death|0|||
23564110|NCT02343003|65793678|FG001|Overall Study|Death|1|||
23564111|NCT02343003|65793677|FG000|Overall Study|exclusion criteria met|1|||
23564112|NCT02343003|65793678|FG001|Overall Study|exclusion criteria met|1|||
23564113|NCT02343003|65793677|FG000|Overall Study|terminated by sponsor|2|||
23564114|NCT02343003|65793678|FG001|Overall Study|terminated by sponsor|0|||
23564115|NCT00633932|65793679|FG000|Overall Study|Adverse Event|1|||
23564116|NCT00633932|65793680|FG001|Overall Study|Adverse Event|3|||
23564117|NCT00633932|65793681|FG002|Overall Study|Adverse Event|4|||
23564118|NCT00633932|65793679|FG000|Overall Study|Withdrawal by Subject|3|||
23564119|NCT00633932|65793680|FG001|Overall Study|Withdrawal by Subject|9|||
23564120|NCT00633932|65793681|FG002|Overall Study|Withdrawal by Subject|1|||
23564121|NCT00633932|65793679|FG000|Overall Study|Lost to Follow-up|1|||
23564122|NCT00633932|65793680|FG001|Overall Study|Lost to Follow-up|0|||
23564123|NCT00633932|65793681|FG002|Overall Study|Lost to Follow-up|2|||
23564124|NCT00633932|65793679|FG000|Overall Study|Protocol Violation|5|||
23564125|NCT00633932|65793680|FG001|Overall Study|Protocol Violation|2|||
23564126|NCT00633932|65793681|FG002|Overall Study|Protocol Violation|3|||
23826881|NCT01027702|66745249|FG005|Overall Study|Received subsequent therapy|0|||
23826882|NCT01027702|66745250|FG006|Overall Study|Received subsequent therapy|1|||
23826883|NCT01027702|66745244|FG000|Overall Study|Death|0|||
23826884|NCT01027702|66745245|FG001|Overall Study|Death|0|||
23826885|NCT01027702|66745246|FG002|Overall Study|Death|1|||
23826886|NCT01027702|66745247|FG003|Overall Study|Death|0|||
23826887|NCT01027702|66745248|FG004|Overall Study|Death|0|||
23826888|NCT01027702|66745249|FG005|Overall Study|Death|0|||
23826889|NCT01027702|66745250|FG006|Overall Study|Death|0|||
23826890|NCT01176513|66745252|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
23826891|NCT02121652|66745254|FG000|Overall Study|Lost to Follow-up|2|||
23564127|NCT00633932|65793679|FG000|Overall Study|Physician Decision|0|||
23564128|NCT00633932|65793680|FG001|Overall Study|Physician Decision|0|||
23564129|NCT00633932|65793681|FG002|Overall Study|Physician Decision|1|||
23564130|NCT00633932|65793679|FG000|Overall Study|Doctor's judgement|1|||
23826892|NCT02121652|66745255|FG001|Overall Study|Lost to Follow-up|1|||
23826893|NCT02121652|66745254|FG000|Overall Study|Death|1|||
23826894|NCT02121652|66745255|FG001|Overall Study|Death|0|||
23826895|NCT02121652|66745254|FG000|Overall Study|Withdrawal by Subject|3|||
23626298|NCT01321723|66020298|FG002|Overall Study|Withdrawal by Subject|2|||
23626299|NCT02386839|66020300|FG000|Overall Study|Death|1|||
23626300|NCT02386839|66020301|FG001|Overall Study|Death|0|||
23626301|NCT02386839|66020300|FG000|Overall Study|Withdrawal by Subject|9|||
23626302|NCT02386839|66020301|FG001|Overall Study|Withdrawal by Subject|10|||
23626303|NCT02386839|66020300|FG000|Overall Study|Lost to Follow-up|4|||
23626304|NCT02386839|66020301|FG001|Overall Study|Lost to Follow-up|4|||
23626305|NCT02386839|66020300|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
23626306|NCT02386839|66020301|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
23626307|NCT02386839|66020300|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
23626308|NCT02386839|66020301|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
23626309|NCT02386839|66020300|FG000|Overall Study|Other (unspecified)|1|||
23626310|NCT02386839|66020301|FG001|Overall Study|Other (unspecified)|0|||
23626311|NCT00632021|66020302|FG000|Overall Study|Withdrawal/death|4|||
23626312|NCT00632021|66020303|FG001|Overall Study|Withdrawal/death|7|||
23626313|NCT00113269|66020304|FG000|Overall Study|Not transplanted, donor issues|4|||
23626314|NCT00113269|66020305|FG001|Overall Study|Not transplanted, donor issues|0|||
23626315|NCT00113269|66020306|FG002|Overall Study|Not transplanted, donor issues|2|||
23626316|NCT00113269|66020307|FG003|Overall Study|Not transplanted, donor issues|2|||
23626317|NCT00113269|66020304|FG000|Overall Study|Not transplanted, recipient issues|2|||
23626318|NCT00113269|66020305|FG001|Overall Study|Not transplanted, recipient issues|1|||
23626319|NCT00113269|66020306|FG002|Overall Study|Not transplanted, recipient issues|7|||
23626320|NCT00113269|66020307|FG003|Overall Study|Not transplanted, recipient issues|4|||
23626321|NCT00113269|66020304|FG000|Overall Study|Early graft loss, technical|0|||
23626322|NCT00113269|66020305|FG001|Overall Study|Early graft loss, technical|0|||
23626323|NCT00113269|66020306|FG002|Overall Study|Early graft loss, technical|2|||
23626324|NCT00113269|66020307|FG003|Overall Study|Early graft loss, technical|0|||
23626325|NCT00113269|66020304|FG000|Overall Study|Death in operating room|0|||
23626326|NCT00113269|66020305|FG001|Overall Study|Death in operating room|0|||
23626327|NCT00113269|66020306|FG002|Overall Study|Death in operating room|0|||
23626328|NCT00113269|66020307|FG003|Overall Study|Death in operating room|1|||
23626329|NCT00113269|66020304|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
23441270|NCT02452424|65358461|FG007|Overall Study|Lost to Follow-up|0|||
23759225|NCT00879970|66498119|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23759226|NCT00879970|66498120|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
23759227|NCT00879970|66498121|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
23759228|NCT00879970|66498117|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23759229|NCT00879970|66498118|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23626330|NCT00113269|66020305|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
23626331|NCT00113269|66020306|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
23626332|NCT00113269|66020307|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
23759230|NCT00879970|66498119|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23626333|NCT00113269|66020304|FG000|Overall Study|Adverse Event|2|||
23759231|NCT00879970|66498120|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23759232|NCT00879970|66498121|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
23759233|NCT00879970|66498117|FG000|Period 2 Vitamin D Randomization|Death|0|||
23759234|NCT00879970|66498118|FG001|Period 2 Vitamin D Randomization|Death|0|||
23759235|NCT00879970|66498119|FG002|Period 2 Vitamin D Randomization|Death|0|||
23626334|NCT00113269|66020305|FG001|Overall Study|Adverse Event|7|||
23626335|NCT00113269|66020306|FG002|Overall Study|Adverse Event|11|||
23626336|NCT00113269|66020307|FG003|Overall Study|Adverse Event|7|||
23626337|NCT00113269|66020304|FG000|Overall Study|Withdrawal by Subject|4|||
23626338|NCT00113269|66020305|FG001|Overall Study|Withdrawal by Subject|3|||
23626339|NCT00113269|66020306|FG002|Overall Study|Withdrawal by Subject|4|||
23626340|NCT00113269|66020307|FG003|Overall Study|Withdrawal by Subject|2|||
23626341|NCT00113269|66020304|FG000|Overall Study|Graft loss|6|||
23626342|NCT00113269|66020305|FG001|Overall Study|Graft loss|6|||
23626343|NCT00113269|66020306|FG002|Overall Study|Graft loss|4|||
23626344|NCT00113269|66020307|FG003|Overall Study|Graft loss|9|||
23626345|NCT00113269|66020304|FG000|Overall Study|Protocol Violation|1|||
23626346|NCT00113269|66020305|FG001|Overall Study|Protocol Violation|0|||
23564131|NCT00633932|65793680|FG001|Overall Study|Doctor's judgement|0|||
23564132|NCT00633932|65793681|FG002|Overall Study|Doctor's judgement|0|||
23564133|NCT00633932|65793679|FG000|Overall Study|Moved Away|1|||
23564134|NCT00633932|65793680|FG001|Overall Study|Moved Away|0|||
23564135|NCT00633932|65793681|FG002|Overall Study|Moved Away|0|||
23564136|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
23564137|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
23564138|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
23564139|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
23564140|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23564141|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23564142|NCT01859793|65793686|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23564143|NCT01859793|65793687|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23564144|NCT03342053|65793688|FG000|Overall Study|Adverse Event|2|||
23564145|NCT03342053|65793689|FG001|Overall Study|Adverse Event|0|||
23564146|NCT03342053|65793688|FG000|Overall Study|Withdrawal by Subject|0|||
23564147|NCT03342053|65793689|FG001|Overall Study|Withdrawal by Subject|1|||
23564148|NCT03713021|65793690|FG000|Overall Study|Did not have CT sim scan available|6|||
23564149|NCT03713021|65793690|FG000|Overall Study|Not eligible|4|||
23626347|NCT00113269|66020306|FG002|Overall Study|Protocol Violation|4|||
23626348|NCT00113269|66020307|FG003|Overall Study|Protocol Violation|2|||
23626349|NCT00113269|66020304|FG000|Overall Study|Lost to Follow-up|2|||
23626350|NCT00113269|66020305|FG001|Overall Study|Lost to Follow-up|3|||
23626351|NCT00113269|66020306|FG002|Overall Study|Lost to Follow-up|6|||
23626352|NCT00113269|66020307|FG003|Overall Study|Lost to Follow-up|3|||
23626353|NCT00113269|66020304|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
23626354|NCT00113269|66020305|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
23626355|NCT00113269|66020306|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
23626356|NCT00113269|66020307|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
23626357|NCT00113269|66020304|FG000|Overall Study|Discontinued due to rejection|0|||
23626358|NCT00113269|66020305|FG001|Overall Study|Discontinued due to rejection|0|||
23626359|NCT00113269|66020306|FG002|Overall Study|Discontinued due to rejection|1|||
23626360|NCT00113269|66020307|FG003|Overall Study|Discontinued due to rejection|0|||
23626361|NCT00113269|66020304|FG000|Overall Study|Moved|0|||
23626362|NCT00113269|66020305|FG001|Overall Study|Moved|1|||
23626363|NCT00113269|66020306|FG002|Overall Study|Moved|0|||
23626364|NCT00113269|66020307|FG003|Overall Study|Moved|3|||
23626365|NCT00113269|66020304|FG000|Overall Study|Received pancreas transplant|0|||
23626366|NCT00113269|66020305|FG001|Overall Study|Received pancreas transplant|0|||
23626367|NCT00113269|66020306|FG002|Overall Study|Received pancreas transplant|0|||
23626368|NCT00113269|66020307|FG003|Overall Study|Received pancreas transplant|2|||
23626369|NCT00113269|66020304|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626370|NCT00113269|66020305|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626371|NCT00113269|66020306|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626372|NCT00113269|66020307|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
23626373|NCT00113269|66020304|FG000|Overall Study|Did not meet eligibility criteria|1|||
23626374|NCT00113269|66020305|FG001|Overall Study|Did not meet eligibility criteria|0|||
23626375|NCT00113269|66020306|FG002|Overall Study|Did not meet eligibility criteria|0|||
23626376|NCT00113269|66020307|FG003|Overall Study|Did not meet eligibility criteria|1|||
23626377|NCT00113269|66020304|FG000|Overall Study|Unable to return for follow up|2|||
23626378|NCT00113269|66020305|FG001|Overall Study|Unable to return for follow up|1|||
23626379|NCT00113269|66020306|FG002|Overall Study|Unable to return for follow up|0|||
23626380|NCT00113269|66020307|FG003|Overall Study|Unable to return for follow up|0|||
23626381|NCT02719743|66020309|FG000|Overall Study|Consent withdrawal|0|||
23626382|NCT02719743|66020310|FG001|Overall Study|Consent withdrawal|2|||
23626383|NCT02719743|66020311|FG002|Overall Study|Consent withdrawal|0|||
23626384|NCT02719743|66020312|FG003|Overall Study|Consent withdrawal|1|||
23626385|NCT02719743|66020313|FG004|Overall Study|Consent withdrawal|0|||
23626386|NCT02719743|66020309|FG000|Overall Study|Migrated/moved from study area|0|||
23626387|NCT02719743|66020310|FG001|Overall Study|Migrated/moved from study area|0|||
23626388|NCT02719743|66020311|FG002|Overall Study|Migrated/moved from study area|0|||
23626389|NCT02719743|66020312|FG003|Overall Study|Migrated/moved from study area|0|||
23626390|NCT02719743|66020313|FG004|Overall Study|Migrated/moved from study area|2|||
23626391|NCT02719743|66020309|FG000|Overall Study|Lost to Follow-up|1|||
23626392|NCT02719743|66020310|FG001|Overall Study|Lost to Follow-up|1|||
23626393|NCT02719743|66020311|FG002|Overall Study|Lost to Follow-up|0|||
23626394|NCT02719743|66020312|FG003|Overall Study|Lost to Follow-up|0|||
23626395|NCT02719743|66020313|FG004|Overall Study|Lost to Follow-up|0|||
23626396|NCT01437423|66020314|FG000|Overall Study|Lost to Follow-up|12|||
23626397|NCT01437423|66020314|FG000|Overall Study|Off label usage|3|||
23626398|NCT02284009|66020317|FG000|Overall Study|Adverse Event|3|||
23626399|NCT02284009|66020318|FG001|Overall Study|Adverse Event|0|||
23626400|NCT02284009|66020317|FG000|Overall Study|Lost to Follow-up|1|||
23626401|NCT02284009|66020318|FG001|Overall Study|Lost to Follow-up|3|||
23626402|NCT02284009|66020317|FG000|Overall Study|Physician Decision|0|||
23626403|NCT02284009|66020318|FG001|Overall Study|Physician Decision|2|||
23626404|NCT02284009|66020317|FG000|Overall Study|Withdrawal by Subject|2|||
23626405|NCT02284009|66020318|FG001|Overall Study|Withdrawal by Subject|5|||
23626406|NCT00085566|66020323|FG000|Overall Study|Adverse Event|0|||
23626407|NCT00085566|66020324|FG001|Overall Study|Adverse Event|0|||
23626408|NCT00085566|66020325|FG002|Overall Study|Adverse Event|10|||
23626409|NCT00085566|66020323|FG000|Overall Study|Patient Not treated|0|||
23626410|NCT00085566|66020324|FG001|Overall Study|Patient Not treated|0|||
23626411|NCT00085566|66020325|FG002|Overall Study|Patient Not treated|3|||
23626412|NCT00085566|66020323|FG000|Overall Study|Clinical progression|0|||
23759236|NCT00879970|66498120|FG003|Period 2 Vitamin D Randomization|Death|2|||
23759237|NCT00879970|66498121|FG004|Period 2 Vitamin D Randomization|Death|0|||
23626413|NCT00085566|66020324|FG001|Overall Study|Clinical progression|0|||
23626414|NCT00085566|66020325|FG002|Overall Study|Clinical progression|1|||
23626415|NCT01470599|66020326|FG000|Overall Study|Did not meet entrance criteria|1|||
23626416|NCT01470599|66020327|FG001|Overall Study|Did not meet entrance criteria|0|||
23626417|NCT01470599|66020326|FG000|Overall Study|Lost to Follow-up|2|||
23626418|NCT01470599|66020327|FG001|Overall Study|Lost to Follow-up|1|||
23626419|NCT01470599|66020326|FG000|Overall Study|Withdrawal by Subject|3|||
23626420|NCT01470599|66020327|FG001|Overall Study|Withdrawal by Subject|4|||
23626421|NCT01470599|66020326|FG000|Overall Study|Other|1|||
23626422|NCT01470599|66020327|FG001|Overall Study|Other|0|||
23626423|NCT01470599|66020326|FG000|Overall Study|Protocol Violation|3|||
23626424|NCT01470599|66020327|FG001|Overall Study|Protocol Violation|1|||
23626425|NCT01470599|66020326|FG000|Overall Study|Adverse event related to study drug|2|||
23626426|NCT01470599|66020327|FG001|Overall Study|Adverse event related to study drug|5|||
23626427|NCT01470599|66020326|FG000|Overall Study|Insufficient clinical response|6|||
23626428|NCT01470599|66020327|FG001|Overall Study|Insufficient clinical response|27|||
23626429|NCT01470599|66020326|FG000|Overall Study|Adverse event not related to study drug|1|||
23626430|NCT01470599|66020327|FG001|Overall Study|Adverse event not related to study drug|5|||
23626431|NCT02994784|66020328|FG000|6 Months Follow-up|Lost to Follow-up|3|||
23626432|NCT01015677|66020329|FG000|Overall Study|Adverse Event|0|||
23626433|NCT01015677|66020330|FG001|Overall Study|Adverse Event|1|||
23759238|NCT03056352|66498124|FG000|Overall Study|Lost to Follow-up|1|||
23759239|NCT00860574|66498128|FG000|Overall Study|Death|2|||
23564150|NCT03713021|65793690|FG000|Overall Study|Issues with TraceIT markers|5|||
23564151|NCT04146896|65793691|FG000|Overall Study|Adverse Event|5|||
23564152|NCT04146896|65793692|FG001|Overall Study|Adverse Event|8|||
23564153|NCT04146896|65793691|FG000|Overall Study|Lack of Efficacy|3|||
23564154|NCT04146896|65793692|FG001|Overall Study|Lack of Efficacy|2|||
23564155|NCT04146896|65793691|FG000|Overall Study|Lost to Follow-up|0|||
23564156|NCT04146896|65793692|FG001|Overall Study|Lost to Follow-up|1|||
23564157|NCT04146896|65793691|FG000|Overall Study|Non-compliance|5|||
23564158|NCT04146896|65793692|FG001|Overall Study|Non-compliance|4|||
23564159|NCT04146896|65793691|FG000|Overall Study|Withdrawal by Subject|3|||
23564160|NCT04146896|65793692|FG001|Overall Study|Withdrawal by Subject|5|||
23564161|NCT04146896|65793691|FG000|Overall Study|Randomized in error|1|||
23564162|NCT04146896|65793692|FG001|Overall Study|Randomized in error|2|||
23564163|NCT01492686|65793694|FG000|Double-blind Phase|Adverse Event|0|||
23564164|NCT01492686|65793695|FG001|Double-blind Phase|Adverse Event|2|||
23564165|NCT01492686|65793694|FG000|Double-blind Phase|Physician Decision|0|||
23564166|NCT01492686|65793695|FG001|Double-blind Phase|Physician Decision|1|||
23564167|NCT01492686|65793694|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23564168|NCT01492686|65793695|FG001|Double-blind Phase|Withdrawal by Subject|2|||
23564169|NCT01492686|65793694|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
23564170|NCT01492686|65793695|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
23564171|NCT01492686|65793694|FG000|Open-label Phase|Adverse Event|1|||
23564172|NCT01492686|65793695|FG001|Open-label Phase|Adverse Event|2|||
23564173|NCT01492686|65793694|FG000|Open-label Phase|Physician Decision|1|||
23564174|NCT01492686|65793695|FG001|Open-label Phase|Physician Decision|0|||
23564175|NCT01492686|65793694|FG000|Open-label Phase|Withdrawal by Subject|6|||
23564176|NCT01492686|65793695|FG001|Open-label Phase|Withdrawal by Subject|7|||
23564177|NCT01492686|65793694|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
23564178|NCT01492686|65793695|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
23564179|NCT03214081|65793699|FG000|Overall Study|Case Report Forms Uncollected|9|||
23564180|NCT03214081|65793699|FG000|Overall Study|Protocol Deviation|54|||
23564181|NCT01686581|65793703|FG000|Overall Study|Side-effects or Health Problems|15|||
23564182|NCT01686581|65793703|FG000|Overall Study|Lack of Efficacy|90|||
23564183|NCT01686581|65793703|FG000|Overall Study|Participant Concerned about Risks|6|||
23564184|NCT01686581|65793703|FG000|Overall Study|Thinks Injections Too Painful|8|||
23564185|NCT01686581|65793703|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
23564186|NCT01686581|65793703|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
23564187|NCT01686581|65793703|FG000|Overall Study|Thinks it is Inconvenient|17|||
23564188|NCT01686581|65793703|FG000|Overall Study|Other Miscellaneous Reasons|36|||
23564189|NCT01686581|65793703|FG000|Overall Study|Reason Missing|1|||
23564190|NCT01289418|65793704|FG000|Day 8 Survey|email address invalid|283|||
23564191|NCT01289418|65793704|FG000|Day 8 Survey|participants did not complete the survey|1935|||
23564192|NCT01289418|65793704|FG000|Day 29 Survey|email address invalid|283|||
23564193|NCT01289418|65793704|FG000|Day 29 Survey|participants did not complete the survey|2185|||
23564194|NCT03328143|65793705|FG000|Overall Study|Declined|3|||
23564195|NCT03328143|65793705|FG000|Overall Study|Required increased sedation|4|||
23564196|NCT03328143|65793705|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
23564197|NCT03328143|65793705|FG000|Overall Study|Surgery cancelled|1|||
23564198|NCT01540565|65793706|FG000|Overall Study|Ineligible|2|||
23564199|NCT01077544|65793710|FG000|Overall Study|New Cancer Therapy|3|||
23564200|NCT01077544|65793711|FG001|Overall Study|New Cancer Therapy|3|||
23564201|NCT01077544|65793710|FG000|Overall Study|Adverse Event|0|||
23564202|NCT01077544|65793711|FG001|Overall Study|Adverse Event|1|||
23564203|NCT01077544|65793710|FG000|Overall Study|Disease Progression|0|||
23564204|NCT01077544|65793711|FG001|Overall Study|Disease Progression|1|||
23564205|NCT02120664|65793712|FG000|Overall Study|Withdrawal by Subject|0|||
23564206|NCT02120664|65793713|FG001|Overall Study|Withdrawal by Subject|0|||
23564207|NCT02120664|65793714|FG002|Overall Study|Withdrawal by Subject|0|||
23564208|NCT02120664|65793715|FG003|Overall Study|Withdrawal by Subject|1|||
23564209|NCT02120664|65793716|FG004|Overall Study|Withdrawal by Subject|0|||
23564210|NCT01338012|65793717|FG000|Overall Study|Death|4|||
23564211|NCT01338012|65793717|FG000|Overall Study|Study terminated|4|||
23626434|NCT01015677|66020331|FG002|Overall Study|Adverse Event|0|||
23626435|NCT01015677|66020329|FG000|Overall Study|Lack of Efficacy|0|||
23759240|NCT00860574|66498128|FG000|Overall Study|Relapse|1|||
23826896|NCT02121652|66745255|FG001|Overall Study|Withdrawal by Subject|3|||
23826897|NCT00580788|66745258|FG000|Overall Study|Adverse Event|0|||
23826898|NCT00580788|66745259|FG001|Overall Study|Adverse Event|0|||
23826899|NCT00580788|66745260|FG002|Overall Study|Adverse Event|0|||
23826900|NCT00580788|66745261|FG003|Overall Study|Adverse Event|1|||
23826901|NCT00729937|66745265|FG000|Overall Study|Lost to Follow-up|49|||
23826902|NCT00729937|66745266|FG001|Overall Study|Lost to Follow-up|58|||
23826903|NCT00729937|66745267|FG002|Overall Study|Lost to Follow-up|18|||
23826904|NCT00729937|66745268|FG003|Overall Study|Lost to Follow-up|33|||
23826905|NCT00729937|66745269|FG004|Overall Study|Lost to Follow-up|18|||
23826906|NCT00729937|66745270|FG005|Overall Study|Lost to Follow-up|23|||
23826907|NCT00729937|66745265|FG000|Overall Study|Physician Decision|7|||
23826908|NCT00729937|66745266|FG001|Overall Study|Physician Decision|16|||
23826909|NCT00729937|66745267|FG002|Overall Study|Physician Decision|2|||
23826910|NCT00729937|66745268|FG003|Overall Study|Physician Decision|0|||
23826911|NCT00729937|66745269|FG004|Overall Study|Physician Decision|5|||
23826912|NCT00729937|66745270|FG005|Overall Study|Physician Decision|8|||
23826913|NCT00729937|66745265|FG000|Overall Study|Death|1|||
23826914|NCT00729937|66745266|FG001|Overall Study|Death|0|||
23826915|NCT00729937|66745267|FG002|Overall Study|Death|1|||
23826916|NCT00729937|66745268|FG003|Overall Study|Death|0|||
23826917|NCT00729937|66745269|FG004|Overall Study|Death|0|||
23826918|NCT00729937|66745270|FG005|Overall Study|Death|1|||
23826919|NCT00729937|66745265|FG000|Overall Study|Withdrawal by Subject|3|||
23826920|NCT00729937|66745266|FG001|Overall Study|Withdrawal by Subject|5|||
23826921|NCT00729937|66745267|FG002|Overall Study|Withdrawal by Subject|6|||
23826922|NCT00729937|66745268|FG003|Overall Study|Withdrawal by Subject|0|||
23826923|NCT00729937|66745269|FG004|Overall Study|Withdrawal by Subject|4|||
23826924|NCT00729937|66745270|FG005|Overall Study|Withdrawal by Subject|2|||
23826925|NCT00729937|66745265|FG000|Overall Study|Randomized but not treated|12|||
23826926|NCT00729937|66745266|FG001|Overall Study|Randomized but not treated|6|||
23826927|NCT00729937|66745267|FG002|Overall Study|Randomized but not treated|1|||
23826928|NCT00729937|66745268|FG003|Overall Study|Randomized but not treated|0|||
23826929|NCT00729937|66745269|FG004|Overall Study|Randomized but not treated|1|||
23826930|NCT00729937|66745270|FG005|Overall Study|Randomized but not treated|3|||
23826931|NCT00729937|66745265|FG000|Overall Study|Did not meet eligibility criteria|2|||
23826932|NCT00729937|66745266|FG001|Overall Study|Did not meet eligibility criteria|1|||
23826933|NCT00729937|66745267|FG002|Overall Study|Did not meet eligibility criteria|0|||
23826934|NCT00729937|66745268|FG003|Overall Study|Did not meet eligibility criteria|0|||
23826935|NCT00729937|66745269|FG004|Overall Study|Did not meet eligibility criteria|0|||
23826936|NCT00729937|66745270|FG005|Overall Study|Did not meet eligibility criteria|0|||
23826937|NCT00729937|66745265|FG000|Overall Study|Incarcerated|0|||
23826938|NCT00729937|66745266|FG001|Overall Study|Incarcerated|2|||
23826939|NCT00729937|66745267|FG002|Overall Study|Incarcerated|1|||
23826940|NCT00729937|66745268|FG003|Overall Study|Incarcerated|1|||
23826941|NCT00729937|66745269|FG004|Overall Study|Incarcerated|0|||
23826942|NCT00729937|66745270|FG005|Overall Study|Incarcerated|0|||
23826943|NCT01276041|66745271|FG000|Overall Study|Adverse Event|2|||
23826944|NCT01276041|66745271|FG000|Overall Study|Protocol Violation|1|||
23564212|NCT01480596|65793718|FG000|Overall Study|Adverse Event|3|||
23564213|NCT01480596|65793719|FG001|Overall Study|Adverse Event|0|||
23564214|NCT01480596|65793718|FG000|Overall Study|MG exacerbation or change in medication|2|||
23564215|NCT01480596|65793719|FG001|Overall Study|MG exacerbation or change in medication|2|||
23564216|NCT00384059|65793726|FG000|Infant Series|Not consented|2|||
23564217|NCT00384059|65793727|FG001|Infant Series|Not consented|6|||
23564218|NCT00384059|65793726|FG000|Infant Series|Withdrawal by Subject|2|||
23564219|NCT00384059|65793727|FG001|Infant Series|Withdrawal by Subject|2|||
23564220|NCT00384059|65793726|FG000|Infant Series|Adverse Event|1|||
23564221|NCT00384059|65793727|FG001|Infant Series|Adverse Event|2|||
23564222|NCT00384059|65793726|FG000|Infant Series|Protocol Violation|1|||
23564223|NCT00384059|65793727|FG001|Infant Series|Protocol Violation|2|||
23564224|NCT00384059|65793726|FG000|Infant Series|Lost to Follow-up|0|||
23564225|NCT00384059|65793727|FG001|Infant Series|Lost to Follow-up|1|||
23564226|NCT00384059|65793726|FG000|After Infant Series|Protocol Violation|2|||
23564227|NCT00384059|65793727|FG001|After Infant Series|Protocol Violation|3|||
23564228|NCT00384059|65793726|FG000|After Infant Series|Withdrawal by Subject|2|||
23564229|NCT00384059|65793727|FG001|After Infant Series|Withdrawal by Subject|2|||
23564230|NCT00384059|65793726|FG000|After Infant Series|Failed to Return|0|||
23564231|NCT00384059|65793727|FG001|After Infant Series|Failed to Return|2|||
23564232|NCT00384059|65793726|FG000|After Infant Series|Adverse Event|0|||
23826945|NCT00742209|66745273|FG000|Overall Study|Adverse Event|11|||
23826946|NCT00742209|66745274|FG001|Overall Study|Adverse Event|4|||
23826947|NCT00742209|66745275|FG002|Overall Study|Adverse Event|17|||
23826948|NCT00742209|66745276|FG003|Overall Study|Adverse Event|16|||
23826949|NCT00742209|66745277|FG004|Overall Study|Adverse Event|13|||
23826950|NCT00742209|66745273|FG000|Overall Study|Participant Withdrew Consent|8|||
23826951|NCT00742209|66745274|FG001|Overall Study|Participant Withdrew Consent|4|||
23826952|NCT00742209|66745275|FG002|Overall Study|Participant Withdrew Consent|14|||
23441271|NCT02452424|65358462|FG008|Overall Study|Lost to Follow-up|0|||
23626436|NCT01015677|66020330|FG001|Overall Study|Lack of Efficacy|1|||
23626437|NCT01015677|66020331|FG002|Overall Study|Lack of Efficacy|0|||
23626438|NCT01015677|66020329|FG000|Overall Study|Protocol Violation|0|||
23626439|NCT01015677|66020330|FG001|Overall Study|Protocol Violation|1|||
23626440|NCT01015677|66020331|FG002|Overall Study|Protocol Violation|0|||
23626441|NCT01015677|66020329|FG000|Overall Study|Withdrawal by Subject|1|||
23626442|NCT01015677|66020330|FG001|Overall Study|Withdrawal by Subject|1|||
23626443|NCT01015677|66020331|FG002|Overall Study|Withdrawal by Subject|0|||
23626444|NCT00321685|66020332|FG000|Overall Study|Adverse Event|18|||
23626445|NCT00321685|66020332|FG000|Overall Study|Death|2|||
23626446|NCT00321685|66020332|FG000|Overall Study|Withdrawal by Subject|8|||
23626447|NCT00321685|66020332|FG000|Overall Study|Alternative therapy|1|||
23626448|NCT00321685|66020332|FG000|Overall Study|Complicating disese|1|||
23626449|NCT00321685|66020332|FG000|Overall Study|Other|5|||
23626450|NCT00321685|66020332|FG000|Overall Study|Not start protocol therapy|2|||
23626451|NCT00321685|66020332|FG000|Overall Study|Ineligible|2|||
23626452|NCT03783689|66020333|FG000|Overall Study|Adverse Event|2|||
23626453|NCT03783689|66020334|FG001|Overall Study|Adverse Event|0|||
23626454|NCT03783689|66020333|FG000|Overall Study|Lost to Follow-up|2|||
23626455|NCT03783689|66020334|FG001|Overall Study|Lost to Follow-up|1|||
23626456|NCT03783689|66020333|FG000|Overall Study|Physician Decision|2|||
23626457|NCT03783689|66020334|FG001|Overall Study|Physician Decision|1|||
23626458|NCT03783689|66020333|FG000|Overall Study|Withdrawal by Subject|3|||
23626459|NCT03783689|66020334|FG001|Overall Study|Withdrawal by Subject|3|||
23626460|NCT00079339|66020335|FG000|Overall Study|Adverse Event|1|||
23626461|NCT00079339|66020336|FG001|Overall Study|Adverse Event|7|||
23626462|NCT00079339|66020337|FG002|Overall Study|Adverse Event|2|||
23626463|NCT00079339|66020335|FG000|Overall Study|Death|1|||
23626464|NCT00079339|66020336|FG001|Overall Study|Death|0|||
23626465|NCT00079339|66020337|FG002|Overall Study|Death|0|||
23626466|NCT00079339|66020335|FG000|Overall Study|Non-compliance|0|||
23626467|NCT00079339|66020336|FG001|Overall Study|Non-compliance|0|||
23626468|NCT00079339|66020337|FG002|Overall Study|Non-compliance|1|||
23626469|NCT00079339|66020335|FG000|Overall Study|Withdrawal by Subject|0|||
23626470|NCT00079339|66020336|FG001|Overall Study|Withdrawal by Subject|4|||
23626471|NCT00079339|66020337|FG002|Overall Study|Withdrawal by Subject|1|||
23626472|NCT00079339|66020335|FG000|Overall Study|Disease progression|3|||
23626473|NCT00079339|66020336|FG001|Overall Study|Disease progression|28|||
23626474|NCT00079339|66020337|FG002|Overall Study|Disease progression|2|||
23626475|NCT02484547|66020338|FG000|Placebo-Controlled Period|Adverse Event|10|||
23626476|NCT02484547|66020339|FG001|Placebo-Controlled Period|Adverse Event|13|||
23626477|NCT02484547|66020340|FG002|Placebo-Controlled Period|Adverse Event|20|||
23759241|NCT02419469|66498131|FG000|Overall Study|Withdrawal by Subject|1|||
23759242|NCT01200394|66498133|FG000|Overall Study|Adverse Event|0|||
23759243|NCT01200394|66498134|FG001|Overall Study|Adverse Event|14|||
23759244|NCT01200394|66498133|FG000|Overall Study|Death|1|||
23759245|NCT01200394|66498134|FG001|Overall Study|Death|0|||
23759246|NCT01200394|66498133|FG000|Overall Study|Lost to Follow-up|0|||
23759247|NCT01200394|66498134|FG001|Overall Study|Lost to Follow-up|1|||
23759248|NCT01200394|66498133|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23759249|NCT01200394|66498134|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
23759250|NCT01200394|66498133|FG000|Overall Study|Protocol Violation|0|||
23759251|NCT01200394|66498134|FG001|Overall Study|Protocol Violation|3|||
23626478|NCT02484547|66020341|FG003|Placebo-Controlled Period|Adverse Event|0|||
23626479|NCT02484547|66020342|FG004|Placebo-Controlled Period|Adverse Event|0|||
23626480|NCT02484547|66020343|FG005|Placebo-Controlled Period|Adverse Event|0|||
23626481|NCT02484547|66020344|FG006|Placebo-Controlled Period|Adverse Event|0|||
23626482|NCT02484547|66020338|FG000|Placebo-Controlled Period|Change of Treatment|0|||
23626483|NCT02484547|66020339|FG001|Placebo-Controlled Period|Change of Treatment|0|||
23626484|NCT02484547|66020340|FG002|Placebo-Controlled Period|Change of Treatment|1|||
23626485|NCT02484547|66020341|FG003|Placebo-Controlled Period|Change of Treatment|0|||
23626486|NCT02484547|66020342|FG004|Placebo-Controlled Period|Change of Treatment|0|||
23626487|NCT02484547|66020343|FG005|Placebo-Controlled Period|Change of Treatment|0|||
23626488|NCT02484547|66020344|FG006|Placebo-Controlled Period|Change of Treatment|0|||
23441272|NCT02452424|65358463|FG009|Overall Study|Lost to Follow-up|0|||
23759252|NCT01200394|66498133|FG000|Overall Study|Withdrawal by Subject|0|||
23826953|NCT00742209|66745276|FG003|Overall Study|Participant Withdrew Consent|7|||
23826954|NCT00742209|66745277|FG004|Overall Study|Participant Withdrew Consent|4|||
23826955|NCT00742209|66745273|FG000|Overall Study|Protocol Violation|6|||
23826956|NCT00742209|66745274|FG001|Overall Study|Protocol Violation|5|||
23826957|NCT00742209|66745275|FG002|Overall Study|Protocol Violation|4|||
23826958|NCT00742209|66745276|FG003|Overall Study|Protocol Violation|5|||
23826959|NCT00742209|66745277|FG004|Overall Study|Protocol Violation|3|||
23826960|NCT00742209|66745273|FG000|Overall Study|Lost to Follow-up|3|||
23826961|NCT00742209|66745274|FG001|Overall Study|Lost to Follow-up|4|||
23626489|NCT02484547|66020338|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
23626490|NCT02484547|66020339|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
23626491|NCT02484547|66020340|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
23626492|NCT02484547|66020341|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
23626493|NCT02484547|66020342|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
23626494|NCT02484547|66020343|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
23626495|NCT02484547|66020344|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
23626496|NCT02484547|66020338|FG000|Placebo-Controlled Period|Death|5|||
23626497|NCT02484547|66020339|FG001|Placebo-Controlled Period|Death|0|||
23626498|NCT02484547|66020340|FG002|Placebo-Controlled Period|Death|6|||
23626499|NCT02484547|66020341|FG003|Placebo-Controlled Period|Death|0|||
23626500|NCT02484547|66020342|FG004|Placebo-Controlled Period|Death|0|||
23626501|NCT02484547|66020343|FG005|Placebo-Controlled Period|Death|0|||
23626502|NCT02484547|66020344|FG006|Placebo-Controlled Period|Death|0|||
23759253|NCT01200394|66498134|FG001|Overall Study|Withdrawal by Subject|5|||
23759254|NCT01200394|66498133|FG000|Overall Study|Other|0|||
23759255|NCT01200394|66498134|FG001|Overall Study|Other|1|||
23759256|NCT02017535|66498140|FG000|Overall Study|Withdrawal by Subject|1|||
23759257|NCT02017535|66498141|FG001|Overall Study|Withdrawal by Subject|0|||
23759258|NCT02017535|66498142|FG002|Overall Study|Withdrawal by Subject|0|||
23759259|NCT02017535|66498143|FG003|Overall Study|Withdrawal by Subject|0|||
23759260|NCT02626182|66498144|FG000|Overall Study|Adverse Event|2|||
23759261|NCT02626182|66498145|FG001|Overall Study|Adverse Event|0|||
23759262|NCT01664494|66498155|FG000|Overall Study|Withdrawal by Subject|27|||
23759263|NCT01664494|66498155|FG000|Overall Study|Death|18|||
23759264|NCT01664494|66498155|FG000|Overall Study|Other|49|||
23759265|NCT01664494|66498155|FG000|Overall Study|Lost to Follow-up|99|||
23759266|NCT03255031|66498156|FG000|Overall Study|Adverse Event|5|||
23759267|NCT03255031|66498157|FG001|Overall Study|Adverse Event|3|||
23759268|NCT03255031|66498156|FG000|Overall Study|Physician Decision|2|||
23759269|NCT03255031|66498157|FG001|Overall Study|Physician Decision|1|||
23759270|NCT03255031|66498156|FG000|Overall Study|Withdrawal by Subject|9|||
23759271|NCT03255031|66498157|FG001|Overall Study|Withdrawal by Subject|3|||
23759272|NCT00591253|66498160|FG000|Overall Study|Adverse Event|3|||
23759273|NCT00591253|66498161|FG001|Overall Study|Adverse Event|3|||
23759274|NCT00591253|66498162|FG002|Overall Study|Adverse Event|1|||
23759275|NCT00591253|66498160|FG000|Overall Study|Protocol Violation|2|||
23759276|NCT00591253|66498161|FG001|Overall Study|Protocol Violation|2|||
23759277|NCT00591253|66498162|FG002|Overall Study|Protocol Violation|2|||
23759278|NCT00591253|66498160|FG000|Overall Study|Lost to Follow-up|2|||
23759279|NCT00591253|66498161|FG001|Overall Study|Lost to Follow-up|4|||
23759280|NCT00591253|66498162|FG002|Overall Study|Lost to Follow-up|0|||
23759281|NCT00591253|66498160|FG000|Overall Study|Withdrawal by Subject|1|||
23759282|NCT00591253|66498161|FG001|Overall Study|Withdrawal by Subject|7|||
23759283|NCT00591253|66498162|FG002|Overall Study|Withdrawal by Subject|6|||
23759284|NCT00591253|66498160|FG000|Overall Study|Lack of Efficacy|1|||
23441273|NCT02452424|65358464|FG010|Overall Study|Lost to Follow-up|0|||
23626503|NCT02484547|66020338|FG000|Placebo-Controlled Period|Disease Progression|2|||
23759285|NCT00591253|66498161|FG001|Overall Study|Lack of Efficacy|0|||
23759286|NCT00591253|66498162|FG002|Overall Study|Lack of Efficacy|3|||
23759287|NCT00591253|66498160|FG000|Overall Study|Other|5|||
23759288|NCT00591253|66498161|FG001|Overall Study|Other|5|||
23759289|NCT00591253|66498162|FG002|Overall Study|Other|3|||
23759290|NCT02253654|66498164|FG000|Overall Study|Withdrawal by Subject|12|||
23759291|NCT02253654|66498165|FG001|Overall Study|Withdrawal by Subject|4|||
23626504|NCT02484547|66020339|FG001|Placebo-Controlled Period|Disease Progression|0|||
23759292|NCT02253654|66498164|FG000|Overall Study|Decision by Sponsor|1|||
23759293|NCT02253654|66498165|FG001|Overall Study|Decision by Sponsor|1|||
23826962|NCT00742209|66745275|FG002|Overall Study|Lost to Follow-up|5|||
23826963|NCT00742209|66745276|FG003|Overall Study|Lost to Follow-up|5|||
23826964|NCT00742209|66745277|FG004|Overall Study|Lost to Follow-up|3|||
23626505|NCT02484547|66020340|FG002|Placebo-Controlled Period|Disease Progression|1|||
23626506|NCT02484547|66020341|FG003|Placebo-Controlled Period|Disease Progression|0|||
23626507|NCT02484547|66020342|FG004|Placebo-Controlled Period|Disease Progression|0|||
23759294|NCT02253654|66498164|FG000|Overall Study|Lost to Follow-up|2|||
23826965|NCT00742209|66745273|FG000|Overall Study|Lack of Efficacy|6|||
23826966|NCT00742209|66745274|FG001|Overall Study|Lack of Efficacy|1|||
23826967|NCT00742209|66745275|FG002|Overall Study|Lack of Efficacy|1|||
23826968|NCT00742209|66745276|FG003|Overall Study|Lack of Efficacy|3|||
23826969|NCT00742209|66745277|FG004|Overall Study|Lack of Efficacy|1|||
23826970|NCT00742209|66745273|FG000|Overall Study|Investigator Discretion|0|||
23826971|NCT00742209|66745274|FG001|Overall Study|Investigator Discretion|0|||
23826972|NCT00742209|66745275|FG002|Overall Study|Investigator Discretion|5|||
23826973|NCT00742209|66745276|FG003|Overall Study|Investigator Discretion|1|||
23826974|NCT00742209|66745277|FG004|Overall Study|Investigator Discretion|1|||
23759295|NCT02253654|66498165|FG001|Overall Study|Lost to Follow-up|5|||
23759296|NCT02253654|66498164|FG000|Overall Study|Death|4|||
23759297|NCT02253654|66498165|FG001|Overall Study|Death|7|||
23759298|NCT02253654|66498164|FG000|Overall Study|Did Not Receive Study Treatment|4|||
23759299|NCT02253654|66498165|FG001|Overall Study|Did Not Receive Study Treatment|1|||
23759300|NCT04130919|66498166|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
23759301|NCT04130919|66498167|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
23759302|NCT04130919|66498168|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
23759303|NCT04130919|66498169|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
23759304|NCT04130919|66498170|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
23759305|NCT04130919|66498171|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
23759306|NCT04130919|66498166|FG000|Blinded Treatment Phase|Adverse Event|0|||
23759307|NCT04130919|66498167|FG001|Blinded Treatment Phase|Adverse Event|0|||
23759308|NCT04130919|66498168|FG002|Blinded Treatment Phase|Adverse Event|1|||
23759309|NCT04130919|66498169|FG003|Blinded Treatment Phase|Adverse Event|0|||
23759310|NCT04130919|66498170|FG004|Blinded Treatment Phase|Adverse Event|0|||
23759311|NCT04130919|66498171|FG005|Blinded Treatment Phase|Adverse Event|0|||
23759312|NCT04130919|66498166|FG000|Blinded Treatment Phase|Disease worsening|0|||
23759313|NCT04130919|66498167|FG001|Blinded Treatment Phase|Disease worsening|0|||
23759314|NCT04130919|66498168|FG002|Blinded Treatment Phase|Disease worsening|1|||
23759315|NCT04130919|66498169|FG003|Blinded Treatment Phase|Disease worsening|0|||
23759316|NCT04130919|66498170|FG004|Blinded Treatment Phase|Disease worsening|0|||
23759317|NCT04130919|66498171|FG005|Blinded Treatment Phase|Disease worsening|0|||
23759318|NCT04130919|66498166|FG000|Blinded Treatment Phase|Investigator's decision|0|||
23759319|NCT04130919|66498167|FG001|Blinded Treatment Phase|Investigator's decision|1|||
23759320|NCT04130919|66498168|FG002|Blinded Treatment Phase|Investigator's decision|0|||
23759321|NCT04130919|66498169|FG003|Blinded Treatment Phase|Investigator's decision|0|||
23759322|NCT04130919|66498170|FG004|Blinded Treatment Phase|Investigator's decision|0|||
23759323|NCT04130919|66498171|FG005|Blinded Treatment Phase|Investigator's decision|0|||
23759324|NCT04130919|66498166|FG000|Blinded Treatment Phase|Withdrew consent|1|||
23759325|NCT04130919|66498167|FG001|Blinded Treatment Phase|Withdrew consent|0|||
23759326|NCT04130919|66498168|FG002|Blinded Treatment Phase|Withdrew consent|0|||
23759327|NCT04130919|66498169|FG003|Blinded Treatment Phase|Withdrew consent|0|||
23759328|NCT04130919|66498170|FG004|Blinded Treatment Phase|Withdrew consent|0|||
23759329|NCT04130919|66498171|FG005|Blinded Treatment Phase|Withdrew consent|0|||
23759330|NCT04130919|66498166|FG000|Open-label Treatment Phase|Withdrew consent|0|||
23759331|NCT04130919|66498167|FG001|Open-label Treatment Phase|Withdrew consent|0|||
23759332|NCT04130919|66498168|FG002|Open-label Treatment Phase|Withdrew consent|0|||
23759333|NCT04130919|66498169|FG003|Open-label Treatment Phase|Withdrew consent|1|||
23759334|NCT04130919|66498170|FG004|Open-label Treatment Phase|Withdrew consent|1|||
23759335|NCT04130919|66498171|FG005|Open-label Treatment Phase|Withdrew consent|1|||
23759336|NCT04130919|66498166|FG000|Open-label Treatment Phase|Disease worsening|0|||
23759337|NCT04130919|66498167|FG001|Open-label Treatment Phase|Disease worsening|0|||
23759338|NCT04130919|66498168|FG002|Open-label Treatment Phase|Disease worsening|0|||
23826975|NCT04747470|66745278|FG000|Overall Study|Death|0|||
23826976|NCT04747470|66745279|FG001|Overall Study|Death|3|||
23826977|NCT04747470|66745280|FG002|Overall Study|Death|2|||
23826978|NCT04747470|66745281|FG003|Overall Study|Death|2|||
23626508|NCT02484547|66020343|FG005|Placebo-Controlled Period|Disease Progression|0|||
23759339|NCT04130919|66498169|FG003|Open-label Treatment Phase|Disease worsening|1|||
23759340|NCT04130919|66498170|FG004|Open-label Treatment Phase|Disease worsening|0|||
23759341|NCT04130919|66498171|FG005|Open-label Treatment Phase|Disease worsening|1|||
23759342|NCT04130919|66498166|FG000|Open-label Treatment Phase|Investigator's decision|0|||
23759343|NCT04130919|66498167|FG001|Open-label Treatment Phase|Investigator's decision|0|||
23759344|NCT04130919|66498168|FG002|Open-label Treatment Phase|Investigator's decision|0|||
23826979|NCT04747470|66745282|FG004|Overall Study|Death|2|||
23826980|NCT04747470|66745283|FG005|Overall Study|Death|0|||
23826981|NCT04747470|66745284|FG006|Overall Study|Death|0|||
23826982|NCT04747470|66745285|FG007|Overall Study|Death|0|||
23441274|NCT02452424|65358454|FG000|Overall Study|Withdrawal by Subject|0|||
23441275|NCT02452424|65358455|FG001|Overall Study|Withdrawal by Subject|0|||
23441276|NCT02452424|65358456|FG002|Overall Study|Withdrawal by Subject|3|||
23441277|NCT02452424|65358457|FG003|Overall Study|Withdrawal by Subject|2|||
23441278|NCT02452424|65358458|FG004|Overall Study|Withdrawal by Subject|0|||
23441279|NCT02452424|65358459|FG005|Overall Study|Withdrawal by Subject|0|||
23441280|NCT02452424|65358460|FG006|Overall Study|Withdrawal by Subject|1|||
23441281|NCT02452424|65358461|FG007|Overall Study|Withdrawal by Subject|0|||
23826983|NCT04747470|66745286|FG008|Overall Study|Death|0|||
23826984|NCT04747470|66745287|FG009|Overall Study|Death|0|||
23441282|NCT02452424|65358462|FG008|Overall Study|Withdrawal by Subject|1|||
23441283|NCT02452424|65358463|FG009|Overall Study|Withdrawal by Subject|1|||
23441284|NCT02452424|65358464|FG010|Overall Study|Withdrawal by Subject|0|||
23826985|NCT04747470|66745288|FG010|Overall Study|Death|0|||
23826986|NCT04747470|66745278|FG000|Overall Study|Withdrew Consent|0|||
23826987|NCT04747470|66745279|FG001|Overall Study|Withdrew Consent|0|||
23826988|NCT04747470|66745280|FG002|Overall Study|Withdrew Consent|0|||
23826989|NCT04747470|66745281|FG003|Overall Study|Withdrew Consent|1|||
23826990|NCT04747470|66745282|FG004|Overall Study|Withdrew Consent|0|||
23826991|NCT04747470|66745283|FG005|Overall Study|Withdrew Consent|0|||
23826992|NCT04747470|66745284|FG006|Overall Study|Withdrew Consent|0|||
23826993|NCT04747470|66745285|FG007|Overall Study|Withdrew Consent|0|||
23826994|NCT04747470|66745286|FG008|Overall Study|Withdrew Consent|0|||
23826995|NCT04747470|66745287|FG009|Overall Study|Withdrew Consent|0|||
23826996|NCT04747470|66745288|FG010|Overall Study|Withdrew Consent|0|||
23826997|NCT04747470|66745278|FG000|Overall Study|Study Terminated by Sponsor|0|||
23826998|NCT04747470|66745279|FG001|Overall Study|Study Terminated by Sponsor|0|||
23826999|NCT04747470|66745280|FG002|Overall Study|Study Terminated by Sponsor|1|||
23827000|NCT04747470|66745281|FG003|Overall Study|Study Terminated by Sponsor|0|||
23827001|NCT04747470|66745282|FG004|Overall Study|Study Terminated by Sponsor|2|||
23827002|NCT04747470|66745283|FG005|Overall Study|Study Terminated by Sponsor|0|||
23827003|NCT04747470|66745284|FG006|Overall Study|Study Terminated by Sponsor|0|||
23827004|NCT04747470|66745285|FG007|Overall Study|Study Terminated by Sponsor|0|||
23827005|NCT04747470|66745286|FG008|Overall Study|Study Terminated by Sponsor|0|||
23827006|NCT04747470|66745287|FG009|Overall Study|Study Terminated by Sponsor|0|||
23827007|NCT04747470|66745288|FG010|Overall Study|Study Terminated by Sponsor|0|||
23441285|NCT02452424|65358454|FG000|Overall Study|Other|0|||
23441286|NCT02452424|65358455|FG001|Overall Study|Other|0|||
23441287|NCT02452424|65358456|FG002|Overall Study|Other|1|||
23441288|NCT02452424|65358457|FG003|Overall Study|Other|0|||
23441289|NCT02452424|65358458|FG004|Overall Study|Other|0|||
23441290|NCT02452424|65358459|FG005|Overall Study|Other|1|||
23441291|NCT02452424|65358460|FG006|Overall Study|Other|4|||
23441292|NCT02452424|65358461|FG007|Overall Study|Other|3|||
23441293|NCT02452424|65358462|FG008|Overall Study|Other|0|||
23441294|NCT02452424|65358463|FG009|Overall Study|Other|0|||
23441295|NCT02452424|65358464|FG010|Overall Study|Other|1|||
23441296|NCT02452424|65358454|FG000|Overall Study|Progressive disease (per RECIST)|0|||
23441297|NCT02452424|65358455|FG001|Overall Study|Progressive disease (per RECIST)|0|||
23441298|NCT02452424|65358456|FG002|Overall Study|Progressive disease (per RECIST)|0|||
23441299|NCT02452424|65358457|FG003|Overall Study|Progressive disease (per RECIST)|0|||
23564233|NCT00384059|65793727|FG001|After Infant Series|Adverse Event|1|||
23827008|NCT01074944|66745289|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
23827009|NCT01074944|66745290|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23827010|NCT01074944|66745291|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23827011|NCT01074944|66745292|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23827012|NCT01074944|66745293|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23441300|NCT02452424|65358458|FG004|Overall Study|Progressive disease (per RECIST)|0|||
23441301|NCT02452424|65358459|FG005|Overall Study|Progressive disease (per RECIST)|0|||
23441302|NCT02452424|65358460|FG006|Overall Study|Progressive disease (per RECIST)|0|||
23441303|NCT02452424|65358461|FG007|Overall Study|Progressive disease (per RECIST)|0|||
23441304|NCT02452424|65358462|FG008|Overall Study|Progressive disease (per RECIST)|2|||
23441305|NCT02452424|65358463|FG009|Overall Study|Progressive disease (per RECIST)|0|||
23441306|NCT02452424|65358464|FG010|Overall Study|Progressive disease (per RECIST)|0|||
23441307|NCT02452424|65358454|FG000|Overall Study|Adverse Event|0|||
23564234|NCT00384059|65793726|FG000|After Infant Series|Physician Decision|0|||
23626509|NCT02484547|66020344|FG006|Placebo-Controlled Period|Disease Progression|0|||
23827013|NCT01074944|66745289|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
23827014|NCT01074944|66745290|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23827015|NCT01074944|66745291|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23827016|NCT01074944|66745292|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23827017|NCT01074944|66745293|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23827018|NCT01074944|66745289|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
23827019|NCT01074944|66745290|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23827020|NCT01074944|66745291|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23827021|NCT01074944|66745292|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23827022|NCT01074944|66745293|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23827023|NCT01074944|66745289|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
23827024|NCT01074944|66745290|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23827025|NCT01074944|66745291|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23827026|NCT01074944|66745292|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23827027|NCT01074944|66745293|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23827028|NCT01074944|66745289|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23827029|NCT01074944|66745290|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
23827030|NCT01074944|66745291|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
23827031|NCT01074944|66745292|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23827032|NCT01074944|66745293|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23441308|NCT02452424|65358455|FG001|Overall Study|Adverse Event|0|||
23626510|NCT02484547|66020338|FG000|Placebo-Controlled Period|Investigator Decision|2|||
23827033|NCT01074944|66745289|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23827034|NCT01074944|66745290|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
23827035|NCT01074944|66745291|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
23827036|NCT01074944|66745292|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23827037|NCT01074944|66745293|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23827038|NCT01074944|66745289|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23827039|NCT01074944|66745290|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
23827040|NCT01074944|66745291|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
23827041|NCT01074944|66745292|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23827042|NCT01074944|66745293|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23827043|NCT01074944|66745289|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23564235|NCT00384059|65793727|FG001|After Infant Series|Physician Decision|1|||
23564236|NCT00384059|65793726|FG000|After Infant Series|Lost to Follow-up|0|||
23564237|NCT00384059|65793727|FG001|After Infant Series|Lost to Follow-up|1|||
23564238|NCT00384059|65793726|FG000|Toddler Dose|Lost to Follow-up|1|||
23564239|NCT00384059|65793727|FG001|Toddler Dose|Lost to Follow-up|1|||
23564240|NCT00384059|65793726|FG000|Toddler Dose|Failed to return|0|||
23564241|NCT00384059|65793727|FG001|Toddler Dose|Failed to return|1|||
23626511|NCT02484547|66020339|FG001|Placebo-Controlled Period|Investigator Decision|2|||
23626512|NCT02484547|66020340|FG002|Placebo-Controlled Period|Investigator Decision|5|||
23564242|NCT02914184|65793728|FG000|Overall Study|Lost to Follow-up|7|||
23441309|NCT02452424|65358456|FG002|Overall Study|Adverse Event|0|||
23564243|NCT02914184|65793729|FG001|Overall Study|Lost to Follow-up|10|||
23564244|NCT02914184|65793730|FG002|Overall Study|Lost to Follow-up|8|||
23564245|NCT02914184|65793731|FG003|Overall Study|Lost to Follow-up|7|||
23564246|NCT02914184|65793728|FG000|Overall Study|Withdrawal by Subject|4|||
23564247|NCT02914184|65793729|FG001|Overall Study|Withdrawal by Subject|2|||
23564248|NCT02914184|65793730|FG002|Overall Study|Withdrawal by Subject|7|||
23564249|NCT02914184|65793731|FG003|Overall Study|Withdrawal by Subject|3|||
23564250|NCT02914184|65793728|FG000|Overall Study|Other|1|||
23564251|NCT02914184|65793729|FG001|Overall Study|Other|0|||
23564252|NCT02914184|65793730|FG002|Overall Study|Other|0|||
23564253|NCT02914184|65793731|FG003|Overall Study|Other|0|||
23564254|NCT02914184|65793728|FG000|Overall Study|Migrated/moved from the study area|2|||
23564255|NCT02914184|65793729|FG001|Overall Study|Migrated/moved from the study area|1|||
23564256|NCT02914184|65793730|FG002|Overall Study|Migrated/moved from the study area|2|||
23564257|NCT02914184|65793731|FG003|Overall Study|Migrated/moved from the study area|1|||
23564258|NCT02312856|65793732|FG000|Overall Study|Death|1|||
23564259|NCT02312856|65793732|FG000|Overall Study|Lost to Follow-up|3|||
23564260|NCT02364180|65793733|FG000|Overall Study|Screen Fail|1|||
23564261|NCT01959347|65793734|FG000|Overall Study|Protocol Violation|9|||
23564262|NCT01959347|65793735|FG001|Overall Study|Protocol Violation|7|||
23564263|NCT01576367|65793736|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23564264|NCT01576367|65793736|FG000|Overall Study|Moved to commercial use after 6 months|1|||
23564265|NCT01802437|65793739|FG000|Overall Study|Lost to Follow-up|1|||
23564266|NCT01802437|65793740|FG001|Overall Study|Lost to Follow-up|0|||
23564267|NCT01802437|65793739|FG000|Overall Study|Withdrawal by Subject|3|||
23564268|NCT01802437|65793740|FG001|Overall Study|Withdrawal by Subject|4|||
23564269|NCT01787097|65793741|FG000|Overall Study|Withdrawal by Subject|1|||
23564270|NCT01787097|65793742|FG001|Overall Study|Withdrawal by Subject|0|||
23564271|NCT01787097|65793743|FG002|Overall Study|Withdrawal by Subject|0|||
23626513|NCT02484547|66020341|FG003|Placebo-Controlled Period|Investigator Decision|0|||
23626514|NCT02484547|66020342|FG004|Placebo-Controlled Period|Investigator Decision|0|||
23626515|NCT02484547|66020343|FG005|Placebo-Controlled Period|Investigator Decision|0|||
23564272|NCT01787097|65793744|FG003|Overall Study|Withdrawal by Subject|0|||
23564273|NCT00255346|65793747|FG000|Overall Study|Adverse Event|1|||
23564274|NCT00255346|65793748|FG001|Overall Study|Adverse Event|0|||
23564275|NCT00255346|65793749|FG002|Overall Study|Adverse Event|0|||
23564276|NCT00255346|65793750|FG003|Overall Study|Adverse Event|0|||
23564277|NCT00255346|65793751|FG004|Overall Study|Adverse Event|0|||
23564278|NCT03502616|65793752|FG000|Up to Week 16|Withdrawal by Subject|1|||
23564279|NCT03502616|65793753|FG001|Up to Week 16|Withdrawal by Subject|2|||
23564280|NCT03502616|65793752|FG000|Up to Week 16|Lost to Follow-up|0|||
23564281|NCT03502616|65793753|FG001|Up to Week 16|Lost to Follow-up|1|||
23564282|NCT03502616|65793752|FG000|Up to Week 16|Randomized, but not treated|1|||
23564283|NCT03502616|65793753|FG001|Up to Week 16|Randomized, but not treated|0|||
23564284|NCT03502616|65793752|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
23564285|NCT03502616|65793753|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
23564286|NCT03502616|65793752|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
23564287|NCT03502616|65793753|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
23564288|NCT00185640|65793754|FG000|Overall Study|Not Eligible|4|||
23564289|NCT00185640|65793754|FG000|Overall Study|Withdrawal by Subject|3|||
23564290|NCT00185640|65793754|FG000|Overall Study|Death|138|||
23564291|NCT01460160|65793769|FG000|Treatment Phase|Lack of Efficacy|3|||
23564292|NCT01460160|65793769|FG000|Treatment Phase|Study Drug Toxicity|2|||
23564293|NCT01460160|65793769|FG000|Treatment Phase|Adverse Event|8|||
23564294|NCT01460160|65793769|FG000|Treatment Phase|Withdrawal by Subject|4|||
23564295|NCT01460160|65793769|FG000|Treatment Phase|Death|2|||
23564296|NCT01460160|65793769|FG000|Treatment Phase|Other reasons|9|||
23564297|NCT01460160|65793769|FG000|Follow-up Phase|Withdrawal by Subject|4|||
23564298|NCT01460160|65793769|FG000|Follow-up Phase|Death|14|||
23564299|NCT01460160|65793769|FG000|Follow-up Phase|Lost to Follow-up|7|||
23564300|NCT01460160|65793769|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
23564301|NCT01460160|65793769|FG000|Follow-up Phase|Other and not reported reasons|5|||
23564302|NCT02569437|65793771|FG000|Overall Study|Lost to Follow-up|12|||
23564303|NCT02569437|65793772|FG001|Overall Study|Lost to Follow-up|14|||
23564304|NCT00744328|65793775|FG000|Overall Study|Lost to Follow-up|2|||
23564305|NCT00744328|65793776|FG001|Overall Study|Lost to Follow-up|5|||
23564306|NCT00744328|65793777|FG002|Overall Study|Lost to Follow-up|3|||
23564307|NCT00744328|65793775|FG000|Overall Study|Withdrawal by Subject|5|||
23564308|NCT00744328|65793776|FG001|Overall Study|Withdrawal by Subject|3|||
23564309|NCT00744328|65793777|FG002|Overall Study|Withdrawal by Subject|4|||
23564310|NCT00744328|65793775|FG000|Overall Study|Found ineligible after randomization|0|||
23564311|NCT00744328|65793776|FG001|Overall Study|Found ineligible after randomization|0|||
23564312|NCT00744328|65793777|FG002|Overall Study|Found ineligible after randomization|1|||
23564313|NCT04359771|65793778|FG000|Overall Study|Lack of Efficacy|2|||
23564314|NCT04359771|65793779|FG001|Overall Study|Lack of Efficacy|2|||
23564315|NCT02669095|65793780|FG000|Overall Study|Adverse Event|1|||
23564316|NCT02669095|65793781|FG001|Overall Study|Adverse Event|0|||
23564317|NCT02669095|65793780|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23564318|NCT02669095|65793781|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23564319|NCT02669095|65793780|FG000|Overall Study|Torn Lens|0|||
23564320|NCT02669095|65793781|FG001|Overall Study|Torn Lens|1|||
23564321|NCT02669095|65793780|FG000|Overall Study|Visit 5 assessments not completed|0|||
23564322|NCT02669095|65793781|FG001|Overall Study|Visit 5 assessments not completed|1|||
23564323|NCT02736968|65793783|FG000|Overall Study|Lost to Follow-up|0|||
23564324|NCT02736968|65793784|FG001|Overall Study|Lost to Follow-up|0|||
23564325|NCT02736968|65793785|FG002|Overall Study|Lost to Follow-up|0|||
23564326|NCT02736968|65793786|FG003|Overall Study|Lost to Follow-up|0|||
23564327|NCT02736968|65793787|FG004|Overall Study|Lost to Follow-up|0|||
23564328|NCT02736968|65793788|FG005|Overall Study|Lost to Follow-up|0|||
23564329|NCT02736968|65793789|FG006|Overall Study|Lost to Follow-up|5|||
23564330|NCT02736968|65793790|FG007|Overall Study|Lost to Follow-up|2|||
23564331|NCT02736968|65793783|FG000|Overall Study|COVID-19 Pandemic|0|||
23564332|NCT02736968|65793784|FG001|Overall Study|COVID-19 Pandemic|0|||
23564333|NCT02736968|65793785|FG002|Overall Study|COVID-19 Pandemic|0|||
23564334|NCT02736968|65793786|FG003|Overall Study|COVID-19 Pandemic|0|||
23564335|NCT02736968|65793787|FG004|Overall Study|COVID-19 Pandemic|0|||
23564336|NCT02736968|65793788|FG005|Overall Study|COVID-19 Pandemic|0|||
23564337|NCT02736968|65793789|FG006|Overall Study|COVID-19 Pandemic|2|||
23564338|NCT02736968|65793790|FG007|Overall Study|COVID-19 Pandemic|0|||
23564339|NCT02736968|65793783|FG000|Overall Study|Withdrawal by Subject|0|||
23564340|NCT02736968|65793784|FG001|Overall Study|Withdrawal by Subject|0|||
23564341|NCT02736968|65793785|FG002|Overall Study|Withdrawal by Subject|0|||
23564342|NCT02736968|65793786|FG003|Overall Study|Withdrawal by Subject|0|||
23564343|NCT02736968|65793787|FG004|Overall Study|Withdrawal by Subject|0|||
23564344|NCT02736968|65793788|FG005|Overall Study|Withdrawal by Subject|0|||
23564345|NCT02736968|65793789|FG006|Overall Study|Withdrawal by Subject|1|||
23564346|NCT02736968|65793790|FG007|Overall Study|Withdrawal by Subject|0|||
23564347|NCT04836858|65793793|FG000|Overall Study|Adverse Event|0|||
23564348|NCT04836858|65793794|FG001|Overall Study|Adverse Event|0|||
23564349|NCT04836858|65793795|FG002|Overall Study|Adverse Event|0|||
23564350|NCT04836858|65793796|FG003|Overall Study|Adverse Event|1|||
23564351|NCT04836858|65793793|FG000|Overall Study|Lost to Follow-up|1|||
23759345|NCT04130919|66498169|FG003|Open-label Treatment Phase|Investigator's decision|1|||
23626516|NCT02484547|66020344|FG006|Placebo-Controlled Period|Investigator Decision|0|||
23626517|NCT02484547|66020338|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
23626518|NCT02484547|66020339|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
23626519|NCT02484547|66020340|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
23626520|NCT02484547|66020341|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
23626521|NCT02484547|66020342|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
23626522|NCT02484547|66020343|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
23626523|NCT02484547|66020344|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
23626524|NCT02484547|66020338|FG000|Placebo-Controlled Period|Relocation|1|||
23626525|NCT02484547|66020339|FG001|Placebo-Controlled Period|Relocation|1|||
23626526|NCT02484547|66020340|FG002|Placebo-Controlled Period|Relocation|1|||
23626527|NCT02484547|66020341|FG003|Placebo-Controlled Period|Relocation|0|||
23626528|NCT02484547|66020342|FG004|Placebo-Controlled Period|Relocation|0|||
23626529|NCT02484547|66020343|FG005|Placebo-Controlled Period|Relocation|0|||
23626530|NCT02484547|66020344|FG006|Placebo-Controlled Period|Relocation|0|||
23626531|NCT02484547|66020338|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
23564352|NCT04836858|65793794|FG001|Overall Study|Lost to Follow-up|0|||
23564353|NCT04836858|65793795|FG002|Overall Study|Lost to Follow-up|0|||
23564354|NCT04836858|65793796|FG003|Overall Study|Lost to Follow-up|0|||
23564355|NCT04836858|65793793|FG000|Overall Study|Subject/Guardian decision|3|||
23564356|NCT04836858|65793794|FG001|Overall Study|Subject/Guardian decision|0|||
23564357|NCT04836858|65793795|FG002|Overall Study|Subject/Guardian decision|0|||
23564358|NCT04836858|65793796|FG003|Overall Study|Subject/Guardian decision|1|||
23564359|NCT04836858|65793793|FG000|Overall Study|Randomized but not treated|4|||
23564360|NCT04836858|65793794|FG001|Overall Study|Randomized but not treated|0|||
23564361|NCT04836858|65793795|FG002|Overall Study|Randomized but not treated|0|||
23564362|NCT04836858|65793796|FG003|Overall Study|Randomized but not treated|0|||
23626532|NCT02484547|66020339|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
23626533|NCT02484547|66020340|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
23626534|NCT02484547|66020341|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
23626535|NCT02484547|66020342|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
23626536|NCT02484547|66020343|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
23759346|NCT04130919|66498170|FG004|Open-label Treatment Phase|Investigator's decision|0|||
23759347|NCT04130919|66498171|FG005|Open-label Treatment Phase|Investigator's decision|0|||
23759348|NCT04130919|66498166|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23759349|NCT04130919|66498167|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23759350|NCT04130919|66498168|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
23759351|NCT04130919|66498169|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
23759352|NCT04130919|66498170|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
23564363|NCT01153269|65793797|FG000|Overall Study|Withdrawal by Subject|1|||
23564364|NCT01153269|65793797|FG000|Overall Study|Antiretroviral therapy break|1|||
23564365|NCT01722162|65793798|FG000|Overall Study|Withdrawal by Subject|1|||
23564366|NCT01722162|65793799|FG001|Overall Study|Withdrawal by Subject|1|||
23564367|NCT01722162|65793798|FG000|Overall Study|Found ineligible|1|||
23564368|NCT01722162|65793799|FG001|Overall Study|Found ineligible|0|||
23564369|NCT01722162|65793798|FG000|Overall Study|Unrelated to study adverse event|2|||
23626537|NCT02484547|66020344|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
23759353|NCT04130919|66498171|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
23759354|NCT04130919|66498166|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23759355|NCT04130919|66498167|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23759356|NCT04130919|66498168|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23759357|NCT04130919|66498169|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23759358|NCT04130919|66498170|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
23759359|NCT04130919|66498171|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23759360|NCT00305110|66498175|FG000|Overall Study|Missing data|29|||
23759361|NCT00700310|66498178|FG000|Overall Study|Adverse Event|6|||
23759362|NCT00700310|66498179|FG001|Overall Study|Adverse Event|10|||
23759363|NCT00700310|66498180|FG002|Overall Study|Adverse Event|5|||
23759364|NCT00700310|66498181|FG003|Overall Study|Adverse Event|11|||
23759365|NCT00700310|66498178|FG000|Overall Study|Lost to Follow-up|4|||
23759366|NCT00700310|66498179|FG001|Overall Study|Lost to Follow-up|1|||
23759367|NCT00700310|66498180|FG002|Overall Study|Lost to Follow-up|0|||
23759368|NCT00700310|66498181|FG003|Overall Study|Lost to Follow-up|1|||
23759369|NCT00700310|66498178|FG000|Overall Study|Withdrawal by Subject|8|||
23564370|NCT01722162|65793799|FG001|Overall Study|Unrelated to study adverse event|2|||
23564371|NCT01722162|65793798|FG000|Overall Study|Adverse Event|1|||
23564372|NCT01722162|65793799|FG001|Overall Study|Adverse Event|1|||
23626538|NCT02484547|66020338|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
23626539|NCT02484547|66020339|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23626540|NCT02484547|66020340|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23441310|NCT02452424|65358457|FG003|Overall Study|Adverse Event|0|||
23564373|NCT01722162|65793798|FG000|Overall Study|Insurance denial post enrollment|0|||
23564374|NCT01722162|65793799|FG001|Overall Study|Insurance denial post enrollment|1|||
23564375|NCT01722162|65793798|FG000|Overall Study|Noncompliance|0|||
23564376|NCT01722162|65793799|FG001|Overall Study|Noncompliance|1|||
23564377|NCT02180438|65793800|FG000|Overall Study|Lost to Follow-up|1|||
23759370|NCT00700310|66498179|FG001|Overall Study|Withdrawal by Subject|9|||
23759371|NCT00700310|66498180|FG002|Overall Study|Withdrawal by Subject|8|||
23759372|NCT00700310|66498181|FG003|Overall Study|Withdrawal by Subject|8|||
23759373|NCT00700310|66498178|FG000|Overall Study|Lack of Efficacy|0|||
23759374|NCT00700310|66498179|FG001|Overall Study|Lack of Efficacy|3|||
23759375|NCT00700310|66498180|FG002|Overall Study|Lack of Efficacy|0|||
23759376|NCT00700310|66498181|FG003|Overall Study|Lack of Efficacy|1|||
23759377|NCT00700310|66498178|FG000|Overall Study|Administrative/Other|1|||
23759378|NCT00700310|66498179|FG001|Overall Study|Administrative/Other|3|||
23759379|NCT00700310|66498180|FG002|Overall Study|Administrative/Other|1|||
23441311|NCT02452424|65358458|FG004|Overall Study|Adverse Event|0|||
23564378|NCT02460263|65796377|FG000|Transition Period|Withdrawal by Subject|1|||
23564379|NCT02460263|65796377|FG000|Transition Period|Death|1|||
23564380|NCT03176238|65796390|FG000|Overall Study|Unacceptable AEs|15|||
23564381|NCT03176238|65796391|FG001|Overall Study|Unacceptable AEs|8|||
23564382|NCT03176238|65796390|FG000|Overall Study|Abnormal lab value(s)|2|||
23564383|NCT03176238|65796391|FG001|Overall Study|Abnormal lab value(s)|0|||
23564384|NCT03176238|65796390|FG000|Overall Study|Inter-current illness|0|||
23564385|NCT03176238|65796391|FG001|Overall Study|Inter-current illness|1|||
23564386|NCT03176238|65796390|FG000|Overall Study|Consent withdrawal|14|||
23564387|NCT03176238|65796391|FG001|Overall Study|Consent withdrawal|2|||
23564388|NCT03176238|65796390|FG000|Overall Study|Lost to Follow-up|3|||
23564389|NCT03176238|65796391|FG001|Overall Study|Lost to Follow-up|0|||
23564390|NCT03176238|65796390|FG000|Overall Study|Administrative problems|1|||
23564391|NCT03176238|65796391|FG001|Overall Study|Administrative problems|0|||
23564392|NCT03176238|65796390|FG000|Overall Study|Death|3|||
23564393|NCT03176238|65796391|FG001|Overall Study|Death|0|||
23564394|NCT03176238|65796390|FG000|Overall Study|Disease Progression|133|||
23564395|NCT03176238|65796391|FG001|Overall Study|Disease Progression|22|||
23564396|NCT03176238|65796390|FG000|Overall Study|Tx duration completed per EAP|0|||
23564397|NCT03176238|65796391|FG001|Overall Study|Tx duration completed per EAP|1|||
23564398|NCT03176238|65796390|FG000|Overall Study|Patient is switched to commercial drug|16|||
23564399|NCT03176238|65796391|FG001|Overall Study|Patient is switched to commercial drug|1|||
23564400|NCT03176238|65796390|FG000|Overall Study|Protocol Violation|1|||
23564401|NCT03176238|65796391|FG001|Overall Study|Protocol Violation|0|||
23564402|NCT03176238|65796390|FG000|Overall Study|Changes in the patient's condition|2|||
23564403|NCT03176238|65796391|FG001|Overall Study|Changes in the patient's condition|1|||
23564404|NCT03176238|65796390|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
23564405|NCT03176238|65796391|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
23441312|NCT02452424|65358459|FG005|Overall Study|Adverse Event|0|||
23626541|NCT02484547|66020341|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23759380|NCT00700310|66498181|FG003|Overall Study|Administrative/Other|3|||
23759381|NCT00700310|66498178|FG000|Overall Study|Randomized, Not Treated|2|||
23564406|NCT04503096|65796392|FG000|Overall Study|Withdrawal by Subject|3|||
23564407|NCT03311230|65796393|FG000|Overall Study|Withdrawal by Subject|1|||
23564408|NCT03311230|65796394|FG001|Overall Study|Withdrawal by Subject|4|||
23564409|NCT03311230|65796395|FG002|Overall Study|Withdrawal by Subject|2|||
23564410|NCT03311230|65796396|FG003|Overall Study|Withdrawal by Subject|7|||
23564411|NCT03311230|65796393|FG000|Overall Study|Unrelated injury|0|||
23564412|NCT03311230|65796394|FG001|Overall Study|Unrelated injury|1|||
23564413|NCT03311230|65796395|FG002|Overall Study|Unrelated injury|0|||
23564414|NCT03311230|65796396|FG003|Overall Study|Unrelated injury|0|||
23564415|NCT03021486|65796405|FG000|Overall Study|Withdrawal by Subject|1|||
23564416|NCT03021486|65796406|FG001|Overall Study|Withdrawal by Subject|1|||
23564417|NCT03021486|65796407|FG002|Overall Study|Withdrawal by Subject|3|||
23564418|NCT03021486|65796405|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
23564419|NCT03021486|65796406|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
23564420|NCT03021486|65796407|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
23564421|NCT00998400|65796413|FG000|Overall Study|Lack of interest/motivation|1|||
23564422|NCT00998400|65796414|FG001|Overall Study|Lack of interest/motivation|2|||
23564423|NCT00998400|65796413|FG000|Overall Study|Logistical problems|1|||
23564424|NCT00998400|65796414|FG001|Overall Study|Logistical problems|0|||
23564425|NCT02118896|65796415|FG000|Overall Study|Death|4|||
23564426|NCT02118896|65796416|FG001|Overall Study|Death|0|||
23564427|NCT02118896|65796417|FG002|Overall Study|Death|4|||
23564428|NCT02118896|65796418|FG003|Overall Study|Death|6|||
23564429|NCT02118896|65796419|FG004|Overall Study|Death|3|||
23564430|NCT02118896|65796420|FG005|Overall Study|Death|1|||
23564431|NCT02118896|65796421|FG006|Overall Study|Death|0|||
23564432|NCT02118896|65796422|FG007|Overall Study|Death|0|||
23564433|NCT02118896|65796423|FG008|Overall Study|Death|0|||
23564434|NCT02118896|65796424|FG009|Overall Study|Death|0|||
23564435|NCT02118896|65796415|FG000|Overall Study|Adverse Event|5|||
23564436|NCT02118896|65796416|FG001|Overall Study|Adverse Event|4|||
23564437|NCT02118896|65796417|FG002|Overall Study|Adverse Event|4|||
23564438|NCT02118896|65796418|FG003|Overall Study|Adverse Event|5|||
23564439|NCT02118896|65796419|FG004|Overall Study|Adverse Event|5|||
23564440|NCT02118896|65796420|FG005|Overall Study|Adverse Event|9|||
23564441|NCT02118896|65796421|FG006|Overall Study|Adverse Event|1|||
23564442|NCT02118896|65796422|FG007|Overall Study|Adverse Event|1|||
23564443|NCT02118896|65796423|FG008|Overall Study|Adverse Event|4|||
23564444|NCT02118896|65796424|FG009|Overall Study|Adverse Event|0|||
23564445|NCT02118896|65796415|FG000|Overall Study|Consent withdrawn|2|||
23564446|NCT02118896|65796416|FG001|Overall Study|Consent withdrawn|0|||
23564447|NCT02118896|65796417|FG002|Overall Study|Consent withdrawn|3|||
23564448|NCT02118896|65796418|FG003|Overall Study|Consent withdrawn|4|||
23564449|NCT02118896|65796419|FG004|Overall Study|Consent withdrawn|1|||
23564450|NCT02118896|65796420|FG005|Overall Study|Consent withdrawn|4|||
23564451|NCT02118896|65796421|FG006|Overall Study|Consent withdrawn|0|||
23564452|NCT02118896|65796422|FG007|Overall Study|Consent withdrawn|0|||
23564453|NCT02118896|65796423|FG008|Overall Study|Consent withdrawn|0|||
23564454|NCT02118896|65796424|FG009|Overall Study|Consent withdrawn|0|||
23564455|NCT02118896|65796415|FG000|Overall Study|Non-compliance|2|||
23564456|NCT02118896|65796416|FG001|Overall Study|Non-compliance|1|||
23564457|NCT02118896|65796417|FG002|Overall Study|Non-compliance|1|||
23564458|NCT02118896|65796418|FG003|Overall Study|Non-compliance|5|||
23564459|NCT02118896|65796419|FG004|Overall Study|Non-compliance|0|||
23564460|NCT02118896|65796420|FG005|Overall Study|Non-compliance|1|||
23564461|NCT02118896|65796421|FG006|Overall Study|Non-compliance|0|||
23564462|NCT02118896|65796422|FG007|Overall Study|Non-compliance|1|||
23564463|NCT02118896|65796423|FG008|Overall Study|Non-compliance|0|||
23564464|NCT02118896|65796424|FG009|Overall Study|Non-compliance|0|||
23564465|NCT02118896|65796415|FG000|Overall Study|Pregnancy|1|||
23564466|NCT02118896|65796416|FG001|Overall Study|Pregnancy|1|||
23564467|NCT02118896|65796417|FG002|Overall Study|Pregnancy|0|||
23564468|NCT02118896|65796418|FG003|Overall Study|Pregnancy|0|||
23441313|NCT02452424|65358460|FG006|Overall Study|Adverse Event|0|||
23441314|NCT02452424|65358461|FG007|Overall Study|Adverse Event|0|||
23441315|NCT02452424|65358462|FG008|Overall Study|Adverse Event|0|||
23441316|NCT02452424|65358463|FG009|Overall Study|Adverse Event|0|||
23564469|NCT02118896|65796419|FG004|Overall Study|Pregnancy|1|||
23564470|NCT02118896|65796420|FG005|Overall Study|Pregnancy|3|||
23564471|NCT02118896|65796421|FG006|Overall Study|Pregnancy|1|||
23564472|NCT02118896|65796422|FG007|Overall Study|Pregnancy|0|||
23564473|NCT02118896|65796423|FG008|Overall Study|Pregnancy|0|||
23564474|NCT02118896|65796424|FG009|Overall Study|Pregnancy|0|||
23564475|NCT02118896|65796415|FG000|Overall Study|Lost to Follow-up|1|||
23564476|NCT02118896|65796416|FG001|Overall Study|Lost to Follow-up|2|||
23564477|NCT02118896|65796417|FG002|Overall Study|Lost to Follow-up|1|||
23564478|NCT02118896|65796418|FG003|Overall Study|Lost to Follow-up|0|||
23564479|NCT02118896|65796419|FG004|Overall Study|Lost to Follow-up|2|||
23564480|NCT02118896|65796420|FG005|Overall Study|Lost to Follow-up|1|||
23441317|NCT02452424|65358464|FG010|Overall Study|Adverse Event|1|||
23441318|NCT01858740|65358465|FG000|Overall Study|Death|4|||
23564481|NCT02118896|65796421|FG006|Overall Study|Lost to Follow-up|0|||
23564482|NCT02118896|65796422|FG007|Overall Study|Lost to Follow-up|0|||
23564483|NCT02118896|65796423|FG008|Overall Study|Lost to Follow-up|0|||
23564484|NCT02118896|65796424|FG009|Overall Study|Lost to Follow-up|0|||
23564485|NCT02118896|65796415|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
23564486|NCT02118896|65796416|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
23759382|NCT00700310|66498179|FG001|Overall Study|Randomized, Not Treated|0|||
23759383|NCT00700310|66498180|FG002|Overall Study|Randomized, Not Treated|2|||
23759384|NCT00700310|66498181|FG003|Overall Study|Randomized, Not Treated|2|||
23759385|NCT02196506|66498183|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
23759386|NCT02196506|66498184|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
23759387|NCT02196506|66498185|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
23759388|NCT02196506|66498186|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
23759389|NCT02196506|66498183|FG000|Phase A|Withdrawal by Subject|34|||
23759390|NCT02196506|66498184|FG001|Phase A|Withdrawal by Subject|0|||
23759391|NCT02196506|66498185|FG002|Phase A|Withdrawal by Subject|0|||
23759392|NCT02196506|66498186|FG003|Phase A|Withdrawal by Subject|0|||
23759393|NCT02196506|66498183|FG000|Phase A|Adverse Event|22|||
23759394|NCT02196506|66498184|FG001|Phase A|Adverse Event|0|||
23759395|NCT02196506|66498185|FG002|Phase A|Adverse Event|0|||
23759396|NCT02196506|66498186|FG003|Phase A|Adverse Event|0|||
23441319|NCT03245398|65358466|FG000|Overall Study|Travelled to another island|1|||
23441320|NCT03245398|65358467|FG001|Overall Study|Travelled to another island|0|||
23441321|NCT02519595|65358468|FG000|Overall Study|Protocol Violation|8|||
23441322|NCT02519595|65358469|FG001|Overall Study|Protocol Violation|22|||
23441323|NCT02519595|65358470|FG002|Overall Study|Protocol Violation|16|||
23441324|NCT02649894|65358474|FG000|Overall Study|Adverse Event|1|||
23441325|NCT02649894|65358475|FG001|Overall Study|Adverse Event|0|||
23441326|NCT02649894|65358474|FG000|Overall Study|Physician Decision|0|||
23441327|NCT02649894|65358475|FG001|Overall Study|Physician Decision|1|||
23564487|NCT02118896|65796417|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
23564488|NCT02118896|65796418|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564489|NCT02118896|65796419|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
23564490|NCT02118896|65796420|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564491|NCT02118896|65796421|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564492|NCT02118896|65796422|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564493|NCT02118896|65796423|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564494|NCT02118896|65796424|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564495|NCT02118896|65796415|FG000|Overall Study|Prohibited medication|0|||
23564496|NCT02118896|65796416|FG001|Overall Study|Prohibited medication|0|||
23564497|NCT02118896|65796417|FG002|Overall Study|Prohibited medication|0|||
23564498|NCT02118896|65796418|FG003|Overall Study|Prohibited medication|0|||
23564499|NCT02118896|65796419|FG004|Overall Study|Prohibited medication|1|||
23564500|NCT02118896|65796420|FG005|Overall Study|Prohibited medication|3|||
23564501|NCT02118896|65796421|FG006|Overall Study|Prohibited medication|0|||
23564502|NCT02118896|65796422|FG007|Overall Study|Prohibited medication|0|||
23564503|NCT02118896|65796423|FG008|Overall Study|Prohibited medication|0|||
23564504|NCT02118896|65796424|FG009|Overall Study|Prohibited medication|0|||
23564505|NCT02118896|65796415|FG000|Overall Study|Miscellaneous|1|||
23564506|NCT02118896|65796416|FG001|Overall Study|Miscellaneous|2|||
23564507|NCT02118896|65796417|FG002|Overall Study|Miscellaneous|0|||
23564508|NCT02118896|65796418|FG003|Overall Study|Miscellaneous|2|||
23564509|NCT02118896|65796419|FG004|Overall Study|Miscellaneous|0|||
23564510|NCT02118896|65796420|FG005|Overall Study|Miscellaneous|4|||
23564511|NCT02118896|65796421|FG006|Overall Study|Miscellaneous|0|||
23564512|NCT02118896|65796422|FG007|Overall Study|Miscellaneous|0|||
23564513|NCT02118896|65796423|FG008|Overall Study|Miscellaneous|0|||
23564514|NCT02118896|65796424|FG009|Overall Study|Miscellaneous|0|||
23564515|NCT03560245|65796426|FG000|Overall Study|Withdrawal by Subject|3|||
23564516|NCT03560245|65796427|FG001|Overall Study|Withdrawal by Subject|2|||
23564517|NCT03560245|65796426|FG000|Overall Study|Adverse Event|1|||
23626542|NCT02484547|66020342|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23564518|NCT03560245|65796427|FG001|Overall Study|Adverse Event|1|||
23564519|NCT03560245|65796426|FG000|Overall Study|Protocol Violation|1|||
23564520|NCT03560245|65796427|FG001|Overall Study|Protocol Violation|0|||
23564521|NCT03560245|65796426|FG000|Overall Study|Death|0|||
23564522|NCT03560245|65796427|FG001|Overall Study|Death|1|||
23759397|NCT02196506|66498183|FG000|Phase A|Lost to Follow-up|9|||
23759398|NCT02196506|66498184|FG001|Phase A|Lost to Follow-up|0|||
23759399|NCT02196506|66498185|FG002|Phase A|Lost to Follow-up|0|||
23759400|NCT02196506|66498186|FG003|Phase A|Lost to Follow-up|0|||
23441328|NCT02649894|65358474|FG000|Overall Study|Withdrawal by Subject|5|||
23441329|NCT02649894|65358475|FG001|Overall Study|Withdrawal by Subject|2|||
23759401|NCT02196506|66498183|FG000|Phase A|Protocol deviation|12|||
23441330|NCT02649894|65358474|FG000|Overall Study|Lost to Follow-up|2|||
23441331|NCT02649894|65358475|FG001|Overall Study|Lost to Follow-up|1|||
23564523|NCT03560245|65796426|FG000|Overall Study|Lost to Follow-up|0|||
23564524|NCT03560245|65796427|FG001|Overall Study|Lost to Follow-up|1|||
23564525|NCT03560245|65796426|FG000|Overall Study|Physician Decision|0|||
23441332|NCT02649894|65358474|FG000|Overall Study|Death|30|||
23441333|NCT02649894|65358475|FG001|Overall Study|Death|7|||
23441334|NCT02649894|65358474|FG000|Overall Study|Other, not specified|6|||
23441335|NCT02649894|65358475|FG001|Overall Study|Other, not specified|0|||
23441336|NCT02100969|65358481|FG000|Overall Study|Did not pass screening phase|1|||
23441337|NCT00145574|65358482|FG000|Double Blind|Adverse Event|0|||
23441338|NCT00145574|65358483|FG001|Double Blind|Adverse Event|3|||
23441339|NCT00145574|65358484|FG002|Double Blind|Adverse Event|1|||
23441340|NCT00145574|65358482|FG000|Double Blind|Withdrawal by Subject|1|||
23441341|NCT00145574|65358483|FG001|Double Blind|Withdrawal by Subject|1|||
23441342|NCT00145574|65358484|FG002|Double Blind|Withdrawal by Subject|1|||
23441343|NCT00145574|65358482|FG000|Double Blind|required restricted medicine|0|||
23441344|NCT00145574|65358483|FG001|Double Blind|required restricted medicine|1|||
23441345|NCT00145574|65358484|FG002|Double Blind|required restricted medicine|0|||
23441346|NCT00145574|65358482|FG000|Open Label Long-term Extension|Adverse Event|0|||
23441347|NCT00145574|65358483|FG001|Open Label Long-term Extension|Adverse Event|0|||
23441348|NCT00145574|65358484|FG002|Open Label Long-term Extension|Adverse Event|5|||
23441349|NCT00145574|65358482|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
23441350|NCT00145574|65358483|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
23441351|NCT00145574|65358484|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
23441352|NCT00145574|65358482|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
23441353|NCT00145574|65358483|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
23441354|NCT00145574|65358484|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
23441355|NCT00145574|65358482|FG000|Open Label Long-term Extension|required restricted medicine|0|||
23441356|NCT00145574|65358483|FG001|Open Label Long-term Extension|required restricted medicine|0|||
23441357|NCT00145574|65358484|FG002|Open Label Long-term Extension|required restricted medicine|1|||
23441358|NCT01240200|65358485|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
23441359|NCT01240200|65358486|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
23441360|NCT02806960|65358489|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441361|NCT02806960|65358490|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441362|NCT02806960|65358491|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441363|NCT02806960|65358492|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441364|NCT00988091|65358495|FG000|Double-blind Period|Withdrawal by Subject|15|||
23441365|NCT00988091|65358496|FG001|Double-blind Period|Withdrawal by Subject|13|||
23441366|NCT00988091|65358495|FG000|Double-blind Period|Lost to Follow-up|12|||
23441367|NCT00988091|65358496|FG001|Double-blind Period|Lost to Follow-up|14|||
23441368|NCT00988091|65358495|FG000|Double-blind Period|Other|8|||
23441369|NCT00988091|65358496|FG001|Double-blind Period|Other|8|||
23441370|NCT00988091|65358495|FG000|Double-blind Period|Adverse Event|6|||
23441371|NCT00988091|65358496|FG001|Double-blind Period|Adverse Event|9|||
23441372|NCT00988091|65358495|FG000|Double-blind Period|Use of exclusionary medication|2|||
23441373|NCT00988091|65358496|FG001|Double-blind Period|Use of exclusionary medication|3|||
23441374|NCT00988091|65358495|FG000|Open-label Period|Adverse Event|4|||
23441375|NCT00988091|65358496|FG001|Open-label Period|Adverse Event|7|||
23441376|NCT00988091|65358495|FG000|Open-label Period|Use of exclusionary medication|1|||
23441377|NCT00988091|65358496|FG001|Open-label Period|Use of exclusionary medication|1|||
23441378|NCT00988091|65358495|FG000|Open-label Period|Protocol Violation|1|||
23441379|NCT00988091|65358496|FG001|Open-label Period|Protocol Violation|1|||
23441380|NCT00988091|65358495|FG000|Open-label Period|Withdrawal by Subject|10|||
23441381|NCT00988091|65358496|FG001|Open-label Period|Withdrawal by Subject|16|||
23441382|NCT00988091|65358495|FG000|Open-label Period|Lost to Follow-up|3|||
23441383|NCT00988091|65358496|FG001|Open-label Period|Lost to Follow-up|5|||
23441384|NCT00988091|65358495|FG000|Open-label Period|Other|2|||
23441385|NCT00988091|65358496|FG001|Open-label Period|Other|3|||
23441386|NCT00203424|65358498|FG000|Treatment Period|Withdrawal by Subject|4|||
23441387|NCT00203424|65358498|FG000|Treatment Period|Adverse Event|5|||
23441388|NCT00203424|65358498|FG000|Treatment Period|progressive disease|2|||
23441389|NCT00203424|65358498|FG000|Follow-up Period|Withdrawal by Subject|1|||
23441390|NCT00203424|65358498|FG000|Follow-up Period|progressive disease|4|||
23441391|NCT00203424|65358498|FG000|Follow-up Period|Lost to Follow-up|1|||
23441392|NCT00291486|65358499|FG000|Overall Study|Adverse Event|0|||
23441393|NCT00291486|65358500|FG001|Overall Study|Adverse Event|3|||
23441394|NCT00291486|65358501|FG002|Overall Study|Adverse Event|0|||
23441395|NCT00291486|65358502|FG003|Overall Study|Adverse Event|1|||
23441396|NCT00291486|65358503|FG004|Overall Study|Adverse Event|0|||
23441397|NCT00291486|65358499|FG000|Overall Study|Withdrawal by Subject|0|||
23441398|NCT00291486|65358500|FG001|Overall Study|Withdrawal by Subject|0|||
23441399|NCT00291486|65358501|FG002|Overall Study|Withdrawal by Subject|0|||
23441400|NCT00291486|65358502|FG003|Overall Study|Withdrawal by Subject|0|||
23441401|NCT00291486|65358503|FG004|Overall Study|Withdrawal by Subject|1|||
23441402|NCT00291486|65358499|FG000|Overall Study|Disease progression|1|||
23564526|NCT03560245|65796427|FG001|Overall Study|Physician Decision|1|||
23564527|NCT03560245|65796426|FG000|Overall Study|Other|0|||
23441403|NCT00291486|65358500|FG001|Overall Study|Disease progression|0|||
23441404|NCT00291486|65358501|FG002|Overall Study|Disease progression|1|||
23441405|NCT00291486|65358502|FG003|Overall Study|Disease progression|0|||
23441406|NCT00291486|65358503|FG004|Overall Study|Disease progression|0|||
23441407|NCT00379912|65358508|FG000|Overall Study|Lack of Efficacy|1|||
23441408|NCT00379912|65358509|FG001|Overall Study|Lack of Efficacy|0|||
23441409|NCT01286077|65358510|FG000|Overall Study|Adverse Event|2|||
23441410|NCT01286077|65358511|FG001|Overall Study|Adverse Event|0|||
23441411|NCT01286077|65358510|FG000|Overall Study|Death|1|||
23441412|NCT01286077|65358511|FG001|Overall Study|Death|0|||
23441413|NCT01286077|65358510|FG000|Overall Study|Protocol Violation|1|||
23441414|NCT01286077|65358511|FG001|Overall Study|Protocol Violation|1|||
23441415|NCT01286077|65358510|FG000|Overall Study|Withdrawal by Subject|0|||
23441416|NCT01286077|65358511|FG001|Overall Study|Withdrawal by Subject|2|||
23441417|NCT01286077|65358510|FG000|Overall Study|Intercurrent illness|1|||
23441418|NCT01286077|65358511|FG001|Overall Study|Intercurrent illness|0|||
23441419|NCT01286077|65358510|FG000|Overall Study|Non-compliance|1|||
23441420|NCT01286077|65358511|FG001|Overall Study|Non-compliance|0|||
23441421|NCT01286077|65358510|FG000|Overall Study|The subject starts with alternative MMY|0|||
23441422|NCT01286077|65358511|FG001|Overall Study|The subject starts with alternative MMY|3|||
23441423|NCT01286077|65358510|FG000|Overall Study|Patient's decision to stop treatment|3|||
23441424|NCT01286077|65358511|FG001|Overall Study|Patient's decision to stop treatment|0|||
23441425|NCT01286077|65358510|FG000|Overall Study|Progression of disease|0|||
23441426|NCT01286077|65358511|FG001|Overall Study|Progression of disease|1|||
23441427|NCT01286077|65358510|FG000|Overall Study|refill medication not received in time|1|||
23441428|NCT01286077|65358511|FG001|Overall Study|refill medication not received in time|0|||
23441429|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Adverse Event|0|||
23441430|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Adverse Event|1|||
23441431|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Adverse Event|0|||
23441432|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Adverse Event|0|||
23441433|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Adverse Event|0|||
23441434|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Adverse Event|0|||
23441435|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Adverse Event|0|||
23441436|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Adverse Event|1|||
23441437|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Adverse Event|1|||
23441438|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Adverse Event|0|||
23441439|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Adverse Event|0|||
23441440|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Physician Decision|0|||
23441441|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Physician Decision|0|||
23441442|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Physician Decision|1|||
23441443|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Physician Decision|0|||
23441444|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Physician Decision|0|||
23441445|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Physician Decision|0|||
23441446|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Physician Decision|0|||
23441447|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Physician Decision|1|||
23441448|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Physician Decision|0|||
23441449|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Physician Decision|0|||
23441450|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Physician Decision|0|||
23441451|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441452|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
23441453|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
23441454|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441455|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441456|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441457|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
23441458|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
23441459|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
23441460|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
23441461|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
23441462|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441463|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441464|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441465|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441466|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441467|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441468|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
23441469|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441470|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23564528|NCT03560245|65796427|FG001|Overall Study|Other|1|||
23564529|NCT01845974|65796428|FG000|Overall Study|screen failure|1|||
23564530|NCT01845974|65796429|FG001|Overall Study|screen failure|0|||
23564531|NCT00265330|65796430|FG000|Overall Study|Adverse Event|41|||
23441471|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441472|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441473|NCT00543387|65358512|FG000|Crossover Participants|Progressive Disease|0|||
23441474|NCT00543387|65358513|FG001|Crossover Participants|Progressive Disease|0|||
23564532|NCT00265330|65796430|FG000|Overall Study|Lost to Follow-up|8|||
23564533|NCT00265330|65796430|FG000|Overall Study|Withdrawal by Subject|34|||
23441475|NCT00543387|65358514|FG002|Crossover Participants|Progressive Disease|0|||
23441476|NCT00543387|65358515|FG003|Crossover Participants|Progressive Disease|0|||
23441477|NCT00543387|65358516|FG004|Crossover Participants|Progressive Disease|0|||
23441478|NCT00543387|65358517|FG005|Crossover Participants|Progressive Disease|0|||
23441479|NCT00543387|65358518|FG006|Crossover Participants|Progressive Disease|0|||
23441480|NCT00543387|65358519|FG007|Crossover Participants|Progressive Disease|0|||
23441481|NCT00543387|65358520|FG008|Crossover Participants|Progressive Disease|0|||
23441482|NCT00543387|65358521|FG009|Crossover Participants|Progressive Disease|1|||
23441483|NCT00543387|65358522|FG010|Crossover Participants|Progressive Disease|2|||
23441484|NCT00543387|65358512|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
23441485|NCT00543387|65358513|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
23759402|NCT02196506|66498184|FG001|Phase A|Protocol deviation|0|||
23759403|NCT02196506|66498185|FG002|Phase A|Protocol deviation|0|||
23759404|NCT02196506|66498186|FG003|Phase A|Protocol deviation|0|||
23759405|NCT02196506|66498183|FG000|Phase A|Participant withdrawn by investigator|10|||
23759406|NCT02196506|66498184|FG001|Phase A|Participant withdrawn by investigator|0|||
23759407|NCT02196506|66498185|FG002|Phase A|Participant withdrawn by investigator|0|||
23759408|NCT02196506|66498186|FG003|Phase A|Participant withdrawn by investigator|0|||
23759409|NCT02196506|66498183|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
23759410|NCT02196506|66498184|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
23759411|NCT02196506|66498185|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
23759412|NCT02196506|66498186|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
23759413|NCT02196506|66498183|FG000|Phase B|Lack of Efficacy|0|||
23759414|NCT02196506|66498184|FG001|Phase B|Lack of Efficacy|1|||
23759415|NCT02196506|66498185|FG002|Phase B|Lack of Efficacy|2|||
23759416|NCT02196506|66498186|FG003|Phase B|Lack of Efficacy|0|||
23759417|NCT02196506|66498183|FG000|Phase B|Withdrawal by Participant|0|||
23759418|NCT02196506|66498184|FG001|Phase B|Withdrawal by Participant|8|||
23759419|NCT02196506|66498185|FG002|Phase B|Withdrawal by Participant|1|||
23759420|NCT02196506|66498186|FG003|Phase B|Withdrawal by Participant|0|||
23759421|NCT02196506|66498183|FG000|Phase B|Adverse Event|0|||
23759422|NCT02196506|66498184|FG001|Phase B|Adverse Event|4|||
23759423|NCT02196506|66498185|FG002|Phase B|Adverse Event|1|||
23759424|NCT02196506|66498186|FG003|Phase B|Adverse Event|0|||
23759425|NCT02196506|66498183|FG000|Phase B|Lost to Follow-up|0|||
23759426|NCT02196506|66498184|FG001|Phase B|Lost to Follow-up|2|||
23759427|NCT02196506|66498185|FG002|Phase B|Lost to Follow-up|1|||
23759428|NCT02196506|66498186|FG003|Phase B|Lost to Follow-up|0|||
23759429|NCT02196506|66498183|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
23759430|NCT02196506|66498184|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
23759431|NCT02196506|66498185|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
23759432|NCT02196506|66498186|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
23827044|NCT01074944|66745290|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
23827045|NCT01074944|66745291|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23827046|NCT01074944|66745292|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23827047|NCT01074944|66745293|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23827048|NCT01074944|66745289|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23827049|NCT01074944|66745290|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
23827050|NCT01074944|66745291|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
23441486|NCT00543387|65358514|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
23441487|NCT00543387|65358515|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
23441488|NCT00543387|65358516|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
23441489|NCT00543387|65358517|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
23441490|NCT00543387|65358518|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
23441491|NCT00543387|65358519|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
23441492|NCT00543387|65358520|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
23441493|NCT00543387|65358521|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
23441494|NCT00543387|65358522|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
23441495|NCT00874848|65358526|FG000|Overall Study|Adverse Event|13|||
23441496|NCT00874848|65358527|FG001|Overall Study|Adverse Event|2|||
23441497|NCT00874848|65358526|FG000|Overall Study|Progressive neoplastic disease|38|||
23441498|NCT00874848|65358527|FG001|Overall Study|Progressive neoplastic disease|18|||
23441499|NCT00874848|65358526|FG000|Overall Study|Withdrawal by Subject|7|||
23759433|NCT02196506|66498183|FG000|Phase A+|Withdrawal by Participant|0|||
23759434|NCT02196506|66498184|FG001|Phase A+|Withdrawal by Participant|0|||
23759435|NCT02196506|66498185|FG002|Phase A+|Withdrawal by Participant|0|||
23759436|NCT02196506|66498186|FG003|Phase A+|Withdrawal by Participant|5|||
23759437|NCT02196506|66498183|FG000|Phase A+|Adverse Event|0|||
23759438|NCT02196506|66498184|FG001|Phase A+|Adverse Event|0|||
23759439|NCT02196506|66498185|FG002|Phase A+|Adverse Event|0|||
23759440|NCT02196506|66498186|FG003|Phase A+|Adverse Event|1|||
23759441|NCT02196506|66498183|FG000|Phase A+|Lost to Follow-up|0|||
23759442|NCT02196506|66498184|FG001|Phase A+|Lost to Follow-up|0|||
23626543|NCT02484547|66020343|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23626544|NCT02484547|66020344|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23626545|NCT02484547|66020338|FG000|Placebo-Controlled Period|Reason not Specified|216|||
23626546|NCT02484547|66020339|FG001|Placebo-Controlled Period|Reason not Specified|194|||
23626547|NCT02484547|66020340|FG002|Placebo-Controlled Period|Reason not Specified|183|||
23626548|NCT02484547|66020341|FG003|Placebo-Controlled Period|Reason not Specified|0|||
23626549|NCT02484547|66020342|FG004|Placebo-Controlled Period|Reason not Specified|0|||
23626550|NCT02484547|66020343|FG005|Placebo-Controlled Period|Reason not Specified|0|||
23626551|NCT02484547|66020344|FG006|Placebo-Controlled Period|Reason not Specified|0|||
23626552|NCT02484547|66020338|FG000|Long-Term Extension Period|Adverse Event|0|||
23759443|NCT02196506|66498185|FG002|Phase A+|Lost to Follow-up|0|||
23759444|NCT02196506|66498186|FG003|Phase A+|Lost to Follow-up|6|||
23759445|NCT02196506|66498183|FG000|Phase A+|Participant withdrawn by investigator|0|||
23759446|NCT02196506|66498184|FG001|Phase A+|Participant withdrawn by investigator|0|||
23759447|NCT02196506|66498185|FG002|Phase A+|Participant withdrawn by investigator|0|||
23759448|NCT02196506|66498186|FG003|Phase A+|Participant withdrawn by investigator|1|||
23759449|NCT00771901|66498187|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
23759450|NCT00771901|66498188|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
23759451|NCT00771901|66498189|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
23759452|NCT03705169|66498190|FG000|Overall Study|Lost to Follow-up|0|||
23759453|NCT03705169|66498191|FG001|Overall Study|Lost to Follow-up|0|||
23759454|NCT03705169|66498192|FG002|Overall Study|Lost to Follow-up|0|||
23759455|NCT03705169|66498193|FG003|Overall Study|Lost to Follow-up|2|||
23759456|NCT03705169|66498194|FG004|Overall Study|Lost to Follow-up|0|||
23759457|NCT03705169|66498195|FG005|Overall Study|Lost to Follow-up|2|||
23759458|NCT03705169|66498196|FG006|Overall Study|Lost to Follow-up|1|||
23759459|NCT03705169|66498197|FG007|Overall Study|Lost to Follow-up|0|||
23759460|NCT03705169|66498198|FG008|Overall Study|Lost to Follow-up|0|||
23759461|NCT03705169|66498199|FG009|Overall Study|Lost to Follow-up|1|||
23759462|NCT03705169|66498190|FG000|Overall Study|Adverse Event|0|||
23759463|NCT03705169|66498191|FG001|Overall Study|Adverse Event|0|||
23759464|NCT03705169|66498192|FG002|Overall Study|Adverse Event|0|||
23759465|NCT03705169|66498193|FG003|Overall Study|Adverse Event|1|||
23759466|NCT03705169|66498194|FG004|Overall Study|Adverse Event|0|||
23759467|NCT03705169|66498195|FG005|Overall Study|Adverse Event|0|||
23759468|NCT03705169|66498196|FG006|Overall Study|Adverse Event|0|||
23759469|NCT03705169|66498197|FG007|Overall Study|Adverse Event|0|||
23759470|NCT03705169|66498198|FG008|Overall Study|Adverse Event|0|||
23759471|NCT03705169|66498199|FG009|Overall Study|Adverse Event|0|||
23759472|NCT03705169|66498190|FG000|Overall Study|Site Closure|0|||
23759473|NCT03705169|66498191|FG001|Overall Study|Site Closure|0|||
23759474|NCT03705169|66498192|FG002|Overall Study|Site Closure|0|||
23759475|NCT03705169|66498193|FG003|Overall Study|Site Closure|1|||
23759476|NCT03705169|66498194|FG004|Overall Study|Site Closure|0|||
23759477|NCT03705169|66498195|FG005|Overall Study|Site Closure|0|||
23759478|NCT03705169|66498196|FG006|Overall Study|Site Closure|0|||
23759479|NCT03705169|66498197|FG007|Overall Study|Site Closure|0|||
23759480|NCT03705169|66498198|FG008|Overall Study|Site Closure|0|||
23759481|NCT03705169|66498199|FG009|Overall Study|Site Closure|0|||
23759482|NCT03705169|66498190|FG000|Overall Study|Did not receive study treatment|0|||
23759483|NCT03705169|66498191|FG001|Overall Study|Did not receive study treatment|0|||
23759484|NCT03705169|66498192|FG002|Overall Study|Did not receive study treatment|0|||
23759485|NCT03705169|66498193|FG003|Overall Study|Did not receive study treatment|1|||
23759486|NCT03705169|66498194|FG004|Overall Study|Did not receive study treatment|0|||
23759487|NCT03705169|66498195|FG005|Overall Study|Did not receive study treatment|0|||
23759488|NCT03705169|66498196|FG006|Overall Study|Did not receive study treatment|0|||
23759489|NCT03705169|66498197|FG007|Overall Study|Did not receive study treatment|0|||
23759490|NCT03705169|66498198|FG008|Overall Study|Did not receive study treatment|0|||
23759491|NCT03705169|66498199|FG009|Overall Study|Did not receive study treatment|0|||
23759492|NCT03705169|66498190|FG000|Overall Study|Concerns about study visit compliance|0|||
23759493|NCT03705169|66498191|FG001|Overall Study|Concerns about study visit compliance|0|||
23759494|NCT03705169|66498192|FG002|Overall Study|Concerns about study visit compliance|0|||
23626553|NCT02484547|66020339|FG001|Long-Term Extension Period|Adverse Event|0|||
23626554|NCT02484547|66020340|FG002|Long-Term Extension Period|Adverse Event|0|||
23759495|NCT03705169|66498193|FG003|Overall Study|Concerns about study visit compliance|1|||
23759496|NCT03705169|66498194|FG004|Overall Study|Concerns about study visit compliance|0|||
23759497|NCT03705169|66498195|FG005|Overall Study|Concerns about study visit compliance|0|||
23759498|NCT03705169|66498196|FG006|Overall Study|Concerns about study visit compliance|0|||
23759499|NCT03705169|66498197|FG007|Overall Study|Concerns about study visit compliance|0|||
23759500|NCT03705169|66498198|FG008|Overall Study|Concerns about study visit compliance|0|||
23759501|NCT03705169|66498199|FG009|Overall Study|Concerns about study visit compliance|0|||
23759502|NCT01416142|66498200|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
23759503|NCT01416142|66498201|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
23759504|NCT01416142|66498202|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
23626555|NCT02484547|66020341|FG003|Long-Term Extension Period|Adverse Event|0|||
23626556|NCT02484547|66020342|FG004|Long-Term Extension Period|Adverse Event|1|||
23626557|NCT02484547|66020343|FG005|Long-Term Extension Period|Adverse Event|3|||
23626558|NCT02484547|66020344|FG006|Long-Term Extension Period|Adverse Event|2|||
23626559|NCT02484547|66020338|FG000|Long-Term Extension Period|Death|0|||
23626560|NCT02484547|66020339|FG001|Long-Term Extension Period|Death|0|||
23626561|NCT02484547|66020340|FG002|Long-Term Extension Period|Death|0|||
23626562|NCT02484547|66020341|FG003|Long-Term Extension Period|Death|0|||
23626563|NCT02484547|66020342|FG004|Long-Term Extension Period|Death|0|||
23626564|NCT02484547|66020343|FG005|Long-Term Extension Period|Death|3|||
23626565|NCT02484547|66020344|FG006|Long-Term Extension Period|Death|0|||
23626566|NCT02484547|66020338|FG000|Long-Term Extension Period|Disease Progression|0|||
23626567|NCT02484547|66020339|FG001|Long-Term Extension Period|Disease Progression|0|||
23626568|NCT02484547|66020340|FG002|Long-Term Extension Period|Disease Progression|0|||
23626569|NCT02484547|66020341|FG003|Long-Term Extension Period|Disease Progression|0|||
23626570|NCT02484547|66020342|FG004|Long-Term Extension Period|Disease Progression|2|||
23626571|NCT02484547|66020343|FG005|Long-Term Extension Period|Disease Progression|4|||
23626572|NCT02484547|66020344|FG006|Long-Term Extension Period|Disease Progression|0|||
23626573|NCT02484547|66020338|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
23626574|NCT02484547|66020339|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
23626575|NCT02484547|66020340|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
23626576|NCT02484547|66020341|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
23626577|NCT02484547|66020342|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
23827051|NCT01074944|66745292|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23827052|NCT01074944|66745293|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23827053|NCT01074944|66745289|FG000|Long Term Treatment|Adverse Event|0|||
23827054|NCT01074944|66745290|FG001|Long Term Treatment|Adverse Event|0|||
23827055|NCT01074944|66745291|FG002|Long Term Treatment|Adverse Event|0|||
23827056|NCT01074944|66745292|FG003|Long Term Treatment|Adverse Event|3|||
23827057|NCT01074944|66745293|FG004|Long Term Treatment|Adverse Event|0|||
23827058|NCT01074944|66745289|FG000|Long Term Treatment|Lost to Follow-up|0|||
23827059|NCT01074944|66745290|FG001|Long Term Treatment|Lost to Follow-up|0|||
23827060|NCT01074944|66745291|FG002|Long Term Treatment|Lost to Follow-up|0|||
23827061|NCT01074944|66745292|FG003|Long Term Treatment|Lost to Follow-up|2|||
23827062|NCT01074944|66745293|FG004|Long Term Treatment|Lost to Follow-up|0|||
23827063|NCT01074944|66745289|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23827064|NCT01074944|66745290|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23827065|NCT01074944|66745291|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23827066|NCT01074944|66745292|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
23827067|NCT01074944|66745293|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23827068|NCT01074944|66745289|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
23827069|NCT01074944|66745290|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
23827070|NCT01074944|66745291|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
23827071|NCT01074944|66745292|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
23827072|NCT01074944|66745293|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
23827073|NCT01074944|66745289|FG000|Long Term Treatment|Withdrawal by Subject|0|||
23827074|NCT01074944|66745290|FG001|Long Term Treatment|Withdrawal by Subject|0|||
23827075|NCT01074944|66745291|FG002|Long Term Treatment|Withdrawal by Subject|0|||
23827076|NCT01074944|66745292|FG003|Long Term Treatment|Withdrawal by Subject|2|||
23827077|NCT01074944|66745293|FG004|Long Term Treatment|Withdrawal by Subject|0|||
23827078|NCT01074944|66745289|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23827079|NCT01074944|66745290|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23827080|NCT01074944|66745291|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23827081|NCT01074944|66745292|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23827082|NCT01074944|66745293|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
23827083|NCT01074944|66745289|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23827084|NCT01074944|66745290|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23827085|NCT01074944|66745291|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23827086|NCT01074944|66745292|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23827087|NCT01074944|66745293|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
23827088|NCT01153425|66745294|FG000|Overall Study|Withdrawal by Subject|3|||
23827089|NCT01153425|66745295|FG001|Overall Study|Withdrawal by Subject|3|||
23827090|NCT04428034|66745299|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
23827091|NCT00124748|66745302|FG000|Overall Study|Adverse Event|8|||
23827092|NCT00124748|66745303|FG001|Overall Study|Adverse Event|39|||
23626578|NCT02484547|66020343|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
23827093|NCT00124748|66745302|FG000|Overall Study|Abnormal laboratory Value|2|||
23827094|NCT00124748|66745303|FG001|Overall Study|Abnormal laboratory Value|2|||
23626579|NCT02484547|66020344|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
23626580|NCT02484547|66020338|FG000|Long-Term Extension Period|Loss of Capacity|0|||
23827095|NCT00124748|66745302|FG000|Overall Study|Abnormal Procedure|0|||
23827096|NCT00124748|66745303|FG001|Overall Study|Abnormal Procedure|1|||
23827097|NCT00124748|66745302|FG000|Overall Study|Lack of Efficacy|20|||
23827098|NCT00124748|66745303|FG001|Overall Study|Lack of Efficacy|41|||
23827099|NCT00124748|66745302|FG000|Overall Study|No longer requires study drug|1|||
23827100|NCT00124748|66745303|FG001|Overall Study|No longer requires study drug|1|||
23827101|NCT00124748|66745302|FG000|Overall Study|Protocol Violation|3|||
23827102|NCT00124748|66745303|FG001|Overall Study|Protocol Violation|1|||
23827103|NCT00124748|66745302|FG000|Overall Study|Withdrawal by Subject|5|||
23827104|NCT00124748|66745303|FG001|Overall Study|Withdrawal by Subject|15|||
23827105|NCT00124748|66745302|FG000|Overall Study|Lost to Follow-up|2|||
23827106|NCT00124748|66745303|FG001|Overall Study|Lost to Follow-up|7|||
23827107|NCT00124748|66745302|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
23827108|NCT00124748|66745303|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
23827109|NCT00124748|66745302|FG000|Overall Study|Death|1|||
23827110|NCT00124748|66745303|FG001|Overall Study|Death|3|||
23827111|NCT02002221|66745304|FG000|Overall Study|Adverse Event|2|||
23827112|NCT02002221|66745305|FG001|Overall Study|Adverse Event|1|||
23827113|NCT02002221|66745304|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23827114|NCT02002221|66745305|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23827115|NCT02002221|66745304|FG000|Overall Study|Patient withdrew consent|0|||
23827116|NCT02002221|66745305|FG001|Overall Study|Patient withdrew consent|1|||
23759505|NCT00525031|66498207|FG000|Overall Study|Disease Progression|1|||
23564534|NCT00265330|65796430|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
23564535|NCT00265330|65796430|FG000|Overall Study|Lack of Efficacy|4|||
23564536|NCT00265330|65796430|FG000|Overall Study|Family Scheduling Conflicts|1|||
23564537|NCT00265330|65796430|FG000|Overall Study|Began Taking Formulary Geodon|1|||
23564538|NCT00265330|65796430|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
23564539|NCT00265330|65796430|FG000|Overall Study|Site Closed by Sponsor|1|||
23564540|NCT00265330|65796430|FG000|Overall Study|Principal Investigators Request|1|||
23564541|NCT00265330|65796430|FG000|Overall Study|Withdrew Consent|1|||
23564542|NCT00265330|65796430|FG000|Overall Study|Protocol Violation|1|||
23564543|NCT04300309|65796436|FG000|Overall Study|Lost to Follow-up|1|||
23564544|NCT04300309|65796437|FG001|Overall Study|Lost to Follow-up|0|||
23759506|NCT00525031|66498208|FG001|Overall Study|Disease Progression|1|||
23759507|NCT03070431|66498209|FG000|Overall Study|Withdrawal by Subject|2|||
23759508|NCT03070431|66498209|FG000|Overall Study|Lost to Follow-up|2|||
23759509|NCT00123487|66498210|FG000|Randomized|Death prior to starting treatment|0|||
23759510|NCT00123487|66498211|FG001|Randomized|Death prior to starting treatment|1|||
23759511|NCT00123487|66498210|FG000|Randomized|SAE prior to starting treatment|1|||
23759512|NCT00123487|66498211|FG001|Randomized|SAE prior to starting treatment|0|||
23759513|NCT00123487|66498210|FG000|Treated With Study Drug|Adverse Event|23|||
23759514|NCT00123487|66498211|FG001|Treated With Study Drug|Adverse Event|22|||
23759515|NCT00123487|66498210|FG000|Treated With Study Drug|Disease Progression|141|||
23759516|NCT00123487|66498211|FG001|Treated With Study Drug|Disease Progression|122|||
23759517|NCT00123487|66498210|FG000|Treated With Study Drug|Physician Decision|8|||
23759518|NCT00123487|66498211|FG001|Treated With Study Drug|Physician Decision|9|||
23759519|NCT00123487|66498210|FG000|Treated With Study Drug|Other|59|||
23759520|NCT00123487|66498211|FG001|Treated With Study Drug|Other|58|||
23759521|NCT00123487|66498210|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
23759522|NCT00123487|66498211|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
23759523|NCT00123487|66498210|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
23827117|NCT02454933|66745310|FG000|Overall Study|Progressive disease|10|||
23827118|NCT02454933|66745311|FG001|Overall Study|Progressive disease|7|||
23564545|NCT04300309|65796436|FG000|Overall Study|Long-term follow up on-going|0|||
23564546|NCT04300309|65796437|FG001|Overall Study|Long-term follow up on-going|2|||
23564547|NCT02821819|65796440|FG000|Overall Study|Protocol Violation|1|||
23759524|NCT00123487|66498211|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
23759525|NCT00123487|66498210|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
23759526|NCT00123487|66498211|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
23759527|NCT02092961|66498212|FG000|Overall Study|Not reported|1|||
23827119|NCT02454933|66745310|FG000|Overall Study|Adverse Event|1|||
23827120|NCT02454933|66745311|FG001|Overall Study|Adverse Event|1|||
23827121|NCT02454933|66745310|FG000|Overall Study|Withdrawal by Subject|0|||
23759528|NCT02092961|66498213|FG001|Overall Study|Not reported|0|||
23759529|NCT02092961|66498214|FG002|Overall Study|Not reported|1|||
23759530|NCT02092961|66498212|FG000|Overall Study|Study stopped|13|||
23759531|NCT02092961|66498213|FG001|Overall Study|Study stopped|9|||
23759532|NCT02092961|66498214|FG002|Overall Study|Study stopped|12|||
23759533|NCT02092961|66498212|FG000|Overall Study|Lack of therapeutic response|2|||
23759534|NCT02092961|66498213|FG001|Overall Study|Lack of therapeutic response|1|||
23759535|NCT02092961|66498214|FG002|Overall Study|Lack of therapeutic response|3|||
23759536|NCT02092961|66498212|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
23759537|NCT02092961|66498213|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23759538|NCT02092961|66498214|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
23759539|NCT02092961|66498212|FG000|Overall Study|Adverse Event|2|||
23759540|NCT02092961|66498213|FG001|Overall Study|Adverse Event|4|||
23759541|NCT02092961|66498214|FG002|Overall Study|Adverse Event|0|||
23759542|NCT00811070|66498216|FG000|Overall Study|Death|0|||
23759543|NCT00811070|66498217|FG001|Overall Study|Death|0|||
23827122|NCT02454933|66745311|FG001|Overall Study|Withdrawal by Subject|3|||
23827123|NCT02454933|66745310|FG000|Overall Study|Lost to Follow-up|1|||
23827124|NCT02454933|66745311|FG001|Overall Study|Lost to Follow-up|0|||
23827125|NCT01524978|66745318|FG000|Overall Study|Other|16|||
23827126|NCT01524978|66745319|FG001|Overall Study|Other|2|||
23827127|NCT01524978|66745320|FG002|Overall Study|Other|1|||
23759544|NCT00811070|66498218|FG002|Overall Study|Death|0|||
23759545|NCT00811070|66498219|FG003|Overall Study|Death|2|||
23759546|NCT00811070|66498220|FG004|Overall Study|Death|5|||
23759547|NCT00811070|66498221|FG005|Overall Study|Death|0|||
23827128|NCT01524978|66745321|FG003|Overall Study|Other|2|||
23827129|NCT01524978|66745322|FG004|Overall Study|Other|1|||
23827130|NCT01524978|66745323|FG005|Overall Study|Other|3|||
23827131|NCT01524978|66745324|FG006|Overall Study|Other|17|||
23827132|NCT01524978|66745325|FG007|Overall Study|Other|1|||
23626581|NCT02484547|66020339|FG001|Long-Term Extension Period|Loss of Capacity|0|||
23626582|NCT02484547|66020340|FG002|Long-Term Extension Period|Loss of Capacity|0|||
23626583|NCT02484547|66020341|FG003|Long-Term Extension Period|Loss of Capacity|0|||
23626584|NCT02484547|66020342|FG004|Long-Term Extension Period|Loss of Capacity|1|||
23626585|NCT02484547|66020343|FG005|Long-Term Extension Period|Loss of Capacity|0|||
23626586|NCT02484547|66020344|FG006|Long-Term Extension Period|Loss of Capacity|0|||
23626587|NCT02484547|66020338|FG000|Long-Term Extension Period|Change of Treatment|0|||
23626588|NCT02484547|66020339|FG001|Long-Term Extension Period|Change of Treatment|0|||
23626589|NCT02484547|66020340|FG002|Long-Term Extension Period|Change of Treatment|0|||
23626590|NCT02484547|66020341|FG003|Long-Term Extension Period|Change of Treatment|0|||
23626591|NCT02484547|66020342|FG004|Long-Term Extension Period|Change of Treatment|0|||
23626592|NCT02484547|66020343|FG005|Long-Term Extension Period|Change of Treatment|0|||
23626593|NCT02484547|66020344|FG006|Long-Term Extension Period|Change of Treatment|1|||
23626594|NCT02484547|66020338|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
23626595|NCT02484547|66020339|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
23626596|NCT02484547|66020340|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
23626597|NCT02484547|66020341|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
23626598|NCT02484547|66020342|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
23626599|NCT02484547|66020343|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
23626600|NCT02484547|66020344|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
23626601|NCT02484547|66020338|FG000|Long-Term Extension Period|Investigator Decision|0|||
23626602|NCT02484547|66020339|FG001|Long-Term Extension Period|Investigator Decision|0|||
23626603|NCT02484547|66020340|FG002|Long-Term Extension Period|Investigator Decision|0|||
23626604|NCT02484547|66020341|FG003|Long-Term Extension Period|Investigator Decision|2|||
23626605|NCT02484547|66020342|FG004|Long-Term Extension Period|Investigator Decision|1|||
23626606|NCT02484547|66020343|FG005|Long-Term Extension Period|Investigator Decision|0|||
23626607|NCT02484547|66020344|FG006|Long-Term Extension Period|Investigator Decision|1|||
23626608|NCT02484547|66020338|FG000|Long-Term Extension Period|Relocation|0|||
23626609|NCT02484547|66020339|FG001|Long-Term Extension Period|Relocation|0|||
23626610|NCT02484547|66020340|FG002|Long-Term Extension Period|Relocation|0|||
23759548|NCT00811070|66498216|FG000|Overall Study|Other|1|||
23759549|NCT00811070|66498217|FG001|Overall Study|Other|0|||
23441500|NCT00874848|65358527|FG001|Overall Study|Withdrawal by Subject|4|||
23441501|NCT00874848|65358526|FG000|Overall Study|Noncompliance|1|||
23626611|NCT02484547|66020341|FG003|Long-Term Extension Period|Relocation|1|||
23626612|NCT02484547|66020342|FG004|Long-Term Extension Period|Relocation|1|||
23626613|NCT02484547|66020343|FG005|Long-Term Extension Period|Relocation|0|||
23759550|NCT00811070|66498218|FG002|Overall Study|Other|0|||
23759551|NCT00811070|66498219|FG003|Overall Study|Other|0|||
23759552|NCT00811070|66498220|FG004|Overall Study|Other|0|||
23827133|NCT01524978|66745326|FG008|Overall Study|Other|2|||
23626614|NCT02484547|66020344|FG006|Long-Term Extension Period|Relocation|0|||
23759553|NCT00811070|66498221|FG005|Overall Study|Other|0|||
23759554|NCT00811070|66498216|FG000|Overall Study|Withdrawal by Subject|0|||
23759555|NCT00811070|66498217|FG001|Overall Study|Withdrawal by Subject|1|||
23827134|NCT01524978|66745327|FG009|Overall Study|Other|2|||
23626615|NCT02484547|66020338|FG000|Long-Term Extension Period|Study Visit Burden|0|||
23626616|NCT02484547|66020339|FG001|Long-Term Extension Period|Study Visit Burden|0|||
23626617|NCT02484547|66020340|FG002|Long-Term Extension Period|Study Visit Burden|0|||
23626618|NCT02484547|66020341|FG003|Long-Term Extension Period|Study Visit Burden|2|||
23626619|NCT02484547|66020342|FG004|Long-Term Extension Period|Study Visit Burden|0|||
23626620|NCT02484547|66020343|FG005|Long-Term Extension Period|Study Visit Burden|0|||
23626621|NCT02484547|66020344|FG006|Long-Term Extension Period|Study Visit Burden|3|||
23626622|NCT02484547|66020338|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626623|NCT02484547|66020339|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626624|NCT02484547|66020340|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626625|NCT02484547|66020341|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23759556|NCT00811070|66498218|FG002|Overall Study|Withdrawal by Subject|0|||
23759557|NCT00811070|66498219|FG003|Overall Study|Withdrawal by Subject|0|||
23759558|NCT00811070|66498220|FG004|Overall Study|Withdrawal by Subject|0|||
23564548|NCT00301080|65796441|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
23564549|NCT00301080|65796442|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564550|NCT00301080|65796443|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564551|NCT00301080|65796444|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564552|NCT00301080|65796445|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564553|NCT02026232|65796446|FG000|Overall Study|incomplete visit/missing data|3|||
23564554|NCT02026232|65796447|FG001|Overall Study|incomplete visit/missing data|2|||
23564555|NCT00882921|65796450|FG000|Overall Study|Death|2|||
23564556|NCT00882921|65796450|FG000|Overall Study|Other|3|||
23564557|NCT00882921|65796450|FG000|Overall Study|Lost to Follow-up|2|||
23564558|NCT00882921|65796450|FG000|Overall Study|Termination By Investigator|3|||
23564559|NCT00882921|65796450|FG000|Overall Study|Withdrawal Of Consent|1|||
23564560|NCT04887948|65796454|FG000|Overall Study|Death|1|||
23564561|NCT04887948|65796455|FG001|Overall Study|Death|0|||
23564562|NCT04887948|65796456|FG002|Overall Study|Death|0|||
23564563|NCT04887948|65796454|FG000|Overall Study|Lost to Follow-up|1|||
23564564|NCT04887948|65796455|FG001|Overall Study|Lost to Follow-up|0|||
23564565|NCT04887948|65796456|FG002|Overall Study|Lost to Follow-up|3|||
23564566|NCT04887948|65796454|FG000|Overall Study|Physician Decision|0|||
23564567|NCT04887948|65796455|FG001|Overall Study|Physician Decision|4|||
23564568|NCT04887948|65796456|FG002|Overall Study|Physician Decision|1|||
23564569|NCT04887948|65796454|FG000|Overall Study|Protocol Violation|1|||
23564570|NCT04887948|65796455|FG001|Overall Study|Protocol Violation|1|||
23564571|NCT04887948|65796456|FG002|Overall Study|Protocol Violation|0|||
23564572|NCT04887948|65796454|FG000|Overall Study|Withdrawal by Subject|0|||
23564573|NCT04887948|65796455|FG001|Overall Study|Withdrawal by Subject|6|||
23564574|NCT04887948|65796456|FG002|Overall Study|Withdrawal by Subject|1|||
23564575|NCT04887948|65796454|FG000|Overall Study|No longer met eligibility criteria|1|||
23564576|NCT04887948|65796455|FG001|Overall Study|No longer met eligibility criteria|2|||
23564577|NCT04887948|65796456|FG002|Overall Study|No longer met eligibility criteria|1|||
23564578|NCT04887948|65796454|FG000|Overall Study|Other|2|||
23564579|NCT04887948|65796455|FG001|Overall Study|Other|1|||
23564580|NCT04887948|65796456|FG002|Overall Study|Other|1|||
23564581|NCT00591864|65796468|FG000|Overall Study|Incomplete Imaging|5|||
23759559|NCT00811070|66498221|FG005|Overall Study|Withdrawal by Subject|0|||
23759560|NCT00811070|66498216|FG000|Overall Study|Physician Decision|0|||
23759561|NCT00811070|66498217|FG001|Overall Study|Physician Decision|0|||
23759562|NCT00811070|66498218|FG002|Overall Study|Physician Decision|0|||
23759563|NCT00811070|66498219|FG003|Overall Study|Physician Decision|0|||
23759564|NCT00811070|66498220|FG004|Overall Study|Physician Decision|0|||
23759565|NCT00811070|66498221|FG005|Overall Study|Physician Decision|1|||
23759566|NCT01270841|66498222|FG000|Overall Study|Adverse Event|0|||
23759567|NCT01270841|66498223|FG001|Overall Study|Adverse Event|1|||
23759568|NCT01270841|66498224|FG002|Overall Study|Adverse Event|0|||
23759569|NCT01270841|66498225|FG003|Overall Study|Adverse Event|3|||
23759570|NCT01270841|66498222|FG000|Overall Study|Withdrawal by Subject|3|||
23759571|NCT01270841|66498223|FG001|Overall Study|Withdrawal by Subject|2|||
23564582|NCT04152343|65796469|FG000|Overall Study|Transplanted|5|||
23564583|NCT04152343|65796469|FG000|Overall Study|Death|20|||
23564584|NCT04152343|65796469|FG000|Overall Study|Lost to Follow-up|3|||
23564585|NCT02223754|65796470|FG000|Period 1|Adverse Event|1|||
23564586|NCT02223754|65796471|FG001|Period 1|Adverse Event|0|||
23564587|NCT02223754|65796470|FG000|Period 1|Lost to Follow-up|0|||
23564588|NCT02223754|65796471|FG001|Period 1|Lost to Follow-up|1|||
23564589|NCT02223754|65796470|FG000|Period 1|Protocol Violation|2|||
23626626|NCT02484547|66020342|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
23759572|NCT01270841|66498224|FG002|Overall Study|Withdrawal by Subject|3|||
23759573|NCT01270841|66498225|FG003|Overall Study|Withdrawal by Subject|3|||
23759574|NCT01270841|66498222|FG000|Overall Study|Lost to Follow-up|3|||
23564590|NCT02223754|65796471|FG001|Period 1|Protocol Violation|4|||
23564591|NCT02223754|65796470|FG000|Period 1|Withdrawal by Subject|0|||
23564592|NCT02223754|65796471|FG001|Period 1|Withdrawal by Subject|4|||
23564593|NCT02223754|65796470|FG000|Period 1|Test Article No Longer Available|1|||
23564594|NCT02223754|65796471|FG001|Period 1|Test Article No Longer Available|5|||
23564595|NCT02223754|65796470|FG000|Period 1|Unsatisfactory Visual Response|0|||
23564596|NCT02223754|65796471|FG001|Period 1|Unsatisfactory Visual Response|1|||
23564597|NCT02223754|65796470|FG000|Period 2|Adverse Event|0|||
23564598|NCT02223754|65796471|FG001|Period 2|Adverse Event|1|||
23564599|NCT02223754|65796470|FG000|Period 2|Protocol Violation|1|||
23564600|NCT02223754|65796471|FG001|Period 2|Protocol Violation|0|||
23564601|NCT02223754|65796470|FG000|Period 2|Lens Discomfort|1|||
23564602|NCT02223754|65796471|FG001|Period 2|Lens Discomfort|1|||
23564603|NCT02223754|65796470|FG000|Period 2|Lost to Follow-up|1|||
23564604|NCT02223754|65796471|FG001|Period 2|Lost to Follow-up|0|||
23564605|NCT02223754|65796470|FG000|Period 2|Test Article No Longer Available|0|||
23564606|NCT02223754|65796471|FG001|Period 2|Test Article No Longer Available|1|||
23564607|NCT05822921|65796472|FG000|Overall Study|Lost to Follow-up|1|||
23564608|NCT05822921|65796473|FG001|Overall Study|Lost to Follow-up|1|||
23564609|NCT03592277|65796474|FG000|Overall Study|Withdrawal by Subject|6|||
23564610|NCT03592277|65796475|FG001|Overall Study|Withdrawal by Subject|8|||
23564611|NCT04741802|65796476|FG000|Overall Study|Death|1|||
23564612|NCT04741802|65796476|FG000|Overall Study|Lost to Follow-up|11|||
23564613|NCT01547299|65796477|FG000|Overall Study|Withdrawal by Subject|2|||
23564614|NCT01547299|65796478|FG001|Overall Study|Withdrawal by Subject|2|||
23564615|NCT02563002|65796479|FG000|Overall Study|Death|72|||
23564616|NCT02563002|65796480|FG001|Overall Study|Death|87|||
23564617|NCT02563002|65796479|FG000|Overall Study|Lost to Follow-up|5|||
23564618|NCT02563002|65796480|FG001|Overall Study|Lost to Follow-up|0|||
23564619|NCT02563002|65796479|FG000|Overall Study|Physician Decision|0|||
23564620|NCT02563002|65796480|FG001|Overall Study|Physician Decision|2|||
23564621|NCT02563002|65796479|FG000|Overall Study|Withdrawal by Subject|2|||
23564622|NCT02563002|65796480|FG001|Overall Study|Withdrawal by Subject|10|||
23564623|NCT02563002|65796479|FG000|Overall Study|Sponsor decision|74|||
23564624|NCT02563002|65796480|FG001|Overall Study|Sponsor decision|55|||
23564625|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Adverse Event|176|||
23564626|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Adverse Event|0|||
23564627|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Adverse Event|0|||
23564628|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Adverse Event|0|||
23564629|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Adverse Event|0|||
23564630|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Adverse Event|0|||
23564631|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Adverse Event|0|||
23564632|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Adverse Event|0|||
23564633|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
23564634|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
23564635|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
23564636|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
23564637|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
23564638|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
23564639|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
23564640|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
23564641|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
23564642|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564643|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564644|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564645|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564646|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564647|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564648|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
23759575|NCT01270841|66498223|FG001|Overall Study|Lost to Follow-up|1|||
23759576|NCT01270841|66498224|FG002|Overall Study|Lost to Follow-up|4|||
23759577|NCT01270841|66498225|FG003|Overall Study|Lost to Follow-up|2|||
23564649|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23759578|NCT01270841|66498222|FG000|Overall Study|Physician Decision|0|||
23759579|NCT01270841|66498223|FG001|Overall Study|Physician Decision|1|||
23759580|NCT01270841|66498224|FG002|Overall Study|Physician Decision|0|||
23564650|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
23564651|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
23564652|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
23564653|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
23564654|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564655|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564656|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564657|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564658|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
23759581|NCT01270841|66498225|FG003|Overall Study|Physician Decision|0|||
23759582|NCT01270841|66498222|FG000|Overall Study|Did not qualify|6|||
23564659|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
23564660|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
23827135|NCT01524978|66745328|FG010|Overall Study|Other|5|||
23827136|NCT01524978|66745318|FG000|Overall Study|Withdrawal by Subject|12|||
23827137|NCT01524978|66745319|FG001|Overall Study|Withdrawal by Subject|0|||
23827138|NCT01524978|66745320|FG002|Overall Study|Withdrawal by Subject|1|||
23827139|NCT01524978|66745321|FG003|Overall Study|Withdrawal by Subject|1|||
23827140|NCT01524978|66745322|FG004|Overall Study|Withdrawal by Subject|3|||
23827141|NCT01524978|66745323|FG005|Overall Study|Withdrawal by Subject|1|||
23827142|NCT01524978|66745324|FG006|Overall Study|Withdrawal by Subject|6|||
23827143|NCT01524978|66745325|FG007|Overall Study|Withdrawal by Subject|2|||
23827144|NCT01524978|66745326|FG008|Overall Study|Withdrawal by Subject|4|||
23827145|NCT01524978|66745327|FG009|Overall Study|Withdrawal by Subject|0|||
23827146|NCT01524978|66745328|FG010|Overall Study|Withdrawal by Subject|5|||
23564661|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
23564662|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564663|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23626627|NCT02484547|66020343|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
23626628|NCT02484547|66020344|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
23626629|NCT02484547|66020338|FG000|Long-Term Extension Period|Reason not Specified|0|||
23626630|NCT02484547|66020339|FG001|Long-Term Extension Period|Reason not Specified|0|||
23626631|NCT02484547|66020340|FG002|Long-Term Extension Period|Reason not Specified|0|||
23626632|NCT02484547|66020341|FG003|Long-Term Extension Period|Reason not Specified|119|||
23626633|NCT02484547|66020342|FG004|Long-Term Extension Period|Reason not Specified|117|||
23626634|NCT02484547|66020343|FG005|Long-Term Extension Period|Reason not Specified|223|||
23626635|NCT02484547|66020344|FG006|Long-Term Extension Period|Reason not Specified|231|||
23626636|NCT02716298|66020345|FG000|First Intervention (1 Month)|Lens discomfort|1|||
23626637|NCT02716298|66020346|FG001|First Intervention (1 Month)|Lens discomfort|1|||
23626638|NCT00550446|66020347|FG000|Up To Week 12|Adverse Event|2|||
23626639|NCT00550446|66020348|FG001|Up To Week 12|Adverse Event|2|||
23626640|NCT00550446|66020349|FG002|Up To Week 12|Adverse Event|0|||
23626641|NCT00550446|66020350|FG003|Up To Week 12|Adverse Event|0|||
23626642|NCT00550446|66020351|FG004|Up To Week 12|Adverse Event|2|||
23626643|NCT00550446|66020352|FG005|Up To Week 12|Adverse Event|2|||
23626644|NCT00550446|66020353|FG006|Up To Week 12|Adverse Event|1|||
23626645|NCT00550446|66020354|FG007|Up To Week 12|Adverse Event|0|||
23626646|NCT00550446|66020355|FG008|Up To Week 12|Adverse Event|0|||
23626647|NCT00550446|66020356|FG009|Up To Week 12|Adverse Event|0|||
23626648|NCT00550446|66020357|FG010|Up To Week 12|Adverse Event|0|||
23626649|NCT00550446|66020347|FG000|Up To Week 12|Lack of Efficacy|3|||
23564664|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564665|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
23564666|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
23626650|NCT00550446|66020348|FG001|Up To Week 12|Lack of Efficacy|1|||
23626651|NCT00550446|66020349|FG002|Up To Week 12|Lack of Efficacy|0|||
23626652|NCT00550446|66020350|FG003|Up To Week 12|Lack of Efficacy|1|||
23626653|NCT00550446|66020351|FG004|Up To Week 12|Lack of Efficacy|0|||
23626654|NCT00550446|66020352|FG005|Up To Week 12|Lack of Efficacy|3|||
23626655|NCT00550446|66020353|FG006|Up To Week 12|Lack of Efficacy|3|||
23626656|NCT00550446|66020354|FG007|Up To Week 12|Lack of Efficacy|0|||
23626657|NCT00550446|66020355|FG008|Up To Week 12|Lack of Efficacy|0|||
23626658|NCT00550446|66020356|FG009|Up To Week 12|Lack of Efficacy|0|||
23626659|NCT00550446|66020357|FG010|Up To Week 12|Lack of Efficacy|0|||
23626660|NCT00550446|66020347|FG000|Up To Week 12|Lost to Follow-up|0|||
23626661|NCT00550446|66020348|FG001|Up To Week 12|Lost to Follow-up|1|||
23626662|NCT00550446|66020349|FG002|Up To Week 12|Lost to Follow-up|0|||
23626663|NCT00550446|66020350|FG003|Up To Week 12|Lost to Follow-up|0|||
23626664|NCT00550446|66020351|FG004|Up To Week 12|Lost to Follow-up|1|||
23626665|NCT00550446|66020352|FG005|Up To Week 12|Lost to Follow-up|1|||
23626666|NCT00550446|66020353|FG006|Up To Week 12|Lost to Follow-up|2|||
23626667|NCT00550446|66020354|FG007|Up To Week 12|Lost to Follow-up|0|||
23626668|NCT00550446|66020355|FG008|Up To Week 12|Lost to Follow-up|0|||
23626669|NCT00550446|66020356|FG009|Up To Week 12|Lost to Follow-up|0|||
23626670|NCT00550446|66020357|FG010|Up To Week 12|Lost to Follow-up|0|||
23827147|NCT01524978|66745318|FG000|Overall Study|Lost to Follow-up|0|||
23827148|NCT01524978|66745319|FG001|Overall Study|Lost to Follow-up|0|||
23626671|NCT00550446|66020347|FG000|Up To Week 12|Withdrawal by Subject|2|||
23626672|NCT00550446|66020348|FG001|Up To Week 12|Withdrawal by Subject|0|||
23626673|NCT00550446|66020349|FG002|Up To Week 12|Withdrawal by Subject|3|||
23626674|NCT00550446|66020350|FG003|Up To Week 12|Withdrawal by Subject|2|||
23827149|NCT01524978|66745320|FG002|Overall Study|Lost to Follow-up|3|||
23626675|NCT00550446|66020351|FG004|Up To Week 12|Withdrawal by Subject|0|||
23626676|NCT00550446|66020352|FG005|Up To Week 12|Withdrawal by Subject|1|||
23626677|NCT00550446|66020353|FG006|Up To Week 12|Withdrawal by Subject|3|||
23827150|NCT01524978|66745321|FG003|Overall Study|Lost to Follow-up|0|||
23626678|NCT00550446|66020354|FG007|Up To Week 12|Withdrawal by Subject|0|||
23626679|NCT00550446|66020355|FG008|Up To Week 12|Withdrawal by Subject|0|||
23626680|NCT00550446|66020356|FG009|Up To Week 12|Withdrawal by Subject|0|||
23626681|NCT00550446|66020357|FG010|Up To Week 12|Withdrawal by Subject|0|||
23626682|NCT00550446|66020347|FG000|Up To Week 12|Other|3|||
23626683|NCT00550446|66020348|FG001|Up To Week 12|Other|0|||
23626684|NCT00550446|66020349|FG002|Up To Week 12|Other|0|||
23564667|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
23564668|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
23564669|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
23564670|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
23564671|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
23564672|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
23564673|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
23564674|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
23564675|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
23564676|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
23564677|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
23564678|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
23564679|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
23564680|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
23564681|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564682|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
23564683|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
23564684|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
23564685|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
23564686|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564687|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564688|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564689|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564690|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
23564691|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
23564692|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564693|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564694|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564695|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564696|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564697|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564698|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23564699|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564700|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23564701|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
23626685|NCT00550446|66020350|FG003|Up To Week 12|Other|0|||
23626686|NCT00550446|66020351|FG004|Up To Week 12|Other|0|||
23626687|NCT00550446|66020352|FG005|Up To Week 12|Other|1|||
23626688|NCT00550446|66020353|FG006|Up To Week 12|Other|4|||
23626689|NCT00550446|66020354|FG007|Up To Week 12|Other|0|||
23626690|NCT00550446|66020355|FG008|Up To Week 12|Other|0|||
23626691|NCT00550446|66020356|FG009|Up To Week 12|Other|0|||
23626692|NCT00550446|66020357|FG010|Up To Week 12|Other|0|||
23626693|NCT00550446|66020347|FG000|Up To Week 12|Randomized not treated|0|||
23626694|NCT00550446|66020348|FG001|Up To Week 12|Randomized not treated|1|||
23626695|NCT00550446|66020349|FG002|Up To Week 12|Randomized not treated|1|||
23626696|NCT00550446|66020350|FG003|Up To Week 12|Randomized not treated|0|||
23626697|NCT00550446|66020351|FG004|Up To Week 12|Randomized not treated|0|||
23626698|NCT00550446|66020352|FG005|Up To Week 12|Randomized not treated|0|||
23626699|NCT00550446|66020353|FG006|Up To Week 12|Randomized not treated|0|||
23759583|NCT01270841|66498223|FG001|Overall Study|Did not qualify|3|||
23759584|NCT01270841|66498224|FG002|Overall Study|Did not qualify|4|||
23759585|NCT01270841|66498225|FG003|Overall Study|Did not qualify|5|||
23759586|NCT01270841|66498222|FG000|Overall Study|Protocol Violation|1|||
23759587|NCT01270841|66498223|FG001|Overall Study|Protocol Violation|5|||
23759588|NCT01270841|66498224|FG002|Overall Study|Protocol Violation|0|||
23626700|NCT00550446|66020354|FG007|Up To Week 12|Randomized not treated|0|||
23759589|NCT01270841|66498225|FG003|Overall Study|Protocol Violation|0|||
23626701|NCT00550446|66020355|FG008|Up To Week 12|Randomized not treated|0|||
23626702|NCT00550446|66020356|FG009|Up To Week 12|Randomized not treated|0|||
23626703|NCT00550446|66020357|FG010|Up To Week 12|Randomized not treated|0|||
23626704|NCT00550446|66020347|FG000|Post Week 12|Adverse Event|2|||
23626705|NCT00550446|66020348|FG001|Post Week 12|Adverse Event|1|||
23626706|NCT00550446|66020349|FG002|Post Week 12|Adverse Event|1|||
23626707|NCT00550446|66020350|FG003|Post Week 12|Adverse Event|1|||
23759590|NCT01270841|66498222|FG000|Overall Study|Enrolled in error|0|||
23759591|NCT01270841|66498223|FG001|Overall Study|Enrolled in error|1|||
23626708|NCT00550446|66020351|FG004|Post Week 12|Adverse Event|1|||
23626709|NCT00550446|66020352|FG005|Post Week 12|Adverse Event|1|||
23626710|NCT00550446|66020353|FG006|Post Week 12|Adverse Event|0|||
23626711|NCT00550446|66020354|FG007|Post Week 12|Adverse Event|0|||
23626712|NCT00550446|66020355|FG008|Post Week 12|Adverse Event|0|||
23626713|NCT00550446|66020356|FG009|Post Week 12|Adverse Event|4|||
23626714|NCT00550446|66020357|FG010|Post Week 12|Adverse Event|0|||
23626715|NCT00550446|66020347|FG000|Post Week 12|Lack of Efficacy|0|||
23626716|NCT00550446|66020348|FG001|Post Week 12|Lack of Efficacy|0|||
23626717|NCT00550446|66020349|FG002|Post Week 12|Lack of Efficacy|1|||
23626718|NCT00550446|66020350|FG003|Post Week 12|Lack of Efficacy|0|||
23626719|NCT00550446|66020351|FG004|Post Week 12|Lack of Efficacy|0|||
23626720|NCT00550446|66020352|FG005|Post Week 12|Lack of Efficacy|0|||
23626721|NCT00550446|66020353|FG006|Post Week 12|Lack of Efficacy|0|||
23626722|NCT00550446|66020354|FG007|Post Week 12|Lack of Efficacy|1|||
23626723|NCT00550446|66020355|FG008|Post Week 12|Lack of Efficacy|1|||
23626724|NCT00550446|66020356|FG009|Post Week 12|Lack of Efficacy|2|||
23626725|NCT00550446|66020357|FG010|Post Week 12|Lack of Efficacy|1|||
23626726|NCT00550446|66020347|FG000|Post Week 12|Lost to Follow-up|0|||
23626727|NCT00550446|66020348|FG001|Post Week 12|Lost to Follow-up|0|||
23626728|NCT00550446|66020349|FG002|Post Week 12|Lost to Follow-up|1|||
23626729|NCT00550446|66020350|FG003|Post Week 12|Lost to Follow-up|1|||
23626730|NCT00550446|66020351|FG004|Post Week 12|Lost to Follow-up|0|||
23626731|NCT00550446|66020352|FG005|Post Week 12|Lost to Follow-up|0|||
23626732|NCT00550446|66020353|FG006|Post Week 12|Lost to Follow-up|1|||
23626733|NCT00550446|66020354|FG007|Post Week 12|Lost to Follow-up|0|||
23626734|NCT00550446|66020355|FG008|Post Week 12|Lost to Follow-up|0|||
23626735|NCT00550446|66020356|FG009|Post Week 12|Lost to Follow-up|0|||
23626736|NCT00550446|66020357|FG010|Post Week 12|Lost to Follow-up|0|||
23626737|NCT00550446|66020347|FG000|Post Week 12|Withdrawal by Subject|0|||
23626738|NCT00550446|66020348|FG001|Post Week 12|Withdrawal by Subject|0|||
23626739|NCT00550446|66020349|FG002|Post Week 12|Withdrawal by Subject|0|||
23626740|NCT00550446|66020350|FG003|Post Week 12|Withdrawal by Subject|0|||
23626741|NCT00550446|66020351|FG004|Post Week 12|Withdrawal by Subject|1|||
23626742|NCT00550446|66020352|FG005|Post Week 12|Withdrawal by Subject|0|||
23626743|NCT00550446|66020353|FG006|Post Week 12|Withdrawal by Subject|0|||
23626744|NCT00550446|66020354|FG007|Post Week 12|Withdrawal by Subject|0|||
23626745|NCT00550446|66020355|FG008|Post Week 12|Withdrawal by Subject|0|||
23626746|NCT00550446|66020356|FG009|Post Week 12|Withdrawal by Subject|0|||
23626747|NCT00550446|66020357|FG010|Post Week 12|Withdrawal by Subject|0|||
23626748|NCT00550446|66020347|FG000|Post Week 12|Other|1|||
23626749|NCT00550446|66020348|FG001|Post Week 12|Other|1|||
23626750|NCT00550446|66020349|FG002|Post Week 12|Other|0|||
23626751|NCT00550446|66020350|FG003|Post Week 12|Other|1|||
23626752|NCT00550446|66020351|FG004|Post Week 12|Other|0|||
23626753|NCT00550446|66020352|FG005|Post Week 12|Other|0|||
23626754|NCT00550446|66020353|FG006|Post Week 12|Other|1|||
23626755|NCT00550446|66020354|FG007|Post Week 12|Other|0|||
23626756|NCT00550446|66020355|FG008|Post Week 12|Other|1|||
23626757|NCT00550446|66020356|FG009|Post Week 12|Other|1|||
23626758|NCT00550446|66020357|FG010|Post Week 12|Other|0|||
23626759|NCT02132117|66020360|FG000|Overall Study|Adverse Event|6|||
23626760|NCT02132117|66020361|FG001|Overall Study|Adverse Event|1|||
23626761|NCT02132117|66020360|FG000|Overall Study|Lost to Follow-up|2|||
23626762|NCT02132117|66020361|FG001|Overall Study|Lost to Follow-up|2|||
23626763|NCT02132117|66020360|FG000|Overall Study|Personal Reasons|1|||
23564702|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564703|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564704|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564705|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564706|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
23564707|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564708|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564709|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564710|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564711|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564712|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564713|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
23626764|NCT02132117|66020361|FG001|Overall Study|Personal Reasons|2|||
23626765|NCT02132117|66020360|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23626766|NCT02132117|66020361|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23626767|NCT04156399|66020363|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
23626768|NCT04156399|66020363|FG000|Overall Study|study suspension due to COVID pandemic|3|||
23626769|NCT01790295|66020366|FG000|Overall Study|Adverse Event|1|||
23626770|NCT01790295|66020366|FG000|Overall Study|Death|4|||
23626771|NCT01790295|66020366|FG000|Overall Study|Lack of Efficacy|2|||
23626772|NCT01790295|66020366|FG000|Overall Study|Study closure|4|||
23626773|NCT00573651|66020367|FG000|Overall Study|Lost to Follow-up|3|||
23626774|NCT00573651|66020367|FG000|Overall Study|Withdrawal by Subject|1|||
23626775|NCT00224029|66020370|FG000|Overall Study|Lost to Follow-up|1|||
23626776|NCT00224029|66020370|FG000|Overall Study|Withdrawal by Subject|4|||
23759592|NCT01270841|66498224|FG002|Overall Study|Enrolled in error|0|||
23564714|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564715|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564716|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564717|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564718|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
23564719|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564720|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
23564721|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564722|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564723|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564724|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564725|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564726|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
23564727|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
23564728|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
23564729|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Death|0|||
23564730|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Death|0|||
23564731|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Death|0|||
23564732|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Death|0|||
23564733|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Death|0|||
23564734|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Death|0|||
23626777|NCT00224029|66020370|FG000|Overall Study|Other|1|||
23626778|NCT01150045|66020373|FG000|Overall Study|Protocol Violation|0|||
23759593|NCT01270841|66498225|FG003|Overall Study|Enrolled in error|0|||
23759594|NCT00185211|66498226|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
23759595|NCT00185211|66498227|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
23759596|NCT00185211|66498226|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
23759597|NCT00185211|66498227|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
23759598|NCT00185211|66498226|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
23759599|NCT00185211|66498227|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
23759600|NCT00185211|66498226|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
23759601|NCT00185211|66498227|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
23759602|NCT00185211|66498226|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
23759603|NCT00185211|66498227|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
23759604|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
23759605|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
23759606|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
23759607|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
23759608|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
23759609|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
23759610|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
23759611|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
23759612|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
23759613|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
23759614|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
23759615|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
23759616|NCT00185211|66498226|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
23759617|NCT00185211|66498227|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
23759618|NCT00420849|66498228|FG000|Overall Study|Lack of Efficacy|154|||
23759619|NCT00420849|66498228|FG000|Overall Study|Adverse Event|107|||
23759620|NCT00420849|66498228|FG000|Overall Study|Withdrawal by Subject|28|||
23759621|NCT00420849|66498228|FG000|Overall Study|Death|18|||
23759622|NCT00420849|66498228|FG000|Overall Study|Other|14|||
23759623|NCT00420849|66498228|FG000|Overall Study|Transplant|8|||
23759624|NCT00420849|66498228|FG000|Overall Study|Protocol Violation|1|||
23759625|NCT00420849|66498228|FG000|Overall Study|Lost to Follow-up|1|||
23759626|NCT02082912|66498229|FG000|Overall Study|Physician Decision|0|||
23759627|NCT02082912|66498230|FG001|Overall Study|Physician Decision|1|||
23759628|NCT01901146|66498231|FG000|Neoadjuvant Phase|Death|1|||
23759629|NCT01901146|66498232|FG001|Neoadjuvant Phase|Death|2|||
23564735|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Death|1|||
23564736|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Death|2|||
23564737|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564738|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23626779|NCT01150045|66020374|FG001|Overall Study|Protocol Violation|1|||
23626780|NCT01150045|66020375|FG002|Overall Study|Protocol Violation|0|||
23759630|NCT01901146|66498233|FG002|Neoadjuvant Phase|Death|0|||
23759631|NCT01901146|66498234|FG003|Neoadjuvant Phase|Death|0|||
23759632|NCT01901146|66498235|FG004|Neoadjuvant Phase|Death|0|||
23759633|NCT01901146|66498231|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
23564739|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564740|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564741|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564742|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564743|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564744|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564745|NCT01370005|65796489|FG000|Overall Study|Not treated|1|||
23564746|NCT01370005|65796490|FG001|Overall Study|Not treated|0|||
23564747|NCT01370005|65796491|FG002|Overall Study|Not treated|0|||
23564748|NCT01370005|65796489|FG000|Overall Study|Adverse Event|5|||
23564749|NCT01370005|65796490|FG001|Overall Study|Adverse Event|5|||
23564750|NCT01370005|65796491|FG002|Overall Study|Adverse Event|6|||
23564751|NCT01370005|65796489|FG000|Overall Study|Lack of Efficacy|1|||
23564752|NCT01370005|65796490|FG001|Overall Study|Lack of Efficacy|0|||
23564753|NCT01370005|65796491|FG002|Overall Study|Lack of Efficacy|0|||
23626781|NCT01150045|66020376|FG003|Overall Study|Protocol Violation|1|||
23626782|NCT00368641|66020377|FG000|Overall Study|Adverse Event|2|||
23626783|NCT00368641|66020378|FG001|Overall Study|Adverse Event|1|||
23626784|NCT00368641|66020377|FG000|Overall Study|Death|1|||
23626785|NCT00368641|66020378|FG001|Overall Study|Death|0|||
23626786|NCT00368641|66020377|FG000|Overall Study|Withdrawal by Subject|1|||
23626787|NCT00368641|66020378|FG001|Overall Study|Withdrawal by Subject|0|||
23626788|NCT00368641|66020377|FG000|Overall Study|Sponsor decision to terminate study|2|||
23626789|NCT00368641|66020378|FG001|Overall Study|Sponsor decision to terminate study|5|||
23626790|NCT02402322|66020381|FG000|Pretreatment|Withdrawal by Subject|3|||
23626791|NCT02402322|66020382|FG001|Pretreatment|Withdrawal by Subject|1|||
23626792|NCT02402322|66020383|FG002|Pretreatment|Withdrawal by Subject|1|||
23626793|NCT02402322|66020381|FG000|Follow-up|Withdrawal by Subject|6|||
23626794|NCT02402322|66020382|FG001|Follow-up|Withdrawal by Subject|3|||
23626795|NCT02402322|66020383|FG002|Follow-up|Withdrawal by Subject|24|||
23626796|NCT02296892|66020384|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
23626797|NCT02296892|66020385|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
23626798|NCT02296892|66020386|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
23626799|NCT02296892|66020384|FG000|Overall Study|Lost to Follow-up|5|||
23626800|NCT02296892|66020385|FG001|Overall Study|Lost to Follow-up|0|||
23626801|NCT02296892|66020386|FG002|Overall Study|Lost to Follow-up|1|||
23626802|NCT01807182|66020387|FG000|Overall Study|Death|1|||
23626803|NCT01807182|66020387|FG000|Overall Study|New therapy|1|||
23626804|NCT01807182|66020387|FG000|Overall Study|Moved to hospice care|1|||
23626805|NCT00025662|66020392|FG000|Overall Study|Withdrawal by Subject|2|||
23759634|NCT01901146|66498232|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
23759635|NCT01901146|66498233|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23759636|NCT01901146|66498234|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23759637|NCT01901146|66498235|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23759638|NCT01901146|66498231|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
23759639|NCT01901146|66498232|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
23759640|NCT01901146|66498233|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
23759641|NCT01901146|66498234|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
23759642|NCT01901146|66498235|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
23759643|NCT01901146|66498231|FG000|Neoadjuvant Phase|Physician Decision|1|||
23759644|NCT01901146|66498232|FG001|Neoadjuvant Phase|Physician Decision|2|||
23759645|NCT01901146|66498233|FG002|Neoadjuvant Phase|Physician Decision|0|||
23759646|NCT01901146|66498234|FG003|Neoadjuvant Phase|Physician Decision|0|||
23759647|NCT01901146|66498235|FG004|Neoadjuvant Phase|Physician Decision|0|||
23759648|NCT01901146|66498231|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
23759649|NCT01901146|66498232|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
23759650|NCT01901146|66498233|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
23759651|NCT01901146|66498234|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
23759652|NCT01901146|66498235|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
23441502|NCT00874848|65358527|FG001|Overall Study|Noncompliance|1|||
23564754|NCT01370005|65796489|FG000|Overall Study|Non compliant with protocol|0|||
23564755|NCT01370005|65796490|FG001|Overall Study|Non compliant with protocol|1|||
23564756|NCT01370005|65796491|FG002|Overall Study|Non compliant with protocol|2|||
23564757|NCT01370005|65796489|FG000|Overall Study|Lost to Follow-up|1|||
23626806|NCT00025662|66020392|FG000|Overall Study|Technical failure of manipulation|1|||
23626807|NCT01056263|66020395|FG000|Overall Study|Adverse Event|12|||
23626808|NCT01056263|66020395|FG000|Overall Study|Death|1|||
23626809|NCT01056263|66020395|FG000|Overall Study|Withdrawal by Subject|1|||
23626810|NCT01056263|66020395|FG000|Overall Study|Lack of Efficacy|29|||
23626811|NCT01056263|66020395|FG000|Overall Study|Progressive disease|2|||
23759653|NCT01901146|66498231|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23759654|NCT01901146|66498232|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
23827151|NCT01524978|66745322|FG004|Overall Study|Lost to Follow-up|1|||
23759655|NCT01901146|66498233|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23759656|NCT01901146|66498234|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23759657|NCT01901146|66498235|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23564758|NCT01370005|65796490|FG001|Overall Study|Lost to Follow-up|1|||
23564759|NCT01370005|65796491|FG002|Overall Study|Lost to Follow-up|1|||
23759658|NCT01901146|66498231|FG000|Adjuvant Phase|Other|0|||
23759659|NCT01901146|66498232|FG001|Adjuvant Phase|Other|0|||
23759660|NCT01901146|66498233|FG002|Adjuvant Phase|Other|1|||
23759661|NCT01901146|66498234|FG003|Adjuvant Phase|Other|0|||
23759662|NCT01901146|66498235|FG004|Adjuvant Phase|Other|0|||
23759663|NCT01901146|66498231|FG000|Adjuvant Phase|Death|0|||
23759664|NCT01901146|66498232|FG001|Adjuvant Phase|Death|0|||
23759665|NCT01901146|66498233|FG002|Adjuvant Phase|Death|0|||
23759666|NCT01901146|66498234|FG003|Adjuvant Phase|Death|0|||
23759667|NCT01901146|66498235|FG004|Adjuvant Phase|Death|3|||
23759668|NCT01901146|66498231|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
23759669|NCT01901146|66498232|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
23759670|NCT01901146|66498233|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
23759671|NCT01901146|66498234|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
23759672|NCT01901146|66498235|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
23759673|NCT01901146|66498231|FG000|Adjuvant Phase|Physician Decision|0|||
23564760|NCT01370005|65796489|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
23564761|NCT01370005|65796490|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
23564762|NCT01370005|65796491|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
23564763|NCT01370005|65796489|FG000|Overall Study|Other reason not defined above|3|||
23564764|NCT01370005|65796490|FG001|Overall Study|Other reason not defined above|0|||
23759674|NCT01901146|66498232|FG001|Adjuvant Phase|Physician Decision|0|||
23759675|NCT01901146|66498233|FG002|Adjuvant Phase|Physician Decision|9|||
23759676|NCT01901146|66498234|FG003|Adjuvant Phase|Physician Decision|2|||
23759677|NCT01901146|66498235|FG004|Adjuvant Phase|Physician Decision|4|||
23759678|NCT01901146|66498231|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
23759679|NCT01901146|66498232|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
23759680|NCT01901146|66498233|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
23759681|NCT01901146|66498234|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
23759682|NCT01901146|66498235|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
23759683|NCT03372083|66498240|FG000|Overall Study|Adverse Event|3|||
23759684|NCT03372083|66498240|FG000|Overall Study|Physician Decision|1|||
23759685|NCT03372083|66498240|FG000|Overall Study|Withdrawal by Subject|1|||
23759686|NCT02402933|66498241|FG000|Overall Study|Withdrawal by Subject|4|||
23759687|NCT02402933|66498241|FG000|Overall Study|Discontinued; Site Termination|10|||
23759688|NCT00789828|66498242|FG000|Core Period (48 Weeks)|Administrative problems|0|||
23759689|NCT00789828|66498243|FG001|Core Period (48 Weeks)|Administrative problems|1|||
23759690|NCT00789828|66498242|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
23759691|NCT00789828|66498243|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
23759692|NCT00789828|66498242|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
23759693|NCT00789828|66498243|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
23759694|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
23759695|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
23759696|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
23759697|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
23759698|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
23759699|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
23759700|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
23759701|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
23759702|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Death|1|||
23759703|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Death|0|||
23759704|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
23759705|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
23759706|NCT00789828|66498242|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
23759707|NCT00789828|66498243|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
23759708|NCT02280356|66498246|FG000|Overall Study|Not Treated|2|||
23759709|NCT02280356|66498246|FG000|Overall Study|Withdrawal by Subject|1|||
23759710|NCT02280356|66498246|FG000|Overall Study|Not evaluable|2|||
23759711|NCT00096486|66498247|FG000|Overall Study|Withdrawal by Subject|0|||
23759712|NCT00096486|66498248|FG001|Overall Study|Withdrawal by Subject|0|||
23759713|NCT00096486|66498249|FG002|Overall Study|Withdrawal by Subject|1|||
23759714|NCT00096486|66498250|FG003|Overall Study|Withdrawal by Subject|1|||
23759715|NCT00096486|66498247|FG000|Overall Study|Not Treated|0|||
23759716|NCT00096486|66498248|FG001|Overall Study|Not Treated|0|||
23759717|NCT00096486|66498249|FG002|Overall Study|Not Treated|1|||
23759718|NCT00096486|66498250|FG003|Overall Study|Not Treated|1|||
23759719|NCT00299728|66498251|FG000|Overall Study|Lost to Follow-up|0|||
23759720|NCT00299728|66498252|FG001|Overall Study|Lost to Follow-up|1|||
23759721|NCT00299728|66498251|FG000|Overall Study|Withdrawal by Subject|0|||
23759722|NCT00299728|66498252|FG001|Overall Study|Withdrawal by Subject|1|||
23759723|NCT00299728|66498251|FG000|Overall Study|Progressive disease|0|||
23759724|NCT00299728|66498252|FG001|Overall Study|Progressive disease|1|||
23759725|NCT01689974|66498253|FG000|Overall Study|Termination of Study|5|||
23759726|NCT01689974|66498254|FG001|Overall Study|Termination of Study|5|||
23759727|NCT01507831|66498258|FG000|Overall Study|Randomized but not treated|0|||
23759728|NCT01507831|66498259|FG001|Overall Study|Randomized but not treated|3|||
23759729|NCT01507831|66498258|FG000|Overall Study|Adverse Event|48|||
23759730|NCT01507831|66498259|FG001|Overall Study|Adverse Event|113|||
23759731|NCT01507831|66498258|FG000|Overall Study|Death|6|||
23759732|NCT01507831|66498259|FG001|Overall Study|Death|2|||
23827152|NCT01524978|66745323|FG005|Overall Study|Lost to Follow-up|1|||
23827153|NCT01524978|66745324|FG006|Overall Study|Lost to Follow-up|2|||
23441503|NCT00874848|65358526|FG000|Overall Study|Failure to comply with protocol|0|||
23441504|NCT00874848|65358527|FG001|Overall Study|Failure to comply with protocol|1|||
23441505|NCT00874848|65358526|FG000|Overall Study|Physician Decision|0|||
23441506|NCT00874848|65358527|FG001|Overall Study|Physician Decision|2|||
23759733|NCT01507831|66498258|FG000|Overall Study|Poor compliance to protocol|38|||
23759734|NCT01507831|66498259|FG001|Overall Study|Poor compliance to protocol|60|||
23759735|NCT01507831|66498258|FG000|Overall Study|Physician Decision|0|||
23827154|NCT01524978|66745325|FG007|Overall Study|Lost to Follow-up|0|||
23827155|NCT01524978|66745326|FG008|Overall Study|Lost to Follow-up|1|||
23827156|NCT01524978|66745327|FG009|Overall Study|Lost to Follow-up|1|||
23827157|NCT01524978|66745328|FG010|Overall Study|Lost to Follow-up|1|||
23827158|NCT01524978|66745318|FG000|Overall Study|Death|34|||
23827159|NCT01524978|66745319|FG001|Overall Study|Death|2|||
23827160|NCT01524978|66745320|FG002|Overall Study|Death|5|||
23827161|NCT01524978|66745321|FG003|Overall Study|Death|24|||
23827162|NCT01524978|66745322|FG004|Overall Study|Death|4|||
23827163|NCT01524978|66745323|FG005|Overall Study|Death|4|||
23827164|NCT01524978|66745324|FG006|Overall Study|Death|1|||
23827165|NCT01524978|66745325|FG007|Overall Study|Death|9|||
23827166|NCT01524978|66745326|FG008|Overall Study|Death|5|||
23441507|NCT03221842|65358530|FG000|Period 1 (Open-label)|Adverse Event|4|||
23441508|NCT03221842|65358531|FG001|Period 1 (Open-label)|Adverse Event|0|||
23441509|NCT03221842|65358530|FG000|Period 1 (Open-label)|Physician Decision|2|||
23441510|NCT03221842|65358531|FG001|Period 1 (Open-label)|Physician Decision|0|||
23441511|NCT03221842|65358530|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
23441512|NCT03221842|65358531|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
23441513|NCT03221842|65358530|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
23441514|NCT03221842|65358531|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
23441515|NCT03221842|65358530|FG000|Period 1 (Open-label)|Other|2|||
23441516|NCT03221842|65358531|FG001|Period 1 (Open-label)|Other|0|||
23441517|NCT03221842|65358530|FG000|Period 2 (Randomized, Blinded)|Death|0|||
23441518|NCT03221842|65358531|FG001|Period 2 (Randomized, Blinded)|Death|1|||
23441519|NCT03221842|65358530|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
23441520|NCT03221842|65358531|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
23441521|NCT02881762|65358532|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23441522|NCT02881762|65358533|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23441523|NCT02522325|65358534|FG000|Overall Study|Adverse Event|0|||
23827167|NCT01524978|66745327|FG009|Overall Study|Death|6|||
23564765|NCT01370005|65796491|FG002|Overall Study|Other reason not defined above|2|||
23564766|NCT01642602|65796492|FG000|Overall Study|Adverse Event|2|||
23441524|NCT02522325|65358535|FG001|Overall Study|Adverse Event|1|||
23564767|NCT01396395|65796493|FG000|Overall Study|Withdrawal by Subject|10|||
23564768|NCT01396395|65796494|FG001|Overall Study|Withdrawal by Subject|12|||
23564769|NCT01396395|65796493|FG000|Overall Study|Protocol Violation|3|||
23564770|NCT01396395|65796494|FG001|Overall Study|Protocol Violation|1|||
23564771|NCT01396395|65796493|FG000|Overall Study|Adverse Event|10|||
23564772|NCT01396395|65796494|FG001|Overall Study|Adverse Event|2|||
23564773|NCT01396395|65796493|FG000|Overall Study|Lost to Follow-up|17|||
23564774|NCT01396395|65796494|FG001|Overall Study|Lost to Follow-up|11|||
23564775|NCT01396395|65796493|FG000|Overall Study|Other|0|||
23564776|NCT01396395|65796494|FG001|Overall Study|Other|1|||
23564777|NCT02044458|65796497|FG000|Overall Study|Protocol Violation|3|||
23564778|NCT02044458|65796498|FG001|Overall Study|Protocol Violation|8|||
23564779|NCT03351738|65796499|FG000|Overall Study|Withdrawal by Subject|0|||
23564780|NCT03351738|65796500|FG001|Overall Study|Withdrawal by Subject|1|||
23564781|NCT03351738|65796501|FG002|Overall Study|Withdrawal by Subject|0|||
23564782|NCT03351738|65796502|FG003|Overall Study|Withdrawal by Subject|1|||
23564783|NCT03351738|65796503|FG004|Overall Study|Withdrawal by Subject|0|||
23564784|NCT03351738|65796504|FG005|Overall Study|Withdrawal by Subject|0|||
23564785|NCT00747123|65796510|FG000|Overall Study|Investigator's request|0|||
23564786|NCT00747123|65796511|FG001|Overall Study|Investigator's request|0|||
23564787|NCT00747123|65796512|FG002|Overall Study|Investigator's request|1|||
23626812|NCT01056263|66020395|FG000|Overall Study|Neoplasm progression|1|||
23626813|NCT01056263|66020395|FG000|Overall Study|Objective progression or relapse|1|||
23626814|NCT01056263|66020395|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
23564788|NCT00747123|65796513|FG003|Overall Study|Investigator's request|0|||
23564789|NCT00747123|65796510|FG000|Overall Study|Withdrew consent|0|||
23564790|NCT00747123|65796511|FG001|Overall Study|Withdrew consent|1|||
23564791|NCT00747123|65796512|FG002|Overall Study|Withdrew consent|0|||
23564792|NCT00747123|65796513|FG003|Overall Study|Withdrew consent|0|||
23564793|NCT00747123|65796510|FG000|Overall Study|Adverse Event|0|||
23626815|NCT00760513|66020396|FG000|Overall Study|Withdrawal by Subject|5|||
23626816|NCT00760513|66020397|FG001|Overall Study|Withdrawal by Subject|7|||
23626817|NCT01209598|66020400|FG000|Overall Study|Withdrawal by Subject|1|||
23626818|NCT01209598|66020401|FG001|Overall Study|Withdrawal by Subject|0|||
23626819|NCT00559377|66020403|FG000|Overall Study|Withdrawal by Subject|9|||
23626820|NCT03448536|66020406|FG000|Overall Study|Protocol Violation|2|||
23626821|NCT03448536|66020407|FG001|Overall Study|Protocol Violation|0|||
23626822|NCT03448536|66020406|FG000|Overall Study|Pregnancy|1|||
23626823|NCT03448536|66020407|FG001|Overall Study|Pregnancy|0|||
23626824|NCT03448536|66020406|FG000|Overall Study|Withdrawal by Subject|1|||
23626825|NCT03448536|66020407|FG001|Overall Study|Withdrawal by Subject|2|||
23626826|NCT03448536|66020406|FG000|Overall Study|Lost to Follow-up|3|||
23626827|NCT03448536|66020407|FG001|Overall Study|Lost to Follow-up|2|||
23626828|NCT03448536|66020406|FG000|Overall Study|Inadequate pain reporter|1|||
23626829|NCT03448536|66020407|FG001|Overall Study|Inadequate pain reporter|0|||
23626830|NCT03448536|66020406|FG000|Overall Study|Other|3|||
23626831|NCT03448536|66020407|FG001|Overall Study|Other|0|||
23626832|NCT03448536|66020406|FG000|Overall Study|Physician Decision|1|||
23626833|NCT03448536|66020407|FG001|Overall Study|Physician Decision|0|||
23626834|NCT02287233|66020408|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
23626835|NCT02287233|66020409|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
23626836|NCT02287233|66020410|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
23626837|NCT02287233|66020408|FG000|Overall Study|Adverse Event Related to Progression|0|||
23626838|NCT02287233|66020409|FG001|Overall Study|Adverse Event Related to Progression|2|||
23626839|NCT02287233|66020410|FG002|Overall Study|Adverse Event Related to Progression|8|||
23626840|NCT02287233|66020408|FG000|Overall Study|Physician Decision|1|||
23626841|NCT02287233|66020409|FG001|Overall Study|Physician Decision|2|||
23759736|NCT01507831|66498259|FG001|Overall Study|Physician Decision|4|||
23759737|NCT01507831|66498258|FG000|Overall Study|Participant moved|5|||
23564794|NCT00747123|65796511|FG001|Overall Study|Adverse Event|1|||
23564795|NCT00747123|65796512|FG002|Overall Study|Adverse Event|0|||
23564796|NCT00747123|65796513|FG003|Overall Study|Adverse Event|1|||
23564797|NCT00879996|65796514|FG000|Overall Study|Lost to Follow-up|7|||
23564798|NCT00879996|65796515|FG001|Overall Study|Lost to Follow-up|6|||
23564799|NCT00879996|65796514|FG000|Overall Study|non-compliance|6|||
23759738|NCT01507831|66498259|FG001|Overall Study|Participant moved|19|||
23759739|NCT01507831|66498258|FG000|Overall Study|Consent withdrawn by participant|34|||
23759740|NCT01507831|66498259|FG001|Overall Study|Consent withdrawn by participant|72|||
23759741|NCT01507831|66498258|FG000|Overall Study|Related to study drug administration|5|||
23759742|NCT01507831|66498259|FG001|Overall Study|Related to study drug administration|14|||
23759743|NCT01507831|66498258|FG000|Overall Study|Last visit outside protocol visit window|51|||
23759744|NCT01507831|66498259|FG001|Overall Study|Last visit outside protocol visit window|143|||
23759745|NCT01507831|66498258|FG000|Overall Study|Selection criteria finally not met|0|||
23759746|NCT01507831|66498259|FG001|Overall Study|Selection criteria finally not met|1|||
23759747|NCT01507831|66498258|FG000|Overall Study|Site closure|0|||
23759748|NCT01507831|66498259|FG001|Overall Study|Site closure|3|||
23759749|NCT01507831|66498258|FG000|Overall Study|Potential lost to follow-up|3|||
23759750|NCT01507831|66498259|FG001|Overall Study|Potential lost to follow-up|0|||
23759751|NCT01507831|66498258|FG000|Overall Study|Other|3|||
23759752|NCT01507831|66498259|FG001|Overall Study|Other|6|||
23759753|NCT03031431|66498260|FG000|Overall Study|Infant removed by maternal request|1|||
23759754|NCT00616928|66498263|FG000|Overall Study|Adverse Event|6|||
23759755|NCT00616928|66498264|FG001|Overall Study|Adverse Event|3|||
23759756|NCT00616928|66498265|FG002|Overall Study|Adverse Event|2|||
23759757|NCT00616928|66498266|FG003|Overall Study|Adverse Event|2|||
23759758|NCT00616928|66498263|FG000|Overall Study|Other|51|||
23759759|NCT00616928|66498264|FG001|Overall Study|Other|8|||
23626842|NCT02287233|66020410|FG002|Overall Study|Physician Decision|4|||
23626843|NCT02287233|66020408|FG000|Overall Study|Progressive Disease with Death|0|||
23626844|NCT02287233|66020409|FG001|Overall Study|Progressive Disease with Death|0|||
23564800|NCT00879996|65796515|FG001|Overall Study|non-compliance|4|||
23626845|NCT02287233|66020410|FG002|Overall Study|Progressive Disease with Death|10|||
23626846|NCT02287233|66020408|FG000|Overall Study|Progressive Disease Without Death|2|||
23626847|NCT02287233|66020409|FG001|Overall Study|Progressive Disease Without Death|3|||
23626848|NCT02287233|66020410|FG002|Overall Study|Progressive Disease Without Death|20|||
23827168|NCT01524978|66745328|FG010|Overall Study|Death|17|||
23827169|NCT03736031|66745329|FG000|Overall Study|Death|2|||
23827170|NCT03736031|66745330|FG001|Overall Study|Death|4|||
23827171|NCT03736031|66745329|FG000|Overall Study|Lost to Follow-up|21|||
23827172|NCT03736031|66745330|FG001|Overall Study|Lost to Follow-up|2|||
23827173|NCT03736031|66745329|FG000|Overall Study|Withdrawal by Subject|9|||
23827174|NCT03736031|66745330|FG001|Overall Study|Withdrawal by Subject|0|||
23827175|NCT00289848|66745333|FG000|Overall Study|Adverse Event|6|||
23827176|NCT00289848|66745334|FG001|Overall Study|Adverse Event|4|||
23827177|NCT00289848|66745333|FG000|Overall Study|Death|1|||
23827178|NCT00289848|66745334|FG001|Overall Study|Death|0|||
23827179|NCT00289848|66745333|FG000|Overall Study|Lack of Efficacy|20|||
23827180|NCT00289848|66745334|FG001|Overall Study|Lack of Efficacy|24|||
23827181|NCT00289848|66745333|FG000|Overall Study|Lost to Follow-up|3|||
23827182|NCT00289848|66745334|FG001|Overall Study|Lost to Follow-up|1|||
23827183|NCT00289848|66745333|FG000|Overall Study|Protocol Violation|5|||
23827184|NCT00289848|66745334|FG001|Overall Study|Protocol Violation|2|||
23827185|NCT00289848|66745333|FG000|Overall Study|Withdrawal by Subject|5|||
23827186|NCT00289848|66745334|FG001|Overall Study|Withdrawal by Subject|11|||
23827187|NCT00289848|66745333|FG000|Overall Study|Patient Moved|6|||
23827188|NCT00289848|66745334|FG001|Overall Study|Patient Moved|2|||
23827189|NCT00289848|66745333|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
23827190|NCT00289848|66745334|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
23827191|NCT02207634|66745335|FG000|Overall Study|Withdrawal by Subject|21|||
23827192|NCT02207634|66745336|FG001|Overall Study|Withdrawal by Subject|31|||
23827193|NCT02207634|66745335|FG000|Overall Study|Lost to Follow-up|1|||
23827194|NCT02207634|66745336|FG001|Overall Study|Lost to Follow-up|0|||
23827195|NCT01289678|66745337|FG000|Overall Study|Physician Decision|6|||
23827196|NCT04324021|66745341|FG000|Overall Study|Adverse Event|1|||
23827197|NCT04324021|66745342|FG001|Overall Study|Adverse Event|0|||
23827198|NCT04324021|66745343|FG002|Overall Study|Adverse Event|0|||
23827199|NCT04324021|66745341|FG000|Overall Study|Lack of Efficacy|0|||
23827200|NCT04324021|66745342|FG001|Overall Study|Lack of Efficacy|0|||
23827201|NCT04324021|66745343|FG002|Overall Study|Lack of Efficacy|1|||
23827202|NCT04324021|66745341|FG000|Overall Study|Death|1|||
23827203|NCT04324021|66745342|FG001|Overall Study|Death|1|||
23827204|NCT04324021|66745343|FG002|Overall Study|Death|0|||
23827205|NCT00908544|66745344|FG000|Overall Study|Withdrawal by Subject|2|||
23827206|NCT00908544|66745345|FG001|Overall Study|Withdrawal by Subject|4|||
23827207|NCT00908544|66745344|FG000|Overall Study|Lack of Efficacy|0|||
23827208|NCT00908544|66745345|FG001|Overall Study|Lack of Efficacy|1|||
23827209|NCT00908544|66745344|FG000|Overall Study|Pregnancy|1|||
23827210|NCT00908544|66745345|FG001|Overall Study|Pregnancy|0|||
23827211|NCT00908544|66745344|FG000|Overall Study|Relocation abroad|1|||
23827212|NCT00908544|66745345|FG001|Overall Study|Relocation abroad|1|||
23827213|NCT00908544|66745344|FG000|Overall Study|Unable to visit sutdy center|1|||
23827214|NCT00908544|66745345|FG001|Overall Study|Unable to visit sutdy center|0|||
23827215|NCT01127256|66745346|FG000|Overall Study|Adverse Event|13|||
23827216|NCT01127256|66745347|FG001|Overall Study|Adverse Event|13|||
23827217|NCT01127256|66745346|FG000|Overall Study|Lack of Efficacy|4|||
23827218|NCT01127256|66745347|FG001|Overall Study|Lack of Efficacy|0|||
23827219|NCT01127256|66745346|FG000|Overall Study|Lost to Follow-up|16|||
23827220|NCT01127256|66745347|FG001|Overall Study|Lost to Follow-up|17|||
23827221|NCT01127256|66745346|FG000|Overall Study|Withdrawal by Subject|5|||
23827222|NCT01127256|66745347|FG001|Overall Study|Withdrawal by Subject|9|||
23827223|NCT01127256|66745346|FG000|Overall Study|Protocol Violation|1|||
23827224|NCT01127256|66745347|FG001|Overall Study|Protocol Violation|0|||
23827225|NCT02556801|66748735|FG000|Overall Study|Lost to Follow-up|1|||
23827226|NCT02556801|66748736|FG001|Overall Study|Lost to Follow-up|0|||
23827227|NCT02556801|66748737|FG002|Overall Study|Lost to Follow-up|2|||
23827228|NCT02556801|66748738|FG003|Overall Study|Lost to Follow-up|0|||
23827229|NCT02556801|66748735|FG000|Overall Study|Withdrawal by Subject|1|||
23827230|NCT02556801|66748736|FG001|Overall Study|Withdrawal by Subject|1|||
23827231|NCT02556801|66748737|FG002|Overall Study|Withdrawal by Subject|1|||
23827232|NCT02556801|66748738|FG003|Overall Study|Withdrawal by Subject|0|||
23827233|NCT02556801|66748735|FG000|Overall Study|Protocol Violation|0|||
23827234|NCT02556801|66748736|FG001|Overall Study|Protocol Violation|3|||
23827235|NCT02556801|66748737|FG002|Overall Study|Protocol Violation|1|||
23827236|NCT02556801|66748738|FG003|Overall Study|Protocol Violation|1|||
23827237|NCT02556801|66748735|FG000|Overall Study|Adverse Event|0|||
23827238|NCT02556801|66748736|FG001|Overall Study|Adverse Event|2|||
23827239|NCT02556801|66748737|FG002|Overall Study|Adverse Event|0|||
23827240|NCT02556801|66748738|FG003|Overall Study|Adverse Event|3|||
23564801|NCT00879996|65796514|FG000|Overall Study|Physician Decision|1|||
23827241|NCT02556801|66748735|FG000|Overall Study|Pregnancy|0|||
23827242|NCT02556801|66748736|FG001|Overall Study|Pregnancy|1|||
23827243|NCT02556801|66748737|FG002|Overall Study|Pregnancy|0|||
23827244|NCT02556801|66748738|FG003|Overall Study|Pregnancy|0|||
23827245|NCT02556801|66748735|FG000|Overall Study|Personal reasons patient|0|||
23827246|NCT02556801|66748736|FG001|Overall Study|Personal reasons patient|0|||
23827247|NCT02556801|66748737|FG002|Overall Study|Personal reasons patient|0|||
23827248|NCT02556801|66748738|FG003|Overall Study|Personal reasons patient|1|||
23827249|NCT04067050|66748739|FG000|One Month|Lost to Follow-up|4|||
23827250|NCT04067050|66748740|FG001|One Month|Lost to Follow-up|0|||
23827251|NCT04067050|66748739|FG000|Two Month|Lost to Follow-up|1|||
23827252|NCT04067050|66748740|FG001|Two Month|Lost to Follow-up|0|||
23827253|NCT04067050|66748739|FG000|Two Month|Adverse Event|1|||
23827254|NCT04067050|66748740|FG001|Two Month|Adverse Event|0|||
23827255|NCT01349192|66748741|FG000|Overall Study|Protocol Violation|0|||
23827256|NCT01349192|66748742|FG001|Overall Study|Protocol Violation|1|||
23827257|NCT01349192|66748741|FG000|Overall Study|Withdrawal by Subject|0|||
23827258|NCT01349192|66748742|FG001|Overall Study|Withdrawal by Subject|2|||
23827259|NCT01349192|66748741|FG000|Overall Study|Lost to Follow-up|1|||
23827260|NCT01349192|66748742|FG001|Overall Study|Lost to Follow-up|3|||
23827261|NCT01349192|66748741|FG000|Overall Study|Failure to adhere to Protocol|2|||
23827262|NCT01349192|66748742|FG001|Overall Study|Failure to adhere to Protocol|0|||
23827263|NCT02208089|66748743|FG000|Overall Study|Withdrawal by Subject|1|||
23827264|NCT02208089|66748744|FG001|Overall Study|Withdrawal by Subject|0|||
23827265|NCT02208089|66748743|FG000|Overall Study|Lost to Follow-up|6|||
23827266|NCT02208089|66748744|FG001|Overall Study|Lost to Follow-up|0|||
23626849|NCT02287233|66020408|FG000|Overall Study|Withdrawal by Subject|1|||
23626850|NCT02287233|66020409|FG001|Overall Study|Withdrawal by Subject|1|||
23626851|NCT02287233|66020410|FG002|Overall Study|Withdrawal by Subject|7|||
23626852|NCT02287233|66020408|FG000|Overall Study|Other|3|||
23626853|NCT02287233|66020409|FG001|Overall Study|Other|0|||
23626854|NCT02287233|66020410|FG002|Overall Study|Other|15|||
23626855|NCT02287233|66020408|FG000|Overall Study|Did Not Receive Treatment|0|||
23626856|NCT02287233|66020409|FG001|Overall Study|Did Not Receive Treatment|0|||
23626857|NCT02287233|66020410|FG002|Overall Study|Did Not Receive Treatment|2|||
23626858|NCT02438371|66020411|FG000|Overall Study|Lost to Follow-up|3|||
23626859|NCT02438371|66020412|FG001|Overall Study|Lost to Follow-up|2|||
23626860|NCT02438371|66020411|FG000|Overall Study|Withdrawal by Subject|1|||
23626861|NCT02438371|66020412|FG001|Overall Study|Withdrawal by Subject|1|||
23626862|NCT01310699|66020417|FG000|Overall Study|Patients did not complete tandem.|4|||
23626863|NCT01310699|66020418|FG001|Overall Study|Patients did not complete tandem.|6|||
23626864|NCT03297398|66020419|FG000|Overall Study|Sponsor's decision|6|||
23626865|NCT03297398|66020420|FG001|Overall Study|Sponsor's decision|9|||
23626866|NCT03297398|66020421|FG002|Overall Study|Sponsor's decision|7|||
23626867|NCT03297398|66020419|FG000|Overall Study|Adverse Event|1|||
23626868|NCT03297398|66020420|FG001|Overall Study|Adverse Event|4|||
23626869|NCT03297398|66020421|FG002|Overall Study|Adverse Event|4|||
23626870|NCT03297398|66020419|FG000|Overall Study|Withdrawal by Subject|1|||
23626871|NCT03297398|66020420|FG001|Overall Study|Withdrawal by Subject|2|||
23626872|NCT03297398|66020421|FG002|Overall Study|Withdrawal by Subject|2|||
23626873|NCT03297398|66020419|FG000|Overall Study|Protocol Violation|0|||
23626874|NCT03297398|66020420|FG001|Overall Study|Protocol Violation|2|||
23626875|NCT03297398|66020421|FG002|Overall Study|Protocol Violation|0|||
23626876|NCT03297398|66020419|FG000|Overall Study|Physician Decision|0|||
23626877|NCT03297398|66020420|FG001|Overall Study|Physician Decision|0|||
23626878|NCT03297398|66020421|FG002|Overall Study|Physician Decision|1|||
23626879|NCT03297398|66020419|FG000|Overall Study|Lost to Follow-up|0|||
23626880|NCT03297398|66020420|FG001|Overall Study|Lost to Follow-up|0|||
23626881|NCT03297398|66020421|FG002|Overall Study|Lost to Follow-up|1|||
23626882|NCT00425607|66020428|FG000|Overall Study|Death|1|||
23626883|NCT00425607|66020428|FG000|Overall Study|Withdrawal by Subject|1|||
23626884|NCT01889069|66020433|FG000|Overall Study|Death|18|||
23827267|NCT00652340|66748747|FG000|Overall Study|Had not progressed.|4|||
23827268|NCT00652340|66748748|FG001|Overall Study|Had not progressed.|3|||
23827269|NCT01866826|66748749|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
23827270|NCT01866826|66748750|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
23441525|NCT01067144|65358536|FG000|Treatment|Did not receive allocated intervention|4|||
23564802|NCT00879996|65796515|FG001|Overall Study|Physician Decision|2|||
23564803|NCT00879996|65796514|FG000|Overall Study|psychiatric problem|0|||
23564804|NCT00879996|65796515|FG001|Overall Study|psychiatric problem|1|||
23564805|NCT00879996|65796514|FG000|Overall Study|put on parole|1|||
23564806|NCT00879996|65796515|FG001|Overall Study|put on parole|0|||
23564807|NCT04399551|65796516|FG000|Overall Study|Adverse Event|15|||
23564808|NCT04399551|65796516|FG000|Overall Study|Withdrawal by Subject|6|||
23564809|NCT04399551|65796516|FG000|Overall Study|Physician Decision|3|||
23564810|NCT04399551|65796516|FG000|Overall Study|Lost to Follow-up|2|||
23564811|NCT04399551|65796516|FG000|Overall Study|Protocol Deviation|2|||
23564812|NCT04631705|65796517|FG000|Overall Study|Withdrawal by Subject|0|||
23564813|NCT04631705|65796518|FG001|Overall Study|Withdrawal by Subject|0|||
23564814|NCT04631705|65796519|FG002|Overall Study|Withdrawal by Subject|0|||
23626885|NCT01889069|66020433|FG000|Overall Study|Progression of Disease|14|||
23827271|NCT01866826|66748749|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
23626886|NCT01889069|66020433|FG000|Overall Study|Lost to Follow-up|6|||
23626887|NCT01889069|66020433|FG000|Overall Study|Other|4|||
23626888|NCT01889069|66020433|FG000|Overall Study|Consent Withdrawal|3|||
23626889|NCT02520310|66020437|FG000|At 6 Months Clinical Follow-up|Death|1|||
23626890|NCT02520310|66020437|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
23626891|NCT02520310|66020437|FG000|AT 3 Year Clinical Follow-up|Death|2|||
23626892|NCT02520310|66020437|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
23626893|NCT02520310|66020437|FG000|AT 4 Year Clinical Follow-up|Death|1|||
23626894|NCT02520310|66020437|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
23626895|NCT02762903|66020438|FG000|Overall Study|Lost to Follow-up|0|||
23626896|NCT02762903|66020439|FG001|Overall Study|Lost to Follow-up|1|||
23626897|NCT01466790|66020440|FG000|Overall Study|Adverse Event|1|||
23626898|NCT01466790|66020441|FG001|Overall Study|Adverse Event|0|||
23626899|NCT01466790|66020442|FG002|Overall Study|Adverse Event|0|||
23626900|NCT01466790|66020443|FG003|Overall Study|Adverse Event|0|||
23626901|NCT01466790|66020444|FG004|Overall Study|Adverse Event|2|||
23626902|NCT01466790|66020445|FG005|Overall Study|Adverse Event|0|||
23626903|NCT01466790|66020446|FG006|Overall Study|Adverse Event|0|||
23626904|NCT01466790|66020447|FG007|Overall Study|Adverse Event|0|||
23626905|NCT01466790|66020440|FG000|Overall Study|Lost to Follow-up|2|||
23626906|NCT01466790|66020441|FG001|Overall Study|Lost to Follow-up|0|||
23626907|NCT01466790|66020442|FG002|Overall Study|Lost to Follow-up|0|||
23564815|NCT04631705|65796520|FG003|Overall Study|Withdrawal by Subject|0|||
23564816|NCT04631705|65796521|FG004|Overall Study|Withdrawal by Subject|0|||
23564817|NCT04631705|65796522|FG005|Overall Study|Withdrawal by Subject|0|||
23564818|NCT04631705|65796523|FG006|Overall Study|Withdrawal by Subject|1|||
23564819|NCT04631705|65796524|FG007|Overall Study|Withdrawal by Subject|0|||
23759760|NCT00616928|66498265|FG002|Overall Study|Other|15|||
23759761|NCT00616928|66498266|FG003|Overall Study|Other|5|||
23759762|NCT00616928|66498263|FG000|Overall Study|Lost to Follow-up|5|||
23759763|NCT00616928|66498264|FG001|Overall Study|Lost to Follow-up|7|||
23759764|NCT00616928|66498265|FG002|Overall Study|Lost to Follow-up|0|||
23759765|NCT00616928|66498266|FG003|Overall Study|Lost to Follow-up|0|||
23759766|NCT00558519|66498294|FG000|Overall Study|Ph+|20|||
23759767|NCT00558519|66498294|FG000|Overall Study|Ineligible|1|||
23759768|NCT00558519|66498294|FG000|Overall Study|Insufficient data|1|||
23827272|NCT01866826|66748750|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
23827273|NCT01866826|66748749|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
23827274|NCT01866826|66748750|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
23827275|NCT00214383|66748751|FG000|Overall Study|Lost to Follow-up|16|||
23827276|NCT00214383|66748752|FG001|Overall Study|Lost to Follow-up|26|||
23827277|NCT02500589|66748758|FG000|Overall Study|Withdrawal by Subject|11|||
23827278|NCT02500589|66748759|FG001|Overall Study|Withdrawal by Subject|14|||
23827279|NCT02500589|66748758|FG000|Overall Study|Lost to Follow-up|10|||
23759769|NCT00558519|66498294|FG000|Overall Study|Never received treatment|1|||
23759770|NCT01484028|66498295|FG000|Period 1|Lost to Follow-up|0|||
23827280|NCT02500589|66748759|FG001|Overall Study|Lost to Follow-up|12|||
23564820|NCT04631705|65796525|FG008|Overall Study|Withdrawal by Subject|0|||
23564821|NCT04858802|65796526|FG000|Overall Study|Lost to Follow-up|1|||
23564822|NCT04858802|65796527|FG001|Overall Study|Lost to Follow-up|1|||
23564823|NCT04858802|65796526|FG000|Overall Study|Withdrawal by Subject|1|||
23564824|NCT04858802|65796527|FG001|Overall Study|Withdrawal by Subject|1|||
23564825|NCT04737109|65796528|FG000|Study Treatment|Disease Progression|5|||
23564826|NCT04737109|65796529|FG001|Study Treatment|Disease Progression|0|||
23564827|NCT04737109|65796530|FG002|Study Treatment|Disease Progression|0|||
23564828|NCT04737109|65796531|FG003|Study Treatment|Disease Progression|0|||
23564829|NCT04737109|65796528|FG000|Study Treatment|Death on study|1|||
23626908|NCT01466790|66020443|FG003|Overall Study|Lost to Follow-up|0|||
23626909|NCT01466790|66020444|FG004|Overall Study|Lost to Follow-up|0|||
23759771|NCT01484028|66498296|FG001|Period 1|Lost to Follow-up|1|||
23759772|NCT01484028|66498297|FG002|Period 1|Lost to Follow-up|0|||
23759773|NCT01484028|66498298|FG003|Period 1|Lost to Follow-up|0|||
23759774|NCT01484028|66498295|FG000|Period 1|Non-Compliance to Protocol|0|||
23564830|NCT04737109|65796529|FG001|Study Treatment|Death on study|0|||
23626910|NCT01466790|66020445|FG005|Overall Study|Lost to Follow-up|0|||
23626911|NCT01466790|66020446|FG006|Overall Study|Lost to Follow-up|0|||
23626912|NCT01466790|66020447|FG007|Overall Study|Lost to Follow-up|0|||
23626913|NCT01466790|66020440|FG000|Overall Study|Withdrawal by Subject|1|||
23759775|NCT01484028|66498296|FG001|Period 1|Non-Compliance to Protocol|1|||
23626914|NCT01466790|66020441|FG001|Overall Study|Withdrawal by Subject|1|||
23759776|NCT01484028|66498297|FG002|Period 1|Non-Compliance to Protocol|0|||
23759777|NCT01484028|66498298|FG003|Period 1|Non-Compliance to Protocol|1|||
23759778|NCT01484028|66498295|FG000|Period 1|Lens Discomfort|0|||
23759779|NCT01484028|66498296|FG001|Period 1|Lens Discomfort|1|||
23759780|NCT01484028|66498297|FG002|Period 1|Lens Discomfort|0|||
23759781|NCT01484028|66498298|FG003|Period 1|Lens Discomfort|0|||
23759782|NCT00845026|66498301|FG000|Study Period III|Adverse Event|23|||
23759783|NCT00845026|66498302|FG001|Study Period III|Adverse Event|19|||
23827281|NCT02500589|66748758|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
23827282|NCT02500589|66748759|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
23827283|NCT02500589|66748758|FG000|Overall Study|Death|7|||
23827284|NCT02500589|66748759|FG001|Overall Study|Death|5|||
23827285|NCT04447040|66748764|FG000|Overall Study|Lost to Follow-up|2|||
23827286|NCT04447040|66748765|FG001|Overall Study|Lost to Follow-up|1|||
23827287|NCT04447040|66748766|FG002|Overall Study|Lost to Follow-up|3|||
23827288|NCT04447040|66748767|FG003|Overall Study|Lost to Follow-up|3|||
23827289|NCT04447040|66748768|FG004|Overall Study|Lost to Follow-up|1|||
23827290|NCT04447040|66748769|FG005|Overall Study|Lost to Follow-up|3|||
23626915|NCT01466790|66020442|FG002|Overall Study|Withdrawal by Subject|0|||
23626916|NCT01466790|66020443|FG003|Overall Study|Withdrawal by Subject|0|||
23626917|NCT01466790|66020444|FG004|Overall Study|Withdrawal by Subject|1|||
23626918|NCT01466790|66020445|FG005|Overall Study|Withdrawal by Subject|0|||
23759784|NCT00845026|66498301|FG000|Study Period III|Perceived lack of efficacy|27|||
23759785|NCT00845026|66498302|FG001|Study Period III|Perceived lack of efficacy|15|||
23564831|NCT04737109|65796530|FG002|Study Treatment|Death on study|0|||
23564832|NCT04737109|65796531|FG003|Study Treatment|Death on study|0|||
23564833|NCT03391960|65796536|FG000|Overall Study|Protocol Violation|0|||
23564834|NCT03391960|65796537|FG001|Overall Study|Protocol Violation|0|||
23564835|NCT02421666|65796539|FG000|6-month Follow-up|Lost to Follow-up|8|||
23564836|NCT02421666|65796540|FG001|6-month Follow-up|Lost to Follow-up|7|||
23564837|NCT02421666|65796539|FG000|6-month Follow-up|Withdrawal by Subject|5|||
23564838|NCT02421666|65796540|FG001|6-month Follow-up|Withdrawal by Subject|6|||
23564839|NCT02421666|65796539|FG000|12-month Follow-up|Lost to Follow-up|5|||
23564840|NCT02421666|65796540|FG001|12-month Follow-up|Lost to Follow-up|5|||
23564841|NCT02421666|65796539|FG000|12-month Follow-up|Withdrawal by Subject|6|||
23564842|NCT02421666|65796540|FG001|12-month Follow-up|Withdrawal by Subject|11|||
23564843|NCT00105586|65796545|FG000|Overall Study|Adverse Event|4|||
23564844|NCT00105586|65796546|FG001|Overall Study|Adverse Event|3|||
23564845|NCT00105586|65796545|FG000|Overall Study|Physician Decision|13|||
23564846|NCT00105586|65796546|FG001|Overall Study|Physician Decision|13|||
23759786|NCT00845026|66498301|FG000|Study Period III|Withdrawal by Subject|19|||
23626919|NCT01466790|66020446|FG006|Overall Study|Withdrawal by Subject|1|||
23759787|NCT00845026|66498302|FG001|Study Period III|Withdrawal by Subject|15|||
23759788|NCT00845026|66498301|FG000|Study Period III|Entry Criteria not met|8|||
23827291|NCT04447040|66748764|FG000|Overall Study|Withdrawal by Subject|0|||
23827292|NCT04447040|66748765|FG001|Overall Study|Withdrawal by Subject|1|||
23827293|NCT04447040|66748766|FG002|Overall Study|Withdrawal by Subject|1|||
23827294|NCT04447040|66748767|FG003|Overall Study|Withdrawal by Subject|1|||
23827295|NCT04447040|66748768|FG004|Overall Study|Withdrawal by Subject|0|||
23827296|NCT04447040|66748769|FG005|Overall Study|Withdrawal by Subject|0|||
23827297|NCT01026194|66748770|FG000|Period 1：Double Blind Period|Adverse Event|2|||
23827298|NCT01026194|66748771|FG001|Period 1：Double Blind Period|Adverse Event|1|||
23827299|NCT01026194|66748770|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
23827300|NCT01026194|66748771|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
23827301|NCT01026194|66748770|FG000|Period 1：Double Blind Period|Physician Decision|0|||
23827302|NCT01026194|66748771|FG001|Period 1：Double Blind Period|Physician Decision|4|||
23827303|NCT01026194|66748770|FG000|Period 2：Open-label Period|Adverse Event|4|||
23827304|NCT01026194|66748771|FG001|Period 2：Open-label Period|Adverse Event|5|||
23827305|NCT01026194|66748770|FG000|Period 2：Open-label Period|Physician Decision|3|||
23827306|NCT01026194|66748771|FG001|Period 2：Open-label Period|Physician Decision|1|||
23827307|NCT01026194|66748770|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
23827308|NCT01026194|66748771|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
23827309|NCT00247676|66748772|FG000|Overall Study|Death|5|||
23827310|NCT00247676|66748772|FG000|Overall Study|Adverse Event|11|||
23827311|NCT00247676|66748772|FG000|Overall Study|Lack of Efficacy|15|||
23827312|NCT00247676|66748772|FG000|Overall Study|Other|3|||
23827313|NCT00247676|66748772|FG000|Overall Study|Withdrawal by Subject|2|||
23827314|NCT00808210|66748773|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
23827315|NCT00808210|66748774|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
23827316|NCT00808210|66748773|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
23827317|NCT00808210|66748774|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
23827318|NCT00808210|66748773|FG000|Double-Blind TX Period|Adverse Event|0|||
23827319|NCT00808210|66748774|FG001|Double-Blind TX Period|Adverse Event|1|||
23827320|NCT00808210|66748773|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
23827321|NCT00808210|66748774|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
23827322|NCT00808210|66748773|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
23827323|NCT00808210|66748774|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
23827324|NCT00808210|66748773|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
23827325|NCT00808210|66748774|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
23827326|NCT03552380|66748775|FG000|Study Treatment|Disease Progression|3|||
23827327|NCT03552380|66748776|FG001|Study Treatment|Disease Progression|4|||
23564847|NCT03724396|65796549|FG000|Overall Study|Lost to Follow-up|1|||
23564848|NCT03724396|65796550|FG001|Overall Study|Lost to Follow-up|1|||
23564849|NCT03724396|65796549|FG000|Overall Study|Withdrawal by Subject|1|||
23564850|NCT03724396|65796550|FG001|Overall Study|Withdrawal by Subject|0|||
23564851|NCT02228395|65796552|FG000|First Intervention Period|No longer willing to participate|1|||
23564852|NCT02228395|65796553|FG001|First Intervention Period|No longer willing to participate|0|||
23564853|NCT02228395|65796554|FG002|First Intervention Period|No longer willing to participate|0|||
23564854|NCT02228395|65796552|FG000|First Intervention Period|Unable to comply with study dates|0|||
23827328|NCT03552380|66748775|FG000|Study Treatment|Adverse Event|2|||
23827329|NCT03552380|66748776|FG001|Study Treatment|Adverse Event|2|||
23827330|NCT03552380|66748775|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
23827331|NCT03552380|66748776|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
23564855|NCT02228395|65796553|FG001|First Intervention Period|Unable to comply with study dates|1|||
23564856|NCT02228395|65796554|FG002|First Intervention Period|Unable to comply with study dates|1|||
23564857|NCT01872910|65796555|FG000|Overall Study|Lost to Follow-up|2|||
23564858|NCT01872910|65796556|FG001|Overall Study|Lost to Follow-up|0|||
23564859|NCT01872910|65796557|FG002|Overall Study|Lost to Follow-up|2|||
23564860|NCT01872910|65796558|FG003|Overall Study|Lost to Follow-up|0|||
23564861|NCT01872910|65796559|FG004|Overall Study|Lost to Follow-up|0|||
23827332|NCT03552380|66748775|FG000|Follow up|Death|3|||
23827333|NCT03552380|66748776|FG001|Follow up|Death|4|||
23827334|NCT03552380|66748775|FG000|Follow up|Site IRB terminated|0|||
23827335|NCT03552380|66748776|FG001|Follow up|Site IRB terminated|1|||
23827336|NCT03565900|66748777|FG000|Overall Study|Disposition Unknown|4|||
23827337|NCT03565900|66748778|FG001|Overall Study|Disposition Unknown|1|||
23827338|NCT03565900|66748777|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23827339|NCT03565900|66748778|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
23827340|NCT03565900|66748777|FG000|Overall Study|Withdrawal by Subject|4|||
23827341|NCT03565900|66748778|FG001|Overall Study|Withdrawal by Subject|5|||
23827342|NCT03565900|66748777|FG000|Overall Study|Randomized By Mistake|0|||
23827343|NCT03565900|66748778|FG001|Overall Study|Randomized By Mistake|2|||
23827344|NCT03565900|66748777|FG000|Overall Study|Physician Decision|7|||
23827345|NCT03565900|66748778|FG001|Overall Study|Physician Decision|11|||
23441526|NCT01067144|65358537|FG001|Treatment|Did not receive allocated intervention|7|||
23441527|NCT01067144|65358536|FG000|Follow-up|Lost to Follow-up|22|||
23441528|NCT01067144|65358537|FG001|Follow-up|Lost to Follow-up|12|||
23827346|NCT03565900|66748777|FG000|Overall Study|Death|9|||
23827347|NCT03565900|66748778|FG001|Overall Study|Death|7|||
23827348|NCT00927589|66748779|FG000|Overall Study|Death|1|||
23827349|NCT00927589|66748779|FG000|Overall Study|Physician Decision|1|||
23827350|NCT00927589|66748779|FG000|Overall Study|Withdrawal by Subject|3|||
23564862|NCT01872910|65796560|FG005|Overall Study|Lost to Follow-up|0|||
23827351|NCT00927589|66748779|FG000|Overall Study|Adverse Event|2|||
23626920|NCT01466790|66020447|FG007|Overall Study|Withdrawal by Subject|1|||
23626921|NCT00381797|66020450|FG000|Overall Study|Withdrawal by Subject|1|||
23626922|NCT00381797|66020451|FG001|Overall Study|Withdrawal by Subject|1|||
23626923|NCT00381797|66020452|FG002|Overall Study|Withdrawal by Subject|0|||
23626924|NCT00381797|66020453|FG003|Overall Study|Withdrawal by Subject|0|||
23626925|NCT00381797|66020454|FG004|Overall Study|Withdrawal by Subject|2|||
23626926|NCT00381797|66020450|FG000|Overall Study|Ineligible|0|||
23626927|NCT00381797|66020451|FG001|Overall Study|Ineligible|0|||
23564863|NCT03749447|65796567|FG000|Overall Study|Adverse Event|11|||
23564864|NCT03749447|65796568|FG001|Overall Study|Adverse Event|3|||
23564865|NCT03749447|65796567|FG000|Overall Study|Death|1|||
23564866|NCT03749447|65796568|FG001|Overall Study|Death|1|||
23564867|NCT03749447|65796567|FG000|Overall Study|Lost to Follow-up|2|||
23564868|NCT03749447|65796568|FG001|Overall Study|Lost to Follow-up|2|||
23564869|NCT03749447|65796567|FG000|Overall Study|Reason Not Specified|0|||
23564870|NCT03749447|65796568|FG001|Overall Study|Reason Not Specified|3|||
23564871|NCT03749447|65796567|FG000|Overall Study|Physician Decision|4|||
23564872|NCT03749447|65796568|FG001|Overall Study|Physician Decision|3|||
23564873|NCT03749447|65796567|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
23564874|NCT03749447|65796568|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
23564875|NCT03749447|65796567|FG000|Overall Study|Study Terminated By Sponsor|112|||
23564876|NCT03749447|65796568|FG001|Overall Study|Study Terminated By Sponsor|105|||
23564877|NCT03749447|65796567|FG000|Overall Study|Withdrawal by Subject|12|||
23564878|NCT03749447|65796568|FG001|Overall Study|Withdrawal by Subject|6|||
23564879|NCT03749447|65796567|FG000|Overall Study|Non-compliance With Study Drug|0|||
23564880|NCT03749447|65796568|FG001|Overall Study|Non-compliance With Study Drug|1|||
23564881|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Adverse Event|1|||
23626928|NCT00381797|66020452|FG002|Overall Study|Ineligible|0|||
23626929|NCT00381797|66020453|FG003|Overall Study|Ineligible|1|||
23626930|NCT00381797|66020454|FG004|Overall Study|Ineligible|0|||
23626931|NCT00755417|66020459|FG000|Overall Study|Adverse Event|28|||
23564882|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Adverse Event|3|||
23564883|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Adverse Event|1|||
23564884|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Adverse Event|0|||
23626932|NCT00755417|66020460|FG001|Overall Study|Adverse Event|20|||
23626933|NCT00755417|66020461|FG002|Overall Study|Adverse Event|7|||
23626934|NCT00755417|66020459|FG000|Overall Study|Lack of Efficacy|8|||
23759789|NCT00845026|66498302|FG001|Study Period III|Entry Criteria not met|11|||
23827352|NCT00927589|66748779|FG000|Overall Study|Disease Progression|8|||
23827353|NCT00927589|66748779|FG000|Overall Study|Non-compliance|1|||
23827354|NCT04720053|66748780|FG000|Overall Study|Lost to Follow-up|12|||
23564885|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Adverse Event|0|||
23564886|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Disease Progression|1|||
23564887|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Disease Progression|4|||
23564888|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Disease Progression|3|||
23564889|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Disease Progression|0|||
23564890|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Disease Progression|0|||
23759790|NCT00845026|66498301|FG000|Study Period III|Lost to Follow-up|4|||
23759791|NCT00845026|66498302|FG001|Study Period III|Lost to Follow-up|5|||
23759792|NCT00845026|66498301|FG000|Study Period III|Protocol Violation|8|||
23759793|NCT00845026|66498302|FG001|Study Period III|Protocol Violation|1|||
23759794|NCT00845026|66498301|FG000|Study Period III|Scheduled conflict|3|||
23759795|NCT00845026|66498302|FG001|Study Period III|Scheduled conflict|1|||
23759796|NCT00845026|66498301|FG000|Study Period III|Subject is moving or has moved|2|||
23759797|NCT00845026|66498302|FG001|Study Period III|Subject is moving or has moved|4|||
23759798|NCT00845026|66498301|FG000|Study Period III|Transportation issues|1|||
23759799|NCT00845026|66498302|FG001|Study Period III|Transportation issues|1|||
23759800|NCT00845026|66498301|FG000|Study Period IV|Adverse Event|4|||
23759801|NCT00845026|66498302|FG001|Study Period IV|Adverse Event|0|||
23759802|NCT00845026|66498301|FG000|Study Period IV|Perceived lack of efficacy|2|||
23759803|NCT00845026|66498302|FG001|Study Period IV|Perceived lack of efficacy|1|||
23759804|NCT00845026|66498301|FG000|Study Period IV|Protocol Violation|3|||
23759805|NCT00845026|66498302|FG001|Study Period IV|Protocol Violation|1|||
23759806|NCT00845026|66498301|FG000|Study Period IV|Lost to Follow-up|1|||
23759807|NCT00845026|66498302|FG001|Study Period IV|Lost to Follow-up|0|||
23759808|NCT00845026|66498301|FG000|Study Period IV|Withdrawal by Subject|4|||
23759809|NCT00845026|66498302|FG001|Study Period IV|Withdrawal by Subject|1|||
23759810|NCT00845026|66498301|FG000|Study Period IV|Entry Criteria Not Met|1|||
23759811|NCT00845026|66498302|FG001|Study Period IV|Entry Criteria Not Met|0|||
23759812|NCT00845026|66498301|FG000|Study Period IV|Subject is moving or has moved|0|||
23759813|NCT00845026|66498302|FG001|Study Period IV|Subject is moving or has moved|1|||
23759814|NCT00845026|66498301|FG000|Study Period IV|Scheduling conflict|1|||
23759815|NCT00845026|66498302|FG001|Study Period IV|Scheduling conflict|0|||
23759816|NCT01716754|66498303|FG000|Overall Study|Death|0|||
23759817|NCT01716754|66498304|FG001|Overall Study|Death|0|||
23759818|NCT01716754|66498305|FG002|Overall Study|Death|0|||
23759819|NCT01716754|66498306|FG003|Overall Study|Death|1|||
23759820|NCT01716754|66498303|FG000|Overall Study|Protocol deviation|0|||
23759821|NCT01716754|66498304|FG001|Overall Study|Protocol deviation|2|||
23759822|NCT01716754|66498305|FG002|Overall Study|Protocol deviation|7|||
23759823|NCT01716754|66498306|FG003|Overall Study|Protocol deviation|2|||
23759824|NCT01716754|66498303|FG000|Overall Study|Non-compliance with study treatment|0|||
23759825|NCT01716754|66498304|FG001|Overall Study|Non-compliance with study treatment|0|||
23759826|NCT01716754|66498305|FG002|Overall Study|Non-compliance with study treatment|1|||
23759827|NCT01716754|66498306|FG003|Overall Study|Non-compliance with study treatment|0|||
23759828|NCT01716754|66498303|FG000|Overall Study|Physician Decision|1|||
23759829|NCT01716754|66498304|FG001|Overall Study|Physician Decision|0|||
23759830|NCT01716754|66498305|FG002|Overall Study|Physician Decision|0|||
23759831|NCT01716754|66498306|FG003|Overall Study|Physician Decision|0|||
23759832|NCT01716754|66498303|FG000|Overall Study|Lost to Follow-up|1|||
23827355|NCT01786993|66748781|FG000|Overall Study|Death|6|||
23827356|NCT01786993|66748782|FG001|Overall Study|Death|7|||
23827357|NCT01786993|66748781|FG000|Overall Study|Withdrawal by Subject|3|||
23827358|NCT01786993|66748782|FG001|Overall Study|Withdrawal by Subject|2|||
23827359|NCT01786993|66748781|FG000|Overall Study|Lost to Follow-up|0|||
23827360|NCT01786993|66748782|FG001|Overall Study|Lost to Follow-up|1|||
23827361|NCT01786993|66748781|FG000|Overall Study|Subject Non-Compliance|1|||
23564891|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23564892|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23759833|NCT01716754|66498304|FG001|Overall Study|Lost to Follow-up|0|||
23759834|NCT01716754|66498305|FG002|Overall Study|Lost to Follow-up|0|||
23759835|NCT01716754|66498306|FG003|Overall Study|Lost to Follow-up|1|||
23759836|NCT01716754|66498303|FG000|Overall Study|Adverse Event|4|||
23759837|NCT01716754|66498304|FG001|Overall Study|Adverse Event|2|||
23759838|NCT01716754|66498305|FG002|Overall Study|Adverse Event|2|||
23759839|NCT01716754|66498306|FG003|Overall Study|Adverse Event|1|||
23827362|NCT01786993|66748782|FG001|Overall Study|Subject Non-Compliance|0|||
23564893|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
23564894|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23759840|NCT01716754|66498303|FG000|Overall Study|Withdrawal by Subject|5|||
23759841|NCT01716754|66498304|FG001|Overall Study|Withdrawal by Subject|0|||
23827363|NCT01786993|66748781|FG000|Overall Study|System Explant|1|||
23759842|NCT01716754|66498305|FG002|Overall Study|Withdrawal by Subject|4|||
23759843|NCT01716754|66498306|FG003|Overall Study|Withdrawal by Subject|3|||
23759844|NCT00854620|66498309|FG000|Overall Study|Adverse Event|1|||
23759845|NCT03451331|66498310|FG000|Overall Study|Withdrawal by Subject|1|||
23759846|NCT03451331|66498311|FG001|Overall Study|Withdrawal by Subject|0|||
23759847|NCT03451331|66498310|FG000|Overall Study|Unable to start treatment.|1|||
23759848|NCT03451331|66498311|FG001|Overall Study|Unable to start treatment.|1|||
23759849|NCT03586830|66498312|FG000|Overall Study|Site terminated by Sponsor|1|||
23759850|NCT03586830|66498313|FG001|Overall Study|Site terminated by Sponsor|4|||
23759851|NCT03586830|66498314|FG002|Overall Study|Site terminated by Sponsor|3|||
23759852|NCT03586830|66498315|FG003|Overall Study|Site terminated by Sponsor|3|||
23759853|NCT03586830|66498312|FG000|Overall Study|Lost to Follow-up|0|||
23759854|NCT03586830|66498313|FG001|Overall Study|Lost to Follow-up|2|||
23759855|NCT03586830|66498314|FG002|Overall Study|Lost to Follow-up|2|||
23759856|NCT03586830|66498315|FG003|Overall Study|Lost to Follow-up|1|||
23759857|NCT03586830|66498312|FG000|Overall Study|Withdrawal by Subject|1|||
23759858|NCT03586830|66498313|FG001|Overall Study|Withdrawal by Subject|0|||
23759859|NCT03586830|66498314|FG002|Overall Study|Withdrawal by Subject|3|||
23759860|NCT03586830|66498315|FG003|Overall Study|Withdrawal by Subject|1|||
23759861|NCT04313283|66498333|FG000|Overall Study|did not complete intervention|4|||
23759862|NCT03412019|66498334|FG000|Overall Study|Withdrawal by Subject|1|||
23759863|NCT03412019|66498335|FG001|Overall Study|Withdrawal by Subject|1|||
23759864|NCT01440595|66498336|FG000|Overall Study|Lost to Follow-up|0|||
23759865|NCT01440595|66498337|FG001|Overall Study|Lost to Follow-up|1|||
23759866|NCT01440595|66498338|FG002|Overall Study|Lost to Follow-up|0|||
23759867|NCT01440595|66498336|FG000|Overall Study|Study terminated by sponsor.|1|||
23759868|NCT01440595|66498337|FG001|Overall Study|Study terminated by sponsor.|2|||
23759869|NCT01440595|66498338|FG002|Overall Study|Study terminated by sponsor.|1|||
23759870|NCT01681771|66498339|FG000|Overall Study|Lost to Follow-up|4|||
23759871|NCT01681771|66498340|FG001|Overall Study|Lost to Follow-up|2|||
23759872|NCT00543439|66498341|FG000|Period 1|Adverse Event|0|||
23759873|NCT00543439|66498342|FG001|Period 1|Adverse Event|2|||
23759874|NCT00543439|66498343|FG002|Period 1|Adverse Event|1|||
23759875|NCT00543439|66498341|FG000|Period 1|Withdrawal by Subject|1|||
23759876|NCT00543439|66498342|FG001|Period 1|Withdrawal by Subject|1|||
23759877|NCT00543439|66498343|FG002|Period 1|Withdrawal by Subject|0|||
23759878|NCT00543439|66498341|FG000|Period 1|Physician Decision|0|||
23759879|NCT00543439|66498342|FG001|Period 1|Physician Decision|0|||
23759880|NCT00543439|66498343|FG002|Period 1|Physician Decision|1|||
23759881|NCT00543439|66498341|FG000|Period 2|Protocol Violation|1|||
23759882|NCT00543439|66498342|FG001|Period 2|Protocol Violation|0|||
23759883|NCT00543439|66498343|FG002|Period 2|Protocol Violation|1|||
23759884|NCT00543439|66498341|FG000|Period 2|Adverse Event|0|||
23759885|NCT00543439|66498342|FG001|Period 2|Adverse Event|1|||
23759886|NCT00543439|66498343|FG002|Period 2|Adverse Event|1|||
23759887|NCT03760510|66498346|FG000|Overall Study|Not ventilated for 24 hours|105|||
23759888|NCT03760510|66498347|FG001|Overall Study|Not ventilated for 24 hours|97|||
23759889|NCT00320593|66498348|FG000|Overall Study|Lost to Follow-up|3|||
23759890|NCT00320593|66498349|FG001|Overall Study|Lost to Follow-up|0|||
23441529|NCT01067144|65358536|FG000|Follow-up|Censored owing to second surgery|19|||
23441530|NCT01067144|65358537|FG001|Follow-up|Censored owing to second surgery|28|||
23759891|NCT00320593|66498348|FG000|Overall Study|Moved to another state|1|||
23759892|NCT00320593|66498349|FG001|Overall Study|Moved to another state|0|||
23759893|NCT00320593|66498348|FG000|Overall Study|Withdrawal by Subject|2|||
23759894|NCT00320593|66498349|FG001|Overall Study|Withdrawal by Subject|1|||
23759895|NCT00320593|66498348|FG000|Overall Study|Withdrawal by clinical center|1|||
23759896|NCT00320593|66498349|FG001|Overall Study|Withdrawal by clinical center|0|||
23759897|NCT01612156|66498356|FG000|Overall Study|Protocol Violation|2|||
23759898|NCT01612156|66498357|FG001|Overall Study|Protocol Violation|0|||
23759899|NCT00409188|66498358|FG000|Overall Study|Ongoing at data cut-off|383|||
23759900|NCT00409188|66498359|FG001|Overall Study|Ongoing at data cut-off|175|||
23759901|NCT01361607|66498360|FG000|Overall Study|Adverse Event|38|||
23759902|NCT01361607|66498361|FG001|Overall Study|Adverse Event|29|||
23759903|NCT01361607|66498360|FG000|Overall Study|Withdrawal by Subject|19|||
23759904|NCT01361607|66498361|FG001|Overall Study|Withdrawal by Subject|8|||
23759905|NCT01361607|66498360|FG000|Overall Study|Withdrawal by Investigator|5|||
23759906|NCT01361607|66498361|FG001|Overall Study|Withdrawal by Investigator|3|||
23759907|NCT01361607|66498360|FG000|Overall Study|Lost to Follow-up|1|||
23759908|NCT01361607|66498361|FG001|Overall Study|Lost to Follow-up|0|||
23759909|NCT01361607|66498360|FG000|Overall Study|Met Withdrawal Criteria|1|||
23759910|NCT01361607|66498361|FG001|Overall Study|Met Withdrawal Criteria|1|||
23759911|NCT01697449|66498366|FG000|Overall Study|Disease progression|47|||
23759912|NCT01697449|66498366|FG000|Overall Study|Adverse Event|7|||
23759913|NCT01697449|66498366|FG000|Overall Study|Lost to Follow-up|5|||
23759914|NCT01697449|66498366|FG000|Overall Study|Withdrawal by Subject|2|||
23759915|NCT01697449|66498366|FG000|Overall Study|Physician Decision|1|||
23759916|NCT01697449|66498366|FG000|Overall Study|Death|2|||
23759917|NCT01697449|66498366|FG000|Overall Study|Other|1|||
23759918|NCT01697449|66498366|FG000|Overall Study|Missing|25|||
23759919|NCT03085485|66498367|FG000|Overall Study|Death|1|||
23759920|NCT03085485|66498368|FG001|Overall Study|Death|0|||
23759921|NCT03085485|66498367|FG000|Overall Study|Lost to Follow-up|1|||
23759922|NCT03085485|66498368|FG001|Overall Study|Lost to Follow-up|0|||
23759923|NCT00871728|66498370|FG000|Overall Study|Adverse Event|1|||
23759924|NCT00871728|66498370|FG000|Overall Study|Protocol Violation|7|||
23759925|NCT00871728|66498370|FG000|Overall Study|Lost to Follow-up|2|||
23759926|NCT00871728|66498370|FG000|Overall Study|Failed to Visit Hospital|4|||
23759927|NCT00871728|66498370|FG000|Overall Study|Participant Non-compliance|1|||
23759928|NCT00871728|66498370|FG000|Overall Study|Withdrawal of Informed Consent|5|||
23759929|NCT01039584|66498371|FG000|Overall Study|Withdrawal by Subject|4|||
23759930|NCT01039584|66498372|FG001|Overall Study|Withdrawal by Subject|2|||
23759931|NCT01039584|66498373|FG002|Overall Study|Withdrawal by Subject|1|||
23441531|NCT01067144|65358536|FG000|Follow-up|Withdrawal by Subject|18|||
23441532|NCT01067144|65358537|FG001|Follow-up|Withdrawal by Subject|14|||
23441533|NCT01067144|65358536|FG000|Follow-up|Surgery cancelled|0|||
23759932|NCT01039584|66498371|FG000|Overall Study|Protocol Violation|10|||
23759933|NCT01039584|66498372|FG001|Overall Study|Protocol Violation|4|||
23759934|NCT01039584|66498373|FG002|Overall Study|Protocol Violation|6|||
23759935|NCT01039584|66498371|FG000|Overall Study|Lost to Follow-up|5|||
23759936|NCT01039584|66498372|FG001|Overall Study|Lost to Follow-up|3|||
23759937|NCT01039584|66498373|FG002|Overall Study|Lost to Follow-up|4|||
23441534|NCT01067144|65358537|FG001|Follow-up|Surgery cancelled|1|||
23441535|NCT01067144|65358536|FG000|Follow-up|Death|0|||
23441536|NCT01067144|65358537|FG001|Follow-up|Death|1|||
23441537|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
23441538|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
23441539|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
23441540|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
23441541|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
23441542|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
23441543|NCT01450098|65358544|FG000|Period 3|Protocol Violation|0|||
23441544|NCT01450098|65358545|FG001|Period 3|Protocol Violation|1|||
23441545|NCT01450098|65358544|FG000|Period 3|Withdrawal by Subject|0|||
23441546|NCT01450098|65358545|FG001|Period 3|Withdrawal by Subject|2|||
23441547|NCT00930930|65358546|FG000|Overall Study|Death|1|||
23441548|NCT00930930|65358547|FG001|Overall Study|Death|0|||
23441549|NCT00930930|65358546|FG000|Overall Study|Physician Decision|1|||
23759938|NCT01039584|66498371|FG000|Overall Study|Negative Baseline culture for Candida|59|||
23759939|NCT01039584|66498372|FG001|Overall Study|Negative Baseline culture for Candida|59|||
23759940|NCT01039584|66498373|FG002|Overall Study|Negative Baseline culture for Candida|24|||
23759941|NCT01039584|66498371|FG000|Overall Study|Lack of Efficacy|7|||
23441550|NCT00930930|65358547|FG001|Overall Study|Physician Decision|0|||
23441551|NCT00930930|65358546|FG000|Overall Study|Adverse Event|13|||
23441552|NCT00930930|65358547|FG001|Overall Study|Adverse Event|3|||
23441553|NCT00930930|65358546|FG000|Overall Study|Withdrawal by Subject|3|||
23759942|NCT01039584|66498372|FG001|Overall Study|Lack of Efficacy|6|||
23759943|NCT01039584|66498373|FG002|Overall Study|Lack of Efficacy|10|||
23759944|NCT01039584|66498371|FG000|Overall Study|other|1|||
23759945|NCT01039584|66498372|FG001|Overall Study|other|3|||
23441554|NCT00930930|65358547|FG001|Overall Study|Withdrawal by Subject|1|||
23441555|NCT00930930|65358546|FG000|Overall Study|Disease progression|2|||
23564895|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23759946|NCT01039584|66498373|FG002|Overall Study|other|1|||
23759947|NCT01039584|66498371|FG000|Overall Study|Pap smear with significant pathology|10|||
23759948|NCT01039584|66498372|FG001|Overall Study|Pap smear with significant pathology|10|||
23759949|NCT01039584|66498373|FG002|Overall Study|Pap smear with significant pathology|3|||
23759950|NCT01039584|66498371|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
23759951|NCT01039584|66498372|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
23759952|NCT01039584|66498373|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
23759953|NCT01076166|66498408|FG000|Overall Study|Adverse Event|3|||
23759954|NCT01076166|66498408|FG000|Overall Study|Symptoms improved/resolved|6|||
23759955|NCT00736099|66498409|FG000|Overall Study|Adverse Event|61|||
23759956|NCT00736099|66498410|FG001|Overall Study|Adverse Event|18|||
23759957|NCT00736099|66498409|FG000|Overall Study|Protocol Violation|10|||
23441556|NCT00930930|65358547|FG001|Overall Study|Disease progression|3|||
23441557|NCT00930930|65358546|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
23441558|NCT00930930|65358547|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
23441559|NCT00930930|65358546|FG000|Overall Study|patients not compliant|1|||
23441560|NCT00930930|65358547|FG001|Overall Study|patients not compliant|1|||
23441561|NCT00003199|65358551|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
23441562|NCT00003199|65358551|FG000|Overall Study|Lack of insurance clearance|2|||
23441563|NCT00003199|65358551|FG000|Overall Study|Screen fail|15|||
23441564|NCT01055314|65358552|FG000|Overall Study|Adverse Event|7|||
23441565|NCT01055314|65358553|FG001|Overall Study|Adverse Event|4|||
23759958|NCT00736099|66498410|FG001|Overall Study|Protocol Violation|4|||
23759959|NCT00736099|66498409|FG000|Overall Study|Lost to Follow-up|12|||
23441566|NCT01055314|65358552|FG000|Overall Study|Death|2|||
23441567|NCT01055314|65358553|FG001|Overall Study|Death|1|||
23441568|NCT01055314|65358552|FG000|Overall Study|Lack of Efficacy|11|||
23441569|NCT01055314|65358553|FG001|Overall Study|Lack of Efficacy|19|||
23441570|NCT01055314|65358552|FG000|Overall Study|Physician Decision|10|||
23441571|NCT01055314|65358553|FG001|Overall Study|Physician Decision|5|||
23441572|NCT01055314|65358552|FG000|Overall Study|Withdrawal by Subject|1|||
23441573|NCT01055314|65358553|FG001|Overall Study|Withdrawal by Subject|0|||
23441574|NCT01055314|65358552|FG000|Overall Study|Ineligible|3|||
23441575|NCT01055314|65358553|FG001|Overall Study|Ineligible|5|||
23441576|NCT01055314|65358552|FG000|Overall Study|Refusal of further protocol therapy|10|||
23441577|NCT01055314|65358553|FG001|Overall Study|Refusal of further protocol therapy|4|||
23441578|NCT01055314|65358552|FG000|Overall Study|No treatment|1|||
23441579|NCT01055314|65358553|FG001|Overall Study|No treatment|0|||
23441580|NCT00549445|65358558|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
23441581|NCT00549445|65358559|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
23441582|NCT00176462|65358566|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
23441583|NCT00176462|65358567|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
23441584|NCT00176462|65358566|FG000|Induction (4 Weeks)|Death|1|||
23441585|NCT00176462|65358567|FG001|Induction (4 Weeks)|Death|2|||
23441586|NCT00176462|65358566|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
23441587|NCT00176462|65358567|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
23441588|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
23441589|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
23441590|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
23441591|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
23441592|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
23441593|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
23441594|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Not documented|0|||
23441595|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Not documented|1|||
23441596|NCT00176462|65358566|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
23441597|NCT00176462|65358567|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
23441598|NCT00176462|65358566|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
23564896|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Adverse Event|0|||
23759960|NCT00736099|66498410|FG001|Overall Study|Lost to Follow-up|5|||
23441599|NCT00176462|65358567|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
23441600|NCT00773747|65358574|FG000|Overall Study|Lack of Efficacy|112|||
23441601|NCT00773747|65358575|FG001|Overall Study|Lack of Efficacy|144|||
23441602|NCT00773747|65358574|FG000|Overall Study|Physician Decision|26|||
23564897|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Adverse Event|0|||
23759961|NCT00736099|66498409|FG000|Overall Study|Withdrawal by Subject|42|||
23759962|NCT00736099|66498410|FG001|Overall Study|Withdrawal by Subject|13|||
23441603|NCT00773747|65358575|FG001|Overall Study|Physician Decision|18|||
23441604|NCT00773747|65358574|FG000|Overall Study|Lost to Follow-up|0|||
23564898|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Adverse Event|0|||
23441605|NCT00773747|65358575|FG001|Overall Study|Lost to Follow-up|1|||
23441606|NCT00773747|65358574|FG000|Overall Study|Protocol Violation|2|||
23441607|NCT00773747|65358575|FG001|Overall Study|Protocol Violation|2|||
23441608|NCT00773747|65358574|FG000|Overall Study|Withdrawal by Subject|89|||
23441609|NCT00773747|65358575|FG001|Overall Study|Withdrawal by Subject|61|||
23441610|NCT00773747|65358574|FG000|Overall Study|Adverse Event|61|||
23441611|NCT00773747|65358575|FG001|Overall Study|Adverse Event|62|||
23759963|NCT00736099|66498409|FG000|Overall Study|Lack of Efficacy|15|||
23441612|NCT00773747|65358574|FG000|Overall Study|Death|5|||
23441613|NCT00773747|65358575|FG001|Overall Study|Death|8|||
23441614|NCT00773747|65358574|FG000|Overall Study|Not Treated|2|||
23441615|NCT00773747|65358575|FG001|Overall Study|Not Treated|0|||
23441616|NCT04412707|65358576|FG000|Cycle 1|Death|0|||
23441617|NCT04412707|65358577|FG001|Cycle 1|Death|3|||
23441618|NCT04412707|65358576|FG000|Cycle 1|Disease progression|1|||
23441619|NCT04412707|65358577|FG001|Cycle 1|Disease progression|2|||
23441620|NCT04412707|65358576|FG000|Cycle 2|Death|0|||
23441621|NCT04412707|65358577|FG001|Cycle 2|Death|1|||
23441622|NCT04412707|65358576|FG000|Cycle 2|Disease progression|3|||
23441623|NCT04412707|65358577|FG001|Cycle 2|Disease progression|0|||
23441624|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
23441625|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
23441626|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
23441627|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
23759964|NCT00736099|66498410|FG001|Overall Study|Lack of Efficacy|8|||
23759965|NCT00736099|66498409|FG000|Overall Study|Other reason|43|||
23759966|NCT00736099|66498410|FG001|Overall Study|Other reason|10|||
23759967|NCT04133519|66498412|FG000|Overall Study|Withdrawal by Subject|5|||
23759968|NCT04133519|66498413|FG001|Overall Study|Withdrawal by Subject|4|||
23759969|NCT04133519|66498412|FG000|Overall Study|Protocol Violation|0|||
23759970|NCT04133519|66498413|FG001|Overall Study|Protocol Violation|1|||
23564899|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Adverse Event|9|||
23759971|NCT04133519|66498412|FG000|Overall Study|Never started treatment|1|||
23759972|NCT04133519|66498413|FG001|Overall Study|Never started treatment|1|||
23759973|NCT01706770|66498414|FG000|Overall Study|Lost to Follow-up|1|||
23759974|NCT01706770|66498415|FG001|Overall Study|Lost to Follow-up|0|||
23759975|NCT01706770|66498414|FG000|Overall Study|Physician Decision|1|||
23759976|NCT01706770|66498415|FG001|Overall Study|Physician Decision|0|||
23759977|NCT03521999|66501338|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
23759978|NCT03521999|66501339|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
23759979|NCT03521999|66501338|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
23759980|NCT03521999|66501339|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
23441628|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
23441629|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
23564900|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Adverse Event|0|||
23564901|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
23759981|NCT03521999|66501338|FG000|Completed 3 Month Follow up|Death|0|||
23759982|NCT03521999|66501339|FG001|Completed 3 Month Follow up|Death|1|||
23441630|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
23441631|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
23759983|NCT03521999|66501338|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
23441632|NCT01835223|65358579|FG000|Overall Study|Adverse Event|1|||
23441633|NCT01835223|65358580|FG001|Overall Study|Adverse Event|0|||
23441634|NCT01835223|65358579|FG000|Overall Study|Withdrawal by Subject|2|||
23441635|NCT01835223|65358580|FG001|Overall Study|Withdrawal by Subject|0|||
23441636|NCT01835223|65358579|FG000|Overall Study|Disease progression|2|||
23441637|NCT01835223|65358580|FG001|Overall Study|Disease progression|1|||
23441638|NCT01835223|65358579|FG000|Overall Study|Became Inelligible|4|||
23441639|NCT01835223|65358580|FG001|Overall Study|Became Inelligible|0|||
23441640|NCT02969356|65358581|FG000|Overall Study|Adverse Event|7|||
23441641|NCT02969356|65358581|FG000|Overall Study|Consent withdrawn|2|||
23441642|NCT02969356|65358581|FG000|Overall Study|Lost to Follow-up|3|||
23441643|NCT02969356|65358581|FG000|Overall Study|Did not need to be reinjected|6|||
23441644|NCT02969356|65358581|FG000|Overall Study|Personal reasons|5|||
23441645|NCT01361178|65358585|FG000|Overall Study|Death|13|||
23441646|NCT01361178|65358586|FG001|Overall Study|Death|0|||
23441647|NCT00720343|65358587|FG000|Overall Study|Lost to Follow-up|1|||
23441648|NCT00720343|65358588|FG001|Overall Study|Lost to Follow-up|0|||
23441649|NCT00720343|65358587|FG000|Overall Study|Protocol Violation|0|||
23441650|NCT00720343|65358588|FG001|Overall Study|Protocol Violation|2|||
23441651|NCT01610336|65358589|FG000|Overall Study|Progressive Disease|4|||
23441652|NCT01610336|65358590|FG001|Overall Study|Progressive Disease|6|||
23441653|NCT01610336|65358591|FG002|Overall Study|Progressive Disease|6|||
23441654|NCT01610336|65358592|FG003|Overall Study|Progressive Disease|5|||
23441655|NCT01610336|65358593|FG004|Overall Study|Progressive Disease|3|||
23441656|NCT01610336|65358594|FG005|Overall Study|Progressive Disease|10|||
23441657|NCT01610336|65358595|FG006|Overall Study|Progressive Disease|1|||
23441658|NCT01610336|65358596|FG007|Overall Study|Progressive Disease|6|||
23441659|NCT01610336|65358597|FG008|Overall Study|Progressive Disease|6|||
23441660|NCT01610336|65358598|FG009|Overall Study|Progressive Disease|40|||
23441661|NCT01610336|65358599|FG010|Overall Study|Progressive Disease|36|||
23441662|NCT01610336|65358589|FG000|Overall Study|Adverse Event|0|||
23441663|NCT01610336|65358590|FG001|Overall Study|Adverse Event|0|||
23441664|NCT01610336|65358591|FG002|Overall Study|Adverse Event|0|||
23441665|NCT01610336|65358592|FG003|Overall Study|Adverse Event|1|||
23441666|NCT01610336|65358593|FG004|Overall Study|Adverse Event|1|||
23441667|NCT01610336|65358594|FG005|Overall Study|Adverse Event|1|||
23441668|NCT01610336|65358595|FG006|Overall Study|Adverse Event|0|||
23441669|NCT01610336|65358596|FG007|Overall Study|Adverse Event|0|||
23441670|NCT01610336|65358597|FG008|Overall Study|Adverse Event|2|||
23441671|NCT01610336|65358598|FG009|Overall Study|Adverse Event|8|||
23441672|NCT01610336|65358599|FG010|Overall Study|Adverse Event|6|||
23441673|NCT01610336|65358589|FG000|Overall Study|Subject/Guardian decision|1|||
23441674|NCT01610336|65358590|FG001|Overall Study|Subject/Guardian decision|1|||
23441675|NCT01610336|65358591|FG002|Overall Study|Subject/Guardian decision|0|||
23626935|NCT00755417|66020460|FG001|Overall Study|Lack of Efficacy|4|||
23759984|NCT03521999|66501339|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
23759985|NCT03156270|66501340|FG000|Overall Study|Failed pre-treatment screening|1|||
23759986|NCT03156270|66501340|FG000|Overall Study|Lost to Follow-up|1|||
23759987|NCT01625845|66501341|FG000|Overall Study|Adverse Event|1|||
23759988|NCT01625845|66501342|FG001|Overall Study|Adverse Event|2|||
23759989|NCT01625845|66501341|FG000|Overall Study|Lost to Follow-up|2|||
23759990|NCT01625845|66501342|FG001|Overall Study|Lost to Follow-up|1|||
23759991|NCT01625845|66501341|FG000|Overall Study|Withdrawal by Subject|2|||
23441676|NCT01610336|65358592|FG003|Overall Study|Subject/Guardian decision|1|||
23441677|NCT01610336|65358593|FG004|Overall Study|Subject/Guardian decision|0|||
23441678|NCT01610336|65358594|FG005|Overall Study|Subject/Guardian decision|0|||
23626936|NCT00755417|66020461|FG002|Overall Study|Lack of Efficacy|9|||
23441679|NCT01610336|65358595|FG006|Overall Study|Subject/Guardian decision|0|||
23759992|NCT01625845|66501342|FG001|Overall Study|Withdrawal by Subject|0|||
23441680|NCT01610336|65358596|FG007|Overall Study|Subject/Guardian decision|1|||
23441681|NCT01610336|65358597|FG008|Overall Study|Subject/Guardian decision|0|||
23441682|NCT01610336|65358598|FG009|Overall Study|Subject/Guardian decision|2|||
23441683|NCT01610336|65358599|FG010|Overall Study|Subject/Guardian decision|2|||
23441684|NCT01610336|65358589|FG000|Overall Study|Death|0|||
23441685|NCT01610336|65358590|FG001|Overall Study|Death|0|||
23441686|NCT01610336|65358591|FG002|Overall Study|Death|0|||
23441687|NCT01610336|65358592|FG003|Overall Study|Death|0|||
23827364|NCT01786993|66748782|FG001|Overall Study|System Explant|0|||
23827365|NCT01786993|66748781|FG000|Overall Study|Hospice Admission|1|||
23827366|NCT01786993|66748782|FG001|Overall Study|Hospice Admission|0|||
23827367|NCT02719184|66748785|FG000|Overall Study|Other than listed|1|||
23827368|NCT02719184|66748786|FG001|Overall Study|Other than listed|12|||
23827369|NCT02719184|66748787|FG002|Overall Study|Other than listed|13|||
23827370|NCT02719184|66748788|FG003|Overall Study|Other than listed|22|||
23827371|NCT02719184|66748789|FG004|Overall Study|Other than listed|9|||
23827372|NCT02719184|66748785|FG000|Overall Study|Withdrawal by Subject|5|||
23827373|NCT02719184|66748786|FG001|Overall Study|Withdrawal by Subject|3|||
23827374|NCT02719184|66748787|FG002|Overall Study|Withdrawal by Subject|6|||
23827375|NCT02719184|66748788|FG003|Overall Study|Withdrawal by Subject|6|||
23441688|NCT01610336|65358593|FG004|Overall Study|Death|0|||
23441689|NCT01610336|65358594|FG005|Overall Study|Death|1|||
23441690|NCT01610336|65358595|FG006|Overall Study|Death|3|||
23441691|NCT01610336|65358596|FG007|Overall Study|Death|0|||
23441692|NCT01610336|65358597|FG008|Overall Study|Death|0|||
23441693|NCT01610336|65358598|FG009|Overall Study|Death|1|||
23441694|NCT01610336|65358599|FG010|Overall Study|Death|2|||
23441695|NCT01610336|65358589|FG000|Overall Study|Non-Compliance with study treatment|0|||
23441696|NCT01610336|65358590|FG001|Overall Study|Non-Compliance with study treatment|0|||
23441697|NCT01610336|65358591|FG002|Overall Study|Non-Compliance with study treatment|0|||
23441698|NCT01610336|65358592|FG003|Overall Study|Non-Compliance with study treatment|0|||
23441699|NCT01610336|65358593|FG004|Overall Study|Non-Compliance with study treatment|0|||
23441700|NCT01610336|65358594|FG005|Overall Study|Non-Compliance with study treatment|0|||
23441701|NCT01610336|65358595|FG006|Overall Study|Non-Compliance with study treatment|0|||
23441702|NCT01610336|65358596|FG007|Overall Study|Non-Compliance with study treatment|0|||
23441703|NCT01610336|65358597|FG008|Overall Study|Non-Compliance with study treatment|0|||
23441704|NCT01610336|65358598|FG009|Overall Study|Non-Compliance with study treatment|1|||
23441705|NCT01610336|65358599|FG010|Overall Study|Non-Compliance with study treatment|0|||
23441706|NCT01610336|65358589|FG000|Overall Study|Physician Decision|0|||
23441707|NCT01610336|65358590|FG001|Overall Study|Physician Decision|0|||
23441708|NCT01610336|65358591|FG002|Overall Study|Physician Decision|0|||
23441709|NCT01610336|65358592|FG003|Overall Study|Physician Decision|0|||
23441710|NCT01610336|65358593|FG004|Overall Study|Physician Decision|0|||
23441711|NCT01610336|65358594|FG005|Overall Study|Physician Decision|0|||
23441712|NCT01610336|65358595|FG006|Overall Study|Physician Decision|1|||
23441713|NCT01610336|65358596|FG007|Overall Study|Physician Decision|0|||
23441714|NCT01610336|65358597|FG008|Overall Study|Physician Decision|0|||
23441715|NCT01610336|65358598|FG009|Overall Study|Physician Decision|0|||
23441716|NCT01610336|65358599|FG010|Overall Study|Physician Decision|0|||
23441717|NCT01610336|65358589|FG000|Overall Study|Protocol Deviation|0|||
23441718|NCT01610336|65358590|FG001|Overall Study|Protocol Deviation|0|||
23441719|NCT01610336|65358591|FG002|Overall Study|Protocol Deviation|0|||
23441720|NCT01610336|65358592|FG003|Overall Study|Protocol Deviation|0|||
23441721|NCT01610336|65358593|FG004|Overall Study|Protocol Deviation|0|||
23441722|NCT01610336|65358594|FG005|Overall Study|Protocol Deviation|0|||
23441723|NCT01610336|65358595|FG006|Overall Study|Protocol Deviation|0|||
23441724|NCT01610336|65358596|FG007|Overall Study|Protocol Deviation|0|||
23441725|NCT01610336|65358597|FG008|Overall Study|Protocol Deviation|0|||
23441726|NCT01610336|65358598|FG009|Overall Study|Protocol Deviation|1|||
23626937|NCT00755417|66020459|FG000|Overall Study|Protocol Violation|2|||
23827376|NCT02719184|66748789|FG004|Overall Study|Withdrawal by Subject|0|||
23441727|NCT01610336|65358599|FG010|Overall Study|Protocol Deviation|0|||
23441728|NCT01610336|65358589|FG000|Overall Study|Transfer to another trial|0|||
23441729|NCT01610336|65358590|FG001|Overall Study|Transfer to another trial|0|||
23441730|NCT01610336|65358591|FG002|Overall Study|Transfer to another trial|0|||
23441731|NCT01610336|65358592|FG003|Overall Study|Transfer to another trial|0|||
23441732|NCT01610336|65358593|FG004|Overall Study|Transfer to another trial|0|||
23441733|NCT01610336|65358594|FG005|Overall Study|Transfer to another trial|0|||
23441734|NCT01610336|65358595|FG006|Overall Study|Transfer to another trial|0|||
23441735|NCT01610336|65358596|FG007|Overall Study|Transfer to another trial|0|||
23441736|NCT01610336|65358597|FG008|Overall Study|Transfer to another trial|0|||
23441737|NCT01610336|65358598|FG009|Overall Study|Transfer to another trial|0|||
23441738|NCT01610336|65358599|FG010|Overall Study|Transfer to another trial|1|||
23441739|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
23441740|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
23441741|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
23441742|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
23441743|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
23441744|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
23441745|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
23441746|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
23441747|NCT02679287|65358600|FG000|Period 2|Work/Scheduling Conflict|1|||
23827377|NCT02719184|66748785|FG000|Overall Study|Lost to Follow-up|0|||
23827378|NCT02719184|66748786|FG001|Overall Study|Lost to Follow-up|4|||
23441748|NCT02679287|65358601|FG001|Period 2|Work/Scheduling Conflict|0|||
23441749|NCT02679287|65358600|FG000|Period 2|Disliked Mobile System|2|||
23441750|NCT02679287|65358601|FG001|Period 2|Disliked Mobile System|0|||
23441751|NCT02679287|65358600|FG000|Period 3|Work/Scheduling Conflict|0|||
23441752|NCT02679287|65358601|FG001|Period 3|Work/Scheduling Conflict|1|||
23441753|NCT04829916|65358602|FG000|Overall Study|Withdrawal by Subject|1|||
23441754|NCT04829916|65358603|FG001|Overall Study|Withdrawal by Subject|0|||
23441755|NCT04618744|65358610|FG000|Overall Study|Adverse Event|0|||
23441756|NCT04618744|65358611|FG001|Overall Study|Adverse Event|1|||
23441757|NCT04618744|65358610|FG000|Overall Study|Withdrawal by Subject|0|||
23441758|NCT04618744|65358611|FG001|Overall Study|Withdrawal by Subject|1|||
23441759|NCT01746225|65358614|FG000|Overall Study|Death|1|||
23441760|NCT01746225|65358615|FG001|Overall Study|Death|0|||
23441761|NCT01746225|65358616|FG002|Overall Study|Death|1|||
23441762|NCT01746225|65358614|FG000|Overall Study|Withdrawal by Subject|5|||
23441763|NCT01746225|65358615|FG001|Overall Study|Withdrawal by Subject|15|||
23441764|NCT01746225|65358616|FG002|Overall Study|Withdrawal by Subject|19|||
23441765|NCT01746225|65358614|FG000|Overall Study|Physician Decision|14|||
23441766|NCT01746225|65358615|FG001|Overall Study|Physician Decision|11|||
23441767|NCT01746225|65358616|FG002|Overall Study|Physician Decision|3|||
23441768|NCT01746225|65358614|FG000|Overall Study|Adverse Event|15|||
23441769|NCT01746225|65358615|FG001|Overall Study|Adverse Event|12|||
23441770|NCT01746225|65358616|FG002|Overall Study|Adverse Event|17|||
23441771|NCT01746225|65358614|FG000|Overall Study|Continuing Treatment|5|||
23441772|NCT01746225|65358615|FG001|Overall Study|Continuing Treatment|8|||
23441773|NCT01746225|65358616|FG002|Overall Study|Continuing Treatment|3|||
23441774|NCT01740401|65358617|FG000|Overall Study|Progression of disease|6|||
23441775|NCT01740401|65358617|FG000|Overall Study|Adverse Event|2|||
23441776|NCT01740401|65358617|FG000|Overall Study|Did not reach primary endpoint|2|||
23759993|NCT00065065|66501343|FG000|Overall Study|Adverse Event|3|||
23759994|NCT00065065|66501344|FG001|Overall Study|Adverse Event|2|||
23759995|NCT00065065|66501343|FG000|Overall Study|Withdrawal by Subject|1|||
23759996|NCT00065065|66501344|FG001|Overall Study|Withdrawal by Subject|5|||
23759997|NCT00065065|66501343|FG000|Overall Study|Lack of Efficacy|4|||
23759998|NCT00065065|66501344|FG001|Overall Study|Lack of Efficacy|11|||
23759999|NCT00065065|66501343|FG000|Overall Study|Other|2|||
23760000|NCT00065065|66501344|FG001|Overall Study|Other|2|||
23760001|NCT00084617|66501345|FG000|Overall Study|Withdrawal by Subject|7|||
23441777|NCT02360228|65358618|FG000|Overall Study|Withdrawal by Subject|1|||
23441778|NCT02360228|65358619|FG001|Overall Study|Withdrawal by Subject|0|||
23441779|NCT02360228|65358620|FG002|Overall Study|Withdrawal by Subject|0|||
23626938|NCT00755417|66020460|FG001|Overall Study|Protocol Violation|1|||
23626939|NCT00755417|66020461|FG002|Overall Study|Protocol Violation|1|||
23626940|NCT00755417|66020459|FG000|Overall Study|Lost to Follow-up|3|||
23626941|NCT00755417|66020460|FG001|Overall Study|Lost to Follow-up|0|||
23626942|NCT00755417|66020461|FG002|Overall Study|Lost to Follow-up|1|||
23626943|NCT00755417|66020459|FG000|Overall Study|Withdrawal by Subject|12|||
23626944|NCT00755417|66020460|FG001|Overall Study|Withdrawal by Subject|12|||
23626945|NCT00755417|66020461|FG002|Overall Study|Withdrawal by Subject|12|||
23827379|NCT02719184|66748787|FG002|Overall Study|Lost to Follow-up|1|||
23827380|NCT02719184|66748788|FG003|Overall Study|Lost to Follow-up|3|||
23827381|NCT02719184|66748789|FG004|Overall Study|Lost to Follow-up|0|||
23827382|NCT02719184|66748785|FG000|Overall Study|Protocol Violation|0|||
23827383|NCT02719184|66748786|FG001|Overall Study|Protocol Violation|3|||
23441780|NCT02360228|65358618|FG000|Overall Study|Self-discontinued medication|0|||
23441781|NCT02360228|65358619|FG001|Overall Study|Self-discontinued medication|1|||
23441782|NCT02360228|65358620|FG002|Overall Study|Self-discontinued medication|0|||
23441783|NCT02360228|65358618|FG000|Overall Study|Unstable symptoms during screening|0|||
23441784|NCT02360228|65358619|FG001|Overall Study|Unstable symptoms during screening|0|||
23441785|NCT02360228|65358620|FG002|Overall Study|Unstable symptoms during screening|1|||
23441786|NCT02141360|65358623|FG000|Overall Study|Withdrawal by Subject|6|||
23626946|NCT00755417|66020459|FG000|Overall Study|Not specified or missing data|9|||
23626947|NCT00755417|66020460|FG001|Overall Study|Not specified or missing data|18|||
23626948|NCT00755417|66020461|FG002|Overall Study|Not specified or missing data|12|||
23760002|NCT00084617|66501345|FG000|Overall Study|Lack of Efficacy|1|||
23441787|NCT02141360|65358624|FG001|Overall Study|Withdrawal by Subject|0|||
23760003|NCT00084617|66501345|FG000|Overall Study|Protocol Violation|1|||
23441788|NCT02141360|65358625|FG002|Overall Study|Withdrawal by Subject|0|||
23441789|NCT02141360|65358623|FG000|Overall Study|Study Terminated before Visit|1|||
23760004|NCT01862328|66501346|FG000|Overall Study|Progressive Disease|3|||
23760005|NCT01862328|66501347|FG001|Overall Study|Progressive Disease|11|||
23760006|NCT01862328|66501348|FG002|Overall Study|Progressive Disease|5|||
23626949|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
23626950|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
23626951|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
23626952|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
23626953|NCT01755546|66020462|FG000|Titration Phase|Adverse Event|11|||
23626954|NCT01755546|66020462|FG000|Titration Phase|Lack of Efficacy|18|||
23626955|NCT01755546|66020462|FG000|Titration Phase|Protocol Violation|9|||
23626956|NCT01755546|66020462|FG000|Titration Phase|Lost to Follow-up|2|||
23626957|NCT01755546|66020462|FG000|Titration Phase|Other and Continuing|22|||
23760007|NCT01862328|66501349|FG003|Overall Study|Progressive Disease|6|||
23760008|NCT01862328|66501350|FG004|Overall Study|Progressive Disease|7|||
23760009|NCT01862328|66501351|FG005|Overall Study|Progressive Disease|4|||
23760010|NCT01862328|66501352|FG006|Overall Study|Progressive Disease|3|||
23760011|NCT01862328|66501346|FG000|Overall Study|Adverse Event|0|||
23760012|NCT01862328|66501347|FG001|Overall Study|Adverse Event|4|||
23760013|NCT01862328|66501348|FG002|Overall Study|Adverse Event|0|||
23760014|NCT01862328|66501349|FG003|Overall Study|Adverse Event|1|||
23760015|NCT01862328|66501350|FG004|Overall Study|Adverse Event|0|||
23760016|NCT01862328|66501351|FG005|Overall Study|Adverse Event|2|||
23827384|NCT02719184|66748787|FG002|Overall Study|Protocol Violation|0|||
23827385|NCT02719184|66748788|FG003|Overall Study|Protocol Violation|2|||
23827386|NCT02719184|66748789|FG004|Overall Study|Protocol Violation|0|||
23827387|NCT02719184|66748785|FG000|Overall Study|Adverse Event|0|||
23827388|NCT02719184|66748786|FG001|Overall Study|Adverse Event|0|||
23827389|NCT02719184|66748787|FG002|Overall Study|Adverse Event|0|||
23827390|NCT02719184|66748788|FG003|Overall Study|Adverse Event|3|||
23827391|NCT02719184|66748789|FG004|Overall Study|Adverse Event|0|||
23827392|NCT00369941|66748792|FG000|Overall Study|Never Treated|1|||
23827393|NCT00369941|66748793|FG001|Overall Study|Never Treated|2|||
23827394|NCT00369941|66748792|FG000|Overall Study|Adverse Event|14|||
23827395|NCT00369941|66748793|FG001|Overall Study|Adverse Event|28|||
23827396|NCT00369941|66748792|FG000|Overall Study|Lack of Efficacy|6|||
23626958|NCT01755546|66020462|FG000|Titration Phase|Withdrawal by Subject|8|||
23626959|NCT01755546|66020462|FG000|Long Term Treatment|Adverse Event|12|||
23626960|NCT01755546|66020462|FG000|Long Term Treatment|Lack of Efficacy|6|||
23760017|NCT01862328|66501352|FG006|Overall Study|Adverse Event|4|||
23760018|NCT01862328|66501346|FG000|Overall Study|Other|0|||
23760019|NCT01862328|66501347|FG001|Overall Study|Other|2|||
23760020|NCT01862328|66501348|FG002|Overall Study|Other|1|||
23441790|NCT02141360|65358624|FG001|Overall Study|Study Terminated before Visit|0|||
23441791|NCT02141360|65358625|FG002|Overall Study|Study Terminated before Visit|0|||
23441792|NCT01221350|65358628|FG000|Overall Study|Discontinued intervention (GERD)|1|||
23441793|NCT01221350|65358629|FG001|Overall Study|Discontinued intervention (GERD)|0|||
23441794|NCT01221350|65358628|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
23441795|NCT01221350|65358629|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
23441796|NCT01221350|65358628|FG000|Overall Study|Withdrawal by Subject|4|||
23441797|NCT01221350|65358629|FG001|Overall Study|Withdrawal by Subject|2|||
23441798|NCT01363661|65358636|FG000|Overall Study|Adverse Event|9|||
23564902|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564903|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564904|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
23626961|NCT01755546|66020462|FG000|Long Term Treatment|Protocol Violation|10|||
23626962|NCT01755546|66020462|FG000|Long Term Treatment|Withdrawal by Subject|35|||
23626963|NCT01755546|66020462|FG000|Long Term Treatment|Lost to Follow-up|17|||
23626964|NCT01755546|66020462|FG000|Long Term Treatment|other and ongoing|41|||
23626965|NCT02895360|66020463|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
23626966|NCT02895360|66020464|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23564905|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564906|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Disease Progression|0|||
23564907|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Disease Progression|0|||
23564908|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Disease Progression|0|||
23564909|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Disease Progression|38|||
23564910|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Disease Progression|0|||
23564911|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564912|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23626967|NCT02895360|66020465|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626968|NCT02895360|66020466|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626969|NCT02895360|66020467|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626970|NCT02895360|66020468|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626971|NCT02895360|66020463|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626972|NCT02895360|66020464|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
23760021|NCT01862328|66501349|FG003|Overall Study|Other|0|||
23760022|NCT01862328|66501350|FG004|Overall Study|Other|4|||
23441799|NCT01363661|65358637|FG001|Overall Study|Adverse Event|2|||
23626973|NCT02895360|66020465|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626974|NCT02895360|66020466|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23760023|NCT01862328|66501351|FG005|Overall Study|Other|0|||
23760024|NCT01862328|66501352|FG006|Overall Study|Other|1|||
23441800|NCT01363661|65358636|FG000|Overall Study|Withdrawal by Subject|1|||
23441801|NCT01363661|65358637|FG001|Overall Study|Withdrawal by Subject|1|||
23760025|NCT01862328|66501346|FG000|Overall Study|Withdrawal by Subject|1|||
23626975|NCT02895360|66020467|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626976|NCT02895360|66020468|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626977|NCT02895360|66020463|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626978|NCT02895360|66020464|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626979|NCT02895360|66020465|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
23626980|NCT02895360|66020466|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626981|NCT02895360|66020467|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626982|NCT02895360|66020468|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626983|NCT02895360|66020463|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626984|NCT02895360|66020464|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626985|NCT02895360|66020465|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
23626986|NCT02895360|66020466|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626987|NCT02895360|66020467|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626988|NCT02895360|66020468|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626989|NCT02895360|66020463|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626990|NCT02895360|66020464|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626991|NCT02895360|66020465|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626992|NCT02895360|66020466|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
23626993|NCT02895360|66020467|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626994|NCT02895360|66020468|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626995|NCT02895360|66020463|FG000|Phase 2a|Adverse Event|0|||
23626996|NCT02895360|66020464|FG001|Phase 2a|Adverse Event|0|||
23626997|NCT02895360|66020465|FG002|Phase 2a|Adverse Event|0|||
23626998|NCT02895360|66020466|FG003|Phase 2a|Adverse Event|0|||
23626999|NCT02895360|66020467|FG004|Phase 2a|Adverse Event|0|||
23627000|NCT02895360|66020468|FG005|Phase 2a|Adverse Event|1|||
23627001|NCT02895360|66020463|FG000|Phase 2a|Progressive disease|0|||
23627002|NCT02895360|66020464|FG001|Phase 2a|Progressive disease|0|||
23627003|NCT02895360|66020465|FG002|Phase 2a|Progressive disease|0|||
23627004|NCT02895360|66020466|FG003|Phase 2a|Progressive disease|0|||
23627005|NCT02895360|66020467|FG004|Phase 2a|Progressive disease|11|||
23627006|NCT02895360|66020468|FG005|Phase 2a|Progressive disease|11|||
23627007|NCT03418493|66020476|FG000|Overall Study|Adverse Event|1|||
23627008|NCT03418493|66020477|FG001|Overall Study|Adverse Event|0|||
23627009|NCT03418493|66020478|FG002|Overall Study|Adverse Event|0|||
23627010|NCT03418493|66020479|FG003|Overall Study|Adverse Event|0|||
23627011|NCT03418493|66020480|FG004|Overall Study|Adverse Event|0|||
23627012|NCT03418493|66020481|FG005|Overall Study|Adverse Event|0|||
23627013|NCT03418493|66020482|FG006|Overall Study|Adverse Event|0|||
23627014|NCT03418493|66020483|FG007|Overall Study|Adverse Event|0|||
23627015|NCT03418493|66020484|FG008|Overall Study|Adverse Event|0|||
23627016|NCT03418493|66020485|FG009|Overall Study|Adverse Event|0|||
23627017|NCT03418493|66020486|FG010|Overall Study|Adverse Event|0|||
23627018|NCT03418493|66020476|FG000|Overall Study|Protocol Violation|0|||
23627019|NCT03418493|66020477|FG001|Overall Study|Protocol Violation|0|||
23627020|NCT03418493|66020478|FG002|Overall Study|Protocol Violation|0|||
23627021|NCT03418493|66020479|FG003|Overall Study|Protocol Violation|0|||
23627022|NCT03418493|66020480|FG004|Overall Study|Protocol Violation|0|||
23627023|NCT03418493|66020481|FG005|Overall Study|Protocol Violation|0|||
23627024|NCT03418493|66020482|FG006|Overall Study|Protocol Violation|0|||
23627025|NCT03418493|66020483|FG007|Overall Study|Protocol Violation|0|||
23627026|NCT03418493|66020484|FG008|Overall Study|Protocol Violation|0|||
23627027|NCT03418493|66020485|FG009|Overall Study|Protocol Violation|1|||
23627028|NCT03418493|66020486|FG010|Overall Study|Protocol Violation|0|||
23627029|NCT03638258|66020488|FG000|Overall Study|Adverse Event|1|||
23627030|NCT03638258|66020489|FG001|Overall Study|Adverse Event|0|||
23627031|NCT03638258|66020490|FG002|Overall Study|Adverse Event|2|||
23627032|NCT03638258|66020488|FG000|Overall Study|Lost to Follow-up|2|||
23827397|NCT00369941|66748793|FG001|Overall Study|Lack of Efficacy|10|||
23827398|NCT00369941|66748792|FG000|Overall Study|Lost to Follow-up|12|||
23827399|NCT00369941|66748793|FG001|Overall Study|Lost to Follow-up|22|||
23827400|NCT00369941|66748792|FG000|Overall Study|Protocol Violation|5|||
23827401|NCT00369941|66748793|FG001|Overall Study|Protocol Violation|3|||
23827402|NCT00369941|66748792|FG000|Overall Study|Withdrawal by Subject|5|||
23827403|NCT00369941|66748793|FG001|Overall Study|Withdrawal by Subject|18|||
23627033|NCT03638258|66020489|FG001|Overall Study|Lost to Follow-up|4|||
23627034|NCT03638258|66020490|FG002|Overall Study|Lost to Follow-up|5|||
23627035|NCT03638258|66020488|FG000|Overall Study|Pregnancy|0|||
23827404|NCT00369941|66748792|FG000|Overall Study|Pregnancy|4|||
23827405|NCT00369941|66748793|FG001|Overall Study|Pregnancy|2|||
23827406|NCT00369941|66748792|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
23627036|NCT03638258|66020489|FG001|Overall Study|Pregnancy|0|||
23627037|NCT03638258|66020490|FG002|Overall Study|Pregnancy|1|||
23627038|NCT03638258|66020488|FG000|Overall Study|Protocol Violation|0|||
23627039|NCT03638258|66020489|FG001|Overall Study|Protocol Violation|0|||
23627040|NCT03638258|66020490|FG002|Overall Study|Protocol Violation|1|||
23627041|NCT03638258|66020488|FG000|Overall Study|Withdrawal by Subject|4|||
23627042|NCT03638258|66020489|FG001|Overall Study|Withdrawal by Subject|5|||
23827407|NCT00369941|66748793|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
23760026|NCT01862328|66501347|FG001|Overall Study|Withdrawal by Subject|1|||
23760027|NCT01862328|66501348|FG002|Overall Study|Withdrawal by Subject|0|||
23760028|NCT01862328|66501349|FG003|Overall Study|Withdrawal by Subject|0|||
23760029|NCT01862328|66501350|FG004|Overall Study|Withdrawal by Subject|1|||
23760030|NCT01862328|66501351|FG005|Overall Study|Withdrawal by Subject|1|||
23760031|NCT01862328|66501352|FG006|Overall Study|Withdrawal by Subject|1|||
23760032|NCT01862328|66501346|FG000|Overall Study|Symptomatic Deterioration|0|||
23760033|NCT01862328|66501347|FG001|Overall Study|Symptomatic Deterioration|0|||
23827408|NCT00369941|66748792|FG000|Overall Study|Moved|11|||
23827409|NCT00369941|66748793|FG001|Overall Study|Moved|5|||
23564913|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564914|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
23564915|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564916|NCT02667886|65796569|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564917|NCT02667886|65796570|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564918|NCT02667886|65796571|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564919|NCT02667886|65796572|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564920|NCT02667886|65796573|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
23564921|NCT02667886|65796569|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
23564922|NCT02667886|65796570|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
23564923|NCT02667886|65796571|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
23564924|NCT02667886|65796572|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
23564925|NCT02667886|65796573|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
23564926|NCT04954586|65796580|FG000|Overall Study|Withdrawal by Subject|5|||
23564927|NCT04186403|65796582|FG000|Overall Study|Adverse Event|1|||
23564928|NCT04186403|65796583|FG001|Overall Study|Adverse Event|8|||
23564929|NCT04186403|65796582|FG000|Overall Study|Lost to Follow-up|7|||
23564930|NCT04186403|65796583|FG001|Overall Study|Lost to Follow-up|3|||
23564931|NCT04186403|65796582|FG000|Overall Study|Physician Decision|1|||
23564932|NCT04186403|65796583|FG001|Overall Study|Physician Decision|0|||
23564933|NCT04186403|65796582|FG000|Overall Study|Withdrawal by Subject|7|||
23564934|NCT04186403|65796583|FG001|Overall Study|Withdrawal by Subject|8|||
23564935|NCT04186403|65796582|FG000|Overall Study|Other: Not Related to Covid-19|3|||
23564936|NCT04186403|65796583|FG001|Overall Study|Other: Not Related to Covid-19|0|||
23564937|NCT01598298|65796586|FG000|Overall Study|Not eligible|5|||
23564938|NCT01598298|65796587|FG001|Overall Study|Not eligible|5|||
23564939|NCT01598298|65796586|FG000|Overall Study|Adverse Event|21|||
23564940|NCT01598298|65796587|FG001|Overall Study|Adverse Event|19|||
23564941|NCT01598298|65796586|FG000|Overall Study|Progression/relapse|0|||
23564942|NCT01598298|65796587|FG001|Overall Study|Progression/relapse|2|||
23564943|NCT01598298|65796586|FG000|Overall Study|Withdrawal by Subject|10|||
23564944|NCT01598298|65796587|FG001|Overall Study|Withdrawal by Subject|15|||
23564945|NCT01598298|65796586|FG000|Overall Study|Other reason (not protocol specified)|4|||
23564946|NCT01598298|65796587|FG001|Overall Study|Other reason (not protocol specified)|0|||
23564947|NCT01008475|65796589|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
23564948|NCT01008475|65796590|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
23564949|NCT01008475|65796591|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
23564950|NCT01008475|65796592|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
23760034|NCT01862328|66501348|FG002|Overall Study|Symptomatic Deterioration|0|||
23760035|NCT01862328|66501349|FG003|Overall Study|Symptomatic Deterioration|0|||
23760036|NCT01862328|66501350|FG004|Overall Study|Symptomatic Deterioration|0|||
23760037|NCT01862328|66501351|FG005|Overall Study|Symptomatic Deterioration|0|||
23827410|NCT00369941|66748792|FG000|Overall Study|Treatment with Prohibited Medication|3|||
23441802|NCT01363661|65358636|FG000|Overall Study|Protocol Violation|1|||
23564951|NCT01008475|65796593|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
23564952|NCT01008475|65796594|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
23564953|NCT01008475|65796595|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
23564954|NCT04128293|65796597|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23827411|NCT00369941|66748793|FG001|Overall Study|Treatment with Prohibited Medication|1|||
23627043|NCT03638258|66020490|FG002|Overall Study|Withdrawal by Subject|12|||
23627044|NCT03638258|66020488|FG000|Overall Study|Lack of Efficacy|0|||
23627045|NCT03638258|66020489|FG001|Overall Study|Lack of Efficacy|0|||
23627046|NCT03638258|66020490|FG002|Overall Study|Lack of Efficacy|2|||
23627047|NCT00958711|66020491|FG000|Overall Study|Withdrawal by Subject|0|||
23627048|NCT00958711|66020492|FG001|Overall Study|Withdrawal by Subject|4|||
23627049|NCT00958711|66020491|FG000|Overall Study|Physician Decision|5|||
23627050|NCT00958711|66020492|FG001|Overall Study|Physician Decision|7|||
23627051|NCT00958711|66020491|FG000|Overall Study|Lost to Follow-up|4|||
23627052|NCT00958711|66020492|FG001|Overall Study|Lost to Follow-up|1|||
23627053|NCT00958711|66020491|FG000|Overall Study|Other|2|||
23627054|NCT00958711|66020492|FG001|Overall Study|Other|5|||
23627055|NCT00958711|66020491|FG000|Overall Study|Death|1|||
23627056|NCT00958711|66020492|FG001|Overall Study|Death|2|||
23627057|NCT00958711|66020491|FG000|Overall Study|Adverse Event|1|||
23627058|NCT00958711|66020492|FG001|Overall Study|Adverse Event|2|||
23627059|NCT03113383|66020493|FG000|Overall Study|Death|4|||
23627060|NCT03113383|66020494|FG001|Overall Study|Death|0|||
23627061|NCT02643628|66020495|FG000|Overall Study|Lost to Follow-up|1|||
23627062|NCT02643628|66020496|FG001|Overall Study|Lost to Follow-up|4|||
23627063|NCT02643628|66020495|FG000|Overall Study|Withdrawal by Subject|0|||
23627064|NCT02643628|66020496|FG001|Overall Study|Withdrawal by Subject|1|||
23627065|NCT02643628|66020495|FG000|Overall Study|Relocated out of state|0|||
23627066|NCT02643628|66020496|FG001|Overall Study|Relocated out of state|1|||
23627067|NCT00590564|66020499|FG000|Overall Study|Withdrawal by Subject|4|||
23627068|NCT00590564|66020499|FG000|Overall Study|Lost to Follow-up|6|||
23627069|NCT00590564|66020499|FG000|Overall Study|Protocol Violation|1|||
23627070|NCT00590564|66020499|FG000|Overall Study|Patient Found to be Ineligible|1|||
23627071|NCT00590564|66020499|FG000|Overall Study|Patient Non-compliance|6|||
23627072|NCT01845805|66020500|FG000|Overall Study|Withdrawal by Subject|1|||
23627073|NCT01845805|66020501|FG001|Overall Study|Withdrawal by Subject|2|||
23627074|NCT01845805|66020500|FG000|Overall Study|Disease Progression|13|||
23627075|NCT01845805|66020501|FG001|Overall Study|Disease Progression|14|||
23627076|NCT01845805|66020500|FG000|Overall Study|Drug-related Toxicity|4|||
23627077|NCT01845805|66020501|FG001|Overall Study|Drug-related Toxicity|0|||
23627078|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
23627079|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
23627080|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
23627081|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
23627082|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
23627083|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
23627084|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
23627085|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
23627086|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
23627087|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
23627088|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
23627089|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
23627090|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
23627091|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
23627092|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
23627093|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
23627094|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
23627095|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
23627096|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
23627097|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
23627098|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
23627099|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
23441803|NCT01363661|65358637|FG001|Overall Study|Protocol Violation|0|||
23627100|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
23627101|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
23627102|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
23627103|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
23627104|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
23627105|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
23760038|NCT01862328|66501352|FG006|Overall Study|Symptomatic Deterioration|1|||
23760039|NCT03439293|66501356|FG000|Overall Study|Death|22|||
23760040|NCT03439293|66501356|FG000|Overall Study|Withdrawal by Subject|8|||
23760041|NCT03439293|66501356|FG000|Overall Study|Lost to Follow-up|2|||
23760042|NCT03439293|66501356|FG000|Overall Study|Reason Not Specified|28|||
23760043|NCT03439293|66501356|FG000|Overall Study|Missing|1|||
23760044|NCT03361956|66501362|FG000|Overall Study|Adverse Event|1|||
23760045|NCT03361956|66501363|FG001|Overall Study|Adverse Event|0|||
23827412|NCT00369941|66748792|FG000|Overall Study|Employment Interfered with Study Visits|1|||
23827413|NCT00369941|66748793|FG001|Overall Study|Employment Interfered with Study Visits|0|||
23827414|NCT00369941|66748792|FG000|Overall Study|Study Site Terminated|2|||
23827415|NCT00369941|66748793|FG001|Overall Study|Study Site Terminated|0|||
23827416|NCT00369941|66748792|FG000|Overall Study|Miscellaneous|3|||
23827417|NCT00369941|66748793|FG001|Overall Study|Miscellaneous|3|||
23827418|NCT00711087|66748796|FG000|Overall Study|Lost to Follow-up|1|||
23827419|NCT00711087|66748797|FG001|Overall Study|Lost to Follow-up|0|||
23827420|NCT01326845|66748800|FG000|Overall Study|Administrative Problems|5|||
23827421|NCT01326845|66748801|FG001|Overall Study|Administrative Problems|2|||
23827422|NCT01326845|66748800|FG000|Overall Study|Adverse Event|1|||
23827423|NCT01326845|66748801|FG001|Overall Study|Adverse Event|0|||
23827424|NCT01326845|66748800|FG000|Overall Study|Misisng|1|||
23827425|NCT01326845|66748801|FG001|Overall Study|Misisng|3|||
23827426|NCT01112059|66748810|FG000|Overall Study|Withdrawal by Subject|1|||
23441804|NCT01363661|65358636|FG000|Overall Study|Lost to Follow-up|3|||
23441805|NCT01363661|65358637|FG001|Overall Study|Lost to Follow-up|1|||
23827427|NCT01112059|66748811|FG001|Overall Study|Withdrawal by Subject|0|||
23627106|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
23627107|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
23760046|NCT03361956|66501364|FG002|Overall Study|Adverse Event|1|||
23827428|NCT00124917|66748812|FG000|Overall Study|Physician Decision|3|||
23564955|NCT04128293|65796598|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23564956|NCT04128293|65796599|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23827429|NCT02854527|66748824|FG000|Overall Study|Adverse Event|0|||
23827430|NCT02854527|66748825|FG001|Overall Study|Adverse Event|0|||
23827431|NCT02854527|66748826|FG002|Overall Study|Adverse Event|0|||
23827432|NCT02854527|66748827|FG003|Overall Study|Adverse Event|0|||
23827433|NCT02854527|66748828|FG004|Overall Study|Adverse Event|1|||
23827434|NCT02854527|66748829|FG005|Overall Study|Adverse Event|0|||
23827435|NCT02854527|66748830|FG006|Overall Study|Adverse Event|0|||
23827436|NCT02854527|66748831|FG007|Overall Study|Adverse Event|0|||
23760047|NCT03361956|66501365|FG003|Overall Study|Adverse Event|1|||
23760048|NCT03361956|66501366|FG004|Overall Study|Adverse Event|0|||
23760049|NCT03361956|66501362|FG000|Overall Study|Other|0|||
23760050|NCT03361956|66501363|FG001|Overall Study|Other|0|||
23827437|NCT02854527|66748832|FG008|Overall Study|Adverse Event|0|||
23827438|NCT02854527|66748833|FG009|Overall Study|Adverse Event|0|||
23827439|NCT02854527|66748824|FG000|Overall Study|Lost to Follow-up|0|||
23760051|NCT03361956|66501364|FG002|Overall Study|Other|0|||
23760052|NCT03361956|66501365|FG003|Overall Study|Other|1|||
23760053|NCT03361956|66501366|FG004|Overall Study|Other|0|||
23827440|NCT02854527|66748825|FG001|Overall Study|Lost to Follow-up|0|||
23827441|NCT02854527|66748826|FG002|Overall Study|Lost to Follow-up|0|||
23827442|NCT02854527|66748827|FG003|Overall Study|Lost to Follow-up|1|||
23827443|NCT02854527|66748828|FG004|Overall Study|Lost to Follow-up|0|||
23827444|NCT02854527|66748829|FG005|Overall Study|Lost to Follow-up|0|||
23827445|NCT02854527|66748830|FG006|Overall Study|Lost to Follow-up|0|||
23827446|NCT02854527|66748831|FG007|Overall Study|Lost to Follow-up|0|||
23827447|NCT02854527|66748832|FG008|Overall Study|Lost to Follow-up|0|||
23827448|NCT02854527|66748833|FG009|Overall Study|Lost to Follow-up|0|||
23827449|NCT03125798|66748834|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
23827450|NCT03125798|66748835|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
23827451|NCT03125798|66748834|FG000|Overall Study|Conversion to thoracotomy|7|||
23760054|NCT03361956|66501362|FG000|Overall Study|Withdrawal by Subject|2|||
23760055|NCT03361956|66501363|FG001|Overall Study|Withdrawal by Subject|2|||
23760056|NCT03361956|66501364|FG002|Overall Study|Withdrawal by Subject|2|||
23760057|NCT03361956|66501365|FG003|Overall Study|Withdrawal by Subject|0|||
23760058|NCT03361956|66501366|FG004|Overall Study|Withdrawal by Subject|3|||
23760059|NCT03361956|66501362|FG000|Overall Study|Disease Relapse|0|||
23827452|NCT03125798|66748835|FG001|Overall Study|Conversion to thoracotomy|7|||
23827453|NCT02387840|66748837|FG000|Overall Study|Death|0|||
23827454|NCT02387840|66748838|FG001|Overall Study|Death|0|||
23827455|NCT02387840|66748839|FG002|Overall Study|Death|0|||
23827456|NCT02387840|66748840|FG003|Overall Study|Death|0|||
23827457|NCT02387840|66748841|FG004|Overall Study|Death|0|||
23827458|NCT02387840|66748842|FG005|Overall Study|Death|1|||
23760060|NCT03361956|66501363|FG001|Overall Study|Disease Relapse|0|||
23760061|NCT03361956|66501364|FG002|Overall Study|Disease Relapse|1|||
23760062|NCT03361956|66501365|FG003|Overall Study|Disease Relapse|0|||
23760063|NCT03361956|66501366|FG004|Overall Study|Disease Relapse|0|||
23760064|NCT03361956|66501362|FG000|Overall Study|Physician Decision|0|||
23760065|NCT03361956|66501363|FG001|Overall Study|Physician Decision|2|||
23760066|NCT03361956|66501364|FG002|Overall Study|Physician Decision|0|||
23760067|NCT03361956|66501365|FG003|Overall Study|Physician Decision|1|||
23760068|NCT03361956|66501366|FG004|Overall Study|Physician Decision|0|||
23760069|NCT03361956|66501362|FG000|Overall Study|Lost to Follow-up|0|||
23760070|NCT03361956|66501363|FG001|Overall Study|Lost to Follow-up|0|||
23760071|NCT03361956|66501364|FG002|Overall Study|Lost to Follow-up|1|||
23760072|NCT03361956|66501365|FG003|Overall Study|Lost to Follow-up|1|||
23760073|NCT03361956|66501366|FG004|Overall Study|Lost to Follow-up|2|||
23760074|NCT02544633|66501371|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
23760075|NCT02544633|66501372|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
23760076|NCT02544633|66501373|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
23760077|NCT02544633|66501374|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
23760078|NCT02544633|66501371|FG000|Treatment Period|Adverse Event|7|||
23760079|NCT02544633|66501372|FG001|Treatment Period|Adverse Event|4|||
23760080|NCT02544633|66501373|FG002|Treatment Period|Adverse Event|0|||
23760081|NCT02544633|66501374|FG003|Treatment Period|Adverse Event|5|||
23760082|NCT02544633|66501371|FG000|Treatment Period|Lack of Efficacy|17|||
23760083|NCT02544633|66501372|FG001|Treatment Period|Lack of Efficacy|11|||
23827459|NCT02392481|66748845|FG000|Overall Study|Adverse Event|0|||
23827460|NCT02392481|66748846|FG001|Overall Study|Adverse Event|0|||
23827461|NCT02392481|66748847|FG002|Overall Study|Adverse Event|1|||
23827462|NCT02392481|66748848|FG003|Overall Study|Adverse Event|2|||
23827463|NCT02392481|66748845|FG000|Overall Study|Withdrawal by Subject|0|||
23564957|NCT04128293|65796600|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23564958|NCT03820323|65796601|FG000|Overall Study|Lost to Follow-up|2|||
23564959|NCT03820323|65796602|FG001|Overall Study|Lost to Follow-up|1|||
23564960|NCT03820323|65796601|FG000|Overall Study|Missed 12-month visit|22|||
23564961|NCT03820323|65796602|FG001|Overall Study|Missed 12-month visit|14|||
23760084|NCT02544633|66501373|FG002|Treatment Period|Lack of Efficacy|5|||
23760085|NCT02544633|66501374|FG003|Treatment Period|Lack of Efficacy|5|||
23760086|NCT02544633|66501371|FG000|Treatment Period|Global Deterioration of Health|3|||
23760087|NCT02544633|66501372|FG001|Treatment Period|Global Deterioration of Health|3|||
23760088|NCT02544633|66501373|FG002|Treatment Period|Global Deterioration of Health|0|||
23760089|NCT02544633|66501374|FG003|Treatment Period|Global Deterioration of Health|1|||
23760090|NCT02544633|66501371|FG000|Treatment Period|Withdrawal by Subject|1|||
23760091|NCT02544633|66501372|FG001|Treatment Period|Withdrawal by Subject|0|||
23760092|NCT02544633|66501373|FG002|Treatment Period|Withdrawal by Subject|0|||
23760093|NCT02544633|66501374|FG003|Treatment Period|Withdrawal by Subject|0|||
23760094|NCT02544633|66501371|FG000|Treatment Period|Lost to Follow-up|0|||
23760095|NCT02544633|66501372|FG001|Treatment Period|Lost to Follow-up|1|||
23760096|NCT02544633|66501373|FG002|Treatment Period|Lost to Follow-up|0|||
23760097|NCT02544633|66501374|FG003|Treatment Period|Lost to Follow-up|0|||
23760098|NCT02544633|66501371|FG000|Treatment Period|Death|0|||
23760099|NCT02544633|66501372|FG001|Treatment Period|Death|0|||
23760100|NCT02544633|66501373|FG002|Treatment Period|Death|1|||
23760101|NCT02544633|66501374|FG003|Treatment Period|Death|0|||
23760102|NCT02544633|66501371|FG000|Treatment Period|Non-compliance|0|||
23760103|NCT02544633|66501372|FG001|Treatment Period|Non-compliance|0|||
23760104|NCT02544633|66501373|FG002|Treatment Period|Non-compliance|1|||
23760105|NCT02544633|66501374|FG003|Treatment Period|Non-compliance|0|||
23760106|NCT02544633|66501371|FG000|Treatment Period|Clinical Disease Progression|0|||
23760107|NCT02544633|66501372|FG001|Treatment Period|Clinical Disease Progression|0|||
23760108|NCT02544633|66501373|FG002|Treatment Period|Clinical Disease Progression|0|||
23760109|NCT02544633|66501374|FG003|Treatment Period|Clinical Disease Progression|1|||
23760110|NCT02544633|66501371|FG000|Survival Follow-up Period|Death|12|||
23760111|NCT02544633|66501372|FG001|Survival Follow-up Period|Death|14|||
23760112|NCT02544633|66501373|FG002|Survival Follow-up Period|Death|3|||
23760113|NCT02544633|66501374|FG003|Survival Follow-up Period|Death|9|||
23760114|NCT02544633|66501371|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
23760115|NCT02544633|66501372|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
23760116|NCT02544633|66501373|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
23760117|NCT02544633|66501374|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
23760118|NCT02544633|66501371|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
23760119|NCT02544633|66501372|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
23760120|NCT02544633|66501373|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
23760121|NCT02544633|66501374|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
23760122|NCT02544633|66501371|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
23760123|NCT02544633|66501372|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
23760124|NCT02544633|66501373|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
23760125|NCT02544633|66501374|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
23760126|NCT00911859|66501387|FG000|Treatment Period|Adverse Event|3|||
23760127|NCT00911859|66501388|FG001|Treatment Period|Adverse Event|3|||
23760128|NCT00911859|66501389|FG002|Treatment Period|Adverse Event|7|||
23760129|NCT00911859|66501387|FG000|Treatment Period|Death|1|||
23760130|NCT00911859|66501388|FG001|Treatment Period|Death|3|||
23760131|NCT00911859|66501389|FG002|Treatment Period|Death|5|||
23760132|NCT00911859|66501387|FG000|Treatment Period|Lack of Efficacy|1|||
23760133|NCT00911859|66501388|FG001|Treatment Period|Lack of Efficacy|7|||
23760134|NCT00911859|66501389|FG002|Treatment Period|Lack of Efficacy|5|||
23760135|NCT00911859|66501387|FG000|Treatment Period|Physician Decision|3|||
23760136|NCT00911859|66501388|FG001|Treatment Period|Physician Decision|3|||
23760137|NCT00911859|66501389|FG002|Treatment Period|Physician Decision|3|||
23760138|NCT00911859|66501387|FG000|Treatment Period|Withdrawal by Subject|0|||
23760139|NCT00911859|66501388|FG001|Treatment Period|Withdrawal by Subject|4|||
23760140|NCT00911859|66501389|FG002|Treatment Period|Withdrawal by Subject|5|||
23760141|NCT00911859|66501387|FG000|Treatment Period|Did not receive study treatment|0|||
23760142|NCT00911859|66501388|FG001|Treatment Period|Did not receive study treatment|1|||
23441806|NCT00858637|65358638|FG000|Active Comparison Phase|Adverse Event|14|||
23760143|NCT00911859|66501389|FG002|Treatment Period|Did not receive study treatment|0|||
23760144|NCT00911859|66501387|FG000|Maintainance Period|Lack of Efficacy|0|||
23441807|NCT00858637|65358639|FG001|Active Comparison Phase|Adverse Event|0|||
23441808|NCT00858637|65358640|FG002|Active Comparison Phase|Adverse Event|0|||
23441809|NCT00858637|65358641|FG003|Active Comparison Phase|Adverse Event|9|||
23441810|NCT00858637|65358642|FG004|Active Comparison Phase|Adverse Event|0|||
23760145|NCT00911859|66501388|FG001|Maintainance Period|Lack of Efficacy|0|||
23760146|NCT00911859|66501389|FG002|Maintainance Period|Lack of Efficacy|9|||
23760147|NCT00911859|66501387|FG000|Maintainance Period|Physician Decision|0|||
23760148|NCT00911859|66501388|FG001|Maintainance Period|Physician Decision|0|||
23760149|NCT00911859|66501389|FG002|Maintainance Period|Physician Decision|9|||
23760150|NCT00911859|66501387|FG000|Maintainance Period|Withdrawal by Subject|0|||
23760151|NCT00911859|66501388|FG001|Maintainance Period|Withdrawal by Subject|0|||
23760152|NCT00911859|66501389|FG002|Maintainance Period|Withdrawal by Subject|3|||
23760153|NCT00911859|66501387|FG000|Follow-up Period|Death|5|||
23760154|NCT00911859|66501388|FG001|Follow-up Period|Death|8|||
23760155|NCT00911859|66501389|FG002|Follow-up Period|Death|10|||
23760156|NCT00911859|66501387|FG000|Follow-up Period|Lost to Follow-up|1|||
23760157|NCT00911859|66501388|FG001|Follow-up Period|Lost to Follow-up|1|||
23760158|NCT00911859|66501389|FG002|Follow-up Period|Lost to Follow-up|0|||
23760159|NCT00911859|66501387|FG000|Follow-up Period|Withdrawal by Subject|0|||
23760160|NCT00911859|66501388|FG001|Follow-up Period|Withdrawal by Subject|4|||
23760161|NCT00911859|66501389|FG002|Follow-up Period|Withdrawal by Subject|4|||
23760162|NCT00911859|66501387|FG000|Follow-up Period|Study terminated by sponsor|5|||
23760163|NCT00911859|66501388|FG001|Follow-up Period|Study terminated by sponsor|33|||
23760164|NCT00911859|66501389|FG002|Follow-up Period|Study terminated by sponsor|27|||
23760165|NCT01252238|66501390|FG000|Overall Study|Sponsor terminated study|4|||
23760166|NCT01252238|66501391|FG001|Overall Study|Sponsor terminated study|4|||
23760167|NCT01252238|66501392|FG002|Overall Study|Sponsor terminated study|4|||
23760168|NCT01272193|66501393|FG000|Overall Study|Adverse Event|1|||
23760169|NCT01272193|66501394|FG001|Overall Study|Adverse Event|1|||
23760170|NCT01272193|66501393|FG000|Overall Study|Lack of Efficacy|0|||
23760171|NCT01272193|66501394|FG001|Overall Study|Lack of Efficacy|3|||
23760172|NCT01272193|66501393|FG000|Overall Study|Withdrawal Criteria|1|||
23760173|NCT01272193|66501394|FG001|Overall Study|Withdrawal Criteria|1|||
23760174|NCT01272193|66501393|FG000|Overall Study|Unclassified|8|||
23760175|NCT01272193|66501394|FG001|Overall Study|Unclassified|7|||
23760176|NCT02451670|66501395|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
23760177|NCT02451670|66501396|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
23760178|NCT04356573|66501404|FG000|Overall Study|Didn't Qualify|1|||
23760179|NCT04356573|66501405|FG001|Overall Study|Didn't Qualify|0|||
23760180|NCT00534092|66501406|FG000|Overall Study|Lost to Follow-up|1|||
23760181|NCT00534092|66501407|FG001|Overall Study|Lost to Follow-up|0|||
23760182|NCT00534092|66501406|FG000|Overall Study|personal reasons/family concerns|1|||
23760183|NCT00534092|66501407|FG001|Overall Study|personal reasons/family concerns|0|||
23760184|NCT01690520|66501408|FG000|Overall Study|Death|25|||
23760185|NCT01690520|66501409|FG001|Overall Study|Death|21|||
23760186|NCT01690520|66501408|FG000|Overall Study|Lost to Follow-up|2|||
23760187|NCT01690520|66501409|FG001|Overall Study|Lost to Follow-up|3|||
23760188|NCT01690520|66501408|FG000|Overall Study|Withdrawal by Subject|2|||
23760189|NCT01690520|66501409|FG001|Overall Study|Withdrawal by Subject|0|||
23760190|NCT01690520|66501408|FG000|Overall Study|Relapse|0|||
23760191|NCT01690520|66501409|FG001|Overall Study|Relapse|1|||
23760192|NCT01690520|66501408|FG000|Overall Study|Other|0|||
23760193|NCT01690520|66501409|FG001|Overall Study|Other|1|||
23760194|NCT01690520|66501408|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
23760195|NCT01690520|66501409|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
23760196|NCT00095199|66501410|FG000|Overall Study|Adverse Event|40|||
23760197|NCT00095199|66501411|FG001|Overall Study|Adverse Event|22|||
23760198|NCT00095199|66501412|FG002|Overall Study|Adverse Event|26|||
23760199|NCT00095199|66501413|FG003|Overall Study|Adverse Event|11|||
23760200|NCT00095199|66501410|FG000|Overall Study|Progressive disease|213|||
23760201|NCT00095199|66501411|FG001|Overall Study|Progressive disease|179|||
23760202|NCT00095199|66501412|FG002|Overall Study|Progressive disease|105|||
23760203|NCT00095199|66501413|FG003|Overall Study|Progressive disease|98|||
23760204|NCT00095199|66501410|FG000|Overall Study|Death|10|||
23760205|NCT00095199|66501411|FG001|Overall Study|Death|6|||
23760206|NCT00095199|66501412|FG002|Overall Study|Death|11|||
23760207|NCT00095199|66501413|FG003|Overall Study|Death|9|||
23760208|NCT00095199|66501410|FG000|Overall Study|Withdrawal by Subject|21|||
23760209|NCT00095199|66501411|FG001|Overall Study|Withdrawal by Subject|16|||
23760210|NCT00095199|66501412|FG002|Overall Study|Withdrawal by Subject|13|||
23760211|NCT00095199|66501413|FG003|Overall Study|Withdrawal by Subject|22|||
23760212|NCT00095199|66501410|FG000|Overall Study|Protocol Violation|4|||
23760213|NCT00095199|66501411|FG001|Overall Study|Protocol Violation|4|||
23760214|NCT00095199|66501412|FG002|Overall Study|Protocol Violation|2|||
23760215|NCT00095199|66501413|FG003|Overall Study|Protocol Violation|0|||
23760216|NCT00095199|66501410|FG000|Overall Study|Liver function test results elevated|0|||
23760217|NCT00095199|66501411|FG001|Overall Study|Liver function test results elevated|0|||
23760218|NCT00095199|66501412|FG002|Overall Study|Liver function test results elevated|1|||
23760219|NCT00095199|66501413|FG003|Overall Study|Liver function test results elevated|1|||
23760220|NCT00095199|66501410|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
23760221|NCT00095199|66501411|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
23760222|NCT00095199|66501412|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
23760223|NCT00095199|66501413|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
23760224|NCT00095199|66501410|FG000|Overall Study|Physician Decision|5|||
23760225|NCT00095199|66501411|FG001|Overall Study|Physician Decision|6|||
23760226|NCT00095199|66501412|FG002|Overall Study|Physician Decision|1|||
23760227|NCT00095199|66501413|FG003|Overall Study|Physician Decision|1|||
23760228|NCT00095199|66501410|FG000|Overall Study|Not eligible|1|||
23760229|NCT00095199|66501411|FG001|Overall Study|Not eligible|7|||
23760230|NCT00095199|66501412|FG002|Overall Study|Not eligible|0|||
23760231|NCT00095199|66501413|FG003|Overall Study|Not eligible|1|||
23760232|NCT00095199|66501410|FG000|Overall Study|Started Palliative Radiotherapy|1|||
23760233|NCT00095199|66501411|FG001|Overall Study|Started Palliative Radiotherapy|0|||
23760234|NCT00095199|66501412|FG002|Overall Study|Started Palliative Radiotherapy|0|||
23760235|NCT00095199|66501413|FG003|Overall Study|Started Palliative Radiotherapy|0|||
23760236|NCT00095199|66501410|FG000|Overall Study|Started radiotherapy regimen|0|||
23760237|NCT00095199|66501411|FG001|Overall Study|Started radiotherapy regimen|1|||
23760238|NCT00095199|66501412|FG002|Overall Study|Started radiotherapy regimen|0|||
23760239|NCT00095199|66501413|FG003|Overall Study|Started radiotherapy regimen|0|||
23760240|NCT00095199|66501410|FG000|Overall Study|Primary tumor removed in other surgery|0|||
23760241|NCT00095199|66501411|FG001|Overall Study|Primary tumor removed in other surgery|1|||
23760242|NCT00095199|66501412|FG002|Overall Study|Primary tumor removed in other surgery|0|||
23760243|NCT00095199|66501413|FG003|Overall Study|Primary tumor removed in other surgery|0|||
23760244|NCT00095199|66501410|FG000|Overall Study|Data inadvertently lost by site|1|||
23760245|NCT00095199|66501411|FG001|Overall Study|Data inadvertently lost by site|0|||
23760246|NCT00095199|66501412|FG002|Overall Study|Data inadvertently lost by site|0|||
23760247|NCT00095199|66501413|FG003|Overall Study|Data inadvertently lost by site|0|||
23760248|NCT02464059|66501414|FG000|Overall Study|Lost to Follow-up|6|||
23760249|NCT01155063|66501415|FG000|Overall Study|Adverse Event|1|||
23760250|NCT01155063|66501415|FG000|Overall Study|Withdrawal by Subject|1|||
23760251|NCT01155063|66501415|FG000|Overall Study|Study terminated by sponsor|87|||
23760252|NCT00931385|66501416|FG000|Overall Study|Adverse Event|2|||
23760253|NCT00931385|66501417|FG001|Overall Study|Adverse Event|1|||
23760254|NCT00931385|66501418|FG002|Overall Study|Adverse Event|0|||
23760255|NCT00931385|66501419|FG003|Overall Study|Adverse Event|3|||
23760256|NCT00931385|66501416|FG000|Overall Study|Protocol Violation|0|||
23760257|NCT00931385|66501417|FG001|Overall Study|Protocol Violation|0|||
23760258|NCT00931385|66501418|FG002|Overall Study|Protocol Violation|1|||
23760259|NCT00931385|66501419|FG003|Overall Study|Protocol Violation|0|||
23760260|NCT00931385|66501416|FG000|Overall Study|Withdrawal by Subject|0|||
23760261|NCT00931385|66501417|FG001|Overall Study|Withdrawal by Subject|1|||
23760262|NCT00931385|66501418|FG002|Overall Study|Withdrawal by Subject|0|||
23760263|NCT00931385|66501419|FG003|Overall Study|Withdrawal by Subject|1|||
23760264|NCT00931385|66501416|FG000|Overall Study|Lost to Follow-up|0|||
23760265|NCT00931385|66501417|FG001|Overall Study|Lost to Follow-up|0|||
23760266|NCT00931385|66501418|FG002|Overall Study|Lost to Follow-up|0|||
23760267|NCT00931385|66501419|FG003|Overall Study|Lost to Follow-up|1|||
23760268|NCT00923195|66501420|FG000|Overall Study|Death|0|||
23760269|NCT00923195|66501421|FG001|Overall Study|Death|1|||
23760270|NCT00593333|66501422|FG000|Overall Study|Lost to Follow-up|10|||
23760271|NCT00593333|66501423|FG001|Overall Study|Lost to Follow-up|11|||
23760272|NCT03877237|66501424|FG000|Overall Study|Adverse Event|1|||
23760273|NCT03877237|66501425|FG001|Overall Study|Adverse Event|2|||
23760274|NCT03877237|66501424|FG000|Overall Study|Death|3|||
23760275|NCT03877237|66501425|FG001|Overall Study|Death|2|||
23760276|NCT03877237|66501424|FG000|Overall Study|Physician Decision|1|||
23760277|NCT03877237|66501425|FG001|Overall Study|Physician Decision|0|||
23760278|NCT03877237|66501424|FG000|Overall Study|Withdrawal by Subject|0|||
23760279|NCT03877237|66501425|FG001|Overall Study|Withdrawal by Subject|2|||
23760280|NCT00736333|66501426|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
23760281|NCT00736333|66501426|FG000|Overall Study|Data Missing|2|||
23760282|NCT00736333|66501426|FG000|Overall Study|Tumor Progression|75|||
23760283|NCT00736333|66501426|FG000|Overall Study|Toxicity|6|||
23760284|NCT00736333|66501426|FG000|Overall Study|Withdrawal by Subject|10|||
23760285|NCT00736333|66501426|FG000|Overall Study|Death|7|||
23760286|NCT00736333|66501426|FG000|Overall Study|Other|4|||
23760287|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
23760288|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
23760289|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
23760290|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
23760291|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
23760292|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
23760293|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
23760294|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
23760295|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
23760296|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
23760297|NCT00124449|66501427|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
23760298|NCT00124449|66501428|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
23760299|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
23760300|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
23760301|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
23760302|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
23760303|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
23760304|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
23760305|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
23760306|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
23760307|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
23760308|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
23760309|NCT00124449|66501427|FG000|18-Month Untreated Observation Period|Relocated|1|||
23760310|NCT00124449|66501428|FG001|18-Month Untreated Observation Period|Relocated|0|||
23760311|NCT02454972|66501429|FG000|Overall Study|Progressive disease|17|||
23760312|NCT02454972|66501430|FG001|Overall Study|Progressive disease|16|||
23760313|NCT02454972|66501431|FG002|Overall Study|Progressive disease|59|||
23760314|NCT02454972|66501432|FG003|Overall Study|Progressive disease|23|||
23760315|NCT02454972|66501433|FG004|Overall Study|Progressive disease|16|||
23760316|NCT02454972|66501434|FG005|Overall Study|Progressive disease|12|||
23760317|NCT02454972|66501435|FG006|Overall Study|Progressive disease|19|||
23760318|NCT02454972|66501436|FG007|Overall Study|Progressive disease|27|||
23760319|NCT02454972|66501437|FG008|Overall Study|Progressive disease|0|||
23760320|NCT02454972|66501429|FG000|Overall Study|Death|0|||
23760321|NCT02454972|66501430|FG001|Overall Study|Death|0|||
23760322|NCT02454972|66501431|FG002|Overall Study|Death|5|||
23760323|NCT02454972|66501432|FG003|Overall Study|Death|1|||
23760324|NCT02454972|66501433|FG004|Overall Study|Death|0|||
23760325|NCT02454972|66501434|FG005|Overall Study|Death|0|||
23760326|NCT02454972|66501435|FG006|Overall Study|Death|0|||
23760327|NCT02454972|66501436|FG007|Overall Study|Death|0|||
23760328|NCT02454972|66501437|FG008|Overall Study|Death|95|||
23760329|NCT02454972|66501429|FG000|Overall Study|Physician Decision|0|||
23760330|NCT02454972|66501430|FG001|Overall Study|Physician Decision|1|||
23760331|NCT02454972|66501431|FG002|Overall Study|Physician Decision|2|||
23760332|NCT02454972|66501432|FG003|Overall Study|Physician Decision|1|||
23760333|NCT02454972|66501433|FG004|Overall Study|Physician Decision|2|||
23760334|NCT02454972|66501434|FG005|Overall Study|Physician Decision|0|||
23760335|NCT02454972|66501435|FG006|Overall Study|Physician Decision|0|||
23760336|NCT02454972|66501436|FG007|Overall Study|Physician Decision|1|||
23760337|NCT02454972|66501437|FG008|Overall Study|Physician Decision|0|||
23760338|NCT02454972|66501429|FG000|Overall Study|Non treatment-related adverse event|2|||
23760339|NCT02454972|66501430|FG001|Overall Study|Non treatment-related adverse event|0|||
23760340|NCT02454972|66501431|FG002|Overall Study|Non treatment-related adverse event|1|||
23760341|NCT02454972|66501432|FG003|Overall Study|Non treatment-related adverse event|0|||
23760342|NCT02454972|66501433|FG004|Overall Study|Non treatment-related adverse event|0|||
23760343|NCT02454972|66501434|FG005|Overall Study|Non treatment-related adverse event|1|||
23760344|NCT02454972|66501435|FG006|Overall Study|Non treatment-related adverse event|0|||
23760345|NCT02454972|66501436|FG007|Overall Study|Non treatment-related adverse event|1|||
23760346|NCT02454972|66501437|FG008|Overall Study|Non treatment-related adverse event|0|||
23760347|NCT02454972|66501429|FG000|Overall Study|Treatment-related adverse events|0|||
23827464|NCT02392481|66748846|FG001|Overall Study|Withdrawal by Subject|0|||
23827465|NCT02392481|66748847|FG002|Overall Study|Withdrawal by Subject|1|||
23827466|NCT02392481|66748848|FG003|Overall Study|Withdrawal by Subject|0|||
23760348|NCT02454972|66501430|FG001|Overall Study|Treatment-related adverse events|1|||
23760349|NCT02454972|66501431|FG002|Overall Study|Treatment-related adverse events|1|||
23760350|NCT02454972|66501432|FG003|Overall Study|Treatment-related adverse events|0|||
23827467|NCT00615199|66748849|FG000|Overall Study|Adverse Event|3|||
23827468|NCT00615199|66748850|FG001|Overall Study|Adverse Event|1|||
23827469|NCT00615199|66748851|FG002|Overall Study|Adverse Event|1|||
23760351|NCT02454972|66501433|FG004|Overall Study|Treatment-related adverse events|2|||
23760352|NCT02454972|66501434|FG005|Overall Study|Treatment-related adverse events|0|||
23760353|NCT02454972|66501435|FG006|Overall Study|Treatment-related adverse events|0|||
23760354|NCT02454972|66501436|FG007|Overall Study|Treatment-related adverse events|2|||
23760355|NCT02454972|66501437|FG008|Overall Study|Treatment-related adverse events|0|||
23760356|NCT02454972|66501429|FG000|Overall Study|Patient moves to compassionate use|0|||
23760357|NCT02454972|66501430|FG001|Overall Study|Patient moves to compassionate use|0|||
23760358|NCT02454972|66501431|FG002|Overall Study|Patient moves to compassionate use|0|||
23760359|NCT02454972|66501432|FG003|Overall Study|Patient moves to compassionate use|0|||
23760360|NCT02454972|66501433|FG004|Overall Study|Patient moves to compassionate use|0|||
23760361|NCT02454972|66501434|FG005|Overall Study|Patient moves to compassionate use|0|||
23760362|NCT02454972|66501435|FG006|Overall Study|Patient moves to compassionate use|2|||
23760363|NCT02454972|66501436|FG007|Overall Study|Patient moves to compassionate use|0|||
23760364|NCT02454972|66501437|FG008|Overall Study|Patient moves to compassionate use|0|||
23760365|NCT02454972|66501429|FG000|Overall Study|Withdrawal by Subject|0|||
23760366|NCT02454972|66501430|FG001|Overall Study|Withdrawal by Subject|1|||
23760367|NCT02454972|66501431|FG002|Overall Study|Withdrawal by Subject|5|||
23827470|NCT00615199|66748852|FG003|Overall Study|Adverse Event|0|||
23564962|NCT03820323|65796601|FG000|Overall Study|Death|2|||
23441811|NCT00858637|65358643|FG005|Active Comparison Phase|Adverse Event|0|||
23441812|NCT00858637|65358638|FG000|Active Comparison Phase|Death|1|||
23441813|NCT00858637|65358639|FG001|Active Comparison Phase|Death|0|||
23441814|NCT00858637|65358640|FG002|Active Comparison Phase|Death|0|||
23441815|NCT00858637|65358641|FG003|Active Comparison Phase|Death|1|||
23441816|NCT00858637|65358642|FG004|Active Comparison Phase|Death|0|||
23441817|NCT00858637|65358643|FG005|Active Comparison Phase|Death|0|||
23441818|NCT00858637|65358638|FG000|Active Comparison Phase|Physician Decision|1|||
23441819|NCT00858637|65358639|FG001|Active Comparison Phase|Physician Decision|0|||
23441820|NCT00858637|65358640|FG002|Active Comparison Phase|Physician Decision|0|||
23441821|NCT00858637|65358641|FG003|Active Comparison Phase|Physician Decision|1|||
23441822|NCT00858637|65358642|FG004|Active Comparison Phase|Physician Decision|0|||
23564963|NCT03820323|65796602|FG001|Overall Study|Death|1|||
23564964|NCT03820323|65796601|FG000|Overall Study|Transferred out|13|||
23760368|NCT02454972|66501432|FG003|Overall Study|Withdrawal by Subject|2|||
23760369|NCT02454972|66501433|FG004|Overall Study|Withdrawal by Subject|3|||
23760370|NCT02454972|66501434|FG005|Overall Study|Withdrawal by Subject|2|||
23760371|NCT02454972|66501435|FG006|Overall Study|Withdrawal by Subject|0|||
23760372|NCT02454972|66501436|FG007|Overall Study|Withdrawal by Subject|1|||
23760373|NCT02454972|66501437|FG008|Overall Study|Withdrawal by Subject|2|||
23760374|NCT02454972|66501429|FG000|Overall Study|Multiple delay/holds on treatment|0|||
23760375|NCT02454972|66501430|FG001|Overall Study|Multiple delay/holds on treatment|0|||
23760376|NCT02454972|66501431|FG002|Overall Study|Multiple delay/holds on treatment|0|||
23760377|NCT02454972|66501432|FG003|Overall Study|Multiple delay/holds on treatment|1|||
23760378|NCT02454972|66501433|FG004|Overall Study|Multiple delay/holds on treatment|0|||
23760379|NCT02454972|66501434|FG005|Overall Study|Multiple delay/holds on treatment|0|||
23760380|NCT02454972|66501435|FG006|Overall Study|Multiple delay/holds on treatment|0|||
23760381|NCT02454972|66501436|FG007|Overall Study|Multiple delay/holds on treatment|0|||
23760382|NCT02454972|66501437|FG008|Overall Study|Multiple delay/holds on treatment|0|||
23760383|NCT02454972|66501429|FG000|Overall Study|Never treated|0|||
23760384|NCT02454972|66501430|FG001|Overall Study|Never treated|0|||
23760385|NCT02454972|66501431|FG002|Overall Study|Never treated|3|||
23760386|NCT02454972|66501432|FG003|Overall Study|Never treated|1|||
23760387|NCT02454972|66501433|FG004|Overall Study|Never treated|1|||
23760388|NCT02454972|66501434|FG005|Overall Study|Never treated|0|||
23760389|NCT02454972|66501435|FG006|Overall Study|Never treated|0|||
23760390|NCT02454972|66501436|FG007|Overall Study|Never treated|0|||
23760391|NCT02454972|66501437|FG008|Overall Study|Never treated|5|||
23760392|NCT02454972|66501429|FG000|Overall Study|Lost to Follow-up|0|||
23760393|NCT02454972|66501430|FG001|Overall Study|Lost to Follow-up|0|||
23760394|NCT02454972|66501431|FG002|Overall Study|Lost to Follow-up|0|||
23760395|NCT02454972|66501432|FG003|Overall Study|Lost to Follow-up|0|||
23760396|NCT02454972|66501433|FG004|Overall Study|Lost to Follow-up|0|||
23827471|NCT00615199|66748849|FG000|Overall Study|Lack of Efficacy|2|||
23827472|NCT00615199|66748850|FG001|Overall Study|Lack of Efficacy|0|||
23827473|NCT00615199|66748851|FG002|Overall Study|Lack of Efficacy|0|||
23827474|NCT00615199|66748852|FG003|Overall Study|Lack of Efficacy|1|||
23827475|NCT00615199|66748849|FG000|Overall Study|Lost to Follow-up|1|||
23441823|NCT00858637|65358643|FG005|Active Comparison Phase|Physician Decision|0|||
23441824|NCT00858637|65358638|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
23441825|NCT00858637|65358639|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
23441826|NCT00858637|65358640|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
23441827|NCT00858637|65358641|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
23441828|NCT00858637|65358642|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
23441829|NCT00858637|65358643|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
23441830|NCT00858637|65358638|FG000|Active Comparison Phase|Other Reasons|1|||
23441831|NCT00858637|65358639|FG001|Active Comparison Phase|Other Reasons|0|||
23441832|NCT00858637|65358640|FG002|Active Comparison Phase|Other Reasons|0|||
23441833|NCT00858637|65358641|FG003|Active Comparison Phase|Other Reasons|1|||
23441834|NCT00858637|65358642|FG004|Active Comparison Phase|Other Reasons|0|||
23441835|NCT00858637|65358643|FG005|Active Comparison Phase|Other Reasons|0|||
23441836|NCT00858637|65358638|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
23441837|NCT00858637|65358639|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
23441838|NCT00858637|65358640|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
23441839|NCT00858637|65358641|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
23441840|NCT00858637|65358642|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
23441841|NCT00858637|65358643|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
23441842|NCT00858637|65358638|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441843|NCT00858637|65358639|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441844|NCT00858637|65358640|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441845|NCT00858637|65358641|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23760397|NCT02454972|66501434|FG005|Overall Study|Lost to Follow-up|0|||
23760398|NCT02454972|66501435|FG006|Overall Study|Lost to Follow-up|0|||
23760399|NCT02454972|66501436|FG007|Overall Study|Lost to Follow-up|0|||
23760400|NCT02454972|66501437|FG008|Overall Study|Lost to Follow-up|2|||
23827476|NCT00615199|66748850|FG001|Overall Study|Lost to Follow-up|0|||
23827477|NCT00615199|66748851|FG002|Overall Study|Lost to Follow-up|0|||
23827478|NCT00615199|66748852|FG003|Overall Study|Lost to Follow-up|0|||
23827479|NCT00615199|66748849|FG000|Overall Study|Other|0|||
23441846|NCT00858637|65358642|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441847|NCT00858637|65358643|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
23441848|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Technical problems|0|||
23441849|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Technical problems|0|||
23760401|NCT02454972|66501429|FG000|Overall Study|Study termination|0|||
23760402|NCT02454972|66501430|FG001|Overall Study|Study termination|0|||
23760403|NCT02454972|66501431|FG002|Overall Study|Study termination|0|||
23760404|NCT02454972|66501432|FG003|Overall Study|Study termination|0|||
23827480|NCT00615199|66748850|FG001|Overall Study|Other|0|||
23827481|NCT00615199|66748851|FG002|Overall Study|Other|0|||
23441850|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Technical problems|0|||
23827482|NCT00615199|66748852|FG003|Overall Study|Other|1|||
23827483|NCT00615199|66748849|FG000|Overall Study|Withdrawal by Subject|2|||
23827484|NCT00615199|66748850|FG001|Overall Study|Withdrawal by Subject|1|||
23827485|NCT00615199|66748851|FG002|Overall Study|Withdrawal by Subject|0|||
23827486|NCT00615199|66748852|FG003|Overall Study|Withdrawal by Subject|0|||
23827487|NCT01207583|66748853|FG000|Overall Study|Withdrawal by Subject|0|||
23827488|NCT01207583|66748854|FG001|Overall Study|Withdrawal by Subject|3|||
23827489|NCT01207583|66748855|FG002|Overall Study|Withdrawal by Subject|1|||
23827490|NCT01207583|66748853|FG000|Overall Study|Participant failed to return|1|||
23827491|NCT01207583|66748854|FG001|Overall Study|Participant failed to return|0|||
23827492|NCT01207583|66748855|FG002|Overall Study|Participant failed to return|0|||
23827493|NCT01207583|66748853|FG000|Overall Study|Lost to Follow-up|0|||
23827494|NCT01207583|66748854|FG001|Overall Study|Lost to Follow-up|2|||
23827495|NCT01207583|66748855|FG002|Overall Study|Lost to Follow-up|0|||
23827496|NCT03593395|66748856|FG000|Overall Study|Lost to Follow-up|48|||
23827497|NCT03593395|66748857|FG001|Overall Study|Lost to Follow-up|3|||
23827498|NCT03593395|66748856|FG000|Overall Study|Withdrawal by Subject|5|||
23827499|NCT03593395|66748857|FG001|Overall Study|Withdrawal by Subject|24|||
23827500|NCT03593395|66748856|FG000|Overall Study|Death|2|||
23827501|NCT03593395|66748857|FG001|Overall Study|Death|3|||
23827502|NCT03593395|66748856|FG000|Overall Study|Physician Decision|0|||
23827503|NCT03593395|66748857|FG001|Overall Study|Physician Decision|6|||
23827504|NCT03593395|66748856|FG000|Overall Study|Participant Relocated|19|||
23827505|NCT03593395|66748857|FG001|Overall Study|Participant Relocated|3|||
23827506|NCT03593395|66748856|FG000|Overall Study|No Information|1|||
23827507|NCT03593395|66748857|FG001|Overall Study|No Information|7|||
23827508|NCT00196326|66748858|FG000|Overall Study|Did not meet protocol requirements|64|||
23827509|NCT00196326|66748858|FG000|Overall Study|Non-compliance with the protocol|81|||
23827510|NCT00196326|66748858|FG000|Overall Study|Physician Decision|3|||
23827511|NCT00196326|66748858|FG000|Overall Study|Withdrawal by Subject|225|||
23827512|NCT00196326|66748858|FG000|Overall Study|Adverse Event|253|||
23827513|NCT00196326|66748858|FG000|Overall Study|Pregnancy|34|||
23827514|NCT00196326|66748858|FG000|Overall Study|Lost to Follow-up|304|||
23827515|NCT00196326|66748858|FG000|Overall Study|Other|22|||
23827516|NCT02585778|66748859|FG000|Overall Study|Adverse Event|17|||
23827517|NCT02585778|66748860|FG001|Overall Study|Adverse Event|4|||
23827518|NCT02585778|66748859|FG000|Overall Study|Participant did not wish to continue|9|||
23627108|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
23627109|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
23627110|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
23627111|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
23627112|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
23627113|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
23627114|NCT04354168|66020510|FG000|Overall Study|Lost to Follow-up|22|||
23627115|NCT00612352|66020511|FG000|Overall Study|Adverse Event|1|||
23627116|NCT00612352|66020512|FG001|Overall Study|Adverse Event|0|||
23627117|NCT00612352|66020511|FG000|Overall Study|Withdrawal by Subject|3|||
23627118|NCT00612352|66020512|FG001|Overall Study|Withdrawal by Subject|5|||
23627119|NCT00612352|66020511|FG000|Overall Study|moved out of state|1|||
23627120|NCT00612352|66020512|FG001|Overall Study|moved out of state|0|||
23627121|NCT00612352|66020511|FG000|Overall Study|didn't return calls/show up on test date|4|||
23827519|NCT02585778|66748860|FG001|Overall Study|Participant did not wish to continue|4|||
23827520|NCT02585778|66748859|FG000|Overall Study|Poor compliance to study protocol|0|||
23827521|NCT02585778|66748860|FG001|Overall Study|Poor compliance to study protocol|2|||
23827522|NCT02585778|66748859|FG000|Overall Study|Death|0|||
23827523|NCT02585778|66748860|FG001|Overall Study|Death|1|||
23827524|NCT02585778|66748859|FG000|Overall Study|Randomized but not treated|1|||
23827525|NCT02585778|66748860|FG001|Overall Study|Randomized but not treated|2|||
23827526|NCT02585778|66748859|FG000|Overall Study|Other than specified above|6|||
23827527|NCT02585778|66748860|FG001|Overall Study|Other than specified above|2|||
23827528|NCT00517881|66748861|FG000|Overall Study|Protocol Violation|2|||
23827529|NCT00517881|66748861|FG000|Overall Study|Adverse Event|1|||
23827530|NCT00517881|66748861|FG000|Overall Study|Renal transplantation|2|||
23827531|NCT00638508|66748868|FG000|Overall Study|Physician Decision|5|||
23627122|NCT00612352|66020512|FG001|Overall Study|didn't return calls/show up on test date|1|||
23627123|NCT00302159|66024363|FG000|Overall Study|pt declined before treatment started|1|||
23627124|NCT00302159|66024363|FG000|Overall Study|pt started Avastin|1|||
23627125|NCT04016272|66024368|FG000|Overall Study|Withdrawal by Subject|1|||
23627126|NCT04016272|66024369|FG001|Overall Study|Withdrawal by Subject|2|||
23627127|NCT02641587|66024370|FG000|Confinement Period|Adverse Event|1|||
23627128|NCT02641587|66024371|FG001|Confinement Period|Adverse Event|0|||
23827532|NCT00638508|66748869|FG001|Overall Study|Physician Decision|2|||
23827533|NCT02899962|66748870|FG000|Open-label Phase|Adverse Event|2|||
23827534|NCT02899962|66748871|FG001|Open-label Phase|Adverse Event|0|||
23827535|NCT02899962|66748872|FG002|Open-label Phase|Adverse Event|0|||
23827536|NCT02899962|66748870|FG000|Open-label Phase|Lost to Follow-up|9|||
23827537|NCT02899962|66748871|FG001|Open-label Phase|Lost to Follow-up|0|||
23827538|NCT02899962|66748872|FG002|Open-label Phase|Lost to Follow-up|0|||
23827539|NCT02899962|66748870|FG000|Open-label Phase|Other reasons|9|||
23827540|NCT02899962|66748871|FG001|Open-label Phase|Other reasons|0|||
23827541|NCT02899962|66748872|FG002|Open-label Phase|Other reasons|0|||
23827542|NCT02899962|66748870|FG000|Open-label Phase|Withdrawal by Subject|7|||
23827543|NCT02899962|66748871|FG001|Open-label Phase|Withdrawal by Subject|0|||
23827544|NCT02899962|66748872|FG002|Open-label Phase|Withdrawal by Subject|0|||
23827545|NCT02899962|66748870|FG000|Maintenance Phase|Adverse Event|0|||
23827546|NCT02899962|66748871|FG001|Maintenance Phase|Adverse Event|2|||
23827547|NCT02899962|66748872|FG002|Maintenance Phase|Adverse Event|1|||
23827548|NCT02899962|66748870|FG000|Maintenance Phase|Death|0|||
23827549|NCT02899962|66748871|FG001|Maintenance Phase|Death|0|||
23827550|NCT02899962|66748872|FG002|Maintenance Phase|Death|1|||
23827551|NCT02899962|66748870|FG000|Maintenance Phase|Lack of Efficacy|0|||
23827552|NCT02899962|66748871|FG001|Maintenance Phase|Lack of Efficacy|20|||
23827553|NCT02899962|66748872|FG002|Maintenance Phase|Lack of Efficacy|16|||
23827554|NCT02899962|66748870|FG000|Maintenance Phase|Lost to Follow-up|0|||
23827555|NCT02899962|66748871|FG001|Maintenance Phase|Lost to Follow-up|12|||
23827556|NCT02899962|66748872|FG002|Maintenance Phase|Lost to Follow-up|14|||
23441851|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Technical problems|1|||
23441852|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23441853|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
23827557|NCT02899962|66748870|FG000|Maintenance Phase|Other reasons|0|||
23827558|NCT02899962|66748871|FG001|Maintenance Phase|Other reasons|9|||
23827559|NCT02899962|66748872|FG002|Maintenance Phase|Other reasons|13|||
23827560|NCT02899962|66748870|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
23827561|NCT02899962|66748871|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
23827562|NCT02899962|66748872|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
23827563|NCT02899962|66748870|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
23827564|NCT02899962|66748871|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
23827565|NCT02899962|66748872|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
23827566|NCT02899962|66748870|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23827567|NCT02899962|66748871|FG001|Maintenance Phase|Withdrawal by Subject|30|||
23827568|NCT02899962|66748872|FG002|Maintenance Phase|Withdrawal by Subject|36|||
23827569|NCT03805412|66748873|FG000|Overall Study|Lost to Follow-up|0|||
23827570|NCT03805412|66748874|FG001|Overall Study|Lost to Follow-up|1|||
23827571|NCT00445432|66748875|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
23827572|NCT00445432|66748876|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
23827573|NCT00445432|66748877|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
23827574|NCT00445432|66748878|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
23827575|NCT00445432|66748875|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23827576|NCT00445432|66748876|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23827577|NCT00445432|66748877|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
23827578|NCT00445432|66748878|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23827579|NCT00445432|66748875|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
23827580|NCT00445432|66748876|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
23827581|NCT00445432|66748877|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
23827582|NCT00445432|66748878|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
23827583|NCT00445432|66748875|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
23827584|NCT00445432|66748876|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
23827585|NCT00445432|66748877|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
23827586|NCT00445432|66748878|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
23827587|NCT00445432|66748875|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23827588|NCT00445432|66748876|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23827589|NCT00445432|66748877|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23827590|NCT00445432|66748878|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
23827591|NCT00445432|66748875|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23827592|NCT00445432|66748876|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23827593|NCT00445432|66748877|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23827594|NCT00445432|66748878|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
23827595|NCT00445432|66748875|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
23827596|NCT00445432|66748876|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
23564965|NCT03820323|65796602|FG001|Overall Study|Transferred out|11|||
23564966|NCT03820323|65796601|FG000|Overall Study|Terminated|0|||
23564967|NCT03820323|65796602|FG001|Overall Study|Terminated|3|||
23441854|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23564968|NCT03820323|65796601|FG000|Overall Study|Withdrawal by Subject|1|||
23564969|NCT03820323|65796602|FG001|Overall Study|Withdrawal by Subject|6|||
23564970|NCT04404478|65796604|FG000|Overall Study|Withdrawal by Subject|1|||
23564971|NCT04404478|65796605|FG001|Overall Study|Withdrawal by Subject|3|||
23564972|NCT04599101|65796606|FG000|Overall Study|Lost to Follow-up|5|||
23627129|NCT02641587|66024370|FG000|Confinement Period|Withdrawal by Subject|2|||
23627130|NCT02641587|66024371|FG001|Confinement Period|Withdrawal by Subject|1|||
23627131|NCT02641587|66024370|FG000|Ambulatory Period|Withdrawal by Subject|1|||
23627132|NCT02641587|66024371|FG001|Ambulatory Period|Withdrawal by Subject|0|||
23627133|NCT00664105|66024372|FG000|Overall Study|Death|3|||
23627134|NCT00664105|66024372|FG000|Overall Study|Withdrawal by Subject|5|||
23627135|NCT00664105|66024372|FG000|Overall Study|Adverse Event|9|||
23827597|NCT00445432|66748877|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
23827598|NCT00445432|66748878|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
23827599|NCT01392963|66748887|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
23827600|NCT01392963|66748888|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
23827601|NCT01392963|66748887|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
23827602|NCT01392963|66748888|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
23827603|NCT01392963|66748887|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
23827604|NCT01392963|66748888|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
23827605|NCT02404805|66748891|FG000|Overall Study|Withdrawal by Subject|1|||
23827606|NCT02404805|66748892|FG001|Overall Study|Withdrawal by Subject|0|||
23827607|NCT02404805|66748893|FG002|Overall Study|Withdrawal by Subject|0|||
23827608|NCT02404805|66748894|FG003|Overall Study|Withdrawal by Subject|0|||
23827609|NCT02404805|66748895|FG004|Overall Study|Withdrawal by Subject|0|||
23827610|NCT02404805|66748896|FG005|Overall Study|Withdrawal by Subject|0|||
23827611|NCT01288079|66748899|FG000|Overall Study|Withdrawal by Subject|2|||
23760405|NCT02454972|66501433|FG004|Overall Study|Study termination|0|||
23760406|NCT02454972|66501434|FG005|Overall Study|Study termination|0|||
23760407|NCT02454972|66501435|FG006|Overall Study|Study termination|0|||
23760408|NCT02454972|66501436|FG007|Overall Study|Study termination|0|||
23760409|NCT02454972|66501437|FG008|Overall Study|Study termination|6|||
23760410|NCT02414854|66501438|FG000|Overall Study|Adverse Event|9|||
23760411|NCT02414854|66501439|FG001|Overall Study|Adverse Event|7|||
23760412|NCT02414854|66501440|FG002|Overall Study|Adverse Event|1|||
23760413|NCT02414854|66501441|FG003|Overall Study|Adverse Event|12|||
23760414|NCT02414854|66501438|FG000|Overall Study|Poor compliance to protocol|1|||
23760415|NCT02414854|66501439|FG001|Overall Study|Poor compliance to protocol|1|||
23760416|NCT02414854|66501440|FG002|Overall Study|Poor compliance to protocol|2|||
23760417|NCT02414854|66501441|FG003|Overall Study|Poor compliance to protocol|2|||
23760418|NCT02414854|66501438|FG000|Overall Study|Other than specified above|12|||
23760419|NCT02414854|66501439|FG001|Overall Study|Other than specified above|37|||
23760420|NCT02414854|66501440|FG002|Overall Study|Other than specified above|17|||
23760421|NCT02414854|66501441|FG003|Overall Study|Other than specified above|37|||
23760422|NCT01890785|66501442|FG000|Third Intervention|Withdrawal by Subject|0|||
23760423|NCT01890785|66501443|FG001|Third Intervention|Withdrawal by Subject|1|||
23760424|NCT01890785|66501444|FG002|Third Intervention|Withdrawal by Subject|0|||
23760425|NCT01890785|66501445|FG003|Third Intervention|Withdrawal by Subject|0|||
23760426|NCT01890785|66501446|FG004|Third Intervention|Withdrawal by Subject|0|||
23827612|NCT01288079|66748900|FG001|Overall Study|Withdrawal by Subject|4|||
23827613|NCT01288079|66748901|FG002|Overall Study|Withdrawal by Subject|1|||
23827614|NCT01288079|66748902|FG003|Overall Study|Withdrawal by Subject|0|||
23627136|NCT00664105|66024372|FG000|Overall Study|Disease progression|7|||
23827615|NCT01288079|66748899|FG000|Overall Study|Adverse Event|2|||
23827616|NCT01288079|66748900|FG001|Overall Study|Adverse Event|1|||
23827617|NCT01288079|66748901|FG002|Overall Study|Adverse Event|2|||
23827618|NCT01288079|66748902|FG003|Overall Study|Adverse Event|3|||
23827619|NCT01288079|66748899|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23827620|NCT01288079|66748900|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
23827621|NCT01288079|66748901|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23827622|NCT01288079|66748902|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
23627137|NCT03004404|66024373|FG000|Period 2|Adverse Event|0|||
23627138|NCT03004404|66024374|FG001|Period 2|Adverse Event|0|||
23627139|NCT03004404|66024375|FG002|Period 2|Adverse Event|0|||
23627140|NCT03004404|66024376|FG003|Period 2|Adverse Event|0|||
23627141|NCT03004404|66024377|FG004|Period 2|Adverse Event|0|||
23627142|NCT03004404|66024378|FG005|Period 2|Adverse Event|0|||
23760427|NCT01890785|66501447|FG005|Third Intervention|Withdrawal by Subject|0|||
23627143|NCT03004404|66024379|FG006|Period 2|Adverse Event|0|||
23627144|NCT03004404|66024380|FG007|Period 2|Adverse Event|0|||
23627145|NCT03004404|66024381|FG008|Period 2|Adverse Event|1|||
23760428|NCT02323295|66501448|FG000|Overall Study|Adverse Event|0|||
23760429|NCT02323295|66501449|FG001|Overall Study|Adverse Event|1|||
23760430|NCT02323295|66501448|FG000|Overall Study|Withdrawal by Subject|0|||
23760431|NCT02323295|66501449|FG001|Overall Study|Withdrawal by Subject|1|||
23760432|NCT02323295|66501448|FG000|Overall Study|Patient did not have surgery as planned.|0|||
23827623|NCT01288079|66748899|FG000|Overall Study|Condition under Investigation Worsened|0|||
23827624|NCT01288079|66748900|FG001|Overall Study|Condition under Investigation Worsened|0|||
23760433|NCT02323295|66501449|FG001|Overall Study|Patient did not have surgery as planned.|1|||
23760434|NCT02278952|66501450|FG000|Overall Study|Insufficient Sample|6|||
23760435|NCT02624518|66501455|FG000|Overall Study|Physician Decision|1|||
23760436|NCT03124381|66501456|FG000|Overall Study|Lost to Follow-up|1|||
23760437|NCT03124381|66501457|FG001|Overall Study|Lost to Follow-up|1|||
23760438|NCT03124381|66501456|FG000|Overall Study|Withdrawal by Subject|6|||
23760439|NCT03124381|66501457|FG001|Overall Study|Withdrawal by Subject|3|||
23760440|NCT03124381|66501456|FG000|Overall Study|Protocol Violation|0|||
23760441|NCT03124381|66501457|FG001|Overall Study|Protocol Violation|1|||
23760442|NCT03124381|66501456|FG000|Overall Study|Adverse Event|1|||
23760443|NCT03124381|66501457|FG001|Overall Study|Adverse Event|1|||
23760444|NCT03124381|66501456|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
23760445|NCT03124381|66501457|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
23760446|NCT02410837|66501459|FG000|Overall Study|Death|387|||
23760447|NCT02410837|66501459|FG000|Overall Study|Lost to Follow-up|50|||
23760448|NCT02410837|66501459|FG000|Overall Study|Withdrawal by Subject|44|||
23760449|NCT02410837|66501459|FG000|Overall Study|Physician Decision|6|||
23441855|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23441856|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
23441857|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
23441858|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
23441859|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
23441860|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
23760450|NCT02410837|66501459|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
23760451|NCT01473758|66501464|FG000|Cycle 1|Adverse Event|10|||
23760452|NCT01473758|66501465|FG001|Cycle 1|Adverse Event|2|||
23760453|NCT01473758|66501466|FG002|Cycle 1|Adverse Event|0|||
23760454|NCT01473758|66501467|FG003|Cycle 1|Adverse Event|0|||
23760455|NCT01473758|66501464|FG000|Cycle 1|Withdrawal by Subject|1|||
23760456|NCT01473758|66501465|FG001|Cycle 1|Withdrawal by Subject|1|||
23760457|NCT01473758|66501466|FG002|Cycle 1|Withdrawal by Subject|0|||
23760458|NCT01473758|66501467|FG003|Cycle 1|Withdrawal by Subject|0|||
23760459|NCT01473758|66501464|FG000|Cycle 2|Adverse Event|0|||
23760460|NCT01473758|66501465|FG001|Cycle 2|Adverse Event|0|||
23760461|NCT01473758|66501466|FG002|Cycle 2|Adverse Event|5|||
23760462|NCT01473758|66501467|FG003|Cycle 2|Adverse Event|0|||
23760463|NCT01020305|66501468|FG000|Overall Study|Adverse Event|2|||
23760464|NCT01504867|66501469|FG000|Overall Study|Inclusion criteria not met|2|||
23760465|NCT01504867|66501470|FG001|Overall Study|Inclusion criteria not met|2|||
23760466|NCT01504867|66501469|FG000|Overall Study|Consent revoked|5|||
23760467|NCT01504867|66501470|FG001|Overall Study|Consent revoked|1|||
23760468|NCT01377233|66501472|FG000|Open-label|Adverse Event|1|||
23760469|NCT01377233|66501473|FG001|Open-label|Adverse Event|0|||
23760470|NCT01377233|66501474|FG002|Open-label|Adverse Event|0|||
23760471|NCT01377233|66501475|FG003|Open-label|Adverse Event|0|||
23760472|NCT01377233|66501476|FG004|Open-label|Adverse Event|0|||
23760473|NCT01377233|66501472|FG000|Open-label|Withdrawal by Subject|3|||
23760474|NCT01377233|66501473|FG001|Open-label|Withdrawal by Subject|0|||
23760475|NCT01377233|66501474|FG002|Open-label|Withdrawal by Subject|0|||
23760476|NCT01377233|66501475|FG003|Open-label|Withdrawal by Subject|0|||
23760477|NCT01377233|66501476|FG004|Open-label|Withdrawal by Subject|0|||
23760478|NCT01377233|66501472|FG000|Double-blind|Adverse Event|0|||
23760479|NCT01377233|66501473|FG001|Double-blind|Adverse Event|1|||
23760480|NCT01377233|66501474|FG002|Double-blind|Adverse Event|2|||
23760481|NCT01377233|66501475|FG003|Double-blind|Adverse Event|2|||
23760482|NCT01377233|66501476|FG004|Double-blind|Adverse Event|0|||
23760483|NCT01377233|66501472|FG000|Double-blind|Protocol Violation|0|||
23760484|NCT01377233|66501473|FG001|Double-blind|Protocol Violation|0|||
23760485|NCT01377233|66501474|FG002|Double-blind|Protocol Violation|0|||
23760486|NCT01377233|66501475|FG003|Double-blind|Protocol Violation|0|||
23441861|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
23564973|NCT04599101|65796607|FG001|Overall Study|Lost to Follow-up|5|||
23564974|NCT01103960|65796610|FG000|Overall Study|Adverse Event|2|||
23564975|NCT01103960|65796611|FG001|Overall Study|Adverse Event|1|||
23564976|NCT01103960|65796610|FG000|Overall Study|Withdrawal by Subject|2|||
23564977|NCT01103960|65796611|FG001|Overall Study|Withdrawal by Subject|1|||
23564978|NCT01103960|65796610|FG000|Overall Study|Other|1|||
23564979|NCT01103960|65796611|FG001|Overall Study|Other|0|||
23760487|NCT01377233|66501476|FG004|Double-blind|Protocol Violation|1|||
23760488|NCT01377233|66501472|FG000|Double-blind|Withdrawal by Subject|0|||
23441862|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
23760489|NCT01377233|66501473|FG001|Double-blind|Withdrawal by Subject|0|||
23760490|NCT01377233|66501474|FG002|Double-blind|Withdrawal by Subject|0|||
23760491|NCT01377233|66501475|FG003|Double-blind|Withdrawal by Subject|1|||
23760492|NCT01377233|66501476|FG004|Double-blind|Withdrawal by Subject|0|||
23760493|NCT01377233|66501472|FG000|Double-blind|Administrative or other|0|||
23564980|NCT00192023|65796614|FG000|Period III - Double-Blind|Adverse Event|3|||
23760494|NCT01377233|66501473|FG001|Double-blind|Administrative or other|0|||
23760495|NCT01377233|66501474|FG002|Double-blind|Administrative or other|0|||
23627146|NCT03004404|66024382|FG009|Period 2|Adverse Event|0|||
23627147|NCT03004404|66024383|FG010|Period 2|Adverse Event|0|||
23627148|NCT03004404|66024384|FG011|Period 2|Adverse Event|0|||
23627149|NCT03004404|66024385|FG012|Period 2|Adverse Event|0|||
23627150|NCT03004404|66024386|FG013|Period 2|Adverse Event|0|||
23627151|NCT03004404|66024387|FG014|Period 2|Adverse Event|0|||
23627152|NCT03004404|66024388|FG015|Period 2|Adverse Event|1|||
23627153|NCT00490945|66024389|FG000|Overall Study|Adverse Event|0|||
23627154|NCT00490945|66024390|FG001|Overall Study|Adverse Event|1|||
23627155|NCT00490945|66024391|FG002|Overall Study|Adverse Event|0|||
23627156|NCT00490945|66024392|FG003|Overall Study|Adverse Event|0|||
23627157|NCT00490945|66024393|FG004|Overall Study|Adverse Event|0|||
23627158|NCT00825305|66024394|FG000|Overall Study|Adverse Event|1|||
23627159|NCT00825305|66024395|FG001|Overall Study|Adverse Event|1|||
23627160|NCT00825305|66024394|FG000|Overall Study|Withdrawal by Subject|6|||
23627161|NCT00825305|66024395|FG001|Overall Study|Withdrawal by Subject|12|||
23627162|NCT00825305|66024394|FG000|Overall Study|Inappropriate inclusion|1|||
23627163|NCT00825305|66024395|FG001|Overall Study|Inappropriate inclusion|0|||
23627164|NCT00825305|66024394|FG000|Overall Study|Protocol Violation|9|||
23627165|NCT00825305|66024395|FG001|Overall Study|Protocol Violation|9|||
23627166|NCT00825305|66024394|FG000|Overall Study|Can not be classified|0|||
23627167|NCT00825305|66024395|FG001|Overall Study|Can not be classified|1|||
23627168|NCT03126110|66024396|FG000|Phase 1|Death|2|||
23627169|NCT03126110|66024397|FG001|Phase 1|Death|2|||
23627170|NCT03126110|66024398|FG002|Phase 1|Death|4|||
23627171|NCT03126110|66024399|FG003|Phase 1|Death|3|||
23627172|NCT03126110|66024400|FG004|Phase 1|Death|4|||
23627173|NCT03126110|66024401|FG005|Phase 1|Death|4|||
23627174|NCT03126110|66024402|FG006|Phase 1|Death|3|||
23627175|NCT03126110|66024403|FG007|Phase 1|Death|4|||
23627176|NCT03126110|66024404|FG008|Phase 1|Death|5|||
23627177|NCT03126110|66024405|FG009|Phase 1|Death|2|||
23627178|NCT03126110|66024406|FG010|Phase 1|Death|6|||
23627179|NCT03126110|66024407|FG011|Phase 1|Death|0|||
23627180|NCT03126110|66024408|FG012|Phase 1|Death|0|||
23627181|NCT03126110|66024409|FG013|Phase 1|Death|0|||
23627182|NCT03126110|66024410|FG014|Phase 1|Death|0|||
23627183|NCT03126110|66024411|FG015|Phase 1|Death|0|||
23760496|NCT01377233|66501475|FG003|Double-blind|Administrative or other|1|||
23760497|NCT01377233|66501476|FG004|Double-blind|Administrative or other|1|||
23760498|NCT02063698|66501480|FG000|Overall Study|did not complete booklet for days 2-8|1|||
23760499|NCT02063698|66501481|FG001|Overall Study|did not complete booklet for days 2-8|2|||
23760500|NCT01021137|66501482|FG000|Overall Study|Lost to Follow-up|9|||
23760501|NCT01021137|66501483|FG001|Overall Study|Lost to Follow-up|4|||
23760502|NCT01021137|66501484|FG002|Overall Study|Lost to Follow-up|2|||
23760503|NCT01021137|66501485|FG003|Overall Study|Lost to Follow-up|6|||
23760504|NCT01021137|66501482|FG000|Overall Study|Withdrawal by Subject|1|||
23760505|NCT01021137|66501483|FG001|Overall Study|Withdrawal by Subject|0|||
23760506|NCT01021137|66501484|FG002|Overall Study|Withdrawal by Subject|0|||
23760507|NCT01021137|66501485|FG003|Overall Study|Withdrawal by Subject|3|||
23760508|NCT03066440|66501486|FG000|Overall Study|Physician Decision|1|||
23760509|NCT03066440|66501487|FG001|Overall Study|Physician Decision|1|||
23760510|NCT03066440|66501486|FG000|Overall Study|Protocol Violation|0|||
23760511|NCT03066440|66501487|FG001|Overall Study|Protocol Violation|2|||
23760512|NCT04908722|66501488|FG000|Overall Study|Protocol deviation|1|||
23760513|NCT04908722|66501489|FG001|Overall Study|Protocol deviation|0|||
23441863|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
23627184|NCT03126110|66024412|FG016|Phase 1|Death|0|||
23627185|NCT03126110|66024396|FG000|Phase 1|Lost to Follow-up|0|||
23627186|NCT03126110|66024397|FG001|Phase 1|Lost to Follow-up|1|||
23627187|NCT03126110|66024398|FG002|Phase 1|Lost to Follow-up|0|||
23627188|NCT03126110|66024399|FG003|Phase 1|Lost to Follow-up|0|||
23627189|NCT03126110|66024400|FG004|Phase 1|Lost to Follow-up|0|||
23627190|NCT03126110|66024401|FG005|Phase 1|Lost to Follow-up|0|||
23627191|NCT03126110|66024402|FG006|Phase 1|Lost to Follow-up|0|||
23627192|NCT03126110|66024403|FG007|Phase 1|Lost to Follow-up|0|||
23627193|NCT03126110|66024404|FG008|Phase 1|Lost to Follow-up|1|||
23627194|NCT03126110|66024405|FG009|Phase 1|Lost to Follow-up|0|||
23627195|NCT03126110|66024406|FG010|Phase 1|Lost to Follow-up|0|||
23627196|NCT03126110|66024407|FG011|Phase 1|Lost to Follow-up|0|||
23627197|NCT03126110|66024408|FG012|Phase 1|Lost to Follow-up|0|||
23627198|NCT03126110|66024409|FG013|Phase 1|Lost to Follow-up|0|||
23627199|NCT03126110|66024410|FG014|Phase 1|Lost to Follow-up|0|||
23627200|NCT03126110|66024411|FG015|Phase 1|Lost to Follow-up|0|||
23627201|NCT03126110|66024412|FG016|Phase 1|Lost to Follow-up|0|||
23627202|NCT03126110|66024396|FG000|Phase 1|Withdrawal by Subject|1|||
23627203|NCT03126110|66024397|FG001|Phase 1|Withdrawal by Subject|0|||
23627204|NCT03126110|66024398|FG002|Phase 1|Withdrawal by Subject|0|||
23627205|NCT03126110|66024399|FG003|Phase 1|Withdrawal by Subject|1|||
23627206|NCT03126110|66024400|FG004|Phase 1|Withdrawal by Subject|1|||
23627207|NCT03126110|66024401|FG005|Phase 1|Withdrawal by Subject|0|||
23627208|NCT03126110|66024402|FG006|Phase 1|Withdrawal by Subject|0|||
23627209|NCT03126110|66024403|FG007|Phase 1|Withdrawal by Subject|0|||
23627210|NCT03126110|66024404|FG008|Phase 1|Withdrawal by Subject|2|||
23627211|NCT03126110|66024405|FG009|Phase 1|Withdrawal by Subject|1|||
23627212|NCT03126110|66024406|FG010|Phase 1|Withdrawal by Subject|0|||
23627213|NCT03126110|66024407|FG011|Phase 1|Withdrawal by Subject|0|||
23627214|NCT03126110|66024408|FG012|Phase 1|Withdrawal by Subject|0|||
23627215|NCT03126110|66024409|FG013|Phase 1|Withdrawal by Subject|0|||
23627216|NCT03126110|66024410|FG014|Phase 1|Withdrawal by Subject|0|||
23627217|NCT03126110|66024411|FG015|Phase 1|Withdrawal by Subject|0|||
23627218|NCT03126110|66024412|FG016|Phase 1|Withdrawal by Subject|0|||
23627219|NCT03126110|66024396|FG000|Phase 1|Safety follow-up no longer necessary|1|||
23627220|NCT03126110|66024397|FG001|Phase 1|Safety follow-up no longer necessary|0|||
23627221|NCT03126110|66024398|FG002|Phase 1|Safety follow-up no longer necessary|0|||
23627222|NCT03126110|66024399|FG003|Phase 1|Safety follow-up no longer necessary|0|||
23627223|NCT03126110|66024400|FG004|Phase 1|Safety follow-up no longer necessary|0|||
23627224|NCT03126110|66024401|FG005|Phase 1|Safety follow-up no longer necessary|0|||
23627225|NCT03126110|66024402|FG006|Phase 1|Safety follow-up no longer necessary|0|||
23627226|NCT03126110|66024403|FG007|Phase 1|Safety follow-up no longer necessary|0|||
23627227|NCT03126110|66024404|FG008|Phase 1|Safety follow-up no longer necessary|0|||
23627228|NCT03126110|66024405|FG009|Phase 1|Safety follow-up no longer necessary|0|||
23627229|NCT03126110|66024406|FG010|Phase 1|Safety follow-up no longer necessary|0|||
23627230|NCT03126110|66024407|FG011|Phase 1|Safety follow-up no longer necessary|0|||
23627231|NCT03126110|66024408|FG012|Phase 1|Safety follow-up no longer necessary|0|||
23627232|NCT03126110|66024409|FG013|Phase 1|Safety follow-up no longer necessary|0|||
23627233|NCT03126110|66024410|FG014|Phase 1|Safety follow-up no longer necessary|0|||
23627234|NCT03126110|66024411|FG015|Phase 1|Safety follow-up no longer necessary|0|||
23627235|NCT03126110|66024412|FG016|Phase 1|Safety follow-up no longer necessary|0|||
23627236|NCT03126110|66024396|FG000|Phase 1|Survival follow-up no longer necessary|0|||
23627237|NCT03126110|66024397|FG001|Phase 1|Survival follow-up no longer necessary|0|||
23627238|NCT03126110|66024398|FG002|Phase 1|Survival follow-up no longer necessary|1|||
23627239|NCT03126110|66024399|FG003|Phase 1|Survival follow-up no longer necessary|0|||
23627240|NCT03126110|66024400|FG004|Phase 1|Survival follow-up no longer necessary|0|||
23627241|NCT03126110|66024401|FG005|Phase 1|Survival follow-up no longer necessary|0|||
23627242|NCT03126110|66024402|FG006|Phase 1|Survival follow-up no longer necessary|0|||
23627243|NCT03126110|66024403|FG007|Phase 1|Survival follow-up no longer necessary|0|||
23627244|NCT03126110|66024404|FG008|Phase 1|Survival follow-up no longer necessary|0|||
23627245|NCT03126110|66024405|FG009|Phase 1|Survival follow-up no longer necessary|0|||
23627246|NCT03126110|66024406|FG010|Phase 1|Survival follow-up no longer necessary|0|||
23760514|NCT04908722|66501490|FG002|Overall Study|Protocol deviation|0|||
23760515|NCT04908722|66501491|FG003|Overall Study|Protocol deviation|0|||
23760516|NCT04908722|66501492|FG004|Overall Study|Protocol deviation|0|||
23760517|NCT04908722|66501493|FG005|Overall Study|Protocol deviation|1|||
23760518|NCT04908722|66501488|FG000|Overall Study|Lost to Follow-up|33|||
23760519|NCT04908722|66501489|FG001|Overall Study|Lost to Follow-up|33|||
23760520|NCT04908722|66501490|FG002|Overall Study|Lost to Follow-up|36|||
23760521|NCT04908722|66501491|FG003|Overall Study|Lost to Follow-up|30|||
23760522|NCT04908722|66501492|FG004|Overall Study|Lost to Follow-up|32|||
23760523|NCT04908722|66501493|FG005|Overall Study|Lost to Follow-up|34|||
23760524|NCT04908722|66501488|FG000|Overall Study|Physician Decision|1|||
23760525|NCT04908722|66501489|FG001|Overall Study|Physician Decision|1|||
23760526|NCT04908722|66501490|FG002|Overall Study|Physician Decision|1|||
23760527|NCT04908722|66501491|FG003|Overall Study|Physician Decision|2|||
23760528|NCT04908722|66501492|FG004|Overall Study|Physician Decision|0|||
23760529|NCT04908722|66501493|FG005|Overall Study|Physician Decision|0|||
23760530|NCT04908722|66501488|FG000|Overall Study|Death|1|||
23760531|NCT04908722|66501489|FG001|Overall Study|Death|0|||
23760532|NCT04908722|66501490|FG002|Overall Study|Death|0|||
23760533|NCT04908722|66501491|FG003|Overall Study|Death|0|||
23760534|NCT04908722|66501492|FG004|Overall Study|Death|0|||
23760535|NCT04908722|66501493|FG005|Overall Study|Death|1|||
23760536|NCT04908722|66501488|FG000|Overall Study|Withdrawal by Subject|12|||
23760537|NCT04908722|66501489|FG001|Overall Study|Withdrawal by Subject|8|||
23760538|NCT04908722|66501490|FG002|Overall Study|Withdrawal by Subject|7|||
23760539|NCT04908722|66501491|FG003|Overall Study|Withdrawal by Subject|6|||
23760540|NCT04908722|66501492|FG004|Overall Study|Withdrawal by Subject|12|||
23760541|NCT04908722|66501493|FG005|Overall Study|Withdrawal by Subject|14|||
23760542|NCT04908722|66501488|FG000|Overall Study|Other|3|||
23760543|NCT04908722|66501489|FG001|Overall Study|Other|1|||
23760544|NCT04908722|66501490|FG002|Overall Study|Other|3|||
23760545|NCT04908722|66501491|FG003|Overall Study|Other|2|||
23760546|NCT04908722|66501492|FG004|Overall Study|Other|4|||
23760547|NCT04908722|66501493|FG005|Overall Study|Other|1|||
23760548|NCT04908722|66501488|FG000|Overall Study|Initiated prohibited medication|0|||
23760549|NCT04908722|66501489|FG001|Overall Study|Initiated prohibited medication|0|||
23760550|NCT04908722|66501490|FG002|Overall Study|Initiated prohibited medication|0|||
23760551|NCT04908722|66501491|FG003|Overall Study|Initiated prohibited medication|1|||
23760552|NCT04908722|66501492|FG004|Overall Study|Initiated prohibited medication|0|||
23760553|NCT04908722|66501493|FG005|Overall Study|Initiated prohibited medication|1|||
23627247|NCT03126110|66024407|FG011|Phase 1|Survival follow-up no longer necessary|0|||
23627248|NCT03126110|66024408|FG012|Phase 1|Survival follow-up no longer necessary|0|||
23627249|NCT03126110|66024409|FG013|Phase 1|Survival follow-up no longer necessary|0|||
23627250|NCT03126110|66024410|FG014|Phase 1|Survival follow-up no longer necessary|0|||
23627251|NCT03126110|66024411|FG015|Phase 1|Survival follow-up no longer necessary|0|||
23627252|NCT03126110|66024412|FG016|Phase 1|Survival follow-up no longer necessary|0|||
23627253|NCT03126110|66024396|FG000|Phase 2|Study terminated by the sponsor|0|||
23627254|NCT03126110|66024397|FG001|Phase 2|Study terminated by the sponsor|0|||
23627255|NCT03126110|66024398|FG002|Phase 2|Study terminated by the sponsor|0|||
23627256|NCT03126110|66024399|FG003|Phase 2|Study terminated by the sponsor|0|||
23627257|NCT03126110|66024400|FG004|Phase 2|Study terminated by the sponsor|0|||
23627258|NCT03126110|66024401|FG005|Phase 2|Study terminated by the sponsor|0|||
23627259|NCT03126110|66024402|FG006|Phase 2|Study terminated by the sponsor|0|||
23627260|NCT03126110|66024403|FG007|Phase 2|Study terminated by the sponsor|0|||
23627261|NCT03126110|66024404|FG008|Phase 2|Study terminated by the sponsor|0|||
23827625|NCT01288079|66748901|FG002|Overall Study|Condition under Investigation Worsened|0|||
23827626|NCT01288079|66748902|FG003|Overall Study|Condition under Investigation Worsened|1|||
23827627|NCT01288079|66748899|FG000|Overall Study|Lack of Efficacy|2|||
23827628|NCT01288079|66748900|FG001|Overall Study|Lack of Efficacy|2|||
23827629|NCT01288079|66748901|FG002|Overall Study|Lack of Efficacy|0|||
23827630|NCT01288079|66748902|FG003|Overall Study|Lack of Efficacy|2|||
23627262|NCT03126110|66024405|FG009|Phase 2|Study terminated by the sponsor|0|||
23627263|NCT03126110|66024406|FG010|Phase 2|Study terminated by the sponsor|0|||
23627264|NCT03126110|66024407|FG011|Phase 2|Study terminated by the sponsor|0|||
23627265|NCT03126110|66024408|FG012|Phase 2|Study terminated by the sponsor|0|||
23627266|NCT03126110|66024409|FG013|Phase 2|Study terminated by the sponsor|4|||
23627267|NCT03126110|66024410|FG014|Phase 2|Study terminated by the sponsor|0|||
23627268|NCT03126110|66024411|FG015|Phase 2|Study terminated by the sponsor|0|||
23627269|NCT03126110|66024412|FG016|Phase 2|Study terminated by the sponsor|0|||
23627270|NCT03126110|66024396|FG000|Phase 2|Withdrawal by Subject|0|||
23627271|NCT03126110|66024397|FG001|Phase 2|Withdrawal by Subject|0|||
23627272|NCT03126110|66024398|FG002|Phase 2|Withdrawal by Subject|0|||
23627273|NCT03126110|66024399|FG003|Phase 2|Withdrawal by Subject|0|||
23627274|NCT03126110|66024400|FG004|Phase 2|Withdrawal by Subject|0|||
23627275|NCT03126110|66024401|FG005|Phase 2|Withdrawal by Subject|0|||
23627276|NCT03126110|66024402|FG006|Phase 2|Withdrawal by Subject|0|||
23627277|NCT03126110|66024403|FG007|Phase 2|Withdrawal by Subject|0|||
23627278|NCT03126110|66024404|FG008|Phase 2|Withdrawal by Subject|0|||
23627279|NCT03126110|66024405|FG009|Phase 2|Withdrawal by Subject|0|||
23627280|NCT03126110|66024406|FG010|Phase 2|Withdrawal by Subject|0|||
23627281|NCT03126110|66024407|FG011|Phase 2|Withdrawal by Subject|1|||
23627282|NCT03126110|66024408|FG012|Phase 2|Withdrawal by Subject|3|||
23627283|NCT03126110|66024409|FG013|Phase 2|Withdrawal by Subject|3|||
23627284|NCT03126110|66024410|FG014|Phase 2|Withdrawal by Subject|2|||
23627285|NCT03126110|66024411|FG015|Phase 2|Withdrawal by Subject|1|||
23627286|NCT03126110|66024412|FG016|Phase 2|Withdrawal by Subject|0|||
23627287|NCT03126110|66024396|FG000|Phase 2|Lost to Follow-up|0|||
23627288|NCT03126110|66024397|FG001|Phase 2|Lost to Follow-up|0|||
23627289|NCT03126110|66024398|FG002|Phase 2|Lost to Follow-up|0|||
23627290|NCT03126110|66024399|FG003|Phase 2|Lost to Follow-up|0|||
23627291|NCT03126110|66024400|FG004|Phase 2|Lost to Follow-up|0|||
23627292|NCT03126110|66024401|FG005|Phase 2|Lost to Follow-up|0|||
23627293|NCT03126110|66024402|FG006|Phase 2|Lost to Follow-up|0|||
23627294|NCT03126110|66024403|FG007|Phase 2|Lost to Follow-up|0|||
23627295|NCT03126110|66024404|FG008|Phase 2|Lost to Follow-up|0|||
23627296|NCT03126110|66024405|FG009|Phase 2|Lost to Follow-up|0|||
23627297|NCT03126110|66024406|FG010|Phase 2|Lost to Follow-up|0|||
23627298|NCT03126110|66024407|FG011|Phase 2|Lost to Follow-up|1|||
23627299|NCT03126110|66024408|FG012|Phase 2|Lost to Follow-up|1|||
23627300|NCT03126110|66024409|FG013|Phase 2|Lost to Follow-up|1|||
23627301|NCT03126110|66024410|FG014|Phase 2|Lost to Follow-up|2|||
23627302|NCT03126110|66024411|FG015|Phase 2|Lost to Follow-up|0|||
23627303|NCT03126110|66024412|FG016|Phase 2|Lost to Follow-up|0|||
23627304|NCT03126110|66024396|FG000|Phase 2|Death|0|||
23627305|NCT03126110|66024397|FG001|Phase 2|Death|0|||
23627306|NCT03126110|66024398|FG002|Phase 2|Death|0|||
23627307|NCT03126110|66024399|FG003|Phase 2|Death|0|||
23627308|NCT03126110|66024400|FG004|Phase 2|Death|0|||
23827631|NCT01288079|66748899|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
23564981|NCT00192023|65796615|FG001|Period III - Double-Blind|Adverse Event|0|||
23564982|NCT00192023|65796614|FG000|Period III - Double-Blind|Physician Decision|2|||
23564983|NCT00192023|65796615|FG001|Period III - Double-Blind|Physician Decision|0|||
23564984|NCT00192023|65796614|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
23627309|NCT03126110|66024401|FG005|Phase 2|Death|0|||
23627310|NCT03126110|66024402|FG006|Phase 2|Death|0|||
23627311|NCT03126110|66024403|FG007|Phase 2|Death|0|||
23627312|NCT03126110|66024404|FG008|Phase 2|Death|0|||
23627313|NCT03126110|66024405|FG009|Phase 2|Death|0|||
23627314|NCT03126110|66024406|FG010|Phase 2|Death|0|||
23627315|NCT03126110|66024407|FG011|Phase 2|Death|6|||
23627316|NCT03126110|66024408|FG012|Phase 2|Death|12|||
23627317|NCT03126110|66024409|FG013|Phase 2|Death|25|||
23627318|NCT03126110|66024410|FG014|Phase 2|Death|11|||
23760554|NCT04908722|66501488|FG000|Overall Study|Randomized but not vaccinated|3|||
23760555|NCT04908722|66501489|FG001|Overall Study|Randomized but not vaccinated|1|||
23760556|NCT04908722|66501490|FG002|Overall Study|Randomized but not vaccinated|2|||
23760557|NCT04908722|66501491|FG003|Overall Study|Randomized but not vaccinated|2|||
23760558|NCT04908722|66501492|FG004|Overall Study|Randomized but not vaccinated|3|||
23760559|NCT04908722|66501493|FG005|Overall Study|Randomized but not vaccinated|4|||
23564985|NCT00192023|65796615|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
23564986|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
23564987|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
23564988|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
23564989|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
23564990|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
23564991|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
23564992|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
23564993|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
23564994|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
23564995|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
23564996|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
23564997|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
23564998|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
23564999|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
23565000|NCT01215357|65796616|FG000|Overall Study|Withdrawal by Subject|3|||
23565001|NCT01215357|65796616|FG000|Overall Study|Protocol Violation|9|||
23760560|NCT02957682|66501496|FG000|Overall Study|Adverse Event|64|||
23760561|NCT02957682|66501497|FG001|Overall Study|Adverse Event|67|||
23760562|NCT02957682|66501496|FG000|Overall Study|Poor Compliance to Protocol|30|||
23760563|NCT02957682|66501497|FG001|Overall Study|Poor Compliance to Protocol|26|||
23760564|NCT02957682|66501496|FG000|Overall Study|Physician Decision|4|||
23760565|NCT02957682|66501497|FG001|Overall Study|Physician Decision|4|||
23760566|NCT02957682|66501496|FG000|Overall Study|Study Terminated by Sponsor|4|||
23760567|NCT02957682|66501497|FG001|Overall Study|Study Terminated by Sponsor|3|||
23760568|NCT02957682|66501496|FG000|Overall Study|Subject Moved|10|||
23760569|NCT02957682|66501497|FG001|Overall Study|Subject Moved|16|||
23760570|NCT02957682|66501496|FG000|Overall Study|Withdrawal by Subject|64|||
23760571|NCT02957682|66501497|FG001|Overall Study|Withdrawal by Subject|33|||
23760572|NCT02957682|66501496|FG000|Overall Study|Related to IMP Administration|3|||
23760573|NCT02957682|66501497|FG001|Overall Study|Related to IMP Administration|6|||
23760574|NCT02957682|66501496|FG000|Overall Study|Non-disclosed|16|||
23760575|NCT02957682|66501497|FG001|Overall Study|Non-disclosed|12|||
23760576|NCT02957682|66501496|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
23760577|NCT02957682|66501497|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
23760578|NCT01325532|66501509|FG000|Overall Study|Withdrawal by Subject|2|||
23760579|NCT01325532|66501510|FG001|Overall Study|Withdrawal by Subject|0|||
23760580|NCT01841359|66501513|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
23565002|NCT02254421|65796621|FG000|Overall Study|Randomized but Not Treated|1|||
23565003|NCT02254421|65796622|FG001|Overall Study|Randomized but Not Treated|0|||
23565004|NCT02254421|65796621|FG000|Overall Study|Death|0|||
23565005|NCT02254421|65796622|FG001|Overall Study|Death|2|||
23565006|NCT02254421|65796621|FG000|Overall Study|Withdrew Consent|1|||
23565007|NCT02254421|65796622|FG001|Overall Study|Withdrew Consent|1|||
23565008|NCT01282801|65796623|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
23627319|NCT03126110|66024411|FG015|Phase 2|Death|3|||
23627320|NCT03126110|66024412|FG016|Phase 2|Death|2|||
23627321|NCT03126110|66024396|FG000|Phase 2|Progressive Disease|0|||
23627322|NCT03126110|66024397|FG001|Phase 2|Progressive Disease|0|||
23760581|NCT01841359|66501513|FG000|Overall Study|Concommitant medical issues|2|||
23627323|NCT03126110|66024398|FG002|Phase 2|Progressive Disease|0|||
23760582|NCT01841359|66501513|FG000|Overall Study|Adverse Event|3|||
23627324|NCT03126110|66024399|FG003|Phase 2|Progressive Disease|0|||
23627325|NCT03126110|66024400|FG004|Phase 2|Progressive Disease|0|||
23627326|NCT03126110|66024401|FG005|Phase 2|Progressive Disease|0|||
23827632|NCT01288079|66748900|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23827633|NCT01288079|66748901|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
23827634|NCT01288079|66748902|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
23827635|NCT01288079|66748899|FG000|Overall Study|Lost to Follow-up|1|||
23827636|NCT01288079|66748900|FG001|Overall Study|Lost to Follow-up|1|||
23827637|NCT01288079|66748901|FG002|Overall Study|Lost to Follow-up|1|||
23827638|NCT01288079|66748902|FG003|Overall Study|Lost to Follow-up|0|||
23827639|NCT01288079|66748899|FG000|Overall Study|Other or Study Termination|11|||
23827640|NCT01288079|66748900|FG001|Overall Study|Other or Study Termination|15|||
23827641|NCT01288079|66748901|FG002|Overall Study|Other or Study Termination|14|||
23827642|NCT01288079|66748902|FG003|Overall Study|Other or Study Termination|8|||
23827643|NCT02492867|66748903|FG000|Overall Study|Alternate therapy|1|||
23827644|NCT02492867|66748903|FG000|Overall Study|Withdrawal by Subject|2|||
23827645|NCT02492867|66748903|FG000|Overall Study|Disease progression after treatment started|1|||
23827646|NCT02492867|66748903|FG000|Overall Study|Death|1|||
23565009|NCT01282801|65796624|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
23565010|NCT00871403|65796625|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
23827647|NCT01622673|66748910|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23827648|NCT01622673|66748911|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23827649|NCT01622673|66748912|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23565011|NCT00871403|65796626|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
23565012|NCT00871403|65796627|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
23565013|NCT00871403|65796625|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
23565014|NCT00871403|65796626|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
23565015|NCT00871403|65796627|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
23565016|NCT00871403|65796625|FG000|Combination Treatment Phase|Adverse Event|0|||
23565017|NCT00871403|65796626|FG001|Combination Treatment Phase|Adverse Event|17|||
23565018|NCT00871403|65796627|FG002|Combination Treatment Phase|Adverse Event|2|||
23760583|NCT01841359|66501513|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
23760584|NCT01299038|66501514|FG000|Overall Study|Withdrawal by Subject|1|||
23760585|NCT01299038|66501515|FG001|Overall Study|Withdrawal by Subject|0|||
23760586|NCT04023994|66501516|FG000|Overall Study|Lost to Follow-up|0|||
23760587|NCT04023994|66501517|FG001|Overall Study|Lost to Follow-up|1|||
23760588|NCT04023994|66501518|FG002|Overall Study|Lost to Follow-up|2|||
23760589|NCT04023994|66501519|FG003|Overall Study|Lost to Follow-up|0|||
23760590|NCT04023994|66501520|FG004|Overall Study|Lost to Follow-up|0|||
23760591|NCT04023994|66501521|FG005|Overall Study|Lost to Follow-up|0|||
23760592|NCT04023994|66501516|FG000|Overall Study|Withdrawal by Subject|0|||
23760593|NCT04023994|66501517|FG001|Overall Study|Withdrawal by Subject|0|||
23760594|NCT04023994|66501518|FG002|Overall Study|Withdrawal by Subject|0|||
23760595|NCT04023994|66501519|FG003|Overall Study|Withdrawal by Subject|1|||
23760596|NCT04023994|66501520|FG004|Overall Study|Withdrawal by Subject|0|||
23827650|NCT01622673|66748913|FG003|Treatment Period 1|Withdrawal by Subject|1|||
23827651|NCT01622673|66748914|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23827652|NCT01622673|66748915|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23827653|NCT01622673|66748910|FG000|Treatment Period 1|Protocol Violation|0|||
23827654|NCT01622673|66748911|FG001|Treatment Period 1|Protocol Violation|1|||
23827655|NCT01622673|66748912|FG002|Treatment Period 1|Protocol Violation|0|||
23827656|NCT01622673|66748913|FG003|Treatment Period 1|Protocol Violation|0|||
23827657|NCT01622673|66748914|FG004|Treatment Period 1|Protocol Violation|0|||
23827658|NCT01622673|66748915|FG005|Treatment Period 1|Protocol Violation|0|||
23827659|NCT01622673|66748910|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23827660|NCT01622673|66748911|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23827661|NCT01622673|66748912|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23827662|NCT01622673|66748913|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23827663|NCT01622673|66748914|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23827664|NCT01622673|66748915|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23827665|NCT01622673|66748910|FG000|Treatment Period 3|Protocol Violation|0|||
23827666|NCT01622673|66748911|FG001|Treatment Period 3|Protocol Violation|1|||
23827667|NCT01622673|66748912|FG002|Treatment Period 3|Protocol Violation|0|||
23827668|NCT01622673|66748913|FG003|Treatment Period 3|Protocol Violation|0|||
23827669|NCT01622673|66748914|FG004|Treatment Period 3|Protocol Violation|0|||
23565019|NCT00871403|65796625|FG000|Combination Treatment Phase|Disease Progression|0|||
23565020|NCT00871403|65796626|FG001|Combination Treatment Phase|Disease Progression|8|||
23565021|NCT00871403|65796627|FG002|Combination Treatment Phase|Disease Progression|5|||
23760597|NCT04023994|66501521|FG005|Overall Study|Withdrawal by Subject|0|||
23760598|NCT00096382|66501522|FG000|Overall Study|Not treated|1|||
23760599|NCT00096382|66501523|FG001|Overall Study|Not treated|0|||
23827670|NCT01622673|66748915|FG005|Treatment Period 3|Protocol Violation|0|||
23827671|NCT00856492|66748916|FG000|Overall Study|Ineligible or withdrew consent|1|||
23827672|NCT00856492|66748917|FG001|Overall Study|Ineligible or withdrew consent|1|||
23827673|NCT00856492|66748918|FG002|Overall Study|Ineligible or withdrew consent|2|||
23827674|NCT02847260|66748919|FG000|Overall Study|Adverse Event|3|||
23827675|NCT02847260|66748919|FG000|Overall Study|Withdrawal by Subject|2|||
23827676|NCT02847260|66748919|FG000|Overall Study|Clinical Deterioration|1|||
23827677|NCT02847260|66748919|FG000|Overall Study|Physician Decision|1|||
23827678|NCT00925704|66748920|FG000|First Intervention|Withdrew consent|0|||
23827679|NCT00925704|66748921|FG001|First Intervention|Withdrew consent|0|||
23827680|NCT00925704|66748922|FG002|First Intervention|Withdrew consent|0|||
23827681|NCT00925704|66748923|FG003|First Intervention|Withdrew consent|1|||
23827682|NCT00925704|66748924|FG004|First Intervention|Withdrew consent|1|||
23827683|NCT00925704|66748925|FG005|First Intervention|Withdrew consent|0|||
23827684|NCT00925704|66748920|FG000|Second Intervention|Withdrawal by Subject|1|||
23827685|NCT00925704|66748921|FG001|Second Intervention|Withdrawal by Subject|0|||
23827686|NCT00925704|66748922|FG002|Second Intervention|Withdrawal by Subject|0|||
23827687|NCT00925704|66748923|FG003|Second Intervention|Withdrawal by Subject|0|||
23565022|NCT00871403|65796625|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
23565023|NCT00871403|65796626|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
23565024|NCT00871403|65796627|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
23565025|NCT00871403|65796625|FG000|Combination Treatment Phase|Physician Decision|0|||
23565026|NCT00871403|65796626|FG001|Combination Treatment Phase|Physician Decision|1|||
23565027|NCT00871403|65796627|FG002|Combination Treatment Phase|Physician Decision|3|||
23827688|NCT00925704|66748924|FG004|Second Intervention|Withdrawal by Subject|1|||
23827689|NCT00925704|66748925|FG005|Second Intervention|Withdrawal by Subject|0|||
23827690|NCT00925704|66748920|FG000|Third Intervention|Withdrew consent|0|||
23827691|NCT00925704|66748921|FG001|Third Intervention|Withdrew consent|0|||
23827692|NCT00925704|66748922|FG002|Third Intervention|Withdrew consent|0|||
23827693|NCT00925704|66748923|FG003|Third Intervention|Withdrew consent|0|||
23565028|NCT00871403|65796625|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
23827694|NCT00925704|66748924|FG004|Third Intervention|Withdrew consent|0|||
23827695|NCT00925704|66748925|FG005|Third Intervention|Withdrew consent|1|||
23827696|NCT02676882|66748926|FG000|Overall Study|Adverse Event|1|||
23565029|NCT00871403|65796626|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
23565030|NCT00871403|65796627|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
23565031|NCT00871403|65796625|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
23565032|NCT00871403|65796626|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
23565033|NCT00871403|65796627|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
23565034|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
23565035|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
23565036|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
23565037|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
23565038|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
23565039|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
23565040|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
23565041|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
23565042|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
23565043|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
23565044|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
23565045|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
23565046|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
23565047|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
23565048|NCT01216163|65796630|FG000|Overall Study|Withdrawal by Subject|1|||
23565049|NCT01216163|65796631|FG001|Overall Study|Withdrawal by Subject|1|||
23565050|NCT01216163|65796632|FG002|Overall Study|Withdrawal by Subject|0|||
23565051|NCT01372605|65796633|FG000|Overall Study|Death|1|||
23565052|NCT01372605|65796634|FG001|Overall Study|Death|2|||
23760600|NCT00096382|66501522|FG000|Overall Study|Death during treatment|1|||
23760601|NCT00096382|66501523|FG001|Overall Study|Death during treatment|0|||
23760602|NCT01446913|66501528|FG000|Overall Study|Significant illness|1|||
23760603|NCT01446913|66501529|FG001|Overall Study|Significant illness|1|||
23760604|NCT01446913|66501530|FG002|Overall Study|Significant illness|1|||
23760605|NCT01446913|66501528|FG000|Overall Study|Withdrawal by Subject|5|||
23760606|NCT01446913|66501529|FG001|Overall Study|Withdrawal by Subject|3|||
23760607|NCT01446913|66501530|FG002|Overall Study|Withdrawal by Subject|5|||
23760608|NCT01446913|66501528|FG000|Overall Study|Physician Decision|0|||
23760609|NCT01446913|66501529|FG001|Overall Study|Physician Decision|0|||
23760610|NCT01446913|66501530|FG002|Overall Study|Physician Decision|2|||
23565053|NCT01372605|65796633|FG000|Overall Study|Lost to Follow-up|2|||
23760611|NCT01446913|66501528|FG000|Overall Study|Lost to Follow-up|3|||
23827697|NCT02676882|66748927|FG001|Overall Study|Adverse Event|0|||
23827698|NCT02676882|66748926|FG000|Overall Study|Lost to Follow-up|1|||
23827699|NCT02676882|66748927|FG001|Overall Study|Lost to Follow-up|0|||
23827700|NCT02676882|66748926|FG000|Overall Study|Withdrawal by Subject|1|||
23827701|NCT02676882|66748927|FG001|Overall Study|Withdrawal by Subject|2|||
23827702|NCT02792517|66748928|FG000|Overall Study|Withdrawal by Subject|10|||
23827703|NCT02792517|66748928|FG000|Overall Study|Decision by Sponsor|7|||
23827704|NCT02792517|66748928|FG000|Overall Study|Lost to Follow-up|3|||
23827705|NCT01720225|66748932|FG000|Overall Study|Withdrawal by Subject|0|||
23827706|NCT01720225|66748933|FG001|Overall Study|Withdrawal by Subject|1|||
23827707|NCT01720225|66748932|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
23827708|NCT01720225|66748933|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
23827709|NCT01368497|66748938|FG000|Overall Study|Lost to Follow-up|2|||
23827710|NCT03305848|66748939|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
23827711|NCT03305848|66748939|FG000|Overall Study|Physician Decision|2|||
23827712|NCT00682786|66748940|FG000|Overall Study|Withdrawal by Subject|2|||
23827713|NCT00682786|66748941|FG001|Overall Study|Withdrawal by Subject|2|||
23827714|NCT00682786|66748940|FG000|Overall Study|Did not receive irinotecan|0|||
23827715|NCT00682786|66748941|FG001|Overall Study|Did not receive irinotecan|1|||
23827716|NCT01125917|66748942|FG000|Overall Study|Adverse Event|43|||
23827717|NCT01125917|66748942|FG000|Overall Study|Lost to Follow-up|23|||
23827718|NCT01125917|66748942|FG000|Overall Study|Withdrawal by Subject|31|||
23827719|NCT01125917|66748942|FG000|Overall Study|Administrative|223|||
23827720|NCT01125917|66748942|FG000|Overall Study|Lack of Efficacy|19|||
23827721|NCT02763046|66748951|FG000|Overall Study|Adverse Event|5|||
23827722|NCT02763046|66748952|FG001|Overall Study|Adverse Event|4|||
23827723|NCT02763046|66748953|FG002|Overall Study|Adverse Event|0|||
23827724|NCT02763046|66748951|FG000|Overall Study|Lack of Efficacy|1|||
23827725|NCT02763046|66748952|FG001|Overall Study|Lack of Efficacy|1|||
23827726|NCT02763046|66748953|FG002|Overall Study|Lack of Efficacy|3|||
23827727|NCT02763046|66748951|FG000|Overall Study|Physician Decision|1|||
23827728|NCT02763046|66748952|FG001|Overall Study|Physician Decision|0|||
23827729|NCT02763046|66748953|FG002|Overall Study|Physician Decision|1|||
23827730|NCT02763046|66748951|FG000|Overall Study|Subject/guardian decision|2|||
23565054|NCT01372605|65796634|FG001|Overall Study|Lost to Follow-up|1|||
23565055|NCT01372605|65796633|FG000|Overall Study|Withdrawal by Subject|4|||
23565056|NCT01372605|65796634|FG001|Overall Study|Withdrawal by Subject|7|||
23565057|NCT01372605|65796633|FG000|Overall Study|Moved|3|||
23565058|NCT01372605|65796634|FG001|Overall Study|Moved|0|||
23565059|NCT01372605|65796633|FG000|Overall Study|Changed medical home|2|||
23565060|NCT01372605|65796634|FG001|Overall Study|Changed medical home|0|||
23565061|NCT00003511|65796635|FG000|Overall Study|Not evaluable|4|||
23565062|NCT03966053|65796641|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
23565063|NCT04844918|65796644|FG000|Overall Study|Adverse Event|7|||
23565064|NCT04844918|65796645|FG001|Overall Study|Adverse Event|8|||
23565065|NCT04844918|65796646|FG002|Overall Study|Adverse Event|5|||
23565066|NCT04844918|65796644|FG000|Overall Study|Physician Decision|0|||
23565067|NCT04844918|65796645|FG001|Overall Study|Physician Decision|1|||
23565068|NCT04844918|65796646|FG002|Overall Study|Physician Decision|0|||
23565069|NCT04844918|65796644|FG000|Overall Study|Withdrawal by Subject|6|||
23565070|NCT04844918|65796645|FG001|Overall Study|Withdrawal by Subject|3|||
23565071|NCT04844918|65796646|FG002|Overall Study|Withdrawal by Subject|3|||
23565072|NCT04844918|65796644|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
23760612|NCT01446913|66501529|FG001|Overall Study|Lost to Follow-up|5|||
23760613|NCT01446913|66501530|FG002|Overall Study|Lost to Follow-up|3|||
23760614|NCT01347879|66501531|FG000|Overall Study|Adverse Event|0|||
23760615|NCT01347879|66501532|FG001|Overall Study|Adverse Event|12|||
23760616|NCT01347879|66501531|FG000|Overall Study|Lost to Follow-up|2|||
23760617|NCT01347879|66501532|FG001|Overall Study|Lost to Follow-up|0|||
23760618|NCT01347879|66501531|FG000|Overall Study|Withdrawal by Subject|3|||
23760619|NCT01347879|66501532|FG001|Overall Study|Withdrawal by Subject|2|||
23760620|NCT01347879|66501531|FG000|Overall Study|Other|2|||
23760621|NCT01347879|66501532|FG001|Overall Study|Other|3|||
23760622|NCT03811249|66501533|FG000|Overall Study|Withdrawal by Subject|44|||
23760623|NCT03811249|66501533|FG000|Overall Study|Missed Visit|24|||
23760624|NCT02230085|66501536|FG000|Overall Study|Physician Decision|1|||
23760625|NCT02230085|66501536|FG000|Overall Study|Withdrawal by Subject|3|||
23760626|NCT01605461|66501540|FG000|Overall Study|Lost to Follow-up|3|||
23760627|NCT01605461|66501540|FG000|Overall Study|Withdrawal by Subject|1|||
23760628|NCT02657356|66501542|FG000|Overall Study|Death|1|||
23760629|NCT02657356|66501543|FG001|Overall Study|Death|0|||
23760630|NCT02657356|66501542|FG000|Overall Study|Withdrawal by Subject|5|||
23565073|NCT04844918|65796645|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
23760631|NCT02657356|66501543|FG001|Overall Study|Withdrawal by Subject|6|||
23565074|NCT04844918|65796646|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
23760632|NCT02657356|66501542|FG000|Overall Study|Terminated by Sponsor|8|||
23827731|NCT02763046|66748952|FG001|Overall Study|Subject/guardian decision|0|||
23760633|NCT02657356|66501543|FG001|Overall Study|Terminated by Sponsor|5|||
23760634|NCT02657356|66501542|FG000|Overall Study|Rolled over to EAP study|6|||
23827732|NCT02763046|66748953|FG002|Overall Study|Subject/guardian decision|4|||
23827733|NCT00768248|66748954|FG000|Overall Study|Research coordinator didn't collect data|1|||
23827734|NCT00768248|66748955|FG001|Overall Study|Research coordinator didn't collect data|1|||
23827735|NCT01371747|66748956|FG000|Overall Study|Adverse Event|4|||
23441864|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Death|0|||
23565075|NCT02091739|65796651|FG000|MP: 16 Weeks|Adverse Event|1|||
23565076|NCT02091739|65796652|FG001|MP: 16 Weeks|Adverse Event|1|||
23565077|NCT02091739|65796653|FG002|MP: 16 Weeks|Adverse Event|1|||
23565078|NCT02091739|65796654|FG003|MP: 16 Weeks|Adverse Event|0|||
23565079|NCT02091739|65796655|FG004|MP: 16 Weeks|Adverse Event|0|||
23565080|NCT02091739|65796651|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
23565081|NCT02091739|65796652|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
23565082|NCT02091739|65796653|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
23565083|NCT02091739|65796654|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
23565084|NCT02091739|65796655|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
23565085|NCT02091739|65796651|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
23565086|NCT02091739|65796652|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
23565087|NCT02091739|65796653|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
23565088|NCT02091739|65796654|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
23565089|NCT02091739|65796655|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
23565090|NCT02091739|65796651|FG000|EP: 48 Weeks|Other|0|||
23565091|NCT02091739|65796652|FG001|EP: 48 Weeks|Other|0|||
23565092|NCT02091739|65796653|FG002|EP: 48 Weeks|Other|0|||
23565093|NCT02091739|65796654|FG003|EP: 48 Weeks|Other|1|||
23565094|NCT02091739|65796655|FG004|EP: 48 Weeks|Other|0|||
23565095|NCT02091739|65796651|FG000|EP: 48 Weeks|Death|0|||
23565096|NCT02091739|65796652|FG001|EP: 48 Weeks|Death|0|||
23565097|NCT02091739|65796653|FG002|EP: 48 Weeks|Death|0|||
23565098|NCT02091739|65796654|FG003|EP: 48 Weeks|Death|3|||
23565099|NCT02091739|65796655|FG004|EP: 48 Weeks|Death|2|||
23565100|NCT02091739|65796651|FG000|EP: 48 Weeks|Adverse Event|0|||
23565101|NCT02091739|65796652|FG001|EP: 48 Weeks|Adverse Event|0|||
23565102|NCT02091739|65796653|FG002|EP: 48 Weeks|Adverse Event|0|||
23565103|NCT02091739|65796654|FG003|EP: 48 Weeks|Adverse Event|2|||
23565104|NCT02091739|65796655|FG004|EP: 48 Weeks|Adverse Event|6|||
23565105|NCT02091739|65796651|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
23565106|NCT02091739|65796652|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
23565107|NCT02091739|65796653|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
23565108|NCT02091739|65796654|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
23565109|NCT02091739|65796655|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
23565110|NCT02276066|65796656|FG000|Overall Study|Lost to Follow-up|21|||
23627327|NCT03126110|66024402|FG006|Phase 2|Progressive Disease|0|||
23627328|NCT03126110|66024403|FG007|Phase 2|Progressive Disease|0|||
23627329|NCT03126110|66024404|FG008|Phase 2|Progressive Disease|0|||
23827736|NCT01371747|66748957|FG001|Overall Study|Adverse Event|2|||
23827737|NCT01371747|66748958|FG002|Overall Study|Adverse Event|7|||
23827738|NCT01371747|66748959|FG003|Overall Study|Adverse Event|2|||
23827739|NCT01371747|66748960|FG004|Overall Study|Adverse Event|2|||
23827740|NCT01371747|66748961|FG005|Overall Study|Adverse Event|2|||
23827741|NCT01371747|66748956|FG000|Overall Study|Death|1|||
23827742|NCT01371747|66748957|FG001|Overall Study|Death|0|||
23827743|NCT01371747|66748958|FG002|Overall Study|Death|4|||
23827744|NCT01371747|66748959|FG003|Overall Study|Death|1|||
23827745|NCT01371747|66748960|FG004|Overall Study|Death|2|||
23827746|NCT01371747|66748961|FG005|Overall Study|Death|0|||
23827747|NCT01371747|66748956|FG000|Overall Study|Abnormal Renal Function|0|||
23827748|NCT01371747|66748957|FG001|Overall Study|Abnormal Renal Function|2|||
23827749|NCT01371747|66748958|FG002|Overall Study|Abnormal Renal Function|0|||
23827750|NCT01371747|66748959|FG003|Overall Study|Abnormal Renal Function|1|||
23827751|NCT01371747|66748960|FG004|Overall Study|Abnormal Renal Function|0|||
23827752|NCT01371747|66748961|FG005|Overall Study|Abnormal Renal Function|1|||
23827753|NCT01371747|66748956|FG000|Overall Study|High Serum Potassium Results|1|||
23827754|NCT01371747|66748957|FG001|Overall Study|High Serum Potassium Results|1|||
23827755|NCT01371747|66748958|FG002|Overall Study|High Serum Potassium Results|1|||
23827756|NCT01371747|66748959|FG003|Overall Study|High Serum Potassium Results|2|||
23827757|NCT01371747|66748960|FG004|Overall Study|High Serum Potassium Results|0|||
23565111|NCT02276066|65796657|FG001|Overall Study|Lost to Follow-up|11|||
23565112|NCT01350505|65799507|FG000|Overall Study|Lost to Follow-up|4|||
23565113|NCT02960763|65799508|FG000|Step 1|Withdrawal by Subject|10|||
23565114|NCT02960763|65799509|FG001|Step 1|Withdrawal by Subject|8|||
23565115|NCT02960763|65799510|FG002|Step 1|Withdrawal by Subject|13|||
23565116|NCT02960763|65799511|FG003|Step 1|Withdrawal by Subject|0|||
23565117|NCT02960763|65799512|FG004|Step 1|Withdrawal by Subject|0|||
23627330|NCT03126110|66024405|FG009|Phase 2|Progressive Disease|0|||
23827758|NCT01371747|66748961|FG005|Overall Study|High Serum Potassium Results|2|||
23827759|NCT01371747|66748956|FG000|Overall Study|Low Serum Potassium Results|1|||
23827760|NCT01371747|66748957|FG001|Overall Study|Low Serum Potassium Results|1|||
23827761|NCT01371747|66748958|FG002|Overall Study|Low Serum Potassium Results|1|||
23565118|NCT02960763|65799508|FG000|Step 1|Lost to Follow-up|7|||
23565119|NCT02960763|65799509|FG001|Step 1|Lost to Follow-up|9|||
23565120|NCT02960763|65799510|FG002|Step 1|Lost to Follow-up|12|||
23565121|NCT02960763|65799511|FG003|Step 1|Lost to Follow-up|0|||
23565122|NCT02960763|65799512|FG004|Step 1|Lost to Follow-up|0|||
23565123|NCT02960763|65799508|FG000|Step 1|Death|1|||
23760635|NCT02657356|66501543|FG001|Overall Study|Rolled over to EAP study|4|||
23760636|NCT04409002|66501544|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
23760637|NCT00066807|66501546|FG000|Overall Study|Study was terminated early|14|||
23760638|NCT00066807|66501547|FG001|Overall Study|Study was terminated early|15|||
23760639|NCT00446654|66501548|FG000|Overall Study|Withdrawal by Subject|1|||
23760640|NCT00446654|66501549|FG001|Overall Study|Withdrawal by Subject|0|||
23760641|NCT00446654|66501548|FG000|Overall Study|Adverse Event|1|||
23760642|NCT00446654|66501549|FG001|Overall Study|Adverse Event|0|||
23760643|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23760644|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
23760645|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23760646|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23760647|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
23760648|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
23760649|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
23760650|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
23760651|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
23760652|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
23760653|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
23760654|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
23760655|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
23760656|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
23760657|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
23760658|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
23760659|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
23760660|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
23760661|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
23760662|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
23760663|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
23760664|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
23760665|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
23760666|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
23760667|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
23760668|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
23760669|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
23760670|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
23760671|NCT01872689|66501550|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
23760672|NCT01872689|66501551|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
23760673|NCT01872689|66501552|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
23760674|NCT01872689|66501553|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
23760675|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
23760676|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
23760677|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
23760678|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
23760679|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
23760680|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
23760681|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
23760682|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
23760683|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23760684|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
23760685|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23760686|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23760687|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
23760688|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
23760689|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
23760690|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
23760691|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
23760692|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
23760693|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
23827762|NCT01371747|66748959|FG003|Overall Study|Low Serum Potassium Results|1|||
23760694|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
23760695|NCT01872689|66501550|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
23760696|NCT01872689|66501551|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
23760697|NCT01872689|66501552|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
23760698|NCT01872689|66501553|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
23760699|NCT01244815|66501554|FG000|Overall Study|Not Treated|0|||
23760700|NCT01244815|66501555|FG001|Overall Study|Not Treated|1|||
23760701|NCT01244815|66501556|FG002|Overall Study|Not Treated|0|||
23760702|NCT01244815|66501557|FG003|Overall Study|Not Treated|0|||
23760703|NCT01244815|66501554|FG000|Overall Study|Adverse Event|4|||
23760704|NCT01244815|66501555|FG001|Overall Study|Adverse Event|7|||
23760705|NCT01244815|66501556|FG002|Overall Study|Adverse Event|5|||
23760706|NCT01244815|66501557|FG003|Overall Study|Adverse Event|5|||
23760707|NCT01244815|66501554|FG000|Overall Study|Treatment Failure|0|||
23760708|NCT01244815|66501555|FG001|Overall Study|Treatment Failure|0|||
23760709|NCT01244815|66501556|FG002|Overall Study|Treatment Failure|0|||
23760710|NCT01244815|66501557|FG003|Overall Study|Treatment Failure|1|||
23760711|NCT01244815|66501554|FG000|Overall Study|Lost to Follow-up|3|||
23760712|NCT01244815|66501555|FG001|Overall Study|Lost to Follow-up|2|||
23760713|NCT01244815|66501556|FG002|Overall Study|Lost to Follow-up|3|||
23760714|NCT01244815|66501557|FG003|Overall Study|Lost to Follow-up|2|||
23760715|NCT01244815|66501554|FG000|Overall Study|Withdrawal by Subject|0|||
23760716|NCT01244815|66501555|FG001|Overall Study|Withdrawal by Subject|2|||
23760717|NCT01244815|66501556|FG002|Overall Study|Withdrawal by Subject|0|||
23760718|NCT01244815|66501557|FG003|Overall Study|Withdrawal by Subject|3|||
23760719|NCT01244815|66501554|FG000|Overall Study|Protocol Violation|7|||
23760720|NCT01244815|66501555|FG001|Overall Study|Protocol Violation|4|||
23760721|NCT01244815|66501556|FG002|Overall Study|Protocol Violation|3|||
23760722|NCT01244815|66501557|FG003|Overall Study|Protocol Violation|1|||
23760723|NCT01244815|66501554|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23760724|NCT01244815|66501555|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23565124|NCT02960763|65799509|FG001|Step 1|Death|1|||
23565125|NCT02960763|65799510|FG002|Step 1|Death|1|||
23565126|NCT02960763|65799511|FG003|Step 1|Death|0|||
23565127|NCT02960763|65799512|FG004|Step 1|Death|0|||
23565128|NCT02960763|65799508|FG000|Step 1|Investigator discretion|1|||
23565129|NCT02960763|65799509|FG001|Step 1|Investigator discretion|0|||
23565130|NCT02960763|65799510|FG002|Step 1|Investigator discretion|1|||
23565131|NCT02960763|65799511|FG003|Step 1|Investigator discretion|0|||
23565132|NCT02960763|65799512|FG004|Step 1|Investigator discretion|0|||
23565133|NCT02960763|65799508|FG000|Step 1|Other|0|||
23565134|NCT02960763|65799509|FG001|Step 1|Other|0|||
23565135|NCT02960763|65799510|FG002|Step 1|Other|1|||
23565136|NCT02960763|65799511|FG003|Step 1|Other|0|||
23565137|NCT02960763|65799512|FG004|Step 1|Other|0|||
23565138|NCT02960763|65799508|FG000|Step 2|Withdrawal by Subject|0|||
23565139|NCT02960763|65799509|FG001|Step 2|Withdrawal by Subject|0|||
23565140|NCT02960763|65799510|FG002|Step 2|Withdrawal by Subject|0|||
23565141|NCT02960763|65799511|FG003|Step 2|Withdrawal by Subject|7|||
23565142|NCT02960763|65799512|FG004|Step 2|Withdrawal by Subject|3|||
23565143|NCT02960763|65799508|FG000|Step 2|Lost to Follow-up|0|||
23565144|NCT02960763|65799509|FG001|Step 2|Lost to Follow-up|0|||
23565145|NCT02960763|65799510|FG002|Step 2|Lost to Follow-up|0|||
23565146|NCT02960763|65799511|FG003|Step 2|Lost to Follow-up|4|||
23565147|NCT02960763|65799512|FG004|Step 2|Lost to Follow-up|1|||
23565148|NCT02960763|65799508|FG000|Step 2|Investigator discretion|0|||
23565149|NCT02960763|65799509|FG001|Step 2|Investigator discretion|0|||
23565150|NCT02960763|65799510|FG002|Step 2|Investigator discretion|0|||
23565151|NCT02960763|65799511|FG003|Step 2|Investigator discretion|0|||
23760725|NCT01244815|66501556|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
23760726|NCT01244815|66501557|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
23760727|NCT02962882|66501558|FG000|Overall Study|Adverse Event|2|||
23760728|NCT02962882|66501558|FG000|Overall Study|Withdrawal by Subject|2|||
23760729|NCT02962882|66501558|FG000|Overall Study|Transfer from ICU|32|||
23760730|NCT00948025|66501566|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
23565152|NCT02960763|65799512|FG004|Step 2|Investigator discretion|1|||
23565153|NCT02306265|65799513|FG000|Overall Study|Withdrawal by Subject|1|||
23565154|NCT01446796|65799520|FG000|Overall Study|Withdrawal by Subject|1|||
23565155|NCT01446796|65799521|FG001|Overall Study|Withdrawal by Subject|0|||
23565156|NCT02213328|65799522|FG000|Overall Study|Withdrawal by Subject|10|||
23441865|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Death|3|||
23441866|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Death|1|||
23441867|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Death|0|||
23441868|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
23441869|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
23441870|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
23441871|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
23441872|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
23441873|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
23441874|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
23565157|NCT02213328|65799522|FG000|Overall Study|Physician Decision|2|||
23565158|NCT02213328|65799522|FG000|Overall Study|Lost to Follow-up|16|||
23565159|NCT03072238|65799523|FG000|Overall Study|Withdrawal by Subject|30|||
23565160|NCT03072238|65799524|FG001|Overall Study|Withdrawal by Subject|51|||
23565161|NCT03072238|65799523|FG000|Overall Study|Lost to Follow-up|7|||
23565162|NCT03072238|65799524|FG001|Overall Study|Lost to Follow-up|4|||
23565163|NCT03072238|65799523|FG000|Overall Study|Physician Decision|1|||
23827763|NCT01371747|66748960|FG004|Overall Study|Low Serum Potassium Results|0|||
23827764|NCT01371747|66748961|FG005|Overall Study|Low Serum Potassium Results|3|||
23441875|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
23441876|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
23441877|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
23441878|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
23441879|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
23441880|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
23441881|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441882|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441883|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441884|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
23441885|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
23441886|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
23441887|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
23441888|NCT02828436|65358658|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
23441889|NCT02828436|65358659|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
23441890|NCT02828436|65358658|FG000|Period 1|Lost to Follow-up|0|||
23441891|NCT02828436|65358659|FG001|Period 1|Lost to Follow-up|1|||
23441892|NCT02828436|65358658|FG000|Period 2|Withdrawal by Subject|4|||
23441893|NCT02828436|65358659|FG001|Period 2|Withdrawal by Subject|0|||
23441894|NCT02828436|65358658|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
23441895|NCT02828436|65358659|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
23441896|NCT02828436|65358658|FG000|Period 2|Lost to Follow-up|1|||
23441897|NCT02828436|65358659|FG001|Period 2|Lost to Follow-up|0|||
23441898|NCT01565694|65358660|FG000|Dose-Titration Period|Adverse Event|4|||
23441899|NCT01565694|65358660|FG000|Dose-Titration Period|Protocol Violation|10|||
23441900|NCT01565694|65358660|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
23441901|NCT00753454|65358661|FG000|Overall Study|Adverse Event|4|||
23441902|NCT00753454|65358661|FG000|Overall Study|Lack of Efficacy|1|||
23441903|NCT00753454|65358661|FG000|Overall Study|Lost to Follow-up|3|||
23441904|NCT00753454|65358661|FG000|Overall Study|Withdrawal by Subject|5|||
23441905|NCT00753454|65358661|FG000|Overall Study|Investigator Decision|1|||
23565164|NCT03072238|65799524|FG001|Overall Study|Physician Decision|3|||
23627331|NCT03126110|66024406|FG010|Phase 2|Progressive Disease|0|||
23627332|NCT03126110|66024407|FG011|Phase 2|Progressive Disease|0|||
23827765|NCT01371747|66748956|FG000|Overall Study|Protocol Violation|0|||
23827766|NCT01371747|66748957|FG001|Overall Study|Protocol Violation|0|||
23827767|NCT01371747|66748958|FG002|Overall Study|Protocol Violation|1|||
23827768|NCT01371747|66748959|FG003|Overall Study|Protocol Violation|0|||
23827769|NCT01371747|66748960|FG004|Overall Study|Protocol Violation|0|||
23827770|NCT01371747|66748961|FG005|Overall Study|Protocol Violation|0|||
23441906|NCT04158583|65358662|FG000|Overall Study|Withdrawal by Subject|1|||
23441907|NCT04158583|65358663|FG001|Overall Study|Withdrawal by Subject|1|||
23441908|NCT04158583|65358664|FG002|Overall Study|Withdrawal by Subject|0|||
23441909|NCT04158583|65358665|FG003|Overall Study|Withdrawal by Subject|0|||
23441910|NCT04158583|65358666|FG004|Overall Study|Withdrawal by Subject|1|||
23441911|NCT04158583|65358667|FG005|Overall Study|Withdrawal by Subject|0|||
23441912|NCT04158583|65358668|FG006|Overall Study|Withdrawal by Subject|0|||
23565165|NCT03072238|65799523|FG000|Overall Study|Death|139|||
23827771|NCT01371747|66748956|FG000|Overall Study|Non-Compliance|3|||
23827772|NCT01371747|66748957|FG001|Overall Study|Non-Compliance|4|||
23441913|NCT04158583|65358669|FG007|Overall Study|Withdrawal by Subject|0|||
23441914|NCT04158583|65358670|FG008|Overall Study|Withdrawal by Subject|2|||
23441915|NCT04158583|65358671|FG009|Overall Study|Withdrawal by Subject|0|||
23441916|NCT04158583|65358662|FG000|Overall Study|Study Terminated by Sponsor|0|||
23565166|NCT03072238|65799524|FG001|Overall Study|Death|121|||
23565167|NCT03072238|65799523|FG000|Overall Study|Other|0|||
23760731|NCT00948025|66501567|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
23627333|NCT03126110|66024408|FG012|Phase 2|Progressive Disease|0|||
23760732|NCT00948025|66501566|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
23760733|NCT00948025|66501567|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
23760734|NCT00948025|66501566|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
23760735|NCT00948025|66501567|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
23760736|NCT03989115|66501568|FG000|Overall Study|Withdrawal by Subject|2|||
23760737|NCT03989115|66501569|FG001|Overall Study|Withdrawal by Subject|1|||
23760738|NCT03989115|66501570|FG002|Overall Study|Withdrawal by Subject|3|||
23760739|NCT03989115|66501571|FG003|Overall Study|Withdrawal by Subject|0|||
23760740|NCT03989115|66501572|FG004|Overall Study|Withdrawal by Subject|17|||
23760741|NCT03989115|66501573|FG005|Overall Study|Withdrawal by Subject|1|||
23760742|NCT03989115|66501574|FG006|Overall Study|Withdrawal by Subject|0|||
23760743|NCT03989115|66501575|FG007|Overall Study|Withdrawal by Subject|0|||
23760744|NCT03989115|66501568|FG000|Overall Study|Sponsor decision to terminate the study|1|||
23760745|NCT03989115|66501569|FG001|Overall Study|Sponsor decision to terminate the study|1|||
23760746|NCT03989115|66501570|FG002|Overall Study|Sponsor decision to terminate the study|0|||
23827773|NCT01371747|66748958|FG002|Overall Study|Non-Compliance|3|||
23827774|NCT01371747|66748959|FG003|Overall Study|Non-Compliance|0|||
23827775|NCT01371747|66748960|FG004|Overall Study|Non-Compliance|0|||
23827776|NCT01371747|66748961|FG005|Overall Study|Non-Compliance|1|||
23565168|NCT03072238|65799524|FG001|Overall Study|Other|1|||
23565169|NCT03072238|65799523|FG000|Overall Study|Ongoing on study|377|||
23565170|NCT03072238|65799524|FG001|Overall Study|Ongoing on study|367|||
23565171|NCT02035332|65799526|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
23565172|NCT01512745|65799529|FG000|Overall Study|Adverse Event|22|||
23565173|NCT01512745|65799530|FG001|Overall Study|Adverse Event|3|||
23565174|NCT01512745|65799529|FG000|Overall Study|Death|9|||
23565175|NCT01512745|65799530|FG001|Overall Study|Death|13|||
23565176|NCT01512745|65799529|FG000|Overall Study|Withdrawal by Subject|2|||
23565177|NCT01512745|65799530|FG001|Overall Study|Withdrawal by Subject|2|||
23565178|NCT01512745|65799529|FG000|Overall Study|Lost to Follow-up|4|||
23565179|NCT01512745|65799530|FG001|Overall Study|Lost to Follow-up|0|||
23565180|NCT01512745|65799529|FG000|Overall Study|Lack of Efficacy|2|||
23565181|NCT01512745|65799530|FG001|Overall Study|Lack of Efficacy|2|||
23565182|NCT01512745|65799529|FG000|Overall Study|Protocol Violation|1|||
23565183|NCT01512745|65799530|FG001|Overall Study|Protocol Violation|0|||
23565184|NCT00949884|65799531|FG000|Overall Study|Adverse Event|14|||
23565185|NCT00949884|65799532|FG001|Overall Study|Adverse Event|3|||
23565186|NCT00949884|65799533|FG002|Overall Study|Adverse Event|12|||
23565187|NCT00949884|65799531|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
23827777|NCT01371747|66748956|FG000|Overall Study|Physician Decision|0|||
23827778|NCT01371747|66748957|FG001|Overall Study|Physician Decision|0|||
23827779|NCT01371747|66748958|FG002|Overall Study|Physician Decision|0|||
23827780|NCT01371747|66748959|FG003|Overall Study|Physician Decision|0|||
23827781|NCT01371747|66748960|FG004|Overall Study|Physician Decision|1|||
23827782|NCT01371747|66748961|FG005|Overall Study|Physician Decision|0|||
23827783|NCT01371747|66748956|FG000|Overall Study|Withdrawal by Subject|6|||
23827784|NCT01371747|66748957|FG001|Overall Study|Withdrawal by Subject|12|||
23827785|NCT01371747|66748958|FG002|Overall Study|Withdrawal by Subject|5|||
23827786|NCT01371747|66748959|FG003|Overall Study|Withdrawal by Subject|2|||
23627334|NCT03126110|66024409|FG013|Phase 2|Progressive Disease|1|||
23627335|NCT03126110|66024410|FG014|Phase 2|Progressive Disease|0|||
23627336|NCT03126110|66024411|FG015|Phase 2|Progressive Disease|0|||
23627337|NCT03126110|66024412|FG016|Phase 2|Progressive Disease|0|||
23627338|NCT03126110|66024396|FG000|Phase 2|Started new treatment|0|||
23627339|NCT03126110|66024397|FG001|Phase 2|Started new treatment|0|||
23627340|NCT03126110|66024398|FG002|Phase 2|Started new treatment|0|||
23827787|NCT01371747|66748960|FG004|Overall Study|Withdrawal by Subject|2|||
23827788|NCT01371747|66748961|FG005|Overall Study|Withdrawal by Subject|4|||
23565188|NCT00949884|65799532|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
23565189|NCT00949884|65799533|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
23565190|NCT00949884|65799531|FG000|Overall Study|Lost to Follow-up|7|||
23627341|NCT03126110|66024399|FG003|Phase 2|Started new treatment|0|||
23627342|NCT03126110|66024400|FG004|Phase 2|Started new treatment|0|||
23627343|NCT03126110|66024401|FG005|Phase 2|Started new treatment|0|||
23627344|NCT03126110|66024402|FG006|Phase 2|Started new treatment|0|||
23760747|NCT03989115|66501571|FG003|Overall Study|Sponsor decision to terminate the study|1|||
23827789|NCT01371747|66748956|FG000|Overall Study|Other Reasons|2|||
23827790|NCT01371747|66748957|FG001|Overall Study|Other Reasons|1|||
23827791|NCT01371747|66748958|FG002|Overall Study|Other Reasons|2|||
23827792|NCT01371747|66748959|FG003|Overall Study|Other Reasons|0|||
23827793|NCT01371747|66748960|FG004|Overall Study|Other Reasons|0|||
23565191|NCT00949884|65799532|FG001|Overall Study|Lost to Follow-up|5|||
23565192|NCT00949884|65799533|FG002|Overall Study|Lost to Follow-up|5|||
23565193|NCT00949884|65799531|FG000|Overall Study|Physician Decision|5|||
23760748|NCT03989115|66501572|FG004|Overall Study|Sponsor decision to terminate the study|11|||
23565194|NCT00949884|65799532|FG001|Overall Study|Physician Decision|0|||
23565195|NCT00949884|65799533|FG002|Overall Study|Physician Decision|6|||
23565196|NCT00949884|65799531|FG000|Overall Study|Treatment non-compliance|5|||
23565197|NCT00949884|65799532|FG001|Overall Study|Treatment non-compliance|0|||
23565198|NCT00949884|65799533|FG002|Overall Study|Treatment non-compliance|8|||
23441917|NCT04158583|65358663|FG001|Overall Study|Study Terminated by Sponsor|0|||
23441918|NCT04158583|65358664|FG002|Overall Study|Study Terminated by Sponsor|0|||
23441919|NCT04158583|65358665|FG003|Overall Study|Study Terminated by Sponsor|1|||
23441920|NCT04158583|65358666|FG004|Overall Study|Study Terminated by Sponsor|0|||
23441921|NCT04158583|65358667|FG005|Overall Study|Study Terminated by Sponsor|0|||
23441922|NCT04158583|65358668|FG006|Overall Study|Study Terminated by Sponsor|0|||
23441923|NCT04158583|65358669|FG007|Overall Study|Study Terminated by Sponsor|0|||
23441924|NCT04158583|65358670|FG008|Overall Study|Study Terminated by Sponsor|0|||
23441925|NCT04158583|65358671|FG009|Overall Study|Study Terminated by Sponsor|0|||
23441926|NCT04158583|65358662|FG000|Overall Study|Progressive Disease|1|||
23441927|NCT04158583|65358663|FG001|Overall Study|Progressive Disease|0|||
23441928|NCT04158583|65358664|FG002|Overall Study|Progressive Disease|3|||
23441929|NCT04158583|65358665|FG003|Overall Study|Progressive Disease|5|||
23441930|NCT04158583|65358666|FG004|Overall Study|Progressive Disease|0|||
23441931|NCT04158583|65358667|FG005|Overall Study|Progressive Disease|1|||
23441932|NCT04158583|65358668|FG006|Overall Study|Progressive Disease|6|||
23441933|NCT04158583|65358669|FG007|Overall Study|Progressive Disease|2|||
23441934|NCT04158583|65358670|FG008|Overall Study|Progressive Disease|1|||
23565199|NCT00949884|65799531|FG000|Overall Study|Withdrawal by Subject|13|||
23565200|NCT00949884|65799532|FG001|Overall Study|Withdrawal by Subject|4|||
23565201|NCT00949884|65799533|FG002|Overall Study|Withdrawal by Subject|16|||
23565202|NCT00949884|65799531|FG000|Overall Study|Lack of Efficacy|4|||
23565203|NCT00949884|65799532|FG001|Overall Study|Lack of Efficacy|2|||
23565204|NCT00949884|65799533|FG002|Overall Study|Lack of Efficacy|7|||
23565205|NCT00949884|65799531|FG000|Overall Study|Study terminated by sponsor|0|||
23627345|NCT03126110|66024403|FG007|Phase 2|Started new treatment|0|||
23760749|NCT03989115|66501573|FG005|Overall Study|Sponsor decision to terminate the study|0|||
23760750|NCT03989115|66501574|FG006|Overall Study|Sponsor decision to terminate the study|2|||
23760751|NCT03989115|66501575|FG007|Overall Study|Sponsor decision to terminate the study|1|||
23760752|NCT03989115|66501568|FG000|Overall Study|Lost to Follow-up|2|||
23760753|NCT03989115|66501569|FG001|Overall Study|Lost to Follow-up|0|||
23760754|NCT03989115|66501570|FG002|Overall Study|Lost to Follow-up|0|||
23760755|NCT03989115|66501571|FG003|Overall Study|Lost to Follow-up|0|||
23760756|NCT03989115|66501572|FG004|Overall Study|Lost to Follow-up|1|||
23760757|NCT03989115|66501573|FG005|Overall Study|Lost to Follow-up|0|||
23760758|NCT03989115|66501574|FG006|Overall Study|Lost to Follow-up|0|||
23760759|NCT03989115|66501575|FG007|Overall Study|Lost to Follow-up|0|||
23760760|NCT03989115|66501568|FG000|Overall Study|Death|2|||
23760761|NCT03989115|66501569|FG001|Overall Study|Death|2|||
23760762|NCT03989115|66501570|FG002|Overall Study|Death|9|||
23760763|NCT03989115|66501571|FG003|Overall Study|Death|6|||
23760764|NCT03989115|66501572|FG004|Overall Study|Death|31|||
23760765|NCT03989115|66501573|FG005|Overall Study|Death|6|||
23760766|NCT03989115|66501574|FG006|Overall Study|Death|2|||
23760767|NCT03989115|66501575|FG007|Overall Study|Death|3|||
23760768|NCT03989115|66501568|FG000|Overall Study|Other|1|||
23760769|NCT03989115|66501569|FG001|Overall Study|Other|2|||
23760770|NCT03989115|66501570|FG002|Overall Study|Other|0|||
23760771|NCT03989115|66501571|FG003|Overall Study|Other|0|||
23760772|NCT03989115|66501572|FG004|Overall Study|Other|5|||
23441935|NCT04158583|65358671|FG009|Overall Study|Progressive Disease|2|||
23441936|NCT04158583|65358662|FG000|Overall Study|Lost to Follow-up|0|||
23441937|NCT04158583|65358663|FG001|Overall Study|Lost to Follow-up|0|||
23441938|NCT04158583|65358664|FG002|Overall Study|Lost to Follow-up|1|||
23627346|NCT03126110|66024404|FG008|Phase 2|Started new treatment|0|||
23760773|NCT03989115|66501573|FG005|Overall Study|Other|0|||
23760774|NCT03989115|66501574|FG006|Overall Study|Other|0|||
23760775|NCT03989115|66501575|FG007|Overall Study|Other|0|||
23760776|NCT02065791|66501579|FG000|Overall Study|Closed Site|1|||
23760777|NCT02065791|66501580|FG001|Overall Study|Closed Site|1|||
23760778|NCT02065791|66501579|FG000|Overall Study|Withdrawal by Subject|11|||
23441939|NCT04158583|65358665|FG003|Overall Study|Lost to Follow-up|1|||
23627347|NCT03126110|66024405|FG009|Phase 2|Started new treatment|0|||
23760779|NCT02065791|66501580|FG001|Overall Study|Withdrawal by Subject|5|||
23760780|NCT02065791|66501579|FG000|Overall Study|Lost to Follow-up|13|||
23441940|NCT04158583|65358666|FG004|Overall Study|Lost to Follow-up|1|||
23441941|NCT04158583|65358667|FG005|Overall Study|Lost to Follow-up|0|||
23441942|NCT04158583|65358668|FG006|Overall Study|Lost to Follow-up|0|||
23441943|NCT04158583|65358669|FG007|Overall Study|Lost to Follow-up|0|||
23565206|NCT00949884|65799532|FG001|Overall Study|Study terminated by sponsor|0|||
23760781|NCT02065791|66501580|FG001|Overall Study|Lost to Follow-up|9|||
23441944|NCT04158583|65358670|FG008|Overall Study|Lost to Follow-up|0|||
23565207|NCT00949884|65799533|FG002|Overall Study|Study terminated by sponsor|1|||
23760782|NCT01255722|66501583|FG000|Overall Study|Adverse Event|0|||
23760783|NCT01255722|66501584|FG001|Overall Study|Adverse Event|1|||
23760784|NCT01255722|66501585|FG002|Overall Study|Adverse Event|1|||
23760785|NCT01255722|66501583|FG000|Overall Study|asymptomatic patient|1|||
23760786|NCT01255722|66501584|FG001|Overall Study|asymptomatic patient|0|||
23760787|NCT01255722|66501585|FG002|Overall Study|asymptomatic patient|0|||
23760788|NCT01255722|66501583|FG000|Overall Study|beta-blocker contraindicated|2|||
23760789|NCT01255722|66501584|FG001|Overall Study|beta-blocker contraindicated|0|||
23760790|NCT01255722|66501585|FG002|Overall Study|beta-blocker contraindicated|0|||
23760791|NCT01098240|66501590|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
23760792|NCT01098240|66501591|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
23760793|NCT01098240|66501592|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
23760794|NCT01098240|66501590|FG000|Open-Label Phase|Protocol Violation|4|||
23760795|NCT01098240|66501591|FG001|Open-Label Phase|Protocol Violation|0|||
23760796|NCT01098240|66501592|FG002|Open-Label Phase|Protocol Violation|0|||
23760797|NCT01098240|66501590|FG000|Open-Label Phase|Lost to Follow-up|13|||
23760798|NCT01098240|66501591|FG001|Open-Label Phase|Lost to Follow-up|0|||
23760799|NCT01098240|66501592|FG002|Open-Label Phase|Lost to Follow-up|0|||
23760800|NCT01098240|66501590|FG000|Open-Label Phase|Other|19|||
23760801|NCT01098240|66501591|FG001|Open-Label Phase|Other|0|||
23760802|NCT01098240|66501592|FG002|Open-Label Phase|Other|0|||
23760803|NCT01098240|66501590|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
23760804|NCT01098240|66501591|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23760805|NCT01098240|66501592|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23760806|NCT01098240|66501590|FG000|Open-Label Phase|Pregnancy|1|||
23760807|NCT01098240|66501591|FG001|Open-Label Phase|Pregnancy|0|||
23760808|NCT01098240|66501592|FG002|Open-Label Phase|Pregnancy|0|||
23760809|NCT01098240|66501590|FG000|Open-Label Phase|Withdrawal by Subject|9|||
23760810|NCT01098240|66501591|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23760811|NCT01098240|66501592|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23760812|NCT01098240|66501590|FG000|Open-Label Phase|Adverse Event|12|||
23760813|NCT01098240|66501591|FG001|Open-Label Phase|Adverse Event|0|||
23760814|NCT01098240|66501592|FG002|Open-Label Phase|Adverse Event|0|||
23760815|NCT01098240|66501590|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
23760816|NCT01098240|66501591|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
23760817|NCT01098240|66501592|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
23760818|NCT01098240|66501590|FG000|Double-Blind Phase|Protocol Violation|0|||
23760819|NCT01098240|66501591|FG001|Double-Blind Phase|Protocol Violation|2|||
23760820|NCT01098240|66501592|FG002|Double-Blind Phase|Protocol Violation|4|||
23760821|NCT01098240|66501590|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23760822|NCT01098240|66501591|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23760823|NCT01098240|66501592|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23760824|NCT01098240|66501590|FG000|Double-Blind Phase|Other|0|||
23760825|NCT01098240|66501591|FG001|Double-Blind Phase|Other|2|||
23760826|NCT01098240|66501592|FG002|Double-Blind Phase|Other|2|||
23760827|NCT01098240|66501590|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
23760828|NCT01098240|66501591|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
23760829|NCT01098240|66501592|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
23760830|NCT01098240|66501590|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
23760831|NCT01098240|66501591|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
23760832|NCT01098240|66501592|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
23760833|NCT01098240|66501590|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23760834|NCT01098240|66501591|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23760835|NCT01098240|66501592|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
23760836|NCT01098240|66501590|FG000|Double-Blind Phase|Adverse Event|0|||
23760837|NCT01098240|66501591|FG001|Double-Blind Phase|Adverse Event|3|||
23760838|NCT01098240|66501592|FG002|Double-Blind Phase|Adverse Event|3|||
23760839|NCT00926289|66501597|FG000|Overall Study|Adverse Event|9|||
23760840|NCT00926289|66501598|FG001|Overall Study|Adverse Event|11|||
23760841|NCT00926289|66501597|FG000|Overall Study|Protocol Violation|8|||
23760842|NCT00926289|66501598|FG001|Overall Study|Protocol Violation|12|||
23760843|NCT00926289|66501597|FG000|Overall Study|Lost to Follow-up|3|||
23760844|NCT00926289|66501598|FG001|Overall Study|Lost to Follow-up|6|||
23760845|NCT00926289|66501597|FG000|Overall Study|Withdrawal by Subject|4|||
23760846|NCT00926289|66501598|FG001|Overall Study|Withdrawal by Subject|4|||
23760847|NCT00926289|66501597|FG000|Overall Study|Other|1|||
23760848|NCT00926289|66501598|FG001|Overall Study|Other|3|||
23760849|NCT02270983|66501599|FG000|Overall Study|Adverse Event|3|||
23760850|NCT02270983|66501600|FG001|Overall Study|Adverse Event|2|||
23760851|NCT02270983|66501601|FG002|Overall Study|Adverse Event|6|||
23760852|NCT02270983|66501599|FG000|Overall Study|Lack of Efficacy|2|||
23627348|NCT03126110|66024406|FG010|Phase 2|Started new treatment|0|||
23760853|NCT02270983|66501600|FG001|Overall Study|Lack of Efficacy|1|||
23760854|NCT02270983|66501601|FG002|Overall Study|Lack of Efficacy|1|||
23760855|NCT02270983|66501599|FG000|Overall Study|Withdrawal by Subject|1|||
23760856|NCT02270983|66501600|FG001|Overall Study|Withdrawal by Subject|0|||
23760857|NCT02270983|66501601|FG002|Overall Study|Withdrawal by Subject|2|||
23760858|NCT02270983|66501599|FG000|Overall Study|Lost to Follow-up|1|||
23760859|NCT02270983|66501600|FG001|Overall Study|Lost to Follow-up|1|||
23760860|NCT02270983|66501601|FG002|Overall Study|Lost to Follow-up|2|||
23760861|NCT02270983|66501599|FG000|Overall Study|Protocol Violation|1|||
23760862|NCT02270983|66501600|FG001|Overall Study|Protocol Violation|1|||
23760863|NCT02270983|66501601|FG002|Overall Study|Protocol Violation|1|||
23760864|NCT02270983|66501599|FG000|Overall Study|family emergency|0|||
23760865|NCT02270983|66501600|FG001|Overall Study|family emergency|1|||
23760866|NCT02270983|66501601|FG002|Overall Study|family emergency|0|||
23760867|NCT02270983|66501599|FG000|Overall Study|study procedure non-compliance|1|||
23760868|NCT02270983|66501600|FG001|Overall Study|study procedure non-compliance|0|||
23760869|NCT02270983|66501601|FG002|Overall Study|study procedure non-compliance|0|||
23760870|NCT02270983|66501599|FG000|Overall Study|moved away from study site|0|||
23760871|NCT02270983|66501600|FG001|Overall Study|moved away from study site|1|||
23760872|NCT02270983|66501601|FG002|Overall Study|moved away from study site|0|||
23760873|NCT01453374|66501602|FG000|Overall Study|Adverse Event|7|||
23760874|NCT01453374|66501602|FG000|Overall Study|Lack of Efficacy|1|||
23760875|NCT01453374|66501602|FG000|Overall Study|Lost to Follow-up|3|||
23760876|NCT01453374|66501602|FG000|Overall Study|Withdrawal by Subject|5|||
23760877|NCT01453374|66501602|FG000|Overall Study|Incarcerated|2|||
23760878|NCT03202511|66501603|FG000|Overall Study|Withdrawal by Subject|1|||
23760879|NCT03202511|66501604|FG001|Overall Study|Withdrawal by Subject|0|||
23760880|NCT02970669|66501612|FG000|Double-blind Period|Adverse Event|4|||
23760881|NCT02970669|66501613|FG001|Double-blind Period|Adverse Event|0|||
23760882|NCT02970669|66501612|FG000|Double-blind Period|Death|1|||
23565208|NCT02690077|65799538|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
23565209|NCT02690077|65799539|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
23565210|NCT02690077|65799538|FG000|Overall Study|Withdrawal by Subject|0|||
23565211|NCT02690077|65799539|FG001|Overall Study|Withdrawal by Subject|5|||
23565212|NCT02690077|65799538|FG000|Overall Study|Excluded by IRB|0|||
23565213|NCT02690077|65799539|FG001|Overall Study|Excluded by IRB|2|||
23565214|NCT01862796|65799547|FG000|Overall Study|Prohibited medications|0|||
23565215|NCT01862796|65799548|FG001|Overall Study|Prohibited medications|0|||
23565216|NCT01862796|65799549|FG002|Overall Study|Prohibited medications|1|||
23565217|NCT02281760|65799553|FG000|Overall Study|Withdrawal by Subject|1|||
23565218|NCT01975220|65799565|FG000|Test Period 1|Not treated|0|||
23565219|NCT01975220|65799566|FG001|Test Period 1|Not treated|1|||
23565220|NCT01975220|65799567|FG002|Test Period 1|Not treated|0|||
23565221|NCT01975220|65799568|FG003|Test Period 1|Not treated|0|||
23565222|NCT01975220|65799569|FG004|Test Period 1|Not treated|0|||
23565223|NCT01975220|65799570|FG005|Test Period 1|Not treated|0|||
23565224|NCT03101241|65799571|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
23565225|NCT03101241|65799572|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
23565226|NCT03101241|65799571|FG000|Overall Study|Participant withdrew consent|3|||
23760883|NCT02970669|66501613|FG001|Double-blind Period|Death|0|||
23760884|NCT02970669|66501612|FG000|Double-blind Period|Study terminated by sponsor|1|||
23760885|NCT02970669|66501613|FG001|Double-blind Period|Study terminated by sponsor|2|||
23760886|NCT02970669|66501612|FG000|Double-blind Period|Physician Decision|0|||
23760887|NCT02970669|66501613|FG001|Double-blind Period|Physician Decision|2|||
23760888|NCT02970669|66501612|FG000|Double-blind Period|Withdrawal by Subject|2|||
23760889|NCT02970669|66501613|FG001|Double-blind Period|Withdrawal by Subject|2|||
23760890|NCT02970669|66501612|FG000|Open-label Period|Withdrawal by Subject|2|||
23760891|NCT02970669|66501613|FG001|Open-label Period|Withdrawal by Subject|2|||
23760892|NCT02970669|66501612|FG000|Open-label Period|Adverse Event|1|||
23760893|NCT02970669|66501613|FG001|Open-label Period|Adverse Event|0|||
23760894|NCT02970669|66501612|FG000|Open-label Period|Physician Decision|1|||
23760895|NCT02970669|66501613|FG001|Open-label Period|Physician Decision|0|||
23760896|NCT01991977|66501614|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
23760897|NCT01991977|66501614|FG000|Overall Study|Withdrew after start of treatment|5|||
23760898|NCT04470622|66501618|FG000|Overall Study|Withdrawal by Subject|0|||
23760899|NCT04470622|66501619|FG001|Overall Study|Withdrawal by Subject|1|||
23760900|NCT04470622|66501618|FG000|Overall Study|Screen Failure|0|||
23760901|NCT04470622|66501619|FG001|Overall Study|Screen Failure|1|||
23760902|NCT04470622|66501618|FG000|Overall Study|Death|0|||
23760903|NCT04470622|66501619|FG001|Overall Study|Death|1|||
23760904|NCT00871169|66505176|FG000|Overall Study|Protocol Violation|1|||
23760905|NCT00871169|66505176|FG000|Overall Study|Patient did not receive study treatment|2|||
23760906|NCT03063632|66505179|FG000|Overall Study|Death|4|||
23760907|NCT03063632|66505180|FG001|Overall Study|Death|6|||
23760908|NCT03063632|66505179|FG000|Overall Study|Lost to Follow-up|0|||
23760909|NCT03063632|66505180|FG001|Overall Study|Lost to Follow-up|1|||
23760910|NCT03063632|66505179|FG000|Overall Study|Withdrawal by Subject|0|||
23760911|NCT03063632|66505180|FG001|Overall Study|Withdrawal by Subject|2|||
23760912|NCT03063632|66505179|FG000|Overall Study|Physician Decision|2|||
23760913|NCT03063632|66505180|FG001|Overall Study|Physician Decision|0|||
23760914|NCT03063632|66505179|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
23760915|NCT03063632|66505180|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
23565227|NCT03101241|65799572|FG001|Overall Study|Participant withdrew consent|1|||
23760916|NCT03740698|66505181|FG000|Overall Study|Physician Decision|0|||
23760917|NCT03740698|66505182|FG001|Overall Study|Physician Decision|1|||
23760918|NCT03740698|66505183|FG002|Overall Study|Physician Decision|1|||
23760919|NCT01512979|66505186|FG000|Overall Study|Adverse Event|2|||
23760920|NCT01512979|66505187|FG001|Overall Study|Adverse Event|2|||
23760921|NCT01512979|66505186|FG000|Overall Study|Protocol Violation|1|||
23760922|NCT01512979|66505187|FG001|Overall Study|Protocol Violation|4|||
23760923|NCT01512979|66505186|FG000|Overall Study|Lost to Follow-up|2|||
23760924|NCT01512979|66505187|FG001|Overall Study|Lost to Follow-up|5|||
23760925|NCT01512979|66505186|FG000|Overall Study|Withdrawal by Subject|1|||
23760926|NCT01512979|66505187|FG001|Overall Study|Withdrawal by Subject|2|||
23760927|NCT01512979|66505186|FG000|Overall Study|Reason other than stated above|13|||
23760928|NCT01512979|66505187|FG001|Overall Study|Reason other than stated above|9|||
23760929|NCT04006847|66505193|FG000|Overall Study|Product issue|1|||
23760930|NCT03083132|66505194|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
23760931|NCT03083132|66505195|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
23760932|NCT03083132|66505194|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
23760933|NCT03083132|66505195|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
23760934|NCT03083132|66505194|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
23760935|NCT03083132|66505195|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
23760936|NCT01759537|66505196|FG000|Overall Study|Death|1|||
23760937|NCT01759537|66505197|FG001|Overall Study|Death|1|||
23760938|NCT01759537|66505196|FG000|Overall Study|Pregnancy|1|||
23760939|NCT01759537|66505197|FG001|Overall Study|Pregnancy|1|||
23760940|NCT01759537|66505196|FG000|Overall Study|Lost to Follow-up|9|||
23760941|NCT01759537|66505197|FG001|Overall Study|Lost to Follow-up|9|||
23760942|NCT01759537|66505196|FG000|Overall Study|Accident involving jaw fracture|1|||
23760943|NCT01759537|66505197|FG001|Overall Study|Accident involving jaw fracture|1|||
23760944|NCT01759537|66505196|FG000|Overall Study|Subcrestal implant too coronal|1|||
23760945|NCT01759537|66505197|FG001|Overall Study|Subcrestal implant too coronal|1|||
23760946|NCT03862625|66505198|FG000|Overall Study|Lost to Follow-up|0|||
23760947|NCT03862625|66505199|FG001|Overall Study|Lost to Follow-up|1|||
23760948|NCT02109133|66505200|FG000|Overall Study|Lost to Follow-up|1|||
23760949|NCT02109133|66505201|FG001|Overall Study|Lost to Follow-up|0|||
23760950|NCT00697112|66505202|FG000|Overall Study|Adverse Event|8|||
23760951|NCT00697112|66505202|FG000|Overall Study|Lost to Follow-up|1|||
23760952|NCT00697112|66505202|FG000|Overall Study|Did not meet inclusion criteria|1|||
23760953|NCT02535000|66505203|FG000|Overall Study|Cancellation of surgery.|1|||
23760954|NCT02535000|66505204|FG001|Overall Study|Cancellation of surgery.|2|||
23760955|NCT00520351|66505207|FG000|First Intervention|Withdrawal by Subject|1|||
23760956|NCT00520351|66505208|FG001|First Intervention|Withdrawal by Subject|1|||
23760957|NCT02513459|66505209|FG000|Overall Study|Adverse Event|7|||
23760958|NCT02513459|66505209|FG000|Overall Study|Withdrew consent|5|||
23760959|NCT02513459|66505209|FG000|Overall Study|Loss of efficacy|2|||
23760960|NCT02513459|66505209|FG000|Overall Study|Pregnancy|2|||
23760961|NCT02513459|66505209|FG000|Overall Study|Subject decision|2|||
23760962|NCT02513459|66505209|FG000|Overall Study|Lack of response|1|||
23760963|NCT02513459|66505209|FG000|Overall Study|Reproductive plans|1|||
23760964|NCT02513459|66505209|FG000|Overall Study|Surgery planned-- not done|1|||
23760965|NCT01851590|66505215|FG000|Overall Study|Withdrawal by Subject|0|||
23760966|NCT01851590|66505216|FG001|Overall Study|Withdrawal by Subject|0|||
23760967|NCT01851590|66505217|FG002|Overall Study|Withdrawal by Subject|1|||
23760968|NCT01851590|66505215|FG000|Overall Study|Adverse Event|0|||
23760969|NCT01851590|66505216|FG001|Overall Study|Adverse Event|0|||
23760970|NCT01851590|66505217|FG002|Overall Study|Adverse Event|2|||
23760971|NCT01851590|66505215|FG000|Overall Study|Lack of Efficacy|0|||
23760972|NCT01851590|66505216|FG001|Overall Study|Lack of Efficacy|1|||
23760973|NCT01851590|66505217|FG002|Overall Study|Lack of Efficacy|0|||
23760974|NCT01677910|66505220|FG000|Double-Blind Treatment Period|Adverse Event|6|||
23441945|NCT04158583|65358671|FG009|Overall Study|Lost to Follow-up|0|||
23441946|NCT04158583|65358662|FG000|Overall Study|Due To Patient Status|0|||
23760975|NCT01677910|66505221|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23760976|NCT01677910|66505222|FG002|Double-Blind Treatment Period|Adverse Event|3|||
23760977|NCT01677910|66505223|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23760978|NCT01677910|66505220|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23760979|NCT01677910|66505221|FG001|Double-Blind Treatment Period|Physician Decision|0|||
23760980|NCT01677910|66505222|FG002|Double-Blind Treatment Period|Physician Decision|1|||
23760981|NCT01677910|66505223|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23760982|NCT01677910|66505220|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
23760983|NCT01677910|66505221|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
23760984|NCT01677910|66505222|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
23760985|NCT01677910|66505223|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
23760986|NCT01677910|66505220|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
23760987|NCT01677910|66505221|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
23441947|NCT04158583|65358663|FG001|Overall Study|Due To Patient Status|0|||
23441948|NCT04158583|65358664|FG002|Overall Study|Due To Patient Status|0|||
23441949|NCT04158583|65358665|FG003|Overall Study|Due To Patient Status|0|||
23441950|NCT04158583|65358666|FG004|Overall Study|Due To Patient Status|0|||
23441951|NCT04158583|65358667|FG005|Overall Study|Due To Patient Status|0|||
23441952|NCT04158583|65358668|FG006|Overall Study|Due To Patient Status|0|||
23441953|NCT04158583|65358669|FG007|Overall Study|Due To Patient Status|0|||
23441954|NCT04158583|65358670|FG008|Overall Study|Due To Patient Status|1|||
23441955|NCT04158583|65358671|FG009|Overall Study|Due To Patient Status|0|||
23441956|NCT04158583|65358662|FG000|Overall Study|Death|3|||
23441957|NCT04158583|65358663|FG001|Overall Study|Death|4|||
23565228|NCT03101241|65799571|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
23565229|NCT03101241|65799572|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
23565230|NCT03101241|65799571|FG000|Overall Study|Lost to Follow-up|2|||
23565231|NCT03101241|65799572|FG001|Overall Study|Lost to Follow-up|0|||
23565232|NCT03101241|65799571|FG000|Overall Study|Lack of Efficacy|0|||
23565233|NCT03101241|65799572|FG001|Overall Study|Lack of Efficacy|1|||
23565234|NCT03101241|65799571|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
23565235|NCT03101241|65799572|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
23565236|NCT00622713|65799578|FG000|Overall Study|Adverse Event|35|||
23565237|NCT00622713|65799578|FG000|Overall Study|Administrative problems|4|||
23565238|NCT00622713|65799578|FG000|Overall Study|Withdrawal by Subject|11|||
23565239|NCT00622713|65799578|FG000|Overall Study|Lost to Follow-up|5|||
23565240|NCT00622713|65799578|FG000|Overall Study|Death|2|||
23565241|NCT00622713|65799578|FG000|Overall Study|Subject no longer required study drug|1|||
23565242|NCT00622713|65799578|FG000|Overall Study|Did not meet eligibility criteria|1|||
23565243|NCT02396537|65799582|FG000|Overall Study|Protocol Violation|0|||
23565244|NCT02396537|65799583|FG001|Overall Study|Protocol Violation|1|||
23565245|NCT01336634|65799585|FG000|Overall Study|Study closed/terminated|5|||
23565246|NCT01336634|65799586|FG001|Overall Study|Study closed/terminated|6|||
23565247|NCT01336634|65799587|FG002|Overall Study|Study closed/terminated|6|||
23565248|NCT01336634|65799585|FG000|Overall Study|Lost to Follow-up|2|||
23565249|NCT01336634|65799586|FG001|Overall Study|Lost to Follow-up|1|||
23565250|NCT01336634|65799587|FG002|Overall Study|Lost to Follow-up|1|||
23565251|NCT01336634|65799585|FG000|Overall Study|Physician Decision|1|||
23627349|NCT03126110|66024407|FG011|Phase 2|Started new treatment|0|||
23627350|NCT03126110|66024408|FG012|Phase 2|Started new treatment|0|||
23627351|NCT03126110|66024409|FG013|Phase 2|Started new treatment|0|||
23627352|NCT03126110|66024410|FG014|Phase 2|Started new treatment|1|||
23627353|NCT03126110|66024411|FG015|Phase 2|Started new treatment|0|||
23627354|NCT03126110|66024412|FG016|Phase 2|Started new treatment|0|||
23827794|NCT01371747|66748961|FG005|Overall Study|Other Reasons|1|||
23827795|NCT01753999|66748962|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
23827796|NCT01753999|66748963|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
23827797|NCT01753999|66748962|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
23827798|NCT01753999|66748963|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
23827799|NCT01753999|66748962|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
23827800|NCT01753999|66748963|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
23827801|NCT01753999|66748962|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
23827802|NCT01753999|66748963|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
23827803|NCT01753999|66748962|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
23827804|NCT01753999|66748963|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
23827805|NCT01753999|66748962|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
23827806|NCT01753999|66748963|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
23441958|NCT04158583|65358664|FG002|Overall Study|Death|2|||
23441959|NCT04158583|65358665|FG003|Overall Study|Death|2|||
23441960|NCT04158583|65358666|FG004|Overall Study|Death|4|||
23565252|NCT01336634|65799586|FG001|Overall Study|Physician Decision|1|||
23627355|NCT04962698|66024413|FG000|Motor Imagery|Technical difficulty|1|||
23441961|NCT04158583|65358667|FG005|Overall Study|Death|3|||
23441962|NCT04158583|65358668|FG006|Overall Study|Death|5|||
23441963|NCT04158583|65358669|FG007|Overall Study|Death|2|||
23565253|NCT01336634|65799587|FG002|Overall Study|Physician Decision|0|||
23565254|NCT01336634|65799585|FG000|Overall Study|Withdrawal by Subject|6|||
23565255|NCT01336634|65799586|FG001|Overall Study|Withdrawal by Subject|0|||
23441964|NCT04158583|65358670|FG008|Overall Study|Death|0|||
23441965|NCT04158583|65358671|FG009|Overall Study|Death|1|||
23441966|NCT04158583|65358662|FG000|Overall Study|Clinical Progression Disease|0|||
23441967|NCT04158583|65358663|FG001|Overall Study|Clinical Progression Disease|0|||
23441968|NCT04158583|65358664|FG002|Overall Study|Clinical Progression Disease|0|||
23441969|NCT04158583|65358665|FG003|Overall Study|Clinical Progression Disease|1|||
23441970|NCT04158583|65358666|FG004|Overall Study|Clinical Progression Disease|0|||
23441971|NCT04158583|65358667|FG005|Overall Study|Clinical Progression Disease|0|||
23441972|NCT04158583|65358668|FG006|Overall Study|Clinical Progression Disease|0|||
23441973|NCT04158583|65358669|FG007|Overall Study|Clinical Progression Disease|0|||
23441974|NCT04158583|65358670|FG008|Overall Study|Clinical Progression Disease|0|||
23441975|NCT04158583|65358671|FG009|Overall Study|Clinical Progression Disease|0|||
23441976|NCT04158583|65358662|FG000|Overall Study|Clinical Progression|0|||
23441977|NCT04158583|65358663|FG001|Overall Study|Clinical Progression|0|||
23441978|NCT04158583|65358664|FG002|Overall Study|Clinical Progression|0|||
23441979|NCT04158583|65358665|FG003|Overall Study|Clinical Progression|0|||
23441980|NCT04158583|65358666|FG004|Overall Study|Clinical Progression|1|||
23441981|NCT04158583|65358667|FG005|Overall Study|Clinical Progression|0|||
23441982|NCT04158583|65358668|FG006|Overall Study|Clinical Progression|2|||
23441983|NCT04158583|65358669|FG007|Overall Study|Clinical Progression|0|||
23441984|NCT04158583|65358670|FG008|Overall Study|Clinical Progression|0|||
23441985|NCT04158583|65358671|FG009|Overall Study|Clinical Progression|0|||
23441986|NCT04158583|65358662|FG000|Overall Study|Clinical Deterioration|0|||
23441987|NCT04158583|65358663|FG001|Overall Study|Clinical Deterioration|0|||
23441988|NCT04158583|65358664|FG002|Overall Study|Clinical Deterioration|0|||
23441989|NCT04158583|65358665|FG003|Overall Study|Clinical Deterioration|1|||
23565256|NCT01336634|65799587|FG002|Overall Study|Withdrawal by Subject|2|||
23565257|NCT00728962|65799588|FG000|Implant Placement Surgery|Adverse Event|8|||
23827807|NCT03639779|66748970|FG000|Overall Study|Lost to Follow-up|1|||
23827808|NCT00618371|66748971|FG000|Overall Study|Withdrawal by Subject|2|||
23827809|NCT02456740|66748972|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23827810|NCT02456740|66748973|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23827811|NCT02456740|66748974|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23827812|NCT02456740|66748975|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827813|NCT02456740|66748976|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827814|NCT02456740|66748977|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827815|NCT02456740|66748978|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827816|NCT02456740|66748979|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827817|NCT02456740|66748980|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23827818|NCT02456740|66748972|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
23827819|NCT02456740|66748973|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
23827820|NCT02456740|66748974|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
23827821|NCT02456740|66748975|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827822|NCT02456740|66748976|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827823|NCT02456740|66748977|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827824|NCT02456740|66748978|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827825|NCT02456740|66748979|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827826|NCT02456740|66748980|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23827827|NCT02456740|66748972|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
23827828|NCT02456740|66748973|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
23827829|NCT02456740|66748974|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
23827830|NCT02456740|66748975|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827831|NCT02456740|66748976|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827832|NCT02456740|66748977|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827833|NCT02456740|66748978|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827834|NCT02456740|66748979|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827835|NCT02456740|66748980|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23827836|NCT02456740|66748972|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23827837|NCT02456740|66748973|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23441990|NCT04158583|65358666|FG004|Overall Study|Clinical Deterioration|0|||
23441991|NCT04158583|65358667|FG005|Overall Study|Clinical Deterioration|0|||
23565258|NCT00728962|65799588|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
23565259|NCT00728962|65799588|FG000|Implant Placement Surgery|Protocol Violation|1|||
23441992|NCT04158583|65358668|FG006|Overall Study|Clinical Deterioration|0|||
23441993|NCT04158583|65358669|FG007|Overall Study|Clinical Deterioration|0|||
23441994|NCT04158583|65358670|FG008|Overall Study|Clinical Deterioration|0|||
23441995|NCT04158583|65358671|FG009|Overall Study|Clinical Deterioration|1|||
23441996|NCT01206582|65358676|FG000|Overall Study|Withdrew prior to study|1|||
23827838|NCT02456740|66748974|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23827839|NCT02456740|66748975|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
23827840|NCT02456740|66748976|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
23827841|NCT02456740|66748977|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23441997|NCT01206582|65358677|FG001|Overall Study|Withdrew prior to study|0|||
23441998|NCT01206582|65358676|FG000|Overall Study|Discontinued intervention before week 8|1|||
23441999|NCT01206582|65358677|FG001|Overall Study|Discontinued intervention before week 8|2|||
23442000|NCT03927144|65358678|FG000|Core Phase|Adverse Event|9|||
23760988|NCT01677910|66505222|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
23760989|NCT01677910|66505223|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
23760990|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
23760991|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
23760992|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
23760993|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
23760994|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23760995|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23760996|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23760997|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
23760998|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23760999|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23761000|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23761001|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
23761002|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23761003|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23761004|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23761005|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
23761006|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
23761007|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
23761008|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
23761009|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
23761010|NCT01677910|66505220|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23761011|NCT01677910|66505221|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23565260|NCT00728962|65799588|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
23565261|NCT00728962|65799588|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
23565262|NCT03579290|65799589|FG000|Overall Study|Lost to Follow-up|9|||
23565263|NCT01108458|65799590|FG000|Overall Study|Withdrawal by Subject|1|||
23761012|NCT01677910|66505222|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23761013|NCT01677910|66505223|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
23761014|NCT01619085|66505224|FG000|Overall Study|Adverse Event|231|||
23761015|NCT01619085|66505224|FG000|Overall Study|Protocol Violation|4|||
23761016|NCT01619085|66505224|FG000|Overall Study|Lost to Follow-up|3|||
23761017|NCT01619085|66505224|FG000|Overall Study|Withdrawal by Subject|45|||
23761018|NCT01619085|66505224|FG000|Overall Study|Other than specified|96|||
23761019|NCT01619085|66505224|FG000|Overall Study|Not treated|1|||
23761020|NCT01619085|66505224|FG000|Overall Study|Death|145|||
23761021|NCT02265952|66505227|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
23761022|NCT02265952|66505228|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
23761023|NCT02265952|66505227|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
23761024|NCT02265952|66505228|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
23761025|NCT02971605|66505231|FG000|Overall Study|Withdrawal by Subject|1|||
23761026|NCT02521948|66505232|FG000|Overall Study|Adverse Event|2|||
23761027|NCT02521948|66505232|FG000|Overall Study|Death|4|||
23761028|NCT02521948|66505232|FG000|Overall Study|Lost to Follow-up|1|||
23761029|NCT02521948|66505232|FG000|Overall Study|Did not attend one or both follow-ups|6|||
23442001|NCT03927144|65358679|FG001|Core Phase|Adverse Event|5|||
23442002|NCT03927144|65358678|FG000|Core Phase|Lost to Follow-up|3|||
23442003|NCT03927144|65358679|FG001|Core Phase|Lost to Follow-up|2|||
23442004|NCT03927144|65358678|FG000|Core Phase|New Therapy for Study Indication|0|||
23442005|NCT03927144|65358679|FG001|Core Phase|New Therapy for Study Indication|1|||
23442006|NCT03927144|65358678|FG000|Core Phase|No Longer Clinically Benefiting|4|||
23442007|NCT03927144|65358679|FG001|Core Phase|No Longer Clinically Benefiting|4|||
23761030|NCT03077828|66505233|FG000|Treatment Cycles|Death|1|||
23761031|NCT03077828|66505233|FG000|Treatment Cycles|Withdrawal by Subject|1|||
23761032|NCT03077828|66505233|FG000|Treatment Cycles|Screen Fail|2|||
23761033|NCT03077828|66505233|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
23761034|NCT03077828|66505233|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
23761035|NCT03077828|66505233|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
23761036|NCT03077828|66505233|FG000|Follow-up|Patients still in follow-up|15|||
23442008|NCT03927144|65358678|FG000|Core Phase|Physician Decision|2|||
23442009|NCT03927144|65358679|FG001|Core Phase|Physician Decision|8|||
23442010|NCT03927144|65358678|FG000|Core Phase|Protocol Violation|2|||
23442011|NCT03927144|65358679|FG001|Core Phase|Protocol Violation|2|||
23442012|NCT03927144|65358678|FG000|Core Phase|Withdrawal by Subject|16|||
23442013|NCT03927144|65358679|FG001|Core Phase|Withdrawal by Subject|40|||
23442014|NCT03927144|65358678|FG000|Extension Phase|Adverse Event|2|||
23442015|NCT03927144|65358679|FG001|Extension Phase|Adverse Event|1|||
23442016|NCT03927144|65358678|FG000|Extension Phase|No longer clinically benefiting|4|||
23442017|NCT03927144|65358679|FG001|Extension Phase|No longer clinically benefiting|5|||
23442018|NCT03927144|65358678|FG000|Extension Phase|Pregnancy|1|||
23442019|NCT03927144|65358679|FG001|Extension Phase|Pregnancy|0|||
23442020|NCT03927144|65358678|FG000|Extension Phase|Protocol Violation|0|||
23442021|NCT03927144|65358679|FG001|Extension Phase|Protocol Violation|1|||
23442022|NCT03927144|65358678|FG000|Extension Phase|Withdrawal by Subject|8|||
23442023|NCT03927144|65358679|FG001|Extension Phase|Withdrawal by Subject|3|||
23442024|NCT01408459|65358683|FG000|Overall Study|Withdrawal by Subject|1|||
23442025|NCT01408459|65358684|FG001|Overall Study|Withdrawal by Subject|1|||
23442026|NCT00193180|65358693|FG000|Overall Study|Lack of Efficacy|1|||
23442027|NCT00193180|65358693|FG000|Overall Study|Adverse Event|8|||
23442028|NCT00193180|65358693|FG000|Overall Study|Protocol Violation|1|||
23442029|NCT01824355|65358694|FG000|Overall Study|Adverse Event|2|||
23442030|NCT01824355|65358694|FG000|Overall Study|unevaluable reference method results per|1|||
23442031|NCT01504412|65358695|FG000|Overall Study|Adverse Event|1|||
23442032|NCT01504412|65358696|FG001|Overall Study|Adverse Event|8|||
23442033|NCT01504412|65358697|FG002|Overall Study|Adverse Event|1|||
23442034|NCT01504412|65358698|FG003|Overall Study|Adverse Event|7|||
23442035|NCT01504412|65358699|FG004|Overall Study|Adverse Event|10|||
23442036|NCT01504412|65358695|FG000|Overall Study|Withdrawal by Subject|2|||
23442037|NCT01504412|65358696|FG001|Overall Study|Withdrawal by Subject|1|||
23442038|NCT01504412|65358697|FG002|Overall Study|Withdrawal by Subject|1|||
23442039|NCT01504412|65358698|FG003|Overall Study|Withdrawal by Subject|5|||
23442040|NCT01504412|65358699|FG004|Overall Study|Withdrawal by Subject|1|||
23442041|NCT01504412|65358695|FG000|Overall Study|Other|2|||
23442042|NCT01504412|65358696|FG001|Overall Study|Other|1|||
23442043|NCT01504412|65358697|FG002|Overall Study|Other|1|||
23442044|NCT01504412|65358698|FG003|Overall Study|Other|6|||
23442045|NCT01504412|65358699|FG004|Overall Study|Other|1|||
23442046|NCT01504412|65358695|FG000|Overall Study|Lost to Follow-up|0|||
23442047|NCT01504412|65358696|FG001|Overall Study|Lost to Follow-up|2|||
23442048|NCT01504412|65358697|FG002|Overall Study|Lost to Follow-up|0|||
23442049|NCT01504412|65358698|FG003|Overall Study|Lost to Follow-up|0|||
23442050|NCT01504412|65358699|FG004|Overall Study|Lost to Follow-up|0|||
23442051|NCT01504412|65358695|FG000|Overall Study|Lack of Efficacy|0|||
23442052|NCT01504412|65358696|FG001|Overall Study|Lack of Efficacy|0|||
23442053|NCT01504412|65358697|FG002|Overall Study|Lack of Efficacy|1|||
23442054|NCT01504412|65358698|FG003|Overall Study|Lack of Efficacy|0|||
23442055|NCT01504412|65358699|FG004|Overall Study|Lack of Efficacy|1|||
23761037|NCT02378506|66505234|FG000|Overall Study|Lack of Efficacy|3|||
23442056|NCT01504412|65358695|FG000|Overall Study|Death|0|||
23442057|NCT01504412|65358696|FG001|Overall Study|Death|0|||
23442058|NCT01504412|65358697|FG002|Overall Study|Death|0|||
23442059|NCT01504412|65358698|FG003|Overall Study|Death|1|||
23442060|NCT01504412|65358699|FG004|Overall Study|Death|0|||
23442061|NCT01949090|65358704|FG000|Overall Study|Serious Adverse Event|0|||
23442062|NCT01949090|65358705|FG001|Overall Study|Serious Adverse Event|1|||
23442063|NCT01949090|65358706|FG002|Overall Study|Serious Adverse Event|2|||
23442064|NCT01949090|65358707|FG003|Overall Study|Serious Adverse Event|0|||
23761038|NCT02378506|66505234|FG000|Overall Study|Withdrawal by Subject|4|||
23442065|NCT01949090|65358708|FG004|Overall Study|Serious Adverse Event|1|||
23442066|NCT01949090|65358704|FG000|Overall Study|Withdrawal by Subject|2|||
23442067|NCT01949090|65358705|FG001|Overall Study|Withdrawal by Subject|0|||
23442068|NCT01949090|65358706|FG002|Overall Study|Withdrawal by Subject|0|||
23442069|NCT01949090|65358707|FG003|Overall Study|Withdrawal by Subject|0|||
23442070|NCT01949090|65358708|FG004|Overall Study|Withdrawal by Subject|1|||
23442071|NCT01949090|65358704|FG000|Overall Study|Protocol non-compliance|0|||
23761039|NCT02378506|66505234|FG000|Overall Study|Protocol Violation|2|||
23442072|NCT01949090|65358705|FG001|Overall Study|Protocol non-compliance|0|||
23761040|NCT02378506|66505234|FG000|Overall Study|Death|1|||
23442073|NCT01949090|65358706|FG002|Overall Study|Protocol non-compliance|0|||
23442074|NCT01949090|65358707|FG003|Overall Study|Protocol non-compliance|0|||
23761041|NCT02378506|66505234|FG000|Overall Study|Adverse Event|14|||
23442075|NCT01949090|65358708|FG004|Overall Study|Protocol non-compliance|1|||
23442076|NCT01949090|65358704|FG000|Overall Study|Lost to Follow-up|2|||
23442077|NCT01949090|65358705|FG001|Overall Study|Lost to Follow-up|1|||
23442078|NCT01949090|65358706|FG002|Overall Study|Lost to Follow-up|0|||
23442079|NCT01949090|65358707|FG003|Overall Study|Lost to Follow-up|1|||
23442080|NCT01949090|65358708|FG004|Overall Study|Lost to Follow-up|1|||
23442081|NCT01856582|65358709|FG000|Overall Study|Died prior to Boost infusion|1|||
23442082|NCT01504841|65358710|FG000|Overall Study|Withdrawal by Subject|1|||
23761042|NCT02378506|66505234|FG000|Overall Study|Randomized But Not Treated|1|||
23761043|NCT01086215|66505235|FG000|Overall Study|Death|14|||
23442083|NCT01504841|65358711|FG001|Overall Study|Withdrawal by Subject|1|||
23442084|NCT01504841|65358712|FG002|Overall Study|Withdrawal by Subject|0|||
23442085|NCT02709330|65358717|FG000|Overall Study|Death|5|||
23442086|NCT02709330|65358718|FG001|Overall Study|Death|0|||
23442087|NCT02709330|65358717|FG000|Overall Study|Lost to Follow-up|2|||
23442088|NCT02709330|65358718|FG001|Overall Study|Lost to Follow-up|0|||
23442089|NCT02709330|65358717|FG000|Overall Study|Physician Decision|2|||
23442090|NCT02709330|65358718|FG001|Overall Study|Physician Decision|0|||
23442091|NCT02709330|65358717|FG000|Overall Study|Withdrawal by Subject|4|||
23442092|NCT02709330|65358718|FG001|Overall Study|Withdrawal by Subject|0|||
23442093|NCT02363959|65358722|FG000|Overall Study|Medical instability|1|||
23442094|NCT02363959|65358723|FG001|Overall Study|Medical instability|0|||
23442095|NCT01777776|65358724|FG000|Overall Study|Adverse Event|2|||
23442096|NCT01777776|65358725|FG001|Overall Study|Adverse Event|4|||
23442097|NCT01777776|65358726|FG002|Overall Study|Adverse Event|0|||
23442098|NCT01777776|65358727|FG003|Overall Study|Adverse Event|0|||
23442099|NCT01777776|65358724|FG000|Overall Study|Disease Progression|4|||
23442100|NCT01777776|65358725|FG001|Overall Study|Disease Progression|8|||
23442101|NCT01777776|65358726|FG002|Overall Study|Disease Progression|6|||
23442102|NCT01777776|65358727|FG003|Overall Study|Disease Progression|3|||
23442103|NCT01777776|65358724|FG000|Overall Study|Withdrawal by Subject|0|||
23442104|NCT01777776|65358725|FG001|Overall Study|Withdrawal by Subject|0|||
23442105|NCT01777776|65358726|FG002|Overall Study|Withdrawal by Subject|0|||
23442106|NCT01777776|65358727|FG003|Overall Study|Withdrawal by Subject|1|||
23442107|NCT00825812|65358728|FG000|Overall Study|Never entered follow up|0|||
23442108|NCT00825812|65358729|FG001|Overall Study|Never entered follow up|0|||
23442109|NCT00825812|65358730|FG002|Overall Study|Never entered follow up|0|||
23442110|NCT00825812|65358731|FG003|Overall Study|Never entered follow up|1|||
23442111|NCT00825812|65358728|FG000|Overall Study|Adverse Event|0|||
23442112|NCT00825812|65358729|FG001|Overall Study|Adverse Event|0|||
23442113|NCT00825812|65358730|FG002|Overall Study|Adverse Event|0|||
23442114|NCT00825812|65358731|FG003|Overall Study|Adverse Event|1|||
23442115|NCT00825812|65358728|FG000|Overall Study|Subject withdrew consent|0|||
23442116|NCT00825812|65358729|FG001|Overall Study|Subject withdrew consent|0|||
23442117|NCT00825812|65358730|FG002|Overall Study|Subject withdrew consent|3|||
23827842|NCT02456740|66748978|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23442118|NCT00825812|65358731|FG003|Overall Study|Subject withdrew consent|2|||
23627356|NCT04962698|66024414|FG001|Motor Imagery|Technical difficulty|0|||
23627357|NCT04962698|66024413|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
23627358|NCT04962698|66024414|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
23442119|NCT00825812|65358728|FG000|Overall Study|Non-compliance with protocol|0|||
23442120|NCT00825812|65358729|FG001|Overall Study|Non-compliance with protocol|0|||
23627359|NCT04962698|66024413|FG000|Kinesthetic MI|Technical difficulty|1|||
23627360|NCT04962698|66024414|FG001|Kinesthetic MI|Technical difficulty|0|||
23627361|NCT04962698|66024413|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
23627362|NCT04962698|66024414|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
23627363|NCT04962698|66024413|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
23627364|NCT04962698|66024414|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
23627365|NCT04962698|66024413|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
23627366|NCT04962698|66024414|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
23627367|NCT04962698|66024413|FG000|Virtual-hand Interaction|Technical difficulty|1|||
23627368|NCT04962698|66024414|FG001|Virtual-hand Interaction|Technical difficulty|0|||
23761044|NCT01086215|66505236|FG001|Overall Study|Death|8|||
23761045|NCT01086215|66505237|FG002|Overall Study|Death|8|||
23761046|NCT01086215|66505238|FG003|Overall Study|Death|1|||
23761047|NCT01086215|66505235|FG000|Overall Study|Lost to Follow-up|22|||
23761048|NCT01086215|66505236|FG001|Overall Study|Lost to Follow-up|39|||
23442121|NCT00825812|65358730|FG002|Overall Study|Non-compliance with protocol|0|||
23442122|NCT00825812|65358731|FG003|Overall Study|Non-compliance with protocol|1|||
23761049|NCT01086215|66505237|FG002|Overall Study|Lost to Follow-up|18|||
23442123|NCT00825812|65358728|FG000|Overall Study|Administrative|0|||
23442124|NCT00825812|65358729|FG001|Overall Study|Administrative|1|||
23627369|NCT04962698|66024413|FG000|Robotic Action Observation|Technical difficulty|1|||
23627370|NCT04962698|66024414|FG001|Robotic Action Observation|Technical difficulty|0|||
23761050|NCT01086215|66505238|FG003|Overall Study|Lost to Follow-up|2|||
23761051|NCT00986154|66505239|FG000|Overall Study|Death|136|||
23761052|NCT00986154|66505240|FG001|Overall Study|Death|127|||
23442125|NCT00825812|65358730|FG002|Overall Study|Administrative|3|||
23442126|NCT00825812|65358731|FG003|Overall Study|Administrative|5|||
23442127|NCT01865448|65358740|FG000|Overall Study|Adverse Event|1|||
23442128|NCT01865448|65358741|FG001|Overall Study|Adverse Event|1|||
23442129|NCT01865448|65358740|FG000|Overall Study|Pregnancy|0|||
23442130|NCT01865448|65358741|FG001|Overall Study|Pregnancy|1|||
23442131|NCT01865448|65358740|FG000|Overall Study|dropout unrelated to study|1|||
23627371|NCT04962698|66024413|FG000|Rest|Technical difficulty|1|||
23627372|NCT04962698|66024414|FG001|Rest|Technical difficulty|0|||
23442132|NCT01865448|65358741|FG001|Overall Study|dropout unrelated to study|1|||
23442133|NCT00344500|65358743|FG000|Overall Study|Adverse Event|6|||
23442134|NCT00344500|65358744|FG001|Overall Study|Adverse Event|2|||
23442135|NCT00344500|65358745|FG002|Overall Study|Adverse Event|0|||
23442136|NCT00344500|65358743|FG000|Overall Study|Lost to Follow-up|5|||
23442137|NCT00344500|65358744|FG001|Overall Study|Lost to Follow-up|13|||
23442138|NCT00344500|65358745|FG002|Overall Study|Lost to Follow-up|1|||
23442139|NCT00344500|65358743|FG000|Overall Study|Withdrawal by Subject|7|||
23442140|NCT00344500|65358744|FG001|Overall Study|Withdrawal by Subject|10|||
23442141|NCT00344500|65358745|FG002|Overall Study|Withdrawal by Subject|0|||
23442142|NCT00344500|65358743|FG000|Overall Study|Protocol Violation|4|||
23442143|NCT00344500|65358744|FG001|Overall Study|Protocol Violation|7|||
23442144|NCT00344500|65358745|FG002|Overall Study|Protocol Violation|1|||
23442145|NCT00344500|65358743|FG000|Overall Study|Not Noted|1|||
23442146|NCT00344500|65358744|FG001|Overall Study|Not Noted|3|||
23442147|NCT00344500|65358745|FG002|Overall Study|Not Noted|0|||
23442148|NCT03785964|65358746|FG000|Overall Study|Adverse Event|14|||
23442149|NCT03785964|65358747|FG001|Overall Study|Adverse Event|1|||
23627373|NCT04962698|66024413|FG000|Rest|Exclusion criteria met after enrollment|0|||
23627374|NCT04962698|66024414|FG001|Rest|Exclusion criteria met after enrollment|2|||
23627375|NCT02270671|66024415|FG000|Overall Study|Withdrawal by Subject|1|||
23627376|NCT02270671|66024416|FG001|Overall Study|Withdrawal by Subject|1|||
23627377|NCT02270671|66024415|FG000|Overall Study|Protocol Violation|0|||
23627378|NCT02270671|66024416|FG001|Overall Study|Protocol Violation|1|||
23627379|NCT02270671|66024415|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
23761053|NCT00986154|66505239|FG000|Overall Study|Lost to Follow-up|7|||
23761054|NCT00986154|66505240|FG001|Overall Study|Lost to Follow-up|4|||
23761055|NCT00986154|66505239|FG000|Overall Study|Withdrawal by Subject|32|||
23761056|NCT00986154|66505240|FG001|Overall Study|Withdrawal by Subject|33|||
23761057|NCT00986154|66505239|FG000|Overall Study|investigator/subject decide not continue|6|||
23761058|NCT00986154|66505240|FG001|Overall Study|investigator/subject decide not continue|3|||
23761059|NCT00986154|66505239|FG000|Overall Study|never received study drug|25|||
23761060|NCT00986154|66505240|FG001|Overall Study|never received study drug|27|||
23761061|NCT04071626|66505241|FG000|Overall Study|Withdrawal by Subject|1|||
23761062|NCT04071626|66505242|FG001|Overall Study|Withdrawal by Subject|1|||
23761063|NCT04071626|66505241|FG000|Overall Study|Protocol Violation|0|||
23761064|NCT04071626|66505242|FG001|Overall Study|Protocol Violation|1|||
23761065|NCT02437890|66505243|FG000|Overall Study|Non-compliance to study drug|0|||
23761066|NCT02437890|66505244|FG001|Overall Study|Non-compliance to study drug|1|||
23761067|NCT02437890|66505245|FG002|Overall Study|Non-compliance to study drug|0|||
23761068|NCT02437890|66505246|FG003|Overall Study|Non-compliance to study drug|0|||
23761069|NCT02437890|66505247|FG004|Overall Study|Non-compliance to study drug|1|||
23761070|NCT02437890|66505243|FG000|Overall Study|Sponsor's decision|1|||
23761071|NCT02437890|66505244|FG001|Overall Study|Sponsor's decision|1|||
23761072|NCT02437890|66505245|FG002|Overall Study|Sponsor's decision|4|||
23761073|NCT02437890|66505246|FG003|Overall Study|Sponsor's decision|0|||
23761074|NCT02437890|66505247|FG004|Overall Study|Sponsor's decision|2|||
23761075|NCT02437890|66505243|FG000|Overall Study|Physician Decision|0|||
23761076|NCT02437890|66505244|FG001|Overall Study|Physician Decision|0|||
23761077|NCT02437890|66505245|FG002|Overall Study|Physician Decision|0|||
23761078|NCT02437890|66505246|FG003|Overall Study|Physician Decision|1|||
23761079|NCT02437890|66505247|FG004|Overall Study|Physician Decision|0|||
23827843|NCT02456740|66748979|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23442150|NCT03785964|65358746|FG000|Overall Study|Unqualified Clinical Progression|1|||
23442151|NCT03785964|65358747|FG001|Overall Study|Unqualified Clinical Progression|1|||
23442152|NCT03785964|65358746|FG000|Overall Study|Participant non-compliance|1|||
23442153|NCT03785964|65358747|FG001|Overall Study|Participant non-compliance|1|||
23442154|NCT03785964|65358746|FG000|Overall Study|Not treated|1|||
23442155|NCT03785964|65358747|FG001|Overall Study|Not treated|0|||
23442156|NCT03785964|65358746|FG000|Overall Study|Other reason|5|||
23565264|NCT01464021|65799591|FG000|Overall Study|Withdrawal by Subject|13|||
23565265|NCT01464021|65799591|FG000|Overall Study|Lost to Follow-up|1|||
23565266|NCT01464021|65799591|FG000|Overall Study|Lack of Efficacy|1|||
23565267|NCT01464021|65799591|FG000|Overall Study|various|11|||
23565268|NCT03097861|65799597|FG000|Overall Study|Adverse Event|3|||
23565269|NCT03097861|65799598|FG001|Overall Study|Adverse Event|8|||
23565270|NCT03097861|65799599|FG002|Overall Study|Adverse Event|4|||
23565271|NCT03097861|65799597|FG000|Overall Study|Investigator Decision|0|||
23565272|NCT03097861|65799598|FG001|Overall Study|Investigator Decision|1|||
23565273|NCT03097861|65799599|FG002|Overall Study|Investigator Decision|0|||
23565274|NCT03097861|65799597|FG000|Overall Study|Lost to Follow-up|0|||
23565275|NCT03097861|65799598|FG001|Overall Study|Lost to Follow-up|7|||
23565276|NCT03097861|65799599|FG002|Overall Study|Lost to Follow-up|1|||
23565277|NCT03097861|65799597|FG000|Overall Study|Withdrawal by Subject|1|||
23565278|NCT03097861|65799598|FG001|Overall Study|Withdrawal by Subject|5|||
23761080|NCT02437890|66505243|FG000|Overall Study|Unable to attend visit(s)|1|||
23761081|NCT02437890|66505244|FG001|Overall Study|Unable to attend visit(s)|0|||
23761082|NCT02437890|66505245|FG002|Overall Study|Unable to attend visit(s)|0|||
23761083|NCT02437890|66505246|FG003|Overall Study|Unable to attend visit(s)|0|||
23761084|NCT02437890|66505247|FG004|Overall Study|Unable to attend visit(s)|0|||
23761085|NCT02437890|66505243|FG000|Overall Study|Lack of Efficacy|1|||
23761086|NCT02437890|66505244|FG001|Overall Study|Lack of Efficacy|3|||
23761087|NCT02437890|66505245|FG002|Overall Study|Lack of Efficacy|0|||
23761088|NCT02437890|66505246|FG003|Overall Study|Lack of Efficacy|3|||
23761089|NCT02437890|66505247|FG004|Overall Study|Lack of Efficacy|1|||
23761090|NCT02437890|66505243|FG000|Overall Study|Adverse Event|4|||
23827844|NCT02456740|66748980|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
23827845|NCT02456740|66748972|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23827846|NCT02456740|66748973|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23827847|NCT02456740|66748974|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23827848|NCT02456740|66748975|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
23827849|NCT02456740|66748976|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
23827850|NCT02456740|66748977|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
23827851|NCT02456740|66748978|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
23442157|NCT03785964|65358747|FG001|Overall Study|Other reason|11|||
23442158|NCT03785964|65358746|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
23442159|NCT03785964|65358747|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
23442160|NCT01574651|65358748|FG000|Overall Study|Lost to Follow-up|2|||
23442161|NCT01574651|65358749|FG001|Overall Study|Lost to Follow-up|4|||
23442162|NCT01574651|65358748|FG000|Overall Study|Administrative problems|0|||
23442163|NCT01574651|65358749|FG001|Overall Study|Administrative problems|1|||
23442164|NCT01574651|65358748|FG000|Overall Study|Death|3|||
23442165|NCT01574651|65358749|FG001|Overall Study|Death|3|||
23442166|NCT01574651|65358748|FG000|Overall Study|Patient's inability to use the device|0|||
23442167|NCT01574651|65358749|FG001|Overall Study|Patient's inability to use the device|1|||
23761091|NCT02437890|66505244|FG001|Overall Study|Adverse Event|9|||
23761092|NCT02437890|66505245|FG002|Overall Study|Adverse Event|5|||
23761093|NCT02437890|66505246|FG003|Overall Study|Adverse Event|11|||
23442168|NCT01574651|65358748|FG000|Overall Study|Adverse Event|36|||
23565279|NCT03097861|65799599|FG002|Overall Study|Withdrawal by Subject|3|||
23565280|NCT03097861|65799597|FG000|Overall Study|Reason not provided|3|||
23761094|NCT02437890|66505247|FG004|Overall Study|Adverse Event|7|||
23761095|NCT02437890|66505243|FG000|Overall Study|Withdrawal by Subject|1|||
23442169|NCT01574651|65358749|FG001|Overall Study|Adverse Event|27|||
23442170|NCT01574651|65358748|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23442171|NCT01574651|65358749|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23442172|NCT01574651|65358748|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23442173|NCT01574651|65358749|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23442174|NCT01574651|65358748|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23442175|NCT01574651|65358749|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23442176|NCT01574651|65358748|FG000|Overall Study|Protocol Violation|3|||
23442177|NCT01574651|65358749|FG001|Overall Study|Protocol Violation|5|||
23442178|NCT01574651|65358748|FG000|Overall Study|Withdrawal by Subject|9|||
23442179|NCT01574651|65358749|FG001|Overall Study|Withdrawal by Subject|10|||
23442180|NCT06359080|65358750|FG000|Overall Study|Withdrawal by Subject|3|||
23827852|NCT02456740|66748979|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
23827853|NCT02456740|66748980|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
23827854|NCT02456740|66748972|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827855|NCT02456740|66748973|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827856|NCT02456740|66748974|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827857|NCT02456740|66748975|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827858|NCT02456740|66748976|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827859|NCT02456740|66748977|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827860|NCT02456740|66748978|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827861|NCT02456740|66748979|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
23827862|NCT02456740|66748980|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23827863|NCT02456740|66748972|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23827864|NCT02456740|66748973|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23827865|NCT02456740|66748974|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23827866|NCT02456740|66748975|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
23827867|NCT02456740|66748976|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
23827868|NCT02456740|66748977|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
23827869|NCT02456740|66748978|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23827870|NCT02456740|66748979|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
23827871|NCT02456740|66748980|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
23827872|NCT02009722|66748981|FG000|Overall Study|Protocol Violation|1|||
23827873|NCT02009722|66748982|FG001|Overall Study|Protocol Violation|2|||
23827874|NCT02009722|66748981|FG000|Overall Study|Did not receive intervention|0|||
23827875|NCT02009722|66748982|FG001|Overall Study|Did not receive intervention|1|||
23827876|NCT02687451|66748983|FG000|Overall Study|Withdrawal by Subject|1|||
23827877|NCT02687451|66748984|FG001|Overall Study|Withdrawal by Subject|0|||
23827878|NCT02687451|66748985|FG002|Overall Study|Withdrawal by Subject|0|||
23827879|NCT02687451|66748986|FG003|Overall Study|Withdrawal by Subject|0|||
23827880|NCT02687451|66748987|FG004|Overall Study|Withdrawal by Subject|0|||
23827881|NCT02687451|66748988|FG005|Overall Study|Withdrawal by Subject|1|||
23827882|NCT02072980|66748991|FG000|Period 2, Second Wear|Adverse Event|0|||
23827883|NCT02072980|66748992|FG001|Period 2, Second Wear|Adverse Event|1|||
23827884|NCT01071915|66748993|FG000|Overall Study|Adverse Event|3|||
23827885|NCT01071915|66748993|FG000|Overall Study|Physician Decision|2|||
23827886|NCT01071915|66748993|FG000|Overall Study|Withdrawal by Subject|2|||
23827887|NCT01071915|66748993|FG000|Overall Study|Miscellaneous Reasons|2|||
23827888|NCT01050530|66748994|FG000|Overall Study|Adverse Event|6|||
23827889|NCT01050530|66748995|FG001|Overall Study|Adverse Event|3|||
23442181|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
23442182|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
23442183|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
23565281|NCT03097861|65799598|FG001|Overall Study|Reason not provided|1|||
23827890|NCT01050530|66748994|FG000|Overall Study|Lack of Efficacy|1|||
23827891|NCT01050530|66748995|FG001|Overall Study|Lack of Efficacy|4|||
23827892|NCT01050530|66748994|FG000|Overall Study|Withdrawal by Subject|0|||
23827893|NCT01050530|66748995|FG001|Overall Study|Withdrawal by Subject|3|||
23827894|NCT01050530|66748994|FG000|Overall Study|Protocol Violation|1|||
23442184|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
23565282|NCT03097861|65799599|FG002|Overall Study|Reason not provided|1|||
23627380|NCT02270671|66024416|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
23627381|NCT02270671|66024415|FG000|Overall Study|Lost to Follow-up|2|||
23627382|NCT02270671|66024416|FG001|Overall Study|Lost to Follow-up|1|||
23627383|NCT04468230|66024418|FG000|Overall Study|Adverse Event|2|||
23627384|NCT02460562|66024419|FG000|Overall Study|Lost to Follow-up|15|||
23627385|NCT02460562|66024420|FG001|Overall Study|Lost to Follow-up|16|||
23627386|NCT02392104|66024421|FG000|Overall Study|discontinuation of warfarin|3|||
23627387|NCT02392104|66024421|FG000|Overall Study|bleeding event|1|||
23627388|NCT02392104|66024421|FG000|Overall Study|transferred care to another doctor|2|||
23627389|NCT02392104|66024421|FG000|Overall Study|INR goal range changed|1|||
23627390|NCT02392104|66024421|FG000|Overall Study|admitted to skilled nursing facility|3|||
23627391|NCT02392104|66024421|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
23627392|NCT01952847|66024425|FG000|Overall Study|Ineligible|1|||
23627393|NCT01952847|66024426|FG001|Overall Study|Ineligible|0|||
23627394|NCT01952847|66024427|FG002|Overall Study|Ineligible|0|||
23627395|NCT01952847|66024428|FG003|Overall Study|Ineligible|0|||
23627396|NCT01952847|66024425|FG000|Overall Study|Lack of Insurance Coverage|0|||
23627397|NCT01952847|66024426|FG001|Overall Study|Lack of Insurance Coverage|1|||
23627398|NCT01952847|66024427|FG002|Overall Study|Lack of Insurance Coverage|0|||
23627399|NCT01952847|66024428|FG003|Overall Study|Lack of Insurance Coverage|0|||
23627400|NCT01952847|66024425|FG000|Overall Study|Withdrawal by Subject|1|||
23627401|NCT01952847|66024426|FG001|Overall Study|Withdrawal by Subject|1|||
23627402|NCT01952847|66024427|FG002|Overall Study|Withdrawal by Subject|0|||
23627403|NCT01952847|66024428|FG003|Overall Study|Withdrawal by Subject|1|||
23627404|NCT04009629|66024429|FG000|Overall Study|Withdrawal by Subject|2|||
23627405|NCT04009629|66024430|FG001|Overall Study|Withdrawal by Subject|0|||
23627406|NCT03602586|66024431|FG000|Overall Study|Withdrawal by Subject|3|||
23627407|NCT02062645|66024434|FG000|Overall Study|Adverse Event|2|||
23627408|NCT02062645|66024434|FG000|Overall Study|Protocol Violation|8|||
23627409|NCT02062645|66024434|FG000|Overall Study|Lost to Follow-up|5|||
23761096|NCT02437890|66505244|FG001|Overall Study|Withdrawal by Subject|2|||
23761097|NCT02437890|66505245|FG002|Overall Study|Withdrawal by Subject|6|||
23761098|NCT02437890|66505246|FG003|Overall Study|Withdrawal by Subject|5|||
23761099|NCT02437890|66505247|FG004|Overall Study|Withdrawal by Subject|5|||
23761100|NCT02437890|66505243|FG000|Overall Study|Death|0|||
23761101|NCT02437890|66505244|FG001|Overall Study|Death|0|||
23761102|NCT02437890|66505245|FG002|Overall Study|Death|0|||
23761103|NCT02437890|66505246|FG003|Overall Study|Death|2|||
23761104|NCT02437890|66505247|FG004|Overall Study|Death|0|||
23761105|NCT00626925|66505248|FG000|Overall Study|Lost to Follow-up|1|||
23761106|NCT00626925|66505249|FG001|Overall Study|Lost to Follow-up|2|||
23761107|NCT00626925|66505248|FG000|Overall Study|relapse|1|||
23761108|NCT00626925|66505249|FG001|Overall Study|relapse|0|||
23761109|NCT00626925|66505248|FG000|Overall Study|Adverse effect|6|||
23761110|NCT00626925|66505249|FG001|Overall Study|Adverse effect|2|||
23761111|NCT00626925|66505248|FG000|Overall Study|Lack of Efficacy|1|||
23761112|NCT00626925|66505249|FG001|Overall Study|Lack of Efficacy|4|||
23761113|NCT00626925|66505248|FG000|Overall Study|Time constraints|3|||
23761114|NCT00626925|66505249|FG001|Overall Study|Time constraints|1|||
23761115|NCT00856778|66505250|FG000|Overall Study|Adverse Event|7|||
23761116|NCT00856778|66505250|FG000|Overall Study|Withdrawal by Subject|10|||
23761117|NCT00856778|66505250|FG000|Overall Study|Study deviation|2|||
23761118|NCT00856778|66505250|FG000|Overall Study|Lost to Follow-up|5|||
23761119|NCT00217971|66505251|FG000|Overall Study|Adverse Event|1|||
23761120|NCT00217971|66505252|FG001|Overall Study|Adverse Event|1|||
23761121|NCT00217971|66505251|FG000|Overall Study|Lost to Follow-up|15|||
23761122|NCT00217971|66505252|FG001|Overall Study|Lost to Follow-up|19|||
23761123|NCT00217971|66505251|FG000|Overall Study|Physician Decision|0|||
23827895|NCT01050530|66748995|FG001|Overall Study|Protocol Violation|0|||
23627410|NCT01649557|66024435|FG000|Overall Study|Lost to Follow-up|5|||
23627411|NCT01649557|66024436|FG001|Overall Study|Lost to Follow-up|0|||
23627412|NCT01649557|66024437|FG002|Overall Study|Lost to Follow-up|3|||
23627413|NCT01649557|66024435|FG000|Overall Study|Adverse Event|7|||
23627414|NCT01649557|66024436|FG001|Overall Study|Adverse Event|5|||
23627415|NCT01649557|66024437|FG002|Overall Study|Adverse Event|1|||
23627416|NCT01649557|66024435|FG000|Overall Study|Met withdrawal criteria|4|||
23627417|NCT01649557|66024436|FG001|Overall Study|Met withdrawal criteria|0|||
23627418|NCT01649557|66024437|FG002|Overall Study|Met withdrawal criteria|0|||
23627419|NCT01649557|66024435|FG000|Overall Study|Physician Decision|8|||
23627420|NCT01649557|66024436|FG001|Overall Study|Physician Decision|2|||
23627421|NCT01649557|66024437|FG002|Overall Study|Physician Decision|1|||
23761124|NCT00217971|66505252|FG001|Overall Study|Physician Decision|1|||
23761125|NCT00217971|66505251|FG000|Overall Study|Withdrawal by Subject|7|||
23761126|NCT00217971|66505252|FG001|Overall Study|Withdrawal by Subject|12|||
23761127|NCT00217971|66505251|FG000|Overall Study|non compliant|1|||
23761128|NCT00217971|66505252|FG001|Overall Study|non compliant|0|||
23761129|NCT04345471|66505253|FG000|Overall Study|Adverse Event|8|||
23761130|NCT04345471|66505254|FG001|Overall Study|Adverse Event|5|||
23761131|NCT04345471|66505255|FG002|Overall Study|Adverse Event|6|||
23442185|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
23442186|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
23442187|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Death|7|||
23442188|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Death|5|||
23442189|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Death|6|||
23442190|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
23442191|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
23442192|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
23442193|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
23442194|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
23442195|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
23442196|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Other|1|||
23442197|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Other|0|||
23442198|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Other|0|||
23442199|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
23442200|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
23442201|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
23442202|NCT00104650|65358755|FG000|Follow-up Period|Physician Decision|1|||
23442203|NCT00104650|65358756|FG001|Follow-up Period|Physician Decision|1|||
23442204|NCT00104650|65358757|FG002|Follow-up Period|Physician Decision|0|||
23442205|NCT00104650|65358755|FG000|Follow-up Period|Adverse Event|1|||
23761132|NCT04345471|66505253|FG000|Overall Study|Lack of Efficacy|1|||
23761133|NCT04345471|66505254|FG001|Overall Study|Lack of Efficacy|1|||
23761134|NCT04345471|66505255|FG002|Overall Study|Lack of Efficacy|0|||
23761135|NCT04345471|66505253|FG000|Overall Study|Protocol Violation|0|||
23761136|NCT04345471|66505254|FG001|Overall Study|Protocol Violation|1|||
23761137|NCT04345471|66505255|FG002|Overall Study|Protocol Violation|2|||
23761138|NCT04345471|66505253|FG000|Overall Study|Withdrawal by Subject|10|||
23761139|NCT04345471|66505254|FG001|Overall Study|Withdrawal by Subject|5|||
23761140|NCT04345471|66505255|FG002|Overall Study|Withdrawal by Subject|10|||
23761141|NCT03769181|66505258|FG000|Overall Study|Adverse Event|1|||
23761142|NCT03769181|66505259|FG001|Overall Study|Adverse Event|0|||
23761143|NCT03769181|66505260|FG002|Overall Study|Adverse Event|2|||
23761144|NCT03769181|66505261|FG003|Overall Study|Adverse Event|4|||
23761145|NCT03769181|66505258|FG000|Overall Study|Withdrawal by Subject|1|||
23761146|NCT03769181|66505259|FG001|Overall Study|Withdrawal by Subject|0|||
23761147|NCT03769181|66505260|FG002|Overall Study|Withdrawal by Subject|2|||
23761148|NCT03769181|66505261|FG003|Overall Study|Withdrawal by Subject|1|||
23761149|NCT03769181|66505258|FG000|Overall Study|Progressive disease|9|||
23827896|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
23827897|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Off-label use|283|||
23827898|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
23761150|NCT03769181|66505259|FG001|Overall Study|Progressive disease|7|||
23761151|NCT03769181|66505260|FG002|Overall Study|Progressive disease|13|||
23761152|NCT03769181|66505261|FG003|Overall Study|Progressive disease|6|||
23761153|NCT03769181|66505258|FG000|Overall Study|Other - Unspecified|2|||
23442206|NCT00104650|65358756|FG001|Follow-up Period|Adverse Event|0|||
23442207|NCT00104650|65358757|FG002|Follow-up Period|Adverse Event|1|||
23442208|NCT00104650|65358755|FG000|Follow-up Period|Withdrawal by Subject|0|||
23442209|NCT00104650|65358756|FG001|Follow-up Period|Withdrawal by Subject|3|||
23442210|NCT00104650|65358757|FG002|Follow-up Period|Withdrawal by Subject|3|||
23442211|NCT00104650|65358755|FG000|Follow-up Period|Death|6|||
23442212|NCT00104650|65358756|FG001|Follow-up Period|Death|6|||
23442213|NCT00104650|65358757|FG002|Follow-up Period|Death|4|||
23442214|NCT00104650|65358755|FG000|Follow-up Period|Disease progression|3|||
23761154|NCT03769181|66505259|FG001|Overall Study|Other - Unspecified|1|||
23761155|NCT03769181|66505260|FG002|Overall Study|Other - Unspecified|0|||
23761156|NCT03769181|66505261|FG003|Overall Study|Other - Unspecified|0|||
23761157|NCT03990389|66505263|FG000|Overall Study|Lost to Follow-up|3|||
23761158|NCT03990389|66505264|FG001|Overall Study|Lost to Follow-up|0|||
23827899|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
23442215|NCT00104650|65358756|FG001|Follow-up Period|Disease progression|1|||
23442216|NCT00104650|65358757|FG002|Follow-up Period|Disease progression|0|||
23442217|NCT00104650|65358755|FG000|Follow-up Period|Lost to Follow-up|0|||
23442218|NCT00104650|65358756|FG001|Follow-up Period|Lost to Follow-up|1|||
23442219|NCT00104650|65358757|FG002|Follow-up Period|Lost to Follow-up|2|||
23442220|NCT00104650|65358755|FG000|Follow-up Period|Other|0|||
23442221|NCT00104650|65358756|FG001|Follow-up Period|Other|1|||
23565283|NCT02401308|65799600|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
23565284|NCT02401308|65799601|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
23565285|NCT01964521|65799608|FG000|Overall Study|Lost to Follow-up|4|||
23565286|NCT01709305|65799609|FG000|Phase 1|Clinical Adverse Event|80|||
23565287|NCT01709305|65799610|FG001|Phase 1|Clinical Adverse Event|0|||
23565288|NCT01709305|65799611|FG002|Phase 1|Clinical Adverse Event|0|||
23565289|NCT01709305|65799612|FG003|Phase 1|Clinical Adverse Event|0|||
23565290|NCT01709305|65799613|FG004|Phase 1|Clinical Adverse Event|0|||
23565291|NCT01709305|65799609|FG000|Phase 1|Death|2|||
23565292|NCT01709305|65799610|FG001|Phase 1|Death|0|||
23565293|NCT01709305|65799611|FG002|Phase 1|Death|0|||
23565294|NCT01709305|65799612|FG003|Phase 1|Death|0|||
23565295|NCT01709305|65799613|FG004|Phase 1|Death|0|||
23565296|NCT01709305|65799609|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
23565297|NCT01709305|65799610|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565298|NCT01709305|65799611|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565299|NCT01709305|65799612|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565300|NCT01709305|65799613|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565301|NCT01709305|65799609|FG000|Phase 1|Laboratory Adverse Event|16|||
23565302|NCT01709305|65799610|FG001|Phase 1|Laboratory Adverse Event|0|||
23565303|NCT01709305|65799611|FG002|Phase 1|Laboratory Adverse Event|0|||
23565304|NCT01709305|65799612|FG003|Phase 1|Laboratory Adverse Event|0|||
23565305|NCT01709305|65799613|FG004|Phase 1|Laboratory Adverse Event|0|||
23565306|NCT01709305|65799609|FG000|Phase 1|Lost to Follow-up|147|||
23565307|NCT01709305|65799610|FG001|Phase 1|Lost to Follow-up|0|||
23565308|NCT01709305|65799611|FG002|Phase 1|Lost to Follow-up|0|||
23761159|NCT04741503|66505265|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
23761160|NCT04741503|66505266|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
23565309|NCT01709305|65799612|FG003|Phase 1|Lost to Follow-up|0|||
23565310|NCT01709305|65799613|FG004|Phase 1|Lost to Follow-up|0|||
23565311|NCT01709305|65799609|FG000|Phase 1|Travel, moving, etc.|30|||
23565312|NCT01709305|65799610|FG001|Phase 1|Travel, moving, etc.|0|||
23565313|NCT01709305|65799611|FG002|Phase 1|Travel, moving, etc.|0|||
23565314|NCT01709305|65799612|FG003|Phase 1|Travel, moving, etc.|0|||
23565315|NCT01709305|65799613|FG004|Phase 1|Travel, moving, etc.|0|||
23565316|NCT01709305|65799609|FG000|Phase 1|Physician Decision|13|||
23565317|NCT01709305|65799610|FG001|Phase 1|Physician Decision|0|||
23565318|NCT01709305|65799611|FG002|Phase 1|Physician Decision|0|||
23565319|NCT01709305|65799612|FG003|Phase 1|Physician Decision|0|||
23565320|NCT01709305|65799613|FG004|Phase 1|Physician Decision|0|||
23565321|NCT01709305|65799609|FG000|Phase 1|Protocol Violation|118|||
23565322|NCT01709305|65799610|FG001|Phase 1|Protocol Violation|0|||
23565323|NCT01709305|65799611|FG002|Phase 1|Protocol Violation|0|||
23565324|NCT01709305|65799612|FG003|Phase 1|Protocol Violation|0|||
23565325|NCT01709305|65799613|FG004|Phase 1|Protocol Violation|0|||
23565326|NCT01709305|65799609|FG000|Phase 1|Withdrawal by Subject|218|||
23565327|NCT01709305|65799610|FG001|Phase 1|Withdrawal by Subject|0|||
23565328|NCT01709305|65799611|FG002|Phase 1|Withdrawal by Subject|0|||
23565329|NCT01709305|65799612|FG003|Phase 1|Withdrawal by Subject|0|||
23565330|NCT01709305|65799613|FG004|Phase 1|Withdrawal by Subject|0|||
23565331|NCT01709305|65799609|FG000|Phase 2|Clinical Adverse Event|0|||
23565332|NCT01709305|65799610|FG001|Phase 2|Clinical Adverse Event|10|||
23565333|NCT01709305|65799611|FG002|Phase 2|Clinical Adverse Event|10|||
23565334|NCT01709305|65799612|FG003|Phase 2|Clinical Adverse Event|6|||
23565335|NCT01709305|65799613|FG004|Phase 2|Clinical Adverse Event|11|||
23565336|NCT01709305|65799609|FG000|Phase 2|Death|0|||
23565337|NCT01709305|65799610|FG001|Phase 2|Death|0|||
23442222|NCT00104650|65358757|FG002|Follow-up Period|Other|0|||
23442223|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442224|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442225|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442226|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
23442227|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23565338|NCT01709305|65799611|FG002|Phase 2|Death|1|||
23565339|NCT01709305|65799612|FG003|Phase 2|Death|0|||
23565340|NCT01709305|65799613|FG004|Phase 2|Death|0|||
23565341|NCT01709305|65799609|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565342|NCT01709305|65799610|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23627422|NCT01649557|66024435|FG000|Overall Study|Withdrawal by Subject|15|||
23565343|NCT01709305|65799611|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565344|NCT01709305|65799612|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565345|NCT01709305|65799613|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
23565346|NCT01709305|65799609|FG000|Phase 2|Laboratory Adverse Event|0|||
23627423|NCT01649557|66024436|FG001|Overall Study|Withdrawal by Subject|5|||
23627424|NCT01649557|66024437|FG002|Overall Study|Withdrawal by Subject|4|||
23627425|NCT01649557|66024435|FG000|Overall Study|Protocol deviation|0|||
23627426|NCT01649557|66024436|FG001|Overall Study|Protocol deviation|2|||
23627427|NCT01649557|66024437|FG002|Overall Study|Protocol deviation|0|||
23627428|NCT01649557|66024435|FG000|Overall Study|Lack of Efficacy|5|||
23627429|NCT01649557|66024436|FG001|Overall Study|Lack of Efficacy|0|||
23627430|NCT01649557|66024437|FG002|Overall Study|Lack of Efficacy|0|||
23627431|NCT01948076|66024438|FG000|Overall Study|Withdrawal by Subject|0|||
23627432|NCT01948076|66024439|FG001|Overall Study|Withdrawal by Subject|1|||
23627433|NCT01814072|66024448|FG000|Overall Study|Lost to Follow-up|2|||
23627434|NCT01814072|66024449|FG001|Overall Study|Lost to Follow-up|2|||
23627435|NCT01814072|66024450|FG002|Overall Study|Lost to Follow-up|2|||
23627436|NCT01814072|66024451|FG003|Overall Study|Lost to Follow-up|0|||
23627437|NCT01814072|66024452|FG004|Overall Study|Lost to Follow-up|2|||
23627438|NCT01814072|66024453|FG005|Overall Study|Lost to Follow-up|3|||
23627439|NCT01814072|66024454|FG006|Overall Study|Lost to Follow-up|3|||
23627440|NCT01814072|66024455|FG007|Overall Study|Lost to Follow-up|1|||
23627441|NCT01814072|66024456|FG008|Overall Study|Lost to Follow-up|2|||
23627442|NCT01814072|66024457|FG009|Overall Study|Lost to Follow-up|3|||
23627443|NCT01814072|66024458|FG010|Overall Study|Lost to Follow-up|1|||
23627444|NCT01814072|66024459|FG011|Overall Study|Lost to Follow-up|2|||
23627445|NCT01814072|66024460|FG012|Overall Study|Lost to Follow-up|2|||
23627446|NCT01814072|66024461|FG013|Overall Study|Lost to Follow-up|1|||
23627447|NCT01814072|66024462|FG014|Overall Study|Lost to Follow-up|2|||
23627448|NCT01814072|66024463|FG015|Overall Study|Lost to Follow-up|1|||
23627449|NCT01814072|66024464|FG016|Overall Study|Lost to Follow-up|3|||
23627450|NCT01814072|66024465|FG017|Overall Study|Lost to Follow-up|1|||
23627451|NCT01814072|66024466|FG018|Overall Study|Lost to Follow-up|3|||
23627452|NCT01814072|66024467|FG019|Overall Study|Lost to Follow-up|3|||
23627453|NCT01814072|66024468|FG020|Overall Study|Lost to Follow-up|2|||
23627454|NCT01814072|66024469|FG021|Overall Study|Lost to Follow-up|1|||
23627455|NCT01814072|66024470|FG022|Overall Study|Lost to Follow-up|3|||
23627456|NCT01814072|66024471|FG023|Overall Study|Lost to Follow-up|1|||
23627457|NCT01814072|66024472|FG024|Overall Study|Lost to Follow-up|4|||
23627458|NCT01814072|66024473|FG025|Overall Study|Lost to Follow-up|1|||
23627459|NCT01814072|66024474|FG026|Overall Study|Lost to Follow-up|1|||
23627460|NCT01814072|66024475|FG027|Overall Study|Lost to Follow-up|2|||
23627461|NCT01814072|66024476|FG028|Overall Study|Lost to Follow-up|3|||
23627462|NCT01814072|66024477|FG029|Overall Study|Lost to Follow-up|3|||
23627463|NCT01814072|66024478|FG030|Overall Study|Lost to Follow-up|2|||
23627464|NCT01814072|66024479|FG031|Overall Study|Lost to Follow-up|0|||
23627465|NCT01814072|66024448|FG000|Overall Study|Withdrawal by Subject|2|||
23627466|NCT01814072|66024449|FG001|Overall Study|Withdrawal by Subject|0|||
23627467|NCT01814072|66024450|FG002|Overall Study|Withdrawal by Subject|1|||
23627468|NCT01814072|66024451|FG003|Overall Study|Withdrawal by Subject|0|||
23627469|NCT01814072|66024452|FG004|Overall Study|Withdrawal by Subject|2|||
23627470|NCT01814072|66024453|FG005|Overall Study|Withdrawal by Subject|3|||
23627471|NCT01814072|66024454|FG006|Overall Study|Withdrawal by Subject|1|||
23627472|NCT01814072|66024455|FG007|Overall Study|Withdrawal by Subject|0|||
23627473|NCT01814072|66024456|FG008|Overall Study|Withdrawal by Subject|1|||
23627474|NCT01814072|66024457|FG009|Overall Study|Withdrawal by Subject|2|||
23627475|NCT01814072|66024458|FG010|Overall Study|Withdrawal by Subject|0|||
23627476|NCT01814072|66024459|FG011|Overall Study|Withdrawal by Subject|0|||
23627477|NCT01814072|66024460|FG012|Overall Study|Withdrawal by Subject|1|||
23627478|NCT01814072|66024461|FG013|Overall Study|Withdrawal by Subject|1|||
23627479|NCT01814072|66024462|FG014|Overall Study|Withdrawal by Subject|1|||
23627480|NCT01814072|66024463|FG015|Overall Study|Withdrawal by Subject|1|||
23627481|NCT01814072|66024464|FG016|Overall Study|Withdrawal by Subject|0|||
23627482|NCT01814072|66024465|FG017|Overall Study|Withdrawal by Subject|0|||
23627483|NCT01814072|66024466|FG018|Overall Study|Withdrawal by Subject|0|||
23627484|NCT01814072|66024467|FG019|Overall Study|Withdrawal by Subject|2|||
23627485|NCT01814072|66024468|FG020|Overall Study|Withdrawal by Subject|0|||
23627486|NCT01814072|66024469|FG021|Overall Study|Withdrawal by Subject|0|||
23627487|NCT01814072|66024470|FG022|Overall Study|Withdrawal by Subject|1|||
23627488|NCT01814072|66024471|FG023|Overall Study|Withdrawal by Subject|0|||
23627489|NCT01814072|66024472|FG024|Overall Study|Withdrawal by Subject|2|||
23627490|NCT01814072|66024473|FG025|Overall Study|Withdrawal by Subject|1|||
23627491|NCT01814072|66024474|FG026|Overall Study|Withdrawal by Subject|1|||
23627492|NCT01814072|66024475|FG027|Overall Study|Withdrawal by Subject|2|||
23627493|NCT01814072|66024476|FG028|Overall Study|Withdrawal by Subject|1|||
23627494|NCT01814072|66024477|FG029|Overall Study|Withdrawal by Subject|0|||
23627495|NCT01814072|66024478|FG030|Overall Study|Withdrawal by Subject|0|||
23627496|NCT01814072|66024479|FG031|Overall Study|Withdrawal by Subject|0|||
23636638|NCT02631577|66052952|FG001|Overall Study|Withdrawal by Subject|3|||
23761161|NCT04741503|66505267|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
23761162|NCT04741503|66505265|FG000|Initial Enrollment|Overquotas removed|0|||
23442228|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442229|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442230|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442231|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442232|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442233|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
23565347|NCT01709305|65799610|FG001|Phase 2|Laboratory Adverse Event|1|||
23565348|NCT01709305|65799611|FG002|Phase 2|Laboratory Adverse Event|0|||
23761163|NCT04741503|66505266|FG001|Initial Enrollment|Overquotas removed|0|||
23761164|NCT04741503|66505267|FG002|Initial Enrollment|Overquotas removed|186|||
23761165|NCT04741503|66505265|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
23761166|NCT04741503|66505266|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
23761167|NCT04741503|66505267|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
23761168|NCT00326885|66505269|FG000|Overall Study|Adverse Event|1|||
23761169|NCT00326885|66505269|FG000|Overall Study|Withdrawal by Subject|3|||
23761170|NCT00326885|66505269|FG000|Overall Study|Physician Decision|1|||
23761171|NCT00326885|66505269|FG000|Overall Study|Hospice withdrew consent|2|||
23761172|NCT05017493|66505272|FG000|Overall Study|Withdrawal by Subject|26|||
23761173|NCT05017493|66505273|FG001|Overall Study|Withdrawal by Subject|0|||
23761174|NCT05017493|66505272|FG000|Overall Study|Physician Decision|15|||
23761175|NCT05017493|66505273|FG001|Overall Study|Physician Decision|0|||
23761176|NCT05017493|66505272|FG000|Overall Study|Protocol Violation|81|||
23761177|NCT05017493|66505273|FG001|Overall Study|Protocol Violation|0|||
23761178|NCT00289458|66505274|FG000|Overall Study|Death|1|||
23761179|NCT00289458|66505275|FG001|Overall Study|Death|0|||
23761180|NCT00289458|66505276|FG002|Overall Study|Death|0|||
23761181|NCT00289458|66505274|FG000|Overall Study|Physician Decision|3|||
23761182|NCT00289458|66505275|FG001|Overall Study|Physician Decision|4|||
23761183|NCT00289458|66505276|FG002|Overall Study|Physician Decision|2|||
23761184|NCT00289458|66505274|FG000|Overall Study|Withdrawal by Subject|2|||
23761185|NCT00289458|66505275|FG001|Overall Study|Withdrawal by Subject|2|||
23761186|NCT00289458|66505276|FG002|Overall Study|Withdrawal by Subject|4|||
23761187|NCT01663714|66505277|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
23761188|NCT01663714|66505277|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
23761189|NCT01663714|66505277|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
23761190|NCT01663714|66505277|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
23761191|NCT01663714|66505277|FG000|Long-Term Follow-Up|Death|4|||
23761192|NCT01663714|66505277|FG000|Long-Term Follow-Up|Non-compliance|1|||
23761193|NCT00707174|66505278|FG000|Overall Study|Adverse Event|1|||
23761194|NCT00707174|66505279|FG001|Overall Study|Adverse Event|6|||
23761195|NCT00707174|66505278|FG000|Overall Study|Withdrawal by Subject|4|||
23761196|NCT00707174|66505279|FG001|Overall Study|Withdrawal by Subject|1|||
23761197|NCT04274192|66505282|FG000|Overall Study|Protocol Violation|1|||
23761198|NCT04274192|66505283|FG001|Overall Study|Protocol Violation|0|||
23761199|NCT03712228|66505285|FG000|Treatment Period 1|Lack of Efficacy|0|||
23761200|NCT03712228|66505286|FG001|Treatment Period 1|Lack of Efficacy|0|||
23442234|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442235|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442236|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442237|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
23565349|NCT01709305|65799612|FG003|Phase 2|Laboratory Adverse Event|1|||
23565350|NCT01709305|65799613|FG004|Phase 2|Laboratory Adverse Event|1|||
23565351|NCT01709305|65799609|FG000|Phase 2|Lost to Follow-up|0|||
23565352|NCT01709305|65799610|FG001|Phase 2|Lost to Follow-up|10|||
23565353|NCT01709305|65799611|FG002|Phase 2|Lost to Follow-up|6|||
23565354|NCT01709305|65799612|FG003|Phase 2|Lost to Follow-up|9|||
23565355|NCT01709305|65799613|FG004|Phase 2|Lost to Follow-up|5|||
23565356|NCT01709305|65799609|FG000|Phase 2|Travel, moving, etc.|0|||
23565357|NCT01709305|65799610|FG001|Phase 2|Travel, moving, etc.|2|||
23565358|NCT01709305|65799611|FG002|Phase 2|Travel, moving, etc.|3|||
23565359|NCT01709305|65799612|FG003|Phase 2|Travel, moving, etc.|3|||
23565360|NCT01709305|65799613|FG004|Phase 2|Travel, moving, etc.|5|||
23565361|NCT01709305|65799609|FG000|Phase 2|Physician Decision|0|||
23565362|NCT01709305|65799610|FG001|Phase 2|Physician Decision|2|||
23565363|NCT01709305|65799611|FG002|Phase 2|Physician Decision|0|||
23565364|NCT01709305|65799612|FG003|Phase 2|Physician Decision|1|||
23565365|NCT01709305|65799613|FG004|Phase 2|Physician Decision|2|||
23565366|NCT01709305|65799609|FG000|Phase 2|Protocol Violation|0|||
23565367|NCT01709305|65799610|FG001|Phase 2|Protocol Violation|19|||
23565368|NCT01709305|65799611|FG002|Phase 2|Protocol Violation|19|||
23565369|NCT01709305|65799612|FG003|Phase 2|Protocol Violation|13|||
23627497|NCT05382039|66024480|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
23627498|NCT05382039|66024481|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
23627499|NCT05382039|66024482|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
23627500|NCT05382039|66024480|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
23627501|NCT05382039|66024481|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
23627502|NCT05382039|66024482|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
23627503|NCT05382039|66024480|FG000|Overall Study|waiting for confirmation|0|||
23627504|NCT05382039|66024481|FG001|Overall Study|waiting for confirmation|0|||
23627505|NCT05382039|66024482|FG002|Overall Study|waiting for confirmation|1|||
23627506|NCT00872001|66024483|FG000|Overall Study|Adverse Event|34|||
23627507|NCT00872001|66024484|FG001|Overall Study|Adverse Event|23|||
23627508|NCT00872001|66024483|FG000|Overall Study|Protocol Defined Clinical Event|5|||
23627509|NCT00872001|66024484|FG001|Overall Study|Protocol Defined Clinical Event|7|||
23627510|NCT00872001|66024483|FG000|Overall Study|Lost to Follow-up|13|||
23827900|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
23827901|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
23827902|NCT01070953|66748997|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
23442238|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442239|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442240|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442241|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442242|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442243|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442244|NCT03268941|65358758|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
23442245|NCT03268941|65358759|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
23442246|NCT03268941|65358760|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
23442247|NCT03268941|65358761|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
23442248|NCT03268941|65358762|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
23442249|NCT03268941|65358763|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
23442250|NCT03268941|65358764|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
23627511|NCT00872001|66024484|FG001|Overall Study|Lost to Follow-up|12|||
23627512|NCT00872001|66024483|FG000|Overall Study|Withdrawal by Subject|18|||
23627513|NCT00872001|66024484|FG001|Overall Study|Withdrawal by Subject|30|||
23442251|NCT03268941|65358758|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442252|NCT03268941|65358759|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442253|NCT03268941|65358760|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442254|NCT03268941|65358761|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442255|NCT03268941|65358762|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442256|NCT03268941|65358763|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442257|NCT03268941|65358764|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
23565370|NCT01709305|65799613|FG004|Phase 2|Protocol Violation|9|||
23565371|NCT01709305|65799609|FG000|Phase 2|Withdrawal by Subject|0|||
23565372|NCT01709305|65799610|FG001|Phase 2|Withdrawal by Subject|8|||
23565373|NCT01709305|65799611|FG002|Phase 2|Withdrawal by Subject|6|||
23565374|NCT01709305|65799612|FG003|Phase 2|Withdrawal by Subject|15|||
23565375|NCT01709305|65799613|FG004|Phase 2|Withdrawal by Subject|12|||
23565376|NCT05033080|65799614|FG000|Overall Study|Adverse Event|4|||
23627514|NCT00872001|66024483|FG000|Overall Study|Protocol Violation|5|||
23627515|NCT00872001|66024484|FG001|Overall Study|Protocol Violation|8|||
23627516|NCT00872001|66024483|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
23627517|NCT00872001|66024484|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
23627518|NCT00872001|66024483|FG000|Overall Study|Administrative|23|||
23761201|NCT03712228|66505287|FG002|Treatment Period 1|Lack of Efficacy|0|||
23761202|NCT03712228|66505288|FG003|Treatment Period 1|Lack of Efficacy|0|||
23761203|NCT03712228|66505289|FG004|Treatment Period 1|Lack of Efficacy|0|||
23761204|NCT03712228|66505290|FG005|Treatment Period 1|Lack of Efficacy|1|||
23761205|NCT03712228|66505285|FG000|Treatment Period 2|Pregnancy|0|||
23761206|NCT03712228|66505286|FG001|Treatment Period 2|Pregnancy|0|||
23761207|NCT03712228|66505287|FG002|Treatment Period 2|Pregnancy|0|||
23761208|NCT03712228|66505288|FG003|Treatment Period 2|Pregnancy|1|||
23761209|NCT03712228|66505289|FG004|Treatment Period 2|Pregnancy|0|||
23761210|NCT03712228|66505290|FG005|Treatment Period 2|Pregnancy|0|||
23761211|NCT03712228|66505285|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23761212|NCT03712228|66505286|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23761213|NCT03712228|66505287|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23761214|NCT03712228|66505288|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23761215|NCT03712228|66505289|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23761216|NCT03712228|66505290|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23761217|NCT04535583|66505291|FG000|Overall Study|Lost to Follow-up|1|||
23761218|NCT04535583|66505291|FG000|Overall Study|Physician Decision|1|||
23761219|NCT04535583|66505291|FG000|Overall Study|Withdrawal by Subject|1|||
23761220|NCT02354976|66505292|FG000|Overall Study|Other - reason not specified|1|||
23761221|NCT02354976|66505293|FG001|Overall Study|Other - reason not specified|0|||
23761222|NCT02354976|66505294|FG002|Overall Study|Other - reason not specified|1|||
23761223|NCT02354976|66505292|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
23761224|NCT02354976|66505293|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
23761225|NCT02354976|66505294|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
23761226|NCT02354976|66505292|FG000|Overall Study|Adverse Event|1|||
23761227|NCT02354976|66505293|FG001|Overall Study|Adverse Event|0|||
23761228|NCT02354976|66505294|FG002|Overall Study|Adverse Event|2|||
23761229|NCT01859390|66505297|FG000|Overall Study|Insufficient Sputum Collected|1|||
23761230|NCT01859390|66505298|FG001|Overall Study|Insufficient Sputum Collected|3|||
23761231|NCT01859390|66505297|FG000|Overall Study|Sample Missing Collection Date|0|||
23761232|NCT01859390|66505298|FG001|Overall Study|Sample Missing Collection Date|1|||
23761233|NCT01859390|66505297|FG000|Overall Study|Tube Cracked|0|||
23761234|NCT01859390|66505298|FG001|Overall Study|Tube Cracked|2|||
23761235|NCT01859390|66505297|FG000|Overall Study|Shipment Error|0|||
23761236|NCT01859390|66505298|FG001|Overall Study|Shipment Error|1|||
23761237|NCT02675426|66505299|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
23442258|NCT00787189|65358765|FG000|Overall Study|Lost to Follow-up|2|||
23565377|NCT05033080|65799615|FG001|Overall Study|Adverse Event|4|||
23565378|NCT05033080|65799614|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
23565379|NCT05033080|65799615|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
23627519|NCT00872001|66024484|FG001|Overall Study|Administrative|15|||
23565380|NCT05033080|65799614|FG000|Overall Study|Lost to Follow-up|1|||
23442259|NCT00787189|65358766|FG001|Overall Study|Lost to Follow-up|2|||
23442260|NCT04395690|65362012|FG000|Overall Study|Lost to Follow-up|1|||
23442261|NCT04395690|65362013|FG001|Overall Study|Lost to Follow-up|1|||
23442262|NCT01670721|65362014|FG000|Overall Study|Participant's decision|15|||
23442263|NCT01670721|65362014|FG000|Overall Study|Other than specified above|38|||
23442264|NCT03386487|65362015|FG000|Overall Study|Lost to Follow-up|5|||
23442265|NCT03386487|65362016|FG001|Overall Study|Lost to Follow-up|6|||
23442266|NCT03386487|65362015|FG000|Overall Study|Withdrawal by Subject|11|||
23442267|NCT03386487|65362016|FG001|Overall Study|Withdrawal by Subject|7|||
23442268|NCT03386487|65362015|FG000|Overall Study|Physician Decision|11|||
23442269|NCT03386487|65362016|FG001|Overall Study|Physician Decision|8|||
23442270|NCT02478164|65362017|FG000|Overall Study|Lack of Efficacy|13|||
23565381|NCT05033080|65799615|FG001|Overall Study|Lost to Follow-up|0|||
23565382|NCT05033080|65799614|FG000|Overall Study|Other non-compliance|0|||
23565383|NCT05033080|65799615|FG001|Overall Study|Other non-compliance|1|||
23565384|NCT05033080|65799614|FG000|Overall Study|Physician Decision|0|||
23565385|NCT05033080|65799615|FG001|Overall Study|Physician Decision|1|||
23565386|NCT05033080|65799614|FG000|Overall Study|Other|1|||
23565387|NCT05033080|65799615|FG001|Overall Study|Other|1|||
23565388|NCT02200939|65799618|FG000|Overall Study|Participant withdrew consent|0|||
23627520|NCT02980523|66024485|FG000|Overall Study|Lost to Follow-up|1|||
23442271|NCT02478164|65362017|FG000|Overall Study|Adverse Event|1|||
23442272|NCT02478164|65362017|FG000|Overall Study|Withdrawal by Subject|1|||
23442273|NCT02279095|65362019|FG000|Overall Study|Non-Compliance|1|||
23442274|NCT02279095|65362019|FG000|Overall Study|Withdrawal by Subject|8|||
23442275|NCT02279095|65362019|FG000|Overall Study|Adverse Event|2|||
23442276|NCT02279095|65362019|FG000|Overall Study|Other|7|||
23442277|NCT02279095|65362019|FG000|Overall Study|Lost to Follow-up|1|||
23442278|NCT01510158|65362020|FG000|Overall Study|Adverse Event|7|||
23442279|NCT01510158|65362021|FG001|Overall Study|Adverse Event|8|||
23442280|NCT01510158|65362022|FG002|Overall Study|Adverse Event|5|||
23442281|NCT01510158|65362020|FG000|Overall Study|Gout flare|1|||
23442282|NCT01510158|65362021|FG001|Overall Study|Gout flare|0|||
23627521|NCT02980523|66024486|FG001|Overall Study|Lost to Follow-up|4|||
23627522|NCT02980523|66024487|FG002|Overall Study|Lost to Follow-up|1|||
23627523|NCT02980523|66024488|FG003|Overall Study|Lost to Follow-up|2|||
23627524|NCT02980523|66024489|FG004|Overall Study|Lost to Follow-up|1|||
23627525|NCT02980523|66024485|FG000|Overall Study|Excluded from analysis|1|||
23627526|NCT02980523|66024486|FG001|Overall Study|Excluded from analysis|3|||
23442283|NCT01510158|65362022|FG002|Overall Study|Gout flare|0|||
23565389|NCT02200939|65799619|FG001|Overall Study|Participant withdrew consent|1|||
23565390|NCT02200939|65799618|FG000|Overall Study|Lost to Follow-up|2|||
23627527|NCT02980523|66024487|FG002|Overall Study|Excluded from analysis|1|||
23627528|NCT02980523|66024488|FG003|Overall Study|Excluded from analysis|1|||
23627529|NCT02980523|66024489|FG004|Overall Study|Excluded from analysis|1|||
23627530|NCT02980523|66024485|FG000|Overall Study|Lack of Efficacy|1|||
23627531|NCT02980523|66024486|FG001|Overall Study|Lack of Efficacy|4|||
23627532|NCT02980523|66024487|FG002|Overall Study|Lack of Efficacy|4|||
23627533|NCT02980523|66024488|FG003|Overall Study|Lack of Efficacy|5|||
23627534|NCT02980523|66024489|FG004|Overall Study|Lack of Efficacy|8|||
23627535|NCT02980523|66024485|FG000|Overall Study|Did not receive intervention|0|||
23627536|NCT02980523|66024486|FG001|Overall Study|Did not receive intervention|0|||
23627537|NCT02980523|66024487|FG002|Overall Study|Did not receive intervention|0|||
23627538|NCT02980523|66024488|FG003|Overall Study|Did not receive intervention|1|||
23627539|NCT02980523|66024489|FG004|Overall Study|Did not receive intervention|0|||
23627540|NCT01318876|66024491|FG000|Day 8 Survey|email address invalid|96|||
23761238|NCT02675426|66505300|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
23761239|NCT02675426|66505301|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
23761240|NCT02675426|66505302|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
23761241|NCT02675426|66505299|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
23761242|NCT02675426|66505300|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
23761243|NCT02675426|66505301|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
23761244|NCT02675426|66505302|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
23761245|NCT02675426|66505299|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
23761246|NCT02675426|66505300|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
23761247|NCT02675426|66505301|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
23761248|NCT02675426|66505302|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
23761249|NCT02675426|66505299|FG000|Period 1: Week 1 to Week 12|Other|2|||
23761250|NCT02675426|66505300|FG001|Period 1: Week 1 to Week 12|Other|1|||
23761251|NCT02675426|66505301|FG002|Period 1: Week 1 to Week 12|Other|0|||
23442284|NCT01510158|65362020|FG000|Overall Study|Protocol Violation|17|||
23442285|NCT01510158|65362021|FG001|Overall Study|Protocol Violation|16|||
23627541|NCT01318876|66024491|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
23442286|NCT01510158|65362022|FG002|Overall Study|Protocol Violation|24|||
23442287|NCT01510158|65362020|FG000|Overall Study|Sponsor terminated study.|2|||
23565391|NCT02200939|65799619|FG001|Overall Study|Lost to Follow-up|9|||
23627542|NCT01318876|66024491|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
23627543|NCT00458393|66024493|FG000|Overall Study|Withdrawal by Subject|67|||
23627544|NCT00458393|66024494|FG001|Overall Study|Withdrawal by Subject|80|||
23627545|NCT00458393|66024493|FG000|Overall Study|Physician Decision|31|||
23627546|NCT00458393|66024494|FG001|Overall Study|Physician Decision|22|||
23627547|NCT00458393|66024493|FG000|Overall Study|Relocated|77|||
23627548|NCT00458393|66024494|FG001|Overall Study|Relocated|81|||
23565392|NCT02200939|65799618|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
23627549|NCT00458393|66024493|FG000|Overall Study|Lost to Follow-up|115|||
23627550|NCT00458393|66024494|FG001|Overall Study|Lost to Follow-up|92|||
23627551|NCT00458393|66024493|FG000|Overall Study|Sites marked other on the form.|19|||
23627552|NCT00458393|66024494|FG001|Overall Study|Sites marked other on the form.|20|||
23627553|NCT00003477|66024496|FG000|Overall Study|Not evalauable|4|||
23627554|NCT02058836|66024497|FG000|Overall Study|Withdrawal by Subject|1|||
23627555|NCT02058836|66024498|FG001|Overall Study|Withdrawal by Subject|1|||
23627556|NCT01547598|66024499|FG000|Overall Study|Withdrew consent|1|||
23627557|NCT01547598|66024500|FG001|Overall Study|Withdrew consent|1|||
23627558|NCT01547598|66024499|FG000|Overall Study|Lost to Follow-up|1|||
23627559|NCT01547598|66024500|FG001|Overall Study|Lost to Follow-up|1|||
23627560|NCT01547598|66024499|FG000|Overall Study|Adverse Event|1|||
23627561|NCT01547598|66024500|FG001|Overall Study|Adverse Event|1|||
23565393|NCT02200939|65799619|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
23565394|NCT01267253|65799620|FG000|Overall Study|Ineligible - required test not done|1|||
23565395|NCT01267253|65799620|FG000|Overall Study|Inevaluable-never received study treatme|2|||
23565396|NCT00926003|65799622|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
23627562|NCT01547598|66024499|FG000|Overall Study|Protocol Violation|1|||
23627563|NCT01547598|66024500|FG001|Overall Study|Protocol Violation|1|||
23761252|NCT02675426|66505302|FG003|Period 1: Week 1 to Week 12|Other|2|||
23761253|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
23761254|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
23761255|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
23761256|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
23827903|NCT01070953|66748997|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
23827904|NCT01070953|66748997|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
23827905|NCT01070953|66748997|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
23827906|NCT01147068|66748998|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
23827907|NCT01147068|66748999|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23827908|NCT01147068|66749000|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23761257|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
23761258|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
23761259|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
23761260|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
23761261|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
23761262|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
23565397|NCT00926003|65799623|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
23565398|NCT00926003|65799624|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
23565399|NCT00926003|65799622|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
23565400|NCT00926003|65799623|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
23565401|NCT00926003|65799624|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
23565402|NCT02961881|65799628|FG000|Overall Study|Adverse Event|1|||
23565403|NCT02961881|65799629|FG001|Overall Study|Adverse Event|2|||
23565404|NCT02961881|65799630|FG002|Overall Study|Adverse Event|2|||
23565405|NCT02961881|65799631|FG003|Overall Study|Adverse Event|0|||
23565406|NCT02961881|65799632|FG004|Overall Study|Adverse Event|1|||
23565407|NCT02961881|65799628|FG000|Overall Study|Participant request|0|||
23565408|NCT02961881|65799629|FG001|Overall Study|Participant request|2|||
23627564|NCT01547598|66024499|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23627565|NCT01547598|66024500|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23761263|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
23761264|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
23827909|NCT01147068|66749001|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23827910|NCT01147068|66749002|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23627566|NCT02397447|66024501|FG000|Overall Study|Lost to Follow-up|2|||
23627567|NCT02397447|66024502|FG001|Overall Study|Lost to Follow-up|2|||
23761265|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
23761266|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
23761267|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
23761268|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
23761269|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
23761270|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
23761271|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
23761272|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
23761273|NCT02675426|66505299|FG000|Period 2: Week 12 to Week 260|Other|8|||
23761274|NCT02675426|66505300|FG001|Period 2: Week 12 to Week 260|Other|12|||
23761275|NCT02675426|66505301|FG002|Period 2: Week 12 to Week 260|Other|23|||
23761276|NCT02675426|66505302|FG003|Period 2: Week 12 to Week 260|Other|15|||
23761277|NCT01489956|66505303|FG000|Overall Study|Lost to Follow-up|1|||
23761278|NCT01489956|66505304|FG001|Overall Study|Lost to Follow-up|0|||
23761279|NCT01489956|66505305|FG002|Overall Study|Lost to Follow-up|0|||
23761280|NCT01489956|66505303|FG000|Overall Study|Withdrawal by Subject|0|||
23761281|NCT01489956|66505304|FG001|Overall Study|Withdrawal by Subject|0|||
23761282|NCT01489956|66505305|FG002|Overall Study|Withdrawal by Subject|1|||
23761283|NCT02725671|66505306|FG000|Overall Study|Lost to Follow-up|1|||
23761284|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
23761285|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23761286|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
23761287|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23761288|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23761289|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23761290|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
23761291|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23761292|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
23761293|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
23761294|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
23761295|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
23761296|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
23761297|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23761298|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23761299|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
23761300|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23761301|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23761302|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
23761303|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23761304|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
23761305|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
23761306|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
23761307|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
23761308|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23761309|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23761310|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
23761311|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23761312|NCT00528879|66505307|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
23761313|NCT00528879|66505308|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
23761314|NCT00528879|66505309|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
23761315|NCT00528879|66505310|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
23761316|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
23761317|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
23761318|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
23761319|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
23761320|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
23761321|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
23827911|NCT01147068|66749003|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
23827912|NCT01147068|66749004|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23827913|NCT01147068|66748998|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
23827914|NCT01147068|66748999|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
23827915|NCT01147068|66749000|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
23827916|NCT01147068|66749001|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
23827917|NCT01147068|66749002|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
23827918|NCT01147068|66749003|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
23827919|NCT01147068|66749004|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
23827920|NCT01147068|66748998|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
23827921|NCT01147068|66748999|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
23827922|NCT01147068|66749000|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
23827923|NCT01147068|66749001|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
23827924|NCT01147068|66749002|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
23827925|NCT01147068|66749003|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
23827926|NCT01147068|66749004|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
23827927|NCT01147068|66748998|FG000|Subjects That Received 2nd Dose|Other|0|||
23827928|NCT01147068|66748999|FG001|Subjects That Received 2nd Dose|Other|3|||
23827929|NCT01147068|66749000|FG002|Subjects That Received 2nd Dose|Other|3|||
23827930|NCT01147068|66749001|FG003|Subjects That Received 2nd Dose|Other|0|||
23827931|NCT01147068|66749002|FG004|Subjects That Received 2nd Dose|Other|1|||
23827932|NCT01147068|66749003|FG005|Subjects That Received 2nd Dose|Other|0|||
23827933|NCT01147068|66749004|FG006|Subjects That Received 2nd Dose|Other|0|||
23827934|NCT01147068|66748998|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23827935|NCT01147068|66748999|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23761322|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
23442288|NCT01510158|65362021|FG001|Overall Study|Sponsor terminated study.|0|||
23442289|NCT01510158|65362022|FG002|Overall Study|Sponsor terminated study.|2|||
23442290|NCT01510158|65362020|FG000|Overall Study|Lost to Follow-up|13|||
23761323|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
23761324|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
23761325|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
23761326|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
23761327|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
23761328|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
23761329|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
23761330|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
23761331|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
23761332|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
23761333|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
23761334|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
23761335|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
23761336|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
23761337|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
23761338|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
23761339|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
23761340|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
23761341|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23761342|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23761343|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23761344|NCT00528879|66505307|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23761345|NCT00528879|66505308|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23761346|NCT00528879|66505309|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23761347|NCT00528879|66505310|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
23761348|NCT00415532|66505321|FG000|Treatment Period|Adverse Event|2|||
23761349|NCT00415532|66505322|FG001|Treatment Period|Adverse Event|3|||
23761350|NCT00415532|66505321|FG000|Treatment Period|Death|2|||
23761351|NCT00415532|66505322|FG001|Treatment Period|Death|1|||
23761352|NCT00415532|66505321|FG000|Treatment Period|Lost to Follow-up|1|||
23761353|NCT00415532|66505322|FG001|Treatment Period|Lost to Follow-up|1|||
23761354|NCT00415532|66505321|FG000|Treatment Period|Protocol Violation|1|||
23761355|NCT00415532|66505322|FG001|Treatment Period|Protocol Violation|0|||
23761356|NCT00415532|66505321|FG000|Treatment Period|Withdrawal by Subject|6|||
23761357|NCT00415532|66505322|FG001|Treatment Period|Withdrawal by Subject|6|||
23761358|NCT00415532|66505321|FG000|Treatment Period|Other|2|||
23761359|NCT00415532|66505322|FG001|Treatment Period|Other|2|||
23761360|NCT00415532|66505321|FG000|Treatment Period|Ineligibility determined|1|||
23761361|NCT00415532|66505322|FG001|Treatment Period|Ineligibility determined|1|||
23761362|NCT00415532|66505321|FG000|Treatment Period|Noncompliance|1|||
23761363|NCT00415532|66505322|FG001|Treatment Period|Noncompliance|1|||
23761364|NCT00415532|66505321|FG000|Treatment Period|Requirement for alternative therapy|1|||
23761365|NCT00415532|66505322|FG001|Treatment Period|Requirement for alternative therapy|0|||
23827936|NCT01147068|66749000|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23442291|NCT01510158|65362021|FG001|Overall Study|Lost to Follow-up|16|||
23761366|NCT00415532|66505321|FG000|Safety Follow Up Period|Adverse Event|1|||
23761367|NCT00415532|66505322|FG001|Safety Follow Up Period|Adverse Event|3|||
23827937|NCT01147068|66749001|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23442292|NCT01510158|65362022|FG002|Overall Study|Lost to Follow-up|9|||
23761368|NCT00415532|66505321|FG000|Safety Follow Up Period|Death|3|||
23761369|NCT00415532|66505322|FG001|Safety Follow Up Period|Death|0|||
23761370|NCT00415532|66505321|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
23761371|NCT00415532|66505322|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
23761372|NCT00415532|66505321|FG000|Safety Follow Up Period|Other|1|||
23761373|NCT00415532|66505322|FG001|Safety Follow Up Period|Other|4|||
23761374|NCT00415532|66505321|FG000|Safety Follow Up Period|Ineligibility determined|1|||
23761375|NCT00415532|66505322|FG001|Safety Follow Up Period|Ineligibility determined|1|||
23761376|NCT00415532|66505321|FG000|Safety Follow Up Period|Noncompliance|1|||
23761377|NCT00415532|66505322|FG001|Safety Follow Up Period|Noncompliance|0|||
23761378|NCT00415532|66505321|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
23761379|NCT00415532|66505322|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
23761380|NCT00597584|66505323|FG000|Overall Study|Adverse Event|4|||
23761381|NCT00597584|66505324|FG001|Overall Study|Adverse Event|2|||
23761382|NCT00597584|66505323|FG000|Overall Study|Death|53|||
23761383|NCT00597584|66505324|FG001|Overall Study|Death|30|||
23761384|NCT00597584|66505323|FG000|Overall Study|Lack of Efficacy|1|||
23761385|NCT00597584|66505324|FG001|Overall Study|Lack of Efficacy|0|||
23761386|NCT00597584|66505323|FG000|Overall Study|Lost to Follow-up|2|||
23761387|NCT00597584|66505324|FG001|Overall Study|Lost to Follow-up|4|||
23761388|NCT00597584|66505323|FG000|Overall Study|Physician Decision|3|||
23761389|NCT00597584|66505324|FG001|Overall Study|Physician Decision|0|||
23761390|NCT00597584|66505323|FG000|Overall Study|Pregnancy|2|||
23761391|NCT00597584|66505324|FG001|Overall Study|Pregnancy|0|||
23761392|NCT00597584|66505323|FG000|Overall Study|Withdrawal by Subject|44|||
23761393|NCT00597584|66505324|FG001|Overall Study|Withdrawal by Subject|12|||
23761394|NCT00597584|66505323|FG000|Overall Study|Discontinued Dialysis|0|||
23761395|NCT00597584|66505324|FG001|Overall Study|Discontinued Dialysis|1|||
23761396|NCT00597584|66505323|FG000|Overall Study|Lost ability to consent|1|||
23761397|NCT00597584|66505324|FG001|Overall Study|Lost ability to consent|1|||
23761398|NCT00597584|66505323|FG000|Overall Study|Never dosed|1|||
23761399|NCT00597584|66505324|FG001|Overall Study|Never dosed|0|||
23761400|NCT00597584|66505323|FG000|Overall Study|Relocation|8|||
23761401|NCT00597584|66505324|FG001|Overall Study|Relocation|6|||
23761402|NCT00597584|66505323|FG000|Overall Study|Renal transplant|9|||
23761403|NCT00597584|66505324|FG001|Overall Study|Renal transplant|7|||
23761404|NCT01306253|66505325|FG000|Overall Study|Lost to Follow-up|1|||
23761405|NCT01306253|66505326|FG001|Overall Study|Lost to Follow-up|1|||
23761406|NCT00399490|66505327|FG000|Overall Study|Adverse Event|19|||
23761407|NCT00399490|66505327|FG000|Overall Study|Lack of Efficacy|31|||
23761408|NCT00399490|66505327|FG000|Overall Study|Lost to Follow-up|5|||
23761409|NCT00399490|66505327|FG000|Overall Study|Withdrawal by Subject|18|||
23761410|NCT00399490|66505327|FG000|Overall Study|Other|25|||
23442293|NCT01510158|65362020|FG000|Overall Study|Withdrawal by Subject|10|||
23442294|NCT01510158|65362021|FG001|Overall Study|Withdrawal by Subject|13|||
23442295|NCT01510158|65362022|FG002|Overall Study|Withdrawal by Subject|10|||
23442296|NCT01510158|65362020|FG000|Overall Study|Death|1|||
23442297|NCT01510158|65362021|FG001|Overall Study|Death|0|||
23442298|NCT01510158|65362022|FG002|Overall Study|Death|0|||
23442299|NCT03521141|65362037|FG000|Overall Study|Death|1|||
23442300|NCT03521141|65362038|FG001|Overall Study|Death|0|||
23442301|NCT03521141|65362039|FG002|Overall Study|Death|1|||
23442302|NCT02926638|65362040|FG000|Overall Study|Progression|2|||
23442303|NCT02926638|65362041|FG001|Overall Study|Progression|5|||
23442304|NCT02926638|65362040|FG000|Overall Study|Ineligible|1|||
23442305|NCT02926638|65362041|FG001|Overall Study|Ineligible|0|||
23442306|NCT02926638|65362040|FG000|Overall Study|Not protocol specified|1|||
23442307|NCT02926638|65362041|FG001|Overall Study|Not protocol specified|0|||
23442308|NCT02703324|65362042|FG000|Period Two|Withdrawal by Subject|0|||
23565409|NCT02961881|65799630|FG002|Overall Study|Participant request|0|||
23565410|NCT02961881|65799631|FG003|Overall Study|Participant request|0|||
23565411|NCT02961881|65799632|FG004|Overall Study|Participant request|0|||
23761411|NCT00345683|66505330|FG000|Overall Study|Lost to Follow-up|19|||
23761412|NCT00345683|66505331|FG001|Overall Study|Lost to Follow-up|7|||
23761413|NCT00345683|66505330|FG000|Overall Study|Other|6|||
23761414|NCT00345683|66505331|FG001|Overall Study|Other|2|||
23761415|NCT02904200|66505334|FG000|Overall Study|Withdrawal by Subject|1|||
23761416|NCT02904200|66505335|FG001|Overall Study|Withdrawal by Subject|0|||
23761417|NCT01637961|66505336|FG000|Overall Study|Ineligible: wrong primary|1|||
23761418|NCT01637961|66505336|FG000|Overall Study|Ineligible: inadequate pathology|1|||
23442309|NCT02703324|65362043|FG001|Period Two|Withdrawal by Subject|0|||
23442310|NCT02703324|65362044|FG002|Period Two|Withdrawal by Subject|1|||
23565412|NCT02961881|65799628|FG000|Overall Study|Disease progression|1|||
23761419|NCT02418910|66505341|FG000|Overall Study|Lost to Follow-up|3|||
23761420|NCT02418910|66505341|FG000|Overall Study|Withdrawal by Subject|4|||
23761421|NCT00947011|66505343|FG000|Overall Study|Study was terminated,PI left institution|12|||
23442311|NCT02703324|65362045|FG003|Period Two|Withdrawal by Subject|0|||
23442312|NCT02703324|65362046|FG004|Period Two|Withdrawal by Subject|0|||
23442313|NCT02703324|65362047|FG005|Period Two|Withdrawal by Subject|0|||
23442314|NCT00713544|65362048|FG000|Overall Study|Adverse Event|5|||
23442315|NCT00713544|65362049|FG001|Overall Study|Adverse Event|3|||
23442316|NCT00713544|65362050|FG002|Overall Study|Adverse Event|7|||
23442317|NCT00713544|65362051|FG003|Overall Study|Adverse Event|7|||
23442318|NCT00713544|65362052|FG004|Overall Study|Adverse Event|3|||
23442319|NCT00713544|65362053|FG005|Overall Study|Adverse Event|5|||
23442320|NCT00713544|65362048|FG000|Overall Study|Withdrawal by Subject|2|||
23442321|NCT00713544|65362049|FG001|Overall Study|Withdrawal by Subject|0|||
23442322|NCT00713544|65362050|FG002|Overall Study|Withdrawal by Subject|3|||
23442323|NCT00713544|65362051|FG003|Overall Study|Withdrawal by Subject|2|||
23442324|NCT00713544|65362052|FG004|Overall Study|Withdrawal by Subject|3|||
23442325|NCT00713544|65362053|FG005|Overall Study|Withdrawal by Subject|1|||
23442326|NCT00713544|65362048|FG000|Overall Study|Protocol Violation|0|||
23442327|NCT00713544|65362049|FG001|Overall Study|Protocol Violation|0|||
23442328|NCT00713544|65362050|FG002|Overall Study|Protocol Violation|0|||
23442329|NCT00713544|65362051|FG003|Overall Study|Protocol Violation|0|||
23442330|NCT00713544|65362052|FG004|Overall Study|Protocol Violation|0|||
23442331|NCT00713544|65362053|FG005|Overall Study|Protocol Violation|1|||
23442332|NCT00713544|65362048|FG000|Overall Study|Physician Decision|0|||
23442333|NCT00713544|65362049|FG001|Overall Study|Physician Decision|0|||
23442334|NCT00713544|65362050|FG002|Overall Study|Physician Decision|0|||
23442335|NCT00713544|65362051|FG003|Overall Study|Physician Decision|0|||
23442336|NCT00713544|65362052|FG004|Overall Study|Physician Decision|0|||
23761422|NCT04335110|66505344|FG000|Overall Study|Withdrawal by Subject|1|||
23761423|NCT04335110|66505345|FG001|Overall Study|Withdrawal by Subject|1|||
23761424|NCT04335110|66505344|FG000|Overall Study|Death|0|||
23761425|NCT04335110|66505345|FG001|Overall Study|Death|1|||
23761426|NCT00686374|66505346|FG000|Overall Study|Lack of Efficacy|10|||
23761427|NCT00686374|66505346|FG000|Overall Study|Adverse Event|8|||
23442337|NCT00713544|65362053|FG005|Overall Study|Physician Decision|2|||
23442338|NCT00713544|65362048|FG000|Overall Study|Lack of Efficacy|0|||
23442339|NCT00713544|65362049|FG001|Overall Study|Lack of Efficacy|1|||
23442340|NCT00713544|65362050|FG002|Overall Study|Lack of Efficacy|0|||
23442341|NCT00713544|65362051|FG003|Overall Study|Lack of Efficacy|1|||
23442342|NCT00713544|65362052|FG004|Overall Study|Lack of Efficacy|1|||
23442343|NCT00713544|65362053|FG005|Overall Study|Lack of Efficacy|0|||
23442344|NCT00713544|65362048|FG000|Overall Study|Lost to Follow-up|0|||
23442345|NCT00713544|65362049|FG001|Overall Study|Lost to Follow-up|0|||
23442346|NCT00713544|65362050|FG002|Overall Study|Lost to Follow-up|1|||
23442347|NCT00713544|65362051|FG003|Overall Study|Lost to Follow-up|0|||
23442348|NCT00713544|65362052|FG004|Overall Study|Lost to Follow-up|0|||
23442349|NCT00713544|65362053|FG005|Overall Study|Lost to Follow-up|0|||
23442350|NCT00713544|65362048|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442351|NCT00713544|65362049|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
23442352|NCT00713544|65362050|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442353|NCT00713544|65362051|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442354|NCT00713544|65362052|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442355|NCT00713544|65362053|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442356|NCT00713544|65362048|FG000|Overall Study|Incorrect enrollment|0|||
23442357|NCT00713544|65362049|FG001|Overall Study|Incorrect enrollment|1|||
23442358|NCT00713544|65362050|FG002|Overall Study|Incorrect enrollment|0|||
23442359|NCT00713544|65362051|FG003|Overall Study|Incorrect enrollment|0|||
23442360|NCT00713544|65362052|FG004|Overall Study|Incorrect enrollment|0|||
23442361|NCT00713544|65362053|FG005|Overall Study|Incorrect enrollment|0|||
23442362|NCT00713544|65362048|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
23442363|NCT00713544|65362049|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
23442364|NCT00713544|65362050|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
23442365|NCT00713544|65362051|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
23442366|NCT00713544|65362052|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
23442367|NCT00713544|65362053|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
23442368|NCT03416127|65362054|FG000|Overall Study|Withdrawal by Subject|0|||
23627568|NCT01090011|66024503|FG000|Overall Study|Progressive disease|128|||
23627569|NCT01090011|66024503|FG000|Overall Study|Adverse Event|32|||
23627570|NCT01090011|66024503|FG000|Overall Study|Protocol Violation|1|||
23761428|NCT00686374|66505346|FG000|Overall Study|Withdrew consent|5|||
23761429|NCT00686374|66505346|FG000|Overall Study|Lost to Follow-up|1|||
23627571|NCT01090011|66024503|FG000|Overall Study|Refusal to start/continue medication|5|||
23761430|NCT00686374|66505346|FG000|Overall Study|Missing reason|33|||
23442369|NCT03416127|65362055|FG001|Overall Study|Withdrawal by Subject|1|||
23442370|NCT03416127|65362056|FG002|Overall Study|Withdrawal by Subject|1|||
23442371|NCT00532298|65362057|FG000|Overall Study|Adverse Event|1|||
23442372|NCT00532298|65362058|FG001|Overall Study|Adverse Event|0|||
23442373|NCT00532298|65362059|FG002|Overall Study|Adverse Event|0|||
23442374|NCT00532298|65362060|FG003|Overall Study|Adverse Event|0|||
23761431|NCT00686374|66505346|FG000|Overall Study|Other, not specified|4|||
23442375|NCT00532298|65362061|FG004|Overall Study|Adverse Event|1|||
23442376|NCT00532298|65362062|FG005|Overall Study|Adverse Event|1|||
23442377|NCT00532298|65362057|FG000|Overall Study|Lost to Follow-up|1|||
23442378|NCT00532298|65362058|FG001|Overall Study|Lost to Follow-up|1|||
23442379|NCT00532298|65362059|FG002|Overall Study|Lost to Follow-up|1|||
23442380|NCT00532298|65362060|FG003|Overall Study|Lost to Follow-up|0|||
23827938|NCT01147068|66749002|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23827939|NCT01147068|66749003|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23827940|NCT01147068|66749004|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23827941|NCT01147068|66748998|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827942|NCT01147068|66748999|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827943|NCT01147068|66749000|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827944|NCT01147068|66749001|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
23827945|NCT01147068|66749002|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827946|NCT01147068|66749003|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827947|NCT01147068|66749004|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23827948|NCT01147068|66748998|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
23827949|NCT01147068|66748999|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
23827950|NCT01147068|66749000|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
23827951|NCT01147068|66749001|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
23827952|NCT01147068|66749002|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
23827953|NCT01147068|66749003|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
23442381|NCT00532298|65362061|FG004|Overall Study|Lost to Follow-up|0|||
23442382|NCT00532298|65362062|FG005|Overall Study|Lost to Follow-up|1|||
23442383|NCT00103740|65362064|FG000|Period 1 - Core|Adverse Event|1|||
23442384|NCT00103740|65362065|FG001|Period 1 - Core|Adverse Event|0|||
23442385|NCT00103740|65362064|FG000|Period 1 - Core|Protocol Violation|3|||
23761432|NCT01827371|66505347|FG000|Overall Study|Adverse Event|0|||
23761433|NCT01827371|66505348|FG001|Overall Study|Adverse Event|0|||
23761434|NCT01827371|66505349|FG002|Overall Study|Adverse Event|4|||
23761435|NCT01827371|66505350|FG003|Overall Study|Adverse Event|2|||
23761436|NCT01827371|66505347|FG000|Overall Study|Lost to Follow-up|0|||
23761437|NCT01827371|66505348|FG001|Overall Study|Lost to Follow-up|2|||
23761438|NCT01827371|66505349|FG002|Overall Study|Lost to Follow-up|0|||
23761439|NCT01827371|66505350|FG003|Overall Study|Lost to Follow-up|4|||
23761440|NCT01827371|66505347|FG000|Overall Study|Protocol Violation|1|||
23442386|NCT00103740|65362065|FG001|Period 1 - Core|Protocol Violation|2|||
23442387|NCT00103740|65362064|FG000|Period 1 - Core|Patient withdrew consent|3|||
23442388|NCT00103740|65362065|FG001|Period 1 - Core|Patient withdrew consent|2|||
23442389|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
23442390|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
23442391|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
23442392|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
23442393|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
23442394|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
23442395|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Death|6|||
23442396|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Death|2|||
23442397|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
23442398|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
23442399|NCT00466921|65362068|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
23442400|NCT00466921|65362068|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
23442401|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
23442402|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
23442403|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
23442404|NCT00466921|65362068|FG000|Follow up for a Minimum of 1 Year|Death|6|||
23442405|NCT00847886|65362070|FG000|Overall Study|Adverse Event|0|||
23442406|NCT00847886|65362071|FG001|Overall Study|Adverse Event|1|||
23442407|NCT00719355|65362072|FG000|Overall Study|Death|0|||
23442408|NCT00719355|65362073|FG001|Overall Study|Death|1|||
23442409|NCT00719355|65362072|FG000|Overall Study|Medical|14|||
23442410|NCT00719355|65362073|FG001|Overall Study|Medical|5|||
23442411|NCT00719355|65362072|FG000|Overall Study|Compliance|4|||
23442412|NCT00719355|65362073|FG001|Overall Study|Compliance|6|||
23761441|NCT01827371|66505348|FG001|Overall Study|Protocol Violation|0|||
23761442|NCT01827371|66505349|FG002|Overall Study|Protocol Violation|0|||
23827954|NCT01147068|66749004|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
23827955|NCT01651117|66749005|FG000|Overall Study|Death|2|||
23442413|NCT00719355|65362072|FG000|Overall Study|Moved|0|||
23442414|NCT00719355|65362073|FG001|Overall Study|Moved|1|||
23442415|NCT03301350|65362074|FG000|Overall Study|Withdrawal by Subject|4|||
23442416|NCT03301350|65362074|FG000|Overall Study|Adverse Event|1|||
23761443|NCT01827371|66505350|FG003|Overall Study|Protocol Violation|0|||
23827956|NCT01651117|66749006|FG001|Overall Study|Death|3|||
23827957|NCT01651117|66749007|FG002|Overall Study|Death|2|||
23827958|NCT01651117|66749008|FG003|Overall Study|Death|2|||
23827959|NCT02094300|66749009|FG000|Overall Study|Death|7|||
23827960|NCT02094300|66749009|FG000|Overall Study|Lost to Follow-up|10|||
23827961|NCT02094300|66749009|FG000|Overall Study|Still be eligible for follow-up|3|||
23827962|NCT02601014|66749023|FG000|Overall Study|Adverse Event|3|||
23827963|NCT02601014|66749024|FG001|Overall Study|Adverse Event|3|||
23827964|NCT02601014|66749023|FG000|Overall Study|Death|3|||
23827965|NCT02601014|66749024|FG001|Overall Study|Death|1|||
23827966|NCT02601014|66749023|FG000|Overall Study|Disease progression|4|||
23827967|NCT02601014|66749024|FG001|Overall Study|Disease progression|8|||
23565413|NCT02961881|65799629|FG001|Overall Study|Disease progression|0|||
23565414|NCT02961881|65799630|FG002|Overall Study|Disease progression|1|||
23565415|NCT02961881|65799631|FG003|Overall Study|Disease progression|0|||
23565416|NCT02961881|65799632|FG004|Overall Study|Disease progression|0|||
23565417|NCT03002038|65799633|FG000|Overall Study|Adverse Event|3|||
23565418|NCT03002038|65799634|FG001|Overall Study|Adverse Event|1|||
23565419|NCT03002038|65799633|FG000|Overall Study|Withdrawal by Subject|8|||
23565420|NCT03002038|65799634|FG001|Overall Study|Withdrawal by Subject|4|||
23565421|NCT03002038|65799633|FG000|Overall Study|Immigration to another region|0|||
23565422|NCT03002038|65799634|FG001|Overall Study|Immigration to another region|2|||
23565423|NCT03406702|65799637|FG000|Overall Study|Missed Day 27 Dosing|1|||
23565424|NCT02002182|65799641|FG000|Overall Study|Withdraw from study|3|||
23565425|NCT02002182|65799642|FG001|Overall Study|Withdraw from study|1|||
23565426|NCT02002182|65799641|FG000|Overall Study|Health Reasons|1|||
23565427|NCT02002182|65799642|FG001|Overall Study|Health Reasons|0|||
23565428|NCT02002182|65799641|FG000|Overall Study|Death|1|||
23565429|NCT02002182|65799642|FG001|Overall Study|Death|0|||
23565430|NCT02714868|65799643|FG000|Overall Study|Withdrawal by Subject|3|||
23565431|NCT02714868|65799644|FG001|Overall Study|Withdrawal by Subject|0|||
23565432|NCT02714868|65799643|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
23565433|NCT02714868|65799644|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
23565434|NCT02714868|65799643|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
23565435|NCT02714868|65799644|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
23565436|NCT01054573|65799653|FG000|Overall Study|Adverse Event|1|||
23565437|NCT01054573|65799654|FG001|Overall Study|Adverse Event|0|||
23565438|NCT01054573|65799655|FG002|Overall Study|Adverse Event|1|||
23565439|NCT01054573|65799656|FG003|Overall Study|Adverse Event|1|||
23565440|NCT01054573|65799653|FG000|Overall Study|Lost to Follow-up|0|||
23565441|NCT01054573|65799654|FG001|Overall Study|Lost to Follow-up|2|||
23565442|NCT01054573|65799655|FG002|Overall Study|Lost to Follow-up|0|||
23565443|NCT01054573|65799656|FG003|Overall Study|Lost to Follow-up|0|||
23565444|NCT01054573|65799653|FG000|Overall Study|Withdrawal by Subject|0|||
23565445|NCT01054573|65799654|FG001|Overall Study|Withdrawal by Subject|2|||
23565446|NCT01054573|65799655|FG002|Overall Study|Withdrawal by Subject|2|||
23565447|NCT01054573|65799656|FG003|Overall Study|Withdrawal by Subject|1|||
23565448|NCT04704154|65799663|FG000|Overall Study|Adverse Event|2|||
23565449|NCT04704154|65799664|FG001|Overall Study|Adverse Event|1|||
23565450|NCT04704154|65799665|FG002|Overall Study|Adverse Event|3|||
23565451|NCT04704154|65799666|FG003|Overall Study|Adverse Event|2|||
23565452|NCT04704154|65799667|FG004|Overall Study|Adverse Event|3|||
23565453|NCT04704154|65799668|FG005|Overall Study|Adverse Event|0|||
23565454|NCT04704154|65799663|FG000|Overall Study|Death|3|||
23565455|NCT04704154|65799664|FG001|Overall Study|Death|0|||
23565456|NCT04704154|65799665|FG002|Overall Study|Death|0|||
23565457|NCT04704154|65799666|FG003|Overall Study|Death|0|||
23565458|NCT04704154|65799667|FG004|Overall Study|Death|3|||
23565459|NCT04704154|65799668|FG005|Overall Study|Death|0|||
23565460|NCT04704154|65799663|FG000|Overall Study|Physician Decision|1|||
23565461|NCT04704154|65799664|FG001|Overall Study|Physician Decision|0|||
23565462|NCT04704154|65799665|FG002|Overall Study|Physician Decision|0|||
23565463|NCT04704154|65799666|FG003|Overall Study|Physician Decision|0|||
23565464|NCT04704154|65799667|FG004|Overall Study|Physician Decision|1|||
23565465|NCT04704154|65799668|FG005|Overall Study|Physician Decision|0|||
23565466|NCT04704154|65799663|FG000|Overall Study|Participant Decision|1|||
23565467|NCT04704154|65799664|FG001|Overall Study|Participant Decision|1|||
23565468|NCT04704154|65799665|FG002|Overall Study|Participant Decision|0|||
23565469|NCT04704154|65799666|FG003|Overall Study|Participant Decision|0|||
23565470|NCT04704154|65799667|FG004|Overall Study|Participant Decision|0|||
23827968|NCT01396512|66749025|FG000|Overall Study|Withdrawal by Subject|0|||
23827969|NCT01396512|66749026|FG001|Overall Study|Withdrawal by Subject|1|||
23827970|NCT03288714|66749028|FG000|Overall Study|Lost to Follow-up|2|||
23565471|NCT04704154|65799668|FG005|Overall Study|Participant Decision|0|||
23565472|NCT04704154|65799663|FG000|Overall Study|Progressive Disease|16|||
23565473|NCT04704154|65799664|FG001|Overall Study|Progressive Disease|17|||
23565474|NCT04704154|65799665|FG002|Overall Study|Progressive Disease|20|||
23827971|NCT03288714|66749029|FG001|Overall Study|Lost to Follow-up|1|||
23827972|NCT03288714|66749028|FG000|Overall Study|Non-compliance with study schedule|2|||
23761444|NCT01827371|66505347|FG000|Overall Study|Withdrawal by Subject|1|||
23761445|NCT01827371|66505348|FG001|Overall Study|Withdrawal by Subject|2|||
23761446|NCT01827371|66505349|FG002|Overall Study|Withdrawal by Subject|2|||
23442417|NCT03301350|65362074|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
23442418|NCT03301350|65362074|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
23442419|NCT03301350|65362074|FG000|Overall Study|no detail provided|1|||
23442420|NCT00851786|65362075|FG000|Overall Study|Withdrawal by Subject|0|||
23442421|NCT00851786|65362076|FG001|Overall Study|Withdrawal by Subject|1|||
23442422|NCT00851786|65362075|FG000|Overall Study|Protocol Violation|0|||
23442423|NCT00851786|65362076|FG001|Overall Study|Protocol Violation|1|||
23442424|NCT00851786|65362075|FG000|Overall Study|Lost to Follow-up|1|||
23442425|NCT00851786|65362076|FG001|Overall Study|Lost to Follow-up|0|||
23761447|NCT01827371|66505350|FG003|Overall Study|Withdrawal by Subject|3|||
23761448|NCT01827371|66505347|FG000|Overall Study|Physician Decision|0|||
23761449|NCT01827371|66505348|FG001|Overall Study|Physician Decision|1|||
23761450|NCT01827371|66505349|FG002|Overall Study|Physician Decision|0|||
23761451|NCT01827371|66505350|FG003|Overall Study|Physician Decision|1|||
23442426|NCT00851786|65362075|FG000|Overall Study|Incarceration|1|||
23442427|NCT00851786|65362076|FG001|Overall Study|Incarceration|0|||
23442428|NCT00851786|65362075|FG000|Overall Study|Site Closure|1|||
23442429|NCT00851786|65362076|FG001|Overall Study|Site Closure|0|||
23442430|NCT00851786|65362075|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
23442431|NCT00851786|65362076|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
23442432|NCT00742183|65362077|FG000|Overall Study|Adverse Event|2|||
23442433|NCT00742183|65362078|FG001|Overall Study|Adverse Event|2|||
23442434|NCT00742183|65362077|FG000|Overall Study|Death|1|||
23442435|NCT00742183|65362078|FG001|Overall Study|Death|0|||
23442436|NCT00742183|65362077|FG000|Overall Study|Physician Decision|0|||
23442437|NCT00742183|65362078|FG001|Overall Study|Physician Decision|2|||
23442438|NCT00742183|65362077|FG000|Overall Study|Lost to Follow-up|4|||
23442439|NCT00742183|65362078|FG001|Overall Study|Lost to Follow-up|4|||
23442440|NCT00742183|65362077|FG000|Overall Study|Required skin-graft|1|||
23442441|NCT00742183|65362078|FG001|Overall Study|Required skin-graft|1|||
23442442|NCT00742183|65362077|FG000|Overall Study|Withdrawal by Subject|1|||
23442443|NCT00742183|65362078|FG001|Overall Study|Withdrawal by Subject|0|||
23442444|NCT00742183|65362077|FG000|Overall Study|Lack of Efficacy|0|||
23442445|NCT00742183|65362078|FG001|Overall Study|Lack of Efficacy|3|||
23442446|NCT03671304|65362079|FG000|Overall Study|study terminated|7|||
23442447|NCT03387020|65362080|FG000|Overall Study|Adverse Event|0|||
23442448|NCT03387020|65362081|FG001|Overall Study|Adverse Event|2|||
23442449|NCT03387020|65362082|FG002|Overall Study|Adverse Event|0|||
23442450|NCT03387020|65362080|FG000|Overall Study|Withdrawal by Subject|2|||
23442451|NCT03387020|65362081|FG001|Overall Study|Withdrawal by Subject|0|||
23442452|NCT03387020|65362082|FG002|Overall Study|Withdrawal by Subject|0|||
23442453|NCT00991939|65362083|FG000|Overall Study|Lost to Follow-up|0|||
23442454|NCT00991939|65362084|FG001|Overall Study|Lost to Follow-up|1|||
23442455|NCT00991939|65362083|FG000|Overall Study|Withdrawal by Subject|1|||
23442456|NCT00991939|65362084|FG001|Overall Study|Withdrawal by Subject|0|||
23442457|NCT00991939|65362083|FG000|Overall Study|Entire study terminated|4|||
23442458|NCT00991939|65362084|FG001|Overall Study|Entire study terminated|1|||
23442459|NCT00348673|65362085|FG000|Stage 1|Randomized but not Treated|0|||
23442460|NCT00348673|65362086|FG001|Stage 1|Randomized but not Treated|0|||
23442461|NCT00348673|65362087|FG002|Stage 1|Randomized but not Treated|1|||
23442462|NCT00348673|65362088|FG003|Stage 1|Randomized but not Treated|0|||
23565475|NCT04704154|65799666|FG003|Overall Study|Progressive Disease|18|||
23565476|NCT04704154|65799667|FG004|Overall Study|Progressive Disease|36|||
23442463|NCT00348673|65362089|FG004|Stage 1|Randomized but not Treated|0|||
23442464|NCT00348673|65362090|FG005|Stage 1|Randomized but not Treated|0|||
23442465|NCT00348673|65362091|FG006|Stage 1|Randomized but not Treated|0|||
23442466|NCT00348673|65362092|FG007|Stage 1|Randomized but not Treated|0|||
23565477|NCT04704154|65799668|FG005|Overall Study|Progressive Disease|30|||
23565478|NCT04704154|65799663|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565479|NCT04704154|65799664|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565480|NCT04704154|65799665|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565481|NCT04704154|65799666|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565482|NCT04704154|65799667|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
23565483|NCT04704154|65799668|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565484|NCT01350141|65799669|FG000|Overall Study|Lost to Follow-up|1|||
23565485|NCT01350141|65799670|FG001|Overall Study|Lost to Follow-up|0|||
23565486|NCT01350141|65799671|FG002|Overall Study|Lost to Follow-up|1|||
23565487|NCT01350141|65799669|FG000|Overall Study|Withdrawal by Subject|1|||
23565488|NCT01350141|65799670|FG001|Overall Study|Withdrawal by Subject|0|||
23627572|NCT01090011|66024503|FG000|Overall Study|Other reason not defined above|5|||
23627573|NCT04411186|66024504|FG000|Overall Study|Withdrawn due to protocol violation|0|||
23627574|NCT04411186|66024505|FG001|Overall Study|Withdrawn due to protocol violation|1|||
23627575|NCT01657799|66024506|FG000|Overall Study|Adverse Event Related to progression|6|||
23627576|NCT01657799|66024507|FG001|Overall Study|Adverse Event Related to progression|8|||
23627577|NCT01657799|66024508|FG002|Overall Study|Adverse Event Related to progression|12|||
23627578|NCT01657799|66024506|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
23627579|NCT01657799|66024507|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
23627580|NCT01657799|66024508|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
23627581|NCT01657799|66024506|FG000|Overall Study|Withdrawal by Subject|13|||
23627582|NCT01657799|66024507|FG001|Overall Study|Withdrawal by Subject|10|||
23627583|NCT01657799|66024508|FG002|Overall Study|Withdrawal by Subject|10|||
23627584|NCT01657799|66024506|FG000|Overall Study|Lost to Follow-up|1|||
23627585|NCT01657799|66024507|FG001|Overall Study|Lost to Follow-up|0|||
23627586|NCT01657799|66024508|FG002|Overall Study|Lost to Follow-up|1|||
23627587|NCT01657799|66024506|FG000|Overall Study|Disease Progression|2|||
23627588|NCT01657799|66024507|FG001|Overall Study|Disease Progression|4|||
23627589|NCT01657799|66024508|FG002|Overall Study|Disease Progression|4|||
23627590|NCT01657799|66024506|FG000|Overall Study|Progressive Disease Clinical|7|||
23627591|NCT01657799|66024507|FG001|Overall Study|Progressive Disease Clinical|4|||
23627592|NCT01657799|66024508|FG002|Overall Study|Progressive Disease Clinical|7|||
23627593|NCT01657799|66024506|FG000|Overall Study|Radiographic & Clinical Progression|16|||
23627594|NCT01657799|66024507|FG001|Overall Study|Radiographic & Clinical Progression|11|||
23627595|NCT01657799|66024508|FG002|Overall Study|Radiographic & Clinical Progression|15|||
23627596|NCT01657799|66024506|FG000|Overall Study|Other|52|||
23627597|NCT01657799|66024507|FG001|Overall Study|Other|62|||
23627598|NCT01657799|66024508|FG002|Overall Study|Other|49|||
23627599|NCT00013611|66024513|FG000|Overall Study|Lost to Follow-up|91|||
23627600|NCT00013611|66024514|FG001|Overall Study|Lost to Follow-up|100|||
23627601|NCT00891046|66024515|FG000|Overall Study|Protocol Violation|1|||
23627602|NCT00891046|66024516|FG001|Overall Study|Protocol Violation|1|||
23627603|NCT00891046|66024517|FG002|Overall Study|Protocol Violation|0|||
23627604|NCT00891046|66024518|FG003|Overall Study|Protocol Violation|0|||
23627605|NCT00891046|66024519|FG004|Overall Study|Protocol Violation|1|||
23627606|NCT00891046|66024515|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23627607|NCT00891046|66024516|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23627608|NCT00891046|66024517|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
23627609|NCT00891046|66024518|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23627610|NCT00891046|66024519|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
23627611|NCT00891046|66024515|FG000|Overall Study|Administrative problems|0|||
23627612|NCT00891046|66024516|FG001|Overall Study|Administrative problems|0|||
23627613|NCT00891046|66024517|FG002|Overall Study|Administrative problems|0|||
23627614|NCT00891046|66024518|FG003|Overall Study|Administrative problems|0|||
23627615|NCT00891046|66024519|FG004|Overall Study|Administrative problems|1|||
23627616|NCT00891046|66024515|FG000|Overall Study|Participant no longer required drug|0|||
23627617|NCT00891046|66024516|FG001|Overall Study|Participant no longer required drug|2|||
23627618|NCT00891046|66024517|FG002|Overall Study|Participant no longer required drug|0|||
23627619|NCT00891046|66024518|FG003|Overall Study|Participant no longer required drug|0|||
23627620|NCT00891046|66024519|FG004|Overall Study|Participant no longer required drug|1|||
23627621|NCT00891046|66024515|FG000|Overall Study|Adverse Event|4|||
23627622|NCT00891046|66024516|FG001|Overall Study|Adverse Event|3|||
23627623|NCT00891046|66024517|FG002|Overall Study|Adverse Event|2|||
23627624|NCT00891046|66024518|FG003|Overall Study|Adverse Event|0|||
23627625|NCT00891046|66024519|FG004|Overall Study|Adverse Event|14|||
23627626|NCT00891046|66024515|FG000|Overall Study|Withdrawal by Subject|2|||
23627627|NCT00891046|66024516|FG001|Overall Study|Withdrawal by Subject|1|||
23627628|NCT00891046|66024517|FG002|Overall Study|Withdrawal by Subject|2|||
23627629|NCT00891046|66024518|FG003|Overall Study|Withdrawal by Subject|1|||
23627630|NCT00891046|66024519|FG004|Overall Study|Withdrawal by Subject|1|||
23627631|NCT00891046|66024515|FG000|Overall Study|Lost to Follow-up|0|||
23627632|NCT00891046|66024516|FG001|Overall Study|Lost to Follow-up|0|||
23627633|NCT00891046|66024517|FG002|Overall Study|Lost to Follow-up|0|||
23761452|NCT01827371|66505347|FG000|Overall Study|Temporary study halt to vaccinations|11|||
23761453|NCT01827371|66505348|FG001|Overall Study|Temporary study halt to vaccinations|2|||
23761454|NCT01827371|66505349|FG002|Overall Study|Temporary study halt to vaccinations|5|||
23761455|NCT01827371|66505350|FG003|Overall Study|Temporary study halt to vaccinations|13|||
23761456|NCT01456052|66505351|FG000|Overall Study|Adverse Event|1|||
23627634|NCT00891046|66024518|FG003|Overall Study|Lost to Follow-up|0|||
23627635|NCT00891046|66024519|FG004|Overall Study|Lost to Follow-up|1|||
23627636|NCT00030823|66024520|FG000|Overall Study|Withdrawal by Subject|1|||
23627637|NCT02367352|66024525|FG000|Overall Study|Progressive disease|7|||
23627638|NCT02367352|66024526|FG001|Overall Study|Progressive disease|0|||
23627639|NCT02367352|66024527|FG002|Overall Study|Progressive disease|0|||
23761457|NCT01456052|66505352|FG001|Overall Study|Adverse Event|1|||
23627640|NCT02367352|66024525|FG000|Overall Study|Participant Received Alternative Therapy|1|||
23761458|NCT01456052|66505353|FG002|Overall Study|Adverse Event|2|||
23761459|NCT01456052|66505351|FG000|Overall Study|Consent withdrawn|0|||
23761460|NCT01456052|66505352|FG001|Overall Study|Consent withdrawn|2|||
23761461|NCT01456052|66505353|FG002|Overall Study|Consent withdrawn|1|||
23761462|NCT01456052|66505351|FG000|Overall Study|Protocol Violation|0|||
23761463|NCT01456052|66505352|FG001|Overall Study|Protocol Violation|1|||
23761464|NCT01456052|66505353|FG002|Overall Study|Protocol Violation|0|||
23761465|NCT01456052|66505351|FG000|Overall Study|Physician Decision|1|||
23761466|NCT01456052|66505352|FG001|Overall Study|Physician Decision|0|||
23761467|NCT01456052|66505353|FG002|Overall Study|Physician Decision|1|||
23761468|NCT01456052|66505351|FG000|Overall Study|Treatment Failure|0|||
23761469|NCT01456052|66505352|FG001|Overall Study|Treatment Failure|1|||
23761470|NCT01456052|66505353|FG002|Overall Study|Treatment Failure|1|||
23761471|NCT01835132|66505356|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
23761472|NCT00409578|66505357|FG000|Overall Study|Adverse Event|27|||
23761473|NCT00409578|66505358|FG001|Overall Study|Adverse Event|37|||
23761474|NCT00409578|66505359|FG002|Overall Study|Adverse Event|25|||
23827973|NCT03288714|66749029|FG001|Overall Study|Non-compliance with study schedule|0|||
23827974|NCT03288714|66749028|FG000|Overall Study|Withdrawal by Subject|3|||
23627641|NCT02367352|66024526|FG001|Overall Study|Participant Received Alternative Therapy|0|||
23627642|NCT02367352|66024527|FG002|Overall Study|Participant Received Alternative Therapy|0|||
23627643|NCT02367352|66024525|FG000|Overall Study|Adverse Event|1|||
23627644|NCT02367352|66024526|FG001|Overall Study|Adverse Event|0|||
23627645|NCT02367352|66024527|FG002|Overall Study|Adverse Event|0|||
23627646|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
23627647|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
23627648|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
23627649|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
23627650|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
23827975|NCT03288714|66749029|FG001|Overall Study|Withdrawal by Subject|1|||
23827976|NCT03288714|66749028|FG000|Overall Study|Clinical Worsening|2|||
23827977|NCT03288714|66749029|FG001|Overall Study|Clinical Worsening|1|||
23827978|NCT03288714|66749028|FG000|Overall Study|Adverse Event|1|||
23627651|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
23627652|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Missing|2|||
23627653|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Missing|2|||
23627654|NCT02659098|66024530|FG000|Overall Study|Withdrawal by Subject|7|||
23627655|NCT03713320|66024531|FG000|Randomized Period|Adverse Event|1|||
23627656|NCT03713320|66024532|FG001|Randomized Period|Adverse Event|5|||
23627657|NCT03713320|66024533|FG002|Randomized Period|Adverse Event|0|||
23627658|NCT03713320|66024531|FG000|Randomized Period|Physician Decision|1|||
23627659|NCT03713320|66024532|FG001|Randomized Period|Physician Decision|1|||
23627660|NCT03713320|66024533|FG002|Randomized Period|Physician Decision|0|||
23627661|NCT03713320|66024531|FG000|Randomized Period|Withdrawal by Subject|4|||
23627662|NCT03713320|66024532|FG001|Randomized Period|Withdrawal by Subject|0|||
23627663|NCT03713320|66024533|FG002|Randomized Period|Withdrawal by Subject|0|||
23627664|NCT03713320|66024531|FG000|Randomized Period|Participant decision|3|||
23627665|NCT03713320|66024532|FG001|Randomized Period|Participant decision|1|||
23627666|NCT03713320|66024533|FG002|Randomized Period|Participant decision|0|||
23627667|NCT03713320|66024531|FG000|Randomized Period|Study terminated by sponsor|6|||
23627668|NCT03713320|66024532|FG001|Randomized Period|Study terminated by sponsor|3|||
23627669|NCT03713320|66024533|FG002|Randomized Period|Study terminated by sponsor|0|||
23627670|NCT03713320|66024531|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
23627671|NCT03713320|66024532|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
23627672|NCT03713320|66024533|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
23827979|NCT03288714|66749029|FG001|Overall Study|Adverse Event|0|||
23827980|NCT01547390|66749030|FG000|Overall Study|Withdrawal by Subject|10|||
23827981|NCT01547390|66749031|FG001|Overall Study|Withdrawal by Subject|7|||
23627673|NCT03713320|66024531|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
23627674|NCT03713320|66024532|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
23627675|NCT03713320|66024533|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
23627676|NCT04952701|66024534|FG000|Control Lens|Physician Decision|4|||
23627677|NCT04952701|66024534|FG000|Test Lens|Physician Decision|1|||
23627678|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
23761475|NCT00409578|66505360|FG003|Overall Study|Adverse Event|33|||
23761476|NCT00409578|66505357|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23761477|NCT00409578|66505358|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23827982|NCT01547390|66749030|FG000|Overall Study|termination of pregnancy|0|||
23827983|NCT01547390|66749031|FG001|Overall Study|termination of pregnancy|1|||
23627679|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
23627680|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
23627681|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
23627682|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
23827984|NCT01547390|66749030|FG000|Overall Study|Lost to Follow-up|0|||
23761478|NCT00409578|66505359|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23565489|NCT01350141|65799671|FG002|Overall Study|Withdrawal by Subject|0|||
23565490|NCT01350141|65799669|FG000|Overall Study|Randomized but not treated|1|||
23565491|NCT01350141|65799670|FG001|Overall Study|Randomized but not treated|0|||
23565492|NCT01350141|65799671|FG002|Overall Study|Randomized but not treated|0|||
23565493|NCT00861614|65799672|FG000|Overall Study|Disease Progression|182|||
23565494|NCT00861614|65799673|FG001|Overall Study|Disease Progression|263|||
23565495|NCT00861614|65799672|FG000|Overall Study|Study Drug Toxicity|79|||
23565496|NCT00861614|65799673|FG001|Overall Study|Study Drug Toxicity|6|||
23565497|NCT00861614|65799672|FG000|Overall Study|Death|32|||
23565498|NCT00861614|65799673|FG001|Overall Study|Death|19|||
23565499|NCT00861614|65799672|FG000|Overall Study|Adverse Event|27|||
23565500|NCT00861614|65799673|FG001|Overall Study|Adverse Event|23|||
23565501|NCT00861614|65799672|FG000|Overall Study|Withdrawal by Subject|34|||
23565502|NCT00861614|65799673|FG001|Overall Study|Withdrawal by Subject|35|||
23565503|NCT00861614|65799672|FG000|Overall Study|Other|17|||
23565504|NCT00861614|65799673|FG001|Overall Study|Other|22|||
23565505|NCT03363659|65799674|FG000|Overall Study|Adverse Event|1|||
23565506|NCT03363659|65799674|FG000|Overall Study|Screen fail|1|||
23565507|NCT03363659|65799674|FG000|Overall Study|Withdrawal by Subject|1|||
23565508|NCT02798211|65799676|FG000|Period 1|Adverse Event|1|||
23565509|NCT02798211|65799677|FG001|Period 1|Adverse Event|1|||
23565510|NCT02798211|65799678|FG002|Period 1|Adverse Event|0|||
23565511|NCT02798211|65799679|FG003|Period 1|Adverse Event|0|||
23565512|NCT02798211|65799680|FG004|Period 1|Adverse Event|0|||
23565513|NCT02798211|65799681|FG005|Period 1|Adverse Event|0|||
23565514|NCT02798211|65799676|FG000|Period 1|Lost to Follow-up|2|||
23565515|NCT02798211|65799677|FG001|Period 1|Lost to Follow-up|1|||
23565516|NCT02798211|65799678|FG002|Period 1|Lost to Follow-up|0|||
23565517|NCT02798211|65799679|FG003|Period 1|Lost to Follow-up|0|||
23565518|NCT02798211|65799680|FG004|Period 1|Lost to Follow-up|0|||
23565519|NCT02798211|65799681|FG005|Period 1|Lost to Follow-up|0|||
23565520|NCT02798211|65799676|FG000|Period 1|Protocol Violation|0|||
23565521|NCT02798211|65799677|FG001|Period 1|Protocol Violation|0|||
23565522|NCT02798211|65799678|FG002|Period 1|Protocol Violation|2|||
23565523|NCT02798211|65799679|FG003|Period 1|Protocol Violation|0|||
23565524|NCT02798211|65799680|FG004|Period 1|Protocol Violation|0|||
23565525|NCT02798211|65799681|FG005|Period 1|Protocol Violation|0|||
23565526|NCT02798211|65799676|FG000|Period 1|Withdrawal by Subject|1|||
23565527|NCT02798211|65799677|FG001|Period 1|Withdrawal by Subject|1|||
23565528|NCT02798211|65799678|FG002|Period 1|Withdrawal by Subject|0|||
23565529|NCT02798211|65799679|FG003|Period 1|Withdrawal by Subject|0|||
23565530|NCT02798211|65799680|FG004|Period 1|Withdrawal by Subject|0|||
23565531|NCT02798211|65799681|FG005|Period 1|Withdrawal by Subject|0|||
23565532|NCT02798211|65799676|FG000|Period 1|Death|0|||
23761479|NCT00409578|66505360|FG003|Overall Study|Abnormal laboratory value(s)|4|||
23761480|NCT00409578|66505357|FG000|Overall Study|Lack of Efficacy|0|||
23761481|NCT00409578|66505358|FG001|Overall Study|Lack of Efficacy|0|||
23761482|NCT00409578|66505359|FG002|Overall Study|Lack of Efficacy|0|||
23761483|NCT00409578|66505360|FG003|Overall Study|Lack of Efficacy|2|||
23761484|NCT00409578|66505357|FG000|Overall Study|Subject no longer requires study drug|0|||
23761485|NCT00409578|66505358|FG001|Overall Study|Subject no longer requires study drug|0|||
23761486|NCT00409578|66505359|FG002|Overall Study|Subject no longer requires study drug|0|||
23761487|NCT00409578|66505360|FG003|Overall Study|Subject no longer requires study drug|1|||
23761488|NCT00409578|66505357|FG000|Overall Study|Withdrawal by Subject|8|||
23761489|NCT00409578|66505358|FG001|Overall Study|Withdrawal by Subject|15|||
23761490|NCT00409578|66505359|FG002|Overall Study|Withdrawal by Subject|16|||
23761491|NCT00409578|66505360|FG003|Overall Study|Withdrawal by Subject|17|||
23761492|NCT00409578|66505357|FG000|Overall Study|Lost to Follow-up|2|||
23761493|NCT00409578|66505358|FG001|Overall Study|Lost to Follow-up|0|||
23761494|NCT00409578|66505359|FG002|Overall Study|Lost to Follow-up|2|||
23761495|NCT00409578|66505360|FG003|Overall Study|Lost to Follow-up|2|||
23761496|NCT00409578|66505357|FG000|Overall Study|Administrative problems|8|||
23761497|NCT00409578|66505358|FG001|Overall Study|Administrative problems|9|||
23761498|NCT00409578|66505359|FG002|Overall Study|Administrative problems|2|||
23761499|NCT00409578|66505360|FG003|Overall Study|Administrative problems|4|||
23761500|NCT00409578|66505357|FG000|Overall Study|Death|2|||
23761501|NCT00409578|66505358|FG001|Overall Study|Death|4|||
23761502|NCT00409578|66505359|FG002|Overall Study|Death|4|||
23761503|NCT00409578|66505360|FG003|Overall Study|Death|2|||
23761504|NCT00409578|66505357|FG000|Overall Study|Protocol Violation|3|||
23761505|NCT00409578|66505358|FG001|Overall Study|Protocol Violation|2|||
23761506|NCT00409578|66505359|FG002|Overall Study|Protocol Violation|3|||
23761507|NCT00409578|66505360|FG003|Overall Study|Protocol Violation|1|||
23761508|NCT00409578|66505357|FG000|Overall Study|Missing|0|||
23761509|NCT00409578|66505358|FG001|Overall Study|Missing|1|||
23761510|NCT00409578|66505359|FG002|Overall Study|Missing|0|||
23761511|NCT00409578|66505360|FG003|Overall Study|Missing|1|||
23827985|NCT01547390|66749031|FG001|Overall Study|Lost to Follow-up|2|||
23827986|NCT01547390|66749030|FG000|Overall Study|Adverse Event|3|||
23827987|NCT01547390|66749031|FG001|Overall Study|Adverse Event|0|||
23627683|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
23627684|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
23627685|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
23627686|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
23627687|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
23627688|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
23761512|NCT01792284|66505361|FG000|Lead-in Period|Adverse Event|15|||
23761513|NCT01792284|66505362|FG001|Lead-in Period|Adverse Event|0|||
23761514|NCT01792284|66505363|FG002|Lead-in Period|Adverse Event|0|||
23761515|NCT01792284|66505361|FG000|Lead-in Period|Lost to Follow-up|2|||
23761516|NCT01792284|66505362|FG001|Lead-in Period|Lost to Follow-up|0|||
23761517|NCT01792284|66505363|FG002|Lead-in Period|Lost to Follow-up|0|||
23761518|NCT01792284|66505361|FG000|Lead-in Period|Protocol Violation|1|||
23761519|NCT01792284|66505362|FG001|Lead-in Period|Protocol Violation|0|||
23761520|NCT01792284|66505363|FG002|Lead-in Period|Protocol Violation|0|||
23761521|NCT01792284|66505361|FG000|Lead-in Period|Withdrawal by Subject|10|||
23761522|NCT01792284|66505362|FG001|Lead-in Period|Withdrawal by Subject|0|||
23761523|NCT01792284|66505363|FG002|Lead-in Period|Withdrawal by Subject|0|||
23761524|NCT01792284|66505361|FG000|Lead-in Period|Physician Decision|1|||
23761525|NCT01792284|66505362|FG001|Lead-in Period|Physician Decision|0|||
23761526|NCT01792284|66505363|FG002|Lead-in Period|Physician Decision|0|||
23761527|NCT01792284|66505361|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
23761528|NCT01792284|66505362|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
23761529|NCT01792284|66505363|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
23761530|NCT01792284|66505361|FG000|Randomization Period 1|Withdrawal by Subject|0|||
23761531|NCT01792284|66505362|FG001|Randomization Period 1|Withdrawal by Subject|1|||
23761532|NCT01792284|66505363|FG002|Randomization Period 1|Withdrawal by Subject|1|||
23761533|NCT01792284|66505361|FG000|Randomization Period 1|Physician Decision|0|||
23761534|NCT01792284|66505362|FG001|Randomization Period 1|Physician Decision|1|||
23761535|NCT01792284|66505363|FG002|Randomization Period 1|Physician Decision|1|||
23761536|NCT01792284|66505361|FG000|Randomization Period 1|Adverse Event|0|||
23761537|NCT01792284|66505362|FG001|Randomization Period 1|Adverse Event|0|||
23761538|NCT01792284|66505363|FG002|Randomization Period 1|Adverse Event|2|||
23761539|NCT01792284|66505361|FG000|Randomization Period 1|Lost to Follow-up|0|||
23761540|NCT01792284|66505362|FG001|Randomization Period 1|Lost to Follow-up|0|||
23761541|NCT01792284|66505363|FG002|Randomization Period 1|Lost to Follow-up|1|||
23761542|NCT01792284|66505361|FG000|Randomization Period 2|Protocol Violation|0|||
23761543|NCT01792284|66505362|FG001|Randomization Period 2|Protocol Violation|1|||
23761544|NCT01792284|66505363|FG002|Randomization Period 2|Protocol Violation|0|||
23761545|NCT01792284|66505361|FG000|Randomization Period 2|Withdrawal by Subject|0|||
23761546|NCT01792284|66505362|FG001|Randomization Period 2|Withdrawal by Subject|2|||
23761547|NCT01792284|66505363|FG002|Randomization Period 2|Withdrawal by Subject|0|||
23761548|NCT00437281|66505364|FG000|Overall Study|Adverse Event|0|||
23761549|NCT00437281|66505365|FG001|Overall Study|Adverse Event|0|||
23761550|NCT00437281|66505366|FG002|Overall Study|Adverse Event|0|||
23761551|NCT00437281|66505367|FG003|Overall Study|Adverse Event|1|||
23761552|NCT00437281|66505368|FG004|Overall Study|Adverse Event|0|||
23761553|NCT00437281|66505369|FG005|Overall Study|Adverse Event|1|||
23761554|NCT00437281|66505370|FG006|Overall Study|Adverse Event|0|||
23761555|NCT00437281|66505371|FG007|Overall Study|Adverse Event|0|||
23761556|NCT00437281|66505372|FG008|Overall Study|Adverse Event|0|||
23761557|NCT00437281|66505373|FG009|Overall Study|Adverse Event|1|||
23761558|NCT00437281|66505374|FG010|Overall Study|Adverse Event|0|||
23761559|NCT00437281|66505375|FG011|Overall Study|Adverse Event|0|||
23761560|NCT00437281|66505376|FG012|Overall Study|Adverse Event|0|||
23761561|NCT00437281|66505377|FG013|Overall Study|Adverse Event|1|||
23761562|NCT00437281|66505378|FG014|Overall Study|Adverse Event|1|||
23761563|NCT00437281|66505379|FG015|Overall Study|Adverse Event|0|||
23761564|NCT00437281|66505380|FG016|Overall Study|Adverse Event|0|||
23761565|NCT00437281|66505381|FG017|Overall Study|Adverse Event|0|||
23761566|NCT00437281|66505382|FG018|Overall Study|Adverse Event|1|||
23761567|NCT00437281|66505383|FG019|Overall Study|Adverse Event|0|||
23761568|NCT00437281|66505364|FG000|Overall Study|Lost to Follow-up|0|||
23761569|NCT00437281|66505365|FG001|Overall Study|Lost to Follow-up|0|||
23761570|NCT00437281|66505366|FG002|Overall Study|Lost to Follow-up|0|||
23761571|NCT00437281|66505367|FG003|Overall Study|Lost to Follow-up|0|||
23761572|NCT00437281|66505368|FG004|Overall Study|Lost to Follow-up|0|||
23761573|NCT00437281|66505369|FG005|Overall Study|Lost to Follow-up|0|||
23761574|NCT00437281|66505370|FG006|Overall Study|Lost to Follow-up|0|||
23827988|NCT01526655|66749032|FG000|Overall Study|Withdrawal by Subject|0|||
23761575|NCT00437281|66505371|FG007|Overall Study|Lost to Follow-up|0|||
23761576|NCT00437281|66505372|FG008|Overall Study|Lost to Follow-up|0|||
23761577|NCT00437281|66505373|FG009|Overall Study|Lost to Follow-up|0|||
23761578|NCT00437281|66505374|FG010|Overall Study|Lost to Follow-up|0|||
23761579|NCT00437281|66505375|FG011|Overall Study|Lost to Follow-up|0|||
23761580|NCT00437281|66505376|FG012|Overall Study|Lost to Follow-up|0|||
23761581|NCT00437281|66505377|FG013|Overall Study|Lost to Follow-up|0|||
23761582|NCT00437281|66505378|FG014|Overall Study|Lost to Follow-up|0|||
23761583|NCT00437281|66505379|FG015|Overall Study|Lost to Follow-up|0|||
23761584|NCT00437281|66505380|FG016|Overall Study|Lost to Follow-up|0|||
23761585|NCT00437281|66505381|FG017|Overall Study|Lost to Follow-up|0|||
23761586|NCT00437281|66505382|FG018|Overall Study|Lost to Follow-up|0|||
23761587|NCT00437281|66505383|FG019|Overall Study|Lost to Follow-up|1|||
23761588|NCT00323609|66505390|FG000|Overall Study|Death|16|||
23761589|NCT00323609|66505391|FG001|Overall Study|Death|21|||
23761590|NCT00323609|66505392|FG002|Overall Study|Death|0|||
23761591|NCT00323609|66505393|FG003|Overall Study|Death|0|||
23761592|NCT00323609|66505390|FG000|Overall Study|Lost to Follow-up|9|||
23761593|NCT00323609|66505391|FG001|Overall Study|Lost to Follow-up|10|||
23761594|NCT00323609|66505392|FG002|Overall Study|Lost to Follow-up|0|||
23761595|NCT00323609|66505393|FG003|Overall Study|Lost to Follow-up|0|||
23761596|NCT00323609|66505390|FG000|Overall Study|Physician Decision|2|||
23761597|NCT00323609|66505391|FG001|Overall Study|Physician Decision|0|||
23761598|NCT00323609|66505392|FG002|Overall Study|Physician Decision|0|||
23761599|NCT00323609|66505393|FG003|Overall Study|Physician Decision|1|||
23761600|NCT00323609|66505390|FG000|Overall Study|Withdrawal by Subject|11|||
23761601|NCT00323609|66505391|FG001|Overall Study|Withdrawal by Subject|23|||
23761602|NCT00323609|66505392|FG002|Overall Study|Withdrawal by Subject|4|||
23761603|NCT00323609|66505393|FG003|Overall Study|Withdrawal by Subject|4|||
23761604|NCT00323609|66505390|FG000|Overall Study|Other non-VCF-related medical condition|3|||
23761605|NCT00323609|66505391|FG001|Overall Study|Other non-VCF-related medical condition|2|||
23761606|NCT00323609|66505392|FG002|Overall Study|Other non-VCF-related medical condition|0|||
23761607|NCT00323609|66505393|FG003|Overall Study|Other non-VCF-related medical condition|0|||
23761608|NCT00323609|66505390|FG000|Overall Study|Sponsor discontinued trial|29|||
23761609|NCT00323609|66505391|FG001|Overall Study|Sponsor discontinued trial|29|||
23761610|NCT00323609|66505392|FG002|Overall Study|Sponsor discontinued trial|0|||
23761611|NCT00323609|66505393|FG003|Overall Study|Sponsor discontinued trial|0|||
23761612|NCT00323609|66505390|FG000|Overall Study|Unrelenting or severe back pain|1|||
23761613|NCT00323609|66505391|FG001|Overall Study|Unrelenting or severe back pain|1|||
23761614|NCT00323609|66505392|FG002|Overall Study|Unrelenting or severe back pain|0|||
23761615|NCT00323609|66505393|FG003|Overall Study|Unrelenting or severe back pain|0|||
23761616|NCT00323609|66505390|FG000|Overall Study|Logistical withdrawal|9|||
23761617|NCT00323609|66505391|FG001|Overall Study|Logistical withdrawal|5|||
23761618|NCT00323609|66505392|FG002|Overall Study|Logistical withdrawal|0|||
23761619|NCT00323609|66505393|FG003|Overall Study|Logistical withdrawal|1|||
23761620|NCT00323609|66505390|FG000|Overall Study|Other reason|11|||
23761621|NCT00323609|66505391|FG001|Overall Study|Other reason|8|||
23761622|NCT00323609|66505392|FG002|Overall Study|Other reason|4|||
23761623|NCT00323609|66505393|FG003|Overall Study|Other reason|9|||
23761624|NCT02290028|66505394|FG000|Overall Study|Death|217|||
23761625|NCT02290028|66505394|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
23761626|NCT02290028|66505394|FG000|Overall Study|No longer under care of study physician|76|||
23761627|NCT02290028|66505394|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
23761628|NCT02290028|66505394|FG000|Overall Study|Withdrawal by Subject|52|||
23761629|NCT02290028|66505394|FG000|Overall Study|Study site closure|44|||
23761630|NCT02290028|66505394|FG000|Overall Study|Lost to Follow-up|34|||
23761631|NCT02290028|66505394|FG000|Overall Study|Miscellaneous|10|||
23761632|NCT02290028|66505394|FG000|Overall Study|Transition to EP PASSION|1295|||
23761633|NCT02290028|66505394|FG000|Overall Study|Planned study completion at 12 months|257|||
23761634|NCT02328547|66505397|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
23761635|NCT02328547|66505398|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
23761636|NCT02328547|66505397|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
23761637|NCT02328547|66505398|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23761638|NCT01388647|66505402|FG000|Overall Study|Adverse Event|1|||
23761639|NCT01388647|66505403|FG001|Overall Study|Adverse Event|2|||
23761640|NCT00068237|66505404|FG000|Overall Study|Ineligible|3|||
23761641|NCT00068237|66505404|FG000|Overall Study|No protocol treatment received|2|||
23761642|NCT02622074|66505405|FG000|Overall Study|Death|4|||
23761643|NCT02622074|66505406|FG001|Overall Study|Death|0|||
23761644|NCT02622074|66505407|FG002|Overall Study|Death|0|||
23761645|NCT02622074|66505408|FG003|Overall Study|Death|1|||
23761646|NCT02622074|66505409|FG004|Overall Study|Death|1|||
23761647|NCT02622074|66505410|FG005|Overall Study|Death|0|||
23761648|NCT02622074|66505405|FG000|Overall Study|Withdrawal by Subject|0|||
23442467|NCT00348673|65362093|FG008|Stage 1|Randomized but not Treated|0|||
23761649|NCT02622074|66505406|FG001|Overall Study|Withdrawal by Subject|1|||
23761650|NCT02622074|66505407|FG002|Overall Study|Withdrawal by Subject|0|||
23761651|NCT02622074|66505408|FG003|Overall Study|Withdrawal by Subject|0|||
23761652|NCT02622074|66505409|FG004|Overall Study|Withdrawal by Subject|0|||
23761653|NCT02622074|66505410|FG005|Overall Study|Withdrawal by Subject|0|||
23761654|NCT03210259|66505419|FG000|12-Week Run-in Period|Adverse Event|1|||
23442468|NCT00992459|65362094|FG000|Overall Study|Withdrawal by Subject|0|||
23442469|NCT00992459|65362095|FG001|Overall Study|Withdrawal by Subject|1|||
23442470|NCT00992459|65362094|FG000|Overall Study|Adverse Event|1|||
23627689|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
23442471|NCT00992459|65362095|FG001|Overall Study|Adverse Event|0|||
23442472|NCT01248949|65362097|FG000|Overall Study|Lost to Follow-up|2|||
23442473|NCT01248949|65362098|FG001|Overall Study|Lost to Follow-up|2|||
23442474|NCT01248949|65362099|FG002|Overall Study|Lost to Follow-up|2|||
23442475|NCT01248949|65362100|FG003|Overall Study|Lost to Follow-up|1|||
23442476|NCT01248949|65362101|FG004|Overall Study|Lost to Follow-up|0|||
23442477|NCT01248949|65362097|FG000|Overall Study|Withdrawal by Subject|5|||
23442478|NCT01248949|65362098|FG001|Overall Study|Withdrawal by Subject|3|||
23442479|NCT01248949|65362099|FG002|Overall Study|Withdrawal by Subject|11|||
23442480|NCT01248949|65362100|FG003|Overall Study|Withdrawal by Subject|3|||
23442481|NCT01248949|65362101|FG004|Overall Study|Withdrawal by Subject|1|||
23442482|NCT01248949|65362097|FG000|Overall Study|Death|22|||
23442483|NCT01248949|65362098|FG001|Overall Study|Death|7|||
23442484|NCT01248949|65362099|FG002|Overall Study|Death|21|||
23442485|NCT01248949|65362100|FG003|Overall Study|Death|6|||
23442486|NCT01248949|65362101|FG004|Overall Study|Death|2|||
23442487|NCT01248949|65362097|FG000|Overall Study|Alternative Therapy|1|||
23442488|NCT01248949|65362098|FG001|Overall Study|Alternative Therapy|0|||
23442489|NCT01248949|65362099|FG002|Overall Study|Alternative Therapy|0|||
23442490|NCT01248949|65362100|FG003|Overall Study|Alternative Therapy|0|||
23442491|NCT01248949|65362101|FG004|Overall Study|Alternative Therapy|0|||
23442492|NCT01248949|65362097|FG000|Overall Study|Alternative Therapy.|1|||
23442493|NCT01248949|65362098|FG001|Overall Study|Alternative Therapy.|0|||
23442494|NCT01248949|65362099|FG002|Overall Study|Alternative Therapy.|0|||
23442495|NCT01248949|65362100|FG003|Overall Study|Alternative Therapy.|0|||
23442496|NCT01248949|65362101|FG004|Overall Study|Alternative Therapy.|0|||
23442497|NCT01248949|65362097|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
23442498|NCT01248949|65362098|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442499|NCT01248949|65362099|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442500|NCT01248949|65362100|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442501|NCT01248949|65362101|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442502|NCT01248949|65362097|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442503|NCT01248949|65362098|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442504|NCT01248949|65362099|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442505|NCT01248949|65362100|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442506|NCT01248949|65362101|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
23442507|NCT01248949|65362097|FG000|Overall Study|Participant Went To Hospice|0|||
23442508|NCT01248949|65362098|FG001|Overall Study|Participant Went To Hospice|0|||
23442509|NCT01248949|65362099|FG002|Overall Study|Participant Went To Hospice|1|||
23442510|NCT01248949|65362100|FG003|Overall Study|Participant Went To Hospice|0|||
23442511|NCT01248949|65362101|FG004|Overall Study|Participant Went To Hospice|0|||
23442512|NCT01248949|65362097|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
23442513|NCT01248949|65362098|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442514|NCT01248949|65362099|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442515|NCT01248949|65362100|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23627690|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Other|4|||
23627691|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Other|4|||
23761655|NCT03210259|66505420|FG001|12-Week Run-in Period|Adverse Event|0|||
23761656|NCT03210259|66505421|FG002|12-Week Run-in Period|Adverse Event|0|||
23761657|NCT03210259|66505419|FG000|12-Week Run-in Period|Death|1|||
23442516|NCT01248949|65362101|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442517|NCT01248949|65362097|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
23442518|NCT01248949|65362098|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
23442519|NCT01248949|65362099|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
23627692|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Other|2|||
23761658|NCT03210259|66505420|FG001|12-Week Run-in Period|Death|0|||
23761659|NCT03210259|66505421|FG002|12-Week Run-in Period|Death|0|||
23761660|NCT03210259|66505419|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
23761661|NCT03210259|66505420|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
23761662|NCT03210259|66505421|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
23761663|NCT03210259|66505419|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
23761664|NCT03210259|66505420|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
23761665|NCT03210259|66505421|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
23761666|NCT03210259|66505419|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
23761667|NCT03210259|66505420|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
23761668|NCT03210259|66505421|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
23761669|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
23761670|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
23761671|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
23761672|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
23761673|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
23761674|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
23761675|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
23827989|NCT01526655|66749033|FG001|Overall Study|Withdrawal by Subject|1|||
23827990|NCT01522456|66749034|FG000|Overall Study|Adverse Event|2|||
23827991|NCT01522456|66749034|FG000|Overall Study|Lost to Follow-up|2|||
23827992|NCT01522456|66749034|FG000|Overall Study|Withdrawal by Subject|2|||
23627693|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Other|2|||
23627694|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627695|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627696|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
23627697|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627698|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
23627699|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
23627700|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
23627701|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
23627702|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
23627703|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
23627704|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
23627705|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
23627706|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627707|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627708|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627709|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
23627710|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Other|1|||
23627711|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Other|0|||
23627712|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Other|1|||
23627713|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Other|4|||
23627714|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
23627715|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
23627716|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
23627717|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
23627718|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
23627719|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
23627720|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
23627721|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
23627722|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
23627723|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
23627724|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
23627725|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
23627726|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
23627727|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
23627728|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
23627729|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
23627730|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Other|8|||
23627731|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Other|5|||
23627732|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Other|15|||
23627733|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Other|15|||
23627734|NCT02547441|66024539|FG000|Double-Blind Study Period|Adverse Event|4|||
23761676|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
23761677|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
23827993|NCT01522456|66749034|FG000|Overall Study|Pregnancy|1|||
23827994|NCT01522456|66749034|FG000|Overall Study|Tolerability Assessment|1|||
23627735|NCT02547441|66024540|FG001|Double-Blind Study Period|Adverse Event|9|||
23627736|NCT02547441|66024539|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
23627737|NCT02547441|66024540|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
23761678|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
23761679|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
23761680|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
23761681|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
23761682|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
23761683|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
23761684|NCT03210259|66505419|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
23761685|NCT03210259|66505420|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
23761686|NCT03210259|66505421|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
23761687|NCT00686920|66505423|FG000|Overall Study|Death|45|||
23761688|NCT00686920|66505424|FG001|Overall Study|Death|14|||
23761689|NCT00686920|66505423|FG000|Overall Study|Liver Transplant|23|||
23761690|NCT00686920|66505424|FG001|Overall Study|Liver Transplant|8|||
23761691|NCT00686920|66505423|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
23761692|NCT00686920|66505424|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
23761693|NCT00686920|66505423|FG000|Overall Study|Withdrawal by Subject|23|||
23761694|NCT00686920|66505424|FG001|Overall Study|Withdrawal by Subject|5|||
23761695|NCT00686920|66505423|FG000|Overall Study|Protocol Violation|2|||
23761696|NCT00686920|66505424|FG001|Overall Study|Protocol Violation|1|||
23761697|NCT00686920|66505423|FG000|Overall Study|Adverse Event|10|||
23761698|NCT00686920|66505424|FG001|Overall Study|Adverse Event|2|||
23761699|NCT00686920|66505423|FG000|Overall Study|Personal Reason|0|||
23761700|NCT00686920|66505424|FG001|Overall Study|Personal Reason|1|||
23761701|NCT00686920|66505423|FG000|Overall Study|Lost to Follow-up|15|||
23761702|NCT00686920|66505424|FG001|Overall Study|Lost to Follow-up|3|||
23761703|NCT00686920|66505423|FG000|Overall Study|Moved to Another State|1|||
23761704|NCT00686920|66505424|FG001|Overall Study|Moved to Another State|0|||
23761705|NCT00686920|66505423|FG000|Overall Study|Transferred to Nursing Home|1|||
23761706|NCT00686920|66505424|FG001|Overall Study|Transferred to Nursing Home|0|||
23761707|NCT00686920|66505423|FG000|Overall Study|Noncompliance|9|||
23761708|NCT00686920|66505424|FG001|Overall Study|Noncompliance|0|||
23761709|NCT00686920|66505423|FG000|Overall Study|Principal Investigator Decision|2|||
23565533|NCT02798211|65799677|FG001|Period 1|Death|0|||
23565534|NCT02798211|65799678|FG002|Period 1|Death|1|||
23565535|NCT02798211|65799679|FG003|Period 1|Death|0|||
23565536|NCT02798211|65799680|FG004|Period 1|Death|0|||
23565537|NCT02798211|65799681|FG005|Period 1|Death|0|||
23565538|NCT02798211|65799676|FG000|Period 1|Withdrawal of Informed Consent|2|||
23565539|NCT02798211|65799677|FG001|Period 1|Withdrawal of Informed Consent|7|||
23565540|NCT02798211|65799678|FG002|Period 1|Withdrawal of Informed Consent|3|||
23565541|NCT02798211|65799679|FG003|Period 1|Withdrawal of Informed Consent|0|||
23565542|NCT02798211|65799680|FG004|Period 1|Withdrawal of Informed Consent|0|||
23565543|NCT02798211|65799681|FG005|Period 1|Withdrawal of Informed Consent|0|||
23565544|NCT02798211|65799676|FG000|Period 2|Withdrawal by Subject|2|||
23565545|NCT02798211|65799677|FG001|Period 2|Withdrawal by Subject|0|||
23565546|NCT02798211|65799678|FG002|Period 2|Withdrawal by Subject|0|||
23565547|NCT02798211|65799679|FG003|Period 2|Withdrawal by Subject|0|||
23565548|NCT02798211|65799680|FG004|Period 2|Withdrawal by Subject|2|||
23565549|NCT02798211|65799681|FG005|Period 2|Withdrawal by Subject|2|||
23565550|NCT02798211|65799676|FG000|Period 2|Adverse Event|5|||
23565551|NCT02798211|65799677|FG001|Period 2|Adverse Event|0|||
23565552|NCT02798211|65799678|FG002|Period 2|Adverse Event|0|||
23565553|NCT02798211|65799679|FG003|Period 2|Adverse Event|0|||
23761710|NCT00686920|66505424|FG001|Overall Study|Principal Investigator Decision|0|||
23761711|NCT00571922|66505428|FG000|Overall Study|Completion unknown|36|||
23761712|NCT00571922|66505429|FG001|Overall Study|Completion unknown|36|||
23761713|NCT00461500|66505432|FG000|Overall Study|Adverse Event|1|||
23761714|NCT00461500|66505433|FG001|Overall Study|Adverse Event|0|||
23761715|NCT00461500|66505432|FG000|Overall Study|Lack of Efficacy|0|||
23761716|NCT00461500|66505433|FG001|Overall Study|Lack of Efficacy|1|||
23761717|NCT00461500|66505432|FG000|Overall Study|Expired Drug Treatment|1|||
23761718|NCT00461500|66505433|FG001|Overall Study|Expired Drug Treatment|1|||
23827995|NCT00838526|66749035|FG000|Overall Study|Adverse Event|3|||
23827996|NCT00838526|66749036|FG001|Overall Study|Adverse Event|12|||
23827997|NCT00838526|66749035|FG000|Overall Study|Lost to Follow-up|4|||
23827998|NCT00838526|66749036|FG001|Overall Study|Lost to Follow-up|12|||
23565554|NCT02798211|65799680|FG004|Period 2|Adverse Event|1|||
23565555|NCT02798211|65799681|FG005|Period 2|Adverse Event|0|||
23565556|NCT02798211|65799676|FG000|Period 2|Lack of Efficacy|1|||
23761719|NCT00461500|66505432|FG000|Overall Study|Study Stopped|1|||
23761720|NCT00461500|66505433|FG001|Overall Study|Study Stopped|2|||
23565557|NCT02798211|65799677|FG001|Period 2|Lack of Efficacy|0|||
23565558|NCT02798211|65799678|FG002|Period 2|Lack of Efficacy|0|||
23565559|NCT02798211|65799679|FG003|Period 2|Lack of Efficacy|1|||
23761721|NCT00461500|66505432|FG000|Overall Study|Drug Treatment Misuse|1|||
23761722|NCT00461500|66505433|FG001|Overall Study|Drug Treatment Misuse|0|||
23761723|NCT00461500|66505432|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
23827999|NCT00838526|66749035|FG000|Overall Study|Withdrawal by Subject|4|||
23761724|NCT00461500|66505433|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
23761725|NCT00461500|66505432|FG000|Overall Study|Lost to Follow-up|2|||
23761726|NCT00461500|66505433|FG001|Overall Study|Lost to Follow-up|2|||
23761727|NCT02024698|66505434|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
23761728|NCT02024698|66505435|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
23761729|NCT02280421|66505436|FG000|Washout (2 Weeks)|Adverse Event|0|||
23761730|NCT02280421|66505437|FG001|Washout (2 Weeks)|Adverse Event|1|||
23761731|NCT02280421|66505436|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23761732|NCT02280421|66505437|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23761733|NCT01348542|66505444|FG000|Overall Study|Withdrawal by Subject|3|||
23761734|NCT01348542|66505445|FG001|Overall Study|Withdrawal by Subject|0|||
23761735|NCT01967888|66505446|FG000|Overall Study|Lost to Follow-up|6|||
23761736|NCT01967888|66505447|FG001|Overall Study|Lost to Follow-up|4|||
23761737|NCT01967888|66505446|FG000|Overall Study|Withdrawal by Subject|1|||
23761738|NCT01967888|66505447|FG001|Overall Study|Withdrawal by Subject|1|||
23761739|NCT01967888|66505446|FG000|Overall Study|Did Not Have Transplant|1|||
23761740|NCT01967888|66505447|FG001|Overall Study|Did Not Have Transplant|0|||
23761741|NCT01967888|66505446|FG000|Overall Study|Research visit not done, data recorded|1|||
23761742|NCT01967888|66505447|FG001|Overall Study|Research visit not done, data recorded|0|||
23761743|NCT01967888|66505446|FG000|Overall Study|Subject excluded after randomization|1|||
23761744|NCT01967888|66505447|FG001|Overall Study|Subject excluded after randomization|0|||
23761745|NCT01967888|66505446|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
23761746|NCT01967888|66505447|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
23761747|NCT01967888|66505446|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
23761748|NCT01967888|66505447|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
23761749|NCT03705351|66505450|FG000|Overall Study|Study termination|3|||
23761750|NCT03705351|66505450|FG000|Overall Study|Death|1|||
23761751|NCT03705351|66505450|FG000|Overall Study|Lack of Efficacy|2|||
23761752|NCT03705351|66505450|FG000|Overall Study|Withdrawal by Subject|1|||
23761753|NCT01335464|66505452|FG000|Overall Study|Adverse Event|15|||
23761754|NCT01335464|66505453|FG001|Overall Study|Adverse Event|25|||
23761755|NCT01335464|66505452|FG000|Overall Study|Non compliant with protocol|2|||
23761756|NCT01335464|66505453|FG001|Overall Study|Non compliant with protocol|0|||
23761757|NCT01335464|66505452|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
23761758|NCT01335464|66505453|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
23761759|NCT01335464|66505452|FG000|Overall Study|Not treated|2|||
23761760|NCT01335464|66505453|FG001|Overall Study|Not treated|0|||
23761761|NCT01335464|66505452|FG000|Overall Study|Reason other than those stated above|1|||
23761762|NCT01335464|66505453|FG001|Overall Study|Reason other than those stated above|1|||
23761763|NCT02984683|66505456|FG000|Overall Study|Adverse Event|3|||
23761764|NCT02984683|66505457|FG001|Overall Study|Adverse Event|3|||
23761765|NCT02984683|66505456|FG000|Overall Study|Withdrawal by Subject|1|||
23761766|NCT02984683|66505457|FG001|Overall Study|Withdrawal by Subject|0|||
23761767|NCT02984683|66505456|FG000|Overall Study|Disease progression|7|||
23761768|NCT02984683|66505457|FG001|Overall Study|Disease progression|9|||
23761769|NCT02133352|66505460|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
23761770|NCT01225991|66505462|FG000|Overall Study|Withdrawal by Subject|6|||
23761771|NCT04071366|66505463|FG000|Part 1: Open-label (29 Days)|Death|4|||
23761772|NCT04071366|66505464|FG001|Part 1: Open-label (29 Days)|Death|2|||
23761773|NCT04071366|66505465|FG002|Part 1: Open-label (29 Days)|Death|8|||
23761774|NCT04071366|66505466|FG003|Part 1: Open-label (29 Days)|Death|0|||
23761775|NCT04071366|66505467|FG004|Part 1: Open-label (29 Days)|Death|0|||
23761776|NCT04071366|66505463|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23761777|NCT04071366|66505464|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23761778|NCT04071366|66505465|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
23761779|NCT04071366|66505466|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23761780|NCT04071366|66505467|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23761781|NCT04071366|66505463|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
23761782|NCT04071366|66505464|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23761783|NCT04071366|66505465|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
23761784|NCT04071366|66505466|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23761785|NCT04071366|66505467|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23761786|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Death|0|||
23828000|NCT00838526|66749036|FG001|Overall Study|Withdrawal by Subject|5|||
23828001|NCT00838526|66749035|FG000|Overall Study|Lack of Efficacy|2|||
23761787|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Death|0|||
23761788|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Death|0|||
23761789|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Death|2|||
23761790|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Death|2|||
23761791|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23761792|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23761793|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23761794|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23761795|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
23761796|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
23761797|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
23761798|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
23761799|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
23761800|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
23761801|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23565560|NCT02798211|65799680|FG004|Period 2|Lack of Efficacy|0|||
23565561|NCT02798211|65799681|FG005|Period 2|Lack of Efficacy|1|||
23565562|NCT02798211|65799676|FG000|Period 2|Lost to Follow-up|3|||
23442520|NCT01248949|65362100|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
23442521|NCT01248949|65362101|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
23442522|NCT01248949|65362097|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442523|NCT01248949|65362098|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
23761802|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23565563|NCT02798211|65799677|FG001|Period 2|Lost to Follow-up|0|||
23565564|NCT02798211|65799678|FG002|Period 2|Lost to Follow-up|0|||
23565565|NCT02798211|65799679|FG003|Period 2|Lost to Follow-up|0|||
23565566|NCT02798211|65799680|FG004|Period 2|Lost to Follow-up|2|||
23565567|NCT02798211|65799681|FG005|Period 2|Lost to Follow-up|0|||
23761803|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23761804|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
23442524|NCT01248949|65362099|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442525|NCT01248949|65362100|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442526|NCT01248949|65362101|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442527|NCT01248949|65362097|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442528|NCT01248949|65362098|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442529|NCT01248949|65362099|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
23442530|NCT01248949|65362100|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442531|NCT01248949|65362101|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442532|NCT02728089|65362104|FG000|Overall Study|Physician Decision|2|||
23442533|NCT02728089|65362104|FG000|Overall Study|Withdrawal by Subject|1|||
23442534|NCT01677858|65362105|FG000|Overall Study|Adverse Event|0|||
23442535|NCT01677858|65362106|FG001|Overall Study|Adverse Event|0|||
23442536|NCT01677858|65362107|FG002|Overall Study|Adverse Event|2|||
23442537|NCT01677858|65362108|FG003|Overall Study|Adverse Event|3|||
23442538|NCT01677858|65362109|FG004|Overall Study|Adverse Event|13|||
23442539|NCT01677858|65362105|FG000|Overall Study|Death|0|||
23442540|NCT01677858|65362106|FG001|Overall Study|Death|0|||
23442541|NCT01677858|65362107|FG002|Overall Study|Death|0|||
23442542|NCT01677858|65362108|FG003|Overall Study|Death|0|||
23442543|NCT01677858|65362109|FG004|Overall Study|Death|1|||
23442544|NCT01677858|65362105|FG000|Overall Study|Physician Decision|1|||
23442545|NCT01677858|65362106|FG001|Overall Study|Physician Decision|0|||
23442546|NCT01677858|65362107|FG002|Overall Study|Physician Decision|2|||
23442547|NCT01677858|65362108|FG003|Overall Study|Physician Decision|0|||
23442548|NCT01677858|65362109|FG004|Overall Study|Physician Decision|12|||
23442549|NCT01677858|65362105|FG000|Overall Study|Progressive Disease|2|||
23442550|NCT01677858|65362106|FG001|Overall Study|Progressive Disease|1|||
23442551|NCT01677858|65362107|FG002|Overall Study|Progressive Disease|9|||
23442552|NCT01677858|65362108|FG003|Overall Study|Progressive Disease|3|||
23442553|NCT01677858|65362109|FG004|Overall Study|Progressive Disease|43|||
23442554|NCT01677858|65362105|FG000|Overall Study|Withdrawal by Subject|0|||
23442555|NCT01677858|65362106|FG001|Overall Study|Withdrawal by Subject|1|||
23442556|NCT01677858|65362107|FG002|Overall Study|Withdrawal by Subject|1|||
23442557|NCT01677858|65362108|FG003|Overall Study|Withdrawal by Subject|0|||
23565568|NCT02798211|65799676|FG000|Period 2|Physician Decision|1|||
23761805|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
23761806|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23761807|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23761808|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23761809|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23828002|NCT00838526|66749036|FG001|Overall Study|Lack of Efficacy|3|||
23828003|NCT00838526|66749035|FG000|Overall Study|Other|11|||
23828004|NCT00838526|66749036|FG001|Overall Study|Other|7|||
23442558|NCT01677858|65362109|FG004|Overall Study|Withdrawal by Subject|15|||
23442559|NCT01677858|65362105|FG000|Overall Study|Lost to Follow-up|0|||
23442560|NCT01677858|65362106|FG001|Overall Study|Lost to Follow-up|0|||
23442561|NCT01677858|65362107|FG002|Overall Study|Lost to Follow-up|0|||
23442562|NCT01677858|65362108|FG003|Overall Study|Lost to Follow-up|0|||
23442563|NCT01677858|65362109|FG004|Overall Study|Lost to Follow-up|1|||
23442564|NCT01843062|65362110|FG000|Overall Study|Protocol Violation|1|||
23442565|NCT01843062|65362111|FG001|Overall Study|Protocol Violation|0|||
23442566|NCT01843062|65362110|FG000|Overall Study|New treatment following progression|2|||
23565569|NCT02798211|65799677|FG001|Period 2|Physician Decision|0|||
23565570|NCT02798211|65799678|FG002|Period 2|Physician Decision|0|||
23442567|NCT01843062|65362111|FG001|Overall Study|New treatment following progression|0|||
23442568|NCT01843062|65362110|FG000|Overall Study|Pregnancy|1|||
23442569|NCT01843062|65362111|FG001|Overall Study|Pregnancy|0|||
23442570|NCT01843062|65362110|FG000|Overall Study|Adverse Event|2|||
23442571|NCT01843062|65362111|FG001|Overall Study|Adverse Event|0|||
23442572|NCT01843062|65362110|FG000|Overall Study|Incorrect randomisation|1|||
23442573|NCT01843062|65362111|FG001|Overall Study|Incorrect randomisation|0|||
23442574|NCT01843062|65362110|FG000|Overall Study|Withdrawal by Subject|12|||
23442575|NCT01843062|65362111|FG001|Overall Study|Withdrawal by Subject|3|||
23442576|NCT01843062|65362110|FG000|Overall Study|Death|1|||
23442577|NCT01843062|65362111|FG001|Overall Study|Death|2|||
23442578|NCT01843062|65362110|FG000|Overall Study|Lost to Follow-up|2|||
23442579|NCT01843062|65362111|FG001|Overall Study|Lost to Follow-up|4|||
23442580|NCT00539305|65362112|FG000|Overall Study|Adverse Event|1|||
23442581|NCT00539305|65362113|FG001|Overall Study|Adverse Event|0|||
23442582|NCT00539305|65362112|FG000|Overall Study|Substance Use|0|||
23442583|NCT00539305|65362113|FG001|Overall Study|Substance Use|1|||
23442584|NCT00539305|65362112|FG000|Overall Study|Withdrawal by Subject|0|||
23442585|NCT00539305|65362113|FG001|Overall Study|Withdrawal by Subject|1|||
23442586|NCT00245037|65362122|FG000|Overall Study|Death|17|||
23442587|NCT02315560|65362128|FG000|Overall Study|noncompliance by subjects|3|||
23761810|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
23761811|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23761812|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23761813|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23761814|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
23761815|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23761816|NCT04071366|66505463|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23761817|NCT04071366|66505464|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23761818|NCT04071366|66505465|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23761819|NCT04071366|66505466|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
23761820|NCT04071366|66505467|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23761821|NCT02094937|66505468|FG000|8 Weeks in Period 1|Adverse Event|9|||
23761822|NCT02094937|66505469|FG001|8 Weeks in Period 1|Adverse Event|0|||
23761823|NCT02094937|66505470|FG002|8 Weeks in Period 1|Adverse Event|0|||
23761824|NCT02094937|66505471|FG003|8 Weeks in Period 1|Adverse Event|0|||
23761825|NCT02094937|66505468|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
23761826|NCT02094937|66505469|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
23761827|NCT02094937|66505470|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
23761828|NCT02094937|66505471|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
23761829|NCT02094937|66505468|FG000|8 Weeks in Period 1|Protocol Violation|2|||
23761830|NCT02094937|66505469|FG001|8 Weeks in Period 1|Protocol Violation|0|||
23761831|NCT02094937|66505470|FG002|8 Weeks in Period 1|Protocol Violation|0|||
23761832|NCT02094937|66505471|FG003|8 Weeks in Period 1|Protocol Violation|0|||
23761833|NCT02094937|66505468|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
23761834|NCT02094937|66505469|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23761835|NCT02094937|66505470|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23761836|NCT02094937|66505471|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23761837|NCT02094937|66505468|FG000|8 Weeks in Period 1|Physician Decision|1|||
23761838|NCT02094937|66505469|FG001|8 Weeks in Period 1|Physician Decision|0|||
23761839|NCT02094937|66505470|FG002|8 Weeks in Period 1|Physician Decision|0|||
23761840|NCT02094937|66505471|FG003|8 Weeks in Period 1|Physician Decision|0|||
23761841|NCT02094937|66505468|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
23761842|NCT02094937|66505469|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
23761843|NCT02094937|66505470|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
23761844|NCT02094937|66505471|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
23761845|NCT02094937|66505468|FG000|12 Weeks in Period 2|Adverse Event|0|||
23761846|NCT02094937|66505469|FG001|12 Weeks in Period 2|Adverse Event|2|||
23761847|NCT02094937|66505470|FG002|12 Weeks in Period 2|Adverse Event|4|||
23761848|NCT02094937|66505471|FG003|12 Weeks in Period 2|Adverse Event|1|||
23761849|NCT02094937|66505468|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
23828005|NCT00276484|66749039|FG000|Overall Study|Adverse Event|4|||
23828006|NCT00276484|66749040|FG001|Overall Study|Adverse Event|7|||
23828007|NCT00276484|66749039|FG000|Overall Study|Lost to Follow-up|1|||
23828008|NCT00276484|66749040|FG001|Overall Study|Lost to Follow-up|1|||
23442588|NCT02863328|65362142|FG000|Overall Study|Lost to Follow-up|4|||
23442589|NCT02863328|65362143|FG001|Overall Study|Lost to Follow-up|10|||
23442590|NCT02863328|65362142|FG000|Overall Study|Withdrawal by Subject|7|||
23442591|NCT02863328|65362143|FG001|Overall Study|Withdrawal by Subject|12|||
23442592|NCT02863328|65362142|FG000|Overall Study|Died|0|||
23442593|NCT02863328|65362143|FG001|Overall Study|Died|1|||
23442594|NCT02488005|65362146|FG000|Overall Study|Lost to Follow-up|2|||
23442595|NCT00555672|65362147|FG000|Overall Study|Death|0|||
23442596|NCT00555672|65362148|FG001|Overall Study|Death|2|||
23828009|NCT00276484|66749039|FG000|Overall Study|Protocol Violation|0|||
23442597|NCT00555672|65362147|FG000|Overall Study|Adverse Event|8|||
23442598|NCT00555672|65362148|FG001|Overall Study|Adverse Event|2|||
23442599|NCT00555672|65362147|FG000|Overall Study|Objective progression or relapse|11|||
23442600|NCT00555672|65362148|FG001|Overall Study|Objective progression or relapse|5|||
23442601|NCT00555672|65362147|FG000|Overall Study|Other|3|||
23442602|NCT00555672|65362148|FG001|Overall Study|Other|1|||
23442603|NCT00555672|65362147|FG000|Overall Study|Participant refused|2|||
23442604|NCT00555672|65362148|FG001|Overall Study|Participant refused|0|||
23442605|NCT03472586|65362149|FG000|Overall Study|Physician Decision|6|||
23442606|NCT03472586|65362149|FG000|Overall Study|Death|6|||
23442607|NCT03472586|65362149|FG000|Overall Study|Adverse Event|1|||
23442608|NCT02978833|65362150|FG000|Overall Study|Study terminated|1|||
23442609|NCT02978833|65362151|FG001|Overall Study|Study terminated|1|||
23442610|NCT02717494|65362152|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
23442611|NCT02717494|65362153|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
23442612|NCT02717494|65362154|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
23442613|NCT02717494|65362152|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
23442614|NCT02717494|65362153|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
23442615|NCT02717494|65362154|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
23442616|NCT02717494|65362152|FG000|First Intervention (Step 1)|Death|0|||
23442617|NCT02717494|65362153|FG001|First Intervention (Step 1)|Death|0|||
23442618|NCT02717494|65362154|FG002|First Intervention (Step 1)|Death|1|||
23442619|NCT02717494|65362152|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
23442620|NCT02717494|65362153|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
23442621|NCT02717494|65362154|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
23442622|NCT01702246|65362155|FG000|Overall Study|Lost to Follow-up|2|||
23442623|NCT01702246|65362155|FG000|Overall Study|Withdrawal by Subject|2|||
23442624|NCT01702246|65362155|FG000|Overall Study|Physician Decision|1|||
23442625|NCT00741013|65362156|FG000|Overall Study|Adverse Event|1|||
23442626|NCT00741013|65362157|FG001|Overall Study|Adverse Event|0|||
23442627|NCT00741013|65362158|FG002|Overall Study|Adverse Event|0|||
23442628|NCT00741013|65362156|FG000|Overall Study|Withdrawal by Subject|0|||
23442629|NCT00741013|65362157|FG001|Overall Study|Withdrawal by Subject|0|||
23442630|NCT00741013|65362158|FG002|Overall Study|Withdrawal by Subject|1|||
23442631|NCT00741013|65362156|FG000|Overall Study|Discovered failed screen after enrolled|0|||
23442632|NCT00741013|65362157|FG001|Overall Study|Discovered failed screen after enrolled|2|||
23442633|NCT00741013|65362158|FG002|Overall Study|Discovered failed screen after enrolled|0|||
23442634|NCT03614325|65362159|FG000|Overall Study|Withdrawal by Subject|0|||
23442635|NCT03614325|65362160|FG001|Overall Study|Withdrawal by Subject|2|||
23442636|NCT03614325|65362159|FG000|Overall Study|Surgery Cancelled|2|||
23442637|NCT03614325|65362160|FG001|Overall Study|Surgery Cancelled|1|||
23442638|NCT03614325|65362159|FG000|Overall Study|Lost to Follow-up|2|||
23442639|NCT03614325|65362160|FG001|Overall Study|Lost to Follow-up|1|||
23442640|NCT03614325|65362159|FG000|Overall Study|Surgery never scheduled|1|||
23442641|NCT03614325|65362160|FG001|Overall Study|Surgery never scheduled|0|||
23442642|NCT02837029|65362165|FG000|Screening|Failed to meet screening requirements.|7|||
23442643|NCT02837029|65362166|FG001|Screening|Failed to meet screening requirements.|3|||
23442644|NCT02837029|65362167|FG002|Screening|Failed to meet screening requirements.|0|||
23442645|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
23442646|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
23442647|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
23442648|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
23442649|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
23442650|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
23442651|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
23442652|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
23442653|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
23627738|NCT02547441|66024539|FG000|Double-Blind Study Period|Physician Decision|1|||
23627739|NCT02547441|66024540|FG001|Double-Blind Study Period|Physician Decision|0|||
23761850|NCT02094937|66505469|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
23442654|NCT02837029|65362165|FG000|Cycle 2 and Beyond|Adverse Event|1|||
23442655|NCT02837029|65362166|FG001|Cycle 2 and Beyond|Adverse Event|0|||
23442656|NCT02837029|65362167|FG002|Cycle 2 and Beyond|Adverse Event|0|||
23442657|NCT02837029|65362165|FG000|2 Year Follow-up|Death|6|||
23442658|NCT02837029|65362166|FG001|2 Year Follow-up|Death|7|||
23442659|NCT02837029|65362167|FG002|2 Year Follow-up|Death|0|||
23761851|NCT02094937|66505470|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
23761852|NCT02094937|66505471|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
23761853|NCT02094937|66505468|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
23761854|NCT02094937|66505469|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
23761855|NCT02094937|66505470|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
23761856|NCT02094937|66505471|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
23761857|NCT02094937|66505468|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
23761858|NCT02094937|66505469|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
23627740|NCT02547441|66024539|FG000|Double-Blind Study Period|Protocol Violation|1|||
23627741|NCT02547441|66024540|FG001|Double-Blind Study Period|Protocol Violation|2|||
23627742|NCT02547441|66024539|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
23627743|NCT02547441|66024540|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
23627744|NCT02547441|66024539|FG000|Double-Blind Study Period|Sponsor Decision|1|||
23627745|NCT02547441|66024540|FG001|Double-Blind Study Period|Sponsor Decision|0|||
23627746|NCT02547441|66024539|FG000|Open-Label Study Period|Adverse Event|10|||
23627747|NCT02547441|66024540|FG001|Open-Label Study Period|Adverse Event|11|||
23627748|NCT02547441|66024539|FG000|Open-Label Study Period|Lack of Efficacy|3|||
23627749|NCT02547441|66024540|FG001|Open-Label Study Period|Lack of Efficacy|2|||
23627750|NCT02547441|66024539|FG000|Open-Label Study Period|Lost to Follow-up|7|||
23627751|NCT02547441|66024540|FG001|Open-Label Study Period|Lost to Follow-up|8|||
23627752|NCT02547441|66024539|FG000|Open-Label Study Period|Physician Decision|1|||
23627753|NCT02547441|66024540|FG001|Open-Label Study Period|Physician Decision|0|||
23627754|NCT02547441|66024539|FG000|Open-Label Study Period|Protocol Violation|2|||
23627755|NCT02547441|66024540|FG001|Open-Label Study Period|Protocol Violation|0|||
23442660|NCT01792115|65362170|FG000|Overall Study|Lost to Follow-up|0|||
23442661|NCT01792115|65362171|FG001|Overall Study|Lost to Follow-up|1|||
23442662|NCT01792115|65362172|FG002|Overall Study|Lost to Follow-up|0|||
23442663|NCT00306527|65362175|FG000|Overall Study|Lost to Follow-up|3|||
23442664|NCT00306527|65362176|FG001|Overall Study|Lost to Follow-up|4|||
23565571|NCT02798211|65799679|FG003|Period 2|Physician Decision|1|||
23627756|NCT02547441|66024539|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
23627757|NCT02547441|66024540|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
23761859|NCT02094937|66505470|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
23761860|NCT02094937|66505471|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
23761861|NCT02094937|66505468|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
23761862|NCT02094937|66505469|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
23761863|NCT02094937|66505470|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
23761864|NCT02094937|66505471|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
23761865|NCT03835975|66505472|FG000|Overall Study|Lost to Follow-up|1|||
23761866|NCT03835975|66505473|FG001|Overall Study|Lost to Follow-up|1|||
23761867|NCT03835975|66505474|FG002|Overall Study|Lost to Follow-up|0|||
23761868|NCT03835975|66505475|FG003|Overall Study|Lost to Follow-up|0|||
23761869|NCT03835975|66505476|FG004|Overall Study|Lost to Follow-up|0|||
23442665|NCT00306527|65362177|FG002|Overall Study|Lost to Follow-up|3|||
23627758|NCT02547441|66024539|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
23627759|NCT02547441|66024540|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
23627760|NCT01677299|66024541|FG000|Overall Study|Adverse Event|0|||
23627761|NCT01677299|66024542|FG001|Overall Study|Adverse Event|2|||
23627762|NCT01677299|66024543|FG002|Overall Study|Adverse Event|1|||
23761870|NCT03835975|66505472|FG000|Overall Study|No longer met eligibility criteria|0|||
23761871|NCT03835975|66505473|FG001|Overall Study|No longer met eligibility criteria|1|||
23442666|NCT00306527|65362178|FG003|Overall Study|Lost to Follow-up|0|||
23442667|NCT00306527|65362175|FG000|Overall Study|Withdrawal by Subject|2|||
23565572|NCT02798211|65799680|FG004|Period 2|Physician Decision|1|||
23565573|NCT02798211|65799681|FG005|Period 2|Physician Decision|0|||
23565574|NCT02798211|65799676|FG000|Period 2|Pregnancy|0|||
23565575|NCT02798211|65799677|FG001|Period 2|Pregnancy|0|||
23565576|NCT02798211|65799678|FG002|Period 2|Pregnancy|0|||
23565577|NCT02798211|65799679|FG003|Period 2|Pregnancy|2|||
23565578|NCT02798211|65799680|FG004|Period 2|Pregnancy|0|||
23565579|NCT02798211|65799681|FG005|Period 2|Pregnancy|0|||
23565580|NCT02798211|65799676|FG000|Period 2|Technical problems|1|||
23565581|NCT02798211|65799677|FG001|Period 2|Technical problems|0|||
23565582|NCT02798211|65799678|FG002|Period 2|Technical problems|0|||
23565583|NCT02798211|65799679|FG003|Period 2|Technical problems|1|||
23565584|NCT02798211|65799680|FG004|Period 2|Technical problems|0|||
23565585|NCT02798211|65799681|FG005|Period 2|Technical problems|0|||
23565586|NCT02798211|65799676|FG000|Period 2|Withdrawal of Informed Consent|1|||
23565587|NCT02798211|65799677|FG001|Period 2|Withdrawal of Informed Consent|0|||
23565588|NCT02798211|65799678|FG002|Period 2|Withdrawal of Informed Consent|0|||
23565589|NCT02798211|65799679|FG003|Period 2|Withdrawal of Informed Consent|2|||
23565590|NCT02798211|65799680|FG004|Period 2|Withdrawal of Informed Consent|2|||
23565591|NCT02798211|65799681|FG005|Period 2|Withdrawal of Informed Consent|3|||
23565592|NCT01725386|65799682|FG000|Overall Study|Death|84|||
23565593|NCT01725386|65799683|FG001|Overall Study|Death|40|||
23627763|NCT01677299|66024544|FG003|Overall Study|Adverse Event|0|||
23761872|NCT03835975|66505474|FG002|Overall Study|No longer met eligibility criteria|0|||
23442668|NCT00306527|65362176|FG001|Overall Study|Withdrawal by Subject|3|||
23565594|NCT01725386|65799682|FG000|Overall Study|Lost to Follow-up|81|||
23565595|NCT01725386|65799683|FG001|Overall Study|Lost to Follow-up|6|||
23627764|NCT01677299|66024541|FG000|Overall Study|Withdrawal by Subject|0|||
23627765|NCT01677299|66024542|FG001|Overall Study|Withdrawal by Subject|1|||
23627766|NCT01677299|66024543|FG002|Overall Study|Withdrawal by Subject|0|||
23627767|NCT01677299|66024544|FG003|Overall Study|Withdrawal by Subject|1|||
23761873|NCT03835975|66505475|FG003|Overall Study|No longer met eligibility criteria|0|||
23627768|NCT00882115|66024545|FG000|Overall Study|Withdrawal by Subject|3|||
23627769|NCT00882115|66024545|FG000|Overall Study|did not respond to DEP challe|6|||
23761874|NCT03835975|66505476|FG004|Overall Study|No longer met eligibility criteria|0|||
23761875|NCT03835975|66505472|FG000|Overall Study|Protocol Violation|1|||
23761876|NCT03835975|66505473|FG001|Overall Study|Protocol Violation|1|||
23761877|NCT03835975|66505474|FG002|Overall Study|Protocol Violation|2|||
23761878|NCT03835975|66505475|FG003|Overall Study|Protocol Violation|0|||
23761879|NCT03835975|66505476|FG004|Overall Study|Protocol Violation|0|||
23761880|NCT03835975|66505472|FG000|Overall Study|Withdrawal by Subject|1|||
23761881|NCT03835975|66505473|FG001|Overall Study|Withdrawal by Subject|0|||
23761882|NCT03835975|66505474|FG002|Overall Study|Withdrawal by Subject|1|||
23761883|NCT03835975|66505475|FG003|Overall Study|Withdrawal by Subject|1|||
23761884|NCT03835975|66505476|FG004|Overall Study|Withdrawal by Subject|0|||
23761885|NCT01155583|66505477|FG000|Phase I|Screen failure - did not start treatment|0|||
23761886|NCT01155583|66505478|FG001|Phase I|Screen failure - did not start treatment|0|||
23761887|NCT01155583|66505479|FG002|Phase I|Screen failure - did not start treatment|0|||
23761888|NCT01155583|66505480|FG003|Phase I|Screen failure - did not start treatment|0|||
23761889|NCT01155583|66505481|FG004|Phase I|Screen failure - did not start treatment|1|||
23761890|NCT01155583|66505482|FG005|Phase I|Screen failure - did not start treatment|0|||
23828010|NCT00276484|66749040|FG001|Overall Study|Protocol Violation|1|||
23828011|NCT00276484|66749039|FG000|Overall Study|Withdrawal by Subject|4|||
23828012|NCT00276484|66749040|FG001|Overall Study|Withdrawal by Subject|3|||
23627770|NCT04594733|66024546|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23627771|NCT04594733|66024547|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23828013|NCT00276484|66749039|FG000|Overall Study|Could not take time off work|0|||
23828014|NCT00276484|66749040|FG001|Overall Study|Could not take time off work|1|||
23828015|NCT01662492|66749046|FG000|Overall Study|Other miscellaneous reasons.|1|||
23627772|NCT04594733|66024546|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
23627773|NCT04594733|66024547|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
23627774|NCT04594733|66024546|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
23627775|NCT04594733|66024547|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23627776|NCT02419417|66024555|FG000|Overall Study|Disease progression|5|||
23627777|NCT02419417|66024556|FG001|Overall Study|Disease progression|4|||
23627778|NCT02419417|66024557|FG002|Overall Study|Disease progression|13|||
23627779|NCT02419417|66024558|FG003|Overall Study|Disease progression|10|||
23627780|NCT02419417|66024559|FG004|Overall Study|Disease progression|10|||
23627781|NCT02419417|66024560|FG005|Overall Study|Disease progression|3|||
23627782|NCT02419417|66024561|FG006|Overall Study|Disease progression|4|||
23627783|NCT02419417|66024562|FG007|Overall Study|Disease progression|5|||
23627784|NCT02419417|66024563|FG008|Overall Study|Disease progression|13|||
23627785|NCT02419417|66024564|FG009|Overall Study|Disease progression|9|||
23627786|NCT02419417|66024565|FG010|Overall Study|Disease progression|0|||
23627787|NCT02419417|66024555|FG000|Overall Study|Study drug toxicity|0|||
23627788|NCT02419417|66024556|FG001|Overall Study|Study drug toxicity|0|||
23627789|NCT02419417|66024557|FG002|Overall Study|Study drug toxicity|0|||
23627790|NCT02419417|66024558|FG003|Overall Study|Study drug toxicity|0|||
23627791|NCT02419417|66024559|FG004|Overall Study|Study drug toxicity|1|||
23627792|NCT02419417|66024560|FG005|Overall Study|Study drug toxicity|0|||
23627793|NCT02419417|66024561|FG006|Overall Study|Study drug toxicity|0|||
23627794|NCT02419417|66024562|FG007|Overall Study|Study drug toxicity|0|||
23627795|NCT02419417|66024563|FG008|Overall Study|Study drug toxicity|0|||
23627796|NCT02419417|66024564|FG009|Overall Study|Study drug toxicity|0|||
23627797|NCT02419417|66024565|FG010|Overall Study|Study drug toxicity|0|||
23627798|NCT02419417|66024555|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23627799|NCT02419417|66024556|FG001|Overall Study|Adverse event unrelated to study drug|0|||
23627800|NCT02419417|66024557|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23627801|NCT02419417|66024558|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23627802|NCT02419417|66024559|FG004|Overall Study|Adverse event unrelated to study drug|2|||
23627803|NCT02419417|66024560|FG005|Overall Study|Adverse event unrelated to study drug|1|||
23627804|NCT02419417|66024561|FG006|Overall Study|Adverse event unrelated to study drug|0|||
23627805|NCT02419417|66024562|FG007|Overall Study|Adverse event unrelated to study drug|1|||
23627806|NCT02419417|66024563|FG008|Overall Study|Adverse event unrelated to study drug|0|||
23627807|NCT02419417|66024564|FG009|Overall Study|Adverse event unrelated to study drug|0|||
23761891|NCT01155583|66505483|FG006|Phase I|Screen failure - did not start treatment|0|||
23761892|NCT01155583|66505484|FG007|Phase I|Screen failure - did not start treatment|2|||
23828016|NCT01662492|66749047|FG001|Overall Study|Other miscellaneous reasons.|0|||
23828017|NCT01662492|66749048|FG002|Overall Study|Other miscellaneous reasons.|1|||
23627808|NCT02419417|66024565|FG010|Overall Study|Adverse event unrelated to study drug|0|||
23627809|NCT02419417|66024555|FG000|Overall Study|Participant request to discontinue|0|||
23627810|NCT02419417|66024556|FG001|Overall Study|Participant request to discontinue|0|||
23627811|NCT02419417|66024557|FG002|Overall Study|Participant request to discontinue|0|||
23627812|NCT02419417|66024558|FG003|Overall Study|Participant request to discontinue|0|||
23627813|NCT02419417|66024559|FG004|Overall Study|Participant request to discontinue|0|||
23627814|NCT02419417|66024560|FG005|Overall Study|Participant request to discontinue|0|||
23627815|NCT02419417|66024561|FG006|Overall Study|Participant request to discontinue|0|||
23627816|NCT02419417|66024562|FG007|Overall Study|Participant request to discontinue|0|||
23627817|NCT02419417|66024563|FG008|Overall Study|Participant request to discontinue|0|||
23627818|NCT02419417|66024564|FG009|Overall Study|Participant request to discontinue|1|||
23627819|NCT02419417|66024565|FG010|Overall Study|Participant request to discontinue|0|||
23627820|NCT02419417|66024555|FG000|Overall Study|Withdrawal by Subject|0|||
23627821|NCT02419417|66024556|FG001|Overall Study|Withdrawal by Subject|0|||
23627822|NCT02419417|66024557|FG002|Overall Study|Withdrawal by Subject|0|||
23565596|NCT01725386|65799682|FG000|Overall Study|Withdrawal by Subject|10|||
23565597|NCT01725386|65799683|FG001|Overall Study|Withdrawal by Subject|0|||
23565598|NCT01306201|65799686|FG000|Overall Study|Arrhythmia|4|||
23565599|NCT01306201|65799686|FG000|Overall Study|Files could not be processed|3|||
23565600|NCT01306201|65799686|FG000|Overall Study|Files unreadable|3|||
23565601|NCT03185832|65799688|FG000|Overall Study|Death|9|||
23565602|NCT03185832|65799689|FG001|Overall Study|Death|14|||
23565603|NCT03185832|65799690|FG002|Overall Study|Death|9|||
23565604|NCT03185832|65799691|FG003|Overall Study|Death|7|||
23565605|NCT03185832|65799688|FG000|Overall Study|Withdrawn - vital status available|0|||
23565606|NCT03185832|65799689|FG001|Overall Study|Withdrawn - vital status available|1|||
23565607|NCT03185832|65799690|FG002|Overall Study|Withdrawn - vital status available|1|||
23565608|NCT03185832|65799691|FG003|Overall Study|Withdrawn - vital status available|4|||
23565609|NCT01821898|65799692|FG000|Overall Study|Withdrawal by Subject|2|||
23565610|NCT01821898|65799693|FG001|Overall Study|Withdrawal by Subject|1|||
23565611|NCT00856661|65799697|FG000|Overall Study|Death|15|||
23565612|NCT00856661|65799698|FG001|Overall Study|Death|18|||
23565613|NCT00856661|65799697|FG000|Overall Study|Protocol Violation|2|||
23565614|NCT00856661|65799698|FG001|Overall Study|Protocol Violation|1|||
23565615|NCT00856661|65799697|FG000|Overall Study|Withdrawal by Subject|1|||
23565616|NCT00856661|65799698|FG001|Overall Study|Withdrawal by Subject|2|||
23565617|NCT00856661|65799697|FG000|Overall Study|Lost to Follow-up|1|||
23565618|NCT00856661|65799698|FG001|Overall Study|Lost to Follow-up|3|||
23565619|NCT00856661|65799697|FG000|Overall Study|Physician Judgement|8|||
23565620|NCT00856661|65799698|FG001|Overall Study|Physician Judgement|5|||
23565621|NCT01078662|65799723|FG000|Overall Study|Death|41|||
23565622|NCT01078662|65799724|FG001|Overall Study|Death|103|||
23565623|NCT01078662|65799725|FG002|Overall Study|Death|18|||
23565624|NCT01078662|65799726|FG003|Overall Study|Death|5|||
23565625|NCT01078662|65799727|FG004|Overall Study|Death|8|||
23565626|NCT01078662|65799723|FG000|Overall Study|Patients reached data cut-off|12|||
23565627|NCT01078662|65799724|FG001|Overall Study|Patients reached data cut-off|53|||
23565628|NCT01078662|65799725|FG002|Overall Study|Patients reached data cut-off|2|||
23565629|NCT01078662|65799726|FG003|Overall Study|Patients reached data cut-off|2|||
23565630|NCT01078662|65799727|FG004|Overall Study|Patients reached data cut-off|3|||
23565631|NCT01078662|65799723|FG000|Overall Study|Withdrawal by Subject|4|||
23565632|NCT01078662|65799724|FG001|Overall Study|Withdrawal by Subject|11|||
23565633|NCT01078662|65799725|FG002|Overall Study|Withdrawal by Subject|1|||
23565634|NCT01078662|65799726|FG003|Overall Study|Withdrawal by Subject|0|||
23565635|NCT01078662|65799727|FG004|Overall Study|Withdrawal by Subject|0|||
23565636|NCT01078662|65799723|FG000|Overall Study|Protocol Violation|0|||
23565637|NCT01078662|65799724|FG001|Overall Study|Protocol Violation|1|||
23565638|NCT01078662|65799725|FG002|Overall Study|Protocol Violation|0|||
23565639|NCT01078662|65799726|FG003|Overall Study|Protocol Violation|0|||
23565640|NCT01078662|65799727|FG004|Overall Study|Protocol Violation|0|||
23565641|NCT01078662|65799723|FG000|Overall Study|Lost to Follow-up|1|||
23627823|NCT02419417|66024558|FG003|Overall Study|Withdrawal by Subject|0|||
23627824|NCT02419417|66024559|FG004|Overall Study|Withdrawal by Subject|0|||
23627825|NCT02419417|66024560|FG005|Overall Study|Withdrawal by Subject|0|||
23627826|NCT02419417|66024561|FG006|Overall Study|Withdrawal by Subject|0|||
23627827|NCT02419417|66024562|FG007|Overall Study|Withdrawal by Subject|0|||
23627828|NCT02419417|66024563|FG008|Overall Study|Withdrawal by Subject|0|||
23627829|NCT02419417|66024564|FG009|Overall Study|Withdrawal by Subject|0|||
23761893|NCT01155583|66505485|FG008|Phase I|Screen failure - did not start treatment|0|||
23761894|NCT01155583|66505477|FG000|Phase I|Withdrawal by Subject|0|||
23761895|NCT01155583|66505478|FG001|Phase I|Withdrawal by Subject|0|||
23565642|NCT01078662|65799724|FG001|Overall Study|Lost to Follow-up|0|||
23565643|NCT01078662|65799725|FG002|Overall Study|Lost to Follow-up|0|||
23565644|NCT01078662|65799726|FG003|Overall Study|Lost to Follow-up|0|||
23565645|NCT01078662|65799727|FG004|Overall Study|Lost to Follow-up|0|||
23565646|NCT00920621|65799728|FG000|Overall Study|Lost to Follow-up|16|||
23565647|NCT00920621|65799729|FG001|Overall Study|Lost to Follow-up|17|||
23627830|NCT02419417|66024565|FG010|Overall Study|Withdrawal by Subject|1|||
23627831|NCT00543062|66024566|FG000|Overall Study|Withdrawal by Subject|1|||
23627832|NCT00543062|66024567|FG001|Overall Study|Withdrawal by Subject|0|||
23627833|NCT00543062|66024568|FG002|Overall Study|Withdrawal by Subject|2|||
23627834|NCT00543062|66024569|FG003|Overall Study|Withdrawal by Subject|0|||
23627835|NCT00543062|66024566|FG000|Overall Study|Adverse Event|0|||
23627836|NCT00543062|66024567|FG001|Overall Study|Adverse Event|1|||
23627837|NCT00543062|66024568|FG002|Overall Study|Adverse Event|1|||
23627838|NCT00543062|66024569|FG003|Overall Study|Adverse Event|1|||
23627839|NCT00543062|66024566|FG000|Overall Study|Protocol Violation|1|||
23627840|NCT00543062|66024567|FG001|Overall Study|Protocol Violation|0|||
23627841|NCT00543062|66024568|FG002|Overall Study|Protocol Violation|0|||
23627842|NCT00543062|66024569|FG003|Overall Study|Protocol Violation|0|||
23627843|NCT00832000|66024570|FG000|Overall Study|Adverse Event|2|||
23627844|NCT00832000|66024571|FG001|Overall Study|Adverse Event|0|||
23627845|NCT00832000|66024570|FG000|Overall Study|Withdrawal by Subject|1|||
23627846|NCT00832000|66024571|FG001|Overall Study|Withdrawal by Subject|0|||
23627847|NCT00832000|66024570|FG000|Overall Study|No calls to IVR in either period|1|||
23627848|NCT00832000|66024571|FG001|Overall Study|No calls to IVR in either period|1|||
23627849|NCT00832000|66024570|FG000|Overall Study|No calls to IVR in period 2|2|||
23627850|NCT00832000|66024571|FG001|Overall Study|No calls to IVR in period 2|0|||
23627851|NCT04650698|66024574|FG000|Overall Study|Protocol Violation|2|||
23627852|NCT04650698|66024575|FG001|Overall Study|Protocol Violation|1|||
23627853|NCT04650698|66024574|FG000|Overall Study|Withdrawal by Subject|0|||
23627854|NCT04650698|66024575|FG001|Overall Study|Withdrawal by Subject|1|||
23627855|NCT02684123|66024579|FG000|Phase 1|Lack of Efficacy|5|||
23627856|NCT02684123|66024580|FG001|Phase 1|Lack of Efficacy|0|||
23627857|NCT02684123|66024579|FG000|Phase 1|Adverse Event|3|||
23627858|NCT02684123|66024580|FG001|Phase 1|Adverse Event|0|||
23627859|NCT02684123|66024579|FG000|Phase 1|Lost to Follow-up|0|||
23627860|NCT02684123|66024580|FG001|Phase 1|Lost to Follow-up|1|||
23627861|NCT02684123|66024579|FG000|Phase 2|Lack of Efficacy|1|||
23627862|NCT02684123|66024580|FG001|Phase 2|Lack of Efficacy|8|||
23627863|NCT01012947|66024581|FG000|Overall Study|Lost to Follow-up|131|||
23627864|NCT01012947|66024582|FG001|Overall Study|Lost to Follow-up|135|||
23627865|NCT01012947|66024583|FG002|Overall Study|Lost to Follow-up|130|||
23627866|NCT01012947|66024584|FG003|Overall Study|Lost to Follow-up|118|||
23627867|NCT01012947|66024585|FG004|Overall Study|Lost to Follow-up|142|||
23627868|NCT01606319|66024587|FG000|Overall Study|Lost to Follow-up|17|||
23627869|NCT01606319|66024588|FG001|Overall Study|Lost to Follow-up|14|||
23627870|NCT01606319|66024587|FG000|Overall Study|Withdrawal by Subject|9|||
23627871|NCT01606319|66024588|FG001|Overall Study|Withdrawal by Subject|12|||
23627872|NCT01606319|66024587|FG000|Overall Study|Physician Decision|1|||
23627873|NCT01606319|66024588|FG001|Overall Study|Physician Decision|2|||
23627874|NCT01606319|66024587|FG000|Overall Study|Lack of Efficacy|6|||
23627875|NCT01606319|66024588|FG001|Overall Study|Lack of Efficacy|8|||
23627876|NCT01606319|66024587|FG000|Overall Study|Adverse Event|1|||
23627877|NCT01606319|66024588|FG001|Overall Study|Adverse Event|4|||
23627878|NCT00583947|66024589|FG000|Cross-over Period|Adverse Event|2|||
23627879|NCT00583947|66024590|FG001|Cross-over Period|Adverse Event|0|||
23627880|NCT00583947|66024589|FG000|Cross-over Period|Withdrawal by Subject|2|||
23627881|NCT00583947|66024590|FG001|Cross-over Period|Withdrawal by Subject|0|||
23627882|NCT00583947|66024589|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
23627883|NCT00583947|66024590|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
23627884|NCT00583947|66024589|FG000|Cross-over Period|Other|1|||
23627885|NCT00583947|66024590|FG001|Cross-over Period|Other|1|||
23627886|NCT01114672|66024598|FG000|Overall Study|Death|0|||
23627887|NCT01114672|66024599|FG001|Overall Study|Death|1|||
23627888|NCT01114672|66024598|FG000|Overall Study|Withdrawal by Subject|2|||
23627889|NCT01114672|66024599|FG001|Overall Study|Withdrawal by Subject|1|||
23627890|NCT01114672|66024598|FG000|Overall Study|Lost to Follow-up|1|||
23627891|NCT01114672|66024599|FG001|Overall Study|Lost to Follow-up|0|||
23627892|NCT01114672|66024598|FG000|Overall Study|transplanted|1|||
23627893|NCT01114672|66024599|FG001|Overall Study|transplanted|0|||
23627894|NCT01436305|66024600|FG000|Overall Study|Death|1|||
23627895|NCT01436305|66024601|FG001|Overall Study|Death|0|||
23627896|NCT01436305|66024602|FG002|Overall Study|Death|0|||
23828018|NCT01662492|66749046|FG000|Overall Study|Withdrawal by Subject|0|||
23828019|NCT01662492|66749047|FG001|Overall Study|Withdrawal by Subject|0|||
23627897|NCT01436305|66024600|FG000|Overall Study|Lost to Follow-up|0|||
23627898|NCT01436305|66024601|FG001|Overall Study|Lost to Follow-up|1|||
23627899|NCT01436305|66024602|FG002|Overall Study|Lost to Follow-up|0|||
23627900|NCT01436305|66024600|FG000|Overall Study|Withdrawal by Subject|1|||
23627901|NCT01436305|66024601|FG001|Overall Study|Withdrawal by Subject|3|||
23627902|NCT01436305|66024602|FG002|Overall Study|Withdrawal by Subject|0|||
23627903|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
23627904|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
23627905|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
23627906|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
23627907|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
23627908|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
23627909|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
23627910|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
23627911|NCT00823836|66024604|FG000|Long-term Phase|Adverse Event|3|||
23627912|NCT00823836|66024605|FG001|Long-term Phase|Adverse Event|2|||
23627913|NCT00823836|66024604|FG000|Long-term Phase|Physician Decision|1|||
23627914|NCT00823836|66024605|FG001|Long-term Phase|Physician Decision|2|||
23627915|NCT00823836|66024604|FG000|Long-term Phase|Withdrawal by Subject|1|||
23627916|NCT00823836|66024605|FG001|Long-term Phase|Withdrawal by Subject|1|||
23627917|NCT03065933|66024606|FG000|Overall Study|study terminated|5|||
23627918|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
23627919|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
23627920|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
23627921|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
23761896|NCT01155583|66505479|FG002|Phase I|Withdrawal by Subject|0|||
23761897|NCT01155583|66505480|FG003|Phase I|Withdrawal by Subject|0|||
23761898|NCT01155583|66505481|FG004|Phase I|Withdrawal by Subject|0|||
23761899|NCT01155583|66505482|FG005|Phase I|Withdrawal by Subject|0|||
23828020|NCT01662492|66749048|FG002|Overall Study|Withdrawal by Subject|1|||
23828021|NCT01662492|66749046|FG000|Overall Study|Protocol Violation|1|||
23828022|NCT01662492|66749047|FG001|Overall Study|Protocol Violation|0|||
23828023|NCT01662492|66749048|FG002|Overall Study|Protocol Violation|0|||
23828024|NCT01662492|66749046|FG000|Overall Study|Lost to Follow-up|0|||
23828025|NCT01662492|66749047|FG001|Overall Study|Lost to Follow-up|0|||
23828026|NCT01662492|66749048|FG002|Overall Study|Lost to Follow-up|2|||
23828027|NCT01662492|66749046|FG000|Overall Study|Lack of Efficacy|1|||
23828028|NCT01662492|66749047|FG001|Overall Study|Lack of Efficacy|1|||
23828029|NCT01662492|66749048|FG002|Overall Study|Lack of Efficacy|2|||
23828030|NCT02906670|66749049|FG000|Cohort 1, QW|Radiological Progression|1|||
23828031|NCT02906670|66749050|FG001|Cohort 1, QW|Radiological Progression|0|||
23828032|NCT02906670|66749051|FG002|Cohort 1, QW|Radiological Progression|0|||
23627922|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
23761900|NCT01155583|66505483|FG006|Phase I|Withdrawal by Subject|0|||
23761901|NCT01155583|66505484|FG007|Phase I|Withdrawal by Subject|1|||
23761902|NCT01155583|66505485|FG008|Phase I|Withdrawal by Subject|0|||
23761903|NCT02995837|66505486|FG000|Overall Study|Lost to Follow-up|9|||
23761904|NCT02995837|66505487|FG001|Overall Study|Lost to Follow-up|8|||
23761905|NCT01084603|66505488|FG000|Baseline|Withdrawal by Subject|2|||
23761906|NCT01084603|66505488|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
23761907|NCT01084603|66505488|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
23761908|NCT01084603|66505488|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
23761909|NCT01084603|66505488|FG000|Washout Period 4|Adverse Event|1|||
23761910|NCT01904383|66505489|FG000|Overall Study|CRF not collected|117|||
23761911|NCT01904383|66505489|FG000|Overall Study|Reason not listed|147|||
23761912|NCT01904383|66505489|FG000|Overall Study|Lost to Follow-up|674|||
23761913|NCT01904383|66505489|FG000|Overall Study|Lack of Efficacy|370|||
23761914|NCT01904383|66505489|FG000|Overall Study|Improvement|141|||
23761915|NCT01904383|66505489|FG000|Overall Study|Adverse Event|271|||
23761916|NCT01904383|66505489|FG000|Overall Study|No patient visit after entry|54|||
23761917|NCT00408876|66505490|FG000|Overall Study|Adverse Event|9|||
23761918|NCT00408876|66505491|FG001|Overall Study|Adverse Event|17|||
23761919|NCT00408876|66505492|FG002|Overall Study|Adverse Event|27|||
23761920|NCT00408876|66505493|FG003|Overall Study|Adverse Event|10|||
23761921|NCT00408876|66505490|FG000|Overall Study|Withdrawal by Subject|3|||
23761922|NCT00408876|66505491|FG001|Overall Study|Withdrawal by Subject|6|||
23761923|NCT00408876|66505492|FG002|Overall Study|Withdrawal by Subject|6|||
23761924|NCT00408876|66505493|FG003|Overall Study|Withdrawal by Subject|14|||
23761925|NCT00408876|66505490|FG000|Overall Study|Lack of Efficacy|2|||
23761926|NCT00408876|66505491|FG001|Overall Study|Lack of Efficacy|4|||
23761927|NCT00408876|66505492|FG002|Overall Study|Lack of Efficacy|5|||
23761928|NCT00408876|66505493|FG003|Overall Study|Lack of Efficacy|6|||
23761929|NCT00408876|66505490|FG000|Overall Study|Lost to Follow-up|1|||
23761930|NCT00408876|66505491|FG001|Overall Study|Lost to Follow-up|6|||
23761931|NCT00408876|66505492|FG002|Overall Study|Lost to Follow-up|5|||
23761932|NCT00408876|66505493|FG003|Overall Study|Lost to Follow-up|2|||
23761933|NCT00408876|66505490|FG000|Overall Study|Protocol Violation|0|||
23828033|NCT02906670|66749052|FG003|Cohort 1, QW|Radiological Progression|0|||
23828034|NCT02906670|66749053|FG004|Cohort 1, QW|Radiological Progression|0|||
23627923|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
23761934|NCT00408876|66505491|FG001|Overall Study|Protocol Violation|3|||
23761935|NCT00408876|66505492|FG002|Overall Study|Protocol Violation|4|||
23761936|NCT00408876|66505493|FG003|Overall Study|Protocol Violation|3|||
23761937|NCT00408876|66505490|FG000|Overall Study|Physician Decision|1|||
23761938|NCT00408876|66505491|FG001|Overall Study|Physician Decision|0|||
23761939|NCT00408876|66505492|FG002|Overall Study|Physician Decision|3|||
23442669|NCT00306527|65362177|FG002|Overall Study|Withdrawal by Subject|0|||
23627924|NCT00798304|66024609|FG000|Overall Study|Adverse Event|0|||
23627925|NCT00798304|66024610|FG001|Overall Study|Adverse Event|1|||
23828035|NCT02906670|66749054|FG005|Cohort 1, QW|Radiological Progression|0|||
23828036|NCT02906670|66749055|FG006|Cohort 1, QW|Radiological Progression|0|||
23627926|NCT00798304|66024611|FG002|Overall Study|Adverse Event|1|||
23627927|NCT00798304|66024609|FG000|Overall Study|Discontinuation by Sponsor|14|||
23627928|NCT00798304|66024610|FG001|Overall Study|Discontinuation by Sponsor|21|||
23627929|NCT00798304|66024611|FG002|Overall Study|Discontinuation by Sponsor|9|||
23627930|NCT03062449|66024612|FG000|Overall Study|Withdrawal by Subject|7|||
23627931|NCT03062449|66024613|FG001|Overall Study|Withdrawal by Subject|1|||
23627932|NCT04140266|66024614|FG000|Overall Study|Physician Decision|2|||
23627933|NCT04140266|66024615|FG001|Overall Study|Physician Decision|0|||
23627934|NCT04140266|66024614|FG000|Overall Study|Withdrawal by Subject|4|||
23627935|NCT04140266|66024615|FG001|Overall Study|Withdrawal by Subject|2|||
23627936|NCT01740154|66024619|FG000|Overall Study|Adverse Event|1|||
23627937|NCT03784820|66024620|FG000|Overall Study|Lost to Follow-up|5|||
23627938|NCT03784820|66024621|FG001|Overall Study|Lost to Follow-up|5|||
23627939|NCT03784820|66024622|FG002|Overall Study|Lost to Follow-up|3|||
23627940|NCT03784820|66024623|FG003|Overall Study|Lost to Follow-up|3|||
23627941|NCT03021551|66024624|FG000|Overall Study|Equipment Issues|2|||
23627942|NCT03021551|66024624|FG000|Overall Study|Protocol Violation|1|||
23627943|NCT01712061|66024625|FG000|Overall Study|Adverse Event|4|||
23627944|NCT01712061|66024626|FG001|Overall Study|Adverse Event|9|||
23627945|NCT01712061|66024627|FG002|Overall Study|Adverse Event|5|||
23627946|NCT01712061|66024625|FG000|Overall Study|Death|0|||
23627947|NCT01712061|66024626|FG001|Overall Study|Death|0|||
23627948|NCT01712061|66024627|FG002|Overall Study|Death|1|||
23627949|NCT01712061|66024625|FG000|Overall Study|Lost to Follow-up|1|||
23627950|NCT01712061|66024626|FG001|Overall Study|Lost to Follow-up|0|||
23627951|NCT01712061|66024627|FG002|Overall Study|Lost to Follow-up|1|||
23627952|NCT01712061|66024625|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
23627953|NCT01712061|66024626|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
23627954|NCT01712061|66024627|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
23627955|NCT01712061|66024625|FG000|Overall Study|Medication Error Without Associated AE|0|||
23627956|NCT01712061|66024626|FG001|Overall Study|Medication Error Without Associated AE|1|||
23627957|NCT01712061|66024627|FG002|Overall Study|Medication Error Without Associated AE|0|||
23627958|NCT01712061|66024625|FG000|Overall Study|Withdrawal by Subject|1|||
23627959|NCT01712061|66024626|FG001|Overall Study|Withdrawal by Subject|7|||
23627960|NCT01712061|66024627|FG002|Overall Study|Withdrawal by Subject|1|||
23627961|NCT01712061|66024625|FG000|Overall Study|Other|0|||
23627962|NCT01712061|66024626|FG001|Overall Study|Other|3|||
23627963|NCT01712061|66024627|FG002|Overall Study|Other|0|||
23627964|NCT00967005|66024628|FG000|Overall Study|Lost to Follow-up|7|||
23627965|NCT00967005|66024629|FG001|Overall Study|Lost to Follow-up|10|||
23627966|NCT04927364|66024631|FG000|Overall Study|Withdrawal by Subject|3|||
23761940|NCT00408876|66505493|FG003|Overall Study|Physician Decision|0|||
23761941|NCT02390219|66507952|FG000|Overall Study|Death|1|||
23761942|NCT02390219|66507952|FG000|Overall Study|Physician Decision|1|||
23761943|NCT02390219|66507952|FG000|Overall Study|Adverse Event|6|||
23761944|NCT02390219|66507952|FG000|Overall Study|Withdrawal by Subject|1|||
23761945|NCT02390219|66507952|FG000|Overall Study|Lost to Follow-up|2|||
23761946|NCT02390219|66507952|FG000|Overall Study|Other|2|||
23761947|NCT01814137|66507955|FG000|Overall Study|Adverse Event|0|||
23761948|NCT01814137|66507956|FG001|Overall Study|Adverse Event|1|||
23761949|NCT01814137|66507955|FG000|Overall Study|Withdrawal by Subject|2|||
23761950|NCT01814137|66507956|FG001|Overall Study|Withdrawal by Subject|2|||
23761951|NCT01814137|66507955|FG000|Overall Study|Physician Decision|1|||
23761952|NCT01814137|66507956|FG001|Overall Study|Physician Decision|1|||
23627967|NCT04927364|66024631|FG000|Overall Study|Unable to complete preassessment MRI|1|||
23627968|NCT00784147|66024632|FG000|Overall Study|Lost to Follow-up|2|||
23627969|NCT00784147|66024633|FG001|Overall Study|Lost to Follow-up|4|||
23627970|NCT00784147|66024632|FG000|Overall Study|Withdrawal by Subject|1|||
23627971|NCT00784147|66024633|FG001|Overall Study|Withdrawal by Subject|3|||
23627972|NCT00784147|66024632|FG000|Overall Study|Physician Decision|2|||
23627973|NCT00784147|66024633|FG001|Overall Study|Physician Decision|1|||
23627974|NCT00784147|66024632|FG000|Overall Study|Protocol Violation|1|||
23627975|NCT00784147|66024633|FG001|Overall Study|Protocol Violation|1|||
23627976|NCT00784147|66024632|FG000|Overall Study|Death|2|||
23761953|NCT01814137|66507955|FG000|Overall Study|Unclassified|2|||
23761954|NCT01814137|66507956|FG001|Overall Study|Unclassified|1|||
23761955|NCT03208933|66507957|FG000|Overall Study|Death|3|||
23761956|NCT03208933|66507957|FG000|Overall Study|Withdrawal by Subject|3|||
23761957|NCT03208933|66507957|FG000|Overall Study|Adverse Event|1|||
23761958|NCT03208933|66507957|FG000|Overall Study|Lost to Follow-up|2|||
23761959|NCT03208933|66507957|FG000|Overall Study|Physician Decision|3|||
23761960|NCT03208933|66507957|FG000|Overall Study|Protocol Violation|1|||
23761961|NCT00614055|66507959|FG000|Overall Study|Adverse Event|1|||
23761962|NCT00614055|66507960|FG001|Overall Study|Adverse Event|0|||
23761963|NCT00614055|66507961|FG002|Overall Study|Adverse Event|0|||
23761964|NCT00614055|66507959|FG000|Overall Study|Protocol Violation|2|||
23761965|NCT00614055|66507960|FG001|Overall Study|Protocol Violation|2|||
23761966|NCT00614055|66507961|FG002|Overall Study|Protocol Violation|1|||
23761967|NCT00614055|66507959|FG000|Overall Study|Lack of Efficacy|0|||
23761968|NCT00614055|66507960|FG001|Overall Study|Lack of Efficacy|0|||
23761969|NCT00614055|66507961|FG002|Overall Study|Lack of Efficacy|2|||
23761970|NCT00614055|66507959|FG000|Overall Study|Unclassified|1|||
23761971|NCT00614055|66507960|FG001|Overall Study|Unclassified|4|||
23761972|NCT00614055|66507961|FG002|Overall Study|Unclassified|2|||
23761973|NCT00006721|66507962|FG000|Overall Study|Adverse Event|0|||
23761974|NCT00006721|66507963|FG001|Overall Study|Adverse Event|4|||
23761975|NCT00006721|66507964|FG002|Overall Study|Adverse Event|4|||
23761976|NCT00006721|66507962|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23761977|NCT00006721|66507963|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
23565648|NCT00920621|65799730|FG002|Overall Study|Lost to Follow-up|19|||
23761978|NCT00006721|66507964|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
23761979|NCT00006721|66507962|FG000|Overall Study|Progression/Relapse|0|||
23761980|NCT00006721|66507963|FG001|Overall Study|Progression/Relapse|1|||
23761981|NCT00006721|66507964|FG002|Overall Study|Progression/Relapse|2|||
23761982|NCT00006721|66507962|FG000|Overall Study|Death|0|||
23761983|NCT00006721|66507963|FG001|Overall Study|Death|1|||
23761984|NCT00006721|66507964|FG002|Overall Study|Death|2|||
23761985|NCT00006721|66507962|FG000|Overall Study|Other - Not Protocol Specified|0|||
23761986|NCT00006721|66507963|FG001|Overall Study|Other - Not Protocol Specified|7|||
23761987|NCT00006721|66507964|FG002|Overall Study|Other - Not Protocol Specified|7|||
23761988|NCT00006721|66507962|FG000|Overall Study|Ineligible|2|||
23761989|NCT00006721|66507963|FG001|Overall Study|Ineligible|12|||
23761990|NCT00006721|66507964|FG002|Overall Study|Ineligible|10|||
23761991|NCT00006721|66507962|FG000|Overall Study|Eligible but no Treatment Received|1|||
23761992|NCT00006721|66507963|FG001|Overall Study|Eligible but no Treatment Received|0|||
23761993|NCT00006721|66507964|FG002|Overall Study|Eligible but no Treatment Received|0|||
23761994|NCT00633152|66507965|FG000|Overall Study|Adverse Event|1|||
23761995|NCT00633152|66507966|FG001|Overall Study|Adverse Event|0|||
23761996|NCT00633152|66507965|FG000|Overall Study|Randomized, did not receive study drug|5|||
23828037|NCT02906670|66749056|FG007|Cohort 1, QW|Radiological Progression|0|||
23828038|NCT02906670|66749057|FG008|Cohort 1, QW|Radiological Progression|0|||
23565649|NCT00920621|65799731|FG003|Overall Study|Lost to Follow-up|21|||
23565650|NCT00920621|65799728|FG000|Overall Study|Fetal/neonatal deaths|16|||
23565651|NCT00920621|65799729|FG001|Overall Study|Fetal/neonatal deaths|14|||
23565652|NCT00920621|65799730|FG002|Overall Study|Fetal/neonatal deaths|16|||
23565653|NCT00920621|65799731|FG003|Overall Study|Fetal/neonatal deaths|14|||
23565654|NCT00920621|65799728|FG000|Overall Study|Blood sample not collected|22|||
23565655|NCT00920621|65799729|FG001|Overall Study|Blood sample not collected|14|||
23627977|NCT00784147|66024633|FG001|Overall Study|Death|0|||
23761997|NCT00633152|66507966|FG001|Overall Study|Randomized, did not receive study drug|2|||
23761998|NCT00633152|66507965|FG000|Overall Study|Withdrawal by Subject|1|||
23761999|NCT00633152|66507966|FG001|Overall Study|Withdrawal by Subject|1|||
23762000|NCT00633152|66507965|FG000|Overall Study|Lost to Follow-up|4|||
23762001|NCT00633152|66507966|FG001|Overall Study|Lost to Follow-up|1|||
23762002|NCT00633152|66507965|FG000|Overall Study|Miscellaneous Other|3|||
23762003|NCT00633152|66507966|FG001|Overall Study|Miscellaneous Other|2|||
23762004|NCT01427803|66507968|FG000|Overall Study|Lost to Follow-up|32|||
23762005|NCT01427803|66507969|FG001|Overall Study|Lost to Follow-up|26|||
23762006|NCT01427803|66507968|FG000|Overall Study|Withdrawal by Subject|20|||
23762007|NCT01427803|66507969|FG001|Overall Study|Withdrawal by Subject|0|||
23762008|NCT01427803|66507968|FG000|Overall Study|Unable to complete full treatment period|6|||
23762009|NCT01427803|66507969|FG001|Overall Study|Unable to complete full treatment period|0|||
23762010|NCT01427803|66507968|FG000|Overall Study|Protocol Violation|1|||
23762011|NCT01427803|66507969|FG001|Overall Study|Protocol Violation|0|||
23565656|NCT00920621|65799730|FG002|Overall Study|Blood sample not collected|0|||
23762012|NCT01427803|66507968|FG000|Overall Study|Physician Decision|3|||
23762013|NCT01427803|66507969|FG001|Overall Study|Physician Decision|0|||
23762014|NCT01427803|66507968|FG000|Overall Study|did not take product|1|||
23762015|NCT01427803|66507969|FG001|Overall Study|did not take product|0|||
23565657|NCT00920621|65799731|FG003|Overall Study|Blood sample not collected|0|||
23565658|NCT02588261|65799732|FG000|Overall Study|Study Terminated by Sponsor|157|||
23762016|NCT03812679|66507977|FG000|Overall Study|Adverse Event|2|||
23762017|NCT03812679|66507977|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
23565659|NCT02588261|65799733|FG001|Overall Study|Study Terminated by Sponsor|142|||
23828039|NCT02906670|66749058|FG009|Cohort 1, QW|Radiological Progression|0|||
23828040|NCT02906670|66749049|FG000|Cohort 2, QW|Radiological Progression|0|||
23828041|NCT02906670|66749050|FG001|Cohort 2, QW|Radiological Progression|1|||
23828042|NCT02906670|66749051|FG002|Cohort 2, QW|Radiological Progression|0|||
23828043|NCT02906670|66749052|FG003|Cohort 2, QW|Radiological Progression|0|||
23828044|NCT02906670|66749053|FG004|Cohort 2, QW|Radiological Progression|0|||
23828045|NCT02906670|66749054|FG005|Cohort 2, QW|Radiological Progression|0|||
23828046|NCT02906670|66749055|FG006|Cohort 2, QW|Radiological Progression|0|||
23828047|NCT02906670|66749056|FG007|Cohort 2, QW|Radiological Progression|0|||
23828048|NCT02906670|66749057|FG008|Cohort 2, QW|Radiological Progression|0|||
23828049|NCT02906670|66749058|FG009|Cohort 2, QW|Radiological Progression|0|||
23828050|NCT02906670|66749049|FG000|Cohort 3, QW|Radiological Progression|0|||
23828051|NCT02906670|66749050|FG001|Cohort 3, QW|Radiological Progression|0|||
23828052|NCT02906670|66749051|FG002|Cohort 3, QW|Radiological Progression|2|||
23828053|NCT02906670|66749052|FG003|Cohort 3, QW|Radiological Progression|0|||
23828054|NCT02906670|66749053|FG004|Cohort 3, QW|Radiological Progression|0|||
23828055|NCT02906670|66749054|FG005|Cohort 3, QW|Radiological Progression|0|||
23828056|NCT02906670|66749055|FG006|Cohort 3, QW|Radiological Progression|0|||
23828057|NCT02906670|66749056|FG007|Cohort 3, QW|Radiological Progression|0|||
23828058|NCT02906670|66749057|FG008|Cohort 3, QW|Radiological Progression|0|||
23828059|NCT02906670|66749058|FG009|Cohort 3, QW|Radiological Progression|0|||
23828060|NCT02906670|66749049|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828061|NCT02906670|66749050|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828062|NCT02906670|66749051|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
23828063|NCT02906670|66749052|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828064|NCT02906670|66749053|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828065|NCT02906670|66749054|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828066|NCT02906670|66749055|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828067|NCT02906670|66749056|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828068|NCT02906670|66749057|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828069|NCT02906670|66749058|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
23828070|NCT02906670|66749049|FG000|Cohort 4, Q2W|Radiological Progression|0|||
23828071|NCT02906670|66749050|FG001|Cohort 4, Q2W|Radiological Progression|0|||
23828072|NCT02906670|66749051|FG002|Cohort 4, Q2W|Radiological Progression|0|||
23828073|NCT02906670|66749052|FG003|Cohort 4, Q2W|Radiological Progression|0|||
23828074|NCT02906670|66749053|FG004|Cohort 4, Q2W|Radiological Progression|0|||
23828075|NCT02906670|66749054|FG005|Cohort 4, Q2W|Radiological Progression|1|||
23828076|NCT02906670|66749055|FG006|Cohort 4, Q2W|Radiological Progression|0|||
23828077|NCT02906670|66749056|FG007|Cohort 4, Q2W|Radiological Progression|0|||
23762018|NCT03812679|66507977|FG000|Overall Study|Renal transplant|1|||
23762019|NCT03812679|66507977|FG000|Overall Study|Withdrawal by Subject|1|||
23762020|NCT03812679|66507977|FG000|Overall Study|Termination of study|2|||
23762021|NCT03812679|66507977|FG000|Overall Study|Water device replacement|1|||
23762022|NCT00490061|66507979|FG000|Overall Study|Physician Decision|1|||
23762023|NCT02981602|66507980|FG000|Overall Study|Adverse Event|0|||
23762024|NCT02981602|66507981|FG001|Overall Study|Adverse Event|0|||
23762025|NCT02981602|66507982|FG002|Overall Study|Adverse Event|0|||
23762026|NCT02981602|66507983|FG003|Overall Study|Adverse Event|1|||
23762027|NCT02981602|66507984|FG004|Overall Study|Adverse Event|0|||
23762028|NCT03763331|66507986|FG000|Overall Study|Lost to Follow-up|1|||
23762029|NCT03763331|66507987|FG001|Overall Study|Lost to Follow-up|0|||
23762030|NCT03763331|66507986|FG000|Overall Study|Withdrawal by Subject|1|||
23762031|NCT03763331|66507987|FG001|Overall Study|Withdrawal by Subject|0|||
23762032|NCT03763331|66507986|FG000|Overall Study|Non-compliance|0|||
23762033|NCT03763331|66507987|FG001|Overall Study|Non-compliance|3|||
23762034|NCT04132232|66507988|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
23762035|NCT04132232|66507989|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
23762036|NCT04132232|66507988|FG000|Overall Study|Lost to Follow-up|6|||
23762037|NCT04132232|66507989|FG001|Overall Study|Lost to Follow-up|7|||
23762038|NCT01623830|66507990|FG000|Overall Study|Withdrawal by Subject|6|||
23762039|NCT01623830|66507991|FG001|Overall Study|Withdrawal by Subject|7|||
23762040|NCT01623830|66507990|FG000|Overall Study|Exclusion from Study|1|||
23762041|NCT01623830|66507991|FG001|Overall Study|Exclusion from Study|2|||
23762042|NCT05476679|66507992|FG000|Overall Study|Withdrawal by Subject|0|||
23762043|NCT05476679|66507993|FG001|Overall Study|Withdrawal by Subject|0|||
23828078|NCT02906670|66749057|FG008|Cohort 4, Q2W|Radiological Progression|0|||
23565660|NCT02588261|65799732|FG000|Overall Study|Protocol Deviation|1|||
23762044|NCT05476679|66507994|FG002|Overall Study|Withdrawal by Subject|0|||
23762045|NCT05476679|66507995|FG003|Overall Study|Withdrawal by Subject|1|||
23762046|NCT05476679|66507996|FG004|Overall Study|Withdrawal by Subject|0|||
23762047|NCT05476679|66507992|FG000|Overall Study|Lost to Follow-up|0|||
23828079|NCT02906670|66749058|FG009|Cohort 4, Q2W|Radiological Progression|0|||
23828080|NCT02906670|66749049|FG000|Cohort 4, Q2W|Clinical Progression|0|||
23828081|NCT02906670|66749050|FG001|Cohort 4, Q2W|Clinical Progression|0|||
23762048|NCT05476679|66507993|FG001|Overall Study|Lost to Follow-up|0|||
23762049|NCT05476679|66507994|FG002|Overall Study|Lost to Follow-up|0|||
23762050|NCT05476679|66507995|FG003|Overall Study|Lost to Follow-up|1|||
23762051|NCT05476679|66507996|FG004|Overall Study|Lost to Follow-up|0|||
23762052|NCT02741271|66507997|FG000|Overall Study|Lost to Follow-up|2|||
23762053|NCT02741271|66507998|FG001|Overall Study|Lost to Follow-up|0|||
23762054|NCT02741271|66507997|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23762055|NCT02741271|66507998|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23762056|NCT00881959|66507999|FG000|Overall Study|Lost to Follow-up|2|||
23762057|NCT00881959|66508000|FG001|Overall Study|Lost to Follow-up|4|||
23762058|NCT03493698|66508001|FG000|Treatment Period C|Adverse Event|1|||
23762059|NCT03493698|66508001|FG000|Treatment Period C|Withdrawal by Subject|1|||
23762060|NCT00475852|66508002|FG000|Overall Study|Death|444|||
23762061|NCT00475852|66508003|FG001|Overall Study|Death|456|||
23762062|NCT00475852|66508002|FG000|Overall Study|Withdrawal by Subject|19|||
23762063|NCT00475852|66508003|FG001|Overall Study|Withdrawal by Subject|24|||
23762064|NCT00475852|66508002|FG000|Overall Study|Lost to Follow-up|54|||
23762065|NCT00475852|66508003|FG001|Overall Study|Lost to Follow-up|68|||
23762066|NCT00770315|66508006|FG000|Overall Study|Adverse Event|11|||
23762067|NCT00770315|66508007|FG001|Overall Study|Adverse Event|17|||
23762068|NCT00770315|66508008|FG002|Overall Study|Adverse Event|16|||
23762069|NCT00770315|66508009|FG003|Overall Study|Adverse Event|6|||
23762070|NCT00770315|66508006|FG000|Overall Study|Lost to Follow-up|9|||
23762071|NCT00770315|66508007|FG001|Overall Study|Lost to Follow-up|5|||
23762072|NCT00770315|66508008|FG002|Overall Study|Lost to Follow-up|10|||
23565661|NCT02588261|65799733|FG001|Overall Study|Protocol Deviation|0|||
23565662|NCT02588261|65799732|FG000|Overall Study|Death|1|||
23565663|NCT02588261|65799733|FG001|Overall Study|Death|2|||
23565664|NCT02588261|65799732|FG000|Overall Study|Withdrawal by Subject|12|||
23565665|NCT02588261|65799733|FG001|Overall Study|Withdrawal by Subject|8|||
23565666|NCT02588261|65799732|FG000|Overall Study|Noncompliance with Study Drug|0|||
23565667|NCT02588261|65799733|FG001|Overall Study|Noncompliance with Study Drug|1|||
23627978|NCT01078922|66024636|FG000|Overall Study|Adverse Event|1|||
23627979|NCT01426347|66024638|FG000|Overall Study|Lost to Follow-up|0|||
23627980|NCT01426347|66024639|FG001|Overall Study|Lost to Follow-up|3|||
23762073|NCT00770315|66508009|FG003|Overall Study|Lost to Follow-up|3|||
23762074|NCT00770315|66508006|FG000|Overall Study|Withdrawal by Subject|13|||
23762075|NCT00770315|66508007|FG001|Overall Study|Withdrawal by Subject|17|||
23762076|NCT00770315|66508008|FG002|Overall Study|Withdrawal by Subject|24|||
23762077|NCT00770315|66508009|FG003|Overall Study|Withdrawal by Subject|20|||
23762078|NCT00770315|66508006|FG000|Overall Study|Noncompliance with Protocol|7|||
23762079|NCT00770315|66508007|FG001|Overall Study|Noncompliance with Protocol|4|||
23762080|NCT00770315|66508008|FG002|Overall Study|Noncompliance with Protocol|7|||
23762081|NCT00770315|66508009|FG003|Overall Study|Noncompliance with Protocol|9|||
23762082|NCT02499354|66508019|FG000|Overall Study|Withdrawal by Subject|1|||
23762083|NCT02499354|66508020|FG001|Overall Study|Withdrawal by Subject|0|||
23762084|NCT02763579|66508021|FG000|Global Period|Death|167|||
23762085|NCT02763579|66508022|FG001|Global Period|Death|151|||
23762086|NCT02763579|66508023|FG002|Global Period|Death|0|||
23762087|NCT02763579|66508024|FG003|Global Period|Death|0|||
23442670|NCT00306527|65362178|FG003|Overall Study|Withdrawal by Subject|3|||
23442671|NCT00306527|65362175|FG000|Overall Study|Adverse Event|0|||
23442672|NCT00306527|65362176|FG001|Overall Study|Adverse Event|0|||
23627981|NCT01426347|66024638|FG000|Overall Study|Protocol Violation|2|||
23627982|NCT01426347|66024639|FG001|Overall Study|Protocol Violation|0|||
23627983|NCT01426347|66024638|FG000|Overall Study|Withdrawal by Subject|5|||
23627984|NCT01426347|66024639|FG001|Overall Study|Withdrawal by Subject|0|||
23627985|NCT02906020|66024640|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
23627986|NCT02906020|66024641|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
23627987|NCT02906020|66024642|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
23627988|NCT02906020|66024643|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
23627989|NCT02906020|66024644|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
23627990|NCT02906020|66024645|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
23762088|NCT02763579|66508021|FG000|Global Period|Lost to Follow-up|2|||
23762089|NCT02763579|66508022|FG001|Global Period|Lost to Follow-up|4|||
23762090|NCT02763579|66508023|FG002|Global Period|Lost to Follow-up|0|||
23762091|NCT02763579|66508024|FG003|Global Period|Lost to Follow-up|0|||
23762092|NCT02763579|66508021|FG000|Global Period|Physician Decision|0|||
23762093|NCT02763579|66508022|FG001|Global Period|Physician Decision|2|||
23828082|NCT02906670|66749051|FG002|Cohort 4, Q2W|Clinical Progression|0|||
23442673|NCT00306527|65362177|FG002|Overall Study|Adverse Event|1|||
23442674|NCT00306527|65362178|FG003|Overall Study|Adverse Event|1|||
23442675|NCT00306527|65362175|FG000|Overall Study|Death|1|||
23565668|NCT02588261|65799732|FG000|Overall Study|Miscellaneous|5|||
23627991|NCT02906020|66024646|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
23627992|NCT02906020|66024647|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
23627993|NCT02906020|66024648|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
23762094|NCT02763579|66508023|FG002|Global Period|Physician Decision|0|||
23762095|NCT02763579|66508024|FG003|Global Period|Physician Decision|0|||
23442676|NCT00306527|65362176|FG001|Overall Study|Death|0|||
23442677|NCT00306527|65362177|FG002|Overall Study|Death|1|||
23442678|NCT00306527|65362178|FG003|Overall Study|Death|2|||
23442679|NCT01505374|65362185|FG000|Overall Study|Lost to Follow-up|1|||
23565669|NCT02588261|65799733|FG001|Overall Study|Miscellaneous|4|||
23565670|NCT02588261|65799732|FG000|Overall Study|Progressive Disease|61|||
23762096|NCT02763579|66508021|FG000|Global Period|Study Terminated By Sponsor|21|||
23762097|NCT02763579|66508022|FG001|Global Period|Study Terminated By Sponsor|26|||
23762098|NCT02763579|66508023|FG002|Global Period|Study Terminated By Sponsor|0|||
23762099|NCT02763579|66508024|FG003|Global Period|Study Terminated By Sponsor|0|||
23762100|NCT02763579|66508021|FG000|Global Period|Withdrawal by Subject|12|||
23762101|NCT02763579|66508022|FG001|Global Period|Withdrawal by Subject|18|||
23762102|NCT02763579|66508023|FG002|Global Period|Withdrawal by Subject|0|||
23762103|NCT02763579|66508024|FG003|Global Period|Withdrawal by Subject|0|||
23762104|NCT02763579|66508021|FG000|China Period|Death|0|||
23762105|NCT02763579|66508022|FG001|China Period|Death|0|||
23762106|NCT02763579|66508023|FG002|China Period|Death|46|||
23762107|NCT02763579|66508024|FG003|China Period|Death|48|||
23762108|NCT02763579|66508021|FG000|China Period|Lost to Follow-up|0|||
23762109|NCT02763579|66508022|FG001|China Period|Lost to Follow-up|0|||
23762110|NCT02763579|66508023|FG002|China Period|Lost to Follow-up|1|||
23762111|NCT02763579|66508024|FG003|China Period|Lost to Follow-up|1|||
23762112|NCT02763579|66508021|FG000|China Period|Physician Decision|0|||
23762113|NCT02763579|66508022|FG001|China Period|Physician Decision|0|||
23762114|NCT02763579|66508023|FG002|China Period|Physician Decision|0|||
23762115|NCT02763579|66508024|FG003|China Period|Physician Decision|1|||
23762116|NCT02763579|66508021|FG000|China Period|Study Terminated By Sponsor|0|||
23762117|NCT02763579|66508022|FG001|China Period|Study Terminated By Sponsor|0|||
23762118|NCT02763579|66508023|FG002|China Period|Study Terminated By Sponsor|3|||
23762119|NCT02763579|66508024|FG003|China Period|Study Terminated By Sponsor|4|||
23762120|NCT02763579|66508021|FG000|China Period|Withdrawal by Subject|0|||
23762121|NCT02763579|66508022|FG001|China Period|Withdrawal by Subject|0|||
23762122|NCT02763579|66508023|FG002|China Period|Withdrawal by Subject|3|||
23762123|NCT02763579|66508024|FG003|China Period|Withdrawal by Subject|3|||
23762124|NCT01326702|66508025|FG000|Overall Study|Other|1|||
23762125|NCT01326702|66508026|FG001|Overall Study|Other|0|||
23762126|NCT01326702|66508027|FG002|Overall Study|Other|0|||
23762127|NCT01326702|66508028|FG003|Overall Study|Other|0|||
23762128|NCT01326702|66508029|FG004|Overall Study|Other|0|||
23762129|NCT01326702|66508030|FG005|Overall Study|Other|1|||
23762130|NCT01326702|66508031|FG006|Overall Study|Other|0|||
23762131|NCT01326702|66508025|FG000|Overall Study|progressive disease|1|||
23762132|NCT01326702|66508026|FG001|Overall Study|progressive disease|1|||
23762133|NCT01326702|66508027|FG002|Overall Study|progressive disease|3|||
23762134|NCT01326702|66508028|FG003|Overall Study|progressive disease|1|||
23762135|NCT01326702|66508029|FG004|Overall Study|progressive disease|3|||
23762136|NCT01326702|66508030|FG005|Overall Study|progressive disease|2|||
23762137|NCT01326702|66508031|FG006|Overall Study|progressive disease|3|||
23762138|NCT01326702|66508025|FG000|Overall Study|Death|0|||
23762139|NCT01326702|66508026|FG001|Overall Study|Death|1|||
23762140|NCT01326702|66508027|FG002|Overall Study|Death|0|||
23762141|NCT01326702|66508028|FG003|Overall Study|Death|0|||
23762142|NCT01326702|66508029|FG004|Overall Study|Death|0|||
23762143|NCT01326702|66508030|FG005|Overall Study|Death|0|||
23762144|NCT01326702|66508031|FG006|Overall Study|Death|0|||
23762145|NCT01326702|66508025|FG000|Overall Study|Adverse Event|0|||
23762146|NCT01326702|66508026|FG001|Overall Study|Adverse Event|0|||
23762147|NCT01326702|66508027|FG002|Overall Study|Adverse Event|1|||
23762148|NCT01326702|66508028|FG003|Overall Study|Adverse Event|1|||
23762149|NCT01326702|66508029|FG004|Overall Study|Adverse Event|0|||
23762150|NCT01326702|66508030|FG005|Overall Study|Adverse Event|3|||
23762151|NCT01326702|66508031|FG006|Overall Study|Adverse Event|1|||
23762152|NCT01326702|66508025|FG000|Overall Study|Withdrawal by Subject|0|||
23762153|NCT01326702|66508026|FG001|Overall Study|Withdrawal by Subject|0|||
23762154|NCT01326702|66508027|FG002|Overall Study|Withdrawal by Subject|1|||
23762155|NCT01326702|66508028|FG003|Overall Study|Withdrawal by Subject|0|||
23762156|NCT01326702|66508029|FG004|Overall Study|Withdrawal by Subject|1|||
23762157|NCT01326702|66508030|FG005|Overall Study|Withdrawal by Subject|1|||
23442680|NCT01505374|65362186|FG001|Overall Study|Lost to Follow-up|0|||
23565671|NCT02588261|65799733|FG001|Overall Study|Progressive Disease|82|||
23762158|NCT01326702|66508031|FG006|Overall Study|Withdrawal by Subject|3|||
23762159|NCT01326702|66508025|FG000|Overall Study|Not Treated|0|||
23762160|NCT01326702|66508026|FG001|Overall Study|Not Treated|0|||
23762161|NCT01326702|66508027|FG002|Overall Study|Not Treated|0|||
23762162|NCT01326702|66508028|FG003|Overall Study|Not Treated|1|||
23762163|NCT01326702|66508029|FG004|Overall Study|Not Treated|0|||
23762164|NCT01326702|66508030|FG005|Overall Study|Not Treated|1|||
23762165|NCT01326702|66508031|FG006|Overall Study|Not Treated|0|||
23762166|NCT01254045|66508032|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
23762167|NCT01254045|66508033|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23762168|NCT01254045|66508034|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23762169|NCT01254045|66508035|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23762170|NCT01254045|66508036|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23762171|NCT01254045|66508037|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23762172|NCT01102777|66508039|FG000|Overall Study|Death|2|||
23762173|NCT01102777|66508040|FG001|Overall Study|Death|6|||
23762174|NCT01102777|66508039|FG000|Overall Study|Lost to Follow-up|7|||
23762175|NCT01102777|66508040|FG001|Overall Study|Lost to Follow-up|10|||
23762176|NCT02762565|66508055|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
23565672|NCT02588261|65799732|FG000|Overall Study|Adverse Event|29|||
23565673|NCT02588261|65799733|FG001|Overall Study|Adverse Event|24|||
23565674|NCT02588261|65799732|FG000|Overall Study|Lost to Follow-up|1|||
23565675|NCT02588261|65799733|FG001|Overall Study|Lost to Follow-up|0|||
23565676|NCT04615182|65799734|FG000|Overall Study|Re-transplanted|2|||
23565677|NCT04615182|65799734|FG000|Overall Study|Protocol Violation|6|||
23565678|NCT04615182|65799734|FG000|Overall Study|Death|6|||
23565679|NCT04615182|65799734|FG000|Overall Study|Death and protocol violation|1|||
23565680|NCT02712398|65799737|FG000|Overall Study|Withdrawal by Subject|6|||
23565681|NCT02712398|65799737|FG000|Overall Study|Lost to Follow-up|6|||
23565682|NCT02712398|65799737|FG000|Overall Study|Sponsor Decision|1|||
23565683|NCT02712398|65799737|FG000|Overall Study|Physician Decision|1|||
23565684|NCT02712398|65799737|FG000|Overall Study|Death|2|||
23565685|NCT02712398|65799737|FG000|Overall Study|Re-operation|21|||
23565686|NCT03203694|65799738|FG000|Overall Study|Withdrawal by Subject|2|||
23565687|NCT03203694|65799739|FG001|Overall Study|Withdrawal by Subject|0|||
23565688|NCT03203694|65799740|FG002|Overall Study|Withdrawal by Subject|0|||
23565689|NCT03203694|65799741|FG003|Overall Study|Withdrawal by Subject|0|||
23565690|NCT03203694|65799742|FG004|Overall Study|Withdrawal by Subject|0|||
23565691|NCT03203694|65799743|FG005|Overall Study|Withdrawal by Subject|0|||
23565692|NCT03439189|65799744|FG000|Overall Study|Protocol Violation|19|||
23565693|NCT03439189|65799744|FG000|Overall Study|Lack of Efficacy|63|||
23565694|NCT02387216|65799747|FG000|Overall Study|Progressive disease|2|||
23565695|NCT02387216|65799748|FG001|Overall Study|Progressive disease|0|||
23565696|NCT02387216|65799747|FG000|Overall Study|Withdrawal by Subject|3|||
23565697|NCT02387216|65799748|FG001|Overall Study|Withdrawal by Subject|5|||
23565698|NCT02387216|65799747|FG000|Overall Study|Physician Decision|2|||
23565699|NCT02387216|65799748|FG001|Overall Study|Physician Decision|0|||
23565700|NCT02387216|65799747|FG000|Overall Study|Sponsor Decision|28|||
23565701|NCT02387216|65799748|FG001|Overall Study|Sponsor Decision|12|||
23762177|NCT01169649|66508063|FG000|Overall Study|Patient Not Treated|3|||
23762178|NCT03549130|66508065|FG000|Overall Study|Adverse Event|0|||
23762179|NCT03549130|66508066|FG001|Overall Study|Adverse Event|1|||
23762180|NCT03549130|66508065|FG000|Overall Study|Lost to Follow-up|0|||
23762181|NCT03549130|66508066|FG001|Overall Study|Lost to Follow-up|1|||
23762182|NCT01664052|66508067|FG000|Phase 1|No device placement|6|||
23762183|NCT01664052|66508068|FG001|Phase 1|No device placement|0|||
23762184|NCT01664052|66508067|FG000|Phase 1|No HSG 1 hr post placement|1|||
23762185|NCT01664052|66508068|FG001|Phase 1|No HSG 1 hr post placement|0|||
23762186|NCT01664052|66508067|FG000|Phase 2|No device placement|0|||
23762187|NCT01664052|66508068|FG001|Phase 2|No device placement|4|||
23762188|NCT00003102|66508069|FG000|Overall Study|Physician Decision|1|||
23762189|NCT00003102|66508070|FG001|Overall Study|Physician Decision|1|||
23762190|NCT00003102|66508071|FG002|Overall Study|Physician Decision|0|||
23762191|NCT00003102|66508069|FG000|Overall Study|Progressive Disease|0|||
23762192|NCT00003102|66508070|FG001|Overall Study|Progressive Disease|1|||
23762193|NCT00003102|66508071|FG002|Overall Study|Progressive Disease|0|||
23762194|NCT00003102|66508069|FG000|Overall Study|Adverse Event|0|||
23565702|NCT02387216|65799747|FG000|Overall Study|Death|60|||
23565703|NCT02387216|65799748|FG001|Overall Study|Death|23|||
23565704|NCT02387216|65799747|FG000|Overall Study|Other|5|||
23565705|NCT02387216|65799748|FG001|Overall Study|Other|4|||
23565706|NCT02387216|65799747|FG000|Overall Study|Lost to Follow-up|0|||
23762195|NCT00003102|66508070|FG001|Overall Study|Adverse Event|1|||
23627994|NCT02906020|66024649|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
23762196|NCT00003102|66508071|FG002|Overall Study|Adverse Event|1|||
23762197|NCT00003102|66508069|FG000|Overall Study|Death|0|||
23442681|NCT01618695|65362188|FG000|Core Phase|Adverse Event|4|||
23442682|NCT01618695|65362189|FG001|Core Phase|Adverse Event|5|||
23442683|NCT01618695|65362190|FG002|Core Phase|Adverse Event|15|||
23565707|NCT02387216|65799748|FG001|Overall Study|Lost to Follow-up|3|||
23565708|NCT01160484|65799749|FG000|Overall Study|Lack of Efficacy|9|||
23565709|NCT01160484|65799749|FG000|Overall Study|Adverse Event|6|||
23565710|NCT01160484|65799749|FG000|Overall Study|Withdrawal by Subject|2|||
23565711|NCT01160484|65799749|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
23762198|NCT00003102|66508070|FG001|Overall Study|Death|0|||
23762199|NCT00003102|66508071|FG002|Overall Study|Death|1|||
23762200|NCT00575328|66508074|FG000|Overall Study|Adverse Event|1|||
23565712|NCT01567865|65799751|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
23565713|NCT01567865|65799752|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
23565714|NCT01567865|65799753|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
23565715|NCT01567865|65799754|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
23762201|NCT00575328|66508075|FG001|Overall Study|Adverse Event|1|||
23762202|NCT00575328|66508074|FG000|Overall Study|Lost to Follow-up|2|||
23762203|NCT00575328|66508075|FG001|Overall Study|Lost to Follow-up|1|||
23762204|NCT03349333|66508076|FG000|Overall Study|Progression of Disease|36|||
23762205|NCT03349333|66508076|FG000|Overall Study|Adverse Event|11|||
23442684|NCT01618695|65362191|FG003|Core Phase|Adverse Event|20|||
23565716|NCT01567865|65799751|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
23565717|NCT01567865|65799752|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
23565718|NCT01567865|65799753|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
23565719|NCT01567865|65799754|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
23565720|NCT00113360|65799757|FG000|Overall Study|Adverse Event|3|||
23565721|NCT00113360|65799757|FG000|Overall Study|Subject required surgery|1|||
23565722|NCT00113360|65799757|FG000|Overall Study|Did not meet eligibility criteria|3|||
23565723|NCT00960752|65799759|FG000|Overall Study|Adverse Event|0|||
23565724|NCT00960752|65799760|FG001|Overall Study|Adverse Event|0|||
23565725|NCT00960752|65799761|FG002|Overall Study|Adverse Event|1|||
23565726|NCT00960752|65799759|FG000|Overall Study|Progression|0|||
23565727|NCT00960752|65799760|FG001|Overall Study|Progression|0|||
23565728|NCT00960752|65799761|FG002|Overall Study|Progression|1|||
23565729|NCT00954733|65799762|FG000|Overall Study|blood gas machine did not work|1|||
23565730|NCT01382602|65799763|FG000|Overall Study|Protocol Violation|0|||
23565731|NCT01382602|65799764|FG001|Overall Study|Protocol Violation|3|||
23565732|NCT01382602|65799763|FG000|Overall Study|Withdrawal by Subject|0|||
23565733|NCT01382602|65799764|FG001|Overall Study|Withdrawal by Subject|1|||
23565734|NCT04772053|65799765|FG000|Overall Study|Physician Decision|2|||
23565735|NCT04772053|65799765|FG000|Overall Study|Withdrawal by Subject|3|||
23565736|NCT04772053|65799765|FG000|Overall Study|Study Terminated by Sponsor|1|||
23565737|NCT02614066|65799766|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
23565738|NCT02614066|65799767|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
23565739|NCT02614066|65799768|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
23565740|NCT02614066|65799769|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
23565741|NCT02614066|65799766|FG000|Overall Study|Full Consent Withdrawn|0|||
23565742|NCT02614066|65799767|FG001|Overall Study|Full Consent Withdrawn|1|||
23565743|NCT02614066|65799768|FG002|Overall Study|Full Consent Withdrawn|0|||
23565744|NCT02614066|65799769|FG003|Overall Study|Full Consent Withdrawn|3|||
23565745|NCT02614066|65799766|FG000|Overall Study|Lost to Follow-up|0|||
23565746|NCT02614066|65799767|FG001|Overall Study|Lost to Follow-up|1|||
23565747|NCT02614066|65799768|FG002|Overall Study|Lost to Follow-up|0|||
23565748|NCT02614066|65799769|FG003|Overall Study|Lost to Follow-up|0|||
23565749|NCT02614066|65799766|FG000|Overall Study|Still on-study|1|||
23565750|NCT02614066|65799767|FG001|Overall Study|Still on-study|9|||
23565751|NCT02614066|65799768|FG002|Overall Study|Still on-study|5|||
23565752|NCT02614066|65799769|FG003|Overall Study|Still on-study|32|||
23565753|NCT02614066|65799766|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
23565754|NCT02614066|65799767|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
23442685|NCT01618695|65362188|FG000|Core Phase|Lost to Follow-up|0|||
23442686|NCT01618695|65362189|FG001|Core Phase|Lost to Follow-up|0|||
23442687|NCT01618695|65362190|FG002|Core Phase|Lost to Follow-up|1|||
23442688|NCT01618695|65362191|FG003|Core Phase|Lost to Follow-up|0|||
23442689|NCT01618695|65362188|FG000|Core Phase|Withdrawal by Subject|16|||
23565755|NCT02614066|65799768|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
23565756|NCT02614066|65799769|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
23442690|NCT01618695|65362189|FG001|Core Phase|Withdrawal by Subject|11|||
23442691|NCT01618695|65362190|FG002|Core Phase|Withdrawal by Subject|9|||
23442692|NCT01618695|65362191|FG003|Core Phase|Withdrawal by Subject|13|||
23442693|NCT01618695|65362188|FG000|Core Phase|Pregnancy|2|||
23442694|NCT01618695|65362189|FG001|Core Phase|Pregnancy|0|||
23627995|NCT02906020|66024650|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
23627996|NCT02906020|66024651|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
23627997|NCT02906020|66024652|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
23762206|NCT03349333|66508076|FG000|Overall Study|Other|6|||
23442695|NCT01618695|65362190|FG002|Core Phase|Pregnancy|0|||
23442696|NCT01618695|65362191|FG003|Core Phase|Pregnancy|0|||
23565757|NCT04105972|65799772|FG000|Overall Study|Adverse Event|2|||
23565758|NCT04105972|65799773|FG001|Overall Study|Adverse Event|1|||
23565759|NCT00785707|65799774|FG000|Overall Study|Lost to Follow-up|7|||
23565760|NCT00787319|65799779|FG000|Overall Study|Lost to Follow-up|2|||
23565761|NCT00787319|65799779|FG000|Overall Study|Withdrawal by Subject|15|||
23442697|NCT01618695|65362188|FG000|Core Phase|Lack of Efficacy|1|||
23565762|NCT00787319|65799779|FG000|Overall Study|Adverse Event|3|||
23627998|NCT02906020|66024653|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
23762207|NCT03349333|66508076|FG000|Overall Study|Withdrawal by Subject|5|||
23627999|NCT02906020|66024654|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
23628000|NCT02906020|66024655|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
23628001|NCT02906020|66024640|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628002|NCT02906020|66024641|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628003|NCT02906020|66024642|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628004|NCT02906020|66024643|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628005|NCT02906020|66024644|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628006|NCT02906020|66024645|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628007|NCT02906020|66024646|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628008|NCT02906020|66024647|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628009|NCT02906020|66024648|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
23628010|NCT02906020|66024649|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
23628011|NCT02906020|66024650|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628012|NCT02906020|66024651|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628013|NCT02906020|66024652|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628014|NCT02906020|66024653|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628015|NCT02906020|66024654|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628016|NCT02906020|66024655|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628017|NCT02906020|66024640|FG000|Part 2: Double-blind Treatment Period|Other|0|||
23628018|NCT02906020|66024641|FG001|Part 2: Double-blind Treatment Period|Other|0|||
23628019|NCT02906020|66024642|FG002|Part 2: Double-blind Treatment Period|Other|0|||
23628020|NCT02906020|66024643|FG003|Part 2: Double-blind Treatment Period|Other|0|||
23628021|NCT02906020|66024644|FG004|Part 2: Double-blind Treatment Period|Other|0|||
23628022|NCT02906020|66024645|FG005|Part 2: Double-blind Treatment Period|Other|0|||
23628023|NCT02906020|66024646|FG006|Part 2: Double-blind Treatment Period|Other|0|||
23628024|NCT02906020|66024647|FG007|Part 2: Double-blind Treatment Period|Other|0|||
23628025|NCT02906020|66024648|FG008|Part 2: Double-blind Treatment Period|Other|6|||
23628026|NCT02906020|66024649|FG009|Part 2: Double-blind Treatment Period|Other|10|||
23628027|NCT02906020|66024650|FG010|Part 2: Double-blind Treatment Period|Other|0|||
23628028|NCT02906020|66024651|FG011|Part 2: Double-blind Treatment Period|Other|0|||
23628029|NCT02906020|66024652|FG012|Part 2: Double-blind Treatment Period|Other|0|||
23628030|NCT02906020|66024653|FG013|Part 2: Double-blind Treatment Period|Other|0|||
23628031|NCT02906020|66024654|FG014|Part 2: Double-blind Treatment Period|Other|0|||
23628032|NCT02906020|66024655|FG015|Part 2: Double-blind Treatment Period|Other|0|||
23628033|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628034|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628035|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628036|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628037|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628038|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628039|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628040|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628041|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628042|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628043|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628044|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628045|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
23628046|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
23628047|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628048|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628049|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628050|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628051|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628052|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628053|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628054|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628055|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628056|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628057|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628058|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628059|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628060|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628061|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
23628062|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
23628063|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628064|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
23628065|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628066|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628067|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628068|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23762208|NCT03349333|66508076|FG000|Overall Study|Conditions interfere with participation|2|||
23762209|NCT03349333|66508076|FG000|Overall Study|Physician Decision|2|||
23762210|NCT03349333|66508076|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
23762211|NCT03349333|66508076|FG000|Overall Study|Patients in treatment less than 24 month|8|||
23762212|NCT03840811|66508079|FG000|Overall Study|Lost to Follow-up|0|||
23442698|NCT01618695|65362189|FG001|Core Phase|Lack of Efficacy|2|||
23442699|NCT01618695|65362190|FG002|Core Phase|Lack of Efficacy|1|||
23762213|NCT03840811|66508080|FG001|Overall Study|Lost to Follow-up|0|||
23762214|NCT03840811|66508081|FG002|Overall Study|Lost to Follow-up|1|||
23762215|NCT03137082|66508083|FG000|Overall Study|Withdrawal by Subject|1|||
23762216|NCT03137082|66508084|FG001|Overall Study|Withdrawal by Subject|1|||
23762217|NCT03137082|66508083|FG000|Overall Study|Lost to Follow-up|1|||
23762218|NCT03137082|66508084|FG001|Overall Study|Lost to Follow-up|0|||
23762219|NCT04242186|66508085|FG000|Overall Study|Death|5|||
23762220|NCT00373685|66508086|FG000|Overall Study|Death|2|||
23762221|NCT00373685|66508087|FG001|Overall Study|Death|1|||
23762222|NCT00373685|66508086|FG000|Overall Study|Adverse Event|278|||
23762223|NCT00373685|66508087|FG001|Overall Study|Adverse Event|253|||
23762224|NCT00373685|66508086|FG000|Overall Study|Insufficient clinical response|169|||
23762225|NCT00373685|66508087|FG001|Overall Study|Insufficient clinical response|119|||
23762226|NCT00373685|66508086|FG000|Overall Study|Did not meet entrance criteria|167|||
23828083|NCT02906670|66749052|FG003|Cohort 4, Q2W|Clinical Progression|0|||
23828084|NCT02906670|66749053|FG004|Cohort 4, Q2W|Clinical Progression|0|||
23828085|NCT02906670|66749054|FG005|Cohort 4, Q2W|Clinical Progression|2|||
23828086|NCT02906670|66749055|FG006|Cohort 4, Q2W|Clinical Progression|0|||
23828087|NCT02906670|66749056|FG007|Cohort 4, Q2W|Clinical Progression|0|||
23828088|NCT02906670|66749057|FG008|Cohort 4, Q2W|Clinical Progression|0|||
23828089|NCT02906670|66749058|FG009|Cohort 4, Q2W|Clinical Progression|0|||
23828090|NCT02906670|66749049|FG000|Cohort 5, Q2W|Radiological Progression|0|||
23828091|NCT02906670|66749050|FG001|Cohort 5, Q2W|Radiological Progression|0|||
23828092|NCT02906670|66749051|FG002|Cohort 5, Q2W|Radiological Progression|0|||
23828093|NCT02906670|66749052|FG003|Cohort 5, Q2W|Radiological Progression|0|||
23828094|NCT02906670|66749053|FG004|Cohort 5, Q2W|Radiological Progression|0|||
23828095|NCT02906670|66749054|FG005|Cohort 5, Q2W|Radiological Progression|0|||
23828096|NCT02906670|66749055|FG006|Cohort 5, Q2W|Radiological Progression|4|||
23828097|NCT02906670|66749056|FG007|Cohort 5, Q2W|Radiological Progression|0|||
23828098|NCT02906670|66749057|FG008|Cohort 5, Q2W|Radiological Progression|0|||
23828099|NCT02906670|66749058|FG009|Cohort 5, Q2W|Radiological Progression|0|||
23828100|NCT02906670|66749049|FG000|Cohort 5, Q2W|Clinical Progression|0|||
23828101|NCT02906670|66749050|FG001|Cohort 5, Q2W|Clinical Progression|0|||
23828102|NCT02906670|66749051|FG002|Cohort 5, Q2W|Clinical Progression|0|||
23828103|NCT02906670|66749052|FG003|Cohort 5, Q2W|Clinical Progression|0|||
23828104|NCT02906670|66749053|FG004|Cohort 5, Q2W|Clinical Progression|0|||
23442700|NCT01618695|65362191|FG003|Core Phase|Lack of Efficacy|1|||
23442701|NCT01618695|65362188|FG000|Core Phase|Other than specified|1|||
23628069|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628070|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23762227|NCT00373685|66508087|FG001|Overall Study|Did not meet entrance criteria|184|||
23762228|NCT00373685|66508086|FG000|Overall Study|Lost to follow up|83|||
23565763|NCT00787319|65799779|FG000|Overall Study|Objective progression or relapse|30|||
23565764|NCT00787319|65799779|FG000|Overall Study|Lack of Efficacy|1|||
23565765|NCT00787319|65799779|FG000|Overall Study|Budget exhausted/exceeded|1|||
23565766|NCT00787319|65799779|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
23565767|NCT00787319|65799779|FG000|Overall Study|No health insurance reimbursement|2|||
23565768|NCT00787319|65799779|FG000|Overall Study|Stabilized disease findings|3|||
23565769|NCT00787319|65799779|FG000|Overall Study|Inactive disease|5|||
23762229|NCT00373685|66508087|FG001|Overall Study|Lost to follow up|103|||
23762230|NCT00373685|66508086|FG000|Overall Study|No longer willing to participate|337|||
23762231|NCT00373685|66508087|FG001|Overall Study|No longer willing to participate|352|||
23762232|NCT00373685|66508086|FG000|Overall Study|Other|149|||
23762233|NCT00373685|66508087|FG001|Overall Study|Other|146|||
23762234|NCT00373685|66508086|FG000|Overall Study|Protocol Violation|191|||
23628071|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23762235|NCT00373685|66508087|FG001|Overall Study|Protocol Violation|182|||
23628072|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628073|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628074|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628075|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628076|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628077|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
23628078|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
23628079|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628080|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628081|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628082|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628083|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628084|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628085|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628086|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628087|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628088|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628089|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628090|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628091|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628092|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628093|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
23628094|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
23628095|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628096|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628097|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628098|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628099|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628100|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628101|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23762236|NCT00373685|66508086|FG000|Overall Study|Final Status Unknown|12|||
23762237|NCT00373685|66508087|FG001|Overall Study|Final Status Unknown|4|||
23565770|NCT02823964|65799782|FG000|Overall Study|Adverse Event|2|||
23565771|NCT02823964|65799782|FG000|Overall Study|Physician Decision|1|||
23565772|NCT02823964|65799782|FG000|Overall Study|Lack of Efficacy|1|||
23628102|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628103|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23762238|NCT00373685|66508086|FG000|Overall Study|Randomized, not treated|51|||
23565773|NCT02823964|65799782|FG000|Overall Study|Withdrawal by Subject|1|||
23565774|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565775|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565776|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565777|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
23565778|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565779|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565780|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565781|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
23628104|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628105|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628106|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628107|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628108|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628109|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
23628110|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
23628111|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
23628112|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
23628113|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Other|0|||
23628114|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Other|0|||
23628115|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Other|0|||
23628116|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Other|0|||
23628117|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Other|0|||
23628118|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Other|0|||
23628119|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Other|0|||
23628120|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Other|0|||
23628121|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Other|0|||
23628122|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Other|0|||
23628123|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Other|0|||
23628124|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Other|0|||
23628125|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Other|13|||
23762239|NCT00373685|66508087|FG001|Overall Study|Randomized, not treated|77|||
23762240|NCT00580983|66508088|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
23762241|NCT01186978|66508089|FG000|Overall Study|Withdrawal by Subject|1|||
23628126|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Other|8|||
23628127|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Other|3|||
23628128|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Other|2|||
23628129|NCT01628692|66024656|FG000|Overall Study|Lack of Efficacy|4|||
23628130|NCT01628692|66024657|FG001|Overall Study|Lack of Efficacy|4|||
23762242|NCT03469271|66508094|FG000|Overall Study|Withdrawal by Subject|2|||
23762243|NCT03469271|66508095|FG001|Overall Study|Withdrawal by Subject|0|||
23762244|NCT03469271|66508096|FG002|Overall Study|Withdrawal by Subject|0|||
23762245|NCT03469271|66508097|FG003|Overall Study|Withdrawal by Subject|1|||
23762246|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
23762247|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
23762248|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
23762249|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
23762250|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
23762251|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
23762252|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
23762253|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
23762254|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
23762255|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
23762256|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
23762257|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
23762258|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
23762259|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
23762260|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
23762261|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
23762262|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
23762263|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
23762264|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
23565782|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23628131|NCT01628692|66024658|FG002|Overall Study|Lack of Efficacy|5|||
23628132|NCT01628692|66024659|FG003|Overall Study|Lack of Efficacy|1|||
23628133|NCT01628692|66024660|FG004|Overall Study|Lack of Efficacy|4|||
23628134|NCT01628692|66024661|FG005|Overall Study|Lack of Efficacy|7|||
23628135|NCT01628692|66024656|FG000|Overall Study|Adverse Event|2|||
23628136|NCT01628692|66024657|FG001|Overall Study|Adverse Event|0|||
23628137|NCT01628692|66024658|FG002|Overall Study|Adverse Event|2|||
23628138|NCT01628692|66024659|FG003|Overall Study|Adverse Event|0|||
23628139|NCT01628692|66024660|FG004|Overall Study|Adverse Event|0|||
23628140|NCT01628692|66024661|FG005|Overall Study|Adverse Event|0|||
23628141|NCT01628692|66024656|FG000|Overall Study|Withdrawal by Subject|0|||
23628142|NCT01628692|66024657|FG001|Overall Study|Withdrawal by Subject|1|||
23628143|NCT01628692|66024658|FG002|Overall Study|Withdrawal by Subject|1|||
23628144|NCT01628692|66024659|FG003|Overall Study|Withdrawal by Subject|0|||
23628145|NCT01628692|66024660|FG004|Overall Study|Withdrawal by Subject|0|||
23565783|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23565784|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
23565785|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23565786|NCT02914314|65799783|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565787|NCT02914314|65799784|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565788|NCT02914314|65799785|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
23628146|NCT01628692|66024661|FG005|Overall Study|Withdrawal by Subject|0|||
23628147|NCT01628692|66024656|FG000|Overall Study|Death|0|||
23628148|NCT01628692|66024657|FG001|Overall Study|Death|1|||
23628149|NCT01628692|66024658|FG002|Overall Study|Death|0|||
23628150|NCT01628692|66024659|FG003|Overall Study|Death|0|||
23628151|NCT01628692|66024660|FG004|Overall Study|Death|0|||
23628152|NCT01628692|66024661|FG005|Overall Study|Death|0|||
23628153|NCT01628692|66024656|FG000|Overall Study|Poor compliance/noncompliance|1|||
23628154|NCT01628692|66024657|FG001|Overall Study|Poor compliance/noncompliance|0|||
23628155|NCT01628692|66024658|FG002|Overall Study|Poor compliance/noncompliance|0|||
23628156|NCT01628692|66024659|FG003|Overall Study|Poor compliance/noncompliance|0|||
23628157|NCT01628692|66024660|FG004|Overall Study|Poor compliance/noncompliance|0|||
23628158|NCT01628692|66024661|FG005|Overall Study|Poor compliance/noncompliance|0|||
23628159|NCT01628692|66024656|FG000|Overall Study|Administrative reason by sponsor|0|||
23628160|NCT01628692|66024657|FG001|Overall Study|Administrative reason by sponsor|0|||
23628161|NCT01628692|66024658|FG002|Overall Study|Administrative reason by sponsor|0|||
23628162|NCT01628692|66024659|FG003|Overall Study|Administrative reason by sponsor|0|||
23628163|NCT01628692|66024660|FG004|Overall Study|Administrative reason by sponsor|0|||
23628164|NCT01628692|66024661|FG005|Overall Study|Administrative reason by sponsor|1|||
23628165|NCT01628692|66024656|FG000|Overall Study|Completed 12 Week only|0|||
23628166|NCT01628692|66024657|FG001|Overall Study|Completed 12 Week only|0|||
23628167|NCT01628692|66024658|FG002|Overall Study|Completed 12 Week only|0|||
23628168|NCT01628692|66024659|FG003|Overall Study|Completed 12 Week only|0|||
23628169|NCT01628692|66024660|FG004|Overall Study|Completed 12 Week only|0|||
23628170|NCT01628692|66024661|FG005|Overall Study|Completed 12 Week only|1|||
23628171|NCT01844726|66024664|FG000|Overall Study|Withdrawal by Subject|0|||
23628172|NCT01844726|66024665|FG001|Overall Study|Withdrawal by Subject|1|||
23628173|NCT01844726|66024664|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
23442702|NCT01618695|65362189|FG001|Core Phase|Other than specified|2|||
23565789|NCT02914314|65799786|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565790|NCT02914314|65799783|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565791|NCT02914314|65799784|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565792|NCT02914314|65799785|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
23565793|NCT02914314|65799786|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565794|NCT01874145|65799790|FG000|Core Period|Non-compliance|1|||
23565795|NCT01874145|65799791|FG001|Core Period|Non-compliance|0|||
23565796|NCT01874145|65799790|FG000|Core Period|Protocol Violation|1|||
23565797|NCT01874145|65799791|FG001|Core Period|Protocol Violation|1|||
23565798|NCT01874145|65799790|FG000|Core Period|Physician Decision|1|||
23565799|NCT01874145|65799791|FG001|Core Period|Physician Decision|1|||
23565800|NCT01874145|65799790|FG000|Core Period|Adverse Event|0|||
23565801|NCT01874145|65799791|FG001|Core Period|Adverse Event|1|||
23565802|NCT01874145|65799790|FG000|Core Period|Withdrawal by Subject|0|||
23565803|NCT01874145|65799791|FG001|Core Period|Withdrawal by Subject|4|||
23565804|NCT01874145|65799790|FG000|Extension Period|Adverse Event|3|||
23565805|NCT01874145|65799791|FG001|Extension Period|Adverse Event|2|||
23565806|NCT01874145|65799790|FG000|Extension Period|Withdrawal by Subject|2|||
23565807|NCT01874145|65799791|FG001|Extension Period|Withdrawal by Subject|1|||
23565808|NCT01874145|65799790|FG000|Extension Period|Lost to Follow-up|1|||
23628174|NCT01844726|66024665|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
23628175|NCT03229486|66024666|FG000|Overall Study|Protocol Violation|0|||
23628176|NCT03229486|66024667|FG001|Overall Study|Protocol Violation|1|||
23628177|NCT01266161|66024668|FG000|Overall Study|Ineligible|1|||
23628178|NCT01266161|66024669|FG001|Overall Study|Ineligible|0|||
23628179|NCT01266161|66024668|FG000|Overall Study|Lack of Efficacy|0|||
23628180|NCT01266161|66024669|FG001|Overall Study|Lack of Efficacy|1|||
23628181|NCT01266161|66024668|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
23628182|NCT01266161|66024669|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
23628183|NCT01256671|66024671|FG000|Overall Study|Adverse Event|29|||
23628184|NCT01256671|66024671|FG000|Overall Study|Lost to Follow-up|16|||
23628185|NCT01256671|66024671|FG000|Overall Study|Withdrawal by Subject|31|||
23628186|NCT01256671|66024671|FG000|Overall Study|Physician Decision|3|||
23628187|NCT01256671|66024671|FG000|Overall Study|Lack of Efficacy|4|||
23628188|NCT01256671|66024671|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
23628189|NCT01288209|66024674|FG000|Overall Study|Withdrawal by Subject|1|||
23628190|NCT01288209|66024675|FG001|Overall Study|Withdrawal by Subject|3|||
23628191|NCT01288209|66024674|FG000|Overall Study|Other|1|||
23628192|NCT01288209|66024675|FG001|Overall Study|Other|0|||
23628193|NCT00760747|66024676|FG000|Study Period II|Adverse Event|3|||
23628194|NCT00760747|66024677|FG001|Study Period II|Adverse Event|4|||
23628195|NCT00760747|66024676|FG000|Study Period II|Lack of Efficacy|0|||
23628196|NCT00760747|66024677|FG001|Study Period II|Lack of Efficacy|6|||
23628197|NCT00760747|66024676|FG000|Study Period II|Parent/Caregiver Decision|3|||
23628198|NCT00760747|66024677|FG001|Study Period II|Parent/Caregiver Decision|0|||
23628199|NCT00760747|66024676|FG000|Study Period II|Protocol Violation|6|||
23628200|NCT00760747|66024677|FG001|Study Period II|Protocol Violation|3|||
23628201|NCT00760747|66024676|FG000|Study Period II|Withdrawal by Subject|1|||
23628202|NCT00760747|66024677|FG001|Study Period II|Withdrawal by Subject|0|||
23628203|NCT00760747|66024676|FG000|Study Period II|No drug administered|0|||
23628204|NCT00760747|66024677|FG001|Study Period II|No drug administered|1|||
23628205|NCT00760747|66024676|FG000|Study Period III|Adverse Event|1|||
23628206|NCT00760747|66024677|FG001|Study Period III|Adverse Event|0|||
23628207|NCT00760747|66024676|FG000|Study Period III|Lack of Efficacy|1|||
23628208|NCT00760747|66024677|FG001|Study Period III|Lack of Efficacy|0|||
23628209|NCT00760747|66024676|FG000|Study Period III|Parent/Caregiver Decision|0|||
23628210|NCT00760747|66024677|FG001|Study Period III|Parent/Caregiver Decision|1|||
23628211|NCT00760747|66024676|FG000|Study Period III|Protocol Violation|1|||
23628212|NCT00760747|66024677|FG001|Study Period III|Protocol Violation|1|||
23628213|NCT00760747|66024676|FG000|Study Period III|Physician Decision|0|||
23628214|NCT00760747|66024677|FG001|Study Period III|Physician Decision|1|||
23628215|NCT01536587|66024678|FG000|Overall Study|Adverse Event|2|||
23628216|NCT02577003|66024679|FG000|Overall Study|Adverse Event|2|||
23628217|NCT02577003|66024680|FG001|Overall Study|Adverse Event|4|||
23628218|NCT02577003|66024679|FG000|Overall Study|Withdrawal by Subject|0|||
23628219|NCT02577003|66024680|FG001|Overall Study|Withdrawal by Subject|1|||
23628220|NCT02242643|66024681|FG000|Overall Study|Protocol Violation|1|||
23628221|NCT02242643|66024682|FG001|Overall Study|Protocol Violation|2|||
23628222|NCT02242643|66024681|FG000|Overall Study|Withdrawal by Subject|15|||
23628223|NCT02242643|66024682|FG001|Overall Study|Withdrawal by Subject|10|||
23628224|NCT02242643|66024681|FG000|Overall Study|Migrated/moved from study area|1|||
23628225|NCT02242643|66024682|FG001|Overall Study|Migrated/moved from study area|3|||
23628226|NCT02242643|66024681|FG000|Overall Study|Lost to Follow-up|54|||
23628227|NCT02242643|66024682|FG001|Overall Study|Lost to Follow-up|61|||
23628228|NCT02242643|66024681|FG000|Overall Study|Child placed in foster care by family|0|||
23628229|NCT02242643|66024682|FG001|Overall Study|Child placed in foster care by family|1|||
23628230|NCT02242643|66024681|FG000|Overall Study|Non-compliance|1|||
23628231|NCT02242643|66024682|FG001|Overall Study|Non-compliance|0|||
23628232|NCT02242643|66024681|FG000|Overall Study|Consent withdrawal by parent|1|||
23628233|NCT02242643|66024682|FG001|Overall Study|Consent withdrawal by parent|0|||
23628234|NCT02242643|66024681|FG000|Overall Study|Protocol requirements not followed|1|||
23628235|NCT02242643|66024682|FG001|Overall Study|Protocol requirements not followed|0|||
23628236|NCT02242643|66024681|FG000|Overall Study|Language barrier|1|||
23628237|NCT02242643|66024682|FG001|Overall Study|Language barrier|0|||
23628238|NCT02242643|66024681|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
23628239|NCT02242643|66024682|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
23628240|NCT01240915|66024685|FG000|Overall Study|Adverse Event|0|||
23628241|NCT01240915|66024686|FG001|Overall Study|Adverse Event|0|||
23628242|NCT01240915|66024687|FG002|Overall Study|Adverse Event|0|||
23565809|NCT01874145|65799791|FG001|Extension Period|Lost to Follow-up|1|||
23565810|NCT02306122|65799792|FG000|Initial Physician Randomization|Physician Decision|0|||
23565811|NCT02306122|65799793|FG001|Initial Physician Randomization|Physician Decision|0|||
23565812|NCT02306122|65799794|FG002|Initial Physician Randomization|Physician Decision|0|||
23565813|NCT02306122|65799795|FG003|Initial Physician Randomization|Physician Decision|0|||
23565814|NCT02306122|65799796|FG004|Initial Physician Randomization|Physician Decision|0|||
23565815|NCT02306122|65799797|FG005|Initial Physician Randomization|Physician Decision|0|||
23565816|NCT02306122|65799798|FG006|Initial Physician Randomization|Physician Decision|0|||
23565817|NCT02306122|65799799|FG007|Initial Physician Randomization|Physician Decision|0|||
23565818|NCT02306122|65799800|FG008|Initial Physician Randomization|Physician Decision|1|||
23628243|NCT01240915|66024688|FG003|Overall Study|Adverse Event|1|||
23628244|NCT01240915|66024689|FG004|Overall Study|Adverse Event|0|||
23628245|NCT01240915|66024690|FG005|Overall Study|Adverse Event|2|||
23628246|NCT01240915|66024691|FG006|Overall Study|Adverse Event|0|||
23628247|NCT01240915|66024692|FG007|Overall Study|Adverse Event|0|||
23628248|NCT01240915|66024693|FG008|Overall Study|Adverse Event|1|||
23628249|NCT01240915|66024685|FG000|Overall Study|Lost to Follow-up|0|||
23628250|NCT01240915|66024686|FG001|Overall Study|Lost to Follow-up|0|||
23762265|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
23762266|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
23762267|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
23762268|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
23762269|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
23762270|NCT00455533|66508098|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
23762271|NCT00455533|66508099|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
23762272|NCT00455533|66508100|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
23762273|NCT00455533|66508098|FG000|Period Two: Randomized Period|Death|0|||
23762274|NCT00455533|66508099|FG001|Period Two: Randomized Period|Death|0|||
23762275|NCT00455533|66508100|FG002|Period Two: Randomized Period|Death|3|||
23565819|NCT02306122|65799801|FG009|Initial Physician Randomization|Physician Decision|0|||
23565820|NCT02306122|65799802|FG010|Initial Physician Randomization|Physician Decision|0|||
23565821|NCT01781390|65799803|FG000|Overall Study|Withdrawal of Consent|0|||
23565822|NCT01781390|65799804|FG001|Overall Study|Withdrawal of Consent|3|||
23565823|NCT01781390|65799805|FG002|Overall Study|Withdrawal of Consent|1|||
23565824|NCT01781390|65799803|FG000|Overall Study|Lost to Follow-up|1|||
23565825|NCT01781390|65799804|FG001|Overall Study|Lost to Follow-up|1|||
23565826|NCT01781390|65799805|FG002|Overall Study|Lost to Follow-up|1|||
23565827|NCT01781390|65799803|FG000|Overall Study|Adverse Event|1|||
23565828|NCT01781390|65799804|FG001|Overall Study|Adverse Event|2|||
23565829|NCT01781390|65799805|FG002|Overall Study|Adverse Event|1|||
23565830|NCT01781390|65799803|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
23565831|NCT01781390|65799804|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
23565832|NCT01781390|65799805|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
23565833|NCT00672958|65799810|FG000|Overall Study|Adverse Event|11|||
23565834|NCT00672958|65799811|FG001|Overall Study|Adverse Event|9|||
23762276|NCT00455533|66508098|FG000|Period Two: Randomized Period|Disease Progression|0|||
23762277|NCT00455533|66508099|FG001|Period Two: Randomized Period|Disease Progression|1|||
23762278|NCT00455533|66508100|FG002|Period Two: Randomized Period|Disease Progression|1|||
23762279|NCT00455533|66508098|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
23762280|NCT00455533|66508099|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
23762281|NCT00455533|66508100|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
23762282|NCT00455533|66508098|FG000|Period Two: Randomized Period|Other - need reasons|0|||
23762283|NCT00455533|66508099|FG001|Period Two: Randomized Period|Other - need reasons|1|||
23762284|NCT00455533|66508100|FG002|Period Two: Randomized Period|Other - need reasons|0|||
23762285|NCT00455533|66508098|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
23762286|NCT00455533|66508099|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
23762287|NCT00455533|66508100|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
23762288|NCT00455533|66508098|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
23762289|NCT00455533|66508099|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
23762290|NCT00455533|66508100|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
23762291|NCT01722266|66508105|FG000|Overall Study|Withdrawal by Subject|1|||
23762292|NCT01722266|66508106|FG001|Overall Study|Withdrawal by Subject|2|||
23762293|NCT01722266|66508107|FG002|Overall Study|Withdrawal by Subject|0|||
23762294|NCT01722266|66508108|FG003|Overall Study|Withdrawal by Subject|0|||
23762295|NCT01722266|66508105|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
23762296|NCT01722266|66508106|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
23762297|NCT01722266|66508107|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
23762298|NCT01722266|66508108|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
23762299|NCT01722266|66508105|FG000|Overall Study|Dropped out due to Nausea|0|||
23762300|NCT01722266|66508106|FG001|Overall Study|Dropped out due to Nausea|0|||
23762301|NCT01722266|66508107|FG002|Overall Study|Dropped out due to Nausea|2|||
23762302|NCT01722266|66508108|FG003|Overall Study|Dropped out due to Nausea|0|||
23762303|NCT00693784|66508112|FG000|Overall Study|Lost to Follow-up|2|||
23762304|NCT00693784|66508112|FG000|Overall Study|Withdrawal by Subject|2|||
23762305|NCT00395083|66508113|FG000|Overall Study|Withdrawal by Subject|6|||
23762306|NCT00395083|66508114|FG001|Overall Study|Withdrawal by Subject|5|||
23762307|NCT00395083|66508113|FG000|Overall Study|Developed another disease|4|||
23762308|NCT00395083|66508114|FG001|Overall Study|Developed another disease|3|||
23762309|NCT00219557|66508117|FG000|Phase 1|Lack of Efficacy|3|||
23762310|NCT00219557|66508118|FG001|Phase 1|Lack of Efficacy|0|||
23762311|NCT00219557|66508119|FG002|Phase 1|Lack of Efficacy|0|||
23565835|NCT00672958|65799810|FG000|Overall Study|Lack of Efficacy|6|||
23762312|NCT00219557|66508117|FG000|Phase 1|Adverse Event|2|||
23762313|NCT00219557|66508118|FG001|Phase 1|Adverse Event|0|||
23762314|NCT00219557|66508119|FG002|Phase 1|Adverse Event|0|||
23762315|NCT00219557|66508117|FG000|Phase 1|Withdrawal by Subject|1|||
23762316|NCT00219557|66508118|FG001|Phase 1|Withdrawal by Subject|0|||
23762317|NCT00219557|66508119|FG002|Phase 1|Withdrawal by Subject|0|||
23762318|NCT00219557|66508117|FG000|Phase 1|Started chemotherapy at other institute|1|||
23762319|NCT00219557|66508118|FG001|Phase 1|Started chemotherapy at other institute|0|||
23762320|NCT00219557|66508119|FG002|Phase 1|Started chemotherapy at other institute|0|||
23762321|NCT00219557|66508117|FG000|Phase 2|Lack of Efficacy|0|||
23762322|NCT00219557|66508118|FG001|Phase 2|Lack of Efficacy|21|||
23762323|NCT00219557|66508119|FG002|Phase 2|Lack of Efficacy|15|||
23762324|NCT00219557|66508117|FG000|Phase 2|Adverse Event|0|||
23762325|NCT00219557|66508118|FG001|Phase 2|Adverse Event|22|||
23762326|NCT00219557|66508119|FG002|Phase 2|Adverse Event|2|||
23762327|NCT00219557|66508117|FG000|Phase 2|Death|0|||
23762328|NCT00219557|66508118|FG001|Phase 2|Death|8|||
23762329|NCT00219557|66508119|FG002|Phase 2|Death|2|||
23762330|NCT00219557|66508117|FG000|Phase 2|Other|0|||
23762331|NCT00219557|66508118|FG001|Phase 2|Other|8|||
23762332|NCT00219557|66508119|FG002|Phase 2|Other|6|||
23762333|NCT00219557|66508117|FG000|Phase 2|Withdrawal by Subject|0|||
23762334|NCT00219557|66508118|FG001|Phase 2|Withdrawal by Subject|9|||
23762335|NCT00219557|66508119|FG002|Phase 2|Withdrawal by Subject|5|||
23762336|NCT00219557|66508117|FG000|Phase 2|Treatment not received|0|||
23762337|NCT00219557|66508118|FG001|Phase 2|Treatment not received|1|||
23762338|NCT00219557|66508119|FG002|Phase 2|Treatment not received|3|||
23762339|NCT00297479|66508120|FG000|Overall Study|Lost to Follow-up|37|||
23762340|NCT00297479|66508121|FG001|Overall Study|Lost to Follow-up|54|||
23762341|NCT00297479|66508122|FG002|Overall Study|Lost to Follow-up|51|||
23762342|NCT02415959|66508123|FG000|Overall Study|Adverse Event|0|||
23762343|NCT02415959|66508124|FG001|Overall Study|Adverse Event|1|||
23762344|NCT02415959|66508125|FG002|Overall Study|Adverse Event|0|||
23762345|NCT02415959|66508126|FG003|Overall Study|Adverse Event|0|||
23762346|NCT02415959|66508127|FG004|Overall Study|Adverse Event|0|||
23762347|NCT02415959|66508123|FG000|Overall Study|Protocol Violation|0|||
23762348|NCT02415959|66508124|FG001|Overall Study|Protocol Violation|0|||
23762349|NCT02415959|66508125|FG002|Overall Study|Protocol Violation|0|||
23762350|NCT02415959|66508126|FG003|Overall Study|Protocol Violation|1|||
23762351|NCT02415959|66508127|FG004|Overall Study|Protocol Violation|0|||
23762352|NCT00787566|66508130|FG000|Overall Study|AE related to chemotherapy|0|||
23762353|NCT00787566|66508131|FG001|Overall Study|AE related to chemotherapy|1|||
23762354|NCT00787566|66508132|FG002|Overall Study|AE related to chemotherapy|0|||
23762355|NCT00905489|66508133|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
23762356|NCT00905489|66508133|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
23762357|NCT00905489|66508133|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
23762358|NCT03555890|66508136|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23762359|NCT03555890|66508137|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23762360|NCT03555890|66508138|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23762361|NCT03555890|66508139|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23762362|NCT02040428|66508143|FG000|Overall Study|Death|4|||
23762363|NCT02040428|66508144|FG001|Overall Study|Death|3|||
23762364|NCT02040428|66508143|FG000|Overall Study|Withdrawal by Subject|1|||
23762365|NCT02040428|66508144|FG001|Overall Study|Withdrawal by Subject|1|||
23762366|NCT01783496|66508145|FG000|Overall Study|Lost to Follow-up|0|||
23762367|NCT01783496|66508146|FG001|Overall Study|Lost to Follow-up|0|||
23762368|NCT01783496|66508147|FG002|Overall Study|Lost to Follow-up|0|||
23762369|NCT01783496|66508148|FG003|Overall Study|Lost to Follow-up|2|||
23762370|NCT01783496|66508149|FG004|Overall Study|Lost to Follow-up|0|||
23762371|NCT01783496|66508150|FG005|Overall Study|Lost to Follow-up|1|||
23762372|NCT01783496|66508145|FG000|Overall Study|Withdrawal by Subject|1|||
23762373|NCT01783496|66508146|FG001|Overall Study|Withdrawal by Subject|0|||
23762374|NCT01783496|66508147|FG002|Overall Study|Withdrawal by Subject|0|||
23762375|NCT01783496|66508148|FG003|Overall Study|Withdrawal by Subject|0|||
23762376|NCT01783496|66508149|FG004|Overall Study|Withdrawal by Subject|0|||
23762377|NCT01783496|66508150|FG005|Overall Study|Withdrawal by Subject|0|||
23762378|NCT03273387|66508152|FG000|Overall Study|Death|2|||
23762379|NCT03273387|66508153|FG001|Overall Study|Death|2|||
23565836|NCT00672958|65799811|FG001|Overall Study|Lack of Efficacy|11|||
23762380|NCT03273387|66508152|FG000|Overall Study|Withdrawal by Subject|1|||
23762381|NCT03273387|66508153|FG001|Overall Study|Withdrawal by Subject|1|||
23762382|NCT01084005|66508154|FG000|Overall Study|Adverse Event|1|||
23762383|NCT01084005|66508155|FG001|Overall Study|Adverse Event|8|||
23565837|NCT00672958|65799810|FG000|Overall Study|Non-compliance with study drug|2|||
23762384|NCT01084005|66508154|FG000|Overall Study|Protocol Violation|3|||
23762385|NCT01084005|66508155|FG001|Overall Study|Protocol Violation|7|||
23762386|NCT01084005|66508154|FG000|Overall Study|Withdrawal by Subject|1|||
23762387|NCT01084005|66508155|FG001|Overall Study|Withdrawal by Subject|1|||
23762388|NCT00003782|66508156|FG000|Overall Study|No follow up data|30|||
23762389|NCT00003782|66508157|FG001|Overall Study|No follow up data|31|||
23762390|NCT00003782|66508158|FG002|Overall Study|No follow up data|26|||
23762391|NCT01806597|66508159|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
23762392|NCT01806597|66508160|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
23762393|NCT01806597|66508161|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23762394|NCT01806597|66508162|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23762395|NCT01806597|66508163|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
23762396|NCT01806597|66508164|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23762397|NCT01806597|66508159|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
23762398|NCT01806597|66508160|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23762399|NCT01806597|66508161|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23762400|NCT01806597|66508162|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23762401|NCT01806597|66508163|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
23762402|NCT01806597|66508164|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23762403|NCT01806597|66508159|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23762404|NCT01806597|66508160|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
23762405|NCT01806597|66508161|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23762406|NCT01806597|66508162|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23762407|NCT01806597|66508163|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23762408|NCT01806597|66508164|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23762409|NCT01806597|66508159|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
23762410|NCT01806597|66508160|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
23762411|NCT01806597|66508161|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23762412|NCT01806597|66508162|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23762413|NCT01806597|66508163|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
23762414|NCT01806597|66508164|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23762415|NCT01806597|66508159|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23762416|NCT01806597|66508160|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
23762417|NCT01806597|66508161|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23762418|NCT01806597|66508162|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23762419|NCT01806597|66508163|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23762420|NCT01806597|66508164|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23762421|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
23762422|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
23762423|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
23762424|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
23762425|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
23762426|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
23762427|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
23762428|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
23762429|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
23762430|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
23762431|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
23762432|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
23762433|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
23762434|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23762435|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23762436|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23762437|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23762438|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23762439|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
23762440|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
23762441|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23762442|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23762443|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23762444|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23762445|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
23762446|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23762447|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23762448|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23762449|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23762450|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23762451|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23762452|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
23762453|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23762454|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
23762455|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23762456|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23762457|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
23762458|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
23762459|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
23442703|NCT01618695|65362190|FG002|Core Phase|Other than specified|2|||
23762460|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
23762461|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
23762462|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
23762463|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
23762464|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
23762465|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
23762466|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
23762467|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
23762468|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
23762469|NCT01806597|66508159|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
23762470|NCT01806597|66508160|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23762471|NCT01806597|66508161|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23762472|NCT01806597|66508162|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23762473|NCT01806597|66508163|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23762474|NCT01806597|66508164|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23762475|NCT01806597|66508159|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23762476|NCT01806597|66508160|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23762477|NCT01806597|66508161|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23762478|NCT01806597|66508162|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23762479|NCT01806597|66508163|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23762480|NCT01806597|66508164|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
23762481|NCT01806597|66508159|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23762482|NCT01806597|66508160|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23762483|NCT01806597|66508161|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23762484|NCT01806597|66508162|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23762485|NCT01806597|66508163|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23762486|NCT01806597|66508164|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
23762487|NCT01806597|66508159|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23762488|NCT01806597|66508160|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23762489|NCT01806597|66508161|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23762490|NCT01806597|66508162|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23762491|NCT01806597|66508163|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23762492|NCT01806597|66508164|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
23762493|NCT01806597|66508159|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23762494|NCT01806597|66508160|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23762495|NCT01806597|66508161|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23762496|NCT01806597|66508162|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23762497|NCT01806597|66508163|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23762498|NCT01806597|66508164|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
23762499|NCT01806597|66508159|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23762500|NCT01806597|66508160|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23762501|NCT01806597|66508161|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23762502|NCT01806597|66508162|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23762503|NCT01806597|66508163|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23762504|NCT01806597|66508164|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
23762505|NCT02087046|66508165|FG000|Overall Study|Adverse Event|4|||
23762506|NCT02087046|66508165|FG000|Overall Study|Death|1|||
23762507|NCT02087046|66508165|FG000|Overall Study|Lost to Follow-up|3|||
23762508|NCT02087046|66508165|FG000|Overall Study|Withdrawal by Subject|2|||
23762509|NCT02087046|66508165|FG000|Overall Study|Physician Decision|1|||
23762510|NCT03111147|66508166|FG000|Overall Study|Lost to Follow-up|2|||
23762511|NCT03111147|66508167|FG001|Overall Study|Lost to Follow-up|5|||
23762512|NCT03111147|66508166|FG000|Overall Study|Withdrawal by Subject|4|||
23565838|NCT00672958|65799811|FG001|Overall Study|Non-compliance with study drug|3|||
23565839|NCT00672958|65799810|FG000|Overall Study|Protocol deviations|11|||
23565840|NCT00672958|65799811|FG001|Overall Study|Protocol deviations|5|||
23565841|NCT00672958|65799810|FG000|Overall Study|Voluntary withdrawal|12|||
23565842|NCT00672958|65799811|FG001|Overall Study|Voluntary withdrawal|8|||
23565843|NCT00672958|65799810|FG000|Overall Study|Lost to Follow-up|22|||
23565844|NCT00672958|65799811|FG001|Overall Study|Lost to Follow-up|17|||
23565845|NCT00672958|65799810|FG000|Overall Study|Reason not specified|0|||
23565846|NCT00672958|65799811|FG001|Overall Study|Reason not specified|3|||
23565847|NCT00152009|65799812|FG000|Overall Study|Adverse Event|9|||
23565848|NCT00152009|65799813|FG001|Overall Study|Adverse Event|13|||
23565849|NCT00152009|65799814|FG002|Overall Study|Adverse Event|20|||
23565850|NCT00152009|65799815|FG003|Overall Study|Adverse Event|1|||
23565851|NCT00152009|65799812|FG000|Overall Study|Protocol Violation|3|||
23762513|NCT03111147|66508167|FG001|Overall Study|Withdrawal by Subject|3|||
23762514|NCT03111147|66508166|FG000|Overall Study|Protocol Violation|2|||
23762515|NCT03111147|66508167|FG001|Overall Study|Protocol Violation|1|||
23762516|NCT03111147|66508166|FG000|Overall Study|Death|1|||
23762517|NCT03111147|66508167|FG001|Overall Study|Death|1|||
23762518|NCT00254397|66508170|FG000|Overall Study|Disease Progression|4|||
23762519|NCT00254397|66508171|FG001|Overall Study|Disease Progression|1|||
23762520|NCT00254397|66508172|FG002|Overall Study|Disease Progression|16|||
23762521|NCT00254397|66508173|FG003|Overall Study|Disease Progression|23|||
23762522|NCT00254397|66508170|FG000|Overall Study|Non-Compliant|0|||
23762523|NCT00254397|66508171|FG001|Overall Study|Non-Compliant|0|||
23762524|NCT00254397|66508172|FG002|Overall Study|Non-Compliant|0|||
23762525|NCT00254397|66508173|FG003|Overall Study|Non-Compliant|1|||
23762526|NCT00254397|66508170|FG000|Overall Study|Adverse Event|2|||
23762527|NCT00254397|66508171|FG001|Overall Study|Adverse Event|0|||
23762528|NCT00254397|66508172|FG002|Overall Study|Adverse Event|3|||
23762529|NCT00254397|66508173|FG003|Overall Study|Adverse Event|1|||
23762530|NCT01588106|66508174|FG000|Overall Study|Withdrawal by Subject|5|||
23762531|NCT01588106|66508175|FG001|Overall Study|Withdrawal by Subject|4|||
23762532|NCT00686790|66508176|FG000|Overall Study|Adverse Event|2|||
23762533|NCT00686790|66508176|FG000|Overall Study|Withdrawal by Subject|1|||
23762534|NCT00686790|66508176|FG000|Overall Study|Death|1|||
23762535|NCT00686790|66508176|FG000|Overall Study|Lost to Follow-up|12|||
23762536|NCT02598193|66508177|FG000|Overall Study|Adverse Event|13|||
23762537|NCT02598193|66508177|FG000|Overall Study|Withdrawal by Subject|1|||
23762538|NCT02598193|66508177|FG000|Overall Study|Listed in active lung transplant list|1|||
23762539|NCT02598193|66508177|FG000|Overall Study|Does not want to take Nintedanib|1|||
23762540|NCT00566098|66508180|FG000|Collection of MILs|Withdrawal by Subject|1|||
23762541|NCT00566098|66508180|FG000|Collection of MILs|Relapsed|1|||
23762542|NCT00566098|66508180|FG000|Generation of MILs Product|Relapsed|1|||
23762543|NCT00566098|66508180|FG000|Administration of ASCT+MILs|Death|10|||
23762544|NCT00566098|66508180|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
23762545|NCT00876733|66508181|FG000|Overall Study|Adverse Event|34|||
23762546|NCT00876733|66508182|FG001|Overall Study|Adverse Event|20|||
23762547|NCT00876733|66508183|FG002|Overall Study|Adverse Event|10|||
23762548|NCT00876733|66508184|FG003|Overall Study|Adverse Event|3|||
23762549|NCT00876733|66508181|FG000|Overall Study|Lack of Efficacy|17|||
23762550|NCT00876733|66508182|FG001|Overall Study|Lack of Efficacy|9|||
23762551|NCT00876733|66508183|FG002|Overall Study|Lack of Efficacy|10|||
23762552|NCT00876733|66508184|FG003|Overall Study|Lack of Efficacy|1|||
23762553|NCT00876733|66508181|FG000|Overall Study|Lost to Follow-up|26|||
23762554|NCT00876733|66508182|FG001|Overall Study|Lost to Follow-up|10|||
23762555|NCT00876733|66508183|FG002|Overall Study|Lost to Follow-up|3|||
23762556|NCT00876733|66508184|FG003|Overall Study|Lost to Follow-up|2|||
23762557|NCT00876733|66508181|FG000|Overall Study|Data not available|14|||
23762558|NCT00876733|66508182|FG001|Overall Study|Data not available|3|||
23762559|NCT00876733|66508183|FG002|Overall Study|Data not available|7|||
23762560|NCT00876733|66508184|FG003|Overall Study|Data not available|1|||
23762561|NCT04428502|66508185|FG000|Overall Study|Did not meet entrance criteria|14|||
23762562|NCT02965820|66508186|FG000|Period 2, Second 30 Days|Adverse Event|1|||
23762563|NCT02965820|66508187|FG001|Period 2, Second 30 Days|Adverse Event|1|||
23762564|NCT02424565|66508188|FG000|Period 1 (D0)|Protocol Violation|0|||
23762565|NCT02424565|66508189|FG001|Period 1 (D0)|Protocol Violation|1|||
23762566|NCT04304950|66508190|FG000|Overall Study|Lost to Follow-up|1|||
23762567|NCT04304950|66508191|FG001|Overall Study|Lost to Follow-up|1|||
23762568|NCT02400905|66508192|FG000|Overall Study|Death|24|||
23762569|NCT02400905|66508192|FG000|Overall Study|Lost to Follow-up|18|||
23762570|NCT02400905|66508192|FG000|Overall Study|Withdrawal by Subject|16|||
23762571|NCT02400905|66508192|FG000|Overall Study|Physician Decision|4|||
23762572|NCT02400905|66508192|FG000|Overall Study|Other|1|||
23762573|NCT01017029|66508193|FG000|Overall Study|Lost to Follow-up|1|||
23762574|NCT01017029|66508194|FG001|Overall Study|Lost to Follow-up|0|||
23762575|NCT01017029|66508193|FG000|Overall Study|Administrative problem|0|||
23762576|NCT01017029|66508194|FG001|Overall Study|Administrative problem|1|||
23762577|NCT01017029|66508193|FG000|Overall Study|Death|3|||
23762578|NCT01017029|66508194|FG001|Overall Study|Death|1|||
23762579|NCT01259401|66508195|FG000|4-month Follow-up|Death|0|||
23762580|NCT01259401|66508196|FG001|4-month Follow-up|Death|1|||
23762581|NCT01259401|66508195|FG000|4-month Follow-up|Lost to Follow-up|0|||
23762582|NCT01259401|66508196|FG001|4-month Follow-up|Lost to Follow-up|1|||
23762583|NCT03558997|66508197|FG000|Overall Study|Adverse Event|0|||
23762584|NCT03558997|66508198|FG001|Overall Study|Adverse Event|2|||
23762585|NCT03558997|66508199|FG002|Overall Study|Adverse Event|5|||
23762586|NCT03558997|66508200|FG003|Overall Study|Adverse Event|1|||
23762587|NCT03558997|66508197|FG000|Overall Study|Physician Decision|0|||
23762588|NCT03558997|66508198|FG001|Overall Study|Physician Decision|0|||
23762589|NCT03558997|66508199|FG002|Overall Study|Physician Decision|1|||
23762590|NCT03558997|66508200|FG003|Overall Study|Physician Decision|0|||
23762591|NCT03558997|66508197|FG000|Overall Study|Withdrawal by Subject|1|||
23762592|NCT03558997|66508198|FG001|Overall Study|Withdrawal by Subject|0|||
23762593|NCT03558997|66508199|FG002|Overall Study|Withdrawal by Subject|1|||
23762594|NCT03558997|66508200|FG003|Overall Study|Withdrawal by Subject|1|||
23762595|NCT03558997|66508197|FG000|Overall Study|Lost to Follow-up|0|||
23762596|NCT03558997|66508198|FG001|Overall Study|Lost to Follow-up|0|||
23762597|NCT03558997|66508199|FG002|Overall Study|Lost to Follow-up|1|||
23762598|NCT03558997|66508200|FG003|Overall Study|Lost to Follow-up|0|||
23762599|NCT01121900|66508201|FG000|First Intervention Period|Adverse Event|1|||
23762600|NCT01121900|66508202|FG001|First Intervention Period|Adverse Event|1|||
23762601|NCT01121900|66508201|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23762602|NCT01121900|66508202|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23762603|NCT02770716|66508204|FG000|Overall Study|Death|101|||
23762604|NCT02770716|66508205|FG001|Overall Study|Death|45|||
23762605|NCT02770716|66508204|FG000|Overall Study|Withdrawal by Subject|4|||
23762606|NCT02770716|66508205|FG001|Overall Study|Withdrawal by Subject|2|||
23762607|NCT02770716|66508204|FG000|Overall Study|Lost to Follow-up|1|||
23762608|NCT02770716|66508205|FG001|Overall Study|Lost to Follow-up|0|||
23762609|NCT02770716|66508204|FG000|Overall Study|Various reasons|6|||
23762610|NCT02770716|66508205|FG001|Overall Study|Various reasons|2|||
23762611|NCT02791659|66508206|FG000|Overall Study|Protocol Violation|0|||
23762612|NCT02791659|66508207|FG001|Overall Study|Protocol Violation|1|||
23762613|NCT02711956|66508212|FG000|Overall Study|Adverse Event|0|||
23762614|NCT02711956|66508213|FG001|Overall Study|Adverse Event|0|||
23762615|NCT02711956|66508214|FG002|Overall Study|Adverse Event|0|||
23762616|NCT02711956|66508215|FG003|Overall Study|Adverse Event|1|||
23762617|NCT02711956|66508216|FG004|Overall Study|Adverse Event|2|||
23762618|NCT02711956|66508217|FG005|Overall Study|Adverse Event|0|||
23762619|NCT02711956|66508218|FG006|Overall Study|Adverse Event|0|||
23762620|NCT02711956|66508219|FG007|Overall Study|Adverse Event|1|||
23762621|NCT02711956|66508220|FG008|Overall Study|Adverse Event|1|||
23762622|NCT02711956|66508221|FG009|Overall Study|Adverse Event|1|||
23762623|NCT02711956|66508222|FG010|Overall Study|Adverse Event|1|||
23762624|NCT02711956|66508223|FG011|Overall Study|Adverse Event|0|||
23762625|NCT02711956|66508224|FG012|Overall Study|Adverse Event|0|||
23762626|NCT02711956|66508225|FG013|Overall Study|Adverse Event|0|||
23762627|NCT02711956|66508226|FG014|Overall Study|Adverse Event|2|||
23762628|NCT02711956|66508212|FG000|Overall Study|Physician Decision|0|||
23762629|NCT02711956|66508213|FG001|Overall Study|Physician Decision|0|||
23762630|NCT02711956|66508214|FG002|Overall Study|Physician Decision|0|||
23762631|NCT02711956|66508215|FG003|Overall Study|Physician Decision|2|||
23762632|NCT02711956|66508216|FG004|Overall Study|Physician Decision|0|||
23762633|NCT02711956|66508217|FG005|Overall Study|Physician Decision|0|||
23762634|NCT02711956|66508218|FG006|Overall Study|Physician Decision|0|||
23762635|NCT02711956|66508219|FG007|Overall Study|Physician Decision|0|||
23762636|NCT02711956|66508220|FG008|Overall Study|Physician Decision|0|||
23762637|NCT02711956|66508221|FG009|Overall Study|Physician Decision|0|||
23762638|NCT02711956|66508222|FG010|Overall Study|Physician Decision|0|||
23762639|NCT02711956|66508223|FG011|Overall Study|Physician Decision|0|||
23762640|NCT02711956|66508224|FG012|Overall Study|Physician Decision|0|||
23762641|NCT02711956|66508225|FG013|Overall Study|Physician Decision|0|||
23762642|NCT02711956|66508226|FG014|Overall Study|Physician Decision|0|||
23762643|NCT02711956|66508212|FG000|Overall Study|Withdrawal by Subject|0|||
23762644|NCT02711956|66508213|FG001|Overall Study|Withdrawal by Subject|0|||
23762645|NCT02711956|66508214|FG002|Overall Study|Withdrawal by Subject|0|||
23762646|NCT02711956|66508215|FG003|Overall Study|Withdrawal by Subject|0|||
23762647|NCT02711956|66508216|FG004|Overall Study|Withdrawal by Subject|0|||
23762648|NCT02711956|66508217|FG005|Overall Study|Withdrawal by Subject|0|||
23762649|NCT02711956|66508218|FG006|Overall Study|Withdrawal by Subject|1|||
23762650|NCT02711956|66508219|FG007|Overall Study|Withdrawal by Subject|0|||
23762651|NCT02711956|66508220|FG008|Overall Study|Withdrawal by Subject|0|||
23762652|NCT02711956|66508221|FG009|Overall Study|Withdrawal by Subject|0|||
23762653|NCT02711956|66508222|FG010|Overall Study|Withdrawal by Subject|0|||
23762654|NCT02711956|66508223|FG011|Overall Study|Withdrawal by Subject|1|||
23762655|NCT02711956|66508224|FG012|Overall Study|Withdrawal by Subject|6|||
23762656|NCT02711956|66508225|FG013|Overall Study|Withdrawal by Subject|0|||
23762657|NCT02711956|66508226|FG014|Overall Study|Withdrawal by Subject|1|||
23762658|NCT02711956|66508212|FG000|Overall Study|Clinical progression|1|||
23762659|NCT02711956|66508213|FG001|Overall Study|Clinical progression|0|||
23762660|NCT02711956|66508214|FG002|Overall Study|Clinical progression|0|||
23762661|NCT02711956|66508215|FG003|Overall Study|Clinical progression|0|||
23762662|NCT02711956|66508216|FG004|Overall Study|Clinical progression|0|||
23762663|NCT02711956|66508217|FG005|Overall Study|Clinical progression|0|||
23762664|NCT02711956|66508218|FG006|Overall Study|Clinical progression|1|||
23762665|NCT02711956|66508219|FG007|Overall Study|Clinical progression|0|||
23762666|NCT02711956|66508220|FG008|Overall Study|Clinical progression|1|||
23762667|NCT02711956|66508221|FG009|Overall Study|Clinical progression|0|||
23762668|NCT02711956|66508222|FG010|Overall Study|Clinical progression|0|||
23762669|NCT02711956|66508223|FG011|Overall Study|Clinical progression|2|||
23762670|NCT02711956|66508224|FG012|Overall Study|Clinical progression|4|||
23762671|NCT02711956|66508225|FG013|Overall Study|Clinical progression|1|||
23762672|NCT02711956|66508226|FG014|Overall Study|Clinical progression|1|||
23762673|NCT02711956|66508212|FG000|Overall Study|Radiographic progression|1|||
23762674|NCT02711956|66508213|FG001|Overall Study|Radiographic progression|1|||
23762675|NCT02711956|66508214|FG002|Overall Study|Radiographic progression|2|||
23762676|NCT02711956|66508215|FG003|Overall Study|Radiographic progression|0|||
23762677|NCT02711956|66508216|FG004|Overall Study|Radiographic progression|1|||
23762678|NCT02711956|66508217|FG005|Overall Study|Radiographic progression|0|||
23762679|NCT02711956|66508218|FG006|Overall Study|Radiographic progression|0|||
23762680|NCT02711956|66508219|FG007|Overall Study|Radiographic progression|0|||
23762681|NCT02711956|66508220|FG008|Overall Study|Radiographic progression|2|||
23762682|NCT02711956|66508221|FG009|Overall Study|Radiographic progression|1|||
23762683|NCT02711956|66508222|FG010|Overall Study|Radiographic progression|0|||
23762684|NCT02711956|66508223|FG011|Overall Study|Radiographic progression|5|||
23762685|NCT02711956|66508224|FG012|Overall Study|Radiographic progression|3|||
23762686|NCT02711956|66508225|FG013|Overall Study|Radiographic progression|0|||
23762687|NCT02711956|66508226|FG014|Overall Study|Radiographic progression|1|||
23762688|NCT02711956|66508212|FG000|Overall Study|PSA progression with clinical progression|0|||
23762689|NCT02711956|66508213|FG001|Overall Study|PSA progression with clinical progression|0|||
23762690|NCT02711956|66508214|FG002|Overall Study|PSA progression with clinical progression|0|||
23762691|NCT02711956|66508215|FG003|Overall Study|PSA progression with clinical progression|0|||
23762692|NCT02711956|66508216|FG004|Overall Study|PSA progression with clinical progression|1|||
23762693|NCT02711956|66508217|FG005|Overall Study|PSA progression with clinical progression|0|||
23762694|NCT02711956|66508218|FG006|Overall Study|PSA progression with clinical progression|0|||
23762695|NCT02711956|66508219|FG007|Overall Study|PSA progression with clinical progression|0|||
23762696|NCT02711956|66508220|FG008|Overall Study|PSA progression with clinical progression|0|||
23762697|NCT02711956|66508221|FG009|Overall Study|PSA progression with clinical progression|0|||
23762698|NCT02711956|66508222|FG010|Overall Study|PSA progression with clinical progression|0|||
23762699|NCT02711956|66508223|FG011|Overall Study|PSA progression with clinical progression|0|||
23762700|NCT02711956|66508224|FG012|Overall Study|PSA progression with clinical progression|1|||
23762701|NCT02711956|66508225|FG013|Overall Study|PSA progression with clinical progression|1|||
23762702|NCT02711956|66508226|FG014|Overall Study|PSA progression with clinical progression|0|||
23762703|NCT02711956|66508212|FG000|Overall Study|PSA progression with radiographic progression|0|||
23762704|NCT02711956|66508213|FG001|Overall Study|PSA progression with radiographic progression|1|||
23762705|NCT02711956|66508214|FG002|Overall Study|PSA progression with radiographic progression|0|||
23762706|NCT02711956|66508215|FG003|Overall Study|PSA progression with radiographic progression|0|||
23762707|NCT02711956|66508216|FG004|Overall Study|PSA progression with radiographic progression|0|||
23762708|NCT02711956|66508217|FG005|Overall Study|PSA progression with radiographic progression|2|||
23762709|NCT02711956|66508218|FG006|Overall Study|PSA progression with radiographic progression|2|||
23762710|NCT02711956|66508219|FG007|Overall Study|PSA progression with radiographic progression|1|||
23762711|NCT02711956|66508220|FG008|Overall Study|PSA progression with radiographic progression|0|||
23762712|NCT02711956|66508221|FG009|Overall Study|PSA progression with radiographic progression|1|||
23762713|NCT02711956|66508222|FG010|Overall Study|PSA progression with radiographic progression|0|||
23762714|NCT02711956|66508223|FG011|Overall Study|PSA progression with radiographic progression|1|||
23762715|NCT02711956|66508224|FG012|Overall Study|PSA progression with radiographic progression|2|||
23762716|NCT02711956|66508225|FG013|Overall Study|PSA progression with radiographic progression|3|||
23762717|NCT02711956|66508226|FG014|Overall Study|PSA progression with radiographic progression|3|||
23762718|NCT02557672|66508227|FG000|Overall Study|Withdrawal by Subject|4|||
23828105|NCT02906670|66749054|FG005|Cohort 5, Q2W|Clinical Progression|0|||
23762719|NCT02557672|66508228|FG001|Overall Study|Withdrawal by Subject|2|||
23762720|NCT01965652|66511233|FG000|Overall Study|Adverse Event|40|||
23762721|NCT01965652|66511234|FG001|Overall Study|Adverse Event|37|||
23762722|NCT01965652|66511233|FG000|Overall Study|Withdrawal by Subject|62|||
23762723|NCT01965652|66511234|FG001|Overall Study|Withdrawal by Subject|69|||
23762724|NCT01965652|66511233|FG000|Overall Study|Lost to Follow-up|53|||
23762725|NCT01965652|66511234|FG001|Overall Study|Lost to Follow-up|40|||
23762726|NCT01965652|66511233|FG000|Overall Study|Protocol Violation|34|||
23762727|NCT01965652|66511234|FG001|Overall Study|Protocol Violation|38|||
23762728|NCT01965652|66511233|FG000|Overall Study|Death|3|||
23762729|NCT01965652|66511234|FG001|Overall Study|Death|4|||
23762730|NCT01965652|66511233|FG000|Overall Study|Other - Miscellaneous|18|||
23762731|NCT01965652|66511234|FG001|Overall Study|Other - Miscellaneous|21|||
23762732|NCT01965652|66511233|FG000|Overall Study|Pregnancy|0|||
23442704|NCT01618695|65362191|FG003|Core Phase|Other than specified|2|||
23442705|NCT01618695|65362188|FG000|Core Phase|Not treated|1|||
23442706|NCT01618695|65362189|FG001|Core Phase|Not treated|0|||
23442707|NCT01618695|65362190|FG002|Core Phase|Not treated|2|||
23442708|NCT01618695|65362191|FG003|Core Phase|Not treated|0|||
23442709|NCT01618695|65362188|FG000|Extension Phase|Lack of Efficacy|17|||
23442710|NCT01618695|65362189|FG001|Extension Phase|Lack of Efficacy|33|||
23442711|NCT01618695|65362190|FG002|Extension Phase|Lack of Efficacy|26|||
23442712|NCT01618695|65362191|FG003|Extension Phase|Lack of Efficacy|24|||
23762733|NCT01965652|66511234|FG001|Overall Study|Pregnancy|1|||
23762734|NCT00526890|66511238|FG000|Overall Study|Adverse Event|2|||
23762735|NCT02268045|66511249|FG000|Overall Study|Death|4|||
23762736|NCT02268045|66511250|FG001|Overall Study|Death|4|||
23762737|NCT02268045|66511249|FG000|Overall Study|Disease Progression|2|||
23762738|NCT02268045|66511250|FG001|Overall Study|Disease Progression|1|||
23762739|NCT02268045|66511249|FG000|Overall Study|Adverse Event|7|||
23762740|NCT02268045|66511250|FG001|Overall Study|Adverse Event|7|||
23762741|NCT02268045|66511249|FG000|Overall Study|Withdrawal by Subject|2|||
23762742|NCT02268045|66511250|FG001|Overall Study|Withdrawal by Subject|6|||
23762743|NCT02268045|66511249|FG000|Overall Study|Physician Decision|0|||
23828106|NCT02906670|66749055|FG006|Cohort 5, Q2W|Clinical Progression|1|||
23442713|NCT01618695|65362188|FG000|Extension Phase|Pregnancy|2|||
23442714|NCT01618695|65362189|FG001|Extension Phase|Pregnancy|0|||
23442715|NCT01618695|65362190|FG002|Extension Phase|Pregnancy|1|||
23442716|NCT01618695|65362191|FG003|Extension Phase|Pregnancy|1|||
23442717|NCT01618695|65362188|FG000|Extension Phase|Withdrawal by Subject|43|||
23442718|NCT01618695|65362189|FG001|Extension Phase|Withdrawal by Subject|48|||
23442719|NCT01618695|65362190|FG002|Extension Phase|Withdrawal by Subject|42|||
23442720|NCT01618695|65362191|FG003|Extension Phase|Withdrawal by Subject|33|||
23442721|NCT01618695|65362188|FG000|Extension Phase|Adverse Event|18|||
23442722|NCT01618695|65362189|FG001|Extension Phase|Adverse Event|16|||
23442723|NCT01618695|65362190|FG002|Extension Phase|Adverse Event|9|||
23442724|NCT01618695|65362191|FG003|Extension Phase|Adverse Event|20|||
23442725|NCT01618695|65362188|FG000|Extension Phase|Lost to Follow-up|2|||
23442726|NCT01618695|65362189|FG001|Extension Phase|Lost to Follow-up|1|||
23442727|NCT01618695|65362190|FG002|Extension Phase|Lost to Follow-up|1|||
23442728|NCT01618695|65362191|FG003|Extension Phase|Lost to Follow-up|1|||
23442729|NCT01618695|65362188|FG000|Extension Phase|Other than specified|13|||
23442730|NCT01618695|65362189|FG001|Extension Phase|Other than specified|18|||
23442731|NCT01618695|65362190|FG002|Extension Phase|Other than specified|13|||
23828107|NCT02906670|66749056|FG007|Cohort 5, Q2W|Clinical Progression|0|||
23828108|NCT02906670|66749057|FG008|Cohort 5, Q2W|Clinical Progression|0|||
23828109|NCT02906670|66749058|FG009|Cohort 5, Q2W|Clinical Progression|0|||
23828110|NCT02906670|66749049|FG000|Cohort 5, Q2W|Adverse Event|0|||
23828111|NCT02906670|66749050|FG001|Cohort 5, Q2W|Adverse Event|0|||
23828112|NCT02906670|66749051|FG002|Cohort 5, Q2W|Adverse Event|0|||
23828113|NCT02906670|66749052|FG003|Cohort 5, Q2W|Adverse Event|0|||
23828114|NCT02906670|66749053|FG004|Cohort 5, Q2W|Adverse Event|0|||
23828115|NCT02906670|66749054|FG005|Cohort 5, Q2W|Adverse Event|0|||
23442732|NCT01618695|65362191|FG003|Extension Phase|Other than specified|18|||
23828116|NCT02906670|66749055|FG006|Cohort 5, Q2W|Adverse Event|1|||
23442733|NCT01832155|65362194|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
23442734|NCT01832155|65362195|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
23442735|NCT01832155|65362194|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
23762744|NCT02268045|66511250|FG001|Overall Study|Physician Decision|1|||
23762745|NCT02268045|66511249|FG000|Overall Study|Protocol Violation|1|||
23442736|NCT01832155|65362195|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
23828117|NCT02906670|66749056|FG007|Cohort 5, Q2W|Adverse Event|0|||
23442737|NCT03688074|65362198|FG000|Overall Study|Adverse Event|0|||
23828118|NCT02906670|66749057|FG008|Cohort 5, Q2W|Adverse Event|0|||
23828119|NCT02906670|66749058|FG009|Cohort 5, Q2W|Adverse Event|0|||
23442738|NCT03688074|65362199|FG001|Overall Study|Adverse Event|1|||
23442739|NCT03688074|65362198|FG000|Overall Study|Other|1|||
23442740|NCT03688074|65362199|FG001|Overall Study|Other|0|||
23442741|NCT00381693|65362203|FG000|Overall Study|Death|1|||
23442742|NCT00381693|65362203|FG000|Overall Study|Adverse Event|4|||
23442743|NCT00381693|65362203|FG000|Overall Study|Patient Choice|1|||
23442744|NCT00381693|65362203|FG000|Overall Study|Progression|2|||
23442745|NCT03539601|65362204|FG000|Overall Study|Withdraw by parent/guardian|1|||
23442746|NCT03539601|65362205|FG001|Overall Study|Withdraw by parent/guardian|0|||
23442747|NCT03539601|65362206|FG002|Overall Study|Withdraw by parent/guardian|1|||
23442748|NCT03539601|65362207|FG003|Overall Study|Withdraw by parent/guardian|0|||
23442749|NCT03539601|65362204|FG000|Overall Study|Adverse Event|0|||
23442750|NCT03539601|65362205|FG001|Overall Study|Adverse Event|2|||
23442751|NCT03539601|65362206|FG002|Overall Study|Adverse Event|0|||
23442752|NCT03539601|65362207|FG003|Overall Study|Adverse Event|0|||
23442753|NCT03539601|65362204|FG000|Overall Study|Lost to Follow-up|2|||
23442754|NCT03539601|65362205|FG001|Overall Study|Lost to Follow-up|4|||
23442755|NCT03539601|65362206|FG002|Overall Study|Lost to Follow-up|5|||
23442756|NCT03539601|65362207|FG003|Overall Study|Lost to Follow-up|0|||
23442757|NCT03539601|65362204|FG000|Overall Study|Withdrawal by Subject|2|||
23442758|NCT03539601|65362205|FG001|Overall Study|Withdrawal by Subject|0|||
23442759|NCT03539601|65362206|FG002|Overall Study|Withdrawal by Subject|0|||
23442760|NCT03539601|65362207|FG003|Overall Study|Withdrawal by Subject|1|||
23442761|NCT03539601|65362204|FG000|Overall Study|Randomized but not treated|1|||
23442762|NCT03539601|65362205|FG001|Overall Study|Randomized but not treated|1|||
23442763|NCT03539601|65362206|FG002|Overall Study|Randomized but not treated|0|||
23442764|NCT03539601|65362207|FG003|Overall Study|Randomized but not treated|0|||
23442765|NCT03160898|65362208|FG000|Overall Study|Adverse Event|4|||
23442766|NCT03160898|65362209|FG001|Overall Study|Adverse Event|8|||
23442767|NCT03160898|65362210|FG002|Overall Study|Adverse Event|7|||
23442768|NCT03160898|65362211|FG003|Overall Study|Adverse Event|10|||
23442769|NCT03160898|65362208|FG000|Overall Study|Death|1|||
23442770|NCT03160898|65362209|FG001|Overall Study|Death|0|||
23442771|NCT03160898|65362210|FG002|Overall Study|Death|0|||
23442772|NCT03160898|65362211|FG003|Overall Study|Death|1|||
23442773|NCT03160898|65362208|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
23442774|NCT03160898|65362209|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
23442775|NCT03160898|65362210|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
23442776|NCT03160898|65362211|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
23442777|NCT03160898|65362208|FG000|Overall Study|Lost to Follow-up|1|||
23442778|NCT03160898|65362209|FG001|Overall Study|Lost to Follow-up|1|||
23442779|NCT03160898|65362210|FG002|Overall Study|Lost to Follow-up|1|||
23442780|NCT03160898|65362211|FG003|Overall Study|Lost to Follow-up|2|||
23442781|NCT03160898|65362208|FG000|Overall Study|Physician Decision|1|||
23442782|NCT03160898|65362209|FG001|Overall Study|Physician Decision|0|||
23442783|NCT03160898|65362210|FG002|Overall Study|Physician Decision|0|||
23442784|NCT03160898|65362211|FG003|Overall Study|Physician Decision|1|||
23442785|NCT03160898|65362208|FG000|Overall Study|Progressive Disease|4|||
23442786|NCT03160898|65362209|FG001|Overall Study|Progressive Disease|1|||
23442787|NCT03160898|65362210|FG002|Overall Study|Progressive Disease|2|||
23442788|NCT03160898|65362211|FG003|Overall Study|Progressive Disease|1|||
23442789|NCT03160898|65362208|FG000|Overall Study|Protocol Violation|1|||
23442790|NCT03160898|65362209|FG001|Overall Study|Protocol Violation|0|||
23442791|NCT03160898|65362210|FG002|Overall Study|Protocol Violation|2|||
23442792|NCT03160898|65362211|FG003|Overall Study|Protocol Violation|0|||
23442793|NCT03160898|65362208|FG000|Overall Study|Sponsor Discretion|2|||
23442794|NCT03160898|65362209|FG001|Overall Study|Sponsor Discretion|0|||
23442795|NCT03160898|65362210|FG002|Overall Study|Sponsor Discretion|0|||
23442796|NCT03160898|65362211|FG003|Overall Study|Sponsor Discretion|0|||
23442797|NCT03160898|65362208|FG000|Overall Study|Withdrawal by Subject|1|||
23442798|NCT03160898|65362209|FG001|Overall Study|Withdrawal by Subject|3|||
23442799|NCT03160898|65362210|FG002|Overall Study|Withdrawal by Subject|2|||
23442800|NCT03160898|65362211|FG003|Overall Study|Withdrawal by Subject|1|||
23442801|NCT03160898|65362208|FG000|Overall Study|Other|2|||
23442802|NCT03160898|65362209|FG001|Overall Study|Other|0|||
23442803|NCT03160898|65362210|FG002|Overall Study|Other|2|||
23762746|NCT02268045|66511250|FG001|Overall Study|Protocol Violation|1|||
23442804|NCT03160898|65362211|FG003|Overall Study|Other|2|||
23442805|NCT01957202|65362212|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442806|NCT01957202|65362213|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
23442807|NCT01957202|65362214|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442808|NCT01957202|65362215|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442809|NCT01957202|65362216|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442810|NCT01957202|65362217|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442811|NCT01957202|65362218|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442812|NCT01957202|65362219|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442813|NCT01957202|65362220|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442814|NCT01957202|65362221|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442815|NCT01957202|65362222|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442816|NCT01957202|65362223|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442817|NCT01957202|65362224|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442818|NCT01957202|65362225|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442819|NCT01957202|65362226|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442820|NCT01957202|65362227|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442821|NCT01957202|65362228|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
23442822|NCT01957202|65362229|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442823|NCT01957202|65362212|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442824|NCT01957202|65362213|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442825|NCT01957202|65362214|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442826|NCT01957202|65362215|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442827|NCT01957202|65362216|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442828|NCT01957202|65362217|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
23762747|NCT00410410|66511251|FG000|Induction Period (IP)|Death|1|||
23762748|NCT00410410|66511252|FG001|Induction Period (IP)|Death|0|||
23762749|NCT00410410|66511253|FG002|Induction Period (IP)|Death|0|||
23762750|NCT00410410|66511254|FG003|Induction Period (IP)|Death|0|||
23762751|NCT00410410|66511255|FG004|Induction Period (IP)|Death|0|||
23762752|NCT00410410|66511256|FG005|Induction Period (IP)|Death|0|||
23762753|NCT00410410|66511257|FG006|Induction Period (IP)|Death|0|||
23762754|NCT00410410|66511258|FG007|Induction Period (IP)|Death|0|||
23442829|NCT01957202|65362218|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442830|NCT01957202|65362219|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442831|NCT01957202|65362220|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442832|NCT01957202|65362221|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442833|NCT01957202|65362222|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442834|NCT01957202|65362223|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442835|NCT01957202|65362224|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442836|NCT01957202|65362225|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442837|NCT01957202|65362226|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442838|NCT01957202|65362227|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442839|NCT01957202|65362228|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
23442840|NCT01957202|65362229|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442841|NCT01843023|65362230|FG000|Overall Study|Death|1|||
23442842|NCT01843023|65362231|FG001|Overall Study|Death|0|||
23442843|NCT01843023|65362230|FG000|Overall Study|Lost to Follow-up|24|||
23442844|NCT01843023|65362231|FG001|Overall Study|Lost to Follow-up|29|||
23442845|NCT01843023|65362230|FG000|Overall Study|Withdrawal by Subject|8|||
23442846|NCT01843023|65362231|FG001|Overall Study|Withdrawal by Subject|6|||
23442847|NCT00887926|65362238|FG000|Overall Study|Withdrawal by Subject|0|||
23442848|NCT00887926|65362239|FG001|Overall Study|Withdrawal by Subject|1|||
23442849|NCT00887926|65362240|FG002|Overall Study|Withdrawal by Subject|0|||
23442850|NCT00887926|65362241|FG003|Overall Study|Withdrawal by Subject|0|||
23442851|NCT03472326|65362244|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
23442852|NCT03472326|65362245|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
23442853|NCT03472326|65362246|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
23442854|NCT03472326|65362247|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
23442855|NCT03472326|65362244|FG000|Part 2: Combination Therapy|Pregnancy|0|||
23442856|NCT03472326|65362245|FG001|Part 2: Combination Therapy|Pregnancy|0|||
23442857|NCT03472326|65362246|FG002|Part 2: Combination Therapy|Pregnancy|0|||
23442858|NCT03472326|65362247|FG003|Part 2: Combination Therapy|Pregnancy|1|||
23442859|NCT01550757|65362250|FG000|Overall Study|Lost to Follow-up|21|||
23442860|NCT01550757|65362251|FG001|Overall Study|Lost to Follow-up|14|||
23442861|NCT01550757|65362252|FG002|Overall Study|Lost to Follow-up|42|||
23762755|NCT00410410|66511259|FG008|Induction Period (IP)|Death|0|||
23565852|NCT00152009|65799813|FG001|Overall Study|Protocol Violation|0|||
23762756|NCT00410410|66511251|FG000|Induction Period (IP)|Adverse Event|3|||
23442862|NCT01550757|65362253|FG003|Overall Study|Lost to Follow-up|53|||
23442863|NCT01550757|65362250|FG000|Overall Study|Withdrawal by Subject|2|||
23762757|NCT00410410|66511252|FG001|Induction Period (IP)|Adverse Event|4|||
23442864|NCT01550757|65362251|FG001|Overall Study|Withdrawal by Subject|0|||
23442865|NCT01550757|65362252|FG002|Overall Study|Withdrawal by Subject|3|||
23442866|NCT01550757|65362253|FG003|Overall Study|Withdrawal by Subject|1|||
23442867|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
23442868|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
23442869|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
23442870|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
23442871|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
23442872|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
23442873|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
23442874|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
23442875|NCT00705367|65362256|FG000|Long-term Extension Period|Adverse Event|2|||
23442876|NCT00705367|65362257|FG001|Long-term Extension Period|Adverse Event|0|||
23442877|NCT00705367|65362256|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
23442878|NCT00705367|65362257|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
23442879|NCT00705367|65362256|FG000|Long-term Extension Period|Lack of Efficacy|1|||
23442880|NCT00705367|65362257|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23442881|NCT00705367|65362256|FG000|Long-term Extension Period|No longer met study criteria|1|||
23442882|NCT00705367|65362257|FG001|Long-term Extension Period|No longer met study criteria|0|||
23442883|NCT00705367|65362256|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
23442884|NCT00705367|65362257|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
23442885|NCT00126776|65362258|FG000|Overall Study|follow up complete on all patients|0|||
23442886|NCT00126776|65362259|FG001|Overall Study|follow up complete on all patients|0|||
23442887|NCT02287467|65362260|FG000|Overall Study|Protocol Violation|12|||
23442888|NCT02287467|65362261|FG001|Overall Study|Protocol Violation|9|||
23442889|NCT02114606|65362262|FG000|Overall Study|Unable to swallow Cytosponge|6|||
23442890|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
23442891|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
23442892|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
23442893|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
23442894|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
23762758|NCT00410410|66511253|FG002|Induction Period (IP)|Adverse Event|2|||
23762759|NCT00410410|66511254|FG003|Induction Period (IP)|Adverse Event|4|||
23762760|NCT00410410|66511255|FG004|Induction Period (IP)|Adverse Event|1|||
23762761|NCT00410410|66511256|FG005|Induction Period (IP)|Adverse Event|0|||
23762762|NCT00410410|66511257|FG006|Induction Period (IP)|Adverse Event|0|||
23762763|NCT00410410|66511258|FG007|Induction Period (IP)|Adverse Event|0|||
23762764|NCT00410410|66511259|FG008|Induction Period (IP)|Adverse Event|0|||
23762765|NCT00410410|66511251|FG000|Induction Period (IP)|Lack of Efficacy|26|||
23762766|NCT00410410|66511252|FG001|Induction Period (IP)|Lack of Efficacy|24|||
23762767|NCT00410410|66511253|FG002|Induction Period (IP)|Lack of Efficacy|8|||
23762768|NCT00410410|66511254|FG003|Induction Period (IP)|Lack of Efficacy|8|||
23762769|NCT00410410|66511255|FG004|Induction Period (IP)|Lack of Efficacy|7|||
23762770|NCT00410410|66511256|FG005|Induction Period (IP)|Lack of Efficacy|7|||
23762771|NCT00410410|66511257|FG006|Induction Period (IP)|Lack of Efficacy|0|||
23762772|NCT00410410|66511258|FG007|Induction Period (IP)|Lack of Efficacy|0|||
23762773|NCT00410410|66511259|FG008|Induction Period (IP)|Lack of Efficacy|0|||
23762774|NCT00410410|66511251|FG000|Induction Period (IP)|Lost to Follow-up|2|||
23762775|NCT00410410|66511252|FG001|Induction Period (IP)|Lost to Follow-up|2|||
23762776|NCT00410410|66511253|FG002|Induction Period (IP)|Lost to Follow-up|2|||
23762777|NCT00410410|66511254|FG003|Induction Period (IP)|Lost to Follow-up|3|||
23762778|NCT00410410|66511255|FG004|Induction Period (IP)|Lost to Follow-up|0|||
23762779|NCT00410410|66511256|FG005|Induction Period (IP)|Lost to Follow-up|1|||
23762780|NCT00410410|66511257|FG006|Induction Period (IP)|Lost to Follow-up|0|||
23762781|NCT00410410|66511258|FG007|Induction Period (IP)|Lost to Follow-up|0|||
23762782|NCT00410410|66511259|FG008|Induction Period (IP)|Lost to Follow-up|0|||
23762783|NCT00410410|66511251|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
23762784|NCT00410410|66511252|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
23762785|NCT00410410|66511253|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
23762786|NCT00410410|66511254|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
23762787|NCT00410410|66511255|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
23762788|NCT00410410|66511256|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
23762789|NCT00410410|66511257|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
23762790|NCT00410410|66511258|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
23762791|NCT00410410|66511259|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
23762792|NCT00410410|66511251|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762793|NCT00410410|66511252|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762794|NCT00410410|66511253|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
23442895|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
23565853|NCT00152009|65799814|FG002|Overall Study|Protocol Violation|0|||
23762795|NCT00410410|66511254|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762796|NCT00410410|66511255|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762797|NCT00410410|66511256|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762798|NCT00410410|66511257|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762799|NCT00410410|66511258|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762800|NCT00410410|66511259|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23762801|NCT00410410|66511251|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762802|NCT00410410|66511252|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762803|NCT00410410|66511253|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762804|NCT00410410|66511254|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762805|NCT00410410|66511255|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
23762806|NCT00410410|66511256|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
23762807|NCT00410410|66511257|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762808|NCT00410410|66511258|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762809|NCT00410410|66511259|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23762810|NCT00410410|66511251|FG000|Induction Period (IP)|Other|0|||
23762811|NCT00410410|66511252|FG001|Induction Period (IP)|Other|0|||
23762812|NCT00410410|66511253|FG002|Induction Period (IP)|Other|1|||
23762813|NCT00410410|66511254|FG003|Induction Period (IP)|Other|0|||
23762814|NCT00410410|66511255|FG004|Induction Period (IP)|Other|0|||
23762815|NCT00410410|66511256|FG005|Induction Period (IP)|Other|0|||
23762816|NCT00410410|66511257|FG006|Induction Period (IP)|Other|0|||
23762817|NCT00410410|66511258|FG007|Induction Period (IP)|Other|0|||
23762818|NCT00410410|66511259|FG008|Induction Period (IP)|Other|0|||
23762819|NCT00410410|66511251|FG000|Maintenance Period (MP)|Death|0|||
23442896|NCT03654885|65362263|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
23442897|NCT03654885|65362264|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
23442898|NCT03654885|65362263|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
23442899|NCT03654885|65362264|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
23442900|NCT03654885|65362263|FG000|Overall Study|Adverse Event in Study Eye|3|||
23442901|NCT03654885|65362264|FG001|Overall Study|Adverse Event in Study Eye|0|||
23442902|NCT03654885|65362263|FG000|Overall Study|Consent Withdrawn|1|||
23442903|NCT03654885|65362264|FG001|Overall Study|Consent Withdrawn|0|||
23442904|NCT03654885|65362263|FG000|Overall Study|Death|3|||
23442905|NCT03654885|65362264|FG001|Overall Study|Death|1|||
23442906|NCT03654885|65362263|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
23442907|NCT03654885|65362264|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
23442908|NCT03654885|65362263|FG000|Overall Study|Lost to Follow-up|3|||
23442909|NCT03654885|65362264|FG001|Overall Study|Lost to Follow-up|3|||
23442910|NCT02524158|65362266|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
23565854|NCT00152009|65799815|FG003|Overall Study|Protocol Violation|1|||
23565855|NCT00152009|65799812|FG000|Overall Study|Withdrawal by Subject|2|||
23565856|NCT00152009|65799813|FG001|Overall Study|Withdrawal by Subject|3|||
23565857|NCT00152009|65799814|FG002|Overall Study|Withdrawal by Subject|4|||
23762820|NCT00410410|66511252|FG001|Maintenance Period (MP)|Death|0|||
23762821|NCT00410410|66511253|FG002|Maintenance Period (MP)|Death|0|||
23762822|NCT00410410|66511254|FG003|Maintenance Period (MP)|Death|0|||
23762823|NCT00410410|66511255|FG004|Maintenance Period (MP)|Death|0|||
23762824|NCT00410410|66511256|FG005|Maintenance Period (MP)|Death|0|||
23762825|NCT00410410|66511257|FG006|Maintenance Period (MP)|Death|1|||
23762826|NCT00410410|66511258|FG007|Maintenance Period (MP)|Death|0|||
23762827|NCT00410410|66511259|FG008|Maintenance Period (MP)|Death|0|||
23565858|NCT00152009|65799815|FG003|Overall Study|Withdrawal by Subject|9|||
23565859|NCT00152009|65799812|FG000|Overall Study|Lost to Follow-up|2|||
23565860|NCT00152009|65799813|FG001|Overall Study|Lost to Follow-up|4|||
23565861|NCT00152009|65799814|FG002|Overall Study|Lost to Follow-up|3|||
23762828|NCT00410410|66511251|FG000|Maintenance Period (MP)|Adverse Event|0|||
23762829|NCT00410410|66511252|FG001|Maintenance Period (MP)|Adverse Event|0|||
23762830|NCT00410410|66511253|FG002|Maintenance Period (MP)|Adverse Event|0|||
23762831|NCT00410410|66511254|FG003|Maintenance Period (MP)|Adverse Event|0|||
23762832|NCT00410410|66511255|FG004|Maintenance Period (MP)|Adverse Event|0|||
23762833|NCT00410410|66511256|FG005|Maintenance Period (MP)|Adverse Event|0|||
23828120|NCT02906670|66749049|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23565862|NCT00152009|65799815|FG003|Overall Study|Lost to Follow-up|3|||
23762834|NCT00410410|66511257|FG006|Maintenance Period (MP)|Adverse Event|1|||
23762835|NCT00410410|66511258|FG007|Maintenance Period (MP)|Adverse Event|3|||
23762836|NCT00410410|66511259|FG008|Maintenance Period (MP)|Adverse Event|0|||
23762837|NCT00410410|66511251|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
23762838|NCT00410410|66511252|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
23828121|NCT02906670|66749050|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23442911|NCT02524158|65362267|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
23565863|NCT00152009|65799812|FG000|Overall Study|Lack of Efficacy|8|||
23762839|NCT00410410|66511253|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
23762840|NCT00410410|66511254|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
23442912|NCT02524158|65362266|FG000|12-weeks Assessment|Lost to Follow-up|18|||
23442913|NCT02524158|65362267|FG001|12-weeks Assessment|Lost to Follow-up|12|||
23442914|NCT02524158|65362266|FG000|6-month Assessment|Withdrawal by Subject|1|||
23442915|NCT02524158|65362267|FG001|6-month Assessment|Withdrawal by Subject|1|||
23442916|NCT02524158|65362266|FG000|6-month Assessment|Lost to Follow-up|21|||
23442917|NCT02524158|65362267|FG001|6-month Assessment|Lost to Follow-up|20|||
23442918|NCT05249569|65362268|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
23442919|NCT01036321|65362270|FG000|Overall Study|Ineligible after randomization|0|||
23442920|NCT01036321|65362271|FG001|Overall Study|Ineligible after randomization|1|||
23442921|NCT01036321|65362270|FG000|Overall Study|Withdrawal by Subject|3|||
23442922|NCT01036321|65362271|FG001|Overall Study|Withdrawal by Subject|2|||
23442923|NCT01036321|65362270|FG000|Overall Study|Adverse Event|2|||
23442924|NCT01036321|65362271|FG001|Overall Study|Adverse Event|1|||
23442925|NCT00637416|65362272|FG000|Overall Study|Lost to Follow-up|1|||
23442926|NCT00637416|65362273|FG001|Overall Study|Lost to Follow-up|1|||
23442927|NCT00637416|65362272|FG000|Overall Study|Unable to take study drug|0|||
23442928|NCT00637416|65362273|FG001|Overall Study|Unable to take study drug|1|||
23442929|NCT01529034|65362274|FG000|Overall Study|Discontinued prior to study treatment|14|||
23442930|NCT01529034|65362274|FG000|Overall Study|Site closure|62|||
23442931|NCT01529034|65362274|FG000|Overall Study|Study termination|29|||
23442932|NCT01529034|65362274|FG000|Overall Study|Withdrawal by Subject|25|||
23442933|NCT01529034|65362274|FG000|Overall Study|No treated SCs within protocol window|13|||
23442934|NCT01529034|65362274|FG000|Overall Study|Noncompliance|8|||
23442935|NCT01529034|65362274|FG000|Overall Study|Caregiver no longer available|7|||
23442936|NCT01529034|65362274|FG000|Overall Study|Adverse Event|4|||
23442937|NCT01529034|65362274|FG000|Overall Study|Protocol Violation|4|||
23442938|NCT01529034|65362274|FG000|Overall Study|Lack of Efficacy|4|||
23442939|NCT01529034|65362274|FG000|Overall Study|Investigator no longer available|2|||
23442940|NCT01529034|65362274|FG000|Overall Study|Study drug not available|2|||
23442941|NCT00770601|65362277|FG000|Overall Study|Withdrawal by Subject|1|||
23442942|NCT00742417|65362280|FG000|Randomized|Withdrawal by legal representative|0|||
23442943|NCT00742417|65362281|FG001|Randomized|Withdrawal by legal representative|1|||
23442944|NCT00742417|65362280|FG000|Randomized|Withdrawal by Subject|1|||
23442945|NCT00742417|65362281|FG001|Randomized|Withdrawal by Subject|0|||
23628251|NCT01240915|66024687|FG002|Overall Study|Lost to Follow-up|0|||
23628252|NCT01240915|66024688|FG003|Overall Study|Lost to Follow-up|0|||
23628253|NCT01240915|66024689|FG004|Overall Study|Lost to Follow-up|1|||
23628254|NCT01240915|66024690|FG005|Overall Study|Lost to Follow-up|1|||
23628255|NCT01240915|66024691|FG006|Overall Study|Lost to Follow-up|0|||
23628256|NCT01240915|66024692|FG007|Overall Study|Lost to Follow-up|1|||
23628257|NCT01240915|66024693|FG008|Overall Study|Lost to Follow-up|1|||
23628258|NCT01240915|66024685|FG000|Overall Study|Withdrawal by Subject|2|||
23628259|NCT01240915|66024686|FG001|Overall Study|Withdrawal by Subject|1|||
23762841|NCT00410410|66511255|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
23762842|NCT00410410|66511256|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
23762843|NCT00410410|66511257|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
23762844|NCT00410410|66511258|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
23762845|NCT00410410|66511259|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
23762846|NCT00410410|66511251|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
23442946|NCT00742417|65362280|FG000|Randomized|Physician Decision|1|||
23442947|NCT00742417|65362281|FG001|Randomized|Physician Decision|0|||
23442948|NCT00742417|65362280|FG000|Intensive Period|Withdrawal by Subject|1|||
23442949|NCT00742417|65362281|FG001|Intensive Period|Withdrawal by Subject|1|||
23442950|NCT00742417|65362280|FG000|Intensive Period|Adverse Event|2|||
23565864|NCT00152009|65799813|FG001|Overall Study|Lack of Efficacy|6|||
23565865|NCT00152009|65799814|FG002|Overall Study|Lack of Efficacy|7|||
23565866|NCT00152009|65799815|FG003|Overall Study|Lack of Efficacy|15|||
23565867|NCT00152009|65799812|FG000|Overall Study|ECG abnormalities|2|||
23565868|NCT00152009|65799813|FG001|Overall Study|ECG abnormalities|2|||
23565869|NCT00152009|65799814|FG002|Overall Study|ECG abnormalities|2|||
23565870|NCT00152009|65799815|FG003|Overall Study|ECG abnormalities|1|||
23565871|NCT00152009|65799812|FG000|Overall Study|Sponsor's decision|3|||
23565872|NCT00152009|65799813|FG001|Overall Study|Sponsor's decision|3|||
23565873|NCT00152009|65799814|FG002|Overall Study|Sponsor's decision|1|||
23442951|NCT00742417|65362281|FG001|Intensive Period|Adverse Event|0|||
23442952|NCT03635996|65362288|FG000|Overall Study|Study terminated by Sponsor|94|||
23442953|NCT03635996|65362288|FG000|Overall Study|Withdrawal by Subject|20|||
23442954|NCT03635996|65362288|FG000|Overall Study|Ablation|26|||
23442955|NCT03635996|65362288|FG000|Overall Study|Adverse Event|7|||
23442956|NCT03635996|65362288|FG000|Overall Study|Physician Decision|3|||
23442957|NCT03635996|65362288|FG000|Overall Study|Prohibited medication|5|||
23565874|NCT00152009|65799815|FG003|Overall Study|Sponsor's decision|3|||
23628260|NCT01240915|66024687|FG002|Overall Study|Withdrawal by Subject|0|||
23628261|NCT01240915|66024688|FG003|Overall Study|Withdrawal by Subject|2|||
23762847|NCT00410410|66511252|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
23442958|NCT03635996|65362288|FG000|Overall Study|Did not meet eligibility criteria|5|||
23442959|NCT03635996|65362288|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
23442960|NCT03635996|65362288|FG000|Overall Study|Protocol Violation|1|||
23442961|NCT03635996|65362288|FG000|Overall Study|Lost to Follow-up|1|||
23442962|NCT04343755|65362296|FG000|Overall Study|Death|11|||
23442963|NCT04343755|65362296|FG000|Overall Study|Screen Failure|1|||
23442964|NCT02274792|65362297|FG000|Overall Study|Withdrawal by Subject|13|||
23442965|NCT02274792|65362297|FG000|Overall Study|Lost to Follow-up|8|||
23628262|NCT01240915|66024689|FG004|Overall Study|Withdrawal by Subject|0|||
23628263|NCT01240915|66024690|FG005|Overall Study|Withdrawal by Subject|4|||
23628264|NCT01240915|66024691|FG006|Overall Study|Withdrawal by Subject|2|||
23628265|NCT01240915|66024692|FG007|Overall Study|Withdrawal by Subject|3|||
23628266|NCT01240915|66024693|FG008|Overall Study|Withdrawal by Subject|3|||
23628267|NCT01240915|66024685|FG000|Overall Study|Other|0|||
23628268|NCT01240915|66024686|FG001|Overall Study|Other|0|||
23628269|NCT01240915|66024687|FG002|Overall Study|Other|0|||
23828122|NCT02906670|66749051|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828123|NCT02906670|66749052|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828124|NCT02906670|66749053|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828125|NCT02906670|66749054|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828126|NCT02906670|66749055|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
23828127|NCT02906670|66749056|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828128|NCT02906670|66749057|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828129|NCT02906670|66749058|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23828130|NCT02906670|66749049|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
23828131|NCT02906670|66749050|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
23828132|NCT02906670|66749051|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
23828133|NCT02906670|66749052|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
23828134|NCT02906670|66749053|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
23828135|NCT02906670|66749054|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
23828136|NCT02906670|66749055|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
23828137|NCT02906670|66749056|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
23828138|NCT02906670|66749057|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
23828139|NCT02906670|66749058|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
23828140|NCT02906670|66749049|FG000|Cohort 5P, Q2W|Adverse Event|0|||
23828141|NCT02906670|66749050|FG001|Cohort 5P, Q2W|Adverse Event|0|||
23828142|NCT02906670|66749051|FG002|Cohort 5P, Q2W|Adverse Event|0|||
23628270|NCT01240915|66024688|FG003|Overall Study|Other|0|||
23762848|NCT00410410|66511253|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
23828143|NCT02906670|66749052|FG003|Cohort 5P, Q2W|Adverse Event|0|||
23828144|NCT02906670|66749053|FG004|Cohort 5P, Q2W|Adverse Event|0|||
23828145|NCT02906670|66749054|FG005|Cohort 5P, Q2W|Adverse Event|0|||
23762849|NCT00410410|66511254|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
23762850|NCT00410410|66511255|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
23762851|NCT00410410|66511256|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
23762852|NCT00410410|66511257|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
23828146|NCT02906670|66749055|FG006|Cohort 5P, Q2W|Adverse Event|0|||
23442966|NCT02274792|65362297|FG000|Overall Study|Protocol Specified Criteria|2|||
23762853|NCT00410410|66511258|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
23762854|NCT00410410|66511259|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
23762855|NCT00410410|66511251|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762856|NCT00410410|66511252|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762857|NCT00410410|66511253|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762858|NCT00410410|66511254|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762859|NCT00410410|66511255|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762860|NCT00410410|66511256|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762861|NCT00410410|66511257|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
23762862|NCT00410410|66511258|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
23762863|NCT00410410|66511259|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
23762864|NCT00410410|66511251|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762865|NCT00410410|66511252|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762866|NCT00410410|66511253|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762867|NCT00410410|66511254|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762868|NCT00410410|66511255|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23828147|NCT02906670|66749056|FG007|Cohort 5P, Q2W|Adverse Event|1|||
23828148|NCT02906670|66749057|FG008|Cohort 5P, Q2W|Adverse Event|0|||
23828149|NCT02906670|66749058|FG009|Cohort 5P, Q2W|Adverse Event|0|||
23828150|NCT02906670|66749049|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
23828151|NCT02906670|66749050|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
23442967|NCT02274792|65362297|FG000|Overall Study|Sponsor Decision|2|||
23442968|NCT04034004|65362302|FG000|Overall Study|Withdrawal by Subject|1|||
23442969|NCT04034004|65362303|FG001|Overall Study|Withdrawal by Subject|2|||
23628271|NCT01240915|66024689|FG004|Overall Study|Other|2|||
23628272|NCT01240915|66024690|FG005|Overall Study|Other|0|||
23628273|NCT01240915|66024691|FG006|Overall Study|Other|0|||
23762869|NCT00410410|66511256|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762870|NCT00410410|66511257|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
23762871|NCT00410410|66511258|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
23762872|NCT00410410|66511259|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23762873|NCT00410410|66511251|FG000|Open-Label Period (OL)|Death|0|||
23828152|NCT02906670|66749051|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
23828153|NCT02906670|66749052|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
23828154|NCT02906670|66749053|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
23828155|NCT02906670|66749054|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
23828156|NCT02906670|66749055|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
23828157|NCT02906670|66749056|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
23828158|NCT02906670|66749057|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
23828159|NCT02906670|66749058|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
23828160|NCT02906670|66749049|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
23828161|NCT02906670|66749050|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
23828162|NCT02906670|66749051|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
23828163|NCT02906670|66749052|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
23828164|NCT02906670|66749053|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
23828165|NCT02906670|66749054|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
23828166|NCT02906670|66749055|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
23828167|NCT02906670|66749056|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
23828168|NCT02906670|66749057|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
23828169|NCT02906670|66749058|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
23828170|NCT02906670|66749049|FG000|Cohort 4P, QW|Radiological Progression|0|||
23828171|NCT02906670|66749050|FG001|Cohort 4P, QW|Radiological Progression|0|||
23828172|NCT02906670|66749051|FG002|Cohort 4P, QW|Radiological Progression|0|||
23828173|NCT02906670|66749052|FG003|Cohort 4P, QW|Radiological Progression|3|||
23828174|NCT02906670|66749053|FG004|Cohort 4P, QW|Radiological Progression|0|||
23828175|NCT02906670|66749054|FG005|Cohort 4P, QW|Radiological Progression|0|||
23828176|NCT02906670|66749055|FG006|Cohort 4P, QW|Radiological Progression|0|||
23762874|NCT00410410|66511252|FG001|Open-Label Period (OL)|Death|0|||
23565875|NCT01535274|65799816|FG000|Overall Study|Determined to be ineligible|0|||
23565876|NCT01535274|65799817|FG001|Overall Study|Determined to be ineligible|1|||
23565877|NCT01535274|65799816|FG000|Overall Study|Misallocated to propofol intervention|0|||
23565878|NCT01535274|65799817|FG001|Overall Study|Misallocated to propofol intervention|1|||
23565879|NCT04498247|65799818|FG000|Overall Study|Lost to Follow-up|0|||
23565880|NCT04498247|65799819|FG001|Overall Study|Lost to Follow-up|0|||
23565881|NCT04498247|65799820|FG002|Overall Study|Lost to Follow-up|0|||
23565882|NCT04498247|65799821|FG003|Overall Study|Lost to Follow-up|1|||
23565883|NCT04498247|65799822|FG004|Overall Study|Lost to Follow-up|0|||
23565884|NCT04498247|65799823|FG005|Overall Study|Lost to Follow-up|0|||
23565885|NCT04498247|65799824|FG006|Overall Study|Lost to Follow-up|0|||
23565886|NCT04498247|65799825|FG007|Overall Study|Lost to Follow-up|0|||
23565887|NCT04498247|65799818|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
23565888|NCT04498247|65799819|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565889|NCT04498247|65799820|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565890|NCT04498247|65799821|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565891|NCT04498247|65799822|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565892|NCT04498247|65799823|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565893|NCT04498247|65799824|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565894|NCT04498247|65799825|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
23762875|NCT00410410|66511253|FG002|Open-Label Period (OL)|Death|0|||
23762876|NCT00410410|66511254|FG003|Open-Label Period (OL)|Death|0|||
23828177|NCT02906670|66749056|FG007|Cohort 4P, QW|Radiological Progression|0|||
23828178|NCT02906670|66749057|FG008|Cohort 4P, QW|Radiological Progression|0|||
23828179|NCT02906670|66749058|FG009|Cohort 4P, QW|Radiological Progression|0|||
23762877|NCT00410410|66511255|FG004|Open-Label Period (OL)|Death|0|||
23762878|NCT00410410|66511256|FG005|Open-Label Period (OL)|Death|0|||
23762879|NCT00410410|66511257|FG006|Open-Label Period (OL)|Death|0|||
23762880|NCT00410410|66511258|FG007|Open-Label Period (OL)|Death|0|||
23828180|NCT02906670|66749049|FG000|Cohort 7P, Q2W|Adverse Event|0|||
23828181|NCT02906670|66749050|FG001|Cohort 7P, Q2W|Adverse Event|0|||
23828182|NCT02906670|66749051|FG002|Cohort 7P, Q2W|Adverse Event|0|||
23828183|NCT02906670|66749052|FG003|Cohort 7P, Q2W|Adverse Event|0|||
23828184|NCT02906670|66749053|FG004|Cohort 7P, Q2W|Adverse Event|0|||
23565895|NCT04498247|65799818|FG000|Overall Study|Withdrawal by Subject|0|||
23565896|NCT04498247|65799819|FG001|Overall Study|Withdrawal by Subject|8|||
23565897|NCT04498247|65799820|FG002|Overall Study|Withdrawal by Subject|0|||
23565898|NCT04498247|65799821|FG003|Overall Study|Withdrawal by Subject|7|||
23565899|NCT04498247|65799822|FG004|Overall Study|Withdrawal by Subject|0|||
23565900|NCT04498247|65799823|FG005|Overall Study|Withdrawal by Subject|0|||
23565901|NCT04498247|65799824|FG006|Overall Study|Withdrawal by Subject|1|||
23565902|NCT04498247|65799825|FG007|Overall Study|Withdrawal by Subject|0|||
23565903|NCT04498247|65799818|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565904|NCT04498247|65799819|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
23565905|NCT04498247|65799820|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565906|NCT04498247|65799821|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
23565907|NCT04498247|65799822|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565908|NCT04498247|65799823|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565909|NCT04498247|65799824|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
23565910|NCT04498247|65799825|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565911|NCT03239873|65799826|FG000|Overall Study|Lost to Follow-up|15|||
23565912|NCT03239873|65799827|FG001|Overall Study|Lost to Follow-up|16|||
23565913|NCT03239873|65799826|FG000|Overall Study|Physician Decision|1|||
23565914|NCT03239873|65799827|FG001|Overall Study|Physician Decision|0|||
23762881|NCT00410410|66511259|FG008|Open-Label Period (OL)|Death|1|||
23828185|NCT02906670|66749054|FG005|Cohort 7P, Q2W|Adverse Event|0|||
23828186|NCT02906670|66749055|FG006|Cohort 7P, Q2W|Adverse Event|0|||
23828187|NCT02906670|66749056|FG007|Cohort 7P, Q2W|Adverse Event|0|||
23828188|NCT02906670|66749057|FG008|Cohort 7P, Q2W|Adverse Event|0|||
23828189|NCT02906670|66749058|FG009|Cohort 7P, Q2W|Adverse Event|1|||
23828190|NCT02906670|66749049|FG000|Cohort 7P, Q2W|Physician Decision|0|||
23828191|NCT02906670|66749050|FG001|Cohort 7P, Q2W|Physician Decision|0|||
23828192|NCT02906670|66749051|FG002|Cohort 7P, Q2W|Physician Decision|0|||
23828193|NCT02906670|66749052|FG003|Cohort 7P, Q2W|Physician Decision|0|||
23828194|NCT02906670|66749053|FG004|Cohort 7P, Q2W|Physician Decision|0|||
23828195|NCT02906670|66749054|FG005|Cohort 7P, Q2W|Physician Decision|0|||
23828196|NCT02906670|66749055|FG006|Cohort 7P, Q2W|Physician Decision|0|||
23762882|NCT00410410|66511251|FG000|Open-Label Period (OL)|Adverse Event|0|||
23762883|NCT00410410|66511252|FG001|Open-Label Period (OL)|Adverse Event|0|||
23762884|NCT00410410|66511253|FG002|Open-Label Period (OL)|Adverse Event|0|||
23762885|NCT00410410|66511254|FG003|Open-Label Period (OL)|Adverse Event|0|||
23762886|NCT00410410|66511255|FG004|Open-Label Period (OL)|Adverse Event|0|||
23762887|NCT00410410|66511256|FG005|Open-Label Period (OL)|Adverse Event|0|||
23762888|NCT00410410|66511257|FG006|Open-Label Period (OL)|Adverse Event|0|||
23762889|NCT00410410|66511258|FG007|Open-Label Period (OL)|Adverse Event|0|||
23762890|NCT00410410|66511259|FG008|Open-Label Period (OL)|Adverse Event|10|||
23762891|NCT00410410|66511251|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
23762892|NCT00410410|66511252|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
23762893|NCT00410410|66511253|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
23762894|NCT00410410|66511254|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
23762895|NCT00410410|66511255|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
23762896|NCT00410410|66511256|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
23762897|NCT00410410|66511257|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
23762898|NCT00410410|66511258|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
23762899|NCT00410410|66511259|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
23762900|NCT00410410|66511251|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
23762901|NCT00410410|66511252|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
23762902|NCT00410410|66511253|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
23828197|NCT02906670|66749056|FG007|Cohort 7P, Q2W|Physician Decision|0|||
23442970|NCT04034004|65362304|FG002|Overall Study|Withdrawal by Subject|2|||
23762903|NCT00410410|66511254|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
23442971|NCT04034004|65362305|FG003|Overall Study|Withdrawal by Subject|3|||
23442972|NCT04034004|65362302|FG000|Overall Study|could not find vein to administer IV|2|||
23762904|NCT00410410|66511255|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
23762905|NCT00410410|66511256|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
23828198|NCT02906670|66749057|FG008|Cohort 7P, Q2W|Physician Decision|0|||
23828199|NCT02906670|66749058|FG009|Cohort 7P, Q2W|Physician Decision|1|||
23828200|NCT02906670|66749049|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23442973|NCT04034004|65362303|FG001|Overall Study|could not find vein to administer IV|1|||
23828201|NCT02906670|66749050|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23762906|NCT00410410|66511257|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
23762907|NCT00410410|66511258|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
23762908|NCT00410410|66511259|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
23762909|NCT00410410|66511251|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762910|NCT00410410|66511252|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762911|NCT00410410|66511253|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762912|NCT00410410|66511254|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762913|NCT00410410|66511255|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762914|NCT00410410|66511256|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762915|NCT00410410|66511257|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762916|NCT00410410|66511258|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
23762917|NCT00410410|66511259|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
23762918|NCT00410410|66511251|FG000|Open-Label Period (OL)|Pregnancy|0|||
23762919|NCT00410410|66511252|FG001|Open-Label Period (OL)|Pregnancy|0|||
23565915|NCT03239873|65799826|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
23565916|NCT03239873|65799827|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
23565917|NCT03239873|65799826|FG000|Overall Study|Withdrawal by Subject|2|||
23565918|NCT03239873|65799827|FG001|Overall Study|Withdrawal by Subject|0|||
23565919|NCT03239873|65799826|FG000|Overall Study|Contraindication to study medication|1|||
23565920|NCT03239873|65799827|FG001|Overall Study|Contraindication to study medication|0|||
23565921|NCT03239873|65799826|FG000|Overall Study|Protocol Violation|1|||
23565922|NCT03239873|65799827|FG001|Overall Study|Protocol Violation|0|||
23565923|NCT02309112|65799828|FG000|Overall Study|Withdrawal by Subject|1|||
23565924|NCT02309112|65799829|FG001|Overall Study|Withdrawal by Subject|0|||
23565925|NCT02309112|65799830|FG002|Overall Study|Withdrawal by Subject|1|||
23565926|NCT02309112|65799828|FG000|Overall Study|Lost to Follow-up|0|||
23565927|NCT02309112|65799829|FG001|Overall Study|Lost to Follow-up|1|||
23565928|NCT02309112|65799830|FG002|Overall Study|Lost to Follow-up|0|||
23565929|NCT04827134|65799831|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565930|NCT04827134|65799832|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565931|NCT04827134|65799833|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
23565932|NCT04827134|65799834|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565933|NCT00876460|65799835|FG000|Combination Therapy Phase|Progressive disease|2|||
23565934|NCT00876460|65799836|FG001|Combination Therapy Phase|Progressive disease|3|||
23565935|NCT00876460|65799837|FG002|Combination Therapy Phase|Progressive disease|3|||
23565936|NCT00876460|65799838|FG003|Combination Therapy Phase|Progressive disease|3|||
23565937|NCT00876460|65799839|FG004|Combination Therapy Phase|Progressive disease|3|||
23565938|NCT00876460|65799840|FG005|Combination Therapy Phase|Progressive disease|1|||
23565939|NCT00876460|65799841|FG006|Combination Therapy Phase|Progressive disease|1|||
23565940|NCT00876460|65799842|FG007|Combination Therapy Phase|Progressive disease|1|||
23565941|NCT00876460|65799835|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
23565942|NCT00876460|65799836|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
23565943|NCT00876460|65799837|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
23565944|NCT00876460|65799838|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
23565945|NCT00876460|65799839|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
23565946|NCT00876460|65799840|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
23565947|NCT00876460|65799841|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
23565948|NCT00876460|65799842|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
23565949|NCT00876460|65799835|FG000|Combination Therapy Phase|Adverse Event|0|||
23565950|NCT00876460|65799836|FG001|Combination Therapy Phase|Adverse Event|2|||
23565951|NCT00876460|65799837|FG002|Combination Therapy Phase|Adverse Event|0|||
23565952|NCT00876460|65799838|FG003|Combination Therapy Phase|Adverse Event|2|||
23565953|NCT00876460|65799839|FG004|Combination Therapy Phase|Adverse Event|2|||
23565954|NCT00876460|65799840|FG005|Combination Therapy Phase|Adverse Event|0|||
23565955|NCT00876460|65799841|FG006|Combination Therapy Phase|Adverse Event|3|||
23565956|NCT00876460|65799842|FG007|Combination Therapy Phase|Adverse Event|2|||
23565957|NCT00876460|65799835|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
23565958|NCT00876460|65799836|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
23565959|NCT00876460|65799837|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
23565960|NCT00876460|65799838|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
23565961|NCT00876460|65799839|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
23565962|NCT00876460|65799840|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
23565963|NCT00876460|65799841|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
23565964|NCT00876460|65799842|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
23565965|NCT00876460|65799835|FG000|Combination Therapy Phase|Other reason not defined above|0|||
23762920|NCT00410410|66511253|FG002|Open-Label Period (OL)|Pregnancy|0|||
23565966|NCT00876460|65799836|FG001|Combination Therapy Phase|Other reason not defined above|0|||
23565967|NCT00876460|65799837|FG002|Combination Therapy Phase|Other reason not defined above|0|||
23565968|NCT00876460|65799838|FG003|Combination Therapy Phase|Other reason not defined above|0|||
23762921|NCT00410410|66511254|FG003|Open-Label Period (OL)|Pregnancy|0|||
23762922|NCT00410410|66511255|FG004|Open-Label Period (OL)|Pregnancy|0|||
23565969|NCT00876460|65799839|FG004|Combination Therapy Phase|Other reason not defined above|0|||
23762923|NCT00410410|66511256|FG005|Open-Label Period (OL)|Pregnancy|0|||
23762924|NCT00410410|66511257|FG006|Open-Label Period (OL)|Pregnancy|0|||
23762925|NCT00410410|66511258|FG007|Open-Label Period (OL)|Pregnancy|0|||
23762926|NCT00410410|66511259|FG008|Open-Label Period (OL)|Pregnancy|1|||
23762927|NCT00410410|66511251|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762928|NCT00410410|66511252|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762929|NCT00410410|66511253|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762930|NCT00410410|66511254|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762931|NCT00410410|66511255|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762932|NCT00410410|66511256|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762933|NCT00410410|66511257|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762934|NCT00410410|66511258|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23762935|NCT00410410|66511259|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
23762936|NCT00410410|66511251|FG000|Open-Label Period (OL)|Other|0|||
23762937|NCT00410410|66511252|FG001|Open-Label Period (OL)|Other|0|||
23762938|NCT00410410|66511253|FG002|Open-Label Period (OL)|Other|0|||
23762939|NCT00410410|66511254|FG003|Open-Label Period (OL)|Other|0|||
23762940|NCT00410410|66511255|FG004|Open-Label Period (OL)|Other|0|||
23762941|NCT00410410|66511256|FG005|Open-Label Period (OL)|Other|0|||
23762942|NCT00410410|66511257|FG006|Open-Label Period (OL)|Other|0|||
23762943|NCT00410410|66511258|FG007|Open-Label Period (OL)|Other|0|||
23762944|NCT00410410|66511259|FG008|Open-Label Period (OL)|Other|7|||
23762945|NCT01159769|66511261|FG000|Overall Study|Adverse Event|1|||
23762946|NCT03568500|66511262|FG000|Overall Study|Lost to Follow-up|1|||
23762947|NCT03568500|66511263|FG001|Overall Study|Lost to Follow-up|1|||
23762948|NCT03568500|66511264|FG002|Overall Study|Lost to Follow-up|2|||
23762949|NCT03568500|66511262|FG000|Overall Study|Adverse Event|1|||
23762950|NCT03568500|66511263|FG001|Overall Study|Adverse Event|1|||
23762951|NCT03568500|66511264|FG002|Overall Study|Adverse Event|2|||
23762952|NCT03568500|66511262|FG000|Overall Study|Physician Decision|1|||
23762953|NCT03568500|66511263|FG001|Overall Study|Physician Decision|0|||
23762954|NCT03568500|66511264|FG002|Overall Study|Physician Decision|0|||
23762955|NCT03568500|66511262|FG000|Overall Study|Withdrawal by Subject|4|||
23762956|NCT03568500|66511263|FG001|Overall Study|Withdrawal by Subject|2|||
23762957|NCT03568500|66511264|FG002|Overall Study|Withdrawal by Subject|0|||
23762958|NCT03568500|66511262|FG000|Overall Study|Technical Problems|2|||
23762959|NCT03568500|66511263|FG001|Overall Study|Technical Problems|1|||
23442974|NCT04034004|65362304|FG002|Overall Study|could not find vein to administer IV|0|||
23442975|NCT04034004|65362305|FG003|Overall Study|could not find vein to administer IV|0|||
23442976|NCT04034004|65362302|FG000|Overall Study|nurse accidentally unblinded subject|0|||
23442977|NCT04034004|65362303|FG001|Overall Study|nurse accidentally unblinded subject|0|||
23442978|NCT04034004|65362304|FG002|Overall Study|nurse accidentally unblinded subject|0|||
23442979|NCT04034004|65362305|FG003|Overall Study|nurse accidentally unblinded subject|1|||
23442980|NCT00571038|65362306|FG000|Overall Study|Lost to Follow-up|1|||
23442981|NCT00571038|65362307|FG001|Overall Study|Lost to Follow-up|4|||
23442982|NCT00571038|65362306|FG000|Overall Study|Death|7|||
23442983|NCT00571038|65362307|FG001|Overall Study|Death|5|||
23442984|NCT00571038|65362306|FG000|Overall Study|Withdrawal by Subject|1|||
23442985|NCT00571038|65362307|FG001|Overall Study|Withdrawal by Subject|3|||
23442986|NCT00571038|65362306|FG000|Overall Study|Moved out of state|2|||
23442987|NCT00571038|65362307|FG001|Overall Study|Moved out of state|2|||
23442988|NCT02688985|65362310|FG000|Overall Study|Adverse Event|1|||
23442989|NCT02688985|65362311|FG001|Overall Study|Adverse Event|2|||
23442990|NCT02688985|65362312|FG002|Overall Study|Adverse Event|2|||
23565970|NCT00876460|65799840|FG005|Combination Therapy Phase|Other reason not defined above|0|||
23762960|NCT03568500|66511264|FG002|Overall Study|Technical Problems|0|||
23828202|NCT02906670|66749051|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23828203|NCT02906670|66749052|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23762961|NCT03568500|66511262|FG000|Overall Study|Participant Noncompliance|1|||
23762962|NCT03568500|66511263|FG001|Overall Study|Participant Noncompliance|1|||
23762963|NCT03568500|66511264|FG002|Overall Study|Participant Noncompliance|0|||
23762964|NCT03751020|66511265|FG000|Overall Study|Withdrawal by Subject|2|||
23762965|NCT03751020|66511266|FG001|Overall Study|Withdrawal by Subject|0|||
23762966|NCT03751020|66511267|FG002|Overall Study|Withdrawal by Subject|0|||
23762967|NCT03751020|66511265|FG000|Overall Study|Lost to Follow-up|7|||
23762968|NCT03751020|66511266|FG001|Overall Study|Lost to Follow-up|4|||
23828204|NCT02906670|66749053|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23442991|NCT02688985|65362313|FG003|Overall Study|Adverse Event|0|||
23442992|NCT02688985|65362314|FG004|Overall Study|Adverse Event|0|||
23762969|NCT03751020|66511267|FG002|Overall Study|Lost to Follow-up|10|||
23762970|NCT02742181|66511268|FG000|Overall Study|Physician Decision|1|||
23762971|NCT02742181|66511269|FG001|Overall Study|Physician Decision|0|||
23762972|NCT00544557|66511270|FG000|Overall Study|Adverse Event|140|||
23762973|NCT00544557|66511270|FG000|Overall Study|Lack of Efficacy|196|||
23442993|NCT02688985|65362310|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
23762974|NCT00544557|66511270|FG000|Overall Study|Other|98|||
23762975|NCT02666430|66511271|FG000|Period 1|Lost to Follow-up|1|||
23762976|NCT02666430|66511272|FG001|Period 1|Lost to Follow-up|0|||
23762977|NCT02666430|66511271|FG000|Period 1|Adverse Event|0|||
23762978|NCT02666430|66511272|FG001|Period 1|Adverse Event|1|||
23762979|NCT02666430|66511271|FG000|Period 2|Withdrawal by Subject|1|||
23762980|NCT02666430|66511272|FG001|Period 2|Withdrawal by Subject|4|||
23762981|NCT02666430|66511271|FG000|Period 3|Lost to Follow-up|1|||
23762982|NCT02666430|66511272|FG001|Period 3|Lost to Follow-up|0|||
23762983|NCT00863057|66511275|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23762984|NCT00863057|66511276|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23762985|NCT00863057|66511277|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
23762986|NCT00863057|66511278|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23762987|NCT00863057|66511275|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23762988|NCT00863057|66511276|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
23762989|NCT00863057|66511277|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23762990|NCT00863057|66511278|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23762991|NCT00863057|66511275|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
23762992|NCT00863057|66511276|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
23762993|NCT00863057|66511277|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
23762994|NCT00863057|66511278|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
23828205|NCT02906670|66749054|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23828206|NCT02906670|66749055|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23762995|NCT00863057|66511275|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
23565971|NCT00876460|65799841|FG006|Combination Therapy Phase|Other reason not defined above|1|||
23565972|NCT00876460|65799842|FG007|Combination Therapy Phase|Other reason not defined above|2|||
23565973|NCT00876460|65799835|FG000|Combination Therapy Phase|Not treated|0|||
23762996|NCT00863057|66511276|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
23762997|NCT00863057|66511277|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
23762998|NCT00863057|66511278|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
23762999|NCT03280537|66511279|FG000|Overall Study|Withdrawal by Subject|2|||
23763000|NCT03280537|66511280|FG001|Overall Study|Withdrawal by Subject|4|||
23763001|NCT01590433|66511281|FG000|Overall Study|Lost to Follow-up|20|||
23763002|NCT01590433|66511282|FG001|Overall Study|Lost to Follow-up|8|||
23763003|NCT01590433|66511281|FG000|Overall Study|Withdrawal by Subject|21|||
23763004|NCT01590433|66511282|FG001|Overall Study|Withdrawal by Subject|11|||
23763005|NCT01590433|66511281|FG000|Overall Study|Adverse Event|11|||
23763006|NCT01590433|66511282|FG001|Overall Study|Adverse Event|3|||
23763007|NCT02082262|66511283|FG000|Overall Study|Withdrawal by Subject|3|||
23763008|NCT02082262|66511283|FG000|Overall Study|Adverse Event|48|||
23763009|NCT01698320|66511284|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
23565974|NCT00876460|65799836|FG001|Combination Therapy Phase|Not treated|0|||
23565975|NCT00876460|65799837|FG002|Combination Therapy Phase|Not treated|0|||
23565976|NCT00876460|65799838|FG003|Combination Therapy Phase|Not treated|0|||
23565977|NCT00876460|65799839|FG004|Combination Therapy Phase|Not treated|0|||
23565978|NCT00876460|65799840|FG005|Combination Therapy Phase|Not treated|0|||
23565979|NCT00876460|65799841|FG006|Combination Therapy Phase|Not treated|1|||
23565980|NCT00876460|65799842|FG007|Combination Therapy Phase|Not treated|0|||
23565981|NCT00876460|65799835|FG000|Mono Therapy Phase|Progressive disease|0|||
23565982|NCT00876460|65799836|FG001|Mono Therapy Phase|Progressive disease|0|||
23628274|NCT01240915|66024692|FG007|Overall Study|Other|0|||
23628275|NCT01240915|66024693|FG008|Overall Study|Other|0|||
23628276|NCT01240915|66024685|FG000|Overall Study|Insufficient Clinical Response|0|||
23628277|NCT01240915|66024686|FG001|Overall Study|Insufficient Clinical Response|0|||
23628278|NCT01240915|66024687|FG002|Overall Study|Insufficient Clinical Response|0|||
23763010|NCT01698320|66511285|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
23763011|NCT01698320|66511286|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
23763012|NCT01698320|66511284|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
23763013|NCT01698320|66511285|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
23763014|NCT01698320|66511286|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
23828207|NCT02906670|66749056|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23828208|NCT02906670|66749057|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23828209|NCT02906670|66749058|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
23828210|NCT02906670|66749049|FG000|Cohort 5P, QW|Radiological Progression|0|||
23828211|NCT02906670|66749050|FG001|Cohort 5P, QW|Radiological Progression|0|||
23442994|NCT02688985|65362311|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
23442995|NCT02688985|65362312|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
23442996|NCT02688985|65362313|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
23565983|NCT00876460|65799837|FG002|Mono Therapy Phase|Progressive disease|0|||
23628279|NCT01240915|66024688|FG003|Overall Study|Insufficient Clinical Response|0|||
23763015|NCT01698320|66511284|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
23763016|NCT01698320|66511285|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
23763017|NCT01698320|66511286|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
23763018|NCT01698320|66511284|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
23763019|NCT01698320|66511285|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
23763020|NCT01698320|66511286|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
23763021|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Adverse Event|0|||
23442997|NCT02688985|65362314|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
23442998|NCT02688985|65362310|FG000|Overall Study|Death|0|||
23442999|NCT02688985|65362311|FG001|Overall Study|Death|0|||
23443000|NCT02688985|65362312|FG002|Overall Study|Death|0|||
23443001|NCT02688985|65362313|FG003|Overall Study|Death|0|||
23443002|NCT02688985|65362314|FG004|Overall Study|Death|1|||
23443003|NCT02688985|65362310|FG000|Overall Study|Lack of Efficacy|0|||
23443004|NCT02688985|65362311|FG001|Overall Study|Lack of Efficacy|0|||
23443005|NCT02688985|65362312|FG002|Overall Study|Lack of Efficacy|0|||
23443006|NCT02688985|65362313|FG003|Overall Study|Lack of Efficacy|0|||
23443007|NCT02688985|65362314|FG004|Overall Study|Lack of Efficacy|1|||
23443008|NCT02688985|65362310|FG000|Overall Study|Lost to Follow-up|2|||
23443009|NCT02688985|65362311|FG001|Overall Study|Lost to Follow-up|0|||
23443010|NCT02688985|65362312|FG002|Overall Study|Lost to Follow-up|1|||
23443011|NCT02688985|65362313|FG003|Overall Study|Lost to Follow-up|1|||
23443012|NCT02688985|65362314|FG004|Overall Study|Lost to Follow-up|1|||
23443013|NCT02688985|65362310|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23443014|NCT02688985|65362311|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23443015|NCT02688985|65362312|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23443016|NCT02688985|65362313|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23443017|NCT02688985|65362314|FG004|Overall Study|Non-Compliance With Study Drug|1|||
23443018|NCT02688985|65362310|FG000|Overall Study|Other|3|||
23443019|NCT02688985|65362311|FG001|Overall Study|Other|4|||
23443020|NCT02688985|65362312|FG002|Overall Study|Other|1|||
23443021|NCT02688985|65362313|FG003|Overall Study|Other|0|||
23443022|NCT02688985|65362314|FG004|Overall Study|Other|0|||
23443023|NCT02688985|65362310|FG000|Overall Study|Physician Decision|2|||
23443024|NCT02688985|65362311|FG001|Overall Study|Physician Decision|2|||
23443025|NCT02688985|65362312|FG002|Overall Study|Physician Decision|0|||
23443026|NCT02688985|65362313|FG003|Overall Study|Physician Decision|0|||
23443027|NCT02688985|65362314|FG004|Overall Study|Physician Decision|1|||
23443028|NCT02688985|65362310|FG000|Overall Study|Pregnancy|0|||
23443029|NCT02688985|65362311|FG001|Overall Study|Pregnancy|0|||
23443030|NCT02688985|65362312|FG002|Overall Study|Pregnancy|2|||
23443031|NCT02688985|65362313|FG003|Overall Study|Pregnancy|1|||
23443032|NCT02688985|65362314|FG004|Overall Study|Pregnancy|0|||
23443033|NCT02688985|65362310|FG000|Overall Study|Study Terminated By Sponsor|0|||
23443034|NCT02688985|65362311|FG001|Overall Study|Study Terminated By Sponsor|0|||
23565984|NCT00876460|65799838|FG003|Mono Therapy Phase|Progressive disease|0|||
23565985|NCT00876460|65799839|FG004|Mono Therapy Phase|Progressive disease|2|||
23763022|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Adverse Event|1|||
23763023|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Adverse Event|1|||
23443035|NCT02688985|65362312|FG002|Overall Study|Study Terminated By Sponsor|0|||
23443036|NCT02688985|65362313|FG003|Overall Study|Study Terminated By Sponsor|1|||
23443037|NCT02688985|65362314|FG004|Overall Study|Study Terminated By Sponsor|0|||
23443038|NCT02688985|65362310|FG000|Overall Study|Withdrawal by Subject|2|||
23443039|NCT02688985|65362311|FG001|Overall Study|Withdrawal by Subject|8|||
23443040|NCT02688985|65362312|FG002|Overall Study|Withdrawal by Subject|7|||
23443041|NCT02688985|65362313|FG003|Overall Study|Withdrawal by Subject|1|||
23443042|NCT02688985|65362314|FG004|Overall Study|Withdrawal by Subject|4|||
23565986|NCT00876460|65799840|FG005|Mono Therapy Phase|Progressive disease|0|||
23443043|NCT00630344|65362315|FG000|Overall Study|Adverse Event|5|||
23763024|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
23763025|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
23763026|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
23763027|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
23763028|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
23763029|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
23763030|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Pregnancy|0|||
23763031|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Pregnancy|1|||
23763032|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Pregnancy|1|||
23763033|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
23443044|NCT00630344|65362315|FG000|Overall Study|Progressive Disease|19|||
23443045|NCT00630344|65362315|FG000|Overall Study|Physician Decision|9|||
23443046|NCT00630344|65362315|FG000|Overall Study|Withdrawal by Subject|1|||
23443047|NCT00630344|65362315|FG000|Overall Study|Intercurrent Illness|1|||
23443048|NCT00630344|65362315|FG000|Overall Study|Other|1|||
23443049|NCT04124705|65362318|FG000|Titration Period|Adverse Event|9|||
23443050|NCT04124705|65362319|FG001|Titration Period|Adverse Event|5|||
23443051|NCT04124705|65362318|FG000|Titration Period|Withdrawal by Subject|6|||
23443052|NCT04124705|65362319|FG001|Titration Period|Withdrawal by Subject|3|||
23443053|NCT04124705|65362318|FG000|Titration Period|Lost to Follow-up|0|||
23443054|NCT04124705|65362319|FG001|Titration Period|Lost to Follow-up|1|||
23443055|NCT04124705|65362318|FG000|Titration Period|Death|1|||
23443056|NCT04124705|65362319|FG001|Titration Period|Death|1|||
23443057|NCT04124705|65362318|FG000|Titration Period|Lack of Efficacy|2|||
23443058|NCT04124705|65362319|FG001|Titration Period|Lack of Efficacy|0|||
23443059|NCT04124705|65362318|FG000|Titration Period|Physician Decision|2|||
23443060|NCT04124705|65362319|FG001|Titration Period|Physician Decision|0|||
23443061|NCT04124705|65362318|FG000|Titration Period|Non-compliance with Study Drug|2|||
23443062|NCT04124705|65362319|FG001|Titration Period|Non-compliance with Study Drug|0|||
23443063|NCT04124705|65362318|FG000|Titration Period|Other|4|||
23443064|NCT04124705|65362319|FG001|Titration Period|Other|9|||
23443065|NCT04124705|65362318|FG000|Stabilization Period|Adverse Event|4|||
23443066|NCT04124705|65362319|FG001|Stabilization Period|Adverse Event|2|||
23443067|NCT04124705|65362318|FG000|Stabilization Period|Withdrawal by Subject|1|||
23443068|NCT04124705|65362319|FG001|Stabilization Period|Withdrawal by Subject|1|||
23443069|NCT04124705|65362318|FG000|Stabilization Period|Lost to Follow-up|0|||
23443070|NCT04124705|65362319|FG001|Stabilization Period|Lost to Follow-up|1|||
23565987|NCT00876460|65799841|FG006|Mono Therapy Phase|Progressive disease|1|||
23565988|NCT00876460|65799842|FG007|Mono Therapy Phase|Progressive disease|3|||
23565989|NCT00876460|65799835|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
23565990|NCT00876460|65799836|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
23565991|NCT00876460|65799837|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
23565992|NCT00876460|65799838|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
23565993|NCT00876460|65799839|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
23565994|NCT00876460|65799840|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
23565995|NCT00876460|65799841|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
23565996|NCT00876460|65799842|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
23565997|NCT00876460|65799835|FG000|Mono Therapy Phase|Adverse Event|0|||
23565998|NCT00876460|65799836|FG001|Mono Therapy Phase|Adverse Event|0|||
23565999|NCT00876460|65799837|FG002|Mono Therapy Phase|Adverse Event|0|||
23566000|NCT00876460|65799838|FG003|Mono Therapy Phase|Adverse Event|1|||
23566001|NCT00876460|65799839|FG004|Mono Therapy Phase|Adverse Event|0|||
23566002|NCT00876460|65799840|FG005|Mono Therapy Phase|Adverse Event|0|||
23566003|NCT00876460|65799841|FG006|Mono Therapy Phase|Adverse Event|0|||
23566004|NCT00876460|65799842|FG007|Mono Therapy Phase|Adverse Event|0|||
23566005|NCT02176421|65803648|FG000|Overall Study|Lost to Follow-up|4|||
23566006|NCT02176421|65803648|FG000|Overall Study|Adverse Event|1|||
23763034|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
23763035|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
23443071|NCT04124705|65362318|FG000|Stabilization Period|Lack of Efficacy|4|||
23443072|NCT04124705|65362319|FG001|Stabilization Period|Lack of Efficacy|2|||
23443073|NCT04124705|65362318|FG000|Stabilization Period|Protocol Deviation|0|||
23443074|NCT04124705|65362319|FG001|Stabilization Period|Protocol Deviation|2|||
23443075|NCT04124705|65362318|FG000|Stabilization Period|Other|2|||
23566007|NCT01735396|65803649|FG000|Overall Study|not evaluable|1|||
23566008|NCT01190215|65803650|FG000|Up to Month 6|Lost to Follow-up|2|||
23566009|NCT01190215|65803651|FG001|Up to Month 6|Lost to Follow-up|0|||
23566010|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
23828212|NCT02906670|66749051|FG002|Cohort 5P, QW|Radiological Progression|0|||
23828213|NCT02906670|66749052|FG003|Cohort 5P, QW|Radiological Progression|0|||
23828214|NCT02906670|66749053|FG004|Cohort 5P, QW|Radiological Progression|3|||
23828215|NCT02906670|66749054|FG005|Cohort 5P, QW|Radiological Progression|0|||
23828216|NCT02906670|66749055|FG006|Cohort 5P, QW|Radiological Progression|0|||
23828217|NCT02906670|66749056|FG007|Cohort 5P, QW|Radiological Progression|0|||
23828218|NCT02906670|66749057|FG008|Cohort 5P, QW|Radiological Progression|0|||
23828219|NCT02906670|66749058|FG009|Cohort 5P, QW|Radiological Progression|0|||
23828220|NCT00470535|66749059|FG000|Overall Study|Disease Progression|13|||
23828221|NCT00470535|66749059|FG000|Overall Study|Withdrawal by Subject|1|||
23828222|NCT00470535|66749059|FG000|Overall Study|Adverse Event|1|||
23828223|NCT00470535|66749059|FG000|Overall Study|Death|1|||
23828224|NCT00470535|66749059|FG000|Overall Study|Other|2|||
23828225|NCT02040805|66749060|FG000|Overall Study|Lost to Follow-up|14|||
23828226|NCT02040805|66749061|FG001|Overall Study|Lost to Follow-up|9|||
23828227|NCT02040805|66749060|FG000|Overall Study|Withdrawal by Subject|28|||
23828228|NCT02040805|66749061|FG001|Overall Study|Withdrawal by Subject|41|||
23828229|NCT00462904|66749062|FG000|Overall Study|Lost to Follow-up|1|||
23828230|NCT00322712|66749063|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
23828231|NCT03055624|66749066|FG000|Overall Study|Study closed|9|||
23828232|NCT02789137|66749067|FG000|Overall Study|Dropped out/Died|58|||
23443076|NCT04124705|65362319|FG001|Stabilization Period|Other|2|||
23443077|NCT03710642|65362320|FG000|Overall Study|Adverse Event|5|||
23443078|NCT03710642|65362321|FG001|Overall Study|Adverse Event|1|||
23443079|NCT03710642|65362320|FG000|Overall Study|non-site physician recommendation|1|||
23443080|NCT03710642|65362321|FG001|Overall Study|non-site physician recommendation|0|||
23443081|NCT03710642|65362320|FG000|Overall Study|Participant unwilling or unable to participate|1|||
23763036|NCT01698320|66511284|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
23763037|NCT01698320|66511285|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
23443082|NCT03710642|65362321|FG001|Overall Study|Participant unwilling or unable to participate|1|||
23566011|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
23763038|NCT01698320|66511286|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
23763039|NCT01698320|66511284|FG000|40-Week Open-Label Period|Adverse Event|0|||
23763040|NCT01698320|66511285|FG001|40-Week Open-Label Period|Adverse Event|3|||
23566012|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
23566013|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
23566014|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
23566015|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
23566016|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Death|0|||
23566017|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Death|1|||
23566018|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Adverse Event|11|||
23566019|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Adverse Event|11|||
23566020|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
23566021|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
23763041|NCT01698320|66511286|FG002|40-Week Open-Label Period|Adverse Event|2|||
23763042|NCT01698320|66511284|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
23763043|NCT01698320|66511285|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
23763044|NCT01698320|66511286|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
23763045|NCT01698320|66511284|FG000|40-Week Open-Label Period|Pregnancy|0|||
23763046|NCT01698320|66511285|FG001|40-Week Open-Label Period|Pregnancy|2|||
23763047|NCT01698320|66511286|FG002|40-Week Open-Label Period|Pregnancy|1|||
23763048|NCT01698320|66511284|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
23763049|NCT01698320|66511285|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
23763050|NCT01698320|66511286|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
23763051|NCT01698320|66511284|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
23763052|NCT01698320|66511285|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
23763053|NCT01698320|66511286|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
23763054|NCT03433001|66511287|FG000|Overall Study|Lack of Efficacy|109|||
23763055|NCT03433001|66511287|FG000|Overall Study|Adverse Event|69|||
23763056|NCT03433001|66511287|FG000|Overall Study|Withdrawal by Subject|10|||
23763057|NCT03433001|66511287|FG000|Overall Study|Death|12|||
23828233|NCT01640249|66749068|FG000|Period 1|Withdrawal by Subject|1|||
23566022|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23763058|NCT03433001|66511287|FG000|Overall Study|Lost to Follow-up|4|||
23828234|NCT01640249|66749069|FG001|Period 1|Withdrawal by Subject|0|||
23828235|NCT01640249|66749070|FG002|Period 1|Withdrawal by Subject|0|||
23828236|NCT01640249|66749071|FG003|Period 1|Withdrawal by Subject|0|||
23828237|NCT01640249|66749072|FG004|Period 1|Withdrawal by Subject|0|||
23566023|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23763059|NCT03433001|66511287|FG000|Overall Study|Other|25|||
23763060|NCT00638157|66511288|FG000|Overall Study|Adverse Event|0|||
23763061|NCT00638157|66511289|FG001|Overall Study|Adverse Event|1|||
23828238|NCT01640249|66749073|FG005|Period 1|Withdrawal by Subject|1|||
23828239|NCT01640249|66749074|FG006|Period 1|Withdrawal by Subject|0|||
23443083|NCT03710642|65362320|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
23443084|NCT03710642|65362321|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
23443085|NCT03710642|65362320|FG000|Overall Study|NA-no code provided|1|||
23443086|NCT03710642|65362321|FG001|Overall Study|NA-no code provided|0|||
23443087|NCT03710642|65362320|FG000|Overall Study|Withdrawal by Subject|1|||
23443088|NCT03710642|65362321|FG001|Overall Study|Withdrawal by Subject|0|||
23443089|NCT00826618|65362327|FG000|Overall Study|Withdrawal by Subject|1|||
23443090|NCT03499314|65362328|FG000|Overall Study|Time Commitment|1|||
23443091|NCT03499314|65362329|FG001|Overall Study|Time Commitment|2|||
23443092|NCT03499314|65362328|FG000|Overall Study|Medical issue unrelated to research study|1|||
23443093|NCT03499314|65362329|FG001|Overall Study|Medical issue unrelated to research study|1|||
23443094|NCT00568126|65362330|FG000|Overall Study|Adverse Event|3|||
23443095|NCT00568126|65362331|FG001|Overall Study|Adverse Event|0|||
23443096|NCT00568126|65362330|FG000|Overall Study|Withdrawal by Subject|2|||
23443097|NCT00568126|65362331|FG001|Overall Study|Withdrawal by Subject|3|||
23443098|NCT00568126|65362330|FG000|Overall Study|Lost to Follow-up|4|||
23443099|NCT00568126|65362331|FG001|Overall Study|Lost to Follow-up|3|||
23443100|NCT00568126|65362330|FG000|Overall Study|Lack of Efficacy|0|||
23443101|NCT00568126|65362331|FG001|Overall Study|Lack of Efficacy|1|||
23443102|NCT00568126|65362330|FG000|Overall Study|Physician Decision|2|||
23443103|NCT00568126|65362331|FG001|Overall Study|Physician Decision|2|||
23443104|NCT01807598|65362334|FG000|Overall Study|Withdrawal by Subject|4|||
23443105|NCT01807598|65362334|FG000|Overall Study|Adverse Event|1|||
23443106|NCT01807598|65362334|FG000|Overall Study|Other Physician Decision|1|||
23828240|NCT02790437|66749075|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
23443107|NCT03305770|65362350|FG000|Overall Study|Physician Decision - prior to dispense|0|||
23443108|NCT03305770|65362351|FG001|Overall Study|Physician Decision - prior to dispense|1|||
23443109|NCT03305770|65362350|FG000|Overall Study|Subject moved|1|||
23443110|NCT03305770|65362351|FG001|Overall Study|Subject moved|0|||
23443111|NCT05274269|65362352|FG000|Overall Study|Adverse Event|0|||
23443112|NCT05274269|65362353|FG001|Overall Study|Adverse Event|3|||
23443113|NCT05274269|65362352|FG000|Overall Study|Death|0|||
23443114|NCT05274269|65362353|FG001|Overall Study|Death|1|||
23443115|NCT05274269|65362352|FG000|Overall Study|Other|0|||
23443116|NCT05274269|65362353|FG001|Overall Study|Other|2|||
23443117|NCT05274269|65362352|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23443118|NCT05274269|65362353|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
23443119|NCT02473367|65362357|FG000|Wait 1|Withdrawal by Subject|1|||
23443120|NCT02473367|65362357|FG000|Period 4|Lost to Follow-up|1|||
23443121|NCT02489942|65362358|FG000|Overall Study|Request by patient|602|||
23443122|NCT02489942|65362358|FG000|Overall Study|Improvement/remission|157|||
23443123|NCT02489942|65362358|FG000|Overall Study|No change/Progressive disease|263|||
23443124|NCT02489942|65362358|FG000|Overall Study|Adverse Event|522|||
23443125|NCT02489942|65362358|FG000|Overall Study|Other personal reasons|1218|||
23443126|NCT02489942|65362358|FG000|Overall Study|Lost to Follow-up|456|||
23443127|NCT02489942|65362358|FG000|Overall Study|Not continuously investigated|7|||
23443128|NCT02489942|65362358|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
23443129|NCT02489942|65362358|FG000|Overall Study|Multiple registration|1|||
23443130|NCT02489942|65362358|FG000|Overall Study|No patient visit after entry|100|||
23443131|NCT02489942|65362358|FG000|Overall Study|No treatment with Jardiance|2|||
23443132|NCT02489942|65362358|FG000|Overall Study|Patient received Jardiance before registration|1|||
23443133|NCT02489942|65362358|FG000|Overall Study|No CRF collected|86|||
23443134|NCT00607087|65362361|FG000|Overall Study|Withdrawal by Subject|9|||
23443135|NCT00607087|65362362|FG001|Overall Study|Withdrawal by Subject|4|||
23443136|NCT00607087|65362363|FG002|Overall Study|Withdrawal by Subject|4|||
23443137|NCT00607087|65362361|FG000|Overall Study|Adverse Event|3|||
23443138|NCT00607087|65362362|FG001|Overall Study|Adverse Event|2|||
23443139|NCT00607087|65362363|FG002|Overall Study|Adverse Event|3|||
23443140|NCT00607087|65362361|FG000|Overall Study|Other reason|1|||
23443141|NCT00607087|65362362|FG001|Overall Study|Other reason|5|||
23443142|NCT00607087|65362363|FG002|Overall Study|Other reason|2|||
23443143|NCT00607087|65362361|FG000|Overall Study|Poor compliance to protocol|1|||
23443144|NCT00607087|65362362|FG001|Overall Study|Poor compliance to protocol|0|||
23443145|NCT00607087|65362363|FG002|Overall Study|Poor compliance to protocol|1|||
23443146|NCT00607087|65362361|FG000|Overall Study|Lost to Follow-up|1|||
23443147|NCT00607087|65362362|FG001|Overall Study|Lost to Follow-up|0|||
23443148|NCT00607087|65362363|FG002|Overall Study|Lost to Follow-up|0|||
23443149|NCT00607087|65362361|FG000|Period 1|Withdrawal by Subject|7|||
23443150|NCT00607087|65362362|FG001|Period 1|Withdrawal by Subject|2|||
23443151|NCT00607087|65362363|FG002|Period 1|Withdrawal by Subject|3|||
23443152|NCT00607087|65362361|FG000|Period 1|Adverse Event|3|||
23443153|NCT00607087|65362362|FG001|Period 1|Adverse Event|0|||
23443154|NCT00607087|65362363|FG002|Period 1|Adverse Event|0|||
23443155|NCT00607087|65362361|FG000|Period 1|Poor compliance to protocol|1|||
23443156|NCT00607087|65362362|FG001|Period 1|Poor compliance to protocol|0|||
23443157|NCT00607087|65362363|FG002|Period 1|Poor compliance to protocol|0|||
23628280|NCT01240915|66024689|FG004|Overall Study|Insufficient Clinical Response|1|||
23628281|NCT01240915|66024690|FG005|Overall Study|Insufficient Clinical Response|3|||
23628282|NCT01240915|66024691|FG006|Overall Study|Insufficient Clinical Response|6|||
23628283|NCT01240915|66024692|FG007|Overall Study|Insufficient Clinical Response|0|||
23628284|NCT01240915|66024693|FG008|Overall Study|Insufficient Clinical Response|3|||
23628285|NCT02872012|66024694|FG000|Overall Study|Withdrawal by Subject|1|||
23566024|NCT02936037|65803654|FG000|Open Label Extension|Adverse Event|0|||
23628286|NCT02872012|66024695|FG001|Overall Study|Withdrawal by Subject|0|||
23763062|NCT00638157|66511288|FG000|Overall Study|Clinical (symptomatic) failure|1|||
23763063|NCT00638157|66511289|FG001|Overall Study|Clinical (symptomatic) failure|1|||
23763064|NCT00638157|66511288|FG000|Overall Study|Microbiological failure|1|||
23763065|NCT00638157|66511289|FG001|Overall Study|Microbiological failure|0|||
23763066|NCT00638157|66511288|FG000|Overall Study|Lost to Follow-up|1|||
23566025|NCT02936037|65803655|FG001|Open Label Extension|Adverse Event|3|||
23566026|NCT02936037|65803654|FG000|Open Label Extension|Other|0|||
23566027|NCT02936037|65803655|FG001|Open Label Extension|Other|3|||
23566028|NCT02936037|65803654|FG000|Open Label Extension|Withdrawal by Subject|0|||
23566029|NCT02936037|65803655|FG001|Open Label Extension|Withdrawal by Subject|4|||
23566030|NCT01953003|65803656|FG000|Overall Study|Not treated|0|||
23566031|NCT01953003|65803657|FG001|Overall Study|Not treated|1|||
23566032|NCT01953003|65803656|FG000|Overall Study|Progressive disease|35|||
23566033|NCT01953003|65803657|FG001|Overall Study|Progressive disease|45|||
23566034|NCT01953003|65803656|FG000|Overall Study|Related Adverse events|7|||
23566035|NCT01953003|65803657|FG001|Overall Study|Related Adverse events|2|||
23566036|NCT01953003|65803656|FG000|Overall Study|Non-related adverse events|0|||
23566037|NCT01953003|65803657|FG001|Overall Study|Non-related adverse events|2|||
23566038|NCT01953003|65803656|FG000|Overall Study|Protocol Violation|0|||
23566039|NCT01953003|65803657|FG001|Overall Study|Protocol Violation|1|||
23566040|NCT01953003|65803656|FG000|Overall Study|Withdrawal by Subject|14|||
23628287|NCT02872012|66024696|FG002|Overall Study|Withdrawal by Subject|0|||
23628288|NCT02872012|66024697|FG003|Overall Study|Withdrawal by Subject|0|||
23628289|NCT02872012|66024698|FG004|Overall Study|Withdrawal by Subject|0|||
23628290|NCT00477464|66024699|FG000|Overall Study|Lost to Follow-up|1|||
23628291|NCT00477464|66024699|FG000|Overall Study|Death|36|||
23628292|NCT00477464|66024699|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
23763067|NCT00638157|66511289|FG001|Overall Study|Lost to Follow-up|0|||
23763068|NCT00638157|66511288|FG000|Overall Study|Physician Decision|1|||
23763069|NCT00638157|66511289|FG001|Overall Study|Physician Decision|0|||
23763070|NCT00638157|66511288|FG000|Overall Study|Other|1|||
23763071|NCT00638157|66511289|FG001|Overall Study|Other|2|||
23763072|NCT00638157|66511288|FG000|Overall Study|Randomized, not treated|2|||
23763073|NCT00638157|66511289|FG001|Overall Study|Randomized, not treated|0|||
23763074|NCT01113710|66511290|FG000|Overall Study|Adverse Event|64|||
23763075|NCT01113710|66511290|FG000|Overall Study|Lack of Efficacy|41|||
23763076|NCT01113710|66511290|FG000|Overall Study|No Information Available|40|||
23763077|NCT01113710|66511290|FG000|Overall Study|Withdrawal by Subject|28|||
23763078|NCT01113710|66511290|FG000|Overall Study|Lost to Follow-up|20|||
23763079|NCT01113710|66511290|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
23763080|NCT01113710|66511290|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
23763081|NCT01113710|66511290|FG000|Overall Study|Lack of Patient's Compliance|8|||
23763082|NCT01113710|66511290|FG000|Overall Study|Other|7|||
23763083|NCT01113710|66511290|FG000|Overall Study|Adverse Event/Other|5|||
23763084|NCT01113710|66511290|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
23763085|NCT01113710|66511290|FG000|Overall Study|Lack of Efficacy/Other|4|||
23763086|NCT01113710|66511290|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
23763087|NCT01113710|66511290|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
23763088|NCT01113710|66511290|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
23763089|NCT01113710|66511290|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
23763090|NCT01113710|66511290|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
23763091|NCT01113710|66511290|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
23763092|NCT01113710|66511290|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
23763093|NCT01113710|66511290|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
23763094|NCT01113710|66511290|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
23763095|NCT01113710|66511290|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
23763096|NCT01113710|66511290|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
23763097|NCT01113710|66511290|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
23763098|NCT01113710|66511290|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
23763099|NCT00671879|66511306|FG000|Overall Study|Withdrawal by Subject|0|||
23763100|NCT00671879|66511307|FG001|Overall Study|Withdrawal by Subject|4|||
23566041|NCT01953003|65803657|FG001|Overall Study|Withdrawal by Subject|4|||
23566042|NCT03015116|65803658|FG000|Overall Study|Lost to Follow-up|3|||
23566043|NCT03015116|65803659|FG001|Overall Study|Lost to Follow-up|0|||
23566044|NCT03015116|65803660|FG002|Overall Study|Lost to Follow-up|2|||
23628293|NCT02312206|66024700|FG000|Overall Study|Adverse Event|3|||
23628294|NCT02312206|66024701|FG001|Overall Study|Adverse Event|6|||
23763101|NCT00671879|66511308|FG002|Overall Study|Withdrawal by Subject|6|||
23763102|NCT03008460|66511309|FG000|Overall Study|Protocol deviation|0|||
23763103|NCT03008460|66511310|FG001|Overall Study|Protocol deviation|2|||
23763104|NCT03008460|66511309|FG000|Overall Study|Study drug not dispensed|0|||
23763105|NCT03008460|66511310|FG001|Overall Study|Study drug not dispensed|1|||
23763106|NCT03008460|66511309|FG000|Overall Study|Adverse Event|0|||
23763107|NCT03008460|66511310|FG001|Overall Study|Adverse Event|1|||
23763108|NCT03008460|66511309|FG000|Overall Study|Withdrawal by Subject|5|||
23763109|NCT03008460|66511310|FG001|Overall Study|Withdrawal by Subject|6|||
23763110|NCT03008460|66511309|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
23763111|NCT03008460|66511310|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
23763112|NCT03008460|66511309|FG000|Overall Study|End of study visit outside permitted time window|0|||
23763113|NCT03008460|66511310|FG001|Overall Study|End of study visit outside permitted time window|1|||
23763114|NCT03008460|66511309|FG000|Overall Study|Lost to Follow-up|1|||
23763115|NCT03008460|66511310|FG001|Overall Study|Lost to Follow-up|3|||
23763116|NCT02370784|66511316|FG000|Overall Study|Patient started prohibited medication|0|||
23763117|NCT02370784|66511317|FG001|Overall Study|Patient started prohibited medication|1|||
23763118|NCT01023269|66511323|FG000|Overall Study|early termination of the study|2|||
23763119|NCT01023269|66511324|FG001|Overall Study|early termination of the study|0|||
23763120|NCT01298596|66511327|FG000|Overall Study|Withdrawal by Subject|1|||
23763121|NCT01298596|66511328|FG001|Overall Study|Withdrawal by Subject|1|||
23566045|NCT03015116|65803658|FG000|Overall Study|Withdrawal by Subject|3|||
23763122|NCT01298596|66511327|FG000|Overall Study|Death|5|||
23763123|NCT01298596|66511328|FG001|Overall Study|Death|3|||
23763124|NCT01298596|66511327|FG000|Overall Study|Lost to Follow-up|6|||
23763125|NCT01298596|66511328|FG001|Overall Study|Lost to Follow-up|14|||
23763126|NCT01298596|66511327|FG000|Overall Study|Referred for further management|16|||
23763127|NCT01298596|66511328|FG001|Overall Study|Referred for further management|15|||
23763128|NCT00310856|66511344|FG000|Overall Study|Withdrawal by Subject|2|||
23763129|NCT00310856|66511345|FG001|Overall Study|Withdrawal by Subject|2|||
23763130|NCT00310856|66511346|FG002|Overall Study|Withdrawal by Subject|2|||
23763131|NCT00310856|66511344|FG000|Overall Study|Lost to Follow-up|1|||
23763132|NCT00310856|66511345|FG001|Overall Study|Lost to Follow-up|2|||
23763133|NCT00310856|66511346|FG002|Overall Study|Lost to Follow-up|6|||
23763134|NCT00310856|66511344|FG000|Overall Study|Inappropriate enrollment|1|||
23763135|NCT00310856|66511345|FG001|Overall Study|Inappropriate enrollment|1|||
23763136|NCT00310856|66511346|FG002|Overall Study|Inappropriate enrollment|0|||
23763137|NCT00310856|66511344|FG000|Overall Study|Unable to classify|1|||
23763138|NCT00310856|66511345|FG001|Overall Study|Unable to classify|0|||
23763139|NCT00310856|66511346|FG002|Overall Study|Unable to classify|0|||
23763140|NCT01034137|66511353|FG000|Overall Study|Adverse Event|9|||
23763141|NCT01034137|66511354|FG001|Overall Study|Adverse Event|10|||
23763142|NCT01034137|66511355|FG002|Overall Study|Adverse Event|8|||
23763143|NCT01034137|66511353|FG000|Overall Study|Withdrawal by Subject|4|||
23763144|NCT01034137|66511354|FG001|Overall Study|Withdrawal by Subject|3|||
23763145|NCT01034137|66511355|FG002|Overall Study|Withdrawal by Subject|3|||
23763146|NCT01034137|66511353|FG000|Overall Study|Lack of Efficacy|9|||
23763147|NCT01034137|66511354|FG001|Overall Study|Lack of Efficacy|4|||
23763148|NCT01034137|66511355|FG002|Overall Study|Lack of Efficacy|13|||
23763149|NCT01034137|66511353|FG000|Overall Study|Protocol Violation|2|||
23763150|NCT01034137|66511354|FG001|Overall Study|Protocol Violation|2|||
23763151|NCT01034137|66511355|FG002|Overall Study|Protocol Violation|1|||
23763152|NCT01034137|66511353|FG000|Overall Study|Refused treatment or did not cooperate|2|||
23763153|NCT01034137|66511354|FG001|Overall Study|Refused treatment or did not cooperate|0|||
23763154|NCT01034137|66511355|FG002|Overall Study|Refused treatment or did not cooperate|1|||
23763155|NCT01034137|66511353|FG000|Overall Study|Administrative or other|2|||
23763156|NCT01034137|66511354|FG001|Overall Study|Administrative or other|3|||
23763157|NCT01034137|66511355|FG002|Overall Study|Administrative or other|4|||
23763158|NCT03770000|66511356|FG000|Overall Study|Premature discontinuation due to PD|0|||
23763159|NCT03770000|66511357|FG001|Overall Study|Premature discontinuation due to PD|0|||
23763160|NCT03770000|66511358|FG002|Overall Study|Premature discontinuation due to PD|1|||
23763161|NCT03770000|66511359|FG003|Overall Study|Premature discontinuation due to PD|3|||
23763162|NCT03770000|66511360|FG004|Overall Study|Premature discontinuation due to PD|2|||
23763163|NCT02139306|66511365|FG000|Overall Study|Withdrawal by Subject|4|||
23763164|NCT02139306|66511366|FG001|Overall Study|Withdrawal by Subject|6|||
23763165|NCT02139306|66511365|FG000|Overall Study|Adverse Event|3|||
23763166|NCT02139306|66511366|FG001|Overall Study|Adverse Event|4|||
23763167|NCT02139306|66511365|FG000|Overall Study|Physician Decision|0|||
23763168|NCT02139306|66511366|FG001|Overall Study|Physician Decision|1|||
23763169|NCT02139306|66511365|FG000|Overall Study|Other Unspecified|2|||
23763170|NCT02139306|66511366|FG001|Overall Study|Other Unspecified|3|||
23763171|NCT02139306|66511365|FG000|Overall Study|Protocol Violation|4|||
23763172|NCT02139306|66511366|FG001|Overall Study|Protocol Violation|0|||
23763173|NCT02780700|66511369|FG000|Overall Study|Progressive disease|1|||
23763174|NCT01337050|66511378|FG000|Overall Study|Death|0|||
23763175|NCT01337050|66511379|FG001|Overall Study|Death|0|||
23763176|NCT01337050|66511380|FG002|Overall Study|Death|4|||
23763177|NCT01337050|66511378|FG000|Overall Study|Other|4|||
23763178|NCT01337050|66511379|FG001|Overall Study|Other|6|||
23763179|NCT01337050|66511380|FG002|Overall Study|Other|8|||
23763180|NCT01337050|66511378|FG000|Overall Study|Participants refused further follow-up|0|||
23763181|NCT01337050|66511379|FG001|Overall Study|Participants refused further follow-up|7|||
23763182|NCT01337050|66511380|FG002|Overall Study|Participants refused further follow-up|7|||
23763183|NCT02732561|66511381|FG000|Overall Study|Lost to Follow-up|1|||
23566046|NCT03015116|65803659|FG001|Overall Study|Withdrawal by Subject|1|||
23763184|NCT02732561|66511382|FG001|Overall Study|Lost to Follow-up|1|||
23763185|NCT02732561|66511381|FG000|Overall Study|Withdrawal by Subject|1|||
23763186|NCT02732561|66511382|FG001|Overall Study|Withdrawal by Subject|0|||
23763187|NCT03016078|66511385|FG000|Overall Study|Protocol Violation|1|||
23763188|NCT03016078|66511385|FG000|Overall Study|Protocol Violation|1|||
23763189|NCT02480010|66511386|FG000|Overall Study|Adverse Event|3|||
23763190|NCT02480010|66511387|FG001|Overall Study|Adverse Event|1|||
23828241|NCT02790437|66749076|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
23763191|NCT02480010|66511386|FG000|Overall Study|Death|1|||
23566047|NCT03015116|65803660|FG002|Overall Study|Withdrawal by Subject|0|||
23763192|NCT02480010|66511387|FG001|Overall Study|Death|0|||
23763193|NCT02480010|66511386|FG000|Overall Study|Insufficient therapeutic response|31|||
23763194|NCT02480010|66511387|FG001|Overall Study|Insufficient therapeutic response|29|||
23443158|NCT00607087|65362361|FG000|Period 1|Lost to Follow-up|1|||
23443159|NCT00607087|65362362|FG001|Period 1|Lost to Follow-up|0|||
23566048|NCT03015116|65803658|FG000|Overall Study|Subject has New Medical Status|1|||
23566049|NCT03015116|65803659|FG001|Overall Study|Subject has New Medical Status|0|||
23566050|NCT03015116|65803660|FG002|Overall Study|Subject has New Medical Status|0|||
23566051|NCT03015116|65803658|FG000|Overall Study|Physician Decision|0|||
23566052|NCT03015116|65803659|FG001|Overall Study|Physician Decision|1|||
23566053|NCT03015116|65803660|FG002|Overall Study|Physician Decision|0|||
23566054|NCT04488003|65803661|FG000|Assessed for Eligibility|Screen Failure|24|||
23566055|NCT04488003|65803662|FG001|Assessed for Eligibility|Screen Failure|0|||
23566056|NCT04488003|65803663|FG002|Assessed for Eligibility|Screen Failure|0|||
23566057|NCT04488003|65803661|FG000|Assessed for Eligibility|Adverse Event|1|||
23566058|NCT04488003|65803662|FG001|Assessed for Eligibility|Adverse Event|0|||
23566059|NCT04488003|65803663|FG002|Assessed for Eligibility|Adverse Event|0|||
23628295|NCT02312206|66024700|FG000|Overall Study|Withdrawal by Subject|6|||
23628296|NCT02312206|66024701|FG001|Overall Study|Withdrawal by Subject|6|||
23628297|NCT02312206|66024700|FG000|Overall Study|Physician Decision|7|||
23628298|NCT02312206|66024701|FG001|Overall Study|Physician Decision|6|||
23628299|NCT02312206|66024700|FG000|Overall Study|Death|31|||
23628300|NCT02312206|66024701|FG001|Overall Study|Death|36|||
23628301|NCT02312206|66024700|FG000|Overall Study|Study Terminated by Sponsor|81|||
23628302|NCT02312206|66024701|FG001|Overall Study|Study Terminated by Sponsor|74|||
23628303|NCT02312206|66024700|FG000|Overall Study|Patient transferred to hospice|0|||
23566060|NCT04488003|65803661|FG000|Assessed for Eligibility|Death|1|||
23628304|NCT02312206|66024701|FG001|Overall Study|Patient transferred to hospice|1|||
23628305|NCT02312206|66024700|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
23628306|NCT02312206|66024701|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
23628307|NCT02312206|66024700|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
23566061|NCT04488003|65803662|FG001|Assessed for Eligibility|Death|0|||
23566062|NCT04488003|65803663|FG002|Assessed for Eligibility|Death|0|||
23628308|NCT02312206|66024701|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
23628309|NCT02312206|66024700|FG000|Overall Study|Disease Progression|1|||
23628310|NCT02312206|66024701|FG001|Overall Study|Disease Progression|0|||
23628311|NCT04593823|66024705|FG000|Overall Study|Withdrawal by Subject|1|||
23628312|NCT04593823|66024706|FG001|Overall Study|Withdrawal by Subject|1|||
23628313|NCT04593823|66024705|FG000|Overall Study|Lost to Follow-up|0|||
23628314|NCT04593823|66024706|FG001|Overall Study|Lost to Follow-up|1|||
23628315|NCT01896726|66024707|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
23628316|NCT01896726|66024707|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
23628317|NCT00778921|66024709|FG000|Overall Study|Adverse Event|9|||
23628318|NCT00778921|66024710|FG001|Overall Study|Adverse Event|10|||
23628319|NCT00778921|66024711|FG002|Overall Study|Adverse Event|14|||
23628320|NCT00778921|66024709|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23628321|NCT00778921|66024710|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
23628322|NCT00778921|66024711|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23828242|NCT02790437|66749075|FG000|Overall Study|Adverse Event|1|||
23828243|NCT02790437|66749076|FG001|Overall Study|Adverse Event|0|||
23828244|NCT02790437|66749075|FG000|Overall Study|Withdrawal by Subject|1|||
23828245|NCT02790437|66749076|FG001|Overall Study|Withdrawal by Subject|0|||
23828246|NCT03644342|66749077|FG000|Overall Study|Adverse Event|2|||
23828247|NCT03644342|66749078|FG001|Overall Study|Adverse Event|0|||
23828248|NCT03644342|66749077|FG000|Overall Study|Protocol Violation|0|||
23828249|NCT03644342|66749078|FG001|Overall Study|Protocol Violation|1|||
23828250|NCT01256879|66749082|FG000|Overall Study|Withdrawal by Subject|1|||
23828251|NCT03301649|66749083|FG000|Overall Study|Need alternate therapy due to live lice|17|||
23828252|NCT03301649|66749084|FG001|Overall Study|Need alternate therapy due to live lice|25|||
23828253|NCT03301649|66749085|FG002|Overall Study|Need alternate therapy due to live lice|81|||
23828254|NCT03301649|66749083|FG000|Overall Study|Lost to Follow-up|11|||
23828255|NCT03301649|66749084|FG001|Overall Study|Lost to Follow-up|11|||
23828256|NCT03301649|66749085|FG002|Overall Study|Lost to Follow-up|3|||
23828257|NCT03301649|66749083|FG000|Overall Study|Protocol Violation|0|||
23828258|NCT03301649|66749084|FG001|Overall Study|Protocol Violation|1|||
23828259|NCT03301649|66749085|FG002|Overall Study|Protocol Violation|1|||
23828260|NCT03301649|66749083|FG000|Overall Study|Withdrawal by Subject|10|||
23828261|NCT03301649|66749084|FG001|Overall Study|Withdrawal by Subject|4|||
23828262|NCT03301649|66749085|FG002|Overall Study|Withdrawal by Subject|0|||
23828263|NCT03301649|66749083|FG000|Overall Study|Other than specified|5|||
23828264|NCT03301649|66749084|FG001|Overall Study|Other than specified|3|||
23828265|NCT03301649|66749085|FG002|Overall Study|Other than specified|0|||
23828266|NCT02500043|66749088|FG000|Overall Study|Randomized, but not Treated|2|||
23828267|NCT02500043|66749089|FG001|Overall Study|Randomized, but not Treated|2|||
23566063|NCT04488003|65803661|FG000|Assessed for Eligibility|Physician Decision|1|||
23566064|NCT04488003|65803662|FG001|Assessed for Eligibility|Physician Decision|0|||
23566065|NCT04488003|65803663|FG002|Assessed for Eligibility|Physician Decision|0|||
23566066|NCT04488003|65803661|FG000|Allocated to Treatment|Progressive Disease|51|||
23566067|NCT04488003|65803662|FG001|Allocated to Treatment|Progressive Disease|0|||
23566068|NCT04488003|65803663|FG002|Allocated to Treatment|Progressive Disease|0|||
23566069|NCT04488003|65803661|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
23566070|NCT04488003|65803662|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
23566071|NCT04488003|65803663|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
23566072|NCT04488003|65803661|FG000|Allocated to Treatment|Adverse Event|6|||
23566073|NCT04488003|65803662|FG001|Allocated to Treatment|Adverse Event|0|||
23566074|NCT04488003|65803663|FG002|Allocated to Treatment|Adverse Event|0|||
23566075|NCT04488003|65803661|FG000|Allocated to Treatment|Other|5|||
23566076|NCT04488003|65803662|FG001|Allocated to Treatment|Other|0|||
23566077|NCT04488003|65803663|FG002|Allocated to Treatment|Other|0|||
23566078|NCT04488003|65803661|FG000|Allocated to Treatment|Physician Decision|4|||
23566079|NCT04488003|65803662|FG001|Allocated to Treatment|Physician Decision|0|||
23566080|NCT04488003|65803663|FG002|Allocated to Treatment|Physician Decision|0|||
23566081|NCT04488003|65803661|FG000|Allocated to Treatment|Death|4|||
23566082|NCT04488003|65803662|FG001|Allocated to Treatment|Death|0|||
23566083|NCT04488003|65803663|FG002|Allocated to Treatment|Death|0|||
23566084|NCT02762981|65803664|FG000|Overall Study|Adverse Event|2|||
23566085|NCT02762981|65803665|FG001|Overall Study|Adverse Event|3|||
23566086|NCT02762981|65803666|FG002|Overall Study|Adverse Event|1|||
23566087|NCT02762981|65803667|FG003|Overall Study|Adverse Event|1|||
23566088|NCT02762981|65803668|FG004|Overall Study|Adverse Event|3|||
23566089|NCT02762981|65803664|FG000|Overall Study|Physician Decision|0|||
23828268|NCT02500043|66749088|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
23828269|NCT02500043|66749089|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
23566090|NCT02762981|65803665|FG001|Overall Study|Physician Decision|1|||
23566091|NCT02762981|65803666|FG002|Overall Study|Physician Decision|0|||
23566092|NCT02762981|65803667|FG003|Overall Study|Physician Decision|0|||
23566093|NCT02762981|65803668|FG004|Overall Study|Physician Decision|1|||
23566094|NCT02762981|65803664|FG000|Overall Study|Disease progression|11|||
23628323|NCT00778921|66024709|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628324|NCT00778921|66024710|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628325|NCT00778921|66024711|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
23828270|NCT02500043|66749088|FG000|Overall Study|Adverse Event|33|||
23763195|NCT02480010|66511386|FG000|Overall Study|Refused Treatment|0|||
23763196|NCT02480010|66511387|FG001|Overall Study|Refused Treatment|3|||
23763197|NCT01798485|66511388|FG000|Overall Study|Adverse Event|32|||
23763198|NCT01798485|66511389|FG001|Overall Study|Adverse Event|40|||
23763199|NCT01798485|66511388|FG000|Overall Study|Withdrawal by Subject|27|||
23763200|NCT01798485|66511389|FG001|Overall Study|Withdrawal by Subject|31|||
23763201|NCT01798485|66511388|FG000|Overall Study|Lost to Follow-up|0|||
23763202|NCT01798485|66511389|FG001|Overall Study|Lost to Follow-up|3|||
23763203|NCT01798485|66511388|FG000|Overall Study|Physician Decision|14|||
23763204|NCT01798485|66511389|FG001|Overall Study|Physician Decision|10|||
23763205|NCT01798485|66511388|FG000|Overall Study|Objective Disease Progression|152|||
23763206|NCT01798485|66511389|FG001|Overall Study|Objective Disease Progression|106|||
23763207|NCT01798485|66511388|FG000|Overall Study|Death|25|||
23763208|NCT01798485|66511389|FG001|Overall Study|Death|22|||
23763209|NCT01798485|66511388|FG000|Overall Study|Sponsor Decision|61|||
23763210|NCT01798485|66511389|FG001|Overall Study|Sponsor Decision|54|||
23763211|NCT01798485|66511388|FG000|Overall Study|Clinical Progression|35|||
23763212|NCT01798485|66511389|FG001|Overall Study|Clinical Progression|24|||
23763213|NCT01261325|66511393|FG000|Overall Study|Lack of Efficacy|1|||
23763214|NCT01261325|66511394|FG001|Overall Study|Lack of Efficacy|1|||
23763215|NCT01261325|66511395|FG002|Overall Study|Lack of Efficacy|0|||
23763216|NCT01261325|66511393|FG000|Overall Study|Withdrawal by Subject|2|||
23763217|NCT01261325|66511394|FG001|Overall Study|Withdrawal by Subject|2|||
23763218|NCT01261325|66511395|FG002|Overall Study|Withdrawal by Subject|4|||
23763219|NCT01261325|66511393|FG000|Overall Study|SAE, non-fatal|1|||
23763220|NCT01261325|66511394|FG001|Overall Study|SAE, non-fatal|5|||
23763221|NCT01261325|66511395|FG002|Overall Study|SAE, non-fatal|1|||
23763222|NCT01261325|66511393|FG000|Overall Study|AE, non-serious non-fatal|9|||
23763223|NCT01261325|66511394|FG001|Overall Study|AE, non-serious non-fatal|15|||
23566095|NCT02762981|65803665|FG001|Overall Study|Disease progression|23|||
23566096|NCT02762981|65803666|FG002|Overall Study|Disease progression|4|||
23566097|NCT02762981|65803667|FG003|Overall Study|Disease progression|10|||
23566098|NCT02762981|65803668|FG004|Overall Study|Disease progression|1|||
23566099|NCT02762981|65803664|FG000|Overall Study|Enrolled not treated|1|||
23566100|NCT02762981|65803665|FG001|Overall Study|Enrolled not treated|5|||
23566101|NCT02762981|65803666|FG002|Overall Study|Enrolled not treated|0|||
23566102|NCT02762981|65803667|FG003|Overall Study|Enrolled not treated|2|||
23566103|NCT02762981|65803668|FG004|Overall Study|Enrolled not treated|0|||
23566104|NCT02762981|65803664|FG000|Overall Study|Other|2|||
23566105|NCT02762981|65803665|FG001|Overall Study|Other|3|||
23566106|NCT02762981|65803666|FG002|Overall Study|Other|1|||
23566107|NCT02762981|65803667|FG003|Overall Study|Other|0|||
23566108|NCT02762981|65803668|FG004|Overall Study|Other|0|||
23566109|NCT02762981|65803664|FG000|Overall Study|Missing|1|||
23566110|NCT02762981|65803665|FG001|Overall Study|Missing|0|||
23566111|NCT02762981|65803666|FG002|Overall Study|Missing|0|||
23566112|NCT02762981|65803667|FG003|Overall Study|Missing|0|||
23566113|NCT02762981|65803668|FG004|Overall Study|Missing|0|||
23566114|NCT02762981|65803664|FG000|Overall Study|Withdrawal by Subject|0|||
23566115|NCT02762981|65803665|FG001|Overall Study|Withdrawal by Subject|5|||
23566116|NCT02762981|65803666|FG002|Overall Study|Withdrawal by Subject|1|||
23566117|NCT02762981|65803667|FG003|Overall Study|Withdrawal by Subject|3|||
23566118|NCT02762981|65803668|FG004|Overall Study|Withdrawal by Subject|0|||
23566119|NCT01674621|65803669|FG000|Overall Study|Adverse Event|3|||
23763224|NCT01261325|66511395|FG002|Overall Study|AE, non-serious non-fatal|13|||
23763225|NCT01261325|66511393|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23763226|NCT01261325|66511394|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23763227|NCT01261325|66511395|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23763228|NCT01261325|66511393|FG000|Overall Study|Non Compliance|2|||
23566120|NCT01674621|65803670|FG001|Overall Study|Adverse Event|2|||
23566121|NCT01674621|65803671|FG002|Overall Study|Adverse Event|5|||
23566122|NCT01674621|65803672|FG003|Overall Study|Adverse Event|5|||
23566123|NCT01674621|65803673|FG004|Overall Study|Adverse Event|1|||
23566124|NCT01674621|65803669|FG000|Overall Study|Inability to Complete Study Procedures|0|||
23763229|NCT01261325|66511394|FG001|Overall Study|Non Compliance|0|||
23763230|NCT01261325|66511395|FG002|Overall Study|Non Compliance|0|||
23763231|NCT01261325|66511393|FG000|Overall Study|Patient Randomized by Mistake|0|||
23763232|NCT01261325|66511394|FG001|Overall Study|Patient Randomized by Mistake|1|||
23763233|NCT01261325|66511395|FG002|Overall Study|Patient Randomized by Mistake|0|||
23763234|NCT01261325|66511393|FG000|Overall Study|Erroneously Randomized|1|||
23566125|NCT01674621|65803670|FG001|Overall Study|Inability to Complete Study Procedures|0|||
23566126|NCT01674621|65803671|FG002|Overall Study|Inability to Complete Study Procedures|0|||
23566127|NCT01674621|65803672|FG003|Overall Study|Inability to Complete Study Procedures|0|||
23763235|NCT01261325|66511394|FG001|Overall Study|Erroneously Randomized|0|||
23763236|NCT01261325|66511395|FG002|Overall Study|Erroneously Randomized|0|||
23763237|NCT01261325|66511393|FG000|Overall Study|Screen Failure|1|||
23763238|NCT01261325|66511394|FG001|Overall Study|Screen Failure|0|||
23763239|NCT01261325|66511395|FG002|Overall Study|Screen Failure|0|||
23763240|NCT01261325|66511393|FG000|Overall Study|Randomized in Error|0|||
23763241|NCT01261325|66511394|FG001|Overall Study|Randomized in Error|0|||
23763242|NCT01261325|66511395|FG002|Overall Study|Randomized in Error|1|||
23763243|NCT01261325|66511393|FG000|Overall Study|Protocol Violation|0|||
23763244|NCT01261325|66511394|FG001|Overall Study|Protocol Violation|3|||
23566128|NCT01674621|65803673|FG004|Overall Study|Inability to Complete Study Procedures|2|||
23566129|NCT01674621|65803669|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566130|NCT01674621|65803670|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566131|NCT01674621|65803671|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566132|NCT01674621|65803672|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
23566133|NCT01674621|65803673|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566134|NCT01674621|65803669|FG000|Overall Study|Withdrawal by Subject|2|||
23566135|NCT01674621|65803670|FG001|Overall Study|Withdrawal by Subject|5|||
23566136|NCT01674621|65803671|FG002|Overall Study|Withdrawal by Subject|2|||
23763245|NCT01261325|66511395|FG002|Overall Study|Protocol Violation|1|||
23763246|NCT01261325|66511393|FG000|Overall Study|Lost to Follow-up|0|||
23763247|NCT01261325|66511394|FG001|Overall Study|Lost to Follow-up|1|||
23763248|NCT01261325|66511395|FG002|Overall Study|Lost to Follow-up|3|||
23763249|NCT01261325|66511393|FG000|Overall Study|AE, serious fatal|0|||
23566137|NCT01674621|65803672|FG003|Overall Study|Withdrawal by Subject|0|||
23763250|NCT01261325|66511394|FG001|Overall Study|AE, serious fatal|0|||
23763251|NCT01261325|66511395|FG002|Overall Study|AE, serious fatal|2|||
23763252|NCT01070394|66511396|FG000|Overall Study|Adverse Event|6|||
23763253|NCT01070394|66511396|FG000|Overall Study|Withdrawal by Subject|1|||
23763254|NCT00706706|66511397|FG000|Overall Study|Death|53|||
23763255|NCT00706706|66511397|FG000|Overall Study|Lost to Follow-up|7|||
23763256|NCT00706706|66511397|FG000|Overall Study|Study endpoint had reached|45|||
23763257|NCT01507896|66511398|FG000|Overall Study|Withdrawal by Subject|1|||
23763258|NCT01507896|66511398|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
23828271|NCT02500043|66749089|FG001|Overall Study|Adverse Event|11|||
23828272|NCT02500043|66749088|FG000|Overall Study|Clinical Progression|54|||
23828273|NCT02500043|66749089|FG001|Overall Study|Clinical Progression|35|||
23828274|NCT02500043|66749088|FG000|Overall Study|Radiological Progression|192|||
23828275|NCT02500043|66749089|FG001|Overall Study|Radiological Progression|110|||
23828276|NCT02500043|66749088|FG000|Overall Study|Physician's Decision|11|||
23828277|NCT02500043|66749089|FG001|Overall Study|Physician's Decision|3|||
23828278|NCT02500043|66749088|FG000|Overall Study|Withdrawal by Subject|14|||
23828279|NCT02500043|66749089|FG001|Overall Study|Withdrawal by Subject|4|||
23828280|NCT02500043|66749088|FG000|Overall Study|Death|11|||
23828281|NCT02500043|66749089|FG001|Overall Study|Death|2|||
23828282|NCT02500043|66749088|FG000|Overall Study|Protocol Deviation|1|||
23828283|NCT02500043|66749089|FG001|Overall Study|Protocol Deviation|0|||
23828284|NCT00153179|66749090|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
23828285|NCT00153179|66749091|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
23828286|NCT00153179|66749092|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
23828287|NCT00153179|66749093|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
23828288|NCT01742897|66749094|FG000|Overall Study|Adverse Event|3|||
23828289|NCT01742897|66749094|FG000|Overall Study|Withdrawal by Subject|1|||
23828290|NCT01742897|66749094|FG000|Overall Study|Other|1|||
23828291|NCT02685735|66749095|FG000|Overall Study|Missing construct or pain data|23|||
23828292|NCT02685735|66749096|FG001|Overall Study|Missing construct or pain data|22|||
23628326|NCT00778921|66024709|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23628327|NCT00778921|66024710|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
23763259|NCT00910858|66511399|FG000|Pharmacokinetic Phase|Adverse Event|1|||
23628328|NCT00778921|66024711|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
23763260|NCT00910858|66511400|FG001|Pharmacokinetic Phase|Adverse Event|0|||
23763261|NCT00910858|66511401|FG002|Pharmacokinetic Phase|Adverse Event|0|||
23763262|NCT00910858|66511399|FG000|Monotherapy Phase|Adverse Event|3|||
23566138|NCT01674621|65803673|FG004|Overall Study|Withdrawal by Subject|1|||
23566139|NCT01674621|65803669|FG000|Overall Study|Other than specified|0|||
23566140|NCT01674621|65803670|FG001|Overall Study|Other than specified|1|||
23763263|NCT00910858|66511400|FG001|Monotherapy Phase|Adverse Event|2|||
23763264|NCT00910858|66511401|FG002|Monotherapy Phase|Adverse Event|0|||
23763265|NCT00910858|66511399|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
23763266|NCT00910858|66511400|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
23763267|NCT00910858|66511401|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
23763268|NCT00910858|66511399|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
23763269|NCT00910858|66511400|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
23763270|NCT00910858|66511401|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
23763271|NCT00910858|66511399|FG000|Monotherapy Phase|Protocol Violation|1|||
23566141|NCT01674621|65803671|FG002|Overall Study|Other than specified|0|||
23566142|NCT01674621|65803672|FG003|Overall Study|Other than specified|0|||
23566143|NCT01674621|65803673|FG004|Overall Study|Other than specified|2|||
23566144|NCT01354106|65803678|FG000|Overall Study|Withdrawal by Subject|2|||
23566145|NCT00709059|65803680|FG000|Overall Study|Lost to Follow-up|34|||
23566146|NCT00709059|65803680|FG000|Overall Study|Withdrawal by Subject|19|||
23566147|NCT00709059|65803680|FG000|Overall Study|Physician Decision|7|||
23566148|NCT00709059|65803680|FG000|Overall Study|Disease complication|3|||
23763272|NCT00910858|66511400|FG001|Monotherapy Phase|Protocol Violation|0|||
23828293|NCT02501928|66749108|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23828294|NCT02501928|66749109|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23828295|NCT02501928|66749110|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
23828296|NCT02501928|66749111|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
23828297|NCT02501928|66749112|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
23763273|NCT00910858|66511401|FG002|Monotherapy Phase|Protocol Violation|0|||
23763274|NCT00910858|66511399|FG000|Monotherapy Phase|Other|3|||
23828298|NCT02501928|66749113|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
23566149|NCT00709059|65803680|FG000|Overall Study|Side effects|20|||
23566150|NCT00709059|65803680|FG000|Overall Study|Serious side effects|11|||
23763275|NCT00910858|66511400|FG001|Monotherapy Phase|Other|4|||
23763276|NCT00910858|66511401|FG002|Monotherapy Phase|Other|2|||
23763277|NCT00910858|66511399|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
23763278|NCT00910858|66511400|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
23763279|NCT00910858|66511401|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
23763280|NCT00910858|66511399|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
23763281|NCT00910858|66511400|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
23763282|NCT00910858|66511401|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
23763283|NCT00910858|66511399|FG000|Combined Treatment Phase|Protocol Violation|1|||
23763284|NCT00910858|66511400|FG001|Combined Treatment Phase|Protocol Violation|0|||
23763285|NCT00910858|66511401|FG002|Combined Treatment Phase|Protocol Violation|0|||
23763286|NCT00910858|66511399|FG000|Combined Treatment Phase|Other|0|||
23763287|NCT00910858|66511400|FG001|Combined Treatment Phase|Other|2|||
23763288|NCT00910858|66511401|FG002|Combined Treatment Phase|Other|1|||
23763289|NCT02295774|66511402|FG000|Overall Study|Physician Decision|1|||
23763290|NCT02295774|66511402|FG000|Overall Study|Withdrawal by Subject|2|||
23763291|NCT04049552|66511403|FG000|Overall Study|Lost to Follow-up|1|||
23763292|NCT02041494|66511410|FG000|Overall Study|Death|1|||
23763293|NCT02041494|66511411|FG001|Overall Study|Death|3|||
23763294|NCT02041494|66511410|FG000|Overall Study|Lost to Follow-up|2|||
23763295|NCT02041494|66511411|FG001|Overall Study|Lost to Follow-up|6|||
23763296|NCT02041494|66511410|FG000|Overall Study|study terminated|16|||
23763297|NCT02041494|66511411|FG001|Overall Study|study terminated|11|||
23763298|NCT02110706|66511416|FG000|Overall Study|Adverse Event|2|||
23763299|NCT02110706|66511417|FG001|Overall Study|Adverse Event|3|||
23763300|NCT02110706|66511416|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
23763301|NCT02110706|66511417|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
23763302|NCT01785875|66511418|FG000|Overall Study|Withdrawal by Subject|41|||
23763303|NCT01785875|66511419|FG001|Overall Study|Withdrawal by Subject|34|||
23763304|NCT01785875|66511420|FG002|Overall Study|Withdrawal by Subject|36|||
23763305|NCT01785875|66511418|FG000|Overall Study|Lost to Follow-up|19|||
23763306|NCT01785875|66511419|FG001|Overall Study|Lost to Follow-up|22|||
23763307|NCT01785875|66511420|FG002|Overall Study|Lost to Follow-up|6|||
23763308|NCT01785875|66511418|FG000|Overall Study|Death|27|||
23763309|NCT01785875|66511419|FG001|Overall Study|Death|16|||
23763310|NCT01785875|66511420|FG002|Overall Study|Death|7|||
23763311|NCT01785875|66511418|FG000|Overall Study|Sponsor Decision|0|||
23763312|NCT01785875|66511419|FG001|Overall Study|Sponsor Decision|2|||
23763313|NCT01785875|66511420|FG002|Overall Study|Sponsor Decision|0|||
23763314|NCT01785875|66511418|FG000|Overall Study|Protocol Specified Criteria|207|||
23763315|NCT01785875|66511419|FG001|Overall Study|Protocol Specified Criteria|214|||
23763316|NCT01785875|66511420|FG002|Overall Study|Protocol Specified Criteria|55|||
23763317|NCT01785875|66511418|FG000|Overall Study|Missing|0|||
23763318|NCT01785875|66511419|FG001|Overall Study|Missing|1|||
23763319|NCT01785875|66511420|FG002|Overall Study|Missing|3|||
23763320|NCT01313728|66511437|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
23763321|NCT01025193|66511438|FG000|Overall Study|Protocol Violation|1|||
23763322|NCT01025193|66511438|FG000|Overall Study|Adverse Event|3|||
23763323|NCT01907087|66511443|FG000|Overall Study|Withdrawal by Subject|1|||
23763324|NCT03567057|66511445|FG000|Overall Study|Adverse Event|56|||
23763325|NCT03567057|66511446|FG001|Overall Study|Adverse Event|53|||
23763326|NCT03567057|66511447|FG002|Overall Study|Adverse Event|28|||
23763327|NCT03567057|66511445|FG000|Overall Study|Withdrawal by Subject|22|||
23763328|NCT03567057|66511446|FG001|Overall Study|Withdrawal by Subject|24|||
23763329|NCT03567057|66511447|FG002|Overall Study|Withdrawal by Subject|13|||
23763330|NCT03567057|66511445|FG000|Overall Study|Lost to Follow-up|3|||
23763331|NCT03567057|66511446|FG001|Overall Study|Lost to Follow-up|5|||
23566151|NCT01375205|65803681|FG000|Overall Study|Lost to Follow-up|15|||
23566152|NCT01375205|65803682|FG001|Overall Study|Lost to Follow-up|12|||
23566153|NCT01375205|65803681|FG000|Overall Study|Withdrawal by Subject|6|||
23566154|NCT01375205|65803682|FG001|Overall Study|Withdrawal by Subject|1|||
23566155|NCT02904902|65803683|FG000|Overall Study|Withdrawal by Subject|1|||
23566156|NCT03292146|65803687|FG000|Baseline to 12 Months|Relocation|1|||
23566157|NCT03292146|65803688|FG001|Baseline to 12 Months|Relocation|0|||
23566158|NCT03292146|65803687|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
23763332|NCT03567057|66511447|FG002|Overall Study|Lost to Follow-up|2|||
23763333|NCT03567057|66511445|FG000|Overall Study|COVID-19 pandemic|4|||
23763334|NCT03567057|66511446|FG001|Overall Study|COVID-19 pandemic|3|||
23763335|NCT03567057|66511447|FG002|Overall Study|COVID-19 pandemic|0|||
23763336|NCT03567057|66511445|FG000|Overall Study|Non-compliance with study drug|4|||
23763337|NCT03567057|66511446|FG001|Overall Study|Non-compliance with study drug|2|||
23763338|NCT03567057|66511447|FG002|Overall Study|Non-compliance with study drug|0|||
23566159|NCT03292146|65803688|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
23763339|NCT03567057|66511445|FG000|Overall Study|Lack of Efficacy|3|||
23763340|NCT03567057|66511446|FG001|Overall Study|Lack of Efficacy|0|||
23763341|NCT03567057|66511447|FG002|Overall Study|Lack of Efficacy|1|||
23763342|NCT03567057|66511445|FG000|Overall Study|Death|1|||
23763343|NCT03567057|66511446|FG001|Overall Study|Death|0|||
23763344|NCT03567057|66511447|FG002|Overall Study|Death|0|||
23763345|NCT03567057|66511445|FG000|Overall Study|Physician Decision|1|||
23763346|NCT03567057|66511446|FG001|Overall Study|Physician Decision|0|||
23763347|NCT03567057|66511447|FG002|Overall Study|Physician Decision|0|||
23763348|NCT03567057|66511445|FG000|Overall Study|Unstable medical condition|1|||
23763349|NCT03567057|66511446|FG001|Overall Study|Unstable medical condition|0|||
23763350|NCT03567057|66511447|FG002|Overall Study|Unstable medical condition|0|||
23763351|NCT03567057|66511445|FG000|Overall Study|Medical history event|0|||
23763352|NCT03567057|66511446|FG001|Overall Study|Medical history event|0|||
23763353|NCT03567057|66511447|FG002|Overall Study|Medical history event|1|||
23763354|NCT03567057|66511445|FG000|Overall Study|Other|0|||
23763355|NCT03567057|66511446|FG001|Overall Study|Other|0|||
23763356|NCT03567057|66511447|FG002|Overall Study|Other|1|||
23763357|NCT01208402|66511448|FG000|Overall Study|Withdrawal by Subject|1|||
23763358|NCT01208402|66511449|FG001|Overall Study|Withdrawal by Subject|0|||
23763359|NCT02436135|66511453|FG000|Overall Study|Progressive Disease|3|||
23763360|NCT02436135|66511454|FG001|Overall Study|Progressive Disease|1|||
23763361|NCT02436135|66511453|FG000|Overall Study|Investigator Discretion|1|||
23763362|NCT02436135|66511454|FG001|Overall Study|Investigator Discretion|2|||
23763363|NCT02436135|66511453|FG000|Overall Study|Adverse Event|1|||
23763364|NCT02436135|66511454|FG001|Overall Study|Adverse Event|0|||
23763365|NCT02436135|66511453|FG000|Overall Study|Withdrawal by Participant|1|||
23763366|NCT02436135|66511454|FG001|Overall Study|Withdrawal by Participant|0|||
23763367|NCT02436135|66511453|FG000|Overall Study|Study Terminated By Sponsor|0|||
23763368|NCT02436135|66511454|FG001|Overall Study|Study Terminated By Sponsor|1|||
23763369|NCT00450216|66511455|FG000|Overall Study|Adverse Event|38|||
23763370|NCT00450216|66511456|FG001|Overall Study|Adverse Event|23|||
23763371|NCT00450216|66511455|FG000|Overall Study|Withdrawal by Subject|48|||
23763372|NCT00450216|66511456|FG001|Overall Study|Withdrawal by Subject|26|||
23763373|NCT00450216|66511455|FG000|Overall Study|Lost to Follow-up|16|||
23763374|NCT00450216|66511456|FG001|Overall Study|Lost to Follow-up|9|||
23763375|NCT00450216|66511455|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
23763376|NCT00450216|66511456|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
23763377|NCT00450216|66511455|FG000|Overall Study|misc|21|||
23763378|NCT00450216|66511456|FG001|Overall Study|misc|20|||
23763379|NCT00303316|66511461|FG000|Overall Study|Protocol Violation|1|||
23763380|NCT00303316|66511462|FG001|Overall Study|Protocol Violation|0|||
23763381|NCT00303316|66511461|FG000|Overall Study|Lost to Follow-up|0|||
23763382|NCT00303316|66511462|FG001|Overall Study|Lost to Follow-up|1|||
23763383|NCT00303316|66511461|FG000|Overall Study|Withdrawal by Subject|1|||
23763384|NCT00303316|66511462|FG001|Overall Study|Withdrawal by Subject|2|||
23763385|NCT01452529|66511463|FG000|Run-in Period|Adverse Event|96|||
23763386|NCT01452529|66511464|FG001|Run-in Period|Adverse Event|0|||
23763387|NCT01452529|66511465|FG002|Run-in Period|Adverse Event|0|||
23763388|NCT01452529|66511463|FG000|Run-in Period|Withdrawal by Subject|49|||
23763389|NCT01452529|66511464|FG001|Run-in Period|Withdrawal by Subject|0|||
23763390|NCT01452529|66511465|FG002|Run-in Period|Withdrawal by Subject|0|||
23763391|NCT01452529|66511463|FG000|Run-in Period|Lost to Follow-up|19|||
23763392|NCT01452529|66511464|FG001|Run-in Period|Lost to Follow-up|0|||
23763393|NCT01452529|66511465|FG002|Run-in Period|Lost to Follow-up|0|||
23763394|NCT01452529|66511463|FG000|Run-in Period|Lack of Efficacy|46|||
23763395|NCT01452529|66511464|FG001|Run-in Period|Lack of Efficacy|0|||
23763396|NCT01452529|66511465|FG002|Run-in Period|Lack of Efficacy|0|||
23763397|NCT01452529|66511463|FG000|Run-in Period|Confirmed or suspected diversion|23|||
23763398|NCT01452529|66511464|FG001|Run-in Period|Confirmed or suspected diversion|0|||
23828299|NCT03347110|66749116|FG000|Overall Study|Other (Participant is incarcerated)|1|||
23828300|NCT03347110|66749116|FG000|Overall Study|Withdrawal by Subject|9|||
23828301|NCT03347110|66749116|FG000|Overall Study|Lost to Follow-up|1|||
23828302|NCT03347110|66749116|FG000|Overall Study|Lack of Efficacy|2|||
23828303|NCT03347110|66749116|FG000|Overall Study|Adverse Event, non-fatal|9|||
23828304|NCT00529373|66752325|FG000|Base Study|Adverse Event|525|||
23828305|NCT00529373|66752326|FG001|Base Study|Adverse Event|470|||
23828306|NCT00529373|66752325|FG000|Base Study|Lack of Efficacy|16|||
23828307|NCT00529373|66752326|FG001|Base Study|Lack of Efficacy|75|||
23828308|NCT00529373|66752325|FG000|Base Study|Lost to Follow-up|221|||
23828309|NCT00529373|66752326|FG001|Base Study|Lost to Follow-up|208|||
23763399|NCT01452529|66511465|FG002|Run-in Period|Confirmed or suspected diversion|0|||
23763400|NCT01452529|66511463|FG000|Run-in Period|Administrative|21|||
23763401|NCT01452529|66511464|FG001|Run-in Period|Administrative|0|||
23763402|NCT01452529|66511465|FG002|Run-in Period|Administrative|0|||
23763403|NCT01452529|66511463|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
23763404|NCT01452529|66511464|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
23763405|NCT01452529|66511465|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
23763406|NCT01452529|66511463|FG000|Double-blind (DB) Period|Adverse Event|0|||
23763407|NCT01452529|66511464|FG001|Double-blind (DB) Period|Adverse Event|18|||
23763408|NCT01452529|66511465|FG002|Double-blind (DB) Period|Adverse Event|11|||
23763409|NCT01452529|66511463|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
23828310|NCT00529373|66752325|FG000|Base Study|Other Protocol Specified Criteria|19|||
23566160|NCT03292146|65803687|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
23566161|NCT03292146|65803688|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
23566162|NCT03292146|65803687|FG000|12 Months to 24 Months|Planning pregnancy|2|||
23566163|NCT03292146|65803688|FG001|12 Months to 24 Months|Planning pregnancy|2|||
23566164|NCT03292146|65803687|FG000|12 Months to 24 Months|Personal reasons|1|||
23566165|NCT03292146|65803688|FG001|12 Months to 24 Months|Personal reasons|0|||
23566166|NCT03292146|65803687|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
23566167|NCT03292146|65803688|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
23566168|NCT01965158|65803694|FG000|Overall Study|Adverse Event|14|||
23566169|NCT01965158|65803695|FG001|Overall Study|Adverse Event|5|||
23828311|NCT00529373|66752326|FG001|Base Study|Other Protocol Specified Criteria|20|||
23828312|NCT00529373|66752325|FG000|Base Study|Physician Decision|60|||
23828313|NCT00529373|66752326|FG001|Base Study|Physician Decision|52|||
23828314|NCT00529373|66752325|FG000|Base Study|Protocol Violation|48|||
23828315|NCT00529373|66752326|FG001|Base Study|Protocol Violation|38|||
23828316|NCT00529373|66752325|FG000|Base Study|Withdrawal by Subject|1062|||
23828317|NCT00529373|66752326|FG001|Base Study|Withdrawal by Subject|967|||
23828318|NCT00529373|66752325|FG000|Base Study|Did not continue into Extension|1795|||
23828319|NCT00529373|66752326|FG001|Base Study|Did not continue into Extension|2238|||
23828320|NCT00529373|66752325|FG000|First Extension Study|Adverse Event|162|||
23828321|NCT00529373|66752326|FG001|First Extension Study|Adverse Event|142|||
23828322|NCT00529373|66752325|FG000|First Extension Study|Lack of Efficacy|65|||
23828323|NCT00529373|66752326|FG001|First Extension Study|Lack of Efficacy|427|||
23828324|NCT00529373|66752325|FG000|First Extension Study|Lost to Follow-up|41|||
23828325|NCT00529373|66752326|FG001|First Extension Study|Lost to Follow-up|37|||
23828326|NCT00529373|66752325|FG000|First Extension Study|Other|27|||
23443160|NCT00607087|65362363|FG002|Period 1|Lost to Follow-up|0|||
23443161|NCT00607087|65362361|FG000|Period 1|Other reason|0|||
23443162|NCT00607087|65362362|FG001|Period 1|Other reason|4|||
23443163|NCT00607087|65362363|FG002|Period 1|Other reason|2|||
23443164|NCT00607087|65362361|FG000|Period 2|Withdrawal by Subject|0|||
23443165|NCT00607087|65362362|FG001|Period 2|Withdrawal by Subject|1|||
23566170|NCT01965158|65803694|FG000|Overall Study|Withdrawal by Subject|16|||
23566171|NCT01965158|65803695|FG001|Overall Study|Withdrawal by Subject|24|||
23566172|NCT01965158|65803694|FG000|Overall Study|Lost to Follow-up|7|||
23566173|NCT01965158|65803695|FG001|Overall Study|Lost to Follow-up|5|||
23566174|NCT01965158|65803694|FG000|Overall Study|Protocol Violation|1|||
23566175|NCT01965158|65803695|FG001|Overall Study|Protocol Violation|1|||
23566176|NCT01965158|65803694|FG000|Overall Study|Other - Miscellaneous|3|||
23566177|NCT01965158|65803695|FG001|Overall Study|Other - Miscellaneous|0|||
23566178|NCT03714022|65803700|FG000|Overall Study|Adverse Event|1|||
23566179|NCT03714022|65803701|FG001|Overall Study|Adverse Event|0|||
23566180|NCT03714022|65803700|FG000|Overall Study|Consent withdrawal|0|||
23566181|NCT03714022|65803701|FG001|Overall Study|Consent withdrawal|1|||
23566182|NCT03714022|65803700|FG000|Overall Study|Lost to Follow-up|3|||
23566183|NCT03714022|65803701|FG001|Overall Study|Lost to Follow-up|2|||
23566184|NCT03077620|65803704|FG000|Overall Study|Unable to place lumbar catheter|1|||
23566185|NCT03077620|65803705|FG001|Overall Study|Unable to place lumbar catheter|0|||
23566186|NCT03077620|65803706|FG002|Overall Study|Unable to place lumbar catheter|1|||
23566187|NCT03077620|65803707|FG003|Overall Study|Unable to place lumbar catheter|0|||
23566188|NCT03077620|65803704|FG000|Overall Study|Withdrawal by Subject|0|||
23566189|NCT03077620|65803705|FG001|Overall Study|Withdrawal by Subject|1|||
23566190|NCT03077620|65803706|FG002|Overall Study|Withdrawal by Subject|0|||
23566191|NCT03077620|65803707|FG003|Overall Study|Withdrawal by Subject|0|||
23566192|NCT03077620|65803704|FG000|Overall Study|Physician Decision|0|||
23828327|NCT00529373|66752326|FG001|First Extension Study|Other|47|||
23828328|NCT00529373|66752325|FG000|First Extension Study|Physician Decision|50|||
23443166|NCT00607087|65362363|FG002|Period 2|Withdrawal by Subject|1|||
23443167|NCT00607087|65362361|FG000|Period 2|Other reason|1|||
23443168|NCT00607087|65362362|FG001|Period 2|Other reason|1|||
23443169|NCT00607087|65362363|FG002|Period 2|Other reason|0|||
23443170|NCT00607087|65362361|FG000|Period 2|Adverse Event|0|||
23443171|NCT00607087|65362362|FG001|Period 2|Adverse Event|1|||
23443172|NCT00607087|65362363|FG002|Period 2|Adverse Event|3|||
23443173|NCT00607087|65362361|FG000|Period 2|Poor compliance to protocol|0|||
23443174|NCT00607087|65362362|FG001|Period 2|Poor compliance to protocol|0|||
23566193|NCT03077620|65803705|FG001|Overall Study|Physician Decision|0|||
23566194|NCT03077620|65803706|FG002|Overall Study|Physician Decision|1|||
23566195|NCT03077620|65803707|FG003|Overall Study|Physician Decision|0|||
23566196|NCT03528174|65803708|FG000|Overall Study|Adverse Event|1|||
23566197|NCT03528174|65803708|FG000|Overall Study|sensors dislodged|1|||
23566198|NCT00980005|65803709|FG000|Overall Study|Withdrawal by Subject|6|||
23566199|NCT00980005|65803710|FG001|Overall Study|Withdrawal by Subject|17|||
23566200|NCT00980005|65803709|FG000|Overall Study|Lost to Follow-up|37|||
23828329|NCT00529373|66752326|FG001|First Extension Study|Physician Decision|45|||
23828330|NCT00529373|66752325|FG000|First Extension Study|Protocol Violation|16|||
23828331|NCT00529373|66752326|FG001|First Extension Study|Protocol Violation|13|||
23828332|NCT00529373|66752325|FG000|First Extension Study|Withdrawal by Subject|296|||
23443175|NCT00607087|65362363|FG002|Period 2|Poor compliance to protocol|1|||
23443176|NCT00607087|65362361|FG000|Period 3|Withdrawal by Subject|2|||
23443177|NCT00607087|65362362|FG001|Period 3|Withdrawal by Subject|1|||
23443178|NCT00607087|65362363|FG002|Period 3|Withdrawal by Subject|0|||
23443179|NCT00607087|65362361|FG000|Period 3|Adverse Event|0|||
23443180|NCT00607087|65362362|FG001|Period 3|Adverse Event|1|||
23443181|NCT00607087|65362363|FG002|Period 3|Adverse Event|0|||
23443182|NCT01687101|65362364|FG000|Overall Study|Lost to Follow-up|7|||
23443183|NCT01514201|65366339|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
23443184|NCT01514201|65366340|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443185|NCT01514201|65366341|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443186|NCT01514201|65366342|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443187|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443188|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
23443189|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
23443190|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443191|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
23443192|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
23443193|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
23443194|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443195|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
23443196|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
23443197|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443198|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443199|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443200|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443201|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443202|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
23443203|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443204|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443205|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443206|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
23443207|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443208|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443209|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443210|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
23443211|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443212|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443213|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443214|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
23443215|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443216|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443217|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443218|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
23443219|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443220|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443221|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443222|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
23443223|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443224|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443225|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443226|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
23443227|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443228|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23628329|NCT00778921|66024709|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
23763410|NCT01452529|66511464|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
23763411|NCT01452529|66511465|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
23763412|NCT01452529|66511463|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
23763413|NCT01452529|66511464|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
23763414|NCT01452529|66511465|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
23763415|NCT01452529|66511463|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
23763416|NCT01452529|66511464|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
23443229|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443230|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
23443231|NCT00377858|65366345|FG000|Overall Study|Withdrawal by Subject|12|||
23443232|NCT00377858|65366346|FG001|Overall Study|Withdrawal by Subject|11|||
23443233|NCT00377858|65366345|FG000|Overall Study|Lost to Follow-up|6|||
23443234|NCT00377858|65366346|FG001|Overall Study|Lost to Follow-up|1|||
23443235|NCT00377858|65366345|FG000|Overall Study|Physician Decision|5|||
23443236|NCT00377858|65366346|FG001|Overall Study|Physician Decision|5|||
23443237|NCT00377858|65366345|FG000|Overall Study|Protocol Violation|3|||
23443238|NCT00377858|65366346|FG001|Overall Study|Protocol Violation|4|||
23443239|NCT00377858|65366345|FG000|Overall Study|Adverse Event|2|||
23443240|NCT00377858|65366346|FG001|Overall Study|Adverse Event|1|||
23443241|NCT00377858|65366345|FG000|Overall Study|Entry Criteria Not Met|2|||
23443242|NCT00377858|65366346|FG001|Overall Study|Entry Criteria Not Met|0|||
23443243|NCT00377858|65366345|FG000|Overall Study|Sponsor Decision|1|||
23443244|NCT00377858|65366346|FG001|Overall Study|Sponsor Decision|2|||
23443245|NCT00377858|65366345|FG000|Overall Study|Death|0|||
23443246|NCT00377858|65366346|FG001|Overall Study|Death|3|||
23443247|NCT01496469|65366347|FG000|Overall Study|Adverse Event|1|||
23443248|NCT01496469|65366348|FG001|Overall Study|Adverse Event|0|||
23443249|NCT01496469|65366347|FG000|Overall Study|Protocol Violation|2|||
23443250|NCT01496469|65366348|FG001|Overall Study|Protocol Violation|0|||
23443251|NCT01496469|65366347|FG000|Overall Study|Lost to Follow-up|1|||
23443252|NCT01496469|65366348|FG001|Overall Study|Lost to Follow-up|1|||
23443253|NCT01496469|65366347|FG000|Overall Study|Withdrawal by Subject|4|||
23443254|NCT01496469|65366348|FG001|Overall Study|Withdrawal by Subject|4|||
23443255|NCT01496469|65366347|FG000|Overall Study|BP exceeds protocol limits|1|||
23443256|NCT01496469|65366348|FG001|Overall Study|BP exceeds protocol limits|2|||
23443257|NCT01496469|65366347|FG000|Overall Study|Other|1|||
23443258|NCT01496469|65366348|FG001|Overall Study|Other|1|||
23443259|NCT01502228|65366349|FG000|Overall Study|Death|1|||
23443260|NCT01456169|65366350|FG000|Overall Study|Adverse Event|1|||
23443261|NCT01456169|65366351|FG001|Overall Study|Adverse Event|2|||
23443262|NCT01456169|65366352|FG002|Overall Study|Adverse Event|7|||
23763417|NCT01452529|66511465|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
23763418|NCT01452529|66511463|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
23763419|NCT01452529|66511464|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
23443263|NCT01456169|65366350|FG000|Overall Study|Major Protocol Deviation|3|||
23443264|NCT01456169|65366351|FG001|Overall Study|Major Protocol Deviation|2|||
23443265|NCT01456169|65366352|FG002|Overall Study|Major Protocol Deviation|3|||
23763420|NCT01452529|66511465|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
23443266|NCT01456169|65366350|FG000|Overall Study|Voluntary Withdrawal|3|||
23443267|NCT01456169|65366351|FG001|Overall Study|Voluntary Withdrawal|0|||
23443268|NCT01456169|65366352|FG002|Overall Study|Voluntary Withdrawal|2|||
23443269|NCT01456169|65366350|FG000|Overall Study|Lack of Efficacy|2|||
23443270|NCT01456169|65366351|FG001|Overall Study|Lack of Efficacy|0|||
23763421|NCT01452529|66511463|FG000|Double-blind (DB) Period|Administrative|0|||
23443271|NCT01456169|65366352|FG002|Overall Study|Lack of Efficacy|0|||
23566201|NCT00980005|65803710|FG001|Overall Study|Lost to Follow-up|43|||
23763422|NCT01452529|66511464|FG001|Double-blind (DB) Period|Administrative|11|||
23763423|NCT01452529|66511465|FG002|Double-blind (DB) Period|Administrative|7|||
23566202|NCT00980005|65803709|FG000|Overall Study|Other|4|||
23566203|NCT00980005|65803710|FG001|Overall Study|Other|3|||
23628330|NCT00778921|66024710|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
23628331|NCT00778921|66024711|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
23628332|NCT00778921|66024709|FG000|Overall Study|Patient withdrew request|3|||
23828333|NCT00529373|66752326|FG001|First Extension Study|Withdrawal by Subject|287|||
23828334|NCT00529373|66752325|FG000|First Extension Study|Disposition record non-existing|0|||
23828335|NCT00529373|66752326|FG001|First Extension Study|Disposition record non-existing|1|||
23828336|NCT00529373|66752325|FG000|First Extension Study|Discontinued after 5 years completion|208|||
23828337|NCT00529373|66752326|FG001|First Extension Study|Discontinued after 5 years completion|346|||
23828338|NCT00529373|66752325|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
23628333|NCT00778921|66024710|FG001|Overall Study|Patient withdrew request|1|||
23628334|NCT00778921|66024711|FG002|Overall Study|Patient withdrew request|6|||
23628335|NCT00778921|66024709|FG000|Overall Study|Lost to Follow-up|0|||
23628336|NCT00778921|66024710|FG001|Overall Study|Lost to Follow-up|2|||
23628337|NCT00778921|66024711|FG002|Overall Study|Lost to Follow-up|1|||
23763424|NCT02260492|66511467|FG000|Overall Study|Adverse Event|6|||
23763425|NCT02260492|66511468|FG001|Overall Study|Adverse Event|1|||
23763426|NCT02260492|66511469|FG002|Overall Study|Adverse Event|2|||
23763427|NCT02260492|66511467|FG000|Overall Study|Death|0|||
23763428|NCT02260492|66511468|FG001|Overall Study|Death|1|||
23763429|NCT02260492|66511469|FG002|Overall Study|Death|0|||
23763430|NCT02260492|66511467|FG000|Overall Study|Lost to Follow-up|12|||
23763431|NCT02260492|66511468|FG001|Overall Study|Lost to Follow-up|9|||
23763432|NCT02260492|66511469|FG002|Overall Study|Lost to Follow-up|0|||
23763433|NCT02260492|66511467|FG000|Overall Study|Physician Decision|2|||
23763434|NCT02260492|66511468|FG001|Overall Study|Physician Decision|0|||
23763435|NCT02260492|66511469|FG002|Overall Study|Physician Decision|1|||
23763436|NCT02260492|66511467|FG000|Overall Study|Withdrawal by Subject|3|||
23763437|NCT02260492|66511468|FG001|Overall Study|Withdrawal by Subject|2|||
23763438|NCT02260492|66511469|FG002|Overall Study|Withdrawal by Subject|2|||
23763439|NCT01162499|66511470|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
23763440|NCT01162499|66511471|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
23763441|NCT00472446|66511472|FG000|Overall Study|Protocol Violation|0|||
23763442|NCT00472446|66511473|FG001|Overall Study|Protocol Violation|0|||
23763443|NCT00472446|66511474|FG002|Overall Study|Protocol Violation|0|||
23763444|NCT00472446|66511475|FG003|Overall Study|Protocol Violation|1|||
23763445|NCT00472446|66511472|FG000|Overall Study|Reintervention|0|||
23763446|NCT00472446|66511473|FG001|Overall Study|Reintervention|0|||
23763447|NCT00472446|66511474|FG002|Overall Study|Reintervention|1|||
23763448|NCT00472446|66511475|FG003|Overall Study|Reintervention|1|||
23763449|NCT00472446|66511472|FG000|Overall Study|Questionnaires not returned|5|||
23763450|NCT00472446|66511473|FG001|Overall Study|Questionnaires not returned|6|||
23763451|NCT00472446|66511474|FG002|Overall Study|Questionnaires not returned|6|||
23763452|NCT00472446|66511475|FG003|Overall Study|Questionnaires not returned|4|||
23763453|NCT00836927|66511478|FG000|Overall Study|Progressive disease|2|||
23763454|NCT00836927|66511479|FG001|Overall Study|Progressive disease|0|||
23763455|NCT00836927|66511480|FG002|Overall Study|Progressive disease|0|||
23763456|NCT00836927|66511481|FG003|Overall Study|Progressive disease|1|||
23763457|NCT00836927|66511482|FG004|Overall Study|Progressive disease|1|||
23763458|NCT00836927|66511478|FG000|Overall Study|Withdrawal by Subject|1|||
23763459|NCT00836927|66511479|FG001|Overall Study|Withdrawal by Subject|0|||
23763460|NCT00836927|66511480|FG002|Overall Study|Withdrawal by Subject|0|||
23763461|NCT00836927|66511481|FG003|Overall Study|Withdrawal by Subject|0|||
23763462|NCT00836927|66511482|FG004|Overall Study|Withdrawal by Subject|0|||
23763463|NCT04317781|66511483|FG000|Overall Study|Adverse Event|1|||
23763464|NCT04317781|66511483|FG000|Overall Study|Disease relapse|1|||
23763465|NCT04317781|66511483|FG000|Overall Study|Withdrawal by Subject|1|||
23763466|NCT00775983|66511484|FG000|Overall Study|Protocol Violation|1|||
23763467|NCT00775983|66511485|FG001|Overall Study|Protocol Violation|2|||
23828339|NCT00529373|66752326|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
23828340|NCT00529373|66752325|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
23828341|NCT00529373|66752326|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
23828342|NCT00529373|66752325|FG000|Second Extension Study|Adverse Event|101|||
23828343|NCT00529373|66752326|FG001|Second Extension Study|Adverse Event|51|||
23828344|NCT00529373|66752325|FG000|Second Extension Study|Lack of Efficacy|7|||
23828345|NCT00529373|66752326|FG001|Second Extension Study|Lack of Efficacy|15|||
23828346|NCT00529373|66752325|FG000|Second Extension Study|Lost to Follow-up|18|||
23828347|NCT00529373|66752326|FG001|Second Extension Study|Lost to Follow-up|12|||
23763468|NCT02151461|66511486|FG000|Overall Study|Adverse Event|5|||
23763469|NCT02151461|66511487|FG001|Overall Study|Adverse Event|1|||
23828348|NCT00529373|66752325|FG000|Second Extension Study|Other|7|||
23763470|NCT02151461|66511488|FG002|Overall Study|Adverse Event|0|||
23763471|NCT02151461|66511489|FG003|Overall Study|Adverse Event|2|||
23763472|NCT02151461|66511486|FG000|Overall Study|Lost to Follow-up|0|||
23763473|NCT02151461|66511487|FG001|Overall Study|Lost to Follow-up|0|||
23443272|NCT01456169|65366350|FG000|Overall Study|Other|1|||
23628338|NCT00778921|66024709|FG000|Overall Study|Administrative Problems|1|||
23763474|NCT02151461|66511488|FG002|Overall Study|Lost to Follow-up|1|||
23763475|NCT02151461|66511489|FG003|Overall Study|Lost to Follow-up|1|||
23763476|NCT02151461|66511486|FG000|Overall Study|Withdrawal by Subject|1|||
23763477|NCT02151461|66511487|FG001|Overall Study|Withdrawal by Subject|0|||
23763478|NCT02151461|66511488|FG002|Overall Study|Withdrawal by Subject|1|||
23763479|NCT02151461|66511489|FG003|Overall Study|Withdrawal by Subject|1|||
23443273|NCT01456169|65366351|FG001|Overall Study|Other|1|||
23443274|NCT01456169|65366352|FG002|Overall Study|Other|0|||
23443275|NCT03792256|65366357|FG000|Overall Study|Death|0|||
23443276|NCT03792256|65366358|FG001|Overall Study|Death|1|||
23443277|NCT03792256|65366357|FG000|Overall Study|Lack of Efficacy|0|||
23443278|NCT03792256|65366358|FG001|Overall Study|Lack of Efficacy|1|||
23443279|NCT03792256|65366357|FG000|Overall Study|Withdrawal by Subject|0|||
23443280|NCT03792256|65366358|FG001|Overall Study|Withdrawal by Subject|1|||
23443281|NCT00965575|65366359|FG000|Overall Study|subject unwillingness to swallow study c|1|||
23443282|NCT00965575|65366360|FG001|Overall Study|subject unwillingness to swallow study c|0|||
23443283|NCT00080301|65366361|FG000|Overall Study|Randomized but Never Treated|5|||
23443284|NCT00080301|65366362|FG001|Overall Study|Randomized but Never Treated|10|||
23443285|NCT00080301|65366361|FG000|Overall Study|Still on Treatment as of CSR date|0|||
23443286|NCT00080301|65366362|FG001|Overall Study|Still on Treatment as of CSR date|1|||
23443287|NCT00622505|65366363|FG000|Overall Study|Adverse Event|9|||
23443288|NCT00622505|65366364|FG001|Overall Study|Adverse Event|7|||
23443289|NCT00622505|65366363|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
23443290|NCT00622505|65366364|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
23763480|NCT02151461|66511486|FG000|Overall Study|Treatment discontinuation|0|||
23763481|NCT02151461|66511487|FG001|Overall Study|Treatment discontinuation|0|||
23763482|NCT02151461|66511488|FG002|Overall Study|Treatment discontinuation|1|||
23763483|NCT02151461|66511489|FG003|Overall Study|Treatment discontinuation|0|||
23763484|NCT00673790|66511497|FG000|Overall Study|Adverse Event|23|||
23763485|NCT00673790|66511498|FG001|Overall Study|Adverse Event|14|||
23763486|NCT00673790|66511499|FG002|Overall Study|Adverse Event|2|||
23763487|NCT00673790|66511497|FG000|Overall Study|Lack of Efficacy|2|||
23763488|NCT00673790|66511498|FG001|Overall Study|Lack of Efficacy|2|||
23763489|NCT00673790|66511499|FG002|Overall Study|Lack of Efficacy|2|||
23763490|NCT00673790|66511497|FG000|Overall Study|Protocol Violation|6|||
23763491|NCT00673790|66511498|FG001|Overall Study|Protocol Violation|9|||
23763492|NCT00673790|66511499|FG002|Overall Study|Protocol Violation|1|||
23763493|NCT00673790|66511497|FG000|Overall Study|Withdrawal by Subject|7|||
23763494|NCT00673790|66511498|FG001|Overall Study|Withdrawal by Subject|4|||
23763495|NCT00673790|66511499|FG002|Overall Study|Withdrawal by Subject|1|||
23763496|NCT00673790|66511497|FG000|Overall Study|Lost to Follow-up|6|||
23763497|NCT00673790|66511498|FG001|Overall Study|Lost to Follow-up|6|||
23763498|NCT00673790|66511499|FG002|Overall Study|Lost to Follow-up|5|||
23763499|NCT00673790|66511497|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
23763500|NCT00673790|66511498|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
23763501|NCT00673790|66511499|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
23763502|NCT00673790|66511497|FG000|Overall Study|Poor compliance|1|||
23763503|NCT00673790|66511498|FG001|Overall Study|Poor compliance|0|||
23763504|NCT00673790|66511499|FG002|Overall Study|Poor compliance|0|||
23763505|NCT00673790|66511497|FG000|Overall Study|Participated in two Nebivolol studies|0|||
23763506|NCT00673790|66511498|FG001|Overall Study|Participated in two Nebivolol studies|0|||
23763507|NCT00673790|66511499|FG002|Overall Study|Participated in two Nebivolol studies|1|||
23566204|NCT00154310|65803711|FG000|Overall Study|Adverse Event|19|||
23566205|NCT00154310|65803712|FG001|Overall Study|Adverse Event|9|||
23566206|NCT00154310|65803711|FG000|Overall Study|Lack of Efficacy|5|||
23566207|NCT00154310|65803712|FG001|Overall Study|Lack of Efficacy|4|||
23566208|NCT00154310|65803711|FG000|Overall Study|Protocol Violation|4|||
23566209|NCT00154310|65803712|FG001|Overall Study|Protocol Violation|2|||
23566210|NCT00154310|65803711|FG000|Overall Study|Withdrawal by Subject|9|||
23566211|NCT00154310|65803712|FG001|Overall Study|Withdrawal by Subject|3|||
23566212|NCT00154310|65803711|FG000|Overall Study|Lost to Follow-up|0|||
23566213|NCT00154310|65803712|FG001|Overall Study|Lost to Follow-up|8|||
23566214|NCT00154310|65803711|FG000|Overall Study|Administrative problems|0|||
23566215|NCT00154310|65803712|FG001|Overall Study|Administrative problems|1|||
23763508|NCT00673790|66511497|FG000|Overall Study|Unconfirmed pregnancy|0|||
23763509|NCT00673790|66511498|FG001|Overall Study|Unconfirmed pregnancy|1|||
23763510|NCT00673790|66511499|FG002|Overall Study|Unconfirmed pregnancy|0|||
23763511|NCT00673790|66511497|FG000|Overall Study|Randomization criteria not met|0|||
23763512|NCT00673790|66511498|FG001|Overall Study|Randomization criteria not met|1|||
23763513|NCT00673790|66511499|FG002|Overall Study|Randomization criteria not met|0|||
23763514|NCT02482805|66511500|FG000|Overall Study|Lost to Follow-up|4|||
23443291|NCT00622505|65366363|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23566216|NCT00154310|65803711|FG000|Overall Study|Death|0|||
23566217|NCT00154310|65803712|FG001|Overall Study|Death|1|||
23566218|NCT01014975|65803713|FG000|Overall Study|Withdrawal by Subject|1|||
23566219|NCT01014975|65803714|FG001|Overall Study|Withdrawal by Subject|0|||
23628339|NCT00778921|66024710|FG001|Overall Study|Administrative Problems|2|||
23628340|NCT00778921|66024711|FG002|Overall Study|Administrative Problems|0|||
23628341|NCT00778921|66024709|FG000|Overall Study|Protocol Violation|3|||
23628342|NCT00778921|66024710|FG001|Overall Study|Protocol Violation|0|||
23628343|NCT00778921|66024711|FG002|Overall Study|Protocol Violation|2|||
23628344|NCT00778921|66024709|FG000|Overall Study|Not treated|0|||
23628345|NCT00778921|66024710|FG001|Overall Study|Not treated|2|||
23628346|NCT00778921|66024711|FG002|Overall Study|Not treated|2|||
23628347|NCT01107899|66024714|FG000|Overall Study|Physician Decision|5|||
23628348|NCT01107899|66024715|FG001|Overall Study|Physician Decision|0|||
23628349|NCT01107899|66024716|FG002|Overall Study|Physician Decision|3|||
23628350|NCT01107899|66024714|FG000|Overall Study|Withdrawal by Subject|0|||
23628351|NCT01107899|66024715|FG001|Overall Study|Withdrawal by Subject|0|||
23628352|NCT01107899|66024716|FG002|Overall Study|Withdrawal by Subject|1|||
23628353|NCT02209181|66024717|FG000|Overall Study|Adverse Event|1|||
23628354|NCT02209181|66024718|FG001|Overall Study|Adverse Event|0|||
23628355|NCT02209181|66024719|FG002|Overall Study|Adverse Event|1|||
23628356|NCT02209181|66024720|FG003|Overall Study|Adverse Event|0|||
23628357|NCT02209181|66024717|FG000|Overall Study|Withdrawal by Subject|0|||
23628358|NCT02209181|66024718|FG001|Overall Study|Withdrawal by Subject|1|||
23628359|NCT02209181|66024719|FG002|Overall Study|Withdrawal by Subject|0|||
23628360|NCT02209181|66024720|FG003|Overall Study|Withdrawal by Subject|0|||
23628361|NCT01322009|66024721|FG000|Overall Study|Death|0|||
23628362|NCT01322009|66024722|FG001|Overall Study|Death|1|||
23628363|NCT01322009|66024721|FG000|Overall Study|Adverse Event|0|||
23628364|NCT01322009|66024722|FG001|Overall Study|Adverse Event|1|||
23628365|NCT01322009|66024721|FG000|Overall Study|ng tube discontinued|0|||
23628366|NCT01322009|66024722|FG001|Overall Study|ng tube discontinued|1|||
23628367|NCT00490698|66024726|FG000|Overall Study|Withdrawal by Subject|1|||
23628368|NCT00490698|66024726|FG000|Overall Study|Disease Progression|7|||
23628369|NCT00490698|66024726|FG000|Overall Study|Physician Decision|2|||
23628370|NCT00926575|66024727|FG000|Overall Study|Adverse Event|1|||
23628371|NCT00926575|66024728|FG001|Overall Study|Adverse Event|1|||
23628372|NCT00926575|66024727|FG000|Overall Study|Death|4|||
23628373|NCT00926575|66024728|FG001|Overall Study|Death|4|||
23628374|NCT00926575|66024727|FG000|Overall Study|Lost to Follow-up|1|||
23628375|NCT00926575|66024728|FG001|Overall Study|Lost to Follow-up|1|||
23443292|NCT00622505|65366364|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628376|NCT00926575|66024727|FG000|Overall Study|Physician Decision|1|||
23628377|NCT00926575|66024728|FG001|Overall Study|Physician Decision|2|||
23628378|NCT00926575|66024727|FG000|Overall Study|Protocol Violation|1|||
23628379|NCT00926575|66024728|FG001|Overall Study|Protocol Violation|0|||
23628380|NCT00926575|66024727|FG000|Overall Study|Withdrawal by Subject|8|||
23628381|NCT00926575|66024728|FG001|Overall Study|Withdrawal by Subject|9|||
23628382|NCT01236352|66024729|FG000|Overall Study|Death|0|||
23628383|NCT01236352|66024730|FG001|Overall Study|Death|0|||
23628384|NCT01236352|66024731|FG002|Overall Study|Death|0|||
23628385|NCT01236352|66024732|FG003|Overall Study|Death|0|||
23628386|NCT01236352|66024733|FG004|Overall Study|Death|0|||
23628387|NCT01236352|66024734|FG005|Overall Study|Death|0|||
23628388|NCT01236352|66024735|FG006|Overall Study|Death|0|||
23443293|NCT00622505|65366363|FG000|Overall Study|Withdrawal by Subject|12|||
23443294|NCT00622505|65366364|FG001|Overall Study|Withdrawal by Subject|5|||
23628389|NCT01236352|66024736|FG007|Overall Study|Death|1|||
23628390|NCT01236352|66024737|FG008|Overall Study|Death|0|||
23628391|NCT01236352|66024738|FG009|Overall Study|Death|0|||
23628392|NCT01236352|66024739|FG010|Overall Study|Death|0|||
23628393|NCT01236352|66024729|FG000|Overall Study|Withdrawal by Subject|0|||
23628394|NCT01236352|66024730|FG001|Overall Study|Withdrawal by Subject|0|||
23628395|NCT01236352|66024731|FG002|Overall Study|Withdrawal by Subject|0|||
23628396|NCT01236352|66024732|FG003|Overall Study|Withdrawal by Subject|0|||
23628397|NCT01236352|66024733|FG004|Overall Study|Withdrawal by Subject|0|||
23628398|NCT01236352|66024734|FG005|Overall Study|Withdrawal by Subject|0|||
23628399|NCT01236352|66024735|FG006|Overall Study|Withdrawal by Subject|0|||
23628400|NCT01236352|66024736|FG007|Overall Study|Withdrawal by Subject|0|||
23628401|NCT01236352|66024737|FG008|Overall Study|Withdrawal by Subject|0|||
23628402|NCT01236352|66024738|FG009|Overall Study|Withdrawal by Subject|2|||
23628403|NCT01236352|66024739|FG010|Overall Study|Withdrawal by Subject|1|||
23628404|NCT01236352|66024729|FG000|Overall Study|Adverse Event|0|||
23566220|NCT01014975|65803715|FG002|Overall Study|Withdrawal by Subject|1|||
23443295|NCT00622505|65366363|FG000|Overall Study|Administrative Problems|2|||
23443296|NCT00622505|65366364|FG001|Overall Study|Administrative Problems|4|||
23443297|NCT00622505|65366363|FG000|Overall Study|Death|2|||
23443298|NCT00622505|65366364|FG001|Overall Study|Death|2|||
23443299|NCT01420926|65366365|FG000|Overall Study|Adverse Event|6|||
23443300|NCT01420926|65366366|FG001|Overall Study|Adverse Event|4|||
23443301|NCT01420926|65366365|FG000|Overall Study|Death|18|||
23566221|NCT01014975|65803713|FG000|Overall Study|Death|3|||
23566222|NCT01014975|65803714|FG001|Overall Study|Death|3|||
23566223|NCT01014975|65803715|FG002|Overall Study|Death|4|||
23566224|NCT01014975|65803713|FG000|Overall Study|Lost to Follow-up|0|||
23566225|NCT01014975|65803714|FG001|Overall Study|Lost to Follow-up|0|||
23566226|NCT01014975|65803715|FG002|Overall Study|Lost to Follow-up|1|||
23566227|NCT04145037|65803719|FG000|Overall Study|Study terminated|2|||
23566228|NCT04145037|65803720|FG001|Overall Study|Study terminated|0|||
23566229|NCT04145037|65803719|FG000|Overall Study|Withdrawal by Subject|1|||
23566230|NCT04145037|65803720|FG001|Overall Study|Withdrawal by Subject|0|||
23566231|NCT04145037|65803719|FG000|Overall Study|Lost to Follow-up|1|||
23566232|NCT04145037|65803720|FG001|Overall Study|Lost to Follow-up|0|||
23566233|NCT00399763|65803726|FG000|Overall Study|Lost to Follow-up|2|||
23566234|NCT00399763|65803727|FG001|Overall Study|Lost to Follow-up|3|||
23566235|NCT01893827|65803729|FG000|Overall Study|Lost to Follow-up|19|||
23566236|NCT01893827|65803730|FG001|Overall Study|Lost to Follow-up|26|||
23566237|NCT02344537|65803735|FG000|Overall Study|Protocol Violation|1|||
23566238|NCT02344537|65803736|FG001|Overall Study|Protocol Violation|1|||
23566239|NCT02344537|65803735|FG000|Overall Study|Subject started another treatment after wk 6|1|||
23566240|NCT02344537|65803736|FG001|Overall Study|Subject started another treatment after wk 6|0|||
23566241|NCT02344537|65803735|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
23628405|NCT01236352|66024730|FG001|Overall Study|Adverse Event|0|||
23628406|NCT01236352|66024731|FG002|Overall Study|Adverse Event|0|||
23628407|NCT01236352|66024732|FG003|Overall Study|Adverse Event|0|||
23628408|NCT01236352|66024733|FG004|Overall Study|Adverse Event|0|||
23628409|NCT01236352|66024734|FG005|Overall Study|Adverse Event|0|||
23628410|NCT01236352|66024735|FG006|Overall Study|Adverse Event|2|||
23628411|NCT01236352|66024736|FG007|Overall Study|Adverse Event|0|||
23628412|NCT01236352|66024737|FG008|Overall Study|Adverse Event|0|||
23628413|NCT01236352|66024738|FG009|Overall Study|Adverse Event|4|||
23628414|NCT01236352|66024739|FG010|Overall Study|Adverse Event|1|||
23628415|NCT01236352|66024729|FG000|Overall Study|Study drug toxicity|0|||
23628416|NCT01236352|66024730|FG001|Overall Study|Study drug toxicity|0|||
23443302|NCT01420926|65366366|FG001|Overall Study|Death|17|||
23566242|NCT02344537|65803736|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
23566243|NCT00874432|65803737|FG000|Overall Study|Withdrawal by Subject|1|||
23566244|NCT00874432|65803738|FG001|Overall Study|Withdrawal by Subject|0|||
23628417|NCT01236352|66024731|FG002|Overall Study|Study drug toxicity|0|||
23628418|NCT01236352|66024732|FG003|Overall Study|Study drug toxicity|0|||
23443303|NCT01420926|65366365|FG000|Overall Study|Withdrawal by Subject|11|||
23443304|NCT01420926|65366366|FG001|Overall Study|Withdrawal by Subject|17|||
23443305|NCT01420926|65366365|FG000|Overall Study|Non-protocol treatment|17|||
23443306|NCT01420926|65366366|FG001|Overall Study|Non-protocol treatment|20|||
23566245|NCT00874432|65803739|FG002|Overall Study|Withdrawal by Subject|0|||
23566246|NCT00874432|65803740|FG003|Overall Study|Withdrawal by Subject|0|||
23566247|NCT00874432|65803737|FG000|Overall Study|Physician Decision|1|||
23628419|NCT01236352|66024733|FG004|Overall Study|Study drug toxicity|0|||
23628420|NCT01236352|66024734|FG005|Overall Study|Study drug toxicity|1|||
23628421|NCT01236352|66024735|FG006|Overall Study|Study drug toxicity|1|||
23628422|NCT01236352|66024736|FG007|Overall Study|Study drug toxicity|0|||
23628423|NCT01236352|66024737|FG008|Overall Study|Study drug toxicity|0|||
23628424|NCT01236352|66024738|FG009|Overall Study|Study drug toxicity|2|||
23566248|NCT00874432|65803738|FG001|Overall Study|Physician Decision|0|||
23566249|NCT00874432|65803739|FG002|Overall Study|Physician Decision|0|||
23566250|NCT00874432|65803740|FG003|Overall Study|Physician Decision|0|||
23566251|NCT00874432|65803737|FG000|Overall Study|Other|1|||
23566252|NCT00874432|65803738|FG001|Overall Study|Other|2|||
23566253|NCT00874432|65803739|FG002|Overall Study|Other|8|||
23566254|NCT00874432|65803740|FG003|Overall Study|Other|3|||
23566255|NCT00860067|65803741|FG000|Overall Study|Lost to Follow-up|46|||
23566256|NCT00860067|65803742|FG001|Overall Study|Lost to Follow-up|9|||
23566257|NCT00860067|65803743|FG002|Overall Study|Lost to Follow-up|9|||
23566258|NCT00860067|65803741|FG000|Overall Study|Withdrawal by Subject|4|||
23566259|NCT00860067|65803742|FG001|Overall Study|Withdrawal by Subject|0|||
23566260|NCT00860067|65803743|FG002|Overall Study|Withdrawal by Subject|0|||
23566261|NCT00860067|65803741|FG000|Overall Study|Pregnancy|1|||
23566262|NCT00860067|65803742|FG001|Overall Study|Pregnancy|0|||
23566263|NCT00860067|65803743|FG002|Overall Study|Pregnancy|0|||
23566264|NCT01126060|65803746|FG000|Overall Study|Protocol Violation|0|||
23443307|NCT01420926|65366365|FG000|Overall Study|Physician Decision|8|||
23443308|NCT01420926|65366366|FG001|Overall Study|Physician Decision|5|||
23443309|NCT01132313|65366367|FG000|Overall Study|Lack of Efficacy|1|||
23443310|NCT01132313|65366368|FG001|Overall Study|Lack of Efficacy|0|||
23443311|NCT01132313|65366369|FG002|Overall Study|Lack of Efficacy|0|||
23443312|NCT01132313|65366370|FG003|Overall Study|Lack of Efficacy|0|||
23443313|NCT01132313|65366371|FG004|Overall Study|Lack of Efficacy|0|||
23443314|NCT01132313|65366372|FG005|Overall Study|Lack of Efficacy|0|||
23443315|NCT01132313|65366373|FG006|Overall Study|Lack of Efficacy|0|||
23443316|NCT01132313|65366374|FG007|Overall Study|Lack of Efficacy|3|||
23566265|NCT01126060|65803747|FG001|Overall Study|Protocol Violation|2|||
23566266|NCT02041923|65803748|FG000|Overall Study|Lost to Follow-up|26|||
23566267|NCT02041923|65803749|FG001|Overall Study|Lost to Follow-up|30|||
23566268|NCT04278417|65803750|FG000|Overall Study|Withdrawal by Subject|13|||
23566269|NCT04278417|65803751|FG001|Overall Study|Withdrawal by Subject|12|||
23566270|NCT04278417|65803750|FG000|Overall Study|Progressive disease|0|||
23566271|NCT04278417|65803751|FG001|Overall Study|Progressive disease|1|||
23566272|NCT04278417|65803750|FG000|Overall Study|Physician Decision|2|||
23566273|NCT04278417|65803751|FG001|Overall Study|Physician Decision|1|||
23566274|NCT04278417|65803750|FG000|Overall Study|Lost to Follow-up|7|||
23566275|NCT04278417|65803751|FG001|Overall Study|Lost to Follow-up|8|||
23628425|NCT01236352|66024739|FG010|Overall Study|Study drug toxicity|2|||
23628426|NCT01236352|66024729|FG000|Overall Study|Disease progression|1|||
23628427|NCT01236352|66024730|FG001|Overall Study|Disease progression|2|||
23828349|NCT00529373|66752326|FG001|Second Extension Study|Other|12|||
23828350|NCT00529373|66752325|FG000|Second Extension Study|Physician Decision|63|||
23566276|NCT04278417|65803750|FG000|Overall Study|Death|6|||
23566277|NCT04278417|65803751|FG001|Overall Study|Death|3|||
23566278|NCT04278417|65803750|FG000|Overall Study|Adverse Event|2|||
23566279|NCT04278417|65803751|FG001|Overall Study|Adverse Event|4|||
23566280|NCT04278417|65803750|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
23566281|NCT04278417|65803751|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
23566282|NCT00720902|65803754|FG000|Overall Study|Withdrawal by Subject|1|||
23566283|NCT00720902|65803755|FG001|Overall Study|Withdrawal by Subject|0|||
23566284|NCT00720902|65803754|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
23566285|NCT00720902|65803755|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
23566286|NCT02796963|65803758|FG000|Overall Study|Lost to Follow-up|89|||
23566287|NCT02796963|65803759|FG001|Overall Study|Lost to Follow-up|76|||
23566288|NCT02796963|65803760|FG002|Overall Study|Lost to Follow-up|69|||
23566289|NCT02796963|65803761|FG003|Overall Study|Lost to Follow-up|72|||
23566290|NCT00369681|65803764|FG000|Overall Study|Death|1|||
23566291|NCT03469349|65803778|FG000|Overall Study|Withdrawal by Subject|1|||
23566292|NCT03469349|65803779|FG001|Overall Study|Withdrawal by Subject|3|||
23566293|NCT03469349|65803778|FG000|Overall Study|Progressive Disease|0|||
23566294|NCT03469349|65803779|FG001|Overall Study|Progressive Disease|1|||
23566295|NCT03469349|65803778|FG000|Overall Study|Lost to Follow-up|2|||
23566296|NCT03469349|65803779|FG001|Overall Study|Lost to Follow-up|2|||
23443317|NCT01132313|65366375|FG008|Overall Study|Lack of Efficacy|14|||
23443318|NCT01132313|65366376|FG009|Overall Study|Lack of Efficacy|16|||
23443319|NCT01132313|65366377|FG010|Overall Study|Lack of Efficacy|0|||
23566297|NCT03469349|65803778|FG000|Overall Study|Adverse Event|2|||
23566298|NCT03469349|65803779|FG001|Overall Study|Adverse Event|4|||
23566299|NCT01659658|65803780|FG000|Overall Study|Withdrawal by Patient|18|||
23566300|NCT01659658|65803781|FG001|Overall Study|Withdrawal by Patient|4|||
23566301|NCT01659658|65803782|FG002|Overall Study|Withdrawal by Patient|2|||
23566302|NCT01659658|65803783|FG003|Overall Study|Withdrawal by Patient|0|||
23566303|NCT01659658|65803784|FG004|Overall Study|Withdrawal by Patient|11|||
23566304|NCT01659658|65803780|FG000|Overall Study|Study Terminated by Sponsor|9|||
23443320|NCT01132313|65366378|FG011|Overall Study|Lack of Efficacy|0|||
23763515|NCT02482805|66511501|FG001|Overall Study|Lost to Follow-up|4|||
23763516|NCT02482805|66511502|FG002|Overall Study|Lost to Follow-up|0|||
23566305|NCT01659658|65803781|FG001|Overall Study|Study Terminated by Sponsor|7|||
23566306|NCT01659658|65803782|FG002|Overall Study|Study Terminated by Sponsor|0|||
23763517|NCT02629133|66511503|FG000|Overall Study|Lost to Follow-up|3|||
23763518|NCT02629133|66511504|FG001|Overall Study|Lost to Follow-up|1|||
23566307|NCT01659658|65803783|FG003|Overall Study|Study Terminated by Sponsor|1|||
23566308|NCT01659658|65803784|FG004|Overall Study|Study Terminated by Sponsor|4|||
23566309|NCT01659658|65803780|FG000|Overall Study|Reason not Specified|61|||
23566310|NCT01659658|65803781|FG001|Overall Study|Reason not Specified|15|||
23566311|NCT01659658|65803782|FG002|Overall Study|Reason not Specified|8|||
23566312|NCT01659658|65803783|FG003|Overall Study|Reason not Specified|1|||
23566313|NCT01659658|65803784|FG004|Overall Study|Reason not Specified|34|||
23566314|NCT01659658|65803780|FG000|Overall Study|Lost to Follow-up|2|||
23566315|NCT01659658|65803781|FG001|Overall Study|Lost to Follow-up|0|||
23566316|NCT01659658|65803782|FG002|Overall Study|Lost to Follow-up|0|||
23566317|NCT01659658|65803783|FG003|Overall Study|Lost to Follow-up|0|||
23566318|NCT01659658|65803784|FG004|Overall Study|Lost to Follow-up|0|||
23566319|NCT01679301|65803785|FG000|Screening Period|screen failure|3|||
23566320|NCT01679301|65803786|FG001|Screening Period|screen failure|0|||
23566321|NCT01679301|65803787|FG002|Screening Period|screen failure|0|||
23566322|NCT04161807|65803793|FG000|Overall Study|Withdrawal by Subject|2|||
23566323|NCT04161807|65803793|FG000|Overall Study|Performed only 1 treatment|2|||
23566324|NCT01782872|65803795|FG000|Overall Study|Protocol Violation|0|||
23566325|NCT01782872|65803796|FG001|Overall Study|Protocol Violation|0|||
23566326|NCT01782872|65803797|FG002|Overall Study|Protocol Violation|0|||
23566327|NCT01782872|65803798|FG003|Overall Study|Protocol Violation|1|||
23566328|NCT01782872|65803795|FG000|Overall Study|Withdrawal by Subject|0|||
23566329|NCT01782872|65803796|FG001|Overall Study|Withdrawal by Subject|1|||
23566330|NCT01782872|65803797|FG002|Overall Study|Withdrawal by Subject|0|||
23566331|NCT01782872|65803798|FG003|Overall Study|Withdrawal by Subject|0|||
23566332|NCT01862991|65803799|FG000|Overall Study|Lost to Follow-up|2|||
23566333|NCT01862991|65803800|FG001|Overall Study|Lost to Follow-up|1|||
23566334|NCT01862991|65803801|FG002|Overall Study|Lost to Follow-up|1|||
23566335|NCT01862991|65803799|FG000|Overall Study|Protocol Violation|1|||
23566336|NCT01862991|65803800|FG001|Overall Study|Protocol Violation|0|||
23566337|NCT01862991|65803801|FG002|Overall Study|Protocol Violation|0|||
23566338|NCT01719237|65803803|FG000|Overall Study|Physician Decision|0|||
23566339|NCT01719237|65803804|FG001|Overall Study|Physician Decision|1|||
23566340|NCT04395183|65803805|FG000|Overall Study|Withdrawal by Subject|1|||
23566341|NCT04395183|65803806|FG001|Overall Study|Withdrawal by Subject|0|||
23566342|NCT04395183|65803807|FG002|Overall Study|Withdrawal by Subject|2|||
23566343|NCT04395183|65803808|FG003|Overall Study|Withdrawal by Subject|2|||
23566344|NCT04035200|65803809|FG000|Overall Study|Lost to Follow-up|0|||
23566345|NCT04035200|65803810|FG001|Overall Study|Lost to Follow-up|1|||
23566346|NCT04035200|65803811|FG002|Overall Study|Lost to Follow-up|0|||
23566347|NCT04035200|65803809|FG000|Overall Study|Withdrawal by Subject|1|||
23566348|NCT04035200|65803810|FG001|Overall Study|Withdrawal by Subject|4|||
23566349|NCT04035200|65803811|FG002|Overall Study|Withdrawal by Subject|4|||
23566350|NCT04035200|65803809|FG000|Overall Study|COVID-19|1|||
23566351|NCT04035200|65803810|FG001|Overall Study|COVID-19|0|||
23566352|NCT04035200|65803811|FG002|Overall Study|COVID-19|0|||
23566353|NCT04035200|65803809|FG000|Overall Study|Early Termination|0|||
23566354|NCT04035200|65803810|FG001|Overall Study|Early Termination|1|||
23566355|NCT04035200|65803811|FG002|Overall Study|Early Termination|0|||
23566356|NCT04035200|65803809|FG000|Overall Study|Non-compliance|0|||
23566357|NCT04035200|65803810|FG001|Overall Study|Non-compliance|1|||
23566358|NCT04035200|65803811|FG002|Overall Study|Non-compliance|0|||
23566359|NCT01265823|65803812|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
23566360|NCT01265823|65803812|FG000|Overall Study|Failure to Return|4|||
23566361|NCT01265823|65803812|FG000|Overall Study|Protocol Violation|1|||
23566362|NCT01265823|65803812|FG000|Overall Study|Participant Request|1|||
23566363|NCT01024959|65803815|FG000|Overall Study|ineligible|12|||
23566364|NCT01024959|65803815|FG000|Overall Study|results not evaluable|12|||
23566365|NCT01024959|65803815|FG000|Overall Study|missing results required for analysis|17|||
23628428|NCT01236352|66024731|FG002|Overall Study|Disease progression|1|||
23566366|NCT00979602|65803816|FG000|Overall Study|Serious Adverse Event|5|||
23763519|NCT02629133|66511503|FG000|Overall Study|Withdrawal by Subject|1|||
23763520|NCT02629133|66511504|FG001|Overall Study|Withdrawal by Subject|1|||
23763521|NCT03237611|66511507|FG000|Overall Study|Withdrawal by Subject|1|||
23566367|NCT00979602|65803817|FG001|Overall Study|Serious Adverse Event|3|||
23566368|NCT00979602|65803816|FG000|Overall Study|Protocol Violation|3|||
23566369|NCT00979602|65803817|FG001|Overall Study|Protocol Violation|0|||
23763522|NCT03237611|66511507|FG000|Overall Study|Ineligible|1|||
23828351|NCT00529373|66752326|FG001|Second Extension Study|Physician Decision|26|||
23828352|NCT00529373|66752325|FG000|Second Extension Study|Protocol Violation|2|||
23828353|NCT00529373|66752326|FG001|Second Extension Study|Protocol Violation|1|||
23828354|NCT00529373|66752325|FG000|Second Extension Study|Withdrawal by Subject|97|||
23828355|NCT00529373|66752326|FG001|Second Extension Study|Withdrawal by Subject|75|||
23828356|NCT00529373|66752325|FG000|Second Extension Study|Status Missing|5|||
23828357|NCT00529373|66752326|FG001|Second Extension Study|Status Missing|5|||
23828358|NCT00266630|66752327|FG000|Overall Study|Adverse Event|8|||
23828359|NCT00266630|66752328|FG001|Overall Study|Adverse Event|6|||
23828360|NCT00266630|66752327|FG000|Overall Study|Lack of Efficacy|1|||
23828361|NCT00266630|66752328|FG001|Overall Study|Lack of Efficacy|4|||
23828362|NCT00266630|66752327|FG000|Overall Study|Entry Criteria not met|1|||
23828363|NCT00266630|66752328|FG001|Overall Study|Entry Criteria not met|0|||
23566370|NCT00979602|65803816|FG000|Overall Study|Withdrawal by Subject|31|||
23566371|NCT00979602|65803817|FG001|Overall Study|Withdrawal by Subject|25|||
23566372|NCT00979602|65803816|FG000|Overall Study|Lost to Follow-up|100|||
23628429|NCT01236352|66024732|FG003|Overall Study|Disease progression|2|||
23628430|NCT01236352|66024733|FG004|Overall Study|Disease progression|2|||
23628431|NCT01236352|66024734|FG005|Overall Study|Disease progression|2|||
23763523|NCT01789281|66511508|FG000|Overall Study|Disease progression|15|||
23566373|NCT00979602|65803817|FG001|Overall Study|Lost to Follow-up|96|||
23566374|NCT00979602|65803816|FG000|Overall Study|Migrated/moved from study area|3|||
23566375|NCT00979602|65803817|FG001|Overall Study|Migrated/moved from study area|6|||
23566376|NCT00979602|65803816|FG000|Overall Study|Others|3|||
23566377|NCT00979602|65803817|FG001|Overall Study|Others|3|||
23566378|NCT04651114|65803820|FG000|Overall Study|Withdrawal by Subject|8|||
23566379|NCT02424591|65803821|FG000|Overall Study|Protocol Violation|2|||
23566380|NCT02424591|65803822|FG001|Overall Study|Protocol Violation|3|||
23566381|NCT02118337|65803826|FG000|Overall Study|Other|1|||
23566382|NCT02118337|65803827|FG001|Overall Study|Other|0|||
23566383|NCT02118337|65803828|FG002|Overall Study|Other|0|||
23566384|NCT02118337|65803829|FG003|Overall Study|Other|0|||
23763524|NCT01789281|66511509|FG001|Overall Study|Disease progression|4|||
23763525|NCT01789281|66511508|FG000|Overall Study|Adverse Event|5|||
23763526|NCT01789281|66511509|FG001|Overall Study|Adverse Event|5|||
23763527|NCT01789281|66511508|FG000|Overall Study|Withdrawal by Subject|1|||
23763528|NCT01789281|66511509|FG001|Overall Study|Withdrawal by Subject|0|||
23763529|NCT01789281|66511508|FG000|Overall Study|Lost to Follow-up|1|||
23763530|NCT01789281|66511509|FG001|Overall Study|Lost to Follow-up|0|||
23763531|NCT01789281|66511508|FG000|Overall Study|Administrative problems|0|||
23763532|NCT01789281|66511509|FG001|Overall Study|Administrative problems|1|||
23763533|NCT02102490|66511513|FG000|Overall Study|Death|6|||
23763534|NCT02102490|66511513|FG000|Overall Study|Lost to Follow-up|1|||
23763535|NCT01223196|66511517|FG000|Overall Study|Lost to Follow-up|2|||
23763536|NCT01223196|66511518|FG001|Overall Study|Lost to Follow-up|0|||
23763537|NCT01223196|66511517|FG000|Overall Study|Physician Decision|1|||
23763538|NCT01223196|66511518|FG001|Overall Study|Physician Decision|0|||
23763539|NCT01223196|66511517|FG000|Overall Study|Withdrawal by Subject|1|||
23566385|NCT02118337|65803830|FG004|Overall Study|Other|2|||
23566386|NCT02118337|65803831|FG005|Overall Study|Other|3|||
23566387|NCT02118337|65803832|FG006|Overall Study|Other|1|||
23566388|NCT02118337|65803833|FG007|Overall Study|Other|28|||
23566389|NCT02118337|65803834|FG008|Overall Study|Other|15|||
23628432|NCT01236352|66024735|FG006|Overall Study|Disease progression|1|||
23763540|NCT01223196|66511518|FG001|Overall Study|Withdrawal by Subject|0|||
23763541|NCT03196791|66511519|FG000|Overall Study|Protocol Violation|7|||
23763542|NCT03196791|66511520|FG001|Overall Study|Protocol Violation|3|||
23763543|NCT03196791|66511519|FG000|Overall Study|Withdrawal by Subject|3|||
23763544|NCT03196791|66511520|FG001|Overall Study|Withdrawal by Subject|2|||
23763545|NCT00772577|66511521|FG000|Overall Study|Adverse Event|6|||
23763546|NCT00772577|66511522|FG001|Overall Study|Adverse Event|3|||
23763547|NCT00772577|66511521|FG000|Overall Study|Abnormal laboratory values|0|||
23763548|NCT00772577|66511522|FG001|Overall Study|Abnormal laboratory values|1|||
23763549|NCT00772577|66511521|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23828364|NCT00266630|66752327|FG000|Overall Study|Protocol Violation|1|||
23828365|NCT00266630|66752328|FG001|Overall Study|Protocol Violation|3|||
23566390|NCT02118337|65803826|FG000|Overall Study|Lost to Follow-up|0|||
23566391|NCT02118337|65803827|FG001|Overall Study|Lost to Follow-up|0|||
23566392|NCT02118337|65803828|FG002|Overall Study|Lost to Follow-up|0|||
23566393|NCT02118337|65803829|FG003|Overall Study|Lost to Follow-up|0|||
23828366|NCT00266630|66752327|FG000|Overall Study|Physician Decision|1|||
23566394|NCT02118337|65803830|FG004|Overall Study|Lost to Follow-up|0|||
23566395|NCT02118337|65803831|FG005|Overall Study|Lost to Follow-up|0|||
23566396|NCT02118337|65803832|FG006|Overall Study|Lost to Follow-up|0|||
23566397|NCT02118337|65803833|FG007|Overall Study|Lost to Follow-up|1|||
23763550|NCT00772577|66511522|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23763551|NCT00772577|66511521|FG000|Overall Study|Patient withdrew consent|8|||
23763552|NCT00772577|66511522|FG001|Overall Study|Patient withdrew consent|5|||
23763553|NCT00772577|66511521|FG000|Overall Study|Lost to Follow-up|4|||
23763554|NCT00772577|66511522|FG001|Overall Study|Lost to Follow-up|3|||
23763555|NCT00772577|66511521|FG000|Overall Study|Administrative problems|2|||
23763556|NCT00772577|66511522|FG001|Overall Study|Administrative problems|1|||
23763557|NCT00772577|66511521|FG000|Overall Study|Protocol Deviation|3|||
23763558|NCT00772577|66511522|FG001|Overall Study|Protocol Deviation|2|||
23763559|NCT02123459|66511523|FG000|Washout Period (1 Day)|Adverse Event|1|||
23763560|NCT02123459|66511524|FG001|Washout Period (1 Day)|Adverse Event|0|||
23763561|NCT01312779|66511530|FG000|Overall Study|Withdrawal by Subject|2|||
23763562|NCT01312779|66511530|FG000|Overall Study|Death|3|||
23763563|NCT01312779|66511530|FG000|Overall Study|Not Implanted with Device|27|||
23763564|NCT02789111|66511537|FG000|Overall Study|Withdrawal by Subject|1|||
23763565|NCT02789111|66511538|FG001|Overall Study|Withdrawal by Subject|4|||
23763566|NCT01154153|66511539|FG000|Overall Study|Poor compliance to protocol|2|||
23763567|NCT01154153|66511540|FG001|Overall Study|Poor compliance to protocol|0|||
23763568|NCT01154153|66511539|FG000|Overall Study|Unable to use labs|2|||
23763569|NCT01154153|66511540|FG001|Overall Study|Unable to use labs|3|||
23763570|NCT01154153|66511539|FG000|Overall Study|Withdrew consent|1|||
23763571|NCT01154153|66511540|FG001|Overall Study|Withdrew consent|0|||
23763572|NCT01381900|66511541|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
23763573|NCT01381900|66511542|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
23763574|NCT01381900|66511543|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
23763575|NCT01381900|66511541|FG000|Overall Study|Adverse Event|4|||
23763576|NCT01381900|66511542|FG001|Overall Study|Adverse Event|6|||
23763577|NCT01381900|66511543|FG002|Overall Study|Adverse Event|7|||
23763578|NCT01381900|66511541|FG000|Overall Study|Noncompliance with study drug|0|||
23763579|NCT01381900|66511542|FG001|Overall Study|Noncompliance with study drug|0|||
23763580|NCT01381900|66511543|FG002|Overall Study|Noncompliance with study drug|1|||
23763581|NCT01381900|66511541|FG000|Overall Study|Physician Decision|0|||
23763582|NCT01381900|66511542|FG001|Overall Study|Physician Decision|1|||
23763583|NCT01381900|66511543|FG002|Overall Study|Physician Decision|1|||
23763584|NCT01381900|66511541|FG000|Overall Study|Protocol Violation|0|||
23763585|NCT01381900|66511542|FG001|Overall Study|Protocol Violation|1|||
23628433|NCT01236352|66024736|FG007|Overall Study|Disease progression|3|||
23628434|NCT01236352|66024737|FG008|Overall Study|Disease progression|2|||
23763586|NCT01381900|66511543|FG002|Overall Study|Protocol Violation|1|||
23763587|NCT01381900|66511541|FG000|Overall Study|Withdrawal by Subject|0|||
23763588|NCT01381900|66511542|FG001|Overall Study|Withdrawal by Subject|0|||
23763589|NCT01381900|66511543|FG002|Overall Study|Withdrawal by Subject|1|||
23628435|NCT01236352|66024738|FG009|Overall Study|Disease progression|2|||
23628436|NCT01236352|66024739|FG010|Overall Study|Disease progression|2|||
23628437|NCT01236352|66024729|FG000|Overall Study|Poor/Non-compliance|1|||
23628438|NCT01236352|66024730|FG001|Overall Study|Poor/Non-compliance|0|||
23628439|NCT01236352|66024731|FG002|Overall Study|Poor/Non-compliance|0|||
23628440|NCT01236352|66024732|FG003|Overall Study|Poor/Non-compliance|0|||
23628441|NCT01236352|66024733|FG004|Overall Study|Poor/Non-compliance|0|||
23628442|NCT01236352|66024734|FG005|Overall Study|Poor/Non-compliance|0|||
23628443|NCT01236352|66024735|FG006|Overall Study|Poor/Non-compliance|0|||
23628444|NCT01236352|66024736|FG007|Overall Study|Poor/Non-compliance|0|||
23628445|NCT01236352|66024737|FG008|Overall Study|Poor/Non-compliance|0|||
23628446|NCT01236352|66024738|FG009|Overall Study|Poor/Non-compliance|0|||
23628447|NCT01236352|66024739|FG010|Overall Study|Poor/Non-compliance|0|||
23628448|NCT01236352|66024729|FG000|Overall Study|Maximum clinical benefit|1|||
23628449|NCT01236352|66024730|FG001|Overall Study|Maximum clinical benefit|1|||
23628450|NCT01236352|66024731|FG002|Overall Study|Maximum clinical benefit|1|||
23763590|NCT01381900|66511541|FG000|Overall Study|Early withdraw|3|||
23628451|NCT01236352|66024732|FG003|Overall Study|Maximum clinical benefit|0|||
23628452|NCT01236352|66024733|FG004|Overall Study|Maximum clinical benefit|2|||
23628453|NCT01236352|66024734|FG005|Overall Study|Maximum clinical benefit|0|||
23763591|NCT01381900|66511542|FG001|Overall Study|Early withdraw|1|||
23763592|NCT01381900|66511543|FG002|Overall Study|Early withdraw|1|||
23763593|NCT02257632|66511544|FG000|Overall Study|Withdrawal by Subject|0|||
23763594|NCT02257632|66511545|FG001|Overall Study|Withdrawal by Subject|1|||
23763595|NCT02257632|66511544|FG000|Overall Study|Adverse Event|1|||
23763596|NCT02257632|66511545|FG001|Overall Study|Adverse Event|2|||
23763597|NCT02472977|66511546|FG000|Overall Study|Disease progression|4|||
23628454|NCT01236352|66024735|FG006|Overall Study|Maximum clinical benefit|3|||
23763598|NCT02472977|66511547|FG001|Overall Study|Disease progression|25|||
23763599|NCT02472977|66511548|FG002|Overall Study|Disease progression|6|||
23763600|NCT02472977|66511546|FG000|Overall Study|Withdrawal by Subject|0|||
23628455|NCT01236352|66024736|FG007|Overall Study|Maximum clinical benefit|1|||
23763601|NCT02472977|66511547|FG001|Overall Study|Withdrawal by Subject|1|||
23763602|NCT02472977|66511548|FG002|Overall Study|Withdrawal by Subject|0|||
23628456|NCT01236352|66024737|FG008|Overall Study|Maximum clinical benefit|1|||
23763603|NCT02472977|66511546|FG000|Overall Study|Study drug toxicity|2|||
23628457|NCT01236352|66024738|FG009|Overall Study|Maximum clinical benefit|4|||
23763604|NCT02472977|66511547|FG001|Overall Study|Study drug toxicity|0|||
23763605|NCT02472977|66511548|FG002|Overall Study|Study drug toxicity|2|||
23763606|NCT02472977|66511546|FG000|Overall Study|Subject request to discontinue treatment|0|||
23763607|NCT02472977|66511547|FG001|Overall Study|Subject request to discontinue treatment|1|||
23763608|NCT02472977|66511548|FG002|Overall Study|Subject request to discontinue treatment|0|||
23763609|NCT01314703|66514377|FG000|Overall Study|screen failure and closed enrollment|8|||
23763610|NCT02168270|66514380|FG000|Overall Study|Lack of Efficacy|4|||
23763611|NCT02004847|66514381|FG000|Overall Study|Protocol Violation|1|||
23763612|NCT02004847|66514382|FG001|Overall Study|Protocol Violation|1|||
23763613|NCT02533999|66514383|FG000|Overall Study|Lost to Follow-up|3|||
23763614|NCT02533999|66514384|FG001|Overall Study|Lost to Follow-up|5|||
23763615|NCT02533999|66514383|FG000|Overall Study|Protocol Violation|3|||
23763616|NCT02533999|66514384|FG001|Overall Study|Protocol Violation|0|||
23763617|NCT02533999|66514383|FG000|Overall Study|Adverse Event|0|||
23763618|NCT02533999|66514384|FG001|Overall Study|Adverse Event|1|||
23828367|NCT00266630|66752328|FG001|Overall Study|Physician Decision|2|||
23828368|NCT00266630|66752327|FG000|Overall Study|Withdrawal by Subject|10|||
23828369|NCT00266630|66752328|FG001|Overall Study|Withdrawal by Subject|2|||
23828370|NCT00266630|66752327|FG000|Overall Study|Lost to Follow-up|1|||
23828371|NCT00266630|66752328|FG001|Overall Study|Lost to Follow-up|0|||
23828372|NCT00266630|66752327|FG000|Overall Study|Other|19|||
23828373|NCT00266630|66752328|FG001|Overall Study|Other|11|||
23828374|NCT04479787|66752330|FG000|Overall Study|Withdrawal by Subject|19|||
23443321|NCT01132313|65366367|FG000|Overall Study|Not treated|2|||
23443322|NCT01132313|65366368|FG001|Overall Study|Not treated|0|||
23443323|NCT01132313|65366369|FG002|Overall Study|Not treated|0|||
23443324|NCT01132313|65366370|FG003|Overall Study|Not treated|0|||
23828375|NCT04479787|66752331|FG001|Overall Study|Withdrawal by Subject|27|||
23828376|NCT04479787|66752330|FG000|Overall Study|Unsuccessful Trial|17|||
23828377|NCT04479787|66752331|FG001|Overall Study|Unsuccessful Trial|7|||
23828378|NCT04479787|66752330|FG000|Overall Study|Subject Participation Terminated By Investigator|14|||
23828379|NCT04479787|66752331|FG001|Overall Study|Subject Participation Terminated By Investigator|5|||
23828380|NCT04479787|66752330|FG000|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
23828381|NCT04479787|66752331|FG001|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
23828382|NCT04479787|66752330|FG000|Overall Study|Lost to Follow-up|3|||
23566398|NCT02118337|65803834|FG008|Overall Study|Lost to Follow-up|0|||
23566399|NCT02118337|65803826|FG000|Overall Study|Withdrawal by Subject|1|||
23566400|NCT02118337|65803827|FG001|Overall Study|Withdrawal by Subject|3|||
23566401|NCT02118337|65803828|FG002|Overall Study|Withdrawal by Subject|2|||
23566402|NCT02118337|65803829|FG003|Overall Study|Withdrawal by Subject|1|||
23566403|NCT02118337|65803830|FG004|Overall Study|Withdrawal by Subject|2|||
23566404|NCT02118337|65803831|FG005|Overall Study|Withdrawal by Subject|2|||
23763619|NCT02533999|66514383|FG000|Overall Study|Randomized but intervention not received|0|||
23763620|NCT02533999|66514384|FG001|Overall Study|Randomized but intervention not received|1|||
23763621|NCT00384033|66514386|FG000|Overall Study|Adverse Event|10|||
23763622|NCT00384033|66514387|FG001|Overall Study|Adverse Event|8|||
23763623|NCT00384033|66514388|FG002|Overall Study|Adverse Event|11|||
23828383|NCT04479787|66752331|FG001|Overall Study|Lost to Follow-up|3|||
23828384|NCT04479787|66752330|FG000|Overall Study|Death|4|||
23828385|NCT04479787|66752331|FG001|Overall Study|Death|0|||
23443325|NCT01132313|65366371|FG004|Overall Study|Not treated|2|||
23566405|NCT02118337|65803832|FG006|Overall Study|Withdrawal by Subject|1|||
23566406|NCT02118337|65803833|FG007|Overall Study|Withdrawal by Subject|4|||
23566407|NCT02118337|65803834|FG008|Overall Study|Withdrawal by Subject|2|||
23443326|NCT01132313|65366372|FG005|Overall Study|Not treated|1|||
23628458|NCT01236352|66024739|FG010|Overall Study|Maximum clinical benefit|2|||
23763624|NCT00384033|66514389|FG003|Overall Study|Adverse Event|20|||
23763625|NCT00384033|66514386|FG000|Overall Study|Failed to return|1|||
23763626|NCT00384033|66514387|FG001|Overall Study|Failed to return|3|||
23763627|NCT00384033|66514388|FG002|Overall Study|Failed to return|2|||
23828386|NCT04479787|66752330|FG000|Overall Study|Inclusion/Exclusion|2|||
23443327|NCT01132313|65366373|FG006|Overall Study|Not treated|3|||
23443328|NCT01132313|65366374|FG007|Overall Study|Not treated|0|||
23443329|NCT01132313|65366375|FG008|Overall Study|Not treated|0|||
23443330|NCT01132313|65366376|FG009|Overall Study|Not treated|0|||
23443331|NCT01132313|65366377|FG010|Overall Study|Not treated|0|||
23443332|NCT01132313|65366378|FG011|Overall Study|Not treated|0|||
23443333|NCT01132313|65366367|FG000|Overall Study|Adverse Event|0|||
23443334|NCT01132313|65366368|FG001|Overall Study|Adverse Event|0|||
23443335|NCT01132313|65366369|FG002|Overall Study|Adverse Event|4|||
23443336|NCT01132313|65366370|FG003|Overall Study|Adverse Event|10|||
23443337|NCT01132313|65366371|FG004|Overall Study|Adverse Event|19|||
23443338|NCT01132313|65366372|FG005|Overall Study|Adverse Event|6|||
23443339|NCT01132313|65366373|FG006|Overall Study|Adverse Event|5|||
23443340|NCT01132313|65366374|FG007|Overall Study|Adverse Event|3|||
23443341|NCT01132313|65366375|FG008|Overall Study|Adverse Event|7|||
23443342|NCT01132313|65366376|FG009|Overall Study|Adverse Event|2|||
23443343|NCT01132313|65366377|FG010|Overall Study|Adverse Event|0|||
23443344|NCT01132313|65366378|FG011|Overall Study|Adverse Event|0|||
23443345|NCT01132313|65366367|FG000|Overall Study|Protocol Violation|0|||
23443346|NCT01132313|65366368|FG001|Overall Study|Protocol Violation|0|||
23443347|NCT01132313|65366369|FG002|Overall Study|Protocol Violation|0|||
23443348|NCT01132313|65366370|FG003|Overall Study|Protocol Violation|1|||
23443349|NCT01132313|65366371|FG004|Overall Study|Protocol Violation|0|||
23443350|NCT01132313|65366372|FG005|Overall Study|Protocol Violation|0|||
23443351|NCT01132313|65366373|FG006|Overall Study|Protocol Violation|0|||
23443352|NCT01132313|65366374|FG007|Overall Study|Protocol Violation|0|||
23443353|NCT01132313|65366375|FG008|Overall Study|Protocol Violation|0|||
23828387|NCT04479787|66752331|FG001|Overall Study|Inclusion/Exclusion|1|||
23828388|NCT04479787|66752330|FG000|Overall Study|Subject Became Pregnant|1|||
23443354|NCT01132313|65366376|FG009|Overall Study|Protocol Violation|0|||
23443355|NCT01132313|65366377|FG010|Overall Study|Protocol Violation|0|||
23443356|NCT01132313|65366378|FG011|Overall Study|Protocol Violation|0|||
23443357|NCT01132313|65366367|FG000|Overall Study|Lost to Follow-up|0|||
23443358|NCT01132313|65366368|FG001|Overall Study|Lost to Follow-up|0|||
23443359|NCT01132313|65366369|FG002|Overall Study|Lost to Follow-up|1|||
23443360|NCT01132313|65366370|FG003|Overall Study|Lost to Follow-up|0|||
23443361|NCT01132313|65366371|FG004|Overall Study|Lost to Follow-up|0|||
23443362|NCT01132313|65366372|FG005|Overall Study|Lost to Follow-up|0|||
23443363|NCT01132313|65366373|FG006|Overall Study|Lost to Follow-up|0|||
23443364|NCT01132313|65366374|FG007|Overall Study|Lost to Follow-up|1|||
23566408|NCT02118337|65803826|FG000|Overall Study|Death|2|||
23566409|NCT02118337|65803827|FG001|Overall Study|Death|2|||
23566410|NCT02118337|65803828|FG002|Overall Study|Death|1|||
23763628|NCT00384033|66514389|FG003|Overall Study|Failed to return|2|||
23763629|NCT00384033|66514386|FG000|Overall Study|Physician Decision|1|||
23763630|NCT00384033|66514387|FG001|Overall Study|Physician Decision|0|||
23763631|NCT00384033|66514388|FG002|Overall Study|Physician Decision|0|||
23763632|NCT00384033|66514389|FG003|Overall Study|Physician Decision|0|||
23763633|NCT00384033|66514386|FG000|Overall Study|Lost to Follow-up|6|||
23763634|NCT00384033|66514387|FG001|Overall Study|Lost to Follow-up|12|||
23763635|NCT00384033|66514388|FG002|Overall Study|Lost to Follow-up|7|||
23763636|NCT00384033|66514389|FG003|Overall Study|Lost to Follow-up|7|||
23763637|NCT00384033|66514386|FG000|Overall Study|Other|2|||
23763638|NCT00384033|66514387|FG001|Overall Study|Other|0|||
23828389|NCT04479787|66752331|FG001|Overall Study|Subject Became Pregnant|1|||
23443365|NCT01132313|65366375|FG008|Overall Study|Lost to Follow-up|0|||
23763639|NCT00384033|66514388|FG002|Overall Study|Other|0|||
23763640|NCT00384033|66514389|FG003|Overall Study|Other|0|||
23763641|NCT00384033|66514386|FG000|Overall Study|Protocol Violation|5|||
23763642|NCT00384033|66514387|FG001|Overall Study|Protocol Violation|0|||
23763643|NCT00384033|66514388|FG002|Overall Study|Protocol Violation|5|||
23763644|NCT00384033|66514389|FG003|Overall Study|Protocol Violation|6|||
23763645|NCT00384033|66514386|FG000|Overall Study|Withdrawal by Subject|6|||
23763646|NCT00384033|66514387|FG001|Overall Study|Withdrawal by Subject|2|||
23828390|NCT04479787|66752330|FG000|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
23443366|NCT01132313|65366376|FG009|Overall Study|Lost to Follow-up|0|||
23443367|NCT01132313|65366377|FG010|Overall Study|Lost to Follow-up|0|||
23443368|NCT01132313|65366378|FG011|Overall Study|Lost to Follow-up|0|||
23443369|NCT01132313|65366367|FG000|Overall Study|Withdrawal by Subject|0|||
23443370|NCT01132313|65366368|FG001|Overall Study|Withdrawal by Subject|0|||
23443371|NCT01132313|65366369|FG002|Overall Study|Withdrawal by Subject|3|||
23443372|NCT01132313|65366370|FG003|Overall Study|Withdrawal by Subject|3|||
23566411|NCT02118337|65803829|FG003|Overall Study|Death|2|||
23763647|NCT00384033|66514388|FG002|Overall Study|Withdrawal by Subject|5|||
23443373|NCT01132313|65366371|FG004|Overall Study|Withdrawal by Subject|6|||
23443374|NCT01132313|65366372|FG005|Overall Study|Withdrawal by Subject|0|||
23443375|NCT01132313|65366373|FG006|Overall Study|Withdrawal by Subject|1|||
23443376|NCT01132313|65366374|FG007|Overall Study|Withdrawal by Subject|0|||
23566412|NCT02118337|65803830|FG004|Overall Study|Death|5|||
23763648|NCT00384033|66514389|FG003|Overall Study|Withdrawal by Subject|2|||
23443377|NCT01132313|65366375|FG008|Overall Study|Withdrawal by Subject|0|||
23443378|NCT01132313|65366376|FG009|Overall Study|Withdrawal by Subject|2|||
23443379|NCT01132313|65366377|FG010|Overall Study|Withdrawal by Subject|0|||
23443380|NCT01132313|65366378|FG011|Overall Study|Withdrawal by Subject|0|||
23443381|NCT01132313|65366367|FG000|Overall Study|Lack of antiviral response|0|||
23443382|NCT01132313|65366368|FG001|Overall Study|Lack of antiviral response|0|||
23443383|NCT01132313|65366369|FG002|Overall Study|Lack of antiviral response|12|||
23443384|NCT01132313|65366370|FG003|Overall Study|Lack of antiviral response|18|||
23443385|NCT01132313|65366371|FG004|Overall Study|Lack of antiviral response|18|||
23443386|NCT01132313|65366372|FG005|Overall Study|Lack of antiviral response|18|||
23443387|NCT01132313|65366373|FG006|Overall Study|Lack of antiviral response|21|||
23443388|NCT01132313|65366374|FG007|Overall Study|Lack of antiviral response|0|||
23443389|NCT01132313|65366375|FG008|Overall Study|Lack of antiviral response|0|||
23443390|NCT01132313|65366376|FG009|Overall Study|Lack of antiviral response|0|||
23443391|NCT01132313|65366377|FG010|Overall Study|Lack of antiviral response|1|||
23443392|NCT01132313|65366378|FG011|Overall Study|Lack of antiviral response|0|||
23443393|NCT01132313|65366367|FG000|Overall Study|Other reason not defined above|0|||
23443394|NCT01132313|65366368|FG001|Overall Study|Other reason not defined above|0|||
23763649|NCT00384033|66514386|FG000|Overall Study|Lack of Efficacy|7|||
23443395|NCT01132313|65366369|FG002|Overall Study|Other reason not defined above|0|||
23443396|NCT01132313|65366370|FG003|Overall Study|Other reason not defined above|0|||
23443397|NCT01132313|65366371|FG004|Overall Study|Other reason not defined above|0|||
23443398|NCT01132313|65366372|FG005|Overall Study|Other reason not defined above|0|||
23443399|NCT01132313|65366373|FG006|Overall Study|Other reason not defined above|0|||
23763650|NCT00384033|66514387|FG001|Overall Study|Lack of Efficacy|3|||
23763651|NCT00384033|66514388|FG002|Overall Study|Lack of Efficacy|3|||
23763652|NCT00384033|66514389|FG003|Overall Study|Lack of Efficacy|1|||
23763653|NCT00384033|66514386|FG000|Overall Study|Randomized but not treated|3|||
23763654|NCT00384033|66514387|FG001|Overall Study|Randomized but not treated|7|||
23763655|NCT00384033|66514388|FG002|Overall Study|Randomized but not treated|10|||
23763656|NCT00384033|66514389|FG003|Overall Study|Randomized but not treated|2|||
23763657|NCT01141283|66514390|FG000|Overall Study|Adverse Event|56|||
23763658|NCT01141283|66514390|FG000|Overall Study|Lost to Follow-up|4|||
23763659|NCT01141283|66514390|FG000|Overall Study|Withdrawal by Subject|14|||
23763660|NCT01141283|66514390|FG000|Overall Study|Administrative|4|||
23763661|NCT01141283|66514390|FG000|Overall Study|Lack of Efficacy|10|||
23763662|NCT03731182|66514391|FG000|Overall Study|Lost to Follow-up|2|||
23443400|NCT01132313|65366374|FG007|Overall Study|Other reason not defined above|1|||
23443401|NCT01132313|65366375|FG008|Overall Study|Other reason not defined above|0|||
23443402|NCT01132313|65366376|FG009|Overall Study|Other reason not defined above|0|||
23443403|NCT01132313|65366377|FG010|Overall Study|Other reason not defined above|0|||
23443404|NCT01132313|65366378|FG011|Overall Study|Other reason not defined above|0|||
23763663|NCT03731182|66514392|FG001|Overall Study|Lost to Follow-up|0|||
23763664|NCT03731182|66514391|FG000|Overall Study|Physician Decision|1|||
23763665|NCT03731182|66514392|FG001|Overall Study|Physician Decision|0|||
23763666|NCT03731182|66514391|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
23443405|NCT00548145|65366383|FG000|Overall Study|Death|0|||
23443406|NCT00548145|65366384|FG001|Overall Study|Death|1|||
23443407|NCT00548145|65366383|FG000|Overall Study|Withdrawal by Subject|0|||
23443408|NCT00548145|65366384|FG001|Overall Study|Withdrawal by Subject|2|||
23443409|NCT00548145|65366383|FG000|Overall Study|Physician Decision|1|||
23443410|NCT00548145|65366384|FG001|Overall Study|Physician Decision|1|||
23443411|NCT03155724|65366389|FG000|Overall Study|Death|3|||
23443412|NCT03155724|65366389|FG000|Overall Study|Physician Decision|1|||
23443413|NCT03155724|65366389|FG000|Overall Study|Study closure|7|||
23443414|NCT00546000|65366390|FG000|Overall Study|Adverse Event|1|||
23443415|NCT00546000|65366390|FG000|Overall Study|Lost to Follow-up|1|||
23443416|NCT00546000|65366390|FG000|Overall Study|Baseline HPA Axis Supression|2|||
23443417|NCT02475278|65366391|FG000|Overall Study|Lost to Follow-up|1|||
23443418|NCT02475278|65366391|FG000|Overall Study|Reason Not Specified|1|||
23443419|NCT05258149|65366392|FG000|Period 1|Protocol Deviation|1|||
23443420|NCT05258149|65366393|FG001|Period 1|Protocol Deviation|0|||
23443421|NCT05258149|65366392|FG000|Period 1|Adverse Event|0|||
23443422|NCT05258149|65366393|FG001|Period 1|Adverse Event|1|||
23443423|NCT05258149|65366392|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
23443424|NCT05258149|65366393|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
23443425|NCT05258149|65366392|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23443426|NCT05258149|65366393|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23763667|NCT03731182|66514392|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23763668|NCT03031899|66514393|FG000|Overall Study|Protocol Violation|1|||
23763669|NCT03031899|66514393|FG000|Overall Study|lesion disappeared after stopping habit|1|||
23763670|NCT01238822|66514394|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
23763671|NCT00576199|66514395|FG000|Overall Study|Adverse Event|12|||
23763672|NCT00576199|66514395|FG000|Overall Study|Insufficient Therapeutic Response|14|||
23763673|NCT00576199|66514395|FG000|Overall Study|Refused Treatment|2|||
23763674|NCT00576199|66514395|FG000|Overall Study|Reason Unspecified|2|||
23443427|NCT05258149|65366392|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
23443428|NCT05258149|65366393|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
23443429|NCT00584415|65366396|FG000|Overall Study|Adverse Event|7|||
23443430|NCT02698826|65366400|FG000|Overall Study|Death|13|||
23443431|NCT02698826|65366400|FG000|Overall Study|Adverse Event|1|||
23443432|NCT01919801|65366402|FG000|Overall Study|Withdrawal by Subject|1|||
23443433|NCT01919801|65366403|FG001|Overall Study|Withdrawal by Subject|0|||
23443434|NCT01919801|65366402|FG000|Overall Study|Physician Decision|0|||
23443435|NCT01919801|65366403|FG001|Overall Study|Physician Decision|1|||
23443436|NCT01919801|65366402|FG000|Overall Study|Lost to Follow-up|0|||
23443437|NCT01919801|65366403|FG001|Overall Study|Lost to Follow-up|1|||
23443438|NCT01919801|65366402|FG000|Overall Study|Other|0|||
23443439|NCT01919801|65366403|FG001|Overall Study|Other|1|||
23443440|NCT00649428|65366404|FG000|Overall Study|Adverse Event|2|||
23443441|NCT00649428|65366405|FG001|Overall Study|Adverse Event|2|||
23443442|NCT00649428|65366404|FG000|Overall Study|Withdrawal by Subject|6|||
23443443|NCT00649428|65366405|FG001|Overall Study|Withdrawal by Subject|6|||
23566413|NCT02118337|65803831|FG005|Overall Study|Death|1|||
23566414|NCT02118337|65803832|FG006|Overall Study|Death|2|||
23566415|NCT02118337|65803833|FG007|Overall Study|Death|9|||
23566416|NCT02118337|65803834|FG008|Overall Study|Death|4|||
23566417|NCT01032044|65803842|FG000|Overall Study|Protocol Violation|14|||
23566418|NCT01032044|65803843|FG001|Overall Study|Protocol Violation|8|||
23566419|NCT01032044|65803842|FG000|Overall Study|Adverse Event|0|||
23566420|NCT01032044|65803843|FG001|Overall Study|Adverse Event|1|||
23566421|NCT01032044|65803842|FG000|Overall Study|Lost to Follow-up|11|||
23566422|NCT01032044|65803843|FG001|Overall Study|Lost to Follow-up|11|||
23566423|NCT02392611|65803844|FG000|Overall Study|Adverse Event|0|||
23566424|NCT02392611|65803845|FG001|Overall Study|Adverse Event|0|||
23566425|NCT02392611|65803846|FG002|Overall Study|Adverse Event|0|||
23566426|NCT02392611|65803847|FG003|Overall Study|Adverse Event|1|||
23566427|NCT02392611|65803848|FG004|Overall Study|Adverse Event|0|||
23566428|NCT02392611|65803849|FG005|Overall Study|Adverse Event|0|||
23566429|NCT02392611|65803850|FG006|Overall Study|Adverse Event|0|||
23566430|NCT02392611|65803851|FG007|Overall Study|Adverse Event|0|||
23566431|NCT02392611|65803852|FG008|Overall Study|Adverse Event|0|||
23566432|NCT02392611|65803844|FG000|Overall Study|Progressive disease|0|||
23566433|NCT02392611|65803845|FG001|Overall Study|Progressive disease|0|||
23566434|NCT02392611|65803846|FG002|Overall Study|Progressive disease|0|||
23763675|NCT02884206|66514397|FG000|Valsartan Run-in Period|Death|1|||
23566435|NCT02392611|65803847|FG003|Overall Study|Progressive disease|2|||
23566436|NCT02392611|65803848|FG004|Overall Study|Progressive disease|1|||
23566437|NCT02392611|65803849|FG005|Overall Study|Progressive disease|0|||
23443444|NCT00649428|65366404|FG000|Overall Study|Lost to Follow-up|1|||
23443445|NCT00649428|65366405|FG001|Overall Study|Lost to Follow-up|3|||
23566438|NCT02392611|65803850|FG006|Overall Study|Progressive disease|0|||
23566439|NCT02392611|65803851|FG007|Overall Study|Progressive disease|0|||
23566440|NCT02392611|65803852|FG008|Overall Study|Progressive disease|0|||
23443446|NCT00649428|65366404|FG000|Overall Study|Insufficient manufacturing yield|5|||
23443447|NCT00649428|65366405|FG001|Overall Study|Insufficient manufacturing yield|1|||
23443448|NCT00649428|65366404|FG000|Overall Study|Protocol Violation|6|||
23628459|NCT01236352|66024729|FG000|Overall Study|Subject request to discontinue treatment|0|||
23628460|NCT01236352|66024730|FG001|Overall Study|Subject request to discontinue treatment|0|||
23443449|NCT00649428|65366405|FG001|Overall Study|Protocol Violation|2|||
23443450|NCT00649428|65366404|FG000|Overall Study|Physician Decision|0|||
23443451|NCT00649428|65366405|FG001|Overall Study|Physician Decision|1|||
23566441|NCT02392611|65803844|FG000|Overall Study|Death|1|||
23566442|NCT02392611|65803845|FG001|Overall Study|Death|0|||
23566443|NCT02392611|65803846|FG002|Overall Study|Death|0|||
23566444|NCT02392611|65803847|FG003|Overall Study|Death|0|||
23566445|NCT02392611|65803848|FG004|Overall Study|Death|0|||
23566446|NCT02392611|65803849|FG005|Overall Study|Death|1|||
23566447|NCT02392611|65803850|FG006|Overall Study|Death|0|||
23566448|NCT02392611|65803851|FG007|Overall Study|Death|0|||
23566449|NCT02392611|65803852|FG008|Overall Study|Death|0|||
23566450|NCT02392611|65803844|FG000|Overall Study|Withdrawal by Subject|0|||
23566451|NCT02392611|65803845|FG001|Overall Study|Withdrawal by Subject|0|||
23566452|NCT02392611|65803846|FG002|Overall Study|Withdrawal by Subject|0|||
23566453|NCT02392611|65803847|FG003|Overall Study|Withdrawal by Subject|1|||
23566454|NCT02392611|65803848|FG004|Overall Study|Withdrawal by Subject|0|||
23566455|NCT02392611|65803849|FG005|Overall Study|Withdrawal by Subject|0|||
23566456|NCT02392611|65803850|FG006|Overall Study|Withdrawal by Subject|0|||
23566457|NCT02392611|65803851|FG007|Overall Study|Withdrawal by Subject|0|||
23566458|NCT02392611|65803852|FG008|Overall Study|Withdrawal by Subject|0|||
23566459|NCT02392611|65803844|FG000|Overall Study|Lost to Follow-up|0|||
23566460|NCT02392611|65803845|FG001|Overall Study|Lost to Follow-up|0|||
23566461|NCT02392611|65803846|FG002|Overall Study|Lost to Follow-up|0|||
23566462|NCT02392611|65803847|FG003|Overall Study|Lost to Follow-up|0|||
23566463|NCT02392611|65803848|FG004|Overall Study|Lost to Follow-up|0|||
23566464|NCT02392611|65803849|FG005|Overall Study|Lost to Follow-up|0|||
23566465|NCT02392611|65803850|FG006|Overall Study|Lost to Follow-up|1|||
23566466|NCT02392611|65803851|FG007|Overall Study|Lost to Follow-up|0|||
23566467|NCT02392611|65803852|FG008|Overall Study|Lost to Follow-up|0|||
23566468|NCT02392611|65803844|FG000|Overall Study|Enrolled, not treated|0|||
23566469|NCT02392611|65803845|FG001|Overall Study|Enrolled, not treated|0|||
23566470|NCT02392611|65803846|FG002|Overall Study|Enrolled, not treated|0|||
23566471|NCT02392611|65803847|FG003|Overall Study|Enrolled, not treated|2|||
23566472|NCT02392611|65803848|FG004|Overall Study|Enrolled, not treated|0|||
23566473|NCT02392611|65803849|FG005|Overall Study|Enrolled, not treated|0|||
23566474|NCT02392611|65803850|FG006|Overall Study|Enrolled, not treated|0|||
23566475|NCT02392611|65803851|FG007|Overall Study|Enrolled, not treated|0|||
23566476|NCT02392611|65803852|FG008|Overall Study|Enrolled, not treated|0|||
23566477|NCT00482274|65803858|FG000|Overall Study|Adverse Event|1|||
23566478|NCT02247804|65803859|FG000|Treatment Period 1|Adverse Event|9|||
23566479|NCT02247804|65803860|FG001|Treatment Period 1|Adverse Event|2|||
23566480|NCT02247804|65803861|FG002|Treatment Period 1|Adverse Event|0|||
23566481|NCT02247804|65803859|FG000|Treatment Period 1|Lack of Efficacy|0|||
23566482|NCT02247804|65803860|FG001|Treatment Period 1|Lack of Efficacy|0|||
23566483|NCT02247804|65803861|FG002|Treatment Period 1|Lack of Efficacy|2|||
23566484|NCT02247804|65803859|FG000|Treatment Period 1|Lost to Follow-up|1|||
23566485|NCT02247804|65803860|FG001|Treatment Period 1|Lost to Follow-up|0|||
23566486|NCT02247804|65803861|FG002|Treatment Period 1|Lost to Follow-up|2|||
23566487|NCT02247804|65803859|FG000|Treatment Period 1|Personal Reasons|7|||
23566488|NCT02247804|65803860|FG001|Treatment Period 1|Personal Reasons|1|||
23566489|NCT02247804|65803861|FG002|Treatment Period 1|Personal Reasons|2|||
23566490|NCT02247804|65803859|FG000|Treatment Period 1|Protocol Deviation|0|||
23566491|NCT02247804|65803860|FG001|Treatment Period 1|Protocol Deviation|0|||
23566492|NCT02247804|65803861|FG002|Treatment Period 1|Protocol Deviation|1|||
23566493|NCT02247804|65803859|FG000|Treatment Period 1|Randomized but not Treated|5|||
23566494|NCT02247804|65803860|FG001|Treatment Period 1|Randomized but not Treated|1|||
23566495|NCT02247804|65803861|FG002|Treatment Period 1|Randomized but not Treated|1|||
23566496|NCT02247804|65803859|FG000|Treatment Period 2|Adverse Event|6|||
23763676|NCT02884206|66514398|FG001|Valsartan Run-in Period|Death|0|||
23763677|NCT02884206|66514399|FG002|Valsartan Run-in Period|Death|0|||
23763678|NCT02884206|66514397|FG000|Valsartan Run-in Period|Adverse Event|31|||
23763679|NCT02884206|66514398|FG001|Valsartan Run-in Period|Adverse Event|0|||
23763680|NCT02884206|66514399|FG002|Valsartan Run-in Period|Adverse Event|0|||
23763681|NCT02884206|66514397|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
23763682|NCT02884206|66514398|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
23763683|NCT02884206|66514399|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
23763684|NCT02884206|66514397|FG000|Valsartan Run-in Period|Protocol deviation|4|||
23763685|NCT02884206|66514398|FG001|Valsartan Run-in Period|Protocol deviation|0|||
23443452|NCT02352753|65366406|FG000|6-Month Dosing Period|Decision by sponsor|2|||
23566497|NCT02247804|65803860|FG001|Treatment Period 2|Adverse Event|3|||
23566498|NCT02247804|65803861|FG002|Treatment Period 2|Adverse Event|3|||
23566499|NCT02247804|65803859|FG000|Treatment Period 2|Lack of Efficacy|0|||
23566500|NCT02247804|65803860|FG001|Treatment Period 2|Lack of Efficacy|0|||
23566501|NCT02247804|65803861|FG002|Treatment Period 2|Lack of Efficacy|1|||
23566502|NCT02247804|65803859|FG000|Treatment Period 2|Lost to Follow-up|0|||
23566503|NCT02247804|65803860|FG001|Treatment Period 2|Lost to Follow-up|1|||
23566504|NCT02247804|65803861|FG002|Treatment Period 2|Lost to Follow-up|1|||
23566505|NCT02247804|65803859|FG000|Treatment Period 2|Personal Reasons|2|||
23566506|NCT02247804|65803860|FG001|Treatment Period 2|Personal Reasons|1|||
23566507|NCT02247804|65803861|FG002|Treatment Period 2|Personal Reasons|1|||
23566508|NCT02247804|65803859|FG000|Treatment Period 2|Reason not Specified|0|||
23566509|NCT02247804|65803860|FG001|Treatment Period 2|Reason not Specified|0|||
23566510|NCT02247804|65803861|FG002|Treatment Period 2|Reason not Specified|2|||
23566511|NCT02247804|65803859|FG000|Treatment Period 3|Adverse Event|4|||
23566512|NCT02247804|65803860|FG001|Treatment Period 3|Adverse Event|3|||
23763686|NCT02884206|66514399|FG002|Valsartan Run-in Period|Protocol deviation|0|||
23566513|NCT02247804|65803861|FG002|Treatment Period 3|Adverse Event|3|||
23566514|NCT02247804|65803859|FG000|Treatment Period 3|Lack of Efficacy|0|||
23566515|NCT02247804|65803860|FG001|Treatment Period 3|Lack of Efficacy|1|||
23566516|NCT02247804|65803861|FG002|Treatment Period 3|Lack of Efficacy|0|||
23763687|NCT02884206|66514397|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
23763688|NCT02884206|66514398|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
23763689|NCT02884206|66514399|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
23763690|NCT02884206|66514397|FG000|Valsartan Run-in Period|Physician Decision|1|||
23763691|NCT02884206|66514398|FG001|Valsartan Run-in Period|Physician Decision|0|||
23763692|NCT02884206|66514399|FG002|Valsartan Run-in Period|Physician Decision|0|||
23443453|NCT02352753|65366406|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
23443454|NCT02352753|65366406|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
23763693|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Adverse Event|38|||
23763694|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Adverse Event|0|||
23763695|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Adverse Event|0|||
23763696|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Death|2|||
23828391|NCT04479787|66752331|FG001|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
23828392|NCT04479787|66752330|FG000|Overall Study|Patient's Health Significantly Declined|0|||
23828393|NCT04479787|66752331|FG001|Overall Study|Patient's Health Significantly Declined|1|||
23828394|NCT04479787|66752330|FG000|Overall Study|Subject Had Back Surgery On March 1st|0|||
23828395|NCT04479787|66752331|FG001|Overall Study|Subject Had Back Surgery On March 1st|1|||
23828396|NCT04479787|66752330|FG000|Overall Study|Withdrawn At Sponsor's Request|1|||
23828397|NCT04479787|66752331|FG001|Overall Study|Withdrawn At Sponsor's Request|0|||
23828398|NCT04479787|66752330|FG000|Overall Study|Subject Failed To Comply With The Protocol Requirements|1|||
23828399|NCT04479787|66752331|FG001|Overall Study|Subject Failed To Comply With The Protocol Requirements|0|||
23828400|NCT02969382|66752335|FG000|Overall Study|Adverse Event|8|||
23828401|NCT02969382|66752336|FG001|Overall Study|Adverse Event|10|||
23828402|NCT02969382|66752335|FG000|Overall Study|Lack of Efficacy|4|||
23828403|NCT02969382|66752336|FG001|Overall Study|Lack of Efficacy|5|||
23828404|NCT02969382|66752335|FG000|Overall Study|Death|0|||
23828405|NCT02969382|66752336|FG001|Overall Study|Death|1|||
23828406|NCT02969382|66752335|FG000|Overall Study|PROTOCOL DEVIATION|0|||
23828407|NCT02969382|66752336|FG001|Overall Study|PROTOCOL DEVIATION|1|||
23566517|NCT02247804|65803859|FG000|Treatment Period 3|Lost to Follow-up|1|||
23566518|NCT02247804|65803860|FG001|Treatment Period 3|Lost to Follow-up|2|||
23566519|NCT02247804|65803861|FG002|Treatment Period 3|Lost to Follow-up|2|||
23566520|NCT02247804|65803859|FG000|Treatment Period 3|Personal Reasons|4|||
23566521|NCT02247804|65803860|FG001|Treatment Period 3|Personal Reasons|3|||
23763697|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Death|0|||
23763698|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Death|0|||
23763699|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
23763700|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
23763701|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
23763702|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
23763703|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
23828408|NCT02969382|66752335|FG000|Overall Study|Withdrawal by Subject|14|||
23828409|NCT02969382|66752336|FG001|Overall Study|Withdrawal by Subject|9|||
23566522|NCT02247804|65803861|FG002|Treatment Period 3|Personal Reasons|2|||
23566523|NCT02247804|65803859|FG000|Treatment Period 3|Reason not Specified|2|||
23828410|NCT02235454|66752337|FG000|Overall Study|Withdrawal by Subject|2|||
23828411|NCT00765102|66752342|FG000|Overall Study|Progressive disease|18|||
23828412|NCT00765102|66752342|FG000|Overall Study|Adverse Event|6|||
23828413|NCT00765102|66752342|FG000|Overall Study|Physician Decision|4|||
23828414|NCT00765102|66752342|FG000|Overall Study|Withdrawal by Subject|2|||
23828415|NCT00765102|66752342|FG000|Overall Study|Protocol Violation|1|||
23828416|NCT00668317|66752354|FG000|Overall Study|Adverse Event|2|||
23828417|NCT01342081|66752355|FG000|Overall Study|Did not receive allocated intervention|0|||
23828418|NCT01342081|66752356|FG001|Overall Study|Did not receive allocated intervention|0|||
23828419|NCT01342081|66752357|FG002|Overall Study|Did not receive allocated intervention|1|||
23828420|NCT01342081|66752355|FG000|Overall Study|Adverse Event|1|||
23828421|NCT01342081|66752356|FG001|Overall Study|Adverse Event|0|||
23828422|NCT01342081|66752357|FG002|Overall Study|Adverse Event|0|||
23628461|NCT01236352|66024731|FG002|Overall Study|Subject request to discontinue treatment|1|||
23628462|NCT01236352|66024732|FG003|Overall Study|Subject request to discontinue treatment|1|||
23628463|NCT01236352|66024733|FG004|Overall Study|Subject request to discontinue treatment|0|||
23628464|NCT01236352|66024734|FG005|Overall Study|Subject request to discontinue treatment|1|||
23628465|NCT01236352|66024735|FG006|Overall Study|Subject request to discontinue treatment|0|||
23628466|NCT01236352|66024736|FG007|Overall Study|Subject request to discontinue treatment|0|||
23628467|NCT01236352|66024737|FG008|Overall Study|Subject request to discontinue treatment|0|||
23628468|NCT01236352|66024738|FG009|Overall Study|Subject request to discontinue treatment|1|||
23628469|NCT01236352|66024739|FG010|Overall Study|Subject request to discontinue treatment|4|||
23628470|NCT01236352|66024729|FG000|Overall Study|Subject to receive drug via EAP|1|||
23628471|NCT01236352|66024730|FG001|Overall Study|Subject to receive drug via EAP|1|||
23628472|NCT01236352|66024731|FG002|Overall Study|Subject to receive drug via EAP|1|||
23628473|NCT01236352|66024732|FG003|Overall Study|Subject to receive drug via EAP|0|||
23628474|NCT01236352|66024733|FG004|Overall Study|Subject to receive drug via EAP|0|||
23628475|NCT01236352|66024734|FG005|Overall Study|Subject to receive drug via EAP|0|||
23628476|NCT01236352|66024735|FG006|Overall Study|Subject to receive drug via EAP|0|||
23628477|NCT01236352|66024736|FG007|Overall Study|Subject to receive drug via EAP|2|||
23628478|NCT01236352|66024737|FG008|Overall Study|Subject to receive drug via EAP|0|||
23628479|NCT01236352|66024738|FG009|Overall Study|Subject to receive drug via EAP|4|||
23628480|NCT01236352|66024739|FG010|Overall Study|Subject to receive drug via EAP|0|||
23628481|NCT01236352|66024729|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
23628482|NCT01236352|66024730|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
23628483|NCT01236352|66024731|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
23628484|NCT01236352|66024732|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
23628485|NCT01236352|66024733|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
23628486|NCT01236352|66024734|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
23628487|NCT01236352|66024735|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
23628488|NCT01236352|66024736|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
23628489|NCT01236352|66024737|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
23628490|NCT01236352|66024738|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
23628491|NCT01236352|66024739|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
23628492|NCT01236352|66024729|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628493|NCT01236352|66024730|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628494|NCT01236352|66024731|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628495|NCT01236352|66024732|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628496|NCT01236352|66024733|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628497|NCT01236352|66024734|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628498|NCT01236352|66024735|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628499|NCT01236352|66024736|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628500|NCT01236352|66024737|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628501|NCT01236352|66024738|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628502|NCT01236352|66024739|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
23628503|NCT01236352|66024729|FG000|Overall Study|Lack of response to drug|0|||
23628504|NCT01236352|66024730|FG001|Overall Study|Lack of response to drug|0|||
23628505|NCT01236352|66024731|FG002|Overall Study|Lack of response to drug|0|||
23628506|NCT01236352|66024732|FG003|Overall Study|Lack of response to drug|0|||
23628507|NCT01236352|66024733|FG004|Overall Study|Lack of response to drug|0|||
23628508|NCT01236352|66024734|FG005|Overall Study|Lack of response to drug|0|||
23628509|NCT01236352|66024735|FG006|Overall Study|Lack of response to drug|0|||
23628510|NCT01236352|66024736|FG007|Overall Study|Lack of response to drug|0|||
23628511|NCT01236352|66024737|FG008|Overall Study|Lack of response to drug|0|||
23628512|NCT01236352|66024738|FG009|Overall Study|Lack of response to drug|1|||
23628513|NCT01236352|66024739|FG010|Overall Study|Lack of response to drug|1|||
23628514|NCT01236352|66024729|FG000|Overall Study|Patient transferred to IST|0|||
23628515|NCT01236352|66024730|FG001|Overall Study|Patient transferred to IST|0|||
23628516|NCT01236352|66024731|FG002|Overall Study|Patient transferred to IST|0|||
23628517|NCT01236352|66024732|FG003|Overall Study|Patient transferred to IST|0|||
23628518|NCT01236352|66024733|FG004|Overall Study|Patient transferred to IST|0|||
23628519|NCT01236352|66024734|FG005|Overall Study|Patient transferred to IST|0|||
23628520|NCT01236352|66024735|FG006|Overall Study|Patient transferred to IST|0|||
23628521|NCT01236352|66024736|FG007|Overall Study|Patient transferred to IST|0|||
23628522|NCT01236352|66024737|FG008|Overall Study|Patient transferred to IST|0|||
23628523|NCT01236352|66024738|FG009|Overall Study|Patient transferred to IST|2|||
23628524|NCT01236352|66024739|FG010|Overall Study|Patient transferred to IST|6|||
23628525|NCT02581059|66024740|FG000|Study Treatment|Disease Progression|1|||
23628526|NCT02581059|66024741|FG001|Study Treatment|Disease Progression|1|||
23628527|NCT02581059|66024740|FG000|Study Treatment|Adverse Event|2|||
23628528|NCT02581059|66024741|FG001|Study Treatment|Adverse Event|1|||
23628529|NCT02581059|66024740|FG000|Study Treatment|Death|1|||
23628530|NCT02581059|66024741|FG001|Study Treatment|Death|1|||
23628531|NCT02581059|66024740|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23628532|NCT02581059|66024741|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23628533|NCT02581059|66024740|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
23628534|NCT02581059|66024741|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
23628535|NCT02581059|66024740|FG000|Follow up|Death|1|||
23628536|NCT02581059|66024741|FG001|Follow up|Death|3|||
23628537|NCT02581059|66024740|FG000|Follow up|study terminated|1|||
23628538|NCT02581059|66024741|FG001|Follow up|study terminated|1|||
23628539|NCT02581059|66024740|FG000|Follow up|screen failure|0|||
23628540|NCT02581059|66024741|FG001|Follow up|screen failure|1|||
23628541|NCT02581059|66024740|FG000|Follow up|Patient started new clinical trial|1|||
23628542|NCT02581059|66024741|FG001|Follow up|Patient started new clinical trial|0|||
23628543|NCT03546816|66024744|FG000|Overall Study|Adverse Event|5|||
23628544|NCT03546816|66024745|FG001|Overall Study|Adverse Event|3|||
23628545|NCT03546816|66024744|FG000|Overall Study|Lack of Efficacy|2|||
23628546|NCT03546816|66024745|FG001|Overall Study|Lack of Efficacy|4|||
23628547|NCT03546816|66024744|FG000|Overall Study|Pregnancy|1|||
23628548|NCT03546816|66024745|FG001|Overall Study|Pregnancy|0|||
23628549|NCT03546816|66024744|FG000|Overall Study|Physician Decision|2|||
23628550|NCT03546816|66024745|FG001|Overall Study|Physician Decision|0|||
23628551|NCT03546816|66024744|FG000|Overall Study|Withdrawal by Subject|8|||
23628552|NCT03546816|66024745|FG001|Overall Study|Withdrawal by Subject|10|||
23628553|NCT03546816|66024744|FG000|Overall Study|Lost to Follow-up|3|||
23628554|NCT03546816|66024745|FG001|Overall Study|Lost to Follow-up|2|||
23628555|NCT01929876|66024746|FG000|Period 2|Non-Compliance|1|||
23636639|NCT00534495|66052953|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
23636640|NCT00534495|66052954|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
23636641|NCT00534495|66052955|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
23636642|NCT00534495|66052953|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
23636643|NCT00534495|66052954|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
23636644|NCT00534495|66052955|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
23636645|NCT00534495|66052953|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
23636646|NCT00534495|66052954|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
23636647|NCT00534495|66052955|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
23636648|NCT00534495|66052953|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
23636649|NCT00534495|66052954|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
23636650|NCT00534495|66052955|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
23636651|NCT00534495|66052953|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
23636652|NCT00534495|66052954|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
23566524|NCT02247804|65803860|FG001|Treatment Period 3|Reason not Specified|1|||
23566525|NCT02247804|65803861|FG002|Treatment Period 3|Reason not Specified|3|||
23566526|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
23566527|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
23566528|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Adverse Event|2|||
23566529|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Adverse Event|5|||
23566530|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
23763704|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
23566531|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
23566532|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
23566533|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
23566534|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Randomized by error|0|||
23566535|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Randomized by error|5|||
23566536|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
23566537|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
23566538|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
23763705|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
23763706|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
23763707|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
23636653|NCT00534495|66052955|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
23763708|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Physician Decision|1|||
23828423|NCT01342081|66752355|FG000|Overall Study|Physician Decision|0|||
23828424|NCT01342081|66752356|FG001|Overall Study|Physician Decision|1|||
23828425|NCT01342081|66752357|FG002|Overall Study|Physician Decision|0|||
23828426|NCT01342081|66752355|FG000|Overall Study|Withdrawal by Subject|1|||
23828427|NCT01342081|66752356|FG001|Overall Study|Withdrawal by Subject|1|||
23828428|NCT01342081|66752357|FG002|Overall Study|Withdrawal by Subject|0|||
23828429|NCT05064397|66752358|FG000|Overall Study|Adverse Event|4|||
23828430|NCT05064397|66752358|FG000|Overall Study|Lack of Efficacy|12|||
23828431|NCT05064397|66752358|FG000|Overall Study|Withdrawal by Subject|3|||
23828432|NCT05064397|66752358|FG000|Overall Study|Lost to Follow-up|1|||
23828433|NCT05064397|66752358|FG000|Overall Study|Other reasons|3|||
23828434|NCT02115269|66752359|FG000|Overall Study|Lost to Follow-up|43|||
23828435|NCT02115269|66752359|FG000|Overall Study|Did not complete patient diary|3|||
23828436|NCT02115269|66752359|FG000|Overall Study|Moved to another city|7|||
23828437|NCT02115269|66752359|FG000|Overall Study|Withdrawal by Subject|2|||
23828438|NCT02115269|66752359|FG000|Overall Study|Didn't take study drug|2|||
23828439|NCT04135937|66752365|FG000|Overall Study|Lost to Follow-up|2|||
23828440|NCT04135937|66752365|FG000|Overall Study|Withdrawal by Subject|1|||
23828441|NCT02414958|66752366|FG000|Overall Study|Adverse Event|6|||
23828442|NCT02414958|66752367|FG001|Overall Study|Adverse Event|6|||
23828443|NCT02414958|66752368|FG002|Overall Study|Adverse Event|3|||
23828444|NCT02414958|66752366|FG000|Overall Study|Protocol Violation|10|||
23828445|NCT02414958|66752367|FG001|Overall Study|Protocol Violation|3|||
23828446|NCT02414958|66752368|FG002|Overall Study|Protocol Violation|1|||
23828447|NCT02414958|66752366|FG000|Overall Study|Lost to Follow-up|7|||
23566539|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
23566540|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Change of residence location|0|||
23566541|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Change of residence location|1|||
23566542|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
23566543|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
23566544|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
23566545|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
23566546|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
23566547|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
23566548|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
23566549|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
23566550|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
23566551|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
23566552|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Study site closure|1|||
23566553|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Study site closure|0|||
23566554|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
23566555|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
23566556|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
23566557|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
23566558|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
23566559|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
23566560|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
23566561|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
23566562|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
23566563|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
23566564|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
23566565|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
23566566|NCT01233609|65803867|FG000|Overall Study|Death|1|||
23566567|NCT01233609|65803868|FG001|Overall Study|Death|0|||
23566568|NCT01233609|65803867|FG000|Overall Study|Lost to Follow-up|3|||
23566569|NCT01233609|65803868|FG001|Overall Study|Lost to Follow-up|1|||
23566570|NCT01233609|65803867|FG000|Overall Study|Adverse Event|2|||
23566571|NCT01233609|65803868|FG001|Overall Study|Adverse Event|1|||
23566572|NCT01233609|65803867|FG000|Overall Study|Withdrawal by Subject|3|||
23566573|NCT01233609|65803868|FG001|Overall Study|Withdrawal by Subject|0|||
23828448|NCT02414958|66752367|FG001|Overall Study|Lost to Follow-up|4|||
23828449|NCT02414958|66752368|FG002|Overall Study|Lost to Follow-up|0|||
23828450|NCT02414958|66752366|FG000|Overall Study|Withdrawal by Subject|5|||
23828451|NCT02414958|66752367|FG001|Overall Study|Withdrawal by Subject|3|||
23828452|NCT02414958|66752368|FG002|Overall Study|Withdrawal by Subject|5|||
23443455|NCT02352753|65366406|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
23443456|NCT02352753|65366406|FG000|3-Month Dosing Period|Decision by sponsor|14|||
23828453|NCT02414958|66752366|FG000|Overall Study|Other than specified|4|||
23443457|NCT02352753|65366406|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
23763709|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Physician Decision|0|||
23763710|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Physician Decision|0|||
23763711|NCT02884206|66514397|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
23763712|NCT02884206|66514398|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
23763713|NCT02884206|66514399|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
23763714|NCT02884206|66514397|FG000|Double-Blind Period|Death|0|||
23763715|NCT02884206|66514398|FG001|Double-Blind Period|Death|28|||
23763716|NCT02884206|66514399|FG002|Double-Blind Period|Death|39|||
23763717|NCT02884206|66514397|FG000|Double-Blind Period|Patient/guardian decision|0|||
23763718|NCT02884206|66514398|FG001|Double-Blind Period|Patient/guardian decision|10|||
23763719|NCT02884206|66514399|FG002|Double-Blind Period|Patient/guardian decision|13|||
23763720|NCT02884206|66514397|FG000|Double-Blind Period|Lost to Follow-up|0|||
23763721|NCT02884206|66514398|FG001|Double-Blind Period|Lost to Follow-up|4|||
23763722|NCT02884206|66514399|FG002|Double-Blind Period|Lost to Follow-up|4|||
23763723|NCT02884206|66514397|FG000|Double-Blind Period|Physician Decision|0|||
23763724|NCT02884206|66514398|FG001|Double-Blind Period|Physician Decision|2|||
23763725|NCT02884206|66514399|FG002|Double-Blind Period|Physician Decision|0|||
23763726|NCT02884206|66514397|FG000|Double-Blind Period|Adverse Event|0|||
23763727|NCT02884206|66514398|FG001|Double-Blind Period|Adverse Event|0|||
23763728|NCT02884206|66514399|FG002|Double-Blind Period|Adverse Event|3|||
23763729|NCT02884206|66514397|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
23763730|NCT02884206|66514398|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
23763731|NCT02884206|66514399|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
23763732|NCT01193517|66514403|FG000|Overall Study|Early Progression|1|||
23763733|NCT01193517|66514404|FG001|Overall Study|Early Progression|0|||
23763734|NCT01193517|66514405|FG002|Overall Study|Early Progression|0|||
23763735|NCT00618774|66514406|FG000|Overall Study|Adverse Event|5|||
23763736|NCT00618774|66514407|FG001|Overall Study|Adverse Event|3|||
23763737|NCT00618774|66514406|FG000|Overall Study|Withdrawal by Subject|1|||
23763738|NCT00618774|66514407|FG001|Overall Study|Withdrawal by Subject|0|||
23763739|NCT00207714|66514408|FG000|Overall Study|Adverse Event|6|||
23763740|NCT00207714|66514409|FG001|Overall Study|Adverse Event|2|||
23763741|NCT00207714|66514410|FG002|Overall Study|Adverse Event|4|||
23763742|NCT00207714|66514411|FG003|Overall Study|Adverse Event|3|||
23566574|NCT01302938|65803870|FG000|Overall Study|Withdrawal by Subject|1|||
23763743|NCT00207714|66514412|FG004|Overall Study|Adverse Event|1|||
23763744|NCT00207714|66514408|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23763745|NCT00207714|66514409|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23763746|NCT00207714|66514410|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23763747|NCT00207714|66514411|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
23763748|NCT00207714|66514412|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
23763749|NCT00207714|66514408|FG000|Overall Study|Other|3|||
23763750|NCT00207714|66514409|FG001|Overall Study|Other|2|||
23566575|NCT01302938|65803871|FG001|Overall Study|Withdrawal by Subject|0|||
23566576|NCT01302938|65803870|FG000|Overall Study|Adverse Event|1|||
23566577|NCT01302938|65803871|FG001|Overall Study|Adverse Event|0|||
23566578|NCT02912468|65803873|FG000|Overall Study|Adverse Event|3|||
23566579|NCT02912468|65803874|FG001|Overall Study|Adverse Event|2|||
23566580|NCT02912468|65803873|FG000|Overall Study|Withdrawal by Subject|6|||
23566581|NCT02912468|65803874|FG001|Overall Study|Withdrawal by Subject|2|||
23566582|NCT02912468|65803873|FG000|Overall Study|Randomized and not treated|0|||
23566583|NCT02912468|65803874|FG001|Overall Study|Randomized and not treated|1|||
23566584|NCT03430063|65803875|FG000|Overall Study|Adverse Event|0|||
23566585|NCT03430063|65803876|FG001|Overall Study|Adverse Event|1|||
23566586|NCT03430063|65803877|FG002|Overall Study|Adverse Event|0|||
23566587|NCT03430063|65803875|FG000|Overall Study|Death|3|||
23566588|NCT03430063|65803876|FG001|Overall Study|Death|2|||
23566589|NCT03430063|65803877|FG002|Overall Study|Death|3|||
23566590|NCT03430063|65803875|FG000|Overall Study|Lost to Follow-up|0|||
23566591|NCT03430063|65803876|FG001|Overall Study|Lost to Follow-up|1|||
23566592|NCT03430063|65803877|FG002|Overall Study|Lost to Follow-up|0|||
23566593|NCT03430063|65803875|FG000|Overall Study|Withdrawal by Subject|0|||
23566594|NCT03430063|65803876|FG001|Overall Study|Withdrawal by Subject|0|||
23763751|NCT00207714|66514410|FG002|Overall Study|Other|5|||
23763752|NCT00207714|66514411|FG003|Overall Study|Other|1|||
23763753|NCT00207714|66514412|FG004|Overall Study|Other|0|||
23763754|NCT02444533|66514413|FG000|Overall Study|Not able to complete forms|0|||
23763755|NCT02444533|66514414|FG001|Overall Study|Not able to complete forms|2|||
23763756|NCT02444533|66514413|FG000|Overall Study|Only gave post-procedure complications|2|||
23763757|NCT02444533|66514414|FG001|Overall Study|Only gave post-procedure complications|2|||
23763758|NCT01405950|66514415|FG000|Overall Study|Withdrawal by Subject|1|||
23763759|NCT01405950|66514416|FG001|Overall Study|Withdrawal by Subject|0|||
23763760|NCT01405950|66514417|FG002|Overall Study|Withdrawal by Subject|0|||
23763761|NCT01405950|66514418|FG003|Overall Study|Withdrawal by Subject|0|||
23763762|NCT00936975|66514419|FG000|Overall Study|Withdrawal by Subject|1|||
23763763|NCT00936975|66514419|FG000|Overall Study|Disease progression|3|||
23763764|NCT00936975|66514419|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
23763765|NCT00827827|66514420|FG000|Overall Study|Lost to Follow-up|3|||
23763766|NCT00827827|66514421|FG001|Overall Study|Lost to Follow-up|0|||
23763767|NCT00827827|66514420|FG000|Overall Study|Fall at home- hospitalization|1|||
23763768|NCT00827827|66514421|FG001|Overall Study|Fall at home- hospitalization|0|||
23763769|NCT00827827|66514420|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
23763770|NCT00827827|66514421|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
23763771|NCT00827827|66514420|FG000|Overall Study|Gout|1|||
23763772|NCT00827827|66514421|FG001|Overall Study|Gout|0|||
23763773|NCT00827827|66514420|FG000|Overall Study|Transportation issues|1|||
23763774|NCT00827827|66514421|FG001|Overall Study|Transportation issues|0|||
23763775|NCT00827827|66514420|FG000|Overall Study|Burned with water at home|1|||
23763776|NCT00827827|66514421|FG001|Overall Study|Burned with water at home|0|||
23763777|NCT00685919|66514422|FG000|Overall Study|Withdrawal by Subject|0|||
23763778|NCT00685919|66514423|FG001|Overall Study|Withdrawal by Subject|0|||
23763779|NCT00685919|66514424|FG002|Overall Study|Withdrawal by Subject|1|||
23763780|NCT00685919|66514425|FG003|Overall Study|Withdrawal by Subject|0|||
23763781|NCT00685919|66514422|FG000|Overall Study|Physician Decision|1|||
23763782|NCT00685919|66514423|FG001|Overall Study|Physician Decision|0|||
23763783|NCT00685919|66514424|FG002|Overall Study|Physician Decision|0|||
23763784|NCT00685919|66514425|FG003|Overall Study|Physician Decision|0|||
23763785|NCT01620983|66514426|FG000|Overall Study|Lost to Follow-up|8|||
23763786|NCT01620983|66514427|FG001|Overall Study|Lost to Follow-up|4|||
23763787|NCT01620983|66514428|FG002|Overall Study|Lost to Follow-up|9|||
23763788|NCT01620983|66514426|FG000|Overall Study|Withdrawal by Subject|6|||
23763789|NCT01620983|66514427|FG001|Overall Study|Withdrawal by Subject|8|||
23763790|NCT01620983|66514428|FG002|Overall Study|Withdrawal by Subject|1|||
23763791|NCT01620983|66514426|FG000|Overall Study|Death|2|||
23763792|NCT01620983|66514427|FG001|Overall Study|Death|0|||
23763793|NCT01620983|66514428|FG002|Overall Study|Death|0|||
23763794|NCT01620983|66514426|FG000|Overall Study|Physician Decision|3|||
23763795|NCT01620983|66514427|FG001|Overall Study|Physician Decision|10|||
23763796|NCT01620983|66514428|FG002|Overall Study|Physician Decision|5|||
23763797|NCT03507439|66514433|FG000|Overall Study|Other|2|||
23763798|NCT03507439|66514434|FG001|Overall Study|Other|1|||
23763799|NCT03507439|66514433|FG000|Overall Study|Withdrawal by Subject|1|||
23763800|NCT03507439|66514434|FG001|Overall Study|Withdrawal by Subject|0|||
23763801|NCT03507439|66514433|FG000|Overall Study|Death|1|||
23763802|NCT03507439|66514434|FG001|Overall Study|Death|1|||
23763803|NCT00798889|66514436|FG000|Overall Study|Adverse Event|53|||
23763804|NCT00798889|66514436|FG000|Overall Study|Protocol Violation|2|||
23763805|NCT00798889|66514436|FG000|Overall Study|Withdrawal by Subject|31|||
23763806|NCT00798889|66514436|FG000|Overall Study|Lost to Follow-up|1|||
23763807|NCT00798889|66514436|FG000|Overall Study|Lack of Efficacy|213|||
23763808|NCT00798889|66514436|FG000|Overall Study|Decision of Sponsor|11|||
23763809|NCT00798889|66514436|FG000|Overall Study|Enrolled, Not treated|3|||
23763810|NCT00319449|66514441|FG000|Overall Study|Subject did not wish to continue|1|||
23763811|NCT00319449|66514442|FG001|Overall Study|Subject did not wish to continue|0|||
23763812|NCT00319449|66514441|FG000|Overall Study|Noncompliance with the protocol|1|||
23763813|NCT00319449|66514442|FG001|Overall Study|Noncompliance with the protocol|0|||
23763814|NCT04079842|66514452|FG000|Overall Study|Request of subject|2|||
23763815|NCT04079842|66514452|FG000|Overall Study|Unable to draw Arterial samples|1|||
23763816|NCT02853929|66514453|FG000|Overall Study|Lost to Follow-up|3|||
23763817|NCT02853929|66514454|FG001|Overall Study|Lost to Follow-up|0|||
23763818|NCT02853929|66514453|FG000|Overall Study|Withdrawal by Subject|1|||
23763819|NCT02853929|66514454|FG001|Overall Study|Withdrawal by Subject|0|||
23763820|NCT02853929|66514453|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
23763821|NCT02853929|66514454|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
23763822|NCT02308111|66514457|FG000|Overall Study|Adverse Event|31|||
23763823|NCT02308111|66514458|FG001|Overall Study|Adverse Event|19|||
23763824|NCT02308111|66514457|FG000|Overall Study|Death|9|||
23763825|NCT02308111|66514458|FG001|Overall Study|Death|6|||
23763826|NCT02308111|66514457|FG000|Overall Study|Lost to Follow-up|2|||
23763827|NCT02308111|66514458|FG001|Overall Study|Lost to Follow-up|7|||
23763828|NCT02308111|66514457|FG000|Overall Study|Physician Decision|6|||
23763829|NCT02308111|66514458|FG001|Overall Study|Physician Decision|17|||
23763830|NCT02308111|66514457|FG000|Overall Study|Protocol Violation|0|||
23763831|NCT02308111|66514458|FG001|Overall Study|Protocol Violation|1|||
23763832|NCT02308111|66514457|FG000|Overall Study|Withdrawal by Subject|28|||
23763833|NCT02308111|66514458|FG001|Overall Study|Withdrawal by Subject|38|||
23763834|NCT02308111|66514457|FG000|Overall Study|Study Terminated by Sponsor|72|||
23763835|NCT02308111|66514458|FG001|Overall Study|Study Terminated by Sponsor|61|||
23763836|NCT02308111|66514457|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
23763837|NCT02308111|66514458|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
23763838|NCT02308111|66514457|FG000|Overall Study|Site Closure|3|||
23763839|NCT02308111|66514458|FG001|Overall Study|Site Closure|3|||
23763840|NCT02308111|66514457|FG000|Overall Study|Non-compliance with Study Drug|3|||
23763841|NCT02308111|66514458|FG001|Overall Study|Non-compliance with Study Drug|1|||
23763842|NCT02308111|66514457|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
23763843|NCT02308111|66514458|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
23763844|NCT02308111|66514457|FG000|Overall Study|Liver Transplant|3|||
23763845|NCT02308111|66514458|FG001|Overall Study|Liver Transplant|3|||
23763846|NCT02308111|66514457|FG000|Overall Study|Liver Transplant Waitlist|2|||
23763847|NCT02308111|66514458|FG001|Overall Study|Liver Transplant Waitlist|2|||
23763848|NCT02308111|66514457|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
23763849|NCT02308111|66514458|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
23763850|NCT01688037|66514459|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
23763851|NCT01688037|66514460|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
23763852|NCT01688037|66514461|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
23763853|NCT01688037|66514459|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
23763854|NCT01688037|66514460|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
23763855|NCT01688037|66514461|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
23763856|NCT01688037|66514459|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
23763857|NCT01688037|66514460|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
23763858|NCT01688037|66514461|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
23763859|NCT01688037|66514459|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23763860|NCT01688037|66514460|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
23763861|NCT01688037|66514461|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23763862|NCT01688037|66514459|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
23763863|NCT01688037|66514460|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
23763864|NCT01688037|66514461|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
23763865|NCT01688037|66514459|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
23763866|NCT01688037|66514460|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
23763867|NCT01688037|66514461|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
23763868|NCT01688037|66514459|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
23763869|NCT01688037|66514460|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
23763870|NCT01688037|66514461|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
23763871|NCT01688037|66514459|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
23763872|NCT01688037|66514460|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
23763873|NCT01688037|66514461|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
23763874|NCT01688037|66514459|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
23763875|NCT01688037|66514460|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
23763876|NCT01688037|66514461|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
23763877|NCT01688037|66514459|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
23763878|NCT01688037|66514460|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
23763879|NCT01688037|66514461|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
23763880|NCT01133392|66514462|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
23763881|NCT01133392|66514463|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
23763882|NCT01133392|66514462|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
23763883|NCT01133392|66514463|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
23763884|NCT01626885|66514464|FG000|Overall Study|Adverse Event|8|||
23763885|NCT01626885|66514464|FG000|Overall Study|Withdrawal by Subject|4|||
23763886|NCT03355742|66514465|FG000|Overall Study|Lost to Follow-up|4|||
23763887|NCT03355742|66514465|FG000|Overall Study|Withdrawal by Subject|29|||
23763888|NCT03355742|66514465|FG000|Overall Study|Physician Decision|6|||
23763889|NCT03355742|66514465|FG000|Overall Study|Death|55|||
23763890|NCT03355742|66514465|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
23763891|NCT02576990|66514467|FG000|Overall Study|Death|29|||
23763892|NCT02576990|66514468|FG001|Overall Study|Death|18|||
23763893|NCT02576990|66514467|FG000|Overall Study|Physician Decision|1|||
23763894|NCT02576990|66514468|FG001|Overall Study|Physician Decision|0|||
23763895|NCT02576990|66514467|FG000|Overall Study|Screen failure|2|||
23763896|NCT02576990|66514468|FG001|Overall Study|Screen failure|0|||
23763897|NCT02576990|66514467|FG000|Overall Study|Sponsor's decision|24|||
23763898|NCT02576990|66514468|FG001|Overall Study|Sponsor's decision|4|||
23763899|NCT02576990|66514467|FG000|Overall Study|Withdrawal by Subject|0|||
23566595|NCT03430063|65803877|FG002|Overall Study|Withdrawal by Subject|1|||
23763900|NCT02576990|66514468|FG001|Overall Study|Withdrawal by Subject|2|||
23763901|NCT01873859|66514469|FG000|Overall Study|Withdrawal by Subject|0|||
23763902|NCT01873859|66514470|FG001|Overall Study|Withdrawal by Subject|4|||
23763903|NCT01896297|66514481|FG000|Overall Study|Died in post treatment phase|1|||
23763904|NCT02891200|66514483|FG000|Overall Study|Lost to Follow-up|31|||
23763905|NCT02891200|66514484|FG001|Overall Study|Lost to Follow-up|36|||
23763906|NCT02891200|66514483|FG000|Overall Study|Death|10|||
23763907|NCT02891200|66514484|FG001|Overall Study|Death|9|||
23443458|NCT00452790|65366407|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
23443459|NCT00452790|65366408|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
23443460|NCT00452790|65366407|FG000|Infant Series|Parent/legal guardian request|8|||
23443461|NCT00452790|65366408|FG001|Infant Series|Parent/legal guardian request|6|||
23443462|NCT00452790|65366407|FG000|Infant Series|Failed to return|4|||
23443463|NCT00452790|65366408|FG001|Infant Series|Failed to return|1|||
23443464|NCT00452790|65366407|FG000|Infant Series|Protocol Violation|1|||
23443465|NCT00452790|65366408|FG001|Infant Series|Protocol Violation|3|||
23443466|NCT00452790|65366407|FG000|Infant Series|Lost to Follow-up|2|||
23443467|NCT00452790|65366408|FG001|Infant Series|Lost to Follow-up|2|||
23443468|NCT00452790|65366407|FG000|Infant Series|Adverse Event|1|||
23443469|NCT00452790|65366408|FG001|Infant Series|Adverse Event|2|||
23443470|NCT00452790|65366407|FG000|Infant Series|Other reasons|1|||
23443471|NCT00452790|65366408|FG001|Infant Series|Other reasons|2|||
23443472|NCT00452790|65366407|FG000|Infant Series|Investigator request|0|||
23443473|NCT00452790|65366408|FG001|Infant Series|Investigator request|1|||
23443474|NCT00452790|65366407|FG000|Infant Series|Death|0|||
23443475|NCT00452790|65366408|FG001|Infant Series|Death|1|||
23443476|NCT00452790|65366407|FG000|After Infant Series|Investigator request|10|||
23443477|NCT00452790|65366408|FG001|After Infant Series|Investigator request|10|||
23443478|NCT00452790|65366407|FG000|After Infant Series|Adverse Event|4|||
23443479|NCT00452790|65366408|FG001|After Infant Series|Adverse Event|1|||
23443480|NCT00452790|65366407|FG000|After Infant Series|Parent/legal guardian request|1|||
23443481|NCT00452790|65366408|FG001|After Infant Series|Parent/legal guardian request|3|||
23443482|NCT00452790|65366407|FG000|After Infant Series|Lost to Follow-up|4|||
23443483|NCT00452790|65366408|FG001|After Infant Series|Lost to Follow-up|0|||
23443484|NCT00452790|65366407|FG000|After Infant Series|Failed to return|1|||
23443485|NCT00452790|65366408|FG001|After Infant Series|Failed to return|0|||
23443486|NCT00452790|65366407|FG000|After Infant Series|Other reasons|1|||
23443487|NCT00452790|65366408|FG001|After Infant Series|Other reasons|0|||
23443488|NCT00452790|65366407|FG000|Toddler Dose|Failed to return|0|||
23443489|NCT00452790|65366408|FG001|Toddler Dose|Failed to return|1|||
23443490|NCT00452790|65366407|FG000|Toddler Dose|Parent/legal guardian request|0|||
23443491|NCT00452790|65366408|FG001|Toddler Dose|Parent/legal guardian request|1|||
23443492|NCT00358436|65366412|FG000|Overall Study|Adverse Event|29|||
23443493|NCT00358436|65366413|FG001|Overall Study|Adverse Event|13|||
23443494|NCT00358436|65366412|FG000|Overall Study|Lack of Efficacy|34|||
23443495|NCT00358436|65366413|FG001|Overall Study|Lack of Efficacy|36|||
23443496|NCT00358436|65366412|FG000|Overall Study|Lost to Follow-up|11|||
23443497|NCT00358436|65366413|FG001|Overall Study|Lost to Follow-up|6|||
23443498|NCT00358436|65366412|FG000|Overall Study|Protocol Violation|8|||
23443499|NCT00358436|65366413|FG001|Overall Study|Protocol Violation|3|||
23443500|NCT00358436|65366412|FG000|Overall Study|Withdrawal by Subject|40|||
23443501|NCT00358436|65366413|FG001|Overall Study|Withdrawal by Subject|17|||
23443502|NCT00358436|65366412|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
23443503|NCT00358436|65366413|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
23443504|NCT00358436|65366412|FG000|Overall Study|COPD exacerbation|22|||
23443505|NCT00358436|65366413|FG001|Overall Study|COPD exacerbation|10|||
23443506|NCT00358436|65366412|FG000|Overall Study|Other|6|||
23443507|NCT00358436|65366413|FG001|Overall Study|Other|1|||
23443508|NCT01415401|65366414|FG000|Overall Study|Adverse Event|5|||
23443509|NCT01415401|65366414|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
23443510|NCT01415401|65366414|FG000|Overall Study|Terminated by Sponsor|1|||
23443511|NCT01461707|65366415|FG000|Overall Study|Withdrawal by Subject|1|||
23443512|NCT01461707|65366416|FG001|Overall Study|Withdrawal by Subject|0|||
23566596|NCT03430063|65803875|FG000|Overall Study|Withdrawal of consent|3|||
23566597|NCT03430063|65803876|FG001|Overall Study|Withdrawal of consent|1|||
23443513|NCT04639219|65366417|FG000|Overall Study|Withdrawal by Subject|8|||
23443514|NCT04639219|65366417|FG000|Overall Study|Lost to Follow-up|6|||
23443515|NCT04639219|65366417|FG000|Overall Study|Death|55|||
23443516|NCT02343406|65366418|FG000|Overall Study|Progressive disease|72|||
23443517|NCT02343406|65366419|FG001|Overall Study|Progressive disease|70|||
23443518|NCT02343406|65366420|FG002|Overall Study|Progressive disease|43|||
23763908|NCT02891200|66514483|FG000|Overall Study|Withdrawal by Subject|1|||
23763909|NCT02891200|66514484|FG001|Overall Study|Withdrawal by Subject|4|||
23763910|NCT02100956|66514485|FG000|At Least One Week Between Injections|Adverse Event|0|||
23763911|NCT02100956|66514486|FG001|At Least One Week Between Injections|Adverse Event|1|||
23763912|NCT00106028|66514489|FG000|Overall Study|Adverse Event|3|||
23763913|NCT00106028|66514490|FG001|Overall Study|Adverse Event|2|||
23763914|NCT00106028|66514489|FG000|Overall Study|Protocol Violation|1|||
23763915|NCT00106028|66514490|FG001|Overall Study|Protocol Violation|1|||
23763916|NCT00106028|66514489|FG000|Overall Study|Withdrawal by Subject|2|||
23443519|NCT02343406|65366421|FG003|Overall Study|Progressive disease|15|||
23443520|NCT02343406|65366422|FG004|Overall Study|Progressive disease|5|||
23443521|NCT02343406|65366418|FG000|Overall Study|Adverse Event|6|||
23443522|NCT02343406|65366419|FG001|Overall Study|Adverse Event|8|||
23443523|NCT02343406|65366420|FG002|Overall Study|Adverse Event|6|||
23566598|NCT03430063|65803877|FG002|Overall Study|Withdrawal of consent|2|||
23828454|NCT02414958|66752367|FG001|Overall Study|Other than specified|4|||
23828455|NCT02414958|66752368|FG002|Overall Study|Other than specified|5|||
23828456|NCT01709500|66752369|FG000|Overall Study|Randomized but not treated|0|||
23828457|NCT01709500|66752370|FG001|Overall Study|Randomized but not treated|1|||
23566599|NCT03430063|65803875|FG000|Overall Study|Progressive disease|1|||
23763917|NCT00106028|66514490|FG001|Overall Study|Withdrawal by Subject|8|||
23763918|NCT00106028|66514489|FG000|Overall Study|Lost to Follow-up|0|||
23763919|NCT00106028|66514490|FG001|Overall Study|Lost to Follow-up|1|||
23763920|NCT00752856|66514491|FG000|Overall Study|randomized but did not do viral kinetics|0|||
23763921|NCT00752856|66514492|FG001|Overall Study|randomized but did not do viral kinetics|1|||
23763922|NCT01294592|66514495|FG000|Overall Study|Adverse Event|28|||
23763923|NCT01294592|66514496|FG001|Overall Study|Adverse Event|13|||
23763924|NCT01294592|66514495|FG000|Overall Study|Lack of Efficacy|7|||
23763925|NCT01294592|66514496|FG001|Overall Study|Lack of Efficacy|5|||
23763926|NCT01294592|66514495|FG000|Overall Study|Protocol Violation|1|||
23763927|NCT01294592|66514496|FG001|Overall Study|Protocol Violation|7|||
23763928|NCT01294592|66514495|FG000|Overall Study|Lost to Follow-up|7|||
23763929|NCT01294592|66514496|FG001|Overall Study|Lost to Follow-up|9|||
23763930|NCT01294592|66514495|FG000|Overall Study|Physician Decision|6|||
23763931|NCT01294592|66514496|FG001|Overall Study|Physician Decision|11|||
23763932|NCT01294592|66514495|FG000|Overall Study|Withdrawal by Subject|28|||
23763933|NCT01294592|66514496|FG001|Overall Study|Withdrawal by Subject|28|||
23763934|NCT03682536|66514497|FG000|Randomization|Withdrawal by Subject|0|||
23763935|NCT03682536|66514498|FG001|Randomization|Withdrawal by Subject|2|||
23763936|NCT03682536|66514497|FG000|Treatment|Other Reasons|8|||
23763937|NCT03682536|66514498|FG001|Treatment|Other Reasons|7|||
23763938|NCT03682536|66514497|FG000|Treatment|Physician Decision|5|||
23763939|NCT03682536|66514498|FG001|Treatment|Physician Decision|5|||
23763940|NCT03682536|66514497|FG000|Treatment|Protocol Violation|1|||
23828458|NCT01709500|66752369|FG000|Overall Study|Adverse Event|5|||
23828459|NCT01709500|66752370|FG001|Overall Study|Adverse Event|1|||
23828460|NCT01709500|66752369|FG000|Overall Study|Poor compliance to protocol|2|||
23828461|NCT01709500|66752370|FG001|Overall Study|Poor compliance to protocol|1|||
23828462|NCT01709500|66752369|FG000|Overall Study|Other|3|||
23828463|NCT01709500|66752370|FG001|Overall Study|Other|1|||
23828464|NCT01709500|66752369|FG000|Overall Study|Related to IMP administration|1|||
23828465|NCT01709500|66752370|FG001|Overall Study|Related to IMP administration|0|||
23828466|NCT01709500|66752369|FG000|Overall Study|Treatment ongoing|156|||
23828467|NCT01709500|66752370|FG001|Overall Study|Treatment ongoing|78|||
23828468|NCT04720105|66752373|FG000|Overall Study|Lack of Efficacy|1|||
23828469|NCT04720105|66752373|FG000|Overall Study|Lost to Follow-up|1|||
23828470|NCT04720105|66752373|FG000|Overall Study|Withdrawal by Subject|3|||
23828471|NCT00349973|66752375|FG000|Overall Study|Adverse Event|3|||
23828472|NCT00349973|66752376|FG001|Overall Study|Adverse Event|3|||
23828473|NCT00349973|66752375|FG000|Overall Study|Withdrawal by Subject|1|||
23828474|NCT00349973|66752376|FG001|Overall Study|Withdrawal by Subject|0|||
23828475|NCT03238651|66752377|FG000|Overall Study|Other|0|||
23828476|NCT03238651|66752378|FG001|Overall Study|Other|0|||
23828477|NCT03238651|66752379|FG002|Overall Study|Other|0|||
23828478|NCT03238651|66752380|FG003|Overall Study|Other|0|||
23828479|NCT03238651|66752381|FG004|Overall Study|Other|1|||
23828480|NCT03238651|66752377|FG000|Overall Study|Progressive Disease|2|||
23828481|NCT03238651|66752378|FG001|Overall Study|Progressive Disease|2|||
23828482|NCT03238651|66752379|FG002|Overall Study|Progressive Disease|2|||
23828483|NCT03238651|66752380|FG003|Overall Study|Progressive Disease|2|||
23828484|NCT03238651|66752381|FG004|Overall Study|Progressive Disease|0|||
23828485|NCT03238651|66752377|FG000|Overall Study|Withdrawal by Subject|0|||
23828486|NCT03238651|66752378|FG001|Overall Study|Withdrawal by Subject|1|||
23828487|NCT03238651|66752379|FG002|Overall Study|Withdrawal by Subject|0|||
23566600|NCT03430063|65803876|FG001|Overall Study|Progressive disease|2|||
23828488|NCT03238651|66752380|FG003|Overall Study|Withdrawal by Subject|1|||
23828489|NCT03238651|66752381|FG004|Overall Study|Withdrawal by Subject|0|||
23443524|NCT02343406|65366421|FG003|Overall Study|Adverse Event|3|||
23763941|NCT03682536|66514498|FG001|Treatment|Protocol Violation|0|||
23763942|NCT03682536|66514497|FG000|Treatment|Study Terminated by Sponsor|1|||
23828490|NCT03238651|66752377|FG000|Overall Study|Adverse Event|1|||
23828491|NCT03238651|66752378|FG001|Overall Study|Adverse Event|3|||
23443525|NCT02343406|65366422|FG004|Overall Study|Adverse Event|0|||
23763943|NCT03682536|66514498|FG001|Treatment|Study Terminated by Sponsor|2|||
23763944|NCT03682536|66514497|FG000|Treatment|Lost to Follow-up|0|||
23763945|NCT03682536|66514498|FG001|Treatment|Lost to Follow-up|1|||
23828492|NCT03238651|66752379|FG002|Overall Study|Adverse Event|2|||
23828493|NCT03238651|66752380|FG003|Overall Study|Adverse Event|0|||
23828494|NCT03238651|66752381|FG004|Overall Study|Adverse Event|0|||
23828495|NCT02540083|66752384|FG000|Overall Study|Withdrawal by Subject|16|||
23828496|NCT00610129|66752385|FG000|Overall Study|Not treated since patients ineligible|3|||
23763946|NCT03682536|66514497|FG000|Treatment|Withdrawal by Subject|16|||
23763947|NCT03682536|66514498|FG001|Treatment|Withdrawal by Subject|18|||
23763948|NCT03682536|66514497|FG000|Treatment|Lack of Efficacy|41|||
23763949|NCT03682536|66514498|FG001|Treatment|Lack of Efficacy|68|||
23763950|NCT03682536|66514497|FG000|Treatment|Disease Progression|9|||
23763951|NCT03682536|66514498|FG001|Treatment|Disease Progression|7|||
23763952|NCT03682536|66514497|FG000|Treatment|Adverse Event|9|||
23763953|NCT03682536|66514498|FG001|Treatment|Adverse Event|5|||
23763954|NCT03682536|66514497|FG000|Treatment|Death|14|||
23763955|NCT03682536|66514498|FG001|Treatment|Death|13|||
23763956|NCT01875445|66514499|FG000|Overall Study|Lost to Follow-up|5|||
23763957|NCT01875445|66514500|FG001|Overall Study|Lost to Follow-up|0|||
23763958|NCT01875445|66514499|FG000|Overall Study|Withdrawal by Subject|2|||
23763959|NCT01875445|66514500|FG001|Overall Study|Withdrawal by Subject|0|||
23763960|NCT01889862|66514501|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
23763961|NCT01889862|66514502|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23763962|NCT01889862|66514503|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23763963|NCT01889862|66514504|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23763964|NCT01889862|66514505|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23763965|NCT01889862|66514501|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
23763966|NCT01889862|66514502|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23763967|NCT01889862|66514503|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23763968|NCT01889862|66514504|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23763969|NCT01889862|66514505|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23763970|NCT01889862|66514501|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
23763971|NCT01889862|66514502|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23763972|NCT01889862|66514503|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23763973|NCT01889862|66514504|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23763974|NCT01889862|66514505|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23763975|NCT01889862|66514501|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
23763976|NCT01889862|66514502|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23763977|NCT01889862|66514503|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23763978|NCT01889862|66514504|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23763979|NCT01889862|66514505|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23763980|NCT01889862|66514501|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23763981|NCT01889862|66514502|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23763982|NCT01889862|66514503|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
23763983|NCT01889862|66514504|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23763984|NCT01889862|66514505|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23763985|NCT01889862|66514501|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23763986|NCT01889862|66514502|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23828497|NCT01777282|66752386|FG000|Overall Study|Persistent Hyperglycemia|0|||
23763987|NCT01889862|66514503|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23763988|NCT01889862|66514504|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23763989|NCT01889862|66514505|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
23763990|NCT01889862|66514501|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23763991|NCT01889862|66514502|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23763992|NCT01889862|66514503|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23763993|NCT01889862|66514504|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23763994|NCT01889862|66514505|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
23763995|NCT01889862|66514501|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23763996|NCT01889862|66514502|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23763997|NCT01889862|66514503|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23828498|NCT01777282|66752387|FG001|Overall Study|Persistent Hyperglycemia|0|||
23828499|NCT01777282|66752388|FG002|Overall Study|Persistent Hyperglycemia|1|||
23763998|NCT01889862|66514504|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23763999|NCT01889862|66514505|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
23764000|NCT01889862|66514501|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23764001|NCT01889862|66514502|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23764002|NCT01889862|66514503|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23764003|NCT01889862|66514504|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23764004|NCT01889862|66514505|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
23764005|NCT01889862|66514501|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23828500|NCT01777282|66752389|FG003|Overall Study|Persistent Hyperglycemia|0|||
23828501|NCT01777282|66752390|FG004|Overall Study|Persistent Hyperglycemia|0|||
23828502|NCT01777282|66752386|FG000|Overall Study|New Antidiabetic Medication|0|||
23828503|NCT01777282|66752387|FG001|Overall Study|New Antidiabetic Medication|0|||
23828504|NCT01777282|66752388|FG002|Overall Study|New Antidiabetic Medication|1|||
23828505|NCT01777282|66752389|FG003|Overall Study|New Antidiabetic Medication|0|||
23828506|NCT01777282|66752390|FG004|Overall Study|New Antidiabetic Medication|0|||
23828507|NCT01777282|66752386|FG000|Overall Study|Adverse Event|4|||
23828508|NCT01777282|66752387|FG001|Overall Study|Adverse Event|4|||
23828509|NCT01777282|66752388|FG002|Overall Study|Adverse Event|2|||
23828510|NCT01777282|66752389|FG003|Overall Study|Adverse Event|1|||
23828511|NCT01777282|66752390|FG004|Overall Study|Adverse Event|3|||
23828512|NCT01777282|66752386|FG000|Overall Study|Withdrawal by Subject|4|||
23828513|NCT01777282|66752387|FG001|Overall Study|Withdrawal by Subject|0|||
23828514|NCT01777282|66752388|FG002|Overall Study|Withdrawal by Subject|0|||
23828515|NCT01777282|66752389|FG003|Overall Study|Withdrawal by Subject|1|||
23828516|NCT01777282|66752390|FG004|Overall Study|Withdrawal by Subject|2|||
23828517|NCT01777282|66752386|FG000|Overall Study|Protocol Violation|2|||
23828518|NCT01777282|66752387|FG001|Overall Study|Protocol Violation|0|||
23828519|NCT01777282|66752388|FG002|Overall Study|Protocol Violation|1|||
23828520|NCT01777282|66752389|FG003|Overall Study|Protocol Violation|0|||
23828521|NCT01777282|66752390|FG004|Overall Study|Protocol Violation|2|||
23828522|NCT01777282|66752386|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
23828523|NCT01777282|66752387|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23828524|NCT01777282|66752388|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
23828525|NCT01777282|66752389|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23828526|NCT01777282|66752390|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23828527|NCT03571828|66752391|FG000|Overall Study|Withdrawal by Subject|1|||
23764006|NCT01889862|66514502|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23764007|NCT01889862|66514503|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23764008|NCT01889862|66514504|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23764009|NCT01889862|66514505|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
23764010|NCT00463866|66514506|FG000|Overall Study|Adverse Event|70|||
23764011|NCT00463866|66514507|FG001|Overall Study|Adverse Event|93|||
23764012|NCT00463866|66514506|FG000|Overall Study|Withdrawal by Subject|81|||
23764013|NCT00463866|66514507|FG001|Overall Study|Withdrawal by Subject|79|||
23764014|NCT00463866|66514506|FG000|Overall Study|Lost to Follow-up|46|||
23764015|NCT00463866|66514507|FG001|Overall Study|Lost to Follow-up|55|||
23764016|NCT00463866|66514506|FG000|Overall Study|Incorrect Enrolment|64|||
23764017|NCT00463866|66514507|FG001|Overall Study|Incorrect Enrolment|66|||
23764018|NCT00463866|66514506|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
23764019|NCT00463866|66514507|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
23764020|NCT00463866|66514506|FG000|Overall Study|Safety Reason|1|||
23764021|NCT00463866|66514507|FG001|Overall Study|Safety Reason|3|||
23764022|NCT00463866|66514506|FG000|Overall Study|Mis-Randomization of subject|0|||
23764023|NCT00463866|66514507|FG001|Overall Study|Mis-Randomization of subject|1|||
23828528|NCT03571828|66752392|FG001|Overall Study|Withdrawal by Subject|0|||
23443526|NCT02343406|65366418|FG000|Overall Study|Withdrawal by Subject|6|||
23443527|NCT02343406|65366419|FG001|Overall Study|Withdrawal by Subject|4|||
23443528|NCT02343406|65366420|FG002|Overall Study|Withdrawal by Subject|8|||
23443529|NCT02343406|65366421|FG003|Overall Study|Withdrawal by Subject|3|||
23443530|NCT02343406|65366422|FG004|Overall Study|Withdrawal by Subject|0|||
23443531|NCT02343406|65366418|FG000|Overall Study|Death|2|||
23443532|NCT02343406|65366419|FG001|Overall Study|Death|1|||
23443533|NCT02343406|65366420|FG002|Overall Study|Death|0|||
23443534|NCT02343406|65366421|FG003|Overall Study|Death|0|||
23443535|NCT02343406|65366422|FG004|Overall Study|Death|0|||
23443536|NCT02343406|65366418|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
23828529|NCT03571828|66752391|FG000|Overall Study|Decision by sponsor|5|||
23828530|NCT03571828|66752392|FG001|Overall Study|Decision by sponsor|1|||
23828531|NCT03571828|66752391|FG000|Overall Study|Death|2|||
23828532|NCT03571828|66752392|FG001|Overall Study|Death|0|||
23828533|NCT00991887|66752394|FG000|Overall Study|Lost to Follow-up|2|||
23443537|NCT02343406|65366419|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
23443538|NCT02343406|65366420|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
23443539|NCT02343406|65366421|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
23764024|NCT00463866|66514506|FG000|Overall Study|Other|22|||
23764025|NCT00463866|66514507|FG001|Overall Study|Other|22|||
23764026|NCT00753714|66514508|FG000|Overall Study|Lack of Efficacy|21|||
23828534|NCT00991887|66752395|FG001|Overall Study|Lost to Follow-up|1|||
23828535|NCT03333941|66752396|FG000|Overall Study|Lost to Follow-up|10|||
23828536|NCT03333941|66752396|FG000|Overall Study|Death|2|||
23828537|NCT03333941|66752396|FG000|Overall Study|Adverse Event|1|||
23828538|NCT03351608|66752397|FG000|Overall Study|Lost to Follow-up|0|||
23828539|NCT03351608|66752398|FG001|Overall Study|Lost to Follow-up|1|||
23443540|NCT02343406|65366422|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
23443541|NCT02343406|65366418|FG000|Overall Study|Other primary malignancy|0|||
23443542|NCT02343406|65366419|FG001|Overall Study|Other primary malignancy|1|||
23443543|NCT02343406|65366420|FG002|Overall Study|Other primary malignancy|0|||
23443544|NCT02343406|65366421|FG003|Overall Study|Other primary malignancy|0|||
23443545|NCT02343406|65366422|FG004|Overall Study|Other primary malignancy|0|||
23443546|NCT02343406|65366418|FG000|Overall Study|Other, not specified|2|||
23443547|NCT02343406|65366419|FG001|Overall Study|Other, not specified|1|||
23443548|NCT02343406|65366420|FG002|Overall Study|Other, not specified|1|||
23443549|NCT02343406|65366421|FG003|Overall Study|Other, not specified|4|||
23443550|NCT02343406|65366422|FG004|Overall Study|Other, not specified|0|||
23443551|NCT00650767|65366427|FG000|Overall Study|Adverse Event|0|||
23443552|NCT00650767|65366428|FG001|Overall Study|Adverse Event|3|||
23443553|NCT00650767|65366429|FG002|Overall Study|Adverse Event|10|||
23443554|NCT00650767|65366430|FG003|Overall Study|Adverse Event|8|||
23443555|NCT00650767|65366427|FG000|Overall Study|Death|1|||
23443556|NCT00650767|65366428|FG001|Overall Study|Death|0|||
23443557|NCT00650767|65366429|FG002|Overall Study|Death|0|||
23443558|NCT00650767|65366430|FG003|Overall Study|Death|0|||
23443559|NCT00650767|65366427|FG000|Overall Study|Withdrawal by Subject|2|||
23443560|NCT00650767|65366428|FG001|Overall Study|Withdrawal by Subject|4|||
23443561|NCT00650767|65366429|FG002|Overall Study|Withdrawal by Subject|3|||
23443562|NCT00650767|65366430|FG003|Overall Study|Withdrawal by Subject|3|||
23443563|NCT00650767|65366427|FG000|Overall Study|Lost to Follow-up|1|||
23443564|NCT00650767|65366428|FG001|Overall Study|Lost to Follow-up|1|||
23443565|NCT00650767|65366429|FG002|Overall Study|Lost to Follow-up|1|||
23443566|NCT00650767|65366430|FG003|Overall Study|Lost to Follow-up|0|||
23443567|NCT00650767|65366427|FG000|Overall Study|Other|1|||
23443568|NCT00650767|65366428|FG001|Overall Study|Other|1|||
23443569|NCT00650767|65366429|FG002|Overall Study|Other|0|||
23443570|NCT00650767|65366430|FG003|Overall Study|Other|0|||
23443571|NCT02950480|65366432|FG000|Overall Study|Withdrawal by Subject|1|||
23443572|NCT02950480|65366433|FG001|Overall Study|Withdrawal by Subject|0|||
23443573|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Death|2|||
23443574|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Death|0|||
23443575|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Death|0|||
23443576|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
23443577|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
23443578|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
23443579|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
23443580|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
23443581|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
23443582|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
23443583|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
23443584|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
23443585|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
23443586|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
23443587|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
23443588|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
23443589|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
23443590|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
23443591|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Death|2|||
23443592|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Death|0|||
23443593|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Death|0|||
23443594|NCT00714415|65366443|FG000|Overall Study|Lack of Efficacy|1|||
23443595|NCT00714415|65366444|FG001|Overall Study|Lack of Efficacy|0|||
23443596|NCT00714415|65366443|FG000|Overall Study|Death|1|||
23443597|NCT00714415|65366444|FG001|Overall Study|Death|0|||
23443598|NCT00303485|65366445|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
23443599|NCT00303485|65366446|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
23443600|NCT00303485|65366445|FG000|Overall Study|Failure to return|0|||
23443601|NCT00303485|65366446|FG001|Overall Study|Failure to return|1|||
23443602|NCT00303485|65366445|FG000|Overall Study|Withdrawal by Subject|1|||
23443603|NCT00303485|65366446|FG001|Overall Study|Withdrawal by Subject|0|||
23443604|NCT01641601|65366448|FG000|Overall Study|Study discontinued.|3|||
23443605|NCT01641601|65366449|FG001|Overall Study|Study discontinued.|5|||
23443606|NCT00660179|65366450|FG000|Overall Study|Death|44|||
23443607|NCT00660179|65366451|FG001|Overall Study|Death|47|||
23443608|NCT00660179|65366452|FG002|Overall Study|Death|34|||
23443609|NCT00660179|65366450|FG000|Overall Study|Withdrawal of consent|4|||
23443610|NCT00660179|65366451|FG001|Overall Study|Withdrawal of consent|6|||
23443611|NCT00660179|65366452|FG002|Overall Study|Withdrawal of consent|4|||
23443612|NCT00660179|65366450|FG000|Overall Study|Lost to Follow-up|7|||
23443613|NCT00660179|65366451|FG001|Overall Study|Lost to Follow-up|5|||
23443614|NCT00660179|65366452|FG002|Overall Study|Lost to Follow-up|2|||
23443615|NCT00660179|65366450|FG000|Overall Study|Administrative reason|0|||
23443616|NCT00660179|65366451|FG001|Overall Study|Administrative reason|0|||
23443617|NCT00660179|65366452|FG002|Overall Study|Administrative reason|1|||
23443618|NCT00660179|65366450|FG000|Overall Study|Incorrect randomization|1|||
23443619|NCT00660179|65366451|FG001|Overall Study|Incorrect randomization|0|||
23443620|NCT00660179|65366452|FG002|Overall Study|Incorrect randomization|0|||
23443621|NCT00765063|65366453|FG000|Overall Study|Lack of Efficacy|5|||
23443622|NCT00765063|65366453|FG000|Overall Study|Withdrawal by Subject|1|||
23443623|NCT00765063|65366453|FG000|Overall Study|Other|16|||
23443624|NCT00765063|65366453|FG000|Overall Study|Protocol Violation|6|||
23443625|NCT00765063|65366453|FG000|Overall Study|Adverse Event|4|||
23443626|NCT01858766|65366456|FG000|Overall Study|Randomized but Never Treated|0|||
23443627|NCT01858766|65366457|FG001|Overall Study|Randomized but Never Treated|0|||
23443628|NCT01858766|65366458|FG002|Overall Study|Randomized but Never Treated|0|||
23443629|NCT01858766|65366459|FG003|Overall Study|Randomized but Never Treated|0|||
23443630|NCT01858766|65366460|FG004|Overall Study|Randomized but Never Treated|0|||
23443631|NCT01858766|65366461|FG005|Overall Study|Randomized but Never Treated|1|||
23443632|NCT01858766|65366462|FG006|Overall Study|Randomized but Never Treated|0|||
23443633|NCT01858766|65366463|FG007|Overall Study|Randomized but Never Treated|0|||
23443634|NCT01858766|65366464|FG008|Overall Study|Randomized but Never Treated|0|||
23443635|NCT01858766|65366465|FG009|Overall Study|Randomized but Never Treated|0|||
23443636|NCT01858766|65366466|FG010|Overall Study|Randomized but Never Treated|0|||
23443637|NCT01858766|65366467|FG011|Overall Study|Randomized but Never Treated|0|||
23443638|NCT01858766|65366468|FG012|Overall Study|Randomized but Never Treated|0|||
23443639|NCT01858766|65366469|FG013|Overall Study|Randomized but Never Treated|0|||
23443640|NCT01858766|65366470|FG014|Overall Study|Randomized but Never Treated|0|||
23764027|NCT00753714|66514509|FG001|Overall Study|Lack of Efficacy|34|||
23764028|NCT00753714|66514508|FG000|Overall Study|Adverse Event|26|||
23764029|NCT00753714|66514509|FG001|Overall Study|Adverse Event|18|||
23764030|NCT00753714|66514508|FG000|Overall Study|Protocol Violation|1|||
23764031|NCT00753714|66514509|FG001|Overall Study|Protocol Violation|0|||
23764032|NCT00753714|66514508|FG000|Overall Study|Lost to Follow-up|0|||
23764033|NCT00753714|66514509|FG001|Overall Study|Lost to Follow-up|1|||
23764034|NCT00753714|66514508|FG000|Overall Study|Withdrawal by Subject|2|||
23764035|NCT00753714|66514509|FG001|Overall Study|Withdrawal by Subject|1|||
23764036|NCT00753714|66514508|FG000|Overall Study|Death|3|||
23764037|NCT00753714|66514509|FG001|Overall Study|Death|3|||
23764038|NCT00753714|66514508|FG000|Overall Study|Other|7|||
23764039|NCT00753714|66514509|FG001|Overall Study|Other|5|||
23764040|NCT00444795|66514510|FG000|Overall Study|Not Treated|1|||
23764041|NCT00444795|66514510|FG000|Overall Study|Treated Prior to the Contract Date|2|||
23764042|NCT00752791|66514511|FG000|Overall Study|Adverse Event|7|||
23764043|NCT00752791|66514511|FG000|Overall Study|Withdrawal by Subject|1|||
23764044|NCT00752791|66514511|FG000|Overall Study|Physician Decision|1|||
23443641|NCT01858766|65366471|FG015|Overall Study|Randomized but Never Treated|0|||
23443642|NCT01858766|65366472|FG016|Overall Study|Randomized but Never Treated|0|||
23443643|NCT01858766|65366473|FG017|Overall Study|Randomized but Never Treated|1|||
23443644|NCT01858766|65366474|FG018|Overall Study|Randomized but Never Treated|0|||
23443645|NCT01858766|65366456|FG000|Overall Study|Death|0|||
23443646|NCT01858766|65366457|FG001|Overall Study|Death|0|||
23443647|NCT01858766|65366458|FG002|Overall Study|Death|1|||
23443648|NCT01858766|65366459|FG003|Overall Study|Death|0|||
23443649|NCT01858766|65366460|FG004|Overall Study|Death|0|||
23443650|NCT01858766|65366461|FG005|Overall Study|Death|0|||
23443651|NCT01858766|65366462|FG006|Overall Study|Death|0|||
23443652|NCT01858766|65366463|FG007|Overall Study|Death|0|||
23443653|NCT01858766|65366464|FG008|Overall Study|Death|0|||
23764045|NCT00752791|66514511|FG000|Overall Study|Death|1|||
23764046|NCT00752791|66514511|FG000|Overall Study|Renal transplant|3|||
23764047|NCT00752791|66514511|FG000|Overall Study|Switched to hemodialysis|2|||
23764048|NCT00752791|66514511|FG000|Overall Study|Protocol deviation|1|||
23764049|NCT02140164|66514512|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
23443654|NCT01858766|65366465|FG009|Overall Study|Death|0|||
23443655|NCT01858766|65366466|FG010|Overall Study|Death|0|||
23443656|NCT01858766|65366467|FG011|Overall Study|Death|0|||
23443657|NCT01858766|65366468|FG012|Overall Study|Death|0|||
23443658|NCT01858766|65366469|FG013|Overall Study|Death|0|||
23443659|NCT01858766|65366470|FG014|Overall Study|Death|0|||
23443660|NCT01858766|65366471|FG015|Overall Study|Death|0|||
23764050|NCT01965535|66514513|FG000|Overall Study|Lack of Efficacy|2|||
23443661|NCT01858766|65366472|FG016|Overall Study|Death|0|||
23443662|NCT01858766|65366473|FG017|Overall Study|Death|0|||
23443663|NCT01858766|65366474|FG018|Overall Study|Death|0|||
23443664|NCT01858766|65366456|FG000|Overall Study|Lack of Efficacy|1|||
23443665|NCT01858766|65366457|FG001|Overall Study|Lack of Efficacy|0|||
23443666|NCT01858766|65366458|FG002|Overall Study|Lack of Efficacy|0|||
23443667|NCT01858766|65366459|FG003|Overall Study|Lack of Efficacy|0|||
23443668|NCT01858766|65366460|FG004|Overall Study|Lack of Efficacy|1|||
23443669|NCT01858766|65366461|FG005|Overall Study|Lack of Efficacy|2|||
23443670|NCT01858766|65366462|FG006|Overall Study|Lack of Efficacy|0|||
23443671|NCT01858766|65366463|FG007|Overall Study|Lack of Efficacy|0|||
23443672|NCT01858766|65366464|FG008|Overall Study|Lack of Efficacy|0|||
23443673|NCT01858766|65366465|FG009|Overall Study|Lack of Efficacy|0|||
23443674|NCT01858766|65366466|FG010|Overall Study|Lack of Efficacy|0|||
23443675|NCT01858766|65366467|FG011|Overall Study|Lack of Efficacy|3|||
23443676|NCT01858766|65366468|FG012|Overall Study|Lack of Efficacy|5|||
23443677|NCT01858766|65366469|FG013|Overall Study|Lack of Efficacy|3|||
23443678|NCT01858766|65366470|FG014|Overall Study|Lack of Efficacy|5|||
23443679|NCT01858766|65366471|FG015|Overall Study|Lack of Efficacy|5|||
23443680|NCT01858766|65366472|FG016|Overall Study|Lack of Efficacy|2|||
23443681|NCT01858766|65366473|FG017|Overall Study|Lack of Efficacy|3|||
23443682|NCT01858766|65366474|FG018|Overall Study|Lack of Efficacy|3|||
23443683|NCT01858766|65366456|FG000|Overall Study|Lost to Follow-up|0|||
23443684|NCT01858766|65366457|FG001|Overall Study|Lost to Follow-up|0|||
23443685|NCT01858766|65366458|FG002|Overall Study|Lost to Follow-up|0|||
23443686|NCT01858766|65366459|FG003|Overall Study|Lost to Follow-up|0|||
23443687|NCT01858766|65366460|FG004|Overall Study|Lost to Follow-up|0|||
23566601|NCT03430063|65803877|FG002|Overall Study|Progressive disease|1|||
23566602|NCT03430063|65803875|FG000|Overall Study|Other un-specified|1|||
23566603|NCT03430063|65803876|FG001|Overall Study|Other un-specified|1|||
23566604|NCT03430063|65803877|FG002|Overall Study|Other un-specified|0|||
23566605|NCT03430063|65803875|FG000|Overall Study|Randomized, but never treated|0|||
23566606|NCT03430063|65803876|FG001|Overall Study|Randomized, but never treated|0|||
23566607|NCT03430063|65803877|FG002|Overall Study|Randomized, but never treated|1|||
23566608|NCT00803101|65803878|FG000|Overall Study|Death / Serious Adverse Event|4|||
23566609|NCT00803101|65803879|FG001|Overall Study|Death / Serious Adverse Event|6|||
23566610|NCT00803101|65803878|FG000|Overall Study|Withdrawal by Subject|6|||
23566611|NCT00803101|65803879|FG001|Overall Study|Withdrawal by Subject|4|||
23566612|NCT00803101|65803878|FG000|Overall Study|Lost to Follow-up|2|||
23566613|NCT00803101|65803879|FG001|Overall Study|Lost to Follow-up|2|||
23566614|NCT00803101|65803878|FG000|Overall Study|Protocol Violation|1|||
23828540|NCT03351608|66752399|FG002|Overall Study|Lost to Follow-up|1|||
23566615|NCT00803101|65803879|FG001|Overall Study|Protocol Violation|7|||
23566616|NCT00803101|65803878|FG000|Overall Study|Surgery finished outside protocol window|1|||
23566617|NCT00803101|65803879|FG001|Overall Study|Surgery finished outside protocol window|1|||
23566618|NCT00803101|65803878|FG000|Overall Study|Patient died outside SAE report period|1|||
23828541|NCT03351608|66752400|FG003|Overall Study|Lost to Follow-up|1|||
23828542|NCT03351608|66752401|FG004|Overall Study|Lost to Follow-up|1|||
23828543|NCT03351608|66752397|FG000|Overall Study|Physician Decision|1|||
23828544|NCT03351608|66752398|FG001|Overall Study|Physician Decision|0|||
23566619|NCT00803101|65803879|FG001|Overall Study|Patient died outside SAE report period|0|||
23566620|NCT00803101|65803878|FG000|Overall Study|Patient did not attend scheduled visit|2|||
23828545|NCT03351608|66752399|FG002|Overall Study|Physician Decision|0|||
23828546|NCT03351608|66752400|FG003|Overall Study|Physician Decision|2|||
23828547|NCT03351608|66752401|FG004|Overall Study|Physician Decision|1|||
23828548|NCT03351608|66752397|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
23828549|NCT03351608|66752398|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
23828550|NCT03351608|66752399|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
23828551|NCT03351608|66752400|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
23828552|NCT03351608|66752401|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
23828553|NCT03351608|66752397|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23828554|NCT03351608|66752398|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23443688|NCT01858766|65366461|FG005|Overall Study|Lost to Follow-up|1|||
23443689|NCT01858766|65366462|FG006|Overall Study|Lost to Follow-up|0|||
23443690|NCT01858766|65366463|FG007|Overall Study|Lost to Follow-up|2|||
23443691|NCT01858766|65366464|FG008|Overall Study|Lost to Follow-up|0|||
23443692|NCT01858766|65366465|FG009|Overall Study|Lost to Follow-up|0|||
23566621|NCT00803101|65803879|FG001|Overall Study|Patient did not attend scheduled visit|1|||
23566622|NCT00803101|65803878|FG000|Overall Study|Patient did not have surgery|1|||
23828555|NCT03351608|66752399|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23828556|NCT03351608|66752400|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23443693|NCT01858766|65366466|FG010|Overall Study|Lost to Follow-up|0|||
23443694|NCT01858766|65366467|FG011|Overall Study|Lost to Follow-up|1|||
23566623|NCT00803101|65803879|FG001|Overall Study|Patient did not have surgery|1|||
23443695|NCT01858766|65366468|FG012|Overall Study|Lost to Follow-up|0|||
23443696|NCT01858766|65366469|FG013|Overall Study|Lost to Follow-up|0|||
23443697|NCT01858766|65366470|FG014|Overall Study|Lost to Follow-up|3|||
23443698|NCT01858766|65366471|FG015|Overall Study|Lost to Follow-up|1|||
23443699|NCT01858766|65366472|FG016|Overall Study|Lost to Follow-up|1|||
23443700|NCT01858766|65366473|FG017|Overall Study|Lost to Follow-up|0|||
23443701|NCT01858766|65366474|FG018|Overall Study|Lost to Follow-up|1|||
23443702|NCT01858766|65366456|FG000|Overall Study|Withdrew Consent|0|||
23443703|NCT01858766|65366457|FG001|Overall Study|Withdrew Consent|0|||
23443704|NCT01858766|65366458|FG002|Overall Study|Withdrew Consent|0|||
23443705|NCT01858766|65366459|FG003|Overall Study|Withdrew Consent|0|||
23443706|NCT01858766|65366460|FG004|Overall Study|Withdrew Consent|0|||
23443707|NCT01858766|65366461|FG005|Overall Study|Withdrew Consent|0|||
23443708|NCT01858766|65366462|FG006|Overall Study|Withdrew Consent|0|||
23443709|NCT01858766|65366463|FG007|Overall Study|Withdrew Consent|0|||
23443710|NCT01858766|65366464|FG008|Overall Study|Withdrew Consent|0|||
23443711|NCT01858766|65366465|FG009|Overall Study|Withdrew Consent|0|||
23443712|NCT01858766|65366466|FG010|Overall Study|Withdrew Consent|0|||
23443713|NCT01858766|65366467|FG011|Overall Study|Withdrew Consent|1|||
23443714|NCT01858766|65366468|FG012|Overall Study|Withdrew Consent|0|||
23443715|NCT01858766|65366469|FG013|Overall Study|Withdrew Consent|0|||
23443716|NCT01858766|65366470|FG014|Overall Study|Withdrew Consent|0|||
23443717|NCT01858766|65366471|FG015|Overall Study|Withdrew Consent|0|||
23443718|NCT01858766|65366472|FG016|Overall Study|Withdrew Consent|0|||
23443719|NCT01858766|65366473|FG017|Overall Study|Withdrew Consent|0|||
23443720|NCT01858766|65366474|FG018|Overall Study|Withdrew Consent|0|||
23828557|NCT03351608|66752401|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23828558|NCT03351608|66752397|FG000|Overall Study|Other|0|||
23828559|NCT03351608|66752398|FG001|Overall Study|Other|1|||
23828560|NCT03351608|66752399|FG002|Overall Study|Other|1|||
23828561|NCT03351608|66752400|FG003|Overall Study|Other|3|||
23443721|NCT00592904|65366481|FG000|Overall Study|Adverse Event|15|||
23443722|NCT00592904|65366482|FG001|Overall Study|Adverse Event|25|||
23443723|NCT00592904|65366483|FG002|Overall Study|Adverse Event|13|||
23443724|NCT00592904|65366484|FG003|Overall Study|Adverse Event|5|||
23443725|NCT00592904|65366481|FG000|Overall Study|Protocol Violation|1|||
23443726|NCT00592904|65366482|FG001|Overall Study|Protocol Violation|1|||
23443727|NCT00592904|65366483|FG002|Overall Study|Protocol Violation|0|||
23443728|NCT00592904|65366484|FG003|Overall Study|Protocol Violation|1|||
23443729|NCT00592904|65366481|FG000|Overall Study|Withdrawal by Subject|4|||
23443730|NCT00592904|65366482|FG001|Overall Study|Withdrawal by Subject|16|||
23443731|NCT00592904|65366483|FG002|Overall Study|Withdrawal by Subject|1|||
23443732|NCT00592904|65366484|FG003|Overall Study|Withdrawal by Subject|2|||
23443733|NCT00592904|65366481|FG000|Overall Study|Lack of Efficacy|2|||
23443734|NCT00592904|65366482|FG001|Overall Study|Lack of Efficacy|7|||
23443735|NCT00592904|65366483|FG002|Overall Study|Lack of Efficacy|2|||
23443736|NCT00592904|65366484|FG003|Overall Study|Lack of Efficacy|3|||
23443737|NCT00592904|65366481|FG000|Overall Study|Physician Decision|0|||
23443738|NCT00592904|65366482|FG001|Overall Study|Physician Decision|3|||
23443739|NCT00592904|65366483|FG002|Overall Study|Physician Decision|1|||
23764051|NCT01965535|66514514|FG001|Overall Study|Lack of Efficacy|1|||
23764052|NCT00252187|66514516|FG000|Overall Study|Adverse Event|3|||
23764053|NCT00252187|66514517|FG001|Overall Study|Adverse Event|1|||
23764054|NCT00252187|66514516|FG000|Overall Study|Withdrawal by Subject|1|||
23764055|NCT00252187|66514517|FG001|Overall Study|Withdrawal by Subject|0|||
23764056|NCT01333033|66514518|FG000|Overall Study|Ineligible|0|||
23764057|NCT01333033|66514519|FG001|Overall Study|Ineligible|0|||
23764058|NCT01333033|66514520|FG002|Overall Study|Ineligible|0|||
23764059|NCT01333033|66514521|FG003|Overall Study|Ineligible|0|||
23764060|NCT01333033|66514522|FG004|Overall Study|Ineligible|6|||
23764061|NCT01333033|66514523|FG005|Overall Study|Ineligible|8|||
23764062|NCT01333033|66514518|FG000|Overall Study|Withdrawal by Subject|0|||
23764063|NCT01333033|66514519|FG001|Overall Study|Withdrawal by Subject|0|||
23764064|NCT01333033|66514520|FG002|Overall Study|Withdrawal by Subject|0|||
23764065|NCT01333033|66514521|FG003|Overall Study|Withdrawal by Subject|0|||
23764066|NCT01333033|66514522|FG004|Overall Study|Withdrawal by Subject|4|||
23764067|NCT01333033|66514523|FG005|Overall Study|Withdrawal by Subject|2|||
23764068|NCT01333033|66514518|FG000|Overall Study|PET inevaluable|0|||
23764069|NCT01333033|66514519|FG001|Overall Study|PET inevaluable|0|||
23764070|NCT01333033|66514520|FG002|Overall Study|PET inevaluable|0|||
23764071|NCT01333033|66514521|FG003|Overall Study|PET inevaluable|0|||
23764072|NCT01333033|66514522|FG004|Overall Study|PET inevaluable|2|||
23764073|NCT01333033|66514523|FG005|Overall Study|PET inevaluable|4|||
23764074|NCT01333033|66514518|FG000|Overall Study|Adverse Event|0|||
23828562|NCT03351608|66752401|FG004|Overall Study|Other|0|||
23828563|NCT02324582|66752402|FG000|Overall Study|Screen Failures|0|||
23764075|NCT01333033|66514519|FG001|Overall Study|Adverse Event|0|||
23764076|NCT01333033|66514520|FG002|Overall Study|Adverse Event|0|||
23443740|NCT00592904|65366484|FG003|Overall Study|Physician Decision|0|||
23443741|NCT00592904|65366481|FG000|Overall Study|Other|3|||
23443742|NCT00592904|65366482|FG001|Overall Study|Other|3|||
23828564|NCT02324582|66752403|FG001|Overall Study|Screen Failures|5|||
23828565|NCT00654095|66752409|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
23764077|NCT01333033|66514521|FG003|Overall Study|Adverse Event|0|||
23443743|NCT00592904|65366483|FG002|Overall Study|Other|0|||
23443744|NCT00592904|65366484|FG003|Overall Study|Other|0|||
23566624|NCT00708305|65803881|FG000|Period 1|Protocol Violation|1|||
23566625|NCT00708305|65803882|FG001|Period 1|Protocol Violation|0|||
23566626|NCT00708305|65803883|FG002|Period 1|Protocol Violation|1|||
23566627|NCT00708305|65803884|FG003|Period 1|Protocol Violation|0|||
23566628|NCT00708305|65803881|FG000|Period 1|Other Reason|0|||
23566629|NCT00708305|65803882|FG001|Period 1|Other Reason|0|||
23566630|NCT00708305|65803883|FG002|Period 1|Other Reason|0|||
23443745|NCT01928927|65366492|FG000|Overall Study|Lost to Follow-up|1|||
23443746|NCT01928927|65366493|FG001|Overall Study|Lost to Follow-up|0|||
23443747|NCT01928927|65366492|FG000|Overall Study|Withdrawal by Subject|1|||
23566631|NCT00708305|65803884|FG003|Period 1|Other Reason|2|||
23443748|NCT01928927|65366493|FG001|Overall Study|Withdrawal by Subject|1|||
23443749|NCT00291018|65366494|FG000|Overall Study|Not Consented or Declined PAS|12|||
23443750|NCT00291018|65366495|FG001|Overall Study|Not Consented or Declined PAS|15|||
23443751|NCT00291018|65366496|FG002|Overall Study|Not Consented or Declined PAS|15|||
23443752|NCT00291018|65366494|FG000|Overall Study|Death|3|||
23443753|NCT00291018|65366495|FG001|Overall Study|Death|3|||
23443754|NCT00291018|65366496|FG002|Overall Study|Death|4|||
23443755|NCT00291018|65366494|FG000|Overall Study|Withdrawal by Subject|2|||
23443756|NCT00291018|65366495|FG001|Overall Study|Withdrawal by Subject|8|||
23443757|NCT00291018|65366496|FG002|Overall Study|Withdrawal by Subject|1|||
23443758|NCT00291018|65366494|FG000|Overall Study|Failures|5|||
23443759|NCT00291018|65366495|FG001|Overall Study|Failures|12|||
23443760|NCT00291018|65366496|FG002|Overall Study|Failures|5|||
23443761|NCT00291018|65366494|FG000|Overall Study|Lost to Follow-up|3|||
23443762|NCT00291018|65366495|FG001|Overall Study|Lost to Follow-up|4|||
23764078|NCT01333033|66514522|FG004|Overall Study|Adverse Event|2|||
23764079|NCT01333033|66514523|FG005|Overall Study|Adverse Event|1|||
23764080|NCT01333033|66514518|FG000|Overall Study|Progression|0|||
23764081|NCT01333033|66514519|FG001|Overall Study|Progression|0|||
23764082|NCT01333033|66514520|FG002|Overall Study|Progression|0|||
23764083|NCT01333033|66514521|FG003|Overall Study|Progression|0|||
23764084|NCT01333033|66514522|FG004|Overall Study|Progression|0|||
23764085|NCT01333033|66514523|FG005|Overall Study|Progression|1|||
23764086|NCT01333033|66514518|FG000|Overall Study|MD Decision|0|||
23764087|NCT01333033|66514519|FG001|Overall Study|MD Decision|0|||
23764088|NCT01333033|66514520|FG002|Overall Study|MD Decision|0|||
23764089|NCT01333033|66514521|FG003|Overall Study|MD Decision|0|||
23764090|NCT01333033|66514522|FG004|Overall Study|MD Decision|0|||
23764091|NCT01333033|66514523|FG005|Overall Study|MD Decision|2|||
23764092|NCT00759148|66514525|FG000|Overall Study|Adverse Event|1|||
23764093|NCT00759148|66514526|FG001|Overall Study|Adverse Event|6|||
23764094|NCT00759148|66514525|FG000|Overall Study|Withdrawal by Subject|3|||
23764095|NCT00759148|66514526|FG001|Overall Study|Withdrawal by Subject|7|||
23764096|NCT00759148|66514525|FG000|Overall Study|Lost to Follow-up|3|||
23764097|NCT00759148|66514526|FG001|Overall Study|Lost to Follow-up|9|||
23764098|NCT00759148|66514525|FG000|Overall Study|Treatment Failure|6|||
23764099|NCT00759148|66514526|FG001|Overall Study|Treatment Failure|10|||
23764100|NCT00759148|66514525|FG000|Overall Study|Reason not given|1|||
23764101|NCT00759148|66514526|FG001|Overall Study|Reason not given|0|||
23764102|NCT00275028|66514527|FG000|Overall Study|Withdrew consent before treatment began|1|||
23764103|NCT00275028|66514527|FG000|Overall Study|Withdrawal by Subject|5|||
23764104|NCT00275028|66514527|FG000|Overall Study|Adverse Event|9|||
23764105|NCT00275028|66514527|FG000|Overall Study|Progressive Disease|30|||
23764106|NCT00275028|66514527|FG000|Overall Study|Physician Decision|2|||
23764107|NCT02764489|66514530|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
23443763|NCT00291018|65366496|FG002|Overall Study|Lost to Follow-up|18|||
23566632|NCT00708305|65803881|FG000|Period 2|Lost to Follow-up|0|||
23764108|NCT02764489|66514531|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
23764109|NCT02764489|66514530|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
23764110|NCT02764489|66514531|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
23764111|NCT02764489|66514530|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
23443764|NCT03932760|65366497|FG000|Overall Study|Became Ineligible|2|||
23566633|NCT00708305|65803882|FG001|Period 2|Lost to Follow-up|1|||
23764112|NCT02764489|66514531|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
23764113|NCT02764489|66514530|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
23764114|NCT02764489|66514531|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
23764115|NCT02006147|66514532|FG000|Overall Study|Protocol Violation|1|||
23764116|NCT02006147|66514533|FG001|Overall Study|Protocol Violation|1|||
23764117|NCT02006147|66514534|FG002|Overall Study|Protocol Violation|0|||
23764118|NCT02006147|66514535|FG003|Overall Study|Protocol Violation|0|||
23764119|NCT02006147|66514532|FG000|Overall Study|Withdrawal by Subject|0|||
23764120|NCT02006147|66514533|FG001|Overall Study|Withdrawal by Subject|1|||
23764121|NCT02006147|66514534|FG002|Overall Study|Withdrawal by Subject|0|||
23828566|NCT00654095|66752409|FG000|Overall Study|Elevated triglyceride level (2)|1|||
23764122|NCT02006147|66514535|FG003|Overall Study|Withdrawal by Subject|0|||
23764123|NCT02006147|66514532|FG000|Overall Study|Withdrawal by Sponsor|1|||
23764124|NCT02006147|66514533|FG001|Overall Study|Withdrawal by Sponsor|0|||
23764125|NCT02006147|66514534|FG002|Overall Study|Withdrawal by Sponsor|0|||
23764126|NCT02006147|66514535|FG003|Overall Study|Withdrawal by Sponsor|0|||
23764127|NCT03551730|66514536|FG000|Overall Study|Adverse Event|1|||
23764128|NCT03551730|66514537|FG001|Overall Study|Adverse Event|0|||
23764129|NCT03551730|66514538|FG002|Overall Study|Adverse Event|0|||
23764130|NCT03551730|66514539|FG003|Overall Study|Adverse Event|0|||
23764131|NCT01907737|66514540|FG000|Overall Study|Withdrawal by Subject|1|||
23764132|NCT02611752|66514541|FG000|Overall Study|Adverse Event|0|||
23764133|NCT02611752|66514542|FG001|Overall Study|Adverse Event|1|||
23764134|NCT01138150|66514543|FG000|Overall Study|blood unable to be processed|0|||
23764135|NCT01138150|66514544|FG001|Overall Study|blood unable to be processed|1|||
23764136|NCT01138150|66514543|FG000|Overall Study|Physician Decision|1|||
23764137|NCT01138150|66514544|FG001|Overall Study|Physician Decision|0|||
23764138|NCT01199601|66514545|FG000|Overall Study|Lost to Follow-up|47|||
23764139|NCT01199601|66514546|FG001|Overall Study|Lost to Follow-up|66|||
23764140|NCT01199601|66514545|FG000|Overall Study|Withdrawal by Subject|15|||
23764141|NCT01199601|66514546|FG001|Overall Study|Withdrawal by Subject|3|||
23764142|NCT01199601|66514545|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
23764143|NCT01199601|66514546|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
23764144|NCT00909727|66514550|FG000|Overall Study|Adverse Event|1|||
23764145|NCT00909727|66514551|FG001|Overall Study|Adverse Event|0|||
23764146|NCT00909727|66514550|FG000|Overall Study|Wrong Genotype|1|||
23764147|NCT00909727|66514551|FG001|Overall Study|Wrong Genotype|0|||
23764148|NCT00909727|66514550|FG000|Overall Study|Withdrawal of Consent|1|||
23764149|NCT00909727|66514551|FG001|Overall Study|Withdrawal of Consent|0|||
23764150|NCT00909727|66514550|FG000|Overall Study|Prohibited Medication|1|||
23764151|NCT00909727|66514551|FG001|Overall Study|Prohibited Medication|0|||
23828567|NCT00654095|66752409|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
23828568|NCT00654095|66752409|FG000|Overall Study|Adverse Event|11|||
23828569|NCT00654095|66752409|FG000|Overall Study|Withdrawal by Subject|5|||
23828570|NCT00654095|66752409|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
23828571|NCT00654095|66752409|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
23828572|NCT00654095|66752409|FG000|Overall Study|Did not meet inclusion criteria|1|||
23828573|NCT01707290|66752410|FG000|Overall Study|Adverse event (AE)|1|||
23828574|NCT01707290|66752411|FG001|Overall Study|Adverse event (AE)|0|||
23828575|NCT01707290|66752410|FG000|Overall Study|Physician Decision|1|||
23828576|NCT01707290|66752411|FG001|Overall Study|Physician Decision|0|||
23828577|NCT01707290|66752410|FG000|Overall Study|Lost to Follow-up|3|||
23828578|NCT01707290|66752411|FG001|Overall Study|Lost to Follow-up|0|||
23828579|NCT01707290|66752410|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
23828580|NCT01707290|66752411|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
23828581|NCT01707290|66752410|FG000|Overall Study|Commercial drug available|60|||
23828582|NCT01707290|66752411|FG001|Overall Study|Commercial drug available|1|||
23828583|NCT01707290|66752410|FG000|Overall Study|Other unspecified|17|||
23828584|NCT01707290|66752411|FG001|Overall Study|Other unspecified|0|||
23828585|NCT03657797|66752412|FG000|Overall Study|Lost to Follow-up|0|||
23828586|NCT03657797|66752413|FG001|Overall Study|Lost to Follow-up|1|||
23828587|NCT03657797|66752414|FG002|Overall Study|Lost to Follow-up|1|||
23828588|NCT03657797|66752415|FG003|Overall Study|Lost to Follow-up|0|||
23828589|NCT03657797|66752412|FG000|Overall Study|Physician Decision|0|||
23828590|NCT03657797|66752413|FG001|Overall Study|Physician Decision|1|||
23828591|NCT03657797|66752414|FG002|Overall Study|Physician Decision|0|||
23828592|NCT03657797|66752415|FG003|Overall Study|Physician Decision|0|||
23828593|NCT03657797|66752412|FG000|Overall Study|Withdrawal by Subject|0|||
23828594|NCT03657797|66752413|FG001|Overall Study|Withdrawal by Subject|1|||
23828595|NCT03657797|66752414|FG002|Overall Study|Withdrawal by Subject|2|||
23828596|NCT03657797|66752415|FG003|Overall Study|Withdrawal by Subject|0|||
23828597|NCT03657797|66752412|FG000|Overall Study|Adverse Event|0|||
23828598|NCT03657797|66752413|FG001|Overall Study|Adverse Event|0|||
23828599|NCT03657797|66752414|FG002|Overall Study|Adverse Event|2|||
23828600|NCT03657797|66752415|FG003|Overall Study|Adverse Event|0|||
23828601|NCT03871543|66752416|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
23828602|NCT03871543|66752416|FG000|Period 1|Investigator Error|1|||
23828603|NCT03871543|66752416|FG000|Period 1|Protocol Violation|2|||
23828604|NCT03871543|66752416|FG000|Period 1|COVID-19 Related|1|||
23828605|NCT03871543|66752416|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
23828606|NCT03871543|66752416|FG000|Period 1|Withdrawal by Subject|10|||
23828607|NCT03871543|66752416|FG000|Period 2|Adverse Event|1|||
23764152|NCT01606137|66514554|FG000|Overall Study|Adverse Event|85|||
23764153|NCT01606137|66514554|FG000|Overall Study|Withdrawal by Subject|74|||
23764154|NCT01606137|66514554|FG000|Overall Study|Lack of Efficacy|56|||
23764155|NCT01606137|66514554|FG000|Overall Study|Lost to Follow-up|15|||
23764156|NCT01606137|66514554|FG000|Overall Study|Protocol Violation|1|||
23764157|NCT01606137|66514554|FG000|Overall Study|Patient non-compliance|9|||
23764158|NCT01606137|66514554|FG000|Overall Study|Death|1|||
23566634|NCT00708305|65803883|FG002|Period 2|Lost to Follow-up|0|||
23566635|NCT00708305|65803884|FG003|Period 2|Lost to Follow-up|0|||
23566636|NCT00708305|65803881|FG000|Period 2|Protocol Violation|0|||
23566637|NCT00708305|65803882|FG001|Period 2|Protocol Violation|1|||
23566638|NCT00708305|65803883|FG002|Period 2|Protocol Violation|0|||
23566639|NCT00708305|65803884|FG003|Period 2|Protocol Violation|0|||
23566640|NCT00708305|65803881|FG000|Period 2|Other Reason|1|||
23566641|NCT00708305|65803882|FG001|Period 2|Other Reason|0|||
23566642|NCT00708305|65803883|FG002|Period 2|Other Reason|0|||
23566643|NCT00708305|65803884|FG003|Period 2|Other Reason|1|||
23566644|NCT00708305|65803881|FG000|Period 3|Protocol Violation|0|||
23566645|NCT00708305|65803882|FG001|Period 3|Protocol Violation|2|||
23566646|NCT00708305|65803883|FG002|Period 3|Protocol Violation|0|||
23566647|NCT00708305|65803884|FG003|Period 3|Protocol Violation|0|||
23764159|NCT01606137|66514554|FG000|Overall Study|Decreased/no pain|4|||
23764160|NCT01606137|66514554|FG000|Overall Study|Issues with driving|4|||
23764161|NCT01606137|66514554|FG000|Overall Study|multiple sclerosis less stable|1|||
23764162|NCT01606137|66514554|FG000|Overall Study|Increased bilirubin|1|||
23764163|NCT01606137|66514554|FG000|Overall Study|Spray causes nausea|1|||
23764164|NCT01606137|66514554|FG000|Overall Study|Not enough improvement|4|||
23764165|NCT01606137|66514554|FG000|Overall Study|Wanted to try another treatment|1|||
23764166|NCT01606137|66514554|FG000|Overall Study|Patient leaving country|1|||
23764167|NCT01606137|66514554|FG000|Overall Study|Personal reasons|1|||
23764168|NCT01606137|66514554|FG000|Overall Study|Unable to tolerate study med. taste|1|||
23764169|NCT01606137|66514554|FG000|Overall Study|Patient moving|1|||
23764170|NCT01606137|66514554|FG000|Overall Study|Unable to collect consistent data|1|||
23764171|NCT00481247|66514557|FG000|Overall Study|Death|0|||
23764172|NCT00481247|66514558|FG001|Overall Study|Death|1|||
23764173|NCT00481247|66514557|FG000|Overall Study|Disease progression|18|||
23764174|NCT00481247|66514558|FG001|Overall Study|Disease progression|22|||
23764175|NCT00481247|66514557|FG000|Overall Study|Intolerance|42|||
23764176|NCT00481247|66514558|FG001|Overall Study|Intolerance|17|||
23764177|NCT00481247|66514557|FG000|Overall Study|Treatment failure|10|||
23764178|NCT00481247|66514558|FG001|Overall Study|Treatment failure|14|||
23764179|NCT00481247|66514557|FG000|Overall Study|AE unrelated to study drug|13|||
23764180|NCT00481247|66514558|FG001|Overall Study|AE unrelated to study drug|4|||
23764181|NCT00481247|66514557|FG000|Overall Study|Withdrawal by Subject|8|||
23764182|NCT00481247|66514558|FG001|Overall Study|Withdrawal by Subject|13|||
23764183|NCT00481247|66514557|FG000|Overall Study|Pregnancy|2|||
23764184|NCT00481247|66514558|FG001|Overall Study|Pregnancy|1|||
23764185|NCT00481247|66514557|FG000|Overall Study|Lost to Follow-up|1|||
23764186|NCT00481247|66514558|FG001|Overall Study|Lost to Follow-up|2|||
23764187|NCT00481247|66514557|FG000|Overall Study|Poor compliance/noncompliance|1|||
23764188|NCT00481247|66514558|FG001|Overall Study|Poor compliance/noncompliance|7|||
23764189|NCT00481247|66514557|FG000|Overall Study|Administrative reason by sponsor|157|||
23764190|NCT00481247|66514558|FG001|Overall Study|Administrative reason by sponsor|162|||
23764191|NCT00481247|66514557|FG000|Overall Study|Varied|6|||
23828608|NCT03871543|66752416|FG000|Period 2|Withdrawal by Subject|1|||
23828609|NCT03500198|66752417|FG000|Overall Study|Lost to Follow-up|0|||
23828610|NCT03500198|66752418|FG001|Overall Study|Lost to Follow-up|1|||
23828611|NCT04158648|66752421|FG000|Overall Study|Ongoing in the Study|69|||
23828612|NCT04158648|66752421|FG000|Overall Study|Withdrawal by Subject|4|||
23566648|NCT00708305|65803881|FG000|Period 3|Other Reason|1|||
23566649|NCT00708305|65803882|FG001|Period 3|Other Reason|0|||
23764192|NCT00481247|66514558|FG001|Overall Study|Varied|15|||
23764193|NCT00481247|66514557|FG000|Overall Study|Did not receive treatment|1|||
23764194|NCT00481247|66514558|FG001|Overall Study|Did not receive treatment|2|||
23764195|NCT04014959|66514561|FG000|Baseline MRI and Assessments|Physician Decision|2|||
23764196|NCT04014959|66514561|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
23764197|NCT04014959|66514561|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
23764198|NCT02035137|66514562|FG000|Overall Study|Physician Decision|0|||
23566650|NCT00708305|65803883|FG002|Period 3|Other Reason|0|||
23566651|NCT00708305|65803884|FG003|Period 3|Other Reason|0|||
23566652|NCT00669903|65803885|FG000|Overall Study|Adverse Event|0|||
23566653|NCT00669903|65803886|FG001|Overall Study|Adverse Event|1|||
23566654|NCT00669903|65803887|FG002|Overall Study|Adverse Event|3|||
23566655|NCT00669903|65803888|FG003|Overall Study|Adverse Event|1|||
23764199|NCT02035137|66514563|FG001|Overall Study|Physician Decision|0|||
23764200|NCT02035137|66514564|FG002|Overall Study|Physician Decision|1|||
23764201|NCT02035137|66514562|FG000|Overall Study|Withdrawal by Subject|0|||
23764202|NCT02035137|66514563|FG001|Overall Study|Withdrawal by Subject|1|||
23764203|NCT02035137|66514564|FG002|Overall Study|Withdrawal by Subject|2|||
23764204|NCT02035137|66514562|FG000|Overall Study|Ineligible|0|||
23764205|NCT02035137|66514563|FG001|Overall Study|Ineligible|1|||
23764206|NCT02035137|66514564|FG002|Overall Study|Ineligible|2|||
23764207|NCT02035137|66514562|FG000|Overall Study|Disease progression prior to treatment start|2|||
23764208|NCT02035137|66514563|FG001|Overall Study|Disease progression prior to treatment start|0|||
23828613|NCT00931411|66752422|FG000|First Intervention - 42 Days|Adverse Event|2|||
23628556|NCT02881047|66028032|FG000|Overall Study|Adverse Event|1|||
23566656|NCT00669903|65803885|FG000|Overall Study|Withdrawal by Subject|0|||
23566657|NCT00669903|65803886|FG001|Overall Study|Withdrawal by Subject|2|||
23566658|NCT00669903|65803887|FG002|Overall Study|Withdrawal by Subject|2|||
23566659|NCT00669903|65803888|FG003|Overall Study|Withdrawal by Subject|2|||
23764209|NCT02035137|66514564|FG002|Overall Study|Disease progression prior to treatment start|0|||
23764210|NCT00979628|66514565|FG000|Overall Study|received regimen < 24 hours|7|||
23764211|NCT00979628|66514566|FG001|Overall Study|received regimen < 24 hours|6|||
23566660|NCT00669903|65803885|FG000|Overall Study|Lost to Follow-up|1|||
23566661|NCT00669903|65803886|FG001|Overall Study|Lost to Follow-up|1|||
23566662|NCT00669903|65803887|FG002|Overall Study|Lost to Follow-up|0|||
23566663|NCT00669903|65803888|FG003|Overall Study|Lost to Follow-up|1|||
23566664|NCT00669903|65803885|FG000|Overall Study|Protocol Violation|0|||
23566665|NCT00669903|65803886|FG001|Overall Study|Protocol Violation|1|||
23566666|NCT00669903|65803887|FG002|Overall Study|Protocol Violation|0|||
23566667|NCT00669903|65803888|FG003|Overall Study|Protocol Violation|0|||
23566668|NCT00779584|65803891|FG000|Overall Study|Protocol Violation|0|||
23764212|NCT00979628|66514567|FG002|Overall Study|received regimen < 24 hours|5|||
23764213|NCT00979628|66514565|FG000|Overall Study|received steroids|1|||
23764214|NCT00979628|66514566|FG001|Overall Study|received steroids|1|||
23764215|NCT00979628|66514567|FG002|Overall Study|received steroids|0|||
23764216|NCT00979628|66514565|FG000|Overall Study|transferred to ICU|1|||
23764217|NCT00979628|66514566|FG001|Overall Study|transferred to ICU|2|||
23764218|NCT00979628|66514567|FG002|Overall Study|transferred to ICU|1|||
23828614|NCT00931411|66752423|FG001|First Intervention - 42 Days|Adverse Event|3|||
23828615|NCT00931411|66752422|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
23828616|NCT00931411|66752423|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
23828617|NCT00931411|66752422|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
23828618|NCT00931411|66752423|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
23828619|NCT01863667|66752424|FG000|Overall Study|Adverse Event|1|||
23828620|NCT01863667|66752425|FG001|Overall Study|Adverse Event|0|||
23828621|NCT01863667|66752424|FG000|Overall Study|Study terminated by Sponsor|30|||
23828622|NCT01863667|66752425|FG001|Overall Study|Study terminated by Sponsor|30|||
23828623|NCT01863667|66752424|FG000|Overall Study|Withdrawal by Subject|2|||
23828624|NCT01863667|66752425|FG001|Overall Study|Withdrawal by Subject|2|||
23828625|NCT00370552|66752426|FG000|Overall Study|Adverse Event|2|||
23828626|NCT00370552|66752427|FG001|Overall Study|Adverse Event|2|||
23828627|NCT00370552|66752428|FG002|Overall Study|Adverse Event|2|||
23828628|NCT00370552|66752426|FG000|Overall Study|Disease progression|23|||
23828629|NCT00370552|66752427|FG001|Overall Study|Disease progression|23|||
23828630|NCT00370552|66752428|FG002|Overall Study|Disease progression|15|||
23828631|NCT00370552|66752426|FG000|Overall Study|Maximum clinical benefit|3|||
23828632|NCT00370552|66752427|FG001|Overall Study|Maximum clinical benefit|5|||
23828633|NCT00370552|66752428|FG002|Overall Study|Maximum clinical benefit|5|||
23828634|NCT00370552|66752426|FG000|Overall Study|Poor or noncompliance|0|||
23828635|NCT00370552|66752427|FG001|Overall Study|Poor or noncompliance|0|||
23828636|NCT00370552|66752428|FG002|Overall Study|Poor or noncompliance|1|||
23828637|NCT00370552|66752426|FG000|Overall Study|Study drug toxicity|11|||
23828638|NCT00370552|66752427|FG001|Overall Study|Study drug toxicity|8|||
23828639|NCT00370552|66752428|FG002|Overall Study|Study drug toxicity|6|||
23828640|NCT00370552|66752426|FG000|Overall Study|Withdrawal by Subject|2|||
23828641|NCT00370552|66752427|FG001|Overall Study|Withdrawal by Subject|0|||
23828642|NCT00370552|66752428|FG002|Overall Study|Withdrawal by Subject|1|||
23828643|NCT00370552|66752426|FG000|Overall Study|Still on treatment|1|||
23828644|NCT00370552|66752427|FG001|Overall Study|Still on treatment|3|||
23828645|NCT00370552|66752428|FG002|Overall Study|Still on treatment|2|||
23828646|NCT00370552|66752426|FG000|Overall Study|Never treated|1|||
23828647|NCT00370552|66752427|FG001|Overall Study|Never treated|0|||
23828648|NCT00370552|66752428|FG002|Overall Study|Never treated|0|||
23828649|NCT00370552|66752426|FG000|Overall Study|Physician Decision|1|||
23828650|NCT00370552|66752427|FG001|Overall Study|Physician Decision|1|||
23764219|NCT02143947|66514574|FG000|Overall Study|Lost to Follow-up|4|||
23828651|NCT00370552|66752428|FG002|Overall Study|Physician Decision|0|||
23828652|NCT00370552|66752426|FG000|Overall Study|Investigator decision|2|||
23828653|NCT00370552|66752427|FG001|Overall Study|Investigator decision|1|||
23828654|NCT00370552|66752428|FG002|Overall Study|Investigator decision|0|||
23828655|NCT00370552|66752426|FG000|Overall Study|High risk of allergic reaction|0|||
23828656|NCT00370552|66752427|FG001|Overall Study|High risk of allergic reaction|1|||
23566669|NCT00779584|65803892|FG001|Overall Study|Protocol Violation|0|||
23566670|NCT00779584|65803893|FG002|Overall Study|Protocol Violation|0|||
23828657|NCT00370552|66752428|FG002|Overall Study|High risk of allergic reaction|0|||
23828658|NCT00370552|66752426|FG000|Overall Study|Planned radiation for palliation|0|||
23828659|NCT00370552|66752427|FG001|Overall Study|Planned radiation for palliation|1|||
23828660|NCT00370552|66752428|FG002|Overall Study|Planned radiation for palliation|0|||
23443765|NCT03932760|65366498|FG001|Overall Study|Became Ineligible|5|||
23764220|NCT02143947|66514575|FG001|Overall Study|Lost to Follow-up|2|||
23566671|NCT00779584|65803894|FG003|Overall Study|Protocol Violation|0|||
23782288|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23828661|NCT02857816|66752430|FG000|Overall Study|Screen Failure|33|||
23828662|NCT02857816|66752430|FG000|Overall Study|Withdrawal by Subject|4|||
23828663|NCT02857816|66752430|FG000|Overall Study|Lost to Follow-up|1|||
23828664|NCT00503698|66752431|FG000|Overall Study|Protocol Violation|5|||
23828665|NCT00503698|66752432|FG001|Overall Study|Protocol Violation|6|||
23828666|NCT00503698|66752431|FG000|Overall Study|Adverse Event|52|||
23828667|NCT00503698|66752432|FG001|Overall Study|Adverse Event|41|||
23566672|NCT00779584|65803895|FG004|Overall Study|Protocol Violation|0|||
23566673|NCT00779584|65803896|FG005|Overall Study|Protocol Violation|1|||
23764221|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
23764222|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764223|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764224|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764225|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764226|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764227|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23764228|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
23764229|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764230|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764231|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764232|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764233|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764234|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23764235|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
23764236|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
23764237|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
23764238|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
23764239|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
23764240|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
23828668|NCT00503698|66752431|FG000|Overall Study|Death|1|||
23443766|NCT03932760|65366497|FG000|Overall Study|Withdrawal by Subject|6|||
23443767|NCT03932760|65366498|FG001|Overall Study|Withdrawal by Subject|6|||
23566674|NCT00779584|65803897|FG006|Overall Study|Protocol Violation|0|||
23566675|NCT00779584|65803898|FG007|Overall Study|Protocol Violation|0|||
23566676|NCT00779584|65803899|FG008|Overall Study|Protocol Violation|0|||
23566677|NCT00779584|65803891|FG000|Overall Study|Withdrawal by Subject|1|||
23566678|NCT00779584|65803892|FG001|Overall Study|Withdrawal by Subject|1|||
23566679|NCT00779584|65803893|FG002|Overall Study|Withdrawal by Subject|2|||
23566680|NCT00779584|65803894|FG003|Overall Study|Withdrawal by Subject|0|||
23566681|NCT00779584|65803895|FG004|Overall Study|Withdrawal by Subject|0|||
23566682|NCT00779584|65803896|FG005|Overall Study|Withdrawal by Subject|2|||
23566683|NCT00779584|65803897|FG006|Overall Study|Withdrawal by Subject|1|||
23566684|NCT00779584|65803898|FG007|Overall Study|Withdrawal by Subject|0|||
23628557|NCT02881047|66028032|FG000|Overall Study|Withdrawal by Subject|1|||
23566685|NCT00779584|65803899|FG008|Overall Study|Withdrawal by Subject|0|||
23566686|NCT00779584|65803891|FG000|Overall Study|Lost to Follow-up|0|||
23566687|NCT00779584|65803892|FG001|Overall Study|Lost to Follow-up|0|||
23566688|NCT00779584|65803893|FG002|Overall Study|Lost to Follow-up|0|||
23566689|NCT00779584|65803894|FG003|Overall Study|Lost to Follow-up|0|||
23566690|NCT00779584|65803895|FG004|Overall Study|Lost to Follow-up|1|||
23566691|NCT00779584|65803896|FG005|Overall Study|Lost to Follow-up|0|||
23566692|NCT00779584|65803897|FG006|Overall Study|Lost to Follow-up|0|||
23566693|NCT00779584|65803898|FG007|Overall Study|Lost to Follow-up|0|||
23566694|NCT00779584|65803899|FG008|Overall Study|Lost to Follow-up|0|||
23566695|NCT00779584|65803891|FG000|Overall Study|Progression of Disease|0|||
23566696|NCT00779584|65803892|FG001|Overall Study|Progression of Disease|1|||
23566697|NCT00779584|65803893|FG002|Overall Study|Progression of Disease|2|||
23628558|NCT03024996|66028033|FG000|Overall Study|Death|57|||
23828669|NCT00503698|66752432|FG001|Overall Study|Death|0|||
23566698|NCT00779584|65803894|FG003|Overall Study|Progression of Disease|6|||
23628559|NCT03024996|66028034|FG001|Overall Study|Death|55|||
23443768|NCT01732770|65366501|FG000|Overall Study|Lost to Follow-up|2|||
23443769|NCT01732770|65366502|FG001|Overall Study|Lost to Follow-up|3|||
23443770|NCT01732770|65366501|FG000|Overall Study|Withdrawal by Subject|5|||
23443771|NCT01732770|65366502|FG001|Overall Study|Withdrawal by Subject|3|||
23443772|NCT01732770|65366501|FG000|Overall Study|Decision by Sponsor|2|||
23628560|NCT03024996|66028033|FG000|Overall Study|Disease relapse|1|||
23628561|NCT03024996|66028034|FG001|Overall Study|Disease relapse|0|||
23628562|NCT03024996|66028033|FG000|Overall Study|Lost to Follow-up|5|||
23628563|NCT03024996|66028034|FG001|Overall Study|Lost to Follow-up|10|||
23628564|NCT03024996|66028033|FG000|Overall Study|Other|3|||
23628565|NCT03024996|66028034|FG001|Overall Study|Other|3|||
23764241|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
23764242|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
23764243|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764244|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764245|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764246|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764247|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764248|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23764249|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
23764250|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23764251|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23764252|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23764253|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23764254|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23764255|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23566699|NCT00779584|65803895|FG004|Overall Study|Progression of Disease|5|||
23566700|NCT00779584|65803896|FG005|Overall Study|Progression of Disease|1|||
23566701|NCT00779584|65803897|FG006|Overall Study|Progression of Disease|4|||
23566702|NCT00779584|65803898|FG007|Overall Study|Progression of Disease|2|||
23566703|NCT00779584|65803899|FG008|Overall Study|Progression of Disease|1|||
23566704|NCT00779584|65803891|FG000|Overall Study|Adverse Event|1|||
23566705|NCT00779584|65803892|FG001|Overall Study|Adverse Event|0|||
23566706|NCT00779584|65803893|FG002|Overall Study|Adverse Event|2|||
23566707|NCT00779584|65803894|FG003|Overall Study|Adverse Event|0|||
23566708|NCT00779584|65803895|FG004|Overall Study|Adverse Event|0|||
23566709|NCT00779584|65803896|FG005|Overall Study|Adverse Event|0|||
23566710|NCT00779584|65803897|FG006|Overall Study|Adverse Event|2|||
23566711|NCT00779584|65803898|FG007|Overall Study|Adverse Event|1|||
23566712|NCT00779584|65803899|FG008|Overall Study|Adverse Event|1|||
23566713|NCT00779584|65803891|FG000|Overall Study|Symptomatic Deterioration|1|||
23566714|NCT00779584|65803892|FG001|Overall Study|Symptomatic Deterioration|1|||
23566715|NCT00779584|65803893|FG002|Overall Study|Symptomatic Deterioration|1|||
23566716|NCT00779584|65803894|FG003|Overall Study|Symptomatic Deterioration|0|||
23566717|NCT00779584|65803895|FG004|Overall Study|Symptomatic Deterioration|0|||
23566718|NCT00779584|65803896|FG005|Overall Study|Symptomatic Deterioration|1|||
23566719|NCT00779584|65803897|FG006|Overall Study|Symptomatic Deterioration|1|||
23566720|NCT00779584|65803898|FG007|Overall Study|Symptomatic Deterioration|0|||
23566721|NCT00779584|65803899|FG008|Overall Study|Symptomatic Deterioration|0|||
23566722|NCT00779584|65803891|FG000|Overall Study|Ongoing in Study|0|||
23566723|NCT00779584|65803892|FG001|Overall Study|Ongoing in Study|0|||
23566724|NCT00779584|65803893|FG002|Overall Study|Ongoing in Study|0|||
23566725|NCT00779584|65803894|FG003|Overall Study|Ongoing in Study|0|||
23566726|NCT00779584|65803895|FG004|Overall Study|Ongoing in Study|1|||
23566727|NCT00779584|65803896|FG005|Overall Study|Ongoing in Study|1|||
23566728|NCT00779584|65803897|FG006|Overall Study|Ongoing in Study|0|||
23566729|NCT00779584|65803898|FG007|Overall Study|Ongoing in Study|0|||
23566730|NCT00779584|65803899|FG008|Overall Study|Ongoing in Study|0|||
23566731|NCT02906202|65803900|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
23566732|NCT02357810|65803901|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
23566733|NCT02357810|65803901|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
23566734|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Adverse Event|5|||
23566735|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
23566736|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
23566737|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
23566738|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Death|1|||
23764256|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
23566739|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Physician Decision|1|||
23566740|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Other|1|||
23566741|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
23566742|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
23566743|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
23566744|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
23628566|NCT03024996|66028033|FG000|Overall Study|Physician Decision|0|||
23764257|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764258|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764259|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764260|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764261|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764262|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
23764263|NCT00606684|66514576|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
23764264|NCT00606684|66514577|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764265|NCT00606684|66514578|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764266|NCT00606684|66514579|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764267|NCT00606684|66514580|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764268|NCT00606684|66514581|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764269|NCT00606684|66514582|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23764270|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23764271|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Adverse Event|3|||
23764272|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Adverse Event|2|||
23764273|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Adverse Event|4|||
23764274|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Adverse Event|2|||
23764275|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Adverse Event|0|||
23764276|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Adverse Event|1|||
23764277|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23764278|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23764279|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23764280|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
23764281|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
23764282|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
23764283|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
23443773|NCT01732770|65366502|FG001|Overall Study|Decision by Sponsor|2|||
23443774|NCT01732770|65366501|FG000|Overall Study|Death|1|||
23443775|NCT01732770|65366502|FG001|Overall Study|Death|0|||
23443776|NCT01559675|65366503|FG000|Overall Study|Protocol Violation|1|||
23443777|NCT01559675|65366504|FG001|Overall Study|Protocol Violation|2|||
23443778|NCT01559675|65366503|FG000|Overall Study|2nd operation on same patient excluded|14|||
23443779|NCT01559675|65366504|FG001|Overall Study|2nd operation on same patient excluded|12|||
23443780|NCT00711971|65366505|FG000|Overall Study|Lost to Follow-up|3|||
23566745|NCT02357810|65803901|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
23566746|NCT02357810|65803901|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
23566747|NCT00845871|65803902|FG000|Assessment Period|Adverse Event|2|||
23566748|NCT00845871|65803902|FG000|Assessment Period|Abnormal laboratory values|1|||
23566749|NCT00845871|65803902|FG000|Assessment Period|Abnormal test procedure results|1|||
23566750|NCT00845871|65803902|FG000|Assessment Period|Patient withdrew consent|3|||
23566751|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566752|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566753|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566754|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566755|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566756|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
23566757|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566758|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566759|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566760|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566761|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566762|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
23566763|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566764|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566765|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566766|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23628567|NCT03024996|66028034|FG001|Overall Study|Physician Decision|1|||
23628568|NCT03024996|66028033|FG000|Overall Study|Study terminated by sponsor|303|||
23628569|NCT03024996|66028034|FG001|Overall Study|Study terminated by sponsor|283|||
23628570|NCT03024996|66028033|FG000|Overall Study|Withdrawal by Subject|21|||
23628571|NCT03024996|66028034|FG001|Overall Study|Withdrawal by Subject|36|||
23764284|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23764285|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
23764286|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
23764287|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
23828670|NCT00503698|66752431|FG000|Overall Study|Lack of Efficacy|3|||
23628572|NCT02706951|66028035|FG000|Period 1|Adverse Event|1|||
23443781|NCT00711971|65366506|FG001|Overall Study|Lost to Follow-up|4|||
23764288|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
23764289|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
23764290|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
23764291|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
23764292|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23764293|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
23764294|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23764295|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
23764296|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
23764297|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23764298|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23764299|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Physician Decision|5|||
23764300|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Physician Decision|1|||
23764301|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23764302|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Physician Decision|3|||
23764303|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Physician Decision|1|||
23764304|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Physician Decision|2|||
23764305|NCT00606684|66514576|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23764306|NCT00606684|66514577|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23764307|NCT00606684|66514578|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23764308|NCT00606684|66514579|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23764309|NCT00606684|66514580|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23764310|NCT00606684|66514581|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23764311|NCT00606684|66514582|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23764312|NCT03627195|66514583|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
23764313|NCT03627195|66514584|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23764314|NCT03627195|66514585|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23764315|NCT03627195|66514586|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23764316|NCT03627195|66514587|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23764317|NCT03627195|66514588|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23764318|NCT02668783|66514589|FG000|Overall Study|Pregnancy|0|||
23764319|NCT02668783|66514590|FG001|Overall Study|Pregnancy|1|||
23764320|NCT02668783|66514589|FG000|Overall Study|Protocol Violation|2|||
23764321|NCT02668783|66514590|FG001|Overall Study|Protocol Violation|1|||
23764322|NCT02668783|66514589|FG000|Overall Study|Study terminated by sponsor|9|||
23764323|NCT02668783|66514590|FG001|Overall Study|Study terminated by sponsor|10|||
23764324|NCT02668783|66514589|FG000|Overall Study|Subject moved|1|||
23764325|NCT02668783|66514590|FG001|Overall Study|Subject moved|0|||
23764326|NCT02668783|66514589|FG000|Overall Study|Withdrawal by Subject|1|||
23764327|NCT02668783|66514590|FG001|Overall Study|Withdrawal by Subject|0|||
23764328|NCT00613574|66514591|FG000|Overall Study|Adverse Event|3|||
23764329|NCT00613574|66514591|FG000|Overall Study|Lost to Follow-up|2|||
23764330|NCT00613574|66514591|FG000|Overall Study|Other|1|||
23764331|NCT01859702|66514602|FG000|Overall Study|Protocol deviation|3|||
23764332|NCT01859702|66514602|FG000|Overall Study|Adverse Event|2|||
23764333|NCT03372369|66514603|FG000|Qualification Period|Withdrawal by Subject|16|||
23764334|NCT03372369|66514604|FG001|Qualification Period|Withdrawal by Subject|13|||
23764335|NCT03372369|66514603|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
23764336|NCT03372369|66514604|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
23764337|NCT03372369|66514603|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
23764338|NCT03372369|66514604|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
23764339|NCT01809314|66514605|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
23764340|NCT01809314|66514605|FG000|Overall Study|Adverse Event|6|||
23764341|NCT01809314|66514605|FG000|Overall Study|Insufficient Therapeutic Response|14|||
23764342|NCT01809314|66514605|FG000|Overall Study|Lost to Follow-up|724|||
23764343|NCT02049359|66514611|FG000|Overall Study|Lost to Follow-up|26|||
23764344|NCT02049359|66514612|FG001|Overall Study|Lost to Follow-up|19|||
23764345|NCT02497391|66514613|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
23764346|NCT02497391|66514614|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
23764347|NCT02497391|66514615|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
23764348|NCT02497391|66514616|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
23828671|NCT00503698|66752432|FG001|Overall Study|Lack of Efficacy|4|||
23566767|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23764349|NCT02497391|66514617|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
23764350|NCT02497391|66514618|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
23764351|NCT02497391|66514613|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
23764352|NCT02497391|66514614|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
23764353|NCT02497391|66514615|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
23764354|NCT02497391|66514616|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
23764355|NCT02497391|66514617|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
23828672|NCT00503698|66752431|FG000|Overall Study|Trial terminated|216|||
23764356|NCT02497391|66514618|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
23764357|NCT02497391|66514613|FG000|Period 3 (14 Days)|Adverse Event|0|||
23764358|NCT02497391|66514614|FG001|Period 3 (14 Days)|Adverse Event|1|||
23764359|NCT02497391|66514615|FG002|Period 3 (14 Days)|Adverse Event|0|||
23764360|NCT02497391|66514616|FG003|Period 3 (14 Days)|Adverse Event|0|||
23764361|NCT02497391|66514617|FG004|Period 3 (14 Days)|Adverse Event|0|||
23764362|NCT02497391|66514618|FG005|Period 3 (14 Days)|Adverse Event|0|||
23764363|NCT02497391|66514613|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
23764364|NCT02497391|66514614|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
23764365|NCT02497391|66514615|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
23764366|NCT02497391|66514616|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
23764367|NCT02497391|66514617|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
23764368|NCT02497391|66514618|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
23764369|NCT02497391|66514613|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
23764370|NCT02497391|66514614|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
23764371|NCT02497391|66514615|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
23764372|NCT02497391|66514616|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
23764373|NCT02497391|66514617|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
23764374|NCT02497391|66514618|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
23764375|NCT03652961|66514619|FG000|Overall Study|Lost to Follow-up|3|||
23764376|NCT03652961|66514619|FG000|Overall Study|Screen Failure|1|||
23764377|NCT02360397|66514620|FG000|Overall Study|Incomplete screening|3|||
23764378|NCT02360397|66514620|FG000|Overall Study|Adverse Event|1|||
23764379|NCT01580020|66514622|FG000|Overall Study|Lack of Efficacy|0|||
23764380|NCT01580020|66514623|FG001|Overall Study|Lack of Efficacy|5|||
23764381|NCT01580020|66514624|FG002|Overall Study|Lack of Efficacy|0|||
23764382|NCT01580020|66514625|FG003|Overall Study|Lack of Efficacy|1|||
23764383|NCT01580020|66514622|FG000|Overall Study|Withdrawal by Subject|0|||
23764384|NCT01580020|66514623|FG001|Overall Study|Withdrawal by Subject|1|||
23764385|NCT01580020|66514624|FG002|Overall Study|Withdrawal by Subject|1|||
23764386|NCT01580020|66514625|FG003|Overall Study|Withdrawal by Subject|0|||
23764387|NCT01580020|66514622|FG000|Overall Study|Adverse Event|1|||
23764388|NCT01580020|66514623|FG001|Overall Study|Adverse Event|1|||
23764389|NCT01580020|66514624|FG002|Overall Study|Adverse Event|1|||
23764390|NCT01580020|66514625|FG003|Overall Study|Adverse Event|1|||
23764391|NCT01580020|66514622|FG000|Overall Study|Administrative Problems|0|||
23566768|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
23566769|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566770|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566771|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566772|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566773|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566774|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566775|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
23566776|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566777|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566778|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566779|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566780|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566781|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566782|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566783|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566784|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
23566785|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566786|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
23566787|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566788|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566789|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
23566790|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566791|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566792|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566793|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566794|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566795|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566796|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566797|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566798|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566799|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566800|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566801|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566802|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566803|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566804|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
23566805|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566806|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566807|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566808|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566809|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566810|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566811|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566812|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566813|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
23566814|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566815|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566816|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566817|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566818|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566819|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566820|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566821|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566822|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566823|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566824|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566825|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566826|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
23764392|NCT01580020|66514623|FG001|Overall Study|Administrative Problems|0|||
23764393|NCT01580020|66514624|FG002|Overall Study|Administrative Problems|1|||
23566827|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
23764394|NCT01580020|66514625|FG003|Overall Study|Administrative Problems|0|||
23764395|NCT01580020|66514622|FG000|Overall Study|Lost to Follow-up|0|||
23566828|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566829|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566830|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566831|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566832|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566833|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566834|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566835|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
23566836|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
23566837|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
23566838|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
23566839|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Other|0|||
23566840|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Other|0|||
23566841|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Other|0|||
23566842|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Other|0|||
23566843|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Other|0|||
23566844|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Other|0|||
23566845|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Other|0|||
23566846|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Other|0|||
23566847|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Other|2|||
23566848|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Other|2|||
23566849|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Other|0|||
23566850|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Death|0|||
23566851|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Death|0|||
23566852|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Death|0|||
23566853|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Death|0|||
23566854|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Death|0|||
23566855|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Death|0|||
23566856|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Death|0|||
23566857|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Death|0|||
23566858|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Death|1|||
23566859|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Death|0|||
23566860|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Death|0|||
23566861|NCT04318093|65803918|FG000|Overall Study|Adverse Event|2|||
23566862|NCT04318093|65803919|FG001|Overall Study|Adverse Event|2|||
23566863|NCT04318093|65803918|FG000|Overall Study|Participant withdrew consent|1|||
23566864|NCT04318093|65803919|FG001|Overall Study|Participant withdrew consent|0|||
23566865|NCT04318093|65803918|FG000|Overall Study|Other reasons|0|||
23566866|NCT04318093|65803919|FG001|Overall Study|Other reasons|1|||
23566867|NCT04041440|65803920|FG000|Overall Study|Withdrawal by Subject|0|||
23566868|NCT04041440|65803921|FG001|Overall Study|Withdrawal by Subject|1|||
23566869|NCT04041440|65803920|FG000|Overall Study|Lost to Follow-up|0|||
23566870|NCT04041440|65803921|FG001|Overall Study|Lost to Follow-up|1|||
23566871|NCT01381874|65803923|FG000|Overall Study|Lost to Follow-up|1|||
23566872|NCT01381874|65803924|FG001|Overall Study|Lost to Follow-up|1|||
23566873|NCT01381874|65803925|FG002|Overall Study|Lost to Follow-up|0|||
23566874|NCT01381874|65803923|FG000|Overall Study|Withdrawal by Subject|9|||
23566875|NCT01381874|65803924|FG001|Overall Study|Withdrawal by Subject|10|||
23566876|NCT01381874|65803925|FG002|Overall Study|Withdrawal by Subject|9|||
23566877|NCT01381874|65803923|FG000|Overall Study|Other|67|||
23566878|NCT01381874|65803924|FG001|Overall Study|Other|52|||
23566879|NCT01381874|65803925|FG002|Overall Study|Other|67|||
23566880|NCT02387996|65803926|FG000|Overall Study|Disease Progression|167|||
23566881|NCT02387996|65803926|FG000|Overall Study|Study Drug Toxicity|31|||
23566882|NCT02387996|65803926|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
23764396|NCT01580020|66514623|FG001|Overall Study|Lost to Follow-up|0|||
23764397|NCT01580020|66514624|FG002|Overall Study|Lost to Follow-up|1|||
23764398|NCT01580020|66514625|FG003|Overall Study|Lost to Follow-up|0|||
23764399|NCT01214330|66514626|FG000|Overall Study|Withdrawal by Subject|2|||
23764400|NCT01214330|66514626|FG000|Overall Study|Withdrawal by Subject|2|||
23764401|NCT00788957|66514627|FG000|Part 1|Death|8|||
23764402|NCT00788957|66514628|FG001|Part 1|Death|0|||
23764403|NCT00788957|66514629|FG002|Part 1|Death|0|||
23764404|NCT00788957|66514630|FG003|Part 1|Death|0|||
23764405|NCT00788957|66514631|FG004|Part 1|Death|0|||
23566883|NCT02387996|65803926|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
23566884|NCT02387996|65803926|FG000|Overall Study|Subject Withdrew Consent|5|||
23566885|NCT02387996|65803926|FG000|Overall Study|Lost to Follow-up|1|||
23566886|NCT02387996|65803926|FG000|Overall Study|Poor/Non-Compliance|1|||
23566887|NCT02387996|65803926|FG000|Overall Study|Other Reasons|5|||
23566888|NCT02387996|65803926|FG000|Overall Study|Death|1|||
23566889|NCT00847301|65803931|FG000|Overall Study|Adverse Event|35|||
23566890|NCT00847301|65803931|FG000|Overall Study|Switch to other anticoagulants|16|||
23566891|NCT00847301|65803931|FG000|Overall Study|Lost to Follow-up|1|||
23566892|NCT00847301|65803931|FG000|Overall Study|No prescription after hospital discharge|1|||
23764406|NCT00788957|66514632|FG005|Part 1|Death|0|||
23566893|NCT00847301|65803931|FG000|Overall Study|Other reason not defined above|1|||
23566894|NCT00152971|65803932|FG000|Overall Study|Adverse Event|12|||
23566895|NCT00152971|65803933|FG001|Overall Study|Adverse Event|10|||
23566896|NCT00152971|65803934|FG002|Overall Study|Adverse Event|9|||
23566897|NCT00152971|65803932|FG000|Overall Study|Protocol Violation|10|||
23566898|NCT00152971|65803933|FG001|Overall Study|Protocol Violation|11|||
23566899|NCT00152971|65803934|FG002|Overall Study|Protocol Violation|8|||
23566900|NCT00152971|65803932|FG000|Overall Study|Lost to Follow-up|17|||
23566901|NCT00152971|65803933|FG001|Overall Study|Lost to Follow-up|14|||
23764407|NCT00788957|66514627|FG000|Part 1|Lost to Follow-up|1|||
23764408|NCT00788957|66514628|FG001|Part 1|Lost to Follow-up|0|||
23764409|NCT00788957|66514629|FG002|Part 1|Lost to Follow-up|0|||
23764410|NCT00788957|66514630|FG003|Part 1|Lost to Follow-up|0|||
23764411|NCT00788957|66514631|FG004|Part 1|Lost to Follow-up|0|||
23764412|NCT00788957|66514632|FG005|Part 1|Lost to Follow-up|0|||
23764413|NCT00788957|66514627|FG000|Part 2|Withdrawal by Subject|0|||
23764414|NCT00788957|66514628|FG001|Part 2|Withdrawal by Subject|9|||
23764415|NCT00788957|66514629|FG002|Part 2|Withdrawal by Subject|5|||
23764416|NCT00788957|66514630|FG003|Part 2|Withdrawal by Subject|3|||
23764417|NCT00788957|66514631|FG004|Part 2|Withdrawal by Subject|0|||
23566902|NCT00152971|65803934|FG002|Overall Study|Lost to Follow-up|13|||
23764418|NCT00788957|66514632|FG005|Part 2|Withdrawal by Subject|0|||
23764419|NCT00788957|66514627|FG000|Part 2|Death|0|||
23764420|NCT00788957|66514628|FG001|Part 2|Death|32|||
23764421|NCT00788957|66514629|FG002|Part 2|Death|35|||
23764422|NCT00788957|66514630|FG003|Part 2|Death|37|||
23764423|NCT00788957|66514631|FG004|Part 2|Death|0|||
23764424|NCT00788957|66514632|FG005|Part 2|Death|0|||
23764425|NCT00788957|66514627|FG000|Part 2|Lost to Follow-up|0|||
23764426|NCT00788957|66514628|FG001|Part 2|Lost to Follow-up|0|||
23764427|NCT00788957|66514629|FG002|Part 2|Lost to Follow-up|3|||
23764428|NCT00788957|66514630|FG003|Part 2|Lost to Follow-up|0|||
23764429|NCT00788957|66514631|FG004|Part 2|Lost to Follow-up|0|||
23764430|NCT00788957|66514632|FG005|Part 2|Lost to Follow-up|0|||
23764431|NCT00788957|66514627|FG000|Part 2|On-study at time of data cut-off|0|||
23764432|NCT00788957|66514628|FG001|Part 2|On-study at time of data cut-off|1|||
23764433|NCT00788957|66514629|FG002|Part 2|On-study at time of data cut-off|1|||
23764434|NCT00788957|66514630|FG003|Part 2|On-study at time of data cut-off|1|||
23764435|NCT00788957|66514631|FG004|Part 2|On-study at time of data cut-off|0|||
23764436|NCT00788957|66514632|FG005|Part 2|On-study at time of data cut-off|0|||
23764437|NCT00788957|66514627|FG000|Part 3|Withdrawal by Subject|0|||
23764438|NCT00788957|66514628|FG001|Part 3|Withdrawal by Subject|0|||
23764439|NCT00788957|66514629|FG002|Part 3|Withdrawal by Subject|0|||
23764440|NCT00788957|66514630|FG003|Part 3|Withdrawal by Subject|0|||
23764441|NCT00788957|66514631|FG004|Part 3|Withdrawal by Subject|0|||
23764442|NCT00788957|66514632|FG005|Part 3|Withdrawal by Subject|2|||
23764443|NCT00788957|66514627|FG000|Part 3|Death|0|||
23764444|NCT00788957|66514628|FG001|Part 3|Death|0|||
23764445|NCT00788957|66514629|FG002|Part 3|Death|0|||
23443782|NCT00711971|65366507|FG002|Overall Study|Lost to Follow-up|1|||
23443783|NCT01946152|65366508|FG000|Overall Study|Adverse Event|1|||
23443784|NCT01946152|65366509|FG001|Overall Study|Adverse Event|0|||
23443785|NCT01946152|65366510|FG002|Overall Study|Adverse Event|0|||
23443786|NCT01946152|65366511|FG003|Overall Study|Adverse Event|0|||
23443787|NCT01946152|65366508|FG000|Overall Study|Withdrawal by Subject|0|||
23443788|NCT01946152|65366509|FG001|Overall Study|Withdrawal by Subject|2|||
23443789|NCT01946152|65366510|FG002|Overall Study|Withdrawal by Subject|0|||
23443790|NCT01946152|65366511|FG003|Overall Study|Withdrawal by Subject|0|||
23443791|NCT01946152|65366508|FG000|Overall Study|Progression|0|||
23443792|NCT01946152|65366509|FG001|Overall Study|Progression|1|||
23566903|NCT00152971|65803932|FG000|Overall Study|Withdrawal by Subject|9|||
23566904|NCT00152971|65803933|FG001|Overall Study|Withdrawal by Subject|8|||
23566905|NCT00152971|65803934|FG002|Overall Study|Withdrawal by Subject|14|||
23443793|NCT01946152|65366510|FG002|Overall Study|Progression|4|||
23443794|NCT01946152|65366511|FG003|Overall Study|Progression|7|||
23566906|NCT00152971|65803932|FG000|Overall Study|Other|3|||
23764446|NCT00788957|66514630|FG003|Part 3|Death|0|||
23764447|NCT00788957|66514631|FG004|Part 3|Death|8|||
23443795|NCT01946152|65366508|FG000|Overall Study|Physician Decision|0|||
23566907|NCT00152971|65803933|FG001|Overall Study|Other|5|||
23764448|NCT00788957|66514632|FG005|Part 3|Death|8|||
23764449|NCT00788957|66514627|FG000|Part 3|On-study at time of data cut-off|0|||
23764450|NCT00788957|66514628|FG001|Part 3|On-study at time of data cut-off|0|||
23764451|NCT00788957|66514629|FG002|Part 3|On-study at time of data cut-off|0|||
23764452|NCT00788957|66514630|FG003|Part 3|On-study at time of data cut-off|0|||
23443796|NCT01946152|65366509|FG001|Overall Study|Physician Decision|0|||
23443797|NCT01946152|65366510|FG002|Overall Study|Physician Decision|1|||
23566908|NCT00152971|65803934|FG002|Overall Study|Other|5|||
23566909|NCT00152971|65803932|FG000|Treatment|Adverse Event|49|||
23764453|NCT00788957|66514631|FG004|Part 3|On-study at time of data cut-off|1|||
23764454|NCT00788957|66514632|FG005|Part 3|On-study at time of data cut-off|0|||
23764455|NCT00583596|66514633|FG000|Overall Study|Lost to Follow-up|110|||
23764456|NCT00583596|66514633|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
23764457|NCT00583596|66514633|FG000|Overall Study|Death|2|||
23764458|NCT00583596|66514633|FG000|Overall Study|Withdrawal by Subject|6|||
23764459|NCT00583596|66514633|FG000|Overall Study|Lost to Follow-up|94|||
23764460|NCT00583596|66514633|FG000|Overall Study|Data not complete|1|||
23764461|NCT00583596|66514633|FG000|Overall Study|Not consented|15|||
23443798|NCT01946152|65366511|FG003|Overall Study|Physician Decision|0|||
23443799|NCT01946152|65366508|FG000|Overall Study|Second malignancy|0|||
23443800|NCT01946152|65366509|FG001|Overall Study|Second malignancy|0|||
23443801|NCT01946152|65366510|FG002|Overall Study|Second malignancy|1|||
23764462|NCT00583596|66514633|FG000|Overall Study|Outside f-up window|26|||
23764463|NCT02752776|66514634|FG000|Overall Study|Adverse Event|15|||
23764464|NCT02752776|66514635|FG001|Overall Study|Adverse Event|23|||
23764465|NCT02752776|66514636|FG002|Overall Study|Adverse Event|11|||
23764466|NCT02752776|66514634|FG000|Overall Study|Lack of Efficacy|2|||
23764467|NCT02752776|66514635|FG001|Overall Study|Lack of Efficacy|6|||
23764468|NCT02752776|66514636|FG002|Overall Study|Lack of Efficacy|14|||
23764469|NCT02752776|66514634|FG000|Overall Study|Lost to Follow-up|11|||
23764470|NCT02752776|66514635|FG001|Overall Study|Lost to Follow-up|12|||
23764471|NCT02752776|66514636|FG002|Overall Study|Lost to Follow-up|4|||
23764472|NCT02752776|66514634|FG000|Overall Study|Non-compliance with study treatment|0|||
23764473|NCT02752776|66514635|FG001|Overall Study|Non-compliance with study treatment|0|||
23764474|NCT02752776|66514636|FG002|Overall Study|Non-compliance with study treatment|1|||
23764475|NCT02752776|66514634|FG000|Overall Study|Physician Decision|2|||
23764476|NCT02752776|66514635|FG001|Overall Study|Physician Decision|6|||
23764477|NCT02752776|66514636|FG002|Overall Study|Physician Decision|2|||
23764478|NCT02752776|66514634|FG000|Overall Study|Pregnancy|1|||
23443802|NCT01946152|65366511|FG003|Overall Study|Second malignancy|0|||
23443803|NCT01946152|65366508|FG000|Overall Study|Adverse Event|0|||
23443804|NCT01946152|65366509|FG001|Overall Study|Adverse Event|0|||
23443805|NCT01946152|65366510|FG002|Overall Study|Adverse Event|0|||
23443806|NCT01946152|65366511|FG003|Overall Study|Adverse Event|1|||
23443807|NCT01970306|65366516|FG000|Overall Study|Not eligible|3|||
23443808|NCT01970306|65366516|FG000|Overall Study|Not able to be treated|9|||
23443809|NCT00566852|65366521|FG000|Overall Study|Protocol Violation|22|||
23443810|NCT00566852|65366522|FG001|Overall Study|Protocol Violation|24|||
23443811|NCT00566852|65366521|FG000|Overall Study|Death|95|||
23443812|NCT00566852|65366522|FG001|Overall Study|Death|78|||
23443813|NCT00566852|65366521|FG000|Overall Study|Withdrawal by Subject|30|||
23443814|NCT00566852|65366522|FG001|Overall Study|Withdrawal by Subject|25|||
23443815|NCT00566852|65366521|FG000|Overall Study|Patient refusal|37|||
23443816|NCT00566852|65366522|FG001|Overall Study|Patient refusal|37|||
23443817|NCT00566852|65366521|FG000|Overall Study|Not tested due to disability|6|||
23443818|NCT00566852|65366522|FG001|Overall Study|Not tested due to disability|12|||
23443819|NCT00566852|65366521|FG000|Overall Study|Missing reason not specified|1|||
23443820|NCT00566852|65366522|FG001|Overall Study|Missing reason not specified|2|||
23443821|NCT00566852|65366521|FG000|Overall Study|Missing reason not reported|16|||
23443822|NCT00566852|65366522|FG001|Overall Study|Missing reason not reported|20|||
23443823|NCT00279916|65366528|FG000|Overall Study|Withdrawal by Subject|4|||
23443824|NCT00279916|65366529|FG001|Overall Study|Withdrawal by Subject|3|||
23443825|NCT00279916|65366528|FG000|Overall Study|Lost to Follow-up|3|||
23443826|NCT00279916|65366529|FG001|Overall Study|Lost to Follow-up|2|||
23443827|NCT01279616|65366533|FG000|Overall Study|donor could not be located|5|||
23443828|NCT01279616|65366533|FG000|Overall Study|no signs of sickle cell disease|2|||
23443829|NCT00596830|65366534|FG000|Overall Study|Death|258|||
23443830|NCT00596830|65366535|FG001|Overall Study|Death|247|||
23443831|NCT00596830|65366534|FG000|Overall Study|Lost to Follow-up|7|||
23764479|NCT02752776|66514635|FG001|Overall Study|Pregnancy|6|||
23764480|NCT02752776|66514636|FG002|Overall Study|Pregnancy|3|||
23443832|NCT00596830|65366535|FG001|Overall Study|Lost to Follow-up|11|||
23443833|NCT00596830|65366534|FG000|Overall Study|Withdrawal by Subject|22|||
23443834|NCT00596830|65366535|FG001|Overall Study|Withdrawal by Subject|12|||
23443835|NCT00596830|65366534|FG000|Overall Study|Study terminated by sponsor|51|||
23443836|NCT00596830|65366535|FG001|Overall Study|Study terminated by sponsor|62|||
23443837|NCT00596830|65366534|FG000|Overall Study|Follow-up was discontinued|1|||
23443838|NCT00596830|65366535|FG001|Overall Study|Follow-up was discontinued|0|||
23443839|NCT00596830|65366534|FG000|Overall Study|Randomized but not treated|3|||
23443840|NCT00596830|65366535|FG001|Overall Study|Randomized but not treated|7|||
23443841|NCT02292446|65366536|FG000|Overall Study|Adverse Event|12|||
23764481|NCT02752776|66514634|FG000|Overall Study|Protocol Violation|10|||
23443842|NCT02292446|65366536|FG000|Overall Study|Death|1|||
23443843|NCT02292446|65366536|FG000|Overall Study|Disease progression|2|||
23764482|NCT02752776|66514635|FG001|Overall Study|Protocol Violation|13|||
23764483|NCT02752776|66514636|FG002|Overall Study|Protocol Violation|6|||
23764484|NCT02752776|66514634|FG000|Overall Study|Subject/guardian decision|8|||
23443844|NCT02292446|65366536|FG000|Overall Study|Subject/guardian decision|2|||
23443845|NCT02292446|65366536|FG000|Overall Study|Withdrawal by Subject|3|||
23764485|NCT02752776|66514635|FG001|Overall Study|Subject/guardian decision|6|||
23764486|NCT02752776|66514636|FG002|Overall Study|Subject/guardian decision|4|||
23764487|NCT02752776|66514634|FG000|Overall Study|Death|0|||
23443846|NCT01835158|65366540|FG000|Overall Study|Withdrawal by Subject|1|||
23443847|NCT01835158|65366541|FG001|Overall Study|Withdrawal by Subject|6|||
23443848|NCT01286740|65366544|FG000|Overall Study|Enrolled but not treated|1|||
23443849|NCT01286740|65366544|FG000|Overall Study|Protocol Violation|1|||
23443850|NCT01587040|65366545|FG000|Overall Study|Protocol Violation|0|||
23443851|NCT01587040|65366546|FG001|Overall Study|Protocol Violation|0|||
23828673|NCT00503698|66752432|FG001|Overall Study|Trial terminated|253|||
23828674|NCT00503698|66752431|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
23828675|NCT00503698|66752432|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
23828676|NCT00503698|66752431|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
23828677|NCT00503698|66752432|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
23828678|NCT00503698|66752431|FG000|Overall Study|Any condition in exclusion criteria|4|||
23828679|NCT00503698|66752432|FG001|Overall Study|Any condition in exclusion criteria|6|||
23828680|NCT00503698|66752431|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
23828681|NCT00503698|66752432|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
23828682|NCT00503698|66752431|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
23828683|NCT00503698|66752432|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
23828684|NCT00503698|66752431|FG000|Overall Study|Critically ill|2|||
23828685|NCT00503698|66752432|FG001|Overall Study|Critically ill|0|||
23828686|NCT00503698|66752431|FG000|Overall Study|Unclassified|48|||
23828687|NCT00503698|66752432|FG001|Overall Study|Unclassified|32|||
23828688|NCT00503698|66752431|FG000|Overall Study|Not exposed to trial drug|11|||
23828689|NCT00503698|66752432|FG001|Overall Study|Not exposed to trial drug|6|||
23828690|NCT01214655|66752437|FG000|Part A|Progressive Disease|7|||
23828691|NCT01214655|66752438|FG001|Part A|Progressive Disease|0|||
23828692|NCT01214655|66752439|FG002|Part A|Progressive Disease|0|||
23828693|NCT01214655|66752437|FG000|Part A|Physician Decision|1|||
23828694|NCT01214655|66752438|FG001|Part A|Physician Decision|0|||
23828695|NCT01214655|66752439|FG002|Part A|Physician Decision|0|||
23828696|NCT01214655|66752437|FG000|Part B|Progressive disease|0|||
23828697|NCT01214655|66752438|FG001|Part B|Progressive disease|10|||
23828698|NCT01214655|66752439|FG002|Part B|Progressive disease|0|||
23828699|NCT01214655|66752437|FG000|Part B|Death|0|||
23828700|NCT01214655|66752438|FG001|Part B|Death|1|||
23828701|NCT01214655|66752439|FG002|Part B|Death|0|||
23828702|NCT01214655|66752437|FG000|Part B|Withdrawal by Subject|0|||
23828703|NCT01214655|66752438|FG001|Part B|Withdrawal by Subject|2|||
23828704|NCT01214655|66752439|FG002|Part B|Withdrawal by Subject|0|||
23828705|NCT01214655|66752437|FG000|Part C|Progressive Disease|0|||
23828706|NCT01214655|66752438|FG001|Part C|Progressive Disease|0|||
23828707|NCT01214655|66752439|FG002|Part C|Progressive Disease|5|||
23828708|NCT01214655|66752437|FG000|Part C|Death|0|||
23828709|NCT01214655|66752438|FG001|Part C|Death|0|||
23828710|NCT01214655|66752439|FG002|Part C|Death|1|||
23828711|NCT01214655|66752437|FG000|Part C|Physician Decision|0|||
23828712|NCT01214655|66752438|FG001|Part C|Physician Decision|0|||
23828713|NCT01214655|66752439|FG002|Part C|Physician Decision|1|||
23828714|NCT02232984|66752440|FG000|Overall Study|Withdrawal by Subject|5|||
23828715|NCT02232984|66752440|FG000|Overall Study|Death|1|||
23828716|NCT02232984|66752440|FG000|Overall Study|Investigator withdrawal|10|||
23828717|NCT02232984|66752440|FG000|Overall Study|Device implant unsuccessful|53|||
23828718|NCT02232984|66752440|FG000|Overall Study|not disclosed by site|7|||
23828719|NCT02232984|66752440|FG000|Overall Study|Protocol Violation|1|||
23828720|NCT02287922|66752441|FG000|Overall Study|Adverse Event|1|||
23828721|NCT02287922|66752442|FG001|Overall Study|Adverse Event|1|||
23443852|NCT01587040|65366547|FG002|Overall Study|Protocol Violation|1|||
23443853|NCT01587040|65366548|FG003|Overall Study|Protocol Violation|0|||
23443854|NCT01587040|65366545|FG000|Overall Study|Adverse Event|0|||
23443855|NCT01587040|65366546|FG001|Overall Study|Adverse Event|1|||
23566910|NCT00152971|65803933|FG001|Treatment|Adverse Event|40|||
23566911|NCT00152971|65803934|FG002|Treatment|Adverse Event|54|||
23566912|NCT00152971|65803932|FG000|Treatment|Protocol Violation|8|||
23566913|NCT00152971|65803933|FG001|Treatment|Protocol Violation|6|||
23566914|NCT00152971|65803934|FG002|Treatment|Protocol Violation|10|||
23566915|NCT00152971|65803932|FG000|Treatment|Lost to Follow-up|1|||
23566916|NCT00152971|65803933|FG001|Treatment|Lost to Follow-up|2|||
23566917|NCT00152971|65803934|FG002|Treatment|Lost to Follow-up|1|||
23566918|NCT00152971|65803932|FG000|Treatment|Withdrawal by Subject|4|||
23566919|NCT00152971|65803933|FG001|Treatment|Withdrawal by Subject|4|||
23566920|NCT00152971|65803934|FG002|Treatment|Withdrawal by Subject|5|||
23566921|NCT00152971|65803932|FG000|Treatment|Other|9|||
23828722|NCT02287922|66752443|FG002|Overall Study|Adverse Event|3|||
23828723|NCT02287922|66752444|FG003|Overall Study|Adverse Event|4|||
23828724|NCT02287922|66752441|FG000|Overall Study|Withdrawal by Subject|1|||
23566922|NCT00152971|65803933|FG001|Treatment|Other|11|||
23566923|NCT00152971|65803934|FG002|Treatment|Other|10|||
23566924|NCT00674323|65803935|FG000|Overall Study|Adverse Event|0|||
23828725|NCT02287922|66752442|FG001|Overall Study|Withdrawal by Subject|1|||
23828726|NCT02287922|66752443|FG002|Overall Study|Withdrawal by Subject|1|||
23828727|NCT02287922|66752444|FG003|Overall Study|Withdrawal by Subject|2|||
23828728|NCT02287922|66752441|FG000|Overall Study|Lost to Follow-up|0|||
23828729|NCT02287922|66752442|FG001|Overall Study|Lost to Follow-up|0|||
23828730|NCT02287922|66752443|FG002|Overall Study|Lost to Follow-up|1|||
23828731|NCT02287922|66752444|FG003|Overall Study|Lost to Follow-up|0|||
23828732|NCT02287922|66752441|FG000|Overall Study|Sponsor's decision|0|||
23828733|NCT02287922|66752442|FG001|Overall Study|Sponsor's decision|0|||
23828734|NCT02287922|66752443|FG002|Overall Study|Sponsor's decision|0|||
23828735|NCT02287922|66752444|FG003|Overall Study|Sponsor's decision|1|||
23828736|NCT02287922|66752441|FG000|Overall Study|Other|1|||
23828737|NCT02287922|66752442|FG001|Overall Study|Other|0|||
23443856|NCT01587040|65366547|FG002|Overall Study|Adverse Event|10|||
23443857|NCT01587040|65366548|FG003|Overall Study|Adverse Event|0|||
23443858|NCT01587040|65366545|FG000|Overall Study|Disease progression|12|||
23443859|NCT01587040|65366546|FG001|Overall Study|Disease progression|1|||
23764488|NCT02752776|66514635|FG001|Overall Study|Death|0|||
23764489|NCT02752776|66514636|FG002|Overall Study|Death|1|||
23764490|NCT02752776|66514634|FG000|Overall Study|Withdrawal by Subject|3|||
23764491|NCT02752776|66514635|FG001|Overall Study|Withdrawal by Subject|4|||
23764492|NCT02752776|66514636|FG002|Overall Study|Withdrawal by Subject|2|||
23764493|NCT00832078|66514637|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
23764494|NCT00832078|66514638|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
23764495|NCT00832078|66514637|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
23764496|NCT00832078|66514638|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
23764497|NCT00814658|66514639|FG000|Overall Study|Lost to Follow-up|0|||
23764498|NCT00814658|66514640|FG001|Overall Study|Lost to Follow-up|1|||
23828738|NCT02287922|66752443|FG002|Overall Study|Other|2|||
23828739|NCT02287922|66752444|FG003|Overall Study|Other|0|||
23828740|NCT04263311|66752449|FG000|Overall Study|Lost to Follow-up|1|||
23828741|NCT04263311|66752450|FG001|Overall Study|Lost to Follow-up|2|||
23764499|NCT00814658|66514639|FG000|Overall Study|Physician Decision|1|||
23764500|NCT00814658|66514640|FG001|Overall Study|Physician Decision|0|||
23764501|NCT00814658|66514639|FG000|Overall Study|Adverse Event|3|||
23828742|NCT04263311|66752449|FG000|Overall Study|Health Issues|1|||
23828743|NCT04263311|66752450|FG001|Overall Study|Health Issues|0|||
23828744|NCT04263311|66752449|FG000|Overall Study|Left the country|1|||
23443860|NCT01587040|65366547|FG002|Overall Study|Disease progression|15|||
23443861|NCT01587040|65366548|FG003|Overall Study|Disease progression|3|||
23566925|NCT00674323|65803936|FG001|Overall Study|Adverse Event|1|||
23566926|NCT00674323|65803937|FG002|Overall Study|Adverse Event|0|||
23566927|NCT00674323|65803935|FG000|Overall Study|Protocol Violation|1|||
23566928|NCT00674323|65803936|FG001|Overall Study|Protocol Violation|0|||
23828745|NCT04263311|66752450|FG001|Overall Study|Left the country|0|||
23828746|NCT04263311|66752449|FG000|Overall Study|Unable to maintain time commitment|1|||
23828747|NCT04263311|66752450|FG001|Overall Study|Unable to maintain time commitment|0|||
23828748|NCT04263311|66752449|FG000|Overall Study|No longer interested|1|||
23828749|NCT04263311|66752450|FG001|Overall Study|No longer interested|0|||
23828750|NCT02968576|66752451|FG000|Overall Study|Pregnancy|0|||
23828751|NCT02968576|66752452|FG001|Overall Study|Pregnancy|1|||
23828752|NCT01812109|66752453|FG000|Overall Study|research personnel delay|16|||
23828753|NCT01812109|66752453|FG000|Overall Study|NIRS Unattainable|17|||
23828754|NCT02762929|66752456|FG000|Overall Study|Adverse Event|0|||
23828755|NCT02762929|66752457|FG001|Overall Study|Adverse Event|0|||
23828756|NCT02762929|66752458|FG002|Overall Study|Adverse Event|0|||
23828757|NCT02762929|66752459|FG003|Overall Study|Adverse Event|1|||
23828758|NCT02762929|66752460|FG004|Overall Study|Adverse Event|0|||
23828759|NCT02762929|66752461|FG005|Overall Study|Adverse Event|0|||
23828760|NCT02762929|66752456|FG000|Overall Study|Lost to Follow-up|1|||
23828761|NCT02762929|66752457|FG001|Overall Study|Lost to Follow-up|2|||
23828762|NCT02762929|66752458|FG002|Overall Study|Lost to Follow-up|0|||
23828763|NCT02762929|66752459|FG003|Overall Study|Lost to Follow-up|1|||
23828764|NCT02762929|66752460|FG004|Overall Study|Lost to Follow-up|0|||
23828765|NCT02762929|66752461|FG005|Overall Study|Lost to Follow-up|0|||
23828766|NCT02762929|66752456|FG000|Overall Study|Withdrawal by Subject|0|||
23828767|NCT02762929|66752457|FG001|Overall Study|Withdrawal by Subject|1|||
23828768|NCT02762929|66752458|FG002|Overall Study|Withdrawal by Subject|0|||
23828769|NCT02762929|66752459|FG003|Overall Study|Withdrawal by Subject|0|||
23828770|NCT02762929|66752460|FG004|Overall Study|Withdrawal by Subject|0|||
23828771|NCT02762929|66752461|FG005|Overall Study|Withdrawal by Subject|0|||
23828772|NCT02762929|66752456|FG000|Overall Study|exclusionary medication disclosed late|0|||
23828773|NCT02762929|66752457|FG001|Overall Study|exclusionary medication disclosed late|0|||
23828774|NCT02762929|66752458|FG002|Overall Study|exclusionary medication disclosed late|0|||
23828775|NCT02762929|66752459|FG003|Overall Study|exclusionary medication disclosed late|1|||
23828776|NCT02762929|66752460|FG004|Overall Study|exclusionary medication disclosed late|0|||
23828777|NCT02762929|66752461|FG005|Overall Study|exclusionary medication disclosed late|0|||
23828778|NCT00955617|66752462|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
23828779|NCT00955617|66752463|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
23828780|NCT00955617|66752462|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
23828781|NCT00955617|66752463|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
23828782|NCT00955617|66752462|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
23828783|NCT00955617|66752463|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
23828784|NCT00955617|66752462|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
23828785|NCT00955617|66752463|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
23566929|NCT00674323|65803937|FG002|Overall Study|Protocol Violation|0|||
23566930|NCT01932294|65803939|FG000|Overall Study|Death|43|||
23566931|NCT01932294|65803939|FG000|Overall Study|Lost to Follow-up|8|||
23566932|NCT01932294|65803939|FG000|Overall Study|VAD Implantation|20|||
23566933|NCT01932294|65803939|FG000|Overall Study|Heart Transplantation|16|||
23566934|NCT01932294|65803939|FG000|Overall Study|Transferred to other hospitals|12|||
23566935|NCT04250337|65803942|FG000|Overall Study|Adverse Event|0|||
23566936|NCT04250337|65803943|FG001|Overall Study|Adverse Event|3|||
23566937|NCT04250337|65803942|FG000|Overall Study|Lack of Efficacy|1|||
23566938|NCT04250337|65803943|FG001|Overall Study|Lack of Efficacy|3|||
23566939|NCT04250337|65803942|FG000|Overall Study|Physician Decision|1|||
23566940|NCT04250337|65803943|FG001|Overall Study|Physician Decision|0|||
23566941|NCT04250337|65803942|FG000|Overall Study|Protocol Deviation|2|||
23566942|NCT04250337|65803943|FG001|Overall Study|Protocol Deviation|2|||
23566943|NCT04250337|65803942|FG000|Overall Study|Withdrawal by Subject|4|||
23828786|NCT03093259|66752464|FG000|Overall Study|Adverse Event|1|||
23828787|NCT03093259|66752465|FG001|Overall Study|Adverse Event|0|||
23828788|NCT03093259|66752464|FG000|Overall Study|Withdrawal by Subject|1|||
23566944|NCT04250337|65803943|FG001|Overall Study|Withdrawal by Subject|3|||
23566945|NCT02254408|65803951|FG000|Overall Study|Randomized But Not Treated|1|||
23566946|NCT02254408|65803952|FG001|Overall Study|Randomized But Not Treated|3|||
23566947|NCT02254408|65803951|FG000|Overall Study|Adverse Event|1|||
23566948|NCT02254408|65803952|FG001|Overall Study|Adverse Event|0|||
23566949|NCT02254408|65803951|FG000|Overall Study|Death|2|||
23566950|NCT02254408|65803952|FG001|Overall Study|Death|3|||
23828789|NCT03093259|66752465|FG001|Overall Study|Withdrawal by Subject|0|||
23828790|NCT00443729|66752466|FG000|Overall Study|Never Treated|0|||
23828791|NCT00443729|66752467|FG001|Overall Study|Never Treated|1|||
23566951|NCT02254408|65803951|FG000|Overall Study|Investigator's Discretion|0|||
23566952|NCT02254408|65803952|FG001|Overall Study|Investigator's Discretion|1|||
23764502|NCT00814658|66514640|FG001|Overall Study|Adverse Event|3|||
23764503|NCT01751412|66514642|FG000|Overall Study|Disease Progression Before Treatment|1|||
23764504|NCT01015612|66514648|FG000|Overall Study|Death|113|||
23764505|NCT01015612|66514648|FG000|Overall Study|Withdrawal by Subject|40|||
23764506|NCT04378010|66514661|FG000|Overall Study|Adverse Event|8|||
23764507|NCT04378010|66514662|FG001|Overall Study|Adverse Event|14|||
23764508|NCT04378010|66514663|FG002|Overall Study|Adverse Event|4|||
23764509|NCT04378010|66514661|FG000|Overall Study|Withdrawal by Subject|0|||
23764510|NCT04378010|66514662|FG001|Overall Study|Withdrawal by Subject|2|||
23764511|NCT04378010|66514663|FG002|Overall Study|Withdrawal by Subject|1|||
23764512|NCT04378010|66514661|FG000|Overall Study|Protocol Violation|2|||
23764513|NCT04378010|66514662|FG001|Overall Study|Protocol Violation|1|||
23764514|NCT04378010|66514663|FG002|Overall Study|Protocol Violation|4|||
23764515|NCT04378010|66514661|FG000|Overall Study|Study terminated by Sponsor|22|||
23764516|NCT04378010|66514662|FG001|Overall Study|Study terminated by Sponsor|16|||
23566953|NCT02254408|65803951|FG000|Overall Study|Withdrawal by Subject|3|||
23566954|NCT02254408|65803952|FG001|Overall Study|Withdrawal by Subject|3|||
23566955|NCT02254408|65803951|FG000|Overall Study|Lost to Follow-up|1|||
23628573|NCT02706951|66028036|FG001|Period 1|Adverse Event|5|||
23628574|NCT02706951|66028037|FG002|Period 1|Adverse Event|3|||
23628575|NCT02706951|66028038|FG003|Period 1|Adverse Event|0|||
23628576|NCT02706951|66028039|FG004|Period 1|Adverse Event|0|||
23628577|NCT02706951|66028035|FG000|Period 1|Withdrawal by Subject|10|||
23628578|NCT02706951|66028036|FG001|Period 1|Withdrawal by Subject|6|||
23628579|NCT02706951|66028037|FG002|Period 1|Withdrawal by Subject|6|||
23628580|NCT02706951|66028038|FG003|Period 1|Withdrawal by Subject|0|||
23628581|NCT02706951|66028039|FG004|Period 1|Withdrawal by Subject|0|||
23628582|NCT02706951|66028035|FG000|Period 1|Lost to Follow-up|0|||
23828792|NCT00443729|66752466|FG000|Overall Study|Lack of Efficacy|4|||
23828793|NCT00443729|66752467|FG001|Overall Study|Lack of Efficacy|2|||
23764517|NCT04378010|66514663|FG002|Overall Study|Study terminated by Sponsor|22|||
23764518|NCT04378010|66514661|FG000|Overall Study|Subject inability to complete study visit|0|||
23764519|NCT04378010|66514662|FG001|Overall Study|Subject inability to complete study visit|0|||
23764520|NCT04378010|66514663|FG002|Overall Study|Subject inability to complete study visit|1|||
23764521|NCT04378010|66514661|FG000|Overall Study|Subject never dosed|0|||
23764522|NCT04378010|66514662|FG001|Overall Study|Subject never dosed|1|||
23443862|NCT01587040|65366545|FG000|Overall Study|Other than specified|5|||
23443863|NCT01587040|65366546|FG001|Overall Study|Other than specified|1|||
23443864|NCT01587040|65366547|FG002|Overall Study|Other than specified|11|||
23764523|NCT04378010|66514663|FG002|Overall Study|Subject never dosed|0|||
23764524|NCT02753400|66518022|FG000|Overall Study|Adverse Event|3|||
23764525|NCT02753400|66518023|FG001|Overall Study|Adverse Event|0|||
23764526|NCT02753400|66518022|FG000|Overall Study|Withdrawal by Subject|2|||
23764527|NCT02753400|66518023|FG001|Overall Study|Withdrawal by Subject|1|||
23764528|NCT02742090|66518024|FG000|Overall Study|Adverse Event|10|||
23828794|NCT00443729|66752466|FG000|Overall Study|Lost to Follow-up|0|||
23828795|NCT00443729|66752467|FG001|Overall Study|Lost to Follow-up|1|||
23764529|NCT02742090|66518024|FG000|Overall Study|Death|3|||
23764530|NCT02742090|66518024|FG000|Overall Study|Disease Progression|25|||
23764531|NCT02742090|66518024|FG000|Overall Study|Investigator's Decision|1|||
23764532|NCT02742090|66518024|FG000|Overall Study|Lost to Follow-up|1|||
23764533|NCT02742090|66518024|FG000|Overall Study|Non-compliance with Study|1|||
23764534|NCT02742090|66518024|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
23764535|NCT02742090|66518024|FG000|Overall Study|Withdrawal by Subject|4|||
23764536|NCT02742090|66518024|FG000|Overall Study|Reason Not Specified|1|||
23443865|NCT01587040|65366548|FG003|Overall Study|Other than specified|1|||
23443866|NCT01178099|65366549|FG000|Overall Study|Physician Decision|0|||
23443867|NCT01178099|65366550|FG001|Overall Study|Physician Decision|1|||
23628583|NCT02706951|66028036|FG001|Period 1|Lost to Follow-up|4|||
23628584|NCT02706951|66028037|FG002|Period 1|Lost to Follow-up|1|||
23628585|NCT02706951|66028038|FG003|Period 1|Lost to Follow-up|0|||
23628586|NCT02706951|66028039|FG004|Period 1|Lost to Follow-up|0|||
23764537|NCT04527471|66518031|FG000|Overall Study|Adverse Event|1|||
23764538|NCT04527471|66518032|FG001|Overall Study|Adverse Event|0|||
23764539|NCT04527471|66518031|FG000|Overall Study|Lost to Follow-up|1|||
23764540|NCT04527471|66518032|FG001|Overall Study|Lost to Follow-up|0|||
23443868|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
23443869|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
23443870|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
23764541|NCT00608205|66518033|FG000|Overall Study|Adverse Event|3|||
23443871|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
23764542|NCT00608205|66518034|FG001|Overall Study|Adverse Event|2|||
23764543|NCT00608205|66518033|FG000|Overall Study|Patient non-compliant|0|||
23764544|NCT00608205|66518034|FG001|Overall Study|Patient non-compliant|1|||
23764545|NCT01783483|66518039|FG000|Overall Study|Death|3|||
23764546|NCT01783483|66518040|FG001|Overall Study|Death|3|||
23764547|NCT01783483|66518039|FG000|Overall Study|Lost to Follow-up|14|||
23764548|NCT01783483|66518040|FG001|Overall Study|Lost to Follow-up|10|||
23828796|NCT00443729|66752466|FG000|Overall Study|Physician Decision|2|||
23628587|NCT02706951|66028035|FG000|Period 1|Other|2|||
23628588|NCT02706951|66028036|FG001|Period 1|Other|1|||
23828797|NCT00443729|66752467|FG001|Overall Study|Physician Decision|1|||
23628589|NCT02706951|66028037|FG002|Period 1|Other|0|||
23566956|NCT02254408|65803952|FG001|Overall Study|Lost to Follow-up|0|||
23566957|NCT00936221|65803961|FG000|Overall Study|Withdrawal by Subject|1|||
23566958|NCT00936221|65803962|FG001|Overall Study|Withdrawal by Subject|1|||
23764549|NCT01783483|66518039|FG000|Overall Study|Withdrawal by Subject|2|||
23764550|NCT01783483|66518040|FG001|Overall Study|Withdrawal by Subject|1|||
23764551|NCT01783483|66518039|FG000|Overall Study|Physician Decision|1|||
23764552|NCT01783483|66518040|FG001|Overall Study|Physician Decision|1|||
23764553|NCT00717756|66518041|FG000|Overall Study|Withdrawal by Subject|1|||
23764554|NCT00429923|66518042|FG000|Overall Study|Adverse Event|0|||
23764555|NCT00429923|66518043|FG001|Overall Study|Adverse Event|2|||
23764556|NCT00429923|66518044|FG002|Overall Study|Adverse Event|3|||
23764557|NCT00429923|66518042|FG000|Overall Study|Lack of Efficacy|4|||
23764558|NCT00429923|66518043|FG001|Overall Study|Lack of Efficacy|1|||
23566959|NCT00171873|65803965|FG000|Overall Study|Withdrawal by Subject|4|||
23566960|NCT00171873|65803966|FG001|Overall Study|Withdrawal by Subject|2|||
23566961|NCT00171873|65803965|FG000|Overall Study|Adverse Event|5|||
23764559|NCT00429923|66518044|FG002|Overall Study|Lack of Efficacy|33|||
23764560|NCT00429923|66518042|FG000|Overall Study|Lost to Follow-up|0|||
23764561|NCT00429923|66518043|FG001|Overall Study|Lost to Follow-up|0|||
23764562|NCT00429923|66518044|FG002|Overall Study|Lost to Follow-up|2|||
23764563|NCT00429923|66518042|FG000|Overall Study|Withdrew Consent|1|||
23764564|NCT00429923|66518043|FG001|Overall Study|Withdrew Consent|0|||
23764565|NCT00429923|66518044|FG002|Overall Study|Withdrew Consent|1|||
23764566|NCT00429923|66518042|FG000|Overall Study|Early Termination|0|||
23566962|NCT00171873|65803966|FG001|Overall Study|Adverse Event|0|||
23764567|NCT00429923|66518043|FG001|Overall Study|Early Termination|1|||
23764568|NCT00429923|66518044|FG002|Overall Study|Early Termination|0|||
23764569|NCT00673361|66518045|FG000|Overall Study|Screen Failure|2|||
23764570|NCT03384745|66518046|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23764571|NCT03384745|66518047|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23764572|NCT03384745|66518048|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
23764573|NCT03384745|66518049|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
23764574|NCT03384745|66518050|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23764575|NCT03384745|66518051|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23764576|NCT03384745|66518046|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23764577|NCT03384745|66518047|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23764578|NCT03384745|66518048|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23764579|NCT03384745|66518049|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23764580|NCT03384745|66518050|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
23764581|NCT03384745|66518051|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
23764582|NCT03384745|66518046|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23764583|NCT03384745|66518047|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23764584|NCT03384745|66518048|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23764585|NCT03384745|66518049|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23764586|NCT03384745|66518050|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23764587|NCT03384745|66518051|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23764588|NCT03384745|66518046|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23764589|NCT03384745|66518047|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23764590|NCT03384745|66518048|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
23764591|NCT03384745|66518049|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23764592|NCT03384745|66518050|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23764593|NCT03384745|66518051|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23566963|NCT00171873|65803965|FG000|Overall Study|Switched to Octreotide|0|||
23566964|NCT00171873|65803966|FG001|Overall Study|Switched to Octreotide|1|||
23566965|NCT00119262|65803967|FG000|Overall Study|Lack of Efficacy|0|||
23566966|NCT00119262|65803968|FG001|Overall Study|Lack of Efficacy|3|||
23566967|NCT00119262|65803967|FG000|Overall Study|Withdrawal by Subject|12|||
23566968|NCT00119262|65803968|FG001|Overall Study|Withdrawal by Subject|11|||
23566969|NCT00119262|65803967|FG000|Overall Study|Adverse Event|33|||
23566970|NCT00119262|65803968|FG001|Overall Study|Adverse Event|35|||
23764594|NCT03384745|66518046|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23764595|NCT03384745|66518047|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23764596|NCT03384745|66518048|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23764597|NCT03384745|66518049|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
23764598|NCT03384745|66518050|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
23764599|NCT03384745|66518051|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23764600|NCT03384745|66518046|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23566971|NCT00119262|65803967|FG000|Overall Study|other disease|0|||
23566972|NCT00119262|65803968|FG001|Overall Study|other disease|2|||
23566973|NCT00119262|65803967|FG000|Overall Study|ineligble|1|||
23764601|NCT03384745|66518047|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23566974|NCT00119262|65803968|FG001|Overall Study|ineligble|2|||
23443872|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
23443873|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
23443874|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
23443875|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
23443876|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
23443877|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
23443878|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
23443879|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
23443880|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
23443881|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
23443882|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
23443883|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
23443884|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
23443885|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
23443886|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443887|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443888|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443889|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
23443890|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
23443891|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
23443892|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
23443893|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
23443894|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
23443895|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
23443896|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
23443897|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
23443898|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
23443899|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
23443900|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
23443901|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
23443902|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
23443903|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
23443904|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443905|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443906|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443907|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
23443908|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
23443909|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
23443910|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
23443911|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
23443912|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
23443913|NCT02702180|65366554|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23443914|NCT02702180|65366555|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23443915|NCT02702180|65366556|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23443916|NCT02702180|65366554|FG000|Double-blind Treatment Period|Adverse Event|0|||
23443917|NCT02702180|65366555|FG001|Double-blind Treatment Period|Adverse Event|0|||
23443918|NCT02702180|65366556|FG002|Double-blind Treatment Period|Adverse Event|1|||
23443919|NCT02702180|65366554|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23443920|NCT02702180|65366555|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23443921|NCT02702180|65366556|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23628590|NCT02706951|66028038|FG003|Period 1|Other|0|||
23628591|NCT02706951|66028039|FG004|Period 1|Other|0|||
23628592|NCT02706951|66028035|FG000|Period 2|Adverse Event|0|||
23628593|NCT02706951|66028036|FG001|Period 2|Adverse Event|0|||
23628594|NCT02706951|66028037|FG002|Period 2|Adverse Event|0|||
23628595|NCT02706951|66028038|FG003|Period 2|Adverse Event|25|||
23628596|NCT02706951|66028039|FG004|Period 2|Adverse Event|34|||
23628597|NCT02706951|66028035|FG000|Period 2|Withdrawal by Subject|0|||
23628598|NCT02706951|66028036|FG001|Period 2|Withdrawal by Subject|0|||
23628599|NCT02706951|66028037|FG002|Period 2|Withdrawal by Subject|0|||
23628600|NCT02706951|66028038|FG003|Period 2|Withdrawal by Subject|38|||
23443922|NCT02702180|65366554|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23443923|NCT02702180|65366555|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23443924|NCT02702180|65366556|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23628601|NCT02706951|66028039|FG004|Period 2|Withdrawal by Subject|44|||
23628602|NCT02706951|66028035|FG000|Period 2|Lost to Follow-up|0|||
23628603|NCT02706951|66028036|FG001|Period 2|Lost to Follow-up|0|||
23764602|NCT03384745|66518048|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23764603|NCT03384745|66518049|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23764604|NCT03384745|66518050|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
23443925|NCT02702180|65366554|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23443926|NCT02702180|65366555|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
23443927|NCT02702180|65366556|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
23443928|NCT02702180|65366554|FG000|Open-label Treatment Period|Withdrawn in error|0|||
23443929|NCT02702180|65366555|FG001|Open-label Treatment Period|Withdrawn in error|0|||
23443930|NCT02702180|65366556|FG002|Open-label Treatment Period|Withdrawn in error|1|||
23443931|NCT04327024|65366562|FG000|Overall Study|Death|1|||
23443932|NCT04327024|65366563|FG001|Overall Study|Death|2|||
23443933|NCT04327024|65366564|FG002|Overall Study|Death|1|||
23443934|NCT04327024|65366562|FG000|Overall Study|Non-compliance with study drug|0|||
23443935|NCT04327024|65366563|FG001|Overall Study|Non-compliance with study drug|1|||
23443936|NCT04327024|65366564|FG002|Overall Study|Non-compliance with study drug|0|||
23443937|NCT04327024|65366562|FG000|Overall Study|Withdrawal by Subject|1|||
23443938|NCT04327024|65366563|FG001|Overall Study|Withdrawal by Subject|1|||
23443939|NCT04327024|65366564|FG002|Overall Study|Withdrawal by Subject|2|||
23443940|NCT03437577|65366565|FG000|Pre-Randomization|Withdrawal by Subject|0|||
23443941|NCT03437577|65366566|FG001|Pre-Randomization|Withdrawal by Subject|0|||
23443942|NCT03437577|65366567|FG002|Pre-Randomization|Withdrawal by Subject|10|||
23443943|NCT03437577|65366565|FG000|Post-Randomization|Physician Decision|0|||
23443944|NCT03437577|65366566|FG001|Post-Randomization|Physician Decision|2|||
23443945|NCT03437577|65366567|FG002|Post-Randomization|Physician Decision|0|||
23443946|NCT01483183|65366568|FG000|Overall Study|Physician Decision|0|||
23443947|NCT01483183|65366569|FG001|Overall Study|Physician Decision|0|||
23443948|NCT01483183|65366570|FG002|Overall Study|Physician Decision|0|||
23443949|NCT01483183|65366571|FG003|Overall Study|Physician Decision|0|||
23443950|NCT01483183|65366572|FG004|Overall Study|Physician Decision|0|||
23443951|NCT01483183|65366573|FG005|Overall Study|Physician Decision|0|||
23443952|NCT01483183|65366574|FG006|Overall Study|Physician Decision|2|||
23443953|NCT01483183|65366575|FG007|Overall Study|Physician Decision|0|||
23443954|NCT01483183|65366576|FG008|Overall Study|Physician Decision|0|||
23443955|NCT01483183|65366577|FG009|Overall Study|Physician Decision|0|||
23443956|NCT01483183|65366568|FG000|Overall Study|Withdrawal by Subject|0|||
23443957|NCT01483183|65366569|FG001|Overall Study|Withdrawal by Subject|0|||
23443958|NCT01483183|65366570|FG002|Overall Study|Withdrawal by Subject|0|||
23443959|NCT01483183|65366571|FG003|Overall Study|Withdrawal by Subject|0|||
23443960|NCT01483183|65366572|FG004|Overall Study|Withdrawal by Subject|0|||
23443961|NCT01483183|65366573|FG005|Overall Study|Withdrawal by Subject|0|||
23443962|NCT01483183|65366574|FG006|Overall Study|Withdrawal by Subject|0|||
23443963|NCT01483183|65366575|FG007|Overall Study|Withdrawal by Subject|0|||
23443964|NCT01483183|65366576|FG008|Overall Study|Withdrawal by Subject|0|||
23443965|NCT01483183|65366577|FG009|Overall Study|Withdrawal by Subject|1|||
23443966|NCT00256724|65366578|FG000|Overall Study|Physician Decision|2|||
23443967|NCT00256724|65366579|FG001|Overall Study|Physician Decision|5|||
23443968|NCT00256724|65366578|FG000|Overall Study|Protocol Violation|3|||
23443969|NCT00256724|65366579|FG001|Overall Study|Protocol Violation|3|||
23443970|NCT01427933|65366580|FG000|Overall Study|Withdrawal by Subject|5|||
23443971|NCT01427933|65366581|FG001|Overall Study|Withdrawal by Subject|8|||
23443972|NCT01427933|65366580|FG000|Overall Study|Lost to Follow-up|1|||
23443973|NCT01427933|65366581|FG001|Overall Study|Lost to Follow-up|5|||
23443974|NCT01427933|65366580|FG000|Overall Study|Other|1|||
23443975|NCT01427933|65366581|FG001|Overall Study|Other|0|||
23443976|NCT01427933|65366580|FG000|Overall Study|Investigator's Decision|1|||
23443977|NCT01427933|65366581|FG001|Overall Study|Investigator's Decision|0|||
23443978|NCT02326597|65366582|FG000|Overall Study|Lost to Follow-up|42|||
23443979|NCT02326597|65366583|FG001|Overall Study|Lost to Follow-up|32|||
23443980|NCT00226811|65366584|FG000|Overall Study|Death|8|||
23443981|NCT00226811|65366584|FG000|Overall Study|Adverse Event|11|||
23443982|NCT00226811|65366584|FG000|Overall Study|Lack of Efficacy|55|||
23443983|NCT00226811|65366584|FG000|Overall Study|Withdrawal by Subject|2|||
23764605|NCT03384745|66518051|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23764606|NCT03384745|66518046|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23764607|NCT03384745|66518047|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23443984|NCT03056339|65366585|FG000|Overall Study|Failed Requirements|0|||
23443985|NCT03056339|65366586|FG001|Overall Study|Failed Requirements|2|||
23443986|NCT03056339|65366587|FG002|Overall Study|Failed Requirements|7|||
23443987|NCT03056339|65366588|FG003|Overall Study|Failed Requirements|1|||
23443988|NCT02058563|65366591|FG000|Overall Study|Lost to Follow-up|26|||
23443989|NCT02058563|65366592|FG001|Overall Study|Lost to Follow-up|22|||
23443990|NCT02058563|65366591|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
23443991|NCT02058563|65366592|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
23443992|NCT02058563|65366591|FG000|Overall Study|Consent Withdrawal|1|||
23443993|NCT02058563|65366592|FG001|Overall Study|Consent Withdrawal|1|||
23764608|NCT03384745|66518048|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
23764609|NCT03384745|66518049|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
23443994|NCT02058563|65366591|FG000|Overall Study|Other (patient incarcerated)|0|||
23443995|NCT02058563|65366592|FG001|Overall Study|Other (patient incarcerated)|1|||
23443996|NCT02669212|65366597|FG000|Overall Study|Lost to Follow-up|1|||
23443997|NCT02669212|65366598|FG001|Overall Study|Lost to Follow-up|0|||
23443998|NCT02669212|65366597|FG000|Overall Study|Medical Condition|3|||
23443999|NCT02669212|65366598|FG001|Overall Study|Medical Condition|4|||
23444000|NCT02669212|65366597|FG000|Overall Study|Withdrawal by Subject|0|||
23444001|NCT02669212|65366598|FG001|Overall Study|Withdrawal by Subject|2|||
23444002|NCT02669212|65366597|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
23444003|NCT02669212|65366598|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
23444004|NCT03350815|65366599|FG000|Period 1|Adverse Event|10|||
23444005|NCT03350815|65366600|FG001|Period 1|Adverse Event|0|||
23444006|NCT03350815|65366601|FG002|Period 1|Adverse Event|0|||
23444007|NCT03350815|65366602|FG003|Period 1|Adverse Event|0|||
23444008|NCT03350815|65366599|FG000|Period 1|Technical problems|1|||
23444009|NCT03350815|65366600|FG001|Period 1|Technical problems|0|||
23444010|NCT03350815|65366601|FG002|Period 1|Technical problems|0|||
23444011|NCT03350815|65366602|FG003|Period 1|Technical problems|0|||
23444012|NCT03350815|65366599|FG000|Period 1|Lost to Follow-up|3|||
23444013|NCT03350815|65366600|FG001|Period 1|Lost to Follow-up|0|||
23444014|NCT03350815|65366601|FG002|Period 1|Lost to Follow-up|0|||
23444015|NCT03350815|65366602|FG003|Period 1|Lost to Follow-up|0|||
23444016|NCT03350815|65366599|FG000|Period 1|Physician Decision|1|||
23444017|NCT03350815|65366600|FG001|Period 1|Physician Decision|0|||
23444018|NCT03350815|65366601|FG002|Period 1|Physician Decision|0|||
23444019|NCT03350815|65366602|FG003|Period 1|Physician Decision|0|||
23444020|NCT03350815|65366599|FG000|Period 1|Withdrawal by Subject|8|||
23444021|NCT03350815|65366600|FG001|Period 1|Withdrawal by Subject|0|||
23444022|NCT03350815|65366601|FG002|Period 1|Withdrawal by Subject|0|||
23444023|NCT03350815|65366602|FG003|Period 1|Withdrawal by Subject|0|||
23444024|NCT03350815|65366599|FG000|Period 1|Lack of Efficacy|15|||
23444025|NCT03350815|65366600|FG001|Period 1|Lack of Efficacy|0|||
23444026|NCT03350815|65366601|FG002|Period 1|Lack of Efficacy|0|||
23444027|NCT03350815|65366602|FG003|Period 1|Lack of Efficacy|0|||
23444028|NCT03350815|65366599|FG000|Period 1|Non-compliance with study treatment|2|||
23444029|NCT03350815|65366600|FG001|Period 1|Non-compliance with study treatment|0|||
23444030|NCT03350815|65366601|FG002|Period 1|Non-compliance with study treatment|0|||
23444031|NCT03350815|65366602|FG003|Period 1|Non-compliance with study treatment|0|||
23444032|NCT03350815|65366599|FG000|Period 1|Protocol Violation|3|||
23444033|NCT03350815|65366600|FG001|Period 1|Protocol Violation|0|||
23444034|NCT03350815|65366601|FG002|Period 1|Protocol Violation|0|||
23444035|NCT03350815|65366602|FG003|Period 1|Protocol Violation|0|||
23444036|NCT03350815|65366599|FG000|Period 2|Adverse Event|0|||
23444037|NCT03350815|65366600|FG001|Period 2|Adverse Event|3|||
23444038|NCT03350815|65366601|FG002|Period 2|Adverse Event|5|||
23444039|NCT03350815|65366602|FG003|Period 2|Adverse Event|0|||
23444040|NCT03350815|65366599|FG000|Period 2|Technical problem|0|||
23444041|NCT03350815|65366600|FG001|Period 2|Technical problem|1|||
23444042|NCT03350815|65366601|FG002|Period 2|Technical problem|0|||
23444043|NCT03350815|65366602|FG003|Period 2|Technical problem|0|||
23444044|NCT03350815|65366599|FG000|Period 2|Lost to Follow-up|0|||
23444045|NCT03350815|65366600|FG001|Period 2|Lost to Follow-up|3|||
23444046|NCT03350815|65366601|FG002|Period 2|Lost to Follow-up|3|||
23444047|NCT03350815|65366602|FG003|Period 2|Lost to Follow-up|0|||
23444048|NCT03350815|65366599|FG000|Period 2|Physician Decision|0|||
23444049|NCT03350815|65366600|FG001|Period 2|Physician Decision|0|||
23444050|NCT03350815|65366601|FG002|Period 2|Physician Decision|1|||
23444051|NCT03350815|65366602|FG003|Period 2|Physician Decision|0|||
23444052|NCT03350815|65366599|FG000|Period 2|Withdrawal by Subject|0|||
23764610|NCT03384745|66518050|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23764611|NCT03384745|66518051|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23764612|NCT03384745|66518046|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23764613|NCT03384745|66518047|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23764614|NCT03384745|66518048|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
23444053|NCT03350815|65366600|FG001|Period 2|Withdrawal by Subject|3|||
23444054|NCT03350815|65366601|FG002|Period 2|Withdrawal by Subject|4|||
23444055|NCT03350815|65366602|FG003|Period 2|Withdrawal by Subject|0|||
23764615|NCT03384745|66518049|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
23444056|NCT03350815|65366599|FG000|Period 2|Lack of Efficacy|0|||
23444057|NCT03350815|65366600|FG001|Period 2|Lack of Efficacy|6|||
23444058|NCT03350815|65366601|FG002|Period 2|Lack of Efficacy|2|||
23444059|NCT03350815|65366602|FG003|Period 2|Lack of Efficacy|0|||
23444060|NCT03350815|65366599|FG000|Period 2|Protocol Violation|0|||
23444061|NCT03350815|65366600|FG001|Period 2|Protocol Violation|0|||
23444062|NCT03350815|65366601|FG002|Period 2|Protocol Violation|1|||
23444063|NCT03350815|65366602|FG003|Period 2|Protocol Violation|0|||
23444064|NCT03350815|65366599|FG000|Period 2|New therapy for study indication|0|||
23444065|NCT03350815|65366600|FG001|Period 2|New therapy for study indication|0|||
23444066|NCT03350815|65366601|FG002|Period 2|New therapy for study indication|1|||
23444067|NCT03350815|65366602|FG003|Period 2|New therapy for study indication|0|||
23444068|NCT02737475|65366605|FG000|Overall Study|Other reasons|0|||
23444069|NCT02737475|65366606|FG001|Overall Study|Other reasons|0|||
23444070|NCT02737475|65366607|FG002|Overall Study|Other reasons|0|||
23444071|NCT02737475|65366608|FG003|Overall Study|Other reasons|0|||
23444072|NCT02737475|65366609|FG004|Overall Study|Other reasons|1|||
23444073|NCT02737475|65366610|FG005|Overall Study|Other reasons|1|||
23444074|NCT02737475|65366611|FG006|Overall Study|Other reasons|0|||
23444075|NCT02737475|65366612|FG007|Overall Study|Other reasons|0|||
23444076|NCT02737475|65366613|FG008|Overall Study|Other reasons|1|||
23444077|NCT02737475|65366614|FG009|Overall Study|Other reasons|0|||
23444078|NCT02737475|65366615|FG010|Overall Study|Other reasons|1|||
23444079|NCT02737475|65366616|FG011|Overall Study|Other reasons|0|||
23444080|NCT02737475|65366617|FG012|Overall Study|Other reasons|0|||
23444081|NCT02737475|65366618|FG013|Overall Study|Other reasons|0|||
23444082|NCT02737475|65366619|FG014|Overall Study|Other reasons|0|||
23444083|NCT02737475|65366620|FG015|Overall Study|Other reasons|0|||
23444084|NCT02737475|65366621|FG016|Overall Study|Other reasons|0|||
23444085|NCT02737475|65366622|FG017|Overall Study|Other reasons|0|||
23444086|NCT02737475|65366623|FG018|Overall Study|Other reasons|0|||
23444087|NCT02737475|65366624|FG019|Overall Study|Other reasons|0|||
23444088|NCT02737475|65366625|FG020|Overall Study|Other reasons|0|||
23444089|NCT02737475|65366626|FG021|Overall Study|Other reasons|1|||
23444090|NCT02737475|65366627|FG022|Overall Study|Other reasons|0|||
23444091|NCT02737475|65366628|FG023|Overall Study|Other reasons|1|||
23444092|NCT02737475|65366629|FG024|Overall Study|Other reasons|1|||
23444093|NCT02737475|65366630|FG025|Overall Study|Other reasons|1|||
23444094|NCT02737475|65366631|FG026|Overall Study|Other reasons|0|||
23444095|NCT02737475|65366605|FG000|Overall Study|Death|1|||
23444096|NCT02737475|65366606|FG001|Overall Study|Death|0|||
23444097|NCT02737475|65366607|FG002|Overall Study|Death|0|||
23444098|NCT02737475|65366608|FG003|Overall Study|Death|1|||
23444099|NCT02737475|65366609|FG004|Overall Study|Death|0|||
23444100|NCT02737475|65366610|FG005|Overall Study|Death|0|||
23444101|NCT02737475|65366611|FG006|Overall Study|Death|0|||
23444102|NCT02737475|65366612|FG007|Overall Study|Death|2|||
23444103|NCT02737475|65366613|FG008|Overall Study|Death|0|||
23444104|NCT02737475|65366614|FG009|Overall Study|Death|0|||
23444105|NCT02737475|65366615|FG010|Overall Study|Death|0|||
23444106|NCT02737475|65366616|FG011|Overall Study|Death|4|||
23444107|NCT02737475|65366617|FG012|Overall Study|Death|2|||
23444108|NCT02737475|65366618|FG013|Overall Study|Death|2|||
23444109|NCT02737475|65366619|FG014|Overall Study|Death|0|||
23444110|NCT02737475|65366620|FG015|Overall Study|Death|2|||
23444111|NCT02737475|65366621|FG016|Overall Study|Death|2|||
23444112|NCT02737475|65366622|FG017|Overall Study|Death|2|||
23444113|NCT02737475|65366623|FG018|Overall Study|Death|1|||
23444114|NCT02737475|65366624|FG019|Overall Study|Death|0|||
23764616|NCT03384745|66518050|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23764617|NCT03384745|66518051|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
23764618|NCT03384745|66518046|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
23764619|NCT03384745|66518047|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
23764620|NCT03384745|66518048|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
23764621|NCT03384745|66518049|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
23764622|NCT03384745|66518050|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
23764623|NCT03384745|66518051|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
23764624|NCT03384745|66518046|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23764625|NCT03384745|66518047|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23764626|NCT03384745|66518048|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23764627|NCT03384745|66518049|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
23764628|NCT03384745|66518050|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23764629|NCT03384745|66518051|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23764630|NCT03384745|66518046|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
23764631|NCT03384745|66518047|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
23764632|NCT03384745|66518048|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
23764633|NCT03384745|66518049|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
23764634|NCT03384745|66518050|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
23444115|NCT02737475|65366625|FG020|Overall Study|Death|0|||
23764635|NCT03384745|66518051|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
23764636|NCT01165684|66518054|FG000|Overall Study|Adverse Event|1|||
23444116|NCT02737475|65366626|FG021|Overall Study|Death|0|||
23444117|NCT02737475|65366627|FG022|Overall Study|Death|0|||
23444118|NCT02737475|65366628|FG023|Overall Study|Death|0|||
23764637|NCT01165684|66518055|FG001|Overall Study|Adverse Event|1|||
23444119|NCT02737475|65366629|FG024|Overall Study|Death|0|||
23444120|NCT02737475|65366630|FG025|Overall Study|Death|0|||
23444121|NCT02737475|65366631|FG026|Overall Study|Death|0|||
23444122|NCT02737475|65366605|FG000|Overall Study|Participant withdrew consent|0|||
23444123|NCT02737475|65366606|FG001|Overall Study|Participant withdrew consent|0|||
23444124|NCT02737475|65366607|FG002|Overall Study|Participant withdrew consent|0|||
23444125|NCT02737475|65366608|FG003|Overall Study|Participant withdrew consent|0|||
23444126|NCT02737475|65366609|FG004|Overall Study|Participant withdrew consent|0|||
23444127|NCT02737475|65366610|FG005|Overall Study|Participant withdrew consent|2|||
23444128|NCT02737475|65366611|FG006|Overall Study|Participant withdrew consent|0|||
23444129|NCT02737475|65366612|FG007|Overall Study|Participant withdrew consent|0|||
23444130|NCT02737475|65366613|FG008|Overall Study|Participant withdrew consent|0|||
23444131|NCT02737475|65366614|FG009|Overall Study|Participant withdrew consent|0|||
23444132|NCT02737475|65366615|FG010|Overall Study|Participant withdrew consent|0|||
23444133|NCT02737475|65366616|FG011|Overall Study|Participant withdrew consent|0|||
23444134|NCT02737475|65366617|FG012|Overall Study|Participant withdrew consent|0|||
23444135|NCT02737475|65366618|FG013|Overall Study|Participant withdrew consent|0|||
23444136|NCT02737475|65366619|FG014|Overall Study|Participant withdrew consent|1|||
23444137|NCT02737475|65366620|FG015|Overall Study|Participant withdrew consent|0|||
23444138|NCT02737475|65366621|FG016|Overall Study|Participant withdrew consent|0|||
23444139|NCT02737475|65366622|FG017|Overall Study|Participant withdrew consent|2|||
23444140|NCT02737475|65366623|FG018|Overall Study|Participant withdrew consent|1|||
23444141|NCT02737475|65366624|FG019|Overall Study|Participant withdrew consent|0|||
23764638|NCT01165684|66518054|FG000|Overall Study|Lack of Efficacy|2|||
23764639|NCT01165684|66518055|FG001|Overall Study|Lack of Efficacy|1|||
23764640|NCT01165684|66518054|FG000|Overall Study|Protocol Violation|7|||
23444142|NCT02737475|65366625|FG020|Overall Study|Participant withdrew consent|2|||
23444143|NCT02737475|65366626|FG021|Overall Study|Participant withdrew consent|0|||
23444144|NCT02737475|65366627|FG022|Overall Study|Participant withdrew consent|0|||
23444145|NCT02737475|65366628|FG023|Overall Study|Participant withdrew consent|0|||
23764641|NCT01165684|66518055|FG001|Overall Study|Protocol Violation|15|||
23764642|NCT01165684|66518054|FG000|Overall Study|Withdrawal Criteria|2|||
23764643|NCT01165684|66518055|FG001|Overall Study|Withdrawal Criteria|13|||
23764644|NCT01165684|66518054|FG000|Overall Study|Unclassified|16|||
23764645|NCT01165684|66518055|FG001|Overall Study|Unclassified|22|||
23764646|NCT00290745|66518056|FG000|Overall Study|Withdrawal by Subject|4|||
23764647|NCT00290745|66518056|FG000|Overall Study|Physician Decision|2|||
23764648|NCT00290745|66518056|FG000|Overall Study|Surgery after 3 months for progression|3|||
23764649|NCT00290745|66518056|FG000|Overall Study|Baseline MRI not available|3|||
23764650|NCT00210626|66518058|FG000|Overall Study|Adverse Event|1|||
23444146|NCT02737475|65366629|FG024|Overall Study|Participant withdrew consent|0|||
23444147|NCT02737475|65366630|FG025|Overall Study|Participant withdrew consent|0|||
23444148|NCT02737475|65366631|FG026|Overall Study|Participant withdrew consent|0|||
23444149|NCT02737475|65366605|FG000|Overall Study|Lost to Follow-up|0|||
23444150|NCT02737475|65366606|FG001|Overall Study|Lost to Follow-up|0|||
23444151|NCT02737475|65366607|FG002|Overall Study|Lost to Follow-up|0|||
23444152|NCT02737475|65366608|FG003|Overall Study|Lost to Follow-up|0|||
23444153|NCT02737475|65366609|FG004|Overall Study|Lost to Follow-up|0|||
23444154|NCT02737475|65366610|FG005|Overall Study|Lost to Follow-up|0|||
23444155|NCT02737475|65366611|FG006|Overall Study|Lost to Follow-up|0|||
23444156|NCT02737475|65366612|FG007|Overall Study|Lost to Follow-up|0|||
23444157|NCT02737475|65366613|FG008|Overall Study|Lost to Follow-up|0|||
23764651|NCT00210626|66518059|FG001|Overall Study|Adverse Event|2|||
23764652|NCT00210626|66518058|FG000|Overall Study|Protocol Violation|1|||
23764653|NCT00210626|66518059|FG001|Overall Study|Protocol Violation|5|||
23764654|NCT00210626|66518058|FG000|Overall Study|Lost to Follow-up|11|||
23764655|NCT00210626|66518059|FG001|Overall Study|Lost to Follow-up|11|||
23764656|NCT00210626|66518058|FG000|Overall Study|Death|1|||
23764657|NCT00210626|66518059|FG001|Overall Study|Death|0|||
23764658|NCT00210626|66518058|FG000|Overall Study|Withdrawal by Subject|29|||
23764659|NCT00210626|66518059|FG001|Overall Study|Withdrawal by Subject|20|||
23764660|NCT00210626|66518058|FG000|Overall Study|Physician Decision|0|||
23444158|NCT02737475|65366614|FG009|Overall Study|Lost to Follow-up|0|||
23444159|NCT02737475|65366615|FG010|Overall Study|Lost to Follow-up|0|||
23764661|NCT00210626|66518059|FG001|Overall Study|Physician Decision|2|||
23444160|NCT02737475|65366616|FG011|Overall Study|Lost to Follow-up|0|||
23444161|NCT02737475|65366617|FG012|Overall Study|Lost to Follow-up|0|||
23444162|NCT02737475|65366618|FG013|Overall Study|Lost to Follow-up|0|||
23566975|NCT00119262|65803967|FG000|Overall Study|others|0|||
23566976|NCT00119262|65803968|FG001|Overall Study|others|5|||
23566977|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
23566978|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566979|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566980|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23764662|NCT00210626|66518058|FG000|Overall Study|Sponser Request|1|||
23444163|NCT02737475|65366619|FG014|Overall Study|Lost to Follow-up|0|||
23444164|NCT02737475|65366620|FG015|Overall Study|Lost to Follow-up|1|||
23764663|NCT00210626|66518059|FG001|Overall Study|Sponser Request|0|||
23444165|NCT02737475|65366621|FG016|Overall Study|Lost to Follow-up|0|||
23444166|NCT02737475|65366622|FG017|Overall Study|Lost to Follow-up|0|||
23764664|NCT00210626|66518058|FG000|Overall Study|Other|4|||
23764665|NCT00210626|66518059|FG001|Overall Study|Other|5|||
23444167|NCT02737475|65366623|FG018|Overall Study|Lost to Follow-up|0|||
23764666|NCT01073020|66518060|FG000|Overall Study|Withdrawal by Subject|6|||
23764667|NCT01073020|66518061|FG001|Overall Study|Withdrawal by Subject|4|||
23628604|NCT02706951|66028037|FG002|Period 2|Lost to Follow-up|0|||
23628605|NCT02706951|66028038|FG003|Period 2|Lost to Follow-up|17|||
23628606|NCT02706951|66028039|FG004|Period 2|Lost to Follow-up|9|||
23628607|NCT02706951|66028035|FG000|Period 2|COVID-19 Related|0|||
23628608|NCT02706951|66028036|FG001|Period 2|COVID-19 Related|0|||
23628609|NCT02706951|66028037|FG002|Period 2|COVID-19 Related|0|||
23628610|NCT02706951|66028038|FG003|Period 2|COVID-19 Related|1|||
23628611|NCT02706951|66028039|FG004|Period 2|COVID-19 Related|2|||
23628612|NCT02706951|66028035|FG000|Period 2|Other|0|||
23628613|NCT02706951|66028036|FG001|Period 2|Other|0|||
23628614|NCT02706951|66028037|FG002|Period 2|Other|0|||
23628615|NCT02706951|66028038|FG003|Period 2|Other|37|||
23628616|NCT02706951|66028039|FG004|Period 2|Other|31|||
23628617|NCT03432390|66028045|FG000|Apnea Period|Protocol Violation|2|||
23628618|NCT03432390|66028046|FG001|Apnea Period|Protocol Violation|2|||
23628619|NCT02498236|66028047|FG000|Overall Study|Did not show for testing|1|||
23628620|NCT02498236|66028048|FG001|Overall Study|Did not show for testing|0|||
23444168|NCT02737475|65366624|FG019|Overall Study|Lost to Follow-up|0|||
23444169|NCT02737475|65366625|FG020|Overall Study|Lost to Follow-up|0|||
23444170|NCT02737475|65366626|FG021|Overall Study|Lost to Follow-up|0|||
23444171|NCT02737475|65366627|FG022|Overall Study|Lost to Follow-up|0|||
23444172|NCT02737475|65366628|FG023|Overall Study|Lost to Follow-up|0|||
23444173|NCT02737475|65366629|FG024|Overall Study|Lost to Follow-up|0|||
23444174|NCT02737475|65366630|FG025|Overall Study|Lost to Follow-up|0|||
23444175|NCT02737475|65366631|FG026|Overall Study|Lost to Follow-up|0|||
23444176|NCT02737475|65366605|FG000|Overall Study|Disease Progression|0|||
23444177|NCT02737475|65366606|FG001|Overall Study|Disease Progression|0|||
23444178|NCT02737475|65366607|FG002|Overall Study|Disease Progression|0|||
23444179|NCT02737475|65366608|FG003|Overall Study|Disease Progression|0|||
23444180|NCT02737475|65366609|FG004|Overall Study|Disease Progression|0|||
23444181|NCT02737475|65366610|FG005|Overall Study|Disease Progression|0|||
23444182|NCT02737475|65366611|FG006|Overall Study|Disease Progression|0|||
23444183|NCT02737475|65366612|FG007|Overall Study|Disease Progression|0|||
23444184|NCT02737475|65366613|FG008|Overall Study|Disease Progression|0|||
23444185|NCT02737475|65366614|FG009|Overall Study|Disease Progression|0|||
23444186|NCT02737475|65366615|FG010|Overall Study|Disease Progression|0|||
23444187|NCT02737475|65366616|FG011|Overall Study|Disease Progression|0|||
23444188|NCT02737475|65366617|FG012|Overall Study|Disease Progression|0|||
23444189|NCT02737475|65366618|FG013|Overall Study|Disease Progression|0|||
23444190|NCT02737475|65366619|FG014|Overall Study|Disease Progression|0|||
23444191|NCT02737475|65366620|FG015|Overall Study|Disease Progression|0|||
23444192|NCT02737475|65366621|FG016|Overall Study|Disease Progression|0|||
23444193|NCT02737475|65366622|FG017|Overall Study|Disease Progression|0|||
23444194|NCT02737475|65366623|FG018|Overall Study|Disease Progression|0|||
23444195|NCT02737475|65366624|FG019|Overall Study|Disease Progression|0|||
23444196|NCT02737475|65366625|FG020|Overall Study|Disease Progression|0|||
23444197|NCT02737475|65366626|FG021|Overall Study|Disease Progression|0|||
23444198|NCT02737475|65366627|FG022|Overall Study|Disease Progression|0|||
23444199|NCT02737475|65366628|FG023|Overall Study|Disease Progression|0|||
23444200|NCT02737475|65366629|FG024|Overall Study|Disease Progression|0|||
23444201|NCT02737475|65366630|FG025|Overall Study|Disease Progression|0|||
23444202|NCT02737475|65366631|FG026|Overall Study|Disease Progression|1|||
23444203|NCT01450761|65366634|FG000|Randomization|Subject no longer meets study criteria|1|||
23444204|NCT01450761|65366635|FG001|Randomization|Subject no longer meets study criteria|2|||
23444205|NCT01450761|65366634|FG000|Randomization|Withdrawal by Subject|2|||
23444206|NCT01450761|65366635|FG001|Randomization|Withdrawal by Subject|0|||
23628621|NCT02498236|66028049|FG002|Overall Study|Did not show for testing|0|||
23628622|NCT02498236|66028050|FG003|Overall Study|Did not show for testing|0|||
23628623|NCT02498236|66028051|FG004|Overall Study|Did not show for testing|0|||
23628624|NCT02498236|66028052|FG005|Overall Study|Did not show for testing|0|||
23828798|NCT00443729|66752466|FG000|Overall Study|Protocol Violation|1|||
23828799|NCT00443729|66752467|FG001|Overall Study|Protocol Violation|1|||
23444207|NCT01450761|65366634|FG000|Randomization|Disease progression|0|||
23444208|NCT01450761|65366635|FG001|Randomization|Disease progression|2|||
23444209|NCT01450761|65366634|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23444210|NCT01450761|65366635|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23444211|NCT01450761|65366634|FG000|Randomization|Other|0|||
23444212|NCT01450761|65366635|FG001|Randomization|Other|1|||
23444213|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Disease progression|33|||
23444214|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Disease progression|32|||
23444215|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
23444216|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
23444217|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
23444218|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
23444219|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
23628625|NCT02498236|66028053|FG006|Overall Study|Did not show for testing|0|||
23628626|NCT02498236|66028054|FG007|Overall Study|Did not show for testing|1|||
23444220|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
23444221|NCT01450761|65366634|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
23444222|NCT01450761|65366635|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
23444223|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Death|3|||
23444224|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Death|3|||
23444225|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Other|2|||
23444226|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Other|2|||
23444227|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
23444228|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
23444229|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
23444230|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
23444231|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
23444232|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
23444233|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
23444234|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
23444235|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
23444236|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
23444237|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
23444238|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
23444239|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Death|5|||
23444240|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Death|6|||
23444241|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
23444242|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
23444243|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
23444244|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
23444245|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
23444246|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
23444247|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
23444248|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
23444249|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
23444250|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
23444251|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
23444252|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
23444253|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
23444254|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
23444255|NCT03831100|65366636|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
23444256|NCT03831100|65366637|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
23444257|NCT02097030|65366638|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
23444258|NCT02097030|65366639|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
23444259|NCT02097030|65366638|FG000|First Intervention (3 Days)|Visual Acuity|0|||
23444260|NCT02097030|65366639|FG001|First Intervention (3 Days)|Visual Acuity|1|||
23444261|NCT02586727|65366642|FG000|Overall Study|Lost to Follow-up|1|||
23444262|NCT02586727|65366643|FG001|Overall Study|Lost to Follow-up|0|||
23444263|NCT02652260|65366651|FG000|Overall Study|Pregnancy|0|||
23444264|NCT02652260|65366652|FG001|Overall Study|Pregnancy|1|||
23764668|NCT01073020|66518062|FG002|Overall Study|Withdrawal by Subject|1|||
23764669|NCT01073020|66518063|FG003|Overall Study|Withdrawal by Subject|2|||
23764670|NCT01073020|66518060|FG000|Overall Study|Physician Decision|1|||
23764671|NCT01073020|66518061|FG001|Overall Study|Physician Decision|0|||
23764672|NCT01073020|66518062|FG002|Overall Study|Physician Decision|2|||
23764673|NCT01073020|66518063|FG003|Overall Study|Physician Decision|0|||
23764674|NCT01073020|66518060|FG000|Overall Study|Death|0|||
23764675|NCT01073020|66518061|FG001|Overall Study|Death|1|||
23764676|NCT01073020|66518062|FG002|Overall Study|Death|0|||
23764677|NCT01073020|66518063|FG003|Overall Study|Death|0|||
23764678|NCT02266706|66518064|FG000|Overall Study|Withdrawal by Subject|0|||
23764679|NCT02266706|66518065|FG001|Overall Study|Withdrawal by Subject|1|||
23764680|NCT02266706|66518066|FG002|Overall Study|Withdrawal by Subject|1|||
23764681|NCT02266706|66518067|FG003|Overall Study|Withdrawal by Subject|0|||
23764682|NCT02266706|66518068|FG004|Overall Study|Withdrawal by Subject|0|||
23764683|NCT02266706|66518069|FG005|Overall Study|Withdrawal by Subject|1|||
23764684|NCT02266706|66518070|FG006|Overall Study|Withdrawal by Subject|0|||
23444265|NCT02652260|65366651|FG000|Overall Study|Withdrawal by Subject|0|||
23444266|NCT02652260|65366652|FG001|Overall Study|Withdrawal by Subject|1|||
23444267|NCT02255461|65366653|FG000|Overall Study|Adverse Event|0|||
23444268|NCT02255461|65366654|FG001|Overall Study|Adverse Event|1|||
23566981|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23764685|NCT02266706|66518071|FG007|Overall Study|Withdrawal by Subject|0|||
23764686|NCT02266706|66518072|FG008|Overall Study|Withdrawal by Subject|0|||
23764687|NCT02266706|66518064|FG000|Overall Study|Screen failure|0|||
23444269|NCT02255461|65366655|FG002|Overall Study|Adverse Event|0|||
23444270|NCT02255461|65366656|FG003|Overall Study|Adverse Event|0|||
23444271|NCT02255461|65366657|FG004|Overall Study|Adverse Event|1|||
23444272|NCT02255461|65366653|FG000|Overall Study|Withdrawal by Subject|0|||
23444273|NCT02255461|65366654|FG001|Overall Study|Withdrawal by Subject|0|||
23444274|NCT02255461|65366655|FG002|Overall Study|Withdrawal by Subject|1|||
23444275|NCT02255461|65366656|FG003|Overall Study|Withdrawal by Subject|0|||
23444276|NCT02255461|65366657|FG004|Overall Study|Withdrawal by Subject|1|||
23444277|NCT02255461|65366653|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
23444278|NCT02255461|65366654|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
23444279|NCT02255461|65366655|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
23444280|NCT02255461|65366656|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
23444281|NCT02255461|65366657|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
23444282|NCT03282097|65366658|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
23444283|NCT03282097|65366659|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
23444284|NCT03282097|65366658|FG000|Intervention Visit Complete|Patient Death|13|||
23444285|NCT03282097|65366659|FG001|Intervention Visit Complete|Patient Death|15|||
23444286|NCT03282097|65366658|FG000|Intervention Visit Complete|Caregiver Death|0|||
23444287|NCT03282097|65366659|FG001|Intervention Visit Complete|Caregiver Death|3|||
23444288|NCT03282097|65366658|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
23444289|NCT03282097|65366659|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
23444290|NCT03282097|65366658|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
23444291|NCT03282097|65366659|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
23444292|NCT03282097|65366658|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
23444293|NCT03282097|65366659|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
23444294|NCT03282097|65366658|FG000|Primary Outcome Data Collection Complete|Missing|2|||
23444295|NCT03282097|65366659|FG001|Primary Outcome Data Collection Complete|Missing|3|||
23444296|NCT03282097|65366658|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
23444297|NCT03282097|65366659|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
23444298|NCT03282097|65366658|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
23444299|NCT03282097|65366659|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
23444300|NCT03282097|65366658|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
23444301|NCT03282097|65366659|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
23444302|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
23444303|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
23444304|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
23444305|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
23444306|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Death|2|||
23444307|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Death|2|||
23444308|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Death|0|||
23444309|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Death|0|||
23444310|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
23444311|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
23444312|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
23444313|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
23444314|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
23444315|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444316|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444317|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444318|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
23444319|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
23444320|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
23444321|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
23444322|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
23444323|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444324|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444325|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444326|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444327|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
23444328|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444329|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444330|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
23444331|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
23444332|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
23444333|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
23444334|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
23444335|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
23444336|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
23444337|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
23444338|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Death|0|||
23444339|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Death|0|||
23444340|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Death|0|||
23444341|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Death|1|||
23444342|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
23444343|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
23444344|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
23444345|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
23444346|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444347|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444348|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
23444349|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444350|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444351|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444352|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
23444353|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444354|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
23444355|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
23444356|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
23444357|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
23444358|NCT00767806|65366671|FG000|Overall Study|Adverse Event|30|||
23444359|NCT00767806|65366672|FG001|Overall Study|Adverse Event|11|||
23444360|NCT00767806|65366671|FG000|Overall Study|Withdrawal by Subject|8|||
23444361|NCT00767806|65366672|FG001|Overall Study|Withdrawal by Subject|13|||
23444362|NCT00767806|65366671|FG000|Overall Study|Protocol Violation|6|||
23444363|NCT00767806|65366672|FG001|Overall Study|Protocol Violation|5|||
23444364|NCT00767806|65366671|FG000|Overall Study|Lack of Efficacy|1|||
23444365|NCT00767806|65366672|FG001|Overall Study|Lack of Efficacy|9|||
23444366|NCT00767806|65366671|FG000|Overall Study|Physician Decision|4|||
23444367|NCT00767806|65366672|FG001|Overall Study|Physician Decision|3|||
23444368|NCT00767806|65366671|FG000|Overall Study|Lost to Follow-up|1|||
23444369|NCT00767806|65366672|FG001|Overall Study|Lost to Follow-up|4|||
23764688|NCT02266706|66518065|FG001|Overall Study|Screen failure|0|||
23764689|NCT02266706|66518066|FG002|Overall Study|Screen failure|0|||
23764690|NCT02266706|66518067|FG003|Overall Study|Screen failure|0|||
23444370|NCT00767806|65366671|FG000|Overall Study|Entry Criteria Not Met|1|||
23444371|NCT00767806|65366672|FG001|Overall Study|Entry Criteria Not Met|1|||
23444372|NCT00767806|65366671|FG000|Overall Study|Sponsor Decision|0|||
23444373|NCT00767806|65366672|FG001|Overall Study|Sponsor Decision|1|||
23444374|NCT02134925|65366673|FG000|Overall Study|Withdrawal by Subject|1|||
23444375|NCT02134925|65366674|FG001|Overall Study|Withdrawal by Subject|0|||
23444376|NCT02134925|65366673|FG000|Overall Study|Cancel|1|||
23444377|NCT02134925|65366674|FG001|Overall Study|Cancel|6|||
23444378|NCT01797263|65366675|FG000|Overall Study|Withdrawal by Subject|21|||
23444379|NCT01797263|65366676|FG001|Overall Study|Withdrawal by Subject|25|||
23444380|NCT01797263|65366675|FG000|Overall Study|Death|1|||
23444381|NCT01797263|65366676|FG001|Overall Study|Death|0|||
23444382|NCT01797263|65366675|FG000|Overall Study|Lost to Follow-up|15|||
23444383|NCT01797263|65366676|FG001|Overall Study|Lost to Follow-up|15|||
23444384|NCT01934010|65366677|FG000|Overall Study|Adverse Event|1|||
23444385|NCT01934010|65366678|FG001|Overall Study|Adverse Event|1|||
23444386|NCT01934010|65366679|FG002|Overall Study|Adverse Event|0|||
23444387|NCT01934010|65366677|FG000|Overall Study|Withdrawal by Subject|15|||
23444388|NCT01934010|65366678|FG001|Overall Study|Withdrawal by Subject|6|||
23444389|NCT01934010|65366679|FG002|Overall Study|Withdrawal by Subject|2|||
23444390|NCT01934010|65366677|FG000|Overall Study|Lost to Follow-up|7|||
23444391|NCT01934010|65366678|FG001|Overall Study|Lost to Follow-up|4|||
23444392|NCT01934010|65366679|FG002|Overall Study|Lost to Follow-up|0|||
23444393|NCT02333799|65366680|FG000|Treatment Period|Withdrawal by Subject|1|||
23764691|NCT02266706|66518068|FG004|Overall Study|Screen failure|0|||
23444394|NCT02333799|65366680|FG000|Treatment Period|Death|6|||
23444395|NCT02333799|65366680|FG000|6 Month Follow Up Period|Physician Decision|1|||
23444396|NCT02333799|65366680|FG000|6 Month Follow Up Period|Death|1|||
23444397|NCT02333799|65366680|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
23444398|NCT02333799|65366680|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
23444399|NCT01397461|65370065|FG000|Overall Study|Withdrawal by Subject|2|||
23444400|NCT01397461|65370066|FG001|Overall Study|Withdrawal by Subject|1|||
23444401|NCT01397461|65370067|FG002|Overall Study|Withdrawal by Subject|0|||
23444402|NCT01397461|65370065|FG000|Overall Study|Lost to Follow-up|0|||
23764692|NCT02266706|66518069|FG005|Overall Study|Screen failure|1|||
23444403|NCT01397461|65370066|FG001|Overall Study|Lost to Follow-up|2|||
23764693|NCT02266706|66518070|FG006|Overall Study|Screen failure|1|||
23628627|NCT02498236|66028047|FG000|Overall Study|Equipment failure|0|||
23628628|NCT02498236|66028048|FG001|Overall Study|Equipment failure|0|||
23628629|NCT02498236|66028049|FG002|Overall Study|Equipment failure|0|||
23628630|NCT02498236|66028050|FG003|Overall Study|Equipment failure|0|||
23628631|NCT02498236|66028051|FG004|Overall Study|Equipment failure|0|||
23628632|NCT02498236|66028052|FG005|Overall Study|Equipment failure|0|||
23628633|NCT02498236|66028053|FG006|Overall Study|Equipment failure|1|||
23628634|NCT02498236|66028054|FG007|Overall Study|Equipment failure|0|||
23628635|NCT02498236|66028047|FG000|Overall Study|Withdrawal by Subject|0|||
23628636|NCT02498236|66028048|FG001|Overall Study|Withdrawal by Subject|0|||
23628637|NCT02498236|66028049|FG002|Overall Study|Withdrawal by Subject|0|||
23628638|NCT02498236|66028050|FG003|Overall Study|Withdrawal by Subject|0|||
23628639|NCT02498236|66028051|FG004|Overall Study|Withdrawal by Subject|1|||
23628640|NCT02498236|66028052|FG005|Overall Study|Withdrawal by Subject|0|||
23628641|NCT02498236|66028053|FG006|Overall Study|Withdrawal by Subject|0|||
23628642|NCT02498236|66028054|FG007|Overall Study|Withdrawal by Subject|0|||
23628643|NCT01536171|66028055|FG000|Overall Study|Withdrawal by Subject|1|||
23628644|NCT01262092|66028056|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
23628645|NCT01262092|66028057|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
23628646|NCT01262092|66028056|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
23628647|NCT01262092|66028057|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
23628648|NCT01262092|66028056|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
23628649|NCT01262092|66028057|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
23628650|NCT01262092|66028056|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
23628651|NCT01262092|66028057|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
23628652|NCT02689453|66028064|FG000|Overall Study|Progressive disease|0|||
23628653|NCT02689453|66028065|FG001|Overall Study|Progressive disease|1|||
23628654|NCT02689453|66028066|FG002|Overall Study|Progressive disease|1|||
23628655|NCT02166476|66028068|FG000|Overall Study|Withdrawal by Subject|5|||
23628656|NCT02166476|66028069|FG001|Overall Study|Withdrawal by Subject|7|||
23628657|NCT02166476|66028068|FG000|Overall Study|Adverse Event|3|||
23628658|NCT02166476|66028069|FG001|Overall Study|Adverse Event|3|||
23628659|NCT02166476|66028068|FG000|Overall Study|Lost to Follow-up|5|||
23628660|NCT02166476|66028069|FG001|Overall Study|Lost to Follow-up|10|||
23628661|NCT02166476|66028068|FG000|Overall Study|Physician Decision|1|||
23628662|NCT02166476|66028069|FG001|Overall Study|Physician Decision|0|||
23628663|NCT02166476|66028068|FG000|Overall Study|Unable to Come for Visit|0|||
23628664|NCT02166476|66028069|FG001|Overall Study|Unable to Come for Visit|3|||
23628665|NCT04092452|66028070|FG000|Overall Study|Adverse Event|1|||
23628666|NCT04092452|66028071|FG001|Overall Study|Adverse Event|3|||
23628667|NCT04092452|66028072|FG002|Overall Study|Adverse Event|3|||
23628668|NCT04092452|66028073|FG003|Overall Study|Adverse Event|7|||
23628669|NCT04092452|66028070|FG000|Overall Study|Lack of Efficacy|1|||
23628670|NCT04092452|66028071|FG001|Overall Study|Lack of Efficacy|1|||
23628671|NCT04092452|66028072|FG002|Overall Study|Lack of Efficacy|1|||
23628672|NCT04092452|66028073|FG003|Overall Study|Lack of Efficacy|0|||
23444404|NCT01397461|65370067|FG002|Overall Study|Lost to Follow-up|1|||
23444405|NCT01397461|65370065|FG000|Overall Study|Lack of Efficacy|0|||
23444406|NCT01397461|65370066|FG001|Overall Study|Lack of Efficacy|3|||
23444407|NCT01397461|65370067|FG002|Overall Study|Lack of Efficacy|0|||
23444408|NCT01397461|65370065|FG000|Overall Study|Not treated|0|||
23444409|NCT01397461|65370066|FG001|Overall Study|Not treated|0|||
23444410|NCT01397461|65370067|FG002|Overall Study|Not treated|1|||
23444411|NCT01331109|65370068|FG000|Overall Study|Adverse Event|6|||
23444412|NCT01331109|65370068|FG000|Overall Study|Lack of Efficacy|2|||
23444413|NCT01331109|65370068|FG000|Overall Study|Protocol Violation|3|||
23444414|NCT01331109|65370068|FG000|Overall Study|Withdrawal by Subject|7|||
23628673|NCT04092452|66028070|FG000|Overall Study|Lost to Follow-up|4|||
23444415|NCT01331109|65370068|FG000|Overall Study|Lost to Follow-up|1|||
23628674|NCT04092452|66028071|FG001|Overall Study|Lost to Follow-up|3|||
23628675|NCT04092452|66028072|FG002|Overall Study|Lost to Follow-up|5|||
23444416|NCT01331109|65370068|FG000|Overall Study|Study Terminated by Sponsor|38|||
23628676|NCT04092452|66028073|FG003|Overall Study|Lost to Follow-up|1|||
23628677|NCT04092452|66028070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23628678|NCT04092452|66028071|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23628679|NCT04092452|66028072|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23628680|NCT04092452|66028073|FG003|Overall Study|Non-Compliance With Study Drug|1|||
23444417|NCT02630472|65370071|FG000|Overall Study|Physician Decision|10|||
23444418|NCT02630472|65370072|FG001|Overall Study|Physician Decision|0|||
23444419|NCT00719680|65370073|FG000|Overall Study|Adverse Event|1|||
23444420|NCT00719680|65370073|FG000|Overall Study|Lost to Follow-up|1|||
23444421|NCT00719680|65370073|FG000|Overall Study|Withdrawal by Subject|3|||
23444422|NCT03549104|65370074|FG000|Overall Study|Withdrawal by Subject|5|||
23444423|NCT03549104|65370075|FG001|Overall Study|Withdrawal by Subject|2|||
23444424|NCT03549104|65370074|FG000|Overall Study|Covid shelter in place|1|||
23444425|NCT03549104|65370075|FG001|Overall Study|Covid shelter in place|2|||
23444426|NCT00853151|65370076|FG000|Overall Study|Adverse Event|1|||
23444427|NCT00853151|65370077|FG001|Overall Study|Adverse Event|4|||
23444428|NCT00853151|65370078|FG002|Overall Study|Adverse Event|2|||
23444429|NCT00853151|65370079|FG003|Overall Study|Adverse Event|0|||
23444430|NCT00853151|65370076|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23444431|NCT00853151|65370077|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444432|NCT00853151|65370078|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444433|NCT00853151|65370079|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444434|NCT00853151|65370076|FG000|Overall Study|Lost to Follow-up|2|||
23444435|NCT00853151|65370077|FG001|Overall Study|Lost to Follow-up|0|||
23444436|NCT00853151|65370078|FG002|Overall Study|Lost to Follow-up|3|||
23444437|NCT00853151|65370079|FG003|Overall Study|Lost to Follow-up|0|||
23444438|NCT00853151|65370076|FG000|Overall Study|Death|1|||
23444439|NCT00853151|65370077|FG001|Overall Study|Death|0|||
23444440|NCT00853151|65370078|FG002|Overall Study|Death|0|||
23444441|NCT00853151|65370079|FG003|Overall Study|Death|1|||
23444442|NCT00853151|65370076|FG000|Overall Study|Protocol Violation|0|||
23444443|NCT00853151|65370077|FG001|Overall Study|Protocol Violation|0|||
23444444|NCT00853151|65370078|FG002|Overall Study|Protocol Violation|0|||
23444445|NCT00853151|65370079|FG003|Overall Study|Protocol Violation|1|||
23444446|NCT00853151|65370076|FG000|Overall Study|Withdrawal by Subject|5|||
23828800|NCT00443729|66752466|FG000|Overall Study|Withdrawal by Subject|3|||
23828801|NCT00443729|66752467|FG001|Overall Study|Withdrawal by Subject|1|||
23828802|NCT02152137|66752470|FG000|Overall Study|Withdrawal by Subject|1|||
23828803|NCT02152137|66752470|FG000|Overall Study|Originally assigned to Arm B|3|||
23828804|NCT02654054|66752471|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23828805|NCT02654054|66752472|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
23828806|NCT02654054|66752473|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
23828807|NCT02654054|66752471|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23828808|NCT02654054|66752472|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23828809|NCT02654054|66752473|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23828810|NCT02654054|66752471|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23828811|NCT02654054|66752472|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23828812|NCT02654054|66752473|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23828813|NCT02654054|66752471|FG000|Post-Treatment Follow-Up Period|Other|1|||
23828814|NCT02654054|66752472|FG001|Post-Treatment Follow-Up Period|Other|0|||
23828815|NCT02654054|66752473|FG002|Post-Treatment Follow-Up Period|Other|4|||
23444447|NCT00853151|65370077|FG001|Overall Study|Withdrawal by Subject|4|||
23444448|NCT00853151|65370078|FG002|Overall Study|Withdrawal by Subject|2|||
23444449|NCT00853151|65370079|FG003|Overall Study|Withdrawal by Subject|1|||
23444450|NCT00853151|65370076|FG000|Overall Study|Physician Decision|0|||
23444451|NCT00853151|65370077|FG001|Overall Study|Physician Decision|2|||
23444452|NCT00853151|65370078|FG002|Overall Study|Physician Decision|1|||
23444453|NCT00853151|65370079|FG003|Overall Study|Physician Decision|0|||
23444454|NCT00853151|65370076|FG000|Overall Study|Sponsor Decision|0|||
23444455|NCT00853151|65370077|FG001|Overall Study|Sponsor Decision|3|||
23444456|NCT00853151|65370078|FG002|Overall Study|Sponsor Decision|0|||
23444457|NCT00853151|65370079|FG003|Overall Study|Sponsor Decision|0|||
23444458|NCT03592368|65370080|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444459|NCT03592368|65370081|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
23828816|NCT02654054|66752471|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23444460|NCT03592368|65370082|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444461|NCT03592368|65370083|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444462|NCT03592368|65370080|FG000|Overall Study|Adverse Event|0|||
23828817|NCT02654054|66752472|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23828818|NCT02654054|66752473|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
23444463|NCT03592368|65370081|FG001|Overall Study|Adverse Event|0|||
23444464|NCT03592368|65370082|FG002|Overall Study|Adverse Event|0|||
23444465|NCT03592368|65370083|FG003|Overall Study|Adverse Event|1|||
23444466|NCT03592368|65370080|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
23444467|NCT03592368|65370081|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
23444468|NCT03592368|65370082|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
23444469|NCT03592368|65370083|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
23444470|NCT01959841|65370086|FG000|Overall Study|Adverse Event|1|||
23444471|NCT01959841|65370087|FG001|Overall Study|Adverse Event|3|||
23444472|NCT01959841|65370088|FG002|Overall Study|Adverse Event|2|||
23444473|NCT01959841|65370086|FG000|Overall Study|Lack of Efficacy|5|||
23444474|NCT01959841|65370087|FG001|Overall Study|Lack of Efficacy|0|||
23444475|NCT01959841|65370088|FG002|Overall Study|Lack of Efficacy|0|||
23444476|NCT01959841|65370086|FG000|Overall Study|Lost to Follow-up|1|||
23444477|NCT01959841|65370087|FG001|Overall Study|Lost to Follow-up|1|||
23444478|NCT01959841|65370088|FG002|Overall Study|Lost to Follow-up|0|||
23444479|NCT01959841|65370086|FG000|Overall Study|Physician Decision|0|||
23444480|NCT01959841|65370087|FG001|Overall Study|Physician Decision|2|||
23444481|NCT01959841|65370088|FG002|Overall Study|Physician Decision|3|||
23444482|NCT01959841|65370086|FG000|Overall Study|Protocol Violation|16|||
23444483|NCT01959841|65370087|FG001|Overall Study|Protocol Violation|23|||
23444484|NCT01959841|65370088|FG002|Overall Study|Protocol Violation|16|||
23444485|NCT01959841|65370086|FG000|Overall Study|Withdrawal by Subject|7|||
23444486|NCT01959841|65370087|FG001|Overall Study|Withdrawal by Subject|7|||
23444487|NCT01959841|65370088|FG002|Overall Study|Withdrawal by Subject|5|||
23444488|NCT01959841|65370086|FG000|Overall Study|Clinical laboratory value|2|||
23444489|NCT01959841|65370087|FG001|Overall Study|Clinical laboratory value|6|||
23444490|NCT01959841|65370088|FG002|Overall Study|Clinical laboratory value|6|||
23444491|NCT01959841|65370086|FG000|Overall Study|Platelet count below on day1 or 4|11|||
23444492|NCT01959841|65370087|FG001|Overall Study|Platelet count below on day1 or 4|15|||
23444493|NCT01959841|65370088|FG002|Overall Study|Platelet count below on day1 or 4|11|||
23444494|NCT02532465|65370089|FG000|Overall Study|Protocol Violation|1|||
23444495|NCT02532465|65370090|FG001|Overall Study|Protocol Violation|0|||
23444496|NCT02532465|65370089|FG000|Overall Study|Lack of Efficacy|0|||
23444497|NCT02532465|65370090|FG001|Overall Study|Lack of Efficacy|1|||
23444498|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
23444499|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
23444500|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
23444501|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
23444502|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
23444503|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444504|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444505|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444506|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444507|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
23444508|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444509|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444510|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444511|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
23444512|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444513|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444514|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
23444515|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
23444516|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
23444517|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
23444518|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
23764694|NCT02266706|66518071|FG007|Overall Study|Screen failure|0|||
23764695|NCT02266706|66518072|FG008|Overall Study|Screen failure|0|||
23764696|NCT02266706|66518064|FG000|Overall Study|Enrollment in another study|0|||
23764697|NCT02266706|66518065|FG001|Overall Study|Enrollment in another study|0|||
23764698|NCT02266706|66518066|FG002|Overall Study|Enrollment in another study|0|||
23764699|NCT02266706|66518067|FG003|Overall Study|Enrollment in another study|1|||
23764700|NCT02266706|66518068|FG004|Overall Study|Enrollment in another study|0|||
23764701|NCT02266706|66518069|FG005|Overall Study|Enrollment in another study|0|||
23764702|NCT02266706|66518070|FG006|Overall Study|Enrollment in another study|0|||
23764703|NCT02266706|66518071|FG007|Overall Study|Enrollment in another study|0|||
23764704|NCT02266706|66518072|FG008|Overall Study|Enrollment in another study|0|||
23764705|NCT01738581|66518073|FG000|Overall Study|Lost to Follow-up|1|||
23764706|NCT01738581|66518074|FG001|Overall Study|Lost to Follow-up|0|||
23764707|NCT01165242|66518075|FG000|Overall Study|Unreachable Subjects|1|||
23764708|NCT01165242|66518076|FG001|Overall Study|Unreachable Subjects|0|||
23764709|NCT01165242|66518077|FG002|Overall Study|Unreachable Subjects|0|||
23764710|NCT01165242|66518075|FG000|Overall Study|Incarcerated Subjects|0|||
23444519|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
23444520|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
23764711|NCT01165242|66518076|FG001|Overall Study|Incarcerated Subjects|1|||
23628681|NCT04092452|66028070|FG000|Overall Study|Physician Decision|1|||
23628682|NCT04092452|66028071|FG001|Overall Study|Physician Decision|0|||
23628683|NCT04092452|66028072|FG002|Overall Study|Physician Decision|1|||
23628684|NCT04092452|66028073|FG003|Overall Study|Physician Decision|0|||
23628685|NCT04092452|66028070|FG000|Overall Study|Pregnancy|2|||
23628686|NCT04092452|66028071|FG001|Overall Study|Pregnancy|0|||
23628687|NCT04092452|66028072|FG002|Overall Study|Pregnancy|0|||
23628688|NCT04092452|66028073|FG003|Overall Study|Pregnancy|0|||
23628689|NCT04092452|66028070|FG000|Overall Study|Protocol Deviation|1|||
23628690|NCT04092452|66028071|FG001|Overall Study|Protocol Deviation|0|||
23628691|NCT04092452|66028072|FG002|Overall Study|Protocol Deviation|0|||
23628692|NCT04092452|66028073|FG003|Overall Study|Protocol Deviation|0|||
23628693|NCT04092452|66028070|FG000|Overall Study|Withdrawal by Subject|3|||
23628694|NCT04092452|66028071|FG001|Overall Study|Withdrawal by Subject|10|||
23628695|NCT04092452|66028072|FG002|Overall Study|Withdrawal by Subject|3|||
23628696|NCT04092452|66028073|FG003|Overall Study|Withdrawal by Subject|5|||
23628697|NCT04092452|66028070|FG000|Overall Study|Other|0|||
23628698|NCT04092452|66028071|FG001|Overall Study|Other|0|||
23628699|NCT04092452|66028072|FG002|Overall Study|Other|1|||
23628700|NCT04092452|66028073|FG003|Overall Study|Other|2|||
23628701|NCT03933462|66028080|FG000|Overall Study|Adverse Event|2|||
23628702|NCT03933462|66028081|FG001|Overall Study|Adverse Event|0|||
23628703|NCT03482752|66028086|FG000|Overall Study|Withdrawal by Subject|2|||
23628704|NCT03482752|66028086|FG000|Overall Study|Lost to Follow-up|1|||
23628705|NCT03482752|66028086|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
23628706|NCT00416598|66028087|FG000|Induction & Intensification|Adverse Event|38|||
23628707|NCT00416598|66028087|FG000|Induction & Intensification|Death|32|||
23628708|NCT00416598|66028087|FG000|Induction & Intensification|Withdrawal by Subject|46|||
23628709|NCT00416598|66028087|FG000|Induction & Intensification|Alternative Treatment|135|||
23628710|NCT00416598|66028087|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
23628711|NCT00416598|66028087|FG000|Induction & Intensification|Relapse/progression|29|||
23628712|NCT00416598|66028087|FG000|Induction & Intensification|Failed induction|87|||
23628713|NCT00416598|66028087|FG000|Decitabine Maintenance|Adverse Event|5|||
23764712|NCT01165242|66518077|FG002|Overall Study|Incarcerated Subjects|0|||
23764713|NCT01165242|66518075|FG000|Overall Study|Visit 2 Declined by Subject|0|||
23628714|NCT00416598|66028087|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
23628715|NCT00416598|66028087|FG000|Decitabine Maintenance|Progression/relapse|38|||
23628716|NCT00416598|66028087|FG000|Decitabine Maintenance|Alternative treatment|2|||
23628717|NCT00416598|66028087|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
23628718|NCT00420784|66028088|FG000|Overall Study|Adverse Event|11|||
23628719|NCT00420784|66028089|FG001|Overall Study|Adverse Event|29|||
23764714|NCT01165242|66518076|FG001|Overall Study|Visit 2 Declined by Subject|0|||
23764715|NCT01165242|66518077|FG002|Overall Study|Visit 2 Declined by Subject|1|||
23764716|NCT01165242|66518075|FG000|Overall Study|Withdrawal by Subject|0|||
23764717|NCT01165242|66518076|FG001|Overall Study|Withdrawal by Subject|2|||
23764718|NCT01165242|66518077|FG002|Overall Study|Withdrawal by Subject|2|||
23764719|NCT01165242|66518075|FG000|Overall Study|Extended Holiday|0|||
23828819|NCT02548156|66752476|FG000|Washout Period 1|Lost to Follow-up|0|||
23628720|NCT00420784|66028090|FG002|Overall Study|Adverse Event|10|||
23628721|NCT00420784|66028091|FG003|Overall Study|Adverse Event|5|||
23628722|NCT00420784|66028088|FG000|Overall Study|Withdrawal by Subject|0|||
23628723|NCT00420784|66028089|FG001|Overall Study|Withdrawal by Subject|1|||
23628724|NCT00420784|66028090|FG002|Overall Study|Withdrawal by Subject|0|||
23444521|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
23444522|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
23444523|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
23444524|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
23444525|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
23444526|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
23444527|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
23444528|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
23444529|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
23444530|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
23444531|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
23444532|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
23444533|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
23444534|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444535|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444536|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444537|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
23444538|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
23444539|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
23444540|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
23566982|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566983|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23764720|NCT01165242|66518076|FG001|Overall Study|Extended Holiday|0|||
23764721|NCT01165242|66518077|FG002|Overall Study|Extended Holiday|1|||
23764722|NCT01165242|66518075|FG000|Overall Study|Lost to Follow-up|9|||
23764723|NCT01165242|66518076|FG001|Overall Study|Lost to Follow-up|7|||
23764724|NCT01165242|66518077|FG002|Overall Study|Lost to Follow-up|10|||
23764725|NCT01960816|66518078|FG000|Overall Study|Lost to Follow-up|1|||
23764726|NCT04896385|66518086|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
23764727|NCT04896385|66518087|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
23764728|NCT04896385|66518088|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
23764729|NCT04896385|66518089|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23764730|NCT04896385|66518086|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
23764731|NCT04896385|66518087|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
23764732|NCT04896385|66518088|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23764733|NCT04896385|66518089|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23764734|NCT04896385|66518086|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23764735|NCT04896385|66518087|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23764736|NCT04896385|66518088|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
23764737|NCT04896385|66518089|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
23764738|NCT04896385|66518086|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23566984|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
23566985|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566986|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23764739|NCT04896385|66518087|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23764740|NCT04896385|66518088|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
23764741|NCT04896385|66518089|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
23764742|NCT04896385|66518086|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
23764743|NCT04896385|66518087|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
23764744|NCT04896385|66518088|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
23764745|NCT04896385|66518089|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
23764746|NCT04896385|66518086|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
23764747|NCT04896385|66518087|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
23764748|NCT04896385|66518088|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
23764749|NCT04896385|66518089|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
23566987|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566988|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566989|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566990|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566991|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
23566992|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566993|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566994|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23764750|NCT03459846|66518090|FG000|Overall Study|Death|52|||
23764751|NCT03459846|66518091|FG001|Overall Study|Death|46|||
23444541|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
23444542|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444543|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444544|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444545|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
23444546|NCT04207749|65370097|FG000|Overall Study|Lost to Follow-up|0|||
23444547|NCT04207749|65370098|FG001|Overall Study|Lost to Follow-up|2|||
23444548|NCT04207749|65370097|FG000|Overall Study|Protocol Violation|0|||
23444549|NCT04207749|65370098|FG001|Overall Study|Protocol Violation|1|||
23444550|NCT04207749|65370097|FG000|Overall Study|Withdrawal by Subject|3|||
23444551|NCT04207749|65370098|FG001|Overall Study|Withdrawal by Subject|0|||
23444552|NCT04207749|65370097|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
23444553|NCT04207749|65370098|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
23444554|NCT01525615|65370099|FG000|Overall Study|Adverse Event|11|||
23566995|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23764752|NCT03459846|66518090|FG000|Overall Study|Study terminated by sponsor|24|||
23444555|NCT01525615|65370100|FG001|Overall Study|Adverse Event|7|||
23628725|NCT00420784|66028091|FG003|Overall Study|Withdrawal by Subject|0|||
23628726|NCT00420784|66028088|FG000|Overall Study|Lost to Follow-up|0|||
23628727|NCT00420784|66028089|FG001|Overall Study|Lost to Follow-up|0|||
23628728|NCT00420784|66028090|FG002|Overall Study|Lost to Follow-up|2|||
23628729|NCT00420784|66028091|FG003|Overall Study|Lost to Follow-up|1|||
23628730|NCT00420784|66028088|FG000|Overall Study|Virologic Stopping Rule|17|||
23628731|NCT00420784|66028089|FG001|Overall Study|Virologic Stopping Rule|26|||
23628732|NCT00420784|66028090|FG002|Overall Study|Virologic Stopping Rule|41|||
23628733|NCT00420784|66028091|FG003|Overall Study|Virologic Stopping Rule|67|||
23628734|NCT00420784|66028088|FG000|Overall Study|Other|1|||
23566996|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23628735|NCT00420784|66028089|FG001|Overall Study|Other|2|||
23628736|NCT00420784|66028090|FG002|Overall Study|Other|0|||
23628737|NCT00420784|66028091|FG003|Overall Study|Other|5|||
23628738|NCT02161406|66028092|FG000|Overall Study|Death|2|||
23628739|NCT02161406|66028093|FG001|Overall Study|Death|1|||
23628740|NCT02161406|66028092|FG000|Overall Study|Lost to Follow-up|2|||
23628741|NCT02161406|66028093|FG001|Overall Study|Lost to Follow-up|1|||
23628742|NCT02161406|66028092|FG000|Overall Study|Withdrawal by Subject|2|||
23628743|NCT02161406|66028093|FG001|Overall Study|Withdrawal by Subject|4|||
23628744|NCT02161406|66028092|FG000|Overall Study|investigator withdrew subject|3|||
23628745|NCT02161406|66028093|FG001|Overall Study|investigator withdrew subject|1|||
23628746|NCT02161406|66028092|FG000|Overall Study|Lack of Efficacy|1|||
23628747|NCT02161406|66028093|FG001|Overall Study|Lack of Efficacy|1|||
23628748|NCT02161406|66028092|FG000|Overall Study|relocation|0|||
23628749|NCT02161406|66028093|FG001|Overall Study|relocation|1|||
23628750|NCT01441583|66028099|FG000|Overall Study|Withdrawal by Subject|1|||
23566997|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566998|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
23566999|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567000|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567001|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567002|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567003|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567004|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567005|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
23567006|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567007|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567008|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23628751|NCT01441583|66028100|FG001|Overall Study|Withdrawal by Subject|1|||
23628752|NCT01441583|66028101|FG002|Overall Study|Withdrawal by Subject|1|||
23628753|NCT01441583|66028099|FG000|Overall Study|Death|1|||
23628754|NCT01441583|66028100|FG001|Overall Study|Death|0|||
23628755|NCT01441583|66028101|FG002|Overall Study|Death|4|||
23628756|NCT01441583|66028099|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
23444556|NCT01525615|65370101|FG002|Overall Study|Adverse Event|5|||
23444557|NCT01525615|65370099|FG000|Overall Study|Lost to Follow-up|1|||
23444558|NCT01525615|65370100|FG001|Overall Study|Lost to Follow-up|0|||
23444559|NCT01525615|65370101|FG002|Overall Study|Lost to Follow-up|0|||
23628757|NCT01441583|66028100|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
23628758|NCT01441583|66028101|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
23444560|NCT01525615|65370099|FG000|Overall Study|Withdrawal by Subject|1|||
23628759|NCT01010204|66028104|FG000|Overall Study|Lost to Follow-up|2|||
23764753|NCT03459846|66518091|FG001|Overall Study|Study terminated by sponsor|28|||
23628760|NCT01010204|66028105|FG001|Overall Study|Lost to Follow-up|2|||
23764754|NCT03459846|66518090|FG000|Overall Study|Withdrawal by Subject|2|||
23764755|NCT03459846|66518091|FG001|Overall Study|Withdrawal by Subject|2|||
23764756|NCT01070966|66518098|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
23764757|NCT01070966|66518098|FG000|Participants for Safety Evaluation|Off-label use|9|||
23764758|NCT01070966|66518098|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
23764759|NCT01070966|66518098|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
23764760|NCT01070966|66518098|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
23764761|NCT01070966|66518098|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
23567009|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567010|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567011|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567012|NCT01576718|65803969|FG000|Treatment Period|Adverse Event|0|||
23567013|NCT01576718|65803970|FG001|Treatment Period|Adverse Event|1|||
23567014|NCT01576718|65803971|FG002|Treatment Period|Adverse Event|1|||
23567015|NCT01576718|65803972|FG003|Treatment Period|Adverse Event|1|||
23567016|NCT01576718|65803973|FG004|Treatment Period|Adverse Event|1|||
23764762|NCT01070966|66518098|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
23764763|NCT01070966|66518098|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
23764764|NCT04947579|66518099|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23764765|NCT04947579|66518100|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23764766|NCT04947579|66518101|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23764767|NCT04947579|66518102|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
23764768|NCT04947579|66518103|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23764769|NCT04947579|66518104|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23764770|NCT04947579|66518099|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23764771|NCT04947579|66518100|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23764772|NCT04947579|66518101|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
23764773|NCT04947579|66518102|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23764774|NCT04947579|66518103|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23764775|NCT04947579|66518104|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23764776|NCT04947579|66518099|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
23764777|NCT04947579|66518100|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
23764778|NCT04947579|66518101|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
23764779|NCT04947579|66518102|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
23764780|NCT04947579|66518103|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
23764781|NCT04947579|66518104|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
23764782|NCT04947579|66518099|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
23764783|NCT04947579|66518100|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
23764784|NCT04947579|66518101|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
23764785|NCT04947579|66518102|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
23764786|NCT04947579|66518103|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
23764787|NCT04947579|66518104|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
23764788|NCT04947579|66518099|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
23764789|NCT04947579|66518100|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23764790|NCT04947579|66518101|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23764791|NCT04947579|66518102|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23764792|NCT04947579|66518103|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23764793|NCT04947579|66518104|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23764794|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23764795|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23764796|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
23764797|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23764798|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23764799|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23764800|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23764801|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
23567017|NCT01576718|65803974|FG005|Treatment Period|Adverse Event|1|||
23567018|NCT01576718|65803975|FG006|Treatment Period|Adverse Event|0|||
23567019|NCT01576718|65803969|FG000|Treatment Period|Withdrawal by Subject|0|||
23567020|NCT01576718|65803970|FG001|Treatment Period|Withdrawal by Subject|1|||
23567021|NCT01576718|65803971|FG002|Treatment Period|Withdrawal by Subject|1|||
23764802|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23764803|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23764804|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23764805|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
23764806|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23764807|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23764808|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
23764809|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23764810|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23764811|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23764812|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
23764813|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
23764814|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
23764815|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
23764816|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
23764817|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
23764818|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
23764819|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
23764820|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
23764821|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
23764822|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
23764823|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
23764824|NCT04947579|66518099|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23764825|NCT04947579|66518100|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
23764826|NCT04947579|66518101|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
23764827|NCT04947579|66518102|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23764828|NCT04947579|66518103|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
23764829|NCT04947579|66518104|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23764830|NCT00901628|66518105|FG000|Overall Study|disconnection of catheter|4|||
23764831|NCT00901628|66518106|FG001|Overall Study|disconnection of catheter|8|||
23764832|NCT00901628|66518105|FG000|Overall Study|disconnection of drain|0|||
23764833|NCT00901628|66518106|FG001|Overall Study|disconnection of drain|1|||
23764834|NCT00901628|66518105|FG000|Overall Study|peroneal nerve palsy|0|||
23764835|NCT00901628|66518106|FG001|Overall Study|peroneal nerve palsy|1|||
23764836|NCT02708277|66518107|FG000|Overall Study|Lost to Follow-up|7|||
23764837|NCT02708277|66518108|FG001|Overall Study|Lost to Follow-up|4|||
23764838|NCT02750761|66518109|FG000|Overall Study|Lost to Follow-up|0|||
23764839|NCT02750761|66518110|FG001|Overall Study|Lost to Follow-up|0|||
23764840|NCT02750761|66518111|FG002|Overall Study|Lost to Follow-up|1|||
23764841|NCT02750761|66518112|FG003|Overall Study|Lost to Follow-up|0|||
23764842|NCT02750761|66518113|FG004|Overall Study|Lost to Follow-up|0|||
23764843|NCT02750761|66518114|FG005|Overall Study|Lost to Follow-up|0|||
23764844|NCT04633837|66518115|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
23764845|NCT04633837|66518116|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
23764846|NCT00458302|66518117|FG000|Overall Study|Adverse Event|4|||
23764847|NCT00458302|66518118|FG001|Overall Study|Adverse Event|14|||
23764848|NCT00458302|66518117|FG000|Overall Study|Pregnancy|2|||
23764849|NCT00458302|66518118|FG001|Overall Study|Pregnancy|1|||
23764850|NCT00458302|66518117|FG000|Overall Study|Protocol Violation|0|||
23764851|NCT00458302|66518118|FG001|Overall Study|Protocol Violation|2|||
23764852|NCT00458302|66518117|FG000|Overall Study|Withdrawal by Subject|6|||
23764853|NCT00458302|66518118|FG001|Overall Study|Withdrawal by Subject|4|||
23444561|NCT01525615|65370100|FG001|Overall Study|Withdrawal by Subject|0|||
23444562|NCT01525615|65370101|FG002|Overall Study|Withdrawal by Subject|0|||
23764854|NCT00458302|66518117|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
23444563|NCT01525615|65370099|FG000|Overall Study|Other reason not described above|1|||
23764855|NCT00458302|66518118|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
23764856|NCT00458302|66518117|FG000|Overall Study|Study Termination By Sponsor|1|||
23444564|NCT01525615|65370100|FG001|Overall Study|Other reason not described above|0|||
23444565|NCT01525615|65370101|FG002|Overall Study|Other reason not described above|1|||
23444566|NCT01979952|65370102|FG000|Overall Study|Adverse Event|4|||
23444567|NCT01979952|65370103|FG001|Overall Study|Adverse Event|5|||
23444568|NCT01979952|65370102|FG000|Overall Study|Protocol Violation|1|||
23444569|NCT01979952|65370103|FG001|Overall Study|Protocol Violation|0|||
23444570|NCT01979952|65370102|FG000|Overall Study|Withdrawal by Subject|2|||
23444571|NCT01979952|65370103|FG001|Overall Study|Withdrawal by Subject|1|||
23444572|NCT01979952|65370102|FG000|Overall Study|Other than specified above|1|||
23444573|NCT01979952|65370103|FG001|Overall Study|Other than specified above|0|||
23444574|NCT02644343|65370104|FG000|Overall Study|Withdrawal by Subject|1|||
23444575|NCT03003962|65370112|FG000|Overall Study|Withdrawal by Subject|5|||
23444576|NCT03003962|65370113|FG001|Overall Study|Withdrawal by Subject|17|||
23444577|NCT03003962|65370112|FG000|Overall Study|Death|274|||
23444578|NCT03003962|65370113|FG001|Overall Study|Death|277|||
23444579|NCT03003962|65370112|FG000|Overall Study|Participants ongoing at DCO|55|||
23444580|NCT03003962|65370113|FG001|Overall Study|Participants ongoing at DCO|40|||
23444581|NCT01136408|65370118|FG000|Overall Study|Adverse Event|4|||
23444582|NCT01136408|65370119|FG001|Overall Study|Adverse Event|8|||
23444583|NCT01136408|65370120|FG002|Overall Study|Adverse Event|4|||
23444584|NCT01136408|65370118|FG000|Overall Study|Protocol Violation|1|||
23444585|NCT01136408|65370119|FG001|Overall Study|Protocol Violation|1|||
23444586|NCT01136408|65370120|FG002|Overall Study|Protocol Violation|1|||
23444587|NCT01378325|65370121|FG000|Overall Study|Protocol Violation|0|||
23444588|NCT01378325|65370122|FG001|Overall Study|Protocol Violation|1|||
23444589|NCT05011513|65370123|FG000|Overall Study|Death|0|||
23567022|NCT01576718|65803972|FG003|Treatment Period|Withdrawal by Subject|0|||
23567023|NCT01576718|65803973|FG004|Treatment Period|Withdrawal by Subject|2|||
23567024|NCT01576718|65803974|FG005|Treatment Period|Withdrawal by Subject|4|||
23567025|NCT01576718|65803975|FG006|Treatment Period|Withdrawal by Subject|2|||
23567026|NCT01576718|65803969|FG000|Treatment Period|Physician Decision|0|||
23567027|NCT01576718|65803970|FG001|Treatment Period|Physician Decision|1|||
23567028|NCT01576718|65803971|FG002|Treatment Period|Physician Decision|1|||
23567029|NCT01576718|65803972|FG003|Treatment Period|Physician Decision|1|||
23567030|NCT01576718|65803973|FG004|Treatment Period|Physician Decision|1|||
23567031|NCT01576718|65803974|FG005|Treatment Period|Physician Decision|0|||
23567032|NCT01576718|65803975|FG006|Treatment Period|Physician Decision|0|||
23567033|NCT01576718|65803969|FG000|Treatment Period|Protocol Violation|0|||
23567034|NCT01576718|65803970|FG001|Treatment Period|Protocol Violation|5|||
23567035|NCT01576718|65803971|FG002|Treatment Period|Protocol Violation|4|||
23567036|NCT01576718|65803972|FG003|Treatment Period|Protocol Violation|10|||
23567037|NCT01576718|65803973|FG004|Treatment Period|Protocol Violation|6|||
23444590|NCT05011513|65370124|FG001|Overall Study|Death|1|||
23567038|NCT01576718|65803974|FG005|Treatment Period|Protocol Violation|8|||
23444591|NCT05011513|65370123|FG000|Overall Study|Lost to Follow-up|4|||
23444592|NCT05011513|65370124|FG001|Overall Study|Lost to Follow-up|0|||
23628761|NCT01010204|66028104|FG000|Overall Study|Adverse Event|1|||
23628762|NCT01010204|66028105|FG001|Overall Study|Adverse Event|3|||
23628763|NCT01010204|66028104|FG000|Overall Study|Withdrawal by Subject|2|||
23628764|NCT01010204|66028105|FG001|Overall Study|Withdrawal by Subject|3|||
23628765|NCT01010204|66028104|FG000|Overall Study|psychiatric hospitalization|2|||
23628766|NCT01010204|66028105|FG001|Overall Study|psychiatric hospitalization|1|||
23628767|NCT04147195|66028106|FG000|Overall Study|Adverse Event|0|||
23628768|NCT04147195|66028107|FG001|Overall Study|Adverse Event|3|||
23628769|NCT04147195|66028106|FG000|Overall Study|Study Terminated by Sponsor|4|||
23628770|NCT04147195|66028107|FG001|Overall Study|Study Terminated by Sponsor|2|||
23628771|NCT04147195|66028106|FG000|Overall Study|Withdrawal by Subject|0|||
23628772|NCT04147195|66028107|FG001|Overall Study|Withdrawal by Subject|1|||
23628773|NCT01485120|66028108|FG000|Overall Study|Withdrawal by Subject|2|||
23828820|NCT02548156|66752477|FG001|Washout Period 1|Lost to Follow-up|0|||
23828821|NCT02548156|66752478|FG002|Washout Period 1|Lost to Follow-up|0|||
23828822|NCT02548156|66752479|FG003|Washout Period 1|Lost to Follow-up|0|||
23828823|NCT02548156|66752480|FG004|Washout Period 1|Lost to Follow-up|1|||
23828824|NCT02548156|66752481|FG005|Washout Period 1|Lost to Follow-up|0|||
23828825|NCT04123405|66752482|FG000|Overall Study|Adverse Event|1|||
23828826|NCT04123405|66752483|FG001|Overall Study|Adverse Event|2|||
23828827|NCT04123405|66752484|FG002|Overall Study|Adverse Event|3|||
23828828|NCT04123405|66752485|FG003|Overall Study|Adverse Event|3|||
23828829|NCT04123405|66752482|FG000|Overall Study|Exclusion criteria met|1|||
23828830|NCT04123405|66752483|FG001|Overall Study|Exclusion criteria met|2|||
23828831|NCT04123405|66752484|FG002|Overall Study|Exclusion criteria met|0|||
23828832|NCT04123405|66752485|FG003|Overall Study|Exclusion criteria met|2|||
23828833|NCT04123405|66752482|FG000|Overall Study|Withdrawal by Subject|1|||
23828834|NCT04123405|66752483|FG001|Overall Study|Withdrawal by Subject|3|||
23828835|NCT04123405|66752484|FG002|Overall Study|Withdrawal by Subject|0|||
23628774|NCT02201901|66028110|FG000|Overall Study|Randomized but never treated|0|||
23628775|NCT02201901|66028111|FG001|Overall Study|Randomized but never treated|1|||
23628776|NCT02201901|66028112|FG002|Overall Study|Randomized but never treated|0|||
23628777|NCT02201901|66028110|FG000|Overall Study|Lack of Efficacy|7|||
23628778|NCT02201901|66028111|FG001|Overall Study|Lack of Efficacy|1|||
23628779|NCT02201901|66028112|FG002|Overall Study|Lack of Efficacy|6|||
23628780|NCT02201901|66028110|FG000|Overall Study|Death|3|||
23628781|NCT02201901|66028111|FG001|Overall Study|Death|3|||
23628782|NCT02201901|66028112|FG002|Overall Study|Death|3|||
23628783|NCT02201901|66028110|FG000|Overall Study|Lost to Follow-up|2|||
23628784|NCT02201901|66028111|FG001|Overall Study|Lost to Follow-up|3|||
23628785|NCT02201901|66028112|FG002|Overall Study|Lost to Follow-up|2|||
23828836|NCT04123405|66752485|FG003|Overall Study|Withdrawal by Subject|2|||
23828837|NCT04123405|66752482|FG000|Overall Study|Contact to subject lost|0|||
23628786|NCT02201901|66028110|FG000|Overall Study|Withdrew Consent|2|||
23628787|NCT02201901|66028111|FG001|Overall Study|Withdrew Consent|0|||
23628788|NCT02201901|66028112|FG002|Overall Study|Withdrew Consent|2|||
23628789|NCT02201901|66028110|FG000|Overall Study|Adverse Event|1|||
23628790|NCT02201901|66028111|FG001|Overall Study|Adverse Event|1|||
23628791|NCT02201901|66028112|FG002|Overall Study|Adverse Event|0|||
23628792|NCT01781832|66028113|FG000|Overall Study|Withdrawal by Subject|1|||
23628793|NCT01375751|66028114|FG000|Overall Study|Other|0|||
23628794|NCT01375751|66028115|FG001|Overall Study|Other|1|||
23628795|NCT01375751|66028116|FG002|Overall Study|Other|0|||
23628796|NCT01210651|66028119|FG000|Overall Study|Lost to Follow-up|1|||
23628797|NCT01210651|66028120|FG001|Overall Study|Lost to Follow-up|1|||
23764857|NCT00458302|66518118|FG001|Overall Study|Study Termination By Sponsor|0|||
23764858|NCT00458302|66518117|FG000|Overall Study|Lost to Follow-up|2|||
23764859|NCT00458302|66518118|FG001|Overall Study|Lost to Follow-up|0|||
23764860|NCT00458302|66518117|FG000|Overall Study|Other|4|||
23764861|NCT00458302|66518118|FG001|Overall Study|Other|2|||
23764862|NCT00112489|66518119|FG000|Overall Study|Refused further treatment|8|||
23764863|NCT00112489|66518119|FG000|Overall Study|Adverse Event|12|||
23764864|NCT00112489|66518119|FG000|Overall Study|Death|2|||
23764865|NCT00112489|66518119|FG000|Overall Study|Other, Not Specified|9|||
23764866|NCT00112489|66518119|FG000|Overall Study|Patient never treated|2|||
23764867|NCT00112489|66518119|FG000|Overall Study|Ineligible|7|||
23764868|NCT04104646|66518120|FG000|Overall Study|Withdrawal by Subject|1|||
23764869|NCT04104646|66518121|FG001|Overall Study|Withdrawal by Subject|1|||
23764870|NCT04104646|66518120|FG000|Overall Study|Lost to Follow-up|1|||
23764871|NCT04104646|66518121|FG001|Overall Study|Lost to Follow-up|0|||
23764872|NCT04104646|66518120|FG000|Overall Study|Physician Decision|2|||
23764873|NCT04104646|66518121|FG001|Overall Study|Physician Decision|0|||
23764874|NCT01759381|66518124|FG000|Overall Study|Death|1|||
23628798|NCT01210651|66028119|FG000|Overall Study|schedule conflicts|1|||
23628799|NCT01210651|66028120|FG001|Overall Study|schedule conflicts|5|||
23764875|NCT01759381|66518125|FG001|Overall Study|Death|0|||
23764876|NCT00368537|66518127|FG000|Randomization|No study drug dosed|13|||
23764877|NCT00368537|66518128|FG001|Randomization|No study drug dosed|6|||
23764878|NCT00368537|66518127|FG000|Baseline Participants|Lost to Follow-up|16|||
23764879|NCT00368537|66518128|FG001|Baseline Participants|Lost to Follow-up|17|||
23764880|NCT00368537|66518127|FG000|Baseline Participants|Withdrawal by Subject|6|||
23764881|NCT00368537|66518128|FG001|Baseline Participants|Withdrawal by Subject|4|||
23764882|NCT00368537|66518127|FG000|Baseline Participants|Death|1|||
23764883|NCT00368537|66518128|FG001|Baseline Participants|Death|2|||
23764884|NCT00368537|66518127|FG000|Baseline Participants|No susceptibility|1|||
23764885|NCT00368537|66518128|FG001|Baseline Participants|No susceptibility|0|||
23764886|NCT00368537|66518127|FG000|Baseline Participants|Patient uncompliant|0|||
23764887|NCT00368537|66518128|FG001|Baseline Participants|Patient uncompliant|1|||
23764888|NCT01625377|66518129|FG000|Overall Study|Death|1|||
23764889|NCT01625377|66518130|FG001|Overall Study|Death|1|||
23764890|NCT01625377|66518129|FG000|Overall Study|Administrative Problem|1|||
23764891|NCT01625377|66518130|FG001|Overall Study|Administrative Problem|1|||
23764892|NCT01625377|66518129|FG000|Overall Study|Protocol Violation|0|||
23764893|NCT01625377|66518130|FG001|Overall Study|Protocol Violation|3|||
23764894|NCT01625377|66518129|FG000|Overall Study|Adverse Event|3|||
23764895|NCT01625377|66518130|FG001|Overall Study|Adverse Event|16|||
23764896|NCT01625377|66518129|FG000|Overall Study|Graft loss|1|||
23764897|NCT01625377|66518130|FG001|Overall Study|Graft loss|0|||
23764898|NCT01625377|66518129|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23764899|NCT01625377|66518130|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23764900|NCT01625377|66518129|FG000|Overall Study|Abnormal laboratory values|1|||
23764901|NCT01625377|66518130|FG001|Overall Study|Abnormal laboratory values|0|||
23764902|NCT00767325|66518134|FG000|Overall Study|Lack of Efficacy|2|||
23764903|NCT00767325|66518134|FG000|Overall Study|Adverse Event|7|||
23764904|NCT00767325|66518134|FG000|Overall Study|Lost to Follow-up|3|||
23764905|NCT00767325|66518134|FG000|Overall Study|No longer met study criteria|2|||
23764906|NCT00767325|66518134|FG000|Overall Study|Missed visit due to family reasons|1|||
23764907|NCT02585258|66518135|FG000|Overall Study|Adverse Event|28|||
23764908|NCT02585258|66518136|FG001|Overall Study|Adverse Event|29|||
23764909|NCT02585258|66518135|FG000|Overall Study|Death|3|||
23764910|NCT02585258|66518136|FG001|Overall Study|Death|2|||
23764911|NCT02585258|66518135|FG000|Overall Study|Lack of Efficacy|7|||
23764912|NCT02585258|66518136|FG001|Overall Study|Lack of Efficacy|9|||
23764913|NCT02585258|66518135|FG000|Overall Study|includes covid-related access problems|42|||
23764914|NCT02585258|66518136|FG001|Overall Study|includes covid-related access problems|46|||
23764915|NCT02585258|66518135|FG000|Overall Study|Lost to Follow-up|5|||
23764916|NCT02585258|66518136|FG001|Overall Study|Lost to Follow-up|2|||
23764917|NCT01706198|66518138|FG000|Overall Study|Adverse Event|12|||
23764918|NCT01706198|66518139|FG001|Overall Study|Adverse Event|15|||
23764919|NCT01706198|66518138|FG000|Overall Study|Protocol Violation|7|||
23764920|NCT01706198|66518139|FG001|Overall Study|Protocol Violation|5|||
23764921|NCT01706198|66518138|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
23764922|NCT01706198|66518139|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
23764923|NCT01706198|66518138|FG000|Overall Study|Lost to Follow-up|97|||
23764924|NCT01706198|66518139|FG001|Overall Study|Lost to Follow-up|93|||
23764925|NCT01706198|66518138|FG000|Overall Study|Physician Decision|23|||
23764926|NCT01706198|66518139|FG001|Overall Study|Physician Decision|37|||
23764927|NCT01706198|66518138|FG000|Overall Study|Withdrawal by Subject|23|||
23764928|NCT01706198|66518139|FG001|Overall Study|Withdrawal by Subject|31|||
23764929|NCT01736553|66518140|FG000|Overall Study|Death|12|||
23764930|NCT01736553|66518141|FG001|Overall Study|Death|0|||
23764931|NCT01736553|66518140|FG000|Overall Study|Withdrawal by Subject|5|||
23764932|NCT01736553|66518141|FG001|Overall Study|Withdrawal by Subject|2|||
23764933|NCT01736553|66518140|FG000|Overall Study|Lost to Follow-up|2|||
23764934|NCT01736553|66518141|FG001|Overall Study|Lost to Follow-up|2|||
23764935|NCT00770991|66518142|FG000|Overall Study|Physician Decision|2|||
23764936|NCT00770991|66518143|FG001|Overall Study|Physician Decision|0|||
23764937|NCT00770991|66518142|FG000|Overall Study|Withdrawal by Subject|1|||
23764938|NCT00770991|66518143|FG001|Overall Study|Withdrawal by Subject|0|||
23444593|NCT05011513|65370123|FG000|Overall Study|Withdrawal by Subject|18|||
23444594|NCT05011513|65370124|FG001|Overall Study|Withdrawal by Subject|17|||
23444595|NCT05011513|65370123|FG000|Overall Study|Other|4|||
23444596|NCT05011513|65370124|FG001|Overall Study|Other|2|||
23444597|NCT00434642|65370125|FG000|Blinded Treatment Phase|Adverse Event|12|||
23444598|NCT00434642|65370126|FG001|Blinded Treatment Phase|Adverse Event|58|||
23444599|NCT00434642|65370125|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
23444600|NCT00434642|65370126|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
23444601|NCT00434642|65370125|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
23444602|NCT00434642|65370126|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
23444603|NCT00434642|65370125|FG000|Blinded Treatment Phase|Physician Decision|19|||
23444604|NCT00434642|65370126|FG001|Blinded Treatment Phase|Physician Decision|27|||
23444605|NCT00434642|65370125|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
23444606|NCT00434642|65370126|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
23444607|NCT00434642|65370125|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
23444608|NCT00434642|65370126|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
23444609|NCT00434642|65370125|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
23444610|NCT00434642|65370126|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
23567039|NCT01576718|65803975|FG006|Treatment Period|Protocol Violation|12|||
23567040|NCT01576718|65803969|FG000|Treatment Period|Sponsor request|0|||
23567041|NCT01576718|65803970|FG001|Treatment Period|Sponsor request|1|||
23567042|NCT01576718|65803971|FG002|Treatment Period|Sponsor request|0|||
23567043|NCT01576718|65803972|FG003|Treatment Period|Sponsor request|0|||
23567044|NCT01576718|65803973|FG004|Treatment Period|Sponsor request|0|||
23567045|NCT01576718|65803974|FG005|Treatment Period|Sponsor request|1|||
23444611|NCT00434642|65370125|FG000|Open-label Treatment Phase|Adverse Event|0|||
23567046|NCT01576718|65803975|FG006|Treatment Period|Sponsor request|0|||
23567047|NCT01576718|65803969|FG000|Treatment Period|Met stopping criteria|0|||
23567048|NCT01576718|65803970|FG001|Treatment Period|Met stopping criteria|16|||
23764939|NCT00770991|66518142|FG000|Overall Study|Adverse Event|1|||
23764940|NCT00770991|66518143|FG001|Overall Study|Adverse Event|5|||
23764941|NCT00770991|66518142|FG000|Overall Study|Pregnancy|1|||
23764942|NCT00770991|66518143|FG001|Overall Study|Pregnancy|0|||
23444612|NCT00434642|65370126|FG001|Open-label Treatment Phase|Adverse Event|5|||
23444613|NCT00434642|65370125|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
23567049|NCT01576718|65803971|FG002|Treatment Period|Met stopping criteria|13|||
23567050|NCT01576718|65803972|FG003|Treatment Period|Met stopping criteria|19|||
23567051|NCT01576718|65803973|FG004|Treatment Period|Met stopping criteria|16|||
23567052|NCT01576718|65803974|FG005|Treatment Period|Met stopping criteria|33|||
23764943|NCT00385541|66518144|FG000|Overall Study|severe pain, clinician requested unblind|0|||
23764944|NCT00385541|66518145|FG001|Overall Study|severe pain, clinician requested unblind|1|||
23764945|NCT02175966|66518146|FG000|Follow-up Period|Lack of Efficacy|10|||
23764946|NCT02175966|66518147|FG001|Follow-up Period|Lack of Efficacy|6|||
23764947|NCT01766778|66518148|FG000|Overall Study|Adverse Event|4|||
23764948|NCT01766778|66518149|FG001|Overall Study|Adverse Event|4|||
23444614|NCT00434642|65370126|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
23444615|NCT03464019|65370127|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
23444616|NCT03464019|65370128|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
23444617|NCT03464019|65370129|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
23444618|NCT03464019|65370127|FG000|NODE-301 Part 1|Ablation|0|||
23444619|NCT03464019|65370128|FG001|NODE-301 Part 1|Ablation|0|||
23444620|NCT03464019|65370129|FG002|NODE-301 Part 1|Ablation|16|||
23444621|NCT03464019|65370127|FG000|NODE-301 Part 1|Test Dose Failure|0|||
23444622|NCT03464019|65370128|FG001|NODE-301 Part 1|Test Dose Failure|0|||
23444623|NCT03464019|65370129|FG002|NODE-301 Part 1|Test Dose Failure|8|||
23444624|NCT03464019|65370127|FG000|NODE-301 Part 1|Adverse Event|0|||
23444625|NCT03464019|65370128|FG001|NODE-301 Part 1|Adverse Event|0|||
23444626|NCT03464019|65370129|FG002|NODE-301 Part 1|Adverse Event|5|||
23444627|NCT03464019|65370127|FG000|NODE-301 Part 1|Physician Decision|0|||
23444628|NCT03464019|65370128|FG001|NODE-301 Part 1|Physician Decision|0|||
23444629|NCT03464019|65370129|FG002|NODE-301 Part 1|Physician Decision|4|||
23444630|NCT03464019|65370127|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
23444631|NCT03464019|65370128|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
23444632|NCT03464019|65370129|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
23444633|NCT03464019|65370127|FG000|NODE-301 Part 1|Protocol Violation|0|||
23444634|NCT03464019|65370128|FG001|NODE-301 Part 1|Protocol Violation|0|||
23444635|NCT03464019|65370129|FG002|NODE-301 Part 1|Protocol Violation|2|||
23444636|NCT03464019|65370127|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
23444637|NCT03464019|65370128|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
23444638|NCT03464019|65370129|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
23444639|NCT03464019|65370127|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
23444640|NCT03464019|65370128|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
23444641|NCT03464019|65370129|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
23444642|NCT03464019|65370127|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
23444643|NCT03464019|65370128|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
23444644|NCT03464019|65370129|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
23444645|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
23444646|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
23444647|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
23444648|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
23444649|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
23444650|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
23444651|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
23444652|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
23444653|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
23444654|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
23444655|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
23444656|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
23444657|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
23444658|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
23444659|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
23444660|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
23444661|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
23444662|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
23444663|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
23444664|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
23444665|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
23444666|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
23444667|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
23444668|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
23444669|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
23764949|NCT01766778|66518148|FG000|Overall Study|Withdrawal by Subject|1|||
23764950|NCT01766778|66518149|FG001|Overall Study|Withdrawal by Subject|0|||
23444670|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
23444671|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
23444672|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
23444673|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
23444674|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
23444675|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
23764951|NCT04828161|66518157|FG000|Overall Study|Withdrawal by Subject|0|||
23444676|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
23444677|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
23444678|NCT00565851|65370130|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
23444679|NCT00565851|65370131|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
23444680|NCT00565851|65370132|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
23444681|NCT00565851|65370133|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
23444682|NCT00565851|65370134|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
23444683|NCT00565851|65370135|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
23444684|NCT00565851|65370136|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
23444685|NCT00565851|65370137|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
23444686|NCT00565851|65370130|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444687|NCT00565851|65370131|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
23444688|NCT00565851|65370132|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444689|NCT00565851|65370133|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
23764952|NCT04828161|66518158|FG001|Overall Study|Withdrawal by Subject|3|||
23764953|NCT04828161|66518159|FG002|Overall Study|Withdrawal by Subject|3|||
23764954|NCT04828161|66518160|FG003|Overall Study|Withdrawal by Subject|4|||
23764955|NCT04828161|66518157|FG000|Overall Study|Lost to Follow-up|1|||
23444690|NCT00565851|65370134|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444691|NCT00565851|65370135|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
23444692|NCT00565851|65370136|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444693|NCT00565851|65370137|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
23444694|NCT00666224|65370138|FG000|Double-Blind|Adverse Event|15|||
23444695|NCT00666224|65370139|FG001|Double-Blind|Adverse Event|5|||
23444696|NCT00666224|65370138|FG000|Double-Blind|Lost to Follow-up|2|||
23444697|NCT00666224|65370139|FG001|Double-Blind|Lost to Follow-up|2|||
23444698|NCT00666224|65370138|FG000|Double-Blind|Withdrawal by Subject|18|||
23444699|NCT00666224|65370139|FG001|Double-Blind|Withdrawal by Subject|14|||
23444700|NCT00666224|65370138|FG000|Double-Blind|Physician Decision|0|||
23444701|NCT00666224|65370139|FG001|Double-Blind|Physician Decision|3|||
23444702|NCT00666224|65370138|FG000|Double-Blind|Sponsor decision|1|||
23444703|NCT00666224|65370139|FG001|Double-Blind|Sponsor decision|0|||
23444704|NCT00666224|65370138|FG000|Double-Blind|Pregnancy|3|||
23444705|NCT00666224|65370139|FG001|Double-Blind|Pregnancy|2|||
23444706|NCT00666224|65370138|FG000|Double-Blind|Noncompliance|1|||
23444707|NCT00666224|65370139|FG001|Double-Blind|Noncompliance|0|||
23444708|NCT00666224|65370138|FG000|Double-Blind|Death|1|||
23444709|NCT00666224|65370139|FG001|Double-Blind|Death|0|||
23444710|NCT00666224|65370138|FG000|Double-Blind|Undefined/Unknown|4|||
23444711|NCT00666224|65370139|FG001|Double-Blind|Undefined/Unknown|1|||
23444712|NCT00666224|65370138|FG000|Open-Label|Adverse Event|8|||
23444713|NCT00666224|65370139|FG001|Open-Label|Adverse Event|43|||
23444714|NCT00666224|65370138|FG000|Open-Label|Lost to Follow-up|4|||
23444715|NCT00666224|65370139|FG001|Open-Label|Lost to Follow-up|5|||
23444716|NCT00666224|65370138|FG000|Open-Label|Withdrawal by Subject|12|||
23444717|NCT00666224|65370139|FG001|Open-Label|Withdrawal by Subject|25|||
23567053|NCT01576718|65803975|FG006|Treatment Period|Met stopping criteria|15|||
23567054|NCT01576718|65803969|FG000|Treatment Period|Lost to Follow-up|0|||
23567055|NCT01576718|65803970|FG001|Treatment Period|Lost to Follow-up|0|||
23567056|NCT01576718|65803971|FG002|Treatment Period|Lost to Follow-up|0|||
23567057|NCT01576718|65803972|FG003|Treatment Period|Lost to Follow-up|0|||
23567058|NCT01576718|65803973|FG004|Treatment Period|Lost to Follow-up|1|||
23764956|NCT04828161|66518158|FG001|Overall Study|Lost to Follow-up|4|||
23764957|NCT04828161|66518159|FG002|Overall Study|Lost to Follow-up|2|||
23764958|NCT04828161|66518160|FG003|Overall Study|Lost to Follow-up|2|||
23764959|NCT04828161|66518157|FG000|Overall Study|Other|2|||
23764960|NCT04828161|66518158|FG001|Overall Study|Other|0|||
23764961|NCT04828161|66518159|FG002|Overall Study|Other|2|||
23764962|NCT04828161|66518160|FG003|Overall Study|Other|0|||
23764963|NCT04828161|66518157|FG000|Overall Study|Death|0|||
23764964|NCT04828161|66518158|FG001|Overall Study|Death|0|||
23764965|NCT04828161|66518159|FG002|Overall Study|Death|0|||
23764966|NCT04828161|66518160|FG003|Overall Study|Death|2|||
23764967|NCT03538756|66518166|FG000|Long-Term Follow-up|Adverse Event|0|||
23764968|NCT03538756|66518167|FG001|Long-Term Follow-up|Adverse Event|0|||
23764969|NCT03538756|66518168|FG002|Long-Term Follow-up|Adverse Event|6|||
23444718|NCT00666224|65370138|FG000|Open-Label|Physician Decision|7|||
23567059|NCT01576718|65803974|FG005|Treatment Period|Lost to Follow-up|0|||
23567060|NCT01576718|65803975|FG006|Treatment Period|Lost to Follow-up|0|||
23764970|NCT03538756|66518166|FG000|Long-Term Follow-up|Death|0|||
23764971|NCT03538756|66518167|FG001|Long-Term Follow-up|Death|0|||
23764972|NCT03538756|66518168|FG002|Long-Term Follow-up|Death|1|||
23764973|NCT03538756|66518166|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
23764974|NCT03538756|66518167|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
23444719|NCT00666224|65370139|FG001|Open-Label|Physician Decision|5|||
23444720|NCT00666224|65370138|FG000|Open-Label|Pregnancy|1|||
23444721|NCT00666224|65370139|FG001|Open-Label|Pregnancy|5|||
23444722|NCT00666224|65370138|FG000|Open-Label|Noncompliance|2|||
23444723|NCT00666224|65370139|FG001|Open-Label|Noncompliance|1|||
23444724|NCT00666224|65370138|FG000|Open-Label|Undefined/Unknown|1|||
23444725|NCT00666224|65370139|FG001|Open-Label|Undefined/Unknown|1|||
23444726|NCT03081884|65370145|FG000|Overall Study|deferred prostate cancer treatment|1|||
23444727|NCT03081884|65370145|FG000|Overall Study|metastasis managed with systemic therapy|3|||
23444728|NCT01080807|65370146|FG000|Overall Study|Adverse Event|9|||
23444729|NCT01080807|65370147|FG001|Overall Study|Adverse Event|1|||
23444730|NCT01080807|65370146|FG000|Overall Study|Lack of Efficacy|0|||
23444731|NCT01080807|65370147|FG001|Overall Study|Lack of Efficacy|1|||
23444732|NCT01080807|65370146|FG000|Overall Study|Withdrawal by Subject|7|||
23444733|NCT01080807|65370147|FG001|Overall Study|Withdrawal by Subject|2|||
23444734|NCT01080807|65370146|FG000|Overall Study|Protocol Violation|7|||
23444735|NCT01080807|65370147|FG001|Overall Study|Protocol Violation|6|||
23444736|NCT01080807|65370146|FG000|Overall Study|Lost to Follow-up|6|||
23444737|NCT01080807|65370147|FG001|Overall Study|Lost to Follow-up|4|||
23444738|NCT01080807|65370146|FG000|Overall Study|Noncompliance with drug administration|1|||
23444739|NCT01080807|65370147|FG001|Overall Study|Noncompliance with drug administration|1|||
23444740|NCT01080807|65370146|FG000|Overall Study|Noncompliance to study procedures|1|||
23444741|NCT01080807|65370147|FG001|Overall Study|Noncompliance to study procedures|1|||
23444742|NCT01080807|65370146|FG000|Overall Study|Began working day shift|0|||
23444743|NCT01080807|65370147|FG001|Overall Study|Began working day shift|2|||
23444744|NCT01080807|65370146|FG000|Overall Study|Laid off or terminated from job|1|||
23444745|NCT01080807|65370147|FG001|Overall Study|Laid off or terminated from job|2|||
23444746|NCT01080807|65370146|FG000|Overall Study|Stopped working consistent night shifts|0|||
23444747|NCT01080807|65370147|FG001|Overall Study|Stopped working consistent night shifts|1|||
23444748|NCT01080807|65370146|FG000|Overall Study|Work schedule changing|1|||
23444749|NCT01080807|65370147|FG001|Overall Study|Work schedule changing|1|||
23444750|NCT01080807|65370146|FG000|Overall Study|Work schedule and travel|0|||
23444751|NCT01080807|65370147|FG001|Overall Study|Work schedule and travel|1|||
23444752|NCT01080807|65370146|FG000|Overall Study|Switched to first shift|1|||
23444753|NCT01080807|65370147|FG001|Overall Study|Switched to first shift|0|||
23444754|NCT01080807|65370146|FG000|Overall Study|Moved away without notifying center|1|||
23444755|NCT01080807|65370147|FG001|Overall Study|Moved away without notifying center|0|||
23444756|NCT02652156|65370148|FG000|Overall Study|Physician Decision|1|||
23444757|NCT02652156|65370149|FG001|Overall Study|Physician Decision|0|||
23444758|NCT02652156|65370150|FG002|Overall Study|Physician Decision|0|||
23444759|NCT00740584|65370151|FG000|Overall Study|Withdrawal by Subject|1|||
23567061|NCT01576718|65803969|FG000|Treatment Period|Noncompliance to study medication|0|||
23567062|NCT01576718|65803970|FG001|Treatment Period|Noncompliance to study medication|0|||
23567063|NCT01576718|65803971|FG002|Treatment Period|Noncompliance to study medication|0|||
23567064|NCT01576718|65803972|FG003|Treatment Period|Noncompliance to study medication|0|||
23567065|NCT01576718|65803973|FG004|Treatment Period|Noncompliance to study medication|0|||
23567066|NCT01576718|65803974|FG005|Treatment Period|Noncompliance to study medication|1|||
23567067|NCT01576718|65803975|FG006|Treatment Period|Noncompliance to study medication|1|||
23567068|NCT00544544|65803976|FG000|Overall Study|Withdrawal by Subject|1|||
23567069|NCT00544544|65803976|FG000|Overall Study|Adverse Event|1|||
23567070|NCT00544544|65803976|FG000|Overall Study|Lost to Follow-up|1|||
23567071|NCT01993017|65803977|FG000|Overall Study|Death|23|||
23567072|NCT01993017|65803978|FG001|Overall Study|Death|26|||
23567073|NCT01993017|65803979|FG002|Overall Study|Death|18|||
23567074|NCT01993017|65803977|FG000|Overall Study|Could not be contacted|43|||
23567075|NCT01993017|65803978|FG001|Overall Study|Could not be contacted|42|||
23764975|NCT03538756|66518168|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
23764976|NCT03538756|66518166|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
23764977|NCT03538756|66518167|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
23444760|NCT01518374|65370155|FG000|Overall Study|Withdrawal by Subject|2|||
23444761|NCT01518374|65370155|FG000|Overall Study|Protocol Violation|3|||
23444762|NCT01518374|65370155|FG000|Overall Study|Lost to Follow-up|2|||
23444763|NCT00731679|65370156|FG000|Overall Study|Adverse Event|7|||
23567076|NCT01993017|65803979|FG002|Overall Study|Could not be contacted|38|||
23567077|NCT01993017|65803977|FG000|Overall Study|Dropped out|19|||
23567078|NCT01993017|65803978|FG001|Overall Study|Dropped out|6|||
23567079|NCT01993017|65803979|FG002|Overall Study|Dropped out|11|||
23444764|NCT00731679|65370157|FG001|Overall Study|Adverse Event|8|||
23444765|NCT00731679|65370156|FG000|Overall Study|Withdrawal by Subject|8|||
23444766|NCT00731679|65370157|FG001|Overall Study|Withdrawal by Subject|8|||
23444767|NCT00731679|65370156|FG000|Overall Study|Lost to Follow-up|7|||
23444768|NCT00731679|65370157|FG001|Overall Study|Lost to Follow-up|8|||
23444769|NCT00731679|65370156|FG000|Overall Study|Noncompliance|0|||
23444770|NCT00731679|65370157|FG001|Overall Study|Noncompliance|1|||
23444771|NCT00731679|65370156|FG000|Overall Study|Pregnancy|0|||
23444772|NCT00731679|65370157|FG001|Overall Study|Pregnancy|1|||
23444773|NCT03116685|65370158|FG000|Overall Study|Physician Decision|0|||
23444774|NCT03116685|65370159|FG001|Overall Study|Physician Decision|1|||
23444775|NCT00479856|65370161|FG000|Overall Study|Adverse Event|1|||
23444776|NCT00479856|65370161|FG000|Overall Study|Withdrawal by Subject|1|||
23444777|NCT00479856|65370161|FG000|Overall Study|Physician Decision|1|||
23444778|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
23444779|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
23444780|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
23444781|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
23444782|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
23444783|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
23444784|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
23444785|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
23444786|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
23444787|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
23444788|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
23444789|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
23444790|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
23444791|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
23444792|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
23444793|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
23444794|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
23444795|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
23444796|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
23444797|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
23444798|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
23444799|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
23444800|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
23444801|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
23444802|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
23444803|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
23444804|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
23444805|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
23444806|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
23444807|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
23444808|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
23444809|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
23444810|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
23444811|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
23444812|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
23444813|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
23567080|NCT01993017|65803977|FG000|Overall Study|Other reasons|17|||
23567081|NCT01993017|65803978|FG001|Overall Study|Other reasons|11|||
23567082|NCT01993017|65803979|FG002|Overall Study|Other reasons|7|||
23567083|NCT01993017|65803977|FG000|Overall Study|Ineligible after randomization|4|||
23567084|NCT01993017|65803978|FG001|Overall Study|Ineligible after randomization|5|||
23567085|NCT01993017|65803979|FG002|Overall Study|Ineligible after randomization|5|||
23628800|NCT01210651|66028119|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
23628801|NCT01210651|66028120|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
23628802|NCT01210651|66028119|FG000|Overall Study|Withdrawal by Subject|1|||
23628803|NCT01210651|66028120|FG001|Overall Study|Withdrawal by Subject|1|||
23444814|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
23444815|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
23567086|NCT02961374|65803980|FG000|Overall Study|Adverse Event|4|||
23567087|NCT03872388|65803981|FG000|Overall Study|Disease Progression|0|||
23567088|NCT03872388|65803982|FG001|Overall Study|Disease Progression|0|||
23567089|NCT03872388|65803983|FG002|Overall Study|Disease Progression|0|||
23567090|NCT03872388|65803984|FG003|Overall Study|Disease Progression|0|||
23567091|NCT03872388|65803985|FG004|Overall Study|Disease Progression|0|||
23567092|NCT03872388|65803986|FG005|Overall Study|Disease Progression|0|||
23567093|NCT03872388|65803987|FG006|Overall Study|Disease Progression|1|||
23628804|NCT01210651|66028119|FG000|Overall Study|Injury outside study|2|||
23628805|NCT01210651|66028120|FG001|Overall Study|Injury outside study|0|||
23628806|NCT03566979|66028121|FG000|Overall Study|Withdrawal by Subject|2|||
23628807|NCT03566979|66028122|FG001|Overall Study|Withdrawal by Subject|0|||
23628808|NCT03566979|66028123|FG002|Overall Study|Withdrawal by Subject|1|||
23628809|NCT03566979|66028124|FG003|Overall Study|Withdrawal by Subject|1|||
23628810|NCT03566979|66028121|FG000|Overall Study|Lost to Follow-up|2|||
23628811|NCT03566979|66028122|FG001|Overall Study|Lost to Follow-up|7|||
23628812|NCT03566979|66028123|FG002|Overall Study|Lost to Follow-up|9|||
23628813|NCT03566979|66028124|FG003|Overall Study|Lost to Follow-up|5|||
23628814|NCT03566979|66028121|FG000|Overall Study|Adverse Event|1|||
23628815|NCT03566979|66028122|FG001|Overall Study|Adverse Event|0|||
23628816|NCT03566979|66028123|FG002|Overall Study|Adverse Event|0|||
23628817|NCT03566979|66028124|FG003|Overall Study|Adverse Event|0|||
23628818|NCT00208325|66028131|FG000|Overall Study|Death|18|||
23628819|NCT00208325|66028132|FG001|Overall Study|Death|19|||
23628820|NCT00208325|66028133|FG002|Overall Study|Death|7|||
23628821|NCT00208325|66028134|FG003|Overall Study|Death|5|||
23628822|NCT00208325|66028131|FG000|Overall Study|Withdrawal by Subject|0|||
23628823|NCT00208325|66028132|FG001|Overall Study|Withdrawal by Subject|1|||
23628824|NCT00208325|66028133|FG002|Overall Study|Withdrawal by Subject|0|||
23628825|NCT00208325|66028134|FG003|Overall Study|Withdrawal by Subject|0|||
23628826|NCT00208325|66028131|FG000|Overall Study|Revision|4|||
23628827|NCT00208325|66028132|FG001|Overall Study|Revision|1|||
23628828|NCT00208325|66028133|FG002|Overall Study|Revision|0|||
23628829|NCT00208325|66028134|FG003|Overall Study|Revision|4|||
23628830|NCT00208325|66028131|FG000|Overall Study|Lost to Follow-up|1|||
23628831|NCT00208325|66028132|FG001|Overall Study|Lost to Follow-up|0|||
23628832|NCT00208325|66028133|FG002|Overall Study|Lost to Follow-up|2|||
23628833|NCT00208325|66028134|FG003|Overall Study|Lost to Follow-up|0|||
23628834|NCT00208325|66028131|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
23628835|NCT00208325|66028132|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
23628836|NCT00208325|66028133|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
23828838|NCT04123405|66752483|FG001|Overall Study|Contact to subject lost|0|||
23828839|NCT04123405|66752484|FG002|Overall Study|Contact to subject lost|0|||
23828840|NCT04123405|66752485|FG003|Overall Study|Contact to subject lost|1|||
23828841|NCT04123405|66752482|FG000|Overall Study|screening failure|1|||
23828842|NCT04123405|66752483|FG001|Overall Study|screening failure|0|||
23828843|NCT04123405|66752484|FG002|Overall Study|screening failure|0|||
23828844|NCT04123405|66752485|FG003|Overall Study|screening failure|0|||
23828845|NCT02071225|66752486|FG000|Overall Study|Withdrawal of Consent|2|||
23828846|NCT02071225|66752486|FG000|Overall Study|Protocol Deviation|1|||
23828847|NCT02071225|66752486|FG000|Overall Study|Lost to Follow-up|2|||
23828848|NCT02071225|66752486|FG000|Overall Study|Death|25|||
23828849|NCT01119859|66752487|FG000|Overall Study|Adverse Event|9|||
23828850|NCT01119859|66752488|FG001|Overall Study|Adverse Event|10|||
23828851|NCT01119859|66752487|FG000|Overall Study|Death|2|||
23828852|NCT01119859|66752488|FG001|Overall Study|Death|0|||
23828853|NCT01119859|66752487|FG000|Overall Study|Insufficient therapeutic response|7|||
23828854|NCT01119859|66752488|FG001|Overall Study|Insufficient therapeutic response|14|||
23828855|NCT01119859|66752487|FG000|Overall Study|Refused treatment|3|||
23828856|NCT01119859|66752488|FG001|Overall Study|Refused treatment|6|||
23828857|NCT01119859|66752487|FG000|Overall Study|Failure to return|3|||
23828858|NCT01119859|66752488|FG001|Overall Study|Failure to return|0|||
23828859|NCT00235755|66752489|FG000|4-Week Titration Phase|Adverse Event|6|||
23828860|NCT00235755|66752490|FG001|4-Week Titration Phase|Adverse Event|14|||
23828861|NCT00235755|66752491|FG002|4-Week Titration Phase|Adverse Event|20|||
23628837|NCT00208325|66028134|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
23628838|NCT00208325|66028131|FG000|Overall Study|Does not wish to Continue in Study|5|||
23628839|NCT00208325|66028132|FG001|Overall Study|Does not wish to Continue in Study|8|||
23828862|NCT00235755|66752489|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
23828863|NCT00235755|66752490|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
23828864|NCT00235755|66752491|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
23828865|NCT00235755|66752489|FG000|4-Week Titration Phase|Protocol Violation|2|||
23828866|NCT00235755|66752490|FG001|4-Week Titration Phase|Protocol Violation|2|||
23828867|NCT00235755|66752491|FG002|4-Week Titration Phase|Protocol Violation|1|||
23828868|NCT00235755|66752489|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
23628840|NCT00208325|66028133|FG002|Overall Study|Does not wish to Continue in Study|3|||
23628841|NCT00208325|66028134|FG003|Overall Study|Does not wish to Continue in Study|2|||
23628842|NCT00208325|66028131|FG000|Overall Study|Other|2|||
23628843|NCT00208325|66028132|FG001|Overall Study|Other|1|||
23628844|NCT00208325|66028133|FG002|Overall Study|Other|1|||
23628845|NCT00208325|66028134|FG003|Overall Study|Other|0|||
23628846|NCT00208325|66028131|FG000|Overall Study|Mis-Randomized|17|||
23628847|NCT00208325|66028132|FG001|Overall Study|Mis-Randomized|20|||
23628848|NCT00208325|66028133|FG002|Overall Study|Mis-Randomized|0|||
23828869|NCT00235755|66752490|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
23828870|NCT00235755|66752491|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
23828871|NCT00235755|66752489|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23828872|NCT00235755|66752490|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23828873|NCT00235755|66752491|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
23828874|NCT00235755|66752489|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
23828875|NCT00235755|66752490|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
23828876|NCT00235755|66752491|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
23828877|NCT00235755|66752489|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
23828878|NCT00235755|66752490|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
23828879|NCT00235755|66752491|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
23828880|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Adverse Event|8|||
23828881|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Adverse Event|12|||
23828882|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Adverse Event|26|||
23828883|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
23567094|NCT03872388|65803988|FG007|Overall Study|Disease Progression|1|||
23567095|NCT00332332|65803989|FG000|Overall Study|Adverse Event|13|||
23567096|NCT00332332|65803989|FG000|Overall Study|Death|1|||
23567097|NCT00332332|65803989|FG000|Overall Study|Withdrawal by Subject|8|||
23764978|NCT03538756|66518168|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
23764979|NCT03538756|66518166|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
23764980|NCT03538756|66518167|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
23764981|NCT03538756|66518168|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
23764982|NCT01830920|66518169|FG000|Overall Study|Adverse Event|1|||
23764983|NCT01830920|66518170|FG001|Overall Study|Adverse Event|0|||
23764984|NCT01830920|66518171|FG002|Overall Study|Adverse Event|1|||
23567098|NCT00332332|65803989|FG000|Overall Study|Physician Decision|1|||
23764985|NCT01830920|66518172|FG003|Overall Study|Adverse Event|0|||
23828884|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
23828885|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
23764986|NCT01830920|66518173|FG004|Overall Study|Adverse Event|0|||
23764987|NCT01830920|66518169|FG000|Overall Study|Withdrawal by Subject|2|||
23764988|NCT01830920|66518170|FG001|Overall Study|Withdrawal by Subject|2|||
23764989|NCT01830920|66518171|FG002|Overall Study|Withdrawal by Subject|1|||
23764990|NCT01830920|66518172|FG003|Overall Study|Withdrawal by Subject|7|||
23764991|NCT01830920|66518173|FG004|Overall Study|Withdrawal by Subject|1|||
23764992|NCT01830920|66518169|FG000|Overall Study|Death|3|||
23764993|NCT01830920|66518170|FG001|Overall Study|Death|3|||
23764994|NCT01830920|66518171|FG002|Overall Study|Death|5|||
23764995|NCT01830920|66518172|FG003|Overall Study|Death|4|||
23764996|NCT01830920|66518173|FG004|Overall Study|Death|4|||
23764997|NCT01830920|66518169|FG000|Overall Study|Other|15|||
23764998|NCT01830920|66518170|FG001|Overall Study|Other|1|||
23764999|NCT01830920|66518171|FG002|Overall Study|Other|1|||
23765000|NCT01830920|66518172|FG003|Overall Study|Other|5|||
23765001|NCT01830920|66518173|FG004|Overall Study|Other|3|||
23765002|NCT03035227|66518178|FG000|Overall Study|study stopped due to PI leaving institut|1|||
23765003|NCT03035227|66518179|FG001|Overall Study|study stopped due to PI leaving institut|1|||
23765004|NCT00712010|66518180|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
23765005|NCT01814761|66518181|FG000|Overall Study|Other Reasons|1|||
23828886|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
23567099|NCT00332332|65803989|FG000|Overall Study|Lost to Follow-up|3|||
23567100|NCT00332332|65803989|FG000|Overall Study|Protocol deviation|4|||
23567101|NCT00332332|65803989|FG000|Overall Study|Noncompliance|2|||
23567102|NCT00332332|65803989|FG000|Overall Study|Disease progression|2|||
23567103|NCT00332332|65803989|FG000|Overall Study|Other|18|||
23828887|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
23765006|NCT01814761|66518182|FG001|Overall Study|Other Reasons|10|||
23765007|NCT01814761|66518181|FG000|Overall Study|Ocular Adverse Event|6|||
23765008|NCT01814761|66518182|FG001|Overall Study|Ocular Adverse Event|15|||
23765009|NCT01814761|66518181|FG000|Overall Study|Lost to Follow-up|1|||
23765010|NCT01814761|66518182|FG001|Overall Study|Lost to Follow-up|5|||
23765011|NCT00623623|66518186|FG000|Overall Study|Previous enrolment into this study|1|||
23765012|NCT00623623|66518187|FG001|Overall Study|Previous enrolment into this study|1|||
23765013|NCT03118739|66518189|FG000|Overall Study|Physician Decision|0|||
23765014|NCT03118739|66518190|FG001|Overall Study|Physician Decision|1|||
23765015|NCT03118739|66518189|FG000|Overall Study|Withdrawal by Subject|5|||
23765016|NCT03118739|66518190|FG001|Overall Study|Withdrawal by Subject|3|||
23765017|NCT03118739|66518189|FG000|Overall Study|Lost to Follow-up|2|||
23765018|NCT03118739|66518190|FG001|Overall Study|Lost to Follow-up|0|||
23765019|NCT05266456|66518193|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
23765020|NCT05266456|66518194|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
23765021|NCT05266456|66518195|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
23765022|NCT05266456|66518196|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
23765023|NCT05266456|66518193|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23765024|NCT05266456|66518194|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23765025|NCT05266456|66518195|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23765026|NCT05266456|66518196|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
23765027|NCT05266456|66518193|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
23765028|NCT05266456|66518194|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
23765029|NCT05266456|66518195|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
23567104|NCT00332332|65803989|FG000|Overall Study|Did not receive study treatment|16|||
23444816|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
23765030|NCT05266456|66518196|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
23765031|NCT05266456|66518193|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23765032|NCT05266456|66518194|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23628849|NCT00208325|66028134|FG003|Overall Study|Mis-Randomized|0|||
23628850|NCT03325777|66028136|FG000|Overall Study|Lost to Follow-up|9|||
23765033|NCT05266456|66518195|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
23765034|NCT05266456|66518196|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23765035|NCT05266456|66518193|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
23765036|NCT05266456|66518194|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
23765037|NCT05266456|66518195|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
23765038|NCT05266456|66518196|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
23765039|NCT03522948|66518197|FG000|Overall Study|Lost to Follow-up|1|||
23765040|NCT01001169|66518200|FG000|Overall Study|Withdrawal by Subject|2|||
23765041|NCT01001169|66518201|FG001|Overall Study|Withdrawal by Subject|1|||
23765042|NCT01042977|66518204|FG000|Overall Study|Adverse Event|4|||
23567105|NCT00313911|65803997|FG000|Overall Study|Serious adverse event|6|||
23567106|NCT00313911|65803998|FG001|Overall Study|Serious adverse event|1|||
23567107|NCT00313911|65803997|FG000|Overall Study|Adverse Event|2|||
23567108|NCT00313911|65803998|FG001|Overall Study|Adverse Event|3|||
23567109|NCT00313911|65803997|FG000|Overall Study|Protocol Violation|19|||
23567110|NCT00313911|65803998|FG001|Overall Study|Protocol Violation|10|||
23567111|NCT00313911|65803997|FG000|Overall Study|Lost to Follow-up|27|||
23765043|NCT01042977|66518205|FG001|Overall Study|Adverse Event|12|||
23765044|NCT01042977|66518204|FG000|Overall Study|Death|2|||
23765045|NCT01042977|66518205|FG001|Overall Study|Death|1|||
23765046|NCT01042977|66518204|FG000|Overall Study|Withdrawal by Subject|8|||
23765047|NCT01042977|66518205|FG001|Overall Study|Withdrawal by Subject|16|||
23765048|NCT01042977|66518204|FG000|Overall Study|Lost to Follow-up|0|||
23765049|NCT01042977|66518205|FG001|Overall Study|Lost to Follow-up|2|||
23765050|NCT01042977|66518204|FG000|Overall Study|Poor/non-compliance|3|||
23765051|NCT01042977|66518205|FG001|Overall Study|Poor/non-compliance|4|||
23765052|NCT01042977|66518204|FG000|Overall Study|Subject no longer meets study criteria|15|||
23765053|NCT01042977|66518205|FG001|Overall Study|Subject no longer meets study criteria|13|||
23765054|NCT01042977|66518204|FG000|Overall Study|Incorrect enrollment|6|||
23765055|NCT01042977|66518205|FG001|Overall Study|Incorrect enrollment|4|||
23765056|NCT01042977|66518204|FG000|Overall Study|Safety|0|||
23765057|NCT01042977|66518205|FG001|Overall Study|Safety|2|||
23765058|NCT01042977|66518204|FG000|Overall Study|Administrative reason by sponsor|0|||
23765059|NCT01042977|66518205|FG001|Overall Study|Administrative reason by sponsor|1|||
23765060|NCT01042977|66518204|FG000|Overall Study|Various|3|||
23765061|NCT01042977|66518205|FG001|Overall Study|Various|0|||
23765062|NCT00720122|66518206|FG000|Overall Study|Lost to Follow-up|1|||
23765063|NCT00720122|66518206|FG000|Overall Study|Physician Decision|1|||
23765064|NCT00720122|66518206|FG000|Overall Study|Withdrawal by Subject|7|||
23765065|NCT01868009|66518207|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
23765066|NCT01868009|66518208|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
23765067|NCT01868009|66518207|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
23567112|NCT00313911|65803998|FG001|Overall Study|Lost to Follow-up|14|||
23628851|NCT03325777|66028137|FG001|Overall Study|Lost to Follow-up|12|||
23628852|NCT02615509|66028138|FG000|Overall Study|Lost to Follow-up|134|||
23765068|NCT01868009|66518208|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
23765069|NCT01868009|66518207|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
23567113|NCT00313911|65803997|FG000|Overall Study|Withdrawal by Subject|39|||
23828888|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
23828889|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
23828890|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
23828891|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
23828892|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
23828893|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
23828894|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
23828895|NCT00235755|66752489|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
23828896|NCT00235755|66752490|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
23828897|NCT00235755|66752491|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
23828898|NCT00365794|66752492|FG000|Overall Study|Withdrawal by Subject|2|||
23828899|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
23828900|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
23828901|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
23828902|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828903|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
23828904|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
23828905|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828906|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828907|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828908|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828909|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828910|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828911|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828912|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828913|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828914|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828915|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23828916|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23828917|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828918|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
23828919|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23828920|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
23828921|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23828922|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828923|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828924|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828925|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828926|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828927|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828928|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23567114|NCT00313911|65803998|FG001|Overall Study|Withdrawal by Subject|12|||
23567115|NCT00313911|65803997|FG000|Overall Study|Did not meet age criteria|1|||
23567116|NCT00313911|65803998|FG001|Overall Study|Did not meet age criteria|1|||
23567117|NCT03107377|65803999|FG000|Overall Study|Adverse Event|3|||
23567118|NCT03107377|65804000|FG001|Overall Study|Adverse Event|3|||
23828929|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828930|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828931|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828932|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23828933|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
23828934|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23828935|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23828936|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
23828937|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
23828938|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23828939|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828940|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828941|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828942|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828943|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828944|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828945|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828946|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828947|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23828948|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23567119|NCT03107377|65803999|FG000|Overall Study|Protocol Violation|9|||
23567120|NCT03107377|65804000|FG001|Overall Study|Protocol Violation|12|||
23567121|NCT03107377|65803999|FG000|Overall Study|Physician Decision|3|||
23765070|NCT01868009|66518208|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
23765071|NCT03377556|66518212|FG000|Overall Study|Adverse Event|5|||
23765072|NCT03377556|66518212|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23765073|NCT03377556|66518212|FG000|Overall Study|Progression/relapse|38|||
23765074|NCT03377556|66518212|FG000|Overall Study|Death|3|||
23765075|NCT05751629|66518215|FG000|Overall Study|Withdrawal by Subject|6|||
23765076|NCT05751629|66518215|FG000|Overall Study|Death|25|||
23765077|NCT05751629|66518215|FG000|Overall Study|Study Site Closed|9|||
23765078|NCT05751629|66518215|FG000|Overall Study|Physician Decision|1|||
23765079|NCT01007916|66518218|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
23765080|NCT01007916|66518219|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
23765081|NCT01007916|66518218|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
23765082|NCT01007916|66518219|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
23765083|NCT04147715|66518220|FG000|Overall Study|Adverse Event|0|||
23567122|NCT03107377|65804000|FG001|Overall Study|Physician Decision|6|||
23567123|NCT03107377|65803999|FG000|Overall Study|Pregnancy|7|||
23567124|NCT03107377|65804000|FG001|Overall Study|Pregnancy|7|||
23567125|NCT03107377|65803999|FG000|Overall Study|Withdrawal by Subject|16|||
23567126|NCT03107377|65804000|FG001|Overall Study|Withdrawal by Subject|22|||
23567127|NCT03107377|65803999|FG000|Overall Study|Lost to Follow-up|37|||
23765084|NCT04147715|66518221|FG001|Overall Study|Adverse Event|0|||
23765085|NCT04147715|66518222|FG002|Overall Study|Adverse Event|0|||
23765086|NCT04147715|66518223|FG003|Overall Study|Adverse Event|0|||
23765087|NCT04147715|66518224|FG004|Overall Study|Adverse Event|0|||
23765088|NCT04147715|66518225|FG005|Overall Study|Adverse Event|0|||
23765089|NCT04147715|66518226|FG006|Overall Study|Adverse Event|0|||
23765090|NCT04147715|66518227|FG007|Overall Study|Adverse Event|2|||
23765091|NCT04147715|66518228|FG008|Overall Study|Adverse Event|1|||
23765092|NCT04147715|66518229|FG009|Overall Study|Adverse Event|0|||
23765093|NCT04147715|66518230|FG010|Overall Study|Adverse Event|0|||
23765094|NCT04147715|66518231|FG011|Overall Study|Adverse Event|0|||
23567128|NCT03107377|65804000|FG001|Overall Study|Lost to Follow-up|34|||
23567129|NCT03107377|65803999|FG000|Overall Study|Other reason not specified|16|||
23567130|NCT03107377|65804000|FG001|Overall Study|Other reason not specified|15|||
23567131|NCT01118455|65804002|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
23567132|NCT01118455|65804003|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
23628853|NCT02615509|66028138|FG000|Overall Study|Death|4|||
23628854|NCT02615509|66028138|FG000|Overall Study|Withdrawal by Subject|8|||
23628855|NCT01774305|66028139|FG000|Overall Study|Physician Decision|1|||
23765095|NCT01620489|66518236|FG000|Overall Study|Adverse Event|17|||
23765096|NCT01620489|66518237|FG001|Overall Study|Adverse Event|4|||
23765097|NCT01620489|66518236|FG000|Overall Study|Protocol Violation|0|||
23765098|NCT01620489|66518237|FG001|Overall Study|Protocol Violation|3|||
23765099|NCT01620489|66518236|FG000|Overall Study|Withdrawal Criteria|17|||
23765100|NCT01620489|66518237|FG001|Overall Study|Withdrawal Criteria|25|||
23765101|NCT01620489|66518236|FG000|Overall Study|Unclassified|1|||
23765102|NCT01620489|66518237|FG001|Overall Study|Unclassified|2|||
23567133|NCT01536145|65804004|FG000|Overall Study|Progressive disease|3|||
23765103|NCT00130520|66518240|FG000|Overall Study|Adverse Event|11|||
23765104|NCT00130520|66518240|FG000|Overall Study|Death|1|||
23765105|NCT00130520|66518240|FG000|Overall Study|Physician Decision|1|||
23765106|NCT00130520|66518240|FG000|Overall Study|Withdrawal by Subject|1|||
23765107|NCT00130520|66518240|FG000|Overall Study|Disease Progression|23|||
23765108|NCT00130520|66518240|FG000|Overall Study|Protocol non-compliance|1|||
23765109|NCT00130520|66518240|FG000|Overall Study|Did not meet re-treatment criteria|1|||
23765110|NCT01886300|66518241|FG000|Overall Study|Trial terminated by sponsor|16|||
23765111|NCT02468557|66518242|FG000|Overall Study|Adverse Event|1|||
23828949|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23444817|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
23444818|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
23444819|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
23444820|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
23444821|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
23444822|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
23444823|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
23444824|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
23444825|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
23444826|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
23444827|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
23444828|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
23444829|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
23444830|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
23444831|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
23444832|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
23444833|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
23444834|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
23444835|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
23828950|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828951|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
23444836|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
23444837|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
23444838|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
23444839|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
23444840|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
23444841|NCT00858208|65370165|FG000|Overall Study|Adverse Event|3|||
23444842|NCT00858208|65370165|FG000|Overall Study|Lost to Follow-up|26|||
23444843|NCT00858208|65370165|FG000|Overall Study|Participant refused|40|||
23444844|NCT00858208|65370165|FG000|Overall Study|Other|10|||
23444845|NCT02462720|65370166|FG000|Part 2|Withdrawal by Subject|1|||
23444846|NCT02462720|65370167|FG001|Part 2|Withdrawal by Subject|0|||
23444847|NCT02462720|65370166|FG000|Part 2|Protocol Violation|0|||
23444848|NCT02462720|65370167|FG001|Part 2|Protocol Violation|1|||
23444849|NCT04050618|65370168|FG000|First Intervention|Withdrawal by Subject|2|||
23444850|NCT04050618|65370169|FG001|First Intervention|Withdrawal by Subject|0|||
23444851|NCT04050618|65370168|FG000|Second Intervention|Withdrawal by Subject|1|||
23444852|NCT04050618|65370169|FG001|Second Intervention|Withdrawal by Subject|0|||
23444853|NCT01012258|65370170|FG000|Overall Study|Death|14|||
23444854|NCT01012258|65370170|FG000|Overall Study|Lost to Follow-up|1|||
23765112|NCT02468557|66518242|FG000|Overall Study|Death|1|||
23828952|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
23828953|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828954|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
23828955|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
23828956|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828957|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828958|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828959|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828960|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828961|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828962|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828963|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23444855|NCT01012258|65370170|FG000|Overall Study|Adverse Event|1|||
23444856|NCT01012258|65370170|FG000|Overall Study|Progressive Disease (PD)|18|||
23765113|NCT02468557|66518242|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
23765114|NCT02468557|66518242|FG000|Overall Study|All Enrolled but Never Dosed|4|||
23828964|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828965|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23444857|NCT01012258|65370170|FG000|Overall Study|Symptomatic Deterioration|1|||
23444858|NCT01012258|65370170|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
23567134|NCT01536145|65804005|FG001|Overall Study|Progressive disease|4|||
23444859|NCT01012258|65370170|FG000|Overall Study|Another Tumor Discovered|1|||
23444860|NCT01012258|65370170|FG000|Overall Study|Ongoing|29|||
23444861|NCT00567359|65370173|FG000|Overall Study|Withdrawal by Subject|1|||
23444862|NCT01636986|65370174|FG000|Overall Study|Withdrawal by Subject|0|||
23444863|NCT01636986|65370175|FG001|Overall Study|Withdrawal by Subject|1|||
23444864|NCT01636986|65370174|FG000|Overall Study|Corneal Staining|0|||
23444865|NCT01636986|65370175|FG001|Overall Study|Corneal Staining|1|||
23444866|NCT00891228|65370178|FG000|Overall Study|Adverse Event|0|||
23444867|NCT00891228|65370179|FG001|Overall Study|Adverse Event|2|||
23444868|NCT00891228|65370180|FG002|Overall Study|Adverse Event|3|||
23444869|NCT00891228|65370178|FG000|Overall Study|Withdrawal by Subject|2|||
23444870|NCT00891228|65370179|FG001|Overall Study|Withdrawal by Subject|4|||
23444871|NCT00891228|65370180|FG002|Overall Study|Withdrawal by Subject|5|||
23444872|NCT00891228|65370178|FG000|Overall Study|Protocol Violation|3|||
23444873|NCT00891228|65370179|FG001|Overall Study|Protocol Violation|1|||
23444874|NCT00891228|65370180|FG002|Overall Study|Protocol Violation|2|||
23444875|NCT00891228|65370178|FG000|Overall Study|Physician Decision|2|||
23444876|NCT00891228|65370179|FG001|Overall Study|Physician Decision|1|||
23444877|NCT00891228|65370180|FG002|Overall Study|Physician Decision|0|||
23444878|NCT00891228|65370178|FG000|Overall Study|Lost to Follow-up|4|||
23444879|NCT00891228|65370179|FG001|Overall Study|Lost to Follow-up|4|||
23444880|NCT00891228|65370180|FG002|Overall Study|Lost to Follow-up|5|||
23444881|NCT00891228|65370178|FG000|Overall Study|Pregnancy|0|||
23444882|NCT00891228|65370179|FG001|Overall Study|Pregnancy|1|||
23444883|NCT00891228|65370180|FG002|Overall Study|Pregnancy|0|||
23444884|NCT01388907|65370181|FG000|Overall Study|Adverse Event|2|||
23444885|NCT01388907|65370182|FG001|Overall Study|Adverse Event|0|||
23444886|NCT04089761|65370183|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
23444887|NCT04089761|65370183|FG000|"Run In Phase"|Lost to Follow-up|1|||
23444888|NCT04089761|65370183|FG000|"Treatment Phase"|No evaluable data|5|||
23444889|NCT04089761|65370183|FG000|"Treatment Phase"|Lost to Follow-up|1|||
23444890|NCT00479713|65370184|FG000|Overall Study|Adverse Event|8|||
23444891|NCT00479713|65370185|FG001|Overall Study|Adverse Event|6|||
23444892|NCT00479713|65370184|FG000|Overall Study|Death|1|||
23444893|NCT00479713|65370185|FG001|Overall Study|Death|0|||
23444894|NCT00479713|65370184|FG000|Overall Study|Lost to Follow-up|0|||
23444895|NCT00479713|65370185|FG001|Overall Study|Lost to Follow-up|1|||
23444896|NCT00479713|65370184|FG000|Overall Study|Protocol Violation|0|||
23444897|NCT00479713|65370185|FG001|Overall Study|Protocol Violation|1|||
23444898|NCT00479713|65370184|FG000|Overall Study|Withdrawal by Subject|4|||
23444899|NCT00479713|65370185|FG001|Overall Study|Withdrawal by Subject|1|||
23444900|NCT00321464|65370186|FG000|Overall Study|Death|169|||
23444901|NCT00321464|65370187|FG001|Overall Study|Death|174|||
23828966|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23828967|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23444902|NCT00321464|65370186|FG000|Overall Study|Disease progression|124|||
23444903|NCT00321464|65370187|FG001|Overall Study|Disease progression|124|||
23444904|NCT00321464|65370186|FG000|Overall Study|Withdrawal by Subject|117|||
23444905|NCT00321464|65370187|FG001|Overall Study|Withdrawal by Subject|118|||
23444906|NCT00321464|65370186|FG000|Overall Study|Participant request|57|||
23444907|NCT00321464|65370187|FG001|Overall Study|Participant request|61|||
23444908|NCT00321464|65370186|FG000|Overall Study|Adverse Event|43|||
23444909|NCT00321464|65370187|FG001|Overall Study|Adverse Event|28|||
23444910|NCT00321464|65370186|FG000|Overall Study|Physician Decision|15|||
23444911|NCT00321464|65370187|FG001|Overall Study|Physician Decision|14|||
23444912|NCT00321464|65370186|FG000|Overall Study|Noncompliance|4|||
23444913|NCT00321464|65370187|FG001|Overall Study|Noncompliance|10|||
23444914|NCT00321464|65370186|FG000|Overall Study|Lost to Follow-up|7|||
23444915|NCT00321464|65370187|FG001|Overall Study|Lost to Follow-up|8|||
23444916|NCT00321464|65370186|FG000|Overall Study|Protocol deviation|0|||
23444917|NCT00321464|65370187|FG001|Overall Study|Protocol deviation|2|||
23444918|NCT00321464|65370186|FG000|Overall Study|Ineligibility determined|2|||
23828968|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828969|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
23828970|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
23828971|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23444919|NCT00321464|65370187|FG001|Overall Study|Ineligibility determined|1|||
23444920|NCT00321464|65370186|FG000|Overall Study|Other|21|||
23444921|NCT00321464|65370187|FG001|Overall Study|Other|18|||
23444922|NCT02396212|65370200|FG000|Overall Study|Adverse Event|1|||
23444923|NCT02396212|65370200|FG000|Overall Study|Lack of Efficacy|2|||
23444924|NCT00981461|65370202|FG000|Overall Study|Lost to Follow-up|5|||
23444925|NCT00981461|65370203|FG001|Overall Study|Lost to Follow-up|2|||
23444926|NCT04531241|65370204|FG000|Period 1|Withdrawal by Subject|2|||
23444927|NCT04531241|65370205|FG001|Period 1|Withdrawal by Subject|0|||
23567135|NCT01536145|65804006|FG002|Overall Study|Progressive disease|1|||
23444928|NCT04531241|65370204|FG000|Period 1|Dispesed incorrect lens power|1|||
23828972|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828973|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828974|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23444929|NCT04531241|65370205|FG001|Period 1|Dispesed incorrect lens power|0|||
23444930|NCT04531241|65370204|FG000|Period 1|Protocol Violation|1|||
23567136|NCT01536145|65804007|FG003|Overall Study|Progressive disease|2|||
23567137|NCT01536145|65804008|FG004|Overall Study|Progressive disease|1|||
23567138|NCT01536145|65804009|FG005|Overall Study|Progressive disease|2|||
23567139|NCT01536145|65804010|FG006|Overall Study|Progressive disease|1|||
23567140|NCT01536145|65804011|FG007|Overall Study|Progressive disease|2|||
23765115|NCT03487796|66518243|FG000|Overall Study|Lost to Follow-up|18|||
23765116|NCT03487796|66518244|FG001|Overall Study|Lost to Follow-up|6|||
23765117|NCT01214603|66518249|FG000|Overall Study|Adverse Event|0|||
23765118|NCT01214603|66518250|FG001|Overall Study|Adverse Event|0|||
23765119|NCT01214603|66518251|FG002|Overall Study|Adverse Event|1|||
23765120|NCT01214603|66518249|FG000|Overall Study|Death|1|||
23765121|NCT01214603|66518250|FG001|Overall Study|Death|0|||
23765122|NCT01214603|66518251|FG002|Overall Study|Death|0|||
23765123|NCT01214603|66518249|FG000|Overall Study|Progressive Disease|4|||
23765124|NCT01214603|66518250|FG001|Overall Study|Progressive Disease|1|||
23765125|NCT01214603|66518251|FG002|Overall Study|Progressive Disease|3|||
23765126|NCT03828461|66518255|FG000|Overall Study|Lost to Follow-up|1|||
23765127|NCT03828461|66518255|FG000|Overall Study|Withdrawal by Subject|3|||
23765128|NCT01618305|66518257|FG000|Overall Study|Death|0|||
23765129|NCT01618305|66518258|FG001|Overall Study|Death|1|||
23765130|NCT01618305|66518257|FG000|Overall Study|Lost to Follow-up|11|||
23765131|NCT01618305|66518258|FG001|Overall Study|Lost to Follow-up|7|||
23765132|NCT01618305|66518257|FG000|Overall Study|Protocol Violation|1|||
23765133|NCT01618305|66518258|FG001|Overall Study|Protocol Violation|0|||
23765134|NCT01618305|66518257|FG000|Overall Study|Withdrawal by Subject|3|||
23765135|NCT01618305|66518258|FG001|Overall Study|Withdrawal by Subject|2|||
23765136|NCT03896490|66518259|FG000|Overall Study|Withdrawal by Subject|1|||
23765137|NCT03896490|66518260|FG001|Overall Study|Withdrawal by Subject|1|||
23765138|NCT04228302|66518262|FG000|Overall Study|Adverse Event|0|||
23765139|NCT04228302|66518263|FG001|Overall Study|Adverse Event|0|||
23765140|NCT04228302|66518264|FG002|Overall Study|Adverse Event|0|||
23765141|NCT04228302|66518265|FG003|Overall Study|Adverse Event|0|||
23765142|NCT04228302|66518266|FG004|Overall Study|Adverse Event|1|||
23765143|NCT04228302|66518267|FG005|Overall Study|Adverse Event|0|||
23765144|NCT00891293|66518268|FG000|Overall Study|Adverse Event|2|||
23765145|NCT00891293|66518268|FG000|Overall Study|Protocol Violation|2|||
23765146|NCT00891293|66518268|FG000|Overall Study|Laboratory abnormality|4|||
23765147|NCT00891293|66518268|FG000|Overall Study|Lost to Follow-up|7|||
23765148|NCT00891293|66518268|FG000|Overall Study|Subject withdrew consent|7|||
23765149|NCT00891293|66518268|FG000|Overall Study|Sponsor termination|62|||
23765150|NCT01754259|66518269|FG000|Overall Study|Withdrawal by Subject|2|||
23765151|NCT01754259|66518270|FG001|Overall Study|Withdrawal by Subject|4|||
23765152|NCT01754259|66518269|FG000|Overall Study|Adverse Event|3|||
23765153|NCT01754259|66518270|FG001|Overall Study|Adverse Event|1|||
23765154|NCT01754259|66518269|FG000|Overall Study|Lost to Follow-up|0|||
23765155|NCT01754259|66518270|FG001|Overall Study|Lost to Follow-up|1|||
23765156|NCT00306384|66518271|FG000|Overall Study|Adverse Event|103|||
23765157|NCT00306384|66518272|FG001|Overall Study|Adverse Event|87|||
23765158|NCT00306384|66518273|FG002|Overall Study|Adverse Event|40|||
23765159|NCT00306384|66518271|FG000|Overall Study|Major protocol deviation|43|||
23765160|NCT00306384|66518272|FG001|Overall Study|Major protocol deviation|51|||
23765161|NCT00306384|66518273|FG002|Overall Study|Major protocol deviation|18|||
23765162|NCT00306384|66518271|FG000|Overall Study|Lost to Follow-up|57|||
23765163|NCT00306384|66518272|FG001|Overall Study|Lost to Follow-up|41|||
23765164|NCT00306384|66518273|FG002|Overall Study|Lost to Follow-up|35|||
23765165|NCT00306384|66518271|FG000|Overall Study|Voluntary withdrawal|199|||
23765166|NCT00306384|66518272|FG001|Overall Study|Voluntary withdrawal|187|||
23765167|NCT00306384|66518273|FG002|Overall Study|Voluntary withdrawal|91|||
23765168|NCT00306384|66518271|FG000|Overall Study|Study termination|1|||
23765169|NCT00306384|66518272|FG001|Overall Study|Study termination|0|||
23765170|NCT00306384|66518273|FG002|Overall Study|Study termination|1|||
23765171|NCT00306384|66518271|FG000|Overall Study|Pregnancy|3|||
23765172|NCT00306384|66518272|FG001|Overall Study|Pregnancy|1|||
23828975|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23444931|NCT04531241|65370205|FG001|Period 1|Protocol Violation|0|||
23765173|NCT00306384|66518273|FG002|Overall Study|Pregnancy|1|||
23765174|NCT00306384|66518271|FG000|Overall Study|Lack of Efficacy|26|||
23765175|NCT00306384|66518272|FG001|Overall Study|Lack of Efficacy|40|||
23828976|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23567141|NCT01536145|65804012|FG008|Overall Study|Progressive disease|1|||
23765176|NCT00306384|66518273|FG002|Overall Study|Lack of Efficacy|38|||
23765177|NCT00306384|66518271|FG000|Overall Study|Investigator discretion|28|||
23567142|NCT01536145|65804013|FG009|Overall Study|Progressive disease|3|||
23567143|NCT01536145|65804014|FG010|Overall Study|Progressive disease|3|||
23765178|NCT00306384|66518272|FG001|Overall Study|Investigator discretion|31|||
23765179|NCT00306384|66518273|FG002|Overall Study|Investigator discretion|21|||
23765180|NCT00306384|66518271|FG000|Overall Study|Other|80|||
23765181|NCT00306384|66518272|FG001|Overall Study|Other|70|||
23765182|NCT00306384|66518273|FG002|Overall Study|Other|32|||
23765183|NCT00306384|66518271|FG000|Overall Study|Site closure|2|||
23765184|NCT00306384|66518272|FG001|Overall Study|Site closure|0|||
23765185|NCT00306384|66518273|FG002|Overall Study|Site closure|0|||
23765186|NCT01847313|66518274|FG000|Overall Study|Death|0|||
23765187|NCT01847313|66518275|FG001|Overall Study|Death|1|||
23765188|NCT01847313|66518274|FG000|Overall Study|Withdrawal by Subject|0|||
23765189|NCT01847313|66518275|FG001|Overall Study|Withdrawal by Subject|1|||
23765190|NCT00549198|66518276|FG000|Overall Study|Adverse Event|28|||
23765191|NCT00549198|66518277|FG001|Overall Study|Adverse Event|26|||
23765192|NCT00549198|66518276|FG000|Overall Study|Insufficient Viral Load Response|4|||
23765193|NCT00549198|66518277|FG001|Overall Study|Insufficient Viral Load Response|2|||
23765194|NCT00549198|66518276|FG000|Overall Study|Protocol-defined Virological Failure|7|||
23765195|NCT00549198|66518277|FG001|Overall Study|Protocol-defined Virological Failure|0|||
23765196|NCT00549198|66518276|FG000|Overall Study|Non-compliance|2|||
23765197|NCT00549198|66518277|FG001|Overall Study|Non-compliance|4|||
23765198|NCT00549198|66518276|FG000|Overall Study|Lost to Follow-up|7|||
23765199|NCT00549198|66518277|FG001|Overall Study|Lost to Follow-up|8|||
23765200|NCT00549198|66518276|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
23765201|NCT00549198|66518277|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23765202|NCT00549198|66518276|FG000|Overall Study|Protocol Violation|7|||
23765203|NCT00549198|66518277|FG001|Overall Study|Protocol Violation|2|||
23444932|NCT04531241|65370204|FG000|Period 1|No longer eligible|0|||
23444933|NCT04531241|65370205|FG001|Period 1|No longer eligible|1|||
23444934|NCT04531241|65370204|FG000|Period 1|Lens Discomfort|0|||
23444935|NCT04531241|65370205|FG001|Period 1|Lens Discomfort|1|||
23444936|NCT04531241|65370204|FG000|Period 2|Covid-19 Related|1|||
23444937|NCT04531241|65370205|FG001|Period 2|Covid-19 Related|1|||
23444938|NCT00832416|65370206|FG000|Overall Study|Lack of Efficacy|17|||
23444939|NCT00832416|65370207|FG001|Overall Study|Lack of Efficacy|15|||
23444940|NCT00832416|65370208|FG002|Overall Study|Lack of Efficacy|13|||
23444941|NCT00832416|65370209|FG003|Overall Study|Lack of Efficacy|52|||
23444942|NCT00832416|65370206|FG000|Overall Study|Withdrawal by Subject|5|||
23444943|NCT00832416|65370207|FG001|Overall Study|Withdrawal by Subject|7|||
23567144|NCT01536145|65804004|FG000|Overall Study|Withdrawal by Subject|0|||
23567145|NCT01536145|65804005|FG001|Overall Study|Withdrawal by Subject|0|||
23567146|NCT01536145|65804006|FG002|Overall Study|Withdrawal by Subject|1|||
23567147|NCT01536145|65804007|FG003|Overall Study|Withdrawal by Subject|0|||
23567148|NCT01536145|65804008|FG004|Overall Study|Withdrawal by Subject|0|||
23567149|NCT01536145|65804009|FG005|Overall Study|Withdrawal by Subject|1|||
23567150|NCT01536145|65804010|FG006|Overall Study|Withdrawal by Subject|0|||
23567151|NCT01536145|65804011|FG007|Overall Study|Withdrawal by Subject|0|||
23567152|NCT01536145|65804012|FG008|Overall Study|Withdrawal by Subject|2|||
23567153|NCT01536145|65804013|FG009|Overall Study|Withdrawal by Subject|0|||
23567154|NCT01536145|65804014|FG010|Overall Study|Withdrawal by Subject|2|||
23567155|NCT01536145|65804004|FG000|Overall Study|Other|0|||
23567156|NCT01536145|65804005|FG001|Overall Study|Other|0|||
23567157|NCT01536145|65804006|FG002|Overall Study|Other|0|||
23567158|NCT01536145|65804007|FG003|Overall Study|Other|0|||
23567159|NCT01536145|65804008|FG004|Overall Study|Other|1|||
23567160|NCT01536145|65804009|FG005|Overall Study|Other|0|||
23567161|NCT01536145|65804010|FG006|Overall Study|Other|0|||
23567162|NCT01536145|65804011|FG007|Overall Study|Other|0|||
23567163|NCT01536145|65804012|FG008|Overall Study|Other|0|||
23567164|NCT01536145|65804013|FG009|Overall Study|Other|3|||
23567165|NCT01536145|65804014|FG010|Overall Study|Other|2|||
23628856|NCT01774305|66028140|FG001|Overall Study|Physician Decision|0|||
23765204|NCT00549198|66518276|FG000|Overall Study|Investigator Decision|4|||
23765205|NCT00549198|66518277|FG001|Overall Study|Investigator Decision|3|||
23765206|NCT00549198|66518276|FG000|Overall Study|Withdrawal by Subject|7|||
23765207|NCT00549198|66518277|FG001|Overall Study|Withdrawal by Subject|7|||
23765208|NCT00549198|66518276|FG000|Overall Study|Disease Progression|1|||
23444944|NCT00832416|65370208|FG002|Overall Study|Withdrawal by Subject|2|||
23567166|NCT01536145|65804004|FG000|Overall Study|Death|0|||
23567167|NCT01536145|65804005|FG001|Overall Study|Death|0|||
23567168|NCT01536145|65804006|FG002|Overall Study|Death|0|||
23567169|NCT01536145|65804007|FG003|Overall Study|Death|0|||
23567170|NCT01536145|65804008|FG004|Overall Study|Death|0|||
23765209|NCT00549198|66518277|FG001|Overall Study|Disease Progression|0|||
23444945|NCT00832416|65370209|FG003|Overall Study|Withdrawal by Subject|10|||
23567171|NCT01536145|65804009|FG005|Overall Study|Death|0|||
23567172|NCT01536145|65804010|FG006|Overall Study|Death|1|||
23567173|NCT01536145|65804011|FG007|Overall Study|Death|0|||
23628857|NCT04547023|66028141|FG000|Overall Study|Did Not Receive Intervention|3|||
23628858|NCT04547023|66028142|FG001|Overall Study|Did Not Receive Intervention|2|||
23628859|NCT04547023|66028141|FG000|Overall Study|Lost to Follow-up|1|||
23628860|NCT04547023|66028142|FG001|Overall Study|Lost to Follow-up|1|||
23628861|NCT03721705|66028145|FG000|Overall Study|Adverse Event|2|||
23628862|NCT03721705|66028146|FG001|Overall Study|Adverse Event|0|||
23628863|NCT03721705|66028145|FG000|Overall Study|Withdrawal by Subject|4|||
23628864|NCT03721705|66028146|FG001|Overall Study|Withdrawal by Subject|10|||
23628865|NCT03721705|66028145|FG000|Overall Study|No Suitable Study Partner|1|||
23628866|NCT03721705|66028146|FG001|Overall Study|No Suitable Study Partner|0|||
23628867|NCT03721705|66028145|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
23628868|NCT03721705|66028146|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
23628869|NCT03721705|66028145|FG000|Overall Study|Death|0|||
23628870|NCT03721705|66028146|FG001|Overall Study|Death|1|||
23628871|NCT01001390|66028147|FG000|Overall Study|Failure to wear AFO device|2|||
23628872|NCT01001390|66028148|FG001|Overall Study|Failure to wear AFO device|0|||
23628873|NCT01496365|66028149|FG000|Overall Study|Adverse Event|2|||
23628874|NCT01496365|66028150|FG001|Overall Study|Adverse Event|3|||
23628875|NCT01496365|66028151|FG002|Overall Study|Adverse Event|3|||
23628876|NCT01496365|66028152|FG003|Overall Study|Adverse Event|2|||
23628877|NCT01496365|66028153|FG004|Overall Study|Adverse Event|5|||
23628878|NCT01496365|66028154|FG005|Overall Study|Adverse Event|6|||
23628879|NCT01496365|66028155|FG006|Overall Study|Adverse Event|4|||
23628880|NCT01496365|66028149|FG000|Overall Study|Withdrawal by Subject|6|||
23628881|NCT01496365|66028150|FG001|Overall Study|Withdrawal by Subject|6|||
23628882|NCT01496365|66028151|FG002|Overall Study|Withdrawal by Subject|0|||
23628883|NCT01496365|66028152|FG003|Overall Study|Withdrawal by Subject|1|||
23628884|NCT01496365|66028153|FG004|Overall Study|Withdrawal by Subject|3|||
23628885|NCT01496365|66028154|FG005|Overall Study|Withdrawal by Subject|2|||
23628886|NCT01496365|66028155|FG006|Overall Study|Withdrawal by Subject|1|||
23628887|NCT01496365|66028149|FG000|Overall Study|Protocol Violation|2|||
23628888|NCT01496365|66028150|FG001|Overall Study|Protocol Violation|1|||
23628889|NCT01496365|66028151|FG002|Overall Study|Protocol Violation|1|||
23628890|NCT01496365|66028152|FG003|Overall Study|Protocol Violation|0|||
23628891|NCT01496365|66028153|FG004|Overall Study|Protocol Violation|0|||
23628892|NCT01496365|66028154|FG005|Overall Study|Protocol Violation|1|||
23628893|NCT01496365|66028155|FG006|Overall Study|Protocol Violation|0|||
23628894|NCT01496365|66028149|FG000|Overall Study|Lack of Efficacy|1|||
23628895|NCT01496365|66028150|FG001|Overall Study|Lack of Efficacy|0|||
23628896|NCT01496365|66028151|FG002|Overall Study|Lack of Efficacy|0|||
23628897|NCT01496365|66028152|FG003|Overall Study|Lack of Efficacy|0|||
23628898|NCT01496365|66028153|FG004|Overall Study|Lack of Efficacy|0|||
23628899|NCT01496365|66028154|FG005|Overall Study|Lack of Efficacy|1|||
23765210|NCT00549198|66518276|FG000|Overall Study|Participant Moved|2|||
23765211|NCT00549198|66518277|FG001|Overall Study|Participant Moved|0|||
23765212|NCT00549198|66518276|FG000|Overall Study|Participant not able to perform Week 96|1|||
23765213|NCT00549198|66518277|FG001|Overall Study|Participant not able to perform Week 96|0|||
23765214|NCT00549198|66518276|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
23765215|NCT00549198|66518277|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
23765216|NCT00549198|66518276|FG000|Overall Study|Prohibited Medication|1|||
23765217|NCT00549198|66518277|FG001|Overall Study|Prohibited Medication|2|||
23765218|NCT00549198|66518276|FG000|Overall Study|Participant planning pregnancy|1|||
23765219|NCT00549198|66518277|FG001|Overall Study|Participant planning pregnancy|0|||
23765220|NCT00549198|66518276|FG000|Overall Study|Participant overweight, no scan possible|1|||
23765221|NCT00549198|66518277|FG001|Overall Study|Participant overweight, no scan possible|0|||
23765222|NCT00549198|66518276|FG000|Overall Study|No scan facilities|0|||
23765223|NCT00549198|66518277|FG001|Overall Study|No scan facilities|2|||
23765224|NCT00549198|66518276|FG000|Overall Study|Pregnancy|0|||
23765225|NCT00549198|66518277|FG001|Overall Study|Pregnancy|3|||
23765226|NCT00549198|66518276|FG000|Overall Study|Not Exposed to Study Drug|3|||
23765227|NCT00549198|66518277|FG001|Overall Study|Not Exposed to Study Drug|4|||
23765228|NCT00891774|66518278|FG000|Overall Study|Lost to Follow-up|5|||
23567174|NCT01536145|65804012|FG008|Overall Study|Death|0|||
23567175|NCT01536145|65804013|FG009|Overall Study|Death|0|||
23567176|NCT01536145|65804014|FG010|Overall Study|Death|0|||
23567177|NCT01536145|65804004|FG000|Overall Study|Adverse Event|0|||
23567178|NCT01536145|65804005|FG001|Overall Study|Adverse Event|0|||
23567179|NCT01536145|65804006|FG002|Overall Study|Adverse Event|0|||
23567180|NCT01536145|65804007|FG003|Overall Study|Adverse Event|0|||
23567181|NCT01536145|65804008|FG004|Overall Study|Adverse Event|0|||
23567182|NCT01536145|65804009|FG005|Overall Study|Adverse Event|0|||
23765229|NCT00891774|66518278|FG000|Overall Study|Illness (Self/Mother)|3|||
23765230|NCT00891774|66518278|FG000|Overall Study|Withdrawal by Subject|2|||
23444946|NCT00832416|65370206|FG000|Overall Study|Physician Decision|2|||
23628900|NCT01496365|66028155|FG006|Overall Study|Lack of Efficacy|0|||
23628901|NCT01496365|66028149|FG000|Overall Study|Lost to Follow-up|0|||
23567183|NCT01536145|65804010|FG006|Overall Study|Adverse Event|0|||
23828977|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828978|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828979|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828980|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828981|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828982|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828983|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23828984|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828985|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828986|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828987|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828988|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
23828989|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828990|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828991|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828992|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828993|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828994|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23628902|NCT01496365|66028150|FG001|Overall Study|Lost to Follow-up|1|||
23628903|NCT01496365|66028151|FG002|Overall Study|Lost to Follow-up|0|||
23628904|NCT01496365|66028152|FG003|Overall Study|Lost to Follow-up|0|||
23628905|NCT01496365|66028153|FG004|Overall Study|Lost to Follow-up|2|||
23628906|NCT01496365|66028154|FG005|Overall Study|Lost to Follow-up|0|||
23628907|NCT01496365|66028155|FG006|Overall Study|Lost to Follow-up|0|||
23628908|NCT01496365|66028149|FG000|Overall Study|Other|4|||
23628909|NCT01496365|66028150|FG001|Overall Study|Other|4|||
23628910|NCT01496365|66028151|FG002|Overall Study|Other|2|||
23628911|NCT01496365|66028152|FG003|Overall Study|Other|1|||
23628912|NCT01496365|66028153|FG004|Overall Study|Other|3|||
23628913|NCT01496365|66028154|FG005|Overall Study|Other|0|||
23628914|NCT01496365|66028155|FG006|Overall Study|Other|1|||
23628915|NCT00979953|66028156|FG000|Overall Study|Adverse Event|5|||
23628916|NCT00979953|66028157|FG001|Overall Study|Adverse Event|2|||
23628917|NCT00979953|66028158|FG002|Overall Study|Adverse Event|17|||
23628918|NCT00979953|66028159|FG003|Overall Study|Adverse Event|4|||
23628919|NCT00979953|66028156|FG000|Overall Study|Lack of Efficacy|1|||
23628920|NCT00979953|66028157|FG001|Overall Study|Lack of Efficacy|2|||
23628921|NCT00979953|66028158|FG002|Overall Study|Lack of Efficacy|0|||
23628922|NCT00979953|66028159|FG003|Overall Study|Lack of Efficacy|0|||
23628923|NCT00979953|66028156|FG000|Overall Study|Lost to Follow-up|1|||
23628924|NCT00979953|66028157|FG001|Overall Study|Lost to Follow-up|1|||
23628925|NCT00979953|66028158|FG002|Overall Study|Lost to Follow-up|1|||
23628926|NCT00979953|66028159|FG003|Overall Study|Lost to Follow-up|0|||
23628927|NCT00979953|66028156|FG000|Overall Study|Withdrawal by Subject|0|||
23628928|NCT00979953|66028157|FG001|Overall Study|Withdrawal by Subject|0|||
23628929|NCT00979953|66028158|FG002|Overall Study|Withdrawal by Subject|2|||
23628930|NCT00979953|66028159|FG003|Overall Study|Withdrawal by Subject|1|||
23628931|NCT00979953|66028156|FG000|Overall Study|Protocol Violation|1|||
23628932|NCT00979953|66028157|FG001|Overall Study|Protocol Violation|0|||
23628933|NCT00979953|66028158|FG002|Overall Study|Protocol Violation|2|||
23628934|NCT00979953|66028159|FG003|Overall Study|Protocol Violation|2|||
23628935|NCT00475644|66028160|FG000|Overall Study|Protocol Violation|13|||
23628936|NCT00193479|66028161|FG000|Induction Chemotherapy|Adverse Event|2|||
23628937|NCT00193479|66028161|FG000|Induction Chemotherapy|Disease Progression|1|||
23628938|NCT00193479|66028161|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
23628939|NCT00193479|66028161|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
23628940|NCT00903760|66028162|FG000|Overall Study|Disease Progression/Death|8|||
23628941|NCT00903760|66028163|FG001|Overall Study|Disease Progression/Death|6|||
23628942|NCT00903760|66028162|FG000|Overall Study|Stem Cell Transplant|8|||
23628943|NCT00903760|66028163|FG001|Overall Study|Stem Cell Transplant|4|||
23628944|NCT00903760|66028162|FG000|Overall Study|Physician Decision|1|||
23628945|NCT00903760|66028163|FG001|Overall Study|Physician Decision|2|||
23628946|NCT00903760|66028162|FG000|Overall Study|Death|0|||
23628947|NCT00903760|66028163|FG001|Overall Study|Death|1|||
23628948|NCT00903760|66028162|FG000|Overall Study|Lost to Follow-up|1|||
23828995|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828996|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23628949|NCT00903760|66028163|FG001|Overall Study|Lost to Follow-up|0|||
23628950|NCT00903760|66028162|FG000|Overall Study|Withdrawal by Subject|1|||
23628951|NCT00903760|66028163|FG001|Overall Study|Withdrawal by Subject|2|||
23628952|NCT00903760|66028162|FG000|Overall Study|Off treatment for long period|0|||
23444947|NCT00832416|65370207|FG001|Overall Study|Physician Decision|12|||
23628953|NCT00903760|66028163|FG001|Overall Study|Off treatment for long period|1|||
23628954|NCT00356759|66028164|FG000|Overall Study|Death|5|||
23628955|NCT00356759|66028165|FG001|Overall Study|Death|2|||
23765231|NCT00891774|66518278|FG000|Overall Study|Protocol Violation|4|||
23765232|NCT00331630|66518283|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
23765233|NCT00331630|66518283|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
23765234|NCT00331630|66518283|FG000|Follow up for 5 Years|Death|5|||
23765235|NCT00331630|66518283|FG000|Follow up for 5 Years|Data collection was stopped|24|||
23765236|NCT01211769|66518284|FG000|Overall Study|Lost to Follow-up|7|||
23765237|NCT01211769|66518285|FG001|Overall Study|Lost to Follow-up|9|||
23765238|NCT01211769|66518286|FG002|Overall Study|Lost to Follow-up|5|||
23765239|NCT01211769|66518287|FG003|Overall Study|Lost to Follow-up|9|||
23765240|NCT01211769|66518284|FG000|Overall Study|Physician Decision|2|||
23765241|NCT01211769|66518285|FG001|Overall Study|Physician Decision|0|||
23765242|NCT01211769|66518286|FG002|Overall Study|Physician Decision|2|||
23765243|NCT01211769|66518287|FG003|Overall Study|Physician Decision|1|||
23765244|NCT01211769|66518284|FG000|Overall Study|Adverse Event|0|||
23765245|NCT01211769|66518285|FG001|Overall Study|Adverse Event|1|||
23765246|NCT01211769|66518286|FG002|Overall Study|Adverse Event|1|||
23765247|NCT01211769|66518287|FG003|Overall Study|Adverse Event|1|||
23765248|NCT00947427|66518288|FG000|Overall Study|Withdrawal by Subject|1|||
23765249|NCT00947427|66518289|FG001|Overall Study|Withdrawal by Subject|3|||
23765250|NCT00947427|66518288|FG000|Overall Study|Protocol Violation|0|||
23765251|NCT00947427|66518289|FG001|Overall Study|Protocol Violation|1|||
23765252|NCT03404206|66518297|FG000|Overall Study|Withdrawal by Subject|1|||
23765253|NCT03404206|66518298|FG001|Overall Study|Withdrawal by Subject|1|||
23765254|NCT03404206|66518299|FG002|Overall Study|Withdrawal by Subject|0|||
23765255|NCT03404206|66518297|FG000|Overall Study|Lost to Follow-up|3|||
23765256|NCT03404206|66518298|FG001|Overall Study|Lost to Follow-up|1|||
23765257|NCT03404206|66518299|FG002|Overall Study|Lost to Follow-up|0|||
23828997|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828998|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23828999|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23829000|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23567184|NCT01536145|65804011|FG007|Overall Study|Adverse Event|2|||
23567185|NCT01536145|65804012|FG008|Overall Study|Adverse Event|0|||
23567186|NCT01536145|65804013|FG009|Overall Study|Adverse Event|0|||
23567187|NCT01536145|65804014|FG010|Overall Study|Adverse Event|3|||
23567188|NCT02294474|65804015|FG000|Overall Study|Adverse Event|7|||
23567189|NCT02294474|65804016|FG001|Overall Study|Adverse Event|7|||
23567190|NCT02294474|65804015|FG000|Overall Study|Lack of Efficacy|2|||
23567191|NCT02294474|65804016|FG001|Overall Study|Lack of Efficacy|1|||
23567192|NCT02294474|65804015|FG000|Overall Study|Protocol Violation|4|||
23628956|NCT00356759|66028164|FG000|Overall Study|Withdrawal by Subject|2|||
23765258|NCT00467818|66518300|FG000|Overall Study|Adverse Event|1|||
23765259|NCT00467818|66518301|FG001|Overall Study|Adverse Event|0|||
23765260|NCT00467818|66518300|FG000|Overall Study|Lost to Follow-up|2|||
23765261|NCT00467818|66518301|FG001|Overall Study|Lost to Follow-up|2|||
23765262|NCT00634179|66518303|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
23765263|NCT01890707|66518304|FG000|Overall Study|Lost to Follow-up|1|||
23829001|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829002|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
23829003|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829004|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829005|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829006|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829007|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829008|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23765264|NCT01890707|66518305|FG001|Overall Study|Lost to Follow-up|1|||
23765265|NCT00417027|66518306|FG000|Overall Study|Protocol Violation|0|||
23567193|NCT02294474|65804016|FG001|Overall Study|Protocol Violation|2|||
23567194|NCT02294474|65804015|FG000|Overall Study|Other than specified above|12|||
23567195|NCT02294474|65804016|FG001|Overall Study|Other than specified above|12|||
23567196|NCT01719224|65806956|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
23567197|NCT01719224|65806957|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
23567198|NCT00636792|65806960|FG000|Overall Study|Adverse Event|16|||
23567199|NCT00636792|65806960|FG000|Overall Study|Physician Decision|7|||
23567200|NCT00636792|65806960|FG000|Overall Study|Progressive Disease|4|||
23567201|NCT00636792|65806960|FG000|Overall Study|Withdrawal by Subject|3|||
23765266|NCT00417027|66518307|FG001|Overall Study|Protocol Violation|5|||
23765267|NCT00417027|66518308|FG002|Overall Study|Protocol Violation|5|||
23765268|NCT01772368|66518309|FG000|Overall Study|Adverse Event|1|||
23765269|NCT01772368|66518309|FG000|Overall Study|Withdrawal by Subject|3|||
23765270|NCT01772368|66518309|FG000|Overall Study|Protocol Violation|2|||
23765271|NCT01772368|66518309|FG000|Overall Study|Other|1|||
23829009|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829010|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829011|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829012|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829013|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829014|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23765272|NCT01132118|66518314|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
23765273|NCT01132118|66518315|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
23765274|NCT01132118|66518314|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23765275|NCT01132118|66518315|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
23765276|NCT01132118|66518314|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
23765277|NCT01132118|66518315|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
23765278|NCT04820842|66518318|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23765279|NCT04820842|66518319|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
23765280|NCT04820842|66518320|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
23567202|NCT00636792|65806960|FG000|Overall Study|Other|3|||
23567203|NCT00758160|65806961|FG000|Overall Study|No Longer Requires Study Medication|4|||
23567204|NCT00758160|65806961|FG000|Overall Study|Administration Problems|3|||
23765281|NCT04820842|66518321|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23765282|NCT04820842|66518322|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23765283|NCT04820842|66518323|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23765284|NCT04820842|66518324|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23765285|NCT04820842|66518318|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
23765286|NCT04820842|66518319|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
23765287|NCT04820842|66518320|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
23765288|NCT04820842|66518321|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765289|NCT04820842|66518322|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765290|NCT04820842|66518323|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765291|NCT04820842|66518324|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765292|NCT04820842|66518318|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765293|NCT04820842|66518319|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
23765294|NCT04820842|66518320|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765295|NCT04820842|66518321|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765296|NCT04820842|66518322|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765297|NCT04820842|66518323|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765298|NCT04820842|66518324|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23765299|NCT04820842|66518318|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765300|NCT04820842|66518319|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23782289|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23567205|NCT00758160|65806961|FG000|Overall Study|Adverse Event|15|||
23567206|NCT00758160|65806961|FG000|Overall Study|Lack of Efficacy|10|||
23567207|NCT00758160|65806961|FG000|Overall Study|Lost to Follow-up|14|||
23567208|NCT00758160|65806961|FG000|Overall Study|Protocol Violation|12|||
23765301|NCT04820842|66518320|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765302|NCT04820842|66518321|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
23765303|NCT04820842|66518322|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765304|NCT04820842|66518323|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23765305|NCT04820842|66518324|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
23765306|NCT01952574|66521616|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
23567209|NCT00758160|65806961|FG000|Overall Study|Withdrawal by Subject|8|||
23567210|NCT02367716|65806966|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
23567211|NCT02006121|65806969|FG000|Double Blind Phase|Adverse Event|6|||
23567212|NCT02006121|65806970|FG001|Double Blind Phase|Adverse Event|0|||
23567213|NCT02006121|65806969|FG000|Double Blind Phase|Lack of Efficacy|1|||
23567214|NCT02006121|65806970|FG001|Double Blind Phase|Lack of Efficacy|16|||
23765307|NCT01952574|66521617|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
23765308|NCT01952574|66521618|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
23765309|NCT01952574|66521619|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
23765310|NCT01952574|66521620|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23765311|NCT01952574|66521621|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23765312|NCT01952574|66521622|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23765313|NCT01952574|66521616|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
23765314|NCT01952574|66521617|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
23765315|NCT01952574|66521618|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
23765316|NCT01952574|66521619|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
23765317|NCT01952574|66521620|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
23765318|NCT01952574|66521621|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
23765319|NCT01952574|66521622|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
23765320|NCT01952574|66521616|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
23765321|NCT01952574|66521617|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23765322|NCT01952574|66521618|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
23765323|NCT01952574|66521619|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
23567215|NCT02006121|65806969|FG000|Double Blind Phase|Withdrawal by Subject|3|||
23567216|NCT02006121|65806970|FG001|Double Blind Phase|Withdrawal by Subject|4|||
23765324|NCT01952574|66521620|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
23765325|NCT01952574|66521621|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
23765326|NCT01952574|66521622|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
23567217|NCT02006121|65806969|FG000|Double Blind Phase|Non-compliance with study drug|1|||
23567218|NCT02006121|65806970|FG001|Double Blind Phase|Non-compliance with study drug|3|||
23567219|NCT02006121|65806969|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
23765327|NCT01952574|66521616|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765328|NCT01952574|66521617|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765329|NCT01952574|66521618|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765330|NCT01952574|66521619|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765331|NCT01952574|66521620|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
23765332|NCT01952574|66521621|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765333|NCT01952574|66521622|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
23765334|NCT01952574|66521616|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
23765335|NCT01952574|66521617|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
23765336|NCT01952574|66521618|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
23765337|NCT01952574|66521619|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
23765338|NCT01952574|66521620|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
23765339|NCT01952574|66521621|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
23765340|NCT01952574|66521622|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
23765341|NCT01952574|66521616|FG000|Open-label Treatment Phase|Missing|0|||
23765342|NCT01952574|66521617|FG001|Open-label Treatment Phase|Missing|0|||
23765343|NCT01952574|66521618|FG002|Open-label Treatment Phase|Missing|0|||
23765344|NCT01952574|66521619|FG003|Open-label Treatment Phase|Missing|0|||
23765345|NCT01952574|66521620|FG004|Open-label Treatment Phase|Missing|4|||
23765346|NCT01952574|66521621|FG005|Open-label Treatment Phase|Missing|0|||
23765347|NCT01952574|66521622|FG006|Open-label Treatment Phase|Missing|0|||
23567220|NCT02006121|65806970|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
23567221|NCT02006121|65806969|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
23567222|NCT02006121|65806970|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
23567223|NCT02006121|65806969|FG000|Open Label Phase|Adverse Event|15|||
23567224|NCT02006121|65806970|FG001|Open Label Phase|Adverse Event|0|||
23567225|NCT02006121|65806969|FG000|Open Label Phase|Lack of Efficacy|2|||
23567226|NCT02006121|65806970|FG001|Open Label Phase|Lack of Efficacy|0|||
23567227|NCT02006121|65806969|FG000|Open Label Phase|Protocol Violation|2|||
23567228|NCT02006121|65806970|FG001|Open Label Phase|Protocol Violation|0|||
23567229|NCT02006121|65806969|FG000|Open Label Phase|Withdrawal by Subject|3|||
23567230|NCT02006121|65806970|FG001|Open Label Phase|Withdrawal by Subject|0|||
23567231|NCT02006121|65806969|FG000|Open Label Phase|Non-compliance with study drug|3|||
23567232|NCT02006121|65806970|FG001|Open Label Phase|Non-compliance with study drug|0|||
23567233|NCT01616771|65806971|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
23567234|NCT03691948|65806975|FG000|Overall Study|Lost to Follow-up|1|||
23567235|NCT03691948|65806976|FG001|Overall Study|Lost to Follow-up|3|||
23567236|NCT00393523|65806977|FG000|Overall Study|Lost to Follow-up|0|||
23567237|NCT00393523|65806978|FG001|Overall Study|Lost to Follow-up|0|||
23567238|NCT00393523|65806979|FG002|Overall Study|Lost to Follow-up|0|||
23567239|NCT00393523|65806980|FG003|Overall Study|Lost to Follow-up|2|||
23567240|NCT00393523|65806981|FG004|Overall Study|Lost to Follow-up|1|||
23567241|NCT00393523|65806977|FG000|Overall Study|Protocol Violation|6|||
23567242|NCT00393523|65806978|FG001|Overall Study|Protocol Violation|2|||
23567243|NCT00393523|65806979|FG002|Overall Study|Protocol Violation|0|||
23567244|NCT00393523|65806980|FG003|Overall Study|Protocol Violation|1|||
23567245|NCT00393523|65806981|FG004|Overall Study|Protocol Violation|0|||
23567246|NCT00393523|65806977|FG000|Overall Study|Withdrawal by Subject|6|||
23567247|NCT00393523|65806978|FG001|Overall Study|Withdrawal by Subject|7|||
23567248|NCT00393523|65806979|FG002|Overall Study|Withdrawal by Subject|2|||
23567249|NCT00393523|65806980|FG003|Overall Study|Withdrawal by Subject|3|||
23567250|NCT00393523|65806981|FG004|Overall Study|Withdrawal by Subject|0|||
23567251|NCT00393523|65806977|FG000|Overall Study|Difficulties in specimen collection|0|||
23567252|NCT00393523|65806978|FG001|Overall Study|Difficulties in specimen collection|0|||
23567253|NCT00393523|65806979|FG002|Overall Study|Difficulties in specimen collection|1|||
23567254|NCT00393523|65806980|FG003|Overall Study|Difficulties in specimen collection|0|||
23765348|NCT01952574|66521616|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23765349|NCT01952574|66521617|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23765350|NCT01952574|66521618|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
23765351|NCT01952574|66521619|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
23765352|NCT01952574|66521620|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
23765353|NCT01952574|66521621|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
23765354|NCT01952574|66521622|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
23567255|NCT00393523|65806981|FG004|Overall Study|Difficulties in specimen collection|0|||
23567256|NCT00393523|65806977|FG000|Overall Study|Vaccine supply issue|0|||
23567257|NCT00393523|65806978|FG001|Overall Study|Vaccine supply issue|0|||
23567258|NCT00393523|65806979|FG002|Overall Study|Vaccine supply issue|1|||
23567259|NCT00393523|65806980|FG003|Overall Study|Vaccine supply issue|0|||
23567260|NCT00393523|65806981|FG004|Overall Study|Vaccine supply issue|0|||
23567261|NCT02153359|65806982|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
23567262|NCT02153359|65806983|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
23567263|NCT00684762|65806987|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
23567264|NCT00684762|65806988|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23765355|NCT01952574|66521616|FG000|Open-label Treatment Phase|Death|0|||
23765356|NCT01952574|66521617|FG001|Open-label Treatment Phase|Death|0|||
23765357|NCT01952574|66521618|FG002|Open-label Treatment Phase|Death|0|||
23765358|NCT01952574|66521619|FG003|Open-label Treatment Phase|Death|0|||
23765359|NCT01952574|66521620|FG004|Open-label Treatment Phase|Death|1|||
23765360|NCT01952574|66521621|FG005|Open-label Treatment Phase|Death|0|||
23765361|NCT01952574|66521622|FG006|Open-label Treatment Phase|Death|0|||
23765362|NCT01952574|66521616|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23765363|NCT01952574|66521617|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23765364|NCT01952574|66521618|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23444948|NCT00832416|65370208|FG002|Overall Study|Physician Decision|5|||
23444949|NCT00832416|65370209|FG003|Overall Study|Physician Decision|10|||
23444950|NCT00832416|65370206|FG000|Overall Study|Administrative|0|||
23765365|NCT01952574|66521619|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23765366|NCT01952574|66521620|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23765367|NCT01952574|66521621|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
23765368|NCT01952574|66521622|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23765369|NCT01952574|66521616|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
23765370|NCT01952574|66521617|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
23765371|NCT01952574|66521618|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
23765372|NCT01952574|66521619|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
23765373|NCT01952574|66521620|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
23765374|NCT01952574|66521621|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
23765375|NCT01952574|66521622|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
23765376|NCT02097121|66521623|FG000|Overall Study|Other, not specified|4|||
23765377|NCT02097121|66521624|FG001|Overall Study|Other, not specified|2|||
23765378|NCT02097121|66521625|FG002|Overall Study|Other, not specified|3|||
23765379|NCT02097121|66521623|FG000|Overall Study|Lack of Efficacy|2|||
23765380|NCT02097121|66521624|FG001|Overall Study|Lack of Efficacy|1|||
23765381|NCT02097121|66521625|FG002|Overall Study|Lack of Efficacy|3|||
23765382|NCT02097121|66521623|FG000|Overall Study|Withdrawal by Subject|0|||
23765383|NCT02097121|66521624|FG001|Overall Study|Withdrawal by Subject|1|||
23765384|NCT02097121|66521625|FG002|Overall Study|Withdrawal by Subject|2|||
23765385|NCT02097121|66521623|FG000|Overall Study|Adverse Event|0|||
23765386|NCT02097121|66521624|FG001|Overall Study|Adverse Event|1|||
23765387|NCT02097121|66521625|FG002|Overall Study|Adverse Event|0|||
23765388|NCT02097121|66521623|FG000|Overall Study|Lost to Follow-up|1|||
23444951|NCT00832416|65370207|FG001|Overall Study|Administrative|0|||
23444952|NCT00832416|65370208|FG002|Overall Study|Administrative|0|||
23444953|NCT00832416|65370209|FG003|Overall Study|Administrative|1|||
23444954|NCT00832416|65370206|FG000|Overall Study|Adverse Event|21|||
23765389|NCT02097121|66521624|FG001|Overall Study|Lost to Follow-up|1|||
23765390|NCT02097121|66521625|FG002|Overall Study|Lost to Follow-up|2|||
23444955|NCT00832416|65370207|FG001|Overall Study|Adverse Event|19|||
23444956|NCT00832416|65370208|FG002|Overall Study|Adverse Event|41|||
23444957|NCT00832416|65370209|FG003|Overall Study|Adverse Event|10|||
23444958|NCT00832416|65370206|FG000|Overall Study|Death|1|||
23444959|NCT00832416|65370207|FG001|Overall Study|Death|0|||
23444960|NCT00832416|65370208|FG002|Overall Study|Death|0|||
23444961|NCT00832416|65370209|FG003|Overall Study|Death|0|||
23444962|NCT00994422|65370210|FG000|Overall Study|Lost to Follow-up|7|||
23444963|NCT00994422|65370211|FG001|Overall Study|Lost to Follow-up|1|||
23444964|NCT01726582|65370212|FG000|Overall Study|Physician Decision|99|||
23444965|NCT01726582|65370212|FG000|Overall Study|Death|85|||
23444966|NCT01391663|65370222|FG000|Overall Study|Withdrawal by Subject|0|||
23444967|NCT01391663|65370223|FG001|Overall Study|Withdrawal by Subject|0|||
23444968|NCT01391663|65370224|FG002|Overall Study|Withdrawal by Subject|1|||
23444969|NCT01391663|65370225|FG003|Overall Study|Withdrawal by Subject|0|||
23444970|NCT03077542|65370226|FG000|Overall Study|Death|4|||
23444971|NCT03077542|65370227|FG001|Overall Study|Death|0|||
23444972|NCT03077542|65370226|FG000|Overall Study|Physician Decision|6|||
23444973|NCT03077542|65370227|FG001|Overall Study|Physician Decision|1|||
23444974|NCT03077542|65370226|FG000|Overall Study|Withdrawal by Subject|0|||
23444975|NCT03077542|65370227|FG001|Overall Study|Withdrawal by Subject|1|||
23444976|NCT02629822|65370228|FG000|Base Study|Lost to Follow-up|2|||
23444977|NCT02629822|65370228|FG000|Base Study|Non-Compliance With Study Drug|1|||
23444978|NCT02629822|65370228|FG000|Extension Study|Adverse Event|1|||
23444979|NCT02629822|65370228|FG000|Extension Study|Lost to Follow-up|1|||
23444980|NCT03461146|65370229|FG000|Overall Study|Adverse Event|2|||
23444981|NCT03461146|65370229|FG000|Overall Study|Physician Decision|1|||
23444982|NCT01871519|65370230|FG000|Overall Study|Death|26|||
23444983|NCT01871519|65370230|FG000|Overall Study|Lost to Follow-up|15|||
23567265|NCT04000594|65806991|FG000|Overall Study|Withdrawal by Subject|1|||
23567266|NCT04000594|65806992|FG001|Overall Study|Withdrawal by Subject|0|||
23567267|NCT04000594|65806993|FG002|Overall Study|Withdrawal by Subject|0|||
23567268|NCT04422639|65806998|FG000|Overall Study|Death|1|||
23567269|NCT04422639|65806999|FG001|Overall Study|Death|0|||
23567270|NCT04422639|65806998|FG000|Overall Study|study closed prior to completion of FU visits|0|||
23567271|NCT04422639|65806999|FG001|Overall Study|study closed prior to completion of FU visits|2|||
23567272|NCT01844115|65807000|FG000|Overall Study|Adverse Event|4|||
23567273|NCT01844115|65807001|FG001|Overall Study|Adverse Event|22|||
23567274|NCT01844115|65807000|FG000|Overall Study|Lack of Efficacy|1|||
23567275|NCT01844115|65807001|FG001|Overall Study|Lack of Efficacy|4|||
23567276|NCT01844115|65807000|FG000|Overall Study|Protocol Violation|12|||
23567277|NCT01844115|65807001|FG001|Overall Study|Protocol Violation|10|||
23567278|NCT01844115|65807000|FG000|Overall Study|Withdrawal by Subject|11|||
23567279|NCT01844115|65807001|FG001|Overall Study|Withdrawal by Subject|11|||
23567280|NCT01844115|65807000|FG000|Overall Study|Lost to Follow-up|11|||
23567281|NCT01844115|65807001|FG001|Overall Study|Lost to Follow-up|10|||
23567282|NCT01844115|65807000|FG000|Overall Study|Pregnancy|0|||
23444984|NCT01871519|65370230|FG000|Overall Study|Withdrawal by Subject|49|||
23444985|NCT02206035|65370231|FG000|Overall Study|Physician Decision|10|||
23444986|NCT02206035|65370232|FG001|Overall Study|Physician Decision|0|||
23444987|NCT02206035|65370233|FG002|Overall Study|Physician Decision|175|||
23567283|NCT01844115|65807001|FG001|Overall Study|Pregnancy|1|||
23444988|NCT03600740|65370234|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
23567284|NCT05593211|65807005|FG000|Overall Study|Withdrawal by Subject|1|||
23567285|NCT03447730|65807006|FG000|Overall Study|Adverse Event|0|||
23567286|NCT03447730|65807007|FG001|Overall Study|Adverse Event|2|||
23567287|NCT03447730|65807008|FG002|Overall Study|Adverse Event|0|||
23567288|NCT01493960|65807009|FG000|Overall Study|Adverse Event|0|||
23567289|NCT01493960|65807010|FG001|Overall Study|Adverse Event|1|||
23444989|NCT00394706|65370236|FG000|Overall Study|Withdrawal by Subject|2|||
23444990|NCT00394706|65370237|FG001|Overall Study|Withdrawal by Subject|0|||
23444991|NCT00394706|65370238|FG002|Overall Study|Withdrawal by Subject|1|||
23444992|NCT00394706|65370239|FG003|Overall Study|Withdrawal by Subject|0|||
23444993|NCT00394706|65370240|FG004|Overall Study|Withdrawal by Subject|0|||
23444994|NCT00394706|65370241|FG005|Overall Study|Withdrawal by Subject|2|||
23444995|NCT00394706|65370242|FG006|Overall Study|Withdrawal by Subject|1|||
23444996|NCT00394706|65370243|FG007|Overall Study|Withdrawal by Subject|0|||
23444997|NCT00394706|65370236|FG000|Overall Study|Lost to Follow-up|2|||
23444998|NCT00394706|65370237|FG001|Overall Study|Lost to Follow-up|2|||
23444999|NCT00394706|65370238|FG002|Overall Study|Lost to Follow-up|8|||
23445000|NCT00394706|65370239|FG003|Overall Study|Lost to Follow-up|1|||
23445001|NCT00394706|65370240|FG004|Overall Study|Lost to Follow-up|2|||
23445002|NCT00394706|65370241|FG005|Overall Study|Lost to Follow-up|5|||
23445003|NCT00394706|65370242|FG006|Overall Study|Lost to Follow-up|2|||
23445004|NCT00394706|65370243|FG007|Overall Study|Lost to Follow-up|0|||
23567290|NCT01493960|65807009|FG000|Overall Study|Lack of Efficacy|15|||
23567291|NCT01493960|65807010|FG001|Overall Study|Lack of Efficacy|9|||
23567292|NCT01493960|65807009|FG000|Overall Study|Protocol Violation|3|||
23567293|NCT01493960|65807010|FG001|Overall Study|Protocol Violation|0|||
23567294|NCT01493960|65807009|FG000|Overall Study|Withdrawal by Subject|10|||
23567295|NCT01493960|65807010|FG001|Overall Study|Withdrawal by Subject|4|||
23567296|NCT01493960|65807009|FG000|Overall Study|Non-specified|4|||
23567297|NCT01493960|65807010|FG001|Overall Study|Non-specified|4|||
23567298|NCT04567693|65807011|FG000|Overall Study|Death|0|||
23567299|NCT04567693|65807012|FG001|Overall Study|Death|0|||
23567300|NCT04567693|65807013|FG002|Overall Study|Death|2|||
23567301|NCT04567693|65807011|FG000|Overall Study|Lost to Follow-up|1|||
23567302|NCT04567693|65807012|FG001|Overall Study|Lost to Follow-up|0|||
23567303|NCT04567693|65807013|FG002|Overall Study|Lost to Follow-up|2|||
23567304|NCT04567693|65807011|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
23567305|NCT04567693|65807012|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
23567306|NCT04567693|65807013|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
23567307|NCT01984424|65807014|FG000|Overall Study|Withdrawal by Subject|3|||
23567308|NCT01984424|65807015|FG001|Overall Study|Withdrawal by Subject|5|||
23567309|NCT01984424|65807014|FG000|Overall Study|Sponsor Decision|0|||
23567310|NCT01984424|65807015|FG001|Overall Study|Sponsor Decision|1|||
23567311|NCT01984424|65807014|FG000|Overall Study|Lost to Follow-up|0|||
23567312|NCT01984424|65807015|FG001|Overall Study|Lost to Follow-up|1|||
23567313|NCT00525265|65807016|FG000|Overall Study|Protocol Violation|1|||
23567314|NCT00525265|65807017|FG001|Overall Study|Protocol Violation|0|||
23567315|NCT02305381|65807022|FG000|Overall Study|Unclassified|5|||
23567316|NCT02305381|65807023|FG001|Overall Study|Unclassified|5|||
23567317|NCT02305381|65807024|FG002|Overall Study|Unclassified|7|||
23567318|NCT01597505|65807031|FG000|Overall Study|Physician Decision|5|||
23567319|NCT01597505|65807032|FG001|Overall Study|Physician Decision|0|||
23567320|NCT01597505|65807031|FG000|Overall Study|Adverse Event|19|||
23567321|NCT01597505|65807032|FG001|Overall Study|Adverse Event|7|||
23567322|NCT01597505|65807031|FG000|Overall Study|Lost to Follow-up|4|||
23567323|NCT01597505|65807032|FG001|Overall Study|Lost to Follow-up|2|||
23567324|NCT01597505|65807031|FG000|Overall Study|Withdrawal by Subject|10|||
23567325|NCT01597505|65807032|FG001|Overall Study|Withdrawal by Subject|18|||
23567326|NCT01597505|65807031|FG000|Overall Study|Other|5|||
23567327|NCT01597505|65807032|FG001|Overall Study|Other|6|||
23567328|NCT01597505|65807031|FG000|Overall Study|Missing|1|||
23567329|NCT01597505|65807032|FG001|Overall Study|Missing|0|||
23567330|NCT00474929|65807033|FG000|Overall Study|Withdrawal by Subject|0|||
23567331|NCT00474929|65807034|FG001|Overall Study|Withdrawal by Subject|1|||
23567332|NCT00474929|65807035|FG002|Overall Study|Withdrawal by Subject|0|||
23567333|NCT00474929|65807036|FG003|Overall Study|Withdrawal by Subject|0|||
23567334|NCT00474929|65807037|FG004|Overall Study|Withdrawal by Subject|0|||
23567335|NCT00474929|65807033|FG000|Overall Study|Unrelated medical condition|0|||
23567336|NCT00474929|65807034|FG001|Overall Study|Unrelated medical condition|0|||
23567337|NCT00474929|65807035|FG002|Overall Study|Unrelated medical condition|1|||
23567338|NCT00474929|65807036|FG003|Overall Study|Unrelated medical condition|0|||
23567339|NCT00474929|65807037|FG004|Overall Study|Unrelated medical condition|0|||
23567340|NCT00474929|65807033|FG000|Overall Study|Physician Decision|0|||
23567341|NCT00474929|65807034|FG001|Overall Study|Physician Decision|0|||
23567342|NCT00474929|65807035|FG002|Overall Study|Physician Decision|1|||
23567343|NCT00474929|65807036|FG003|Overall Study|Physician Decision|2|||
23567344|NCT00474929|65807037|FG004|Overall Study|Physician Decision|0|||
23567345|NCT00337662|65807040|FG000|Study Period II|Lost to Follow-up|0|||
23567346|NCT00337662|65807041|FG001|Study Period II|Lost to Follow-up|0|||
23445005|NCT03712787|65370244|FG000|Overall Study|Adverse Event|2|||
23445006|NCT03712787|65370245|FG001|Overall Study|Adverse Event|3|||
23445007|NCT03712787|65370246|FG002|Overall Study|Adverse Event|0|||
23445008|NCT03712787|65370247|FG003|Overall Study|Adverse Event|4|||
23567347|NCT00337662|65807042|FG002|Study Period II|Lost to Follow-up|0|||
23829015|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23445009|NCT03712787|65370244|FG000|Overall Study|Withdrawal by Subject|4|||
23567348|NCT00337662|65807043|FG003|Study Period II|Lost to Follow-up|35|||
23567349|NCT00337662|65807040|FG000|Study Period II|Withdrawal by Subject|0|||
23567350|NCT00337662|65807041|FG001|Study Period II|Withdrawal by Subject|0|||
23567351|NCT00337662|65807042|FG002|Study Period II|Withdrawal by Subject|0|||
23567352|NCT00337662|65807043|FG003|Study Period II|Withdrawal by Subject|20|||
23567353|NCT00337662|65807040|FG000|Study Period II|Adverse Event|0|||
23567354|NCT00337662|65807041|FG001|Study Period II|Adverse Event|0|||
23567355|NCT00337662|65807042|FG002|Study Period II|Adverse Event|0|||
23567356|NCT00337662|65807043|FG003|Study Period II|Adverse Event|16|||
23567357|NCT00337662|65807040|FG000|Study Period II|Physician Decision|0|||
23567358|NCT00337662|65807041|FG001|Study Period II|Physician Decision|0|||
23567359|NCT00337662|65807042|FG002|Study Period II|Physician Decision|0|||
23567360|NCT00337662|65807043|FG003|Study Period II|Physician Decision|13|||
23567361|NCT00337662|65807040|FG000|Study Period II|Entry Criteria Not Met|0|||
23567362|NCT00337662|65807041|FG001|Study Period II|Entry Criteria Not Met|0|||
23567363|NCT00337662|65807042|FG002|Study Period II|Entry Criteria Not Met|0|||
23567364|NCT00337662|65807043|FG003|Study Period II|Entry Criteria Not Met|6|||
23567365|NCT00337662|65807040|FG000|Study Period II|Protocol Violation|0|||
23567366|NCT00337662|65807041|FG001|Study Period II|Protocol Violation|0|||
23567367|NCT00337662|65807042|FG002|Study Period II|Protocol Violation|0|||
23567368|NCT00337662|65807043|FG003|Study Period II|Protocol Violation|6|||
23567369|NCT00337662|65807040|FG000|Study Period II|Lack of Efficacy|0|||
23567370|NCT00337662|65807041|FG001|Study Period II|Lack of Efficacy|0|||
23567371|NCT00337662|65807042|FG002|Study Period II|Lack of Efficacy|0|||
23567372|NCT00337662|65807043|FG003|Study Period II|Lack of Efficacy|7|||
23567373|NCT00337662|65807040|FG000|Study Period II|Sponsor Decision|0|||
23567374|NCT00337662|65807041|FG001|Study Period II|Sponsor Decision|0|||
23567375|NCT00337662|65807042|FG002|Study Period II|Sponsor Decision|0|||
23567376|NCT00337662|65807043|FG003|Study Period II|Sponsor Decision|2|||
23567377|NCT00337662|65807040|FG000|Study Period II|Parent/Caregiver Decision|0|||
23567378|NCT00337662|65807041|FG001|Study Period II|Parent/Caregiver Decision|0|||
23765391|NCT00319956|66521627|FG000|Overall Study|Death|20|||
23765392|NCT00319956|66521628|FG001|Overall Study|Death|24|||
23765393|NCT01533428|66521629|FG000|Overall Study|Adverse Event|0|||
23765394|NCT01533428|66521630|FG001|Overall Study|Adverse Event|1|||
23765395|NCT01533428|66521629|FG000|Overall Study|Lost to Follow-up|2|||
23765396|NCT01533428|66521630|FG001|Overall Study|Lost to Follow-up|1|||
23765397|NCT01533428|66521629|FG000|Overall Study|Withdrawal by Subject|7|||
23765398|NCT01533428|66521630|FG001|Overall Study|Withdrawal by Subject|6|||
23765399|NCT00681863|66521633|FG000|Overall Study|Adverse Event|1|||
23765400|NCT00681863|66521633|FG000|Overall Study|Lost to Follow-up|2|||
23765401|NCT00681863|66521633|FG000|Overall Study|Lack of Efficacy|2|||
23765402|NCT00681863|66521633|FG000|Overall Study|Other|18|||
23765403|NCT00679783|66521654|FG000|Overall Study|Adverse Event|0|||
23765404|NCT00679783|66521655|FG001|Overall Study|Adverse Event|0|||
23765405|NCT00679783|66521656|FG002|Overall Study|Adverse Event|0|||
23765406|NCT00679783|66521657|FG003|Overall Study|Adverse Event|3|||
23765407|NCT00679783|66521658|FG004|Overall Study|Adverse Event|0|||
23765408|NCT00679783|66521659|FG005|Overall Study|Adverse Event|0|||
23765409|NCT00679783|66521660|FG006|Overall Study|Adverse Event|1|||
23765410|NCT00679783|66521654|FG000|Overall Study|Lack of Efficacy|0|||
23765411|NCT00679783|66521655|FG001|Overall Study|Lack of Efficacy|1|||
23765412|NCT00679783|66521656|FG002|Overall Study|Lack of Efficacy|0|||
23765413|NCT00679783|66521657|FG003|Overall Study|Lack of Efficacy|2|||
23445010|NCT03712787|65370245|FG001|Overall Study|Withdrawal by Subject|14|||
23445011|NCT03712787|65370246|FG002|Overall Study|Withdrawal by Subject|12|||
23567379|NCT00337662|65807042|FG002|Study Period II|Parent/Caregiver Decision|0|||
23567380|NCT00337662|65807043|FG003|Study Period II|Parent/Caregiver Decision|1|||
23567381|NCT00337662|65807040|FG000|Study Period III|Lost to Follow-up|14|||
23567382|NCT00337662|65807041|FG001|Study Period III|Lost to Follow-up|16|||
23567383|NCT00337662|65807042|FG002|Study Period III|Lost to Follow-up|14|||
23567384|NCT00337662|65807043|FG003|Study Period III|Lost to Follow-up|0|||
23567385|NCT00337662|65807040|FG000|Study Period III|Withdrawal by Subject|18|||
23567386|NCT00337662|65807041|FG001|Study Period III|Withdrawal by Subject|14|||
23628957|NCT00356759|66028165|FG001|Overall Study|Withdrawal by Subject|2|||
23445012|NCT03712787|65370247|FG003|Overall Study|Withdrawal by Subject|8|||
23765414|NCT00679783|66521658|FG004|Overall Study|Lack of Efficacy|0|||
23765415|NCT00679783|66521659|FG005|Overall Study|Lack of Efficacy|0|||
23765416|NCT00679783|66521660|FG006|Overall Study|Lack of Efficacy|0|||
23765417|NCT00679783|66521654|FG000|Overall Study|Withdrawal by Subject|0|||
23765418|NCT00679783|66521655|FG001|Overall Study|Withdrawal by Subject|0|||
23829016|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829017|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23829018|NCT00758524|66752493|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829019|NCT00758524|66752494|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
23829020|NCT00758524|66752495|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829021|NCT00758524|66752496|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829022|NCT00758524|66752497|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829023|NCT00758524|66752498|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829024|NCT00758524|66752499|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829025|NCT00758524|66752500|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829026|NCT00758524|66752501|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829027|NCT00758524|66752502|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829028|NCT00758524|66752503|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829029|NCT00758524|66752504|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829030|NCT00758524|66752505|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829031|NCT00758524|66752506|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829032|NCT00758524|66752507|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829033|NCT00758524|66752508|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829034|NCT00758524|66752509|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23829035|NCT00758524|66752493|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829036|NCT00758524|66752494|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829037|NCT00758524|66752495|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829038|NCT00758524|66752496|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829039|NCT00758524|66752497|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829040|NCT00758524|66752498|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829041|NCT00758524|66752499|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829042|NCT00758524|66752500|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829043|NCT00758524|66752501|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
23829044|NCT00758524|66752502|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829045|NCT00758524|66752503|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829046|NCT00758524|66752504|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829047|NCT00758524|66752505|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829048|NCT00758524|66752506|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829049|NCT00758524|66752507|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829050|NCT00758524|66752508|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829051|NCT00758524|66752509|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23829052|NCT00758524|66752493|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829053|NCT00758524|66752494|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829054|NCT00758524|66752495|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829055|NCT00758524|66752496|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829056|NCT00758524|66752497|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829057|NCT00758524|66752498|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829058|NCT00758524|66752499|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
23829059|NCT00758524|66752500|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829060|NCT00758524|66752501|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829061|NCT00758524|66752502|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829062|NCT00758524|66752503|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829063|NCT00758524|66752504|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829064|NCT00758524|66752505|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829065|NCT00758524|66752506|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829066|NCT00758524|66752507|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829067|NCT00758524|66752508|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829068|NCT00758524|66752509|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23829069|NCT02137252|66752512|FG000|Overall Study|trial terminated early|2|||
23567387|NCT00337662|65807042|FG002|Study Period III|Withdrawal by Subject|12|||
23567388|NCT00337662|65807043|FG003|Study Period III|Withdrawal by Subject|0|||
23567389|NCT00337662|65807040|FG000|Study Period III|Adverse Event|9|||
23567390|NCT00337662|65807041|FG001|Study Period III|Adverse Event|10|||
23567391|NCT00337662|65807042|FG002|Study Period III|Adverse Event|8|||
23567392|NCT00337662|65807043|FG003|Study Period III|Adverse Event|0|||
23567393|NCT00337662|65807040|FG000|Study Period III|Protocol Violation|3|||
23567394|NCT00337662|65807041|FG001|Study Period III|Protocol Violation|8|||
23567395|NCT00337662|65807042|FG002|Study Period III|Protocol Violation|2|||
23567396|NCT00337662|65807043|FG003|Study Period III|Protocol Violation|0|||
23829070|NCT02137252|66752513|FG001|Overall Study|trial terminated early|1|||
23829071|NCT03359850|66752524|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
23829072|NCT03359850|66752525|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
23829073|NCT03359850|66752524|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
23829074|NCT03359850|66752525|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
23829075|NCT03359850|66752524|FG000|Extension Phase (Up to 28 Months)|Death|2|||
23829076|NCT03359850|66752525|FG001|Extension Phase (Up to 28 Months)|Death|4|||
23829077|NCT03359850|66752524|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
23829078|NCT03359850|66752525|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
23829079|NCT03359850|66752524|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
23829080|NCT03359850|66752525|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
23829081|NCT01895777|66752529|FG000|Overall Study|Adverse Event|1|||
23829082|NCT01895777|66752530|FG001|Overall Study|Adverse Event|2|||
23829083|NCT01895777|66752529|FG000|Overall Study|Lost to Follow-up|2|||
23829084|NCT01895777|66752530|FG001|Overall Study|Lost to Follow-up|0|||
23829085|NCT01895777|66752529|FG000|Overall Study|Not treated|1|||
23829086|NCT01895777|66752530|FG001|Overall Study|Not treated|0|||
23829087|NCT01895777|66752529|FG000|Overall Study|Other reasons|3|||
23829088|NCT01895777|66752530|FG001|Overall Study|Other reasons|2|||
23829089|NCT01895777|66752529|FG000|Overall Study|Non-compliance with the CTP|2|||
23829090|NCT01895777|66752530|FG001|Overall Study|Non-compliance with the CTP|1|||
23445013|NCT03712787|65370244|FG000|Overall Study|Lost to Follow-up|1|||
23445014|NCT03712787|65370245|FG001|Overall Study|Lost to Follow-up|1|||
23445015|NCT03712787|65370246|FG002|Overall Study|Lost to Follow-up|2|||
23445016|NCT03712787|65370247|FG003|Overall Study|Lost to Follow-up|1|||
23567397|NCT00337662|65807040|FG000|Study Period III|Physician Decision|6|||
23567398|NCT00337662|65807041|FG001|Study Period III|Physician Decision|5|||
23567399|NCT00337662|65807042|FG002|Study Period III|Physician Decision|0|||
23567400|NCT00337662|65807043|FG003|Study Period III|Physician Decision|0|||
23567401|NCT00337662|65807040|FG000|Study Period III|Entry Criteria Not Met|4|||
23567402|NCT00337662|65807041|FG001|Study Period III|Entry Criteria Not Met|1|||
23567403|NCT00337662|65807042|FG002|Study Period III|Entry Criteria Not Met|3|||
23567404|NCT00337662|65807043|FG003|Study Period III|Entry Criteria Not Met|0|||
23567405|NCT00337662|65807040|FG000|Study Period III|Lack of Efficacy|4|||
23567406|NCT00337662|65807041|FG001|Study Period III|Lack of Efficacy|4|||
23567407|NCT00337662|65807042|FG002|Study Period III|Lack of Efficacy|2|||
23567408|NCT00337662|65807043|FG003|Study Period III|Lack of Efficacy|0|||
23567409|NCT00337662|65807040|FG000|Study Period III|Parent/Caregiver Decision|0|||
23567410|NCT00337662|65807041|FG001|Study Period III|Parent/Caregiver Decision|0|||
23567411|NCT00337662|65807042|FG002|Study Period III|Parent/Caregiver Decision|2|||
23567412|NCT00337662|65807043|FG003|Study Period III|Parent/Caregiver Decision|0|||
23567413|NCT00337662|65807040|FG000|Study Period III|Sponsor Decision|1|||
23628958|NCT00356759|66028164|FG000|Overall Study|Adverse Event|1|||
23765419|NCT00679783|66521656|FG002|Overall Study|Withdrawal by Subject|1|||
23765420|NCT00679783|66521657|FG003|Overall Study|Withdrawal by Subject|1|||
23765421|NCT00679783|66521658|FG004|Overall Study|Withdrawal by Subject|0|||
23765422|NCT00679783|66521659|FG005|Overall Study|Withdrawal by Subject|0|||
23765423|NCT00679783|66521660|FG006|Overall Study|Withdrawal by Subject|0|||
23765424|NCT00679783|66521654|FG000|Overall Study|Not Captured|0|||
23765425|NCT00679783|66521655|FG001|Overall Study|Not Captured|0|||
23765426|NCT00679783|66521656|FG002|Overall Study|Not Captured|0|||
23765427|NCT00679783|66521657|FG003|Overall Study|Not Captured|5|||
23765428|NCT00679783|66521658|FG004|Overall Study|Not Captured|0|||
23765429|NCT00679783|66521659|FG005|Overall Study|Not Captured|0|||
23765430|NCT00679783|66521660|FG006|Overall Study|Not Captured|0|||
23765431|NCT00679783|66521654|FG000|Overall Study|Ongoing at data cut-off|2|||
23765432|NCT00679783|66521655|FG001|Overall Study|Ongoing at data cut-off|2|||
23765433|NCT00679783|66521656|FG002|Overall Study|Ongoing at data cut-off|0|||
23765434|NCT00679783|66521657|FG003|Overall Study|Ongoing at data cut-off|9|||
23765435|NCT00679783|66521658|FG004|Overall Study|Ongoing at data cut-off|1|||
23765436|NCT00679783|66521659|FG005|Overall Study|Ongoing at data cut-off|0|||
23765437|NCT00679783|66521660|FG006|Overall Study|Ongoing at data cut-off|0|||
23765438|NCT02232074|66521693|FG000|Overall Study|Withdrawal by Subject|5|||
23765439|NCT02232074|66521694|FG001|Overall Study|Withdrawal by Subject|3|||
23765440|NCT02232074|66521693|FG000|Overall Study|No legal concerns at baseline|36|||
23765441|NCT02232074|66521694|FG001|Overall Study|No legal concerns at baseline|41|||
23765442|NCT02232074|66521693|FG000|Overall Study|deemed ineligible|0|||
23765443|NCT02232074|66521694|FG001|Overall Study|deemed ineligible|1|||
23765444|NCT01797120|66521701|FG000|Overall Study|Disesae progression|37|||
23765445|NCT01797120|66521702|FG001|Overall Study|Disesae progression|49|||
23765446|NCT01797120|66521701|FG000|Overall Study|Adverse Event|13|||
23765447|NCT01797120|66521702|FG001|Overall Study|Adverse Event|5|||
23765448|NCT01797120|66521701|FG000|Overall Study|Withdrawal by Subject|6|||
23765449|NCT01797120|66521702|FG001|Overall Study|Withdrawal by Subject|6|||
23765450|NCT01797120|66521701|FG000|Overall Study|Symptomatic progression|2|||
23765451|NCT01797120|66521702|FG001|Overall Study|Symptomatic progression|1|||
23765452|NCT01797120|66521701|FG000|Overall Study|Non-compliance|1|||
23628959|NCT00356759|66028165|FG001|Overall Study|Adverse Event|3|||
23628960|NCT00356759|66028164|FG000|Overall Study|Lost to Follow-up|1|||
23628961|NCT00356759|66028165|FG001|Overall Study|Lost to Follow-up|1|||
23628962|NCT00356759|66028164|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
23628963|NCT00356759|66028165|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
23628964|NCT00943722|66028170|FG000|Base Study|Adverse Event|0|||
23628965|NCT00943722|66028171|FG001|Base Study|Adverse Event|0|||
23628966|NCT00943722|66028172|FG002|Base Study|Adverse Event|0|||
23628967|NCT00943722|66028173|FG003|Base Study|Adverse Event|1|||
23829091|NCT04211831|66752531|FG000|Overall Study|Withdrawal by Subject|4|||
23829092|NCT04211831|66752532|FG001|Overall Study|Withdrawal by Subject|1|||
23829093|NCT04211831|66752533|FG002|Overall Study|Withdrawal by Subject|1|||
23829094|NCT04211831|66752531|FG000|Overall Study|Protocol Violation|0|||
23829095|NCT04211831|66752532|FG001|Overall Study|Protocol Violation|0|||
23829096|NCT04211831|66752533|FG002|Overall Study|Protocol Violation|1|||
23829097|NCT04211831|66752531|FG000|Overall Study|Adverse Event|0|||
23829098|NCT04211831|66752532|FG001|Overall Study|Adverse Event|1|||
23829099|NCT04211831|66752533|FG002|Overall Study|Adverse Event|0|||
23829100|NCT04211831|66752531|FG000|Overall Study|Lack of Efficacy|0|||
23829101|NCT04211831|66752532|FG001|Overall Study|Lack of Efficacy|0|||
23829102|NCT04211831|66752533|FG002|Overall Study|Lack of Efficacy|1|||
23829103|NCT04211831|66752531|FG000|Overall Study|Lost to Follow-up|0|||
23829104|NCT04211831|66752532|FG001|Overall Study|Lost to Follow-up|0|||
23829105|NCT04211831|66752533|FG002|Overall Study|Lost to Follow-up|2|||
23829106|NCT04211831|66752531|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
23829107|NCT04211831|66752532|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
23829108|NCT04211831|66752533|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
23829109|NCT04211831|66752531|FG000|Overall Study|Other|0|||
23829110|NCT04211831|66752532|FG001|Overall Study|Other|1|||
23829111|NCT04211831|66752533|FG002|Overall Study|Other|0|||
23829112|NCT01062425|66752534|FG000|Overall Study|Protocol Violation|3|||
23829113|NCT01062425|66752535|FG001|Overall Study|Protocol Violation|6|||
23829114|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
23829115|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Death|1|||
23829116|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
23628968|NCT00943722|66028174|FG004|Base Study|Adverse Event|0|||
23628969|NCT00943722|66028175|FG005|Base Study|Adverse Event|0|||
23628970|NCT00943722|66028176|FG006|Base Study|Adverse Event|0|||
23628971|NCT00943722|66028170|FG000|Base Study|Lost to Follow-up|12|||
23628972|NCT00943722|66028171|FG001|Base Study|Lost to Follow-up|8|||
23628973|NCT00943722|66028172|FG002|Base Study|Lost to Follow-up|10|||
23628974|NCT00943722|66028173|FG003|Base Study|Lost to Follow-up|8|||
23628975|NCT00943722|66028174|FG004|Base Study|Lost to Follow-up|11|||
23765453|NCT01797120|66521702|FG001|Overall Study|Non-compliance|0|||
23765454|NCT01797120|66521701|FG000|Overall Study|Physician Decision|3|||
23765455|NCT01797120|66521702|FG001|Overall Study|Physician Decision|0|||
23765456|NCT01797120|66521701|FG000|Overall Study|still on treatment|2|||
23765457|NCT01797120|66521702|FG001|Overall Study|still on treatment|4|||
23765458|NCT01797120|66521701|FG000|Overall Study|never start protocol therapy|2|||
23765459|NCT01797120|66521702|FG001|Overall Study|never start protocol therapy|0|||
23765460|NCT02008721|66521703|FG000|Overall Study|Withdrawal by Subject|5|||
23765461|NCT02008721|66521704|FG001|Overall Study|Withdrawal by Subject|1|||
23765462|NCT02008721|66521703|FG000|Overall Study|Death|4|||
23765463|NCT02008721|66521704|FG001|Overall Study|Death|2|||
23765464|NCT02008721|66521703|FG000|Overall Study|Adverse Event|3|||
23765465|NCT02008721|66521704|FG001|Overall Study|Adverse Event|5|||
23765466|NCT02008721|66521703|FG000|Overall Study|Protocol Violation|3|||
23765467|NCT02008721|66521704|FG001|Overall Study|Protocol Violation|2|||
23765468|NCT00441584|66521705|FG000|Overall Study|Lack of Efficacy|79|||
23765469|NCT00441584|66521705|FG000|Overall Study|Withdrawal by Subject|8|||
23765470|NCT00441584|66521705|FG000|Overall Study|Adverse Event|6|||
23765471|NCT00441584|66521705|FG000|Overall Study|Protocol Violation|5|||
23765472|NCT00441584|66521705|FG000|Overall Study|Lost to Follow-up|4|||
23765473|NCT00441584|66521705|FG000|Overall Study|Failure to meet eligibility criteria|3|||
23829117|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
23829118|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
23829119|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
23829120|NCT02001987|66752539|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
23829121|NCT02001987|66752539|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
23765474|NCT01347710|66521712|FG000|Overall Study|Withdrawal by Subject|2|||
23628976|NCT00943722|66028175|FG005|Base Study|Lost to Follow-up|0|||
23765475|NCT01347710|66521712|FG000|Overall Study|Adverse Event|4|||
23765476|NCT01347710|66521712|FG000|Overall Study|Angio or SPECT not completed|18|||
23765477|NCT01347710|66521712|FG000|Overall Study|issue with vitals prior to dosing|1|||
23765478|NCT01347710|66521712|FG000|Overall Study|Lost to Follow-up|1|||
23765479|NCT01347710|66521712|FG000|Overall Study|Physician Decision|2|||
23829122|NCT02001987|66752539|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
23829123|NCT02001987|66752539|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
23765480|NCT01347710|66521712|FG000|Overall Study|Other|3|||
23765481|NCT01280981|66521714|FG000|Overall Study|Withdrawal by Subject|11|||
23765482|NCT01280981|66521714|FG000|Overall Study|Protocol Violation|2|||
23765483|NCT01280981|66521714|FG000|Overall Study|Lack of Efficacy|13|||
23765484|NCT01280981|66521714|FG000|Overall Study|Lost to Follow-up|3|||
23765485|NCT01280981|66521714|FG000|Overall Study|Adverse Event|6|||
23765486|NCT01280981|66521714|FG000|Overall Study|Irregular or discontinued menses|3|||
23765487|NCT01280981|66521714|FG000|Overall Study|Failed to return|45|||
23765488|NCT01280981|66521714|FG000|Overall Study|Non-compliance with protocol|3|||
23765489|NCT01280981|66521714|FG000|Overall Study|Withdrawal of consent|3|||
23765490|NCT01280981|66521714|FG000|Overall Study|Elective surgery|2|||
23765491|NCT01280981|66521714|FG000|Overall Study|Study site closure|1|||
23765492|NCT00969332|66521715|FG000|Overall Study|Physician Decision|8|||
23765493|NCT00969332|66521715|FG000|Overall Study|Withdrawal by Subject|3|||
23765494|NCT02545998|66521724|FG000|Overall Study|Lost to Follow-up|12|||
23765495|NCT02545998|66521725|FG001|Overall Study|Lost to Follow-up|3|||
23765496|NCT02545998|66521724|FG000|Overall Study|Withdrawal by Subject|3|||
23567414|NCT00337662|65807041|FG001|Study Period III|Sponsor Decision|0|||
23567415|NCT00337662|65807042|FG002|Study Period III|Sponsor Decision|1|||
23567416|NCT00337662|65807043|FG003|Study Period III|Sponsor Decision|0|||
23567417|NCT00337662|65807040|FG000|Study Period III|Clinical Relapse|1|||
23567418|NCT00337662|65807041|FG001|Study Period III|Clinical Relapse|0|||
23567419|NCT00337662|65807042|FG002|Study Period III|Clinical Relapse|0|||
23567420|NCT00337662|65807043|FG003|Study Period III|Clinical Relapse|0|||
23567421|NCT00409786|65807044|FG000|Overall Study|Withdrawal by Subject|3|||
23567422|NCT01027364|65807045|FG000|Overall Study|Adverse Event|1|||
23567423|NCT01027364|65807046|FG001|Overall Study|Adverse Event|0|||
23567424|NCT01027364|65807047|FG002|Overall Study|Adverse Event|1|||
23567425|NCT01027364|65807048|FG003|Overall Study|Adverse Event|0|||
23567426|NCT01027364|65807045|FG000|Overall Study|Lost to Follow-up|1|||
23567427|NCT01027364|65807046|FG001|Overall Study|Lost to Follow-up|0|||
23567428|NCT01027364|65807047|FG002|Overall Study|Lost to Follow-up|0|||
23765497|NCT02545998|66521725|FG001|Overall Study|Withdrawal by Subject|2|||
23765498|NCT01464827|66521727|FG000|Overall Study|Adverse Event|0|||
23765499|NCT01464827|66521728|FG001|Overall Study|Adverse Event|0|||
23765500|NCT01464827|66521729|FG002|Overall Study|Adverse Event|0|||
23765501|NCT01464827|66521730|FG003|Overall Study|Adverse Event|0|||
23765502|NCT01464827|66521731|FG004|Overall Study|Adverse Event|0|||
23765503|NCT01464827|66521732|FG005|Overall Study|Adverse Event|0|||
23765504|NCT01464827|66521733|FG006|Overall Study|Adverse Event|0|||
23765505|NCT01464827|66521734|FG007|Overall Study|Adverse Event|0|||
23765506|NCT01464827|66521735|FG008|Overall Study|Adverse Event|0|||
23765507|NCT01464827|66521736|FG009|Overall Study|Adverse Event|0|||
23765508|NCT01464827|66521737|FG010|Overall Study|Adverse Event|0|||
23765509|NCT01464827|66521738|FG011|Overall Study|Adverse Event|0|||
23567429|NCT01027364|65807048|FG003|Overall Study|Lost to Follow-up|0|||
23567430|NCT01027364|65807045|FG000|Overall Study|Protocol Violation|1|||
23567431|NCT01027364|65807046|FG001|Overall Study|Protocol Violation|0|||
23567432|NCT01027364|65807047|FG002|Overall Study|Protocol Violation|0|||
23567433|NCT01027364|65807048|FG003|Overall Study|Protocol Violation|1|||
23567434|NCT01027364|65807045|FG000|Overall Study|Withdrawal by Subject|1|||
23567435|NCT01027364|65807046|FG001|Overall Study|Withdrawal by Subject|2|||
23567436|NCT01027364|65807047|FG002|Overall Study|Withdrawal by Subject|0|||
23567437|NCT01027364|65807048|FG003|Overall Study|Withdrawal by Subject|0|||
23567438|NCT01462162|65807053|FG000|Overall Study|Adverse Event|5|||
23567439|NCT01462162|65807053|FG000|Overall Study|Lack of Efficacy|4|||
23567440|NCT01462162|65807053|FG000|Overall Study|Abnormal laboratory parameters|1|||
23567441|NCT01462162|65807053|FG000|Overall Study|Other|2|||
23628977|NCT00943722|66028176|FG006|Base Study|Lost to Follow-up|0|||
23765510|NCT01464827|66521739|FG012|Overall Study|Adverse Event|1|||
23765511|NCT01464827|66521740|FG013|Overall Study|Adverse Event|0|||
23765512|NCT01464827|66521727|FG000|Overall Study|Withdrawal by Subject|1|||
23567442|NCT00692406|65807054|FG000|Overall Study|PI dropped, bad data|57|||
23567443|NCT04397523|65807057|FG000|Overall Study|Lost to Follow-up|3|||
23567444|NCT04397523|65807057|FG000|Overall Study|Transfer from/to other hospital|8|||
23567445|NCT03151395|65807058|FG000|Overall Study|Adverse Event|2|||
23765513|NCT01464827|66521728|FG001|Overall Study|Withdrawal by Subject|0|||
23765514|NCT01464827|66521729|FG002|Overall Study|Withdrawal by Subject|0|||
23765515|NCT01464827|66521730|FG003|Overall Study|Withdrawal by Subject|0|||
23765516|NCT01464827|66521731|FG004|Overall Study|Withdrawal by Subject|1|||
23567446|NCT03151395|65807058|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
23567447|NCT03151395|65807058|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
23628978|NCT00943722|66028170|FG000|Base Study|Physician Decision|1|||
23765517|NCT01464827|66521732|FG005|Overall Study|Withdrawal by Subject|0|||
23829124|NCT02001987|66752539|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
23829125|NCT02001987|66752539|FG000|LTE Period (52 Weeks)|Other|3|||
23829126|NCT01009814|66752540|FG000|Overall Study|No longer met study criteria|1|||
23829127|NCT01009814|66752541|FG001|Overall Study|No longer met study criteria|1|||
23829128|NCT01009814|66752542|FG002|Overall Study|No longer met study criteria|0|||
23829129|NCT01009814|66752543|FG003|Overall Study|No longer met study criteria|0|||
23829130|NCT01009814|66752544|FG004|Overall Study|No longer met study criteria|0|||
23829131|NCT02152605|66752545|FG000|Overall Study|Adverse Event|6|||
23829132|NCT02152605|66752546|FG001|Overall Study|Adverse Event|8|||
23829133|NCT02152605|66752545|FG000|Overall Study|Lack of Efficacy|7|||
23829134|NCT02152605|66752546|FG001|Overall Study|Lack of Efficacy|4|||
23829135|NCT02152605|66752545|FG000|Overall Study|Protocol deviation|1|||
23829136|NCT02152605|66752546|FG001|Overall Study|Protocol deviation|4|||
23829137|NCT02152605|66752545|FG000|Overall Study|Lost to Follow-up|1|||
23829138|NCT02152605|66752546|FG001|Overall Study|Lost to Follow-up|0|||
23829139|NCT02152605|66752545|FG000|Overall Study|Withdrew consent|4|||
23829140|NCT02152605|66752546|FG001|Overall Study|Withdrew consent|2|||
23829141|NCT00725491|66752547|FG000|Overall Study|Adverse Event|3|||
23829142|NCT00725491|66752548|FG001|Overall Study|Adverse Event|2|||
23829143|NCT00725491|66752547|FG000|Overall Study|Pregnancy|0|||
23829144|NCT00725491|66752548|FG001|Overall Study|Pregnancy|3|||
23829145|NCT00725491|66752547|FG000|Overall Study|Risk for hyperstimulation|2|||
23829146|NCT00725491|66752548|FG001|Overall Study|Risk for hyperstimulation|9|||
23829147|NCT00725491|66752547|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
23829148|NCT00725491|66752548|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
23829149|NCT00725491|66752547|FG000|Overall Study|Fertilization failure|0|||
23829150|NCT00725491|66752548|FG001|Overall Study|Fertilization failure|1|||
23829151|NCT00725491|66752547|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
23829152|NCT00725491|66752548|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
23829153|NCT00182325|66752553|FG000|Overall Study|Lost to Follow-up|7|||
23829154|NCT00182325|66752554|FG001|Overall Study|Lost to Follow-up|7|||
23829155|NCT00182325|66752553|FG000|Overall Study|Miscarriage|5|||
23829156|NCT00182325|66752554|FG001|Overall Study|Miscarriage|3|||
23829157|NCT00182325|66752553|FG000|Overall Study|Did not complete survey|22|||
23829158|NCT00182325|66752554|FG001|Overall Study|Did not complete survey|43|||
23829159|NCT03170544|66752561|FG000|Part 1|Lost to Follow-up|1|||
23829160|NCT03170544|66752562|FG001|Part 1|Lost to Follow-up|0|||
23829161|NCT03170544|66752563|FG002|Part 1|Lost to Follow-up|0|||
23829162|NCT03170544|66752564|FG003|Part 1|Lost to Follow-up|0|||
23567448|NCT03151395|65807058|FG000|Overall Study|Unspecified reason|4|||
23829163|NCT03170544|66752565|FG004|Part 1|Lost to Follow-up|0|||
23829164|NCT03170544|66752566|FG005|Part 1|Lost to Follow-up|0|||
23829165|NCT03170544|66752567|FG006|Part 1|Lost to Follow-up|0|||
23829166|NCT03170544|66752568|FG007|Part 1|Lost to Follow-up|0|||
23829167|NCT03170544|66752569|FG008|Part 1|Lost to Follow-up|0|||
23829168|NCT03170544|66752570|FG009|Part 1|Lost to Follow-up|0|||
23829169|NCT03170544|66752571|FG010|Part 1|Lost to Follow-up|0|||
23829170|NCT03170544|66752572|FG011|Part 1|Lost to Follow-up|0|||
23829171|NCT03170544|66752561|FG000|Part 1|Not treated|0|||
23829172|NCT03170544|66752562|FG001|Part 1|Not treated|0|||
23829173|NCT03170544|66752563|FG002|Part 1|Not treated|0|||
23829174|NCT03170544|66752564|FG003|Part 1|Not treated|1|||
23829175|NCT03170544|66752565|FG004|Part 1|Not treated|0|||
23829176|NCT03170544|66752566|FG005|Part 1|Not treated|0|||
23829177|NCT03170544|66752567|FG006|Part 1|Not treated|0|||
23829178|NCT03170544|66752568|FG007|Part 1|Not treated|0|||
23829179|NCT03170544|66752569|FG008|Part 1|Not treated|0|||
23829180|NCT03170544|66752570|FG009|Part 1|Not treated|0|||
23829181|NCT03170544|66752571|FG010|Part 1|Not treated|0|||
23829182|NCT03170544|66752572|FG011|Part 1|Not treated|0|||
23829183|NCT04753216|66752575|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
23829184|NCT04753216|66752575|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
23829185|NCT04753216|66752575|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
23829186|NCT00967330|66752581|FG000|Overall Study|Protocol Violation|3|||
23829187|NCT00967330|66752582|FG001|Overall Study|Protocol Violation|4|||
23829188|NCT00967330|66752581|FG000|Overall Study|Regular|10|||
23829189|NCT00967330|66752582|FG001|Overall Study|Regular|3|||
23829190|NCT00967330|66752581|FG000|Overall Study|Withdrawal by Subject|6|||
23829191|NCT00967330|66752582|FG001|Overall Study|Withdrawal by Subject|0|||
23829192|NCT00967330|66752581|FG000|Overall Study|Lost to Follow-up|1|||
23829193|NCT00967330|66752582|FG001|Overall Study|Lost to Follow-up|1|||
23829194|NCT00967330|66752581|FG000|Overall Study|Death|102|||
23829195|NCT00967330|66752582|FG001|Overall Study|Death|51|||
23829196|NCT00967330|66752581|FG000|Overall Study|Severe protocol deviation|0|||
23829197|NCT00967330|66752582|FG001|Overall Study|Severe protocol deviation|1|||
23829198|NCT01977417|66752585|FG000|Overall Study|Adverse Event|1|||
23829199|NCT01977417|66752586|FG001|Overall Study|Adverse Event|0|||
23765518|NCT01464827|66521733|FG006|Overall Study|Withdrawal by Subject|0|||
23765519|NCT01464827|66521734|FG007|Overall Study|Withdrawal by Subject|1|||
23765520|NCT01464827|66521735|FG008|Overall Study|Withdrawal by Subject|0|||
23765521|NCT01464827|66521736|FG009|Overall Study|Withdrawal by Subject|0|||
23765522|NCT01464827|66521737|FG010|Overall Study|Withdrawal by Subject|0|||
23765523|NCT01464827|66521738|FG011|Overall Study|Withdrawal by Subject|0|||
23765524|NCT01464827|66521739|FG012|Overall Study|Withdrawal by Subject|0|||
23765525|NCT01464827|66521740|FG013|Overall Study|Withdrawal by Subject|0|||
23765526|NCT01464827|66521727|FG000|Overall Study|Lost to Follow-up|0|||
23765527|NCT01464827|66521728|FG001|Overall Study|Lost to Follow-up|2|||
23765528|NCT01464827|66521729|FG002|Overall Study|Lost to Follow-up|0|||
23765529|NCT01464827|66521730|FG003|Overall Study|Lost to Follow-up|2|||
23765530|NCT01464827|66521731|FG004|Overall Study|Lost to Follow-up|3|||
23765531|NCT01464827|66521732|FG005|Overall Study|Lost to Follow-up|1|||
23765532|NCT01464827|66521733|FG006|Overall Study|Lost to Follow-up|2|||
23765533|NCT01464827|66521734|FG007|Overall Study|Lost to Follow-up|2|||
23765534|NCT01464827|66521735|FG008|Overall Study|Lost to Follow-up|0|||
23765535|NCT01464827|66521736|FG009|Overall Study|Lost to Follow-up|0|||
23765536|NCT01464827|66521737|FG010|Overall Study|Lost to Follow-up|0|||
23765537|NCT01464827|66521738|FG011|Overall Study|Lost to Follow-up|1|||
23765538|NCT01464827|66521739|FG012|Overall Study|Lost to Follow-up|0|||
23765539|NCT01464827|66521740|FG013|Overall Study|Lost to Follow-up|1|||
23765540|NCT01464827|66521727|FG000|Overall Study|Other|2|||
23765541|NCT01464827|66521728|FG001|Overall Study|Other|3|||
23765542|NCT01464827|66521729|FG002|Overall Study|Other|0|||
23765543|NCT01464827|66521730|FG003|Overall Study|Other|2|||
23765544|NCT01464827|66521731|FG004|Overall Study|Other|3|||
23829200|NCT01977417|66752585|FG000|Overall Study|Withdrawal by Subject|2|||
23829201|NCT01977417|66752586|FG001|Overall Study|Withdrawal by Subject|4|||
23829202|NCT01977417|66752585|FG000|Overall Study|Female enrollment goal met|0|||
23829203|NCT01977417|66752586|FG001|Overall Study|Female enrollment goal met|2|||
23829204|NCT01565889|66752589|FG000|Part A|Withdrawal by Subject|1|||
23829205|NCT01565889|66752590|FG001|Part A|Withdrawal by Subject|0|||
23765545|NCT01464827|66521732|FG005|Overall Study|Other|0|||
23765546|NCT01464827|66521733|FG006|Overall Study|Other|1|||
23765547|NCT01464827|66521734|FG007|Overall Study|Other|0|||
23765548|NCT01464827|66521735|FG008|Overall Study|Other|3|||
23765549|NCT01464827|66521736|FG009|Overall Study|Other|1|||
23765550|NCT01464827|66521737|FG010|Overall Study|Other|2|||
23829206|NCT01565889|66752591|FG002|Part A|Withdrawal by Subject|0|||
23829207|NCT01565889|66752592|FG003|Part A|Withdrawal by Subject|0|||
23829208|NCT01565889|66752593|FG004|Part A|Withdrawal by Subject|0|||
23829209|NCT01565889|66752594|FG005|Part A|Withdrawal by Subject|0|||
23829210|NCT01565889|66752589|FG000|Part B|Withdrawal by Subject|0|||
23829211|NCT01565889|66752590|FG001|Part B|Withdrawal by Subject|0|||
23829212|NCT01565889|66752591|FG002|Part B|Withdrawal by Subject|0|||
23567449|NCT00383240|65807061|FG000|Overall Study|Adverse Event|4|||
23567450|NCT00383240|65807062|FG001|Overall Study|Adverse Event|6|||
23567451|NCT00383240|65807063|FG002|Overall Study|Adverse Event|9|||
23567452|NCT00383240|65807064|FG003|Overall Study|Adverse Event|7|||
23829213|NCT01565889|66752592|FG003|Part B|Withdrawal by Subject|0|||
23567453|NCT00383240|65807061|FG000|Overall Study|Treatment Failure|8|||
23567454|NCT00383240|65807062|FG001|Overall Study|Treatment Failure|13|||
23567455|NCT00383240|65807063|FG002|Overall Study|Treatment Failure|47|||
23567456|NCT00383240|65807064|FG003|Overall Study|Treatment Failure|46|||
23567457|NCT00383240|65807061|FG000|Overall Study|Lost to Follow-up|3|||
23567458|NCT00383240|65807062|FG001|Overall Study|Lost to Follow-up|0|||
23567459|NCT00383240|65807063|FG002|Overall Study|Lost to Follow-up|0|||
23567460|NCT00383240|65807064|FG003|Overall Study|Lost to Follow-up|2|||
23567461|NCT00383240|65807061|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
23567462|NCT00383240|65807062|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
23567463|NCT00383240|65807063|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
23567464|NCT00383240|65807064|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
23567465|NCT00383240|65807061|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
23567466|NCT00383240|65807062|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
23567467|NCT00383240|65807063|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
23567468|NCT00383240|65807064|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
23765551|NCT01464827|66521738|FG011|Overall Study|Other|0|||
23765552|NCT01464827|66521739|FG012|Overall Study|Other|1|||
23765553|NCT01464827|66521740|FG013|Overall Study|Other|0|||
23765554|NCT01464827|66521727|FG000|Overall Study|Not Treated|0|||
23765555|NCT01464827|66521728|FG001|Overall Study|Not Treated|2|||
23765556|NCT01464827|66521729|FG002|Overall Study|Not Treated|0|||
23765557|NCT01464827|66521730|FG003|Overall Study|Not Treated|0|||
23765558|NCT01464827|66521731|FG004|Overall Study|Not Treated|1|||
23765559|NCT01464827|66521732|FG005|Overall Study|Not Treated|0|||
23765560|NCT01464827|66521733|FG006|Overall Study|Not Treated|1|||
23765561|NCT01464827|66521734|FG007|Overall Study|Not Treated|0|||
23765562|NCT01464827|66521735|FG008|Overall Study|Not Treated|0|||
23567469|NCT00383240|65807061|FG000|Overall Study|Protocol Violation|4|||
23567470|NCT00383240|65807062|FG001|Overall Study|Protocol Violation|5|||
23567471|NCT00383240|65807063|FG002|Overall Study|Protocol Violation|9|||
23567472|NCT00383240|65807064|FG003|Overall Study|Protocol Violation|6|||
23567473|NCT00383240|65807061|FG000|Overall Study|Did not meet protocol eligibility|9|||
23567474|NCT00383240|65807062|FG001|Overall Study|Did not meet protocol eligibility|4|||
23567475|NCT00383240|65807063|FG002|Overall Study|Did not meet protocol eligibility|9|||
23567476|NCT00383240|65807064|FG003|Overall Study|Did not meet protocol eligibility|3|||
23567477|NCT00383240|65807061|FG000|Overall Study|Administrative|1|||
23567478|NCT00383240|65807062|FG001|Overall Study|Administrative|1|||
23567479|NCT00383240|65807063|FG002|Overall Study|Administrative|0|||
23765563|NCT01464827|66521736|FG009|Overall Study|Not Treated|2|||
23765564|NCT01464827|66521737|FG010|Overall Study|Not Treated|0|||
23765565|NCT01464827|66521738|FG011|Overall Study|Not Treated|1|||
23765566|NCT01464827|66521739|FG012|Overall Study|Not Treated|0|||
23765567|NCT01464827|66521740|FG013|Overall Study|Not Treated|2|||
23765568|NCT01844583|66521741|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
23765569|NCT01844583|66521742|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
23765570|NCT00906347|66521743|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
23765571|NCT00906347|66521744|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
23765572|NCT00906347|66521743|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
23765573|NCT00906347|66521744|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
23765574|NCT00906347|66521743|FG000|Received Study Drug|Refused study drug|1|||
23765575|NCT00906347|66521744|FG001|Received Study Drug|Refused study drug|0|||
23765576|NCT00906347|66521743|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
23765577|NCT00906347|66521744|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
23765578|NCT02322879|66521745|FG000|First Intervention|Physician Decision|1|||
23765579|NCT02322879|66521746|FG001|First Intervention|Physician Decision|0|||
23765580|NCT01709383|66521747|FG000|Overall Study|Lost to Follow-up|1|||
23829214|NCT01565889|66752593|FG004|Part B|Withdrawal by Subject|0|||
23829215|NCT01565889|66752594|FG005|Part B|Withdrawal by Subject|1|||
23829216|NCT01565889|66752589|FG000|Part B|Lack of Efficacy|0|||
23829217|NCT01565889|66752590|FG001|Part B|Lack of Efficacy|0|||
23829218|NCT01565889|66752591|FG002|Part B|Lack of Efficacy|0|||
23567480|NCT00383240|65807064|FG003|Overall Study|Administrative|0|||
23567481|NCT01777321|65807065|FG000|Overall Study|Withdrawal by Subject|0|||
23567482|NCT01777321|65807066|FG001|Overall Study|Withdrawal by Subject|1|||
23567483|NCT02998021|65807067|FG000|Overall Study|Withdrawal by Subject|3|||
23765581|NCT01709383|66521748|FG001|Overall Study|Lost to Follow-up|0|||
23765582|NCT02739984|66521753|FG000|Overall Study|Sponsor Decision|1|||
23765583|NCT02739984|66521754|FG001|Overall Study|Sponsor Decision|0|||
23765584|NCT02739984|66521753|FG000|Overall Study|Withdrawal by Subject|1|||
23567484|NCT02998021|65807068|FG001|Overall Study|Withdrawal by Subject|1|||
23829219|NCT01565889|66752592|FG003|Part B|Lack of Efficacy|0|||
23829220|NCT01565889|66752593|FG004|Part B|Lack of Efficacy|0|||
23765585|NCT02739984|66521754|FG001|Overall Study|Withdrawal by Subject|1|||
23765586|NCT02739984|66521753|FG000|Overall Study|Death|0|||
23765587|NCT02739984|66521754|FG001|Overall Study|Death|1|||
23765588|NCT02739984|66521753|FG000|Overall Study|Lost to Follow-up|3|||
23765589|NCT02739984|66521754|FG001|Overall Study|Lost to Follow-up|0|||
23765590|NCT03305055|66521755|FG000|Overall Study|Withdrawal by Subject|0|||
23765591|NCT03305055|66521756|FG001|Overall Study|Withdrawal by Subject|1|||
23765592|NCT03305055|66521755|FG000|Overall Study|Adverse Event|1|||
23765593|NCT03305055|66521756|FG001|Overall Study|Adverse Event|1|||
23765594|NCT02577354|66521759|FG000|Overall Study|Lack of Efficacy|4|||
23765595|NCT02577354|66521760|FG001|Overall Study|Lack of Efficacy|4|||
23765596|NCT02577354|66521759|FG000|Overall Study|Lost to Follow-up|3|||
23765597|NCT02577354|66521760|FG001|Overall Study|Lost to Follow-up|1|||
23765598|NCT02577354|66521759|FG000|Overall Study|Missed Visit|4|||
23765599|NCT02577354|66521760|FG001|Overall Study|Missed Visit|3|||
23765600|NCT02577354|66521759|FG000|Overall Study|Adverse Event|4|||
23567485|NCT02998021|65807067|FG000|Overall Study|unsafe home|0|||
23567486|NCT02998021|65807068|FG001|Overall Study|unsafe home|1|||
23567487|NCT02086162|65807072|FG000|Overall Study|Withdrawal by Subject|4|||
23567488|NCT02086162|65807073|FG001|Overall Study|Withdrawal by Subject|4|||
23567489|NCT02086162|65807072|FG000|Overall Study|moved|1|||
23567490|NCT02086162|65807073|FG001|Overall Study|moved|1|||
23567491|NCT02086162|65807072|FG000|Overall Study|Lost to Follow-up|4|||
23567492|NCT02086162|65807073|FG001|Overall Study|Lost to Follow-up|2|||
23567493|NCT02086162|65807072|FG000|Overall Study|Death|1|||
23567494|NCT02086162|65807073|FG001|Overall Study|Death|0|||
23628979|NCT00943722|66028171|FG001|Base Study|Physician Decision|0|||
23628980|NCT00943722|66028172|FG002|Base Study|Physician Decision|0|||
23628981|NCT00943722|66028173|FG003|Base Study|Physician Decision|0|||
23628982|NCT00943722|66028174|FG004|Base Study|Physician Decision|1|||
23628983|NCT00943722|66028175|FG005|Base Study|Physician Decision|0|||
23765601|NCT02577354|66521760|FG001|Overall Study|Adverse Event|5|||
23765602|NCT01894984|66521761|FG000|Overall Study|Other|314|||
23765603|NCT01894984|66521762|FG001|Overall Study|Other|175|||
23765604|NCT01393990|66521768|FG000|Overall Study|Adverse Event|0|||
23765605|NCT01393990|66521769|FG001|Overall Study|Adverse Event|0|||
23765606|NCT01393990|66521770|FG002|Overall Study|Adverse Event|0|||
23765607|NCT01393990|66521771|FG003|Overall Study|Adverse Event|0|||
23765608|NCT01393990|66521772|FG004|Overall Study|Adverse Event|0|||
23765609|NCT01393990|66521773|FG005|Overall Study|Adverse Event|0|||
23765610|NCT01393990|66521774|FG006|Overall Study|Adverse Event|0|||
23765611|NCT01393990|66521775|FG007|Overall Study|Adverse Event|0|||
23765612|NCT01393990|66521776|FG008|Overall Study|Adverse Event|0|||
23765613|NCT01393990|66521777|FG009|Overall Study|Adverse Event|0|||
23765614|NCT01393990|66521778|FG010|Overall Study|Adverse Event|0|||
23765615|NCT01393990|66521779|FG011|Overall Study|Adverse Event|0|||
23765616|NCT01393990|66521780|FG012|Overall Study|Adverse Event|0|||
23567495|NCT00114634|65807074|FG000|Overall Study|failure to return forms|3|||
23567496|NCT02058290|65807078|FG000|Overall Study|Protocol Violation|2|||
23567497|NCT02058290|65807079|FG001|Overall Study|Protocol Violation|1|||
23567498|NCT02058290|65807078|FG000|Overall Study|Physician Decision|1|||
23628984|NCT00943722|66028176|FG006|Base Study|Physician Decision|0|||
23628985|NCT00943722|66028170|FG000|Base Study|Pregnancy|0|||
23628986|NCT00943722|66028171|FG001|Base Study|Pregnancy|0|||
23628987|NCT00943722|66028172|FG002|Base Study|Pregnancy|1|||
23628988|NCT00943722|66028173|FG003|Base Study|Pregnancy|0|||
23628989|NCT00943722|66028174|FG004|Base Study|Pregnancy|2|||
23628990|NCT00943722|66028175|FG005|Base Study|Pregnancy|0|||
23628991|NCT00943722|66028176|FG006|Base Study|Pregnancy|0|||
23628992|NCT00943722|66028170|FG000|Base Study|Protocol Violation|0|||
23628993|NCT00943722|66028171|FG001|Base Study|Protocol Violation|1|||
23628994|NCT00943722|66028172|FG002|Base Study|Protocol Violation|0|||
23628995|NCT00943722|66028173|FG003|Base Study|Protocol Violation|0|||
23628996|NCT00943722|66028174|FG004|Base Study|Protocol Violation|2|||
23628997|NCT00943722|66028175|FG005|Base Study|Protocol Violation|0|||
23628998|NCT00943722|66028176|FG006|Base Study|Protocol Violation|0|||
23628999|NCT00943722|66028170|FG000|Base Study|Withdrawal by Subject|12|||
23629000|NCT00943722|66028171|FG001|Base Study|Withdrawal by Subject|13|||
23765617|NCT01393990|66521781|FG013|Overall Study|Adverse Event|0|||
23765618|NCT01393990|66521782|FG014|Overall Study|Adverse Event|1|||
23765619|NCT01393990|66521783|FG015|Overall Study|Adverse Event|1|||
23765620|NCT01393990|66521784|FG016|Overall Study|Adverse Event|0|||
23765621|NCT01393990|66521785|FG017|Overall Study|Adverse Event|0|||
23629001|NCT00943722|66028172|FG002|Base Study|Withdrawal by Subject|2|||
23629002|NCT00943722|66028173|FG003|Base Study|Withdrawal by Subject|13|||
23765622|NCT01393990|66521768|FG000|Overall Study|Progressive Disease|1|||
23765623|NCT01393990|66521769|FG001|Overall Study|Progressive Disease|0|||
23629003|NCT00943722|66028174|FG004|Base Study|Withdrawal by Subject|8|||
23629004|NCT00943722|66028175|FG005|Base Study|Withdrawal by Subject|0|||
23629005|NCT00943722|66028176|FG006|Base Study|Withdrawal by Subject|0|||
23765624|NCT01393990|66521770|FG002|Overall Study|Progressive Disease|0|||
23765625|NCT01393990|66521771|FG003|Overall Study|Progressive Disease|1|||
23765626|NCT01393990|66521772|FG004|Overall Study|Progressive Disease|1|||
23765627|NCT01393990|66521773|FG005|Overall Study|Progressive Disease|1|||
23765628|NCT01393990|66521774|FG006|Overall Study|Progressive Disease|1|||
23765629|NCT01393990|66521775|FG007|Overall Study|Progressive Disease|1|||
23765630|NCT01393990|66521776|FG008|Overall Study|Progressive Disease|3|||
23765631|NCT01393990|66521777|FG009|Overall Study|Progressive Disease|1|||
23765632|NCT01393990|66521778|FG010|Overall Study|Progressive Disease|0|||
23765633|NCT01393990|66521779|FG011|Overall Study|Progressive Disease|0|||
23765634|NCT01393990|66521780|FG012|Overall Study|Progressive Disease|0|||
23765635|NCT01393990|66521781|FG013|Overall Study|Progressive Disease|1|||
23765636|NCT01393990|66521782|FG014|Overall Study|Progressive Disease|6|||
23765637|NCT01393990|66521783|FG015|Overall Study|Progressive Disease|1|||
23765638|NCT01393990|66521784|FG016|Overall Study|Progressive Disease|0|||
23765639|NCT01393990|66521785|FG017|Overall Study|Progressive Disease|0|||
23765640|NCT01393990|66521768|FG000|Overall Study|Death|0|||
23765641|NCT01393990|66521769|FG001|Overall Study|Death|0|||
23765642|NCT01393990|66521770|FG002|Overall Study|Death|0|||
23765643|NCT01393990|66521771|FG003|Overall Study|Death|0|||
23765644|NCT01393990|66521772|FG004|Overall Study|Death|1|||
23765645|NCT01393990|66521773|FG005|Overall Study|Death|0|||
23765646|NCT01393990|66521774|FG006|Overall Study|Death|0|||
23765647|NCT01393990|66521775|FG007|Overall Study|Death|0|||
23829221|NCT01565889|66752594|FG005|Part B|Lack of Efficacy|2|||
23829222|NCT01565889|66752589|FG000|Part B|Lost to Follow-up|0|||
23829223|NCT01565889|66752590|FG001|Part B|Lost to Follow-up|0|||
23445017|NCT03712787|65370244|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23567499|NCT02058290|65807079|FG001|Overall Study|Physician Decision|0|||
23567500|NCT02058290|65807078|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
23567501|NCT02058290|65807079|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
23567502|NCT02058290|65807078|FG000|Overall Study|Withdrawal by Subject|0|||
23567503|NCT02058290|65807079|FG001|Overall Study|Withdrawal by Subject|1|||
23567504|NCT03734991|65807082|FG000|Overall Study|Adverse Event|4|||
23567505|NCT03734991|65807083|FG001|Overall Study|Adverse Event|0|||
23567506|NCT03734991|65807082|FG000|Overall Study|Lost to Follow-up|4|||
23567507|NCT03734991|65807083|FG001|Overall Study|Lost to Follow-up|0|||
23567508|NCT03734991|65807082|FG000|Overall Study|Physician Decision|0|||
23567509|NCT03734991|65807083|FG001|Overall Study|Physician Decision|1|||
23567510|NCT03734991|65807082|FG000|Overall Study|Pregnancy|1|||
23567511|NCT03734991|65807083|FG001|Overall Study|Pregnancy|0|||
23629006|NCT00943722|66028170|FG000|Base Study|Month 12 visit not completed|0|||
23629007|NCT00943722|66028171|FG001|Base Study|Month 12 visit not completed|0|||
23629008|NCT00943722|66028172|FG002|Base Study|Month 12 visit not completed|0|||
23629009|NCT00943722|66028173|FG003|Base Study|Month 12 visit not completed|0|||
23629010|NCT00943722|66028174|FG004|Base Study|Month 12 visit not completed|2|||
23567512|NCT03734991|65807082|FG000|Overall Study|Withdrawal by Subject|6|||
23567513|NCT03734991|65807083|FG001|Overall Study|Withdrawal by Subject|3|||
23629011|NCT00943722|66028175|FG005|Base Study|Month 12 visit not completed|0|||
23629012|NCT00943722|66028176|FG006|Base Study|Month 12 visit not completed|0|||
23629013|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Adverse Event|0|||
23629014|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Adverse Event|0|||
23629015|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Adverse Event|0|||
23629016|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Adverse Event|0|||
23629017|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Adverse Event|0|||
23629018|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Adverse Event|1|||
23629019|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Adverse Event|0|||
23629020|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629021|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629022|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629023|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629024|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629025|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
23629026|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
23629027|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23629028|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23567514|NCT03734991|65807082|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
23629029|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23765648|NCT01393990|66521776|FG008|Overall Study|Death|0|||
23765649|NCT01393990|66521777|FG009|Overall Study|Death|0|||
23765650|NCT01393990|66521778|FG010|Overall Study|Death|0|||
23765651|NCT01393990|66521779|FG011|Overall Study|Death|0|||
23765652|NCT01393990|66521780|FG012|Overall Study|Death|0|||
23567515|NCT03734991|65807083|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
23765653|NCT01393990|66521781|FG013|Overall Study|Death|1|||
23629030|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23765654|NCT01393990|66521782|FG014|Overall Study|Death|1|||
23765655|NCT01393990|66521783|FG015|Overall Study|Death|0|||
23765656|NCT01393990|66521784|FG016|Overall Study|Death|0|||
23829224|NCT01565889|66752591|FG002|Part B|Lost to Follow-up|0|||
23765657|NCT01393990|66521785|FG017|Overall Study|Death|0|||
23765658|NCT01393990|66521768|FG000|Overall Study|Withdrawal by Subject|0|||
23765659|NCT01393990|66521769|FG001|Overall Study|Withdrawal by Subject|0|||
23765660|NCT01393990|66521770|FG002|Overall Study|Withdrawal by Subject|0|||
23765661|NCT01393990|66521771|FG003|Overall Study|Withdrawal by Subject|0|||
23765662|NCT01393990|66521772|FG004|Overall Study|Withdrawal by Subject|0|||
23765663|NCT01393990|66521773|FG005|Overall Study|Withdrawal by Subject|0|||
23765664|NCT01393990|66521774|FG006|Overall Study|Withdrawal by Subject|0|||
23765665|NCT01393990|66521775|FG007|Overall Study|Withdrawal by Subject|0|||
23765666|NCT01393990|66521776|FG008|Overall Study|Withdrawal by Subject|0|||
23765667|NCT01393990|66521777|FG009|Overall Study|Withdrawal by Subject|0|||
23765668|NCT01393990|66521778|FG010|Overall Study|Withdrawal by Subject|0|||
23765669|NCT01393990|66521779|FG011|Overall Study|Withdrawal by Subject|0|||
23765670|NCT01393990|66521780|FG012|Overall Study|Withdrawal by Subject|0|||
23765671|NCT01393990|66521781|FG013|Overall Study|Withdrawal by Subject|0|||
23765672|NCT01393990|66521782|FG014|Overall Study|Withdrawal by Subject|1|||
23765673|NCT01393990|66521783|FG015|Overall Study|Withdrawal by Subject|1|||
23765674|NCT01393990|66521784|FG016|Overall Study|Withdrawal by Subject|0|||
23765675|NCT01393990|66521785|FG017|Overall Study|Withdrawal by Subject|0|||
23765676|NCT00124020|66521786|FG000|Overall Study|Death|67|||
23765677|NCT00124020|66521787|FG001|Overall Study|Death|71|||
23765678|NCT00124020|66521786|FG000|Overall Study|Withdrawal by Subject|13|||
23765679|NCT00124020|66521787|FG001|Overall Study|Withdrawal by Subject|11|||
23765680|NCT00124020|66521786|FG000|Overall Study|Lost to Follow-up|5|||
23765681|NCT00124020|66521787|FG001|Overall Study|Lost to Follow-up|8|||
23765682|NCT00124020|66521786|FG000|Overall Study|Other|1|||
23765683|NCT00124020|66521787|FG001|Overall Study|Other|1|||
23765684|NCT00124020|66521786|FG000|Overall Study|Transfer to another hospital|2|||
23765685|NCT00124020|66521787|FG001|Overall Study|Transfer to another hospital|0|||
23765686|NCT00903383|66521788|FG000|Overall Study|Adverse Event|1|||
23765687|NCT00903383|66521789|FG001|Overall Study|Adverse Event|2|||
23765688|NCT00903383|66521790|FG002|Overall Study|Adverse Event|3|||
23765689|NCT00903383|66521791|FG003|Overall Study|Adverse Event|1|||
23765690|NCT00903383|66521788|FG000|Overall Study|Physician Decision|1|||
23765691|NCT00903383|66521789|FG001|Overall Study|Physician Decision|2|||
23765692|NCT00903383|66521790|FG002|Overall Study|Physician Decision|0|||
23765693|NCT00903383|66521791|FG003|Overall Study|Physician Decision|0|||
23765694|NCT00903383|66521788|FG000|Overall Study|Lost to Follow-up|0|||
23765695|NCT00903383|66521789|FG001|Overall Study|Lost to Follow-up|0|||
23765696|NCT00903383|66521790|FG002|Overall Study|Lost to Follow-up|0|||
23765697|NCT00903383|66521791|FG003|Overall Study|Lost to Follow-up|1|||
23765698|NCT00903383|66521788|FG000|Overall Study|Decision of Sponsor|1|||
23765699|NCT00903383|66521789|FG001|Overall Study|Decision of Sponsor|0|||
23765700|NCT00903383|66521790|FG002|Overall Study|Decision of Sponsor|0|||
23765701|NCT00903383|66521791|FG003|Overall Study|Decision of Sponsor|0|||
23765702|NCT00903383|66521788|FG000|Overall Study|Withdrawal by Subject|4|||
23765703|NCT00903383|66521789|FG001|Overall Study|Withdrawal by Subject|1|||
23765704|NCT00903383|66521790|FG002|Overall Study|Withdrawal by Subject|0|||
23765705|NCT00903383|66521791|FG003|Overall Study|Withdrawal by Subject|2|||
23765706|NCT00903383|66521788|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
23765707|NCT00903383|66521789|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
23765708|NCT00903383|66521790|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
23765709|NCT00903383|66521791|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
23765710|NCT00903383|66521788|FG000|Overall Study|Patient Decision|0|||
23765711|NCT00903383|66521789|FG001|Overall Study|Patient Decision|0|||
23765712|NCT00903383|66521790|FG002|Overall Study|Patient Decision|0|||
23765713|NCT00903383|66521791|FG003|Overall Study|Patient Decision|1|||
23765714|NCT00419926|66521792|FG000|Overall Study|Withdrawal by Subject|7|||
23765715|NCT00419926|66521793|FG001|Overall Study|Withdrawal by Subject|3|||
23765716|NCT00419926|66521792|FG000|Overall Study|Administrative Problem|4|||
23765717|NCT00419926|66521793|FG001|Overall Study|Administrative Problem|4|||
23765718|NCT00419926|66521792|FG000|Overall Study|Lost to Follow-up|1|||
23765719|NCT00419926|66521793|FG001|Overall Study|Lost to Follow-up|2|||
23765720|NCT00419926|66521792|FG000|Overall Study|Death|2|||
23765721|NCT00419926|66521793|FG001|Overall Study|Death|1|||
23765722|NCT03937466|66521794|FG000|Overall Study|not eligbile after the 2-week diary|9|||
23765723|NCT03937466|66521794|FG000|Overall Study|never returned their diary|6|||
23765724|NCT03937466|66521794|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
23765725|NCT03937466|66521794|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
23765726|NCT02497781|66521795|FG000|Overall Study|Withdrawal by Subject|2|||
23765727|NCT02497781|66521796|FG001|Overall Study|Withdrawal by Subject|0|||
23765728|NCT02497781|66521795|FG000|Overall Study|Lack of Efficacy|0|||
23765729|NCT02497781|66521796|FG001|Overall Study|Lack of Efficacy|1|||
23765730|NCT02497781|66521795|FG000|Overall Study|Randomised but not treated|1|||
23765731|NCT02497781|66521796|FG001|Overall Study|Randomised but not treated|1|||
23765732|NCT02497781|66521795|FG000|Overall Study|Lost to Follow-up|1|||
23765733|NCT02497781|66521796|FG001|Overall Study|Lost to Follow-up|1|||
23765734|NCT02038634|66521797|FG000|Overall Study|Lost to Follow-up|0|||
23765735|NCT02038634|66521798|FG001|Overall Study|Lost to Follow-up|1|||
23765736|NCT05216978|66521799|FG000|Overall Study|Withdrawal by Subject|3|||
23765737|NCT05216978|66521799|FG000|Overall Study|Lost to Follow-up|5|||
23765738|NCT05188521|66521800|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
23765739|NCT05188521|66521801|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
23765740|NCT01339910|66521802|FG000|Overall Study|Withdrawal by Subject|1|||
23765741|NCT01339910|66521803|FG001|Overall Study|Withdrawal by Subject|0|||
23765742|NCT01339910|66521802|FG000|Overall Study|Physician Decision|1|||
23765743|NCT01339910|66521803|FG001|Overall Study|Physician Decision|0|||
23765744|NCT01339910|66521802|FG000|Overall Study|Disease relapse|1|||
23765745|NCT01339910|66521803|FG001|Overall Study|Disease relapse|4|||
23765746|NCT02736227|66521804|FG000|Overall Study|Withdrawal by Subject|0|||
23765747|NCT02736227|66521805|FG001|Overall Study|Withdrawal by Subject|0|||
23765748|NCT02736227|66521806|FG002|Overall Study|Withdrawal by Subject|1|||
23765749|NCT02736227|66521804|FG000|Overall Study|Physician Decision|0|||
23765750|NCT02736227|66521805|FG001|Overall Study|Physician Decision|0|||
23765751|NCT02736227|66521806|FG002|Overall Study|Physician Decision|5|||
23765752|NCT02736227|66521804|FG000|Overall Study|Non Compliant|0|||
23765753|NCT02736227|66521805|FG001|Overall Study|Non Compliant|0|||
23765754|NCT02736227|66521806|FG002|Overall Study|Non Compliant|2|||
23765755|NCT00704418|66521809|FG000|Overall Study|Withdrawal by Subject|2|||
23765756|NCT00704418|66521810|FG001|Overall Study|Withdrawal by Subject|0|||
23765757|NCT00704418|66521809|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
23765758|NCT00704418|66521810|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
23765759|NCT03982433|66521811|FG000|Overall Study|Lost to Follow-up|1|||
23765760|NCT00264810|66521817|FG000|Baseline|Withdrawal by Subject|10|||
23765761|NCT00264810|66521818|FG001|Baseline|Withdrawal by Subject|10|||
23765762|NCT00264810|66521817|FG000|Baseline|Physician Decision|7|||
23765763|NCT00264810|66521818|FG001|Baseline|Physician Decision|8|||
23765764|NCT00264810|66521817|FG000|Baseline|Subject Compliance Failure|3|||
23765765|NCT00264810|66521818|FG001|Baseline|Subject Compliance Failure|3|||
23765766|NCT00264810|66521817|FG000|Baseline|Insufficient Seizure Frequency|2|||
23765767|NCT00264810|66521818|FG001|Baseline|Insufficient Seizure Frequency|2|||
23765768|NCT00264810|66521817|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
23765769|NCT00264810|66521818|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
23765770|NCT00264810|66521817|FG000|Baseline|Other|0|||
23765771|NCT00264810|66521818|FG001|Baseline|Other|1|||
23765772|NCT00264810|66521817|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
23765773|NCT00264810|66521818|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
23765774|NCT00264810|66521817|FG000|Stimulation Optimization Period|Death|0|||
23765775|NCT00264810|66521818|FG001|Stimulation Optimization Period|Death|1|||
23765776|NCT00264810|66521817|FG000|Blinded Evaluation Period|Explant due to infection|1|||
23445018|NCT03712787|65370245|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23629031|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23629032|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
23629033|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
23629034|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
23629035|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
23629036|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
23629037|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
23629038|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
23629039|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
23765777|NCT00264810|66521818|FG001|Blinded Evaluation Period|Explant due to infection|1|||
23765778|NCT00264810|66521817|FG000|Open Label Evaluation Period|Explant due to infection|1|||
23765779|NCT00264810|66521818|FG001|Open Label Evaluation Period|Explant due to infection|1|||
23765780|NCT00264810|66521817|FG000|Open Label Evaluation Period|Death|3|||
23765781|NCT00264810|66521818|FG001|Open Label Evaluation Period|Death|2|||
23765782|NCT00264810|66521817|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
23765783|NCT00264810|66521818|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
23567516|NCT03734991|65807082|FG000|Overall Study|Other|2|||
23567517|NCT03734991|65807083|FG001|Overall Study|Other|2|||
23567518|NCT01834222|65807085|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
23567519|NCT01062763|65807086|FG000|Overall Study|Adverse Event|3|||
23567520|NCT01062763|65807087|FG001|Overall Study|Adverse Event|4|||
23567521|NCT00390455|65807094|FG000|Overall Study|Adverse Event|17|||
23567522|NCT00390455|65807095|FG001|Overall Study|Adverse Event|3|||
23567523|NCT00390455|65807094|FG000|Overall Study|Withdrawal by Subject|8|||
23567524|NCT00390455|65807095|FG001|Overall Study|Withdrawal by Subject|8|||
23567525|NCT00390455|65807094|FG000|Overall Study|Alternate Treatment|0|||
23567526|NCT00390455|65807095|FG001|Overall Study|Alternate Treatment|1|||
23567527|NCT00390455|65807094|FG000|Overall Study|Other Medical Reasons|7|||
23567528|NCT00390455|65807095|FG001|Overall Study|Other Medical Reasons|11|||
23567529|NCT01913639|65807099|FG000|Overall Study|Not Eligible|3|||
23567530|NCT00284141|65807100|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
23765784|NCT01090765|66521819|FG000|Overall Study|Patient withdrew consent|0|||
23765785|NCT01090765|66521820|FG001|Overall Study|Patient withdrew consent|0|||
23765786|NCT01090765|66521821|FG002|Overall Study|Patient withdrew consent|0|||
23765787|NCT01090765|66521822|FG003|Overall Study|Patient withdrew consent|0|||
23765788|NCT01090765|66521823|FG004|Overall Study|Patient withdrew consent|1|||
23765789|NCT01090765|66521824|FG005|Overall Study|Patient withdrew consent|1|||
23765790|NCT01090765|66521819|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
23765791|NCT01090765|66521820|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
23765792|NCT01090765|66521821|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
23765793|NCT01090765|66521822|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
23765794|NCT01090765|66521823|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
23765795|NCT01090765|66521824|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
23765796|NCT01090765|66521819|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
23765797|NCT01090765|66521820|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
23765798|NCT01090765|66521821|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
23765799|NCT01090765|66521822|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
23765800|NCT01090765|66521823|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
23765801|NCT01090765|66521824|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
23765802|NCT01628120|66521825|FG000|Overall Study|Withdrawal by Subject|7|||
23765803|NCT01628120|66521825|FG000|Overall Study|Adverse Event|12|||
23765804|NCT01628120|66521825|FG000|Overall Study|Lost to Follow-up|1|||
23765805|NCT01628120|66521825|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
23765806|NCT01628120|66521825|FG000|Overall Study|Non-compliant with Study Procedures|1|||
23765807|NCT01628120|66521825|FG000|Overall Study|Not Treated|3|||
23765808|NCT01628120|66521825|FG000|Overall Study|Sponsor Decision|5|||
23765809|NCT01628120|66521825|FG000|Overall Study|Switched Dialysis Method|2|||
23765810|NCT01628120|66521825|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
23765811|NCT01628120|66521825|FG000|Overall Study|Moved or Relocated|5|||
23765812|NCT01628120|66521825|FG000|Overall Study|Kidney Transplant|2|||
23765813|NCT01628120|66521825|FG000|Overall Study|Use of Standard of Care|1|||
23765814|NCT01725113|66521828|FG000|Overall Study|Kidney Transplant|1|||
23765815|NCT01725113|66521829|FG001|Overall Study|Kidney Transplant|1|||
23765816|NCT01725113|66521828|FG000|Overall Study|Withdrawal by Subject|0|||
23765817|NCT01725113|66521829|FG001|Overall Study|Withdrawal by Subject|1|||
23765818|NCT00278200|66521830|FG000|Overall Study|Death|1|||
23765819|NCT00278200|66521831|FG001|Overall Study|Death|3|||
23765820|NCT00278200|66521830|FG000|Overall Study|Physician Decision|0|||
23765821|NCT00278200|66521831|FG001|Overall Study|Physician Decision|1|||
23765822|NCT01118728|66521833|FG000|Overall Study|Adverse Event|17|||
23765823|NCT01118728|66521833|FG000|Overall Study|Lack of Efficacy|27|||
23765824|NCT01118728|66521833|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
23765825|NCT01118728|66521833|FG000|Overall Study|Withdrawal by Subject|3|||
23765826|NCT01118728|66521833|FG000|Overall Study|Lost to Follow-up|4|||
23765827|NCT00952484|66521834|FG000|Overall Study|Withdrawal by Subject|0|||
23765828|NCT00952484|66521835|FG001|Overall Study|Withdrawal by Subject|1|||
23765829|NCT00952484|66521836|FG002|Overall Study|Withdrawal by Subject|0|||
23765830|NCT03850509|66521837|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
23765831|NCT03850509|66521838|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
23765832|NCT02614703|66521844|FG000|Overall Study|Withdrawal by Subject|7|||
23765833|NCT02614703|66521845|FG001|Overall Study|Withdrawal by Subject|1|||
23765834|NCT02473510|66521846|FG000|Overall Study|Lost to Follow-up|1|||
23765835|NCT02473510|66521847|FG001|Overall Study|Lost to Follow-up|2|||
23765836|NCT00829413|66521850|FG000|Overall Study|No study drug admimnistered|13|||
23765837|NCT00829413|66521850|FG000|Overall Study|Training Patients|67|||
23765838|NCT00829413|66521850|FG000|Overall Study|No truth standard procedure available|9|||
23765839|NCT00829413|66521850|FG000|Overall Study|Technically inadequate truth standard|2|||
23765840|NCT00829413|66521850|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
23765841|NCT01564758|66521851|FG000|Overall Study|Death|8|||
23765842|NCT01564758|66521851|FG000|Overall Study|Adverse Event|3|||
23765843|NCT01564758|66521851|FG000|Overall Study|Other|3|||
23765844|NCT02231710|66521854|FG000|Overall Study|Physician Decision|1|||
23765845|NCT01078623|66521859|FG000|Treatment Period 1|Adverse Event|1|||
23765846|NCT01078623|66521860|FG001|Treatment Period 1|Adverse Event|1|||
23765847|NCT01078623|66521861|FG002|Treatment Period 1|Adverse Event|1|||
23829225|NCT01565889|66752592|FG003|Part B|Lost to Follow-up|0|||
23765848|NCT01078623|66521862|FG003|Treatment Period 1|Adverse Event|0|||
23829226|NCT01565889|66752593|FG004|Part B|Lost to Follow-up|0|||
23829227|NCT01565889|66752594|FG005|Part B|Lost to Follow-up|1|||
23765849|NCT01078623|66521863|FG004|Treatment Period 1|Adverse Event|0|||
23765850|NCT01078623|66521864|FG005|Treatment Period 1|Adverse Event|0|||
23765851|NCT01078623|66521865|FG006|Treatment Period 1|Adverse Event|1|||
23829228|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
23765852|NCT01078623|66521866|FG007|Treatment Period 1|Adverse Event|0|||
23765853|NCT01078623|66521867|FG008|Treatment Period 1|Adverse Event|1|||
23829229|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
23445019|NCT03712787|65370246|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23445020|NCT03712787|65370247|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
23445021|NCT03712787|65370244|FG000|Overall Study|COVID-19 Infection|0|||
23445022|NCT03712787|65370245|FG001|Overall Study|COVID-19 Infection|1|||
23445023|NCT03712787|65370246|FG002|Overall Study|COVID-19 Infection|0|||
23445024|NCT03712787|65370247|FG003|Overall Study|COVID-19 Infection|0|||
23445025|NCT03712787|65370244|FG000|Overall Study|Other, Not Specified|79|||
23445026|NCT03712787|65370245|FG001|Overall Study|Other, Not Specified|77|||
23445027|NCT03712787|65370246|FG002|Overall Study|Other, Not Specified|74|||
23445028|NCT03712787|65370247|FG003|Overall Study|Other, Not Specified|78|||
23445029|NCT02291419|65370252|FG000|Overall Study|Early study termination|1|||
23445030|NCT02291419|65370253|FG001|Overall Study|Early study termination|5|||
23445031|NCT01959139|65370254|FG000|Phase II|Disease progression|0|||
23445032|NCT01959139|65370255|FG001|Phase II|Disease progression|0|||
23445033|NCT01959139|65370256|FG002|Phase II|Disease progression|26|||
23445034|NCT01959139|65370257|FG003|Phase II|Disease progression|34|||
23445035|NCT01959139|65370254|FG000|Phase II|Adverse Event|0|||
23445036|NCT01959139|65370255|FG001|Phase II|Adverse Event|0|||
23445037|NCT01959139|65370256|FG002|Phase II|Adverse Event|10|||
23445038|NCT01959139|65370257|FG003|Phase II|Adverse Event|11|||
23445039|NCT01959139|65370254|FG000|Phase II|Patient Refusal|0|||
23445040|NCT01959139|65370255|FG001|Phase II|Patient Refusal|0|||
23445041|NCT01959139|65370256|FG002|Phase II|Patient Refusal|5|||
23445042|NCT01959139|65370257|FG003|Phase II|Patient Refusal|4|||
23445043|NCT01959139|65370254|FG000|Phase II|Death|0|||
23445044|NCT01959139|65370255|FG001|Phase II|Death|0|||
23445045|NCT01959139|65370256|FG002|Phase II|Death|3|||
23445046|NCT01959139|65370257|FG003|Phase II|Death|1|||
23445047|NCT01959139|65370254|FG000|Phase II|Other/Unknown|0|||
23445048|NCT01959139|65370255|FG001|Phase II|Other/Unknown|0|||
23445049|NCT01959139|65370256|FG002|Phase II|Other/Unknown|8|||
23445050|NCT01959139|65370257|FG003|Phase II|Other/Unknown|5|||
23445051|NCT01959139|65370254|FG000|Phase II|On treatment|0|||
23445052|NCT01959139|65370255|FG001|Phase II|On treatment|0|||
23445053|NCT01959139|65370256|FG002|Phase II|On treatment|4|||
23445054|NCT01959139|65370257|FG003|Phase II|On treatment|0|||
23445055|NCT01919229|65370258|FG000|Overall Study|Subject/guardian decision|0|||
23445056|NCT01919229|65370259|FG001|Overall Study|Subject/guardian decision|0|||
23445057|NCT01919229|65370260|FG002|Overall Study|Subject/guardian decision|1|||
23445058|NCT00536471|65370266|FG000|Overall Study|Lost to Follow-up|48|||
23445059|NCT00536471|65370267|FG001|Overall Study|Lost to Follow-up|23|||
23445060|NCT00536471|65370268|FG002|Overall Study|Lost to Follow-up|48|||
23445061|NCT00536471|65370269|FG003|Overall Study|Lost to Follow-up|22|||
23445062|NCT00536471|65370266|FG000|Overall Study|Adverse Event|32|||
23445063|NCT00536471|65370267|FG001|Overall Study|Adverse Event|16|||
23445064|NCT00536471|65370268|FG002|Overall Study|Adverse Event|28|||
23829230|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
23445065|NCT00536471|65370269|FG003|Overall Study|Adverse Event|13|||
23445066|NCT00536471|65370266|FG000|Overall Study|Withdrawal by Subject|40|||
23445067|NCT00536471|65370267|FG001|Overall Study|Withdrawal by Subject|24|||
23445068|NCT00536471|65370268|FG002|Overall Study|Withdrawal by Subject|43|||
23445069|NCT00536471|65370269|FG003|Overall Study|Withdrawal by Subject|21|||
23629040|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
23629041|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
23629042|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
23629043|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
23629044|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
23629045|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
23629046|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
23629047|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
23629048|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23445070|NCT00536471|65370266|FG000|Overall Study|Lack of Efficacy|17|||
23445071|NCT00536471|65370267|FG001|Overall Study|Lack of Efficacy|18|||
23445072|NCT00536471|65370268|FG002|Overall Study|Lack of Efficacy|11|||
23445073|NCT00536471|65370269|FG003|Overall Study|Lack of Efficacy|9|||
23629049|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23629050|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23445074|NCT00536471|65370266|FG000|Overall Study|Protocol Violation|8|||
23445075|NCT00536471|65370267|FG001|Overall Study|Protocol Violation|1|||
23445076|NCT00536471|65370268|FG002|Overall Study|Protocol Violation|2|||
23445077|NCT00536471|65370269|FG003|Overall Study|Protocol Violation|3|||
23445078|NCT00536471|65370266|FG000|Overall Study|Physician Decision|11|||
23445079|NCT00536471|65370267|FG001|Overall Study|Physician Decision|1|||
23445080|NCT00536471|65370268|FG002|Overall Study|Physician Decision|3|||
23445081|NCT00536471|65370269|FG003|Overall Study|Physician Decision|2|||
23445082|NCT00536471|65370266|FG000|Overall Study|Death|0|||
23445083|NCT00536471|65370267|FG001|Overall Study|Death|0|||
23445084|NCT00536471|65370268|FG002|Overall Study|Death|1|||
23445085|NCT00536471|65370269|FG003|Overall Study|Death|2|||
23445086|NCT00536471|65370266|FG000|Overall Study|Sponsor Decision|0|||
23445087|NCT00536471|65370267|FG001|Overall Study|Sponsor Decision|1|||
23445088|NCT00536471|65370268|FG002|Overall Study|Sponsor Decision|3|||
23445089|NCT00536471|65370269|FG003|Overall Study|Sponsor Decision|2|||
23445090|NCT02735343|65370270|FG000|Overall Study|screen fail|0|||
23445091|NCT02735343|65370271|FG001|Overall Study|screen fail|2|||
23445092|NCT02045095|65370279|FG000|Overall Study|Other|0|||
23445093|NCT02045095|65370280|FG001|Overall Study|Other|0|||
23445094|NCT02045095|65370281|FG002|Overall Study|Other|1|||
23445095|NCT02045095|65370282|FG003|Overall Study|Other|0|||
23445096|NCT02045095|65370283|FG004|Overall Study|Other|0|||
23445097|NCT02045095|65370284|FG005|Overall Study|Other|2|||
23445098|NCT02045095|65370285|FG006|Overall Study|Other|0|||
23445099|NCT02045095|65370279|FG000|Overall Study|Progressive Disease|3|||
23445100|NCT02045095|65370280|FG001|Overall Study|Progressive Disease|3|||
23445101|NCT02045095|65370281|FG002|Overall Study|Progressive Disease|2|||
23445102|NCT02045095|65370282|FG003|Overall Study|Progressive Disease|4|||
23445103|NCT02045095|65370283|FG004|Overall Study|Progressive Disease|2|||
23445104|NCT02045095|65370284|FG005|Overall Study|Progressive Disease|4|||
23445105|NCT02045095|65370285|FG006|Overall Study|Progressive Disease|1|||
23445106|NCT02045095|65370279|FG000|Overall Study|Withdrawal by Subject|0|||
23445107|NCT02045095|65370280|FG001|Overall Study|Withdrawal by Subject|0|||
23445108|NCT02045095|65370281|FG002|Overall Study|Withdrawal by Subject|0|||
23445109|NCT02045095|65370282|FG003|Overall Study|Withdrawal by Subject|0|||
23445110|NCT02045095|65370283|FG004|Overall Study|Withdrawal by Subject|3|||
23445111|NCT02045095|65370284|FG005|Overall Study|Withdrawal by Subject|0|||
23445112|NCT02045095|65370285|FG006|Overall Study|Withdrawal by Subject|0|||
23445113|NCT02045095|65370279|FG000|Overall Study|Adverse Event|0|||
23445114|NCT02045095|65370280|FG001|Overall Study|Adverse Event|1|||
23445115|NCT02045095|65370281|FG002|Overall Study|Adverse Event|1|||
23445116|NCT02045095|65370282|FG003|Overall Study|Adverse Event|0|||
23445117|NCT02045095|65370283|FG004|Overall Study|Adverse Event|0|||
23445118|NCT02045095|65370284|FG005|Overall Study|Adverse Event|2|||
23445119|NCT02045095|65370285|FG006|Overall Study|Adverse Event|0|||
23445120|NCT01156714|65370286|FG000|Overall Study|Withdrawal by Subject|9|||
23445121|NCT01156714|65370287|FG001|Overall Study|Withdrawal by Subject|4|||
23445122|NCT01156714|65370288|FG002|Overall Study|Withdrawal by Subject|3|||
23445123|NCT01008943|65370295|FG000|Overall Study|Withdrawal by Subject|1|||
23445124|NCT04862065|65370296|FG000|Screening|Protocol Violation|54|||
23445125|NCT04862065|65370297|FG001|Screening|Protocol Violation|0|||
23445126|NCT04862065|65370298|FG002|Screening|Protocol Violation|0|||
23445127|NCT04862065|65370296|FG000|Screening|Insufficient Sample|1|||
23445128|NCT04862065|65370297|FG001|Screening|Insufficient Sample|0|||
23445129|NCT04862065|65370298|FG002|Screening|Insufficient Sample|0|||
23445130|NCT04862065|65370296|FG000|Follow-Up|Lost to Follow-up|3|||
23445131|NCT04862065|65370297|FG001|Follow-Up|Lost to Follow-up|0|||
23445132|NCT04862065|65370298|FG002|Follow-Up|Lost to Follow-up|0|||
23445133|NCT02292719|65370299|FG000|Overall Study|Withdrawal by Subject|0|||
23445134|NCT02292719|65370300|FG001|Overall Study|Withdrawal by Subject|0|||
23445135|NCT02292719|65370301|FG002|Overall Study|Withdrawal by Subject|0|||
23445136|NCT02292719|65370302|FG003|Overall Study|Withdrawal by Subject|1|||
23445137|NCT02292719|65370303|FG004|Overall Study|Withdrawal by Subject|1|||
23445138|NCT02292719|65370304|FG005|Overall Study|Withdrawal by Subject|0|||
23445139|NCT02292719|65370299|FG000|Overall Study|Subject enrolled in new study.|0|||
23445140|NCT02292719|65370300|FG001|Overall Study|Subject enrolled in new study.|0|||
23445141|NCT02292719|65370301|FG002|Overall Study|Subject enrolled in new study.|1|||
23445142|NCT02292719|65370302|FG003|Overall Study|Subject enrolled in new study.|0|||
23445143|NCT02292719|65370303|FG004|Overall Study|Subject enrolled in new study.|0|||
23445144|NCT02292719|65370304|FG005|Overall Study|Subject enrolled in new study.|0|||
23629051|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23629052|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23765854|NCT01078623|66521868|FG009|Treatment Period 1|Adverse Event|1|||
23829231|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
23829232|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Pregnancy|0|||
23829233|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Pregnancy|1|||
23829234|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
23829235|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
23445145|NCT02640547|65370307|FG000|Overall Study|Failure to Return|1|||
23445146|NCT02640547|65370307|FG000|Overall Study|Withdrawal by Subject|1|||
23445147|NCT02640547|65370307|FG000|Overall Study|Death|6|||
23445148|NCT02640547|65370307|FG000|Overall Study|Miscellaneous|3|||
23445149|NCT01787461|65370308|FG000|Overall Study|Adverse Event|4|||
23445150|NCT01787461|65370309|FG001|Overall Study|Adverse Event|3|||
23445151|NCT01787461|65370308|FG000|Overall Study|Lost to Follow-up|3|||
23445152|NCT01787461|65370309|FG001|Overall Study|Lost to Follow-up|2|||
23445153|NCT01787461|65370308|FG000|Overall Study|No longer met eligibility criteria|1|||
23445154|NCT01787461|65370309|FG001|Overall Study|No longer met eligibility criteria|0|||
23445155|NCT01787461|65370308|FG000|Overall Study|Withdrawal by Subject|3|||
23445156|NCT01787461|65370309|FG001|Overall Study|Withdrawal by Subject|4|||
23829236|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
23829237|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
23829238|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
23829239|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
23829240|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Other|3|||
23829241|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Other|0|||
23829242|NCT01006122|66752595|FG000|First Double-blind Intervention Period|Adverse Event|0|||
23445157|NCT01787461|65370308|FG000|Overall Study|Protocol Violation|3|||
23445158|NCT01787461|65370309|FG001|Overall Study|Protocol Violation|0|||
23445159|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
23445160|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445161|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445162|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445163|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445164|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445165|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
23445166|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445167|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445168|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445169|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445170|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445171|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
23445172|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445173|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445174|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445175|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445176|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445177|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
23445178|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445179|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445180|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445181|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445182|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445183|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
23445184|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445185|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445186|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445187|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445188|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445189|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
23445190|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445191|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445192|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445193|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445194|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445195|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23445196|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
23445197|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
23445198|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
23445199|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
23445200|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
23453638|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
23765855|NCT01078623|66521869|FG010|Treatment Period 1|Adverse Event|0|||
23765856|NCT01078623|66521870|FG011|Treatment Period 1|Adverse Event|0|||
23765857|NCT01078623|66521871|FG012|Treatment Period 1|Adverse Event|0|||
23765858|NCT01078623|66521872|FG013|Treatment Period 1|Adverse Event|0|||
23765859|NCT01078623|66521873|FG014|Treatment Period 1|Adverse Event|0|||
23765860|NCT01078623|66521874|FG015|Treatment Period 1|Adverse Event|0|||
23765861|NCT01078623|66521875|FG016|Treatment Period 1|Adverse Event|0|||
23765862|NCT01078623|66521876|FG017|Treatment Period 1|Adverse Event|0|||
23765863|NCT01078623|66521877|FG018|Treatment Period 1|Adverse Event|0|||
23765864|NCT01078623|66521878|FG019|Treatment Period 1|Adverse Event|0|||
23765865|NCT01078623|66521859|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23765866|NCT01078623|66521860|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23765867|NCT01078623|66521861|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23765868|NCT01078623|66521862|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23765869|NCT01078623|66521863|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23765870|NCT01078623|66521864|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23765871|NCT01078623|66521865|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23765872|NCT01078623|66521866|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23765873|NCT01078623|66521867|FG008|Treatment Period 1|Withdrawal by Subject|0|||
23445201|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23445202|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23445203|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23445204|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23445205|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23445206|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23445207|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23445208|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
23445209|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
23445210|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23445211|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
23629053|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
23765874|NCT01078623|66521868|FG009|Treatment Period 1|Withdrawal by Subject|0|||
23765875|NCT01078623|66521869|FG010|Treatment Period 1|Withdrawal by Subject|1|||
23765876|NCT01078623|66521870|FG011|Treatment Period 1|Withdrawal by Subject|0|||
23445212|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
23445213|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23445214|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23445215|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23445216|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23445217|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
23445218|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23445219|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23445220|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
23445221|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
23445222|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
23445223|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23445224|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
23445225|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23445226|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
23445227|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23445228|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23445229|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23445230|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23445231|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23445232|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445233|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
23445234|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445235|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445236|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
23567531|NCT00284141|65807100|FG000|Overall Study|Adverse Event|19|||
23567532|NCT00284141|65807100|FG000|Overall Study|Participant's request|9|||
23567533|NCT00284141|65807100|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
23567534|NCT00284141|65807100|FG000|Overall Study|Clinical deterioration / death|2|||
23567535|NCT00284141|65807100|FG000|Overall Study|General decline|1|||
23567536|NCT00284141|65807100|FG000|Overall Study|Pneumonia|1|||
23567537|NCT00284141|65807100|FG000|Overall Study|Did not take study medication|2|||
23567538|NCT00284141|65807100|FG000|Overall Study|Ongoing treatment|2|||
23567539|NCT03556358|65807101|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
23765877|NCT01078623|66521871|FG012|Treatment Period 1|Withdrawal by Subject|0|||
23765878|NCT01078623|66521872|FG013|Treatment Period 1|Withdrawal by Subject|0|||
23765879|NCT01078623|66521873|FG014|Treatment Period 1|Withdrawal by Subject|0|||
23765880|NCT01078623|66521874|FG015|Treatment Period 1|Withdrawal by Subject|0|||
23765881|NCT01078623|66521875|FG016|Treatment Period 1|Withdrawal by Subject|0|||
23765882|NCT01078623|66521876|FG017|Treatment Period 1|Withdrawal by Subject|0|||
23445237|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23445238|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
23445239|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23445240|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23445241|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
23445242|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23445243|NCT00193206|65370316|FG000|Preoperative Therapy|Lack of Efficacy|2|||
23445244|NCT00193206|65370316|FG000|Preoperative Therapy|Adverse Event|2|||
23445245|NCT00193206|65370316|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
23445246|NCT00193206|65370316|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
23445247|NCT00193206|65370316|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
23445248|NCT00193206|65370316|FG000|Postoperative Therapy|Physician Decision|3|||
23445249|NCT00193206|65370316|FG000|Postoperative Therapy|Intercurrent Illness|2|||
23445250|NCT00193206|65370316|FG000|Postoperative Therapy|Lack of Efficacy|1|||
23445251|NCT00193206|65370316|FG000|Postoperative Therapy|Protocol Violation|1|||
23445252|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Death|0|||
23445253|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Death|0|||
23445254|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Death|0|||
23445255|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Death|0|||
23445256|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Death|1|||
23445257|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Death|0|||
23445258|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Death|0|||
23445259|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Death|0|||
23445260|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
23445261|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
23445262|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
23445263|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
23445264|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
23445265|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
23445266|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
23445267|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
23445268|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
23445269|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445270|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445271|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
23445272|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445273|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
23445274|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445275|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445276|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
23445277|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
23445278|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
23445279|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
23445280|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
23445281|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
23445282|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
23445283|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
23445284|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
23445285|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445286|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445287|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
23445288|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
23445289|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445290|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
23445291|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
23445292|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
23445293|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445294|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445295|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
23445296|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
23445297|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
23445298|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445299|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445300|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
23629054|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
23629055|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
23629056|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
23445301|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445302|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445303|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445304|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445305|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445306|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445307|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445308|NCT00726232|65370317|FG000|Expansion Phase|Death|0|||
23445309|NCT00726232|65370318|FG001|Expansion Phase|Death|0|||
23445310|NCT00726232|65370319|FG002|Expansion Phase|Death|0|||
23445311|NCT00726232|65370320|FG003|Expansion Phase|Death|0|||
23445312|NCT00726232|65370321|FG004|Expansion Phase|Death|0|||
23445313|NCT00726232|65370322|FG005|Expansion Phase|Death|0|||
23445314|NCT00726232|65370323|FG006|Expansion Phase|Death|0|||
23445315|NCT00726232|65370324|FG007|Expansion Phase|Death|1|||
23445316|NCT00726232|65370317|FG000|Expansion Phase|Adverse Event|0|||
23445317|NCT00726232|65370318|FG001|Expansion Phase|Adverse Event|0|||
23445318|NCT00726232|65370319|FG002|Expansion Phase|Adverse Event|0|||
23445319|NCT00726232|65370320|FG003|Expansion Phase|Adverse Event|0|||
23445320|NCT00726232|65370321|FG004|Expansion Phase|Adverse Event|0|||
23445321|NCT00726232|65370322|FG005|Expansion Phase|Adverse Event|0|||
23445322|NCT00726232|65370323|FG006|Expansion Phase|Adverse Event|6|||
23445323|NCT00726232|65370324|FG007|Expansion Phase|Adverse Event|11|||
23445324|NCT00726232|65370317|FG000|Expansion Phase|Withdrawal by Subject|0|||
23445325|NCT00726232|65370318|FG001|Expansion Phase|Withdrawal by Subject|0|||
23445326|NCT00726232|65370319|FG002|Expansion Phase|Withdrawal by Subject|0|||
23445327|NCT00726232|65370320|FG003|Expansion Phase|Withdrawal by Subject|0|||
23445328|NCT00726232|65370321|FG004|Expansion Phase|Withdrawal by Subject|0|||
23445329|NCT00726232|65370322|FG005|Expansion Phase|Withdrawal by Subject|0|||
23445330|NCT00726232|65370323|FG006|Expansion Phase|Withdrawal by Subject|2|||
23445331|NCT00726232|65370324|FG007|Expansion Phase|Withdrawal by Subject|3|||
23445332|NCT00726232|65370317|FG000|Expansion Phase|Disease progression|0|||
23445333|NCT00726232|65370318|FG001|Expansion Phase|Disease progression|0|||
23445334|NCT00726232|65370319|FG002|Expansion Phase|Disease progression|0|||
23445335|NCT00726232|65370320|FG003|Expansion Phase|Disease progression|0|||
23445336|NCT00726232|65370321|FG004|Expansion Phase|Disease progression|0|||
23445337|NCT00726232|65370322|FG005|Expansion Phase|Disease progression|0|||
23445338|NCT00726232|65370323|FG006|Expansion Phase|Disease progression|4|||
23445339|NCT00726232|65370324|FG007|Expansion Phase|Disease progression|0|||
23445340|NCT00726232|65370317|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
23445341|NCT00726232|65370318|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
23445342|NCT00726232|65370319|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
23445343|NCT00726232|65370320|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
23445344|NCT00726232|65370321|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
23445345|NCT00726232|65370322|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
23445346|NCT00726232|65370323|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
23445347|NCT00726232|65370324|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
23445348|NCT00726232|65370317|FG000|Expansion Phase|Per Investigator: lack of response|0|||
23445349|NCT00726232|65370318|FG001|Expansion Phase|Per Investigator: lack of response|0|||
23445350|NCT00726232|65370319|FG002|Expansion Phase|Per Investigator: lack of response|0|||
23445351|NCT00726232|65370320|FG003|Expansion Phase|Per Investigator: lack of response|0|||
23445352|NCT00726232|65370321|FG004|Expansion Phase|Per Investigator: lack of response|0|||
23445353|NCT00726232|65370322|FG005|Expansion Phase|Per Investigator: lack of response|0|||
23445354|NCT00726232|65370323|FG006|Expansion Phase|Per Investigator: lack of response|1|||
23445355|NCT00726232|65370324|FG007|Expansion Phase|Per Investigator: lack of response|7|||
23445356|NCT00726232|65370317|FG000|Expansion Phase|Unspecified reason|0|||
23445357|NCT00726232|65370318|FG001|Expansion Phase|Unspecified reason|0|||
23445358|NCT00726232|65370319|FG002|Expansion Phase|Unspecified reason|0|||
23445359|NCT00726232|65370320|FG003|Expansion Phase|Unspecified reason|0|||
23445360|NCT00726232|65370321|FG004|Expansion Phase|Unspecified reason|0|||
23445361|NCT00726232|65370322|FG005|Expansion Phase|Unspecified reason|0|||
23445362|NCT00726232|65370323|FG006|Expansion Phase|Unspecified reason|1|||
23445363|NCT00726232|65370324|FG007|Expansion Phase|Unspecified reason|0|||
23445364|NCT03755882|65370325|FG000|Period 1|Protocol Violation|1|||
23445365|NCT03755882|65370326|FG001|Period 1|Protocol Violation|0|||
23445366|NCT03755882|65370325|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
23445367|NCT03755882|65370326|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
23445368|NCT01922271|65370327|FG000|WASHOUT Period|Withdrawal by Subject|1|||
23445369|NCT01922271|65370328|FG001|WASHOUT Period|Withdrawal by Subject|0|||
23445370|NCT00930553|65370334|FG000|Overall Study|Adverse Event|1|||
23445371|NCT00930553|65370334|FG000|Overall Study|Lack of Efficacy|7|||
23445372|NCT00930553|65370334|FG000|Overall Study|Physician Decision|39|||
23445373|NCT00930553|65370334|FG000|Overall Study|Protocol Violation|1|||
23445374|NCT00930553|65370334|FG000|Overall Study|Pregnancy|1|||
23445375|NCT00930553|65370334|FG000|Overall Study|Withdrawal by Subject|88|||
23445376|NCT00930553|65370334|FG000|Overall Study|Lost to Follow-up|25|||
23445377|NCT00930553|65370334|FG000|Overall Study|Death|9|||
23445378|NCT00930553|65370334|FG000|Overall Study|Study terminated by sponsor|24|||
23445379|NCT00930553|65370334|FG000|Overall Study|Other than specified above|28|||
23445380|NCT02128724|65370335|FG000|Overall Study|Death|1|||
23445381|NCT02128724|65370336|FG001|Overall Study|Death|0|||
23445382|NCT02128724|65370337|FG002|Overall Study|Death|0|||
23445383|NCT02128724|65370338|FG003|Overall Study|Death|0|||
23445384|NCT02128724|65370335|FG000|Overall Study|Adverse Event|0|||
23445385|NCT02128724|65370336|FG001|Overall Study|Adverse Event|1|||
23445386|NCT02128724|65370337|FG002|Overall Study|Adverse Event|0|||
23445387|NCT02128724|65370338|FG003|Overall Study|Adverse Event|0|||
23445388|NCT02128724|65370335|FG000|Overall Study|Physician Decision|0|||
23445389|NCT02128724|65370336|FG001|Overall Study|Physician Decision|0|||
23445390|NCT02128724|65370337|FG002|Overall Study|Physician Decision|0|||
23445391|NCT02128724|65370338|FG003|Overall Study|Physician Decision|2|||
23445392|NCT02128724|65370335|FG000|Overall Study|Withdrawal by Subject|0|||
23445393|NCT02128724|65370336|FG001|Overall Study|Withdrawal by Subject|0|||
23445394|NCT02128724|65370337|FG002|Overall Study|Withdrawal by Subject|0|||
23445395|NCT02128724|65370338|FG003|Overall Study|Withdrawal by Subject|1|||
23445396|NCT00699608|65370339|FG000|First Intervention|Withdrawal by Subject|0|||
23445397|NCT00699608|65370340|FG001|First Intervention|Withdrawal by Subject|0|||
23445398|NCT00699608|65370341|FG002|First Intervention|Withdrawal by Subject|1|||
23445399|NCT00699608|65370342|FG003|First Intervention|Withdrawal by Subject|0|||
23445400|NCT00699608|65370343|FG004|First Intervention|Withdrawal by Subject|0|||
23445401|NCT00699608|65370344|FG005|First Intervention|Withdrawal by Subject|0|||
23445402|NCT00699608|65370339|FG000|First Intervention|Protocol Violation|0|||
23445403|NCT00699608|65370340|FG001|First Intervention|Protocol Violation|0|||
23445404|NCT00699608|65370341|FG002|First Intervention|Protocol Violation|0|||
23445405|NCT00699608|65370342|FG003|First Intervention|Protocol Violation|0|||
23445406|NCT00699608|65370343|FG004|First Intervention|Protocol Violation|1|||
23445407|NCT00699608|65370344|FG005|First Intervention|Protocol Violation|0|||
23445408|NCT00699608|65370339|FG000|Second Intervention|Adverse Event|0|||
23445409|NCT00699608|65370340|FG001|Second Intervention|Adverse Event|0|||
23445410|NCT00699608|65370341|FG002|Second Intervention|Adverse Event|1|||
23445411|NCT00699608|65370342|FG003|Second Intervention|Adverse Event|0|||
23445412|NCT00699608|65370343|FG004|Second Intervention|Adverse Event|0|||
23445413|NCT00699608|65370344|FG005|Second Intervention|Adverse Event|0|||
23445414|NCT00699608|65370339|FG000|Second Intervention|Withdrawal by Subject|0|||
23629057|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
23629058|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
23629059|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
23629060|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
23629061|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
23445415|NCT00699608|65370340|FG001|Second Intervention|Withdrawal by Subject|0|||
23629062|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
23629063|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
23629064|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
23629065|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
23629066|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
23629067|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
23629068|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
23629069|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629070|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629071|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629072|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629073|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629074|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
23629075|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
23629076|NCT01443923|66028177|FG000|Overall Study|Adverse Event|1|||
23629077|NCT01443923|66028178|FG001|Overall Study|Adverse Event|0|||
23629078|NCT00263211|66028179|FG000|Overall Study|Death|1|||
23629079|NCT00263211|66028180|FG001|Overall Study|Death|0|||
23629080|NCT00263211|66028179|FG000|Overall Study|Withdrawal by Subject|3|||
23629081|NCT00263211|66028180|FG001|Overall Study|Withdrawal by Subject|0|||
23629082|NCT00263211|66028179|FG000|Overall Study|Protocol Violation|1|||
23629083|NCT00263211|66028180|FG001|Overall Study|Protocol Violation|0|||
23445416|NCT00699608|65370341|FG002|Second Intervention|Withdrawal by Subject|0|||
23445417|NCT00699608|65370342|FG003|Second Intervention|Withdrawal by Subject|1|||
23445418|NCT00699608|65370343|FG004|Second Intervention|Withdrawal by Subject|0|||
23445419|NCT00699608|65370344|FG005|Second Intervention|Withdrawal by Subject|0|||
23445420|NCT02391363|65370345|FG000|Overall Study|Lost to Follow-up|5|||
23629084|NCT00263211|66028179|FG000|Overall Study|Disease Progression|0|||
23629085|NCT00263211|66028180|FG001|Overall Study|Disease Progression|1|||
23629086|NCT04936685|66028181|FG000|Overall Study|Protocol Violation|1|||
23629087|NCT04936685|66028182|FG001|Overall Study|Protocol Violation|0|||
23765883|NCT01078623|66521877|FG018|Treatment Period 1|Withdrawal by Subject|0|||
23765884|NCT01078623|66521878|FG019|Treatment Period 1|Withdrawal by Subject|0|||
23765885|NCT01078623|66521859|FG000|Treatment Period 1|Protocol Violation|0|||
23765886|NCT01078623|66521860|FG001|Treatment Period 1|Protocol Violation|0|||
23765887|NCT01078623|66521861|FG002|Treatment Period 1|Protocol Violation|0|||
23765888|NCT01078623|66521862|FG003|Treatment Period 1|Protocol Violation|0|||
23765889|NCT01078623|66521863|FG004|Treatment Period 1|Protocol Violation|0|||
23765890|NCT01078623|66521864|FG005|Treatment Period 1|Protocol Violation|1|||
23765891|NCT01078623|66521865|FG006|Treatment Period 1|Protocol Violation|0|||
23765892|NCT01078623|66521866|FG007|Treatment Period 1|Protocol Violation|0|||
23765893|NCT01078623|66521867|FG008|Treatment Period 1|Protocol Violation|0|||
23765894|NCT01078623|66521868|FG009|Treatment Period 1|Protocol Violation|0|||
23765895|NCT01078623|66521869|FG010|Treatment Period 1|Protocol Violation|0|||
23765896|NCT01078623|66521870|FG011|Treatment Period 1|Protocol Violation|0|||
23765897|NCT01078623|66521871|FG012|Treatment Period 1|Protocol Violation|0|||
23765898|NCT01078623|66521872|FG013|Treatment Period 1|Protocol Violation|0|||
23445421|NCT02391363|65370346|FG001|Overall Study|Lost to Follow-up|5|||
23445422|NCT02391363|65370345|FG000|Overall Study|Withdrawal by Subject|6|||
23445423|NCT02391363|65370346|FG001|Overall Study|Withdrawal by Subject|3|||
23445424|NCT03018691|65370347|FG000|Overall Study|Adverse Event|1|||
23445425|NCT03018691|65370348|FG001|Overall Study|Adverse Event|1|||
23445426|NCT03018691|65370349|FG002|Overall Study|Adverse Event|4|||
23445427|NCT03018691|65370347|FG000|Overall Study|Lack of Efficacy|0|||
23445428|NCT03018691|65370348|FG001|Overall Study|Lack of Efficacy|0|||
23445429|NCT03018691|65370349|FG002|Overall Study|Lack of Efficacy|1|||
23445430|NCT03018691|65370347|FG000|Overall Study|Withdrawal by Subject|0|||
23445431|NCT03018691|65370348|FG001|Overall Study|Withdrawal by Subject|0|||
23445432|NCT03018691|65370349|FG002|Overall Study|Withdrawal by Subject|1|||
23445433|NCT03018691|65370347|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23445434|NCT03018691|65370348|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23445435|NCT03018691|65370349|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23445436|NCT00786799|65370351|FG000|Overall Study|Lost to Follow-up|1|||
23445437|NCT00786799|65370352|FG001|Overall Study|Lost to Follow-up|1|||
23445438|NCT03089580|65370353|FG000|Overall Study|Lost to Follow-up|2|||
23445439|NCT03354273|65370356|FG000|Overall Study|Adverse Event|5|||
23445440|NCT03354273|65370356|FG000|Overall Study|Screen Failure|21|||
23445441|NCT03354273|65370356|FG000|Overall Study|Withdrawal by Subject|34|||
23445442|NCT03354273|65370356|FG000|Overall Study|Technical Problems|30|||
23445443|NCT03354273|65370356|FG000|Overall Study|Lost to Follow-up|4|||
23445444|NCT03354273|65370356|FG000|Overall Study|Investigator Decision|3|||
23445445|NCT03354273|65370356|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
23445446|NCT03354273|65370356|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
23445447|NCT03354273|65370356|FG000|Overall Study|COVID-19 Restrictions|9|||
23445448|NCT03354273|65370356|FG000|Overall Study|Other|5|||
23445449|NCT03495102|65370357|FG000|Overall Study|Adverse Event|5|||
23445450|NCT03495102|65370358|FG001|Overall Study|Adverse Event|7|||
23445451|NCT03495102|65370359|FG002|Overall Study|Adverse Event|10|||
23445452|NCT03495102|65370357|FG000|Overall Study|Death|3|||
23445453|NCT03495102|65370358|FG001|Overall Study|Death|4|||
23445454|NCT03495102|65370359|FG002|Overall Study|Death|4|||
23445455|NCT03495102|65370357|FG000|Overall Study|Lost to Follow-up|15|||
23445456|NCT03495102|65370358|FG001|Overall Study|Lost to Follow-up|16|||
23445457|NCT03495102|65370359|FG002|Overall Study|Lost to Follow-up|17|||
23445458|NCT03495102|65370357|FG000|Overall Study|Physician Decision|2|||
23445459|NCT03495102|65370358|FG001|Overall Study|Physician Decision|0|||
23445460|NCT03495102|65370359|FG002|Overall Study|Physician Decision|2|||
23445461|NCT03495102|65370357|FG000|Overall Study|Withdrawal by Subject|25|||
23445462|NCT03495102|65370358|FG001|Overall Study|Withdrawal by Subject|36|||
23445463|NCT03495102|65370359|FG002|Overall Study|Withdrawal by Subject|18|||
23445464|NCT03495102|65370357|FG000|Overall Study|Protocol Violation|1|||
23445465|NCT03495102|65370358|FG001|Overall Study|Protocol Violation|1|||
23445466|NCT03495102|65370359|FG002|Overall Study|Protocol Violation|0|||
23445467|NCT03495102|65370357|FG000|Overall Study|Site Closure|3|||
23445468|NCT03495102|65370358|FG001|Overall Study|Site Closure|1|||
23445469|NCT03495102|65370359|FG002|Overall Study|Site Closure|2|||
23445470|NCT03495102|65370357|FG000|Overall Study|Non-compliance|1|||
23445471|NCT03495102|65370358|FG001|Overall Study|Non-compliance|0|||
23445472|NCT03495102|65370359|FG002|Overall Study|Non-compliance|0|||
23445473|NCT03495102|65370357|FG000|Overall Study|Participant Duplicated at Another Site|0|||
23445474|NCT03495102|65370358|FG001|Overall Study|Participant Duplicated at Another Site|0|||
23445475|NCT03495102|65370359|FG002|Overall Study|Participant Duplicated at Another Site|1|||
23567540|NCT03556358|65807102|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
23445476|NCT03495102|65370357|FG000|Overall Study|Primary Care Physician Recommendation|0|||
23445477|NCT03495102|65370358|FG001|Overall Study|Primary Care Physician Recommendation|1|||
23765899|NCT01078623|66521873|FG014|Treatment Period 1|Protocol Violation|0|||
23765900|NCT01078623|66521874|FG015|Treatment Period 1|Protocol Violation|0|||
23765901|NCT01078623|66521875|FG016|Treatment Period 1|Protocol Violation|0|||
23445478|NCT03495102|65370359|FG002|Overall Study|Primary Care Physician Recommendation|0|||
23445479|NCT03495102|65370357|FG000|Overall Study|Relocated to Another Country|0|||
23445480|NCT03495102|65370358|FG001|Overall Study|Relocated to Another Country|1|||
23445481|NCT03495102|65370359|FG002|Overall Study|Relocated to Another Country|0|||
23445482|NCT03495102|65370357|FG000|Overall Study|Participant was in Rehabilitation|1|||
23445483|NCT03495102|65370358|FG001|Overall Study|Participant was in Rehabilitation|0|||
23445484|NCT03495102|65370359|FG002|Overall Study|Participant was in Rehabilitation|0|||
23445485|NCT02073682|65370360|FG000|Overall Study|Low Creatinine Clearance|1|||
23445486|NCT02073682|65370361|FG001|Overall Study|Low Creatinine Clearance|2|||
23445487|NCT02073682|65370360|FG000|Overall Study|Death|86|||
23445488|NCT02073682|65370361|FG001|Overall Study|Death|100|||
23445489|NCT02073682|65370360|FG000|Overall Study|Cancer Cured|10|||
23445490|NCT02073682|65370361|FG001|Overall Study|Cancer Cured|15|||
23445491|NCT02073682|65370360|FG000|Overall Study|ID: Patient Noncompliance|1|||
23445492|NCT02073682|65370361|FG001|Overall Study|ID: Patient Noncompliance|2|||
23445493|NCT02073682|65370360|FG000|Overall Study|ID: Palliative Treatment Only|10|||
23445494|NCT02073682|65370361|FG001|Overall Study|ID: Palliative Treatment Only|7|||
23445495|NCT02073682|65370360|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
23445496|NCT02073682|65370361|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
23445497|NCT02073682|65370360|FG000|Overall Study|Platelet Count <50,000/mL|1|||
23765902|NCT01078623|66521876|FG017|Treatment Period 1|Protocol Violation|0|||
23765903|NCT01078623|66521877|FG018|Treatment Period 1|Protocol Violation|0|||
23445498|NCT02073682|65370361|FG001|Overall Study|Platelet Count <50,000/mL|2|||
23445499|NCT02073682|65370360|FG000|Overall Study|Surgery/Medical Procedure|3|||
23445500|NCT02073682|65370361|FG001|Overall Study|Surgery/Medical Procedure|1|||
23445501|NCT02073682|65370360|FG000|Overall Study|Withdrawal by Subject|6|||
23445502|NCT02073682|65370361|FG001|Overall Study|Withdrawal by Subject|8|||
23445503|NCT02073682|65370360|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
23445504|NCT02073682|65370361|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
23445505|NCT02073682|65370360|FG000|Overall Study|Cancer Progression|53|||
23445506|NCT02073682|65370361|FG001|Overall Study|Cancer Progression|33|||
23445507|NCT02073682|65370360|FG000|Overall Study|Protocol Violation|1|||
23445508|NCT02073682|65370361|FG001|Overall Study|Protocol Violation|0|||
23445509|NCT02073682|65370360|FG000|Overall Study|Adverse Event|79|||
23445510|NCT02073682|65370361|FG001|Overall Study|Adverse Event|62|||
23445511|NCT02073682|65370360|FG000|Overall Study|No reason provided|11|||
23445512|NCT02073682|65370361|FG001|Overall Study|No reason provided|9|||
23445513|NCT02073682|65370360|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
23445514|NCT02073682|65370361|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
23445515|NCT02073682|65370360|FG000|Overall Study|Lost to Follow-up|1|||
23445516|NCT02073682|65370361|FG001|Overall Study|Lost to Follow-up|1|||
23445517|NCT02073682|65370360|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
23445518|NCT02073682|65370361|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
23445519|NCT01369784|65370362|FG000|Overall Study|Protocol Violation|12|||
23445520|NCT01359904|65370363|FG000|Overall Study|Withdrawal by Subject|1|||
23445521|NCT01359904|65370364|FG001|Overall Study|Withdrawal by Subject|0|||
23445522|NCT00413036|65370365|FG000|Overall Study|Adverse Event|44|||
23445523|NCT00413036|65370365|FG000|Overall Study|Lack of Efficacy|129|||
23445524|NCT00413036|65370365|FG000|Overall Study|Withdrawal by Subject|7|||
23445525|NCT00413036|65370365|FG000|Overall Study|Death|9|||
23445526|NCT00413036|65370365|FG000|Overall Study|Other|26|||
23445527|NCT00413036|65370365|FG000|Overall Study|Missing|2|||
23445528|NCT00577824|65370366|FG000|Overall Study|Adverse Event|6|||
23445529|NCT00577824|65370367|FG001|Overall Study|Adverse Event|18|||
23445530|NCT00577824|65370368|FG002|Overall Study|Adverse Event|1|||
23445531|NCT00577824|65370366|FG000|Overall Study|Patient decision|0|||
23445532|NCT00577824|65370367|FG001|Overall Study|Patient decision|1|||
23445533|NCT00577824|65370368|FG002|Overall Study|Patient decision|1|||
23445534|NCT00577824|65370366|FG000|Overall Study|Protocol Violation|1|||
23445535|NCT00577824|65370367|FG001|Overall Study|Protocol Violation|1|||
23445536|NCT00577824|65370368|FG002|Overall Study|Protocol Violation|0|||
23445537|NCT01487265|65370369|FG000|Overall Study|Adverse Event|8|||
23445538|NCT01487265|65370369|FG000|Overall Study|Withdrawal by Subject|5|||
23445539|NCT01487265|65370369|FG000|Overall Study|Disease Progression|21|||
23765904|NCT01078623|66521878|FG019|Treatment Period 1|Protocol Violation|0|||
23445540|NCT01487265|65370369|FG000|Overall Study|Death|2|||
23445541|NCT01487265|65370369|FG000|Overall Study|Still on Treatment|1|||
23445542|NCT01442714|65370370|FG000|Overall Study|Death|11|||
23445543|NCT01442714|65370370|FG000|Overall Study|Withdrawal by Subject|1|||
23445544|NCT03801174|65373663|FG000|Overall Study|Withdrawal by Subject|14|||
23445545|NCT03801174|65373664|FG001|Overall Study|Withdrawal by Subject|15|||
23445546|NCT03801174|65373663|FG000|Overall Study|Death|1|||
23765905|NCT01078623|66521859|FG000|Treatment Period 2|Adverse Event|0|||
23445547|NCT03801174|65373664|FG001|Overall Study|Death|0|||
23445548|NCT03801174|65373663|FG000|Overall Study|Pregnancy|2|||
23445549|NCT03801174|65373664|FG001|Overall Study|Pregnancy|2|||
23765906|NCT01078623|66521860|FG001|Treatment Period 2|Adverse Event|0|||
23445550|NCT03801174|65373663|FG000|Overall Study|Lost to Follow-up|19|||
23445551|NCT03801174|65373664|FG001|Overall Study|Lost to Follow-up|10|||
23445552|NCT03801174|65373663|FG000|Overall Study|Other|4|||
23445553|NCT03801174|65373664|FG001|Overall Study|Other|3|||
23445554|NCT03801174|65373663|FG000|Overall Study|Lack of Efficacy|4|||
23445555|NCT03801174|65373664|FG001|Overall Study|Lack of Efficacy|0|||
23445556|NCT03801174|65373663|FG000|Overall Study|Unwilling to complete activities|5|||
23445557|NCT03801174|65373664|FG001|Overall Study|Unwilling to complete activities|6|||
23445558|NCT03801174|65373663|FG000|Overall Study|Moved out of area|3|||
23445559|NCT03801174|65373664|FG001|Overall Study|Moved out of area|0|||
23445560|NCT01128244|65373665|FG000|Overall Study|Adverse Event|1|||
23445561|NCT01128244|65373665|FG000|Overall Study|Scheduling conflict|2|||
23445562|NCT01272635|65373667|FG000|Overall Study|Lost to Follow-up|31|||
23445563|NCT01272635|65373668|FG001|Overall Study|Lost to Follow-up|20|||
23445564|NCT01272635|65373669|FG002|Overall Study|Lost to Follow-up|31|||
23445565|NCT01272635|65373670|FG003|Overall Study|Lost to Follow-up|23|||
23445566|NCT00806988|65373674|FG000|Overall Study|Death|15|||
23445567|NCT00806988|65373675|FG001|Overall Study|Death|16|||
23445568|NCT00806988|65373674|FG000|Overall Study|Withdrawal by Subject|8|||
23445569|NCT00806988|65373675|FG001|Overall Study|Withdrawal by Subject|8|||
23445570|NCT00806988|65373674|FG000|Overall Study|Lost to Follow-up|4|||
23445571|NCT00806988|65373675|FG001|Overall Study|Lost to Follow-up|19|||
23445572|NCT01685697|65373678|FG000|Overall Study|Protocol Violation|3|||
23445573|NCT01685697|65373679|FG001|Overall Study|Protocol Violation|3|||
23445574|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
23445575|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
23445576|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
23445577|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
23445578|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
23445579|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
23445580|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
23445581|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
23445582|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
23445583|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
23445584|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
23445585|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
23445586|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
23445587|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
23445588|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
23445589|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
23445590|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23445591|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
23445592|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23445593|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23629088|NCT01639742|66028183|FG000|Overall Study|Study Ongoing|17|||
23629089|NCT01639742|66028183|FG000|Overall Study|Lost to Follow-up|1|||
23629090|NCT02165826|66028187|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
23629091|NCT02165826|66028188|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
23629092|NCT02165826|66028189|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
23629093|NCT02165826|66028187|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
23629094|NCT02165826|66028188|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
23629095|NCT02165826|66028189|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
23629096|NCT02165826|66028187|FG000|Main Treatment Period|Lost to Follow-up|4|||
23629097|NCT02165826|66028188|FG001|Main Treatment Period|Lost to Follow-up|2|||
23629098|NCT02165826|66028189|FG002|Main Treatment Period|Lost to Follow-up|1|||
23629099|NCT02165826|66028187|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
23629100|NCT02165826|66028188|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
23629101|NCT02165826|66028189|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
23629102|NCT02165826|66028187|FG000|Main Treatment Period|Lack of Efficacy|2|||
23629103|NCT02165826|66028188|FG001|Main Treatment Period|Lack of Efficacy|0|||
23629104|NCT02165826|66028189|FG002|Main Treatment Period|Lack of Efficacy|0|||
23629105|NCT02165826|66028187|FG000|Main Treatment Period|Reason Not Specified|8|||
23629106|NCT02165826|66028188|FG001|Main Treatment Period|Reason Not Specified|5|||
23629107|NCT02165826|66028189|FG002|Main Treatment Period|Reason Not Specified|16|||
23629108|NCT02165826|66028187|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
23445594|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
23445595|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
23765907|NCT01078623|66521861|FG002|Treatment Period 2|Adverse Event|0|||
23445596|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
23445597|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
23445598|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
23445599|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
23629109|NCT02165826|66028188|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
23629110|NCT02165826|66028189|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
23629111|NCT02165826|66028187|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
23629112|NCT02165826|66028188|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
23629113|NCT02165826|66028189|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
23629114|NCT02165826|66028187|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
23629115|NCT02165826|66028188|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
23629116|NCT02165826|66028189|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
23629117|NCT02165826|66028187|FG000|Down-Titration Period|Reason Not Specified|1|||
23629118|NCT02165826|66028188|FG001|Down-Titration Period|Reason Not Specified|0|||
23629119|NCT02165826|66028189|FG002|Down-Titration Period|Reason Not Specified|2|||
23629120|NCT02763215|66028190|FG000|Overall Study|Participants withdrew from study|3|||
23629121|NCT02763215|66028190|FG000|Overall Study|Missed visit|1|||
23629122|NCT02763215|66028190|FG000|Overall Study|Visit outside visit-window|1|||
23629123|NCT02763215|66028190|FG000|Overall Study|Death|1|||
23629124|NCT02763215|66028190|FG000|Overall Study|Lost to Follow-up|1|||
23629125|NCT03865953|66028191|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
23829243|NCT01006122|66752596|FG001|First Double-blind Intervention Period|Adverse Event|4|||
23829244|NCT01006122|66752595|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
23829245|NCT01006122|66752596|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
23829246|NCT01006122|66752595|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
23629126|NCT03865953|66028192|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23629127|NCT03865953|66028191|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
23445600|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
23445601|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
23567541|NCT03556358|65807101|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
23629128|NCT03865953|66028192|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
23629129|NCT03865953|66028191|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
23629130|NCT03865953|66028192|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
23629131|NCT00356811|66028193|FG000|Overall Study|Death|35|||
23629132|NCT00356811|66028193|FG000|Overall Study|Lost to Follow-up|2|||
23629133|NCT00356811|66028193|FG000|Overall Study|Withdrawal by Subject|6|||
23765908|NCT01078623|66521862|FG003|Treatment Period 2|Adverse Event|0|||
23765909|NCT01078623|66521863|FG004|Treatment Period 2|Adverse Event|0|||
23765910|NCT01078623|66521864|FG005|Treatment Period 2|Adverse Event|0|||
23765911|NCT01078623|66521865|FG006|Treatment Period 2|Adverse Event|1|||
23765912|NCT01078623|66521866|FG007|Treatment Period 2|Adverse Event|0|||
23765913|NCT01078623|66521867|FG008|Treatment Period 2|Adverse Event|0|||
23829247|NCT01006122|66752596|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
23829248|NCT01006122|66752595|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23829249|NCT01006122|66752596|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
23445602|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
23567542|NCT03556358|65807102|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
23567543|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
23567544|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
23567545|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
23567546|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
23567547|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
23567548|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
23567549|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
23567550|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
23567551|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
23567552|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
23567553|NCT02500979|65807109|FG000|Period 1|Hyperglycemia|1|||
23567554|NCT02500979|65807110|FG001|Period 1|Hyperglycemia|0|||
23567555|NCT02500979|65807109|FG000|Period 1|Severe non-compliance to protocol|0|||
23567556|NCT02500979|65807110|FG001|Period 1|Severe non-compliance to protocol|1|||
23567557|NCT02500979|65807109|FG000|Period 1|Adverse Event|1|||
23567558|NCT02500979|65807110|FG001|Period 1|Adverse Event|0|||
23567559|NCT02500979|65807109|FG000|Period 1|Subject decision|2|||
23567560|NCT02500979|65807110|FG001|Period 1|Subject decision|0|||
23567561|NCT02500979|65807109|FG000|Period 2|Change in risk|1|||
23567562|NCT02500979|65807110|FG001|Period 2|Change in risk|0|||
23567563|NCT03086018|65807111|FG000|Final Testing for End of Trial|Adverse Event|1|||
23567564|NCT03086018|65807111|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
23629134|NCT00356811|66028193|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
23629135|NCT00356811|66028193|FG000|Overall Study|Study Is Terminating|3|||
23629136|NCT00356811|66028193|FG000|Overall Study|Site Closed during Follow-up|2|||
23765914|NCT01078623|66521868|FG009|Treatment Period 2|Adverse Event|0|||
23765915|NCT01078623|66521869|FG010|Treatment Period 2|Adverse Event|0|||
23629137|NCT01986114|66028194|FG000|Overall Study|Adverse Event|59|||
23629138|NCT01986114|66028194|FG000|Overall Study|Lack of Efficacy|23|||
23629139|NCT01986114|66028194|FG000|Overall Study|Withdrawal by Subject|58|||
23629140|NCT01986114|66028194|FG000|Overall Study|Noncompliance|3|||
23629141|NCT01986114|66028194|FG000|Overall Study|Protocol Violation|1|||
23629142|NCT01986114|66028194|FG000|Overall Study|Lost to Follow-up|5|||
23629143|NCT01986114|66028194|FG000|Overall Study|Other reason|7|||
23629144|NCT01163474|66028196|FG000|Overall Study|Withdrawal by Subject|1|||
23629145|NCT01163474|66028196|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
23629146|NCT01163474|66028196|FG000|Overall Study|Lost to Follow-up|3|||
23629147|NCT01304498|66028198|FG000|Overall Study|Adverse Event|1|||
23629148|NCT01304498|66028199|FG001|Overall Study|Adverse Event|1|||
23629149|NCT01304498|66028198|FG000|Overall Study|Withdrawal by Subject|2|||
23629150|NCT01304498|66028199|FG001|Overall Study|Withdrawal by Subject|3|||
23629151|NCT01304498|66028198|FG000|Overall Study|Protocol Violation|1|||
23629152|NCT01304498|66028199|FG001|Overall Study|Protocol Violation|0|||
23629153|NCT01304498|66028198|FG000|Overall Study|Lost to Follow-up|2|||
23629154|NCT01304498|66028199|FG001|Overall Study|Lost to Follow-up|1|||
23629155|NCT04292470|66028202|FG000|Overall Study|Withdrawal by Subject|0|||
23629156|NCT04292470|66028203|FG001|Overall Study|Withdrawal by Subject|1|||
23629157|NCT02595372|66028204|FG000|Overall Study|Adverse Event|6|||
23629158|NCT02595372|66028204|FG000|Overall Study|Physician Decision|2|||
23629159|NCT02595372|66028204|FG000|Overall Study|Disease Progression|1|||
23629160|NCT00694109|66028205|FG000|Overall Study|Physician Decision|3|||
23629161|NCT00694109|66028205|FG000|Overall Study|Adverse Event|74|||
23629162|NCT00694109|66028205|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
23629163|NCT00694109|66028205|FG000|Overall Study|Lack of Efficacy|2|||
23629164|NCT00694109|66028205|FG000|Overall Study|Withdrawal by Subject|13|||
23629165|NCT00694109|66028205|FG000|Overall Study|Pregnancy|1|||
23629166|NCT00694109|66028205|FG000|Overall Study|Enrolled but not treated|1|||
23629167|NCT00694109|66028205|FG000|Overall Study|Other|2|||
23629168|NCT00694109|66028205|FG000|Overall Study|Consented but no additional treatment|3|||
23629169|NCT00844597|66028208|FG000|Overall Study|Adverse Event|0|||
23629170|NCT00844597|66028209|FG001|Overall Study|Adverse Event|0|||
23629171|NCT00844597|66028210|FG002|Overall Study|Adverse Event|0|||
23629172|NCT00844597|66028211|FG003|Overall Study|Adverse Event|1|||
23629173|NCT00844597|66028212|FG004|Overall Study|Adverse Event|0|||
23629174|NCT00844597|66028213|FG005|Overall Study|Adverse Event|0|||
23445603|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
23445604|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
23445605|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
23445606|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
23445607|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
23765916|NCT01078623|66521870|FG011|Treatment Period 2|Adverse Event|0|||
23765917|NCT01078623|66521871|FG012|Treatment Period 2|Adverse Event|0|||
23765918|NCT01078623|66521872|FG013|Treatment Period 2|Adverse Event|0|||
23765919|NCT01078623|66521873|FG014|Treatment Period 2|Adverse Event|0|||
23765920|NCT01078623|66521874|FG015|Treatment Period 2|Adverse Event|0|||
23765921|NCT01078623|66521875|FG016|Treatment Period 2|Adverse Event|0|||
23765922|NCT01078623|66521876|FG017|Treatment Period 2|Adverse Event|0|||
23765923|NCT01078623|66521877|FG018|Treatment Period 2|Adverse Event|1|||
23765924|NCT01078623|66521878|FG019|Treatment Period 2|Adverse Event|0|||
23765925|NCT01078623|66521859|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23765926|NCT01078623|66521860|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23765927|NCT01078623|66521861|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23765928|NCT01078623|66521862|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23765929|NCT01078623|66521863|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23765930|NCT01078623|66521864|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23765931|NCT01078623|66521865|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23765932|NCT01078623|66521866|FG007|Treatment Period 2|Withdrawal by Subject|0|||
23765933|NCT01078623|66521867|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23765934|NCT01078623|66521868|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23765935|NCT01078623|66521869|FG010|Treatment Period 2|Withdrawal by Subject|0|||
23765936|NCT01078623|66521870|FG011|Treatment Period 2|Withdrawal by Subject|0|||
23765937|NCT01078623|66521871|FG012|Treatment Period 2|Withdrawal by Subject|0|||
23765938|NCT01078623|66521872|FG013|Treatment Period 2|Withdrawal by Subject|0|||
23765939|NCT01078623|66521873|FG014|Treatment Period 2|Withdrawal by Subject|0|||
23765940|NCT01078623|66521874|FG015|Treatment Period 2|Withdrawal by Subject|0|||
23629175|NCT02844777|66028214|FG000|Overall Study|Withdrawal by Subject|2|||
23629176|NCT02844777|66028215|FG001|Overall Study|Withdrawal by Subject|0|||
23629177|NCT02844777|66028216|FG002|Overall Study|Withdrawal by Subject|0|||
23629178|NCT00884650|66028222|FG000|Overall Study|Did not return complete pain diaries|7|||
23629179|NCT00884650|66028223|FG001|Overall Study|Did not return complete pain diaries|7|||
23629180|NCT00884650|66028222|FG000|Overall Study|Admitted Post-Op|1|||
23629181|NCT00884650|66028223|FG001|Overall Study|Admitted Post-Op|0|||
23765941|NCT01078623|66521875|FG016|Treatment Period 2|Withdrawal by Subject|0|||
23765942|NCT01078623|66521876|FG017|Treatment Period 2|Withdrawal by Subject|0|||
23629182|NCT00884650|66028222|FG000|Overall Study|Femoral Stress Fracture|1|||
23629183|NCT00884650|66028223|FG001|Overall Study|Femoral Stress Fracture|0|||
23629184|NCT00884650|66028222|FG000|Overall Study|Pain Pump Complication|0|||
23629185|NCT00884650|66028223|FG001|Overall Study|Pain Pump Complication|1|||
23629186|NCT00504075|66028224|FG000|Overall Study|Adverse Event|1|||
23629187|NCT00504075|66028224|FG000|Overall Study|Lost to Follow-up|5|||
23629188|NCT00504075|66028224|FG000|Overall Study|Withdrawal by Subject|1|||
23629189|NCT00504075|66028224|FG000|Overall Study|Required other therapeutic intervention|1|||
23629190|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
23629191|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
23629192|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
23629193|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
23629194|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
23629195|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
23629196|NCT02567708|66028225|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
23629197|NCT02567708|66028226|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
23629198|NCT02593123|66028240|FG000|Overall Study|Physician Decision|2|||
23629199|NCT02593123|66028241|FG001|Overall Study|Physician Decision|1|||
23629200|NCT02593123|66028240|FG000|Overall Study|Relapse|1|||
23629201|NCT02593123|66028241|FG001|Overall Study|Relapse|1|||
23629202|NCT01821937|66028242|FG000|Overall Study|Adverse Event|0|||
23629203|NCT01821937|66028243|FG001|Overall Study|Adverse Event|3|||
23629204|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
23629205|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
23629206|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
23629207|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
23629208|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
23629209|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
23629210|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
23629211|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
23629212|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Unclassified|10|||
23629213|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Unclassified|15|||
23629214|NCT00781937|66028244|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
23629215|NCT00781937|66028245|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
23629216|NCT00781937|66028244|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
23629217|NCT00781937|66028245|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
23629218|NCT00250432|66028246|FG000|Overall Study|Adverse Event|25|||
23629219|NCT00250432|66028247|FG001|Overall Study|Adverse Event|29|||
23629220|NCT00250432|66028246|FG000|Overall Study|Lack of Efficacy|2|||
23629221|NCT00250432|66028247|FG001|Overall Study|Lack of Efficacy|1|||
23629222|NCT00250432|66028246|FG000|Overall Study|Lost to Follow-up|6|||
23629223|NCT00250432|66028247|FG001|Overall Study|Lost to Follow-up|5|||
23629224|NCT00250432|66028246|FG000|Overall Study|Patient Moved|0|||
23629225|NCT00250432|66028247|FG001|Overall Study|Patient Moved|1|||
23629226|NCT00250432|66028246|FG000|Overall Study|Protocol Violation|0|||
23629227|NCT00250432|66028247|FG001|Overall Study|Protocol Violation|3|||
23629228|NCT00250432|66028246|FG000|Overall Study|Withdrawal by Subject|6|||
23629229|NCT00250432|66028247|FG001|Overall Study|Withdrawal by Subject|2|||
23629230|NCT00250432|66028246|FG000|Overall Study|Pt died out of posttherapy report period|6|||
23629231|NCT00250432|66028247|FG001|Overall Study|Pt died out of posttherapy report period|5|||
23629232|NCT00250432|66028246|FG000|Overall Study|Pt was considered untreatable|0|||
23629233|NCT00250432|66028247|FG001|Overall Study|Pt was considered untreatable|1|||
23629234|NCT02229578|66028251|FG000|Overall Study|Withdrawal by Subject|1|||
23629235|NCT02229578|66028252|FG001|Overall Study|Withdrawal by Subject|3|||
23629236|NCT02229578|66028251|FG000|Overall Study|Protocol Violation|2|||
23629237|NCT02229578|66028252|FG001|Overall Study|Protocol Violation|0|||
23629238|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
23629239|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629240|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629241|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
23765943|NCT01078623|66521877|FG018|Treatment Period 2|Withdrawal by Subject|0|||
23765944|NCT01078623|66521878|FG019|Treatment Period 2|Withdrawal by Subject|0|||
23765945|NCT01078623|66521859|FG000|Treatment Period 3|Adverse Event|0|||
23765946|NCT01078623|66521860|FG001|Treatment Period 3|Adverse Event|0|||
23765947|NCT01078623|66521861|FG002|Treatment Period 3|Adverse Event|0|||
23765948|NCT01078623|66521862|FG003|Treatment Period 3|Adverse Event|0|||
23765949|NCT01078623|66521863|FG004|Treatment Period 3|Adverse Event|1|||
23765950|NCT01078623|66521864|FG005|Treatment Period 3|Adverse Event|0|||
23629242|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23765951|NCT01078623|66521865|FG006|Treatment Period 3|Adverse Event|0|||
23629243|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629244|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
23629245|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
23629246|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
23629247|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629248|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629249|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629250|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629251|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629252|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
23629253|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629254|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629255|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629256|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629257|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629258|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
23629259|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
23629260|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629261|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629262|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23629263|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23629264|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23765952|NCT01078623|66521866|FG007|Treatment Period 3|Adverse Event|0|||
23567565|NCT01960790|65807116|FG000|Overall Study|Survey forms could not be recovered|3|||
23567566|NCT01960790|65807116|FG000|Overall Study|Treat with Humira outside survey period|3|||
23567567|NCT01960790|65807116|FG000|Overall Study|Transferred to another hospital|4|||
23567568|NCT01960790|65807116|FG000|Overall Study|Unevaluable for safety|1|||
23567569|NCT02917941|65807117|FG000|Treatment Period|Adverse Event|11|||
23567570|NCT02917941|65807117|FG000|Treatment Period|Progressive Disease|11|||
23567571|NCT02917941|65807117|FG000|Treatment Period|Reason not Specified|2|||
23567572|NCT02917941|65807117|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
23567573|NCT02917941|65807117|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
23567574|NCT02959671|65807119|FG000|Overall Study|Adverse Event|2|||
23567575|NCT02959671|65807119|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
23567576|NCT00951509|65807120|FG000|Overall Study|Withdrawal by Subject|2|||
23567577|NCT03485911|65807123|FG000|Part 1|Perceived lack of efficacy|1|||
23567578|NCT03485911|65807124|FG001|Part 1|Perceived lack of efficacy|1|||
23567579|NCT03485911|65807125|FG002|Part 1|Perceived lack of efficacy|2|||
23567580|NCT03485911|65807126|FG003|Part 1|Perceived lack of efficacy|0|||
23567581|NCT03485911|65807123|FG000|Part 1|Subject withdrew consent|0|||
23567582|NCT03485911|65807124|FG001|Part 1|Subject withdrew consent|1|||
23567583|NCT03485911|65807125|FG002|Part 1|Subject withdrew consent|0|||
23567584|NCT03485911|65807126|FG003|Part 1|Subject withdrew consent|1|||
23567585|NCT03485911|65807123|FG000|Part 1|Lab abnormalities/AEs|3|||
23567586|NCT03485911|65807124|FG001|Part 1|Lab abnormalities/AEs|1|||
23567587|NCT03485911|65807125|FG002|Part 1|Lab abnormalities/AEs|1|||
23567588|NCT03485911|65807126|FG003|Part 1|Lab abnormalities/AEs|0|||
23567589|NCT03485911|65807123|FG000|Part 1|Withdrew Consent prior to dosing|0|||
23567590|NCT03485911|65807124|FG001|Part 1|Withdrew Consent prior to dosing|0|||
23567591|NCT03485911|65807125|FG002|Part 1|Withdrew Consent prior to dosing|0|||
23567592|NCT03485911|65807126|FG003|Part 1|Withdrew Consent prior to dosing|1|||
23567593|NCT03485911|65807123|FG000|Part 1|Other NOS|0|||
23567594|NCT03485911|65807124|FG001|Part 1|Other NOS|0|||
23567595|NCT03485911|65807125|FG002|Part 1|Other NOS|0|||
23567596|NCT03485911|65807126|FG003|Part 1|Other NOS|1|||
23629265|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23765953|NCT01078623|66521867|FG008|Treatment Period 3|Adverse Event|0|||
23765954|NCT01078623|66521868|FG009|Treatment Period 3|Adverse Event|0|||
23765955|NCT01078623|66521869|FG010|Treatment Period 3|Adverse Event|0|||
23765956|NCT01078623|66521870|FG011|Treatment Period 3|Adverse Event|0|||
23765957|NCT01078623|66521871|FG012|Treatment Period 3|Adverse Event|0|||
23765958|NCT01078623|66521872|FG013|Treatment Period 3|Adverse Event|1|||
23765959|NCT01078623|66521873|FG014|Treatment Period 3|Adverse Event|0|||
23765960|NCT01078623|66521874|FG015|Treatment Period 3|Adverse Event|0|||
23765961|NCT01078623|66521875|FG016|Treatment Period 3|Adverse Event|0|||
23765962|NCT01078623|66521876|FG017|Treatment Period 3|Adverse Event|0|||
23765963|NCT01078623|66521877|FG018|Treatment Period 3|Adverse Event|0|||
23765964|NCT01078623|66521878|FG019|Treatment Period 3|Adverse Event|0|||
23829250|NCT01006122|66752595|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23567597|NCT03485911|65807123|FG000|Part 2|Perceived lack of efficacy|5|||
23567598|NCT03485911|65807124|FG001|Part 2|Perceived lack of efficacy|3|||
23567599|NCT03485911|65807125|FG002|Part 2|Perceived lack of efficacy|0|||
23765965|NCT01078623|66521859|FG000|Treatment Period 4|Adverse Event|0|||
23765966|NCT01078623|66521860|FG001|Treatment Period 4|Adverse Event|0|||
23829251|NCT01006122|66752596|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
23829252|NCT01006122|66752595|FG000|Second Double-blind Intervention Period|Death|0|||
23829253|NCT01006122|66752596|FG001|Second Double-blind Intervention Period|Death|1|||
23829254|NCT01149863|66752597|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
23829255|NCT00733005|66752602|FG000|Overall Study|Adverse Event|0|||
23829256|NCT00733005|66752603|FG001|Overall Study|Adverse Event|1|||
23829257|NCT00733005|66752602|FG000|Overall Study|Treatment Failure|0|||
23829258|NCT00733005|66752603|FG001|Overall Study|Treatment Failure|1|||
23829259|NCT00733005|66752602|FG000|Overall Study|Withdrawal by Subject|0|||
23829260|NCT00733005|66752603|FG001|Overall Study|Withdrawal by Subject|1|||
23829261|NCT00733005|66752602|FG000|Overall Study|Protocol Violation|2|||
23829262|NCT00733005|66752603|FG001|Overall Study|Protocol Violation|0|||
23829263|NCT00811733|66752604|FG000|Overall Study|Investigator Discretion|10|||
23829264|NCT00811733|66752605|FG001|Overall Study|Investigator Discretion|8|||
23829265|NCT00811733|66752604|FG000|Overall Study|Withdrawal by Subject|1|||
23829266|NCT00811733|66752605|FG001|Overall Study|Withdrawal by Subject|2|||
23829267|NCT00560391|66752606|FG000|Overall Study|Still on treatment|0|||
23829268|NCT00560391|66752607|FG001|Overall Study|Still on treatment|0|||
23829269|NCT00560391|66752608|FG002|Overall Study|Still on treatment|0|||
23829270|NCT00560391|66752609|FG003|Overall Study|Still on treatment|1|||
23829271|NCT00560391|66752610|FG004|Overall Study|Still on treatment|2|||
23829272|NCT03832686|66752612|FG000|Overall Study|Lost to Follow-up|6|||
23829273|NCT03832686|66752613|FG001|Overall Study|Lost to Follow-up|9|||
23829274|NCT03832686|66752612|FG000|Overall Study|Discontinued Intervention|5|||
23829275|NCT03832686|66752613|FG001|Overall Study|Discontinued Intervention|4|||
23829276|NCT03633825|66752614|FG000|Enrollment|Did not post on network|5066|||
23829277|NCT03633825|66752615|FG001|Enrollment|Did not post on network|5080|||
23829278|NCT03633825|66752614|FG000|Enrollment|Post not classified as crisis|13967|||
23829279|NCT03633825|66752615|FG001|Enrollment|Post not classified as crisis|13757|||
23829280|NCT03633825|66752614|FG000|Follow up|Lost to Follow-up|478|||
23829281|NCT03633825|66752615|FG001|Follow up|Lost to Follow-up|450|||
23829282|NCT01609790|66752616|FG000|Overall Study|Protocol Violation|1|||
23829283|NCT01609790|66752617|FG001|Overall Study|Protocol Violation|7|||
23829284|NCT01609790|66752618|FG002|Overall Study|Protocol Violation|8|||
23829285|NCT00312338|66752624|FG000|Overall Study|Adverse Event|7|||
23829286|NCT00312338|66752625|FG001|Overall Study|Adverse Event|2|||
23829287|NCT00312338|66752624|FG000|Overall Study|Lost to Follow-up|9|||
23829288|NCT00312338|66752625|FG001|Overall Study|Lost to Follow-up|1|||
23829289|NCT00312338|66752624|FG000|Overall Study|Withdrawal by Subject|4|||
23829290|NCT00312338|66752625|FG001|Overall Study|Withdrawal by Subject|0|||
23829291|NCT00312338|66752624|FG000|Overall Study|Subsequent infection|2|||
23829292|NCT00312338|66752625|FG001|Overall Study|Subsequent infection|0|||
23829293|NCT04495829|66752626|FG000|Overall Study|Lost to Follow-up|2|||
23829294|NCT04495829|66752626|FG000|Overall Study|Inclusion criterion not met|3|||
23829295|NCT00974922|66752629|FG000|Overall Study|study terminated|24|||
23829296|NCT02389829|66752633|FG000|Overall Study|Lost to Follow-up|0|||
23829297|NCT02389829|66752634|FG001|Overall Study|Lost to Follow-up|1|||
23829298|NCT00942084|66755809|FG000|Overall Study|Death|2|||
23829299|NCT01217112|66755814|FG000|Overall Study|Adverse Event|0|||
23829300|NCT01217112|66755815|FG001|Overall Study|Adverse Event|2|||
23829301|NCT01217112|66755816|FG002|Overall Study|Adverse Event|0|||
23829302|NCT01217112|66755817|FG003|Overall Study|Adverse Event|2|||
23829303|NCT01217112|66755818|FG004|Overall Study|Adverse Event|0|||
23829304|NCT01217112|66755814|FG000|Overall Study|Withdrawal by Subject|0|||
23829305|NCT01217112|66755815|FG001|Overall Study|Withdrawal by Subject|0|||
23829306|NCT01217112|66755816|FG002|Overall Study|Withdrawal by Subject|1|||
23829307|NCT01217112|66755817|FG003|Overall Study|Withdrawal by Subject|0|||
23829308|NCT01217112|66755818|FG004|Overall Study|Withdrawal by Subject|0|||
23829309|NCT01217112|66755814|FG000|Overall Study|Physician Decision|0|||
23829310|NCT01217112|66755815|FG001|Overall Study|Physician Decision|0|||
23829311|NCT01217112|66755816|FG002|Overall Study|Physician Decision|0|||
23829312|NCT01217112|66755817|FG003|Overall Study|Physician Decision|0|||
23445608|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
23829313|NCT01217112|66755818|FG004|Overall Study|Physician Decision|1|||
23829314|NCT02090725|66755820|FG000|Overall Study|Withdrawal by Subject|1|||
23829315|NCT02090725|66755820|FG000|Overall Study|participants moved from area|3|||
23829316|NCT00468819|66755821|FG000|Overall Study|Withdrawal by Subject|4|||
23445609|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
23829317|NCT00468819|66755822|FG001|Overall Study|Withdrawal by Subject|0|||
23829318|NCT00468819|66755823|FG002|Overall Study|Withdrawal by Subject|1|||
23829319|NCT00468819|66755821|FG000|Overall Study|Lost to Follow-up|0|||
23829320|NCT00468819|66755822|FG001|Overall Study|Lost to Follow-up|0|||
23829321|NCT00468819|66755823|FG002|Overall Study|Lost to Follow-up|1|||
23829322|NCT00468819|66755821|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
23829323|NCT00468819|66755822|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
23829324|NCT00468819|66755823|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
23829325|NCT00470470|66755824|FG000|Overall Study|Adverse Event|2|||
23829326|NCT00470470|66755824|FG000|Overall Study|Death|2|||
23829327|NCT00470470|66755824|FG000|Overall Study|Not treated|1|||
23829328|NCT02969044|66755825|FG000|Overall Study|Withdrawal by Subject|2|||
23829329|NCT02969044|66755826|FG001|Overall Study|Withdrawal by Subject|6|||
23829330|NCT02969044|66755825|FG000|Overall Study|Adverse Event|3|||
23829331|NCT02969044|66755826|FG001|Overall Study|Adverse Event|0|||
23829332|NCT02077140|66755830|FG000|Overall Study|Lost to Follow-up|4|||
23829333|NCT02077140|66755831|FG001|Overall Study|Lost to Follow-up|1|||
23829334|NCT02077140|66755832|FG002|Overall Study|Lost to Follow-up|2|||
23829335|NCT02077140|66755833|FG003|Overall Study|Lost to Follow-up|2|||
23829336|NCT02077140|66755834|FG004|Overall Study|Lost to Follow-up|3|||
23829337|NCT02077140|66755830|FG000|Overall Study|Withdrawal by Subject|0|||
23829338|NCT02077140|66755831|FG001|Overall Study|Withdrawal by Subject|1|||
23829339|NCT02077140|66755832|FG002|Overall Study|Withdrawal by Subject|0|||
23829340|NCT02077140|66755833|FG003|Overall Study|Withdrawal by Subject|2|||
23829341|NCT02077140|66755834|FG004|Overall Study|Withdrawal by Subject|2|||
23829342|NCT02069015|66755835|FG000|Overall Study|Lost to Follow-up|39|||
23829343|NCT02069015|66755836|FG001|Overall Study|Lost to Follow-up|32|||
23829344|NCT02069015|66755835|FG000|Overall Study|Withdrawal by Subject|1|||
23829345|NCT02069015|66755836|FG001|Overall Study|Withdrawal by Subject|1|||
23829346|NCT04021914|66755837|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
23829347|NCT01403051|66755841|FG000|Overall Study|Protocol Violation|2|||
23829348|NCT01403051|66755842|FG001|Overall Study|Protocol Violation|0|||
23829349|NCT01403051|66755841|FG000|Overall Study|Death|1|||
23829350|NCT01403051|66755842|FG001|Overall Study|Death|0|||
23829351|NCT01403051|66755841|FG000|Overall Study|Withdrawal by Subject|2|||
23829352|NCT01403051|66755842|FG001|Overall Study|Withdrawal by Subject|1|||
23829353|NCT01403051|66755841|FG000|Overall Study|Lost to Follow-up|5|||
23829354|NCT01403051|66755842|FG001|Overall Study|Lost to Follow-up|5|||
23829355|NCT00129389|66755843|FG000|Overall Study|Adverse Event|19|||
23829356|NCT00129389|66755844|FG001|Overall Study|Adverse Event|87|||
23829357|NCT00129389|66755843|FG000|Overall Study|Death|0|||
23829358|NCT00129389|66755844|FG001|Overall Study|Death|1|||
23829359|NCT00129389|66755843|FG000|Overall Study|Lost to Follow-up|2|||
23829360|NCT00129389|66755844|FG001|Overall Study|Lost to Follow-up|1|||
23829361|NCT00129389|66755843|FG000|Overall Study|Physician Decision|0|||
23829362|NCT00129389|66755844|FG001|Overall Study|Physician Decision|4|||
23829363|NCT00129389|66755843|FG000|Overall Study|Protocol Violation|0|||
23829364|NCT00129389|66755844|FG001|Overall Study|Protocol Violation|6|||
23829365|NCT00129389|66755843|FG000|Overall Study|Withdrawal by Subject|9|||
23829366|NCT00129389|66755844|FG001|Overall Study|Withdrawal by Subject|23|||
23829367|NCT00129389|66755843|FG000|Overall Study|Relapse|1|||
23829368|NCT00129389|66755844|FG001|Overall Study|Relapse|0|||
23567600|NCT03485911|65807126|FG003|Part 2|Perceived lack of efficacy|2|||
23829369|NCT00129389|66755843|FG000|Overall Study|Not eligible|1|||
23829370|NCT00129389|66755844|FG001|Overall Study|Not eligible|2|||
23829371|NCT00129389|66755843|FG000|Overall Study|Crossed to the other arm|1|||
23829372|NCT00129389|66755844|FG001|Overall Study|Crossed to the other arm|16|||
23829373|NCT01103180|66755846|FG000|Overall Study|Withdrawal by Subject|8|||
23829374|NCT01103180|66755847|FG001|Overall Study|Withdrawal by Subject|13|||
23567601|NCT03485911|65807123|FG000|Part 2|Subject withdrew consent|1|||
23567602|NCT03485911|65807124|FG001|Part 2|Subject withdrew consent|0|||
23567603|NCT03485911|65807125|FG002|Part 2|Subject withdrew consent|2|||
23567604|NCT03485911|65807126|FG003|Part 2|Subject withdrew consent|1|||
23567605|NCT03485911|65807123|FG000|Part 2|Lab abnormalities/AEs|1|||
23567606|NCT03485911|65807124|FG001|Part 2|Lab abnormalities/AEs|2|||
23567607|NCT03485911|65807125|FG002|Part 2|Lab abnormalities/AEs|0|||
23567608|NCT03485911|65807126|FG003|Part 2|Lab abnormalities/AEs|0|||
23567609|NCT03485911|65807123|FG000|Part 2|Other NOS|0|||
23567610|NCT03485911|65807124|FG001|Part 2|Other NOS|1|||
23567611|NCT03485911|65807125|FG002|Part 2|Other NOS|0|||
23567612|NCT03485911|65807126|FG003|Part 2|Other NOS|0|||
23567613|NCT03485911|65807123|FG000|Part 2|Intercurrent illness/new medical condition|1|||
23567614|NCT03485911|65807124|FG001|Part 2|Intercurrent illness/new medical condition|0|||
23567615|NCT03485911|65807125|FG002|Part 2|Intercurrent illness/new medical condition|0|||
23567616|NCT03485911|65807126|FG003|Part 2|Intercurrent illness/new medical condition|0|||
23567617|NCT03485911|65807123|FG000|Part 2|Investigator judgement|1|||
23567618|NCT03485911|65807124|FG001|Part 2|Investigator judgement|0|||
23567619|NCT03485911|65807125|FG002|Part 2|Investigator judgement|0|||
23567620|NCT03485911|65807126|FG003|Part 2|Investigator judgement|0|||
23567621|NCT03485911|65807123|FG000|Part 3|Perceived lack of efficacy|2|||
23567622|NCT03485911|65807124|FG001|Part 3|Perceived lack of efficacy|2|||
23567623|NCT03485911|65807125|FG002|Part 3|Perceived lack of efficacy|2|||
23567624|NCT03485911|65807126|FG003|Part 3|Perceived lack of efficacy|0|||
23567625|NCT03485911|65807123|FG000|Part 3|Subject withdrew consent|1|||
23567626|NCT03485911|65807124|FG001|Part 3|Subject withdrew consent|4|||
23629266|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
23629267|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
23629268|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629269|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629270|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629271|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629272|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
23629273|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
23629274|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629275|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629276|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629277|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629278|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
23629279|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629280|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629281|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629282|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629283|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629284|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
23629285|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
23629286|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629287|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629288|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629289|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629290|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629291|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
23629292|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629293|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629294|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629295|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629296|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629297|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
23629298|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629299|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629300|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629301|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629302|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629303|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
23629304|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629305|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629306|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629307|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629308|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
23629309|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629310|NCT01333111|66028259|FG000|Overall Study|patient undergoing major surgery|0|||
23629311|NCT01333111|66028260|FG001|Overall Study|patient undergoing major surgery|2|||
23629312|NCT01333111|66028261|FG002|Overall Study|patient undergoing major surgery|0|||
23629313|NCT01333111|66028259|FG000|Overall Study|personal reasons|0|||
23629314|NCT01333111|66028260|FG001|Overall Study|personal reasons|0|||
23629315|NCT01333111|66028261|FG002|Overall Study|personal reasons|1|||
23629316|NCT01333111|66028259|FG000|Overall Study|unclassified|1|||
23629317|NCT01333111|66028260|FG001|Overall Study|unclassified|0|||
23629318|NCT01333111|66028261|FG002|Overall Study|unclassified|0|||
23629319|NCT01333111|66028259|FG000|Overall Study|withdrawal criteria|0|||
23629320|NCT01333111|66028260|FG001|Overall Study|withdrawal criteria|1|||
23629321|NCT01333111|66028261|FG002|Overall Study|withdrawal criteria|0|||
23629322|NCT01333111|66028259|FG000|Overall Study|Non-compliance|1|||
23629323|NCT01333111|66028260|FG001|Overall Study|Non-compliance|0|||
23629324|NCT01333111|66028261|FG002|Overall Study|Non-compliance|0|||
23629325|NCT01333111|66028259|FG000|Overall Study|Ineffective therapy|0|||
23629326|NCT01333111|66028260|FG001|Overall Study|Ineffective therapy|0|||
23629327|NCT01333111|66028261|FG002|Overall Study|Ineffective therapy|1|||
23629328|NCT01013961|66028265|FG000|Overall Study|Adverse Event|2|||
23629329|NCT01013961|66028266|FG001|Overall Study|Adverse Event|2|||
23765967|NCT01078623|66521861|FG002|Treatment Period 4|Adverse Event|1|||
23765968|NCT01078623|66521862|FG003|Treatment Period 4|Adverse Event|0|||
23765969|NCT01078623|66521863|FG004|Treatment Period 4|Adverse Event|0|||
23629330|NCT01013961|66028265|FG000|Overall Study|Withdrawal by Subject|1|||
23629331|NCT01013961|66028266|FG001|Overall Study|Withdrawal by Subject|0|||
23765970|NCT01078623|66521864|FG005|Treatment Period 4|Adverse Event|0|||
23629332|NCT01013961|66028265|FG000|Overall Study|Physician Decision|0|||
23629333|NCT01013961|66028266|FG001|Overall Study|Physician Decision|1|||
23629334|NCT00478205|66028269|FG000|Overall Study|Adverse Event|182|||
23629335|NCT00478205|66028270|FG001|Overall Study|Adverse Event|39|||
23629336|NCT00478205|66028269|FG000|Overall Study|Medication Non-compliance|9|||
23629337|NCT00478205|66028270|FG001|Overall Study|Medication Non-compliance|4|||
23629338|NCT00478205|66028269|FG000|Overall Study|Protocol Violation|15|||
23629339|NCT00478205|66028270|FG001|Overall Study|Protocol Violation|5|||
23629340|NCT00478205|66028269|FG000|Overall Study|Request of Investigator or Sponsor|4|||
23629341|NCT00478205|66028270|FG001|Overall Study|Request of Investigator or Sponsor|5|||
23629342|NCT00478205|66028269|FG000|Overall Study|Withdrawal by Subject|61|||
23629343|NCT00478205|66028270|FG001|Overall Study|Withdrawal by Subject|22|||
23629344|NCT00478205|66028269|FG000|Overall Study|Lack of Efficacy|1|||
23629345|NCT00478205|66028270|FG001|Overall Study|Lack of Efficacy|0|||
23629346|NCT00478205|66028269|FG000|Overall Study|Other|24|||
23629347|NCT00478205|66028270|FG001|Overall Study|Other|12|||
23629348|NCT01468077|66028277|FG000|Overall Study|Adverse Event|2|||
23629349|NCT01468077|66028278|FG001|Overall Study|Adverse Event|2|||
23567627|NCT03485911|65807125|FG002|Part 3|Subject withdrew consent|0|||
23567628|NCT03485911|65807126|FG003|Part 3|Subject withdrew consent|1|||
23567629|NCT03485911|65807123|FG000|Part 3|Lab abnormalities/AEs|1|||
23567630|NCT03485911|65807124|FG001|Part 3|Lab abnormalities/AEs|1|||
23567631|NCT03485911|65807125|FG002|Part 3|Lab abnormalities/AEs|0|||
23567632|NCT03485911|65807126|FG003|Part 3|Lab abnormalities/AEs|2|||
23567633|NCT03485911|65807123|FG000|Part 3|Other NOS|1|||
23567634|NCT03485911|65807124|FG001|Part 3|Other NOS|1|||
23567635|NCT03485911|65807125|FG002|Part 3|Other NOS|0|||
23567636|NCT03485911|65807126|FG003|Part 3|Other NOS|0|||
23567637|NCT03485911|65807123|FG000|Part 3|Intercurrent illness/new medical condition|0|||
23567638|NCT03485911|65807124|FG001|Part 3|Intercurrent illness/new medical condition|1|||
23567639|NCT03485911|65807125|FG002|Part 3|Intercurrent illness/new medical condition|1|||
23567640|NCT03485911|65807126|FG003|Part 3|Intercurrent illness/new medical condition|0|||
23567641|NCT03485911|65807123|FG000|Part 3|Sponsor discontinuation|1|||
23567642|NCT03485911|65807124|FG001|Part 3|Sponsor discontinuation|0|||
23567643|NCT03485911|65807125|FG002|Part 3|Sponsor discontinuation|0|||
23567644|NCT03485911|65807126|FG003|Part 3|Sponsor discontinuation|0|||
23567645|NCT03485911|65807123|FG000|Part 3|Berotralstat provided by alternative means|13|||
23567646|NCT03485911|65807124|FG001|Part 3|Berotralstat provided by alternative means|13|||
23567647|NCT03485911|65807125|FG002|Part 3|Berotralstat provided by alternative means|7|||
23567648|NCT03485911|65807126|FG003|Part 3|Berotralstat provided by alternative means|7|||
23567649|NCT02593305|65807127|FG000|Post 1|Comparison only group. No intervention.|0|||
23567650|NCT02593305|65807128|FG001|Post 1|Comparison only group. No intervention.|0|||
23567651|NCT02593305|65807129|FG002|Post 1|Comparison only group. No intervention.|10|||
23567652|NCT00810082|65807130|FG000|Overall Study|Lost to Follow-up|0|||
23567653|NCT00810082|65807131|FG001|Overall Study|Lost to Follow-up|4|||
23567654|NCT01678820|65807135|FG000|Overall Study|Study Terminated by Sponsor|45|||
23567655|NCT01678820|65807136|FG001|Overall Study|Study Terminated by Sponsor|43|||
23567656|NCT01678820|65807137|FG002|Overall Study|Study Terminated by Sponsor|43|||
23567657|NCT01678820|65807135|FG000|Overall Study|Withdrawal by Subject|2|||
23567658|NCT01678820|65807136|FG001|Overall Study|Withdrawal by Subject|5|||
23567659|NCT01678820|65807137|FG002|Overall Study|Withdrawal by Subject|2|||
23567660|NCT01678820|65807135|FG000|Overall Study|Protocol Specified Criteria|2|||
23567661|NCT01678820|65807136|FG001|Overall Study|Protocol Specified Criteria|3|||
23567662|NCT01678820|65807137|FG002|Overall Study|Protocol Specified Criteria|1|||
23567663|NCT01678820|65807135|FG000|Overall Study|Adverse Event|2|||
23567664|NCT01678820|65807136|FG001|Overall Study|Adverse Event|2|||
23567665|NCT01678820|65807137|FG002|Overall Study|Adverse Event|2|||
23567666|NCT01678820|65807135|FG000|Overall Study|Lost to Follow-up|7|||
23567667|NCT01678820|65807136|FG001|Overall Study|Lost to Follow-up|2|||
23567668|NCT01678820|65807137|FG002|Overall Study|Lost to Follow-up|2|||
23567669|NCT01678820|65807135|FG000|Overall Study|Non-compliance with study drug|0|||
23567670|NCT01678820|65807136|FG001|Overall Study|Non-compliance with study drug|1|||
23567671|NCT01678820|65807137|FG002|Overall Study|Non-compliance with study drug|0|||
23567672|NCT01678820|65807135|FG000|Overall Study|Physician Decision|0|||
23567673|NCT01678820|65807136|FG001|Overall Study|Physician Decision|0|||
23567674|NCT01678820|65807137|FG002|Overall Study|Physician Decision|1|||
23567675|NCT01678820|65807135|FG000|Overall Study|Protocol Violation|4|||
23567676|NCT01678820|65807136|FG001|Overall Study|Protocol Violation|5|||
23567677|NCT01678820|65807137|FG002|Overall Study|Protocol Violation|4|||
23567678|NCT01678820|65807135|FG000|Overall Study|Not treated with double-blind study drug|0|||
23567679|NCT01678820|65807136|FG001|Overall Study|Not treated with double-blind study drug|2|||
23567680|NCT01678820|65807137|FG002|Overall Study|Not treated with double-blind study drug|2|||
23567681|NCT04789577|65807140|FG000|Overall Study|Withdrawal by Subject|1|||
23567682|NCT04789577|65807141|FG001|Overall Study|Withdrawal by Subject|1|||
23567683|NCT04789577|65807142|FG002|Overall Study|Withdrawal by Subject|1|||
23629350|NCT01468077|66028277|FG000|Overall Study|Lack of Efficacy|1|||
23629351|NCT01468077|66028278|FG001|Overall Study|Lack of Efficacy|1|||
23629352|NCT01468077|66028277|FG000|Overall Study|Physician Decision|1|||
23629353|NCT01468077|66028278|FG001|Overall Study|Physician Decision|0|||
23629354|NCT03334253|66028283|FG000|Overall Study|Withdrawal by Subject|1|||
23629355|NCT03334253|66028284|FG001|Overall Study|Withdrawal by Subject|0|||
23629356|NCT03334253|66028283|FG000|Overall Study|Lost to Follow-up|4|||
23629357|NCT03334253|66028284|FG001|Overall Study|Lost to Follow-up|3|||
23629358|NCT03334253|66028283|FG000|Overall Study|Moved residence|2|||
23629359|NCT03334253|66028284|FG001|Overall Study|Moved residence|2|||
23629360|NCT02818998|66028285|FG000|Overall Study|Adverse Event|3|||
23629361|NCT02818998|66028286|FG001|Overall Study|Adverse Event|2|||
23629362|NCT02818998|66028287|FG002|Overall Study|Adverse Event|1|||
23629363|NCT02818998|66028285|FG000|Overall Study|Lost to Follow-up|4|||
23765971|NCT01078623|66521865|FG006|Treatment Period 4|Adverse Event|0|||
23765972|NCT01078623|66521866|FG007|Treatment Period 4|Adverse Event|0|||
23765973|NCT01078623|66521867|FG008|Treatment Period 4|Adverse Event|0|||
23765974|NCT01078623|66521868|FG009|Treatment Period 4|Adverse Event|0|||
23765975|NCT01078623|66521869|FG010|Treatment Period 4|Adverse Event|0|||
23765976|NCT01078623|66521870|FG011|Treatment Period 4|Adverse Event|0|||
23765977|NCT01078623|66521871|FG012|Treatment Period 4|Adverse Event|0|||
23765978|NCT01078623|66521872|FG013|Treatment Period 4|Adverse Event|0|||
23765979|NCT01078623|66521873|FG014|Treatment Period 4|Adverse Event|0|||
23765980|NCT01078623|66521874|FG015|Treatment Period 4|Adverse Event|0|||
23567684|NCT04789577|65807143|FG003|Overall Study|Withdrawal by Subject|3|||
23765981|NCT01078623|66521875|FG016|Treatment Period 4|Adverse Event|0|||
23765982|NCT01078623|66521876|FG017|Treatment Period 4|Adverse Event|0|||
23765983|NCT01078623|66521877|FG018|Treatment Period 4|Adverse Event|0|||
23765984|NCT01078623|66521878|FG019|Treatment Period 4|Adverse Event|0|||
23765985|NCT01078623|66521859|FG000|Treatment Period 4|Withdrawal by Subject|0|||
23765986|NCT01078623|66521860|FG001|Treatment Period 4|Withdrawal by Subject|0|||
23765987|NCT01078623|66521861|FG002|Treatment Period 4|Withdrawal by Subject|0|||
23765988|NCT01078623|66521862|FG003|Treatment Period 4|Withdrawal by Subject|0|||
23765989|NCT01078623|66521863|FG004|Treatment Period 4|Withdrawal by Subject|0|||
23765990|NCT01078623|66521864|FG005|Treatment Period 4|Withdrawal by Subject|0|||
23765991|NCT01078623|66521865|FG006|Treatment Period 4|Withdrawal by Subject|0|||
23765992|NCT01078623|66521866|FG007|Treatment Period 4|Withdrawal by Subject|0|||
23765993|NCT01078623|66521867|FG008|Treatment Period 4|Withdrawal by Subject|0|||
23765994|NCT01078623|66521868|FG009|Treatment Period 4|Withdrawal by Subject|0|||
23765995|NCT01078623|66521869|FG010|Treatment Period 4|Withdrawal by Subject|0|||
23765996|NCT01078623|66521870|FG011|Treatment Period 4|Withdrawal by Subject|0|||
23765997|NCT01078623|66521871|FG012|Treatment Period 4|Withdrawal by Subject|0|||
23765998|NCT01078623|66521872|FG013|Treatment Period 4|Withdrawal by Subject|0|||
23765999|NCT01078623|66521873|FG014|Treatment Period 4|Withdrawal by Subject|0|||
23766000|NCT01078623|66521874|FG015|Treatment Period 4|Withdrawal by Subject|1|||
23766001|NCT01078623|66521875|FG016|Treatment Period 4|Withdrawal by Subject|0|||
23766002|NCT01078623|66521876|FG017|Treatment Period 4|Withdrawal by Subject|0|||
23766003|NCT01078623|66521877|FG018|Treatment Period 4|Withdrawal by Subject|0|||
23766004|NCT01078623|66521878|FG019|Treatment Period 4|Withdrawal by Subject|0|||
23766005|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
23766006|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
23766007|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
23766008|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
23766009|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
23766010|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
23766011|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
23766012|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
23766013|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
23766014|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
23766015|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
23567685|NCT04789577|65807144|FG004|Overall Study|Withdrawal by Subject|1|||
23567686|NCT04789577|65807145|FG005|Overall Study|Withdrawal by Subject|7|||
23567687|NCT04789577|65807146|FG006|Overall Study|Withdrawal by Subject|1|||
23567688|NCT04789577|65807140|FG000|Overall Study|Lost to Follow-up|7|||
23567689|NCT04789577|65807141|FG001|Overall Study|Lost to Follow-up|12|||
23567690|NCT04789577|65807142|FG002|Overall Study|Lost to Follow-up|7|||
23567691|NCT04789577|65807143|FG003|Overall Study|Lost to Follow-up|10|||
23629364|NCT02818998|66028286|FG001|Overall Study|Lost to Follow-up|1|||
23766016|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
23629365|NCT02818998|66028287|FG002|Overall Study|Lost to Follow-up|2|||
23629366|NCT02818998|66028285|FG000|Overall Study|Withdrawal by sponsor|0|||
23629367|NCT02818998|66028286|FG001|Overall Study|Withdrawal by sponsor|1|||
23766017|NCT01227668|66521879|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
23829375|NCT01103180|66755846|FG000|Overall Study|Lost to Follow-up|13|||
23567692|NCT04789577|65807144|FG004|Overall Study|Lost to Follow-up|8|||
23567693|NCT04789577|65807145|FG005|Overall Study|Lost to Follow-up|6|||
23629368|NCT02818998|66028287|FG002|Overall Study|Withdrawal by sponsor|1|||
23629369|NCT02818998|66028285|FG000|Overall Study|Death|3|||
23629370|NCT02818998|66028286|FG001|Overall Study|Death|6|||
23629371|NCT02818998|66028287|FG002|Overall Study|Death|8|||
23629372|NCT02818998|66028285|FG000|Overall Study|Withdrawal by Subject|7|||
23629373|NCT02818998|66028286|FG001|Overall Study|Withdrawal by Subject|6|||
23629374|NCT02818998|66028287|FG002|Overall Study|Withdrawal by Subject|6|||
23629375|NCT02818998|66028285|FG000|Overall Study|Physician Decision|1|||
23629376|NCT02818998|66028286|FG001|Overall Study|Physician Decision|0|||
23629377|NCT02818998|66028287|FG002|Overall Study|Physician Decision|0|||
23629378|NCT01261247|66028288|FG000|Overall Study|Ineligible|2|||
23629379|NCT00681668|66028289|FG000|Overall Study|Protocol Violation|1|||
23629380|NCT00681668|66028289|FG000|Overall Study|Withdrawal by Subject|1|||
23629381|NCT01594827|66028290|FG000|Overall Study|Adverse Event|1|||
23629382|NCT01594827|66028291|FG001|Overall Study|Adverse Event|0|||
23629383|NCT01594827|66028290|FG000|Overall Study|Physician Decision|3|||
23629384|NCT01594827|66028291|FG001|Overall Study|Physician Decision|0|||
23629385|NCT02636608|66028298|FG000|Overall Study|Failure to Return|4|||
23629386|NCT02636608|66028298|FG000|Overall Study|Insufficient Virological Response|1|||
23629387|NCT02636608|66028298|FG000|Overall Study|Death|3|||
23629388|NCT02636608|66028298|FG000|Overall Study|Other|2|||
23629389|NCT02636608|66028298|FG000|Overall Study|Did Not Receive Treatment|1|||
23629390|NCT02522728|66028301|FG000|Overall Study|Withdrawal by Subject|6|||
23629391|NCT02522728|66028302|FG001|Overall Study|Withdrawal by Subject|6|||
23629392|NCT02522728|66028301|FG000|Overall Study|Death|4|||
23629393|NCT02522728|66028302|FG001|Overall Study|Death|3|||
23629394|NCT02522728|66028301|FG000|Overall Study|Adverse Event|2|||
23629395|NCT02522728|66028302|FG001|Overall Study|Adverse Event|1|||
23629396|NCT02522728|66028301|FG000|Overall Study|Did not receive randomized study device|0|||
23629397|NCT02522728|66028302|FG001|Overall Study|Did not receive randomized study device|1|||
23629398|NCT00936598|66028303|FG000|Overall Study|Withdrawal by Subject|1|||
23629399|NCT00936598|66028304|FG001|Overall Study|Withdrawal by Subject|0|||
23629400|NCT00936598|66028303|FG000|Overall Study|Ineligible after consent|1|||
23629401|NCT00936598|66028304|FG001|Overall Study|Ineligible after consent|0|||
23629402|NCT01660256|66028307|FG000|Overall Study|Adverse Event|4|||
23629403|NCT01660256|66028308|FG001|Overall Study|Adverse Event|0|||
23629404|NCT01660256|66028309|FG002|Overall Study|Adverse Event|2|||
23629405|NCT01660256|66028307|FG000|Overall Study|Withdrawal by Subject|1|||
23629406|NCT01660256|66028308|FG001|Overall Study|Withdrawal by Subject|0|||
23629407|NCT01660256|66028309|FG002|Overall Study|Withdrawal by Subject|2|||
23629408|NCT03513068|66028311|FG000|Overall Study|Death|1|||
23629409|NCT03513068|66028312|FG001|Overall Study|Death|0|||
23629410|NCT03513068|66028311|FG000|Overall Study|Withdrawal by Subject|4|||
23629411|NCT03513068|66028312|FG001|Overall Study|Withdrawal by Subject|6|||
23629412|NCT00916305|66028313|FG000|Overall Study|Lost to Follow-up|21|||
23629413|NCT00916305|66028314|FG001|Overall Study|Lost to Follow-up|27|||
23629414|NCT00916305|66028313|FG000|Overall Study|Withdrawal by Subject|0|||
23629415|NCT00916305|66028314|FG001|Overall Study|Withdrawal by Subject|1|||
23629416|NCT02344342|66028315|FG000|Overall Study|Industry partner dropped out|11|||
23629417|NCT02344342|66028316|FG001|Overall Study|Industry partner dropped out|9|||
23629418|NCT02344342|66028317|FG002|Overall Study|Industry partner dropped out|14|||
23629419|NCT02344342|66028318|FG003|Overall Study|Industry partner dropped out|10|||
23629420|NCT03178045|66028320|FG000|Overall Study|Withdrawal by Subject|5|||
23629421|NCT03178045|66028321|FG001|Overall Study|Withdrawal by Subject|7|||
23629422|NCT03178045|66028320|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
23629423|NCT03178045|66028321|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
23629424|NCT03178045|66028320|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
23629425|NCT03178045|66028321|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
23629426|NCT00913523|66028322|FG000|Overall Study|Withdrawal by Subject|3|||
23629427|NCT00913523|66028323|FG001|Overall Study|Withdrawal by Subject|2|||
23766018|NCT01227668|66521880|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
23766019|NCT01227668|66521879|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
23766020|NCT01227668|66521880|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
23766021|NCT01227668|66521879|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
23629428|NCT00913523|66028324|FG002|Overall Study|Withdrawal by Subject|2|||
23629429|NCT00913523|66028322|FG000|Overall Study|Lost to Follow-up|1|||
23629430|NCT00913523|66028323|FG001|Overall Study|Lost to Follow-up|1|||
23629431|NCT00913523|66028324|FG002|Overall Study|Lost to Follow-up|1|||
23629432|NCT00913523|66028322|FG000|Overall Study|Adverse Event|1|||
23629433|NCT00913523|66028323|FG001|Overall Study|Adverse Event|0|||
23629434|NCT00913523|66028324|FG002|Overall Study|Adverse Event|0|||
23629435|NCT00913523|66028322|FG000|Overall Study|Protocol Violation|5|||
23629436|NCT00913523|66028323|FG001|Overall Study|Protocol Violation|8|||
23629437|NCT00913523|66028324|FG002|Overall Study|Protocol Violation|8|||
23629438|NCT00913523|66028322|FG000|Overall Study|Pregnancy|1|||
23629439|NCT00913523|66028323|FG001|Overall Study|Pregnancy|3|||
23629440|NCT00913523|66028324|FG002|Overall Study|Pregnancy|0|||
23629441|NCT00913523|66028322|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
23629442|NCT00913523|66028323|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
23629443|NCT00913523|66028324|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
23629444|NCT00383123|66028325|FG000|Overall Study|Adverse Event|1|||
23629445|NCT00383123|66028326|FG001|Overall Study|Adverse Event|0|||
23629446|NCT00383123|66028325|FG000|Overall Study|Lost to Follow-up|68|||
23629447|NCT00383123|66028326|FG001|Overall Study|Lost to Follow-up|61|||
23629448|NCT00383123|66028325|FG000|Overall Study|Protocol Violation|5|||
23629449|NCT00383123|66028326|FG001|Overall Study|Protocol Violation|1|||
23629450|NCT00383123|66028325|FG000|Overall Study|Withdrawal by Subject|27|||
23629451|NCT00383123|66028326|FG001|Overall Study|Withdrawal by Subject|18|||
23629452|NCT00383123|66028325|FG000|Overall Study|Other reason|10|||
23629453|NCT00383123|66028326|FG001|Overall Study|Other reason|6|||
23629454|NCT02825251|66028327|FG000|Overall Study|Adverse Event|0|||
23629455|NCT02825251|66028328|FG001|Overall Study|Adverse Event|1|||
23629456|NCT02825251|66028327|FG000|Overall Study|Lost to Follow-up|0|||
23629457|NCT02825251|66028328|FG001|Overall Study|Lost to Follow-up|1|||
23629458|NCT02825251|66028327|FG000|Overall Study|Withdrawal by Subject|1|||
23629459|NCT02825251|66028328|FG001|Overall Study|Withdrawal by Subject|4|||
23629460|NCT02825251|66028327|FG000|Overall Study|Unclassified|2|||
23629461|NCT02825251|66028328|FG001|Overall Study|Unclassified|0|||
23629462|NCT01791413|66028329|FG000|Overall Study|Lost to Follow-up|5|||
23629463|NCT01791413|66028330|FG001|Overall Study|Lost to Follow-up|1|||
23629464|NCT00475228|66028331|FG000|Overall Study|Lost to Follow-up|17|||
23629465|NCT00475228|66028332|FG001|Overall Study|Lost to Follow-up|17|||
23629466|NCT00447590|66028339|FG000|Overall Study|Withdrawal by Subject|26|||
23629467|NCT00447590|66028339|FG000|Overall Study|Lost to Follow-up|24|||
23629468|NCT00447590|66028339|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
23629469|NCT03358238|66028340|FG000|Overall Study|Withdrawal by Subject|0|||
23629470|NCT03358238|66028341|FG001|Overall Study|Withdrawal by Subject|1|||
23629471|NCT00839956|66028344|FG000|Overall Study|Adverse Event|2|||
23629472|NCT00839956|66028344|FG000|Overall Study|Lack of Efficacy|6|||
23629473|NCT00839956|66028344|FG000|Overall Study|Physician Decision|1|||
23629474|NCT00839956|66028344|FG000|Overall Study|Withdrawal by Subject|3|||
23636654|NCT00534495|66052953|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
23636655|NCT00534495|66052954|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
23636656|NCT00534495|66052955|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
23636657|NCT00534495|66052953|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
23636658|NCT00534495|66052954|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
23636659|NCT00534495|66052955|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
23636660|NCT00534495|66052953|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
23636661|NCT00534495|66052954|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
23636662|NCT00534495|66052955|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
23636663|NCT00534495|66052953|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
23636664|NCT00534495|66052954|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
23636665|NCT00534495|66052955|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
23636666|NCT02159040|66052956|FG000|Overall Study|Death|1|||
23636667|NCT00734591|66052957|FG000|Screening for Prospective Period|Site did not participate|1604|||
23636668|NCT00734591|66052958|FG001|Screening for Prospective Period|Site did not participate|1488|||
23636669|NCT00734591|66052957|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
23636670|NCT00734591|66052958|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
23636671|NCT00734591|66052957|FG000|Prospective Period|Withdrawal by Subject|11|||
23829376|NCT01103180|66755847|FG001|Overall Study|Lost to Follow-up|7|||
23567694|NCT04789577|65807146|FG006|Overall Study|Lost to Follow-up|10|||
23567695|NCT04789577|65807140|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
23567696|NCT04789577|65807141|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
23567697|NCT04789577|65807142|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
23567698|NCT04789577|65807143|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
23567699|NCT04789577|65807144|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
23567700|NCT04789577|65807145|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
23567701|NCT04789577|65807146|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
23567702|NCT04789577|65807140|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
23567703|NCT04789577|65807141|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
23567704|NCT04789577|65807142|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
23567705|NCT04789577|65807143|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
23567706|NCT04789577|65807144|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
23567707|NCT04789577|65807145|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
23567708|NCT04789577|65807146|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
23567709|NCT01486758|65807147|FG000|Overall Study|Lost to Follow-up|0|||
23567710|NCT01486758|65807148|FG001|Overall Study|Lost to Follow-up|1|||
23567711|NCT00976482|65807153|FG000|Overall Study|Death|208|||
23567712|NCT00976482|65807153|FG000|Overall Study|Withdrawal by Subject|45|||
23567713|NCT00976482|65807153|FG000|Overall Study|Center terminated|1|||
23629475|NCT04120376|66031951|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
23445610|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
23629476|NCT04120376|66031952|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
23629477|NCT00307047|66031953|FG000|Overall Study|Lost to Follow-up|35|||
23629478|NCT00307047|66031954|FG001|Overall Study|Lost to Follow-up|24|||
23629479|NCT00307047|66031953|FG000|Overall Study|Withdrawal by Subject|6|||
23629480|NCT00307047|66031954|FG001|Overall Study|Withdrawal by Subject|6|||
23629481|NCT00307047|66031953|FG000|Overall Study|Physician Decision|1|||
23629482|NCT00307047|66031954|FG001|Overall Study|Physician Decision|2|||
23629483|NCT00307047|66031953|FG000|Overall Study|Lost to follow-up for other reasons|0|||
23629484|NCT00307047|66031954|FG001|Overall Study|Lost to follow-up for other reasons|1|||
23766022|NCT01227668|66521880|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
23766023|NCT01227668|66521879|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
23766024|NCT01227668|66521880|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
23766025|NCT01227668|66521879|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
23766026|NCT01227668|66521880|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
23766027|NCT01227668|66521879|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
23629485|NCT00307047|66031953|FG000|Overall Study|All death, all MI, all Revascularization|27|||
23629486|NCT00307047|66031954|FG001|Overall Study|All death, all MI, all Revascularization|16|||
23629487|NCT02232399|66031955|FG000|Overall Study|Adverse Event|1|||
23629488|NCT02232399|66031956|FG001|Overall Study|Adverse Event|0|||
23629489|NCT02232399|66031955|FG000|Overall Study|Withdrawal by Subject|0|||
23629490|NCT02232399|66031956|FG001|Overall Study|Withdrawal by Subject|1|||
23629491|NCT01519778|66031957|FG000|Overall Study|Withdrawal by Subject|3|||
23629492|NCT01519778|66031957|FG000|Overall Study|Lost to Follow-up|10|||
23629493|NCT01519778|66031957|FG000|Overall Study|Physician Decision|1|||
23629494|NCT00350727|66031958|FG000|Phase I: Dose Escalation|Adverse Event|4|||
23629495|NCT00350727|66031959|FG001|Phase I: Dose Escalation|Adverse Event|0|||
23629496|NCT00350727|66031960|FG002|Phase I: Dose Escalation|Adverse Event|0|||
23629497|NCT00350727|66031958|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
23629498|NCT00350727|66031959|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
23629499|NCT00350727|66031960|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
23629500|NCT00350727|66031958|FG000|Phase I: Dose Escalation|Death|1|||
23629501|NCT00350727|66031959|FG001|Phase I: Dose Escalation|Death|0|||
23629502|NCT00350727|66031960|FG002|Phase I: Dose Escalation|Death|0|||
23629503|NCT00350727|66031958|FG000|Phase I: Dose Escalation|Physician Decision|1|||
23629504|NCT00350727|66031959|FG001|Phase I: Dose Escalation|Physician Decision|0|||
23629505|NCT00350727|66031960|FG002|Phase I: Dose Escalation|Physician Decision|0|||
23629506|NCT00350727|66031958|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
23629507|NCT00350727|66031959|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
23629508|NCT00350727|66031960|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
23629509|NCT00350727|66031958|FG000|Phase II|Disease Progression|0|||
23629510|NCT00350727|66031959|FG001|Phase II|Disease Progression|15|||
23629511|NCT00350727|66031960|FG002|Phase II|Disease Progression|16|||
23629512|NCT00350727|66031958|FG000|Phase II|Clinical Deterioration|0|||
23766028|NCT01227668|66521880|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
23766029|NCT03734237|66521881|FG000|Overall Study|Lost to Follow-up|1|||
23766030|NCT03734237|66521882|FG001|Overall Study|Lost to Follow-up|3|||
23766031|NCT03734237|66521883|FG002|Overall Study|Lost to Follow-up|0|||
23766032|NCT03734237|66521881|FG000|Overall Study|Withdrawal by Subject|7|||
23766033|NCT03734237|66521882|FG001|Overall Study|Withdrawal by Subject|9|||
23766034|NCT03734237|66521883|FG002|Overall Study|Withdrawal by Subject|10|||
23445611|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
23629513|NCT00350727|66031959|FG001|Phase II|Clinical Deterioration|1|||
23629514|NCT00350727|66031960|FG002|Phase II|Clinical Deterioration|0|||
23766035|NCT00927810|66521884|FG000|Overall Study|Withdrawal by Subject|0|||
23766036|NCT00927810|66521885|FG001|Overall Study|Withdrawal by Subject|3|||
23629515|NCT00350727|66031958|FG000|Phase II|Withdrawal by Subject|0|||
23629516|NCT00350727|66031959|FG001|Phase II|Withdrawal by Subject|2|||
23629517|NCT00350727|66031960|FG002|Phase II|Withdrawal by Subject|1|||
23629518|NCT00350727|66031958|FG000|Phase II|Adverse Event|0|||
23629519|NCT00350727|66031959|FG001|Phase II|Adverse Event|1|||
23629520|NCT00350727|66031960|FG002|Phase II|Adverse Event|1|||
23629521|NCT00350727|66031958|FG000|Phase II|Death|0|||
23629522|NCT00350727|66031959|FG001|Phase II|Death|0|||
23629523|NCT00350727|66031960|FG002|Phase II|Death|2|||
23766037|NCT00927810|66521886|FG002|Overall Study|Withdrawal by Subject|0|||
23766038|NCT00927810|66521887|FG003|Overall Study|Withdrawal by Subject|1|||
23766039|NCT00927810|66521884|FG000|Overall Study|Lost to Follow-up|0|||
23766040|NCT00927810|66521885|FG001|Overall Study|Lost to Follow-up|2|||
23766041|NCT00927810|66521886|FG002|Overall Study|Lost to Follow-up|1|||
23766042|NCT00927810|66521887|FG003|Overall Study|Lost to Follow-up|1|||
23766043|NCT00927810|66521884|FG000|Overall Study|Death|0|||
23766044|NCT00927810|66521885|FG001|Overall Study|Death|2|||
23766045|NCT00927810|66521886|FG002|Overall Study|Death|0|||
23766046|NCT00927810|66521887|FG003|Overall Study|Death|0|||
23766047|NCT00927810|66521884|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23766048|NCT00927810|66521885|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23766049|NCT00927810|66521886|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23766050|NCT00927810|66521887|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23766051|NCT00601484|66521888|FG000|Overall Study|Adverse Event|0|||
23766052|NCT00601484|66521889|FG001|Overall Study|Adverse Event|1|||
23766053|NCT00601484|66521888|FG000|Overall Study|Lost to Follow-up|4|||
23766054|NCT00601484|66521889|FG001|Overall Study|Lost to Follow-up|3|||
23766055|NCT00601484|66521888|FG000|Overall Study|Lack of Efficacy|0|||
23766056|NCT00601484|66521889|FG001|Overall Study|Lack of Efficacy|2|||
23766057|NCT00601484|66521888|FG000|Overall Study|Withdrawal by Subject|1|||
23766058|NCT00601484|66521889|FG001|Overall Study|Withdrawal by Subject|1|||
23766059|NCT00601484|66521888|FG000|Overall Study|Randomized, but not treated|0|||
23766060|NCT00601484|66521889|FG001|Overall Study|Randomized, but not treated|1|||
23766061|NCT02919475|66521892|FG000|Overall Study|Adverse Event|3|||
23766062|NCT02919475|66521893|FG001|Overall Study|Adverse Event|3|||
23766063|NCT02919475|66521894|FG002|Overall Study|Adverse Event|3|||
23829377|NCT01103180|66755846|FG000|Overall Study|Physician Decision|1|||
23629524|NCT00350727|66031958|FG000|Phase II|Sponsor Terminated Study|0|||
23766064|NCT02919475|66521895|FG003|Overall Study|Adverse Event|9|||
23766065|NCT02919475|66521896|FG004|Overall Study|Adverse Event|2|||
23629525|NCT00350727|66031959|FG001|Phase II|Sponsor Terminated Study|0|||
23629526|NCT00350727|66031960|FG002|Phase II|Sponsor Terminated Study|1|||
23766066|NCT02919475|66521892|FG000|Overall Study|Death|0|||
23766067|NCT02919475|66521893|FG001|Overall Study|Death|1|||
23766068|NCT02919475|66521894|FG002|Overall Study|Death|0|||
23766069|NCT02919475|66521895|FG003|Overall Study|Death|0|||
23766070|NCT02919475|66521896|FG004|Overall Study|Death|0|||
23766071|NCT02919475|66521892|FG000|Overall Study|Lost to Follow-up|0|||
23766072|NCT02919475|66521893|FG001|Overall Study|Lost to Follow-up|0|||
23766073|NCT02919475|66521894|FG002|Overall Study|Lost to Follow-up|0|||
23766074|NCT02919475|66521895|FG003|Overall Study|Lost to Follow-up|1|||
23766075|NCT02919475|66521896|FG004|Overall Study|Lost to Follow-up|0|||
23766076|NCT02919475|66521892|FG000|Overall Study|Withdrawal by Subject|2|||
23766077|NCT02919475|66521893|FG001|Overall Study|Withdrawal by Subject|3|||
23766078|NCT02919475|66521894|FG002|Overall Study|Withdrawal by Subject|1|||
23766079|NCT02919475|66521895|FG003|Overall Study|Withdrawal by Subject|2|||
23766080|NCT02919475|66521896|FG004|Overall Study|Withdrawal by Subject|2|||
23766081|NCT02919475|66521892|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23766082|NCT02919475|66521893|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23766083|NCT02919475|66521894|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23766084|NCT02919475|66521895|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23766085|NCT02919475|66521896|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23766086|NCT01165996|66521897|FG000|Overall Study|Death|1|||
23766087|NCT01165996|66521897|FG000|Overall Study|Physician Decision|1|||
23766088|NCT01048333|66521898|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23567714|NCT00976482|65807153|FG000|Overall Study|Protocol Violation|5|||
23567715|NCT02468934|65807165|FG000|Overall Study|Withdrawal by Subject|4|||
23567716|NCT02468934|65807165|FG000|Overall Study|Screen Failure|3|||
23567717|NCT01794117|65807166|FG000|Overall Study|Adverse Event|1|||
23567718|NCT01794117|65807167|FG001|Overall Study|Adverse Event|0|||
23567719|NCT01794117|65807168|FG002|Overall Study|Adverse Event|0|||
23567720|NCT01794117|65807169|FG003|Overall Study|Adverse Event|0|||
23567721|NCT01794117|65807166|FG000|Overall Study|Participant noncompliance|0|||
23567722|NCT01794117|65807167|FG001|Overall Study|Participant noncompliance|1|||
23567723|NCT01794117|65807168|FG002|Overall Study|Participant noncompliance|0|||
23567724|NCT01794117|65807169|FG003|Overall Study|Participant noncompliance|0|||
23567725|NCT01794117|65807166|FG000|Overall Study|Refused further treatment|0|||
23567726|NCT01794117|65807167|FG001|Overall Study|Refused further treatment|2|||
23567727|NCT01794117|65807168|FG002|Overall Study|Refused further treatment|0|||
23567728|NCT01794117|65807169|FG003|Overall Study|Refused further treatment|0|||
23567729|NCT01848834|65807170|FG000|Overall Study|Adverse Event|3|||
23567730|NCT01848834|65807171|FG001|Overall Study|Adverse Event|11|||
23567731|NCT01848834|65807172|FG002|Overall Study|Adverse Event|3|||
23567732|NCT01848834|65807173|FG003|Overall Study|Adverse Event|5|||
23567733|NCT01848834|65807174|FG004|Overall Study|Adverse Event|9|||
23567734|NCT01848834|65807170|FG000|Overall Study|Death|2|||
23567735|NCT01848834|65807171|FG001|Overall Study|Death|11|||
23567736|NCT01848834|65807172|FG002|Overall Study|Death|1|||
23567737|NCT01848834|65807173|FG003|Overall Study|Death|8|||
23567738|NCT01848834|65807174|FG004|Overall Study|Death|27|||
23567739|NCT01848834|65807170|FG000|Overall Study|Excluded Medication|5|||
23567740|NCT01848834|65807171|FG001|Overall Study|Excluded Medication|4|||
23567741|NCT01848834|65807172|FG002|Overall Study|Excluded Medication|3|||
23629527|NCT00350727|66031958|FG000|Phase II|Enrolled in Rollover Study|0|||
23567742|NCT01848834|65807173|FG003|Overall Study|Excluded Medication|6|||
23567743|NCT01848834|65807174|FG004|Overall Study|Excluded Medication|6|||
23567744|NCT01848834|65807170|FG000|Overall Study|Lost to Follow-up|5|||
23567745|NCT01848834|65807171|FG001|Overall Study|Lost to Follow-up|5|||
23766089|NCT01048333|66521899|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
23766090|NCT01048333|66521900|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23766091|NCT01048333|66521901|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23445612|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
23445613|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
23445614|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
23445615|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
23445616|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
23445617|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
23445618|NCT00685165|65373700|FG000|Washout Period of 14 Days|Adverse Event|1|||
23445619|NCT00685165|65373701|FG001|Washout Period of 14 Days|Adverse Event|0|||
23445620|NCT01288989|65373703|FG000|Overall Study|Death|0|||
23445621|NCT01288989|65373704|FG001|Overall Study|Death|0|||
23445622|NCT01288989|65373705|FG002|Overall Study|Death|0|||
23445623|NCT01288989|65373706|FG003|Overall Study|Death|1|||
23445624|NCT01288989|65373707|FG004|Overall Study|Death|0|||
23445625|NCT01288989|65373703|FG000|Overall Study|Dose limiting toxicity|1|||
23445626|NCT01288989|65373704|FG001|Overall Study|Dose limiting toxicity|0|||
23445627|NCT01288989|65373705|FG002|Overall Study|Dose limiting toxicity|0|||
23445628|NCT01288989|65373706|FG003|Overall Study|Dose limiting toxicity|0|||
23445629|NCT01288989|65373707|FG004|Overall Study|Dose limiting toxicity|0|||
23445630|NCT01288989|65373703|FG000|Overall Study|Adverse Event|0|||
23445631|NCT01288989|65373704|FG001|Overall Study|Adverse Event|0|||
23445632|NCT01288989|65373705|FG002|Overall Study|Adverse Event|0|||
23445633|NCT01288989|65373706|FG003|Overall Study|Adverse Event|0|||
23445634|NCT01288989|65373707|FG004|Overall Study|Adverse Event|2|||
23445635|NCT01288989|65373703|FG000|Overall Study|Physician Decision|0|||
23445636|NCT01288989|65373704|FG001|Overall Study|Physician Decision|0|||
23445637|NCT01288989|65373705|FG002|Overall Study|Physician Decision|0|||
23445638|NCT01288989|65373706|FG003|Overall Study|Physician Decision|0|||
23445639|NCT01288989|65373707|FG004|Overall Study|Physician Decision|1|||
23445640|NCT01288989|65373703|FG000|Overall Study|Withdrawal by Subject|0|||
23445641|NCT01288989|65373704|FG001|Overall Study|Withdrawal by Subject|0|||
23445642|NCT01288989|65373705|FG002|Overall Study|Withdrawal by Subject|0|||
23445643|NCT01288989|65373706|FG003|Overall Study|Withdrawal by Subject|0|||
23445644|NCT01288989|65373707|FG004|Overall Study|Withdrawal by Subject|3|||
23567746|NCT01848834|65807172|FG002|Overall Study|Lost to Follow-up|3|||
23567747|NCT01848834|65807173|FG003|Overall Study|Lost to Follow-up|0|||
23567748|NCT01848834|65807174|FG004|Overall Study|Lost to Follow-up|3|||
23567749|NCT01848834|65807170|FG000|Overall Study|Physician Decision|1|||
23567750|NCT01848834|65807171|FG001|Overall Study|Physician Decision|3|||
23567751|NCT01848834|65807172|FG002|Overall Study|Physician Decision|4|||
23567752|NCT01848834|65807173|FG003|Overall Study|Physician Decision|0|||
23567753|NCT01848834|65807174|FG004|Overall Study|Physician Decision|11|||
23567754|NCT01848834|65807170|FG000|Overall Study|Protocol Violation|0|||
23567755|NCT01848834|65807171|FG001|Overall Study|Protocol Violation|0|||
23567756|NCT01848834|65807172|FG002|Overall Study|Protocol Violation|0|||
23567757|NCT01848834|65807173|FG003|Overall Study|Protocol Violation|0|||
23567758|NCT01848834|65807174|FG004|Overall Study|Protocol Violation|1|||
23567759|NCT01848834|65807170|FG000|Overall Study|Sponsor Decision|1|||
23567760|NCT01848834|65807171|FG001|Overall Study|Sponsor Decision|1|||
23766092|NCT01048333|66521902|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23766093|NCT01048333|66521903|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23766094|NCT01579474|66521904|FG000|Overall Study|Adverse Event|1|||
23829378|NCT01103180|66755847|FG001|Overall Study|Physician Decision|0|||
23829379|NCT01103180|66755846|FG000|Overall Study|Protocol Violation|0|||
23766095|NCT01579474|66521905|FG001|Overall Study|Adverse Event|13|||
23766096|NCT01579474|66521906|FG002|Overall Study|Adverse Event|2|||
23766097|NCT01579474|66521907|FG003|Overall Study|Adverse Event|0|||
23766098|NCT01579474|66521908|FG004|Overall Study|Adverse Event|0|||
23766099|NCT01579474|66521909|FG005|Overall Study|Adverse Event|1|||
23766100|NCT01579474|66521904|FG000|Overall Study|Lack of Efficacy|1|||
23766101|NCT01579474|66521905|FG001|Overall Study|Lack of Efficacy|0|||
23766102|NCT01579474|66521906|FG002|Overall Study|Lack of Efficacy|0|||
23829380|NCT01103180|66755847|FG001|Overall Study|Protocol Violation|1|||
23829381|NCT00226499|66755848|FG000|Overall Study|Adverse Event|10|||
23829382|NCT00226499|66755849|FG001|Overall Study|Adverse Event|6|||
23829383|NCT00226499|66755850|FG002|Overall Study|Adverse Event|3|||
23829384|NCT00226499|66755848|FG000|Overall Study|Others|1064|||
23829385|NCT00226499|66755849|FG001|Overall Study|Others|1066|||
23829386|NCT00226499|66755850|FG002|Overall Study|Others|356|||
23829387|NCT02503540|66755851|FG000|Overall Study|Death|2|||
23829388|NCT02503540|66755851|FG000|Overall Study|Withdrawal by Subject|1|||
23829389|NCT00118157|66755852|FG000|Overall Study|Adverse Event|2|||
23829390|NCT00118157|66755852|FG000|Overall Study|Death|8|||
23829391|NCT00118157|66755852|FG000|Overall Study|Withdrawal by Subject|2|||
23829392|NCT01796392|66755854|FG000|Overall Study|Withdrawal by Subject|2|||
23829393|NCT01796392|66755855|FG001|Overall Study|Withdrawal by Subject|0|||
23829394|NCT01796392|66755854|FG000|Overall Study|Death|5|||
23829395|NCT01796392|66755855|FG001|Overall Study|Death|1|||
23829396|NCT01796392|66755854|FG000|Overall Study|Excluded for medical reasons|1|||
23829397|NCT01796392|66755855|FG001|Overall Study|Excluded for medical reasons|2|||
23829398|NCT01796392|66755854|FG000|Overall Study|Lost to Follow-up|1|||
23829399|NCT01796392|66755855|FG001|Overall Study|Lost to Follow-up|0|||
23829400|NCT03103087|66755895|FG000|Overall Study|Did not receive any study drug|1|||
23829401|NCT03103087|66755896|FG001|Overall Study|Did not receive any study drug|0|||
23829402|NCT03103087|66755897|FG002|Overall Study|Did not receive any study drug|0|||
23567761|NCT01848834|65807172|FG002|Overall Study|Sponsor Decision|0|||
23766103|NCT01579474|66521907|FG003|Overall Study|Lack of Efficacy|0|||
23766104|NCT01579474|66521908|FG004|Overall Study|Lack of Efficacy|1|||
23766105|NCT01579474|66521909|FG005|Overall Study|Lack of Efficacy|0|||
23766106|NCT01579474|66521904|FG000|Overall Study|Withdrawal by Subject|1|||
23766107|NCT01579474|66521905|FG001|Overall Study|Withdrawal by Subject|0|||
23766108|NCT01579474|66521906|FG002|Overall Study|Withdrawal by Subject|0|||
23766109|NCT01579474|66521907|FG003|Overall Study|Withdrawal by Subject|0|||
23766110|NCT01579474|66521908|FG004|Overall Study|Withdrawal by Subject|0|||
23766111|NCT01579474|66521909|FG005|Overall Study|Withdrawal by Subject|0|||
23766112|NCT01104662|66521914|FG000|Overall Study|Adverse Event|2|||
23766113|NCT01104662|66521915|FG001|Overall Study|Adverse Event|2|||
23766114|NCT01104662|66521916|FG002|Overall Study|Adverse Event|0|||
23766115|NCT01104662|66521917|FG003|Overall Study|Adverse Event|1|||
23766116|NCT01104662|66521918|FG004|Overall Study|Adverse Event|1|||
23766117|NCT01104662|66521919|FG005|Overall Study|Adverse Event|1|||
23766118|NCT01104662|66521920|FG006|Overall Study|Adverse Event|0|||
23766119|NCT01104662|66521921|FG007|Overall Study|Adverse Event|0|||
23766120|NCT01104662|66521914|FG000|Overall Study|Clinical Failure|1|||
23766121|NCT01104662|66521915|FG001|Overall Study|Clinical Failure|0|||
23766122|NCT01104662|66521916|FG002|Overall Study|Clinical Failure|0|||
23766123|NCT01104662|66521917|FG003|Overall Study|Clinical Failure|0|||
23766124|NCT01104662|66521918|FG004|Overall Study|Clinical Failure|0|||
23766125|NCT01104662|66521919|FG005|Overall Study|Clinical Failure|1|||
23766126|NCT01104662|66521920|FG006|Overall Study|Clinical Failure|0|||
23766127|NCT01104662|66521921|FG007|Overall Study|Clinical Failure|0|||
23766128|NCT01104662|66521914|FG000|Overall Study|Participant left investigator's care|1|||
23766129|NCT01104662|66521915|FG001|Overall Study|Participant left investigator's care|1|||
23829403|NCT03103087|66755895|FG000|Overall Study|Protocol Violation|1|||
23829404|NCT03103087|66755896|FG001|Overall Study|Protocol Violation|2|||
23829405|NCT03103087|66755897|FG002|Overall Study|Protocol Violation|1|||
23567762|NCT01848834|65807173|FG003|Overall Study|Sponsor Decision|1|||
23567763|NCT01848834|65807174|FG004|Overall Study|Sponsor Decision|1|||
23567764|NCT01848834|65807170|FG000|Overall Study|Withdrawal by Subject|2|||
23567765|NCT01848834|65807171|FG001|Overall Study|Withdrawal by Subject|13|||
23567766|NCT01848834|65807172|FG002|Overall Study|Withdrawal by Subject|10|||
23567767|NCT01848834|65807173|FG003|Overall Study|Withdrawal by Subject|6|||
23567768|NCT01848834|65807174|FG004|Overall Study|Withdrawal by Subject|36|||
23567769|NCT01868035|65807175|FG000|Overall Study|Lost to Follow-up|3|||
23567770|NCT01868035|65807175|FG000|Overall Study|Withdrawal by Subject|1|||
23567771|NCT01868035|65807175|FG000|Overall Study|Progressive Disease|2|||
23567772|NCT01868035|65807175|FG000|Overall Study|Non-compliance|1|||
23567773|NCT00406419|65807179|FG000|Overall Study|Death|3|||
23445669|NCT02342223|65373715|FG000|Overall Study|Lost to Follow-up|1|||
23445670|NCT00511134|65373716|FG000|Overall Study|Withdrawal by Subject|0|||
23445671|NCT00511134|65373717|FG001|Overall Study|Withdrawal by Subject|2|||
23445672|NCT00132808|65373718|FG000|Stratum I|Adverse Event|2|||
23445673|NCT00132808|65373719|FG001|Stratum I|Adverse Event|1|||
23445674|NCT00132808|65373720|FG002|Stratum I|Adverse Event|0|||
23445675|NCT00132808|65373718|FG000|Stratum I|Lost to Follow-up|3|||
23445676|NCT00132808|65373719|FG001|Stratum I|Lost to Follow-up|4|||
23445677|NCT00132808|65373720|FG002|Stratum I|Lost to Follow-up|1|||
23445678|NCT00132808|65373718|FG000|Stratum I|Withdrawal by Subject|4|||
23445679|NCT00132808|65373719|FG001|Stratum I|Withdrawal by Subject|7|||
23445680|NCT00132808|65373720|FG002|Stratum I|Withdrawal by Subject|3|||
23445681|NCT00132808|65373718|FG000|Stratum I|Abnormal test procedure result (s)|0|||
23445682|NCT00132808|65373719|FG001|Stratum I|Abnormal test procedure result (s)|0|||
23445683|NCT00132808|65373720|FG002|Stratum I|Abnormal test procedure result (s)|1|||
23445684|NCT00132808|65373718|FG000|Stratum II|Adverse Event|1|||
23445685|NCT00132808|65373719|FG001|Stratum II|Adverse Event|2|||
23445686|NCT00132808|65373720|FG002|Stratum II|Adverse Event|1|||
23445687|NCT00132808|65373718|FG000|Stratum II|Death|1|||
23445688|NCT00132808|65373719|FG001|Stratum II|Death|0|||
23445689|NCT00132808|65373720|FG002|Stratum II|Death|0|||
23445690|NCT00132808|65373718|FG000|Stratum II|Lost to Follow-up|2|||
23445691|NCT00132808|65373719|FG001|Stratum II|Lost to Follow-up|2|||
23445692|NCT00132808|65373720|FG002|Stratum II|Lost to Follow-up|1|||
23445693|NCT00132808|65373718|FG000|Stratum II|Protocol Violation|0|||
23445694|NCT00132808|65373719|FG001|Stratum II|Protocol Violation|2|||
23445695|NCT00132808|65373720|FG002|Stratum II|Protocol Violation|1|||
23445696|NCT00132808|65373718|FG000|Stratum II|Withdrawal by Subject|4|||
23445697|NCT00132808|65373719|FG001|Stratum II|Withdrawal by Subject|9|||
23445698|NCT00132808|65373720|FG002|Stratum II|Withdrawal by Subject|6|||
23445699|NCT00782717|65373721|FG000|Overall Study|Adverse Event|2|||
23445700|NCT00782717|65373722|FG001|Overall Study|Adverse Event|5|||
23445701|NCT00782717|65373721|FG000|Overall Study|Patient decision unrelated to AE|6|||
23445702|NCT00782717|65373722|FG001|Overall Study|Patient decision unrelated to AE|3|||
23445703|NCT00782717|65373721|FG000|Overall Study|Noncompliance|2|||
23445704|NCT00782717|65373722|FG001|Overall Study|Noncompliance|1|||
23445705|NCT00782717|65373721|FG000|Overall Study|Treatment failure|3|||
23445706|NCT00782717|65373722|FG001|Overall Study|Treatment failure|14|||
23445707|NCT00782717|65373721|FG000|Overall Study|Enrollment close prior to surgery|1|||
23445708|NCT00782717|65373722|FG001|Overall Study|Enrollment close prior to surgery|0|||
23445709|NCT00782717|65373721|FG000|Overall Study|Did not meet entrance criteria|1|||
23445710|NCT00782717|65373722|FG001|Overall Study|Did not meet entrance criteria|3|||
23445711|NCT00782717|65373721|FG000|Overall Study|Exited in error|0|||
23445712|NCT00782717|65373722|FG001|Overall Study|Exited in error|2|||
23445713|NCT03738618|65373730|FG000|Overall Study|Protocol deviation|23|||
23445714|NCT03738618|65373731|FG001|Overall Study|Protocol deviation|0|||
23445715|NCT03738618|65373730|FG000|Overall Study|Adverse Event|4|||
23445716|NCT03738618|65373731|FG001|Overall Study|Adverse Event|0|||
23445717|NCT03738618|65373730|FG000|Overall Study|Lost to Follow-up|2|||
23445718|NCT03738618|65373731|FG001|Overall Study|Lost to Follow-up|0|||
23445719|NCT03738618|65373730|FG000|Overall Study|Randomization failure|1|||
23445720|NCT03738618|65373731|FG001|Overall Study|Randomization failure|0|||
23445721|NCT03738618|65373730|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
23445722|NCT03738618|65373731|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
23445723|NCT03738618|65373730|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
23445724|NCT03738618|65373731|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
23445725|NCT00931606|65373734|FG000|Overall Study|Death|1|||
23445726|NCT00931606|65373735|FG001|Overall Study|Death|3|||
23445727|NCT00931606|65373736|FG002|Overall Study|Death|2|||
23445728|NCT00931606|65373737|FG003|Overall Study|Death|0|||
23629528|NCT00350727|66031959|FG001|Phase II|Enrolled in Rollover Study|0|||
23445729|NCT00931606|65373734|FG000|Overall Study|Lost to Follow-up|0|||
23445730|NCT00931606|65373735|FG001|Overall Study|Lost to Follow-up|1|||
23445731|NCT00931606|65373736|FG002|Overall Study|Lost to Follow-up|0|||
23445732|NCT00931606|65373737|FG003|Overall Study|Lost to Follow-up|0|||
23445733|NCT00931606|65373734|FG000|Overall Study|Physician Decision|0|||
23445734|NCT00931606|65373735|FG001|Overall Study|Physician Decision|0|||
23445735|NCT00931606|65373736|FG002|Overall Study|Physician Decision|3|||
23445736|NCT00931606|65373737|FG003|Overall Study|Physician Decision|0|||
23445737|NCT00931606|65373734|FG000|Overall Study|Sponsor Decision|1|||
23445738|NCT00931606|65373735|FG001|Overall Study|Sponsor Decision|4|||
23445739|NCT00931606|65373736|FG002|Overall Study|Sponsor Decision|0|||
23445740|NCT00931606|65373737|FG003|Overall Study|Sponsor Decision|2|||
23445741|NCT00931606|65373734|FG000|Overall Study|Withdrawal by Subject|3|||
23445742|NCT00931606|65373735|FG001|Overall Study|Withdrawal by Subject|1|||
23445743|NCT00931606|65373736|FG002|Overall Study|Withdrawal by Subject|1|||
23445744|NCT00931606|65373737|FG003|Overall Study|Withdrawal by Subject|1|||
23445745|NCT02223715|65373738|FG000|Overall Study|Death|31|||
23445746|NCT02223715|65373738|FG000|Overall Study|Lost to Follow-up|73|||
23445747|NCT01010971|65373739|FG000|Overall Study|Adverse Event|2|||
23445748|NCT01010971|65373740|FG001|Overall Study|Adverse Event|4|||
23445749|NCT01010971|65373741|FG002|Overall Study|Adverse Event|3|||
23445750|NCT01010971|65373739|FG000|Overall Study|Withdrawal by Subject|0|||
23445751|NCT01010971|65373740|FG001|Overall Study|Withdrawal by Subject|2|||
23445752|NCT01010971|65373741|FG002|Overall Study|Withdrawal by Subject|5|||
23445753|NCT01010971|65373739|FG000|Overall Study|Lost to Follow-up|0|||
23445754|NCT01010971|65373740|FG001|Overall Study|Lost to Follow-up|2|||
23445755|NCT01010971|65373741|FG002|Overall Study|Lost to Follow-up|3|||
23445756|NCT01010971|65373739|FG000|Overall Study|Other|1|||
23445757|NCT01010971|65373740|FG001|Overall Study|Other|0|||
23445758|NCT01010971|65373741|FG002|Overall Study|Other|2|||
23445759|NCT03386721|65373742|FG000|Overall Study|Death|12|||
23445760|NCT03386721|65373743|FG001|Overall Study|Death|21|||
23445761|NCT03386721|65373744|FG002|Overall Study|Death|2|||
23445762|NCT03386721|65373745|FG003|Overall Study|Death|5|||
23445763|NCT03386721|65373746|FG004|Overall Study|Death|1|||
23445764|NCT03386721|65373747|FG005|Overall Study|Death|12|||
23445765|NCT03386721|65373748|FG006|Overall Study|Death|1|||
23445766|NCT03386721|65373749|FG007|Overall Study|Death|1|||
23445767|NCT03386721|65373750|FG008|Overall Study|Death|12|||
23445768|NCT03386721|65373751|FG009|Overall Study|Death|20|||
23445769|NCT03386721|65373752|FG010|Overall Study|Death|21|||
23445770|NCT03386721|65373753|FG011|Overall Study|Death|21|||
23445771|NCT03386721|65373754|FG012|Overall Study|Death|14|||
23445772|NCT03386721|65373755|FG013|Overall Study|Death|2|||
23445773|NCT03386721|65373756|FG014|Overall Study|Death|1|||
23445774|NCT03386721|65373742|FG000|Overall Study|Lost to Follow-up|1|||
23445775|NCT03386721|65373743|FG001|Overall Study|Lost to Follow-up|3|||
23445776|NCT03386721|65373744|FG002|Overall Study|Lost to Follow-up|0|||
23445777|NCT03386721|65373745|FG003|Overall Study|Lost to Follow-up|0|||
23445778|NCT03386721|65373746|FG004|Overall Study|Lost to Follow-up|0|||
23445779|NCT03386721|65373747|FG005|Overall Study|Lost to Follow-up|2|||
23445780|NCT03386721|65373748|FG006|Overall Study|Lost to Follow-up|1|||
23445781|NCT03386721|65373749|FG007|Overall Study|Lost to Follow-up|0|||
23445782|NCT03386721|65373750|FG008|Overall Study|Lost to Follow-up|1|||
23445783|NCT03386721|65373751|FG009|Overall Study|Lost to Follow-up|2|||
23629529|NCT00350727|66031960|FG002|Phase II|Enrolled in Rollover Study|1|||
23766130|NCT01104662|66521916|FG002|Overall Study|Participant left investigator's care|0|||
23445784|NCT03386721|65373752|FG010|Overall Study|Lost to Follow-up|1|||
23445785|NCT03386721|65373753|FG011|Overall Study|Lost to Follow-up|0|||
23445786|NCT03386721|65373754|FG012|Overall Study|Lost to Follow-up|0|||
23445787|NCT03386721|65373755|FG013|Overall Study|Lost to Follow-up|0|||
23567774|NCT00406419|65807180|FG001|Overall Study|Death|1|||
23567775|NCT00406419|65807181|FG002|Overall Study|Death|4|||
23567776|NCT00406419|65807179|FG000|Overall Study|Protocol Violation|6|||
23567777|NCT00406419|65807180|FG001|Overall Study|Protocol Violation|2|||
23567778|NCT00406419|65807181|FG002|Overall Study|Protocol Violation|5|||
23567779|NCT00406419|65807179|FG000|Overall Study|Study Terminated by Sponsor|260|||
23567780|NCT00406419|65807180|FG001|Overall Study|Study Terminated by Sponsor|288|||
23567781|NCT00406419|65807181|FG002|Overall Study|Study Terminated by Sponsor|282|||
23567782|NCT00406419|65807179|FG000|Overall Study|Withdrawal by Subject|17|||
23567783|NCT00406419|65807180|FG001|Overall Study|Withdrawal by Subject|24|||
23567784|NCT00406419|65807181|FG002|Overall Study|Withdrawal by Subject|26|||
23567785|NCT00406419|65807179|FG000|Overall Study|Lack of Efficacy|12|||
23629530|NCT01667926|66031961|FG000|Overall Study|Withdrawal by Subject|1|||
23629531|NCT01667926|66031962|FG001|Overall Study|Withdrawal by Subject|2|||
23629532|NCT01667926|66031963|FG002|Overall Study|Withdrawal by Subject|2|||
23629533|NCT01667926|66031961|FG000|Overall Study|Physician Decision|0|||
23445788|NCT03386721|65373756|FG014|Overall Study|Lost to Follow-up|0|||
23445789|NCT03386721|65373742|FG000|Overall Study|Reason not specified|3|||
23445790|NCT03386721|65373743|FG001|Overall Study|Reason not specified|0|||
23567786|NCT00406419|65807180|FG001|Overall Study|Lack of Efficacy|1|||
23567787|NCT00406419|65807181|FG002|Overall Study|Lack of Efficacy|6|||
23445791|NCT03386721|65373744|FG002|Overall Study|Reason not specified|0|||
23445792|NCT03386721|65373745|FG003|Overall Study|Reason not specified|0|||
23445793|NCT03386721|65373746|FG004|Overall Study|Reason not specified|0|||
23445794|NCT03386721|65373747|FG005|Overall Study|Reason not specified|3|||
23445795|NCT03386721|65373748|FG006|Overall Study|Reason not specified|1|||
23445796|NCT03386721|65373749|FG007|Overall Study|Reason not specified|0|||
23629534|NCT01667926|66031962|FG001|Overall Study|Physician Decision|0|||
23629535|NCT01667926|66031963|FG002|Overall Study|Physician Decision|1|||
23629536|NCT01667926|66031961|FG000|Overall Study|Time committment|0|||
23629537|NCT01667926|66031962|FG001|Overall Study|Time committment|0|||
23629538|NCT01667926|66031963|FG002|Overall Study|Time committment|2|||
23629539|NCT01667926|66031961|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
23629540|NCT01667926|66031962|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23629541|NCT01667926|66031963|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
23629542|NCT01667926|66031961|FG000|Overall Study|Lost to Follow-up|1|||
23629543|NCT01667926|66031962|FG001|Overall Study|Lost to Follow-up|2|||
23629544|NCT01667926|66031963|FG002|Overall Study|Lost to Follow-up|1|||
23629545|NCT01667926|66031961|FG000|Overall Study|Side effects|3|||
23629546|NCT01667926|66031962|FG001|Overall Study|Side effects|0|||
23629547|NCT01667926|66031963|FG002|Overall Study|Side effects|0|||
23629548|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
23629549|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
23629550|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
23629551|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
23629552|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
23629553|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23629554|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
23629555|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
23629556|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
23629557|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
23629558|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
23629559|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
23629560|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
23629561|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
23629562|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
23629563|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
23629564|NCT04210843|66031968|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
23629565|NCT04210843|66031969|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
23629566|NCT04210843|66031968|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
23629567|NCT04210843|66031969|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
23629568|NCT04210843|66031968|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
23629569|NCT04210843|66031969|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
23629570|NCT04210843|66031968|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23629571|NCT04210843|66031969|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23629572|NCT04210843|66031968|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
23629573|NCT04210843|66031969|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
23629574|NCT04210843|66031968|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
23629575|NCT04210843|66031969|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
23629576|NCT04210843|66031968|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
23629577|NCT04210843|66031969|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
23629578|NCT04210843|66031968|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
23629579|NCT04210843|66031969|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
23629580|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
23629581|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
23629582|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
23629583|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
23629584|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
23629585|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
23629586|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
23629587|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
23629588|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
23629589|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
23629590|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
23629591|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
23629592|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
23629593|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
23629594|NCT04210843|66031968|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
23629595|NCT04210843|66031969|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
23629596|NCT02366143|66031970|FG000|Overall Study|Death|307|||
23629597|NCT02366143|66031971|FG001|Overall Study|Death|278|||
23629598|NCT02366143|66031972|FG002|Overall Study|Death|280|||
23629599|NCT02366143|66031970|FG000|Overall Study|Lost to Follow-up|2|||
23629600|NCT02366143|66031971|FG001|Overall Study|Lost to Follow-up|4|||
23629601|NCT02366143|66031972|FG002|Overall Study|Lost to Follow-up|2|||
23629602|NCT02366143|66031970|FG000|Overall Study|Physician Decision|1|||
23629603|NCT02366143|66031971|FG001|Overall Study|Physician Decision|2|||
23629604|NCT02366143|66031972|FG002|Overall Study|Physician Decision|1|||
23629605|NCT02366143|66031970|FG000|Overall Study|Protocol Violation|0|||
23629606|NCT02366143|66031971|FG001|Overall Study|Protocol Violation|0|||
23629607|NCT02366143|66031972|FG002|Overall Study|Protocol Violation|2|||
23629608|NCT02366143|66031970|FG000|Overall Study|Withdrawal by Subject|16|||
23629609|NCT02366143|66031971|FG001|Overall Study|Withdrawal by Subject|17|||
23629610|NCT02366143|66031972|FG002|Overall Study|Withdrawal by Subject|22|||
23629611|NCT02366143|66031970|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
23629612|NCT02366143|66031971|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
23629613|NCT02366143|66031972|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
23629614|NCT02366143|66031970|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
23629615|NCT02366143|66031971|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
23629616|NCT02366143|66031972|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
23629617|NCT02366143|66031970|FG000|Overall Study|Randomization Error|1|||
23629618|NCT02366143|66031971|FG001|Overall Study|Randomization Error|0|||
23629619|NCT02366143|66031972|FG002|Overall Study|Randomization Error|0|||
23629620|NCT02366143|66031970|FG000|Overall Study|PI Move and Site Closure|1|||
23629621|NCT02366143|66031971|FG001|Overall Study|PI Move and Site Closure|0|||
23629622|NCT02366143|66031972|FG002|Overall Study|PI Move and Site Closure|1|||
23629623|NCT02366143|66031970|FG000|Overall Study|Study Terminated By Sponsor|0|||
23629624|NCT02366143|66031971|FG001|Overall Study|Study Terminated By Sponsor|0|||
23629625|NCT02366143|66031972|FG002|Overall Study|Study Terminated By Sponsor|2|||
23629626|NCT02366143|66031970|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
23629627|NCT02366143|66031971|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
23629628|NCT02366143|66031972|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
23629629|NCT02366143|66031970|FG000|Overall Study|Patient moved to roll-over study|1|||
23629630|NCT02366143|66031971|FG001|Overall Study|Patient moved to roll-over study|19|||
23629631|NCT02366143|66031972|FG002|Overall Study|Patient moved to roll-over study|28|||
23629632|NCT02366143|66031970|FG000|Overall Study|Patient moved to commercial stock|0|||
23629633|NCT02366143|66031971|FG001|Overall Study|Patient moved to commercial stock|0|||
23629634|NCT02366143|66031972|FG002|Overall Study|Patient moved to commercial stock|1|||
23629635|NCT02366143|66031970|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
23629636|NCT02366143|66031971|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
23629637|NCT02366143|66031972|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
23629638|NCT02366143|66031970|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
23629639|NCT02366143|66031971|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
23629640|NCT02366143|66031972|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
23629641|NCT02366143|66031970|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
23629642|NCT02366143|66031971|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
23629643|NCT02366143|66031972|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
23629644|NCT02366143|66031970|FG000|Overall Study|Requester's instructions|1|||
23629645|NCT02366143|66031971|FG001|Overall Study|Requester's instructions|1|||
23629646|NCT02366143|66031972|FG002|Overall Study|Requester's instructions|1|||
23629647|NCT02366143|66031970|FG000|Overall Study|Uneligible|0|||
23629648|NCT02366143|66031971|FG001|Overall Study|Uneligible|1|||
23629649|NCT02366143|66031972|FG002|Overall Study|Uneligible|0|||
23629650|NCT02366143|66031970|FG000|Overall Study|Post Trial Migration|0|||
23629651|NCT02366143|66031971|FG001|Overall Study|Post Trial Migration|1|||
23629652|NCT02366143|66031972|FG002|Overall Study|Post Trial Migration|0|||
23629653|NCT02366143|66031970|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
23629654|NCT02366143|66031971|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
23629655|NCT02366143|66031972|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
23629656|NCT02366143|66031970|FG000|Overall Study|Patient switched to PTAP|0|||
23629657|NCT02366143|66031971|FG001|Overall Study|Patient switched to PTAP|1|||
23829406|NCT03103087|66755895|FG000|Overall Study|Lack of Efficacy|2|||
23829407|NCT03103087|66755896|FG001|Overall Study|Lack of Efficacy|1|||
23629658|NCT02366143|66031972|FG002|Overall Study|Patient switched to PTAP|0|||
23629659|NCT02366143|66031970|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
23629660|NCT02366143|66031971|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
23629661|NCT02366143|66031972|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
23629662|NCT03080493|66031973|FG000|Overall Study|Did not provide NRS pain results|1|||
23629663|NCT03080493|66031974|FG001|Overall Study|Did not provide NRS pain results|0|||
23629664|NCT03080493|66031973|FG000|Overall Study|Adverse Event|0|||
23629665|NCT03080493|66031974|FG001|Overall Study|Adverse Event|1|||
23629666|NCT03080493|66031973|FG000|Overall Study|Randomization error (parity group)|0|||
23629667|NCT03080493|66031974|FG001|Overall Study|Randomization error (parity group)|1|||
23829408|NCT03103087|66755897|FG002|Overall Study|Lack of Efficacy|1|||
23629668|NCT01250509|66031975|FG000|Overall Study|Lost to Follow-up|5|||
23629669|NCT01250509|66031976|FG001|Overall Study|Lost to Follow-up|2|||
23629670|NCT01077128|66031982|FG000|Overall Study|Adverse Event|8|||
23629671|NCT01077128|66031982|FG000|Overall Study|Lack of Efficacy|1|||
23629672|NCT01077128|66031982|FG000|Overall Study|Disease exacerbation|1|||
23629673|NCT01077128|66031982|FG000|Overall Study|Adverse event and consent withdrawal|1|||
23629674|NCT01077128|66031982|FG000|Overall Study|Adverse event and disease exacerbation|1|||
23629675|NCT01077128|66031982|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
23629676|NCT01077128|66031982|FG000|Overall Study|Other|54|||
23629677|NCT01453023|66031984|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
23629678|NCT01453023|66031985|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
23629679|NCT01453023|66031984|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
23629680|NCT01453023|66031985|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
23629681|NCT01453023|66031984|FG000|Treatment Period 2|Protocol Violation|0|||
23629682|NCT01453023|66031985|FG001|Treatment Period 2|Protocol Violation|1|||
23629683|NCT01099917|66031986|FG000|Overall Study|Adverse Event|3|||
23629684|NCT01099917|66031986|FG000|Overall Study|Not Treated|24|||
23629685|NCT01327612|66031987|FG000|Overall Study|Withdrawal by Subject|0|||
23629686|NCT01327612|66031988|FG001|Overall Study|Withdrawal by Subject|0|||
23629687|NCT01327612|66031989|FG002|Overall Study|Withdrawal by Subject|0|||
23629688|NCT01327612|66031990|FG003|Overall Study|Withdrawal by Subject|0|||
23629689|NCT01327612|66031991|FG004|Overall Study|Withdrawal by Subject|0|||
23629690|NCT01327612|66031992|FG005|Overall Study|Withdrawal by Subject|1|||
23629691|NCT01327612|66031993|FG006|Overall Study|Withdrawal by Subject|0|||
23629692|NCT01327612|66031987|FG000|Overall Study|Disease Progression|1|||
23629693|NCT01327612|66031988|FG001|Overall Study|Disease Progression|1|||
23766131|NCT01104662|66521917|FG003|Overall Study|Participant left investigator's care|0|||
23829409|NCT03103087|66755895|FG000|Overall Study|Pregnancy|0|||
23829410|NCT03103087|66755896|FG001|Overall Study|Pregnancy|0|||
23829411|NCT03103087|66755897|FG002|Overall Study|Pregnancy|1|||
23766132|NCT01104662|66521918|FG004|Overall Study|Participant left investigator's care|0|||
23766133|NCT01104662|66521919|FG005|Overall Study|Participant left investigator's care|0|||
23766134|NCT01104662|66521920|FG006|Overall Study|Participant left investigator's care|0|||
23766135|NCT01104662|66521921|FG007|Overall Study|Participant left investigator's care|0|||
23766136|NCT01104662|66521914|FG000|Overall Study|Reason not specified|3|||
23766137|NCT01104662|66521915|FG001|Overall Study|Reason not specified|3|||
23766138|NCT01104662|66521916|FG002|Overall Study|Reason not specified|0|||
23766139|NCT01104662|66521917|FG003|Overall Study|Reason not specified|0|||
23766140|NCT01104662|66521918|FG004|Overall Study|Reason not specified|0|||
23766141|NCT01104662|66521919|FG005|Overall Study|Reason not specified|1|||
23766142|NCT01104662|66521920|FG006|Overall Study|Reason not specified|0|||
23766143|NCT01104662|66521921|FG007|Overall Study|Reason not specified|0|||
23766144|NCT01104662|66521914|FG000|Overall Study|Randomized but not treated|3|||
23766145|NCT01104662|66521915|FG001|Overall Study|Randomized but not treated|4|||
23766146|NCT01104662|66521916|FG002|Overall Study|Randomized but not treated|1|||
23766147|NCT01104662|66521917|FG003|Overall Study|Randomized but not treated|0|||
23766148|NCT01104662|66521918|FG004|Overall Study|Randomized but not treated|0|||
23766149|NCT01104662|66521919|FG005|Overall Study|Randomized but not treated|1|||
23766150|NCT01104662|66521920|FG006|Overall Study|Randomized but not treated|0|||
23766151|NCT01104662|66521921|FG007|Overall Study|Randomized but not treated|0|||
23766152|NCT01336894|66521922|FG000|Follow-up|Study terminated prematurely|2|||
23766153|NCT01336894|66521923|FG001|Follow-up|Study terminated prematurely|7|||
23766154|NCT01497938|66521936|FG000|Overall Study|Adverse Event|0|||
23766155|NCT01497938|66521937|FG001|Overall Study|Adverse Event|1|||
23766156|NCT01497938|66521936|FG000|Overall Study|Physician Decision|0|||
23766157|NCT01497938|66521937|FG001|Overall Study|Physician Decision|1|||
23766158|NCT01497938|66521936|FG000|Overall Study|Withdrawal by Subject|4|||
23766159|NCT01497938|66521937|FG001|Overall Study|Withdrawal by Subject|0|||
23766160|NCT01497938|66521936|FG000|Overall Study|Device Violation|1|||
23766161|NCT01497938|66521937|FG001|Overall Study|Device Violation|0|||
23766162|NCT02672553|66521944|FG000|Overall Study|Death|3|||
23766163|NCT02672553|66521945|FG001|Overall Study|Death|5|||
23766164|NCT02672553|66521944|FG000|Overall Study|Valve Explant|1|||
23766165|NCT02672553|66521945|FG001|Overall Study|Valve Explant|0|||
23766166|NCT02672553|66521944|FG000|Overall Study|Conversion to Commercial Valve|3|||
23629694|NCT01327612|66031989|FG002|Overall Study|Disease Progression|1|||
23629695|NCT01327612|66031990|FG003|Overall Study|Disease Progression|0|||
23766167|NCT02672553|66521945|FG001|Overall Study|Conversion to Commercial Valve|0|||
23766168|NCT02672553|66521944|FG000|Overall Study|Withdrawal by Subject|3|||
23766169|NCT02672553|66521945|FG001|Overall Study|Withdrawal by Subject|3|||
23766170|NCT02672553|66521944|FG000|Overall Study|Intraoperative screen failure|2|||
23766171|NCT02672553|66521945|FG001|Overall Study|Intraoperative screen failure|0|||
23829412|NCT03103087|66755895|FG000|Overall Study|Adverse Event|2|||
23829413|NCT03103087|66755896|FG001|Overall Study|Adverse Event|15|||
23829414|NCT03103087|66755897|FG002|Overall Study|Adverse Event|6|||
23829415|NCT03103087|66755895|FG000|Overall Study|Withdrawal by Subject|13|||
23567788|NCT00406419|65807179|FG000|Overall Study|Non-Compliance with Study Drug|5|||
23567789|NCT00406419|65807180|FG001|Overall Study|Non-Compliance with Study Drug|6|||
23567790|NCT00406419|65807181|FG002|Overall Study|Non-Compliance with Study Drug|3|||
23567791|NCT00406419|65807179|FG000|Overall Study|Adverse Event|10|||
23567792|NCT00406419|65807180|FG001|Overall Study|Adverse Event|12|||
23567793|NCT00406419|65807181|FG002|Overall Study|Adverse Event|16|||
23567794|NCT00406419|65807179|FG000|Overall Study|Lost to Follow-up|11|||
23567795|NCT00406419|65807180|FG001|Overall Study|Lost to Follow-up|10|||
23567796|NCT00406419|65807181|FG002|Overall Study|Lost to Follow-up|5|||
23567797|NCT00857805|65807182|FG000|Overall Study|Withdrawal by Subject|1|||
23567798|NCT00857805|65807183|FG001|Overall Study|Withdrawal by Subject|1|||
23567799|NCT00996580|65807186|FG000|Overall Study|Adverse Event|466|||
23567800|NCT00996580|65807186|FG000|Overall Study|Lost to Follow-up|480|||
23567801|NCT00996580|65807186|FG000|Overall Study|Noncompliance with the protocol|137|||
23567802|NCT00996580|65807186|FG000|Overall Study|Physician Decision|5|||
23567803|NCT00996580|65807186|FG000|Overall Study|Pregnancy|68|||
23567804|NCT00996580|65807186|FG000|Overall Study|Protocol Violation|16|||
23567805|NCT00996580|65807186|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
23567806|NCT00996580|65807186|FG000|Overall Study|Withdrawal by Subject|217|||
23567807|NCT00996580|65807186|FG000|Overall Study|Other|29|||
23567808|NCT01317875|65807187|FG000|Overall Study|Other|0|||
23567809|NCT01317875|65807188|FG001|Overall Study|Other|0|||
23766172|NCT01488578|66521946|FG000|Overall Study|Protocol Violation|1836|||
23766173|NCT02784106|66521947|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
23766174|NCT02784106|66521948|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
23766175|NCT02784106|66521949|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23766176|NCT02784106|66521950|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23766177|NCT02784106|66521947|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
23766178|NCT02784106|66521948|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
23766179|NCT02784106|66521949|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23766180|NCT02784106|66521950|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23766181|NCT02784106|66521947|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
23766182|NCT02784106|66521948|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23766183|NCT02784106|66521949|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23766184|NCT02784106|66521950|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23766185|NCT02784106|66521947|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
23766186|NCT02784106|66521948|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23766187|NCT02784106|66521949|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23766188|NCT02784106|66521950|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23766189|NCT02784106|66521947|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
23766190|NCT02784106|66521948|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
23766191|NCT02784106|66521949|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
23766192|NCT02784106|66521950|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
23766193|NCT02784106|66521947|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
23766194|NCT02784106|66521948|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
23766195|NCT02784106|66521949|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
23766196|NCT02784106|66521950|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
23766197|NCT01415921|66521951|FG000|Overall Study|Adverse Event|0|||
23766198|NCT01415921|66521952|FG001|Overall Study|Adverse Event|1|||
23766199|NCT01415921|66521951|FG000|Overall Study|Physician Decision|1|||
23766200|NCT01415921|66521952|FG001|Overall Study|Physician Decision|1|||
23766201|NCT01415921|66521951|FG000|Overall Study|Withdrawal by Subject|0|||
23766202|NCT01415921|66521952|FG001|Overall Study|Withdrawal by Subject|1|||
23766203|NCT01415921|66521951|FG000|Overall Study|Other|2|||
23766204|NCT01415921|66521952|FG001|Overall Study|Other|0|||
23766205|NCT01508936|66521953|FG000|Overall Study|Adverse Event|11|||
23766206|NCT01508936|66521954|FG001|Overall Study|Adverse Event|32|||
23766207|NCT01508936|66521953|FG000|Overall Study|Lack of Efficacy|0|||
23766208|NCT01508936|66521954|FG001|Overall Study|Lack of Efficacy|1|||
23766209|NCT01508936|66521953|FG000|Overall Study|Withdrawal by Subject|4|||
23766210|NCT01508936|66521954|FG001|Overall Study|Withdrawal by Subject|18|||
23829416|NCT03103087|66755896|FG001|Overall Study|Withdrawal by Subject|6|||
23829417|NCT03103087|66755897|FG002|Overall Study|Withdrawal by Subject|6|||
23829418|NCT03103087|66755895|FG000|Overall Study|Lost to Follow-up|4|||
23829419|NCT03103087|66755896|FG001|Overall Study|Lost to Follow-up|2|||
23829420|NCT03103087|66755897|FG002|Overall Study|Lost to Follow-up|7|||
23829421|NCT03103087|66755895|FG000|Overall Study|Other reason not reported|1|||
23829422|NCT03103087|66755896|FG001|Overall Study|Other reason not reported|3|||
23829423|NCT03103087|66755897|FG002|Overall Study|Other reason not reported|5|||
23829424|NCT01321879|66755898|FG000|Overall Study|Lack of Efficacy|5|||
23766211|NCT01508936|66521953|FG000|Overall Study|Protocol Violation|2|||
23766212|NCT01508936|66521954|FG001|Overall Study|Protocol Violation|3|||
23766213|NCT01508936|66521953|FG000|Overall Study|Lost to Follow-up|2|||
23766214|NCT01508936|66521954|FG001|Overall Study|Lost to Follow-up|9|||
23766215|NCT01508936|66521953|FG000|Overall Study|Other|0|||
23766216|NCT01508936|66521954|FG001|Overall Study|Other|5|||
23766217|NCT01508936|66521953|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
23766218|NCT01508936|66521954|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
23766219|NCT03692676|66521955|FG000|Overall Study|exclude patients with prior use|4424|||
23766220|NCT03692676|66521956|FG001|Overall Study|exclude patients with prior use|24726|||
23766221|NCT03692676|66521957|FG002|Overall Study|exclude patients with prior use|0|||
23629696|NCT01327612|66031991|FG004|Overall Study|Disease Progression|1|||
23629697|NCT01327612|66031992|FG005|Overall Study|Disease Progression|2|||
23629698|NCT01327612|66031993|FG006|Overall Study|Disease Progression|2|||
23629699|NCT01327612|66031987|FG000|Overall Study|Administrative Decision|0|||
23629700|NCT01327612|66031988|FG001|Overall Study|Administrative Decision|0|||
23629701|NCT01327612|66031989|FG002|Overall Study|Administrative Decision|0|||
23629702|NCT01327612|66031990|FG003|Overall Study|Administrative Decision|1|||
23629703|NCT01327612|66031991|FG004|Overall Study|Administrative Decision|0|||
23629704|NCT01327612|66031992|FG005|Overall Study|Administrative Decision|0|||
23629705|NCT01327612|66031993|FG006|Overall Study|Administrative Decision|0|||
23629706|NCT01327612|66031987|FG000|Overall Study|Death|0|||
23629707|NCT01327612|66031988|FG001|Overall Study|Death|0|||
23629708|NCT01327612|66031989|FG002|Overall Study|Death|0|||
23629709|NCT01327612|66031990|FG003|Overall Study|Death|0|||
23629710|NCT01327612|66031991|FG004|Overall Study|Death|1|||
23629711|NCT01327612|66031992|FG005|Overall Study|Death|0|||
23629712|NCT01327612|66031993|FG006|Overall Study|Death|0|||
23629713|NCT01124097|66031997|FG000|Overall Study|Withdrawal by Subject|4|||
23629714|NCT01124097|66031998|FG001|Overall Study|Withdrawal by Subject|3|||
23629715|NCT01124097|66031999|FG002|Overall Study|Withdrawal by Subject|2|||
23629716|NCT01124097|66032000|FG003|Overall Study|Withdrawal by Subject|3|||
23629717|NCT01124097|66031997|FG000|Overall Study|Lack of Efficacy|2|||
23629718|NCT01124097|66031998|FG001|Overall Study|Lack of Efficacy|3|||
23629719|NCT01124097|66031999|FG002|Overall Study|Lack of Efficacy|1|||
23629720|NCT01124097|66032000|FG003|Overall Study|Lack of Efficacy|3|||
23629721|NCT01124097|66031997|FG000|Overall Study|Adverse Event|24|||
23629722|NCT01124097|66031998|FG001|Overall Study|Adverse Event|15|||
23629723|NCT01124097|66031999|FG002|Overall Study|Adverse Event|15|||
23629724|NCT01124097|66032000|FG003|Overall Study|Adverse Event|7|||
23629725|NCT01124097|66031997|FG000|Overall Study|Protocol Violation|2|||
23629726|NCT01124097|66031998|FG001|Overall Study|Protocol Violation|0|||
23629727|NCT01124097|66031999|FG002|Overall Study|Protocol Violation|2|||
23629728|NCT01124097|66032000|FG003|Overall Study|Protocol Violation|1|||
23629729|NCT01124097|66031997|FG000|Overall Study|Physician Decision|2|||
23629730|NCT01124097|66031998|FG001|Overall Study|Physician Decision|1|||
23629731|NCT01124097|66031999|FG002|Overall Study|Physician Decision|0|||
23629732|NCT01124097|66032000|FG003|Overall Study|Physician Decision|0|||
23629733|NCT02990468|66032001|FG000|Phase 2: MTD|Change in treatment|0|||
23629734|NCT02990468|66032002|FG001|Phase 2: MTD|Change in treatment|0|||
23629735|NCT02990468|66032003|FG002|Phase 2: MTD|Change in treatment|1|||
23629736|NCT00940875|66032011|FG000|Treatment Phase|Adverse Event|9|||
23629737|NCT00940875|66032012|FG001|Treatment Phase|Adverse Event|3|||
23629738|NCT00940875|66032011|FG000|Treatment Phase|Death|3|||
23629739|NCT00940875|66032012|FG001|Treatment Phase|Death|5|||
23629740|NCT00940875|66032011|FG000|Treatment Phase|Lack of Efficacy|1|||
23629741|NCT00940875|66032012|FG001|Treatment Phase|Lack of Efficacy|0|||
23766222|NCT03692676|66521958|FG003|Overall Study|exclude patients with prior use|0|||
23829425|NCT01321879|66755898|FG000|Overall Study|Adverse Event|5|||
23629742|NCT00940875|66032011|FG000|Treatment Phase|Withdrawal by Subject|3|||
23629743|NCT00940875|66032012|FG001|Treatment Phase|Withdrawal by Subject|0|||
23629744|NCT00940875|66032011|FG000|Treatment Phase|Disease progression|9|||
23766223|NCT03692676|66521955|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
23829426|NCT01321879|66755898|FG000|Overall Study|Death|3|||
23629745|NCT00940875|66032012|FG001|Treatment Phase|Disease progression|11|||
23629746|NCT00940875|66032011|FG000|Treatment Phase|Physician Decision|1|||
23629747|NCT00940875|66032012|FG001|Treatment Phase|Physician Decision|0|||
23629748|NCT00940875|66032011|FG000|Post-Study Treatment|Death|0|||
23629749|NCT00940875|66032012|FG001|Post-Study Treatment|Death|1|||
23629750|NCT00940875|66032011|FG000|Post-Study Treatment|Disease Progression|0|||
23629751|NCT00940875|66032012|FG001|Post-Study Treatment|Disease Progression|2|||
23629752|NCT00634842|66032013|FG000|Overall Study|Adverse Event|2|||
23629753|NCT00634842|66032014|FG001|Overall Study|Adverse Event|3|||
23629754|NCT00634842|66032013|FG000|Overall Study|Protocol Violation|8|||
23629755|NCT00634842|66032014|FG001|Overall Study|Protocol Violation|4|||
23629756|NCT00634842|66032013|FG000|Overall Study|Move to another state|1|||
23629757|NCT00634842|66032014|FG001|Overall Study|Move to another state|0|||
23629758|NCT00634842|66032013|FG000|Overall Study|Inclusion criteria were not met|1|||
23629759|NCT00634842|66032014|FG001|Overall Study|Inclusion criteria were not met|0|||
23629760|NCT00634842|66032013|FG000|Overall Study|Lost to Follow-up|1|||
23629761|NCT00634842|66032014|FG001|Overall Study|Lost to Follow-up|2|||
23629762|NCT00634842|66032013|FG000|Overall Study|Physician Decision|1|||
23629763|NCT00634842|66032014|FG001|Overall Study|Physician Decision|0|||
23629764|NCT00634842|66032013|FG000|Overall Study|Withdrawal by Subject|1|||
23629765|NCT00634842|66032014|FG001|Overall Study|Withdrawal by Subject|3|||
23629766|NCT00634842|66032013|FG000|Overall Study|Lack of time and intolerance to drug|0|||
23629767|NCT00634842|66032014|FG001|Overall Study|Lack of time and intolerance to drug|1|||
23629768|NCT00634842|66032013|FG000|Overall Study|Discontinued due to injection|0|||
23629769|NCT00634842|66032014|FG001|Overall Study|Discontinued due to injection|2|||
23629770|NCT00634842|66032013|FG000|Overall Study|No need of study drug to treat diabetes|0|||
23629771|NCT00634842|66032014|FG001|Overall Study|No need of study drug to treat diabetes|1|||
23829427|NCT01321879|66755898|FG000|Overall Study|Withdrawal by Subject|1|||
23829428|NCT03518008|66755902|FG000|Period 2, Second Week of Wear|Family emergency|0|||
23829429|NCT03518008|66755903|FG001|Period 2, Second Week of Wear|Family emergency|1|||
23829430|NCT01350271|66755904|FG000|Overall Study|Lost to Follow-up|21|||
23829431|NCT01350271|66755905|FG001|Overall Study|Lost to Follow-up|17|||
23829432|NCT01350271|66755906|FG002|Overall Study|Lost to Follow-up|26|||
23829433|NCT01486446|66755907|FG000|Overall Study|Adverse Event|1|||
23567810|NCT01317875|65807189|FG002|Overall Study|Other|1|||
23567811|NCT01317875|65807190|FG003|Overall Study|Other|0|||
23567812|NCT01317875|65807191|FG004|Overall Study|Other|0|||
23567813|NCT01317875|65807192|FG005|Overall Study|Other|0|||
23567814|NCT01317875|65807193|FG006|Overall Study|Other|0|||
23766224|NCT03692676|66521956|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
23766225|NCT03692676|66521957|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
23766226|NCT03692676|66521958|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
23766227|NCT03692676|66521955|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
23766228|NCT03692676|66521956|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
23766229|NCT03692676|66521957|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
23766230|NCT03692676|66521958|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
23766231|NCT03692676|66521955|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
23766232|NCT03692676|66521956|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
23766233|NCT03692676|66521957|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
23766234|NCT03692676|66521958|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
23766235|NCT03692676|66521955|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
23766236|NCT03692676|66521956|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
23766237|NCT03692676|66521957|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
23766238|NCT03692676|66521958|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
23766239|NCT03692676|66521955|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
23766240|NCT03692676|66521956|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
23766241|NCT03692676|66521957|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
23766242|NCT03692676|66521958|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
23766243|NCT03692676|66521955|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
23829434|NCT01486446|66755908|FG001|Overall Study|Adverse Event|0|||
23829435|NCT02347813|66755909|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
23829436|NCT02347813|66755910|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
23567815|NCT01317875|65807194|FG007|Overall Study|Other|0|||
23567816|NCT01317875|65807195|FG008|Overall Study|Other|0|||
23567817|NCT01317875|65807196|FG009|Overall Study|Other|0|||
23567818|NCT01317875|65807187|FG000|Overall Study|Noncompliance with study drug|0|||
23567819|NCT01317875|65807188|FG001|Overall Study|Noncompliance with study drug|0|||
23567820|NCT01317875|65807189|FG002|Overall Study|Noncompliance with study drug|1|||
23567821|NCT01317875|65807190|FG003|Overall Study|Noncompliance with study drug|0|||
23567822|NCT01317875|65807191|FG004|Overall Study|Noncompliance with study drug|0|||
23629772|NCT00634842|66032013|FG000|Overall Study|No wish to keep taking Avandia|0|||
23629773|NCT00634842|66032014|FG001|Overall Study|No wish to keep taking Avandia|1|||
23629774|NCT00634842|66032013|FG000|Overall Study|Subject off study drug for too long|0|||
23629775|NCT00634842|66032014|FG001|Overall Study|Subject off study drug for too long|1|||
23766244|NCT03692676|66521956|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
23766245|NCT03692676|66521957|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
23766246|NCT03692676|66521958|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
23766247|NCT03692676|66521955|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
23766248|NCT03692676|66521956|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
23567823|NCT01317875|65807192|FG005|Overall Study|Noncompliance with study drug|0|||
23567824|NCT01317875|65807193|FG006|Overall Study|Noncompliance with study drug|0|||
23567825|NCT01317875|65807194|FG007|Overall Study|Noncompliance with study drug|0|||
23567826|NCT01317875|65807195|FG008|Overall Study|Noncompliance with study drug|0|||
23567827|NCT01317875|65807196|FG009|Overall Study|Noncompliance with study drug|0|||
23567828|NCT01317875|65807187|FG000|Overall Study|Progressive Disease|1|||
23567829|NCT01317875|65807188|FG001|Overall Study|Progressive Disease|0|||
23567830|NCT01317875|65807189|FG002|Overall Study|Progressive Disease|2|||
23567831|NCT01317875|65807190|FG003|Overall Study|Progressive Disease|0|||
23567832|NCT01317875|65807191|FG004|Overall Study|Progressive Disease|1|||
23567833|NCT01317875|65807192|FG005|Overall Study|Progressive Disease|0|||
23567834|NCT01317875|65807193|FG006|Overall Study|Progressive Disease|0|||
23567835|NCT01317875|65807194|FG007|Overall Study|Progressive Disease|1|||
23567836|NCT01317875|65807195|FG008|Overall Study|Progressive Disease|0|||
23567837|NCT01317875|65807196|FG009|Overall Study|Progressive Disease|0|||
23567838|NCT01317875|65807187|FG000|Overall Study|Withdrawal by Subject|0|||
23567839|NCT01317875|65807188|FG001|Overall Study|Withdrawal by Subject|0|||
23567840|NCT01317875|65807189|FG002|Overall Study|Withdrawal by Subject|0|||
23567841|NCT01317875|65807190|FG003|Overall Study|Withdrawal by Subject|0|||
23567842|NCT01317875|65807191|FG004|Overall Study|Withdrawal by Subject|1|||
23567843|NCT01317875|65807192|FG005|Overall Study|Withdrawal by Subject|0|||
23567844|NCT01317875|65807193|FG006|Overall Study|Withdrawal by Subject|0|||
23567845|NCT01317875|65807194|FG007|Overall Study|Withdrawal by Subject|3|||
23567846|NCT01317875|65807195|FG008|Overall Study|Withdrawal by Subject|0|||
23567847|NCT01317875|65807196|FG009|Overall Study|Withdrawal by Subject|0|||
23567848|NCT01317875|65807187|FG000|Overall Study|Physician Decision|0|||
23567849|NCT01317875|65807188|FG001|Overall Study|Physician Decision|1|||
23567850|NCT01317875|65807189|FG002|Overall Study|Physician Decision|1|||
23567851|NCT01317875|65807190|FG003|Overall Study|Physician Decision|0|||
23567852|NCT01317875|65807191|FG004|Overall Study|Physician Decision|2|||
23567853|NCT01317875|65807192|FG005|Overall Study|Physician Decision|0|||
23567854|NCT01317875|65807193|FG006|Overall Study|Physician Decision|0|||
23567855|NCT01317875|65807194|FG007|Overall Study|Physician Decision|2|||
23567856|NCT01317875|65807195|FG008|Overall Study|Physician Decision|0|||
23567857|NCT01317875|65807196|FG009|Overall Study|Physician Decision|0|||
23567858|NCT01317875|65807187|FG000|Overall Study|Death|0|||
23567859|NCT01317875|65807188|FG001|Overall Study|Death|0|||
23567860|NCT01317875|65807189|FG002|Overall Study|Death|2|||
23567861|NCT01317875|65807190|FG003|Overall Study|Death|1|||
23567862|NCT01317875|65807191|FG004|Overall Study|Death|0|||
23567863|NCT01317875|65807192|FG005|Overall Study|Death|1|||
23567864|NCT01317875|65807193|FG006|Overall Study|Death|0|||
23567865|NCT01317875|65807194|FG007|Overall Study|Death|4|||
23567866|NCT01317875|65807195|FG008|Overall Study|Death|0|||
23567867|NCT01317875|65807196|FG009|Overall Study|Death|0|||
23567868|NCT01317875|65807187|FG000|Overall Study|Adverse Event|2|||
23567869|NCT01317875|65807188|FG001|Overall Study|Adverse Event|1|||
23567870|NCT01317875|65807189|FG002|Overall Study|Adverse Event|2|||
23567871|NCT01317875|65807190|FG003|Overall Study|Adverse Event|1|||
23567872|NCT01317875|65807191|FG004|Overall Study|Adverse Event|5|||
23567873|NCT01317875|65807192|FG005|Overall Study|Adverse Event|1|||
23567874|NCT01317875|65807193|FG006|Overall Study|Adverse Event|2|||
23567875|NCT01317875|65807194|FG007|Overall Study|Adverse Event|5|||
23782290|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23567876|NCT01317875|65807195|FG008|Overall Study|Adverse Event|0|||
23567877|NCT01317875|65807196|FG009|Overall Study|Adverse Event|0|||
23567878|NCT02291432|65807198|FG000|Overall Study|Withdrawal by Subject|2|||
23567879|NCT00077636|65807199|FG000|Overall Study|Refused Treatment|9|||
23567880|NCT00077636|65807200|FG001|Overall Study|Refused Treatment|31|||
23567881|NCT00077636|65807199|FG000|Overall Study|Admin|3|||
23567882|NCT00077636|65807200|FG001|Overall Study|Admin|3|||
23567883|NCT00077636|65807199|FG000|Overall Study|Withdrawal by Subject|2|||
23567884|NCT00077636|65807200|FG001|Overall Study|Withdrawal by Subject|2|||
23567885|NCT00077636|65807199|FG000|Overall Study|Adverse Event|17|||
23567886|NCT00077636|65807200|FG001|Overall Study|Adverse Event|34|||
23567887|NCT00077636|65807199|FG000|Overall Study|Protocol Violation|0|||
23567888|NCT00077636|65807200|FG001|Overall Study|Protocol Violation|2|||
23567889|NCT00077636|65807199|FG000|Overall Study|Lost to Follow-up|10|||
23567890|NCT00077636|65807200|FG001|Overall Study|Lost to Follow-up|18|||
23567891|NCT00077636|65807199|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
23567892|NCT00077636|65807200|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
23567893|NCT01478113|65807207|FG000|Overall Study|Withdrawal by Subject|0|||
23567894|NCT01478113|65807208|FG001|Overall Study|Withdrawal by Subject|1|||
23629776|NCT00379769|66032023|FG000|Main Study|Death|57|||
23629777|NCT00379769|66032024|FG001|Main Study|Death|67|||
23629778|NCT00379769|66032025|FG002|Main Study|Death|54|||
23629779|NCT00379769|66032026|FG003|Main Study|Death|72|||
23629780|NCT00379769|66032027|FG004|Main Study|Death|0|||
23629781|NCT00379769|66032028|FG005|Main Study|Death|0|||
23629782|NCT00379769|66032023|FG000|Main Study|Adverse Event|5|||
23629783|NCT00379769|66032024|FG001|Main Study|Adverse Event|8|||
23629784|NCT00379769|66032025|FG002|Main Study|Adverse Event|10|||
23629785|NCT00379769|66032026|FG003|Main Study|Adverse Event|11|||
23629786|NCT00379769|66032027|FG004|Main Study|Adverse Event|0|||
23629787|NCT00379769|66032028|FG005|Main Study|Adverse Event|0|||
23629788|NCT00379769|66032023|FG000|Main Study|Lost to Follow-up|29|||
23629789|NCT00379769|66032024|FG001|Main Study|Lost to Follow-up|29|||
23629790|NCT00379769|66032025|FG002|Main Study|Lost to Follow-up|25|||
23629791|NCT00379769|66032026|FG003|Main Study|Lost to Follow-up|26|||
23629792|NCT00379769|66032027|FG004|Main Study|Lost to Follow-up|0|||
23629793|NCT00379769|66032028|FG005|Main Study|Lost to Follow-up|0|||
23629794|NCT00379769|66032023|FG000|Main Study|Withdrawal by Subject|46|||
23629795|NCT00379769|66032024|FG001|Main Study|Withdrawal by Subject|56|||
23629796|NCT00379769|66032025|FG002|Main Study|Withdrawal by Subject|72|||
23629797|NCT00379769|66032026|FG003|Main Study|Withdrawal by Subject|70|||
23629798|NCT00379769|66032027|FG004|Main Study|Withdrawal by Subject|0|||
23629799|NCT00379769|66032028|FG005|Main Study|Withdrawal by Subject|0|||
23629800|NCT00379769|66032023|FG000|Main Study|Moved to survival status follow-up only|27|||
23629801|NCT00379769|66032024|FG001|Main Study|Moved to survival status follow-up only|25|||
23629802|NCT00379769|66032025|FG002|Main Study|Moved to survival status follow-up only|32|||
23629803|NCT00379769|66032026|FG003|Main Study|Moved to survival status follow-up only|36|||
23567895|NCT01478113|65807207|FG000|Overall Study|Physician Decision|1|||
23567896|NCT01478113|65807208|FG001|Overall Study|Physician Decision|0|||
23567897|NCT00655551|65807209|FG000|All Periods Combined|Adverse Event|0|||
23567898|NCT00655551|65807210|FG001|All Periods Combined|Adverse Event|3|||
23567899|NCT00655551|65807211|FG002|All Periods Combined|Adverse Event|4|||
23567900|NCT00655551|65807209|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
23567901|NCT00655551|65807210|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
23567902|NCT00655551|65807211|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
23567903|NCT00655551|65807209|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
23567904|NCT00655551|65807210|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
23567905|NCT00655551|65807211|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
23567906|NCT00655551|65807209|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
23567907|NCT00655551|65807210|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
23567908|NCT00655551|65807211|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
23567909|NCT01613027|65807212|FG000|Overall Study|Lost to Follow-up|5|||
23567910|NCT01613027|65807212|FG000|Overall Study|Switched Physician|1|||
23567911|NCT01613027|65807212|FG000|Overall Study|Lack of Efficacy|1|||
23567912|NCT01613027|65807212|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
23567913|NCT01734434|65807213|FG000|Overall Study|Death Infant|3|||
23567914|NCT01734434|65807214|FG001|Overall Study|Death Infant|1|||
23567915|NCT01734434|65807215|FG002|Overall Study|Death Infant|17|||
23567916|NCT01734434|65807216|FG003|Overall Study|Death Infant|5|||
23567917|NCT01734434|65807213|FG000|Overall Study|Lost to Follow-up|2|||
23567918|NCT01734434|65807214|FG001|Overall Study|Lost to Follow-up|9|||
23567919|NCT01734434|65807215|FG002|Overall Study|Lost to Follow-up|67|||
23567920|NCT01734434|65807216|FG003|Overall Study|Lost to Follow-up|11|||
23567921|NCT01734434|65807213|FG000|Overall Study|No Live Birth|1|||
23567922|NCT01734434|65807214|FG001|Overall Study|No Live Birth|2|||
23567923|NCT01734434|65807215|FG002|Overall Study|No Live Birth|32|||
23567924|NCT01734434|65807216|FG003|Overall Study|No Live Birth|6|||
23567925|NCT01734434|65807213|FG000|Overall Study|Withdrawal by Subject|4|||
23567926|NCT01734434|65807214|FG001|Overall Study|Withdrawal by Subject|0|||
23567927|NCT01734434|65807215|FG002|Overall Study|Withdrawal by Subject|8|||
23567928|NCT01734434|65807216|FG003|Overall Study|Withdrawal by Subject|1|||
23629804|NCT00379769|66032027|FG004|Main Study|Moved to survival status follow-up only|0|||
23629805|NCT00379769|66032028|FG005|Main Study|Moved to survival status follow-up only|0|||
23629806|NCT00379769|66032023|FG000|Main Study|Participant moved|3|||
23629807|NCT00379769|66032024|FG001|Main Study|Participant moved|2|||
23629808|NCT00379769|66032025|FG002|Main Study|Participant moved|3|||
23629809|NCT00379769|66032026|FG003|Main Study|Participant moved|3|||
23629810|NCT00379769|66032027|FG004|Main Study|Participant moved|0|||
23567929|NCT01734434|65807213|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
23567930|NCT01734434|65807214|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
23567931|NCT01734434|65807215|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
23567932|NCT01734434|65807216|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
23567933|NCT01734434|65807213|FG000|Overall Study|Subject Not Reachable|0|||
23567934|NCT01734434|65807214|FG001|Overall Study|Subject Not Reachable|0|||
23629811|NCT00379769|66032028|FG005|Main Study|Participant moved|0|||
23629812|NCT00379769|66032023|FG000|Main Study|Poor compliance|3|||
23629813|NCT00379769|66032024|FG001|Main Study|Poor compliance|2|||
23629814|NCT00379769|66032025|FG002|Main Study|Poor compliance|2|||
23629815|NCT00379769|66032026|FG003|Main Study|Poor compliance|1|||
23629816|NCT00379769|66032027|FG004|Main Study|Poor compliance|0|||
23629817|NCT00379769|66032028|FG005|Main Study|Poor compliance|0|||
23629818|NCT00379769|66032023|FG000|Main Study|Prohibited glucose lowering medication|0|||
23629819|NCT00379769|66032024|FG001|Main Study|Prohibited glucose lowering medication|3|||
23629820|NCT00379769|66032025|FG002|Main Study|Prohibited glucose lowering medication|0|||
23629821|NCT00379769|66032026|FG003|Main Study|Prohibited glucose lowering medication|1|||
23629822|NCT00379769|66032027|FG004|Main Study|Prohibited glucose lowering medication|0|||
23629823|NCT00379769|66032028|FG005|Main Study|Prohibited glucose lowering medication|0|||
23629824|NCT00379769|66032023|FG000|Main Study|Site closed|4|||
23629825|NCT00379769|66032024|FG001|Main Study|Site closed|4|||
23629826|NCT00379769|66032025|FG002|Main Study|Site closed|4|||
23629827|NCT00379769|66032026|FG003|Main Study|Site closed|8|||
23629828|NCT00379769|66032027|FG004|Main Study|Site closed|0|||
23629829|NCT00379769|66032028|FG005|Main Study|Site closed|0|||
23629830|NCT00379769|66032023|FG000|Main Study|Entry criteria violation|0|||
23629831|NCT00379769|66032024|FG001|Main Study|Entry criteria violation|0|||
23629832|NCT00379769|66032025|FG002|Main Study|Entry criteria violation|1|||
23629833|NCT00379769|66032026|FG003|Main Study|Entry criteria violation|1|||
23629834|NCT00379769|66032027|FG004|Main Study|Entry criteria violation|0|||
23629835|NCT00379769|66032028|FG005|Main Study|Entry criteria violation|0|||
23629836|NCT00379769|66032023|FG000|Main Study|Participant did not take study drug|0|||
23629837|NCT00379769|66032024|FG001|Main Study|Participant did not take study drug|0|||
23629838|NCT00379769|66032025|FG002|Main Study|Participant did not take study drug|1|||
23629839|NCT00379769|66032026|FG003|Main Study|Participant did not take study drug|0|||
23629840|NCT00379769|66032027|FG004|Main Study|Participant did not take study drug|0|||
23629841|NCT00379769|66032028|FG005|Main Study|Participant did not take study drug|0|||
23629842|NCT00379769|66032023|FG000|Main Study|Physician Decision|2|||
23629843|NCT00379769|66032024|FG001|Main Study|Physician Decision|2|||
23629844|NCT00379769|66032025|FG002|Main Study|Physician Decision|1|||
23629845|NCT00379769|66032026|FG003|Main Study|Physician Decision|1|||
23766249|NCT03692676|66521957|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
23766250|NCT03692676|66521958|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
23766251|NCT03692676|66521955|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
23766252|NCT03692676|66521956|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
23766253|NCT03692676|66521957|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
23766254|NCT03692676|66521958|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
23766255|NCT03692676|66521955|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
23766256|NCT03692676|66521956|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
23766257|NCT03692676|66521957|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
23766258|NCT03692676|66521958|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
23766259|NCT03692676|66521955|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23766260|NCT03692676|66521956|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23766261|NCT03692676|66521957|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23766262|NCT03692676|66521958|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
23766263|NCT03692676|66521955|FG000|Overall Study|Other|0|||
23766264|NCT03692676|66521956|FG001|Overall Study|Other|805|||
23766265|NCT03692676|66521957|FG002|Overall Study|Other|758|||
23766266|NCT03692676|66521958|FG003|Overall Study|Other|277|||
23766267|NCT03692676|66521955|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23766268|NCT03692676|66521956|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23766269|NCT03692676|66521957|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23766270|NCT03692676|66521958|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
23766271|NCT02688400|66521959|FG000|Overall Study|Protocol Violation|2|||
23766272|NCT02688400|66521960|FG001|Overall Study|Protocol Violation|5|||
23766273|NCT02688400|66521959|FG000|Overall Study|Lack of Efficacy|7|||
23567935|NCT01734434|65807215|FG002|Overall Study|Subject Not Reachable|1|||
23567936|NCT01734434|65807216|FG003|Overall Study|Subject Not Reachable|0|||
23567937|NCT01734434|65807213|FG000|Overall Study|Treatment Defaulter|0|||
23567938|NCT01734434|65807214|FG001|Overall Study|Treatment Defaulter|0|||
23567939|NCT01734434|65807215|FG002|Overall Study|Treatment Defaulter|1|||
23567940|NCT01734434|65807216|FG003|Overall Study|Treatment Defaulter|0|||
23567941|NCT01734434|65807213|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
23567942|NCT01734434|65807214|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
23567943|NCT01734434|65807215|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
23567944|NCT01734434|65807216|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
23567945|NCT01734434|65807213|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23829437|NCT02347813|66755909|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
23629846|NCT00379769|66032027|FG004|Main Study|Physician Decision|0|||
23629847|NCT00379769|66032028|FG005|Main Study|Physician Decision|0|||
23629848|NCT00379769|66032023|FG000|Main Study|Participant completed study at visit 27|1|||
23629849|NCT00379769|66032024|FG001|Main Study|Participant completed study at visit 27|0|||
23629850|NCT00379769|66032025|FG002|Main Study|Participant completed study at visit 27|0|||
23629851|NCT00379769|66032026|FG003|Main Study|Participant completed study at visit 27|0|||
23629852|NCT00379769|66032027|FG004|Main Study|Participant completed study at visit 27|0|||
23629853|NCT00379769|66032028|FG005|Main Study|Participant completed study at visit 27|0|||
23629854|NCT00379769|66032023|FG000|Main Study|Personal reasons|1|||
23629855|NCT00379769|66032024|FG001|Main Study|Personal reasons|0|||
23629856|NCT00379769|66032025|FG002|Main Study|Personal reasons|0|||
23629857|NCT00379769|66032026|FG003|Main Study|Personal reasons|0|||
23629858|NCT00379769|66032027|FG004|Main Study|Personal reasons|0|||
23629859|NCT00379769|66032028|FG005|Main Study|Personal reasons|0|||
23629860|NCT00379769|66032023|FG000|Main Study|Risk of heart failure|0|||
23629861|NCT00379769|66032024|FG001|Main Study|Risk of heart failure|1|||
23629862|NCT00379769|66032025|FG002|Main Study|Risk of heart failure|0|||
23629863|NCT00379769|66032026|FG003|Main Study|Risk of heart failure|0|||
23629864|NCT00379769|66032027|FG004|Main Study|Risk of heart failure|0|||
23629865|NCT00379769|66032028|FG005|Main Study|Risk of heart failure|0|||
23829438|NCT02347813|66755910|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
23829439|NCT00513240|66755911|FG000|Overall Study|Did not have intended surgery|3|||
23829440|NCT00513240|66755912|FG001|Overall Study|Did not have intended surgery|0|||
23445797|NCT03386721|65373750|FG008|Overall Study|Reason not specified|0|||
23445798|NCT03386721|65373751|FG009|Overall Study|Reason not specified|1|||
23445799|NCT03386721|65373752|FG010|Overall Study|Reason not specified|2|||
23445800|NCT03386721|65373753|FG011|Overall Study|Reason not specified|6|||
23445801|NCT03386721|65373754|FG012|Overall Study|Reason not specified|1|||
23445802|NCT03386721|65373755|FG013|Overall Study|Reason not specified|0|||
23445803|NCT03386721|65373756|FG014|Overall Study|Reason not specified|0|||
23829441|NCT00513240|66755911|FG000|Overall Study|Death|3|||
23829442|NCT00513240|66755912|FG001|Overall Study|Death|3|||
23829443|NCT00513240|66755911|FG000|Overall Study|Withdrawal by Subject|7|||
23829444|NCT00513240|66755912|FG001|Overall Study|Withdrawal by Subject|4|||
23829445|NCT01515423|66755915|FG000|Open Label Phase|Adverse Event|57|||
23829446|NCT01515423|66755916|FG001|Open Label Phase|Adverse Event|0|||
23829447|NCT01515423|66755917|FG002|Open Label Phase|Adverse Event|0|||
23829448|NCT01515423|66755915|FG000|Open Label Phase|Death|2|||
23829449|NCT01515423|66755916|FG001|Open Label Phase|Death|0|||
23829450|NCT01515423|66755917|FG002|Open Label Phase|Death|0|||
23829451|NCT01515423|66755915|FG000|Open Label Phase|Lack of Efficacy|117|||
23829452|NCT01515423|66755916|FG001|Open Label Phase|Lack of Efficacy|0|||
23829453|NCT01515423|66755917|FG002|Open Label Phase|Lack of Efficacy|0|||
23445804|NCT03386721|65373742|FG000|Overall Study|Progressive Disease|0|||
23445805|NCT03386721|65373743|FG001|Overall Study|Progressive Disease|0|||
23445806|NCT03386721|65373744|FG002|Overall Study|Progressive Disease|1|||
23629866|NCT00379769|66032023|FG000|Main Study|Investigator refused to log temperature|0|||
23629867|NCT00379769|66032024|FG001|Main Study|Investigator refused to log temperature|0|||
23829454|NCT01515423|66755915|FG000|Open Label Phase|Lost to Follow-up|21|||
23829455|NCT01515423|66755916|FG001|Open Label Phase|Lost to Follow-up|0|||
23829456|NCT01515423|66755917|FG002|Open Label Phase|Lost to Follow-up|0|||
23766274|NCT02688400|66521960|FG001|Overall Study|Lack of Efficacy|7|||
23766275|NCT02688400|66521959|FG000|Overall Study|Adverse Event|21|||
23445807|NCT03386721|65373745|FG003|Overall Study|Progressive Disease|0|||
23567946|NCT01734434|65807214|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23567947|NCT01734434|65807215|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
23567948|NCT01734434|65807216|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23567949|NCT01351025|65807217|FG000|Week 0 - 20|Lost to Follow-up|2|||
23567950|NCT01351025|65807218|FG001|Week 0 - 20|Lost to Follow-up|1|||
23567951|NCT01351025|65807217|FG000|Week 0 - 20|Withdrawal by Subject|1|||
23567952|NCT01351025|65807218|FG001|Week 0 - 20|Withdrawal by Subject|0|||
23567953|NCT01351025|65807217|FG000|Week 24 - 44|Lost to Follow-up|0|||
23567954|NCT01351025|65807218|FG001|Week 24 - 44|Lost to Follow-up|2|||
23567955|NCT01351025|65807217|FG000|Week 24 - 44|Site closed|0|||
23567956|NCT01351025|65807218|FG001|Week 24 - 44|Site closed|1|||
23567957|NCT01351025|65807217|FG000|Week 24 - 44|unable to get to clinic|1|||
23445808|NCT03386721|65373746|FG004|Overall Study|Progressive Disease|0|||
23445809|NCT03386721|65373747|FG005|Overall Study|Progressive Disease|1|||
23445810|NCT03386721|65373748|FG006|Overall Study|Progressive Disease|0|||
23445811|NCT03386721|65373749|FG007|Overall Study|Progressive Disease|0|||
23445812|NCT03386721|65373750|FG008|Overall Study|Progressive Disease|2|||
23445813|NCT03386721|65373751|FG009|Overall Study|Progressive Disease|1|||
23445814|NCT03386721|65373752|FG010|Overall Study|Progressive Disease|1|||
23766276|NCT02688400|66521960|FG001|Overall Study|Adverse Event|12|||
23766277|NCT02688400|66521959|FG000|Overall Study|Withdrawal by Subject|15|||
23766278|NCT02688400|66521960|FG001|Overall Study|Withdrawal by Subject|13|||
23766279|NCT02688400|66521959|FG000|Overall Study|No study medication intake|1|||
23766280|NCT02688400|66521960|FG001|Overall Study|No study medication intake|4|||
23766281|NCT02688400|66521959|FG000|Overall Study|Lost to Follow-up|0|||
23445815|NCT03386721|65373753|FG011|Overall Study|Progressive Disease|0|||
23445816|NCT03386721|65373754|FG012|Overall Study|Progressive Disease|1|||
23766282|NCT02688400|66521960|FG001|Overall Study|Lost to Follow-up|3|||
23445817|NCT03386721|65373755|FG013|Overall Study|Progressive Disease|0|||
23445818|NCT03386721|65373756|FG014|Overall Study|Progressive Disease|0|||
23766283|NCT03907280|66521961|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
23766284|NCT03907280|66521962|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
23766285|NCT03907280|66521963|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
23766286|NCT03387059|66521971|FG000|Overall Study|Study termination|5|||
23766287|NCT03387059|66521972|FG001|Overall Study|Study termination|4|||
23766288|NCT00947856|66521975|FG000|Treatment Period|Progressive Disease|33|||
23766289|NCT00947856|66521976|FG001|Treatment Period|Progressive Disease|12|||
23766290|NCT00947856|66521975|FG000|Treatment Period|Adverse Event|15|||
23766291|NCT00947856|66521976|FG001|Treatment Period|Adverse Event|9|||
23766292|NCT00947856|66521975|FG000|Treatment Period|Physician Decision|14|||
23766293|NCT00947856|66521976|FG001|Treatment Period|Physician Decision|6|||
23766294|NCT00947856|66521975|FG000|Treatment Period|Study Stopped by Sponsor|4|||
23766295|NCT00947856|66521976|FG001|Treatment Period|Study Stopped by Sponsor|4|||
23567958|NCT01351025|65807218|FG001|Week 24 - 44|unable to get to clinic|1|||
23567959|NCT00308737|65807219|FG000|Overall Study|Adverse Event|104|||
23766296|NCT00947856|66521975|FG000|Treatment Period|Withdrawal by Subject|12|||
23766297|NCT00947856|66521976|FG001|Treatment Period|Withdrawal by Subject|1|||
23766298|NCT00947856|66521975|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
23766299|NCT00947856|66521976|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
23766300|NCT00947856|66521975|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
23766301|NCT00947856|66521976|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
23766302|NCT00947856|66521975|FG000|Follow-up Period|Lost to Follow-up|7|||
23766303|NCT00947856|66521976|FG001|Follow-up Period|Lost to Follow-up|0|||
23567960|NCT00308737|65807220|FG001|Overall Study|Adverse Event|9|||
23567961|NCT00308737|65807221|FG002|Overall Study|Adverse Event|0|||
23567962|NCT00308737|65807219|FG000|Overall Study|Death|4|||
23567963|NCT00308737|65807220|FG001|Overall Study|Death|3|||
23567964|NCT00308737|65807221|FG002|Overall Study|Death|0|||
23567965|NCT00308737|65807219|FG000|Overall Study|Lost to Follow-up|56|||
23567966|NCT00308737|65807220|FG001|Overall Study|Lost to Follow-up|80|||
23766304|NCT00947856|66521975|FG000|Follow-up Period|Patient unavailable for site visits|1|||
23766305|NCT00947856|66521976|FG001|Follow-up Period|Patient unavailable for site visits|0|||
23567967|NCT00308737|65807221|FG002|Overall Study|Lost to Follow-up|5|||
23567968|NCT00308737|65807219|FG000|Overall Study|Physician Decision|15|||
23567969|NCT00308737|65807220|FG001|Overall Study|Physician Decision|2|||
23766306|NCT00947856|66521975|FG000|Follow-up Period|Withdrawal by Subject|1|||
23766307|NCT00947856|66521976|FG001|Follow-up Period|Withdrawal by Subject|0|||
23766308|NCT01078090|66521977|FG000|Overall Study|Lost to Follow-up|2363|||
23766309|NCT01078090|66521977|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
23766310|NCT01078090|66521977|FG000|Overall Study|Lack of Efficacy|1193|||
23766311|NCT01078090|66521977|FG000|Overall Study|ADR and lack of efficacy|61|||
23766312|NCT01078090|66521977|FG000|Overall Study|Other|523|||
23766313|NCT00993616|66521978|FG000|Overall Study|No tumor at entry|1|||
23766314|NCT00993616|66521978|FG000|Overall Study|Never treated|1|||
23766315|NCT03572933|66521979|FG000|Overall Study|Adverse Event|4|||
23766316|NCT03572933|66521980|FG001|Overall Study|Adverse Event|1|||
23766317|NCT03572933|66521979|FG000|Overall Study|Withdrawal by Subject|0|||
23766318|NCT03572933|66521980|FG001|Overall Study|Withdrawal by Subject|1|||
23766319|NCT01346410|66521981|FG000|Overall Study|Death|1|||
23766320|NCT03465891|66521984|FG000|Overall Study|Withdrawal by Subject|0|||
23766321|NCT03465891|66521985|FG001|Overall Study|Withdrawal by Subject|1|||
23766322|NCT03465891|66521984|FG000|Overall Study|Disease progression|1|||
23766323|NCT03465891|66521985|FG001|Overall Study|Disease progression|0|||
23567970|NCT00308737|65807221|FG002|Overall Study|Physician Decision|1|||
23567971|NCT00308737|65807219|FG000|Overall Study|Protocol Violation|34|||
23766324|NCT00669955|66521986|FG000|Overall Study|Adverse Event|3|||
23766325|NCT00669955|66521987|FG001|Overall Study|Adverse Event|5|||
23766326|NCT00669955|66521986|FG000|Overall Study|Death|0|||
23766327|NCT00669955|66521987|FG001|Overall Study|Death|1|||
23766328|NCT00669955|66521986|FG000|Overall Study|Withdrawal by Subject|2|||
23766329|NCT00669955|66521987|FG001|Overall Study|Withdrawal by Subject|3|||
23766330|NCT00669955|66521986|FG000|Overall Study|Lost to Follow-up|5|||
23766331|NCT00669955|66521987|FG001|Overall Study|Lost to Follow-up|7|||
23766332|NCT00669955|66521986|FG000|Overall Study|Protocol Violation|2|||
23766333|NCT00669955|66521987|FG001|Overall Study|Protocol Violation|7|||
23766334|NCT00669955|66521986|FG000|Overall Study|Investigator Sponsor Judgement|0|||
23766335|NCT00669955|66521987|FG001|Overall Study|Investigator Sponsor Judgement|1|||
23766336|NCT00669955|66521986|FG000|Overall Study|not compliant with study drug/visit|2|||
23766337|NCT00669955|66521987|FG001|Overall Study|not compliant with study drug/visit|3|||
23766338|NCT00423800|66521988|FG000|Overall Study|Protocol Violation|0|||
23766339|NCT00423800|66521989|FG001|Overall Study|Protocol Violation|1|||
23766340|NCT01368276|66521990|FG000|Overall Study|Death|1|||
23766341|NCT01368276|66521991|FG001|Overall Study|Death|10|||
23766342|NCT03083483|66521992|FG000|Overall Study|Adverse Event|1|||
23766343|NCT03083483|66521993|FG001|Overall Study|Adverse Event|1|||
23766344|NCT03083483|66521994|FG002|Overall Study|Adverse Event|1|||
23766345|NCT03083483|66521992|FG000|Overall Study|Lost to Follow-up|2|||
23766346|NCT03083483|66521993|FG001|Overall Study|Lost to Follow-up|1|||
23766347|NCT03083483|66521994|FG002|Overall Study|Lost to Follow-up|1|||
23766348|NCT03083483|66521992|FG000|Overall Study|technological issues|1|||
23766349|NCT03083483|66521993|FG001|Overall Study|technological issues|0|||
23766350|NCT03083483|66521994|FG002|Overall Study|technological issues|1|||
23766351|NCT02058628|66521997|FG000|Overall Study|Adverse Event|1|||
23766352|NCT02058628|66521998|FG001|Overall Study|Adverse Event|0|||
23766353|NCT02058628|66521997|FG000|Overall Study|Withdrawal by Subject|2|||
23766354|NCT02058628|66521998|FG001|Overall Study|Withdrawal by Subject|2|||
23766355|NCT02058628|66521997|FG000|Overall Study|Lost to Follow-up|2|||
23766356|NCT02058628|66521998|FG001|Overall Study|Lost to Follow-up|4|||
23766357|NCT02058628|66521997|FG000|Overall Study|Not in time schedule|0|||
23766358|NCT02058628|66521998|FG001|Overall Study|Not in time schedule|1|||
23766359|NCT02058628|66521997|FG000|Overall Study|The visit date was not in timeline|0|||
23766360|NCT02058628|66521998|FG001|Overall Study|The visit date was not in timeline|1|||
23766361|NCT02058628|66521997|FG000|Overall Study|A lot of time for study for participant|1|||
23766362|NCT02058628|66521998|FG001|Overall Study|A lot of time for study for participant|0|||
23567972|NCT00308737|65807220|FG001|Overall Study|Protocol Violation|9|||
23567973|NCT00308737|65807221|FG002|Overall Study|Protocol Violation|5|||
23766363|NCT02058628|66521997|FG000|Overall Study|Non compliance|1|||
23766364|NCT02058628|66521998|FG001|Overall Study|Non compliance|0|||
23766365|NCT03072459|66521999|FG000|Overall Study|Device revised/removed|1|||
23766366|NCT03072459|66521999|FG000|Overall Study|Subject not able to return|1|||
23766367|NCT00745251|66522000|FG000|Overall Study|Adverse Event|1|||
23766368|NCT00745251|66522001|FG001|Overall Study|Adverse Event|2|||
23567974|NCT00308737|65807219|FG000|Overall Study|Withdrawal by Subject|218|||
23567975|NCT00308737|65807220|FG001|Overall Study|Withdrawal by Subject|166|||
23766369|NCT00745251|66522000|FG000|Overall Study|Withdrawal by Subject|1|||
23766370|NCT00745251|66522001|FG001|Overall Study|Withdrawal by Subject|1|||
23766371|NCT02180061|66522006|FG000|Overall Study|Adverse Event|4|||
23766372|NCT02180061|66522007|FG001|Overall Study|Adverse Event|2|||
23766373|NCT02180061|66522006|FG000|Overall Study|Clinical Progression|5|||
23766374|NCT02180061|66522007|FG001|Overall Study|Clinical Progression|1|||
23766375|NCT02180061|66522006|FG000|Overall Study|Progressive Disease|15|||
23766376|NCT02180061|66522007|FG001|Overall Study|Progressive Disease|5|||
23766377|NCT02180061|66522006|FG000|Overall Study|Physician Decision|1|||
23766378|NCT02180061|66522007|FG001|Overall Study|Physician Decision|0|||
23766379|NCT03650400|66522008|FG000|Overall Study|Study terminated by sponsor|0|||
23766380|NCT03650400|66522009|FG001|Overall Study|Study terminated by sponsor|5|||
23766381|NCT02087059|66522010|FG000|Overall Study|Disease Progression|1|||
23766382|NCT02087059|66522010|FG000|Overall Study|Adverse Event|5|||
23766383|NCT02087059|66522010|FG000|Overall Study|Lost to Follow-up|1|||
23766384|NCT00814320|66522011|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
23766385|NCT00814320|66522012|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
23766386|NCT00814320|66522011|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
23766387|NCT00814320|66522012|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
23766388|NCT00814320|66522011|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
23766389|NCT00814320|66522012|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
23766390|NCT00814320|66522011|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
23766391|NCT00814320|66522012|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
23766392|NCT00814320|66522011|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
23766393|NCT00814320|66522012|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
23766394|NCT00814320|66522011|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
23766395|NCT00814320|66522012|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
23766396|NCT00814320|66522011|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
23766397|NCT00814320|66522012|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
23766398|NCT00814320|66522011|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
23766399|NCT00814320|66522012|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
23445819|NCT03386721|65373742|FG000|Overall Study|Site Terminated by Sponsor|5|||
23766400|NCT00814320|66522011|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
23766401|NCT00814320|66522012|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
23445820|NCT03386721|65373743|FG001|Overall Study|Site Terminated by Sponsor|5|||
23445821|NCT03386721|65373744|FG002|Overall Study|Site Terminated by Sponsor|0|||
23445822|NCT03386721|65373745|FG003|Overall Study|Site Terminated by Sponsor|0|||
23445823|NCT03386721|65373746|FG004|Overall Study|Site Terminated by Sponsor|1|||
23445824|NCT03386721|65373747|FG005|Overall Study|Site Terminated by Sponsor|3|||
23445825|NCT03386721|65373748|FG006|Overall Study|Site Terminated by Sponsor|0|||
23445826|NCT03386721|65373749|FG007|Overall Study|Site Terminated by Sponsor|1|||
23766402|NCT00814320|66522011|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
23766403|NCT00814320|66522012|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
23445827|NCT03386721|65373750|FG008|Overall Study|Site Terminated by Sponsor|4|||
23445828|NCT03386721|65373751|FG009|Overall Study|Site Terminated by Sponsor|5|||
23445829|NCT03386721|65373752|FG010|Overall Study|Site Terminated by Sponsor|3|||
23445830|NCT03386721|65373753|FG011|Overall Study|Site Terminated by Sponsor|11|||
23766404|NCT01752920|66522013|FG000|Overall Study|Adverse Event|1|||
23766405|NCT01752920|66522014|FG001|Overall Study|Adverse Event|0|||
23766406|NCT01752920|66522015|FG002|Overall Study|Adverse Event|5|||
23766407|NCT01752920|66522016|FG003|Overall Study|Adverse Event|10|||
23766408|NCT01752920|66522013|FG000|Overall Study|Clinical Disease Progression|6|||
23766409|NCT01752920|66522014|FG001|Overall Study|Clinical Disease Progression|4|||
23445831|NCT03386721|65373754|FG012|Overall Study|Site Terminated by Sponsor|6|||
23445832|NCT03386721|65373755|FG013|Overall Study|Site Terminated by Sponsor|0|||
23445833|NCT03386721|65373756|FG014|Overall Study|Site Terminated by Sponsor|0|||
23445834|NCT03386721|65373742|FG000|Overall Study|Symptomatic Deterioration|0|||
23445835|NCT03386721|65373743|FG001|Overall Study|Symptomatic Deterioration|0|||
23445836|NCT03386721|65373744|FG002|Overall Study|Symptomatic Deterioration|0|||
23445837|NCT03386721|65373745|FG003|Overall Study|Symptomatic Deterioration|0|||
23445838|NCT03386721|65373746|FG004|Overall Study|Symptomatic Deterioration|0|||
23445839|NCT03386721|65373747|FG005|Overall Study|Symptomatic Deterioration|0|||
23445840|NCT03386721|65373748|FG006|Overall Study|Symptomatic Deterioration|0|||
23445841|NCT03386721|65373749|FG007|Overall Study|Symptomatic Deterioration|0|||
23445842|NCT03386721|65373750|FG008|Overall Study|Symptomatic Deterioration|1|||
23445843|NCT03386721|65373751|FG009|Overall Study|Symptomatic Deterioration|0|||
23445844|NCT03386721|65373752|FG010|Overall Study|Symptomatic Deterioration|0|||
23445845|NCT03386721|65373753|FG011|Overall Study|Symptomatic Deterioration|1|||
23445846|NCT03386721|65373754|FG012|Overall Study|Symptomatic Deterioration|0|||
23445847|NCT03386721|65373755|FG013|Overall Study|Symptomatic Deterioration|0|||
23445848|NCT03386721|65373756|FG014|Overall Study|Symptomatic Deterioration|0|||
23445849|NCT03386721|65373742|FG000|Overall Study|Withdrawal by Subject|1|||
23445850|NCT03386721|65373743|FG001|Overall Study|Withdrawal by Subject|2|||
23445851|NCT03386721|65373744|FG002|Overall Study|Withdrawal by Subject|0|||
23445852|NCT03386721|65373745|FG003|Overall Study|Withdrawal by Subject|0|||
23445853|NCT03386721|65373746|FG004|Overall Study|Withdrawal by Subject|0|||
23445854|NCT03386721|65373747|FG005|Overall Study|Withdrawal by Subject|0|||
23445855|NCT03386721|65373748|FG006|Overall Study|Withdrawal by Subject|0|||
23445856|NCT03386721|65373749|FG007|Overall Study|Withdrawal by Subject|0|||
23445857|NCT03386721|65373750|FG008|Overall Study|Withdrawal by Subject|2|||
23445858|NCT03386721|65373751|FG009|Overall Study|Withdrawal by Subject|1|||
23445859|NCT03386721|65373752|FG010|Overall Study|Withdrawal by Subject|3|||
23445860|NCT03386721|65373753|FG011|Overall Study|Withdrawal by Subject|2|||
23445861|NCT03386721|65373754|FG012|Overall Study|Withdrawal by Subject|3|||
23445862|NCT03386721|65373755|FG013|Overall Study|Withdrawal by Subject|0|||
23445863|NCT03386721|65373756|FG014|Overall Study|Withdrawal by Subject|0|||
23445864|NCT04170543|65373757|FG000|Overall Study|Death|1|||
23445865|NCT04170543|65373758|FG001|Overall Study|Death|1|||
23445866|NCT04170543|65373759|FG002|Overall Study|Death|1|||
23445867|NCT04170543|65373760|FG003|Overall Study|Death|1|||
23445868|NCT04170543|65373761|FG004|Overall Study|Death|1|||
23445869|NCT04170543|65373757|FG000|Overall Study|Lost to Follow-up|3|||
23445870|NCT04170543|65373758|FG001|Overall Study|Lost to Follow-up|3|||
23766410|NCT01752920|66522015|FG002|Overall Study|Clinical Disease Progression|1|||
23766411|NCT01752920|66522016|FG003|Overall Study|Clinical Disease Progression|13|||
23766412|NCT01752920|66522013|FG000|Overall Study|Physician Decision|1|||
23766413|NCT01752920|66522014|FG001|Overall Study|Physician Decision|0|||
23766414|NCT01752920|66522015|FG002|Overall Study|Physician Decision|0|||
23766415|NCT01752920|66522016|FG003|Overall Study|Physician Decision|3|||
23445871|NCT04170543|65373759|FG002|Overall Study|Lost to Follow-up|0|||
23445872|NCT04170543|65373760|FG003|Overall Study|Lost to Follow-up|3|||
23445873|NCT04170543|65373761|FG004|Overall Study|Lost to Follow-up|1|||
23445874|NCT04170543|65373757|FG000|Overall Study|Withdrawal by Subject|13|||
23445875|NCT04170543|65373758|FG001|Overall Study|Withdrawal by Subject|6|||
23766416|NCT01752920|66522013|FG000|Overall Study|Radiographic Disease Progression|20|||
23766417|NCT01752920|66522014|FG001|Overall Study|Radiographic Disease Progression|7|||
23766418|NCT01752920|66522015|FG002|Overall Study|Radiographic Disease Progression|12|||
23445876|NCT04170543|65373759|FG002|Overall Study|Withdrawal by Subject|5|||
23445877|NCT04170543|65373760|FG003|Overall Study|Withdrawal by Subject|4|||
23445878|NCT04170543|65373761|FG004|Overall Study|Withdrawal by Subject|9|||
23445879|NCT04170543|65373757|FG000|Overall Study|Not able to transition to phase 2b|8|||
23445880|NCT04170543|65373758|FG001|Overall Study|Not able to transition to phase 2b|0|||
23445881|NCT04170543|65373759|FG002|Overall Study|Not able to transition to phase 2b|10|||
23445882|NCT04170543|65373760|FG003|Overall Study|Not able to transition to phase 2b|0|||
23445883|NCT04170543|65373761|FG004|Overall Study|Not able to transition to phase 2b|6|||
23445884|NCT04170543|65373757|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
23445885|NCT04170543|65373758|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
23445886|NCT04170543|65373759|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
23445887|NCT04170543|65373760|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
23445888|NCT04170543|65373761|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
23445889|NCT04170543|65373757|FG000|Overall Study|Not Treated|0|||
23445890|NCT04170543|65373758|FG001|Overall Study|Not Treated|0|||
23445891|NCT04170543|65373759|FG002|Overall Study|Not Treated|0|||
23766419|NCT01752920|66522016|FG003|Overall Study|Radiographic Disease Progression|29|||
23766420|NCT01752920|66522013|FG000|Overall Study|Study Terminated by Sponsor|0|||
23766421|NCT01752920|66522014|FG001|Overall Study|Study Terminated by Sponsor|0|||
23766422|NCT01752920|66522015|FG002|Overall Study|Study Terminated by Sponsor|0|||
23766423|NCT01752920|66522016|FG003|Overall Study|Study Terminated by Sponsor|1|||
23766424|NCT01752920|66522013|FG000|Overall Study|Withdrawal by Subject|0|||
23445892|NCT04170543|65373760|FG003|Overall Study|Not Treated|0|||
23445893|NCT04170543|65373761|FG004|Overall Study|Not Treated|2|||
23445894|NCT04170543|65373757|FG000|Overall Study|(CRF)|16|||
23445895|NCT04170543|65373758|FG001|Overall Study|(CRF)|15|||
23445896|NCT04170543|65373759|FG002|Overall Study|(CRF)|12|||
23445897|NCT04170543|65373760|FG003|Overall Study|(CRF)|17|||
23445898|NCT04170543|65373761|FG004|Overall Study|(CRF)|17|||
23445899|NCT04170543|65373757|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
23445900|NCT04170543|65373758|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
23445901|NCT04170543|65373759|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
23445902|NCT04170543|65373760|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
23445903|NCT04170543|65373761|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
23445904|NCT01687296|65373765|FG000|Overall Study|Lack of Efficacy|1|||
23445905|NCT01687296|65373766|FG001|Overall Study|Lack of Efficacy|1|||
23445906|NCT01687296|65373765|FG000|Overall Study|Protocol Violation|0|||
23445907|NCT01687296|65373766|FG001|Overall Study|Protocol Violation|1|||
23445908|NCT01687296|65373765|FG000|Overall Study|Withdrawal by Subject|6|||
23445909|NCT01687296|65373766|FG001|Overall Study|Withdrawal by Subject|3|||
23445910|NCT01818596|65373769|FG000|Overall Study|Enrolled but Not Treated|4|||
23445911|NCT01818596|65373770|FG001|Overall Study|Enrolled but Not Treated|0|||
23445912|NCT01818596|65373769|FG000|Overall Study|Adverse Event|7|||
23445913|NCT01818596|65373770|FG001|Overall Study|Adverse Event|0|||
23445914|NCT01818596|65373769|FG000|Overall Study|Death|3|||
23445915|NCT01818596|65373770|FG001|Overall Study|Death|0|||
23445916|NCT01818596|65373769|FG000|Overall Study|Investigator's Discretion|4|||
23445917|NCT01818596|65373770|FG001|Overall Study|Investigator's Discretion|0|||
23445918|NCT01818596|65373769|FG000|Overall Study|Protocol Violation|1|||
23445919|NCT01818596|65373770|FG001|Overall Study|Protocol Violation|0|||
23445920|NCT01818596|65373769|FG000|Overall Study|Withdrew Consent|5|||
23445921|NCT01818596|65373770|FG001|Overall Study|Withdrew Consent|0|||
23445922|NCT01818596|65373769|FG000|Overall Study|Lost to Follow-up|7|||
23445923|NCT01818596|65373770|FG001|Overall Study|Lost to Follow-up|0|||
23445924|NCT02454478|65373774|FG000|Overall Study|Incomplete DLT Evaluation|1|||
23445925|NCT00183625|65373775|FG000|Overall Study|Withdrawal by Subject|18|||
23445926|NCT00183625|65373776|FG001|Overall Study|Withdrawal by Subject|18|||
23445927|NCT00183625|65373777|FG002|Overall Study|Withdrawal by Subject|19|||
23445928|NCT00183625|65373778|FG003|Overall Study|Withdrawal by Subject|14|||
23445929|NCT00602420|65373779|FG000|Overall Study|Death|1|||
23629868|NCT00379769|66032025|FG002|Main Study|Investigator refused to log temperature|1|||
23629869|NCT00379769|66032026|FG003|Main Study|Investigator refused to log temperature|0|||
23629870|NCT00379769|66032027|FG004|Main Study|Investigator refused to log temperature|0|||
23629871|NCT00379769|66032028|FG005|Main Study|Investigator refused to log temperature|0|||
23629872|NCT00379769|66032023|FG000|Main Study|Reason unspecified|0|||
23629873|NCT00379769|66032024|FG001|Main Study|Reason unspecified|0|||
23629874|NCT00379769|66032025|FG002|Main Study|Reason unspecified|1|||
23766425|NCT01752920|66522014|FG001|Overall Study|Withdrawal by Subject|1|||
23766426|NCT01752920|66522015|FG002|Overall Study|Withdrawal by Subject|0|||
23445930|NCT00602420|65373780|FG001|Overall Study|Death|4|||
23445931|NCT00602420|65373779|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
23629875|NCT00379769|66032026|FG003|Main Study|Reason unspecified|0|||
23445932|NCT00602420|65373780|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
23445933|NCT00602420|65373779|FG000|Overall Study|Withdrawal by Subject|18|||
23445934|NCT00602420|65373780|FG001|Overall Study|Withdrawal by Subject|17|||
23629876|NCT00379769|66032027|FG004|Main Study|Reason unspecified|0|||
23629877|NCT00379769|66032028|FG005|Main Study|Reason unspecified|0|||
23766427|NCT01752920|66522016|FG003|Overall Study|Withdrawal by Subject|1|||
23766428|NCT01752920|66522013|FG000|Overall Study|Lack of clinical benefit|1|||
23445935|NCT00602420|65373779|FG000|Overall Study|Adverse Event|1|||
23445936|NCT00602420|65373780|FG001|Overall Study|Adverse Event|0|||
23629878|NCT00379769|66032023|FG000|Observational Follow-up|Death|0|||
23629879|NCT00379769|66032024|FG001|Observational Follow-up|Death|0|||
23629880|NCT00379769|66032025|FG002|Observational Follow-up|Death|0|||
23629881|NCT00379769|66032026|FG003|Observational Follow-up|Death|0|||
23629882|NCT00379769|66032027|FG004|Observational Follow-up|Death|78|||
23629883|NCT00379769|66032028|FG005|Observational Follow-up|Death|70|||
23629884|NCT00379769|66032023|FG000|Observational Follow-up|Adverse Event|0|||
23629885|NCT00379769|66032024|FG001|Observational Follow-up|Adverse Event|0|||
23629886|NCT00379769|66032025|FG002|Observational Follow-up|Adverse Event|0|||
23629887|NCT00379769|66032026|FG003|Observational Follow-up|Adverse Event|0|||
23629888|NCT00379769|66032027|FG004|Observational Follow-up|Adverse Event|1|||
23629889|NCT00379769|66032028|FG005|Observational Follow-up|Adverse Event|0|||
23629890|NCT00379769|66032023|FG000|Observational Follow-up|Lost to Follow-up|0|||
23629891|NCT00379769|66032024|FG001|Observational Follow-up|Lost to Follow-up|0|||
23629892|NCT00379769|66032025|FG002|Observational Follow-up|Lost to Follow-up|0|||
23629893|NCT00379769|66032026|FG003|Observational Follow-up|Lost to Follow-up|0|||
23629894|NCT00379769|66032027|FG004|Observational Follow-up|Lost to Follow-up|25|||
23629895|NCT00379769|66032028|FG005|Observational Follow-up|Lost to Follow-up|27|||
23629896|NCT00379769|66032023|FG000|Observational Follow-up|Withdrawal by Subject|0|||
23629897|NCT00379769|66032024|FG001|Observational Follow-up|Withdrawal by Subject|0|||
23629898|NCT00379769|66032025|FG002|Observational Follow-up|Withdrawal by Subject|0|||
23629899|NCT00379769|66032026|FG003|Observational Follow-up|Withdrawal by Subject|0|||
23629900|NCT00379769|66032027|FG004|Observational Follow-up|Withdrawal by Subject|12|||
23629901|NCT00379769|66032028|FG005|Observational Follow-up|Withdrawal by Subject|12|||
23629902|NCT00379769|66032023|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
23629903|NCT00379769|66032024|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
23629904|NCT00379769|66032025|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
23629905|NCT00379769|66032026|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
23629906|NCT00379769|66032027|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
23629907|NCT00379769|66032028|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
23629908|NCT00379769|66032023|FG000|Observational Follow-up|Physician Decision|0|||
23629909|NCT00379769|66032024|FG001|Observational Follow-up|Physician Decision|0|||
23629910|NCT00379769|66032025|FG002|Observational Follow-up|Physician Decision|0|||
23629911|NCT00379769|66032026|FG003|Observational Follow-up|Physician Decision|0|||
23629912|NCT00379769|66032027|FG004|Observational Follow-up|Physician Decision|8|||
23629913|NCT00379769|66032028|FG005|Observational Follow-up|Physician Decision|8|||
23629914|NCT00379769|66032023|FG000|Observational Follow-up|Site Closed Early|0|||
23629915|NCT00379769|66032024|FG001|Observational Follow-up|Site Closed Early|0|||
23629916|NCT00379769|66032025|FG002|Observational Follow-up|Site Closed Early|0|||
23629917|NCT00379769|66032026|FG003|Observational Follow-up|Site Closed Early|0|||
23629918|NCT00379769|66032027|FG004|Observational Follow-up|Site Closed Early|6|||
23629919|NCT00379769|66032028|FG005|Observational Follow-up|Site Closed Early|7|||
23629920|NCT00379769|66032023|FG000|Observational Follow-up|Participant Moved|0|||
23629921|NCT00379769|66032024|FG001|Observational Follow-up|Participant Moved|0|||
23629922|NCT00379769|66032025|FG002|Observational Follow-up|Participant Moved|0|||
23629923|NCT00379769|66032026|FG003|Observational Follow-up|Participant Moved|0|||
23629924|NCT00379769|66032027|FG004|Observational Follow-up|Participant Moved|0|||
23629925|NCT00379769|66032028|FG005|Observational Follow-up|Participant Moved|1|||
23629926|NCT00379769|66032023|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
23629927|NCT00379769|66032024|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
23629928|NCT00379769|66032025|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
23629929|NCT00379769|66032026|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
23629930|NCT00379769|66032027|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
23629931|NCT00379769|66032028|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
23629932|NCT02586415|66032029|FG000|Overall Study|Death|13|||
23629933|NCT02586415|66032030|FG001|Overall Study|Death|23|||
23629934|NCT02586415|66032029|FG000|Overall Study|Lost to Follow-up|1|||
23629935|NCT02586415|66032030|FG001|Overall Study|Lost to Follow-up|2|||
23629936|NCT02034162|66032032|FG000|Double-blind|Lost to Follow-up|3|||
23629937|NCT02034162|66032033|FG001|Double-blind|Lost to Follow-up|0|||
23629938|NCT02034162|66032034|FG002|Double-blind|Lost to Follow-up|0|||
23766429|NCT01752920|66522014|FG001|Overall Study|Lack of clinical benefit|1|||
23766430|NCT01752920|66522015|FG002|Overall Study|Lack of clinical benefit|1|||
23766431|NCT01752920|66522016|FG003|Overall Study|Lack of clinical benefit|1|||
23766432|NCT00982410|66522018|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
23766433|NCT00982410|66522019|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
23766434|NCT00982410|66522018|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
23629939|NCT02034162|66032032|FG000|Double-blind|Physician Decision|1|||
23629940|NCT02034162|66032033|FG001|Double-blind|Physician Decision|0|||
23766435|NCT00982410|66522019|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
23766436|NCT00982410|66522018|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
23629941|NCT02034162|66032034|FG002|Double-blind|Physician Decision|0|||
23629942|NCT02034162|66032032|FG000|Double-blind|Protocol Violation|0|||
23629943|NCT02034162|66032033|FG001|Double-blind|Protocol Violation|1|||
23629944|NCT02034162|66032034|FG002|Double-blind|Protocol Violation|0|||
23629945|NCT02034162|66032032|FG000|Double-blind|Withdrawal by Subject|5|||
23629946|NCT02034162|66032033|FG001|Double-blind|Withdrawal by Subject|7|||
23629947|NCT02034162|66032034|FG002|Double-blind|Withdrawal by Subject|0|||
23766437|NCT00982410|66522019|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
23766438|NCT00982410|66522018|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
23766439|NCT00982410|66522019|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
23766440|NCT00982410|66522018|FG000|6-month Follow-up Assessment|participant no transportation|1|||
23766441|NCT00982410|66522019|FG001|6-month Follow-up Assessment|participant no transportation|0|||
23766442|NCT00982410|66522018|FG000|6-month Follow-up Assessment|incarceration|0|||
23766443|NCT00982410|66522019|FG001|6-month Follow-up Assessment|incarceration|2|||
23766444|NCT00982410|66522018|FG000|6-month Follow-up Assessment|patent surgery|0|||
23766445|NCT00982410|66522019|FG001|6-month Follow-up Assessment|patent surgery|1|||
23766446|NCT00982410|66522018|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
23766447|NCT00982410|66522019|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
23766448|NCT00982410|66522018|FG000|12-month Follow-up Assessment|Death|0|||
23445937|NCT03594773|65373786|FG000|Overall Study|Withdrawal by Subject|3|||
23766449|NCT00982410|66522019|FG001|12-month Follow-up Assessment|Death|2|||
23766450|NCT00982410|66522018|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
23766451|NCT00982410|66522019|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
23766452|NCT00982410|66522018|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
23766453|NCT00982410|66522019|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
23766454|NCT00982410|66522018|FG000|12-month Follow-up Assessment|incarceration|2|||
23766455|NCT00982410|66522019|FG001|12-month Follow-up Assessment|incarceration|1|||
23766456|NCT00982410|66522018|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
23766457|NCT00982410|66522019|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
23766458|NCT00447603|66522021|FG000|Screening|Withdrawal by Subject|1|||
23766459|NCT00447603|66522022|FG001|Screening|Withdrawal by Subject|0|||
23766460|NCT00447603|66522023|FG002|Screening|Withdrawal by Subject|0|||
23766461|NCT00447603|66522021|FG000|Screening|Protocol Violation|1|||
23766462|NCT00447603|66522022|FG001|Screening|Protocol Violation|0|||
23766463|NCT00447603|66522023|FG002|Screening|Protocol Violation|0|||
23766464|NCT00447603|66522021|FG000|Screening|Screen Failure|4|||
23766465|NCT00447603|66522022|FG001|Screening|Screen Failure|0|||
23766466|NCT00447603|66522023|FG002|Screening|Screen Failure|0|||
23766467|NCT00447603|66522021|FG000|Screening|Study Terminated by Sponsor|15|||
23766468|NCT00447603|66522022|FG001|Screening|Study Terminated by Sponsor|0|||
23629948|NCT02878603|66032038|FG000|Overall Study|Lost to Follow-up|4|||
23766469|NCT00447603|66522023|FG002|Screening|Study Terminated by Sponsor|0|||
23766470|NCT00447603|66522021|FG000|Filter Period|Adverse Event|0|||
23766471|NCT00447603|66522022|FG001|Filter Period|Adverse Event|0|||
23766472|NCT00447603|66522023|FG002|Filter Period|Adverse Event|1|||
23629949|NCT02878603|66032039|FG001|Overall Study|Lost to Follow-up|1|||
23766473|NCT00447603|66522021|FG000|Filter Period|Screen Failure|0|||
23766474|NCT00447603|66522022|FG001|Filter Period|Screen Failure|3|||
23629950|NCT02878603|66032038|FG000|Overall Study|Withdrawal by Subject|1|||
23629951|NCT02878603|66032039|FG001|Overall Study|Withdrawal by Subject|1|||
23629952|NCT02878603|66032038|FG000|Overall Study|Death|1|||
23445938|NCT03594773|65373787|FG001|Overall Study|Withdrawal by Subject|2|||
23567976|NCT00308737|65807221|FG002|Overall Study|Withdrawal by Subject|18|||
23629953|NCT02878603|66032039|FG001|Overall Study|Death|0|||
23766475|NCT00447603|66522023|FG002|Filter Period|Screen Failure|4|||
23766476|NCT00447603|66522021|FG000|Filter Period|Study terminated by Sponsor|0|||
23766477|NCT00447603|66522022|FG001|Filter Period|Study terminated by Sponsor|1|||
23766478|NCT00447603|66522023|FG002|Filter Period|Study terminated by Sponsor|10|||
23766479|NCT02207621|66522028|FG000|Overall Study|Adverse Event|71|||
23766480|NCT02207621|66522029|FG001|Overall Study|Adverse Event|15|||
23766481|NCT02207621|66522030|FG002|Overall Study|Adverse Event|132|||
23567977|NCT00308737|65807219|FG000|Overall Study|Various|32|||
23766482|NCT02207621|66522028|FG000|Overall Study|Withdrawal by Subject|9|||
23766483|NCT02207621|66522029|FG001|Overall Study|Withdrawal by Subject|9|||
23766484|NCT02207621|66522030|FG002|Overall Study|Withdrawal by Subject|13|||
23766485|NCT02207621|66522028|FG000|Overall Study|Non-Compliant|3|||
23766486|NCT02207621|66522029|FG001|Overall Study|Non-Compliant|3|||
23766487|NCT02207621|66522030|FG002|Overall Study|Non-Compliant|1|||
23766488|NCT02207621|66522028|FG000|Overall Study|Lost to Follow-up|1|||
23766489|NCT02207621|66522029|FG001|Overall Study|Lost to Follow-up|0|||
23766490|NCT02207621|66522030|FG002|Overall Study|Lost to Follow-up|3|||
23766491|NCT02207621|66522028|FG000|Overall Study|Lack of Efficacy|10|||
23766492|NCT02207621|66522029|FG001|Overall Study|Lack of Efficacy|2|||
23766493|NCT02207621|66522030|FG002|Overall Study|Lack of Efficacy|4|||
23766494|NCT02207621|66522028|FG000|Overall Study|Disallowed Concurrent Medication|2|||
23766495|NCT02207621|66522029|FG001|Overall Study|Disallowed Concurrent Medication|5|||
23766496|NCT02207621|66522030|FG002|Overall Study|Disallowed Concurrent Medication|2|||
23766497|NCT02207621|66522028|FG000|Overall Study|Physician Decision|1|||
23766498|NCT02207621|66522029|FG001|Overall Study|Physician Decision|2|||
23766499|NCT02207621|66522030|FG002|Overall Study|Physician Decision|2|||
23766500|NCT02207621|66522028|FG000|Overall Study|Protocol Violation|4|||
23766501|NCT02207621|66522029|FG001|Overall Study|Protocol Violation|10|||
23766502|NCT02207621|66522030|FG002|Overall Study|Protocol Violation|6|||
23766503|NCT02207621|66522028|FG000|Overall Study|Death|2|||
23766504|NCT02207621|66522029|FG001|Overall Study|Death|0|||
23766505|NCT02207621|66522030|FG002|Overall Study|Death|0|||
23766506|NCT02207621|66522028|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
23766507|NCT02207621|66522029|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
23766508|NCT02207621|66522030|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
23766509|NCT00760383|66522031|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
23766510|NCT00760383|66522032|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
23766511|NCT01829477|66522033|FG000|Overall Study|Study Terminated by Sponsor|15|||
23766512|NCT01829477|66522034|FG001|Overall Study|Study Terminated by Sponsor|15|||
23766513|NCT01829477|66522033|FG000|Overall Study|Withdrawal by Subject|1|||
23766514|NCT01829477|66522034|FG001|Overall Study|Withdrawal by Subject|0|||
23766515|NCT02826603|66524681|FG000|Overall Study|Adverse Event|17|||
23766516|NCT02826603|66524682|FG001|Overall Study|Adverse Event|9|||
23766517|NCT02826603|66524681|FG000|Overall Study|Lack of Efficacy|4|||
23766518|NCT02826603|66524682|FG001|Overall Study|Lack of Efficacy|9|||
23766519|NCT02826603|66524681|FG000|Overall Study|Lost to Follow-up|13|||
23445939|NCT03594773|65373786|FG000|Overall Study|Lost to Follow-up|3|||
23445940|NCT03594773|65373787|FG001|Overall Study|Lost to Follow-up|4|||
23567978|NCT00308737|65807220|FG001|Overall Study|Various|20|||
23567979|NCT00308737|65807221|FG002|Overall Study|Various|8|||
23567980|NCT00245856|65807222|FG000|Period Two|Withdrawal by Subject|0|||
23567981|NCT00245856|65807223|FG001|Period Two|Withdrawal by Subject|1|||
23567982|NCT02009696|65807224|FG000|Overall Study|Withdrawal by Subject|2|||
23567983|NCT00519636|65807227|FG000|Treatment Period 1|Adverse Event|1|||
23629954|NCT02878603|66032038|FG000|Overall Study|Physician Decision|0|||
23629955|NCT02878603|66032039|FG001|Overall Study|Physician Decision|3|||
23629956|NCT02630706|66032040|FG000|Overall Study|Adverse Event|2|||
23629957|NCT02630706|66032041|FG001|Overall Study|Adverse Event|1|||
23766520|NCT02826603|66524682|FG001|Overall Study|Lost to Follow-up|12|||
23766521|NCT02826603|66524681|FG000|Overall Study|Noncompliance with treatment|0|||
23766522|NCT02826603|66524682|FG001|Overall Study|Noncompliance with treatment|2|||
23766523|NCT02826603|66524681|FG000|Overall Study|Physician Decision|1|||
23766524|NCT02826603|66524682|FG001|Overall Study|Physician Decision|7|||
23766525|NCT02826603|66524681|FG000|Overall Study|Pregnancy|1|||
23766526|NCT02826603|66524682|FG001|Overall Study|Pregnancy|2|||
23766527|NCT02826603|66524681|FG000|Overall Study|Protocol Violation|3|||
23766528|NCT02826603|66524682|FG001|Overall Study|Protocol Violation|3|||
23445941|NCT00391027|65373788|FG000|Overall Study|Adverse Event|8|||
23567984|NCT00519636|65807228|FG001|Treatment Period 1|Adverse Event|0|||
23567985|NCT00519636|65807229|FG002|Treatment Period 1|Adverse Event|1|||
23567986|NCT00519636|65807230|FG003|Treatment Period 1|Adverse Event|0|||
23445942|NCT00391027|65373789|FG001|Overall Study|Adverse Event|8|||
23445943|NCT00391027|65373788|FG000|Overall Study|Lack of Efficacy|3|||
23445944|NCT00391027|65373789|FG001|Overall Study|Lack of Efficacy|0|||
23445945|NCT00391027|65373788|FG000|Overall Study|Withdrawal by Subject|10|||
23445946|NCT00391027|65373789|FG001|Overall Study|Withdrawal by Subject|1|||
23445947|NCT00391027|65373788|FG000|Overall Study|Other|4|||
23445948|NCT00391027|65373789|FG001|Overall Study|Other|3|||
23445949|NCT01625000|65373794|FG000|Overall Study|Physician Decision|15|||
23445950|NCT01625000|65373795|FG001|Overall Study|Physician Decision|7|||
23445951|NCT01625000|65373796|FG002|Overall Study|Physician Decision|7|||
23445952|NCT01625000|65373797|FG003|Overall Study|Physician Decision|2|||
23445953|NCT01625000|65373798|FG004|Overall Study|Physician Decision|15|||
23445954|NCT01625000|65373794|FG000|Overall Study|Protocol Violation|3|||
23445955|NCT01625000|65373795|FG001|Overall Study|Protocol Violation|10|||
23445956|NCT01625000|65373796|FG002|Overall Study|Protocol Violation|4|||
23445957|NCT01625000|65373797|FG003|Overall Study|Protocol Violation|1|||
23445958|NCT01625000|65373798|FG004|Overall Study|Protocol Violation|2|||
23829457|NCT01515423|66755915|FG000|Open Label Phase|Withdrawal by Subject|118|||
23829458|NCT01515423|66755916|FG001|Open Label Phase|Withdrawal by Subject|0|||
23829459|NCT01515423|66755917|FG002|Open Label Phase|Withdrawal by Subject|0|||
23567987|NCT00519636|65807227|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
23567988|NCT00519636|65807228|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
23567989|NCT00519636|65807229|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
23567990|NCT00519636|65807230|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
23567991|NCT00519636|65807227|FG000|Washout Period|Adverse Event|2|||
23567992|NCT00519636|65807228|FG001|Washout Period|Adverse Event|1|||
23567993|NCT00519636|65807229|FG002|Washout Period|Adverse Event|1|||
23567994|NCT00519636|65807230|FG003|Washout Period|Adverse Event|0|||
23567995|NCT00519636|65807227|FG000|Washout Period|Lost to Follow-up|1|||
23567996|NCT00519636|65807228|FG001|Washout Period|Lost to Follow-up|0|||
23567997|NCT00519636|65807229|FG002|Washout Period|Lost to Follow-up|0|||
23567998|NCT00519636|65807230|FG003|Washout Period|Lost to Follow-up|0|||
23567999|NCT00519636|65807227|FG000|Washout Period|Protocol Violation|0|||
23568000|NCT00519636|65807228|FG001|Washout Period|Protocol Violation|0|||
23568001|NCT00519636|65807229|FG002|Washout Period|Protocol Violation|1|||
23568002|NCT00519636|65807230|FG003|Washout Period|Protocol Violation|2|||
23568003|NCT00519636|65807227|FG000|Washout Period|Withdrawal by Subject|1|||
23568004|NCT00519636|65807228|FG001|Washout Period|Withdrawal by Subject|0|||
23629958|NCT02630706|66032042|FG002|Overall Study|Adverse Event|1|||
23629959|NCT02630706|66032040|FG000|Overall Study|Lost to Follow-up|0|||
23829460|NCT01515423|66755915|FG000|Open Label Phase|excluded from DB Phase|70|||
23829461|NCT01515423|66755916|FG001|Open Label Phase|excluded from DB Phase|0|||
23829462|NCT01515423|66755917|FG002|Open Label Phase|excluded from DB Phase|0|||
23829463|NCT01515423|66755915|FG000|Open Label Phase|Other|28|||
23829464|NCT01515423|66755916|FG001|Open Label Phase|Other|0|||
23445959|NCT01625000|65373794|FG000|Overall Study|Withdrawal by Subject|19|||
23445960|NCT01625000|65373795|FG001|Overall Study|Withdrawal by Subject|16|||
23445961|NCT01625000|65373796|FG002|Overall Study|Withdrawal by Subject|11|||
23568005|NCT00519636|65807229|FG002|Washout Period|Withdrawal by Subject|1|||
23568006|NCT00519636|65807230|FG003|Washout Period|Withdrawal by Subject|0|||
23568007|NCT00519636|65807227|FG000|Washout Period|Failed to meet continuation criteria|14|||
23568008|NCT00519636|65807228|FG001|Washout Period|Failed to meet continuation criteria|11|||
23766529|NCT02826603|66524681|FG000|Overall Study|Withdrawal by Subject|20|||
23766530|NCT02826603|66524682|FG001|Overall Study|Withdrawal by Subject|19|||
23766531|NCT02826603|66524681|FG000|Overall Study|Death|2|||
23766532|NCT02826603|66524682|FG001|Overall Study|Death|0|||
23766533|NCT02826603|66524681|FG000|Overall Study|New therapy for study indication|0|||
23766534|NCT02826603|66524682|FG001|Overall Study|New therapy for study indication|1|||
23766535|NCT01966042|66524683|FG000|Overall Study|Death|2|||
23766536|NCT01717456|66524690|FG000|End of Treatment|Physician Decision|0|||
23766537|NCT01717456|66524691|FG001|End of Treatment|Physician Decision|1|||
23766538|NCT01717456|66524690|FG000|End of Treatment|Lost to Follow-up|0|||
23766539|NCT01717456|66524691|FG001|End of Treatment|Lost to Follow-up|1|||
23766540|NCT01717456|66524690|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
23766541|NCT01717456|66524691|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
23766542|NCT02637557|66524695|FG000|Overall Study|Adverse Event|3|||
23766543|NCT02637557|66524696|FG001|Overall Study|Adverse Event|1|||
23766544|NCT02637557|66524697|FG002|Overall Study|Adverse Event|3|||
23766545|NCT02637557|66524698|FG003|Overall Study|Adverse Event|3|||
23766546|NCT02637557|66524695|FG000|Overall Study|Lost to Follow-up|1|||
23766547|NCT02637557|66524696|FG001|Overall Study|Lost to Follow-up|1|||
23766548|NCT02637557|66524697|FG002|Overall Study|Lost to Follow-up|0|||
23766549|NCT02637557|66524698|FG003|Overall Study|Lost to Follow-up|1|||
23766550|NCT02637557|66524695|FG000|Overall Study|Physician Decision|1|||
23766551|NCT02637557|66524696|FG001|Overall Study|Physician Decision|0|||
23829465|NCT01515423|66755917|FG002|Open Label Phase|Other|0|||
23568009|NCT00519636|65807229|FG002|Washout Period|Failed to meet continuation criteria|9|||
23629960|NCT02630706|66032041|FG001|Overall Study|Lost to Follow-up|1|||
23629961|NCT02630706|66032042|FG002|Overall Study|Lost to Follow-up|2|||
23629962|NCT02630706|66032040|FG000|Overall Study|Physician Decision|1|||
23629963|NCT02630706|66032041|FG001|Overall Study|Physician Decision|1|||
23629964|NCT02630706|66032042|FG002|Overall Study|Physician Decision|0|||
23629965|NCT02630706|66032040|FG000|Overall Study|Pregnancy|0|||
23629966|NCT02630706|66032041|FG001|Overall Study|Pregnancy|1|||
23629967|NCT02630706|66032042|FG002|Overall Study|Pregnancy|0|||
23629968|NCT02630706|66032040|FG000|Overall Study|Withdrawal by Subject|4|||
23629969|NCT02630706|66032041|FG001|Overall Study|Withdrawal by Subject|5|||
23766552|NCT02637557|66524697|FG002|Overall Study|Physician Decision|0|||
23445962|NCT01625000|65373797|FG003|Overall Study|Withdrawal by Subject|9|||
23445963|NCT01625000|65373798|FG004|Overall Study|Withdrawal by Subject|17|||
23445964|NCT01625000|65373794|FG000|Overall Study|Adverse Event (including Death)|15|||
23445965|NCT01625000|65373795|FG001|Overall Study|Adverse Event (including Death)|19|||
23445966|NCT01625000|65373796|FG002|Overall Study|Adverse Event (including Death)|11|||
23445967|NCT01625000|65373797|FG003|Overall Study|Adverse Event (including Death)|7|||
23445968|NCT01625000|65373798|FG004|Overall Study|Adverse Event (including Death)|21|||
23445969|NCT05066165|65373799|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
23445970|NCT05066165|65373800|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
23445971|NCT05066165|65373799|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
23445972|NCT05066165|65373800|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
23766553|NCT02637557|66524698|FG003|Overall Study|Physician Decision|0|||
23766554|NCT02637557|66524695|FG000|Overall Study|Protocol Violation|2|||
23766555|NCT02637557|66524696|FG001|Overall Study|Protocol Violation|0|||
23766556|NCT02637557|66524697|FG002|Overall Study|Protocol Violation|2|||
23766557|NCT02637557|66524698|FG003|Overall Study|Protocol Violation|1|||
23766558|NCT02637557|66524695|FG000|Overall Study|Withdrawal by Subject|1|||
23766559|NCT02637557|66524696|FG001|Overall Study|Withdrawal by Subject|3|||
23766560|NCT02637557|66524697|FG002|Overall Study|Withdrawal by Subject|4|||
23766561|NCT02637557|66524698|FG003|Overall Study|Withdrawal by Subject|2|||
23766562|NCT02660242|66524699|FG000|Glucose Tabs|Lost to Follow-up|1|||
23766563|NCT02660242|66524699|FG000|Glucagon Injection|Lost to Follow-up|1|||
23766564|NCT01427920|66524708|FG000|Overall Study|Adverse Event|1|||
23766565|NCT01427920|66524709|FG001|Overall Study|Adverse Event|2|||
23766566|NCT01427920|66524708|FG000|Overall Study|Lack of Efficacy|1|||
23766567|NCT01427920|66524709|FG001|Overall Study|Lack of Efficacy|0|||
23766568|NCT01427920|66524708|FG000|Overall Study|Protocol Violation|1|||
23766569|NCT01427920|66524709|FG001|Overall Study|Protocol Violation|3|||
23766570|NCT01427920|66524708|FG000|Overall Study|Withdrawal Criteria|4|||
23766571|NCT01427920|66524709|FG001|Overall Study|Withdrawal Criteria|4|||
23766572|NCT01427920|66524708|FG000|Overall Study|Unclassified|2|||
23766573|NCT01427920|66524709|FG001|Overall Study|Unclassified|8|||
23766574|NCT00988169|66524711|FG000|Overall Study|Withdrawal by Subject|1|||
23445973|NCT02219334|65373801|FG000|Overall Study|Withdrawal by Subject|1|||
23568010|NCT00519636|65807230|FG003|Washout Period|Failed to meet continuation criteria|3|||
23568011|NCT00519636|65807227|FG000|Washout Period|Out of pollen area > 48 hours|1|||
23568012|NCT00519636|65807228|FG001|Washout Period|Out of pollen area > 48 hours|0|||
23568013|NCT00519636|65807229|FG002|Washout Period|Out of pollen area > 48 hours|0|||
23568014|NCT00519636|65807230|FG003|Washout Period|Out of pollen area > 48 hours|0|||
23568015|NCT00519636|65807227|FG000|Washout Period|Participating in study at another site|1|||
23568016|NCT00519636|65807228|FG001|Washout Period|Participating in study at another site|0|||
23568017|NCT00519636|65807229|FG002|Washout Period|Participating in study at another site|0|||
23568018|NCT00519636|65807230|FG003|Washout Period|Participating in study at another site|0|||
23568019|NCT00519636|65807227|FG000|Washout Period|Non-compliant|0|||
23568020|NCT00519636|65807228|FG001|Washout Period|Non-compliant|1|||
23568021|NCT00519636|65807229|FG002|Washout Period|Non-compliant|0|||
23568022|NCT00519636|65807230|FG003|Washout Period|Non-compliant|0|||
23568023|NCT00519636|65807227|FG000|Washout Period|Per doctors request|0|||
23568024|NCT00519636|65807228|FG001|Washout Period|Per doctors request|1|||
23568025|NCT00519636|65807229|FG002|Washout Period|Per doctors request|0|||
23568026|NCT00519636|65807230|FG003|Washout Period|Per doctors request|0|||
23568027|NCT00519636|65807227|FG000|Washout Period|Subject randomized in error|0|||
23629970|NCT02630706|66032042|FG002|Overall Study|Withdrawal by Subject|7|||
23629971|NCT04978090|66032043|FG000|Overall Study|unable to adequately fit device|2|||
23766575|NCT04120194|66524712|FG000|Overall Study|Lost to Follow-up|11|||
23766576|NCT04120194|66524713|FG001|Overall Study|Lost to Follow-up|8|||
23829466|NCT01515423|66755915|FG000|DOUBLE BLIND|Adverse Event|0|||
23445974|NCT02219334|65373802|FG001|Overall Study|Withdrawal by Subject|0|||
23445975|NCT02219334|65373801|FG000|Overall Study|Protocol Violation|7|||
23445976|NCT02219334|65373802|FG001|Overall Study|Protocol Violation|3|||
23568028|NCT00519636|65807228|FG001|Washout Period|Subject randomized in error|0|||
23568029|NCT00519636|65807229|FG002|Washout Period|Subject randomized in error|1|||
23766577|NCT04120194|66524712|FG000|Overall Study|Adverse Event|4|||
23766578|NCT04120194|66524713|FG001|Overall Study|Adverse Event|5|||
23829467|NCT01515423|66755916|FG001|DOUBLE BLIND|Adverse Event|15|||
23766579|NCT04120194|66524712|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
23766580|NCT04120194|66524713|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
23766581|NCT04120194|66524712|FG000|Overall Study|Miscellaneous|4|||
23766582|NCT04120194|66524713|FG001|Overall Study|Miscellaneous|5|||
23766583|NCT01618266|66524714|FG000|Overall Study|Lost to Follow-up|9|||
23766584|NCT01618266|66524714|FG000|Overall Study|Treatment satisfaction|10|||
23766585|NCT01618266|66524714|FG000|Overall Study|Other reasons|11|||
23766586|NCT01618266|66524714|FG000|Overall Study|Lack of Efficacy|23|||
23766587|NCT01618266|66524714|FG000|Overall Study|Protocol Violation|43|||
23829468|NCT01515423|66755917|FG002|DOUBLE BLIND|Adverse Event|13|||
23829469|NCT01515423|66755915|FG000|DOUBLE BLIND|Death|0|||
23829470|NCT01515423|66755916|FG001|DOUBLE BLIND|Death|1|||
23829471|NCT01515423|66755917|FG002|DOUBLE BLIND|Death|2|||
23829472|NCT01515423|66755915|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
23829473|NCT01515423|66755916|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
23829474|NCT01515423|66755917|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
23829475|NCT01515423|66755915|FG000|DOUBLE BLIND|Pregnancy|0|||
23829476|NCT01515423|66755916|FG001|DOUBLE BLIND|Pregnancy|2|||
23829477|NCT01515423|66755917|FG002|DOUBLE BLIND|Pregnancy|0|||
23829478|NCT01515423|66755915|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
23829479|NCT01515423|66755916|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
23829480|NCT01515423|66755917|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
23568030|NCT00519636|65807230|FG003|Washout Period|Subject randomized in error|0|||
23568031|NCT00519636|65807227|FG000|Washout Period|Prohibited medications|0|||
23568032|NCT00519636|65807228|FG001|Washout Period|Prohibited medications|0|||
23766588|NCT01059071|66524715|FG000|Overall Study|Lack of Efficacy|1|||
23766589|NCT01059071|66524716|FG001|Overall Study|Lack of Efficacy|4|||
23766590|NCT01059071|66524717|FG002|Overall Study|Lack of Efficacy|2|||
23568033|NCT00519636|65807229|FG002|Washout Period|Prohibited medications|1|||
23829481|NCT01515423|66755915|FG000|DOUBLE BLIND|Other|0|||
23829482|NCT01515423|66755916|FG001|DOUBLE BLIND|Other|6|||
23829483|NCT01515423|66755917|FG002|DOUBLE BLIND|Other|12|||
23568034|NCT00519636|65807230|FG003|Washout Period|Prohibited medications|0|||
23568035|NCT00519636|65807227|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23568036|NCT00519636|65807228|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23568037|NCT00519636|65807229|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23568038|NCT00519636|65807230|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
23568039|NCT00519636|65807227|FG000|Treatment Period 2|Subject randomized in error|0|||
23568040|NCT00519636|65807228|FG001|Treatment Period 2|Subject randomized in error|1|||
23568041|NCT00519636|65807229|FG002|Treatment Period 2|Subject randomized in error|0|||
23568042|NCT00519636|65807230|FG003|Treatment Period 2|Subject randomized in error|0|||
23568043|NCT00519636|65807227|FG000|Treatment Period 2|Per doctors request|0|||
23568044|NCT00519636|65807228|FG001|Treatment Period 2|Per doctors request|0|||
23568045|NCT00519636|65807229|FG002|Treatment Period 2|Per doctors request|1|||
23568046|NCT00519636|65807230|FG003|Treatment Period 2|Per doctors request|0|||
23568047|NCT00519636|65807227|FG000|Treatment Period 2|Subject misrandomized|0|||
23568048|NCT00519636|65807228|FG001|Treatment Period 2|Subject misrandomized|0|||
23568049|NCT00519636|65807229|FG002|Treatment Period 2|Subject misrandomized|0|||
23568050|NCT00519636|65807230|FG003|Treatment Period 2|Subject misrandomized|1|||
23568051|NCT00519636|65807227|FG000|Post Study Period|Subject randomized in error|0|||
23568052|NCT00519636|65807228|FG001|Post Study Period|Subject randomized in error|0|||
23568053|NCT00519636|65807229|FG002|Post Study Period|Subject randomized in error|0|||
23568054|NCT00519636|65807230|FG003|Post Study Period|Subject randomized in error|1|||
23568055|NCT01216176|65807231|FG000|Overall Study|Adverse Event|0|||
23568056|NCT01216176|65807232|FG001|Overall Study|Adverse Event|8|||
23568057|NCT01216176|65807233|FG002|Overall Study|Adverse Event|0|||
23568058|NCT01216176|65807231|FG000|Overall Study|Physician Decision|0|||
23568059|NCT01216176|65807232|FG001|Overall Study|Physician Decision|0|||
23568060|NCT01216176|65807233|FG002|Overall Study|Physician Decision|1|||
23568061|NCT03285295|65807234|FG000|Alinity s HBsAg|Protocol Violation|11|||
23568062|NCT03285295|65807235|FG001|Alinity s HBsAg|Protocol Violation|0|||
23568063|NCT03285295|65807236|FG002|Alinity s HBsAg|Protocol Violation|0|||
23766591|NCT01059071|66524718|FG003|Overall Study|Lack of Efficacy|3|||
23766592|NCT01059071|66524715|FG000|Overall Study|Withdrawal by Subject|1|||
23766593|NCT01059071|66524716|FG001|Overall Study|Withdrawal by Subject|0|||
23568064|NCT03285295|65807237|FG003|Alinity s HBsAg|Protocol Violation|0|||
23568065|NCT03285295|65807238|FG004|Alinity s HBsAg|Protocol Violation|0|||
23568066|NCT03285295|65807234|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
23568067|NCT03285295|65807235|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568068|NCT03285295|65807236|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568069|NCT03285295|65807237|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568070|NCT03285295|65807238|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568071|NCT03285295|65807234|FG000|Alinity s HBsAg|No Results Generated|74|||
23568072|NCT03285295|65807235|FG001|Alinity s HBsAg|No Results Generated|6|||
23568073|NCT03285295|65807236|FG002|Alinity s HBsAg|No Results Generated|0|||
23568074|NCT03285295|65807237|FG003|Alinity s HBsAg|No Results Generated|0|||
23568075|NCT03285295|65807238|FG004|Alinity s HBsAg|No Results Generated|0|||
23568076|NCT03285295|65807234|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
23568077|NCT03285295|65807235|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
23568078|NCT03285295|65807236|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
23568079|NCT03285295|65807237|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
23568080|NCT03285295|65807238|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
23568081|NCT03285295|65807234|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
23568082|NCT03285295|65807235|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568083|NCT03285295|65807236|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568084|NCT03285295|65807237|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568085|NCT03285295|65807238|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568086|NCT03285295|65807234|FG000|Alinity s HTLV I/II|No Results Generated|70|||
23568087|NCT03285295|65807235|FG001|Alinity s HTLV I/II|No Results Generated|0|||
23568088|NCT03285295|65807236|FG002|Alinity s HTLV I/II|No Results Generated|0|||
23568089|NCT03285295|65807237|FG003|Alinity s HTLV I/II|No Results Generated|0|||
23568090|NCT03285295|65807238|FG004|Alinity s HTLV I/II|No Results Generated|0|||
23568091|NCT03285295|65807234|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
23568092|NCT03285295|65807235|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568093|NCT03285295|65807236|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568094|NCT03285295|65807237|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568095|NCT03285295|65807238|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23629972|NCT00664534|66032044|FG000|Overall Study|Adverse Event|2|||
23629973|NCT00664534|66032045|FG001|Overall Study|Adverse Event|3|||
23629974|NCT00664534|66032044|FG000|Overall Study|Lost to Follow-up|6|||
23629975|NCT00664534|66032045|FG001|Overall Study|Lost to Follow-up|10|||
23629976|NCT00664534|66032044|FG000|Overall Study|Protocol Violation|10|||
23629977|NCT00664534|66032045|FG001|Overall Study|Protocol Violation|8|||
23766594|NCT01059071|66524717|FG002|Overall Study|Withdrawal by Subject|0|||
23766595|NCT01059071|66524718|FG003|Overall Study|Withdrawal by Subject|2|||
23766596|NCT01059071|66524715|FG000|Overall Study|Physician Decision|0|||
23829484|NCT01515423|66755915|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
23829485|NCT01515423|66755916|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
23829486|NCT01515423|66755917|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
23568096|NCT03285295|65807234|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
23766597|NCT01059071|66524716|FG001|Overall Study|Physician Decision|0|||
23829487|NCT02738138|66755918|FG000|Overall Study|Adverse Event|0|||
23829488|NCT02738138|66755919|FG001|Overall Study|Adverse Event|1|||
23766598|NCT01059071|66524717|FG002|Overall Study|Physician Decision|0|||
23766599|NCT01059071|66524718|FG003|Overall Study|Physician Decision|1|||
23766600|NCT01565083|66524719|FG000|Overall Study|Withdrawal by Subject|6|||
23766601|NCT01565083|66524720|FG001|Overall Study|Withdrawal by Subject|4|||
23766602|NCT01565083|66524719|FG000|Overall Study|Lost to Follow-up|2|||
23766603|NCT01565083|66524720|FG001|Overall Study|Lost to Follow-up|7|||
23766604|NCT01565083|66524719|FG000|Overall Study|Death|22|||
23766605|NCT01565083|66524720|FG001|Overall Study|Death|23|||
23766606|NCT01565083|66524719|FG000|Overall Study|Other|3|||
23766607|NCT01565083|66524720|FG001|Overall Study|Other|5|||
23766608|NCT00321711|66524721|FG000|Part A|Adverse Event|3|||
23766609|NCT00321711|66524722|FG001|Part A|Adverse Event|3|||
23766610|NCT00321711|66524723|FG002|Part A|Adverse Event|2|||
23766611|NCT00321711|66524724|FG003|Part A|Adverse Event|0|||
23766612|NCT00321711|66524725|FG004|Part A|Adverse Event|0|||
23766613|NCT00321711|66524721|FG000|Part A|Withdrawal by Subject|1|||
23766614|NCT00321711|66524722|FG001|Part A|Withdrawal by Subject|1|||
23766615|NCT00321711|66524723|FG002|Part A|Withdrawal by Subject|1|||
23766616|NCT00321711|66524724|FG003|Part A|Withdrawal by Subject|0|||
23766617|NCT00321711|66524725|FG004|Part A|Withdrawal by Subject|0|||
23766618|NCT00321711|66524721|FG000|Part A|Disease progression|0|||
23766619|NCT00321711|66524722|FG001|Part A|Disease progression|1|||
23766620|NCT00321711|66524723|FG002|Part A|Disease progression|0|||
23766621|NCT00321711|66524724|FG003|Part A|Disease progression|0|||
23766622|NCT00321711|66524725|FG004|Part A|Disease progression|0|||
23766623|NCT00321711|66524721|FG000|Part A|Requirement for alternative therapy|0|||
23766624|NCT00321711|66524722|FG001|Part A|Requirement for alternative therapy|2|||
23766625|NCT00321711|66524723|FG002|Part A|Requirement for alternative therapy|1|||
23829489|NCT02738138|66755918|FG000|Overall Study|Lost to Follow-up|2|||
23829490|NCT02738138|66755919|FG001|Overall Study|Lost to Follow-up|0|||
23766626|NCT00321711|66524724|FG003|Part A|Requirement for alternative therapy|0|||
23766627|NCT00321711|66524725|FG004|Part A|Requirement for alternative therapy|0|||
23568097|NCT03285295|65807235|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
23568098|NCT03285295|65807236|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
23629978|NCT00664534|66032044|FG000|Overall Study|Withdrawal by Subject|7|||
23766628|NCT00321711|66524721|FG000|Part A|Physician Decision|0|||
23766629|NCT00321711|66524722|FG001|Part A|Physician Decision|1|||
23766630|NCT00321711|66524723|FG002|Part A|Physician Decision|3|||
23766631|NCT00321711|66524724|FG003|Part A|Physician Decision|0|||
23766632|NCT00321711|66524725|FG004|Part A|Physician Decision|0|||
23766633|NCT00321711|66524721|FG000|Part A|Other|1|||
23766634|NCT00321711|66524722|FG001|Part A|Other|2|||
23766635|NCT00321711|66524723|FG002|Part A|Other|3|||
23766636|NCT00321711|66524724|FG003|Part A|Other|0|||
23766637|NCT00321711|66524725|FG004|Part A|Other|0|||
23766638|NCT00321711|66524721|FG000|Part A|Protocol deviation|0|||
23766639|NCT00321711|66524722|FG001|Part A|Protocol deviation|0|||
23766640|NCT00321711|66524723|FG002|Part A|Protocol deviation|1|||
23766641|NCT00321711|66524724|FG003|Part A|Protocol deviation|0|||
23766642|NCT00321711|66524725|FG004|Part A|Protocol deviation|0|||
23766643|NCT00321711|66524721|FG000|Part B|Noncompliance|0|||
23766644|NCT00321711|66524722|FG001|Part B|Noncompliance|0|||
23766645|NCT00321711|66524723|FG002|Part B|Noncompliance|0|||
23766646|NCT00321711|66524724|FG003|Part B|Noncompliance|0|||
23766647|NCT00321711|66524725|FG004|Part B|Noncompliance|1|||
23766648|NCT00321711|66524721|FG000|Part B|Adverse Event|0|||
23766649|NCT00321711|66524722|FG001|Part B|Adverse Event|0|||
23766650|NCT00321711|66524723|FG002|Part B|Adverse Event|0|||
23766651|NCT00321711|66524724|FG003|Part B|Adverse Event|2|||
23766652|NCT00321711|66524725|FG004|Part B|Adverse Event|1|||
23766653|NCT00321711|66524721|FG000|Part B|Disease progression|0|||
23766654|NCT00321711|66524722|FG001|Part B|Disease progression|0|||
23766655|NCT00321711|66524723|FG002|Part B|Disease progression|0|||
23766656|NCT00321711|66524724|FG003|Part B|Disease progression|1|||
23766657|NCT00321711|66524725|FG004|Part B|Disease progression|0|||
23766658|NCT00321711|66524721|FG000|Part B|Physician Decision|0|||
23766659|NCT00321711|66524722|FG001|Part B|Physician Decision|0|||
23766660|NCT00321711|66524723|FG002|Part B|Physician Decision|0|||
23766661|NCT00321711|66524724|FG003|Part B|Physician Decision|1|||
23766662|NCT00321711|66524725|FG004|Part B|Physician Decision|2|||
23829491|NCT02738138|66755918|FG000|Overall Study|Other - not further specified|1|||
23829492|NCT02738138|66755919|FG001|Overall Study|Other - not further specified|0|||
23829493|NCT01487525|66755922|FG000|Overall Study|Withdrawal by Subject|0|||
23829494|NCT01487525|66755923|FG001|Overall Study|Withdrawal by Subject|1|||
23829495|NCT00708461|66755924|FG000|Overall Study|Lost to Follow-up|18|||
23829496|NCT00708461|66755925|FG001|Overall Study|Lost to Follow-up|11|||
23829497|NCT00708461|66755924|FG000|Overall Study|Withdrawal by Subject|8|||
23829498|NCT00708461|66755925|FG001|Overall Study|Withdrawal by Subject|9|||
23829499|NCT00708461|66755924|FG000|Overall Study|left workforce|115|||
23829500|NCT00708461|66755925|FG001|Overall Study|left workforce|180|||
23829501|NCT00116779|66755928|FG000|Overall Study|Adverse Event|4|||
23829502|NCT00116779|66755929|FG001|Overall Study|Adverse Event|2|||
23829503|NCT00116779|66755928|FG000|Overall Study|Protocol Violation|1|||
23829504|NCT00116779|66755929|FG001|Overall Study|Protocol Violation|4|||
23829505|NCT00116779|66755928|FG000|Overall Study|Withdrawal by Subject|4|||
23829506|NCT00116779|66755929|FG001|Overall Study|Withdrawal by Subject|1|||
23829507|NCT00116779|66755928|FG000|Overall Study|Inadequate testosterone suppression|7|||
23829508|NCT00116779|66755929|FG001|Overall Study|Inadequate testosterone suppression|9|||
23829509|NCT00116779|66755928|FG000|Overall Study|Physician Decision|3|||
23829510|NCT00116779|66755929|FG001|Overall Study|Physician Decision|1|||
23829511|NCT00116779|66755928|FG000|Overall Study|Elevated PSA levels|2|||
23829512|NCT00116779|66755929|FG001|Overall Study|Elevated PSA levels|2|||
23829513|NCT01753570|66755932|FG000|Overall Study|Adverse Event|1|||
23829514|NCT01753570|66755933|FG001|Overall Study|Adverse Event|0|||
23829515|NCT01753570|66755934|FG002|Overall Study|Adverse Event|1|||
23829516|NCT01753570|66755932|FG000|Overall Study|Physician Decision|0|||
23829517|NCT01753570|66755933|FG001|Overall Study|Physician Decision|1|||
23829518|NCT01753570|66755934|FG002|Overall Study|Physician Decision|0|||
23829519|NCT01753570|66755932|FG000|Overall Study|Withdrawal by Subject|1|||
23829520|NCT01753570|66755933|FG001|Overall Study|Withdrawal by Subject|4|||
23829521|NCT01753570|66755934|FG002|Overall Study|Withdrawal by Subject|0|||
23766663|NCT00321711|66524721|FG000|Part B|Death|0|||
23766664|NCT00321711|66524722|FG001|Part B|Death|0|||
23766665|NCT00321711|66524723|FG002|Part B|Death|0|||
23766666|NCT00321711|66524724|FG003|Part B|Death|2|||
23766667|NCT00321711|66524725|FG004|Part B|Death|1|||
23829522|NCT00485264|66755935|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
23766668|NCT02178709|66524726|FG000|Overall Study|Adverse Event|5|||
23766669|NCT02178709|66524726|FG000|Overall Study|Death|2|||
23766670|NCT02178709|66524726|FG000|Overall Study|Withdrawal by Subject|2|||
23766671|NCT02178709|66524726|FG000|Overall Study|Physician Decision|2|||
23766672|NCT02178709|66524726|FG000|Overall Study|Disease Progression|5|||
23766673|NCT01612000|66524737|FG000|Overall Study|Lost to Follow-up|6|||
23766674|NCT01612000|66524738|FG001|Overall Study|Lost to Follow-up|4|||
23766675|NCT01612000|66524739|FG002|Overall Study|Lost to Follow-up|4|||
23829523|NCT00485264|66755936|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
23829524|NCT00485264|66755937|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
23829525|NCT00485264|66755938|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
23829526|NCT00485264|66755939|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
23829527|NCT00485264|66755940|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
23766676|NCT01612000|66524740|FG003|Overall Study|Lost to Follow-up|8|||
23766677|NCT01612000|66524737|FG000|Overall Study|Physician Decision|0|||
23766678|NCT01612000|66524738|FG001|Overall Study|Physician Decision|0|||
23766679|NCT01612000|66524739|FG002|Overall Study|Physician Decision|1|||
23766680|NCT01612000|66524740|FG003|Overall Study|Physician Decision|0|||
23766681|NCT01612000|66524737|FG000|Overall Study|Withdrawal by Subject|3|||
23766682|NCT01612000|66524738|FG001|Overall Study|Withdrawal by Subject|1|||
23766683|NCT01612000|66524739|FG002|Overall Study|Withdrawal by Subject|2|||
23766684|NCT01612000|66524740|FG003|Overall Study|Withdrawal by Subject|2|||
23766685|NCT01047345|66524741|FG000|Base Study|Adverse Event|3|||
23766686|NCT01047345|66524742|FG001|Base Study|Adverse Event|0|||
23766687|NCT01047345|66524743|FG002|Base Study|Adverse Event|0|||
23766688|NCT01047345|66524741|FG000|Base Study|Lost to Follow-up|4|||
23766689|NCT01047345|66524742|FG001|Base Study|Lost to Follow-up|1|||
23766690|NCT01047345|66524743|FG002|Base Study|Lost to Follow-up|0|||
23766691|NCT01047345|66524741|FG000|Base Study|Protocol Violation|3|||
23766692|NCT01047345|66524742|FG001|Base Study|Protocol Violation|1|||
23766693|NCT01047345|66524743|FG002|Base Study|Protocol Violation|0|||
23766694|NCT01047345|66524741|FG000|Base Study|Withdrawal by Subject|12|||
23766695|NCT01047345|66524742|FG001|Base Study|Withdrawal by Subject|4|||
23766696|NCT01047345|66524743|FG002|Base Study|Withdrawal by Subject|0|||
23766697|NCT01047345|66524741|FG000|Extension|Withdrawal by Subject|0|||
23766698|NCT01047345|66524742|FG001|Extension|Withdrawal by Subject|0|||
23766699|NCT01047345|66524743|FG002|Extension|Withdrawal by Subject|1|||
23766700|NCT01047345|66524741|FG000|Extension|Lost to Follow-up|0|||
23766701|NCT01047345|66524742|FG001|Extension|Lost to Follow-up|0|||
23766702|NCT01047345|66524743|FG002|Extension|Lost to Follow-up|5|||
23766703|NCT03271528|66524744|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
23766704|NCT03271528|66524745|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
23766705|NCT03271528|66524744|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
23766706|NCT03271528|66524745|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
23766707|NCT03271528|66524744|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
23766708|NCT03271528|66524745|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
23766709|NCT03271528|66524744|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
23766710|NCT03271528|66524745|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
23766711|NCT03271528|66524744|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
23766712|NCT03271528|66524745|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
23766713|NCT03271528|66524744|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
23766714|NCT03271528|66524745|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
23766715|NCT03271528|66524744|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
23766716|NCT03271528|66524745|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
23766717|NCT01498484|66524755|FG000|Overall Study|Death|6|||
23766718|NCT01498484|66524756|FG001|Overall Study|Death|3|||
23766719|NCT01498484|66524757|FG002|Overall Study|Death|1|||
23766720|NCT01498484|66524758|FG003|Overall Study|Death|1|||
23766721|NCT01498484|66524759|FG004|Overall Study|Death|0|||
23766722|NCT01498484|66524760|FG005|Overall Study|Death|0|||
23766723|NCT01498484|66524761|FG006|Overall Study|Death|10|||
23766724|NCT01498484|66524762|FG007|Overall Study|Death|1|||
23766725|NCT01498484|66524763|FG008|Overall Study|Death|0|||
23766726|NCT01498484|66524755|FG000|Overall Study|Physician Decision|3|||
23766727|NCT01498484|66524756|FG001|Overall Study|Physician Decision|2|||
23766728|NCT01498484|66524757|FG002|Overall Study|Physician Decision|1|||
23766729|NCT01498484|66524758|FG003|Overall Study|Physician Decision|1|||
23766730|NCT01498484|66524759|FG004|Overall Study|Physician Decision|0|||
23766731|NCT01498484|66524760|FG005|Overall Study|Physician Decision|0|||
23766732|NCT01498484|66524761|FG006|Overall Study|Physician Decision|8|||
23766733|NCT01498484|66524762|FG007|Overall Study|Physician Decision|13|||
23766734|NCT01498484|66524763|FG008|Overall Study|Physician Decision|1|||
23766735|NCT01498484|66524755|FG000|Overall Study|Adverse Event|0|||
23766736|NCT01498484|66524756|FG001|Overall Study|Adverse Event|0|||
23766737|NCT01498484|66524757|FG002|Overall Study|Adverse Event|0|||
23766738|NCT01498484|66524758|FG003|Overall Study|Adverse Event|0|||
23766739|NCT01498484|66524759|FG004|Overall Study|Adverse Event|0|||
23766740|NCT01498484|66524760|FG005|Overall Study|Adverse Event|1|||
23766741|NCT01498484|66524761|FG006|Overall Study|Adverse Event|0|||
23766742|NCT01498484|66524762|FG007|Overall Study|Adverse Event|0|||
23766743|NCT01498484|66524763|FG008|Overall Study|Adverse Event|0|||
23766744|NCT01498484|66524755|FG000|Overall Study|Withdrawal by Subject|0|||
23766745|NCT01498484|66524756|FG001|Overall Study|Withdrawal by Subject|0|||
23766746|NCT01498484|66524757|FG002|Overall Study|Withdrawal by Subject|0|||
23766747|NCT01498484|66524758|FG003|Overall Study|Withdrawal by Subject|1|||
23766748|NCT01498484|66524759|FG004|Overall Study|Withdrawal by Subject|0|||
23766749|NCT01498484|66524760|FG005|Overall Study|Withdrawal by Subject|0|||
23829528|NCT00485264|66755935|FG000|Overall Study|Death|1|||
23766750|NCT01498484|66524761|FG006|Overall Study|Withdrawal by Subject|1|||
23829529|NCT00485264|66755936|FG001|Overall Study|Death|0|||
23766751|NCT01498484|66524762|FG007|Overall Study|Withdrawal by Subject|0|||
23766752|NCT01498484|66524763|FG008|Overall Study|Withdrawal by Subject|0|||
23766753|NCT01498484|66524755|FG000|Overall Study|Other|5|||
23766754|NCT01498484|66524756|FG001|Overall Study|Other|2|||
23766755|NCT01498484|66524757|FG002|Overall Study|Other|0|||
23766756|NCT01498484|66524758|FG003|Overall Study|Other|0|||
23766757|NCT01498484|66524759|FG004|Overall Study|Other|1|||
23766758|NCT01498484|66524760|FG005|Overall Study|Other|0|||
23766759|NCT01498484|66524761|FG006|Overall Study|Other|3|||
23766760|NCT01498484|66524762|FG007|Overall Study|Other|0|||
23766761|NCT01498484|66524763|FG008|Overall Study|Other|1|||
23766762|NCT03342898|66524768|FG000|Overall Study|Adverse Event|3|||
23766763|NCT03342898|66524769|FG001|Overall Study|Adverse Event|1|||
23829530|NCT00485264|66755937|FG002|Overall Study|Death|0|||
23829531|NCT00485264|66755938|FG003|Overall Study|Death|0|||
23829532|NCT00485264|66755939|FG004|Overall Study|Death|1|||
23829533|NCT00485264|66755940|FG005|Overall Study|Death|0|||
23829534|NCT00485264|66755935|FG000|Overall Study|Adverse Event|1|||
23829535|NCT00485264|66755936|FG001|Overall Study|Adverse Event|0|||
23829536|NCT00485264|66755937|FG002|Overall Study|Adverse Event|2|||
23829537|NCT00485264|66755938|FG003|Overall Study|Adverse Event|3|||
23829538|NCT00485264|66755939|FG004|Overall Study|Adverse Event|1|||
23829539|NCT00485264|66755940|FG005|Overall Study|Adverse Event|3|||
23829540|NCT00485264|66755935|FG000|Overall Study|Pregnancy|4|||
23829541|NCT00485264|66755936|FG001|Overall Study|Pregnancy|0|||
23829542|NCT00485264|66755937|FG002|Overall Study|Pregnancy|0|||
23829543|NCT00485264|66755938|FG003|Overall Study|Pregnancy|0|||
23568099|NCT03285295|65807237|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
23568100|NCT03285295|65807238|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
23568101|NCT03285295|65807234|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
23568102|NCT03285295|65807235|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568103|NCT03285295|65807236|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568104|NCT03285295|65807237|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568105|NCT03285295|65807238|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568106|NCT03285295|65807234|FG000|Alinity s Anti-HCV|No Results Generated|71|||
23568107|NCT03285295|65807235|FG001|Alinity s Anti-HCV|No Results Generated|0|||
23568108|NCT03285295|65807236|FG002|Alinity s Anti-HCV|No Results Generated|0|||
23568109|NCT03285295|65807237|FG003|Alinity s Anti-HCV|No Results Generated|0|||
23568110|NCT03285295|65807238|FG004|Alinity s Anti-HCV|No Results Generated|0|||
23568111|NCT03285295|65807234|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
23568112|NCT03285295|65807235|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568113|NCT03285295|65807236|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568114|NCT03285295|65807237|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568115|NCT03285295|65807238|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568116|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
23568117|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568118|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568119|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568120|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568121|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
23568122|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568123|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568124|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568125|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568126|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
23568127|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568128|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568129|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568130|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568131|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
23766764|NCT03342898|66524770|FG002|Overall Study|Adverse Event|0|||
23766765|NCT03342898|66524768|FG000|Overall Study|Lost to Follow-up|44|||
23568132|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23766766|NCT03342898|66524769|FG001|Overall Study|Lost to Follow-up|40|||
23568133|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23766767|NCT03342898|66524770|FG002|Overall Study|Lost to Follow-up|42|||
23766768|NCT03342898|66524768|FG000|Overall Study|Withdrawal of Consent|5|||
23829544|NCT00485264|66755939|FG004|Overall Study|Pregnancy|0|||
23829545|NCT00485264|66755940|FG005|Overall Study|Pregnancy|0|||
23829546|NCT00485264|66755935|FG000|Overall Study|Disallowed Medication|0|||
23829547|NCT00485264|66755936|FG001|Overall Study|Disallowed Medication|0|||
23829548|NCT00485264|66755937|FG002|Overall Study|Disallowed Medication|0|||
23568134|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23568135|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23568136|NCT03285295|65807234|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
23568137|NCT03285295|65807235|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
23568138|NCT03285295|65807236|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
23568139|NCT03285295|65807237|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
23568140|NCT03285295|65807238|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
23568141|NCT03285295|65807234|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
23568142|NCT03285295|65807235|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
23568143|NCT03285295|65807236|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568144|NCT03285295|65807237|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568145|NCT03285295|65807238|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568146|NCT03285295|65807234|FG000|Alinity s Anti-HBc|No Results Generated|70|||
23568147|NCT03285295|65807235|FG001|Alinity s Anti-HBc|No Results Generated|0|||
23568148|NCT03285295|65807236|FG002|Alinity s Anti-HBc|No Results Generated|0|||
23568149|NCT03285295|65807237|FG003|Alinity s Anti-HBc|No Results Generated|0|||
23568150|NCT03285295|65807238|FG004|Alinity s Anti-HBc|No Results Generated|0|||
23629979|NCT00664534|66032045|FG001|Overall Study|Withdrawal by Subject|6|||
23629980|NCT00664534|66032044|FG000|Overall Study|Physician Decision|8|||
23629981|NCT00664534|66032045|FG001|Overall Study|Physician Decision|0|||
23629982|NCT00664534|66032044|FG000|Overall Study|Sponsor decision|8|||
23629983|NCT00664534|66032045|FG001|Overall Study|Sponsor decision|6|||
23629984|NCT00281320|66032046|FG000|Overall Study|Adverse Event|12|||
23629985|NCT00281320|66032047|FG001|Overall Study|Adverse Event|9|||
23629986|NCT00281320|66032046|FG000|Overall Study|Lack of Efficacy|4|||
23629987|NCT00281320|66032047|FG001|Overall Study|Lack of Efficacy|3|||
23629988|NCT00281320|66032046|FG000|Overall Study|Withdrawal by Subject|5|||
23629989|NCT00281320|66032047|FG001|Overall Study|Withdrawal by Subject|6|||
23629990|NCT00281320|66032046|FG000|Overall Study|Lost to Follow-up|1|||
23629991|NCT00281320|66032047|FG001|Overall Study|Lost to Follow-up|2|||
23629992|NCT00281320|66032046|FG000|Overall Study|Other|3|||
23568151|NCT03285295|65807234|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
23568152|NCT03285295|65807235|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568153|NCT03285295|65807236|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23629993|NCT00281320|66032047|FG001|Overall Study|Other|1|||
23568154|NCT03285295|65807237|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568155|NCT03285295|65807238|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568156|NCT03285295|65807234|FG000|Alinity s Chagas|Protocol Violation|76|||
23568157|NCT03285295|65807235|FG001|Alinity s Chagas|Protocol Violation|0|||
23568158|NCT03285295|65807236|FG002|Alinity s Chagas|Protocol Violation|0|||
23568159|NCT03285295|65807237|FG003|Alinity s Chagas|Protocol Violation|0|||
23568160|NCT03285295|65807238|FG004|Alinity s Chagas|Protocol Violation|0|||
23568161|NCT03285295|65807234|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
23568162|NCT03285295|65807235|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
23568163|NCT03285295|65807236|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
23568164|NCT03285295|65807237|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
23568165|NCT03285295|65807238|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
23568166|NCT03285295|65807234|FG000|Alinity s Chagas|No Results Generated|105|||
23568167|NCT03285295|65807235|FG001|Alinity s Chagas|No Results Generated|0|||
23568168|NCT03285295|65807236|FG002|Alinity s Chagas|No Results Generated|0|||
23568169|NCT03285295|65807237|FG003|Alinity s Chagas|No Results Generated|0|||
23568170|NCT03285295|65807238|FG004|Alinity s Chagas|No Results Generated|0|||
23568171|NCT03285295|65807234|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
23568172|NCT03285295|65807235|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23766769|NCT03342898|66524769|FG001|Overall Study|Withdrawal of Consent|9|||
23766770|NCT03342898|66524770|FG002|Overall Study|Withdrawal of Consent|11|||
23766771|NCT03342898|66524768|FG000|Overall Study|Death|0|||
23766772|NCT03342898|66524769|FG001|Overall Study|Death|1|||
23766773|NCT03342898|66524770|FG002|Overall Study|Death|1|||
23766774|NCT03342898|66524768|FG000|Overall Study|Reason not Specified|2|||
23766775|NCT03342898|66524769|FG001|Overall Study|Reason not Specified|2|||
23766776|NCT03342898|66524770|FG002|Overall Study|Reason not Specified|0|||
23766777|NCT02224391|66524776|FG000|Overall Study|Lost to Follow-up|26|||
23766778|NCT02224391|66524777|FG001|Overall Study|Lost to Follow-up|19|||
23766779|NCT02224391|66524776|FG000|Overall Study|Withdrawal by Subject|6|||
23766780|NCT02224391|66524777|FG001|Overall Study|Withdrawal by Subject|5|||
23766781|NCT00661505|66524778|FG000|Overall Study|Adverse Event|3|||
23766782|NCT00661505|66524778|FG000|Overall Study|Protocol Violation|14|||
23766783|NCT00661505|66524778|FG000|Overall Study|Withdrawal by Subject|8|||
23766784|NCT00661505|66524778|FG000|Overall Study|Lost to Follow-up|3|||
23766785|NCT00661505|66524778|FG000|Overall Study|Other|2|||
23766786|NCT01341639|66524779|FG000|Infant Series|Protocol Violation|1|||
23766787|NCT01341639|66524780|FG001|Infant Series|Protocol Violation|0|||
23766788|NCT01341639|66524779|FG000|Infant Series|Not Vaccinated|0|||
23766789|NCT01341639|66524780|FG001|Infant Series|Not Vaccinated|1|||
23766790|NCT01341639|66524779|FG000|Infant Series|Adverse Event|0|||
23766791|NCT01341639|66524780|FG001|Infant Series|Adverse Event|5|||
23766792|NCT01341639|66524779|FG000|Infant Series|Withdrawal by Subject|11|||
23766793|NCT01341639|66524780|FG001|Infant Series|Withdrawal by Subject|8|||
23766794|NCT01341639|66524779|FG000|Infant Series|Lost to Follow-up|0|||
23766795|NCT01341639|66524780|FG001|Infant Series|Lost to Follow-up|2|||
23766796|NCT01341639|66524779|FG000|Infant Series|Site 0048 Participants|17|||
23766797|NCT01341639|66524780|FG001|Infant Series|Site 0048 Participants|16|||
23766798|NCT01341639|66524779|FG000|Interim Period|Withdrawal by Subject|6|||
23766799|NCT01341639|66524780|FG001|Interim Period|Withdrawal by Subject|7|||
23766800|NCT01341639|66524779|FG000|Interim Period|Lost to Follow-up|2|||
23766801|NCT01341639|66524780|FG001|Interim Period|Lost to Follow-up|0|||
23766802|NCT01341639|66524779|FG000|Interim Period|Physician Decision|0|||
23766803|NCT01341639|66524780|FG001|Interim Period|Physician Decision|1|||
23766804|NCT01341639|66524779|FG000|Interim Period|Protocol Violation|0|||
23766805|NCT01341639|66524780|FG001|Interim Period|Protocol Violation|1|||
23766806|NCT01341639|66524779|FG000|Post-Treatment|Withdrawal by Subject|0|||
23766807|NCT01341639|66524780|FG001|Post-Treatment|Withdrawal by Subject|1|||
23766808|NCT01341639|66524779|FG000|Post-Treatment|Adverse Event|0|||
23766809|NCT01341639|66524780|FG001|Post-Treatment|Adverse Event|2|||
23766810|NCT01958281|66524781|FG000|Overall Study|Lack of Efficacy|5|||
23766811|NCT01958281|66524782|FG001|Overall Study|Lack of Efficacy|2|||
23766812|NCT01958281|66524783|FG002|Overall Study|Lack of Efficacy|0|||
23766813|NCT01958281|66524781|FG000|Overall Study|Adverse Event|0|||
23766814|NCT01958281|66524782|FG001|Overall Study|Adverse Event|2|||
23766815|NCT01958281|66524783|FG002|Overall Study|Adverse Event|0|||
23766816|NCT01958281|66524781|FG000|Overall Study|Withdrew Consent|1|||
23766817|NCT01958281|66524782|FG001|Overall Study|Withdrew Consent|0|||
23568173|NCT03285295|65807236|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23568174|NCT03285295|65807237|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23568175|NCT03285295|65807238|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23766818|NCT01958281|66524783|FG002|Overall Study|Withdrew Consent|0|||
23766819|NCT02019979|66524784|FG000|Overall Study|study terminated|14|||
23766820|NCT00928252|66524787|FG000|Overall Study|Physician Decision|3|||
23766821|NCT01724359|66524788|FG000|Overall Study|Adverse Event|10|||
23766822|NCT01724359|66524788|FG000|Overall Study|Death|1|||
23766823|NCT01724359|66524788|FG000|Overall Study|Other|20|||
23766824|NCT01066052|66524791|FG000|Overall Study|Enrolled But Not Treated|3|||
23766825|NCT01066052|66524792|FG001|Overall Study|Enrolled But Not Treated|0|||
23766826|NCT02843074|66524795|FG000|Overall Study|Withdrawal by Subject|5|||
23766827|NCT02843074|66524795|FG000|Overall Study|Progressive disease|1|||
23766828|NCT02843074|66524795|FG000|Overall Study|Physician Decision|1|||
23766829|NCT02843074|66524795|FG000|Overall Study|Lost to Follow-up|1|||
23766830|NCT02843074|66524795|FG000|Overall Study|Death|9|||
23766831|NCT00686036|66524797|FG000|Overall Study|Adverse Event|3|||
23766832|NCT00686036|66524798|FG001|Overall Study|Adverse Event|0|||
23766833|NCT00686036|66524797|FG000|Overall Study|Withdrawal by Subject|3|||
23766834|NCT00686036|66524798|FG001|Overall Study|Withdrawal by Subject|1|||
23766835|NCT00686036|66524797|FG000|Overall Study|Study terminated by AstraZeneca|2|||
23766836|NCT00686036|66524798|FG001|Overall Study|Study terminated by AstraZeneca|1|||
23766837|NCT00686036|66524797|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
23766838|NCT00686036|66524798|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
23766839|NCT00686036|66524797|FG000|Overall Study|Other reasons not identified|0|||
23766840|NCT00686036|66524798|FG001|Overall Study|Other reasons not identified|4|||
23766841|NCT04534283|66524806|FG000|Overall Study|Physician Decision|2|||
23766842|NCT04534283|66524806|FG000|Overall Study|Withdrawal by Subject|1|||
23766843|NCT04534283|66524806|FG000|Overall Study|Disease Progression|12|||
23766844|NCT04534283|66524806|FG000|Overall Study|Adverse Event|1|||
23766845|NCT02570165|66524807|FG000|Overall Study|Adverse Event|1|||
23829549|NCT00485264|66755938|FG003|Overall Study|Disallowed Medication|0|||
23829550|NCT00485264|66755939|FG004|Overall Study|Disallowed Medication|0|||
23568176|NCT01923896|65807239|FG000|Overall Study|Adverse Event|1|||
23568177|NCT01923896|65807240|FG001|Overall Study|Adverse Event|0|||
23568178|NCT01370603|65807243|FG000|Period 1|Adverse Event|5|||
23568179|NCT01370603|65807244|FG001|Period 1|Adverse Event|3|||
23568180|NCT01370603|65807243|FG000|Period 1|Lost to Follow-up|2|||
23568181|NCT01370603|65807244|FG001|Period 1|Lost to Follow-up|0|||
23568182|NCT01370603|65807243|FG000|Period 1|Protocol Violation|2|||
23568183|NCT01370603|65807244|FG001|Period 1|Protocol Violation|2|||
23568184|NCT01370603|65807243|FG000|Period 1|Withdrawal by Subject|5|||
23629994|NCT00856245|66032048|FG000|Overall Study|Was not transplanted|5|||
23629995|NCT02786004|66032057|FG000|Overall Study|Withdrawal by Subject|0|||
23629996|NCT02786004|66032058|FG001|Overall Study|Withdrawal by Subject|1|||
23629997|NCT02820597|66032059|FG000|Overall Study|Lost to Follow-up|12|||
23629998|NCT00362375|66032060|FG000|Overall Study|Lost to Follow-up|40|||
23629999|NCT00362375|66032061|FG001|Overall Study|Lost to Follow-up|35|||
23630000|NCT04463680|66032062|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
23630001|NCT04463680|66032062|FG000|Overall Study|Not eligible due to implant duration of use|1|||
23630002|NCT04463680|66032062|FG000|Overall Study|Withdrawal by Subject|3|||
23630003|NCT01867047|66032064|FG000|Overall Study|Lost to Follow-up|3|||
23630004|NCT01867047|66032065|FG001|Overall Study|Lost to Follow-up|3|||
23630005|NCT01867047|66032064|FG000|Overall Study|Withdrawal by Subject|2|||
23630006|NCT01867047|66032065|FG001|Overall Study|Withdrawal by Subject|0|||
23630007|NCT01867047|66032064|FG000|Overall Study|Physician Decision|2|||
23630008|NCT01867047|66032065|FG001|Overall Study|Physician Decision|0|||
23630009|NCT01867047|66032064|FG000|Overall Study|surgery not indicated in protocol|1|||
23630010|NCT01867047|66032065|FG001|Overall Study|surgery not indicated in protocol|2|||
23630011|NCT02417441|66032066|FG000|Overall Study|Inconclusive due to missing data|52|||
23630012|NCT02417441|66032067|FG001|Overall Study|Inconclusive due to missing data|19|||
23630013|NCT03054337|66032068|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23630014|NCT03054337|66032069|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
23630015|NCT03054337|66032070|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23630016|NCT03054337|66032071|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
23630017|NCT03054337|66032072|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
23630018|NCT03054337|66032073|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23630019|NCT00909532|66032074|FG000|Overall Study|Adverse Event|4|||
23630020|NCT00909532|66032075|FG001|Overall Study|Adverse Event|1|||
23630021|NCT00909532|66032074|FG000|Overall Study|Pregnancy|0|||
23630022|NCT00909532|66032075|FG001|Overall Study|Pregnancy|1|||
23829551|NCT00485264|66755940|FG005|Overall Study|Disallowed Medication|1|||
23630023|NCT00909532|66032074|FG000|Overall Study|Prohibited Medication|2|||
23630024|NCT00909532|66032075|FG001|Overall Study|Prohibited Medication|1|||
23630025|NCT00909532|66032074|FG000|Overall Study|Withdrawal of Consent|1|||
23630026|NCT00909532|66032075|FG001|Overall Study|Withdrawal of Consent|1|||
23766846|NCT02570165|66524808|FG001|Overall Study|Adverse Event|0|||
23766847|NCT02570165|66524809|FG002|Overall Study|Adverse Event|2|||
23766848|NCT02570165|66524810|FG003|Overall Study|Adverse Event|0|||
23630027|NCT00909532|66032074|FG000|Overall Study|Noncompliance with Study Requirements|0|||
23766849|NCT02570165|66524811|FG004|Overall Study|Adverse Event|0|||
23568185|NCT01370603|65807244|FG001|Period 1|Withdrawal by Subject|5|||
23568186|NCT01370603|65807243|FG000|Crossover Washout|Adverse Event|2|||
23568187|NCT01370603|65807244|FG001|Crossover Washout|Adverse Event|1|||
23766850|NCT02570165|66524812|FG005|Overall Study|Adverse Event|0|||
23766851|NCT02570165|66524813|FG006|Overall Study|Adverse Event|0|||
23568188|NCT01370603|65807243|FG000|Crossover Washout|Lost to Follow-up|2|||
23568189|NCT01370603|65807244|FG001|Crossover Washout|Lost to Follow-up|0|||
23766852|NCT02570165|66524807|FG000|Overall Study|Lack of Efficacy|0|||
23766853|NCT02570165|66524808|FG001|Overall Study|Lack of Efficacy|1|||
23766854|NCT02570165|66524809|FG002|Overall Study|Lack of Efficacy|0|||
23766855|NCT02570165|66524810|FG003|Overall Study|Lack of Efficacy|0|||
23766856|NCT02570165|66524811|FG004|Overall Study|Lack of Efficacy|4|||
23766857|NCT02570165|66524812|FG005|Overall Study|Lack of Efficacy|0|||
23766858|NCT02570165|66524813|FG006|Overall Study|Lack of Efficacy|0|||
23766859|NCT02570165|66524807|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
23766860|NCT02570165|66524808|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
23766861|NCT02570165|66524809|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
23766862|NCT02570165|66524810|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
23766863|NCT02570165|66524811|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
23766864|NCT02570165|66524812|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
23766865|NCT02570165|66524813|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
23766866|NCT02570165|66524807|FG000|Overall Study|Lost to Follow-up|0|||
23766867|NCT02570165|66524808|FG001|Overall Study|Lost to Follow-up|0|||
23766868|NCT02570165|66524809|FG002|Overall Study|Lost to Follow-up|1|||
23766869|NCT02570165|66524810|FG003|Overall Study|Lost to Follow-up|1|||
23766870|NCT02570165|66524811|FG004|Overall Study|Lost to Follow-up|0|||
23766871|NCT02570165|66524812|FG005|Overall Study|Lost to Follow-up|0|||
23766872|NCT02570165|66524813|FG006|Overall Study|Lost to Follow-up|0|||
23766873|NCT02570165|66524807|FG000|Overall Study|Physician Decision|0|||
23766874|NCT02570165|66524808|FG001|Overall Study|Physician Decision|1|||
23766875|NCT02570165|66524809|FG002|Overall Study|Physician Decision|0|||
23766876|NCT02570165|66524810|FG003|Overall Study|Physician Decision|0|||
23766877|NCT02570165|66524811|FG004|Overall Study|Physician Decision|0|||
23766878|NCT02570165|66524812|FG005|Overall Study|Physician Decision|0|||
23766879|NCT02570165|66524813|FG006|Overall Study|Physician Decision|0|||
23766880|NCT02570165|66524807|FG000|Overall Study|Withdrawal by Subject|0|||
23766881|NCT02570165|66524808|FG001|Overall Study|Withdrawal by Subject|0|||
23766882|NCT02570165|66524809|FG002|Overall Study|Withdrawal by Subject|0|||
23766883|NCT02570165|66524810|FG003|Overall Study|Withdrawal by Subject|2|||
23766884|NCT02570165|66524811|FG004|Overall Study|Withdrawal by Subject|1|||
23766885|NCT02570165|66524812|FG005|Overall Study|Withdrawal by Subject|0|||
23766886|NCT02570165|66524813|FG006|Overall Study|Withdrawal by Subject|0|||
23766887|NCT02570165|66524807|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766888|NCT02570165|66524808|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766889|NCT02570165|66524809|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766890|NCT02570165|66524810|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766891|NCT02570165|66524811|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766892|NCT02570165|66524812|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
23766893|NCT02570165|66524813|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
23766894|NCT02570165|66524807|FG000|Overall Study|Withdrawal Request by GSK|0|||
23766895|NCT02570165|66524808|FG001|Overall Study|Withdrawal Request by GSK|0|||
23766896|NCT02570165|66524809|FG002|Overall Study|Withdrawal Request by GSK|2|||
23445977|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
23445978|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
23766897|NCT02570165|66524810|FG003|Overall Study|Withdrawal Request by GSK|0|||
23766898|NCT02570165|66524811|FG004|Overall Study|Withdrawal Request by GSK|0|||
23766899|NCT02570165|66524812|FG005|Overall Study|Withdrawal Request by GSK|0|||
23766900|NCT02570165|66524813|FG006|Overall Study|Withdrawal Request by GSK|0|||
23766901|NCT02006706|66524823|FG000|Overall Study|Lost to Follow-up|1|||
23766902|NCT00696709|66524824|FG000|Overall Study|Withdrawal by Subject|1|||
23766903|NCT00696709|66524825|FG001|Overall Study|Withdrawal by Subject|2|||
23766904|NCT00696709|66524826|FG002|Overall Study|Withdrawal by Subject|1|||
23766905|NCT00696709|66524827|FG003|Overall Study|Withdrawal by Subject|4|||
23766906|NCT00696709|66524828|FG004|Overall Study|Withdrawal by Subject|3|||
23445979|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
23445980|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
23445981|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
23445982|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
23445983|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
23568190|NCT01370603|65807243|FG000|Crossover Washout|Protocol Violation|1|||
23568191|NCT01370603|65807244|FG001|Crossover Washout|Protocol Violation|0|||
23766907|NCT00696709|66524824|FG000|Overall Study|Protocol Violation|1|||
23766908|NCT00696709|66524825|FG001|Overall Study|Protocol Violation|0|||
23766909|NCT00696709|66524826|FG002|Overall Study|Protocol Violation|0|||
23766910|NCT00696709|66524827|FG003|Overall Study|Protocol Violation|0|||
23445984|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
23445985|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
23568192|NCT01370603|65807243|FG000|Crossover Washout|Withdrawal by Subject|4|||
23568193|NCT01370603|65807244|FG001|Crossover Washout|Withdrawal by Subject|1|||
23766911|NCT00696709|66524828|FG004|Overall Study|Protocol Violation|0|||
23445986|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
23445987|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
23445988|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
23445989|NCT01973998|65373812|FG000|Overall Study|Death|2|||
23445990|NCT01973998|65373813|FG001|Overall Study|Death|2|||
23445991|NCT01076036|65373814|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
23445992|NCT01380769|65373817|FG000|Overall Study|Withdrawal by Subject|7|||
23445993|NCT01380769|65373818|FG001|Overall Study|Withdrawal by Subject|11|||
23445994|NCT01380769|65373817|FG000|Overall Study|Physician Decision|1|||
23445995|NCT01380769|65373818|FG001|Overall Study|Physician Decision|1|||
23445996|NCT01380769|65373817|FG000|Overall Study|Adverse Event|1|||
23445997|NCT01380769|65373818|FG001|Overall Study|Adverse Event|1|||
23445998|NCT01380769|65373817|FG000|Overall Study|Protocol Violation|0|||
23445999|NCT01380769|65373818|FG001|Overall Study|Protocol Violation|1|||
23446000|NCT04071158|65373819|FG000|Overall Study|Lost to Follow-up|1|||
23446001|NCT04071158|65373820|FG001|Overall Study|Lost to Follow-up|2|||
23446002|NCT04071158|65373821|FG002|Overall Study|Lost to Follow-up|3|||
23446003|NCT04071158|65373822|FG003|Overall Study|Lost to Follow-up|3|||
23446004|NCT04071158|65373823|FG004|Overall Study|Lost to Follow-up|5|||
23446005|NCT04071158|65373819|FG000|Overall Study|Randomized but not treated|2|||
23446006|NCT04071158|65373820|FG001|Overall Study|Randomized but not treated|2|||
23446007|NCT04071158|65373821|FG002|Overall Study|Randomized but not treated|0|||
23446008|NCT04071158|65373822|FG003|Overall Study|Randomized but not treated|0|||
23446009|NCT04071158|65373823|FG004|Overall Study|Randomized but not treated|0|||
23446010|NCT01220167|65373824|FG000|Period 3|Urine positive for substance abuse|0|||
23446011|NCT01220167|65373825|FG001|Period 3|Urine positive for substance abuse|1|||
23446012|NCT01220167|65373826|FG002|Period 3|Urine positive for substance abuse|0|||
23446013|NCT00871338|65373830|FG000|Prior to Booster|Withdrawal by Subject|1|||
23446014|NCT00871338|65373831|FG001|Prior to Booster|Withdrawal by Subject|3|||
23446015|NCT00871338|65373830|FG000|Prior to Booster|Lost to Follow-up|1|||
23446016|NCT00871338|65373831|FG001|Prior to Booster|Lost to Follow-up|0|||
23446017|NCT02598297|65373834|FG000|Overall Study|Study terminated by Sponsor|21|||
23446018|NCT02598297|65373835|FG001|Overall Study|Study terminated by Sponsor|23|||
23446019|NCT02598297|65373834|FG000|Overall Study|Adverse Event|1|||
23446020|NCT02598297|65373835|FG001|Overall Study|Adverse Event|1|||
23446021|NCT02598297|65373834|FG000|Overall Study|Physician Decision|1|||
23446022|NCT02598297|65373835|FG001|Overall Study|Physician Decision|0|||
23446023|NCT02598297|65373834|FG000|Overall Study|Subject/guardian decision|1|||
23446024|NCT02598297|65373835|FG001|Overall Study|Subject/guardian decision|0|||
23446025|NCT02598297|65373834|FG000|Overall Study|Followed for survival|1|||
23446026|NCT02598297|65373835|FG001|Overall Study|Followed for survival|0|||
23446027|NCT01168349|65373836|FG000|Overall Study|Death|157|||
23446028|NCT01168349|65373836|FG000|Overall Study|Lost to Follow-up|34|||
23446029|NCT01168349|65373836|FG000|Overall Study|Withdrawal by Subject|9|||
23446030|NCT01168349|65373836|FG000|Overall Study|Kidney transplantation|3|||
23446031|NCT01168349|65373836|FG000|Overall Study|Other|22|||
23446032|NCT01168349|65373836|FG000|Overall Study|Protocol Violation|76|||
23446033|NCT02517541|65373837|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
23446034|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
23446035|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
23446036|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
23446037|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
23446038|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
23446039|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
23446040|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
23446041|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
23446042|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
23446043|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
23446044|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
23446045|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
23446046|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
23446047|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
23446048|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
23446049|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
23446050|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
23568194|NCT01370603|65807243|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
23568195|NCT01370603|65807244|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
23568196|NCT01370603|65807243|FG000|Period 2|Adverse Event|1|||
23568197|NCT01370603|65807244|FG001|Period 2|Adverse Event|4|||
23568198|NCT01370603|65807243|FG000|Period 2|Lost to Follow-up|1|||
23446051|NCT03500640|65373838|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
23446052|NCT03500640|65373839|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
23568199|NCT01370603|65807244|FG001|Period 2|Lost to Follow-up|0|||
23446053|NCT03500640|65373840|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
23446054|NCT03500640|65373838|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
23446055|NCT03500640|65373839|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
23446056|NCT03500640|65373840|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
23446057|NCT03500640|65373838|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
23446058|NCT03500640|65373839|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
23446059|NCT03500640|65373840|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
23446060|NCT03500640|65373838|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
23446061|NCT03500640|65373839|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
23446062|NCT03500640|65373840|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
23446063|NCT03500640|65373838|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
23446064|NCT03500640|65373839|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
23446065|NCT03500640|65373840|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
23446066|NCT03500640|65373838|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
23446067|NCT03500640|65373839|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
23446068|NCT03500640|65373840|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
23446069|NCT01147055|65373841|FG000|First Intervention Period|Lost to Follow-up|1|||
23446070|NCT01147055|65373842|FG001|First Intervention Period|Lost to Follow-up|0|||
23446071|NCT01698814|65373843|FG000|Overall Study|Adverse Event|0|||
23446072|NCT01698814|65373844|FG001|Overall Study|Adverse Event|2|||
23446073|NCT01698814|65373843|FG000|Overall Study|Lost to Follow-up|0|||
23446074|NCT01698814|65373844|FG001|Overall Study|Lost to Follow-up|1|||
23446075|NCT01698814|65373843|FG000|Overall Study|Pregnancy|1|||
23446076|NCT01698814|65373844|FG001|Overall Study|Pregnancy|0|||
23446077|NCT01698814|65373843|FG000|Overall Study|Randomized in error|1|||
23446078|NCT01698814|65373844|FG001|Overall Study|Randomized in error|0|||
23446079|NCT00086047|65373847|FG000|Overall Study|Lost to Follow-up|7|||
23446080|NCT00086047|65373848|FG001|Overall Study|Lost to Follow-up|6|||
23446081|NCT00086047|65373847|FG000|Overall Study|Physician Decision|0|||
23446082|NCT00086047|65373848|FG001|Overall Study|Physician Decision|1|||
23446083|NCT00082407|65373849|FG000|Overall Study|Adverse Event|20|||
23446084|NCT00082407|65373850|FG001|Overall Study|Adverse Event|0|||
23446085|NCT00082407|65373849|FG000|Overall Study|Protocol Violation|14|||
23446086|NCT00082407|65373850|FG001|Overall Study|Protocol Violation|12|||
23446087|NCT00082407|65373849|FG000|Overall Study|Patient Decision|13|||
23446088|NCT00082407|65373850|FG001|Overall Study|Patient Decision|6|||
23446089|NCT00082407|65373849|FG000|Overall Study|Physician Decision|5|||
23446090|NCT00082407|65373850|FG001|Overall Study|Physician Decision|3|||
23446091|NCT00082407|65373849|FG000|Overall Study|Loss of Glucose Control|2|||
23446092|NCT00082407|65373850|FG001|Overall Study|Loss of Glucose Control|2|||
23446093|NCT00082407|65373849|FG000|Overall Study|Death|2|||
23446094|NCT00082407|65373850|FG001|Overall Study|Death|1|||
23446095|NCT00082407|65373849|FG000|Overall Study|Lost to Follow-up|0|||
23446096|NCT00082407|65373850|FG001|Overall Study|Lost to Follow-up|3|||
23446097|NCT03201419|65373851|FG000|Overall Study|Adverse Event|3|||
23446098|NCT03201419|65373852|FG001|Overall Study|Adverse Event|1|||
23446099|NCT03201419|65373853|FG002|Overall Study|Adverse Event|0|||
23446100|NCT03201419|65373854|FG003|Overall Study|Adverse Event|0|||
23446101|NCT03201419|65373855|FG004|Overall Study|Adverse Event|1|||
23446102|NCT03201419|65373856|FG005|Overall Study|Adverse Event|1|||
23446103|NCT03201419|65373857|FG006|Overall Study|Adverse Event|5|||
23446104|NCT03201419|65373858|FG007|Overall Study|Adverse Event|0|||
23446105|NCT03201419|65373859|FG008|Overall Study|Adverse Event|0|||
23446106|NCT03201419|65373851|FG000|Overall Study|Lost to Follow-up|1|||
23446107|NCT03201419|65373852|FG001|Overall Study|Lost to Follow-up|0|||
23446108|NCT03201419|65373853|FG002|Overall Study|Lost to Follow-up|0|||
23446109|NCT03201419|65373854|FG003|Overall Study|Lost to Follow-up|0|||
23446110|NCT03201419|65373855|FG004|Overall Study|Lost to Follow-up|0|||
23446111|NCT03201419|65373856|FG005|Overall Study|Lost to Follow-up|0|||
23446112|NCT03201419|65373857|FG006|Overall Study|Lost to Follow-up|0|||
23446113|NCT03201419|65373858|FG007|Overall Study|Lost to Follow-up|0|||
23446114|NCT03201419|65373859|FG008|Overall Study|Lost to Follow-up|0|||
23446115|NCT03201419|65373851|FG000|Overall Study|Protocol Deviation|0|||
23568200|NCT01370603|65807243|FG000|Period 2|Withdrawal by Subject|1|||
23568201|NCT01370603|65807244|FG001|Period 2|Withdrawal by Subject|0|||
23446116|NCT03201419|65373852|FG001|Overall Study|Protocol Deviation|0|||
23446117|NCT03201419|65373853|FG002|Overall Study|Protocol Deviation|0|||
23446118|NCT03201419|65373854|FG003|Overall Study|Protocol Deviation|0|||
23446119|NCT03201419|65373855|FG004|Overall Study|Protocol Deviation|0|||
23446120|NCT03201419|65373856|FG005|Overall Study|Protocol Deviation|0|||
23446121|NCT03201419|65373857|FG006|Overall Study|Protocol Deviation|1|||
23446122|NCT03201419|65373858|FG007|Overall Study|Protocol Deviation|0|||
23446123|NCT03201419|65373859|FG008|Overall Study|Protocol Deviation|0|||
23446124|NCT03201419|65373851|FG000|Overall Study|Withdrawal by Subject|4|||
23446125|NCT03201419|65373852|FG001|Overall Study|Withdrawal by Subject|2|||
23568202|NCT01263106|65807247|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
23568203|NCT01263106|65807248|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
23446126|NCT03201419|65373853|FG002|Overall Study|Withdrawal by Subject|1|||
23446127|NCT03201419|65373854|FG003|Overall Study|Withdrawal by Subject|0|||
23446128|NCT03201419|65373855|FG004|Overall Study|Withdrawal by Subject|0|||
23446129|NCT03201419|65373856|FG005|Overall Study|Withdrawal by Subject|0|||
23446130|NCT03201419|65373857|FG006|Overall Study|Withdrawal by Subject|0|||
23446131|NCT03201419|65373858|FG007|Overall Study|Withdrawal by Subject|1|||
23446132|NCT03201419|65373859|FG008|Overall Study|Withdrawal by Subject|2|||
23446133|NCT03201419|65373851|FG000|Overall Study|Other|0|||
23446134|NCT03201419|65373852|FG001|Overall Study|Other|0|||
23446135|NCT03201419|65373853|FG002|Overall Study|Other|1|||
23446136|NCT03201419|65373854|FG003|Overall Study|Other|0|||
23446137|NCT03201419|65373855|FG004|Overall Study|Other|0|||
23446138|NCT03201419|65373856|FG005|Overall Study|Other|0|||
23446139|NCT03201419|65373857|FG006|Overall Study|Other|0|||
23446140|NCT03201419|65373858|FG007|Overall Study|Other|0|||
23446141|NCT03201419|65373859|FG008|Overall Study|Other|0|||
23446142|NCT01395901|65373862|FG000|Overall Study|Lost to Follow-up|4|||
23446143|NCT01395901|65373863|FG001|Overall Study|Lost to Follow-up|0|||
23446144|NCT01395901|65373862|FG000|Overall Study|Randomized but not received study drug|5|||
23446145|NCT01395901|65373863|FG001|Overall Study|Randomized but not received study drug|4|||
23446146|NCT01395901|65373862|FG000|Overall Study|Adverse Event|0|||
23568204|NCT00675506|65807251|FG000|Overall Study|Lost to Follow-up|1|||
23568205|NCT00675506|65807252|FG001|Overall Study|Lost to Follow-up|5|||
23568206|NCT00675506|65807251|FG000|Overall Study|Lost interest|3|||
23568207|NCT00675506|65807252|FG001|Overall Study|Lost interest|5|||
23568208|NCT00675506|65807251|FG000|Overall Study|Elevated fasting glucose|2|||
23568209|NCT00675506|65807252|FG001|Overall Study|Elevated fasting glucose|1|||
23568210|NCT00675506|65807251|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
23568211|NCT00675506|65807252|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
23568212|NCT00675506|65807251|FG000|Overall Study|Elevated IGF-1|2|||
23568213|NCT00675506|65807252|FG001|Overall Study|Elevated IGF-1|0|||
23568214|NCT00675506|65807251|FG000|Overall Study|Hypersensitivity Reaction|1|||
23568215|NCT00675506|65807252|FG001|Overall Study|Hypersensitivity Reaction|0|||
23568216|NCT00675506|65807251|FG000|Overall Study|Disclosed history of cancer|1|||
23568217|NCT00675506|65807252|FG001|Overall Study|Disclosed history of cancer|0|||
23568218|NCT00675506|65807251|FG000|Overall Study|Declined participation|1|||
23568219|NCT00675506|65807252|FG001|Overall Study|Declined participation|0|||
23568220|NCT00675506|65807251|FG000|Overall Study|Schedule conflict|0|||
23568221|NCT00675506|65807252|FG001|Overall Study|Schedule conflict|1|||
23568222|NCT02802319|65807253|FG000|Overall Study|Physician Decision|2|||
23568223|NCT02802319|65807254|FG001|Overall Study|Physician Decision|1|||
23630028|NCT00909532|66032075|FG001|Overall Study|Noncompliance with Study Requirements|2|||
23568224|NCT02802319|65807253|FG000|Overall Study|Lost to Follow-up|0|||
23568225|NCT02802319|65807254|FG001|Overall Study|Lost to Follow-up|4|||
23568226|NCT00734214|65807259|FG000|Overall Study|Withdrawal by Subject|3|||
23568227|NCT00734214|65807260|FG001|Overall Study|Withdrawal by Subject|4|||
23568228|NCT00734214|65807259|FG000|Overall Study|MD withdrawal|1|||
23568229|NCT00734214|65807260|FG001|Overall Study|MD withdrawal|0|||
23568230|NCT01090310|65807261|FG000|Core Study|Adverse Event|2|||
23568231|NCT01090310|65807262|FG001|Core Study|Adverse Event|2|||
23568232|NCT01090310|65807263|FG002|Core Study|Adverse Event|1|||
23568233|NCT01090310|65807264|FG003|Core Study|Adverse Event|1|||
23568234|NCT01090310|65807261|FG000|Core Study|Subject withdrew consent|0|||
23568235|NCT01090310|65807262|FG001|Core Study|Subject withdrew consent|3|||
23568236|NCT01090310|65807263|FG002|Core Study|Subject withdrew consent|1|||
23568237|NCT01090310|65807264|FG003|Core Study|Subject withdrew consent|1|||
23568238|NCT01090310|65807261|FG000|Core Study|Abnormal test procedure result|0|||
23568239|NCT01090310|65807262|FG001|Core Study|Abnormal test procedure result|0|||
23568240|NCT01090310|65807263|FG002|Core Study|Abnormal test procedure result|1|||
23766912|NCT00696709|66524824|FG000|Overall Study|Lost to Follow-up|1|||
23766913|NCT00696709|66524825|FG001|Overall Study|Lost to Follow-up|1|||
23766914|NCT00696709|66524826|FG002|Overall Study|Lost to Follow-up|0|||
23766915|NCT00696709|66524827|FG003|Overall Study|Lost to Follow-up|0|||
23766916|NCT00696709|66524828|FG004|Overall Study|Lost to Follow-up|0|||
23766917|NCT00696709|66524824|FG000|Overall Study|Adverse Event|0|||
23766918|NCT00696709|66524825|FG001|Overall Study|Adverse Event|0|||
23766919|NCT00696709|66524826|FG002|Overall Study|Adverse Event|0|||
23766920|NCT00696709|66524827|FG003|Overall Study|Adverse Event|1|||
23766921|NCT00696709|66524828|FG004|Overall Study|Adverse Event|0|||
23766922|NCT02101853|66524831|FG000|Block 1 Induction|Adverse Event|11|||
23766923|NCT02101853|66524832|FG001|Block 1 Induction|Adverse Event|0|||
23766924|NCT02101853|66524833|FG002|Block 1 Induction|Adverse Event|0|||
23766925|NCT02101853|66524834|FG003|Block 1 Induction|Adverse Event|0|||
23766926|NCT02101853|66524835|FG004|Block 1 Induction|Adverse Event|0|||
23766927|NCT02101853|66524836|FG005|Block 1 Induction|Adverse Event|0|||
23766928|NCT02101853|66524831|FG000|Block 1 Induction|Death|20|||
23568241|NCT01090310|65807264|FG003|Core Study|Abnormal test procedure result|0|||
23568242|NCT01090310|65807261|FG000|Core Study|Administrative reasons|5|||
23568243|NCT01090310|65807262|FG001|Core Study|Administrative reasons|6|||
23568244|NCT01090310|65807263|FG002|Core Study|Administrative reasons|4|||
23568245|NCT01090310|65807264|FG003|Core Study|Administrative reasons|4|||
23568246|NCT01090310|65807261|FG000|Core Study|Protocol deviation|1|||
23568247|NCT01090310|65807262|FG001|Core Study|Protocol deviation|0|||
23568248|NCT01090310|65807263|FG002|Core Study|Protocol deviation|0|||
23568249|NCT01090310|65807264|FG003|Core Study|Protocol deviation|1|||
23568250|NCT01090310|65807261|FG000|Extension Study|Aministrative problems|13|||
23568251|NCT01090310|65807262|FG001|Extension Study|Aministrative problems|15|||
23568252|NCT01090310|65807263|FG002|Extension Study|Aministrative problems|14|||
23568253|NCT01090310|65807264|FG003|Extension Study|Aministrative problems|18|||
23630029|NCT00909532|66032074|FG000|Overall Study|Physician Decision|1|||
23630030|NCT00909532|66032075|FG001|Overall Study|Physician Decision|0|||
23630031|NCT00909532|66032074|FG000|Overall Study|Wrong Genotype|1|||
23630032|NCT00909532|66032075|FG001|Overall Study|Wrong Genotype|0|||
23630033|NCT00909532|66032074|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
23630034|NCT00909532|66032075|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
23630035|NCT00730015|66032076|FG000|Overall Study|Adverse Event|11|||
23630036|NCT00730015|66032077|FG001|Overall Study|Adverse Event|10|||
23630037|NCT00730015|66032078|FG002|Overall Study|Adverse Event|8|||
23630038|NCT00730015|66032076|FG000|Overall Study|Protocol Violation|2|||
23630039|NCT00730015|66032077|FG001|Overall Study|Protocol Violation|6|||
23630040|NCT00730015|66032078|FG002|Overall Study|Protocol Violation|4|||
23630041|NCT00730015|66032076|FG000|Overall Study|Withdrawal by Subject|12|||
23630042|NCT00730015|66032077|FG001|Overall Study|Withdrawal by Subject|12|||
23630043|NCT00730015|66032078|FG002|Overall Study|Withdrawal by Subject|8|||
23630044|NCT00730015|66032076|FG000|Overall Study|Lost to Follow-up|4|||
23630045|NCT00730015|66032077|FG001|Overall Study|Lost to Follow-up|10|||
23630046|NCT00730015|66032078|FG002|Overall Study|Lost to Follow-up|3|||
23630047|NCT00730015|66032076|FG000|Overall Study|Lack of Efficacy|1|||
23630048|NCT00730015|66032077|FG001|Overall Study|Lack of Efficacy|2|||
23630049|NCT00730015|66032078|FG002|Overall Study|Lack of Efficacy|8|||
23630050|NCT00730015|66032076|FG000|Overall Study|Other Reason|1|||
23630051|NCT00730015|66032077|FG001|Overall Study|Other Reason|0|||
23630052|NCT00730015|66032078|FG002|Overall Study|Other Reason|1|||
23630053|NCT01183390|66032079|FG000|First Intervention|Adverse Event|0|||
23630054|NCT01183390|66032080|FG001|First Intervention|Adverse Event|1|||
23630055|NCT01131104|66032081|FG000|Overall Study|Withdrawal by Subject|3|||
23630056|NCT01131104|66032081|FG000|Overall Study|Physician Decision|4|||
23630057|NCT01131104|66032081|FG000|Overall Study|Information Not Available|5|||
23630058|NCT01131104|66032081|FG000|Overall Study|No Information on Index Date of Onset|1|||
23630059|NCT00497874|66032084|FG000|Overall Study|Withdrawal by Subject|48|||
23630060|NCT00497874|66032085|FG001|Overall Study|Withdrawal by Subject|17|||
23630061|NCT00497874|66032084|FG000|Overall Study|Illness|8|||
23630062|NCT00497874|66032085|FG001|Overall Study|Illness|4|||
23446147|NCT01395901|65373863|FG001|Overall Study|Adverse Event|1|||
23568254|NCT01090310|65807261|FG000|Extension Study|Adverse Event|0|||
23630063|NCT00497874|66032084|FG000|Overall Study|Death|2|||
23630064|NCT00497874|66032085|FG001|Overall Study|Death|4|||
23630065|NCT00497874|66032084|FG000|Overall Study|Unable to contact|52|||
23630066|NCT00497874|66032085|FG001|Overall Study|Unable to contact|67|||
23630067|NCT00497874|66032084|FG000|Overall Study|Unable to schedule|37|||
23630068|NCT00497874|66032085|FG001|Overall Study|Unable to schedule|24|||
23630069|NCT02394665|66032089|FG000|Overall Study|Physician Decision|1|||
23630070|NCT02394665|66032090|FG001|Overall Study|Physician Decision|0|||
23630071|NCT02394665|66032091|FG002|Overall Study|Physician Decision|0|||
23630072|NCT02106195|66032092|FG000|Overall Study|Adverse Event|2|||
23630073|NCT02106195|66032092|FG000|Overall Study|Protocol Violation|1|||
23630074|NCT00725543|66032093|FG000|Overall Study|Adverse Event|10|||
23766929|NCT02101853|66524832|FG001|Block 1 Induction|Death|0|||
23766930|NCT02101853|66524833|FG002|Block 1 Induction|Death|0|||
23766931|NCT02101853|66524834|FG003|Block 1 Induction|Death|0|||
23766932|NCT02101853|66524835|FG004|Block 1 Induction|Death|0|||
23766933|NCT02101853|66524836|FG005|Block 1 Induction|Death|0|||
23766934|NCT02101853|66524831|FG000|Block 1 Induction|Lack of Efficacy|6|||
23630075|NCT00725543|66032093|FG000|Overall Study|Lack of Efficacy|3|||
23630076|NCT00725543|66032093|FG000|Overall Study|Withdrawal by Subject|10|||
23630077|NCT00725543|66032093|FG000|Overall Study|Physician Decision|5|||
23630078|NCT00725543|66032093|FG000|Overall Study|Lost to Follow-up|4|||
23630079|NCT00725543|66032093|FG000|Overall Study|Non-compliance|2|||
23630080|NCT00725543|66032093|FG000|Overall Study|Other|119|||
23630081|NCT01371708|66032094|FG000|Overall Study|Insufficient clinical response|3|||
23630082|NCT01371708|66032095|FG001|Overall Study|Insufficient clinical response|2|||
23766935|NCT02101853|66524832|FG001|Block 1 Induction|Lack of Efficacy|0|||
23766936|NCT02101853|66524833|FG002|Block 1 Induction|Lack of Efficacy|0|||
23568255|NCT01090310|65807262|FG001|Extension Study|Adverse Event|0|||
23630083|NCT01371708|66032096|FG002|Overall Study|Insufficient clinical response|0|||
23630084|NCT01371708|66032094|FG000|Overall Study|Lost to Follow-up|5|||
23630085|NCT01371708|66032095|FG001|Overall Study|Lost to Follow-up|9|||
23630086|NCT01371708|66032096|FG002|Overall Study|Lost to Follow-up|7|||
23630087|NCT01371708|66032094|FG000|Overall Study|Protocol Violation|2|||
23630088|NCT01371708|66032095|FG001|Overall Study|Protocol Violation|1|||
23630089|NCT01371708|66032096|FG002|Overall Study|Protocol Violation|2|||
23630090|NCT01371708|66032094|FG000|Overall Study|No longer willing to participate|7|||
23568256|NCT01090310|65807263|FG002|Extension Study|Adverse Event|0|||
23630091|NCT01371708|66032095|FG001|Overall Study|No longer willing to participate|7|||
23630092|NCT01371708|66032096|FG002|Overall Study|No longer willing to participate|13|||
23630093|NCT01371708|66032094|FG000|Overall Study|Medication error/not related to AE|0|||
23630094|NCT01371708|66032095|FG001|Overall Study|Medication error/not related to AE|1|||
23630095|NCT01371708|66032096|FG002|Overall Study|Medication error/not related to AE|0|||
23568257|NCT01090310|65807264|FG003|Extension Study|Adverse Event|1|||
23568258|NCT01090310|65807261|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
23568259|NCT01090310|65807262|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
23568260|NCT01090310|65807263|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
23568261|NCT01090310|65807264|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
23568262|NCT01090310|65807261|FG000|Extension Study|Subject withdrew consent|0|||
23568263|NCT01090310|65807262|FG001|Extension Study|Subject withdrew consent|1|||
23568264|NCT01090310|65807263|FG002|Extension Study|Subject withdrew consent|0|||
23568265|NCT01090310|65807264|FG003|Extension Study|Subject withdrew consent|0|||
23568266|NCT01248962|65809773|FG000|Overall Study|Withdrawal by Subject|1|||
23829552|NCT00485264|66755935|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
23829553|NCT00485264|66755936|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
23829554|NCT00485264|66755937|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
23630096|NCT01371708|66032094|FG000|Overall Study|Other|3|||
23829555|NCT00485264|66755938|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
23829556|NCT00485264|66755939|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
23829557|NCT00485264|66755940|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
23829558|NCT00485264|66755935|FG000|Overall Study|Lack of Efficacy|0|||
23630097|NCT01371708|66032095|FG001|Overall Study|Other|2|||
23630098|NCT01371708|66032096|FG002|Overall Study|Other|4|||
23829559|NCT00485264|66755936|FG001|Overall Study|Lack of Efficacy|1|||
23766937|NCT02101853|66524834|FG003|Block 1 Induction|Lack of Efficacy|0|||
23766938|NCT02101853|66524835|FG004|Block 1 Induction|Lack of Efficacy|0|||
23766939|NCT02101853|66524836|FG005|Block 1 Induction|Lack of Efficacy|0|||
23766940|NCT02101853|66524831|FG000|Block 1 Induction|Physician Decision|61|||
23766941|NCT02101853|66524832|FG001|Block 1 Induction|Physician Decision|0|||
23766942|NCT02101853|66524833|FG002|Block 1 Induction|Physician Decision|0|||
23766943|NCT02101853|66524834|FG003|Block 1 Induction|Physician Decision|0|||
23568267|NCT01248962|65809774|FG001|Overall Study|Withdrawal by Subject|1|||
23766944|NCT02101853|66524835|FG004|Block 1 Induction|Physician Decision|0|||
23766945|NCT02101853|66524836|FG005|Block 1 Induction|Physician Decision|0|||
23766946|NCT02101853|66524831|FG000|Block 1 Induction|Protocol Violation|2|||
23766947|NCT02101853|66524832|FG001|Block 1 Induction|Protocol Violation|0|||
23766948|NCT02101853|66524833|FG002|Block 1 Induction|Protocol Violation|0|||
23766949|NCT02101853|66524834|FG003|Block 1 Induction|Protocol Violation|0|||
23766950|NCT02101853|66524835|FG004|Block 1 Induction|Protocol Violation|0|||
23766951|NCT02101853|66524836|FG005|Block 1 Induction|Protocol Violation|0|||
23766952|NCT02101853|66524831|FG000|Block 1 Induction|Withdrawal by Subject|65|||
23766953|NCT02101853|66524832|FG001|Block 1 Induction|Withdrawal by Subject|0|||
23766954|NCT02101853|66524833|FG002|Block 1 Induction|Withdrawal by Subject|0|||
23766955|NCT02101853|66524834|FG003|Block 1 Induction|Withdrawal by Subject|0|||
23766956|NCT02101853|66524835|FG004|Block 1 Induction|Withdrawal by Subject|0|||
23766957|NCT02101853|66524836|FG005|Block 1 Induction|Withdrawal by Subject|0|||
23568268|NCT01248962|65809773|FG000|Overall Study|Adverse Event|2|||
23568269|NCT01248962|65809774|FG001|Overall Study|Adverse Event|1|||
23568270|NCT01248962|65809773|FG000|Overall Study|Complete Response after 4 Cycles|1|||
23568271|NCT01248962|65809774|FG001|Overall Study|Complete Response after 4 Cycles|0|||
23568272|NCT01248962|65809773|FG000|Overall Study|Complete Response after 3 Cycles|0|||
23568273|NCT01248962|65809774|FG001|Overall Study|Complete Response after 3 Cycles|1|||
23568274|NCT01248962|65809773|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
23568275|NCT01248962|65809774|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
23568276|NCT02756832|65809775|FG000|Overall Study|Lost for Observation after Baseline|6|||
23568277|NCT02756832|65809775|FG000|Overall Study|Lost for Observation|13|||
23568278|NCT02756832|65809775|FG000|Overall Study|Patient's Unwillingness|12|||
23568279|NCT02756832|65809775|FG000|Overall Study|Insufficient Efficacy|2|||
23568280|NCT02756832|65809775|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
23568281|NCT02756832|65809775|FG000|Overall Study|Reason not Specified|9|||
23568282|NCT02756832|65809775|FG000|Overall Study|Protocol Deviation|10|||
23568283|NCT02302066|65809777|FG000|Overall Study|Adverse Event|1|||
23568284|NCT02302066|65809778|FG001|Overall Study|Adverse Event|1|||
23568285|NCT02302066|65809779|FG002|Overall Study|Adverse Event|3|||
23568286|NCT02302066|65809780|FG003|Overall Study|Adverse Event|0|||
23568287|NCT02302066|65809777|FG000|Overall Study|Lost to Follow-up|4|||
23568288|NCT02302066|65809778|FG001|Overall Study|Lost to Follow-up|5|||
23568289|NCT02302066|65809779|FG002|Overall Study|Lost to Follow-up|24|||
23568290|NCT02302066|65809780|FG003|Overall Study|Lost to Follow-up|7|||
23568291|NCT02302066|65809777|FG000|Overall Study|Withdrawal by Subject|25|||
23568292|NCT02302066|65809778|FG001|Overall Study|Withdrawal by Subject|58|||
23568293|NCT02302066|65809779|FG002|Overall Study|Withdrawal by Subject|124|||
23568294|NCT02302066|65809780|FG003|Overall Study|Withdrawal by Subject|33|||
23568295|NCT02302066|65809777|FG000|Overall Study|Pregnancy|2|||
23568296|NCT02302066|65809778|FG001|Overall Study|Pregnancy|10|||
23568297|NCT02302066|65809779|FG002|Overall Study|Pregnancy|12|||
23568298|NCT02302066|65809780|FG003|Overall Study|Pregnancy|0|||
23568299|NCT02302066|65809777|FG000|Overall Study|Reason Not Specified|1|||
23568300|NCT02302066|65809778|FG001|Overall Study|Reason Not Specified|1|||
23568301|NCT02302066|65809779|FG002|Overall Study|Reason Not Specified|9|||
23568302|NCT02302066|65809780|FG003|Overall Study|Reason Not Specified|1|||
23568303|NCT02609659|65809783|FG000|Overall Study|Adverse Event|1|||
23630099|NCT01371708|66032094|FG000|Overall Study|Adverse Event|5|||
23630100|NCT01371708|66032095|FG001|Overall Study|Adverse Event|8|||
23568304|NCT02609659|65809783|FG000|Overall Study|Lost to Follow-up|6|||
23568305|NCT02609659|65809783|FG000|Overall Study|Other|1|||
23568306|NCT01380990|65809784|FG000|Overall Study|Treatment Failure|1|||
23568307|NCT01380990|65809785|FG001|Overall Study|Treatment Failure|0|||
23766958|NCT02101853|66524831|FG000|Block 1 Induction|Ineligible|8|||
23766959|NCT02101853|66524832|FG001|Block 1 Induction|Ineligible|0|||
23766960|NCT02101853|66524833|FG002|Block 1 Induction|Ineligible|0|||
23630101|NCT01371708|66032096|FG002|Overall Study|Adverse Event|12|||
23630102|NCT01371708|66032094|FG000|Overall Study|Started but did not receive treatment|1|||
23630103|NCT01371708|66032095|FG001|Overall Study|Started but did not receive treatment|0|||
23630104|NCT01371708|66032096|FG002|Overall Study|Started but did not receive treatment|1|||
23630105|NCT01663506|66032097|FG000|Overall Study|Lack of Efficacy|3|||
23630106|NCT01663506|66032097|FG000|Overall Study|Consent Withdrawal by Subject|1|||
23630107|NCT01663506|66032097|FG000|Overall Study|Lost to Follow-up|1|||
23630108|NCT01663506|66032097|FG000|Overall Study|Adverse Event|1|||
23630109|NCT01663506|66032097|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
23630110|NCT02080403|66032104|FG000|Overall Study|Adverse Event|5|||
23630111|NCT02080403|66032105|FG001|Overall Study|Adverse Event|1|||
23630112|NCT02080403|66032104|FG000|Overall Study|Death|0|||
23630113|NCT02080403|66032105|FG001|Overall Study|Death|2|||
23630114|NCT02080403|66032104|FG000|Overall Study|Lost to Follow-up|2|||
23630115|NCT02080403|66032105|FG001|Overall Study|Lost to Follow-up|0|||
23630116|NCT02080403|66032104|FG000|Overall Study|Pregnancy|0|||
23630117|NCT02080403|66032105|FG001|Overall Study|Pregnancy|1|||
23630118|NCT02080403|66032104|FG000|Overall Study|Protocol Violation|3|||
23630119|NCT02080403|66032105|FG001|Overall Study|Protocol Violation|7|||
23630120|NCT02080403|66032104|FG000|Overall Study|Withdrawal by Subject|5|||
23630121|NCT02080403|66032105|FG001|Overall Study|Withdrawal by Subject|1|||
23630122|NCT02229227|66032109|FG000|Overall Study|Adverse Event|14|||
23630123|NCT02229227|66032110|FG001|Overall Study|Adverse Event|9|||
23630124|NCT02229227|66032109|FG000|Overall Study|Lack of Efficacy|3|||
23630125|NCT02229227|66032110|FG001|Overall Study|Lack of Efficacy|3|||
23630126|NCT02229227|66032109|FG000|Overall Study|Protocol Violation|6|||
23630127|NCT02229227|66032110|FG001|Overall Study|Protocol Violation|8|||
23630128|NCT02229227|66032109|FG000|Overall Study|Protocol defined stopping criteria|1|||
23630129|NCT02229227|66032110|FG001|Overall Study|Protocol defined stopping criteria|3|||
23630130|NCT02229227|66032109|FG000|Overall Study|Lost to Follow-up|3|||
23630131|NCT02229227|66032110|FG001|Overall Study|Lost to Follow-up|3|||
23630132|NCT02229227|66032109|FG000|Overall Study|Study terminated by sponsor|11|||
23630133|NCT02229227|66032110|FG001|Overall Study|Study terminated by sponsor|11|||
23630134|NCT02229227|66032109|FG000|Overall Study|Withdrawal by Subject|8|||
23630135|NCT02229227|66032110|FG001|Overall Study|Withdrawal by Subject|12|||
23630136|NCT02229227|66032109|FG000|Overall Study|Other|0|||
23630137|NCT02229227|66032110|FG001|Overall Study|Other|1|||
23630138|NCT02229227|66032109|FG000|Overall Study|Physician Decision|5|||
23630139|NCT02229227|66032110|FG001|Overall Study|Physician Decision|12|||
23829560|NCT00485264|66755937|FG002|Overall Study|Lack of Efficacy|0|||
23829561|NCT00485264|66755938|FG003|Overall Study|Lack of Efficacy|0|||
23829562|NCT00485264|66755939|FG004|Overall Study|Lack of Efficacy|0|||
23829563|NCT00485264|66755940|FG005|Overall Study|Lack of Efficacy|0|||
23829564|NCT00485264|66755935|FG000|Overall Study|Guardian Consent Withdrawn|1|||
23829565|NCT00485264|66755936|FG001|Overall Study|Guardian Consent Withdrawn|0|||
23829566|NCT00485264|66755937|FG002|Overall Study|Guardian Consent Withdrawn|0|||
23829567|NCT00485264|66755938|FG003|Overall Study|Guardian Consent Withdrawn|0|||
23829568|NCT00485264|66755939|FG004|Overall Study|Guardian Consent Withdrawn|1|||
23829569|NCT00485264|66755940|FG005|Overall Study|Guardian Consent Withdrawn|0|||
23829570|NCT00485264|66755935|FG000|Overall Study|Physician Decision|0|||
23829571|NCT00485264|66755936|FG001|Overall Study|Physician Decision|2|||
23829572|NCT00485264|66755937|FG002|Overall Study|Physician Decision|0|||
23829573|NCT00485264|66755938|FG003|Overall Study|Physician Decision|0|||
23829574|NCT00485264|66755939|FG004|Overall Study|Physician Decision|0|||
23829575|NCT00485264|66755940|FG005|Overall Study|Physician Decision|0|||
23829576|NCT00485264|66755935|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23829577|NCT00485264|66755936|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23829578|NCT00485264|66755937|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
23829579|NCT00485264|66755938|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23829580|NCT00485264|66755939|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23829581|NCT00485264|66755940|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23829582|NCT00485264|66755935|FG000|Overall Study|Not Able to Attend Clinic|5|||
23829583|NCT00485264|66755936|FG001|Overall Study|Not Able to Attend Clinic|0|||
23829584|NCT00485264|66755937|FG002|Overall Study|Not Able to Attend Clinic|0|||
23829585|NCT00485264|66755938|FG003|Overall Study|Not Able to Attend Clinic|1|||
23829586|NCT00485264|66755939|FG004|Overall Study|Not Able to Attend Clinic|1|||
23630140|NCT00203047|66032111|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
23829587|NCT00485264|66755940|FG005|Overall Study|Not Able to Attend Clinic|2|||
23829588|NCT00485264|66755935|FG000|Overall Study|Non-Compliant|17|||
23829589|NCT00485264|66755936|FG001|Overall Study|Non-Compliant|2|||
23829590|NCT00485264|66755937|FG002|Overall Study|Non-Compliant|1|||
23829591|NCT00485264|66755938|FG003|Overall Study|Non-Compliant|0|||
23829592|NCT00485264|66755939|FG004|Overall Study|Non-Compliant|1|||
23630141|NCT00203047|66032112|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
23630142|NCT00203047|66032111|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
23630143|NCT00203047|66032112|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
23630144|NCT00203047|66032111|FG000|Overall Study|Withdrawal by Subject|13|||
23568308|NCT01380990|65809784|FG000|Overall Study|Death|0|||
23568309|NCT01380990|65809785|FG001|Overall Study|Death|1|||
23568310|NCT02118714|65809786|FG000|Overall Study|Lost to Follow-up|2|||
23568311|NCT02118714|65809786|FG000|Overall Study|Protocol Violation|1|||
23568312|NCT00251927|65809787|FG000|Overall Study|Adverse Event|3|||
23568313|NCT00251927|65809788|FG001|Overall Study|Adverse Event|15|||
23568314|NCT00251927|65809787|FG000|Overall Study|Lack of Efficacy|22|||
23568315|NCT00251927|65809788|FG001|Overall Study|Lack of Efficacy|16|||
23568316|NCT00251927|65809787|FG000|Overall Study|Lost to Follow-up|22|||
23829593|NCT00485264|66755940|FG005|Overall Study|Non-Compliant|0|||
23829594|NCT00485264|66755935|FG000|Overall Study|Lost to Follow-up|2|||
23829595|NCT00485264|66755936|FG001|Overall Study|Lost to Follow-up|1|||
23829596|NCT00485264|66755937|FG002|Overall Study|Lost to Follow-up|1|||
23829597|NCT00485264|66755938|FG003|Overall Study|Lost to Follow-up|0|||
23829598|NCT00485264|66755939|FG004|Overall Study|Lost to Follow-up|0|||
23829599|NCT00485264|66755940|FG005|Overall Study|Lost to Follow-up|1|||
23829600|NCT00485264|66755935|FG000|Overall Study|Other Reason|3|||
23829601|NCT00485264|66755936|FG001|Overall Study|Other Reason|0|||
23829602|NCT00485264|66755937|FG002|Overall Study|Other Reason|0|||
23829603|NCT00485264|66755938|FG003|Overall Study|Other Reason|0|||
23829604|NCT00485264|66755939|FG004|Overall Study|Other Reason|0|||
23829605|NCT00485264|66755940|FG005|Overall Study|Other Reason|0|||
23829606|NCT01330303|66755944|FG000|Period 1|Adverse Event|1|||
23829607|NCT01330303|66755945|FG001|Period 1|Adverse Event|0|||
23829608|NCT01330303|66755944|FG000|Period 1|Protocol Violation|0|||
23829609|NCT01330303|66755945|FG001|Period 1|Protocol Violation|1|||
23829610|NCT01330303|66755944|FG000|Period 1|Withdrawal by Subject|0|||
23829611|NCT01330303|66755945|FG001|Period 1|Withdrawal by Subject|1|||
23829612|NCT03170362|66755949|FG000|Overall Study|Death|2|||
23829613|NCT03170362|66755950|FG001|Overall Study|Death|2|||
23829614|NCT03170362|66755949|FG000|Overall Study|Withdrawal by Subject|23|||
23829615|NCT03170362|66755950|FG001|Overall Study|Withdrawal by Subject|22|||
23829616|NCT03170362|66755949|FG000|Overall Study|Lost to Follow-up|187|||
23568317|NCT00251927|65809788|FG001|Overall Study|Lost to Follow-up|8|||
23568318|NCT00251927|65809787|FG000|Overall Study|Protocol Violation|1|||
23568319|NCT00251927|65809788|FG001|Overall Study|Protocol Violation|2|||
23568320|NCT00251927|65809787|FG000|Overall Study|Pregnancy|2|||
23568321|NCT00251927|65809788|FG001|Overall Study|Pregnancy|0|||
23568322|NCT00251927|65809787|FG000|Overall Study|Withdrawal by Subject|40|||
23630145|NCT00203047|66032112|FG001|Overall Study|Withdrawal by Subject|47|||
23630146|NCT00203047|66032111|FG000|Overall Study|Teva requested participant withdrawal|1|||
23829617|NCT03170362|66755950|FG001|Overall Study|Lost to Follow-up|167|||
23829618|NCT01383174|66755954|FG000|3 Month Assessment|Death|0|||
23829619|NCT01383174|66755955|FG001|3 Month Assessment|Death|1|||
23829620|NCT01383174|66755954|FG000|3 Month Assessment|Lost to Follow-up|2|||
23829621|NCT01383174|66755955|FG001|3 Month Assessment|Lost to Follow-up|0|||
23829622|NCT01383174|66755954|FG000|3 Month Assessment|Refused to complete|4|||
23829623|NCT01383174|66755955|FG001|3 Month Assessment|Refused to complete|0|||
23829624|NCT01383174|66755954|FG000|6 Month Assessment|Lost to Follow-up|1|||
23829625|NCT01383174|66755955|FG001|6 Month Assessment|Lost to Follow-up|1|||
23829626|NCT01383174|66755954|FG000|6 Month Assessment|Refused to complete|4|||
23829627|NCT01383174|66755955|FG001|6 Month Assessment|Refused to complete|0|||
23829628|NCT02892331|66755956|FG000|Overall Study|Withdrawal by Subject|0|||
23568323|NCT00251927|65809788|FG001|Overall Study|Withdrawal by Subject|25|||
23630147|NCT00203047|66032112|FG001|Overall Study|Teva requested participant withdrawal|1|||
23829629|NCT02892331|66755957|FG001|Overall Study|Withdrawal by Subject|1|||
23568324|NCT00251927|65809787|FG000|Overall Study|Study-specific discont. achieved|13|||
23568325|NCT00251927|65809788|FG001|Overall Study|Study-specific discont. achieved|2|||
23568326|NCT00251927|65809787|FG000|Overall Study|Study procedure non-compliance|5|||
23568327|NCT00251927|65809788|FG001|Overall Study|Study procedure non-compliance|6|||
23568328|NCT04581200|65809794|FG000|Overall Study|Lost to Follow-up|6|||
23568329|NCT04581200|65809795|FG001|Overall Study|Lost to Follow-up|5|||
23568330|NCT01987830|65809796|FG000|Overall Study|Never received baseline scan|1|||
23568331|NCT00068380|65809797|FG000|Overall Study|Withdrawal by Subject|3|||
23568332|NCT00068380|65809797|FG000|Overall Study|Adverse Event|2|||
23568333|NCT01806740|65809798|FG000|Overall Study|Withdrawal by Subject|4|||
23568334|NCT01806740|65809798|FG000|Overall Study|Physician Decision|1|||
23568335|NCT01806740|65809798|FG000|Overall Study|Patient's refusal of treatment|1|||
23568336|NCT01406717|65809799|FG000|Overall Study|Subject non-compliance|4|||
23568337|NCT01406717|65809800|FG001|Overall Study|Subject non-compliance|3|||
23568338|NCT01406717|65809799|FG000|Overall Study|Protocol Violation|5|||
23568339|NCT01406717|65809800|FG001|Overall Study|Protocol Violation|1|||
23568340|NCT01406717|65809799|FG000|Overall Study|Lost to Follow-up|14|||
23568341|NCT01406717|65809800|FG001|Overall Study|Lost to Follow-up|8|||
23568342|NCT01406717|65809799|FG000|Overall Study|Withdrawal by Subject|19|||
23568343|NCT01406717|65809800|FG001|Overall Study|Withdrawal by Subject|15|||
23568344|NCT01406717|65809799|FG000|Overall Study|Adverse Event|1|||
23568345|NCT01406717|65809800|FG001|Overall Study|Adverse Event|2|||
23568346|NCT01406717|65809799|FG000|Overall Study|Lack of Efficacy|0|||
23568347|NCT01406717|65809800|FG001|Overall Study|Lack of Efficacy|1|||
23568348|NCT01406717|65809799|FG000|Overall Study|Non-completion of visit activity|0|||
23568349|NCT01406717|65809800|FG001|Overall Study|Non-completion of visit activity|1|||
23568350|NCT03377790|65809801|FG000|Overall Study|Withdrawal by Subject|1|||
23766961|NCT02101853|66524834|FG003|Block 1 Induction|Ineligible|0|||
23766962|NCT02101853|66524835|FG004|Block 1 Induction|Ineligible|0|||
23766963|NCT02101853|66524836|FG005|Block 1 Induction|Ineligible|0|||
23766964|NCT02101853|66524831|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
23766965|NCT02101853|66524832|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23766966|NCT02101853|66524833|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23766967|NCT02101853|66524834|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23766968|NCT02101853|66524835|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23766969|NCT02101853|66524836|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23766970|NCT02101853|66524831|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
23766971|NCT02101853|66524832|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23766972|NCT02101853|66524833|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23766973|NCT02101853|66524834|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23766974|NCT02101853|66524835|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23766975|NCT02101853|66524836|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23766976|NCT02101853|66524831|FG000|Post Induction Randomization|Adverse Event|0|||
23766977|NCT02101853|66524832|FG001|Post Induction Randomization|Adverse Event|3|||
23766978|NCT02101853|66524833|FG002|Post Induction Randomization|Adverse Event|8|||
23766979|NCT02101853|66524834|FG003|Post Induction Randomization|Adverse Event|4|||
23766980|NCT02101853|66524835|FG004|Post Induction Randomization|Adverse Event|4|||
23766981|NCT02101853|66524836|FG005|Post Induction Randomization|Adverse Event|0|||
23766982|NCT02101853|66524831|FG000|Post Induction Randomization|Death|0|||
23766983|NCT02101853|66524832|FG001|Post Induction Randomization|Death|9|||
23766984|NCT02101853|66524833|FG002|Post Induction Randomization|Death|2|||
23829630|NCT02892331|66755958|FG002|Overall Study|Withdrawal by Subject|1|||
23829631|NCT02892331|66755956|FG000|Overall Study|Sick family member|0|||
23568351|NCT03377790|65809802|FG001|Overall Study|Withdrawal by Subject|0|||
23568352|NCT03377790|65809801|FG000|Overall Study|Adverse Event|1|||
23766985|NCT02101853|66524834|FG003|Post Induction Randomization|Death|2|||
23766986|NCT02101853|66524835|FG004|Post Induction Randomization|Death|0|||
23766987|NCT02101853|66524836|FG005|Post Induction Randomization|Death|0|||
23766988|NCT02101853|66524831|FG000|Post Induction Randomization|Lack of Efficacy|0|||
23766989|NCT02101853|66524832|FG001|Post Induction Randomization|Lack of Efficacy|14|||
23766990|NCT02101853|66524833|FG002|Post Induction Randomization|Lack of Efficacy|23|||
23766991|NCT02101853|66524834|FG003|Post Induction Randomization|Lack of Efficacy|18|||
23766992|NCT02101853|66524835|FG004|Post Induction Randomization|Lack of Efficacy|21|||
23766993|NCT02101853|66524836|FG005|Post Induction Randomization|Lack of Efficacy|0|||
23766994|NCT02101853|66524831|FG000|Post Induction Randomization|Physician Decision|0|||
23766995|NCT02101853|66524832|FG001|Post Induction Randomization|Physician Decision|43|||
23766996|NCT02101853|66524833|FG002|Post Induction Randomization|Physician Decision|23|||
23766997|NCT02101853|66524834|FG003|Post Induction Randomization|Physician Decision|14|||
23766998|NCT02101853|66524835|FG004|Post Induction Randomization|Physician Decision|14|||
23766999|NCT02101853|66524836|FG005|Post Induction Randomization|Physician Decision|0|||
23767000|NCT02101853|66524831|FG000|Post Induction Randomization|Protocol Violation|0|||
23767001|NCT02101853|66524832|FG001|Post Induction Randomization|Protocol Violation|3|||
23767002|NCT02101853|66524833|FG002|Post Induction Randomization|Protocol Violation|0|||
23767003|NCT02101853|66524834|FG003|Post Induction Randomization|Protocol Violation|0|||
23767004|NCT02101853|66524835|FG004|Post Induction Randomization|Protocol Violation|0|||
23767005|NCT02101853|66524836|FG005|Post Induction Randomization|Protocol Violation|0|||
23767006|NCT02101853|66524831|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
23767007|NCT02101853|66524832|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
23767008|NCT02101853|66524833|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
23767009|NCT02101853|66524834|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
23767010|NCT02101853|66524835|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
23767011|NCT02101853|66524836|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
23767012|NCT02101853|66524831|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23767013|NCT02101853|66524832|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23767014|NCT02101853|66524833|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23767015|NCT02101853|66524834|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
23767016|NCT02101853|66524835|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23767017|NCT02101853|66524836|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23767018|NCT02101853|66524831|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23767019|NCT02101853|66524832|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
23767020|NCT02101853|66524833|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
23767021|NCT02101853|66524834|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23767022|NCT02101853|66524835|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23767023|NCT02101853|66524836|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23767024|NCT02101853|66524831|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23767025|NCT02101853|66524832|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
23767026|NCT02101853|66524833|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23767027|NCT02101853|66524834|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23767028|NCT02101853|66524835|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23767029|NCT02101853|66524836|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23767030|NCT02101853|66524831|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23767031|NCT02101853|66524832|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23767032|NCT02101853|66524833|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23767033|NCT02101853|66524834|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
23767034|NCT02101853|66524835|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
23767035|NCT02101853|66524836|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23767036|NCT02101853|66524831|FG000|Blinatumomab Salvage Therapy|Death|0|||
23767037|NCT02101853|66524832|FG001|Blinatumomab Salvage Therapy|Death|0|||
23767038|NCT02101853|66524833|FG002|Blinatumomab Salvage Therapy|Death|0|||
23767039|NCT02101853|66524834|FG003|Blinatumomab Salvage Therapy|Death|0|||
23767040|NCT02101853|66524835|FG004|Blinatumomab Salvage Therapy|Death|0|||
23767041|NCT02101853|66524836|FG005|Blinatumomab Salvage Therapy|Death|2|||
23767042|NCT02101853|66524831|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23767043|NCT02101853|66524832|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23767044|NCT02101853|66524833|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23767045|NCT02101853|66524834|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23767046|NCT02101853|66524835|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23767047|NCT02101853|66524836|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
23767048|NCT02101853|66524831|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
23767049|NCT02101853|66524832|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
23767050|NCT02101853|66524833|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
23767051|NCT02101853|66524834|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
23767052|NCT02101853|66524835|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
23767053|NCT02101853|66524836|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
23767054|NCT02101853|66524831|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23767055|NCT02101853|66524832|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23767056|NCT02101853|66524833|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23767057|NCT02101853|66524834|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23767058|NCT02101853|66524835|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23767059|NCT02101853|66524836|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
23767060|NCT00295854|66524837|FG000|Overall Study|Adverse Event|7|||
23767061|NCT00295854|66524838|FG001|Overall Study|Adverse Event|7|||
23767062|NCT00295854|66524839|FG002|Overall Study|Adverse Event|6|||
23767063|NCT00295854|66524837|FG000|Overall Study|Protocol Violation|1|||
23767064|NCT00295854|66524838|FG001|Overall Study|Protocol Violation|1|||
23767065|NCT00295854|66524839|FG002|Overall Study|Protocol Violation|1|||
23767066|NCT00295854|66524837|FG000|Overall Study|Lost to Follow-up|2|||
23767067|NCT00295854|66524838|FG001|Overall Study|Lost to Follow-up|0|||
23767068|NCT00295854|66524839|FG002|Overall Study|Lost to Follow-up|1|||
23767069|NCT00295854|66524837|FG000|Overall Study|Withdrawal by Subject|3|||
23767070|NCT00295854|66524838|FG001|Overall Study|Withdrawal by Subject|7|||
23767071|NCT00295854|66524839|FG002|Overall Study|Withdrawal by Subject|4|||
23767072|NCT00295854|66524837|FG000|Overall Study|did not continue to meet criteria|1|||
23767073|NCT00295854|66524838|FG001|Overall Study|did not continue to meet criteria|1|||
23767074|NCT00295854|66524839|FG002|Overall Study|did not continue to meet criteria|2|||
23767075|NCT00295854|66524837|FG000|Overall Study|required a prohibited medication|1|||
23767076|NCT00295854|66524838|FG001|Overall Study|required a prohibited medication|0|||
23767077|NCT00295854|66524839|FG002|Overall Study|required a prohibited medication|0|||
23767078|NCT00295854|66524837|FG000|Overall Study|Other|3|||
23767079|NCT00295854|66524838|FG001|Overall Study|Other|5|||
23767080|NCT00295854|66524839|FG002|Overall Study|Other|1|||
23767081|NCT03093454|66524844|FG000|Overall Study|Withdrawal by Subject|1|||
23767082|NCT03093454|66524845|FG001|Overall Study|Withdrawal by Subject|1|||
23767083|NCT03093454|66524844|FG000|Overall Study|Scheduling conflict|3|||
23767084|NCT03093454|66524845|FG001|Overall Study|Scheduling conflict|1|||
23767085|NCT03093454|66524844|FG000|Overall Study|Physician Decision|2|||
23767086|NCT03093454|66524845|FG001|Overall Study|Physician Decision|1|||
23767087|NCT00278512|66524846|FG000|Overall Study|Death|1|||
23767088|NCT00278512|66524847|FG001|Overall Study|Death|0|||
23767089|NCT01298323|66524850|FG000|Overall Study|Adverse Event|2|||
23568353|NCT03377790|65809802|FG001|Overall Study|Adverse Event|0|||
23568354|NCT03377790|65809801|FG000|Overall Study|Lost to Follow-up|0|||
23767090|NCT01298323|66524851|FG001|Overall Study|Adverse Event|4|||
23767091|NCT01298323|66524850|FG000|Overall Study|Death|11|||
23568355|NCT03377790|65809802|FG001|Overall Study|Lost to Follow-up|2|||
23767092|NCT01298323|66524851|FG001|Overall Study|Death|16|||
23767093|NCT01298323|66524850|FG000|Overall Study|Lost to Follow-up|1|||
23767094|NCT01298323|66524851|FG001|Overall Study|Lost to Follow-up|0|||
23767095|NCT01298323|66524850|FG000|Overall Study|Withdrawal by Subject|6|||
23767096|NCT01298323|66524851|FG001|Overall Study|Withdrawal by Subject|3|||
23767097|NCT01298323|66524850|FG000|Overall Study|Protocol Violation|1|||
23767098|NCT01298323|66524851|FG001|Overall Study|Protocol Violation|0|||
23767099|NCT01298323|66524850|FG000|Overall Study|Other|10|||
23767100|NCT01298323|66524851|FG001|Overall Study|Other|9|||
23767101|NCT01298323|66524850|FG000|Overall Study|Ongoing|55|||
23767102|NCT01298323|66524851|FG001|Overall Study|Ongoing|55|||
23767103|NCT01298323|66524850|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23767104|NCT01298323|66524851|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23767105|NCT00622908|66524852|FG000|Overall Study|Protocol Violation|1|||
23829632|NCT02892331|66755957|FG001|Overall Study|Sick family member|0|||
23630148|NCT00203047|66032111|FG000|Overall Study|Physician Decision|8|||
23767106|NCT00622908|66524853|FG001|Overall Study|Protocol Violation|0|||
23767107|NCT00622908|66524852|FG000|Overall Study|Adverse Event|0|||
23568356|NCT03377790|65809801|FG000|Overall Study|Randomized but not treated|1|||
23568357|NCT03377790|65809802|FG001|Overall Study|Randomized but not treated|0|||
23568358|NCT03377790|65809801|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
23568359|NCT03377790|65809802|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
23568360|NCT02693834|65809803|FG000|Baseline Measurement|Withdrawal by Subject|1|||
23568361|NCT02693834|65809804|FG001|Baseline Measurement|Withdrawal by Subject|0|||
23568362|NCT02693834|65809803|FG000|Baseline Measurement|Adverse Event|1|||
23829633|NCT02892331|66755958|FG002|Overall Study|Sick family member|1|||
23829634|NCT02892331|66755956|FG000|Overall Study|Corona virus pandemic|1|||
23829635|NCT02892331|66755957|FG001|Overall Study|Corona virus pandemic|0|||
23829636|NCT02892331|66755958|FG002|Overall Study|Corona virus pandemic|1|||
23829637|NCT02892331|66755956|FG000|Overall Study|Lost to Follow-up|1|||
23630149|NCT00203047|66032112|FG001|Overall Study|Physician Decision|7|||
23630150|NCT00203047|66032111|FG000|Overall Study|Non-compliance|4|||
23630151|NCT00203047|66032112|FG001|Overall Study|Non-compliance|8|||
23630152|NCT00203047|66032111|FG000|Overall Study|Protocol Violation|1|||
23630153|NCT00203047|66032112|FG001|Overall Study|Protocol Violation|0|||
23630154|NCT00203047|66032111|FG000|Overall Study|Lost to Follow-up|11|||
23767108|NCT00622908|66524853|FG001|Overall Study|Adverse Event|1|||
23767109|NCT00622908|66524852|FG000|Overall Study|Lack of Efficacy|1|||
23767110|NCT00622908|66524853|FG001|Overall Study|Lack of Efficacy|7|||
23767111|NCT00622908|66524852|FG000|Overall Study|Lost to Follow-up|1|||
23767112|NCT00622908|66524853|FG001|Overall Study|Lost to Follow-up|0|||
23767113|NCT00622908|66524852|FG000|Overall Study|Refusal|0|||
23767114|NCT00622908|66524853|FG001|Overall Study|Refusal|1|||
23767115|NCT00622908|66524852|FG000|Overall Study|Termination by study sponser|0|||
23767116|NCT00622908|66524853|FG001|Overall Study|Termination by study sponser|1|||
23767117|NCT00698685|66524857|FG000|Overall Study|Sister withdrew as donor|1|||
23767118|NCT00698685|66524857|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
23767119|NCT02507375|66524858|FG000|Overall Study|Progressive Disease|4|||
23767120|NCT02507375|66524859|FG001|Overall Study|Progressive Disease|5|||
23767121|NCT02507375|66524858|FG000|Overall Study|Death|0|||
23568363|NCT02693834|65809804|FG001|Baseline Measurement|Adverse Event|0|||
23568364|NCT02693834|65809803|FG000|Week 2 Practice|Adverse Event|0|||
23568365|NCT02693834|65809804|FG001|Week 2 Practice|Adverse Event|1|||
23568366|NCT00366301|65809805|FG000|Overall Study|Lost to Follow-up|4|||
23568367|NCT00366301|65809806|FG001|Overall Study|Lost to Follow-up|4|||
23630155|NCT00203047|66032112|FG001|Overall Study|Lost to Follow-up|5|||
23630156|NCT00203047|66032111|FG000|Overall Study|Adverse Event|8|||
23767122|NCT02507375|66524859|FG001|Overall Study|Death|1|||
23829638|NCT02892331|66755957|FG001|Overall Study|Lost to Follow-up|0|||
23829639|NCT02892331|66755958|FG002|Overall Study|Lost to Follow-up|1|||
23829640|NCT02892331|66755956|FG000|Overall Study|Blood pressure was too elevated|0|||
23829641|NCT02892331|66755957|FG001|Overall Study|Blood pressure was too elevated|1|||
23829642|NCT02892331|66755958|FG002|Overall Study|Blood pressure was too elevated|0|||
23829643|NCT02892331|66755956|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
23829644|NCT02892331|66755957|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
23829645|NCT02892331|66755958|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
23829646|NCT01213966|66755963|FG000|Overall Study|Protocol Violation|1|||
23829647|NCT01213966|66755964|FG001|Overall Study|Protocol Violation|0|||
23829648|NCT01213966|66755965|FG002|Overall Study|Protocol Violation|3|||
23829649|NCT01213966|66755966|FG003|Overall Study|Protocol Violation|1|||
23829650|NCT02383017|66755967|FG000|Overall Study|Injury Sustained Outside Study|1|||
23829651|NCT02383017|66755968|FG001|Overall Study|Injury Sustained Outside Study|0|||
23829652|NCT02383017|66755967|FG000|Overall Study|Compliance|3|||
23829653|NCT02383017|66755968|FG001|Overall Study|Compliance|2|||
23829654|NCT02383017|66755967|FG000|Overall Study|Found to be Hypogonadal|1|||
23829655|NCT02383017|66755968|FG001|Overall Study|Found to be Hypogonadal|0|||
23568368|NCT00366301|65809807|FG002|Overall Study|Lost to Follow-up|3|||
23568369|NCT00366301|65809808|FG003|Overall Study|Lost to Follow-up|7|||
23767123|NCT02507375|66524858|FG000|Overall Study|Refused treatment|0|||
23767124|NCT02507375|66524859|FG001|Overall Study|Refused treatment|1|||
23767125|NCT02507375|66524858|FG000|Overall Study|Adverse Event|0|||
23767126|NCT02507375|66524859|FG001|Overall Study|Adverse Event|1|||
23767127|NCT00582309|66524861|FG000|Overall Study|Protocol Violation|0|||
23767128|NCT00582309|66524862|FG001|Overall Study|Protocol Violation|0|||
23767129|NCT00582309|66524863|FG002|Overall Study|Protocol Violation|2|||
23767130|NCT04272775|66524868|FG000|Overall Study|Study Terminated by Sponsor|1|||
23767131|NCT04272775|66524869|FG001|Overall Study|Study Terminated by Sponsor|0|||
23767132|NCT04272775|66524868|FG000|Overall Study|Protocol Violation|0|||
23767133|NCT04272775|66524869|FG001|Overall Study|Protocol Violation|1|||
23767134|NCT04272775|66524868|FG000|Overall Study|Symptomatic Deterioration|1|||
23767135|NCT04272775|66524869|FG001|Overall Study|Symptomatic Deterioration|1|||
23767136|NCT04272775|66524868|FG000|Overall Study|Withdrawal by Subject|1|||
23767137|NCT04272775|66524869|FG001|Overall Study|Withdrawal by Subject|2|||
23767138|NCT04272775|66524868|FG000|Overall Study|Adverse Event|1|||
23767139|NCT04272775|66524869|FG001|Overall Study|Adverse Event|2|||
23767140|NCT04272775|66524868|FG000|Overall Study|Progressive Disease|3|||
23568370|NCT00366301|65809805|FG000|Overall Study|Withdrawal by Subject|4|||
23568371|NCT00366301|65809806|FG001|Overall Study|Withdrawal by Subject|2|||
23568372|NCT00366301|65809807|FG002|Overall Study|Withdrawal by Subject|1|||
23568373|NCT00366301|65809808|FG003|Overall Study|Withdrawal by Subject|1|||
23568374|NCT01973491|65809812|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
23568375|NCT01973491|65809812|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
23568376|NCT01973491|65809812|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
23568377|NCT03119610|65809813|FG000|Overall Study|Adverse Event|1|||
23568378|NCT03119610|65809814|FG001|Overall Study|Adverse Event|0|||
23568379|NCT03119610|65809813|FG000|Overall Study|Lost to Follow-up|0|||
23568380|NCT03119610|65809814|FG001|Overall Study|Lost to Follow-up|1|||
23568381|NCT02494921|65809815|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
23568382|NCT02494921|65809816|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
23568383|NCT02494921|65809817|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
23568384|NCT02494921|65809818|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
23568385|NCT02494921|65809819|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
23568386|NCT02494921|65809815|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
23630157|NCT00203047|66032112|FG001|Overall Study|Adverse Event|18|||
23630158|NCT00203047|66032111|FG000|Overall Study|Death|1|||
23630159|NCT00203047|66032112|FG001|Overall Study|Death|2|||
23630160|NCT00203047|66032111|FG000|Overall Study|Pregnancy|3|||
23630161|NCT00203047|66032112|FG001|Overall Study|Pregnancy|0|||
23767141|NCT04272775|66524869|FG001|Overall Study|Progressive Disease|1|||
23767142|NCT00553540|66524870|FG000|Overall Study|discharged after first visit|2|||
23767143|NCT00553540|66524871|FG001|Overall Study|discharged after first visit|5|||
23767144|NCT00146770|66524872|FG000|Overall Study|Adverse Event|2|||
23767145|NCT00146770|66524873|FG001|Overall Study|Adverse Event|0|||
23767146|NCT00146770|66524872|FG000|Overall Study|Pregnancy|1|||
23767147|NCT00146770|66524873|FG001|Overall Study|Pregnancy|0|||
23767148|NCT00146770|66524872|FG000|Overall Study|Withdrawal by Subject|2|||
23767149|NCT00146770|66524873|FG001|Overall Study|Withdrawal by Subject|0|||
23767150|NCT00522457|66524877|FG000|Overall Study|Due to disease progression|16|||
23767151|NCT00522457|66524877|FG000|Overall Study|Adverse Event|2|||
23767152|NCT01767597|66524878|FG000|Overall Study|Incomplete intervention|3|||
23767153|NCT01767597|66524879|FG001|Overall Study|Incomplete intervention|1|||
23767154|NCT01767597|66524878|FG000|Overall Study|Withdrawal by Subject|1|||
23767155|NCT01767597|66524879|FG001|Overall Study|Withdrawal by Subject|0|||
23767156|NCT01748890|66524880|FG000|Overall Study|Insufficient recruitment for analysis|4|||
23767157|NCT02866175|66524884|FG000|Overall Study|Adverse Event|56|||
23767158|NCT02866175|66524885|FG001|Overall Study|Adverse Event|54|||
23767159|NCT02866175|66524884|FG000|Overall Study|Withdrawal by Subject|31|||
23767160|NCT02866175|66524885|FG001|Overall Study|Withdrawal by Subject|52|||
23767161|NCT02866175|66524884|FG000|Overall Study|Death|30|||
23446148|NCT01395901|65373862|FG000|Overall Study|Withdrawal of consent|1|||
23630162|NCT00203047|66032111|FG000|Overall Study|Other|5|||
23630163|NCT00203047|66032112|FG001|Overall Study|Other|5|||
23630164|NCT02172911|66032113|FG000|Overall Study|Serious Adverse Event|0|||
23630165|NCT02172911|66032114|FG001|Overall Study|Serious Adverse Event|1|||
23630166|NCT02172911|66032113|FG000|Overall Study|Progression of Disease|0|||
23767162|NCT02866175|66524885|FG001|Overall Study|Death|23|||
23767163|NCT02866175|66524884|FG000|Overall Study|Other|7|||
23767164|NCT02866175|66524885|FG001|Overall Study|Other|14|||
23767165|NCT02866175|66524884|FG000|Overall Study|Progressive disease|1|||
23446149|NCT01395901|65373863|FG001|Overall Study|Withdrawal of consent|0|||
23446150|NCT01327599|65373866|FG000|Overall Study|Adverse Event|1|||
23630167|NCT02172911|66032114|FG001|Overall Study|Progression of Disease|1|||
23630168|NCT02172911|66032113|FG000|Overall Study|Loss of insurance coverage|1|||
23767166|NCT02866175|66524885|FG001|Overall Study|Progressive disease|1|||
23767167|NCT02866175|66524884|FG000|Overall Study|Lost to Follow-up|2|||
23767168|NCT02866175|66524885|FG001|Overall Study|Lost to Follow-up|0|||
23767169|NCT02866175|66524884|FG000|Overall Study|Lack of Efficacy|0|||
23767170|NCT02866175|66524885|FG001|Overall Study|Lack of Efficacy|1|||
23767171|NCT02866175|66524884|FG000|Overall Study|Physician Decision|3|||
23767172|NCT02866175|66524885|FG001|Overall Study|Physician Decision|15|||
23767173|NCT02866175|66524884|FG000|Overall Study|Did not receive treatment|5|||
23767174|NCT02866175|66524885|FG001|Overall Study|Did not receive treatment|15|||
23767175|NCT01901055|66524886|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
23767176|NCT01901055|66524887|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
23767177|NCT01901055|66524886|FG000|Randomization But Not Titrated|Physician Decision|0|||
23767178|NCT01901055|66524887|FG001|Randomization But Not Titrated|Physician Decision|1|||
23767179|NCT01901055|66524886|FG000|Started Protocol to Week 6|Physician Decision|2|||
23767180|NCT01901055|66524887|FG001|Started Protocol to Week 6|Physician Decision|1|||
23767181|NCT01901055|66524886|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
23767182|NCT01901055|66524887|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
23767183|NCT01901055|66524886|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
23767184|NCT01901055|66524887|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
23767185|NCT01901055|66524886|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
23767186|NCT01901055|66524887|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
23767187|NCT01901055|66524886|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
23767188|NCT01901055|66524887|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
23767189|NCT01901055|66524886|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
23767190|NCT01901055|66524887|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
23767191|NCT01901055|66524886|FG000|Week 24|Withdrawal by Subject|13|||
23767192|NCT01901055|66524887|FG001|Week 24|Withdrawal by Subject|19|||
23767193|NCT01901055|66524886|FG000|Week 24|Physician Decision|1|||
23767194|NCT01901055|66524887|FG001|Week 24|Physician Decision|0|||
23767195|NCT01901055|66524886|FG000|Week 36|Withdrawal by Subject|0|||
23767196|NCT01901055|66524887|FG001|Week 36|Withdrawal by Subject|5|||
23767197|NCT00672620|66524888|FG000|Overall Study|Adverse Event|7|||
23767198|NCT00672620|66524889|FG001|Overall Study|Adverse Event|7|||
23767199|NCT00672620|66524890|FG002|Overall Study|Adverse Event|12|||
23767200|NCT00672620|66524891|FG003|Overall Study|Adverse Event|17|||
23767201|NCT00672620|66524888|FG000|Overall Study|Lack of Efficacy|1|||
23767202|NCT00672620|66524889|FG001|Overall Study|Lack of Efficacy|2|||
23767203|NCT00672620|66524890|FG002|Overall Study|Lack of Efficacy|2|||
23767204|NCT00672620|66524891|FG003|Overall Study|Lack of Efficacy|0|||
23767205|NCT00672620|66524888|FG000|Overall Study|Noncompliance with Study Drug|3|||
23767206|NCT00672620|66524889|FG001|Overall Study|Noncompliance with Study Drug|4|||
23767207|NCT00672620|66524890|FG002|Overall Study|Noncompliance with Study Drug|0|||
23767208|NCT00672620|66524891|FG003|Overall Study|Noncompliance with Study Drug|2|||
23767209|NCT00672620|66524888|FG000|Overall Study|Protocol Deviations|5|||
23446151|NCT01327599|65373866|FG000|Overall Study|Could Not Attend Visit|1|||
23446152|NCT01327599|65373866|FG000|Overall Study|Withdrawal of Consent|1|||
23446153|NCT00785980|65373867|FG000|7 Day Washout Period|Protocol Violation|3|||
23446154|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
23446155|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
23829656|NCT01431079|66755969|FG000|Overall Study|Lost to Follow-up|35|||
23829657|NCT01431079|66755970|FG001|Overall Study|Lost to Follow-up|39|||
23446156|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
23446157|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
23446158|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
23446159|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
23568387|NCT02494921|65809816|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
23568388|NCT02494921|65809817|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
23568389|NCT02494921|65809818|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
23568390|NCT02494921|65809819|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
23568391|NCT02494921|65809815|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568392|NCT02494921|65809816|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568393|NCT02494921|65809817|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
23568394|NCT02494921|65809818|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568395|NCT02494921|65809819|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568396|NCT01193582|65809820|FG000|Vaccination Series|Withdrawal by Subject|11|||
23568397|NCT01193582|65809821|FG001|Vaccination Series|Withdrawal by Subject|13|||
23767210|NCT00672620|66524889|FG001|Overall Study|Protocol Deviations|7|||
23767211|NCT00672620|66524890|FG002|Overall Study|Protocol Deviations|2|||
23767212|NCT00672620|66524891|FG003|Overall Study|Protocol Deviations|5|||
23767213|NCT00672620|66524888|FG000|Overall Study|Withdrawal of Consent|6|||
23767214|NCT00672620|66524889|FG001|Overall Study|Withdrawal of Consent|12|||
23829658|NCT01779440|66755976|FG000|Overall Study|Withdrawal by Subject|3|||
23446160|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
23446161|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
23446162|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
23446163|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
23453639|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23446164|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
23446165|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
23446166|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
23446167|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
23767215|NCT00672620|66524890|FG002|Overall Study|Withdrawal of Consent|5|||
23767216|NCT00672620|66524891|FG003|Overall Study|Withdrawal of Consent|6|||
23767217|NCT00672620|66524888|FG000|Overall Study|Lost to Follow-up|8|||
23767218|NCT00672620|66524889|FG001|Overall Study|Lost to Follow-up|19|||
23767219|NCT00672620|66524890|FG002|Overall Study|Lost to Follow-up|8|||
23767220|NCT00672620|66524891|FG003|Overall Study|Lost to Follow-up|11|||
23767221|NCT00672620|66524888|FG000|Overall Study|Reason not Specified|3|||
23767222|NCT00672620|66524889|FG001|Overall Study|Reason not Specified|3|||
23767223|NCT00672620|66524890|FG002|Overall Study|Reason not Specified|2|||
23446168|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
23568398|NCT01193582|65809822|FG002|Vaccination Series|Withdrawal by Subject|8|||
23568399|NCT01193582|65809823|FG003|Vaccination Series|Withdrawal by Subject|3|||
23568400|NCT01193582|65809820|FG000|12 Month Follow-up|Death|0|||
23568401|NCT01193582|65809821|FG001|12 Month Follow-up|Death|0|||
23568402|NCT01193582|65809822|FG002|12 Month Follow-up|Death|1|||
23568403|NCT01193582|65809823|FG003|12 Month Follow-up|Death|0|||
23568404|NCT01193582|65809820|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
23568405|NCT01193582|65809821|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
23568406|NCT01193582|65809822|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
23568407|NCT01193582|65809823|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
23568408|NCT01588990|65809824|FG000|Phase A|Withdrawal by Subject|5|||
23568409|NCT01588990|65809824|FG000|Phase A|Physician Decision|11|||
23568410|NCT01588990|65809824|FG000|Phase A|Other|14|||
23568411|NCT01588990|65809824|FG000|Phase A|Lost to Follow-up|1|||
23568412|NCT01588990|65809824|FG000|Phase A|Death|5|||
23568413|NCT01588990|65809824|FG000|Phase A|Adverse Event|28|||
23568414|NCT01588990|65809824|FG000|Phase A|Still on therapy at end of study|6|||
23568415|NCT01588990|65809824|FG000|Phase B|Adverse Event|2|||
23568416|NCT01588990|65809824|FG000|Phase B|Still on therapy at end of study|5|||
23568417|NCT01588990|65809824|FG000|Phase B|Withdrawal by Subject|3|||
23568418|NCT01588990|65809824|FG000|Phase B|Physician Decision|4|||
23568419|NCT01588990|65809824|FG000|Phase B|Other|2|||
23568420|NCT01737996|65809825|FG000|Overall Study|Adverse Event|0|||
23568421|NCT01737996|65809826|FG001|Overall Study|Adverse Event|1|||
23568422|NCT01737996|65809827|FG002|Overall Study|Adverse Event|1|||
23568423|NCT01737996|65809825|FG000|Overall Study|Withdrawal by Subject|0|||
23568424|NCT01737996|65809826|FG001|Overall Study|Withdrawal by Subject|0|||
23568425|NCT01737996|65809827|FG002|Overall Study|Withdrawal by Subject|1|||
23568426|NCT00519896|65809828|FG000|Overall Study|Protocol Violation|1|||
23568427|NCT00519896|65809828|FG000|Overall Study|Adverse Event|1|||
23568428|NCT03008122|65809830|FG000|Overall Study|Physician Decision|3|||
23568429|NCT03008122|65809831|FG001|Overall Study|Physician Decision|2|||
23568430|NCT03008122|65809832|FG002|Overall Study|Physician Decision|0|||
23568431|NCT03008122|65809830|FG000|Overall Study|Withdrawal by Subject|1|||
23568432|NCT03008122|65809831|FG001|Overall Study|Withdrawal by Subject|3|||
23568433|NCT03008122|65809832|FG002|Overall Study|Withdrawal by Subject|0|||
23568434|NCT03008122|65809830|FG000|Overall Study|Lost to Follow-up|4|||
23568435|NCT03008122|65809831|FG001|Overall Study|Lost to Follow-up|8|||
23568436|NCT03008122|65809832|FG002|Overall Study|Lost to Follow-up|3|||
23568437|NCT03008122|65809830|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
23568438|NCT03008122|65809831|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23568439|NCT03008122|65809832|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
23568440|NCT03008122|65809830|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
23568441|NCT03008122|65809831|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
23568442|NCT03008122|65809832|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
23568443|NCT03008122|65809830|FG000|Overall Study|Death|0|||
23568444|NCT03008122|65809831|FG001|Overall Study|Death|0|||
23767224|NCT00672620|66524891|FG003|Overall Study|Reason not Specified|1|||
23767225|NCT03443869|66524892|FG000|Overall Study|Death|3|||
23767226|NCT03443869|66524893|FG001|Overall Study|Death|3|||
23767227|NCT03443869|66524892|FG000|Overall Study|Withdrawal by Subject|34|||
23568445|NCT03008122|65809832|FG002|Overall Study|Death|1|||
23568446|NCT03321513|65809835|FG000|Overall Study|Death|11|||
23568447|NCT03321513|65809836|FG001|Overall Study|Death|5|||
23568448|NCT03321513|65809835|FG000|Overall Study|Withdrawal by Subject|5|||
23568449|NCT03321513|65809836|FG001|Overall Study|Withdrawal by Subject|10|||
23568450|NCT03321513|65809835|FG000|Overall Study|Lost to Follow-up|10|||
23568451|NCT03321513|65809836|FG001|Overall Study|Lost to Follow-up|11|||
23568452|NCT02875834|65809837|FG000|Open-label Phase|Withdrawal by Subject|3|||
23568453|NCT02875834|65809838|FG001|Open-label Phase|Withdrawal by Subject|0|||
23568454|NCT02875834|65809839|FG002|Open-label Phase|Withdrawal by Subject|0|||
23630169|NCT02172911|66032114|FG001|Overall Study|Loss of insurance coverage|0|||
23630170|NCT01200290|66032115|FG000|Treatment Period|Adverse Event|1|||
23630171|NCT01200290|66032115|FG000|Post-Treatment Follow-Up Period|Death|2|||
23630172|NCT00798434|66032116|FG000|Double-Blind|Adverse Event|22|||
23630173|NCT00798434|66032117|FG001|Double-Blind|Adverse Event|46|||
23630174|NCT00798434|66032116|FG000|Double-Blind|Death|0|||
23630175|NCT00798434|66032117|FG001|Double-Blind|Death|1|||
23630176|NCT00798434|66032116|FG000|Double-Blind|Lost to Follow-up|1|||
23630177|NCT00798434|66032117|FG001|Double-Blind|Lost to Follow-up|0|||
23630178|NCT00798434|66032116|FG000|Double-Blind|Lack of Efficacy|8|||
23630179|NCT00798434|66032117|FG001|Double-Blind|Lack of Efficacy|12|||
23630180|NCT00798434|66032116|FG000|Double-Blind|Withdrawal by Subject|17|||
23630181|NCT00798434|66032117|FG001|Double-Blind|Withdrawal by Subject|14|||
23630182|NCT00798434|66032116|FG000|Double-Blind|Protocol Violation|1|||
23630183|NCT00798434|66032117|FG001|Double-Blind|Protocol Violation|4|||
23630184|NCT00798434|66032116|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
23630185|NCT00798434|66032117|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
23630186|NCT00798434|66032116|FG000|Double-Blind|Other|1|||
23630187|NCT00798434|66032117|FG001|Double-Blind|Other|0|||
23630188|NCT00798434|66032116|FG000|Double-Blind|Not Treated|3|||
23630189|NCT00798434|66032117|FG001|Double-Blind|Not Treated|6|||
23630190|NCT00798434|66032116|FG000|Open-Label|Adverse Event|33|||
23630191|NCT00798434|66032117|FG001|Open-Label|Adverse Event|11|||
23630192|NCT00798434|66032116|FG000|Open-Label|Lack of Efficacy|5|||
23630193|NCT00798434|66032117|FG001|Open-Label|Lack of Efficacy|11|||
23630194|NCT00798434|66032116|FG000|Open-Label|Withdrawal by Subject|2|||
23630195|NCT00798434|66032117|FG001|Open-Label|Withdrawal by Subject|7|||
23630196|NCT00798434|66032116|FG000|Open-Label|Protocol Violation|1|||
23630197|NCT00798434|66032117|FG001|Open-Label|Protocol Violation|0|||
23630198|NCT00798434|66032116|FG000|Open-Label|Other|1|||
23767228|NCT03443869|66524893|FG001|Overall Study|Withdrawal by Subject|22|||
23767229|NCT03443869|66524892|FG000|Overall Study|Lost to Follow-up|1|||
23767230|NCT03443869|66524893|FG001|Overall Study|Lost to Follow-up|2|||
23767231|NCT03443869|66524892|FG000|Overall Study|Physician Decision|3|||
23767232|NCT03443869|66524893|FG001|Overall Study|Physician Decision|3|||
23767233|NCT03443869|66524892|FG000|Overall Study|Other|4|||
23767234|NCT03443869|66524893|FG001|Overall Study|Other|4|||
23767235|NCT03267264|66524895|FG000|Overall Study|Withdrawal by Subject|1|||
23829659|NCT01779440|66755977|FG001|Overall Study|Withdrawal by Subject|5|||
23829660|NCT01153815|66755981|FG000|Overall Study|Adverse Event|3|||
23829661|NCT01153815|66755982|FG001|Overall Study|Adverse Event|1|||
23829662|NCT01153815|66755981|FG000|Overall Study|Withdrawal by Subject|6|||
23630199|NCT00798434|66032117|FG001|Open-Label|Other|2|||
23767236|NCT03267264|66524896|FG001|Overall Study|Withdrawal by Subject|0|||
23767237|NCT03267264|66524897|FG002|Overall Study|Withdrawal by Subject|2|||
23767238|NCT03267264|66524898|FG003|Overall Study|Withdrawal by Subject|4|||
23767239|NCT04081337|66524899|FG000|Overall Study|Adverse Event|0|||
23767240|NCT04081337|66524900|FG001|Overall Study|Adverse Event|1|||
23767241|NCT04081337|66524899|FG000|Overall Study|Withdrawal by Subject|2|||
23767242|NCT04081337|66524900|FG001|Overall Study|Withdrawal by Subject|0|||
23767243|NCT04081337|66524899|FG000|Overall Study|Physician Decision|1|||
23767244|NCT04081337|66524900|FG001|Overall Study|Physician Decision|2|||
23767245|NCT04081337|66524899|FG000|Overall Study|Lost to Follow-up|1|||
23767246|NCT04081337|66524900|FG001|Overall Study|Lost to Follow-up|0|||
23767247|NCT02710071|66524907|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
23767248|NCT02710071|66524908|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
23767249|NCT02710071|66524907|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
23767250|NCT02710071|66524908|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
23767251|NCT02637076|66524909|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
23767252|NCT02637076|66524910|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
23767253|NCT02637076|66524909|FG000|Overall Study|Withdrawal by Subject|0|||
23630200|NCT00798434|66032116|FG000|Open-Label|Not Treated|0|||
23630201|NCT00798434|66032117|FG001|Open-Label|Not Treated|1|||
23630202|NCT01646385|66032118|FG000|Overall Study|Death|202|||
23630203|NCT01646385|66032119|FG001|Overall Study|Death|222|||
23630204|NCT01646385|66032118|FG000|Overall Study|Switched to alternate biologic|636|||
23630205|NCT01646385|66032119|FG001|Overall Study|Switched to alternate biologic|649|||
23630206|NCT01165177|66032120|FG000|Overall Study|Serious Adverse Event|227|||
23630207|NCT01165177|66032121|FG001|Overall Study|Serious Adverse Event|235|||
23767254|NCT02637076|66524910|FG001|Overall Study|Withdrawal by Subject|4|||
23767255|NCT02688608|66524912|FG000|Overall Study|Lost to Follow-up|1|||
23767256|NCT03922477|66524913|FG000|Overall Study|Death|9|||
23767257|NCT03922477|66524913|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
23767258|NCT03922477|66524913|FG000|Overall Study|Physician Decision|1|||
23630208|NCT01165177|66032120|FG000|Overall Study|Withdrawal by Subject|368|||
23630209|NCT01165177|66032121|FG001|Overall Study|Withdrawal by Subject|354|||
23630210|NCT01165177|66032120|FG000|Overall Study|Protocol Violation|19|||
23767259|NCT03922477|66524913|FG000|Overall Study|Withdrawal by Subject|2|||
23767260|NCT00859469|66524914|FG000|Overall Study|Adverse Event|2|||
23767261|NCT00859469|66524914|FG000|Overall Study|Lack of Efficacy|9|||
23767262|NCT00859469|66524914|FG000|Overall Study|Withdrawal by Subject|1|||
23767263|NCT00859469|66524914|FG000|Overall Study|Death|16|||
23767264|NCT01411995|66524915|FG000|Overall Study|Failed IUD insertion|0|||
23767265|NCT01411995|66524916|FG001|Overall Study|Failed IUD insertion|1|||
23767266|NCT01855126|66524917|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
23767267|NCT01855126|66524918|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
23767268|NCT01855126|66524917|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23767269|NCT01855126|66524918|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23767270|NCT02043366|66524919|FG000|Overall Study|Lost to Follow-up|2|||
23767271|NCT02043366|66524920|FG001|Overall Study|Lost to Follow-up|2|||
23767272|NCT02043366|66524921|FG002|Overall Study|Lost to Follow-up|2|||
23767273|NCT02043366|66524922|FG003|Overall Study|Lost to Follow-up|2|||
23767274|NCT02043366|66524923|FG004|Overall Study|Lost to Follow-up|2|||
23767275|NCT02043366|66524924|FG005|Overall Study|Lost to Follow-up|2|||
23767276|NCT01953783|66524925|FG000|Overall Study|Progressive disease|2|||
23767277|NCT00322556|66524926|FG000|Overall Study|Adverse Event|1|||
23767278|NCT00322556|66524926|FG000|Overall Study|Withdrawal by Subject|1|||
23767279|NCT00322556|66524926|FG000|Overall Study|Lost to Follow-up|3|||
23767280|NCT00322556|66524926|FG000|Overall Study|Other Reason|7|||
23767281|NCT01691859|66524932|FG000|Overall Study|Adverse Event|19|||
23767282|NCT01691859|66524932|FG000|Overall Study|Lack of Efficacy|11|||
23767283|NCT01691859|66524932|FG000|Overall Study|Protocol Violation|4|||
23767284|NCT01691859|66524932|FG000|Overall Study|Product commercially available|221|||
23767285|NCT01691859|66524932|FG000|Overall Study|Study closed/terminated|50|||
23767286|NCT01691859|66524932|FG000|Overall Study|Lost to Follow-up|5|||
23767287|NCT01691859|66524932|FG000|Overall Study|Physician Decision|6|||
23767288|NCT01691859|66524932|FG000|Overall Study|Withdrawal by Subject|31|||
23767289|NCT01399723|66524933|FG000|Overall Study|Lost to Follow-up|0|||
23767290|NCT01399723|66524934|FG001|Overall Study|Lost to Follow-up|1|||
23767291|NCT02795104|66524935|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
23767292|NCT02795104|66524936|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
23767293|NCT02795104|66524937|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
23767294|NCT02795104|66524935|FG000|Overall Study|Withdrawal by Subject|0|||
23767295|NCT02795104|66524936|FG001|Overall Study|Withdrawal by Subject|2|||
23767296|NCT02795104|66524937|FG002|Overall Study|Withdrawal by Subject|0|||
23767297|NCT02795104|66524935|FG000|Overall Study|Lost to Follow-up|0|||
23767298|NCT02795104|66524936|FG001|Overall Study|Lost to Follow-up|0|||
23767299|NCT02795104|66524937|FG002|Overall Study|Lost to Follow-up|1|||
23767300|NCT00192296|66524938|FG000|Overall Study|Withdrawal by Subject|0|||
23767301|NCT00192296|66524939|FG001|Overall Study|Withdrawal by Subject|1|||
23767302|NCT00192296|66524940|FG002|Overall Study|Withdrawal by Subject|0|||
23767303|NCT00192296|66524941|FG003|Overall Study|Withdrawal by Subject|0|||
23767304|NCT00524459|66524942|FG000|Overall Study|Withdrawal by Subject|1|||
23767305|NCT00524459|66524942|FG000|Overall Study|Other|1|||
23767306|NCT00125359|66524943|FG000|Overall Study|Death|4|||
23767307|NCT00125359|66524943|FG000|Overall Study|Adverse Event|5|||
23767308|NCT00125359|66524943|FG000|Overall Study|Physician Decision|14|||
23767309|NCT00329602|66524944|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
23767310|NCT00329602|66524945|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
23767311|NCT00329602|66524946|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
23767312|NCT00329602|66524944|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
23767313|NCT00329602|66524945|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
23767314|NCT00329602|66524946|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
23767315|NCT00329602|66524944|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
23767316|NCT00329602|66524945|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
23767317|NCT00329602|66524946|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
23767318|NCT00329602|66524944|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
23767319|NCT00329602|66524945|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
23767320|NCT00329602|66524946|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
23767321|NCT00329602|66524944|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
23767322|NCT00329602|66524945|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
23767323|NCT00329602|66524946|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
23767324|NCT00329602|66524944|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
23767325|NCT00329602|66524945|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
23767326|NCT00329602|66524946|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
23767327|NCT00598559|66524947|FG000|Overall Study|Adverse Event|11|||
23767328|NCT00598559|66524948|FG001|Overall Study|Adverse Event|7|||
23767329|NCT00598559|66524949|FG002|Overall Study|Adverse Event|0|||
23767330|NCT00598559|66524947|FG000|Overall Study|Withdrawal by Subject|2|||
23767331|NCT00598559|66524948|FG001|Overall Study|Withdrawal by Subject|2|||
23829663|NCT01153815|66755982|FG001|Overall Study|Withdrawal by Subject|4|||
23829664|NCT01037218|66755983|FG000|Overall Study|Adverse Event|4|||
23829665|NCT01037218|66755984|FG001|Overall Study|Adverse Event|2|||
23829666|NCT01037218|66755985|FG002|Overall Study|Adverse Event|2|||
23829667|NCT01037218|66755986|FG003|Overall Study|Adverse Event|1|||
23829668|NCT01037218|66755983|FG000|Overall Study|Lack of Efficacy|0|||
23829669|NCT01037218|66755984|FG001|Overall Study|Lack of Efficacy|2|||
23829670|NCT01037218|66755985|FG002|Overall Study|Lack of Efficacy|1|||
23829671|NCT01037218|66755986|FG003|Overall Study|Lack of Efficacy|5|||
23829672|NCT01037218|66755983|FG000|Overall Study|Lost to Follow-up|3|||
23829673|NCT01037218|66755984|FG001|Overall Study|Lost to Follow-up|5|||
23829674|NCT01037218|66755985|FG002|Overall Study|Lost to Follow-up|4|||
23829675|NCT01037218|66755986|FG003|Overall Study|Lost to Follow-up|2|||
23829676|NCT01037218|66755983|FG000|Overall Study|Withdrawal by Subject|6|||
23829677|NCT01037218|66755984|FG001|Overall Study|Withdrawal by Subject|7|||
23829678|NCT01037218|66755985|FG002|Overall Study|Withdrawal by Subject|7|||
23829679|NCT01037218|66755986|FG003|Overall Study|Withdrawal by Subject|4|||
23829680|NCT01037218|66755983|FG000|Overall Study|Partner Withdrew Consent|0|||
23829681|NCT01037218|66755984|FG001|Overall Study|Partner Withdrew Consent|3|||
23829682|NCT01037218|66755985|FG002|Overall Study|Partner Withdrew Consent|2|||
23829683|NCT01037218|66755986|FG003|Overall Study|Partner Withdrew Consent|1|||
23829684|NCT01037218|66755983|FG000|Overall Study|Protocol Violation|0|||
23829685|NCT01037218|66755984|FG001|Overall Study|Protocol Violation|0|||
23829686|NCT01037218|66755985|FG002|Overall Study|Protocol Violation|2|||
23829687|NCT01037218|66755986|FG003|Overall Study|Protocol Violation|2|||
23829688|NCT01037218|66755983|FG000|Overall Study|Various|3|||
23829689|NCT01037218|66755984|FG001|Overall Study|Various|2|||
23829690|NCT01037218|66755985|FG002|Overall Study|Various|3|||
23829691|NCT01037218|66755986|FG003|Overall Study|Various|1|||
23829692|NCT01578239|66755989|FG000|Treatment Period|Progressive Disease|19|||
23829693|NCT01578239|66755990|FG001|Treatment Period|Progressive Disease|64|||
23829694|NCT01578239|66755989|FG000|Treatment Period|Physician Decision|17|||
23829695|NCT01578239|66755990|FG001|Treatment Period|Physician Decision|17|||
23829696|NCT01578239|66755989|FG000|Treatment Period|Adverse Event|13|||
23829697|NCT01578239|66755990|FG001|Treatment Period|Adverse Event|10|||
23829698|NCT01578239|66755989|FG000|Treatment Period|Non-compliance|2|||
23829699|NCT01578239|66755990|FG001|Treatment Period|Non-compliance|0|||
23829700|NCT01578239|66755989|FG000|Treatment Period|Withdrawal by Subject|10|||
23829701|NCT01578239|66755990|FG001|Treatment Period|Withdrawal by Subject|9|||
23829702|NCT01578239|66755989|FG000|Treatment Period|Other|6|||
23829703|NCT01578239|66755990|FG001|Treatment Period|Other|1|||
23829704|NCT01578239|66755989|FG000|Long-term Follow-Up Period|Death|69|||
23829705|NCT01578239|66755990|FG001|Long-term Follow-Up Period|Death|64|||
23829706|NCT01578239|66755989|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
23829707|NCT01578239|66755990|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
23829708|NCT01578239|66755989|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
23829709|NCT01578239|66755990|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
23829710|NCT01578239|66755989|FG000|Long-term Follow-Up Period|Other|2|||
23829711|NCT01578239|66755990|FG001|Long-term Follow-Up Period|Other|2|||
23829712|NCT01129557|66755991|FG000|Overall Study|Adverse Event|1|||
23829713|NCT01129557|66755992|FG001|Overall Study|Adverse Event|2|||
23829714|NCT01129557|66755993|FG002|Overall Study|Adverse Event|2|||
23829715|NCT01129557|66755991|FG000|Overall Study|Novartis terminated study early|3|||
23829716|NCT01129557|66755992|FG001|Overall Study|Novartis terminated study early|3|||
23829717|NCT01129557|66755993|FG002|Overall Study|Novartis terminated study early|2|||
23829718|NCT02301169|66756000|FG000|Overall Study|Adverse Event|1|||
23829719|NCT02301169|66756001|FG001|Overall Study|Adverse Event|0|||
23829720|NCT02550561|66756002|FG000|Overall Study|Lost to Follow-up|5|||
23829721|NCT02550561|66756002|FG000|Overall Study|Withdrawal by Subject|1|||
23829722|NCT01922037|66756003|FG000|Overall Study|Withdrawal by Subject|2|||
23829723|NCT01922037|66756004|FG001|Overall Study|Withdrawal by Subject|44|||
23829724|NCT01922037|66756003|FG000|Overall Study|Adverse Event|1|||
23829725|NCT01922037|66756004|FG001|Overall Study|Adverse Event|7|||
23829726|NCT01922037|66756003|FG000|Overall Study|Death|0|||
23829727|NCT01922037|66756004|FG001|Overall Study|Death|5|||
23829728|NCT01922037|66756003|FG000|Overall Study|Pregnancy|0|||
23829729|NCT01922037|66756004|FG001|Overall Study|Pregnancy|2|||
23829730|NCT01922037|66756003|FG000|Overall Study|Participant non-compliance|4|||
23829731|NCT01922037|66756004|FG001|Overall Study|Participant non-compliance|46|||
23829732|NCT01922037|66756003|FG000|Overall Study|Investigator/Sponsor decision|1|||
23829733|NCT01922037|66756004|FG001|Overall Study|Investigator/Sponsor decision|4|||
23829734|NCT01922037|66756003|FG000|Overall Study|Other unspecified|2|||
23829735|NCT01922037|66756004|FG001|Overall Study|Other unspecified|66|||
23829736|NCT02203357|66756005|FG000|Overall Study|Lost to Follow-up|58|||
23829737|NCT02203357|66756006|FG001|Overall Study|Lost to Follow-up|66|||
23829738|NCT02203357|66756007|FG002|Overall Study|Lost to Follow-up|70|||
23829739|NCT00459355|66756016|FG000|Overall Study|Subject no longer met inc criteria|20|||
23829740|NCT00459355|66756017|FG001|Overall Study|Subject no longer met inc criteria|18|||
23829741|NCT01215136|66756024|FG000|Overall Study|Adverse Event|2|||
23829742|NCT01215136|66756025|FG001|Overall Study|Adverse Event|9|||
23829743|NCT01215136|66756024|FG000|Overall Study|Disease Progression|3|||
23829744|NCT01215136|66756025|FG001|Overall Study|Disease Progression|14|||
23829745|NCT01215136|66756024|FG000|Overall Study|Symptomatic Deterioration|1|||
23829746|NCT01215136|66756025|FG001|Overall Study|Symptomatic Deterioration|1|||
23829747|NCT01215136|66756024|FG000|Overall Study|Death|0|||
23829748|NCT01215136|66756025|FG001|Overall Study|Death|2|||
23829749|NCT01215136|66756024|FG000|Overall Study|Withdrawal by Subject|0|||
23829750|NCT01215136|66756025|FG001|Overall Study|Withdrawal by Subject|1|||
23829751|NCT00882518|66756026|FG000|Overall Study|Adverse Event|9|||
23829752|NCT00882518|66756027|FG001|Overall Study|Adverse Event|18|||
23829753|NCT00882518|66756026|FG000|Overall Study|Withdrawal by Subject|9|||
23829754|NCT00882518|66756027|FG001|Overall Study|Withdrawal by Subject|13|||
23829755|NCT00882518|66756026|FG000|Overall Study|Lack of Efficacy|12|||
23829756|NCT00882518|66756027|FG001|Overall Study|Lack of Efficacy|9|||
23829757|NCT00882518|66756026|FG000|Overall Study|Severe non-compliance to protocol|3|||
23829758|NCT00882518|66756027|FG001|Overall Study|Severe non-compliance to protocol|1|||
23829759|NCT00882518|66756026|FG000|Overall Study|Incorrect enrolment|4|||
23829760|NCT00882518|66756027|FG001|Overall Study|Incorrect enrolment|2|||
23829761|NCT00882518|66756026|FG000|Overall Study|Central lab closure for National day|1|||
23829762|NCT00882518|66756027|FG001|Overall Study|Central lab closure for National day|0|||
23829763|NCT00882518|66756026|FG000|Overall Study|Allocating random number by mistake|0|||
23829764|NCT00882518|66756027|FG001|Overall Study|Allocating random number by mistake|1|||
23829765|NCT00360282|66756036|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
23829766|NCT00360282|66756037|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
23829767|NCT00360282|66756038|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
23829768|NCT00360282|66756039|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
23829769|NCT00360282|66756036|FG000|Second Intervention|Adverse Event|0|||
23829770|NCT00360282|66756037|FG001|Second Intervention|Adverse Event|1|||
23829771|NCT00360282|66756038|FG002|Second Intervention|Adverse Event|0|||
23829772|NCT00360282|66756039|FG003|Second Intervention|Adverse Event|0|||
23829773|NCT04054765|66756040|FG000|Baseline|Withdrawal by Subject|5|||
23829774|NCT04054765|66756041|FG001|Baseline|Withdrawal by Subject|3|||
23829775|NCT04054765|66756040|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
23829776|NCT04054765|66756041|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
23829777|NCT04054765|66756040|FG000|3-month Follow up|Withdrawal by Subject|0|||
23829778|NCT04054765|66756041|FG001|3-month Follow up|Withdrawal by Subject|3|||
23829779|NCT04054765|66756040|FG000|6-month Follow up|Lost to Follow-up|32|||
23829780|NCT04054765|66756041|FG001|6-month Follow up|Lost to Follow-up|32|||
23829781|NCT02328014|66756046|FG000|Overall Study|Adverse Event|1|||
23829782|NCT02328014|66756047|FG001|Overall Study|Adverse Event|0|||
23829783|NCT02328014|66756048|FG002|Overall Study|Adverse Event|0|||
23829784|NCT02328014|66756049|FG003|Overall Study|Adverse Event|1|||
23829785|NCT02328014|66756046|FG000|Overall Study|Death|0|||
23829786|NCT02328014|66756047|FG001|Overall Study|Death|0|||
23829787|NCT02328014|66756048|FG002|Overall Study|Death|0|||
23829788|NCT02328014|66756049|FG003|Overall Study|Death|4|||
23829789|NCT02328014|66756046|FG000|Overall Study|Physician Decision|0|||
23829790|NCT02328014|66756047|FG001|Overall Study|Physician Decision|0|||
23829791|NCT02328014|66756048|FG002|Overall Study|Physician Decision|0|||
23829792|NCT02328014|66756049|FG003|Overall Study|Physician Decision|1|||
23829793|NCT02328014|66756046|FG000|Overall Study|Disease Progression|1|||
23829794|NCT02328014|66756047|FG001|Overall Study|Disease Progression|0|||
23829795|NCT02328014|66756048|FG002|Overall Study|Disease Progression|1|||
23829796|NCT02328014|66756049|FG003|Overall Study|Disease Progression|3|||
23829797|NCT02328014|66756046|FG000|Overall Study|Study Terminated by Sponsor|4|||
23829798|NCT02328014|66756047|FG001|Overall Study|Study Terminated by Sponsor|1|||
23829799|NCT02328014|66756048|FG002|Overall Study|Study Terminated by Sponsor|1|||
23829800|NCT02328014|66756049|FG003|Overall Study|Study Terminated by Sponsor|0|||
23829801|NCT02328014|66756046|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
23829802|NCT02328014|66756047|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
23829803|NCT02328014|66756048|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
23829804|NCT02328014|66756049|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
23829805|NCT02328014|66756046|FG000|Overall Study|Withdrawal by Subject|0|||
23829806|NCT02328014|66756047|FG001|Overall Study|Withdrawal by Subject|0|||
23829807|NCT02328014|66756048|FG002|Overall Study|Withdrawal by Subject|0|||
23829808|NCT02328014|66756049|FG003|Overall Study|Withdrawal by Subject|1|||
23829809|NCT02747108|66756061|FG000|Overall Study|Death|2|||
23829810|NCT02747108|66756062|FG001|Overall Study|Death|2|||
23829811|NCT02747108|66756061|FG000|Overall Study|Withdrawal by Subject|1|||
23829812|NCT02747108|66756062|FG001|Overall Study|Withdrawal by Subject|0|||
23829813|NCT02747108|66756061|FG000|Overall Study|Protocol Violation|2|||
23829814|NCT02747108|66756062|FG001|Overall Study|Protocol Violation|0|||
23829815|NCT01482312|66756068|FG000|Period 1, 90 Minutes of Wear|Other|1|||
23829816|NCT01482312|66756069|FG001|Period 1, 90 Minutes of Wear|Other|0|||
23829817|NCT01482312|66756070|FG002|Period 1, 90 Minutes of Wear|Other|0|||
23829818|NCT01482312|66756068|FG000|Period 2, 90 Minutes of Wear|Other|1|||
23630211|NCT01165177|66032121|FG001|Overall Study|Protocol Violation|21|||
23630212|NCT01165177|66032120|FG000|Overall Study|Non-serious adverse event|30|||
23630213|NCT01165177|66032121|FG001|Overall Study|Non-serious adverse event|18|||
23630214|NCT01165177|66032120|FG000|Overall Study|Other unspecified reasons|47|||
23630215|NCT01165177|66032121|FG001|Overall Study|Other unspecified reasons|35|||
23630216|NCT01165177|66032120|FG000|Overall Study|Suspected HZ episode|0|||
23630217|NCT01165177|66032121|FG001|Overall Study|Suspected HZ episode|2|||
23630218|NCT01165177|66032120|FG000|Overall Study|Lost to Follow-up|183|||
23630219|NCT01165177|66032121|FG001|Overall Study|Lost to Follow-up|194|||
23630220|NCT01165177|66032120|FG000|Overall Study|Migrated/ moved from study area|48|||
23630221|NCT01165177|66032121|FG001|Overall Study|Migrated/ moved from study area|43|||
23630222|NCT00935532|66032122|FG000|Overall Study|Adverse Event|11|||
23630223|NCT00935532|66032123|FG001|Overall Study|Adverse Event|6|||
23630224|NCT00935532|66032122|FG000|Overall Study|Death|1|||
23630225|NCT00935532|66032123|FG001|Overall Study|Death|0|||
23630226|NCT00935532|66032122|FG000|Overall Study|Lost to Follow-up|1|||
23630227|NCT00935532|66032123|FG001|Overall Study|Lost to Follow-up|0|||
23630228|NCT00935532|66032122|FG000|Overall Study|Physician Decision|1|||
23630229|NCT00935532|66032123|FG001|Overall Study|Physician Decision|2|||
23630230|NCT00935532|66032122|FG000|Overall Study|Protocol Violation|2|||
23630231|NCT00935532|66032123|FG001|Overall Study|Protocol Violation|1|||
23630232|NCT00935532|66032122|FG000|Overall Study|Subject Decision|2|||
23630233|NCT00935532|66032123|FG001|Overall Study|Subject Decision|1|||
23630234|NCT00935532|66032122|FG000|Overall Study|Sponsor Decision|0|||
23630235|NCT00935532|66032123|FG001|Overall Study|Sponsor Decision|1|||
23630236|NCT00935532|66032122|FG000|Overall Study|Loss Glucose Control|4|||
23630237|NCT00935532|66032123|FG001|Overall Study|Loss Glucose Control|0|||
23630238|NCT00401258|66032124|FG000|Overall Study|Adverse Event|7|||
23630239|NCT01896557|66032126|FG000|Clopidogrel Alone|Adverse Event|1|||
23630240|NCT01896557|66032127|FG001|Clopidogrel Alone|Adverse Event|0|||
23630241|NCT01896557|66032126|FG000|Clopidogrel + GI Protector|low adherence|1|||
23630242|NCT01896557|66032127|FG001|Clopidogrel + GI Protector|low adherence|1|||
23630243|NCT01896557|66032126|FG000|Clopidogrel + GI Protector|Reading error|1|||
23630244|NCT01896557|66032127|FG001|Clopidogrel + GI Protector|Reading error|3|||
23630245|NCT02552147|66032128|FG000|First Intervention (7 Days)|Protocol Violation|1|||
23630246|NCT02552147|66032129|FG001|First Intervention (7 Days)|Protocol Violation|0|||
23630247|NCT02552147|66032128|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
23630248|NCT02552147|66032129|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
23630249|NCT01081886|66032136|FG000|Overall Study|Study termination|11|||
23630250|NCT01081886|66032137|FG001|Overall Study|Study termination|13|||
23630251|NCT00575042|66032138|FG000|Overall Study|Adverse Event|2|||
23630252|NCT00575042|66032138|FG000|Overall Study|Lost to Follow-up|1|||
23630253|NCT02388347|66032139|FG000|Overall Study|Withdrawal by Subject|0|||
23630254|NCT02388347|66032140|FG001|Overall Study|Withdrawal by Subject|0|||
23630255|NCT02388347|66032141|FG002|Overall Study|Withdrawal by Subject|1|||
23630256|NCT02388347|66032142|FG003|Overall Study|Withdrawal by Subject|0|||
23630257|NCT02388347|66032143|FG004|Overall Study|Withdrawal by Subject|0|||
23630258|NCT01289210|66032144|FG000|Overall Study|Adverse Event|1|||
23630259|NCT02493946|66032145|FG000|DB Period|Withdrawal by Subject|8|||
23630260|NCT02493946|66032146|FG001|DB Period|Withdrawal by Subject|5|||
23630261|NCT02493946|66032147|FG002|DB Period|Withdrawal by Subject|0|||
23630262|NCT02493946|66032145|FG000|Open Label Period|Withdrawal by Subject|0|||
23630263|NCT02493946|66032146|FG001|Open Label Period|Withdrawal by Subject|0|||
23630264|NCT02493946|66032147|FG002|Open Label Period|Withdrawal by Subject|74|||
23630265|NCT02493946|66032145|FG000|Open Label Period|Adverse Event|0|||
23630266|NCT02493946|66032146|FG001|Open Label Period|Adverse Event|0|||
23630267|NCT02493946|66032147|FG002|Open Label Period|Adverse Event|4|||
23630268|NCT02493946|66032145|FG000|Open Label Period|Lost to Follow-up|0|||
23630269|NCT02493946|66032146|FG001|Open Label Period|Lost to Follow-up|0|||
23630270|NCT02493946|66032147|FG002|Open Label Period|Lost to Follow-up|1|||
23767332|NCT00598559|66524949|FG002|Overall Study|Withdrawal by Subject|0|||
23767333|NCT00598559|66524947|FG000|Overall Study|Protocol Non-compliance|1|||
23767334|NCT00598559|66524948|FG001|Overall Study|Protocol Non-compliance|0|||
23767335|NCT00598559|66524949|FG002|Overall Study|Protocol Non-compliance|0|||
23767336|NCT00598559|66524947|FG000|Overall Study|Early discharge from hospital|9|||
23630271|NCT02493946|66032145|FG000|Open Label Period|Investigator decision, non-compliance|0|||
23630272|NCT02493946|66032146|FG001|Open Label Period|Investigator decision, non-compliance|0|||
23630273|NCT02493946|66032147|FG002|Open Label Period|Investigator decision, non-compliance|2|||
23630274|NCT02493946|66032145|FG000|Open Label Period|Investigator decision, non-availability|0|||
23630275|NCT02493946|66032146|FG001|Open Label Period|Investigator decision, non-availability|0|||
23630276|NCT02493946|66032147|FG002|Open Label Period|Investigator decision, non-availability|1|||
23630277|NCT02493946|66032145|FG000|Open Label Period|Pregnancy|0|||
23630278|NCT02493946|66032146|FG001|Open Label Period|Pregnancy|0|||
23630279|NCT02493946|66032147|FG002|Open Label Period|Pregnancy|3|||
23630280|NCT02493946|66032145|FG000|Open Label Period|Site error|0|||
23630281|NCT02493946|66032146|FG001|Open Label Period|Site error|0|||
23446169|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
23446170|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
23446171|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
23446172|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
23446173|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
23446174|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
23446175|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
23446176|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
23446177|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
23446178|NCT00550407|65373868|FG000|26-Week Randomized Phase|Adverse Event|0|||
23446179|NCT00550407|65373869|FG001|26-Week Randomized Phase|Adverse Event|5|||
23446180|NCT00550407|65373870|FG002|26-Week Randomized Phase|Adverse Event|2|||
23446181|NCT00550407|65373868|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
23446182|NCT00550407|65373869|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
23446183|NCT00550407|65373870|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
23446184|NCT00550407|65373868|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
23446185|NCT00550407|65373869|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
23446186|NCT00550407|65373870|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
23446187|NCT00550407|65373868|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
23446188|NCT00550407|65373869|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
23446189|NCT00550407|65373870|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
23767337|NCT00598559|66524948|FG001|Overall Study|Early discharge from hospital|12|||
23767338|NCT00598559|66524949|FG002|Overall Study|Early discharge from hospital|3|||
23767339|NCT00598559|66524947|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
23767340|NCT00598559|66524948|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
23446190|NCT04137731|65373871|FG000|Overall Study|Surgery Cancellation|1|||
23446191|NCT04137731|65373872|FG001|Overall Study|Surgery Cancellation|2|||
23446192|NCT04137731|65373871|FG000|Overall Study|Withdrawal by Subject|2|||
23446193|NCT04137731|65373872|FG001|Overall Study|Withdrawal by Subject|0|||
23446194|NCT04137731|65373871|FG000|Overall Study|Protocol Violation|0|||
23446195|NCT04137731|65373872|FG001|Overall Study|Protocol Violation|1|||
23446196|NCT00398567|65373879|FG000|Overall Study|Disease Progression|3|||
23446197|NCT00398567|65373880|FG001|Overall Study|Disease Progression|4|||
23446198|NCT00398567|65373881|FG002|Overall Study|Disease Progression|27|||
23446199|NCT00398567|65373879|FG000|Overall Study|Withdrawal by Subject|1|||
23446200|NCT00398567|65373880|FG001|Overall Study|Withdrawal by Subject|0|||
23446201|NCT00398567|65373881|FG002|Overall Study|Withdrawal by Subject|4|||
23446202|NCT00398567|65373879|FG000|Overall Study|Adverse Event|0|||
23446203|NCT00398567|65373880|FG001|Overall Study|Adverse Event|0|||
23630282|NCT02493946|66032147|FG002|Open Label Period|Site error|1|||
23767341|NCT00598559|66524949|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
23767342|NCT01992107|66524950|FG000|Overall Study|Administrative reasons|2|||
23767343|NCT01992107|66524951|FG001|Overall Study|Administrative reasons|0|||
23446204|NCT00398567|65373881|FG002|Overall Study|Adverse Event|2|||
23446205|NCT00398567|65373879|FG000|Overall Study|Protocol Violation|0|||
23446206|NCT00398567|65373880|FG001|Overall Study|Protocol Violation|0|||
23446207|NCT00398567|65373881|FG002|Overall Study|Protocol Violation|1|||
23630283|NCT01174264|66032151|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
23767344|NCT01992107|66524952|FG002|Overall Study|Administrative reasons|0|||
23767345|NCT01992107|66524950|FG000|Overall Study|Adverse Event|0|||
23767346|NCT01992107|66524951|FG001|Overall Study|Adverse Event|1|||
23630284|NCT01174264|66032152|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
23630285|NCT01174264|66032153|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
23630286|NCT01174264|66032151|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
23630287|NCT01174264|66032152|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
23630288|NCT01174264|66032153|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
23630289|NCT01174264|66032151|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
23630290|NCT01174264|66032152|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
23630291|NCT01174264|66032153|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
23630292|NCT05262751|66032154|FG000|Washout Period 2|Adverse Event|1|||
23630293|NCT05262751|66032155|FG001|Washout Period 2|Adverse Event|0|||
23630294|NCT05262751|66032156|FG002|Washout Period 2|Adverse Event|0|||
23630295|NCT05262751|66032157|FG003|Washout Period 2|Adverse Event|0|||
23767347|NCT01992107|66524952|FG002|Overall Study|Adverse Event|0|||
23767348|NCT01992107|66524950|FG000|Overall Study|Lost to Follow-up|46|||
23767349|NCT01992107|66524951|FG001|Overall Study|Lost to Follow-up|22|||
23767350|NCT01992107|66524952|FG002|Overall Study|Lost to Follow-up|26|||
23767351|NCT01992107|66524950|FG000|Overall Study|noncompliance and were unavailable|7|||
23767352|NCT01992107|66524951|FG001|Overall Study|noncompliance and were unavailable|3|||
23446208|NCT01016600|65373886|FG000|Overall Study|Did not start treatment|1|||
23446209|NCT01016600|65373887|FG001|Overall Study|Did not start treatment|0|||
23767353|NCT01992107|66524952|FG002|Overall Study|noncompliance and were unavailable|2|||
23767354|NCT01992107|66524950|FG000|Overall Study|Withdrawal by Subject|13|||
23767355|NCT01992107|66524951|FG001|Overall Study|Withdrawal by Subject|7|||
23767356|NCT01992107|66524952|FG002|Overall Study|Withdrawal by Subject|8|||
23767357|NCT01405820|66524953|FG000|Randomized Treatment Period|Adverse Event|3|||
23767358|NCT01405820|66524954|FG001|Randomized Treatment Period|Adverse Event|3|||
23767359|NCT01405820|66524955|FG002|Randomized Treatment Period|Adverse Event|3|||
23767360|NCT01405820|66524956|FG003|Randomized Treatment Period|Adverse Event|0|||
23767361|NCT01405820|66524957|FG004|Randomized Treatment Period|Adverse Event|2|||
23767362|NCT01405820|66524958|FG005|Randomized Treatment Period|Adverse Event|1|||
23767363|NCT01405820|66524953|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
23767364|NCT01405820|66524954|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
23767365|NCT01405820|66524955|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
23767366|NCT01405820|66524956|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
23767367|NCT01405820|66524957|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
23767368|NCT01405820|66524958|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
23767369|NCT01405820|66524953|FG000|Randomized Treatment Period|Other|2|||
23767370|NCT01405820|66524954|FG001|Randomized Treatment Period|Other|2|||
23767371|NCT01405820|66524955|FG002|Randomized Treatment Period|Other|1|||
23767372|NCT01405820|66524956|FG003|Randomized Treatment Period|Other|1|||
23446210|NCT01016600|65373888|FG002|Overall Study|Did not start treatment|0|||
23446211|NCT01016600|65373889|FG003|Overall Study|Did not start treatment|0|||
23446212|NCT01219985|65373895|FG000|Overall Study|Physician Decision|20|||
23446213|NCT03826186|65373896|FG000|Overall Study|Protocol Violation|2|||
23446214|NCT03826186|65373897|FG001|Overall Study|Protocol Violation|0|||
23630296|NCT05262751|66032158|FG004|Washout Period 2|Adverse Event|0|||
23630297|NCT05262751|66032159|FG005|Washout Period 2|Adverse Event|0|||
23767373|NCT01405820|66524957|FG004|Randomized Treatment Period|Other|0|||
23767374|NCT01405820|66524958|FG005|Randomized Treatment Period|Other|0|||
23767375|NCT01405820|66524953|FG000|Randomized Treatment Period|Physician Decision|0|||
23446215|NCT03826186|65373896|FG000|Overall Study|Withdrawal by Subject|1|||
23767376|NCT01405820|66524954|FG001|Randomized Treatment Period|Physician Decision|2|||
23767377|NCT01405820|66524955|FG002|Randomized Treatment Period|Physician Decision|1|||
23767378|NCT01405820|66524956|FG003|Randomized Treatment Period|Physician Decision|0|||
23446216|NCT03826186|65373897|FG001|Overall Study|Withdrawal by Subject|0|||
23446217|NCT03250182|65373898|FG000|Overall Study|Withdrawal by Subject|1|||
23446218|NCT00239928|65373902|FG000|Overall Study|Lack of Efficacy|1|||
23446219|NCT00239928|65373902|FG000|Overall Study|Adverse Event|4|||
23446220|NCT00239928|65373902|FG000|Overall Study|Not need to continue study|3|||
23446221|NCT00239928|65373902|FG000|Overall Study|Withdrawal by Subject|2|||
23568455|NCT02875834|65809840|FG003|Open-label Phase|Withdrawal by Subject|0|||
23630298|NCT05262751|66032154|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
23568456|NCT02875834|65809837|FG000|Open-label Phase|(Not collected)|4|||
23568457|NCT02875834|65809838|FG001|Open-label Phase|(Not collected)|0|||
23568458|NCT02875834|65809839|FG002|Open-label Phase|(Not collected)|0|||
23568459|NCT02875834|65809840|FG003|Open-label Phase|(Not collected)|0|||
23767379|NCT01405820|66524957|FG004|Randomized Treatment Period|Physician Decision|0|||
23767380|NCT01405820|66524958|FG005|Randomized Treatment Period|Physician Decision|0|||
23767381|NCT01405820|66524953|FG000|Randomized Treatment Period|Rescue|0|||
23767382|NCT01405820|66524954|FG001|Randomized Treatment Period|Rescue|1|||
23767383|NCT01405820|66524955|FG002|Randomized Treatment Period|Rescue|13|||
23767384|NCT01405820|66524956|FG003|Randomized Treatment Period|Rescue|10|||
23767385|NCT01405820|66524957|FG004|Randomized Treatment Period|Rescue|8|||
23767386|NCT01405820|66524958|FG005|Randomized Treatment Period|Rescue|8|||
23767387|NCT01405820|66524953|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
23767388|NCT01405820|66524954|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
23767389|NCT01405820|66524955|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
23630299|NCT05262751|66032155|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
23630300|NCT05262751|66032156|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
23630301|NCT05262751|66032157|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
23630302|NCT05262751|66032158|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
23767390|NCT01405820|66524956|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
23767391|NCT01405820|66524957|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
23767392|NCT01405820|66524958|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
23767393|NCT01405820|66524953|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
23767394|NCT01405820|66524954|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
23767395|NCT01405820|66524955|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
23568460|NCT02875834|65809837|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
23630303|NCT05262751|66032159|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
23630304|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
23630305|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
23630306|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
23630307|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
23767396|NCT01405820|66524956|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
23446222|NCT02294058|65373903|FG000|Overall Study|Adverse Event|16|||
23568461|NCT02875834|65809838|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
23568462|NCT02875834|65809839|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
23568463|NCT02875834|65809840|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
23568464|NCT02875834|65809837|FG000|Randomized Treatment Phase|Protocol Violation|0|||
23568465|NCT02875834|65809838|FG001|Randomized Treatment Phase|Protocol Violation|2|||
23568466|NCT02875834|65809839|FG002|Randomized Treatment Phase|Protocol Violation|0|||
23630308|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
23767397|NCT01405820|66524957|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
23767398|NCT01405820|66524958|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
23630309|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
23446223|NCT02294058|65373904|FG001|Overall Study|Adverse Event|7|||
23446224|NCT02294058|65373905|FG002|Overall Study|Adverse Event|13|||
23446225|NCT02294058|65373903|FG000|Overall Study|Lack of Efficacy|3|||
23446226|NCT02294058|65373904|FG001|Overall Study|Lack of Efficacy|3|||
23446227|NCT02294058|65373905|FG002|Overall Study|Lack of Efficacy|0|||
23446228|NCT02294058|65373903|FG000|Overall Study|Lost to Follow-up|1|||
23446229|NCT02294058|65373904|FG001|Overall Study|Lost to Follow-up|0|||
23630310|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
23630311|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
23446230|NCT02294058|65373905|FG002|Overall Study|Lost to Follow-up|2|||
23446231|NCT02294058|65373903|FG000|Overall Study|Withdrawal by Subject|10|||
23446232|NCT02294058|65373904|FG001|Overall Study|Withdrawal by Subject|14|||
23446233|NCT02294058|65373905|FG002|Overall Study|Withdrawal by Subject|13|||
23446234|NCT02294058|65373903|FG000|Overall Study|Physician Decision|2|||
23446235|NCT02294058|65373904|FG001|Overall Study|Physician Decision|1|||
23446236|NCT02294058|65373905|FG002|Overall Study|Physician Decision|0|||
23446237|NCT02294058|65373903|FG000|Overall Study|Miscellaneous|4|||
23446238|NCT02294058|65373904|FG001|Overall Study|Miscellaneous|1|||
23446239|NCT02294058|65373905|FG002|Overall Study|Miscellaneous|1|||
23446240|NCT02596230|65373906|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
23446241|NCT02596230|65373907|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
23446242|NCT02596230|65373908|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
23446243|NCT02596230|65373909|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
23446244|NCT02596230|65373910|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
23446245|NCT02596230|65373906|FG000|Objective 2, One Year|Lost to Follow-up|0|||
23446246|NCT02596230|65373907|FG001|Objective 2, One Year|Lost to Follow-up|41|||
23446247|NCT02596230|65373908|FG002|Objective 2, One Year|Lost to Follow-up|41|||
23446248|NCT02596230|65373909|FG003|Objective 2, One Year|Lost to Follow-up|32|||
23446249|NCT02596230|65373910|FG004|Objective 2, One Year|Lost to Follow-up|46|||
23446250|NCT02596230|65373906|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
23446251|NCT02596230|65373907|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
23446252|NCT02596230|65373908|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
23446253|NCT02596230|65373909|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
23446254|NCT02596230|65373910|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
23446255|NCT02596230|65373906|FG000|Objective 2, One Year|Adverse drug reaction|0|||
23446256|NCT02596230|65373907|FG001|Objective 2, One Year|Adverse drug reaction|1|||
23446257|NCT02596230|65373908|FG002|Objective 2, One Year|Adverse drug reaction|0|||
23446258|NCT02596230|65373909|FG003|Objective 2, One Year|Adverse drug reaction|0|||
23446259|NCT02596230|65373910|FG004|Objective 2, One Year|Adverse drug reaction|0|||
23630312|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
23630313|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
23630314|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
23630315|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
23767399|NCT01405820|66524953|FG000|Randomized Treatment Period|Death|0|||
23446260|NCT02596230|65373906|FG000|Objective 2, One Year|Death|0|||
23446261|NCT02596230|65373907|FG001|Objective 2, One Year|Death|12|||
23767400|NCT01405820|66524954|FG001|Randomized Treatment Period|Death|0|||
23446262|NCT02596230|65373908|FG002|Objective 2, One Year|Death|41|||
23767401|NCT01405820|66524955|FG002|Randomized Treatment Period|Death|0|||
23767402|NCT01405820|66524956|FG003|Randomized Treatment Period|Death|1|||
23767403|NCT01405820|66524957|FG004|Randomized Treatment Period|Death|0|||
23767404|NCT01405820|66524958|FG005|Randomized Treatment Period|Death|0|||
23767405|NCT01405820|66524953|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23767406|NCT01405820|66524954|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23767407|NCT01405820|66524955|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23446263|NCT02596230|65373909|FG003|Objective 2, One Year|Death|21|||
23446264|NCT02596230|65373910|FG004|Objective 2, One Year|Death|30|||
23446265|NCT02596230|65373906|FG000|Objective 2, One Year|Other|0|||
23446266|NCT02596230|65373907|FG001|Objective 2, One Year|Other|3|||
23446267|NCT02596230|65373908|FG002|Objective 2, One Year|Other|2|||
23446268|NCT02596230|65373909|FG003|Objective 2, One Year|Other|0|||
23446269|NCT02596230|65373910|FG004|Objective 2, One Year|Other|0|||
23446270|NCT03361293|65373913|FG000|Overall Study|Lost to Follow-up|0|||
23446271|NCT03361293|65373914|FG001|Overall Study|Lost to Follow-up|2|||
23446272|NCT03361293|65373913|FG000|Overall Study|Withdrawal by Subject|1|||
23446273|NCT03361293|65373914|FG001|Overall Study|Withdrawal by Subject|3|||
23446274|NCT00837213|65373917|FG000|Overall Study|Lost to Follow-up|3|||
23446275|NCT00837213|65373918|FG001|Overall Study|Lost to Follow-up|2|||
23446276|NCT00837213|65373917|FG000|Overall Study|Withdrawal by Subject|2|||
23446277|NCT00837213|65373918|FG001|Overall Study|Withdrawal by Subject|2|||
23446278|NCT00837213|65373917|FG000|Overall Study|not stated|1|||
23446279|NCT00837213|65373918|FG001|Overall Study|not stated|1|||
23446280|NCT04538417|65373920|FG000|Overall Study|Withdrawal by Subject|2|||
23446281|NCT03948334|65373930|FG000|Overall Study|Adverse Event|1|||
23446282|NCT03948334|65373931|FG001|Overall Study|Adverse Event|4|||
23446283|NCT03948334|65373930|FG000|Overall Study|Lack of Efficacy|2|||
23446284|NCT03948334|65373931|FG001|Overall Study|Lack of Efficacy|0|||
23446285|NCT03948334|65373930|FG000|Overall Study|Lost to Follow-up|1|||
23446286|NCT03948334|65373931|FG001|Overall Study|Lost to Follow-up|0|||
23446287|NCT03948334|65373930|FG000|Overall Study|Physician Decision|1|||
23446288|NCT03948334|65373931|FG001|Overall Study|Physician Decision|0|||
23446289|NCT03948334|65373930|FG000|Overall Study|Pregnancy|0|||
23446290|NCT03948334|65373931|FG001|Overall Study|Pregnancy|1|||
23446291|NCT03948334|65373930|FG000|Overall Study|Protocol Deviation|1|||
23446292|NCT03948334|65373931|FG001|Overall Study|Protocol Deviation|0|||
23446293|NCT03948334|65373930|FG000|Overall Study|Study terminated by Sponsor|50|||
23446294|NCT03948334|65373931|FG001|Overall Study|Study terminated by Sponsor|51|||
23446295|NCT03948334|65373930|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
23446296|NCT03948334|65373931|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
23446297|NCT01292187|65373932|FG000|Overall Study|Adverse Event|10|||
23446298|NCT01292187|65373933|FG001|Overall Study|Adverse Event|5|||
23446299|NCT01292187|65373932|FG000|Overall Study|Withdrawal by Subject|6|||
23446300|NCT01292187|65373933|FG001|Overall Study|Withdrawal by Subject|5|||
23446301|NCT01292187|65373932|FG000|Overall Study|All other reasons|1|||
23446302|NCT01292187|65373933|FG001|Overall Study|All other reasons|3|||
23446303|NCT04566601|65373936|FG000|Overall Study|Other than listed|13|||
23446304|NCT04566601|65373937|FG001|Overall Study|Other than listed|4|||
23446305|NCT04566601|65373938|FG002|Overall Study|Other than listed|2|||
23568467|NCT02875834|65809840|FG003|Randomized Treatment Phase|Protocol Violation|0|||
23568468|NCT02875834|65809837|FG000|Randomized Treatment Phase|(Not collected)|0|||
23446306|NCT04566601|65373939|FG003|Overall Study|Other than listed|1|||
23446307|NCT04566601|65373940|FG004|Overall Study|Other than listed|4|||
23446308|NCT04566601|65373936|FG000|Overall Study|Protocol deviation|3|||
23767408|NCT01405820|66524956|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
23767409|NCT01405820|66524957|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23446309|NCT04566601|65373937|FG001|Overall Study|Protocol deviation|0|||
23446310|NCT04566601|65373938|FG002|Overall Study|Protocol deviation|1|||
23446311|NCT04566601|65373939|FG003|Overall Study|Protocol deviation|1|||
23446312|NCT04566601|65373940|FG004|Overall Study|Protocol deviation|1|||
23446313|NCT04566601|65373936|FG000|Overall Study|Technical problems|0|||
23446314|NCT04566601|65373937|FG001|Overall Study|Technical problems|0|||
23446315|NCT04566601|65373938|FG002|Overall Study|Technical problems|1|||
23568469|NCT02875834|65809838|FG001|Randomized Treatment Phase|(Not collected)|9|||
23446316|NCT04566601|65373939|FG003|Overall Study|Technical problems|0|||
23446317|NCT04566601|65373940|FG004|Overall Study|Technical problems|0|||
23446318|NCT04566601|65373936|FG000|Overall Study|No reason available|3|||
23446319|NCT04566601|65373937|FG001|Overall Study|No reason available|2|||
23446320|NCT04566601|65373938|FG002|Overall Study|No reason available|7|||
23446321|NCT04566601|65373939|FG003|Overall Study|No reason available|1|||
23446322|NCT04566601|65373940|FG004|Overall Study|No reason available|5|||
23446323|NCT04566601|65373936|FG000|Overall Study|Burden of study procedures|3|||
23446324|NCT04566601|65373937|FG001|Overall Study|Burden of study procedures|0|||
23446325|NCT04566601|65373938|FG002|Overall Study|Burden of study procedures|0|||
23446326|NCT04566601|65373939|FG003|Overall Study|Burden of study procedures|3|||
23446327|NCT04566601|65373940|FG004|Overall Study|Burden of study procedures|1|||
23446328|NCT04566601|65373936|FG000|Overall Study|Change of residence|2|||
23446329|NCT04566601|65373937|FG001|Overall Study|Change of residence|2|||
23446330|NCT04566601|65373938|FG002|Overall Study|Change of residence|0|||
23446331|NCT04566601|65373939|FG003|Overall Study|Change of residence|1|||
23446332|NCT04566601|65373940|FG004|Overall Study|Change of residence|2|||
23446333|NCT04566601|65373936|FG000|Overall Study|Perceived lack of efficacy|2|||
23446334|NCT04566601|65373937|FG001|Overall Study|Perceived lack of efficacy|0|||
23446335|NCT04566601|65373938|FG002|Overall Study|Perceived lack of efficacy|1|||
23446336|NCT04566601|65373939|FG003|Overall Study|Perceived lack of efficacy|1|||
23446337|NCT04566601|65373940|FG004|Overall Study|Perceived lack of efficacy|2|||
23446338|NCT04566601|65373936|FG000|Overall Study|Adverse Event|7|||
23446339|NCT04566601|65373937|FG001|Overall Study|Adverse Event|4|||
23446340|NCT04566601|65373938|FG002|Overall Study|Adverse Event|6|||
23446341|NCT04566601|65373939|FG003|Overall Study|Adverse Event|5|||
23446342|NCT04566601|65373940|FG004|Overall Study|Adverse Event|12|||
23446343|NCT01217463|65373941|FG000|Overall Study|Adverse Event|8|||
23446344|NCT01217463|65373942|FG001|Overall Study|Adverse Event|5|||
23446345|NCT01217463|65373941|FG000|Overall Study|Physician Decision|0|||
23446346|NCT01217463|65373942|FG001|Overall Study|Physician Decision|1|||
23446347|NCT01217463|65373941|FG000|Overall Study|Withdrawal by Subject|3|||
23446348|NCT01217463|65373942|FG001|Overall Study|Withdrawal by Subject|0|||
23446349|NCT01217463|65373941|FG000|Overall Study|Surgery on the Target Limb|0|||
23446350|NCT01217463|65373942|FG001|Overall Study|Surgery on the Target Limb|1|||
23446351|NCT01217463|65373941|FG000|Overall Study|Patient Non-compliant|1|||
23446352|NCT01217463|65373942|FG001|Overall Study|Patient Non-compliant|0|||
23446353|NCT01217463|65373941|FG000|Overall Study|Other|1|||
23446354|NCT01217463|65373942|FG001|Overall Study|Other|1|||
23446355|NCT00824473|65373953|FG000|Overall Study|Adverse Event|4|||
23446356|NCT00824473|65373954|FG001|Overall Study|Adverse Event|5|||
23446357|NCT00824473|65373953|FG000|Overall Study|Lack of Efficacy|2|||
23446358|NCT00824473|65373954|FG001|Overall Study|Lack of Efficacy|2|||
23446359|NCT00824473|65373953|FG000|Overall Study|Protocol Violation|2|||
23446360|NCT00824473|65373954|FG001|Overall Study|Protocol Violation|0|||
23446361|NCT00824473|65373953|FG000|Overall Study|Non-Compliance|4|||
23446362|NCT00824473|65373954|FG001|Overall Study|Non-Compliance|2|||
23446363|NCT00824473|65373953|FG000|Overall Study|Withdrawal by Subject|2|||
23446364|NCT00824473|65373954|FG001|Overall Study|Withdrawal by Subject|3|||
23446365|NCT00824473|65373953|FG000|Overall Study|Other|1|||
23446366|NCT00824473|65373954|FG001|Overall Study|Other|1|||
23446367|NCT02003534|65373955|FG000|Overall Study|Lost to Follow-up|47|||
23446368|NCT01031979|65373956|FG000|Overall Study|Lost to Follow-up|5|||
23446369|NCT01031979|65373957|FG001|Overall Study|Lost to Follow-up|4|||
23446370|NCT04079816|65373960|FG000|Overall Study|Request of Subject|2|||
23446371|NCT04079816|65373960|FG000|Overall Study|Unable to draw samples|1|||
23829819|NCT01482312|66756069|FG001|Period 2, 90 Minutes of Wear|Other|0|||
23829820|NCT01482312|66756070|FG002|Period 2, 90 Minutes of Wear|Other|0|||
23829821|NCT04650204|66756072|FG000|Overall Study|Study was Terminated|2|||
23829822|NCT04650204|66756073|FG001|Overall Study|Study was Terminated|1|||
23829823|NCT03642262|66756074|FG000|Period 1|Withdrawal by Subject|1|||
23446372|NCT03259087|65377615|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446373|NCT03259087|65377616|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446374|NCT03259087|65377617|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446375|NCT03259087|65377618|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446376|NCT03259087|65377619|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
23446377|NCT03259087|65377615|FG000|Period 2 of Part 2|Adverse Event|0|||
23829824|NCT03642262|66756075|FG001|Period 1|Withdrawal by Subject|1|||
23446378|NCT03259087|65377616|FG001|Period 2 of Part 2|Adverse Event|0|||
23446379|NCT03259087|65377617|FG002|Period 2 of Part 2|Adverse Event|0|||
23446380|NCT03259087|65377618|FG003|Period 2 of Part 2|Adverse Event|0|||
23446381|NCT03259087|65377619|FG004|Period 2 of Part 2|Adverse Event|1|||
23446382|NCT02678351|65377628|FG000|Overall Study|Withdrawal by Subject|1|||
23446383|NCT00191334|65377633|FG000|Overall Study|Adverse Event|4|||
23829825|NCT03642262|66756074|FG000|Period 1|Adverse Event|0|||
23446384|NCT00191334|65377633|FG000|Overall Study|Disease Progression or Relapse|8|||
23446385|NCT00191334|65377633|FG000|Overall Study|Physician Decision|1|||
23446386|NCT00191334|65377633|FG000|Overall Study|Withdrawal by Subject|4|||
23446387|NCT02330055|65377634|FG000|Overall Study|technical issues|2|||
23446388|NCT02330055|65377635|FG001|Overall Study|technical issues|0|||
23446389|NCT02330055|65377634|FG000|Overall Study|participant forgot to wear device|5|||
23446390|NCT02330055|65377635|FG001|Overall Study|participant forgot to wear device|5|||
23446391|NCT02330055|65377634|FG000|Overall Study|data for less than 60 minutes|3|||
23446392|NCT02330055|65377635|FG001|Overall Study|data for less than 60 minutes|3|||
23446393|NCT02330055|65377634|FG000|Overall Study|participant did not sleep|0|||
23446394|NCT02330055|65377635|FG001|Overall Study|participant did not sleep|1|||
23446395|NCT00191308|65377636|FG000|Overall Study|Adverse Event|1|||
23446396|NCT01691794|65377638|FG000|Overall Study|Poor/Non-Compliance|1|||
23446397|NCT01691794|65377639|FG001|Overall Study|Poor/Non-Compliance|4|||
23446398|NCT01691794|65377640|FG002|Overall Study|Poor/Non-Compliance|1|||
23446399|NCT01691794|65377638|FG000|Overall Study|Death|0|||
23446400|NCT01691794|65377639|FG001|Overall Study|Death|0|||
23446401|NCT01691794|65377640|FG002|Overall Study|Death|1|||
23446402|NCT01691794|65377638|FG000|Overall Study|Lack of Efficacy|0|||
23446403|NCT01691794|65377639|FG001|Overall Study|Lack of Efficacy|7|||
23446404|NCT01691794|65377640|FG002|Overall Study|Lack of Efficacy|1|||
23446405|NCT01691794|65377638|FG000|Overall Study|Participant request to discontinue|0|||
23446406|NCT01691794|65377639|FG001|Overall Study|Participant request to discontinue|1|||
23446407|NCT01691794|65377640|FG002|Overall Study|Participant request to discontinue|0|||
23446408|NCT01691794|65377638|FG000|Overall Study|Adverse Event|0|||
23446409|NCT01691794|65377639|FG001|Overall Study|Adverse Event|1|||
23446410|NCT01691794|65377640|FG002|Overall Study|Adverse Event|1|||
23446411|NCT01691794|65377638|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
23446412|NCT01691794|65377639|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
23568470|NCT02875834|65809839|FG002|Randomized Treatment Phase|(Not collected)|10|||
23568471|NCT02875834|65809840|FG003|Randomized Treatment Phase|(Not collected)|9|||
23630316|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
23630317|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
23630318|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
23630319|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
23630320|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
23630321|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
23630322|NCT00132678|66032160|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
23630323|NCT00132678|66032161|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
23446413|NCT01691794|65377640|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
23568472|NCT01992549|65809841|FG000|Overall Study|Lost to Follow-up|2|||
23568473|NCT01992549|65809841|FG000|Overall Study|Serious Adverse Event|1|||
23568474|NCT01992549|65809841|FG000|Overall Study|Product Switch to Extend Half Life|1|||
23568475|NCT01083641|65809847|FG000|Overall Study|Withdrawal by Subject|2|||
23568476|NCT04192630|65809851|FG000|Overall Study|Discontinued before surgery|2|||
23568477|NCT04192630|65809852|FG001|Overall Study|Discontinued before surgery|0|||
23568478|NCT04192630|65809851|FG000|Overall Study|Discontinued after surgery|5|||
23568479|NCT04192630|65809852|FG001|Overall Study|Discontinued after surgery|3|||
23568480|NCT02262260|65809854|FG000|Overall Study|Adverse Event|4|||
23568481|NCT02262260|65809855|FG001|Overall Study|Adverse Event|1|||
23568482|NCT02262260|65809854|FG000|Overall Study|Withdrawal of consent|4|||
23568483|NCT02262260|65809855|FG001|Overall Study|Withdrawal of consent|2|||
23568484|NCT02262260|65809854|FG000|Overall Study|Lost to Follow-up|1|||
23568485|NCT02262260|65809855|FG001|Overall Study|Lost to Follow-up|2|||
23568486|NCT02262260|65809854|FG000|Overall Study|Protocol deviation|2|||
23568487|NCT02262260|65809855|FG001|Overall Study|Protocol deviation|5|||
23568488|NCT01130883|65809858|FG000|Overall Study|Patient Noncompliance|6|||
23568489|NCT01130883|65809858|FG000|Overall Study|Reason Unknown|1|||
23568490|NCT01130883|65809858|FG000|Overall Study|Adverse Event|3|||
23568491|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
23568492|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
23568493|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
23568494|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
23568495|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
23568496|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
23568497|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
23630324|NCT00132678|66032162|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
23568498|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
23568499|NCT01863043|65809862|FG000|Overall Study|Death|6|||
23630325|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Death|2|||
23829826|NCT03642262|66756075|FG001|Period 1|Adverse Event|1|||
23568500|NCT01863043|65809863|FG001|Overall Study|Death|1|||
23568501|NCT01863043|65809862|FG000|Overall Study|Withdrawal by Subject|0|||
23446414|NCT01691794|65377638|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
23446415|NCT01691794|65377639|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
23446416|NCT01691794|65377640|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
23446417|NCT03980730|65377641|FG000|Overall Study|Study Terminated by Sponsor|0|||
23446418|NCT03980730|65377642|FG001|Overall Study|Study Terminated by Sponsor|3|||
23446419|NCT03980730|65377641|FG000|Overall Study|Adverse Event|2|||
23446420|NCT03980730|65377642|FG001|Overall Study|Adverse Event|0|||
23446421|NCT03980730|65377641|FG000|Overall Study|Sponsor Request|0|||
23446422|NCT03980730|65377642|FG001|Overall Study|Sponsor Request|1|||
23446423|NCT03040674|65377646|FG000|Overall Study|Lost to Follow-up|225|||
23446424|NCT03040674|65377646|FG000|Overall Study|Death|23|||
23446425|NCT02741245|65377647|FG000|Overall Study|Adverse Event|0|||
23446426|NCT02741245|65377648|FG001|Overall Study|Adverse Event|0|||
23446427|NCT02741245|65377649|FG002|Overall Study|Adverse Event|0|||
23446428|NCT02741245|65377650|FG003|Overall Study|Adverse Event|2|||
23446429|NCT02741245|65377651|FG004|Overall Study|Adverse Event|2|||
23446430|NCT02741245|65377647|FG000|Overall Study|Protocol Violation|0|||
23446431|NCT02741245|65377648|FG001|Overall Study|Protocol Violation|1|||
23446432|NCT02741245|65377649|FG002|Overall Study|Protocol Violation|0|||
23446433|NCT02741245|65377650|FG003|Overall Study|Protocol Violation|1|||
23446434|NCT02741245|65377651|FG004|Overall Study|Protocol Violation|0|||
23446435|NCT02741245|65377647|FG000|Overall Study|Withdrawal by Subject|0|||
23446436|NCT02741245|65377648|FG001|Overall Study|Withdrawal by Subject|0|||
23446437|NCT02741245|65377649|FG002|Overall Study|Withdrawal by Subject|0|||
23446438|NCT02741245|65377650|FG003|Overall Study|Withdrawal by Subject|1|||
23446439|NCT02741245|65377651|FG004|Overall Study|Withdrawal by Subject|0|||
23446440|NCT02611479|65377652|FG000|Baseline Enrollment|Exited study|13|||
23446441|NCT02611479|65377652|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
23446442|NCT02611479|65377652|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
23446443|NCT02611479|65377652|FG000|Data Cleaning|No baseline function or pain metrics|2|||
23446444|NCT03515824|65377654|FG000|Overall Study|Death|3|||
23446445|NCT03515824|65377655|FG001|Overall Study|Death|2|||
23446446|NCT03515824|65377656|FG002|Overall Study|Death|6|||
23446447|NCT03515824|65377657|FG003|Overall Study|Death|0|||
23446448|NCT03515824|65377654|FG000|Overall Study|Lost to Follow-up|0|||
23446449|NCT03515824|65377655|FG001|Overall Study|Lost to Follow-up|1|||
23446450|NCT03515824|65377656|FG002|Overall Study|Lost to Follow-up|1|||
23446451|NCT03515824|65377657|FG003|Overall Study|Lost to Follow-up|0|||
23446452|NCT03515824|65377654|FG000|Overall Study|Study terminated by sponsor|0|||
23446453|NCT03515824|65377655|FG001|Overall Study|Study terminated by sponsor|1|||
23446454|NCT03515824|65377656|FG002|Overall Study|Study terminated by sponsor|6|||
23446455|NCT03515824|65377657|FG003|Overall Study|Study terminated by sponsor|0|||
23446456|NCT03515824|65377654|FG000|Overall Study|Status not recorded|0|||
23446457|NCT03515824|65377655|FG001|Overall Study|Status not recorded|0|||
23446458|NCT03515824|65377656|FG002|Overall Study|Status not recorded|2|||
23446459|NCT03515824|65377657|FG003|Overall Study|Status not recorded|0|||
23446460|NCT02487095|65377658|FG000|Dose Expansion|Unable to scan/restage participant|0|||
23446461|NCT02487095|65377659|FG001|Dose Expansion|Unable to scan/restage participant|0|||
23446462|NCT02487095|65377660|FG002|Dose Expansion|Unable to scan/restage participant|0|||
23446463|NCT02487095|65377661|FG003|Dose Expansion|Unable to scan/restage participant|0|||
23568502|NCT01863043|65809863|FG001|Overall Study|Withdrawal by Subject|2|||
23568503|NCT01863043|65809862|FG000|Overall Study|Adverse Event|7|||
23568504|NCT01863043|65809863|FG001|Overall Study|Adverse Event|8|||
23568505|NCT01863043|65809862|FG000|Overall Study|exclusion criteria found after enrollment|0|||
23568506|NCT01863043|65809863|FG001|Overall Study|exclusion criteria found after enrollment|1|||
23568507|NCT01291225|65809865|FG000|Overall Study|Lost to Follow-up|85|||
23568508|NCT01291225|65809866|FG001|Overall Study|Lost to Follow-up|39|||
23568509|NCT04248465|65809871|FG000|Randomized-Controlled Period|Death|12|||
23568510|NCT04248465|65809872|FG001|Randomized-Controlled Period|Death|5|||
23568511|NCT04248465|65809871|FG000|Randomized-Controlled Period|Adverse Event|2|||
23568512|NCT04248465|65809872|FG001|Randomized-Controlled Period|Adverse Event|0|||
23568513|NCT04248465|65809871|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
23568514|NCT04248465|65809872|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
23568515|NCT04248465|65809871|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
23568516|NCT04248465|65809872|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
23568517|NCT04248465|65809871|FG000|Randomized-Controlled Period|Physician Decision|1|||
23446464|NCT02487095|65377662|FG004|Dose Expansion|Unable to scan/restage participant|1|||
23446465|NCT03078556|65377663|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446466|NCT03078556|65377664|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
23446467|NCT03078556|65377665|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446468|NCT03078556|65377666|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446469|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
23446470|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
23446471|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
23446472|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
23446473|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23446474|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
23446475|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23446476|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
23446477|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
23568518|NCT04248465|65809872|FG001|Randomized-Controlled Period|Physician Decision|1|||
23568519|NCT04248465|65809871|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
23568520|NCT04248465|65809872|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
23568521|NCT04248465|65809871|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
23568522|NCT04248465|65809872|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
23568523|NCT04248465|65809871|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23568524|NCT04248465|65809872|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
23568525|NCT02584855|65809873|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
23568526|NCT02584855|65809874|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23446478|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
23446479|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
23630326|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Death|0|||
23446480|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
23568527|NCT02584855|65809875|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23568528|NCT02584855|65809876|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23630327|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Death|0|||
23630328|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
23630329|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
23630330|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
23630331|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
23630332|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
23630333|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
23630334|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
23630335|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
23630336|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
23630337|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
23630338|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
23630339|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
23630340|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
23829827|NCT03866577|66756076|FG000|Overall Study|Protocol Violation|0|||
23568529|NCT02584855|65809877|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
23630341|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
23630342|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
23630343|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
23767410|NCT01405820|66524958|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23767411|NCT01405820|66524953|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
23767412|NCT01405820|66524954|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
23767413|NCT01405820|66524955|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
23767414|NCT01405820|66524956|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
23767415|NCT01405820|66524957|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
23767416|NCT01405820|66524958|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
23767417|NCT01405820|66524953|FG000|Open-Label Treatment Period|Other|1|||
23767418|NCT01405820|66524954|FG001|Open-Label Treatment Period|Other|1|||
23767419|NCT01405820|66524955|FG002|Open-Label Treatment Period|Other|1|||
23568530|NCT02584855|65809878|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
23568531|NCT02584855|65809873|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
23568532|NCT02584855|65809874|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568533|NCT02584855|65809875|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568534|NCT02584855|65809876|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568535|NCT02584855|65809877|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568536|NCT02584855|65809878|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568537|NCT02584855|65809873|FG000|Open-Label Treatment Period|Adverse Event|14|||
23568538|NCT02584855|65809874|FG001|Open-Label Treatment Period|Adverse Event|0|||
23568539|NCT02584855|65809875|FG002|Open-Label Treatment Period|Adverse Event|0|||
23568540|NCT02584855|65809876|FG003|Open-Label Treatment Period|Adverse Event|0|||
23568541|NCT02584855|65809877|FG004|Open-Label Treatment Period|Adverse Event|0|||
23568542|NCT02584855|65809878|FG005|Open-Label Treatment Period|Adverse Event|0|||
23568543|NCT02584855|65809873|FG000|Open-Label Treatment Period|Death|2|||
23568544|NCT02584855|65809874|FG001|Open-Label Treatment Period|Death|0|||
23568545|NCT02584855|65809875|FG002|Open-Label Treatment Period|Death|0|||
23568546|NCT02584855|65809876|FG003|Open-Label Treatment Period|Death|0|||
23568547|NCT02584855|65809877|FG004|Open-Label Treatment Period|Death|0|||
23630344|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
23767420|NCT01405820|66524956|FG003|Open-Label Treatment Period|Other|1|||
23767421|NCT01405820|66524957|FG004|Open-Label Treatment Period|Other|1|||
23767422|NCT01405820|66524958|FG005|Open-Label Treatment Period|Other|1|||
23767423|NCT01405820|66524953|FG000|Open-Label Treatment Period|Physician Decision|0|||
23767424|NCT01405820|66524954|FG001|Open-Label Treatment Period|Physician Decision|0|||
23568548|NCT02584855|65809878|FG005|Open-Label Treatment Period|Death|0|||
23568549|NCT02584855|65809873|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
23446481|NCT00265317|65377667|FG000|Lead-In|Objective progression or relapse|6|||
23446482|NCT00265317|65377668|FG001|Lead-In|Objective progression or relapse|11|||
23446483|NCT00265317|65377669|FG002|Lead-In|Objective progression or relapse|0|||
23446484|NCT00265317|65377670|FG003|Lead-In|Objective progression or relapse|0|||
23446485|NCT00265317|65377667|FG000|Lead-In|Adverse Event|2|||
23446486|NCT00265317|65377668|FG001|Lead-In|Adverse Event|1|||
23446487|NCT00265317|65377669|FG002|Lead-In|Adverse Event|0|||
23446488|NCT00265317|65377670|FG003|Lead-In|Adverse Event|0|||
23446489|NCT00265317|65377667|FG000|Lead-In|Death|3|||
23446490|NCT00265317|65377668|FG001|Lead-In|Death|5|||
23446491|NCT00265317|65377669|FG002|Lead-In|Death|0|||
23446492|NCT00265317|65377670|FG003|Lead-In|Death|0|||
23446493|NCT00265317|65377667|FG000|Lead-In|Withdrawal/other than adverse event|1|||
23446494|NCT00265317|65377668|FG001|Lead-In|Withdrawal/other than adverse event|0|||
23446495|NCT00265317|65377669|FG002|Lead-In|Withdrawal/other than adverse event|0|||
23446496|NCT00265317|65377670|FG003|Lead-In|Withdrawal/other than adverse event|0|||
23446497|NCT00265317|65377667|FG000|Phase 2|Objective progression or relapse|0|||
23446498|NCT00265317|65377668|FG001|Phase 2|Objective progression or relapse|0|||
23446499|NCT00265317|65377669|FG002|Phase 2|Objective progression or relapse|37|||
23446500|NCT00265317|65377670|FG003|Phase 2|Objective progression or relapse|38|||
23446501|NCT00265317|65377667|FG000|Phase 2|Global deterioration of health status|0|||
23446502|NCT00265317|65377668|FG001|Phase 2|Global deterioration of health status|0|||
23446503|NCT00265317|65377669|FG002|Phase 2|Global deterioration of health status|3|||
23446504|NCT00265317|65377670|FG003|Phase 2|Global deterioration of health status|0|||
23446505|NCT00265317|65377667|FG000|Phase 2|Adverse Event|0|||
23446506|NCT00265317|65377668|FG001|Phase 2|Adverse Event|0|||
23446507|NCT00265317|65377669|FG002|Phase 2|Adverse Event|7|||
23446508|NCT00265317|65377670|FG003|Phase 2|Adverse Event|5|||
23446509|NCT00265317|65377667|FG000|Phase 2|Death|0|||
23446510|NCT00265317|65377668|FG001|Phase 2|Death|0|||
23446511|NCT00265317|65377669|FG002|Phase 2|Death|12|||
23446512|NCT00265317|65377670|FG003|Phase 2|Death|15|||
23446513|NCT00265317|65377667|FG000|Phase 2|Protocol Violation|0|||
23446514|NCT00265317|65377668|FG001|Phase 2|Protocol Violation|0|||
23446515|NCT00265317|65377669|FG002|Phase 2|Protocol Violation|1|||
23446516|NCT00265317|65377670|FG003|Phase 2|Protocol Violation|4|||
23446517|NCT00265317|65377667|FG000|Phase 2|Lost to Follow-up|0|||
23446518|NCT00265317|65377668|FG001|Phase 2|Lost to Follow-up|0|||
23446519|NCT00265317|65377669|FG002|Phase 2|Lost to Follow-up|0|||
23446520|NCT00265317|65377670|FG003|Phase 2|Lost to Follow-up|1|||
23446521|NCT00265317|65377667|FG000|Phase 2|Withdrawal/other than adverse event|0|||
23446522|NCT00265317|65377668|FG001|Phase 2|Withdrawal/other than adverse event|0|||
23446523|NCT00265317|65377669|FG002|Phase 2|Withdrawal/other than adverse event|2|||
23446524|NCT00265317|65377670|FG003|Phase 2|Withdrawal/other than adverse event|1|||
23446525|NCT00265317|65377667|FG000|Phase 2|Study terminated by sponsor|0|||
23446526|NCT00265317|65377668|FG001|Phase 2|Study terminated by sponsor|0|||
23446527|NCT00265317|65377669|FG002|Phase 2|Study terminated by sponsor|1|||
23446528|NCT00265317|65377670|FG003|Phase 2|Study terminated by sponsor|0|||
23446529|NCT00265317|65377667|FG000|Phase 2|Other|0|||
23446530|NCT00265317|65377668|FG001|Phase 2|Other|0|||
23446531|NCT00265317|65377669|FG002|Phase 2|Other|1|||
23767425|NCT01405820|66524955|FG002|Open-Label Treatment Period|Physician Decision|1|||
23767426|NCT01405820|66524956|FG003|Open-Label Treatment Period|Physician Decision|2|||
23446532|NCT00265317|65377670|FG003|Phase 2|Other|1|||
23446533|NCT00475709|65377671|FG000|Overall Study|Did not meet eligibility criteria|8|||
23446534|NCT00475709|65377671|FG000|Overall Study|Death|41|||
23446535|NCT00475709|65377671|FG000|Overall Study|Device Explant|6|||
23446536|NCT00475709|65377671|FG000|Overall Study|Lost to Follow-up|21|||
23446537|NCT03088917|65377674|FG000|Overall Study|In care/cured elsewhere|15|||
23767427|NCT01405820|66524957|FG004|Open-Label Treatment Period|Physician Decision|1|||
23767428|NCT01405820|66524958|FG005|Open-Label Treatment Period|Physician Decision|0|||
23767429|NCT01405820|66524953|FG000|Open-Label Treatment Period|Adverse Event|0|||
23767430|NCT01405820|66524954|FG001|Open-Label Treatment Period|Adverse Event|0|||
23767431|NCT01405820|66524955|FG002|Open-Label Treatment Period|Adverse Event|0|||
23446538|NCT03088917|65377674|FG000|Overall Study|Refuse re-evaluation|13|||
23446539|NCT03088917|65377674|FG000|Overall Study|Contact not established|13|||
23446540|NCT03088917|65377674|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
23446541|NCT03088917|65377674|FG000|Overall Study|Moved outside study region|50|||
23446542|NCT03087513|65377675|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
23568550|NCT02584855|65809874|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23446543|NCT00894361|65377679|FG000|Overall Study|deaths and less than 2 years followup|24|||
23446544|NCT00894361|65377680|FG001|Overall Study|deaths and less than 2 years followup|64|||
23446545|NCT01449006|65377681|FG000|Overall Study|Lost to Follow-up|1|||
23446546|NCT01449006|65377682|FG001|Overall Study|Lost to Follow-up|0|||
23446547|NCT01449006|65377681|FG000|Overall Study|Withdrawal by Subject|1|||
23446548|NCT01449006|65377682|FG001|Overall Study|Withdrawal by Subject|0|||
23446549|NCT01449006|65377681|FG000|Overall Study|Protocol Violation|1|||
23446550|NCT01449006|65377682|FG001|Overall Study|Protocol Violation|0|||
23446551|NCT01544920|65377683|FG000|Overall Study|Adverse Event|0|||
23446552|NCT01544920|65377684|FG001|Overall Study|Adverse Event|3|||
23446553|NCT01544920|65377683|FG000|Overall Study|Death|0|||
23767432|NCT01405820|66524956|FG003|Open-Label Treatment Period|Adverse Event|1|||
23767433|NCT01405820|66524957|FG004|Open-Label Treatment Period|Adverse Event|0|||
23767434|NCT01405820|66524958|FG005|Open-Label Treatment Period|Adverse Event|0|||
23767435|NCT05085964|66524959|FG000|Overall Study|Premature termination of study|21|||
23767436|NCT05085964|66524960|FG001|Overall Study|Premature termination of study|0|||
23767437|NCT00182091|66524965|FG000|Overall Study|Withdrawal by Subject|1|||
23767438|NCT00182091|66524966|FG001|Overall Study|Withdrawal by Subject|0|||
23767439|NCT00182091|66524967|FG002|Overall Study|Withdrawal by Subject|0|||
23446554|NCT01544920|65377684|FG001|Overall Study|Death|1|||
23446555|NCT01544920|65377683|FG000|Overall Study|Lost to Follow-up|11|||
23446556|NCT01544920|65377684|FG001|Overall Study|Lost to Follow-up|12|||
23829828|NCT03866577|66756077|FG001|Overall Study|Protocol Violation|0|||
23767440|NCT00182091|66524968|FG003|Overall Study|Withdrawal by Subject|0|||
23767441|NCT02974114|66524970|FG000|Overall Study|Other (Not specified)|0|||
23767442|NCT02974114|66524971|FG001|Overall Study|Other (Not specified)|1|||
23767443|NCT02974114|66524972|FG002|Overall Study|Other (Not specified)|2|||
23767444|NCT04467697|66524974|FG000|Overall Study|Adverse Event|2|||
23767445|NCT04467697|66524974|FG000|Overall Study|Lost to Follow-up|6|||
23767446|NCT04467697|66524974|FG000|Overall Study|Withdrawal by Subject|9|||
23767447|NCT04467697|66524974|FG000|Overall Study|Protocol Violation|3|||
23767448|NCT02115256|66527635|FG000|Overall Study|Withdrawal by Subject|0|||
23767449|NCT02115256|66527636|FG001|Overall Study|Withdrawal by Subject|1|||
23767450|NCT01466686|66527637|FG000|Overall Study|Withdrawal by Subject|1|||
23767451|NCT03141177|66527638|FG000|Overall Study|Death|62|||
23829829|NCT03866577|66756078|FG002|Overall Study|Protocol Violation|0|||
23446557|NCT01544920|65377683|FG000|Overall Study|Protocol Violation|0|||
23446558|NCT01544920|65377684|FG001|Overall Study|Protocol Violation|2|||
23446559|NCT01544920|65377683|FG000|Overall Study|Physician Decision|4|||
23446560|NCT01544920|65377684|FG001|Overall Study|Physician Decision|1|||
23446561|NCT01544920|65377683|FG000|Overall Study|Withdrawal by Subject|4|||
23446562|NCT01544920|65377684|FG001|Overall Study|Withdrawal by Subject|4|||
23446563|NCT02100475|65377692|FG000|Overall Study|Unclassified|1|||
23446564|NCT02100475|65377693|FG001|Overall Study|Unclassified|2|||
23446565|NCT02100475|65377692|FG000|Overall Study|Withdrawal criteria|1|||
23446566|NCT02100475|65377693|FG001|Overall Study|Withdrawal criteria|0|||
23446567|NCT00867165|65377694|FG000|Overall Study|Adverse Event|3|||
23446568|NCT00867165|65377695|FG001|Overall Study|Adverse Event|0|||
23446569|NCT00867165|65377694|FG000|Overall Study|Withdrawal by Subject|1|||
23446570|NCT00867165|65377695|FG001|Overall Study|Withdrawal by Subject|0|||
23446571|NCT00780416|65377696|FG000|Overall Study|Physician Decision|3|||
23568551|NCT02584855|65809875|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23568552|NCT02584855|65809876|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23446572|NCT00780416|65377697|FG001|Overall Study|Physician Decision|3|||
23446573|NCT00780416|65377696|FG000|Overall Study|Protocol Violation|1|||
23446574|NCT00780416|65377697|FG001|Overall Study|Protocol Violation|0|||
23568553|NCT02584855|65809877|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
23568554|NCT02584855|65809878|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
23767452|NCT03141177|66527639|FG001|Overall Study|Death|13|||
23446575|NCT00780416|65377696|FG000|Overall Study|Withdrawal by Subject|8|||
23767453|NCT03141177|66527640|FG002|Overall Study|Death|84|||
23767454|NCT03141177|66527638|FG000|Overall Study|Participant withdrew consent|9|||
23446576|NCT00780416|65377697|FG001|Overall Study|Withdrawal by Subject|6|||
23446577|NCT04492722|65377698|FG000|Overall Study|Adverse Event|7|||
23446578|NCT04492722|65377699|FG001|Overall Study|Adverse Event|2|||
23446579|NCT04492722|65377700|FG002|Overall Study|Adverse Event|3|||
23829830|NCT03866577|66756079|FG003|Overall Study|Protocol Violation|0|||
23829831|NCT03866577|66756080|FG004|Overall Study|Protocol Violation|0|||
23446580|NCT04492722|65377701|FG003|Overall Study|Adverse Event|0|||
23446581|NCT04492722|65377698|FG000|Overall Study|Death|0|||
23446582|NCT04492722|65377699|FG001|Overall Study|Death|0|||
23446583|NCT04492722|65377700|FG002|Overall Study|Death|0|||
23446584|NCT04492722|65377701|FG003|Overall Study|Death|1|||
23446585|NCT04492722|65377698|FG000|Overall Study|Lost to Follow-up|0|||
23767455|NCT03141177|66527639|FG001|Overall Study|Participant withdrew consent|2|||
23568555|NCT02584855|65809873|FG000|Open-Label Treatment Period|Protocol Violation|1|||
23568556|NCT02584855|65809874|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23568557|NCT02584855|65809875|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23568558|NCT02584855|65809876|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23568559|NCT02584855|65809877|FG004|Open-Label Treatment Period|Protocol Violation|0|||
23568560|NCT02584855|65809878|FG005|Open-Label Treatment Period|Protocol Violation|0|||
23568561|NCT02584855|65809873|FG000|Open-Label Treatment Period|No PI Available|2|||
23568562|NCT02584855|65809874|FG001|Open-Label Treatment Period|No PI Available|0|||
23568563|NCT02584855|65809875|FG002|Open-Label Treatment Period|No PI Available|0|||
23568564|NCT02584855|65809876|FG003|Open-Label Treatment Period|No PI Available|0|||
23568565|NCT02584855|65809877|FG004|Open-Label Treatment Period|No PI Available|0|||
23568566|NCT02584855|65809878|FG005|Open-Label Treatment Period|No PI Available|0|||
23568567|NCT02584855|65809873|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
23568568|NCT02584855|65809874|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
23568569|NCT02584855|65809875|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
23568570|NCT02584855|65809876|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
23568571|NCT02584855|65809877|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
23568572|NCT02584855|65809878|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
23568573|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568574|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568575|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
23568576|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568577|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568578|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568579|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
23568580|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
23568581|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
23568582|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
23568583|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
23568584|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
23568585|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568586|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
23568587|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568588|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568589|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568590|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568591|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568592|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
23568593|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568594|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568595|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568596|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568597|NCT02584855|65809873|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568598|NCT02584855|65809874|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568599|NCT02584855|65809875|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568600|NCT02584855|65809876|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568601|NCT02584855|65809877|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
23568602|NCT02584855|65809878|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568603|NCT02584855|65809873|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
23568604|NCT02584855|65809874|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
23568605|NCT02584855|65809875|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
23568606|NCT02584855|65809876|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
23568607|NCT02584855|65809877|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
23568608|NCT02584855|65809878|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
23568609|NCT00235443|65809879|FG000|Overall Study|Adverse Event|4|||
23568610|NCT00235443|65809880|FG001|Overall Study|Adverse Event|12|||
23630345|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
23630346|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
23630347|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
23630348|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
23767456|NCT03141177|66527640|FG002|Overall Study|Participant withdrew consent|13|||
23767457|NCT03141177|66527638|FG000|Overall Study|Not reported|1|||
23767458|NCT03141177|66527639|FG001|Overall Study|Not reported|0|||
23767459|NCT03141177|66527640|FG002|Overall Study|Not reported|1|||
23568611|NCT00235443|65809881|FG002|Overall Study|Adverse Event|17|||
23568612|NCT00235443|65809882|FG003|Overall Study|Adverse Event|44|||
23568613|NCT00235443|65809883|FG004|Overall Study|Adverse Event|10|||
23630349|NCT00132678|66032160|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
23630350|NCT00132678|66032161|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
23630351|NCT00132678|66032162|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
23630352|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
23568614|NCT00235443|65809884|FG005|Overall Study|Adverse Event|15|||
23568615|NCT00235443|65809879|FG000|Overall Study|Lack of Efficacy|0|||
23568616|NCT00235443|65809880|FG001|Overall Study|Lack of Efficacy|1|||
23568617|NCT00235443|65809881|FG002|Overall Study|Lack of Efficacy|5|||
23568618|NCT00235443|65809882|FG003|Overall Study|Lack of Efficacy|12|||
23568619|NCT00235443|65809883|FG004|Overall Study|Lack of Efficacy|2|||
23568620|NCT00235443|65809884|FG005|Overall Study|Lack of Efficacy|9|||
23568621|NCT00235443|65809879|FG000|Overall Study|Withdrawal by Subject|3|||
23568622|NCT00235443|65809880|FG001|Overall Study|Withdrawal by Subject|9|||
23568623|NCT00235443|65809881|FG002|Overall Study|Withdrawal by Subject|25|||
23568624|NCT00235443|65809882|FG003|Overall Study|Withdrawal by Subject|24|||
23568625|NCT00235443|65809883|FG004|Overall Study|Withdrawal by Subject|10|||
23568626|NCT00235443|65809884|FG005|Overall Study|Withdrawal by Subject|12|||
23568627|NCT00235443|65809879|FG000|Overall Study|Lost to Follow-up|0|||
23568628|NCT00235443|65809880|FG001|Overall Study|Lost to Follow-up|8|||
23568629|NCT00235443|65809881|FG002|Overall Study|Lost to Follow-up|6|||
23568630|NCT00235443|65809882|FG003|Overall Study|Lost to Follow-up|6|||
23568631|NCT00235443|65809883|FG004|Overall Study|Lost to Follow-up|4|||
23568632|NCT00235443|65809884|FG005|Overall Study|Lost to Follow-up|3|||
23568633|NCT00235443|65809879|FG000|Overall Study|Unsatisfactory compliance|0|||
23568634|NCT00235443|65809880|FG001|Overall Study|Unsatisfactory compliance|2|||
23568635|NCT00235443|65809881|FG002|Overall Study|Unsatisfactory compliance|3|||
23568636|NCT00235443|65809882|FG003|Overall Study|Unsatisfactory compliance|4|||
23568637|NCT00235443|65809883|FG004|Overall Study|Unsatisfactory compliance|1|||
23568638|NCT00235443|65809884|FG005|Overall Study|Unsatisfactory compliance|0|||
23568639|NCT00235443|65809879|FG000|Overall Study|Other reasons for premature termination|1|||
23568640|NCT00235443|65809880|FG001|Overall Study|Other reasons for premature termination|6|||
23568641|NCT00235443|65809881|FG002|Overall Study|Other reasons for premature termination|6|||
23568642|NCT00235443|65809882|FG003|Overall Study|Other reasons for premature termination|7|||
23568643|NCT00235443|65809883|FG004|Overall Study|Other reasons for premature termination|3|||
23568644|NCT00235443|65809884|FG005|Overall Study|Other reasons for premature termination|6|||
23568645|NCT00579982|65809885|FG000|Overall Study|Adverse Event|4|||
23568646|NCT00579982|65809885|FG000|Overall Study|Protocol Violation|4|||
23630353|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
23630354|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
23767460|NCT03141177|66527638|FG000|Overall Study|Lost to Follow-up|2|||
23568647|NCT04170686|65809889|FG000|Screening|Physician Decision|12|||
23767461|NCT03141177|66527639|FG001|Overall Study|Lost to Follow-up|1|||
23767462|NCT03141177|66527640|FG002|Overall Study|Lost to Follow-up|1|||
23767463|NCT03141177|66527638|FG000|Overall Study|Other reasons|4|||
23568648|NCT04170686|65809890|FG001|Screening|Physician Decision|13|||
23568649|NCT04170686|65809889|FG000|Randomization and Treatment|Lost to Follow-up|26|||
23568650|NCT04170686|65809890|FG001|Randomization and Treatment|Lost to Follow-up|15|||
23630355|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
23630356|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
23630357|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
23630358|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
23630359|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
23630360|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
23630361|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
23630362|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
23630363|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
23630364|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
23630365|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
23630366|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
23630367|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
23630368|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
23630369|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
23630370|NCT00132678|66032160|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
23630371|NCT00132678|66032161|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
23630372|NCT00132678|66032162|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
23630373|NCT04351269|66032163|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
23630374|NCT04351269|66032164|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
23630375|NCT04351269|66032165|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
23630376|NCT04351269|66032163|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
23630377|NCT04351269|66032164|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
23630378|NCT04351269|66032165|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
23630379|NCT04351269|66032163|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
23630380|NCT04351269|66032164|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
23630381|NCT04351269|66032165|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
23630382|NCT04351269|66032163|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
23630383|NCT04351269|66032164|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
23630384|NCT04351269|66032165|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
23630385|NCT04351269|66032163|FG000|Overall Study|Lost to Follow-up|1|||
23630386|NCT04351269|66032164|FG001|Overall Study|Lost to Follow-up|3|||
23630387|NCT04351269|66032165|FG002|Overall Study|Lost to Follow-up|0|||
23630388|NCT00725712|66032166|FG000|Overall Study|Withdrawal by Subject|2|||
23630389|NCT00725712|66032167|FG001|Overall Study|Withdrawal by Subject|1|||
23630390|NCT00725712|66032166|FG000|Overall Study|Protocol Violation|1|||
23630391|NCT00725712|66032167|FG001|Overall Study|Protocol Violation|0|||
23630392|NCT00725712|66032166|FG000|Overall Study|Progressive disease|37|||
23630393|NCT00725712|66032167|FG001|Overall Study|Progressive disease|16|||
23630394|NCT00725712|66032166|FG000|Overall Study|Clinical progression not based on RECIST|0|||
23630395|NCT00725712|66032167|FG001|Overall Study|Clinical progression not based on RECIST|3|||
23630396|NCT00725712|66032166|FG000|Overall Study|Adverse Event|5|||
23630397|NCT00725712|66032167|FG001|Overall Study|Adverse Event|5|||
23630398|NCT00725712|66032166|FG000|Overall Study|Death|2|||
23630399|NCT00725712|66032167|FG001|Overall Study|Death|0|||
23630400|NCT00725712|66032166|FG000|Overall Study|Other: Death|1|||
23630401|NCT00725712|66032167|FG001|Overall Study|Other: Death|0|||
23630402|NCT00725712|66032166|FG000|Overall Study|Hospitalized, unable to continue|0|||
23630403|NCT00725712|66032167|FG001|Overall Study|Hospitalized, unable to continue|1|||
23630404|NCT03712449|66032168|FG000|Overall Study|Withdraw Consent|0|||
23630405|NCT03712449|66032169|FG001|Overall Study|Withdraw Consent|1|||
23630406|NCT04887506|66032170|FG000|Overall Study|Death|1|||
23630407|NCT04887506|66032171|FG001|Overall Study|Death|1|||
23630408|NCT04887506|66032170|FG000|Overall Study|Withdrawal by Subject|0|||
23630409|NCT04887506|66032171|FG001|Overall Study|Withdrawal by Subject|3|||
23829832|NCT03866577|66756081|FG005|Overall Study|Protocol Violation|0|||
23630410|NCT04887506|66032170|FG000|Overall Study|Adverse Event|4|||
23630411|NCT04887506|66032171|FG001|Overall Study|Adverse Event|3|||
23630412|NCT04887506|66032170|FG000|Overall Study|Other - Not Reported|1|||
23630413|NCT04887506|66032171|FG001|Overall Study|Other - Not Reported|1|||
23630414|NCT02031536|66032172|FG000|Overall Study|ineligible|1|||
23630415|NCT02031536|66032173|FG001|Overall Study|ineligible|0|||
23630416|NCT02536742|66032186|FG000|Overall Study|Did not start protocol therapy|1|||
23630417|NCT02536742|66032186|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
23630418|NCT03631407|66032189|FG000|Overall Study|Withdrawal by Subject|3|||
23630419|NCT03631407|66032190|FG001|Overall Study|Withdrawal by Subject|2|||
23767464|NCT03141177|66527639|FG001|Overall Study|Other reasons|0|||
23767465|NCT03141177|66527640|FG002|Overall Study|Other reasons|11|||
23767466|NCT03141177|66527638|FG000|Overall Study|Participants did not start treatment period|3|||
23829833|NCT03866577|66756082|FG006|Overall Study|Protocol Violation|0|||
23829834|NCT03866577|66756083|FG007|Overall Study|Protocol Violation|0|||
23829835|NCT03866577|66756084|FG008|Overall Study|Protocol Violation|0|||
23829836|NCT03866577|66756085|FG009|Overall Study|Protocol Violation|0|||
23829837|NCT03866577|66756086|FG010|Overall Study|Protocol Violation|0|||
23829838|NCT03866577|66756087|FG011|Overall Study|Protocol Violation|1|||
23829839|NCT03866577|66756088|FG012|Overall Study|Protocol Violation|0|||
23829840|NCT03866577|66756076|FG000|Overall Study|Withdrawal by Subject|0|||
23829841|NCT03866577|66756077|FG001|Overall Study|Withdrawal by Subject|0|||
23829842|NCT03866577|66756078|FG002|Overall Study|Withdrawal by Subject|0|||
23829843|NCT03866577|66756079|FG003|Overall Study|Withdrawal by Subject|0|||
23829844|NCT03866577|66756080|FG004|Overall Study|Withdrawal by Subject|0|||
23829845|NCT03866577|66756081|FG005|Overall Study|Withdrawal by Subject|0|||
23829846|NCT03866577|66756082|FG006|Overall Study|Withdrawal by Subject|0|||
23829847|NCT03866577|66756083|FG007|Overall Study|Withdrawal by Subject|0|||
23829848|NCT03866577|66756084|FG008|Overall Study|Withdrawal by Subject|1|||
23446586|NCT04492722|65377699|FG001|Overall Study|Lost to Follow-up|1|||
23568651|NCT00621296|65809891|FG000|Overall Study|Adverse Event|2|||
23568652|NCT00621296|65809891|FG000|Overall Study|Lack of Efficacy|1|||
23568653|NCT00621296|65809891|FG000|Overall Study|Physician Decision|7|||
23568654|NCT00621296|65809891|FG000|Overall Study|Unmatch Criteria|1|||
23568655|NCT00621296|65809891|FG000|Overall Study|Stopping Criteria|3|||
23568656|NCT01148862|65809892|FG000|Second Intervention|Withdrawal by Subject|0|||
23568657|NCT01148862|65809893|FG001|Second Intervention|Withdrawal by Subject|2|||
23568658|NCT01912781|65809894|FG000|Overall Study|Withdrawal by Subject|2|||
23568659|NCT01912781|65809895|FG001|Overall Study|Withdrawal by Subject|0|||
23568660|NCT01250119|65809896|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
23568661|NCT01250119|65809897|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
23568662|NCT01250119|65809896|FG000|Diagnostic Phase|Participants Not Tested|44|||
23568663|NCT01250119|65809897|FG001|Diagnostic Phase|Participants Not Tested|0|||
23568664|NCT01250119|65809896|FG000|Treatment Phase|Progressive Disease|0|||
23568665|NCT01250119|65809897|FG001|Treatment Phase|Progressive Disease|32|||
23568666|NCT01250119|65809896|FG000|Treatment Phase|Death|0|||
23568667|NCT01250119|65809897|FG001|Treatment Phase|Death|2|||
23568668|NCT01250119|65809896|FG000|Treatment Phase|Withdrawal by Subject|0|||
23568669|NCT01250119|65809897|FG001|Treatment Phase|Withdrawal by Subject|1|||
23568670|NCT01250119|65809896|FG000|Treatment Phase|Adverse Event|0|||
23568671|NCT01250119|65809897|FG001|Treatment Phase|Adverse Event|2|||
23568672|NCT01250119|65809896|FG000|Treatment Phase|Unknown reason|0|||
23568673|NCT01250119|65809897|FG001|Treatment Phase|Unknown reason|4|||
23568674|NCT00098254|65809903|FG000|Overall Study|Adverse Event|2|||
23568675|NCT00098254|65809903|FG000|Overall Study|Death|1|||
23568676|NCT01463293|65809904|FG000|Overall Study|Lost to Follow-up|1|||
23568677|NCT01463293|65809905|FG001|Overall Study|Lost to Follow-up|4|||
23568678|NCT01463293|65809906|FG002|Overall Study|Lost to Follow-up|5|||
23568679|NCT01463293|65809904|FG000|Overall Study|Adverse Event|1|||
23568680|NCT01463293|65809905|FG001|Overall Study|Adverse Event|2|||
23568681|NCT01463293|65809906|FG002|Overall Study|Adverse Event|0|||
23568682|NCT01463293|65809904|FG000|Overall Study|Withdrawal by Subject|4|||
23568683|NCT01463293|65809905|FG001|Overall Study|Withdrawal by Subject|10|||
23568684|NCT01463293|65809906|FG002|Overall Study|Withdrawal by Subject|5|||
23568685|NCT01463293|65809904|FG000|Overall Study|Other|0|||
23568686|NCT01463293|65809905|FG001|Overall Study|Other|0|||
23568687|NCT01463293|65809906|FG002|Overall Study|Other|2|||
23568688|NCT00932646|65809907|FG000|Overall Study|Adverse Event|2|||
23568689|NCT00932646|65809908|FG001|Overall Study|Adverse Event|1|||
23568690|NCT00932646|65809909|FG002|Overall Study|Adverse Event|1|||
23568691|NCT00932646|65809910|FG003|Overall Study|Adverse Event|1|||
23568692|NCT00932646|65809907|FG000|Overall Study|Lost to Follow-up|2|||
23568693|NCT00932646|65809908|FG001|Overall Study|Lost to Follow-up|1|||
23568694|NCT00932646|65809909|FG002|Overall Study|Lost to Follow-up|0|||
23568695|NCT00932646|65809910|FG003|Overall Study|Lost to Follow-up|0|||
23568696|NCT00932646|65809907|FG000|Overall Study|Withdrawal by Subject|1|||
23568697|NCT00932646|65809908|FG001|Overall Study|Withdrawal by Subject|1|||
23568698|NCT00932646|65809909|FG002|Overall Study|Withdrawal by Subject|3|||
23568699|NCT00932646|65809910|FG003|Overall Study|Withdrawal by Subject|0|||
23568700|NCT01680458|65809912|FG000|Overall Study|Protocol Violation|3|||
23568701|NCT02145078|65809913|FG000|Overall Study|Death|1|||
23568702|NCT02145078|65809913|FG000|Overall Study|Reason not given|3|||
23568703|NCT00258440|65809914|FG000|Overall Study|Withdrawal by Subject|0|||
23568704|NCT00258440|65809915|FG001|Overall Study|Withdrawal by Subject|0|||
23568705|NCT00258440|65809916|FG002|Overall Study|Withdrawal by Subject|1|||
23568706|NCT02635724|65809917|FG000|Overall Study|Withdrawal by Subject|0|||
23568707|NCT02635724|65809918|FG001|Overall Study|Withdrawal by Subject|1|||
23568708|NCT02635724|65809919|FG002|Overall Study|Withdrawal by Subject|0|||
23568709|NCT00562978|65809921|FG000|Overall Study|Patient had imaging dose only|1|||
23568710|NCT00562978|65809922|FG001|Overall Study|Patient had imaging dose only|11|||
23829849|NCT03866577|66756085|FG009|Overall Study|Withdrawal by Subject|1|||
23568711|NCT00582491|65809925|FG000|Overall Study|Withdrawal by Subject|1|||
23568712|NCT00582491|65809926|FG001|Overall Study|Withdrawal by Subject|0|||
23568713|NCT01364727|65809927|FG000|Overall Study|Not Eligible|2|||
23568714|NCT00744237|65809928|FG000|Overall Study|Lack of Efficacy|1|||
23568715|NCT00744237|65809929|FG001|Overall Study|Lack of Efficacy|1|||
23568716|NCT00744237|65809930|FG002|Overall Study|Lack of Efficacy|0|||
23568717|NCT00744237|65809928|FG000|Overall Study|Withdrawal by Subject|9|||
23568718|NCT00744237|65809929|FG001|Overall Study|Withdrawal by Subject|5|||
23630420|NCT03631407|66032189|FG000|Overall Study|Sponsor Decision|0|||
23630421|NCT03631407|66032190|FG001|Overall Study|Sponsor Decision|2|||
23630422|NCT03631407|66032189|FG000|Overall Study|Death|16|||
23630423|NCT03631407|66032190|FG001|Overall Study|Death|16|||
23630424|NCT03631407|66032189|FG000|Overall Study|Randomized by mistake without study treatment|1|||
23630425|NCT03631407|66032190|FG001|Overall Study|Randomized by mistake without study treatment|0|||
23630426|NCT01080300|66032191|FG000|Overall Study|Adverse Event|49|||
23630427|NCT01080300|66032192|FG001|Overall Study|Adverse Event|35|||
23630428|NCT01080300|66032191|FG000|Overall Study|Lack of Efficacy|12|||
23630429|NCT01080300|66032192|FG001|Overall Study|Lack of Efficacy|15|||
23630430|NCT01080300|66032191|FG000|Overall Study|Protocol Violation|7|||
23630431|NCT01080300|66032192|FG001|Overall Study|Protocol Violation|13|||
23630432|NCT01080300|66032191|FG000|Overall Study|Lost to Follow-up|10|||
23630433|NCT01080300|66032192|FG001|Overall Study|Lost to Follow-up|6|||
23630434|NCT01080300|66032191|FG000|Overall Study|Death|0|||
23630435|NCT01080300|66032192|FG001|Overall Study|Death|1|||
23767467|NCT03141177|66527639|FG001|Overall Study|Participants did not start treatment period|0|||
23767468|NCT03141177|66527640|FG002|Overall Study|Participants did not start treatment period|8|||
23767469|NCT00783796|66527641|FG000|Overall Study|Did not receive any stent|4|||
23767470|NCT00783796|66527641|FG000|Overall Study|Received non-XIENCE V stent|1|||
23767471|NCT00783796|66527641|FG000|Overall Study|Received commercial XIENCE V stent|1|||
23767472|NCT00434161|66527644|FG000|Overall Study|Adverse Event|5|||
23767473|NCT00434161|66527645|FG001|Overall Study|Adverse Event|1|||
23767474|NCT00434161|66527646|FG002|Overall Study|Adverse Event|4|||
23767475|NCT00434161|66527644|FG000|Overall Study|Lost to Follow-up|0|||
23767476|NCT00434161|66527645|FG001|Overall Study|Lost to Follow-up|1|||
23767477|NCT00434161|66527646|FG002|Overall Study|Lost to Follow-up|0|||
23767478|NCT00434161|66527644|FG000|Overall Study|Death|1|||
23767479|NCT00434161|66527645|FG001|Overall Study|Death|0|||
23767480|NCT00434161|66527646|FG002|Overall Study|Death|1|||
23767481|NCT00434161|66527644|FG000|Overall Study|Non-Compliance|1|||
23767482|NCT00434161|66527645|FG001|Overall Study|Non-Compliance|1|||
23767483|NCT00434161|66527646|FG002|Overall Study|Non-Compliance|0|||
23767484|NCT00434161|66527644|FG000|Overall Study|Withdrawal by Subject|2|||
23767485|NCT00434161|66527645|FG001|Overall Study|Withdrawal by Subject|0|||
23767486|NCT00434161|66527646|FG002|Overall Study|Withdrawal by Subject|3|||
23767487|NCT00434161|66527644|FG000|Overall Study|Logistical error study assessments|1|||
23767488|NCT00434161|66527645|FG001|Overall Study|Logistical error study assessments|0|||
23767489|NCT00434161|66527646|FG002|Overall Study|Logistical error study assessments|3|||
23767490|NCT00449072|66527651|FG000|Overall Study|Adverse Event|3|||
23767491|NCT00449072|66527652|FG001|Overall Study|Adverse Event|1|||
23767492|NCT00449072|66527651|FG000|Overall Study|Protocol Violation|14|||
23767493|NCT00449072|66527652|FG001|Overall Study|Protocol Violation|12|||
23767494|NCT00449072|66527651|FG000|Overall Study|Lost to Follow-up|5|||
23767495|NCT00449072|66527652|FG001|Overall Study|Lost to Follow-up|7|||
23767496|NCT00449072|66527651|FG000|Overall Study|Withdrawal by Subject|11|||
23767497|NCT00449072|66527652|FG001|Overall Study|Withdrawal by Subject|8|||
23767498|NCT00449072|66527651|FG000|Overall Study|Lack of Efficacy|1|||
23767499|NCT00449072|66527652|FG001|Overall Study|Lack of Efficacy|1|||
23767500|NCT00449072|66527651|FG000|Overall Study|Physician Decision|1|||
23767501|NCT00449072|66527652|FG001|Overall Study|Physician Decision|0|||
23767502|NCT00449072|66527651|FG000|Overall Study|Not treated|0|||
23767503|NCT00449072|66527652|FG001|Overall Study|Not treated|1|||
23767504|NCT00449072|66527651|FG000|Overall Study|Excluded medication|0|||
23767505|NCT00449072|66527652|FG001|Overall Study|Excluded medication|2|||
23767506|NCT00449072|66527651|FG000|Overall Study|Non-compliance|2|||
23767507|NCT00449072|66527652|FG001|Overall Study|Non-compliance|5|||
23767508|NCT00449072|66527651|FG000|Overall Study|Sponsor decision|1|||
23767509|NCT00449072|66527652|FG001|Overall Study|Sponsor decision|3|||
23630436|NCT01080300|66032191|FG000|Overall Study|Withdrawal by Subject|12|||
23630437|NCT01080300|66032192|FG001|Overall Study|Withdrawal by Subject|28|||
23630438|NCT01080300|66032191|FG000|Overall Study|Reasons not specified|4|||
23767510|NCT00449072|66527651|FG000|Overall Study|Relocation|3|||
23630439|NCT01080300|66032192|FG001|Overall Study|Reasons not specified|6|||
23630440|NCT03768336|66032193|FG000|Overall Study|Lost to Follow-up|3|||
23767511|NCT00449072|66527652|FG001|Overall Study|Relocation|2|||
23767512|NCT02315898|66527654|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
23767513|NCT02315898|66527655|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
23767514|NCT02315898|66527656|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
23767515|NCT02315898|66527657|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
23767516|NCT03341273|66527658|FG000|Overall Study|Lost to Follow-up|7|||
23767517|NCT03341273|66527659|FG001|Overall Study|Lost to Follow-up|7|||
23767518|NCT03341273|66527658|FG000|Overall Study|Withdrawal by Subject|4|||
23767519|NCT03341273|66527659|FG001|Overall Study|Withdrawal by Subject|2|||
23767520|NCT03341273|66527658|FG000|Overall Study|Physician Decision|1|||
23767521|NCT03341273|66527659|FG001|Overall Study|Physician Decision|0|||
23767522|NCT03341273|66527658|FG000|Overall Study|Protocol Violation|0|||
23767523|NCT03341273|66527659|FG001|Overall Study|Protocol Violation|1|||
23767524|NCT03341273|66527658|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
23767525|NCT03341273|66527659|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
23767526|NCT03341273|66527658|FG000|Overall Study|Became ineligible after enrollment|1|||
23767527|NCT03341273|66527659|FG001|Overall Study|Became ineligible after enrollment|0|||
23767528|NCT03341273|66527658|FG000|Overall Study|Not Eligible at Enrollment|0|||
23767529|NCT03341273|66527659|FG001|Overall Study|Not Eligible at Enrollment|1|||
23767530|NCT03341273|66527658|FG000|Overall Study|Participant incarcerated|1|||
23767531|NCT03341273|66527659|FG001|Overall Study|Participant incarcerated|0|||
23767532|NCT02396381|66527660|FG000|Overall Study|Adverse Event|3|||
23767533|NCT02396381|66527661|FG001|Overall Study|Adverse Event|2|||
23767534|NCT02396381|66527660|FG000|Overall Study|Withdrawal by Subject|33|||
23568719|NCT00744237|65809930|FG002|Overall Study|Withdrawal by Subject|3|||
23568720|NCT00744237|65809928|FG000|Overall Study|Lost to Follow-up|1|||
23568721|NCT00744237|65809929|FG001|Overall Study|Lost to Follow-up|1|||
23568722|NCT00744237|65809930|FG002|Overall Study|Lost to Follow-up|1|||
23568723|NCT00744237|65809928|FG000|Overall Study|Protocol Violation|3|||
23568724|NCT00744237|65809929|FG001|Overall Study|Protocol Violation|4|||
23568725|NCT00744237|65809930|FG002|Overall Study|Protocol Violation|3|||
23568726|NCT00744237|65809928|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
23767535|NCT02396381|66527661|FG001|Overall Study|Withdrawal by Subject|24|||
23568727|NCT00744237|65809929|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
23568728|NCT00744237|65809930|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
23568729|NCT00744237|65809928|FG000|Overall Study|Dosing Error|1|||
23568730|NCT00744237|65809929|FG001|Overall Study|Dosing Error|0|||
23568731|NCT00744237|65809930|FG002|Overall Study|Dosing Error|1|||
23568732|NCT00744237|65809928|FG000|Overall Study|Study Drug Error|1|||
23568733|NCT00744237|65809929|FG001|Overall Study|Study Drug Error|0|||
23568734|NCT00744237|65809930|FG002|Overall Study|Study Drug Error|0|||
23568735|NCT00744237|65809928|FG000|Overall Study|Prohibited Concomitant Medication|0|||
23568736|NCT00744237|65809929|FG001|Overall Study|Prohibited Concomitant Medication|0|||
23568737|NCT00744237|65809930|FG002|Overall Study|Prohibited Concomitant Medication|1|||
23568738|NCT00744237|65809928|FG000|Overall Study|Poor Compliance|0|||
23568739|NCT00744237|65809929|FG001|Overall Study|Poor Compliance|2|||
23630441|NCT03768336|66032194|FG001|Overall Study|Lost to Follow-up|2|||
23630442|NCT03768336|66032193|FG000|Overall Study|Became Ineligible|2|||
23630443|NCT03768336|66032194|FG001|Overall Study|Became Ineligible|0|||
23630444|NCT03768336|66032193|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
23630445|NCT03768336|66032194|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
23630446|NCT03768336|66032193|FG000|Overall Study|Missed final survey (post-treatment|0|||
23630447|NCT03768336|66032194|FG001|Overall Study|Missed final survey (post-treatment|1|||
23630448|NCT00358644|66032197|FG000|Overall Study|Progressive Disease|21|||
23630449|NCT00358644|66032197|FG000|Overall Study|Adverse Event|7|||
23630450|NCT00358644|66032197|FG000|Overall Study|Death|11|||
23630451|NCT00358644|66032197|FG000|Overall Study|Withdrawal by Subject|4|||
23630452|NCT00358644|66032197|FG000|Overall Study|Physician Decision|6|||
23630453|NCT00358644|66032197|FG000|Overall Study|Patient not eligible for study|1|||
23630454|NCT02375347|66032198|FG000|Overall Study|Protocol Violation|1|||
23630455|NCT04732871|66032199|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
23568740|NCT00744237|65809930|FG002|Overall Study|Poor Compliance|0|||
23630456|NCT04732871|66032200|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
23630457|NCT04732871|66032201|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
23630458|NCT04732871|66032199|FG000|Overall Study|Lost to Follow-up|7|||
23630459|NCT04732871|66032200|FG001|Overall Study|Lost to Follow-up|4|||
23630460|NCT04732871|66032201|FG002|Overall Study|Lost to Follow-up|3|||
23767536|NCT02396381|66527660|FG000|Overall Study|Lost to Follow-up|49|||
23767537|NCT02396381|66527661|FG001|Overall Study|Lost to Follow-up|31|||
23568741|NCT00744237|65809928|FG000|Overall Study|Administrative. Site Closed|1|||
23767538|NCT02396381|66527660|FG000|Overall Study|Protocol Violation|1|||
23568742|NCT00744237|65809929|FG001|Overall Study|Administrative. Site Closed|1|||
23767539|NCT02396381|66527661|FG001|Overall Study|Protocol Violation|0|||
23767540|NCT02396381|66527660|FG000|Overall Study|Site terminated by sponsor|7|||
23767541|NCT02396381|66527661|FG001|Overall Study|Site terminated by sponsor|8|||
23767542|NCT02396381|66527660|FG000|Overall Study|Physician Decision|5|||
23767543|NCT02396381|66527661|FG001|Overall Study|Physician Decision|5|||
23767544|NCT02396381|66527660|FG000|Overall Study|Pregnancy|2|||
23767545|NCT02396381|66527661|FG001|Overall Study|Pregnancy|0|||
23767546|NCT02396381|66527660|FG000|Overall Study|Non-compliance with study procedures|1|||
23767547|NCT02396381|66527661|FG001|Overall Study|Non-compliance with study procedures|0|||
23767548|NCT02396381|66527660|FG000|Overall Study|Moved out of town/state|1|||
23767549|NCT02396381|66527661|FG001|Overall Study|Moved out of town/state|3|||
23829850|NCT03866577|66756086|FG010|Overall Study|Withdrawal by Subject|0|||
23829851|NCT03866577|66756087|FG011|Overall Study|Withdrawal by Subject|0|||
23829852|NCT03866577|66756088|FG012|Overall Study|Withdrawal by Subject|0|||
23829853|NCT03866577|66756076|FG000|Overall Study|Not qualified for IVIg infusion|0|||
23829854|NCT03866577|66756077|FG001|Overall Study|Not qualified for IVIg infusion|0|||
23829855|NCT03866577|66756078|FG002|Overall Study|Not qualified for IVIg infusion|0|||
23829856|NCT03866577|66756079|FG003|Overall Study|Not qualified for IVIg infusion|0|||
23829857|NCT03866577|66756080|FG004|Overall Study|Not qualified for IVIg infusion|0|||
23829858|NCT03866577|66756081|FG005|Overall Study|Not qualified for IVIg infusion|0|||
23829859|NCT03866577|66756082|FG006|Overall Study|Not qualified for IVIg infusion|0|||
23829860|NCT03866577|66756083|FG007|Overall Study|Not qualified for IVIg infusion|0|||
23829861|NCT03866577|66756084|FG008|Overall Study|Not qualified for IVIg infusion|0|||
23829862|NCT03866577|66756085|FG009|Overall Study|Not qualified for IVIg infusion|1|||
23829863|NCT03866577|66756086|FG010|Overall Study|Not qualified for IVIg infusion|0|||
23829864|NCT03866577|66756087|FG011|Overall Study|Not qualified for IVIg infusion|0|||
23829865|NCT03866577|66756088|FG012|Overall Study|Not qualified for IVIg infusion|0|||
23829866|NCT00595621|66756089|FG000|Open Label Run in|Adverse Event|1|||
23829867|NCT00595621|66756090|FG001|Open Label Run in|Adverse Event|0|||
23829868|NCT00595621|66756089|FG000|Open Label Run in|Physician Decision|1|||
23568743|NCT00744237|65809930|FG002|Overall Study|Administrative. Site Closed|1|||
23568744|NCT00744237|65809928|FG000|Overall Study|Adverse Event|9|||
23568745|NCT00744237|65809929|FG001|Overall Study|Adverse Event|13|||
23568746|NCT00744237|65809930|FG002|Overall Study|Adverse Event|5|||
23568747|NCT02049710|65809931|FG000|Overall Study|Lost to Follow-up|319|||
23568748|NCT02049710|65809932|FG001|Overall Study|Lost to Follow-up|324|||
23568749|NCT04076020|65809933|FG000|Overall Study|Death|4|||
23568750|NCT04076020|65809934|FG001|Overall Study|Death|6|||
23568751|NCT04076020|65809933|FG000|Overall Study|Withdrawal by Subject|12|||
23568752|NCT04076020|65809934|FG001|Overall Study|Withdrawal by Subject|8|||
23568753|NCT01473381|65809935|FG000|Overall Study|Adverse Event|8|||
23568754|NCT01473381|65809936|FG001|Overall Study|Adverse Event|20|||
23568755|NCT01473381|65809937|FG002|Overall Study|Adverse Event|25|||
23568756|NCT01473381|65809938|FG003|Overall Study|Adverse Event|17|||
23568757|NCT01473381|65809935|FG000|Overall Study|Insufficient Therapeutic Response|10|||
23568758|NCT01473381|65809936|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23568759|NCT01473381|65809937|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23568760|NCT01473381|65809938|FG003|Overall Study|Insufficient Therapeutic Response|3|||
23568761|NCT01473381|65809935|FG000|Overall Study|Protocol Violation|17|||
23568762|NCT01473381|65809936|FG001|Overall Study|Protocol Violation|23|||
23568763|NCT01473381|65809937|FG002|Overall Study|Protocol Violation|19|||
23568764|NCT01473381|65809938|FG003|Overall Study|Protocol Violation|17|||
23568765|NCT01473381|65809935|FG000|Overall Study|Withdrawal of Consent|20|||
23568766|NCT01473381|65809936|FG001|Overall Study|Withdrawal of Consent|21|||
23568767|NCT01473381|65809937|FG002|Overall Study|Withdrawal of Consent|20|||
23630461|NCT04732871|66032199|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
23767550|NCT02396381|66527660|FG000|Overall Study|Could not complete visit|1|||
23767551|NCT02396381|66527661|FG001|Overall Study|Could not complete visit|0|||
23829869|NCT00595621|66756090|FG001|Open Label Run in|Physician Decision|0|||
23829870|NCT00595621|66756089|FG000|Open Label Run in|Withdrawal by Subject|1|||
23446587|NCT04492722|65377700|FG002|Overall Study|Lost to Follow-up|0|||
23829871|NCT00595621|66756090|FG001|Open Label Run in|Withdrawal by Subject|0|||
23829872|NCT00595621|66756089|FG000|Randomization and Study|Adverse Event|2|||
23568768|NCT01473381|65809938|FG003|Overall Study|Withdrawal of Consent|26|||
23568769|NCT01473381|65809935|FG000|Overall Study|Lost to Follow-up|25|||
23568770|NCT01473381|65809936|FG001|Overall Study|Lost to Follow-up|28|||
23568771|NCT01473381|65809937|FG002|Overall Study|Lost to Follow-up|35|||
23568772|NCT01473381|65809938|FG003|Overall Study|Lost to Follow-up|23|||
23829873|NCT00595621|66756090|FG001|Randomization and Study|Adverse Event|0|||
23829874|NCT00595621|66756089|FG000|Randomization and Study|Withdrawal by Subject|0|||
23829875|NCT00595621|66756090|FG001|Randomization and Study|Withdrawal by Subject|1|||
23829876|NCT03591874|66756092|FG000|Overall Study|Adverse Event|4|||
23829877|NCT03591874|66756093|FG001|Overall Study|Adverse Event|0|||
23829878|NCT03591874|66756092|FG000|Overall Study|Withdrawal by Subject|2|||
23829879|NCT03591874|66756093|FG001|Overall Study|Withdrawal by Subject|1|||
23829880|NCT03591874|66756092|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
23829881|NCT03591874|66756093|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
23829882|NCT03591874|66756092|FG000|Overall Study|On Study at Time of Study Termination|12|||
23829883|NCT03591874|66756093|FG001|Overall Study|On Study at Time of Study Termination|6|||
23829884|NCT01418378|66756094|FG000|Overall Study|Death|1|||
23829885|NCT01418378|66756095|FG001|Overall Study|Death|2|||
23829886|NCT01418378|66756094|FG000|Overall Study|Physician Decision|0|||
23829887|NCT01418378|66756095|FG001|Overall Study|Physician Decision|1|||
23829888|NCT01418378|66756094|FG000|Overall Study|ligament imbalance|0|||
23829889|NCT01418378|66756095|FG001|Overall Study|ligament imbalance|1|||
23829890|NCT01418378|66756094|FG000|Overall Study|developed chronic myopathy|0|||
23829891|NCT01418378|66756095|FG001|Overall Study|developed chronic myopathy|1|||
23829892|NCT02394600|66756096|FG000|Overall Study|Adverse Event|3|||
23829893|NCT02394600|66756097|FG001|Overall Study|Adverse Event|0|||
23829894|NCT02394600|66756096|FG000|Overall Study|Lost to Follow-up|0|||
23829895|NCT02394600|66756097|FG001|Overall Study|Lost to Follow-up|1|||
23829896|NCT02394600|66756096|FG000|Overall Study|Withdrawal by Subject|0|||
23829897|NCT02394600|66756097|FG001|Overall Study|Withdrawal by Subject|1|||
23829898|NCT02394600|66756096|FG000|Overall Study|Protocol Violation|1|||
23829899|NCT02394600|66756097|FG001|Overall Study|Protocol Violation|0|||
23829900|NCT05377749|66756100|FG000|3 Weeks|Lost to Follow-up|2|||
23829901|NCT05377749|66756101|FG001|3 Weeks|Lost to Follow-up|4|||
23829902|NCT05377749|66756100|FG000|3 Weeks|Withdrawal by Subject|1|||
23829903|NCT05377749|66756101|FG001|3 Weeks|Withdrawal by Subject|1|||
23829904|NCT01306305|66756109|FG000|Overall Study|Lost to Follow-up|1|||
23829905|NCT01306305|66756110|FG001|Overall Study|Lost to Follow-up|0|||
23829906|NCT01306305|66756109|FG000|Overall Study|Withdrew consent|1|||
23829907|NCT01306305|66756110|FG001|Overall Study|Withdrew consent|0|||
23829908|NCT00570063|66756111|FG000|Overall Study|Adverse Event|4|||
23829909|NCT00570063|66756112|FG001|Overall Study|Adverse Event|1|||
23829910|NCT00570063|66756111|FG000|Overall Study|Lack of Efficacy|0|||
23829911|NCT00570063|66756112|FG001|Overall Study|Lack of Efficacy|1|||
23829912|NCT00570063|66756111|FG000|Overall Study|Withdrawal by Subject|4|||
23829913|NCT00570063|66756112|FG001|Overall Study|Withdrawal by Subject|3|||
23829914|NCT00570063|66756111|FG000|Overall Study|Sponsor's Decision|7|||
23829915|NCT00570063|66756112|FG001|Overall Study|Sponsor's Decision|3|||
23829916|NCT01827111|66756115|FG000|Overall Study|Disease Progression|1|||
23829917|NCT03640312|66756116|FG000|Overall Study|Lost to Follow-up|3|||
23829918|NCT03640312|66756117|FG001|Overall Study|Lost to Follow-up|6|||
23829919|NCT03564119|66756118|FG000|Overall Study|Adverse Event|4|||
23829920|NCT03564119|66756119|FG001|Overall Study|Adverse Event|0|||
23568773|NCT01473381|65809935|FG000|Overall Study|Other Reasons|0|||
23767552|NCT02396381|66527660|FG000|Overall Study|Possible conflict of interest|1|||
23767553|NCT02396381|66527661|FG001|Overall Study|Possible conflict of interest|0|||
23767554|NCT02396381|66527660|FG000|Overall Study|Randomization/Screening Error|3|||
23767555|NCT02396381|66527661|FG001|Overall Study|Randomization/Screening Error|1|||
23767556|NCT00506753|66527662|FG000|Overall Study|Lost to Follow-up|21|||
23767557|NCT00506753|66527663|FG001|Overall Study|Lost to Follow-up|15|||
23767558|NCT02040766|66527666|FG000|Overall Study|Adverse Event|1|||
23767559|NCT02040766|66527667|FG001|Overall Study|Adverse Event|1|||
23767560|NCT02040766|66527668|FG002|Overall Study|Adverse Event|1|||
23767561|NCT02040766|66527669|FG003|Overall Study|Adverse Event|0|||
23767562|NCT02040766|66527670|FG004|Overall Study|Adverse Event|2|||
23767563|NCT02040766|66527666|FG000|Overall Study|Withdrawal by Subject|4|||
23767564|NCT02040766|66527667|FG001|Overall Study|Withdrawal by Subject|3|||
23767565|NCT02040766|66527668|FG002|Overall Study|Withdrawal by Subject|2|||
23767566|NCT02040766|66527669|FG003|Overall Study|Withdrawal by Subject|3|||
23767567|NCT02040766|66527670|FG004|Overall Study|Withdrawal by Subject|2|||
23767568|NCT02040766|66527666|FG000|Overall Study|Non-compliance|0|||
23767569|NCT02040766|66527667|FG001|Overall Study|Non-compliance|1|||
23767570|NCT02040766|66527668|FG002|Overall Study|Non-compliance|0|||
23767571|NCT02040766|66527669|FG003|Overall Study|Non-compliance|0|||
23767572|NCT02040766|66527670|FG004|Overall Study|Non-compliance|0|||
23767573|NCT02040766|66527666|FG000|Overall Study|Protocol Violation|2|||
23767574|NCT02040766|66527667|FG001|Overall Study|Protocol Violation|1|||
23767575|NCT02040766|66527668|FG002|Overall Study|Protocol Violation|2|||
23767576|NCT02040766|66527669|FG003|Overall Study|Protocol Violation|3|||
23767577|NCT02040766|66527670|FG004|Overall Study|Protocol Violation|0|||
23767578|NCT02040766|66527666|FG000|Overall Study|Lost to Follow-up|4|||
23767579|NCT02040766|66527667|FG001|Overall Study|Lost to Follow-up|1|||
23767580|NCT02040766|66527668|FG002|Overall Study|Lost to Follow-up|3|||
23767581|NCT02040766|66527669|FG003|Overall Study|Lost to Follow-up|1|||
23829921|NCT03564119|66756118|FG000|Overall Study|Lost to Follow-up|1|||
23829922|NCT03564119|66756119|FG001|Overall Study|Lost to Follow-up|4|||
23829923|NCT03564119|66756118|FG000|Overall Study|Protocol Violation|1|||
23829924|NCT03564119|66756119|FG001|Overall Study|Protocol Violation|0|||
23829925|NCT03564119|66756118|FG000|Overall Study|Withdrawal by Subject|9|||
23829926|NCT03564119|66756119|FG001|Overall Study|Withdrawal by Subject|4|||
23829927|NCT03564119|66756118|FG000|Overall Study|Other Than Specified|0|||
23829928|NCT03564119|66756119|FG001|Overall Study|Other Than Specified|1|||
23568774|NCT01473381|65809936|FG001|Overall Study|Other Reasons|0|||
23568775|NCT01473381|65809937|FG002|Overall Study|Other Reasons|1|||
23568776|NCT01473381|65809938|FG003|Overall Study|Other Reasons|3|||
23568777|NCT03898180|65809939|FG000|Overall Study|Ongoing in Study|133|||
23568778|NCT03898180|65809940|FG001|Overall Study|Ongoing in Study|134|||
23568779|NCT03898180|65809939|FG000|Overall Study|Withdrawal by Subject|3|||
23568780|NCT03898180|65809940|FG001|Overall Study|Withdrawal by Subject|2|||
23568781|NCT03898180|65809939|FG000|Overall Study|Death|109|||
23767582|NCT02040766|66527670|FG004|Overall Study|Lost to Follow-up|4|||
23767583|NCT02040766|66527666|FG000|Overall Study|Not reported|1|||
23767584|NCT02040766|66527667|FG001|Overall Study|Not reported|0|||
23767585|NCT02040766|66527668|FG002|Overall Study|Not reported|0|||
23767586|NCT02040766|66527669|FG003|Overall Study|Not reported|0|||
23767587|NCT02040766|66527670|FG004|Overall Study|Not reported|0|||
23767588|NCT02040766|66527666|FG000|Overall Study|Lack of Efficacy|6|||
23767589|NCT02040766|66527667|FG001|Overall Study|Lack of Efficacy|3|||
23767590|NCT02040766|66527668|FG002|Overall Study|Lack of Efficacy|4|||
23767591|NCT02040766|66527669|FG003|Overall Study|Lack of Efficacy|6|||
23767592|NCT02040766|66527670|FG004|Overall Study|Lack of Efficacy|5|||
23767593|NCT02354586|66527671|FG000|Overall Study|Death|230|||
23767594|NCT02354586|66527671|FG000|Overall Study|Withdrawal by Subject|59|||
23767595|NCT02354586|66527671|FG000|Overall Study|Lost to Follow-up|11|||
23767596|NCT02354586|66527671|FG000|Overall Study|Sponsor decision|51|||
23767597|NCT02354586|66527671|FG000|Overall Study|Site closure|2|||
23767598|NCT02354586|66527671|FG000|Overall Study|Intercurrent illness|1|||
23767599|NCT02354586|66527671|FG000|Overall Study|Protocol Violation|3|||
23568782|NCT03898180|65809940|FG001|Overall Study|Death|106|||
23630462|NCT04732871|66032200|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
23767600|NCT02354586|66527671|FG000|Overall Study|Physician Decision|13|||
23767601|NCT02354586|66527671|FG000|Overall Study|Lack of Efficacy|86|||
23767602|NCT02354586|66527671|FG000|Overall Study|Adverse Event|7|||
23767603|NCT02224456|66527673|FG000|Overall Study|Lack of Efficacy|1|||
23767604|NCT02224456|66527673|FG000|Overall Study|Lost to Follow-up|15|||
23767605|NCT02224456|66527673|FG000|Overall Study|Withdrawal by Subject|9|||
23767606|NCT02224456|66527673|FG000|Overall Study|Physician Decision|3|||
23767607|NCT02224456|66527673|FG000|Overall Study|Death|2|||
23767608|NCT02224456|66527673|FG000|Overall Study|Pregnancy|4|||
23630463|NCT04732871|66032201|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
23630464|NCT04732871|66032199|FG000|Overall Study|Migrated / moved from the study area|5|||
23630465|NCT04732871|66032200|FG001|Overall Study|Migrated / moved from the study area|0|||
23630466|NCT04732871|66032201|FG002|Overall Study|Migrated / moved from the study area|0|||
23630467|NCT04732871|66032199|FG000|Overall Study|Other|1|||
23630468|NCT04732871|66032200|FG001|Overall Study|Other|0|||
23630469|NCT04732871|66032201|FG002|Overall Study|Other|1|||
23630470|NCT04732871|66032199|FG000|Overall Study|Ongoing|6|||
23630471|NCT04732871|66032200|FG001|Overall Study|Ongoing|0|||
23630472|NCT04732871|66032201|FG002|Overall Study|Ongoing|1|||
23829929|NCT01890122|66756122|FG000|Overall Study|Adverse Event|1|||
23829930|NCT01890122|66756123|FG001|Overall Study|Adverse Event|1|||
23829931|NCT01890122|66756124|FG002|Overall Study|Adverse Event|1|||
23829932|NCT01890122|66756125|FG003|Overall Study|Adverse Event|2|||
23829933|NCT01890122|66756122|FG000|Overall Study|Major Protocol Deviation|3|||
23829934|NCT01890122|66756123|FG001|Overall Study|Major Protocol Deviation|1|||
23829935|NCT01890122|66756124|FG002|Overall Study|Major Protocol Deviation|0|||
23829936|NCT01890122|66756125|FG003|Overall Study|Major Protocol Deviation|1|||
23829937|NCT01890122|66756122|FG000|Overall Study|Lost to Follow-up|0|||
23630473|NCT04732871|66032199|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
23630474|NCT04732871|66032200|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
23630475|NCT04732871|66032201|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
23767609|NCT02224456|66527673|FG000|Overall Study|Protocol Violation|1|||
23767610|NCT02224456|66527673|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
23829938|NCT01890122|66756123|FG001|Overall Study|Lost to Follow-up|1|||
23767611|NCT01326026|66527674|FG000|Overall Study|Adverse Event|4|||
23767612|NCT01326026|66527675|FG001|Overall Study|Adverse Event|3|||
23767613|NCT01326026|66527674|FG000|Overall Study|Withdrawal Criteria|5|||
23829939|NCT01890122|66756124|FG002|Overall Study|Lost to Follow-up|2|||
23630476|NCT01907906|66032202|FG000|Overall Study|Withdrawal by Subject|1|||
23767614|NCT01326026|66527675|FG001|Overall Study|Withdrawal Criteria|7|||
23568783|NCT00594906|65809941|FG000|Overall Study|Physician Decision|1|||
23568784|NCT00594906|65809942|FG001|Overall Study|Physician Decision|0|||
23568785|NCT00594906|65809941|FG000|Overall Study|Physician Decision|0|||
23767615|NCT01326026|66527674|FG000|Overall Study|Other|3|||
23767616|NCT01326026|66527675|FG001|Overall Study|Other|3|||
23767617|NCT00582036|66527676|FG000|Overall Study|Withdrawal by Subject|0|||
23767618|NCT00582036|66527677|FG001|Overall Study|Withdrawal by Subject|1|||
23767619|NCT00720798|66527678|FG000|Overall Study|Adverse Event|304|||
23767620|NCT00720798|66527678|FG000|Overall Study|Death|39|||
23767621|NCT00720798|66527678|FG000|Overall Study|Insufficient Therapeutic Response|129|||
23767622|NCT00720798|66527678|FG000|Overall Study|Protocol Violation|4|||
23767623|NCT00720798|66527678|FG000|Overall Study|Refused Treatment|151|||
23767624|NCT00720798|66527678|FG000|Overall Study|Failure to Return|46|||
23767625|NCT00720798|66527678|FG000|Overall Study|Reason not Specified|83|||
23767626|NCT00619385|66527682|FG000|Overall Study|Adverse Event|0|||
23767627|NCT00619385|66527683|FG001|Overall Study|Adverse Event|0|||
23767628|NCT00619385|66527684|FG002|Overall Study|Adverse Event|3|||
23767629|NCT00619385|66527682|FG000|Overall Study|Other|1|||
23767630|NCT00619385|66527683|FG001|Overall Study|Other|2|||
23767631|NCT00619385|66527684|FG002|Overall Study|Other|1|||
23767632|NCT03870997|66527687|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
23767633|NCT03870997|66527688|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
23767634|NCT03870997|66527689|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
23767635|NCT03870997|66527690|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
23767636|NCT03870997|66527691|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
23767637|NCT03870997|66527692|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
23767638|NCT02649231|66527693|FG000|Overall Study|Adverse Event|0|||
23767639|NCT02649231|66527694|FG001|Overall Study|Adverse Event|0|||
23767640|NCT02649231|66527695|FG002|Overall Study|Adverse Event|0|||
23767641|NCT02649231|66527696|FG003|Overall Study|Adverse Event|1|||
23767642|NCT02649231|66527693|FG000|Overall Study|Lost to Follow-up|2|||
23767643|NCT02649231|66527694|FG001|Overall Study|Lost to Follow-up|1|||
23767644|NCT02649231|66527695|FG002|Overall Study|Lost to Follow-up|1|||
23767645|NCT02649231|66527696|FG003|Overall Study|Lost to Follow-up|0|||
23767646|NCT02649231|66527693|FG000|Overall Study|Withdrawal by Subject|0|||
23767647|NCT02649231|66527694|FG001|Overall Study|Withdrawal by Subject|1|||
23767648|NCT02649231|66527695|FG002|Overall Study|Withdrawal by Subject|0|||
23767649|NCT02649231|66527696|FG003|Overall Study|Withdrawal by Subject|1|||
23767650|NCT02649231|66527693|FG000|Overall Study|Protocol Violation|2|||
23767651|NCT02649231|66527694|FG001|Overall Study|Protocol Violation|1|||
23767652|NCT02649231|66527695|FG002|Overall Study|Protocol Violation|1|||
23767653|NCT02649231|66527696|FG003|Overall Study|Protocol Violation|0|||
23767654|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
23767655|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
23767656|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Death|0|||
23767657|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Death|1|||
23568786|NCT00594906|65809942|FG001|Overall Study|Physician Decision|1|||
23568787|NCT00594906|65809941|FG000|Overall Study|Death|0|||
23568788|NCT00594906|65809942|FG001|Overall Study|Death|1|||
23568789|NCT00003458|65809943|FG000|Overall Study|Not evaluable|4|||
23568790|NCT05284019|65809944|FG000|Overall Study|Study terminated|2|||
23568791|NCT05284019|65809945|FG001|Overall Study|Study terminated|2|||
23568792|NCT05284019|65809946|FG002|Overall Study|Study terminated|2|||
23568793|NCT05284019|65809947|FG003|Overall Study|Study terminated|5|||
23568794|NCT05284019|65809948|FG004|Overall Study|Study terminated|15|||
23568795|NCT05284019|65809944|FG000|Overall Study|Withdrawal by Subject|0|||
23568796|NCT05284019|65809945|FG001|Overall Study|Withdrawal by Subject|0|||
23568797|NCT05284019|65809946|FG002|Overall Study|Withdrawal by Subject|0|||
23568798|NCT05284019|65809947|FG003|Overall Study|Withdrawal by Subject|1|||
23568799|NCT05284019|65809948|FG004|Overall Study|Withdrawal by Subject|1|||
23630477|NCT01907906|66032203|FG001|Overall Study|Withdrawal by Subject|0|||
23630478|NCT01907906|66032202|FG000|Overall Study|Physician Decision|3|||
23630479|NCT01907906|66032203|FG001|Overall Study|Physician Decision|1|||
23630480|NCT03194867|66032204|FG000|Overall Study|Incorrect completion of end of study form|0|||
23630481|NCT03194867|66032205|FG001|Overall Study|Incorrect completion of end of study form|0|||
23630482|NCT03194867|66032206|FG002|Overall Study|Incorrect completion of end of study form|1|||
23630483|NCT03194867|66032207|FG003|Overall Study|Incorrect completion of end of study form|0|||
23630484|NCT01592045|66034744|FG000|Overall Study|Disease Progression|1|||
23630485|NCT01592045|66034745|FG001|Overall Study|Disease Progression|1|||
23630486|NCT01592045|66034744|FG000|Overall Study|Adverse Event|1|||
23630487|NCT01592045|66034745|FG001|Overall Study|Adverse Event|1|||
23630488|NCT01592045|66034744|FG000|Overall Study|Withdrawal by Subject|1|||
23767658|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
23767659|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
23767660|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
23767661|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
23568800|NCT05284019|65809944|FG000|Overall Study|Lost to Follow-up|1|||
23568801|NCT05284019|65809945|FG001|Overall Study|Lost to Follow-up|0|||
23767662|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
23767663|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
23630489|NCT01592045|66034745|FG001|Overall Study|Withdrawal by Subject|0|||
23630490|NCT01592045|66034744|FG000|Overall Study|Moved out of country|2|||
23767664|NCT01656889|66527697|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
23767665|NCT01656889|66527698|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
23767666|NCT01656889|66527697|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
23767667|NCT01656889|66527698|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
23767668|NCT01656889|66527697|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
23767669|NCT01656889|66527698|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
23767670|NCT01656889|66527697|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
23767671|NCT01656889|66527698|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
23767672|NCT01656889|66527697|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
23767673|NCT01656889|66527698|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
23767674|NCT05487456|66527699|FG000|Overall Study|Withdrawal by Subject|0|||
23767675|NCT05487456|66527700|FG001|Overall Study|Withdrawal by Subject|0|||
23767676|NCT05487456|66527701|FG002|Overall Study|Withdrawal by Subject|1|||
23767677|NCT05487456|66527702|FG003|Overall Study|Withdrawal by Subject|0|||
23767678|NCT02114931|66527703|FG000|Overall Study|Withdrawal by Subject|15|||
23767679|NCT02114931|66527704|FG001|Overall Study|Withdrawal by Subject|18|||
23767680|NCT02114931|66527703|FG000|Overall Study|Adverse Event|4|||
23767681|NCT02114931|66527704|FG001|Overall Study|Adverse Event|6|||
23767682|NCT02114931|66527703|FG000|Overall Study|Lost to Follow-up|3|||
23767683|NCT02114931|66527704|FG001|Overall Study|Lost to Follow-up|3|||
23767684|NCT02114931|66527703|FG000|Overall Study|Physician Decision|1|||
23446588|NCT04492722|65377701|FG003|Overall Study|Lost to Follow-up|1|||
23446589|NCT04492722|65377698|FG000|Overall Study|Physician Decision|0|||
23446590|NCT04492722|65377699|FG001|Overall Study|Physician Decision|3|||
23446591|NCT04492722|65377700|FG002|Overall Study|Physician Decision|1|||
23568802|NCT05284019|65809946|FG002|Overall Study|Lost to Follow-up|0|||
23568803|NCT05284019|65809947|FG003|Overall Study|Lost to Follow-up|2|||
23568804|NCT05284019|65809948|FG004|Overall Study|Lost to Follow-up|1|||
23446592|NCT04492722|65377701|FG003|Overall Study|Physician Decision|1|||
23446593|NCT04492722|65377698|FG000|Overall Study|Withdrawal by Subject|6|||
23446594|NCT04492722|65377699|FG001|Overall Study|Withdrawal by Subject|6|||
23446595|NCT04492722|65377700|FG002|Overall Study|Withdrawal by Subject|0|||
23446596|NCT04492722|65377701|FG003|Overall Study|Withdrawal by Subject|3|||
23568805|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
23568806|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568807|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568808|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568809|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568810|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
23568811|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568812|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23630491|NCT01592045|66034745|FG001|Overall Study|Moved out of country|0|||
23630492|NCT03192462|66034746|FG000|Overall Study|Death|13|||
23630493|NCT03192462|66034747|FG001|Overall Study|Death|11|||
23630494|NCT03192462|66034748|FG002|Overall Study|Death|9|||
23630495|NCT03192462|66034746|FG000|Overall Study|Lost to Follow-up|0|||
23630496|NCT03192462|66034747|FG001|Overall Study|Lost to Follow-up|1|||
23630497|NCT03192462|66034748|FG002|Overall Study|Lost to Follow-up|0|||
23630498|NCT03192462|66034746|FG000|Overall Study|On follow up|0|||
23630499|NCT03192462|66034747|FG001|Overall Study|On follow up|0|||
23630500|NCT03192462|66034748|FG002|Overall Study|On follow up|3|||
23630501|NCT01732549|66034749|FG000|Overall Study|Adverse Event|13|||
23630502|NCT01732549|66034750|FG001|Overall Study|Adverse Event|3|||
23767685|NCT02114931|66527704|FG001|Overall Study|Physician Decision|2|||
23767686|NCT02114931|66527703|FG000|Overall Study|Other|2|||
23767687|NCT02114931|66527704|FG001|Overall Study|Other|1|||
23829940|NCT01890122|66756125|FG003|Overall Study|Lost to Follow-up|2|||
23829941|NCT01890122|66756122|FG000|Overall Study|Voluntary Withdrawal|8|||
23829942|NCT01890122|66756123|FG001|Overall Study|Voluntary Withdrawal|8|||
23829943|NCT01890122|66756124|FG002|Overall Study|Voluntary Withdrawal|2|||
23829944|NCT01890122|66756125|FG003|Overall Study|Voluntary Withdrawal|11|||
23829945|NCT01890122|66756122|FG000|Overall Study|Lack of Efficacy|14|||
23829946|NCT01890122|66756123|FG001|Overall Study|Lack of Efficacy|24|||
23829947|NCT01890122|66756124|FG002|Overall Study|Lack of Efficacy|7|||
23829948|NCT01890122|66756125|FG003|Overall Study|Lack of Efficacy|41|||
23829949|NCT01890122|66756122|FG000|Overall Study|Reason not Specified|0|||
23446597|NCT04492722|65377698|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
23446598|NCT04492722|65377699|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
23446599|NCT04492722|65377700|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
23446600|NCT04492722|65377701|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
23446601|NCT04492722|65377698|FG000|Overall Study|Due to Covid-19 pandemic|7|||
23446602|NCT04492722|65377699|FG001|Overall Study|Due to Covid-19 pandemic|3|||
23446603|NCT04492722|65377700|FG002|Overall Study|Due to Covid-19 pandemic|7|||
23446604|NCT04492722|65377701|FG003|Overall Study|Due to Covid-19 pandemic|6|||
23446605|NCT04492722|65377698|FG000|Overall Study|Failure to meet randomisation criteria|2|||
23446606|NCT04492722|65377699|FG001|Overall Study|Failure to meet randomisation criteria|3|||
23446607|NCT04492722|65377700|FG002|Overall Study|Failure to meet randomisation criteria|4|||
23568813|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568814|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568815|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
23568816|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568817|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568818|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568819|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568820|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
23568821|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568822|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568823|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568824|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568825|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
23568826|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568827|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568828|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568829|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568830|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
23568831|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23829950|NCT01890122|66756123|FG001|Overall Study|Reason not Specified|1|||
23446608|NCT04492722|65377701|FG003|Overall Study|Failure to meet randomisation criteria|2|||
23446609|NCT04492722|65377698|FG000|Overall Study|Early termination from the study|54|||
23446610|NCT04492722|65377699|FG001|Overall Study|Early termination from the study|51|||
23446611|NCT04492722|65377700|FG002|Overall Study|Early termination from the study|50|||
23446612|NCT04492722|65377701|FG003|Overall Study|Early termination from the study|50|||
23446613|NCT04492722|65377698|FG000|Overall Study|Missing|3|||
23446614|NCT04492722|65377699|FG001|Overall Study|Missing|0|||
23630503|NCT01732549|66034749|FG000|Overall Study|Consent withdrawn|13|||
23630504|NCT01732549|66034750|FG001|Overall Study|Consent withdrawn|6|||
23630505|NCT01732549|66034749|FG000|Overall Study|Disease progression|37|||
23630506|NCT01732549|66034750|FG001|Overall Study|Disease progression|50|||
23630507|NCT01732549|66034749|FG000|Overall Study|Other|8|||
23630508|NCT01732549|66034750|FG001|Overall Study|Other|14|||
23630509|NCT02559310|66034751|FG000|Overall Study|Death|4|||
23630510|NCT02559310|66034752|FG001|Overall Study|Death|3|||
23630511|NCT02559310|66034751|FG000|Overall Study|Lost to Follow-up|5|||
23630512|NCT02559310|66034752|FG001|Overall Study|Lost to Follow-up|3|||
23630513|NCT02559310|66034751|FG000|Overall Study|Physician Decision|2|||
23630514|NCT02559310|66034752|FG001|Overall Study|Physician Decision|1|||
23630515|NCT02559310|66034751|FG000|Overall Study|Withdrawal by Subject|13|||
23630516|NCT02559310|66034752|FG001|Overall Study|Withdrawal by Subject|9|||
23630517|NCT02559310|66034751|FG000|Overall Study|Sponsor Decision|0|||
23630518|NCT02559310|66034752|FG001|Overall Study|Sponsor Decision|1|||
23630519|NCT02559310|66034751|FG000|Overall Study|Randomized but not treated|3|||
23446615|NCT04492722|65377700|FG002|Overall Study|Missing|0|||
23446616|NCT04492722|65377701|FG003|Overall Study|Missing|5|||
23446617|NCT04492722|65377698|FG000|Overall Study|Participants who did not receive treatment|0|||
23446618|NCT04492722|65377699|FG001|Overall Study|Participants who did not receive treatment|1|||
23446619|NCT04492722|65377700|FG002|Overall Study|Participants who did not receive treatment|4|||
23446620|NCT04492722|65377701|FG003|Overall Study|Participants who did not receive treatment|0|||
23446621|NCT01054456|65377702|FG000|Overall Study|Other|1|||
23568832|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23446622|NCT03294590|65377703|FG000|Overall Study|Lost to Follow-up|105|||
23446623|NCT03294590|65377704|FG001|Overall Study|Lost to Follow-up|107|||
23568833|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23568834|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23568835|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
23568836|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568837|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568838|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568839|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23630520|NCT02559310|66034752|FG001|Overall Study|Randomized but not treated|2|||
23630521|NCT03690427|66034753|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
23630522|NCT03690427|66034754|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
23767688|NCT02410252|66527707|FG000|Overall Study|Withdrawal by Subject|4|||
23630523|NCT02127125|66034760|FG000|Overall Study|Lost to Follow-up|0|||
23630524|NCT02127125|66034761|FG001|Overall Study|Lost to Follow-up|0|||
23446624|NCT02370420|65377705|FG000|Overall Study|Physician Decision|3|||
23446625|NCT02370420|65377706|FG001|Overall Study|Physician Decision|3|||
23446626|NCT02370420|65377705|FG000|Overall Study|Lost to Follow-up|11|||
23446627|NCT02370420|65377706|FG001|Overall Study|Lost to Follow-up|9|||
23446628|NCT00154297|65377712|FG000|Overall Study|Death|5|||
23446629|NCT00154297|65377713|FG001|Overall Study|Death|2|||
23446630|NCT00154297|65377712|FG000|Overall Study|Withdrawal by Subject|0|||
23446631|NCT00154297|65377713|FG001|Overall Study|Withdrawal by Subject|5|||
23446632|NCT00154297|65377712|FG000|Overall Study|Lost to Follow-up|3|||
23446633|NCT00154297|65377713|FG001|Overall Study|Lost to Follow-up|0|||
23446634|NCT04524858|65377714|FG000|Overall Study|Adverse Event|1|||
23446635|NCT00920855|65377715|FG000|Overall Study|Adverse Event|1|||
23446636|NCT00920855|65377716|FG001|Overall Study|Adverse Event|1|||
23630525|NCT02127125|66034762|FG002|Overall Study|Lost to Follow-up|0|||
23630526|NCT02127125|66034763|FG003|Overall Study|Lost to Follow-up|0|||
23630527|NCT02127125|66034764|FG004|Overall Study|Lost to Follow-up|2|||
23630528|NCT02127125|66034765|FG005|Overall Study|Lost to Follow-up|1|||
23630529|NCT02127125|66034766|FG006|Overall Study|Lost to Follow-up|0|||
23630530|NCT02127125|66034767|FG007|Overall Study|Lost to Follow-up|0|||
23630531|NCT02127125|66034768|FG008|Overall Study|Lost to Follow-up|0|||
23630532|NCT02127125|66034760|FG000|Overall Study|Withdrawal by Subject|0|||
23630533|NCT02127125|66034761|FG001|Overall Study|Withdrawal by Subject|0|||
23630534|NCT02127125|66034762|FG002|Overall Study|Withdrawal by Subject|0|||
23630535|NCT02127125|66034763|FG003|Overall Study|Withdrawal by Subject|1|||
23630536|NCT02127125|66034764|FG004|Overall Study|Withdrawal by Subject|0|||
23630537|NCT02127125|66034765|FG005|Overall Study|Withdrawal by Subject|0|||
23630538|NCT02127125|66034766|FG006|Overall Study|Withdrawal by Subject|0|||
23630539|NCT02127125|66034767|FG007|Overall Study|Withdrawal by Subject|0|||
23630540|NCT02127125|66034768|FG008|Overall Study|Withdrawal by Subject|0|||
23630541|NCT02127125|66034760|FG000|Overall Study|Physician Decision|0|||
23630542|NCT02127125|66034761|FG001|Overall Study|Physician Decision|0|||
23630543|NCT02127125|66034762|FG002|Overall Study|Physician Decision|1|||
23630544|NCT02127125|66034763|FG003|Overall Study|Physician Decision|0|||
23767689|NCT02410252|66527707|FG000|Overall Study|Physician Decision|2|||
23630545|NCT02127125|66034764|FG004|Overall Study|Physician Decision|1|||
23630546|NCT02127125|66034765|FG005|Overall Study|Physician Decision|2|||
23630547|NCT02127125|66034766|FG006|Overall Study|Physician Decision|0|||
23630548|NCT02127125|66034767|FG007|Overall Study|Physician Decision|0|||
23630549|NCT02127125|66034768|FG008|Overall Study|Physician Decision|0|||
23630550|NCT05071313|66034769|FG000|Overall Study|Lost to Follow-up|17|||
23630551|NCT05071313|66034770|FG001|Overall Study|Lost to Follow-up|10|||
23630552|NCT05071313|66034769|FG000|Overall Study|Physician Decision|1|||
23630553|NCT05071313|66034770|FG001|Overall Study|Physician Decision|6|||
23630554|NCT05071313|66034769|FG000|Overall Study|Death|1|||
23767690|NCT01842958|66527721|FG000|Overall Study|Lost to Follow-up|1|||
23767691|NCT01842958|66527722|FG001|Overall Study|Lost to Follow-up|1|||
23767692|NCT01400113|66527724|FG000|Overall Study|Withdrawal by Subject|1|||
23767693|NCT01400113|66527725|FG001|Overall Study|Withdrawal by Subject|1|||
23767694|NCT00368277|66527726|FG000|Overall Study|Adverse Event|33|||
23767695|NCT00368277|66527727|FG001|Overall Study|Adverse Event|49|||
23767696|NCT00368277|66527726|FG000|Overall Study|Death|2|||
23767697|NCT00368277|66527727|FG001|Overall Study|Death|1|||
23767698|NCT00368277|66527726|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
23767699|NCT00368277|66527727|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
23767700|NCT00368277|66527726|FG000|Overall Study|Protocol deviation|7|||
23767701|NCT00368277|66527727|FG001|Overall Study|Protocol deviation|0|||
23767702|NCT00368277|66527726|FG000|Overall Study|Patient withdrew consent|32|||
23630555|NCT05071313|66034770|FG001|Overall Study|Death|0|||
23630556|NCT05071313|66034769|FG000|Overall Study|Withdrawal by Subject|10|||
23767703|NCT00368277|66527727|FG001|Overall Study|Patient withdrew consent|28|||
23767704|NCT00368277|66527726|FG000|Overall Study|Lost to Follow-up|8|||
23767705|NCT00368277|66527727|FG001|Overall Study|Lost to Follow-up|6|||
23446637|NCT00920855|65377717|FG002|Overall Study|Adverse Event|4|||
23446638|NCT00920855|65377715|FG000|Overall Study|Withdrawal by Subject|2|||
23630557|NCT05071313|66034770|FG001|Overall Study|Withdrawal by Subject|15|||
23630558|NCT05071313|66034769|FG000|Overall Study|Other|1|||
23630559|NCT05071313|66034770|FG001|Overall Study|Other|0|||
23767706|NCT00113490|66527731|FG000|Overall Study|Withdrawal by Subject|1|||
23767707|NCT00113490|66527732|FG001|Overall Study|Withdrawal by Subject|3|||
23767708|NCT00113490|66527731|FG000|Overall Study|Lost to Follow-up|1|||
23767709|NCT00113490|66527732|FG001|Overall Study|Lost to Follow-up|0|||
23767710|NCT01058421|66527735|FG000|1 Month Outcomes|Death|10|||
23767711|NCT01058421|66527736|FG001|1 Month Outcomes|Death|6|||
23767712|NCT01058421|66527735|FG000|1 Month Outcomes|Lost to Follow-up|8|||
23767713|NCT01058421|66527736|FG001|1 Month Outcomes|Lost to Follow-up|7|||
23767714|NCT01058421|66527735|FG000|1 Month Outcomes|Remained in Hospital|5|||
23767715|NCT01058421|66527736|FG001|1 Month Outcomes|Remained in Hospital|12|||
23767716|NCT01058421|66527735|FG000|1 Month Outcomes|Remained in Other Facility|16|||
23767717|NCT01058421|66527736|FG001|1 Month Outcomes|Remained in Other Facility|17|||
23767718|NCT01058421|66527735|FG000|3 Month Outcomes|Death|3|||
23767719|NCT01058421|66527736|FG001|3 Month Outcomes|Death|5|||
23767720|NCT01058421|66527735|FG000|3 Month Outcomes|Lost to Follow-up|12|||
23767721|NCT01058421|66527736|FG001|3 Month Outcomes|Lost to Follow-up|11|||
23767722|NCT01058421|66527735|FG000|3 Month Outcomes|Remained in Hospital|0|||
23767723|NCT01058421|66527736|FG001|3 Month Outcomes|Remained in Hospital|2|||
23767724|NCT01058421|66527735|FG000|3 Month Outcomes|Remained in Other Facility|5|||
23767725|NCT01058421|66527736|FG001|3 Month Outcomes|Remained in Other Facility|8|||
23767726|NCT01058421|66527735|FG000|6 Month Outcomes|Death|2|||
23767727|NCT01058421|66527736|FG001|6 Month Outcomes|Death|2|||
23767728|NCT01058421|66527735|FG000|6 Month Outcomes|Lost to Follow-up|16|||
23767729|NCT01058421|66527736|FG001|6 Month Outcomes|Lost to Follow-up|21|||
23767730|NCT01058421|66527735|FG000|6 Month Outcomes|Remained in Other Facility|1|||
23767731|NCT01058421|66527736|FG001|6 Month Outcomes|Remained in Other Facility|3|||
23767732|NCT01793610|66527737|FG000|Overall Study|Withdrawal by Subject|1|||
23767733|NCT01793610|66527738|FG001|Overall Study|Withdrawal by Subject|0|||
23568840|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
23568841|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568842|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568843|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568844|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568845|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
23568846|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568847|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568848|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568849|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568850|NCT03893825|65809957|FG000|Overall Study|Death|2|||
23568851|NCT03893825|65809958|FG001|Overall Study|Death|1|||
23568852|NCT03893825|65809957|FG000|Overall Study|Adverse Event|0|||
23568853|NCT03893825|65809958|FG001|Overall Study|Adverse Event|2|||
23568854|NCT03893825|65809957|FG000|Overall Study|Withdrawal by Subject|19|||
23568855|NCT03893825|65809958|FG001|Overall Study|Withdrawal by Subject|21|||
23568856|NCT03893825|65809957|FG000|Overall Study|Protocol deviation|1|||
23568857|NCT03893825|65809958|FG001|Overall Study|Protocol deviation|0|||
23568858|NCT03893825|65809957|FG000|Overall Study|Lost to Follow-up|10|||
23568859|NCT03893825|65809958|FG001|Overall Study|Lost to Follow-up|10|||
23568860|NCT03893825|65809957|FG000|Overall Study|Other than specified|7|||
23568861|NCT03893825|65809958|FG001|Overall Study|Other than specified|6|||
23568862|NCT00423293|65809960|FG000|Overall Study|Ineligible / No protocol treatment|11|||
23568863|NCT01216293|65809961|FG000|Main Study|Adverse Event|1|||
23568864|NCT01216293|65809962|FG001|Main Study|Adverse Event|4|||
23568865|NCT01216293|65809963|FG002|Main Study|Adverse Event|2|||
23568866|NCT01216293|65809961|FG000|Main Study|Major Protocol Deviation|1|||
23568867|NCT01216293|65809962|FG001|Main Study|Major Protocol Deviation|0|||
23568868|NCT01216293|65809963|FG002|Main Study|Major Protocol Deviation|1|||
23568869|NCT01216293|65809961|FG000|Main Study|Lost to Follow-up|3|||
23568870|NCT01216293|65809962|FG001|Main Study|Lost to Follow-up|1|||
23568871|NCT01216293|65809963|FG002|Main Study|Lost to Follow-up|0|||
23568872|NCT01216293|65809961|FG000|Main Study|Voluntary Withdrawal|2|||
23568873|NCT01216293|65809962|FG001|Main Study|Voluntary Withdrawal|2|||
23568874|NCT01216293|65809963|FG002|Main Study|Voluntary Withdrawal|2|||
23568875|NCT01216293|65809961|FG000|Main Study|Other Reason Not Specified|0|||
23568876|NCT01216293|65809962|FG001|Main Study|Other Reason Not Specified|1|||
23568877|NCT01216293|65809963|FG002|Main Study|Other Reason Not Specified|1|||
23568878|NCT01216293|65809961|FG000|Main Study|Randomized, Not Treated|1|||
23568879|NCT01216293|65809962|FG001|Main Study|Randomized, Not Treated|0|||
23568880|NCT01216293|65809963|FG002|Main Study|Randomized, Not Treated|0|||
23568881|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Adverse Event|0|||
23568882|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Adverse Event|2|||
23568883|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Adverse Event|0|||
23767734|NCT01793610|66527739|FG002|Overall Study|Withdrawal by Subject|1|||
23767735|NCT00545233|66527744|FG000|Overall Study|Adverse Event|10|||
23767736|NCT00545233|66527745|FG001|Overall Study|Adverse Event|5|||
23767737|NCT00545233|66527744|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
23767738|NCT00545233|66527745|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23767739|NCT00545233|66527744|FG000|Overall Study|Protocol Violation|2|||
23829951|NCT01890122|66756124|FG002|Overall Study|Reason not Specified|1|||
23829952|NCT01890122|66756125|FG003|Overall Study|Reason not Specified|2|||
23829953|NCT01890122|66756122|FG000|Overall Study|Randomized but not Treated|1|||
23829954|NCT01890122|66756123|FG001|Overall Study|Randomized but not Treated|1|||
23829955|NCT01890122|66756124|FG002|Overall Study|Randomized but not Treated|0|||
23829956|NCT01890122|66756125|FG003|Overall Study|Randomized but not Treated|0|||
23829957|NCT00979654|66756126|FG000|Overall Study|Lost to Follow-up|1|||
23829958|NCT00979654|66756126|FG000|Overall Study|Withdrawal by Subject|22|||
23829959|NCT00979654|66756126|FG000|Overall Study|Death|1|||
23829960|NCT00979654|66756126|FG000|Overall Study|Lack of Efficacy|6|||
23568884|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
23568885|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
23829961|NCT00979654|66756126|FG000|Overall Study|Adverse Event|1|||
23829962|NCT00979654|66756126|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
23829963|NCT00979654|66756126|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
23829964|NCT00979654|66756126|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
23829965|NCT00979654|66756126|FG000|Overall Study|Serious Adverse Event|1|||
23829966|NCT00979654|66756126|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
23829967|NCT00662649|66756127|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
23767740|NCT00545233|66527745|FG001|Overall Study|Protocol Violation|0|||
23767741|NCT00545233|66527744|FG000|Overall Study|Refused Treatment|9|||
23767742|NCT00545233|66527745|FG001|Overall Study|Refused Treatment|7|||
23767743|NCT00545233|66527744|FG000|Overall Study|Failure to Return|4|||
23767744|NCT00545233|66527745|FG001|Overall Study|Failure to Return|6|||
23767745|NCT00545233|66527744|FG000|Overall Study|Insufficient response|14|||
23829968|NCT00662649|66756128|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
23829969|NCT00662649|66756129|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
23829970|NCT00662649|66756130|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
23829971|NCT00662649|66756131|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
23829972|NCT00662649|66756127|FG000|Core Study (24 Months)|Adverse Event|22|||
23829973|NCT00662649|66756128|FG001|Core Study (24 Months)|Adverse Event|13|||
23829974|NCT00662649|66756129|FG002|Core Study (24 Months)|Adverse Event|18|||
23829975|NCT00662649|66756130|FG003|Core Study (24 Months)|Adverse Event|0|||
23829976|NCT00662649|66756131|FG004|Core Study (24 Months)|Adverse Event|0|||
23829977|NCT00662649|66756127|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
23829978|NCT00662649|66756128|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
23829979|NCT00662649|66756129|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
23829980|NCT00662649|66756130|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
23829981|NCT00662649|66756131|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
23829982|NCT00662649|66756127|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
23829983|NCT00662649|66756128|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
23568886|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
23568887|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
23568888|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
23568889|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
23568890|NCT00147225|65809964|FG000|Overall Study|Withdrawal by Subject|1|||
23568891|NCT00147225|65809965|FG001|Overall Study|Withdrawal by Subject|0|||
23568892|NCT00147225|65809966|FG002|Overall Study|Withdrawal by Subject|1|||
23568893|NCT00147225|65809967|FG003|Overall Study|Withdrawal by Subject|0|||
23568894|NCT00147225|65809968|FG004|Overall Study|Withdrawal by Subject|0|||
23568895|NCT00147225|65809969|FG005|Overall Study|Withdrawal by Subject|1|||
23568896|NCT00147225|65809964|FG000|Overall Study|Adverse Event|0|||
23568897|NCT00147225|65809965|FG001|Overall Study|Adverse Event|0|||
23568898|NCT00147225|65809966|FG002|Overall Study|Adverse Event|1|||
23568899|NCT00147225|65809967|FG003|Overall Study|Adverse Event|1|||
23568900|NCT00147225|65809968|FG004|Overall Study|Adverse Event|0|||
23568901|NCT00147225|65809969|FG005|Overall Study|Adverse Event|0|||
23568902|NCT00147225|65809964|FG000|Overall Study|Screen Failure|0|||
23568903|NCT00147225|65809965|FG001|Overall Study|Screen Failure|0|||
23568904|NCT00147225|65809966|FG002|Overall Study|Screen Failure|0|||
23568905|NCT00147225|65809967|FG003|Overall Study|Screen Failure|0|||
23568906|NCT00147225|65809968|FG004|Overall Study|Screen Failure|1|||
23568907|NCT00147225|65809969|FG005|Overall Study|Screen Failure|0|||
23568908|NCT00147225|65809964|FG000|Overall Study|Chemotherapy Changed|0|||
23568909|NCT00147225|65809965|FG001|Overall Study|Chemotherapy Changed|0|||
23568910|NCT00147225|65809966|FG002|Overall Study|Chemotherapy Changed|0|||
23568911|NCT00147225|65809967|FG003|Overall Study|Chemotherapy Changed|0|||
23767746|NCT00545233|66527745|FG001|Overall Study|Insufficient response|15|||
23767747|NCT00545233|66527744|FG000|Overall Study|Physician Decision|2|||
23829984|NCT00662649|66756129|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
23829985|NCT00662649|66756130|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
23829986|NCT00662649|66756131|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
23829987|NCT00662649|66756127|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
23767748|NCT00545233|66527745|FG001|Overall Study|Physician Decision|1|||
23446639|NCT00920855|65377716|FG001|Overall Study|Withdrawal by Subject|1|||
23446640|NCT00920855|65377717|FG002|Overall Study|Withdrawal by Subject|6|||
23446641|NCT00920855|65377715|FG000|Overall Study|Disease progression|2|||
23446642|NCT00920855|65377716|FG001|Overall Study|Disease progression|1|||
23446643|NCT00920855|65377717|FG002|Overall Study|Disease progression|10|||
23446644|NCT00920855|65377715|FG000|Overall Study|Noncompliance to study medication|0|||
23630560|NCT05071313|66034769|FG000|Overall Study|Randomized but not vaccinated|4|||
23630561|NCT05071313|66034770|FG001|Overall Study|Randomized but not vaccinated|2|||
23630562|NCT02094898|66034771|FG000|Overall Study|Clinical Worsening|2|||
23630563|NCT02094898|66034771|FG000|Overall Study|Adverse Event|2|||
23630564|NCT02094898|66034771|FG000|Overall Study|Lack of Efficacy|1|||
23630565|NCT02125279|66034772|FG000|Overall Study|Lack of Efficacy|2|||
23630566|NCT02125279|66034772|FG000|Overall Study|Withdrawal by Subject|6|||
23630567|NCT02125279|66034772|FG000|Overall Study|Protocol Violation|1|||
23630568|NCT02125279|66034772|FG000|Overall Study|Lost to Follow-up|4|||
23630569|NCT01240551|66034774|FG000|Overall Study|Refused further treatment|3|||
23630570|NCT01240551|66034775|FG001|Overall Study|Refused further treatment|2|||
23630571|NCT01240551|66034774|FG000|Overall Study|Lost to Follow-up|1|||
23767749|NCT00433381|66527756|FG000|Overall Study|Ineligible / no protocol treatment|3|||
23767750|NCT00433381|66527757|FG001|Overall Study|Ineligible / no protocol treatment|3|||
23767751|NCT04634409|66527758|FG000|Overall Study|Death|0|||
23767752|NCT04634409|66527759|FG001|Overall Study|Death|0|||
23446645|NCT00920855|65377716|FG001|Overall Study|Noncompliance to study medication|0|||
23446646|NCT00920855|65377717|FG002|Overall Study|Noncompliance to study medication|1|||
23446647|NCT00920855|65377715|FG000|Overall Study|Response plateau; started maintenance|0|||
23446648|NCT00920855|65377716|FG001|Overall Study|Response plateau; started maintenance|0|||
23446649|NCT00920855|65377717|FG002|Overall Study|Response plateau; started maintenance|1|||
23446650|NCT02021643|65377726|FG000|Overall Study|Enrolled but Never Treated|1|||
23446651|NCT02021643|65377727|FG001|Overall Study|Enrolled but Never Treated|0|||
23446652|NCT02021643|65377728|FG002|Overall Study|Enrolled but Never Treated|0|||
23568912|NCT00147225|65809968|FG004|Overall Study|Chemotherapy Changed|0|||
23568913|NCT00147225|65809969|FG005|Overall Study|Chemotherapy Changed|1|||
23568914|NCT03443713|65809973|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
23568915|NCT03443713|65809974|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
23568916|NCT03443713|65809975|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
23568917|NCT01213173|65809976|FG000|Overall Study|Protocol Violation|2|||
23568918|NCT01213173|65809977|FG001|Overall Study|Protocol Violation|0|||
23568919|NCT01213173|65809976|FG000|Overall Study|Adverse Event|4|||
23568920|NCT01213173|65809977|FG001|Overall Study|Adverse Event|8|||
23568921|NCT01213173|65809976|FG000|Overall Study|Withdrawal by Subject|5|||
23568922|NCT01213173|65809977|FG001|Overall Study|Withdrawal by Subject|5|||
23767753|NCT04634409|66527760|FG002|Overall Study|Death|0|||
23767754|NCT04634409|66527761|FG003|Overall Study|Death|0|||
23767755|NCT04634409|66527762|FG004|Overall Study|Death|0|||
23767756|NCT04634409|66527763|FG005|Overall Study|Death|0|||
23767757|NCT04634409|66527764|FG006|Overall Study|Death|0|||
23767758|NCT04634409|66527765|FG007|Overall Study|Death|0|||
23568923|NCT01213173|65809976|FG000|Overall Study|Incorrect Enrollment|1|||
23630572|NCT01240551|66034775|FG001|Overall Study|Lost to Follow-up|1|||
23767759|NCT04634409|66527766|FG008|Overall Study|Death|0|||
23767760|NCT04634409|66527767|FG009|Overall Study|Death|0|||
23767761|NCT04634409|66527768|FG010|Overall Study|Death|1|||
23767762|NCT04634409|66527769|FG011|Overall Study|Death|0|||
23767763|NCT04634409|66527770|FG012|Overall Study|Death|1|||
23767764|NCT04634409|66527771|FG013|Overall Study|Death|0|||
23767765|NCT04634409|66527772|FG014|Overall Study|Death|0|||
23767766|NCT04634409|66527773|FG015|Overall Study|Death|0|||
23767767|NCT04634409|66527774|FG016|Overall Study|Death|0|||
23767768|NCT04634409|66527775|FG017|Overall Study|Death|0|||
23767769|NCT04634409|66527776|FG018|Overall Study|Death|0|||
23767770|NCT04634409|66527777|FG019|Overall Study|Death|0|||
23446653|NCT02021643|65377729|FG003|Overall Study|Enrolled but Never Treated|0|||
23446654|NCT02021643|65377726|FG000|Overall Study|Adverse Event|0|||
23630573|NCT00847626|66034777|FG000|Overall Study|Adverse Event|10|||
23630574|NCT00847626|66034778|FG001|Overall Study|Adverse Event|10|||
23630575|NCT00847626|66034779|FG002|Overall Study|Adverse Event|6|||
23630576|NCT00847626|66034780|FG003|Overall Study|Adverse Event|19|||
23630577|NCT00847626|66034781|FG004|Overall Study|Adverse Event|11|||
23630578|NCT00847626|66034782|FG005|Overall Study|Adverse Event|22|||
23767771|NCT04634409|66527778|FG020|Overall Study|Death|0|||
23767772|NCT04634409|66527779|FG021|Overall Study|Death|0|||
23767773|NCT04634409|66527780|FG022|Overall Study|Death|0|||
23767774|NCT04634409|66527781|FG023|Overall Study|Death|0|||
23767775|NCT04634409|66527782|FG024|Overall Study|Death|0|||
23767776|NCT04634409|66527783|FG025|Overall Study|Death|0|||
23767777|NCT04634409|66527784|FG026|Overall Study|Death|0|||
23767778|NCT04634409|66527758|FG000|Overall Study|Adverse Event|0|||
23767779|NCT04634409|66527759|FG001|Overall Study|Adverse Event|0|||
23767780|NCT04634409|66527760|FG002|Overall Study|Adverse Event|1|||
23446655|NCT02021643|65377727|FG001|Overall Study|Adverse Event|1|||
23446656|NCT02021643|65377728|FG002|Overall Study|Adverse Event|0|||
23446657|NCT02021643|65377729|FG003|Overall Study|Adverse Event|0|||
23829988|NCT00662649|66756128|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
23446658|NCT02021643|65377726|FG000|Overall Study|Death|0|||
23568924|NCT01213173|65809977|FG001|Overall Study|Incorrect Enrollment|3|||
23568925|NCT00545363|65809982|FG000|Overall Study|Adverse Event|6|||
23630579|NCT00847626|66034783|FG006|Overall Study|Adverse Event|4|||
23630580|NCT00847626|66034784|FG007|Overall Study|Adverse Event|6|||
23630581|NCT00847626|66034785|FG008|Overall Study|Adverse Event|3|||
23630582|NCT00847626|66034786|FG009|Overall Study|Adverse Event|6|||
23630583|NCT00847626|66034787|FG010|Overall Study|Adverse Event|6|||
23630584|NCT00847626|66034777|FG000|Overall Study|Protocol Violation|2|||
23630585|NCT00847626|66034778|FG001|Overall Study|Protocol Violation|1|||
23630586|NCT00847626|66034779|FG002|Overall Study|Protocol Violation|2|||
23630587|NCT00847626|66034780|FG003|Overall Study|Protocol Violation|1|||
23630588|NCT00847626|66034781|FG004|Overall Study|Protocol Violation|1|||
23630589|NCT00847626|66034782|FG005|Overall Study|Protocol Violation|1|||
23630590|NCT00847626|66034783|FG006|Overall Study|Protocol Violation|1|||
23630591|NCT00847626|66034784|FG007|Overall Study|Protocol Violation|1|||
23630592|NCT00847626|66034785|FG008|Overall Study|Protocol Violation|0|||
23630593|NCT00847626|66034786|FG009|Overall Study|Protocol Violation|1|||
23630594|NCT00847626|66034787|FG010|Overall Study|Protocol Violation|1|||
23630595|NCT00847626|66034777|FG000|Overall Study|Lost to Follow-up|0|||
23630596|NCT00847626|66034778|FG001|Overall Study|Lost to Follow-up|1|||
23630597|NCT00847626|66034779|FG002|Overall Study|Lost to Follow-up|1|||
23630598|NCT00847626|66034780|FG003|Overall Study|Lost to Follow-up|1|||
23630599|NCT00847626|66034781|FG004|Overall Study|Lost to Follow-up|0|||
23630600|NCT00847626|66034782|FG005|Overall Study|Lost to Follow-up|3|||
23630601|NCT00847626|66034783|FG006|Overall Study|Lost to Follow-up|1|||
23630602|NCT00847626|66034784|FG007|Overall Study|Lost to Follow-up|3|||
23630603|NCT00847626|66034785|FG008|Overall Study|Lost to Follow-up|1|||
23630604|NCT00847626|66034786|FG009|Overall Study|Lost to Follow-up|0|||
23630605|NCT00847626|66034787|FG010|Overall Study|Lost to Follow-up|1|||
23630606|NCT00847626|66034777|FG000|Overall Study|Withdrawal by Subject|5|||
23568926|NCT00545363|65809983|FG001|Overall Study|Adverse Event|7|||
23568927|NCT00545363|65809982|FG000|Overall Study|Withdrawal by Subject|6|||
23568928|NCT00545363|65809983|FG001|Overall Study|Withdrawal by Subject|5|||
23568929|NCT00545363|65809982|FG000|Overall Study|Non-compliance|3|||
23568930|NCT00545363|65809983|FG001|Overall Study|Non-compliance|1|||
23568931|NCT00545363|65809982|FG000|Overall Study|Did not meet entry criteria|1|||
23568932|NCT00545363|65809983|FG001|Overall Study|Did not meet entry criteria|1|||
23630607|NCT00847626|66034778|FG001|Overall Study|Withdrawal by Subject|5|||
23630608|NCT00847626|66034779|FG002|Overall Study|Withdrawal by Subject|3|||
23568933|NCT00545363|65809982|FG000|Overall Study|Lost to Follow-up|2|||
23568934|NCT00545363|65809983|FG001|Overall Study|Lost to Follow-up|0|||
23568935|NCT00545363|65809982|FG000|Overall Study|Other|1|||
23568936|NCT00545363|65809983|FG001|Overall Study|Other|1|||
23568937|NCT01671748|65809985|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
23568938|NCT01671748|65809986|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
23568939|NCT01671748|65809985|FG000|4 Week run-in Phase|Adverse Event|1|||
23568940|NCT01671748|65809986|FG001|4 Week run-in Phase|Adverse Event|0|||
23630609|NCT00847626|66034780|FG003|Overall Study|Withdrawal by Subject|8|||
23630610|NCT00847626|66034781|FG004|Overall Study|Withdrawal by Subject|12|||
23630611|NCT00847626|66034782|FG005|Overall Study|Withdrawal by Subject|9|||
23568941|NCT01671748|65809985|FG000|4 Week run-in Phase|Not eligible|9|||
23568942|NCT01671748|65809986|FG001|4 Week run-in Phase|Not eligible|0|||
23568943|NCT02032173|65809987|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
23446659|NCT02021643|65377727|FG001|Overall Study|Death|1|||
23568944|NCT03856996|65809988|FG000|Overall Study|Withdrawal by Subject|1|||
23568945|NCT03856996|65809989|FG001|Overall Study|Withdrawal by Subject|0|||
23568946|NCT03856996|65809988|FG000|Overall Study|Lost to Follow-up|0|||
23630612|NCT00847626|66034783|FG006|Overall Study|Withdrawal by Subject|8|||
23446660|NCT02021643|65377728|FG002|Overall Study|Death|0|||
23568947|NCT03856996|65809989|FG001|Overall Study|Lost to Follow-up|1|||
23630613|NCT00847626|66034784|FG007|Overall Study|Withdrawal by Subject|4|||
23630614|NCT00847626|66034785|FG008|Overall Study|Withdrawal by Subject|4|||
23767781|NCT04634409|66527761|FG003|Overall Study|Adverse Event|0|||
23767782|NCT04634409|66527762|FG004|Overall Study|Adverse Event|0|||
23767783|NCT04634409|66527763|FG005|Overall Study|Adverse Event|1|||
23767784|NCT04634409|66527764|FG006|Overall Study|Adverse Event|0|||
23767785|NCT04634409|66527765|FG007|Overall Study|Adverse Event|0|||
23767786|NCT04634409|66527766|FG008|Overall Study|Adverse Event|0|||
23767787|NCT04634409|66527767|FG009|Overall Study|Adverse Event|0|||
23767788|NCT04634409|66527768|FG010|Overall Study|Adverse Event|0|||
23767789|NCT04634409|66527769|FG011|Overall Study|Adverse Event|0|||
23767790|NCT04634409|66527770|FG012|Overall Study|Adverse Event|0|||
23767791|NCT04634409|66527771|FG013|Overall Study|Adverse Event|0|||
23767792|NCT04634409|66527772|FG014|Overall Study|Adverse Event|0|||
23630615|NCT00847626|66034786|FG009|Overall Study|Withdrawal by Subject|5|||
23767793|NCT04634409|66527773|FG015|Overall Study|Adverse Event|0|||
23767794|NCT04634409|66527774|FG016|Overall Study|Adverse Event|0|||
23767795|NCT04634409|66527775|FG017|Overall Study|Adverse Event|0|||
23767796|NCT04634409|66527776|FG018|Overall Study|Adverse Event|0|||
23767797|NCT04634409|66527777|FG019|Overall Study|Adverse Event|0|||
23767798|NCT04634409|66527778|FG020|Overall Study|Adverse Event|0|||
23767799|NCT04634409|66527779|FG021|Overall Study|Adverse Event|0|||
23767800|NCT04634409|66527780|FG022|Overall Study|Adverse Event|0|||
23767801|NCT04634409|66527781|FG023|Overall Study|Adverse Event|0|||
23767802|NCT04634409|66527782|FG024|Overall Study|Adverse Event|0|||
23767803|NCT04634409|66527783|FG025|Overall Study|Adverse Event|0|||
23767804|NCT04634409|66527784|FG026|Overall Study|Adverse Event|0|||
23767805|NCT04634409|66527758|FG000|Overall Study|Lost to Follow-up|3|||
23630616|NCT00847626|66034787|FG010|Overall Study|Withdrawal by Subject|2|||
23630617|NCT00847626|66034777|FG000|Overall Study|Lack of Efficacy|3|||
23630618|NCT00847626|66034778|FG001|Overall Study|Lack of Efficacy|1|||
23630619|NCT00847626|66034779|FG002|Overall Study|Lack of Efficacy|0|||
23630620|NCT00847626|66034780|FG003|Overall Study|Lack of Efficacy|1|||
23630621|NCT00847626|66034781|FG004|Overall Study|Lack of Efficacy|2|||
23630622|NCT00847626|66034782|FG005|Overall Study|Lack of Efficacy|0|||
23630623|NCT00847626|66034783|FG006|Overall Study|Lack of Efficacy|6|||
23630624|NCT00847626|66034784|FG007|Overall Study|Lack of Efficacy|2|||
23630625|NCT00847626|66034785|FG008|Overall Study|Lack of Efficacy|5|||
23630626|NCT00847626|66034786|FG009|Overall Study|Lack of Efficacy|1|||
23630627|NCT00847626|66034787|FG010|Overall Study|Lack of Efficacy|7|||
23630628|NCT00847626|66034777|FG000|Overall Study|Other|1|||
23630629|NCT00847626|66034778|FG001|Overall Study|Other|5|||
23630630|NCT00847626|66034779|FG002|Overall Study|Other|4|||
23630631|NCT00847626|66034780|FG003|Overall Study|Other|1|||
23568948|NCT03856996|65809988|FG000|Overall Study|Adverse Event|1|||
23568949|NCT03856996|65809989|FG001|Overall Study|Adverse Event|1|||
23568950|NCT03856996|65809988|FG000|Overall Study|Other|1|||
23568951|NCT03856996|65809989|FG001|Overall Study|Other|0|||
23568952|NCT01342887|65809990|FG000|Overall Study|Death|2|||
23568953|NCT00924560|65813168|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
23568954|NCT00924560|65813169|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
23568955|NCT00924560|65813170|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
23568956|NCT00924560|65813168|FG000|Overall Study|Non Compliance with the Protocol|20|||
23568957|NCT00924560|65813169|FG001|Overall Study|Non Compliance with the Protocol|15|||
23568958|NCT00924560|65813170|FG002|Overall Study|Non Compliance with the Protocol|4|||
23568959|NCT00924560|65813168|FG000|Overall Study|Physician Decision|2|||
23568960|NCT00924560|65813169|FG001|Overall Study|Physician Decision|3|||
23568961|NCT00924560|65813170|FG002|Overall Study|Physician Decision|4|||
23568962|NCT00924560|65813168|FG000|Overall Study|Withdrawal by Subject|50|||
23568963|NCT00924560|65813169|FG001|Overall Study|Withdrawal by Subject|44|||
23568964|NCT00924560|65813170|FG002|Overall Study|Withdrawal by Subject|18|||
23568965|NCT00924560|65813168|FG000|Overall Study|Adverse Event|39|||
23568966|NCT00924560|65813169|FG001|Overall Study|Adverse Event|33|||
23568967|NCT00924560|65813170|FG002|Overall Study|Adverse Event|0|||
23568968|NCT00924560|65813168|FG000|Overall Study|Pregnancy|5|||
23568969|NCT00924560|65813169|FG001|Overall Study|Pregnancy|7|||
23568970|NCT00924560|65813170|FG002|Overall Study|Pregnancy|1|||
23568971|NCT00924560|65813168|FG000|Overall Study|Lost to Follow-up|78|||
23568972|NCT00924560|65813169|FG001|Overall Study|Lost to Follow-up|94|||
23568973|NCT00924560|65813170|FG002|Overall Study|Lost to Follow-up|45|||
23568974|NCT00924560|65813168|FG000|Overall Study|Miscellaneous Reasons|13|||
23568975|NCT00924560|65813169|FG001|Overall Study|Miscellaneous Reasons|10|||
23568976|NCT00924560|65813170|FG002|Overall Study|Miscellaneous Reasons|10|||
23568977|NCT01987596|65813172|FG000|Overall Study|Physician Decision|1|||
23568978|NCT01987596|65813173|FG001|Overall Study|Physician Decision|0|||
23568979|NCT01987596|65813172|FG000|Overall Study|Progressive Disease; missing all period|0|||
23568980|NCT01987596|65813173|FG001|Overall Study|Progressive Disease; missing all period|1|||
23568981|NCT00924469|65813174|FG000|Overall Study|Adverse Event|2|||
23568982|NCT00924469|65813175|FG001|Overall Study|Adverse Event|0|||
23568983|NCT00924469|65813174|FG000|Overall Study|Withdrawal by Subject|0|||
23568984|NCT00924469|65813175|FG001|Overall Study|Withdrawal by Subject|1|||
23568985|NCT00924469|65813174|FG000|Overall Study|Lost to Follow-up|0|||
23568986|NCT00924469|65813175|FG001|Overall Study|Lost to Follow-up|1|||
23568987|NCT00088205|65813178|FG000|Overall Study|Adverse Event|4|||
23568988|NCT00088205|65813178|FG000|Overall Study|Progressive Disease|51|||
23630632|NCT00847626|66034781|FG004|Overall Study|Other|2|||
23630633|NCT00847626|66034782|FG005|Overall Study|Other|2|||
23630634|NCT00847626|66034783|FG006|Overall Study|Other|2|||
23630635|NCT00847626|66034784|FG007|Overall Study|Other|3|||
23767806|NCT04634409|66527759|FG001|Overall Study|Lost to Follow-up|1|||
23767807|NCT04634409|66527760|FG002|Overall Study|Lost to Follow-up|1|||
23767808|NCT04634409|66527761|FG003|Overall Study|Lost to Follow-up|3|||
23767809|NCT04634409|66527762|FG004|Overall Study|Lost to Follow-up|1|||
23767810|NCT04634409|66527763|FG005|Overall Study|Lost to Follow-up|1|||
23767811|NCT04634409|66527764|FG006|Overall Study|Lost to Follow-up|1|||
23767812|NCT04634409|66527765|FG007|Overall Study|Lost to Follow-up|3|||
23767813|NCT04634409|66527766|FG008|Overall Study|Lost to Follow-up|3|||
23767814|NCT04634409|66527767|FG009|Overall Study|Lost to Follow-up|11|||
23767815|NCT04634409|66527768|FG010|Overall Study|Lost to Follow-up|8|||
23767816|NCT04634409|66527769|FG011|Overall Study|Lost to Follow-up|15|||
23767817|NCT04634409|66527770|FG012|Overall Study|Lost to Follow-up|3|||
23767818|NCT04634409|66527771|FG013|Overall Study|Lost to Follow-up|2|||
23767819|NCT04634409|66527772|FG014|Overall Study|Lost to Follow-up|7|||
23767820|NCT04634409|66527773|FG015|Overall Study|Lost to Follow-up|0|||
23767821|NCT04634409|66527774|FG016|Overall Study|Lost to Follow-up|0|||
23767822|NCT04634409|66527775|FG017|Overall Study|Lost to Follow-up|0|||
23767823|NCT04634409|66527776|FG018|Overall Study|Lost to Follow-up|0|||
23767824|NCT04634409|66527777|FG019|Overall Study|Lost to Follow-up|0|||
23767825|NCT04634409|66527778|FG020|Overall Study|Lost to Follow-up|0|||
23767826|NCT04634409|66527779|FG021|Overall Study|Lost to Follow-up|0|||
23767827|NCT04634409|66527780|FG022|Overall Study|Lost to Follow-up|0|||
23767828|NCT04634409|66527781|FG023|Overall Study|Lost to Follow-up|0|||
23767829|NCT04634409|66527782|FG024|Overall Study|Lost to Follow-up|0|||
23767830|NCT04634409|66527783|FG025|Overall Study|Lost to Follow-up|0|||
23767831|NCT04634409|66527784|FG026|Overall Study|Lost to Follow-up|0|||
23767832|NCT04634409|66527758|FG000|Overall Study|Withdrawal by Subject|3|||
23767833|NCT04634409|66527759|FG001|Overall Study|Withdrawal by Subject|1|||
23767834|NCT04634409|66527760|FG002|Overall Study|Withdrawal by Subject|6|||
23767835|NCT04634409|66527761|FG003|Overall Study|Withdrawal by Subject|4|||
23767836|NCT04634409|66527762|FG004|Overall Study|Withdrawal by Subject|2|||
23767837|NCT04634409|66527763|FG005|Overall Study|Withdrawal by Subject|0|||
23767838|NCT04634409|66527764|FG006|Overall Study|Withdrawal by Subject|0|||
23829989|NCT00662649|66756129|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
23829990|NCT00662649|66756130|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
23829991|NCT00662649|66756131|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
23829992|NCT00662649|66756127|FG000|Core Study (24 Months)|Protocol Violation|5|||
23446661|NCT02021643|65377729|FG003|Overall Study|Death|0|||
23630636|NCT00847626|66034785|FG008|Overall Study|Other|1|||
23630637|NCT00847626|66034786|FG009|Overall Study|Other|1|||
23630638|NCT00847626|66034787|FG010|Overall Study|Other|3|||
23630639|NCT01736189|66034788|FG000|Overall Study|Violation of registration criteria|41|||
23630640|NCT01736189|66034788|FG000|Overall Study|Protocol Violation|4|||
23630641|NCT01736189|66034788|FG000|Overall Study|Criteria and protocol violations|1|||
23630642|NCT03210519|66034789|FG000|Overall Study|Adverse Event|2|||
23630643|NCT03210519|66034790|FG001|Overall Study|Adverse Event|0|||
23630644|NCT02353468|66034795|FG000|Overall Study|Study terminated|3|||
23630645|NCT01931098|66034797|FG000|Overall Study|Withdrawal by Subject|0|||
23630646|NCT01931098|66034798|FG001|Overall Study|Withdrawal by Subject|1|||
23630647|NCT01931098|66034797|FG000|Overall Study|Enrolled in different protocol|0|||
23630648|NCT01931098|66034798|FG001|Overall Study|Enrolled in different protocol|1|||
23630649|NCT01931098|66034797|FG000|Overall Study|Unable to begin trmt:active infection|0|||
23630650|NCT01931098|66034798|FG001|Overall Study|Unable to begin trmt:active infection|1|||
23630651|NCT01931098|66034797|FG000|Overall Study|Refused further treatment|0|||
23630652|NCT01931098|66034798|FG001|Overall Study|Refused further treatment|1|||
23630653|NCT00633945|66034800|FG000|Overall Study|Physician Decision|2|||
23630654|NCT00594880|66034801|FG000|Overall Study|Withdrawal by Subject|1|||
23767839|NCT04634409|66527765|FG007|Overall Study|Withdrawal by Subject|2|||
23767840|NCT04634409|66527766|FG008|Overall Study|Withdrawal by Subject|3|||
23767841|NCT04634409|66527767|FG009|Overall Study|Withdrawal by Subject|2|||
23767842|NCT04634409|66527768|FG010|Overall Study|Withdrawal by Subject|3|||
23767843|NCT04634409|66527769|FG011|Overall Study|Withdrawal by Subject|2|||
23446662|NCT02021643|65377726|FG000|Overall Study|Investigator's Discretion|1|||
23446663|NCT02021643|65377727|FG001|Overall Study|Investigator's Discretion|0|||
23630655|NCT00594880|66034802|FG001|Overall Study|Withdrawal by Subject|1|||
23630656|NCT00594880|66034801|FG000|Overall Study|Lost to Follow-up|1|||
23630657|NCT00594880|66034802|FG001|Overall Study|Lost to Follow-up|0|||
23630658|NCT00334542|66034805|FG000|Overall Study|Adverse Event|3|||
23767844|NCT04634409|66527770|FG012|Overall Study|Withdrawal by Subject|2|||
23767845|NCT04634409|66527771|FG013|Overall Study|Withdrawal by Subject|1|||
23767846|NCT04634409|66527772|FG014|Overall Study|Withdrawal by Subject|5|||
23767847|NCT04634409|66527773|FG015|Overall Study|Withdrawal by Subject|0|||
23767848|NCT04634409|66527774|FG016|Overall Study|Withdrawal by Subject|0|||
23767849|NCT04634409|66527775|FG017|Overall Study|Withdrawal by Subject|1|||
23767850|NCT04634409|66527776|FG018|Overall Study|Withdrawal by Subject|0|||
23767851|NCT04634409|66527777|FG019|Overall Study|Withdrawal by Subject|0|||
23767852|NCT04634409|66527778|FG020|Overall Study|Withdrawal by Subject|0|||
23767853|NCT04634409|66527779|FG021|Overall Study|Withdrawal by Subject|0|||
23767854|NCT04634409|66527780|FG022|Overall Study|Withdrawal by Subject|0|||
23767855|NCT04634409|66527781|FG023|Overall Study|Withdrawal by Subject|1|||
23767856|NCT04634409|66527782|FG024|Overall Study|Withdrawal by Subject|0|||
23767857|NCT04634409|66527783|FG025|Overall Study|Withdrawal by Subject|0|||
23767858|NCT04634409|66527784|FG026|Overall Study|Withdrawal by Subject|0|||
23767859|NCT04634409|66527758|FG000|Overall Study|Other - As reported by Investigator|1|||
23767860|NCT04634409|66527759|FG001|Overall Study|Other - As reported by Investigator|0|||
23767861|NCT04634409|66527760|FG002|Overall Study|Other - As reported by Investigator|0|||
23767862|NCT04634409|66527761|FG003|Overall Study|Other - As reported by Investigator|0|||
23767863|NCT04634409|66527762|FG004|Overall Study|Other - As reported by Investigator|0|||
23767864|NCT04634409|66527763|FG005|Overall Study|Other - As reported by Investigator|0|||
23767865|NCT04634409|66527764|FG006|Overall Study|Other - As reported by Investigator|0|||
23767866|NCT04634409|66527765|FG007|Overall Study|Other - As reported by Investigator|6|||
23767867|NCT04634409|66527766|FG008|Overall Study|Other - As reported by Investigator|4|||
23767868|NCT04634409|66527767|FG009|Overall Study|Other - As reported by Investigator|0|||
23767869|NCT04634409|66527768|FG010|Overall Study|Other - As reported by Investigator|1|||
23767870|NCT04634409|66527769|FG011|Overall Study|Other - As reported by Investigator|2|||
23767871|NCT04634409|66527770|FG012|Overall Study|Other - As reported by Investigator|2|||
23767872|NCT04634409|66527771|FG013|Overall Study|Other - As reported by Investigator|1|||
23767873|NCT04634409|66527772|FG014|Overall Study|Other - As reported by Investigator|0|||
23568989|NCT00088205|65813178|FG000|Overall Study|Physician Decision|1|||
23568990|NCT00088205|65813178|FG000|Overall Study|Death Due to Study Disease|4|||
23568991|NCT00539643|65813179|FG000|Overall Study|Adverse Event|1|||
23568992|NCT00539643|65813180|FG001|Overall Study|Adverse Event|0|||
23568993|NCT00539643|65813179|FG000|Overall Study|Death|2|||
23568994|NCT00539643|65813180|FG001|Overall Study|Death|1|||
23568995|NCT00539643|65813179|FG000|Overall Study|Physician Decision|3|||
23568996|NCT00539643|65813180|FG001|Overall Study|Physician Decision|1|||
23568997|NCT00539643|65813179|FG000|Overall Study|Withdrawal by Subject|0|||
23568998|NCT00539643|65813180|FG001|Overall Study|Withdrawal by Subject|1|||
23568999|NCT00514046|65813181|FG000|Overall Study|transferred to another protocol|2|||
23569000|NCT00514046|65813182|FG001|Overall Study|transferred to another protocol|1|||
23569001|NCT00514046|65813183|FG002|Overall Study|transferred to another protocol|3|||
23569002|NCT00514046|65813184|FG003|Overall Study|transferred to another protocol|0|||
23569003|NCT00514046|65813185|FG004|Overall Study|transferred to another protocol|1|||
23569004|NCT00514046|65813186|FG005|Overall Study|transferred to another protocol|0|||
23569005|NCT00514046|65813187|FG006|Overall Study|transferred to another protocol|0|||
23569006|NCT00514046|65813188|FG007|Overall Study|transferred to another protocol|0|||
23569007|NCT00514046|65813189|FG008|Overall Study|transferred to another protocol|0|||
23569008|NCT00514046|65813181|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
23569009|NCT00514046|65813182|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
23569010|NCT00514046|65813183|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
23569011|NCT00514046|65813184|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
23569012|NCT00514046|65813185|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
23569013|NCT00514046|65813186|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
23569014|NCT00514046|65813187|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
23569015|NCT00514046|65813188|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
23569016|NCT00514046|65813189|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
23569017|NCT00514046|65813181|FG000|Overall Study|Disease progression on study|0|||
23569018|NCT00514046|65813182|FG001|Overall Study|Disease progression on study|0|||
23569019|NCT00514046|65813183|FG002|Overall Study|Disease progression on study|2|||
23569020|NCT00514046|65813184|FG003|Overall Study|Disease progression on study|0|||
23569021|NCT00514046|65813185|FG004|Overall Study|Disease progression on study|0|||
23569022|NCT00514046|65813186|FG005|Overall Study|Disease progression on study|1|||
23569023|NCT00514046|65813187|FG006|Overall Study|Disease progression on study|0|||
23569024|NCT00514046|65813188|FG007|Overall Study|Disease progression on study|0|||
23767874|NCT04634409|66527773|FG015|Overall Study|Other - As reported by Investigator|0|||
23767875|NCT04634409|66527774|FG016|Overall Study|Other - As reported by Investigator|0|||
23767876|NCT04634409|66527775|FG017|Overall Study|Other - As reported by Investigator|0|||
23767877|NCT04634409|66527776|FG018|Overall Study|Other - As reported by Investigator|0|||
23767878|NCT04634409|66527777|FG019|Overall Study|Other - As reported by Investigator|0|||
23767879|NCT04634409|66527778|FG020|Overall Study|Other - As reported by Investigator|0|||
23569025|NCT00514046|65813189|FG008|Overall Study|Disease progression on study|0|||
23569026|NCT01582789|65813192|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23767880|NCT04634409|66527779|FG021|Overall Study|Other - As reported by Investigator|0|||
23767881|NCT04634409|66527780|FG022|Overall Study|Other - As reported by Investigator|0|||
23767882|NCT04634409|66527781|FG023|Overall Study|Other - As reported by Investigator|0|||
23767883|NCT04634409|66527782|FG024|Overall Study|Other - As reported by Investigator|0|||
23767884|NCT04634409|66527783|FG025|Overall Study|Other - As reported by Investigator|0|||
23767885|NCT04634409|66527784|FG026|Overall Study|Other - As reported by Investigator|0|||
23767886|NCT02220907|66527789|FG000|Overall Study|Adverse Event|7|||
23767887|NCT02220907|66527789|FG000|Overall Study|Physician Decision|1|||
23767888|NCT02220907|66527789|FG000|Overall Study|Withdrawal by Subject|2|||
23767889|NCT02220907|66527789|FG000|Overall Study|Conflict with the stopping criteria|1|||
23767890|NCT03131999|66527792|FG000|Overall Study|Withdrawal by Subject|0|||
23767891|NCT03131999|66527793|FG001|Overall Study|Withdrawal by Subject|1|||
23569027|NCT01582789|65813193|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23569028|NCT01617005|65813198|FG000|Overall Study|Pregnancy|1|||
23569029|NCT01617005|65813198|FG000|Overall Study|Lack of motivation for treatment|1|||
23569030|NCT00993317|65813199|FG000|Overall Study|Adverse Event|2|||
23569031|NCT00993317|65813200|FG001|Overall Study|Adverse Event|4|||
23569032|NCT00993317|65813199|FG000|Overall Study|Lack of Efficacy|18|||
23569033|NCT00993317|65813200|FG001|Overall Study|Lack of Efficacy|18|||
23569034|NCT00993317|65813199|FG000|Overall Study|Withdrawal by Subject|0|||
23569035|NCT00993317|65813200|FG001|Overall Study|Withdrawal by Subject|2|||
23569036|NCT00993317|65813199|FG000|Overall Study|Investigator's opinion|0|||
23569037|NCT00993317|65813200|FG001|Overall Study|Investigator's opinion|1|||
23630659|NCT00334542|66034805|FG000|Overall Study|Withdrawal by Subject|1|||
23767892|NCT00475020|66527796|FG000|Overall Study|Physician Decision|3|||
23767893|NCT00475020|66527796|FG000|Overall Study|Insurance Denial|1|||
23767894|NCT00475020|66527796|FG000|Overall Study|Donor not able to donate the last minute|1|||
23767895|NCT01567306|66527797|FG000|Overall Study|Protocol Violation|2|||
23829993|NCT00662649|66756128|FG001|Core Study (24 Months)|Protocol Violation|5|||
23829994|NCT00662649|66756129|FG002|Core Study (24 Months)|Protocol Violation|4|||
23630660|NCT00334542|66034805|FG000|Overall Study|New cancer diagnosis|1|||
23767896|NCT01567306|66527798|FG001|Overall Study|Protocol Violation|2|||
23767897|NCT01567306|66527799|FG002|Overall Study|Protocol Violation|0|||
23767898|NCT01567306|66527800|FG003|Overall Study|Protocol Violation|3|||
23767899|NCT01567306|66527801|FG004|Overall Study|Protocol Violation|1|||
23767900|NCT01567306|66527802|FG005|Overall Study|Protocol Violation|1|||
23767901|NCT01567306|66527797|FG000|Overall Study|Change site living|1|||
23767902|NCT01567306|66527798|FG001|Overall Study|Change site living|0|||
23767903|NCT01567306|66527799|FG002|Overall Study|Change site living|0|||
23767904|NCT01567306|66527800|FG003|Overall Study|Change site living|0|||
23767905|NCT01567306|66527801|FG004|Overall Study|Change site living|0|||
23767906|NCT01567306|66527802|FG005|Overall Study|Change site living|0|||
23767907|NCT01567306|66527797|FG000|Overall Study|Adverse Event|0|||
23767908|NCT01567306|66527798|FG001|Overall Study|Adverse Event|0|||
23767909|NCT01567306|66527799|FG002|Overall Study|Adverse Event|0|||
23767910|NCT01567306|66527800|FG003|Overall Study|Adverse Event|2|||
23767911|NCT01567306|66527801|FG004|Overall Study|Adverse Event|4|||
23767912|NCT01567306|66527802|FG005|Overall Study|Adverse Event|1|||
23767913|NCT01567306|66527797|FG000|Overall Study|Lost to Follow-up|0|||
23767914|NCT01567306|66527798|FG001|Overall Study|Lost to Follow-up|0|||
23767915|NCT01567306|66527799|FG002|Overall Study|Lost to Follow-up|0|||
23767916|NCT01567306|66527800|FG003|Overall Study|Lost to Follow-up|0|||
23767917|NCT01567306|66527801|FG004|Overall Study|Lost to Follow-up|2|||
23630661|NCT03614676|66034811|FG000|Overall Study|Delivery before planned visit|2|||
23630662|NCT03614676|66034812|FG001|Overall Study|Delivery before planned visit|0|||
23630663|NCT03614676|66034811|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
23630664|NCT03614676|66034812|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
23767918|NCT01567306|66527802|FG005|Overall Study|Lost to Follow-up|0|||
23767919|NCT01567306|66527797|FG000|Overall Study|Withdrawal by Subject|0|||
23767920|NCT01567306|66527798|FG001|Overall Study|Withdrawal by Subject|0|||
23767921|NCT01567306|66527799|FG002|Overall Study|Withdrawal by Subject|0|||
23767922|NCT01567306|66527800|FG003|Overall Study|Withdrawal by Subject|0|||
23767923|NCT01567306|66527801|FG004|Overall Study|Withdrawal by Subject|0|||
23767924|NCT01567306|66527802|FG005|Overall Study|Withdrawal by Subject|1|||
23767925|NCT02427607|66527803|FG000|Overall Study|Withdrawal by Subject|1|||
23767926|NCT02456909|66527809|FG000|Overall Study|Did not receive allocated intervention|24|||
23829995|NCT00662649|66756130|FG003|Core Study (24 Months)|Protocol Violation|0|||
23767927|NCT02456909|66527810|FG001|Overall Study|Did not receive allocated intervention|26|||
23767928|NCT02456909|66527809|FG000|Overall Study|Did not complete the primary outcome|0|||
23767929|NCT02456909|66527810|FG001|Overall Study|Did not complete the primary outcome|1|||
23767930|NCT03519256|66527811|FG000|Overall Study|Disease recurrence|4|||
23829996|NCT00662649|66756131|FG004|Core Study (24 Months)|Protocol Violation|0|||
23569038|NCT00993317|65813199|FG000|Overall Study|Early study termination at the site|1|||
23569039|NCT00993317|65813200|FG001|Overall Study|Early study termination at the site|0|||
23569040|NCT02388074|65813201|FG000|Overall Study|Lost in Transit|2|||
23569041|NCT02388074|65813201|FG000|Overall Study|Sample Not Returned|1|||
23569042|NCT00592319|65813204|FG000|Overall Study|Lost to Follow-up|0|||
23569043|NCT00592319|65813205|FG001|Overall Study|Lost to Follow-up|3|||
23569044|NCT00839917|65813209|FG000|Overall Study|Lost to Follow-up|1|||
23569045|NCT00839917|65813210|FG001|Overall Study|Lost to Follow-up|0|||
23569046|NCT00839917|65813209|FG000|Overall Study|Did not receive vaccine|0|||
23569047|NCT00839917|65813210|FG001|Overall Study|Did not receive vaccine|1|||
23569048|NCT02337478|65813215|FG000|Overall Study|Lack of Efficacy|5|||
23569049|NCT02285595|65813231|FG000|Overall Study|Lost to Follow-up|14|||
23569050|NCT02285595|65813231|FG000|Overall Study|Withdrawal by Subject|1|||
23569051|NCT04880161|65813235|FG000|Overall Study|Withdrawal by Subject|1|||
23569052|NCT04880161|65813236|FG001|Overall Study|Withdrawal by Subject|0|||
23569053|NCT04880161|65813235|FG000|Overall Study|Lack of Compliance|1|||
23569054|NCT04880161|65813236|FG001|Overall Study|Lack of Compliance|1|||
23569055|NCT04880161|65813235|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
23569056|NCT04880161|65813236|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
23569057|NCT04880161|65813235|FG000|Overall Study|Screen Failure|0|||
23569058|NCT04880161|65813236|FG001|Overall Study|Screen Failure|1|||
23569059|NCT03853317|65813237|FG000|Overall Study|Progressive Disease|5|||
23569060|NCT03853317|65813237|FG000|Overall Study|Adverse Event|1|||
23569061|NCT03853317|65813237|FG000|Overall Study|Death|1|||
23569062|NCT03853317|65813237|FG000|Overall Study|other event|2|||
23569063|NCT00423852|65813238|FG000|Overall Study|Removed pior to the high-dose portion|3|||
23569064|NCT01928225|65813239|FG000|Overall Study|Pregnancy|1|||
23569065|NCT01928225|65813240|FG001|Overall Study|Pregnancy|0|||
23569066|NCT01928225|65813239|FG000|Overall Study|basaloid cervical cancer|1|||
23569067|NCT01928225|65813240|FG001|Overall Study|basaloid cervical cancer|0|||
23569068|NCT01928225|65813239|FG000|Overall Study|Lost to Follow-up|1|||
23569069|NCT01928225|65813240|FG001|Overall Study|Lost to Follow-up|3|||
23569070|NCT01155661|65813241|FG000|Overall Study|Adverse Event|101|||
23569071|NCT01155661|65813241|FG000|Overall Study|Death|1|||
23569072|NCT01155661|65813241|FG000|Overall Study|Lack of Efficacy|32|||
23569073|NCT01155661|65813241|FG000|Overall Study|Lost to Follow-up|22|||
23569074|NCT01155661|65813241|FG000|Overall Study|Physician Decision|3|||
23569075|NCT01155661|65813241|FG000|Overall Study|Protocol Violation|35|||
23569076|NCT01155661|65813241|FG000|Overall Study|Withdrawal by Subject|73|||
23569077|NCT01155661|65813241|FG000|Overall Study|Sponsor Decision|13|||
23569078|NCT00904150|65813244|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
23569079|NCT00904150|65813245|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
23569080|NCT00904150|65813244|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
23569081|NCT00904150|65813245|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
23569082|NCT02572817|65813246|FG000|Overall Study|Death|6|||
23569083|NCT02572817|65813247|FG001|Overall Study|Death|3|||
23569084|NCT02572817|65813246|FG000|Overall Study|Lost to Follow-up|3|||
23569085|NCT02572817|65813247|FG001|Overall Study|Lost to Follow-up|3|||
23569086|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569087|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569088|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569089|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569090|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23630665|NCT03614676|66034811|FG000|Overall Study|Migrated / moved from the study area|30|||
23630666|NCT03614676|66034812|FG001|Overall Study|Migrated / moved from the study area|22|||
23630667|NCT03614676|66034811|FG000|Overall Study|Lost to Follow-up|17|||
23630668|NCT03614676|66034812|FG001|Overall Study|Lost to Follow-up|42|||
23630669|NCT03614676|66034811|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
23630670|NCT03614676|66034812|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
23630671|NCT03614676|66034811|FG000|Overall Study|Other|16|||
23630672|NCT03614676|66034812|FG001|Overall Study|Other|47|||
23630673|NCT03614676|66034811|FG000|Overall Study|Protocol Violation|0|||
23630674|NCT03614676|66034812|FG001|Overall Study|Protocol Violation|2|||
23446664|NCT02021643|65377728|FG002|Overall Study|Investigator's Discretion|0|||
23630675|NCT03614676|66034811|FG000|Overall Study|Neonatal event of interest|0|||
23446665|NCT02021643|65377729|FG003|Overall Study|Investigator's Discretion|0|||
23569091|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569092|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569093|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23630676|NCT03614676|66034812|FG001|Overall Study|Neonatal event of interest|6|||
23630677|NCT03614676|66034811|FG000|Overall Study|Death in infant greater than 28 days old|0|||
23446666|NCT02021643|65377726|FG000|Overall Study|Lack of Efficacy|7|||
23446667|NCT02021643|65377727|FG001|Overall Study|Lack of Efficacy|6|||
23446668|NCT02021643|65377728|FG002|Overall Study|Lack of Efficacy|0|||
23446669|NCT02021643|65377729|FG003|Overall Study|Lack of Efficacy|12|||
23446670|NCT02021643|65377726|FG000|Overall Study|Lost to Follow-up|0|||
23446671|NCT02021643|65377727|FG001|Overall Study|Lost to Follow-up|1|||
23767931|NCT03519256|66527812|FG001|Overall Study|Disease recurrence|4|||
23767932|NCT03519256|66527813|FG002|Overall Study|Disease recurrence|5|||
23446672|NCT02021643|65377728|FG002|Overall Study|Lost to Follow-up|0|||
23446673|NCT02021643|65377729|FG003|Overall Study|Lost to Follow-up|0|||
23767933|NCT03519256|66527814|FG003|Overall Study|Disease recurrence|2|||
23767934|NCT03519256|66527811|FG000|Overall Study|Study drug toxicity|0|||
23767935|NCT03519256|66527812|FG001|Overall Study|Study drug toxicity|2|||
23767936|NCT03519256|66527813|FG002|Overall Study|Study drug toxicity|5|||
23767937|NCT03519256|66527814|FG003|Overall Study|Study drug toxicity|2|||
23767938|NCT03519256|66527811|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23767939|NCT03519256|66527812|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23767940|NCT03519256|66527813|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23767941|NCT03519256|66527814|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23767942|NCT03519256|66527811|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23767943|NCT03519256|66527812|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23829997|NCT00662649|66756127|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
23829998|NCT00662649|66756128|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
23446674|NCT02021643|65377726|FG000|Overall Study|Withdrew Consent|0|||
23446675|NCT02021643|65377727|FG001|Overall Study|Withdrew Consent|1|||
23767944|NCT03519256|66527813|FG002|Overall Study|Participant request to discontinue study treatment|0|||
23767945|NCT03519256|66527814|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23630678|NCT03614676|66034812|FG001|Overall Study|Death in infant greater than 28 days old|12|||
23630679|NCT03614676|66034811|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
23630680|NCT03614676|66034812|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
23630681|NCT00150618|66034814|FG000|Overall Study|Adverse Event|2|||
23630682|NCT00150618|66034815|FG001|Overall Study|Adverse Event|2|||
23630683|NCT00150618|66034816|FG002|Overall Study|Adverse Event|6|||
23630684|NCT00150618|66034817|FG003|Overall Study|Adverse Event|9|||
23630685|NCT00150618|66034818|FG004|Overall Study|Adverse Event|5|||
23630686|NCT00150618|66034814|FG000|Overall Study|Withdrawal by Subject|6|||
23630687|NCT00150618|66034815|FG001|Overall Study|Withdrawal by Subject|8|||
23630688|NCT00150618|66034816|FG002|Overall Study|Withdrawal by Subject|8|||
23630689|NCT00150618|66034817|FG003|Overall Study|Withdrawal by Subject|4|||
23630690|NCT00150618|66034818|FG004|Overall Study|Withdrawal by Subject|5|||
23630691|NCT00150618|66034814|FG000|Overall Study|Lost to Follow-up|4|||
23630692|NCT00150618|66034815|FG001|Overall Study|Lost to Follow-up|1|||
23630693|NCT00150618|66034816|FG002|Overall Study|Lost to Follow-up|5|||
23630694|NCT00150618|66034817|FG003|Overall Study|Lost to Follow-up|8|||
23630695|NCT00150618|66034818|FG004|Overall Study|Lost to Follow-up|4|||
23630696|NCT00150618|66034814|FG000|Overall Study|Protocol Violation|1|||
23630697|NCT00150618|66034815|FG001|Overall Study|Protocol Violation|0|||
23630698|NCT00150618|66034816|FG002|Overall Study|Protocol Violation|0|||
23630699|NCT00150618|66034817|FG003|Overall Study|Protocol Violation|0|||
23630700|NCT00150618|66034818|FG004|Overall Study|Protocol Violation|1|||
23630701|NCT00150618|66034814|FG000|Overall Study|Lack of Efficacy|1|||
23630702|NCT00150618|66034815|FG001|Overall Study|Lack of Efficacy|4|||
23630703|NCT00150618|66034816|FG002|Overall Study|Lack of Efficacy|7|||
23630704|NCT00150618|66034817|FG003|Overall Study|Lack of Efficacy|4|||
23630705|NCT00150618|66034818|FG004|Overall Study|Lack of Efficacy|6|||
23630706|NCT00150618|66034814|FG000|Overall Study|No study meds|0|||
23630707|NCT00150618|66034815|FG001|Overall Study|No study meds|0|||
23630708|NCT00150618|66034816|FG002|Overall Study|No study meds|0|||
23630709|NCT00150618|66034817|FG003|Overall Study|No study meds|0|||
23630710|NCT00150618|66034818|FG004|Overall Study|No study meds|2|||
23630711|NCT00150618|66034814|FG000|Overall Study|Physician Decision|0|||
23630712|NCT00150618|66034815|FG001|Overall Study|Physician Decision|2|||
23630713|NCT00150618|66034816|FG002|Overall Study|Physician Decision|0|||
23630714|NCT00150618|66034817|FG003|Overall Study|Physician Decision|0|||
23630715|NCT00150618|66034818|FG004|Overall Study|Physician Decision|1|||
23630716|NCT00150618|66034814|FG000|Overall Study|Lack of compliance|2|||
23630717|NCT00150618|66034815|FG001|Overall Study|Lack of compliance|1|||
23630718|NCT00150618|66034816|FG002|Overall Study|Lack of compliance|1|||
23630719|NCT00150618|66034817|FG003|Overall Study|Lack of compliance|0|||
23767946|NCT03519256|66527811|FG000|Overall Study|Other reasons|0|||
23767947|NCT03519256|66527812|FG001|Overall Study|Other reasons|0|||
23767948|NCT03519256|66527813|FG002|Overall Study|Other reasons|2|||
23767949|NCT03519256|66527814|FG003|Overall Study|Other reasons|0|||
23630720|NCT00150618|66034818|FG004|Overall Study|Lack of compliance|1|||
23630721|NCT00150618|66034814|FG000|Overall Study|Abnormal ECG|1|||
23630722|NCT00150618|66034815|FG001|Overall Study|Abnormal ECG|0|||
23630723|NCT00150618|66034816|FG002|Overall Study|Abnormal ECG|0|||
23630724|NCT00150618|66034817|FG003|Overall Study|Abnormal ECG|0|||
23630725|NCT00150618|66034818|FG004|Overall Study|Abnormal ECG|0|||
23630726|NCT00150618|66034814|FG000|Overall Study|Sponsor's decision|0|||
23630727|NCT00150618|66034815|FG001|Overall Study|Sponsor's decision|0|||
23630728|NCT00150618|66034816|FG002|Overall Study|Sponsor's decision|0|||
23630729|NCT00150618|66034817|FG003|Overall Study|Sponsor's decision|1|||
23630730|NCT00150618|66034818|FG004|Overall Study|Sponsor's decision|0|||
23630731|NCT00520845|66034821|FG000|Overall Study|Death|3|||
23767950|NCT03519256|66527811|FG000|Overall Study|Disease progression|6|||
23767951|NCT03519256|66527812|FG001|Overall Study|Disease progression|3|||
23829999|NCT00662649|66756129|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
23830000|NCT00662649|66756130|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
23830001|NCT00662649|66756131|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
23830002|NCT00662649|66756127|FG000|Core Study (24 Months)|Death|1|||
23830003|NCT00662649|66756128|FG001|Core Study (24 Months)|Death|0|||
23830004|NCT00662649|66756129|FG002|Core Study (24 Months)|Death|2|||
23830005|NCT00662649|66756130|FG003|Core Study (24 Months)|Death|0|||
23830006|NCT00662649|66756131|FG004|Core Study (24 Months)|Death|0|||
23830007|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
23830008|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
23830009|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
23830010|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
23830011|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
23830012|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
23830013|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
23830014|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
23830015|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
23830016|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
23830017|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
23830018|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
23830019|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
23830020|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
23830021|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
23830022|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
23830023|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
23830024|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
23830025|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
23830026|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
23830027|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
23830028|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
23830029|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
23830030|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
23830031|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
23830032|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
23830033|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
23830034|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23830035|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23446676|NCT02021643|65377728|FG002|Overall Study|Withdrew Consent|0|||
23446677|NCT02021643|65377729|FG003|Overall Study|Withdrew Consent|0|||
23446678|NCT03852719|65377730|FG000|Overall Study|Still on study after Week 144|49|||
23446679|NCT03852719|65377731|FG001|Overall Study|Still on study after Week 144|44|||
23830036|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23830037|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
23830038|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
23830039|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
23830040|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
23830041|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
23830042|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23830043|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
23830044|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23830045|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23830046|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23830047|NCT00662649|66756127|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
23830048|NCT00662649|66756128|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
23830049|NCT00662649|66756129|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
23830050|NCT00662649|66756130|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
23446680|NCT03852719|65377732|FG002|Overall Study|Still on study after Week 144|44|||
23446681|NCT03852719|65377730|FG000|Overall Study|Withdrawal of consent|0|||
23446682|NCT03852719|65377731|FG001|Overall Study|Withdrawal of consent|4|||
23446683|NCT03852719|65377732|FG002|Overall Study|Withdrawal of consent|5|||
23569094|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
23830051|NCT00662649|66756131|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
23830052|NCT03597295|66756132|FG000|Overall Study|Death|70|||
23830053|NCT03597295|66756132|FG000|Overall Study|Lost to Follow-up|7|||
23830054|NCT01422213|66759878|FG000|Overall Study|Adverse Event|8|||
23630732|NCT00520845|66034821|FG000|Overall Study|Adverse Event|4|||
23569095|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
23569096|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569097|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569098|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569099|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569100|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569101|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23630733|NCT00520845|66034821|FG000|Overall Study|Disease Progression, relapse|13|||
23630734|NCT00520845|66034821|FG000|Overall Study|Withdrawal by Subject|1|||
23630735|NCT00520845|66034821|FG000|Overall Study|Alternative Therapy|1|||
23630736|NCT00738283|66034826|FG000|Overall Study|Death|1|||
23630737|NCT00738283|66034826|FG000|Overall Study|Transfer to another facility|2|||
23630738|NCT00738283|66034826|FG000|Overall Study|Discharge home prior to end of study|1|||
23630739|NCT00666198|66034829|FG000|Overall Study|Protocol Violation|10|||
23630740|NCT00666198|66034829|FG000|Overall Study|No Visit After First Day of Treatment|13|||
23630741|NCT00666198|66034829|FG000|Overall Study|Safety Not Assessable|6|||
23630742|NCT00666198|66034829|FG000|Overall Study|No Drug Administration|4|||
23630743|NCT00731133|66034830|FG000|Overall Study|Withdrawal by Subject|10|||
23630744|NCT03994731|66034831|FG000|Pegloticase + IMM Period|Death|2|||
23630745|NCT03994731|66034832|FG001|Pegloticase + IMM Period|Death|0|||
23630746|NCT03994731|66034831|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
23630747|NCT03994731|66034832|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
23630748|NCT03994731|66034831|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
23630749|NCT03994731|66034832|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
23630750|NCT01246999|66034838|FG000|Overall Study|Lost to Follow-up|0|||
23767952|NCT03519256|66527813|FG002|Overall Study|Disease progression|2|||
23767953|NCT03519256|66527814|FG003|Overall Study|Disease progression|1|||
23630751|NCT01246999|66034839|FG001|Overall Study|Lost to Follow-up|1|||
23630752|NCT01246999|66034840|FG002|Overall Study|Lost to Follow-up|0|||
23630753|NCT01246999|66034841|FG003|Overall Study|Lost to Follow-up|0|||
23630754|NCT01246999|66034838|FG000|Overall Study|Withdrawal by Subject|0|||
23630755|NCT01246999|66034839|FG001|Overall Study|Withdrawal by Subject|0|||
23767954|NCT03519256|66527811|FG000|Overall Study|Lost to Follow-up|0|||
23767955|NCT03519256|66527812|FG001|Overall Study|Lost to Follow-up|1|||
23767956|NCT03519256|66527813|FG002|Overall Study|Lost to Follow-up|0|||
23767957|NCT03519256|66527814|FG003|Overall Study|Lost to Follow-up|0|||
23767958|NCT02352337|66527815|FG000|Overall Study|Patients never treated|4|||
23569102|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
23569103|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
23569104|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569105|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569106|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569107|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569108|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569109|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569110|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569111|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569112|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
23569113|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23767959|NCT02352337|66527816|FG001|Overall Study|Patients never treated|1|||
23767960|NCT02352337|66527817|FG002|Overall Study|Patients never treated|2|||
23767961|NCT02518113|66527818|FG000|Overall Study|Adverse Event|1|||
23767962|NCT02518113|66527819|FG001|Overall Study|Adverse Event|0|||
23767963|NCT02518113|66527820|FG002|Overall Study|Adverse Event|1|||
23767964|NCT02518113|66527821|FG003|Overall Study|Adverse Event|0|||
23767965|NCT02518113|66527818|FG000|Overall Study|Death|1|||
23767966|NCT02518113|66527819|FG001|Overall Study|Death|2|||
23767967|NCT02518113|66527820|FG002|Overall Study|Death|0|||
23767968|NCT02518113|66527821|FG003|Overall Study|Death|0|||
23767969|NCT02518113|66527818|FG000|Overall Study|Physician Decision|0|||
23767970|NCT02518113|66527819|FG001|Overall Study|Physician Decision|1|||
23767971|NCT02518113|66527820|FG002|Overall Study|Physician Decision|0|||
23767972|NCT02518113|66527821|FG003|Overall Study|Physician Decision|0|||
23767973|NCT02518113|66527818|FG000|Overall Study|Progressive Disease|1|||
23569114|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23630756|NCT01246999|66034840|FG002|Overall Study|Withdrawal by Subject|0|||
23767974|NCT02518113|66527819|FG001|Overall Study|Progressive Disease|2|||
23767975|NCT02518113|66527820|FG002|Overall Study|Progressive Disease|3|||
23767976|NCT02518113|66527821|FG003|Overall Study|Progressive Disease|0|||
23767977|NCT00467584|66527822|FG000|Overall Study|Withdrawal by Subject|4|||
23767978|NCT00467584|66527823|FG001|Overall Study|Withdrawal by Subject|5|||
23767979|NCT00467584|66527824|FG002|Overall Study|Withdrawal by Subject|1|||
23569115|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
23569116|NCT00572624|65813258|FG000|Overall Study|Lost to Follow-up|10|||
23569117|NCT00572624|65813259|FG001|Overall Study|Lost to Follow-up|4|||
23569118|NCT00572624|65813258|FG000|Overall Study|Wanted to do a different diet program|1|||
23569119|NCT00572624|65813259|FG001|Overall Study|Wanted to do a different diet program|0|||
23569120|NCT00572624|65813258|FG000|Overall Study|Medication change|1|||
23569121|NCT00572624|65813259|FG001|Overall Study|Medication change|0|||
23569122|NCT00572624|65813258|FG000|Overall Study|Started a new job-- no time for study|1|||
23569123|NCT00572624|65813259|FG001|Overall Study|Started a new job-- no time for study|0|||
23569124|NCT00572624|65813258|FG000|Overall Study|Admitted to being a smoker|1|||
23569125|NCT00572624|65813259|FG001|Overall Study|Admitted to being a smoker|0|||
23569126|NCT00572624|65813258|FG000|Overall Study|Refused to do the stress test|1|||
23569127|NCT00572624|65813259|FG001|Overall Study|Refused to do the stress test|0|||
23569128|NCT00572624|65813258|FG000|Overall Study|Problem with vascular access|1|||
23569129|NCT00572624|65813259|FG001|Overall Study|Problem with vascular access|0|||
23569130|NCT00572624|65813258|FG000|Overall Study|Health issues unrelated to the study|1|||
23569131|NCT00572624|65813259|FG001|Overall Study|Health issues unrelated to the study|0|||
23569132|NCT00195715|65813262|FG000|Overall Study|Adverse Event|122|||
23569133|NCT00195715|65813262|FG000|Overall Study|Withdrawal by Subject|58|||
23569134|NCT00195715|65813262|FG000|Overall Study|Lost to Follow-up|27|||
23569135|NCT00195715|65813262|FG000|Overall Study|Protocol Violation|13|||
23569136|NCT00195715|65813262|FG000|Overall Study|Lack of Efficacy|93|||
23569137|NCT00195715|65813262|FG000|Overall Study|Pregnancy|14|||
23569138|NCT00195715|65813262|FG000|Overall Study|Investigative site closure|8|||
23569139|NCT00195715|65813262|FG000|Overall Study|Subject moved/relocated|7|||
23569140|NCT00195715|65813262|FG000|Overall Study|Subject non-compliance|6|||
23569141|NCT00195715|65813262|FG000|Overall Study|Subject started commercial Humira|5|||
23569142|NCT00195715|65813262|FG000|Overall Study|Subject choice|3|||
23569143|NCT00195715|65813262|FG000|Overall Study|Loss of response/no improvement|3|||
23569144|NCT00195715|65813262|FG000|Overall Study|Sponsor stopped study|1|||
23569145|NCT00195715|65813262|FG000|Overall Study|Administrative reasons|2|||
23569146|NCT00195715|65813262|FG000|Overall Study|Investigator's decision|2|||
23569147|NCT00195715|65813262|FG000|Overall Study|Subject wants to get pregnant|4|||
23569148|NCT00195715|65813262|FG000|Overall Study|Use of prohibited medication|2|||
23569149|NCT00195715|65813262|FG000|Overall Study|Planned surgery|2|||
23569150|NCT00195715|65813262|FG000|Overall Study|Increased infection rate|1|||
23569151|NCT00195715|65813262|FG000|Overall Study|Ineligible|1|||
23569152|NCT00195715|65813262|FG000|Overall Study|Colonic stricture|1|||
23569153|NCT00195715|65813262|FG000|Overall Study|Sponsor discontinued trial|1|||
23569154|NCT00195715|65813262|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
23569155|NCT00210119|65813265|FG000|Overall Study|Protocol Violation|1|||
23569156|NCT00210119|65813265|FG000|Overall Study|Withdrawal by Subject|1|||
23569157|NCT03225846|65813266|FG000|Overall Study|Adverse Event|0|||
23569158|NCT03225846|65813267|FG001|Overall Study|Adverse Event|0|||
23569159|NCT03225846|65813268|FG002|Overall Study|Adverse Event|0|||
23569160|NCT03225846|65813269|FG003|Overall Study|Adverse Event|0|||
23569161|NCT03225846|65813270|FG004|Overall Study|Adverse Event|0|||
23569162|NCT03225846|65813271|FG005|Overall Study|Adverse Event|0|||
23569163|NCT03225846|65813272|FG006|Overall Study|Adverse Event|6|||
23569164|NCT03225846|65813266|FG000|Overall Study|Withdrawal by Subject|0|||
23569165|NCT03225846|65813267|FG001|Overall Study|Withdrawal by Subject|1|||
23569166|NCT03225846|65813268|FG002|Overall Study|Withdrawal by Subject|0|||
23569167|NCT03225846|65813269|FG003|Overall Study|Withdrawal by Subject|0|||
23569168|NCT03225846|65813270|FG004|Overall Study|Withdrawal by Subject|0|||
23569169|NCT03225846|65813271|FG005|Overall Study|Withdrawal by Subject|0|||
23569170|NCT03225846|65813272|FG006|Overall Study|Withdrawal by Subject|0|||
23569171|NCT03225846|65813266|FG000|Overall Study|Death|0|||
23569172|NCT03225846|65813267|FG001|Overall Study|Death|1|||
23569173|NCT03225846|65813268|FG002|Overall Study|Death|0|||
23569174|NCT03225846|65813269|FG003|Overall Study|Death|0|||
23569175|NCT03225846|65813270|FG004|Overall Study|Death|0|||
23569176|NCT03225846|65813271|FG005|Overall Study|Death|0|||
23569177|NCT03225846|65813272|FG006|Overall Study|Death|0|||
23569178|NCT03225846|65813266|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569179|NCT03225846|65813267|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
23630757|NCT01246999|66034841|FG003|Overall Study|Withdrawal by Subject|2|||
23767980|NCT01909466|66527825|FG000|Overall Study|Lost to Follow-up|5|||
23767981|NCT01909466|66527826|FG001|Overall Study|Lost to Follow-up|7|||
23569180|NCT03225846|65813268|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
23569181|NCT03225846|65813269|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569182|NCT03225846|65813270|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569183|NCT03225846|65813271|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569184|NCT03225846|65813272|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569185|NCT03225846|65813266|FG000|Overall Study|Patient decision|0|||
23569186|NCT03225846|65813267|FG001|Overall Study|Patient decision|0|||
23569187|NCT03225846|65813268|FG002|Overall Study|Patient decision|0|||
23569188|NCT03225846|65813269|FG003|Overall Study|Patient decision|0|||
23569189|NCT03225846|65813270|FG004|Overall Study|Patient decision|0|||
23569190|NCT03225846|65813271|FG005|Overall Study|Patient decision|0|||
23569191|NCT03225846|65813272|FG006|Overall Study|Patient decision|1|||
23569192|NCT03679767|65813274|FG000|Overall Study|Death|16|||
23569193|NCT03679767|65813275|FG001|Overall Study|Death|11|||
23569194|NCT03679767|65813276|FG002|Overall Study|Death|17|||
23569195|NCT03679767|65813277|FG003|Overall Study|Death|10|||
23569196|NCT03679767|65813274|FG000|Overall Study|Lost to Follow-up|1|||
23569197|NCT03679767|65813275|FG001|Overall Study|Lost to Follow-up|1|||
23569198|NCT03679767|65813276|FG002|Overall Study|Lost to Follow-up|1|||
23569199|NCT03679767|65813277|FG003|Overall Study|Lost to Follow-up|1|||
23569200|NCT03679767|65813274|FG000|Overall Study|Withdrawal by Subject|0|||
23569201|NCT03679767|65813275|FG001|Overall Study|Withdrawal by Subject|0|||
23569202|NCT03679767|65813276|FG002|Overall Study|Withdrawal by Subject|0|||
23569203|NCT03679767|65813277|FG003|Overall Study|Withdrawal by Subject|1|||
23569204|NCT03679767|65813274|FG000|Overall Study|Follow-up Completed|18|||
23569205|NCT03679767|65813275|FG001|Overall Study|Follow-up Completed|11|||
23569206|NCT03679767|65813276|FG002|Overall Study|Follow-up Completed|11|||
23569207|NCT03679767|65813277|FG003|Overall Study|Follow-up Completed|20|||
23569208|NCT03679767|65813274|FG000|Overall Study|Entered Hospice Care|0|||
23569209|NCT03679767|65813275|FG001|Overall Study|Entered Hospice Care|0|||
23569210|NCT03679767|65813276|FG002|Overall Study|Entered Hospice Care|0|||
23569211|NCT03679767|65813277|FG003|Overall Study|Entered Hospice Care|1|||
23569212|NCT03679767|65813274|FG000|Overall Study|Progressive Disease|0|||
23569213|NCT03679767|65813275|FG001|Overall Study|Progressive Disease|0|||
23569214|NCT03679767|65813276|FG002|Overall Study|Progressive Disease|0|||
23569215|NCT03679767|65813277|FG003|Overall Study|Progressive Disease|1|||
23569216|NCT03428815|65813279|FG000|Overall Study|Lost to Follow-up|2|||
23569217|NCT03428815|65813280|FG001|Overall Study|Lost to Follow-up|2|||
23569218|NCT03428815|65813279|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
23569219|NCT03428815|65813280|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
23569220|NCT03428815|65813279|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
23569221|NCT03428815|65813280|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
23569222|NCT02748694|65813284|FG000|Overall Study|Voluntary Withdrawal|0|||
23569223|NCT02748694|65813285|FG001|Overall Study|Voluntary Withdrawal|0|||
23569224|NCT02748694|65813286|FG002|Overall Study|Voluntary Withdrawal|0|||
23569225|NCT02748694|65813287|FG003|Overall Study|Voluntary Withdrawal|0|||
23569226|NCT02748694|65813288|FG004|Overall Study|Voluntary Withdrawal|0|||
23569227|NCT02748694|65813289|FG005|Overall Study|Voluntary Withdrawal|0|||
23569228|NCT02748694|65813290|FG006|Overall Study|Voluntary Withdrawal|0|||
23569229|NCT02748694|65813291|FG007|Overall Study|Voluntary Withdrawal|0|||
23569230|NCT02748694|65813292|FG008|Overall Study|Voluntary Withdrawal|0|||
23569231|NCT02748694|65813293|FG009|Overall Study|Voluntary Withdrawal|0|||
23569232|NCT02748694|65813294|FG010|Overall Study|Voluntary Withdrawal|0|||
23569233|NCT02748694|65813295|FG011|Overall Study|Voluntary Withdrawal|0|||
23569234|NCT02748694|65813296|FG012|Overall Study|Voluntary Withdrawal|0|||
23569235|NCT02748694|65813297|FG013|Overall Study|Voluntary Withdrawal|0|||
23569236|NCT02748694|65813298|FG014|Overall Study|Voluntary Withdrawal|2|||
23569237|NCT02589392|65813301|FG000|Overall Study|Adverse Event|1|||
23569238|NCT02589392|65813302|FG001|Overall Study|Adverse Event|1|||
23569239|NCT02589392|65813301|FG000|Overall Study|Withdrawal by Subject|1|||
23569240|NCT02589392|65813302|FG001|Overall Study|Withdrawal by Subject|2|||
23569241|NCT02589392|65813301|FG000|Overall Study|Protocol Violation|1|||
23569242|NCT02589392|65813302|FG001|Overall Study|Protocol Violation|1|||
23569243|NCT02589392|65813301|FG000|Overall Study|Lost to Follow-up|2|||
23569244|NCT02589392|65813302|FG001|Overall Study|Lost to Follow-up|2|||
23569245|NCT02589392|65813301|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
23569246|NCT02589392|65813302|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
23569247|NCT00895843|65813303|FG000|Overall Study|Protocol Violation|12|||
23569248|NCT00895843|65813304|FG001|Overall Study|Protocol Violation|12|||
23569249|NCT00553202|65813307|FG000|Overall Study|Death|16|||
23569250|NCT00553202|65813307|FG000|Overall Study|Lost to Follow-up|1|||
23569251|NCT00553202|65813307|FG000|Overall Study|Physician Decision|28|||
23569252|NCT00553202|65813307|FG000|Overall Study|Withdrawal by Subject|1|||
23569253|NCT00553202|65813307|FG000|Overall Study|No donor identified|16|||
23569254|NCT00553202|65813307|FG000|Overall Study|Fails to meet organ function|6|||
23569255|NCT00453310|65813308|FG000|Overall Study|Progression of Disease|10|||
23569256|NCT01108510|65813312|FG000|Overall Study|Randomized but Not Treated|5|||
23569257|NCT01108510|65813313|FG001|Overall Study|Randomized but Not Treated|1|||
23569258|NCT01108510|65813312|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
23569259|NCT01108510|65813313|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
23569260|NCT01108510|65813312|FG000|Overall Study|Adverse Event|26|||
23569261|NCT01108510|65813313|FG001|Overall Study|Adverse Event|19|||
23569262|NCT01108510|65813312|FG000|Overall Study|Lost to Follow-up|20|||
23569263|NCT01108510|65813313|FG001|Overall Study|Lost to Follow-up|17|||
23569264|NCT01108510|65813312|FG000|Overall Study|Withdrew Consent|21|||
23569265|NCT01108510|65813313|FG001|Overall Study|Withdrew Consent|15|||
23569266|NCT01108510|65813312|FG000|Overall Study|Investigator's Discretion|12|||
23569267|NCT01108510|65813313|FG001|Overall Study|Investigator's Discretion|10|||
23569268|NCT01108510|65813312|FG000|Overall Study|Participant Noncompliance|5|||
23569269|NCT01108510|65813313|FG001|Overall Study|Participant Noncompliance|7|||
23569270|NCT01108510|65813312|FG000|Overall Study|Lack of Efficacy|3|||
23569271|NCT01108510|65813313|FG001|Overall Study|Lack of Efficacy|0|||
23569272|NCT01108510|65813312|FG000|Overall Study|Pregnancy|0|||
23569273|NCT01108510|65813313|FG001|Overall Study|Pregnancy|3|||
23569274|NCT01108510|65813312|FG000|Overall Study|Death|1|||
23569275|NCT01108510|65813313|FG001|Overall Study|Death|1|||
23569276|NCT01051063|65813325|FG000|Overall Study|Death|2|||
23569277|NCT01051063|65813326|FG001|Overall Study|Death|2|||
23569278|NCT01051063|65813325|FG000|Overall Study|Withdrawal by Subject|1|||
23569279|NCT01051063|65813326|FG001|Overall Study|Withdrawal by Subject|1|||
23569280|NCT01051063|65813325|FG000|Overall Study|Termination of the study|5|||
23569281|NCT01051063|65813326|FG001|Overall Study|Termination of the study|0|||
23569282|NCT01051063|65813325|FG000|Overall Study|Moved from the study site area|1|||
23569283|NCT01051063|65813326|FG001|Overall Study|Moved from the study site area|0|||
23569284|NCT01051063|65813325|FG000|Overall Study|Other|1|||
23569285|NCT01051063|65813326|FG001|Overall Study|Other|0|||
23569286|NCT01051063|65813325|FG000|Overall Study|Lost to Follow-up|0|||
23569287|NCT01051063|65813326|FG001|Overall Study|Lost to Follow-up|1|||
23569288|NCT03857841|65813328|FG000|Overall Study|Death|1|||
23830055|NCT01422213|66759879|FG001|Overall Study|Adverse Event|7|||
23830056|NCT01422213|66759880|FG002|Overall Study|Adverse Event|11|||
23830057|NCT01422213|66759878|FG000|Overall Study|Lack of Efficacy|10|||
23767982|NCT01909466|66527825|FG000|Overall Study|Adverse Event|3|||
23767983|NCT01909466|66527826|FG001|Overall Study|Adverse Event|4|||
23767984|NCT01909466|66527825|FG000|Overall Study|Met Withdrawal Criteria|0|||
23767985|NCT01909466|66527826|FG001|Overall Study|Met Withdrawal Criteria|3|||
23767986|NCT01909466|66527825|FG000|Overall Study|Physician Decision|2|||
23767987|NCT01909466|66527826|FG001|Overall Study|Physician Decision|0|||
23767988|NCT01909466|66527825|FG000|Overall Study|Withdrawal by Subject|11|||
23767989|NCT01909466|66527826|FG001|Overall Study|Withdrawal by Subject|9|||
23767990|NCT01909466|66527825|FG000|Overall Study|Lack of Efficacy|1|||
23767991|NCT01909466|66527826|FG001|Overall Study|Lack of Efficacy|0|||
23767992|NCT03687125|66527827|FG000|Overall Study|Progressive Disease|2|||
23767993|NCT03687125|66527828|FG001|Overall Study|Progressive Disease|1|||
23767994|NCT03687125|66527827|FG000|Overall Study|Protocol Violation|1|||
23767995|NCT03687125|66527828|FG001|Overall Study|Protocol Violation|0|||
23767996|NCT02001558|66527829|FG000|Overall Study|Lost to Follow-up|8|||
23767997|NCT02001558|66527830|FG001|Overall Study|Lost to Follow-up|14|||
23767998|NCT01003886|66527834|FG000|Overall Study|Lack of Efficacy|5|||
23767999|NCT01003886|66527834|FG000|Overall Study|Lost to Follow-up|169|||
23830058|NCT01422213|66759879|FG001|Overall Study|Lack of Efficacy|2|||
23830059|NCT01422213|66759880|FG002|Overall Study|Lack of Efficacy|2|||
23569289|NCT03857841|65813329|FG001|Overall Study|Death|0|||
23569290|NCT03857841|65813330|FG002|Overall Study|Death|0|||
23569291|NCT03857841|65813331|FG003|Overall Study|Death|0|||
23569292|NCT03857841|65813328|FG000|Overall Study|Study Terminated by Sponsor|1|||
23569293|NCT03857841|65813329|FG001|Overall Study|Study Terminated by Sponsor|0|||
23569294|NCT03857841|65813330|FG002|Overall Study|Study Terminated by Sponsor|0|||
23569295|NCT03857841|65813331|FG003|Overall Study|Study Terminated by Sponsor|0|||
23569296|NCT03125941|65813344|FG000|Overall Study|did not receive intervention|1|||
23569297|NCT03125941|65813345|FG001|Overall Study|did not receive intervention|2|||
23569298|NCT01751113|65813356|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569299|NCT01751113|65813357|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569300|NCT01751113|65813358|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23768000|NCT01003886|66527834|FG000|Overall Study|Withdrawal by Subject|39|||
23768001|NCT01003886|66527834|FG000|Overall Study|Other|14|||
23768002|NCT01003886|66527834|FG000|Overall Study|Adverse Event|3|||
23768003|NCT01031537|66527835|FG000|Overall Study|medical reasons not related to study|3|||
23830060|NCT01422213|66759878|FG000|Overall Study|Non-compliance with study drug|0|||
23446684|NCT03852719|65377730|FG000|Overall Study|Physician Decision|0|||
23569301|NCT01751113|65813359|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23569302|NCT01751113|65813360|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23569303|NCT01751113|65813361|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569304|NCT01751113|65813356|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569305|NCT01751113|65813357|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569306|NCT01751113|65813358|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569307|NCT01751113|65813359|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23768004|NCT01031537|66527835|FG000|Overall Study|Lack of Efficacy|1|||
23768005|NCT01031537|66527835|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
23768006|NCT01031537|66527835|FG000|Overall Study|moved, met exclusion criteria|10|||
23768007|NCT01031537|66527835|FG000|Overall Study|Withdrawal by Subject|5|||
23569308|NCT01751113|65813360|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569309|NCT01751113|65813361|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
23569310|NCT00957931|65813362|FG000|Overall Study|Death|4|||
23569311|NCT02318719|65813370|FG000|Double-blind Phase|Adverse Event|7|||
23569312|NCT02318719|65813371|FG001|Double-blind Phase|Adverse Event|6|||
23569313|NCT02318719|65813372|FG002|Double-blind Phase|Adverse Event|12|||
23768008|NCT01031537|66527835|FG000|Overall Study|PI removal, no longer met eligibility|12|||
23768009|NCT01298570|66527836|FG000|Overall Study|Disease progression, relapse during acti|64|||
23768010|NCT01298570|66527837|FG001|Overall Study|Disease progression, relapse during acti|40|||
23768011|NCT01298570|66527836|FG000|Overall Study|Adverse Event|20|||
23768012|NCT01298570|66527837|FG001|Overall Study|Adverse Event|2|||
23830061|NCT01422213|66759879|FG001|Overall Study|Non-compliance with study drug|1|||
23830062|NCT01422213|66759880|FG002|Overall Study|Non-compliance with study drug|0|||
23830063|NCT01422213|66759878|FG000|Overall Study|Protocol Violation|0|||
23830064|NCT01422213|66759879|FG001|Overall Study|Protocol Violation|2|||
23830065|NCT01422213|66759880|FG002|Overall Study|Protocol Violation|4|||
23830066|NCT01422213|66759878|FG000|Overall Study|Withdrawal of Consent|7|||
23830067|NCT01422213|66759879|FG001|Overall Study|Withdrawal of Consent|3|||
23830068|NCT01422213|66759880|FG002|Overall Study|Withdrawal of Consent|5|||
23830069|NCT01422213|66759878|FG000|Overall Study|Lost to Follow-up|3|||
23830070|NCT01422213|66759879|FG001|Overall Study|Lost to Follow-up|3|||
23830071|NCT01422213|66759880|FG002|Overall Study|Lost to Follow-up|5|||
23830072|NCT01422213|66759878|FG000|Overall Study|Administrative or Other Reason(s)|5|||
23830073|NCT01422213|66759879|FG001|Overall Study|Administrative or Other Reason(s)|4|||
23830074|NCT01422213|66759880|FG002|Overall Study|Administrative or Other Reason(s)|2|||
23830075|NCT00725283|66759881|FG000|Overall Study|Missing Code|3|||
23830076|NCT00725283|66759881|FG000|Overall Study|Death|5|||
23569314|NCT02318719|65813373|FG003|Double-blind Phase|Adverse Event|4|||
23569315|NCT02318719|65813374|FG004|Double-blind Phase|Adverse Event|0|||
23569316|NCT02318719|65813370|FG000|Double-blind Phase|Lack of Efficacy|5|||
23569317|NCT02318719|65813371|FG001|Double-blind Phase|Lack of Efficacy|0|||
23569318|NCT02318719|65813372|FG002|Double-blind Phase|Lack of Efficacy|1|||
23569319|NCT02318719|65813373|FG003|Double-blind Phase|Lack of Efficacy|1|||
23768013|NCT01298570|66527836|FG000|Overall Study|Withdrawal by Subject|21|||
23768014|NCT01298570|66527837|FG001|Overall Study|Withdrawal by Subject|6|||
23768015|NCT01298570|66527836|FG000|Overall Study|Treatment delay > 4 weeks|4|||
23569320|NCT02318719|65813374|FG004|Double-blind Phase|Lack of Efficacy|0|||
23768016|NCT01298570|66527837|FG001|Overall Study|Treatment delay > 4 weeks|5|||
23768017|NCT01298570|66527836|FG000|Overall Study|Physician Decision|4|||
23830077|NCT00725283|66759881|FG000|Overall Study|Other|6|||
23768018|NCT01298570|66527837|FG001|Overall Study|Physician Decision|2|||
23768019|NCT01298570|66527836|FG000|Overall Study|Other complicating disease|2|||
23768020|NCT01298570|66527837|FG001|Overall Study|Other complicating disease|1|||
23768021|NCT01298570|66527836|FG000|Overall Study|Surgery|2|||
23768022|NCT01298570|66527837|FG001|Overall Study|Surgery|1|||
23768023|NCT01298570|66527836|FG000|Overall Study|Symptomatic progression/deterioration|3|||
23768024|NCT01298570|66527837|FG001|Overall Study|Symptomatic progression/deterioration|2|||
23768025|NCT01298570|66527836|FG000|Overall Study|Death|0|||
23830078|NCT00725283|66759881|FG000|Overall Study|Withdrawal by Subject|10|||
23830079|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
23830080|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
23830081|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
23830082|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
23830083|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
23830084|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
23830085|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
23768026|NCT01298570|66527837|FG001|Overall Study|Death|1|||
23830086|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
23830087|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
23569321|NCT02318719|65813370|FG000|Double-blind Phase|Protocol Violation|0|||
23569322|NCT02318719|65813371|FG001|Double-blind Phase|Protocol Violation|1|||
23569323|NCT02318719|65813372|FG002|Double-blind Phase|Protocol Violation|3|||
23768027|NCT01298570|66527836|FG000|Overall Study|Ineligibility|0|||
23768028|NCT01298570|66527837|FG001|Overall Study|Ineligibility|1|||
23768029|NCT02918162|66527838|FG000|Overall Study|Withdrawal by Subject|1|||
23830088|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
23830089|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
23830090|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
23830091|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
23830092|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
23830093|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
23768030|NCT02918162|66527838|FG000|Overall Study|Omental Disease|1|||
23768031|NCT02034799|66527839|FG000|Overall Study|Withdrawal by Subject|0|||
23768032|NCT02034799|66527840|FG001|Overall Study|Withdrawal by Subject|2|||
23569324|NCT02318719|65813373|FG003|Double-blind Phase|Protocol Violation|0|||
23569325|NCT02318719|65813374|FG004|Double-blind Phase|Protocol Violation|0|||
23569326|NCT02318719|65813370|FG000|Double-blind Phase|Withdrawal by Subject|25|||
23569327|NCT02318719|65813371|FG001|Double-blind Phase|Withdrawal by Subject|7|||
23569328|NCT02318719|65813372|FG002|Double-blind Phase|Withdrawal by Subject|9|||
23569329|NCT02318719|65813373|FG003|Double-blind Phase|Withdrawal by Subject|10|||
23569330|NCT02318719|65813374|FG004|Double-blind Phase|Withdrawal by Subject|0|||
23569331|NCT02318719|65813370|FG000|Double-blind Phase|Other|1|||
23569332|NCT02318719|65813371|FG001|Double-blind Phase|Other|2|||
23569333|NCT02318719|65813372|FG002|Double-blind Phase|Other|0|||
23569334|NCT02318719|65813373|FG003|Double-blind Phase|Other|0|||
23569335|NCT02318719|65813374|FG004|Double-blind Phase|Other|0|||
23569336|NCT02318719|65813370|FG000|Open-label Extension Phase|Adverse Event|0|||
23569337|NCT02318719|65813371|FG001|Open-label Extension Phase|Adverse Event|0|||
23569338|NCT02318719|65813372|FG002|Open-label Extension Phase|Adverse Event|0|||
23768033|NCT02034799|66527839|FG000|Overall Study|Lost to Follow-up|0|||
23768034|NCT02034799|66527840|FG001|Overall Study|Lost to Follow-up|1|||
23768035|NCT02034799|66527839|FG000|Overall Study|Death|2|||
23768036|NCT02034799|66527840|FG001|Overall Study|Death|1|||
23768037|NCT02093689|66527841|FG000|Overall Study|Physician Decision|4|||
23768038|NCT02093689|66527842|FG001|Overall Study|Physician Decision|0|||
23768039|NCT02093689|66527843|FG002|Overall Study|Physician Decision|0|||
23768040|NCT05431153|66527848|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23768041|NCT05431153|66527849|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23768042|NCT05431153|66527850|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23768043|NCT05431153|66527851|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23768044|NCT05431153|66527852|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
23768045|NCT05431153|66527853|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23768046|NCT01703741|66527854|FG000|Overall Study|Withdrawal by Subject|6|||
23768047|NCT01703741|66527854|FG000|Overall Study|Adverse Event|2|||
23569339|NCT02318719|65813373|FG003|Open-label Extension Phase|Adverse Event|0|||
23569340|NCT02318719|65813374|FG004|Open-label Extension Phase|Adverse Event|15|||
23569341|NCT02318719|65813370|FG000|Open-label Extension Phase|Death|0|||
23569342|NCT02318719|65813371|FG001|Open-label Extension Phase|Death|0|||
23569343|NCT02318719|65813372|FG002|Open-label Extension Phase|Death|0|||
23569344|NCT02318719|65813373|FG003|Open-label Extension Phase|Death|0|||
23569345|NCT02318719|65813374|FG004|Open-label Extension Phase|Death|1|||
23569346|NCT02318719|65813370|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
23569347|NCT02318719|65813371|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23569348|NCT02318719|65813372|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
23569349|NCT02318719|65813373|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
23569350|NCT02318719|65813374|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
23569351|NCT02318719|65813370|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
23569352|NCT02318719|65813371|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23768048|NCT01703741|66527854|FG000|Overall Study|Physician Decision|2|||
23768049|NCT01703741|66527854|FG000|Overall Study|Protocol Violation|1|||
23768050|NCT01703741|66527854|FG000|Overall Study|Lost to Follow-up|3|||
23569353|NCT02318719|65813372|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
23569354|NCT02318719|65813373|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
23569355|NCT02318719|65813374|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
23569356|NCT02318719|65813370|FG000|Open-label Extension Phase|Other|0|||
23569357|NCT02318719|65813371|FG001|Open-label Extension Phase|Other|0|||
23569358|NCT02318719|65813372|FG002|Open-label Extension Phase|Other|0|||
23768051|NCT01703741|66527854|FG000|Overall Study|Subject did not want to continue|2|||
23768052|NCT01703741|66527854|FG000|Overall Study|Subject cannot comply with study visits|1|||
23768053|NCT01703741|66527854|FG000|Overall Study|Subject started testosterone injections|1|||
23768054|NCT00970281|66527857|FG000|Overall Study|Lack of Efficacy|1|||
23768055|NCT00970281|66527858|FG001|Overall Study|Lack of Efficacy|14|||
23768056|NCT00970281|66527857|FG000|Overall Study|Withdrawal by Subject|0|||
23569359|NCT02318719|65813373|FG003|Open-label Extension Phase|Other|0|||
23569360|NCT02318719|65813374|FG004|Open-label Extension Phase|Other|7|||
23768057|NCT00970281|66527858|FG001|Overall Study|Withdrawal by Subject|1|||
23768058|NCT00970281|66527857|FG000|Overall Study|Physician Decision|1|||
23768059|NCT00970281|66527858|FG001|Overall Study|Physician Decision|1|||
23569361|NCT01112514|65813375|FG000|Overall Study|Lost to Follow-up|1|||
23768060|NCT01107535|66527863|FG000|Overall Study|Death|5|||
23768061|NCT02668302|66527864|FG000|Overall Study|Withdrawal by Subject|1|||
23768062|NCT02668302|66527865|FG001|Overall Study|Withdrawal by Subject|0|||
23768063|NCT02607800|66527866|FG000|Overall Study|Lost to Follow-up|7|||
23569362|NCT02045433|65813376|FG000|Overall Study|Withdrawal by Subject|1|||
23569363|NCT00452413|65813380|FG000|Overall Study|Progressive Disease|4|||
23569364|NCT00452413|65813381|FG001|Overall Study|Progressive Disease|11|||
23569365|NCT00452413|65813382|FG002|Overall Study|Progressive Disease|30|||
23569366|NCT00452413|65813380|FG000|Overall Study|Withdrawal by Subject|0|||
23569367|NCT00452413|65813381|FG001|Overall Study|Withdrawal by Subject|1|||
23569368|NCT00452413|65813382|FG002|Overall Study|Withdrawal by Subject|4|||
23569369|NCT00452413|65813380|FG000|Overall Study|Adverse Event|0|||
23569370|NCT00452413|65813381|FG001|Overall Study|Adverse Event|0|||
23569371|NCT00452413|65813382|FG002|Overall Study|Adverse Event|5|||
23569372|NCT00452413|65813380|FG000|Overall Study|Physician Decision|0|||
23569373|NCT00452413|65813381|FG001|Overall Study|Physician Decision|0|||
23569374|NCT00452413|65813382|FG002|Overall Study|Physician Decision|4|||
23569375|NCT00452413|65813380|FG000|Overall Study|Death due to study disease|0|||
23768064|NCT02607800|66527867|FG001|Overall Study|Lost to Follow-up|10|||
23768065|NCT02607800|66527866|FG000|Overall Study|Withdrew Consent|2|||
23768066|NCT02607800|66527867|FG001|Overall Study|Withdrew Consent|0|||
23768067|NCT02607800|66527866|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
23768068|NCT02607800|66527867|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
23768069|NCT02669264|66527870|FG000|Overall Study|Death|5|||
23768070|NCT02669264|66527871|FG001|Overall Study|Death|5|||
23768071|NCT02669264|66527872|FG002|Overall Study|Death|3|||
23768072|NCT02669264|66527873|FG003|Overall Study|Death|3|||
23768073|NCT02669264|66527874|FG004|Overall Study|Death|3|||
23768074|NCT02669264|66527875|FG005|Overall Study|Death|6|||
23768075|NCT02669264|66527876|FG006|Overall Study|Death|3|||
23768076|NCT02669264|66527870|FG000|Overall Study|Withdrawal by Subject|0|||
23768077|NCT02669264|66527871|FG001|Overall Study|Withdrawal by Subject|1|||
23768078|NCT02669264|66527872|FG002|Overall Study|Withdrawal by Subject|0|||
23768079|NCT02669264|66527873|FG003|Overall Study|Withdrawal by Subject|0|||
23768080|NCT02669264|66527874|FG004|Overall Study|Withdrawal by Subject|1|||
23768081|NCT02669264|66527875|FG005|Overall Study|Withdrawal by Subject|0|||
23768082|NCT02669264|66527876|FG006|Overall Study|Withdrawal by Subject|0|||
23768083|NCT02669264|66527870|FG000|Overall Study|Lost to Follow-up|0|||
23768084|NCT02669264|66527871|FG001|Overall Study|Lost to Follow-up|0|||
23768085|NCT02669264|66527872|FG002|Overall Study|Lost to Follow-up|0|||
23768086|NCT02669264|66527873|FG003|Overall Study|Lost to Follow-up|0|||
23768087|NCT02669264|66527874|FG004|Overall Study|Lost to Follow-up|1|||
23768088|NCT02669264|66527875|FG005|Overall Study|Lost to Follow-up|0|||
23768089|NCT02669264|66527876|FG006|Overall Study|Lost to Follow-up|0|||
23768090|NCT02669264|66527870|FG000|Overall Study|Miscellaneous|0|||
23768091|NCT02669264|66527871|FG001|Overall Study|Miscellaneous|0|||
23768092|NCT02669264|66527872|FG002|Overall Study|Miscellaneous|0|||
23768093|NCT02669264|66527873|FG003|Overall Study|Miscellaneous|0|||
23768094|NCT02669264|66527874|FG004|Overall Study|Miscellaneous|0|||
23768095|NCT02669264|66527875|FG005|Overall Study|Miscellaneous|0|||
23768096|NCT02669264|66527876|FG006|Overall Study|Miscellaneous|2|||
23768097|NCT00265759|66527877|FG000|Overall Study|Withdrawal by Subject|0|||
23768098|NCT00265759|66527878|FG001|Overall Study|Withdrawal by Subject|1|||
23768099|NCT00265759|66527879|FG002|Overall Study|Withdrawal by Subject|2|||
23768100|NCT00265759|66527880|FG003|Overall Study|Withdrawal by Subject|2|||
23768101|NCT00265759|66527877|FG000|Overall Study|Cancel|0|||
23768102|NCT00265759|66527878|FG001|Overall Study|Cancel|0|||
23768103|NCT00265759|66527879|FG002|Overall Study|Cancel|0|||
23768104|NCT00265759|66527880|FG003|Overall Study|Cancel|3|||
23830094|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
23830095|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
23830096|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
23830097|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
23830098|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
23830099|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
23830100|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
23569376|NCT00452413|65813381|FG001|Overall Study|Death due to study disease|0|||
23569377|NCT00452413|65813382|FG002|Overall Study|Death due to study disease|2|||
23768105|NCT00265759|66527877|FG000|Overall Study|Ineligible|0|||
23768106|NCT00265759|66527878|FG001|Overall Study|Ineligible|0|||
23768107|NCT00265759|66527879|FG002|Overall Study|Ineligible|0|||
23768108|NCT00265759|66527880|FG003|Overall Study|Ineligible|1|||
23768109|NCT00265759|66527877|FG000|Overall Study|Bilateral disease|0|||
23768110|NCT00265759|66527878|FG001|Overall Study|Bilateral disease|0|||
23830101|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
23768111|NCT00265759|66527879|FG002|Overall Study|Bilateral disease|0|||
23768112|NCT00265759|66527880|FG003|Overall Study|Bilateral disease|2|||
23830102|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
23830103|NCT01130532|66759882|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
23569378|NCT00452413|65813380|FG000|Overall Study|Death due to adverse event (AE)|0|||
23569379|NCT00452413|65813381|FG001|Overall Study|Death due to adverse event (AE)|0|||
23768113|NCT00265759|66527877|FG000|Overall Study|Discontinued due to intolerability|0|||
23768114|NCT00265759|66527878|FG001|Overall Study|Discontinued due to intolerability|0|||
23630758|NCT00108745|66034842|FG000|Overall Study|Withdrawal by Subject|19|||
23630759|NCT00108745|66034843|FG001|Overall Study|Withdrawal by Subject|12|||
23768115|NCT00265759|66527879|FG002|Overall Study|Discontinued due to intolerability|0|||
23768116|NCT00265759|66527880|FG003|Overall Study|Discontinued due to intolerability|1|||
23768117|NCT02153736|66527883|FG000|Overall Study|Lost to Follow-up|1|||
23768118|NCT02153736|66527884|FG001|Overall Study|Lost to Follow-up|0|||
23768119|NCT02153736|66527883|FG000|Overall Study|Medical status change made ineligible|1|||
23768120|NCT02153736|66527884|FG001|Overall Study|Medical status change made ineligible|0|||
23768121|NCT02153736|66527883|FG000|Overall Study|Death|0|||
23768122|NCT02153736|66527884|FG001|Overall Study|Death|1|||
23768123|NCT02153736|66527883|FG000|Overall Study|Withdrawal by Subject|0|||
23768124|NCT02153736|66527884|FG001|Overall Study|Withdrawal by Subject|1|||
23768125|NCT02737306|66527885|FG000|Overall Study|Adverse Event|3|||
23830104|NCT01130532|66759883|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
23830105|NCT01130532|66759884|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
23830106|NCT01130532|66759885|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
23830107|NCT01130532|66759882|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
23830108|NCT01130532|66759883|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
23446685|NCT03852719|65377731|FG001|Overall Study|Physician Decision|0|||
23569380|NCT00452413|65813382|FG002|Overall Study|Death due to adverse event (AE)|1|||
23569381|NCT00452413|65813380|FG000|Overall Study|On treatment|0|||
23569382|NCT00452413|65813381|FG001|Overall Study|On treatment|0|||
23569383|NCT00452413|65813382|FG002|Overall Study|On treatment|3|||
23569384|NCT03661996|65813383|FG000|Overall Study|Adverse Event|0|||
23569385|NCT03661996|65813384|FG001|Overall Study|Adverse Event|0|||
23569386|NCT03661996|65813385|FG002|Overall Study|Adverse Event|1|||
23569387|NCT03661996|65813386|FG003|Overall Study|Adverse Event|1|||
23569388|NCT03661996|65813387|FG004|Overall Study|Adverse Event|0|||
23569389|NCT03661996|65813383|FG000|Overall Study|Lost to Follow-up|5|||
23569390|NCT03661996|65813384|FG001|Overall Study|Lost to Follow-up|1|||
23569391|NCT03661996|65813385|FG002|Overall Study|Lost to Follow-up|2|||
23569392|NCT03661996|65813386|FG003|Overall Study|Lost to Follow-up|2|||
23569393|NCT03661996|65813387|FG004|Overall Study|Lost to Follow-up|6|||
23569394|NCT03661996|65813383|FG000|Overall Study|Physician Decision|1|||
23569395|NCT03661996|65813384|FG001|Overall Study|Physician Decision|1|||
23569396|NCT03661996|65813385|FG002|Overall Study|Physician Decision|1|||
23569397|NCT03661996|65813386|FG003|Overall Study|Physician Decision|2|||
23569398|NCT03661996|65813387|FG004|Overall Study|Physician Decision|0|||
23569399|NCT03661996|65813383|FG000|Overall Study|Protocol Violation|0|||
23569400|NCT03661996|65813384|FG001|Overall Study|Protocol Violation|0|||
23569401|NCT03661996|65813385|FG002|Overall Study|Protocol Violation|0|||
23569402|NCT03661996|65813386|FG003|Overall Study|Protocol Violation|0|||
23569403|NCT03661996|65813387|FG004|Overall Study|Protocol Violation|1|||
23569404|NCT03661996|65813383|FG000|Overall Study|Withdrawal by Subject|3|||
23569405|NCT03661996|65813384|FG001|Overall Study|Withdrawal by Subject|5|||
23569406|NCT03661996|65813385|FG002|Overall Study|Withdrawal by Subject|1|||
23569407|NCT03661996|65813386|FG003|Overall Study|Withdrawal by Subject|7|||
23569408|NCT03661996|65813387|FG004|Overall Study|Withdrawal by Subject|7|||
23569409|NCT03661996|65813383|FG000|Overall Study|Sponsors Decision|2|||
23569410|NCT03661996|65813384|FG001|Overall Study|Sponsors Decision|0|||
23569411|NCT03661996|65813385|FG002|Overall Study|Sponsors Decision|0|||
23569412|NCT03661996|65813386|FG003|Overall Study|Sponsors Decision|0|||
23446686|NCT03852719|65377732|FG002|Overall Study|Physician Decision|1|||
23446687|NCT03852719|65377730|FG000|Overall Study|Pregnancy|1|||
23446688|NCT03852719|65377731|FG001|Overall Study|Pregnancy|1|||
23446689|NCT03852719|65377732|FG002|Overall Study|Pregnancy|0|||
23569413|NCT03661996|65813387|FG004|Overall Study|Sponsors Decision|0|||
23569414|NCT03661996|65813383|FG000|Overall Study|Other|1|||
23569415|NCT03661996|65813384|FG001|Overall Study|Other|1|||
23569416|NCT03661996|65813385|FG002|Overall Study|Other|1|||
23569417|NCT03661996|65813386|FG003|Overall Study|Other|1|||
23569418|NCT03661996|65813387|FG004|Overall Study|Other|0|||
23569419|NCT03283696|65813390|FG000|Overall Study|Physician Decision|5|||
23569420|NCT03283696|65813391|FG001|Overall Study|Physician Decision|6|||
23569421|NCT03283696|65813390|FG000|Overall Study|Withdrawal by Subject|2|||
23569422|NCT03283696|65813391|FG001|Overall Study|Withdrawal by Subject|0|||
23569423|NCT03354637|65813392|FG000|Double-blind Period|Protocol Violation|2|||
23569424|NCT03354637|65813393|FG001|Double-blind Period|Protocol Violation|0|||
23630760|NCT00108745|66034844|FG002|Overall Study|Withdrawal by Subject|12|||
23768126|NCT02737306|66527886|FG001|Overall Study|Adverse Event|0|||
23830109|NCT01130532|66759884|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
23446690|NCT03852719|65377730|FG000|Overall Study|Death|1|||
23446691|NCT03852719|65377731|FG001|Overall Study|Death|0|||
23569425|NCT03354637|65813394|FG002|Double-blind Period|Protocol Violation|0|||
23569426|NCT03354637|65813392|FG000|Double-blind Period|Adverse Event|1|||
23569427|NCT03354637|65813393|FG001|Double-blind Period|Adverse Event|2|||
23569428|NCT03354637|65813394|FG002|Double-blind Period|Adverse Event|0|||
23569429|NCT03354637|65813392|FG000|Double-blind Period|Lost to Follow-up|3|||
23630761|NCT00108745|66034842|FG000|Overall Study|Never Treated|8|||
23630762|NCT00108745|66034843|FG001|Overall Study|Never Treated|10|||
23630763|NCT00108745|66034844|FG002|Overall Study|Never Treated|12|||
23630764|NCT00108745|66034842|FG000|Overall Study|Ineligible|7|||
23630765|NCT00108745|66034843|FG001|Overall Study|Ineligible|13|||
23630766|NCT00108745|66034844|FG002|Overall Study|Ineligible|13|||
23630767|NCT05144945|66034850|FG000|Overall Study|Withdrawal by Subject|1|||
23569430|NCT03354637|65813393|FG001|Double-blind Period|Lost to Follow-up|4|||
23569431|NCT03354637|65813394|FG002|Double-blind Period|Lost to Follow-up|3|||
23569432|NCT03354637|65813392|FG000|Double-blind Period|Withdrawal by Subject|10|||
23569433|NCT03354637|65813393|FG001|Double-blind Period|Withdrawal by Subject|6|||
23630768|NCT05144945|66034851|FG001|Overall Study|Withdrawal by Subject|0|||
23630769|NCT00966264|66034852|FG000|Overall Study|Lost to Follow-up|4|||
23768127|NCT02737306|66527885|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
23830110|NCT01130532|66759885|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
23830111|NCT01130532|66759882|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23569434|NCT03354637|65813394|FG002|Double-blind Period|Withdrawal by Subject|4|||
23569435|NCT03354637|65813392|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
23569436|NCT03354637|65813393|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
23569437|NCT03354637|65813394|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
23569438|NCT03354637|65813392|FG000|Open Label Extension|Adverse Event|0|||
23569439|NCT03354637|65813393|FG001|Open Label Extension|Adverse Event|0|||
23569440|NCT03354637|65813394|FG002|Open Label Extension|Adverse Event|1|||
23569441|NCT03354637|65813392|FG000|Open Label Extension|Lost to Follow-up|0|||
23569442|NCT03354637|65813393|FG001|Open Label Extension|Lost to Follow-up|0|||
23569443|NCT03354637|65813394|FG002|Open Label Extension|Lost to Follow-up|2|||
23569444|NCT03354637|65813392|FG000|Open Label Extension|Withdrawal by Subject|0|||
23569445|NCT03354637|65813393|FG001|Open Label Extension|Withdrawal by Subject|0|||
23768128|NCT02737306|66527886|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
23768129|NCT03276975|66527891|FG000|Overall Study|Withdrawal by Subject|1|||
23768130|NCT03276975|66527892|FG001|Overall Study|Withdrawal by Subject|0|||
23768131|NCT02322047|66527893|FG000|Overall Study|Physician Decision|1|||
23768132|NCT02322047|66527894|FG001|Overall Study|Physician Decision|0|||
23768133|NCT02322047|66527895|FG002|Overall Study|Physician Decision|0|||
23768134|NCT02322047|66527896|FG003|Overall Study|Physician Decision|0|||
23830112|NCT01130532|66759883|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23830113|NCT01130532|66759884|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23830114|NCT01130532|66759885|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
23830115|NCT01130532|66759882|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23830116|NCT01130532|66759883|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23830117|NCT01130532|66759884|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23830118|NCT01130532|66759885|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
23830119|NCT01130532|66759882|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23830120|NCT01130532|66759883|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23830121|NCT01130532|66759884|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23830122|NCT01130532|66759885|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
23830123|NCT02440464|66759886|FG000|Overall Study|Withdrawal by Subject|3|||
23830124|NCT02440464|66759887|FG001|Overall Study|Withdrawal by Subject|2|||
23630770|NCT00966264|66034853|FG001|Overall Study|Lost to Follow-up|3|||
23630771|NCT00983853|66034854|FG000|Overall Study|Lost to Follow-up|1|||
23569446|NCT03354637|65813394|FG002|Open Label Extension|Withdrawal by Subject|5|||
23630772|NCT00983853|66034855|FG001|Overall Study|Lost to Follow-up|1|||
23768135|NCT02322047|66527893|FG000|Overall Study|Withdrawal by Subject|1|||
23830125|NCT01891864|66759888|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
23768136|NCT02322047|66527894|FG001|Overall Study|Withdrawal by Subject|0|||
23630773|NCT00983853|66034856|FG002|Overall Study|Lost to Follow-up|2|||
23630774|NCT00983853|66034857|FG003|Overall Study|Lost to Follow-up|2|||
23630775|NCT00983853|66034858|FG004|Overall Study|Lost to Follow-up|2|||
23630776|NCT00983853|66034859|FG005|Overall Study|Lost to Follow-up|1|||
23630777|NCT00983853|66034854|FG000|Overall Study|Withdrawal by Subject|0|||
23630778|NCT00983853|66034855|FG001|Overall Study|Withdrawal by Subject|0|||
23630779|NCT00983853|66034856|FG002|Overall Study|Withdrawal by Subject|1|||
23630780|NCT00983853|66034857|FG003|Overall Study|Withdrawal by Subject|0|||
23569447|NCT03354637|65813392|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
23569448|NCT03354637|65813393|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
23630781|NCT00983853|66034858|FG004|Overall Study|Withdrawal by Subject|1|||
23630782|NCT00983853|66034859|FG005|Overall Study|Withdrawal by Subject|0|||
23830126|NCT01891864|66759889|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
23830127|NCT01891864|66759890|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23830128|NCT01891864|66759891|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23830129|NCT01891864|66759892|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23768137|NCT02322047|66527895|FG002|Overall Study|Withdrawal by Subject|0|||
23768138|NCT02322047|66527896|FG003|Overall Study|Withdrawal by Subject|1|||
23768139|NCT02322047|66527893|FG000|Overall Study|Adverse Event|0|||
23768140|NCT02322047|66527894|FG001|Overall Study|Adverse Event|1|||
23768141|NCT02322047|66527895|FG002|Overall Study|Adverse Event|0|||
23446692|NCT03852719|65377732|FG002|Overall Study|Death|0|||
23446693|NCT00855816|65377733|FG000|Overall Study|Withdrawal by Subject|22|||
23446694|NCT00855816|65377734|FG001|Overall Study|Withdrawal by Subject|15|||
23446695|NCT00855816|65377733|FG000|Overall Study|Lost to Follow-up|3|||
23569449|NCT03354637|65813394|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
23830130|NCT01891864|66759893|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23830131|NCT01891864|66759888|FG000|Treatment Period 1|Physician Decision|0|||
23830132|NCT01891864|66759889|FG001|Treatment Period 1|Physician Decision|1|||
23830133|NCT01891864|66759890|FG002|Treatment Period 1|Physician Decision|0|||
23830134|NCT01891864|66759891|FG003|Treatment Period 1|Physician Decision|0|||
23830135|NCT01891864|66759892|FG004|Treatment Period 1|Physician Decision|0|||
23830136|NCT01891864|66759893|FG005|Treatment Period 1|Physician Decision|0|||
23830137|NCT01891864|66759888|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23630783|NCT00983853|66034854|FG000|Overall Study|Unable to come to study follow-up visits|0|||
23630784|NCT00983853|66034855|FG001|Overall Study|Unable to come to study follow-up visits|1|||
23630785|NCT00983853|66034856|FG002|Overall Study|Unable to come to study follow-up visits|0|||
23768142|NCT02322047|66527896|FG003|Overall Study|Adverse Event|0|||
23768143|NCT02322047|66527893|FG000|Overall Study|Lost to Follow-up|0|||
23768144|NCT02322047|66527894|FG001|Overall Study|Lost to Follow-up|0|||
23569450|NCT03354637|65813392|FG000|Open Label Extension|Subject Noncompliance|0|||
23569451|NCT03354637|65813393|FG001|Open Label Extension|Subject Noncompliance|0|||
23569452|NCT03354637|65813394|FG002|Open Label Extension|Subject Noncompliance|1|||
23569453|NCT03354637|65813392|FG000|Open Label Extension|Lack of Efficacy|0|||
23569454|NCT03354637|65813393|FG001|Open Label Extension|Lack of Efficacy|0|||
23569455|NCT03354637|65813394|FG002|Open Label Extension|Lack of Efficacy|1|||
23569456|NCT03354637|65813392|FG000|Open Label Extension|Physician Decision|0|||
23569457|NCT03354637|65813393|FG001|Open Label Extension|Physician Decision|0|||
23830138|NCT01891864|66759889|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
23830139|NCT01891864|66759890|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23830140|NCT01891864|66759891|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23830141|NCT01891864|66759892|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23569458|NCT03354637|65813394|FG002|Open Label Extension|Physician Decision|1|||
23630786|NCT00983853|66034857|FG003|Overall Study|Unable to come to study follow-up visits|0|||
23768145|NCT02322047|66527895|FG002|Overall Study|Lost to Follow-up|1|||
23768146|NCT02322047|66527896|FG003|Overall Study|Lost to Follow-up|1|||
23768147|NCT01621490|66527897|FG000|Overall Study|Subject no longer meets study criteria|0|||
23768148|NCT01621490|66527898|FG001|Overall Study|Subject no longer meets study criteria|0|||
23768149|NCT01621490|66527899|FG002|Overall Study|Subject no longer meets study criteria|0|||
23768150|NCT01621490|66527900|FG003|Overall Study|Subject no longer meets study criteria|0|||
23768151|NCT01621490|66527901|FG004|Overall Study|Subject no longer meets study criteria|1|||
23768152|NCT01621490|66527902|FG005|Overall Study|Subject no longer meets study criteria|0|||
23768153|NCT01621490|66527903|FG006|Overall Study|Subject no longer meets study criteria|0|||
23768154|NCT01621490|66527904|FG007|Overall Study|Subject no longer meets study criteria|0|||
23446696|NCT00855816|65377734|FG001|Overall Study|Lost to Follow-up|5|||
23630787|NCT00983853|66034858|FG004|Overall Study|Unable to come to study follow-up visits|0|||
23830142|NCT01891864|66759893|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23446697|NCT00855816|65377733|FG000|Overall Study|Death|1|||
23446698|NCT00855816|65377734|FG001|Overall Study|Death|0|||
23446699|NCT00855816|65377733|FG000|Overall Study|Became ineligible|0|||
23446700|NCT00855816|65377734|FG001|Overall Study|Became ineligible|1|||
23446701|NCT03369418|65377735|FG000|Overall Study|Withdrawal by Subject|3|||
23446702|NCT03369418|65377736|FG001|Overall Study|Withdrawal by Subject|3|||
23446703|NCT02634333|65377738|FG000|Overall Study|Completed out of Window|3|||
23446704|NCT02634333|65377739|FG001|Overall Study|Completed out of Window|2|||
23446705|NCT02634333|65377738|FG000|Overall Study|Missed Visit|5|||
23446706|NCT02634333|65377739|FG001|Overall Study|Missed Visit|2|||
23446707|NCT02634333|65377738|FG000|Overall Study|Lost to Follow-up|12|||
23446708|NCT02634333|65377739|FG001|Overall Study|Lost to Follow-up|7|||
23446709|NCT02634333|65377738|FG000|Overall Study|Withdrawal by Subject|9|||
23446710|NCT02634333|65377739|FG001|Overall Study|Withdrawal by Subject|13|||
23446711|NCT02634333|65377738|FG000|Overall Study|Death|11|||
23446712|NCT02634333|65377739|FG001|Overall Study|Death|8|||
23446713|NCT03010527|65377740|FG000|Overall Study|Death|0|||
23446714|NCT03010527|65377741|FG001|Overall Study|Death|0|||
23446715|NCT03010527|65377742|FG002|Overall Study|Death|1|||
23446716|NCT03010527|65377740|FG000|Overall Study|Adverse Event|0|||
23446717|NCT03010527|65377741|FG001|Overall Study|Adverse Event|4|||
23446718|NCT03010527|65377742|FG002|Overall Study|Adverse Event|2|||
23446719|NCT03010527|65377740|FG000|Overall Study|Protocol Violation|0|||
23446720|NCT03010527|65377741|FG001|Overall Study|Protocol Violation|1|||
23446721|NCT03010527|65377742|FG002|Overall Study|Protocol Violation|0|||
23446722|NCT03010527|65377740|FG000|Overall Study|Lost to Follow-up|0|||
23446723|NCT03010527|65377741|FG001|Overall Study|Lost to Follow-up|2|||
23446724|NCT03010527|65377742|FG002|Overall Study|Lost to Follow-up|1|||
23446725|NCT03010527|65377740|FG000|Overall Study|Withdrawal by Subject|0|||
23446726|NCT03010527|65377741|FG001|Overall Study|Withdrawal by Subject|3|||
23446727|NCT03010527|65377742|FG002|Overall Study|Withdrawal by Subject|4|||
23446728|NCT03010527|65377740|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
23446729|NCT03010527|65377741|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
23446730|NCT03010527|65377742|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
23446731|NCT03010527|65377740|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
23569459|NCT01679236|65813397|FG000|Overall Study|Lost to Follow-up|15|||
23768155|NCT01621490|66527905|FG008|Overall Study|Subject no longer meets study criteria|0|||
23768156|NCT01621490|66527906|FG009|Overall Study|Subject no longer meets study criteria|0|||
23768157|NCT01621490|66527907|FG010|Overall Study|Subject no longer meets study criteria|0|||
23768158|NCT01621490|66527897|FG000|Overall Study|Maximum clinical benefit|3|||
23768159|NCT01621490|66527898|FG001|Overall Study|Maximum clinical benefit|2|||
23768160|NCT01621490|66527899|FG002|Overall Study|Maximum clinical benefit|0|||
23768161|NCT01621490|66527900|FG003|Overall Study|Maximum clinical benefit|0|||
23768162|NCT01621490|66527901|FG004|Overall Study|Maximum clinical benefit|0|||
23768163|NCT01621490|66527902|FG005|Overall Study|Maximum clinical benefit|0|||
23768164|NCT01621490|66527903|FG006|Overall Study|Maximum clinical benefit|1|||
23768165|NCT01621490|66527904|FG007|Overall Study|Maximum clinical benefit|2|||
23768166|NCT01621490|66527905|FG008|Overall Study|Maximum clinical benefit|2|||
23768167|NCT01621490|66527906|FG009|Overall Study|Maximum clinical benefit|0|||
23768168|NCT01621490|66527907|FG010|Overall Study|Maximum clinical benefit|0|||
23768169|NCT01621490|66527897|FG000|Overall Study|Withdrawal by Subject|1|||
23768170|NCT01621490|66527898|FG001|Overall Study|Withdrawal by Subject|0|||
23768171|NCT01621490|66527899|FG002|Overall Study|Withdrawal by Subject|0|||
23768172|NCT01621490|66527900|FG003|Overall Study|Withdrawal by Subject|0|||
23768173|NCT01621490|66527901|FG004|Overall Study|Withdrawal by Subject|0|||
23768174|NCT01621490|66527902|FG005|Overall Study|Withdrawal by Subject|1|||
23768175|NCT01621490|66527903|FG006|Overall Study|Withdrawal by Subject|0|||
23768176|NCT01621490|66527904|FG007|Overall Study|Withdrawal by Subject|0|||
23768177|NCT01621490|66527905|FG008|Overall Study|Withdrawal by Subject|0|||
23768178|NCT01621490|66527906|FG009|Overall Study|Withdrawal by Subject|0|||
23768179|NCT01621490|66527907|FG010|Overall Study|Withdrawal by Subject|0|||
23768180|NCT01621490|66527897|FG000|Overall Study|Subject request to discontinue study|1|||
23446732|NCT03010527|65377741|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
23446733|NCT03010527|65377742|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
23446734|NCT03010527|65377740|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
23446735|NCT03010527|65377741|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
23446736|NCT03010527|65377742|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
23446737|NCT01216683|65377743|FG000|Induction|Never started treatment|0|||
23446738|NCT01216683|65377744|FG001|Induction|Never started treatment|6|||
23446739|NCT01216683|65377745|FG002|Induction|Never started treatment|3|||
23446740|NCT01216683|65377743|FG000|Induction|Lack of Efficacy|4|||
23446741|NCT01216683|65377744|FG001|Induction|Lack of Efficacy|3|||
23446742|NCT01216683|65377745|FG002|Induction|Lack of Efficacy|7|||
23446743|NCT01216683|65377743|FG000|Induction|Adverse Event|0|||
23446744|NCT01216683|65377744|FG001|Induction|Adverse Event|5|||
23446745|NCT01216683|65377745|FG002|Induction|Adverse Event|5|||
23446746|NCT01216683|65377743|FG000|Induction|Death|0|||
23569460|NCT01679236|65813398|FG001|Overall Study|Lost to Follow-up|15|||
23569461|NCT00064025|65813403|FG000|Overall Study|Ineligible|4|||
23569462|NCT00064025|65813403|FG000|Overall Study|Inevaluable|3|||
23569463|NCT03075501|65813405|FG000|Overall Study|Scheduling difficulties|15|||
23569464|NCT03075501|65813406|FG001|Overall Study|Scheduling difficulties|9|||
23569465|NCT04489888|65813407|FG000|Overall Study|Death|61|||
23569466|NCT04489888|65813407|FG000|Overall Study|Participant On-going|40|||
23569467|NCT03327402|65813408|FG000|Overall Study|Withdrawal by Subject|1|||
23569468|NCT03327402|65813408|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
23569469|NCT04170296|65813411|FG000|Overall Study|Adverse Event|1|||
23569470|NCT04170296|65813412|FG001|Overall Study|Adverse Event|0|||
23569471|NCT04170296|65813411|FG000|Overall Study|Withdrawal by Subject|3|||
23569472|NCT04170296|65813412|FG001|Overall Study|Withdrawal by Subject|2|||
23569473|NCT04170296|65813411|FG000|Overall Study|Lost to Follow-up|4|||
23569474|NCT04170296|65813412|FG001|Overall Study|Lost to Follow-up|2|||
23569475|NCT00786474|65813413|FG000|Overall Study|Death|5|||
23569476|NCT00786474|65813414|FG001|Overall Study|Death|4|||
23446747|NCT01216683|65377744|FG001|Induction|Death|0|||
23446748|NCT01216683|65377745|FG002|Induction|Death|2|||
23446749|NCT01216683|65377743|FG000|Induction|Withdrawal by Subject|0|||
23446750|NCT01216683|65377744|FG001|Induction|Withdrawal by Subject|4|||
23569477|NCT00786474|65813413|FG000|Overall Study|Withdrawal by Subject|23|||
23569478|NCT00786474|65813414|FG001|Overall Study|Withdrawal by Subject|31|||
23569479|NCT00786474|65813413|FG000|Overall Study|Lost to Follow-up|3|||
23569480|NCT00786474|65813414|FG001|Overall Study|Lost to Follow-up|3|||
23446751|NCT01216683|65377745|FG002|Induction|Withdrawal by Subject|2|||
23446752|NCT01216683|65377743|FG000|Induction|Other disease|0|||
23446753|NCT01216683|65377744|FG001|Induction|Other disease|1|||
23446754|NCT01216683|65377745|FG002|Induction|Other disease|2|||
23446755|NCT01216683|65377743|FG000|Continuation|Lack of Efficacy|3|||
23446756|NCT01216683|65377744|FG001|Continuation|Lack of Efficacy|2|||
23446757|NCT01216683|65377745|FG002|Continuation|Lack of Efficacy|7|||
23446758|NCT01216683|65377743|FG000|Continuation|Adverse Event|5|||
23569481|NCT00786474|65813413|FG000|Overall Study|Physician Decision|2|||
23569482|NCT00786474|65813414|FG001|Overall Study|Physician Decision|1|||
23569483|NCT00786474|65813413|FG000|Overall Study|Other|4|||
23446759|NCT01216683|65377744|FG001|Continuation|Adverse Event|3|||
23446760|NCT01216683|65377745|FG002|Continuation|Adverse Event|16|||
23569484|NCT00786474|65813414|FG001|Overall Study|Other|4|||
23569485|NCT02917265|65813415|FG000|Overall Study|Physician Decision|1|||
23569486|NCT02917265|65813416|FG001|Overall Study|Physician Decision|0|||
23569487|NCT02917265|65813415|FG000|Overall Study|Withdrawal by Subject|1|||
23569488|NCT02917265|65813416|FG001|Overall Study|Withdrawal by Subject|0|||
23569489|NCT02340520|65813418|FG000|Overall Study|Lost to Follow-up|1|||
23569490|NCT02340520|65813418|FG000|Overall Study|Patient did not take drug as specified|1|||
23569491|NCT02340520|65813418|FG000|Overall Study|Withdrawal by Subject|1|||
23569492|NCT01146574|65813425|FG000|Overall Study|Death|0|||
23446761|NCT01216683|65377743|FG000|Continuation|Death|1|||
23446762|NCT01216683|65377744|FG001|Continuation|Death|0|||
23446763|NCT01216683|65377745|FG002|Continuation|Death|2|||
23446764|NCT01216683|65377743|FG000|Continuation|Withdrawal by Subject|4|||
23446765|NCT01216683|65377744|FG001|Continuation|Withdrawal by Subject|5|||
23446766|NCT01216683|65377745|FG002|Continuation|Withdrawal by Subject|9|||
23446767|NCT01216683|65377743|FG000|Continuation|Other diseases|0|||
23569493|NCT01146574|65813426|FG001|Overall Study|Death|1|||
23569494|NCT01146574|65813427|FG002|Overall Study|Death|1|||
23569495|NCT01146574|65813428|FG003|Overall Study|Death|0|||
23569496|NCT01146574|65813429|FG004|Overall Study|Death|0|||
23569497|NCT01146574|65813430|FG005|Overall Study|Death|0|||
23569498|NCT01146574|65813431|FG006|Overall Study|Death|0|||
23569499|NCT01146574|65813425|FG000|Overall Study|Other reasons|0|||
23768181|NCT01621490|66527898|FG001|Overall Study|Subject request to discontinue study|3|||
23768182|NCT01621490|66527899|FG002|Overall Study|Subject request to discontinue study|1|||
23768183|NCT01621490|66527900|FG003|Overall Study|Subject request to discontinue study|1|||
23768184|NCT01621490|66527901|FG004|Overall Study|Subject request to discontinue study|0|||
23768185|NCT01621490|66527902|FG005|Overall Study|Subject request to discontinue study|2|||
23768186|NCT01621490|66527903|FG006|Overall Study|Subject request to discontinue study|1|||
23768187|NCT01621490|66527904|FG007|Overall Study|Subject request to discontinue study|0|||
23768188|NCT01621490|66527905|FG008|Overall Study|Subject request to discontinue study|1|||
23768189|NCT01621490|66527906|FG009|Overall Study|Subject request to discontinue study|0|||
23768190|NCT01621490|66527907|FG010|Overall Study|Subject request to discontinue study|0|||
23768191|NCT01621490|66527897|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23768192|NCT01621490|66527898|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23768193|NCT01621490|66527899|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23768194|NCT01621490|66527900|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23768195|NCT01621490|66527901|FG004|Overall Study|Adverse event unrelated to study drug|0|||
23768196|NCT01621490|66527902|FG005|Overall Study|Adverse event unrelated to study drug|0|||
23768197|NCT01621490|66527903|FG006|Overall Study|Adverse event unrelated to study drug|0|||
23768198|NCT01621490|66527904|FG007|Overall Study|Adverse event unrelated to study drug|2|||
23768199|NCT01621490|66527905|FG008|Overall Study|Adverse event unrelated to study drug|0|||
23768200|NCT01621490|66527906|FG009|Overall Study|Adverse event unrelated to study drug|0|||
23768201|NCT01621490|66527907|FG010|Overall Study|Adverse event unrelated to study drug|0|||
23768202|NCT01621490|66527897|FG000|Overall Study|Disease progression|27|||
23768203|NCT01621490|66527898|FG001|Overall Study|Disease progression|28|||
23768204|NCT01621490|66527899|FG002|Overall Study|Disease progression|1|||
23768205|NCT01621490|66527900|FG003|Overall Study|Disease progression|5|||
23768206|NCT01621490|66527901|FG004|Overall Study|Disease progression|3|||
23768207|NCT01621490|66527902|FG005|Overall Study|Disease progression|8|||
23768208|NCT01621490|66527903|FG006|Overall Study|Disease progression|7|||
23768209|NCT01621490|66527904|FG007|Overall Study|Disease progression|1|||
23768210|NCT01621490|66527905|FG008|Overall Study|Disease progression|4|||
23768211|NCT01621490|66527906|FG009|Overall Study|Disease progression|1|||
23768212|NCT01621490|66527907|FG010|Overall Study|Disease progression|1|||
23768213|NCT01621490|66527897|FG000|Overall Study|Study drug toxicity|1|||
23768214|NCT01621490|66527898|FG001|Overall Study|Study drug toxicity|4|||
23768215|NCT01621490|66527899|FG002|Overall Study|Study drug toxicity|5|||
23768216|NCT01621490|66527900|FG003|Overall Study|Study drug toxicity|3|||
23768217|NCT01621490|66527901|FG004|Overall Study|Study drug toxicity|1|||
23768218|NCT01621490|66527902|FG005|Overall Study|Study drug toxicity|10|||
23768219|NCT01621490|66527903|FG006|Overall Study|Study drug toxicity|1|||
23768220|NCT01621490|66527904|FG007|Overall Study|Study drug toxicity|4|||
23768221|NCT01621490|66527905|FG008|Overall Study|Study drug toxicity|1|||
23768222|NCT01621490|66527906|FG009|Overall Study|Study drug toxicity|0|||
23768223|NCT01621490|66527907|FG010|Overall Study|Study drug toxicity|0|||
23768224|NCT01621490|66527897|FG000|Overall Study|Death|0|||
23768225|NCT01621490|66527898|FG001|Overall Study|Death|0|||
23446768|NCT01216683|65377744|FG001|Continuation|Other diseases|2|||
23446769|NCT01216683|65377745|FG002|Continuation|Other diseases|1|||
23446770|NCT01216683|65377743|FG000|Continuation|Physician Decision|1|||
23446771|NCT01216683|65377744|FG001|Continuation|Physician Decision|0|||
23569500|NCT01146574|65813426|FG001|Overall Study|Other reasons|0|||
23569501|NCT01146574|65813427|FG002|Overall Study|Other reasons|3|||
23569502|NCT01146574|65813428|FG003|Overall Study|Other reasons|0|||
23569503|NCT01146574|65813429|FG004|Overall Study|Other reasons|0|||
23569504|NCT01146574|65813430|FG005|Overall Study|Other reasons|0|||
23569505|NCT01146574|65813431|FG006|Overall Study|Other reasons|0|||
23569506|NCT01146574|65813425|FG000|Overall Study|Kidney transplant|0|||
23569507|NCT01146574|65813426|FG001|Overall Study|Kidney transplant|0|||
23569508|NCT01146574|65813427|FG002|Overall Study|Kidney transplant|1|||
23569509|NCT01146574|65813428|FG003|Overall Study|Kidney transplant|1|||
23569510|NCT01146574|65813429|FG004|Overall Study|Kidney transplant|0|||
23569511|NCT01146574|65813430|FG005|Overall Study|Kidney transplant|0|||
23569512|NCT01146574|65813431|FG006|Overall Study|Kidney transplant|0|||
23569513|NCT01146574|65813425|FG000|Overall Study|Withdrew consent|0|||
23569514|NCT01146574|65813426|FG001|Overall Study|Withdrew consent|0|||
23569515|NCT01146574|65813427|FG002|Overall Study|Withdrew consent|1|||
23569516|NCT01146574|65813428|FG003|Overall Study|Withdrew consent|1|||
23569517|NCT01146574|65813429|FG004|Overall Study|Withdrew consent|2|||
23569518|NCT01146574|65813430|FG005|Overall Study|Withdrew consent|1|||
23569519|NCT01146574|65813431|FG006|Overall Study|Withdrew consent|1|||
23768226|NCT01621490|66527899|FG002|Overall Study|Death|0|||
23569520|NCT02038764|65813433|FG000|Overall Study|Adverse Event|0|||
23768227|NCT01621490|66527900|FG003|Overall Study|Death|0|||
23768228|NCT01621490|66527901|FG004|Overall Study|Death|0|||
23768229|NCT01621490|66527902|FG005|Overall Study|Death|0|||
23768230|NCT01621490|66527903|FG006|Overall Study|Death|0|||
23768231|NCT01621490|66527904|FG007|Overall Study|Death|0|||
23446772|NCT01216683|65377745|FG002|Continuation|Physician Decision|1|||
23569521|NCT02038764|65813434|FG001|Overall Study|Adverse Event|0|||
23768232|NCT01621490|66527905|FG008|Overall Study|Death|1|||
23446773|NCT01216683|65377743|FG000|Continuation|Non-compliance|1|||
23446774|NCT01216683|65377744|FG001|Continuation|Non-compliance|0|||
23446775|NCT01216683|65377745|FG002|Continuation|Non-compliance|1|||
23446776|NCT01216683|65377743|FG000|Continuation|Insurance change|0|||
23446777|NCT01216683|65377744|FG001|Continuation|Insurance change|1|||
23446778|NCT01216683|65377745|FG002|Continuation|Insurance change|0|||
23446779|NCT01216683|65377743|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
23446780|NCT01216683|65377744|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
23446781|NCT01216683|65377745|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
23768233|NCT01621490|66527906|FG009|Overall Study|Death|0|||
23768234|NCT01621490|66527907|FG010|Overall Study|Death|0|||
23446782|NCT01216683|65377743|FG000|Continuation|Not reported|0|||
23569522|NCT02038764|65813435|FG002|Overall Study|Adverse Event|1|||
23569523|NCT02038764|65813436|FG003|Overall Study|Adverse Event|0|||
23569524|NCT02038764|65813437|FG004|Overall Study|Adverse Event|0|||
23768235|NCT01621490|66527897|FG000|Overall Study|Other reasons|7|||
23569525|NCT02038764|65813433|FG000|Overall Study|Lost to Follow-up|0|||
23569526|NCT02038764|65813434|FG001|Overall Study|Lost to Follow-up|1|||
23446783|NCT01216683|65377744|FG001|Continuation|Not reported|0|||
23446784|NCT01216683|65377745|FG002|Continuation|Not reported|1|||
23446785|NCT01216683|65377743|FG000|Continuation|Never started treatment|0|||
23446786|NCT01216683|65377744|FG001|Continuation|Never started treatment|1|||
23446787|NCT01216683|65377745|FG002|Continuation|Never started treatment|5|||
23446788|NCT00556894|65377748|FG000|Overall Study|Adverse Event|2|||
23446789|NCT00556894|65377749|FG001|Overall Study|Adverse Event|3|||
23446790|NCT00556894|65377750|FG002|Overall Study|Adverse Event|3|||
23446791|NCT00556894|65377748|FG000|Overall Study|Death|1|||
23446792|NCT00556894|65377749|FG001|Overall Study|Death|0|||
23446793|NCT00556894|65377750|FG002|Overall Study|Death|0|||
23768236|NCT01621490|66527898|FG001|Overall Study|Other reasons|6|||
23768237|NCT01621490|66527899|FG002|Overall Study|Other reasons|4|||
23768238|NCT01621490|66527900|FG003|Overall Study|Other reasons|1|||
23768239|NCT01621490|66527901|FG004|Overall Study|Other reasons|1|||
23768240|NCT01621490|66527902|FG005|Overall Study|Other reasons|3|||
23768241|NCT01621490|66527903|FG006|Overall Study|Other reasons|1|||
23446794|NCT00556894|65377748|FG000|Overall Study|regulatory decision in Bulgaria|10|||
23446795|NCT00556894|65377749|FG001|Overall Study|regulatory decision in Bulgaria|14|||
23446796|NCT00556894|65377750|FG002|Overall Study|regulatory decision in Bulgaria|13|||
23446797|NCT00556894|65377748|FG000|Overall Study|Change in therapy|2|||
23446798|NCT00556894|65377749|FG001|Overall Study|Change in therapy|1|||
23446799|NCT00556894|65377750|FG002|Overall Study|Change in therapy|2|||
23446800|NCT00556894|65377748|FG000|Overall Study|Withdrawal by Subject|1|||
23446801|NCT00556894|65377749|FG001|Overall Study|Withdrawal by Subject|1|||
23446802|NCT00556894|65377750|FG002|Overall Study|Withdrawal by Subject|1|||
23446803|NCT01101035|65377751|FG000|Overall Study|Adverse Event|191|||
23446804|NCT01101035|65377752|FG001|Overall Study|Adverse Event|172|||
23446805|NCT01101035|65377751|FG000|Overall Study|Major Protocol Deviation|52|||
23446806|NCT01101035|65377752|FG001|Overall Study|Major Protocol Deviation|46|||
23446807|NCT01101035|65377751|FG000|Overall Study|Lost to Follow-up|226|||
23446808|NCT01101035|65377752|FG001|Overall Study|Lost to Follow-up|223|||
23446809|NCT01101035|65377751|FG000|Overall Study|Voluntary Withdrawal|595|||
23446810|NCT01101035|65377752|FG001|Overall Study|Voluntary Withdrawal|587|||
23446811|NCT01101035|65377751|FG000|Overall Study|Reason not Specified|333|||
23446812|NCT01101035|65377752|FG001|Overall Study|Reason not Specified|363|||
23446813|NCT02995980|65377754|FG000|Overall Study|Lost to Follow-up|14|||
23446814|NCT01858363|65377755|FG000|Overall Study|Death|35|||
23446815|NCT01858363|65377756|FG001|Overall Study|Death|9|||
23446816|NCT01858363|65377755|FG000|Overall Study|Withdrawal by Subject|28|||
23446817|NCT01858363|65377756|FG001|Overall Study|Withdrawal by Subject|14|||
23446818|NCT01858363|65377755|FG000|Overall Study|Lost to Follow-up|13|||
23569527|NCT02038764|65813435|FG002|Overall Study|Lost to Follow-up|0|||
23569528|NCT02038764|65813436|FG003|Overall Study|Lost to Follow-up|0|||
23569529|NCT02038764|65813437|FG004|Overall Study|Lost to Follow-up|0|||
23569530|NCT02038764|65813433|FG000|Overall Study|Withdrawal by Subject|0|||
23569531|NCT02038764|65813434|FG001|Overall Study|Withdrawal by Subject|0|||
23569532|NCT02038764|65813435|FG002|Overall Study|Withdrawal by Subject|0|||
23569533|NCT02038764|65813436|FG003|Overall Study|Withdrawal by Subject|0|||
23569534|NCT02038764|65813437|FG004|Overall Study|Withdrawal by Subject|1|||
23569535|NCT02038764|65813433|FG000|Overall Study|Other|1|||
23569536|NCT02038764|65813434|FG001|Overall Study|Other|0|||
23569537|NCT02038764|65813435|FG002|Overall Study|Other|1|||
23569538|NCT02038764|65813436|FG003|Overall Study|Other|0|||
23768242|NCT01621490|66527904|FG007|Overall Study|Other reasons|1|||
23768243|NCT01621490|66527905|FG008|Overall Study|Other reasons|1|||
23768244|NCT01621490|66527906|FG009|Overall Study|Other reasons|0|||
23768245|NCT01621490|66527907|FG010|Overall Study|Other reasons|0|||
23768246|NCT00886483|66527908|FG000|Overall Study|Lost to Follow-up|0|||
23768247|NCT00886483|66527909|FG001|Overall Study|Lost to Follow-up|1|||
23830143|NCT01891864|66759888|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
23446819|NCT01858363|65377756|FG001|Overall Study|Lost to Follow-up|3|||
23446820|NCT02919761|65377758|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
23446821|NCT02919761|65377759|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
23446822|NCT02919761|65377760|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
23446823|NCT02919761|65377758|FG000|Part 1: Open Label|Adverse Event|1|||
23446824|NCT02919761|65377759|FG001|Part 1: Open Label|Adverse Event|0|||
23446825|NCT02919761|65377760|FG002|Part 1: Open Label|Adverse Event|0|||
23446826|NCT02919761|65377758|FG000|Part 1: Open Label|Lost to Follow-up|1|||
23446827|NCT02919761|65377759|FG001|Part 1: Open Label|Lost to Follow-up|0|||
23446828|NCT02919761|65377760|FG002|Part 1: Open Label|Lost to Follow-up|0|||
23446829|NCT02919761|65377758|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
23569539|NCT02038764|65813437|FG004|Overall Study|Other|0|||
23569540|NCT02550873|65813439|FG000|Randomized Double Blind|Adverse Event|3|||
23569541|NCT02550873|65813440|FG001|Randomized Double Blind|Adverse Event|1|||
23569542|NCT02550873|65813441|FG002|Randomized Double Blind|Adverse Event|0|||
23768248|NCT00886483|66527908|FG000|Overall Study|Pursue medications|1|||
23446830|NCT02919761|65377759|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
23446831|NCT02919761|65377760|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
23446832|NCT02919761|65377758|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
23446833|NCT02919761|65377759|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
23446834|NCT02919761|65377760|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
23446835|NCT02919761|65377758|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
23446836|NCT02919761|65377759|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
23446837|NCT02919761|65377760|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
23446838|NCT02919761|65377758|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
23446839|NCT02919761|65377759|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
23446840|NCT02919761|65377760|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
23446841|NCT02919761|65377758|FG000|Part 1: Open Label|Termination by Sponsor|1|||
23446842|NCT02919761|65377759|FG001|Part 1: Open Label|Termination by Sponsor|0|||
23446843|NCT02919761|65377760|FG002|Part 1: Open Label|Termination by Sponsor|0|||
23446844|NCT02919761|65377758|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
23446845|NCT02919761|65377759|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
23446846|NCT02919761|65377760|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
23446847|NCT02919761|65377758|FG000|Part 2: Double-blind|Adverse Event|0|||
23446848|NCT02919761|65377759|FG001|Part 2: Double-blind|Adverse Event|1|||
23446849|NCT02919761|65377760|FG002|Part 2: Double-blind|Adverse Event|0|||
23446850|NCT02919761|65377758|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
23446851|NCT02919761|65377759|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
23446852|NCT02919761|65377760|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
23446853|NCT02919761|65377758|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
23446854|NCT02919761|65377759|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
23446855|NCT02919761|65377760|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
23569543|NCT02550873|65813439|FG000|Randomized Double Blind|Disease progression|1|||
23569544|NCT02550873|65813440|FG001|Randomized Double Blind|Disease progression|1|||
23569545|NCT02550873|65813441|FG002|Randomized Double Blind|Disease progression|0|||
23569546|NCT02550873|65813439|FG000|Open Label Extension|Study ongoing|0|||
23569547|NCT02550873|65813440|FG001|Open Label Extension|Study ongoing|0|||
23569548|NCT02550873|65813441|FG002|Open Label Extension|Study ongoing|111|||
23569549|NCT00152763|65813442|FG000|Overall Study|Death|4|||
23569550|NCT00152763|65813443|FG001|Overall Study|Death|1|||
23569551|NCT00152763|65813444|FG002|Overall Study|Death|2|||
23569552|NCT00152763|65813445|FG003|Overall Study|Death|1|||
23569553|NCT00152763|65813442|FG000|Overall Study|Lost to Follow-up|6|||
23569554|NCT00152763|65813443|FG001|Overall Study|Lost to Follow-up|4|||
23446856|NCT02919761|65377758|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
23630788|NCT00983853|66034859|FG005|Overall Study|Unable to come to study follow-up visits|0|||
23630789|NCT02601209|66034862|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23630790|NCT02601209|66034863|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23630791|NCT02601209|66034864|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23630792|NCT02601209|66034865|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23630793|NCT02601209|66034866|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23768249|NCT00886483|66527909|FG001|Overall Study|Pursue medications|2|||
23768250|NCT00886483|66527908|FG000|Overall Study|Distance to center, poor grades|1|||
23768251|NCT00886483|66527909|FG001|Overall Study|Distance to center, poor grades|0|||
23569555|NCT00152763|65813444|FG002|Overall Study|Lost to Follow-up|2|||
23569556|NCT00152763|65813445|FG003|Overall Study|Lost to Follow-up|13|||
23569557|NCT02611830|65813446|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
23768252|NCT04543136|66527915|FG000|Overall Study|Withdrawal by Subject|0|||
23768253|NCT04543136|66527916|FG001|Overall Study|Withdrawal by Subject|1|||
23768254|NCT04543136|66527917|FG002|Overall Study|Withdrawal by Subject|0|||
23768255|NCT04543136|66527918|FG003|Overall Study|Withdrawal by Subject|1|||
23768256|NCT04543136|66527919|FG004|Overall Study|Withdrawal by Subject|0|||
23768257|NCT04543136|66527920|FG005|Overall Study|Withdrawal by Subject|0|||
23768258|NCT02961920|66527921|FG000|Overall Study|did not achive stydy protocol schedule|1|||
23569558|NCT02611830|65813447|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23569559|NCT02611830|65813448|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23446857|NCT02919761|65377759|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
23569560|NCT02611830|65813449|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23569561|NCT02611830|65813446|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
23630794|NCT02601209|66034867|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23630795|NCT02601209|66034868|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23630796|NCT02601209|66034869|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23630797|NCT02601209|66034870|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23630798|NCT02601209|66034862|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630799|NCT02601209|66034863|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630800|NCT02601209|66034864|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630801|NCT02601209|66034865|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630802|NCT02601209|66034866|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
23630803|NCT02601209|66034867|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
23630804|NCT02601209|66034868|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
23630805|NCT02601209|66034869|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630806|NCT02601209|66034870|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23630807|NCT00658606|66034871|FG000|Overall Study|Adverse Event|2|||
23630808|NCT00658606|66034872|FG001|Overall Study|Adverse Event|1|||
23830144|NCT01891864|66759889|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
23830145|NCT01891864|66759890|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23830146|NCT01891864|66759891|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23830147|NCT01891864|66759892|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23830148|NCT01891864|66759893|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23830149|NCT01891864|66759888|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23830150|NCT01891864|66759889|FG001|Treatment Period 1|Withdrawal by Subject|5|||
23830151|NCT01891864|66759890|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23830152|NCT01891864|66759891|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23830153|NCT01891864|66759892|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23830154|NCT01891864|66759893|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23830155|NCT01891864|66759888|FG000|Treatment Period 1|Lost to Follow-up|1|||
23830156|NCT01891864|66759889|FG001|Treatment Period 1|Lost to Follow-up|0|||
23830157|NCT01891864|66759890|FG002|Treatment Period 1|Lost to Follow-up|0|||
23569562|NCT02611830|65813447|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
23569563|NCT02611830|65813448|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
23569564|NCT02611830|65813449|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
23569565|NCT02611830|65813446|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
23569566|NCT02611830|65813447|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
23569567|NCT02611830|65813448|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
23569568|NCT02611830|65813449|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
23569569|NCT02611830|65813446|FG000|OL Induction Phase|Lack of Efficacy|9|||
23830158|NCT01891864|66759891|FG003|Treatment Period 1|Lost to Follow-up|0|||
23830159|NCT01891864|66759892|FG004|Treatment Period 1|Lost to Follow-up|0|||
23830160|NCT01891864|66759893|FG005|Treatment Period 1|Lost to Follow-up|0|||
23830161|NCT01891864|66759888|FG000|Treatment Period 2|Protocol Violation|0|||
23830162|NCT01891864|66759889|FG001|Treatment Period 2|Protocol Violation|0|||
23830163|NCT01891864|66759890|FG002|Treatment Period 2|Protocol Violation|0|||
23830164|NCT01891864|66759891|FG003|Treatment Period 2|Protocol Violation|1|||
23830165|NCT01891864|66759892|FG004|Treatment Period 2|Protocol Violation|0|||
23830166|NCT01891864|66759893|FG005|Treatment Period 2|Protocol Violation|0|||
23830167|NCT01891864|66759888|FG000|Treatment Period 2|Physician Decision|0|||
23830168|NCT01891864|66759889|FG001|Treatment Period 2|Physician Decision|0|||
23830169|NCT01891864|66759890|FG002|Treatment Period 2|Physician Decision|1|||
23830170|NCT01891864|66759891|FG003|Treatment Period 2|Physician Decision|0|||
23569570|NCT02611830|65813447|FG001|OL Induction Phase|Lack of Efficacy|0|||
23630809|NCT00658606|66034871|FG000|Overall Study|Lack of Efficacy|6|||
23630810|NCT00658606|66034872|FG001|Overall Study|Lack of Efficacy|3|||
23630811|NCT00658606|66034871|FG000|Overall Study|Lost to Follow-up|1|||
23569571|NCT02611830|65813448|FG002|OL Induction Phase|Lack of Efficacy|0|||
23569572|NCT02611830|65813449|FG003|OL Induction Phase|Lack of Efficacy|0|||
23630812|NCT00658606|66034872|FG001|Overall Study|Lost to Follow-up|0|||
23630813|NCT00658606|66034871|FG000|Overall Study|Withdrawal by Subject|7|||
23630814|NCT00658606|66034872|FG001|Overall Study|Withdrawal by Subject|16|||
23569573|NCT02611830|65813446|FG000|OL Induction Phase|Reason not specified|3|||
23569574|NCT02611830|65813447|FG001|OL Induction Phase|Reason not specified|0|||
23569575|NCT02611830|65813448|FG002|OL Induction Phase|Reason not specified|0|||
23630815|NCT00658606|66034871|FG000|Overall Study|Lack of Compliance|0|||
23630816|NCT00658606|66034872|FG001|Overall Study|Lack of Compliance|3|||
23830171|NCT01891864|66759892|FG004|Treatment Period 2|Physician Decision|0|||
23830172|NCT01891864|66759893|FG005|Treatment Period 2|Physician Decision|0|||
23830173|NCT01891864|66759888|FG000|Treatment Period 2|Site Termination|0|||
23830174|NCT01891864|66759889|FG001|Treatment Period 2|Site Termination|0|||
23830175|NCT01891864|66759890|FG002|Treatment Period 2|Site Termination|1|||
23569576|NCT02611830|65813449|FG003|OL Induction Phase|Reason not specified|0|||
23630817|NCT02358668|66034873|FG000|Overall Study|Adverse Event|2|||
23569577|NCT02611830|65813446|FG000|Maintenance Phase|Lack of Efficacy|0|||
23569578|NCT02611830|65813447|FG001|Maintenance Phase|Lack of Efficacy|29|||
23569579|NCT02611830|65813448|FG002|Maintenance Phase|Lack of Efficacy|18|||
23569580|NCT02611830|65813449|FG003|Maintenance Phase|Lack of Efficacy|6|||
23569581|NCT02611830|65813446|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23569582|NCT02611830|65813447|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
23569583|NCT02611830|65813448|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
23569584|NCT02611830|65813449|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
23569585|NCT02611830|65813446|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
23569586|NCT02611830|65813447|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
23569587|NCT02611830|65813448|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
23569588|NCT02611830|65813449|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
23569589|NCT02611830|65813446|FG000|Maintenance Phase|Lost to Follow-up|0|||
23569590|NCT02611830|65813447|FG001|Maintenance Phase|Lost to Follow-up|0|||
23569591|NCT02611830|65813448|FG002|Maintenance Phase|Lost to Follow-up|0|||
23569592|NCT02611830|65813449|FG003|Maintenance Phase|Lost to Follow-up|1|||
23569593|NCT02611830|65813446|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
23569594|NCT02611830|65813447|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
23569595|NCT02611830|65813448|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
23569596|NCT02611830|65813449|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
23569597|NCT02611830|65813446|FG000|Maintenance Phase|Pregnancy|0|||
23569598|NCT02611830|65813447|FG001|Maintenance Phase|Pregnancy|0|||
23569599|NCT02611830|65813448|FG002|Maintenance Phase|Pregnancy|1|||
23569600|NCT02611830|65813449|FG003|Maintenance Phase|Pregnancy|0|||
23569601|NCT02611830|65813446|FG000|Maintenance Phase|Reason not specified|0|||
23569602|NCT02611830|65813447|FG001|Maintenance Phase|Reason not specified|1|||
23569603|NCT02611830|65813448|FG002|Maintenance Phase|Reason not specified|4|||
23569604|NCT02611830|65813449|FG003|Maintenance Phase|Reason not specified|0|||
23569605|NCT02366936|65813450|FG000|Overall Study|Withdrawal by Subject|2|||
23569606|NCT02366936|65813450|FG000|Overall Study|Lost to Follow-up|4|||
23569607|NCT02366936|65813450|FG000|Overall Study|Physician Decision|2|||
23569608|NCT01254890|65813451|FG000|Overall Study|Ineligible|0|||
23569609|NCT01254890|65813452|FG001|Overall Study|Ineligible|3|||
23569610|NCT01254890|65813451|FG000|Overall Study|Withdrawal by Subject|1|||
23569611|NCT01254890|65813452|FG001|Overall Study|Withdrawal by Subject|2|||
23569612|NCT01254890|65813451|FG000|Overall Study|Disease Progression|0|||
23569613|NCT01254890|65813452|FG001|Overall Study|Disease Progression|5|||
23569614|NCT01018563|65813456|FG000|Overall Study|Termination of the study by Sponsor|2|||
23569615|NCT01018563|65813457|FG001|Overall Study|Termination of the study by Sponsor|1|||
23569616|NCT01231503|65813459|FG000|Overall Study|Adverse Event|0|||
23569617|NCT01231503|65813460|FG001|Overall Study|Adverse Event|0|||
23569618|NCT01231503|65813461|FG002|Overall Study|Adverse Event|0|||
23569619|NCT01231503|65813462|FG003|Overall Study|Adverse Event|0|||
23569620|NCT01231503|65813463|FG004|Overall Study|Adverse Event|0|||
23569621|NCT01231503|65813464|FG005|Overall Study|Adverse Event|1|||
23569622|NCT01231503|65813465|FG006|Overall Study|Adverse Event|0|||
23569623|NCT01231503|65813466|FG007|Overall Study|Adverse Event|0|||
23569624|NCT01231503|65813459|FG000|Overall Study|Adverse event, serious fatal|0|||
23569625|NCT01231503|65813460|FG001|Overall Study|Adverse event, serious fatal|0|||
23569626|NCT01231503|65813461|FG002|Overall Study|Adverse event, serious fatal|1|||
23569627|NCT01231503|65813462|FG003|Overall Study|Adverse event, serious fatal|1|||
23569628|NCT01231503|65813463|FG004|Overall Study|Adverse event, serious fatal|0|||
23569629|NCT01231503|65813464|FG005|Overall Study|Adverse event, serious fatal|1|||
23569630|NCT01231503|65813465|FG006|Overall Study|Adverse event, serious fatal|0|||
23569631|NCT01231503|65813466|FG007|Overall Study|Adverse event, serious fatal|0|||
23569632|NCT01231503|65813459|FG000|Overall Study|Withdrawal by Subject|6|||
23569633|NCT01231503|65813460|FG001|Overall Study|Withdrawal by Subject|3|||
23569634|NCT01231503|65813461|FG002|Overall Study|Withdrawal by Subject|3|||
23569635|NCT01231503|65813462|FG003|Overall Study|Withdrawal by Subject|1|||
23569636|NCT01231503|65813463|FG004|Overall Study|Withdrawal by Subject|3|||
23569637|NCT01231503|65813464|FG005|Overall Study|Withdrawal by Subject|5|||
23569638|NCT01231503|65813465|FG006|Overall Study|Withdrawal by Subject|1|||
23569639|NCT01231503|65813466|FG007|Overall Study|Withdrawal by Subject|2|||
23569640|NCT01231503|65813459|FG000|Overall Study|Lost to Follow-up|8|||
23569641|NCT01231503|65813460|FG001|Overall Study|Lost to Follow-up|10|||
23569642|NCT01231503|65813461|FG002|Overall Study|Lost to Follow-up|8|||
23569643|NCT01231503|65813462|FG003|Overall Study|Lost to Follow-up|5|||
23569644|NCT01231503|65813463|FG004|Overall Study|Lost to Follow-up|7|||
23569645|NCT01231503|65813464|FG005|Overall Study|Lost to Follow-up|9|||
23569646|NCT01231503|65813465|FG006|Overall Study|Lost to Follow-up|6|||
23569647|NCT01231503|65813466|FG007|Overall Study|Lost to Follow-up|6|||
23569648|NCT01231503|65813459|FG000|Overall Study|Protocol Violation|0|||
23569649|NCT01231503|65813460|FG001|Overall Study|Protocol Violation|0|||
23569650|NCT01231503|65813461|FG002|Overall Study|Protocol Violation|0|||
23569651|NCT01231503|65813462|FG003|Overall Study|Protocol Violation|1|||
23569652|NCT01231503|65813463|FG004|Overall Study|Protocol Violation|0|||
23569653|NCT01231503|65813464|FG005|Overall Study|Protocol Violation|0|||
23569654|NCT01231503|65813465|FG006|Overall Study|Protocol Violation|0|||
23569655|NCT01231503|65813466|FG007|Overall Study|Protocol Violation|0|||
23569656|NCT02684903|65813471|FG000|Overall Study|COVID-19 shutdown of lab|4|||
23768259|NCT02961920|66527922|FG001|Overall Study|did not achive stydy protocol schedule|1|||
23768260|NCT03347695|66527924|FG000|Overall Study|Death|0|||
23768261|NCT03347695|66527925|FG001|Overall Study|Death|4|||
23768262|NCT03347695|66527924|FG000|Overall Study|Lost to Follow-up|0|||
23768263|NCT03347695|66527925|FG001|Overall Study|Lost to Follow-up|1|||
23768264|NCT03066999|66527926|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
23768265|NCT03066999|66527927|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
23768266|NCT00738673|66527928|FG000|Overall Study|Adverse Event|1|||
23768267|NCT00738673|66527929|FG001|Overall Study|Adverse Event|0|||
23768268|NCT00738673|66527928|FG000|Overall Study|Lack of Efficacy|19|||
23768269|NCT00738673|66527929|FG001|Overall Study|Lack of Efficacy|8|||
23768270|NCT00738673|66527928|FG000|Overall Study|Protocol Violation|1|||
23768271|NCT00738673|66527929|FG001|Overall Study|Protocol Violation|2|||
23768272|NCT00738673|66527928|FG000|Overall Study|Withdrawal by Subject|3|||
23768273|NCT00738673|66527929|FG001|Overall Study|Withdrawal by Subject|1|||
23768274|NCT00319111|66527934|FG000|Overall Study|Adverse Event|20|||
23768275|NCT00319111|66527934|FG000|Overall Study|Withdrawal of consent|11|||
23768276|NCT00319111|66527934|FG000|Overall Study|Death|9|||
23768277|NCT00319111|66527934|FG000|Overall Study|Lack of clinical improvement|4|||
23768278|NCT00319111|66527934|FG000|Overall Study|Administrative|2|||
23768279|NCT00319111|66527934|FG000|Overall Study|Treatment failure|1|||
23768280|NCT00729859|66527936|FG000|Overall Study|Adverse Event|0|||
23768281|NCT00729859|66527937|FG001|Overall Study|Adverse Event|1|||
23768282|NCT00729859|66527938|FG002|Overall Study|Adverse Event|0|||
23768283|NCT00729859|66527936|FG000|Overall Study|Withdrawal by Subject|0|||
23768284|NCT00729859|66527937|FG001|Overall Study|Withdrawal by Subject|1|||
23768285|NCT00729859|66527938|FG002|Overall Study|Withdrawal by Subject|0|||
23768286|NCT00376220|66527939|FG000|Overall Study|Lost to Follow-up|7|||
23768287|NCT00376220|66527940|FG001|Overall Study|Lost to Follow-up|10|||
23768288|NCT00376220|66527939|FG000|Overall Study|Withdrawal by Subject|3|||
23768289|NCT00376220|66527940|FG001|Overall Study|Withdrawal by Subject|2|||
23768290|NCT04128007|66531684|FG000|Overall Study|Withdrawal by Subject|9|||
23768291|NCT04128007|66531685|FG001|Overall Study|Withdrawal by Subject|6|||
23768292|NCT04128007|66531684|FG000|Overall Study|Protocol Violation|1|||
23768293|NCT04128007|66531685|FG001|Overall Study|Protocol Violation|0|||
23768294|NCT04128007|66531684|FG000|Overall Study|Lost to Follow-up|8|||
23768295|NCT04128007|66531685|FG001|Overall Study|Lost to Follow-up|7|||
23768296|NCT04128007|66531684|FG000|Overall Study|Adverse Event|5|||
23768297|NCT04128007|66531685|FG001|Overall Study|Adverse Event|2|||
23768298|NCT04128007|66531684|FG000|Overall Study|Not reported|0|||
23768299|NCT04128007|66531685|FG001|Overall Study|Not reported|2|||
23768300|NCT03532009|66531686|FG000|Overall Study|Other|1|||
23768301|NCT03532009|66531687|FG001|Overall Study|Other|1|||
23768302|NCT03532009|66531686|FG000|Overall Study|Death|1|||
23768303|NCT03532009|66531687|FG001|Overall Study|Death|1|||
23768304|NCT03532009|66531686|FG000|Overall Study|Withdrawal by Patient|0|||
23768305|NCT03532009|66531687|FG001|Overall Study|Withdrawal by Patient|2|||
23569657|NCT02684903|65813472|FG001|Overall Study|COVID-19 shutdown of lab|6|||
23768306|NCT01974895|66531688|FG000|Overall Study|Protocol Violation|1|||
23768307|NCT01974895|66531689|FG001|Overall Study|Protocol Violation|0|||
23768308|NCT01974895|66531688|FG000|Overall Study|Lost to Follow-up|4|||
23768309|NCT01974895|66531689|FG001|Overall Study|Lost to Follow-up|6|||
23768310|NCT01974895|66531688|FG000|Overall Study|Withdrawal by Subject|0|||
23830176|NCT01891864|66759891|FG003|Treatment Period 2|Site Termination|2|||
23830177|NCT01891864|66759892|FG004|Treatment Period 2|Site Termination|0|||
23569658|NCT02684903|65813471|FG000|Overall Study|Lost to Follow-up|31|||
23569659|NCT02684903|65813472|FG001|Overall Study|Lost to Follow-up|41|||
23569660|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
23569661|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
23569662|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
23569663|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
23569664|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
23569665|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
23569666|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
23630818|NCT02358668|66034874|FG001|Overall Study|Adverse Event|0|||
23768311|NCT01974895|66531689|FG001|Overall Study|Withdrawal by Subject|1|||
23768312|NCT01974895|66531688|FG000|Overall Study|Other (Missed Visit)|1|||
23768313|NCT01974895|66531689|FG001|Overall Study|Other (Missed Visit)|0|||
23768314|NCT01974895|66531688|FG000|Overall Study|Other (Reason unknown)|9|||
23768315|NCT01974895|66531689|FG001|Overall Study|Other (Reason unknown)|8|||
23768316|NCT02848599|66531690|FG000|Overall Study|Protocol Violation|7|||
23768317|NCT02848599|66531691|FG001|Overall Study|Protocol Violation|9|||
23768318|NCT00268346|66531692|FG000|Overall Study|Adverse Event|0|||
23768319|NCT00268346|66531693|FG001|Overall Study|Adverse Event|1|||
23768320|NCT00268346|66531692|FG000|Overall Study|Death|0|||
23768321|NCT00268346|66531693|FG001|Overall Study|Death|1|||
23768322|NCT00268346|66531692|FG000|Overall Study|Withdrawal by Subject|0|||
23768323|NCT00268346|66531693|FG001|Overall Study|Withdrawal by Subject|1|||
23768324|NCT01185288|66531694|FG000|Overall Study|Adverse Event|7|||
23569667|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
23569668|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
23569669|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
23569670|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
23830178|NCT01891864|66759893|FG005|Treatment Period 2|Site Termination|0|||
23830179|NCT01891864|66759888|FG000|Treatment Period 2|Lack of Efficacy|0|||
23830180|NCT01891864|66759889|FG001|Treatment Period 2|Lack of Efficacy|0|||
23830181|NCT01891864|66759890|FG002|Treatment Period 2|Lack of Efficacy|1|||
23830182|NCT01891864|66759891|FG003|Treatment Period 2|Lack of Efficacy|0|||
23830183|NCT01891864|66759892|FG004|Treatment Period 2|Lack of Efficacy|1|||
23768325|NCT01185288|66531695|FG001|Overall Study|Adverse Event|6|||
23768326|NCT01185288|66531694|FG000|Overall Study|Withdrawal by Subject|6|||
23768327|NCT01185288|66531695|FG001|Overall Study|Withdrawal by Subject|4|||
23768328|NCT01185288|66531694|FG000|Overall Study|Lost to Follow-up|2|||
23768329|NCT01185288|66531695|FG001|Overall Study|Lost to Follow-up|5|||
23768330|NCT01185288|66531694|FG000|Overall Study|Lack of Efficacy|2|||
23768331|NCT01185288|66531695|FG001|Overall Study|Lack of Efficacy|0|||
23830184|NCT01891864|66759893|FG005|Treatment Period 2|Lack of Efficacy|0|||
23830185|NCT01891864|66759888|FG000|Treatment Period 2|Adverse Event|0|||
23569671|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
23569672|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
23569673|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
23569674|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
23569675|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
23569676|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
23569677|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
23569678|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
23569679|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
23569680|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
23569681|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
23768332|NCT01185288|66531694|FG000|Overall Study|Investigator discretion|1|||
23768333|NCT01185288|66531695|FG001|Overall Study|Investigator discretion|0|||
23768334|NCT01185288|66531694|FG000|Overall Study|Did not meet inclusion criteria|1|||
23830186|NCT01891864|66759889|FG001|Treatment Period 2|Adverse Event|0|||
23830187|NCT01891864|66759890|FG002|Treatment Period 2|Adverse Event|1|||
23768335|NCT01185288|66531695|FG001|Overall Study|Did not meet inclusion criteria|0|||
23768336|NCT01185288|66531694|FG000|Overall Study|Noncompliance|0|||
23768337|NCT01185288|66531695|FG001|Overall Study|Noncompliance|1|||
23768338|NCT00922779|66531702|FG000|Overall Study|Adverse Event|67|||
23768339|NCT00922779|66531702|FG000|Overall Study|Pregnancy|7|||
23768340|NCT00922779|66531702|FG000|Overall Study|Withdrawal by Subject|308|||
23768341|NCT00922779|66531702|FG000|Overall Study|Lost to Follow-up|44|||
23768342|NCT00922779|66531702|FG000|Overall Study|Other|27|||
23768343|NCT00922779|66531702|FG000|Overall Study|Missing|1874|||
23768344|NCT02518685|66531703|FG000|Overall Study|Adverse Event|29|||
23768345|NCT02518685|66531704|FG001|Overall Study|Adverse Event|1|||
23768346|NCT02518685|66531703|FG000|Overall Study|Withdrawal by Subject|10|||
23768347|NCT02518685|66531704|FG001|Overall Study|Withdrawal by Subject|3|||
23768348|NCT02518685|66531703|FG000|Overall Study|relocation, study fatigue|7|||
23768349|NCT02518685|66531704|FG001|Overall Study|relocation, study fatigue|2|||
23768350|NCT02518685|66531703|FG000|Overall Study|Pregnancy|1|||
23768351|NCT02518685|66531704|FG001|Overall Study|Pregnancy|0|||
23768352|NCT02518685|66531703|FG000|Overall Study|Physician Decision|1|||
23768353|NCT02518685|66531704|FG001|Overall Study|Physician Decision|0|||
23768354|NCT02518685|66531703|FG000|Overall Study|Lost to Follow-up|1|||
23768355|NCT02518685|66531704|FG001|Overall Study|Lost to Follow-up|4|||
23768356|NCT01937364|66531705|FG000|Overall Study|Adverse Event|2|||
23768357|NCT01937364|66531706|FG001|Overall Study|Adverse Event|1|||
23768358|NCT01941095|66531707|FG000|Overall Study|Insufficient therapeutic response|13|||
23768359|NCT01941095|66531707|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
23768360|NCT01941095|66531707|FG000|Overall Study|Adverse Event|11|||
23630819|NCT02358668|66034875|FG002|Overall Study|Adverse Event|0|||
23630820|NCT02358668|66034873|FG000|Overall Study|Withdrawal by Subject|0|||
23630821|NCT02358668|66034874|FG001|Overall Study|Withdrawal by Subject|1|||
23830188|NCT01891864|66759891|FG003|Treatment Period 2|Adverse Event|2|||
23830189|NCT01891864|66759892|FG004|Treatment Period 2|Adverse Event|0|||
23830190|NCT01891864|66759893|FG005|Treatment Period 2|Adverse Event|4|||
23830191|NCT01891864|66759888|FG000|Treatment Period 2|Termination of Site|0|||
23830192|NCT01891864|66759889|FG001|Treatment Period 2|Termination of Site|0|||
23830193|NCT01891864|66759890|FG002|Treatment Period 2|Termination of Site|0|||
23830194|NCT01891864|66759891|FG003|Treatment Period 2|Termination of Site|0|||
23830195|NCT01891864|66759892|FG004|Treatment Period 2|Termination of Site|2|||
23830196|NCT01891864|66759893|FG005|Treatment Period 2|Termination of Site|0|||
23630822|NCT02358668|66034875|FG002|Overall Study|Withdrawal by Subject|0|||
23630823|NCT03682185|66034876|FG000|Overall Study|Lost to Follow-up|4|||
23630824|NCT03682185|66034877|FG001|Overall Study|Lost to Follow-up|7|||
23630825|NCT03682185|66034878|FG002|Overall Study|Lost to Follow-up|4|||
23630826|NCT03682185|66034879|FG003|Overall Study|Lost to Follow-up|7|||
23630827|NCT03682185|66034880|FG004|Overall Study|Lost to Follow-up|1|||
23630828|NCT03682185|66034876|FG000|Overall Study|Withdrawal by Subject|7|||
23630829|NCT03682185|66034877|FG001|Overall Study|Withdrawal by Subject|3|||
23630830|NCT03682185|66034878|FG002|Overall Study|Withdrawal by Subject|7|||
23630831|NCT03682185|66034879|FG003|Overall Study|Withdrawal by Subject|3|||
23630832|NCT03682185|66034880|FG004|Overall Study|Withdrawal by Subject|0|||
23630833|NCT01647542|66034881|FG000|Overall Study|Major Protocol Deviation|1|||
23630834|NCT01647542|66034882|FG001|Overall Study|Major Protocol Deviation|0|||
23630835|NCT01647542|66034883|FG002|Overall Study|Major Protocol Deviation|0|||
23630836|NCT01647542|66034881|FG000|Overall Study|Adverse Event|4|||
23630837|NCT01647542|66034882|FG001|Overall Study|Adverse Event|5|||
23630838|NCT01647542|66034883|FG002|Overall Study|Adverse Event|4|||
23630839|NCT01647542|66034881|FG000|Overall Study|Lost to Follow-up|0|||
23630840|NCT01647542|66034882|FG001|Overall Study|Lost to Follow-up|2|||
23630841|NCT01647542|66034883|FG002|Overall Study|Lost to Follow-up|2|||
23630842|NCT01647542|66034881|FG000|Overall Study|Withdrawal by Subject|6|||
23630843|NCT01647542|66034882|FG001|Overall Study|Withdrawal by Subject|4|||
23630844|NCT01647542|66034883|FG002|Overall Study|Withdrawal by Subject|0|||
23630845|NCT01647542|66034881|FG000|Overall Study|Study Termination|64|||
23768361|NCT01941095|66531707|FG000|Overall Study|Physician Decision|3|||
23768362|NCT01941095|66531707|FG000|Overall Study|Withdrawal by Subject|17|||
23768363|NCT01941095|66531707|FG000|Overall Study|Lost to Follow-up|10|||
23768364|NCT02768298|66531708|FG000|Overall Study|Adverse Event|1|||
23830197|NCT01891864|66759888|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23830198|NCT01891864|66759889|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23830199|NCT01891864|66759890|FG002|Treatment Period 2|Withdrawal by Subject|3|||
23630846|NCT01647542|66034882|FG001|Overall Study|Study Termination|61|||
23630847|NCT01647542|66034883|FG002|Overall Study|Study Termination|65|||
23630848|NCT01647542|66034881|FG000|Overall Study|Lack of Efficacy|1|||
23630849|NCT01647542|66034882|FG001|Overall Study|Lack of Efficacy|1|||
23630850|NCT01647542|66034883|FG002|Overall Study|Lack of Efficacy|0|||
23630851|NCT01647542|66034881|FG000|Overall Study|Death|0|||
23630852|NCT01647542|66034882|FG001|Overall Study|Death|0|||
23630853|NCT01647542|66034883|FG002|Overall Study|Death|1|||
23768365|NCT02768298|66531709|FG001|Overall Study|Adverse Event|4|||
23768366|NCT02768298|66531708|FG000|Overall Study|Death|2|||
23768367|NCT02768298|66531709|FG001|Overall Study|Death|1|||
23768368|NCT02768298|66531708|FG000|Overall Study|Non-compliance with study treatment|0|||
23630854|NCT01263509|66034884|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
23630855|NCT01263509|66034885|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
23630856|NCT01263509|66034886|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
23630857|NCT01263509|66034887|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
23630858|NCT01263509|66034884|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23630859|NCT01263509|66034885|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23630860|NCT01263509|66034886|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23630861|NCT01263509|66034887|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23630862|NCT01263509|66034884|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23630863|NCT01263509|66034885|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23630864|NCT01263509|66034886|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23630865|NCT01263509|66034887|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23630866|NCT01263509|66034884|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23630867|NCT01263509|66034885|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23630868|NCT01263509|66034886|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23630869|NCT01263509|66034887|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23630870|NCT01263509|66034884|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23630871|NCT01263509|66034885|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23630872|NCT01263509|66034886|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23630873|NCT01263509|66034887|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
23630874|NCT01602510|66034888|FG000|Open Label Phase|Adverse Event|46|||
23630875|NCT01602510|66034889|FG001|Open Label Phase|Adverse Event|0|||
23630876|NCT01602510|66034890|FG002|Open Label Phase|Adverse Event|0|||
23630877|NCT01602510|66034888|FG000|Open Label Phase|Lack of Efficacy|22|||
23630878|NCT01602510|66034889|FG001|Open Label Phase|Lack of Efficacy|0|||
23630879|NCT01602510|66034890|FG002|Open Label Phase|Lack of Efficacy|0|||
23630880|NCT01602510|66034888|FG000|Open Label Phase|Protocol Violation|15|||
23630881|NCT01602510|66034889|FG001|Open Label Phase|Protocol Violation|0|||
23630882|NCT01602510|66034890|FG002|Open Label Phase|Protocol Violation|0|||
23630883|NCT01602510|66034888|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
23630884|NCT01602510|66034889|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
23630885|NCT01602510|66034890|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
23630886|NCT01602510|66034888|FG000|Open Label Phase|Lost to Follow-up|22|||
23630887|NCT01602510|66034889|FG001|Open Label Phase|Lost to Follow-up|0|||
23569682|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
23569683|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
23569684|NCT02307513|65813489|FG000|Long-term Extension|Physician Decision|1|||
23569685|NCT02307513|65813490|FG001|Long-term Extension|Physician Decision|0|||
23569686|NCT00871351|65813492|FG000|Overall Study|Withdrawal by Subject|1|||
23569687|NCT00871351|65813493|FG001|Overall Study|Withdrawal by Subject|0|||
23569688|NCT00871351|65813494|FG002|Overall Study|Withdrawal by Subject|0|||
23569689|NCT00871351|65813492|FG000|Overall Study|Adverse Event|3|||
23569690|NCT00871351|65813493|FG001|Overall Study|Adverse Event|1|||
23569691|NCT00871351|65813494|FG002|Overall Study|Adverse Event|0|||
23569692|NCT01290822|65813503|FG000|Overall Study|Withdrawal by Subject|1|||
23569693|NCT01290822|65813503|FG000|Overall Study|Physician Decision|10|||
23569694|NCT02133924|65813504|FG000|Overall Study|Death|38|||
23569695|NCT02133924|65813504|FG000|Overall Study|Physician Decision|1|||
23569696|NCT02133924|65813504|FG000|Overall Study|Withdrawal by Subject|3|||
23569697|NCT02105636|65813507|FG000|Pre-Treatment|Disease Progression|1|||
23569698|NCT02105636|65813508|FG001|Pre-Treatment|Disease Progression|0|||
23569699|NCT02105636|65813507|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
23569700|NCT02105636|65813508|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
23569701|NCT02105636|65813507|FG000|Pre-Treatment|Participant withdrew consent|0|||
23569702|NCT02105636|65813508|FG001|Pre-Treatment|Participant withdrew consent|6|||
23569703|NCT02105636|65813507|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23569704|NCT02105636|65813508|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
23630888|NCT01602510|66034890|FG002|Open Label Phase|Lost to Follow-up|0|||
23630889|NCT01602510|66034888|FG000|Open Label Phase|Physician Decision|19|||
23630890|NCT01602510|66034889|FG001|Open Label Phase|Physician Decision|0|||
23630891|NCT01602510|66034890|FG002|Open Label Phase|Physician Decision|0|||
23768369|NCT02768298|66531709|FG001|Overall Study|Non-compliance with study treatment|1|||
23768370|NCT02768298|66531708|FG000|Overall Study|Subject/guardian decision|1|||
23768371|NCT02768298|66531709|FG001|Overall Study|Subject/guardian decision|0|||
23768372|NCT02768298|66531708|FG000|Overall Study|Withdrawal of informed consent|0|||
23768373|NCT02768298|66531709|FG001|Overall Study|Withdrawal of informed consent|1|||
23768374|NCT01996033|66531710|FG000|Overall Study|Death|1|||
23768375|NCT01996033|66531710|FG000|Overall Study|Physician Decision|1|||
23569705|NCT02105636|65813507|FG000|Treatment|Study Drug Toxicity|14|||
23569706|NCT02105636|65813508|FG001|Treatment|Study Drug Toxicity|10|||
23569707|NCT02105636|65813507|FG000|Treatment|Adverse event unrelated to study drug|19|||
23830200|NCT01891864|66759891|FG003|Treatment Period 2|Withdrawal by Subject|4|||
23830201|NCT01891864|66759892|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23830202|NCT01891864|66759893|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23830203|NCT01891864|66759888|FG000|Extension Period|Lack of Efficacy|0|||
23830204|NCT01891864|66759889|FG001|Extension Period|Lack of Efficacy|0|||
23830205|NCT01891864|66759890|FG002|Extension Period|Lack of Efficacy|0|||
23830206|NCT01891864|66759891|FG003|Extension Period|Lack of Efficacy|1|||
23830207|NCT01891864|66759892|FG004|Extension Period|Lack of Efficacy|1|||
23830208|NCT01891864|66759893|FG005|Extension Period|Lack of Efficacy|0|||
23830209|NCT01891864|66759888|FG000|Extension Period|Pregnancy|0|||
23830210|NCT01891864|66759889|FG001|Extension Period|Pregnancy|0|||
23830211|NCT01891864|66759890|FG002|Extension Period|Pregnancy|1|||
23830212|NCT01891864|66759891|FG003|Extension Period|Pregnancy|0|||
23830213|NCT01891864|66759892|FG004|Extension Period|Pregnancy|0|||
23830214|NCT01891864|66759893|FG005|Extension Period|Pregnancy|0|||
23830215|NCT01891864|66759888|FG000|Extension Period|Adverse Event|0|||
23830216|NCT01891864|66759889|FG001|Extension Period|Adverse Event|0|||
23630892|NCT01602510|66034888|FG000|Open Label Phase|Withdrawal by Subject|57|||
23630893|NCT01602510|66034889|FG001|Open Label Phase|Withdrawal by Subject|0|||
23630894|NCT01602510|66034890|FG002|Open Label Phase|Withdrawal by Subject|0|||
23630895|NCT01602510|66034888|FG000|Randomized Phase|Adverse Event|0|||
23630896|NCT01602510|66034889|FG001|Randomized Phase|Adverse Event|2|||
23630897|NCT01602510|66034890|FG002|Randomized Phase|Adverse Event|6|||
23630898|NCT01602510|66034888|FG000|Randomized Phase|Lack of Efficacy|0|||
23630899|NCT01602510|66034889|FG001|Randomized Phase|Lack of Efficacy|4|||
23630900|NCT01602510|66034890|FG002|Randomized Phase|Lack of Efficacy|4|||
23569708|NCT02105636|65813508|FG001|Treatment|Adverse event unrelated to study drug|3|||
23569709|NCT02105636|65813507|FG000|Treatment|Participant request to discontinue study treatment|8|||
23569710|NCT02105636|65813508|FG001|Treatment|Participant request to discontinue study treatment|6|||
23569711|NCT02105636|65813507|FG000|Treatment|Participant withdrew consent|5|||
23569712|NCT02105636|65813508|FG001|Treatment|Participant withdrew consent|1|||
23569713|NCT02105636|65813507|FG000|Treatment|Lost to Follow-up|1|||
23569714|NCT02105636|65813508|FG001|Treatment|Lost to Follow-up|0|||
23569715|NCT02105636|65813507|FG000|Treatment|Maximum Clinical Benefit|1|||
23569716|NCT02105636|65813508|FG001|Treatment|Maximum Clinical Benefit|3|||
23569717|NCT02105636|65813507|FG000|Treatment|Poor/Non-compliance|0|||
23569718|NCT02105636|65813508|FG001|Treatment|Poor/Non-compliance|1|||
23630901|NCT01602510|66034888|FG000|Randomized Phase|Protocol Violation|0|||
23630902|NCT01602510|66034889|FG001|Randomized Phase|Protocol Violation|3|||
23630903|NCT01602510|66034890|FG002|Randomized Phase|Protocol Violation|3|||
23630904|NCT01602510|66034888|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
23630905|NCT01602510|66034889|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
23630906|NCT01602510|66034890|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
23630907|NCT01602510|66034888|FG000|Randomized Phase|Lost to Follow-up|0|||
23630908|NCT01602510|66034889|FG001|Randomized Phase|Lost to Follow-up|1|||
23630909|NCT01602510|66034890|FG002|Randomized Phase|Lost to Follow-up|3|||
23630910|NCT01602510|66034888|FG000|Randomized Phase|Physician Decision|0|||
23630911|NCT01602510|66034889|FG001|Randomized Phase|Physician Decision|0|||
23630912|NCT01602510|66034890|FG002|Randomized Phase|Physician Decision|2|||
23630913|NCT01602510|66034888|FG000|Randomized Phase|Withdrawal by Subject|0|||
23830217|NCT01891864|66759890|FG002|Extension Period|Adverse Event|4|||
23830218|NCT01891864|66759891|FG003|Extension Period|Adverse Event|2|||
23830219|NCT01891864|66759892|FG004|Extension Period|Adverse Event|2|||
23830220|NCT01891864|66759893|FG005|Extension Period|Adverse Event|0|||
23830221|NCT01891864|66759888|FG000|Extension Period|Withdrawal by Subject|0|||
23830222|NCT01891864|66759889|FG001|Extension Period|Withdrawal by Subject|0|||
23830223|NCT01891864|66759890|FG002|Extension Period|Withdrawal by Subject|1|||
23830224|NCT01891864|66759891|FG003|Extension Period|Withdrawal by Subject|2|||
23830225|NCT01891864|66759892|FG004|Extension Period|Withdrawal by Subject|4|||
23830226|NCT01891864|66759893|FG005|Extension Period|Withdrawal by Subject|0|||
23830227|NCT01891864|66759888|FG000|Extension Period|Lost to Follow-up|0|||
23630914|NCT01602510|66034889|FG001|Randomized Phase|Withdrawal by Subject|6|||
23630915|NCT01602510|66034890|FG002|Randomized Phase|Withdrawal by Subject|7|||
23830228|NCT01891864|66759889|FG001|Extension Period|Lost to Follow-up|0|||
23830229|NCT01891864|66759890|FG002|Extension Period|Lost to Follow-up|2|||
23830230|NCT01891864|66759891|FG003|Extension Period|Lost to Follow-up|0|||
23830231|NCT01891864|66759892|FG004|Extension Period|Lost to Follow-up|0|||
23830232|NCT01891864|66759893|FG005|Extension Period|Lost to Follow-up|0|||
23830233|NCT05266053|66759898|FG000|Overall Study|Withdrawal by Subject|8|||
23830234|NCT05266053|66759899|FG001|Overall Study|Withdrawal by Subject|4|||
23830235|NCT01000155|66759900|FG000|Overall Study|Withdrawal by Subject|1|||
23569719|NCT02105636|65813507|FG000|Treatment|Participant no longer meets study criteria|1|||
23569720|NCT02105636|65813508|FG001|Treatment|Participant no longer meets study criteria|0|||
23569721|NCT02105636|65813507|FG000|Treatment|Other reasons|1|||
23569722|NCT02105636|65813508|FG001|Treatment|Other reasons|0|||
23569723|NCT02105636|65813507|FG000|Treatment|Disease Progression|185|||
23569724|NCT02105636|65813508|FG001|Treatment|Disease Progression|87|||
23569725|NCT00130793|65813509|FG000|Overall Study|Lost to Follow-up|1|||
23569726|NCT00130793|65813510|FG001|Overall Study|Lost to Follow-up|4|||
23569727|NCT00130793|65813509|FG000|Overall Study|Withdrew consent|2|||
23569728|NCT00130793|65813510|FG001|Overall Study|Withdrew consent|0|||
23569729|NCT02670538|65816563|FG000|Overall Study|Withdrawal of Consent|8|||
23569730|NCT02670538|65816564|FG001|Overall Study|Withdrawal of Consent|6|||
23569731|NCT02670538|65816565|FG002|Overall Study|Withdrawal of Consent|5|||
23569732|NCT02670538|65816563|FG000|Overall Study|Lost to Follow-up|8|||
23569733|NCT02670538|65816564|FG001|Overall Study|Lost to Follow-up|12|||
23569734|NCT02670538|65816565|FG002|Overall Study|Lost to Follow-up|7|||
23569735|NCT02670538|65816563|FG000|Overall Study|Adverse Event|5|||
23569736|NCT02670538|65816564|FG001|Overall Study|Adverse Event|5|||
23569737|NCT02670538|65816565|FG002|Overall Study|Adverse Event|11|||
23569738|NCT02670538|65816563|FG000|Overall Study|Lack of Efficacy|7|||
23569739|NCT02670538|65816564|FG001|Overall Study|Lack of Efficacy|1|||
23569740|NCT02670538|65816565|FG002|Overall Study|Lack of Efficacy|2|||
23768376|NCT01996033|66531710|FG000|Overall Study|Withdrawal by Subject|4|||
23768377|NCT01996033|66531710|FG000|Overall Study|Lost to Follow-up|3|||
23768378|NCT02419313|66531713|FG000|First Intervention|Lost to Follow-up|2|||
23768379|NCT02419313|66531714|FG001|First Intervention|Lost to Follow-up|0|||
23768380|NCT02419313|66531713|FG000|Second Intervention|Lost to Follow-up|1|||
23768381|NCT02419313|66531714|FG001|Second Intervention|Lost to Follow-up|0|||
23768382|NCT01025037|66531716|FG000|Overall Study|Adverse Event|3|||
23768383|NCT01025037|66531716|FG000|Overall Study|Lost to Follow-up|7|||
23768384|NCT01025037|66531716|FG000|Overall Study|Withdrawal by Subject|1|||
23768385|NCT01939197|66531717|FG000|Overall Study|Withdrawal by Subject|1|||
23768386|NCT01939197|66531718|FG001|Overall Study|Withdrawal by Subject|0|||
23768387|NCT01939197|66531719|FG002|Overall Study|Withdrawal by Subject|0|||
23768388|NCT01939197|66531720|FG003|Overall Study|Withdrawal by Subject|0|||
23768389|NCT01939197|66531721|FG004|Overall Study|Withdrawal by Subject|1|||
23768390|NCT01939197|66531722|FG005|Overall Study|Withdrawal by Subject|0|||
23768391|NCT01939197|66531723|FG006|Overall Study|Withdrawal by Subject|0|||
23768392|NCT01939197|66531717|FG000|Overall Study|Lost to Follow-up|0|||
23768393|NCT01939197|66531718|FG001|Overall Study|Lost to Follow-up|1|||
23768394|NCT01939197|66531719|FG002|Overall Study|Lost to Follow-up|0|||
23768395|NCT01939197|66531720|FG003|Overall Study|Lost to Follow-up|1|||
23768396|NCT01939197|66531721|FG004|Overall Study|Lost to Follow-up|3|||
23768397|NCT01939197|66531722|FG005|Overall Study|Lost to Follow-up|1|||
23768398|NCT01939197|66531723|FG006|Overall Study|Lost to Follow-up|2|||
23569741|NCT02670538|65816563|FG000|Overall Study|Protocol Violation|3|||
23768399|NCT03702621|66531724|FG000|Overall Study|Physician Decision|6|||
23768400|NCT03702621|66531725|FG001|Overall Study|Physician Decision|6|||
23768401|NCT05200858|66531726|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
23768402|NCT05200858|66531727|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
23768403|NCT05200858|66531728|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
23830236|NCT01000155|66759900|FG000|Overall Study|Adverse Event|1|||
23569742|NCT02670538|65816564|FG001|Overall Study|Protocol Violation|4|||
23569743|NCT02670538|65816565|FG002|Overall Study|Protocol Violation|1|||
23569744|NCT02670538|65816563|FG000|Overall Study|Noncompliance with Study Drug|1|||
23569745|NCT02670538|65816564|FG001|Overall Study|Noncompliance with Study Drug|3|||
23630916|NCT04367480|66034891|FG000|Overall Study|Adverse Event|1|||
23569746|NCT02670538|65816565|FG002|Overall Study|Noncompliance with Study Drug|2|||
23569747|NCT02670538|65816563|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23569748|NCT02670538|65816564|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23569749|NCT02670538|65816565|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23768404|NCT05200858|66531729|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
23768405|NCT03402893|66531730|FG000|Overall Study|Withdrawal by Subject|1|||
23768406|NCT00806156|66531731|FG000|Overall Study|Death|35|||
23768407|NCT00806156|66531732|FG001|Overall Study|Death|95|||
23768408|NCT00806156|66531731|FG000|Overall Study|Did not meet eligibility criteria|1|||
23768409|NCT00806156|66531732|FG001|Overall Study|Did not meet eligibility criteria|0|||
23768410|NCT00806156|66531731|FG000|Overall Study|Study terminated by Sponsor|2|||
23768411|NCT00806156|66531732|FG001|Overall Study|Study terminated by Sponsor|40|||
23768412|NCT00806156|66531731|FG000|Overall Study|Consent withdrawn by subject|1|||
23768413|NCT00806156|66531732|FG001|Overall Study|Consent withdrawn by subject|3|||
23768414|NCT00806156|66531731|FG000|Overall Study|Lost to Follow-up|0|||
23768415|NCT00806156|66531732|FG001|Overall Study|Lost to Follow-up|1|||
23768416|NCT01309919|66531736|FG000|Overall Study|Did not receive a postpartum IUD|17|||
23768417|NCT01309919|66531737|FG001|Overall Study|Did not receive a postpartum IUD|48|||
23768418|NCT01799590|66531738|FG000|Overall Study|Adverse Event|13|||
23768419|NCT01799590|66531739|FG001|Overall Study|Adverse Event|7|||
23768420|NCT01799590|66531740|FG002|Overall Study|Adverse Event|5|||
23768421|NCT01799590|66531738|FG000|Overall Study|Pregnancy|2|||
23768422|NCT01799590|66531739|FG001|Overall Study|Pregnancy|0|||
23569750|NCT03621982|65816566|FG000|Overall Study|Withdrawal by Subject|1|||
23569751|NCT03621982|65816567|FG001|Overall Study|Withdrawal by Subject|0|||
23569752|NCT03621982|65816568|FG002|Overall Study|Withdrawal by Subject|0|||
23569753|NCT03621982|65816569|FG003|Overall Study|Withdrawal by Subject|1|||
23569754|NCT03621982|65816570|FG004|Overall Study|Withdrawal by Subject|0|||
23569755|NCT03621982|65816571|FG005|Overall Study|Withdrawal by Subject|1|||
23569756|NCT03621982|65816572|FG006|Overall Study|Withdrawal by Subject|1|||
23569757|NCT03621982|65816573|FG007|Overall Study|Withdrawal by Subject|0|||
23569758|NCT03621982|65816574|FG008|Overall Study|Withdrawal by Subject|1|||
23569759|NCT03621982|65816575|FG009|Overall Study|Withdrawal by Subject|0|||
23569760|NCT03621982|65816576|FG010|Overall Study|Withdrawal by Subject|2|||
23569761|NCT03621982|65816577|FG011|Overall Study|Withdrawal by Subject|1|||
23569762|NCT03621982|65816578|FG012|Overall Study|Withdrawal by Subject|2|||
23569763|NCT03621982|65816579|FG013|Overall Study|Withdrawal by Subject|2|||
23569764|NCT03621982|65816566|FG000|Overall Study|Investigator/Sponsor decision|0|||
23569765|NCT03621982|65816567|FG001|Overall Study|Investigator/Sponsor decision|0|||
23569766|NCT03621982|65816568|FG002|Overall Study|Investigator/Sponsor decision|0|||
23569767|NCT03621982|65816569|FG003|Overall Study|Investigator/Sponsor decision|0|||
23569768|NCT03621982|65816570|FG004|Overall Study|Investigator/Sponsor decision|0|||
23569769|NCT03621982|65816571|FG005|Overall Study|Investigator/Sponsor decision|0|||
23569770|NCT03621982|65816572|FG006|Overall Study|Investigator/Sponsor decision|0|||
23569771|NCT03621982|65816573|FG007|Overall Study|Investigator/Sponsor decision|0|||
23630917|NCT04367480|66034892|FG001|Overall Study|Adverse Event|1|||
23768423|NCT01799590|66531740|FG002|Overall Study|Pregnancy|0|||
23768424|NCT01799590|66531738|FG000|Overall Study|Lack of Efficacy|3|||
23768425|NCT01799590|66531739|FG001|Overall Study|Lack of Efficacy|1|||
23768426|NCT01799590|66531740|FG002|Overall Study|Lack of Efficacy|3|||
23768427|NCT01799590|66531738|FG000|Overall Study|Participants convenience|4|||
23768428|NCT01799590|66531739|FG001|Overall Study|Participants convenience|4|||
23569772|NCT03621982|65816574|FG008|Overall Study|Investigator/Sponsor decision|0|||
23569773|NCT03621982|65816575|FG009|Overall Study|Investigator/Sponsor decision|0|||
23569774|NCT03621982|65816576|FG010|Overall Study|Investigator/Sponsor decision|0|||
23630918|NCT04367480|66034891|FG000|Overall Study|Death|1|||
23768429|NCT01799590|66531740|FG002|Overall Study|Participants convenience|2|||
23768430|NCT01799590|66531738|FG000|Overall Study|Aggravation of complications|0|||
23768431|NCT01799590|66531739|FG001|Overall Study|Aggravation of complications|1|||
23768432|NCT01799590|66531740|FG002|Overall Study|Aggravation of complications|1|||
23768433|NCT01799590|66531738|FG000|Overall Study|Using drugs with restricted days of use|0|||
23768434|NCT01799590|66531739|FG001|Overall Study|Using drugs with restricted days of use|3|||
23768435|NCT01799590|66531740|FG002|Overall Study|Using drugs with restricted days of use|2|||
23768436|NCT01799590|66531738|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
23768437|NCT01799590|66531739|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
23768438|NCT01799590|66531740|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
23768439|NCT01799590|66531738|FG000|Overall Study|Other|3|||
23768440|NCT01799590|66531739|FG001|Overall Study|Other|0|||
23768441|NCT01799590|66531740|FG002|Overall Study|Other|1|||
23768442|NCT02448771|66531741|FG000|Overall Study|Disease Progression|30|||
23768443|NCT02448771|66531741|FG000|Overall Study|Unacceptable Toxicity|1|||
23768444|NCT02448771|66531741|FG000|Overall Study|Physician Decision|3|||
23768445|NCT02448771|66531741|FG000|Overall Study|Started new therapy|2|||
23768446|NCT02192905|66531742|FG000|Overall Study|Lost to Follow-up|1|||
23768447|NCT00635778|66531743|FG000|Overall Study|Adverse Event|1|||
23768448|NCT00635778|66531744|FG001|Overall Study|Adverse Event|0|||
23768449|NCT00635778|66531745|FG002|Overall Study|Adverse Event|0|||
23768450|NCT00635778|66531746|FG003|Overall Study|Adverse Event|3|||
23768451|NCT00635778|66531747|FG004|Overall Study|Adverse Event|3|||
23768452|NCT00635778|66531748|FG005|Overall Study|Adverse Event|6|||
23768453|NCT00635778|66531749|FG006|Overall Study|Adverse Event|1|||
23768454|NCT00635778|66531743|FG000|Overall Study|Withdrawal by Subject|0|||
23768455|NCT00635778|66531744|FG001|Overall Study|Withdrawal by Subject|0|||
23768456|NCT00635778|66531745|FG002|Overall Study|Withdrawal by Subject|0|||
23768457|NCT00635778|66531746|FG003|Overall Study|Withdrawal by Subject|1|||
23768458|NCT00635778|66531747|FG004|Overall Study|Withdrawal by Subject|0|||
23768459|NCT00635778|66531748|FG005|Overall Study|Withdrawal by Subject|1|||
23768460|NCT00635778|66531749|FG006|Overall Study|Withdrawal by Subject|1|||
23768461|NCT00635778|66531743|FG000|Overall Study|Progressive disease|0|||
23768462|NCT00635778|66531744|FG001|Overall Study|Progressive disease|3|||
23768463|NCT00635778|66531745|FG002|Overall Study|Progressive disease|3|||
23768464|NCT00635778|66531746|FG003|Overall Study|Progressive disease|4|||
23768465|NCT00635778|66531747|FG004|Overall Study|Progressive disease|5|||
23768466|NCT00635778|66531748|FG005|Overall Study|Progressive disease|14|||
23768467|NCT00635778|66531749|FG006|Overall Study|Progressive disease|4|||
23768468|NCT01144663|66531750|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
23768469|NCT01144663|66531751|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
23768470|NCT01144663|66531752|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
23768471|NCT01144663|66531753|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
23768472|NCT01144663|66531750|FG000|Primary Vaccination Phase|Adverse Event|1|||
23768473|NCT01144663|66531751|FG001|Primary Vaccination Phase|Adverse Event|0|||
23768474|NCT01144663|66531752|FG002|Primary Vaccination Phase|Adverse Event|0|||
23768475|NCT01144663|66531753|FG003|Primary Vaccination Phase|Adverse Event|1|||
23768476|NCT01144663|66531750|FG000|Primary Vaccination Phase|Protocol Violation|2|||
23768477|NCT01144663|66531751|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23768478|NCT01144663|66531752|FG002|Primary Vaccination Phase|Protocol Violation|1|||
23630919|NCT04367480|66034892|FG001|Overall Study|Death|0|||
23630920|NCT04367480|66034891|FG000|Overall Study|Lost to Follow-up|1|||
23630921|NCT04367480|66034892|FG001|Overall Study|Lost to Follow-up|1|||
23630922|NCT04367480|66034891|FG000|Overall Study|Withdrawal by Subject|0|||
23630923|NCT04367480|66034892|FG001|Overall Study|Withdrawal by Subject|3|||
23630924|NCT04367480|66034891|FG000|Overall Study|App glitch during the study|1|||
23630925|NCT04367480|66034892|FG001|Overall Study|App glitch during the study|0|||
23630926|NCT04367480|66034891|FG000|Overall Study|Device Distribution Error|0|||
23630927|NCT04367480|66034892|FG001|Overall Study|Device Distribution Error|2|||
23630928|NCT04367480|66034891|FG000|Overall Study|Ineligible after Randomization|0|||
23630929|NCT04367480|66034892|FG001|Overall Study|Ineligible after Randomization|1|||
23630930|NCT04367480|66034891|FG000|Overall Study|Other Medical Reasons|0|||
23630931|NCT04367480|66034892|FG001|Overall Study|Other Medical Reasons|2|||
23630932|NCT02833077|66034894|FG000|Overall Study|Adverse Event|1|||
23768479|NCT01144663|66531753|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23630933|NCT02833077|66034895|FG001|Overall Study|Adverse Event|2|||
23630934|NCT02833077|66034894|FG000|Overall Study|Lost to Follow-up|10|||
23768480|NCT01144663|66531750|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
23768481|NCT01144663|66531751|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
23768482|NCT01144663|66531752|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
23768483|NCT01144663|66531753|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
23768484|NCT01144663|66531750|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
23768485|NCT01144663|66531751|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
23630935|NCT02833077|66034895|FG001|Overall Study|Lost to Follow-up|1|||
23630936|NCT02833077|66034894|FG000|Overall Study|Personal Reasons|6|||
23768486|NCT01144663|66531752|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
23830237|NCT00764881|66759901|FG000|Overall Study|Adverse Event|5|||
23768487|NCT01144663|66531753|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
23768488|NCT01144663|66531750|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
23768489|NCT01144663|66531751|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
23768490|NCT01144663|66531752|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
23768491|NCT01144663|66531753|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
23768492|NCT01144663|66531750|FG000|Primary Vaccination Phase|Other|0|||
23768493|NCT01144663|66531751|FG001|Primary Vaccination Phase|Other|1|||
23830238|NCT00764881|66759902|FG001|Overall Study|Adverse Event|1|||
23830239|NCT00764881|66759901|FG000|Overall Study|Withdrawal by Subject|1|||
23830240|NCT00764881|66759902|FG001|Overall Study|Withdrawal by Subject|3|||
23830241|NCT00764881|66759901|FG000|Overall Study|Protocol Violation|2|||
23830242|NCT00764881|66759902|FG001|Overall Study|Protocol Violation|2|||
23830243|NCT00764881|66759901|FG000|Overall Study|Lost to Follow-up|2|||
23830244|NCT00764881|66759902|FG001|Overall Study|Lost to Follow-up|0|||
23830245|NCT00764881|66759901|FG000|Overall Study|Noncompliant|1|||
23830246|NCT00764881|66759902|FG001|Overall Study|Noncompliant|0|||
23830247|NCT00764881|66759901|FG000|Overall Study|Accidentally discontinued study drug|1|||
23830248|NCT00764881|66759902|FG001|Overall Study|Accidentally discontinued study drug|0|||
23830249|NCT00764881|66759901|FG000|Overall Study|Wished to become pregnant|1|||
23830250|NCT00764881|66759902|FG001|Overall Study|Wished to become pregnant|0|||
23830251|NCT00764881|66759901|FG000|Overall Study|Carcinoma detected|1|||
23830252|NCT00764881|66759902|FG001|Overall Study|Carcinoma detected|0|||
23830253|NCT00764881|66759901|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
23830254|NCT00764881|66759902|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
23830255|NCT00764881|66759901|FG000|Overall Study|no treatment or no observation|2|||
23830256|NCT00764881|66759902|FG001|Overall Study|no treatment or no observation|2|||
23830257|NCT04173507|66759903|FG000|Overall Study|On Treatment|3|||
23830258|NCT04173507|66759903|FG000|Overall Study|Adverse Event|3|||
23830259|NCT04173507|66759903|FG000|Overall Study|Progression/Relapse|34|||
23830260|NCT04173507|66759903|FG000|Overall Study|Death|2|||
23830261|NCT03022084|66759909|FG000|Overall Study|Lost to Follow-up|2|||
23830262|NCT03022084|66759910|FG001|Overall Study|Lost to Follow-up|3|||
23830263|NCT00075816|66759912|FG000|Overall Study|Did not undergo transplantation|14|||
23830264|NCT00075816|66759913|FG001|Overall Study|Did not undergo transplantation|11|||
23830265|NCT00122382|66759917|FG000|Double-Blind Study|Adverse Event|9|||
23830266|NCT00122382|66759918|FG001|Double-Blind Study|Adverse Event|11|||
23830267|NCT00122382|66759919|FG002|Double-Blind Study|Adverse Event|0|||
23830268|NCT00122382|66759917|FG000|Double-Blind Study|Death|2|||
23446858|NCT02919761|65377760|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
23569775|NCT03621982|65816577|FG011|Overall Study|Investigator/Sponsor decision|4|||
23569776|NCT03621982|65816578|FG012|Overall Study|Investigator/Sponsor decision|0|||
23569777|NCT03621982|65816579|FG013|Overall Study|Investigator/Sponsor decision|2|||
23569778|NCT03621982|65816566|FG000|Overall Study|Death|2|||
23569779|NCT03621982|65816567|FG001|Overall Study|Death|4|||
23569780|NCT03621982|65816568|FG002|Overall Study|Death|4|||
23768494|NCT01144663|66531752|FG002|Primary Vaccination Phase|Other|0|||
23768495|NCT01144663|66531753|FG003|Primary Vaccination Phase|Other|2|||
23768496|NCT01144663|66531750|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
23830269|NCT00122382|66759918|FG001|Double-Blind Study|Death|2|||
23830270|NCT00122382|66759919|FG002|Double-Blind Study|Death|0|||
23830271|NCT00122382|66759917|FG000|Double-Blind Study|Lack of Efficacy|0|||
23830272|NCT00122382|66759918|FG001|Double-Blind Study|Lack of Efficacy|8|||
23830273|NCT00122382|66759919|FG002|Double-Blind Study|Lack of Efficacy|0|||
23830274|NCT00122382|66759917|FG000|Double-Blind Study|Lost to Follow-up|2|||
23830275|NCT00122382|66759918|FG001|Double-Blind Study|Lost to Follow-up|1|||
23569781|NCT03621982|65816569|FG003|Overall Study|Death|3|||
23830276|NCT00122382|66759919|FG002|Double-Blind Study|Lost to Follow-up|0|||
23768497|NCT01144663|66531751|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23768498|NCT01144663|66531752|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
23768499|NCT01144663|66531753|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
23768500|NCT01144663|66531750|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
23768501|NCT01144663|66531751|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
23768502|NCT01144663|66531752|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
23768503|NCT01144663|66531753|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
23768504|NCT01144663|66531750|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
23768505|NCT01144663|66531751|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
23768506|NCT01144663|66531752|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
23569782|NCT03621982|65816570|FG004|Overall Study|Death|8|||
23569783|NCT03621982|65816571|FG005|Overall Study|Death|4|||
23569784|NCT03621982|65816572|FG006|Overall Study|Death|6|||
23569785|NCT03621982|65816573|FG007|Overall Study|Death|3|||
23569786|NCT03621982|65816574|FG008|Overall Study|Death|0|||
23569787|NCT03621982|65816575|FG009|Overall Study|Death|3|||
23569788|NCT03621982|65816576|FG010|Overall Study|Death|8|||
23569789|NCT03621982|65816577|FG011|Overall Study|Death|4|||
23569790|NCT03621982|65816578|FG012|Overall Study|Death|2|||
23569791|NCT03621982|65816579|FG013|Overall Study|Death|2|||
23569792|NCT03621982|65816566|FG000|Overall Study|Lost to Follow-up|0|||
23569793|NCT03621982|65816567|FG001|Overall Study|Lost to Follow-up|0|||
23569794|NCT03621982|65816568|FG002|Overall Study|Lost to Follow-up|1|||
23569795|NCT03621982|65816569|FG003|Overall Study|Lost to Follow-up|0|||
23569796|NCT03621982|65816570|FG004|Overall Study|Lost to Follow-up|0|||
23569797|NCT03621982|65816571|FG005|Overall Study|Lost to Follow-up|0|||
23630937|NCT02833077|66034895|FG001|Overall Study|Personal Reasons|4|||
23768507|NCT01144663|66531753|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
23569798|NCT03621982|65816572|FG006|Overall Study|Lost to Follow-up|1|||
23569799|NCT03621982|65816573|FG007|Overall Study|Lost to Follow-up|0|||
23569800|NCT03621982|65816574|FG008|Overall Study|Lost to Follow-up|0|||
23569801|NCT03621982|65816575|FG009|Overall Study|Lost to Follow-up|1|||
23569802|NCT03621982|65816576|FG010|Overall Study|Lost to Follow-up|0|||
23630938|NCT02833077|66034894|FG000|Overall Study|Protocol Deviation|0|||
23630939|NCT02833077|66034895|FG001|Overall Study|Protocol Deviation|1|||
23630940|NCT02514551|66034896|FG000|Overall Study|Lost to Follow-up|0|||
23630941|NCT02514551|66034897|FG001|Overall Study|Lost to Follow-up|1|||
23630942|NCT02514551|66034896|FG000|Overall Study|Participant Never Treated|0|||
23630943|NCT02514551|66034897|FG001|Overall Study|Participant Never Treated|2|||
23630944|NCT00983749|66034898|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
23630945|NCT00983749|66034899|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
23630946|NCT00267098|66034902|FG000|Overall Study|Death|0|||
23630947|NCT00267098|66034903|FG001|Overall Study|Death|0|||
23630948|NCT00267098|66034904|FG002|Overall Study|Death|57|||
23630949|NCT00267098|66034905|FG003|Overall Study|Death|66|||
23630950|NCT00267098|66034906|FG004|Overall Study|Death|14|||
23630951|NCT00267098|66034907|FG005|Overall Study|Death|23|||
23630952|NCT00267098|66034908|FG006|Overall Study|Death|28|||
23630953|NCT00267098|66034909|FG007|Overall Study|Death|9|||
23630954|NCT00267098|66034902|FG000|Overall Study|Lost to Follow-up|0|||
23630955|NCT00267098|66034903|FG001|Overall Study|Lost to Follow-up|0|||
23630956|NCT00267098|66034904|FG002|Overall Study|Lost to Follow-up|6|||
23630957|NCT00267098|66034905|FG003|Overall Study|Lost to Follow-up|5|||
23630958|NCT00267098|66034906|FG004|Overall Study|Lost to Follow-up|2|||
23630959|NCT00267098|66034907|FG005|Overall Study|Lost to Follow-up|3|||
23630960|NCT00267098|66034908|FG006|Overall Study|Lost to Follow-up|1|||
23630961|NCT00267098|66034909|FG007|Overall Study|Lost to Follow-up|1|||
23630962|NCT00267098|66034902|FG000|Overall Study|Withdrawal by Subject|8|||
23630963|NCT00267098|66034903|FG001|Overall Study|Withdrawal by Subject|0|||
23630964|NCT00267098|66034904|FG002|Overall Study|Withdrawal by Subject|24|||
23630965|NCT00267098|66034905|FG003|Overall Study|Withdrawal by Subject|21|||
23630966|NCT00267098|66034906|FG004|Overall Study|Withdrawal by Subject|12|||
23630967|NCT00267098|66034907|FG005|Overall Study|Withdrawal by Subject|9|||
23630968|NCT00267098|66034908|FG006|Overall Study|Withdrawal by Subject|12|||
23630969|NCT00267098|66034909|FG007|Overall Study|Withdrawal by Subject|5|||
23630970|NCT00267098|66034902|FG000|Overall Study|Physician Decision|5|||
23630971|NCT00267098|66034903|FG001|Overall Study|Physician Decision|0|||
23630972|NCT00267098|66034904|FG002|Overall Study|Physician Decision|7|||
23630973|NCT00267098|66034905|FG003|Overall Study|Physician Decision|11|||
23630974|NCT00267098|66034906|FG004|Overall Study|Physician Decision|5|||
23630975|NCT00267098|66034907|FG005|Overall Study|Physician Decision|4|||
23630976|NCT00267098|66034908|FG006|Overall Study|Physician Decision|3|||
23630977|NCT00267098|66034909|FG007|Overall Study|Physician Decision|0|||
23630978|NCT00267098|66034902|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
23630979|NCT00267098|66034903|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630980|NCT00267098|66034904|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630981|NCT00267098|66034905|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630982|NCT00267098|66034906|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23630983|NCT00267098|66034907|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630984|NCT00267098|66034908|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630985|NCT00267098|66034909|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23630986|NCT00267098|66034902|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630987|NCT00267098|66034903|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
23630988|NCT00267098|66034904|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630989|NCT00267098|66034905|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630990|NCT00267098|66034906|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630991|NCT00267098|66034907|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630992|NCT00267098|66034908|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630993|NCT00267098|66034909|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23630994|NCT00267098|66034902|FG000|Overall Study|Site closure|0|||
23630995|NCT00267098|66034903|FG001|Overall Study|Site closure|0|||
23830277|NCT00122382|66759917|FG000|Double-Blind Study|Pregnancy|2|||
23830278|NCT00122382|66759918|FG001|Double-Blind Study|Pregnancy|0|||
23569803|NCT03621982|65816577|FG011|Overall Study|Lost to Follow-up|0|||
23569804|NCT03621982|65816578|FG012|Overall Study|Lost to Follow-up|0|||
23569805|NCT03621982|65816579|FG013|Overall Study|Lost to Follow-up|0|||
23569806|NCT02878213|65816580|FG000|Overall Study|Withdrawal by Subject|2|||
23569807|NCT02878213|65816580|FG000|Overall Study|Adverse Event|1|||
23569808|NCT02791490|65816581|FG000|Overall Study|Lost to Follow-up|1|||
23569809|NCT02791490|65816582|FG001|Overall Study|Lost to Follow-up|2|||
23569810|NCT02791490|65816581|FG000|Overall Study|Withdrawal by Subject|2|||
23569811|NCT02791490|65816582|FG001|Overall Study|Withdrawal by Subject|6|||
23569812|NCT01775930|65816583|FG000|Overall Study|Futility stopping boundary met|1|||
23569813|NCT01155388|65816584|FG000|Overall Study|Adverse Event|1|||
23569814|NCT01155388|65816585|FG001|Overall Study|Adverse Event|0|||
23569815|NCT01242176|65816589|FG000|Washout Period of 7 Days|Adverse Event|0|||
23569816|NCT01242176|65816590|FG001|Washout Period of 7 Days|Adverse Event|2|||
23569817|NCT01242176|65816589|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
23569818|NCT01242176|65816590|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
23569819|NCT00358150|65816593|FG000|Overall Study|Adverse Event|3|||
23569820|NCT00358150|65816593|FG000|Overall Study|Withdrawal by Subject|1|||
23569821|NCT00358150|65816593|FG000|Overall Study|Undefined|3|||
23569822|NCT00065468|65816594|FG000|Overall Study|Death|172|||
23569823|NCT00065468|65816595|FG001|Overall Study|Death|169|||
23630996|NCT00267098|66034904|FG002|Overall Study|Site closure|0|||
23830279|NCT00122382|66759919|FG002|Double-Blind Study|Pregnancy|0|||
23830280|NCT00122382|66759917|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
23830281|NCT00122382|66759918|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
23830282|NCT00122382|66759919|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
23830283|NCT00122382|66759917|FG000|Double-Blind Study|Withdrawal of Consent|7|||
23830284|NCT00122382|66759918|FG001|Double-Blind Study|Withdrawal of Consent|3|||
23830285|NCT00122382|66759919|FG002|Double-Blind Study|Withdrawal of Consent|0|||
23830286|NCT00122382|66759917|FG000|Double-Blind Study|Protocol Violation|1|||
23830287|NCT00122382|66759918|FG001|Double-Blind Study|Protocol Violation|0|||
23830288|NCT00122382|66759919|FG002|Double-Blind Study|Protocol Violation|0|||
23569824|NCT00065468|65816596|FG002|Overall Study|Death|171|||
23569825|NCT00065468|65816594|FG000|Overall Study|Withdrawal by Subject|3|||
23569826|NCT00065468|65816595|FG001|Overall Study|Withdrawal by Subject|4|||
23569827|NCT00065468|65816596|FG002|Overall Study|Withdrawal by Subject|5|||
23569828|NCT00065468|65816594|FG000|Overall Study|Lost to Follow-up|5|||
23569829|NCT00065468|65816595|FG001|Overall Study|Lost to Follow-up|3|||
23569830|NCT00065468|65816596|FG002|Overall Study|Lost to Follow-up|2|||
23569831|NCT00065468|65816594|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
23569832|NCT00065468|65816595|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
23569833|NCT00065468|65816596|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
23569834|NCT00065468|65816594|FG000|Overall Study|Disease progression|0|||
23830289|NCT00122382|66759917|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
23830290|NCT00122382|66759918|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
23830291|NCT00122382|66759919|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
23830292|NCT00122382|66759917|FG000|Double-Blind Study|Randomized but not treated|0|||
23830293|NCT00122382|66759918|FG001|Double-Blind Study|Randomized but not treated|2|||
23830294|NCT00122382|66759919|FG002|Double-Blind Study|Randomized but not treated|0|||
23830295|NCT00122382|66759917|FG000|Open-Label Study|Adverse Event|0|||
23830296|NCT00122382|66759918|FG001|Open-Label Study|Adverse Event|0|||
23830297|NCT00122382|66759919|FG002|Open-Label Study|Adverse Event|11|||
23830298|NCT00122382|66759917|FG000|Open-Label Study|Death|0|||
23830299|NCT00122382|66759918|FG001|Open-Label Study|Death|0|||
23830300|NCT00122382|66759919|FG002|Open-Label Study|Death|2|||
23830301|NCT00122382|66759917|FG000|Open-Label Study|Lack of Efficacy|0|||
23830302|NCT00122382|66759918|FG001|Open-Label Study|Lack of Efficacy|0|||
23830303|NCT00122382|66759919|FG002|Open-Label Study|Lack of Efficacy|3|||
23830304|NCT00122382|66759917|FG000|Open-Label Study|Lost to Follow-up|0|||
23830305|NCT00122382|66759918|FG001|Open-Label Study|Lost to Follow-up|0|||
23830306|NCT00122382|66759919|FG002|Open-Label Study|Lost to Follow-up|3|||
23830307|NCT00122382|66759917|FG000|Open-Label Study|Pregnancy|0|||
23569835|NCT00065468|65816595|FG001|Overall Study|Disease progression|0|||
23569836|NCT00065468|65816596|FG002|Overall Study|Disease progression|1|||
23630997|NCT00267098|66034905|FG003|Overall Study|Site closure|1|||
23830308|NCT00122382|66759918|FG001|Open-Label Study|Pregnancy|0|||
23830309|NCT00122382|66759919|FG002|Open-Label Study|Pregnancy|2|||
23830310|NCT00122382|66759917|FG000|Open-Label Study|Poor/Non-Compliance|0|||
23830311|NCT00122382|66759918|FG001|Open-Label Study|Poor/Non-Compliance|0|||
23830312|NCT00122382|66759919|FG002|Open-Label Study|Poor/Non-Compliance|1|||
23830313|NCT00122382|66759917|FG000|Open-Label Study|Withdrawal of Consent|0|||
23830314|NCT00122382|66759918|FG001|Open-Label Study|Withdrawal of Consent|0|||
23830315|NCT00122382|66759919|FG002|Open-Label Study|Withdrawal of Consent|4|||
23830316|NCT02750618|66759920|FG000|Overall Study|Withdrawal by Subject|1|||
23569837|NCT00065468|65816594|FG000|Overall Study|Other|14|||
23569838|NCT00065468|65816595|FG001|Overall Study|Other|24|||
23830317|NCT00473590|66759921|FG000|Overall Study|Adverse Event|3|||
23830318|NCT00473590|66759922|FG001|Overall Study|Adverse Event|3|||
23830319|NCT00473590|66759921|FG000|Overall Study|Death|4|||
23830320|NCT00473590|66759922|FG001|Overall Study|Death|2|||
23830321|NCT00473590|66759921|FG000|Overall Study|Progression not resulting in death|24|||
23630998|NCT00267098|66034906|FG004|Overall Study|Site closure|0|||
23630999|NCT00267098|66034907|FG005|Overall Study|Site closure|1|||
23631000|NCT00267098|66034908|FG006|Overall Study|Site closure|1|||
23631001|NCT00267098|66034909|FG007|Overall Study|Site closure|0|||
23631002|NCT00267098|66034902|FG000|Overall Study|Explanted Medtronic device|0|||
23631003|NCT00267098|66034903|FG001|Overall Study|Explanted Medtronic device|0|||
23631004|NCT00267098|66034904|FG002|Overall Study|Explanted Medtronic device|0|||
23631005|NCT00267098|66034905|FG003|Overall Study|Explanted Medtronic device|1|||
23631006|NCT00267098|66034906|FG004|Overall Study|Explanted Medtronic device|0|||
23830322|NCT00473590|66759922|FG001|Overall Study|Progression not resulting in death|20|||
23830323|NCT00473590|66759921|FG000|Overall Study|Non-protocol-specified therapy|7|||
23830324|NCT00473590|66759922|FG001|Overall Study|Non-protocol-specified therapy|5|||
23830325|NCT00473590|66759921|FG000|Overall Study|Physician Decision|2|||
23830326|NCT00473590|66759922|FG001|Overall Study|Physician Decision|4|||
23830327|NCT00473590|66759921|FG000|Overall Study|Withdrawal by Subject|5|||
23830328|NCT00473590|66759922|FG001|Overall Study|Withdrawal by Subject|3|||
23830329|NCT00473590|66759921|FG000|Overall Study|Other|0|||
23830330|NCT00473590|66759922|FG001|Overall Study|Other|1|||
23830331|NCT00450437|66759925|FG000|Overall Study|Withdrawal by Subject|10|||
23830332|NCT00450437|66759926|FG001|Overall Study|Withdrawal by Subject|2|||
23830333|NCT00450437|66759927|FG002|Overall Study|Withdrawal by Subject|0|||
23830334|NCT00450437|66759928|FG003|Overall Study|Withdrawal by Subject|1|||
23569839|NCT00065468|65816596|FG002|Overall Study|Other|18|||
23569840|NCT02597933|65816599|FG000|Overall Study|Withdrawal by Subject|7|||
23569841|NCT02597933|65816600|FG001|Overall Study|Withdrawal by Subject|5|||
23569842|NCT02597933|65816599|FG000|Overall Study|Protocol Violation|2|||
23569843|NCT02597933|65816600|FG001|Overall Study|Protocol Violation|2|||
23569844|NCT02597933|65816599|FG000|Overall Study|Adverse Event|20|||
23569845|NCT02597933|65816600|FG001|Overall Study|Adverse Event|28|||
23569846|NCT02597933|65816599|FG000|Overall Study|Not treated|2|||
23569847|NCT02597933|65816600|FG001|Overall Study|Not treated|2|||
23569848|NCT02597933|65816599|FG000|Overall Study|Other than stated above|7|||
23569849|NCT02597933|65816600|FG001|Overall Study|Other than stated above|14|||
23569850|NCT01744782|65816601|FG000|Overall Study|Death|1|||
23569851|NCT01267825|65816602|FG000|Overall Study|study terminated. no data collected.|1|||
23569852|NCT01267825|65816603|FG001|Overall Study|study terminated. no data collected.|0|||
23569853|NCT00735644|65816604|FG000|Overall Study|Did not receive study vaccine|0|||
23569854|NCT00735644|65816605|FG001|Overall Study|Did not receive study vaccine|1|||
23569855|NCT00735644|65816606|FG002|Overall Study|Did not receive study vaccine|0|||
23569856|NCT00735644|65816607|FG003|Overall Study|Did not receive study vaccine|0|||
23569857|NCT00735644|65816608|FG004|Overall Study|Did not receive study vaccine|0|||
23569858|NCT00735644|65816604|FG000|Overall Study|Withdrawal by Subject|0|||
23569859|NCT00735644|65816605|FG001|Overall Study|Withdrawal by Subject|1|||
23569860|NCT00735644|65816606|FG002|Overall Study|Withdrawal by Subject|1|||
23569861|NCT00735644|65816607|FG003|Overall Study|Withdrawal by Subject|1|||
23569862|NCT00735644|65816608|FG004|Overall Study|Withdrawal by Subject|0|||
23569863|NCT01284140|65816609|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
23569864|NCT01284140|65816610|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
23569865|NCT01284140|65816609|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
23569866|NCT01284140|65816610|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
23569867|NCT01004250|65816615|FG000|Induction Therapy Period|Adverse Event|10|||
23569868|NCT01004250|65816615|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
23569869|NCT01004250|65816615|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
23569870|NCT01004250|65816615|FG000|Induction Therapy Period|Physician Decision|2|||
23569871|NCT01004250|65816615|FG000|Maintenance Therapy Period|Adverse Event|15|||
23569872|NCT01004250|65816615|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
23569873|NCT01004250|65816615|FG000|Maintenance Therapy Period|Protocol Violation|1|||
23569874|NCT01004250|65816615|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
23569875|NCT01004250|65816615|FG000|Maintenance Therapy Period|Physician Decision|4|||
23569876|NCT01004250|65816615|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
23569877|NCT01630590|65816616|FG000|Overall Study|Adverse Event|9|||
23569878|NCT01630590|65816616|FG000|Overall Study|Lack of Efficacy|37|||
23569879|NCT01630590|65816616|FG000|Overall Study|Withdrawal by Subject|4|||
23631007|NCT00267098|66034907|FG005|Overall Study|Explanted Medtronic device|0|||
23830335|NCT00450437|66759925|FG000|Overall Study|Lost to Follow-up|31|||
23830336|NCT00450437|66759926|FG001|Overall Study|Lost to Follow-up|12|||
23830337|NCT00450437|66759927|FG002|Overall Study|Lost to Follow-up|19|||
23569880|NCT01630590|65816616|FG000|Overall Study|2nd primary tumor|2|||
23569881|NCT01630590|65816616|FG000|Overall Study|Automobile accident|1|||
23569882|NCT01630590|65816616|FG000|Overall Study|Maximum benefit|4|||
23569883|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
23569884|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
23569885|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
23569886|NCT00867490|65816617|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
23830338|NCT00450437|66759928|FG003|Overall Study|Lost to Follow-up|9|||
23631008|NCT00267098|66034908|FG006|Overall Study|Explanted Medtronic device|0|||
23631009|NCT00267098|66034909|FG007|Overall Study|Explanted Medtronic device|0|||
23631010|NCT00267098|66034902|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631011|NCT00267098|66034903|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631012|NCT00267098|66034904|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631013|NCT00267098|66034905|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631014|NCT00267098|66034906|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
23631015|NCT00267098|66034907|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23768508|NCT01144663|66531750|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
23768509|NCT01144663|66531751|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
23768510|NCT01144663|66531752|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
23768511|NCT01144663|66531753|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
23768512|NCT01144663|66531750|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
23768513|NCT01144663|66531751|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
23768514|NCT01144663|66531752|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
23768515|NCT01144663|66531753|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
23768516|NCT01144663|66531750|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
23768517|NCT01144663|66531751|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
23768518|NCT01144663|66531752|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
23768519|NCT01144663|66531753|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
23768520|NCT03175120|66531759|FG000|Overall Study|Adverse Event|2|||
23768521|NCT03175120|66531760|FG001|Overall Study|Adverse Event|2|||
23768522|NCT03175120|66531759|FG000|Overall Study|Protocol Violation|5|||
23768523|NCT03175120|66531760|FG001|Overall Study|Protocol Violation|2|||
23768524|NCT03175120|66531759|FG000|Overall Study|Lost to Follow-up|1|||
23768525|NCT03175120|66531760|FG001|Overall Study|Lost to Follow-up|0|||
23768526|NCT03175120|66531759|FG000|Overall Study|Withdrawal by Subject|2|||
23768527|NCT03175120|66531760|FG001|Overall Study|Withdrawal by Subject|5|||
23768528|NCT03175120|66531759|FG000|Overall Study|Other|2|||
23768529|NCT03175120|66531760|FG001|Overall Study|Other|3|||
23768530|NCT01659567|66531761|FG000|Overall Study|Lack of Efficacy|22|||
23768531|NCT01659567|66531761|FG000|Overall Study|Switched to Pegferon|6|||
23768532|NCT01659567|66531761|FG000|Overall Study|Adverse Event|12|||
23768533|NCT01659567|66531761|FG000|Overall Study|Good result at early stage of treatment|5|||
23768534|NCT01659567|66531761|FG000|Overall Study|Withdrawal by Subject|64|||
23768535|NCT01659567|66531761|FG000|Overall Study|Progression of the main disease|1|||
23768536|NCT01659567|66531761|FG000|Overall Study|Other|13|||
23768537|NCT01387282|66531762|FG000|Overall Study|Death|47|||
23768538|NCT01387282|66531763|FG001|Overall Study|Death|16|||
23768539|NCT01387282|66531762|FG000|Overall Study|Other|5|||
23768540|NCT01387282|66531763|FG001|Overall Study|Other|1|||
23768541|NCT01387282|66531762|FG000|Overall Study|Unrelated AE|6|||
23768542|NCT01387282|66531763|FG001|Overall Study|Unrelated AE|4|||
23768543|NCT01387282|66531762|FG000|Overall Study|Withdrawal by patient|33|||
23768544|NCT01387282|66531763|FG001|Overall Study|Withdrawal by patient|23|||
23768545|NCT01387282|66531762|FG000|Overall Study|Study drug-related AE|2|||
23768546|NCT01387282|66531763|FG001|Overall Study|Study drug-related AE|2|||
23768547|NCT01387282|66531762|FG000|Overall Study|Lost to Follow-up|4|||
23768548|NCT01387282|66531763|FG001|Overall Study|Lost to Follow-up|1|||
23768549|NCT02540356|66531764|FG000|Overall Study|Terminated due to disease progression|1|||
23768550|NCT02540356|66531765|FG001|Overall Study|Terminated due to disease progression|0|||
23768551|NCT00617461|66531766|FG000|First Treatment Intervention Period|Adverse Event|2|||
23768552|NCT00617461|66531767|FG001|First Treatment Intervention Period|Adverse Event|0|||
23768553|NCT00617461|66531766|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
23768554|NCT00617461|66531767|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
23768555|NCT00617461|66531766|FG000|First Treatment Intervention Period|Protocol Violation|2|||
23768556|NCT00617461|66531767|FG001|First Treatment Intervention Period|Protocol Violation|1|||
23768557|NCT00617461|66531766|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
23768558|NCT00617461|66531767|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
23768559|NCT00617461|66531766|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
23768560|NCT00617461|66531767|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
23768561|NCT00617461|66531766|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
23768562|NCT00617461|66531767|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
23768563|NCT00617461|66531766|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
23768564|NCT00617461|66531767|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
23768565|NCT00617461|66531766|FG000|Second Treatment Intervention Period|Adverse Event|0|||
23768566|NCT00617461|66531767|FG001|Second Treatment Intervention Period|Adverse Event|1|||
23768567|NCT00617461|66531766|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
23768568|NCT00617461|66531767|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
23768569|NCT00617461|66531766|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
23768570|NCT00617461|66531767|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
23631016|NCT00267098|66034908|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631017|NCT00267098|66034909|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23631018|NCT00267098|66034902|FG000|Overall Study|Subject listed for heart transplant|0|||
23631019|NCT00267098|66034903|FG001|Overall Study|Subject listed for heart transplant|0|||
23631020|NCT00267098|66034904|FG002|Overall Study|Subject listed for heart transplant|0|||
23631021|NCT00267098|66034905|FG003|Overall Study|Subject listed for heart transplant|0|||
23631022|NCT00267098|66034906|FG004|Overall Study|Subject listed for heart transplant|0|||
23569887|NCT00867490|65816617|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
23569888|NCT00432835|65816619|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
23569889|NCT00432835|65816620|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
23569890|NCT01346514|65816621|FG000|Overall Study|Lost to Follow-up|19|||
23569891|NCT01346514|65816622|FG001|Overall Study|Lost to Follow-up|30|||
23569892|NCT01346514|65816621|FG000|Overall Study|Withdrawal by Subject|7|||
23569893|NCT01346514|65816622|FG001|Overall Study|Withdrawal by Subject|3|||
23569894|NCT01346514|65816621|FG000|Overall Study|Death|3|||
23569895|NCT01346514|65816622|FG001|Overall Study|Death|4|||
23569896|NCT02443103|65816623|FG000|Overall Study|Adverse Event|2|||
23569897|NCT02443103|65816623|FG000|Overall Study|Noncompliance|1|||
23569898|NCT04848662|65816633|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
23569899|NCT04848662|65816634|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
23569900|NCT00597714|65816635|FG000|Overall Study|Death|56|||
23569901|NCT00597714|65816636|FG001|Overall Study|Death|46|||
23569902|NCT00597714|65816637|FG002|Overall Study|Death|0|||
23569903|NCT00597714|65816635|FG000|Overall Study|Recipient death|0|||
23569904|NCT00597714|65816636|FG001|Overall Study|Recipient death|0|||
23569905|NCT00597714|65816637|FG002|Overall Study|Recipient death|10|||
23569906|NCT02753530|65816638|FG000|Overall Study|Adverse Event|7|||
23569907|NCT02753530|65816639|FG001|Overall Study|Adverse Event|1|||
23569908|NCT02753530|65816638|FG000|Overall Study|Death|0|||
23569909|NCT02753530|65816639|FG001|Overall Study|Death|1|||
23569910|NCT02753530|65816638|FG000|Overall Study|Physician Decision|0|||
23569911|NCT02753530|65816639|FG001|Overall Study|Physician Decision|1|||
23569912|NCT02753530|65816638|FG000|Overall Study|Protocol Violation|1|||
23569913|NCT02753530|65816639|FG001|Overall Study|Protocol Violation|0|||
23569914|NCT02753530|65816638|FG000|Overall Study|Withdrawal by Subject|4|||
23569915|NCT02753530|65816639|FG001|Overall Study|Withdrawal by Subject|3|||
23569916|NCT01651936|65816640|FG000|Base Study|Adverse Event|3|||
23569917|NCT01651936|65816641|FG001|Base Study|Adverse Event|0|||
23569918|NCT01651936|65816642|FG002|Base Study|Adverse Event|0|||
23569919|NCT01651936|65816640|FG000|Base Study|Withdrawal by Subject|1|||
23569920|NCT01651936|65816641|FG001|Base Study|Withdrawal by Subject|1|||
23569921|NCT01651936|65816642|FG002|Base Study|Withdrawal by Subject|0|||
23569922|NCT01651936|65816640|FG000|Base Study|Early Escape|2|||
23569923|NCT01651936|65816641|FG001|Base Study|Early Escape|8|||
23569924|NCT01651936|65816642|FG002|Base Study|Early Escape|0|||
23569925|NCT01651936|65816640|FG000|Base Study|Study terminated by sponsor|21|||
23569926|NCT01651936|65816641|FG001|Base Study|Study terminated by sponsor|16|||
23569927|NCT01651936|65816642|FG002|Base Study|Study terminated by sponsor|0|||
23569928|NCT01651936|65816640|FG000|Extension Study|Lack of Efficacy|0|||
23569929|NCT01651936|65816641|FG001|Extension Study|Lack of Efficacy|0|||
23569930|NCT01651936|65816642|FG002|Extension Study|Lack of Efficacy|1|||
23569931|NCT01651936|65816640|FG000|Extension Study|Study terminated by sponsor|0|||
23569932|NCT01651936|65816641|FG001|Extension Study|Study terminated by sponsor|0|||
23569933|NCT01651936|65816642|FG002|Extension Study|Study terminated by sponsor|13|||
23569934|NCT01258660|65816643|FG000|Overall Study|Adverse Event|2|||
23446859|NCT02919761|65377758|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
23569935|NCT01258660|65816644|FG001|Overall Study|Adverse Event|4|||
23569936|NCT01258660|65816643|FG000|Overall Study|Withdrawal by Subject|3|||
23569937|NCT01258660|65816644|FG001|Overall Study|Withdrawal by Subject|0|||
23569938|NCT01258660|65816643|FG000|Overall Study|due to relocation|2|||
23569939|NCT01258660|65816644|FG001|Overall Study|due to relocation|0|||
23569940|NCT01258660|65816643|FG000|Overall Study|Protocol Violation|0|||
23569941|NCT01258660|65816644|FG001|Overall Study|Protocol Violation|1|||
23569942|NCT01258660|65816643|FG000|Overall Study|Invalid for primary analysis data set|4|||
23569943|NCT01258660|65816644|FG001|Overall Study|Invalid for primary analysis data set|6|||
23569944|NCT00402337|65816645|FG000|Overall Study|Adverse Event|0|||
23631023|NCT00267098|66034907|FG005|Overall Study|Subject listed for heart transplant|0|||
23446860|NCT02919761|65377759|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
23446861|NCT02919761|65377760|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
23569945|NCT00402337|65816646|FG001|Overall Study|Adverse Event|2|||
23569946|NCT00402337|65816647|FG002|Overall Study|Adverse Event|2|||
23569947|NCT00402337|65816648|FG003|Overall Study|Adverse Event|3|||
23569948|NCT00402337|65816649|FG004|Overall Study|Adverse Event|2|||
23569949|NCT00402337|65816645|FG000|Overall Study|Noncompliance|0|||
23569950|NCT00402337|65816646|FG001|Overall Study|Noncompliance|0|||
23569951|NCT00402337|65816647|FG002|Overall Study|Noncompliance|0|||
23569952|NCT00402337|65816648|FG003|Overall Study|Noncompliance|0|||
23569953|NCT00402337|65816649|FG004|Overall Study|Noncompliance|2|||
23569954|NCT00402337|65816645|FG000|Overall Study|Withdrawal by Subject|5|||
23569955|NCT00402337|65816646|FG001|Overall Study|Withdrawal by Subject|3|||
23569956|NCT00402337|65816647|FG002|Overall Study|Withdrawal by Subject|1|||
23569957|NCT00402337|65816648|FG003|Overall Study|Withdrawal by Subject|6|||
23569958|NCT00402337|65816649|FG004|Overall Study|Withdrawal by Subject|4|||
23569959|NCT00402337|65816645|FG000|Overall Study|Lost to Follow-up|0|||
23569960|NCT00402337|65816646|FG001|Overall Study|Lost to Follow-up|0|||
23569961|NCT00402337|65816647|FG002|Overall Study|Lost to Follow-up|1|||
23569962|NCT00402337|65816648|FG003|Overall Study|Lost to Follow-up|2|||
23569963|NCT00402337|65816649|FG004|Overall Study|Lost to Follow-up|0|||
23569964|NCT00402337|65816645|FG000|Overall Study|Physician Decision|0|||
23569965|NCT00402337|65816646|FG001|Overall Study|Physician Decision|0|||
23569966|NCT00402337|65816647|FG002|Overall Study|Physician Decision|0|||
23569967|NCT00402337|65816648|FG003|Overall Study|Physician Decision|1|||
23569968|NCT00402337|65816649|FG004|Overall Study|Physician Decision|0|||
23631024|NCT00267098|66034908|FG006|Overall Study|Subject listed for heart transplant|1|||
23631025|NCT00267098|66034909|FG007|Overall Study|Subject listed for heart transplant|0|||
23631026|NCT00267098|66034902|FG000|Overall Study|Sponsor withdrew subject|0|||
23631027|NCT00267098|66034903|FG001|Overall Study|Sponsor withdrew subject|0|||
23631028|NCT00267098|66034904|FG002|Overall Study|Sponsor withdrew subject|0|||
23631029|NCT00267098|66034905|FG003|Overall Study|Sponsor withdrew subject|1|||
23631030|NCT00267098|66034906|FG004|Overall Study|Sponsor withdrew subject|0|||
23631031|NCT00267098|66034907|FG005|Overall Study|Sponsor withdrew subject|0|||
23631032|NCT00267098|66034908|FG006|Overall Study|Sponsor withdrew subject|0|||
23446862|NCT02919761|65377758|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
23446863|NCT02919761|65377759|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
23446864|NCT02919761|65377760|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
23446865|NCT02919761|65377758|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
23446866|NCT02919761|65377759|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
23569969|NCT00402337|65816645|FG000|Overall Study|Other Reason|0|||
23631033|NCT00267098|66034909|FG007|Overall Study|Sponsor withdrew subject|0|||
23631034|NCT02227992|66034911|FG000|Overall Study|Lost to Follow-up|1|||
23631035|NCT02227992|66034912|FG001|Overall Study|Lost to Follow-up|1|||
23631036|NCT04596995|66034913|FG000|Overall Study|Lack of Efficacy|8|||
23631037|NCT04596995|66034913|FG000|Overall Study|Lost to Follow-up|3|||
23631038|NCT04596995|66034913|FG000|Overall Study|Withdrawal by Subject|12|||
23631039|NCT04596995|66034913|FG000|Overall Study|Sponsor decision|3|||
23631040|NCT04596995|66034913|FG000|Overall Study|Enrolled in managed access program|3|||
23631041|NCT00978562|66034914|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
23631042|NCT00879775|66034915|FG000|Overall Study|Lost to Follow-up|2|||
23631043|NCT00879775|66034916|FG001|Overall Study|Lost to Follow-up|1|||
23631044|NCT01228175|66034920|FG000|Overall Study|Lost to Follow-up|64|||
23631045|NCT01228175|66034921|FG001|Overall Study|Lost to Follow-up|50|||
23631046|NCT01228175|66034920|FG000|Overall Study|Withdrawal by Subject|1|||
23631047|NCT01228175|66034921|FG001|Overall Study|Withdrawal by Subject|2|||
23631048|NCT01228175|66034920|FG000|Overall Study|Physician Decision|1|||
23631049|NCT01228175|66034921|FG001|Overall Study|Physician Decision|1|||
23631050|NCT01261000|66034922|FG000|Overall Study|Screen failure|1|||
23631051|NCT02638103|66034923|FG000|Overall Study|Adverse Event|13|||
23569970|NCT00402337|65816646|FG001|Overall Study|Other Reason|1|||
23569971|NCT00402337|65816647|FG002|Overall Study|Other Reason|0|||
23569972|NCT00402337|65816648|FG003|Overall Study|Other Reason|0|||
23569973|NCT00402337|65816649|FG004|Overall Study|Other Reason|0|||
23631052|NCT02638103|66034924|FG001|Overall Study|Adverse Event|12|||
23631053|NCT02638103|66034925|FG002|Overall Study|Adverse Event|19|||
23631054|NCT02638103|66034926|FG003|Overall Study|Adverse Event|12|||
23631055|NCT02638103|66034923|FG000|Overall Study|Withdrawal by Subject|43|||
23631056|NCT02638103|66034924|FG001|Overall Study|Withdrawal by Subject|53|||
23631057|NCT02638103|66034925|FG002|Overall Study|Withdrawal by Subject|30|||
23631058|NCT02638103|66034926|FG003|Overall Study|Withdrawal by Subject|61|||
23631059|NCT02638103|66034923|FG000|Overall Study|Protocol Violation|1|||
23569974|NCT04867785|65816652|FG000|Overall Study|Adverse Event|1|||
23631060|NCT02638103|66034924|FG001|Overall Study|Protocol Violation|2|||
23631061|NCT02638103|66034925|FG002|Overall Study|Protocol Violation|1|||
23631062|NCT02638103|66034926|FG003|Overall Study|Protocol Violation|4|||
23631063|NCT02638103|66034923|FG000|Overall Study|Pregnancy|2|||
23631064|NCT02638103|66034924|FG001|Overall Study|Pregnancy|3|||
23631065|NCT02638103|66034925|FG002|Overall Study|Pregnancy|0|||
23631066|NCT02638103|66034926|FG003|Overall Study|Pregnancy|1|||
23631067|NCT02638103|66034923|FG000|Overall Study|Non-compliance to Study Procedures|2|||
23631068|NCT02638103|66034924|FG001|Overall Study|Non-compliance to Study Procedures|1|||
23631069|NCT02638103|66034925|FG002|Overall Study|Non-compliance to Study Procedures|1|||
23631070|NCT02638103|66034926|FG003|Overall Study|Non-compliance to Study Procedures|1|||
23631071|NCT02638103|66034923|FG000|Overall Study|Lost to Follow-up|26|||
23631072|NCT02638103|66034924|FG001|Overall Study|Lost to Follow-up|33|||
23569975|NCT04867785|65816653|FG001|Overall Study|Adverse Event|0|||
23768571|NCT00617461|66531766|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
23768572|NCT00617461|66531767|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
23768573|NCT00745095|66531768|FG000|Overall Study|Declined to participate|1|||
23768574|NCT00745095|66531769|FG001|Overall Study|Declined to participate|0|||
23768575|NCT00745095|66531770|FG002|Overall Study|Declined to participate|0|||
23768576|NCT00745095|66531771|FG003|Overall Study|Declined to participate|0|||
23768577|NCT00745095|66531772|FG004|Overall Study|Declined to participate|92|||
23768578|NCT00745095|66531773|FG005|Overall Study|Declined to participate|95|||
23569976|NCT04867785|65816654|FG002|Overall Study|Adverse Event|1|||
23569977|NCT04867785|65816655|FG003|Overall Study|Adverse Event|0|||
23569978|NCT04867785|65816656|FG004|Overall Study|Adverse Event|0|||
23569979|NCT04867785|65816657|FG005|Overall Study|Adverse Event|0|||
23569980|NCT04867785|65816658|FG006|Overall Study|Adverse Event|0|||
23569981|NCT04867785|65816659|FG007|Overall Study|Adverse Event|2|||
23569982|NCT04867785|65816652|FG000|Overall Study|Lost to Follow-up|4|||
23569983|NCT04867785|65816653|FG001|Overall Study|Lost to Follow-up|4|||
23569984|NCT04867785|65816654|FG002|Overall Study|Lost to Follow-up|3|||
23569985|NCT04867785|65816655|FG003|Overall Study|Lost to Follow-up|2|||
23569986|NCT04867785|65816656|FG004|Overall Study|Lost to Follow-up|0|||
23569987|NCT04867785|65816657|FG005|Overall Study|Lost to Follow-up|1|||
23569988|NCT04867785|65816658|FG006|Overall Study|Lost to Follow-up|0|||
23569989|NCT04867785|65816659|FG007|Overall Study|Lost to Follow-up|1|||
23569990|NCT04867785|65816652|FG000|Overall Study|Withdrawal by Subject|6|||
23631073|NCT02638103|66034925|FG002|Overall Study|Lost to Follow-up|20|||
23569991|NCT04867785|65816653|FG001|Overall Study|Withdrawal by Subject|2|||
23569992|NCT04867785|65816654|FG002|Overall Study|Withdrawal by Subject|2|||
23569993|NCT04867785|65816655|FG003|Overall Study|Withdrawal by Subject|1|||
23631074|NCT02638103|66034926|FG003|Overall Study|Lost to Follow-up|37|||
23631075|NCT02638103|66034923|FG000|Overall Study|Lack of Efficacy|14|||
23631076|NCT02638103|66034924|FG001|Overall Study|Lack of Efficacy|10|||
23631077|NCT02638103|66034925|FG002|Overall Study|Lack of Efficacy|12|||
23768579|NCT00745095|66531768|FG000|Overall Study|Ineligible due to GFR criteria|0|||
23569994|NCT04867785|65816656|FG004|Overall Study|Withdrawal by Subject|2|||
23569995|NCT04867785|65816657|FG005|Overall Study|Withdrawal by Subject|0|||
23569996|NCT04867785|65816658|FG006|Overall Study|Withdrawal by Subject|2|||
23569997|NCT04867785|65816659|FG007|Overall Study|Withdrawal by Subject|5|||
23569998|NCT04867785|65816652|FG000|Overall Study|Physician Decision|0|||
23569999|NCT04867785|65816653|FG001|Overall Study|Physician Decision|0|||
23570000|NCT04867785|65816654|FG002|Overall Study|Physician Decision|0|||
23570001|NCT04867785|65816655|FG003|Overall Study|Physician Decision|0|||
23768580|NCT00745095|66531769|FG001|Overall Study|Ineligible due to GFR criteria|2|||
23768581|NCT00745095|66531770|FG002|Overall Study|Ineligible due to GFR criteria|3|||
23768582|NCT00745095|66531771|FG003|Overall Study|Ineligible due to GFR criteria|3|||
23768583|NCT00745095|66531772|FG004|Overall Study|Ineligible due to GFR criteria|30|||
23768584|NCT00745095|66531773|FG005|Overall Study|Ineligible due to GFR criteria|28|||
23768585|NCT01927757|66531774|FG000|Overall Study|Withdrawal by Subject|14|||
23768586|NCT01927757|66531774|FG000|Overall Study|Lost to Follow-up|2|||
23768587|NCT01927757|66531774|FG000|Overall Study|Decision by Sponsor|2|||
23768588|NCT01927757|66531774|FG000|Overall Study|Other|1|||
23768589|NCT01927757|66531774|FG000|Overall Study|Ethical Reasons|4|||
23768590|NCT00566709|66531777|FG000|Overall Study|Protocol Violation|5|||
23768591|NCT00566709|66531778|FG001|Overall Study|Protocol Violation|0|||
23631078|NCT02638103|66034926|FG003|Overall Study|Lack of Efficacy|22|||
23631079|NCT02638103|66034923|FG000|Overall Study|Other than specified|5|||
23631080|NCT02638103|66034924|FG001|Overall Study|Other than specified|4|||
23631081|NCT02638103|66034925|FG002|Overall Study|Other than specified|2|||
23631082|NCT02638103|66034926|FG003|Overall Study|Other than specified|4|||
23631083|NCT00955708|66034928|FG000|Overall Study|Death|269|||
23631084|NCT00955708|66034928|FG000|Overall Study|Lost to Follow-up|72|||
23631085|NCT00955708|66034928|FG000|Overall Study|Physician Decision|36|||
23631086|NCT00955708|66034928|FG000|Overall Study|Protocol Violation|134|||
23631087|NCT00955708|66034928|FG000|Overall Study|Registry Conclusion|186|||
23631088|NCT00955708|66034928|FG000|Overall Study|Product removed from service|94|||
23631089|NCT00955708|66034928|FG000|Overall Study|Patient Refused to participate further|116|||
23631090|NCT00955708|66034928|FG000|Overall Study|Closure of study location|60|||
23631091|NCT00955708|66034928|FG000|Overall Study|Patient changed care provider/moved|91|||
23631092|NCT00455741|66034936|FG000|Overall Study|Physician Decision|0|||
23631093|NCT00455741|66034937|FG001|Overall Study|Physician Decision|1|||
23830339|NCT00450437|66759925|FG000|Overall Study|Protocol Violation|0|||
23830340|NCT00450437|66759926|FG001|Overall Study|Protocol Violation|1|||
23830341|NCT00450437|66759927|FG002|Overall Study|Protocol Violation|0|||
23830342|NCT00450437|66759928|FG003|Overall Study|Protocol Violation|1|||
23830343|NCT00450437|66759925|FG000|Overall Study|Inappropriate enrollment|4|||
23830344|NCT00450437|66759926|FG001|Overall Study|Inappropriate enrollment|1|||
23570002|NCT04867785|65816656|FG004|Overall Study|Physician Decision|0|||
23768592|NCT01432171|66531779|FG000|Overall Study|Death|1|||
23768593|NCT01432171|66531780|FG001|Overall Study|Death|2|||
23768594|NCT01432171|66531779|FG000|Overall Study|Lost to Follow-up|6|||
23768595|NCT01432171|66531780|FG001|Overall Study|Lost to Follow-up|5|||
23768596|NCT01432171|66531779|FG000|Overall Study|Withdrawal by Subject|3|||
23768597|NCT01432171|66531780|FG001|Overall Study|Withdrawal by Subject|1|||
23768598|NCT01432171|66531779|FG000|Overall Study|Noncompliance|2|||
23830345|NCT00450437|66759927|FG002|Overall Study|Inappropriate enrollment|3|||
23830346|NCT00450437|66759928|FG003|Overall Study|Inappropriate enrollment|0|||
23830347|NCT00450437|66759925|FG000|Overall Study|Administrative reason|0|||
23570003|NCT04867785|65816657|FG005|Overall Study|Physician Decision|0|||
23570004|NCT04867785|65816658|FG006|Overall Study|Physician Decision|0|||
23570005|NCT04867785|65816659|FG007|Overall Study|Physician Decision|1|||
23570006|NCT04867785|65816652|FG000|Overall Study|Inadvertent Enrollment|0|||
23631094|NCT04211389|66034938|FG000|Overall Study|Adverse Event|1|||
23631095|NCT04211389|66034939|FG001|Overall Study|Adverse Event|2|||
23631096|NCT04211389|66034938|FG000|Overall Study|Lost to Follow-up|15|||
23631097|NCT04211389|66034939|FG001|Overall Study|Lost to Follow-up|7|||
23631098|NCT04211389|66034938|FG000|Overall Study|Protocol Violation|0|||
23768599|NCT01432171|66531780|FG001|Overall Study|Noncompliance|3|||
23768600|NCT01432171|66531779|FG000|Overall Study|Insurance denial trial coverage|1|||
23768601|NCT01432171|66531780|FG001|Overall Study|Insurance denial trial coverage|0|||
23768602|NCT01432171|66531779|FG000|Overall Study|Patient moved to palliative care|1|||
23830348|NCT00450437|66759926|FG001|Overall Study|Administrative reason|0|||
23768603|NCT01432171|66531780|FG001|Overall Study|Patient moved to palliative care|0|||
23768604|NCT00708422|66531785|FG000|Overall Study|Adverse Event|3|||
23631099|NCT04211389|66034939|FG001|Overall Study|Protocol Violation|1|||
23631100|NCT04211389|66034938|FG000|Overall Study|Withdrawal by Subject|10|||
23631101|NCT04211389|66034939|FG001|Overall Study|Withdrawal by Subject|11|||
23631102|NCT01777334|66034940|FG000|Overall Study|Adverse Event|18|||
23631103|NCT01777334|66034941|FG001|Overall Study|Adverse Event|14|||
23631104|NCT01777334|66034940|FG000|Overall Study|Lack of Efficacy|15|||
23631105|NCT01777334|66034941|FG001|Overall Study|Lack of Efficacy|29|||
23631106|NCT01777334|66034940|FG000|Overall Study|Protocol Violation|3|||
23631107|NCT01777334|66034941|FG001|Overall Study|Protocol Violation|7|||
23631108|NCT01777334|66034940|FG000|Overall Study|Lost to Follow-up|3|||
23631109|NCT01777334|66034941|FG001|Overall Study|Lost to Follow-up|2|||
23631110|NCT01777334|66034940|FG000|Overall Study|Withdrawal by Subject|14|||
23631111|NCT01777334|66034941|FG001|Overall Study|Withdrawal by Subject|11|||
23631112|NCT04147858|66034942|FG000|Overall Study|Adverse Event|6|||
23631113|NCT04147858|66034943|FG001|Overall Study|Adverse Event|6|||
23631114|NCT04147858|66034944|FG002|Overall Study|Adverse Event|6|||
23631115|NCT04147858|66034942|FG000|Overall Study|Lack of Efficacy|3|||
23631116|NCT04147858|66034943|FG001|Overall Study|Lack of Efficacy|3|||
23631117|NCT04147858|66034944|FG002|Overall Study|Lack of Efficacy|1|||
23631118|NCT04147858|66034942|FG000|Overall Study|Lost to Follow-up|1|||
23768605|NCT00708422|66531786|FG001|Overall Study|Adverse Event|1|||
23768606|NCT00708422|66531785|FG000|Overall Study|Withdrawal by Subject|1|||
23768607|NCT00708422|66531786|FG001|Overall Study|Withdrawal by Subject|0|||
23768608|NCT02130466|66531787|FG000|Overall Study|Death|4|||
23768609|NCT02130466|66531788|FG001|Overall Study|Death|1|||
23570007|NCT04867785|65816653|FG001|Overall Study|Inadvertent Enrollment|0|||
23570008|NCT04867785|65816654|FG002|Overall Study|Inadvertent Enrollment|0|||
23570009|NCT04867785|65816655|FG003|Overall Study|Inadvertent Enrollment|1|||
23570010|NCT04867785|65816656|FG004|Overall Study|Inadvertent Enrollment|1|||
23570011|NCT04867785|65816657|FG005|Overall Study|Inadvertent Enrollment|0|||
23570012|NCT04867785|65816658|FG006|Overall Study|Inadvertent Enrollment|0|||
23570013|NCT04867785|65816659|FG007|Overall Study|Inadvertent Enrollment|1|||
23570014|NCT04867785|65816652|FG000|Overall Study|Eligibility Criteria Not Met|0|||
23570015|NCT04867785|65816653|FG001|Overall Study|Eligibility Criteria Not Met|0|||
23768610|NCT02130466|66531789|FG002|Overall Study|Death|1|||
23768611|NCT02130466|66531790|FG003|Overall Study|Death|3|||
23768612|NCT02130466|66531791|FG004|Overall Study|Death|2|||
23768613|NCT02130466|66531792|FG005|Overall Study|Death|30|||
23768614|NCT02130466|66531793|FG006|Overall Study|Death|45|||
23768615|NCT02130466|66531794|FG007|Overall Study|Death|2|||
23768616|NCT02130466|66531795|FG008|Overall Study|Death|3|||
23768617|NCT02130466|66531796|FG009|Overall Study|Death|4|||
23768618|NCT02130466|66531797|FG010|Overall Study|Death|5|||
23768619|NCT02130466|66531798|FG011|Overall Study|Death|3|||
23768620|NCT02130466|66531799|FG012|Overall Study|Death|11|||
23768621|NCT02130466|66531800|FG013|Overall Study|Death|7|||
23768622|NCT02130466|66531787|FG000|Overall Study|Lost to Follow-up|1|||
23768623|NCT02130466|66531788|FG001|Overall Study|Lost to Follow-up|0|||
23768624|NCT02130466|66531789|FG002|Overall Study|Lost to Follow-up|0|||
23768625|NCT02130466|66531790|FG003|Overall Study|Lost to Follow-up|0|||
23768626|NCT02130466|66531791|FG004|Overall Study|Lost to Follow-up|0|||
23768627|NCT02130466|66531792|FG005|Overall Study|Lost to Follow-up|1|||
23830349|NCT00450437|66759927|FG002|Overall Study|Administrative reason|1|||
23570016|NCT04867785|65816654|FG002|Overall Study|Eligibility Criteria Not Met|0|||
23570017|NCT04867785|65816655|FG003|Overall Study|Eligibility Criteria Not Met|0|||
23570018|NCT04867785|65816656|FG004|Overall Study|Eligibility Criteria Not Met|0|||
23570019|NCT04867785|65816657|FG005|Overall Study|Eligibility Criteria Not Met|0|||
23631119|NCT04147858|66034943|FG001|Overall Study|Lost to Follow-up|6|||
23631120|NCT04147858|66034944|FG002|Overall Study|Lost to Follow-up|2|||
23631121|NCT04147858|66034942|FG000|Overall Study|Withdrawal by Subject|3|||
23631122|NCT04147858|66034943|FG001|Overall Study|Withdrawal by Subject|4|||
23631123|NCT04147858|66034944|FG002|Overall Study|Withdrawal by Subject|10|||
23631124|NCT04147858|66034942|FG000|Overall Study|Subject Noncompliance, Other|4|||
23631125|NCT04147858|66034943|FG001|Overall Study|Subject Noncompliance, Other|3|||
23631126|NCT04147858|66034944|FG002|Overall Study|Subject Noncompliance, Other|1|||
23631127|NCT02053610|66034947|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
23631128|NCT02053610|66034948|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
23631129|NCT02053610|66034947|FG000|Overall Study|Withdrew Consent|2|||
23768628|NCT02130466|66531793|FG006|Overall Study|Lost to Follow-up|0|||
23768629|NCT02130466|66531794|FG007|Overall Study|Lost to Follow-up|0|||
23768630|NCT02130466|66531795|FG008|Overall Study|Lost to Follow-up|0|||
23768631|NCT02130466|66531796|FG009|Overall Study|Lost to Follow-up|0|||
23768632|NCT02130466|66531797|FG010|Overall Study|Lost to Follow-up|0|||
23768633|NCT02130466|66531798|FG011|Overall Study|Lost to Follow-up|0|||
23768634|NCT02130466|66531799|FG012|Overall Study|Lost to Follow-up|1|||
23768635|NCT02130466|66531800|FG013|Overall Study|Lost to Follow-up|0|||
23768636|NCT02130466|66531787|FG000|Overall Study|Physician Decision|0|||
23768637|NCT02130466|66531788|FG001|Overall Study|Physician Decision|0|||
23768638|NCT02130466|66531789|FG002|Overall Study|Physician Decision|0|||
23768639|NCT02130466|66531790|FG003|Overall Study|Physician Decision|0|||
23768640|NCT02130466|66531791|FG004|Overall Study|Physician Decision|0|||
23768641|NCT02130466|66531792|FG005|Overall Study|Physician Decision|1|||
23768642|NCT02130466|66531793|FG006|Overall Study|Physician Decision|1|||
23768643|NCT02130466|66531794|FG007|Overall Study|Physician Decision|0|||
23768644|NCT02130466|66531795|FG008|Overall Study|Physician Decision|0|||
23830350|NCT00450437|66759928|FG003|Overall Study|Administrative reason|0|||
23830351|NCT00450437|66759925|FG000|Overall Study|Unable to Classify|1|||
23446867|NCT02919761|65377760|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
23446868|NCT00799903|65377761|FG000|Overall Study|Investigator Site Closed|25|||
23446869|NCT00799903|65377762|FG001|Overall Study|Investigator Site Closed|23|||
23446870|NCT00799903|65377761|FG000|Overall Study|Withdrawal by Subject|179|||
23446871|NCT00799903|65377762|FG001|Overall Study|Withdrawal by Subject|175|||
23446872|NCT00799903|65377761|FG000|Overall Study|Lost to Follow-up|69|||
23768645|NCT02130466|66531796|FG009|Overall Study|Physician Decision|0|||
23768646|NCT02130466|66531797|FG010|Overall Study|Physician Decision|0|||
23768647|NCT02130466|66531798|FG011|Overall Study|Physician Decision|0|||
23768648|NCT02130466|66531799|FG012|Overall Study|Physician Decision|0|||
23830352|NCT00450437|66759926|FG001|Overall Study|Unable to Classify|0|||
23830353|NCT00450437|66759927|FG002|Overall Study|Unable to Classify|1|||
23830354|NCT00450437|66759928|FG003|Overall Study|Unable to Classify|0|||
23830355|NCT03164551|66759929|FG000|Overall Study|Imaging discontinued prior completion|8|||
23830356|NCT03164551|66759930|FG001|Overall Study|Imaging discontinued prior completion|0|||
23830357|NCT03164551|66759929|FG000|Overall Study|Participant was non-compliant|1|||
23830358|NCT03164551|66759930|FG001|Overall Study|Participant was non-compliant|0|||
23830359|NCT03164551|66759929|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
23830360|NCT03164551|66759930|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
23830361|NCT03164551|66759929|FG000|Overall Study|Other|8|||
23830362|NCT03164551|66759930|FG001|Overall Study|Other|2|||
23830363|NCT02832687|66759931|FG000|Overall Study|Adverse Event|0|||
23830364|NCT02832687|66759932|FG001|Overall Study|Adverse Event|2|||
23830365|NCT02568189|66759937|FG000|Overall Study|Protocol Violation|0|||
23830366|NCT02568189|66759938|FG001|Overall Study|Protocol Violation|0|||
23768649|NCT02130466|66531800|FG013|Overall Study|Physician Decision|0|||
23768650|NCT02130466|66531787|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23830367|NCT02568189|66759939|FG002|Overall Study|Protocol Violation|19|||
23830368|NCT02568189|66759940|FG003|Overall Study|Protocol Violation|18|||
23830369|NCT03850483|66759941|FG000|Treatment for Stage 1|Adverse Event|1|||
23446873|NCT00799903|65377762|FG001|Overall Study|Lost to Follow-up|80|||
23446874|NCT02910466|65377763|FG000|Overall Study|Adverse Event|1|||
23446875|NCT02910466|65377763|FG000|Overall Study|Withdrawal by Subject|3|||
23446876|NCT02910466|65377763|FG000|Overall Study|Lost to Follow-up|5|||
23446877|NCT02910466|65377763|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
23446878|NCT02910466|65377763|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
23446879|NCT03760081|65377768|FG000|Overall Study|Miscellaneous|0|||
23631130|NCT02053610|66034948|FG001|Overall Study|Withdrew Consent|9|||
23631131|NCT02053610|66034947|FG000|Overall Study|Death|5|||
23631132|NCT02053610|66034948|FG001|Overall Study|Death|5|||
23446880|NCT03760081|65377769|FG001|Overall Study|Miscellaneous|1|||
23446881|NCT03760081|65377768|FG000|Overall Study|Progressive Disease|5|||
23446882|NCT03760081|65377769|FG001|Overall Study|Progressive Disease|10|||
23446883|NCT03760081|65377768|FG000|Overall Study|Death|1|||
23570020|NCT04867785|65816658|FG006|Overall Study|Eligibility Criteria Not Met|0|||
23570021|NCT04867785|65816659|FG007|Overall Study|Eligibility Criteria Not Met|1|||
23570022|NCT01923428|65816663|FG000|Overall Study|Adverse Event|8|||
23631133|NCT02053610|66034947|FG000|Overall Study|Administrative/Other|1|||
23631134|NCT02053610|66034948|FG001|Overall Study|Administrative/Other|1|||
23631135|NCT02053610|66034947|FG000|Overall Study|Disease Progression|2|||
23631136|NCT02053610|66034948|FG001|Overall Study|Disease Progression|3|||
23631137|NCT02053610|66034947|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
23631138|NCT02053610|66034948|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
23631139|NCT02053610|66034947|FG000|Overall Study|Did not Receive Treatment|4|||
23631140|NCT02053610|66034948|FG001|Overall Study|Did not Receive Treatment|2|||
23631141|NCT02053610|66034947|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23631142|NCT02053610|66034948|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23631143|NCT02053610|66034947|FG000|Overall Study|Violation of Selection Criteria|1|||
23631144|NCT02053610|66034948|FG001|Overall Study|Violation of Selection Criteria|0|||
23631145|NCT01358331|66034952|FG000|Overall Study|Lost to Follow-up|0|||
23631146|NCT01358331|66034953|FG001|Overall Study|Lost to Follow-up|0|||
23631147|NCT01358331|66034954|FG002|Overall Study|Lost to Follow-up|0|||
23631148|NCT01358331|66034955|FG003|Overall Study|Lost to Follow-up|1|||
23631149|NCT01358331|66034956|FG004|Overall Study|Lost to Follow-up|0|||
23631150|NCT01358331|66034957|FG005|Overall Study|Lost to Follow-up|0|||
23631151|NCT01358331|66034952|FG000|Overall Study|Withdrawal by Subject|0|||
23631152|NCT01358331|66034953|FG001|Overall Study|Withdrawal by Subject|0|||
23446884|NCT03760081|65377769|FG001|Overall Study|Death|1|||
23446885|NCT00773513|65377770|FG000|Overall Study|Renal Transplant|254|||
23446886|NCT00773513|65377771|FG001|Overall Study|Renal Transplant|263|||
23446887|NCT00773513|65377770|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
23446888|NCT00773513|65377771|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
23446889|NCT00773513|65377770|FG000|Overall Study|Withdrew Consent|68|||
23446890|NCT00773513|65377771|FG001|Overall Study|Withdrew Consent|69|||
23570023|NCT01923428|65816664|FG001|Overall Study|Adverse Event|6|||
23570024|NCT01923428|65816665|FG002|Overall Study|Adverse Event|3|||
23570025|NCT01923428|65816666|FG003|Overall Study|Adverse Event|3|||
23570026|NCT01923428|65816663|FG000|Overall Study|Withdrawal by Subject|5|||
23570027|NCT01923428|65816664|FG001|Overall Study|Withdrawal by Subject|3|||
23570028|NCT01923428|65816665|FG002|Overall Study|Withdrawal by Subject|0|||
23570029|NCT01923428|65816666|FG003|Overall Study|Withdrawal by Subject|4|||
23570030|NCT01923428|65816663|FG000|Overall Study|Lost to Follow-up|2|||
23570031|NCT01923428|65816664|FG001|Overall Study|Lost to Follow-up|1|||
23570032|NCT01923428|65816665|FG002|Overall Study|Lost to Follow-up|5|||
23570033|NCT01923428|65816666|FG003|Overall Study|Lost to Follow-up|0|||
23570034|NCT01923428|65816663|FG000|Overall Study|Protocol Violation|3|||
23570035|NCT01923428|65816664|FG001|Overall Study|Protocol Violation|0|||
23570036|NCT01923428|65816665|FG002|Overall Study|Protocol Violation|2|||
23570037|NCT01923428|65816666|FG003|Overall Study|Protocol Violation|1|||
23631153|NCT01358331|66034954|FG002|Overall Study|Withdrawal by Subject|0|||
23631154|NCT01358331|66034955|FG003|Overall Study|Withdrawal by Subject|1|||
23631155|NCT01358331|66034956|FG004|Overall Study|Withdrawal by Subject|1|||
23631156|NCT01358331|66034957|FG005|Overall Study|Withdrawal by Subject|1|||
23768651|NCT02130466|66531788|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
23631157|NCT01358331|66034952|FG000|Overall Study|Adverse Events|1|||
23631158|NCT01358331|66034953|FG001|Overall Study|Adverse Events|1|||
23631159|NCT01358331|66034954|FG002|Overall Study|Adverse Events|1|||
23631160|NCT01358331|66034955|FG003|Overall Study|Adverse Events|0|||
23768652|NCT02130466|66531789|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23768653|NCT02130466|66531790|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
23768654|NCT02130466|66531791|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23768655|NCT02130466|66531792|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
23768656|NCT02130466|66531793|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
23768657|NCT02130466|66531794|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23768658|NCT02130466|66531795|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23631161|NCT01358331|66034956|FG004|Overall Study|Adverse Events|1|||
23631162|NCT01358331|66034957|FG005|Overall Study|Adverse Events|5|||
23631163|NCT01358331|66034952|FG000|Overall Study|Symptomatic Deterioration|0|||
23631164|NCT01358331|66034953|FG001|Overall Study|Symptomatic Deterioration|0|||
23631165|NCT01358331|66034954|FG002|Overall Study|Symptomatic Deterioration|0|||
23631166|NCT01358331|66034955|FG003|Overall Study|Symptomatic Deterioration|0|||
23631167|NCT01358331|66034956|FG004|Overall Study|Symptomatic Deterioration|1|||
23631168|NCT01358331|66034957|FG005|Overall Study|Symptomatic Deterioration|0|||
23631169|NCT01358331|66034952|FG000|Overall Study|Participants did not wish to continue|0|||
23631170|NCT01358331|66034953|FG001|Overall Study|Participants did not wish to continue|0|||
23631171|NCT01358331|66034954|FG002|Overall Study|Participants did not wish to continue|0|||
23631172|NCT01358331|66034955|FG003|Overall Study|Participants did not wish to continue|0|||
23631173|NCT01358331|66034956|FG004|Overall Study|Participants did not wish to continue|1|||
23631174|NCT01358331|66034957|FG005|Overall Study|Participants did not wish to continue|0|||
23631175|NCT01358331|66034952|FG000|Overall Study|Progress of disease under investigation|1|||
23631176|NCT01358331|66034953|FG001|Overall Study|Progress of disease under investigation|2|||
23631177|NCT01358331|66034954|FG002|Overall Study|Progress of disease under investigation|3|||
23631178|NCT01358331|66034955|FG003|Overall Study|Progress of disease under investigation|1|||
23631179|NCT01358331|66034956|FG004|Overall Study|Progress of disease under investigation|3|||
23631180|NCT01358331|66034957|FG005|Overall Study|Progress of disease under investigation|0|||
23631181|NCT01327846|66034958|FG000|Core Phase|Subject decision (vital status: missing)|1|||
23631182|NCT01327846|66034959|FG001|Core Phase|Subject decision (vital status: missing)|2|||
23631183|NCT01327846|66034960|FG002|Core Phase|Subject decision (vital status: missing)|2|||
23631184|NCT01327846|66034961|FG003|Core Phase|Subject decision (vital status: missing)|1|||
23631185|NCT01327846|66034958|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
23631186|NCT01327846|66034959|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
23631187|NCT01327846|66034960|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
23631188|NCT01327846|66034961|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
23631189|NCT01327846|66034958|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
23631190|NCT01327846|66034959|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
23631191|NCT01327846|66034960|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
23631192|NCT01327846|66034961|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
23446891|NCT00773513|65377770|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
23570038|NCT01923428|65816663|FG000|Overall Study|Non Compliance to treatment|1|||
23570039|NCT01923428|65816664|FG001|Overall Study|Non Compliance to treatment|2|||
23570040|NCT01923428|65816665|FG002|Overall Study|Non Compliance to treatment|0|||
23570041|NCT01923428|65816666|FG003|Overall Study|Non Compliance to treatment|1|||
23570042|NCT01923428|65816663|FG000|Overall Study|Lack of Efficacy|0|||
23570043|NCT01923428|65816664|FG001|Overall Study|Lack of Efficacy|0|||
23570044|NCT01923428|65816665|FG002|Overall Study|Lack of Efficacy|1|||
23570045|NCT01923428|65816666|FG003|Overall Study|Lack of Efficacy|1|||
23570046|NCT02638623|65816671|FG000|Overall Study|Surgery timing|5|||
23570047|NCT02638623|65816672|FG001|Overall Study|Surgery timing|6|||
23570048|NCT02638623|65816671|FG000|Overall Study|Not given intervention|2|||
23570049|NCT02638623|65816672|FG001|Overall Study|Not given intervention|0|||
23570050|NCT02982720|65816673|FG000|Overall Study|Adverse Event|3|||
23570051|NCT02982720|65816673|FG000|Overall Study|Death|1|||
23570052|NCT01556763|65816676|FG000|Overall Study|Withdrawal by Subject|0|||
23570053|NCT01556763|65816677|FG001|Overall Study|Withdrawal by Subject|1|||
23570054|NCT01556763|65816678|FG002|Overall Study|Withdrawal by Subject|0|||
23570055|NCT03358329|65816681|FG000|Overall Study|Lost to Follow-up|2|||
23570056|NCT03358329|65816681|FG000|Overall Study|Withdrawal by Subject|2|||
23570057|NCT00453102|65816687|FG000|Overall Study|Withdrawal by Subject|2|||
23570058|NCT03580356|65816688|FG000|Treatment Period|Withdrawal by Subject|13|||
23570059|NCT03580356|65816689|FG001|Treatment Period|Withdrawal by Subject|0|||
23570060|NCT03580356|65816690|FG002|Treatment Period|Withdrawal by Subject|13|||
23570061|NCT03580356|65816691|FG003|Treatment Period|Withdrawal by Subject|1|||
23631193|NCT01327846|66034958|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
23446892|NCT00773513|65377771|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
23446893|NCT00773513|65377770|FG000|Overall Study|Failure to Return|22|||
23446894|NCT00773513|65377771|FG001|Overall Study|Failure to Return|8|||
23570062|NCT03580356|65816692|FG004|Treatment Period|Withdrawal by Subject|17|||
23570063|NCT03580356|65816693|FG005|Treatment Period|Withdrawal by Subject|0|||
23570064|NCT03580356|65816694|FG006|Treatment Period|Withdrawal by Subject|5|||
23570065|NCT03580356|65816695|FG007|Treatment Period|Withdrawal by Subject|0|||
23570066|NCT03580356|65816688|FG000|Treatment Period|Adverse Event|10|||
23570067|NCT03580356|65816689|FG001|Treatment Period|Adverse Event|0|||
23570068|NCT03580356|65816690|FG002|Treatment Period|Adverse Event|13|||
23631194|NCT01327846|66034959|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
23631195|NCT01327846|66034960|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
23631196|NCT01327846|66034961|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
23631197|NCT01327846|66034958|FG000|Core Phase|Lost to Follow-up|3|||
23631198|NCT01327846|66034959|FG001|Core Phase|Lost to Follow-up|3|||
23631199|NCT01327846|66034960|FG002|Core Phase|Lost to Follow-up|4|||
23631200|NCT01327846|66034961|FG003|Core Phase|Lost to Follow-up|5|||
23631201|NCT01327846|66034958|FG000|Extension Phase|Study terminated by sponsor|1073|||
23631202|NCT01327846|66034959|FG001|Extension Phase|Study terminated by sponsor|1124|||
23631203|NCT01327846|66034960|FG002|Extension Phase|Study terminated by sponsor|1067|||
23631204|NCT01327846|66034961|FG003|Extension Phase|Study terminated by sponsor|1660|||
23631205|NCT01327846|66034958|FG000|Extension Phase|Withdrawal by Subject|20|||
23631206|NCT01327846|66034959|FG001|Extension Phase|Withdrawal by Subject|13|||
23631207|NCT01327846|66034960|FG002|Extension Phase|Withdrawal by Subject|19|||
23631208|NCT01327846|66034961|FG003|Extension Phase|Withdrawal by Subject|37|||
23631209|NCT01327846|66034958|FG000|Extension Phase|Lost to Follow-up|4|||
23631210|NCT01327846|66034959|FG001|Extension Phase|Lost to Follow-up|3|||
23631211|NCT01327846|66034960|FG002|Extension Phase|Lost to Follow-up|4|||
23631212|NCT01327846|66034961|FG003|Extension Phase|Lost to Follow-up|7|||
23631213|NCT01327846|66034958|FG000|Extension Phase|Technical Problems|2|||
23631214|NCT01327846|66034959|FG001|Extension Phase|Technical Problems|4|||
23631215|NCT01327846|66034960|FG002|Extension Phase|Technical Problems|2|||
23631216|NCT01327846|66034961|FG003|Extension Phase|Technical Problems|2|||
23631217|NCT01432626|66034963|FG000|Overall Study|LV function recovered|2|||
23631218|NCT01432626|66034963|FG000|Overall Study|Withdrawal by Subject|2|||
23631219|NCT01432626|66034963|FG000|Overall Study|Only 1 image competed|2|||
23631220|NCT01432626|66034963|FG000|Overall Study|Imaging agent not available|1|||
23631221|NCT01067846|66034964|FG000|Overall Study|Lost to Follow-up|17|||
23631222|NCT01067846|66034965|FG001|Overall Study|Lost to Follow-up|19|||
23631223|NCT01067846|66034964|FG000|Overall Study|Withdrawal by Subject|1|||
23631224|NCT01067846|66034965|FG001|Overall Study|Withdrawal by Subject|0|||
23446895|NCT00773513|65377770|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23446896|NCT00773513|65377771|FG001|Overall Study|Insufficient Therapeutic Response|18|||
23446897|NCT00773513|65377770|FG000|Overall Study|Reason Not Specified|159|||
23446898|NCT00773513|65377771|FG001|Overall Study|Reason Not Specified|126|||
23631225|NCT01067846|66034964|FG000|Overall Study|participation in other tx study|1|||
23631226|NCT01067846|66034965|FG001|Overall Study|participation in other tx study|0|||
23631227|NCT01681992|66034968|FG000|Overall Study|Adverse Event|3|||
23631228|NCT01681992|66034969|FG001|Overall Study|Adverse Event|2|||
23631229|NCT01681992|66034970|FG002|Overall Study|Adverse Event|3|||
23631230|NCT01681992|66034968|FG000|Overall Study|Lost to Follow-up|36|||
23631231|NCT01681992|66034969|FG001|Overall Study|Lost to Follow-up|38|||
23631232|NCT01681992|66034970|FG002|Overall Study|Lost to Follow-up|53|||
23631233|NCT01681992|66034968|FG000|Overall Study|As Per Sponsor Decision|0|||
23631234|NCT01681992|66034969|FG001|Overall Study|As Per Sponsor Decision|0|||
23631235|NCT01681992|66034970|FG002|Overall Study|As Per Sponsor Decision|1|||
23631236|NCT01681992|66034968|FG000|Overall Study|Protocol Violation|0|||
23631237|NCT01681992|66034969|FG001|Overall Study|Protocol Violation|0|||
23631238|NCT01681992|66034970|FG002|Overall Study|Protocol Violation|1|||
23446899|NCT00773513|65377770|FG000|Overall Study|Death|531|||
23446900|NCT00773513|65377771|FG001|Overall Study|Death|545|||
23446901|NCT01253291|65377772|FG000|Overall Study|Withdrawal by Subject|1|||
23446902|NCT01253291|65377773|FG001|Overall Study|Withdrawal by Subject|1|||
23446903|NCT01253291|65377774|FG002|Overall Study|Withdrawal by Subject|0|||
23446904|NCT01253291|65377775|FG003|Overall Study|Withdrawal by Subject|0|||
23446905|NCT01253291|65377776|FG004|Overall Study|Withdrawal by Subject|0|||
23446906|NCT01253291|65377772|FG000|Overall Study|Adverse Event|0|||
23446907|NCT01253291|65377773|FG001|Overall Study|Adverse Event|1|||
23446908|NCT01253291|65377774|FG002|Overall Study|Adverse Event|0|||
23446909|NCT01253291|65377775|FG003|Overall Study|Adverse Event|0|||
23446910|NCT01253291|65377776|FG004|Overall Study|Adverse Event|0|||
23446911|NCT01253291|65377772|FG000|Overall Study|Lack of Efficacy|1|||
23446912|NCT01253291|65377773|FG001|Overall Study|Lack of Efficacy|0|||
23446913|NCT01253291|65377774|FG002|Overall Study|Lack of Efficacy|0|||
23446914|NCT01253291|65377775|FG003|Overall Study|Lack of Efficacy|0|||
23631239|NCT01681992|66034968|FG000|Overall Study|Withdrawal by Subject|27|||
23631240|NCT01681992|66034969|FG001|Overall Study|Withdrawal by Subject|30|||
23631241|NCT01681992|66034970|FG002|Overall Study|Withdrawal by Subject|25|||
23631242|NCT00632502|66034971|FG000|Overall Study|Adverse Event|0|||
23631243|NCT00632502|66034972|FG001|Overall Study|Adverse Event|1|||
23631244|NCT00632502|66034971|FG000|Overall Study|Randomized not treated|3|||
23631245|NCT00632502|66034972|FG001|Overall Study|Randomized not treated|0|||
23631246|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Adverse Event|10|||
23631247|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Adverse Event|9|||
23631248|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Adverse Event|7|||
23631249|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
23631250|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
23631251|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
23631252|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
23631253|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
23631254|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
23631255|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Physician Decision|7|||
23631256|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Physician Decision|3|||
23631257|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Physician Decision|2|||
23631258|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Pregnancy|2|||
23631259|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Pregnancy|1|||
23631260|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Pregnancy|3|||
23631261|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
23631262|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
23631263|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
23631264|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
23631265|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
23631266|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
23631267|NCT02614183|66034976|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
23631268|NCT02614183|66034977|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
23631269|NCT02614183|66034978|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
23631270|NCT02614183|66034976|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
23631271|NCT02614183|66034977|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23631272|NCT02614183|66034978|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
23631273|NCT02614183|66034976|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
23631274|NCT02614183|66034977|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
23631275|NCT02614183|66034978|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
23631276|NCT02614183|66034976|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
23631277|NCT02614183|66034977|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
23768659|NCT02130466|66531796|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23768660|NCT02130466|66531797|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23768661|NCT02130466|66531798|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23631278|NCT02614183|66034978|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
23631279|NCT02614183|66034976|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
23631280|NCT02614183|66034977|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
23631281|NCT02614183|66034978|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
23631282|NCT01234883|66034985|FG000|Overall Study|Early treatment release|8|||
23631283|NCT01234883|66034986|FG001|Overall Study|Early treatment release|10|||
23446915|NCT01253291|65377776|FG004|Overall Study|Lack of Efficacy|0|||
23768662|NCT02130466|66531799|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23768663|NCT02130466|66531800|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
23570069|NCT03580356|65816691|FG003|Treatment Period|Adverse Event|0|||
23570070|NCT03580356|65816692|FG004|Treatment Period|Adverse Event|5|||
23570071|NCT03580356|65816693|FG005|Treatment Period|Adverse Event|0|||
23570072|NCT03580356|65816694|FG006|Treatment Period|Adverse Event|8|||
23570073|NCT03580356|65816695|FG007|Treatment Period|Adverse Event|0|||
23570074|NCT03580356|65816688|FG000|Treatment Period|Protocol Violation|5|||
23570075|NCT03580356|65816689|FG001|Treatment Period|Protocol Violation|0|||
23570076|NCT03580356|65816690|FG002|Treatment Period|Protocol Violation|6|||
23570077|NCT03580356|65816691|FG003|Treatment Period|Protocol Violation|1|||
23570078|NCT03580356|65816692|FG004|Treatment Period|Protocol Violation|9|||
23570079|NCT03580356|65816693|FG005|Treatment Period|Protocol Violation|1|||
23570080|NCT03580356|65816694|FG006|Treatment Period|Protocol Violation|1|||
23570081|NCT03580356|65816695|FG007|Treatment Period|Protocol Violation|0|||
23570082|NCT03580356|65816688|FG000|Treatment Period|Lack of Efficacy|6|||
23570083|NCT03580356|65816689|FG001|Treatment Period|Lack of Efficacy|0|||
23570084|NCT03580356|65816690|FG002|Treatment Period|Lack of Efficacy|2|||
23570085|NCT03580356|65816691|FG003|Treatment Period|Lack of Efficacy|0|||
23570086|NCT03580356|65816692|FG004|Treatment Period|Lack of Efficacy|3|||
23570087|NCT03580356|65816693|FG005|Treatment Period|Lack of Efficacy|0|||
23570088|NCT03580356|65816694|FG006|Treatment Period|Lack of Efficacy|3|||
23768664|NCT02130466|66531787|FG000|Overall Study|Withdrawal by Subject|1|||
23570089|NCT03580356|65816695|FG007|Treatment Period|Lack of Efficacy|0|||
23570090|NCT03580356|65816688|FG000|Treatment Period|Pregnancy|1|||
23570091|NCT03580356|65816689|FG001|Treatment Period|Pregnancy|0|||
23570092|NCT03580356|65816690|FG002|Treatment Period|Pregnancy|7|||
23768665|NCT02130466|66531788|FG001|Overall Study|Withdrawal by Subject|0|||
23570093|NCT03580356|65816691|FG003|Treatment Period|Pregnancy|0|||
23570094|NCT03580356|65816692|FG004|Treatment Period|Pregnancy|2|||
23570095|NCT03580356|65816693|FG005|Treatment Period|Pregnancy|0|||
23570096|NCT03580356|65816694|FG006|Treatment Period|Pregnancy|1|||
23631284|NCT01234883|66034985|FG000|Overall Study|Parent/guardian withdrew consent|1|||
23631285|NCT01234883|66034986|FG001|Overall Study|Parent/guardian withdrew consent|2|||
23631286|NCT01234883|66034985|FG000|Overall Study|Technical difficulties with IV infusion|0|||
23631287|NCT01234883|66034986|FG001|Overall Study|Technical difficulties with IV infusion|1|||
23631288|NCT01234883|66034985|FG000|Overall Study|Inclusion/exclusion failure|1|||
23570097|NCT03580356|65816695|FG007|Treatment Period|Pregnancy|0|||
23570098|NCT03580356|65816688|FG000|Treatment Period|Physician Decision|2|||
23570099|NCT03580356|65816689|FG001|Treatment Period|Physician Decision|0|||
23570100|NCT03580356|65816690|FG002|Treatment Period|Physician Decision|1|||
23570101|NCT03580356|65816691|FG003|Treatment Period|Physician Decision|0|||
23570102|NCT03580356|65816692|FG004|Treatment Period|Physician Decision|4|||
23570103|NCT03580356|65816693|FG005|Treatment Period|Physician Decision|0|||
23570104|NCT03580356|65816694|FG006|Treatment Period|Physician Decision|2|||
23570105|NCT03580356|65816695|FG007|Treatment Period|Physician Decision|0|||
23570106|NCT03580356|65816688|FG000|Treatment Period|Lost to Follow-up|1|||
23570107|NCT03580356|65816689|FG001|Treatment Period|Lost to Follow-up|1|||
23570108|NCT03580356|65816690|FG002|Treatment Period|Lost to Follow-up|1|||
23570109|NCT03580356|65816691|FG003|Treatment Period|Lost to Follow-up|0|||
23570110|NCT03580356|65816692|FG004|Treatment Period|Lost to Follow-up|3|||
23570111|NCT03580356|65816693|FG005|Treatment Period|Lost to Follow-up|0|||
23570112|NCT03580356|65816694|FG006|Treatment Period|Lost to Follow-up|1|||
23570113|NCT03580356|65816695|FG007|Treatment Period|Lost to Follow-up|0|||
23570114|NCT03580356|65816688|FG000|Treatment Period|Death|0|||
23570115|NCT03580356|65816689|FG001|Treatment Period|Death|0|||
23570116|NCT03580356|65816690|FG002|Treatment Period|Death|1|||
23570117|NCT03580356|65816691|FG003|Treatment Period|Death|0|||
23570118|NCT03580356|65816692|FG004|Treatment Period|Death|0|||
23570119|NCT03580356|65816693|FG005|Treatment Period|Death|0|||
23570120|NCT03580356|65816694|FG006|Treatment Period|Death|0|||
23570121|NCT03580356|65816695|FG007|Treatment Period|Death|0|||
23631289|NCT01234883|66034986|FG001|Overall Study|Inclusion/exclusion failure|0|||
23631290|NCT03898700|66034987|FG000|Overall Study|Withdrawal by Subject|2|||
23631291|NCT00486252|66034988|FG000|Overall Study|Adverse Event|7|||
23631292|NCT00486252|66034988|FG000|Overall Study|Lack of Efficacy|9|||
23631293|NCT00486252|66034988|FG000|Overall Study|Lost to Follow-up|24|||
23631294|NCT00486252|66034988|FG000|Overall Study|Other|18|||
23631295|NCT00127842|66034992|FG000|Overall Study|Adverse Event|15|||
23631296|NCT00127842|66034992|FG000|Overall Study|Withdrawal by Subject|3|||
23631297|NCT00127842|66034992|FG000|Overall Study|Lost to Follow-up|1|||
23631298|NCT00127842|66034992|FG000|Overall Study|Lack of Efficacy|12|||
23631299|NCT00127842|66034992|FG000|Overall Study|Noncompliance|2|||
23631300|NCT00127842|66034992|FG000|Overall Study|Protocol Violation|1|||
23631301|NCT00127842|66034992|FG000|Overall Study|Other|5|||
23631302|NCT02473965|66034993|FG000|Overall Study|Adverse Event|6|||
23631303|NCT02473965|66034994|FG001|Overall Study|Adverse Event|4|||
23631304|NCT02473965|66034993|FG000|Overall Study|MG worsening|4|||
23631305|NCT02473965|66034994|FG001|Overall Study|MG worsening|1|||
23631306|NCT02473965|66034993|FG000|Overall Study|Withdrawal by Subject|2|||
23631307|NCT02473965|66034994|FG001|Overall Study|Withdrawal by Subject|3|||
23631308|NCT02473965|66034993|FG000|Overall Study|Physician Decision|0|||
23631309|NCT02473965|66034994|FG001|Overall Study|Physician Decision|2|||
23631310|NCT01516749|66034995|FG000|Active Therapy|Lost to Follow-up|1|||
23631311|NCT01516749|66034995|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
23631312|NCT03197766|66034996|FG000|Overall Study|Withdrawal by Subject|2|||
23631313|NCT03197766|66034997|FG001|Overall Study|Withdrawal by Subject|0|||
23631314|NCT00402051|66034998|FG000|Overall Study|Progressive Disease|13|||
23631315|NCT00402051|66034999|FG001|Overall Study|Progressive Disease|20|||
23631316|NCT00402051|66034998|FG000|Overall Study|Adverse Event|11|||
23631317|NCT00402051|66034999|FG001|Overall Study|Adverse Event|4|||
23631318|NCT00402051|66034998|FG000|Overall Study|Physician Decision|7|||
23631319|NCT00402051|66034999|FG001|Overall Study|Physician Decision|3|||
23631320|NCT00402051|66034998|FG000|Overall Study|Withdrawal by Subject|3|||
23631321|NCT00402051|66034999|FG001|Overall Study|Withdrawal by Subject|3|||
23631322|NCT00402051|66034998|FG000|Overall Study|Death - Related to Study Drug|1|||
23631323|NCT00402051|66034999|FG001|Overall Study|Death - Related to Study Drug|2|||
23631324|NCT00402051|66034998|FG000|Overall Study|Death Due to Study Disease|2|||
23631325|NCT00402051|66034999|FG001|Overall Study|Death Due to Study Disease|1|||
23631326|NCT00402051|66034998|FG000|Overall Study|Death Due to Adverse Event|0|||
23631327|NCT00402051|66034999|FG001|Overall Study|Death Due to Adverse Event|2|||
23631328|NCT00402051|66034998|FG000|Overall Study|Lost to Follow-up|1|||
23446916|NCT01253291|65377772|FG000|Overall Study|Physician Decision|2|||
23570122|NCT03580356|65816688|FG000|Treatment Period|Technical problems|0|||
23570123|NCT03580356|65816689|FG001|Treatment Period|Technical problems|0|||
23570124|NCT03580356|65816690|FG002|Treatment Period|Technical problems|0|||
23570125|NCT03580356|65816691|FG003|Treatment Period|Technical problems|0|||
23570126|NCT03580356|65816692|FG004|Treatment Period|Technical problems|1|||
23570127|NCT03580356|65816693|FG005|Treatment Period|Technical problems|0|||
23631329|NCT00402051|66034999|FG001|Overall Study|Lost to Follow-up|0|||
23631330|NCT01721954|66035000|FG000|Overall Study|Death|58|||
23631331|NCT01721954|66035001|FG001|Overall Study|Death|64|||
23631332|NCT01721954|66035000|FG000|Overall Study|Withdrawal by Subject|8|||
23631333|NCT01721954|66035001|FG001|Overall Study|Withdrawal by Subject|4|||
23631334|NCT01721954|66035000|FG000|Overall Study|Adverse Event|2|||
23631335|NCT01721954|66035001|FG001|Overall Study|Adverse Event|0|||
23631336|NCT01721954|66035000|FG000|Overall Study|Lost to Follow-up|2|||
23631337|NCT01721954|66035001|FG001|Overall Study|Lost to Follow-up|1|||
23631338|NCT00943787|66035004|FG000|Overall Study|Physician Decision|4|||
23631339|NCT00943787|66035004|FG000|Overall Study|Withdrawal by Subject|3|||
23631340|NCT00701909|66035008|FG000|Overall Study|Withdrawal by Subject|0|||
23631341|NCT00701909|66035009|FG001|Overall Study|Withdrawal by Subject|1|||
23631342|NCT01825798|66038402|FG000|Overall Study|Adverse Event|1|||
23631343|NCT01825798|66038403|FG001|Overall Study|Adverse Event|5|||
23631344|NCT01825798|66038402|FG000|Overall Study|Lost to Follow-up|1|||
23631345|NCT01825798|66038403|FG001|Overall Study|Lost to Follow-up|0|||
23631346|NCT02579772|66038404|FG000|Overall Study|Withdrawal by Subject|0|||
23631347|NCT02579772|66038405|FG001|Overall Study|Withdrawal by Subject|1|||
23631348|NCT02579772|66038404|FG000|Overall Study|Usage of additional antioxidants|1|||
23631349|NCT02579772|66038405|FG001|Overall Study|Usage of additional antioxidants|0|||
23631350|NCT02579772|66038404|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
23631351|NCT02579772|66038405|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
23631352|NCT00570908|66038411|FG000|Overall Study|Adverse Event|5|||
23631353|NCT00570908|66038411|FG000|Overall Study|Withdrawal by Subject|2|||
23631354|NCT04949802|66038412|FG000|Overall Study|Lost to Follow-up|3|||
23631355|NCT00572533|66038415|FG000|Overall Study|Death|4|||
23631356|NCT00572533|66038416|FG001|Overall Study|Death|1|||
23631357|NCT00572533|66038415|FG000|Overall Study|Received Kidney Transplant|2|||
23631358|NCT00572533|66038416|FG001|Overall Study|Received Kidney Transplant|1|||
23631359|NCT00572533|66038415|FG000|Overall Study|Social Issues|1|||
23631360|NCT00572533|66038416|FG001|Overall Study|Social Issues|0|||
23631361|NCT00572533|66038415|FG000|Overall Study|Transfer out of Facility|0|||
23631362|NCT00572533|66038416|FG001|Overall Study|Transfer out of Facility|1|||
23631363|NCT00384397|66038417|FG000|Overall Study|Adverse Event|0|||
23631364|NCT00384397|66038418|FG001|Overall Study|Adverse Event|1|||
23631365|NCT00384397|66038419|FG002|Overall Study|Adverse Event|2|||
23631366|NCT00384397|66038417|FG000|Overall Study|Protocol Violation|7|||
23631367|NCT00384397|66038418|FG001|Overall Study|Protocol Violation|15|||
23631368|NCT00384397|66038419|FG002|Overall Study|Protocol Violation|13|||
23631369|NCT00384397|66038417|FG000|Overall Study|Lost to Follow-up|11|||
23631370|NCT00384397|66038418|FG001|Overall Study|Lost to Follow-up|13|||
23631371|NCT00384397|66038419|FG002|Overall Study|Lost to Follow-up|3|||
23631372|NCT00384397|66038417|FG000|Overall Study|Withdrawal by Subject|14|||
23631373|NCT00384397|66038418|FG001|Overall Study|Withdrawal by Subject|17|||
23631374|NCT00384397|66038419|FG002|Overall Study|Withdrawal by Subject|15|||
23631375|NCT01999972|66038420|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
23631376|NCT01999972|66038421|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
23631377|NCT01999972|66038422|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
23631378|NCT01999972|66038423|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
23631379|NCT01999972|66038424|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
23631380|NCT01999972|66038425|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
23631381|NCT01999972|66038420|FG000|Dose Escalation Part|Death|0|||
23631382|NCT01999972|66038421|FG001|Dose Escalation Part|Death|1|||
23631383|NCT01999972|66038422|FG002|Dose Escalation Part|Death|0|||
23631384|NCT01999972|66038423|FG003|Dose Escalation Part|Death|0|||
23631385|NCT01999972|66038424|FG004|Dose Escalation Part|Death|0|||
23631386|NCT01999972|66038425|FG005|Dose Escalation Part|Death|0|||
23631387|NCT01999972|66038420|FG000|Dose Escalation Part|Enrolled but not treated|0|||
23631388|NCT01999972|66038421|FG001|Dose Escalation Part|Enrolled but not treated|0|||
23631389|NCT01999972|66038422|FG002|Dose Escalation Part|Enrolled but not treated|1|||
23631390|NCT01999972|66038423|FG003|Dose Escalation Part|Enrolled but not treated|1|||
23631391|NCT01999972|66038424|FG004|Dose Escalation Part|Enrolled but not treated|0|||
23631392|NCT01999972|66038425|FG005|Dose Escalation Part|Enrolled but not treated|0|||
23631393|NCT01999972|66038420|FG000|Dose Escalation Part|Disease progression|3|||
23631394|NCT01999972|66038421|FG001|Dose Escalation Part|Disease progression|2|||
23631395|NCT01999972|66038422|FG002|Dose Escalation Part|Disease progression|3|||
23631396|NCT01999972|66038423|FG003|Dose Escalation Part|Disease progression|6|||
23631397|NCT01999972|66038424|FG004|Dose Escalation Part|Disease progression|0|||
23631398|NCT01999972|66038425|FG005|Dose Escalation Part|Disease progression|0|||
23768666|NCT02130466|66531789|FG002|Overall Study|Withdrawal by Subject|0|||
23631399|NCT01999972|66038420|FG000|Dose Escalation Part|Adverse Event|0|||
23631400|NCT01999972|66038421|FG001|Dose Escalation Part|Adverse Event|0|||
23631401|NCT01999972|66038422|FG002|Dose Escalation Part|Adverse Event|0|||
23631402|NCT01999972|66038423|FG003|Dose Escalation Part|Adverse Event|2|||
23631403|NCT01999972|66038424|FG004|Dose Escalation Part|Adverse Event|0|||
23631404|NCT01999972|66038425|FG005|Dose Escalation Part|Adverse Event|0|||
23631405|NCT01999972|66038420|FG000|Dose Escalation Part|Global deterioration of health status|1|||
23631406|NCT01999972|66038421|FG001|Dose Escalation Part|Global deterioration of health status|0|||
23631407|NCT01999972|66038422|FG002|Dose Escalation Part|Global deterioration of health status|0|||
23631408|NCT01999972|66038423|FG003|Dose Escalation Part|Global deterioration of health status|1|||
23631409|NCT01999972|66038424|FG004|Dose Escalation Part|Global deterioration of health status|0|||
23631410|NCT01999972|66038425|FG005|Dose Escalation Part|Global deterioration of health status|0|||
23631411|NCT01999972|66038420|FG000|Dose Expansion Part|Death|0|||
23631412|NCT01999972|66038421|FG001|Dose Expansion Part|Death|0|||
23631413|NCT01999972|66038422|FG002|Dose Expansion Part|Death|0|||
23631414|NCT01999972|66038423|FG003|Dose Expansion Part|Death|0|||
23768667|NCT02130466|66531790|FG003|Overall Study|Withdrawal by Subject|0|||
23768668|NCT02130466|66531791|FG004|Overall Study|Withdrawal by Subject|0|||
23768669|NCT02130466|66531792|FG005|Overall Study|Withdrawal by Subject|1|||
23768670|NCT02130466|66531793|FG006|Overall Study|Withdrawal by Subject|0|||
23768671|NCT02130466|66531794|FG007|Overall Study|Withdrawal by Subject|0|||
23768672|NCT02130466|66531795|FG008|Overall Study|Withdrawal by Subject|1|||
23768673|NCT02130466|66531796|FG009|Overall Study|Withdrawal by Subject|0|||
23768674|NCT02130466|66531797|FG010|Overall Study|Withdrawal by Subject|0|||
23446917|NCT01253291|65377773|FG001|Overall Study|Physician Decision|0|||
23446918|NCT01253291|65377774|FG002|Overall Study|Physician Decision|0|||
23446919|NCT01253291|65377775|FG003|Overall Study|Physician Decision|0|||
23446920|NCT01253291|65377776|FG004|Overall Study|Physician Decision|2|||
23446921|NCT01362608|65377779|FG000|Overall Study|Protocol Violation|0|||
23631415|NCT01999972|66038424|FG004|Dose Expansion Part|Death|2|||
23768675|NCT02130466|66531798|FG011|Overall Study|Withdrawal by Subject|0|||
23768676|NCT02130466|66531799|FG012|Overall Study|Withdrawal by Subject|0|||
23768677|NCT02130466|66531800|FG013|Overall Study|Withdrawal by Subject|0|||
23631416|NCT01999972|66038425|FG005|Dose Expansion Part|Death|1|||
23631417|NCT01999972|66038420|FG000|Dose Expansion Part|Disease progression|0|||
23446922|NCT01362608|65377780|FG001|Overall Study|Protocol Violation|1|||
23446923|NCT01362608|65377779|FG000|Overall Study|Lost to Follow-up|3|||
23768678|NCT04583579|66531801|FG000|Overall Study|Lost to Follow-up|4|||
23768679|NCT02564263|66531802|FG000|Overall Study|Adverse Event|31|||
23768680|NCT02564263|66531803|FG001|Overall Study|Adverse Event|29|||
23768681|NCT02564263|66531802|FG000|Overall Study|Death|270|||
23768682|NCT02564263|66531803|FG001|Overall Study|Death|262|||
23768683|NCT02564263|66531802|FG000|Overall Study|Withdrawal by Subject|4|||
23768684|NCT02564263|66531803|FG001|Overall Study|Withdrawal by Subject|19|||
23768685|NCT02564263|66531802|FG000|Overall Study|Sponsor's decision|9|||
23768686|NCT02564263|66531803|FG001|Overall Study|Sponsor's decision|4|||
23768687|NCT02985151|66531804|FG000|Original Randomization|Withdrawal by Subject|0|||
23768688|NCT02985151|66531805|FG001|Original Randomization|Withdrawal by Subject|1|||
23768689|NCT00294723|66531808|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
23768690|NCT00294723|66531809|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
23768691|NCT00294723|66531810|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
23446924|NCT01362608|65377780|FG001|Overall Study|Lost to Follow-up|1|||
23446925|NCT01362608|65377779|FG000|Overall Study|Withdrawal by Subject|1|||
23446926|NCT01362608|65377780|FG001|Overall Study|Withdrawal by Subject|2|||
23446927|NCT01362608|65377779|FG000|Overall Study|Lack of Efficacy|0|||
23570128|NCT03580356|65816694|FG006|Treatment Period|Technical problems|0|||
23570129|NCT03580356|65816695|FG007|Treatment Period|Technical problems|0|||
23570130|NCT03580356|65816688|FG000|Treatment Period|Misrandomized, no treatment|0|||
23570131|NCT03580356|65816689|FG001|Treatment Period|Misrandomized, no treatment|0|||
23570132|NCT03580356|65816690|FG002|Treatment Period|Misrandomized, no treatment|1|||
23570133|NCT03580356|65816691|FG003|Treatment Period|Misrandomized, no treatment|0|||
23570134|NCT03580356|65816692|FG004|Treatment Period|Misrandomized, no treatment|2|||
23570135|NCT03580356|65816693|FG005|Treatment Period|Misrandomized, no treatment|0|||
23570136|NCT03580356|65816694|FG006|Treatment Period|Misrandomized, no treatment|0|||
23570137|NCT03580356|65816695|FG007|Treatment Period|Misrandomized, no treatment|0|||
23570138|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
23570139|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
23631418|NCT01999972|66038421|FG001|Dose Expansion Part|Disease progression|0|||
23768692|NCT00294723|66531808|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
23768693|NCT00294723|66531809|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
23768694|NCT00294723|66531810|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
23768695|NCT00294723|66531808|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
23768696|NCT00294723|66531809|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
23631419|NCT01999972|66038422|FG002|Dose Expansion Part|Disease progression|0|||
23446928|NCT01362608|65377780|FG001|Overall Study|Lack of Efficacy|2|||
23570140|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
23570141|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
23631420|NCT01999972|66038423|FG003|Dose Expansion Part|Disease progression|0|||
23631421|NCT01999972|66038424|FG004|Dose Expansion Part|Disease progression|9|||
23631422|NCT01999972|66038425|FG005|Dose Expansion Part|Disease progression|3|||
23631423|NCT01999972|66038420|FG000|Dose Expansion Part|Sponsor decision|0|||
23631424|NCT01999972|66038421|FG001|Dose Expansion Part|Sponsor decision|0|||
23631425|NCT01999972|66038422|FG002|Dose Expansion Part|Sponsor decision|0|||
23631426|NCT01999972|66038423|FG003|Dose Expansion Part|Sponsor decision|0|||
23631427|NCT01999972|66038424|FG004|Dose Expansion Part|Sponsor decision|1|||
23631428|NCT01999972|66038425|FG005|Dose Expansion Part|Sponsor decision|0|||
23631429|NCT01999972|66038420|FG000|Dose Expansion Part|Adverse Event|0|||
23631430|NCT01999972|66038421|FG001|Dose Expansion Part|Adverse Event|0|||
23631431|NCT01999972|66038422|FG002|Dose Expansion Part|Adverse Event|0|||
23631432|NCT01999972|66038423|FG003|Dose Expansion Part|Adverse Event|0|||
23631433|NCT01999972|66038424|FG004|Dose Expansion Part|Adverse Event|4|||
23830370|NCT03850483|66759942|FG001|Treatment for Stage 1|Adverse Event|1|||
23830371|NCT03850483|66759943|FG002|Treatment for Stage 1|Adverse Event|3|||
23830372|NCT03850483|66759944|FG003|Treatment for Stage 1|Adverse Event|0|||
23830373|NCT03850483|66759945|FG004|Treatment for Stage 1|Adverse Event|2|||
23830374|NCT03850483|66759946|FG005|Treatment for Stage 1|Adverse Event|0|||
23830375|NCT03850483|66759947|FG006|Treatment for Stage 1|Adverse Event|2|||
23830376|NCT03850483|66759948|FG007|Treatment for Stage 1|Adverse Event|2|||
23830377|NCT03850483|66759949|FG008|Treatment for Stage 1|Adverse Event|0|||
23830378|NCT03850483|66759950|FG009|Treatment for Stage 1|Adverse Event|0|||
23830379|NCT03850483|66759941|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
23830380|NCT03850483|66759942|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
23830381|NCT03850483|66759943|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
23830382|NCT03850483|66759944|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
23830383|NCT03850483|66759945|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
23830384|NCT03850483|66759946|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
23830385|NCT03850483|66759947|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
23830386|NCT03850483|66759948|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
23830387|NCT03850483|66759949|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
23830388|NCT03850483|66759950|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
23830389|NCT03850483|66759941|FG000|Treatment for Stage 1|Protocol Violation|1|||
23830390|NCT03850483|66759942|FG001|Treatment for Stage 1|Protocol Violation|0|||
23830391|NCT03850483|66759943|FG002|Treatment for Stage 1|Protocol Violation|0|||
23830392|NCT03850483|66759944|FG003|Treatment for Stage 1|Protocol Violation|0|||
23446929|NCT01362608|65377779|FG000|Overall Study|Adverse Event|0|||
23570142|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
23570143|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
23570144|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
23570145|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
23570146|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
23570147|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570148|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
23570149|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570150|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
23570151|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570152|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570153|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570154|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
23570155|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
23570156|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
23570157|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
23570158|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
23570159|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
23570160|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
23570161|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
23570162|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570163|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570164|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
23570165|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570166|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
23570167|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23830393|NCT03850483|66759945|FG004|Treatment for Stage 1|Protocol Violation|0|||
23830394|NCT03850483|66759946|FG005|Treatment for Stage 1|Protocol Violation|0|||
23631434|NCT01999972|66038425|FG005|Dose Expansion Part|Adverse Event|2|||
23631435|NCT01999972|66038420|FG000|Dose Expansion Part|Participant's non-compliance|0|||
23830395|NCT03850483|66759947|FG006|Treatment for Stage 1|Protocol Violation|1|||
23830396|NCT03850483|66759948|FG007|Treatment for Stage 1|Protocol Violation|0|||
23570168|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570169|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570170|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
23570171|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
23570172|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
23570173|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
23570174|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
23570175|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
23570176|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
23570177|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
23570178|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
23570179|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
23570180|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
23570181|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
23570182|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
23570183|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
23570184|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
23570185|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
23570186|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
23570187|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
23570188|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
23570189|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
23570190|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
23570191|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
23631436|NCT01999972|66038421|FG001|Dose Expansion Part|Participant's non-compliance|0|||
23631437|NCT01999972|66038422|FG002|Dose Expansion Part|Participant's non-compliance|0|||
23631438|NCT01999972|66038423|FG003|Dose Expansion Part|Participant's non-compliance|0|||
23631439|NCT01999972|66038424|FG004|Dose Expansion Part|Participant's non-compliance|0|||
23631440|NCT01999972|66038425|FG005|Dose Expansion Part|Participant's non-compliance|1|||
23631441|NCT01999972|66038420|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
23631442|NCT01999972|66038421|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
23631443|NCT01999972|66038422|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
23631444|NCT01999972|66038423|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
23631445|NCT01999972|66038424|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
23631446|NCT01999972|66038425|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
23631447|NCT01999972|66038420|FG000|Dose Expansion Part|Changed to standard of care|0|||
23631448|NCT01999972|66038421|FG001|Dose Expansion Part|Changed to standard of care|0|||
23631449|NCT01999972|66038422|FG002|Dose Expansion Part|Changed to standard of care|0|||
23768697|NCT00294723|66531810|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
23768698|NCT00294723|66531808|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
23768699|NCT00294723|66531809|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
23768700|NCT00294723|66531810|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
23768701|NCT00294723|66531808|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
23768702|NCT00294723|66531809|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
23768703|NCT00294723|66531810|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
23768704|NCT00294723|66531808|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
23768705|NCT00294723|66531809|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
23768706|NCT00294723|66531810|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
23768707|NCT00294723|66531808|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
23768708|NCT00294723|66531809|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
23768709|NCT00294723|66531810|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
23768710|NCT00294723|66531808|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
23768711|NCT00294723|66531809|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
23768712|NCT00294723|66531810|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
23768713|NCT00294723|66531808|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
23570192|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
23631450|NCT01999972|66038423|FG003|Dose Expansion Part|Changed to standard of care|0|||
23631451|NCT01999972|66038424|FG004|Dose Expansion Part|Changed to standard of care|1|||
23631452|NCT01999972|66038425|FG005|Dose Expansion Part|Changed to standard of care|0|||
23631453|NCT04343976|66038426|FG000|Overall Study|Withdrawal by Subject|0|||
23631454|NCT04343976|66038427|FG001|Overall Study|Withdrawal by Subject|1|||
23631455|NCT00643617|66038432|FG000|Overall Study|Death|6|||
23631456|NCT00643617|66038433|FG001|Overall Study|Death|9|||
23631457|NCT00643617|66038432|FG000|Overall Study|Lost to Follow-up|42|||
23631458|NCT00643617|66038433|FG001|Overall Study|Lost to Follow-up|51|||
23631459|NCT00513708|66038434|FG000|Overall Study|Lost to Follow-up|4|||
23631460|NCT00513708|66038435|FG001|Overall Study|Lost to Follow-up|4|||
23631461|NCT00513708|66038436|FG002|Overall Study|Lost to Follow-up|4|||
23631462|NCT04206085|66038446|FG000|Overall Study|Lost to Follow-up|0|||
23631463|NCT04206085|66038447|FG001|Overall Study|Lost to Follow-up|1|||
23631464|NCT04206085|66038448|FG002|Overall Study|Lost to Follow-up|0|||
23631465|NCT04206085|66038446|FG000|Overall Study|Lost to Follow-up|0|||
23631466|NCT04206085|66038447|FG001|Overall Study|Lost to Follow-up|0|||
23631467|NCT04206085|66038448|FG002|Overall Study|Lost to Follow-up|1|||
23631468|NCT01967069|66038449|FG000|Overall Study|Adverse Event|2|||
23631469|NCT01967069|66038450|FG001|Overall Study|Adverse Event|2|||
23631470|NCT01967069|66038449|FG000|Overall Study|Lost to Follow-up|5|||
23631471|NCT01967069|66038450|FG001|Overall Study|Lost to Follow-up|2|||
23631472|NCT01967069|66038449|FG000|Overall Study|Withdrawal by Subject|1|||
23631473|NCT01967069|66038450|FG001|Overall Study|Withdrawal by Subject|3|||
23631474|NCT01967069|66038449|FG000|Overall Study|Lack of Efficacy|0|||
23631475|NCT01967069|66038450|FG001|Overall Study|Lack of Efficacy|1|||
23631476|NCT00487825|66038454|FG000|Overall Study|Adverse Event|2|||
23631477|NCT00487825|66038455|FG001|Overall Study|Adverse Event|2|||
23631478|NCT00487825|66038454|FG000|Overall Study|Lack of Efficacy|1|||
23631479|NCT00487825|66038455|FG001|Overall Study|Lack of Efficacy|1|||
23631480|NCT00487825|66038454|FG000|Overall Study|Other|3|||
23631481|NCT00487825|66038455|FG001|Overall Study|Other|2|||
23631482|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23631483|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23631484|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23631485|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
23631486|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23631487|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
23631488|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
23631489|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
23631490|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
23631491|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
23631492|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
23631493|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
23631494|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
23631495|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
23631496|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631497|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631498|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631499|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631500|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631501|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23631502|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
23631503|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23631504|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23631505|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
23631506|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23631507|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23768714|NCT00294723|66531809|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
23631508|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23631509|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23768715|NCT00294723|66531810|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
23768716|NCT00294723|66531808|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
23768717|NCT00294723|66531809|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
23768718|NCT00294723|66531810|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
23631510|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23631511|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23631512|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23636672|NCT00734591|66052958|FG001|Prospective Period|Withdrawal by Subject|9|||
23570193|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
23570194|NCT02036515|65816701|FG000|Overall Study|Adverse Event|1|||
23570195|NCT02036515|65816702|FG001|Overall Study|Adverse Event|1|||
23570196|NCT02036515|65816703|FG002|Overall Study|Adverse Event|2|||
23570197|NCT02036515|65816701|FG000|Overall Study|Lost to Follow-up|0|||
23570198|NCT02036515|65816702|FG001|Overall Study|Lost to Follow-up|2|||
23570199|NCT02036515|65816703|FG002|Overall Study|Lost to Follow-up|0|||
23570200|NCT02036515|65816701|FG000|Overall Study|Non-compliance with study drug|0|||
23631513|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23631514|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
23631515|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23631516|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23631517|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23631518|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
23631519|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23631520|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23631521|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23631522|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23768719|NCT00294723|66531808|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23570201|NCT02036515|65816702|FG001|Overall Study|Non-compliance with study drug|0|||
23570202|NCT02036515|65816703|FG002|Overall Study|Non-compliance with study drug|2|||
23570203|NCT02036515|65816701|FG000|Overall Study|Screen failure|0|||
23570204|NCT02036515|65816702|FG001|Overall Study|Screen failure|2|||
23768720|NCT00294723|66531809|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23768721|NCT00294723|66531810|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23768722|NCT00294723|66531808|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
23768723|NCT00294723|66531809|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
23768724|NCT00294723|66531810|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
23768725|NCT00282256|66531811|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
23768726|NCT00282256|66531811|FG000|Extension Treatment Period|Adverse Event|2|||
23768727|NCT01478620|66531826|FG000|Overall Study|Lost to Follow-up|6|||
23768728|NCT03504852|66531827|FG000|Overall Study|Withdrawal of informed consent|2|||
23768729|NCT03504852|66531828|FG001|Overall Study|Withdrawal of informed consent|1|||
23768730|NCT03504852|66531829|FG002|Overall Study|Withdrawal of informed consent|0|||
23768731|NCT03504852|66531827|FG000|Overall Study|Withdrawal by Subject|5|||
23768732|NCT03504852|66531828|FG001|Overall Study|Withdrawal by Subject|5|||
23768733|NCT03504852|66531829|FG002|Overall Study|Withdrawal by Subject|1|||
23768734|NCT03504852|66531827|FG000|Overall Study|Lost to Follow-up|4|||
23768735|NCT03504852|66531828|FG001|Overall Study|Lost to Follow-up|1|||
23768736|NCT03504852|66531829|FG002|Overall Study|Lost to Follow-up|0|||
23768737|NCT03504852|66531827|FG000|Overall Study|New therapy for study indication|1|||
23570205|NCT02036515|65816703|FG002|Overall Study|Screen failure|0|||
23570206|NCT02036515|65816701|FG000|Overall Study|Withdrawal by Subject|4|||
23570207|NCT02036515|65816702|FG001|Overall Study|Withdrawal by Subject|7|||
23570208|NCT02036515|65816703|FG002|Overall Study|Withdrawal by Subject|9|||
23570209|NCT02036515|65816701|FG000|Overall Study|Hyperglycemia|0|||
23570210|NCT02036515|65816702|FG001|Overall Study|Hyperglycemia|0|||
23570211|NCT02036515|65816703|FG002|Overall Study|Hyperglycemia|1|||
23570212|NCT02440594|65816704|FG000|Overall Study|Lost to Follow-up|34|||
23570213|NCT02440594|65816705|FG001|Overall Study|Lost to Follow-up|33|||
23570214|NCT02440594|65816706|FG002|Overall Study|Lost to Follow-up|54|||
23570215|NCT02440594|65816707|FG003|Overall Study|Lost to Follow-up|47|||
23768738|NCT03504852|66531828|FG001|Overall Study|New therapy for study indication|0|||
23768739|NCT03504852|66531829|FG002|Overall Study|New therapy for study indication|0|||
23768740|NCT03504852|66531827|FG000|Overall Study|Lack of Efficacy|1|||
23768741|NCT03504852|66531828|FG001|Overall Study|Lack of Efficacy|2|||
23768742|NCT03504852|66531829|FG002|Overall Study|Lack of Efficacy|0|||
23768743|NCT03504852|66531827|FG000|Overall Study|Death|0|||
23768744|NCT03504852|66531828|FG001|Overall Study|Death|1|||
23768745|NCT03504852|66531829|FG002|Overall Study|Death|0|||
23768746|NCT03504852|66531827|FG000|Overall Study|Adverse Event|4|||
23768747|NCT03504852|66531828|FG001|Overall Study|Adverse Event|8|||
23768748|NCT03504852|66531829|FG002|Overall Study|Adverse Event|2|||
23768749|NCT02674334|66531830|FG000|Overall Study|Lost to Follow-up|5|||
23768750|NCT02674334|66531831|FG001|Overall Study|Lost to Follow-up|3|||
23768751|NCT02674334|66531830|FG000|Overall Study|participant difficulty breathing|1|||
23768752|NCT02674334|66531831|FG001|Overall Study|participant difficulty breathing|0|||
23768753|NCT02674334|66531830|FG000|Overall Study|NIRS not recording|1|||
23768754|NCT02674334|66531831|FG001|Overall Study|NIRS not recording|0|||
23768755|NCT02896361|66531836|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
23768756|NCT02896361|66531837|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
23768757|NCT02896361|66531838|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
23768758|NCT02896361|66531836|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
23768759|NCT02896361|66531837|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
23768760|NCT02896361|66531838|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
23768761|NCT01808209|66531839|FG000|Overall Study|Lost to Follow-up|0|||
23570216|NCT02440594|65816708|FG004|Overall Study|Lost to Follow-up|5|||
23570217|NCT02440594|65816709|FG005|Overall Study|Lost to Follow-up|4|||
23570218|NCT02440594|65816710|FG006|Overall Study|Lost to Follow-up|28|||
23570219|NCT02440594|65816711|FG007|Overall Study|Lost to Follow-up|48|||
23768762|NCT01808209|66531840|FG001|Overall Study|Lost to Follow-up|1|||
23768763|NCT01485536|66531841|FG000|Overall Study|Withdrawal by Subject|3|||
23768764|NCT01485536|66531841|FG000|Overall Study|Adverse Event|1|||
23768765|NCT01247922|66531842|FG000|Overall Study|Disease progression|4|||
23768766|NCT00536575|66531845|FG000|Overall Study|Withdrawal by Subject|1|||
23768767|NCT00536575|66531845|FG000|Overall Study|Death|1|||
23768768|NCT01595009|66531853|FG000|Core|Patients completed per protocol|85|||
23768769|NCT01595009|66531854|FG001|Core|Patients completed per protocol|44|||
23768770|NCT01595009|66531855|FG002|Core|Patients completed per protocol|0|||
23570220|NCT02440594|65816704|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
23570221|NCT02440594|65816705|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
23570222|NCT02440594|65816706|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
23570223|NCT02440594|65816707|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
23768771|NCT01595009|66531856|FG003|Core|Patients completed per protocol|0|||
23768772|NCT01595009|66531853|FG000|Core|Adverse Event|19|||
23768773|NCT01595009|66531854|FG001|Core|Adverse Event|23|||
23768774|NCT01595009|66531855|FG002|Core|Adverse Event|0|||
23768775|NCT01595009|66531856|FG003|Core|Adverse Event|0|||
23768776|NCT01595009|66531853|FG000|Core|Disease progression|14|||
23768777|NCT01595009|66531854|FG001|Core|Disease progression|26|||
23768778|NCT01595009|66531855|FG002|Core|Disease progression|0|||
23768779|NCT01595009|66531856|FG003|Core|Disease progression|0|||
23768780|NCT01595009|66531853|FG000|Core|Withdrawal by Subject|4|||
23768781|NCT01595009|66531854|FG001|Core|Withdrawal by Subject|17|||
23570224|NCT02440594|65816708|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
23570225|NCT02440594|65816709|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
23570226|NCT02440594|65816710|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
23570227|NCT02440594|65816711|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
23570228|NCT02440594|65816704|FG000|Overall Study|Withdrawal by Subject|81|||
23570229|NCT02440594|65816705|FG001|Overall Study|Withdrawal by Subject|67|||
23570230|NCT02440594|65816706|FG002|Overall Study|Withdrawal by Subject|59|||
23570231|NCT02440594|65816707|FG003|Overall Study|Withdrawal by Subject|38|||
23570232|NCT02440594|65816708|FG004|Overall Study|Withdrawal by Subject|2|||
23570233|NCT02440594|65816709|FG005|Overall Study|Withdrawal by Subject|2|||
23570234|NCT02440594|65816710|FG006|Overall Study|Withdrawal by Subject|7|||
23570235|NCT02440594|65816711|FG007|Overall Study|Withdrawal by Subject|7|||
23570236|NCT02440594|65816704|FG000|Overall Study|Administratively w/drawn|3|||
23768782|NCT01595009|66531855|FG002|Core|Withdrawal by Subject|0|||
23768783|NCT01595009|66531856|FG003|Core|Withdrawal by Subject|0|||
23768784|NCT01595009|66531853|FG000|Core|Death|3|||
23768785|NCT01595009|66531854|FG001|Core|Death|6|||
23768786|NCT01595009|66531855|FG002|Core|Death|0|||
23768787|NCT01595009|66531856|FG003|Core|Death|0|||
23768788|NCT01595009|66531853|FG000|Core|Lost to Follow-up|1|||
23768789|NCT01595009|66531854|FG001|Core|Lost to Follow-up|2|||
23768790|NCT01595009|66531855|FG002|Core|Lost to Follow-up|0|||
23768791|NCT01595009|66531856|FG003|Core|Lost to Follow-up|0|||
23768792|NCT01595009|66531853|FG000|Core|Protocol deviation|0|||
23768793|NCT01595009|66531854|FG001|Core|Protocol deviation|1|||
23768794|NCT01595009|66531855|FG002|Core|Protocol deviation|0|||
23768795|NCT01595009|66531856|FG003|Core|Protocol deviation|0|||
23768796|NCT01595009|66531853|FG000|Core|Administrative problems|0|||
23768797|NCT01595009|66531854|FG001|Core|Administrative problems|1|||
23768798|NCT01595009|66531855|FG002|Core|Administrative problems|0|||
23768799|NCT01595009|66531856|FG003|Core|Administrative problems|0|||
23768800|NCT01595009|66531853|FG000|Extension|Administrative problems|0|||
23768801|NCT01595009|66531854|FG001|Extension|Administrative problems|0|||
23768802|NCT01595009|66531855|FG002|Extension|Administrative problems|0|||
23768803|NCT01595009|66531856|FG003|Extension|Administrative problems|1|||
23768804|NCT01595009|66531853|FG000|Extension|Patients completed per protocol|0|||
23768805|NCT01595009|66531854|FG001|Extension|Patients completed per protocol|0|||
23768806|NCT01595009|66531855|FG002|Extension|Patients completed per protocol|0|||
23768807|NCT01595009|66531856|FG003|Extension|Patients completed per protocol|2|||
23768808|NCT01595009|66531853|FG000|Extension|Disease progression|0|||
23768809|NCT01595009|66531854|FG001|Extension|Disease progression|0|||
23768810|NCT01595009|66531855|FG002|Extension|Disease progression|4|||
23768811|NCT01595009|66531856|FG003|Extension|Disease progression|7|||
23768812|NCT01595009|66531853|FG000|Extension|Adverse Event|0|||
23570237|NCT02440594|65816705|FG001|Overall Study|Administratively w/drawn|2|||
23570238|NCT02440594|65816706|FG002|Overall Study|Administratively w/drawn|0|||
23446930|NCT01362608|65377780|FG001|Overall Study|Adverse Event|2|||
23446931|NCT04303572|65377781|FG000|Overall Study|Study closed due to poor enrollment|1|||
23570239|NCT02440594|65816707|FG003|Overall Study|Administratively w/drawn|0|||
23570240|NCT02440594|65816708|FG004|Overall Study|Administratively w/drawn|0|||
23570241|NCT02440594|65816709|FG005|Overall Study|Administratively w/drawn|0|||
23570242|NCT02440594|65816710|FG006|Overall Study|Administratively w/drawn|2|||
23768813|NCT01595009|66531854|FG001|Extension|Adverse Event|0|||
23768814|NCT01595009|66531855|FG002|Extension|Adverse Event|0|||
23768815|NCT01595009|66531856|FG003|Extension|Adverse Event|1|||
23768816|NCT04588259|66531867|FG000|Run-in Period|Run-in failure|0|||
23768817|NCT04588259|66531868|FG001|Run-in Period|Run-in failure|23|||
23768818|NCT04588259|66531867|FG000|Run-in Period|Withdrawn before randomisation|0|||
23768819|NCT04588259|66531868|FG001|Run-in Period|Withdrawn before randomisation|8|||
23768820|NCT04588259|66531867|FG000|Treatment Period|Withdrawal by Subject|6|||
23446932|NCT01633541|65377790|FG000|Overall Study|Death|1|||
23768821|NCT04588259|66531868|FG001|Treatment Period|Withdrawal by Subject|6|||
23768822|NCT01691248|66531871|FG000|Overall Study|Protocol Violation|43|||
23768823|NCT01691248|66531872|FG001|Overall Study|Protocol Violation|27|||
23830397|NCT03850483|66759949|FG008|Treatment for Stage 1|Protocol Violation|0|||
23830398|NCT03850483|66759950|FG009|Treatment for Stage 1|Protocol Violation|0|||
23830399|NCT03850483|66759941|FG000|Treatment for Stage 1|Physician Decision|0|||
23830400|NCT03850483|66759942|FG001|Treatment for Stage 1|Physician Decision|0|||
23830401|NCT03850483|66759943|FG002|Treatment for Stage 1|Physician Decision|0|||
23830402|NCT03850483|66759944|FG003|Treatment for Stage 1|Physician Decision|0|||
23830403|NCT03850483|66759945|FG004|Treatment for Stage 1|Physician Decision|0|||
23830404|NCT03850483|66759946|FG005|Treatment for Stage 1|Physician Decision|1|||
23830405|NCT03850483|66759947|FG006|Treatment for Stage 1|Physician Decision|0|||
23768824|NCT01691248|66531871|FG000|Overall Study|Adverse Event|24|||
23768825|NCT01691248|66531872|FG001|Overall Study|Adverse Event|22|||
23768826|NCT01691248|66531871|FG000|Overall Study|Withdrawal by Subject|20|||
23768827|NCT01691248|66531872|FG001|Overall Study|Withdrawal by Subject|18|||
23768828|NCT01691248|66531871|FG000|Overall Study|Confirmed CDAD|14|||
23768829|NCT01691248|66531872|FG001|Overall Study|Confirmed CDAD|31|||
23631523|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23631524|NCT01888874|66038456|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23768830|NCT01691248|66531871|FG000|Overall Study|Lost to Follow-up|2|||
23631525|NCT01888874|66038457|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
23768831|NCT01691248|66531872|FG001|Overall Study|Lost to Follow-up|5|||
23768832|NCT01691248|66531871|FG000|Overall Study|Reason not provided|4|||
23768833|NCT01691248|66531872|FG001|Overall Study|Reason not provided|4|||
23768834|NCT01691248|66531871|FG000|Overall Study|Not Treated|4|||
23768835|NCT01691248|66531872|FG001|Overall Study|Not Treated|7|||
23768836|NCT00586521|66531873|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
23768837|NCT02204371|66531878|FG000|Overall Study|Adverse Event|1|||
23768838|NCT03882047|66531881|FG000|Overall Study|Adverse Event|0|||
23768839|NCT03882047|66531882|FG001|Overall Study|Adverse Event|2|||
23768840|NCT03882047|66531883|FG002|Overall Study|Adverse Event|2|||
23768841|NCT03882047|66531881|FG000|Overall Study|Treatment Failure|3|||
23768842|NCT03882047|66531882|FG001|Overall Study|Treatment Failure|3|||
23768843|NCT03882047|66531883|FG002|Overall Study|Treatment Failure|12|||
23768844|NCT03882047|66531881|FG000|Overall Study|Lost to Follow-up|0|||
23768845|NCT03882047|66531882|FG001|Overall Study|Lost to Follow-up|1|||
23768846|NCT03882047|66531883|FG002|Overall Study|Lost to Follow-up|0|||
23768847|NCT03882047|66531881|FG000|Overall Study|Did Not Wish to Continue|1|||
23768848|NCT03882047|66531882|FG001|Overall Study|Did Not Wish to Continue|4|||
23768849|NCT03882047|66531883|FG002|Overall Study|Did Not Wish to Continue|1|||
23830406|NCT03850483|66759948|FG007|Treatment for Stage 1|Physician Decision|0|||
23631526|NCT01888874|66038458|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23631527|NCT01888874|66038459|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23631528|NCT01888874|66038460|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23631529|NCT01888874|66038461|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
23631530|NCT01888874|66038462|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23631531|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23768850|NCT03882047|66531881|FG000|Overall Study|Noncompliance With Protocol|2|||
23768851|NCT03882047|66531882|FG001|Overall Study|Noncompliance With Protocol|0|||
23768852|NCT03882047|66531883|FG002|Overall Study|Noncompliance With Protocol|0|||
23768853|NCT03882047|66531881|FG000|Overall Study|Did Not Meet Eligibility|0|||
23768854|NCT03882047|66531882|FG001|Overall Study|Did Not Meet Eligibility|0|||
23768855|NCT03882047|66531883|FG002|Overall Study|Did Not Meet Eligibility|1|||
23768856|NCT00721409|66531884|FG000|Overall Study|Global deterioration of health status|2|||
23830407|NCT03850483|66759949|FG008|Treatment for Stage 1|Physician Decision|0|||
23830408|NCT03850483|66759950|FG009|Treatment for Stage 1|Physician Decision|0|||
23830409|NCT03850483|66759941|FG000|Treatment for Stage 1|Other|0|||
23830410|NCT03850483|66759942|FG001|Treatment for Stage 1|Other|0|||
23631532|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23631533|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
23631534|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23631535|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23631536|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23631537|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23631538|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631539|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631540|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631541|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631542|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
23631543|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631544|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23631545|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23768857|NCT00721409|66531885|FG001|Overall Study|Global deterioration of health status|6|||
23768858|NCT00721409|66531886|FG002|Overall Study|Global deterioration of health status|3|||
23768859|NCT00721409|66531884|FG000|Overall Study|Death|0|||
23768860|NCT00721409|66531885|FG001|Overall Study|Death|1|||
23768861|NCT00721409|66531886|FG002|Overall Study|Death|0|||
23768862|NCT00721409|66531884|FG000|Overall Study|Randomized not Treated|0|||
23768863|NCT00721409|66531885|FG001|Overall Study|Randomized not Treated|1|||
23768864|NCT00721409|66531886|FG002|Overall Study|Randomized not Treated|4|||
23768865|NCT00721409|66531884|FG000|Overall Study|Reason not specified|1|||
23768866|NCT00721409|66531885|FG001|Overall Study|Reason not specified|0|||
23768867|NCT00721409|66531886|FG002|Overall Study|Reason not specified|2|||
23768868|NCT00721409|66531884|FG000|Overall Study|Adverse Event|0|||
23570243|NCT02440594|65816711|FG007|Overall Study|Administratively w/drawn|1|||
23570244|NCT01827254|65816712|FG000|Overall Study|Death|10|||
23570245|NCT01827254|65816712|FG000|Overall Study|Case report form not completed|4|||
23570246|NCT01827254|65816712|FG000|Overall Study|Invalidated centre|3|||
23570247|NCT01827254|65816712|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
23570248|NCT01827254|65816712|FG000|Overall Study|Did not complete re-challenge|1|||
23570249|NCT01827254|65816712|FG000|Overall Study|Disease progression|36|||
23570250|NCT01827254|65816712|FG000|Overall Study|Intolerance to treatment|4|||
23570251|NCT02374593|65816713|FG000|Overall Study|non-compliant|2|||
23570252|NCT02374593|65816714|FG001|Overall Study|non-compliant|0|||
23570253|NCT00663962|65816715|FG000|Overall Study|somnolence|1|||
23570254|NCT00663962|65816716|FG001|Overall Study|somnolence|0|||
23570255|NCT00661258|65816717|FG000|Overall Study|Death|1|||
23570256|NCT00661258|65816718|FG001|Overall Study|Death|0|||
23570257|NCT00661258|65816717|FG000|Overall Study|caught by police and in detox center|2|||
23570258|NCT00661258|65816718|FG001|Overall Study|caught by police and in detox center|1|||
23570259|NCT01000376|65816721|FG000|Cycle 1 Day 1|Adverse Event|1|||
23570260|NCT01000376|65816722|FG001|Cycle 1 Day 1|Adverse Event|0|||
23570261|NCT01000376|65816721|FG000|Cycle 1 Day 1|Progressive Disease|1|||
23570262|NCT01000376|65816722|FG001|Cycle 1 Day 1|Progressive Disease|0|||
23570263|NCT01544582|65816723|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
23570264|NCT01544582|65816724|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570265|NCT01544582|65816725|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570266|NCT01544582|65816726|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570267|NCT01544582|65816723|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
23570268|NCT01544582|65816724|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570269|NCT01544582|65816725|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570270|NCT01544582|65816726|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570271|NCT01544582|65816723|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
23570272|NCT01544582|65816724|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
23570273|NCT01544582|65816725|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
23570274|NCT01544582|65816726|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
23570275|NCT01544582|65816723|FG000|Analysis Population|Physician Decision|0|||
23570276|NCT01544582|65816724|FG001|Analysis Population|Physician Decision|13|||
23570277|NCT01544582|65816725|FG002|Analysis Population|Physician Decision|10|||
23570278|NCT01544582|65816726|FG003|Analysis Population|Physician Decision|9|||
23570279|NCT01544582|65816723|FG000|Analysis Population|Safety Reason|0|||
23570280|NCT01544582|65816724|FG001|Analysis Population|Safety Reason|33|||
23570281|NCT01544582|65816725|FG002|Analysis Population|Safety Reason|31|||
23570282|NCT01544582|65816726|FG003|Analysis Population|Safety Reason|8|||
23570283|NCT01544582|65816723|FG000|Analysis Population|Effectiveness Reason|0|||
23570284|NCT01544582|65816724|FG001|Analysis Population|Effectiveness Reason|48|||
23570285|NCT01544582|65816725|FG002|Analysis Population|Effectiveness Reason|29|||
23570286|NCT01544582|65816726|FG003|Analysis Population|Effectiveness Reason|12|||
23768869|NCT00721409|66531885|FG001|Overall Study|Adverse Event|13|||
23830411|NCT03850483|66759943|FG002|Treatment for Stage 1|Other|0|||
23631546|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23631547|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
23631548|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23631549|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23631550|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
23631551|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23631552|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631553|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631554|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
23631555|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631556|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631557|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631558|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23631559|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23631560|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
23631561|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23631562|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23631563|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23631564|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23570287|NCT01544582|65816723|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23570288|NCT01544582|65816724|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23631565|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23631566|NCT01888874|66038456|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23631567|NCT01888874|66038457|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
23631568|NCT01888874|66038458|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23631569|NCT01888874|66038459|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23570289|NCT01544582|65816725|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23570290|NCT01544582|65816726|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
23446933|NCT01633541|65377791|FG001|Overall Study|Death|0|||
23446934|NCT02043938|65377804|FG000|Overall Study|Withdrawal by Subject|7|||
23446935|NCT02043938|65377804|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
23570291|NCT01544582|65816723|FG000|Analysis Population|Lost to Follow-up|0|||
23570292|NCT01544582|65816724|FG001|Analysis Population|Lost to Follow-up|6|||
23570293|NCT01544582|65816725|FG002|Analysis Population|Lost to Follow-up|6|||
23570294|NCT01544582|65816726|FG003|Analysis Population|Lost to Follow-up|5|||
23570295|NCT01544582|65816723|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
23570296|NCT01544582|65816724|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
23570297|NCT01544582|65816725|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
23570298|NCT01544582|65816726|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
23631570|NCT01888874|66038460|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23631571|NCT01888874|66038461|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
23631572|NCT01888874|66038462|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23631573|NCT00243074|66038466|FG000|Overall Study|Ineligible|6|||
23631574|NCT00243074|66038466|FG000|Overall Study|Adverse Event|6|||
23570299|NCT01544582|65816723|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570300|NCT01544582|65816724|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570301|NCT01544582|65816725|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
23570302|NCT01544582|65816726|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570303|NCT01544582|65816723|FG000|Analysis Population|Intolerance|0|||
23570304|NCT01544582|65816724|FG001|Analysis Population|Intolerance|1|||
23570305|NCT01544582|65816725|FG002|Analysis Population|Intolerance|0|||
23570306|NCT01544582|65816726|FG003|Analysis Population|Intolerance|0|||
23570307|NCT01544582|65816723|FG000|Analysis Population|Liver Transplantation|0|||
23570308|NCT01544582|65816724|FG001|Analysis Population|Liver Transplantation|0|||
23631575|NCT00243074|66038466|FG000|Overall Study|Withdrawal by Subject|2|||
23768870|NCT00721409|66531886|FG002|Overall Study|Adverse Event|2|||
23768871|NCT00721409|66531884|FG000|Overall Study|Lost to Follow-up|0|||
23631576|NCT00243074|66038466|FG000|Overall Study|Lack of Efficacy|36|||
23631577|NCT00243074|66038466|FG000|Overall Study|Death|2|||
23768872|NCT00721409|66531885|FG001|Overall Study|Lost to Follow-up|0|||
23446936|NCT02043938|65377804|FG000|Overall Study|No show by subject|1|||
23631578|NCT00243074|66038466|FG000|Overall Study|not protocol specified|1|||
23631579|NCT00243074|66038466|FG000|Overall Study|Did not receive any treatment|1|||
23631580|NCT00706654|66038468|FG000|Conversion Phase|Lost to Follow-up|4|||
23768873|NCT00721409|66531886|FG002|Overall Study|Lost to Follow-up|1|||
23768874|NCT00721409|66531884|FG000|Overall Study|Withdrawal by Subject|1|||
23570309|NCT01544582|65816725|FG002|Analysis Population|Liver Transplantation|1|||
23570310|NCT01544582|65816726|FG003|Analysis Population|Liver Transplantation|0|||
23631581|NCT00706654|66038469|FG001|Conversion Phase|Lost to Follow-up|0|||
23631582|NCT00706654|66038470|FG002|Conversion Phase|Lost to Follow-up|0|||
23446937|NCT02043938|65377804|FG000|Overall Study|Investigator decision|1|||
23570311|NCT01544582|65816723|FG000|Analysis Population|No Social Insurance|0|||
23570312|NCT01544582|65816724|FG001|Analysis Population|No Social Insurance|0|||
23570313|NCT01544582|65816725|FG002|Analysis Population|No Social Insurance|1|||
23570314|NCT01544582|65816726|FG003|Analysis Population|No Social Insurance|0|||
23570315|NCT01544582|65816723|FG000|Analysis Population|Poor Adherence|0|||
23570316|NCT01544582|65816724|FG001|Analysis Population|Poor Adherence|0|||
23570317|NCT01544582|65816725|FG002|Analysis Population|Poor Adherence|1|||
23570318|NCT01544582|65816726|FG003|Analysis Population|Poor Adherence|0|||
23570319|NCT01544582|65816723|FG000|Analysis Population|Poor Participant Compliance|0|||
23570320|NCT01544582|65816724|FG001|Analysis Population|Poor Participant Compliance|1|||
23570321|NCT01544582|65816725|FG002|Analysis Population|Poor Participant Compliance|0|||
23570322|NCT01544582|65816726|FG003|Analysis Population|Poor Participant Compliance|0|||
23570323|NCT01544582|65816723|FG000|Analysis Population|Programmed Surgery|0|||
23570324|NCT01544582|65816724|FG001|Analysis Population|Programmed Surgery|1|||
23570325|NCT01544582|65816725|FG002|Analysis Population|Programmed Surgery|0|||
23570326|NCT01544582|65816726|FG003|Analysis Population|Programmed Surgery|0|||
23570327|NCT01544582|65816723|FG000|Analysis Population|Participant in Jail|0|||
23570328|NCT01544582|65816724|FG001|Analysis Population|Participant in Jail|0|||
23570329|NCT01544582|65816725|FG002|Analysis Population|Participant in Jail|1|||
23570330|NCT01544582|65816726|FG003|Analysis Population|Participant in Jail|0|||
23570331|NCT03875911|65816729|FG000|Overall Study|Lost to Follow-up|3|||
23570332|NCT03875911|65816730|FG001|Overall Study|Lost to Follow-up|6|||
23570333|NCT03875911|65816731|FG002|Overall Study|Lost to Follow-up|2|||
23570334|NCT03875911|65816729|FG000|Overall Study|Surgery cancelled|1|||
23570335|NCT03875911|65816730|FG001|Overall Study|Surgery cancelled|0|||
23570336|NCT03875911|65816731|FG002|Overall Study|Surgery cancelled|1|||
23570337|NCT03875911|65816729|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
23570338|NCT03875911|65816730|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
23570339|NCT03875911|65816731|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
23570340|NCT01995357|65816732|FG000|Period 5|Lack of Efficacy|1|||
23570341|NCT01995357|65816733|FG001|Period 5|Lack of Efficacy|0|||
23570342|NCT01995357|65816734|FG002|Period 5|Lack of Efficacy|0|||
23570343|NCT01995357|65816735|FG003|Period 5|Lack of Efficacy|0|||
23570344|NCT01995357|65816736|FG004|Period 5|Lack of Efficacy|0|||
23570345|NCT01995357|65816737|FG005|Period 5|Lack of Efficacy|0|||
23570346|NCT01995357|65816732|FG000|Period 5|Adverse Event|1|||
23570347|NCT01995357|65816733|FG001|Period 5|Adverse Event|0|||
23570348|NCT01995357|65816734|FG002|Period 5|Adverse Event|1|||
23570349|NCT01995357|65816735|FG003|Period 5|Adverse Event|0|||
23570350|NCT01995357|65816736|FG004|Period 5|Adverse Event|0|||
23570351|NCT01995357|65816737|FG005|Period 5|Adverse Event|0|||
23570352|NCT02293837|65816738|FG000|Overall Study|Lost to Follow-up|0|||
23570353|NCT02293837|65816739|FG001|Overall Study|Lost to Follow-up|2|||
23570354|NCT02293837|65816740|FG002|Overall Study|Lost to Follow-up|1|||
23570355|NCT02293837|65816741|FG003|Overall Study|Lost to Follow-up|0|||
23570356|NCT02293837|65816738|FG000|Overall Study|Withdrawal by Subject|2|||
23570357|NCT02293837|65816739|FG001|Overall Study|Withdrawal by Subject|1|||
23570358|NCT02293837|65816740|FG002|Overall Study|Withdrawal by Subject|2|||
23570359|NCT02293837|65816741|FG003|Overall Study|Withdrawal by Subject|1|||
23570360|NCT02293837|65816738|FG000|Overall Study|COVID-19 Related|1|||
23570361|NCT02293837|65816739|FG001|Overall Study|COVID-19 Related|1|||
23570362|NCT02293837|65816740|FG002|Overall Study|COVID-19 Related|0|||
23570363|NCT02293837|65816741|FG003|Overall Study|COVID-19 Related|0|||
23570364|NCT02293837|65816738|FG000|Overall Study|Participant ill and could not be infused|0|||
23570365|NCT02293837|65816739|FG001|Overall Study|Participant ill and could not be infused|0|||
23570366|NCT02293837|65816740|FG002|Overall Study|Participant ill and could not be infused|1|||
23570367|NCT02293837|65816741|FG003|Overall Study|Participant ill and could not be infused|0|||
23570368|NCT03154359|65816742|FG000|Overall Study|Adverse Event|1|||
23570369|NCT03154359|65816742|FG000|Overall Study|Lack of Efficacy|2|||
23570370|NCT03154359|65816742|FG000|Overall Study|Lost to Follow-up|3|||
23570371|NCT03154359|65816742|FG000|Overall Study|Physician Decision|3|||
23570372|NCT03154359|65816742|FG000|Overall Study|Protocol Violation|4|||
23570373|NCT03154359|65816742|FG000|Overall Study|Withdrawal by Subject|5|||
23570374|NCT03154359|65816742|FG000|Overall Study|Disruption of study due to COVID-19|4|||
23570375|NCT04297241|65816745|FG000|Overall Study|Withdrawal by Subject|1|||
23570376|NCT04297241|65816745|FG000|Overall Study|Adverse Event|1|||
23570377|NCT04297241|65816745|FG000|Overall Study|Physician Decision|3|||
23570378|NCT04666922|65816746|FG000|Overall Study|Withdrawal by Subject|1|||
23570379|NCT04666922|65816747|FG001|Overall Study|Withdrawal by Subject|0|||
23570380|NCT04666922|65816748|FG002|Overall Study|Withdrawal by Subject|0|||
23570381|NCT04666922|65816749|FG003|Overall Study|Withdrawal by Subject|0|||
23570382|NCT04666922|65816750|FG004|Overall Study|Withdrawal by Subject|0|||
23830412|NCT03850483|66759944|FG003|Treatment for Stage 1|Other|0|||
23570383|NCT04666922|65816751|FG005|Overall Study|Withdrawal by Subject|0|||
23570384|NCT04666922|65816752|FG006|Overall Study|Withdrawal by Subject|0|||
23570385|NCT01107743|65816753|FG000|Overall Study|Protocol Violation|46|||
23570386|NCT02746575|65816756|FG000|Overall Study|Surgery cancelled or time chaned|13|||
23570387|NCT02746575|65816756|FG000|Overall Study|Received epidural|10|||
23570388|NCT02746575|65816756|FG000|Overall Study|Withdrawal by Subject|3|||
23570389|NCT02746575|65816756|FG000|Overall Study|Bradycardia/hypotension|9|||
23570390|NCT02746575|65816756|FG000|Overall Study|Study paused|8|||
23570391|NCT02746575|65816756|FG000|Overall Study|put on beta-blocker|3|||
23570392|NCT02746575|65816756|FG000|Overall Study|type of surgery|1|||
23570393|NCT02746575|65816756|FG000|Overall Study|typ of surgery|1|||
23570394|NCT02746575|65816756|FG000|Overall Study|PI unavailable|1|||
23570395|NCT02746575|65816756|FG000|Overall Study|Unknown history of CVA|1|||
23570396|NCT01254305|65816757|FG000|Overall Study|Adverse Event|6|||
23570397|NCT01254305|65816758|FG001|Overall Study|Adverse Event|3|||
23570398|NCT01254305|65816759|FG002|Overall Study|Adverse Event|2|||
23570399|NCT01254305|65816757|FG000|Overall Study|Lack of Efficacy|1|||
23570400|NCT01254305|65816758|FG001|Overall Study|Lack of Efficacy|0|||
23570401|NCT01254305|65816759|FG002|Overall Study|Lack of Efficacy|1|||
23570402|NCT01254305|65816757|FG000|Overall Study|Protocol Violation|1|||
23570403|NCT01254305|65816758|FG001|Overall Study|Protocol Violation|7|||
23768875|NCT00721409|66531885|FG001|Overall Study|Withdrawal by Subject|6|||
23768876|NCT00721409|66531886|FG002|Overall Study|Withdrawal by Subject|5|||
23768877|NCT00721409|66531884|FG000|Overall Study|Objective progression or relapse|8|||
23768878|NCT00721409|66531885|FG001|Overall Study|Objective progression or relapse|55|||
23768879|NCT00721409|66531886|FG002|Overall Study|Objective progression or relapse|62|||
23768880|NCT01215942|66531887|FG000|Treatment Period|Adverse Event|15|||
23768881|NCT01215942|66531888|FG001|Treatment Period|Adverse Event|26|||
23768882|NCT01215942|66531887|FG000|Treatment Period|Death|2|||
23768883|NCT01215942|66531888|FG001|Treatment Period|Death|4|||
23768884|NCT01215942|66531887|FG000|Treatment Period|Lack of Efficacy|23|||
23768885|NCT01215942|66531888|FG001|Treatment Period|Lack of Efficacy|62|||
23768886|NCT01215942|66531887|FG000|Treatment Period|Lost to Follow-up|3|||
23830413|NCT03850483|66759945|FG004|Treatment for Stage 1|Other|2|||
23830414|NCT03850483|66759946|FG005|Treatment for Stage 1|Other|1|||
23830415|NCT03850483|66759947|FG006|Treatment for Stage 1|Other|0|||
23830416|NCT03850483|66759948|FG007|Treatment for Stage 1|Other|0|||
23570404|NCT01254305|65816759|FG002|Overall Study|Protocol Violation|3|||
23570405|NCT01254305|65816757|FG000|Overall Study|Withdrawal by Subject|4|||
23570406|NCT01254305|65816758|FG001|Overall Study|Withdrawal by Subject|2|||
23570407|NCT01254305|65816759|FG002|Overall Study|Withdrawal by Subject|4|||
23768887|NCT01215942|66531888|FG001|Treatment Period|Lost to Follow-up|4|||
23768888|NCT01215942|66531887|FG000|Treatment Period|Withdrawal by Subject|17|||
23768889|NCT01215942|66531888|FG001|Treatment Period|Withdrawal by Subject|40|||
23768890|NCT01215942|66531887|FG000|Treatment Period|Physician Decision|5|||
23830417|NCT03850483|66759949|FG008|Treatment for Stage 1|Other|0|||
23570408|NCT01254305|65816757|FG000|Overall Study|Lost to Follow-up|10|||
23570409|NCT01254305|65816758|FG001|Overall Study|Lost to Follow-up|6|||
23570410|NCT01254305|65816759|FG002|Overall Study|Lost to Follow-up|5|||
23570411|NCT01254305|65816757|FG000|Overall Study|Other Reasons|0|||
23570412|NCT01254305|65816758|FG001|Overall Study|Other Reasons|0|||
23570413|NCT01254305|65816759|FG002|Overall Study|Other Reasons|2|||
23570414|NCT00794820|65816760|FG000|Overall Study|Adverse Event|11|||
23570415|NCT00794820|65816760|FG000|Overall Study|Secondary Malignancies|2|||
23570416|NCT00794820|65816760|FG000|Overall Study|Resistant Disease|2|||
23570417|NCT00794820|65816760|FG000|Overall Study|Ineligible/Screen Failure|1|||
23570418|NCT02310126|65816761|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
23570419|NCT02310126|65816762|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
23570420|NCT02310126|65816761|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
23570421|NCT02310126|65816762|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
23570422|NCT01348776|65816763|FG000|Overall Study|Lost to Follow-up|3|||
23570423|NCT00127413|65816764|FG000|Overall Study|Lost to Follow-up|6|||
23570424|NCT00127413|65816765|FG001|Overall Study|Lost to Follow-up|4|||
23570425|NCT00127413|65816766|FG002|Overall Study|Lost to Follow-up|8|||
23570426|NCT00127413|65816767|FG003|Overall Study|Lost to Follow-up|2|||
23570427|NCT01976364|65816768|FG000|Main Study (36 Months)|Adverse Event|63|||
23570428|NCT01976364|65816769|FG001|Main Study (36 Months)|Adverse Event|0|||
23570429|NCT01976364|65816770|FG002|Main Study (36 Months)|Adverse Event|0|||
23830418|NCT03850483|66759950|FG009|Treatment for Stage 1|Other|0|||
23768891|NCT01215942|66531888|FG001|Treatment Period|Physician Decision|5|||
23570430|NCT01976364|65816768|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
23570431|NCT01976364|65816769|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
23570432|NCT01976364|65816770|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
23570433|NCT01976364|65816768|FG000|Main Study (36 Months)|Other|13|||
23570434|NCT01976364|65816769|FG001|Main Study (36 Months)|Other|0|||
23570435|NCT01976364|65816770|FG002|Main Study (36 Months)|Other|0|||
23768892|NCT01215942|66531887|FG000|Treatment Period|Protocol Violation|0|||
23768893|NCT01215942|66531888|FG001|Treatment Period|Protocol Violation|1|||
23768894|NCT01215942|66531887|FG000|Treatment Period|Sponsor Decision|349|||
23768895|NCT01215942|66531888|FG001|Treatment Period|Sponsor Decision|530|||
23768896|NCT01215942|66531887|FG000|Post-Treatment Follow-Up Period|Death|0|||
23830419|NCT03850483|66759941|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23768897|NCT01215942|66531888|FG001|Post-Treatment Follow-Up Period|Death|1|||
23768898|NCT01215942|66531887|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23768899|NCT01215942|66531888|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23768900|NCT01215942|66531887|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
23768901|NCT01215942|66531888|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
23768902|NCT01215942|66531887|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
23768903|NCT01215942|66531888|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
23768904|NCT01215942|66531887|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
23768905|NCT01215942|66531888|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
23768906|NCT00680121|66531891|FG000|Overall Study|Lost to Follow-up|27|||
23768907|NCT00680121|66531892|FG001|Overall Study|Lost to Follow-up|23|||
23768908|NCT03206203|66531895|FG000|Treatment|Death|38|||
23768909|NCT03206203|66531896|FG001|Treatment|Death|26|||
23768910|NCT03206203|66531897|FG002|Treatment|Death|0|||
23768911|NCT03206203|66531895|FG000|Treatment|Withdrawal by Subject|1|||
23768912|NCT03206203|66531896|FG001|Treatment|Withdrawal by Subject|0|||
23768913|NCT03206203|66531897|FG002|Treatment|Withdrawal by Subject|0|||
23768914|NCT03206203|66531895|FG000|Treatment|Lost to Follow-up|4|||
23768915|NCT03206203|66531896|FG001|Treatment|Lost to Follow-up|0|||
23768916|NCT03206203|66531897|FG002|Treatment|Lost to Follow-up|0|||
23768917|NCT03206203|66531895|FG000|Treatment|N/A in Follow-Up|8|||
23768918|NCT03206203|66531896|FG001|Treatment|N/A in Follow-Up|1|||
23768919|NCT03206203|66531897|FG002|Treatment|N/A in Follow-Up|0|||
23768920|NCT03206203|66531895|FG000|Treatment|Disease progression|0|||
23768921|NCT03206203|66531896|FG001|Treatment|Disease progression|1|||
23768922|NCT03206203|66531897|FG002|Treatment|Disease progression|0|||
23768923|NCT03206203|66531895|FG000|Treatment|Refused follow-up|0|||
23768924|NCT03206203|66531896|FG001|Treatment|Refused follow-up|1|||
23768925|NCT03206203|66531897|FG002|Treatment|Refused follow-up|0|||
23768926|NCT03206203|66531895|FG000|Treatment|Cross over to Arm 1|0|||
23768927|NCT03206203|66531896|FG001|Treatment|Cross over to Arm 1|19|||
23768928|NCT03206203|66531897|FG002|Treatment|Cross over to Arm 1|0|||
23768929|NCT03206203|66531895|FG000|Optional Cross-Over|Death|0|||
23768930|NCT03206203|66531896|FG001|Optional Cross-Over|Death|0|||
23768931|NCT03206203|66531897|FG002|Optional Cross-Over|Death|14|||
23768932|NCT03206203|66531895|FG000|Optional Cross-Over|Refused follow-up|0|||
23768933|NCT03206203|66531896|FG001|Optional Cross-Over|Refused follow-up|0|||
23768934|NCT03206203|66531897|FG002|Optional Cross-Over|Refused follow-up|2|||
23570436|NCT01976364|65816768|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
23570437|NCT01976364|65816769|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
23570438|NCT01976364|65816770|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
23570439|NCT01976364|65816768|FG000|Main Study (36 Months)|Medication error|1|||
23570440|NCT01976364|65816769|FG001|Main Study (36 Months)|Medication error|0|||
23570441|NCT01976364|65816770|FG002|Main Study (36 Months)|Medication error|0|||
23570442|NCT01976364|65816768|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
23570443|NCT01976364|65816769|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
23570444|NCT01976364|65816770|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
23570445|NCT01976364|65816768|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
23570446|NCT01976364|65816769|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
23570447|NCT01976364|65816770|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
23570448|NCT01976364|65816768|FG000|Main Study (36 Months)|Protocol Violation|13|||
23570449|NCT01976364|65816769|FG001|Main Study (36 Months)|Protocol Violation|0|||
23570450|NCT01976364|65816770|FG002|Main Study (36 Months)|Protocol Violation|0|||
23570451|NCT01976364|65816768|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
23570452|NCT01976364|65816769|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
23570453|NCT01976364|65816770|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
23570454|NCT01976364|65816768|FG000|Main Study (36 Months)|Death|5|||
23570455|NCT01976364|65816769|FG001|Main Study (36 Months)|Death|0|||
23570456|NCT01976364|65816770|FG002|Main Study (36 Months)|Death|0|||
23570457|NCT01976364|65816768|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
23570458|NCT01976364|65816769|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
23570459|NCT01976364|65816770|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
23570460|NCT01976364|65816768|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
23768935|NCT01977092|66531906|FG000|Overall Study|Death|3|||
23768936|NCT01977092|66531907|FG001|Overall Study|Death|4|||
23768937|NCT01977092|66531906|FG000|Overall Study|Lost to Follow-up|23|||
23570461|NCT01976364|65816769|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
23570462|NCT01976364|65816770|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
23768938|NCT01977092|66531907|FG001|Overall Study|Lost to Follow-up|14|||
23768939|NCT01977092|66531906|FG000|Overall Study|Withdrawal by Subject|2|||
23768940|NCT01977092|66531907|FG001|Overall Study|Withdrawal by Subject|1|||
23768941|NCT01977092|66531906|FG000|Overall Study|In prison|3|||
23768942|NCT01977092|66531907|FG001|Overall Study|In prison|11|||
23768943|NCT01046253|66531908|FG000|Second Intervention|Adverse Event|0|||
23768944|NCT01046253|66531909|FG001|Second Intervention|Adverse Event|1|||
23768945|NCT01046253|66531908|FG000|Second Intervention|Protocol Violation|0|||
23768946|NCT01046253|66531909|FG001|Second Intervention|Protocol Violation|1|||
23570463|NCT01976364|65816768|FG000|Sub-study (12 Months)|Protocol Violation|0|||
23570464|NCT01976364|65816769|FG001|Sub-study (12 Months)|Protocol Violation|1|||
23570465|NCT01976364|65816770|FG002|Sub-study (12 Months)|Protocol Violation|1|||
23570466|NCT01976364|65816768|FG000|Sub-study (12 Months)|Adverse Event|0|||
23570467|NCT01976364|65816769|FG001|Sub-study (12 Months)|Adverse Event|4|||
23570468|NCT01976364|65816770|FG002|Sub-study (12 Months)|Adverse Event|3|||
23570469|NCT01320735|65816775|FG000|Overall Study|Adverse Event|3|||
23570470|NCT01320735|65816775|FG000|Overall Study|Withdrawal by Subject|3|||
23570471|NCT01320735|65816775|FG000|Overall Study|Lost to Follow-up|13|||
23570472|NCT01320735|65816775|FG000|Overall Study|Administrative Reason|6|||
23570473|NCT01320735|65816775|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
23570474|NCT01320735|65816775|FG000|Overall Study|Protocol Violation|1|||
23570475|NCT01320735|65816775|FG000|Overall Study|Other|1|||
23768947|NCT03565211|66531910|FG000|Overall Study|Withdrawal by Subject|2|||
23768948|NCT03565211|66531910|FG000|Overall Study|Lost to Follow-up|1|||
23768949|NCT03565211|66531910|FG000|Overall Study|Adverse Event|44|||
23768950|NCT03565211|66531910|FG000|Overall Study|Personal issues|1|||
23768951|NCT00929708|66531922|FG000|Overall Study|Protocol Violation|2|||
23768952|NCT00929708|66531923|FG001|Overall Study|Protocol Violation|1|||
23570476|NCT01320735|65816775|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
23570477|NCT01320735|65816775|FG000|Overall Study|Investigator Unable to be Contacted|17|||
23570478|NCT04182880|65816777|FG000|Overall Study|Pregnancy|1|||
23570479|NCT04182880|65816778|FG001|Overall Study|Pregnancy|0|||
23570480|NCT01822353|65816779|FG000|Overall Study|Adverse Event|1|||
23570481|NCT01822353|65816780|FG001|Overall Study|Adverse Event|3|||
23570482|NCT01822353|65816781|FG002|Overall Study|Adverse Event|1|||
23570483|NCT01822353|65816779|FG000|Overall Study|Pregnancy|0|||
23570484|NCT01822353|65816780|FG001|Overall Study|Pregnancy|1|||
23570485|NCT01822353|65816781|FG002|Overall Study|Pregnancy|0|||
23570486|NCT01822353|65816779|FG000|Overall Study|Withdrawal by Subject|3|||
23570487|NCT01822353|65816780|FG001|Overall Study|Withdrawal by Subject|1|||
23570488|NCT01822353|65816781|FG002|Overall Study|Withdrawal by Subject|0|||
23768953|NCT00929708|66531924|FG002|Overall Study|Protocol Violation|1|||
23768954|NCT00929708|66531925|FG003|Overall Study|Protocol Violation|1|||
23768955|NCT00929708|66531926|FG004|Overall Study|Protocol Violation|1|||
23768956|NCT00929708|66531922|FG000|Overall Study|Withdrawal by Subject|2|||
23768957|NCT00929708|66531923|FG001|Overall Study|Withdrawal by Subject|0|||
23768958|NCT00929708|66531924|FG002|Overall Study|Withdrawal by Subject|0|||
23768959|NCT00929708|66531925|FG003|Overall Study|Withdrawal by Subject|2|||
23768960|NCT00929708|66531926|FG004|Overall Study|Withdrawal by Subject|1|||
23768961|NCT00929708|66531922|FG000|Overall Study|Adverse Event|0|||
23768962|NCT00929708|66531923|FG001|Overall Study|Adverse Event|0|||
23570489|NCT03306043|65816782|FG000|Overall Study|Adverse Event|1|||
23570490|NCT03306043|65816782|FG000|Overall Study|Lost to Follow-up|1|||
23570491|NCT03306043|65816782|FG000|Overall Study|Withdrawal by Subject|2|||
23570492|NCT00854295|65816783|FG000|Overall Study|Death|7|||
23570493|NCT00854295|65816784|FG001|Overall Study|Death|0|||
23570494|NCT00854295|65816785|FG002|Overall Study|Death|1|||
23570495|NCT00854295|65816786|FG003|Overall Study|Death|1|||
23570496|NCT00854295|65816783|FG000|Overall Study|Adverse Event|6|||
23570497|NCT00854295|65816784|FG001|Overall Study|Adverse Event|1|||
23570498|NCT00854295|65816785|FG002|Overall Study|Adverse Event|1|||
23570499|NCT00854295|65816786|FG003|Overall Study|Adverse Event|3|||
23570500|NCT00854295|65816783|FG000|Overall Study|Lost to Follow-up|18|||
23768963|NCT00929708|66531924|FG002|Overall Study|Adverse Event|0|||
23768964|NCT00929708|66531925|FG003|Overall Study|Adverse Event|0|||
23768965|NCT00929708|66531926|FG004|Overall Study|Adverse Event|3|||
23570501|NCT00854295|65816784|FG001|Overall Study|Lost to Follow-up|5|||
23570502|NCT00854295|65816785|FG002|Overall Study|Lost to Follow-up|21|||
23570503|NCT00854295|65816786|FG003|Overall Study|Lost to Follow-up|21|||
23570504|NCT00854295|65816783|FG000|Overall Study|Physician Decision|10|||
23570505|NCT00854295|65816784|FG001|Overall Study|Physician Decision|0|||
23768966|NCT00929708|66531922|FG000|Overall Study|Physician Decision|0|||
23768967|NCT00929708|66531923|FG001|Overall Study|Physician Decision|2|||
23570506|NCT00854295|65816785|FG002|Overall Study|Physician Decision|0|||
23570507|NCT00854295|65816786|FG003|Overall Study|Physician Decision|0|||
23570508|NCT02757521|65816789|FG000|Overall Study|Adverse Event|1|||
23446938|NCT01684202|65377809|FG000|Dose-escalation Period|Adverse Event|0|||
23570509|NCT02757521|65816790|FG001|Overall Study|Adverse Event|0|||
23768968|NCT00929708|66531924|FG002|Overall Study|Physician Decision|2|||
23570510|NCT00806624|65816792|FG000|Overall Study|Adverse Event|2|||
23570511|NCT00806624|65816793|FG001|Overall Study|Adverse Event|8|||
23570512|NCT00806624|65816794|FG002|Overall Study|Adverse Event|0|||
23570513|NCT00806624|65816792|FG000|Overall Study|Death|0|||
23570514|NCT00806624|65816793|FG001|Overall Study|Death|1|||
23570515|NCT00806624|65816794|FG002|Overall Study|Death|1|||
23570516|NCT00806624|65816792|FG000|Overall Study|Lost to Follow-up|1|||
23768969|NCT00929708|66531925|FG003|Overall Study|Physician Decision|2|||
23768970|NCT00929708|66531926|FG004|Overall Study|Physician Decision|1|||
23768971|NCT00929708|66531922|FG000|Overall Study|Lost to Follow-up|0|||
23768972|NCT00929708|66531923|FG001|Overall Study|Lost to Follow-up|0|||
23768973|NCT00929708|66531924|FG002|Overall Study|Lost to Follow-up|0|||
23768974|NCT00929708|66531925|FG003|Overall Study|Lost to Follow-up|1|||
23768975|NCT00929708|66531926|FG004|Overall Study|Lost to Follow-up|0|||
23768976|NCT02729896|66531928|FG000|Overall Study|Death|0|||
23768977|NCT02729896|66531929|FG001|Overall Study|Death|2|||
23768978|NCT02729896|66531930|FG002|Overall Study|Death|13|||
23768979|NCT02729896|66531928|FG000|Overall Study|Lost to Follow-up|0|||
23768980|NCT02729896|66531929|FG001|Overall Study|Lost to Follow-up|2|||
23570517|NCT00806624|65816793|FG001|Overall Study|Lost to Follow-up|0|||
23570518|NCT00806624|65816794|FG002|Overall Study|Lost to Follow-up|1|||
23570519|NCT00806624|65816792|FG000|Overall Study|Withdrawal by Subject|6|||
23570520|NCT00806624|65816793|FG001|Overall Study|Withdrawal by Subject|3|||
23570521|NCT00806624|65816794|FG002|Overall Study|Withdrawal by Subject|3|||
23570522|NCT00806624|65816792|FG000|Overall Study|discontinued before start of treatment|0|||
23570523|NCT00806624|65816793|FG001|Overall Study|discontinued before start of treatment|0|||
23570524|NCT00806624|65816794|FG002|Overall Study|discontinued before start of treatment|1|||
23570525|NCT01340482|65816800|FG000|Overall Study|Adverse Event|2|||
23570526|NCT01340482|65816801|FG001|Overall Study|Adverse Event|0|||
23570527|NCT01340482|65816802|FG002|Overall Study|Adverse Event|0|||
23570528|NCT02066532|65816803|FG000|Phase II|Withdrawal by Subject|1|||
23570529|NCT02066532|65816804|FG001|Phase II|Withdrawal by Subject|0|||
23570530|NCT02066532|65816805|FG002|Phase II|Withdrawal by Subject|0|||
23570531|NCT02066532|65816806|FG003|Phase II|Withdrawal by Subject|0|||
23570532|NCT01464255|65816810|FG000|Overall Study|unresolve corneal staining|0|||
23570533|NCT01464255|65816811|FG001|Overall Study|unresolve corneal staining|1|||
23570534|NCT03075904|65816812|FG000|Overall Study|Physician Decision|3|||
23570535|NCT03075904|65816812|FG000|Overall Study|Need for Medication not Permitted|1|||
23570536|NCT01590771|65816815|FG000|Overall Study|Other Protocol Specified Criteria|5|||
23570537|NCT01590771|65816816|FG001|Overall Study|Other Protocol Specified Criteria|14|||
23570538|NCT01590771|65816815|FG000|Overall Study|Withdrawal by Subject|8|||
23570539|NCT01590771|65816816|FG001|Overall Study|Withdrawal by Subject|15|||
23570540|NCT01590771|65816815|FG000|Overall Study|Protocol Violation|1|||
23570541|NCT01590771|65816816|FG001|Overall Study|Protocol Violation|2|||
23570542|NCT01590771|65816815|FG000|Overall Study|Lost to Follow-up|1|||
23570543|NCT01590771|65816816|FG001|Overall Study|Lost to Follow-up|1|||
23570544|NCT01590771|65816815|FG000|Overall Study|Lack of Efficacy|1|||
23570545|NCT01590771|65816816|FG001|Overall Study|Lack of Efficacy|0|||
23570546|NCT01590771|65816815|FG000|Overall Study|Adverse Event|3|||
23570547|NCT01590771|65816816|FG001|Overall Study|Adverse Event|7|||
23570548|NCT00472186|65816817|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
23570549|NCT00472186|65816818|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
23570550|NCT01515189|65816819|FG000|Induction|Disease Progression|109|||
23570551|NCT01515189|65816820|FG001|Induction|Disease Progression|155|||
23570552|NCT01515189|65816819|FG000|Induction|Study drug toxicity|86|||
23570553|NCT01515189|65816820|FG001|Induction|Study drug toxicity|36|||
23570554|NCT01515189|65816819|FG000|Induction|Death|24|||
23570555|NCT01515189|65816820|FG001|Induction|Death|17|||
23570556|NCT01515189|65816819|FG000|Induction|Adverse Event|14|||
23570557|NCT01515189|65816820|FG001|Induction|Adverse Event|9|||
23570558|NCT01515189|65816819|FG000|Induction|Withdrawal by Subject|3|||
23570559|NCT01515189|65816820|FG001|Induction|Withdrawal by Subject|9|||
23570560|NCT01515189|65816819|FG000|Induction|No longer meets study criteria|0|||
23570561|NCT01515189|65816820|FG001|Induction|No longer meets study criteria|2|||
23570562|NCT01515189|65816819|FG000|Induction|Lost to Follow-up|1|||
23570563|NCT01515189|65816820|FG001|Induction|Lost to Follow-up|0|||
23570564|NCT01515189|65816819|FG000|Induction|Other|0|||
23570565|NCT01515189|65816820|FG001|Induction|Other|4|||
23570566|NCT01515189|65816819|FG000|First Re-Induction Phase|Disease progression|6|||
23570567|NCT01515189|65816820|FG001|First Re-Induction Phase|Disease progression|14|||
23570568|NCT01515189|65816819|FG000|First Re-Induction Phase|Study drug toxicity|5|||
23570569|NCT01515189|65816820|FG001|First Re-Induction Phase|Study drug toxicity|0|||
23570570|NCT01515189|65816819|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
23768981|NCT02729896|66531930|FG002|Overall Study|Lost to Follow-up|3|||
23768982|NCT02729896|66531928|FG000|Overall Study|Other|0|||
23768983|NCT02729896|66531929|FG001|Overall Study|Other|2|||
23570571|NCT01515189|65816820|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
23570572|NCT01515189|65816819|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
23570573|NCT01515189|65816820|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
23570574|NCT01515189|65816819|FG000|First Re-Induction Phase|Other|1|||
23570575|NCT01515189|65816820|FG001|First Re-Induction Phase|Other|0|||
23570576|NCT01592695|65816821|FG000|Overall Study|Lost to Follow-up|8|||
23570577|NCT01592695|65816822|FG001|Overall Study|Lost to Follow-up|4|||
23570578|NCT01950273|65816823|FG000|Overall Study|Protocol Violation|1|||
23570579|NCT01950273|65816824|FG001|Overall Study|Protocol Violation|0|||
23768984|NCT02729896|66531930|FG002|Overall Study|Other|0|||
23768985|NCT02729896|66531928|FG000|Overall Study|Physician Decision|1|||
23768986|NCT02729896|66531929|FG001|Overall Study|Physician Decision|2|||
23570580|NCT01950273|65816823|FG000|Overall Study|Withdrawal by Subject|2|||
23570581|NCT01950273|65816824|FG001|Overall Study|Withdrawal by Subject|0|||
23570582|NCT01950273|65816823|FG000|Overall Study|Other not defined above|1|||
23570583|NCT01950273|65816824|FG001|Overall Study|Other not defined above|0|||
23570584|NCT00641186|65816825|FG000|Overall Study|Adverse Event|3|||
23570585|NCT03204695|65816828|FG000|Overall Study|Death|1|||
23570586|NCT03204695|65816828|FG000|Overall Study|Participant was treated with another device|1|||
23570587|NCT03204695|65816828|FG000|Overall Study|Physician Decision|2|||
23570588|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570589|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570590|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
23570591|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
23570592|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
23570593|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570594|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570595|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570596|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
23570597|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
23570598|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
23570599|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
23570600|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
23570601|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
23570602|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
23570603|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
23570604|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
23570605|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
23570606|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
23570607|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
23570608|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
23570609|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
23570610|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
23570611|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
23570612|NCT02855164|65816832|FG000|Part C (Randomized Set)|Adverse Event|0|||
23570613|NCT02855164|65816833|FG001|Part C (Randomized Set)|Adverse Event|0|||
23570614|NCT02855164|65816834|FG002|Part C (Randomized Set)|Adverse Event|0|||
23570615|NCT02855164|65816835|FG003|Part C (Randomized Set)|Adverse Event|0|||
23570616|NCT02855164|65816836|FG004|Part C (Randomized Set)|Adverse Event|0|||
23570617|NCT02855164|65816837|FG005|Part C (Randomized Set)|Adverse Event|5|||
23570618|NCT02855164|65816838|FG006|Part C (Randomized Set)|Adverse Event|9|||
23570619|NCT02855164|65816839|FG007|Part C (Randomized Set)|Adverse Event|2|||
23570620|NCT02855164|65816832|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
23570621|NCT02855164|65816833|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
23570622|NCT02855164|65816834|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
23570623|NCT02855164|65816835|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
23570624|NCT02855164|65816836|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
23570625|NCT02855164|65816837|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
23570626|NCT02855164|65816838|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
23570627|NCT02855164|65816839|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
23570628|NCT02855164|65816832|FG000|Part C (Randomized Set)|Physician Decision|0|||
23570629|NCT02855164|65816833|FG001|Part C (Randomized Set)|Physician Decision|0|||
23768987|NCT02729896|66531930|FG002|Overall Study|Physician Decision|3|||
23768988|NCT02729896|66531928|FG000|Overall Study|Progressive Disease|0|||
23768989|NCT02729896|66531929|FG001|Overall Study|Progressive Disease|1|||
23768990|NCT02729896|66531930|FG002|Overall Study|Progressive Disease|0|||
23768991|NCT02729896|66531928|FG000|Overall Study|Withdrawal by Subject|1|||
23768992|NCT02729896|66531929|FG001|Overall Study|Withdrawal by Subject|0|||
23768993|NCT02729896|66531930|FG002|Overall Study|Withdrawal by Subject|3|||
23768994|NCT02330081|66531938|FG000|Overall Study|Adverse Event|1|||
23768995|NCT02330081|66531938|FG000|Overall Study|Donation did not meet criteria|1|||
23570630|NCT02855164|65816834|FG002|Part C (Randomized Set)|Physician Decision|0|||
23570631|NCT02855164|65816835|FG003|Part C (Randomized Set)|Physician Decision|0|||
23570632|NCT02855164|65816836|FG004|Part C (Randomized Set)|Physician Decision|0|||
23631583|NCT00706654|66038471|FG003|Conversion Phase|Lost to Follow-up|0|||
23768996|NCT02330081|66531938|FG000|Overall Study|Protocol Violation|6|||
23768997|NCT01922349|66531939|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23768998|NCT01922349|66531940|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23570633|NCT02855164|65816837|FG005|Part C (Randomized Set)|Physician Decision|1|||
23570634|NCT02855164|65816838|FG006|Part C (Randomized Set)|Physician Decision|0|||
23570635|NCT02855164|65816839|FG007|Part C (Randomized Set)|Physician Decision|1|||
23570636|NCT02855164|65816832|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
23768999|NCT01922349|66531941|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23570637|NCT02855164|65816833|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570638|NCT02855164|65816834|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570639|NCT02855164|65816835|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570640|NCT02855164|65816836|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570641|NCT02855164|65816837|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
23570642|NCT02855164|65816838|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
23570643|NCT02855164|65816839|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
23570644|NCT02790073|65816846|FG000|Overall Study|Death|1|||
23570645|NCT02790073|65816846|FG000|Overall Study|Withdrawal from HD|1|||
23570646|NCT02790073|65816846|FG000|Overall Study|Withdrawal by Subject|1|||
23570647|NCT04320615|65816847|FG000|Overall Study|Withdrawal by Subject|4|||
23570648|NCT04320615|65816848|FG001|Overall Study|Withdrawal by Subject|10|||
23570649|NCT04320615|65816847|FG000|Overall Study|Physician Decision|2|||
23570650|NCT04320615|65816848|FG001|Overall Study|Physician Decision|0|||
23570651|NCT04320615|65816847|FG000|Overall Study|Other|2|||
23570652|NCT04320615|65816848|FG001|Overall Study|Other|0|||
23570653|NCT04320615|65816847|FG000|Overall Study|Lost to Follow-up|5|||
23570654|NCT04320615|65816848|FG001|Overall Study|Lost to Follow-up|23|||
23570655|NCT04320615|65816847|FG000|Overall Study|Death|35|||
23570656|NCT04320615|65816848|FG001|Overall Study|Death|71|||
23769000|NCT01922349|66531942|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
23769001|NCT01644890|66531949|FG000|Overall Study|Adverse Event|7|||
23570657|NCT00318149|65816852|FG000|Overall Study|Adverse Event|0|||
23570658|NCT00318149|65816853|FG001|Overall Study|Adverse Event|0|||
23631584|NCT00706654|66038468|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
23631585|NCT00706654|66038469|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
23631586|NCT00706654|66038470|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
23631587|NCT00706654|66038471|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
23631588|NCT00706654|66038468|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
23631589|NCT00706654|66038469|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
23631590|NCT00706654|66038470|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
23631591|NCT00706654|66038471|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
23631592|NCT00706654|66038468|FG000|Conversion Phase|Withdrawn by Investigator|14|||
23631593|NCT00706654|66038469|FG001|Conversion Phase|Withdrawn by Investigator|0|||
23631594|NCT00706654|66038470|FG002|Conversion Phase|Withdrawn by Investigator|0|||
23631595|NCT00706654|66038471|FG003|Conversion Phase|Withdrawn by Investigator|0|||
23631596|NCT00706654|66038468|FG000|Conversion Phase|Withdrew Consent|38|||
23631597|NCT00706654|66038469|FG001|Conversion Phase|Withdrew Consent|0|||
23631598|NCT00706654|66038470|FG002|Conversion Phase|Withdrew Consent|0|||
23631599|NCT00706654|66038471|FG003|Conversion Phase|Withdrew Consent|0|||
23631600|NCT00706654|66038468|FG000|Conversion Phase|Adverse Event|18|||
23769002|NCT01644890|66531950|FG001|Overall Study|Adverse Event|20|||
23769003|NCT01644890|66531949|FG000|Overall Study|Death|1|||
23769004|NCT01644890|66531950|FG001|Overall Study|Death|3|||
23769005|NCT01644890|66531949|FG000|Overall Study|Physician Decision|3|||
23769006|NCT01644890|66531950|FG001|Overall Study|Physician Decision|9|||
23769007|NCT01644890|66531949|FG000|Overall Study|Protocol Violation|6|||
23570659|NCT00318149|65816854|FG002|Overall Study|Adverse Event|0|||
23570660|NCT00318149|65816855|FG003|Overall Study|Adverse Event|0|||
23570661|NCT00318149|65816856|FG004|Overall Study|Adverse Event|0|||
23570662|NCT00318149|65816857|FG005|Overall Study|Adverse Event|2|||
23570663|NCT01533714|65816860|FG000|Overall Study|Adverse Event|0|||
23570664|NCT01533714|65816861|FG001|Overall Study|Adverse Event|1|||
23570665|NCT01533714|65816862|FG002|Overall Study|Adverse Event|2|||
23570666|NCT01533714|65816863|FG003|Overall Study|Adverse Event|2|||
23570667|NCT01533714|65816864|FG004|Overall Study|Adverse Event|2|||
23570668|NCT01533714|65816865|FG005|Overall Study|Adverse Event|1|||
23570669|NCT01533714|65816860|FG000|Overall Study|Lack of Efficacy|0|||
23570670|NCT01533714|65816861|FG001|Overall Study|Lack of Efficacy|0|||
23570671|NCT01533714|65816862|FG002|Overall Study|Lack of Efficacy|0|||
23570672|NCT01533714|65816863|FG003|Overall Study|Lack of Efficacy|0|||
23570673|NCT01533714|65816864|FG004|Overall Study|Lack of Efficacy|0|||
23570674|NCT01533714|65816865|FG005|Overall Study|Lack of Efficacy|1|||
23570675|NCT01533714|65816860|FG000|Overall Study|Withdrawal by Subject|0|||
23570676|NCT01533714|65816861|FG001|Overall Study|Withdrawal by Subject|1|||
23570677|NCT01533714|65816862|FG002|Overall Study|Withdrawal by Subject|0|||
23570678|NCT01533714|65816863|FG003|Overall Study|Withdrawal by Subject|1|||
23570679|NCT01533714|65816864|FG004|Overall Study|Withdrawal by Subject|1|||
23570680|NCT01533714|65816865|FG005|Overall Study|Withdrawal by Subject|0|||
23570681|NCT01533714|65816860|FG000|Overall Study|Exclusion criteria|0|||
23570682|NCT01533714|65816861|FG001|Overall Study|Exclusion criteria|1|||
23570683|NCT01533714|65816862|FG002|Overall Study|Exclusion criteria|0|||
23570684|NCT01533714|65816863|FG003|Overall Study|Exclusion criteria|0|||
23570685|NCT01533714|65816864|FG004|Overall Study|Exclusion criteria|0|||
23570686|NCT01533714|65816865|FG005|Overall Study|Exclusion criteria|0|||
23769008|NCT01644890|66531950|FG001|Overall Study|Protocol Violation|7|||
23769009|NCT01644890|66531949|FG000|Overall Study|Withdrawal by Subject|19|||
23769010|NCT01644890|66531950|FG001|Overall Study|Withdrawal by Subject|27|||
23769011|NCT01644890|66531949|FG000|Overall Study|Progression Disease|160|||
23769012|NCT01644890|66531950|FG001|Overall Study|Progression Disease|131|||
23769013|NCT01644890|66531949|FG000|Overall Study|Clinical Progression|6|||
23769014|NCT01644890|66531950|FG001|Overall Study|Clinical Progression|6|||
23769015|NCT01644890|66531949|FG000|Overall Study|> 28 days since last dose of study drug|6|||
23769016|NCT01644890|66531950|FG001|Overall Study|> 28 days since last dose of study drug|3|||
23769017|NCT01644890|66531949|FG000|Overall Study|Other|8|||
23769018|NCT01644890|66531950|FG001|Overall Study|Other|9|||
23769019|NCT03495869|66531951|FG000|Overall Study|Lost to Follow-up|4|||
23769020|NCT03495869|66531952|FG001|Overall Study|Lost to Follow-up|17|||
23769021|NCT03495869|66531953|FG002|Overall Study|Lost to Follow-up|8|||
23769022|NCT03495869|66531954|FG003|Overall Study|Lost to Follow-up|14|||
23769023|NCT03495869|66531951|FG000|Overall Study|Withdrawal by Subject|0|||
23769024|NCT03495869|66531952|FG001|Overall Study|Withdrawal by Subject|3|||
23769025|NCT03495869|66531953|FG002|Overall Study|Withdrawal by Subject|0|||
23769026|NCT03495869|66531954|FG003|Overall Study|Withdrawal by Subject|3|||
23769027|NCT03495869|66531951|FG000|Overall Study|Dropped from study|0|||
23769028|NCT03495869|66531952|FG001|Overall Study|Dropped from study|7|||
23769029|NCT03495869|66531953|FG002|Overall Study|Dropped from study|2|||
23769030|NCT03495869|66531954|FG003|Overall Study|Dropped from study|4|||
23769031|NCT02492958|66531955|FG000|Overall Study|Withdrawal by Subject|0|||
23769032|NCT02492958|66531956|FG001|Overall Study|Withdrawal by Subject|0|||
23769033|NCT02492958|66531957|FG002|Overall Study|Withdrawal by Subject|1|||
23769034|NCT02492958|66531958|FG003|Overall Study|Withdrawal by Subject|0|||
23769035|NCT02492958|66531955|FG000|Overall Study|Adverse Event|1|||
23769036|NCT02492958|66531956|FG001|Overall Study|Adverse Event|0|||
23769037|NCT02492958|66531957|FG002|Overall Study|Adverse Event|1|||
23769038|NCT02492958|66531958|FG003|Overall Study|Adverse Event|0|||
23769039|NCT01606306|66531963|FG000|Overall Study|Lack of Efficacy|2|||
23769040|NCT01606306|66531964|FG001|Overall Study|Lack of Efficacy|1|||
23769041|NCT01606306|66531965|FG002|Overall Study|Lack of Efficacy|4|||
23769042|NCT01606306|66531966|FG003|Overall Study|Lack of Efficacy|4|||
23769043|NCT01606306|66531967|FG004|Overall Study|Lack of Efficacy|1|||
23769044|NCT01606306|66531968|FG005|Overall Study|Lack of Efficacy|2|||
23769045|NCT01606306|66531963|FG000|Overall Study|Adverse Event|1|||
23769046|NCT01606306|66531964|FG001|Overall Study|Adverse Event|0|||
23769047|NCT01606306|66531965|FG002|Overall Study|Adverse Event|1|||
23570687|NCT01533714|65816860|FG000|Overall Study|Positive for purified protein derivative|0|||
23570688|NCT01533714|65816861|FG001|Overall Study|Positive for purified protein derivative|0|||
23570689|NCT01533714|65816862|FG002|Overall Study|Positive for purified protein derivative|1|||
23769048|NCT01606306|66531966|FG003|Overall Study|Adverse Event|1|||
23570690|NCT01533714|65816863|FG003|Overall Study|Positive for purified protein derivative|0|||
23769049|NCT01606306|66531967|FG004|Overall Study|Adverse Event|2|||
23769050|NCT01606306|66531968|FG005|Overall Study|Adverse Event|0|||
23769051|NCT01606306|66531963|FG000|Overall Study|Lost to Follow-up|7|||
23769052|NCT01606306|66531964|FG001|Overall Study|Lost to Follow-up|4|||
23570691|NCT01533714|65816864|FG004|Overall Study|Positive for purified protein derivative|1|||
23769053|NCT01606306|66531965|FG002|Overall Study|Lost to Follow-up|5|||
23570692|NCT01533714|65816865|FG005|Overall Study|Positive for purified protein derivative|0|||
23570693|NCT01533714|65816860|FG000|Overall Study|Withdrawal criteria|0|||
23769054|NCT01606306|66531966|FG003|Overall Study|Lost to Follow-up|4|||
23769055|NCT01606306|66531967|FG004|Overall Study|Lost to Follow-up|3|||
23570694|NCT01533714|65816861|FG001|Overall Study|Withdrawal criteria|0|||
23570695|NCT01533714|65816862|FG002|Overall Study|Withdrawal criteria|1|||
23570696|NCT01533714|65816863|FG003|Overall Study|Withdrawal criteria|0|||
23570697|NCT01533714|65816864|FG004|Overall Study|Withdrawal criteria|3|||
23570698|NCT01533714|65816865|FG005|Overall Study|Withdrawal criteria|1|||
23570699|NCT01533714|65816860|FG000|Overall Study|Ineligibility reason|0|||
23570700|NCT01533714|65816861|FG001|Overall Study|Ineligibility reason|0|||
23570701|NCT01533714|65816862|FG002|Overall Study|Ineligibility reason|0|||
23570702|NCT01533714|65816863|FG003|Overall Study|Ineligibility reason|1|||
23570703|NCT01533714|65816864|FG004|Overall Study|Ineligibility reason|0|||
23570704|NCT01533714|65816865|FG005|Overall Study|Ineligibility reason|0|||
23570705|NCT01700348|65816866|FG000|Overall Study|Withdrawal by Subject|22|||
23570706|NCT01700348|65816866|FG000|Overall Study|Lost to Follow-up|1|||
23570707|NCT02138747|65816867|FG000|Treatment Period 1|Adverse Event|10|||
23570708|NCT02138747|65816868|FG001|Treatment Period 1|Adverse Event|14|||
23570709|NCT02138747|65816869|FG002|Treatment Period 1|Adverse Event|2|||
23570710|NCT02138747|65816870|FG003|Treatment Period 1|Adverse Event|1|||
23570711|NCT02138747|65816867|FG000|Treatment Period 1|Lost to Follow-up|0|||
23570712|NCT02138747|65816868|FG001|Treatment Period 1|Lost to Follow-up|1|||
23570713|NCT02138747|65816869|FG002|Treatment Period 1|Lost to Follow-up|1|||
23570714|NCT02138747|65816870|FG003|Treatment Period 1|Lost to Follow-up|0|||
23570715|NCT02138747|65816867|FG000|Treatment Period 1|Protocol Violation|0|||
23570716|NCT02138747|65816868|FG001|Treatment Period 1|Protocol Violation|2|||
23570717|NCT02138747|65816869|FG002|Treatment Period 1|Protocol Violation|0|||
23570718|NCT02138747|65816870|FG003|Treatment Period 1|Protocol Violation|0|||
23570719|NCT02138747|65816867|FG000|Treatment Period 1|Withdrawal by Subject|8|||
23570720|NCT02138747|65816868|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23570721|NCT02138747|65816869|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23570722|NCT02138747|65816870|FG003|Treatment Period 1|Withdrawal by Subject|3|||
23570723|NCT02138747|65816867|FG000|Treatment Period 1|Other - Miscellaneous|2|||
23631601|NCT00706654|66038469|FG001|Conversion Phase|Adverse Event|0|||
23631602|NCT00706654|66038470|FG002|Conversion Phase|Adverse Event|0|||
23631603|NCT00706654|66038471|FG003|Conversion Phase|Adverse Event|0|||
23631604|NCT00706654|66038468|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
23631605|NCT00706654|66038469|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23631606|NCT00706654|66038470|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23631607|NCT00706654|66038471|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23631608|NCT00706654|66038468|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
23631609|NCT00706654|66038469|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23631610|NCT00706654|66038470|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23631611|NCT00706654|66038471|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23631612|NCT00706654|66038468|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
23631613|NCT00706654|66038469|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
23631614|NCT00706654|66038470|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
23631615|NCT00706654|66038471|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
23631616|NCT00706654|66038468|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
23631617|NCT00706654|66038469|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23631618|NCT00706654|66038470|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23631619|NCT00706654|66038471|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23631620|NCT00706654|66038468|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
23631621|NCT00706654|66038469|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23631622|NCT00706654|66038470|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23631623|NCT00706654|66038471|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23631624|NCT00706654|66038468|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
23631625|NCT00706654|66038469|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23631626|NCT00706654|66038470|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23631627|NCT00706654|66038471|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23769056|NCT01606306|66531968|FG005|Overall Study|Lost to Follow-up|5|||
23769057|NCT01606306|66531963|FG000|Overall Study|Withdrawal by Subject|4|||
23769058|NCT01606306|66531964|FG001|Overall Study|Withdrawal by Subject|3|||
23769059|NCT01606306|66531965|FG002|Overall Study|Withdrawal by Subject|4|||
23570724|NCT02138747|65816868|FG001|Treatment Period 1|Other - Miscellaneous|4|||
23570725|NCT02138747|65816869|FG002|Treatment Period 1|Other - Miscellaneous|0|||
23570726|NCT02138747|65816870|FG003|Treatment Period 1|Other - Miscellaneous|0|||
23570727|NCT02138747|65816867|FG000|Treatment Period 2|Adverse Event|6|||
23570728|NCT02138747|65816868|FG001|Treatment Period 2|Adverse Event|3|||
23570729|NCT02138747|65816869|FG002|Treatment Period 2|Adverse Event|1|||
23570730|NCT02138747|65816870|FG003|Treatment Period 2|Adverse Event|1|||
23570731|NCT02138747|65816867|FG000|Treatment Period 2|Lost to Follow-up|2|||
23570732|NCT02138747|65816868|FG001|Treatment Period 2|Lost to Follow-up|0|||
23570733|NCT02138747|65816869|FG002|Treatment Period 2|Lost to Follow-up|0|||
23570734|NCT02138747|65816870|FG003|Treatment Period 2|Lost to Follow-up|0|||
23570735|NCT02138747|65816867|FG000|Treatment Period 2|Protocol Violation|1|||
23570736|NCT02138747|65816868|FG001|Treatment Period 2|Protocol Violation|0|||
23570737|NCT02138747|65816869|FG002|Treatment Period 2|Protocol Violation|0|||
23570738|NCT02138747|65816870|FG003|Treatment Period 2|Protocol Violation|0|||
23570739|NCT02138747|65816867|FG000|Treatment Period 2|Withdrawal by Subject|5|||
23570740|NCT02138747|65816868|FG001|Treatment Period 2|Withdrawal by Subject|4|||
23570741|NCT02138747|65816869|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23570742|NCT02138747|65816870|FG003|Treatment Period 2|Withdrawal by Subject|2|||
23570743|NCT02138747|65816867|FG000|Treatment Period 2|Other - Miscellaneous|3|||
23570744|NCT02138747|65816868|FG001|Treatment Period 2|Other - Miscellaneous|0|||
23570745|NCT02138747|65816869|FG002|Treatment Period 2|Other - Miscellaneous|0|||
23570746|NCT02138747|65816870|FG003|Treatment Period 2|Other - Miscellaneous|0|||
23570747|NCT05764239|65816873|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
23769060|NCT01606306|66531966|FG003|Overall Study|Withdrawal by Subject|4|||
23769061|NCT01606306|66531967|FG004|Overall Study|Withdrawal by Subject|5|||
23769062|NCT01606306|66531968|FG005|Overall Study|Withdrawal by Subject|4|||
23769063|NCT01606306|66531963|FG000|Overall Study|Physician Decision|1|||
23769064|NCT01606306|66531964|FG001|Overall Study|Physician Decision|2|||
23769065|NCT01606306|66531965|FG002|Overall Study|Physician Decision|0|||
23769066|NCT01606306|66531966|FG003|Overall Study|Physician Decision|0|||
23769067|NCT01606306|66531967|FG004|Overall Study|Physician Decision|0|||
23769068|NCT01606306|66531968|FG005|Overall Study|Physician Decision|0|||
23769069|NCT01029353|66531969|FG000|Overall Study|Lost to Follow-up|4|||
23769070|NCT01029353|66531970|FG001|Overall Study|Lost to Follow-up|5|||
23769071|NCT01029353|66531971|FG002|Overall Study|Lost to Follow-up|5|||
23769072|NCT01029353|66531972|FG003|Overall Study|Lost to Follow-up|4|||
23769073|NCT01029353|66531969|FG000|Overall Study|Consent Withdrawn|2|||
23769074|NCT01029353|66531970|FG001|Overall Study|Consent Withdrawn|0|||
23769075|NCT01029353|66531971|FG002|Overall Study|Consent Withdrawn|0|||
23769076|NCT01029353|66531972|FG003|Overall Study|Consent Withdrawn|0|||
23769077|NCT01029353|66531969|FG000|Overall Study|Primary Outcome Indeterminate|1|||
23769078|NCT01029353|66531970|FG001|Overall Study|Primary Outcome Indeterminate|3|||
23769079|NCT01029353|66531971|FG002|Overall Study|Primary Outcome Indeterminate|2|||
23570748|NCT05764239|65816873|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
23570749|NCT05764239|65816873|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
23570750|NCT05764239|65816873|FG000|DEP (Part 1)|Adverse Event|1|||
23570751|NCT05764239|65816873|FG000|DEP (Part 1)|Lost to Follow-up|1|||
23570752|NCT05764239|65816873|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
23570753|NCT05764239|65816873|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
23769080|NCT01029353|66531972|FG003|Overall Study|Primary Outcome Indeterminate|0|||
23769081|NCT02153398|66531973|FG000|Overall Study|Withdrawal by Subject|1|||
23769082|NCT02153398|66531974|FG001|Overall Study|Withdrawal by Subject|0|||
23769083|NCT02153398|66531975|FG002|Overall Study|Withdrawal by Subject|0|||
23570754|NCT05764239|65816873|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
23570755|NCT05764239|65816873|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
23570756|NCT00154063|65816874|FG000|Overall Study|Adverse Event|4|||
23570757|NCT00154063|65816875|FG001|Overall Study|Adverse Event|8|||
23570758|NCT00154063|65816874|FG000|Overall Study|Protocol Violation|1|||
23570759|NCT00154063|65816875|FG001|Overall Study|Protocol Violation|1|||
23769084|NCT02153398|66531976|FG003|Overall Study|Withdrawal by Subject|0|||
23769085|NCT02153398|66531977|FG004|Overall Study|Withdrawal by Subject|0|||
23769086|NCT02153398|66531973|FG000|Overall Study|Adverse Event|0|||
23446939|NCT01684202|65377810|FG001|Dose-escalation Period|Adverse Event|1|||
23446940|NCT01684202|65377811|FG002|Dose-escalation Period|Adverse Event|0|||
23446941|NCT01684202|65377812|FG003|Dose-escalation Period|Adverse Event|0|||
23446942|NCT01684202|65377809|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
23446943|NCT01684202|65377810|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
23446944|NCT01684202|65377811|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
23446945|NCT01684202|65377812|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
23446946|NCT01684202|65377809|FG000|Maintenance Period|Adverse Event|1|||
23446947|NCT01684202|65377810|FG001|Maintenance Period|Adverse Event|1|||
23446948|NCT01684202|65377811|FG002|Maintenance Period|Adverse Event|1|||
23446949|NCT01684202|65377812|FG003|Maintenance Period|Adverse Event|1|||
23446950|NCT01684202|65377809|FG000|Maintenance Period|Physician Decision|0|||
23446951|NCT01684202|65377810|FG001|Maintenance Period|Physician Decision|1|||
23446952|NCT01684202|65377811|FG002|Maintenance Period|Physician Decision|0|||
23446953|NCT01684202|65377812|FG003|Maintenance Period|Physician Decision|0|||
23446954|NCT01684202|65377809|FG000|Maintenance Period|Withdrawal by Subject|0|||
23446955|NCT01684202|65377810|FG001|Maintenance Period|Withdrawal by Subject|1|||
23446956|NCT01684202|65377811|FG002|Maintenance Period|Withdrawal by Subject|0|||
23446957|NCT01684202|65377812|FG003|Maintenance Period|Withdrawal by Subject|0|||
23446958|NCT00687739|65377822|FG000|Overall Study|Lost to Follow-up|2|||
23446959|NCT00687739|65377823|FG001|Overall Study|Lost to Follow-up|2|||
23446960|NCT00687739|65377824|FG002|Overall Study|Lost to Follow-up|1|||
23446961|NCT00687739|65377825|FG003|Overall Study|Lost to Follow-up|2|||
23446962|NCT00687739|65377822|FG000|Overall Study|Adverse Event|0|||
23446963|NCT00687739|65377823|FG001|Overall Study|Adverse Event|1|||
23446964|NCT00687739|65377824|FG002|Overall Study|Adverse Event|1|||
23446965|NCT00687739|65377825|FG003|Overall Study|Adverse Event|0|||
23446966|NCT00410761|65377829|FG000|Overall Study|Adverse Event|29|||
23446967|NCT00410761|65377830|FG001|Overall Study|Adverse Event|3|||
23446968|NCT00410761|65377829|FG000|Overall Study|objective disease progression|71|||
23446969|NCT00410761|65377830|FG001|Overall Study|objective disease progression|55|||
23446970|NCT00410761|65377829|FG000|Overall Study|Withdrawal by Subject|8|||
23446971|NCT00410761|65377830|FG001|Overall Study|Withdrawal by Subject|4|||
23446972|NCT00410761|65377829|FG000|Overall Study|Other|12|||
23446973|NCT00410761|65377830|FG001|Overall Study|Other|9|||
23446974|NCT00410761|65377829|FG000|Overall Study|Never received randomised treatment|0|||
23570760|NCT00154063|65816874|FG000|Overall Study|Investigator or Sponsor Request|0|||
23570761|NCT00154063|65816875|FG001|Overall Study|Investigator or Sponsor Request|1|||
23570762|NCT00154063|65816874|FG000|Overall Study|Withdrawal by Subject|4|||
23570763|NCT00154063|65816875|FG001|Overall Study|Withdrawal by Subject|9|||
23570764|NCT00154063|65816874|FG000|Overall Study|Other|3|||
23570765|NCT00154063|65816875|FG001|Overall Study|Other|3|||
23570766|NCT02243631|65816876|FG000|Overall Study|no synovial fluid on second aspirate|0|||
23570767|NCT02243631|65816877|FG001|Overall Study|no synovial fluid on second aspirate|1|||
23570768|NCT01830881|65816880|FG000|Overall Study|Changed decision to have an abortion|0|||
23570769|NCT01830881|65816881|FG001|Overall Study|Changed decision to have an abortion|1|||
23446975|NCT00410761|65377830|FG001|Overall Study|Never received randomised treatment|1|||
23446976|NCT02525588|65377837|FG000|Overall Study|Death|3|||
23446977|NCT02525588|65377838|FG001|Overall Study|Death|1|||
23446978|NCT02525588|65377837|FG000|Overall Study|Lost to Follow-up|2|||
23446979|NCT02525588|65377838|FG001|Overall Study|Lost to Follow-up|0|||
23446980|NCT02525588|65377837|FG000|Overall Study|Withdrawal by Subject|1|||
23570770|NCT04267614|65820756|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
23570771|NCT04267614|65820756|FG000|Overall Study|Lost to Follow-up|115|||
23570772|NCT03017235|65820757|FG000|Overall Study|Withdrawal by Subject|4|||
23570773|NCT03017235|65820758|FG001|Overall Study|Withdrawal by Subject|3|||
23570774|NCT03017235|65820757|FG000|Overall Study|Lost to Follow-up|2|||
23570775|NCT03017235|65820758|FG001|Overall Study|Lost to Follow-up|7|||
23570776|NCT03017235|65820757|FG000|Overall Study|Adverse Event|0|||
23570777|NCT03017235|65820758|FG001|Overall Study|Adverse Event|1|||
23570778|NCT03017235|65820757|FG000|Overall Study|Protocol Violation|2|||
23570779|NCT03017235|65820758|FG001|Overall Study|Protocol Violation|1|||
23570780|NCT03017235|65820757|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
23570781|NCT03017235|65820758|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
23570782|NCT01368211|65820759|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
23570783|NCT01368211|65820760|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
23570784|NCT00363896|65820761|FG000|Overall Study|Withdrawal by Subject|29|||
23570785|NCT00363896|65820762|FG001|Overall Study|Withdrawal by Subject|16|||
23570786|NCT00363896|65820761|FG000|Overall Study|Adverse Event|24|||
23570787|NCT00363896|65820762|FG001|Overall Study|Adverse Event|13|||
23570788|NCT00363896|65820761|FG000|Overall Study|COPD exacerbation|13|||
23570789|NCT00363896|65820762|FG001|Overall Study|COPD exacerbation|7|||
23570790|NCT00363896|65820761|FG000|Overall Study|Lack of Efficacy|12|||
23570791|NCT00363896|65820762|FG001|Overall Study|Lack of Efficacy|8|||
23570792|NCT00363896|65820761|FG000|Overall Study|Protocol Violation|6|||
23570793|NCT00363896|65820762|FG001|Overall Study|Protocol Violation|1|||
23570794|NCT00363896|65820761|FG000|Overall Study|Lost to Follow-up|3|||
23570795|NCT00363896|65820762|FG001|Overall Study|Lost to Follow-up|0|||
23570796|NCT00363896|65820761|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
23570797|NCT00363896|65820762|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
23570798|NCT00363896|65820761|FG000|Overall Study|Other|1|||
23570799|NCT00363896|65820762|FG001|Overall Study|Other|2|||
23446981|NCT02525588|65377838|FG001|Overall Study|Withdrawal by Subject|1|||
23446982|NCT02525588|65377837|FG000|Overall Study|Adverse Event|0|||
23570800|NCT01563978|65820763|FG000|Overall Study|Physician Decision|1|||
23570801|NCT01563978|65820764|FG001|Overall Study|Physician Decision|0|||
23570802|NCT01563978|65820763|FG000|Overall Study|Lost to Follow-up|1|||
23570803|NCT01563978|65820764|FG001|Overall Study|Lost to Follow-up|0|||
23570804|NCT01563978|65820763|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
23570805|NCT01563978|65820764|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23570806|NCT01563978|65820763|FG000|Overall Study|Adverse Event|1|||
23446983|NCT02525588|65377838|FG001|Overall Study|Adverse Event|1|||
23446984|NCT03229109|65377840|FG000|Overall Study|Withdrawal by Subject|0|||
23446985|NCT03229109|65377841|FG001|Overall Study|Withdrawal by Subject|0|||
23446986|NCT03229109|65377842|FG002|Overall Study|Withdrawal by Subject|0|||
23446987|NCT03229109|65377843|FG003|Overall Study|Withdrawal by Subject|1|||
23446988|NCT01200368|65377844|FG000|Infant Series|Adverse Event|2|||
23446989|NCT01200368|65377845|FG001|Infant Series|Adverse Event|2|||
23446990|NCT01200368|65377846|FG002|Infant Series|Adverse Event|3|||
23446991|NCT01200368|65377844|FG000|Infant Series|Withdrawal by Subject|0|||
23446992|NCT01200368|65377845|FG001|Infant Series|Withdrawal by Subject|2|||
23446993|NCT01200368|65377846|FG002|Infant Series|Withdrawal by Subject|2|||
23830420|NCT03850483|66759942|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830421|NCT03850483|66759943|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
23830422|NCT03850483|66759944|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830423|NCT03850483|66759945|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830424|NCT03850483|66759946|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830425|NCT03850483|66759947|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830426|NCT03850483|66759948|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830427|NCT03850483|66759949|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830428|NCT03850483|66759950|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23830429|NCT03850483|66759941|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830430|NCT03850483|66759942|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830431|NCT03850483|66759943|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830432|NCT03850483|66759944|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830433|NCT03850483|66759945|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830434|NCT03850483|66759946|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
23830435|NCT03850483|66759947|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830436|NCT03850483|66759948|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830437|NCT03850483|66759949|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830438|NCT03850483|66759950|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23830439|NCT03850483|66759941|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
23830440|NCT03850483|66759942|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
23830441|NCT03850483|66759943|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
23830442|NCT03850483|66759944|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
23830443|NCT03850483|66759945|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
23446994|NCT01200368|65377844|FG000|Infant Series|Did not meet entrance criteria|0|||
23446995|NCT01200368|65377845|FG001|Infant Series|Did not meet entrance criteria|1|||
23830444|NCT03850483|66759946|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
23830445|NCT03850483|66759947|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
23830446|NCT03850483|66759948|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
23830447|NCT03850483|66759949|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
23570807|NCT01563978|65820764|FG001|Overall Study|Adverse Event|2|||
23570808|NCT02887989|65820769|FG000|Overall Study|Withdrawal by Subject|8|||
23570809|NCT02887989|65820770|FG001|Overall Study|Withdrawal by Subject|11|||
23570810|NCT02887989|65820769|FG000|Overall Study|Death|1|||
23570811|NCT02887989|65820770|FG001|Overall Study|Death|0|||
23570812|NCT03567993|65820771|FG000|Overall Study|Lost to Follow-up|4|||
23570813|NCT03567993|65820772|FG001|Overall Study|Lost to Follow-up|2|||
23570814|NCT03567993|65820771|FG000|Overall Study|Death|1|||
23570815|NCT03567993|65820772|FG001|Overall Study|Death|1|||
23570816|NCT03567993|65820771|FG000|Overall Study|Withdrawal by Subject|1|||
23570817|NCT03567993|65820772|FG001|Overall Study|Withdrawal by Subject|0|||
23570818|NCT01254565|65820777|FG000|Overall Study|Non-compliance to Study Procedures|0|||
23769087|NCT02153398|66531974|FG001|Overall Study|Adverse Event|0|||
23769088|NCT02153398|66531975|FG002|Overall Study|Adverse Event|1|||
23769089|NCT02153398|66531976|FG003|Overall Study|Adverse Event|1|||
23769090|NCT02153398|66531977|FG004|Overall Study|Adverse Event|0|||
23769091|NCT04480463|66531978|FG000|Overall Study|Death|0|||
23769092|NCT04480463|66531979|FG001|Overall Study|Death|1|||
23769093|NCT04480463|66531978|FG000|Overall Study|Adverse Event|6|||
23570819|NCT01254565|65820778|FG001|Overall Study|Non-compliance to Study Procedures|0|||
23570820|NCT01254565|65820779|FG002|Overall Study|Non-compliance to Study Procedures|0|||
23570821|NCT01254565|65820780|FG003|Overall Study|Non-compliance to Study Procedures|0|||
23769094|NCT04480463|66531979|FG001|Overall Study|Adverse Event|8|||
23570822|NCT01254565|65820781|FG004|Overall Study|Non-compliance to Study Procedures|1|||
23830448|NCT03850483|66759950|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
23830449|NCT03850483|66759941|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
23830450|NCT03850483|66759942|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
23830451|NCT03850483|66759943|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
23631628|NCT00706654|66038468|FG000|Oral Stabilization Phase|Withdrew consent|55|||
23631629|NCT00706654|66038469|FG001|Oral Stabilization Phase|Withdrew consent|0|||
23830452|NCT03850483|66759944|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
23830453|NCT03850483|66759945|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
23830454|NCT03850483|66759946|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
23830455|NCT03850483|66759947|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
23830456|NCT03850483|66759948|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
23830457|NCT03850483|66759949|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
23830458|NCT03850483|66759950|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
23830459|NCT03850483|66759941|FG000|Treatment for Stage 1|Death|0|||
23830460|NCT03850483|66759942|FG001|Treatment for Stage 1|Death|0|||
23830461|NCT03850483|66759943|FG002|Treatment for Stage 1|Death|0|||
23830462|NCT03850483|66759944|FG003|Treatment for Stage 1|Death|0|||
23830463|NCT03850483|66759945|FG004|Treatment for Stage 1|Death|0|||
23830464|NCT03850483|66759946|FG005|Treatment for Stage 1|Death|1|||
23830465|NCT03850483|66759947|FG006|Treatment for Stage 1|Death|0|||
23830466|NCT03850483|66759948|FG007|Treatment for Stage 1|Death|0|||
23830467|NCT03850483|66759949|FG008|Treatment for Stage 1|Death|0|||
23830468|NCT03850483|66759950|FG009|Treatment for Stage 1|Death|0|||
23830469|NCT03850483|66759941|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
23830470|NCT03850483|66759942|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
23830471|NCT03850483|66759943|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
23830472|NCT03850483|66759944|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
23830473|NCT03850483|66759945|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
23830474|NCT03850483|66759946|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
23830475|NCT03850483|66759947|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
23830476|NCT03850483|66759948|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
23830477|NCT03850483|66759949|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
23830478|NCT03850483|66759950|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
23830479|NCT03850483|66759941|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
23830480|NCT03850483|66759942|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
23830481|NCT03850483|66759943|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
23830482|NCT03850483|66759944|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
23830483|NCT03850483|66759945|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
23830484|NCT03850483|66759946|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
23830485|NCT03850483|66759947|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
23830486|NCT03850483|66759948|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
23830487|NCT03850483|66759949|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
23830488|NCT03850483|66759950|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
23631630|NCT00706654|66038470|FG002|Oral Stabilization Phase|Withdrew consent|0|||
23769095|NCT04480463|66531978|FG000|Overall Study|Lost to Follow-up|3|||
23631631|NCT00706654|66038471|FG003|Oral Stabilization Phase|Withdrew consent|0|||
23769096|NCT04480463|66531979|FG001|Overall Study|Lost to Follow-up|2|||
23769097|NCT04480463|66531978|FG000|Overall Study|Physician Decision|2|||
23769098|NCT04480463|66531979|FG001|Overall Study|Physician Decision|5|||
23769099|NCT04480463|66531978|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
23769100|NCT04480463|66531979|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
23769101|NCT04480463|66531978|FG000|Overall Study|Protocol Violation|2|||
23769102|NCT04480463|66531979|FG001|Overall Study|Protocol Violation|1|||
23769103|NCT04480463|66531978|FG000|Overall Study|Withdrawal by Subject|6|||
23769104|NCT04480463|66531979|FG001|Overall Study|Withdrawal by Subject|7|||
23769105|NCT04480463|66531978|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
23769106|NCT04480463|66531979|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
23769107|NCT04480463|66531978|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
23769108|NCT04480463|66531979|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
23782291|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
23631632|NCT00706654|66038468|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
23631633|NCT00706654|66038469|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
23631634|NCT00706654|66038470|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
23631635|NCT00706654|66038471|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
23769109|NCT04480463|66531978|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
23446996|NCT01200368|65377846|FG002|Infant Series|Did not meet entrance criteria|0|||
23446997|NCT01200368|65377844|FG000|Infant Series|Randomized, not vaccinated|0|||
23570823|NCT01254565|65820782|FG005|Overall Study|Non-compliance to Study Procedures|0|||
23570824|NCT01254565|65820777|FG000|Overall Study|Did not Receive Treatment|1|||
23570825|NCT01254565|65820778|FG001|Overall Study|Did not Receive Treatment|1|||
23570826|NCT01254565|65820779|FG002|Overall Study|Did not Receive Treatment|0|||
23570827|NCT01254565|65820780|FG003|Overall Study|Did not Receive Treatment|0|||
23570828|NCT01254565|65820781|FG004|Overall Study|Did not Receive Treatment|3|||
23570829|NCT01254565|65820782|FG005|Overall Study|Did not Receive Treatment|4|||
23570830|NCT01254565|65820777|FG000|Overall Study|Other|0|||
23570831|NCT01254565|65820778|FG001|Overall Study|Other|0|||
23570832|NCT01254565|65820779|FG002|Overall Study|Other|0|||
23570833|NCT01254565|65820780|FG003|Overall Study|Other|1|||
23570834|NCT01254565|65820781|FG004|Overall Study|Other|0|||
23570835|NCT01254565|65820782|FG005|Overall Study|Other|0|||
23570836|NCT01266993|65820783|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
23570837|NCT01266993|65820784|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
23570838|NCT01266993|65820783|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
23570839|NCT01266993|65820784|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
23570840|NCT01003184|65820788|FG000|Overall Study|Adverse Event|12|||
23570841|NCT01003184|65820789|FG001|Overall Study|Adverse Event|5|||
23570842|NCT01003184|65820788|FG000|Overall Study|Lost to Follow-up|1|||
23570843|NCT01003184|65820789|FG001|Overall Study|Lost to Follow-up|0|||
23570844|NCT01003184|65820788|FG000|Overall Study|Loss of glucose control|1|||
23570845|NCT01003184|65820789|FG001|Overall Study|Loss of glucose control|1|||
23570846|NCT01003184|65820788|FG000|Overall Study|Protocol Violation|3|||
23570847|NCT01003184|65820789|FG001|Overall Study|Protocol Violation|0|||
23570848|NCT01003184|65820788|FG000|Overall Study|Withdrawal by Subject|1|||
23570849|NCT01003184|65820789|FG001|Overall Study|Withdrawal by Subject|6|||
23570850|NCT01003184|65820788|FG000|Overall Study|Physician Decision|1|||
23570851|NCT01003184|65820789|FG001|Overall Study|Physician Decision|0|||
23570852|NCT00557622|65820812|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
23570853|NCT00557622|65820813|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
23570854|NCT00557622|65820812|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
23570855|NCT00557622|65820813|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
23570856|NCT00557622|65820812|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
23570857|NCT00557622|65820813|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
23570858|NCT01289041|65820814|FG000|Overall Study|Adverse Event|24|||
23570859|NCT01289041|65820814|FG000|Overall Study|Physician Decision|1|||
23570860|NCT01289041|65820814|FG000|Overall Study|Progressive Disease|41|||
23570861|NCT01289041|65820814|FG000|Overall Study|Withdrawal by Subject|3|||
23570862|NCT01289041|65820814|FG000|Overall Study|Death|1|||
23570863|NCT02533258|65820815|FG000|Overall Study|Adverse Event|1|||
23570864|NCT02533258|65820815|FG000|Overall Study|Death|2|||
23570865|NCT02533258|65820815|FG000|Overall Study|Other|1|||
23570866|NCT02533258|65820815|FG000|Overall Study|Economic factor|1|||
23570867|NCT02533258|65820815|FG000|Overall Study|Progression of pleural effusion|1|||
23570868|NCT02533258|65820815|FG000|Overall Study|Lack of Efficacy|2|||
23570869|NCT02141659|65820816|FG000|Overall Study|Major Protocol Deviation|0|||
23570870|NCT02141659|65820817|FG001|Overall Study|Major Protocol Deviation|1|||
23570871|NCT02141659|65820818|FG002|Overall Study|Major Protocol Deviation|0|||
23570872|NCT02141659|65820819|FG003|Overall Study|Major Protocol Deviation|0|||
23570873|NCT02141659|65820820|FG004|Overall Study|Major Protocol Deviation|0|||
23570874|NCT02141659|65820821|FG005|Overall Study|Major Protocol Deviation|0|||
23570875|NCT02141659|65820816|FG000|Overall Study|Lack of Efficacy|0|||
23570876|NCT02141659|65820817|FG001|Overall Study|Lack of Efficacy|0|||
23570877|NCT02141659|65820818|FG002|Overall Study|Lack of Efficacy|0|||
23570878|NCT02141659|65820819|FG003|Overall Study|Lack of Efficacy|0|||
23570879|NCT02141659|65820820|FG004|Overall Study|Lack of Efficacy|0|||
23570880|NCT02141659|65820821|FG005|Overall Study|Lack of Efficacy|1|||
23570881|NCT02141659|65820816|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
23631636|NCT00706654|66038468|FG000|Oral Stabilization Phase|Adverse Event|21|||
23631637|NCT00706654|66038469|FG001|Oral Stabilization Phase|Adverse Event|0|||
23570882|NCT02141659|65820817|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570883|NCT02141659|65820818|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570884|NCT02141659|65820819|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570885|NCT02141659|65820820|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
23570886|NCT02141659|65820821|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
23570887|NCT01591460|65820824|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
23570888|NCT01591460|65820824|FG000|Overall Study|Futility Rule (Week 12)|7|||
23570889|NCT01591460|65820824|FG000|Overall Study|Futility Rule (Week 24)|3|||
23570890|NCT01591460|65820824|FG000|Overall Study|Rebound or Breakthrough|3|||
23570891|NCT01591460|65820824|FG000|Overall Study|Treatment Discontinued by Error|1|||
23570892|NCT01591460|65820824|FG000|Overall Study|Lost to Follow-up|1|||
23570893|NCT01591460|65820824|FG000|Overall Study|Noncompliance|1|||
23570894|NCT01591460|65820824|FG000|Overall Study|Participant Refusal|3|||
23570895|NCT01591460|65820824|FG000|Overall Study|Withdrawal by Subject|1|||
23570896|NCT01591460|65820824|FG000|Overall Study|Protocol Violation|1|||
23570897|NCT00429494|65820827|FG000|Overall Study|Withdrawal by Subject|9|||
23570898|NCT00429494|65820827|FG000|Overall Study|Death|6|||
23631638|NCT00706654|66038470|FG002|Oral Stabilization Phase|Adverse Event|0|||
23631639|NCT00706654|66038471|FG003|Oral Stabilization Phase|Adverse Event|0|||
23631640|NCT00706654|66038468|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
23631641|NCT00706654|66038469|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23631642|NCT00706654|66038470|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23631643|NCT00706654|66038471|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23631644|NCT00706654|66038468|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
23631645|NCT00706654|66038469|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23570899|NCT00569803|65820828|FG000|Overall Study|Lost to Follow-up|1|||
23570900|NCT00569803|65820829|FG001|Overall Study|Lost to Follow-up|0|||
23570901|NCT00569803|65820830|FG002|Overall Study|Lost to Follow-up|0|||
23570902|NCT00569803|65820831|FG003|Overall Study|Lost to Follow-up|0|||
23570903|NCT00569803|65820832|FG004|Overall Study|Lost to Follow-up|0|||
23570904|NCT00569803|65820833|FG005|Overall Study|Lost to Follow-up|0|||
23570905|NCT00569803|65820834|FG006|Overall Study|Lost to Follow-up|0|||
23570906|NCT00569803|65820835|FG007|Overall Study|Lost to Follow-up|0|||
23570907|NCT00569803|65820828|FG000|Overall Study|injection syringe leaked during dosing|0|||
23570908|NCT00569803|65820829|FG001|Overall Study|injection syringe leaked during dosing|0|||
23570909|NCT00569803|65820830|FG002|Overall Study|injection syringe leaked during dosing|0|||
23570910|NCT00569803|65820831|FG003|Overall Study|injection syringe leaked during dosing|1|||
23570911|NCT00569803|65820832|FG004|Overall Study|injection syringe leaked during dosing|0|||
23570912|NCT00569803|65820833|FG005|Overall Study|injection syringe leaked during dosing|0|||
23570913|NCT00569803|65820834|FG006|Overall Study|injection syringe leaked during dosing|0|||
23570914|NCT00569803|65820835|FG007|Overall Study|injection syringe leaked during dosing|0|||
23570915|NCT00569803|65820828|FG000|Overall Study|Withdrawal by Subject|0|||
23570916|NCT00569803|65820829|FG001|Overall Study|Withdrawal by Subject|0|||
23570917|NCT00569803|65820830|FG002|Overall Study|Withdrawal by Subject|0|||
23570918|NCT00569803|65820831|FG003|Overall Study|Withdrawal by Subject|0|||
23570919|NCT00569803|65820832|FG004|Overall Study|Withdrawal by Subject|0|||
23570920|NCT00569803|65820833|FG005|Overall Study|Withdrawal by Subject|0|||
23570921|NCT00569803|65820834|FG006|Overall Study|Withdrawal by Subject|0|||
23631646|NCT00706654|66038470|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23631647|NCT00706654|66038471|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23631648|NCT00706654|66038468|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
23631649|NCT00706654|66038469|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
23631650|NCT00706654|66038470|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
23631651|NCT00706654|66038471|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
23631652|NCT00706654|66038468|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
23570922|NCT00569803|65820835|FG007|Overall Study|Withdrawal by Subject|1|||
23570923|NCT02258464|65820836|FG000|Overall Study|Progressive disease (PD)|9|||
23631653|NCT00706654|66038469|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
23631654|NCT00706654|66038470|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
23631655|NCT00706654|66038471|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
23631656|NCT00706654|66038468|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
23631657|NCT00706654|66038469|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23631658|NCT00706654|66038470|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
23631659|NCT00706654|66038471|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23631660|NCT00706654|66038468|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
23631661|NCT00706654|66038469|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
23570924|NCT02258464|65820837|FG001|Overall Study|Progressive disease (PD)|17|||
23570925|NCT02258464|65820836|FG000|Overall Study|Study drug never administered|1|||
23570926|NCT02258464|65820837|FG001|Overall Study|Study drug never administered|1|||
23631662|NCT00706654|66038470|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
23631663|NCT00706654|66038471|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
23631664|NCT00706654|66038468|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
23631665|NCT00706654|66038469|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
23769110|NCT04480463|66531979|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
23769111|NCT04480463|66531978|FG000|Overall Study|Other|6|||
23769112|NCT04480463|66531979|FG001|Overall Study|Other|4|||
23570927|NCT02258464|65820836|FG000|Overall Study|AE not related to clinical PD|1|||
23570928|NCT02258464|65820837|FG001|Overall Study|AE not related to clinical PD|3|||
23631666|NCT00706654|66038470|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
23631667|NCT00706654|66038471|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
23631668|NCT00706654|66038468|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
23631669|NCT00706654|66038469|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
23631670|NCT00706654|66038470|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
23631671|NCT00706654|66038471|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
23570929|NCT02258464|65820836|FG000|Overall Study|Withdrawal by Subject|5|||
23570930|NCT02258464|65820837|FG001|Overall Study|Withdrawal by Subject|4|||
23570931|NCT02258464|65820836|FG000|Overall Study|AE related to clinical PD|1|||
23570932|NCT02258464|65820837|FG001|Overall Study|AE related to clinical PD|0|||
23570933|NCT01558674|65820838|FG000|Part 1|Study Terminated by Sponsor|10|||
23570934|NCT01558674|65820839|FG001|Part 1|Study Terminated by Sponsor|0|||
23570935|NCT01558674|65820838|FG000|Part 1|Withdrawal by Subject|1|||
23570936|NCT01558674|65820839|FG001|Part 1|Withdrawal by Subject|0|||
23570937|NCT00785538|65820840|FG000|Treatment Period|Adverse Event|1|||
23570938|NCT00785538|65820841|FG001|Treatment Period|Adverse Event|2|||
23570939|NCT00785538|65820842|FG002|Treatment Period|Adverse Event|2|||
23570940|NCT00785538|65820843|FG003|Treatment Period|Adverse Event|0|||
23570941|NCT00785538|65820840|FG000|Treatment Period|Withdrawal by Subject|0|||
23570942|NCT00785538|65820841|FG001|Treatment Period|Withdrawal by Subject|0|||
23570943|NCT00785538|65820842|FG002|Treatment Period|Withdrawal by Subject|0|||
23631672|NCT00706654|66038468|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
23631673|NCT00706654|66038469|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
23631674|NCT00706654|66038470|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
23631675|NCT00706654|66038471|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
23631676|NCT00706654|66038468|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
23631677|NCT00706654|66038469|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
23631678|NCT00706654|66038470|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
23631679|NCT00706654|66038471|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
23631680|NCT03809039|66038478|FG000|Part 1|Withdrawal by Subject|1|||
23631681|NCT03809039|66038479|FG001|Part 1|Withdrawal by Subject|0|||
23631682|NCT03809039|66038480|FG002|Part 1|Withdrawal by Subject|0|||
23631683|NCT03809039|66038481|FG003|Part 1|Withdrawal by Subject|1|||
23631684|NCT03809039|66038482|FG004|Part 1|Withdrawal by Subject|0|||
23570944|NCT00785538|65820843|FG003|Treatment Period|Withdrawal by Subject|1|||
23570945|NCT04022889|65820846|FG000|Stage 1: Period 1|Adverse Event|1|||
23631685|NCT03809039|66038483|FG005|Part 1|Withdrawal by Subject|0|||
23631686|NCT03809039|66038484|FG006|Part 1|Withdrawal by Subject|0|||
23631687|NCT03809039|66038485|FG007|Part 1|Withdrawal by Subject|0|||
23631688|NCT03809039|66038486|FG008|Part 1|Withdrawal by Subject|0|||
23631689|NCT03809039|66038478|FG000|Part 3|Withdrawn by study termination|0|||
23570946|NCT04022889|65820847|FG001|Stage 1: Period 1|Adverse Event|0|||
23570947|NCT04022889|65820848|FG002|Stage 1: Period 1|Adverse Event|0|||
23582246|NCT00567879|65862413|FG003|Overall Study|Abnormal test procedure(s)|0|||
23570948|NCT04022889|65820846|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
23570949|NCT04022889|65820847|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
23570950|NCT04022889|65820848|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
23570951|NCT04022889|65820846|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
23570952|NCT04022889|65820847|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
23570953|NCT04022889|65820848|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
23570954|NCT04022889|65820846|FG000|Stage 2|Screen Failure|0|||
23570955|NCT04022889|65820847|FG001|Stage 2|Screen Failure|0|||
23570956|NCT04022889|65820848|FG002|Stage 2|Screen Failure|3|||
23769113|NCT01077713|66531980|FG000|Overall Study|Withdrawal by Subject|1|||
23769114|NCT01077713|66531981|FG001|Overall Study|Withdrawal by Subject|2|||
23769115|NCT01077713|66531980|FG000|Overall Study|Progressive Disease (PD)|0|||
23769116|NCT01077713|66531981|FG001|Overall Study|Progressive Disease (PD)|1|||
23769117|NCT01077713|66531980|FG000|Overall Study|Death|28|||
23769118|NCT01077713|66531981|FG001|Overall Study|Death|29|||
23769119|NCT01077713|66531980|FG000|Overall Study|Lost to Follow-up|1|||
23769120|NCT01077713|66531981|FG001|Overall Study|Lost to Follow-up|1|||
23769121|NCT01077713|66531980|FG000|Overall Study|Adverse Event|2|||
23769122|NCT01077713|66531981|FG001|Overall Study|Adverse Event|1|||
23570957|NCT04022889|65820846|FG000|Stage 2|Ineligible for apheresis donation|0|||
23570958|NCT04022889|65820847|FG001|Stage 2|Ineligible for apheresis donation|0|||
23570959|NCT04022889|65820848|FG002|Stage 2|Ineligible for apheresis donation|2|||
23570960|NCT04022889|65820846|FG000|Stage 2|Adverse Event|0|||
23570961|NCT04022889|65820847|FG001|Stage 2|Adverse Event|0|||
23570962|NCT04022889|65820848|FG002|Stage 2|Adverse Event|2|||
23570963|NCT04022889|65820846|FG000|Stage 2|Protocol Violation|0|||
23570964|NCT04022889|65820847|FG001|Stage 2|Protocol Violation|0|||
23570965|NCT04022889|65820848|FG002|Stage 2|Protocol Violation|1|||
23570966|NCT04022889|65820846|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
23570967|NCT04022889|65820847|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
23570968|NCT04022889|65820848|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
23769123|NCT01077713|66531980|FG000|Overall Study|Other|4|||
23769124|NCT01077713|66531981|FG001|Overall Study|Other|2|||
23769125|NCT02236130|66531982|FG000|Overall Study|Lost to Follow-up|7|||
23769126|NCT02236130|66531983|FG001|Overall Study|Lost to Follow-up|12|||
23570969|NCT01816763|65820849|FG000|Overall Study|The main reason for an incomplete survey|4|||
23769127|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
23769128|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23769129|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
23769130|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
23570970|NCT01816763|65820850|FG001|Overall Study|The main reason for an incomplete survey|15|||
23570971|NCT01816763|65820851|FG002|Overall Study|The main reason for an incomplete survey|11|||
23570972|NCT03548064|65820852|FG000|Overall Study|Withdrawal by Subject|0|||
23570973|NCT03548064|65820853|FG001|Overall Study|Withdrawal by Subject|0|||
23570974|NCT03548064|65820854|FG002|Overall Study|Withdrawal by Subject|0|||
23570975|NCT03548064|65820855|FG003|Overall Study|Withdrawal by Subject|1|||
23570976|NCT03548064|65820856|FG004|Overall Study|Withdrawal by Subject|0|||
23570977|NCT03548064|65820857|FG005|Overall Study|Withdrawal by Subject|0|||
23570978|NCT03548064|65820858|FG006|Overall Study|Withdrawal by Subject|0|||
23570979|NCT03548064|65820859|FG007|Overall Study|Withdrawal by Subject|0|||
23570980|NCT03548064|65820852|FG000|Overall Study|Lost to Follow-up|0|||
23570981|NCT03548064|65820853|FG001|Overall Study|Lost to Follow-up|0|||
23570982|NCT03548064|65820854|FG002|Overall Study|Lost to Follow-up|0|||
23570983|NCT03548064|65820855|FG003|Overall Study|Lost to Follow-up|0|||
23570984|NCT03548064|65820856|FG004|Overall Study|Lost to Follow-up|2|||
23570985|NCT03548064|65820857|FG005|Overall Study|Lost to Follow-up|0|||
23570986|NCT03548064|65820858|FG006|Overall Study|Lost to Follow-up|0|||
23570987|NCT03548064|65820859|FG007|Overall Study|Lost to Follow-up|0|||
23570988|NCT03548064|65820852|FG000|Overall Study|Covid-19 Pandemic|0|||
23570989|NCT03548064|65820853|FG001|Overall Study|Covid-19 Pandemic|0|||
23570990|NCT03548064|65820854|FG002|Overall Study|Covid-19 Pandemic|0|||
23570991|NCT03548064|65820855|FG003|Overall Study|Covid-19 Pandemic|0|||
23570992|NCT03548064|65820856|FG004|Overall Study|Covid-19 Pandemic|10|||
23570993|NCT03548064|65820857|FG005|Overall Study|Covid-19 Pandemic|3|||
23570994|NCT03548064|65820858|FG006|Overall Study|Covid-19 Pandemic|0|||
23570995|NCT03548064|65820859|FG007|Overall Study|Covid-19 Pandemic|0|||
23570996|NCT00238420|65820860|FG000|Overall Study|Protocol Violation|1|||
23570997|NCT00238420|65820861|FG001|Overall Study|Protocol Violation|1|||
23570998|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
23570999|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
23571000|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
23571001|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
23571002|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
23571003|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
23571004|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
23571005|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
23571006|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
23571007|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
23571008|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
23571009|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
23571010|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
23571011|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
23571012|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
23571013|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
23571014|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
23571015|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
23571016|NCT02023879|65820862|FG000|Extension Open Label Treatment|Adverse Event|1|||
23571017|NCT02023879|65820863|FG001|Extension Open Label Treatment|Adverse Event|7|||
23571018|NCT02023879|65820864|FG002|Extension Open Label Treatment|Adverse Event|3|||
23571019|NCT02023879|65820862|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
23571020|NCT02023879|65820863|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
23571021|NCT02023879|65820864|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
23571022|NCT02023879|65820862|FG000|Extension Open Label Treatment|Participant moved|1|||
23571023|NCT02023879|65820863|FG001|Extension Open Label Treatment|Participant moved|2|||
23571024|NCT02023879|65820864|FG002|Extension Open Label Treatment|Participant moved|0|||
23571025|NCT02023879|65820862|FG000|Extension Open Label Treatment|Other than specified above|2|||
23571026|NCT02023879|65820863|FG001|Extension Open Label Treatment|Other than specified above|7|||
23571027|NCT02023879|65820864|FG002|Extension Open Label Treatment|Other than specified above|2|||
23571028|NCT01539863|65820865|FG000|Overall Study|Lost to Follow-up|5|||
23571029|NCT01539863|65820866|FG001|Overall Study|Lost to Follow-up|4|||
23571030|NCT03462706|65820867|FG000|Overall Study|Polyp was pedunculated|1|||
23571031|NCT03462706|65820868|FG001|Overall Study|Polyp was pedunculated|0|||
23571032|NCT03462706|65820869|FG002|Overall Study|Polyp was pedunculated|1|||
23571033|NCT03462706|65820870|FG003|Overall Study|Polyp was pedunculated|0|||
23571034|NCT03462706|65820867|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
23571035|NCT03462706|65820868|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
23571036|NCT03462706|65820869|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
23571037|NCT03462706|65820870|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
23571038|NCT02406261|65820871|FG000|Period 1|Lost to Follow-up|2|||
23571039|NCT02406261|65820872|FG001|Period 1|Lost to Follow-up|0|||
23571040|NCT02406261|65820871|FG000|Period 1|Adverse Event|1|||
23571041|NCT02406261|65820872|FG001|Period 1|Adverse Event|0|||
23571042|NCT02406261|65820871|FG000|Period 2|Physician Decision|0|||
23571043|NCT02406261|65820872|FG001|Period 2|Physician Decision|1|||
23571044|NCT02406261|65820871|FG000|Period 2|Protocol Violation|0|||
23571045|NCT02406261|65820872|FG001|Period 2|Protocol Violation|1|||
23571046|NCT02406261|65820871|FG000|Period 2|Withdrawal by Subject|0|||
23571047|NCT02406261|65820872|FG001|Period 2|Withdrawal by Subject|1|||
23571048|NCT00309608|65820874|FG000|Overall Study|Adverse Event|1|||
23571049|NCT00309608|65820875|FG001|Overall Study|Adverse Event|5|||
23571050|NCT00309608|65820876|FG002|Overall Study|Adverse Event|3|||
23571051|NCT00309608|65820877|FG003|Overall Study|Adverse Event|2|||
23571052|NCT00309608|65820878|FG004|Overall Study|Adverse Event|3|||
23571053|NCT00309608|65820874|FG000|Overall Study|Protocol Violation|2|||
23571054|NCT00309608|65820875|FG001|Overall Study|Protocol Violation|0|||
23571055|NCT00309608|65820876|FG002|Overall Study|Protocol Violation|0|||
23571056|NCT00309608|65820877|FG003|Overall Study|Protocol Violation|0|||
23571057|NCT00309608|65820878|FG004|Overall Study|Protocol Violation|0|||
23571058|NCT00309608|65820874|FG000|Overall Study|Lost to Follow-up|0|||
23571059|NCT00309608|65820875|FG001|Overall Study|Lost to Follow-up|0|||
23571060|NCT00309608|65820876|FG002|Overall Study|Lost to Follow-up|2|||
23571061|NCT00309608|65820877|FG003|Overall Study|Lost to Follow-up|0|||
23571062|NCT00309608|65820878|FG004|Overall Study|Lost to Follow-up|1|||
23571063|NCT00309608|65820874|FG000|Overall Study|Withdrawal by Subject|1|||
23571064|NCT00309608|65820875|FG001|Overall Study|Withdrawal by Subject|4|||
23571065|NCT00309608|65820876|FG002|Overall Study|Withdrawal by Subject|2|||
23571066|NCT00309608|65820877|FG003|Overall Study|Withdrawal by Subject|0|||
23571067|NCT00309608|65820878|FG004|Overall Study|Withdrawal by Subject|0|||
23571068|NCT00309608|65820874|FG000|Overall Study|Other incl. Lack of efficacy|10|||
23571069|NCT00309608|65820875|FG001|Overall Study|Other incl. Lack of efficacy|4|||
23571070|NCT00309608|65820876|FG002|Overall Study|Other incl. Lack of efficacy|3|||
23571071|NCT00309608|65820877|FG003|Overall Study|Other incl. Lack of efficacy|4|||
23571072|NCT00309608|65820878|FG004|Overall Study|Other incl. Lack of efficacy|0|||
23446998|NCT01200368|65377845|FG001|Infant Series|Randomized, not vaccinated|1|||
23446999|NCT01200368|65377846|FG002|Infant Series|Randomized, not vaccinated|1|||
23571073|NCT01394250|65820880|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
23571074|NCT01394250|65820881|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
23571075|NCT01394250|65820880|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
23571076|NCT01394250|65820881|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
23571077|NCT01189890|65820884|FG000|Overall Study|Adverse Event|3|||
23571078|NCT01189890|65820885|FG001|Overall Study|Adverse Event|4|||
23571079|NCT01189890|65820884|FG000|Overall Study|Lack of Efficacy|7|||
23571080|NCT01189890|65820885|FG001|Overall Study|Lack of Efficacy|2|||
23571081|NCT01189890|65820884|FG000|Overall Study|Lost to Follow-up|1|||
23571082|NCT01189890|65820885|FG001|Overall Study|Lost to Follow-up|7|||
23571083|NCT01189890|65820884|FG000|Overall Study|Protocol Violation|1|||
23571084|NCT01189890|65820885|FG001|Overall Study|Protocol Violation|5|||
23571085|NCT01189890|65820884|FG000|Overall Study|Withdrawal by Subject|15|||
23571086|NCT01189890|65820885|FG001|Overall Study|Withdrawal by Subject|11|||
23571087|NCT01189890|65820884|FG000|Overall Study|Non Compliance|0|||
23631690|NCT03809039|66038479|FG001|Part 3|Withdrawn by study termination|0|||
23631691|NCT03809039|66038480|FG002|Part 3|Withdrawn by study termination|0|||
23631692|NCT03809039|66038481|FG003|Part 3|Withdrawn by study termination|0|||
23631693|NCT03809039|66038482|FG004|Part 3|Withdrawn by study termination|0|||
23631694|NCT03809039|66038483|FG005|Part 3|Withdrawn by study termination|0|||
23631695|NCT03809039|66038484|FG006|Part 3|Withdrawn by study termination|0|||
23631696|NCT03809039|66038485|FG007|Part 3|Withdrawn by study termination|2|||
23631697|NCT03809039|66038486|FG008|Part 3|Withdrawn by study termination|6|||
23631698|NCT03392168|66038487|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
23631699|NCT03392168|66038488|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
23447000|NCT01200368|65377844|FG000|Infant Series|Other|1|||
23447001|NCT01200368|65377845|FG001|Infant Series|Other|0|||
23571088|NCT01189890|65820885|FG001|Overall Study|Non Compliance|1|||
23571089|NCT01189890|65820884|FG000|Overall Study|Physician Decision|5|||
23571090|NCT01189890|65820885|FG001|Overall Study|Physician Decision|4|||
23571091|NCT01189890|65820884|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
23571092|NCT01189890|65820885|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
23571093|NCT01622348|65820892|FG000|Overall Study|Withdrawal by Subject|1|||
23571094|NCT01622348|65820893|FG001|Overall Study|Withdrawal by Subject|0|||
23571095|NCT01622348|65820894|FG002|Overall Study|Withdrawal by Subject|1|||
23571096|NCT03525574|65820898|FG000|Overall Study|Adverse Event|15|||
23571097|NCT03525574|65820899|FG001|Overall Study|Adverse Event|0|||
23571098|NCT03525574|65820898|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
23631700|NCT03392168|66038489|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
23571099|NCT03525574|65820899|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
23571100|NCT03525574|65820898|FG000|Overall Study|Lost to Follow-up|4|||
23571101|NCT03525574|65820899|FG001|Overall Study|Lost to Follow-up|0|||
23571102|NCT03525574|65820898|FG000|Overall Study|Commercial drug is Available for participant|48|||
23571103|NCT03525574|65820899|FG001|Overall Study|Commercial drug is Available for participant|0|||
23571104|NCT03525574|65820898|FG000|Overall Study|Death|1|||
23571105|NCT03525574|65820899|FG001|Overall Study|Death|0|||
23571106|NCT03525574|65820898|FG000|Overall Study|Other non-compliance|2|||
23769131|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23769132|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23769133|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
23769134|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
23769135|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
23769136|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
23769137|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
23769138|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
23769139|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
23769140|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
23769141|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
23769142|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
23769143|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
23769144|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
23769145|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23769146|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23769147|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23769148|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23769149|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23769150|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
23769151|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23571107|NCT03525574|65820899|FG001|Overall Study|Other non-compliance|0|||
23571108|NCT03525574|65820898|FG000|Overall Study|Physician Decision|6|||
23571109|NCT03525574|65820899|FG001|Overall Study|Physician Decision|0|||
23571110|NCT03525574|65820898|FG000|Overall Study|Other|58|||
23571111|NCT03525574|65820899|FG001|Overall Study|Other|0|||
23571112|NCT03525574|65820898|FG000|Overall Study|Enrolled but never dosed|1|||
23571113|NCT03525574|65820899|FG001|Overall Study|Enrolled but never dosed|0|||
23571114|NCT03525574|65820898|FG000|Overall Study|Not enrolled in 105 study|0|||
23571115|NCT03525574|65820899|FG001|Overall Study|Not enrolled in 105 study|3|||
23571116|NCT03918239|65820900|FG000|Overall Study|Lost to Follow-up|3|||
23571117|NCT03918239|65820901|FG001|Overall Study|Lost to Follow-up|1|||
23571118|NCT03918239|65820900|FG000|Overall Study|Pregnancy|0|||
23571119|NCT03918239|65820901|FG001|Overall Study|Pregnancy|2|||
23769152|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23769153|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23769154|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23769155|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
23769156|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23769157|NCT01957488|66535500|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
23769158|NCT01957488|66535501|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
23769159|NCT01957488|66535502|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
23769160|NCT01957488|66535503|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
23769161|NCT01957488|66535504|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
23769162|NCT01957488|66535505|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
23769163|NCT01957488|66535500|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
23769164|NCT01957488|66535501|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23769165|NCT01957488|66535502|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
23769166|NCT01957488|66535503|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
23769167|NCT01957488|66535504|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23769168|NCT01957488|66535505|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23769169|NCT01957488|66535500|FG000|Test Period 2 (2 Weeks)|Other|1|||
23769170|NCT01957488|66535501|FG001|Test Period 2 (2 Weeks)|Other|0|||
23769171|NCT01957488|66535502|FG002|Test Period 2 (2 Weeks)|Other|0|||
23769172|NCT01957488|66535503|FG003|Test Period 2 (2 Weeks)|Other|0|||
23769173|NCT01957488|66535504|FG004|Test Period 2 (2 Weeks)|Other|0|||
23769174|NCT01957488|66535505|FG005|Test Period 2 (2 Weeks)|Other|0|||
23571120|NCT03918239|65820900|FG000|Overall Study|Withdrawal by Subject|3|||
23571121|NCT03918239|65820901|FG001|Overall Study|Withdrawal by Subject|3|||
23571122|NCT03918239|65820900|FG000|Overall Study|positive urine drug screening results|4|||
23769175|NCT01957488|66535500|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23769176|NCT01957488|66535501|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
23571123|NCT03918239|65820901|FG001|Overall Study|positive urine drug screening results|1|||
23571124|NCT00972543|65820902|FG000|Overall Study|Adverse Event|1|||
23571125|NCT00972543|65820903|FG001|Overall Study|Adverse Event|0|||
23769177|NCT01957488|66535502|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23769178|NCT01957488|66535503|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23769179|NCT01957488|66535504|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23769180|NCT01957488|66535505|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23769181|NCT01957488|66535500|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
23769182|NCT01957488|66535501|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
23769183|NCT01957488|66535502|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
23769184|NCT01957488|66535503|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
23769185|NCT01957488|66535504|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
23769186|NCT01957488|66535505|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
23769187|NCT01957488|66535500|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23769188|NCT01957488|66535501|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23769189|NCT01957488|66535502|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23769190|NCT01957488|66535503|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23769191|NCT01957488|66535504|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23769192|NCT01957488|66535505|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
23769193|NCT01957488|66535500|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
23769194|NCT01957488|66535501|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23769195|NCT01957488|66535502|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23447002|NCT01200368|65377846|FG002|Infant Series|Other|0|||
23447003|NCT01200368|65377844|FG000|After Infant Series|Adverse Event|6|||
23447004|NCT01200368|65377845|FG001|After Infant Series|Adverse Event|6|||
23447005|NCT01200368|65377846|FG002|After Infant Series|Adverse Event|3|||
23447006|NCT01200368|65377844|FG000|After Infant Series|Withdrawal by Subject|10|||
23447007|NCT01200368|65377845|FG001|After Infant Series|Withdrawal by Subject|8|||
23447008|NCT01200368|65377846|FG002|After Infant Series|Withdrawal by Subject|4|||
23447009|NCT01200368|65377844|FG000|After Infant Series|Lost to Follow-up|1|||
23447010|NCT01200368|65377845|FG001|After Infant Series|Lost to Follow-up|0|||
23447011|NCT01200368|65377846|FG002|After Infant Series|Lost to Follow-up|0|||
23447012|NCT01200368|65377844|FG000|After Infant Series|Other|1|||
23769196|NCT01957488|66535503|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23769197|NCT01957488|66535504|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23769198|NCT01957488|66535505|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23769199|NCT01957488|66535500|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23769200|NCT01957488|66535501|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
23769201|NCT01957488|66535502|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23769202|NCT01957488|66535503|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23769203|NCT01957488|66535504|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23769204|NCT01957488|66535505|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23769205|NCT02658084|66535508|FG000|Overall Study|Withdrawal by Subject|1|||
23769206|NCT02658084|66535509|FG001|Overall Study|Withdrawal by Subject|0|||
23769207|NCT02658084|66535508|FG000|Overall Study|Study Termination|1|||
23769208|NCT02658084|66535509|FG001|Overall Study|Study Termination|0|||
23769209|NCT01521559|66535511|FG000|Overall Study|Adverse Event|0|||
23769210|NCT01521559|66535512|FG001|Overall Study|Adverse Event|4|||
23769211|NCT01521559|66535511|FG000|Overall Study|Death|1|||
23769212|NCT01521559|66535512|FG001|Overall Study|Death|0|||
23769213|NCT01521559|66535511|FG000|Overall Study|Withdrawal by Subject|9|||
23769214|NCT01521559|66535512|FG001|Overall Study|Withdrawal by Subject|11|||
23769215|NCT01521559|66535511|FG000|Overall Study|Lost to Follow-up|3|||
23769216|NCT01521559|66535512|FG001|Overall Study|Lost to Follow-up|1|||
23769217|NCT01521559|66535511|FG000|Overall Study|Protocol Violation|1|||
23769218|NCT01521559|66535512|FG001|Overall Study|Protocol Violation|0|||
23769219|NCT01521559|66535511|FG000|Overall Study|Other|1|||
23769220|NCT01521559|66535512|FG001|Overall Study|Other|2|||
23769221|NCT01249664|66535513|FG000|Overall Study|Withdrawal by Subject|5|||
23769222|NCT01249664|66535514|FG001|Overall Study|Withdrawal by Subject|0|||
23769223|NCT01249664|66535513|FG000|Overall Study|Adverse Event|1|||
23447013|NCT01200368|65377845|FG001|After Infant Series|Other|2|||
23447014|NCT01200368|65377846|FG002|After Infant Series|Other|2|||
23447015|NCT01200368|65377844|FG000|Toddler Dose|Adverse Event|0|||
23447016|NCT01200368|65377845|FG001|Toddler Dose|Adverse Event|3|||
23769224|NCT01249664|66535514|FG001|Overall Study|Adverse Event|0|||
23769225|NCT04471207|66535515|FG000|Overall Study|Lost to Follow-up|4|||
23769226|NCT04471207|66535516|FG001|Overall Study|Lost to Follow-up|1|||
23769227|NCT04471207|66535515|FG000|Overall Study|Medication Contraindication|0|||
23769228|NCT04471207|66535516|FG001|Overall Study|Medication Contraindication|1|||
23769229|NCT04471207|66535515|FG000|Overall Study|Loss of Interest|2|||
23769230|NCT04471207|66535516|FG001|Overall Study|Loss of Interest|1|||
23769231|NCT04471207|66535515|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
23769232|NCT04471207|66535516|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
23769233|NCT04471207|66535515|FG000|Overall Study|Scheduling Conflicts|3|||
23769234|NCT04471207|66535516|FG001|Overall Study|Scheduling Conflicts|1|||
23769235|NCT04471207|66535515|FG000|Overall Study|Physician Decision|1|||
23769236|NCT04471207|66535516|FG001|Overall Study|Physician Decision|0|||
23447017|NCT01200368|65377846|FG002|Toddler Dose|Adverse Event|1|||
23769237|NCT04471207|66535515|FG000|Overall Study|Unwilling to Use System|0|||
23769238|NCT04471207|66535516|FG001|Overall Study|Unwilling to Use System|1|||
23769239|NCT00819247|66535517|FG000|Overall Study|Adverse Event|0|||
23769240|NCT00819247|66535518|FG001|Overall Study|Adverse Event|5|||
23769241|NCT00819247|66535519|FG002|Overall Study|Adverse Event|3|||
23769242|NCT00819247|66535517|FG000|Overall Study|Insufficient testosterone response|5|||
23769243|NCT00819247|66535518|FG001|Overall Study|Insufficient testosterone response|8|||
23769244|NCT00819247|66535519|FG002|Overall Study|Insufficient testosterone response|10|||
23769245|NCT00819247|66535517|FG000|Overall Study|Withdrawal by Subject|1|||
23769246|NCT00819247|66535518|FG001|Overall Study|Withdrawal by Subject|0|||
23769247|NCT00819247|66535519|FG002|Overall Study|Withdrawal by Subject|0|||
23769248|NCT00819247|66535517|FG000|Overall Study|Protocol Violation|1|||
23769249|NCT00819247|66535518|FG001|Overall Study|Protocol Violation|0|||
23769250|NCT00819247|66535519|FG002|Overall Study|Protocol Violation|1|||
23769251|NCT00819247|66535517|FG000|Overall Study|Mistakenly withdrawn|0|||
23769252|NCT00819247|66535518|FG001|Overall Study|Mistakenly withdrawn|1|||
23769253|NCT00819247|66535519|FG002|Overall Study|Mistakenly withdrawn|0|||
23769254|NCT00819247|66535517|FG000|Overall Study|Bad prostate-specific antigen response|3|||
23769255|NCT00819247|66535518|FG001|Overall Study|Bad prostate-specific antigen response|2|||
23769256|NCT00819247|66535519|FG002|Overall Study|Bad prostate-specific antigen response|0|||
23769257|NCT00819247|66535517|FG000|Overall Study|Other|1|||
23769258|NCT00819247|66535518|FG001|Overall Study|Other|0|||
23769259|NCT00819247|66535519|FG002|Overall Study|Other|0|||
23769260|NCT00249821|66535520|FG000|Overall Study|Technical problem|0|||
23769261|NCT00249821|66535521|FG001|Overall Study|Technical problem|1|||
23769262|NCT04161144|66535522|FG000|Overall Study|Withdrawal by Subject|0|||
23769263|NCT04161144|66535523|FG001|Overall Study|Withdrawal by Subject|1|||
23769264|NCT04161144|66535522|FG000|Overall Study|Protocol Violation|1|||
23769265|NCT04161144|66535523|FG001|Overall Study|Protocol Violation|0|||
23769266|NCT02806232|66535524|FG000|Overall Study|Lost to Follow-up|1|||
23769267|NCT02806232|66535525|FG001|Overall Study|Lost to Follow-up|2|||
23769268|NCT02806232|66535526|FG002|Overall Study|Lost to Follow-up|1|||
23769269|NCT02806232|66535527|FG003|Overall Study|Lost to Follow-up|0|||
23769270|NCT02806232|66535528|FG004|Overall Study|Lost to Follow-up|0|||
23769271|NCT02806232|66535529|FG005|Overall Study|Lost to Follow-up|1|||
23769272|NCT02806232|66535530|FG006|Overall Study|Lost to Follow-up|0|||
23769273|NCT02806232|66535531|FG007|Overall Study|Lost to Follow-up|0|||
23769274|NCT02806232|66535532|FG008|Overall Study|Lost to Follow-up|0|||
23769275|NCT02806232|66535524|FG000|Overall Study|Withdrawal by Subject|0|||
23769276|NCT02806232|66535525|FG001|Overall Study|Withdrawal by Subject|2|||
23769277|NCT02806232|66535526|FG002|Overall Study|Withdrawal by Subject|0|||
23769278|NCT02806232|66535527|FG003|Overall Study|Withdrawal by Subject|0|||
23769279|NCT02806232|66535528|FG004|Overall Study|Withdrawal by Subject|2|||
23769280|NCT02806232|66535529|FG005|Overall Study|Withdrawal by Subject|1|||
23769281|NCT02806232|66535530|FG006|Overall Study|Withdrawal by Subject|0|||
23769282|NCT02806232|66535531|FG007|Overall Study|Withdrawal by Subject|0|||
23769283|NCT02806232|66535532|FG008|Overall Study|Withdrawal by Subject|0|||
23769284|NCT01787825|66535535|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
23769285|NCT01787825|66535536|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
23769286|NCT01787825|66535535|FG000|Overall Study|Data Not Analyzable|5|||
23769287|NCT01787825|66535536|FG001|Overall Study|Data Not Analyzable|1|||
23769288|NCT02524379|66535539|FG000|Overall Study|Death|1|||
23769289|NCT01133821|66535541|FG000|Overall Study|Lost to Follow-up|8|||
23769290|NCT01133821|66535542|FG001|Overall Study|Lost to Follow-up|11|||
23769291|NCT01133821|66535541|FG000|Overall Study|Withdrawal by Subject|8|||
23769292|NCT01133821|66535542|FG001|Overall Study|Withdrawal by Subject|3|||
23769293|NCT01133821|66535541|FG000|Overall Study|preferred other treatment|1|||
23769294|NCT01133821|66535542|FG001|Overall Study|preferred other treatment|1|||
23769295|NCT01133821|66535541|FG000|Overall Study|Protocol Violation|0|||
23769296|NCT01133821|66535542|FG001|Overall Study|Protocol Violation|1|||
23769297|NCT01133821|66535541|FG000|Overall Study|Refused participation|1|||
23769298|NCT01133821|66535542|FG001|Overall Study|Refused participation|3|||
23769299|NCT02187042|66535543|FG000|Overall Study|Death|1|||
23769300|NCT02187042|66535544|FG001|Overall Study|Death|1|||
23769301|NCT02187042|66535543|FG000|Overall Study|Toxicity|6|||
23769302|NCT02187042|66535544|FG001|Overall Study|Toxicity|5|||
23447018|NCT01633788|65377847|FG000|Overall Study|Adverse Event|1|||
23447019|NCT01633788|65377848|FG001|Overall Study|Adverse Event|3|||
23769303|NCT02187042|66535543|FG000|Overall Study|Participant choice|1|||
23769304|NCT02187042|66535544|FG001|Overall Study|Participant choice|0|||
23769305|NCT02187042|66535543|FG000|Overall Study|Doctor choice|1|||
23769306|NCT02187042|66535544|FG001|Overall Study|Doctor choice|0|||
23769307|NCT02187042|66535543|FG000|Overall Study|Progressive disease|4|||
23769308|NCT02187042|66535544|FG001|Overall Study|Progressive disease|8|||
23769309|NCT04538170|66535545|FG000|Overall Study|Withdrawal by Subject|104|||
23769310|NCT04538170|66535546|FG001|Overall Study|Withdrawal by Subject|210|||
23447020|NCT01633788|65377849|FG002|Overall Study|Adverse Event|3|||
23447021|NCT01633788|65377850|FG003|Overall Study|Adverse Event|3|||
23447022|NCT01633788|65377847|FG000|Overall Study|Lost to Follow-up|2|||
23631701|NCT03392168|66038490|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
23631702|NCT03392168|66038487|FG000|Period 2: Cohort 2|Other|0|||
23631703|NCT03392168|66038488|FG001|Period 2: Cohort 2|Other|1|||
23631704|NCT03392168|66038489|FG002|Period 2: Cohort 2|Other|0|||
23631705|NCT03392168|66038490|FG003|Period 2: Cohort 2|Other|0|||
23631706|NCT01932762|66038493|FG000|Overall Study|Withdrawal by Subject|1|||
23631707|NCT01932762|66038494|FG001|Overall Study|Withdrawal by Subject|2|||
23769311|NCT03144687|66535547|FG000|Overall Study|Death|0|||
23769312|NCT03144687|66535548|FG001|Overall Study|Death|2|||
23769313|NCT03144687|66535547|FG000|Overall Study|Lost to Follow-up|0|||
23769314|NCT03144687|66535548|FG001|Overall Study|Lost to Follow-up|1|||
23830489|NCT03850483|66759941|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
23830490|NCT03850483|66759942|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
23830491|NCT03850483|66759943|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
23631708|NCT01932762|66038495|FG002|Overall Study|Withdrawal by Subject|0|||
23769315|NCT03144687|66535547|FG000|Overall Study|Physician Decision|0|||
23769316|NCT03144687|66535548|FG001|Overall Study|Physician Decision|1|||
23769317|NCT03144687|66535547|FG000|Overall Study|Withdrawal by Subject|1|||
23830492|NCT03850483|66759944|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
23830493|NCT03850483|66759945|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
23447023|NCT01633788|65377848|FG001|Overall Study|Lost to Follow-up|2|||
23447024|NCT01633788|65377849|FG002|Overall Study|Lost to Follow-up|2|||
23447025|NCT01633788|65377850|FG003|Overall Study|Lost to Follow-up|0|||
23631709|NCT01932762|66038496|FG003|Overall Study|Withdrawal by Subject|0|||
23631710|NCT01932762|66038493|FG000|Overall Study|Lost to Follow-up|4|||
23769318|NCT03144687|66535548|FG001|Overall Study|Withdrawal by Subject|3|||
23769319|NCT03144687|66535547|FG000|Overall Study|Not Reported|2|||
23769320|NCT03144687|66535548|FG001|Overall Study|Not Reported|0|||
23769321|NCT00358826|66535549|FG000|Core Study|Adverse Event|1|||
23830494|NCT03850483|66759946|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
23447026|NCT01633788|65377847|FG000|Overall Study|Personal Reasons|3|||
23631711|NCT01932762|66038494|FG001|Overall Study|Lost to Follow-up|0|||
23769322|NCT00358826|66535550|FG001|Core Study|Adverse Event|3|||
23769323|NCT00358826|66535551|FG002|Core Study|Adverse Event|1|||
23447027|NCT01633788|65377848|FG001|Overall Study|Personal Reasons|1|||
23447028|NCT01633788|65377849|FG002|Overall Study|Personal Reasons|1|||
23447029|NCT01633788|65377850|FG003|Overall Study|Personal Reasons|3|||
23447030|NCT01633788|65377847|FG000|Overall Study|Protocol Violation|1|||
23769324|NCT00358826|66535552|FG003|Core Study|Adverse Event|1|||
23447031|NCT01633788|65377848|FG001|Overall Study|Protocol Violation|0|||
23447032|NCT01633788|65377849|FG002|Overall Study|Protocol Violation|1|||
23447033|NCT01633788|65377850|FG003|Overall Study|Protocol Violation|0|||
23447034|NCT01633788|65377847|FG000|Overall Study|Other Reasons|0|||
23447035|NCT01633788|65377848|FG001|Overall Study|Other Reasons|2|||
23447036|NCT01633788|65377849|FG002|Overall Study|Other Reasons|3|||
23447037|NCT01633788|65377850|FG003|Overall Study|Other Reasons|7|||
23447038|NCT03828617|65377852|FG000|Overall Study|Lost to Follow-up|22|||
23447039|NCT03828617|65377853|FG001|Overall Study|Lost to Follow-up|12|||
23447040|NCT03828617|65377854|FG002|Overall Study|Lost to Follow-up|23|||
23447041|NCT03828617|65377855|FG003|Overall Study|Lost to Follow-up|7|||
23447042|NCT03828617|65377852|FG000|Overall Study|No longer met eligibility criteria|0|||
23447043|NCT03828617|65377853|FG001|Overall Study|No longer met eligibility criteria|1|||
23447044|NCT03828617|65377854|FG002|Overall Study|No longer met eligibility criteria|1|||
23447045|NCT03828617|65377855|FG003|Overall Study|No longer met eligibility criteria|3|||
23447046|NCT03828617|65377852|FG000|Overall Study|Protocol Violation|0|||
23447047|NCT03828617|65377853|FG001|Overall Study|Protocol Violation|2|||
23447048|NCT03828617|65377854|FG002|Overall Study|Protocol Violation|0|||
23447049|NCT03828617|65377855|FG003|Overall Study|Protocol Violation|0|||
23447050|NCT03828617|65377852|FG000|Overall Study|Withdrawal by Subject|2|||
23447051|NCT03828617|65377853|FG001|Overall Study|Withdrawal by Subject|0|||
23447052|NCT03828617|65377854|FG002|Overall Study|Withdrawal by Subject|2|||
23447053|NCT03828617|65377855|FG003|Overall Study|Withdrawal by Subject|0|||
23447054|NCT03672292|65377856|FG000|Overall Study|Adverse Event|3|||
23447055|NCT03672292|65377857|FG001|Overall Study|Adverse Event|1|||
23447056|NCT03672292|65377856|FG000|Overall Study|Physician Decision|0|||
23571126|NCT00972543|65820902|FG000|Overall Study|Early study termination by sponsor|4|||
23571127|NCT00972543|65820903|FG001|Overall Study|Early study termination by sponsor|1|||
23571128|NCT03051659|65820904|FG000|Treatment Period|Withdrawal by Subject|0|||
23571129|NCT03051659|65820905|FG001|Treatment Period|Withdrawal by Subject|2|||
23769325|NCT00358826|66535553|FG004|Core Study|Adverse Event|0|||
23769326|NCT00358826|66535554|FG005|Core Study|Adverse Event|0|||
23769327|NCT00358826|66535555|FG006|Core Study|Adverse Event|0|||
23769328|NCT00358826|66535556|FG007|Core Study|Adverse Event|0|||
23769329|NCT00358826|66535549|FG000|Core Study|Withdrawal by Subject|2|||
23769330|NCT00358826|66535550|FG001|Core Study|Withdrawal by Subject|2|||
23769331|NCT00358826|66535551|FG002|Core Study|Withdrawal by Subject|0|||
23769332|NCT00358826|66535552|FG003|Core Study|Withdrawal by Subject|0|||
23769333|NCT00358826|66535553|FG004|Core Study|Withdrawal by Subject|0|||
23571130|NCT03051659|65820904|FG000|Survival Follow-up|Lost to Follow-up|23|||
23571131|NCT03051659|65820905|FG001|Survival Follow-up|Lost to Follow-up|22|||
23571132|NCT01275196|65820906|FG000|Overall Study|Adverse Event|3|||
23571133|NCT01275196|65820907|FG001|Overall Study|Adverse Event|5|||
23447057|NCT03672292|65377857|FG001|Overall Study|Physician Decision|1|||
23447058|NCT03672292|65377856|FG000|Overall Study|Withdrawal by Subject|1|||
23447059|NCT03672292|65377857|FG001|Overall Study|Withdrawal by Subject|2|||
23447060|NCT00844376|65377858|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
23571134|NCT01275196|65820906|FG000|Overall Study|Withdrawal by Subject|4|||
23571135|NCT01275196|65820907|FG001|Overall Study|Withdrawal by Subject|5|||
23769334|NCT00358826|66535554|FG005|Core Study|Withdrawal by Subject|0|||
23769335|NCT00358826|66535555|FG006|Core Study|Withdrawal by Subject|0|||
23769336|NCT00358826|66535556|FG007|Core Study|Withdrawal by Subject|0|||
23571136|NCT01275196|65820906|FG000|Overall Study|Lost to Follow-up|1|||
23769337|NCT00358826|66535549|FG000|Core Study|Lost to Follow-up|0|||
23769338|NCT00358826|66535550|FG001|Core Study|Lost to Follow-up|0|||
23631712|NCT01932762|66038495|FG002|Overall Study|Lost to Follow-up|0|||
23631713|NCT01932762|66038496|FG003|Overall Study|Lost to Follow-up|1|||
23631714|NCT01932762|66038493|FG000|Overall Study|Physician Decision|1|||
23631715|NCT01932762|66038494|FG001|Overall Study|Physician Decision|0|||
23769339|NCT00358826|66535551|FG002|Core Study|Lost to Follow-up|0|||
23631716|NCT01932762|66038495|FG002|Overall Study|Physician Decision|0|||
23631717|NCT01932762|66038496|FG003|Overall Study|Physician Decision|0|||
23631718|NCT00129935|66038497|FG000|Overall Study|Adverse Event|18|||
23631719|NCT00129935|66038498|FG001|Overall Study|Adverse Event|56|||
23631720|NCT00129935|66038497|FG000|Overall Study|Death|1|||
23631721|NCT00129935|66038498|FG001|Overall Study|Death|1|||
23631722|NCT00129935|66038497|FG000|Overall Study|Withdrawal by Subject|7|||
23631723|NCT00129935|66038498|FG001|Overall Study|Withdrawal by Subject|20|||
23631724|NCT00129935|66038497|FG000|Overall Study|Protocol Violation|0|||
23631725|NCT00129935|66038498|FG001|Overall Study|Protocol Violation|4|||
23631726|NCT00129935|66038497|FG000|Overall Study|Physician Decision|3|||
23631727|NCT00129935|66038498|FG001|Overall Study|Physician Decision|4|||
23631728|NCT00129935|66038497|FG000|Overall Study|Recurrence|1|||
23631729|NCT00129935|66038498|FG001|Overall Study|Recurrence|3|||
23631730|NCT00129935|66038497|FG000|Overall Study|Second primary|0|||
23631731|NCT00129935|66038498|FG001|Overall Study|Second primary|1|||
23631732|NCT00129935|66038497|FG000|Overall Study|Other|3|||
23631733|NCT00129935|66038498|FG001|Overall Study|Other|2|||
23631734|NCT00129935|66038497|FG000|Overall Study|Crossed to the other arm|2|||
23631735|NCT00129935|66038498|FG001|Overall Study|Crossed to the other arm|1|||
23631736|NCT00129935|66038497|FG000|Overall Study|Incorrect study treatment|1|||
23631737|NCT00129935|66038498|FG001|Overall Study|Incorrect study treatment|0|||
23631738|NCT01439867|66038502|FG000|Overall Study|Non-compliance|0|||
23631739|NCT01439867|66038503|FG001|Overall Study|Non-compliance|1|||
23631740|NCT01439867|66038502|FG000|Overall Study|Withdrawal by Subject|1|||
23769340|NCT00358826|66535552|FG003|Core Study|Lost to Follow-up|1|||
23769341|NCT00358826|66535553|FG004|Core Study|Lost to Follow-up|0|||
23769342|NCT00358826|66535554|FG005|Core Study|Lost to Follow-up|0|||
23769343|NCT00358826|66535555|FG006|Core Study|Lost to Follow-up|0|||
23769344|NCT00358826|66535556|FG007|Core Study|Lost to Follow-up|0|||
23769345|NCT00358826|66535549|FG000|Core Study|Physician Decision|0|||
23769346|NCT00358826|66535550|FG001|Core Study|Physician Decision|0|||
23769347|NCT00358826|66535551|FG002|Core Study|Physician Decision|1|||
23769348|NCT00358826|66535552|FG003|Core Study|Physician Decision|0|||
23769349|NCT00358826|66535553|FG004|Core Study|Physician Decision|0|||
23769350|NCT00358826|66535554|FG005|Core Study|Physician Decision|0|||
23769351|NCT00358826|66535555|FG006|Core Study|Physician Decision|0|||
23769352|NCT00358826|66535556|FG007|Core Study|Physician Decision|0|||
23769353|NCT00358826|66535549|FG000|MDCT Substudy|Adverse Event|0|||
23769354|NCT00358826|66535550|FG001|MDCT Substudy|Adverse Event|0|||
23769355|NCT00358826|66535551|FG002|MDCT Substudy|Adverse Event|0|||
23769356|NCT00358826|66535552|FG003|MDCT Substudy|Adverse Event|0|||
23769357|NCT00358826|66535553|FG004|MDCT Substudy|Adverse Event|1|||
23769358|NCT00358826|66535554|FG005|MDCT Substudy|Adverse Event|0|||
23769359|NCT00358826|66535555|FG006|MDCT Substudy|Adverse Event|0|||
23769360|NCT00358826|66535556|FG007|MDCT Substudy|Adverse Event|0|||
23447061|NCT00844376|65377859|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
23631741|NCT01439867|66038503|FG001|Overall Study|Withdrawal by Subject|2|||
23631742|NCT01439867|66038502|FG000|Overall Study|Administrative Decision|4|||
23631743|NCT01439867|66038503|FG001|Overall Study|Administrative Decision|5|||
23631744|NCT01439867|66038502|FG000|Overall Study|Protocol-specified Criteria|1|||
23631745|NCT01439867|66038503|FG001|Overall Study|Protocol-specified Criteria|0|||
23769361|NCT00358826|66535549|FG000|MDCT Substudy|Lost to Follow-up|0|||
23631746|NCT02035696|66038504|FG000|Overall Study|Lost to Follow-up|0|||
23631747|NCT02035696|66038505|FG001|Overall Study|Lost to Follow-up|3|||
23769362|NCT00358826|66535550|FG001|MDCT Substudy|Lost to Follow-up|0|||
23769363|NCT00358826|66535551|FG002|MDCT Substudy|Lost to Follow-up|0|||
23631748|NCT02035696|66038506|FG002|Overall Study|Lost to Follow-up|1|||
23631749|NCT02035696|66038507|FG003|Overall Study|Lost to Follow-up|2|||
23769364|NCT00358826|66535552|FG003|MDCT Substudy|Lost to Follow-up|0|||
23769365|NCT00358826|66535553|FG004|MDCT Substudy|Lost to Follow-up|0|||
23769366|NCT00358826|66535554|FG005|MDCT Substudy|Lost to Follow-up|1|||
23769367|NCT00358826|66535555|FG006|MDCT Substudy|Lost to Follow-up|0|||
23769368|NCT00358826|66535556|FG007|MDCT Substudy|Lost to Follow-up|0|||
23769369|NCT00358826|66535549|FG000|MDCT Substudy|Withdrawal by Subject|0|||
23769370|NCT00358826|66535550|FG001|MDCT Substudy|Withdrawal by Subject|0|||
23769371|NCT00358826|66535551|FG002|MDCT Substudy|Withdrawal by Subject|0|||
23769372|NCT00358826|66535552|FG003|MDCT Substudy|Withdrawal by Subject|0|||
23769373|NCT00358826|66535553|FG004|MDCT Substudy|Withdrawal by Subject|0|||
23447062|NCT03210961|65377863|FG000|Overall Study|Adverse Event|0|||
23769374|NCT00358826|66535554|FG005|MDCT Substudy|Withdrawal by Subject|1|||
23769375|NCT00358826|66535555|FG006|MDCT Substudy|Withdrawal by Subject|0|||
23769376|NCT00358826|66535556|FG007|MDCT Substudy|Withdrawal by Subject|0|||
23769377|NCT03361423|66535557|FG000|Overall Study|Withdrawal by Subject|4|||
23769378|NCT03361423|66535558|FG001|Overall Study|Withdrawal by Subject|3|||
23769379|NCT03361423|66535557|FG000|Overall Study|Did not treat|19|||
23769380|NCT03361423|66535558|FG001|Overall Study|Did not treat|18|||
23769381|NCT03361423|66535557|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
23769382|NCT03361423|66535558|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
23769383|NCT03361423|66535557|FG000|Overall Study|Missing data|4|||
23769384|NCT03361423|66535558|FG001|Overall Study|Missing data|1|||
23769385|NCT04582266|66535559|FG000|Overall Study|Lost to Follow-up|7|||
23769386|NCT04582266|66535560|FG001|Overall Study|Lost to Follow-up|5|||
23769387|NCT04582266|66535559|FG000|Overall Study|Withdrawal by Subject|1|||
23769388|NCT04582266|66535560|FG001|Overall Study|Withdrawal by Subject|0|||
23769389|NCT04582266|66535559|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
23769390|NCT04582266|66535560|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
23769391|NCT00989261|66535563|FG000|Overall Study|Still in follow up|12|||
23769392|NCT00989261|66535564|FG001|Overall Study|Still in follow up|21|||
23769393|NCT00989261|66535563|FG000|Overall Study|Withdrawal by Subject|0|||
23769394|NCT00989261|66535564|FG001|Overall Study|Withdrawal by Subject|1|||
23769395|NCT00989261|66535563|FG000|Overall Study|Lost to Follow-up|3|||
23769396|NCT00989261|66535564|FG001|Overall Study|Lost to Follow-up|0|||
23769397|NCT02292238|66535565|FG000|Overall Study|Protocol Violation|1|||
23769398|NCT02292238|66535566|FG001|Overall Study|Protocol Violation|2|||
23769399|NCT02292238|66535565|FG000|Overall Study|Withdrawal by Subject|2|||
23769400|NCT02292238|66535566|FG001|Overall Study|Withdrawal by Subject|1|||
23769401|NCT02292238|66535565|FG000|Overall Study|Lost to Follow-up|1|||
23769402|NCT02292238|66535566|FG001|Overall Study|Lost to Follow-up|0|||
23769403|NCT02292238|66535565|FG000|Overall Study|Physician Decision|0|||
23769404|NCT02292238|66535566|FG001|Overall Study|Physician Decision|1|||
23769405|NCT00299156|66535567|FG000|Period 2 (Randomized)|Screen Failure|0|||
23769406|NCT00299156|66535568|FG001|Period 2 (Randomized)|Screen Failure|1|||
23769407|NCT00299156|66535569|FG002|Period 2 (Randomized)|Screen Failure|0|||
23769408|NCT04471935|66535570|FG000|Overall Study|Withdrawal by Subject|1|||
23769409|NCT04471935|66535570|FG000|Overall Study|Deemed ineligible to participate|1|||
23769410|NCT01315249|66535571|FG000|Overall Study|Adverse Event|22|||
23769411|NCT01315249|66535572|FG001|Overall Study|Adverse Event|26|||
23769412|NCT01315249|66535571|FG000|Overall Study|Withdrawal by Subject|11|||
23769413|NCT01315249|66535572|FG001|Overall Study|Withdrawal by Subject|10|||
23769414|NCT01315249|66535571|FG000|Overall Study|Protocol Violation|8|||
23769415|NCT01315249|66535572|FG001|Overall Study|Protocol Violation|5|||
23769416|NCT01315249|66535571|FG000|Overall Study|Abnormal test results|1|||
23769417|NCT01315249|66535572|FG001|Overall Study|Abnormal test results|2|||
23769418|NCT01315249|66535571|FG000|Overall Study|Administrative problems|1|||
23769419|NCT01315249|66535572|FG001|Overall Study|Administrative problems|0|||
23769420|NCT01315249|66535571|FG000|Overall Study|inability to use device|1|||
23769421|NCT01315249|66535572|FG001|Overall Study|inability to use device|0|||
23769422|NCT01315249|66535571|FG000|Overall Study|Lack of Efficacy|0|||
23769423|NCT01315249|66535572|FG001|Overall Study|Lack of Efficacy|1|||
23769424|NCT01315249|66535571|FG000|Overall Study|Lost to Follow-up|0|||
23769425|NCT01315249|66535572|FG001|Overall Study|Lost to Follow-up|2|||
23769426|NCT01315249|66535571|FG000|Overall Study|Death|0|||
23631750|NCT02035696|66038504|FG000|Overall Study|Withdrawal by Subject|3|||
23631751|NCT02035696|66038505|FG001|Overall Study|Withdrawal by Subject|0|||
23631752|NCT02035696|66038506|FG002|Overall Study|Withdrawal by Subject|2|||
23631753|NCT02035696|66038507|FG003|Overall Study|Withdrawal by Subject|1|||
23631754|NCT02370251|66038508|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
23631755|NCT02370251|66038508|FG000|Overall Study|Death|4|||
23631756|NCT00340704|66038509|FG000|PK Study|Adverse Event|0|||
23631757|NCT00340704|66038510|FG001|PK Study|Adverse Event|1|||
23631758|NCT00340704|66038511|FG002|PK Study|Adverse Event|0|||
23631759|NCT00340704|66038512|FG003|PK Study|Adverse Event|0|||
23631760|NCT00340704|66038513|FG004|PK Study|Adverse Event|0|||
23631761|NCT00340704|66038514|FG005|PK Study|Adverse Event|0|||
23631762|NCT00340704|66038515|FG006|PK Study|Adverse Event|0|||
23769427|NCT01315249|66535572|FG001|Overall Study|Death|1|||
23769428|NCT02158936|66535574|FG000|Overall Study|Study closed/ terminated|57|||
23769429|NCT02158936|66535575|FG001|Overall Study|Study closed/ terminated|77|||
23769430|NCT02158936|66535574|FG000|Overall Study|Azacitidine tx discontinued|53|||
23769431|NCT02158936|66535575|FG001|Overall Study|Azacitidine tx discontinued|46|||
23769432|NCT02158936|66535574|FG000|Overall Study|Adverse Event|39|||
23769433|NCT02158936|66535575|FG001|Overall Study|Adverse Event|24|||
23769434|NCT02158936|66535574|FG000|Overall Study|Withdrawal by Subject|15|||
23769435|NCT02158936|66535575|FG001|Overall Study|Withdrawal by Subject|16|||
23769436|NCT02158936|66535574|FG000|Overall Study|Physician Decision|15|||
23769437|NCT02158936|66535575|FG001|Overall Study|Physician Decision|13|||
23769438|NCT02158936|66535574|FG000|Overall Study|Lost to Follow-up|0|||
23769439|NCT02158936|66535575|FG001|Overall Study|Lost to Follow-up|1|||
23769440|NCT00635154|66535576|FG000|Overall Study|Alternative Treatment|8|||
23769441|NCT00635154|66535576|FG000|Overall Study|Other|4|||
23769442|NCT00635154|66535576|FG000|Overall Study|Still on treatment|21|||
23769443|NCT02346201|66535586|FG000|Overall Study|Adverse Event|3|||
23769444|NCT02346201|66535587|FG001|Overall Study|Adverse Event|2|||
23769445|NCT02346201|66535586|FG000|Overall Study|Lost to Follow-up|1|||
23769446|NCT02346201|66535587|FG001|Overall Study|Lost to Follow-up|0|||
23769447|NCT02346201|66535586|FG000|Overall Study|Withdrawal by Subject|6|||
23769448|NCT02346201|66535587|FG001|Overall Study|Withdrawal by Subject|3|||
23769449|NCT02346201|66535586|FG000|Overall Study|Unavailable for future follow-up|0|||
23769450|NCT02346201|66535587|FG001|Overall Study|Unavailable for future follow-up|1|||
23769451|NCT02346201|66535586|FG000|Overall Study|Physician Decision|0|||
23769452|NCT02346201|66535587|FG001|Overall Study|Physician Decision|1|||
23769453|NCT02346201|66535586|FG000|Overall Study|Missed final visit|0|||
23769454|NCT02346201|66535587|FG001|Overall Study|Missed final visit|2|||
23769455|NCT01296932|66535591|FG000|Overall Study|Dose limiting toxicity|0|||
23769456|NCT01296932|66535592|FG001|Overall Study|Dose limiting toxicity|0|||
23769457|NCT01296932|66535593|FG002|Overall Study|Dose limiting toxicity|0|||
23769458|NCT01296932|66535594|FG003|Overall Study|Dose limiting toxicity|0|||
23769459|NCT01296932|66535595|FG004|Overall Study|Dose limiting toxicity|0|||
23769460|NCT01296932|66535596|FG005|Overall Study|Dose limiting toxicity|0|||
23769461|NCT01296932|66535597|FG006|Overall Study|Dose limiting toxicity|1|||
23769462|NCT01296932|66535598|FG007|Overall Study|Dose limiting toxicity|0|||
23769463|NCT01296932|66535599|FG008|Overall Study|Dose limiting toxicity|1|||
23769464|NCT01296932|66535591|FG000|Overall Study|Progressive disease|2|||
23769465|NCT01296932|66535592|FG001|Overall Study|Progressive disease|0|||
23769466|NCT01296932|66535593|FG002|Overall Study|Progressive disease|1|||
23769467|NCT01296932|66535594|FG003|Overall Study|Progressive disease|1|||
23769468|NCT01296932|66535595|FG004|Overall Study|Progressive disease|2|||
23631763|NCT00340704|66038516|FG007|PK Study|Adverse Event|0|||
23631764|NCT00340704|66038517|FG008|PK Study|Adverse Event|0|||
23631765|NCT00340704|66038509|FG000|PK Study|Not treated|0|||
23769469|NCT01296932|66535596|FG005|Overall Study|Progressive disease|3|||
23769470|NCT01296932|66535597|FG006|Overall Study|Progressive disease|1|||
23769471|NCT01296932|66535598|FG007|Overall Study|Progressive disease|0|||
23769472|NCT01296932|66535599|FG008|Overall Study|Progressive disease|0|||
23769473|NCT01296932|66535591|FG000|Overall Study|Withdrawal by Subject|0|||
23769474|NCT01296932|66535592|FG001|Overall Study|Withdrawal by Subject|0|||
23769475|NCT01296932|66535593|FG002|Overall Study|Withdrawal by Subject|1|||
23769476|NCT01296932|66535594|FG003|Overall Study|Withdrawal by Subject|1|||
23769477|NCT01296932|66535595|FG004|Overall Study|Withdrawal by Subject|0|||
23769478|NCT01296932|66535596|FG005|Overall Study|Withdrawal by Subject|0|||
23631766|NCT00340704|66038510|FG001|PK Study|Not treated|0|||
23631767|NCT00340704|66038511|FG002|PK Study|Not treated|1|||
23769479|NCT01296932|66535597|FG006|Overall Study|Withdrawal by Subject|3|||
23769480|NCT01296932|66535598|FG007|Overall Study|Withdrawal by Subject|0|||
23631768|NCT00340704|66038512|FG003|PK Study|Not treated|0|||
23769481|NCT01296932|66535599|FG008|Overall Study|Withdrawal by Subject|0|||
23769482|NCT01296932|66535591|FG000|Overall Study|Adverse Event|1|||
23830495|NCT03850483|66759947|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
23830496|NCT03850483|66759948|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
23830497|NCT03850483|66759949|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
23830498|NCT03850483|66759950|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
23830499|NCT03850483|66759941|FG000|Follow-up for Stage 1|Physician Decision|0|||
23830500|NCT03850483|66759942|FG001|Follow-up for Stage 1|Physician Decision|0|||
23830501|NCT03850483|66759943|FG002|Follow-up for Stage 1|Physician Decision|0|||
23830502|NCT03850483|66759944|FG003|Follow-up for Stage 1|Physician Decision|0|||
23830503|NCT03850483|66759945|FG004|Follow-up for Stage 1|Physician Decision|1|||
23830504|NCT03850483|66759946|FG005|Follow-up for Stage 1|Physician Decision|0|||
23830505|NCT03850483|66759947|FG006|Follow-up for Stage 1|Physician Decision|1|||
23830506|NCT03850483|66759948|FG007|Follow-up for Stage 1|Physician Decision|0|||
23830507|NCT03850483|66759949|FG008|Follow-up for Stage 1|Physician Decision|0|||
23830508|NCT03850483|66759950|FG009|Follow-up for Stage 1|Physician Decision|0|||
23830509|NCT03850483|66759941|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
23830510|NCT03850483|66759942|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
23769483|NCT01296932|66535592|FG001|Overall Study|Adverse Event|1|||
23769484|NCT01296932|66535593|FG002|Overall Study|Adverse Event|1|||
23769485|NCT01296932|66535594|FG003|Overall Study|Adverse Event|2|||
23830511|NCT03850483|66759943|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
23830512|NCT03850483|66759944|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
23830513|NCT03850483|66759945|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
23830514|NCT03850483|66759946|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
23830515|NCT03850483|66759947|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
23769486|NCT01296932|66535595|FG004|Overall Study|Adverse Event|1|||
23769487|NCT01296932|66535596|FG005|Overall Study|Adverse Event|0|||
23769488|NCT01296932|66535597|FG006|Overall Study|Adverse Event|0|||
23769489|NCT01296932|66535598|FG007|Overall Study|Adverse Event|0|||
23769490|NCT01296932|66535599|FG008|Overall Study|Adverse Event|1|||
23769491|NCT01296932|66535591|FG000|Overall Study|Investigator decision|0|||
23769492|NCT01296932|66535592|FG001|Overall Study|Investigator decision|1|||
23769493|NCT01296932|66535593|FG002|Overall Study|Investigator decision|0|||
23769494|NCT01296932|66535594|FG003|Overall Study|Investigator decision|1|||
23769495|NCT01296932|66535595|FG004|Overall Study|Investigator decision|0|||
23769496|NCT01296932|66535596|FG005|Overall Study|Investigator decision|0|||
23769497|NCT01296932|66535597|FG006|Overall Study|Investigator decision|1|||
23769498|NCT01296932|66535598|FG007|Overall Study|Investigator decision|0|||
23769499|NCT01296932|66535599|FG008|Overall Study|Investigator decision|1|||
23769500|NCT01296932|66535591|FG000|Overall Study|No clinical benefit anymore|0|||
23769501|NCT01296932|66535592|FG001|Overall Study|No clinical benefit anymore|1|||
23769502|NCT01296932|66535593|FG002|Overall Study|No clinical benefit anymore|0|||
23769503|NCT01296932|66535594|FG003|Overall Study|No clinical benefit anymore|0|||
23769504|NCT01296932|66535595|FG004|Overall Study|No clinical benefit anymore|0|||
23769505|NCT01296932|66535596|FG005|Overall Study|No clinical benefit anymore|0|||
23769506|NCT01296932|66535597|FG006|Overall Study|No clinical benefit anymore|0|||
23769507|NCT01296932|66535598|FG007|Overall Study|No clinical benefit anymore|0|||
23769508|NCT01296932|66535599|FG008|Overall Study|No clinical benefit anymore|0|||
23769509|NCT01296932|66535591|FG000|Overall Study|Physician Decision|0|||
23769510|NCT01296932|66535592|FG001|Overall Study|Physician Decision|0|||
23769511|NCT01296932|66535593|FG002|Overall Study|Physician Decision|1|||
23769512|NCT01296932|66535594|FG003|Overall Study|Physician Decision|0|||
23769513|NCT01296932|66535595|FG004|Overall Study|Physician Decision|0|||
23769514|NCT01296932|66535596|FG005|Overall Study|Physician Decision|0|||
23769515|NCT01296932|66535597|FG006|Overall Study|Physician Decision|0|||
23769516|NCT01296932|66535598|FG007|Overall Study|Physician Decision|0|||
23830516|NCT03850483|66759948|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
23830517|NCT03850483|66759949|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
23769517|NCT01296932|66535599|FG008|Overall Study|Physician Decision|0|||
23830518|NCT03850483|66759950|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
23830519|NCT03850483|66759941|FG000|Follow-up for Stage 1|Adverse Event|0|||
23830520|NCT03850483|66759942|FG001|Follow-up for Stage 1|Adverse Event|0|||
23830521|NCT03850483|66759943|FG002|Follow-up for Stage 1|Adverse Event|1|||
23830522|NCT03850483|66759944|FG003|Follow-up for Stage 1|Adverse Event|0|||
23830523|NCT03850483|66759945|FG004|Follow-up for Stage 1|Adverse Event|0|||
23830524|NCT03850483|66759946|FG005|Follow-up for Stage 1|Adverse Event|1|||
23830525|NCT03850483|66759947|FG006|Follow-up for Stage 1|Adverse Event|0|||
23769518|NCT01296932|66535591|FG000|Overall Study|IV problems, administration not possible|0|||
23769519|NCT01296932|66535592|FG001|Overall Study|IV problems, administration not possible|0|||
23769520|NCT01296932|66535593|FG002|Overall Study|IV problems, administration not possible|1|||
23769521|NCT01296932|66535594|FG003|Overall Study|IV problems, administration not possible|0|||
23769522|NCT01296932|66535595|FG004|Overall Study|IV problems, administration not possible|0|||
23769523|NCT01296932|66535596|FG005|Overall Study|IV problems, administration not possible|0|||
23769524|NCT01296932|66535597|FG006|Overall Study|IV problems, administration not possible|0|||
23769525|NCT01296932|66535598|FG007|Overall Study|IV problems, administration not possible|0|||
23769526|NCT01296932|66535599|FG008|Overall Study|IV problems, administration not possible|0|||
23769527|NCT01296932|66535591|FG000|Overall Study|per protocol|0|||
23769528|NCT01296932|66535592|FG001|Overall Study|per protocol|0|||
23769529|NCT01296932|66535593|FG002|Overall Study|per protocol|1|||
23769530|NCT01296932|66535594|FG003|Overall Study|per protocol|1|||
23769531|NCT01296932|66535595|FG004|Overall Study|per protocol|0|||
23769532|NCT01296932|66535596|FG005|Overall Study|per protocol|0|||
23769533|NCT01296932|66535597|FG006|Overall Study|per protocol|0|||
23769534|NCT01296932|66535598|FG007|Overall Study|per protocol|0|||
23769535|NCT01296932|66535599|FG008|Overall Study|per protocol|0|||
23769536|NCT01296932|66535591|FG000|Overall Study|Low benefit and too many side effects|0|||
23769537|NCT01296932|66535592|FG001|Overall Study|Low benefit and too many side effects|0|||
23769538|NCT01296932|66535593|FG002|Overall Study|Low benefit and too many side effects|0|||
23769539|NCT01296932|66535594|FG003|Overall Study|Low benefit and too many side effects|0|||
23769540|NCT01296932|66535595|FG004|Overall Study|Low benefit and too many side effects|0|||
23769541|NCT01296932|66535596|FG005|Overall Study|Low benefit and too many side effects|0|||
23769542|NCT01296932|66535597|FG006|Overall Study|Low benefit and too many side effects|0|||
23769543|NCT01296932|66535598|FG007|Overall Study|Low benefit and too many side effects|1|||
23769544|NCT01296932|66535599|FG008|Overall Study|Low benefit and too many side effects|0|||
23769545|NCT01296932|66535591|FG000|Overall Study|No adequate treatment response|0|||
23769546|NCT01296932|66535592|FG001|Overall Study|No adequate treatment response|0|||
23769547|NCT01296932|66535593|FG002|Overall Study|No adequate treatment response|0|||
23769548|NCT01296932|66535594|FG003|Overall Study|No adequate treatment response|0|||
23769549|NCT01296932|66535595|FG004|Overall Study|No adequate treatment response|0|||
23769550|NCT01296932|66535596|FG005|Overall Study|No adequate treatment response|0|||
23769551|NCT01296932|66535597|FG006|Overall Study|No adequate treatment response|0|||
23769552|NCT01296932|66535598|FG007|Overall Study|No adequate treatment response|1|||
23769553|NCT01296932|66535599|FG008|Overall Study|No adequate treatment response|0|||
23769554|NCT01296932|66535591|FG000|Overall Study|Dosage already reduced, AE still present|0|||
23769555|NCT01296932|66535592|FG001|Overall Study|Dosage already reduced, AE still present|0|||
23769556|NCT01296932|66535593|FG002|Overall Study|Dosage already reduced, AE still present|0|||
23769557|NCT01296932|66535594|FG003|Overall Study|Dosage already reduced, AE still present|0|||
23769558|NCT01296932|66535595|FG004|Overall Study|Dosage already reduced, AE still present|0|||
23769559|NCT01296932|66535596|FG005|Overall Study|Dosage already reduced, AE still present|0|||
23769560|NCT01296932|66535597|FG006|Overall Study|Dosage already reduced, AE still present|0|||
23769561|NCT01296932|66535598|FG007|Overall Study|Dosage already reduced, AE still present|0|||
23769562|NCT01296932|66535599|FG008|Overall Study|Dosage already reduced, AE still present|1|||
23769563|NCT01400425|66535600|FG000|Overall Study|Withdrawal by Subject|10|||
23769564|NCT01202747|66535601|FG000|Overall Study|Withdrawal by Subject|1|||
23769565|NCT00678392|66535602|FG000|Overall Study|Adverse Event|0|||
23769566|NCT00678392|66535603|FG001|Overall Study|Adverse Event|6|||
23769567|NCT00678392|66535602|FG000|Overall Study|Death|280|||
23769568|NCT00678392|66535603|FG001|Overall Study|Death|269|||
23769569|NCT00678392|66535602|FG000|Overall Study|Lost to Follow-up|15|||
23769570|NCT00678392|66535603|FG001|Overall Study|Lost to Follow-up|13|||
23769571|NCT00678392|66535602|FG000|Overall Study|Objective Progression or Relapse|3|||
23769572|NCT00678392|66535603|FG001|Overall Study|Objective Progression or Relapse|8|||
23769573|NCT00678392|66535602|FG000|Overall Study|Sponsor's Decision|1|||
23769574|NCT00678392|66535603|FG001|Overall Study|Sponsor's Decision|2|||
23769575|NCT00678392|66535602|FG000|Overall Study|Withdrawal by Subject|4|||
23769576|NCT00678392|66535603|FG001|Overall Study|Withdrawal by Subject|4|||
23769577|NCT00678392|66535602|FG000|Overall Study|Randomized But Not Treated|2|||
23769578|NCT00678392|66535603|FG001|Overall Study|Randomized But Not Treated|7|||
23769579|NCT00678392|66535602|FG000|Overall Study|Other|56|||
23769580|NCT00678392|66535603|FG001|Overall Study|Other|53|||
23769581|NCT03341507|66535604|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
23769582|NCT02015793|66535605|FG000|Overall Study|Adverse Event|3|||
23769583|NCT02015793|66535606|FG001|Overall Study|Adverse Event|3|||
23631769|NCT00340704|66038513|FG004|PK Study|Not treated|0|||
23631770|NCT00340704|66038514|FG005|PK Study|Not treated|0|||
23631771|NCT00340704|66038515|FG006|PK Study|Not treated|0|||
23631772|NCT00340704|66038516|FG007|PK Study|Not treated|0|||
23631773|NCT00340704|66038517|FG008|PK Study|Not treated|0|||
23769584|NCT02015793|66535605|FG000|Overall Study|Withdrawal by Subject|1|||
23769585|NCT02015793|66535606|FG001|Overall Study|Withdrawal by Subject|1|||
23769586|NCT00944697|66535609|FG000|Overall Study|Withdrawal by Subject|1|||
23769587|NCT00944697|66535610|FG001|Overall Study|Withdrawal by Subject|1|||
23769588|NCT00944697|66535609|FG000|Overall Study|Adverse Event|0|||
23631774|NCT00340704|66038509|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23769589|NCT00944697|66535610|FG001|Overall Study|Adverse Event|3|||
23769590|NCT00944697|66535609|FG000|Overall Study|Administrative|1|||
23769591|NCT00944697|66535610|FG001|Overall Study|Administrative|1|||
23769592|NCT00601354|66535611|FG000|Overall Study|Lost to Follow-up|4|||
23769593|NCT00601354|66535612|FG001|Overall Study|Lost to Follow-up|5|||
23769594|NCT02199509|66535615|FG000|Overall Study|Suicidal Ideation|0|||
23769595|NCT02199509|66535616|FG001|Overall Study|Suicidal Ideation|1|||
23769596|NCT02199509|66535615|FG000|Overall Study|Misunderstood titration schedule|1|||
23769597|NCT02199509|66535616|FG001|Overall Study|Misunderstood titration schedule|0|||
23769598|NCT00585351|66535617|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
23769599|NCT00585351|66535618|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
23769600|NCT00585351|66535619|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
23769601|NCT00585351|66535620|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
23769602|NCT00585351|66535621|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
23769603|NCT00585351|66535622|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
23769604|NCT00585351|66535623|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
23769605|NCT00585351|66535624|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
23769606|NCT00585351|66535617|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
23769607|NCT00585351|66535618|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
23769608|NCT00585351|66535619|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
23769609|NCT00585351|66535620|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
23769610|NCT00585351|66535621|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
23769611|NCT00585351|66535622|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
23769612|NCT00585351|66535623|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
23571137|NCT01275196|65820907|FG001|Overall Study|Lost to Follow-up|0|||
23571138|NCT01275196|65820906|FG000|Overall Study|Disease Progression|6|||
23571139|NCT01275196|65820907|FG001|Overall Study|Disease Progression|5|||
23571140|NCT01275196|65820906|FG000|Overall Study|Protocol Violation|1|||
23571141|NCT01275196|65820907|FG001|Overall Study|Protocol Violation|0|||
23571142|NCT01275196|65820906|FG000|Overall Study|Suboptimal response/treatment failure|5|||
23571143|NCT01275196|65820907|FG001|Overall Study|Suboptimal response/treatment failure|6|||
23571144|NCT00917267|65820908|FG000|Overall Study|Adverse Event|15|||
23571145|NCT00917267|65820909|FG001|Overall Study|Adverse Event|36|||
23571146|NCT00917267|65820908|FG000|Overall Study|Physician Decision|2|||
23769613|NCT00585351|66535624|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
23571147|NCT00917267|65820909|FG001|Overall Study|Physician Decision|4|||
23571148|NCT00917267|65820908|FG000|Overall Study|Protocol Violation|9|||
23571149|NCT00917267|65820909|FG001|Overall Study|Protocol Violation|18|||
23571150|NCT00917267|65820908|FG000|Overall Study|Withdrawal by Subject|5|||
23571151|NCT00917267|65820909|FG001|Overall Study|Withdrawal by Subject|12|||
23571152|NCT00917267|65820908|FG000|Overall Study|Lost to follow up|0|||
23571153|NCT00917267|65820909|FG001|Overall Study|Lost to follow up|2|||
23571154|NCT00917267|65820908|FG000|Overall Study|Entry Criteria Not Met|1|||
23769614|NCT00585351|66535617|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
23769615|NCT00585351|66535618|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
23769616|NCT00585351|66535619|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
23769617|NCT00585351|66535620|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
23769618|NCT00585351|66535621|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
23769619|NCT00585351|66535622|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
23769620|NCT00585351|66535623|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
23769621|NCT00585351|66535624|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
23769622|NCT00585351|66535617|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
23769623|NCT00585351|66535618|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
23769624|NCT00585351|66535619|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23769625|NCT00585351|66535620|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23769626|NCT00585351|66535621|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23769627|NCT00585351|66535622|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23769628|NCT00585351|66535623|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23571155|NCT00917267|65820909|FG001|Overall Study|Entry Criteria Not Met|0|||
23571156|NCT00917267|65820908|FG000|Overall Study|Sponsor Decision|5|||
23571157|NCT00917267|65820909|FG001|Overall Study|Sponsor Decision|5|||
23571158|NCT00917267|65820908|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
23769629|NCT00585351|66535624|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23769630|NCT00585351|66535617|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769631|NCT00585351|66535618|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769632|NCT00585351|66535619|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769633|NCT00585351|66535620|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769634|NCT00585351|66535621|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769635|NCT00585351|66535622|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23769636|NCT00585351|66535623|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
23769637|NCT00585351|66535624|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
23769638|NCT00585351|66535617|FG000|Enrollment Period (Intervention)|Death|0|||
23769639|NCT00585351|66535618|FG001|Enrollment Period (Intervention)|Death|0|||
23769640|NCT00585351|66535619|FG002|Enrollment Period (Intervention)|Death|0|||
23769641|NCT00585351|66535620|FG003|Enrollment Period (Intervention)|Death|0|||
23769642|NCT00585351|66535621|FG004|Enrollment Period (Intervention)|Death|1|||
23769643|NCT00585351|66535622|FG005|Enrollment Period (Intervention)|Death|0|||
23769644|NCT00585351|66535623|FG006|Enrollment Period (Intervention)|Death|1|||
23769645|NCT00585351|66535624|FG007|Enrollment Period (Intervention)|Death|0|||
23769646|NCT00585351|66535617|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769647|NCT00585351|66535618|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769648|NCT00585351|66535619|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769649|NCT00585351|66535620|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769650|NCT00585351|66535621|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
23769651|NCT00585351|66535622|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
23769652|NCT00585351|66535623|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769653|NCT00585351|66535624|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23769654|NCT02514174|66535629|FG000|Overall Study|Patient refused to continue medication|1|||
23769655|NCT02514174|66535629|FG000|Overall Study|Adverse Event|2|||
23769656|NCT02514174|66535629|FG000|Overall Study|Study closed by sponsor|9|||
23769657|NCT02514174|66535629|FG000|Overall Study|Progressive disease|11|||
23769658|NCT02514174|66535629|FG000|Overall Study|Treatment change|1|||
23769659|NCT02514174|66535629|FG000|Overall Study|Treated off study with Afatinib.|1|||
23769660|NCT00925769|66535630|FG000|Overall Study|Major toxicity|1|||
23769661|NCT00925769|66535631|FG001|Overall Study|Major toxicity|0|||
23769662|NCT00925769|66535632|FG002|Overall Study|Major toxicity|1|||
23769663|NCT00925769|66535633|FG003|Overall Study|Major toxicity|1|||
23769664|NCT00925769|66535634|FG004|Overall Study|Major toxicity|0|||
23769665|NCT00925769|66535635|FG005|Overall Study|Major toxicity|0|||
23769666|NCT00925769|66535630|FG000|Overall Study|Disease progression|4|||
23769667|NCT00925769|66535631|FG001|Overall Study|Disease progression|5|||
23769668|NCT00925769|66535632|FG002|Overall Study|Disease progression|3|||
23769669|NCT00925769|66535633|FG003|Overall Study|Disease progression|4|||
23769670|NCT00925769|66535634|FG004|Overall Study|Disease progression|2|||
23769671|NCT00925769|66535635|FG005|Overall Study|Disease progression|3|||
23769672|NCT00925769|66535630|FG000|Overall Study|Death|0|||
23769673|NCT00925769|66535631|FG001|Overall Study|Death|0|||
23769674|NCT00925769|66535632|FG002|Overall Study|Death|1|||
23769675|NCT00925769|66535633|FG003|Overall Study|Death|0|||
23769676|NCT00925769|66535634|FG004|Overall Study|Death|0|||
23769677|NCT00925769|66535635|FG005|Overall Study|Death|0|||
23769678|NCT00925769|66535630|FG000|Overall Study|Physician Decision|1|||
23769679|NCT00925769|66535631|FG001|Overall Study|Physician Decision|0|||
23769680|NCT00925769|66535632|FG002|Overall Study|Physician Decision|0|||
23769681|NCT00925769|66535633|FG003|Overall Study|Physician Decision|0|||
23769682|NCT00925769|66535634|FG004|Overall Study|Physician Decision|0|||
23769683|NCT00925769|66535635|FG005|Overall Study|Physician Decision|0|||
23769684|NCT00925769|66535630|FG000|Overall Study|Missing documentation|0|||
23769685|NCT00925769|66535631|FG001|Overall Study|Missing documentation|1|||
23769686|NCT00925769|66535632|FG002|Overall Study|Missing documentation|0|||
23769687|NCT00925769|66535633|FG003|Overall Study|Missing documentation|0|||
23769688|NCT00925769|66535634|FG004|Overall Study|Missing documentation|0|||
23769689|NCT00925769|66535635|FG005|Overall Study|Missing documentation|0|||
23769690|NCT00925769|66535630|FG000|Overall Study|End of study visit not done|0|||
23769691|NCT00925769|66535631|FG001|Overall Study|End of study visit not done|0|||
23769692|NCT00925769|66535632|FG002|Overall Study|End of study visit not done|1|||
23769693|NCT00925769|66535633|FG003|Overall Study|End of study visit not done|0|||
23769694|NCT00925769|66535634|FG004|Overall Study|End of study visit not done|0|||
23769695|NCT00925769|66535635|FG005|Overall Study|End of study visit not done|0|||
23769696|NCT00925769|66535630|FG000|Overall Study|Participant is unable to swallow drug|0|||
23769697|NCT00925769|66535631|FG001|Overall Study|Participant is unable to swallow drug|0|||
23769698|NCT00925769|66535632|FG002|Overall Study|Participant is unable to swallow drug|0|||
23769699|NCT00925769|66535633|FG003|Overall Study|Participant is unable to swallow drug|1|||
23769700|NCT00925769|66535634|FG004|Overall Study|Participant is unable to swallow drug|0|||
23769701|NCT00925769|66535635|FG005|Overall Study|Participant is unable to swallow drug|0|||
23769702|NCT00925769|66535630|FG000|Overall Study|Adverse Event|0|||
23830526|NCT03850483|66759948|FG007|Follow-up for Stage 1|Adverse Event|0|||
23830527|NCT03850483|66759949|FG008|Follow-up for Stage 1|Adverse Event|0|||
23830528|NCT03850483|66759950|FG009|Follow-up for Stage 1|Adverse Event|0|||
23571159|NCT00917267|65820909|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
23571160|NCT01734850|65820910|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
23571161|NCT01734850|65820911|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
23571162|NCT01734850|65820912|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
23571163|NCT01734850|65820910|FG000|Overall Study|Not infused due to manufacturing failure|0|||
23571164|NCT01734850|65820911|FG001|Overall Study|Not infused due to manufacturing failure|0|||
23571165|NCT01734850|65820912|FG002|Overall Study|Not infused due to manufacturing failure|1|||
23571166|NCT00962585|65820915|FG000|Overall Study|Adverse Event|0|||
23571167|NCT00962585|65820916|FG001|Overall Study|Adverse Event|2|||
23571168|NCT00962585|65820917|FG002|Overall Study|Adverse Event|1|||
23571169|NCT00962585|65820918|FG003|Overall Study|Adverse Event|0|||
23571170|NCT00962585|65820915|FG000|Overall Study|Lost to Follow-up|3|||
23571171|NCT00962585|65820916|FG001|Overall Study|Lost to Follow-up|0|||
23571172|NCT00962585|65820917|FG002|Overall Study|Lost to Follow-up|1|||
23571173|NCT00962585|65820918|FG003|Overall Study|Lost to Follow-up|0|||
23571174|NCT00962585|65820915|FG000|Overall Study|Protocol Violation|0|||
23571175|NCT00962585|65820916|FG001|Overall Study|Protocol Violation|0|||
23571176|NCT00962585|65820917|FG002|Overall Study|Protocol Violation|1|||
23631775|NCT00340704|66038510|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23631776|NCT00340704|66038511|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23631777|NCT00340704|66038512|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
23631778|NCT00340704|66038513|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
23571177|NCT00962585|65820918|FG003|Overall Study|Protocol Violation|0|||
23571178|NCT00962585|65820915|FG000|Overall Study|Withdrawal by Subject|1|||
23571179|NCT00962585|65820916|FG001|Overall Study|Withdrawal by Subject|0|||
23571180|NCT00962585|65820917|FG002|Overall Study|Withdrawal by Subject|0|||
23631779|NCT00340704|66038514|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23631780|NCT00340704|66038515|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23631781|NCT00340704|66038516|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
23769703|NCT00925769|66535631|FG001|Overall Study|Adverse Event|0|||
23769704|NCT00925769|66535632|FG002|Overall Study|Adverse Event|0|||
23769705|NCT00925769|66535633|FG003|Overall Study|Adverse Event|0|||
23769706|NCT00925769|66535634|FG004|Overall Study|Adverse Event|1|||
23769707|NCT00925769|66535635|FG005|Overall Study|Adverse Event|0|||
23769708|NCT03529955|66535636|FG000|Overall Study|Adverse Event|1|||
23769709|NCT03529955|66535636|FG000|Overall Study|Lack of Efficacy|1|||
23830529|NCT03850483|66759941|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23571181|NCT00962585|65820918|FG003|Overall Study|Withdrawal by Subject|0|||
23571182|NCT00962585|65820915|FG000|Overall Study|Withdrew Consent|2|||
23571183|NCT00962585|65820916|FG001|Overall Study|Withdrew Consent|0|||
23571184|NCT00962585|65820917|FG002|Overall Study|Withdrew Consent|0|||
23571185|NCT00962585|65820918|FG003|Overall Study|Withdrew Consent|0|||
23769710|NCT00421174|66535637|FG000|Overall Study|Withdrawal by Subject|0|||
23769711|NCT00421174|66535638|FG001|Overall Study|Withdrawal by Subject|1|||
23769712|NCT00421174|66535637|FG000|Overall Study|Ineligible due to infection|2|||
23769713|NCT00421174|66535638|FG001|Overall Study|Ineligible due to infection|0|||
23769714|NCT01054599|66535641|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
23571186|NCT01807221|65820927|FG000|Overall Study|Progressive disease|1|||
23571187|NCT01807221|65820928|FG001|Overall Study|Progressive disease|0|||
23571188|NCT01807221|65820929|FG002|Overall Study|Progressive disease|1|||
23571189|NCT01807221|65820930|FG003|Overall Study|Progressive disease|0|||
23571190|NCT01807221|65820931|FG004|Overall Study|Progressive disease|0|||
23571191|NCT01807221|65820932|FG005|Overall Study|Progressive disease|0|||
23571192|NCT01807221|65820927|FG000|Overall Study|Death|7|||
23571193|NCT01807221|65820928|FG001|Overall Study|Death|9|||
23571194|NCT01807221|65820929|FG002|Overall Study|Death|4|||
23571195|NCT01807221|65820930|FG003|Overall Study|Death|2|||
23571196|NCT01807221|65820931|FG004|Overall Study|Death|1|||
23571197|NCT01807221|65820932|FG005|Overall Study|Death|6|||
23571198|NCT01807221|65820927|FG000|Overall Study|Physician Decision|2|||
23571199|NCT01807221|65820928|FG001|Overall Study|Physician Decision|1|||
23571200|NCT01807221|65820929|FG002|Overall Study|Physician Decision|0|||
23571201|NCT01807221|65820930|FG003|Overall Study|Physician Decision|0|||
23571202|NCT01807221|65820931|FG004|Overall Study|Physician Decision|0|||
23571203|NCT01807221|65820932|FG005|Overall Study|Physician Decision|0|||
23571204|NCT01807221|65820927|FG000|Overall Study|Adverse Event|33|||
23571205|NCT01807221|65820928|FG001|Overall Study|Adverse Event|22|||
23571206|NCT01807221|65820929|FG002|Overall Study|Adverse Event|26|||
23571207|NCT01807221|65820930|FG003|Overall Study|Adverse Event|25|||
23571208|NCT01807221|65820931|FG004|Overall Study|Adverse Event|18|||
23769715|NCT01054599|66535642|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
23769716|NCT01054599|66535641|FG000|Overall Study|Protocol Violation|1|||
23769717|NCT01054599|66535642|FG001|Overall Study|Protocol Violation|0|||
23769718|NCT01054599|66535641|FG000|Overall Study|Spells/seizure-like episodes|1|||
23769719|NCT01054599|66535642|FG001|Overall Study|Spells/seizure-like episodes|1|||
23769720|NCT01054599|66535641|FG000|Overall Study|Timing/scheduling difficulties|1|||
23769721|NCT01054599|66535642|FG001|Overall Study|Timing/scheduling difficulties|1|||
23769722|NCT01054599|66535641|FG000|Overall Study|Visual impairment, WTAR <80|0|||
23769723|NCT01054599|66535642|FG001|Overall Study|Visual impairment, WTAR <80|1|||
23769724|NCT01054599|66535641|FG000|Overall Study|Lost to Follow-up|0|||
23769725|NCT01054599|66535642|FG001|Overall Study|Lost to Follow-up|2|||
23769726|NCT01054599|66535641|FG000|Overall Study|Adverse Event|0|||
23769727|NCT01054599|66535642|FG001|Overall Study|Adverse Event|1|||
23769728|NCT01054599|66535641|FG000|Overall Study|Withdrawal by Subject|0|||
23769729|NCT01054599|66535642|FG001|Overall Study|Withdrawal by Subject|1|||
23769730|NCT02486796|66535645|FG000|Overall Study|Withdrawal by Subject|1|||
23769731|NCT02486796|66535646|FG001|Overall Study|Withdrawal by Subject|1|||
23769732|NCT02486796|66535645|FG000|Overall Study|Physician Decision|1|||
23769733|NCT02486796|66535646|FG001|Overall Study|Physician Decision|0|||
23769734|NCT02623829|66535662|FG000|Overall Study|Lost to Follow-up|1|||
23769735|NCT02623829|66535663|FG001|Overall Study|Lost to Follow-up|1|||
23769736|NCT01835145|66535664|FG000|Overall Study|Ineligible prior to treatment|1|||
23769737|NCT01835145|66535665|FG001|Overall Study|Ineligible prior to treatment|0|||
23769738|NCT01475474|66535666|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
23769739|NCT01475474|66535666|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
23769740|NCT00958256|66535667|FG000|Overall Study|Adverse Event|3|||
23769741|NCT02750306|66535668|FG000|Overall Study|Withdrawal by Subject|5|||
23769742|NCT02750306|66535669|FG001|Overall Study|Withdrawal by Subject|2|||
23769743|NCT02750306|66535668|FG000|Overall Study|Protocol Violation|1|||
23571209|NCT01807221|65820932|FG005|Overall Study|Adverse Event|21|||
23571210|NCT01807221|65820927|FG000|Overall Study|Protocol Violation|0|||
23571211|NCT01807221|65820928|FG001|Overall Study|Protocol Violation|2|||
23769744|NCT02750306|66535669|FG001|Overall Study|Protocol Violation|0|||
23769745|NCT00662129|66535673|FG000|Overall Study|Protocol Violation|1|||
23769746|NCT00662129|66535673|FG000|Overall Study|Cancel prior to beginning treatment|1|||
23571212|NCT01807221|65820929|FG002|Overall Study|Protocol Violation|1|||
23769747|NCT00662129|66535673|FG000|Overall Study|Ineligible|1|||
23571213|NCT01807221|65820930|FG003|Overall Study|Protocol Violation|2|||
23571214|NCT01807221|65820931|FG004|Overall Study|Protocol Violation|0|||
23571215|NCT01807221|65820932|FG005|Overall Study|Protocol Violation|1|||
23631782|NCT00340704|66038517|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
23631783|NCT00340704|66038509|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631784|NCT00340704|66038510|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631785|NCT00340704|66038511|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631786|NCT00340704|66038512|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631787|NCT00340704|66038513|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631788|NCT00340704|66038514|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
23631789|NCT00340704|66038515|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631790|NCT00340704|66038516|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631791|NCT00340704|66038517|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23631792|NCT00340704|66038509|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631793|NCT00340704|66038510|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631794|NCT00340704|66038511|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631795|NCT00340704|66038512|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23769748|NCT03381248|66535674|FG000|0-6 Months|Withdrawal by Subject|4|||
23769749|NCT03381248|66535675|FG001|0-6 Months|Withdrawal by Subject|1|||
23769750|NCT03381248|66535674|FG000|0-6 Months|Lost to Follow-up|3|||
23631796|NCT00340704|66038513|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
23769751|NCT03381248|66535675|FG001|0-6 Months|Lost to Follow-up|2|||
23769752|NCT03381248|66535674|FG000|0-6 Months|Lack of Efficacy|1|||
23769753|NCT03381248|66535675|FG001|0-6 Months|Lack of Efficacy|0|||
23769754|NCT03381248|66535674|FG000|0-6 Months|Adverse Event|1|||
23769755|NCT03381248|66535675|FG001|0-6 Months|Adverse Event|0|||
23769756|NCT03381248|66535674|FG000|0-6 Months|Protocol Violation|2|||
23769757|NCT03381248|66535675|FG001|0-6 Months|Protocol Violation|1|||
23631797|NCT00340704|66038514|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
23631798|NCT00340704|66038515|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631799|NCT00340704|66038516|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631800|NCT00340704|66038517|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23631801|NCT00340704|66038509|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23769758|NCT03381248|66535674|FG000|0-6 Months|Physician Decision|1|||
23769759|NCT03381248|66535675|FG001|0-6 Months|Physician Decision|0|||
23769760|NCT03381248|66535674|FG000|0-6 Months|Planning another procedure|1|||
23830530|NCT03850483|66759942|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
23830531|NCT03850483|66759943|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830532|NCT03850483|66759944|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830533|NCT03850483|66759945|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
23830534|NCT03850483|66759946|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
23830535|NCT03850483|66759947|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830536|NCT03850483|66759948|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830537|NCT03850483|66759949|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830538|NCT03850483|66759950|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23830539|NCT03850483|66759941|FG000|Follow-up for Stage 1|Other|0|||
23830540|NCT03850483|66759942|FG001|Follow-up for Stage 1|Other|2|||
23830541|NCT03850483|66759943|FG002|Follow-up for Stage 1|Other|0|||
23447063|NCT03210961|65377864|FG001|Overall Study|Adverse Event|0|||
23769761|NCT03381248|66535675|FG001|0-6 Months|Planning another procedure|2|||
23769762|NCT03381248|66535674|FG000|6-12 Months|Withdrawal by Subject|1|||
23769763|NCT03381248|66535675|FG001|6-12 Months|Withdrawal by Subject|3|||
23769764|NCT03381248|66535674|FG000|6-12 Months|Lost to Follow-up|0|||
23830542|NCT03850483|66759944|FG003|Follow-up for Stage 1|Other|2|||
23830543|NCT03850483|66759945|FG004|Follow-up for Stage 1|Other|0|||
23571216|NCT01807221|65820927|FG000|Overall Study|Non-compliance|1|||
23571217|NCT01807221|65820928|FG001|Overall Study|Non-compliance|2|||
23571218|NCT01807221|65820929|FG002|Overall Study|Non-compliance|0|||
23571219|NCT01807221|65820930|FG003|Overall Study|Non-compliance|1|||
23571220|NCT01807221|65820931|FG004|Overall Study|Non-compliance|0|||
23571221|NCT01807221|65820932|FG005|Overall Study|Non-compliance|0|||
23571222|NCT01807221|65820927|FG000|Overall Study|Logistical difficulties|0|||
23631802|NCT00340704|66038510|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23631803|NCT00340704|66038511|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23631804|NCT00340704|66038512|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23631805|NCT00340704|66038513|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23631806|NCT00340704|66038514|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
23631807|NCT00340704|66038515|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
23631808|NCT00340704|66038516|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
23631809|NCT00340704|66038517|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
23631810|NCT00422734|66038521|FG000|Overall Study|Physician Decision|1|||
23769765|NCT03381248|66535675|FG001|6-12 Months|Lost to Follow-up|2|||
23571223|NCT01807221|65820928|FG001|Overall Study|Logistical difficulties|1|||
23631811|NCT00422734|66038522|FG001|Overall Study|Physician Decision|1|||
23631812|NCT00422734|66038521|FG000|Overall Study|Protocol Violation|1|||
23769766|NCT03381248|66535674|FG000|6-12 Months|Protocol Violation|3|||
23769767|NCT03381248|66535675|FG001|6-12 Months|Protocol Violation|2|||
23769768|NCT03381248|66535674|FG000|6-12 Months|Planning another procedure|6|||
23769769|NCT03381248|66535675|FG001|6-12 Months|Planning another procedure|2|||
23769770|NCT03381248|66535674|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
23769771|NCT03381248|66535675|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
23769772|NCT03381248|66535674|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
23769773|NCT03381248|66535675|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
23769774|NCT03381248|66535674|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
23769775|NCT03381248|66535675|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
23769776|NCT03583333|66535676|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
23769777|NCT03583333|66535677|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
23769778|NCT03583333|66535676|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
23769779|NCT03583333|66535677|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
23769780|NCT03583333|66535676|FG000|Overall Study|Withdrawal by Subject|9|||
23769781|NCT03583333|66535677|FG001|Overall Study|Withdrawal by Subject|5|||
23769782|NCT03583333|66535676|FG000|Overall Study|Physician Decision|3|||
23769783|NCT03583333|66535677|FG001|Overall Study|Physician Decision|2|||
23769784|NCT03583333|66535676|FG000|Overall Study|Death|12|||
23769785|NCT03583333|66535677|FG001|Overall Study|Death|7|||
23769786|NCT03211156|66535678|FG000|Overall Study|Withdrawal by Subject|0|||
23769787|NCT03211156|66535679|FG001|Overall Study|Withdrawal by Subject|2|||
23769788|NCT03211156|66535678|FG000|Overall Study|Lost to Follow-up|1|||
23769789|NCT03211156|66535679|FG001|Overall Study|Lost to Follow-up|1|||
23769790|NCT03211156|66535678|FG000|Overall Study|Adverse Event|1|||
23631813|NCT00422734|66038522|FG001|Overall Study|Protocol Violation|6|||
23631814|NCT00422734|66038521|FG000|Overall Study|Withdrawal by Subject|12|||
23631815|NCT00422734|66038522|FG001|Overall Study|Withdrawal by Subject|8|||
23631816|NCT00422734|66038521|FG000|Overall Study|Adverse Event|0|||
23631817|NCT00422734|66038522|FG001|Overall Study|Adverse Event|3|||
23631818|NCT00422734|66038521|FG000|Overall Study|Partner Decision|0|||
23631819|NCT00422734|66038522|FG001|Overall Study|Partner Decision|3|||
23631820|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
23631821|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
23631822|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
23631823|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
23631824|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
23631825|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
23631826|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
23631827|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
23769791|NCT03211156|66535679|FG001|Overall Study|Adverse Event|0|||
23769792|NCT00135707|66535684|FG000|Overall Study|Lost to Follow-up|94|||
23571224|NCT01807221|65820929|FG002|Overall Study|Logistical difficulties|0|||
23571225|NCT01807221|65820930|FG003|Overall Study|Logistical difficulties|0|||
23631828|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
23769793|NCT00135707|66535685|FG001|Overall Study|Lost to Follow-up|89|||
23769794|NCT00135707|66535684|FG000|Overall Study|Withdrawal by Subject|0|||
23769795|NCT00135707|66535685|FG001|Overall Study|Withdrawal by Subject|1|||
23631829|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
23631830|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
23631831|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
23631832|NCT00790400|66038523|FG000|Double-blind Period (Core Phase)|Death|1|||
23631833|NCT00790400|66038524|FG001|Double-blind Period (Core Phase)|Death|0|||
23631834|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
23631835|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
23631836|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
23631837|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
23631838|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
23769796|NCT00135707|66535684|FG000|Overall Study|Institutional review board request|1|||
23769797|NCT00135707|66535685|FG001|Overall Study|Institutional review board request|0|||
23769798|NCT00368966|66535688|FG000|Infant Series|Withdrawal by Subject|11|||
23769799|NCT00368966|66535689|FG001|Infant Series|Withdrawal by Subject|6|||
23769800|NCT00368966|66535688|FG000|Infant Series|Protocol Violation|2|||
23769801|NCT00368966|66535689|FG001|Infant Series|Protocol Violation|1|||
23631839|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
23631840|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
23631841|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
23631842|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
23631843|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
23631844|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Death|1|||
23631845|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Death|0|||
23631846|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
23631847|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
23631848|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
23631849|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
23631850|NCT00790400|66038523|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
23631851|NCT00790400|66038524|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
23631852|NCT01151215|66038525|FG000|Overall Study|Worsening of condition under study|1|||
23631853|NCT01151215|66038526|FG001|Overall Study|Worsening of condition under study|1|||
23631854|NCT01151215|66038527|FG002|Overall Study|Worsening of condition under study|1|||
23631855|NCT01151215|66038525|FG000|Overall Study|Death|16|||
23631856|NCT01151215|66038526|FG001|Overall Study|Death|20|||
23631857|NCT01151215|66038527|FG002|Overall Study|Death|11|||
23631858|NCT01151215|66038525|FG000|Overall Study|Lost to Follow-up|0|||
23631859|NCT01151215|66038526|FG001|Overall Study|Lost to Follow-up|0|||
23631860|NCT01151215|66038527|FG002|Overall Study|Lost to Follow-up|3|||
23631861|NCT01151215|66038525|FG000|Overall Study|Withdrawal by Subject|3|||
23631862|NCT01151215|66038526|FG001|Overall Study|Withdrawal by Subject|1|||
23769802|NCT00368966|66535688|FG000|Infant Series|Lost to Follow-up|2|||
23769803|NCT00368966|66535689|FG001|Infant Series|Lost to Follow-up|0|||
23571226|NCT01807221|65820931|FG004|Overall Study|Logistical difficulties|1|||
23571227|NCT01807221|65820932|FG005|Overall Study|Logistical difficulties|0|||
23571228|NCT01807221|65820927|FG000|Overall Study|Withdrawal by Subject|33|||
23571229|NCT01807221|65820928|FG001|Overall Study|Withdrawal by Subject|15|||
23571230|NCT01807221|65820929|FG002|Overall Study|Withdrawal by Subject|8|||
23571231|NCT01807221|65820930|FG003|Overall Study|Withdrawal by Subject|14|||
23571232|NCT01807221|65820931|FG004|Overall Study|Withdrawal by Subject|16|||
23571233|NCT01807221|65820932|FG005|Overall Study|Withdrawal by Subject|13|||
23571234|NCT01807221|65820927|FG000|Overall Study|Sponsor decision|2|||
23571235|NCT01807221|65820928|FG001|Overall Study|Sponsor decision|0|||
23571236|NCT01807221|65820929|FG002|Overall Study|Sponsor decision|1|||
23631863|NCT01151215|66038527|FG002|Overall Study|Withdrawal by Subject|2|||
23769804|NCT00368966|66535688|FG000|Infant Series|Randomization error|0|||
23769805|NCT00368966|66535689|FG001|Infant Series|Randomization error|1|||
23769806|NCT00368966|66535688|FG000|Infant Series|Failed to meet eligibility criteria|0|||
23769807|NCT00368966|66535689|FG001|Infant Series|Failed to meet eligibility criteria|1|||
23769808|NCT00368966|66535688|FG000|Infant Series|Adverse Event|0|||
23769809|NCT00368966|66535689|FG001|Infant Series|Adverse Event|1|||
23769810|NCT00368966|66535688|FG000|Infant Series|Failed to return|1|||
23769811|NCT00368966|66535689|FG001|Infant Series|Failed to return|0|||
23769812|NCT00368966|66535688|FG000|After Infant|Failed to return|3|||
23769813|NCT00368966|66535689|FG001|After Infant|Failed to return|1|||
23447064|NCT03210961|65377865|FG002|Overall Study|Adverse Event|0|||
23447065|NCT03210961|65377866|FG003|Overall Study|Adverse Event|0|||
23571237|NCT01807221|65820930|FG003|Overall Study|Sponsor decision|1|||
23571238|NCT01807221|65820931|FG004|Overall Study|Sponsor decision|0|||
23631864|NCT01151215|66038525|FG000|Overall Study|Disease progression|0|||
23769814|NCT00368966|66535688|FG000|After Infant|Adverse Event|1|||
23769815|NCT00368966|66535689|FG001|After Infant|Adverse Event|2|||
23769816|NCT00368966|66535688|FG000|After Infant|Withdrawal by Subject|1|||
23769817|NCT00368966|66535689|FG001|After Infant|Withdrawal by Subject|1|||
23769818|NCT00368966|66535688|FG000|After Infant|Death|1|||
23769819|NCT00368966|66535689|FG001|After Infant|Death|0|||
23769820|NCT00368966|66535688|FG000|After Infant|Lost to Follow-up|0|||
23769821|NCT00368966|66535689|FG001|After Infant|Lost to Follow-up|1|||
23769822|NCT00368966|66535688|FG000|Toddler Dose|Withdrawal by Subject|1|||
23769823|NCT00368966|66535689|FG001|Toddler Dose|Withdrawal by Subject|1|||
23769824|NCT00368966|66535688|FG000|Toddler Dose|Lost to Follow-up|0|||
23769825|NCT00368966|66535689|FG001|Toddler Dose|Lost to Follow-up|2|||
23769826|NCT03331042|66535694|FG000|Overall Study|Protocol Violation|1|||
23769827|NCT03331042|66535695|FG001|Overall Study|Protocol Violation|0|||
23769828|NCT03331042|66535696|FG002|Overall Study|Protocol Violation|0|||
23769829|NCT03331042|66535697|FG003|Overall Study|Protocol Violation|0|||
23769830|NCT03331042|66535694|FG000|Overall Study|Physician Decision|0|||
23769831|NCT03331042|66535695|FG001|Overall Study|Physician Decision|0|||
23769832|NCT03331042|66535696|FG002|Overall Study|Physician Decision|1|||
23769833|NCT03331042|66535697|FG003|Overall Study|Physician Decision|0|||
23769834|NCT03331042|66535694|FG000|Overall Study|Lost to Follow-up|0|||
23769835|NCT03331042|66535695|FG001|Overall Study|Lost to Follow-up|0|||
23769836|NCT03331042|66535696|FG002|Overall Study|Lost to Follow-up|0|||
23769837|NCT03331042|66535697|FG003|Overall Study|Lost to Follow-up|1|||
23769838|NCT02532764|66535698|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769839|NCT02532764|66535699|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769840|NCT02532764|66535700|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769841|NCT02532764|66535701|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769842|NCT02532764|66535702|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769843|NCT02532764|66535703|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769844|NCT02532764|66535704|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23769845|NCT02532764|66535705|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23769846|NCT02532764|66535706|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23769847|NCT02532764|66535707|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23769848|NCT00442936|66535711|FG000|Overall Study|Protocol Violation|1|||
23769849|NCT00442936|66535712|FG001|Overall Study|Protocol Violation|0|||
23769850|NCT00442936|66535713|FG002|Overall Study|Protocol Violation|1|||
23769851|NCT00442936|66535714|FG003|Overall Study|Protocol Violation|1|||
23769852|NCT00743197|66535715|FG000|Overall Study|Study terminated due to departure of PI.|1|||
23769853|NCT00743197|66535716|FG001|Overall Study|Study terminated due to departure of PI.|2|||
23769854|NCT04956666|66535717|FG000|Overall Study|Adverse Event|18|||
23769855|NCT04956666|66535717|FG000|Overall Study|Physician Decision|5|||
23769856|NCT01929109|66535727|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
23769857|NCT01929109|66535728|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
23769858|NCT01929109|66535729|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
23769859|NCT01929109|66535730|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
23769860|NCT01929109|66535731|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
23769861|NCT02398188|66535732|FG000|Overall Study|Adverse Event|2|||
23769862|NCT02398188|66535733|FG001|Overall Study|Adverse Event|3|||
23769863|NCT02398188|66535732|FG000|Overall Study|Lost to Follow-up|5|||
23769864|NCT02398188|66535733|FG001|Overall Study|Lost to Follow-up|0|||
23769865|NCT02398188|66535732|FG000|Overall Study|Non-compliance|4|||
23769866|NCT02398188|66535733|FG001|Overall Study|Non-compliance|4|||
23769867|NCT02398188|66535732|FG000|Overall Study|Protocol Violation|6|||
23769868|NCT02398188|66535733|FG001|Overall Study|Protocol Violation|10|||
23769869|NCT02398188|66535732|FG000|Overall Study|Sponsor Decision|2|||
23769870|NCT02398188|66535733|FG001|Overall Study|Sponsor Decision|1|||
23769871|NCT02398188|66535732|FG000|Overall Study|Pregnancy|1|||
23769872|NCT02398188|66535733|FG001|Overall Study|Pregnancy|0|||
23769873|NCT02398188|66535732|FG000|Overall Study|Withdrawal by Subject|7|||
23769874|NCT02398188|66535733|FG001|Overall Study|Withdrawal by Subject|16|||
23769875|NCT04000009|66535739|FG000|Overall Study|Adverse Event|13|||
23769876|NCT04000009|66535739|FG000|Overall Study|Lack of Efficacy|7|||
23769877|NCT04000009|66535739|FG000|Overall Study|Lost to Follow-up|8|||
23769878|NCT04000009|66535739|FG000|Overall Study|Noncompliance with study drug|4|||
23769879|NCT04000009|66535739|FG000|Overall Study|Physician Decision|1|||
23769880|NCT04000009|66535739|FG000|Overall Study|Use of prohibited medication|3|||
23769881|NCT04000009|66535739|FG000|Overall Study|Pregnancy|1|||
23769882|NCT04000009|66535739|FG000|Overall Study|Withdrawal by Subject|22|||
23769883|NCT04000009|66535739|FG000|Overall Study|Study terminated by sponsor|98|||
23769884|NCT04000009|66535739|FG000|Overall Study|Not further specified|8|||
23769885|NCT03283709|66535741|FG000|Overall Study|trial terminated|0|||
23769886|NCT03283709|66535742|FG001|Overall Study|trial terminated|1|||
23769887|NCT04604184|66535744|FG000|Overall Study|Adverse Event|5|||
23830544|NCT03850483|66759946|FG005|Follow-up for Stage 1|Other|1|||
23830545|NCT03850483|66759947|FG006|Follow-up for Stage 1|Other|0|||
23830546|NCT03850483|66759948|FG007|Follow-up for Stage 1|Other|0|||
23830547|NCT03850483|66759949|FG008|Follow-up for Stage 1|Other|0|||
23830548|NCT03850483|66759950|FG009|Follow-up for Stage 1|Other|0|||
23631865|NCT01151215|66038526|FG001|Overall Study|Disease progression|1|||
23631866|NCT01151215|66038527|FG002|Overall Study|Disease progression|1|||
23631867|NCT01151215|66038525|FG000|Overall Study|Safety as judged by the investigator|0|||
23631868|NCT01151215|66038526|FG001|Overall Study|Safety as judged by the investigator|0|||
23631869|NCT01151215|66038527|FG002|Overall Study|Safety as judged by the investigator|1|||
23631870|NCT02980042|66038532|FG000|Overall Study|Lost to Follow-up|5|||
23631871|NCT02980042|66038533|FG001|Overall Study|Lost to Follow-up|0|||
23631872|NCT02980042|66038532|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
23631873|NCT02980042|66038533|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
23631874|NCT03559062|66038535|FG000|Overall Study|Other|0|||
23631875|NCT03559062|66038536|FG001|Overall Study|Other|1|||
23631876|NCT03559062|66038537|FG002|Overall Study|Other|0|||
23631877|NCT00953615|66038538|FG000|Overall Study|Adverse Event|1|||
23631878|NCT01162486|66038541|FG000|Overall Study|low ANC|1|||
23631879|NCT01162486|66038542|FG001|Overall Study|low ANC|0|||
23631880|NCT01162486|66038543|FG002|Overall Study|low ANC|0|||
23631881|NCT01162486|66038544|FG003|Overall Study|low ANC|0|||
23631882|NCT01162486|66038545|FG004|Overall Study|low ANC|0|||
23631883|NCT01162486|66038541|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
23631884|NCT01162486|66038542|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23631885|NCT01162486|66038543|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23631886|NCT01162486|66038544|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23631887|NCT01162486|66038545|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23631888|NCT01162486|66038541|FG000|Overall Study|elevated LFTs|0|||
23631889|NCT01162486|66038542|FG001|Overall Study|elevated LFTs|0|||
23631890|NCT01162486|66038543|FG002|Overall Study|elevated LFTs|1|||
23631891|NCT01162486|66038544|FG003|Overall Study|elevated LFTs|0|||
23631892|NCT01162486|66038545|FG004|Overall Study|elevated LFTs|0|||
23631893|NCT01162486|66038541|FG000|Overall Study|Pregnancy|0|||
23631894|NCT01162486|66038542|FG001|Overall Study|Pregnancy|0|||
23631895|NCT01162486|66038543|FG002|Overall Study|Pregnancy|0|||
23631896|NCT01162486|66038544|FG003|Overall Study|Pregnancy|1|||
23631897|NCT01162486|66038545|FG004|Overall Study|Pregnancy|0|||
23631898|NCT01784523|66038546|FG000|Overall Study|Study closed early|7|||
23631899|NCT01784523|66038547|FG001|Overall Study|Study closed early|4|||
23631900|NCT01411241|66038548|FG000|Overall Study|Protocol Violation|0|||
23631901|NCT01411241|66038549|FG001|Overall Study|Protocol Violation|5|||
23631902|NCT01411241|66038548|FG000|Overall Study|Withdrawal by Subject|9|||
23631903|NCT01411241|66038549|FG001|Overall Study|Withdrawal by Subject|10|||
23631904|NCT01411241|66038548|FG000|Overall Study|Serious Adverse Event|0|||
23631905|NCT01411241|66038549|FG001|Overall Study|Serious Adverse Event|3|||
23631906|NCT01411241|66038548|FG000|Overall Study|Lost to Follow-up|2|||
23631907|NCT01411241|66038549|FG001|Overall Study|Lost to Follow-up|4|||
23631908|NCT00971997|66038550|FG000|Overall Study|Adverse Event|2|||
23631909|NCT00971997|66038550|FG000|Overall Study|Death|1|||
23631910|NCT00971997|66038550|FG000|Overall Study|Protocol Violation|4|||
23631911|NCT00971997|66038550|FG000|Overall Study|Withdrawal by Subject|5|||
23631912|NCT00971997|66038550|FG000|Overall Study|Physician Decision|7|||
23631913|NCT01483144|66038553|FG000|Overall Study|Adverse Event|9|||
23631914|NCT01483144|66038554|FG001|Overall Study|Adverse Event|4|||
23631915|NCT01483144|66038555|FG002|Overall Study|Adverse Event|6|||
23631916|NCT01483144|66038553|FG000|Overall Study|Withdrawal by Subject|0|||
23631917|NCT01483144|66038554|FG001|Overall Study|Withdrawal by Subject|2|||
23631918|NCT01483144|66038555|FG002|Overall Study|Withdrawal by Subject|5|||
23631919|NCT01483144|66038553|FG000|Overall Study|Physician Decision|1|||
23631920|NCT01483144|66038554|FG001|Overall Study|Physician Decision|0|||
23631921|NCT01483144|66038555|FG002|Overall Study|Physician Decision|0|||
23631922|NCT01483144|66038553|FG000|Overall Study|Lost to Follow-up|2|||
23631923|NCT01483144|66038554|FG001|Overall Study|Lost to Follow-up|4|||
23631924|NCT01483144|66038555|FG002|Overall Study|Lost to Follow-up|1|||
23631925|NCT01483144|66038553|FG000|Overall Study|Protocol Violation|3|||
23631926|NCT01483144|66038554|FG001|Overall Study|Protocol Violation|3|||
23631927|NCT01483144|66038555|FG002|Overall Study|Protocol Violation|3|||
23830549|NCT03850483|66759941|FG000|Treatment for Stage 2|Adverse Event|0|||
23830550|NCT03850483|66759942|FG001|Treatment for Stage 2|Adverse Event|0|||
23631928|NCT01850030|66038560|FG000|Overall Study|Adverse Event|64|||
23631929|NCT01850030|66038561|FG001|Overall Study|Adverse Event|82|||
23631930|NCT01850030|66038560|FG000|Overall Study|Lack of Efficacy|3|||
23631931|NCT01850030|66038561|FG001|Overall Study|Lack of Efficacy|1|||
23631932|NCT01850030|66038560|FG000|Overall Study|Lost to Follow-up|5|||
23631933|NCT01850030|66038561|FG001|Overall Study|Lost to Follow-up|5|||
23631934|NCT01850030|66038560|FG000|Overall Study|Withdrawal by Subject|3|||
23631935|NCT01850030|66038561|FG001|Overall Study|Withdrawal by Subject|4|||
23631936|NCT01850030|66038560|FG000|Overall Study|Protocol Violation|24|||
23631937|NCT01850030|66038561|FG001|Overall Study|Protocol Violation|28|||
23631938|NCT01850030|66038560|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
23631939|NCT01850030|66038561|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
23631940|NCT00953147|66038562|FG000|Overall Study|Adverse Event|8|||
23631941|NCT00953147|66038563|FG001|Overall Study|Adverse Event|16|||
23631942|NCT00953147|66038564|FG002|Overall Study|Adverse Event|6|||
23631943|NCT00953147|66038562|FG000|Overall Study|Protocol Violation|2|||
23631944|NCT00953147|66038563|FG001|Overall Study|Protocol Violation|8|||
23631945|NCT00953147|66038564|FG002|Overall Study|Protocol Violation|4|||
23631946|NCT00953147|66038562|FG000|Overall Study|Withdrawal by Subject|13|||
23631947|NCT00953147|66038563|FG001|Overall Study|Withdrawal by Subject|15|||
23631948|NCT00953147|66038564|FG002|Overall Study|Withdrawal by Subject|12|||
23631949|NCT00953147|66038562|FG000|Overall Study|Lost to Follow-up|8|||
23631950|NCT00953147|66038563|FG001|Overall Study|Lost to Follow-up|9|||
23631951|NCT00953147|66038564|FG002|Overall Study|Lost to Follow-up|4|||
23631952|NCT00953147|66038562|FG000|Overall Study|Physician Decision|2|||
23631953|NCT00953147|66038563|FG001|Overall Study|Physician Decision|7|||
23631954|NCT00953147|66038564|FG002|Overall Study|Physician Decision|3|||
23631955|NCT00953147|66038562|FG000|Overall Study|Other|4|||
23631956|NCT00953147|66038563|FG001|Overall Study|Other|11|||
23631957|NCT00953147|66038564|FG002|Overall Study|Other|13|||
23631958|NCT01174446|66038567|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23631959|NCT01174446|66038568|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23631960|NCT01174446|66038569|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
23631961|NCT01174446|66038570|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23631962|NCT01174446|66038567|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23631963|NCT01174446|66038568|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23631964|NCT01174446|66038569|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
23631965|NCT01174446|66038570|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23631966|NCT01174446|66038567|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
23631967|NCT01174446|66038568|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23631968|NCT01174446|66038569|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23631969|NCT01174446|66038570|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23631970|NCT01174446|66038567|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23631971|NCT01174446|66038568|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
23631972|NCT01174446|66038569|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23631973|NCT01174446|66038570|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23631974|NCT03721172|66038571|FG000|Placebo-controlled Phase|Adverse Event|7|||
23631975|NCT03721172|66038572|FG001|Placebo-controlled Phase|Adverse Event|7|||
23631976|NCT03721172|66038573|FG002|Placebo-controlled Phase|Adverse Event|0|||
23631977|NCT03721172|66038571|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
23631978|NCT03721172|66038572|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
23631979|NCT03721172|66038573|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23631980|NCT03721172|66038571|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
23631981|NCT03721172|66038572|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
23631982|NCT03721172|66038573|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
23631983|NCT03721172|66038571|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
23631984|NCT03721172|66038572|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
23631985|NCT03721172|66038573|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23631986|NCT03721172|66038571|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
23631987|NCT03721172|66038572|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
23631988|NCT03721172|66038573|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23631989|NCT03721172|66038571|FG000|Placebo-controlled Phase|Other|3|||
23631990|NCT03721172|66038572|FG001|Placebo-controlled Phase|Other|0|||
23631991|NCT03721172|66038573|FG002|Placebo-controlled Phase|Other|0|||
23631992|NCT03721172|66038571|FG000|Apremilast Extension Phase|Adverse Event|0|||
23631993|NCT03721172|66038572|FG001|Apremilast Extension Phase|Adverse Event|0|||
23631994|NCT03721172|66038573|FG002|Apremilast Extension Phase|Adverse Event|10|||
23631995|NCT03721172|66038571|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23769888|NCT04604184|66535745|FG001|Overall Study|Adverse Event|5|||
23769889|NCT04604184|66535744|FG000|Overall Study|Death|2|||
23769890|NCT04604184|66535745|FG001|Overall Study|Death|1|||
23631996|NCT03721172|66038572|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23631997|NCT03721172|66038573|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
23631998|NCT03721172|66038571|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
23631999|NCT03721172|66038572|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
23632000|NCT03721172|66038573|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
23769891|NCT04604184|66535744|FG000|Overall Study|Withdrawal by Subject|1|||
23632001|NCT03721172|66038571|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23632002|NCT03721172|66038572|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23632003|NCT03721172|66038573|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
23769892|NCT04604184|66535745|FG001|Overall Study|Withdrawal by Subject|3|||
23830551|NCT03850483|66759943|FG002|Treatment for Stage 2|Adverse Event|0|||
23830552|NCT03850483|66759944|FG003|Treatment for Stage 2|Adverse Event|0|||
23830553|NCT03850483|66759945|FG004|Treatment for Stage 2|Adverse Event|0|||
23830554|NCT03850483|66759946|FG005|Treatment for Stage 2|Adverse Event|0|||
23830555|NCT03850483|66759947|FG006|Treatment for Stage 2|Adverse Event|0|||
23830556|NCT03850483|66759948|FG007|Treatment for Stage 2|Adverse Event|0|||
23830557|NCT03850483|66759949|FG008|Treatment for Stage 2|Adverse Event|0|||
23830558|NCT03850483|66759950|FG009|Treatment for Stage 2|Adverse Event|1|||
23830559|NCT03850483|66759941|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
23830560|NCT03850483|66759942|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
23830561|NCT03850483|66759943|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
23830562|NCT03850483|66759944|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
23830563|NCT03850483|66759945|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
23830564|NCT03850483|66759946|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
23830565|NCT03850483|66759947|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
23830566|NCT03850483|66759948|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
23830567|NCT03850483|66759949|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
23830568|NCT03850483|66759950|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
23830569|NCT03850483|66759941|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
23830570|NCT03850483|66759942|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
23830571|NCT03850483|66759943|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
23830572|NCT03850483|66759944|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
23830573|NCT03850483|66759945|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
23830574|NCT03850483|66759946|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
23830575|NCT03850483|66759947|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
23830576|NCT03850483|66759948|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
23830577|NCT03850483|66759949|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
23830578|NCT03850483|66759950|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
23830579|NCT03850483|66759941|FG000|Treatment for Stage 2|Physician Decision|0|||
23830580|NCT03850483|66759942|FG001|Treatment for Stage 2|Physician Decision|0|||
23830581|NCT03850483|66759943|FG002|Treatment for Stage 2|Physician Decision|0|||
23830582|NCT03850483|66759944|FG003|Treatment for Stage 2|Physician Decision|0|||
23830583|NCT03850483|66759945|FG004|Treatment for Stage 2|Physician Decision|0|||
23830584|NCT03850483|66759946|FG005|Treatment for Stage 2|Physician Decision|0|||
23830585|NCT03850483|66759947|FG006|Treatment for Stage 2|Physician Decision|0|||
23830586|NCT03850483|66759948|FG007|Treatment for Stage 2|Physician Decision|0|||
23830587|NCT03850483|66759949|FG008|Treatment for Stage 2|Physician Decision|0|||
23830588|NCT03850483|66759950|FG009|Treatment for Stage 2|Physician Decision|1|||
23830589|NCT03850483|66759941|FG000|Treatment for Stage 2|Protocol Violation|0|||
23830590|NCT03850483|66759942|FG001|Treatment for Stage 2|Protocol Violation|0|||
23830591|NCT03850483|66759943|FG002|Treatment for Stage 2|Protocol Violation|0|||
23830592|NCT03850483|66759944|FG003|Treatment for Stage 2|Protocol Violation|0|||
23830593|NCT03850483|66759945|FG004|Treatment for Stage 2|Protocol Violation|0|||
23571239|NCT01807221|65820932|FG005|Overall Study|Sponsor decision|0|||
23571240|NCT01807221|65820927|FG000|Overall Study|Lost to Follow-up|1|||
23571241|NCT01807221|65820928|FG001|Overall Study|Lost to Follow-up|0|||
23571242|NCT01807221|65820929|FG002|Overall Study|Lost to Follow-up|2|||
23571243|NCT01807221|65820930|FG003|Overall Study|Lost to Follow-up|1|||
23571244|NCT01807221|65820931|FG004|Overall Study|Lost to Follow-up|0|||
23830594|NCT03850483|66759946|FG005|Treatment for Stage 2|Protocol Violation|0|||
23830595|NCT03850483|66759947|FG006|Treatment for Stage 2|Protocol Violation|0|||
23830596|NCT03850483|66759948|FG007|Treatment for Stage 2|Protocol Violation|0|||
23830597|NCT03850483|66759949|FG008|Treatment for Stage 2|Protocol Violation|1|||
23830598|NCT03850483|66759950|FG009|Treatment for Stage 2|Protocol Violation|0|||
23830599|NCT03850483|66759941|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
23830600|NCT03850483|66759942|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
23571245|NCT01807221|65820932|FG005|Overall Study|Lost to Follow-up|0|||
23571246|NCT03387514|65820937|FG000|Overall Study|Withdrawal by Subject|2|||
23571247|NCT03387514|65820937|FG000|Overall Study|Physician Decision|1|||
23571248|NCT03387514|65820937|FG000|Overall Study|Lost to Follow-up|2|||
23571249|NCT02204293|65820943|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
23571250|NCT02204293|65820944|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
23571251|NCT02204293|65820945|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
23571252|NCT02204293|65820946|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
23571253|NCT02204293|65820947|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
23571254|NCT02204293|65820948|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
23571255|NCT02204293|65820943|FG000|Core Study Part I|Adverse Event|1|||
23571256|NCT02204293|65820944|FG001|Core Study Part I|Adverse Event|0|||
23571257|NCT02204293|65820945|FG002|Core Study Part I|Adverse Event|0|||
23571258|NCT02204293|65820946|FG003|Core Study Part I|Adverse Event|0|||
23571259|NCT02204293|65820947|FG004|Core Study Part I|Adverse Event|0|||
23571260|NCT02204293|65820948|FG005|Core Study Part I|Adverse Event|0|||
23571261|NCT02204293|65820943|FG000|Core Study Part I|Physician Decision|0|||
23571262|NCT02204293|65820944|FG001|Core Study Part I|Physician Decision|3|||
23571263|NCT02204293|65820945|FG002|Core Study Part I|Physician Decision|0|||
23571264|NCT02204293|65820946|FG003|Core Study Part I|Physician Decision|0|||
23571265|NCT02204293|65820947|FG004|Core Study Part I|Physician Decision|0|||
23571266|NCT02204293|65820948|FG005|Core Study Part I|Physician Decision|0|||
23571267|NCT02204293|65820943|FG000|LTE Phase|Study Suspended|0|||
23571268|NCT02204293|65820944|FG001|LTE Phase|Study Suspended|0|||
23571269|NCT02204293|65820945|FG002|LTE Phase|Study Suspended|0|||
23571270|NCT02204293|65820946|FG003|LTE Phase|Study Suspended|0|||
23632004|NCT03721172|66038571|FG000|Apremilast Extension Phase|Protocol Violation|0|||
23632005|NCT03721172|66038572|FG001|Apremilast Extension Phase|Protocol Violation|0|||
23632006|NCT03721172|66038573|FG002|Apremilast Extension Phase|Protocol Violation|1|||
23632007|NCT03721172|66038571|FG000|Apremilast Extension Phase|Physician Decision|0|||
23632008|NCT03721172|66038572|FG001|Apremilast Extension Phase|Physician Decision|0|||
23632009|NCT03721172|66038573|FG002|Apremilast Extension Phase|Physician Decision|1|||
23632010|NCT03721172|66038571|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23571271|NCT02204293|65820947|FG004|LTE Phase|Study Suspended|0|||
23571272|NCT02204293|65820948|FG005|LTE Phase|Study Suspended|7|||
23571273|NCT01313182|65820949|FG000|Overall Study|Protocol Violation|66|||
23632011|NCT03721172|66038572|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23632012|NCT03721172|66038573|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
23632013|NCT03721172|66038571|FG000|Apremilast Extension Phase|Other|0|||
23632014|NCT03721172|66038572|FG001|Apremilast Extension Phase|Other|0|||
23632015|NCT03721172|66038573|FG002|Apremilast Extension Phase|Other|3|||
23632016|NCT03721172|66038571|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
23632017|NCT03721172|66038572|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
23632018|NCT03721172|66038573|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
23632019|NCT00126659|66038580|FG000|Overall Study|Adverse Event|0|||
23632020|NCT00126659|66038581|FG001|Overall Study|Adverse Event|0|||
23632021|NCT00126659|66038582|FG002|Overall Study|Adverse Event|2|||
23632022|NCT03327831|66038585|FG000|Overall Study|Lost to Follow-up|2|||
23632023|NCT03274453|66038586|FG000|Overall Study|Lost to Follow-up|2|||
23632024|NCT03274453|66038587|FG001|Overall Study|Lost to Follow-up|5|||
23632025|NCT03274453|66038588|FG002|Overall Study|Lost to Follow-up|4|||
23632026|NCT03274453|66038589|FG003|Overall Study|Lost to Follow-up|1|||
23632027|NCT03274453|66038586|FG000|Overall Study|Physician Decision|2|||
23632028|NCT03274453|66038587|FG001|Overall Study|Physician Decision|0|||
23632029|NCT03274453|66038588|FG002|Overall Study|Physician Decision|0|||
23632030|NCT03274453|66038589|FG003|Overall Study|Physician Decision|3|||
23447066|NCT03210961|65377867|FG004|Overall Study|Adverse Event|0|||
23447067|NCT03210961|65377868|FG005|Overall Study|Adverse Event|0|||
23632031|NCT03274453|66038586|FG000|Overall Study|Surgery Cancelled|0|||
23632032|NCT03274453|66038587|FG001|Overall Study|Surgery Cancelled|1|||
23632033|NCT03274453|66038588|FG002|Overall Study|Surgery Cancelled|0|||
23632034|NCT03274453|66038589|FG003|Overall Study|Surgery Cancelled|0|||
23632035|NCT01810939|66038590|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
23632036|NCT01810939|66038591|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
23632037|NCT01810939|66038592|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
23632038|NCT01810939|66038590|FG000|Part A Treatment Period|Protocol Violation|2|||
23632039|NCT01810939|66038591|FG001|Part A Treatment Period|Protocol Violation|0|||
23632040|NCT01810939|66038592|FG002|Part A Treatment Period|Protocol Violation|0|||
23632041|NCT01810939|66038590|FG000|Part A Treatment Period|Adverse Event|10|||
23632042|NCT01810939|66038591|FG001|Part A Treatment Period|Adverse Event|0|||
23632043|NCT01810939|66038592|FG002|Part A Treatment Period|Adverse Event|0|||
23447068|NCT03210961|65377869|FG006|Overall Study|Adverse Event|0|||
23571274|NCT01313182|65820950|FG001|Overall Study|Protocol Violation|92|||
23571275|NCT04249336|65820954|FG000|Overall Study|Lost to Follow-up|3|||
23571276|NCT04249336|65820955|FG001|Overall Study|Lost to Follow-up|3|||
23571277|NCT04249336|65820956|FG002|Overall Study|Lost to Follow-up|3|||
23769893|NCT04604184|66535744|FG000|Overall Study|Not treated|2|||
23769894|NCT04604184|66535745|FG001|Overall Study|Not treated|2|||
23769895|NCT04604184|66535744|FG000|Overall Study|Due to sponsor decision|9|||
23769896|NCT04604184|66535745|FG001|Overall Study|Due to sponsor decision|7|||
23769897|NCT04604184|66535744|FG000|Overall Study|Physician Decision|0|||
23769898|NCT04604184|66535745|FG001|Overall Study|Physician Decision|1|||
23769899|NCT04604184|66535744|FG000|Overall Study|Transfer to healthcare|1|||
23769900|NCT04604184|66535745|FG001|Overall Study|Transfer to healthcare|0|||
23769901|NCT01254409|66535746|FG000|Overall Study|Adverse Event|0|||
23769902|NCT01254409|66535747|FG001|Overall Study|Adverse Event|1|||
23769903|NCT01254409|66535748|FG002|Overall Study|Adverse Event|0|||
23769904|NCT01254409|66535749|FG003|Overall Study|Adverse Event|0|||
23447069|NCT03210961|65377870|FG007|Overall Study|Adverse Event|0|||
23769905|NCT01325207|66535751|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23769906|NCT01325207|66535752|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23769907|NCT01325207|66535753|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23769908|NCT01325207|66535754|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23769909|NCT01325207|66535755|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
23769910|NCT01325207|66535756|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23632044|NCT01810939|66038590|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
23769911|NCT01325207|66535751|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
23769912|NCT01325207|66535752|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
23769913|NCT01325207|66535753|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
23769914|NCT01325207|66535754|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
23769915|NCT01325207|66535755|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
23769916|NCT01325207|66535756|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
23769917|NCT01325207|66535751|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23632045|NCT01810939|66038591|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
23632046|NCT01810939|66038592|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
23632047|NCT01810939|66038590|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
23447070|NCT03210961|65377871|FG008|Overall Study|Adverse Event|0|||
23632048|NCT01810939|66038591|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
23769918|NCT01325207|66535752|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23447071|NCT03210961|65377872|FG009|Overall Study|Adverse Event|0|||
23447072|NCT03210961|65377873|FG010|Overall Study|Adverse Event|0|||
23632049|NCT01810939|66038592|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
23632050|NCT01810939|66038590|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
23632051|NCT01810939|66038591|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
23632052|NCT01810939|66038592|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
23632053|NCT01810939|66038590|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
23830601|NCT03850483|66759943|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
23830602|NCT03850483|66759944|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
23830603|NCT03850483|66759945|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
23830604|NCT03850483|66759946|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
23830605|NCT03850483|66759947|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
23830606|NCT03850483|66759948|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
23830607|NCT03850483|66759949|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
23830608|NCT03850483|66759950|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
23830609|NCT03850483|66759941|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830610|NCT03850483|66759942|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830611|NCT03850483|66759943|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830612|NCT03850483|66759944|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830613|NCT03850483|66759945|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830614|NCT03850483|66759946|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830615|NCT03850483|66759947|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23632054|NCT01810939|66038591|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
23632055|NCT01810939|66038592|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
23632056|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
23632057|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
23632058|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
23632059|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
23632060|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
23632061|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
23571278|NCT04249336|65820957|FG003|Overall Study|Lost to Follow-up|3|||
23571279|NCT03545113|65820960|FG000|Overall Study|Surgery Cancelled|1|||
23571280|NCT03545113|65820961|FG001|Overall Study|Surgery Cancelled|0|||
23571281|NCT03545113|65820960|FG000|Overall Study|Death|1|||
23571282|NCT03545113|65820961|FG001|Overall Study|Death|0|||
23571283|NCT03545113|65820960|FG000|Overall Study|Adverse Event|2|||
23571284|NCT03545113|65820961|FG001|Overall Study|Adverse Event|0|||
23571285|NCT03545113|65820960|FG000|Overall Study|Received different surgery|1|||
23571286|NCT03545113|65820961|FG001|Overall Study|Received different surgery|0|||
23571287|NCT01993823|65820964|FG000|Overall Study|Requested by the patient|6|||
23571288|NCT01993823|65820965|FG001|Overall Study|Requested by the patient|11|||
23571289|NCT01993823|65820964|FG000|Overall Study|Protocol Violation|0|||
23571290|NCT01993823|65820965|FG001|Overall Study|Protocol Violation|1|||
23571291|NCT01993823|65820964|FG000|Overall Study|Lost to Follow-up|1|||
23571292|NCT01993823|65820965|FG001|Overall Study|Lost to Follow-up|4|||
23571293|NCT01003639|65820971|FG000|Overall Study|Lost to Follow-up|6|||
23571294|NCT01003639|65820972|FG001|Overall Study|Lost to Follow-up|9|||
23571295|NCT01003639|65820971|FG000|Overall Study|Withdrawal by Subject|9|||
23571296|NCT01003639|65820972|FG001|Overall Study|Withdrawal by Subject|5|||
23632062|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
23632063|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
23632064|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
23571297|NCT01003639|65820971|FG000|Overall Study|Lack of Efficacy|1|||
23571298|NCT01003639|65820972|FG001|Overall Study|Lack of Efficacy|6|||
23571299|NCT01003639|65820971|FG000|Overall Study|Adverse Event|0|||
23571300|NCT01003639|65820972|FG001|Overall Study|Adverse Event|1|||
23571301|NCT01003639|65820971|FG000|Overall Study|Protocol Violation|0|||
23571302|NCT01003639|65820972|FG001|Overall Study|Protocol Violation|1|||
23571303|NCT01003639|65820971|FG000|Overall Study|Physician Decision|1|||
23571304|NCT01003639|65820972|FG001|Overall Study|Physician Decision|0|||
23571305|NCT02372058|65820973|FG000|Overall Study|Withdrawal by Subject|3|||
23571306|NCT02788006|65820974|FG000|Overall Study|Patient not treated|1|||
23571307|NCT02726399|65820978|FG000|Overall Study|Participant Non-Compliance|1|||
23571308|NCT02726399|65820978|FG000|Overall Study|Adverse Event|2|||
23571309|NCT02726399|65820978|FG000|Overall Study|Progression of disease|4|||
23571310|NCT00630058|65820981|FG000|Overall Study|Adverse Event|1|||
23571311|NCT00630058|65820982|FG001|Overall Study|Adverse Event|1|||
23571312|NCT00630058|65820981|FG000|Overall Study|Withdrawal by Subject|0|||
23571313|NCT00630058|65820982|FG001|Overall Study|Withdrawal by Subject|1|||
23571314|NCT00630058|65820981|FG000|Overall Study|stopping criteria|3|||
23571315|NCT00630058|65820982|FG001|Overall Study|stopping criteria|2|||
23571316|NCT01129336|65820985|FG000|Overall Study|Protocol Violation|1|||
23571317|NCT01129336|65820986|FG001|Overall Study|Protocol Violation|0|||
23571318|NCT01129336|65820985|FG000|Overall Study|Disease Progression|1|||
23571319|NCT01129336|65820986|FG001|Overall Study|Disease Progression|4|||
23571320|NCT01129336|65820985|FG000|Overall Study|Lost to Follow-up|1|||
23571321|NCT01129336|65820986|FG001|Overall Study|Lost to Follow-up|0|||
23571322|NCT01129336|65820985|FG000|Overall Study|Withdrawal by Subject|7|||
23571323|NCT01129336|65820986|FG001|Overall Study|Withdrawal by Subject|4|||
23571324|NCT01129336|65820985|FG000|Overall Study|Adverse Event|0|||
23571325|NCT01129336|65820986|FG001|Overall Study|Adverse Event|1|||
23571326|NCT01129336|65820985|FG000|Overall Study|Missing Study Completion Status|2|||
23571327|NCT01129336|65820986|FG001|Overall Study|Missing Study Completion Status|3|||
23571328|NCT01129336|65820985|FG000|Overall Study|Death|0|||
23571329|NCT01129336|65820986|FG001|Overall Study|Death|4|||
23769919|NCT01325207|66535753|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23571330|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
23571331|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
23571332|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
23571333|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
23571334|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
23571335|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
23571336|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23571337|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
23571338|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23571339|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
23571340|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
23571341|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
23571342|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
23571343|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
23571344|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
23571345|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
23571346|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
23571347|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
23571348|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
23571349|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
23571350|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
23571351|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
23571352|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
23571353|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
23571354|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
23571355|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
23571356|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
23571357|NCT02441946|65820987|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
23571358|NCT02441946|65820988|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
23571359|NCT02441946|65820989|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
23571360|NCT02441946|65820987|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
23571361|NCT02441946|65820988|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23571362|NCT02441946|65820989|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23571363|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
23571364|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
23571365|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
23571366|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
23571367|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Other|0|||
23571368|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Other|1|||
23571369|NCT00975221|65820990|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
23571370|NCT00975221|65820991|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
23571371|NCT00975221|65820990|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
23571372|NCT00975221|65820991|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
23571373|NCT00975221|65820990|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
23571374|NCT00975221|65820991|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
23571375|NCT03881059|65820992|FG000|Treatment Period - Part A|Adverse Event|1|||
23571376|NCT03881059|65820993|FG001|Treatment Period - Part A|Adverse Event|3|||
23571377|NCT03881059|65820994|FG002|Treatment Period - Part A|Adverse Event|4|||
23571378|NCT03881059|65820992|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
23571379|NCT03881059|65820993|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
23571380|NCT03881059|65820994|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
23571381|NCT03881059|65820992|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
23571382|NCT03881059|65820993|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
23769920|NCT01325207|66535754|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23769921|NCT01325207|66535755|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
23769922|NCT01325207|66535756|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
23769923|NCT01325207|66535751|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23769924|NCT01325207|66535752|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
23769925|NCT01325207|66535753|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23769926|NCT01325207|66535754|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23769927|NCT01325207|66535755|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23769928|NCT01325207|66535756|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23769929|NCT01325207|66535751|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23769930|NCT01325207|66535752|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23769931|NCT01325207|66535753|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23769932|NCT01325207|66535754|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23830616|NCT03850483|66759948|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23571383|NCT03881059|65820994|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
23571384|NCT03881059|65820992|FG000|Treatment Period - Part A|Other reasons|2|||
23571385|NCT03881059|65820993|FG001|Treatment Period - Part A|Other reasons|1|||
23571386|NCT03881059|65820994|FG002|Treatment Period - Part A|Other reasons|0|||
23769933|NCT01325207|66535755|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23769934|NCT01325207|66535756|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
23769935|NCT01325207|66535751|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23769936|NCT01325207|66535752|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23769937|NCT01325207|66535753|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23769938|NCT01325207|66535754|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23769939|NCT01325207|66535755|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23769940|NCT01325207|66535756|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
23769941|NCT01325207|66535751|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23769942|NCT01325207|66535752|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23769943|NCT01325207|66535753|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23769944|NCT01325207|66535754|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23769945|NCT01325207|66535755|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
23769946|NCT01325207|66535756|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23769947|NCT01654380|66535759|FG000|Part B, Period 1|Physician Decision|0|||
23769948|NCT01654380|66535760|FG001|Part B, Period 1|Physician Decision|0|||
23769949|NCT01654380|66535761|FG002|Part B, Period 1|Physician Decision|1|||
23769950|NCT01654380|66535762|FG003|Part B, Period 1|Physician Decision|0|||
23769951|NCT01658943|66535763|FG000|Overall Study|Adverse Event|6|||
23769952|NCT01658943|66535764|FG001|Overall Study|Adverse Event|13|||
23769953|NCT01658943|66535763|FG000|Overall Study|Withdrawal by Subject|9|||
23769954|NCT01658943|66535764|FG001|Overall Study|Withdrawal by Subject|2|||
23769955|NCT01658943|66535763|FG000|Overall Study|Progression/Relapse|39|||
23769956|NCT01658943|66535764|FG001|Overall Study|Progression/Relapse|40|||
23769957|NCT01658943|66535763|FG000|Overall Study|Death|4|||
23769958|NCT01658943|66535764|FG001|Overall Study|Death|2|||
23769959|NCT01658943|66535763|FG000|Overall Study|not protocol specified|4|||
23769960|NCT01658943|66535764|FG001|Overall Study|not protocol specified|1|||
23571387|NCT03881059|65820992|FG000|Treatment Period - Part B|Adverse Event|0|||
23571388|NCT03881059|65820993|FG001|Treatment Period - Part B|Adverse Event|0|||
23571389|NCT03881059|65820994|FG002|Treatment Period - Part B|Adverse Event|3|||
23571390|NCT03881059|65820992|FG000|Treatment Period - Part B|Death|0|||
23571391|NCT03881059|65820993|FG001|Treatment Period - Part B|Death|1|||
23769961|NCT01658943|66535763|FG000|Overall Study|Not eligible|7|||
23769962|NCT01658943|66535764|FG001|Overall Study|Not eligible|9|||
23769963|NCT01658943|66535763|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
23769964|NCT01658943|66535764|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
23769965|NCT03775681|66535767|FG000|Overall Study|Physician Decision|3|||
23769966|NCT00198029|66535768|FG000|Overall Study|Withdrawal by Subject|4|||
23769967|NCT00658320|66535769|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
23769968|NCT00658320|66535770|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
23769969|NCT00658320|66535769|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
23769970|NCT00658320|66535770|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
23769971|NCT00658320|66535769|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
23769972|NCT00658320|66535770|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
23769973|NCT00658320|66535769|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
23769974|NCT00658320|66535770|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
23769975|NCT00193609|66535772|FG000|Overall Study|Lack of Efficacy|2|||
23769976|NCT00193609|66535772|FG000|Overall Study|Adverse Event|2|||
23769977|NCT02132247|66535773|FG000|Overall Study|Protocol Violation|1|||
23769978|NCT02132247|66535774|FG001|Overall Study|Protocol Violation|0|||
23769979|NCT00424489|66535776|FG000|Overall Study|Death|3|||
23769980|NCT02603952|66535777|FG000|Overall Study|Withdrawal by Subject|1|||
23769981|NCT02603952|66535778|FG001|Overall Study|Withdrawal by Subject|0|||
23769982|NCT02603952|66535779|FG002|Overall Study|Withdrawal by Subject|0|||
23769983|NCT02603952|66535780|FG003|Overall Study|Withdrawal by Subject|0|||
23769984|NCT02603952|66535777|FG000|Overall Study|Received oseltamivir by error|0|||
23769985|NCT02603952|66535778|FG001|Overall Study|Received oseltamivir by error|0|||
23769986|NCT02603952|66535779|FG002|Overall Study|Received oseltamivir by error|0|||
23769987|NCT02603952|66535780|FG003|Overall Study|Received oseltamivir by error|1|||
23769988|NCT03019965|66535789|FG000|Overall Study|Withdrawal by Subject|1|||
23769989|NCT03019965|66535790|FG001|Overall Study|Withdrawal by Subject|0|||
23769990|NCT03019965|66535789|FG000|Overall Study|Protocol Violation|1|||
23769991|NCT03019965|66535790|FG001|Overall Study|Protocol Violation|3|||
23769992|NCT03019965|66535789|FG000|Overall Study|viral or fungal infection|3|||
23769993|NCT03019965|66535790|FG001|Overall Study|viral or fungal infection|4|||
23769994|NCT03019965|66535789|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
23769995|NCT03019965|66535790|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
23769996|NCT03019965|66535789|FG000|Overall Study|Physician Decision|1|||
23769997|NCT03019965|66535790|FG001|Overall Study|Physician Decision|1|||
23571392|NCT03881059|65820994|FG002|Treatment Period - Part B|Death|1|||
23447073|NCT03210961|65377874|FG011|Overall Study|Adverse Event|0|||
23447074|NCT03210961|65377875|FG012|Overall Study|Adverse Event|0|||
23447075|NCT03210961|65377876|FG013|Overall Study|Adverse Event|1|||
23632065|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
23447076|NCT03210961|65377877|FG014|Overall Study|Adverse Event|0|||
23632066|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
23632067|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
23632068|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
23632069|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
23632070|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
23632071|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
23632072|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
23632073|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
23447077|NCT03210961|65377863|FG000|Overall Study|Lost to Follow-up|0|||
23769998|NCT00387712|66535792|FG000|Overall Study|Physician Decision|6|||
23769999|NCT00387712|66535793|FG001|Overall Study|Physician Decision|4|||
23770000|NCT00387712|66535792|FG000|Overall Study|Lost to Follow-up|17|||
23770001|NCT00387712|66535793|FG001|Overall Study|Lost to Follow-up|20|||
23447078|NCT03210961|65377864|FG001|Overall Study|Lost to Follow-up|0|||
23447079|NCT03210961|65377865|FG002|Overall Study|Lost to Follow-up|0|||
23447080|NCT03210961|65377866|FG003|Overall Study|Lost to Follow-up|0|||
23447081|NCT03210961|65377867|FG004|Overall Study|Lost to Follow-up|0|||
23447082|NCT03210961|65377868|FG005|Overall Study|Lost to Follow-up|0|||
23632074|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
23632075|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
23632076|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
23632077|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
23632078|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
23632079|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
23632080|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
23632081|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
23632082|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
23632083|NCT01810939|66038590|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
23632084|NCT01810939|66038591|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
23632085|NCT01810939|66038592|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
23632086|NCT01250925|66038593|FG000|Overall Study|Lost to Follow-up|1|||
23632087|NCT01250925|66038594|FG001|Overall Study|Lost to Follow-up|1|||
23632088|NCT01250925|66038595|FG002|Overall Study|Lost to Follow-up|0|||
23632089|NCT01250925|66038593|FG000|Overall Study|Withdrawal by Subject|2|||
23632090|NCT01250925|66038594|FG001|Overall Study|Withdrawal by Subject|0|||
23632091|NCT01250925|66038595|FG002|Overall Study|Withdrawal by Subject|0|||
23632092|NCT01250925|66038593|FG000|Overall Study|Protocol Violation|2|||
23632093|NCT01250925|66038594|FG001|Overall Study|Protocol Violation|0|||
23632094|NCT01250925|66038595|FG002|Overall Study|Protocol Violation|0|||
23632095|NCT01250925|66038593|FG000|Overall Study|Physician Decision|0|||
23632096|NCT01250925|66038594|FG001|Overall Study|Physician Decision|2|||
23632097|NCT01250925|66038595|FG002|Overall Study|Physician Decision|1|||
23632098|NCT01250925|66038593|FG000|Overall Study|Adverse Event|0|||
23632099|NCT01250925|66038594|FG001|Overall Study|Adverse Event|0|||
23632100|NCT01250925|66038595|FG002|Overall Study|Adverse Event|1|||
23632101|NCT01375673|66038596|FG000|Overall Study|Withdrawal by Subject|0|||
23632102|NCT01375673|66038597|FG001|Overall Study|Withdrawal by Subject|1|||
23632103|NCT01987895|66038598|FG000|Overall Study|Withdrawal by Subject|12|||
23447083|NCT03210961|65377869|FG006|Overall Study|Lost to Follow-up|0|||
23447084|NCT03210961|65377870|FG007|Overall Study|Lost to Follow-up|0|||
23447085|NCT03210961|65377871|FG008|Overall Study|Lost to Follow-up|0|||
23571393|NCT03881059|65820992|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
23571394|NCT03881059|65820993|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
23571395|NCT03881059|65820994|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
23571396|NCT03881059|65820992|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
23571397|NCT03881059|65820993|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
23571398|NCT03881059|65820994|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
23571399|NCT03881059|65820992|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
23571400|NCT03881059|65820993|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
23571401|NCT03881059|65820994|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
23571402|NCT03881059|65820992|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
23571403|NCT03881059|65820993|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
23571404|NCT03881059|65820994|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
23571405|NCT03881059|65820992|FG000|Treatment Period - Part B|Other reasons|4|||
23571406|NCT03881059|65820993|FG001|Treatment Period - Part B|Other reasons|3|||
23571407|NCT03881059|65820994|FG002|Treatment Period - Part B|Other reasons|3|||
23571408|NCT04078035|65820997|FG000|Session 2|Lost to Follow-up|3|||
23571409|NCT04078035|65820998|FG001|Session 2|Lost to Follow-up|1|||
23571410|NCT04078035|65820997|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
23571411|NCT04078035|65820998|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
23571412|NCT00649389|65821001|FG000|Overall Study|Adverse Event|22|||
23571413|NCT00649389|65821002|FG001|Overall Study|Adverse Event|46|||
23571414|NCT00649389|65821003|FG002|Overall Study|Adverse Event|38|||
23571415|NCT00649389|65821004|FG003|Overall Study|Adverse Event|48|||
23571416|NCT00649389|65821001|FG000|Overall Study|Lost to Follow-up|15|||
23571417|NCT00649389|65821002|FG001|Overall Study|Lost to Follow-up|17|||
23571418|NCT00649389|65821003|FG002|Overall Study|Lost to Follow-up|21|||
23571419|NCT00649389|65821004|FG003|Overall Study|Lost to Follow-up|26|||
23571420|NCT00649389|65821001|FG000|Overall Study|Protocol Violation|11|||
23571421|NCT00649389|65821002|FG001|Overall Study|Protocol Violation|13|||
23632104|NCT01987895|66038599|FG001|Overall Study|Withdrawal by Subject|7|||
23632105|NCT01987895|66038598|FG000|Overall Study|Physician Decision|8|||
23632106|NCT01987895|66038599|FG001|Overall Study|Physician Decision|10|||
23632107|NCT01987895|66038598|FG000|Overall Study|Death|7|||
23632108|NCT01987895|66038599|FG001|Overall Study|Death|7|||
23632109|NCT01987895|66038598|FG000|Overall Study|Lost to Follow-up|3|||
23632110|NCT01987895|66038599|FG001|Overall Study|Lost to Follow-up|5|||
23632111|NCT01987895|66038598|FG000|Overall Study|randomized before giving IC|0|||
23632112|NCT01987895|66038599|FG001|Overall Study|randomized before giving IC|1|||
23632113|NCT01575873|66038600|FG000|Overall Study|Withdrawal by Subject|15|||
23632114|NCT01575873|66038601|FG001|Overall Study|Withdrawal by Subject|20|||
23632115|NCT01575873|66038602|FG002|Overall Study|Withdrawal by Subject|34|||
23632116|NCT01575873|66038603|FG003|Overall Study|Withdrawal by Subject|34|||
23632117|NCT01575873|66038600|FG000|Overall Study|Adverse Event|7|||
23632118|NCT01575873|66038601|FG001|Overall Study|Adverse Event|7|||
23632119|NCT01575873|66038602|FG002|Overall Study|Adverse Event|9|||
23632120|NCT01575873|66038603|FG003|Overall Study|Adverse Event|12|||
23632121|NCT01575873|66038600|FG000|Overall Study|Lost to Follow-up|1|||
23632122|NCT01575873|66038601|FG001|Overall Study|Lost to Follow-up|3|||
23632123|NCT01575873|66038602|FG002|Overall Study|Lost to Follow-up|13|||
23632124|NCT01575873|66038603|FG003|Overall Study|Lost to Follow-up|5|||
23632125|NCT01575873|66038600|FG000|Overall Study|Death|3|||
23632126|NCT01575873|66038601|FG001|Overall Study|Death|2|||
23632127|NCT01575873|66038602|FG002|Overall Study|Death|8|||
23632128|NCT01575873|66038603|FG003|Overall Study|Death|9|||
23632129|NCT01575873|66038600|FG000|Overall Study|Noncompliance|1|||
23632130|NCT01575873|66038601|FG001|Overall Study|Noncompliance|2|||
23632131|NCT01575873|66038602|FG002|Overall Study|Noncompliance|4|||
23632132|NCT01575873|66038603|FG003|Overall Study|Noncompliance|3|||
23632133|NCT01575873|66038600|FG000|Overall Study|Administrative decision|1|||
23632134|NCT01575873|66038601|FG001|Overall Study|Administrative decision|1|||
23632135|NCT01575873|66038602|FG002|Overall Study|Administrative decision|1|||
23632136|NCT01575873|66038603|FG003|Overall Study|Administrative decision|0|||
23632137|NCT01575873|66038600|FG000|Overall Study|Protocol deviation|0|||
23632138|NCT01575873|66038601|FG001|Overall Study|Protocol deviation|1|||
23632139|NCT01575873|66038602|FG002|Overall Study|Protocol deviation|0|||
23632140|NCT01575873|66038603|FG003|Overall Study|Protocol deviation|1|||
23632141|NCT01575873|66038600|FG000|Overall Study|Requirement for Alternative Therapy|0|||
23632142|NCT01575873|66038601|FG001|Overall Study|Requirement for Alternative Therapy|0|||
23632143|NCT01575873|66038602|FG002|Overall Study|Requirement for Alternative Therapy|1|||
23632144|NCT01575873|66038603|FG003|Overall Study|Requirement for Alternative Therapy|1|||
23571422|NCT00649389|65821003|FG002|Overall Study|Protocol Violation|9|||
23571423|NCT00649389|65821004|FG003|Overall Study|Protocol Violation|8|||
23632145|NCT01575873|66038600|FG000|Overall Study|Other|0|||
23632146|NCT01575873|66038601|FG001|Overall Study|Other|0|||
23447086|NCT03210961|65377872|FG009|Overall Study|Lost to Follow-up|0|||
23571424|NCT00649389|65821001|FG000|Overall Study|Withdrawal by Subject|20|||
23571425|NCT00649389|65821002|FG001|Overall Study|Withdrawal by Subject|21|||
23770002|NCT00387712|66535792|FG000|Overall Study|Withdrawal by Subject|6|||
23770003|NCT00387712|66535793|FG001|Overall Study|Withdrawal by Subject|12|||
23770004|NCT00337077|66535794|FG000|Overall Study|Progressive disease|25|||
23770005|NCT00337077|66535795|FG001|Overall Study|Progressive disease|37|||
23770006|NCT00337077|66535796|FG002|Overall Study|Progressive disease|19|||
23770007|NCT00337077|66535794|FG000|Overall Study|Adverse Event|7|||
23770008|NCT00337077|66535795|FG001|Overall Study|Adverse Event|7|||
23770009|NCT00337077|66535796|FG002|Overall Study|Adverse Event|1|||
23770010|NCT00337077|66535794|FG000|Overall Study|Death|0|||
23770011|NCT00337077|66535795|FG001|Overall Study|Death|1|||
23770012|NCT00337077|66535796|FG002|Overall Study|Death|0|||
23770013|NCT00337077|66535794|FG000|Overall Study|Withdrawal by Subject|7|||
23770014|NCT00337077|66535795|FG001|Overall Study|Withdrawal by Subject|2|||
23770015|NCT00337077|66535796|FG002|Overall Study|Withdrawal by Subject|2|||
23770016|NCT00337077|66535794|FG000|Overall Study|Alternative therapy|1|||
23770017|NCT00337077|66535795|FG001|Overall Study|Alternative therapy|0|||
23770018|NCT00337077|66535796|FG002|Overall Study|Alternative therapy|0|||
23770019|NCT00337077|66535794|FG000|Overall Study|Physician Decision|1|||
23770020|NCT00337077|66535795|FG001|Overall Study|Physician Decision|4|||
23770021|NCT00337077|66535796|FG002|Overall Study|Physician Decision|2|||
23770022|NCT00337077|66535794|FG000|Overall Study|Never started treatment|1|||
23770023|NCT00337077|66535795|FG001|Overall Study|Never started treatment|1|||
23770024|NCT00337077|66535796|FG002|Overall Study|Never started treatment|0|||
23770025|NCT00337077|66535794|FG000|Overall Study|Ineligible|1|||
23770026|NCT00337077|66535795|FG001|Overall Study|Ineligible|1|||
23770027|NCT00337077|66535796|FG002|Overall Study|Ineligible|1|||
23770028|NCT00266409|66535797|FG000|Overall Study|Lack of Efficacy|2|||
23770029|NCT00266409|66535798|FG001|Overall Study|Lack of Efficacy|6|||
23770030|NCT00266409|66535799|FG002|Overall Study|Lack of Efficacy|1|||
23770031|NCT00266409|66535800|FG003|Overall Study|Lack of Efficacy|2|||
23770032|NCT00266409|66535797|FG000|Overall Study|Adverse Event|7|||
23770033|NCT00266409|66535798|FG001|Overall Study|Adverse Event|2|||
23770034|NCT00266409|66535799|FG002|Overall Study|Adverse Event|1|||
23770035|NCT00266409|66535800|FG003|Overall Study|Adverse Event|1|||
23770036|NCT00266409|66535797|FG000|Overall Study|Lost to Follow-up|18|||
23770037|NCT00266409|66535798|FG001|Overall Study|Lost to Follow-up|21|||
23770038|NCT00266409|66535799|FG002|Overall Study|Lost to Follow-up|6|||
23770039|NCT00266409|66535800|FG003|Overall Study|Lost to Follow-up|8|||
23770040|NCT00266409|66535797|FG000|Overall Study|Withdrawal by Subject|6|||
23770041|NCT00266409|66535798|FG001|Overall Study|Withdrawal by Subject|10|||
23770042|NCT00266409|66535799|FG002|Overall Study|Withdrawal by Subject|3|||
23770043|NCT00266409|66535800|FG003|Overall Study|Withdrawal by Subject|9|||
23770044|NCT00266409|66535797|FG000|Overall Study|Protocol Violation|5|||
23770045|NCT00266409|66535798|FG001|Overall Study|Protocol Violation|3|||
23770046|NCT00266409|66535799|FG002|Overall Study|Protocol Violation|4|||
23770047|NCT00266409|66535800|FG003|Overall Study|Protocol Violation|2|||
23770048|NCT00266409|66535797|FG000|Overall Study|Other|7|||
23770049|NCT00266409|66535798|FG001|Overall Study|Other|4|||
23770050|NCT00266409|66535799|FG002|Overall Study|Other|2|||
23770051|NCT00266409|66535800|FG003|Overall Study|Other|0|||
23770052|NCT01673009|66535804|FG000|Overall Study|Physician Decision|5|||
23770053|NCT01673009|66535804|FG000|Overall Study|Withdrawal by Subject|8|||
23770054|NCT00497796|66535811|FG000|Overall Study|Adverse event (not related)|9|||
23770055|NCT00497796|66535812|FG001|Overall Study|Adverse event (not related)|9|||
23770056|NCT00497796|66535811|FG000|Overall Study|Adverse event (related)|5|||
23770057|NCT00497796|66535812|FG001|Overall Study|Adverse event (related)|4|||
23770058|NCT00497796|66535811|FG000|Overall Study|CMV infection or disease treatment|30|||
23770059|NCT00497796|66535812|FG001|Overall Study|CMV infection or disease treatment|4|||
23770060|NCT00497796|66535811|FG000|Overall Study|Consent withdrawn|10|||
23770061|NCT00497796|66535812|FG001|Overall Study|Consent withdrawn|3|||
23571426|NCT00649389|65821003|FG002|Overall Study|Withdrawal by Subject|19|||
23770062|NCT00497796|66535811|FG000|Overall Study|Investigator/sponsor discretion|31|||
23770063|NCT00497796|66535812|FG001|Overall Study|Investigator/sponsor discretion|34|||
23770064|NCT00497796|66535811|FG000|Overall Study|Lost to Follow-up|0|||
23770065|NCT00497796|66535812|FG001|Overall Study|Lost to Follow-up|1|||
23571427|NCT00649389|65821004|FG003|Overall Study|Withdrawal by Subject|23|||
23571428|NCT00649389|65821001|FG000|Overall Study|Other|3|||
23571429|NCT00649389|65821002|FG001|Overall Study|Other|9|||
23770066|NCT00497796|66535811|FG000|Overall Study|Not applicable (randomized not treated)|0|||
23770067|NCT00497796|66535812|FG001|Overall Study|Not applicable (randomized not treated)|4|||
23770068|NCT03036579|66535813|FG000|2 Years|Lost to Follow-up|1|||
23770069|NCT03036579|66535814|FG001|2 Years|Lost to Follow-up|0|||
23770070|NCT03036579|66535813|FG000|3 Years|Lost to Follow-up|0|||
23770071|NCT03036579|66535814|FG001|3 Years|Lost to Follow-up|1|||
23770072|NCT02324465|66535815|FG000|Overall Study|device failure|0|||
23770073|NCT02324465|66535816|FG001|Overall Study|device failure|1|||
23770074|NCT01821625|66535819|FG000|Overall Study|Withdrawal by Subject|2|||
23770075|NCT01821625|66535819|FG000|Overall Study|Lack of Efficacy|2|||
23447087|NCT03210961|65377873|FG010|Overall Study|Lost to Follow-up|0|||
23632147|NCT01575873|66038602|FG002|Overall Study|Other|4|||
23632148|NCT01575873|66038603|FG003|Overall Study|Other|2|||
23632149|NCT00862836|66038604|FG000|Overall Study|Withdrawal by Subject|1|||
23632150|NCT00203268|66038610|FG000|Early Treatment|only treated one headache|2|||
23632151|NCT00203268|66038610|FG000|Early Treatment|Lost to Follow-up|1|||
23632152|NCT00203268|66038610|FG000|Early Treatment|Withdrawal by Subject|1|||
23632153|NCT03548220|66038616|FG000|Overall Study|Lost to Follow-up|1|||
23830617|NCT03850483|66759949|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23830618|NCT03850483|66759950|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
23830619|NCT03850483|66759941|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
23830620|NCT03850483|66759942|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
23830621|NCT03850483|66759943|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
23830622|NCT03850483|66759944|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
23830623|NCT03850483|66759945|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
23632154|NCT03548220|66038617|FG001|Overall Study|Lost to Follow-up|0|||
23632155|NCT03548220|66038618|FG002|Overall Study|Lost to Follow-up|0|||
23632156|NCT03548220|66038619|FG003|Overall Study|Lost to Follow-up|0|||
23830624|NCT03850483|66759946|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
23632157|NCT00757627|66038620|FG000|Overall Study|Adverse Event|15|||
23632158|NCT00757627|66038620|FG000|Overall Study|Lack of Efficacy|10|||
23632159|NCT00757627|66038620|FG000|Overall Study|Lost to Follow-up|28|||
23632160|NCT00757627|66038620|FG000|Overall Study|Withdrawal by Subject|27|||
23830625|NCT03850483|66759947|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
23830626|NCT03850483|66759948|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
23830627|NCT03850483|66759949|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
23830628|NCT03850483|66759950|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
23830629|NCT03850483|66759941|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
23830630|NCT03850483|66759942|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
23830631|NCT03850483|66759943|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
23632161|NCT00757627|66038620|FG000|Overall Study|Other|1|||
23632162|NCT00277095|66038621|FG000|Overall Study|Death|2|||
23632163|NCT00277095|66038621|FG000|Overall Study|Explanted|7|||
23632164|NCT00277095|66038621|FG000|Overall Study|Lost to Follow-up|2|||
23632165|NCT00277095|66038621|FG000|Overall Study|Missed Follow-up|9|||
23632166|NCT00277095|66038621|FG000|Overall Study|Physician Decision|1|||
23632167|NCT02993406|66038622|FG000|Overall Study|Withdrawal by Subject|170|||
23632168|NCT02993406|66038623|FG001|Overall Study|Withdrawal by Subject|196|||
23632169|NCT02993406|66038622|FG000|Overall Study|Physician Decision|3|||
23632170|NCT02993406|66038623|FG001|Overall Study|Physician Decision|5|||
23632171|NCT02993406|66038622|FG000|Overall Study|Lost to Follow-up|12|||
23632172|NCT02993406|66038623|FG001|Overall Study|Lost to Follow-up|13|||
23632173|NCT02993406|66038622|FG000|Overall Study|Unclassifiable Response|105|||
23632174|NCT02993406|66038623|FG001|Overall Study|Unclassifiable Response|139|||
23632175|NCT02993406|66038622|FG000|Overall Study|Administrative decision|1|||
23632176|NCT02993406|66038623|FG001|Overall Study|Administrative decision|0|||
23632177|NCT02993406|66038622|FG000|Overall Study|Sponsor decision|4|||
23632178|NCT02993406|66038623|FG001|Overall Study|Sponsor decision|5|||
23632179|NCT02963090|66038624|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
23632180|NCT02963090|66038625|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
23632181|NCT01031628|66038626|FG000|Overall Study|Study terminated early|0|||
23632182|NCT01031628|66038627|FG001|Overall Study|Study terminated early|1|||
23632183|NCT01031628|66038628|FG002|Overall Study|Study terminated early|3|||
23632184|NCT01031628|66038629|FG003|Overall Study|Study terminated early|0|||
23632185|NCT02406248|66038630|FG000|Overall Study|Death|7|||
23632186|NCT02406248|66038630|FG000|Overall Study|Withdrawal by Subject|2|||
23632187|NCT01154140|66038631|FG000|Overall Study|Death|71|||
23632188|NCT01154140|66038632|FG001|Overall Study|Death|81|||
23632189|NCT01154140|66038631|FG000|Overall Study|Lost to Follow-up|4|||
23632190|NCT01154140|66038632|FG001|Overall Study|Lost to Follow-up|5|||
23632191|NCT01154140|66038631|FG000|Overall Study|Withdrawal by Subject|12|||
23632192|NCT01154140|66038632|FG001|Overall Study|Withdrawal by Subject|13|||
23830632|NCT03850483|66759944|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
23830633|NCT03850483|66759945|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
23830634|NCT03850483|66759946|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
23447088|NCT03210961|65377874|FG011|Overall Study|Lost to Follow-up|0|||
23632193|NCT01154140|66038631|FG000|Overall Study|Other|3|||
23632194|NCT01154140|66038632|FG001|Overall Study|Other|1|||
23632195|NCT01154140|66038631|FG000|Overall Study|Randomized but not treated|1|||
23632196|NCT01154140|66038632|FG001|Overall Study|Randomized but not treated|2|||
23632197|NCT01435772|66038635|FG000|Overall Study|Adverse Event|1|||
23632198|NCT01435772|66038636|FG001|Overall Study|Adverse Event|0|||
23830635|NCT03850483|66759947|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
23632199|NCT01435772|66038637|FG002|Overall Study|Adverse Event|2|||
23447089|NCT03210961|65377875|FG012|Overall Study|Lost to Follow-up|0|||
23770076|NCT01821625|66535819|FG000|Overall Study|Adverse Event|1|||
23770077|NCT01821625|66535819|FG000|Overall Study|Medical contraindication|1|||
23770078|NCT00625807|66535820|FG000|Overall Study|schedule conflict|2|||
23770079|NCT00625807|66535821|FG001|Overall Study|schedule conflict|8|||
23770080|NCT00865709|66535822|FG000|Treatment|Adverse Event|9|||
23770081|NCT00865709|66535823|FG001|Treatment|Adverse Event|6|||
23632200|NCT01435772|66038635|FG000|Overall Study|Withdrawal by Subject|0|||
23632201|NCT01435772|66038636|FG001|Overall Study|Withdrawal by Subject|1|||
23770082|NCT00865709|66535822|FG000|Treatment|Withdrawal by Subject|10|||
23770083|NCT00865709|66535823|FG001|Treatment|Withdrawal by Subject|7|||
23770084|NCT00865709|66535822|FG000|Treatment|Physician Decision|3|||
23770085|NCT00865709|66535823|FG001|Treatment|Physician Decision|2|||
23770086|NCT00865709|66535822|FG000|Treatment|Surgery|8|||
23770087|NCT00865709|66535823|FG001|Treatment|Surgery|3|||
23770088|NCT02162758|66535824|FG000|Overall Study|Study termination|0|||
23770089|NCT02162758|66535825|FG001|Overall Study|Study termination|1|||
23770090|NCT02863575|66535826|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
23770091|NCT02863575|66535827|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
23830636|NCT03850483|66759948|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
23830637|NCT03850483|66759949|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
23830638|NCT03850483|66759950|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
23632202|NCT01435772|66038637|FG002|Overall Study|Withdrawal by Subject|3|||
23632203|NCT01435772|66038635|FG000|Overall Study|Other - study termination|2|||
23632204|NCT01435772|66038636|FG001|Overall Study|Other - study termination|2|||
23632205|NCT01435772|66038637|FG002|Overall Study|Other - study termination|10|||
23632206|NCT00874731|66038640|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
23632207|NCT00874731|66038641|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
23632208|NCT00874731|66038642|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
23632209|NCT00874731|66038640|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
23632210|NCT00874731|66038641|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
23632211|NCT00874731|66038642|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
23632212|NCT00874731|66038640|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
23632213|NCT00874731|66038641|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
23830639|NCT03850483|66759941|FG000|Follow-up For Stage 2|Other|0|||
23830640|NCT03850483|66759942|FG001|Follow-up For Stage 2|Other|0|||
23830641|NCT03850483|66759943|FG002|Follow-up For Stage 2|Other|0|||
23830642|NCT03850483|66759944|FG003|Follow-up For Stage 2|Other|0|||
23830643|NCT03850483|66759945|FG004|Follow-up For Stage 2|Other|0|||
23830644|NCT03850483|66759946|FG005|Follow-up For Stage 2|Other|0|||
23830645|NCT03850483|66759947|FG006|Follow-up For Stage 2|Other|0|||
23830646|NCT03850483|66759948|FG007|Follow-up For Stage 2|Other|0|||
23830647|NCT03850483|66759949|FG008|Follow-up For Stage 2|Other|0|||
23830648|NCT03850483|66759950|FG009|Follow-up For Stage 2|Other|1|||
23830649|NCT00273182|66759953|FG000|Overall Study|Death|450|||
23830650|NCT00273182|66759953|FG000|Overall Study|Lost to Follow-up|88|||
23830651|NCT00273182|66759953|FG000|Overall Study|Withdrawal by Subject|257|||
23830652|NCT00273182|66759953|FG000|Overall Study|Device/System Explant|154|||
23830653|NCT00273182|66759953|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
23830654|NCT01139775|66759961|FG000|Overall Study|Adverse Event|0|||
23830655|NCT01139775|66759962|FG001|Overall Study|Adverse Event|6|||
23830656|NCT01139775|66759963|FG002|Overall Study|Adverse Event|2|||
23830657|NCT01139775|66759961|FG000|Overall Study|Protocol Violation|0|||
23830658|NCT01139775|66759962|FG001|Overall Study|Protocol Violation|5|||
23830659|NCT01139775|66759963|FG002|Overall Study|Protocol Violation|0|||
23830660|NCT01139775|66759961|FG000|Overall Study|Withdrawal by Subject|1|||
23830661|NCT01139775|66759962|FG001|Overall Study|Withdrawal by Subject|0|||
23632214|NCT00874731|66038642|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
23632215|NCT01367847|66038643|FG000|Overall Study|Withdrawal by Subject|2|||
23770092|NCT02863575|66535828|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
23770093|NCT02863575|66535826|FG000|Overall Study|Withdrawal by Subject|0|||
23632216|NCT01367847|66038644|FG001|Overall Study|Withdrawal by Subject|2|||
23770094|NCT02863575|66535827|FG001|Overall Study|Withdrawal by Subject|1|||
23770095|NCT02863575|66535828|FG002|Overall Study|Withdrawal by Subject|1|||
23830662|NCT01139775|66759963|FG002|Overall Study|Withdrawal by Subject|2|||
23830663|NCT01139775|66759961|FG000|Overall Study|Physician Decision|0|||
23830664|NCT01139775|66759962|FG001|Overall Study|Physician Decision|2|||
23632217|NCT02354651|66038662|FG000|Overall Study|Withdrawal by Subject|2|||
23632218|NCT02354651|66038662|FG000|Overall Study|Physician Decision|1|||
23632219|NCT01156376|66038663|FG000|Overall Study|Adverse Event|1|||
23770096|NCT02863575|66535826|FG000|Overall Study|Adverse Event|0|||
23830665|NCT01139775|66759963|FG002|Overall Study|Physician Decision|2|||
23830666|NCT00886015|66759964|FG000|Overall Study|Death|0|||
23770097|NCT02863575|66535827|FG001|Overall Study|Adverse Event|1|||
23770098|NCT02863575|66535828|FG002|Overall Study|Adverse Event|0|||
23770099|NCT01725451|66535829|FG000|Period 1|Withdrawal by Subject|1|||
23770100|NCT01725451|66535830|FG001|Period 1|Withdrawal by Subject|0|||
23447090|NCT03210961|65377876|FG013|Overall Study|Lost to Follow-up|0|||
23770101|NCT01725451|66535831|FG002|Period 1|Withdrawal by Subject|0|||
23770102|NCT01725451|66535832|FG003|Period 1|Withdrawal by Subject|0|||
23770103|NCT01725451|66535829|FG000|Washout From Period 3|Protocol Violation|0|||
23770104|NCT01725451|66535830|FG001|Washout From Period 3|Protocol Violation|0|||
23770105|NCT01725451|66535831|FG002|Washout From Period 3|Protocol Violation|1|||
23770106|NCT01725451|66535832|FG003|Washout From Period 3|Protocol Violation|0|||
23770107|NCT01725451|66535829|FG000|Washout From Period 3|Adverse Event|0|||
23770108|NCT01725451|66535830|FG001|Washout From Period 3|Adverse Event|1|||
23770109|NCT01725451|66535831|FG002|Washout From Period 3|Adverse Event|0|||
23770110|NCT01725451|66535832|FG003|Washout From Period 3|Adverse Event|0|||
23770111|NCT01725451|66535829|FG000|Period 4|Adverse Event|0|||
23770112|NCT01725451|66535830|FG001|Period 4|Adverse Event|0|||
23770113|NCT01725451|66535831|FG002|Period 4|Adverse Event|1|||
23770114|NCT01725451|66535832|FG003|Period 4|Adverse Event|0|||
23770115|NCT00576381|66535837|FG000|Overall Study|Reoperation|3|||
23770116|NCT00576381|66535837|FG000|Overall Study|Adverse Event|4|||
23770117|NCT01075763|66535838|FG000|Overall Study|Lost to Follow-up|2|||
23770118|NCT01075763|66535839|FG001|Overall Study|Lost to Follow-up|1|||
23770119|NCT01075763|66535838|FG000|Overall Study|Lack of Efficacy|0|||
23770120|NCT01075763|66535839|FG001|Overall Study|Lack of Efficacy|1|||
23770121|NCT01075763|66535838|FG000|Overall Study|Withdrawal by Subject|2|||
23770122|NCT01075763|66535839|FG001|Overall Study|Withdrawal by Subject|2|||
23770123|NCT02022007|66539429|FG000|Overall Study|Withdrawal by Subject|1|||
23770124|NCT02022007|66539430|FG001|Overall Study|Withdrawal by Subject|1|||
23770125|NCT02022007|66539431|FG002|Overall Study|Withdrawal by Subject|1|||
23770126|NCT02022007|66539429|FG000|Overall Study|Noncompliant|0|||
23770127|NCT02022007|66539430|FG001|Overall Study|Noncompliant|0|||
23830667|NCT00886015|66759965|FG001|Overall Study|Death|2|||
23830668|NCT02630251|66759966|FG000|Overall Study|Physician Decision|0|||
23830669|NCT02630251|66759967|FG001|Overall Study|Physician Decision|0|||
23830670|NCT02630251|66759968|FG002|Overall Study|Physician Decision|1|||
23830671|NCT02630251|66759969|FG003|Overall Study|Physician Decision|0|||
23830672|NCT05317312|66759970|FG000|Overall Study|Withdrawal by Subject|0|||
23770128|NCT02022007|66539431|FG002|Overall Study|Noncompliant|1|||
23447091|NCT03210961|65377877|FG014|Overall Study|Lost to Follow-up|1|||
23447092|NCT03210961|65377863|FG000|Overall Study|Withdrawal by Subject|0|||
23447093|NCT03210961|65377864|FG001|Overall Study|Withdrawal by Subject|0|||
23447094|NCT03210961|65377865|FG002|Overall Study|Withdrawal by Subject|0|||
23447095|NCT03210961|65377866|FG003|Overall Study|Withdrawal by Subject|0|||
23447096|NCT03210961|65377867|FG004|Overall Study|Withdrawal by Subject|0|||
23447097|NCT03210961|65377868|FG005|Overall Study|Withdrawal by Subject|0|||
23447098|NCT03210961|65377869|FG006|Overall Study|Withdrawal by Subject|0|||
23447099|NCT03210961|65377870|FG007|Overall Study|Withdrawal by Subject|0|||
23447100|NCT03210961|65377871|FG008|Overall Study|Withdrawal by Subject|0|||
23447101|NCT03210961|65377872|FG009|Overall Study|Withdrawal by Subject|0|||
23632220|NCT01156376|66038664|FG001|Overall Study|Adverse Event|0|||
23770129|NCT01153984|66539432|FG000|Overall Study|Withdrawal by Subject|1|||
23770130|NCT01153984|66539432|FG000|Overall Study|Adverse Event|1|||
23770131|NCT00502775|66539435|FG000|Overall Study|Adverse Event|1|||
23770132|NCT00502775|66539436|FG001|Overall Study|Adverse Event|2|||
23770133|NCT00502775|66539437|FG002|Overall Study|Adverse Event|1|||
23770134|NCT00502775|66539435|FG000|Overall Study|Protocol Violation|1|||
23632221|NCT01156376|66038665|FG002|Overall Study|Adverse Event|1|||
23770135|NCT00502775|66539436|FG001|Overall Study|Protocol Violation|5|||
23770136|NCT00502775|66539437|FG002|Overall Study|Protocol Violation|2|||
23447102|NCT03210961|65377873|FG010|Overall Study|Withdrawal by Subject|0|||
23447103|NCT03210961|65377874|FG011|Overall Study|Withdrawal by Subject|0|||
23770137|NCT00502775|66539435|FG000|Overall Study|Withdrawal by Subject|1|||
23770138|NCT00502775|66539436|FG001|Overall Study|Withdrawal by Subject|1|||
23770139|NCT00502775|66539437|FG002|Overall Study|Withdrawal by Subject|2|||
23770140|NCT00502775|66539435|FG000|Overall Study|Sponsor Terminated Study|1|||
23447104|NCT03210961|65377875|FG012|Overall Study|Withdrawal by Subject|0|||
23447105|NCT03210961|65377876|FG013|Overall Study|Withdrawal by Subject|0|||
23830673|NCT05317312|66759971|FG001|Overall Study|Withdrawal by Subject|1|||
23830674|NCT05317312|66759972|FG002|Overall Study|Withdrawal by Subject|0|||
23830675|NCT05317312|66759973|FG003|Overall Study|Withdrawal by Subject|0|||
23830676|NCT05317312|66759970|FG000|Overall Study|Lost to Follow-up|0|||
23830677|NCT05317312|66759971|FG001|Overall Study|Lost to Follow-up|0|||
23830678|NCT05317312|66759972|FG002|Overall Study|Lost to Follow-up|0|||
23447106|NCT03210961|65377877|FG014|Overall Study|Withdrawal by Subject|1|||
23447107|NCT03210961|65377863|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447108|NCT03210961|65377864|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447109|NCT03210961|65377865|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447110|NCT03210961|65377866|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447111|NCT03210961|65377867|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447112|NCT03210961|65377868|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447113|NCT03210961|65377869|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447114|NCT03210961|65377870|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447115|NCT03210961|65377871|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447116|NCT03210961|65377872|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447117|NCT03210961|65377873|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447118|NCT03210961|65377874|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447119|NCT03210961|65377875|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447120|NCT03210961|65377876|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
23447121|NCT03210961|65377877|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447122|NCT03210961|65377863|FG000|Overall Study|Other|0|||
23447123|NCT03210961|65377864|FG001|Overall Study|Other|0|||
23447124|NCT03210961|65377865|FG002|Overall Study|Other|0|||
23447125|NCT03210961|65377866|FG003|Overall Study|Other|1|||
23447126|NCT03210961|65377867|FG004|Overall Study|Other|0|||
23447127|NCT03210961|65377868|FG005|Overall Study|Other|0|||
23447128|NCT03210961|65377869|FG006|Overall Study|Other|1|||
23447129|NCT03210961|65377870|FG007|Overall Study|Other|0|||
23447130|NCT03210961|65377871|FG008|Overall Study|Other|0|||
23447131|NCT03210961|65377872|FG009|Overall Study|Other|0|||
23447132|NCT03210961|65377873|FG010|Overall Study|Other|1|||
23571430|NCT00649389|65821003|FG002|Overall Study|Other|1|||
23571431|NCT00649389|65821004|FG003|Overall Study|Other|6|||
23571432|NCT02491892|65821009|FG000|Overall Study|Adverse Event|1|||
23571433|NCT02491892|65821010|FG001|Overall Study|Adverse Event|1|||
23571434|NCT02491892|65821009|FG000|Overall Study|Death|1|||
23571435|NCT02491892|65821010|FG001|Overall Study|Death|1|||
23571436|NCT02491892|65821009|FG000|Overall Study|Lack of Efficacy|37|||
23571437|NCT02491892|65821010|FG001|Overall Study|Lack of Efficacy|36|||
23571438|NCT02491892|65821009|FG000|Overall Study|Refused Treatment|1|||
23571439|NCT02491892|65821010|FG001|Overall Study|Refused Treatment|0|||
23571440|NCT02491892|65821009|FG000|Overall Study|Lost to Follow-up|1|||
23571441|NCT02491892|65821010|FG001|Overall Study|Lost to Follow-up|0|||
23571442|NCT00245011|65821011|FG000|Overall Study|Lack of Efficacy|1|||
23571443|NCT02111213|65821012|FG000|Overall Study|Withdrawal by Subject|3|||
23571444|NCT02111213|65821013|FG001|Overall Study|Withdrawal by Subject|2|||
23571445|NCT02111213|65821012|FG000|Overall Study|Lost to Follow-up|3|||
23571446|NCT02111213|65821013|FG001|Overall Study|Lost to Follow-up|4|||
23571447|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
23571448|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571449|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571450|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571451|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571452|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
23571453|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571454|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571455|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
23571456|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
23571457|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23571458|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23571459|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
23571460|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
23447133|NCT03210961|65377874|FG011|Overall Study|Other|0|||
23447134|NCT03210961|65377875|FG012|Overall Study|Other|2|||
23447135|NCT03210961|65377876|FG013|Overall Study|Other|2|||
23571461|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23571462|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23830679|NCT05317312|66759973|FG003|Overall Study|Lost to Follow-up|1|||
23571463|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
23447136|NCT03210961|65377877|FG014|Overall Study|Other|0|||
23830680|NCT05317312|66759970|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
23830681|NCT05317312|66759971|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
23830682|NCT05317312|66759972|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
23830683|NCT05317312|66759973|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
23830684|NCT01125189|66759974|FG000|Treatment Period|Lack of Efficacy|15|||
23830685|NCT01125189|66759975|FG001|Treatment Period|Lack of Efficacy|18|||
23830686|NCT01125189|66759976|FG002|Treatment Period|Lack of Efficacy|25|||
23830687|NCT01125189|66759974|FG000|Treatment Period|Adverse Event|7|||
23770141|NCT00502775|66539436|FG001|Overall Study|Sponsor Terminated Study|0|||
23770142|NCT00502775|66539437|FG002|Overall Study|Sponsor Terminated Study|1|||
23770143|NCT00502775|66539435|FG000|Overall Study|Non-compliance with eDiary|4|||
23770144|NCT00502775|66539436|FG001|Overall Study|Non-compliance with eDiary|1|||
23770145|NCT00502775|66539437|FG002|Overall Study|Non-compliance with eDiary|1|||
23770146|NCT00502775|66539435|FG000|Overall Study|Subject unable to swallow capsule|1|||
23770147|NCT00502775|66539436|FG001|Overall Study|Subject unable to swallow capsule|0|||
23770148|NCT00502775|66539437|FG002|Overall Study|Subject unable to swallow capsule|1|||
23770149|NCT00502775|66539435|FG000|Overall Study|Logpad compliance <80%|1|||
23770150|NCT00502775|66539436|FG001|Overall Study|Logpad compliance <80%|0|||
23571464|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
23571465|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
23770151|NCT00502775|66539437|FG002|Overall Study|Logpad compliance <80%|0|||
23770152|NCT00502775|66539435|FG000|Overall Study|Randomized in error|0|||
23770153|NCT00502775|66539436|FG001|Overall Study|Randomized in error|1|||
23770154|NCT00502775|66539437|FG002|Overall Study|Randomized in error|1|||
23770155|NCT00502775|66539435|FG000|Overall Study|Non-compliance|0|||
23770156|NCT00502775|66539436|FG001|Overall Study|Non-compliance|2|||
23770157|NCT00502775|66539437|FG002|Overall Study|Non-compliance|2|||
23770158|NCT00502775|66539435|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
23770159|NCT00502775|66539436|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
23770160|NCT00502775|66539437|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
23770161|NCT00502775|66539435|FG000|Overall Study|Declining pollen counts|0|||
23770162|NCT00502775|66539436|FG001|Overall Study|Declining pollen counts|1|||
23770163|NCT00502775|66539437|FG002|Overall Study|Declining pollen counts|1|||
23770164|NCT00502775|66539435|FG000|Overall Study|Subject in jail|0|||
23770165|NCT00502775|66539436|FG001|Overall Study|Subject in jail|1|||
23830688|NCT01125189|66759975|FG001|Treatment Period|Adverse Event|8|||
23571466|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
23571467|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
23571468|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
23571469|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
23571470|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
23632222|NCT01156376|66038663|FG000|Overall Study|Withdrawal by Subject|0|||
23632223|NCT01156376|66038664|FG001|Overall Study|Withdrawal by Subject|0|||
23770166|NCT00502775|66539437|FG002|Overall Study|Subject in jail|0|||
23770167|NCT00502775|66539435|FG000|Overall Study|Subject took disallowed drug|0|||
23770168|NCT00502775|66539436|FG001|Overall Study|Subject took disallowed drug|0|||
23770169|NCT00502775|66539437|FG002|Overall Study|Subject took disallowed drug|1|||
23770170|NCT01469546|66539438|FG000|Received 5 mg Dose|Adverse Event|13|||
23770171|NCT01469546|66539438|FG000|Received 5 mg Dose|Death|2|||
23770172|NCT01469546|66539438|FG000|Received 5 mg Dose|Protocol Violation|2|||
23770173|NCT01469546|66539438|FG000|Received 5 mg Dose|Progressive Disease|3|||
23830689|NCT01125189|66759976|FG002|Treatment Period|Adverse Event|8|||
23830690|NCT01125189|66759974|FG000|Treatment Period|Withdrawal by Subject|3|||
23571471|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
23571472|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571473|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571474|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571475|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
23571476|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
23571477|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
23571478|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
23571479|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23770174|NCT01469546|66539438|FG000|Received 5 mg Dose|Physician Decision|3|||
23770175|NCT00881621|66539442|FG000|Overall Study|Physician Decision|34|||
23770176|NCT01006707|66539446|FG000|Study Session 1|Lost to Follow-up|2|||
23770177|NCT01006707|66539447|FG001|Study Session 1|Lost to Follow-up|0|||
23770178|NCT01006707|66539448|FG002|Study Session 1|Lost to Follow-up|0|||
23770179|NCT01006707|66539446|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
23770180|NCT01006707|66539447|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
23770181|NCT01006707|66539448|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
23770182|NCT02003183|66539452|FG000|Overall Study|Lost to Follow-up|0|||
23770183|NCT02003183|66539453|FG001|Overall Study|Lost to Follow-up|2|||
23770184|NCT02563522|66539454|FG000|Overall Study|Adverse Event|2|||
23770185|NCT02563522|66539455|FG001|Overall Study|Adverse Event|3|||
23770186|NCT02563522|66539454|FG000|Overall Study|Lost to Follow-up|1|||
23770187|NCT02563522|66539455|FG001|Overall Study|Lost to Follow-up|0|||
23770188|NCT02563522|66539454|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
23571480|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23571481|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
23571482|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
23571483|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571484|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571485|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
23571486|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571487|NCT00547911|65821023|FG000|Overall Study|Adverse Event|0|||
23571488|NCT00547911|65821024|FG001|Overall Study|Adverse Event|0|||
23571489|NCT00547911|65821025|FG002|Overall Study|Adverse Event|0|||
23571490|NCT00547911|65821026|FG003|Overall Study|Adverse Event|1|||
23571491|NCT00547911|65821027|FG004|Overall Study|Adverse Event|0|||
23571492|NCT00547911|65821028|FG005|Overall Study|Adverse Event|0|||
23571493|NCT02353832|65821029|FG000|Overall Study|Ineligible after enrollment|1|||
23571494|NCT02353832|65821029|FG000|Overall Study|Lost to Follow-up|1|||
23571495|NCT01087723|65821030|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
23571496|NCT01087723|65821031|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
23571497|NCT01087723|65821030|FG000|Overall Study|Withdrawal by Subject|10|||
23571498|NCT01087723|65821031|FG001|Overall Study|Withdrawal by Subject|13|||
23571499|NCT01087723|65821030|FG000|Overall Study|Physician Decision|2|||
23571500|NCT01087723|65821031|FG001|Overall Study|Physician Decision|0|||
23571501|NCT01087723|65821030|FG000|Overall Study|Lost to Follow-up|1|||
23571502|NCT01087723|65821031|FG001|Overall Study|Lost to Follow-up|4|||
23571503|NCT01087723|65821030|FG000|Overall Study|Reason Not Specified|1|||
23571504|NCT01087723|65821031|FG001|Overall Study|Reason Not Specified|2|||
23571505|NCT04296890|65821032|FG000|Overall Study|Withdrawal by Subject|1|||
23571506|NCT04296890|65821032|FG000|Overall Study|Death|62|||
23571507|NCT04296890|65821032|FG000|Overall Study|Lost to Follow-up|3|||
23571508|NCT04296890|65821032|FG000|Overall Study|Other than specified|2|||
23571509|NCT01644474|65821035|FG000|Overall Study|Poor compliance to protocol|1|||
23571510|NCT01644474|65821036|FG001|Overall Study|Poor compliance to protocol|0|||
23571511|NCT01644474|65821035|FG000|Overall Study|Consent withdrawn by participant|0|||
23571512|NCT01644474|65821036|FG001|Overall Study|Consent withdrawn by participant|1|||
23571513|NCT01644474|65821035|FG000|Overall Study|Participant moved|0|||
23571514|NCT01644474|65821036|FG001|Overall Study|Participant moved|1|||
23571515|NCT01644474|65821035|FG000|Overall Study|Adverse Event|4|||
23632224|NCT01156376|66038665|FG002|Overall Study|Withdrawal by Subject|3|||
23770189|NCT02563522|66539455|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
23770190|NCT03444038|66539456|FG000|Overall Study|Adverse Event|12|||
23770191|NCT03444038|66539456|FG000|Overall Study|Withdrawal by Subject|7|||
23571516|NCT01644474|65821036|FG001|Overall Study|Adverse Event|5|||
23571517|NCT01644474|65821035|FG000|Overall Study|Site scheduling error|1|||
23571518|NCT01644474|65821036|FG001|Overall Study|Site scheduling error|1|||
23571519|NCT01644474|65821035|FG000|Overall Study|Protocol Violation|1|||
23571520|NCT01644474|65821036|FG001|Overall Study|Protocol Violation|0|||
23571521|NCT01282476|65821039|FG000|Overall Study|Death|11|||
23571522|NCT01382940|65821040|FG000|Overall Study|Adverse Event|19|||
23571523|NCT01382940|65821040|FG000|Overall Study|Lost to Follow-up|4|||
23571524|NCT01382940|65821040|FG000|Overall Study|Physician Decision|7|||
23571525|NCT01382940|65821040|FG000|Overall Study|Withdrawal by Subject|23|||
23632225|NCT04071301|66038666|FG000|Overall Study|Withdrawal by Subject|6|||
23632226|NCT04071301|66038666|FG000|Overall Study|Death|1|||
23632227|NCT01011868|66038667|FG000|After Week 18 Follow-up|Adverse Event|8|||
23632228|NCT01011868|66038668|FG001|After Week 18 Follow-up|Adverse Event|6|||
23830691|NCT01125189|66759975|FG001|Treatment Period|Withdrawal by Subject|1|||
23571526|NCT01382940|65821040|FG000|Overall Study|Protocol Violation|20|||
23571527|NCT01115491|65821041|FG000|Overall Study|Death|22|||
23632229|NCT01011868|66038669|FG002|After Week 18 Follow-up|Adverse Event|13|||
23571528|NCT01115491|65821041|FG000|Overall Study|Adverse Event|3|||
23571529|NCT01115491|65821041|FG000|Overall Study|Lost to Follow-up|3|||
23571530|NCT01115491|65821041|FG000|Overall Study|Withdrawal by Subject|1|||
23571531|NCT01115491|65821041|FG000|Overall Study|Physician Decision|1|||
23770192|NCT03444038|66539456|FG000|Overall Study|Lost to Follow-up|1|||
23770193|NCT03444038|66539456|FG000|Overall Study|Physician Decision|2|||
23571532|NCT00840996|65821044|FG000|Overall Study|Withdrawal by Subject|1|||
23571533|NCT00840996|65821045|FG001|Overall Study|Withdrawal by Subject|0|||
23571534|NCT01163747|65821048|FG000|Overall Study|Adverse Event|0|||
23571535|NCT01163747|65821049|FG001|Overall Study|Adverse Event|5|||
23571536|NCT01163747|65821048|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23571537|NCT01163747|65821049|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23571538|NCT01163747|65821048|FG000|Overall Study|Protocol Violation|0|||
23571539|NCT01163747|65821049|FG001|Overall Study|Protocol Violation|1|||
23571540|NCT01163747|65821048|FG000|Overall Study|Refused Treatment|6|||
23571541|NCT01163747|65821049|FG001|Overall Study|Refused Treatment|4|||
23571542|NCT03990363|65821053|FG000|Overall Study|Withdrawal by Subject|10|||
23571543|NCT03990363|65821054|FG001|Overall Study|Withdrawal by Subject|9|||
23571544|NCT03990363|65821055|FG002|Overall Study|Withdrawal by Subject|18|||
23571545|NCT03990363|65821056|FG003|Overall Study|Withdrawal by Subject|11|||
23571546|NCT03990363|65821057|FG004|Overall Study|Withdrawal by Subject|9|||
23632230|NCT01011868|66038667|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
23632231|NCT01011868|66038668|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
23632232|NCT01011868|66038669|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
23632233|NCT01011868|66038667|FG000|After Week 18 Follow-up|Protocol Violation|1|||
23632234|NCT01011868|66038668|FG001|After Week 18 Follow-up|Protocol Violation|1|||
23632235|NCT01011868|66038669|FG002|After Week 18 Follow-up|Protocol Violation|1|||
23632236|NCT01011868|66038667|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
23632237|NCT01011868|66038668|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
23770194|NCT03444038|66539456|FG000|Overall Study|Lack of Efficacy|7|||
23770195|NCT02305758|66539465|FG000|Overall Study|Death|27|||
23770196|NCT02305758|66539466|FG001|Overall Study|Death|27|||
23770197|NCT02305758|66539465|FG000|Overall Study|Withdrew consent|9|||
23770198|NCT02305758|66539466|FG001|Overall Study|Withdrew consent|2|||
23770199|NCT02305758|66539465|FG000|Overall Study|Lost to Follow-up|6|||
23770200|NCT02305758|66539466|FG001|Overall Study|Lost to Follow-up|1|||
23571547|NCT03990363|65821053|FG000|Overall Study|Physician Decision|1|||
23571548|NCT03990363|65821054|FG001|Overall Study|Physician Decision|0|||
23571549|NCT03990363|65821055|FG002|Overall Study|Physician Decision|0|||
23571550|NCT03990363|65821056|FG003|Overall Study|Physician Decision|0|||
23571551|NCT03990363|65821057|FG004|Overall Study|Physician Decision|0|||
23571552|NCT03990363|65821053|FG000|Overall Study|Adverse Event|1|||
23571553|NCT03990363|65821054|FG001|Overall Study|Adverse Event|3|||
23632238|NCT01011868|66038669|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
23632239|NCT01011868|66038667|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
23770201|NCT02305758|66539465|FG000|Overall Study|Study Terminated by Sponsor|21|||
23770202|NCT02305758|66539466|FG001|Overall Study|Study Terminated by Sponsor|34|||
23770203|NCT02305758|66539465|FG000|Overall Study|Other, not specified|2|||
23770204|NCT02305758|66539466|FG001|Overall Study|Other, not specified|1|||
23770205|NCT01631864|66539469|FG000|Overall Study|Withdrawal by Subject|0|||
23770206|NCT01631864|66539470|FG001|Overall Study|Withdrawal by Subject|1|||
23770207|NCT01631864|66539469|FG000|Overall Study|Adverse Event|2|||
23770208|NCT01631864|66539470|FG001|Overall Study|Adverse Event|3|||
23632240|NCT01011868|66038668|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
23632241|NCT01011868|66038669|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
23632242|NCT01011868|66038667|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
23632243|NCT01011868|66038668|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
23770209|NCT01626859|66539473|FG000|Overall Study|Adverse Event|1|||
23571554|NCT03990363|65821055|FG002|Overall Study|Adverse Event|2|||
23571555|NCT03990363|65821056|FG003|Overall Study|Adverse Event|2|||
23571556|NCT03990363|65821057|FG004|Overall Study|Adverse Event|0|||
23571557|NCT03990363|65821053|FG000|Overall Study|Death|14|||
23571558|NCT03990363|65821054|FG001|Overall Study|Death|8|||
23571559|NCT03990363|65821055|FG002|Overall Study|Death|14|||
23571560|NCT03990363|65821056|FG003|Overall Study|Death|10|||
23571561|NCT03990363|65821057|FG004|Overall Study|Death|11|||
23632244|NCT01011868|66038669|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
23770210|NCT01626859|66539474|FG001|Overall Study|Adverse Event|3|||
23571562|NCT03990363|65821053|FG000|Overall Study|Failure to meet randomization criteria|0|||
23770211|NCT01626859|66539475|FG002|Overall Study|Adverse Event|2|||
23770212|NCT01626859|66539473|FG000|Overall Study|Physician Decision|0|||
23571563|NCT03990363|65821054|FG001|Overall Study|Failure to meet randomization criteria|1|||
23571564|NCT03990363|65821055|FG002|Overall Study|Failure to meet randomization criteria|1|||
23571565|NCT03990363|65821056|FG003|Overall Study|Failure to meet randomization criteria|0|||
23571566|NCT03990363|65821057|FG004|Overall Study|Failure to meet randomization criteria|0|||
23571567|NCT03990363|65821053|FG000|Overall Study|Lost to Follow-up|0|||
23571568|NCT03990363|65821054|FG001|Overall Study|Lost to Follow-up|0|||
23770213|NCT01626859|66539474|FG001|Overall Study|Physician Decision|1|||
23770214|NCT01626859|66539475|FG002|Overall Study|Physician Decision|0|||
23770215|NCT01626859|66539473|FG000|Overall Study|Withdrawal by Subject|1|||
23770216|NCT01626859|66539474|FG001|Overall Study|Withdrawal by Subject|4|||
23770217|NCT01626859|66539475|FG002|Overall Study|Withdrawal by Subject|2|||
23770218|NCT00996736|66539476|FG000|Overall Study|Death|1|||
23770219|NCT00996736|66539477|FG001|Overall Study|Death|1|||
23770220|NCT00996736|66539476|FG000|Overall Study|Lost to Follow-up|15|||
23770221|NCT00996736|66539477|FG001|Overall Study|Lost to Follow-up|14|||
23770222|NCT00996736|66539476|FG000|Overall Study|Visit not within 3-month window|5|||
23770223|NCT00996736|66539477|FG001|Overall Study|Visit not within 3-month window|3|||
23770224|NCT02275364|66539483|FG000|Period 1|Withdrawal by Subject|1|||
23770225|NCT02275364|66539484|FG001|Period 1|Withdrawal by Subject|0|||
23770226|NCT02275364|66539483|FG000|Period 1|Other reason|1|||
23770227|NCT02275364|66539484|FG001|Period 1|Other reason|0|||
23770228|NCT01890915|66539485|FG000|Overall Study|Adverse Event|1|||
23770229|NCT01890915|66539486|FG001|Overall Study|Adverse Event|0|||
23770230|NCT01890915|66539485|FG000|Overall Study|Protocol Violation|2|||
23770231|NCT01890915|66539486|FG001|Overall Study|Protocol Violation|0|||
23770232|NCT01890915|66539485|FG000|Overall Study|Equipment Malfunction|0|||
23770233|NCT01890915|66539486|FG001|Overall Study|Equipment Malfunction|1|||
23770234|NCT03222141|66539489|FG000|Overall Study|Death|15|||
23770235|NCT03222141|66539489|FG000|Overall Study|Lost to Follow-up|3|||
23770236|NCT00720096|66539490|FG000|Overall Study|Withdrawal by Subject|0|||
23770237|NCT00720096|66539491|FG001|Overall Study|Withdrawal by Subject|2|||
23770238|NCT02568384|66539495|FG000|Overall Study|Mobile devices incompatible with App|2|||
23770239|NCT03980483|66539496|FG000|Overall Study|Adverse Event|13|||
23770240|NCT03980483|66539497|FG001|Overall Study|Adverse Event|29|||
23770241|NCT03980483|66539498|FG002|Overall Study|Adverse Event|11|||
23770242|NCT03980483|66539499|FG003|Overall Study|Adverse Event|2|||
23770243|NCT03980483|66539500|FG004|Overall Study|Adverse Event|2|||
23770244|NCT03980483|66539501|FG005|Overall Study|Adverse Event|2|||
23770245|NCT03980483|66539496|FG000|Overall Study|Lack of Efficacy|7|||
23770246|NCT03980483|66539497|FG001|Overall Study|Lack of Efficacy|6|||
23770247|NCT03980483|66539498|FG002|Overall Study|Lack of Efficacy|0|||
23770248|NCT03980483|66539499|FG003|Overall Study|Lack of Efficacy|3|||
23770249|NCT03980483|66539500|FG004|Overall Study|Lack of Efficacy|1|||
23770250|NCT03980483|66539501|FG005|Overall Study|Lack of Efficacy|1|||
23770251|NCT03980483|66539496|FG000|Overall Study|Lost to Follow-up|2|||
23770252|NCT03980483|66539497|FG001|Overall Study|Lost to Follow-up|4|||
23770253|NCT03980483|66539498|FG002|Overall Study|Lost to Follow-up|2|||
23770254|NCT03980483|66539499|FG003|Overall Study|Lost to Follow-up|1|||
23770255|NCT03980483|66539500|FG004|Overall Study|Lost to Follow-up|2|||
23770256|NCT03980483|66539501|FG005|Overall Study|Lost to Follow-up|0|||
23770257|NCT03980483|66539496|FG000|Overall Study|Protocol Violation|4|||
23770258|NCT03980483|66539497|FG001|Overall Study|Protocol Violation|2|||
23770259|NCT03980483|66539498|FG002|Overall Study|Protocol Violation|1|||
23770260|NCT03980483|66539499|FG003|Overall Study|Protocol Violation|1|||
23770261|NCT03980483|66539500|FG004|Overall Study|Protocol Violation|0|||
23770262|NCT03980483|66539501|FG005|Overall Study|Protocol Violation|0|||
23770263|NCT03980483|66539496|FG000|Overall Study|Physician Decision|14|||
23770264|NCT03980483|66539497|FG001|Overall Study|Physician Decision|10|||
23770265|NCT03980483|66539498|FG002|Overall Study|Physician Decision|7|||
23770266|NCT03980483|66539499|FG003|Overall Study|Physician Decision|4|||
23770267|NCT03980483|66539500|FG004|Overall Study|Physician Decision|4|||
23770268|NCT03980483|66539501|FG005|Overall Study|Physician Decision|2|||
23447137|NCT00502671|65377880|FG000|Overall Study|Disease Progression|13|||
23770269|NCT03980483|66539496|FG000|Overall Study|Withdrawal by Subject|38|||
23770270|NCT03980483|66539497|FG001|Overall Study|Withdrawal by Subject|21|||
23770271|NCT03980483|66539498|FG002|Overall Study|Withdrawal by Subject|15|||
23770272|NCT03980483|66539499|FG003|Overall Study|Withdrawal by Subject|5|||
23770273|NCT03980483|66539500|FG004|Overall Study|Withdrawal by Subject|3|||
23770274|NCT03980483|66539501|FG005|Overall Study|Withdrawal by Subject|4|||
23770275|NCT03980483|66539496|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
23571569|NCT03990363|65821055|FG002|Overall Study|Lost to Follow-up|0|||
23770276|NCT03980483|66539497|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23770277|NCT03980483|66539498|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23571570|NCT03990363|65821056|FG003|Overall Study|Lost to Follow-up|1|||
23571571|NCT03990363|65821057|FG004|Overall Study|Lost to Follow-up|2|||
23571572|NCT03990363|65821053|FG000|Overall Study|Non-compliance with study drug|2|||
23571573|NCT03990363|65821054|FG001|Overall Study|Non-compliance with study drug|1|||
23571574|NCT03990363|65821055|FG002|Overall Study|Non-compliance with study drug|2|||
23571575|NCT03990363|65821056|FG003|Overall Study|Non-compliance with study drug|0|||
23571576|NCT03990363|65821057|FG004|Overall Study|Non-compliance with study drug|0|||
23770278|NCT03980483|66539499|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23770279|NCT03980483|66539500|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23770280|NCT03980483|66539501|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23770281|NCT03980483|66539496|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23770282|NCT03980483|66539497|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
23770283|NCT03980483|66539498|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23770284|NCT03980483|66539499|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23770285|NCT03980483|66539500|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23770286|NCT03980483|66539501|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23770287|NCT03980483|66539496|FG000|Overall Study|Other|0|||
23770288|NCT03980483|66539497|FG001|Overall Study|Other|1|||
23770289|NCT03980483|66539498|FG002|Overall Study|Other|0|||
23770290|NCT03980483|66539499|FG003|Overall Study|Other|0|||
23770291|NCT03980483|66539500|FG004|Overall Study|Other|0|||
23770292|NCT03980483|66539501|FG005|Overall Study|Other|0|||
23770293|NCT00718159|66539504|FG000|Overall Study|Progressive Disease|3|||
23770294|NCT00718159|66539505|FG001|Overall Study|Progressive Disease|3|||
23830692|NCT01125189|66759976|FG002|Treatment Period|Withdrawal by Subject|1|||
23830693|NCT01125189|66759974|FG000|Treatment Period|Death|1|||
23830694|NCT01125189|66759975|FG001|Treatment Period|Death|0|||
23830695|NCT01125189|66759976|FG002|Treatment Period|Death|0|||
23830696|NCT01125189|66759974|FG000|Treatment Period|Lost to Follow-up|1|||
23830697|NCT01125189|66759975|FG001|Treatment Period|Lost to Follow-up|2|||
23830698|NCT01125189|66759976|FG002|Treatment Period|Lost to Follow-up|1|||
23830699|NCT01125189|66759974|FG000|Treatment Period|Poor compliance/noncompliance|0|||
23830700|NCT01125189|66759975|FG001|Treatment Period|Poor compliance/noncompliance|1|||
23830701|NCT01125189|66759976|FG002|Treatment Period|Poor compliance/noncompliance|0|||
23830702|NCT01125189|66759974|FG000|Treatment Period|Participants requested to discontinue|1|||
23830703|NCT01125189|66759975|FG001|Treatment Period|Participants requested to discontinue|3|||
23830704|NCT01125189|66759976|FG002|Treatment Period|Participants requested to discontinue|4|||
23830705|NCT01125189|66759974|FG000|Treatment Period|Other reasons|1|||
23830706|NCT01125189|66759975|FG001|Treatment Period|Other reasons|1|||
23830707|NCT01125189|66759976|FG002|Treatment Period|Other reasons|0|||
23830708|NCT01125189|66759974|FG000|Treatment Period|Completed 24 week treatment period only|2|||
23830709|NCT01125189|66759975|FG001|Treatment Period|Completed 24 week treatment period only|1|||
23830710|NCT01125189|66759976|FG002|Treatment Period|Completed 24 week treatment period only|2|||
23830711|NCT01125189|66759974|FG000|Follow up Period|Withdrawal by Subject|3|||
23830712|NCT01125189|66759975|FG001|Follow up Period|Withdrawal by Subject|2|||
23571577|NCT03990363|65821053|FG000|Overall Study|Study terminated by sponsor|0|||
23571578|NCT03990363|65821054|FG001|Overall Study|Study terminated by sponsor|1|||
23571579|NCT03990363|65821055|FG002|Overall Study|Study terminated by sponsor|0|||
23571580|NCT03990363|65821056|FG003|Overall Study|Study terminated by sponsor|0|||
23571581|NCT03990363|65821057|FG004|Overall Study|Study terminated by sponsor|0|||
23571582|NCT03990363|65821053|FG000|Overall Study|Site terminated by sponsor|2|||
23571583|NCT03990363|65821054|FG001|Overall Study|Site terminated by sponsor|1|||
23571584|NCT03990363|65821055|FG002|Overall Study|Site terminated by sponsor|2|||
23571585|NCT03990363|65821056|FG003|Overall Study|Site terminated by sponsor|0|||
23571586|NCT03990363|65821057|FG004|Overall Study|Site terminated by sponsor|2|||
23571587|NCT03990363|65821053|FG000|Overall Study|Not categorized|5|||
23571588|NCT03990363|65821054|FG001|Overall Study|Not categorized|5|||
23571589|NCT03990363|65821055|FG002|Overall Study|Not categorized|3|||
23571590|NCT03990363|65821056|FG003|Overall Study|Not categorized|2|||
23571591|NCT03990363|65821057|FG004|Overall Study|Not categorized|2|||
23571592|NCT00287469|65821060|FG000|Overall Study|serious adverse event|1|||
23770295|NCT00718159|66539506|FG002|Overall Study|Progressive Disease|2|||
23770296|NCT00718159|66539507|FG003|Overall Study|Progressive Disease|0|||
23770297|NCT00718159|66539508|FG004|Overall Study|Progressive Disease|6|||
23770298|NCT00718159|66539509|FG005|Overall Study|Progressive Disease|0|||
23830713|NCT01125189|66759976|FG002|Follow up Period|Withdrawal by Subject|5|||
23830714|NCT01125189|66759974|FG000|Follow up Period|Death|1|||
23830715|NCT01125189|66759975|FG001|Follow up Period|Death|0|||
23830716|NCT01125189|66759976|FG002|Follow up Period|Death|0|||
23571593|NCT00287469|65821061|FG001|Overall Study|serious adverse event|6|||
23571594|NCT00287469|65821060|FG000|Overall Study|Adverse Event|1|||
23571595|NCT00287469|65821061|FG001|Overall Study|Adverse Event|1|||
23571596|NCT00287469|65821060|FG000|Overall Study|moved from area|144|||
23571597|NCT00287469|65821061|FG001|Overall Study|moved from area|138|||
23770299|NCT00718159|66539510|FG006|Overall Study|Progressive Disease|0|||
23830717|NCT01125189|66759974|FG000|Follow up Period|Lost to Follow-up|12|||
23830718|NCT01125189|66759975|FG001|Follow up Period|Lost to Follow-up|9|||
23830719|NCT01125189|66759976|FG002|Follow up Period|Lost to Follow-up|6|||
23830720|NCT01125189|66759974|FG000|Follow up Period|Other reasons|4|||
23830721|NCT01125189|66759975|FG001|Follow up Period|Other reasons|4|||
23830722|NCT01125189|66759976|FG002|Follow up Period|Other reasons|5|||
23830723|NCT02837731|66759978|FG000|Allocation|Admitted to General Floor|3|||
23830724|NCT02837731|66759979|FG001|Allocation|Admitted to General Floor|4|||
23830725|NCT02837731|66759978|FG000|Allocation|Immediate surgery/withdrew|2|||
23830726|NCT02837731|66759979|FG001|Allocation|Immediate surgery/withdrew|0|||
23830727|NCT02837731|66759978|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
23830728|NCT02837731|66759979|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
23830729|NCT02837731|66759978|FG000|Allocation|Withdrawal by Subject|2|||
23830730|NCT02837731|66759979|FG001|Allocation|Withdrawal by Subject|0|||
23830731|NCT02837731|66759978|FG000|Allocation|Device not available|1|||
23830732|NCT02837731|66759979|FG001|Allocation|Device not available|0|||
23770300|NCT00718159|66539504|FG000|Overall Study|Death due to Adverse Event|0|||
23770301|NCT00718159|66539505|FG001|Overall Study|Death due to Adverse Event|0|||
23770302|NCT00718159|66539506|FG002|Overall Study|Death due to Adverse Event|0|||
23770303|NCT00718159|66539507|FG003|Overall Study|Death due to Adverse Event|2|||
23770304|NCT00718159|66539508|FG004|Overall Study|Death due to Adverse Event|2|||
23770305|NCT00718159|66539509|FG005|Overall Study|Death due to Adverse Event|0|||
23770306|NCT00718159|66539510|FG006|Overall Study|Death due to Adverse Event|0|||
23770307|NCT00718159|66539504|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
23830733|NCT02837731|66759978|FG000|Allocation|Protocol not implemented|7|||
23830734|NCT02837731|66759979|FG001|Allocation|Protocol not implemented|0|||
23830735|NCT02837731|66759978|FG000|Allocation|Moribund/Do not resuscitate|2|||
23830736|NCT02837731|66759979|FG001|Allocation|Moribund/Do not resuscitate|0|||
23447138|NCT00502671|65377880|FG000|Overall Study|Personal Reasons|22|||
23770308|NCT00718159|66539505|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
23830737|NCT02837731|66759978|FG000|Allocation|Did not meet sepsis criteria|1|||
23830738|NCT02837731|66759979|FG001|Allocation|Did not meet sepsis criteria|2|||
23830739|NCT02837731|66759978|FG000|Allocation|Known aortic abnormalities|0|||
23770309|NCT00718159|66539506|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
23770310|NCT00718159|66539507|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
23770311|NCT00718159|66539508|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
23770312|NCT00718159|66539509|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
23770313|NCT00718159|66539510|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
23770314|NCT00718159|66539504|FG000|Overall Study|Investigator Decision|0|||
23770315|NCT00718159|66539505|FG001|Overall Study|Investigator Decision|0|||
23770316|NCT00718159|66539506|FG002|Overall Study|Investigator Decision|0|||
23770317|NCT00718159|66539507|FG003|Overall Study|Investigator Decision|0|||
23770318|NCT00718159|66539508|FG004|Overall Study|Investigator Decision|0|||
23770319|NCT00718159|66539509|FG005|Overall Study|Investigator Decision|1|||
23830740|NCT02837731|66759979|FG001|Allocation|Known aortic abnormalities|1|||
23830741|NCT00884117|66759980|FG000|Overall Study|Adverse Event|2|||
23830742|NCT00884117|66759980|FG000|Overall Study|Withdrawal by Subject|89|||
23830743|NCT00884117|66759980|FG000|Overall Study|Death|3|||
23830744|NCT00884117|66759980|FG000|Overall Study|Lost to Follow-up|143|||
23830745|NCT00884117|66759980|FG000|Overall Study|Other|12|||
23770320|NCT00718159|66539510|FG006|Overall Study|Investigator Decision|1|||
23770321|NCT03481309|66539511|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
23770322|NCT03481309|66539512|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23770323|NCT03481309|66539513|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23770324|NCT03481309|66539514|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23632245|NCT01011868|66038667|FG000|After Week 78 Follow-up|Adverse Event|14|||
23632246|NCT01011868|66038668|FG001|After Week 78 Follow-up|Adverse Event|18|||
23632247|NCT01011868|66038669|FG002|After Week 78 Follow-up|Adverse Event|21|||
23632248|NCT01011868|66038667|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
23632249|NCT01011868|66038668|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
23632250|NCT01011868|66038669|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
23632251|NCT01011868|66038667|FG000|After Week 78 Follow-up|Protocol Violation|9|||
23632252|NCT01011868|66038668|FG001|After Week 78 Follow-up|Protocol Violation|1|||
23632253|NCT01011868|66038669|FG002|After Week 78 Follow-up|Protocol Violation|2|||
23632254|NCT01011868|66038667|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
23632255|NCT01011868|66038668|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
23632256|NCT01011868|66038669|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
23632257|NCT01011868|66038667|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
23632258|NCT01011868|66038668|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
23632259|NCT01011868|66038669|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
23632260|NCT01011868|66038667|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
23632261|NCT01011868|66038668|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
23632262|NCT01011868|66038669|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
23632263|NCT03519204|66038670|FG000|Overall Study|Lost to Follow-up|3|||
23632264|NCT03519204|66038671|FG001|Overall Study|Lost to Follow-up|8|||
23632265|NCT03519204|66038670|FG000|Overall Study|Withdrawal by Subject|9|||
23632266|NCT03519204|66038671|FG001|Overall Study|Withdrawal by Subject|7|||
23632267|NCT03519204|66038670|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23830746|NCT02038010|66759981|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23830747|NCT02038010|66759982|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
23830748|NCT02038010|66759983|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23632268|NCT03519204|66038671|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23632269|NCT01658020|66038672|FG000|Overall Study|Adverse Event|3|||
23632270|NCT01658020|66038673|FG001|Overall Study|Adverse Event|3|||
23632271|NCT01658020|66038672|FG000|Overall Study|Lost to Follow-up|1|||
23632272|NCT01658020|66038673|FG001|Overall Study|Lost to Follow-up|0|||
23632273|NCT01658020|66038672|FG000|Overall Study|Withdrawal by Subject|4|||
23632274|NCT01658020|66038673|FG001|Overall Study|Withdrawal by Subject|5|||
23632275|NCT01658020|66038672|FG000|Overall Study|Protocol Violation|0|||
23632276|NCT01658020|66038673|FG001|Overall Study|Protocol Violation|1|||
23632277|NCT02879383|66038676|FG000|First 24 Weeks|Physician Decision|0|||
23632278|NCT02879383|66038677|FG001|First 24 Weeks|Physician Decision|1|||
23632279|NCT02879383|66038678|FG002|First 24 Weeks|Physician Decision|0|||
23632280|NCT02879383|66038679|FG003|First 24 Weeks|Physician Decision|0|||
23632281|NCT02807883|66038682|FG000|Overall Study|Withdrawal by Subject|2|||
23632282|NCT03445533|66038685|FG000|Overall Study|Progressive Disease|48|||
23632283|NCT03445533|66038686|FG001|Overall Study|Progressive Disease|81|||
23632284|NCT03445533|66038685|FG000|Overall Study|Adverse Event|60|||
23632285|NCT03445533|66038686|FG001|Overall Study|Adverse Event|64|||
23632286|NCT03445533|66038685|FG000|Overall Study|Death|9|||
23632287|NCT03445533|66038686|FG001|Overall Study|Death|19|||
23632288|NCT03445533|66038685|FG000|Overall Study|Miscellaneous|0|||
23632289|NCT03445533|66038686|FG001|Overall Study|Miscellaneous|16|||
23632290|NCT03445533|66038685|FG000|Overall Study|Withdrawal by Subject|3|||
23632291|NCT03445533|66038686|FG001|Overall Study|Withdrawal by Subject|4|||
23770325|NCT03481309|66539515|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23830749|NCT02038010|66759984|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23770326|NCT03481309|66539516|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23770327|NCT02761980|66539517|FG000|Overall Study|Adverse Event|4|||
23770328|NCT02761980|66539518|FG001|Overall Study|Adverse Event|6|||
23770329|NCT02761980|66539519|FG002|Overall Study|Adverse Event|5|||
23770330|NCT02761980|66539520|FG003|Overall Study|Adverse Event|6|||
23770331|NCT02761980|66539517|FG000|Overall Study|Withdrawal by Subject|0|||
23770332|NCT02761980|66539518|FG001|Overall Study|Withdrawal by Subject|1|||
23770333|NCT02761980|66539519|FG002|Overall Study|Withdrawal by Subject|0|||
23770334|NCT02761980|66539520|FG003|Overall Study|Withdrawal by Subject|0|||
23632292|NCT03445533|66038685|FG000|Overall Study|Physician Decision|1|||
23632293|NCT03445533|66038686|FG001|Overall Study|Physician Decision|3|||
23571598|NCT00287469|65821060|FG000|Overall Study|Lost to Follow-up|74|||
23571599|NCT00287469|65821061|FG001|Overall Study|Lost to Follow-up|69|||
23571600|NCT01388530|65821062|FG000|Overall Study|Lost to Follow-up|5|||
23571601|NCT01077362|65821064|FG000|Overall Study|Lack of Efficacy|13|||
23571602|NCT01077362|65821065|FG001|Overall Study|Lack of Efficacy|8|||
23571603|NCT01077362|65821066|FG002|Overall Study|Lack of Efficacy|10|||
23571604|NCT01077362|65821064|FG000|Overall Study|Lost to Follow-up|1|||
23571605|NCT01077362|65821065|FG001|Overall Study|Lost to Follow-up|0|||
23571606|NCT01077362|65821066|FG002|Overall Study|Lost to Follow-up|3|||
23571607|NCT01077362|65821064|FG000|Overall Study|Adverse Event|12|||
23571608|NCT01077362|65821065|FG001|Overall Study|Adverse Event|7|||
23571609|NCT01077362|65821066|FG002|Overall Study|Adverse Event|4|||
23571610|NCT01077362|65821064|FG000|Overall Study|Withdrawal by Subject|5|||
23571611|NCT01077362|65821065|FG001|Overall Study|Withdrawal by Subject|3|||
23770335|NCT02761980|66539517|FG000|Overall Study|Other|0|||
23770336|NCT02761980|66539518|FG001|Overall Study|Other|0|||
23770337|NCT02761980|66539519|FG002|Overall Study|Other|1|||
23632294|NCT03445533|66038685|FG000|Overall Study|Sponsor Decision|0|||
23632295|NCT03445533|66038686|FG001|Overall Study|Sponsor Decision|1|||
23632296|NCT03445533|66038685|FG000|Overall Study|Lost to Follow-up|0|||
23632297|NCT03445533|66038686|FG001|Overall Study|Lost to Follow-up|1|||
23632298|NCT03445533|66038685|FG000|Overall Study|Never Received any Study Treatment|7|||
23770338|NCT02761980|66539520|FG003|Overall Study|Other|0|||
23830750|NCT02038010|66759981|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
23830751|NCT02038010|66759982|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23830752|NCT02038010|66759983|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23830753|NCT02038010|66759984|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23830754|NCT02038010|66759981|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23830755|NCT02038010|66759982|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
23830756|NCT02038010|66759983|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23830757|NCT02038010|66759984|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23830758|NCT02038010|66759981|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
23830759|NCT02038010|66759982|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
23830760|NCT02038010|66759983|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
23830761|NCT02038010|66759984|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
23830762|NCT02038010|66759981|FG000|Follow Up|Death|4|||
23830763|NCT02038010|66759982|FG001|Follow Up|Death|3|||
23830764|NCT02038010|66759983|FG002|Follow Up|Death|0|||
23830765|NCT02038010|66759984|FG003|Follow Up|Death|0|||
23830766|NCT02038010|66759981|FG000|Follow Up|Other|3|||
23830767|NCT02038010|66759982|FG001|Follow Up|Other|0|||
23830768|NCT02038010|66759983|FG002|Follow Up|Other|0|||
23830769|NCT02038010|66759984|FG003|Follow Up|Other|0|||
23830770|NCT00752128|66759986|FG000|Overall Study|Withdrawal by Subject|4|||
23830771|NCT00634036|66759989|FG000|Overall Study|Lost to Follow-up|1|||
23830772|NCT00634036|66759990|FG001|Overall Study|Lost to Follow-up|1|||
23830773|NCT00634036|66759989|FG000|Overall Study|Withdrawal by Subject|1|||
23830774|NCT00634036|66759990|FG001|Overall Study|Withdrawal by Subject|1|||
23830775|NCT00697463|66759996|FG000|Overall Study|Withdrawal by Subject|1|||
23830776|NCT01372618|66759999|FG000|Overall Study|PI Died. Study Terminated|9|||
23830777|NCT00666328|66760002|FG000|Overall Study|Death|2|||
23632299|NCT03445533|66038686|FG001|Overall Study|Never Received any Study Treatment|4|||
23632300|NCT03238963|66038688|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
23632301|NCT03238963|66038689|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
23571612|NCT01077362|65821066|FG002|Overall Study|Withdrawal by Subject|5|||
23571613|NCT01077362|65821064|FG000|Overall Study|Other|0|||
23571614|NCT01077362|65821065|FG001|Overall Study|Other|1|||
23571615|NCT01077362|65821066|FG002|Overall Study|Other|2|||
23830778|NCT00666328|66760002|FG000|Overall Study|Lost to Follow-up|2|||
23830779|NCT00666328|66760002|FG000|Overall Study|No longer met eligibility criteria|1|||
23830780|NCT00564850|66760005|FG000|Overall Study|Protocol Violation|2|||
23830781|NCT04358081|66760006|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
23830782|NCT04358081|66760007|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
23830783|NCT04358081|66760008|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
23830784|NCT04358081|66760006|FG000|Treatment Phase of Study|Adverse Event|1|||
23830785|NCT04358081|66760007|FG001|Treatment Phase of Study|Adverse Event|0|||
23830786|NCT04358081|66760008|FG002|Treatment Phase of Study|Adverse Event|1|||
23830787|NCT04358081|66760006|FG000|Treatment Phase of Study|Physician Decision|2|||
23830788|NCT04358081|66760007|FG001|Treatment Phase of Study|Physician Decision|0|||
23830789|NCT04358081|66760008|FG002|Treatment Phase of Study|Physician Decision|1|||
23830790|NCT04358081|66760006|FG000|Treatment Phase of Study|Protocol Violation|1|||
23830791|NCT04358081|66760007|FG001|Treatment Phase of Study|Protocol Violation|0|||
23830792|NCT04358081|66760008|FG002|Treatment Phase of Study|Protocol Violation|0|||
23830793|NCT04358081|66760006|FG000|Study Completion Phase|Death|0|||
23830794|NCT04358081|66760007|FG001|Study Completion Phase|Death|0|||
23830795|NCT04358081|66760008|FG002|Study Completion Phase|Death|1|||
23830796|NCT04358081|66760006|FG000|Study Completion Phase|Lost to Follow-up|1|||
23830797|NCT04358081|66760007|FG001|Study Completion Phase|Lost to Follow-up|0|||
23830798|NCT04358081|66760008|FG002|Study Completion Phase|Lost to Follow-up|1|||
23830799|NCT00287586|66760009|FG000|Overall Study|Withdrew Consent|19|||
23830800|NCT00287586|66760010|FG001|Overall Study|Withdrew Consent|30|||
23830801|NCT00287586|66760009|FG000|Overall Study|Lost to Follow-up|5|||
23830802|NCT00287586|66760010|FG001|Overall Study|Lost to Follow-up|4|||
23830803|NCT00287586|66760009|FG000|Overall Study|Death|2|||
23830804|NCT00287586|66760010|FG001|Overall Study|Death|3|||
23830805|NCT00287586|66760009|FG000|Overall Study|Elevated Hematocrit|3|||
23830806|NCT00287586|66760010|FG001|Overall Study|Elevated Hematocrit|0|||
23830807|NCT00287586|66760009|FG000|Overall Study|Rash|3|||
23830808|NCT00287586|66760010|FG001|Overall Study|Rash|0|||
23830809|NCT00287586|66760009|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
23830810|NCT00287586|66760010|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
23571616|NCT01208415|65821067|FG000|Overall Study|Death|1|||
23571617|NCT01208415|65821067|FG000|Overall Study|Lost to Follow-up|2|||
23571618|NCT01208415|65821067|FG000|Overall Study|Withdrawal by Subject|3|||
23571619|NCT01208415|65821067|FG000|Overall Study|Device not placed|1|||
23571620|NCT01208415|65821067|FG000|Overall Study|Still be eligible for follow-up|33|||
23571621|NCT04362137|65821068|FG000|Overall Study|Death|9|||
23571622|NCT04362137|65821069|FG001|Overall Study|Death|3|||
23571623|NCT04362137|65821068|FG000|Overall Study|Patient decision|6|||
23571624|NCT04362137|65821069|FG001|Overall Study|Patient decision|3|||
23571625|NCT04362137|65821068|FG000|Overall Study|Adverse Event|1|||
23571626|NCT04362137|65821069|FG001|Overall Study|Adverse Event|0|||
23571627|NCT04362137|65821068|FG000|Overall Study|Lost to Follow-up|1|||
23571628|NCT04362137|65821069|FG001|Overall Study|Lost to Follow-up|0|||
23571629|NCT04362137|65821068|FG000|Overall Study|Protocol deviation|1|||
23632302|NCT03238963|66038688|FG000|Overall Study|Withdrawal by Subject|1|||
23632303|NCT03238963|66038689|FG001|Overall Study|Withdrawal by Subject|1|||
23830811|NCT00287586|66760009|FG000|Overall Study|Stroke|2|||
23830812|NCT00287586|66760010|FG001|Overall Study|Stroke|0|||
23830813|NCT00287586|66760009|FG000|Overall Study|Myocardial Infarction|1|||
23830814|NCT00287586|66760010|FG001|Overall Study|Myocardial Infarction|0|||
23830815|NCT00287586|66760009|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
23632304|NCT03238963|66038688|FG000|Overall Study|Lost to Follow-up|1|||
23632305|NCT03238963|66038689|FG001|Overall Study|Lost to Follow-up|0|||
23632306|NCT03238963|66038688|FG000|Overall Study|Protocol Violation|1|||
23632307|NCT03238963|66038689|FG001|Overall Study|Protocol Violation|1|||
23632308|NCT03238963|66038688|FG000|Overall Study|Adverse Event|1|||
23632309|NCT03238963|66038689|FG001|Overall Study|Adverse Event|0|||
23632310|NCT03510455|66038690|FG000|Overall Study|Physician Decision|1|||
23632311|NCT00943852|66038694|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632312|NCT00943852|66038695|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632313|NCT00943852|66038696|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632314|NCT00943852|66038697|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
23632315|NCT00943852|66038698|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632316|NCT00943852|66038699|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23830816|NCT00287586|66760010|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
23830817|NCT00287586|66760009|FG000|Overall Study|Cognitive Impairment|1|||
23830818|NCT00287586|66760010|FG001|Overall Study|Cognitive Impairment|0|||
23830819|NCT00287586|66760009|FG000|Overall Study|Pancreatic Cancer|1|||
23830820|NCT00287586|66760010|FG001|Overall Study|Pancreatic Cancer|3|||
23830821|NCT00287586|66760009|FG000|Overall Study|Sleep Apnea|1|||
23571630|NCT04362137|65821069|FG001|Overall Study|Protocol deviation|0|||
23571631|NCT01927731|65821074|FG000|Overall Study|Graft Failure|1|||
23571632|NCT01927731|65821075|FG001|Overall Study|Graft Failure|2|||
23571633|NCT01927731|65821074|FG000|Overall Study|Physician Decision|2|||
23830822|NCT00287586|66760010|FG001|Overall Study|Sleep Apnea|0|||
23830823|NCT00287586|66760009|FG000|Overall Study|Shoulder Pain|1|||
23830824|NCT00287586|66760010|FG001|Overall Study|Shoulder Pain|0|||
23830825|NCT00287586|66760009|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
23830826|NCT00287586|66760010|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
23632317|NCT00943852|66038700|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632318|NCT00943852|66038701|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632319|NCT00943852|66038702|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632320|NCT00943852|66038703|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23632321|NCT00943852|66038694|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632322|NCT00943852|66038695|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632323|NCT00943852|66038696|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632324|NCT00943852|66038697|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632325|NCT00943852|66038698|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632326|NCT00943852|66038699|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
23632327|NCT00943852|66038700|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632328|NCT00943852|66038701|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632329|NCT00943852|66038702|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632330|NCT00943852|66038703|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23632331|NCT00943852|66038694|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632332|NCT00943852|66038695|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632333|NCT00943852|66038696|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632334|NCT00943852|66038697|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632335|NCT00943852|66038698|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632336|NCT00943852|66038699|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632337|NCT00943852|66038700|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
23632338|NCT00943852|66038701|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632339|NCT00943852|66038702|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632340|NCT00943852|66038703|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23632341|NCT00943852|66038694|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632342|NCT00943852|66038695|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632343|NCT00943852|66038696|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632344|NCT00943852|66038697|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632345|NCT00943852|66038698|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632346|NCT00943852|66038699|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632347|NCT00943852|66038700|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632348|NCT00943852|66038701|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
23830827|NCT00287586|66760009|FG000|Overall Study|Nonadherence|1|||
23830828|NCT00287586|66760010|FG001|Overall Study|Nonadherence|1|||
23830829|NCT00287586|66760009|FG000|Overall Study|Enrolled in Another Study|1|||
23830830|NCT00287586|66760010|FG001|Overall Study|Enrolled in Another Study|0|||
23830831|NCT00287586|66760009|FG000|Overall Study|Major Depression|0|||
23632349|NCT00943852|66038702|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632350|NCT00943852|66038703|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23632351|NCT00943852|66038694|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23632352|NCT00943852|66038695|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23632353|NCT00943852|66038696|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23632354|NCT00943852|66038697|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23632355|NCT00943852|66038698|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23632356|NCT00943852|66038699|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23632357|NCT00943852|66038700|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23632358|NCT00943852|66038701|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23632359|NCT00943852|66038702|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23632360|NCT00943852|66038703|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23770339|NCT00992407|66539521|FG000|Overall Study|Protocol Violation|2|||
23770340|NCT00992407|66539522|FG001|Overall Study|Protocol Violation|1|||
23770341|NCT00992407|66539521|FG000|Overall Study|Lost to Follow-up|3|||
23770342|NCT00992407|66539522|FG001|Overall Study|Lost to Follow-up|3|||
23770343|NCT00992407|66539521|FG000|Overall Study|Adverse Event|3|||
23770344|NCT00992407|66539522|FG001|Overall Study|Adverse Event|2|||
23770345|NCT00992407|66539521|FG000|Overall Study|protocol Violation & Adverse events|2|||
23770346|NCT00992407|66539522|FG001|Overall Study|protocol Violation & Adverse events|4|||
23770347|NCT00992407|66539521|FG000|Overall Study|Other|2|||
23770348|NCT00992407|66539522|FG001|Overall Study|Other|0|||
23770349|NCT00992407|66539521|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
23770350|NCT00992407|66539522|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
23830832|NCT00287586|66760010|FG001|Overall Study|Major Depression|2|||
23632361|NCT01843777|66038704|FG000|Overall Study|Withdrawal by Subject|1|||
23632362|NCT01843777|66038705|FG001|Overall Study|Withdrawal by Subject|0|||
23632363|NCT00911768|66038709|FG000|Overall Study|Protocol Violation|5|||
23632364|NCT00911768|66038710|FG001|Overall Study|Protocol Violation|4|||
23632365|NCT00911768|66038709|FG000|Overall Study|Withdrawal by Subject|1|||
23632366|NCT00911768|66038710|FG001|Overall Study|Withdrawal by Subject|0|||
23632367|NCT01053247|66038711|FG000|Overall Study|Withdrawal by Subject|9|||
23632368|NCT01053247|66038712|FG001|Overall Study|Withdrawal by Subject|4|||
23770351|NCT00992407|66539521|FG000|Overall Study|Study medication not administered|17|||
23770352|NCT00992407|66539522|FG001|Overall Study|Study medication not administered|13|||
23571634|NCT01927731|65821075|FG001|Overall Study|Physician Decision|3|||
23571635|NCT01927731|65821074|FG000|Overall Study|Withdrawal by Subject|0|||
23571636|NCT01927731|65821075|FG001|Overall Study|Withdrawal by Subject|2|||
23571637|NCT01927731|65821074|FG000|Overall Study|Death|0|||
23571638|NCT01927731|65821075|FG001|Overall Study|Death|3|||
23571639|NCT02341456|65821076|FG000|Overall Study|Disease progression|2|||
23571640|NCT02341456|65821077|FG001|Overall Study|Disease progression|3|||
23571641|NCT02341456|65821078|FG002|Overall Study|Disease progression|1|||
23571642|NCT02341456|65821076|FG000|Overall Study|Death|1|||
23571643|NCT02341456|65821077|FG001|Overall Study|Death|1|||
23571644|NCT02341456|65821078|FG002|Overall Study|Death|1|||
23571645|NCT02341456|65821076|FG000|Overall Study|Withdrawal by Subject|0|||
23571646|NCT02341456|65821077|FG001|Overall Study|Withdrawal by Subject|1|||
23571647|NCT02341456|65821078|FG002|Overall Study|Withdrawal by Subject|1|||
23571648|NCT02341456|65821076|FG000|Overall Study|Moved to local access programme.|0|||
23571649|NCT02341456|65821077|FG001|Overall Study|Moved to local access programme.|1|||
23571650|NCT02341456|65821078|FG002|Overall Study|Moved to local access programme.|1|||
23571651|NCT02341456|65821076|FG000|Overall Study|Physician Decision|1|||
23571652|NCT02341456|65821077|FG001|Overall Study|Physician Decision|0|||
23571653|NCT02341456|65821078|FG002|Overall Study|Physician Decision|0|||
23571654|NCT00570661|65821079|FG000|Overall Study|Disease worsening|5|||
23571655|NCT00570661|65821079|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
23571656|NCT00570661|65821079|FG000|Overall Study|Adverse Event|1|||
23571657|NCT01448044|65821080|FG000|Treatment Period|Adverse Event|4|||
23571658|NCT01448044|65821081|FG001|Treatment Period|Adverse Event|3|||
23571659|NCT01448044|65821080|FG000|Treatment Period|Lack of Efficacy|5|||
23571660|NCT01448044|65821081|FG001|Treatment Period|Lack of Efficacy|12|||
23571661|NCT01448044|65821080|FG000|Treatment Period|Subject requested discontinue study drug|1|||
23571662|NCT01448044|65821081|FG001|Treatment Period|Subject requested discontinue study drug|0|||
23571663|NCT01448044|65821080|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
23571664|NCT01448044|65821081|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
23571665|NCT01448044|65821080|FG000|Treatment Period|Participant does not meet study criteria|1|||
23571666|NCT01448044|65821081|FG001|Treatment Period|Participant does not meet study criteria|0|||
23571667|NCT01448044|65821080|FG000|Treatment Period|Lost to Follow-up|2|||
23571668|NCT01448044|65821081|FG001|Treatment Period|Lost to Follow-up|1|||
23571669|NCT01448044|65821080|FG000|Treatment Period|Other reason|2|||
23571670|NCT01448044|65821081|FG001|Treatment Period|Other reason|0|||
23571671|NCT01448044|65821080|FG000|Follow Up Period|Withdrawal by Subject|1|||
23571672|NCT01448044|65821081|FG001|Follow Up Period|Withdrawal by Subject|1|||
23571673|NCT01448044|65821080|FG000|Follow Up Period|Lost to Follow-up|6|||
23571674|NCT01448044|65821081|FG001|Follow Up Period|Lost to Follow-up|2|||
23571675|NCT01448044|65821080|FG000|Follow Up Period|Other|5|||
23571676|NCT01448044|65821081|FG001|Follow Up Period|Other|11|||
23770353|NCT01802879|66539525|FG000|Overall Study|Administrative problems|2|||
23770354|NCT01802879|66539525|FG000|Overall Study|Disease progression|6|||
23770355|NCT03992196|66539526|FG000|Enrollment|lost to follow-up prior dosing|1|||
23770356|NCT03992196|66539527|FG001|Enrollment|lost to follow-up prior dosing|0|||
23770357|NCT03992196|66539528|FG002|Enrollment|lost to follow-up prior dosing|0|||
23770358|NCT03992196|66539526|FG000|Treatment|Protocol Violation|0|||
23770359|NCT03992196|66539527|FG001|Treatment|Protocol Violation|0|||
23770360|NCT03992196|66539528|FG002|Treatment|Protocol Violation|1|||
23770361|NCT03992196|66539526|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
23770362|NCT03992196|66539527|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
23770363|NCT03992196|66539528|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
23770364|NCT03992196|66539526|FG000|Treatment|Withdrawal due to non-compliance|0|||
23830833|NCT00287586|66760009|FG000|Overall Study|Lung Cancer|0|||
23830834|NCT00287586|66760010|FG001|Overall Study|Lung Cancer|2|||
23571677|NCT01990300|65821082|FG000|Overall Study|Case Report Forms Uncollected|89|||
23632369|NCT01053247|66038713|FG002|Overall Study|Withdrawal by Subject|15|||
23632370|NCT01053247|66038711|FG000|Overall Study|Lack of Efficacy|1|||
23571678|NCT01990300|65821082|FG000|Overall Study|Protocol Deviation|53|||
23770365|NCT03992196|66539527|FG001|Treatment|Withdrawal due to non-compliance|0|||
23571679|NCT01234649|65821086|FG000|Overall Study|Withdrawal by Subject|32|||
23571680|NCT01234649|65821087|FG001|Overall Study|Withdrawal by Subject|26|||
23571681|NCT01234649|65821086|FG000|Overall Study|Pregnancy|6|||
23830835|NCT00287586|66760009|FG000|Overall Study|Elevated IPSS Score|0|||
23632371|NCT01053247|66038712|FG001|Overall Study|Lack of Efficacy|0|||
23830836|NCT00287586|66760010|FG001|Overall Study|Elevated IPSS Score|1|||
23830837|NCT00287586|66760009|FG000|Overall Study|Retroperitoneal Cancer|0|||
23830838|NCT00287586|66760010|FG001|Overall Study|Retroperitoneal Cancer|1|||
23830839|NCT00287586|66760009|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
23830840|NCT00287586|66760010|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
23830841|NCT00287586|66760009|FG000|Overall Study|Mood Swings and Irritability|0|||
23830842|NCT00287586|66760010|FG001|Overall Study|Mood Swings and Irritability|1|||
23830843|NCT00287586|66760009|FG000|Overall Study|Bradycardia|0|||
23830844|NCT00287586|66760010|FG001|Overall Study|Bradycardia|1|||
23830845|NCT00287586|66760009|FG000|Overall Study|Itchy Swollen Eyes|0|||
23830846|NCT00287586|66760010|FG001|Overall Study|Itchy Swollen Eyes|1|||
23830847|NCT00287586|66760009|FG000|Overall Study|Recurrent Melanoma|0|||
23830848|NCT00287586|66760010|FG001|Overall Study|Recurrent Melanoma|1|||
23770366|NCT03992196|66539528|FG002|Treatment|Withdrawal due to non-compliance|1|||
23770367|NCT03992196|66539526|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
23770368|NCT03992196|66539527|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
23770369|NCT03992196|66539528|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
23770370|NCT03992196|66539526|FG000|Treatment|Withdrawal by parent/guardian|0|||
23770371|NCT03992196|66539527|FG001|Treatment|Withdrawal by parent/guardian|0|||
23770372|NCT03992196|66539528|FG002|Treatment|Withdrawal by parent/guardian|2|||
23770373|NCT01893138|66539531|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23770374|NCT01893138|66539532|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23770375|NCT01893138|66539531|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
23770376|NCT01893138|66539532|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
23770377|NCT01893138|66539531|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
23770378|NCT01893138|66539532|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
23770379|NCT01893138|66539531|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
23770380|NCT01893138|66539532|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
23770381|NCT01893138|66539531|FG000|Open Label - Unblinded Period|Adverse Event|1|||
23770382|NCT01893138|66539532|FG001|Open Label - Unblinded Period|Adverse Event|0|||
23770383|NCT02343120|66539535|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
23770384|NCT02343120|66539536|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
23770385|NCT02343120|66539537|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
23770386|NCT02343120|66539538|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
23770387|NCT02343120|66539539|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
23830849|NCT01199939|66760021|FG000|Overall Study|Adverse Event|4|||
23830850|NCT01199939|66760021|FG000|Overall Study|Protocol Violation|3|||
23830851|NCT01199939|66760021|FG000|Overall Study|Lost to Follow-up|2|||
23830852|NCT01199939|66760021|FG000|Overall Study|Reached a virologic endpoint|4|||
23830853|NCT00699816|66760024|FG000|Overall Study|Protocol Violation|1|||
23830854|NCT00699816|66760025|FG001|Overall Study|Protocol Violation|3|||
23830855|NCT03839628|66760026|FG000|Overall Study|Withdrawal by Subject|1|||
23830856|NCT02568072|66760027|FG000|Overall Study|Unavailable for appointment|23|||
23830857|NCT02568072|66760027|FG000|Overall Study|Unable to contact|3|||
23770388|NCT02343120|66539535|FG000|Part 1: Dose Escalation|Death|1|||
23770389|NCT02343120|66539536|FG001|Part 1: Dose Escalation|Death|2|||
23770390|NCT02343120|66539537|FG002|Part 1: Dose Escalation|Death|2|||
23770391|NCT02343120|66539538|FG003|Part 1: Dose Escalation|Death|2|||
23830858|NCT02568072|66760027|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
23632372|NCT01053247|66038713|FG002|Overall Study|Lack of Efficacy|1|||
23632373|NCT01053247|66038711|FG000|Overall Study|Protocol Violation|2|||
23632374|NCT01053247|66038712|FG001|Overall Study|Protocol Violation|1|||
23632375|NCT01053247|66038713|FG002|Overall Study|Protocol Violation|2|||
23632376|NCT01053247|66038711|FG000|Overall Study|Lost to Follow-up|8|||
23632377|NCT01053247|66038712|FG001|Overall Study|Lost to Follow-up|5|||
23632378|NCT01053247|66038713|FG002|Overall Study|Lost to Follow-up|7|||
23632379|NCT01053247|66038711|FG000|Overall Study|Adverse Event|0|||
23632380|NCT01053247|66038712|FG001|Overall Study|Adverse Event|9|||
23830859|NCT02568072|66760027|FG000|Overall Study|Withdrawal by Subject|1|||
23830860|NCT02568072|66760027|FG000|Overall Study|Sustained injury, marathon not run|24|||
23830861|NCT02182843|66760028|FG000|Overall Study|Withdrawal by Subject|7|||
23830862|NCT02182843|66760028|FG000|Overall Study|Lost to Follow-up|2|||
23830863|NCT02182843|66760028|FG000|Overall Study|Adverse Event|1|||
23830864|NCT02604407|66760029|FG000|Overall Study|Adverse Event|0|||
23632381|NCT01053247|66038713|FG002|Overall Study|Adverse Event|3|||
23632382|NCT01245374|66038714|FG000|Overall Study|Protocol Violation|1|||
23632383|NCT01245374|66038714|FG000|Overall Study|Withdrawal by Subject|3|||
23632384|NCT01144377|66038715|FG000|52 Week Treatment Period|Adverse Event|0|||
23830865|NCT02604407|66760030|FG001|Overall Study|Adverse Event|7|||
23632385|NCT01144377|66038716|FG001|52 Week Treatment Period|Adverse Event|0|||
23632386|NCT01144377|66038717|FG002|52 Week Treatment Period|Adverse Event|3|||
23830866|NCT02604407|66760031|FG002|Overall Study|Adverse Event|5|||
23830867|NCT02604407|66760029|FG000|Overall Study|Protocol Violation|2|||
23830868|NCT02604407|66760030|FG001|Overall Study|Protocol Violation|0|||
23830869|NCT02604407|66760031|FG002|Overall Study|Protocol Violation|0|||
23830870|NCT02604407|66760029|FG000|Overall Study|Withdrawal by Subject|3|||
23830871|NCT02604407|66760030|FG001|Overall Study|Withdrawal by Subject|3|||
23830872|NCT02604407|66760031|FG002|Overall Study|Withdrawal by Subject|5|||
23830873|NCT02604407|66760029|FG000|Overall Study|Lost to Follow-up|2|||
23830874|NCT02604407|66760030|FG001|Overall Study|Lost to Follow-up|1|||
23830875|NCT02604407|66760031|FG002|Overall Study|Lost to Follow-up|2|||
23830876|NCT02604407|66760029|FG000|Overall Study|Lack of Efficacy|1|||
23830877|NCT02604407|66760030|FG001|Overall Study|Lack of Efficacy|0|||
23830878|NCT02604407|66760031|FG002|Overall Study|Lack of Efficacy|0|||
23830879|NCT02604407|66760029|FG000|Overall Study|Other|3|||
23830880|NCT02604407|66760030|FG001|Overall Study|Other|1|||
23830881|NCT02604407|66760031|FG002|Overall Study|Other|4|||
23830882|NCT03539302|66760032|FG000|Overall Study|Spontaneous cardio version|0|||
23830883|NCT03539302|66760033|FG001|Overall Study|Spontaneous cardio version|0|||
23830884|NCT03539302|66760034|FG002|Overall Study|Spontaneous cardio version|0|||
23830885|NCT03539302|66760035|FG003|Overall Study|Spontaneous cardio version|0|||
23830886|NCT03539302|66760036|FG004|Overall Study|Spontaneous cardio version|0|||
23830887|NCT03539302|66760037|FG005|Overall Study|Spontaneous cardio version|1|||
23830888|NCT03539302|66760038|FG006|Overall Study|Spontaneous cardio version|1|||
23830889|NCT01202175|66760045|FG000|Overall Study|Lost to Follow-up|2|||
23830890|NCT01202175|66760045|FG000|Overall Study|Withdrawal by Subject|1|||
23830891|NCT01202175|66760045|FG000|Overall Study|Adverse Event|2|||
23830892|NCT01169350|66760049|FG000|Overall Study|Physician Decision|3|||
23830893|NCT01169350|66760049|FG000|Overall Study|Lost to Follow-up|2|||
23830894|NCT00071110|66760050|FG000|Overall Study|Protocol Violation|0|||
23830895|NCT00071110|66760051|FG001|Overall Study|Protocol Violation|4|||
23830896|NCT03411863|66760055|FG000|Overall Study|Withdrawal by Subject|3|||
23830897|NCT03411863|66760056|FG001|Overall Study|Withdrawal by Subject|1|||
23830898|NCT03411863|66760055|FG000|Overall Study|Physician Decision|0|||
23830899|NCT03411863|66760056|FG001|Overall Study|Physician Decision|1|||
23830900|NCT01068860|66760057|FG000|Overall Study|Withdrawal by Subject|0|||
23830901|NCT01068860|66760058|FG001|Overall Study|Withdrawal by Subject|0|||
23571682|NCT01234649|65821087|FG001|Overall Study|Pregnancy|6|||
23571683|NCT01234649|65821086|FG000|Overall Study|intolerant to side effects|4|||
23571684|NCT01234649|65821087|FG001|Overall Study|intolerant to side effects|3|||
23571685|NCT01234649|65821086|FG000|Overall Study|Allergic reaction|1|||
23571686|NCT01234649|65821087|FG001|Overall Study|Allergic reaction|0|||
23571687|NCT01234649|65821086|FG000|Overall Study|Lack of Efficacy|0|||
23571688|NCT01234649|65821087|FG001|Overall Study|Lack of Efficacy|3|||
23571689|NCT01586338|65821092|FG000|Overall Study|Adverse Event|3|||
23571690|NCT01586338|65821092|FG000|Overall Study|Lost to Follow-up|1|||
23830902|NCT01068860|66760059|FG002|Overall Study|Withdrawal by Subject|0|||
23830903|NCT01068860|66760060|FG003|Overall Study|Withdrawal by Subject|0|||
23830904|NCT01068860|66760061|FG004|Overall Study|Withdrawal by Subject|0|||
23830905|NCT01068860|66760062|FG005|Overall Study|Withdrawal by Subject|2|||
23830906|NCT01068860|66760063|FG006|Overall Study|Withdrawal by Subject|0|||
23830907|NCT01068860|66760064|FG007|Overall Study|Withdrawal by Subject|0|||
23830908|NCT01068860|66760065|FG008|Overall Study|Withdrawal by Subject|0|||
23830909|NCT01068860|66760066|FG009|Overall Study|Withdrawal by Subject|3|||
23830910|NCT01068860|66760057|FG000|Overall Study|Administrative problems; misrandomized|0|||
23830911|NCT01068860|66760058|FG001|Overall Study|Administrative problems; misrandomized|0|||
23830912|NCT01068860|66760059|FG002|Overall Study|Administrative problems; misrandomized|0|||
23830913|NCT01068860|66760060|FG003|Overall Study|Administrative problems; misrandomized|1|||
23830914|NCT01068860|66760061|FG004|Overall Study|Administrative problems; misrandomized|0|||
23830915|NCT01068860|66760062|FG005|Overall Study|Administrative problems; misrandomized|0|||
23830916|NCT01068860|66760063|FG006|Overall Study|Administrative problems; misrandomized|0|||
23830917|NCT01068860|66760064|FG007|Overall Study|Administrative problems; misrandomized|0|||
23830918|NCT01068860|66760065|FG008|Overall Study|Administrative problems; misrandomized|0|||
23830919|NCT01068860|66760066|FG009|Overall Study|Administrative problems; misrandomized|1|||
23830920|NCT01068860|66760057|FG000|Overall Study|Lost to Follow-up|0|||
23830921|NCT01068860|66760058|FG001|Overall Study|Lost to Follow-up|1|||
23571691|NCT01586338|65821092|FG000|Overall Study|Withdrawal by participant|3|||
23571692|NCT01586338|65821092|FG000|Overall Study|Other|1|||
23571693|NCT02065570|65821093|FG000|Induction Study|Adverse Event|5|||
23830922|NCT01068860|66760059|FG002|Overall Study|Lost to Follow-up|0|||
23830923|NCT01068860|66760060|FG003|Overall Study|Lost to Follow-up|0|||
23830924|NCT01068860|66760061|FG004|Overall Study|Lost to Follow-up|0|||
23632387|NCT01144377|66038718|FG003|52 Week Treatment Period|Adverse Event|2|||
23830925|NCT01068860|66760062|FG005|Overall Study|Lost to Follow-up|0|||
23830926|NCT01068860|66760063|FG006|Overall Study|Lost to Follow-up|0|||
23830927|NCT01068860|66760064|FG007|Overall Study|Lost to Follow-up|0|||
23830928|NCT01068860|66760065|FG008|Overall Study|Lost to Follow-up|0|||
23830929|NCT01068860|66760066|FG009|Overall Study|Lost to Follow-up|0|||
23830930|NCT02633293|66760078|FG000|Overall Study|Death|56|||
23830931|NCT02633293|66760078|FG000|Overall Study|Progressive Disease|12|||
23830932|NCT02633293|66760078|FG000|Overall Study|Adverse Event|29|||
23830933|NCT02633293|66760078|FG000|Overall Study|Withdrawal by Subject|41|||
23447139|NCT00502671|65377880|FG000|Overall Study|Lost to Follow-up|7|||
23447140|NCT00502671|65377880|FG000|Overall Study|Protocol Violation|16|||
23447141|NCT00502671|65377880|FG000|Overall Study|Adverse Event|19|||
23447142|NCT00872599|65377881|FG000|Second Washout Period|Adverse Event|1|||
23447143|NCT00872599|65377882|FG001|Second Washout Period|Adverse Event|1|||
23447144|NCT03359174|65377883|FG000|Overall Study|Adverse Event|1|||
23447145|NCT00483405|65377886|FG000|Overall Study|Adverse Event|8|||
23447146|NCT00483405|65377886|FG000|Overall Study|Lack of Efficacy|14|||
23447147|NCT00483405|65377886|FG000|Overall Study|Death|3|||
23447148|NCT00483405|65377886|FG000|Overall Study|Withdrawal by Subject|2|||
23447149|NCT00483405|65377886|FG000|Overall Study|Other complicating disease|1|||
23447150|NCT01964963|65377887|FG000|Overall Study|Case Report Forms Uncollected|888|||
23447151|NCT01964963|65377887|FG000|Overall Study|Protocol Deviation|50|||
23447152|NCT01964963|65377887|FG000|Overall Study|Data Reliability was not Assured|5|||
23447153|NCT02756338|65377892|FG000|Overall Study|Withdrawn by Investigator|1|||
23447154|NCT02756338|65377892|FG000|Overall Study|Device Replaced with Pacemaker|4|||
23447155|NCT00596752|65377896|FG000|Overall Study|Other Reason|44|||
23571694|NCT02065570|65821094|FG001|Induction Study|Adverse Event|12|||
23571695|NCT02065570|65821095|FG002|Induction Study|Adverse Event|0|||
23571696|NCT02065570|65821096|FG003|Induction Study|Adverse Event|0|||
23571697|NCT02065570|65821093|FG000|Induction Study|Withdrawal by Subject|2|||
23571698|NCT02065570|65821094|FG001|Induction Study|Withdrawal by Subject|3|||
23571699|NCT02065570|65821095|FG002|Induction Study|Withdrawal by Subject|0|||
23571700|NCT02065570|65821096|FG003|Induction Study|Withdrawal by Subject|0|||
23571701|NCT02065570|65821093|FG000|Induction Study|Lost to Follow-up|1|||
23571702|NCT02065570|65821094|FG001|Induction Study|Lost to Follow-up|1|||
23571703|NCT02065570|65821095|FG002|Induction Study|Lost to Follow-up|0|||
23571704|NCT02065570|65821096|FG003|Induction Study|Lost to Follow-up|0|||
23571705|NCT02065570|65821093|FG000|Induction Study|Other, Not Specified|6|||
23571706|NCT02065570|65821094|FG001|Induction Study|Other, Not Specified|5|||
23571707|NCT02065570|65821095|FG002|Induction Study|Other, Not Specified|0|||
23632388|NCT01144377|66038719|FG004|52 Week Treatment Period|Adverse Event|1|||
23447156|NCT00596752|65377897|FG001|Overall Study|Other Reason|49|||
23447157|NCT00596752|65377896|FG000|Overall Study|Adverse Event|34|||
23571708|NCT02065570|65821096|FG003|Induction Study|Other, Not Specified|0|||
23571709|NCT02065570|65821093|FG000|Maintenance Study|Adverse Event|0|||
23571710|NCT02065570|65821094|FG001|Maintenance Study|Adverse Event|0|||
23571711|NCT02065570|65821095|FG002|Maintenance Study|Adverse Event|8|||
23632389|NCT01144377|66038715|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
23632390|NCT01144377|66038716|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
23632391|NCT01144377|66038717|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
23632392|NCT01144377|66038718|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
23632393|NCT01144377|66038719|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
23632394|NCT01144377|66038715|FG000|52 Week Treatment Period|Protocol Violation|0|||
23632395|NCT01144377|66038716|FG001|52 Week Treatment Period|Protocol Violation|0|||
23632396|NCT01144377|66038717|FG002|52 Week Treatment Period|Protocol Violation|0|||
23632397|NCT01144377|66038718|FG003|52 Week Treatment Period|Protocol Violation|0|||
23632398|NCT01144377|66038719|FG004|52 Week Treatment Period|Protocol Violation|1|||
23632399|NCT01144377|66038715|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
23632400|NCT01144377|66038716|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
23632401|NCT01144377|66038717|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
23632402|NCT01144377|66038718|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
23632403|NCT01144377|66038719|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
23632404|NCT01144377|66038715|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
23632405|NCT01144377|66038716|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
23632406|NCT01144377|66038717|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
23632407|NCT01144377|66038718|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
23632408|NCT01144377|66038719|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
23632409|NCT01144377|66038715|FG000|52 Week Treatment Period|Sponsor Decision|0|||
23632410|NCT01144377|66038716|FG001|52 Week Treatment Period|Sponsor Decision|0|||
23770392|NCT02343120|66539539|FG004|Part 1: Dose Escalation|Death|1|||
23770393|NCT02343120|66539535|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
23770394|NCT02343120|66539536|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
23770395|NCT02343120|66539537|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
23770396|NCT02343120|66539538|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
23770397|NCT02343120|66539539|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
23770398|NCT02343120|66539535|FG000|Part 2: Expansion|Sponsor decision|0|||
23770399|NCT02343120|66539536|FG001|Part 2: Expansion|Sponsor decision|0|||
23770400|NCT02343120|66539537|FG002|Part 2: Expansion|Sponsor decision|0|||
23770401|NCT02343120|66539538|FG003|Part 2: Expansion|Sponsor decision|165|||
23770402|NCT02343120|66539539|FG004|Part 2: Expansion|Sponsor decision|67|||
23770403|NCT02343120|66539535|FG000|Part 2: Expansion|Death|0|||
23770404|NCT02343120|66539536|FG001|Part 2: Expansion|Death|0|||
23571712|NCT02065570|65821096|FG003|Maintenance Study|Adverse Event|8|||
23770405|NCT02343120|66539537|FG002|Part 2: Expansion|Death|0|||
23770406|NCT02343120|66539538|FG003|Part 2: Expansion|Death|74|||
23447158|NCT00596752|65377897|FG001|Overall Study|Adverse Event|34|||
23447159|NCT00596752|65377896|FG000|Overall Study|Lost to Follow-up|22|||
23447160|NCT00596752|65377897|FG001|Overall Study|Lost to Follow-up|38|||
23447161|NCT00596752|65377896|FG000|Overall Study|Withdrawal by Subject|12|||
23830934|NCT02633293|66760078|FG000|Overall Study|Protocol Violation|1|||
23830935|NCT02633293|66760078|FG000|Overall Study|Lost to Follow-up|1|||
23830936|NCT02633293|66760078|FG000|Overall Study|Study Terminated by Sponsor|24|||
23830937|NCT02633293|66760078|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
23830938|NCT02633293|66760078|FG000|Overall Study|Lung Transplant|5|||
23830939|NCT02633293|66760078|FG000|Overall Study|Lack of Efficacy|2|||
23830940|NCT02633293|66760078|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
23830941|NCT00586703|66760081|FG000|Overall Study|Death|12|||
23770407|NCT02343120|66539539|FG004|Part 2: Expansion|Death|17|||
23770408|NCT02343120|66539535|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
23770409|NCT02343120|66539536|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
23770410|NCT02343120|66539537|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
23770411|NCT02343120|66539538|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
23770412|NCT02343120|66539539|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
23770413|NCT02343120|66539535|FG000|Part 2: Expansion|Lost to Follow-up|0|||
23770414|NCT02343120|66539536|FG001|Part 2: Expansion|Lost to Follow-up|0|||
23770415|NCT02343120|66539537|FG002|Part 2: Expansion|Lost to Follow-up|0|||
23770416|NCT02343120|66539538|FG003|Part 2: Expansion|Lost to Follow-up|5|||
23770417|NCT02343120|66539539|FG004|Part 2: Expansion|Lost to Follow-up|2|||
23830942|NCT04982575|66760085|FG000|Overall Study|Withdrawal by Subject|2|||
23830943|NCT04982575|66760086|FG001|Overall Study|Withdrawal by Subject|0|||
23830944|NCT04982575|66760087|FG002|Overall Study|Withdrawal by Subject|2|||
23830945|NCT00359424|66760088|FG000|Overall Study|Death|99|||
23830946|NCT00359424|66760089|FG001|Overall Study|Death|58|||
23830947|NCT00359424|66760088|FG000|Overall Study|Lost to Follow-up|19|||
23830948|NCT00359424|66760089|FG001|Overall Study|Lost to Follow-up|7|||
23830949|NCT00359424|66760088|FG000|Overall Study|Withdrawal by Subject|10|||
23830950|NCT00359424|66760089|FG001|Overall Study|Withdrawal by Subject|2|||
23830951|NCT00359424|66760088|FG000|Overall Study|follow up not conducted|2|||
23830952|NCT00359424|66760089|FG001|Overall Study|follow up not conducted|0|||
23830953|NCT00942357|66760090|FG000|Overall Study|Ineligible|37|||
23830954|NCT00942357|66760091|FG001|Overall Study|Ineligible|40|||
23830955|NCT01841593|66760092|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
23830956|NCT01841593|66760093|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
23830957|NCT01841593|66760092|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
23830958|NCT01841593|66760093|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
23830959|NCT01499095|66760096|FG000|Overall Study|Randomized But Not Treated|1|||
23830960|NCT01499095|66760097|FG001|Overall Study|Randomized But Not Treated|1|||
23830961|NCT01499095|66760096|FG000|Overall Study|Adverse Event|12|||
23830962|NCT01499095|66760097|FG001|Overall Study|Adverse Event|7|||
23830963|NCT01499095|66760096|FG000|Overall Study|Lack of Efficacy|2|||
23830964|NCT01499095|66760097|FG001|Overall Study|Lack of Efficacy|1|||
23830965|NCT01499095|66760096|FG000|Overall Study|Protocol Violation|6|||
23830966|NCT01499095|66760097|FG001|Overall Study|Protocol Violation|7|||
23830967|NCT01499095|66760096|FG000|Overall Study|Received Rescue Therapy|32|||
23830968|NCT01499095|66760097|FG001|Overall Study|Received Rescue Therapy|40|||
23830969|NCT01499095|66760096|FG000|Overall Study|Diverse Reasons|22|||
23830970|NCT01499095|66760097|FG001|Overall Study|Diverse Reasons|25|||
23830971|NCT01499095|66760096|FG000|Overall Study|Lost to Follow-up|6|||
23830972|NCT01499095|66760097|FG001|Overall Study|Lost to Follow-up|4|||
23830973|NCT01499095|66760096|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
23830974|NCT01499095|66760097|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
23830975|NCT01499095|66760096|FG000|Overall Study|Hypoglycemia|3|||
23830976|NCT01499095|66760097|FG001|Overall Study|Hypoglycemia|1|||
23830977|NCT01499095|66760096|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
23830978|NCT01499095|66760097|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
23830979|NCT01499095|66760096|FG000|Overall Study|Change in Injection Schedule|2|||
23447162|NCT00596752|65377897|FG001|Overall Study|Withdrawal by Subject|9|||
23770418|NCT02343120|66539535|FG000|Part 2: Expansion|Other|0|||
23770419|NCT02343120|66539536|FG001|Part 2: Expansion|Other|0|||
23830980|NCT01499095|66760097|FG001|Overall Study|Change in Injection Schedule|0|||
23830981|NCT01499095|66760096|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23447163|NCT00596752|65377896|FG000|Overall Study|Unsatisfactory Compliance|9|||
23770420|NCT02343120|66539537|FG002|Part 2: Expansion|Other|0|||
23830982|NCT01499095|66760097|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23830983|NCT01433471|66760100|FG000|Overall Study|Withdrawal by Subject|0|||
23830984|NCT01433471|66760101|FG001|Overall Study|Withdrawal by Subject|1|||
23830985|NCT01791894|66760103|FG000|Overall Study|Adverse Event|1|||
23830986|NCT01778855|66760106|FG000|Overall Study|Death|0|||
23830987|NCT01778855|66760107|FG001|Overall Study|Death|1|||
23830988|NCT02291237|66760108|FG000|Overall Study|Study Terminated by Sponsor|72|||
23770421|NCT02343120|66539538|FG003|Part 2: Expansion|Other|1|||
23770422|NCT02343120|66539539|FG004|Part 2: Expansion|Other|5|||
23830989|NCT02291237|66760109|FG001|Overall Study|Study Terminated by Sponsor|67|||
23830990|NCT02291237|66760108|FG000|Overall Study|Adverse Event|1|||
23830991|NCT02291237|66760109|FG001|Overall Study|Adverse Event|3|||
23830992|NCT02291237|66760108|FG000|Overall Study|Investigator's Discretion|0|||
23830993|NCT02291237|66760109|FG001|Overall Study|Investigator's Discretion|3|||
23830994|NCT02291237|66760108|FG000|Overall Study|Withdrew Consent|11|||
23830995|NCT02291237|66760109|FG001|Overall Study|Withdrew Consent|11|||
23830996|NCT02291237|66760108|FG000|Overall Study|Lost to Follow-up|0|||
23830997|NCT02291237|66760109|FG001|Overall Study|Lost to Follow-up|2|||
23830998|NCT02291237|66760108|FG000|Overall Study|Subject Required Prohibited Medication|2|||
23830999|NCT02291237|66760109|FG001|Overall Study|Subject Required Prohibited Medication|0|||
23831000|NCT01942993|66760110|FG000|Overall Study|Lost to Follow-up|1|||
23831001|NCT01942993|66760110|FG000|Overall Study|Physician Decision|1|||
23831002|NCT00350207|66760111|FG000|Overall Study|Adverse Event|5|||
23831003|NCT00350207|66760112|FG001|Overall Study|Adverse Event|2|||
23831004|NCT00350207|66760113|FG002|Overall Study|Adverse Event|2|||
23831005|NCT00350207|66760111|FG000|Overall Study|Lack of Efficacy|1|||
23831006|NCT00350207|66760112|FG001|Overall Study|Lack of Efficacy|0|||
23831007|NCT00350207|66760113|FG002|Overall Study|Lack of Efficacy|2|||
23831008|NCT00350207|66760111|FG000|Overall Study|Lost to Follow-up|1|||
23831009|NCT00350207|66760112|FG001|Overall Study|Lost to Follow-up|0|||
23831010|NCT00350207|66760113|FG002|Overall Study|Lost to Follow-up|1|||
23831011|NCT00350207|66760111|FG000|Overall Study|Withdrawal by Subject|0|||
23831012|NCT00350207|66760112|FG001|Overall Study|Withdrawal by Subject|1|||
23831013|NCT00350207|66760113|FG002|Overall Study|Withdrawal by Subject|1|||
23831014|NCT00350207|66760111|FG000|Overall Study|Other|1|||
23831015|NCT00350207|66760112|FG001|Overall Study|Other|3|||
23831016|NCT00350207|66760113|FG002|Overall Study|Other|1|||
23831017|NCT03408639|66760116|FG000|Overall Study|Death|5|||
23831018|NCT03408639|66760117|FG001|Overall Study|Death|5|||
23831019|NCT03408639|66760116|FG000|Overall Study|Lost to Follow-up|1|||
23831020|NCT03408639|66760117|FG001|Overall Study|Lost to Follow-up|4|||
23831021|NCT03408639|66760116|FG000|Overall Study|Withdrawal by Subject|2|||
23831022|NCT03408639|66760117|FG001|Overall Study|Withdrawal by Subject|7|||
23831023|NCT03408639|66760116|FG000|Overall Study|Physician Decision|3|||
23831024|NCT03408639|66760117|FG001|Overall Study|Physician Decision|6|||
23831025|NCT02462603|66760118|FG000|Overall Study|Investigator Decision|1|||
23831026|NCT02462603|66760118|FG000|Overall Study|Non-Compliance|1|||
23831027|NCT02462603|66760118|FG000|Overall Study|Withdrawal by Subject|2|||
23831028|NCT01730053|66760120|FG000|Overall Study|Participant moved|0|||
23831029|NCT01730053|66760121|FG001|Overall Study|Participant moved|0|||
23831030|NCT01730053|66760122|FG002|Overall Study|Participant moved|1|||
23831031|NCT01730053|66760123|FG003|Overall Study|Participant moved|0|||
23831032|NCT01730053|66760124|FG004|Overall Study|Participant moved|0|||
23831033|NCT01730053|66760125|FG005|Overall Study|Participant moved|0|||
23831034|NCT01730053|66760120|FG000|Overall Study|Physician Decision|0|||
23831035|NCT01730053|66760121|FG001|Overall Study|Physician Decision|0|||
23831036|NCT01730053|66760122|FG002|Overall Study|Physician Decision|0|||
23831037|NCT01730053|66760123|FG003|Overall Study|Physician Decision|1|||
23831038|NCT01730053|66760124|FG004|Overall Study|Physician Decision|0|||
23831039|NCT01730053|66760125|FG005|Overall Study|Physician Decision|0|||
23831040|NCT01730053|66760120|FG000|Overall Study|Adverse Event|2|||
23831041|NCT01730053|66760121|FG001|Overall Study|Adverse Event|6|||
23831042|NCT01730053|66760122|FG002|Overall Study|Adverse Event|3|||
23831043|NCT01730053|66760123|FG003|Overall Study|Adverse Event|3|||
23831044|NCT01730053|66760124|FG004|Overall Study|Adverse Event|2|||
23831045|NCT01730053|66760125|FG005|Overall Study|Adverse Event|2|||
23831046|NCT01730053|66760120|FG000|Overall Study|Poor compliance to protocol|1|||
23831047|NCT01730053|66760121|FG001|Overall Study|Poor compliance to protocol|2|||
23831048|NCT01730053|66760122|FG002|Overall Study|Poor compliance to protocol|2|||
23831049|NCT01730053|66760123|FG003|Overall Study|Poor compliance to protocol|0|||
23831050|NCT01730053|66760124|FG004|Overall Study|Poor compliance to protocol|0|||
23831051|NCT01730053|66760125|FG005|Overall Study|Poor compliance to protocol|2|||
23831052|NCT01730053|66760120|FG000|Overall Study|Other than specified|2|||
23831053|NCT01730053|66760121|FG001|Overall Study|Other than specified|6|||
23831054|NCT01730053|66760122|FG002|Overall Study|Other than specified|5|||
23831055|NCT01730053|66760123|FG003|Overall Study|Other than specified|4|||
23831056|NCT01730053|66760124|FG004|Overall Study|Other than specified|7|||
23831057|NCT01730053|66760125|FG005|Overall Study|Other than specified|9|||
23831058|NCT01686373|66760128|FG000|Overall Study|Lost to Follow-up|3|||
23831059|NCT01686373|66760129|FG001|Overall Study|Lost to Follow-up|0|||
23831060|NCT01686373|66760128|FG000|Overall Study|Withdrawal by Subject|0|||
23831061|NCT01686373|66760129|FG001|Overall Study|Withdrawal by Subject|1|||
23831062|NCT01686373|66760128|FG000|Overall Study|Adverse Event|0|||
23831063|NCT01686373|66760129|FG001|Overall Study|Adverse Event|1|||
23831064|NCT00725920|66760130|FG000|Overall Study|Lack of Efficacy|3|||
23831065|NCT00725920|66760131|FG001|Overall Study|Lack of Efficacy|6|||
23831066|NCT01402570|66760137|FG000|Overall Study|Adverse Event|1|||
23831067|NCT03627546|66760138|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
23831068|NCT03627546|66760139|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
23831069|NCT03627546|66760140|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
23831070|NCT03627546|66760138|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
23831071|NCT03627546|66760139|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
23831072|NCT03627546|66760140|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
23831073|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Other|34|||
23831074|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Other|0|||
23831075|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Other|0|||
23831076|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Other|0|||
23571713|NCT02065570|65821093|FG000|Maintenance Study|Withdrawal by Subject|0|||
23571714|NCT02065570|65821094|FG001|Maintenance Study|Withdrawal by Subject|0|||
23571715|NCT02065570|65821095|FG002|Maintenance Study|Withdrawal by Subject|1|||
23571716|NCT02065570|65821096|FG003|Maintenance Study|Withdrawal by Subject|4|||
23571717|NCT02065570|65821093|FG000|Maintenance Study|Lost to Follow-up|0|||
23571718|NCT02065570|65821094|FG001|Maintenance Study|Lost to Follow-up|0|||
23571719|NCT02065570|65821095|FG002|Maintenance Study|Lost to Follow-up|2|||
23571720|NCT02065570|65821096|FG003|Maintenance Study|Lost to Follow-up|2|||
23571721|NCT02065570|65821093|FG000|Maintenance Study|Other, Not Specified|0|||
23571722|NCT02065570|65821094|FG001|Maintenance Study|Other, Not Specified|0|||
23571723|NCT02065570|65821095|FG002|Maintenance Study|Other, Not Specified|11|||
23571724|NCT02065570|65821096|FG003|Maintenance Study|Other, Not Specified|5|||
23571725|NCT04445155|65821101|FG000|Overall Study|Lost to Follow-up|11|||
23571726|NCT04445155|65821102|FG001|Overall Study|Lost to Follow-up|2|||
23571727|NCT04445155|65821103|FG002|Overall Study|Lost to Follow-up|3|||
23571728|NCT04445155|65821104|FG003|Overall Study|Lost to Follow-up|0|||
23571729|NCT04445155|65821101|FG000|Overall Study|Withdrawal by Subject|8|||
23571730|NCT04445155|65821102|FG001|Overall Study|Withdrawal by Subject|0|||
23571731|NCT04445155|65821103|FG002|Overall Study|Withdrawal by Subject|0|||
23571732|NCT04445155|65821104|FG003|Overall Study|Withdrawal by Subject|0|||
23571733|NCT04445155|65821101|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
23571734|NCT04445155|65821102|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571735|NCT04445155|65821103|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571736|NCT04445155|65821104|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571737|NCT04445155|65821101|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
23571738|NCT04445155|65821102|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571739|NCT04445155|65821103|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571740|NCT04445155|65821104|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571741|NCT01513967|65824532|FG000|Overall Study|Pregnancy|0|||
23571742|NCT01513967|65824533|FG001|Overall Study|Pregnancy|0|||
23571743|NCT01513967|65824534|FG002|Overall Study|Pregnancy|0|||
23571744|NCT01513967|65824535|FG003|Overall Study|Pregnancy|0|||
23571745|NCT01513967|65824536|FG004|Overall Study|Pregnancy|0|||
23571746|NCT01513967|65824537|FG005|Overall Study|Pregnancy|0|||
23571747|NCT01513967|65824538|FG006|Overall Study|Pregnancy|1|||
23571748|NCT01513967|65824539|FG007|Overall Study|Pregnancy|0|||
23831077|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Death|14|||
23831078|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Death|0|||
23831079|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Death|0|||
23571749|NCT01513967|65824532|FG000|Overall Study|missed a study visit|0|||
23831080|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Death|0|||
23831081|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
23831082|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
23831083|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
23831084|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
23831085|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
23831086|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23831087|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23831088|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23831089|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
23831090|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
23831091|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
23831092|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
23831093|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
23831094|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23831095|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23831096|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23831097|NCT01995513|66760143|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
23831098|NCT01995513|66760144|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23831099|NCT01995513|66760145|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23831100|NCT01995513|66760146|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23831101|NCT01995513|66760143|FG000|Period 1: Second Open Label Treatment|Other|0|||
23831102|NCT01995513|66760144|FG001|Period 1: Second Open Label Treatment|Other|2|||
23831103|NCT01995513|66760145|FG002|Period 1: Second Open Label Treatment|Other|0|||
23831104|NCT01995513|66760146|FG003|Period 1: Second Open Label Treatment|Other|0|||
23831105|NCT01995513|66760143|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
23831106|NCT01995513|66760144|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
23831107|NCT01995513|66760145|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
23831108|NCT01995513|66760146|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
23831109|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Death|0|||
23831110|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Death|0|||
23831111|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Death|0|||
23831112|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Death|1|||
23831113|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Other|0|||
23831114|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Other|0|||
23831115|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Other|3|||
23831116|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Other|3|||
23831117|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
23831118|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
23831119|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
23831120|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
23831121|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
23831122|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
23831123|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
23831124|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
23831125|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
23831126|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
23831127|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
23831128|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
23831129|NCT01995513|66760143|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23831130|NCT01995513|66760144|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23571750|NCT01513967|65824533|FG001|Overall Study|missed a study visit|0|||
23571751|NCT01513967|65824534|FG002|Overall Study|missed a study visit|0|||
23571752|NCT01513967|65824535|FG003|Overall Study|missed a study visit|0|||
23571753|NCT01513967|65824536|FG004|Overall Study|missed a study visit|0|||
23571754|NCT01513967|65824537|FG005|Overall Study|missed a study visit|0|||
23571755|NCT01513967|65824538|FG006|Overall Study|missed a study visit|1|||
23571756|NCT01513967|65824539|FG007|Overall Study|missed a study visit|0|||
23571757|NCT01513967|65824532|FG000|Overall Study|excluded due to positive drug screen|0|||
23571758|NCT01513967|65824533|FG001|Overall Study|excluded due to positive drug screen|0|||
23571759|NCT01513967|65824534|FG002|Overall Study|excluded due to positive drug screen|0|||
23571760|NCT01513967|65824535|FG003|Overall Study|excluded due to positive drug screen|0|||
23571761|NCT01513967|65824536|FG004|Overall Study|excluded due to positive drug screen|0|||
23571762|NCT01513967|65824537|FG005|Overall Study|excluded due to positive drug screen|0|||
23571763|NCT01513967|65824538|FG006|Overall Study|excluded due to positive drug screen|0|||
23831131|NCT01995513|66760145|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23831132|NCT01995513|66760146|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
23831133|NCT04515147|66760156|FG000|Overall Study|Withdrawal by Subject|1|||
23831134|NCT04515147|66760157|FG001|Overall Study|Withdrawal by Subject|0|||
23831135|NCT04515147|66760158|FG002|Overall Study|Withdrawal by Subject|10|||
23831136|NCT04515147|66760159|FG003|Overall Study|Withdrawal by Subject|18|||
23831137|NCT04515147|66760160|FG004|Overall Study|Withdrawal by Subject|1|||
23831138|NCT04515147|66760161|FG005|Overall Study|Withdrawal by Subject|8|||
23831139|NCT04515147|66760156|FG000|Overall Study|Lost to Follow-up|0|||
23831140|NCT04515147|66760157|FG001|Overall Study|Lost to Follow-up|1|||
23831141|NCT04515147|66760158|FG002|Overall Study|Lost to Follow-up|5|||
23831142|NCT04515147|66760159|FG003|Overall Study|Lost to Follow-up|6|||
23831143|NCT04515147|66760160|FG004|Overall Study|Lost to Follow-up|2|||
23831144|NCT04515147|66760161|FG005|Overall Study|Lost to Follow-up|1|||
23831145|NCT04515147|66760156|FG000|Overall Study|Adverse Event|0|||
23831146|NCT04515147|66760157|FG001|Overall Study|Adverse Event|0|||
23831147|NCT04515147|66760158|FG002|Overall Study|Adverse Event|0|||
23831148|NCT04515147|66760159|FG003|Overall Study|Adverse Event|2|||
23831149|NCT04515147|66760160|FG004|Overall Study|Adverse Event|0|||
23831150|NCT04515147|66760161|FG005|Overall Study|Adverse Event|0|||
23831151|NCT04515147|66760156|FG000|Overall Study|Miscellaneous|0|||
23831152|NCT04515147|66760157|FG001|Overall Study|Miscellaneous|0|||
23831153|NCT04515147|66760158|FG002|Overall Study|Miscellaneous|0|||
23831154|NCT04515147|66760159|FG003|Overall Study|Miscellaneous|1|||
23831155|NCT04515147|66760160|FG004|Overall Study|Miscellaneous|0|||
23831156|NCT04515147|66760161|FG005|Overall Study|Miscellaneous|1|||
23571764|NCT01513967|65824539|FG007|Overall Study|excluded due to positive drug screen|2|||
23571765|NCT01513967|65824532|FG000|Overall Study|Physician Decision|0|||
23571766|NCT01513967|65824533|FG001|Overall Study|Physician Decision|0|||
23571767|NCT01513967|65824534|FG002|Overall Study|Physician Decision|0|||
23571768|NCT01513967|65824535|FG003|Overall Study|Physician Decision|0|||
23571769|NCT01513967|65824536|FG004|Overall Study|Physician Decision|0|||
23571770|NCT01513967|65824537|FG005|Overall Study|Physician Decision|1|||
23571771|NCT01513967|65824538|FG006|Overall Study|Physician Decision|0|||
23571772|NCT01513967|65824539|FG007|Overall Study|Physician Decision|0|||
23571773|NCT03929913|65824542|FG000|Overall Study|Death|4|||
23571774|NCT03929913|65824542|FG000|Overall Study|Lost to Follow-up|1|||
23571775|NCT03929913|65824542|FG000|Overall Study|Failed Procedure|2|||
23571776|NCT02771210|65824543|FG000|Period 1|Adverse Event|5|||
23571777|NCT02771210|65824544|FG001|Period 1|Adverse Event|3|||
23571778|NCT02771210|65824543|FG000|Period 1|Lack of Efficacy|3|||
23571779|NCT02771210|65824544|FG001|Period 1|Lack of Efficacy|6|||
23770423|NCT02343120|66539535|FG000|Part 2: Expansion|Adverse Event|0|||
23770424|NCT02343120|66539536|FG001|Part 2: Expansion|Adverse Event|0|||
23770425|NCT02343120|66539537|FG002|Part 2: Expansion|Adverse Event|0|||
23770426|NCT02343120|66539538|FG003|Part 2: Expansion|Adverse Event|1|||
23571780|NCT02771210|65824543|FG000|Period 1|Lost to Follow-up|2|||
23632411|NCT01144377|66038717|FG002|52 Week Treatment Period|Sponsor Decision|0|||
23632412|NCT01144377|66038718|FG003|52 Week Treatment Period|Sponsor Decision|0|||
23632413|NCT01144377|66038719|FG004|52 Week Treatment Period|Sponsor Decision|1|||
23632414|NCT01144377|66038715|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23632415|NCT01144377|66038716|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
23632416|NCT01144377|66038717|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23632417|NCT01144377|66038718|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23632418|NCT01144377|66038719|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
23632419|NCT01144377|66038715|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23770427|NCT02343120|66539539|FG004|Part 2: Expansion|Adverse Event|1|||
23770428|NCT03294538|66539540|FG000|Overall Study|Adverse Event|0|||
23770429|NCT03294538|66539541|FG001|Overall Study|Adverse Event|1|||
23770430|NCT03294538|66539542|FG002|Overall Study|Adverse Event|1|||
23770431|NCT03294538|66539540|FG000|Overall Study|Lost to Follow-up|1|||
23770432|NCT03294538|66539541|FG001|Overall Study|Lost to Follow-up|0|||
23770433|NCT03294538|66539542|FG002|Overall Study|Lost to Follow-up|0|||
23770434|NCT03294538|66539540|FG000|Overall Study|Outside of Visit Window|4|||
23770435|NCT03294538|66539541|FG001|Overall Study|Outside of Visit Window|4|||
23770436|NCT03294538|66539542|FG002|Overall Study|Outside of Visit Window|1|||
23770437|NCT01364870|66539543|FG000|Overall Study|Withdrawal by Subject|13|||
23831157|NCT00105079|66760168|FG000|Overall Study|Adverse Event|5|||
23831158|NCT00105079|66760169|FG001|Overall Study|Adverse Event|12|||
23831159|NCT00105079|66760168|FG000|Overall Study|Death|3|||
23831160|NCT00105079|66760169|FG001|Overall Study|Death|1|||
23571781|NCT02771210|65824544|FG001|Period 1|Lost to Follow-up|0|||
23571782|NCT02771210|65824543|FG000|Period 1|Physician Decision|0|||
23571783|NCT02771210|65824544|FG001|Period 1|Physician Decision|1|||
23571784|NCT02771210|65824543|FG000|Period 1|Withdrawal by Subject|0|||
23571785|NCT02771210|65824544|FG001|Period 1|Withdrawal by Subject|3|||
23571786|NCT02771210|65824543|FG000|Period 1|Withdrawal of informed consent|1|||
23831161|NCT00105079|66760168|FG000|Overall Study|Lost to Follow-up|12|||
23831162|NCT00105079|66760169|FG001|Overall Study|Lost to Follow-up|12|||
23831163|NCT00105079|66760168|FG000|Overall Study|Lack of Efficacy|9|||
23831164|NCT00105079|66760169|FG001|Overall Study|Lack of Efficacy|3|||
23831165|NCT00105079|66760168|FG000|Overall Study|Refused treatment|6|||
23571787|NCT02771210|65824544|FG001|Period 1|Withdrawal of informed consent|5|||
23571788|NCT02771210|65824543|FG000|Period 2|Adverse Event|1|||
23571789|NCT02771210|65824544|FG001|Period 2|Adverse Event|0|||
23571790|NCT02771210|65824543|FG000|Period 2|Lack of Efficacy|0|||
23571791|NCT02771210|65824544|FG001|Period 2|Lack of Efficacy|1|||
23571792|NCT02771210|65824543|FG000|Period 2|Withdrawal by Subject|1|||
23571793|NCT02771210|65824544|FG001|Period 2|Withdrawal by Subject|0|||
23571794|NCT02771210|65824543|FG000|Period 2|Withdrawal of informed consent|0|||
23571795|NCT02771210|65824544|FG001|Period 2|Withdrawal of informed consent|2|||
23571796|NCT03662997|65824545|FG000|Overall Study|Adverse Event|0|||
23571797|NCT03662997|65824546|FG001|Overall Study|Adverse Event|2|||
23571798|NCT03662997|65824547|FG002|Overall Study|Adverse Event|0|||
23571799|NCT03662997|65824548|FG003|Overall Study|Adverse Event|0|||
23571800|NCT03638635|65824551|FG000|Initial Hospitalization|Study terminated prematurely|0|||
23571801|NCT03638635|65824552|FG001|Initial Hospitalization|Study terminated prematurely|1|||
23571802|NCT03638635|65824551|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
23571803|NCT03638635|65824552|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
23571804|NCT03638635|65824551|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
23632420|NCT01144377|66038716|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23632421|NCT01144377|66038717|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23632422|NCT01144377|66038718|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23632423|NCT01144377|66038719|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
23632424|NCT01144377|66038715|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
23632425|NCT01144377|66038716|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23632426|NCT01144377|66038717|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23632427|NCT01144377|66038718|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23632428|NCT01144377|66038719|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23632429|NCT00121667|66038720|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
23632430|NCT00121667|66038721|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
23632431|NCT00121667|66038722|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
23632432|NCT00121667|66038723|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
23632433|NCT00121667|66038720|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
23632434|NCT00121667|66038721|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
23632435|NCT00121667|66038722|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
23632436|NCT00121667|66038723|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
23632437|NCT00121667|66038720|FG000|Short Term (ST) Period|Adverse Event|5|||
23632438|NCT00121667|66038721|FG001|Short Term (ST) Period|Adverse Event|6|||
23632439|NCT00121667|66038722|FG002|Short Term (ST) Period|Adverse Event|5|||
23632440|NCT00121667|66038723|FG003|Short Term (ST) Period|Adverse Event|3|||
23632441|NCT00121667|66038720|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
23632442|NCT00121667|66038721|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
23632443|NCT00121667|66038722|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
23831166|NCT00105079|66760169|FG001|Overall Study|Refused treatment|4|||
23831167|NCT00105079|66760168|FG000|Overall Study|Violation of selection criteria at entry|0|||
23831168|NCT00105079|66760169|FG001|Overall Study|Violation of selection criteria at entry|2|||
23831169|NCT00105079|66760168|FG000|Overall Study|Protocol Violation|1|||
23831170|NCT00105079|66760169|FG001|Overall Study|Protocol Violation|0|||
23831171|NCT00105079|66760168|FG000|Overall Study|Other|3|||
23831172|NCT00105079|66760169|FG001|Overall Study|Other|1|||
23831173|NCT01894919|66760172|FG000|Overall Study|Withdrawal by Subject|1|||
23831174|NCT01894919|66760173|FG001|Overall Study|Withdrawal by Subject|0|||
23831175|NCT01894919|66760174|FG002|Overall Study|Withdrawal by Subject|0|||
23831176|NCT01894919|66760175|FG003|Overall Study|Withdrawal by Subject|0|||
23447164|NCT00596752|65377897|FG001|Overall Study|Unsatisfactory Compliance|6|||
23571805|NCT03638635|65824552|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
23571806|NCT01058863|65824556|FG000|Overall Study|Lost to Follow-up|1|||
23571807|NCT01058863|65824556|FG000|Overall Study|Withdrawal by Subject|1|||
23571808|NCT01058863|65824556|FG000|Overall Study|Sponsor requested withdrawal|1|||
23571809|NCT01058863|65824556|FG000|Overall Study|Randomized in error|1|||
23571810|NCT05033743|65824557|FG000|Overall Study|Lost to Follow-up|1|||
23571811|NCT05033743|65824557|FG000|Overall Study|Protocol Violation|2|||
23571812|NCT05033743|65824557|FG000|Overall Study|Withdrawal by Subject|1|||
23571813|NCT01313923|65824558|FG000|Overall Study|Physician Decision|3|||
23571814|NCT00988351|65824566|FG000|Overall Study|Withdrawal by Subject|8|||
23571815|NCT00988351|65824567|FG001|Overall Study|Withdrawal by Subject|0|||
23571816|NCT00988351|65824566|FG000|Overall Study|Lost to Follow-up|6|||
23571817|NCT00988351|65824567|FG001|Overall Study|Lost to Follow-up|9|||
23632444|NCT00121667|66038723|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
23571818|NCT00988351|65824566|FG000|Overall Study|not using CPAP|5|||
23571819|NCT00988351|65824567|FG001|Overall Study|not using CPAP|3|||
23632445|NCT00121667|66038720|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
23632446|NCT00121667|66038721|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
23632447|NCT00121667|66038722|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
23831177|NCT01894919|66760176|FG004|Overall Study|Withdrawal by Subject|1|||
23571820|NCT03044353|65824568|FG000|Overall Study|Adverse Event|0|||
23571821|NCT03044353|65824569|FG001|Overall Study|Adverse Event|1|||
23571822|NCT03044353|65824570|FG002|Overall Study|Adverse Event|0|||
23571823|NCT01076088|65824574|FG000|Overall Study|Adverse Event|1|||
23571824|NCT01076088|65824575|FG001|Overall Study|Adverse Event|6|||
23831178|NCT01894919|66760177|FG005|Overall Study|Withdrawal by Subject|0|||
23831179|NCT01894919|66760178|FG006|Overall Study|Withdrawal by Subject|0|||
23831180|NCT01894919|66760179|FG007|Overall Study|Withdrawal by Subject|0|||
23831181|NCT01894919|66760180|FG008|Overall Study|Withdrawal by Subject|0|||
23831182|NCT01894919|66760181|FG009|Overall Study|Withdrawal by Subject|1|||
23831183|NCT01894919|66760182|FG010|Overall Study|Withdrawal by Subject|1|||
23831184|NCT01894919|66760183|FG011|Overall Study|Withdrawal by Subject|0|||
23831185|NCT01894919|66760184|FG012|Overall Study|Withdrawal by Subject|0|||
23831186|NCT01894919|66760172|FG000|Overall Study|Adverse Event|0|||
23831187|NCT01894919|66760173|FG001|Overall Study|Adverse Event|0|||
23831188|NCT01894919|66760174|FG002|Overall Study|Adverse Event|0|||
23831189|NCT01894919|66760175|FG003|Overall Study|Adverse Event|0|||
23831190|NCT01894919|66760176|FG004|Overall Study|Adverse Event|0|||
23831191|NCT01894919|66760177|FG005|Overall Study|Adverse Event|0|||
23831192|NCT01894919|66760178|FG006|Overall Study|Adverse Event|0|||
23831193|NCT01894919|66760179|FG007|Overall Study|Adverse Event|0|||
23831194|NCT01894919|66760180|FG008|Overall Study|Adverse Event|0|||
23831195|NCT01894919|66760181|FG009|Overall Study|Adverse Event|0|||
23831196|NCT01894919|66760182|FG010|Overall Study|Adverse Event|1|||
23831197|NCT01894919|66760183|FG011|Overall Study|Adverse Event|0|||
23831198|NCT01894919|66760184|FG012|Overall Study|Adverse Event|0|||
23831199|NCT01894919|66760172|FG000|Overall Study|Other-Unspecified|1|||
23831200|NCT01894919|66760173|FG001|Overall Study|Other-Unspecified|0|||
23831201|NCT01894919|66760174|FG002|Overall Study|Other-Unspecified|0|||
23831202|NCT01894919|66760175|FG003|Overall Study|Other-Unspecified|0|||
23831203|NCT01894919|66760176|FG004|Overall Study|Other-Unspecified|0|||
23831204|NCT01894919|66760177|FG005|Overall Study|Other-Unspecified|0|||
23831205|NCT01894919|66760178|FG006|Overall Study|Other-Unspecified|0|||
23831206|NCT01894919|66760179|FG007|Overall Study|Other-Unspecified|0|||
23831207|NCT01894919|66760180|FG008|Overall Study|Other-Unspecified|0|||
23831208|NCT01894919|66760181|FG009|Overall Study|Other-Unspecified|0|||
23831209|NCT01894919|66760182|FG010|Overall Study|Other-Unspecified|0|||
23831210|NCT01894919|66760183|FG011|Overall Study|Other-Unspecified|0|||
23831211|NCT01894919|66760184|FG012|Overall Study|Other-Unspecified|0|||
23831212|NCT01894919|66760172|FG000|Overall Study|Lost to Follow-up|0|||
23831213|NCT01894919|66760173|FG001|Overall Study|Lost to Follow-up|0|||
23831214|NCT01894919|66760174|FG002|Overall Study|Lost to Follow-up|0|||
23831215|NCT01894919|66760175|FG003|Overall Study|Lost to Follow-up|0|||
23831216|NCT01894919|66760176|FG004|Overall Study|Lost to Follow-up|2|||
23831217|NCT01894919|66760177|FG005|Overall Study|Lost to Follow-up|0|||
23831218|NCT01894919|66760178|FG006|Overall Study|Lost to Follow-up|0|||
23831219|NCT01894919|66760179|FG007|Overall Study|Lost to Follow-up|0|||
23831220|NCT01894919|66760180|FG008|Overall Study|Lost to Follow-up|0|||
23831221|NCT01894919|66760181|FG009|Overall Study|Lost to Follow-up|0|||
23831222|NCT01894919|66760182|FG010|Overall Study|Lost to Follow-up|0|||
23831223|NCT01894919|66760183|FG011|Overall Study|Lost to Follow-up|0|||
23571825|NCT01076088|65824576|FG002|Overall Study|Adverse Event|3|||
23571826|NCT01076088|65824577|FG003|Overall Study|Adverse Event|2|||
23571827|NCT01076088|65824578|FG004|Overall Study|Adverse Event|3|||
23571828|NCT01076088|65824579|FG005|Overall Study|Adverse Event|3|||
23571829|NCT01076088|65824574|FG000|Overall Study|Lost to Follow-up|1|||
23571830|NCT01076088|65824575|FG001|Overall Study|Lost to Follow-up|1|||
23571831|NCT01076088|65824576|FG002|Overall Study|Lost to Follow-up|0|||
23831224|NCT01894919|66760184|FG012|Overall Study|Lost to Follow-up|0|||
23831225|NCT03896022|66760185|FG000|Overall Study|Withdrawal by Subject|1|||
23831226|NCT03896022|66760186|FG001|Overall Study|Withdrawal by Subject|0|||
23571832|NCT01076088|65824577|FG003|Overall Study|Lost to Follow-up|1|||
23571833|NCT01076088|65824578|FG004|Overall Study|Lost to Follow-up|1|||
23571834|NCT01076088|65824579|FG005|Overall Study|Lost to Follow-up|2|||
23571835|NCT01076088|65824574|FG000|Overall Study|Non-compliance with study drug|0|||
23770438|NCT01364870|66539544|FG001|Overall Study|Withdrawal by Subject|24|||
23770439|NCT01364870|66539545|FG002|Overall Study|Withdrawal by Subject|10|||
23831227|NCT03896022|66760187|FG002|Overall Study|Withdrawal by Subject|0|||
23831228|NCT03896022|66760185|FG000|Overall Study|Did not have procedure|3|||
23831229|NCT03896022|66760186|FG001|Overall Study|Did not have procedure|0|||
23831230|NCT03896022|66760187|FG002|Overall Study|Did not have procedure|0|||
23831231|NCT05048329|66760188|FG000|Overall Study|Withdrawal by Subject|1|||
23831232|NCT05048329|66760188|FG000|Overall Study|Screenfail|1|||
23770440|NCT01364870|66539543|FG000|Overall Study|Adverse Event|8|||
23831233|NCT00413699|66760193|FG000|Initial Period|Death|25|||
23831234|NCT00413699|66760194|FG001|Initial Period|Death|30|||
23831235|NCT00413699|66760195|FG002|Initial Period|Death|0|||
23831236|NCT00413699|66760193|FG000|Initial Period|Lack of Efficacy|59|||
23831237|NCT00413699|66760194|FG001|Initial Period|Lack of Efficacy|115|||
23831238|NCT00413699|66760195|FG002|Initial Period|Lack of Efficacy|0|||
23770441|NCT01364870|66539544|FG001|Overall Study|Adverse Event|6|||
23770442|NCT01364870|66539545|FG002|Overall Study|Adverse Event|4|||
23770443|NCT01364870|66539543|FG000|Overall Study|Protocol Violation|1|||
23770444|NCT01364870|66539544|FG001|Overall Study|Protocol Violation|0|||
23571836|NCT01076088|65824575|FG001|Overall Study|Non-compliance with study drug|0|||
23571837|NCT01076088|65824576|FG002|Overall Study|Non-compliance with study drug|0|||
23571838|NCT01076088|65824577|FG003|Overall Study|Non-compliance with study drug|1|||
23571839|NCT01076088|65824578|FG004|Overall Study|Non-compliance with study drug|0|||
23571840|NCT01076088|65824579|FG005|Overall Study|Non-compliance with study drug|0|||
23571841|NCT01076088|65824574|FG000|Overall Study|Physician Decision|1|||
23571842|NCT01076088|65824575|FG001|Overall Study|Physician Decision|3|||
23571843|NCT01076088|65824576|FG002|Overall Study|Physician Decision|0|||
23571844|NCT01076088|65824577|FG003|Overall Study|Physician Decision|1|||
23571845|NCT01076088|65824578|FG004|Overall Study|Physician Decision|1|||
23770445|NCT01364870|66539545|FG002|Overall Study|Protocol Violation|0|||
23770446|NCT04529109|66539546|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
23770447|NCT04529109|66539547|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23770448|NCT03103100|66539549|FG000|Overall Study|Adverse Event|1|||
23770449|NCT03103100|66539550|FG001|Overall Study|Adverse Event|0|||
23770450|NCT03103100|66539551|FG002|Overall Study|Adverse Event|0|||
23770451|NCT03103100|66539549|FG000|Overall Study|Physician Decision|1|||
23770452|NCT03103100|66539550|FG001|Overall Study|Physician Decision|0|||
23770453|NCT03103100|66539551|FG002|Overall Study|Physician Decision|2|||
23770454|NCT02576509|66539552|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
23770455|NCT02576509|66539553|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
23770456|NCT02576509|66539552|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23770457|NCT02576509|66539553|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
23770458|NCT02576509|66539552|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
23770459|NCT02576509|66539553|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
23770460|NCT02576509|66539552|FG000|Treatment Period|Disease progression|245|||
23770461|NCT02576509|66539553|FG001|Treatment Period|Disease progression|240|||
23770462|NCT02576509|66539552|FG000|Treatment Period|Study drug toxicity|32|||
23770463|NCT02576509|66539553|FG001|Treatment Period|Study drug toxicity|41|||
23770464|NCT02576509|66539552|FG000|Treatment Period|Death|1|||
23770465|NCT02576509|66539553|FG001|Treatment Period|Death|1|||
23770466|NCT02576509|66539552|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
23770467|NCT02576509|66539553|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
23770468|NCT02576509|66539552|FG000|Treatment Period|Participant request to stop treatment|8|||
23770469|NCT02576509|66539553|FG001|Treatment Period|Participant request to stop treatment|17|||
23770470|NCT02576509|66539552|FG000|Treatment Period|Participant withdrew consent|2|||
23770471|NCT02576509|66539553|FG001|Treatment Period|Participant withdrew consent|7|||
23770472|NCT02576509|66539552|FG000|Treatment Period|Lost to Follow-up|0|||
23770473|NCT02576509|66539553|FG001|Treatment Period|Lost to Follow-up|1|||
23770474|NCT02576509|66539552|FG000|Treatment Period|Maximum clinical benefit|1|||
23770475|NCT02576509|66539553|FG001|Treatment Period|Maximum clinical benefit|0|||
23770476|NCT02576509|66539552|FG000|Treatment Period|Poor/non-compliance|0|||
23770477|NCT02576509|66539553|FG001|Treatment Period|Poor/non-compliance|1|||
23770478|NCT02576509|66539552|FG000|Treatment Period|Participant no longer meets criteria|1|||
23770479|NCT02576509|66539553|FG001|Treatment Period|Participant no longer meets criteria|0|||
23770480|NCT02576509|66539552|FG000|Treatment Period|Other reason|2|||
23770481|NCT02576509|66539553|FG001|Treatment Period|Other reason|7|||
23770482|NCT02576509|66539552|FG000|Follow-up Period|Death|41|||
23770483|NCT02576509|66539553|FG001|Follow-up Period|Death|35|||
23770484|NCT02576509|66539552|FG000|Follow-up Period|Participant withdrew consent|7|||
23770485|NCT02576509|66539553|FG001|Follow-up Period|Participant withdrew consent|14|||
23770486|NCT02576509|66539552|FG000|Follow-up Period|Lost to Follow-up|0|||
23770487|NCT02576509|66539553|FG001|Follow-up Period|Lost to Follow-up|1|||
23770488|NCT02576509|66539552|FG000|Follow-up Period|Other reason|1|||
23770489|NCT02576509|66539553|FG001|Follow-up Period|Other reason|2|||
23770490|NCT04025879|66539554|FG000|Randomization|Participant withdrew consent|0|||
23770491|NCT04025879|66539555|FG001|Randomization|Participant withdrew consent|1|||
23770492|NCT04025879|66539554|FG000|Randomization|Participant no longer met study criteria|1|||
23770493|NCT04025879|66539555|FG001|Randomization|Participant no longer met study criteria|1|||
23770494|NCT04025879|66539554|FG000|Treatment|Ongoing treatment|10|||
23770495|NCT04025879|66539555|FG001|Treatment|Ongoing treatment|8|||
23770496|NCT04025879|66539554|FG000|Treatment|Disease progression/recurrence|36|||
23770497|NCT04025879|66539555|FG001|Treatment|Disease progression/recurrence|72|||
23770498|NCT04025879|66539554|FG000|Treatment|Study drug toxicity|36|||
23770499|NCT04025879|66539555|FG001|Treatment|Study drug toxicity|13|||
23770500|NCT04025879|66539554|FG000|Treatment|Death|2|||
23770501|NCT04025879|66539555|FG001|Treatment|Death|0|||
23770502|NCT04025879|66539554|FG000|Treatment|Adverse event unrelated to study drug|21|||
23571846|NCT01076088|65824579|FG005|Overall Study|Physician Decision|0|||
23770503|NCT04025879|66539555|FG001|Treatment|Adverse event unrelated to study drug|14|||
23770504|NCT04025879|66539554|FG000|Treatment|Participant request to discontinue study treatment|16|||
23571847|NCT01076088|65824574|FG000|Overall Study|Withdrawal by Subject|8|||
23571848|NCT01076088|65824575|FG001|Overall Study|Withdrawal by Subject|8|||
23571849|NCT01076088|65824576|FG002|Overall Study|Withdrawal by Subject|14|||
23571850|NCT01076088|65824577|FG003|Overall Study|Withdrawal by Subject|10|||
23571851|NCT01076088|65824578|FG004|Overall Study|Withdrawal by Subject|11|||
23632448|NCT00121667|66038723|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
23632449|NCT00121667|66038720|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
23632450|NCT00121667|66038721|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
23632451|NCT00121667|66038722|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
23632452|NCT00121667|66038723|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
23632453|NCT00121667|66038720|FG000|Short Term (ST) Period|Other Reason|3|||
23632454|NCT00121667|66038721|FG001|Short Term (ST) Period|Other Reason|0|||
23632455|NCT00121667|66038722|FG002|Short Term (ST) Period|Other Reason|0|||
23632456|NCT00121667|66038723|FG003|Short Term (ST) Period|Other Reason|0|||
23632457|NCT00121667|66038720|FG000|Short Term (ST) Period|Death|0|||
23632458|NCT00121667|66038721|FG001|Short Term (ST) Period|Death|0|||
23632459|NCT00121667|66038722|FG002|Short Term (ST) Period|Death|0|||
23632460|NCT00121667|66038723|FG003|Short Term (ST) Period|Death|1|||
23571852|NCT01076088|65824579|FG005|Overall Study|Withdrawal by Subject|17|||
23571853|NCT01076088|65824574|FG000|Overall Study|Other protocol specified criteria|0|||
23571854|NCT01076088|65824575|FG001|Overall Study|Other protocol specified criteria|0|||
23571855|NCT01076088|65824576|FG002|Overall Study|Other protocol specified criteria|0|||
23632461|NCT00121667|66038720|FG000|Short Term (ST) Period|Pregnancy|0|||
23632462|NCT00121667|66038721|FG001|Short Term (ST) Period|Pregnancy|0|||
23632463|NCT00121667|66038722|FG002|Short Term (ST) Period|Pregnancy|0|||
23632464|NCT00121667|66038723|FG003|Short Term (ST) Period|Pregnancy|1|||
23632465|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
23632466|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
23632467|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
23632468|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
23632469|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
23632470|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
23632471|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
23632472|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
23632473|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
23632474|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
23770505|NCT04025879|66539555|FG001|Treatment|Participant request to discontinue study treatment|8|||
23770506|NCT04025879|66539554|FG000|Treatment|Participant withdrew consent|1|||
23770507|NCT04025879|66539555|FG001|Treatment|Participant withdrew consent|3|||
23770508|NCT04025879|66539554|FG000|Treatment|Participant no longer meets study criteria|3|||
23770509|NCT04025879|66539555|FG001|Treatment|Participant no longer meets study criteria|2|||
23770510|NCT04025879|66539554|FG000|Treatment|Lost to Follow-up|1|||
23770511|NCT04025879|66539555|FG001|Treatment|Lost to Follow-up|0|||
23770512|NCT04025879|66539554|FG000|Treatment|Other reasons|15|||
23770513|NCT04025879|66539555|FG001|Treatment|Other reasons|17|||
23571856|NCT01076088|65824577|FG003|Overall Study|Other protocol specified criteria|0|||
23571857|NCT01076088|65824578|FG004|Overall Study|Other protocol specified criteria|0|||
23571858|NCT01076088|65824579|FG005|Overall Study|Other protocol specified criteria|1|||
23571859|NCT01778062|65824580|FG000|Overall Study|Adverse Event|1|||
23571860|NCT01778062|65824581|FG001|Overall Study|Adverse Event|3|||
23571861|NCT01778062|65824580|FG000|Overall Study|Consent Withdrawal|1|||
23571862|NCT01778062|65824581|FG001|Overall Study|Consent Withdrawal|5|||
23571863|NCT01778062|65824580|FG000|Overall Study|major protocol deviation|4|||
23571864|NCT01778062|65824581|FG001|Overall Study|major protocol deviation|3|||
23571865|NCT01454830|65824585|FG000|Overall Study|Withdrawal by Subject|4|||
23571866|NCT01454830|65824586|FG001|Overall Study|Withdrawal by Subject|4|||
23571867|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
23571868|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
23571869|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
23571870|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
23571871|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
23571872|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
23571873|NCT01454830|65824585|FG000|Overall Study|Withdrawal - no polysomnography|3|||
23571874|NCT01454830|65824586|FG001|Overall Study|Withdrawal - no polysomnography|2|||
23632475|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
23632476|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
23571875|NCT03632434|65824592|FG000|Overall Study|Withdrawal by Subject|2|||
23571876|NCT01310868|65824593|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
23571877|NCT03390036|65824594|FG000|Overall Study|Lost to Follow-up|1|||
23571878|NCT03390036|65824595|FG001|Overall Study|Lost to Follow-up|0|||
23632477|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
23770514|NCT04025879|66539554|FG000|Treatment|Administrative reason by sponsor|0|||
23571879|NCT03390036|65824596|FG002|Overall Study|Lost to Follow-up|0|||
23571880|NCT03390036|65824594|FG000|Overall Study|Lack of Efficacy|1|||
23571881|NCT03390036|65824595|FG001|Overall Study|Lack of Efficacy|0|||
23571882|NCT03390036|65824596|FG002|Overall Study|Lack of Efficacy|0|||
23571883|NCT02019602|65824597|FG000|Screening Period|Ineligibility|4|||
23571884|NCT02019602|65824598|FG001|Screening Period|Ineligibility|0|||
23571885|NCT02019602|65824597|FG000|Screening Period|Adverse Event|1|||
23571886|NCT02019602|65824598|FG001|Screening Period|Adverse Event|0|||
23571887|NCT04276090|65824604|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
23571888|NCT04276090|65824605|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
23571889|NCT03722264|65824610|FG000|Overall Study|Physician Decision|3|||
23571890|NCT00581113|65824611|FG000|Overall Study|Withdrawal by Subject|0|||
23571891|NCT00581113|65824612|FG001|Overall Study|Withdrawal by Subject|1|||
23571892|NCT02593539|65824613|FG000|Overall Study|Adverse Event|1|||
23571893|NCT04426006|65824616|FG000|Inclusion|Protocol Violation|1|||
23571894|NCT04426006|65824616|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
23571895|NCT04426006|65824616|FG000|Inclusion|Blood sample at inclusion not done|1|||
23571896|NCT04426006|65824616|FG000|3 Months|Lost to Follow-up|17|||
23571897|NCT04426006|65824616|FG000|12 Months|Lost to Follow-up|38|||
23571898|NCT01951092|65824617|FG000|Overall Study|Lost to Follow-up|10|||
23571899|NCT01951092|65824617|FG000|Overall Study|Incarceration|1|||
23632478|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
23831239|NCT00413699|66760193|FG000|Initial Period|Lost to Follow-up|31|||
23632479|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
23632480|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
23632481|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
23632482|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
23632483|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
23831240|NCT00413699|66760194|FG001|Initial Period|Lost to Follow-up|101|||
23831241|NCT00413699|66760195|FG002|Initial Period|Lost to Follow-up|0|||
23632484|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
23632485|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
23632486|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
23632487|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
23632488|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
23831242|NCT00413699|66760193|FG000|Initial Period|Protocol Violation|38|||
23831243|NCT00413699|66760194|FG001|Initial Period|Protocol Violation|89|||
23831244|NCT00413699|66760195|FG002|Initial Period|Protocol Violation|0|||
23831245|NCT00413699|66760193|FG000|Initial Period|Pregnancy|10|||
23831246|NCT00413699|66760194|FG001|Initial Period|Pregnancy|8|||
23831247|NCT00413699|66760195|FG002|Initial Period|Pregnancy|0|||
23831248|NCT00413699|66760193|FG000|Initial Period|Did not meet entrance criteria|2|||
23831249|NCT00413699|66760194|FG001|Initial Period|Did not meet entrance criteria|2|||
23831250|NCT00413699|66760195|FG002|Initial Period|Did not meet entrance criteria|0|||
23571900|NCT01951092|65824617|FG000|Overall Study|Transfer of Care|1|||
23571901|NCT04230980|65824622|FG000|Overall Study|Lost to Follow-up|1|||
23571902|NCT04230980|65824623|FG001|Overall Study|Lost to Follow-up|2|||
23632489|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
23632490|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
23632491|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
23632492|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
23632493|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23632494|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23632495|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
23632496|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23632497|NCT00121667|66038720|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
23632498|NCT00121667|66038721|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
23632499|NCT00121667|66038722|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
23632500|NCT00121667|66038723|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
23632501|NCT01040169|66038724|FG000|Overall Study|Lost to Follow-up|3|||
23632502|NCT01040169|66038725|FG001|Overall Study|Lost to Follow-up|8|||
23632503|NCT00762476|66038730|FG000|Overall Study|Adverse Event|7|||
23632504|NCT00762476|66038731|FG001|Overall Study|Adverse Event|1|||
23632505|NCT00762476|66038730|FG000|Overall Study|Lost to Follow-up|2|||
23632506|NCT00762476|66038731|FG001|Overall Study|Lost to Follow-up|0|||
23571903|NCT04230980|65824622|FG000|Overall Study|Adverse Event|0|||
23632507|NCT00762476|66038730|FG000|Overall Study|Protocol Violation|5|||
23632508|NCT00762476|66038731|FG001|Overall Study|Protocol Violation|6|||
23632509|NCT00762476|66038730|FG000|Overall Study|Physician Decision|2|||
23831251|NCT00413699|66760193|FG000|Initial Period|Medication error without adverse event|0|||
23831252|NCT00413699|66760194|FG001|Initial Period|Medication error without adverse event|1|||
23831253|NCT00413699|66760195|FG002|Initial Period|Medication error without adverse event|0|||
23571904|NCT04230980|65824623|FG001|Overall Study|Adverse Event|1|||
23571905|NCT04006366|65824624|FG000|Overall Study|Withdrawal by Subject|1|||
23571906|NCT00209274|65824625|FG000|Overall Study|Missed visit|3|||
23571907|NCT00209274|65824626|FG001|Overall Study|Missed visit|2|||
23571908|NCT00209274|65824625|FG000|Overall Study|Death|32|||
23571909|NCT00209274|65824626|FG001|Overall Study|Death|15|||
23571910|NCT00209274|65824625|FG000|Overall Study|Withdrawal by Subject|30|||
23571911|NCT00209274|65824626|FG001|Overall Study|Withdrawal by Subject|15|||
23571912|NCT00209274|65824625|FG000|Overall Study|Randomized not treated (RNT)|6|||
23571913|NCT00209274|65824626|FG001|Overall Study|Randomized not treated (RNT)|15|||
23571914|NCT03810313|65824629|FG000|Overall Study|Study terminated by sponsor|164|||
23571915|NCT03810313|65824630|FG001|Overall Study|Study terminated by sponsor|159|||
23571916|NCT03810313|65824629|FG000|Overall Study|Subject decision|10|||
23571917|NCT03810313|65824630|FG001|Overall Study|Subject decision|11|||
23571918|NCT03810313|65824629|FG000|Overall Study|Lost to Follow-up|3|||
23571919|NCT03810313|65824630|FG001|Overall Study|Lost to Follow-up|3|||
23571920|NCT03810313|65824629|FG000|Overall Study|Adverse Event|2|||
23571921|NCT03810313|65824630|FG001|Overall Study|Adverse Event|1|||
23571922|NCT03810313|65824629|FG000|Overall Study|Death|2|||
23571923|NCT03810313|65824630|FG001|Overall Study|Death|1|||
23571924|NCT03810313|65824629|FG000|Overall Study|Physician Decision|0|||
23571925|NCT03810313|65824630|FG001|Overall Study|Physician Decision|1|||
23571926|NCT01555021|65824635|FG000|Overall Study|Lost to Follow-up|1|||
23571927|NCT01555021|65824636|FG001|Overall Study|Lost to Follow-up|2|||
23571928|NCT02836613|65824637|FG000|Overall Study|Accidental drowning|1|||
23571929|NCT02836613|65824638|FG001|Overall Study|Accidental drowning|0|||
23571930|NCT02836613|65824637|FG000|Overall Study|Lost to Follow-up|0|||
23571931|NCT02836613|65824638|FG001|Overall Study|Lost to Follow-up|1|||
23571932|NCT02836613|65824637|FG000|Overall Study|Withdrawal by Subject|0|||
23571933|NCT02836613|65824638|FG001|Overall Study|Withdrawal by Subject|2|||
23571934|NCT01009047|65824642|FG000|Overall Study|Adverse Event|5|||
23571935|NCT01009047|65824643|FG001|Overall Study|Adverse Event|0|||
23571936|NCT01009047|65824642|FG000|Overall Study|Lost to Follow-up|0|||
23571937|NCT01009047|65824643|FG001|Overall Study|Lost to Follow-up|2|||
23571938|NCT01009047|65824642|FG000|Overall Study|Lack of Efficacy|4|||
23571939|NCT01009047|65824643|FG001|Overall Study|Lack of Efficacy|11|||
23571940|NCT01009047|65824642|FG000|Overall Study|Withdrawal by consent|16|||
23571941|NCT01009047|65824643|FG001|Overall Study|Withdrawal by consent|11|||
23571942|NCT01009047|65824642|FG000|Overall Study|Other|3|||
23571943|NCT01009047|65824643|FG001|Overall Study|Other|2|||
23571944|NCT02769065|65824647|FG000|Overall Study|Voluntary Withdrawal|1|||
23571945|NCT02769065|65824648|FG001|Overall Study|Voluntary Withdrawal|0|||
23571946|NCT02769065|65824649|FG002|Overall Study|Voluntary Withdrawal|0|||
23571947|NCT02769065|65824650|FG003|Overall Study|Voluntary Withdrawal|0|||
23571948|NCT02769065|65824651|FG004|Overall Study|Voluntary Withdrawal|0|||
23571949|NCT02769065|65824652|FG005|Overall Study|Voluntary Withdrawal|0|||
23571950|NCT02769065|65824653|FG006|Overall Study|Voluntary Withdrawal|0|||
23571951|NCT02769065|65824654|FG007|Overall Study|Voluntary Withdrawal|0|||
23571952|NCT02769065|65824655|FG008|Overall Study|Voluntary Withdrawal|0|||
23571953|NCT02769065|65824656|FG009|Overall Study|Voluntary Withdrawal|0|||
23571954|NCT02769065|65824657|FG010|Overall Study|Voluntary Withdrawal|0|||
23571955|NCT02769065|65824658|FG011|Overall Study|Voluntary Withdrawal|0|||
23571956|NCT02769065|65824659|FG012|Overall Study|Voluntary Withdrawal|0|||
23571957|NCT02769065|65824660|FG013|Overall Study|Voluntary Withdrawal|0|||
23571958|NCT02769065|65824661|FG014|Overall Study|Voluntary Withdrawal|0|||
23571959|NCT02769065|65824662|FG015|Overall Study|Voluntary Withdrawal|0|||
23571960|NCT02769065|65824663|FG016|Overall Study|Voluntary Withdrawal|0|||
23571961|NCT02769065|65824664|FG017|Overall Study|Voluntary Withdrawal|0|||
23571962|NCT02769065|65824665|FG018|Overall Study|Voluntary Withdrawal|0|||
23571963|NCT02769065|65824666|FG019|Overall Study|Voluntary Withdrawal|0|||
23571964|NCT02769065|65824667|FG020|Overall Study|Voluntary Withdrawal|0|||
23770515|NCT04025879|66539555|FG001|Treatment|Administrative reason by sponsor|1|||
23770516|NCT04025879|66539554|FG000|Treatment|Not reported|2|||
23770517|NCT04025879|66539555|FG001|Treatment|Not reported|0|||
23770518|NCT03500484|66539556|FG000|Overall Study|Adverse Event|2|||
23770519|NCT03500484|66539557|FG001|Overall Study|Adverse Event|0|||
23770520|NCT03500484|66539556|FG000|Overall Study|Physician Decision|1|||
23571965|NCT02769065|65824668|FG021|Overall Study|Voluntary Withdrawal|0|||
23571966|NCT02769065|65824669|FG022|Overall Study|Voluntary Withdrawal|0|||
23571967|NCT02769065|65824670|FG023|Overall Study|Voluntary Withdrawal|0|||
23571968|NCT02769065|65824671|FG024|Overall Study|Voluntary Withdrawal|0|||
23571969|NCT02769065|65824672|FG025|Overall Study|Voluntary Withdrawal|0|||
23571970|NCT02769065|65824673|FG026|Overall Study|Voluntary Withdrawal|0|||
23571971|NCT02769065|65824674|FG027|Overall Study|Voluntary Withdrawal|0|||
23571972|NCT02769065|65824675|FG028|Overall Study|Voluntary Withdrawal|0|||
23571973|NCT02769065|65824676|FG029|Overall Study|Voluntary Withdrawal|0|||
23571974|NCT02769065|65824647|FG000|Overall Study|Reason Not Specified|0|||
23770521|NCT03500484|66539557|FG001|Overall Study|Physician Decision|0|||
23632510|NCT00762476|66038731|FG001|Overall Study|Physician Decision|14|||
23632511|NCT00762476|66038730|FG000|Overall Study|Withdrawal by Subject|6|||
23632512|NCT00762476|66038731|FG001|Overall Study|Withdrawal by Subject|12|||
23632513|NCT00762476|66038730|FG000|Overall Study|antibiotic use|0|||
23632514|NCT00762476|66038731|FG001|Overall Study|antibiotic use|1|||
23632515|NCT00762476|66038730|FG000|Overall Study|non-compliance with study visits|0|||
23632516|NCT00762476|66038731|FG001|Overall Study|non-compliance with study visits|2|||
23632517|NCT00762476|66038730|FG000|Overall Study|Seasonal allergies|1|||
23632518|NCT00762476|66038731|FG001|Overall Study|Seasonal allergies|0|||
23632519|NCT03819634|66038732|FG000|Overall Study|Physician Decision|2|||
23632520|NCT01454739|66038733|FG000|Overall Study|Protocol Violation|2|||
23632521|NCT01454739|66038734|FG001|Overall Study|Protocol Violation|3|||
23632522|NCT01454739|66038733|FG000|Overall Study|Withdrawal by Subject|2|||
23632523|NCT01454739|66038734|FG001|Overall Study|Withdrawal by Subject|6|||
23632524|NCT01454739|66038733|FG000|Overall Study|Other|3|||
23632525|NCT01454739|66038734|FG001|Overall Study|Other|5|||
23632526|NCT01454739|66038733|FG000|Overall Study|Physician Decision|0|||
23632527|NCT01454739|66038734|FG001|Overall Study|Physician Decision|5|||
23632528|NCT01454739|66038733|FG000|Overall Study|Lost to Follow-up|0|||
23632529|NCT01454739|66038734|FG001|Overall Study|Lost to Follow-up|1|||
23632530|NCT01454739|66038733|FG000|Overall Study|Adverse Event|0|||
23632531|NCT01454739|66038734|FG001|Overall Study|Adverse Event|1|||
23632532|NCT03057847|66038738|FG000|Overall Study|Lost to Follow-up|16|||
23632533|NCT02666664|66038739|FG000|Overall Study|Physician Decision|0|||
23770522|NCT03500484|66539556|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
23770523|NCT03500484|66539557|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
23770524|NCT01937390|66539558|FG000|Overall Study|Death|2|||
23770525|NCT01937390|66539558|FG000|Overall Study|Lost to Follow-up|7|||
23632534|NCT02666664|66038740|FG001|Overall Study|Physician Decision|1|||
23632535|NCT02666664|66038739|FG000|Overall Study|Protocol Violation|0|||
23632536|NCT02666664|66038740|FG001|Overall Study|Protocol Violation|2|||
23632537|NCT02666664|66038739|FG000|Overall Study|Other|0|||
23632538|NCT02666664|66038740|FG001|Overall Study|Other|1|||
23632539|NCT02666664|66038739|FG000|Overall Study|Adverse Event|12|||
23632540|NCT02666664|66038740|FG001|Overall Study|Adverse Event|37|||
23632541|NCT02666664|66038739|FG000|Overall Study|Withdrawal by participant|23|||
23632542|NCT02666664|66038740|FG001|Overall Study|Withdrawal by participant|40|||
23632543|NCT02666664|66038739|FG000|Overall Study|Sponsor decision|0|||
23632544|NCT02666664|66038740|FG001|Overall Study|Sponsor decision|1|||
23632545|NCT02666664|66038739|FG000|Overall Study|Lost to Follow-up|1|||
23770526|NCT01937390|66539558|FG000|Overall Study|Withdrawal by Subject|5|||
23632546|NCT02666664|66038740|FG001|Overall Study|Lost to Follow-up|2|||
23632547|NCT03019640|66038750|FG000|Overall Study|Screen Failures|4|||
23632548|NCT03019640|66038750|FG000|Overall Study|Adverse Event|3|||
23632549|NCT03019640|66038750|FG000|Overall Study|Participant Relapsed|1|||
23632550|NCT03041792|66038751|FG000|Overall Study|Adverse Event|4|||
23632551|NCT03041792|66038752|FG001|Overall Study|Adverse Event|0|||
23632552|NCT03041792|66038751|FG000|Overall Study|Death in the family|0|||
23632553|NCT03041792|66038752|FG001|Overall Study|Death in the family|2|||
23632554|NCT03041792|66038751|FG000|Overall Study|Randomized but not treated|0|||
23632555|NCT03041792|66038752|FG001|Overall Study|Randomized but not treated|1|||
23632556|NCT01594970|66038754|FG000|Overall Study|Non-Adverse Event Related|4|||
23632557|NCT01594970|66038755|FG001|Overall Study|Non-Adverse Event Related|5|||
23632558|NCT01594970|66038756|FG002|Overall Study|Non-Adverse Event Related|6|||
23632559|NCT01594970|66038754|FG000|Overall Study|Adverse Event|17|||
23632560|NCT01594970|66038755|FG001|Overall Study|Adverse Event|23|||
23632561|NCT01594970|66038756|FG002|Overall Study|Adverse Event|23|||
23632562|NCT01594970|66038754|FG000|Overall Study|Lost to Follow-up|54|||
23632563|NCT01594970|66038755|FG001|Overall Study|Lost to Follow-up|54|||
23632564|NCT01594970|66038756|FG002|Overall Study|Lost to Follow-up|37|||
23770527|NCT01937390|66539558|FG000|Overall Study|Fail to return|21|||
23770528|NCT02374918|66539559|FG000|Overall Study|Protocol Violation|2|||
23770529|NCT02374918|66539560|FG001|Overall Study|Protocol Violation|0|||
23632565|NCT01381575|66041890|FG000|Overall Study|Serious Adverse Event|1|||
23632566|NCT01381575|66041891|FG001|Overall Study|Serious Adverse Event|0|||
23632567|NCT01381575|66041892|FG002|Overall Study|Serious Adverse Event|0|||
23632568|NCT01381575|66041890|FG000|Overall Study|Non-Serious Adverse Event|0|||
23632569|NCT01381575|66041891|FG001|Overall Study|Non-Serious Adverse Event|0|||
23632570|NCT01381575|66041892|FG002|Overall Study|Non-Serious Adverse Event|1|||
23632571|NCT01381575|66041890|FG000|Overall Study|Protocol Violation|0|||
23632572|NCT01381575|66041891|FG001|Overall Study|Protocol Violation|1|||
23632573|NCT01381575|66041892|FG002|Overall Study|Protocol Violation|1|||
23632574|NCT01381575|66041890|FG000|Overall Study|Withdrawal by Subject|15|||
23632575|NCT01381575|66041891|FG001|Overall Study|Withdrawal by Subject|9|||
23770530|NCT02374918|66539561|FG002|Overall Study|Protocol Violation|2|||
23770531|NCT02374918|66539562|FG003|Overall Study|Protocol Violation|1|||
23770532|NCT02374918|66539559|FG000|Overall Study|Withdrawal by Subject|1|||
23770533|NCT02374918|66539560|FG001|Overall Study|Withdrawal by Subject|1|||
23770534|NCT02374918|66539561|FG002|Overall Study|Withdrawal by Subject|1|||
23770535|NCT02374918|66539562|FG003|Overall Study|Withdrawal by Subject|0|||
23770536|NCT02374918|66539559|FG000|Overall Study|Lack of Efficacy|0|||
23770537|NCT02374918|66539560|FG001|Overall Study|Lack of Efficacy|0|||
23770538|NCT02374918|66539561|FG002|Overall Study|Lack of Efficacy|1|||
23770539|NCT02374918|66539562|FG003|Overall Study|Lack of Efficacy|1|||
23770540|NCT01506323|66539567|FG000|Overall Study|Lost to Follow-up|5|||
23770541|NCT01506323|66539568|FG001|Overall Study|Lost to Follow-up|4|||
23770542|NCT01506323|66539567|FG000|Overall Study|Withdrawal by Subject|4|||
23770543|NCT01506323|66539568|FG001|Overall Study|Withdrawal by Subject|4|||
23770544|NCT01506323|66539567|FG000|Overall Study|Lack of Efficacy|1|||
23770545|NCT01506323|66539568|FG001|Overall Study|Lack of Efficacy|3|||
23770546|NCT01506323|66539567|FG000|Overall Study|Moved out of area|5|||
23770547|NCT01506323|66539568|FG001|Overall Study|Moved out of area|2|||
23770548|NCT01506323|66539567|FG000|Overall Study|Schedule or Transportation conflict|8|||
23770549|NCT01506323|66539568|FG001|Overall Study|Schedule or Transportation conflict|0|||
23770550|NCT01506323|66539567|FG000|Overall Study|Started another treatment|1|||
23770551|NCT01506323|66539568|FG001|Overall Study|Started another treatment|0|||
23571975|NCT02769065|65824648|FG001|Overall Study|Reason Not Specified|0|||
23571976|NCT02769065|65824649|FG002|Overall Study|Reason Not Specified|0|||
23571977|NCT02769065|65824650|FG003|Overall Study|Reason Not Specified|0|||
23571978|NCT02769065|65824651|FG004|Overall Study|Reason Not Specified|0|||
23571979|NCT02769065|65824652|FG005|Overall Study|Reason Not Specified|0|||
23571980|NCT02769065|65824653|FG006|Overall Study|Reason Not Specified|1|||
23571981|NCT02769065|65824654|FG007|Overall Study|Reason Not Specified|0|||
23571982|NCT02769065|65824655|FG008|Overall Study|Reason Not Specified|0|||
23571983|NCT02769065|65824656|FG009|Overall Study|Reason Not Specified|0|||
23571984|NCT02769065|65824657|FG010|Overall Study|Reason Not Specified|0|||
23571985|NCT02769065|65824658|FG011|Overall Study|Reason Not Specified|0|||
23571986|NCT02769065|65824659|FG012|Overall Study|Reason Not Specified|0|||
23571987|NCT02769065|65824660|FG013|Overall Study|Reason Not Specified|0|||
23571988|NCT02769065|65824661|FG014|Overall Study|Reason Not Specified|0|||
23571989|NCT02769065|65824662|FG015|Overall Study|Reason Not Specified|0|||
23571990|NCT02769065|65824663|FG016|Overall Study|Reason Not Specified|0|||
23571991|NCT02769065|65824664|FG017|Overall Study|Reason Not Specified|0|||
23571992|NCT02769065|65824665|FG018|Overall Study|Reason Not Specified|0|||
23571993|NCT02769065|65824666|FG019|Overall Study|Reason Not Specified|0|||
23571994|NCT02769065|65824667|FG020|Overall Study|Reason Not Specified|0|||
23571995|NCT02769065|65824668|FG021|Overall Study|Reason Not Specified|0|||
23571996|NCT02769065|65824669|FG022|Overall Study|Reason Not Specified|0|||
23571997|NCT02769065|65824670|FG023|Overall Study|Reason Not Specified|0|||
23571998|NCT02769065|65824671|FG024|Overall Study|Reason Not Specified|0|||
23571999|NCT02769065|65824672|FG025|Overall Study|Reason Not Specified|0|||
23572000|NCT02769065|65824673|FG026|Overall Study|Reason Not Specified|0|||
23572001|NCT02769065|65824674|FG027|Overall Study|Reason Not Specified|0|||
23572002|NCT02769065|65824675|FG028|Overall Study|Reason Not Specified|0|||
23572003|NCT02769065|65824676|FG029|Overall Study|Reason Not Specified|0|||
23572004|NCT02769065|65824647|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572005|NCT02769065|65824648|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572006|NCT02769065|65824649|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572007|NCT02769065|65824650|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572008|NCT02769065|65824651|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572009|NCT02769065|65824652|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572010|NCT02769065|65824653|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572011|NCT02769065|65824654|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572012|NCT02769065|65824655|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572013|NCT02769065|65824656|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
23770552|NCT01345019|66539571|FG000|Blinded Treatment Phase|Death|147|||
23770553|NCT01345019|66539572|FG001|Blinded Treatment Phase|Death|137|||
23572014|NCT02769065|65824657|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
23572015|NCT02769065|65824658|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572016|NCT02769065|65824659|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572017|NCT02769065|65824660|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572018|NCT02769065|65824661|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572019|NCT02769065|65824662|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572020|NCT02769065|65824663|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
23770554|NCT01345019|66539571|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
23632576|NCT01381575|66041892|FG002|Overall Study|Withdrawal by Subject|7|||
23632577|NCT01381575|66041890|FG000|Overall Study|Migrated/moved from study area|2|||
23632578|NCT01381575|66041891|FG001|Overall Study|Migrated/moved from study area|12|||
23632579|NCT01381575|66041892|FG002|Overall Study|Migrated/moved from study area|2|||
23632580|NCT01381575|66041890|FG000|Overall Study|Lost to Follow-up|8|||
23632581|NCT01381575|66041891|FG001|Overall Study|Lost to Follow-up|17|||
23770555|NCT01345019|66539572|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
23770556|NCT01345019|66539571|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
23770557|NCT01345019|66539572|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
23770558|NCT01345019|66539571|FG000|Blinded Treatment Phase|Disease Progression|12|||
23770559|NCT01345019|66539572|FG001|Blinded Treatment Phase|Disease Progression|10|||
23770560|NCT01345019|66539571|FG000|Blinded Treatment Phase|Adverse Event|6|||
23770561|NCT01345019|66539572|FG001|Blinded Treatment Phase|Adverse Event|13|||
23770562|NCT01345019|66539571|FG000|Blinded Treatment Phase|Administrative Decision|10|||
23770563|NCT01345019|66539572|FG001|Blinded Treatment Phase|Administrative Decision|8|||
23572021|NCT02769065|65824664|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572022|NCT02769065|65824665|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
23770564|NCT01345019|66539571|FG000|Blinded Treatment Phase|Noncompliance|5|||
23770565|NCT01345019|66539572|FG001|Blinded Treatment Phase|Noncompliance|3|||
23770566|NCT01345019|66539571|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
23831254|NCT00413699|66760193|FG000|Initial Period|Study terminated by Sponsor|0|||
23831255|NCT00413699|66760194|FG001|Initial Period|Study terminated by Sponsor|1|||
23831256|NCT00413699|66760195|FG002|Initial Period|Study terminated by Sponsor|0|||
23831257|NCT00413699|66760193|FG000|Initial Period|Other|67|||
23831258|NCT00413699|66760194|FG001|Initial Period|Other|211|||
23831259|NCT00413699|66760195|FG002|Initial Period|Other|0|||
23831260|NCT00413699|66760193|FG000|Initial Period|Adverse event related to study drug|178|||
23831261|NCT00413699|66760194|FG001|Initial Period|Adverse event related to study drug|527|||
23831262|NCT00413699|66760195|FG002|Initial Period|Adverse event related to study drug|0|||
23831263|NCT00413699|66760193|FG000|Initial Period|Adverse event not related to study drug|113|||
23831264|NCT00413699|66760194|FG001|Initial Period|Adverse event not related to study drug|248|||
23831265|NCT00413699|66760195|FG002|Initial Period|Adverse event not related to study drug|0|||
23831266|NCT00413699|66760193|FG000|Initial Period|Missing end of study page|0|||
23831267|NCT00413699|66760194|FG001|Initial Period|Missing end of study page|4|||
23831268|NCT00413699|66760195|FG002|Initial Period|Missing end of study page|0|||
23831269|NCT00413699|66760193|FG000|Initial Period|No longer willing to participate|116|||
23831270|NCT00413699|66760194|FG001|Initial Period|No longer willing to participate|368|||
23831271|NCT00413699|66760195|FG002|Initial Period|No longer willing to participate|0|||
23831272|NCT00413699|66760193|FG000|Extension Period|No Longer Willing to Participate|0|||
23831273|NCT00413699|66760194|FG001|Extension Period|No Longer Willing to Participate|0|||
23831274|NCT00413699|66760195|FG002|Extension Period|No Longer Willing to Participate|2|||
23831275|NCT00413699|66760193|FG000|Extension Period|Protocol Violation|0|||
23831276|NCT00413699|66760194|FG001|Extension Period|Protocol Violation|0|||
23831277|NCT00413699|66760195|FG002|Extension Period|Protocol Violation|1|||
23831278|NCT00413699|66760193|FG000|Extension Period|Adverse Event|0|||
23831279|NCT00413699|66760194|FG001|Extension Period|Adverse Event|0|||
23831280|NCT00413699|66760195|FG002|Extension Period|Adverse Event|2|||
23831281|NCT04871776|66760196|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
23831282|NCT04871776|66760197|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
23831283|NCT04871776|66760198|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
23831284|NCT04871776|66760196|FG000|Overall Study|Did not meet eligibility criteria|1|||
23831285|NCT04871776|66760197|FG001|Overall Study|Did not meet eligibility criteria|1|||
23831286|NCT04871776|66760198|FG002|Overall Study|Did not meet eligibility criteria|1|||
23831287|NCT02942017|66762959|FG000|Overall Study|Adverse Event|0|||
23572023|NCT02769065|65824666|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572024|NCT02769065|65824667|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572025|NCT02769065|65824668|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572026|NCT02769065|65824669|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572027|NCT02769065|65824670|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572028|NCT02769065|65824671|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572029|NCT02769065|65824672|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572030|NCT02769065|65824673|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572031|NCT02769065|65824674|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572032|NCT02769065|65824675|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
23632582|NCT01381575|66041892|FG002|Overall Study|Lost to Follow-up|9|||
23770567|NCT01345019|66539572|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
23770568|NCT01345019|66539571|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
23831288|NCT02942017|66762960|FG001|Overall Study|Adverse Event|1|||
23831289|NCT02942017|66762959|FG000|Overall Study|Withdrawal by Subject|0|||
23831290|NCT02942017|66762960|FG001|Overall Study|Withdrawal by Subject|1|||
23572033|NCT02769065|65824676|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
23831291|NCT02942017|66762959|FG000|Overall Study|Lost to Follow-up|1|||
23831292|NCT02942017|66762960|FG001|Overall Study|Lost to Follow-up|1|||
23831293|NCT02942017|66762959|FG000|Overall Study|Randomized but not dosed|1|||
23831294|NCT02942017|66762960|FG001|Overall Study|Randomized but not dosed|3|||
23831295|NCT03214224|66762961|FG000|Overall Study|Protocol Violation|1|||
23831296|NCT03214224|66762961|FG000|Overall Study|Withdrawal by Subject|2|||
23831297|NCT03214224|66762961|FG000|Overall Study|Practice controls or therapists|6|||
23831298|NCT03194542|66762962|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
23831299|NCT03194542|66762963|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23831300|NCT03194542|66762964|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23831301|NCT03194542|66762965|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23831302|NCT03194542|66762962|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
23831303|NCT03194542|66762963|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
23831304|NCT03194542|66762964|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
23831305|NCT03194542|66762965|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
23831306|NCT03194542|66762962|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
23831307|NCT03194542|66762963|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
23831308|NCT03194542|66762964|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
23831309|NCT03194542|66762965|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
23831310|NCT03194542|66762962|FG000|Overall Study|Loss of Response|4|||
23831311|NCT03194542|66762963|FG001|Overall Study|Loss of Response|2|||
23831312|NCT03194542|66762964|FG002|Overall Study|Loss of Response|3|||
23831313|NCT03194542|66762965|FG003|Overall Study|Loss of Response|4|||
23831314|NCT03194542|66762962|FG000|Overall Study|Physician Decision|0|||
23831315|NCT03194542|66762963|FG001|Overall Study|Physician Decision|1|||
23831316|NCT03194542|66762964|FG002|Overall Study|Physician Decision|0|||
23831317|NCT03194542|66762965|FG003|Overall Study|Physician Decision|0|||
23831318|NCT03194542|66762962|FG000|Overall Study|Lack of Efficacy|2|||
23831319|NCT03194542|66762963|FG001|Overall Study|Lack of Efficacy|2|||
23831320|NCT03194542|66762964|FG002|Overall Study|Lack of Efficacy|2|||
23831321|NCT03194542|66762965|FG003|Overall Study|Lack of Efficacy|6|||
23831322|NCT03194542|66762962|FG000|Overall Study|Withdrawal by Subject|2|||
23831323|NCT03194542|66762963|FG001|Overall Study|Withdrawal by Subject|1|||
23831324|NCT03194542|66762964|FG002|Overall Study|Withdrawal by Subject|5|||
23831325|NCT03194542|66762965|FG003|Overall Study|Withdrawal by Subject|4|||
23831326|NCT03194542|66762962|FG000|Overall Study|Progressive Disease|1|||
23831327|NCT03194542|66762963|FG001|Overall Study|Progressive Disease|0|||
23831328|NCT03194542|66762964|FG002|Overall Study|Progressive Disease|1|||
23831329|NCT03194542|66762965|FG003|Overall Study|Progressive Disease|1|||
23831330|NCT03194542|66762962|FG000|Overall Study|Adverse Event|1|||
23831331|NCT03194542|66762963|FG001|Overall Study|Adverse Event|2|||
23831332|NCT03194542|66762964|FG002|Overall Study|Adverse Event|0|||
23831333|NCT03194542|66762965|FG003|Overall Study|Adverse Event|5|||
23831334|NCT03194542|66762962|FG000|Overall Study|Death|1|||
23831335|NCT03194542|66762963|FG001|Overall Study|Death|2|||
23831336|NCT03194542|66762964|FG002|Overall Study|Death|0|||
23831337|NCT03194542|66762965|FG003|Overall Study|Death|5|||
23831338|NCT03194542|66762962|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
23831339|NCT03194542|66762963|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
23831340|NCT03194542|66762964|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
23831341|NCT03194542|66762965|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
23831342|NCT01692626|66762966|FG000|Overall Study|Death|0|||
23831343|NCT01692626|66762967|FG001|Overall Study|Death|1|||
23831344|NCT01692626|66762966|FG000|Overall Study|Adverse Event|2|||
23831345|NCT01692626|66762967|FG001|Overall Study|Adverse Event|3|||
23831346|NCT01692626|66762966|FG000|Overall Study|Protocol Violation|1|||
23831347|NCT01692626|66762967|FG001|Overall Study|Protocol Violation|2|||
23831348|NCT01692626|66762966|FG000|Overall Study|Withdrawal by Subject|1|||
23831349|NCT01692626|66762967|FG001|Overall Study|Withdrawal by Subject|0|||
23831350|NCT00720213|66762968|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
23831351|NCT00720213|66762969|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
23831352|NCT00720213|66762970|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
23831353|NCT04011722|66762971|FG000|30 Days|Death|5|||
23831354|NCT04011722|66762972|FG001|30 Days|Death|1|||
23831355|NCT04011722|66762971|FG000|1 Year|Death|13|||
23831356|NCT04011722|66762972|FG001|1 Year|Death|5|||
23831357|NCT04011722|66762971|FG000|1 Year|Withdrawal by Subject|8|||
23831358|NCT04011722|66762972|FG001|1 Year|Withdrawal by Subject|2|||
23831359|NCT04011722|66762971|FG000|1 Year|Missed Visit|6|||
23831360|NCT04011722|66762972|FG001|1 Year|Missed Visit|1|||
23831361|NCT04011722|66762971|FG000|1 Year|Pending Visit|0|||
23831362|NCT04011722|66762972|FG001|1 Year|Pending Visit|11|||
23831363|NCT04011722|66762971|FG000|1 Year|Not Yet Due|0|||
23831364|NCT04011722|66762972|FG001|1 Year|Not Yet Due|9|||
23831365|NCT04011722|66762971|FG000|2 Year|Death|16|||
23770569|NCT01345019|66539572|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
23770570|NCT01345019|66539571|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
23770571|NCT01345019|66539572|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
23770572|NCT01345019|66539571|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
23770573|NCT01345019|66539572|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
23770574|NCT01345019|66539571|FG000|Open Label Treatment Phase|Death|49|||
23770575|NCT01345019|66539572|FG001|Open Label Treatment Phase|Death|48|||
23770576|NCT01345019|66539571|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
23770577|NCT01345019|66539572|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
23770578|NCT01345019|66539571|FG000|Open Label Treatment Phase|Adverse Event|30|||
23770579|NCT01345019|66539572|FG001|Open Label Treatment Phase|Adverse Event|51|||
23770580|NCT01345019|66539571|FG000|Open Label Treatment Phase|Administrative Decision|30|||
23770581|NCT01345019|66539572|FG001|Open Label Treatment Phase|Administrative Decision|15|||
23770582|NCT01345019|66539571|FG000|Open Label Treatment Phase|Disease Progression|17|||
23770583|NCT01345019|66539572|FG001|Open Label Treatment Phase|Disease Progression|18|||
23770584|NCT01345019|66539571|FG000|Open Label Treatment Phase|Noncompliance|5|||
23770585|NCT01345019|66539572|FG001|Open Label Treatment Phase|Noncompliance|4|||
23770586|NCT01345019|66539571|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
23770587|NCT01345019|66539572|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
23770588|NCT01345019|66539571|FG000|Open Label Treatment Phase|Pregnancy|1|||
23770589|NCT01345019|66539572|FG001|Open Label Treatment Phase|Pregnancy|0|||
23770590|NCT01345019|66539571|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
23632583|NCT01294397|66041893|FG000|Overall Study|Withdrawal by Subject|1|||
23632584|NCT01294397|66041893|FG000|Overall Study|Administrative Decision|1|||
23632585|NCT01989169|66041894|FG000|Period 2|Adverse Event|0|||
23632586|NCT01989169|66041895|FG001|Period 2|Adverse Event|1|||
23632587|NCT01939353|66041898|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
23632588|NCT01939353|66041898|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
23632589|NCT01939353|66041898|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
23632590|NCT01939353|66041898|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23770591|NCT01345019|66539572|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
23770592|NCT01345019|66539571|FG000|Open Label Treatment Phase|Protocol Violation|0|||
23770593|NCT01345019|66539572|FG001|Open Label Treatment Phase|Protocol Violation|1|||
23770594|NCT00356200|66539577|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
23770595|NCT00356200|66539578|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
23770596|NCT00356200|66539577|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
23770597|NCT00356200|66539578|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
23770598|NCT00777829|66539579|FG000|Overall Study|Withdrawal by Subject|0|||
23770599|NCT00777829|66539580|FG001|Overall Study|Withdrawal by Subject|2|||
23770600|NCT01338636|66539584|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
23770601|NCT00634907|66539586|FG000|Overall Study|Withdrawal by Subject|3|||
23770602|NCT00634907|66539587|FG001|Overall Study|Withdrawal by Subject|0|||
23770603|NCT00634907|66539586|FG000|Overall Study|Physician Decision|3|||
23770604|NCT00634907|66539587|FG001|Overall Study|Physician Decision|9|||
23770605|NCT00634907|66539586|FG000|Overall Study|Withdrawal by Subject|11|||
23770606|NCT00634907|66539587|FG001|Overall Study|Withdrawal by Subject|8|||
23770607|NCT00108732|66539590|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
23770608|NCT00108732|66539590|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
23770609|NCT00108732|66539590|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
23770610|NCT00108732|66539590|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
23770611|NCT00108732|66539590|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
23770612|NCT00108732|66539590|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
23770613|NCT00108732|66539590|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
23770614|NCT01620177|66539591|FG000|Overall Study|Failure at Screening Visit|43|||
23770615|NCT01620177|66539591|FG000|Overall Study|Withdrawal by Subject|26|||
23770616|NCT01620177|66539591|FG000|Overall Study|Lost to Follow-up|7|||
23770617|NCT01620177|66539591|FG000|Overall Study|Physician Decision|2|||
23770618|NCT01620177|66539591|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
23770619|NCT02201251|66539594|FG000|Overall Study|Adverse Event|1|||
23770620|NCT02201251|66539595|FG001|Overall Study|Adverse Event|1|||
23770621|NCT02201251|66539594|FG000|Overall Study|Protocol Violation|1|||
23770622|NCT02201251|66539595|FG001|Overall Study|Protocol Violation|0|||
23770623|NCT02201251|66539594|FG000|Overall Study|Noncompliance with Study Drug|0|||
23632591|NCT01939353|66041898|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
23632592|NCT02271984|66041899|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632593|NCT02271984|66041900|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23770624|NCT02201251|66539595|FG001|Overall Study|Noncompliance with Study Drug|1|||
23770625|NCT02201251|66539594|FG000|Overall Study|Withdrawal by Subject|2|||
23770626|NCT02201251|66539595|FG001|Overall Study|Withdrawal by Subject|1|||
23770627|NCT01759290|66539597|FG000|Overall Study|Subjects withdrawn consent|5|||
23770628|NCT01759290|66539597|FG000|Overall Study|Physician Decision|2|||
23632594|NCT02271984|66041901|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23770629|NCT01759290|66539597|FG000|Overall Study|Death|17|||
23770630|NCT01759290|66539597|FG000|Overall Study|Lost to Follow-up|53|||
23770631|NCT01759290|66539597|FG000|Overall Study|Unknown reason|4|||
23770632|NCT04099888|66539607|FG000|Overall Study|Study terminated by sponsor|9|||
23770633|NCT04099888|66539608|FG001|Overall Study|Study terminated by sponsor|11|||
23770634|NCT04099888|66539607|FG000|Overall Study|Lost to Follow-up|1|||
23770635|NCT04099888|66539608|FG001|Overall Study|Lost to Follow-up|1|||
23770636|NCT04099888|66539607|FG000|Overall Study|Withdrawal by Subject|5|||
23770637|NCT04099888|66539608|FG001|Overall Study|Withdrawal by Subject|6|||
23770638|NCT04099888|66539607|FG000|Overall Study|Death|5|||
23770639|NCT04099888|66539608|FG001|Overall Study|Death|2|||
23770640|NCT04099888|66539607|FG000|Overall Study|Other|1|||
23770641|NCT04099888|66539608|FG001|Overall Study|Other|0|||
23770642|NCT01531205|66539609|FG000|Overall Study|Did not proceed to surgery|1|||
23831366|NCT04011722|66762972|FG001|2 Year|Death|1|||
23831367|NCT04011722|66762971|FG000|2 Year|Withdrawal by Subject|10|||
23831368|NCT04011722|66762972|FG001|2 Year|Withdrawal by Subject|1|||
23831369|NCT04011722|66762971|FG000|2 Year|Missed Visit|9|||
23770643|NCT03038113|66539612|FG000|Overall Study|Withdrawal by Subject|0|||
23770644|NCT03038113|66539613|FG001|Overall Study|Withdrawal by Subject|0|||
23770645|NCT03038113|66539614|FG002|Overall Study|Withdrawal by Subject|1|||
23770646|NCT03038113|66539615|FG003|Overall Study|Withdrawal by Subject|0|||
23770647|NCT03038113|66539616|FG004|Overall Study|Withdrawal by Subject|0|||
23770648|NCT03038113|66539617|FG005|Overall Study|Withdrawal by Subject|0|||
23770649|NCT03038113|66539618|FG006|Overall Study|Withdrawal by Subject|0|||
23770650|NCT03038113|66539619|FG007|Overall Study|Withdrawal by Subject|0|||
23770651|NCT03038113|66539620|FG008|Overall Study|Withdrawal by Subject|0|||
23770652|NCT03038113|66539621|FG009|Overall Study|Withdrawal by Subject|0|||
23770653|NCT03038113|66539622|FG010|Overall Study|Withdrawal by Subject|0|||
23831370|NCT04011722|66762972|FG001|2 Year|Missed Visit|0|||
23831371|NCT04011722|66762971|FG000|2 Year|Visit Pending|1|||
23831372|NCT04011722|66762972|FG001|2 Year|Visit Pending|3|||
23831373|NCT04011722|66762971|FG000|2 Year|Not Yet Due|43|||
23831374|NCT04011722|66762972|FG001|2 Year|Not Yet Due|54|||
23831375|NCT04011722|66762971|FG000|3 Year|Death|10|||
23831376|NCT04011722|66762972|FG001|3 Year|Death|0|||
23831377|NCT04011722|66762971|FG000|3 Year|Withdrawal by Subject|2|||
23831378|NCT04011722|66762972|FG001|3 Year|Withdrawal by Subject|0|||
23831379|NCT04011722|66762971|FG000|3 Year|Missed Visit|2|||
23831380|NCT04011722|66762972|FG001|3 Year|Missed Visit|0|||
23831381|NCT04011722|66762971|FG000|3 Year|Pending Visit|34|||
23831382|NCT04011722|66762972|FG001|3 Year|Pending Visit|0|||
23831383|NCT04011722|66762971|FG000|3 Year|Not Yet Due|99|||
23831384|NCT04011722|66762972|FG001|3 Year|Not Yet Due|0|||
23831385|NCT00712712|66762977|FG000|Overall Study|Protocol Violation|11|||
23831386|NCT00712712|66762977|FG000|Overall Study|Radiofrequency not done|3|||
23831387|NCT00712712|66762977|FG000|Overall Study|Death|8|||
23831388|NCT00712712|66762977|FG000|Overall Study|Withdrawal by Subject|1|||
23831389|NCT03181633|66762978|FG000|Overall Study|Withdrawal by Subject|1|||
23831390|NCT03181633|66762978|FG000|Overall Study|Missing follow-up visit|1|||
23831391|NCT00745901|66762979|FG000|Overall Study|Adverse Event|3|||
23831392|NCT00745901|66762980|FG001|Overall Study|Adverse Event|4|||
23831393|NCT00745901|66762979|FG000|Overall Study|Protocol Violation|0|||
23831394|NCT00745901|66762980|FG001|Overall Study|Protocol Violation|1|||
23831395|NCT00745901|66762979|FG000|Overall Study|Withdrawal by Subject|1|||
23831396|NCT00745901|66762980|FG001|Overall Study|Withdrawal by Subject|0|||
23831397|NCT00745901|66762979|FG000|Overall Study|Lost to Follow-up|7|||
23831398|NCT00745901|66762980|FG001|Overall Study|Lost to Follow-up|4|||
23831399|NCT00745901|66762979|FG000|Overall Study|Pregnancy|2|||
23831400|NCT00745901|66762980|FG001|Overall Study|Pregnancy|4|||
23831401|NCT00745901|66762979|FG000|Overall Study|Lack of compliance|2|||
23770654|NCT03038113|66539623|FG011|Overall Study|Withdrawal by Subject|0|||
23447165|NCT00596752|65377896|FG000|Overall Study|Lack of Efficacy|4|||
23447166|NCT00596752|65377897|FG001|Overall Study|Lack of Efficacy|7|||
23447167|NCT00596752|65377896|FG000|Overall Study|Protocol Violation|1|||
23770655|NCT03038113|66539624|FG012|Overall Study|Withdrawal by Subject|0|||
23770656|NCT03038113|66539625|FG013|Overall Study|Withdrawal by Subject|1|||
23770657|NCT03038113|66539612|FG000|Overall Study|Lost to Follow-up|0|||
23770658|NCT03038113|66539613|FG001|Overall Study|Lost to Follow-up|0|||
23770659|NCT03038113|66539614|FG002|Overall Study|Lost to Follow-up|0|||
23831402|NCT00745901|66762980|FG001|Overall Study|Lack of compliance|2|||
23831403|NCT00745901|66762979|FG000|Overall Study|Patient's next menses did not start with|1|||
23831404|NCT00745901|66762980|FG001|Overall Study|Patient's next menses did not start with|0|||
23831405|NCT00745901|66762979|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
23831406|NCT00745901|66762980|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
23831407|NCT00745901|66762979|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
23831408|NCT00745901|66762980|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
23831409|NCT00745901|66762979|FG000|Overall Study|Patient didn't take any study medication|7|||
23831410|NCT00745901|66762980|FG001|Overall Study|Patient didn't take any study medication|3|||
23831411|NCT03751098|66762981|FG000|Overall Study|Withdrawal by Subject|0|||
23831412|NCT03751098|66762982|FG001|Overall Study|Withdrawal by Subject|1|||
23831413|NCT01982682|66762985|FG000|Overall Study|Physician Decision|1|||
23831414|NCT00897715|66762989|FG000|Overall Study|Lost to Follow-up|0|||
23572034|NCT01349660|65824679|FG000|Overall Study|Still Receiving Study Treatment|0|||
23572035|NCT01349660|65824680|FG001|Overall Study|Still Receiving Study Treatment|0|||
23632595|NCT02271984|66041902|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632596|NCT02271984|66041903|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23572036|NCT01349660|65824681|FG002|Overall Study|Still Receiving Study Treatment|1|||
23632597|NCT02271984|66041904|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23632598|NCT02271984|66041905|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632599|NCT02271984|66041906|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23632600|NCT02271984|66041907|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632601|NCT02271984|66041908|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632602|NCT02271984|66041909|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632603|NCT02271984|66041910|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23632604|NCT00895895|66041912|FG000|Period 1|Adverse Event|7|||
23632605|NCT00895895|66041913|FG001|Period 1|Adverse Event|6|||
23632606|NCT00895895|66041914|FG002|Period 1|Adverse Event|4|||
23632607|NCT00895895|66041915|FG003|Period 1|Adverse Event|6|||
23632608|NCT00895895|66041916|FG004|Period 1|Adverse Event|7|||
23632609|NCT00895895|66041912|FG000|Period 1|Death|0|||
23632610|NCT00895895|66041913|FG001|Period 1|Death|0|||
23632611|NCT00895895|66041914|FG002|Period 1|Death|0|||
23632612|NCT00895895|66041915|FG003|Period 1|Death|0|||
23632613|NCT00895895|66041916|FG004|Period 1|Death|1|||
23632614|NCT00895895|66041912|FG000|Period 1|discontinued by sponsor|2|||
23632615|NCT00895895|66041913|FG001|Period 1|discontinued by sponsor|1|||
23632616|NCT00895895|66041914|FG002|Period 1|discontinued by sponsor|2|||
23632617|NCT00895895|66041915|FG003|Period 1|discontinued by sponsor|1|||
23632618|NCT00895895|66041916|FG004|Period 1|discontinued by sponsor|1|||
23632619|NCT00895895|66041912|FG000|Period 1|failed to return|0|||
23632620|NCT00895895|66041913|FG001|Period 1|failed to return|0|||
23632621|NCT00895895|66041914|FG002|Period 1|failed to return|1|||
23632622|NCT00895895|66041915|FG003|Period 1|failed to return|0|||
23632623|NCT00895895|66041916|FG004|Period 1|failed to return|1|||
23632624|NCT00895895|66041912|FG000|Period 1|investigator request|0|||
23632625|NCT00895895|66041913|FG001|Period 1|investigator request|1|||
23632626|NCT00895895|66041914|FG002|Period 1|investigator request|0|||
23632627|NCT00895895|66041915|FG003|Period 1|investigator request|0|||
23632628|NCT00895895|66041916|FG004|Period 1|investigator request|0|||
23632629|NCT00895895|66041912|FG000|Period 1|Lost to Follow-up|2|||
23632630|NCT00895895|66041913|FG001|Period 1|Lost to Follow-up|1|||
23632631|NCT00895895|66041914|FG002|Period 1|Lost to Follow-up|3|||
23632632|NCT00895895|66041915|FG003|Period 1|Lost to Follow-up|2|||
23632633|NCT00895895|66041916|FG004|Period 1|Lost to Follow-up|3|||
23632634|NCT00895895|66041912|FG000|Period 1|Other|1|||
23632635|NCT00895895|66041913|FG001|Period 1|Other|2|||
23632636|NCT00895895|66041914|FG002|Period 1|Other|1|||
23632637|NCT00895895|66041915|FG003|Period 1|Other|1|||
23632638|NCT00895895|66041916|FG004|Period 1|Other|1|||
23632639|NCT00895895|66041912|FG000|Period 1|Protocol Violation|0|||
23632640|NCT00895895|66041913|FG001|Period 1|Protocol Violation|1|||
23632641|NCT00895895|66041914|FG002|Period 1|Protocol Violation|0|||
23632642|NCT00895895|66041915|FG003|Period 1|Protocol Violation|0|||
23632643|NCT00895895|66041916|FG004|Period 1|Protocol Violation|0|||
23632644|NCT00895895|66041912|FG000|Period 1|Withdrawal by Subject|6|||
23831415|NCT00897715|66762990|FG001|Overall Study|Lost to Follow-up|1|||
23831416|NCT00897715|66762989|FG000|Overall Study|Physician Decision|1|||
23572037|NCT01349660|65824679|FG000|Overall Study|Disease Progression|2|||
23572038|NCT01349660|65824680|FG001|Overall Study|Disease Progression|4|||
23572039|NCT01349660|65824681|FG002|Overall Study|Disease Progression|50|||
23572040|NCT01349660|65824679|FG000|Overall Study|Adverse Event|1|||
23572041|NCT01349660|65824680|FG001|Overall Study|Adverse Event|1|||
23632645|NCT00895895|66041913|FG001|Period 1|Withdrawal by Subject|6|||
23632646|NCT00895895|66041914|FG002|Period 1|Withdrawal by Subject|8|||
23632647|NCT00895895|66041915|FG003|Period 1|Withdrawal by Subject|2|||
23632648|NCT00895895|66041916|FG004|Period 1|Withdrawal by Subject|4|||
23632649|NCT00895895|66041912|FG000|Period 1|unsatisfactory response-efficacy|2|||
23632650|NCT00895895|66041913|FG001|Period 1|unsatisfactory response-efficacy|0|||
23632651|NCT00895895|66041914|FG002|Period 1|unsatisfactory response-efficacy|0|||
23632652|NCT00895895|66041915|FG003|Period 1|unsatisfactory response-efficacy|0|||
23632653|NCT00895895|66041916|FG004|Period 1|unsatisfactory response-efficacy|0|||
23632654|NCT00895895|66041912|FG000|Period 1|randomized and not treated|1|||
23632655|NCT00895895|66041913|FG001|Period 1|randomized and not treated|3|||
23632656|NCT00895895|66041914|FG002|Period 1|randomized and not treated|1|||
23632657|NCT00895895|66041915|FG003|Period 1|randomized and not treated|1|||
23632658|NCT00895895|66041916|FG004|Period 1|randomized and not treated|2|||
23632659|NCT00895895|66041912|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
23831417|NCT00897715|66762990|FG001|Overall Study|Physician Decision|0|||
23572042|NCT01349660|65824681|FG002|Overall Study|Adverse Event|12|||
23572043|NCT01349660|65824679|FG000|Overall Study|Withdrawal by Subject|2|||
23572044|NCT01349660|65824680|FG001|Overall Study|Withdrawal by Subject|0|||
23572045|NCT01349660|65824681|FG002|Overall Study|Withdrawal by Subject|9|||
23572046|NCT01349660|65824679|FG000|Overall Study|Death|1|||
23572047|NCT01349660|65824680|FG001|Overall Study|Death|1|||
23572048|NCT01349660|65824681|FG002|Overall Study|Death|0|||
23572049|NCT01349660|65824679|FG000|Overall Study|Non-Permitted Interventions|0|||
23572050|NCT01349660|65824680|FG001|Overall Study|Non-Permitted Interventions|0|||
23572051|NCT01349660|65824681|FG002|Overall Study|Non-Permitted Interventions|2|||
23572052|NCT01349660|65824679|FG000|Overall Study|Study Compliance|0|||
23572053|NCT01349660|65824680|FG001|Overall Study|Study Compliance|0|||
23572054|NCT01349660|65824681|FG002|Overall Study|Study Compliance|1|||
23572055|NCT01349660|65824679|FG000|Overall Study|Declining Performance Status|0|||
23572056|NCT01349660|65824680|FG001|Overall Study|Declining Performance Status|0|||
23572057|NCT01349660|65824681|FG002|Overall Study|Declining Performance Status|1|||
23572058|NCT04908683|65824682|FG000|Overall Study|Failure to meet continuation criteria|34|||
23572059|NCT04908683|65824683|FG001|Overall Study|Failure to meet continuation criteria|22|||
23572060|NCT04908683|65824682|FG000|Overall Study|Initiated prohibited medication|3|||
23572061|NCT04908683|65824683|FG001|Overall Study|Initiated prohibited medication|0|||
23572062|NCT04908683|65824682|FG000|Overall Study|Randomized by mistake|1|||
23572063|NCT04908683|65824683|FG001|Overall Study|Randomized by mistake|0|||
23572064|NCT04908683|65824682|FG000|Overall Study|Lost to Follow-up|679|||
23572065|NCT04908683|65824683|FG001|Overall Study|Lost to Follow-up|341|||
23572066|NCT04908683|65824682|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
23572067|NCT04908683|65824683|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
23572068|NCT04908683|65824682|FG000|Overall Study|Physician Decision|44|||
23572069|NCT04908683|65824683|FG001|Overall Study|Physician Decision|35|||
23572070|NCT04908683|65824682|FG000|Overall Study|Technical problems|12|||
23572071|NCT04908683|65824683|FG001|Overall Study|Technical problems|9|||
23572072|NCT04908683|65824682|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
23572073|NCT04908683|65824683|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
23572074|NCT04908683|65824682|FG000|Overall Study|Protocol Violation|2|||
23572075|NCT04908683|65824683|FG001|Overall Study|Protocol Violation|0|||
23572076|NCT04908683|65824682|FG000|Overall Study|Withdrawal by Subject|1188|||
23572077|NCT04908683|65824683|FG001|Overall Study|Withdrawal by Subject|570|||
23572078|NCT04908683|65824682|FG000|Overall Study|Site Closure by Sponsor|6|||
23572079|NCT04908683|65824683|FG001|Overall Study|Site Closure by Sponsor|3|||
23572080|NCT04908683|65824682|FG000|Overall Study|Adverse Event|21|||
23572081|NCT04908683|65824683|FG001|Overall Study|Adverse Event|11|||
23572082|NCT04908683|65824682|FG000|Overall Study|Death|101|||
23572083|NCT04908683|65824683|FG001|Overall Study|Death|61|||
23572084|NCT04908683|65824682|FG000|Overall Study|Sponsor's decision|14398|||
23572085|NCT04908683|65824683|FG001|Overall Study|Sponsor's decision|7205|||
23572086|NCT04908683|65824682|FG000|Overall Study|Other|92|||
23572087|NCT04908683|65824683|FG001|Overall Study|Other|50|||
23572088|NCT04908683|65824682|FG000|Overall Study|Randomized not vaccinated|108|||
23572089|NCT04908683|65824683|FG001|Overall Study|Randomized not vaccinated|52|||
23572090|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
23572091|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
23572092|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
23572093|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
23572094|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
23572095|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
23572096|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
23572097|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
23572098|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
23572099|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
23572100|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
23572101|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
23572102|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
23572103|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
23572104|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
23572105|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
23572106|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
23572107|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
23572108|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
23572109|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
23572110|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
23572111|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
23572112|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
23632660|NCT00895895|66041913|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
23632661|NCT00895895|66041914|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
23632662|NCT00895895|66041915|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
23632663|NCT00895895|66041916|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
23770660|NCT03038113|66539615|FG003|Overall Study|Lost to Follow-up|0|||
23770661|NCT03038113|66539616|FG004|Overall Study|Lost to Follow-up|0|||
23770662|NCT03038113|66539617|FG005|Overall Study|Lost to Follow-up|0|||
23770663|NCT03038113|66539618|FG006|Overall Study|Lost to Follow-up|1|||
23770664|NCT03038113|66539619|FG007|Overall Study|Lost to Follow-up|0|||
23770665|NCT03038113|66539620|FG008|Overall Study|Lost to Follow-up|0|||
23770666|NCT03038113|66539621|FG009|Overall Study|Lost to Follow-up|0|||
23770667|NCT03038113|66539622|FG010|Overall Study|Lost to Follow-up|0|||
23770668|NCT03038113|66539623|FG011|Overall Study|Lost to Follow-up|0|||
23770669|NCT03038113|66539624|FG012|Overall Study|Lost to Follow-up|0|||
23770670|NCT03038113|66539625|FG013|Overall Study|Lost to Follow-up|0|||
23770671|NCT01569152|66539627|FG000|Phase IIa, Period 1|Early Escape|5|||
23770672|NCT01569152|66539628|FG001|Phase IIa, Period 1|Early Escape|22|||
23770673|NCT01569152|66539629|FG002|Phase IIa, Period 1|Early Escape|0|||
23770674|NCT01569152|66539627|FG000|Phase IIa, Period 1|Adverse Event|4|||
23770675|NCT01569152|66539628|FG001|Phase IIa, Period 1|Adverse Event|0|||
23770676|NCT01569152|66539629|FG002|Phase IIa, Period 1|Adverse Event|0|||
23770677|NCT01569152|66539627|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
23770678|NCT01569152|66539628|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
23770679|NCT01569152|66539629|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
23770680|NCT01569152|66539627|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
23770681|NCT01569152|66539628|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
23770682|NCT01569152|66539629|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
23770683|NCT01569152|66539627|FG000|Phase IIa, Period 1|Protocol Violation|0|||
23770684|NCT01569152|66539628|FG001|Phase IIa, Period 1|Protocol Violation|1|||
23770685|NCT01569152|66539629|FG002|Phase IIa, Period 1|Protocol Violation|0|||
23770686|NCT01569152|66539627|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
23770687|NCT01569152|66539628|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
23770688|NCT01569152|66539629|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
23770689|NCT01569152|66539627|FG000|Safety Extension, Period 3|Adverse Event|0|||
23831418|NCT00897715|66762989|FG000|Overall Study|increased risk of infection|1|||
23831419|NCT00897715|66762990|FG001|Overall Study|increased risk of infection|0|||
23831420|NCT02342678|66762991|FG000|Overall Study|Lost to Follow-up|0|||
23831421|NCT02342678|66762992|FG001|Overall Study|Lost to Follow-up|1|||
23831422|NCT02342678|66762991|FG000|Overall Study|Too busy to complete study|0|||
23831423|NCT02342678|66762992|FG001|Overall Study|Too busy to complete study|2|||
23831424|NCT02342678|66762991|FG000|Overall Study|Family illness/emergency|0|||
23831425|NCT02342678|66762992|FG001|Overall Study|Family illness/emergency|1|||
23831426|NCT02342678|66762991|FG000|Overall Study|Illness/medical reason|1|||
23831427|NCT02342678|66762992|FG001|Overall Study|Illness/medical reason|1|||
23831428|NCT03335475|66762993|FG000|Overall Study|Did not wear accelerometer|4|||
23831429|NCT03335475|66762994|FG001|Overall Study|Did not wear accelerometer|0|||
23831430|NCT03335475|66762993|FG000|Overall Study|Withdrawal by Subject|0|||
23831431|NCT03335475|66762994|FG001|Overall Study|Withdrawal by Subject|1|||
23831432|NCT02640482|66762995|FG000|Overall Study|Lost to Follow-up|3|||
23831433|NCT02640482|66762996|FG001|Overall Study|Lost to Follow-up|0|||
23831434|NCT05005507|66762997|FG000|Overall Study|Premature termination of study|1|||
23831435|NCT03655405|66762998|FG000|Overall Study|Death after initial data collection|4|||
23831436|NCT03655405|66762999|FG001|Overall Study|Death after initial data collection|2|||
23831437|NCT03655405|66762998|FG000|Overall Study|Died before initial data collection|1|||
23632664|NCT00895895|66041912|FG000|After Period 1, Prior to Period 2|Other|0|||
23632665|NCT00895895|66041913|FG001|After Period 1, Prior to Period 2|Other|0|||
23632666|NCT00895895|66041914|FG002|After Period 1, Prior to Period 2|Other|1|||
23632667|NCT00895895|66041915|FG003|After Period 1, Prior to Period 2|Other|0|||
23632668|NCT00895895|66041916|FG004|After Period 1, Prior to Period 2|Other|0|||
23632669|NCT00895895|66041912|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
23632670|NCT00895895|66041913|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
23632671|NCT00895895|66041914|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
23632672|NCT00895895|66041915|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
23831438|NCT03655405|66762999|FG001|Overall Study|Died before initial data collection|2|||
23447168|NCT00596752|65377897|FG001|Overall Study|Protocol Violation|0|||
23632673|NCT00895895|66041916|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
23632674|NCT00895895|66041912|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23770690|NCT01569152|66539628|FG001|Safety Extension, Period 3|Adverse Event|0|||
23770691|NCT01569152|66539629|FG002|Safety Extension, Period 3|Adverse Event|4|||
23770692|NCT01569152|66539627|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
23770693|NCT01569152|66539628|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
23770694|NCT01569152|66539629|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
23770695|NCT01569152|66539627|FG000|Safety Extension, Period 3|Physician Decision|0|||
23770696|NCT01569152|66539628|FG001|Safety Extension, Period 3|Physician Decision|0|||
23831439|NCT03655405|66762998|FG000|Overall Study|Protocol Violation|0|||
23770697|NCT01569152|66539629|FG002|Safety Extension, Period 3|Physician Decision|2|||
23770698|NCT01569152|66539627|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
23770699|NCT01569152|66539628|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
23572113|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
23770700|NCT01569152|66539629|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
23770701|NCT03387098|66539630|FG000|Overall Study|progressive disease|1|||
23770702|NCT03387098|66539630|FG000|Overall Study|Withdrawal by Subject|2|||
23770703|NCT03387098|66539630|FG000|Overall Study|study terminated by sponsor|1|||
23770704|NCT01829464|66539632|FG000|Overall Study|Adverse Event|1|||
23770705|NCT01829464|66539633|FG001|Overall Study|Adverse Event|0|||
23770706|NCT01829464|66539634|FG002|Overall Study|Adverse Event|0|||
23770707|NCT01829464|66539632|FG000|Overall Study|Lost to Follow-up|0|||
23770708|NCT01829464|66539633|FG001|Overall Study|Lost to Follow-up|0|||
23770709|NCT01829464|66539634|FG002|Overall Study|Lost to Follow-up|1|||
23770710|NCT01829464|66539632|FG000|Overall Study|Withdrawal by Subject|2|||
23770711|NCT01829464|66539633|FG001|Overall Study|Withdrawal by Subject|0|||
23770712|NCT01829464|66539634|FG002|Overall Study|Withdrawal by Subject|0|||
23770713|NCT01829464|66539632|FG000|Overall Study|Study terminated by sponsor|25|||
23770714|NCT01829464|66539633|FG001|Overall Study|Study terminated by sponsor|28|||
23770715|NCT01829464|66539634|FG002|Overall Study|Study terminated by sponsor|25|||
23770716|NCT01829464|66539632|FG000|Overall Study|Lack of Efficacy|0|||
23770717|NCT01829464|66539633|FG001|Overall Study|Lack of Efficacy|1|||
23572114|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
23572115|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572116|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572117|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572118|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572119|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
23572120|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572121|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572122|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572123|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
23572124|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572125|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572126|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
23572127|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
23572128|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
23572129|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
23572130|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
23572131|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
23572132|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
23572133|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
23572134|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572135|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572136|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572137|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
23572138|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572139|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572140|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
23572141|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572142|NCT04642469|65824690|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
23572143|NCT04642469|65824691|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
23572144|NCT04642469|65824690|FG000|Overall Study|Death|1|||
23572145|NCT04642469|65824691|FG001|Overall Study|Death|2|||
23572146|NCT04642469|65824690|FG000|Overall Study|Study/site closed following amendment 1|11|||
23572147|NCT04642469|65824691|FG001|Overall Study|Study/site closed following amendment 1|11|||
23572148|NCT04642469|65824690|FG000|Overall Study|Other|1|||
23572149|NCT04642469|65824691|FG001|Overall Study|Other|1|||
23572150|NCT04642469|65824690|FG000|Overall Study|Withdrawal by Subject|1|||
23572151|NCT04642469|65824691|FG001|Overall Study|Withdrawal by Subject|0|||
23572152|NCT01785628|65824697|FG000|Overall Study|Lost to Follow-up|2|||
23572153|NCT01785628|65824698|FG001|Overall Study|Lost to Follow-up|3|||
23572154|NCT03685708|65824699|FG000|Overall Study|Withdrawal by Subject|0|||
23572155|NCT03685708|65824700|FG001|Overall Study|Withdrawal by Subject|0|||
23572156|NCT03685708|65824701|FG002|Overall Study|Withdrawal by Subject|1|||
23572157|NCT03685708|65824699|FG000|Overall Study|Screen Fail|0|||
23572158|NCT03685708|65824700|FG001|Overall Study|Screen Fail|1|||
23770718|NCT01829464|66539634|FG002|Overall Study|Lack of Efficacy|0|||
23770719|NCT02994056|66539643|FG000|Overall Study|Death|8|||
23447169|NCT03077919|65377898|FG000|Overall Study|Lost to Follow-up|4|||
23447170|NCT03077919|65377899|FG001|Overall Study|Lost to Follow-up|1|||
23632675|NCT00895895|66041913|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23632676|NCT00895895|66041914|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23632677|NCT00895895|66041915|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23632678|NCT00895895|66041916|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
23632679|NCT00895895|66041912|FG000|Period 2|Adverse Event|3|||
23632680|NCT00895895|66041913|FG001|Period 2|Adverse Event|3|||
23632681|NCT00895895|66041914|FG002|Period 2|Adverse Event|5|||
23632682|NCT00895895|66041915|FG003|Period 2|Adverse Event|2|||
23632683|NCT00895895|66041916|FG004|Period 2|Adverse Event|5|||
23632684|NCT00895895|66041912|FG000|Period 2|Death|0|||
23632685|NCT00895895|66041913|FG001|Period 2|Death|0|||
23632686|NCT00895895|66041914|FG002|Period 2|Death|1|||
23632687|NCT00895895|66041915|FG003|Period 2|Death|0|||
23632688|NCT00895895|66041916|FG004|Period 2|Death|0|||
23632689|NCT00895895|66041912|FG000|Period 2|discontinued by sponsor|44|||
23632690|NCT00895895|66041913|FG001|Period 2|discontinued by sponsor|44|||
23632691|NCT00895895|66041914|FG002|Period 2|discontinued by sponsor|38|||
23632692|NCT00895895|66041915|FG003|Period 2|discontinued by sponsor|46|||
23632693|NCT00895895|66041916|FG004|Period 2|discontinued by sponsor|37|||
23632694|NCT00895895|66041912|FG000|Period 2|failed to return|2|||
23632695|NCT00895895|66041913|FG001|Period 2|failed to return|0|||
23632696|NCT00895895|66041914|FG002|Period 2|failed to return|0|||
23632697|NCT00895895|66041915|FG003|Period 2|failed to return|0|||
23632698|NCT00895895|66041916|FG004|Period 2|failed to return|0|||
23632699|NCT00895895|66041912|FG000|Period 2|investigator request|2|||
23632700|NCT00895895|66041913|FG001|Period 2|investigator request|0|||
23632701|NCT00895895|66041914|FG002|Period 2|investigator request|0|||
23632702|NCT00895895|66041915|FG003|Period 2|investigator request|0|||
23632703|NCT00895895|66041916|FG004|Period 2|investigator request|0|||
23632704|NCT00895895|66041912|FG000|Period 2|Lost to Follow-up|1|||
23632705|NCT00895895|66041913|FG001|Period 2|Lost to Follow-up|2|||
23632706|NCT00895895|66041914|FG002|Period 2|Lost to Follow-up|1|||
23632707|NCT00895895|66041915|FG003|Period 2|Lost to Follow-up|1|||
23632708|NCT00895895|66041916|FG004|Period 2|Lost to Follow-up|0|||
23632709|NCT00895895|66041912|FG000|Period 2|Other|1|||
23632710|NCT00895895|66041913|FG001|Period 2|Other|1|||
23632711|NCT00895895|66041914|FG002|Period 2|Other|3|||
23632712|NCT00895895|66041915|FG003|Period 2|Other|1|||
23632713|NCT00895895|66041916|FG004|Period 2|Other|1|||
23632714|NCT00895895|66041912|FG000|Period 2|Protocol Violation|1|||
23632715|NCT00895895|66041913|FG001|Period 2|Protocol Violation|0|||
23632716|NCT00895895|66041914|FG002|Period 2|Protocol Violation|1|||
23632717|NCT00895895|66041915|FG003|Period 2|Protocol Violation|1|||
23632718|NCT00895895|66041916|FG004|Period 2|Protocol Violation|1|||
23632719|NCT00895895|66041912|FG000|Period 2|Withdrawal by Subject|0|||
23632720|NCT00895895|66041913|FG001|Period 2|Withdrawal by Subject|2|||
23632721|NCT00895895|66041914|FG002|Period 2|Withdrawal by Subject|0|||
23632722|NCT00895895|66041915|FG003|Period 2|Withdrawal by Subject|3|||
23632723|NCT00895895|66041916|FG004|Period 2|Withdrawal by Subject|5|||
23632724|NCT00895895|66041912|FG000|Period 2|unsatisfactory response-efficacy|2|||
23632725|NCT00895895|66041913|FG001|Period 2|unsatisfactory response-efficacy|1|||
23632726|NCT00895895|66041914|FG002|Period 2|unsatisfactory response-efficacy|0|||
23632727|NCT00895895|66041915|FG003|Period 2|unsatisfactory response-efficacy|0|||
23632728|NCT00895895|66041916|FG004|Period 2|unsatisfactory response-efficacy|0|||
23632729|NCT01607476|66041917|FG000|Overall Study|Withdrawal by Subject|1|||
23632730|NCT01607476|66041918|FG001|Overall Study|Withdrawal by Subject|0|||
23632731|NCT01607476|66041919|FG002|Overall Study|Withdrawal by Subject|1|||
23632732|NCT01607476|66041917|FG000|Overall Study|Lost to Follow-up|0|||
23572159|NCT03685708|65824701|FG002|Overall Study|Screen Fail|1|||
23572160|NCT03685708|65824699|FG000|Overall Study|COVID 19 Pandemic|1|||
23572161|NCT03685708|65824700|FG001|Overall Study|COVID 19 Pandemic|1|||
23572162|NCT03685708|65824701|FG002|Overall Study|COVID 19 Pandemic|6|||
23572163|NCT03685708|65824699|FG000|Overall Study|Disease Progression|0|||
23572164|NCT03685708|65824700|FG001|Overall Study|Disease Progression|0|||
23572165|NCT03685708|65824701|FG002|Overall Study|Disease Progression|1|||
23572166|NCT01625338|65824705|FG000|Overall Study|Enrolled but not Treated|0|||
23572167|NCT01625338|65824706|FG001|Overall Study|Enrolled but not Treated|0|||
23632733|NCT01607476|66041918|FG001|Overall Study|Lost to Follow-up|0|||
23632734|NCT01607476|66041919|FG002|Overall Study|Lost to Follow-up|2|||
23632735|NCT00848484|66041920|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
23632736|NCT00848484|66041921|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
23572168|NCT01625338|65824707|FG002|Overall Study|Enrolled but not Treated|1|||
23572169|NCT01625338|65824705|FG000|Overall Study|Efficacy Failure|27|||
23632737|NCT00848484|66041920|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
23632738|NCT00848484|66041921|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
23632739|NCT00848484|66041920|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
23632740|NCT00848484|66041921|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
23632741|NCT00848484|66041920|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
23632742|NCT00848484|66041921|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
23770720|NCT02994056|66539643|FG000|Overall Study|Withdrew Consent|1|||
23632743|NCT00848484|66041920|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
23632744|NCT00848484|66041921|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
23632745|NCT03301155|66041922|FG000|Overall Study|Сompliance with exclusion criteria|8|||
23632746|NCT03301155|66041923|FG001|Overall Study|Сompliance with exclusion criteria|7|||
23632747|NCT03838731|66041928|FG000|Overall Study|Pregnancy|0|||
23632748|NCT03838731|66041929|FG001|Overall Study|Pregnancy|1|||
23632749|NCT03838731|66041928|FG000|Overall Study|Withdrawal of consent|1|||
23632750|NCT03838731|66041929|FG001|Overall Study|Withdrawal of consent|0|||
23770721|NCT02483975|66539644|FG000|Overall Study|Adverse Event|0|||
23447171|NCT00337207|65377902|FG000|Overall Study|Withdrawal by Subject|3|||
23572170|NCT01625338|65824706|FG001|Overall Study|Efficacy Failure|39|||
23572171|NCT01625338|65824707|FG002|Overall Study|Efficacy Failure|31|||
23572172|NCT01625338|65824705|FG000|Overall Study|Lost to Follow-up|3|||
23572173|NCT01625338|65824706|FG001|Overall Study|Lost to Follow-up|3|||
23447172|NCT02741596|65377903|FG000|Overall Study|Adverse Event|1|||
23447173|NCT02741596|65377904|FG001|Overall Study|Adverse Event|5|||
23447174|NCT02741596|65377903|FG000|Overall Study|Lost to Follow-up|1|||
23447175|NCT02741596|65377904|FG001|Overall Study|Lost to Follow-up|1|||
23447176|NCT02741596|65377903|FG000|Overall Study|Physician Decision|2|||
23572174|NCT01625338|65824707|FG002|Overall Study|Lost to Follow-up|2|||
23572175|NCT01625338|65824705|FG000|Overall Study|Investigator Decision|0|||
23572176|NCT01625338|65824706|FG001|Overall Study|Investigator Decision|2|||
23572177|NCT01625338|65824707|FG002|Overall Study|Investigator Decision|1|||
23572178|NCT01625338|65824705|FG000|Overall Study|Subject Withdrew Consent|1|||
23572179|NCT01625338|65824706|FG001|Overall Study|Subject Withdrew Consent|0|||
23572180|NCT01625338|65824707|FG002|Overall Study|Subject Withdrew Consent|2|||
23572181|NCT01625338|65824705|FG000|Overall Study|Adverse Event|1|||
23572182|NCT01625338|65824706|FG001|Overall Study|Adverse Event|0|||
23572183|NCT01625338|65824707|FG002|Overall Study|Adverse Event|1|||
23572184|NCT01625338|65824705|FG000|Overall Study|Study Discontinued by Sponsor|0|||
23572185|NCT01625338|65824706|FG001|Overall Study|Study Discontinued by Sponsor|0|||
23572186|NCT01625338|65824707|FG002|Overall Study|Study Discontinued by Sponsor|1|||
23572187|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
23572188|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572189|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572190|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572191|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572192|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
23572193|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572194|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572195|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572196|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572197|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
23572198|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572199|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572200|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572201|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572202|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
23572203|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572204|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572205|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572206|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572207|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
23572208|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572209|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572210|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572211|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572212|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23572213|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
23572214|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
23632751|NCT00335140|66041934|FG000|Overall Study|Ineligible|1|||
23770722|NCT02483975|66539645|FG001|Overall Study|Adverse Event|1|||
23770723|NCT02483975|66539644|FG000|Overall Study|Lost to Follow-up|0|||
23770724|NCT02483975|66539645|FG001|Overall Study|Lost to Follow-up|1|||
23770725|NCT02483975|66539644|FG000|Overall Study|Physician Decision|2|||
23770726|NCT02483975|66539645|FG001|Overall Study|Physician Decision|0|||
23770727|NCT02247479|66539646|FG000|Overall Study|Adverse Event|8|||
23770728|NCT02247479|66539647|FG001|Overall Study|Adverse Event|9|||
23447177|NCT02741596|65377904|FG001|Overall Study|Physician Decision|1|||
23572215|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23632752|NCT01271504|66041938|FG000|Overall Study|Death|7|||
23770729|NCT02247479|66539648|FG002|Overall Study|Adverse Event|8|||
23447178|NCT02741596|65377903|FG000|Overall Study|Pregnancy|3|||
23447179|NCT02741596|65377904|FG001|Overall Study|Pregnancy|1|||
23447180|NCT02741596|65377903|FG000|Overall Study|Other (Unspecified)|0|||
23447181|NCT02741596|65377904|FG001|Overall Study|Other (Unspecified)|3|||
23447182|NCT02741596|65377903|FG000|Overall Study|Subject withdrawn-Other|17|||
23447183|NCT02741596|65377904|FG001|Overall Study|Subject withdrawn-Other|4|||
23447184|NCT02741596|65377903|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
23447185|NCT02741596|65377904|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
23447186|NCT01011673|65377905|FG000|Randomized|Secondary headache|2|||
23572216|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23572217|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572218|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
23572219|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
23572220|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572221|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572222|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572223|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
23572224|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572225|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572226|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572227|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572228|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
23572229|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
23572230|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572231|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572232|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572233|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572234|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572235|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
23572236|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572237|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572238|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572239|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572240|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
23572241|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572242|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572243|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572244|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572245|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572246|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
23572247|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572248|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572249|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572250|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572251|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
23572252|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572253|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572254|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572255|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
23572256|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572257|NCT02207374|65824719|FG000|Overall Study|Withdrawal by Subject|5|||
23572258|NCT02207374|65824720|FG001|Overall Study|Withdrawal by Subject|9|||
23572259|NCT02207374|65824721|FG002|Overall Study|Withdrawal by Subject|4|||
23572260|NCT02207374|65824719|FG000|Overall Study|Death|1|||
23572261|NCT02207374|65824720|FG001|Overall Study|Death|0|||
23572262|NCT02207374|65824721|FG002|Overall Study|Death|1|||
23572263|NCT02207374|65824719|FG000|Overall Study|Missing follow-up information|0|||
23572264|NCT02207374|65824720|FG001|Overall Study|Missing follow-up information|1|||
23572265|NCT02207374|65824721|FG002|Overall Study|Missing follow-up information|1|||
23572266|NCT03040687|65824726|FG000|Overall Study|Withdrawal by Subject|1|||
23572267|NCT03040687|65824727|FG001|Overall Study|Withdrawal by Subject|0|||
23572268|NCT03040687|65824728|FG002|Overall Study|Withdrawal by Subject|0|||
23632753|NCT01271504|66041939|FG001|Overall Study|Death|6|||
23447187|NCT01011673|65377906|FG001|Randomized|Secondary headache|1|||
23447188|NCT01011673|65377905|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
23572269|NCT01551303|65824730|FG000|Overall Study|failed awareness check on vision test|4|||
23572270|NCT01551303|65824731|FG001|Overall Study|failed awareness check on vision test|7|||
23632754|NCT01271504|66041940|FG002|Overall Study|Death|32|||
23632755|NCT01271504|66041941|FG003|Overall Study|Death|32|||
23572271|NCT00179010|65824734|FG000|Overall Study|Muscle probe defective|1|||
23572272|NCT00179010|65824735|FG001|Overall Study|Muscle probe defective|1|||
23572273|NCT00179010|65824734|FG000|Overall Study|Failure to place arterial line|0|||
23572274|NCT00179010|65824735|FG001|Overall Study|Failure to place arterial line|1|||
23572275|NCT02765490|65824749|FG000|Overall Study|Lost to Follow-up|1|||
23572276|NCT02765490|65824750|FG001|Overall Study|Lost to Follow-up|1|||
23572277|NCT02765490|65824749|FG000|Overall Study|Other|0|||
23770730|NCT02247479|66539646|FG000|Overall Study|Death|5|||
23770731|NCT02247479|66539647|FG001|Overall Study|Death|4|||
23770732|NCT02247479|66539648|FG002|Overall Study|Death|6|||
23770733|NCT02247479|66539646|FG000|Overall Study|Lost to Follow-up|3|||
23770734|NCT02247479|66539647|FG001|Overall Study|Lost to Follow-up|3|||
23770735|NCT02247479|66539648|FG002|Overall Study|Lost to Follow-up|1|||
23770736|NCT02247479|66539646|FG000|Overall Study|Non-compliance|0|||
23770737|NCT02247479|66539647|FG001|Overall Study|Non-compliance|0|||
23572278|NCT02765490|65824750|FG001|Overall Study|Other|1|||
23572279|NCT02765490|65824749|FG000|Overall Study|Death|0|||
23572280|NCT02765490|65824750|FG001|Overall Study|Death|1|||
23572281|NCT03864926|65824751|FG000|Overall Study|Death|0|||
23572282|NCT03864926|65824752|FG001|Overall Study|Death|2|||
23572283|NCT00089895|65824753|FG000|Overall Study|Consent Withdrawn|11|||
23572284|NCT00089895|65824754|FG001|Overall Study|Consent Withdrawn|14|||
23572285|NCT00089895|65824753|FG000|Overall Study|Technical reason|7|||
23572286|NCT00089895|65824754|FG001|Overall Study|Technical reason|2|||
23572287|NCT00089895|65824753|FG000|Overall Study|Surgery|0|||
23572288|NCT00089895|65824754|FG001|Overall Study|Surgery|1|||
23572289|NCT00089895|65824753|FG000|Overall Study|Bleeding|0|||
23572290|NCT00089895|65824754|FG001|Overall Study|Bleeding|2|||
23572291|NCT00089895|65824753|FG000|Overall Study|Physician Decision|3|||
23572292|NCT00089895|65824754|FG001|Overall Study|Physician Decision|7|||
23572293|NCT00089895|65824753|FG000|Overall Study|Exclusion criteria met|6|||
23572294|NCT00089895|65824754|FG001|Overall Study|Exclusion criteria met|6|||
23572295|NCT00089895|65824753|FG000|Overall Study|Not otherwise specified|4|||
23572296|NCT00089895|65824754|FG001|Overall Study|Not otherwise specified|8|||
23572297|NCT00089895|65824753|FG000|Overall Study|Missing|4|||
23572298|NCT00089895|65824754|FG001|Overall Study|Missing|2|||
23572299|NCT04147260|65824758|FG000|Overall Study|Adverse Event|1|||
23572300|NCT04147260|65824759|FG001|Overall Study|Adverse Event|0|||
23572301|NCT04147260|65824760|FG002|Overall Study|Adverse Event|1|||
23572302|NCT04147260|65824761|FG003|Overall Study|Adverse Event|2|||
23572303|NCT04147260|65824762|FG004|Overall Study|Adverse Event|0|||
23572304|NCT04147260|65824758|FG000|Overall Study|Withdrawal by Subject|0|||
23572305|NCT04147260|65824759|FG001|Overall Study|Withdrawal by Subject|0|||
23572306|NCT04147260|65824760|FG002|Overall Study|Withdrawal by Subject|1|||
23572307|NCT04147260|65824761|FG003|Overall Study|Withdrawal by Subject|1|||
23572308|NCT04147260|65824762|FG004|Overall Study|Withdrawal by Subject|0|||
23572309|NCT01225822|65824763|FG000|Overall Study|Adverse Event|13|||
23572310|NCT01225822|65824764|FG001|Overall Study|Adverse Event|31|||
23572311|NCT01225822|65824765|FG002|Overall Study|Adverse Event|18|||
23572312|NCT01225822|65824766|FG003|Overall Study|Adverse Event|23|||
23572313|NCT01225822|65824767|FG004|Overall Study|Adverse Event|14|||
23572314|NCT01225822|65824763|FG000|Overall Study|Protocol Violation|6|||
23572315|NCT01225822|65824764|FG001|Overall Study|Protocol Violation|8|||
23572316|NCT01225822|65824765|FG002|Overall Study|Protocol Violation|6|||
23572317|NCT01225822|65824766|FG003|Overall Study|Protocol Violation|7|||
23572318|NCT01225822|65824767|FG004|Overall Study|Protocol Violation|4|||
23632756|NCT01271504|66041938|FG000|Overall Study|Lost to Follow-up|0|||
23632757|NCT01271504|66041939|FG001|Overall Study|Lost to Follow-up|1|||
23632758|NCT01271504|66041940|FG002|Overall Study|Lost to Follow-up|3|||
23770738|NCT02247479|66539648|FG002|Overall Study|Non-compliance|1|||
23770739|NCT02247479|66539646|FG000|Overall Study|Withdrawal by Subject|25|||
23572319|NCT01225822|65824763|FG000|Overall Study|Lost to Follow-up|0|||
23572320|NCT01225822|65824764|FG001|Overall Study|Lost to Follow-up|0|||
23572321|NCT01225822|65824765|FG002|Overall Study|Lost to Follow-up|0|||
23770740|NCT02247479|66539647|FG001|Overall Study|Withdrawal by Subject|29|||
23572322|NCT01225822|65824766|FG003|Overall Study|Lost to Follow-up|1|||
23572323|NCT01225822|65824767|FG004|Overall Study|Lost to Follow-up|0|||
23572324|NCT01225822|65824763|FG000|Overall Study|Withdrawal by Subject|6|||
23572325|NCT01225822|65824764|FG001|Overall Study|Withdrawal by Subject|7|||
23572326|NCT01225822|65824765|FG002|Overall Study|Withdrawal by Subject|7|||
23572327|NCT01225822|65824766|FG003|Overall Study|Withdrawal by Subject|11|||
23572328|NCT01225822|65824767|FG004|Overall Study|Withdrawal by Subject|6|||
23572329|NCT01225822|65824763|FG000|Overall Study|Other|13|||
23572330|NCT01225822|65824764|FG001|Overall Study|Other|10|||
23632759|NCT01271504|66041941|FG003|Overall Study|Lost to Follow-up|1|||
23632760|NCT01271504|66041938|FG000|Overall Study|Protocol Violation|0|||
23770741|NCT02247479|66539648|FG002|Overall Study|Withdrawal by Subject|24|||
23572331|NCT01225822|65824765|FG002|Overall Study|Other|7|||
23572332|NCT01225822|65824766|FG003|Overall Study|Other|10|||
23572333|NCT01225822|65824767|FG004|Overall Study|Other|7|||
23770742|NCT02247479|66539646|FG000|Overall Study|Study Terminated by Sponsor|98|||
23770743|NCT02247479|66539647|FG001|Overall Study|Study Terminated by Sponsor|88|||
23770744|NCT02247479|66539648|FG002|Overall Study|Study Terminated by Sponsor|94|||
23770745|NCT02247479|66539646|FG000|Overall Study|Physician Decision|1|||
23447189|NCT01011673|65377906|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
23447190|NCT03347123|65377907|FG000|Overall Study|Death|1|||
23572334|NCT00584805|65824768|FG000|Overall Study|No longer at risk of exposure|39|||
23572335|NCT00584805|65824768|FG000|Overall Study|Relocation|36|||
23572336|NCT00584805|65824768|FG000|Overall Study|Withdrawal by Subject|18|||
23572337|NCT00584805|65824768|FG000|Overall Study|Non-compliance|1|||
23572338|NCT00584805|65824768|FG000|Overall Study|Lost to follow up|3|||
23572339|NCT00584805|65824768|FG000|Overall Study|Screen failures|2|||
23572340|NCT01468922|65824769|FG000|Overall Study|Screening failure|0|||
23572341|NCT01468922|65824770|FG001|Overall Study|Screening failure|0|||
23572342|NCT01468922|65824771|FG002|Overall Study|Screening failure|0|||
23572343|NCT01468922|65824772|FG003|Overall Study|Screening failure|0|||
23572344|NCT01468922|65824773|FG004|Overall Study|Screening failure|0|||
23572345|NCT01468922|65824774|FG005|Overall Study|Screening failure|0|||
23572346|NCT01468922|65824775|FG006|Overall Study|Screening failure|0|||
23572347|NCT01468922|65824776|FG007|Overall Study|Screening failure|0|||
23572348|NCT01468922|65824777|FG008|Overall Study|Screening failure|1|||
23572349|NCT01468922|65824769|FG000|Overall Study|Per patient choice|1|||
23572350|NCT01468922|65824770|FG001|Overall Study|Per patient choice|0|||
23572351|NCT01468922|65824771|FG002|Overall Study|Per patient choice|0|||
23572352|NCT01468922|65824772|FG003|Overall Study|Per patient choice|0|||
23572353|NCT01468922|65824773|FG004|Overall Study|Per patient choice|0|||
23572354|NCT01468922|65824774|FG005|Overall Study|Per patient choice|0|||
23572355|NCT01468922|65824775|FG006|Overall Study|Per patient choice|0|||
23572356|NCT01468922|65824776|FG007|Overall Study|Per patient choice|0|||
23572357|NCT01468922|65824777|FG008|Overall Study|Per patient choice|0|||
23572358|NCT01468922|65824769|FG000|Overall Study|Switched to alternative treatment|1|||
23572359|NCT01468922|65824770|FG001|Overall Study|Switched to alternative treatment|0|||
23572360|NCT01468922|65824771|FG002|Overall Study|Switched to alternative treatment|0|||
23572361|NCT01468922|65824772|FG003|Overall Study|Switched to alternative treatment|0|||
23572362|NCT01468922|65824773|FG004|Overall Study|Switched to alternative treatment|1|||
23572363|NCT01468922|65824774|FG005|Overall Study|Switched to alternative treatment|0|||
23572364|NCT01468922|65824775|FG006|Overall Study|Switched to alternative treatment|0|||
23572365|NCT01468922|65824776|FG007|Overall Study|Switched to alternative treatment|0|||
23572366|NCT01468922|65824777|FG008|Overall Study|Switched to alternative treatment|0|||
23572367|NCT01468922|65824769|FG000|Overall Study|Enrolled on new protocol|0|||
23572368|NCT01468922|65824770|FG001|Overall Study|Enrolled on new protocol|0|||
23572369|NCT01468922|65824771|FG002|Overall Study|Enrolled on new protocol|0|||
23572370|NCT01468922|65824772|FG003|Overall Study|Enrolled on new protocol|0|||
23572371|NCT01468922|65824773|FG004|Overall Study|Enrolled on new protocol|1|||
23572372|NCT01468922|65824774|FG005|Overall Study|Enrolled on new protocol|0|||
23572373|NCT01468922|65824775|FG006|Overall Study|Enrolled on new protocol|0|||
23572374|NCT01468922|65824776|FG007|Overall Study|Enrolled on new protocol|0|||
23572375|NCT01468922|65824777|FG008|Overall Study|Enrolled on new protocol|0|||
23572376|NCT01468922|65824769|FG000|Overall Study|Adverse Event|0|||
23572377|NCT01468922|65824770|FG001|Overall Study|Adverse Event|0|||
23572378|NCT01468922|65824771|FG002|Overall Study|Adverse Event|0|||
23572379|NCT01468922|65824772|FG003|Overall Study|Adverse Event|0|||
23572380|NCT01468922|65824773|FG004|Overall Study|Adverse Event|0|||
23572381|NCT01468922|65824774|FG005|Overall Study|Adverse Event|0|||
23572382|NCT01468922|65824775|FG006|Overall Study|Adverse Event|0|||
23572383|NCT01468922|65824776|FG007|Overall Study|Adverse Event|1|||
23572384|NCT01468922|65824777|FG008|Overall Study|Adverse Event|0|||
23572385|NCT01468922|65824769|FG000|Overall Study|Infection of blood|0|||
23572386|NCT01468922|65824770|FG001|Overall Study|Infection of blood|0|||
23572387|NCT01468922|65824771|FG002|Overall Study|Infection of blood|0|||
23572388|NCT01468922|65824772|FG003|Overall Study|Infection of blood|0|||
23770746|NCT02247479|66539647|FG001|Overall Study|Physician Decision|0|||
23447191|NCT03347123|65377908|FG001|Overall Study|Death|2|||
23447192|NCT03347123|65377909|FG002|Overall Study|Death|0|||
23447193|NCT03347123|65377910|FG003|Overall Study|Death|0|||
23572389|NCT01468922|65824773|FG004|Overall Study|Infection of blood|0|||
23572390|NCT01468922|65824774|FG005|Overall Study|Infection of blood|0|||
23572391|NCT01468922|65824775|FG006|Overall Study|Infection of blood|0|||
23572392|NCT01468922|65824776|FG007|Overall Study|Infection of blood|1|||
23572393|NCT01468922|65824777|FG008|Overall Study|Infection of blood|0|||
23572394|NCT01468922|65824769|FG000|Overall Study|Patient choice - surgery|0|||
23572395|NCT01468922|65824770|FG001|Overall Study|Patient choice - surgery|0|||
23572396|NCT01468922|65824771|FG002|Overall Study|Patient choice - surgery|0|||
23572397|NCT01468922|65824772|FG003|Overall Study|Patient choice - surgery|0|||
23572398|NCT01468922|65824773|FG004|Overall Study|Patient choice - surgery|0|||
23572399|NCT01468922|65824774|FG005|Overall Study|Patient choice - surgery|0|||
23572400|NCT01468922|65824775|FG006|Overall Study|Patient choice - surgery|0|||
23632761|NCT01271504|66041939|FG001|Overall Study|Protocol Violation|0|||
23447194|NCT03347123|65377911|FG004|Overall Study|Death|0|||
23572401|NCT01468922|65824776|FG007|Overall Study|Patient choice - surgery|1|||
23572402|NCT01468922|65824777|FG008|Overall Study|Patient choice - surgery|0|||
23572403|NCT01468922|65824769|FG000|Overall Study|Refused further treatment|0|||
23572404|NCT01468922|65824770|FG001|Overall Study|Refused further treatment|0|||
23572405|NCT01468922|65824771|FG002|Overall Study|Refused further treatment|0|||
23572406|NCT01468922|65824772|FG003|Overall Study|Refused further treatment|0|||
23572407|NCT01468922|65824773|FG004|Overall Study|Refused further treatment|0|||
23572408|NCT01468922|65824774|FG005|Overall Study|Refused further treatment|0|||
23572409|NCT01468922|65824775|FG006|Overall Study|Refused further treatment|0|||
23572410|NCT01468922|65824776|FG007|Overall Study|Refused further treatment|1|||
23572411|NCT01468922|65824777|FG008|Overall Study|Refused further treatment|0|||
23572412|NCT03518658|65824781|FG000|Overall Study|Other|51|||
23572413|NCT03518658|65824782|FG001|Overall Study|Other|0|||
23572414|NCT04424290|65824783|FG000|Overall Study|Not treated|0|||
23572415|NCT04424290|65824784|FG001|Overall Study|Not treated|0|||
23572416|NCT04424290|65824785|FG002|Overall Study|Not treated|1|||
23572417|NCT04424290|65824786|FG003|Overall Study|Not treated|0|||
23572418|NCT04424290|65824787|FG004|Overall Study|Not treated|1|||
23572419|NCT04424290|65824783|FG000|Overall Study|Adverse Event|0|||
23572420|NCT04424290|65824784|FG001|Overall Study|Adverse Event|0|||
23572421|NCT04424290|65824785|FG002|Overall Study|Adverse Event|0|||
23572422|NCT04424290|65824786|FG003|Overall Study|Adverse Event|2|||
23572423|NCT04424290|65824787|FG004|Overall Study|Adverse Event|0|||
23572424|NCT04424290|65824783|FG000|Overall Study|Withdrawal by Subject|0|||
23572425|NCT04424290|65824784|FG001|Overall Study|Withdrawal by Subject|0|||
23632762|NCT01271504|66041940|FG002|Overall Study|Protocol Violation|0|||
23770747|NCT02247479|66539648|FG002|Overall Study|Physician Decision|2|||
23770748|NCT02247479|66539646|FG000|Overall Study|Unspecified Reason|2|||
23770749|NCT02247479|66539647|FG001|Overall Study|Unspecified Reason|5|||
23770750|NCT02247479|66539648|FG002|Overall Study|Unspecified Reason|2|||
23770751|NCT03655106|66539653|FG000|Overall Study|Withdrawal by Subject|3|||
23770752|NCT03655106|66539654|FG001|Overall Study|Withdrawal by Subject|2|||
23770753|NCT03655106|66539653|FG000|Overall Study|Lost to Follow-up|2|||
23770754|NCT03655106|66539654|FG001|Overall Study|Lost to Follow-up|1|||
23770755|NCT03655106|66539653|FG000|Overall Study|Duplicate Enrollment|1|||
23770756|NCT03655106|66539654|FG001|Overall Study|Duplicate Enrollment|1|||
23770757|NCT03655106|66539653|FG000|Overall Study|Protocol Violation|3|||
23770758|NCT03655106|66539654|FG001|Overall Study|Protocol Violation|0|||
23770759|NCT01290263|66539656|FG000|Overall Study|Adverse Event|0|||
23770760|NCT01290263|66539657|FG001|Overall Study|Adverse Event|0|||
23770761|NCT01290263|66539658|FG002|Overall Study|Adverse Event|0|||
23770762|NCT01290263|66539659|FG003|Overall Study|Adverse Event|1|||
23770763|NCT01290263|66539660|FG004|Overall Study|Adverse Event|1|||
23770764|NCT01290263|66539656|FG000|Overall Study|Lack of Efficacy|8|||
23632763|NCT01271504|66041941|FG003|Overall Study|Protocol Violation|2|||
23632764|NCT01271504|66041938|FG000|Overall Study|Administrative Reasons|0|||
23632765|NCT01271504|66041939|FG001|Overall Study|Administrative Reasons|0|||
23632766|NCT01271504|66041940|FG002|Overall Study|Administrative Reasons|6|||
23632767|NCT01271504|66041941|FG003|Overall Study|Administrative Reasons|5|||
23632768|NCT01271504|66041938|FG000|Overall Study|Withdrawal by Subject|0|||
23632769|NCT01271504|66041939|FG001|Overall Study|Withdrawal by Subject|0|||
23632770|NCT01271504|66041940|FG002|Overall Study|Withdrawal by Subject|1|||
23632771|NCT01271504|66041941|FG003|Overall Study|Withdrawal by Subject|3|||
23632772|NCT01271504|66041938|FG000|Overall Study|Other|0|||
23632773|NCT01271504|66041939|FG001|Overall Study|Other|1|||
23632774|NCT01271504|66041940|FG002|Overall Study|Other|2|||
23632775|NCT01271504|66041941|FG003|Overall Study|Other|0|||
23632776|NCT05186311|66041942|FG000|Part A: Serum|Withdrawal by Subject|1|||
23632777|NCT04954326|66041943|FG000|Overall Study|Protocol Violation|0|||
23632778|NCT04954326|66041944|FG001|Overall Study|Protocol Violation|1|||
23632779|NCT04954326|66041943|FG000|Overall Study|Death|0|||
23632780|NCT04954326|66041944|FG001|Overall Study|Death|2|||
23770765|NCT01290263|66539657|FG001|Overall Study|Lack of Efficacy|2|||
23572426|NCT04424290|65824785|FG002|Overall Study|Withdrawal by Subject|0|||
23572427|NCT04424290|65824786|FG003|Overall Study|Withdrawal by Subject|0|||
23572428|NCT04424290|65824787|FG004|Overall Study|Withdrawal by Subject|1|||
23572429|NCT04424290|65824783|FG000|Overall Study|Other than listed|0|||
23572430|NCT04424290|65824784|FG001|Overall Study|Other than listed|0|||
23632781|NCT04954326|66041943|FG000|Overall Study|Physician Decision|0|||
23632782|NCT04954326|66041944|FG001|Overall Study|Physician Decision|1|||
23770766|NCT01290263|66539658|FG002|Overall Study|Lack of Efficacy|7|||
23770767|NCT01290263|66539659|FG003|Overall Study|Lack of Efficacy|24|||
23770768|NCT01290263|66539660|FG004|Overall Study|Lack of Efficacy|33|||
23572431|NCT04424290|65824785|FG002|Overall Study|Other than listed|0|||
23632783|NCT00246090|66041953|FG000|Overall Study|Adverse Event|25|||
23632784|NCT00246090|66041953|FG000|Overall Study|Withdrawal by Subject|7|||
23770769|NCT01290263|66539656|FG000|Overall Study|Withdrawal by Subject|3|||
23632785|NCT00246090|66041953|FG000|Overall Study|Progressive Disease|212|||
23770770|NCT01290263|66539657|FG001|Overall Study|Withdrawal by Subject|1|||
23632786|NCT00246090|66041953|FG000|Overall Study|Clinical Progression|30|||
23632787|NCT00246090|66041953|FG000|Overall Study|Physician Decision|11|||
23632788|NCT00246090|66041953|FG000|Overall Study|Not Otherwise Specified|10|||
23632789|NCT01191008|66041959|FG000|Overall Study|Protocol Violation|7|||
23632790|NCT01191008|66041959|FG000|Overall Study|Lost to Follow-up|8|||
23632791|NCT03909971|66041962|FG000|Overall Study|Other Reasons Not Specified|0|||
23632792|NCT03909971|66041963|FG001|Overall Study|Other Reasons Not Specified|1|||
23632793|NCT03909971|66041962|FG000|Overall Study|Global Deterioration of Health Status|2|||
23632794|NCT03909971|66041963|FG001|Overall Study|Global Deterioration of Health Status|1|||
23632795|NCT03909971|66041962|FG000|Overall Study|Progressive Disease|6|||
23632796|NCT03909971|66041963|FG001|Overall Study|Progressive Disease|14|||
23632797|NCT03909971|66041962|FG000|Overall Study|Death|2|||
23632798|NCT03909971|66041963|FG001|Overall Study|Death|6|||
23632799|NCT04843579|66041964|FG000|Overall Study|Adverse Event|1|||
23632800|NCT04843579|66041964|FG000|Overall Study|Disease Progression|1|||
23632801|NCT01217437|66041965|FG000|Overall Study|Adverse Event|0|||
23632802|NCT01217437|66041966|FG001|Overall Study|Adverse Event|8|||
23632803|NCT01217437|66041965|FG000|Overall Study|Death|5|||
23632804|NCT01217437|66041966|FG001|Overall Study|Death|0|||
23831440|NCT03655405|66762999|FG001|Overall Study|Protocol Violation|1|||
23831441|NCT00840749|66763005|FG000|Overall Study|Death|1|||
23831442|NCT00840749|66763006|FG001|Overall Study|Death|2|||
23831443|NCT00840749|66763005|FG000|Overall Study|not treated on study arm|11|||
23831444|NCT00840749|66763006|FG001|Overall Study|not treated on study arm|11|||
23831445|NCT00840749|66763005|FG000|Overall Study|study closed|19|||
23831446|NCT00840749|66763006|FG001|Overall Study|study closed|14|||
23831447|NCT03877068|66763007|FG000|Overall Study|Physician Decision|9|||
23831448|NCT03877068|66763008|FG001|Overall Study|Physician Decision|3|||
23831449|NCT00987337|66763015|FG000|Overall Study|Adverse Event|10|||
23831450|NCT00987337|66763016|FG001|Overall Study|Adverse Event|9|||
23831451|NCT00987337|66763017|FG002|Overall Study|Adverse Event|8|||
23831452|NCT00987337|66763015|FG000|Overall Study|Insufficient Virologic Response|10|||
23831453|NCT00987337|66763016|FG001|Overall Study|Insufficient Virologic Response|7|||
23831454|NCT00987337|66763017|FG002|Overall Study|Insufficient Virologic Response|12|||
23831455|NCT00987337|66763015|FG000|Overall Study|Virologic Breakthrough|2|||
23831456|NCT00987337|66763016|FG001|Overall Study|Virologic Breakthrough|2|||
23831457|NCT00987337|66763017|FG002|Overall Study|Virologic Breakthrough|8|||
23831458|NCT00987337|66763015|FG000|Overall Study|Lost to Follow-up|10|||
23831459|NCT00987337|66763016|FG001|Overall Study|Lost to Follow-up|6|||
23831460|NCT00987337|66763017|FG002|Overall Study|Lost to Follow-up|2|||
23831461|NCT00987337|66763015|FG000|Overall Study|Withdrawal by Subject|6|||
23831462|NCT00987337|66763016|FG001|Overall Study|Withdrawal by Subject|9|||
23831463|NCT00987337|66763017|FG002|Overall Study|Withdrawal by Subject|9|||
23831464|NCT00987337|66763015|FG000|Overall Study|Other|0|||
23831465|NCT00987337|66763016|FG001|Overall Study|Other|2|||
23831466|NCT00987337|66763017|FG002|Overall Study|Other|5|||
23831467|NCT00987337|66763015|FG000|Overall Study|Protocol Violation|1|||
23831468|NCT00987337|66763016|FG001|Overall Study|Protocol Violation|0|||
23831469|NCT00987337|66763017|FG002|Overall Study|Protocol Violation|2|||
23831470|NCT00987337|66763015|FG000|Overall Study|Participant Relapsed|18|||
23831471|NCT00987337|66763016|FG001|Overall Study|Participant Relapsed|20|||
23572432|NCT04424290|65824786|FG003|Overall Study|Other than listed|1|||
23572433|NCT04424290|65824787|FG004|Overall Study|Other than listed|0|||
23572434|NCT01681368|65824788|FG000|Overall Study|Refused further treatment|1|||
23572435|NCT01681368|65824788|FG000|Overall Study|Refused further follow up|1|||
23572436|NCT00358215|65824791|FG000|Overall Study|Ineligibility determined|4|||
23572437|NCT00358215|65824792|FG001|Overall Study|Ineligibility determined|3|||
23572438|NCT00358215|65824791|FG000|Overall Study|Adverse Event|83|||
23572439|NCT00358215|65824792|FG001|Overall Study|Adverse Event|65|||
23572440|NCT00358215|65824791|FG000|Overall Study|Withdrawal by Subject|111|||
23572441|NCT00358215|65824792|FG001|Overall Study|Withdrawal by Subject|102|||
23572442|NCT00358215|65824791|FG000|Overall Study|Participant request|65|||
23572443|NCT00358215|65824792|FG001|Overall Study|Participant request|64|||
23572444|NCT00358215|65824791|FG000|Overall Study|Physician Decision|47|||
23572445|NCT00358215|65824792|FG001|Overall Study|Physician Decision|39|||
23632805|NCT01217437|66041965|FG000|Overall Study|Lack of Efficacy|29|||
23632806|NCT01217437|66041966|FG001|Overall Study|Lack of Efficacy|25|||
23632807|NCT01217437|66041965|FG000|Overall Study|Physician Decision|8|||
23632808|NCT01217437|66041966|FG001|Overall Study|Physician Decision|5|||
23632809|NCT01217437|66041965|FG000|Overall Study|Withdrawal by Subject|0|||
23572446|NCT00358215|65824791|FG000|Overall Study|Lost to Follow-up|16|||
23572447|NCT00358215|65824792|FG001|Overall Study|Lost to Follow-up|22|||
23572448|NCT00358215|65824791|FG000|Overall Study|Death|265|||
23632810|NCT01217437|66041966|FG001|Overall Study|Withdrawal by Subject|2|||
23831472|NCT00987337|66763017|FG002|Overall Study|Participant Relapsed|5|||
23831473|NCT02505217|66763018|FG000|Overall Study|Withdrawal by Subject|1|||
23831474|NCT02505217|66763019|FG001|Overall Study|Withdrawal by Subject|2|||
23831475|NCT03922321|66763020|FG000|Overall Study|Participant Moved|1|||
23831476|NCT03922321|66763020|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
23831477|NCT02058069|66763021|FG000|Overall Study|Exclusion due to implant size|5|||
23831478|NCT02058069|66763021|FG000|Overall Study|Withdrawal by Subject|6|||
23831479|NCT03711188|66763022|FG000|Overall Study|Disease progression|11|||
23831480|NCT03711188|66763022|FG000|Overall Study|Adverse Event|1|||
23831481|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
23831482|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23831483|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23831484|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23831485|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23831486|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23770771|NCT01290263|66539658|FG002|Overall Study|Withdrawal by Subject|0|||
23770772|NCT01290263|66539659|FG003|Overall Study|Withdrawal by Subject|1|||
23770773|NCT01290263|66539660|FG004|Overall Study|Withdrawal by Subject|2|||
23770774|NCT01290263|66539656|FG000|Overall Study|Participant Non-Compliance|0|||
23770775|NCT01290263|66539657|FG001|Overall Study|Participant Non-Compliance|0|||
23770776|NCT01290263|66539658|FG002|Overall Study|Participant Non-Compliance|0|||
23770777|NCT01290263|66539659|FG003|Overall Study|Participant Non-Compliance|1|||
23770778|NCT01290263|66539660|FG004|Overall Study|Participant Non-Compliance|1|||
23770779|NCT02339909|66539661|FG000|Overall Study|Became ineligible after randomisation|89|||
23770780|NCT02339909|66539662|FG001|Overall Study|Became ineligible after randomisation|63|||
23831487|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
23831488|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
23831489|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23831490|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23831491|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23831492|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23831493|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
23831494|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
23831495|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831496|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831497|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831498|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831499|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23831500|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23831501|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23447195|NCT03347123|65377912|FG005|Overall Study|Death|0|||
23447196|NCT03347123|65377913|FG006|Overall Study|Death|0|||
23447197|NCT03347123|65377907|FG000|Overall Study|Withdrawal by Subject|1|||
23447198|NCT03347123|65377908|FG001|Overall Study|Withdrawal by Subject|0|||
23447199|NCT03347123|65377909|FG002|Overall Study|Withdrawal by Subject|0|||
23447200|NCT03347123|65377910|FG003|Overall Study|Withdrawal by Subject|0|||
23447201|NCT03347123|65377911|FG004|Overall Study|Withdrawal by Subject|0|||
23447202|NCT03347123|65377912|FG005|Overall Study|Withdrawal by Subject|0|||
23447203|NCT03347123|65377913|FG006|Overall Study|Withdrawal by Subject|0|||
23447204|NCT03347123|65377907|FG000|Overall Study|Reason not Specified|3|||
23447205|NCT03347123|65377908|FG001|Overall Study|Reason not Specified|4|||
23447206|NCT03347123|65377909|FG002|Overall Study|Reason not Specified|0|||
23447207|NCT03347123|65377910|FG003|Overall Study|Reason not Specified|0|||
23447208|NCT03347123|65377911|FG004|Overall Study|Reason not Specified|0|||
23447209|NCT03347123|65377912|FG005|Overall Study|Reason not Specified|0|||
23447210|NCT03347123|65377913|FG006|Overall Study|Reason not Specified|0|||
23447211|NCT02814175|65377914|FG000|Part 1|Adverse Event|2|||
23447212|NCT02814175|65377915|FG001|Part 1|Adverse Event|3|||
23447213|NCT02814175|65377916|FG002|Part 1|Adverse Event|0|||
23447214|NCT02814175|65377917|FG003|Part 1|Adverse Event|0|||
23447215|NCT02814175|65377918|FG004|Part 1|Adverse Event|0|||
23447216|NCT02814175|65377919|FG005|Part 1|Adverse Event|0|||
23447217|NCT02814175|65377914|FG000|Part 1|Withdrawal Consent|8|||
23447218|NCT02814175|65377915|FG001|Part 1|Withdrawal Consent|1|||
23447219|NCT02814175|65377916|FG002|Part 1|Withdrawal Consent|0|||
23447220|NCT02814175|65377917|FG003|Part 1|Withdrawal Consent|0|||
23447221|NCT02814175|65377918|FG004|Part 1|Withdrawal Consent|0|||
23447222|NCT02814175|65377919|FG005|Part 1|Withdrawal Consent|0|||
23447223|NCT02814175|65377914|FG000|Part 1|Lost to Follow-up|1|||
23770781|NCT02339909|66539663|FG002|Overall Study|Became ineligible after randomisation|71|||
23447224|NCT02814175|65377915|FG001|Part 1|Lost to Follow-up|0|||
23447225|NCT02814175|65377916|FG002|Part 1|Lost to Follow-up|0|||
23770782|NCT01361126|66539664|FG000|Overall Study|Sponsor decision|0|||
23770783|NCT01361126|66539665|FG001|Overall Study|Sponsor decision|2|||
23447226|NCT02814175|65377917|FG003|Part 1|Lost to Follow-up|0|||
23447227|NCT02814175|65377918|FG004|Part 1|Lost to Follow-up|0|||
23447228|NCT02814175|65377919|FG005|Part 1|Lost to Follow-up|0|||
23770784|NCT00922974|66539666|FG000|Phase II Component|Protocol Violation|2|||
23831502|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831503|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23447229|NCT02814175|65377914|FG000|Part 1|Lack of Efficacy|1|||
23447230|NCT02814175|65377915|FG001|Part 1|Lack of Efficacy|2|||
23447231|NCT02814175|65377916|FG002|Part 1|Lack of Efficacy|0|||
23447232|NCT02814175|65377917|FG003|Part 1|Lack of Efficacy|0|||
23447233|NCT02814175|65377918|FG004|Part 1|Lack of Efficacy|0|||
23447234|NCT02814175|65377919|FG005|Part 1|Lack of Efficacy|0|||
23447235|NCT02814175|65377914|FG000|Part 2|Adverse Event|0|||
23447236|NCT02814175|65377915|FG001|Part 2|Adverse Event|0|||
23447237|NCT02814175|65377916|FG002|Part 2|Adverse Event|0|||
23447238|NCT02814175|65377917|FG003|Part 2|Adverse Event|1|||
23447239|NCT02814175|65377918|FG004|Part 2|Adverse Event|1|||
23447240|NCT02814175|65377919|FG005|Part 2|Adverse Event|2|||
23447241|NCT02814175|65377914|FG000|Part 2|Withdrawal Consent|0|||
23447242|NCT02814175|65377915|FG001|Part 2|Withdrawal Consent|0|||
23447243|NCT02814175|65377916|FG002|Part 2|Withdrawal Consent|0|||
23447244|NCT02814175|65377917|FG003|Part 2|Withdrawal Consent|2|||
23447245|NCT02814175|65377918|FG004|Part 2|Withdrawal Consent|1|||
23447246|NCT02814175|65377919|FG005|Part 2|Withdrawal Consent|1|||
23447247|NCT02814175|65377914|FG000|Part 2|Lost to Follow-up|0|||
23447248|NCT02814175|65377915|FG001|Part 2|Lost to Follow-up|0|||
23447249|NCT02814175|65377916|FG002|Part 2|Lost to Follow-up|0|||
23447250|NCT02814175|65377917|FG003|Part 2|Lost to Follow-up|1|||
23447251|NCT02814175|65377918|FG004|Part 2|Lost to Follow-up|0|||
23447252|NCT02814175|65377919|FG005|Part 2|Lost to Follow-up|0|||
23447253|NCT02814175|65377914|FG000|Part 2|Lack of Efficacy|0|||
23447254|NCT02814175|65377915|FG001|Part 2|Lack of Efficacy|0|||
23572449|NCT00358215|65824792|FG001|Overall Study|Death|281|||
23572450|NCT00358215|65824791|FG000|Overall Study|Protocol Violation|64|||
23572451|NCT00358215|65824792|FG001|Overall Study|Protocol Violation|59|||
23572452|NCT00358215|65824791|FG000|Overall Study|Pregnancy|1|||
23572453|NCT00358215|65824792|FG001|Overall Study|Pregnancy|0|||
23572454|NCT00358215|65824791|FG000|Overall Study|Other|21|||
23572455|NCT00358215|65824792|FG001|Overall Study|Other|14|||
23572456|NCT00358215|65824791|FG000|Overall Study|Did not receive investigational product|2|||
23572457|NCT00358215|65824792|FG001|Overall Study|Did not receive investigational product|3|||
23572458|NCT02494206|65824795|FG000|Overall Study|Adverse Event|1|||
23572459|NCT02494206|65824795|FG000|Overall Study|Disease Progression|1|||
23572460|NCT03537261|65824804|FG000|Overall Study|Lost to Follow-up|4|||
23572461|NCT03537261|65824805|FG001|Overall Study|Lost to Follow-up|5|||
23572462|NCT03537261|65824804|FG000|Overall Study|Withdrawal by Subject|4|||
23572463|NCT03537261|65824805|FG001|Overall Study|Withdrawal by Subject|6|||
23572464|NCT03537261|65824804|FG000|Overall Study|Did not return study questionnaires|0|||
23572465|NCT03537261|65824805|FG001|Overall Study|Did not return study questionnaires|1|||
23572466|NCT03688711|65824806|FG000|Overall Study|Withdrawal by Subject|0|||
23572467|NCT03688711|65824807|FG001|Overall Study|Withdrawal by Subject|1|||
23572468|NCT02743793|65824808|FG000|Overall Study|Death|1|||
23572469|NCT02743793|65824809|FG001|Overall Study|Death|1|||
23572470|NCT02743793|65824808|FG000|Overall Study|Withdrawal by Subject|0|||
23572471|NCT02743793|65824809|FG001|Overall Study|Withdrawal by Subject|1|||
23572472|NCT02743793|65824808|FG000|Overall Study|Screen Failure|4|||
23572473|NCT02743793|65824809|FG001|Overall Study|Screen Failure|0|||
23572474|NCT02743793|65824808|FG000|Overall Study|No Primary Care Physician|0|||
23572475|NCT02743793|65824809|FG001|Overall Study|No Primary Care Physician|1|||
23572476|NCT02743793|65824808|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
23572477|NCT02743793|65824809|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
23572478|NCT02743793|65824808|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
23572479|NCT02743793|65824809|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
23572480|NCT04039503|65824810|FG000|Overall Study|Adverse Event|3|||
23572481|NCT04039503|65824811|FG001|Overall Study|Adverse Event|0|||
23572482|NCT04039503|65824812|FG002|Overall Study|Adverse Event|2|||
23572483|NCT04039503|65824813|FG003|Overall Study|Adverse Event|0|||
23572484|NCT04039503|65824810|FG000|Overall Study|Lost to Follow-up|0|||
23572485|NCT04039503|65824811|FG001|Overall Study|Lost to Follow-up|0|||
23572486|NCT04039503|65824812|FG002|Overall Study|Lost to Follow-up|1|||
23447255|NCT02814175|65377916|FG002|Part 2|Lack of Efficacy|0|||
23447256|NCT02814175|65377917|FG003|Part 2|Lack of Efficacy|0|||
23447257|NCT02814175|65377918|FG004|Part 2|Lack of Efficacy|0|||
23447258|NCT02814175|65377919|FG005|Part 2|Lack of Efficacy|3|||
23572487|NCT04039503|65824813|FG003|Overall Study|Lost to Follow-up|0|||
23572488|NCT04039503|65824810|FG000|Overall Study|Protocol Violation|0|||
23572489|NCT04039503|65824811|FG001|Overall Study|Protocol Violation|1|||
23572490|NCT04039503|65824812|FG002|Overall Study|Protocol Violation|2|||
23447259|NCT03551626|65377920|FG000|Overall Study|Adverse Event|88|||
23447260|NCT03551626|65377920|FG000|Overall Study|Disease relapse|18|||
23447261|NCT03551626|65377920|FG000|Overall Study|Withdrawal of informed consent|6|||
23447262|NCT03551626|65377920|FG000|Overall Study|Patient decision|5|||
23572491|NCT04039503|65824813|FG003|Overall Study|Protocol Violation|1|||
23572492|NCT04039503|65824810|FG000|Overall Study|Withdrawal by Subject|4|||
23572493|NCT04039503|65824811|FG001|Overall Study|Withdrawal by Subject|3|||
23572494|NCT04039503|65824812|FG002|Overall Study|Withdrawal by Subject|5|||
23572495|NCT04039503|65824813|FG003|Overall Study|Withdrawal by Subject|2|||
23831504|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831505|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
23831506|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
23831507|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23831508|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23831509|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23831510|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23831511|NCT02105987|66763023|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23831512|NCT02105987|66763024|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
23831513|NCT02105987|66763025|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23831514|NCT02105987|66763026|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23831515|NCT02105987|66763027|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23831516|NCT02105987|66763028|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23831517|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23831518|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23831519|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
23831520|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
23831521|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23831522|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23831523|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23831524|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23831525|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
23831526|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
23831527|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23831528|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23831529|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831530|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831531|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
23831532|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
23831533|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831534|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23831535|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831536|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831537|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
23831538|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23831539|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831540|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23831541|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23831542|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23831543|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
23831544|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23831545|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23831546|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23831547|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23831548|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23831549|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23831550|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
23831551|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23831552|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23831553|NCT02105987|66763023|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23831554|NCT02105987|66763024|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23831555|NCT02105987|66763025|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
23831556|NCT02105987|66763026|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23831557|NCT02105987|66763027|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23831558|NCT02105987|66763028|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23831559|NCT02105987|66763023|FG000|Continuation Phase|Protocol Violation|0|||
23831560|NCT02105987|66763024|FG001|Continuation Phase|Protocol Violation|0|||
23831561|NCT02105987|66763025|FG002|Continuation Phase|Protocol Violation|0|||
23831562|NCT02105987|66763026|FG003|Continuation Phase|Protocol Violation|0|||
23831563|NCT02105987|66763027|FG004|Continuation Phase|Protocol Violation|1|||
23831564|NCT02105987|66763028|FG005|Continuation Phase|Protocol Violation|0|||
23831565|NCT00315458|66763030|FG000|Overall Study|Administrative|0|||
23831566|NCT00315458|66763031|FG001|Overall Study|Administrative|3|||
23831567|NCT00315458|66763032|FG002|Overall Study|Administrative|8|||
23831568|NCT00315458|66763033|FG003|Overall Study|Administrative|21|||
23831569|NCT00315458|66763030|FG000|Overall Study|Adverse Event|2|||
23831570|NCT00315458|66763031|FG001|Overall Study|Adverse Event|4|||
23831571|NCT00315458|66763032|FG002|Overall Study|Adverse Event|23|||
23831572|NCT00315458|66763033|FG003|Overall Study|Adverse Event|3|||
23831573|NCT00315458|66763030|FG000|Overall Study|Lost to Follow-up|1|||
23447263|NCT03551626|65377920|FG000|Overall Study|Physician Decision|4|||
23447264|NCT03551626|65377920|FG000|Overall Study|Lost to Follow-up|3|||
23447265|NCT03551626|65377920|FG000|Overall Study|Pregnancy|1|||
23447266|NCT03551626|65377920|FG000|Overall Study|Protocol deviation|1|||
23572496|NCT03285113|65824818|FG000|Overall Study|Unable to implant leads|2|||
23770785|NCT00922974|66539667|FG001|Phase II Component|Protocol Violation|0|||
23770786|NCT00922974|66539666|FG000|Phase II Component|Not evaluable for treatment review|5|||
23770787|NCT00922974|66539667|FG001|Phase II Component|Not evaluable for treatment review|0|||
23770788|NCT00922974|66539666|FG000|Phase III Component|Protocol Violation|8|||
23770789|NCT00922974|66539667|FG001|Phase III Component|Protocol Violation|6|||
23770790|NCT01367275|66539668|FG000|Overall Study|Ineligible|1|||
23770791|NCT01367275|66539668|FG000|Overall Study|Disease Progression|2|||
23770792|NCT02309099|66539669|FG000|Overall Study|Adverse Event|2|||
23770793|NCT02309099|66539670|FG001|Overall Study|Adverse Event|0|||
23770794|NCT00973700|66539671|FG000|Overall Study|Withdrawal by Subject|2|||
23831574|NCT00315458|66763031|FG001|Overall Study|Lost to Follow-up|2|||
23831575|NCT00315458|66763032|FG002|Overall Study|Lost to Follow-up|0|||
23831576|NCT00315458|66763033|FG003|Overall Study|Lost to Follow-up|2|||
23831577|NCT00315458|66763030|FG000|Overall Study|Withdrawal by Subject|0|||
23831578|NCT00315458|66763031|FG001|Overall Study|Withdrawal by Subject|3|||
23831579|NCT00315458|66763032|FG002|Overall Study|Withdrawal by Subject|0|||
23831580|NCT00315458|66763033|FG003|Overall Study|Withdrawal by Subject|2|||
23831581|NCT00315458|66763030|FG000|Overall Study|Lack of Efficacy|0|||
23831582|NCT00315458|66763031|FG001|Overall Study|Lack of Efficacy|0|||
23831583|NCT00315458|66763032|FG002|Overall Study|Lack of Efficacy|20|||
23572497|NCT01091428|65824819|FG000|Phase 1|Progressive Disease|24|||
23831584|NCT00315458|66763033|FG003|Overall Study|Lack of Efficacy|1|||
23831585|NCT00315458|66763030|FG000|Overall Study|Did not qualify|0|||
23831586|NCT00315458|66763031|FG001|Overall Study|Did not qualify|0|||
23831587|NCT00315458|66763032|FG002|Overall Study|Did not qualify|1|||
23831588|NCT00315458|66763033|FG003|Overall Study|Did not qualify|0|||
23831589|NCT01464593|66763034|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
23831590|NCT00837148|66763035|FG000|Overall Study|Adverse Event|1|||
23831591|NCT00837148|66763035|FG000|Overall Study|Death|1|||
23831592|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
23831593|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23831594|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23831595|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23831596|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
23831597|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23831598|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23831599|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23831600|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
23831601|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23831602|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23831603|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23831604|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
23831605|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23831606|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23831607|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23831608|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
23831609|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23572498|NCT01091428|65824820|FG001|Phase 1|Progressive Disease|8|||
23572499|NCT01091428|65824821|FG002|Phase 1|Progressive Disease|0|||
23572500|NCT01091428|65824822|FG003|Phase 1|Progressive Disease|0|||
23572501|NCT01091428|65824819|FG000|Phase 1|Symptomatic Deterioration|3|||
23572502|NCT01091428|65824820|FG001|Phase 1|Symptomatic Deterioration|2|||
23770795|NCT00973700|66539672|FG001|Overall Study|Withdrawal by Subject|2|||
23447267|NCT03551626|65377920|FG000|Overall Study|Technical problems|1|||
23572503|NCT01091428|65824821|FG002|Phase 1|Symptomatic Deterioration|0|||
23572504|NCT01091428|65824822|FG003|Phase 1|Symptomatic Deterioration|0|||
23572505|NCT01091428|65824819|FG000|Phase 1|Adverse Event|2|||
23572506|NCT01091428|65824820|FG001|Phase 1|Adverse Event|0|||
23632811|NCT01217437|66041965|FG000|Overall Study|Ineligible|1|||
23632812|NCT01217437|66041966|FG001|Overall Study|Ineligible|1|||
23632813|NCT02138786|66041970|FG000|Overall Study|Adverse Event|0|||
23770796|NCT00973700|66539673|FG002|Overall Study|Withdrawal by Subject|8|||
23770797|NCT00973700|66539674|FG003|Overall Study|Withdrawal by Subject|4|||
23572507|NCT01091428|65824821|FG002|Phase 1|Adverse Event|0|||
23447268|NCT03109184|65377921|FG000|Overall Study|Lost to Follow-up|6|||
23572508|NCT01091428|65824822|FG003|Phase 1|Adverse Event|0|||
23632814|NCT02138786|66041971|FG001|Overall Study|Adverse Event|2|||
23770798|NCT00973700|66539675|FG004|Overall Study|Withdrawal by Subject|4|||
23770799|NCT00973700|66539671|FG000|Overall Study|Lost to Follow-up|5|||
23770800|NCT00973700|66539672|FG001|Overall Study|Lost to Follow-up|0|||
23770801|NCT00973700|66539673|FG002|Overall Study|Lost to Follow-up|1|||
23770802|NCT00973700|66539674|FG003|Overall Study|Lost to Follow-up|8|||
23770803|NCT00973700|66539675|FG004|Overall Study|Lost to Follow-up|5|||
23831610|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23831611|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23831612|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
23831613|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23831614|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23831615|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23572509|NCT01091428|65824819|FG000|Phase 1|Withdrawal by Subject|7|||
23572510|NCT01091428|65824820|FG001|Phase 1|Withdrawal by Subject|0|||
23572511|NCT01091428|65824821|FG002|Phase 1|Withdrawal by Subject|0|||
23572512|NCT01091428|65824822|FG003|Phase 1|Withdrawal by Subject|0|||
23572513|NCT01091428|65824819|FG000|Phase 1|Reason not specified|0|||
23572514|NCT01091428|65824820|FG001|Phase 1|Reason not specified|1|||
23572515|NCT01091428|65824821|FG002|Phase 1|Reason not specified|0|||
23572516|NCT01091428|65824822|FG003|Phase 1|Reason not specified|0|||
23572517|NCT01091428|65824819|FG000|Phase 1|Single-Patient IND|2|||
23572518|NCT01091428|65824820|FG001|Phase 1|Single-Patient IND|0|||
23572519|NCT01091428|65824821|FG002|Phase 1|Single-Patient IND|0|||
23632815|NCT02138786|66041972|FG002|Overall Study|Adverse Event|1|||
23770804|NCT00973700|66539671|FG000|Overall Study|Inappropriate enrolment|0|||
23770805|NCT00973700|66539672|FG001|Overall Study|Inappropriate enrolment|0|||
23770806|NCT00973700|66539673|FG002|Overall Study|Inappropriate enrolment|0|||
23770807|NCT00973700|66539674|FG003|Overall Study|Inappropriate enrolment|4|||
23770808|NCT00973700|66539675|FG004|Overall Study|Inappropriate enrolment|0|||
23770809|NCT00973700|66539671|FG000|Overall Study|Unable to Classify|0|||
23770810|NCT00973700|66539672|FG001|Overall Study|Unable to Classify|0|||
23770811|NCT00973700|66539673|FG002|Overall Study|Unable to Classify|1|||
23770812|NCT00973700|66539674|FG003|Overall Study|Unable to Classify|2|||
23770813|NCT00973700|66539675|FG004|Overall Study|Unable to Classify|1|||
23770814|NCT02534493|66539676|FG000|Overall Study|Lost to Follow-up|1|||
23770815|NCT02534493|66539676|FG000|Overall Study|Withdrawal by Subject|1|||
23770816|NCT03322462|66539677|FG000|Overall Study|Technical difficulties|2|||
23770817|NCT03322462|66539677|FG000|Overall Study|Other|1|||
23770818|NCT01170364|66539678|FG000|Overall Study|Protocol Violation|4|||
23770819|NCT01170364|66539679|FG001|Overall Study|Protocol Violation|1|||
23770820|NCT00782509|66539682|FG000|Overall Study|Adverse Event|20|||
23770821|NCT00782509|66539683|FG001|Overall Study|Adverse Event|10|||
23770822|NCT00782509|66539684|FG002|Overall Study|Adverse Event|20|||
23770823|NCT00782509|66539682|FG000|Overall Study|Lost to Follow-up|1|||
23770824|NCT00782509|66539683|FG001|Overall Study|Lost to Follow-up|2|||
23770825|NCT00782509|66539684|FG002|Overall Study|Lost to Follow-up|3|||
23770826|NCT00782509|66539682|FG000|Overall Study|Withdrawal by Subject|3|||
23770827|NCT00782509|66539683|FG001|Overall Study|Withdrawal by Subject|5|||
23770828|NCT00782509|66539684|FG002|Overall Study|Withdrawal by Subject|8|||
23770829|NCT00782509|66539682|FG000|Overall Study|Non compliance with protocol|2|||
23770830|NCT00782509|66539683|FG001|Overall Study|Non compliance with protocol|0|||
23770831|NCT00782509|66539684|FG002|Overall Study|Non compliance with protocol|0|||
23770832|NCT00782509|66539682|FG000|Overall Study|Other reasons not stated above|5|||
23770833|NCT00782509|66539683|FG001|Overall Study|Other reasons not stated above|2|||
23770834|NCT00782509|66539684|FG002|Overall Study|Other reasons not stated above|3|||
23770835|NCT00782509|66539682|FG000|Overall Study|Lack of Efficacy|10|||
23770836|NCT00782509|66539683|FG001|Overall Study|Lack of Efficacy|5|||
23770837|NCT00782509|66539684|FG002|Overall Study|Lack of Efficacy|2|||
23770838|NCT04849988|66539688|FG000|Overall Study|Lack of Efficacy|3|||
23770839|NCT04849988|66539689|FG001|Overall Study|Lack of Efficacy|4|||
23770840|NCT04849988|66539690|FG002|Overall Study|Lack of Efficacy|1|||
23770841|NCT04849988|66539691|FG003|Overall Study|Lack of Efficacy|4|||
23770842|NCT04849988|66539688|FG000|Overall Study|Other reasons|1|||
23770843|NCT04849988|66539689|FG001|Overall Study|Other reasons|2|||
23770844|NCT04849988|66539690|FG002|Overall Study|Other reasons|2|||
23770845|NCT04849988|66539691|FG003|Overall Study|Other reasons|1|||
23770846|NCT00418184|66539695|FG000|Double-blind Phase|Withdrawal by Subject|22|||
23770847|NCT00418184|66539696|FG001|Double-blind Phase|Withdrawal by Subject|9|||
23770848|NCT00418184|66539695|FG000|Double-blind Phase|Adverse Event|2|||
23831616|NCT02513160|66763036|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
23572520|NCT01091428|65824822|FG003|Phase 1|Single-Patient IND|0|||
23572521|NCT01091428|65824819|FG000|Phase 2|Progressive Disease|0|||
23572522|NCT01091428|65824820|FG001|Phase 2|Progressive Disease|0|||
23572523|NCT01091428|65824821|FG002|Phase 2|Progressive Disease|44|||
23572524|NCT01091428|65824822|FG003|Phase 2|Progressive Disease|46|||
23770849|NCT00418184|66539696|FG001|Double-blind Phase|Adverse Event|1|||
23770850|NCT00418184|66539695|FG000|Double-blind Phase|Poor compliance|3|||
23770851|NCT00418184|66539696|FG001|Double-blind Phase|Poor compliance|1|||
23831617|NCT02513160|66763037|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23770852|NCT00531206|66539697|FG000|Overall Study|Adverse Event related|5|||
23770853|NCT00531206|66539697|FG000|Overall Study|Lack of Efficacy|2|||
23770854|NCT00531206|66539697|FG000|Overall Study|Lost to Follow-up|5|||
23770855|NCT00531206|66539697|FG000|Overall Study|including non-related adverse events|8|||
23770856|NCT03335371|66539698|FG000|Overall Study|Lost to Follow-up|0|||
23770857|NCT03335371|66539699|FG001|Overall Study|Lost to Follow-up|0|||
23770858|NCT03335371|66539700|FG002|Overall Study|Lost to Follow-up|0|||
23831618|NCT02513160|66763038|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23831619|NCT02513160|66763039|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23632816|NCT02138786|66041970|FG000|Overall Study|Death|1|||
23831620|NCT02513160|66763036|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
23831621|NCT02513160|66763037|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
23831622|NCT02513160|66763038|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
23831623|NCT02513160|66763039|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
23831624|NCT02513160|66763036|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
23831625|NCT02513160|66763037|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23831626|NCT02513160|66763038|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23831627|NCT02513160|66763039|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23831628|NCT02513160|66763036|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
23831629|NCT02513160|66763037|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23831630|NCT02513160|66763038|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23831631|NCT02513160|66763039|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23831632|NCT02513160|66763036|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
23831633|NCT02513160|66763037|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23831634|NCT02513160|66763038|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23632817|NCT02138786|66041971|FG001|Overall Study|Death|7|||
23632818|NCT02138786|66041972|FG002|Overall Study|Death|2|||
23632819|NCT02138786|66041970|FG000|Overall Study|Disease Progression|1|||
23831635|NCT02513160|66763039|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23831636|NCT02513160|66763036|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23831637|NCT02513160|66763037|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
23572525|NCT01091428|65824819|FG000|Phase 2|Symptomatic Deterioration|0|||
23572526|NCT01091428|65824820|FG001|Phase 2|Symptomatic Deterioration|0|||
23572527|NCT01091428|65824821|FG002|Phase 2|Symptomatic Deterioration|1|||
23572528|NCT01091428|65824822|FG003|Phase 2|Symptomatic Deterioration|6|||
23572529|NCT01091428|65824819|FG000|Phase 2|Adverse Event|0|||
23572530|NCT01091428|65824820|FG001|Phase 2|Adverse Event|0|||
23572531|NCT01091428|65824821|FG002|Phase 2|Adverse Event|12|||
23572532|NCT01091428|65824822|FG003|Phase 2|Adverse Event|5|||
23572533|NCT01091428|65824819|FG000|Phase 2|Withdrawal by Subject|0|||
23572534|NCT01091428|65824820|FG001|Phase 2|Withdrawal by Subject|0|||
23572535|NCT01091428|65824821|FG002|Phase 2|Withdrawal by Subject|9|||
23572536|NCT01091428|65824822|FG003|Phase 2|Withdrawal by Subject|8|||
23572537|NCT01091428|65824819|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
23572538|NCT01091428|65824820|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
23572539|NCT01091428|65824821|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
23572540|NCT01091428|65824822|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
23572541|NCT01091428|65824819|FG000|Phase 2|Reason not specified|0|||
23572542|NCT01091428|65824820|FG001|Phase 2|Reason not specified|0|||
23572543|NCT01091428|65824821|FG002|Phase 2|Reason not specified|4|||
23572544|NCT01091428|65824822|FG003|Phase 2|Reason not specified|3|||
23572545|NCT01091428|65824819|FG000|Phase 2|Physician Decision|0|||
23572546|NCT01091428|65824820|FG001|Phase 2|Physician Decision|0|||
23572547|NCT01091428|65824821|FG002|Phase 2|Physician Decision|2|||
23572548|NCT01091428|65824822|FG003|Phase 2|Physician Decision|0|||
23572549|NCT02213055|65824825|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
23572550|NCT02213055|65824826|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
23572551|NCT02213055|65824825|FG000|Overall Study|Protocol was not Followed during Study|1|||
23572552|NCT02213055|65824826|FG001|Overall Study|Protocol was not Followed during Study|0|||
23572553|NCT02213055|65824825|FG000|Overall Study|Documentation Issue at Enrollment|1|||
23572554|NCT02213055|65824826|FG001|Overall Study|Documentation Issue at Enrollment|0|||
23572555|NCT02213055|65824825|FG000|Overall Study|Documentation Issue during Study|10|||
23831638|NCT02513160|66763038|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23831639|NCT02513160|66763039|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23831640|NCT02418182|66763040|FG000|Overall Study|Unable to re-consent|18|||
23572556|NCT02213055|65824826|FG001|Overall Study|Documentation Issue during Study|0|||
23572557|NCT02213055|65824825|FG000|Overall Study|Did not have Live Lice|8|||
23572558|NCT02213055|65824826|FG001|Overall Study|Did not have Live Lice|0|||
23572559|NCT02213055|65824825|FG000|Overall Study|Had another Treatment during the Study|3|||
23632820|NCT02138786|66041971|FG001|Overall Study|Disease Progression|1|||
23632821|NCT02138786|66041972|FG002|Overall Study|Disease Progression|3|||
23770859|NCT03335371|66539701|FG003|Overall Study|Lost to Follow-up|0|||
23572560|NCT02213055|65824826|FG001|Overall Study|Had another Treatment during the Study|0|||
23572561|NCT02213055|65824825|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
23572562|NCT02213055|65824826|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
23572563|NCT02213055|65824825|FG000|Overall Study|Did not Return to School|5|||
23572564|NCT02213055|65824826|FG001|Overall Study|Did not Return to School|0|||
23572565|NCT00432679|65824827|FG000|Overall Study|Adverse Event|2|||
23572566|NCT00432679|65824828|FG001|Overall Study|Adverse Event|1|||
23572567|NCT00432679|65824827|FG000|Overall Study|Withdrawal by Subject|3|||
23572568|NCT00432679|65824828|FG001|Overall Study|Withdrawal by Subject|2|||
23831641|NCT02418182|66763041|FG001|Overall Study|Unable to re-consent|15|||
23831642|NCT02418182|66763040|FG000|Overall Study|Lost to Follow-up|0|||
23572569|NCT03317379|65824831|FG000|Overall Study|Lost to Follow-up|0|||
23572570|NCT03317379|65824832|FG001|Overall Study|Lost to Follow-up|3|||
23572571|NCT03317379|65824833|FG002|Overall Study|Lost to Follow-up|2|||
23572572|NCT03382600|65824834|FG000|Overall Study|Adverse Event|3|||
23831643|NCT02418182|66763041|FG001|Overall Study|Lost to Follow-up|2|||
23831644|NCT04030299|66763042|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
23831645|NCT04030299|66763042|FG000|Overall Study|Withdrawal by Subject|3|||
23831646|NCT02547428|66763043|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
23831647|NCT02547428|66763044|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
23831648|NCT02547428|66763043|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
23831649|NCT02547428|66763044|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
23831650|NCT02547428|66763043|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
23831651|NCT02547428|66763044|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
23831652|NCT02547428|66763043|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
23831653|NCT02547428|66763044|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
23831654|NCT02547428|66763043|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
23831655|NCT02547428|66763044|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
23831656|NCT02547428|66763043|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
23831657|NCT02547428|66763044|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
23831658|NCT02547428|66763043|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
23831659|NCT02547428|66763044|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
23831660|NCT02547428|66763043|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
23831661|NCT02547428|66763044|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
23831662|NCT01276756|66763047|FG000|Overall Study|Lost to Follow-up|2|||
23831663|NCT01276756|66763048|FG001|Overall Study|Lost to Follow-up|0|||
23831664|NCT01276756|66763047|FG000|Overall Study|Adverse Event|3|||
23831665|NCT01276756|66763048|FG001|Overall Study|Adverse Event|2|||
23831666|NCT01532934|66763053|FG000|Overall Study|Lost to Follow-up|11|||
23831667|NCT01532934|66763054|FG001|Overall Study|Lost to Follow-up|11|||
23831668|NCT01532934|66763053|FG000|Overall Study|In controlled environment|3|||
23831669|NCT01532934|66763054|FG001|Overall Study|In controlled environment|2|||
23831670|NCT02653625|66763055|FG000|Overall Study|Adverse Event|1|||
23831671|NCT02653625|66763055|FG000|Overall Study|Non-compliance with Study Drug|1|||
23831672|NCT02653625|66763055|FG000|Overall Study|Protocol Violation|1|||
23831673|NCT02653625|66763055|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
23831674|NCT04526288|66763058|FG000|Overall Study|Disease Progression|1|||
23831675|NCT04526288|66763059|FG001|Overall Study|Disease Progression|0|||
23831676|NCT03207815|66763060|FG000|Overall Study|Protocol Violation|3|||
23831677|NCT03207815|66763061|FG001|Overall Study|Protocol Violation|1|||
23831678|NCT03207815|66763060|FG000|Overall Study|Adverse Event|1|||
23831679|NCT03207815|66763061|FG001|Overall Study|Adverse Event|2|||
23831680|NCT03207815|66763060|FG000|Overall Study|Lost to Follow-up|1|||
23831681|NCT03207815|66763061|FG001|Overall Study|Lost to Follow-up|2|||
23831682|NCT03207815|66763060|FG000|Overall Study|Investigator's Discretion|1|||
23831683|NCT03207815|66763061|FG001|Overall Study|Investigator's Discretion|1|||
23831684|NCT03207815|66763060|FG000|Overall Study|Lack of Efficacy|0|||
23831685|NCT03207815|66763061|FG001|Overall Study|Lack of Efficacy|1|||
23831686|NCT03207815|66763060|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
23831687|NCT03207815|66763061|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
23831688|NCT03207815|66763060|FG000|Overall Study|Withdrew Consent|1|||
23831689|NCT03207815|66763061|FG001|Overall Study|Withdrew Consent|0|||
23831690|NCT02166333|66763062|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
23831691|NCT02166333|66763063|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23831692|NCT02166333|66763064|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23831693|NCT02166333|66763065|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23831694|NCT02166333|66763066|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
23572573|NCT03382600|65824835|FG001|Overall Study|Adverse Event|3|||
23572574|NCT03382600|65824834|FG000|Overall Study|Clinical Disease Progression|2|||
23572575|NCT03382600|65824835|FG001|Overall Study|Clinical Disease Progression|4|||
23572576|NCT03382600|65824834|FG000|Overall Study|Radiological Progression|40|||
23831695|NCT02166333|66763067|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
23831696|NCT02166333|66763062|FG000|Stage 1|Death|4|||
23831697|NCT02166333|66763063|FG001|Stage 1|Death|0|||
23831698|NCT02166333|66763064|FG002|Stage 1|Death|2|||
23831699|NCT02166333|66763065|FG003|Stage 1|Death|0|||
23831700|NCT02166333|66763066|FG004|Stage 1|Death|3|||
23831701|NCT02166333|66763067|FG005|Stage 1|Death|2|||
23831702|NCT02166333|66763062|FG000|Stage 1|Lost to Follow-up|12|||
23831703|NCT02166333|66763063|FG001|Stage 1|Lost to Follow-up|0|||
23831704|NCT02166333|66763064|FG002|Stage 1|Lost to Follow-up|6|||
23831705|NCT02166333|66763065|FG003|Stage 1|Lost to Follow-up|0|||
23831706|NCT02166333|66763066|FG004|Stage 1|Lost to Follow-up|3|||
23831707|NCT02166333|66763067|FG005|Stage 1|Lost to Follow-up|3|||
23831708|NCT02166333|66763062|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
23831709|NCT02166333|66763063|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
23831710|NCT02166333|66763064|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
23831711|NCT02166333|66763065|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
23831712|NCT02166333|66763066|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
23831713|NCT02166333|66763067|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
23831714|NCT02166333|66763062|FG000|Stage 2|Death|4|||
23831715|NCT02166333|66763063|FG001|Stage 2|Death|2|||
23831716|NCT02166333|66763064|FG002|Stage 2|Death|1|||
23831717|NCT02166333|66763065|FG003|Stage 2|Death|0|||
23831718|NCT02166333|66763066|FG004|Stage 2|Death|0|||
23831719|NCT02166333|66763067|FG005|Stage 2|Death|1|||
23831720|NCT02166333|66763062|FG000|Stage 2|Lost to Follow-up|23|||
23831721|NCT02166333|66763063|FG001|Stage 2|Lost to Follow-up|4|||
23831722|NCT02166333|66763064|FG002|Stage 2|Lost to Follow-up|11|||
23831723|NCT02166333|66763065|FG003|Stage 2|Lost to Follow-up|9|||
23831724|NCT02166333|66763066|FG004|Stage 2|Lost to Follow-up|3|||
23831725|NCT02166333|66763067|FG005|Stage 2|Lost to Follow-up|6|||
23831726|NCT05393037|66763068|FG000|Overall Study|Death|1|||
23831727|NCT05393037|66763069|FG001|Overall Study|Death|0|||
23831728|NCT05393037|66763068|FG000|Overall Study|Lost to Follow-up|1|||
23831729|NCT05393037|66763069|FG001|Overall Study|Lost to Follow-up|1|||
23831730|NCT05393037|66763068|FG000|Overall Study|Withdrawal by Subject|2|||
23831731|NCT05393037|66763069|FG001|Overall Study|Withdrawal by Subject|4|||
23831732|NCT05393037|66763068|FG000|Overall Study|Ongoing|152|||
23831733|NCT05393037|66763069|FG001|Overall Study|Ongoing|0|||
23831734|NCT01052480|66763075|FG000|Overall Study|Lost to Follow-up|3|||
23831735|NCT01052480|66763076|FG001|Overall Study|Lost to Follow-up|3|||
23831736|NCT01052480|66763075|FG000|Overall Study|Protocol Violation|1|||
23831737|NCT01052480|66763076|FG001|Overall Study|Protocol Violation|0|||
23831738|NCT01052480|66763075|FG000|Overall Study|Withdrawal by Subject|3|||
23831739|NCT01052480|66763076|FG001|Overall Study|Withdrawal by Subject|7|||
23831740|NCT01052480|66763075|FG000|Overall Study|Physician Decision|0|||
23831741|NCT01052480|66763076|FG001|Overall Study|Physician Decision|2|||
23831742|NCT01052480|66763075|FG000|Overall Study|Death|1|||
23831743|NCT01052480|66763076|FG001|Overall Study|Death|5|||
23831744|NCT03534687|66763078|FG000|Overall Study|Lost to Follow-up|7|||
23831745|NCT03534687|66763079|FG001|Overall Study|Lost to Follow-up|2|||
23831746|NCT02064816|66763082|FG000|Overall Study|Adverse Event|3|||
23831747|NCT02064816|66763083|FG001|Overall Study|Adverse Event|2|||
23831748|NCT02064816|66763082|FG000|Overall Study|Withdrawal by Subject|2|||
23831749|NCT02064816|66763083|FG001|Overall Study|Withdrawal by Subject|1|||
23831750|NCT02064816|66763082|FG000|Overall Study|Lost to Follow-up|2|||
23831751|NCT02064816|66763083|FG001|Overall Study|Lost to Follow-up|1|||
23831752|NCT02064816|66763082|FG000|Overall Study|Therapeutic failure|0|||
23831753|NCT02064816|66763083|FG001|Overall Study|Therapeutic failure|1|||
23831754|NCT02064816|66763082|FG000|Overall Study|Other|1|||
23831755|NCT02064816|66763083|FG001|Overall Study|Other|3|||
23831756|NCT02157935|66763084|FG000|Overall Study|Withdrawal by Subject|25|||
23831757|NCT02157935|66763085|FG001|Overall Study|Withdrawal by Subject|39|||
23831758|NCT02157935|66763084|FG000|Overall Study|Screen failure|1|||
23831759|NCT02157935|66763085|FG001|Overall Study|Screen failure|2|||
23831760|NCT02157935|66763084|FG000|Overall Study|Protocol Violation|1|||
23632822|NCT02138786|66041970|FG000|Overall Study|Withdrawal by Subject|1|||
23831761|NCT02157935|66763085|FG001|Overall Study|Protocol Violation|0|||
23831762|NCT02157935|66763084|FG000|Overall Study|Progressive disease|0|||
23831763|NCT02157935|66763085|FG001|Overall Study|Progressive disease|2|||
23831764|NCT02157935|66763084|FG000|Overall Study|Other|5|||
23831765|NCT02157935|66763085|FG001|Overall Study|Other|12|||
23831766|NCT02157935|66763084|FG000|Overall Study|Lack of Efficacy|0|||
23831767|NCT02157935|66763085|FG001|Overall Study|Lack of Efficacy|1|||
23831768|NCT02157935|66763084|FG000|Overall Study|Death|4|||
23831769|NCT02157935|66763085|FG001|Overall Study|Death|4|||
23831770|NCT02157935|66763084|FG000|Overall Study|Adverse Event|3|||
23831771|NCT02157935|66763085|FG001|Overall Study|Adverse Event|5|||
23831772|NCT04830969|66763086|FG000|Overall Study|Withdrawal by Subject|6|||
23831773|NCT04830969|66763087|FG001|Overall Study|Withdrawal by Subject|2|||
23632823|NCT02138786|66041971|FG001|Overall Study|Withdrawal by Subject|2|||
23632824|NCT02138786|66041972|FG002|Overall Study|Withdrawal by Subject|0|||
23632825|NCT02138786|66041970|FG000|Overall Study|Patient's Wish|0|||
23632826|NCT02138786|66041971|FG001|Overall Study|Patient's Wish|2|||
23632827|NCT02138786|66041972|FG002|Overall Study|Patient's Wish|0|||
23632828|NCT02138786|66041970|FG000|Overall Study|Sponsor Terminated Study|0|||
23632829|NCT02138786|66041971|FG001|Overall Study|Sponsor Terminated Study|1|||
23632830|NCT02138786|66041972|FG002|Overall Study|Sponsor Terminated Study|1|||
23632831|NCT02138786|66041970|FG000|Overall Study|Non-Compliance|0|||
23632832|NCT02138786|66041971|FG001|Overall Study|Non-Compliance|0|||
23632833|NCT02138786|66041972|FG002|Overall Study|Non-Compliance|1|||
23632834|NCT02838134|66041976|FG000|Overall Study|Lost to Follow-up|1|||
23632835|NCT02838134|66041977|FG001|Overall Study|Lost to Follow-up|2|||
23632836|NCT02838134|66041976|FG000|Overall Study|logistic problems|1|||
23632837|NCT02838134|66041977|FG001|Overall Study|logistic problems|1|||
23632838|NCT01195623|66041978|FG000|Overall Study|Lost to Follow-up|35|||
23632839|NCT01195623|66041979|FG001|Overall Study|Lost to Follow-up|37|||
23632840|NCT01208103|66041981|FG000|Overall Study|Adverse Event|1|||
23632841|NCT01208103|66041981|FG000|Overall Study|Withdrawal by Subject|1|||
23632842|NCT01572740|66041983|FG000|Overall Study|Adverse Event|1|||
23632843|NCT01572740|66041984|FG001|Overall Study|Adverse Event|1|||
23632844|NCT01572740|66041983|FG000|Overall Study|Withdrawal by Subject|1|||
23632845|NCT01572740|66041984|FG001|Overall Study|Withdrawal by Subject|1|||
23632846|NCT01572740|66041983|FG000|Overall Study|unclassified|4|||
23632847|NCT01572740|66041984|FG001|Overall Study|unclassified|3|||
23632848|NCT01417104|66041985|FG000|Overall Study|Withdrawal by Subject|5|||
23632849|NCT01417104|66041986|FG001|Overall Study|Withdrawal by Subject|1|||
23632850|NCT01417104|66041985|FG000|Overall Study|Failure to make contact|0|||
23632851|NCT01417104|66041986|FG001|Overall Study|Failure to make contact|1|||
23632852|NCT01417104|66041985|FG000|Overall Study|Adverse Event|1|||
23632853|NCT01417104|66041986|FG001|Overall Study|Adverse Event|0|||
23770860|NCT03335371|66539702|FG004|Overall Study|Lost to Follow-up|1|||
23770861|NCT03335371|66539698|FG000|Overall Study|Withdrawal by Subject|0|||
23770862|NCT03335371|66539699|FG001|Overall Study|Withdrawal by Subject|0|||
23770863|NCT03335371|66539700|FG002|Overall Study|Withdrawal by Subject|0|||
23770864|NCT03335371|66539701|FG003|Overall Study|Withdrawal by Subject|0|||
23770865|NCT03335371|66539702|FG004|Overall Study|Withdrawal by Subject|1|||
23770866|NCT03335371|66539698|FG000|Overall Study|Randomization Error|0|||
23770867|NCT03335371|66539699|FG001|Overall Study|Randomization Error|0|||
23770868|NCT03335371|66539700|FG002|Overall Study|Randomization Error|1|||
23770869|NCT03335371|66539701|FG003|Overall Study|Randomization Error|0|||
23770870|NCT03335371|66539702|FG004|Overall Study|Randomization Error|0|||
23770871|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
23770872|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
23770873|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
23770874|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
23770875|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
23770876|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
23770877|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
23770878|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
23770879|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23770880|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23770881|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23770882|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
23770883|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
23770884|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
23770885|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
23770886|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
23770887|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23770888|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23770889|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
23770890|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23770891|NCT02207231|66539703|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
23770892|NCT02207231|66539704|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
23770893|NCT02207231|66539705|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
23770894|NCT02207231|66539706|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
23632854|NCT00965497|66041987|FG000|Overall Study|Physician Decision|1|||
23632855|NCT01747551|66041988|FG000|Overall Study|Progressive Disease|24|||
23632856|NCT01747551|66041989|FG001|Overall Study|Progressive Disease|17|||
23632857|NCT01747551|66041988|FG000|Overall Study|Death|3|||
23632858|NCT01747551|66041989|FG001|Overall Study|Death|1|||
23632859|NCT01747551|66041988|FG000|Overall Study|Adverse Event|7|||
23632860|NCT01747551|66041989|FG001|Overall Study|Adverse Event|1|||
23632861|NCT01747551|66041988|FG000|Overall Study|Prolonged Treatment Delay|2|||
23572577|NCT03382600|65824835|FG001|Overall Study|Radiological Progression|31|||
23572578|NCT03382600|65824834|FG000|Overall Study|Withdrawal by Subject|0|||
23572579|NCT03382600|65824835|FG001|Overall Study|Withdrawal by Subject|1|||
23572580|NCT03382600|65824834|FG000|Overall Study|Other|9|||
23572581|NCT03382600|65824835|FG001|Overall Study|Other|7|||
23572582|NCT00556374|65824836|FG000|Overall Study|Withdrawal by Subject|235|||
23572583|NCT00556374|65824837|FG001|Overall Study|Withdrawal by Subject|205|||
23572584|NCT00556374|65824836|FG000|Overall Study|Death|158|||
23572585|NCT00556374|65824837|FG001|Overall Study|Death|127|||
23572586|NCT00556374|65824836|FG000|Overall Study|Lost to Follow-up|24|||
23572587|NCT00556374|65824837|FG001|Overall Study|Lost to Follow-up|17|||
23770895|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
23770896|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
23770897|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
23770898|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
23770899|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23770900|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23770901|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
23770902|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23770903|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
23770904|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
23770905|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
23770906|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
23770907|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
23770908|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
23770909|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
23770910|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
23770911|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
23770912|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
23770913|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
23770914|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
23770915|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23770916|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
23770917|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23770918|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23770919|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
23770920|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
23770921|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
23770922|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
23770923|NCT02207231|66539703|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
23770924|NCT02207231|66539704|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
23770925|NCT02207231|66539705|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
23770926|NCT02207231|66539706|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
23770927|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
23770928|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
23770929|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
23770930|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
23770931|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
23770932|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
23770933|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
23770934|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
23770935|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
23770936|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
23770937|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
23770938|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
23770939|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
23770940|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
23770941|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
23770942|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
23770943|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
23572588|NCT00556374|65824836|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
23572589|NCT00556374|65824837|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
23770944|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
23770945|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
23770946|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
23770947|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
23770948|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
23572590|NCT01912222|65824840|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
23831774|NCT04830969|66763086|FG000|Overall Study|Protocol Violation|3|||
23831775|NCT04830969|66763087|FG001|Overall Study|Protocol Violation|9|||
23831776|NCT04830969|66763086|FG000|Overall Study|Lost to Follow-up|4|||
23831777|NCT04830969|66763087|FG001|Overall Study|Lost to Follow-up|4|||
23831778|NCT02949973|66763088|FG000|Overall Study|Physician Decision|1|||
23831779|NCT01958437|66763097|FG000|Overall Study|Incidental MRI findings|0|||
23831780|NCT01958437|66763098|FG001|Overall Study|Incidental MRI findings|0|||
23831781|NCT01958437|66763099|FG002|Overall Study|Incidental MRI findings|1|||
23831782|NCT01958437|66763100|FG003|Overall Study|Incidental MRI findings|1|||
23831783|NCT01530464|66763101|FG000|Washout (24h)|Withdrawal by Subject|1|||
23831784|NCT01530464|66763102|FG001|Washout (24h)|Withdrawal by Subject|0|||
23831785|NCT01530464|66763101|FG000|Washout (24h)|Withdrawal by Subject|0|||
23572591|NCT01912222|65824841|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
23572592|NCT01912222|65824842|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
23572593|NCT01912222|65824840|FG000|Part B: Treatment Period|Progressive disease|10|||
23572594|NCT01912222|65824841|FG001|Part B: Treatment Period|Progressive disease|12|||
23572595|NCT01912222|65824842|FG002|Part B: Treatment Period|Progressive disease|15|||
23572596|NCT01912222|65824840|FG000|Part B: Treatment Period|Adverse Event|1|||
23572597|NCT01912222|65824841|FG001|Part B: Treatment Period|Adverse Event|2|||
23572598|NCT01912222|65824842|FG002|Part B: Treatment Period|Adverse Event|3|||
23572599|NCT01912222|65824840|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
23572600|NCT01912222|65824841|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
23572601|NCT01912222|65824842|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
23572602|NCT00211237|65824843|FG000|Baseline|Withdrew|1|||
23572603|NCT00211237|65824844|FG001|Baseline|Withdrew|3|||
23572604|NCT00211237|65824845|FG002|Baseline|Withdrew|0|||
23572605|NCT00211237|65824843|FG000|Baseline|Refused random assignment|1|||
23572606|NCT00211237|65824844|FG001|Baseline|Refused random assignment|0|||
23572607|NCT00211237|65824845|FG002|Baseline|Refused random assignment|0|||
23572608|NCT00211237|65824843|FG000|1 Month|Death|2|||
23572609|NCT00211237|65824844|FG001|1 Month|Death|1|||
23572610|NCT00211237|65824845|FG002|1 Month|Death|0|||
23572611|NCT00211237|65824843|FG000|1 Month|Lost to Follow-up|0|||
23572612|NCT00211237|65824844|FG001|1 Month|Lost to Follow-up|2|||
23572613|NCT00211237|65824845|FG002|1 Month|Lost to Follow-up|0|||
23572614|NCT00211237|65824843|FG000|1 Month|Withdrew|0|||
23572615|NCT00211237|65824844|FG001|1 Month|Withdrew|4|||
23572616|NCT00211237|65824845|FG002|1 Month|Withdrew|0|||
23572617|NCT00211237|65824843|FG000|1 Month|Additional surgery needed|1|||
23572618|NCT00211237|65824844|FG001|1 Month|Additional surgery needed|0|||
23572619|NCT00211237|65824845|FG002|1 Month|Additional surgery needed|0|||
23572620|NCT00211237|65824843|FG000|1 Month|Non-medical problem|0|||
23572621|NCT00211237|65824844|FG001|1 Month|Non-medical problem|2|||
23572622|NCT00211237|65824845|FG002|1 Month|Non-medical problem|0|||
23572623|NCT00211237|65824843|FG000|3 Months|Death|7|||
23572624|NCT00211237|65824844|FG001|3 Months|Death|3|||
23572625|NCT00211237|65824845|FG002|3 Months|Death|0|||
23572626|NCT00211237|65824843|FG000|3 Months|Could not comply with protocol|1|||
23572627|NCT00211237|65824844|FG001|3 Months|Could not comply with protocol|0|||
23572628|NCT00211237|65824845|FG002|3 Months|Could not comply with protocol|0|||
23572629|NCT00211237|65824843|FG000|3 Months|Withdrew|0|||
23572630|NCT00211237|65824844|FG001|3 Months|Withdrew|1|||
23572631|NCT00211237|65824845|FG002|3 Months|Withdrew|0|||
23572632|NCT00211237|65824843|FG000|3 Months|Non-medical problem|0|||
23572633|NCT00211237|65824844|FG001|3 Months|Non-medical problem|0|||
23572634|NCT00211237|65824845|FG002|3 Months|Non-medical problem|1|||
23572635|NCT00211237|65824843|FG000|6 Months|Death|6|||
23572636|NCT00211237|65824844|FG001|6 Months|Death|0|||
23572637|NCT00211237|65824845|FG002|6 Months|Death|3|||
23572638|NCT00211237|65824843|FG000|6 Months|Lost to Follow-up|2|||
23572639|NCT00211237|65824844|FG001|6 Months|Lost to Follow-up|0|||
23831786|NCT01530464|66763102|FG001|Washout (24h)|Withdrawal by Subject|1|||
23831787|NCT01518322|66763103|FG000|Overall Study|FeNO measurement was missing|13|||
23831788|NCT01269918|66763104|FG000|Overall Study|Did not receive study drug|0|||
23831789|NCT01269918|66763105|FG001|Overall Study|Did not receive study drug|3|||
23831790|NCT04688671|66763106|FG000|Overall Study|Adverse Event|3|||
23572640|NCT00211237|65824845|FG002|6 Months|Lost to Follow-up|0|||
23831791|NCT04688671|66763107|FG001|Overall Study|Adverse Event|1|||
23572641|NCT00211237|65824843|FG000|6 Months|Could not comply with protocol|0|||
23572642|NCT00211237|65824844|FG001|6 Months|Could not comply with protocol|2|||
23572643|NCT00211237|65824845|FG002|6 Months|Could not comply with protocol|0|||
23572644|NCT00211237|65824843|FG000|12 Months|Death|8|||
23572645|NCT00211237|65824844|FG001|12 Months|Death|2|||
23572646|NCT00211237|65824845|FG002|12 Months|Death|3|||
23572647|NCT00211237|65824843|FG000|12 Months|Lost to Follow-up|1|||
23572648|NCT00211237|65824844|FG001|12 Months|Lost to Follow-up|0|||
23572649|NCT00211237|65824845|FG002|12 Months|Lost to Follow-up|1|||
23572650|NCT00211237|65824843|FG000|12 Months|Withdrew|0|||
23572651|NCT00211237|65824844|FG001|12 Months|Withdrew|0|||
23572652|NCT00211237|65824845|FG002|12 Months|Withdrew|1|||
23572653|NCT00211237|65824843|FG000|12 Months|unrelated medical problem|0|||
23572654|NCT00211237|65824844|FG001|12 Months|unrelated medical problem|0|||
23572655|NCT00211237|65824845|FG002|12 Months|unrelated medical problem|1|||
23572656|NCT02148718|65824854|FG000|Overall Study|Protocol Violation|26|||
23572657|NCT02148718|65824854|FG000|Overall Study|Discontinued Study Prematurely|5|||
23572658|NCT00767104|65824859|FG000|Overall Study|Lost to Follow-up|1|||
23572659|NCT00767104|65824860|FG001|Overall Study|Lost to Follow-up|2|||
23572660|NCT02632786|65827363|FG000|Overall Study|Adverse Event|2|||
23572661|NCT02632786|65827364|FG001|Overall Study|Adverse Event|1|||
23572662|NCT02632786|65827363|FG000|Overall Study|Death|3|||
23572663|NCT02632786|65827364|FG001|Overall Study|Death|2|||
23572664|NCT02632786|65827363|FG000|Overall Study|Physician Decision|5|||
23572665|NCT02632786|65827364|FG001|Overall Study|Physician Decision|4|||
23572666|NCT02632786|65827363|FG000|Overall Study|Withdrawal by Subject|1|||
23572667|NCT02632786|65827364|FG001|Overall Study|Withdrawal by Subject|0|||
23572668|NCT04242875|65827365|FG000|Overall Study|Adverse Event|2|||
23572669|NCT00289770|65827366|FG000|Year 15|Withdrawal by Subject|1|||
23572670|NCT00750893|65827367|FG000|Overall Study|Adverse Event|5|||
23572671|NCT00750893|65827367|FG000|Overall Study|Withdrawal by Subject|10|||
23572672|NCT00750893|65827367|FG000|Overall Study|Lost to Follow-up|510|||
23572673|NCT00750893|65827367|FG000|Overall Study|Other|17|||
23572674|NCT03824938|65827368|FG000|Overall Study|Withdrawal by Subject|2|||
23572675|NCT03824938|65827369|FG001|Overall Study|Withdrawal by Subject|1|||
23572676|NCT03824938|65827370|FG002|Overall Study|Withdrawal by Subject|0|||
23572677|NCT03824938|65827371|FG003|Overall Study|Withdrawal by Subject|2|||
23572678|NCT03824938|65827372|FG004|Overall Study|Withdrawal by Subject|0|||
23572679|NCT03824938|65827373|FG005|Overall Study|Withdrawal by Subject|1|||
23572680|NCT03824938|65827368|FG000|Overall Study|Lost to Follow-up|0|||
23572681|NCT03824938|65827369|FG001|Overall Study|Lost to Follow-up|1|||
23572682|NCT03824938|65827370|FG002|Overall Study|Lost to Follow-up|0|||
23572683|NCT03824938|65827371|FG003|Overall Study|Lost to Follow-up|0|||
23572684|NCT03824938|65827372|FG004|Overall Study|Lost to Follow-up|1|||
23572685|NCT03824938|65827373|FG005|Overall Study|Lost to Follow-up|0|||
23572686|NCT02698436|65827377|FG000|Overall Study|Adverse Event|1|||
23572687|NCT02698436|65827378|FG001|Overall Study|Adverse Event|0|||
23770949|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
23770950|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
23770951|NCT02207231|66539703|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
23770952|NCT02207231|66539704|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
23572688|NCT02698436|65827377|FG000|Overall Study|Withdrawal by Subject|3|||
23632862|NCT01747551|66041989|FG001|Overall Study|Prolonged Treatment Delay|0|||
23632863|NCT01747551|66041988|FG000|Overall Study|Withdrawal by Subject|3|||
23632864|NCT01747551|66041989|FG001|Overall Study|Withdrawal by Subject|1|||
23632865|NCT01747551|66041988|FG000|Overall Study|Physician Decision|2|||
23632866|NCT01747551|66041989|FG001|Overall Study|Physician Decision|1|||
23632867|NCT01747551|66041988|FG000|Overall Study|Other|2|||
23632868|NCT01747551|66041989|FG001|Overall Study|Other|0|||
23632869|NCT02609672|66041990|FG000|Overall Study|Lost to Follow-up|3|||
23632870|NCT02609672|66041991|FG001|Overall Study|Lost to Follow-up|1|||
23632871|NCT03406078|66041992|FG000|Overall Study|Death|1|||
23632872|NCT03406078|66041993|FG001|Overall Study|Death|0|||
23632873|NCT03406078|66041992|FG000|Overall Study|Lost to Follow-up|0|||
23632874|NCT03406078|66041993|FG001|Overall Study|Lost to Follow-up|1|||
23632875|NCT03406078|66041992|FG000|Overall Study|Withdrawal by Subject|5|||
23632876|NCT03406078|66041993|FG001|Overall Study|Withdrawal by Subject|2|||
23632877|NCT01735175|66041994|FG000|Overall Study|Withdrawal by Subject|9|||
23632878|NCT01735175|66041995|FG001|Overall Study|Withdrawal by Subject|2|||
23632879|NCT01735175|66041994|FG000|Overall Study|Lost to Follow-up|4|||
23632880|NCT01735175|66041995|FG001|Overall Study|Lost to Follow-up|2|||
23632881|NCT01735175|66041994|FG000|Overall Study|Death|3|||
23632882|NCT01735175|66041995|FG001|Overall Study|Death|2|||
23632883|NCT01735175|66041994|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
23632884|NCT01735175|66041995|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
23632885|NCT00822770|66041996|FG000|Overall Study|Not treated|1|||
23632886|NCT00822770|66041997|FG001|Overall Study|Not treated|0|||
23632887|NCT00822770|66041996|FG000|Overall Study|Complication/Incomplete treatment|1|||
23632888|NCT00822770|66041997|FG001|Overall Study|Complication/Incomplete treatment|0|||
23632889|NCT00822770|66041996|FG000|Overall Study|Death|1|||
23632890|NCT00822770|66041997|FG001|Overall Study|Death|1|||
23770953|NCT02207231|66539705|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
23770954|NCT02207231|66539706|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
23572689|NCT02698436|65827378|FG001|Overall Study|Withdrawal by Subject|3|||
23572690|NCT02698436|65827377|FG000|Overall Study|Lost to Follow-up|2|||
23572691|NCT02698436|65827378|FG001|Overall Study|Lost to Follow-up|4|||
23572692|NCT02698436|65827377|FG000|Overall Study|Non-compliance with study regimen|1|||
23572693|NCT02698436|65827378|FG001|Overall Study|Non-compliance with study regimen|0|||
23572694|NCT04102540|65827379|FG000|Overall Study|Withdrawn by PI|2|||
23572695|NCT04102540|65827379|FG000|Overall Study|Lost to Follow-up|6|||
23572696|NCT02080520|65827380|FG000|Overall Study|Self-reported symptoms|5|||
23770955|NCT02888171|66539709|FG000|Overall Study|Lost to Follow-up|2|||
23770956|NCT02888171|66539710|FG001|Overall Study|Lost to Follow-up|1|||
23770957|NCT02888171|66539709|FG000|Overall Study|Withdrawal by Subject|3|||
23770958|NCT02888171|66539710|FG001|Overall Study|Withdrawal by Subject|2|||
23770959|NCT02888171|66539709|FG000|Overall Study|Adverse Event|0|||
23770960|NCT02888171|66539710|FG001|Overall Study|Adverse Event|1|||
23770961|NCT00084084|66539714|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
23770962|NCT00084084|66539714|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
23770963|NCT04041570|66539719|FG000|Overall Study|Moved from Area|0|||
23770964|NCT04041570|66539720|FG001|Overall Study|Moved from Area|2|||
23770965|NCT00878995|66539731|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
23770966|NCT00878995|66539732|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
23770967|NCT01241461|66539735|FG000|Overall Study|Progressive Disease|3|||
23770968|NCT01241461|66539736|FG001|Overall Study|Progressive Disease|6|||
23770969|NCT01193608|66539747|FG000|Overall Study|Other|0|||
23770970|NCT01193608|66539748|FG001|Overall Study|Other|1|||
23831792|NCT04688671|66763106|FG000|Overall Study|Withdrawal by Subject|3|||
23831793|NCT04688671|66763107|FG001|Overall Study|Withdrawal by Subject|1|||
23831794|NCT04688671|66763106|FG000|Overall Study|Lack of Efficacy|1|||
23831795|NCT04688671|66763107|FG001|Overall Study|Lack of Efficacy|1|||
23831796|NCT04688671|66763106|FG000|Overall Study|Protocol Violation|1|||
23831797|NCT04688671|66763107|FG001|Overall Study|Protocol Violation|0|||
23831798|NCT04688671|66763106|FG000|Overall Study|Lost to Follow-up|0|||
23831799|NCT04688671|66763107|FG001|Overall Study|Lost to Follow-up|1|||
23770971|NCT01193608|66539749|FG002|Overall Study|Other|0|||
23770972|NCT01193608|66539750|FG003|Overall Study|Other|0|||
23770973|NCT01193608|66539751|FG004|Overall Study|Other|0|||
23770974|NCT01193608|66539752|FG005|Overall Study|Other|0|||
23770975|NCT01193608|66539747|FG000|Overall Study|Withdrawal by Subject|0|||
23770976|NCT01193608|66539748|FG001|Overall Study|Withdrawal by Subject|1|||
23770977|NCT01193608|66539749|FG002|Overall Study|Withdrawal by Subject|2|||
23770978|NCT01193608|66539750|FG003|Overall Study|Withdrawal by Subject|3|||
23831800|NCT01134939|66763110|FG000|Overall Study|Adverse Event|9|||
23831801|NCT01134939|66763111|FG001|Overall Study|Adverse Event|3|||
23831802|NCT01134939|66763112|FG002|Overall Study|Adverse Event|4|||
23572697|NCT02080520|65827381|FG001|Overall Study|Self-reported symptoms|6|||
23572698|NCT02080520|65827380|FG000|Overall Study|Unable to contact|2|||
23572699|NCT02080520|65827381|FG001|Overall Study|Unable to contact|1|||
23572700|NCT02080520|65827380|FG000|Overall Study|Initiated aspirin|2|||
23572701|NCT02080520|65827381|FG001|Overall Study|Initiated aspirin|0|||
23572702|NCT02080520|65827380|FG000|Overall Study|Atrial fibrillation|1|||
23572703|NCT02080520|65827381|FG001|Overall Study|Atrial fibrillation|1|||
23572704|NCT02080520|65827380|FG000|Overall Study|Cancer|1|||
23831803|NCT01134939|66763113|FG003|Overall Study|Adverse Event|5|||
23831804|NCT01134939|66763114|FG004|Overall Study|Adverse Event|5|||
23831805|NCT01134939|66763115|FG005|Overall Study|Adverse Event|5|||
23831806|NCT01134939|66763116|FG006|Overall Study|Adverse Event|1|||
23831807|NCT01134939|66763117|FG007|Overall Study|Adverse Event|0|||
23831808|NCT01134939|66763110|FG000|Overall Study|Lack of Efficacy|2|||
23572705|NCT02080520|65827381|FG001|Overall Study|Cancer|2|||
23572706|NCT02080520|65827380|FG000|Overall Study|Not interested in study|1|||
23572707|NCT02080520|65827381|FG001|Overall Study|Not interested in study|3|||
23572708|NCT02080520|65827380|FG000|Overall Study|Too busy|1|||
23572709|NCT02080520|65827381|FG001|Overall Study|Too busy|1|||
23572710|NCT02080520|65827380|FG000|Overall Study|Work-related injury|1|||
23572711|NCT02080520|65827381|FG001|Overall Study|Work-related injury|0|||
23572712|NCT02080520|65827380|FG000|Overall Study|Personal reasons|0|||
23572713|NCT02080520|65827381|FG001|Overall Study|Personal reasons|3|||
23572714|NCT01900054|65827382|FG000|Overall Study|Physician Decision|1|||
23572715|NCT01900054|65827382|FG000|Overall Study|Withdrawal by Subject|1|||
23572716|NCT00550173|65827385|FG000|Overall Study|Death|45|||
23770979|NCT01193608|66539751|FG004|Overall Study|Withdrawal by Subject|3|||
23770980|NCT01193608|66539752|FG005|Overall Study|Withdrawal by Subject|0|||
23770981|NCT01193608|66539747|FG000|Overall Study|Lost to Follow-up|0|||
23770982|NCT01193608|66539748|FG001|Overall Study|Lost to Follow-up|0|||
23770983|NCT01193608|66539749|FG002|Overall Study|Lost to Follow-up|0|||
23770984|NCT01193608|66539750|FG003|Overall Study|Lost to Follow-up|0|||
23770985|NCT01193608|66539751|FG004|Overall Study|Lost to Follow-up|1|||
23770986|NCT01193608|66539752|FG005|Overall Study|Lost to Follow-up|2|||
23770987|NCT01193608|66539747|FG000|Overall Study|Adverse Event|0|||
23770988|NCT01193608|66539748|FG001|Overall Study|Adverse Event|0|||
23770989|NCT01193608|66539749|FG002|Overall Study|Adverse Event|0|||
23770990|NCT01193608|66539750|FG003|Overall Study|Adverse Event|0|||
23572717|NCT00550173|65827386|FG001|Overall Study|Death|38|||
23572718|NCT00550173|65827387|FG002|Overall Study|Death|50|||
23572719|NCT00550173|65827385|FG000|Overall Study|Physician Decision|1|||
23572720|NCT00550173|65827386|FG001|Overall Study|Physician Decision|2|||
23572721|NCT00550173|65827387|FG002|Overall Study|Physician Decision|2|||
23770991|NCT01193608|66539751|FG004|Overall Study|Adverse Event|1|||
23831809|NCT01134939|66763111|FG001|Overall Study|Lack of Efficacy|5|||
23831810|NCT01134939|66763112|FG002|Overall Study|Lack of Efficacy|1|||
23831811|NCT01134939|66763113|FG003|Overall Study|Lack of Efficacy|0|||
23831812|NCT01134939|66763114|FG004|Overall Study|Lack of Efficacy|3|||
23770992|NCT01193608|66539752|FG005|Overall Study|Adverse Event|0|||
23572722|NCT00550173|65827385|FG000|Overall Study|Withdrawal by Subject|9|||
23572723|NCT00550173|65827386|FG001|Overall Study|Withdrawal by Subject|12|||
23572724|NCT00550173|65827387|FG002|Overall Study|Withdrawal by Subject|17|||
23572725|NCT00550173|65827385|FG000|Overall Study|Sponsor Decision|13|||
23770993|NCT02359890|66539754|FG000|Overall Study|Not meeting eligibility|4|||
23770994|NCT02359890|66539754|FG000|Overall Study|Never treated with study catheter|6|||
23770995|NCT01769378|66539755|FG000|Overall Study|Adverse Event|10|||
23770996|NCT01769378|66539756|FG001|Overall Study|Adverse Event|0|||
23770997|NCT01769378|66539755|FG000|Overall Study|Entry criteria not met|1|||
23770998|NCT01769378|66539756|FG001|Overall Study|Entry criteria not met|0|||
23770999|NCT01769378|66539755|FG000|Overall Study|Protocol Violation|1|||
23771000|NCT01769378|66539756|FG001|Overall Study|Protocol Violation|1|||
23771001|NCT01769378|66539755|FG000|Overall Study|Withdrawal by Subject|10|||
23831813|NCT01134939|66763115|FG005|Overall Study|Lack of Efficacy|0|||
23831814|NCT01134939|66763116|FG006|Overall Study|Lack of Efficacy|1|||
23831815|NCT01134939|66763117|FG007|Overall Study|Lack of Efficacy|0|||
23831816|NCT01134939|66763110|FG000|Overall Study|Lost to Follow-up|2|||
23831817|NCT01134939|66763111|FG001|Overall Study|Lost to Follow-up|3|||
23831818|NCT01134939|66763112|FG002|Overall Study|Lost to Follow-up|0|||
23831819|NCT01134939|66763113|FG003|Overall Study|Lost to Follow-up|1|||
23831820|NCT01134939|66763114|FG004|Overall Study|Lost to Follow-up|2|||
23831821|NCT01134939|66763115|FG005|Overall Study|Lost to Follow-up|1|||
23831822|NCT01134939|66763116|FG006|Overall Study|Lost to Follow-up|0|||
23831823|NCT01134939|66763117|FG007|Overall Study|Lost to Follow-up|0|||
23572726|NCT00550173|65827386|FG001|Overall Study|Sponsor Decision|7|||
23572727|NCT00550173|65827387|FG002|Overall Study|Sponsor Decision|1|||
23572728|NCT00550173|65827385|FG000|Overall Study|Lost to Follow-up|4|||
23572729|NCT00550173|65827386|FG001|Overall Study|Lost to Follow-up|4|||
23572730|NCT00550173|65827387|FG002|Overall Study|Lost to Follow-up|3|||
23572731|NCT00437125|65827390|FG000|Overall Study|Adverse Event|12|||
23572732|NCT00437125|65827390|FG000|Overall Study|Death|1|||
23831824|NCT01134939|66763110|FG000|Overall Study|Death|0|||
23831825|NCT01134939|66763111|FG001|Overall Study|Death|1|||
23831826|NCT01134939|66763112|FG002|Overall Study|Death|0|||
23831827|NCT01134939|66763113|FG003|Overall Study|Death|0|||
23831828|NCT01134939|66763114|FG004|Overall Study|Death|0|||
23831829|NCT01134939|66763115|FG005|Overall Study|Death|0|||
23831830|NCT01134939|66763116|FG006|Overall Study|Death|0|||
23831831|NCT01134939|66763117|FG007|Overall Study|Death|0|||
23831832|NCT01134939|66763110|FG000|Overall Study|Termination page not available|4|||
23831833|NCT01134939|66763111|FG001|Overall Study|Termination page not available|6|||
23831834|NCT01134939|66763112|FG002|Overall Study|Termination page not available|5|||
23831835|NCT01134939|66763113|FG003|Overall Study|Termination page not available|8|||
23831836|NCT01134939|66763114|FG004|Overall Study|Termination page not available|0|||
23831837|NCT01134939|66763115|FG005|Overall Study|Termination page not available|3|||
23831838|NCT01134939|66763116|FG006|Overall Study|Termination page not available|7|||
23831839|NCT01134939|66763117|FG007|Overall Study|Termination page not available|0|||
23831840|NCT02741076|66763118|FG000|Overall Study|Adverse Event|0|||
23831841|NCT02741076|66763119|FG001|Overall Study|Adverse Event|1|||
23831842|NCT02741076|66763120|FG002|Overall Study|Adverse Event|1|||
23831843|NCT02741076|66763121|FG003|Overall Study|Adverse Event|0|||
23831844|NCT02741076|66763118|FG000|Overall Study|Lack of Efficacy|1|||
23831845|NCT02741076|66763119|FG001|Overall Study|Lack of Efficacy|0|||
23831846|NCT02741076|66763120|FG002|Overall Study|Lack of Efficacy|0|||
23831847|NCT02741076|66763121|FG003|Overall Study|Lack of Efficacy|0|||
23831848|NCT02741076|66763118|FG000|Overall Study|Withdrawal by Subject|0|||
23831849|NCT02741076|66763119|FG001|Overall Study|Withdrawal by Subject|1|||
23831850|NCT02741076|66763120|FG002|Overall Study|Withdrawal by Subject|0|||
23831851|NCT02741076|66763121|FG003|Overall Study|Withdrawal by Subject|0|||
23831852|NCT02741076|66763118|FG000|Overall Study|Sponsor Request|2|||
23831853|NCT02741076|66763119|FG001|Overall Study|Sponsor Request|3|||
23771002|NCT01769378|66539756|FG001|Overall Study|Withdrawal by Subject|3|||
23831854|NCT02741076|66763120|FG002|Overall Study|Sponsor Request|0|||
23831855|NCT02741076|66763121|FG003|Overall Study|Sponsor Request|1|||
23831856|NCT02741076|66763118|FG000|Overall Study|No additional information available|0|||
23771003|NCT01769378|66539755|FG000|Overall Study|Sponsor Decision|1|||
23771004|NCT01769378|66539756|FG001|Overall Study|Sponsor Decision|0|||
23831857|NCT02741076|66763119|FG001|Overall Study|No additional information available|0|||
23831858|NCT02741076|66763120|FG002|Overall Study|No additional information available|1|||
23572733|NCT00437125|65827390|FG000|Overall Study|Clinical Relapse|1|||
23572734|NCT00437125|65827390|FG000|Overall Study|Lack of Efficacy|1|||
23572735|NCT00437125|65827390|FG000|Overall Study|Lost to Follow-up|1|||
23771005|NCT01769378|66539755|FG000|Overall Study|Lost to Follow-up|2|||
23771006|NCT01769378|66539756|FG001|Overall Study|Lost to Follow-up|0|||
23831859|NCT02741076|66763121|FG003|Overall Study|No additional information available|1|||
23632891|NCT02975102|66041998|FG000|Overall Study|Adverse Event|2|||
23632892|NCT02975102|66041999|FG001|Overall Study|Adverse Event|1|||
23632893|NCT01754753|66042010|FG000|Overall Study|Study close|43|||
23632894|NCT01754753|66042011|FG001|Overall Study|Study close|44|||
23632895|NCT01754753|66042010|FG000|Overall Study|Lost to Follow-up|9|||
23632896|NCT01754753|66042011|FG001|Overall Study|Lost to Follow-up|5|||
23632897|NCT00567567|66042012|FG000|Overall Study|Adverse Event|0|||
23632898|NCT00567567|66042013|FG001|Overall Study|Adverse Event|2|||
23632899|NCT00567567|66042014|FG002|Overall Study|Adverse Event|5|||
23632900|NCT00567567|66042012|FG000|Overall Study|Death|8|||
23632901|NCT00567567|66042013|FG001|Overall Study|Death|1|||
23632902|NCT00567567|66042014|FG002|Overall Study|Death|5|||
23632903|NCT00567567|66042012|FG000|Overall Study|Lack of Efficacy|16|||
23632904|NCT00567567|66042013|FG001|Overall Study|Lack of Efficacy|17|||
23632905|NCT00567567|66042014|FG002|Overall Study|Lack of Efficacy|48|||
23632906|NCT00567567|66042012|FG000|Overall Study|Lost to Follow-up|0|||
23632907|NCT00567567|66042013|FG001|Overall Study|Lost to Follow-up|0|||
23632908|NCT00567567|66042014|FG002|Overall Study|Lost to Follow-up|1|||
23632909|NCT00567567|66042012|FG000|Overall Study|Physician Decision|16|||
23632910|NCT00567567|66042013|FG001|Overall Study|Physician Decision|18|||
23632911|NCT00567567|66042014|FG002|Overall Study|Physician Decision|84|||
23632912|NCT00567567|66042012|FG000|Overall Study|Withdrawal by Subject|0|||
23632913|NCT00567567|66042013|FG001|Overall Study|Withdrawal by Subject|0|||
23632914|NCT00567567|66042014|FG002|Overall Study|Withdrawal by Subject|2|||
23632915|NCT00567567|66042012|FG000|Overall Study|Ineligible|4|||
23632916|NCT00567567|66042013|FG001|Overall Study|Ineligible|0|||
23632917|NCT00567567|66042014|FG002|Overall Study|Ineligible|9|||
23632918|NCT00567567|66042012|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
23632919|NCT00567567|66042013|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
23831860|NCT03918629|66763122|FG000|Overall Study|Adverse Event|19|||
23831861|NCT03918629|66763123|FG001|Overall Study|Adverse Event|20|||
23831862|NCT03918629|66763122|FG000|Overall Study|Death|14|||
23831863|NCT03918629|66763123|FG001|Overall Study|Death|7|||
23831864|NCT03918629|66763122|FG000|Overall Study|Lost to Follow-up|36|||
23831865|NCT03918629|66763123|FG001|Overall Study|Lost to Follow-up|28|||
23831866|NCT03918629|66763122|FG000|Overall Study|Physician Decision|1|||
23831867|NCT03918629|66763123|FG001|Overall Study|Physician Decision|0|||
23831868|NCT03918629|66763122|FG000|Overall Study|Protocol Violation|7|||
23831869|NCT03918629|66763123|FG001|Overall Study|Protocol Violation|4|||
23831870|NCT03918629|66763122|FG000|Overall Study|Withdrawal by Subject|47|||
23831871|NCT03918629|66763123|FG001|Overall Study|Withdrawal by Subject|47|||
23831872|NCT03918629|66763122|FG000|Overall Study|Other|7|||
23831873|NCT03918629|66763123|FG001|Overall Study|Other|11|||
23831874|NCT03918629|66763122|FG000|Overall Study|Randomized but not vaccinated|2|||
23831875|NCT03918629|66763123|FG001|Overall Study|Randomized but not vaccinated|1|||
23831876|NCT00661193|66763128|FG000|Overall Study|Adverse Event|2|||
23831877|NCT00661193|66763129|FG001|Overall Study|Adverse Event|1|||
23831878|NCT00661193|66763128|FG000|Overall Study|Withdrawal by Subject|3|||
23831879|NCT00661193|66763129|FG001|Overall Study|Withdrawal by Subject|1|||
23831880|NCT00661193|66763128|FG000|Overall Study|Progression|27|||
23572736|NCT00437125|65827390|FG000|Overall Study|Withdrawal by Subject|13|||
23572737|NCT00437125|65827390|FG000|Overall Study|Withdrawal by Caregiver|2|||
23572738|NCT00437125|65827390|FG000|Overall Study|Physician Decision|1|||
23572739|NCT01734382|65827391|FG000|Part 1|Adverse Event|2|||
23572740|NCT01734382|65827392|FG001|Part 1|Adverse Event|0|||
23572741|NCT01734382|65827393|FG002|Part 1|Adverse Event|0|||
23572742|NCT01734382|65827391|FG000|Part 2|Adverse Event|0|||
23572743|NCT01734382|65827392|FG001|Part 2|Adverse Event|0|||
23572744|NCT01734382|65827393|FG002|Part 2|Adverse Event|1|||
23572745|NCT01734382|65827391|FG000|Part 2|Lack of Efficacy|0|||
23572746|NCT01734382|65827392|FG001|Part 2|Lack of Efficacy|1|||
23572747|NCT01734382|65827393|FG002|Part 2|Lack of Efficacy|1|||
23572748|NCT01734382|65827391|FG000|Part 2|Other|0|||
23572749|NCT01734382|65827392|FG001|Part 2|Other|0|||
23572750|NCT01734382|65827393|FG002|Part 2|Other|1|||
23632920|NCT00567567|66042014|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
23632921|NCT00567567|66042012|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
23632922|NCT00567567|66042013|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
23632923|NCT00567567|66042014|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
23632924|NCT00567567|66042012|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
23632925|NCT00567567|66042013|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
23831881|NCT00661193|66763129|FG001|Overall Study|Progression|24|||
23831882|NCT00661193|66763128|FG000|Overall Study|Not protocol specified|1|||
23572751|NCT01734382|65827391|FG000|Part 2|Physician Decision|0|||
23572752|NCT01734382|65827392|FG001|Part 2|Physician Decision|0|||
23572753|NCT01734382|65827393|FG002|Part 2|Physician Decision|3|||
23572754|NCT01734382|65827391|FG000|Part 2|Protocol Violation|0|||
23632926|NCT00567567|66042014|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
23831883|NCT00661193|66763129|FG001|Overall Study|Not protocol specified|0|||
23572755|NCT01734382|65827392|FG001|Part 2|Protocol Violation|1|||
23572756|NCT01734382|65827393|FG002|Part 2|Protocol Violation|0|||
23831884|NCT01836471|66763133|FG000|Overall Study|Pregnancy|1|||
23831885|NCT01836471|66763134|FG001|Overall Study|Pregnancy|0|||
23831886|NCT01836471|66763135|FG002|Overall Study|Pregnancy|0|||
23831887|NCT01836471|66763136|FG003|Overall Study|Pregnancy|0|||
23831888|NCT01836471|66763137|FG004|Overall Study|Pregnancy|0|||
23831889|NCT01836471|66763133|FG000|Overall Study|Withdrawal by Subject|3|||
23831890|NCT01836471|66763134|FG001|Overall Study|Withdrawal by Subject|4|||
23831891|NCT01836471|66763135|FG002|Overall Study|Withdrawal by Subject|1|||
23831892|NCT01836471|66763136|FG003|Overall Study|Withdrawal by Subject|0|||
23831893|NCT01836471|66763137|FG004|Overall Study|Withdrawal by Subject|2|||
23831894|NCT01836471|66763133|FG000|Overall Study|Physician Decision|0|||
23831895|NCT01836471|66763134|FG001|Overall Study|Physician Decision|1|||
23831896|NCT01836471|66763135|FG002|Overall Study|Physician Decision|0|||
23831897|NCT01836471|66763136|FG003|Overall Study|Physician Decision|0|||
23831898|NCT01836471|66763137|FG004|Overall Study|Physician Decision|0|||
23831899|NCT01836471|66763133|FG000|Overall Study|Lost to Follow-up|0|||
23831900|NCT01836471|66763134|FG001|Overall Study|Lost to Follow-up|0|||
23831901|NCT01836471|66763135|FG002|Overall Study|Lost to Follow-up|0|||
23831902|NCT01836471|66763136|FG003|Overall Study|Lost to Follow-up|1|||
23831903|NCT01836471|66763137|FG004|Overall Study|Lost to Follow-up|1|||
23831904|NCT01836471|66763133|FG000|Overall Study|Adverse Event|6|||
23831905|NCT01836471|66763134|FG001|Overall Study|Adverse Event|3|||
23831906|NCT01836471|66763135|FG002|Overall Study|Adverse Event|1|||
23831907|NCT01836471|66763136|FG003|Overall Study|Adverse Event|1|||
23831908|NCT01836471|66763137|FG004|Overall Study|Adverse Event|2|||
23831909|NCT01836471|66763133|FG000|Overall Study|Non compliance with tx|1|||
23831910|NCT01836471|66763134|FG001|Overall Study|Non compliance with tx|1|||
23831911|NCT01836471|66763135|FG002|Overall Study|Non compliance with tx|0|||
23831912|NCT01836471|66763136|FG003|Overall Study|Non compliance with tx|0|||
23831913|NCT01836471|66763137|FG004|Overall Study|Non compliance with tx|0|||
23831914|NCT00395629|66763139|FG000|Core Study|Adverse Event|0|||
23831915|NCT00395629|66763140|FG001|Core Study|Adverse Event|3|||
23831916|NCT00395629|66763141|FG002|Core Study|Adverse Event|4|||
23831917|NCT00395629|66763139|FG000|Core Study|Abnormal laboratory value(s)|0|||
23831918|NCT00395629|66763140|FG001|Core Study|Abnormal laboratory value(s)|0|||
23831919|NCT00395629|66763141|FG002|Core Study|Abnormal laboratory value(s)|1|||
23831920|NCT00395629|66763139|FG000|Core Study|Protocol Violation|1|||
23831921|NCT00395629|66763140|FG001|Core Study|Protocol Violation|0|||
23831922|NCT00395629|66763141|FG002|Core Study|Protocol Violation|0|||
23831923|NCT00395629|66763139|FG000|Core Study|Withdrawal by Subject|0|||
23831924|NCT00395629|66763140|FG001|Core Study|Withdrawal by Subject|1|||
23831925|NCT00395629|66763141|FG002|Core Study|Withdrawal by Subject|1|||
23831926|NCT00395629|66763139|FG000|Core Study|Lost to Follow-up|0|||
23831927|NCT00395629|66763140|FG001|Core Study|Lost to Follow-up|0|||
23831928|NCT00395629|66763141|FG002|Core Study|Lost to Follow-up|1|||
23831929|NCT00395629|66763139|FG000|Extension Study|Adverse Event|0|||
23831930|NCT00395629|66763140|FG001|Extension Study|Adverse Event|0|||
23831931|NCT00395629|66763141|FG002|Extension Study|Adverse Event|2|||
23831932|NCT00395629|66763139|FG000|Extension Study|Administrative problems|0|||
23831933|NCT00395629|66763140|FG001|Extension Study|Administrative problems|0|||
23831934|NCT00395629|66763141|FG002|Extension Study|Administrative problems|1|||
23831935|NCT00594165|66763142|FG000|Overall Study|Major protocol violation|1|||
23831936|NCT00594165|66763142|FG000|Overall Study|Lack of Efficacy|12|||
23831937|NCT00594165|66763142|FG000|Overall Study|Adverse Event|52|||
23831938|NCT00594165|66763142|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
23831939|NCT00594165|66763142|FG000|Overall Study|Subject withdrew consent|27|||
23831940|NCT00594165|66763142|FG000|Overall Study|Study ended per sponsor|102|||
23831941|NCT00594165|66763142|FG000|Overall Study|Lost to Follow-up|4|||
23831942|NCT00594165|66763142|FG000|Overall Study|Other: PI discretion|5|||
23831943|NCT00594165|66763142|FG000|Overall Study|Other: Subject moving|3|||
23831944|NCT00594165|66763142|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
23831945|NCT00594165|66763142|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
23831946|NCT00594165|66763142|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
23831947|NCT00594165|66763142|FG000|Overall Study|Other: Site terminated participation|2|||
23831948|NCT01787292|66763143|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
23831949|NCT01787292|66763144|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
23572757|NCT01734382|65827391|FG000|Part 2|Withdrawal by Subject|0|||
23572758|NCT01734382|65827392|FG001|Part 2|Withdrawal by Subject|0|||
23572759|NCT01734382|65827393|FG002|Part 2|Withdrawal by Subject|1|||
23831950|NCT01787292|66763143|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
23831951|NCT01787292|66763144|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
23831952|NCT03382834|66763148|FG000|Step 1|Lost to Follow-up|0|||
23831953|NCT03382834|66763149|FG001|Step 1|Lost to Follow-up|1|||
23831954|NCT03382834|66763148|FG000|Step 2|Death|1|||
23831955|NCT03382834|66763149|FG001|Step 2|Death|0|||
23831956|NCT03382834|66763148|FG000|Step 2|Lost to Follow-up|2|||
23831957|NCT03382834|66763149|FG001|Step 2|Lost to Follow-up|2|||
23831958|NCT03382834|66763148|FG000|Step 2|Site Terminated by Sponsor|1|||
23831959|NCT03382834|66763149|FG001|Step 2|Site Terminated by Sponsor|0|||
23831960|NCT03517540|66763150|FG000|Overall Study|Protocol Violation|2|||
23831961|NCT03517540|66763151|FG001|Overall Study|Protocol Violation|0|||
23831962|NCT03517540|66763152|FG002|Overall Study|Protocol Violation|0|||
23831963|NCT03517540|66763153|FG003|Overall Study|Protocol Violation|1|||
23831964|NCT03517540|66763150|FG000|Overall Study|Adverse Event|9|||
23831965|NCT03517540|66763151|FG001|Overall Study|Adverse Event|3|||
23831966|NCT03517540|66763152|FG002|Overall Study|Adverse Event|8|||
23831967|NCT03517540|66763153|FG003|Overall Study|Adverse Event|1|||
23831968|NCT03517540|66763150|FG000|Overall Study|Withdrawal by Subject|3|||
23831969|NCT03517540|66763151|FG001|Overall Study|Withdrawal by Subject|4|||
23831970|NCT03517540|66763152|FG002|Overall Study|Withdrawal by Subject|1|||
23831971|NCT03517540|66763153|FG003|Overall Study|Withdrawal by Subject|3|||
23831972|NCT03762850|66763154|FG000|Overall Study|Death|0|||
23831973|NCT03762850|66763155|FG001|Overall Study|Death|1|||
23831974|NCT03762850|66763154|FG000|Overall Study|Lost to Follow-up|0|||
23831975|NCT03762850|66763155|FG001|Overall Study|Lost to Follow-up|1|||
23831976|NCT03762850|66763154|FG000|Overall Study|Physician Decision|0|||
23831977|NCT03762850|66763155|FG001|Overall Study|Physician Decision|1|||
23831978|NCT03762850|66763154|FG000|Overall Study|Withdrawal by Subject|4|||
23831979|NCT03762850|66763155|FG001|Overall Study|Withdrawal by Subject|9|||
23831980|NCT00380874|66763156|FG000|Overall Study|Adverse Event|7|||
23831981|NCT00380874|66763157|FG001|Overall Study|Adverse Event|7|||
23831982|NCT00380874|66763156|FG000|Overall Study|Death|1|||
23831983|NCT00380874|66763157|FG001|Overall Study|Death|0|||
23831984|NCT00380874|66763156|FG000|Overall Study|Withdrawal by Subject|2|||
23831985|NCT00380874|66763157|FG001|Overall Study|Withdrawal by Subject|1|||
23831986|NCT00380874|66763156|FG000|Overall Study|Not related to study drug|3|||
23831987|NCT00380874|66763157|FG001|Overall Study|Not related to study drug|2|||
23831988|NCT02554682|66763158|FG000|Overall Study|Lost to Follow-up|11|||
23831989|NCT02554682|66763159|FG001|Overall Study|Lost to Follow-up|9|||
23831990|NCT02554682|66763160|FG002|Overall Study|Lost to Follow-up|4|||
23831991|NCT02554682|66763161|FG003|Overall Study|Lost to Follow-up|3|||
23831992|NCT02554682|66763162|FG004|Overall Study|Lost to Follow-up|2|||
23831993|NCT02554682|66763163|FG005|Overall Study|Lost to Follow-up|1|||
23831994|NCT02554682|66763164|FG006|Overall Study|Lost to Follow-up|6|||
23831995|NCT02554682|66763165|FG007|Overall Study|Lost to Follow-up|6|||
23831996|NCT02554682|66763166|FG008|Overall Study|Lost to Follow-up|2|||
23831997|NCT02554682|66763167|FG009|Overall Study|Lost to Follow-up|2|||
23831998|NCT02554682|66763158|FG000|Overall Study|Withdrawal by Subject|2|||
23831999|NCT02554682|66763159|FG001|Overall Study|Withdrawal by Subject|1|||
23832000|NCT02554682|66763160|FG002|Overall Study|Withdrawal by Subject|0|||
23832001|NCT02554682|66763161|FG003|Overall Study|Withdrawal by Subject|0|||
23832002|NCT02554682|66763162|FG004|Overall Study|Withdrawal by Subject|0|||
23832003|NCT02554682|66763163|FG005|Overall Study|Withdrawal by Subject|0|||
23832004|NCT02554682|66763164|FG006|Overall Study|Withdrawal by Subject|0|||
23832005|NCT02554682|66763165|FG007|Overall Study|Withdrawal by Subject|0|||
23832006|NCT02554682|66763166|FG008|Overall Study|Withdrawal by Subject|0|||
23832007|NCT02554682|66763167|FG009|Overall Study|Withdrawal by Subject|0|||
23832008|NCT02554682|66763158|FG000|Overall Study|Physician Decision|2|||
23832009|NCT02554682|66763159|FG001|Overall Study|Physician Decision|2|||
23832010|NCT02554682|66763160|FG002|Overall Study|Physician Decision|0|||
23832011|NCT02554682|66763161|FG003|Overall Study|Physician Decision|0|||
23832012|NCT02554682|66763162|FG004|Overall Study|Physician Decision|0|||
23832013|NCT02554682|66763163|FG005|Overall Study|Physician Decision|0|||
23832014|NCT02554682|66763164|FG006|Overall Study|Physician Decision|0|||
23832015|NCT02554682|66763165|FG007|Overall Study|Physician Decision|0|||
23832016|NCT02554682|66763166|FG008|Overall Study|Physician Decision|0|||
23832017|NCT02554682|66763167|FG009|Overall Study|Physician Decision|0|||
23832018|NCT02656303|66763168|FG000|Overall Study|Adverse Event|3|||
23832019|NCT02656303|66763169|FG001|Overall Study|Adverse Event|2|||
23832020|NCT02656303|66763170|FG002|Overall Study|Adverse Event|0|||
23832021|NCT02656303|66763168|FG000|Overall Study|Death|12|||
23832022|NCT02656303|66763169|FG001|Overall Study|Death|4|||
23832023|NCT02656303|66763170|FG002|Overall Study|Death|1|||
23832024|NCT02656303|66763168|FG000|Overall Study|Lack of Efficacy|1|||
23832025|NCT02656303|66763169|FG001|Overall Study|Lack of Efficacy|0|||
23832026|NCT02656303|66763170|FG002|Overall Study|Lack of Efficacy|0|||
23832027|NCT02656303|66763168|FG000|Overall Study|Non-Compliance with Study|1|||
23832028|NCT02656303|66763169|FG001|Overall Study|Non-Compliance with Study|1|||
23832029|NCT02656303|66763170|FG002|Overall Study|Non-Compliance with Study|0|||
23832030|NCT02656303|66763168|FG000|Overall Study|Investigator Decision|2|||
23832031|NCT02656303|66763169|FG001|Overall Study|Investigator Decision|1|||
23832032|NCT02656303|66763170|FG002|Overall Study|Investigator Decision|0|||
23832033|NCT02656303|66763168|FG000|Overall Study|Progressive Disease|25|||
23832034|NCT02656303|66763169|FG001|Overall Study|Progressive Disease|14|||
23832035|NCT02656303|66763170|FG002|Overall Study|Progressive Disease|10|||
23832036|NCT02656303|66763168|FG000|Overall Study|Study Terminated by Sponsor|20|||
23832037|NCT02656303|66763169|FG001|Overall Study|Study Terminated by Sponsor|7|||
23832038|NCT02656303|66763170|FG002|Overall Study|Study Terminated by Sponsor|5|||
23832039|NCT02656303|66763168|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
23832040|NCT02656303|66763169|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
23832041|NCT02656303|66763170|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
23832042|NCT02656303|66763168|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
23832043|NCT02656303|66763169|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
23572760|NCT02411591|65827399|FG000|Overall Study|Adverse Event|0|||
23572761|NCT02411591|65827400|FG001|Overall Study|Adverse Event|4|||
23572762|NCT02411591|65827401|FG002|Overall Study|Adverse Event|2|||
23572763|NCT02411591|65827399|FG000|Overall Study|Withdrawal by Subject|0|||
23832044|NCT02656303|66763170|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
23832045|NCT02656303|66763168|FG000|Overall Study|Reason not Specified|1|||
23832046|NCT02656303|66763169|FG001|Overall Study|Reason not Specified|1|||
23832047|NCT02656303|66763170|FG002|Overall Study|Reason not Specified|2|||
23832048|NCT00114140|66763174|FG000|Overall Study|Protocol Violation|7|||
23832049|NCT00828568|66763175|FG000|Randomized|Withdrawal by Subject|1|||
23832050|NCT00828568|66763176|FG001|Randomized|Withdrawal by Subject|0|||
23832051|NCT00828568|66763177|FG002|Randomized|Withdrawal by Subject|2|||
23832052|NCT00828568|66763175|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
23832053|NCT00828568|66763176|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
23832054|NCT00828568|66763177|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
23832055|NCT00828568|66763175|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
23832056|NCT00828568|66763176|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
23832057|NCT00828568|66763177|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
23832058|NCT00828568|66763175|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
23832059|NCT00828568|66763176|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
23832060|NCT00828568|66763177|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
23832061|NCT00828568|66763175|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
23832062|NCT00828568|66763176|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
23832063|NCT00828568|66763177|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
23832064|NCT00536939|66763181|FG000|Overall Study|Withdrawal by Subject|1|||
23832065|NCT00536939|66763182|FG001|Overall Study|Withdrawal by Subject|0|||
23832066|NCT00536939|66763181|FG000|Overall Study|Other Complicating Disease|1|||
23832067|NCT00536939|66763182|FG001|Overall Study|Other Complicating Disease|0|||
23832068|NCT03472014|66763183|FG000|Overall Study|Lost to Follow-up|4|||
23832069|NCT02105467|66763184|FG000|Period 1|Lost to Follow-up|1|||
23832070|NCT02105467|66763185|FG001|Period 1|Lost to Follow-up|0|||
23832071|NCT02105467|66763184|FG000|Period 1|Death|1|||
23832072|NCT02105467|66763185|FG001|Period 1|Death|0|||
23832073|NCT02105467|66763184|FG000|Period 2|Lost to Follow-up|1|||
23832074|NCT02105467|66763185|FG001|Period 2|Lost to Follow-up|0|||
23832075|NCT02105467|66763184|FG000|Period 2|Death|1|||
23832076|NCT02105467|66763185|FG001|Period 2|Death|0|||
23832077|NCT02105467|66763184|FG000|Period 2|Withdrawal by Subject|0|||
23832078|NCT02105467|66763185|FG001|Period 2|Withdrawal by Subject|2|||
23832079|NCT02105467|66763184|FG000|Period 3|Lost to Follow-up|0|||
23832080|NCT02105467|66763185|FG001|Period 3|Lost to Follow-up|1|||
23832081|NCT04390113|66763186|FG000|Overall Study|Not Treated|0|||
23832082|NCT04390113|66763187|FG001|Overall Study|Not Treated|1|||
23832083|NCT04390113|66763186|FG000|Overall Study|Adverse Event|1|||
23832084|NCT04390113|66763187|FG001|Overall Study|Adverse Event|0|||
23832085|NCT04390113|66763186|FG000|Overall Study|Death|2|||
23832086|NCT04390113|66763187|FG001|Overall Study|Death|1|||
23832087|NCT04390113|66763186|FG000|Overall Study|Physician Decision|1|||
23832088|NCT04390113|66763187|FG001|Overall Study|Physician Decision|3|||
23832089|NCT04390113|66763186|FG000|Overall Study|Study Terminated by Sponsor|5|||
23832090|NCT04390113|66763187|FG001|Overall Study|Study Terminated by Sponsor|3|||
23832091|NCT04390113|66763186|FG000|Overall Study|Withdrawal by Subject|10|||
23832092|NCT04390113|66763187|FG001|Overall Study|Withdrawal by Subject|5|||
23832093|NCT04390113|66763186|FG000|Overall Study|Other|1|||
23832094|NCT04390113|66763187|FG001|Overall Study|Other|0|||
23832095|NCT04390113|66763186|FG000|Overall Study|Missing|0|||
23832096|NCT04390113|66763187|FG001|Overall Study|Missing|1|||
23832097|NCT01954056|66763190|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
23832098|NCT01954056|66763191|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
23832099|NCT00858273|66763192|FG000|Overall Study|Protocol Violation|3|||
23832100|NCT00858273|66763193|FG001|Overall Study|Protocol Violation|5|||
23832101|NCT01431716|66763198|FG000|Overall Study|Withdrawal of consent|1|||
23832102|NCT04152837|66763199|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
23832103|NCT04152837|66763199|FG000|Maintenance Period|Adverse Event|1|||
23832104|NCT04152837|66763199|FG000|Maintenance Period|Withdrawal by Subject|1|||
23832105|NCT04152837|66763199|FG000|Maintenance Period|Sponsor Termination of Study|2|||
23832106|NCT04314037|66763204|FG000|Treatment Period 2|Adverse Event|1|||
23832107|NCT04314037|66763205|FG001|Treatment Period 2|Adverse Event|0|||
23832108|NCT04314037|66763204|FG000|Treatment Period 3|Protocol Violation|1|||
23832109|NCT04314037|66763205|FG001|Treatment Period 3|Protocol Violation|0|||
23572764|NCT02411591|65827400|FG001|Overall Study|Withdrawal by Subject|3|||
23771007|NCT00810368|66539760|FG000|Overall Study|Lost to Follow-up|4|||
23771008|NCT00810368|66539761|FG001|Overall Study|Lost to Follow-up|2|||
23771009|NCT00810368|66539760|FG000|Overall Study|Lack of Efficacy|2|||
23771010|NCT00810368|66539761|FG001|Overall Study|Lack of Efficacy|0|||
23771011|NCT02041702|66539762|FG000|Overall Study|Lost to Follow-up|1|||
23771012|NCT02041702|66539763|FG001|Overall Study|Lost to Follow-up|6|||
23771013|NCT02041702|66539762|FG000|Overall Study|Death|4|||
23771014|NCT02041702|66539763|FG001|Overall Study|Death|0|||
23771015|NCT02041702|66539762|FG000|Overall Study|Withdrawal by Subject|4|||
23771016|NCT02041702|66539763|FG001|Overall Study|Withdrawal by Subject|3|||
23771017|NCT02041702|66539762|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
23771018|NCT02041702|66539763|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
23771019|NCT02041702|66539762|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
23771020|NCT02041702|66539763|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
23771021|NCT03247556|66539765|FG000|Overall Study|Adverse Event|1|||
23771022|NCT03247556|66539766|FG001|Overall Study|Adverse Event|4|||
23771023|NCT03247556|66539767|FG002|Overall Study|Adverse Event|5|||
23771024|NCT03247556|66539765|FG000|Overall Study|Lost to Follow-up|5|||
23771025|NCT03247556|66539766|FG001|Overall Study|Lost to Follow-up|5|||
23771026|NCT03247556|66539767|FG002|Overall Study|Lost to Follow-up|4|||
23771027|NCT03247556|66539765|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
23771028|NCT03247556|66539766|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
23771029|NCT03247556|66539767|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
23771030|NCT03247556|66539765|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
23771031|NCT03247556|66539766|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
23771032|NCT03247556|66539767|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
23771033|NCT03247556|66539765|FG000|Overall Study|Protocol Violation|2|||
23771034|NCT03247556|66539766|FG001|Overall Study|Protocol Violation|0|||
23771035|NCT03247556|66539767|FG002|Overall Study|Protocol Violation|1|||
23771036|NCT03247556|66539765|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
23771037|NCT03247556|66539766|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
23771038|NCT03247556|66539767|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
23771039|NCT03594123|66542982|FG000|Overall Study|Lost to Follow-up|0|||
23771040|NCT03594123|66542983|FG001|Overall Study|Lost to Follow-up|1|||
23771041|NCT03594123|66542982|FG000|Overall Study|Adverse Event|8|||
23771042|NCT03594123|66542983|FG001|Overall Study|Adverse Event|5|||
23771043|NCT03594123|66542982|FG000|Overall Study|Site Terminated by Sponsor|4|||
23771044|NCT03594123|66542983|FG001|Overall Study|Site Terminated by Sponsor|1|||
23771045|NCT03594123|66542982|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
23771046|NCT03594123|66542983|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
23832110|NCT04314037|66763204|FG000|Treatment Period 3|Adverse Event|0|||
23771047|NCT03594123|66542982|FG000|Overall Study|Lack of Efficacy|1|||
23771048|NCT03594123|66542983|FG001|Overall Study|Lack of Efficacy|0|||
23771049|NCT03594123|66542982|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
23771050|NCT03594123|66542983|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
23771051|NCT01611090|66542984|FG000|Randomized Period|Lost to Follow-up|8|||
23771052|NCT01611090|66542985|FG001|Randomized Period|Lost to Follow-up|3|||
23771053|NCT01611090|66542986|FG002|Randomized Period|Lost to Follow-up|0|||
23832111|NCT04314037|66763205|FG001|Treatment Period 3|Adverse Event|1|||
23832112|NCT04341363|66763206|FG000|Overall Study|Adverse Event|1|||
23832113|NCT04341363|66763206|FG000|Overall Study|Withdrawal by Subject|1|||
23832114|NCT03620708|66763209|FG000|Overall Study|Lost to Follow-up|1|||
23832115|NCT03620708|66763210|FG001|Overall Study|Lost to Follow-up|1|||
23832116|NCT03620708|66763211|FG002|Overall Study|Lost to Follow-up|2|||
23832117|NCT03620708|66763209|FG000|Overall Study|Withdrawal by Subject|0|||
23832118|NCT03620708|66763210|FG001|Overall Study|Withdrawal by Subject|0|||
23832119|NCT03620708|66763211|FG002|Overall Study|Withdrawal by Subject|1|||
23832120|NCT01254643|66763212|FG000|Overall Study|Withdrawal by Subject|1|||
23832121|NCT02070965|66763213|FG000|Overall Study|Lost to Follow-up|0|||
23632927|NCT00968526|66042015|FG000|Overall Study|Adverse Event|2|||
23832122|NCT02070965|66763214|FG001|Overall Study|Lost to Follow-up|1|||
23832123|NCT02070965|66763215|FG002|Overall Study|Lost to Follow-up|0|||
23832124|NCT02070965|66763213|FG000|Overall Study|Withdrawal by Subject|1|||
23832125|NCT02070965|66763214|FG001|Overall Study|Withdrawal by Subject|1|||
23832126|NCT02070965|66763215|FG002|Overall Study|Withdrawal by Subject|1|||
23832127|NCT02070965|66763213|FG000|Overall Study|Subject moved|1|||
23832128|NCT02070965|66763214|FG001|Overall Study|Subject moved|0|||
23832129|NCT02070965|66763215|FG002|Overall Study|Subject moved|0|||
23832130|NCT02515331|66763216|FG000|Overall Study|Withdrawal by Subject|0|||
23832131|NCT02515331|66763217|FG001|Overall Study|Withdrawal by Subject|0|||
23832132|NCT02515331|66763218|FG002|Overall Study|Withdrawal by Subject|1|||
23832133|NCT02515331|66763216|FG000|Overall Study|Protocol deviation|0|||
23832134|NCT02515331|66763217|FG001|Overall Study|Protocol deviation|0|||
23832135|NCT02515331|66763218|FG002|Overall Study|Protocol deviation|3|||
23832136|NCT02515331|66763216|FG000|Overall Study|Adverse Event|2|||
23832137|NCT02515331|66763217|FG001|Overall Study|Adverse Event|0|||
23832138|NCT02515331|66763218|FG002|Overall Study|Adverse Event|0|||
23832139|NCT00740636|66763219|FG000|Overall Study|Adverse Event|0|||
23832140|NCT00740636|66763220|FG001|Overall Study|Adverse Event|2|||
23832141|NCT00740636|66763219|FG000|Overall Study|Patient Ineligible|0|||
23832142|NCT00740636|66763220|FG001|Overall Study|Patient Ineligible|1|||
23832143|NCT00740636|66763219|FG000|Overall Study|Patient Not Treated|0|||
23832144|NCT00740636|66763220|FG001|Overall Study|Patient Not Treated|1|||
23832145|NCT00740636|66763219|FG000|Overall Study|Progressive Disease|1|||
23832146|NCT00740636|66763220|FG001|Overall Study|Progressive Disease|0|||
23832147|NCT00740636|66763219|FG000|Overall Study|Death|1|||
23832148|NCT00740636|66763220|FG001|Overall Study|Death|0|||
23832149|NCT01207687|66763223|FG000|Overall Study|Adverse Event|1|||
23832150|NCT01207687|66763223|FG000|Overall Study|Withdrawal by Subject|1|||
23832151|NCT04537078|66763224|FG000|Overall Study|Protocol Violation|3|||
23832152|NCT04537078|66763225|FG001|Overall Study|Protocol Violation|2|||
23832153|NCT04537078|66763224|FG000|Overall Study|Lost to Follow-up|1|||
23832154|NCT04537078|66763225|FG001|Overall Study|Lost to Follow-up|0|||
23832155|NCT04537078|66763224|FG000|Overall Study|Withdrawal by Subject|0|||
23832156|NCT04537078|66763225|FG001|Overall Study|Withdrawal by Subject|1|||
23572765|NCT02411591|65827401|FG002|Overall Study|Withdrawal by Subject|0|||
23572766|NCT02411591|65827399|FG000|Overall Study|Physician Decision|0|||
23572767|NCT02411591|65827400|FG001|Overall Study|Physician Decision|3|||
23572768|NCT02411591|65827401|FG002|Overall Study|Physician Decision|1|||
23572769|NCT03590743|65827402|FG000|Overall Study|Withdrawal by Subject|0|||
23572770|NCT03590743|65827403|FG001|Overall Study|Withdrawal by Subject|1|||
23572771|NCT00478608|65827404|FG000|Overall Study|Adverse Event|1|||
23572772|NCT00478608|65827404|FG000|Overall Study|Serious Adverse Event|14|||
23572773|NCT00478608|65827404|FG000|Overall Study|Withdrawal by Subject|2|||
23572774|NCT00478608|65827404|FG000|Overall Study|Protocol Violation|3|||
23572775|NCT00849680|65827407|FG000|Overall Study|Adverse Event|0|||
23572776|NCT00849680|65827408|FG001|Overall Study|Adverse Event|0|||
23572777|NCT00849680|65827409|FG002|Overall Study|Adverse Event|0|||
23572778|NCT00849680|65827410|FG003|Overall Study|Adverse Event|0|||
23572779|NCT00849680|65827411|FG004|Overall Study|Adverse Event|0|||
23832157|NCT00696423|66763226|FG000|Overall Study|Lost to Follow-up|0|||
23832158|NCT00696423|66763227|FG001|Overall Study|Lost to Follow-up|5|||
23832159|NCT01991743|66763228|FG000|Overall Study|external cephalic version not performed|0|||
23832160|NCT01991743|66763229|FG001|Overall Study|external cephalic version not performed|0|||
23832161|NCT01991743|66763230|FG002|Overall Study|external cephalic version not performed|1|||
23832162|NCT01991743|66763231|FG003|Overall Study|external cephalic version not performed|0|||
23832163|NCT00739882|66763234|FG000|Double-blind Period|Adverse Event|1|||
23832164|NCT00739882|66763235|FG001|Double-blind Period|Adverse Event|2|||
23832165|NCT00739882|66763234|FG000|Double-blind Period|Protocol Violation|1|||
23832166|NCT00739882|66763235|FG001|Double-blind Period|Protocol Violation|0|||
23832167|NCT00739882|66763234|FG000|Double-blind Period|Lack of Efficacy|1|||
23832168|NCT00739882|66763235|FG001|Double-blind Period|Lack of Efficacy|1|||
23832169|NCT00739882|66763234|FG000|Double-blind Period|Other|16|||
23572780|NCT00849680|65827412|FG005|Overall Study|Adverse Event|0|||
23572781|NCT00849680|65827413|FG006|Overall Study|Adverse Event|2|||
23572782|NCT00849680|65827414|FG007|Overall Study|Adverse Event|0|||
23572783|NCT00849680|65827407|FG000|Overall Study|Lost to Follow-up|7|||
23832170|NCT00739882|66763235|FG001|Double-blind Period|Other|8|||
23832171|NCT00739882|66763234|FG000|Open-label Period|Adverse Event|1|||
23832172|NCT00739882|66763235|FG001|Open-label Period|Adverse Event|0|||
23832173|NCT00739882|66763234|FG000|Open-label Period|Other|9|||
23832174|NCT00739882|66763235|FG001|Open-label Period|Other|5|||
23832175|NCT02727478|66763239|FG000|Overall Study|Withdrawal by Subject|8|||
23832176|NCT02727478|66763240|FG001|Overall Study|Withdrawal by Subject|10|||
23843103|NCT01738503|66805586|FG005|Treatment Period|Protocol Violation|2|||
23843104|NCT01738503|66805587|FG006|Treatment Period|Protocol Violation|0|||
23843105|NCT01738503|66805581|FG000|Treatment Period|Other|0|||
23843106|NCT01738503|66805582|FG001|Treatment Period|Other|0|||
23843107|NCT01738503|66805583|FG002|Treatment Period|Other|1|||
23843108|NCT01738503|66805584|FG003|Treatment Period|Other|0|||
23843109|NCT01738503|66805585|FG004|Treatment Period|Other|0|||
23843110|NCT01738503|66805586|FG005|Treatment Period|Other|0|||
23843111|NCT01738503|66805587|FG006|Treatment Period|Other|0|||
23843112|NCT01738503|66805581|FG000|PET Imaging Sub-study|Adverse Event|0|||
23843113|NCT01738503|66805582|FG001|PET Imaging Sub-study|Adverse Event|0|||
23572784|NCT00849680|65827408|FG001|Overall Study|Lost to Follow-up|3|||
23572785|NCT00849680|65827409|FG002|Overall Study|Lost to Follow-up|12|||
23572786|NCT00849680|65827410|FG003|Overall Study|Lost to Follow-up|11|||
23572787|NCT00849680|65827411|FG004|Overall Study|Lost to Follow-up|8|||
23843114|NCT01738503|66805583|FG002|PET Imaging Sub-study|Adverse Event|0|||
23572788|NCT00849680|65827412|FG005|Overall Study|Lost to Follow-up|11|||
23572789|NCT00849680|65827413|FG006|Overall Study|Lost to Follow-up|12|||
23572790|NCT00849680|65827414|FG007|Overall Study|Lost to Follow-up|5|||
23572791|NCT00849680|65827407|FG000|Overall Study|Subject moved|1|||
23572792|NCT00849680|65827408|FG001|Overall Study|Subject moved|0|||
23572793|NCT00849680|65827409|FG002|Overall Study|Subject moved|3|||
23572794|NCT00849680|65827410|FG003|Overall Study|Subject moved|1|||
23572795|NCT00849680|65827411|FG004|Overall Study|Subject moved|0|||
23572796|NCT00849680|65827412|FG005|Overall Study|Subject moved|2|||
23572797|NCT00849680|65827413|FG006|Overall Study|Subject moved|2|||
23572798|NCT00849680|65827414|FG007|Overall Study|Subject moved|2|||
23572799|NCT00849680|65827407|FG000|Overall Study|Withdrawal by Subject|2|||
23572800|NCT00849680|65827408|FG001|Overall Study|Withdrawal by Subject|0|||
23572801|NCT00849680|65827409|FG002|Overall Study|Withdrawal by Subject|0|||
23572802|NCT00849680|65827410|FG003|Overall Study|Withdrawal by Subject|2|||
23572803|NCT00849680|65827411|FG004|Overall Study|Withdrawal by Subject|2|||
23572804|NCT00849680|65827412|FG005|Overall Study|Withdrawal by Subject|2|||
23572805|NCT00849680|65827413|FG006|Overall Study|Withdrawal by Subject|1|||
23572806|NCT00849680|65827414|FG007|Overall Study|Withdrawal by Subject|1|||
23632928|NCT00968526|66042016|FG001|Overall Study|Adverse Event|0|||
23771054|NCT01611090|66542984|FG000|Randomized Period|Withdrawal by Subject|22|||
23771055|NCT01611090|66542985|FG001|Randomized Period|Withdrawal by Subject|26|||
23771056|NCT01611090|66542986|FG002|Randomized Period|Withdrawal by Subject|0|||
23771057|NCT01611090|66542984|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
23771058|NCT01611090|66542985|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
23771059|NCT01611090|66542986|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
23771060|NCT01611090|66542984|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
23771061|NCT01611090|66542985|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
23771062|NCT01611090|66542986|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
23771063|NCT01439165|66542987|FG000|Overall Study|Protocol Violation|3|||
23771064|NCT01439165|66542988|FG001|Overall Study|Protocol Violation|0|||
23771065|NCT01439165|66542987|FG000|Overall Study|Lost to Follow-up|11|||
23843115|NCT01738503|66805584|FG003|PET Imaging Sub-study|Adverse Event|0|||
23843116|NCT01738503|66805585|FG004|PET Imaging Sub-study|Adverse Event|0|||
23843117|NCT01738503|66805586|FG005|PET Imaging Sub-study|Adverse Event|1|||
23572807|NCT00849680|65827407|FG000|Overall Study|Subject unable to comply with protocol|1|||
23572808|NCT00849680|65827408|FG001|Overall Study|Subject unable to comply with protocol|0|||
23572809|NCT00849680|65827409|FG002|Overall Study|Subject unable to comply with protocol|0|||
23843118|NCT01738503|66805587|FG006|PET Imaging Sub-study|Adverse Event|0|||
23572810|NCT00849680|65827410|FG003|Overall Study|Subject unable to comply with protocol|0|||
23572811|NCT00849680|65827411|FG004|Overall Study|Subject unable to comply with protocol|0|||
23572812|NCT00849680|65827412|FG005|Overall Study|Subject unable to comply with protocol|0|||
23632929|NCT00968526|66042015|FG000|Overall Study|Migrated/moved from study area|1|||
23632930|NCT00968526|66042016|FG001|Overall Study|Migrated/moved from study area|0|||
23771066|NCT01439165|66542988|FG001|Overall Study|Lost to Follow-up|1|||
23771067|NCT01439165|66542987|FG000|Overall Study|Withdrawal by Subject|7|||
23771068|NCT01439165|66542988|FG001|Overall Study|Withdrawal by Subject|1|||
23771069|NCT00623103|66542989|FG000|Overall Study|Adverse Event|70|||
23771070|NCT00623103|66542990|FG001|Overall Study|Adverse Event|60|||
23843119|NCT01738503|66805581|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23572813|NCT00849680|65827413|FG006|Overall Study|Subject unable to comply with protocol|0|||
23572814|NCT00849680|65827414|FG007|Overall Study|Subject unable to comply with protocol|0|||
23572815|NCT00884286|65827424|FG000|Overall Study|Progressive disease|21|||
23572816|NCT00884286|65827425|FG001|Overall Study|Progressive disease|28|||
23572817|NCT00884286|65827424|FG000|Overall Study|Toxicity|4|||
23572818|NCT00884286|65827425|FG001|Overall Study|Toxicity|1|||
23572819|NCT00884286|65827424|FG000|Overall Study|Death|2|||
23572820|NCT00884286|65827425|FG001|Overall Study|Death|2|||
23572821|NCT00884286|65827424|FG000|Overall Study|Physician Decision|1|||
23771071|NCT00623103|66542989|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23832177|NCT02288325|66767570|FG000|Run-in Period|Adverse Event|48|||
23832178|NCT02288325|66767571|FG001|Run-in Period|Adverse Event|0|||
23832179|NCT02288325|66767572|FG002|Run-in Period|Adverse Event|0|||
23832180|NCT02288325|66767570|FG000|Run-in Period|Lack of Efficacy|16|||
23832181|NCT02288325|66767571|FG001|Run-in Period|Lack of Efficacy|0|||
23832182|NCT02288325|66767572|FG002|Run-in Period|Lack of Efficacy|0|||
23832183|NCT02288325|66767570|FG000|Run-in Period|Withdrawal of Consent|28|||
23832184|NCT02288325|66767571|FG001|Run-in Period|Withdrawal of Consent|0|||
23832185|NCT02288325|66767572|FG002|Run-in Period|Withdrawal of Consent|0|||
23832186|NCT02288325|66767570|FG000|Run-in Period|Lost to Follow-up|25|||
23832187|NCT02288325|66767571|FG001|Run-in Period|Lost to Follow-up|0|||
23832188|NCT02288325|66767572|FG002|Run-in Period|Lost to Follow-up|0|||
23832189|NCT02288325|66767570|FG000|Run-in Period|Protocol Violation|17|||
23832190|NCT02288325|66767571|FG001|Run-in Period|Protocol Violation|0|||
23832191|NCT02288325|66767572|FG002|Run-in Period|Protocol Violation|0|||
23832192|NCT02288325|66767570|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
23771072|NCT00623103|66542990|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
23771073|NCT00623103|66542989|FG000|Overall Study|Withdrawal by Subject|18|||
23771074|NCT00623103|66542990|FG001|Overall Study|Withdrawal by Subject|24|||
23771075|NCT00623103|66542989|FG000|Overall Study|Lost to Follow-up|4|||
23771076|NCT00623103|66542990|FG001|Overall Study|Lost to Follow-up|1|||
23771077|NCT00623103|66542989|FG000|Overall Study|Administrative problems|2|||
23771078|NCT00623103|66542990|FG001|Overall Study|Administrative problems|4|||
23771079|NCT00623103|66542989|FG000|Overall Study|Death|11|||
23771080|NCT00623103|66542990|FG001|Overall Study|Death|11|||
23771081|NCT00623103|66542989|FG000|Overall Study|Protocol deviation|2|||
23771082|NCT00623103|66542990|FG001|Overall Study|Protocol deviation|1|||
23771083|NCT00669864|66542991|FG000|Overall Study|Lost to Follow-up|2|||
23771084|NCT00669864|66542991|FG000|Overall Study|Protocol Violation|2|||
23771085|NCT00669864|66542991|FG000|Overall Study|Withdrawal by Subject|3|||
23832193|NCT02288325|66767571|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
23832194|NCT02288325|66767572|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
23832195|NCT02288325|66767570|FG000|Run-in Period|Reason not Specified|8|||
23832196|NCT02288325|66767571|FG001|Run-in Period|Reason not Specified|0|||
23832197|NCT02288325|66767572|FG002|Run-in Period|Reason not Specified|0|||
23832198|NCT02288325|66767570|FG000|Stabilization Period|Adverse Event|13|||
23771086|NCT00669864|66542991|FG000|Overall Study|Other|2|||
23832199|NCT02288325|66767571|FG001|Stabilization Period|Adverse Event|0|||
23832200|NCT02288325|66767572|FG002|Stabilization Period|Adverse Event|0|||
23832201|NCT02288325|66767570|FG000|Stabilization Period|Lack of Efficacy|22|||
23832202|NCT02288325|66767571|FG001|Stabilization Period|Lack of Efficacy|0|||
23832203|NCT02288325|66767572|FG002|Stabilization Period|Lack of Efficacy|0|||
23771087|NCT03267277|66542992|FG000|Overall Study|Withdrawal by Subject|1|||
23832204|NCT02288325|66767570|FG000|Stabilization Period|Withdrawal of Consent|23|||
23832205|NCT02288325|66767571|FG001|Stabilization Period|Withdrawal of Consent|0|||
23832206|NCT02288325|66767572|FG002|Stabilization Period|Withdrawal of Consent|0|||
23832207|NCT02288325|66767570|FG000|Stabilization Period|Lost to Follow-up|12|||
23832208|NCT02288325|66767571|FG001|Stabilization Period|Lost to Follow-up|0|||
23832209|NCT02288325|66767572|FG002|Stabilization Period|Lost to Follow-up|0|||
23832210|NCT02288325|66767570|FG000|Stabilization Period|Protocol Violation|8|||
23771088|NCT02460159|66542999|FG000|Overall Study|Adverse Event|4|||
23572822|NCT00884286|65827425|FG001|Overall Study|Physician Decision|0|||
23572823|NCT00884286|65827424|FG000|Overall Study|Septic shock|1|||
23572824|NCT00884286|65827425|FG001|Overall Study|Septic shock|0|||
23572825|NCT00884286|65827424|FG000|Overall Study|Thrombus in right auricle|1|||
23572826|NCT00884286|65827425|FG001|Overall Study|Thrombus in right auricle|0|||
23572827|NCT00884286|65827424|FG000|Overall Study|Not treated|2|||
23572828|NCT00884286|65827425|FG001|Overall Study|Not treated|1|||
23572829|NCT00884286|65827424|FG000|Overall Study|Comprised lung carcinoma|0|||
23572830|NCT00884286|65827425|FG001|Overall Study|Comprised lung carcinoma|1|||
23632931|NCT01840410|66042017|FG000|Overall Study|Physician Decision|1|||
23632932|NCT01840410|66042018|FG001|Overall Study|Physician Decision|2|||
23632933|NCT01840410|66042017|FG000|Overall Study|Pregnancy|1|||
23632934|NCT01840410|66042018|FG001|Overall Study|Pregnancy|0|||
23632935|NCT01840410|66042017|FG000|Overall Study|Protocol deviation|1|||
23632936|NCT01840410|66042018|FG001|Overall Study|Protocol deviation|0|||
23632937|NCT01840410|66042017|FG000|Overall Study|Lost to Follow-up|1|||
23632938|NCT01840410|66042018|FG001|Overall Study|Lost to Follow-up|0|||
23771089|NCT02460159|66543000|FG001|Overall Study|Adverse Event|1|||
23771090|NCT02460159|66542999|FG000|Overall Study|Withdrawal by Subject|2|||
23632939|NCT01840410|66042017|FG000|Overall Study|Withdrawal by Subject|2|||
23632940|NCT01840410|66042018|FG001|Overall Study|Withdrawal by Subject|1|||
23632941|NCT01840410|66042017|FG000|Overall Study|Adverse Event|1|||
23632942|NCT01840410|66042018|FG001|Overall Study|Adverse Event|1|||
23632943|NCT02808975|66042019|FG000|Overall Study|Adverse Event|3|||
23632944|NCT02808975|66042020|FG001|Overall Study|Adverse Event|4|||
23632945|NCT02808975|66042019|FG000|Overall Study|Withdrew consent|9|||
23632946|NCT02808975|66042020|FG001|Overall Study|Withdrew consent|8|||
23771091|NCT02460159|66543000|FG001|Overall Study|Withdrawal by Subject|0|||
23771092|NCT02192099|66543001|FG000|Overall Study|Adverse Event|1|||
23771093|NCT02192099|66543001|FG000|Overall Study|Lost to Follow-up|2|||
23771094|NCT02192099|66543001|FG000|Overall Study|Physician Decision|1|||
23771095|NCT02192099|66543001|FG000|Overall Study|Pregnancy|1|||
23771096|NCT02192099|66543001|FG000|Overall Study|Protocol Violation|8|||
23771097|NCT02192099|66543001|FG000|Overall Study|Study Terminated by Sponsor|32|||
23771098|NCT02192099|66543001|FG000|Overall Study|Withdrawal by Subject|11|||
23771099|NCT02192099|66543001|FG000|Overall Study|Miscellaneous Reasons|5|||
23771100|NCT01694485|66543002|FG000|Overall Study|Withdrawal by Subject|20|||
23771101|NCT01694485|66543003|FG001|Overall Study|Withdrawal by Subject|6|||
23771102|NCT01694485|66543004|FG002|Overall Study|Withdrawal by Subject|7|||
23771103|NCT01694485|66543005|FG003|Overall Study|Withdrawal by Subject|25|||
23771104|NCT01694485|66543006|FG004|Overall Study|Withdrawal by Subject|18|||
23771105|NCT01694485|66543002|FG000|Overall Study|Sponsor Decision|3|||
23771106|NCT01694485|66543003|FG001|Overall Study|Sponsor Decision|0|||
23771107|NCT01694485|66543004|FG002|Overall Study|Sponsor Decision|0|||
23771108|NCT01694485|66543005|FG003|Overall Study|Sponsor Decision|2|||
23771109|NCT01694485|66543006|FG004|Overall Study|Sponsor Decision|0|||
23771110|NCT01694485|66543002|FG000|Overall Study|Lost to Follow-up|9|||
23771111|NCT01694485|66543003|FG001|Overall Study|Lost to Follow-up|1|||
23771112|NCT01694485|66543004|FG002|Overall Study|Lost to Follow-up|6|||
23832211|NCT02288325|66767571|FG001|Stabilization Period|Protocol Violation|0|||
23832212|NCT02288325|66767572|FG002|Stabilization Period|Protocol Violation|0|||
23832213|NCT02288325|66767570|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
23632947|NCT02808975|66042019|FG000|Overall Study|Lost to Follow-up|4|||
23632948|NCT02808975|66042020|FG001|Overall Study|Lost to Follow-up|6|||
23632949|NCT02808975|66042019|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
23632950|NCT02808975|66042020|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
23632951|NCT02808975|66042019|FG000|Overall Study|Other, not specified|5|||
23832214|NCT02288325|66767571|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
23572831|NCT02222896|65827429|FG000|Abdomen|Did not qualify|34|||
23572832|NCT02222896|65827430|FG001|Abdomen|Did not qualify|10|||
23572833|NCT02222896|65827431|FG002|Abdomen|Did not qualify|32|||
23771113|NCT01694485|66543005|FG003|Overall Study|Lost to Follow-up|10|||
23771114|NCT01694485|66543006|FG004|Overall Study|Lost to Follow-up|7|||
23771115|NCT01694485|66543002|FG000|Overall Study|Death|1|||
23771116|NCT01694485|66543003|FG001|Overall Study|Death|0|||
23771117|NCT01694485|66543004|FG002|Overall Study|Death|0|||
23771118|NCT01694485|66543005|FG003|Overall Study|Death|1|||
23771119|NCT01694485|66543006|FG004|Overall Study|Death|0|||
23832215|NCT02288325|66767572|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
23572834|NCT02222896|65827429|FG000|Groin|Did not qualify|43|||
23572835|NCT02222896|65827430|FG001|Groin|Did not qualify|9|||
23572836|NCT02222896|65827431|FG002|Groin|Did not qualify|40|||
23572837|NCT04537949|65827439|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
23572838|NCT04537949|65827440|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
23572839|NCT04537949|65827441|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
23572840|NCT04537949|65827442|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
23572841|NCT04537949|65827443|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
23572842|NCT04537949|65827444|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
23572843|NCT04537949|65827445|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
23572844|NCT04537949|65827446|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
23572845|NCT04537949|65827439|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
23832216|NCT02288325|66767570|FG000|Stabilization Period|Reason not Specified|15|||
23572846|NCT04537949|65827440|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572847|NCT04537949|65827441|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
23572848|NCT04537949|65827442|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
23572849|NCT04537949|65827443|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572850|NCT04537949|65827444|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572851|NCT04537949|65827445|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
23572852|NCT04537949|65827446|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
23572853|NCT04537949|65827439|FG000|Follow-up Phase|Lost to Follow-up|0|||
23572854|NCT04537949|65827440|FG001|Follow-up Phase|Lost to Follow-up|3|||
23572855|NCT04537949|65827441|FG002|Follow-up Phase|Lost to Follow-up|0|||
23572856|NCT04537949|65827442|FG003|Follow-up Phase|Lost to Follow-up|0|||
23572857|NCT04537949|65827443|FG004|Follow-up Phase|Lost to Follow-up|0|||
23572858|NCT04537949|65827444|FG005|Follow-up Phase|Lost to Follow-up|0|||
23572859|NCT04537949|65827445|FG006|Follow-up Phase|Lost to Follow-up|0|||
23572860|NCT04537949|65827446|FG007|Follow-up Phase|Lost to Follow-up|0|||
23572861|NCT04537949|65827439|FG000|Follow-up Phase|personal reasons|0|||
23572862|NCT04537949|65827440|FG001|Follow-up Phase|personal reasons|0|||
23632952|NCT02808975|66042020|FG001|Overall Study|Other, not specified|1|||
23632953|NCT01736540|66042021|FG000|Overall Study|Did not complete scan within 45 days|2|||
23632954|NCT01736540|66042021|FG000|Overall Study|Death|1|||
23632955|NCT01736540|66042021|FG000|Overall Study|Abnormal test procedure|1|||
23632956|NCT01736540|66042021|FG000|Overall Study|Withdrawal by Subject|5|||
23632957|NCT01736540|66042021|FG000|Overall Study|Protocol Violation|1|||
23632958|NCT01736540|66042021|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
23632959|NCT01736540|66042021|FG000|Overall Study|No show for MRI appointment|1|||
23632960|NCT01736540|66042021|FG000|Overall Study|Unable to make MRI appointment|3|||
23632961|NCT00623805|66042025|FG000|Overall Study|Adverse Event|9|||
23632962|NCT00623805|66042026|FG001|Overall Study|Adverse Event|6|||
23632963|NCT00623805|66042025|FG000|Overall Study|Death|2|||
23632964|NCT00623805|66042026|FG001|Overall Study|Death|0|||
23632965|NCT00623805|66042025|FG000|Overall Study|Lack of Efficacy|3|||
23632966|NCT00623805|66042026|FG001|Overall Study|Lack of Efficacy|7|||
23632967|NCT00623805|66042025|FG000|Overall Study|Lost to Follow-up|2|||
23771120|NCT01755858|66543007|FG000|Overall Study|Adverse Event|1|||
23832217|NCT02288325|66767571|FG001|Stabilization Period|Reason not Specified|0|||
23832218|NCT02288325|66767572|FG002|Stabilization Period|Reason not Specified|0|||
23832219|NCT02288325|66767570|FG000|Double-blind Treatment Period|Adverse Event|0|||
23832220|NCT02288325|66767571|FG001|Double-blind Treatment Period|Adverse Event|2|||
23771121|NCT01755858|66543008|FG001|Overall Study|Adverse Event|1|||
23771122|NCT00287118|66543009|FG000|Overall Study|Adverse Event|30|||
23771123|NCT00287118|66543009|FG000|Overall Study|Death|1|||
23771124|NCT00287118|66543009|FG000|Overall Study|Lack of Efficacy|11|||
23771125|NCT00287118|66543009|FG000|Overall Study|Lost to Follow-up|1|||
23832221|NCT02288325|66767572|FG002|Double-blind Treatment Period|Adverse Event|5|||
23771126|NCT00287118|66543009|FG000|Overall Study|Protocol Violation|2|||
23771127|NCT00287118|66543009|FG000|Overall Study|Other|7|||
23771128|NCT01617668|66543010|FG000|Overall Study|Adverse Event|7|||
23832222|NCT02288325|66767570|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
23832223|NCT02288325|66767571|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
23572863|NCT04537949|65827441|FG002|Follow-up Phase|personal reasons|0|||
23572864|NCT04537949|65827442|FG003|Follow-up Phase|personal reasons|1|||
23572865|NCT04537949|65827443|FG004|Follow-up Phase|personal reasons|1|||
23572866|NCT04537949|65827444|FG005|Follow-up Phase|personal reasons|0|||
23572867|NCT04537949|65827445|FG006|Follow-up Phase|personal reasons|0|||
23572868|NCT04537949|65827446|FG007|Follow-up Phase|personal reasons|0|||
23572869|NCT04537949|65827439|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23572870|NCT04537949|65827440|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23632968|NCT00623805|66042026|FG001|Overall Study|Lost to Follow-up|2|||
23771129|NCT01617668|66543011|FG001|Overall Study|Adverse Event|0|||
23771130|NCT01617668|66543012|FG002|Overall Study|Adverse Event|12|||
23771131|NCT01617668|66543013|FG003|Overall Study|Adverse Event|5|||
23771132|NCT01617668|66543010|FG000|Overall Study|Physician Decision|1|||
23832224|NCT02288325|66767572|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
23832225|NCT02288325|66767570|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23832226|NCT02288325|66767571|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
23832227|NCT02288325|66767572|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23832228|NCT02288325|66767570|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23832229|NCT02288325|66767571|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23832230|NCT02288325|66767572|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23832231|NCT02288325|66767570|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
23832232|NCT02288325|66767571|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
23832233|NCT02288325|66767572|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
23832234|NCT02288325|66767570|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
23832235|NCT02288325|66767571|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
23832236|NCT02288325|66767572|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
23832237|NCT02512302|66767573|FG000|Period 1|Adverse Event|0|||
23832238|NCT02512302|66767574|FG001|Period 1|Adverse Event|1|||
23832239|NCT02512302|66767575|FG002|Period 1|Adverse Event|0|||
23832240|NCT02512302|66767576|FG003|Period 1|Adverse Event|0|||
23832241|NCT02512302|66767577|FG004|Period 1|Adverse Event|0|||
23832242|NCT02512302|66767578|FG005|Period 1|Adverse Event|0|||
23832243|NCT02512302|66767579|FG006|Period 1|Adverse Event|0|||
23832244|NCT02512302|66767580|FG007|Period 1|Adverse Event|0|||
23832245|NCT02512302|66767581|FG008|Period 1|Adverse Event|0|||
23832246|NCT02512302|66767582|FG009|Period 1|Adverse Event|0|||
23832247|NCT02512302|66767573|FG000|Period 2|Adverse Event|0|||
23832248|NCT02512302|66767574|FG001|Period 2|Adverse Event|0|||
23832249|NCT02512302|66767575|FG002|Period 2|Adverse Event|0|||
23832250|NCT02512302|66767576|FG003|Period 2|Adverse Event|0|||
23832251|NCT02512302|66767577|FG004|Period 2|Adverse Event|0|||
23832252|NCT02512302|66767578|FG005|Period 2|Adverse Event|0|||
23832253|NCT02512302|66767579|FG006|Period 2|Adverse Event|0|||
23832254|NCT02512302|66767580|FG007|Period 2|Adverse Event|0|||
23832255|NCT02512302|66767581|FG008|Period 2|Adverse Event|0|||
23832256|NCT02512302|66767582|FG009|Period 2|Adverse Event|1|||
23832257|NCT02512302|66767573|FG000|Period 3|Lost to Follow-up|0|||
23832258|NCT02512302|66767574|FG001|Period 3|Lost to Follow-up|0|||
23832259|NCT02512302|66767575|FG002|Period 3|Lost to Follow-up|1|||
23832260|NCT02512302|66767576|FG003|Period 3|Lost to Follow-up|0|||
23832261|NCT02512302|66767577|FG004|Period 3|Lost to Follow-up|0|||
23832262|NCT02512302|66767578|FG005|Period 3|Lost to Follow-up|0|||
23832263|NCT02512302|66767579|FG006|Period 3|Lost to Follow-up|0|||
23832264|NCT02512302|66767580|FG007|Period 3|Lost to Follow-up|0|||
23832265|NCT02512302|66767581|FG008|Period 3|Lost to Follow-up|0|||
23832266|NCT02512302|66767582|FG009|Period 3|Lost to Follow-up|0|||
23832267|NCT02512302|66767573|FG000|Period 4|Adverse Event|0|||
23832268|NCT02512302|66767574|FG001|Period 4|Adverse Event|0|||
23832269|NCT02512302|66767575|FG002|Period 4|Adverse Event|0|||
23832270|NCT02512302|66767576|FG003|Period 4|Adverse Event|0|||
23832271|NCT02512302|66767577|FG004|Period 4|Adverse Event|0|||
23832272|NCT02512302|66767578|FG005|Period 4|Adverse Event|0|||
23832273|NCT02512302|66767579|FG006|Period 4|Adverse Event|1|||
23832274|NCT02512302|66767580|FG007|Period 4|Adverse Event|0|||
23832275|NCT02512302|66767581|FG008|Period 4|Adverse Event|0|||
23832276|NCT02512302|66767582|FG009|Period 4|Adverse Event|0|||
23832277|NCT02314026|66767583|FG000|Overall Study|Protocol Violation|28|||
23832278|NCT01218087|66767588|FG000|Overall Study|Death|2|||
23832279|NCT01218087|66767589|FG001|Overall Study|Death|1|||
23832280|NCT01218087|66767588|FG000|Overall Study|Withdrawal by Subject|5|||
23832281|NCT01218087|66767589|FG001|Overall Study|Withdrawal by Subject|0|||
23832282|NCT01218087|66767588|FG000|Overall Study|Transferred|8|||
23832283|NCT01218087|66767589|FG001|Overall Study|Transferred|5|||
23832284|NCT01801865|66767591|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
23832285|NCT01801865|66767591|FG000|Overall Study|Physician Decision|7|||
23572871|NCT04537949|65827441|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23832286|NCT01823328|66767592|FG000|Overall Study|Withdrawal by Subject|8|||
23832287|NCT01823328|66767593|FG001|Overall Study|Withdrawal by Subject|6|||
23832288|NCT02548143|66767594|FG000|Overall Study|Adverse Event|1|||
23832289|NCT02548143|66767595|FG001|Overall Study|Adverse Event|0|||
23832290|NCT02548143|66767594|FG000|Overall Study|Withdrawal by Subject|0|||
23572872|NCT04537949|65827442|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23832291|NCT02548143|66767595|FG001|Overall Study|Withdrawal by Subject|1|||
23832292|NCT05244122|66767596|FG000|Overall Study|Withdrawal by Subject|318|||
23832293|NCT01697748|66767597|FG000|Overall Study|ineligible skin incision|1|||
23832294|NCT01697748|66767598|FG001|Overall Study|ineligible skin incision|2|||
23832295|NCT01697748|66767597|FG000|Overall Study|ineligible uterine incision|4|||
23832296|NCT01697748|66767598|FG001|Overall Study|ineligible uterine incision|1|||
23832297|NCT01697748|66767597|FG000|Overall Study|Lost to Follow-up|53|||
23832298|NCT01697748|66767598|FG001|Overall Study|Lost to Follow-up|65|||
23832299|NCT02810457|66767599|FG000|Overall Study|Randomised but no treatment received|2|||
23832300|NCT02810457|66767600|FG001|Overall Study|Randomised but no treatment received|1|||
23832301|NCT02810457|66767599|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
23771133|NCT01617668|66543011|FG001|Overall Study|Physician Decision|2|||
23771134|NCT01617668|66543012|FG002|Overall Study|Physician Decision|3|||
23771135|NCT01617668|66543013|FG003|Overall Study|Physician Decision|0|||
23771136|NCT01617668|66543010|FG000|Overall Study|Progressive Disease|4|||
23771137|NCT01617668|66543011|FG001|Overall Study|Progressive Disease|4|||
23771138|NCT01617668|66543012|FG002|Overall Study|Progressive Disease|6|||
23771139|NCT01617668|66543013|FG003|Overall Study|Progressive Disease|9|||
23771140|NCT01617668|66543010|FG000|Overall Study|Subject/guardian decision|1|||
23771141|NCT01617668|66543011|FG001|Overall Study|Subject/guardian decision|3|||
23771142|NCT01617668|66543012|FG002|Overall Study|Subject/guardian decision|2|||
23771143|NCT01617668|66543013|FG003|Overall Study|Subject/guardian decision|1|||
23771144|NCT01867242|66543018|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
23771145|NCT01867242|66543019|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
23771146|NCT01867242|66543020|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
23771147|NCT01789320|66543021|FG000|Overall Study|Re-enrolled into study|1|||
23771148|NCT01789320|66543021|FG000|Overall Study|Lost to Follow-up|1|||
23771149|NCT03039023|66543022|FG000|Overall Study|Withdrawal by Subject|1|||
23771150|NCT03039023|66543023|FG001|Overall Study|Withdrawal by Subject|0|||
23771151|NCT03039023|66543024|FG002|Overall Study|Withdrawal by Subject|1|||
23771152|NCT03039023|66543025|FG003|Overall Study|Withdrawal by Subject|1|||
23771153|NCT03039023|66543026|FG004|Overall Study|Withdrawal by Subject|0|||
23771154|NCT03039023|66543022|FG000|Overall Study|Physician Decision|0|||
23771155|NCT03039023|66543023|FG001|Overall Study|Physician Decision|0|||
23771156|NCT03039023|66543024|FG002|Overall Study|Physician Decision|0|||
23771157|NCT03039023|66543025|FG003|Overall Study|Physician Decision|1|||
23771158|NCT03039023|66543026|FG004|Overall Study|Physician Decision|0|||
23771159|NCT04524364|66543027|FG000|Overall Study|Physician Decision|3|||
23771160|NCT04524364|66543028|FG001|Overall Study|Physician Decision|6|||
23771161|NCT04524364|66543027|FG000|Overall Study|Adverse Event|0|||
23771162|NCT04524364|66543028|FG001|Overall Study|Adverse Event|1|||
23771163|NCT04524364|66543027|FG000|Overall Study|Investigational device deficiency|0|||
23771164|NCT04524364|66543028|FG001|Overall Study|Investigational device deficiency|1|||
23771165|NCT04524364|66543027|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
23771166|NCT04524364|66543028|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
23771167|NCT04524364|66543027|FG000|Overall Study|Device unavailability|0|||
23771168|NCT04524364|66543028|FG001|Overall Study|Device unavailability|2|||
23771169|NCT04524364|66543027|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
23771170|NCT04524364|66543028|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
23771171|NCT04524364|66543027|FG000|Overall Study|Low International normalized ratio (INR)|1|||
23771172|NCT04524364|66543028|FG001|Overall Study|Low International normalized ratio (INR)|0|||
23771173|NCT01506947|66543029|FG000|Overall Study|Lost to Follow-up|7|||
23771174|NCT01506947|66543029|FG000|Overall Study|Adverse Event|5|||
23771175|NCT01506947|66543029|FG000|Overall Study|Death|1|||
23771176|NCT01506947|66543029|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
23771177|NCT02841709|66543030|FG000|5th Intervention|Adverse Event|2|||
23771178|NCT02841709|66543031|FG001|5th Intervention|Adverse Event|0|||
23771179|NCT02841709|66543032|FG002|5th Intervention|Adverse Event|0|||
23771180|NCT02841709|66543033|FG003|5th Intervention|Adverse Event|0|||
23771181|NCT02841709|66543034|FG004|5th Intervention|Adverse Event|2|||
23771182|NCT01030965|66543036|FG000|Overall Study|Lack of Efficacy|3|||
23771183|NCT01030965|66543037|FG001|Overall Study|Lack of Efficacy|2|||
23771184|NCT01030965|66543038|FG002|Overall Study|Lack of Efficacy|0|||
23832302|NCT02810457|66767600|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
23832303|NCT02810457|66767599|FG000|Overall Study|Adverse Event|37|||
23771185|NCT01030965|66543039|FG003|Overall Study|Lack of Efficacy|3|||
23771186|NCT01030965|66543036|FG000|Overall Study|Protocol Violation|1|||
23771187|NCT01030965|66543037|FG001|Overall Study|Protocol Violation|1|||
23771188|NCT01030965|66543038|FG002|Overall Study|Protocol Violation|1|||
23771189|NCT01030965|66543039|FG003|Overall Study|Protocol Violation|1|||
23771190|NCT01030965|66543036|FG000|Overall Study|Adverse Event|0|||
23771191|NCT01030965|66543037|FG001|Overall Study|Adverse Event|1|||
23771192|NCT01030965|66543038|FG002|Overall Study|Adverse Event|2|||
23771193|NCT01030965|66543039|FG003|Overall Study|Adverse Event|1|||
23832304|NCT02810457|66767600|FG001|Overall Study|Adverse Event|43|||
23832305|NCT02810457|66767599|FG000|Overall Study|Patient decision|31|||
23832306|NCT02810457|66767600|FG001|Overall Study|Patient decision|35|||
23771194|NCT01030965|66543036|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
23771195|NCT01030965|66543037|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
23771196|NCT01030965|66543038|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
23771197|NCT01030965|66543039|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
23771198|NCT01030965|66543036|FG000|Overall Study|Withdrawal by Subject|0|||
23771199|NCT01030965|66543037|FG001|Overall Study|Withdrawal by Subject|1|||
23771200|NCT01030965|66543038|FG002|Overall Study|Withdrawal by Subject|0|||
23771201|NCT01030965|66543039|FG003|Overall Study|Withdrawal by Subject|2|||
23771202|NCT03738332|66543040|FG000|Overall Study|Withdrawal by Subject|1|||
23832307|NCT02810457|66767599|FG000|Overall Study|Patient lost to follow-up|2|||
23771203|NCT02636907|66543041|FG000|Autoinjector Assessment Period|Adverse Event|2|||
23771204|NCT02636907|66543041|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
23771205|NCT02636907|66543041|FG000|Extension Phase|Adverse Event|2|||
23771206|NCT02636907|66543041|FG000|Extension Phase|Withdrawal by Subject|4|||
23771207|NCT02636907|66543041|FG000|Extension Phase|Physician Decision|1|||
23771208|NCT02636907|66543041|FG000|Extension Phase|Lost to Follow-up|2|||
23832308|NCT02810457|66767600|FG001|Overall Study|Patient lost to follow-up|2|||
23832309|NCT02810457|66767599|FG000|Overall Study|Death|39|||
23832310|NCT02810457|66767600|FG001|Overall Study|Death|28|||
23832311|NCT02810457|66767599|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
23832312|NCT02810457|66767600|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
23832313|NCT02810457|66767599|FG000|Overall Study|Clinical progression|15|||
23832314|NCT02810457|66767600|FG001|Overall Study|Clinical progression|16|||
23832315|NCT02810457|66767599|FG000|Overall Study|Investigator decision|3|||
23832316|NCT02810457|66767600|FG001|Overall Study|Investigator decision|2|||
23832317|NCT02810457|66767599|FG000|Overall Study|Patient ineligibility|3|||
23832318|NCT02810457|66767600|FG001|Overall Study|Patient ineligibility|0|||
23832319|NCT02810457|66767599|FG000|Overall Study|Miscalculated PD|1|||
23832320|NCT02810457|66767600|FG001|Overall Study|Miscalculated PD|0|||
23832321|NCT02810457|66767599|FG000|Overall Study|Physician Decision|0|||
23832322|NCT02810457|66767600|FG001|Overall Study|Physician Decision|1|||
23832323|NCT00495391|66767601|FG000|Overall Study|Lack of Efficacy|34|||
23832324|NCT00495391|66767602|FG001|Overall Study|Lack of Efficacy|18|||
23572873|NCT04537949|65827443|FG004|Follow-up Phase|Withdrawal by Subject|1|||
23572874|NCT04537949|65827444|FG005|Follow-up Phase|Withdrawal by Subject|0|||
23572875|NCT04537949|65827445|FG006|Follow-up Phase|Withdrawal by Subject|0|||
23572876|NCT04537949|65827446|FG007|Follow-up Phase|Withdrawal by Subject|0|||
23572877|NCT01225835|65827450|FG000|Overall Study|Completed protocol|2|||
23572878|NCT01225835|65827451|FG001|Overall Study|Completed protocol|1|||
23572879|NCT01225835|65827450|FG000|Overall Study|Did not meet hCG criterion|2|||
23572880|NCT01225835|65827451|FG001|Overall Study|Did not meet hCG criterion|0|||
23572881|NCT01225835|65827450|FG000|Overall Study|Adverse Event|2|||
23572882|NCT01225835|65827451|FG001|Overall Study|Adverse Event|1|||
23572883|NCT01225835|65827450|FG000|Overall Study|Other|1|||
23572884|NCT01225835|65827451|FG001|Overall Study|Other|1|||
23572885|NCT04467840|65827456|FG000|Overall Study|Death|35|||
23572886|NCT04467840|65827457|FG001|Overall Study|Death|39|||
23572887|NCT04467840|65827456|FG000|Overall Study|Withdrawal by Subject|8|||
23572888|NCT04467840|65827457|FG001|Overall Study|Withdrawal by Subject|4|||
23572889|NCT04467840|65827456|FG000|Overall Study|Adverse Event|2|||
23572890|NCT04467840|65827457|FG001|Overall Study|Adverse Event|0|||
23572891|NCT04467840|65827456|FG000|Overall Study|Lost to Follow-up|1|||
23572892|NCT04467840|65827457|FG001|Overall Study|Lost to Follow-up|3|||
23572893|NCT04467840|65827456|FG000|Overall Study|Physician Decision|1|||
23572894|NCT04467840|65827457|FG001|Overall Study|Physician Decision|0|||
23572895|NCT04467840|65827456|FG000|Overall Study|Other|1|||
23572896|NCT04467840|65827457|FG001|Overall Study|Other|5|||
23572897|NCT04467840|65827456|FG000|Overall Study|Missing study completion status|3|||
23572898|NCT04467840|65827457|FG001|Overall Study|Missing study completion status|1|||
23572899|NCT01818141|65827458|FG000|Overall Study|Withdrawal by Subject|2|||
23572900|NCT01818141|65827459|FG001|Overall Study|Withdrawal by Subject|0|||
23572901|NCT01818141|65827458|FG000|Overall Study|No baseline C.diff colonies|1|||
23572902|NCT01818141|65827459|FG001|Overall Study|No baseline C.diff colonies|1|||
23572903|NCT01818141|65827458|FG000|Overall Study|Lost to Follow-up|0|||
23572904|NCT01818141|65827459|FG001|Overall Study|Lost to Follow-up|2|||
23572905|NCT00451217|65827460|FG000|Overall Study|Lost to Follow-up|0|||
23572906|NCT00451217|65827461|FG001|Overall Study|Lost to Follow-up|1|||
23572907|NCT00451217|65827462|FG002|Overall Study|Lost to Follow-up|1|||
23572908|NCT00451217|65827463|FG003|Overall Study|Lost to Follow-up|1|||
23572909|NCT00451217|65827460|FG000|Overall Study|Withdrawal by Subject|1|||
23572910|NCT00451217|65827461|FG001|Overall Study|Withdrawal by Subject|0|||
23572911|NCT00451217|65827462|FG002|Overall Study|Withdrawal by Subject|0|||
23572912|NCT00451217|65827463|FG003|Overall Study|Withdrawal by Subject|0|||
23572913|NCT00451217|65827460|FG000|Overall Study|Not Treated|1|||
23572914|NCT00451217|65827461|FG001|Overall Study|Not Treated|1|||
23572915|NCT00451217|65827462|FG002|Overall Study|Not Treated|3|||
23572916|NCT00451217|65827463|FG003|Overall Study|Not Treated|4|||
23572917|NCT02169830|65827464|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
23832325|NCT00495391|66767601|FG000|Overall Study|Withdrawal by Subject|2|||
23572918|NCT02169830|65827465|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
23572919|NCT02169830|65827466|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
23572920|NCT02169830|65827464|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
23572921|NCT02169830|65827465|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23832326|NCT00495391|66767602|FG001|Overall Study|Withdrawal by Subject|3|||
23572922|NCT02169830|65827466|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23632969|NCT00623805|66042025|FG000|Overall Study|Protocol Violation|1|||
23832327|NCT02623725|66767603|FG000|Overall Study|Non compliance with protocol|9|||
23832328|NCT02623725|66767604|FG001|Overall Study|Non compliance with protocol|3|||
23632970|NCT00623805|66042026|FG001|Overall Study|Protocol Violation|1|||
23572923|NCT02169830|65827464|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23572924|NCT02169830|65827465|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
23572925|NCT02169830|65827466|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572926|NCT02169830|65827464|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
23572927|NCT02169830|65827465|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
23572928|NCT02169830|65827466|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
23572929|NCT02169830|65827464|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572930|NCT02169830|65827465|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
23572931|NCT02169830|65827466|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572932|NCT02102464|65827467|FG000|Randomized Study|Withdrawal by Subject|0|||
23572933|NCT02102464|65827468|FG001|Randomized Study|Withdrawal by Subject|1|||
23572934|NCT02102464|65827469|FG002|Randomized Study|Withdrawal by Subject|0|||
23572935|NCT01868074|65827475|FG000|Overall Study|Lost to Follow-up|3|||
23572936|NCT01868074|65827476|FG001|Overall Study|Lost to Follow-up|2|||
23572937|NCT01868074|65827475|FG000|Overall Study|Withdrawal by Subject|4|||
23572938|NCT01868074|65827476|FG001|Overall Study|Withdrawal by Subject|2|||
23632971|NCT00623805|66042025|FG000|Overall Study|Reason not Specified|3|||
23632972|NCT00623805|66042026|FG001|Overall Study|Reason not Specified|6|||
23632973|NCT00863512|66042027|FG000|Overall Study|Adverse Event|2|||
23632974|NCT00863512|66042028|FG001|Overall Study|Adverse Event|0|||
23632975|NCT00863512|66042027|FG000|Overall Study|Withdrawal by Subject|11|||
23632976|NCT00863512|66042028|FG001|Overall Study|Withdrawal by Subject|0|||
23632977|NCT00863512|66042027|FG000|Overall Study|Physician Decision|1|||
23632978|NCT00863512|66042028|FG001|Overall Study|Physician Decision|0|||
23632979|NCT00351377|66042029|FG000|Overall Study|Adverse Event|5|||
23632980|NCT00351377|66042029|FG000|Overall Study|Death|1|||
23632981|NCT00351377|66042029|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23632982|NCT02637323|66042030|FG000|Overall Study|Lost to Follow-up|2|||
23632983|NCT02637323|66042031|FG001|Overall Study|Lost to Follow-up|0|||
23632984|NCT02637323|66042030|FG000|Overall Study|Protocol Violation|0|||
23632985|NCT02637323|66042031|FG001|Overall Study|Protocol Violation|1|||
23632986|NCT01509547|66042033|FG000|Overall Study|Lost to Follow-up|24|||
23632987|NCT01509547|66042034|FG001|Overall Study|Lost to Follow-up|14|||
23632988|NCT01509547|66042033|FG000|Overall Study|Withdrawal by Subject|11|||
23632989|NCT01509547|66042034|FG001|Overall Study|Withdrawal by Subject|24|||
23632990|NCT01509547|66042033|FG000|Overall Study|Physician Decision|0|||
23632991|NCT01509547|66042034|FG001|Overall Study|Physician Decision|1|||
23632992|NCT04497389|66042035|FG000|Overall Study|Withdrawal by Subject|1|||
23771209|NCT02636907|66543041|FG000|Extension Phase|Lack of Efficacy|1|||
23771210|NCT03309956|66543042|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
23771211|NCT01265784|66543046|FG000|Overall Study|Lost to Follow-up|5|||
23771212|NCT01265784|66543047|FG001|Overall Study|Lost to Follow-up|3|||
23771213|NCT01265784|66543048|FG002|Overall Study|Lost to Follow-up|2|||
23771214|NCT01265784|66543046|FG000|Overall Study|Withdrawal by Subject|0|||
23771215|NCT01265784|66543047|FG001|Overall Study|Withdrawal by Subject|5|||
23771216|NCT01265784|66543048|FG002|Overall Study|Withdrawal by Subject|0|||
23771217|NCT01265784|66543046|FG000|Overall Study|Physician Decision|1|||
23771218|NCT01265784|66543047|FG001|Overall Study|Physician Decision|0|||
23771219|NCT01265784|66543048|FG002|Overall Study|Physician Decision|1|||
23771220|NCT01265784|66543046|FG000|Overall Study|Adverse Event|1|||
23771221|NCT01265784|66543047|FG001|Overall Study|Adverse Event|0|||
23771222|NCT01265784|66543048|FG002|Overall Study|Adverse Event|0|||
23771223|NCT01265784|66543046|FG000|Overall Study|Death|3|||
23771224|NCT01265784|66543047|FG001|Overall Study|Death|0|||
23771225|NCT01265784|66543048|FG002|Overall Study|Death|0|||
23771226|NCT01265784|66543046|FG000|Overall Study|Protocol Violation|2|||
23771227|NCT01265784|66543047|FG001|Overall Study|Protocol Violation|0|||
23771228|NCT01265784|66543048|FG002|Overall Study|Protocol Violation|0|||
23771229|NCT01265784|66543046|FG000|Overall Study|Incorrectly Randomized|0|||
23771230|NCT01265784|66543047|FG001|Overall Study|Incorrectly Randomized|0|||
23771231|NCT01265784|66543048|FG002|Overall Study|Incorrectly Randomized|1|||
23771232|NCT03810495|66543049|FG000|Overall Study|Lost to Follow-up|2|||
23572939|NCT00284089|65827477|FG000|Multiple Dose Phase|Adverse Event|1|||
23572940|NCT00284089|65827478|FG001|Multiple Dose Phase|Adverse Event|0|||
23572941|NCT00284089|65827479|FG002|Multiple Dose Phase|Adverse Event|1|||
23632993|NCT04497389|66042036|FG001|Overall Study|Withdrawal by Subject|0|||
23632994|NCT00611975|66042037|FG000|Overall Study|Withdrawal by Subject|3|||
23632995|NCT00611975|66042038|FG001|Overall Study|Withdrawal by Subject|7|||
23632996|NCT00611975|66042037|FG000|Overall Study|Pregnancy|2|||
23632997|NCT00611975|66042038|FG001|Overall Study|Pregnancy|1|||
23632998|NCT00972322|66042056|FG000|Overall Study|Adverse Event|2|||
23632999|NCT00972322|66042057|FG001|Overall Study|Adverse Event|1|||
23771233|NCT03810495|66543049|FG000|Overall Study|Withdrawal by Subject|1|||
23771234|NCT01545076|66543050|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
23771235|NCT01545076|66543051|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
23572942|NCT00284089|65827480|FG003|Multiple Dose Phase|Adverse Event|1|||
23572943|NCT00284089|65827477|FG000|Multiple Dose Phase|Protocol Violation|0|||
23572944|NCT00284089|65827478|FG001|Multiple Dose Phase|Protocol Violation|0|||
23572945|NCT00284089|65827479|FG002|Multiple Dose Phase|Protocol Violation|1|||
23572946|NCT00284089|65827480|FG003|Multiple Dose Phase|Protocol Violation|0|||
23572947|NCT00284089|65827477|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
23572948|NCT00284089|65827478|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
23572949|NCT00284089|65827479|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
23572950|NCT00284089|65827480|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
23572951|NCT00284089|65827477|FG000|Multiple Dose Phase|Death|0|||
23572952|NCT00284089|65827478|FG001|Multiple Dose Phase|Death|0|||
23572953|NCT00284089|65827479|FG002|Multiple Dose Phase|Death|1|||
23572954|NCT00284089|65827480|FG003|Multiple Dose Phase|Death|1|||
23572955|NCT00284089|65827477|FG000|Extension Phase|Adverse Event|0|||
23572956|NCT00284089|65827478|FG001|Extension Phase|Adverse Event|0|||
23572957|NCT00284089|65827479|FG002|Extension Phase|Adverse Event|2|||
23572958|NCT00284089|65827480|FG003|Extension Phase|Adverse Event|2|||
23572959|NCT00284089|65827477|FG000|Extension Phase|condition no longer requires study drug|2|||
23572960|NCT00284089|65827478|FG001|Extension Phase|condition no longer requires study drug|0|||
23572961|NCT00284089|65827479|FG002|Extension Phase|condition no longer requires study drug|2|||
23572962|NCT00284089|65827480|FG003|Extension Phase|condition no longer requires study drug|7|||
23572963|NCT00284089|65827477|FG000|Extension Phase|Protocol Violation|0|||
23572964|NCT00284089|65827478|FG001|Extension Phase|Protocol Violation|0|||
23572965|NCT00284089|65827479|FG002|Extension Phase|Protocol Violation|1|||
23572966|NCT00284089|65827480|FG003|Extension Phase|Protocol Violation|0|||
23572967|NCT00284089|65827477|FG000|Extension Phase|Withdrawal by Subject|0|||
23572968|NCT00284089|65827478|FG001|Extension Phase|Withdrawal by Subject|0|||
23572969|NCT00284089|65827479|FG002|Extension Phase|Withdrawal by Subject|1|||
23572970|NCT00284089|65827480|FG003|Extension Phase|Withdrawal by Subject|3|||
23572971|NCT01449721|65827486|FG000|Overall Study|Physician Decision|0|||
23572972|NCT01449721|65827487|FG001|Overall Study|Physician Decision|1|||
23572973|NCT01449721|65827486|FG000|Overall Study|Physician Decision|0|||
23572974|NCT01449721|65827487|FG001|Overall Study|Physician Decision|1|||
23572975|NCT01804816|65827490|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
23572976|NCT01804816|65827490|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
23572977|NCT04668989|65827491|FG000|First Intervention|Covid-19 related self-isolation|0|||
23572978|NCT04668989|65827492|FG001|First Intervention|Covid-19 related self-isolation|1|||
23572979|NCT04668989|65827491|FG000|Second Intervention|Adverse Event|0|||
23572980|NCT04668989|65827492|FG001|Second Intervention|Adverse Event|1|||
23572981|NCT03541642|65827502|FG000|Overall Study|Withdrawal by Subject|1|||
23572982|NCT03541642|65827503|FG001|Overall Study|Withdrawal by Subject|2|||
23572983|NCT03541642|65827502|FG000|Overall Study|Lost to Follow-up|16|||
23572984|NCT03541642|65827503|FG001|Overall Study|Lost to Follow-up|12|||
23572985|NCT03541642|65827502|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
23572986|NCT03541642|65827503|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
23572987|NCT02954575|65827504|FG000|Overall Study|Withdrawal by Subject|2|||
23572988|NCT02954575|65827504|FG000|Overall Study|Adverse Event|1|||
23572989|NCT03255941|65827505|FG000|Overall Study|Not eligible or refused injection|37|||
23572990|NCT03255941|65827506|FG001|Overall Study|Not eligible or refused injection|44|||
23572991|NCT03255941|65827507|FG002|Overall Study|Not eligible or refused injection|5|||
23572992|NCT03255941|65827508|FG003|Overall Study|Not eligible or refused injection|6|||
23572993|NCT03255941|65827505|FG000|Overall Study|Did not complete exit interview|1|||
23572994|NCT03255941|65827506|FG001|Overall Study|Did not complete exit interview|2|||
23572995|NCT03255941|65827507|FG002|Overall Study|Did not complete exit interview|0|||
23572996|NCT03255941|65827508|FG003|Overall Study|Did not complete exit interview|0|||
23572997|NCT04716881|65827509|FG000|Overall Study|Adverse Event|1|||
23572998|NCT04716881|65827509|FG000|Overall Study|Lost to Follow-up|1|||
23572999|NCT04140890|65827510|FG000|Overall Study|Withdrawal by Subject|0|||
23573000|NCT04140890|65827511|FG001|Overall Study|Withdrawal by Subject|1|||
23573001|NCT01676220|65827512|FG000|Overall Study|Randomized But Not Treated|4|||
23573002|NCT01676220|65827513|FG001|Overall Study|Randomized But Not Treated|1|||
23573003|NCT01676220|65827512|FG000|Overall Study|Adverse Event|10|||
23573004|NCT01676220|65827513|FG001|Overall Study|Adverse Event|8|||
23573005|NCT01676220|65827512|FG000|Overall Study|Lack of Efficacy|2|||
23573006|NCT01676220|65827513|FG001|Overall Study|Lack of Efficacy|5|||
23573007|NCT01676220|65827512|FG000|Overall Study|Protocol Violation|11|||
23573008|NCT01676220|65827513|FG001|Overall Study|Protocol Violation|12|||
23573009|NCT01676220|65827512|FG000|Overall Study|Received Rescue Therapy|14|||
23573010|NCT01676220|65827513|FG001|Overall Study|Received Rescue Therapy|22|||
23573011|NCT01676220|65827512|FG000|Overall Study|Personal Reason|34|||
23573012|NCT01676220|65827513|FG001|Overall Study|Personal Reason|45|||
23573013|NCT01676220|65827512|FG000|Overall Study|Lost to Follow-up|11|||
23573014|NCT01676220|65827513|FG001|Overall Study|Lost to Follow-up|18|||
23573015|NCT01676220|65827512|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
23573016|NCT01676220|65827513|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
23573017|NCT01676220|65827512|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
23573018|NCT01676220|65827513|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
23573019|NCT01676220|65827512|FG000|Overall Study|Perceived Lack of Efficacy|3|||
23573020|NCT01676220|65827513|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23573021|NCT01676220|65827512|FG000|Overall Study|Non Serious Hypoglycemia|2|||
23573022|NCT01676220|65827513|FG001|Overall Study|Non Serious Hypoglycemia|0|||
23573023|NCT01676220|65827512|FG000|Overall Study|No More Need of Insulin|1|||
23573024|NCT01676220|65827513|FG001|Overall Study|No More Need of Insulin|0|||
23573025|NCT00967018|65827521|FG000|Overall Study|Adverse Event|2|||
23573026|NCT00967018|65827521|FG000|Overall Study|Physician Decision|7|||
23573027|NCT00967018|65827521|FG000|Overall Study|Lost to Follow-up|2|||
23573028|NCT00967018|65827521|FG000|Overall Study|Withdrawal by Subject|1|||
23573029|NCT00967018|65827521|FG000|Overall Study|Miscellaneous Reasons|9|||
23573030|NCT03958630|65827528|FG000|Overall Study|Withdrawal by Subject|0|||
23573031|NCT03958630|65827529|FG001|Overall Study|Withdrawal by Subject|0|||
23573032|NCT03958630|65827530|FG002|Overall Study|Withdrawal by Subject|1|||
23573033|NCT03958630|65827528|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
23573034|NCT03958630|65827529|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
23573035|NCT03958630|65827530|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
23573036|NCT02930122|65827531|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
23573037|NCT02930122|65827532|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
23573038|NCT00709592|65827533|FG000|Overall Study|Unable to proceed to transplant|0|||
23573039|NCT00709592|65827534|FG001|Overall Study|Unable to proceed to transplant|1|||
23573040|NCT02087150|65827537|FG000|Overall Study|Death|0|||
23573041|NCT02087150|65827538|FG001|Overall Study|Death|1|||
23573042|NCT02087150|65827539|FG002|Overall Study|Death|0|||
23573043|NCT02087150|65827537|FG000|Overall Study|Lost to Follow-up|6|||
23573044|NCT02087150|65827538|FG001|Overall Study|Lost to Follow-up|13|||
23573045|NCT02087150|65827539|FG002|Overall Study|Lost to Follow-up|7|||
23573046|NCT02087150|65827537|FG000|Overall Study|Withdrawal by Subject|2|||
23573047|NCT02087150|65827538|FG001|Overall Study|Withdrawal by Subject|5|||
23573048|NCT02087150|65827539|FG002|Overall Study|Withdrawal by Subject|3|||
23573049|NCT02087150|65827537|FG000|Overall Study|Physician Decision|0|||
23573050|NCT02087150|65827538|FG001|Overall Study|Physician Decision|1|||
23573051|NCT02087150|65827539|FG002|Overall Study|Physician Decision|0|||
23573052|NCT02087150|65827537|FG000|Overall Study|Procedure not done|1|||
23573053|NCT02087150|65827538|FG001|Overall Study|Procedure not done|13|||
23573054|NCT02087150|65827539|FG002|Overall Study|Procedure not done|0|||
23573055|NCT02087150|65827537|FG000|Overall Study|F/U not completed w/in study window|0|||
23573056|NCT02087150|65827538|FG001|Overall Study|F/U not completed w/in study window|0|||
23573057|NCT02087150|65827539|FG002|Overall Study|F/U not completed w/in study window|1|||
23573058|NCT02087150|65827537|FG000|Overall Study|Other|1|||
23573059|NCT02087150|65827538|FG001|Overall Study|Other|0|||
23573060|NCT02087150|65827539|FG002|Overall Study|Other|0|||
23573061|NCT02087150|65827537|FG000|Overall Study|Pt moved out of town|0|||
23573062|NCT02087150|65827538|FG001|Overall Study|Pt moved out of town|1|||
23573063|NCT02087150|65827539|FG002|Overall Study|Pt moved out of town|0|||
23573064|NCT04466618|65827540|FG000|Overall Study|Withdrawal by Subject|0|||
23573065|NCT04466618|65827541|FG001|Overall Study|Withdrawal by Subject|1|||
23573066|NCT01880554|65827545|FG000|Overall Study|Protocol Violation|14|||
23573067|NCT01880554|65827545|FG000|Overall Study|Simon's design requirements|2|||
23573068|NCT01781611|65827548|FG000|Overall Study|Adverse Event|4|||
23573069|NCT01781611|65827549|FG001|Overall Study|Adverse Event|0|||
23573070|NCT00604786|65827553|FG000|Overall Study|Lost to Follow-up|2|||
23573071|NCT00604786|65827554|FG001|Overall Study|Lost to Follow-up|0|||
23573072|NCT02269943|65827555|FG000|Treatment Period|Death|0|||
23573073|NCT02269943|65827556|FG001|Treatment Period|Death|1|||
23573074|NCT02269943|65827555|FG000|Treatment Period|Adverse Event|1|||
23573075|NCT02269943|65827556|FG001|Treatment Period|Adverse Event|10|||
23573076|NCT02269943|65827555|FG000|Treatment Period|Progressive Disease|5|||
23573077|NCT02269943|65827556|FG001|Treatment Period|Progressive Disease|17|||
23573078|NCT02269943|65827555|FG000|Treatment Period|Symptomatic Deterioration|0|||
23573079|NCT02269943|65827556|FG001|Treatment Period|Symptomatic Deterioration|2|||
23573080|NCT02269943|65827555|FG000|Follow-Up Survival Period|Death|3|||
23573081|NCT02269943|65827556|FG001|Follow-Up Survival Period|Death|16|||
23573082|NCT02269943|65827555|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
23573083|NCT02269943|65827556|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
23573084|NCT02269943|65827555|FG000|Follow-Up Survival Period|Alive|2|||
23573085|NCT02269943|65827556|FG001|Follow-Up Survival Period|Alive|8|||
23573086|NCT01425632|65827567|FG000|Overall Study|Adverse Event|0|||
23573087|NCT01425632|65827568|FG001|Overall Study|Adverse Event|1|||
23573088|NCT01425632|65827569|FG002|Overall Study|Adverse Event|1|||
23573089|NCT01425632|65827567|FG000|Overall Study|Physician Decision|1|||
23633000|NCT00972322|66042056|FG000|Overall Study|Positive drug screen|0|||
23633001|NCT00972322|66042057|FG001|Overall Study|Positive drug screen|1|||
23633002|NCT00972322|66042056|FG000|Overall Study|Lost to Follow-up|0|||
23633003|NCT00972322|66042057|FG001|Overall Study|Lost to Follow-up|1|||
23633004|NCT00972322|66042056|FG000|Overall Study|Consistently high glucose values|1|||
23633005|NCT00972322|66042057|FG001|Overall Study|Consistently high glucose values|0|||
23633006|NCT01475461|66042059|FG000|Run-in Period|Not meet eligibility criteria|16|||
23633007|NCT01475461|66042060|FG001|Run-in Period|Not meet eligibility criteria|0|||
23633008|NCT01475461|66042061|FG002|Run-in Period|Not meet eligibility criteria|0|||
23633009|NCT01475461|66042062|FG003|Run-in Period|Not meet eligibility criteria|0|||
23633010|NCT01475461|66042063|FG004|Run-in Period|Not meet eligibility criteria|0|||
23633011|NCT01475461|66042064|FG005|Run-in Period|Not meet eligibility criteria|0|||
23633012|NCT01475461|66042065|FG006|Run-in Period|Not meet eligibility criteria|0|||
23633013|NCT01475461|66042059|FG000|Run-in Period|Lost to Follow-up|7|||
23633014|NCT01475461|66042060|FG001|Run-in Period|Lost to Follow-up|0|||
23633015|NCT01475461|66042061|FG002|Run-in Period|Lost to Follow-up|0|||
23633016|NCT01475461|66042062|FG003|Run-in Period|Lost to Follow-up|0|||
23633017|NCT01475461|66042063|FG004|Run-in Period|Lost to Follow-up|0|||
23633018|NCT01475461|66042064|FG005|Run-in Period|Lost to Follow-up|0|||
23633019|NCT01475461|66042065|FG006|Run-in Period|Lost to Follow-up|0|||
23633020|NCT01475461|66042059|FG000|Run-in Period|Withdrawal by Subject|11|||
23633021|NCT01475461|66042060|FG001|Run-in Period|Withdrawal by Subject|0|||
23633022|NCT01475461|66042061|FG002|Run-in Period|Withdrawal by Subject|0|||
23633023|NCT01475461|66042062|FG003|Run-in Period|Withdrawal by Subject|0|||
23633024|NCT01475461|66042063|FG004|Run-in Period|Withdrawal by Subject|0|||
23633025|NCT01475461|66042064|FG005|Run-in Period|Withdrawal by Subject|0|||
23633026|NCT01475461|66042065|FG006|Run-in Period|Withdrawal by Subject|0|||
23633027|NCT01475461|66042059|FG000|Run-in Period|Other|3|||
23633028|NCT01475461|66042060|FG001|Run-in Period|Other|0|||
23771236|NCT01545076|66543052|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
23573090|NCT01425632|65827568|FG001|Overall Study|Physician Decision|0|||
23573091|NCT01425632|65827569|FG002|Overall Study|Physician Decision|0|||
23832329|NCT02623725|66767603|FG000|Overall Study|Serious adverse event|0|||
23832330|NCT02623725|66767604|FG001|Overall Study|Serious adverse event|2|||
23832331|NCT02623725|66767603|FG000|Overall Study|Withdrawal by Subject|7|||
23832332|NCT02623725|66767604|FG001|Overall Study|Withdrawal by Subject|1|||
23832333|NCT00460811|66767605|FG000|Overall Study|Adverse Event|4|||
23832334|NCT00460811|66767606|FG001|Overall Study|Adverse Event|6|||
23832335|NCT00460811|66767607|FG002|Overall Study|Adverse Event|3|||
23832336|NCT00460811|66767608|FG003|Overall Study|Adverse Event|10|||
23573092|NCT01425632|65827567|FG000|Overall Study|Protocol Violation|0|||
23573093|NCT01425632|65827568|FG001|Overall Study|Protocol Violation|0|||
23573094|NCT01425632|65827569|FG002|Overall Study|Protocol Violation|2|||
23573095|NCT01425632|65827567|FG000|Overall Study|Withdrawal by Subject|0|||
23573096|NCT01425632|65827568|FG001|Overall Study|Withdrawal by Subject|0|||
23573097|NCT01425632|65827569|FG002|Overall Study|Withdrawal by Subject|1|||
23573098|NCT05221749|65827570|FG000|Overall Study|Lost to Follow-up|2|||
23573099|NCT05221749|65827571|FG001|Overall Study|Lost to Follow-up|3|||
23573100|NCT03257995|65827574|FG000|Overall Study|Adverse Event|0|||
23573101|NCT03257995|65827575|FG001|Overall Study|Adverse Event|1|||
23573102|NCT03257995|65827576|FG002|Overall Study|Adverse Event|0|||
23573103|NCT03257995|65827577|FG003|Overall Study|Adverse Event|0|||
23573104|NCT03257995|65827578|FG004|Overall Study|Adverse Event|0|||
23633029|NCT01475461|66042061|FG002|Run-in Period|Other|0|||
23633030|NCT01475461|66042062|FG003|Run-in Period|Other|0|||
23771237|NCT01545076|66543053|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
23771238|NCT01545076|66543054|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
23633031|NCT01475461|66042063|FG004|Run-in Period|Other|0|||
23771239|NCT01545076|66543050|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
23771240|NCT01545076|66543051|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
23771241|NCT01545076|66543052|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
23771242|NCT01545076|66543053|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
23771243|NCT01545076|66543054|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
23771244|NCT01545076|66543050|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
23771245|NCT01545076|66543051|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
23832337|NCT00460811|66767609|FG004|Overall Study|Adverse Event|2|||
23771246|NCT01545076|66543052|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
23832338|NCT00460811|66767605|FG000|Overall Study|Noncompliance|1|||
23832339|NCT00460811|66767606|FG001|Overall Study|Noncompliance|0|||
23573105|NCT03257995|65827579|FG005|Overall Study|Adverse Event|0|||
23573106|NCT03257995|65827574|FG000|Overall Study|Protocol deviation|0|||
23573107|NCT03257995|65827575|FG001|Overall Study|Protocol deviation|0|||
23573108|NCT03257995|65827576|FG002|Overall Study|Protocol deviation|0|||
23633032|NCT01475461|66042064|FG005|Run-in Period|Other|0|||
23633033|NCT01475461|66042065|FG006|Run-in Period|Other|0|||
23633034|NCT01475461|66042059|FG000|Run-in Period|Protocol Violation|4|||
23633035|NCT01475461|66042060|FG001|Run-in Period|Protocol Violation|0|||
23771247|NCT01545076|66543053|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
23771248|NCT01545076|66543054|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
23771249|NCT01545076|66543050|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
23771250|NCT01545076|66543051|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23771251|NCT01545076|66543052|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23771252|NCT01545076|66543053|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23771253|NCT01545076|66543054|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23771254|NCT01545076|66543050|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
23771255|NCT01545076|66543051|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23832340|NCT00460811|66767607|FG002|Overall Study|Noncompliance|0|||
23832341|NCT00460811|66767608|FG003|Overall Study|Noncompliance|2|||
23832342|NCT00460811|66767609|FG004|Overall Study|Noncompliance|1|||
23832343|NCT00460811|66767605|FG000|Overall Study|Withdrawal by Subject|7|||
23832344|NCT00460811|66767606|FG001|Overall Study|Withdrawal by Subject|7|||
23832345|NCT00460811|66767607|FG002|Overall Study|Withdrawal by Subject|6|||
23832346|NCT00460811|66767608|FG003|Overall Study|Withdrawal by Subject|3|||
23832347|NCT00460811|66767609|FG004|Overall Study|Withdrawal by Subject|11|||
23832348|NCT00460811|66767605|FG000|Overall Study|Physician Decision|1|||
23832349|NCT00460811|66767606|FG001|Overall Study|Physician Decision|0|||
23832350|NCT00460811|66767607|FG002|Overall Study|Physician Decision|0|||
23832351|NCT00460811|66767608|FG003|Overall Study|Physician Decision|0|||
23832352|NCT00460811|66767609|FG004|Overall Study|Physician Decision|0|||
23832353|NCT00460811|66767605|FG000|Overall Study|Lost to Follow-up|3|||
23832354|NCT00460811|66767606|FG001|Overall Study|Lost to Follow-up|2|||
23832355|NCT00460811|66767607|FG002|Overall Study|Lost to Follow-up|5|||
23832356|NCT00460811|66767608|FG003|Overall Study|Lost to Follow-up|3|||
23832357|NCT00460811|66767609|FG004|Overall Study|Lost to Follow-up|6|||
23832358|NCT00014495|66767610|FG000|Overall Study|Death|0|||
23832359|NCT00014495|66767611|FG001|Overall Study|Death|0|||
23832360|NCT00014495|66767612|FG002|Overall Study|Death|1|||
23832361|NCT00014495|66767613|FG003|Overall Study|Death|0|||
23832362|NCT00014495|66767610|FG000|Overall Study|Clinical deterioration|0|||
23832363|NCT00014495|66767611|FG001|Overall Study|Clinical deterioration|0|||
23832364|NCT00014495|66767612|FG002|Overall Study|Clinical deterioration|0|||
23832365|NCT00014495|66767613|FG003|Overall Study|Clinical deterioration|1|||
23832366|NCT00314327|66767614|FG000|Overall Study|Withdrawal by Subject|1|||
23832367|NCT02088177|66767615|FG000|Overall Study|Lost to Follow-up|3|||
23832368|NCT03859427|66767616|FG000|Overall Study|Withdrawal by Subject|4|||
23832369|NCT03859427|66767617|FG001|Overall Study|Withdrawal by Subject|7|||
23832370|NCT03859427|66767616|FG000|Overall Study|Decision by sponsor|0|||
23832371|NCT03859427|66767617|FG001|Overall Study|Decision by sponsor|3|||
23832372|NCT03859427|66767616|FG000|Overall Study|Lost to Follow-up|3|||
23832373|NCT03859427|66767617|FG001|Overall Study|Lost to Follow-up|2|||
23832374|NCT03859427|66767616|FG000|Overall Study|Death|22|||
23832375|NCT03859427|66767617|FG001|Overall Study|Death|25|||
23771256|NCT01545076|66543052|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23771257|NCT01545076|66543053|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23771258|NCT01545076|66543054|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23771259|NCT01545076|66543050|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23771260|NCT01545076|66543051|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23771261|NCT01545076|66543052|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23771262|NCT01545076|66543053|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
23771263|NCT01545076|66543054|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23771264|NCT01545076|66543050|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
23771265|NCT01545076|66543051|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
23771266|NCT01545076|66543052|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
23771267|NCT01545076|66543053|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
23771268|NCT01545076|66543054|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
23771269|NCT01545076|66543050|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23771270|NCT01545076|66543051|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
23771271|NCT01545076|66543052|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
23771272|NCT01545076|66543053|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23832376|NCT03361306|66767618|FG000|Overall Study|Death|5|||
23832377|NCT03361306|66767618|FG000|Overall Study|Still On Study (on study treatment)|3|||
23832378|NCT03361306|66767618|FG000|Overall Study|Still On Study (in follow up)|7|||
23832379|NCT01870973|66767645|FG000|Overall Study|Lost to Follow-up|10|||
23832380|NCT01870973|66767646|FG001|Overall Study|Lost to Follow-up|3|||
23832381|NCT02044302|66767647|FG000|Overall Study|study terminated|2|||
23832382|NCT02044302|66767648|FG001|Overall Study|study terminated|0|||
23832383|NCT01343043|66767661|FG000|Overall Study|Disease progression before treatment|1|||
23771273|NCT01545076|66543054|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23771274|NCT01545076|66543050|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
23771275|NCT01545076|66543051|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
23771276|NCT01545076|66543052|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
23771277|NCT01545076|66543053|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
23771278|NCT01545076|66543054|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
23771279|NCT00275002|66543055|FG000|Overall Study|Death|1|||
23771280|NCT00275002|66543056|FG001|Overall Study|Death|0|||
23771281|NCT00275002|66543055|FG000|Overall Study|Disease progression|21|||
23771282|NCT00275002|66543056|FG001|Overall Study|Disease progression|15|||
23771283|NCT00275002|66543055|FG000|Overall Study|Adverse Event|0|||
23771284|NCT00275002|66543056|FG001|Overall Study|Adverse Event|1|||
23771285|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
23771286|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
23771287|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
23771288|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
23771289|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
23771290|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
23771291|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
23771292|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
23771293|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23771294|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23771295|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23771296|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
23771297|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
23771298|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23771299|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23771300|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23771301|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
23771302|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
23771303|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
23771304|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
23771305|NCT04700449|66543057|FG000|Stage 1: Double-Blind Period|Other|0|||
23771306|NCT04700449|66543058|FG001|Stage 1: Double-Blind Period|Other|0|||
23771307|NCT04700449|66543059|FG002|Stage 1: Double-Blind Period|Other|1|||
23771308|NCT04700449|66543060|FG003|Stage 1: Double-Blind Period|Other|0|||
23771309|NCT04700449|66543057|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
23771310|NCT04700449|66543058|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
23771311|NCT04700449|66543059|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
23771312|NCT04700449|66543060|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
23771313|NCT04700449|66543057|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23832384|NCT01343043|66767662|FG001|Overall Study|Disease progression before treatment|0|||
23832385|NCT01343043|66767663|FG002|Overall Study|Disease progression before treatment|0|||
23832386|NCT01343043|66767664|FG003|Overall Study|Disease progression before treatment|0|||
23832387|NCT01343043|66767661|FG000|Overall Study|Withdrawal by Subject|1|||
23832388|NCT01343043|66767662|FG001|Overall Study|Withdrawal by Subject|0|||
23832389|NCT01343043|66767663|FG002|Overall Study|Withdrawal by Subject|0|||
23832390|NCT01343043|66767664|FG003|Overall Study|Withdrawal by Subject|0|||
23832391|NCT01343043|66767661|FG000|Overall Study|Death|1|||
23633036|NCT01475461|66042061|FG002|Run-in Period|Protocol Violation|0|||
23771314|NCT04700449|66543058|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23771315|NCT04700449|66543059|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23771316|NCT04700449|66543060|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
23771317|NCT04700449|66543057|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23771318|NCT04700449|66543058|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23832392|NCT01343043|66767662|FG001|Overall Study|Death|1|||
23832393|NCT01343043|66767663|FG002|Overall Study|Death|0|||
23832394|NCT01343043|66767664|FG003|Overall Study|Death|1|||
23832395|NCT02564900|66767665|FG000|Dose Escalation|Progressive disease per RECIST|2|||
23832396|NCT02564900|66767666|FG001|Dose Escalation|Progressive disease per RECIST|3|||
23832397|NCT02564900|66767667|FG002|Dose Escalation|Progressive disease per RECIST|3|||
23573109|NCT03257995|65827577|FG003|Overall Study|Protocol deviation|0|||
23573110|NCT03257995|65827578|FG004|Overall Study|Protocol deviation|0|||
23447269|NCT03109184|65377922|FG001|Overall Study|Lost to Follow-up|6|||
23573111|NCT03257995|65827579|FG005|Overall Study|Protocol deviation|2|||
23573112|NCT03486899|65827580|FG000|Overall Study|Lost to Follow-up|4|||
23573113|NCT03486899|65827581|FG001|Overall Study|Lost to Follow-up|1|||
23573114|NCT03486899|65827582|FG002|Overall Study|Lost to Follow-up|4|||
23573115|NCT03486899|65827583|FG003|Overall Study|Lost to Follow-up|3|||
23573116|NCT03486899|65827580|FG000|Overall Study|Death|1|||
23573117|NCT03486899|65827581|FG001|Overall Study|Death|0|||
23573118|NCT03486899|65827582|FG002|Overall Study|Death|0|||
23573119|NCT03486899|65827583|FG003|Overall Study|Death|1|||
23573120|NCT03486899|65827580|FG000|Overall Study|Adverse Event|0|||
23573121|NCT03486899|65827581|FG001|Overall Study|Adverse Event|2|||
23573122|NCT03486899|65827582|FG002|Overall Study|Adverse Event|0|||
23573123|NCT03486899|65827583|FG003|Overall Study|Adverse Event|2|||
23573124|NCT03486899|65827580|FG000|Overall Study|Withdrawal by Subject|3|||
23573125|NCT03486899|65827581|FG001|Overall Study|Withdrawal by Subject|7|||
23573126|NCT03486899|65827582|FG002|Overall Study|Withdrawal by Subject|4|||
23573127|NCT03486899|65827583|FG003|Overall Study|Withdrawal by Subject|3|||
23573128|NCT03486899|65827580|FG000|Overall Study|Other Reasons|0|||
23573129|NCT03486899|65827581|FG001|Overall Study|Other Reasons|1|||
23573130|NCT03486899|65827582|FG002|Overall Study|Other Reasons|0|||
23573131|NCT03486899|65827583|FG003|Overall Study|Other Reasons|1|||
23573132|NCT00445601|65827584|FG000|Overall Study|Withdrawal by Subject|11|||
23573133|NCT00445601|65827585|FG001|Overall Study|Withdrawal by Subject|11|||
23573134|NCT00445601|65827584|FG000|Overall Study|TURBT Complication|12|||
23573135|NCT00445601|65827585|FG001|Overall Study|TURBT Complication|8|||
23573136|NCT00445601|65827584|FG000|Overall Study|Incorrect Disease Status|6|||
23573137|NCT00445601|65827585|FG001|Overall Study|Incorrect Disease Status|6|||
23573138|NCT00445601|65827584|FG000|Overall Study|Drug Delivery Issue|2|||
23573139|NCT00445601|65827585|FG001|Overall Study|Drug Delivery Issue|2|||
23633037|NCT01475461|66042062|FG003|Run-in Period|Protocol Violation|0|||
23633038|NCT01475461|66042063|FG004|Run-in Period|Protocol Violation|0|||
23633039|NCT01475461|66042064|FG005|Run-in Period|Protocol Violation|0|||
23633040|NCT01475461|66042065|FG006|Run-in Period|Protocol Violation|0|||
23633041|NCT01475461|66042059|FG000|Treatment Period|Death|0|||
23633042|NCT01475461|66042060|FG001|Treatment Period|Death|0|||
23633043|NCT01475461|66042061|FG002|Treatment Period|Death|0|||
23633044|NCT01475461|66042062|FG003|Treatment Period|Death|1|||
23633045|NCT01475461|66042063|FG004|Treatment Period|Death|0|||
23633046|NCT01475461|66042064|FG005|Treatment Period|Death|0|||
23633047|NCT01475461|66042065|FG006|Treatment Period|Death|0|||
23633048|NCT01475461|66042059|FG000|Treatment Period|Lost to Follow-up|0|||
23633049|NCT01475461|66042060|FG001|Treatment Period|Lost to Follow-up|3|||
23633050|NCT01475461|66042061|FG002|Treatment Period|Lost to Follow-up|2|||
23633051|NCT01475461|66042062|FG003|Treatment Period|Lost to Follow-up|3|||
23633052|NCT01475461|66042063|FG004|Treatment Period|Lost to Follow-up|1|||
23633053|NCT01475461|66042064|FG005|Treatment Period|Lost to Follow-up|2|||
23633054|NCT01475461|66042065|FG006|Treatment Period|Lost to Follow-up|1|||
23633055|NCT01475461|66042059|FG000|Treatment Period|Withdrawal by Subject|0|||
23633056|NCT01475461|66042060|FG001|Treatment Period|Withdrawal by Subject|2|||
23633057|NCT01475461|66042061|FG002|Treatment Period|Withdrawal by Subject|2|||
23633058|NCT01475461|66042062|FG003|Treatment Period|Withdrawal by Subject|0|||
23771319|NCT04700449|66543059|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
23771320|NCT04700449|66543060|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23771321|NCT04700449|66543057|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23771322|NCT04700449|66543058|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23771323|NCT04700449|66543059|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
23771324|NCT04700449|66543060|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23771325|NCT04700449|66543057|FG000|Stage 2 Sub-study 1|Other|1|||
23771326|NCT04700449|66543058|FG001|Stage 2 Sub-study 1|Other|2|||
23771327|NCT04700449|66543059|FG002|Stage 2 Sub-study 1|Other|0|||
23771328|NCT04700449|66543060|FG003|Stage 2 Sub-study 1|Other|0|||
23771329|NCT04700449|66543057|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
23573140|NCT00445601|65827584|FG000|Overall Study|Adverse Event|2|||
23633059|NCT01475461|66042063|FG004|Treatment Period|Withdrawal by Subject|2|||
23633060|NCT01475461|66042064|FG005|Treatment Period|Withdrawal by Subject|2|||
23771330|NCT04700449|66543058|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
23771331|NCT04700449|66543059|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
23832398|NCT02564900|66767668|FG003|Dose Escalation|Progressive disease per RECIST|3|||
23573141|NCT00445601|65827585|FG001|Overall Study|Adverse Event|0|||
23633061|NCT01475461|66042065|FG006|Treatment Period|Withdrawal by Subject|0|||
23447270|NCT03109184|65377921|FG000|Overall Study|Withdrawal by Subject|1|||
23573142|NCT00445601|65827584|FG000|Overall Study|Death prior to TURBT|0|||
23573143|NCT00445601|65827585|FG001|Overall Study|Death prior to TURBT|1|||
23573144|NCT00598481|65827586|FG000|Treatment|Physician Decision|1|||
23573145|NCT00474175|65827591|FG000|Overall Study|Lack of Efficacy|0|||
23573146|NCT00474175|65827592|FG001|Overall Study|Lack of Efficacy|0|||
23573147|NCT00474175|65827593|FG002|Overall Study|Lack of Efficacy|1|||
23573148|NCT00474175|65827591|FG000|Overall Study|Withdrawal by Subject|0|||
23573149|NCT00474175|65827592|FG001|Overall Study|Withdrawal by Subject|1|||
23573150|NCT00474175|65827593|FG002|Overall Study|Withdrawal by Subject|1|||
23573151|NCT00474175|65827591|FG000|Overall Study|Ineligible|1|||
23573152|NCT00474175|65827592|FG001|Overall Study|Ineligible|3|||
23573153|NCT00474175|65827593|FG002|Overall Study|Ineligible|1|||
23573154|NCT00474175|65827591|FG000|Overall Study|Protocol Violation|0|||
23573155|NCT00474175|65827592|FG001|Overall Study|Protocol Violation|2|||
23573156|NCT00474175|65827593|FG002|Overall Study|Protocol Violation|1|||
23573157|NCT00474175|65827591|FG000|Overall Study|Administrative|0|||
23573158|NCT00474175|65827592|FG001|Overall Study|Administrative|1|||
23573159|NCT00474175|65827593|FG002|Overall Study|Administrative|0|||
23573160|NCT02226172|65827598|FG000|Overall Study|Participant refused further follow-up|4|||
23573161|NCT02226172|65827598|FG000|Overall Study|Other|5|||
23573162|NCT02226172|65827598|FG000|Overall Study|Death|1|||
23573163|NCT02226172|65827598|FG000|Overall Study|Study terminated by sponsor|1|||
23573164|NCT02226172|65827598|FG000|Overall Study|Adverse Event|6|||
23573165|NCT00918749|65827599|FG000|Overall Study|Adverse Event|1|||
23573166|NCT00918749|65827600|FG001|Overall Study|Adverse Event|0|||
23573167|NCT00918749|65827601|FG002|Overall Study|Adverse Event|1|||
23573168|NCT00918749|65827599|FG000|Overall Study|Lost to Follow-up|0|||
23573169|NCT00918749|65827600|FG001|Overall Study|Lost to Follow-up|0|||
23573170|NCT00918749|65827601|FG002|Overall Study|Lost to Follow-up|1|||
23573171|NCT00918749|65827599|FG000|Overall Study|Withdrawal by Subject|5|||
23573172|NCT00918749|65827600|FG001|Overall Study|Withdrawal by Subject|3|||
23573173|NCT00918749|65827601|FG002|Overall Study|Withdrawal by Subject|5|||
23573174|NCT00918749|65827599|FG000|Overall Study|No Study Medication Taken|1|||
23573175|NCT00918749|65827600|FG001|Overall Study|No Study Medication Taken|0|||
23573176|NCT00918749|65827601|FG002|Overall Study|No Study Medication Taken|0|||
23573177|NCT00393094|65827602|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
23573178|NCT00393094|65827602|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
23573179|NCT04537897|65827603|FG000|Overall Study|Other than listed|0|||
23573180|NCT04537897|65827604|FG001|Overall Study|Other than listed|0|||
23573181|NCT04537897|65827605|FG002|Overall Study|Other than listed|0|||
23573182|NCT04537897|65827606|FG003|Overall Study|Other than listed|0|||
23573183|NCT04537897|65827607|FG004|Overall Study|Other than listed|0|||
23573184|NCT04537897|65827608|FG005|Overall Study|Other than listed|0|||
23573185|NCT04537897|65827609|FG006|Overall Study|Other than listed|1|||
23573186|NCT04537897|65827610|FG007|Overall Study|Other than listed|0|||
23573187|NCT04537897|65827611|FG008|Overall Study|Other than listed|0|||
23573188|NCT04537897|65827603|FG000|Overall Study|Adverse Event|0|||
23573189|NCT04537897|65827604|FG001|Overall Study|Adverse Event|0|||
23573190|NCT04537897|65827605|FG002|Overall Study|Adverse Event|0|||
23573191|NCT04537897|65827606|FG003|Overall Study|Adverse Event|1|||
23573192|NCT04537897|65827607|FG004|Overall Study|Adverse Event|0|||
23573193|NCT04537897|65827608|FG005|Overall Study|Adverse Event|0|||
23573194|NCT04537897|65827609|FG006|Overall Study|Adverse Event|0|||
23573195|NCT04537897|65827610|FG007|Overall Study|Adverse Event|0|||
23573196|NCT04537897|65827611|FG008|Overall Study|Adverse Event|0|||
23573197|NCT04537897|65827603|FG000|Overall Study|Withdrawal by Subject|0|||
23573198|NCT04537897|65827604|FG001|Overall Study|Withdrawal by Subject|1|||
23573199|NCT04537897|65827605|FG002|Overall Study|Withdrawal by Subject|0|||
23573200|NCT04537897|65827606|FG003|Overall Study|Withdrawal by Subject|0|||
23573201|NCT04537897|65827607|FG004|Overall Study|Withdrawal by Subject|0|||
23573202|NCT04537897|65827608|FG005|Overall Study|Withdrawal by Subject|0|||
23573203|NCT04537897|65827609|FG006|Overall Study|Withdrawal by Subject|0|||
23573204|NCT04537897|65827610|FG007|Overall Study|Withdrawal by Subject|0|||
23573205|NCT04537897|65827611|FG008|Overall Study|Withdrawal by Subject|0|||
23573206|NCT01235975|65827612|FG000|Overall Study|Serious Adverse Event|0|||
23573207|NCT01235975|65827613|FG001|Overall Study|Serious Adverse Event|1|||
23573208|NCT01235975|65827612|FG000|Overall Study|Withdrawal by Subject|8|||
23573209|NCT01235975|65827613|FG001|Overall Study|Withdrawal by Subject|2|||
23573210|NCT01235975|65827612|FG000|Overall Study|Migrated/moved from study area|2|||
23573211|NCT01235975|65827613|FG001|Overall Study|Migrated/moved from study area|1|||
23573212|NCT01235975|65827612|FG000|Overall Study|Lost to Follow-up|7|||
23573213|NCT01235975|65827613|FG001|Overall Study|Lost to Follow-up|3|||
23573214|NCT01811563|65827615|FG000|Overall Study|Lost to Follow-up|5|||
23573215|NCT01811563|65827616|FG001|Overall Study|Lost to Follow-up|2|||
23573216|NCT01811563|65827615|FG000|Overall Study|Incorrect Randomization procedure|0|||
23573217|NCT01811563|65827616|FG001|Overall Study|Incorrect Randomization procedure|1|||
23573218|NCT01461993|65827617|FG000|Overall Study|Withdrawal by Subject|60|||
23573219|NCT01461993|65827618|FG001|Overall Study|Withdrawal by Subject|53|||
23573220|NCT01461993|65827619|FG002|Overall Study|Withdrawal by Subject|16|||
23633062|NCT01475461|66042059|FG000|Treatment Period|Other|0|||
23573221|NCT01461993|65827617|FG000|Overall Study|Lost to Follow-up|44|||
23573222|NCT01461993|65827618|FG001|Overall Study|Lost to Follow-up|48|||
23573223|NCT01461993|65827619|FG002|Overall Study|Lost to Follow-up|22|||
23573224|NCT01461993|65827617|FG000|Overall Study|Protocol Violation|10|||
23573225|NCT01461993|65827618|FG001|Overall Study|Protocol Violation|9|||
23573226|NCT01461993|65827619|FG002|Overall Study|Protocol Violation|7|||
23573227|NCT01461993|65827617|FG000|Overall Study|Adverse Event|9|||
23573228|NCT01461993|65827618|FG001|Overall Study|Adverse Event|11|||
23573229|NCT01461993|65827619|FG002|Overall Study|Adverse Event|3|||
23573230|NCT01461993|65827617|FG000|Overall Study|No longer met eligibility criteria|13|||
23573231|NCT01461993|65827618|FG001|Overall Study|No longer met eligibility criteria|18|||
23573232|NCT01461993|65827619|FG002|Overall Study|No longer met eligibility criteria|10|||
23573233|NCT01461993|65827617|FG000|Overall Study|Did not meet entrance criteria|2|||
23573234|NCT01461993|65827618|FG001|Overall Study|Did not meet entrance criteria|3|||
23573235|NCT01461993|65827619|FG002|Overall Study|Did not meet entrance criteria|0|||
23573236|NCT01461993|65827617|FG000|Overall Study|Other|13|||
23573237|NCT01461993|65827618|FG001|Overall Study|Other|15|||
23573238|NCT01461993|65827619|FG002|Overall Study|Other|6|||
23573239|NCT01500226|65827620|FG000|Overall Study|Adverse Event|31|||
23573240|NCT01500226|65827621|FG001|Overall Study|Adverse Event|38|||
23573241|NCT01500226|65827620|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
23573242|NCT01500226|65827621|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
23573243|NCT01500226|65827620|FG000|Overall Study|Withdrawal by Subject|93|||
23573244|NCT01500226|65827621|FG001|Overall Study|Withdrawal by Subject|96|||
23573245|NCT01500226|65827620|FG000|Overall Study|Death|12|||
23573246|NCT01500226|65827621|FG001|Overall Study|Death|4|||
23573247|NCT01500226|65827620|FG000|Overall Study|Disease Progression|16|||
23573248|NCT01500226|65827621|FG001|Overall Study|Disease Progression|14|||
23573249|NCT01500226|65827620|FG000|Overall Study|Protocol Violation|53|||
23573250|NCT01500226|65827621|FG001|Overall Study|Protocol Violation|39|||
23633063|NCT01475461|66042060|FG001|Treatment Period|Other|1|||
23633064|NCT01475461|66042061|FG002|Treatment Period|Other|0|||
23633065|NCT01475461|66042062|FG003|Treatment Period|Other|0|||
23633066|NCT01475461|66042063|FG004|Treatment Period|Other|0|||
23633067|NCT01475461|66042064|FG005|Treatment Period|Other|0|||
23633068|NCT01475461|66042065|FG006|Treatment Period|Other|0|||
23633069|NCT01475461|66042059|FG000|Treatment Period|Protocol Violation|0|||
23633070|NCT01475461|66042060|FG001|Treatment Period|Protocol Violation|1|||
23633071|NCT01475461|66042061|FG002|Treatment Period|Protocol Violation|0|||
23633072|NCT01475461|66042062|FG003|Treatment Period|Protocol Violation|0|||
23633073|NCT01475461|66042063|FG004|Treatment Period|Protocol Violation|0|||
23633074|NCT01475461|66042064|FG005|Treatment Period|Protocol Violation|0|||
23633075|NCT01475461|66042065|FG006|Treatment Period|Protocol Violation|1|||
23633076|NCT01475461|66042059|FG000|Treatment Period|Lack of Efficacy|0|||
23633077|NCT01475461|66042060|FG001|Treatment Period|Lack of Efficacy|2|||
23633078|NCT01475461|66042061|FG002|Treatment Period|Lack of Efficacy|0|||
23633079|NCT01475461|66042062|FG003|Treatment Period|Lack of Efficacy|2|||
23573251|NCT01500226|65827620|FG000|Overall Study|Physician Decision|17|||
23573252|NCT01500226|65827621|FG001|Overall Study|Physician Decision|15|||
23573253|NCT01500226|65827620|FG000|Overall Study|Lack of Efficacy|14|||
23573254|NCT01500226|65827621|FG001|Overall Study|Lack of Efficacy|30|||
23573255|NCT01500226|65827620|FG000|Overall Study|Lost to Follow-up|9|||
23573256|NCT01500226|65827621|FG001|Overall Study|Lost to Follow-up|5|||
23573257|NCT01500226|65827620|FG000|Overall Study|Other Reasons|19|||
23573258|NCT01500226|65827621|FG001|Overall Study|Other Reasons|16|||
23573259|NCT04157686|65827622|FG000|Overall Study|Adverse Event|1|||
23573260|NCT04157686|65827623|FG001|Overall Study|Adverse Event|0|||
23573261|NCT04157686|65827624|FG002|Overall Study|Adverse Event|1|||
23573262|NCT04157686|65827625|FG003|Overall Study|Adverse Event|0|||
23573263|NCT04157686|65827626|FG004|Overall Study|Adverse Event|1|||
23573264|NCT04157686|65827627|FG005|Overall Study|Adverse Event|0|||
23633080|NCT01475461|66042063|FG004|Treatment Period|Lack of Efficacy|1|||
23633081|NCT01475461|66042064|FG005|Treatment Period|Lack of Efficacy|1|||
23573265|NCT04157686|65827628|FG006|Overall Study|Adverse Event|0|||
23573266|NCT04157686|65827629|FG007|Overall Study|Adverse Event|0|||
23573267|NCT04157686|65827622|FG000|Overall Study|Pregnancy|0|||
23573268|NCT04157686|65827623|FG001|Overall Study|Pregnancy|1|||
23573269|NCT04157686|65827624|FG002|Overall Study|Pregnancy|3|||
23573270|NCT04157686|65827625|FG003|Overall Study|Pregnancy|0|||
23573271|NCT04157686|65827626|FG004|Overall Study|Pregnancy|0|||
23573272|NCT04157686|65827627|FG005|Overall Study|Pregnancy|0|||
23573273|NCT04157686|65827628|FG006|Overall Study|Pregnancy|3|||
23573274|NCT04157686|65827629|FG007|Overall Study|Pregnancy|0|||
23573275|NCT04157686|65827622|FG000|Overall Study|Lost to Follow-up|1|||
23573276|NCT04157686|65827623|FG001|Overall Study|Lost to Follow-up|2|||
23573277|NCT04157686|65827624|FG002|Overall Study|Lost to Follow-up|8|||
23633082|NCT01475461|66042065|FG006|Treatment Period|Lack of Efficacy|0|||
23633083|NCT01475461|66042059|FG000|Treatment Period|Medication Error|0|||
23633084|NCT01475461|66042060|FG001|Treatment Period|Medication Error|0|||
23832399|NCT02564900|66767669|FG004|Dose Escalation|Progressive disease per RECIST|3|||
23832400|NCT02564900|66767670|FG005|Dose Escalation|Progressive disease per RECIST|1|||
23573278|NCT04157686|65827625|FG003|Overall Study|Lost to Follow-up|6|||
23573279|NCT04157686|65827626|FG004|Overall Study|Lost to Follow-up|6|||
23573280|NCT04157686|65827627|FG005|Overall Study|Lost to Follow-up|3|||
23573281|NCT04157686|65827628|FG006|Overall Study|Lost to Follow-up|7|||
23573282|NCT04157686|65827629|FG007|Overall Study|Lost to Follow-up|9|||
23573283|NCT04157686|65827622|FG000|Overall Study|Lack of Efficacy|0|||
23573284|NCT04157686|65827623|FG001|Overall Study|Lack of Efficacy|0|||
23771332|NCT04700449|66543060|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
23771333|NCT04700449|66543057|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23771334|NCT04700449|66543058|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23771335|NCT04700449|66543059|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23771336|NCT04700449|66543060|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
23771337|NCT04700449|66543057|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23771338|NCT04700449|66543058|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23771339|NCT04700449|66543059|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23771340|NCT04700449|66543060|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
23771341|NCT04700449|66543057|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23771342|NCT04700449|66543058|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23771343|NCT04700449|66543059|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23771344|NCT04700449|66543060|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
23771345|NCT04700449|66543057|FG000|Stage 2 Sub-study 2|Other|0|||
23771346|NCT04700449|66543058|FG001|Stage 2 Sub-study 2|Other|0|||
23771347|NCT04700449|66543059|FG002|Stage 2 Sub-study 2|Other|0|||
23771348|NCT04700449|66543060|FG003|Stage 2 Sub-study 2|Other|5|||
23771349|NCT01513551|66543068|FG000|Overall Study|Death|0|||
23771350|NCT01513551|66543069|FG001|Overall Study|Death|1|||
23771351|NCT01513551|66543070|FG002|Overall Study|Death|0|||
23771352|NCT01513551|66543068|FG000|Overall Study|Lost to Follow-up|3|||
23771353|NCT01513551|66543069|FG001|Overall Study|Lost to Follow-up|5|||
23771354|NCT01513551|66543070|FG002|Overall Study|Lost to Follow-up|2|||
23771355|NCT01513551|66543068|FG000|Overall Study|Withdrawal by Subject|1|||
23771356|NCT01513551|66543069|FG001|Overall Study|Withdrawal by Subject|0|||
23771357|NCT01513551|66543070|FG002|Overall Study|Withdrawal by Subject|2|||
23771358|NCT01513551|66543068|FG000|Overall Study|Randomized but not vaccinated|0|||
23771359|NCT01513551|66543069|FG001|Overall Study|Randomized but not vaccinated|0|||
23771360|NCT01513551|66543070|FG002|Overall Study|Randomized but not vaccinated|1|||
23771361|NCT01884025|66543071|FG000|Overall Study|Lost to Follow-up|3|||
23771362|NCT01884025|66543072|FG001|Overall Study|Lost to Follow-up|4|||
23771363|NCT04591626|66543074|FG000|Overall Study|Adverse Event|4|||
23771364|NCT04591626|66543075|FG001|Overall Study|Adverse Event|0|||
23771365|NCT04591626|66543074|FG000|Overall Study|Withdrawal by Subject|5|||
23771366|NCT04591626|66543075|FG001|Overall Study|Withdrawal by Subject|3|||
23771367|NCT04591626|66543074|FG000|Overall Study|Physician Decision|0|||
23771368|NCT04591626|66543075|FG001|Overall Study|Physician Decision|1|||
23771369|NCT04591626|66543074|FG000|Overall Study|Death|0|||
23771370|NCT04591626|66543075|FG001|Overall Study|Death|1|||
23771371|NCT04591626|66543074|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23771372|NCT04591626|66543075|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23771373|NCT01666730|66543076|FG000|Overall Study|Adverse Event|16|||
23771374|NCT01666730|66543076|FG000|Overall Study|Death|2|||
23832401|NCT02564900|66767671|FG006|Dose Escalation|Progressive disease per RECIST|0|||
23832402|NCT02564900|66767672|FG007|Dose Escalation|Progressive disease per RECIST|0|||
23832403|NCT02564900|66767673|FG008|Dose Escalation|Progressive disease per RECIST|0|||
23832404|NCT02564900|66767674|FG009|Dose Escalation|Progressive disease per RECIST|0|||
23832405|NCT02564900|66767675|FG010|Dose Escalation|Progressive disease per RECIST|0|||
23832406|NCT02564900|66767676|FG011|Dose Escalation|Progressive disease per RECIST|0|||
23573285|NCT04157686|65827624|FG002|Overall Study|Lack of Efficacy|0|||
23573286|NCT04157686|65827625|FG003|Overall Study|Lack of Efficacy|0|||
23771375|NCT01666730|66543076|FG000|Overall Study|Physician Decision|5|||
23771376|NCT01666730|66543076|FG000|Overall Study|Withdrawal by Subject|9|||
23771377|NCT01666730|66543076|FG000|Overall Study|Disease progression/relapse|18|||
23771378|NCT00048568|66543079|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
23771379|NCT00048568|66543080|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
23771380|NCT00048568|66543081|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
23771381|NCT00048568|66543079|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
23771382|NCT00048568|66543080|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
23832407|NCT02564900|66767677|FG012|Dose Escalation|Progressive disease per RECIST|0|||
23832408|NCT02564900|66767678|FG013|Dose Escalation|Progressive disease per RECIST|0|||
23573287|NCT04157686|65827626|FG004|Overall Study|Lack of Efficacy|0|||
23573288|NCT04157686|65827627|FG005|Overall Study|Lack of Efficacy|2|||
23573289|NCT04157686|65827628|FG006|Overall Study|Lack of Efficacy|0|||
23771383|NCT00048568|66543081|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
23771384|NCT00048568|66543079|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
23771385|NCT00048568|66543080|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
23771386|NCT00048568|66543081|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
23771387|NCT00048568|66543079|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
23771388|NCT00048568|66543080|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
23771389|NCT00048568|66543081|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
23771390|NCT00048568|66543079|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
23771391|NCT00048568|66543080|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
23771392|NCT00048568|66543081|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
23832409|NCT02564900|66767679|FG014|Dose Escalation|Progressive disease per RECIST|0|||
23633085|NCT01475461|66042061|FG002|Treatment Period|Medication Error|0|||
23633086|NCT01475461|66042062|FG003|Treatment Period|Medication Error|1|||
23633087|NCT01475461|66042063|FG004|Treatment Period|Medication Error|0|||
23633088|NCT01475461|66042064|FG005|Treatment Period|Medication Error|0|||
23771393|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Death|1|||
23832410|NCT02564900|66767665|FG000|Dose Escalation|Ongoing|1|||
23573290|NCT04157686|65827629|FG007|Overall Study|Lack of Efficacy|1|||
23573291|NCT04157686|65827622|FG000|Overall Study|Withdrawal by Subject|10|||
23573292|NCT04157686|65827623|FG001|Overall Study|Withdrawal by Subject|10|||
23573293|NCT04157686|65827624|FG002|Overall Study|Withdrawal by Subject|12|||
23573294|NCT04157686|65827625|FG003|Overall Study|Withdrawal by Subject|20|||
23573295|NCT04157686|65827626|FG004|Overall Study|Withdrawal by Subject|12|||
23573296|NCT04157686|65827627|FG005|Overall Study|Withdrawal by Subject|11|||
23573297|NCT04157686|65827628|FG006|Overall Study|Withdrawal by Subject|18|||
23573298|NCT04157686|65827629|FG007|Overall Study|Withdrawal by Subject|24|||
23573299|NCT04157686|65827622|FG000|Overall Study|Physician Decision|0|||
23573300|NCT04157686|65827623|FG001|Overall Study|Physician Decision|0|||
23573301|NCT04157686|65827624|FG002|Overall Study|Physician Decision|1|||
23573302|NCT04157686|65827625|FG003|Overall Study|Physician Decision|0|||
23573303|NCT04157686|65827626|FG004|Overall Study|Physician Decision|1|||
23573304|NCT04157686|65827627|FG005|Overall Study|Physician Decision|0|||
23573305|NCT04157686|65827628|FG006|Overall Study|Physician Decision|3|||
23573306|NCT04157686|65827629|FG007|Overall Study|Physician Decision|0|||
23573307|NCT04157686|65827622|FG000|Overall Study|Death|0|||
23573308|NCT04157686|65827623|FG001|Overall Study|Death|0|||
23573309|NCT04157686|65827624|FG002|Overall Study|Death|0|||
23573310|NCT04157686|65827625|FG003|Overall Study|Death|2|||
23573311|NCT04157686|65827626|FG004|Overall Study|Death|0|||
23573312|NCT04157686|65827627|FG005|Overall Study|Death|0|||
23573313|NCT04157686|65827628|FG006|Overall Study|Death|0|||
23573314|NCT04157686|65827629|FG007|Overall Study|Death|0|||
23573315|NCT04157686|65827622|FG000|Overall Study|Protocol Violation|0|||
23573316|NCT04157686|65827623|FG001|Overall Study|Protocol Violation|0|||
23573317|NCT04157686|65827624|FG002|Overall Study|Protocol Violation|0|||
23573318|NCT04157686|65827625|FG003|Overall Study|Protocol Violation|0|||
23573319|NCT04157686|65827626|FG004|Overall Study|Protocol Violation|1|||
23573320|NCT04157686|65827627|FG005|Overall Study|Protocol Violation|0|||
23573321|NCT04157686|65827628|FG006|Overall Study|Protocol Violation|0|||
23573322|NCT04157686|65827629|FG007|Overall Study|Protocol Violation|0|||
23573323|NCT04157686|65827622|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
23832411|NCT02564900|66767666|FG001|Dose Escalation|Ongoing|0|||
23832412|NCT02564900|66767667|FG002|Dose Escalation|Ongoing|0|||
23832413|NCT02564900|66767668|FG003|Dose Escalation|Ongoing|2|||
23832414|NCT02564900|66767669|FG004|Dose Escalation|Ongoing|2|||
23832415|NCT02564900|66767670|FG005|Dose Escalation|Ongoing|2|||
23832416|NCT02564900|66767671|FG006|Dose Escalation|Ongoing|0|||
23832417|NCT02564900|66767672|FG007|Dose Escalation|Ongoing|0|||
23832418|NCT02564900|66767673|FG008|Dose Escalation|Ongoing|0|||
23832419|NCT02564900|66767674|FG009|Dose Escalation|Ongoing|0|||
23832420|NCT02564900|66767675|FG010|Dose Escalation|Ongoing|0|||
23573324|NCT04157686|65827623|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
23573325|NCT04157686|65827624|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
23573326|NCT04157686|65827625|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
23573327|NCT04157686|65827626|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
23573328|NCT04157686|65827627|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
23573329|NCT04157686|65827628|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
23573330|NCT04157686|65827629|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
23573331|NCT01865617|65827630|FG000|Overall Study|Death|27|||
23832421|NCT02564900|66767676|FG011|Dose Escalation|Ongoing|0|||
23633089|NCT01475461|66042065|FG006|Treatment Period|Medication Error|0|||
23573332|NCT01865617|65827631|FG001|Overall Study|Death|3|||
23573333|NCT01865617|65827632|FG002|Overall Study|Death|1|||
23573334|NCT01865617|65827633|FG003|Overall Study|Death|1|||
23573335|NCT01865617|65827634|FG004|Overall Study|Death|5|||
23573336|NCT01865617|65827635|FG005|Overall Study|Death|1|||
23573337|NCT01865617|65827636|FG006|Overall Study|Death|11|||
23573338|NCT01865617|65827637|FG007|Overall Study|Death|1|||
23573339|NCT01865617|65827638|FG008|Overall Study|Death|11|||
23573340|NCT01865617|65827639|FG009|Overall Study|Death|3|||
23573341|NCT01865617|65827640|FG010|Overall Study|Death|32|||
23573342|NCT01865617|65827641|FG011|Overall Study|Death|6|||
23573343|NCT01865617|65827642|FG012|Overall Study|Death|13|||
23573344|NCT01865617|65827630|FG000|Overall Study|Lost to Follow-up|2|||
23573345|NCT01865617|65827631|FG001|Overall Study|Lost to Follow-up|0|||
23573346|NCT01865617|65827632|FG002|Overall Study|Lost to Follow-up|0|||
23573347|NCT01865617|65827633|FG003|Overall Study|Lost to Follow-up|0|||
23573348|NCT01865617|65827634|FG004|Overall Study|Lost to Follow-up|0|||
23573349|NCT01865617|65827635|FG005|Overall Study|Lost to Follow-up|0|||
23573350|NCT01865617|65827636|FG006|Overall Study|Lost to Follow-up|0|||
23573351|NCT01865617|65827637|FG007|Overall Study|Lost to Follow-up|0|||
23573352|NCT01865617|65827638|FG008|Overall Study|Lost to Follow-up|0|||
23573353|NCT01865617|65827639|FG009|Overall Study|Lost to Follow-up|0|||
23573354|NCT01865617|65827640|FG010|Overall Study|Lost to Follow-up|0|||
23573355|NCT01865617|65827641|FG011|Overall Study|Lost to Follow-up|0|||
23573356|NCT01865617|65827642|FG012|Overall Study|Lost to Follow-up|0|||
23573357|NCT01865617|65827630|FG000|Overall Study|Withdrawal by Subject|1|||
23573358|NCT01865617|65827631|FG001|Overall Study|Withdrawal by Subject|0|||
23573359|NCT01865617|65827632|FG002|Overall Study|Withdrawal by Subject|0|||
23573360|NCT01865617|65827633|FG003|Overall Study|Withdrawal by Subject|0|||
23573361|NCT01865617|65827634|FG004|Overall Study|Withdrawal by Subject|0|||
23573362|NCT01865617|65827635|FG005|Overall Study|Withdrawal by Subject|0|||
23573363|NCT01865617|65827636|FG006|Overall Study|Withdrawal by Subject|0|||
23573364|NCT01865617|65827637|FG007|Overall Study|Withdrawal by Subject|0|||
23573365|NCT01865617|65827638|FG008|Overall Study|Withdrawal by Subject|0|||
23573366|NCT01865617|65827639|FG009|Overall Study|Withdrawal by Subject|0|||
23573367|NCT01865617|65827640|FG010|Overall Study|Withdrawal by Subject|0|||
23573368|NCT01865617|65827641|FG011|Overall Study|Withdrawal by Subject|0|||
23573369|NCT01865617|65827642|FG012|Overall Study|Withdrawal by Subject|0|||
23573370|NCT01865617|65827630|FG000|Overall Study|Patient proceeded to new therapy|0|||
23573371|NCT01865617|65827631|FG001|Overall Study|Patient proceeded to new therapy|0|||
23573372|NCT01865617|65827632|FG002|Overall Study|Patient proceeded to new therapy|0|||
23573373|NCT01865617|65827633|FG003|Overall Study|Patient proceeded to new therapy|0|||
23573374|NCT01865617|65827634|FG004|Overall Study|Patient proceeded to new therapy|2|||
23573375|NCT01865617|65827635|FG005|Overall Study|Patient proceeded to new therapy|0|||
23573376|NCT01865617|65827636|FG006|Overall Study|Patient proceeded to new therapy|0|||
23573377|NCT01865617|65827637|FG007|Overall Study|Patient proceeded to new therapy|0|||
23573378|NCT01865617|65827638|FG008|Overall Study|Patient proceeded to new therapy|0|||
23573379|NCT01865617|65827639|FG009|Overall Study|Patient proceeded to new therapy|0|||
23573380|NCT01865617|65827640|FG010|Overall Study|Patient proceeded to new therapy|0|||
23573381|NCT01865617|65827641|FG011|Overall Study|Patient proceeded to new therapy|0|||
23573382|NCT01865617|65827642|FG012|Overall Study|Patient proceeded to new therapy|0|||
23573383|NCT01865617|65827630|FG000|Overall Study|Other|0|||
23573384|NCT01865617|65827631|FG001|Overall Study|Other|0|||
23573385|NCT01865617|65827632|FG002|Overall Study|Other|0|||
23573386|NCT01865617|65827633|FG003|Overall Study|Other|0|||
23573387|NCT01865617|65827634|FG004|Overall Study|Other|0|||
23573388|NCT01865617|65827635|FG005|Overall Study|Other|0|||
23573389|NCT01865617|65827636|FG006|Overall Study|Other|1|||
23573390|NCT01865617|65827637|FG007|Overall Study|Other|0|||
23573391|NCT01865617|65827638|FG008|Overall Study|Other|0|||
23573392|NCT01865617|65827639|FG009|Overall Study|Other|0|||
23573393|NCT01865617|65827640|FG010|Overall Study|Other|0|||
23573394|NCT01865617|65827641|FG011|Overall Study|Other|0|||
23573395|NCT01865617|65827642|FG012|Overall Study|Other|0|||
23573396|NCT03249376|65827643|FG000|Overall Study|Adverse Event|11|||
23573397|NCT03249376|65827644|FG001|Overall Study|Adverse Event|5|||
23573398|NCT03249376|65827643|FG000|Overall Study|Lack of Efficacy|2|||
23633090|NCT01475461|66042059|FG000|Treatment Period|Adverse Event|0|||
23633091|NCT01475461|66042060|FG001|Treatment Period|Adverse Event|0|||
23573399|NCT03249376|65827644|FG001|Overall Study|Lack of Efficacy|4|||
23573400|NCT03249376|65827643|FG000|Overall Study|Protocol Violation|3|||
23573401|NCT03249376|65827644|FG001|Overall Study|Protocol Violation|2|||
23573402|NCT03249376|65827643|FG000|Overall Study|Physician Decision|0|||
23573403|NCT03249376|65827644|FG001|Overall Study|Physician Decision|2|||
23573404|NCT03249376|65827643|FG000|Overall Study|Withdrawal by Subject|3|||
23573405|NCT03249376|65827644|FG001|Overall Study|Withdrawal by Subject|9|||
23573406|NCT03249376|65827643|FG000|Overall Study|LTFU|2|||
23573407|NCT03249376|65827644|FG001|Overall Study|LTFU|1|||
23573408|NCT02291289|65827647|FG000|Induction Treatment|Withdrawal by Subject|0|||
23633092|NCT01475461|66042061|FG002|Treatment Period|Adverse Event|0|||
23573409|NCT02291289|65827648|FG001|Induction Treatment|Withdrawal by Subject|0|||
23573410|NCT02291289|65827649|FG002|Induction Treatment|Withdrawal by Subject|0|||
23573411|NCT02291289|65827650|FG003|Induction Treatment|Withdrawal by Subject|24|||
23573412|NCT02291289|65827651|FG004|Induction Treatment|Withdrawal by Subject|0|||
23573413|NCT02291289|65827652|FG005|Induction Treatment|Withdrawal by Subject|0|||
23573414|NCT02291289|65827653|FG006|Induction Treatment|Withdrawal by Subject|0|||
23573415|NCT02291289|65827654|FG007|Induction Treatment|Withdrawal by Subject|0|||
23573416|NCT02291289|65827655|FG008|Induction Treatment|Withdrawal by Subject|0|||
23573417|NCT02291289|65827656|FG009|Induction Treatment|Withdrawal by Subject|18|||
23573418|NCT02291289|65827657|FG010|Induction Treatment|Withdrawal by Subject|0|||
23573419|NCT02291289|65827658|FG011|Induction Treatment|Withdrawal by Subject|0|||
23573420|NCT02291289|65827659|FG012|Induction Treatment|Withdrawal by Subject|0|||
23573421|NCT02291289|65827647|FG000|Induction Treatment|Adverse Event|0|||
23573422|NCT02291289|65827648|FG001|Induction Treatment|Adverse Event|0|||
23573423|NCT02291289|65827649|FG002|Induction Treatment|Adverse Event|0|||
23573424|NCT02291289|65827650|FG003|Induction Treatment|Adverse Event|3|||
23573425|NCT02291289|65827651|FG004|Induction Treatment|Adverse Event|0|||
23573426|NCT02291289|65827652|FG005|Induction Treatment|Adverse Event|0|||
23573427|NCT02291289|65827653|FG006|Induction Treatment|Adverse Event|0|||
23573428|NCT02291289|65827654|FG007|Induction Treatment|Adverse Event|0|||
23573429|NCT02291289|65827655|FG008|Induction Treatment|Adverse Event|0|||
23573430|NCT02291289|65827656|FG009|Induction Treatment|Adverse Event|1|||
23573431|NCT02291289|65827657|FG010|Induction Treatment|Adverse Event|0|||
23573432|NCT02291289|65827658|FG011|Induction Treatment|Adverse Event|0|||
23573433|NCT02291289|65827659|FG012|Induction Treatment|Adverse Event|0|||
23573434|NCT02291289|65827647|FG000|Induction Treatment|Death|25|||
23573435|NCT02291289|65827648|FG001|Induction Treatment|Death|0|||
23573436|NCT02291289|65827649|FG002|Induction Treatment|Death|0|||
23573437|NCT02291289|65827650|FG003|Induction Treatment|Death|111|||
23573438|NCT02291289|65827651|FG004|Induction Treatment|Death|0|||
23573439|NCT02291289|65827652|FG005|Induction Treatment|Death|0|||
23573440|NCT02291289|65827653|FG006|Induction Treatment|Death|1|||
23573441|NCT02291289|65827654|FG007|Induction Treatment|Death|0|||
23573442|NCT02291289|65827655|FG008|Induction Treatment|Death|0|||
23573443|NCT02291289|65827656|FG009|Induction Treatment|Death|82|||
23573444|NCT02291289|65827657|FG010|Induction Treatment|Death|0|||
23573445|NCT02291289|65827658|FG011|Induction Treatment|Death|0|||
23573446|NCT02291289|65827659|FG012|Induction Treatment|Death|0|||
23573447|NCT02291289|65827647|FG000|Induction Treatment|Lost to Follow-up|1|||
23573448|NCT02291289|65827648|FG001|Induction Treatment|Lost to Follow-up|0|||
23573449|NCT02291289|65827649|FG002|Induction Treatment|Lost to Follow-up|0|||
23573450|NCT02291289|65827650|FG003|Induction Treatment|Lost to Follow-up|12|||
23573451|NCT02291289|65827651|FG004|Induction Treatment|Lost to Follow-up|0|||
23573452|NCT02291289|65827652|FG005|Induction Treatment|Lost to Follow-up|0|||
23573453|NCT02291289|65827653|FG006|Induction Treatment|Lost to Follow-up|0|||
23573454|NCT02291289|65827654|FG007|Induction Treatment|Lost to Follow-up|0|||
23573455|NCT02291289|65827655|FG008|Induction Treatment|Lost to Follow-up|0|||
23573456|NCT02291289|65827656|FG009|Induction Treatment|Lost to Follow-up|9|||
23573457|NCT02291289|65827657|FG010|Induction Treatment|Lost to Follow-up|0|||
23573458|NCT02291289|65827658|FG011|Induction Treatment|Lost to Follow-up|0|||
23573459|NCT02291289|65827659|FG012|Induction Treatment|Lost to Follow-up|0|||
23573460|NCT02291289|65827647|FG000|Induction Treatment|Non-Compliance|0|||
23573461|NCT02291289|65827648|FG001|Induction Treatment|Non-Compliance|0|||
23573462|NCT02291289|65827649|FG002|Induction Treatment|Non-Compliance|0|||
23573463|NCT02291289|65827650|FG003|Induction Treatment|Non-Compliance|1|||
23573464|NCT02291289|65827651|FG004|Induction Treatment|Non-Compliance|0|||
23573465|NCT02291289|65827652|FG005|Induction Treatment|Non-Compliance|0|||
23573466|NCT02291289|65827653|FG006|Induction Treatment|Non-Compliance|0|||
23573467|NCT02291289|65827654|FG007|Induction Treatment|Non-Compliance|0|||
23573468|NCT02291289|65827655|FG008|Induction Treatment|Non-Compliance|0|||
23573469|NCT02291289|65827656|FG009|Induction Treatment|Non-Compliance|1|||
23573470|NCT02291289|65827657|FG010|Induction Treatment|Non-Compliance|0|||
23573471|NCT02291289|65827658|FG011|Induction Treatment|Non-Compliance|0|||
23573472|NCT02291289|65827659|FG012|Induction Treatment|Non-Compliance|0|||
23573473|NCT02291289|65827647|FG000|Induction Treatment|Reason Not Specified|0|||
23573474|NCT02291289|65827648|FG001|Induction Treatment|Reason Not Specified|0|||
23573475|NCT02291289|65827649|FG002|Induction Treatment|Reason Not Specified|0|||
23573476|NCT02291289|65827650|FG003|Induction Treatment|Reason Not Specified|4|||
23573477|NCT02291289|65827651|FG004|Induction Treatment|Reason Not Specified|0|||
23573478|NCT02291289|65827652|FG005|Induction Treatment|Reason Not Specified|0|||
23573479|NCT02291289|65827653|FG006|Induction Treatment|Reason Not Specified|0|||
23573480|NCT02291289|65827654|FG007|Induction Treatment|Reason Not Specified|0|||
23573481|NCT02291289|65827655|FG008|Induction Treatment|Reason Not Specified|0|||
23573482|NCT02291289|65827656|FG009|Induction Treatment|Reason Not Specified|7|||
23573483|NCT02291289|65827657|FG010|Induction Treatment|Reason Not Specified|0|||
23573484|NCT02291289|65827658|FG011|Induction Treatment|Reason Not Specified|0|||
23573485|NCT02291289|65827659|FG012|Induction Treatment|Reason Not Specified|0|||
23573486|NCT02291289|65827647|FG000|Induction Treatment|Physician Decision|0|||
23573487|NCT02291289|65827648|FG001|Induction Treatment|Physician Decision|0|||
23573488|NCT02291289|65827649|FG002|Induction Treatment|Physician Decision|0|||
23573489|NCT02291289|65827650|FG003|Induction Treatment|Physician Decision|3|||
23573490|NCT02291289|65827651|FG004|Induction Treatment|Physician Decision|0|||
23573491|NCT02291289|65827652|FG005|Induction Treatment|Physician Decision|0|||
23573492|NCT02291289|65827653|FG006|Induction Treatment|Physician Decision|0|||
23573493|NCT02291289|65827654|FG007|Induction Treatment|Physician Decision|0|||
23633093|NCT01475461|66042062|FG003|Treatment Period|Adverse Event|1|||
23633094|NCT01475461|66042063|FG004|Treatment Period|Adverse Event|0|||
23633095|NCT01475461|66042064|FG005|Treatment Period|Adverse Event|0|||
23633096|NCT01475461|66042065|FG006|Treatment Period|Adverse Event|0|||
23633097|NCT00609947|66042066|FG000|Overall Study|Death|1|||
23771394|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Death|1|||
23771395|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Death|0|||
23573494|NCT02291289|65827655|FG008|Induction Treatment|Physician Decision|0|||
23573495|NCT02291289|65827656|FG009|Induction Treatment|Physician Decision|1|||
23573496|NCT02291289|65827657|FG010|Induction Treatment|Physician Decision|0|||
23573497|NCT02291289|65827658|FG011|Induction Treatment|Physician Decision|0|||
23573498|NCT02291289|65827659|FG012|Induction Treatment|Physician Decision|0|||
23573499|NCT02291289|65827647|FG000|Induction Treatment|Protocol Violation|0|||
23573500|NCT02291289|65827648|FG001|Induction Treatment|Protocol Violation|0|||
23573501|NCT02291289|65827649|FG002|Induction Treatment|Protocol Violation|0|||
23573502|NCT02291289|65827650|FG003|Induction Treatment|Protocol Violation|3|||
23573503|NCT02291289|65827651|FG004|Induction Treatment|Protocol Violation|0|||
23573504|NCT02291289|65827652|FG005|Induction Treatment|Protocol Violation|0|||
23573505|NCT02291289|65827653|FG006|Induction Treatment|Protocol Violation|0|||
23573506|NCT02291289|65827654|FG007|Induction Treatment|Protocol Violation|0|||
23573507|NCT02291289|65827655|FG008|Induction Treatment|Protocol Violation|0|||
23573508|NCT02291289|65827656|FG009|Induction Treatment|Protocol Violation|2|||
23573509|NCT02291289|65827657|FG010|Induction Treatment|Protocol Violation|0|||
23573510|NCT02291289|65827658|FG011|Induction Treatment|Protocol Violation|0|||
23573511|NCT02291289|65827659|FG012|Induction Treatment|Protocol Violation|0|||
23573512|NCT02291289|65827647|FG000|Induction Treatment|Missing|4|||
23573513|NCT02291289|65827648|FG001|Induction Treatment|Missing|0|||
23573514|NCT02291289|65827649|FG002|Induction Treatment|Missing|0|||
23573515|NCT02291289|65827650|FG003|Induction Treatment|Missing|14|||
23573516|NCT02291289|65827651|FG004|Induction Treatment|Missing|0|||
23573517|NCT02291289|65827652|FG005|Induction Treatment|Missing|0|||
23573518|NCT02291289|65827653|FG006|Induction Treatment|Missing|0|||
23573519|NCT02291289|65827654|FG007|Induction Treatment|Missing|0|||
23573520|NCT02291289|65827655|FG008|Induction Treatment|Missing|0|||
23573521|NCT02291289|65827656|FG009|Induction Treatment|Missing|54|||
23573522|NCT02291289|65827657|FG010|Induction Treatment|Missing|0|||
23573523|NCT02291289|65827658|FG011|Induction Treatment|Missing|0|||
23573524|NCT02291289|65827659|FG012|Induction Treatment|Missing|0|||
23573525|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573526|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573527|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573528|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573529|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
23573530|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
23573531|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573532|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573533|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573534|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573535|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
23573536|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
23573537|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573538|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Death|0|||
23573539|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Death|29|||
23573540|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Death|16|||
23573541|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Death|0|||
23573542|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Death|188|||
23573543|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Death|107|||
23573544|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Death|0|||
23573545|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Death|1|||
23573546|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Death|1|||
23573547|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Death|0|||
23573548|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Death|46|||
23573549|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Death|19|||
23573550|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Death|0|||
23573551|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23573552|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Adverse Event|0|||
23573553|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Adverse Event|0|||
23573554|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Adverse Event|0|||
23633098|NCT01730378|66042067|FG000|Overall Study|Lost to Follow-up|1|||
23633099|NCT01730378|66042068|FG001|Overall Study|Lost to Follow-up|0|||
23573555|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Adverse Event|1|||
23573556|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Adverse Event|1|||
23573557|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Adverse Event|0|||
23573558|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Adverse Event|0|||
23573559|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Adverse Event|0|||
23573560|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Adverse Event|0|||
23633100|NCT01825577|66042069|FG000|Overall Study|Physician Decision|2|||
23633101|NCT01825577|66042069|FG000|Overall Study|Withdrawal by Subject|1|||
23633102|NCT01825577|66042069|FG000|Overall Study|Withdrawn by family members|2|||
23633103|NCT01825577|66042069|FG000|Overall Study|Lack of Efficacy|3|||
23832422|NCT02564900|66767677|FG012|Dose Escalation|Ongoing|0|||
23832423|NCT02564900|66767678|FG013|Dose Escalation|Ongoing|0|||
23832424|NCT02564900|66767679|FG014|Dose Escalation|Ongoing|0|||
23633104|NCT04707664|66042072|FG000|Overall Study|Adverse Event|2|||
23633105|NCT04707664|66042073|FG001|Overall Study|Adverse Event|0|||
23633106|NCT04707664|66042072|FG000|Overall Study|Death|1|||
23633107|NCT04707664|66042073|FG001|Overall Study|Death|2|||
23633108|NCT04707664|66042072|FG000|Overall Study|Withdrawal by Subject|13|||
23633109|NCT04707664|66042073|FG001|Overall Study|Withdrawal by Subject|21|||
23633110|NCT04707664|66042072|FG000|Overall Study|Lost to Follow-up|11|||
23633111|NCT04707664|66042073|FG001|Overall Study|Lost to Follow-up|13|||
23633112|NCT04707664|66042072|FG000|Overall Study|Not treated|2|||
23633113|NCT04707664|66042073|FG001|Overall Study|Not treated|0|||
23633114|NCT02807272|66042076|FG000|Overall Study|Death|9|||
23633115|NCT02807272|66042077|FG001|Overall Study|Death|5|||
23633116|NCT02807272|66042078|FG002|Overall Study|Death|2|||
23832425|NCT02564900|66767665|FG000|Dose Escalation|Adverse Event|0|||
23832426|NCT02564900|66767666|FG001|Dose Escalation|Adverse Event|0|||
23832427|NCT02564900|66767667|FG002|Dose Escalation|Adverse Event|0|||
23832428|NCT02564900|66767668|FG003|Dose Escalation|Adverse Event|1|||
23832429|NCT02564900|66767669|FG004|Dose Escalation|Adverse Event|1|||
23832430|NCT02564900|66767670|FG005|Dose Escalation|Adverse Event|3|||
23832431|NCT02564900|66767671|FG006|Dose Escalation|Adverse Event|0|||
23832432|NCT02564900|66767672|FG007|Dose Escalation|Adverse Event|0|||
23832433|NCT02564900|66767673|FG008|Dose Escalation|Adverse Event|0|||
23832434|NCT02564900|66767674|FG009|Dose Escalation|Adverse Event|0|||
23832435|NCT02564900|66767675|FG010|Dose Escalation|Adverse Event|0|||
23832436|NCT02564900|66767676|FG011|Dose Escalation|Adverse Event|0|||
23832437|NCT02564900|66767677|FG012|Dose Escalation|Adverse Event|0|||
23832438|NCT02564900|66767678|FG013|Dose Escalation|Adverse Event|0|||
23832439|NCT02564900|66767679|FG014|Dose Escalation|Adverse Event|0|||
23832440|NCT02564900|66767665|FG000|Dose Expansion|Progressive disease per RECIST|0|||
23832441|NCT02564900|66767666|FG001|Dose Expansion|Progressive disease per RECIST|0|||
23832442|NCT02564900|66767667|FG002|Dose Expansion|Progressive disease per RECIST|0|||
23832443|NCT02564900|66767668|FG003|Dose Expansion|Progressive disease per RECIST|0|||
23832444|NCT02564900|66767669|FG004|Dose Expansion|Progressive disease per RECIST|0|||
23832445|NCT02564900|66767670|FG005|Dose Expansion|Progressive disease per RECIST|0|||
23832446|NCT02564900|66767671|FG006|Dose Expansion|Progressive disease per RECIST|19|||
23832447|NCT02564900|66767672|FG007|Dose Expansion|Progressive disease per RECIST|17|||
23832448|NCT02564900|66767673|FG008|Dose Expansion|Progressive disease per RECIST|8|||
23832449|NCT02564900|66767674|FG009|Dose Expansion|Progressive disease per RECIST|16|||
23832450|NCT02564900|66767675|FG010|Dose Expansion|Progressive disease per RECIST|13|||
23832451|NCT02564900|66767676|FG011|Dose Expansion|Progressive disease per RECIST|19|||
23573561|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Adverse Event|0|||
23573562|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Adverse Event|0|||
23573563|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Adverse Event|0|||
23573564|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573565|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
23573566|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573567|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573568|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
23573569|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
23633117|NCT02807272|66042079|FG003|Overall Study|Death|0|||
23832452|NCT02564900|66767677|FG012|Dose Expansion|Progressive disease per RECIST|10|||
23832453|NCT02564900|66767678|FG013|Dose Expansion|Progressive disease per RECIST|13|||
23832454|NCT02564900|66767679|FG014|Dose Expansion|Progressive disease per RECIST|11|||
23832455|NCT02564900|66767665|FG000|Dose Expansion|Clinical progression|0|||
23832456|NCT02564900|66767666|FG001|Dose Expansion|Clinical progression|0|||
23832457|NCT02564900|66767667|FG002|Dose Expansion|Clinical progression|0|||
23573570|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573571|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
23573572|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
23633118|NCT02807272|66042080|FG004|Overall Study|Death|1|||
23633119|NCT02807272|66042076|FG000|Overall Study|Lost to Follow-up|1|||
23633120|NCT02807272|66042077|FG001|Overall Study|Lost to Follow-up|0|||
23633121|NCT02807272|66042078|FG002|Overall Study|Lost to Follow-up|0|||
23633122|NCT02807272|66042079|FG003|Overall Study|Lost to Follow-up|0|||
23832458|NCT02564900|66767668|FG003|Dose Expansion|Clinical progression|0|||
23832459|NCT02564900|66767669|FG004|Dose Expansion|Clinical progression|0|||
23832460|NCT02564900|66767670|FG005|Dose Expansion|Clinical progression|0|||
23832461|NCT02564900|66767671|FG006|Dose Expansion|Clinical progression|5|||
23832462|NCT02564900|66767672|FG007|Dose Expansion|Clinical progression|12|||
23832463|NCT02564900|66767673|FG008|Dose Expansion|Clinical progression|0|||
23832464|NCT02564900|66767674|FG009|Dose Expansion|Clinical progression|3|||
23832465|NCT02564900|66767675|FG010|Dose Expansion|Clinical progression|2|||
23832466|NCT02564900|66767676|FG011|Dose Expansion|Clinical progression|0|||
23832467|NCT02564900|66767677|FG012|Dose Expansion|Clinical progression|1|||
23832468|NCT02564900|66767678|FG013|Dose Expansion|Clinical progression|3|||
23832469|NCT02564900|66767679|FG014|Dose Expansion|Clinical progression|1|||
23832470|NCT02564900|66767665|FG000|Dose Expansion|Adverse Event|0|||
23832471|NCT02564900|66767666|FG001|Dose Expansion|Adverse Event|0|||
23832472|NCT02564900|66767667|FG002|Dose Expansion|Adverse Event|0|||
23633123|NCT02807272|66042080|FG004|Overall Study|Lost to Follow-up|0|||
23633124|NCT02807272|66042076|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
23633125|NCT02807272|66042077|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
23633126|NCT02807272|66042078|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
23633127|NCT02807272|66042079|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
23633128|NCT02807272|66042080|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
23633129|NCT02807272|66042076|FG000|Overall Study|Protocol-defined Disease Progression|0|||
23633130|NCT02807272|66042077|FG001|Overall Study|Protocol-defined Disease Progression|1|||
23633131|NCT02807272|66042078|FG002|Overall Study|Protocol-defined Disease Progression|0|||
23633132|NCT02807272|66042079|FG003|Overall Study|Protocol-defined Disease Progression|0|||
23633133|NCT02807272|66042080|FG004|Overall Study|Protocol-defined Disease Progression|1|||
23633134|NCT02807272|66042076|FG000|Overall Study|Study Terminated by Sponsor|1|||
23633135|NCT02807272|66042077|FG001|Overall Study|Study Terminated by Sponsor|0|||
23633136|NCT02807272|66042078|FG002|Overall Study|Study Terminated by Sponsor|0|||
23633137|NCT02807272|66042079|FG003|Overall Study|Study Terminated by Sponsor|1|||
23633138|NCT02807272|66042080|FG004|Overall Study|Study Terminated by Sponsor|0|||
23832473|NCT02564900|66767668|FG003|Dose Expansion|Adverse Event|0|||
23832474|NCT02564900|66767669|FG004|Dose Expansion|Adverse Event|0|||
23832475|NCT02564900|66767670|FG005|Dose Expansion|Adverse Event|0|||
23832476|NCT02564900|66767671|FG006|Dose Expansion|Adverse Event|9|||
23573573|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573574|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
23573575|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
23573576|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573577|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
23573578|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
23573579|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
23573580|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
23573581|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
23573582|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
23573583|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
23573584|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
23573585|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
23573586|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
23573587|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
23573588|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
23573589|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
23573590|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Physician Decision|0|||
23573591|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Physician Decision|2|||
23573592|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Physician Decision|0|||
23573593|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Physician Decision|0|||
23573594|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Physician Decision|3|||
23573595|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Physician Decision|0|||
23573596|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Physician Decision|0|||
23573597|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Physician Decision|0|||
23633139|NCT02807272|66042076|FG000|Overall Study|Other|1|||
23832477|NCT02564900|66767672|FG007|Dose Expansion|Adverse Event|22|||
23832478|NCT02564900|66767673|FG008|Dose Expansion|Adverse Event|0|||
23832479|NCT02564900|66767674|FG009|Dose Expansion|Adverse Event|11|||
23832480|NCT02564900|66767675|FG010|Dose Expansion|Adverse Event|0|||
23832481|NCT02564900|66767676|FG011|Dose Expansion|Adverse Event|5|||
23832482|NCT02564900|66767677|FG012|Dose Expansion|Adverse Event|2|||
23832483|NCT02564900|66767678|FG013|Dose Expansion|Adverse Event|2|||
23573598|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Physician Decision|0|||
23573599|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Physician Decision|0|||
23573600|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Physician Decision|1|||
23633140|NCT02807272|66042077|FG001|Overall Study|Other|0|||
23832484|NCT02564900|66767679|FG014|Dose Expansion|Adverse Event|1|||
23832485|NCT02564900|66767665|FG000|Dose Expansion|Ongoing|0|||
23633141|NCT02807272|66042078|FG002|Overall Study|Other|0|||
23633142|NCT02807272|66042079|FG003|Overall Study|Other|0|||
23633143|NCT02807272|66042080|FG004|Overall Study|Other|1|||
23633144|NCT00996606|66042081|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
23633145|NCT00996606|66042081|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23633146|NCT00996606|66042081|FG000|Overall Study|Protocol Violation|1|||
23633147|NCT00996606|66042081|FG000|Overall Study|Withdrawal by Subject|3|||
23633148|NCT01681277|66042083|FG000|Overall Study|Adverse Event|1|||
23633149|NCT01681277|66042084|FG001|Overall Study|Adverse Event|0|||
23633150|NCT01681277|66042085|FG002|Overall Study|Adverse Event|0|||
23633151|NCT01681277|66042086|FG003|Overall Study|Adverse Event|0|||
23633152|NCT01681277|66042087|FG004|Overall Study|Adverse Event|0|||
23633153|NCT01252355|66042094|FG000|Overall Study|Adverse Event|9|||
23633154|NCT01252355|66042095|FG001|Overall Study|Adverse Event|17|||
23633155|NCT01252355|66042096|FG002|Overall Study|Adverse Event|22|||
23633156|NCT01252355|66042094|FG000|Overall Study|Lack of Efficacy|6|||
23633157|NCT01252355|66042095|FG001|Overall Study|Lack of Efficacy|4|||
23633158|NCT01252355|66042096|FG002|Overall Study|Lack of Efficacy|2|||
23633159|NCT01252355|66042094|FG000|Overall Study|Lost to Follow-up|0|||
23633160|NCT01252355|66042095|FG001|Overall Study|Lost to Follow-up|0|||
23633161|NCT01252355|66042096|FG002|Overall Study|Lost to Follow-up|1|||
23633162|NCT01252355|66042094|FG000|Overall Study|Poor Compliance to Protocol|1|||
23633163|NCT01252355|66042095|FG001|Overall Study|Poor Compliance to Protocol|1|||
23633164|NCT01252355|66042096|FG002|Overall Study|Poor Compliance to Protocol|1|||
23633165|NCT01252355|66042094|FG000|Overall Study|Progressive Disease|2|||
23633166|NCT01252355|66042095|FG001|Overall Study|Progressive Disease|0|||
23633167|NCT01252355|66042096|FG002|Overall Study|Progressive Disease|0|||
23633168|NCT01252355|66042094|FG000|Overall Study|Sponsor Early Termination of Study|149|||
23633169|NCT01252355|66042095|FG001|Overall Study|Sponsor Early Termination of Study|149|||
23633170|NCT01252355|66042096|FG002|Overall Study|Sponsor Early Termination of Study|146|||
23633171|NCT01252355|66042094|FG000|Overall Study|Randomized but not Treated|2|||
23633172|NCT01252355|66042095|FG001|Overall Study|Randomized but not Treated|0|||
23633173|NCT01252355|66042096|FG002|Overall Study|Randomized but not Treated|0|||
23633174|NCT01252355|66042094|FG000|Overall Study|Other Than Above|8|||
23633175|NCT01252355|66042095|FG001|Overall Study|Other Than Above|7|||
23633176|NCT01252355|66042096|FG002|Overall Study|Other Than Above|7|||
23633177|NCT03023722|66042109|FG000|Overall Study|No follow-up assessment|4|||
23633178|NCT00547534|66042113|FG000|Overall Study|Adverse Event|7|||
23633179|NCT00547534|66042113|FG000|Overall Study|Disease Progression|4|||
23771396|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
23771397|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
23771398|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
23771399|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
23771400|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
23771401|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
23771402|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
23771403|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
23771404|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
23832486|NCT02564900|66767666|FG001|Dose Expansion|Ongoing|0|||
23633204|NCT01254747|66042120|FG000|Overall Study|Unacceptable subjective vision|0|||
23633205|NCT01254747|66042121|FG001|Overall Study|Unacceptable subjective vision|0|||
23633206|NCT01254747|66042122|FG002|Overall Study|Unacceptable subjective vision|0|||
23573601|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Physician Decision|3|||
23573602|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Physician Decision|0|||
23573603|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Not Treated|0|||
23573604|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Not Treated|0|||
23573605|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Not Treated|2|||
23573606|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Not Treated|0|||
23573607|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Not Treated|0|||
23573608|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Not Treated|0|||
23633207|NCT01254747|66042123|FG003|Overall Study|Unacceptable subjective vision|2|||
23633208|NCT01254747|66042120|FG000|Overall Study|Difficult removal handling|0|||
23832487|NCT02564900|66767667|FG002|Dose Expansion|Ongoing|0|||
23832488|NCT02564900|66767668|FG003|Dose Expansion|Ongoing|0|||
23832489|NCT02564900|66767669|FG004|Dose Expansion|Ongoing|0|||
23832490|NCT02564900|66767670|FG005|Dose Expansion|Ongoing|0|||
23832491|NCT02564900|66767671|FG006|Dose Expansion|Ongoing|9|||
23832492|NCT02564900|66767672|FG007|Dose Expansion|Ongoing|10|||
23832493|NCT02564900|66767673|FG008|Dose Expansion|Ongoing|11|||
23832494|NCT02564900|66767674|FG009|Dose Expansion|Ongoing|3|||
23832495|NCT02564900|66767675|FG010|Dose Expansion|Ongoing|0|||
23832496|NCT02564900|66767676|FG011|Dose Expansion|Ongoing|0|||
23832497|NCT02564900|66767677|FG012|Dose Expansion|Ongoing|4|||
23832498|NCT02564900|66767678|FG013|Dose Expansion|Ongoing|0|||
23832499|NCT02564900|66767679|FG014|Dose Expansion|Ongoing|6|||
23447271|NCT03109184|65377922|FG001|Overall Study|Withdrawal by Subject|1|||
23633209|NCT01254747|66042121|FG001|Overall Study|Difficult removal handling|0|||
23633210|NCT01254747|66042122|FG002|Overall Study|Difficult removal handling|1|||
23633211|NCT01254747|66042123|FG003|Overall Study|Difficult removal handling|0|||
23633212|NCT01254747|66042120|FG000|Overall Study|Symptoms and problems|0|||
23633213|NCT01254747|66042121|FG001|Overall Study|Symptoms and problems|2|||
23633214|NCT01254747|66042122|FG002|Overall Study|Symptoms and problems|1|||
23633215|NCT01254747|66042123|FG003|Overall Study|Symptoms and problems|0|||
23633216|NCT01254747|66042120|FG000|Overall Study|Lost to Follow-up|0|||
23633217|NCT01254747|66042121|FG001|Overall Study|Lost to Follow-up|0|||
23633218|NCT01254747|66042122|FG002|Overall Study|Lost to Follow-up|1|||
23633219|NCT01254747|66042123|FG003|Overall Study|Lost to Follow-up|0|||
23633220|NCT01254747|66042120|FG000|Overall Study|Biomicroscopy|0|||
23633221|NCT01254747|66042121|FG001|Overall Study|Biomicroscopy|0|||
23633222|NCT01254747|66042122|FG002|Overall Study|Biomicroscopy|1|||
23633223|NCT01254747|66042123|FG003|Overall Study|Biomicroscopy|0|||
23633224|NCT01254747|66042120|FG000|Overall Study|Discomfort|0|||
23633225|NCT01254747|66042121|FG001|Overall Study|Discomfort|4|||
23633226|NCT01254747|66042122|FG002|Overall Study|Discomfort|0|||
23633227|NCT01254747|66042123|FG003|Overall Study|Discomfort|0|||
23633228|NCT01441635|66042125|FG000|Overall Study|Adverse Event|4|||
23633229|NCT01441635|66042126|FG001|Overall Study|Adverse Event|3|||
23633230|NCT01441635|66042127|FG002|Overall Study|Adverse Event|1|||
23633231|NCT01441635|66042128|FG003|Overall Study|Adverse Event|5|||
23633232|NCT01441635|66042129|FG004|Overall Study|Adverse Event|1|||
23633233|NCT01441635|66042130|FG005|Overall Study|Adverse Event|2|||
23633234|NCT01441635|66042131|FG006|Overall Study|Adverse Event|2|||
23633235|NCT01441635|66042132|FG007|Overall Study|Adverse Event|2|||
23633236|NCT01441635|66042133|FG008|Overall Study|Adverse Event|1|||
23633237|NCT01441635|66042134|FG009|Overall Study|Adverse Event|0|||
23633238|NCT01441635|66042125|FG000|Overall Study|Withdrawal by Subject|1|||
23633239|NCT01441635|66042126|FG001|Overall Study|Withdrawal by Subject|1|||
23633240|NCT01441635|66042127|FG002|Overall Study|Withdrawal by Subject|0|||
23633241|NCT01441635|66042128|FG003|Overall Study|Withdrawal by Subject|1|||
23633242|NCT01441635|66042129|FG004|Overall Study|Withdrawal by Subject|0|||
23633243|NCT01441635|66042130|FG005|Overall Study|Withdrawal by Subject|0|||
23633244|NCT01441635|66042131|FG006|Overall Study|Withdrawal by Subject|2|||
23633245|NCT01441635|66042132|FG007|Overall Study|Withdrawal by Subject|0|||
23633246|NCT01441635|66042133|FG008|Overall Study|Withdrawal by Subject|1|||
23832500|NCT02564900|66767665|FG000|Dose Expansion|Death|0|||
23832501|NCT02564900|66767666|FG001|Dose Expansion|Death|0|||
23633247|NCT01441635|66042134|FG009|Overall Study|Withdrawal by Subject|1|||
23832502|NCT02564900|66767667|FG002|Dose Expansion|Death|0|||
23832503|NCT02564900|66767668|FG003|Dose Expansion|Death|0|||
23447272|NCT03920254|65377927|FG000|Overall Study|Adverse Event|1|||
23447273|NCT03920254|65377928|FG001|Overall Study|Adverse Event|0|||
23633248|NCT01441635|66042125|FG000|Overall Study|Lost to Follow-up|0|||
23633249|NCT01441635|66042126|FG001|Overall Study|Lost to Follow-up|1|||
23633250|NCT01441635|66042127|FG002|Overall Study|Lost to Follow-up|1|||
23633251|NCT01441635|66042128|FG003|Overall Study|Lost to Follow-up|1|||
23633252|NCT01441635|66042129|FG004|Overall Study|Lost to Follow-up|1|||
23633253|NCT01441635|66042130|FG005|Overall Study|Lost to Follow-up|3|||
23633254|NCT01441635|66042131|FG006|Overall Study|Lost to Follow-up|1|||
23832504|NCT02564900|66767669|FG004|Dose Expansion|Death|0|||
23832505|NCT02564900|66767670|FG005|Dose Expansion|Death|0|||
23832506|NCT02564900|66767671|FG006|Dose Expansion|Death|1|||
23832507|NCT02564900|66767672|FG007|Dose Expansion|Death|0|||
23832508|NCT02564900|66767673|FG008|Dose Expansion|Death|0|||
23832509|NCT02564900|66767674|FG009|Dose Expansion|Death|0|||
23832510|NCT02564900|66767675|FG010|Dose Expansion|Death|1|||
23832511|NCT02564900|66767676|FG011|Dose Expansion|Death|0|||
23832512|NCT02564900|66767677|FG012|Dose Expansion|Death|1|||
23832513|NCT02564900|66767678|FG013|Dose Expansion|Death|1|||
23832514|NCT02564900|66767679|FG014|Dose Expansion|Death|0|||
23573609|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Not Treated|0|||
23573610|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Not Treated|0|||
23573611|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Not Treated|0|||
23573612|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Not Treated|0|||
23573613|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Not Treated|0|||
23573614|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Not Treated|0|||
23573615|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Not Treated|0|||
23573616|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573617|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
23573618|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573619|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573620|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573621|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573622|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573623|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573624|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573625|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573626|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573627|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573628|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573629|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
23573630|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
23573631|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
23573632|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
23573633|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
23573634|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
23573635|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
23573636|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
23573637|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
23573638|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
23573639|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
23573640|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
23573641|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
23573642|NCT02291289|65827647|FG000|Early Disease Progression|Death|0|||
23573643|NCT02291289|65827648|FG001|Early Disease Progression|Death|0|||
23573644|NCT02291289|65827649|FG002|Early Disease Progression|Death|0|||
23573645|NCT02291289|65827650|FG003|Early Disease Progression|Death|0|||
23573646|NCT02291289|65827651|FG004|Early Disease Progression|Death|0|||
23573647|NCT02291289|65827652|FG005|Early Disease Progression|Death|0|||
23573648|NCT02291289|65827653|FG006|Early Disease Progression|Death|0|||
23573649|NCT02291289|65827654|FG007|Early Disease Progression|Death|0|||
23573650|NCT02291289|65827655|FG008|Early Disease Progression|Death|0|||
23573651|NCT02291289|65827656|FG009|Early Disease Progression|Death|0|||
23573652|NCT02291289|65827657|FG010|Early Disease Progression|Death|0|||
23573653|NCT02291289|65827658|FG011|Early Disease Progression|Death|0|||
23447274|NCT03920254|65377929|FG002|Overall Study|Adverse Event|0|||
23573654|NCT02291289|65827659|FG012|Early Disease Progression|Death|10|||
23573655|NCT02291289|65827647|FG000|Early Disease Progression|Lost to Follow-up|0|||
23573656|NCT02291289|65827648|FG001|Early Disease Progression|Lost to Follow-up|0|||
23573657|NCT02291289|65827649|FG002|Early Disease Progression|Lost to Follow-up|0|||
23573658|NCT02291289|65827650|FG003|Early Disease Progression|Lost to Follow-up|0|||
23832515|NCT02564900|66767665|FG000|Dose Expansion|Withdrawal by Subject|0|||
23832516|NCT02564900|66767666|FG001|Dose Expansion|Withdrawal by Subject|0|||
23633255|NCT01441635|66042132|FG007|Overall Study|Lost to Follow-up|1|||
23633256|NCT01441635|66042133|FG008|Overall Study|Lost to Follow-up|0|||
23633257|NCT01441635|66042134|FG009|Overall Study|Lost to Follow-up|1|||
23633258|NCT01441635|66042125|FG000|Overall Study|Noncompliance|0|||
23633259|NCT01441635|66042126|FG001|Overall Study|Noncompliance|1|||
23633260|NCT01441635|66042127|FG002|Overall Study|Noncompliance|0|||
23633261|NCT01441635|66042128|FG003|Overall Study|Noncompliance|0|||
23633262|NCT01441635|66042129|FG004|Overall Study|Noncompliance|0|||
23633263|NCT01441635|66042130|FG005|Overall Study|Noncompliance|0|||
23633264|NCT01441635|66042131|FG006|Overall Study|Noncompliance|1|||
23633265|NCT01441635|66042132|FG007|Overall Study|Noncompliance|0|||
23832517|NCT02564900|66767667|FG002|Dose Expansion|Withdrawal by Subject|0|||
23832518|NCT02564900|66767668|FG003|Dose Expansion|Withdrawal by Subject|0|||
23832519|NCT02564900|66767669|FG004|Dose Expansion|Withdrawal by Subject|0|||
23832520|NCT02564900|66767670|FG005|Dose Expansion|Withdrawal by Subject|0|||
23832521|NCT02564900|66767671|FG006|Dose Expansion|Withdrawal by Subject|4|||
23832522|NCT02564900|66767672|FG007|Dose Expansion|Withdrawal by Subject|0|||
23832523|NCT02564900|66767673|FG008|Dose Expansion|Withdrawal by Subject|0|||
23832524|NCT02564900|66767674|FG009|Dose Expansion|Withdrawal by Subject|0|||
23832525|NCT02564900|66767675|FG010|Dose Expansion|Withdrawal by Subject|1|||
23832526|NCT02564900|66767676|FG011|Dose Expansion|Withdrawal by Subject|0|||
23832527|NCT02564900|66767677|FG012|Dose Expansion|Withdrawal by Subject|0|||
23832528|NCT02564900|66767678|FG013|Dose Expansion|Withdrawal by Subject|1|||
23832529|NCT02564900|66767679|FG014|Dose Expansion|Withdrawal by Subject|1|||
23832530|NCT02564900|66767665|FG000|Dose Expansion|Other|0|||
23832531|NCT02564900|66767666|FG001|Dose Expansion|Other|0|||
23832532|NCT02564900|66767667|FG002|Dose Expansion|Other|0|||
23832533|NCT02564900|66767668|FG003|Dose Expansion|Other|0|||
23832534|NCT02564900|66767669|FG004|Dose Expansion|Other|0|||
23832535|NCT02564900|66767670|FG005|Dose Expansion|Other|0|||
23832536|NCT02564900|66767671|FG006|Dose Expansion|Other|1|||
23832537|NCT02564900|66767672|FG007|Dose Expansion|Other|0|||
23573659|NCT02291289|65827651|FG004|Early Disease Progression|Lost to Follow-up|0|||
23573660|NCT02291289|65827652|FG005|Early Disease Progression|Lost to Follow-up|0|||
23573661|NCT02291289|65827653|FG006|Early Disease Progression|Lost to Follow-up|0|||
23573662|NCT02291289|65827654|FG007|Early Disease Progression|Lost to Follow-up|0|||
23573663|NCT02291289|65827655|FG008|Early Disease Progression|Lost to Follow-up|0|||
23633266|NCT01441635|66042133|FG008|Overall Study|Noncompliance|0|||
23633267|NCT01441635|66042134|FG009|Overall Study|Noncompliance|0|||
23633268|NCT01441635|66042125|FG000|Overall Study|Surgery or Invasive Intervention|0|||
23633269|NCT01441635|66042126|FG001|Overall Study|Surgery or Invasive Intervention|0|||
23573664|NCT02291289|65827656|FG009|Early Disease Progression|Lost to Follow-up|0|||
23573665|NCT02291289|65827657|FG010|Early Disease Progression|Lost to Follow-up|0|||
23573666|NCT02291289|65827658|FG011|Early Disease Progression|Lost to Follow-up|0|||
23573667|NCT02291289|65827659|FG012|Early Disease Progression|Lost to Follow-up|1|||
23573668|NCT03653416|65827665|FG000|Overall Study|Protocol Violation|6|||
23573669|NCT03653416|65827666|FG001|Overall Study|Protocol Violation|1|||
23573670|NCT00791921|65831433|FG000|Overall Study|Protocol planed|24|||
23573671|NCT00791921|65831434|FG001|Overall Study|Protocol planed|88|||
23573672|NCT00791921|65831433|FG000|Overall Study|Withdrawal by Subject|1|||
23573673|NCT00791921|65831434|FG001|Overall Study|Withdrawal by Subject|2|||
23573674|NCT00791921|65831433|FG000|Overall Study|Adverse Event|8|||
23573675|NCT00791921|65831434|FG001|Overall Study|Adverse Event|2|||
23573676|NCT00791921|65831433|FG000|Overall Study|Lack of Efficacy|0|||
23573677|NCT00791921|65831434|FG001|Overall Study|Lack of Efficacy|2|||
23573678|NCT00791921|65831433|FG000|Overall Study|Lack of study drug administration|1|||
23573679|NCT00791921|65831434|FG001|Overall Study|Lack of study drug administration|1|||
23573680|NCT00791921|65831433|FG000|Overall Study|Reason other than those above|0|||
23573681|NCT00791921|65831434|FG001|Overall Study|Reason other than those above|1|||
23832538|NCT02564900|66767673|FG008|Dose Expansion|Other|1|||
23832539|NCT02564900|66767674|FG009|Dose Expansion|Other|0|||
23447275|NCT03920254|65377927|FG000|Overall Study|Physician Decision|0|||
23573682|NCT01799720|65831439|FG000|Overall Study|Withdrawal by Subject|3|||
23573683|NCT01799720|65831440|FG001|Overall Study|Withdrawal by Subject|0|||
23573684|NCT01799720|65831441|FG002|Overall Study|Withdrawal by Subject|0|||
23573685|NCT01799720|65831439|FG000|Overall Study|Protocol Violation|0|||
23573686|NCT01799720|65831440|FG001|Overall Study|Protocol Violation|1|||
23573687|NCT01799720|65831441|FG002|Overall Study|Protocol Violation|0|||
23633270|NCT01441635|66042127|FG002|Overall Study|Surgery or Invasive Intervention|1|||
23633271|NCT01441635|66042128|FG003|Overall Study|Surgery or Invasive Intervention|0|||
23633272|NCT01441635|66042129|FG004|Overall Study|Surgery or Invasive Intervention|0|||
23633273|NCT01441635|66042130|FG005|Overall Study|Surgery or Invasive Intervention|0|||
23832540|NCT02564900|66767675|FG010|Dose Expansion|Other|0|||
23832541|NCT02564900|66767676|FG011|Dose Expansion|Other|0|||
23832542|NCT02564900|66767677|FG012|Dose Expansion|Other|0|||
23832543|NCT02564900|66767678|FG013|Dose Expansion|Other|0|||
23832544|NCT02564900|66767679|FG014|Dose Expansion|Other|1|||
23832545|NCT02564900|66767665|FG000|Dose Expansion|Did not receive treatment|0|||
23573688|NCT01799720|65831439|FG000|Overall Study|Pregnancy|0|||
23573689|NCT01799720|65831440|FG001|Overall Study|Pregnancy|0|||
23573690|NCT01799720|65831441|FG002|Overall Study|Pregnancy|1|||
23771405|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
23771406|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
23771407|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
23771408|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
23771409|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
23771410|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
23771411|NCT00048568|66543079|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
23771412|NCT00048568|66543080|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
23771413|NCT00048568|66543081|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
23771414|NCT00048568|66543079|FG000|Open-Label Period|Death|0|||
23771415|NCT00048568|66543080|FG001|Open-Label Period|Death|0|||
23771416|NCT00048568|66543081|FG002|Open-Label Period|Death|13|||
23771417|NCT00048568|66543079|FG000|Open-Label Period|Adverse Event|0|||
23771418|NCT00048568|66543080|FG001|Open-Label Period|Adverse Event|0|||
23771419|NCT00048568|66543081|FG002|Open-Label Period|Adverse Event|49|||
23771420|NCT00048568|66543079|FG000|Open-Label Period|Lack of Efficacy|0|||
23771421|NCT00048568|66543080|FG001|Open-Label Period|Lack of Efficacy|0|||
23771422|NCT00048568|66543081|FG002|Open-Label Period|Lack of Efficacy|32|||
23771423|NCT00048568|66543079|FG000|Open-Label Period|Withdrawal by Subject|0|||
23771424|NCT00048568|66543080|FG001|Open-Label Period|Withdrawal by Subject|0|||
23771425|NCT00048568|66543081|FG002|Open-Label Period|Withdrawal by Subject|26|||
23771426|NCT00048568|66543079|FG000|Open-Label Period|Pregnancy|0|||
23771427|NCT00048568|66543080|FG001|Open-Label Period|Pregnancy|0|||
23771428|NCT00048568|66543081|FG002|Open-Label Period|Pregnancy|5|||
23771429|NCT00048568|66543079|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
23771430|NCT00048568|66543080|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
23771431|NCT00048568|66543081|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
23771432|NCT00048568|66543079|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
23771433|NCT00048568|66543080|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
23771434|NCT00048568|66543081|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
23771435|NCT00048568|66543079|FG000|Open-Label Period|Unknown Reasons|0|||
23771436|NCT00048568|66543080|FG001|Open-Label Period|Unknown Reasons|0|||
23771437|NCT00048568|66543081|FG002|Open-Label Period|Unknown Reasons|25|||
23771438|NCT00048568|66543079|FG000|Open-Label Period|Lost to Follow-up|0|||
23771439|NCT00048568|66543080|FG001|Open-Label Period|Lost to Follow-up|0|||
23573691|NCT03056040|65831453|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
23573692|NCT03056040|65831454|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
23573693|NCT03056040|65831453|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
23573694|NCT03056040|65831454|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
23573695|NCT03056040|65831453|FG000|Primary Evaluation Period|Pregnancy|0|||
23573696|NCT03056040|65831454|FG001|Primary Evaluation Period|Pregnancy|1|||
23573697|NCT03056040|65831453|FG000|Extension Period|Physician Decision|3|||
23633274|NCT01441635|66042131|FG006|Overall Study|Surgery or Invasive Intervention|0|||
23633275|NCT01441635|66042132|FG007|Overall Study|Surgery or Invasive Intervention|0|||
23633276|NCT01441635|66042133|FG008|Overall Study|Surgery or Invasive Intervention|0|||
23633277|NCT01441635|66042134|FG009|Overall Study|Surgery or Invasive Intervention|0|||
23771440|NCT00048568|66543081|FG002|Open-Label Period|Lost to Follow-up|7|||
23771441|NCT01004172|66543086|FG000|Overall Study|Progressive Disease in CNS Only|16|||
23771442|NCT01004172|66543086|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
23771443|NCT01004172|66543086|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
23771444|NCT01004172|66543086|FG000|Overall Study|Adverse Event|1|||
23771445|NCT01004172|66543086|FG000|Overall Study|Physician Decision|1|||
23573698|NCT03056040|65831454|FG001|Extension Period|Physician Decision|3|||
23573699|NCT03056040|65831453|FG000|Extension Period|Lost to Follow-up|0|||
23771446|NCT01004172|66543086|FG000|Overall Study|Symptomatic Deterioration|2|||
23771447|NCT01267266|66543087|FG000|Enrollment Phase|Withdrawal by Subject|2|||
23771448|NCT01267266|66543088|FG001|Enrollment Phase|Withdrawal by Subject|0|||
23771449|NCT01267266|66543087|FG000|Lead-in Phase|Lack of Efficacy|20|||
23771450|NCT01267266|66543088|FG001|Lead-in Phase|Lack of Efficacy|0|||
23573700|NCT03056040|65831454|FG001|Extension Period|Lost to Follow-up|1|||
23573701|NCT03056040|65831453|FG000|Extension Period|Death|0|||
23573702|NCT03056040|65831454|FG001|Extension Period|Death|3|||
23633278|NCT01441635|66042125|FG000|Overall Study|Received Exclusionary Medication|1|||
23573703|NCT03056040|65831453|FG000|Extension Period|Withdrawal by Subject|1|||
23573704|NCT03056040|65831454|FG001|Extension Period|Withdrawal by Subject|0|||
23573705|NCT00653263|65831455|FG000|Overall Study|Withdrawal by Subject|1|||
23573706|NCT00653263|65831455|FG000|Overall Study|Physician Decision|1|||
23573707|NCT03873246|65831457|FG000|Overall Study|Adverse Event|1|||
23573708|NCT03873246|65831458|FG001|Overall Study|Adverse Event|3|||
23573709|NCT03873246|65831459|FG002|Overall Study|Adverse Event|3|||
23573710|NCT03873246|65831457|FG000|Overall Study|Lost to Follow-up|4|||
23573711|NCT03873246|65831458|FG001|Overall Study|Lost to Follow-up|4|||
23573712|NCT03873246|65831459|FG002|Overall Study|Lost to Follow-up|5|||
23573713|NCT03873246|65831457|FG000|Overall Study|Protocol Violation|0|||
23573714|NCT03873246|65831458|FG001|Overall Study|Protocol Violation|1|||
23573715|NCT03873246|65831459|FG002|Overall Study|Protocol Violation|0|||
23573716|NCT03873246|65831457|FG000|Overall Study|Withdrawal by Subject|0|||
23633279|NCT01441635|66042126|FG001|Overall Study|Received Exclusionary Medication|0|||
23633280|NCT01441635|66042127|FG002|Overall Study|Received Exclusionary Medication|0|||
23633281|NCT01441635|66042128|FG003|Overall Study|Received Exclusionary Medication|0|||
23573717|NCT03873246|65831458|FG001|Overall Study|Withdrawal by Subject|4|||
23573718|NCT03873246|65831459|FG002|Overall Study|Withdrawal by Subject|1|||
23573719|NCT00729690|65831460|FG000|Overall Study|IT Catheter Malfunction|0|||
23573720|NCT00729690|65831461|FG001|Overall Study|IT Catheter Malfunction|2|||
23573721|NCT00729690|65831462|FG002|Overall Study|IT Catheter Malfunction|2|||
23573722|NCT02169219|65831463|FG000|Overall Study|Lack of Efficacy|6|||
23573723|NCT00802737|65831466|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
23573724|NCT00802737|65831467|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
23573725|NCT00802737|65831468|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
23573726|NCT00802737|65831466|FG000|Overall Study|Death|6|||
23573727|NCT00802737|65831467|FG001|Overall Study|Death|5|||
23573728|NCT00802737|65831468|FG002|Overall Study|Death|1|||
23573729|NCT00802737|65831466|FG000|Overall Study|Adverse Event|1|||
23573730|NCT00802737|65831467|FG001|Overall Study|Adverse Event|0|||
23573731|NCT00802737|65831468|FG002|Overall Study|Adverse Event|0|||
23573732|NCT00802737|65831466|FG000|Overall Study|Received Prohibited Therapy|1|||
23573733|NCT00802737|65831467|FG001|Overall Study|Received Prohibited Therapy|0|||
23573734|NCT00802737|65831468|FG002|Overall Study|Received Prohibited Therapy|0|||
23573735|NCT00802737|65831466|FG000|Overall Study|Ongoing CLL-Treatment|0|||
23573736|NCT00802737|65831467|FG001|Overall Study|Ongoing CLL-Treatment|1|||
23573737|NCT00802737|65831468|FG002|Overall Study|Ongoing CLL-Treatment|0|||
23573738|NCT00802737|65831466|FG000|Overall Study|Participant too Unwell|0|||
23573739|NCT00802737|65831467|FG001|Overall Study|Participant too Unwell|2|||
23573740|NCT00802737|65831468|FG002|Overall Study|Participant too Unwell|0|||
23573741|NCT01088529|65831470|FG000|Overall Study|Did not receive study treatment|0|||
23573742|NCT01088529|65831471|FG001|Overall Study|Did not receive study treatment|1|||
23573743|NCT01729728|65831472|FG000|Overall Study|Adverse Event|0|||
23573744|NCT01729728|65831473|FG001|Overall Study|Adverse Event|6|||
23573745|NCT01729728|65831474|FG002|Overall Study|Adverse Event|0|||
23573746|NCT01729728|65831472|FG000|Overall Study|Protocol Violation|1|||
23573747|NCT01729728|65831473|FG001|Overall Study|Protocol Violation|0|||
23771451|NCT01267266|66543087|FG000|Lead-in Phase|Adverse Event|2|||
23771452|NCT01267266|66543088|FG001|Lead-in Phase|Adverse Event|0|||
23771453|NCT01267266|66543087|FG000|Lead-in Phase|Withdrawal by Subject|1|||
23771454|NCT01267266|66543088|FG001|Lead-in Phase|Withdrawal by Subject|0|||
23573748|NCT01729728|65831474|FG002|Overall Study|Protocol Violation|1|||
23573749|NCT03135548|65831475|FG000|Overall Study|Lost to Follow-up|3|||
23573750|NCT03135548|65831476|FG001|Overall Study|Lost to Follow-up|0|||
23771455|NCT02385526|66543089|FG000|Overall Study|Withdrawal by Subject|0|||
23771456|NCT02385526|66543090|FG001|Overall Study|Withdrawal by Subject|2|||
23771457|NCT02385526|66543091|FG002|Overall Study|Withdrawal by Subject|0|||
23771458|NCT02385526|66543089|FG000|Overall Study|Lost to Follow-up|0|||
23771459|NCT02385526|66543090|FG001|Overall Study|Lost to Follow-up|1|||
23771460|NCT02385526|66543091|FG002|Overall Study|Lost to Follow-up|0|||
23771461|NCT02385526|66543089|FG000|Overall Study|Physician Decision|1|||
23771462|NCT02385526|66543090|FG001|Overall Study|Physician Decision|0|||
23771463|NCT02385526|66543091|FG002|Overall Study|Physician Decision|0|||
23573751|NCT03135548|65831477|FG002|Overall Study|Lost to Follow-up|0|||
23573752|NCT03135548|65831475|FG000|Overall Study|Withdrawal by Subject|2|||
23633282|NCT01441635|66042129|FG004|Overall Study|Received Exclusionary Medication|0|||
23771464|NCT02385526|66543089|FG000|Overall Study|Protocol Violation|1|||
23771465|NCT02385526|66543090|FG001|Overall Study|Protocol Violation|0|||
23447276|NCT03920254|65377928|FG001|Overall Study|Physician Decision|1|||
23573753|NCT03135548|65831476|FG001|Overall Study|Withdrawal by Subject|2|||
23573754|NCT03135548|65831477|FG002|Overall Study|Withdrawal by Subject|1|||
23573755|NCT03135548|65831475|FG000|Overall Study|Other than listed|0|||
23573756|NCT03135548|65831476|FG001|Overall Study|Other than listed|2|||
23633283|NCT01441635|66042130|FG005|Overall Study|Received Exclusionary Medication|0|||
23771466|NCT02385526|66543091|FG002|Overall Study|Protocol Violation|0|||
23771467|NCT01706926|66543095|FG000|Overall Study|Lost to Follow-up|0|||
23771468|NCT01706926|66543096|FG001|Overall Study|Lost to Follow-up|0|||
23573757|NCT03135548|65831477|FG002|Overall Study|Other than listed|2|||
23771469|NCT01706926|66543097|FG002|Overall Study|Lost to Follow-up|1|||
23771470|NCT01706926|66543098|FG003|Overall Study|Lost to Follow-up|0|||
23573758|NCT00507026|65831478|FG000|Overall Study|Lack of Efficacy|6|||
23573759|NCT00507026|65831479|FG001|Overall Study|Lack of Efficacy|4|||
23573760|NCT00507026|65831480|FG002|Overall Study|Lack of Efficacy|21|||
23573761|NCT00507026|65831478|FG000|Overall Study|Withdrawal by Subject|2|||
23573762|NCT00507026|65831479|FG001|Overall Study|Withdrawal by Subject|0|||
23573763|NCT00507026|65831480|FG002|Overall Study|Withdrawal by Subject|0|||
23573764|NCT00507026|65831478|FG000|Overall Study|Investigator Decision|1|||
23573765|NCT00507026|65831479|FG001|Overall Study|Investigator Decision|0|||
23573766|NCT00507026|65831480|FG002|Overall Study|Investigator Decision|0|||
23573767|NCT00507026|65831478|FG000|Overall Study|Adverse Event|2|||
23573768|NCT00507026|65831479|FG001|Overall Study|Adverse Event|0|||
23573769|NCT00507026|65831480|FG002|Overall Study|Adverse Event|0|||
23573770|NCT00507026|65831478|FG000|Overall Study|Protocol Violation|1|||
23573771|NCT00507026|65831479|FG001|Overall Study|Protocol Violation|0|||
23573772|NCT00507026|65831480|FG002|Overall Study|Protocol Violation|0|||
23573773|NCT00507026|65831478|FG000|Overall Study|Other|1|||
23573774|NCT00507026|65831479|FG001|Overall Study|Other|0|||
23573775|NCT00507026|65831480|FG002|Overall Study|Other|0|||
23573776|NCT01991197|65831484|FG000|Overall Study|Lost to Follow-up|1|||
23573777|NCT01991197|65831485|FG001|Overall Study|Lost to Follow-up|1|||
23573778|NCT01991197|65831484|FG000|Overall Study|Physician Decision|0|||
23573779|NCT01991197|65831485|FG001|Overall Study|Physician Decision|2|||
23573780|NCT01991197|65831484|FG000|Overall Study|Withdrawal by Subject|2|||
23573781|NCT01991197|65831485|FG001|Overall Study|Withdrawal by Subject|0|||
23573782|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
23573783|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
23573784|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
23573785|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
23573786|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
23573787|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
23573788|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
23573789|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
23573790|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23573791|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23573792|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
23573793|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
23573794|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
23573795|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
23573796|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
23573797|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
23573798|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
23573799|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
23573800|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
23573801|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
23573802|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
23573803|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
23573804|NCT00802659|65831492|FG000|Overall Study|Physician Decision|0|||
23771471|NCT01706926|66543095|FG000|Overall Study|Withdrawal by Subject|2|||
23771472|NCT01706926|66543096|FG001|Overall Study|Withdrawal by Subject|0|||
23832546|NCT02564900|66767666|FG001|Dose Expansion|Did not receive treatment|0|||
23832547|NCT02564900|66767667|FG002|Dose Expansion|Did not receive treatment|0|||
23832548|NCT02564900|66767668|FG003|Dose Expansion|Did not receive treatment|0|||
23771473|NCT01706926|66543097|FG002|Overall Study|Withdrawal by Subject|1|||
23771474|NCT01706926|66543098|FG003|Overall Study|Withdrawal by Subject|2|||
23771475|NCT01706926|66543095|FG000|Overall Study|Other|4|||
23832549|NCT02564900|66767669|FG004|Dose Expansion|Did not receive treatment|0|||
23832550|NCT02564900|66767670|FG005|Dose Expansion|Did not receive treatment|0|||
23832551|NCT02564900|66767671|FG006|Dose Expansion|Did not receive treatment|1|||
23832552|NCT02564900|66767672|FG007|Dose Expansion|Did not receive treatment|1|||
23771476|NCT01706926|66543096|FG001|Overall Study|Other|4|||
23447277|NCT03920254|65377929|FG002|Overall Study|Physician Decision|2|||
23573805|NCT00802659|65831493|FG001|Overall Study|Physician Decision|1|||
23573806|NCT00802659|65831494|FG002|Overall Study|Physician Decision|0|||
23573807|NCT00802659|65831495|FG003|Overall Study|Physician Decision|0|||
23573808|NCT01458249|65831497|FG000|Overall Study|Not treated|1|||
23573809|NCT01458249|65831497|FG000|Overall Study|Adverse Event|4|||
23573810|NCT01458249|65831497|FG000|Overall Study|Other|2|||
23771477|NCT01706926|66543097|FG002|Overall Study|Other|4|||
23771478|NCT01706926|66543098|FG003|Overall Study|Other|3|||
23771479|NCT00048048|66543099|FG000|Core Treatment|Withdrawal by Subject|0|||
23832553|NCT02564900|66767673|FG008|Dose Expansion|Did not receive treatment|0|||
23832554|NCT02564900|66767674|FG009|Dose Expansion|Did not receive treatment|0|||
23447278|NCT03920254|65377927|FG000|Overall Study|Study Terminated By Sponsor|12|||
23447279|NCT03920254|65377928|FG001|Overall Study|Study Terminated By Sponsor|17|||
23573811|NCT01458249|65831497|FG000|Overall Study|Ongoing|1|||
23573812|NCT02139982|65831498|FG000|Overall Study|Lack of Efficacy|0|||
23573813|NCT02139982|65831499|FG001|Overall Study|Lack of Efficacy|1|||
23573814|NCT02139982|65831500|FG002|Overall Study|Lack of Efficacy|0|||
23573815|NCT02139982|65831501|FG003|Overall Study|Lack of Efficacy|1|||
23573816|NCT02139982|65831502|FG004|Overall Study|Lack of Efficacy|0|||
23573817|NCT02139982|65831503|FG005|Overall Study|Lack of Efficacy|0|||
23573818|NCT02139982|65831504|FG006|Overall Study|Lack of Efficacy|0|||
23573819|NCT02139982|65831505|FG007|Overall Study|Lack of Efficacy|0|||
23573820|NCT02139982|65831506|FG008|Overall Study|Lack of Efficacy|0|||
23573821|NCT02139982|65831507|FG009|Overall Study|Lack of Efficacy|0|||
23573822|NCT04430335|65831511|FG000|Overall Study|Withdrawal by Subject|1|||
23573823|NCT00976703|65831512|FG000|Overall Study|Physician Decision|1|||
23573824|NCT00976703|65831513|FG001|Overall Study|Physician Decision|1|||
23573825|NCT00976703|65831512|FG000|Overall Study|ineligible for study|2|||
23573826|NCT00976703|65831513|FG001|Overall Study|ineligible for study|2|||
23573827|NCT00681187|65831514|FG000|Overall Study|Withdrawal by Subject|1|||
23573828|NCT00681187|65831515|FG001|Overall Study|Withdrawal by Subject|0|||
23573829|NCT00681187|65831514|FG000|Overall Study|Death|0|||
23573830|NCT00681187|65831515|FG001|Overall Study|Death|1|||
23573831|NCT00681187|65831514|FG000|Overall Study|Adverse Event|0|||
23573832|NCT00681187|65831515|FG001|Overall Study|Adverse Event|1|||
23573833|NCT03050398|65831516|FG000|Overall Study|Study terminated by sponsor|8|||
23573834|NCT00442286|65831517|FG000|Overall Study|Death|2|||
23573835|NCT00442286|65831518|FG001|Overall Study|Death|2|||
23573836|NCT00442286|65831517|FG000|Overall Study|Lost to Follow-up|1|||
23573837|NCT00442286|65831518|FG001|Overall Study|Lost to Follow-up|0|||
23573838|NCT00442286|65831517|FG000|Overall Study|Withdrawal by Subject|2|||
23573839|NCT00442286|65831518|FG001|Overall Study|Withdrawal by Subject|0|||
23573840|NCT00442286|65831517|FG000|Overall Study|System explanted|1|||
23573841|NCT00442286|65831518|FG001|Overall Study|System explanted|0|||
23573842|NCT00442286|65831517|FG000|Overall Study|Patient Injury|1|||
23633284|NCT01441635|66042131|FG006|Overall Study|Received Exclusionary Medication|0|||
23633285|NCT01441635|66042132|FG007|Overall Study|Received Exclusionary Medication|0|||
23633286|NCT01441635|66042133|FG008|Overall Study|Received Exclusionary Medication|0|||
23633287|NCT01441635|66042134|FG009|Overall Study|Received Exclusionary Medication|0|||
23633288|NCT01441635|66042125|FG000|Overall Study|Other|0|||
23771480|NCT00048048|66543100|FG001|Core Treatment|Withdrawal by Subject|0|||
23771481|NCT00048048|66543101|FG002|Core Treatment|Withdrawal by Subject|1|||
23771482|NCT00048048|66543102|FG003|Core Treatment|Withdrawal by Subject|0|||
23771483|NCT00048048|66543103|FG004|Core Treatment|Withdrawal by Subject|0|||
23771484|NCT00048048|66543104|FG005|Core Treatment|Withdrawal by Subject|0|||
23771485|NCT00048048|66543105|FG006|Core Treatment|Withdrawal by Subject|0|||
23771486|NCT00048048|66543106|FG007|Core Treatment|Withdrawal by Subject|0|||
23771487|NCT00048048|66543107|FG008|Core Treatment|Withdrawal by Subject|0|||
23771488|NCT00048048|66543108|FG009|Core Treatment|Withdrawal by Subject|0|||
23771489|NCT00048048|66543109|FG010|Core Treatment|Withdrawal by Subject|0|||
23771490|NCT00048048|66543110|FG011|Core Treatment|Withdrawal by Subject|0|||
23771491|NCT00048048|66543099|FG000|Core Treatment|Adverse Event|0|||
23771492|NCT00048048|66543100|FG001|Core Treatment|Adverse Event|0|||
23771493|NCT00048048|66543101|FG002|Core Treatment|Adverse Event|0|||
23771494|NCT00048048|66543102|FG003|Core Treatment|Adverse Event|0|||
23771495|NCT00048048|66543103|FG004|Core Treatment|Adverse Event|0|||
23771496|NCT00048048|66543104|FG005|Core Treatment|Adverse Event|0|||
23771497|NCT00048048|66543105|FG006|Core Treatment|Adverse Event|0|||
23771498|NCT00048048|66543106|FG007|Core Treatment|Adverse Event|1|||
23771499|NCT00048048|66543107|FG008|Core Treatment|Adverse Event|0|||
23771500|NCT00048048|66543108|FG009|Core Treatment|Adverse Event|0|||
23771501|NCT00048048|66543109|FG010|Core Treatment|Adverse Event|0|||
23573843|NCT00442286|65831518|FG001|Overall Study|Patient Injury|0|||
23573844|NCT01489020|65831519|FG000|Overall Study|Withdrawal by Subject|1|||
23573845|NCT01489020|65831520|FG001|Overall Study|Withdrawal by Subject|0|||
23573846|NCT01489020|65831521|FG002|Overall Study|Withdrawal by Subject|0|||
23573847|NCT01489020|65831522|FG003|Overall Study|Withdrawal by Subject|0|||
23573848|NCT01489020|65831523|FG004|Overall Study|Withdrawal by Subject|0|||
23771502|NCT00048048|66543110|FG011|Core Treatment|Adverse Event|0|||
23771503|NCT00048048|66543099|FG000|Extension Year 1|Early withdrawals|0|||
23771504|NCT00048048|66543100|FG001|Extension Year 1|Early withdrawals|0|||
23771505|NCT00048048|66543101|FG002|Extension Year 1|Early withdrawals|0|||
23771506|NCT00048048|66543102|FG003|Extension Year 1|Early withdrawals|0|||
23771507|NCT00048048|66543103|FG004|Extension Year 1|Early withdrawals|0|||
23771508|NCT00048048|66543104|FG005|Extension Year 1|Early withdrawals|0|||
23771509|NCT00048048|66543105|FG006|Extension Year 1|Early withdrawals|0|||
23573849|NCT01489020|65831524|FG005|Overall Study|Withdrawal by Subject|0|||
23573850|NCT01489020|65831519|FG000|Overall Study|Adverse Event|0|||
23573851|NCT01489020|65831520|FG001|Overall Study|Adverse Event|0|||
23573852|NCT01489020|65831521|FG002|Overall Study|Adverse Event|3|||
23573853|NCT01489020|65831522|FG003|Overall Study|Adverse Event|0|||
23573854|NCT01489020|65831523|FG004|Overall Study|Adverse Event|3|||
23573855|NCT01489020|65831524|FG005|Overall Study|Adverse Event|0|||
23573856|NCT01489020|65831519|FG000|Overall Study|Concomitant disease|0|||
23573857|NCT01489020|65831520|FG001|Overall Study|Concomitant disease|0|||
23573858|NCT01489020|65831521|FG002|Overall Study|Concomitant disease|0|||
23573859|NCT01489020|65831522|FG003|Overall Study|Concomitant disease|0|||
23573860|NCT01489020|65831523|FG004|Overall Study|Concomitant disease|3|||
23573861|NCT01489020|65831524|FG005|Overall Study|Concomitant disease|0|||
23573862|NCT02696226|65831531|FG000|Overall Study|Study terminated - lack of enrollment|1|||
23573863|NCT02696226|65831532|FG001|Overall Study|Study terminated - lack of enrollment|0|||
23573864|NCT02696226|65831533|FG002|Overall Study|Study terminated - lack of enrollment|2|||
23573865|NCT02696226|65831534|FG003|Overall Study|Study terminated - lack of enrollment|0|||
23573866|NCT00896454|65831535|FG000|Overall Study|Death|10|||
23573867|NCT00896454|65831535|FG000|Overall Study|Adverse Event|8|||
23573868|NCT00896454|65831535|FG000|Overall Study|Disease Progression|5|||
23573869|NCT00896454|65831535|FG000|Overall Study|Other|4|||
23573870|NCT00896454|65831535|FG000|Overall Study|Requirement for alternative therapy|3|||
23573871|NCT00896454|65831535|FG000|Overall Study|Ongoing in study|2|||
23832555|NCT02564900|66767675|FG010|Dose Expansion|Did not receive treatment|0|||
23832556|NCT02564900|66767676|FG011|Dose Expansion|Did not receive treatment|0|||
23832557|NCT02564900|66767677|FG012|Dose Expansion|Did not receive treatment|0|||
23832558|NCT02564900|66767678|FG013|Dose Expansion|Did not receive treatment|0|||
23832559|NCT02564900|66767679|FG014|Dose Expansion|Did not receive treatment|1|||
23832560|NCT01998919|66767680|FG000|Overall Study|Death|2|||
23832561|NCT01998919|66767681|FG001|Overall Study|Death|2|||
23832562|NCT01998919|66767680|FG000|Overall Study|Adverse Event|0|||
23832563|NCT01998919|66767681|FG001|Overall Study|Adverse Event|5|||
23832564|NCT01998919|66767680|FG000|Overall Study|Disease progression|31|||
23832565|NCT01998919|66767681|FG001|Overall Study|Disease progression|22|||
23832566|NCT01998919|66767680|FG000|Overall Study|Withdrawal by Subject|2|||
23832567|NCT01998919|66767681|FG001|Overall Study|Withdrawal by Subject|4|||
23832568|NCT01998919|66767680|FG000|Overall Study|Lost to Follow-up|2|||
23832569|NCT01998919|66767681|FG001|Overall Study|Lost to Follow-up|0|||
23832570|NCT01998919|66767680|FG000|Overall Study|Other|5|||
23573872|NCT00896454|65831535|FG000|Overall Study|Withdrawal by Subject|1|||
23573873|NCT00386308|65831536|FG000|Overall Study|Adverse Event|3|||
23573874|NCT00386308|65831537|FG001|Overall Study|Adverse Event|3|||
23573875|NCT00386308|65831536|FG000|Overall Study|Protocol Violation|2|||
23573876|NCT00386308|65831537|FG001|Overall Study|Protocol Violation|5|||
23832571|NCT01998919|66767681|FG001|Overall Study|Other|2|||
23832572|NCT03192488|66767682|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
23832573|NCT03192488|66767683|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
23832574|NCT03192488|66767684|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
23832575|NCT03192488|66767685|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
23832576|NCT03192488|66767686|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
23832577|NCT03192488|66767687|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
23832578|NCT03192488|66767682|FG000|Third Intervention (d1)|Adverse Event|0|||
23832579|NCT03192488|66767683|FG001|Third Intervention (d1)|Adverse Event|0|||
23832580|NCT03192488|66767684|FG002|Third Intervention (d1)|Adverse Event|0|||
23832581|NCT03192488|66767685|FG003|Third Intervention (d1)|Adverse Event|0|||
23832582|NCT03192488|66767686|FG004|Third Intervention (d1)|Adverse Event|1|||
23832583|NCT03192488|66767687|FG005|Third Intervention (d1)|Adverse Event|0|||
23832584|NCT02375971|66767693|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
23832585|NCT02375971|66767694|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
23832586|NCT02375971|66767695|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
23832587|NCT02375971|66767693|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23832588|NCT02375971|66767694|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23832589|NCT02375971|66767695|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23832590|NCT02375971|66767693|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
23832591|NCT02375971|66767694|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
23573877|NCT00386308|65831536|FG000|Overall Study|Lack of Efficacy|0|||
23573878|NCT00386308|65831537|FG001|Overall Study|Lack of Efficacy|2|||
23573879|NCT00386308|65831536|FG000|Overall Study|Lost to Follow-up|10|||
23573880|NCT00386308|65831537|FG001|Overall Study|Lost to Follow-up|6|||
23573881|NCT00386308|65831536|FG000|Overall Study|Withdrawal by Subject|6|||
23573882|NCT00386308|65831537|FG001|Overall Study|Withdrawal by Subject|2|||
23573883|NCT00386308|65831536|FG000|Overall Study|Other Event|8|||
23573884|NCT00386308|65831537|FG001|Overall Study|Other Event|1|||
23832592|NCT02375971|66767695|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
23832593|NCT02375971|66767693|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
23832594|NCT02375971|66767694|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
23832595|NCT02375971|66767695|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
23832596|NCT02375971|66767693|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
23832597|NCT02375971|66767694|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
23832598|NCT02375971|66767695|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
23832599|NCT02375971|66767693|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
23832600|NCT02375971|66767694|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
23832601|NCT02375971|66767695|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
23832602|NCT02375971|66767693|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
23832603|NCT02375971|66767694|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
23832604|NCT02375971|66767695|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
23832605|NCT02375971|66767693|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
23832606|NCT02375971|66767694|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
23832607|NCT02375971|66767695|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
23832608|NCT00733421|66767696|FG000|Overall Study|Withdrawal by Subject|1|||
23832609|NCT00733421|66767697|FG001|Overall Study|Withdrawal by Subject|1|||
23832610|NCT00571727|66767698|FG000|Overall Study|Did not enter in this study|1|||
23832611|NCT00571727|66767698|FG000|Overall Study|Non-compliance|4|||
23832612|NCT00571727|66767698|FG000|Overall Study|Lost to Follow-up|30|||
23832613|NCT00571727|66767698|FG000|Overall Study|Poor growth|1|||
23832614|NCT00571727|66767698|FG000|Overall Study|Parent/patient decision|2|||
23832615|NCT00571727|66767698|FG000|Overall Study|Participant transferred to commercial drug|14|||
23832616|NCT00571727|66767698|FG000|Overall Study|Unable to provide study drug|6|||
23832617|NCT00571727|66767698|FG000|Overall Study|On-treatment at end of study|8|||
23832618|NCT02273388|66767702|FG000|Overall Study|Adverse Event|0|||
23832619|NCT02273388|66767703|FG001|Overall Study|Adverse Event|0|||
23832620|NCT02273388|66767704|FG002|Overall Study|Adverse Event|0|||
23832621|NCT02273388|66767705|FG003|Overall Study|Adverse Event|0|||
23832622|NCT02273388|66767706|FG004|Overall Study|Adverse Event|0|||
23832623|NCT02273388|66767707|FG005|Overall Study|Adverse Event|0|||
23832624|NCT02273388|66767708|FG006|Overall Study|Adverse Event|1|||
23832625|NCT02273388|66767709|FG007|Overall Study|Adverse Event|2|||
23771510|NCT00048048|66543106|FG007|Extension Year 1|Early withdrawals|0|||
23771511|NCT00048048|66543107|FG008|Extension Year 1|Early withdrawals|0|||
23771512|NCT00048048|66543108|FG009|Extension Year 1|Early withdrawals|2|||
23771513|NCT00048048|66543109|FG010|Extension Year 1|Early withdrawals|2|||
23771514|NCT00048048|66543110|FG011|Extension Year 1|Early withdrawals|4|||
23771515|NCT00048048|66543099|FG000|Extension Year 2|Early withdrawals|0|||
23771516|NCT00048048|66543100|FG001|Extension Year 2|Early withdrawals|0|||
23771517|NCT00048048|66543101|FG002|Extension Year 2|Early withdrawals|0|||
23771518|NCT00048048|66543102|FG003|Extension Year 2|Early withdrawals|0|||
23771519|NCT00048048|66543103|FG004|Extension Year 2|Early withdrawals|0|||
23771520|NCT00048048|66543104|FG005|Extension Year 2|Early withdrawals|0|||
23771521|NCT00048048|66543105|FG006|Extension Year 2|Early withdrawals|0|||
23771522|NCT00048048|66543106|FG007|Extension Year 2|Early withdrawals|0|||
23771523|NCT00048048|66543107|FG008|Extension Year 2|Early withdrawals|0|||
23771524|NCT00048048|66543108|FG009|Extension Year 2|Early withdrawals|0|||
23771525|NCT00048048|66543109|FG010|Extension Year 2|Early withdrawals|4|||
23771526|NCT00048048|66543110|FG011|Extension Year 2|Early withdrawals|2|||
23771527|NCT03295721|66543111|FG000|Overall Study|Adverse Event|1|||
23771528|NCT03295721|66543112|FG001|Overall Study|Adverse Event|0|||
23771529|NCT03295721|66543113|FG002|Overall Study|Adverse Event|0|||
23771530|NCT03295721|66543111|FG000|Overall Study|Lost to Follow-up|1|||
23771531|NCT03295721|66543112|FG001|Overall Study|Lost to Follow-up|1|||
23771532|NCT03295721|66543113|FG002|Overall Study|Lost to Follow-up|1|||
23771533|NCT03295721|66543111|FG000|Overall Study|Withdrawal by Subject|1|||
23771534|NCT03295721|66543112|FG001|Overall Study|Withdrawal by Subject|0|||
23771535|NCT03295721|66543113|FG002|Overall Study|Withdrawal by Subject|1|||
23771536|NCT03295721|66543111|FG000|Overall Study|Death|0|||
23771537|NCT03295721|66543112|FG001|Overall Study|Death|0|||
23771538|NCT03295721|66543113|FG002|Overall Study|Death|1|||
23771539|NCT00472290|66543114|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
23771540|NCT00472290|66543114|FG000|Overall Study|Protocol Specified Criteria|7|||
23771541|NCT00472290|66543114|FG000|Overall Study|Administrative Decision|37|||
23771542|NCT00472290|66543114|FG000|Overall Study|Death|3|||
23771543|NCT00472290|66543114|FG000|Overall Study|Lost to Follow-up|1|||
23771544|NCT00472290|66543114|FG000|Overall Study|Lack of Efficacy|1|||
23832626|NCT02273388|66767710|FG008|Overall Study|Adverse Event|0|||
23832627|NCT02273388|66767711|FG009|Overall Study|Adverse Event|0|||
23832628|NCT02273388|66767712|FG010|Overall Study|Adverse Event|0|||
23832629|NCT02273388|66767713|FG011|Overall Study|Adverse Event|0|||
23832630|NCT02273388|66767702|FG000|Overall Study|Adverse Event study disease worse|4|||
23771545|NCT00472290|66543114|FG000|Overall Study|Disease Progression|4|||
23771546|NCT00472290|66543114|FG000|Overall Study|Withdrawal by Subject|5|||
23771547|NCT00472290|66543114|FG000|Overall Study|Adverse Event|6|||
23771548|NCT00472290|66543114|FG000|Overall Study|Requirement for alternative therapy|7|||
23771549|NCT01424722|66543115|FG000|Overall Study|Sponsor terminated investigation|2258|||
23771550|NCT00462982|66543116|FG000|Overall Study|Adverse Event|1|||
23832631|NCT02273388|66767703|FG001|Overall Study|Adverse Event study disease worse|3|||
23832632|NCT02273388|66767704|FG002|Overall Study|Adverse Event study disease worse|3|||
23771551|NCT00462982|66543116|FG000|Overall Study|Patient Not Treated|2|||
23771552|NCT04094870|66543117|FG000|Overall Study|Lost to Follow-up|1|||
23771553|NCT04094870|66543118|FG001|Overall Study|Lost to Follow-up|1|||
23771554|NCT03997448|66543119|FG000|Study Treatment|Disease Progression|1|||
23771555|NCT03997448|66543119|FG000|Study Treatment|Symptomatic Deterioration|1|||
23771556|NCT03997448|66543119|FG000|Follow up|Death|2|||
23771557|NCT03997448|66543119|FG000|Follow up|study terminated|1|||
23771558|NCT00561730|66543120|FG000|Overall Study|Adverse Event|2|||
23771559|NCT00561730|66543120|FG000|Overall Study|Handling of the drug|1|||
23771560|NCT00561730|66543120|FG000|Overall Study|Lost to Follow-up|5|||
23771561|NCT00561730|66543120|FG000|Overall Study|Not specified reasons|1|||
23771562|NCT02849652|66543124|FG000|Overall Study|Lost to Follow-up|104|||
23771563|NCT02849652|66543125|FG001|Overall Study|Lost to Follow-up|35|||
23771564|NCT02849652|66543126|FG002|Overall Study|Lost to Follow-up|116|||
23771565|NCT02849652|66543127|FG003|Overall Study|Lost to Follow-up|22|||
23771566|NCT02849652|66543124|FG000|Overall Study|Withdrawal by Subject|10|||
23771567|NCT02849652|66543125|FG001|Overall Study|Withdrawal by Subject|2|||
23771568|NCT02849652|66543126|FG002|Overall Study|Withdrawal by Subject|8|||
23771569|NCT02849652|66543127|FG003|Overall Study|Withdrawal by Subject|4|||
23771570|NCT02228382|66543128|FG000|Overall Study|Death|5|||
23771571|NCT02228382|66543129|FG001|Overall Study|Death|7|||
23771572|NCT02228382|66543130|FG002|Overall Study|Death|5|||
23771573|NCT02228382|66543131|FG003|Overall Study|Death|0|||
23771574|NCT02228382|66543132|FG004|Overall Study|Death|2|||
23771575|NCT02228382|66543128|FG000|Overall Study|Participant refused further follow-up|0|||
23771576|NCT02228382|66543129|FG001|Overall Study|Participant refused further follow-up|0|||
23771577|NCT02228382|66543130|FG002|Overall Study|Participant refused further follow-up|1|||
23771578|NCT02228382|66543131|FG003|Overall Study|Participant refused further follow-up|0|||
23771579|NCT02228382|66543132|FG004|Overall Study|Participant refused further follow-up|0|||
23771580|NCT02228382|66543128|FG000|Overall Study|Study terminated by sponsor|3|||
23771581|NCT02228382|66543129|FG001|Overall Study|Study terminated by sponsor|5|||
23771582|NCT02228382|66543130|FG002|Overall Study|Study terminated by sponsor|7|||
23771583|NCT02228382|66543131|FG003|Overall Study|Study terminated by sponsor|0|||
23771584|NCT02228382|66543132|FG004|Overall Study|Study terminated by sponsor|0|||
23771585|NCT02228382|66543128|FG000|Overall Study|Lost to Follow-up|0|||
23771586|NCT02228382|66543129|FG001|Overall Study|Lost to Follow-up|0|||
23573885|NCT00180674|65831538|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
23573886|NCT00180674|65831538|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
23573887|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
23573888|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
23771587|NCT02228382|66543130|FG002|Overall Study|Lost to Follow-up|3|||
23573889|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
23771588|NCT02228382|66543131|FG003|Overall Study|Lost to Follow-up|1|||
23771589|NCT02228382|66543132|FG004|Overall Study|Lost to Follow-up|0|||
23771590|NCT02228382|66543128|FG000|Overall Study|Withdrawal by Subject|0|||
23771591|NCT02228382|66543129|FG001|Overall Study|Withdrawal by Subject|3|||
23771592|NCT02228382|66543130|FG002|Overall Study|Withdrawal by Subject|2|||
23771593|NCT02228382|66543131|FG003|Overall Study|Withdrawal by Subject|1|||
23771594|NCT02228382|66543132|FG004|Overall Study|Withdrawal by Subject|0|||
23771595|NCT02228382|66543128|FG000|Overall Study|Other|2|||
23771596|NCT02228382|66543129|FG001|Overall Study|Other|3|||
23771597|NCT02228382|66543130|FG002|Overall Study|Other|3|||
23771598|NCT02228382|66543131|FG003|Overall Study|Other|0|||
23771599|NCT02228382|66543132|FG004|Overall Study|Other|0|||
23771600|NCT00090857|66543136|FG000|Overall Study|Lost to Follow-up|0|||
23771601|NCT00090857|66543137|FG001|Overall Study|Lost to Follow-up|1|||
23771602|NCT00090857|66543136|FG000|Overall Study|Withdrawal by Subject|2|||
23771603|NCT00090857|66543137|FG001|Overall Study|Withdrawal by Subject|0|||
23771604|NCT00090857|66543136|FG000|Overall Study|Adverse Event|2|||
23771605|NCT00090857|66543137|FG001|Overall Study|Adverse Event|2|||
23771606|NCT01087970|66543138|FG000|Overall Study|Protocol Violation|2|||
23771607|NCT02070744|66543141|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23771608|NCT02070744|66543142|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23771609|NCT02070744|66543143|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23771610|NCT02070744|66543144|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
23771611|NCT02070744|66543145|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23771612|NCT02070744|66543141|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23771613|NCT02070744|66543142|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23771614|NCT02070744|66543143|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23771615|NCT02070744|66543144|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23771616|NCT02070744|66543145|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
23771617|NCT02070744|66543141|FG000|OLE Phase (48 Weeks)|Other|0|||
23771618|NCT02070744|66543142|FG001|OLE Phase (48 Weeks)|Other|0|||
23771619|NCT02070744|66543143|FG002|OLE Phase (48 Weeks)|Other|0|||
23771620|NCT02070744|66543144|FG003|OLE Phase (48 Weeks)|Other|0|||
23771621|NCT02070744|66543145|FG004|OLE Phase (48 Weeks)|Other|1|||
23771622|NCT00602030|66543146|FG000|Lead-in Phase|Disease Progression|2|||
23771623|NCT00602030|66543147|FG001|Lead-in Phase|Disease Progression|3|||
23771624|NCT00602030|66543148|FG002|Lead-in Phase|Disease Progression|0|||
23771625|NCT00602030|66543149|FG003|Lead-in Phase|Disease Progression|0|||
23573890|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
23633289|NCT01441635|66042126|FG001|Overall Study|Other|0|||
23633290|NCT01441635|66042127|FG002|Overall Study|Other|0|||
23633291|NCT01441635|66042128|FG003|Overall Study|Other|0|||
23633292|NCT01441635|66042129|FG004|Overall Study|Other|0|||
23633293|NCT01441635|66042130|FG005|Overall Study|Other|0|||
23771626|NCT00602030|66543150|FG004|Lead-in Phase|Disease Progression|0|||
23573891|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
23573892|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
23573893|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
23573894|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
23573895|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
23573896|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
23573897|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
23573898|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
23573899|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
23771627|NCT00602030|66543146|FG000|Lead-in Phase|Adverse Event|0|||
23832633|NCT02273388|66767705|FG003|Overall Study|Adverse Event study disease worse|2|||
23832634|NCT02273388|66767706|FG004|Overall Study|Adverse Event study disease worse|4|||
23771628|NCT00602030|66543147|FG001|Lead-in Phase|Adverse Event|2|||
23771629|NCT00602030|66543148|FG002|Lead-in Phase|Adverse Event|0|||
23771630|NCT00602030|66543149|FG003|Lead-in Phase|Adverse Event|0|||
23771631|NCT00602030|66543150|FG004|Lead-in Phase|Adverse Event|0|||
23771632|NCT00602030|66543146|FG000|Double-blind Phase|Disease progression|0|||
23832635|NCT02273388|66767707|FG005|Overall Study|Adverse Event study disease worse|3|||
23832636|NCT02273388|66767708|FG006|Overall Study|Adverse Event study disease worse|14|||
23771633|NCT00602030|66543147|FG001|Double-blind Phase|Disease progression|0|||
23771634|NCT00602030|66543148|FG002|Double-blind Phase|Disease progression|33|||
23573900|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
23633294|NCT01441635|66042131|FG006|Overall Study|Other|0|||
23771635|NCT00602030|66543149|FG003|Double-blind Phase|Disease progression|30|||
23771636|NCT00602030|66543150|FG004|Double-blind Phase|Disease progression|0|||
23771637|NCT00602030|66543146|FG000|Double-blind Phase|Adverse Event|0|||
23771638|NCT00602030|66543147|FG001|Double-blind Phase|Adverse Event|0|||
23771639|NCT00602030|66543148|FG002|Double-blind Phase|Adverse Event|9|||
23771640|NCT00602030|66543149|FG003|Double-blind Phase|Adverse Event|18|||
23771641|NCT00602030|66543150|FG004|Double-blind Phase|Adverse Event|0|||
23771642|NCT00602030|66543146|FG000|Double-blind Phase|Consent withdrawal|0|||
23771643|NCT00602030|66543147|FG001|Double-blind Phase|Consent withdrawal|0|||
23771644|NCT00602030|66543148|FG002|Double-blind Phase|Consent withdrawal|4|||
23771645|NCT00602030|66543149|FG003|Double-blind Phase|Consent withdrawal|3|||
23771646|NCT00602030|66543150|FG004|Double-blind Phase|Consent withdrawal|0|||
23771647|NCT00602030|66543146|FG000|Double-blind Phase|Death|0|||
23771648|NCT00602030|66543147|FG001|Double-blind Phase|Death|0|||
23771649|NCT00602030|66543148|FG002|Double-blind Phase|Death|3|||
23771650|NCT00602030|66543149|FG003|Double-blind Phase|Death|3|||
23771651|NCT00602030|66543150|FG004|Double-blind Phase|Death|0|||
23771652|NCT00602030|66543146|FG000|Double-blind Phase|Administrative decision|0|||
23771653|NCT00602030|66543147|FG001|Double-blind Phase|Administrative decision|0|||
23771654|NCT00602030|66543148|FG002|Double-blind Phase|Administrative decision|0|||
23771655|NCT00602030|66543149|FG003|Double-blind Phase|Administrative decision|2|||
23771656|NCT00602030|66543150|FG004|Double-blind Phase|Administrative decision|0|||
23771657|NCT00602030|66543146|FG000|Double-blind Phase|Ineligibility|0|||
23771658|NCT00602030|66543147|FG001|Double-blind Phase|Ineligibility|0|||
23771659|NCT00602030|66543148|FG002|Double-blind Phase|Ineligibility|0|||
23771660|NCT00602030|66543149|FG003|Double-blind Phase|Ineligibility|1|||
23771661|NCT00602030|66543150|FG004|Double-blind Phase|Ineligibility|0|||
23771662|NCT00602030|66543146|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
23771663|NCT00602030|66543147|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
23771664|NCT00602030|66543148|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
23573901|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
23573902|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
23573903|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
23573904|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
23573905|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
23573906|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
23573907|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
23573908|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
23573909|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
23573910|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
23573911|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Death|1|||
23573912|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Death|0|||
23573913|NCT02218489|65831543|FG000|Overall Study|Withdrawal by Subject|4|||
23573914|NCT02218489|65831544|FG001|Overall Study|Withdrawal by Subject|3|||
23573915|NCT02218489|65831543|FG000|Overall Study|Lost to Follow-up|1|||
23573916|NCT02218489|65831544|FG001|Overall Study|Lost to Follow-up|0|||
23573917|NCT02404493|65831549|FG000|Overall Study|Adverse Event|1|||
23573918|NCT02404493|65831550|FG001|Overall Study|Adverse Event|1|||
23573919|NCT00802841|65831555|FG000|Overall Study|Administrative problems|1|||
23573920|NCT00802841|65831556|FG001|Overall Study|Administrative problems|0|||
23573921|NCT00802841|65831555|FG000|Overall Study|Lost to Follow-up|2|||
23573922|NCT00802841|65831556|FG001|Overall Study|Lost to Follow-up|1|||
23573923|NCT00802841|65831555|FG000|Overall Study|Death|1|||
23573924|NCT00802841|65831556|FG001|Overall Study|Death|2|||
23573925|NCT00802841|65831555|FG000|Overall Study|Adverse Event|8|||
23573926|NCT00802841|65831556|FG001|Overall Study|Adverse Event|2|||
23573927|NCT00802841|65831555|FG000|Overall Study|Disease progression|7|||
23573928|NCT00802841|65831556|FG001|Overall Study|Disease progression|3|||
23573929|NCT00802841|65831555|FG000|Overall Study|Withdrawal by Subject|9|||
23573930|NCT00802841|65831556|FG001|Overall Study|Withdrawal by Subject|5|||
23573931|NCT00802841|65831555|FG000|Overall Study|Protocol deviation|2|||
23573932|NCT00802841|65831556|FG001|Overall Study|Protocol deviation|6|||
23573933|NCT00802841|65831555|FG000|Overall Study|Treatment duration completed|66|||
23573934|NCT00802841|65831556|FG001|Overall Study|Treatment duration completed|76|||
23573935|NCT00109928|65831559|FG000|Overall Study|Adverse Event|2|||
23573936|NCT00109928|65831559|FG000|Overall Study|Progression|6|||
23573937|NCT00109928|65831559|FG000|Overall Study|Death|2|||
23573938|NCT00109928|65831559|FG000|Overall Study|not protocol specified|2|||
23573939|NCT00109928|65831559|FG000|Overall Study|not eligible|1|||
23573940|NCT01196104|65831563|FG000|Overall Study|Lost to Follow-up|1|||
23573941|NCT01196104|65831564|FG001|Overall Study|Lost to Follow-up|0|||
23573942|NCT01196104|65831563|FG000|Overall Study|Physician Decision|0|||
23573943|NCT01196104|65831564|FG001|Overall Study|Physician Decision|1|||
23573944|NCT01196104|65831563|FG000|Overall Study|Withdrawal by Subject|3|||
23771665|NCT00602030|66543149|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
23771666|NCT00602030|66543150|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
23771667|NCT00602030|66543146|FG000|Double-blind Phase|Reason not specified|0|||
23573945|NCT01196104|65831564|FG001|Overall Study|Withdrawal by Subject|3|||
23573946|NCT01196104|65831563|FG000|Overall Study|Various|0|||
23573947|NCT01196104|65831564|FG001|Overall Study|Various|1|||
23771668|NCT00602030|66543147|FG001|Double-blind Phase|Reason not specified|0|||
23573948|NCT01712789|65831566|FG000|Overall Study|Lack of Efficacy|2|||
23573949|NCT01712789|65831566|FG000|Overall Study|Lost to Follow-up|1|||
23573950|NCT01712789|65831566|FG000|Overall Study|Progressive Disease|504|||
23573951|NCT01712789|65831566|FG000|Overall Study|Death|57|||
23633295|NCT01441635|66042132|FG007|Overall Study|Other|1|||
23633296|NCT01441635|66042133|FG008|Overall Study|Other|0|||
23633297|NCT01441635|66042134|FG009|Overall Study|Other|0|||
23573952|NCT01712789|65831566|FG000|Overall Study|Adverse Event|52|||
23573953|NCT01712789|65831566|FG000|Overall Study|Miscellaneous|31|||
23573954|NCT01712789|65831566|FG000|Overall Study|Withdrawal by Subject|21|||
23573955|NCT01712789|65831566|FG000|Overall Study|Transition to Commercial Treatment|8|||
23573956|NCT01712789|65831566|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
23573957|NCT04213989|65831567|FG000|Overall Study|Withdrawal by Subject|3|||
23573958|NCT04213989|65831568|FG001|Overall Study|Withdrawal by Subject|2|||
23573959|NCT04213989|65831567|FG000|Overall Study|Physician Decision|1|||
23573960|NCT04213989|65831568|FG001|Overall Study|Physician Decision|0|||
23573961|NCT04213989|65831567|FG000|Overall Study|Lost to Follow-up|0|||
23573962|NCT04213989|65831568|FG001|Overall Study|Lost to Follow-up|4|||
23573963|NCT03935217|65831569|FG000|Overall Study|Adverse Event|1|||
23573964|NCT03935217|65831570|FG001|Overall Study|Adverse Event|0|||
23573965|NCT03935217|65831569|FG000|Overall Study|Lost to Follow-up|0|||
23573966|NCT03935217|65831570|FG001|Overall Study|Lost to Follow-up|1|||
23573967|NCT03935217|65831569|FG000|Overall Study|Withdrawal by Subject|0|||
23633298|NCT01912404|66042135|FG000|Overall Study|Due to personal reasons|1|||
23573968|NCT03935217|65831570|FG001|Overall Study|Withdrawal by Subject|2|||
23573969|NCT02942004|65831571|FG000|Overall Study|Withdrawal by Subject|0|||
23573970|NCT02942004|65831572|FG001|Overall Study|Withdrawal by Subject|2|||
23573971|NCT02942004|65831573|FG002|Overall Study|Withdrawal by Subject|3|||
23573972|NCT02942004|65831571|FG000|Overall Study|Lost to Follow-up|1|||
23573973|NCT02942004|65831572|FG001|Overall Study|Lost to Follow-up|1|||
23573974|NCT02942004|65831573|FG002|Overall Study|Lost to Follow-up|2|||
23633299|NCT01912404|66042136|FG001|Overall Study|Due to personal reasons|0|||
23633300|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
23633301|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
23633302|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
23633303|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
23633304|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
23633305|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
23633306|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
23633307|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
23633308|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
23633309|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
23633310|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
23633311|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
23633312|NCT01216072|66042137|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
23633313|NCT01216072|66042138|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
23633314|NCT01216072|66042137|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
23633315|NCT01216072|66042138|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
23633316|NCT01216072|66042137|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
23633317|NCT01216072|66042138|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
23771669|NCT00602030|66543148|FG002|Double-blind Phase|Reason not specified|4|||
23573975|NCT02942004|65831571|FG000|Overall Study|Randomized but not dosed|3|||
23573976|NCT02942004|65831572|FG001|Overall Study|Randomized but not dosed|9|||
23573977|NCT02942004|65831573|FG002|Overall Study|Randomized but not dosed|4|||
23573978|NCT04793464|65831580|FG000|Overall Study|Lost to Follow-up|458|||
23573979|NCT04793464|65831581|FG001|Overall Study|Lost to Follow-up|168|||
23573980|NCT04793464|65831582|FG002|Overall Study|Lost to Follow-up|5|||
23573981|NCT04793464|65831580|FG000|Overall Study|Withdrawal by Subject|43|||
23573982|NCT04793464|65831581|FG001|Overall Study|Withdrawal by Subject|15|||
23573983|NCT04793464|65831582|FG002|Overall Study|Withdrawal by Subject|0|||
23573984|NCT00654238|65831583|FG000|Overall Study|Screen Failures|4|||
23573985|NCT04159896|65831584|FG000|Overall Study|Lack of Efficacy|7|||
23573986|NCT04159896|65831584|FG000|Overall Study|Withdrawal by Subject|1|||
23573987|NCT04159896|65831584|FG000|Overall Study|Adverse Event|1|||
23573988|NCT04159896|65831584|FG000|Overall Study|A transient ischaemic attack|1|||
23573989|NCT01383993|65831588|FG000|Overall Study|Adverse Event|1|||
23771670|NCT00602030|66543149|FG003|Double-blind Phase|Reason not specified|2|||
23771671|NCT00602030|66543150|FG004|Double-blind Phase|Reason not specified|0|||
23573990|NCT01383993|65831589|FG001|Overall Study|Adverse Event|1|||
23771672|NCT00602030|66543146|FG000|Crossover Phase|Disease Progression|0|||
23573991|NCT01383993|65831590|FG002|Overall Study|Adverse Event|0|||
23573992|NCT01383993|65831588|FG000|Overall Study|Withdrawal by Subject|0|||
23573993|NCT01383993|65831589|FG001|Overall Study|Withdrawal by Subject|0|||
23573994|NCT01383993|65831590|FG002|Overall Study|Withdrawal by Subject|1|||
23573995|NCT01383993|65831588|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
23573996|NCT01383993|65831589|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
23573997|NCT01383993|65831590|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
23573998|NCT00293462|65831593|FG000|Overall Study|Withdrawal by Subject|4|||
23573999|NCT00293462|65831594|FG001|Overall Study|Withdrawal by Subject|3|||
23574000|NCT00293462|65831595|FG002|Overall Study|Withdrawal by Subject|8|||
23574001|NCT00293462|65831593|FG000|Overall Study|Death|1|||
23771673|NCT00602030|66543147|FG001|Crossover Phase|Disease Progression|0|||
23771674|NCT00602030|66543148|FG002|Crossover Phase|Disease Progression|0|||
23832637|NCT02273388|66767709|FG007|Overall Study|Adverse Event study disease worse|6|||
23832638|NCT02273388|66767710|FG008|Overall Study|Adverse Event study disease worse|6|||
23832639|NCT02273388|66767711|FG009|Overall Study|Adverse Event study disease worse|5|||
23832640|NCT02273388|66767712|FG010|Overall Study|Adverse Event study disease worse|10|||
23832641|NCT02273388|66767713|FG011|Overall Study|Adverse Event study disease worse|1|||
23832642|NCT02273388|66767702|FG000|Overall Study|Sponsor decision|0|||
23832643|NCT02273388|66767703|FG001|Overall Study|Sponsor decision|0|||
23832644|NCT02273388|66767704|FG002|Overall Study|Sponsor decision|0|||
23832645|NCT02273388|66767705|FG003|Overall Study|Sponsor decision|0|||
23832646|NCT02273388|66767706|FG004|Overall Study|Sponsor decision|0|||
23832647|NCT02273388|66767707|FG005|Overall Study|Sponsor decision|0|||
23832648|NCT02273388|66767708|FG006|Overall Study|Sponsor decision|0|||
23832649|NCT02273388|66767709|FG007|Overall Study|Sponsor decision|0|||
23832650|NCT02273388|66767710|FG008|Overall Study|Sponsor decision|0|||
23832651|NCT02273388|66767711|FG009|Overall Study|Sponsor decision|0|||
23832652|NCT02273388|66767712|FG010|Overall Study|Sponsor decision|0|||
23832653|NCT02273388|66767713|FG011|Overall Study|Sponsor decision|1|||
23832654|NCT01808066|66767714|FG000|Overall Study|Withdrawal by Subject|15|||
23832655|NCT01464424|66767718|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
23832656|NCT01464424|66767719|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
23832657|NCT00391768|66767720|FG000|Overall Study|Withdrawal by Subject|0|||
23832658|NCT00391768|66767721|FG001|Overall Study|Withdrawal by Subject|0|||
23832659|NCT00391768|66767722|FG002|Overall Study|Withdrawal by Subject|1|||
23832660|NCT00391768|66767723|FG003|Overall Study|Withdrawal by Subject|0|||
23832661|NCT00391768|66767724|FG004|Overall Study|Withdrawal by Subject|0|||
23447280|NCT03920254|65377929|FG002|Overall Study|Study Terminated By Sponsor|12|||
23574002|NCT00293462|65831594|FG001|Overall Study|Death|0|||
23771675|NCT00602030|66543149|FG003|Crossover Phase|Disease Progression|0|||
23771676|NCT00602030|66543150|FG004|Crossover Phase|Disease Progression|11|||
23771677|NCT00602030|66543146|FG000|Crossover Phase|Adverse Event|0|||
23771678|NCT00602030|66543147|FG001|Crossover Phase|Adverse Event|0|||
23771679|NCT00602030|66543148|FG002|Crossover Phase|Adverse Event|0|||
23771680|NCT00602030|66543149|FG003|Crossover Phase|Adverse Event|0|||
23771681|NCT00602030|66543150|FG004|Crossover Phase|Adverse Event|3|||
23771682|NCT00602030|66543146|FG000|Crossover Phase|Consent withdrawal|0|||
23771683|NCT00602030|66543147|FG001|Crossover Phase|Consent withdrawal|0|||
23771684|NCT00602030|66543148|FG002|Crossover Phase|Consent withdrawal|0|||
23771685|NCT00602030|66543149|FG003|Crossover Phase|Consent withdrawal|0|||
23771686|NCT00602030|66543150|FG004|Crossover Phase|Consent withdrawal|2|||
23771687|NCT05546411|66543151|FG000|Overall Study|Progressive Disease|1|||
23771688|NCT05546411|66543152|FG001|Overall Study|Progressive Disease|0|||
23771689|NCT05546411|66543151|FG000|Overall Study|Adverse Event|0|||
23771690|NCT05546411|66543152|FG001|Overall Study|Adverse Event|1|||
23771691|NCT05546411|66543151|FG000|Overall Study|Metastatic disease|1|||
23771692|NCT05546411|66543152|FG001|Overall Study|Metastatic disease|0|||
23771693|NCT00812253|66543154|FG000|Overall Study|Withdrawal by Subject|3|||
23771694|NCT00812253|66543155|FG001|Overall Study|Withdrawal by Subject|2|||
23771695|NCT00812253|66543154|FG000|Overall Study|Protocol Violation|1|||
23771696|NCT00812253|66543155|FG001|Overall Study|Protocol Violation|1|||
23771697|NCT00812253|66543154|FG000|Overall Study|Lost to Follow-up|2|||
23771698|NCT00812253|66543155|FG001|Overall Study|Lost to Follow-up|0|||
23771699|NCT00429364|66543156|FG000|Overall Study|Withdrawal by Subject|11|||
23771700|NCT00429364|66543157|FG001|Overall Study|Withdrawal by Subject|5|||
23771701|NCT00429364|66543156|FG000|Overall Study|Physician Decision|4|||
23771702|NCT00429364|66543157|FG001|Overall Study|Physician Decision|2|||
23771703|NCT00429364|66543156|FG000|Overall Study|Lost to Follow-up|7|||
23771704|NCT00429364|66543157|FG001|Overall Study|Lost to Follow-up|6|||
23771705|NCT00429364|66543156|FG000|Overall Study|Death|0|||
23574003|NCT00293462|65831595|FG002|Overall Study|Death|0|||
23574004|NCT00293462|65831593|FG000|Overall Study|Lost to Follow-up|0|||
23771706|NCT00429364|66543157|FG001|Overall Study|Death|1|||
23771707|NCT00429364|66543156|FG000|Overall Study|Underwent aortic root surgery|10|||
23771708|NCT00429364|66543157|FG001|Overall Study|Underwent aortic root surgery|18|||
23832662|NCT00391768|66767725|FG005|Overall Study|Withdrawal by Subject|1|||
23832663|NCT00391768|66767726|FG006|Overall Study|Withdrawal by Subject|1|||
23832664|NCT00391768|66767720|FG000|Overall Study|Lost to Follow-up|0|||
23832665|NCT00391768|66767721|FG001|Overall Study|Lost to Follow-up|0|||
23832666|NCT00391768|66767722|FG002|Overall Study|Lost to Follow-up|0|||
23832667|NCT00391768|66767723|FG003|Overall Study|Lost to Follow-up|1|||
23832668|NCT00391768|66767724|FG004|Overall Study|Lost to Follow-up|2|||
23832669|NCT00391768|66767725|FG005|Overall Study|Lost to Follow-up|2|||
23832670|NCT00391768|66767726|FG006|Overall Study|Lost to Follow-up|3|||
23832671|NCT01252095|66767734|FG000|Overall Study|Disease progression|1|||
23832672|NCT01252095|66767735|FG001|Overall Study|Disease progression|0|||
23832673|NCT02286713|66767738|FG000|One Week Follow-Up|Death|1|||
23832674|NCT02286713|66767739|FG001|One Week Follow-Up|Death|0|||
23832675|NCT02286713|66767738|FG000|One Week Follow-Up|Lost to Follow-up|17|||
23633318|NCT01216072|66042137|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
23633319|NCT01216072|66042138|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
23633320|NCT00842244|66042139|FG000|Overall Study|Death|3|||
23574005|NCT00293462|65831594|FG001|Overall Study|Lost to Follow-up|1|||
23574006|NCT00293462|65831595|FG002|Overall Study|Lost to Follow-up|0|||
23574007|NCT00293462|65831593|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
23574008|NCT00293462|65831594|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
23574009|NCT00293462|65831595|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
23574010|NCT00293462|65831593|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
23574011|NCT00293462|65831594|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
23574012|NCT00293462|65831595|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
23574013|NCT00293462|65831593|FG000|Overall Study|Refuse Radiation Treatment|1|||
23574014|NCT00293462|65831594|FG001|Overall Study|Refuse Radiation Treatment|0|||
23574015|NCT00293462|65831595|FG002|Overall Study|Refuse Radiation Treatment|0|||
23574016|NCT00293462|65831593|FG000|Overall Study|No Show|0|||
23574017|NCT00293462|65831594|FG001|Overall Study|No Show|0|||
23574018|NCT00293462|65831595|FG002|Overall Study|No Show|1|||
23574019|NCT00293462|65831593|FG000|Overall Study|Went back to his home country|0|||
23574020|NCT00293462|65831594|FG001|Overall Study|Went back to his home country|0|||
23574021|NCT00293462|65831595|FG002|Overall Study|Went back to his home country|1|||
23574022|NCT00293462|65831593|FG000|Overall Study|Blood clot after chemotherapy|0|||
23574023|NCT00293462|65831594|FG001|Overall Study|Blood clot after chemotherapy|0|||
23771709|NCT00429364|66543156|FG000|Overall Study|Pregnancy|0|||
23771710|NCT00429364|66543157|FG001|Overall Study|Pregnancy|1|||
23771711|NCT00948675|66543161|FG000|Overall Study|Lost to Follow-up|1|||
23771712|NCT00948675|66543162|FG001|Overall Study|Lost to Follow-up|0|||
23771713|NCT01440283|66543163|FG000|Overall Study|Death|3|||
23771714|NCT01440283|66543163|FG000|Overall Study|Withdrawal by Subject|4|||
23771715|NCT01440283|66543163|FG000|Overall Study|Physician Decision|3|||
23771716|NCT00841100|66543164|FG000|Phase 1 (28 Days)|Adverse Event|1|||
23771717|NCT00841100|66543164|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
23771718|NCT01720264|66543165|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
23771719|NCT01720264|66543165|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
23771720|NCT01720264|66543165|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
23771721|NCT03679741|66543166|FG000|Period 1|No longer meet eligibility criteria|1|||
23771722|NCT03679741|66543167|FG001|Period 1|No longer meet eligibility criteria|0|||
23771723|NCT03679741|66543166|FG000|Period 1|Lost to Follow-up|0|||
23771724|NCT03679741|66543167|FG001|Period 1|Lost to Follow-up|1|||
23771725|NCT03679741|66543166|FG000|Period 1|Adverse Event|1|||
23771726|NCT03679741|66543167|FG001|Period 1|Adverse Event|1|||
23771727|NCT03679741|66543166|FG000|Period 1|Withdrawal by Subject|0|||
23771728|NCT03679741|66543167|FG001|Period 1|Withdrawal by Subject|1|||
23771729|NCT03679741|66543166|FG000|Period 2|Adverse Event|2|||
23771730|NCT03679741|66543167|FG001|Period 2|Adverse Event|1|||
23771731|NCT03679741|66543166|FG000|Period 2|Withdrawal by Subject|1|||
23771732|NCT03679741|66543167|FG001|Period 2|Withdrawal by Subject|1|||
23771733|NCT00555009|66543169|FG000|Overall Study|Withdrawal by Subject|0|||
23771734|NCT00555009|66543170|FG001|Overall Study|Withdrawal by Subject|1|||
23771735|NCT00555009|66543169|FG000|Overall Study|Terminated by Sponsor|2|||
23771736|NCT00555009|66543170|FG001|Overall Study|Terminated by Sponsor|5|||
23771737|NCT03717064|66543179|FG000|Period 2|Adverse Event|1|||
23771738|NCT01238848|66543180|FG000|Overall Study|Physician Decision|13|||
23771739|NCT01238848|66543181|FG001|Overall Study|Physician Decision|5|||
23771740|NCT04117607|66543182|FG000|Overall Study|Early Termination|0|||
23771741|NCT04117607|66543183|FG001|Overall Study|Early Termination|1|||
23771742|NCT04117607|66543184|FG002|Overall Study|Early Termination|0|||
23574024|NCT00293462|65831595|FG002|Overall Study|Blood clot after chemotherapy|1|||
23574025|NCT00293462|65831593|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
23771743|NCT04117607|66543185|FG003|Overall Study|Early Termination|0|||
23771744|NCT04117607|66543186|FG004|Overall Study|Early Termination|0|||
23574026|NCT00293462|65831594|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
23633321|NCT00842244|66042139|FG000|Overall Study|Withdrawal by Subject|1|||
23771745|NCT04117607|66543187|FG005|Overall Study|Early Termination|0|||
23771746|NCT04117607|66543188|FG006|Overall Study|Early Termination|1|||
23771747|NCT04117607|66543189|FG007|Overall Study|Early Termination|0|||
23832676|NCT02286713|66767739|FG001|One Week Follow-Up|Lost to Follow-up|21|||
23832677|NCT02286713|66767738|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
23832678|NCT02286713|66767739|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
23633322|NCT00842244|66042139|FG000|Overall Study|Other|17|||
23633323|NCT00794924|66042140|FG000|Overall Study|Lost to Follow-up|6|||
23633324|NCT00794924|66042141|FG001|Overall Study|Lost to Follow-up|8|||
23633325|NCT00794924|66042140|FG000|Overall Study|Withdrawal by Subject|48|||
23633326|NCT00794924|66042141|FG001|Overall Study|Withdrawal by Subject|60|||
23633327|NCT00794924|66042140|FG000|Overall Study|Adverse Event|6|||
23633328|NCT00794924|66042141|FG001|Overall Study|Adverse Event|2|||
23633329|NCT01727505|66042144|FG000|First 24 Hours|Adverse Event|0|||
23633330|NCT01727505|66042145|FG001|First 24 Hours|Adverse Event|1|||
23633331|NCT01727505|66042144|FG000|Second 24 Hours|Missing data|0|||
23633332|NCT01727505|66042145|FG001|Second 24 Hours|Missing data|1|||
23633333|NCT01377389|66042146|FG000|Overall Study|Withdrawal by Subject|1|||
23633334|NCT01377389|66042146|FG000|Overall Study|Screen failure|2|||
23633335|NCT00504777|66042147|FG000|Overall Study|Adverse Event|1|||
23633336|NCT02336451|66042149|FG000|Overall Study|Adverse Event|1|||
23633337|NCT02336451|66042150|FG001|Overall Study|Adverse Event|2|||
23633338|NCT02336451|66042151|FG002|Overall Study|Adverse Event|0|||
23633339|NCT02336451|66042152|FG003|Overall Study|Adverse Event|6|||
23633340|NCT02336451|66042153|FG004|Overall Study|Adverse Event|4|||
23633341|NCT02336451|66042149|FG000|Overall Study|Death|6|||
23633342|NCT02336451|66042150|FG001|Overall Study|Death|2|||
23633343|NCT02336451|66042151|FG002|Overall Study|Death|3|||
23447281|NCT03920254|65377927|FG000|Overall Study|Withdrawal by Subject|0|||
23447282|NCT03920254|65377928|FG001|Overall Study|Withdrawal by Subject|0|||
23447283|NCT03920254|65377929|FG002|Overall Study|Withdrawal by Subject|1|||
23447284|NCT02915263|65377932|FG000|Overall Study|Covid|3|||
23633344|NCT02336451|66042152|FG003|Overall Study|Death|6|||
23633345|NCT02336451|66042153|FG004|Overall Study|Death|6|||
23633346|NCT02336451|66042149|FG000|Overall Study|Physician Decision|9|||
23633347|NCT02336451|66042150|FG001|Overall Study|Physician Decision|6|||
23633348|NCT02336451|66042151|FG002|Overall Study|Physician Decision|7|||
23633349|NCT02336451|66042152|FG003|Overall Study|Physician Decision|16|||
23633350|NCT02336451|66042153|FG004|Overall Study|Physician Decision|3|||
23633351|NCT02336451|66042149|FG000|Overall Study|Progressive disease|23|||
23633352|NCT02336451|66042150|FG001|Overall Study|Progressive disease|26|||
23771748|NCT04117607|66543190|FG008|Overall Study|Early Termination|0|||
23771749|NCT04117607|66543191|FG009|Overall Study|Early Termination|0|||
23771750|NCT04117607|66543192|FG010|Overall Study|Early Termination|0|||
23771751|NCT04117607|66543193|FG011|Overall Study|Early Termination|0|||
23771752|NCT04117607|66543194|FG012|Overall Study|Early Termination|0|||
23771753|NCT04117607|66543195|FG013|Overall Study|Early Termination|0|||
23771754|NCT01574248|66543200|FG000|Overall Study|Withdrawal by Subject|2|||
23771755|NCT01574248|66543201|FG001|Overall Study|Withdrawal by Subject|0|||
23771756|NCT01574248|66543200|FG000|Overall Study|Missing primary endpoint data|1|||
23771757|NCT01574248|66543201|FG001|Overall Study|Missing primary endpoint data|0|||
23771758|NCT00379340|66543202|FG000|Overall Study|Death|0|||
23771759|NCT00379340|66543203|FG001|Overall Study|Death|0|||
23771760|NCT00379340|66543204|FG002|Overall Study|Death|0|||
23771761|NCT00379340|66543205|FG003|Overall Study|Death|2|||
23771762|NCT00379340|66543206|FG004|Overall Study|Death|0|||
23771763|NCT00379340|66543202|FG000|Overall Study|Lack of Efficacy|6|||
23771764|NCT00379340|66543203|FG001|Overall Study|Lack of Efficacy|1|||
23771765|NCT00379340|66543204|FG002|Overall Study|Lack of Efficacy|0|||
23771766|NCT00379340|66543205|FG003|Overall Study|Lack of Efficacy|4|||
23771767|NCT00379340|66543206|FG004|Overall Study|Lack of Efficacy|3|||
23771768|NCT00379340|66543202|FG000|Overall Study|Physician Decision|6|||
23771769|NCT00379340|66543203|FG001|Overall Study|Physician Decision|2|||
23771770|NCT00379340|66543204|FG002|Overall Study|Physician Decision|1|||
23771771|NCT00379340|66543205|FG003|Overall Study|Physician Decision|2|||
23771772|NCT00379340|66543206|FG004|Overall Study|Physician Decision|3|||
23771773|NCT00379340|66543202|FG000|Overall Study|Withdrawal by Subject|0|||
23771774|NCT00379340|66543203|FG001|Overall Study|Withdrawal by Subject|0|||
23771775|NCT00379340|66543204|FG002|Overall Study|Withdrawal by Subject|0|||
23771776|NCT00379340|66543205|FG003|Overall Study|Withdrawal by Subject|1|||
23771777|NCT00379340|66543206|FG004|Overall Study|Withdrawal by Subject|0|||
23771778|NCT00379340|66543202|FG000|Overall Study|Refusal of further protocol therapy|1|||
23771779|NCT00379340|66543203|FG001|Overall Study|Refusal of further protocol therapy|0|||
23771780|NCT00379340|66543204|FG002|Overall Study|Refusal of further protocol therapy|1|||
23771781|NCT00379340|66543205|FG003|Overall Study|Refusal of further protocol therapy|1|||
23771782|NCT00379340|66543206|FG004|Overall Study|Refusal of further protocol therapy|7|||
23771783|NCT00379340|66543202|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
23771784|NCT00379340|66543203|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
23447285|NCT02915263|65377933|FG001|Overall Study|Covid|2|||
23633353|NCT02336451|66042151|FG002|Overall Study|Progressive disease|2|||
23633354|NCT02336451|66042152|FG003|Overall Study|Progressive disease|14|||
23633355|NCT02336451|66042153|FG004|Overall Study|Progressive disease|4|||
23832679|NCT02286713|66767738|FG000|Three Month Follow-Up|Death|1|||
23633356|NCT02336451|66042149|FG000|Overall Study|Protocol Violation|1|||
23633357|NCT02336451|66042150|FG001|Overall Study|Protocol Violation|0|||
23633358|NCT02336451|66042151|FG002|Overall Study|Protocol Violation|0|||
23832680|NCT02286713|66767739|FG001|Three Month Follow-Up|Death|1|||
23832681|NCT02286713|66767738|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
23832682|NCT02286713|66767739|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
23832683|NCT02286713|66767738|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
23832684|NCT02286713|66767739|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
23832685|NCT02286713|66767738|FG000|Six Month Follow-Up|Death|2|||
23832686|NCT02286713|66767739|FG001|Six Month Follow-Up|Death|0|||
23832687|NCT02286713|66767738|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
23832688|NCT02286713|66767739|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
23832689|NCT03307252|66767740|FG000|Part 2, Period 1|Treatment not received|0|||
23832690|NCT03307252|66767741|FG001|Part 2, Period 1|Treatment not received|0|||
23832691|NCT03307252|66767742|FG002|Part 2, Period 1|Treatment not received|0|||
23832692|NCT03307252|66767743|FG003|Part 2, Period 1|Treatment not received|0|||
23832693|NCT03307252|66767744|FG004|Part 2, Period 1|Treatment not received|0|||
23832694|NCT03307252|66767745|FG005|Part 2, Period 1|Treatment not received|1|||
23832695|NCT03307252|66767746|FG006|Part 2, Period 1|Treatment not received|0|||
23832696|NCT03307252|66767747|FG007|Part 2, Period 1|Treatment not received|0|||
23832697|NCT03307252|66767748|FG008|Part 2, Period 1|Treatment not received|0|||
23832698|NCT03307252|66767749|FG009|Part 2, Period 1|Treatment not received|0|||
23832699|NCT03307252|66767750|FG010|Part 2, Period 1|Treatment not received|0|||
23832700|NCT03307252|66767740|FG000|Part 2, Period 3|Other than listed|0|||
23832701|NCT03307252|66767741|FG001|Part 2, Period 3|Other than listed|0|||
23832702|NCT03307252|66767742|FG002|Part 2, Period 3|Other than listed|0|||
23832703|NCT03307252|66767743|FG003|Part 2, Period 3|Other than listed|0|||
23832704|NCT03307252|66767744|FG004|Part 2, Period 3|Other than listed|1|||
23832705|NCT03307252|66767745|FG005|Part 2, Period 3|Other than listed|0|||
23832706|NCT03307252|66767746|FG006|Part 2, Period 3|Other than listed|0|||
23832707|NCT03307252|66767747|FG007|Part 2, Period 3|Other than listed|0|||
23832708|NCT03307252|66767748|FG008|Part 2, Period 3|Other than listed|0|||
23832709|NCT03307252|66767749|FG009|Part 2, Period 3|Other than listed|0|||
23832710|NCT03307252|66767750|FG010|Part 2, Period 3|Other than listed|0|||
23832711|NCT03307252|66767740|FG000|Part 2, Period 4|Other than listed|0|||
23832712|NCT03307252|66767741|FG001|Part 2, Period 4|Other than listed|0|||
23832713|NCT03307252|66767742|FG002|Part 2, Period 4|Other than listed|0|||
23574027|NCT00293462|65831595|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
23574028|NCT00293462|65831593|FG000|Overall Study|Possible Tracheostomy leakage|0|||
23832714|NCT03307252|66767743|FG003|Part 2, Period 4|Other than listed|0|||
23832715|NCT03307252|66767744|FG004|Part 2, Period 4|Other than listed|0|||
23832716|NCT03307252|66767745|FG005|Part 2, Period 4|Other than listed|0|||
23832717|NCT03307252|66767746|FG006|Part 2, Period 4|Other than listed|1|||
23832718|NCT03307252|66767747|FG007|Part 2, Period 4|Other than listed|0|||
23832719|NCT03307252|66767748|FG008|Part 2, Period 4|Other than listed|0|||
23832720|NCT03307252|66767749|FG009|Part 2, Period 4|Other than listed|0|||
23832721|NCT03307252|66767750|FG010|Part 2, Period 4|Other than listed|0|||
23832722|NCT03307252|66767740|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832723|NCT03307252|66767741|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832724|NCT03307252|66767742|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832725|NCT03307252|66767743|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832726|NCT03307252|66767744|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832727|NCT03307252|66767745|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832728|NCT03307252|66767746|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832729|NCT03307252|66767747|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832730|NCT03307252|66767748|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832731|NCT03307252|66767749|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23832732|NCT03307252|66767750|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
23832733|NCT03367819|66767751|FG000|Overall Study|Adverse Event|4|||
23832734|NCT03367819|66767752|FG001|Overall Study|Adverse Event|4|||
23832735|NCT03367819|66767751|FG000|Overall Study|Progressive Disease|15|||
23832736|NCT03367819|66767752|FG001|Overall Study|Progressive Disease|13|||
23574029|NCT00293462|65831594|FG001|Overall Study|Possible Tracheostomy leakage|1|||
23574030|NCT00293462|65831595|FG002|Overall Study|Possible Tracheostomy leakage|0|||
23574031|NCT00293462|65831593|FG000|Overall Study|Low radiation dose in oral cavity|0|||
23574032|NCT00293462|65831594|FG001|Overall Study|Low radiation dose in oral cavity|1|||
23832737|NCT03367819|66767751|FG000|Overall Study|Withdrawal by Subject|1|||
23574033|NCT00293462|65831595|FG002|Overall Study|Low radiation dose in oral cavity|0|||
23574034|NCT00293462|65831593|FG000|Overall Study|Physician Decision|0|||
23832738|NCT03367819|66767752|FG001|Overall Study|Withdrawal by Subject|0|||
23832739|NCT03367819|66767751|FG000|Overall Study|Other|4|||
23832740|NCT03367819|66767752|FG001|Overall Study|Other|2|||
23832741|NCT01205269|66767753|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23832742|NCT01205269|66767754|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23832743|NCT01205269|66767755|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23447286|NCT00950846|65377934|FG000|Overall Study|Death|6|||
23832744|NCT01205269|66767756|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
23832745|NCT01205269|66767757|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23832746|NCT01205269|66767758|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23447287|NCT00950846|65377934|FG000|Overall Study|Lost to Follow-up|3|||
23574035|NCT00293462|65831594|FG001|Overall Study|Physician Decision|1|||
23574036|NCT00293462|65831595|FG002|Overall Study|Physician Decision|0|||
23574037|NCT00463151|65831603|FG000|Overall Study|Adverse Event|0|||
23574038|NCT00463151|65831604|FG001|Overall Study|Adverse Event|0|||
23574039|NCT00463151|65831605|FG002|Overall Study|Adverse Event|1|||
23574040|NCT00463151|65831606|FG003|Overall Study|Adverse Event|0|||
23574041|NCT00463151|65831603|FG000|Overall Study|Lack of Efficacy|2|||
23574042|NCT00463151|65831604|FG001|Overall Study|Lack of Efficacy|5|||
23574043|NCT00463151|65831605|FG002|Overall Study|Lack of Efficacy|2|||
23574044|NCT00463151|65831606|FG003|Overall Study|Lack of Efficacy|5|||
23574045|NCT00463151|65831603|FG000|Overall Study|Protocol Violation|0|||
23574046|NCT00463151|65831604|FG001|Overall Study|Protocol Violation|0|||
23574047|NCT00463151|65831605|FG002|Overall Study|Protocol Violation|0|||
23574048|NCT00463151|65831606|FG003|Overall Study|Protocol Violation|1|||
23574049|NCT00463151|65831603|FG000|Overall Study|Withdrawal by Subject|0|||
23574050|NCT00463151|65831604|FG001|Overall Study|Withdrawal by Subject|0|||
23574051|NCT00463151|65831605|FG002|Overall Study|Withdrawal by Subject|0|||
23574052|NCT00463151|65831606|FG003|Overall Study|Withdrawal by Subject|1|||
23574053|NCT03095599|65831631|FG000|Overall Study|Withdrawal by Subject|1|||
23574054|NCT03095599|65831632|FG001|Overall Study|Withdrawal by Subject|0|||
23574055|NCT03095599|65831631|FG000|Overall Study|Lost to Follow-up|1|||
23574056|NCT03095599|65831632|FG001|Overall Study|Lost to Follow-up|0|||
23574057|NCT03095599|65831631|FG000|Overall Study|Withdrawal prior to vaccination|1|||
23574058|NCT03095599|65831632|FG001|Overall Study|Withdrawal prior to vaccination|0|||
23574059|NCT01316692|65831633|FG000|Overall Study|Adverse Event|5|||
23574060|NCT01316692|65831633|FG000|Overall Study|Disease Progression|7|||
23574061|NCT01167179|65831637|FG000|Overall Study|disease recurrence|4|||
23574062|NCT01167179|65831638|FG001|Overall Study|disease recurrence|4|||
23574063|NCT01167179|65831637|FG000|Overall Study|Death|4|||
23633359|NCT02336451|66042152|FG003|Overall Study|Protocol Violation|0|||
23633360|NCT02336451|66042153|FG004|Overall Study|Protocol Violation|0|||
23633361|NCT02336451|66042149|FG000|Overall Study|Patient/guardian decision|2|||
23633362|NCT02336451|66042150|FG001|Overall Study|Patient/guardian decision|4|||
23633363|NCT02336451|66042151|FG002|Overall Study|Patient/guardian decision|0|||
23633364|NCT02336451|66042152|FG003|Overall Study|Patient/guardian decision|2|||
23633365|NCT02336451|66042153|FG004|Overall Study|Patient/guardian decision|1|||
23633366|NCT04829747|66042154|FG000|Overall Study|Protocol Violation|1|||
23633367|NCT00600613|66042155|FG000|Overall Study|Protocol Deviation|1|||
23633368|NCT03834519|66042156|FG000|Overall Study|Ongoing|234|||
23633369|NCT03834519|66042157|FG001|Overall Study|Ongoing|111|||
23633370|NCT03834519|66042156|FG000|Overall Study|Withdrawal by Subject|4|||
23633371|NCT03834519|66042157|FG001|Overall Study|Withdrawal by Subject|7|||
23633372|NCT03834519|66042156|FG000|Overall Study|Death|291|||
23633373|NCT03834519|66042157|FG001|Overall Study|Death|146|||
23633374|NCT01371825|66042161|FG000|Overall Study|Death|4|||
23633375|NCT00581477|66042162|FG000|Overall Study|Physician Decision|2|||
23633376|NCT03232931|66045292|FG000|Overall Study|Physician Decision|1|||
23633377|NCT03232931|66045293|FG001|Overall Study|Physician Decision|1|||
23633378|NCT03232931|66045292|FG000|Overall Study|Withdrawal by Subject|6|||
23633379|NCT03232931|66045293|FG001|Overall Study|Withdrawal by Subject|0|||
23633380|NCT03232931|66045292|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
23447288|NCT00950846|65377934|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
23633381|NCT03232931|66045293|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
23633382|NCT03232931|66045292|FG000|Overall Study|Parent did not record voice|1|||
23633383|NCT03232931|66045293|FG001|Overall Study|Parent did not record voice|2|||
23633384|NCT03232931|66045292|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
23633385|NCT03232931|66045293|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
23633386|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
23633387|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
23633388|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
23633389|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
23633390|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
23633391|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
23832747|NCT01113892|66767759|FG000|Overall Study|Lost to Follow-up|2|||
23832748|NCT01113892|66767760|FG001|Overall Study|Lost to Follow-up|2|||
23574064|NCT01167179|65831638|FG001|Overall Study|Death|10|||
23574065|NCT01167179|65831637|FG000|Overall Study|Withdrawal by Subject|1|||
23574066|NCT01167179|65831638|FG001|Overall Study|Withdrawal by Subject|2|||
23574067|NCT01167179|65831637|FG000|Overall Study|diverse|6|||
23832749|NCT01113892|66767759|FG000|Overall Study|Withdrawal by Subject|1|||
23832750|NCT01113892|66767760|FG001|Overall Study|Withdrawal by Subject|1|||
23832751|NCT01113892|66767759|FG000|Overall Study|Death|2|||
23832752|NCT01113892|66767760|FG001|Overall Study|Death|4|||
23832753|NCT01113892|66767759|FG000|Overall Study|Graft no longer evaluable|9|||
23832754|NCT01113892|66767760|FG001|Overall Study|Graft no longer evaluable|9|||
23832755|NCT01290068|66767761|FG000|Overall Study|Adverse Event|1|||
23832756|NCT01290068|66767762|FG001|Overall Study|Adverse Event|3|||
23832757|NCT01290068|66767761|FG000|Overall Study|Lost to Follow-up|3|||
23832758|NCT01290068|66767762|FG001|Overall Study|Lost to Follow-up|0|||
23832759|NCT01290068|66767761|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
23832760|NCT01290068|66767762|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
23832761|NCT01290068|66767761|FG000|Overall Study|Other|3|||
23832762|NCT01290068|66767762|FG001|Overall Study|Other|1|||
23832763|NCT00982657|66767763|FG000|Overall Study|Death|1|||
23832764|NCT00982657|66767764|FG001|Overall Study|Death|0|||
23832765|NCT00982657|66767765|FG002|Overall Study|Death|1|||
23832766|NCT00982657|66767766|FG003|Overall Study|Death|1|||
23832767|NCT00982657|66767763|FG000|Overall Study|Withdrawal by Subject|0|||
23832768|NCT00982657|66767764|FG001|Overall Study|Withdrawal by Subject|0|||
23832769|NCT00982657|66767765|FG002|Overall Study|Withdrawal by Subject|1|||
23832770|NCT00982657|66767766|FG003|Overall Study|Withdrawal by Subject|3|||
23832771|NCT00982657|66767763|FG000|Overall Study|Other|0|||
23832772|NCT00982657|66767764|FG001|Overall Study|Other|0|||
23832773|NCT00982657|66767765|FG002|Overall Study|Other|0|||
23832774|NCT00982657|66767766|FG003|Overall Study|Other|4|||
23832775|NCT00982657|66767763|FG000|Overall Study|On going at date of cut-off|0|||
23832776|NCT00982657|66767764|FG001|Overall Study|On going at date of cut-off|0|||
23832777|NCT00982657|66767765|FG002|Overall Study|On going at date of cut-off|0|||
23832778|NCT00982657|66767766|FG003|Overall Study|On going at date of cut-off|1|||
23832779|NCT00678210|66767770|FG000|Overall Study|Adverse Event|1|||
23832780|NCT00678210|66767771|FG001|Overall Study|Adverse Event|2|||
23832781|NCT00678210|66767772|FG002|Overall Study|Adverse Event|3|||
23832782|NCT00678210|66767773|FG003|Overall Study|Adverse Event|3|||
23832783|NCT00678210|66767770|FG000|Overall Study|Lack of Efficacy|2|||
23832784|NCT00678210|66767771|FG001|Overall Study|Lack of Efficacy|3|||
23832785|NCT00678210|66767772|FG002|Overall Study|Lack of Efficacy|1|||
23832786|NCT00678210|66767773|FG003|Overall Study|Lack of Efficacy|9|||
23832787|NCT00678210|66767770|FG000|Overall Study|Lost to Follow-up|4|||
23832788|NCT00678210|66767771|FG001|Overall Study|Lost to Follow-up|2|||
23832789|NCT00678210|66767772|FG002|Overall Study|Lost to Follow-up|0|||
23832790|NCT00678210|66767773|FG003|Overall Study|Lost to Follow-up|1|||
23447289|NCT00732875|65377935|FG000|Overall Study|Adverse Event|16|||
23574068|NCT01167179|65831638|FG001|Overall Study|diverse|5|||
23574069|NCT00278564|65831639|FG000|Overall Study|Lack of Efficacy|4|||
23574070|NCT00777803|65831642|FG000|Overall Study|Lost to Follow-up|12|||
23574071|NCT00777803|65831643|FG001|Overall Study|Lost to Follow-up|5|||
23574072|NCT00777803|65831642|FG000|Overall Study|Adverse Event|1|||
23574073|NCT00777803|65831643|FG001|Overall Study|Adverse Event|0|||
23574074|NCT00777803|65831642|FG000|Overall Study|Non-compliance|2|||
23574075|NCT00777803|65831643|FG001|Overall Study|Non-compliance|2|||
23574076|NCT00873093|65831644|FG000|Overall Study|Adverse Event|0|||
23574077|NCT00873093|65831645|FG001|Overall Study|Adverse Event|2|||
23574078|NCT00873093|65831646|FG002|Overall Study|Adverse Event|0|||
23574079|NCT00873093|65831647|FG003|Overall Study|Adverse Event|0|||
23574080|NCT00873093|65831648|FG004|Overall Study|Adverse Event|0|||
23574081|NCT00873093|65831644|FG000|Overall Study|Death|0|||
23574082|NCT00873093|65831645|FG001|Overall Study|Death|3|||
23574083|NCT00873093|65831646|FG002|Overall Study|Death|2|||
23574084|NCT00873093|65831647|FG003|Overall Study|Death|0|||
23574085|NCT00873093|65831648|FG004|Overall Study|Death|0|||
23574086|NCT00873093|65831644|FG000|Overall Study|Physician Decision|0|||
23574087|NCT00873093|65831645|FG001|Overall Study|Physician Decision|17|||
23771785|NCT00379340|66543204|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
23771786|NCT00379340|66543205|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
23771787|NCT00379340|66543206|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
23771788|NCT00379340|66543202|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
23771789|NCT00379340|66543203|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
23771790|NCT00379340|66543204|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
23771791|NCT00379340|66543205|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
23771792|NCT00379340|66543206|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
23771793|NCT01513148|66543211|FG000|Overall Study|Protocol Violation|2|||
23771794|NCT01513148|66543212|FG001|Overall Study|Protocol Violation|2|||
23771795|NCT00449150|66543213|FG000|Overall Study|Adverse Event|11|||
23771796|NCT00449150|66543214|FG001|Overall Study|Adverse Event|18|||
23771797|NCT00449150|66543215|FG002|Overall Study|Adverse Event|9|||
23771798|NCT00449150|66543213|FG000|Overall Study|Lack of Efficacy|1|||
23771799|NCT00449150|66543214|FG001|Overall Study|Lack of Efficacy|2|||
23771800|NCT00449150|66543215|FG002|Overall Study|Lack of Efficacy|2|||
23771801|NCT00449150|66543213|FG000|Overall Study|Other|16|||
23574088|NCT00873093|65831646|FG002|Overall Study|Physician Decision|10|||
23574089|NCT00873093|65831647|FG003|Overall Study|Physician Decision|10|||
23574090|NCT00873093|65831648|FG004|Overall Study|Physician Decision|2|||
23832791|NCT00678210|66767770|FG000|Overall Study|Withdrawal by Subject|3|||
23832792|NCT00678210|66767771|FG001|Overall Study|Withdrawal by Subject|4|||
23832793|NCT00678210|66767772|FG002|Overall Study|Withdrawal by Subject|1|||
23832794|NCT00678210|66767773|FG003|Overall Study|Withdrawal by Subject|7|||
23832795|NCT00678210|66767770|FG000|Overall Study|Other|1|||
23832796|NCT00678210|66767771|FG001|Overall Study|Other|0|||
23832797|NCT00678210|66767772|FG002|Overall Study|Other|1|||
23832798|NCT00678210|66767773|FG003|Overall Study|Other|0|||
23832799|NCT01293695|66767776|FG000|Overall Study|Withdrawal by Subject|7|||
23832800|NCT01293695|66767777|FG001|Overall Study|Withdrawal by Subject|1|||
23447290|NCT00732875|65377935|FG000|Overall Study|Withdrawal by Subject|6|||
23447291|NCT00732875|65377935|FG000|Overall Study|Lack of Efficacy|13|||
23771802|NCT00449150|66543214|FG001|Overall Study|Other|13|||
23771803|NCT00449150|66543215|FG002|Overall Study|Other|14|||
23771804|NCT00449150|66543213|FG000|Overall Study|Withdrawal by Subject|17|||
23771805|NCT00449150|66543214|FG001|Overall Study|Withdrawal by Subject|18|||
23771806|NCT00449150|66543215|FG002|Overall Study|Withdrawal by Subject|21|||
23771807|NCT00449150|66543213|FG000|Overall Study|Protocol Violation|1|||
23771808|NCT00449150|66543214|FG001|Overall Study|Protocol Violation|2|||
23771809|NCT00449150|66543215|FG002|Overall Study|Protocol Violation|1|||
23771810|NCT01856309|66543222|FG000|Overall Study|Death|4|||
23771811|NCT01856309|66543223|FG001|Overall Study|Death|6|||
23771812|NCT01856309|66543224|FG002|Overall Study|Death|11|||
23771813|NCT01856309|66543225|FG003|Overall Study|Death|6|||
23771814|NCT01856309|66543222|FG000|Overall Study|Lost to Follow-up|6|||
23832801|NCT01293695|66767776|FG000|Overall Study|Lost to Follow-up|8|||
23447292|NCT01632020|65377936|FG000|Overall Study|Withdrawal by Subject|1|||
23447293|NCT01632020|65377937|FG001|Overall Study|Withdrawal by Subject|0|||
23447294|NCT01632020|65377936|FG000|Overall Study|Adverse Event|1|||
23447295|NCT01632020|65377937|FG001|Overall Study|Adverse Event|0|||
23447296|NCT01774799|65377938|FG000|Overall Study|Lost to Follow-up|1|||
23447297|NCT01774799|65377939|FG001|Overall Study|Lost to Follow-up|1|||
23447298|NCT01774799|65377940|FG002|Overall Study|Lost to Follow-up|0|||
23447299|NCT01774799|65377941|FG003|Overall Study|Lost to Follow-up|0|||
23447300|NCT04303559|65377945|FG000|Overall Study|Study closed due to poor enrollment.|1|||
23447301|NCT03384940|65380401|FG000|Overall Study|Progressive disease|36|||
23447302|NCT03384940|65380402|FG001|Overall Study|Progressive disease|11|||
23447303|NCT03384940|65380403|FG002|Overall Study|Progressive disease|13|||
23447304|NCT03384940|65380401|FG000|Overall Study|Clinical progression|4|||
23574091|NCT00873093|65831644|FG000|Overall Study|Withdrawal by Subject|1|||
23574092|NCT00873093|65831645|FG001|Overall Study|Withdrawal by Subject|4|||
23574093|NCT00873093|65831646|FG002|Overall Study|Withdrawal by Subject|4|||
23574094|NCT00873093|65831647|FG003|Overall Study|Withdrawal by Subject|0|||
23574095|NCT00873093|65831648|FG004|Overall Study|Withdrawal by Subject|0|||
23574096|NCT00873093|65831644|FG000|Overall Study|Ineligible|0|||
23574097|NCT00873093|65831645|FG001|Overall Study|Ineligible|1|||
23574098|NCT00873093|65831646|FG002|Overall Study|Ineligible|0|||
23574099|NCT00873093|65831647|FG003|Overall Study|Ineligible|1|||
23574100|NCT00873093|65831648|FG004|Overall Study|Ineligible|0|||
23574101|NCT01083160|65831653|FG000|Overall Study|Adverse Event|1|||
23574102|NCT03398356|65831655|FG000|Before Treatment|Lost to Follow-up|1|||
23574103|NCT03398356|65831656|FG001|Before Treatment|Lost to Follow-up|2|||
23574104|NCT03398356|65831657|FG002|Before Treatment|Lost to Follow-up|0|||
23574105|NCT03398356|65831655|FG000|Before Treatment|drug intolerance|2|||
23574106|NCT03398356|65831656|FG001|Before Treatment|drug intolerance|1|||
23574107|NCT03398356|65831657|FG002|Before Treatment|drug intolerance|0|||
23574108|NCT03398356|65831655|FG000|Before Treatment|Withdrawal by Subject|0|||
23574109|NCT03398356|65831656|FG001|Before Treatment|Withdrawal by Subject|5|||
23574110|NCT03398356|65831657|FG002|Before Treatment|Withdrawal by Subject|0|||
23574111|NCT03398356|65831655|FG000|Before Treatment|Physician Decision|0|||
23574112|NCT03398356|65831656|FG001|Before Treatment|Physician Decision|0|||
23771815|NCT01856309|66543223|FG001|Overall Study|Lost to Follow-up|2|||
23574113|NCT03398356|65831657|FG002|Before Treatment|Physician Decision|11|||
23574114|NCT03398356|65831655|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
23574115|NCT03398356|65831656|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
23574116|NCT03398356|65831657|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
23771816|NCT01856309|66543224|FG002|Overall Study|Lost to Follow-up|4|||
23771817|NCT01856309|66543225|FG003|Overall Study|Lost to Follow-up|8|||
23832802|NCT01293695|66767777|FG001|Overall Study|Lost to Follow-up|6|||
23447305|NCT03384940|65380402|FG001|Overall Study|Clinical progression|0|||
23447306|NCT03384940|65380403|FG002|Overall Study|Clinical progression|3|||
23574117|NCT00305864|65831658|FG000|Overall Study|Ineligible / No protocol treatment|0|||
23771818|NCT01856309|66543222|FG000|Overall Study|Withdrawal by Subject|11|||
23832803|NCT00444535|66767784|FG000|Overall Study|Withdrawal by Subject|5|||
23832804|NCT00444535|66767784|FG000|Overall Study|Physician Decision|5|||
23832805|NCT00444535|66767784|FG000|Overall Study|progressive disease|1|||
23832806|NCT00444535|66767784|FG000|Overall Study|Adverse Event|2|||
23832807|NCT00658723|66767787|FG000|Overall Study|Lost to Follow-up|0|||
23832808|NCT00658723|66767788|FG001|Overall Study|Lost to Follow-up|2|||
23574118|NCT00305864|65831659|FG001|Overall Study|Ineligible / No protocol treatment|1|||
23574119|NCT00305864|65831660|FG002|Overall Study|Ineligible / No protocol treatment|1|||
23633392|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
23633393|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
23633394|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
23633395|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
23633396|NCT00245960|66045304|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
23633397|NCT00245960|66045305|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
23633398|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
23633399|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
23633400|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
23633401|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
23633402|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
23633403|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
23832809|NCT00658723|66767789|FG002|Overall Study|Lost to Follow-up|2|||
23832810|NCT00658723|66767787|FG000|Overall Study|Death|2|||
23447307|NCT03384940|65380401|FG000|Overall Study|Adverse Event|7|||
23447308|NCT03384940|65380402|FG001|Overall Study|Adverse Event|1|||
23447309|NCT03384940|65380403|FG002|Overall Study|Adverse Event|1|||
23447310|NCT03384940|65380401|FG000|Overall Study|Withdrawal by Subject|3|||
23447311|NCT03384940|65380402|FG001|Overall Study|Withdrawal by Subject|1|||
23447312|NCT03384940|65380403|FG002|Overall Study|Withdrawal by Subject|0|||
23447313|NCT03384940|65380401|FG000|Overall Study|Physician Decision|1|||
23447314|NCT03384940|65380402|FG001|Overall Study|Physician Decision|1|||
23771819|NCT01856309|66543223|FG001|Overall Study|Withdrawal by Subject|13|||
23447315|NCT03384940|65380403|FG002|Overall Study|Physician Decision|0|||
23447316|NCT03384940|65380401|FG000|Overall Study|Death|2|||
23447317|NCT03384940|65380402|FG001|Overall Study|Death|1|||
23447318|NCT03384940|65380403|FG002|Overall Study|Death|0|||
23447319|NCT03384940|65380401|FG000|Overall Study|Other|0|||
23447320|NCT03384940|65380402|FG001|Overall Study|Other|0|||
23447321|NCT03384940|65380403|FG002|Overall Study|Other|1|||
23574120|NCT00305864|65831661|FG003|Overall Study|Ineligible / No protocol treatment|13|||
23574121|NCT00422799|65831662|FG000|Overall Study|Withdrawal by Subject|6|||
23574122|NCT00422799|65831662|FG000|Overall Study|Adverse Event|7|||
23574123|NCT02248961|65831663|FG000|Overall Study|Adverse Event|1|||
23574124|NCT02248961|65831664|FG001|Overall Study|Adverse Event|0|||
23574125|NCT02248961|65831663|FG000|Overall Study|Withdrawal by Subject|1|||
23574126|NCT02248961|65831664|FG001|Overall Study|Withdrawal by Subject|2|||
23574127|NCT02248961|65831663|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
23574128|NCT02248961|65831664|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
23574129|NCT02206152|65831667|FG000|Pre-Randomization|Withdrawal by Subject|2|||
23574130|NCT03237013|65831669|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
23574131|NCT03237013|65831670|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
23633404|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
23633405|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
23633406|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
23633407|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
23633408|NCT00245960|66045304|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
23633409|NCT00245960|66045305|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
23771820|NCT01856309|66543224|FG002|Overall Study|Withdrawal by Subject|28|||
23771821|NCT01856309|66543225|FG003|Overall Study|Withdrawal by Subject|26|||
23771822|NCT01856309|66543222|FG000|Overall Study|Other|227|||
23771823|NCT01856309|66543223|FG001|Overall Study|Other|225|||
23771824|NCT01856309|66543224|FG002|Overall Study|Other|447|||
23447322|NCT03010319|65380407|FG000|Overall Study|Adverse Event|15|||
23633410|NCT01399918|66045306|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
23771825|NCT01856309|66543225|FG003|Overall Study|Other|469|||
23771826|NCT01856309|66543222|FG000|Overall Study|Lack of Efficacy|14|||
23447323|NCT03010319|65380408|FG001|Overall Study|Adverse Event|9|||
23771827|NCT01856309|66543223|FG001|Overall Study|Lack of Efficacy|9|||
23771828|NCT01856309|66543224|FG002|Overall Study|Lack of Efficacy|40|||
23832811|NCT00658723|66767788|FG001|Overall Study|Death|1|||
23832812|NCT00658723|66767789|FG002|Overall Study|Death|4|||
23447324|NCT03010319|65380407|FG000|Overall Study|Withdrawal by Subject|1|||
23447325|NCT03010319|65380408|FG001|Overall Study|Withdrawal by Subject|6|||
23447326|NCT03010319|65380407|FG000|Overall Study|Physician Decision|2|||
23574132|NCT03237013|65831671|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
23574133|NCT01477749|65831672|FG000|Overall Study|Physician Decision|4|||
23447327|NCT03010319|65380408|FG001|Overall Study|Physician Decision|4|||
23447328|NCT03010319|65380407|FG000|Overall Study|Sponsor requested withdrawal|2|||
23447329|NCT03010319|65380408|FG001|Overall Study|Sponsor requested withdrawal|2|||
23447330|NCT03010319|65380407|FG000|Overall Study|Death|1|||
23447331|NCT03010319|65380408|FG001|Overall Study|Death|0|||
23447332|NCT03010319|65380407|FG000|Overall Study|Lost to Follow-up|0|||
23447333|NCT03010319|65380408|FG001|Overall Study|Lost to Follow-up|1|||
23447334|NCT03010319|65380407|FG000|Overall Study|Other Reason|5|||
23447335|NCT03010319|65380408|FG001|Overall Study|Other Reason|7|||
23447336|NCT03329846|65380411|FG000|Overall Study|Disease progression|4|||
23447337|NCT03329846|65380412|FG001|Overall Study|Disease progression|6|||
23447338|NCT03329846|65380411|FG000|Overall Study|Study drug toxicity|1|||
23447339|NCT03329846|65380412|FG001|Overall Study|Study drug toxicity|0|||
23771829|NCT01856309|66543225|FG003|Overall Study|Lack of Efficacy|25|||
23771830|NCT01856309|66543222|FG000|Overall Study|Adverse Event|31|||
23633411|NCT00709228|66045309|FG000|Overall Study|Not treated|14|||
23633412|NCT00709228|66045309|FG000|Overall Study|Eligibility criteria not met|281|||
23771831|NCT01856309|66543223|FG001|Overall Study|Adverse Event|31|||
23771832|NCT01856309|66543224|FG002|Overall Study|Adverse Event|55|||
23771833|NCT01856309|66543225|FG003|Overall Study|Adverse Event|65|||
23771834|NCT01856309|66543222|FG000|Overall Study|Pregnancy|0|||
23771835|NCT01856309|66543223|FG001|Overall Study|Pregnancy|0|||
23771836|NCT01856309|66543224|FG002|Overall Study|Pregnancy|0|||
23771837|NCT01856309|66543225|FG003|Overall Study|Pregnancy|1|||
23771838|NCT01856309|66543222|FG000|Overall Study|Physician Decision|6|||
23771839|NCT01856309|66543223|FG001|Overall Study|Physician Decision|1|||
23771840|NCT01856309|66543224|FG002|Overall Study|Physician Decision|6|||
23771841|NCT01856309|66543225|FG003|Overall Study|Physician Decision|8|||
23771842|NCT01856309|66543222|FG000|Overall Study|Noncompliance With Study Drug|0|||
23771843|NCT01856309|66543223|FG001|Overall Study|Noncompliance With Study Drug|1|||
23771844|NCT01856309|66543224|FG002|Overall Study|Noncompliance With Study Drug|4|||
23771845|NCT01856309|66543225|FG003|Overall Study|Noncompliance With Study Drug|1|||
23771846|NCT02388763|66543226|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
23771847|NCT02388763|66543227|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
23771848|NCT02388763|66543226|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
23771849|NCT02388763|66543227|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
23771850|NCT02154529|66543228|FG000|Overall Study|Death|1|||
23771851|NCT02154529|66543229|FG001|Overall Study|Death|1|||
23771852|NCT02154529|66543230|FG002|Overall Study|Death|5|||
23771853|NCT02154529|66543231|FG003|Overall Study|Death|1|||
23771854|NCT02154529|66543228|FG000|Overall Study|Termination of study by sponsor|2|||
23771855|NCT02154529|66543229|FG001|Overall Study|Termination of study by sponsor|2|||
23771856|NCT02154529|66543230|FG002|Overall Study|Termination of study by sponsor|3|||
23771857|NCT02154529|66543231|FG003|Overall Study|Termination of study by sponsor|1|||
23771858|NCT02154529|66543228|FG000|Overall Study|Lost to Follow-up|1|||
23633413|NCT00709228|66045309|FG000|Overall Study|Adverse events|2|||
23633414|NCT00709228|66045309|FG000|Overall Study|Discontinued treatment|14|||
23633415|NCT00709228|66045309|FG000|Overall Study|Did not enter follow-up|4|||
23832813|NCT00658723|66767787|FG000|Overall Study|Scheduling Issue|1|||
23832814|NCT00658723|66767788|FG001|Overall Study|Scheduling Issue|1|||
23832815|NCT00658723|66767789|FG002|Overall Study|Scheduling Issue|0|||
23633416|NCT00709228|66045309|FG000|Overall Study|Discontinued follow-up|5|||
23633417|NCT00709228|66045309|FG000|Overall Study|Disease progression|1|||
23633418|NCT00709228|66045309|FG000|Overall Study|Lost to Follow-up|6|||
23633419|NCT00709228|66045309|FG000|Overall Study|Non-compliance|5|||
23633420|NCT03926195|66045310|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
23633421|NCT03926195|66045311|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
23771859|NCT02154529|66543229|FG001|Overall Study|Lost to Follow-up|0|||
23832816|NCT00658723|66767787|FG000|Overall Study|Withdrawal by Subject|1|||
23771860|NCT02154529|66543230|FG002|Overall Study|Lost to Follow-up|0|||
23771861|NCT02154529|66543231|FG003|Overall Study|Lost to Follow-up|0|||
23771862|NCT02623959|66543233|FG000|Overall Study|Progression|0|||
23771863|NCT02623959|66543234|FG001|Overall Study|Progression|1|||
23447340|NCT03329846|65380411|FG000|Overall Study|Participant request to discontinue treatment|0|||
23447341|NCT03329846|65380412|FG001|Overall Study|Participant request to discontinue treatment|1|||
23574134|NCT01628874|65831673|FG000|Overall Study|Physician Decision|1|||
23574135|NCT01628874|65831674|FG001|Overall Study|Physician Decision|1|||
23574136|NCT01628874|65831673|FG000|Overall Study|Age >4 months|4|||
23574137|NCT01628874|65831674|FG001|Overall Study|Age >4 months|2|||
23574138|NCT04496167|65831675|FG000|Overall Study|Adverse Event|6|||
23574139|NCT04496167|65831676|FG001|Overall Study|Adverse Event|2|||
23574140|NCT04496167|65831675|FG000|Overall Study|Withdrawal by Subject|7|||
23574141|NCT04496167|65831676|FG001|Overall Study|Withdrawal by Subject|6|||
23574142|NCT04496167|65831675|FG000|Overall Study|Lost to Follow-up|3|||
23771864|NCT02097290|66543235|FG000|Overall Study|Death|6|||
23771865|NCT02097290|66543235|FG000|Overall Study|Total Withdrawals|3|||
23832817|NCT00658723|66767788|FG001|Overall Study|Withdrawal by Subject|0|||
23633422|NCT03926195|66045310|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
23633423|NCT03926195|66045311|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
23633424|NCT03926195|66045310|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
23633425|NCT03926195|66045311|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
23633426|NCT03926195|66045310|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
23633427|NCT03926195|66045311|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
23633428|NCT03926195|66045310|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
23633429|NCT03926195|66045311|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
23633430|NCT03926195|66045310|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
23771866|NCT02097290|66543235|FG000|Overall Study|Attempt|8|||
23832818|NCT00658723|66767789|FG002|Overall Study|Withdrawal by Subject|1|||
23832819|NCT02220764|66767790|FG000|Overall Study|Lost to Follow-up|3|||
23832820|NCT02220764|66767791|FG001|Overall Study|Lost to Follow-up|1|||
23832821|NCT02220764|66767790|FG000|Overall Study|Death|1|||
23574143|NCT04496167|65831676|FG001|Overall Study|Lost to Follow-up|5|||
23574144|NCT04496167|65831675|FG000|Overall Study|Not Treated|1|||
23574145|NCT04496167|65831676|FG001|Overall Study|Not Treated|2|||
23574146|NCT04496167|65831675|FG000|Overall Study|Other Than Specified|1|||
23574147|NCT04496167|65831676|FG001|Overall Study|Other Than Specified|1|||
23574148|NCT02959138|65831678|FG000|Overall Study|Enrolled but Never Treated|0|||
23574149|NCT02959138|65831679|FG001|Overall Study|Enrolled but Never Treated|1|||
23574150|NCT02959138|65831680|FG002|Overall Study|Enrolled but Never Treated|0|||
23574151|NCT02846558|65831682|FG000|Overall Study|Adverse Event|1|||
23574152|NCT02846558|65831683|FG001|Overall Study|Adverse Event|0|||
23574153|NCT02846558|65831684|FG002|Overall Study|Adverse Event|0|||
23574154|NCT02846558|65831685|FG003|Overall Study|Adverse Event|0|||
23574155|NCT02846558|65831682|FG000|Overall Study|Withdrawal by Subject|5|||
23574156|NCT02846558|65831683|FG001|Overall Study|Withdrawal by Subject|4|||
23574157|NCT02846558|65831684|FG002|Overall Study|Withdrawal by Subject|2|||
23574158|NCT02846558|65831685|FG003|Overall Study|Withdrawal by Subject|2|||
23574159|NCT02846558|65831682|FG000|Overall Study|Lost to Follow-up|2|||
23574160|NCT02846558|65831683|FG001|Overall Study|Lost to Follow-up|0|||
23574161|NCT02846558|65831684|FG002|Overall Study|Lost to Follow-up|0|||
23574162|NCT02846558|65831685|FG003|Overall Study|Lost to Follow-up|0|||
23574163|NCT00647348|65831686|FG000|Overall Study|Lost to Follow-up|3|||
23574164|NCT00647348|65831687|FG001|Overall Study|Lost to Follow-up|6|||
23574165|NCT00627042|65831688|FG000|Overall Study|Withdrawal by Subject|2|||
23574166|NCT02531295|65831690|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574167|NCT02531295|65831691|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574168|NCT02531295|65831692|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
23771867|NCT02428699|66543237|FG000|Washout Period 1|Screen Failure|1|||
23771868|NCT02428699|66543238|FG001|Washout Period 1|Screen Failure|2|||
23771869|NCT01946165|66543239|FG000|Overall Study|Physician Decision|2|||
23771870|NCT01946165|66543240|FG001|Overall Study|Physician Decision|0|||
23771871|NCT01946165|66543239|FG000|Overall Study|Withdrawal by Subject|0|||
23771872|NCT01946165|66543240|FG001|Overall Study|Withdrawal by Subject|2|||
23574169|NCT02531295|65831693|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
23771873|NCT00525590|66543241|FG000|Overall Study|Adverse Event|3|||
23574170|NCT02531295|65831694|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574171|NCT02531295|65831695|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
23574172|NCT02397460|65831701|FG000|Treatment Period 2|Adverse Event|0|||
23574173|NCT02397460|65831702|FG001|Treatment Period 2|Adverse Event|0|||
23574174|NCT02397460|65831703|FG002|Treatment Period 2|Adverse Event|0|||
23574175|NCT02397460|65831704|FG003|Treatment Period 2|Adverse Event|0|||
23574176|NCT02397460|65831705|FG004|Treatment Period 2|Adverse Event|0|||
23574177|NCT02397460|65831706|FG005|Treatment Period 2|Adverse Event|0|||
23574178|NCT02397460|65831707|FG006|Treatment Period 2|Adverse Event|0|||
23574179|NCT02397460|65831708|FG007|Treatment Period 2|Adverse Event|1|||
23574180|NCT02397460|65831701|FG000|Treatment Period 4|Adverse Event|0|||
23574181|NCT02397460|65831702|FG001|Treatment Period 4|Adverse Event|1|||
23574182|NCT02397460|65831703|FG002|Treatment Period 4|Adverse Event|0|||
23574183|NCT02397460|65831704|FG003|Treatment Period 4|Adverse Event|0|||
23574184|NCT02397460|65831705|FG004|Treatment Period 4|Adverse Event|0|||
23574185|NCT02397460|65831706|FG005|Treatment Period 4|Adverse Event|0|||
23574186|NCT02397460|65831707|FG006|Treatment Period 4|Adverse Event|0|||
23574187|NCT02397460|65831708|FG007|Treatment Period 4|Adverse Event|0|||
23633431|NCT03926195|66045311|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
23633432|NCT00863681|66045312|FG000|Overall Study|Other|2|||
23771874|NCT00525590|66543241|FG000|Overall Study|Physician Decision|3|||
23771875|NCT00525590|66543241|FG000|Overall Study|Withdrawal by Subject|16|||
23771876|NCT00525590|66543241|FG000|Overall Study|Lost to Follow-up|1|||
23832822|NCT02220764|66767791|FG001|Overall Study|Death|0|||
23574188|NCT02397460|65831701|FG000|Treatment Period 4|Physician Decision|0|||
23574189|NCT02397460|65831702|FG001|Treatment Period 4|Physician Decision|0|||
23574190|NCT02397460|65831703|FG002|Treatment Period 4|Physician Decision|0|||
23574191|NCT02397460|65831704|FG003|Treatment Period 4|Physician Decision|0|||
23574192|NCT02397460|65831705|FG004|Treatment Period 4|Physician Decision|1|||
23574193|NCT02397460|65831706|FG005|Treatment Period 4|Physician Decision|0|||
23574194|NCT02397460|65831707|FG006|Treatment Period 4|Physician Decision|0|||
23574195|NCT02397460|65831708|FG007|Treatment Period 4|Physician Decision|0|||
23574196|NCT01579578|65831711|FG000|Overall Study|Death|4|||
23574197|NCT01579578|65831712|FG001|Overall Study|Death|1|||
23574198|NCT01579578|65831711|FG000|Overall Study|Lost to Follow-up|1|||
23574199|NCT01579578|65831712|FG001|Overall Study|Lost to Follow-up|1|||
23574200|NCT01579578|65831711|FG000|Overall Study|Withdrawal by Subject|2|||
23574201|NCT01579578|65831712|FG001|Overall Study|Withdrawal by Subject|1|||
23574202|NCT01579578|65831711|FG000|Overall Study|Eligibility criteria|3|||
23574203|NCT01579578|65831712|FG001|Overall Study|Eligibility criteria|9|||
23574204|NCT01579578|65831711|FG000|Overall Study|Ongoing|3|||
23574205|NCT01579578|65831712|FG001|Overall Study|Ongoing|0|||
23574206|NCT00776100|65831713|FG000|Overall Study|Disease Progression|1|||
23574207|NCT00776100|65831714|FG001|Overall Study|Disease Progression|0|||
23574208|NCT01244763|65831715|FG000|Overall Study|Adverse Event|1|||
23574209|NCT01244763|65831716|FG001|Overall Study|Adverse Event|0|||
23574210|NCT01244763|65831717|FG002|Overall Study|Adverse Event|0|||
23574211|NCT01244763|65831718|FG003|Overall Study|Adverse Event|0|||
23574212|NCT01244763|65831719|FG004|Overall Study|Adverse Event|0|||
23574213|NCT01244763|65831720|FG005|Overall Study|Adverse Event|1|||
23771877|NCT00525590|66543241|FG000|Overall Study|Death|9|||
23771878|NCT00525590|66543241|FG000|Overall Study|Other|13|||
23771879|NCT01126736|66543242|FG000|Overall Study|Death|2|||
23771880|NCT01126736|66543243|FG001|Overall Study|Death|2|||
23771881|NCT01126736|66543244|FG002|Overall Study|Death|1|||
23771882|NCT01126736|66543245|FG003|Overall Study|Death|19|||
23771883|NCT01126736|66543246|FG004|Overall Study|Death|19|||
23771884|NCT01126736|66543242|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23771885|NCT01126736|66543243|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23771886|NCT01126736|66543244|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23771887|NCT01126736|66543245|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
23771888|NCT01126736|66543246|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
23771889|NCT01126736|66543242|FG000|Overall Study|Lost to Follow-up|0|||
23771890|NCT01126736|66543243|FG001|Overall Study|Lost to Follow-up|0|||
23771891|NCT01126736|66543244|FG002|Overall Study|Lost to Follow-up|0|||
23771892|NCT01126736|66543245|FG003|Overall Study|Lost to Follow-up|1|||
23771893|NCT01126736|66543246|FG004|Overall Study|Lost to Follow-up|1|||
23771894|NCT01126736|66543242|FG000|Overall Study|Administrative reasons|0|||
23771895|NCT01126736|66543243|FG001|Overall Study|Administrative reasons|0|||
23771896|NCT01126736|66543244|FG002|Overall Study|Administrative reasons|0|||
23771897|NCT01126736|66543245|FG003|Overall Study|Administrative reasons|0|||
23771898|NCT01126736|66543246|FG004|Overall Study|Administrative reasons|1|||
23771899|NCT01126736|66543242|FG000|Overall Study|Progressive disease|0|||
23771900|NCT01126736|66543243|FG001|Overall Study|Progressive disease|0|||
23771901|NCT01126736|66543244|FG002|Overall Study|Progressive disease|0|||
23771902|NCT01126736|66543245|FG003|Overall Study|Progressive disease|2|||
23771903|NCT01126736|66543246|FG004|Overall Study|Progressive disease|1|||
23771904|NCT01126736|66543242|FG000|Overall Study|Withdrawal by Subject|0|||
23771905|NCT01126736|66543243|FG001|Overall Study|Withdrawal by Subject|0|||
23771906|NCT01126736|66543244|FG002|Overall Study|Withdrawal by Subject|0|||
23771907|NCT01126736|66543245|FG003|Overall Study|Withdrawal by Subject|1|||
23771908|NCT01126736|66543246|FG004|Overall Study|Withdrawal by Subject|1|||
23771909|NCT01126736|66543242|FG000|Overall Study|Other|2|||
23771910|NCT01126736|66543243|FG001|Overall Study|Other|4|||
23771911|NCT01126736|66543244|FG002|Overall Study|Other|4|||
23771912|NCT01126736|66543245|FG003|Overall Study|Other|16|||
23771913|NCT01126736|66543246|FG004|Overall Study|Other|15|||
23771914|NCT02114697|66543247|FG000|Overall Study|Study terminated|5|||
23771915|NCT02114697|66543248|FG001|Overall Study|Study terminated|4|||
23771916|NCT03464136|66543249|FG000|Overall Study|Lost to Follow-up|5|||
23771917|NCT03464136|66543250|FG001|Overall Study|Lost to Follow-up|8|||
23633433|NCT00863681|66045313|FG001|Overall Study|Other|0|||
23771918|NCT03464136|66543249|FG000|Overall Study|Withdrawal by Subject|16|||
23771919|NCT03464136|66543250|FG001|Overall Study|Withdrawal by Subject|13|||
23771920|NCT03464136|66543249|FG000|Overall Study|Death|1|||
23771921|NCT03464136|66543250|FG001|Overall Study|Death|0|||
23574214|NCT01244763|65831715|FG000|Overall Study|Death|1|||
23574215|NCT01244763|65831716|FG001|Overall Study|Death|0|||
23574216|NCT01244763|65831717|FG002|Overall Study|Death|1|||
23574217|NCT01244763|65831718|FG003|Overall Study|Death|0|||
23574218|NCT01244763|65831719|FG004|Overall Study|Death|2|||
23574219|NCT01244763|65831720|FG005|Overall Study|Death|0|||
23574220|NCT01244763|65831715|FG000|Overall Study|Physician Decision|0|||
23771922|NCT03464136|66543249|FG000|Overall Study|Other|8|||
23771923|NCT03464136|66543250|FG001|Overall Study|Other|4|||
23832823|NCT03802825|66767792|FG000|Overall Study|Lost to follow-up for intervention|12|||
23832824|NCT03802825|66767793|FG001|Overall Study|Lost to follow-up for intervention|3|||
23832825|NCT03802825|66767792|FG000|Overall Study|Received only 1 component of intervention|0|||
23832826|NCT03802825|66767793|FG001|Overall Study|Received only 1 component of intervention|13|||
23832827|NCT01277601|66767801|FG000|Overall Study|Adverse Event|5|||
23832828|NCT01277601|66767802|FG001|Overall Study|Adverse Event|3|||
23832829|NCT01277601|66767803|FG002|Overall Study|Adverse Event|0|||
23832830|NCT01277601|66767804|FG003|Overall Study|Adverse Event|7|||
23574221|NCT01244763|65831716|FG001|Overall Study|Physician Decision|0|||
23574222|NCT01244763|65831717|FG002|Overall Study|Physician Decision|1|||
23574223|NCT01244763|65831718|FG003|Overall Study|Physician Decision|0|||
23574224|NCT01244763|65831719|FG004|Overall Study|Physician Decision|0|||
23574225|NCT01244763|65831720|FG005|Overall Study|Physician Decision|0|||
23574226|NCT01244763|65831715|FG000|Overall Study|Withdrawal by Subject|1|||
23574227|NCT01244763|65831716|FG001|Overall Study|Withdrawal by Subject|2|||
23574228|NCT01244763|65831717|FG002|Overall Study|Withdrawal by Subject|0|||
23574229|NCT01244763|65831718|FG003|Overall Study|Withdrawal by Subject|1|||
23574230|NCT01244763|65831719|FG004|Overall Study|Withdrawal by Subject|1|||
23574231|NCT01244763|65831720|FG005|Overall Study|Withdrawal by Subject|2|||
23574232|NCT01244763|65831715|FG000|Overall Study|Lost to Follow-up|0|||
23574233|NCT01244763|65831716|FG001|Overall Study|Lost to Follow-up|1|||
23574234|NCT01244763|65831717|FG002|Overall Study|Lost to Follow-up|0|||
23574235|NCT01244763|65831718|FG003|Overall Study|Lost to Follow-up|0|||
23574236|NCT01244763|65831719|FG004|Overall Study|Lost to Follow-up|0|||
23574237|NCT01244763|65831720|FG005|Overall Study|Lost to Follow-up|0|||
23832831|NCT01277601|66767801|FG000|Overall Study|Withdrawal by Subject|18|||
23574238|NCT01244763|65831715|FG000|Overall Study|Enrolled into the Extension Study|0|||
23633434|NCT00863681|66045314|FG002|Overall Study|Other|0|||
23633435|NCT00863681|66045312|FG000|Overall Study|Missing|1|||
23574239|NCT01244763|65831716|FG001|Overall Study|Enrolled into the Extension Study|0|||
23633436|NCT00863681|66045313|FG001|Overall Study|Missing|0|||
23633437|NCT00863681|66045314|FG002|Overall Study|Missing|0|||
23633438|NCT00863681|66045312|FG000|Overall Study|Death|40|||
23633439|NCT00863681|66045313|FG001|Overall Study|Death|23|||
23633440|NCT00863681|66045314|FG002|Overall Study|Death|6|||
23633441|NCT00863681|66045312|FG000|Overall Study|Withdrawal by Subject|12|||
23633442|NCT00863681|66045313|FG001|Overall Study|Withdrawal by Subject|5|||
23633443|NCT00863681|66045314|FG002|Overall Study|Withdrawal by Subject|2|||
23633444|NCT00863681|66045312|FG000|Overall Study|Protocol Violation|2|||
23633445|NCT00863681|66045313|FG001|Overall Study|Protocol Violation|0|||
23633446|NCT00863681|66045314|FG002|Overall Study|Protocol Violation|0|||
23633447|NCT00863681|66045312|FG000|Overall Study|Lost to Follow-up|3|||
23633448|NCT00863681|66045313|FG001|Overall Study|Lost to Follow-up|0|||
23633449|NCT00863681|66045314|FG002|Overall Study|Lost to Follow-up|3|||
23633450|NCT00863681|66045312|FG000|Overall Study|Adverse Event|28|||
23633451|NCT00863681|66045313|FG001|Overall Study|Adverse Event|10|||
23633452|NCT00863681|66045314|FG002|Overall Study|Adverse Event|6|||
23633453|NCT00863681|66045312|FG000|Overall Study|Lack of Efficacy|2|||
23633454|NCT00863681|66045313|FG001|Overall Study|Lack of Efficacy|2|||
23633455|NCT00863681|66045314|FG002|Overall Study|Lack of Efficacy|1|||
23633456|NCT00863681|66045312|FG000|Overall Study|Non-compliance with study drug|1|||
23633457|NCT00863681|66045313|FG001|Overall Study|Non-compliance with study drug|3|||
23633458|NCT00863681|66045314|FG002|Overall Study|Non-compliance with study drug|0|||
23633459|NCT01305408|66045316|FG000|Overall Study|Adverse Event|10|||
23633460|NCT01305408|66045317|FG001|Overall Study|Adverse Event|7|||
23633461|NCT01305408|66045316|FG000|Overall Study|Lack of Efficacy|3|||
23633462|NCT01305408|66045317|FG001|Overall Study|Lack of Efficacy|4|||
23633463|NCT01305408|66045316|FG000|Overall Study|Withdrawal by Subject|9|||
23633464|NCT01305408|66045317|FG001|Overall Study|Withdrawal by Subject|9|||
23633465|NCT01305408|66045316|FG000|Overall Study|Protocol Violation|4|||
23633466|NCT01305408|66045317|FG001|Overall Study|Protocol Violation|6|||
23633467|NCT01305408|66045316|FG000|Overall Study|Lost to Follow-up|5|||
23633468|NCT01305408|66045317|FG001|Overall Study|Lost to Follow-up|3|||
23633469|NCT01305408|66045316|FG000|Overall Study|Noncompliance with study medication|0|||
23633470|NCT01305408|66045317|FG001|Overall Study|Noncompliance with study medication|1|||
23633471|NCT01305408|66045316|FG000|Overall Study|Noncompliance with study procedures|0|||
23633472|NCT01305408|66045317|FG001|Overall Study|Noncompliance with study procedures|1|||
23633473|NCT01305408|66045316|FG000|Overall Study|Other|1|||
23633474|NCT01305408|66045317|FG001|Overall Study|Other|0|||
23633475|NCT01661205|66045318|FG000|Overall Study|Physician Decision|2|||
23633476|NCT02037477|66045320|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23633477|NCT02037477|66045321|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23574240|NCT01244763|65831717|FG002|Overall Study|Enrolled into the Extension Study|0|||
23574241|NCT01244763|65831718|FG003|Overall Study|Enrolled into the Extension Study|0|||
23574242|NCT01244763|65831719|FG004|Overall Study|Enrolled into the Extension Study|0|||
23574243|NCT01244763|65831720|FG005|Overall Study|Enrolled into the Extension Study|1|||
23832832|NCT01277601|66767802|FG001|Overall Study|Withdrawal by Subject|21|||
23633478|NCT02037477|66045322|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
23633479|NCT02037477|66045323|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23633480|NCT02956837|66045324|FG000|Overall Study|Serious Adverse Events|0|||
23633481|NCT02956837|66045325|FG001|Overall Study|Serious Adverse Events|1|||
23633482|NCT02956837|66045326|FG002|Overall Study|Serious Adverse Events|0|||
23633483|NCT02956837|66045327|FG003|Overall Study|Serious Adverse Events|0|||
23633484|NCT02956837|66045324|FG000|Overall Study|Withdrawal by Subject|0|||
23633485|NCT02956837|66045325|FG001|Overall Study|Withdrawal by Subject|1|||
23633486|NCT02956837|66045326|FG002|Overall Study|Withdrawal by Subject|0|||
23633487|NCT02956837|66045327|FG003|Overall Study|Withdrawal by Subject|3|||
23633488|NCT02956837|66045324|FG000|Overall Study|Lost to Follow-up|0|||
23633489|NCT02956837|66045325|FG001|Overall Study|Lost to Follow-up|1|||
23633490|NCT02956837|66045326|FG002|Overall Study|Lost to Follow-up|2|||
23633491|NCT02956837|66045327|FG003|Overall Study|Lost to Follow-up|0|||
23633492|NCT03552523|66045328|FG000|Overall Study|Withdrawal by Subject|1|||
23633493|NCT03552523|66045329|FG001|Overall Study|Withdrawal by Subject|1|||
23633494|NCT04148651|66045330|FG000|Overall Study|Lost to Follow-up|2|||
23633495|NCT00078377|66045332|FG000|Overall Study|Adverse Event|2|||
23633496|NCT00078377|66045333|FG001|Overall Study|Adverse Event|5|||
23633497|NCT00078377|66045334|FG002|Overall Study|Adverse Event|1|||
23633498|NCT00078377|66045332|FG000|Overall Study|Lack of Efficacy|2|||
23633499|NCT00078377|66045333|FG001|Overall Study|Lack of Efficacy|0|||
23633500|NCT00078377|66045334|FG002|Overall Study|Lack of Efficacy|2|||
23633501|NCT00078377|66045332|FG000|Overall Study|Lost to Follow-up|0|||
23633502|NCT00078377|66045333|FG001|Overall Study|Lost to Follow-up|1|||
23633503|NCT00078377|66045334|FG002|Overall Study|Lost to Follow-up|1|||
23633504|NCT00078377|66045332|FG000|Overall Study|Physician Decision|2|||
23633505|NCT00078377|66045333|FG001|Overall Study|Physician Decision|0|||
23633506|NCT00078377|66045334|FG002|Overall Study|Physician Decision|0|||
23633507|NCT00078377|66045332|FG000|Overall Study|Withdrawal by Subject|3|||
23633508|NCT00078377|66045333|FG001|Overall Study|Withdrawal by Subject|4|||
23633509|NCT00078377|66045334|FG002|Overall Study|Withdrawal by Subject|4|||
23633510|NCT00078377|66045332|FG000|Overall Study|Miscellaneous|2|||
23633511|NCT00078377|66045333|FG001|Overall Study|Miscellaneous|6|||
23633512|NCT00078377|66045334|FG002|Overall Study|Miscellaneous|1|||
23633513|NCT02683785|66045337|FG000|Overall Study|Withdrawal by Subject|1|||
23633514|NCT02683785|66045338|FG001|Overall Study|Withdrawal by Subject|1|||
23633515|NCT02683785|66045337|FG000|Overall Study|Lost to Follow-up|0|||
23633516|NCT02683785|66045338|FG001|Overall Study|Lost to Follow-up|1|||
23633517|NCT02683785|66045337|FG000|Overall Study|Adverse Event|0|||
23633518|NCT02683785|66045338|FG001|Overall Study|Adverse Event|2|||
23633519|NCT02091206|66045341|FG000|Treatment Period|Adverse Event|0|||
23633520|NCT02091206|66045342|FG001|Treatment Period|Adverse Event|1|||
23633521|NCT02091206|66045343|FG002|Treatment Period|Adverse Event|0|||
23633522|NCT02091206|66045344|FG003|Treatment Period|Adverse Event|0|||
23633523|NCT02091206|66045341|FG000|Treatment Period|Met withdrawal criteria|0|||
23633524|NCT02091206|66045342|FG001|Treatment Period|Met withdrawal criteria|0|||
23633525|NCT02091206|66045343|FG002|Treatment Period|Met withdrawal criteria|1|||
23633526|NCT02091206|66045344|FG003|Treatment Period|Met withdrawal criteria|0|||
23633527|NCT02091206|66045341|FG000|Taper Period|Participant refused study drug|1|||
23633528|NCT02091206|66045342|FG001|Taper Period|Participant refused study drug|0|||
23633529|NCT02091206|66045343|FG002|Taper Period|Participant refused study drug|0|||
23633530|NCT02091206|66045344|FG003|Taper Period|Participant refused study drug|1|||
23633531|NCT02091206|66045341|FG000|Taper Period|Lost to Follow-up|0|||
23633532|NCT02091206|66045342|FG001|Taper Period|Lost to Follow-up|0|||
23633533|NCT02091206|66045343|FG002|Taper Period|Lost to Follow-up|0|||
23633534|NCT02091206|66045344|FG003|Taper Period|Lost to Follow-up|1|||
23633535|NCT00633880|66045345|FG000|Open Label Titration|Lack of Efficacy|1|||
23633536|NCT00633880|66045346|FG001|Open Label Titration|Lack of Efficacy|0|||
23771924|NCT02277769|66543251|FG000|Overall Study|Protocol Violation|3|||
23771925|NCT02277769|66543252|FG001|Overall Study|Protocol Violation|3|||
23771926|NCT02277769|66543253|FG002|Overall Study|Protocol Violation|5|||
23771927|NCT02277769|66543251|FG000|Overall Study|Lack of Efficacy|17|||
23771928|NCT02277769|66543252|FG001|Overall Study|Lack of Efficacy|0|||
23771929|NCT02277769|66543253|FG002|Overall Study|Lack of Efficacy|4|||
23633537|NCT00633880|66045347|FG002|Open Label Titration|Lack of Efficacy|0|||
23633538|NCT00633880|66045345|FG000|Open Label Titration|Adverse Event|13|||
23633539|NCT00633880|66045346|FG001|Open Label Titration|Adverse Event|0|||
23633540|NCT00633880|66045347|FG002|Open Label Titration|Adverse Event|0|||
23633541|NCT00633880|66045345|FG000|Open Label Titration|Treatment Failure|55|||
23633542|NCT00633880|66045346|FG001|Open Label Titration|Treatment Failure|0|||
23633543|NCT00633880|66045347|FG002|Open Label Titration|Treatment Failure|0|||
23633544|NCT00633880|66045345|FG000|Open Label Titration|Protocol Violation|6|||
23633545|NCT00633880|66045346|FG001|Open Label Titration|Protocol Violation|0|||
23633546|NCT00633880|66045347|FG002|Open Label Titration|Protocol Violation|0|||
23633547|NCT00633880|66045345|FG000|Open Label Titration|Physician Decision|1|||
23633548|NCT00633880|66045346|FG001|Open Label Titration|Physician Decision|0|||
23574244|NCT00333788|65831721|FG000|Overall Study|Adverse Event|44|||
23574245|NCT00333788|65831721|FG000|Overall Study|Lack of Efficacy|80|||
23574246|NCT00333788|65831721|FG000|Overall Study|Lost to Follow-up|2|||
23574247|NCT00333788|65831721|FG000|Overall Study|Withdrawal by Subject|24|||
23574248|NCT00333788|65831721|FG000|Overall Study|Other: Non-compliance|2|||
23574249|NCT00333788|65831721|FG000|Overall Study|Other: Moved|2|||
23574250|NCT00333788|65831721|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
23574251|NCT00333788|65831721|FG000|Overall Study|Other: Investigator decision|1|||
23574252|NCT00333788|65831721|FG000|Overall Study|Other: Quality of life concern|1|||
23832833|NCT01277601|66767803|FG002|Overall Study|Withdrawal by Subject|8|||
23832834|NCT01277601|66767804|FG003|Overall Study|Withdrawal by Subject|17|||
23832835|NCT01277601|66767801|FG000|Overall Study|Lost to Follow-up|7|||
23832836|NCT01277601|66767802|FG001|Overall Study|Lost to Follow-up|9|||
23832837|NCT01277601|66767803|FG002|Overall Study|Lost to Follow-up|4|||
23832838|NCT01277601|66767804|FG003|Overall Study|Lost to Follow-up|2|||
23574253|NCT00333788|65831721|FG000|Overall Study|Other: Sponsor decision|1|||
23574254|NCT00333788|65831721|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
23574255|NCT00333788|65831721|FG000|Overall Study|Other: Medical monitor decision|1|||
23574256|NCT00333788|65831721|FG000|Overall Study|Other: Physician decision|1|||
23574257|NCT00333788|65831721|FG000|Overall Study|Other: Signed consent for another study|1|||
23832839|NCT01277601|66767801|FG000|Overall Study|Physician Decision|3|||
23832840|NCT01277601|66767802|FG001|Overall Study|Physician Decision|5|||
23832841|NCT01277601|66767803|FG002|Overall Study|Physician Decision|1|||
23574258|NCT01012973|65831724|FG000|Overall Study|Adverse Event|5|||
23832842|NCT01277601|66767804|FG003|Overall Study|Physician Decision|6|||
23832843|NCT01277601|66767801|FG000|Overall Study|Pregnancy|2|||
23832844|NCT01277601|66767802|FG001|Overall Study|Pregnancy|2|||
23832845|NCT01277601|66767803|FG002|Overall Study|Pregnancy|4|||
23574259|NCT01012973|65831725|FG001|Overall Study|Adverse Event|5|||
23574260|NCT01012973|65831724|FG000|Overall Study|Lack of Efficacy|0|||
23832846|NCT01277601|66767804|FG003|Overall Study|Pregnancy|1|||
23832847|NCT01277601|66767801|FG000|Overall Study|Noncompliance with Study Drug|1|||
23832848|NCT01277601|66767802|FG001|Overall Study|Noncompliance with Study Drug|3|||
23832849|NCT01277601|66767803|FG002|Overall Study|Noncompliance with Study Drug|2|||
23832850|NCT01277601|66767804|FG003|Overall Study|Noncompliance with Study Drug|0|||
23832851|NCT01277601|66767801|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
23574261|NCT01012973|65831725|FG001|Overall Study|Lack of Efficacy|5|||
23574262|NCT01012973|65831724|FG000|Overall Study|Lost to Follow-up|1|||
23574263|NCT01012973|65831725|FG001|Overall Study|Lost to Follow-up|0|||
23574264|NCT01012973|65831724|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
23574265|NCT01012973|65831725|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
23574266|NCT01012973|65831724|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
23574267|NCT01012973|65831725|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
23574268|NCT01012973|65831724|FG000|Overall Study|Protocol Violation|5|||
23574269|NCT01012973|65831725|FG001|Overall Study|Protocol Violation|2|||
23574270|NCT01012973|65831724|FG000|Overall Study|Withdrawal by Subject|4|||
23832852|NCT01277601|66767802|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
23832853|NCT01277601|66767803|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
23832854|NCT01277601|66767804|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
23574271|NCT01012973|65831725|FG001|Overall Study|Withdrawal by Subject|6|||
23832855|NCT01277601|66767801|FG000|Overall Study|Protocol Violation|0|||
23832856|NCT01277601|66767802|FG001|Overall Study|Protocol Violation|2|||
23832857|NCT01277601|66767803|FG002|Overall Study|Protocol Violation|5|||
23832858|NCT01277601|66767804|FG003|Overall Study|Protocol Violation|0|||
23832859|NCT01277601|66767801|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
23832860|NCT01277601|66767802|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
23832861|NCT01277601|66767803|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
23832862|NCT01277601|66767804|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
23832863|NCT00615550|66767805|FG000|Overall Study|Lost to Follow-up|6|||
23832864|NCT00615550|66767806|FG001|Overall Study|Lost to Follow-up|1|||
23832865|NCT03926117|66767807|FG000|Overall Study|Unclassified|1|||
23832866|NCT03926117|66767808|FG001|Overall Study|Unclassified|4|||
23832867|NCT03926117|66767809|FG002|Overall Study|Unclassified|1|||
23832868|NCT03926117|66767810|FG003|Overall Study|Unclassified|4|||
23832869|NCT03926117|66767807|FG000|Overall Study|Withdrawal by Subject|3|||
23832870|NCT03926117|66767808|FG001|Overall Study|Withdrawal by Subject|0|||
23832871|NCT03926117|66767809|FG002|Overall Study|Withdrawal by Subject|1|||
23832872|NCT03926117|66767810|FG003|Overall Study|Withdrawal by Subject|1|||
23832873|NCT03926117|66767807|FG000|Overall Study|Lost to Follow-up|0|||
23832874|NCT03926117|66767808|FG001|Overall Study|Lost to Follow-up|2|||
23832875|NCT03926117|66767809|FG002|Overall Study|Lost to Follow-up|1|||
23832876|NCT03926117|66767810|FG003|Overall Study|Lost to Follow-up|0|||
23832877|NCT03926117|66767807|FG000|Overall Study|Adverse Event|1|||
23832878|NCT03926117|66767808|FG001|Overall Study|Adverse Event|2|||
23832879|NCT03926117|66767809|FG002|Overall Study|Adverse Event|3|||
23832880|NCT03926117|66767810|FG003|Overall Study|Adverse Event|1|||
23832881|NCT03926117|66767807|FG000|Overall Study|Randomized but not treated|1|||
23832882|NCT03926117|66767808|FG001|Overall Study|Randomized but not treated|1|||
23832883|NCT03926117|66767809|FG002|Overall Study|Randomized but not treated|0|||
23832884|NCT03926117|66767810|FG003|Overall Study|Randomized but not treated|1|||
23832885|NCT02549859|66767811|FG000|Long-term 60 Hz DBS|Study Closed|1|||
23832886|NCT04200651|66767812|FG000|Overall Study|Moved to another country during follow-up|2|||
23832887|NCT04200651|66767813|FG001|Overall Study|Moved to another country during follow-up|2|||
23832888|NCT04200651|66767812|FG000|Overall Study|Lost to Follow-up|1|||
23832889|NCT04200651|66767813|FG001|Overall Study|Lost to Follow-up|3|||
23832890|NCT02714218|66767814|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23832891|NCT02714218|66767815|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23832892|NCT02714218|66767816|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23832893|NCT02714218|66767814|FG000|Pre-Treatment Period|Other reasons|0|||
23832894|NCT02714218|66767815|FG001|Pre-Treatment Period|Other reasons|1|||
23832895|NCT02714218|66767816|FG002|Pre-Treatment Period|Other reasons|0|||
23574272|NCT02471404|65831732|FG000|Overall Study|Adverse Event|7|||
23574273|NCT02471404|65831733|FG001|Overall Study|Adverse Event|1|||
23574274|NCT02471404|65831734|FG002|Overall Study|Adverse Event|2|||
23574275|NCT02471404|65831732|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
23574276|NCT02471404|65831733|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
23574277|NCT02471404|65831734|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
23574278|NCT02471404|65831732|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
23574279|NCT02471404|65831733|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23574280|NCT02471404|65831734|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
23574281|NCT02471404|65831732|FG000|Overall Study|Lost to Follow-up|1|||
23574282|NCT02471404|65831733|FG001|Overall Study|Lost to Follow-up|1|||
23574283|NCT02471404|65831734|FG002|Overall Study|Lost to Follow-up|3|||
23574284|NCT02471404|65831732|FG000|Overall Study|Protocol Violation|1|||
23832896|NCT02714218|66767814|FG000|Treatment Period|Disease Progression|55|||
23832897|NCT02714218|66767815|FG001|Treatment Period|Disease Progression|52|||
23832898|NCT02714218|66767816|FG002|Treatment Period|Disease Progression|14|||
23832899|NCT02714218|66767814|FG000|Treatment Period|Study drug toxicity|46|||
23832900|NCT02714218|66767815|FG001|Treatment Period|Study drug toxicity|70|||
23832901|NCT02714218|66767816|FG002|Treatment Period|Study drug toxicity|6|||
23832902|NCT02714218|66767814|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
23574285|NCT02471404|65831733|FG001|Overall Study|Protocol Violation|0|||
23574286|NCT02471404|65831734|FG002|Overall Study|Protocol Violation|0|||
23574287|NCT02471404|65831732|FG000|Overall Study|Withdrawal by Subject|8|||
23574288|NCT02471404|65831733|FG001|Overall Study|Withdrawal by Subject|4|||
23574289|NCT02471404|65831734|FG002|Overall Study|Withdrawal by Subject|5|||
23574290|NCT02471404|65831732|FG000|Overall Study|Other reasons not specified|10|||
23832903|NCT02714218|66767815|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
23832904|NCT02714218|66767816|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
23832905|NCT02714218|66767814|FG000|Treatment Period|Request to discontinue treatment|1|||
23832906|NCT02714218|66767815|FG001|Treatment Period|Request to discontinue treatment|4|||
23832907|NCT02714218|66767816|FG002|Treatment Period|Request to discontinue treatment|1|||
23832908|NCT02714218|66767814|FG000|Treatment Period|Participant withdrew consent|2|||
23832909|NCT02714218|66767815|FG001|Treatment Period|Participant withdrew consent|2|||
23832910|NCT02714218|66767816|FG002|Treatment Period|Participant withdrew consent|0|||
23832911|NCT02714218|66767814|FG000|Treatment Period|Maximum clinical benefit|4|||
23574291|NCT02471404|65831733|FG001|Overall Study|Other reasons not specified|7|||
23574292|NCT02471404|65831734|FG002|Overall Study|Other reasons not specified|12|||
23574293|NCT01190176|65831744|FG000|Overall Study|Withdrawal by Subject|1|||
23574294|NCT01190176|65831744|FG000|Overall Study|Lost to Follow-up|1|||
23574295|NCT02268396|65831746|FG000|Overall Study|Adverse Event|3|||
23574296|NCT02268396|65831746|FG000|Overall Study|Administrative|2|||
23574297|NCT02268396|65831746|FG000|Overall Study|Withdrawal by Subject|1|||
23574298|NCT02268396|65831746|FG000|Overall Study|Lost to Follow-up|2|||
23574299|NCT02268396|65831746|FG000|Overall Study|Protocol-Specified Criteria|2|||
23574300|NCT02268396|65831746|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
23832912|NCT02714218|66767815|FG001|Treatment Period|Maximum clinical benefit|2|||
23832913|NCT02714218|66767816|FG002|Treatment Period|Maximum clinical benefit|0|||
23832914|NCT02714218|66767814|FG000|Treatment Period|Administrative reason by sponsor|2|||
23832915|NCT02714218|66767815|FG001|Treatment Period|Administrative reason by sponsor|1|||
23832916|NCT02714218|66767816|FG002|Treatment Period|Administrative reason by sponsor|0|||
23832917|NCT02714218|66767814|FG000|Treatment Period|Other reasons|6|||
23832918|NCT02714218|66767815|FG001|Treatment Period|Other reasons|6|||
23832919|NCT02714218|66767816|FG002|Treatment Period|Other reasons|0|||
23832920|NCT02714218|66767814|FG000|Treatment Period|Completed treatment as per protocol|36|||
23832921|NCT02714218|66767815|FG001|Treatment Period|Completed treatment as per protocol|27|||
23832922|NCT02714218|66767816|FG002|Treatment Period|Completed treatment as per protocol|3|||
23832923|NCT02714218|66767814|FG000|Treatment Period|Not reported|9|||
23832924|NCT02714218|66767815|FG001|Treatment Period|Not reported|6|||
23832925|NCT02714218|66767816|FG002|Treatment Period|Not reported|0|||
23832926|NCT00529087|66767817|FG000|Overall Study|Adverse Event|10|||
23832927|NCT00529087|66767818|FG001|Overall Study|Adverse Event|13|||
23832928|NCT00529087|66767819|FG002|Overall Study|Adverse Event|4|||
23832929|NCT00529087|66767817|FG000|Overall Study|Lost to Follow-up|6|||
23832930|NCT00529087|66767818|FG001|Overall Study|Lost to Follow-up|4|||
23832931|NCT00529087|66767819|FG002|Overall Study|Lost to Follow-up|1|||
23574301|NCT02733042|65831747|FG000|Overall Study|Adverse Event|1|||
23574302|NCT02733042|65831748|FG001|Overall Study|Adverse Event|0|||
23574303|NCT02733042|65831749|FG002|Overall Study|Adverse Event|1|||
23574304|NCT02733042|65831750|FG003|Overall Study|Adverse Event|1|||
23574305|NCT02733042|65831751|FG004|Overall Study|Adverse Event|0|||
23574306|NCT02733042|65831752|FG005|Overall Study|Adverse Event|0|||
23633549|NCT00633880|66045347|FG002|Open Label Titration|Physician Decision|0|||
23832932|NCT00529087|66767817|FG000|Overall Study|Protocol Violation|8|||
23832933|NCT00529087|66767818|FG001|Overall Study|Protocol Violation|7|||
23832934|NCT00529087|66767819|FG002|Overall Study|Protocol Violation|6|||
23832935|NCT00529087|66767817|FG000|Overall Study|Withdrawal by Subject|3|||
23832936|NCT00529087|66767818|FG001|Overall Study|Withdrawal by Subject|3|||
23832937|NCT00529087|66767819|FG002|Overall Study|Withdrawal by Subject|3|||
23574307|NCT02733042|65831753|FG006|Overall Study|Adverse Event|0|||
23633550|NCT00633880|66045345|FG000|Open Label Titration|Withdrawal by Subject|4|||
23633551|NCT00633880|66045346|FG001|Open Label Titration|Withdrawal by Subject|0|||
23633552|NCT00633880|66045347|FG002|Open Label Titration|Withdrawal by Subject|0|||
23633553|NCT01605019|66045348|FG000|Overall Study|pt did not meet transplant endpoint|3|||
23633554|NCT01605019|66045349|FG001|Overall Study|pt did not meet transplant endpoint|0|||
23633555|NCT01199068|66045350|FG000|Overall Study|Unacceptable toxicity|0|||
23633556|NCT01199068|66045351|FG001|Overall Study|Unacceptable toxicity|0|||
23633557|NCT01199068|66045352|FG002|Overall Study|Unacceptable toxicity|2|||
23633558|NCT01199068|66045350|FG000|Overall Study|Progressive disease|3|||
23633559|NCT01199068|66045351|FG001|Overall Study|Progressive disease|3|||
23633560|NCT01199068|66045352|FG002|Overall Study|Progressive disease|6|||
23633561|NCT01199068|66045350|FG000|Overall Study|Withdrawal by Subject|0|||
23633562|NCT01199068|66045351|FG001|Overall Study|Withdrawal by Subject|0|||
23633563|NCT01199068|66045352|FG002|Overall Study|Withdrawal by Subject|1|||
23633564|NCT02336425|66045356|FG000|Overall Study|Study terminated.|2|||
23633565|NCT02336425|66045357|FG001|Overall Study|Study terminated.|2|||
23633566|NCT02336425|66045358|FG002|Overall Study|Study terminated.|3|||
23633567|NCT02336425|66045359|FG003|Overall Study|Study terminated.|3|||
23832938|NCT00529087|66767817|FG000|Overall Study|Protocol deviation|1|||
23832939|NCT00529087|66767818|FG001|Overall Study|Protocol deviation|1|||
23832940|NCT00529087|66767819|FG002|Overall Study|Protocol deviation|2|||
23832941|NCT05271175|66767820|FG000|One Week Follow up|Lost to Follow-up|10|||
23832942|NCT05271175|66767821|FG001|One Week Follow up|Lost to Follow-up|7|||
23574308|NCT02733042|65831754|FG007|Overall Study|Adverse Event|0|||
23574309|NCT02733042|65831755|FG008|Overall Study|Adverse Event|0|||
23574310|NCT02733042|65831756|FG009|Overall Study|Adverse Event|0|||
23832943|NCT05271175|66767822|FG002|One Week Follow up|Lost to Follow-up|5|||
23832944|NCT05271175|66767820|FG000|One Month Follow up|Lost to Follow-up|12|||
23832945|NCT05271175|66767821|FG001|One Month Follow up|Lost to Follow-up|7|||
23574311|NCT02733042|65831757|FG010|Overall Study|Adverse Event|2|||
23633568|NCT03017742|66045360|FG000|Overall Study|Protocol Violation|36|||
23633569|NCT03017742|66045360|FG000|Overall Study|Withdrawal by Subject|37|||
23633570|NCT04674189|66045361|FG000|Overall Study|Adverse Event|0|||
23832946|NCT05271175|66767822|FG002|One Month Follow up|Lost to Follow-up|9|||
23832947|NCT05271175|66767820|FG000|Six Months Follow up|Lost to Follow-up|8|||
23832948|NCT05271175|66767821|FG001|Six Months Follow up|Lost to Follow-up|2|||
23832949|NCT05271175|66767822|FG002|Six Months Follow up|Lost to Follow-up|2|||
23832950|NCT03631706|66767827|FG000|Overall Study|Randomized, not treated|1|||
23574312|NCT02733042|65831758|FG011|Overall Study|Adverse Event|2|||
23574313|NCT02733042|65831759|FG012|Overall Study|Adverse Event|0|||
23574314|NCT02733042|65831760|FG013|Overall Study|Adverse Event|2|||
23574315|NCT02733042|65831761|FG014|Overall Study|Adverse Event|0|||
23574316|NCT02733042|65831762|FG015|Overall Study|Adverse Event|0|||
23832951|NCT03631706|66767828|FG001|Overall Study|Randomized, not treated|0|||
23832952|NCT03631706|66767827|FG000|Overall Study|Treatment ongoing|26|||
23832953|NCT03631706|66767828|FG001|Overall Study|Treatment ongoing|57|||
23832954|NCT03631706|66767827|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
23832955|NCT03631706|66767828|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
23832956|NCT02157376|66767829|FG000|Overall Study|Death|10|||
23832957|NCT02157376|66767830|FG001|Overall Study|Death|4|||
23832958|NCT02157376|66767829|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23832959|NCT02157376|66767830|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23832960|NCT02157376|66767829|FG000|Overall Study|Withdrawal by Subject|3|||
23832961|NCT02157376|66767830|FG001|Overall Study|Withdrawal by Subject|8|||
23832962|NCT02157376|66767829|FG000|Overall Study|Not treated|8|||
23832963|NCT02157376|66767830|FG001|Overall Study|Not treated|3|||
23832964|NCT02157376|66767829|FG000|Overall Study|Investigator's misjudgement|1|||
23832965|NCT02157376|66767830|FG001|Overall Study|Investigator's misjudgement|2|||
23832966|NCT00764660|66767831|FG000|Overall Study|Adverse Event|6|||
23832967|NCT00764660|66767832|FG001|Overall Study|Adverse Event|3|||
23832968|NCT00764660|66767831|FG000|Overall Study|Lost to Follow-up|3|||
23832969|NCT00764660|66767832|FG001|Overall Study|Lost to Follow-up|4|||
23832970|NCT00764660|66767831|FG000|Overall Study|Withdrawal by Subject|7|||
23832971|NCT00764660|66767832|FG001|Overall Study|Withdrawal by Subject|3|||
23832972|NCT00764660|66767831|FG000|Overall Study|Noncompliance With Protocol|5|||
23771930|NCT02277769|66543251|FG000|Overall Study|Adverse Event|14|||
23771931|NCT02277769|66543252|FG001|Overall Study|Adverse Event|2|||
23771932|NCT02277769|66543253|FG002|Overall Study|Adverse Event|4|||
23771933|NCT02277769|66543251|FG000|Overall Study|Other than specified above|12|||
23771934|NCT02277769|66543252|FG001|Overall Study|Other than specified above|8|||
23771935|NCT02277769|66543253|FG002|Overall Study|Other than specified above|5|||
23771936|NCT00203307|66543254|FG000|First Intervention|Adverse Event|2|||
23771937|NCT00203307|66543255|FG001|First Intervention|Adverse Event|0|||
23771938|NCT01816477|66543256|FG000|Overall Study|Withdrawal by Subject|13|||
23771939|NCT01816477|66543257|FG001|Overall Study|Withdrawal by Subject|1|||
23771940|NCT01816477|66543256|FG000|Overall Study|Unable to tolerate catheter placement|3|||
23771941|NCT01816477|66543257|FG001|Overall Study|Unable to tolerate catheter placement|0|||
23771942|NCT02536378|66543266|FG000|Overall Study|Physician Decision|0|||
23832973|NCT00764660|66767832|FG001|Overall Study|Noncompliance With Protocol|1|||
23832974|NCT00764660|66767831|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23832975|NCT00764660|66767832|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23832976|NCT00954941|66767833|FG000|Overall Study|Received treatment at home|1|||
23832977|NCT00954941|66767834|FG001|Overall Study|Received treatment at home|0|||
23832978|NCT00954941|66767833|FG000|Overall Study|Withdrawal by Subject|1|||
23832979|NCT00954941|66767834|FG001|Overall Study|Withdrawal by Subject|0|||
23832980|NCT00954941|66767833|FG000|Overall Study|Insurance Denial|2|||
23832981|NCT00954941|66767834|FG001|Overall Study|Insurance Denial|2|||
23832982|NCT00954941|66767833|FG000|Overall Study|Physician Decision|2|||
23832983|NCT00954941|66767834|FG001|Overall Study|Physician Decision|2|||
23832984|NCT00954941|66767833|FG000|Overall Study|Ineligible|2|||
23832985|NCT00954941|66767834|FG001|Overall Study|Ineligible|2|||
23832986|NCT00954941|66767833|FG000|Overall Study|Adverse Event|0|||
23832987|NCT00954941|66767834|FG001|Overall Study|Adverse Event|1|||
23832988|NCT00669669|66767835|FG000|Overall Study|To late to start treatment|1|||
23832989|NCT00793871|66767836|FG000|Overall Study|Death|50|||
23832990|NCT00793871|66767836|FG000|Overall Study|Lost to Follow-up|3|||
23832991|NCT00793871|66767836|FG000|Overall Study|Study terminated by the Sponsor|7|||
23832992|NCT02502149|66767837|FG000|Intermediate|Discontinued prematurely|1|||
23832993|NCT02502149|66767838|FG001|Intermediate|Discontinued prematurely|0|||
23832994|NCT02502149|66767839|FG002|Intermediate|Discontinued prematurely|0|||
23832995|NCT02502149|66767840|FG003|Intermediate|Discontinued prematurely|0|||
23832996|NCT02502149|66767841|FG004|Intermediate|Discontinued prematurely|0|||
23832997|NCT00915018|66767845|FG000|Overall Study|Death|75|||
23832998|NCT00915018|66767846|FG001|Overall Study|Death|70|||
23832999|NCT00915018|66767845|FG000|Overall Study|Lost to Follow-up|10|||
23771943|NCT02536378|66543267|FG001|Overall Study|Physician Decision|2|||
23771944|NCT02536378|66543266|FG000|Overall Study|Withdrawal by Subject|0|||
23771945|NCT02536378|66543267|FG001|Overall Study|Withdrawal by Subject|1|||
23771946|NCT02536378|66543266|FG000|Overall Study|Death|1|||
23771947|NCT02536378|66543267|FG001|Overall Study|Death|2|||
23771948|NCT02536378|66543266|FG000|Overall Study|Patient refused further follow up|6|||
23771949|NCT02536378|66543267|FG001|Overall Study|Patient refused further follow up|2|||
23771950|NCT01278862|66543269|FG000|Overall Study|Lost to Follow-up|1|||
23771951|NCT01278862|66543270|FG001|Overall Study|Lost to Follow-up|1|||
23771952|NCT02579096|66543271|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
23771953|NCT02579096|66543272|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
23771954|NCT02579096|66543271|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
23771955|NCT02579096|66543272|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
23771956|NCT02579096|66543271|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
23771957|NCT02579096|66543272|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
23771958|NCT02579096|66543271|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
23771959|NCT02579096|66543272|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
23771960|NCT02579096|66543271|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
23771961|NCT02579096|66543272|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
23771962|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Death|2|||
23574317|NCT02733042|65831763|FG016|Overall Study|Adverse Event|0|||
23771963|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Death|4|||
23771964|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
23833000|NCT00915018|66767846|FG001|Overall Study|Lost to Follow-up|5|||
23833001|NCT00915018|66767845|FG000|Overall Study|Withdrawal by Subject|38|||
23833002|NCT00915018|66767846|FG001|Overall Study|Withdrawal by Subject|27|||
23833003|NCT00915018|66767845|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
23833004|NCT00915018|66767846|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
23833005|NCT02259010|66767847|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
23833006|NCT02712320|66767848|FG000|Overall Study|Lost to Follow-up|1|||
23771965|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
23771966|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
23771967|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
23771968|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
23771969|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
23771970|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
23771971|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
23771972|NCT02579096|66543271|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
23771973|NCT02579096|66543272|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
23771974|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Death|3|||
23771975|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Death|2|||
23771976|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
23771977|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
23771978|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
23771979|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
23771980|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
23771981|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
23771982|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
23771983|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
23771984|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
23771985|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
23771986|NCT02579096|66543271|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
23771987|NCT02579096|66543272|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
23771988|NCT00818883|66543273|FG000|Overall Study|Adverse Event|28|||
23771989|NCT00818883|66543274|FG001|Overall Study|Adverse Event|19|||
23771990|NCT00818883|66543273|FG000|Overall Study|Protocol Violation|2|||
23771991|NCT00818883|66543274|FG001|Overall Study|Protocol Violation|2|||
23771992|NCT00818883|66543273|FG000|Overall Study|Lost to Follow-up|3|||
23771993|NCT00818883|66543274|FG001|Overall Study|Lost to Follow-up|2|||
23771994|NCT00818883|66543273|FG000|Overall Study|Withdrawal by Subject|16|||
23771995|NCT00818883|66543274|FG001|Overall Study|Withdrawal by Subject|14|||
23771996|NCT00818883|66543273|FG000|Overall Study|Lack of Efficacy|0|||
23771997|NCT00818883|66543274|FG001|Overall Study|Lack of Efficacy|2|||
23771998|NCT00818883|66543273|FG000|Overall Study|Other|2|||
23771999|NCT00818883|66543274|FG001|Overall Study|Other|7|||
23772000|NCT00491504|66543275|FG000|Overall Study|Adverse Event|0|||
23833007|NCT02712320|66767848|FG000|Overall Study|Withdrawal by Subject|1|||
23833008|NCT02712320|66767848|FG000|Overall Study|Transferred to another facility|1|||
23833009|NCT02712320|66767848|FG000|Overall Study|Treating with the prohibited medications|2|||
23772001|NCT00491504|66543276|FG001|Overall Study|Adverse Event|1|||
23772002|NCT00491504|66543277|FG002|Overall Study|Adverse Event|0|||
23772003|NCT00491504|66543278|FG003|Overall Study|Adverse Event|0|||
23772004|NCT00491504|66543275|FG000|Overall Study|Withdrawal by Subject|0|||
23772005|NCT00491504|66543276|FG001|Overall Study|Withdrawal by Subject|0|||
23772006|NCT00491504|66543277|FG002|Overall Study|Withdrawal by Subject|1|||
23772007|NCT00491504|66543278|FG003|Overall Study|Withdrawal by Subject|2|||
23772008|NCT00491504|66543275|FG000|Overall Study|Protocol Violation|0|||
23772009|NCT00491504|66543276|FG001|Overall Study|Protocol Violation|0|||
23772010|NCT00491504|66543277|FG002|Overall Study|Protocol Violation|3|||
23772011|NCT00491504|66543278|FG003|Overall Study|Protocol Violation|2|||
23772012|NCT00243932|66543279|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
23772013|NCT00243932|66543280|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
23772014|NCT00243932|66543281|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
23772015|NCT00094302|66543282|FG000|Overall Study|Lost to Follow-up|43|||
23772016|NCT00094302|66543283|FG001|Overall Study|Lost to Follow-up|41|||
23833010|NCT02025725|66767849|FG000|Overall Study|Adverse Event|5|||
23833011|NCT02025725|66767850|FG001|Overall Study|Adverse Event|0|||
23574318|NCT02733042|65831764|FG017|Overall Study|Adverse Event|1|||
23772017|NCT00094302|66543282|FG000|Overall Study|Physician Decision|5|||
23833012|NCT02025725|66767849|FG000|Overall Study|Lost to Follow-up|2|||
23833013|NCT02025725|66767850|FG001|Overall Study|Lost to Follow-up|0|||
23833014|NCT02025725|66767849|FG000|Overall Study|Protocol Violation|1|||
23833015|NCT02025725|66767850|FG001|Overall Study|Protocol Violation|1|||
23833016|NCT02025725|66767849|FG000|Overall Study|Withdrawal by Subject|3|||
23833017|NCT02025725|66767850|FG001|Overall Study|Withdrawal by Subject|2|||
23833018|NCT02025725|66767849|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
23833019|NCT02025725|66767850|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
23833020|NCT02222922|66767855|FG000|Overall Study|Death|0|||
23833021|NCT02222922|66767856|FG001|Overall Study|Death|0|||
23833022|NCT02222922|66767857|FG002|Overall Study|Death|0|||
23833023|NCT02222922|66767858|FG003|Overall Study|Death|0|||
23833024|NCT02222922|66767859|FG004|Overall Study|Death|13|||
23833025|NCT02222922|66767860|FG005|Overall Study|Death|0|||
23833026|NCT02222922|66767861|FG006|Overall Study|Death|0|||
23833027|NCT02222922|66767862|FG007|Overall Study|Death|0|||
23833028|NCT02222922|66767863|FG008|Overall Study|Death|2|||
23833029|NCT02222922|66767855|FG000|Overall Study|Lost to Follow-up|0|||
23833030|NCT02222922|66767856|FG001|Overall Study|Lost to Follow-up|0|||
23772018|NCT00094302|66543283|FG001|Overall Study|Physician Decision|8|||
23772019|NCT00094302|66543282|FG000|Overall Study|Withdrawal by Subject|103|||
23833031|NCT02222922|66767857|FG002|Overall Study|Lost to Follow-up|1|||
23833032|NCT02222922|66767858|FG003|Overall Study|Lost to Follow-up|0|||
23833033|NCT02222922|66767859|FG004|Overall Study|Lost to Follow-up|9|||
23833034|NCT02222922|66767860|FG005|Overall Study|Lost to Follow-up|1|||
23833035|NCT02222922|66767861|FG006|Overall Study|Lost to Follow-up|0|||
23772020|NCT00094302|66543283|FG001|Overall Study|Withdrawal by Subject|111|||
23772021|NCT00094302|66543282|FG000|Overall Study|Death|266|||
23772022|NCT00094302|66543283|FG001|Overall Study|Death|246|||
23772023|NCT02928848|66543284|FG000|Arm 2|Withdrawal by Subject|1|||
23772024|NCT02928848|66543285|FG001|Arm 2|Withdrawal by Subject|0|||
23772025|NCT03708211|66543287|FG000|Overall Study|Progressive Disease|10|||
23772026|NCT03708211|66543288|FG001|Overall Study|Progressive Disease|7|||
23772027|NCT03708211|66543287|FG000|Overall Study|Withdrawal by Subject|0|||
23772028|NCT03708211|66543288|FG001|Overall Study|Withdrawal by Subject|1|||
23772029|NCT03708211|66543287|FG000|Overall Study|Other|2|||
23772030|NCT03708211|66543288|FG001|Overall Study|Other|0|||
23772031|NCT03552757|66543289|FG000|Overall Study|Withdrawal by Subject|10|||
23772032|NCT03552757|66543290|FG001|Overall Study|Withdrawal by Subject|5|||
23772033|NCT03552757|66543291|FG002|Overall Study|Withdrawal by Subject|12|||
23772034|NCT03552757|66543289|FG000|Overall Study|Lost to Follow-up|2|||
23772035|NCT03552757|66543290|FG001|Overall Study|Lost to Follow-up|7|||
23772036|NCT03552757|66543291|FG002|Overall Study|Lost to Follow-up|7|||
23772037|NCT03552757|66543289|FG000|Overall Study|Death|1|||
23772038|NCT03552757|66543290|FG001|Overall Study|Death|1|||
23772039|NCT03552757|66543291|FG002|Overall Study|Death|1|||
23772040|NCT05894577|66543292|FG000|Overall Study|No receipt of study drug|14|||
23772041|NCT05894577|66543293|FG001|Overall Study|No receipt of study drug|13|||
23772042|NCT05894577|66543292|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
23772043|NCT05894577|66543293|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
23772044|NCT05894577|66543292|FG000|Overall Study|Screen Fail|2|||
23772045|NCT05894577|66543293|FG001|Overall Study|Screen Fail|0|||
23772046|NCT05894577|66543292|FG000|Overall Study|Study drug recall|86|||
23772047|NCT05894577|66543293|FG001|Overall Study|Study drug recall|63|||
23772048|NCT02927847|66546447|FG000|Overall Study|Lost to Follow-up|1|||
23772049|NCT02927847|66546448|FG001|Overall Study|Lost to Follow-up|0|||
23772050|NCT02927847|66546447|FG000|Overall Study|Withdrawal by Subject|4|||
23772051|NCT02927847|66546448|FG001|Overall Study|Withdrawal by Subject|2|||
23772052|NCT02927847|66546447|FG000|Overall Study|PI withdrawn due to missed visits|1|||
23772053|NCT02927847|66546448|FG001|Overall Study|PI withdrawn due to missed visits|1|||
23772054|NCT03209570|66546449|FG000|Overall Study|Death|1|||
23772055|NCT03209570|66546450|FG001|Overall Study|Death|0|||
23772056|NCT03209570|66546449|FG000|Overall Study|Incomplete Data|8|||
23772057|NCT03209570|66546450|FG001|Overall Study|Incomplete Data|10|||
23772058|NCT03209570|66546449|FG000|Overall Study|Protocol Violation|1|||
23574319|NCT02733042|65831765|FG018|Overall Study|Adverse Event|0|||
23574320|NCT02733042|65831747|FG000|Overall Study|Progressive Disease|2|||
23574321|NCT02733042|65831748|FG001|Overall Study|Progressive Disease|1|||
23574322|NCT02733042|65831749|FG002|Overall Study|Progressive Disease|3|||
23574323|NCT02733042|65831750|FG003|Overall Study|Progressive Disease|1|||
23574324|NCT02733042|65831751|FG004|Overall Study|Progressive Disease|2|||
23574325|NCT02733042|65831752|FG005|Overall Study|Progressive Disease|3|||
23574326|NCT02733042|65831753|FG006|Overall Study|Progressive Disease|0|||
23574327|NCT02733042|65831754|FG007|Overall Study|Progressive Disease|3|||
23574328|NCT02733042|65831755|FG008|Overall Study|Progressive Disease|3|||
23574329|NCT02733042|65831756|FG009|Overall Study|Progressive Disease|2|||
23574330|NCT02733042|65831757|FG010|Overall Study|Progressive Disease|2|||
23574331|NCT02733042|65831758|FG011|Overall Study|Progressive Disease|2|||
23574332|NCT02733042|65831759|FG012|Overall Study|Progressive Disease|8|||
23574333|NCT02733042|65831760|FG013|Overall Study|Progressive Disease|1|||
23574334|NCT02733042|65831761|FG014|Overall Study|Progressive Disease|4|||
23574335|NCT02733042|65831762|FG015|Overall Study|Progressive Disease|7|||
23574336|NCT02733042|65831763|FG016|Overall Study|Progressive Disease|2|||
23574337|NCT02733042|65831764|FG017|Overall Study|Progressive Disease|3|||
23574338|NCT02733042|65831765|FG018|Overall Study|Progressive Disease|4|||
23574339|NCT02733042|65831747|FG000|Overall Study|Withdrawal by Subject|0|||
23574340|NCT02733042|65831748|FG001|Overall Study|Withdrawal by Subject|1|||
23574341|NCT02733042|65831749|FG002|Overall Study|Withdrawal by Subject|2|||
23574342|NCT02733042|65831750|FG003|Overall Study|Withdrawal by Subject|1|||
23447342|NCT03329846|65380411|FG000|Overall Study|Participant withdrew consent|1|||
23574343|NCT02733042|65831751|FG004|Overall Study|Withdrawal by Subject|1|||
23574344|NCT02733042|65831752|FG005|Overall Study|Withdrawal by Subject|0|||
23574345|NCT02733042|65831753|FG006|Overall Study|Withdrawal by Subject|0|||
23574346|NCT02733042|65831754|FG007|Overall Study|Withdrawal by Subject|0|||
23447343|NCT03329846|65380412|FG001|Overall Study|Participant withdrew consent|0|||
23447344|NCT03329846|65380411|FG000|Overall Study|Other reasons|2|||
23447345|NCT03329846|65380412|FG001|Overall Study|Other reasons|2|||
23447346|NCT00795704|65380413|FG000|Overall Study|Withdrawal by Subject|3|||
23447347|NCT00795704|65380414|FG001|Overall Study|Withdrawal by Subject|2|||
23447348|NCT00795704|65380413|FG000|Overall Study|Adverse Event|1|||
23447349|NCT00795704|65380414|FG001|Overall Study|Adverse Event|1|||
23447350|NCT02792231|65380415|FG000|Overall Study|Patient/guardian decision|32|||
23574347|NCT02733042|65831755|FG008|Overall Study|Withdrawal by Subject|1|||
23772059|NCT03209570|66546450|FG001|Overall Study|Protocol Violation|0|||
23772060|NCT03209570|66546449|FG000|Overall Study|Withdrawal by Subject|0|||
23772061|NCT03209570|66546450|FG001|Overall Study|Withdrawal by Subject|3|||
23772062|NCT00723554|66546451|FG000|Overall Study|Adverse Event|12|||
23772063|NCT00723554|66546451|FG000|Overall Study|Investigator's judgement|5|||
23772064|NCT00723554|66546451|FG000|Overall Study|Inhaled medication other than iloprost|4|||
23772065|NCT00723554|66546451|FG000|Overall Study|Withdrawal of consent|3|||
23772066|NCT00723554|66546451|FG000|Overall Study|Other|3|||
23772067|NCT00723554|66546451|FG000|Overall Study|Lost to Follow-up|1|||
23772068|NCT00723554|66546451|FG000|Overall Study|Non-compliance|1|||
23772069|NCT01492361|66546452|FG000|Overall Study|Withdrawal by Subject|281|||
23772070|NCT01492361|66546453|FG001|Overall Study|Withdrawal by Subject|297|||
23772071|NCT01492361|66546452|FG000|Overall Study|Physician Decision|12|||
23772072|NCT01492361|66546453|FG001|Overall Study|Physician Decision|12|||
23772073|NCT01492361|66546452|FG000|Overall Study|Lost to Follow-up|6|||
23772074|NCT01492361|66546453|FG001|Overall Study|Lost to Follow-up|13|||
23772075|NCT01492361|66546452|FG000|Overall Study|Other than specified above|106|||
23772076|NCT01492361|66546453|FG001|Overall Study|Other than specified above|138|||
23772077|NCT01379781|66546456|FG000|Overall Study|Lost to Follow-up|11|||
23772078|NCT01379781|66546457|FG001|Overall Study|Lost to Follow-up|8|||
23772079|NCT00454636|66546459|FG000|Overall Study|Adverse Event|10|||
23772080|NCT00454636|66546460|FG001|Overall Study|Adverse Event|6|||
23772081|NCT00454636|66546461|FG002|Overall Study|Adverse Event|9|||
23772082|NCT00454636|66546462|FG003|Overall Study|Adverse Event|15|||
23772083|NCT00454636|66546459|FG000|Overall Study|Disease Progression|11|||
23772084|NCT00454636|66546460|FG001|Overall Study|Disease Progression|12|||
23772085|NCT00454636|66546461|FG002|Overall Study|Disease Progression|4|||
23772086|NCT00454636|66546462|FG003|Overall Study|Disease Progression|11|||
23772087|NCT00454636|66546459|FG000|Overall Study|Protocol Violation|3|||
23772088|NCT00454636|66546460|FG001|Overall Study|Protocol Violation|2|||
23772089|NCT00454636|66546461|FG002|Overall Study|Protocol Violation|3|||
23772090|NCT00454636|66546462|FG003|Overall Study|Protocol Violation|3|||
23772091|NCT00454636|66546459|FG000|Overall Study|Death|6|||
23772092|NCT00454636|66546460|FG001|Overall Study|Death|1|||
23772093|NCT00454636|66546461|FG002|Overall Study|Death|1|||
23772094|NCT00454636|66546462|FG003|Overall Study|Death|1|||
23772095|NCT00454636|66546459|FG000|Overall Study|Patient refusal|1|||
23772096|NCT00454636|66546460|FG001|Overall Study|Patient refusal|1|||
23772097|NCT00454636|66546461|FG002|Overall Study|Patient refusal|3|||
23772098|NCT00454636|66546462|FG003|Overall Study|Patient refusal|2|||
23772099|NCT00454636|66546459|FG000|Overall Study|Lost to Follow-up|0|||
23772100|NCT00454636|66546460|FG001|Overall Study|Lost to Follow-up|1|||
23772101|NCT00454636|66546461|FG002|Overall Study|Lost to Follow-up|0|||
23772102|NCT00454636|66546462|FG003|Overall Study|Lost to Follow-up|0|||
23772103|NCT05034731|66546463|FG000|Overall Study|Screen fail|1|||
23772104|NCT05034731|66546464|FG001|Overall Study|Screen fail|1|||
23772105|NCT02785913|66546467|FG000|Overall Study|Adverse Event|5|||
23772106|NCT02785913|66546467|FG000|Overall Study|Death|2|||
23772107|NCT02785913|66546467|FG000|Overall Study|Progression|18|||
23772108|NCT02785913|66546467|FG000|Overall Study|Not protocol specified|1|||
23772109|NCT01682083|66546472|FG000|Overall Study|Lost to Follow-up|11|||
23772110|NCT01682083|66546473|FG001|Overall Study|Lost to Follow-up|18|||
23772111|NCT01682083|66546472|FG000|Overall Study|Withdrawal by Subject|31|||
23772112|NCT01682083|66546473|FG001|Overall Study|Withdrawal by Subject|40|||
23772113|NCT01682083|66546472|FG000|Overall Study|Death|60|||
23772114|NCT01682083|66546473|FG001|Overall Study|Death|93|||
23772115|NCT01682083|66546472|FG000|Overall Study|Physician Decision|5|||
23772116|NCT01682083|66546473|FG001|Overall Study|Physician Decision|4|||
23772117|NCT02655237|66546474|FG000|Overall Study|Adverse Event|10|||
23772118|NCT02655237|66546475|FG001|Overall Study|Adverse Event|7|||
23833036|NCT02222922|66767862|FG007|Overall Study|Lost to Follow-up|0|||
23833037|NCT02222922|66767863|FG008|Overall Study|Lost to Follow-up|0|||
23772119|NCT02655237|66546474|FG000|Overall Study|Protocol Deviation|2|||
23772120|NCT02655237|66546475|FG001|Overall Study|Protocol Deviation|0|||
23772121|NCT02655237|66546474|FG000|Overall Study|Withdrawal by Participant|1|||
23772122|NCT02655237|66546475|FG001|Overall Study|Withdrawal by Participant|2|||
23772123|NCT02655237|66546474|FG000|Overall Study|Lack of Efficacy|0|||
23772124|NCT02655237|66546475|FG001|Overall Study|Lack of Efficacy|1|||
23772125|NCT02655237|66546474|FG000|Overall Study|Recovery Leading to Surgery|2|||
23772126|NCT02655237|66546475|FG001|Overall Study|Recovery Leading to Surgery|1|||
23772127|NCT02655237|66546474|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
23772128|NCT02655237|66546475|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
23772129|NCT02655237|66546474|FG000|Overall Study|Randomized but Not Treated|1|||
23772130|NCT02655237|66546475|FG001|Overall Study|Randomized but Not Treated|0|||
23772131|NCT00832377|66546476|FG000|Overall Study|Protocol Violation|1|||
23772132|NCT02978326|66546480|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
23772133|NCT02978326|66546481|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
23772134|NCT02978326|66546482|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
23772135|NCT02978326|66546480|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
23772136|NCT02978326|66546481|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
23772137|NCT02978326|66546482|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
23772138|NCT02978326|66546480|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
23772139|NCT02978326|66546481|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
23574348|NCT02733042|65831756|FG009|Overall Study|Withdrawal by Subject|1|||
23574349|NCT02733042|65831757|FG010|Overall Study|Withdrawal by Subject|0|||
23574350|NCT02733042|65831758|FG011|Overall Study|Withdrawal by Subject|2|||
23574351|NCT02733042|65831759|FG012|Overall Study|Withdrawal by Subject|1|||
23574352|NCT02733042|65831760|FG013|Overall Study|Withdrawal by Subject|1|||
23574353|NCT02733042|65831761|FG014|Overall Study|Withdrawal by Subject|0|||
23574354|NCT02733042|65831762|FG015|Overall Study|Withdrawal by Subject|0|||
23574355|NCT02733042|65831763|FG016|Overall Study|Withdrawal by Subject|0|||
23574356|NCT02733042|65831764|FG017|Overall Study|Withdrawal by Subject|0|||
23574357|NCT02733042|65831765|FG018|Overall Study|Withdrawal by Subject|0|||
23574358|NCT02733042|65831747|FG000|Overall Study|Other Reasons|0|||
23574359|NCT02733042|65831748|FG001|Overall Study|Other Reasons|0|||
23574360|NCT02733042|65831749|FG002|Overall Study|Other Reasons|1|||
23574361|NCT02733042|65831750|FG003|Overall Study|Other Reasons|0|||
23574362|NCT02733042|65831751|FG004|Overall Study|Other Reasons|0|||
23574363|NCT02733042|65831752|FG005|Overall Study|Other Reasons|0|||
23574364|NCT02733042|65831753|FG006|Overall Study|Other Reasons|0|||
23574365|NCT02733042|65831754|FG007|Overall Study|Other Reasons|0|||
23574366|NCT02733042|65831755|FG008|Overall Study|Other Reasons|0|||
23574367|NCT02733042|65831756|FG009|Overall Study|Other Reasons|1|||
23574368|NCT02733042|65831757|FG010|Overall Study|Other Reasons|1|||
23574369|NCT02733042|65831758|FG011|Overall Study|Other Reasons|0|||
23574370|NCT02733042|65831759|FG012|Overall Study|Other Reasons|0|||
23574371|NCT02733042|65831760|FG013|Overall Study|Other Reasons|0|||
23574372|NCT02733042|65831761|FG014|Overall Study|Other Reasons|0|||
23574373|NCT02733042|65831762|FG015|Overall Study|Other Reasons|1|||
23574374|NCT02733042|65831763|FG016|Overall Study|Other Reasons|0|||
23574375|NCT02733042|65831764|FG017|Overall Study|Other Reasons|1|||
23574376|NCT02733042|65831765|FG018|Overall Study|Other Reasons|0|||
23574377|NCT02733042|65831747|FG000|Overall Study|Death|0|||
23772140|NCT02978326|66546482|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
23772141|NCT02978326|66546480|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
23772142|NCT02978326|66546481|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
23772143|NCT02978326|66546482|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
23772144|NCT02152566|66546487|FG000|Overall Study|Lost to Follow-up|1|||
23772145|NCT02152566|66546487|FG000|Overall Study|Withdrawal by Subject|2|||
23772146|NCT02173704|66546489|FG000|Overall Study|Adverse Event|1|||
23772147|NCT02173704|66546490|FG001|Overall Study|Adverse Event|0|||
23772148|NCT02173704|66546489|FG000|Overall Study|Lost to Follow-up|1|||
23772149|NCT02173704|66546490|FG001|Overall Study|Lost to Follow-up|0|||
23772150|NCT02173704|66546489|FG000|Overall Study|Other|1|||
23772151|NCT02173704|66546490|FG001|Overall Study|Other|0|||
23772152|NCT02173704|66546489|FG000|Overall Study|Protocol Violation|1|||
23772153|NCT02173704|66546490|FG001|Overall Study|Protocol Violation|0|||
23772154|NCT02173704|66546489|FG000|Overall Study|Withdrawal by Subject|9|||
23772155|NCT02173704|66546490|FG001|Overall Study|Withdrawal by Subject|4|||
23772156|NCT00677365|66546491|FG000|Overall Study|Adverse Event|2|||
23772157|NCT00677365|66546492|FG001|Overall Study|Adverse Event|1|||
23772158|NCT00677365|66546493|FG002|Overall Study|Adverse Event|1|||
23772159|NCT00677365|66546494|FG003|Overall Study|Adverse Event|2|||
23772160|NCT00677365|66546491|FG000|Overall Study|Withdrawal by Subject|0|||
23574378|NCT02733042|65831748|FG001|Overall Study|Death|0|||
23574379|NCT02733042|65831749|FG002|Overall Study|Death|0|||
23574380|NCT02733042|65831750|FG003|Overall Study|Death|0|||
23772161|NCT00677365|66546492|FG001|Overall Study|Withdrawal by Subject|0|||
23772162|NCT00677365|66546493|FG002|Overall Study|Withdrawal by Subject|1|||
23574381|NCT02733042|65831751|FG004|Overall Study|Death|0|||
23574382|NCT02733042|65831752|FG005|Overall Study|Death|0|||
23772163|NCT00677365|66546494|FG003|Overall Study|Withdrawal by Subject|0|||
23772164|NCT00677365|66546491|FG000|Overall Study|Other reason|0|||
23574383|NCT02733042|65831753|FG006|Overall Study|Death|1|||
23574384|NCT02733042|65831754|FG007|Overall Study|Death|0|||
23574385|NCT02733042|65831755|FG008|Overall Study|Death|1|||
23772165|NCT00677365|66546492|FG001|Overall Study|Other reason|0|||
23772166|NCT00677365|66546493|FG002|Overall Study|Other reason|0|||
23772167|NCT00677365|66546494|FG003|Overall Study|Other reason|1|||
23574386|NCT02733042|65831756|FG009|Overall Study|Death|0|||
23574387|NCT02733042|65831757|FG010|Overall Study|Death|1|||
23574388|NCT02733042|65831758|FG011|Overall Study|Death|0|||
23574389|NCT02733042|65831759|FG012|Overall Study|Death|0|||
23574390|NCT02733042|65831760|FG013|Overall Study|Death|0|||
23574391|NCT02733042|65831761|FG014|Overall Study|Death|1|||
23574392|NCT02733042|65831762|FG015|Overall Study|Death|2|||
23574393|NCT02733042|65831763|FG016|Overall Study|Death|0|||
23574394|NCT02733042|65831764|FG017|Overall Study|Death|0|||
23574395|NCT02733042|65831765|FG018|Overall Study|Death|0|||
23574396|NCT04640571|65831766|FG000|Overall Study|Withdrawal by Subject|0|||
23574397|NCT04640571|65831767|FG001|Overall Study|Withdrawal by Subject|0|||
23574398|NCT04640571|65831768|FG002|Overall Study|Withdrawal by Subject|0|||
23574399|NCT04640571|65831769|FG003|Overall Study|Withdrawal by Subject|0|||
23574400|NCT04640571|65831770|FG004|Overall Study|Withdrawal by Subject|0|||
23574401|NCT04640571|65831771|FG005|Overall Study|Withdrawal by Subject|2|||
23574402|NCT00003509|65831774|FG000|Overall Study|Not evaluable|5|||
23574403|NCT01040780|65831776|FG000|Overall Study|Protocol Violation|1|||
23574404|NCT01040780|65831777|FG001|Overall Study|Protocol Violation|3|||
23574405|NCT00312858|65831778|FG000|Overall Study|Adverse Event|0|||
23574406|NCT00312858|65831779|FG001|Overall Study|Adverse Event|1|||
23574407|NCT00312858|65831778|FG000|Overall Study|Lost to Follow-up|25|||
23574408|NCT00312858|65831779|FG001|Overall Study|Lost to Follow-up|42|||
23574409|NCT00312858|65831778|FG000|Overall Study|Protocol Violation|3|||
23574410|NCT00312858|65831779|FG001|Overall Study|Protocol Violation|8|||
23574411|NCT00312858|65831778|FG000|Overall Study|Withdraw by Participant|20|||
23574412|NCT00312858|65831779|FG001|Overall Study|Withdraw by Participant|20|||
23574413|NCT00312858|65831778|FG000|Overall Study|Participant Moved|11|||
23574414|NCT00312858|65831779|FG001|Overall Study|Participant Moved|10|||
23574415|NCT00312858|65831778|FG000|Overall Study|Other|9|||
23574416|NCT00312858|65831779|FG001|Overall Study|Other|12|||
23574417|NCT00180713|65831780|FG000|Overall Study|Withdrawal by Subject|2|||
23574418|NCT00180713|65831781|FG001|Overall Study|Withdrawal by Subject|0|||
23772168|NCT01915732|66546495|FG000|Overall Study|Withdrawal by Subject|18|||
23772169|NCT01915732|66546496|FG001|Overall Study|Withdrawal by Subject|18|||
23772170|NCT01915732|66546495|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
23772171|NCT01915732|66546496|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23772172|NCT01915732|66546495|FG000|Overall Study|Adverse Event|12|||
23772173|NCT01915732|66546496|FG001|Overall Study|Adverse Event|4|||
23772174|NCT01915732|66546495|FG000|Overall Study|Protocol Violation|5|||
23772175|NCT01915732|66546496|FG001|Overall Study|Protocol Violation|5|||
23772176|NCT01915732|66546495|FG000|Overall Study|Lack of Efficacy|6|||
23772177|NCT01915732|66546496|FG001|Overall Study|Lack of Efficacy|11|||
23772178|NCT01915732|66546495|FG000|Overall Study|Lost to Follow-up|22|||
23772179|NCT01915732|66546496|FG001|Overall Study|Lost to Follow-up|26|||
23772180|NCT01915732|66546495|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
23772181|NCT01915732|66546496|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
23772182|NCT01915732|66546495|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
23772183|NCT01915732|66546496|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
23772184|NCT01915732|66546495|FG000|Overall Study|Drug Release Error|1|||
23772185|NCT01915732|66546496|FG001|Overall Study|Drug Release Error|0|||
23772186|NCT01915732|66546495|FG000|Overall Study|Recovered|1|||
23772187|NCT01915732|66546496|FG001|Overall Study|Recovered|0|||
23772188|NCT01915732|66546495|FG000|Overall Study|Pregnancy|1|||
23772189|NCT01915732|66546496|FG001|Overall Study|Pregnancy|0|||
23772190|NCT01915732|66546495|FG000|Overall Study|Poor Perceived Efficacy|1|||
23772191|NCT01915732|66546496|FG001|Overall Study|Poor Perceived Efficacy|0|||
23772192|NCT01915732|66546495|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
23772193|NCT01915732|66546496|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
23772194|NCT01915732|66546495|FG000|Overall Study|Got Well|0|||
23772195|NCT01915732|66546496|FG001|Overall Study|Got Well|1|||
23772196|NCT01915732|66546495|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
23574419|NCT00180713|65831780|FG000|Overall Study|Adverse Event|3|||
23772197|NCT01915732|66546496|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
23772198|NCT01915732|66546495|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
23772199|NCT01915732|66546496|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
23772200|NCT01915732|66546495|FG000|Overall Study|Job Transfer|0|||
23772201|NCT01915732|66546496|FG001|Overall Study|Job Transfer|1|||
23772202|NCT01915732|66546495|FG000|Overall Study|Improper Facial Procedure|0|||
23574420|NCT00180713|65831781|FG001|Overall Study|Adverse Event|3|||
23574421|NCT02838628|65831788|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
23574422|NCT02838628|65831789|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
23574423|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Adverse Event|1|||
23574424|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Adverse Event|0|||
23772203|NCT01915732|66546496|FG001|Overall Study|Improper Facial Procedure|1|||
23772204|NCT01915732|66546495|FG000|Overall Study|Poor Conscious Effect|0|||
23772205|NCT01915732|66546496|FG001|Overall Study|Poor Conscious Effect|1|||
23574425|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Non-compliance|0|||
23574426|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Non-compliance|1|||
23574427|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
23574428|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
23574429|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Other un-specified|1|||
23574430|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Other un-specified|1|||
23574431|NCT03405662|65831790|FG000|Overall Study|COVID-19 restriction|1|||
23574432|NCT03405662|65831791|FG001|Overall Study|COVID-19 restriction|0|||
23574433|NCT03405662|65831790|FG000|Overall Study|unblinding|0|||
23574434|NCT03405662|65831791|FG001|Overall Study|unblinding|1|||
23574435|NCT03405662|65831790|FG000|Overall Study|placement in memory care facility|0|||
23574436|NCT03405662|65831791|FG001|Overall Study|placement in memory care facility|2|||
23574437|NCT01007552|65831793|FG000|Overall Study|Withdrawal by Subject|1|||
23574438|NCT01066156|65835303|FG000|Overall Study|ineligible|2|||
23574439|NCT01066156|65835303|FG000|Overall Study|Lost to Follow-up|7|||
23574440|NCT01066156|65835303|FG000|Overall Study|Withdrawal by Subject|1|||
23574441|NCT03100838|65835308|FG000|Overall Study|Adverse Event|1|||
23574442|NCT03100838|65835309|FG001|Overall Study|Adverse Event|0|||
23574443|NCT03100838|65835310|FG002|Overall Study|Adverse Event|0|||
23574444|NCT03100838|65835311|FG003|Overall Study|Adverse Event|0|||
23574445|NCT03100838|65835308|FG000|Overall Study|Physician Decision|1|||
23574446|NCT03100838|65835309|FG001|Overall Study|Physician Decision|1|||
23574447|NCT03100838|65835310|FG002|Overall Study|Physician Decision|1|||
23574448|NCT03100838|65835311|FG003|Overall Study|Physician Decision|1|||
23574449|NCT03100838|65835308|FG000|Overall Study|Pregnancy|0|||
23574450|NCT03100838|65835309|FG001|Overall Study|Pregnancy|1|||
23574451|NCT03100838|65835310|FG002|Overall Study|Pregnancy|0|||
23574452|NCT03100838|65835311|FG003|Overall Study|Pregnancy|0|||
23574453|NCT03100838|65835308|FG000|Overall Study|Lost to Follow-up|0|||
23574454|NCT03100838|65835309|FG001|Overall Study|Lost to Follow-up|0|||
23574455|NCT03100838|65835310|FG002|Overall Study|Lost to Follow-up|1|||
23574456|NCT03100838|65835311|FG003|Overall Study|Lost to Follow-up|0|||
23574457|NCT01458275|65835312|FG000|Overall Study|Adverse Event|3|||
23574458|NCT01458275|65835313|FG001|Overall Study|Adverse Event|4|||
23574459|NCT01458275|65835314|FG002|Overall Study|Adverse Event|1|||
23574460|NCT01458275|65835312|FG000|Overall Study|Lost to Follow-up|3|||
23574461|NCT01458275|65835313|FG001|Overall Study|Lost to Follow-up|2|||
23574462|NCT01458275|65835314|FG002|Overall Study|Lost to Follow-up|5|||
23574463|NCT01458275|65835312|FG000|Overall Study|Protocol Violation|5|||
23574464|NCT01458275|65835313|FG001|Overall Study|Protocol Violation|5|||
23574465|NCT01458275|65835314|FG002|Overall Study|Protocol Violation|2|||
23574466|NCT01458275|65835312|FG000|Overall Study|Withdrawal by Subject|3|||
23574467|NCT01458275|65835313|FG001|Overall Study|Withdrawal by Subject|2|||
23574468|NCT01458275|65835314|FG002|Overall Study|Withdrawal by Subject|1|||
23574469|NCT01544491|65835315|FG000|Overall Study|Withdrawal by Subject|3|||
23574470|NCT01544491|65835316|FG001|Overall Study|Withdrawal by Subject|2|||
23772206|NCT01060670|66546501|FG000|Run In|screen failure|0|||
23772207|NCT01060670|66546502|FG001|Run In|screen failure|238|||
23772208|NCT01179919|66546503|FG000|Overall Study|Protocol Violation|1|||
23772209|NCT01179919|66546503|FG000|Overall Study|Adverse Event|1|||
23772210|NCT03125200|66546504|FG000|Overall Study|Study Termination|0|||
23772211|NCT03125200|66546505|FG001|Overall Study|Study Termination|0|||
23772212|NCT03125200|66546506|FG002|Overall Study|Study Termination|0|||
23772213|NCT03125200|66546507|FG003|Overall Study|Study Termination|1|||
23772214|NCT03125200|66546508|FG004|Overall Study|Study Termination|1|||
23772215|NCT03125200|66546509|FG005|Overall Study|Study Termination|2|||
23772216|NCT03125200|66546510|FG006|Overall Study|Study Termination|1|||
23772217|NCT03125200|66546504|FG000|Overall Study|Clinical Progression|0|||
23772218|NCT03125200|66546505|FG001|Overall Study|Clinical Progression|0|||
23574471|NCT01544491|65835315|FG000|Overall Study|Lost to Follow-up|0|||
23574472|NCT01544491|65835316|FG001|Overall Study|Lost to Follow-up|1|||
23772219|NCT03125200|66546506|FG002|Overall Study|Clinical Progression|0|||
23772220|NCT03125200|66546507|FG003|Overall Study|Clinical Progression|1|||
23833038|NCT02222922|66767855|FG000|Overall Study|Other|0|||
23574473|NCT01544491|65835315|FG000|Overall Study|administrative problems|2|||
23574474|NCT01544491|65835316|FG001|Overall Study|administrative problems|0|||
23574475|NCT01106976|65835317|FG000|Overall Study|Lost to Follow-up|8|||
23574476|NCT00146640|65835318|FG000|Overall Study|Adverse Event|12|||
23574477|NCT00146640|65835319|FG001|Overall Study|Adverse Event|10|||
23574478|NCT00146640|65835318|FG000|Overall Study|Medical Reasons|3|||
23574479|NCT00146640|65835319|FG001|Overall Study|Medical Reasons|0|||
23772221|NCT03125200|66546508|FG004|Overall Study|Clinical Progression|0|||
23574480|NCT00146640|65835318|FG000|Overall Study|Non-Medical Reasons|8|||
23574481|NCT00146640|65835319|FG001|Overall Study|Non-Medical Reasons|4|||
23772222|NCT03125200|66546509|FG005|Overall Study|Clinical Progression|1|||
23833039|NCT02222922|66767856|FG001|Overall Study|Other|0|||
23574482|NCT01439711|65835324|FG000|Overall Study|Ineligible|13|||
23772223|NCT03125200|66546510|FG006|Overall Study|Clinical Progression|0|||
23772224|NCT03125200|66546504|FG000|Overall Study|Progressive Disease|2|||
23574483|NCT01439711|65835324|FG000|Overall Study|Cancel|3|||
23574484|NCT01439711|65835324|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
23574485|NCT01439711|65835324|FG000|Overall Study|Adverse Event|5|||
23574486|NCT01439711|65835324|FG000|Overall Study|Withdrawal by Subject|3|||
23574487|NCT01439711|65835324|FG000|Overall Study|Progression During Active Tx|3|||
23574488|NCT01439711|65835324|FG000|Overall Study|Noncompliance|3|||
23574489|NCT01439711|65835324|FG000|Overall Study|No MRI|9|||
23574490|NCT01804673|65835325|FG000|Overall Study|Adverse Event|4|||
23574491|NCT01804673|65835325|FG000|Overall Study|Withdrawal by Subject|1|||
23772225|NCT03125200|66546505|FG001|Overall Study|Progressive Disease|1|||
23772226|NCT03125200|66546506|FG002|Overall Study|Progressive Disease|2|||
23772227|NCT03125200|66546507|FG003|Overall Study|Progressive Disease|1|||
23772228|NCT03125200|66546508|FG004|Overall Study|Progressive Disease|2|||
23772229|NCT03125200|66546509|FG005|Overall Study|Progressive Disease|0|||
23772230|NCT03125200|66546510|FG006|Overall Study|Progressive Disease|1|||
23772231|NCT03125200|66546504|FG000|Overall Study|Lack of Efficacy|0|||
23772232|NCT03125200|66546505|FG001|Overall Study|Lack of Efficacy|0|||
23772233|NCT03125200|66546506|FG002|Overall Study|Lack of Efficacy|0|||
23772234|NCT03125200|66546507|FG003|Overall Study|Lack of Efficacy|1|||
23772235|NCT03125200|66546508|FG004|Overall Study|Lack of Efficacy|0|||
23772236|NCT03125200|66546509|FG005|Overall Study|Lack of Efficacy|0|||
23772237|NCT03125200|66546510|FG006|Overall Study|Lack of Efficacy|0|||
23772238|NCT03125200|66546504|FG000|Overall Study|Toxicity|0|||
23772239|NCT03125200|66546505|FG001|Overall Study|Toxicity|0|||
23772240|NCT03125200|66546506|FG002|Overall Study|Toxicity|0|||
23772241|NCT03125200|66546507|FG003|Overall Study|Toxicity|1|||
23772242|NCT03125200|66546508|FG004|Overall Study|Toxicity|0|||
23772243|NCT03125200|66546509|FG005|Overall Study|Toxicity|0|||
23772244|NCT03125200|66546510|FG006|Overall Study|Toxicity|0|||
23772245|NCT03125200|66546504|FG000|Overall Study|Consent Withdrawn by Subject|0|||
23772246|NCT03125200|66546505|FG001|Overall Study|Consent Withdrawn by Subject|1|||
23772247|NCT03125200|66546506|FG002|Overall Study|Consent Withdrawn by Subject|0|||
23772248|NCT03125200|66546507|FG003|Overall Study|Consent Withdrawn by Subject|0|||
23772249|NCT03125200|66546508|FG004|Overall Study|Consent Withdrawn by Subject|1|||
23574492|NCT01804673|65835325|FG000|Overall Study|Lack of Efficacy|9|||
23772250|NCT03125200|66546509|FG005|Overall Study|Consent Withdrawn by Subject|0|||
23772251|NCT03125200|66546510|FG006|Overall Study|Consent Withdrawn by Subject|1|||
23833040|NCT02222922|66767857|FG002|Overall Study|Other|0|||
23833041|NCT02222922|66767858|FG003|Overall Study|Other|2|||
23447351|NCT02792231|65380416|FG001|Overall Study|Patient/guardian decision|42|||
23772252|NCT00860028|66546511|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
23772253|NCT00860028|66546512|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
23833042|NCT02222922|66767859|FG004|Overall Study|Other|10|||
23633571|NCT04674189|66045362|FG001|Overall Study|Adverse Event|0|||
23447352|NCT02792231|65380415|FG000|Overall Study|Adverse Event|15|||
23772254|NCT00543309|66546513|FG000|Overall Study|Physician Decision|0|||
23772255|NCT00543309|66546514|FG001|Overall Study|Physician Decision|1|||
23772256|NCT00543309|66546515|FG002|Overall Study|Physician Decision|0|||
23772257|NCT01717976|66546518|FG000|Overall Study|Protocol Violation|0|||
23772258|NCT01717976|66546519|FG001|Overall Study|Protocol Violation|1|||
23772259|NCT00262600|66546522|FG000|Overall Study|Lost to Follow-up|17|||
23772260|NCT00262600|66546523|FG001|Overall Study|Lost to Follow-up|31|||
23772261|NCT00262600|66546524|FG002|Overall Study|Lost to Follow-up|41|||
23772262|NCT00262600|66546522|FG000|Overall Study|Withdrawal by Subject|128|||
23772263|NCT00262600|66546523|FG001|Overall Study|Withdrawal by Subject|145|||
23772264|NCT00262600|66546524|FG002|Overall Study|Withdrawal by Subject|139|||
23772265|NCT00262600|66546522|FG000|Overall Study|Not Treated|32|||
23772266|NCT00262600|66546523|FG001|Overall Study|Not Treated|17|||
23772267|NCT00262600|66546524|FG002|Overall Study|Not Treated|24|||
23772268|NCT00262600|66546522|FG000|Overall Study|Other|58|||
23772269|NCT00262600|66546523|FG001|Overall Study|Other|59|||
23772270|NCT00262600|66546524|FG002|Overall Study|Other|62|||
23772271|NCT01644500|66546526|FG000|Overall Study|Adverse Event|6|||
23772272|NCT01644500|66546527|FG001|Overall Study|Adverse Event|1|||
23574493|NCT01804673|65835325|FG000|Overall Study|Change to Oral Therapy|37|||
23574494|NCT01804673|65835325|FG000|Overall Study|No Further Therapy Required|84|||
23574495|NCT01804673|65835325|FG000|Overall Study|Use of Prohibited Medication|1|||
23574496|NCT01804673|65835325|FG000|Overall Study|Other|4|||
23574497|NCT03053492|65835326|FG000|Overall Study|Adverse Event|1|||
23574498|NCT03053492|65835327|FG001|Overall Study|Adverse Event|1|||
23574499|NCT03053492|65835326|FG000|Overall Study|Withdrawal by Subject|7|||
23574500|NCT03053492|65835327|FG001|Overall Study|Withdrawal by Subject|5|||
23574501|NCT01824472|65835328|FG000|Overall Study|Lost to Follow-up|0|||
23574502|NCT01824472|65835329|FG001|Overall Study|Lost to Follow-up|0|||
23574503|NCT01824472|65835330|FG002|Overall Study|Lost to Follow-up|1|||
23574504|NCT01824472|65835328|FG000|Overall Study|Withdrawal by Subject|1|||
23574505|NCT01824472|65835329|FG001|Overall Study|Withdrawal by Subject|5|||
23574506|NCT01824472|65835330|FG002|Overall Study|Withdrawal by Subject|3|||
23574507|NCT01824472|65835328|FG000|Overall Study|Ineligible post randomization&screening|0|||
23574508|NCT01824472|65835329|FG001|Overall Study|Ineligible post randomization&screening|2|||
23574509|NCT01824472|65835330|FG002|Overall Study|Ineligible post randomization&screening|0|||
23574510|NCT01024751|65835336|FG000|Enrolled Participants|Ineligible at baseline|3|||
23574511|NCT01024751|65835337|FG001|Enrolled Participants|Ineligible at baseline|4|||
23574512|NCT01024751|65835336|FG000|Eligible Participants|Withdrawal by Subject|0|||
23574513|NCT01024751|65835337|FG001|Eligible Participants|Withdrawal by Subject|1|||
23574514|NCT01024751|65835336|FG000|Eligible Participants|Lost to Follow-up|0|||
23574515|NCT01024751|65835337|FG001|Eligible Participants|Lost to Follow-up|1|||
23574516|NCT01024751|65835336|FG000|Eligible Participants|Ineligible|0|||
23574517|NCT01024751|65835337|FG001|Eligible Participants|Ineligible|1|||
23574518|NCT00919893|65835338|FG000|Overall Study|Protocol Violation|19|||
23574519|NCT00919893|65835339|FG001|Overall Study|Protocol Violation|9|||
23574520|NCT04963062|65835346|FG000|Overall Study|withdrew by the study team|4|||
23574521|NCT04963062|65835347|FG001|Overall Study|withdrew by the study team|2|||
23574522|NCT00429793|65835350|FG000|Overall Study|Improper pre-protocol treatment|3|||
23833043|NCT02222922|66767860|FG005|Overall Study|Other|2|||
23574523|NCT00429793|65835350|FG000|Overall Study|Required test not done|1|||
23772273|NCT01644500|66546528|FG002|Overall Study|Adverse Event|2|||
23833044|NCT02222922|66767861|FG006|Overall Study|Other|2|||
23772274|NCT01644500|66546526|FG000|Overall Study|Death|0|||
23772275|NCT01644500|66546527|FG001|Overall Study|Death|1|||
23772276|NCT01644500|66546528|FG002|Overall Study|Death|0|||
23833045|NCT02222922|66767862|FG007|Overall Study|Other|4|||
23574524|NCT00429793|65835350|FG000|Overall Study|Never treated|1|||
23574525|NCT00429793|65835350|FG000|Overall Study|Non-measurable|1|||
23574526|NCT00577720|65835353|FG000|Overall Study|Adverse Event|2|||
23574527|NCT00577720|65835354|FG001|Overall Study|Adverse Event|1|||
23574528|NCT00577720|65835355|FG002|Overall Study|Adverse Event|0|||
23574529|NCT00577720|65835356|FG003|Overall Study|Adverse Event|4|||
23574530|NCT00577720|65835353|FG000|Overall Study|Lost to Follow-up|0|||
23574531|NCT00577720|65835354|FG001|Overall Study|Lost to Follow-up|0|||
23574532|NCT00577720|65835355|FG002|Overall Study|Lost to Follow-up|1|||
23574533|NCT00577720|65835356|FG003|Overall Study|Lost to Follow-up|0|||
23574534|NCT00577720|65835353|FG000|Overall Study|Protocol Violation|0|||
23574535|NCT00577720|65835354|FG001|Overall Study|Protocol Violation|0|||
23574536|NCT00577720|65835355|FG002|Overall Study|Protocol Violation|0|||
23574537|NCT00577720|65835356|FG003|Overall Study|Protocol Violation|1|||
23574538|NCT00577720|65835353|FG000|Overall Study|Withdrawal by Subject|2|||
23574539|NCT00577720|65835354|FG001|Overall Study|Withdrawal by Subject|0|||
23574540|NCT00577720|65835355|FG002|Overall Study|Withdrawal by Subject|0|||
23574541|NCT00577720|65835356|FG003|Overall Study|Withdrawal by Subject|2|||
23574542|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
23574543|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
23574544|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
23574545|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
23574546|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
23574547|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23574548|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
23574549|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23574550|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
23574551|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
23574552|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
23574553|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
23574554|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23574555|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23772277|NCT01644500|66546526|FG000|Overall Study|Lost to Follow-up|3|||
23772278|NCT01644500|66546527|FG001|Overall Study|Lost to Follow-up|8|||
23772279|NCT01644500|66546528|FG002|Overall Study|Lost to Follow-up|0|||
23772280|NCT01644500|66546526|FG000|Overall Study|Protocol Violation|1|||
23772281|NCT01644500|66546527|FG001|Overall Study|Protocol Violation|1|||
23772282|NCT01644500|66546528|FG002|Overall Study|Protocol Violation|0|||
23772283|NCT01644500|66546526|FG000|Overall Study|Withdrawal by Subject|11|||
23772284|NCT01644500|66546527|FG001|Overall Study|Withdrawal by Subject|12|||
23772285|NCT01644500|66546528|FG002|Overall Study|Withdrawal by Subject|12|||
23772286|NCT01644500|66546526|FG000|Overall Study|Physician Decision|1|||
23772287|NCT01644500|66546527|FG001|Overall Study|Physician Decision|1|||
23772288|NCT01644500|66546528|FG002|Overall Study|Physician Decision|1|||
23772289|NCT03687736|66546529|FG000|Overall Study|Lost to Follow-up|7|||
23772290|NCT03687736|66546529|FG000|Overall Study|Withdrawal by Subject|3|||
23772291|NCT03977584|66546535|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
23772292|NCT03977584|66546536|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
23772293|NCT03977584|66546537|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
23772294|NCT01575054|66546538|FG000|Overall Study|Other Reasons|5|||
23772295|NCT01575054|66546539|FG001|Overall Study|Other Reasons|3|||
23772296|NCT01575054|66546538|FG000|Overall Study|Protocol Violation|2|||
23574556|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23574557|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
23574558|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
23772297|NCT01575054|66546539|FG001|Overall Study|Protocol Violation|1|||
23772298|NCT01575054|66546538|FG000|Overall Study|Personal Reasons|10|||
23772299|NCT01575054|66546539|FG001|Overall Study|Personal Reasons|11|||
23772300|NCT01575054|66546538|FG000|Overall Study|Lost to Follow-up|3|||
23574559|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
23574560|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
23574561|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
23574562|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
23574563|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
23574564|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
23574565|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
23574566|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
23574567|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
23574568|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
23574569|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
23574570|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
23574571|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
23574572|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Death|0|||
23574573|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Death|0|||
23574574|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Death|0|||
23574575|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Death|0|||
23574576|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Death|1|||
23772301|NCT01575054|66546539|FG001|Overall Study|Lost to Follow-up|3|||
23772302|NCT01575054|66546538|FG000|Overall Study|Adverse Event|9|||
23772303|NCT01575054|66546539|FG001|Overall Study|Adverse Event|8|||
23772304|NCT00818623|66546542|FG000|Overall Study|Adverse Event|1|||
23772305|NCT00818623|66546543|FG001|Overall Study|Adverse Event|0|||
23772306|NCT00818623|66546544|FG002|Overall Study|Adverse Event|1|||
23772307|NCT00818623|66546545|FG003|Overall Study|Adverse Event|0|||
23772308|NCT00818623|66546546|FG004|Overall Study|Adverse Event|0|||
23772309|NCT00818623|66546547|FG005|Overall Study|Adverse Event|1|||
23772310|NCT00818623|66546548|FG006|Overall Study|Adverse Event|0|||
23772311|NCT00818623|66546549|FG007|Overall Study|Adverse Event|0|||
23772312|NCT00818623|66546542|FG000|Overall Study|Bad prostate specific antigen response|0|||
23772313|NCT00818623|66546543|FG001|Overall Study|Bad prostate specific antigen response|3|||
23772314|NCT00818623|66546544|FG002|Overall Study|Bad prostate specific antigen response|2|||
23772315|NCT00818623|66546545|FG003|Overall Study|Bad prostate specific antigen response|5|||
23772316|NCT00818623|66546546|FG004|Overall Study|Bad prostate specific antigen response|0|||
23772317|NCT00818623|66546547|FG005|Overall Study|Bad prostate specific antigen response|1|||
23772318|NCT00818623|66546548|FG006|Overall Study|Bad prostate specific antigen response|0|||
23772319|NCT00818623|66546549|FG007|Overall Study|Bad prostate specific antigen response|0|||
23772320|NCT00818623|66546542|FG000|Overall Study|Withdrawal by Subject|0|||
23772321|NCT00818623|66546543|FG001|Overall Study|Withdrawal by Subject|1|||
23772322|NCT00818623|66546544|FG002|Overall Study|Withdrawal by Subject|1|||
23772323|NCT00818623|66546545|FG003|Overall Study|Withdrawal by Subject|0|||
23772324|NCT00818623|66546546|FG004|Overall Study|Withdrawal by Subject|0|||
23772325|NCT00818623|66546547|FG005|Overall Study|Withdrawal by Subject|1|||
23772326|NCT00818623|66546548|FG006|Overall Study|Withdrawal by Subject|1|||
23772327|NCT00818623|66546549|FG007|Overall Study|Withdrawal by Subject|1|||
23772328|NCT00818623|66546542|FG000|Overall Study|Protocol Violation|1|||
23772329|NCT00818623|66546543|FG001|Overall Study|Protocol Violation|0|||
23833046|NCT02222922|66767863|FG008|Overall Study|Other|1|||
23833047|NCT02222922|66767855|FG000|Overall Study|Participant refused further follow-up|1|||
23772330|NCT00818623|66546544|FG002|Overall Study|Protocol Violation|0|||
23772331|NCT00818623|66546545|FG003|Overall Study|Protocol Violation|0|||
23772332|NCT00818623|66546546|FG004|Overall Study|Protocol Violation|1|||
23772333|NCT00818623|66546547|FG005|Overall Study|Protocol Violation|0|||
23772334|NCT00818623|66546548|FG006|Overall Study|Protocol Violation|1|||
23772335|NCT00818623|66546549|FG007|Overall Study|Protocol Violation|0|||
23772336|NCT00818623|66546542|FG000|Overall Study|Need of additional treatment|0|||
23772337|NCT00818623|66546543|FG001|Overall Study|Need of additional treatment|0|||
23772338|NCT00818623|66546544|FG002|Overall Study|Need of additional treatment|0|||
23772339|NCT00818623|66546545|FG003|Overall Study|Need of additional treatment|0|||
23833048|NCT02222922|66767856|FG001|Overall Study|Participant refused further follow-up|0|||
23772340|NCT00818623|66546546|FG004|Overall Study|Need of additional treatment|1|||
23772341|NCT00818623|66546547|FG005|Overall Study|Need of additional treatment|0|||
23833049|NCT02222922|66767857|FG002|Overall Study|Participant refused further follow-up|0|||
23574577|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
23574578|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
23574579|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
23772342|NCT00818623|66546548|FG006|Overall Study|Need of additional treatment|0|||
23833050|NCT02222922|66767858|FG003|Overall Study|Participant refused further follow-up|1|||
23574580|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
23574581|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
23574582|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574583|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574584|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
23574585|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574586|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
23772343|NCT00818623|66546549|FG007|Overall Study|Need of additional treatment|0|||
23772344|NCT00818623|66546542|FG000|Overall Study|Lack of trial drug at site|0|||
23772345|NCT00818623|66546543|FG001|Overall Study|Lack of trial drug at site|0|||
23772346|NCT00818623|66546544|FG002|Overall Study|Lack of trial drug at site|0|||
23772347|NCT00818623|66546545|FG003|Overall Study|Lack of trial drug at site|0|||
23772348|NCT00818623|66546546|FG004|Overall Study|Lack of trial drug at site|2|||
23772349|NCT00818623|66546547|FG005|Overall Study|Lack of trial drug at site|0|||
23772350|NCT00818623|66546548|FG006|Overall Study|Lack of trial drug at site|1|||
23772351|NCT00818623|66546549|FG007|Overall Study|Lack of trial drug at site|0|||
23772352|NCT00818623|66546542|FG000|Overall Study|Disease progression|0|||
23772353|NCT00818623|66546543|FG001|Overall Study|Disease progression|0|||
23772354|NCT00818623|66546544|FG002|Overall Study|Disease progression|0|||
23772355|NCT00818623|66546545|FG003|Overall Study|Disease progression|0|||
23772356|NCT00818623|66546546|FG004|Overall Study|Disease progression|0|||
23772357|NCT00818623|66546547|FG005|Overall Study|Disease progression|0|||
23772358|NCT00818623|66546548|FG006|Overall Study|Disease progression|1|||
23772359|NCT00818623|66546549|FG007|Overall Study|Disease progression|0|||
23772360|NCT04015232|66546552|FG000|Overall Study|Withdrawal by Subject|7|||
23772361|NCT04015232|66546553|FG001|Overall Study|Withdrawal by Subject|4|||
23772362|NCT04015232|66546552|FG000|Overall Study|Protocol Violation|1|||
23772363|NCT04015232|66546553|FG001|Overall Study|Protocol Violation|0|||
23772364|NCT04015232|66546552|FG000|Overall Study|Medical Grounds|3|||
23772365|NCT04015232|66546553|FG001|Overall Study|Medical Grounds|3|||
23772366|NCT03805438|66546554|FG000|Overall Study|Lack of Efficacy|1|||
23772367|NCT03805438|66546554|FG000|Overall Study|Protocol Violation|1|||
23772368|NCT00918567|66546555|FG000|Overall Study|Lack of Efficacy|3|||
23772369|NCT00918567|66546556|FG001|Overall Study|Lack of Efficacy|1|||
23772370|NCT00918567|66546555|FG000|Overall Study|Withdrawal by Subject|1|||
23772371|NCT00918567|66546556|FG001|Overall Study|Withdrawal by Subject|1|||
23772372|NCT00918567|66546555|FG000|Overall Study|Adverse Event|1|||
23772373|NCT00918567|66546556|FG001|Overall Study|Adverse Event|0|||
23772374|NCT01893905|66546557|FG000|Overall Study|Withdrawal by Subject|1|||
23772375|NCT01893905|66546558|FG001|Overall Study|Withdrawal by Subject|0|||
23772376|NCT01893905|66546557|FG000|Overall Study|Adverse Event|9|||
23772377|NCT01893905|66546558|FG001|Overall Study|Adverse Event|3|||
23772378|NCT01893905|66546557|FG000|Overall Study|Lack of Efficacy|5|||
23772379|NCT01893905|66546558|FG001|Overall Study|Lack of Efficacy|7|||
23772380|NCT01893905|66546557|FG000|Overall Study|Lost to Follow-up|1|||
23772381|NCT01893905|66546558|FG001|Overall Study|Lost to Follow-up|0|||
23833051|NCT02222922|66767859|FG004|Overall Study|Participant refused further follow-up|6|||
23833052|NCT02222922|66767860|FG005|Overall Study|Participant refused further follow-up|0|||
23833053|NCT02222922|66767861|FG006|Overall Study|Participant refused further follow-up|0|||
23833054|NCT02222922|66767862|FG007|Overall Study|Participant refused further follow-up|0|||
23833055|NCT02222922|66767863|FG008|Overall Study|Participant refused further follow-up|3|||
23833056|NCT03313180|66767864|FG000|Overall Study|Adverse Event|120|||
23833057|NCT03313180|66767864|FG000|Overall Study|Lost to Follow-up|3|||
23833058|NCT03313180|66767864|FG000|Overall Study|Withdrawal by Subject|39|||
23833059|NCT03313180|66767864|FG000|Overall Study|Other than listed above|15|||
23833060|NCT03313180|66767864|FG000|Overall Study|Covid-19 related|2|||
23833061|NCT00568451|66767869|FG000|Overall Study|Disease Progression|0|||
23833062|NCT00568451|66767870|FG001|Overall Study|Disease Progression|0|||
23833063|NCT00568451|66767871|FG002|Overall Study|Disease Progression|2|||
23833064|NCT00568451|66767872|FG003|Overall Study|Disease Progression|7|||
23833065|NCT00707239|66767875|FG000|Overall Study|Adverse Event|5|||
23833066|NCT00707239|66767876|FG001|Overall Study|Adverse Event|3|||
23833067|NCT00707239|66767877|FG002|Overall Study|Adverse Event|2|||
23833068|NCT00707239|66767875|FG000|Overall Study|Death|3|||
23833069|NCT00707239|66767876|FG001|Overall Study|Death|1|||
23833070|NCT00707239|66767877|FG002|Overall Study|Death|3|||
23833071|NCT00707239|66767875|FG000|Overall Study|Physician Decision|1|||
23833072|NCT00707239|66767876|FG001|Overall Study|Physician Decision|1|||
23833073|NCT00707239|66767877|FG002|Overall Study|Physician Decision|2|||
23833074|NCT00707239|66767875|FG000|Overall Study|Protocol Violation|0|||
23833075|NCT00707239|66767876|FG001|Overall Study|Protocol Violation|0|||
23833076|NCT00707239|66767877|FG002|Overall Study|Protocol Violation|1|||
23833077|NCT00707239|66767875|FG000|Overall Study|Lack of Efficacy|1|||
23833078|NCT00707239|66767876|FG001|Overall Study|Lack of Efficacy|2|||
23833079|NCT00707239|66767877|FG002|Overall Study|Lack of Efficacy|0|||
23833080|NCT00707239|66767875|FG000|Overall Study|Randomized, but not treated|1|||
23833081|NCT00707239|66767876|FG001|Overall Study|Randomized, but not treated|1|||
23833082|NCT00707239|66767877|FG002|Overall Study|Randomized, but not treated|1|||
23833083|NCT00707239|66767875|FG000|Overall Study|Other|8|||
23833084|NCT00707239|66767876|FG001|Overall Study|Other|3|||
23833085|NCT00707239|66767877|FG002|Overall Study|Other|5|||
23833086|NCT00396656|66767878|FG000|First Treatment Period|Withdrawal by Subject|0|||
23833087|NCT00396656|66767879|FG001|First Treatment Period|Withdrawal by Subject|2|||
23833088|NCT00396656|66767878|FG000|Second Treatment Period|Adverse Event|0|||
23833089|NCT00396656|66767879|FG001|Second Treatment Period|Adverse Event|1|||
23833090|NCT00813150|66767880|FG000|Treatment Period|Adverse Event|16|||
23574587|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
23574588|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
23574589|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
23833091|NCT00813150|66767881|FG001|Treatment Period|Adverse Event|15|||
23833092|NCT00813150|66767880|FG000|Treatment Period|Death|2|||
23833093|NCT00813150|66767881|FG001|Treatment Period|Death|0|||
23833094|NCT00813150|66767880|FG000|Treatment Period|Progressive disease|1|||
23833095|NCT00813150|66767881|FG001|Treatment Period|Progressive disease|0|||
23833096|NCT00813150|66767880|FG000|Treatment Period|Complete response|0|||
23833097|NCT00813150|66767881|FG001|Treatment Period|Complete response|1|||
23833098|NCT00813150|66767880|FG000|Treatment Period|Stable disease|1|||
23833099|NCT00813150|66767881|FG001|Treatment Period|Stable disease|2|||
23833100|NCT00813150|66767880|FG000|Treatment Period|Protocol Violation|3|||
23833101|NCT00813150|66767881|FG001|Treatment Period|Protocol Violation|4|||
23833102|NCT00813150|66767880|FG000|Treatment Period|Withdrawal by Subject|5|||
23833103|NCT00813150|66767881|FG001|Treatment Period|Withdrawal by Subject|3|||
23833104|NCT00813150|66767880|FG000|Treatment Period|Non compliance|0|||
23833105|NCT00813150|66767881|FG001|Treatment Period|Non compliance|1|||
23833106|NCT00813150|66767880|FG000|Treatment Period|Reason not specified|3|||
23833107|NCT00813150|66767881|FG001|Treatment Period|Reason not specified|4|||
23833108|NCT00813150|66767880|FG000|Treatment Period|Data not available|1|||
23833109|NCT00813150|66767881|FG001|Treatment Period|Data not available|2|||
23833110|NCT00813150|66767880|FG000|Long Term Follow-up|Death|0|||
23574590|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
23833111|NCT00813150|66767881|FG001|Long Term Follow-up|Death|4|||
23833112|NCT00813150|66767880|FG000|Long Term Follow-up|Other|0|||
23833113|NCT00813150|66767881|FG001|Long Term Follow-up|Other|3|||
23833114|NCT00813150|66767880|FG000|Long Term Follow-up|Lost to Follow-up|2|||
23447353|NCT02792231|65380416|FG001|Overall Study|Adverse Event|11|||
23447354|NCT02792231|65380415|FG000|Overall Study|Physician Decision|14|||
23447355|NCT02792231|65380416|FG001|Overall Study|Physician Decision|12|||
23447356|NCT02792231|65380415|FG000|Overall Study|Lack of Efficacy|7|||
23447357|NCT02792231|65380416|FG001|Overall Study|Lack of Efficacy|9|||
23772382|NCT01893905|66546557|FG000|Overall Study|Protocol Violation|6|||
23772383|NCT01893905|66546558|FG001|Overall Study|Protocol Violation|1|||
23772384|NCT01893905|66546557|FG000|Overall Study|Lack of adherence to treatment|2|||
23772385|NCT01893905|66546558|FG001|Overall Study|Lack of adherence to treatment|0|||
23772386|NCT01893905|66546557|FG000|Overall Study|Other reason|1|||
23772387|NCT01893905|66546558|FG001|Overall Study|Other reason|3|||
23772388|NCT00626548|66546559|FG000|Overall Study|Adverse Event|164|||
23772389|NCT00626548|66546560|FG001|Overall Study|Adverse Event|44|||
23772390|NCT00626548|66546559|FG000|Overall Study|Withdrawal by Subject|42|||
23772391|NCT00626548|66546560|FG001|Overall Study|Withdrawal by Subject|46|||
23772392|NCT00626548|66546559|FG000|Overall Study|Protocol Violation|4|||
23772393|NCT00626548|66546560|FG001|Overall Study|Protocol Violation|11|||
23447358|NCT02792231|65380415|FG000|Overall Study|Lost to Follow-up|9|||
23447359|NCT02792231|65380416|FG001|Overall Study|Lost to Follow-up|5|||
23447360|NCT02792231|65380415|FG000|Overall Study|Pregnancy|1|||
23447361|NCT02792231|65380416|FG001|Overall Study|Pregnancy|3|||
23447362|NCT02792231|65380415|FG000|Overall Study|Non-compliance with study treatment|2|||
23447363|NCT02792231|65380416|FG001|Overall Study|Non-compliance with study treatment|1|||
23447364|NCT02792231|65380415|FG000|Overall Study|Protocol deviation|2|||
23447365|NCT02792231|65380416|FG001|Overall Study|Protocol deviation|0|||
23447366|NCT02792231|65380415|FG000|Overall Study|Technical problems|0|||
23447367|NCT02792231|65380416|FG001|Overall Study|Technical problems|1|||
23447368|NCT00626275|65380417|FG000|Part A - Treatment Period 1|Adverse Event|1|||
23447369|NCT00626275|65380418|FG001|Part A - Treatment Period 1|Adverse Event|0|||
23447370|NCT00626275|65380419|FG002|Part A - Treatment Period 1|Adverse Event|0|||
23447371|NCT00626275|65380420|FG003|Part A - Treatment Period 1|Adverse Event|0|||
23447372|NCT00626275|65380421|FG004|Part A - Treatment Period 1|Adverse Event|0|||
23574591|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
23574592|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
23574593|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
23574594|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
23574595|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
23574596|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
23574597|NCT01177813|65835362|FG000|Overall Study|Adverse Event|8|||
23574598|NCT01177813|65835363|FG001|Overall Study|Adverse Event|2|||
23574599|NCT01177813|65835364|FG002|Overall Study|Adverse Event|4|||
23574600|NCT01177813|65835365|FG003|Overall Study|Adverse Event|6|||
23574601|NCT01177813|65835366|FG004|Overall Study|Adverse Event|3|||
23574602|NCT01177813|65835362|FG000|Overall Study|Lack of Efficacy|1|||
23574603|NCT01177813|65835363|FG001|Overall Study|Lack of Efficacy|0|||
23574604|NCT01177813|65835364|FG002|Overall Study|Lack of Efficacy|0|||
23574605|NCT01177813|65835365|FG003|Overall Study|Lack of Efficacy|0|||
23574606|NCT01177813|65835366|FG004|Overall Study|Lack of Efficacy|0|||
23574607|NCT01177813|65835362|FG000|Overall Study|Protocol Violation|3|||
23574608|NCT01177813|65835363|FG001|Overall Study|Protocol Violation|2|||
23574609|NCT01177813|65835364|FG002|Overall Study|Protocol Violation|2|||
23574610|NCT01177813|65835365|FG003|Overall Study|Protocol Violation|0|||
23574611|NCT01177813|65835366|FG004|Overall Study|Protocol Violation|1|||
23574612|NCT01177813|65835362|FG000|Overall Study|Lost to Follow-up|12|||
23772394|NCT00626548|66546559|FG000|Overall Study|Lost to Follow-up|2|||
23574613|NCT01177813|65835363|FG001|Overall Study|Lost to Follow-up|5|||
23574614|NCT01177813|65835364|FG002|Overall Study|Lost to Follow-up|6|||
23574615|NCT01177813|65835365|FG003|Overall Study|Lost to Follow-up|3|||
23574616|NCT01177813|65835366|FG004|Overall Study|Lost to Follow-up|0|||
23574617|NCT01177813|65835362|FG000|Overall Study|Withdrawal by Subject|12|||
23447373|NCT00626275|65380422|FG005|Part A - Treatment Period 1|Adverse Event|0|||
23447374|NCT00626275|65380423|FG006|Part A - Treatment Period 1|Adverse Event|0|||
23447375|NCT00626275|65380424|FG007|Part A - Treatment Period 1|Adverse Event|0|||
23447376|NCT00626275|65380417|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447377|NCT00626275|65380418|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447378|NCT00626275|65380419|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
23447379|NCT00626275|65380420|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447380|NCT00626275|65380421|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447381|NCT00626275|65380422|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23574618|NCT01177813|65835363|FG001|Overall Study|Withdrawal by Subject|7|||
23574619|NCT01177813|65835364|FG002|Overall Study|Withdrawal by Subject|6|||
23772395|NCT00626548|66546560|FG001|Overall Study|Lost to Follow-up|2|||
23772396|NCT00626548|66546559|FG000|Overall Study|Other termination reason|493|||
23447382|NCT00626275|65380423|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447383|NCT00626275|65380424|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447384|NCT00626275|65380417|FG000|Part B|Lost to Follow-up|0|||
23574620|NCT01177813|65835365|FG003|Overall Study|Withdrawal by Subject|5|||
23574621|NCT01177813|65835366|FG004|Overall Study|Withdrawal by Subject|3|||
23574622|NCT01177813|65835362|FG000|Overall Study|Other reason not defined above|5|||
23574623|NCT01177813|65835363|FG001|Overall Study|Other reason not defined above|2|||
23574624|NCT01177813|65835364|FG002|Overall Study|Other reason not defined above|2|||
23574625|NCT01177813|65835365|FG003|Overall Study|Other reason not defined above|3|||
23574626|NCT01177813|65835366|FG004|Overall Study|Other reason not defined above|2|||
23574627|NCT01327547|65835367|FG000|Overall Study|Adverse Event|4|||
23574628|NCT01327547|65835368|FG001|Overall Study|Adverse Event|1|||
23574629|NCT01327547|65835367|FG000|Overall Study|Death|1|||
23772397|NCT00626548|66546560|FG001|Overall Study|Other termination reason|613|||
23772398|NCT02720510|66546561|FG000|Overall Study|Study Terminated by the sponsor|2|||
23447385|NCT00626275|65380418|FG001|Part B|Lost to Follow-up|0|||
23574630|NCT01327547|65835368|FG001|Overall Study|Death|2|||
23574631|NCT01327547|65835367|FG000|Overall Study|Lost to Follow-up|6|||
23574632|NCT01327547|65835368|FG001|Overall Study|Lost to Follow-up|6|||
23574633|NCT01327547|65835367|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23574634|NCT01327547|65835368|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
23574635|NCT01327547|65835367|FG000|Overall Study|Withdrawal by Subject|3|||
23574636|NCT01327547|65835368|FG001|Overall Study|Withdrawal by Subject|7|||
23574637|NCT01327547|65835367|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
23574638|NCT01327547|65835368|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
23574639|NCT01327547|65835367|FG000|Overall Study|Protocol Violation|1|||
23574640|NCT01327547|65835368|FG001|Overall Study|Protocol Violation|0|||
23574641|NCT01327547|65835367|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
23574642|NCT01327547|65835368|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
23574643|NCT01327547|65835367|FG000|Overall Study|Required prohibited medication|2|||
23574644|NCT01327547|65835368|FG001|Overall Study|Required prohibited medication|0|||
23574645|NCT01327547|65835367|FG000|Overall Study|Non-compliance with study procedures|1|||
23574646|NCT01327547|65835368|FG001|Overall Study|Non-compliance with study procedures|0|||
23574647|NCT01327547|65835367|FG000|Overall Study|By investigator in subject's interest|0|||
23574648|NCT01327547|65835368|FG001|Overall Study|By investigator in subject's interest|1|||
23574649|NCT01440049|65835369|FG000|Overall Study|Adverse Event|5|||
23574650|NCT02462083|65835370|FG000|Overall Study|Sponsor request|39|||
23574651|NCT02462083|65835370|FG000|Overall Study|Withdrawal by Subject|87|||
23574652|NCT02462083|65835370|FG000|Overall Study|Lost to Follow-up|41|||
23574653|NCT02462083|65835370|FG000|Overall Study|Lack of Efficacy|151|||
23574654|NCT02462083|65835370|FG000|Overall Study|Pregnancy|1|||
23574655|NCT02462083|65835370|FG000|Overall Study|Protocol Violation|6|||
23574656|NCT02462083|65835370|FG000|Overall Study|Adverse Event|33|||
23574657|NCT02462083|65835370|FG000|Overall Study|Worsening condition|16|||
23574658|NCT02462083|65835370|FG000|Overall Study|Other than specified|45|||
23574659|NCT00378105|65835371|FG000|Overall Study|Adverse Event|3|||
23574660|NCT00378105|65835372|FG001|Overall Study|Adverse Event|1|||
23574661|NCT00378105|65835371|FG000|Overall Study|Withdrawal by Subject|3|||
23574662|NCT00378105|65835372|FG001|Overall Study|Withdrawal by Subject|3|||
23574663|NCT00378105|65835371|FG000|Overall Study|Death|1|||
23574664|NCT00378105|65835372|FG001|Overall Study|Death|0|||
23574665|NCT00378105|65835371|FG000|Overall Study|Going to transplant|7|||
23574666|NCT00378105|65835372|FG001|Overall Study|Going to transplant|8|||
23574667|NCT00378105|65835371|FG000|Overall Study|Progressive disease|3|||
23574668|NCT00378105|65835372|FG001|Overall Study|Progressive disease|3|||
23574669|NCT00378105|65835371|FG000|Overall Study|remain on study|3|||
23574670|NCT00378105|65835372|FG001|Overall Study|remain on study|11|||
23574671|NCT00378105|65835371|FG000|Overall Study|Physician Decision|0|||
23574672|NCT00378105|65835372|FG001|Overall Study|Physician Decision|2|||
23574673|NCT00378105|65835371|FG000|Overall Study|Going non-protocol therapy|0|||
23574674|NCT00378105|65835372|FG001|Overall Study|Going non-protocol therapy|1|||
23574675|NCT00378105|65835371|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
23574676|NCT00378105|65835372|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
23574677|NCT02189863|65835373|FG000|First 2 Weeks|Motion Sickness|4|||
23574678|NCT02189863|65835374|FG001|First 2 Weeks|Motion Sickness|2|||
23574679|NCT02764775|65835375|FG000|Overall Study|Death|1|||
23574680|NCT02764775|65835375|FG000|Overall Study|Lost to Follow-up|2|||
23574681|NCT02764775|65835375|FG000|Overall Study|Withdrawal by Subject|3|||
23574682|NCT02297503|65835377|FG000|Overall Study|Withdrawal by Subject|1|||
23574683|NCT02297503|65835378|FG001|Overall Study|Withdrawal by Subject|1|||
23574684|NCT02297503|65835377|FG000|Overall Study|Protocol Violation|1|||
23574685|NCT02297503|65835378|FG001|Overall Study|Protocol Violation|0|||
23574686|NCT02297503|65835377|FG000|Overall Study|Pregnancy|0|||
23574687|NCT02297503|65835378|FG001|Overall Study|Pregnancy|1|||
23574688|NCT02297503|65835377|FG000|Overall Study|Lost to Follow-up|0|||
23574689|NCT02297503|65835378|FG001|Overall Study|Lost to Follow-up|1|||
23574690|NCT02297503|65835377|FG000|Overall Study|Medical reason|0|||
23574691|NCT02297503|65835378|FG001|Overall Study|Medical reason|1|||
23574692|NCT00322374|65835381|FG000|Starting Dose|Physician Decision|2|||
23574693|NCT00322374|65835382|FG001|Starting Dose|Physician Decision|0|||
23833115|NCT00813150|66767881|FG001|Long Term Follow-up|Lost to Follow-up|0|||
23833116|NCT00813150|66767880|FG000|Long Term Follow-up|Progression/Relapse|22|||
23833117|NCT00813150|66767881|FG001|Long Term Follow-up|Progression/Relapse|24|||
23833118|NCT02946463|66767882|FG000|Primary Evaluation Period|Physician Decision|0|||
23833119|NCT02946463|66767883|FG001|Primary Evaluation Period|Physician Decision|1|||
23833120|NCT02946463|66767884|FG002|Primary Evaluation Period|Physician Decision|0|||
23833121|NCT02946463|66767885|FG003|Primary Evaluation Period|Physician Decision|0|||
23833122|NCT02946463|66767882|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
23833123|NCT02946463|66767883|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
23574694|NCT00322374|65835383|FG002|Starting Dose|Physician Decision|0|||
23833124|NCT02946463|66767884|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
23833125|NCT02946463|66767885|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
23833126|NCT02946463|66767882|FG000|Extension Period|Death|4|||
23833127|NCT02946463|66767883|FG001|Extension Period|Death|4|||
23833128|NCT02946463|66767884|FG002|Extension Period|Death|0|||
23833129|NCT02946463|66767885|FG003|Extension Period|Death|0|||
23833130|NCT02946463|66767882|FG000|Extension Period|Withdrawal by Subject|4|||
23833131|NCT02946463|66767883|FG001|Extension Period|Withdrawal by Subject|3|||
23833132|NCT02946463|66767884|FG002|Extension Period|Withdrawal by Subject|0|||
23833133|NCT02946463|66767885|FG003|Extension Period|Withdrawal by Subject|0|||
23833134|NCT02946463|66767882|FG000|Extension Period|Other than specified|2|||
23833135|NCT02946463|66767883|FG001|Extension Period|Other than specified|3|||
23833136|NCT02946463|66767884|FG002|Extension Period|Other than specified|2|||
23833137|NCT02946463|66767885|FG003|Extension Period|Other than specified|0|||
23833138|NCT02946463|66767882|FG000|Extension Period|Physician Decision|1|||
23833139|NCT02946463|66767883|FG001|Extension Period|Physician Decision|4|||
23833140|NCT02946463|66767884|FG002|Extension Period|Physician Decision|0|||
23833141|NCT02946463|66767885|FG003|Extension Period|Physician Decision|0|||
23833142|NCT02946463|66767882|FG000|Extension Period|Pregnancy|3|||
23833143|NCT02946463|66767883|FG001|Extension Period|Pregnancy|1|||
23833144|NCT02946463|66767884|FG002|Extension Period|Pregnancy|0|||
23833145|NCT02946463|66767885|FG003|Extension Period|Pregnancy|0|||
23833146|NCT02946463|66767882|FG000|Extension Period|Adverse Event|1|||
23833147|NCT02946463|66767883|FG001|Extension Period|Adverse Event|2|||
23833148|NCT02946463|66767884|FG002|Extension Period|Adverse Event|0|||
23833149|NCT02946463|66767885|FG003|Extension Period|Adverse Event|0|||
23833150|NCT02946463|66767882|FG000|Extension Period|Lost to Follow-up|1|||
23447386|NCT00626275|65380419|FG002|Part B|Lost to Follow-up|0|||
23772399|NCT02720510|66546562|FG001|Overall Study|Study Terminated by the sponsor|0|||
23772400|NCT02720510|66546561|FG000|Overall Study|Adverse Event|0|||
23772401|NCT02720510|66546562|FG001|Overall Study|Adverse Event|1|||
23772402|NCT02720510|66546561|FG000|Overall Study|Physician Decision|1|||
23772403|NCT02720510|66546562|FG001|Overall Study|Physician Decision|2|||
23772404|NCT01226797|66546565|FG000|Overall Study|Adverse Event|1|||
23772405|NCT01226797|66546566|FG001|Overall Study|Adverse Event|0|||
23772406|NCT01226797|66546565|FG000|Overall Study|No longer willing to participate|1|||
23772407|NCT01226797|66546566|FG001|Overall Study|No longer willing to participate|0|||
23772408|NCT01226797|66546565|FG000|Overall Study|Protocol Violation|0|||
23772409|NCT01226797|66546566|FG001|Overall Study|Protocol Violation|1|||
23772410|NCT04060680|66546575|FG000|Overall Study|Unsuccessful implant|17|||
23833151|NCT02946463|66767883|FG001|Extension Period|Lost to Follow-up|0|||
23833152|NCT02946463|66767884|FG002|Extension Period|Lost to Follow-up|0|||
23833153|NCT02946463|66767885|FG003|Extension Period|Lost to Follow-up|0|||
23833154|NCT01965860|66767886|FG000|Overall Study|Pregnancy|1|||
23833155|NCT01965860|66767887|FG001|Overall Study|Pregnancy|0|||
23833156|NCT01965860|66767888|FG002|Overall Study|Pregnancy|1|||
23833157|NCT01965860|66767886|FG000|Overall Study|Logistics|1|||
23833158|NCT01965860|66767887|FG001|Overall Study|Logistics|0|||
23833159|NCT01965860|66767888|FG002|Overall Study|Logistics|0|||
23833160|NCT04846569|66767889|FG000|Overall Study|Withdrawal by Subject|3|||
23833161|NCT04846569|66767890|FG001|Overall Study|Withdrawal by Subject|1|||
23833162|NCT01641640|66767891|FG000|Overall Study|Enrolled but not treated|1|||
23833163|NCT01641640|66767891|FG000|Overall Study|Efficacy failure|29|||
23833164|NCT01641640|66767891|FG000|Overall Study|Lost to Follow-up|3|||
23833165|NCT01641640|66767891|FG000|Overall Study|Withdrawal by Subject|2|||
23833166|NCT01641640|66767891|FG000|Overall Study|Adverse Event|1|||
23833167|NCT01205776|66767892|FG000|Overall Study|Lost to Follow-up|53|||
23833168|NCT01205776|66767893|FG001|Overall Study|Lost to Follow-up|61|||
23833169|NCT01205776|66767892|FG000|Overall Study|Withdrawal by Subject|11|||
23833170|NCT01205776|66767893|FG001|Overall Study|Withdrawal by Subject|34|||
23833171|NCT00460603|66767898|FG000|Phase 1|Death|1|||
23833172|NCT00460603|66767899|FG001|Phase 1|Death|0|||
23833173|NCT00460603|66767900|FG002|Phase 1|Death|0|||
23833174|NCT00460603|66767901|FG003|Phase 1|Death|2|||
23833175|NCT00460603|66767902|FG004|Phase 1|Death|0|||
23833176|NCT00460603|66767903|FG005|Phase 1|Death|0|||
23833177|NCT00460603|66767904|FG006|Phase 1|Death|0|||
23833178|NCT00460603|66767905|FG007|Phase 1|Death|0|||
23833179|NCT00460603|66767906|FG008|Phase 1|Death|1|||
23833180|NCT00460603|66767907|FG009|Phase 1|Death|0|||
23833181|NCT00460603|66767908|FG010|Phase 1|Death|0|||
23447387|NCT00626275|65380420|FG003|Part B|Lost to Follow-up|0|||
23833182|NCT00460603|66767909|FG011|Phase 1|Death|0|||
23833183|NCT00460603|66767898|FG000|Phase 1|Adverse Event|3|||
23772411|NCT04060680|66546575|FG000|Overall Study|Adverse Event|3|||
23772412|NCT04060680|66546575|FG000|Overall Study|Death|2|||
23772413|NCT04060680|66546575|FG000|Overall Study|Study product no longer in use|1|||
23772414|NCT04060680|66546575|FG000|Overall Study|Withdrawal by Subject|1|||
23772415|NCT00322491|66546578|FG000|Overall Study|Adverse Event|1|||
23772416|NCT00322491|66546579|FG001|Overall Study|Adverse Event|0|||
23772417|NCT00322491|66546578|FG000|Overall Study|Death|1|||
23772418|NCT00322491|66546579|FG001|Overall Study|Death|2|||
23447388|NCT00626275|65380421|FG004|Part B|Lost to Follow-up|0|||
23447389|NCT00626275|65380422|FG005|Part B|Lost to Follow-up|0|||
23772419|NCT02073643|66546582|FG000|Overall Study|Lost to Follow-up|24|||
23772420|NCT00577460|66546583|FG000|Overall Study|Adverse Event|11|||
23772421|NCT00577460|66546584|FG001|Overall Study|Adverse Event|7|||
23772422|NCT00577460|66546585|FG002|Overall Study|Adverse Event|14|||
23772423|NCT00577460|66546583|FG000|Overall Study|Protocol Violation|0|||
23772424|NCT00577460|66546584|FG001|Overall Study|Protocol Violation|1|||
23772425|NCT00577460|66546585|FG002|Overall Study|Protocol Violation|1|||
23772426|NCT00577460|66546583|FG000|Overall Study|Lost to Follow-up|0|||
23772427|NCT00577460|66546584|FG001|Overall Study|Lost to Follow-up|3|||
23772428|NCT00577460|66546585|FG002|Overall Study|Lost to Follow-up|4|||
23772429|NCT00577460|66546583|FG000|Overall Study|Withdrawal by Subject|5|||
23772430|NCT00577460|66546584|FG001|Overall Study|Withdrawal by Subject|5|||
23772431|NCT00577460|66546585|FG002|Overall Study|Withdrawal by Subject|6|||
23772432|NCT00577460|66546583|FG000|Overall Study|Other|0|||
23772433|NCT00577460|66546584|FG001|Overall Study|Other|3|||
23772434|NCT00577460|66546585|FG002|Overall Study|Other|2|||
23772435|NCT01766921|66546590|FG000|Overall Study|Administrative Reason|5|||
23833184|NCT00460603|66767899|FG001|Phase 1|Adverse Event|1|||
23633572|NCT04674189|66045363|FG002|Overall Study|Adverse Event|1|||
23772436|NCT01766921|66546591|FG001|Overall Study|Administrative Reason|5|||
23833185|NCT00460603|66767900|FG002|Phase 1|Adverse Event|1|||
23772437|NCT01766921|66546590|FG000|Overall Study|Death|1|||
23772438|NCT01766921|66546591|FG001|Overall Study|Death|1|||
23833186|NCT00460603|66767901|FG003|Phase 1|Adverse Event|2|||
23833187|NCT00460603|66767902|FG004|Phase 1|Adverse Event|0|||
23633573|NCT04674189|66045361|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
23633574|NCT04674189|66045362|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
23633575|NCT04674189|66045363|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
23633576|NCT04674189|66045361|FG000|Overall Study|Physician Decision|1|||
23633577|NCT04674189|66045362|FG001|Overall Study|Physician Decision|0|||
23633578|NCT04674189|66045363|FG002|Overall Study|Physician Decision|0|||
23633579|NCT04674189|66045361|FG000|Overall Study|Withdrawal by Participant|83|||
23633580|NCT04674189|66045362|FG001|Overall Study|Withdrawal by Participant|71|||
23633581|NCT04674189|66045363|FG002|Overall Study|Withdrawal by Participant|142|||
23633582|NCT04674189|66045361|FG000|Overall Study|Lost to Follow-up|55|||
23633583|NCT04674189|66045362|FG001|Overall Study|Lost to Follow-up|53|||
23633584|NCT04674189|66045363|FG002|Overall Study|Lost to Follow-up|44|||
23447390|NCT00626275|65380423|FG006|Part B|Lost to Follow-up|1|||
23447391|NCT00626275|65380424|FG007|Part B|Lost to Follow-up|0|||
23447392|NCT00626275|65380417|FG000|Part B|Withdrawal by Subject|0|||
23574695|NCT00322374|65835384|FG003|Starting Dose|Physician Decision|0|||
23574696|NCT00322374|65835381|FG000|Starting Dose|Study Drug Toxicity|4|||
23574697|NCT00322374|65835382|FG001|Starting Dose|Study Drug Toxicity|0|||
23574698|NCT00322374|65835383|FG002|Starting Dose|Study Drug Toxicity|0|||
23574699|NCT00322374|65835384|FG003|Starting Dose|Study Drug Toxicity|0|||
23574700|NCT00322374|65835381|FG000|First Escalation|Documented Disease Progression|0|||
23633585|NCT04674189|66045361|FG000|Overall Study|Miscellaneous|27|||
23633586|NCT04674189|66045362|FG001|Overall Study|Miscellaneous|23|||
23633587|NCT04674189|66045363|FG002|Overall Study|Miscellaneous|207|||
23633588|NCT04674189|66045361|FG000|Overall Study|Did Not Receive Treatment|3|||
23633589|NCT04674189|66045362|FG001|Overall Study|Did Not Receive Treatment|1|||
23772439|NCT01766921|66546590|FG000|Overall Study|Lost to Follow-up|1|||
23772440|NCT01766921|66546591|FG001|Overall Study|Lost to Follow-up|3|||
23574701|NCT00322374|65835382|FG001|First Escalation|Documented Disease Progression|6|||
23574702|NCT00322374|65835383|FG002|First Escalation|Documented Disease Progression|0|||
23574703|NCT00322374|65835384|FG003|First Escalation|Documented Disease Progression|0|||
23633590|NCT04674189|66045363|FG002|Overall Study|Did Not Receive Treatment|2|||
23633591|NCT02406677|66045372|FG000|Overall Study|Death|16|||
23633592|NCT02406677|66045373|FG001|Overall Study|Death|8|||
23633593|NCT02406677|66045372|FG000|Overall Study|Discharged without P2Y12|1|||
23772441|NCT01766921|66546590|FG000|Overall Study|Unclassified|2|||
23772442|NCT01766921|66546591|FG001|Overall Study|Unclassified|2|||
23772443|NCT01766921|66546590|FG000|Overall Study|Protocol Violation|1|||
23772444|NCT01766921|66546591|FG001|Overall Study|Protocol Violation|1|||
23772445|NCT01766921|66546590|FG000|Overall Study|Withdrawal by Subject|14|||
23772446|NCT01766921|66546591|FG001|Overall Study|Withdrawal by Subject|5|||
23772447|NCT02270736|66546592|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23447393|NCT00626275|65380418|FG001|Part B|Withdrawal by Subject|0|||
23633594|NCT02406677|66045373|FG001|Overall Study|Discharged without P2Y12|3|||
23633595|NCT02406677|66045372|FG000|Overall Study|Discharged on prasugrel|283|||
23633596|NCT02406677|66045373|FG001|Overall Study|Discharged on prasugrel|587|||
23633597|NCT02406677|66045372|FG000|Overall Study|Withdrawal by Subject|1|||
23772448|NCT02270736|66546593|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
23772449|NCT02270736|66546594|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23833188|NCT00460603|66767903|FG005|Phase 1|Adverse Event|0|||
23833189|NCT00460603|66767904|FG006|Phase 1|Adverse Event|3|||
23833190|NCT00460603|66767905|FG007|Phase 1|Adverse Event|0|||
23833191|NCT00460603|66767906|FG008|Phase 1|Adverse Event|4|||
23574704|NCT00322374|65835381|FG000|First Escalation|Physician Decision|0|||
23574705|NCT00322374|65835382|FG001|First Escalation|Physician Decision|12|||
23574706|NCT00322374|65835383|FG002|First Escalation|Physician Decision|0|||
23574707|NCT00322374|65835384|FG003|First Escalation|Physician Decision|0|||
23574708|NCT00322374|65835381|FG000|First Escalation|Study Drug Toxicity|0|||
23574709|NCT00322374|65835382|FG001|First Escalation|Study Drug Toxicity|11|||
23574710|NCT00322374|65835383|FG002|First Escalation|Study Drug Toxicity|0|||
23574711|NCT00322374|65835384|FG003|First Escalation|Study Drug Toxicity|0|||
23574712|NCT00322374|65835381|FG000|First Escalation|Participant Request|0|||
23633598|NCT02406677|66045373|FG001|Overall Study|Withdrawal by Subject|0|||
23833192|NCT00460603|66767907|FG009|Phase 1|Adverse Event|0|||
23833193|NCT00460603|66767908|FG010|Phase 1|Adverse Event|0|||
23833194|NCT00460603|66767909|FG011|Phase 1|Adverse Event|0|||
23833195|NCT00460603|66767898|FG000|Phase 1|Lack of Efficacy|1|||
23833196|NCT00460603|66767899|FG001|Phase 1|Lack of Efficacy|0|||
23833197|NCT00460603|66767900|FG002|Phase 1|Lack of Efficacy|1|||
23833198|NCT00460603|66767901|FG003|Phase 1|Lack of Efficacy|2|||
23833199|NCT00460603|66767902|FG004|Phase 1|Lack of Efficacy|2|||
23833200|NCT00460603|66767903|FG005|Phase 1|Lack of Efficacy|2|||
23833201|NCT00460603|66767904|FG006|Phase 1|Lack of Efficacy|2|||
23833202|NCT00460603|66767905|FG007|Phase 1|Lack of Efficacy|2|||
23833203|NCT00460603|66767906|FG008|Phase 1|Lack of Efficacy|11|||
23633599|NCT03332784|66045374|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633600|NCT03332784|66045375|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
23633601|NCT03332784|66045376|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633602|NCT03332784|66045377|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633603|NCT03332784|66045378|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633604|NCT03332784|66045379|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633605|NCT03332784|66045380|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633606|NCT03332784|66045381|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633607|NCT03332784|66045382|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23772450|NCT02270736|66546595|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23772451|NCT02270736|66546596|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23772452|NCT02270736|66546592|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
23772453|NCT02270736|66546593|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23772454|NCT02270736|66546594|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
23772455|NCT02270736|66546595|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23772456|NCT02270736|66546596|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23772457|NCT02270736|66546592|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23772458|NCT02270736|66546593|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
23772459|NCT02270736|66546594|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23772460|NCT02270736|66546595|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23772461|NCT02270736|66546596|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23772462|NCT02270736|66546592|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23772463|NCT02270736|66546593|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23772464|NCT02270736|66546594|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
23772465|NCT02270736|66546595|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23772466|NCT02270736|66546596|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23772467|NCT02270736|66546592|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23772468|NCT02270736|66546593|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23772469|NCT02270736|66546594|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23772470|NCT02270736|66546595|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
23772471|NCT02270736|66546596|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23772472|NCT02270736|66546592|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23772473|NCT02270736|66546593|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23833204|NCT00460603|66767907|FG009|Phase 1|Lack of Efficacy|0|||
23574713|NCT00322374|65835382|FG001|First Escalation|Participant Request|1|||
23574714|NCT00322374|65835383|FG002|First Escalation|Participant Request|0|||
23833205|NCT00460603|66767908|FG010|Phase 1|Lack of Efficacy|0|||
23833206|NCT00460603|66767909|FG011|Phase 1|Lack of Efficacy|0|||
23833207|NCT00460603|66767898|FG000|Phase 1|Withdrawal by Subject|1|||
23833208|NCT00460603|66767899|FG001|Phase 1|Withdrawal by Subject|2|||
23574715|NCT00322374|65835384|FG003|First Escalation|Participant Request|0|||
23633608|NCT03332784|66045383|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633609|NCT03332784|66045384|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23833209|NCT00460603|66767900|FG002|Phase 1|Withdrawal by Subject|1|||
23833210|NCT00460603|66767901|FG003|Phase 1|Withdrawal by Subject|1|||
23833211|NCT00460603|66767902|FG004|Phase 1|Withdrawal by Subject|3|||
23833212|NCT00460603|66767903|FG005|Phase 1|Withdrawal by Subject|0|||
23833213|NCT00460603|66767904|FG006|Phase 1|Withdrawal by Subject|1|||
23574716|NCT00322374|65835381|FG000|Second Escalation|Physician Decision|0|||
23574717|NCT00322374|65835382|FG001|Second Escalation|Physician Decision|0|||
23574718|NCT00322374|65835383|FG002|Second Escalation|Physician Decision|5|||
23574719|NCT00322374|65835384|FG003|Second Escalation|Physician Decision|0|||
23574720|NCT00322374|65835381|FG000|Second Escalation|Study Drug Toxicity|0|||
23574721|NCT00322374|65835382|FG001|Second Escalation|Study Drug Toxicity|0|||
23574722|NCT00322374|65835383|FG002|Second Escalation|Study Drug Toxicity|1|||
23574723|NCT00322374|65835384|FG003|Second Escalation|Study Drug Toxicity|0|||
23574724|NCT01923389|65835386|FG000|Overall Study|Protocol Violation|1|||
23574725|NCT01923389|65835387|FG001|Overall Study|Protocol Violation|0|||
23574726|NCT04003974|65835394|FG000|Overall Study|Missing|1|||
23574727|NCT04003974|65835395|FG001|Overall Study|Missing|0|||
23574728|NCT04003974|65835394|FG000|Overall Study|Withdrawal by Subject|0|||
23574729|NCT04003974|65835395|FG001|Overall Study|Withdrawal by Subject|2|||
23574730|NCT01221181|65835396|FG000|Overall Study|Lost to Follow-up|1|||
23574731|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
23574732|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574733|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574734|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574735|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574736|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574737|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574738|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574739|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574740|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
23574741|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574742|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574743|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574744|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574745|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
23574746|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
23574747|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
23574748|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574749|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574750|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574751|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574752|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574753|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
23574754|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574755|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574756|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574757|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574758|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574759|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
23574760|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574761|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
23574762|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574763|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574764|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574765|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574766|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23772474|NCT02270736|66546594|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23772475|NCT02270736|66546595|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
23772476|NCT02270736|66546596|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23772477|NCT02270736|66546592|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23772478|NCT02270736|66546593|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23772479|NCT02270736|66546594|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23772480|NCT02270736|66546595|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
23772481|NCT02270736|66546596|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23772482|NCT02270736|66546592|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23772483|NCT02270736|66546593|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23772484|NCT02270736|66546594|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23772485|NCT02270736|66546595|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
23772486|NCT02270736|66546596|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23772487|NCT02270736|66546592|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23772488|NCT02270736|66546593|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23772489|NCT02270736|66546594|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23772490|NCT02270736|66546595|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
23574767|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23574768|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23574769|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574770|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574771|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
23833214|NCT00460603|66767905|FG007|Phase 1|Withdrawal by Subject|0|||
23833215|NCT00460603|66767906|FG008|Phase 1|Withdrawal by Subject|2|||
23833216|NCT00460603|66767907|FG009|Phase 1|Withdrawal by Subject|0|||
23574772|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574773|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574774|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574775|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574776|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
23833217|NCT00460603|66767908|FG010|Phase 1|Withdrawal by Subject|0|||
23833218|NCT00460603|66767909|FG011|Phase 1|Withdrawal by Subject|0|||
23833219|NCT00460603|66767898|FG000|Phase 1|Other|0|||
23633610|NCT03332784|66045385|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633611|NCT03332784|66045386|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633612|NCT03332784|66045387|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633613|NCT03332784|66045388|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
23633614|NCT03332784|66045389|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23772491|NCT02270736|66546596|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23772492|NCT03823300|66546601|FG000|Overall Study|Withdrawal by Subject|16|||
23772493|NCT03823300|66546602|FG001|Overall Study|Withdrawal by Subject|22|||
23772494|NCT03823300|66546601|FG000|Overall Study|Death|10|||
23772495|NCT03823300|66546602|FG001|Overall Study|Death|14|||
23772496|NCT03823300|66546601|FG000|Overall Study|Adverse Event|3|||
23574777|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574778|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
23574779|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
23574780|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574781|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574782|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574783|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574784|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574785|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574786|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574787|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23574788|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23633615|NCT03332784|66045390|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633616|NCT03332784|66045391|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633617|NCT03332784|66045392|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633618|NCT03332784|66045393|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23633619|NCT00667459|66045394|FG000|Overall Study|Death|0|||
23633620|NCT00667459|66045395|FG001|Overall Study|Death|2|||
23633621|NCT00667459|66045394|FG000|Overall Study|Lost to Follow-up|8|||
23633622|NCT00667459|66045395|FG001|Overall Study|Lost to Follow-up|43|||
23633623|NCT01564277|66045396|FG000|Overall Study|Protocol Violation|0|||
23633624|NCT01564277|66045397|FG001|Overall Study|Protocol Violation|1|||
23633625|NCT01564277|66045396|FG000|Overall Study|Physician Decision|1|||
23633626|NCT01564277|66045397|FG001|Overall Study|Physician Decision|0|||
23633627|NCT02870972|66045400|FG000|Overall Study|Adverse Event|1|||
23574789|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23772497|NCT03823300|66546602|FG001|Overall Study|Adverse Event|5|||
23833220|NCT00460603|66767899|FG001|Phase 1|Other|3|||
23633628|NCT02870972|66045401|FG001|Overall Study|Adverse Event|0|||
23633629|NCT02870972|66045402|FG002|Overall Study|Adverse Event|0|||
23633630|NCT02870972|66045403|FG003|Overall Study|Adverse Event|0|||
23772498|NCT03823300|66546601|FG000|Overall Study|Physician Decision|1|||
23772499|NCT03823300|66546602|FG001|Overall Study|Physician Decision|7|||
23833221|NCT00460603|66767900|FG002|Phase 1|Other|1|||
23833222|NCT00460603|66767901|FG003|Phase 1|Other|1|||
23833223|NCT00460603|66767902|FG004|Phase 1|Other|1|||
23833224|NCT00460603|66767903|FG005|Phase 1|Other|2|||
23833225|NCT00460603|66767904|FG006|Phase 1|Other|0|||
23833226|NCT00460603|66767905|FG007|Phase 1|Other|1|||
23833227|NCT00460603|66767906|FG008|Phase 1|Other|0|||
23833228|NCT00460603|66767907|FG009|Phase 1|Other|0|||
23833229|NCT00460603|66767908|FG010|Phase 1|Other|0|||
23833230|NCT00460603|66767909|FG011|Phase 1|Other|0|||
23833231|NCT00460603|66767898|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833232|NCT00460603|66767899|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833233|NCT00460603|66767900|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833234|NCT00460603|66767901|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833235|NCT00460603|66767902|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833236|NCT00460603|66767903|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833237|NCT00460603|66767904|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833238|NCT00460603|66767905|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833239|NCT00460603|66767906|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833240|NCT00460603|66767907|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
23833241|NCT00460603|66767908|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833242|NCT00460603|66767909|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23833243|NCT00460603|66767898|FG000|Phase 2|Adverse Event|0|||
23833244|NCT00460603|66767899|FG001|Phase 2|Adverse Event|0|||
23833245|NCT00460603|66767900|FG002|Phase 2|Adverse Event|0|||
23833246|NCT00460603|66767901|FG003|Phase 2|Adverse Event|0|||
23833247|NCT00460603|66767902|FG004|Phase 2|Adverse Event|0|||
23574790|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
23574791|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
23574792|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
23574793|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
23574794|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574795|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574796|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574797|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574798|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
23574799|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
23574800|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
23574801|NCT01959880|65835406|FG000|Overall Study|Withdrawal by Subject|11|||
23574802|NCT01959880|65835407|FG001|Overall Study|Withdrawal by Subject|13|||
23574803|NCT01959880|65835408|FG002|Overall Study|Withdrawal by Subject|8|||
23574804|NCT01959880|65835409|FG003|Overall Study|Withdrawal by Subject|7|||
23574805|NCT01959880|65835406|FG000|Overall Study|Death|1|||
23574806|NCT01959880|65835407|FG001|Overall Study|Death|10|||
23574807|NCT01959880|65835408|FG002|Overall Study|Death|1|||
23574808|NCT01959880|65835409|FG003|Overall Study|Death|2|||
23574809|NCT01959880|65835406|FG000|Overall Study|Lost to Follow-up|95|||
23574810|NCT01959880|65835407|FG001|Overall Study|Lost to Follow-up|18|||
23574811|NCT01959880|65835408|FG002|Overall Study|Lost to Follow-up|15|||
23574812|NCT01959880|65835409|FG003|Overall Study|Lost to Follow-up|8|||
23574813|NCT01959880|65835406|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
23574814|NCT01959880|65835407|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
23574815|NCT01959880|65835408|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
23574816|NCT01959880|65835409|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
23574817|NCT01959880|65835406|FG000|Overall Study|Study completed early-FDA approved|1003|||
23574818|NCT01959880|65835407|FG001|Overall Study|Study completed early-FDA approved|311|||
23574819|NCT01959880|65835408|FG002|Overall Study|Study completed early-FDA approved|179|||
23574820|NCT01959880|65835409|FG003|Overall Study|Study completed early-FDA approved|152|||
23574821|NCT01333943|65835410|FG000|Overall Study|Known neuropathy|1|||
23574822|NCT01333943|65835411|FG001|Overall Study|Known neuropathy|0|||
23574823|NCT03606460|65835412|FG000|Overall Study|Lost to Follow-up|1|||
23574824|NCT03606460|65835413|FG001|Overall Study|Lost to Follow-up|8|||
23574825|NCT01708187|65835414|FG000|Overall Study|Lost to Follow-up|0|||
23574826|NCT01708187|65835415|FG001|Overall Study|Lost to Follow-up|1|||
23574827|NCT01857323|65835418|FG000|Overall Study|Adverse Event|1|||
23574828|NCT01857323|65835418|FG000|Overall Study|Withdrawal by Subject|3|||
23833248|NCT00460603|66767903|FG005|Phase 2|Adverse Event|0|||
23833249|NCT00460603|66767904|FG006|Phase 2|Adverse Event|0|||
23833250|NCT00460603|66767905|FG007|Phase 2|Adverse Event|0|||
23833251|NCT00460603|66767906|FG008|Phase 2|Adverse Event|0|||
23833252|NCT00460603|66767907|FG009|Phase 2|Adverse Event|12|||
23833253|NCT00460603|66767908|FG010|Phase 2|Adverse Event|9|||
23833254|NCT00460603|66767909|FG011|Phase 2|Adverse Event|10|||
23833255|NCT00460603|66767898|FG000|Phase 2|Death|0|||
23833256|NCT00460603|66767899|FG001|Phase 2|Death|0|||
23833257|NCT00460603|66767900|FG002|Phase 2|Death|0|||
23833258|NCT00460603|66767901|FG003|Phase 2|Death|0|||
23833259|NCT00460603|66767902|FG004|Phase 2|Death|0|||
23833260|NCT00460603|66767903|FG005|Phase 2|Death|0|||
23833261|NCT00460603|66767904|FG006|Phase 2|Death|0|||
23833262|NCT00460603|66767905|FG007|Phase 2|Death|0|||
23833263|NCT00460603|66767906|FG008|Phase 2|Death|0|||
23772500|NCT03823300|66546601|FG000|Overall Study|Lost to Follow-up|1|||
23772501|NCT03823300|66546602|FG001|Overall Study|Lost to Follow-up|3|||
23772502|NCT03823300|66546601|FG000|Overall Study|Protocol Violation|1|||
23772503|NCT03823300|66546602|FG001|Overall Study|Protocol Violation|1|||
23772504|NCT03823300|66546601|FG000|Overall Study|Lack of Efficacy|1|||
23772505|NCT03823300|66546602|FG001|Overall Study|Lack of Efficacy|1|||
23772506|NCT03823300|66546601|FG000|Overall Study|Not Eligible|0|||
23772507|NCT03823300|66546602|FG001|Overall Study|Not Eligible|1|||
23772508|NCT03823300|66546601|FG000|Overall Study|Other|1|||
23772509|NCT03823300|66546602|FG001|Overall Study|Other|0|||
23772510|NCT00440557|66546605|FG000|Overall Study|Withdrawal by Subject|10|||
23772511|NCT00440557|66546606|FG001|Overall Study|Withdrawal by Subject|5|||
23772512|NCT00440557|66546607|FG002|Overall Study|Withdrawal by Subject|11|||
23772513|NCT00440557|66546605|FG000|Overall Study|Lost to Follow-up|1|||
23772514|NCT00440557|66546606|FG001|Overall Study|Lost to Follow-up|2|||
23772515|NCT00440557|66546607|FG002|Overall Study|Lost to Follow-up|6|||
23772516|NCT00440557|66546605|FG000|Overall Study|Adverse Event|3|||
23772517|NCT00440557|66546606|FG001|Overall Study|Adverse Event|3|||
23772518|NCT00440557|66546607|FG002|Overall Study|Adverse Event|5|||
23772519|NCT00440557|66546605|FG000|Overall Study|Death|2|||
23772520|NCT00440557|66546606|FG001|Overall Study|Death|6|||
23772521|NCT00440557|66546607|FG002|Overall Study|Death|3|||
23772522|NCT00440557|66546605|FG000|Overall Study|Began Dialysis|4|||
23772523|NCT00440557|66546606|FG001|Overall Study|Began Dialysis|1|||
23772524|NCT00440557|66546607|FG002|Overall Study|Began Dialysis|4|||
23772525|NCT00440557|66546605|FG000|Overall Study|Principal Investigator decision|0|||
23772526|NCT00440557|66546606|FG001|Overall Study|Principal Investigator decision|3|||
23772527|NCT00440557|66546607|FG002|Overall Study|Principal Investigator decision|1|||
23772528|NCT00440557|66546605|FG000|Overall Study|Patient moved|1|||
23772529|NCT00440557|66546606|FG001|Overall Study|Patient moved|2|||
23772530|NCT00440557|66546607|FG002|Overall Study|Patient moved|1|||
23772531|NCT00440557|66546605|FG000|Overall Study|Principal Investigator's office closed|3|||
23772532|NCT00440557|66546606|FG001|Overall Study|Principal Investigator's office closed|6|||
23772533|NCT00440557|66546607|FG002|Overall Study|Principal Investigator's office closed|4|||
23772534|NCT00440557|66546605|FG000|Overall Study|Patient transferred to nursing home|0|||
23772535|NCT00440557|66546606|FG001|Overall Study|Patient transferred to nursing home|1|||
23772536|NCT00440557|66546607|FG002|Overall Study|Patient transferred to nursing home|0|||
23772537|NCT00440557|66546605|FG000|Overall Study|Patient had surgery|1|||
23772538|NCT00440557|66546606|FG001|Overall Study|Patient had surgery|0|||
23772539|NCT00440557|66546607|FG002|Overall Study|Patient had surgery|0|||
23772540|NCT00365352|66546612|FG000|Overall Study|Adverse Event|6|||
23772541|NCT00365352|66546613|FG001|Overall Study|Adverse Event|7|||
23772542|NCT00365352|66546614|FG002|Overall Study|Adverse Event|8|||
23772543|NCT00365352|66546612|FG000|Overall Study|Participant Withdrew Consent|8|||
23772544|NCT00365352|66546613|FG001|Overall Study|Participant Withdrew Consent|3|||
23772545|NCT00365352|66546614|FG002|Overall Study|Participant Withdrew Consent|4|||
23772546|NCT00365352|66546612|FG000|Overall Study|Lack of Efficacy|3|||
23772547|NCT00365352|66546613|FG001|Overall Study|Lack of Efficacy|0|||
23772548|NCT00365352|66546614|FG002|Overall Study|Lack of Efficacy|0|||
23772549|NCT00365352|66546612|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
23772550|NCT00365352|66546613|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
23772551|NCT00365352|66546614|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
23772552|NCT00365352|66546612|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
23772553|NCT00365352|66546613|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
23772554|NCT00365352|66546614|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
23772555|NCT00365352|66546612|FG000|Overall Study|Lost to Follow-up|1|||
23772556|NCT00365352|66546613|FG001|Overall Study|Lost to Follow-up|1|||
23772557|NCT00365352|66546614|FG002|Overall Study|Lost to Follow-up|0|||
23772558|NCT00365352|66546612|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
23772559|NCT00365352|66546613|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
23772560|NCT00365352|66546614|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
23772561|NCT00770510|66546615|FG000|Overall Study|Lost to Follow-up|2|||
23772562|NCT00770510|66546615|FG000|Overall Study|Pregnancy|1|||
23772563|NCT00770510|66546615|FG000|Overall Study|Withdrawal by Subject|2|||
23772564|NCT02979353|66546616|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
23772565|NCT02979353|66546617|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
23772566|NCT02979353|66546616|FG000|Overall Study|Withdrawal by Subject|16|||
23772567|NCT02979353|66546617|FG001|Overall Study|Withdrawal by Subject|12|||
23772568|NCT02979353|66546616|FG000|Overall Study|Death|10|||
23772569|NCT02979353|66546617|FG001|Overall Study|Death|11|||
23772570|NCT02979353|66546616|FG000|Overall Study|Transfer to Hospice Care|19|||
23772571|NCT02979353|66546617|FG001|Overall Study|Transfer to Hospice Care|14|||
23772572|NCT02979353|66546616|FG000|Overall Study|Lost to Follow-up|1|||
23772573|NCT02979353|66546617|FG001|Overall Study|Lost to Follow-up|5|||
23772574|NCT00870870|66546618|FG000|Overall Study|Withdrawal by Subject|0|||
23772575|NCT00870870|66546619|FG001|Overall Study|Withdrawal by Subject|1|||
23772576|NCT00870870|66546620|FG002|Overall Study|Withdrawal by Subject|1|||
23772577|NCT00870870|66546621|FG003|Overall Study|Withdrawal by Subject|3|||
23772578|NCT00870870|66546618|FG000|Overall Study|Adverse Event|0|||
23772579|NCT00870870|66546619|FG001|Overall Study|Adverse Event|0|||
23772580|NCT00870870|66546620|FG002|Overall Study|Adverse Event|2|||
23772581|NCT00870870|66546621|FG003|Overall Study|Adverse Event|2|||
23772582|NCT00337571|66546624|FG000|Overall Study|Lack of Efficacy|3|||
23772583|NCT00337571|66546625|FG001|Overall Study|Lack of Efficacy|0|||
23772584|NCT00337571|66546626|FG002|Overall Study|Lack of Efficacy|0|||
23772585|NCT00337571|66546627|FG003|Overall Study|Lack of Efficacy|0|||
23772586|NCT00337571|66546624|FG000|Overall Study|Adverse Event|4|||
23772587|NCT00337571|66546625|FG001|Overall Study|Adverse Event|5|||
23772588|NCT00337571|66546626|FG002|Overall Study|Adverse Event|8|||
23772589|NCT00337571|66546627|FG003|Overall Study|Adverse Event|4|||
23772590|NCT00337571|66546624|FG000|Overall Study|Withdrawal by Subject|2|||
23772591|NCT00337571|66546625|FG001|Overall Study|Withdrawal by Subject|2|||
23772592|NCT00337571|66546626|FG002|Overall Study|Withdrawal by Subject|1|||
23772593|NCT00337571|66546627|FG003|Overall Study|Withdrawal by Subject|0|||
23772594|NCT00337571|66546624|FG000|Overall Study|Lost to Follow-up|3|||
23772595|NCT00337571|66546625|FG001|Overall Study|Lost to Follow-up|1|||
23772596|NCT00337571|66546626|FG002|Overall Study|Lost to Follow-up|0|||
23772597|NCT00337571|66546627|FG003|Overall Study|Lost to Follow-up|1|||
23772598|NCT00337571|66546624|FG000|Overall Study|Poor/noncompliance|1|||
23772599|NCT00337571|66546625|FG001|Overall Study|Poor/noncompliance|1|||
23772600|NCT00337571|66546626|FG002|Overall Study|Poor/noncompliance|1|||
23772601|NCT00337571|66546627|FG003|Overall Study|Poor/noncompliance|1|||
23772602|NCT00337571|66546624|FG000|Overall Study|No longer met study criteria|1|||
23772603|NCT00337571|66546625|FG001|Overall Study|No longer met study criteria|0|||
23772604|NCT00337571|66546626|FG002|Overall Study|No longer met study criteria|0|||
23772605|NCT00337571|66546627|FG003|Overall Study|No longer met study criteria|0|||
23772606|NCT00337571|66546624|FG000|Overall Study|High Potassium level|0|||
23772607|NCT00337571|66546625|FG001|Overall Study|High Potassium level|0|||
23772608|NCT00337571|66546626|FG002|Overall Study|High Potassium level|0|||
23772609|NCT00337571|66546627|FG003|Overall Study|High Potassium level|1|||
23772610|NCT01479439|66546630|FG000|Overall Study|Adverse Event|1|||
23772611|NCT01479439|66546631|FG001|Overall Study|Adverse Event|0|||
23772612|NCT01479439|66546632|FG002|Overall Study|Adverse Event|0|||
23772613|NCT01479439|66546630|FG000|Overall Study|Lost to Follow-up|0|||
23772614|NCT01479439|66546631|FG001|Overall Study|Lost to Follow-up|1|||
23772615|NCT01479439|66546632|FG002|Overall Study|Lost to Follow-up|0|||
23772616|NCT01479439|66546630|FG000|Overall Study|Protocol Violation|0|||
23772617|NCT01479439|66546631|FG001|Overall Study|Protocol Violation|0|||
23772618|NCT01479439|66546632|FG002|Overall Study|Protocol Violation|2|||
23772619|NCT03093324|66546635|FG000|Overall Study|Adverse Event|4|||
23772620|NCT03093324|66546636|FG001|Overall Study|Adverse Event|15|||
23772621|NCT03093324|66546635|FG000|Overall Study|Lost to Follow-up|1|||
23772622|NCT03093324|66546636|FG001|Overall Study|Lost to Follow-up|0|||
23772623|NCT03093324|66546635|FG000|Overall Study|Protocol Deviation|2|||
23772624|NCT03093324|66546636|FG001|Overall Study|Protocol Deviation|2|||
23772625|NCT03093324|66546635|FG000|Overall Study|Withdrawal by Subject|2|||
23772626|NCT03093324|66546636|FG001|Overall Study|Withdrawal by Subject|2|||
23772627|NCT01196052|66546637|FG000|Overall Study|Adverse Event|9|||
23772628|NCT01196052|66546637|FG000|Overall Study|Lost to Follow-up|1|||
23772629|NCT01196052|66546637|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
23772630|NCT01196052|66546637|FG000|Overall Study|Reason not Specified|5|||
23772631|NCT01196052|66546637|FG000|Overall Study|Withdrawal by Subject|6|||
23772632|NCT02336737|66546638|FG000|Overall Study|Withdrawal by Subject|5|||
23772633|NCT02336737|66546638|FG000|Overall Study|Physician Decision|8|||
23772634|NCT00510510|66546645|FG000|Overall Study|Adverse Event|4|||
23772635|NCT00510510|66546646|FG001|Overall Study|Adverse Event|3|||
23772636|NCT00510510|66546647|FG002|Overall Study|Adverse Event|6|||
23772637|NCT00510510|66546645|FG000|Overall Study|Lack of Efficacy|0|||
23772638|NCT00510510|66546646|FG001|Overall Study|Lack of Efficacy|1|||
23772639|NCT00510510|66546647|FG002|Overall Study|Lack of Efficacy|1|||
23772640|NCT00510510|66546645|FG000|Overall Study|Subjects no longer requires study drug|0|||
23772641|NCT00510510|66546646|FG001|Overall Study|Subjects no longer requires study drug|0|||
23772642|NCT00510510|66546647|FG002|Overall Study|Subjects no longer requires study drug|2|||
23772643|NCT00510510|66546645|FG000|Overall Study|Withdrawal by Subject|1|||
23772644|NCT00510510|66546646|FG001|Overall Study|Withdrawal by Subject|2|||
23772645|NCT00510510|66546647|FG002|Overall Study|Withdrawal by Subject|3|||
23772646|NCT00510510|66546645|FG000|Overall Study|Lost to Follow-up|0|||
23772647|NCT00510510|66546646|FG001|Overall Study|Lost to Follow-up|0|||
23772648|NCT00510510|66546647|FG002|Overall Study|Lost to Follow-up|1|||
23772649|NCT00510510|66546645|FG000|Overall Study|Protocol Violation|0|||
23772650|NCT00510510|66546646|FG001|Overall Study|Protocol Violation|3|||
23772651|NCT00510510|66546647|FG002|Overall Study|Protocol Violation|4|||
23772652|NCT02799602|66546648|FG000|Overall Study|Protocol Violation|1|||
23772653|NCT02799602|66546649|FG001|Overall Study|Protocol Violation|0|||
23574829|NCT01857323|65835418|FG000|Overall Study|Non-compliance|1|||
23772654|NCT02799602|66546648|FG000|Overall Study|Physician Decision|5|||
23772655|NCT02799602|66546649|FG001|Overall Study|Physician Decision|6|||
23574830|NCT01857323|65835418|FG000|Overall Study|Protocol Violation|6|||
23574831|NCT01857323|65835418|FG000|Overall Study|Lost to Follow-up|1|||
23574832|NCT01857323|65835418|FG000|Overall Study|Other|4|||
23574833|NCT01857323|65835418|FG000|Overall Study|Did not complete 180 doses|48|||
23574834|NCT02564055|65835419|FG000|Overall Study|Adverse Event|1|||
23574835|NCT02564055|65835420|FG001|Overall Study|Adverse Event|0|||
23574836|NCT02564055|65835421|FG002|Overall Study|Adverse Event|4|||
23574837|NCT02564055|65835422|FG003|Overall Study|Adverse Event|1|||
23574838|NCT02564055|65835423|FG004|Overall Study|Adverse Event|4|||
23574839|NCT02564055|65835424|FG005|Overall Study|Adverse Event|1|||
23574840|NCT02564055|65835419|FG000|Overall Study|Protocol Violation|1|||
23574841|NCT02564055|65835420|FG001|Overall Study|Protocol Violation|0|||
23574842|NCT02564055|65835421|FG002|Overall Study|Protocol Violation|0|||
23772656|NCT02799602|66546648|FG000|Overall Study|Lost to Follow-up|4|||
23833264|NCT00460603|66767907|FG009|Phase 2|Death|4|||
23833265|NCT00460603|66767908|FG010|Phase 2|Death|2|||
23833266|NCT00460603|66767909|FG011|Phase 2|Death|2|||
23833267|NCT00460603|66767898|FG000|Phase 2|Protocol Violation|0|||
23833268|NCT00460603|66767899|FG001|Phase 2|Protocol Violation|0|||
23772657|NCT02799602|66546649|FG001|Overall Study|Lost to Follow-up|2|||
23772658|NCT02799602|66546648|FG000|Overall Study|Additional primary malignancy|11|||
23772659|NCT02799602|66546649|FG001|Overall Study|Additional primary malignancy|6|||
23772660|NCT02799602|66546648|FG000|Overall Study|Non-compliance with study drug|14|||
23772661|NCT02799602|66546649|FG001|Overall Study|Non-compliance with study drug|12|||
23772662|NCT02799602|66546648|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
23772663|NCT02799602|66546649|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
23772664|NCT02799602|66546648|FG000|Overall Study|Withdrawal by Subject|26|||
23772665|NCT02799602|66546649|FG001|Overall Study|Withdrawal by Subject|40|||
23772666|NCT02799602|66546648|FG000|Overall Study|Progressive disease - clinical progression|131|||
23772667|NCT02799602|66546649|FG001|Overall Study|Progressive disease - clinical progression|276|||
23772668|NCT02799602|66546648|FG000|Overall Study|Progressive disease - radiological progression|90|||
23772669|NCT02799602|66546649|FG001|Overall Study|Progressive disease - radiological progression|133|||
23772670|NCT02799602|66546648|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
23772671|NCT02799602|66546649|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
23772672|NCT02799602|66546648|FG000|Overall Study|Death|9|||
23772673|NCT02799602|66546649|FG001|Overall Study|Death|5|||
23772674|NCT02799602|66546648|FG000|Overall Study|Other|287|||
23772675|NCT02799602|66546649|FG001|Overall Study|Other|118|||
23772676|NCT02799602|66546648|FG000|Overall Study|Study drug never administered|0|||
23772677|NCT02799602|66546649|FG001|Overall Study|Study drug never administered|3|||
23772678|NCT01180244|66546652|FG000|Overall Study|Lack of Efficacy|0|||
23772679|NCT01180244|66546653|FG001|Overall Study|Lack of Efficacy|7|||
23772680|NCT01180244|66546652|FG000|Overall Study|Physician Decision|3|||
23772681|NCT01180244|66546653|FG001|Overall Study|Physician Decision|0|||
23772682|NCT01180244|66546652|FG000|Overall Study|Adverse Event|1|||
23772683|NCT01180244|66546653|FG001|Overall Study|Adverse Event|0|||
23772684|NCT01180244|66546652|FG000|Overall Study|Withdrawal by Subject|0|||
23772685|NCT01180244|66546653|FG001|Overall Study|Withdrawal by Subject|1|||
23772686|NCT01180244|66546652|FG000|Overall Study|Protocol Violation|1|||
23772687|NCT01180244|66546653|FG001|Overall Study|Protocol Violation|0|||
23772688|NCT01180244|66546652|FG000|Overall Study|Lost to Follow-up|1|||
23772689|NCT01180244|66546653|FG001|Overall Study|Lost to Follow-up|0|||
23772690|NCT04652453|66546654|FG000|Overall Study|Death|8|||
23772691|NCT04652453|66546655|FG001|Overall Study|Death|2|||
23772692|NCT04652453|66546656|FG002|Overall Study|Death|0|||
23772693|NCT04652453|66546654|FG000|Overall Study|Hospice|5|||
23772694|NCT04652453|66546655|FG001|Overall Study|Hospice|5|||
23772695|NCT04652453|66546656|FG002|Overall Study|Hospice|0|||
23772696|NCT04652453|66546654|FG000|Overall Study|Withdrawal by Subject|2|||
23772697|NCT04652453|66546655|FG001|Overall Study|Withdrawal by Subject|0|||
23772698|NCT04652453|66546656|FG002|Overall Study|Withdrawal by Subject|0|||
23772699|NCT00797108|66546658|FG000|Overall Study|Adverse Event|1|||
23772700|NCT00797108|66546659|FG001|Overall Study|Adverse Event|0|||
23772701|NCT00797108|66546660|FG002|Overall Study|Adverse Event|3|||
23833269|NCT00460603|66767900|FG002|Phase 2|Protocol Violation|0|||
23833270|NCT00460603|66767901|FG003|Phase 2|Protocol Violation|0|||
23833271|NCT00460603|66767902|FG004|Phase 2|Protocol Violation|0|||
23833272|NCT00460603|66767903|FG005|Phase 2|Protocol Violation|0|||
23772702|NCT00797108|66546658|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
23833273|NCT00460603|66767904|FG006|Phase 2|Protocol Violation|0|||
23833274|NCT00460603|66767905|FG007|Phase 2|Protocol Violation|0|||
23833275|NCT00460603|66767906|FG008|Phase 2|Protocol Violation|0|||
23833276|NCT00460603|66767907|FG009|Phase 2|Protocol Violation|1|||
23833277|NCT00460603|66767908|FG010|Phase 2|Protocol Violation|1|||
23574843|NCT02564055|65835422|FG003|Overall Study|Protocol Violation|0|||
23772703|NCT00797108|66546659|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
23772704|NCT00797108|66546660|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
23772705|NCT00797108|66546658|FG000|Overall Study|Global Deterioration of Health Status|0|||
23447394|NCT00626275|65380419|FG002|Part B|Withdrawal by Subject|0|||
23447395|NCT00626275|65380420|FG003|Part B|Withdrawal by Subject|0|||
23574844|NCT02564055|65835423|FG004|Overall Study|Protocol Violation|0|||
23574845|NCT02564055|65835424|FG005|Overall Study|Protocol Violation|0|||
23574846|NCT02564055|65835419|FG000|Overall Study|Reached stopping criteria|0|||
23574847|NCT02564055|65835420|FG001|Overall Study|Reached stopping criteria|0|||
23574848|NCT02564055|65835421|FG002|Overall Study|Reached stopping criteria|0|||
23772706|NCT00797108|66546659|FG001|Overall Study|Global Deterioration of Health Status|1|||
23772707|NCT00797108|66546660|FG002|Overall Study|Global Deterioration of Health Status|0|||
23772708|NCT00797108|66546658|FG000|Overall Study|Lack of Efficacy|1|||
23772709|NCT00797108|66546659|FG001|Overall Study|Lack of Efficacy|0|||
23772710|NCT00797108|66546660|FG002|Overall Study|Lack of Efficacy|1|||
23772711|NCT00797108|66546658|FG000|Overall Study|Other|0|||
23772712|NCT00797108|66546659|FG001|Overall Study|Other|0|||
23772713|NCT00797108|66546660|FG002|Overall Study|Other|2|||
23772714|NCT00797108|66546658|FG000|Overall Study|Randomized but not Treated|2|||
23772715|NCT00797108|66546659|FG001|Overall Study|Randomized but not Treated|0|||
23772716|NCT00797108|66546660|FG002|Overall Study|Randomized but not Treated|0|||
23772717|NCT05346055|66546661|FG000|Overall Study|Withdrawal by Subject|1|||
23772718|NCT05346055|66546661|FG000|Overall Study|Protocol Violation|1|||
23772719|NCT05346055|66546661|FG000|Overall Study|Therapist decision|1|||
23772720|NCT00824265|66546662|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
23772721|NCT00824265|66546663|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
23772722|NCT00824265|66546662|FG000|Treatment Phase|Protocol Violation|1|||
23772723|NCT00824265|66546663|FG001|Treatment Phase|Protocol Violation|0|||
23772724|NCT00824265|66546662|FG000|Treatment Phase|Lost to Follow-up|1|||
23772725|NCT00824265|66546663|FG001|Treatment Phase|Lost to Follow-up|1|||
23772726|NCT00824265|66546662|FG000|Treatment Phase|Physician Decision|6|||
23447396|NCT00626275|65380421|FG004|Part B|Withdrawal by Subject|0|||
23447397|NCT00626275|65380422|FG005|Part B|Withdrawal by Subject|0|||
23447398|NCT00626275|65380423|FG006|Part B|Withdrawal by Subject|0|||
23447399|NCT00626275|65380424|FG007|Part B|Withdrawal by Subject|1|||
23447400|NCT04716426|65380425|FG000|Overall Study|Vaccination|1|||
23447401|NCT04716426|65380426|FG001|Overall Study|Vaccination|1|||
23447402|NCT04716426|65380425|FG000|Overall Study|Contamination|1|||
23772727|NCT00824265|66546663|FG001|Treatment Phase|Physician Decision|12|||
23772728|NCT00824265|66546662|FG000|Treatment Phase|Withdrawal by Subject|6|||
23772729|NCT00824265|66546663|FG001|Treatment Phase|Withdrawal by Subject|15|||
23772730|NCT00824265|66546662|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
23772731|NCT00824265|66546663|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
23772732|NCT00824265|66546662|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
23772733|NCT00824265|66546663|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
23447403|NCT04716426|65380426|FG001|Overall Study|Contamination|0|||
23447404|NCT00936702|65380427|FG000|Overall Study|Disease progression|34|||
23772734|NCT01256684|66546664|FG000|Overall Study|Adverse Event|1|||
23447405|NCT00936702|65380427|FG000|Overall Study|Adverse Event|8|||
23447406|NCT00936702|65380427|FG000|Overall Study|Withdrawal by Subject|2|||
23447407|NCT00936702|65380427|FG000|Overall Study|Alternative Treatment|1|||
23447408|NCT00936702|65380427|FG000|Overall Study|Other|1|||
23447409|NCT04794270|65380430|FG000|Period 1|Non Compliance|1|||
23447410|NCT04794270|65380431|FG001|Period 1|Non Compliance|0|||
23447411|NCT04794270|65380430|FG000|Period 1|Adverse Event|1|||
23447412|NCT04794270|65380431|FG001|Period 1|Adverse Event|0|||
23447413|NCT04794270|65380430|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
23447414|NCT04794270|65380431|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
23447415|NCT03400852|65380432|FG000|Blinded Treatment Period|Physician Decision|0|||
23447416|NCT03400852|65380433|FG001|Blinded Treatment Period|Physician Decision|1|||
23447417|NCT03400852|65380434|FG002|Blinded Treatment Period|Physician Decision|0|||
23447418|NCT03400852|65380432|FG000|Blinded Treatment Period|Adverse Event|1|||
23447419|NCT03400852|65380433|FG001|Blinded Treatment Period|Adverse Event|1|||
23447420|NCT03400852|65380434|FG002|Blinded Treatment Period|Adverse Event|0|||
23833278|NCT00460603|66767909|FG011|Phase 2|Protocol Violation|0|||
23833279|NCT00460603|66767898|FG000|Phase 2|Lost to Follow-up|0|||
23447421|NCT03400852|65380432|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
23447422|NCT03400852|65380433|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
23447423|NCT03400852|65380434|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
23447424|NCT03400852|65380432|FG000|Open Label Period|Physician Decision|0|||
23447425|NCT03400852|65380433|FG001|Open Label Period|Physician Decision|0|||
23447426|NCT03400852|65380434|FG002|Open Label Period|Physician Decision|1|||
23447427|NCT03400852|65380432|FG000|Open Label Period|Study terminated by sponsor|0|||
23447428|NCT03400852|65380433|FG001|Open Label Period|Study terminated by sponsor|0|||
23447429|NCT03400852|65380434|FG002|Open Label Period|Study terminated by sponsor|21|||
23447430|NCT02034877|65380435|FG000|Overall Study|Lost to Follow-up|0|||
23447431|NCT02034877|65380436|FG001|Overall Study|Lost to Follow-up|3|||
23447432|NCT02034877|65380435|FG000|Overall Study|No Longer Willing to Participate|0|||
23574849|NCT02564055|65835422|FG003|Overall Study|Reached stopping criteria|0|||
23574850|NCT02564055|65835423|FG004|Overall Study|Reached stopping criteria|0|||
23574851|NCT02564055|65835424|FG005|Overall Study|Reached stopping criteria|1|||
23574852|NCT02564055|65835419|FG000|Overall Study|Lost to Follow-up|0|||
23772735|NCT01256684|66546665|FG001|Overall Study|Adverse Event|4|||
23772736|NCT01256684|66546666|FG002|Overall Study|Adverse Event|2|||
23772737|NCT01256684|66546664|FG000|Overall Study|Withdrawal by Subject|4|||
23772738|NCT01256684|66546665|FG001|Overall Study|Withdrawal by Subject|0|||
23772739|NCT01256684|66546666|FG002|Overall Study|Withdrawal by Subject|2|||
23772740|NCT01256684|66546664|FG000|Overall Study|Physician Decision|0|||
23772741|NCT01256684|66546665|FG001|Overall Study|Physician Decision|1|||
23772742|NCT01256684|66546666|FG002|Overall Study|Physician Decision|0|||
23772743|NCT01256684|66546664|FG000|Overall Study|Lack of Efficacy|0|||
23772744|NCT01256684|66546665|FG001|Overall Study|Lack of Efficacy|1|||
23772745|NCT01256684|66546666|FG002|Overall Study|Lack of Efficacy|1|||
23772746|NCT01256684|66546664|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
23833280|NCT00460603|66767899|FG001|Phase 2|Lost to Follow-up|0|||
23833281|NCT00460603|66767900|FG002|Phase 2|Lost to Follow-up|0|||
23574853|NCT02564055|65835420|FG001|Overall Study|Lost to Follow-up|1|||
23574854|NCT02564055|65835421|FG002|Overall Study|Lost to Follow-up|4|||
23574855|NCT02564055|65835422|FG003|Overall Study|Lost to Follow-up|2|||
23574856|NCT02564055|65835423|FG004|Overall Study|Lost to Follow-up|1|||
23574857|NCT02564055|65835424|FG005|Overall Study|Lost to Follow-up|0|||
23574858|NCT02564055|65835419|FG000|Overall Study|Physician Decision|0|||
23574859|NCT02564055|65835420|FG001|Overall Study|Physician Decision|0|||
23574860|NCT02564055|65835421|FG002|Overall Study|Physician Decision|1|||
23574861|NCT02564055|65835422|FG003|Overall Study|Physician Decision|0|||
23772747|NCT01256684|66546665|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
23833282|NCT00460603|66767901|FG003|Phase 2|Lost to Follow-up|0|||
23833283|NCT00460603|66767902|FG004|Phase 2|Lost to Follow-up|0|||
23447433|NCT02034877|65380436|FG001|Overall Study|No Longer Willing to Participate|3|||
23447434|NCT02675231|65380441|FG000|Overall Study|Withdrawal by Subject|1|||
23447435|NCT02675231|65380442|FG001|Overall Study|Withdrawal by Subject|3|||
23447436|NCT02675231|65380443|FG002|Overall Study|Withdrawal by Subject|1|||
23574862|NCT02564055|65835423|FG004|Overall Study|Physician Decision|0|||
23772748|NCT01256684|66546666|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
23772749|NCT01411332|66546667|FG000|Enrollment|Protocol Violation|0|||
23772750|NCT01411332|66546668|FG001|Enrollment|Protocol Violation|1|||
23574863|NCT02564055|65835424|FG005|Overall Study|Physician Decision|0|||
23772751|NCT01411332|66546667|FG000|Enrollment|Withdrawal by Subject|0|||
23833284|NCT00460603|66767903|FG005|Phase 2|Lost to Follow-up|0|||
23574864|NCT02564055|65835419|FG000|Overall Study|Withdrawal by Subject|4|||
23574865|NCT02564055|65835420|FG001|Overall Study|Withdrawal by Subject|4|||
23574866|NCT02564055|65835421|FG002|Overall Study|Withdrawal by Subject|3|||
23574867|NCT02564055|65835422|FG003|Overall Study|Withdrawal by Subject|3|||
23574868|NCT02564055|65835423|FG004|Overall Study|Withdrawal by Subject|10|||
23574869|NCT02564055|65835424|FG005|Overall Study|Withdrawal by Subject|10|||
23574870|NCT04227340|65835433|FG000|Overall Study|Withdrawal by Subject|3|||
23574871|NCT00654940|65835434|FG000|Period 1|Adverse Event|0|||
23574872|NCT00654940|65835435|FG001|Period 1|Adverse Event|1|||
23574873|NCT00654940|65835434|FG000|Period 1|Intolerable Pain Level|1|||
23574874|NCT00654940|65835435|FG001|Period 1|Intolerable Pain Level|0|||
23574875|NCT02419755|65835436|FG000|Overall Study|Death|1|||
23574876|NCT02419755|65835437|FG001|Overall Study|Death|3|||
23574877|NCT02419755|65835436|FG000|Overall Study|Relapse|0|||
23574878|NCT02419755|65835437|FG001|Overall Study|Relapse|1|||
23574879|NCT02419755|65835436|FG000|Overall Study|Ineligible|1|||
23574880|NCT02419755|65835437|FG001|Overall Study|Ineligible|0|||
23574881|NCT02419755|65835436|FG000|Overall Study|Withdrawal by Subject|1|||
23574882|NCT02419755|65835437|FG001|Overall Study|Withdrawal by Subject|0|||
23574883|NCT03389893|65835445|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
23574884|NCT03389893|65835446|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574885|NCT03389893|65835447|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574886|NCT03389893|65835448|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574887|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
23574888|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
23574889|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
23574890|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
23574891|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
23574892|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
23574893|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
23574894|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
23574895|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
23574896|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
23574897|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
23574898|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
23574899|NCT00680056|65835449|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
23574900|NCT00680056|65835450|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
23574901|NCT00680056|65835449|FG000|Second Intervention|Protocol Violation|3|||
23574902|NCT00680056|65835450|FG001|Second Intervention|Protocol Violation|1|||
23574903|NCT03824236|65835454|FG000|Overall Study|Lost to Follow-up|0|||
23772752|NCT01411332|66546668|FG001|Enrollment|Withdrawal by Subject|1|||
23772753|NCT01411332|66546667|FG000|Treatment|Lost to Follow-up|1|||
23772754|NCT01411332|66546668|FG001|Treatment|Lost to Follow-up|0|||
23772755|NCT02016300|66546669|FG000|Overall Study|Lost to Follow-up|0|||
23772756|NCT02016300|66546670|FG001|Overall Study|Lost to Follow-up|3|||
23772757|NCT01475838|66546671|FG000|Randomized Phase|Randomized but Not Treated|0|||
23772758|NCT01475838|66546672|FG001|Randomized Phase|Randomized but Not Treated|5|||
23772759|NCT01475838|66546671|FG000|Randomized Phase|Adverse Event|6|||
23772760|NCT01475838|66546672|FG001|Randomized Phase|Adverse Event|1|||
23772761|NCT01475838|66546671|FG000|Randomized Phase|Pregnancy|0|||
23772762|NCT01475838|66546672|FG001|Randomized Phase|Pregnancy|1|||
23772763|NCT01475838|66546671|FG000|Randomized Phase|Investigators Discretion|1|||
23772764|NCT01475838|66546672|FG001|Randomized Phase|Investigators Discretion|2|||
23772765|NCT01475838|66546671|FG000|Randomized Phase|Withdrew Consent|10|||
23772766|NCT01475838|66546672|FG001|Randomized Phase|Withdrew Consent|14|||
23772767|NCT01475838|66546671|FG000|Randomized Phase|Lost to Follow-up|3|||
23772768|NCT01475838|66546672|FG001|Randomized Phase|Lost to Follow-up|4|||
23772769|NCT01475838|66546671|FG000|Randomized Phase|Participant Noncompliance|1|||
23772770|NCT01475838|66546672|FG001|Randomized Phase|Participant Noncompliance|5|||
23772771|NCT01475838|66546671|FG000|Randomized Phase|Protocol Violation|9|||
23772772|NCT01475838|66546672|FG001|Randomized Phase|Protocol Violation|4|||
23574904|NCT03824236|65835455|FG001|Overall Study|Lost to Follow-up|0|||
23574905|NCT03824236|65835456|FG002|Overall Study|Lost to Follow-up|1|||
23772773|NCT01475838|66546671|FG000|Extension Phase|Participant Noncompliance|1|||
23772774|NCT01475838|66546672|FG001|Extension Phase|Participant Noncompliance|0|||
23772775|NCT00788125|66546677|FG000|Overall Study|Death|6|||
23772776|NCT00620763|66546678|FG000|Period: First Intervention|Withdrawal by Subject|0|||
23574906|NCT02117544|65835464|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
23574907|NCT02117544|65835465|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
23574908|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
23574909|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
23574910|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
23574911|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
23574912|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
23574913|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
23574914|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
23574915|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
23574916|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
23574917|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
23574918|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
23574919|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
23574920|NCT01567163|65835473|FG000|Overall Study|Progressive Disease|2|||
23574921|NCT01567163|65835473|FG000|Overall Study|Lost to Follow-up|2|||
23574922|NCT00219141|65835476|FG000|Overall Study|Adverse Event|4|||
23574923|NCT00219141|65835477|FG001|Overall Study|Adverse Event|10|||
23574924|NCT00219141|65835478|FG002|Overall Study|Adverse Event|5|||
23772777|NCT00620763|66546679|FG001|Period: First Intervention|Withdrawal by Subject|2|||
23772778|NCT00620763|66546678|FG000|Period: First Intervention|Protocol Violation|0|||
23772779|NCT00620763|66546679|FG001|Period: First Intervention|Protocol Violation|3|||
23772780|NCT00620763|66546678|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
23772781|NCT00620763|66546679|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
23772782|NCT00520741|66546680|FG000|Overall Study|Adverse Event|16|||
23574925|NCT00219141|65835476|FG000|Overall Study|Lack of Efficacy|3|||
23574926|NCT00219141|65835477|FG001|Overall Study|Lack of Efficacy|2|||
23574927|NCT00219141|65835478|FG002|Overall Study|Lack of Efficacy|0|||
23574928|NCT00219141|65835476|FG000|Overall Study|Administrative problems|0|||
23574929|NCT00219141|65835477|FG001|Overall Study|Administrative problems|1|||
23574930|NCT00219141|65835478|FG002|Overall Study|Administrative problems|0|||
23772783|NCT00520741|66546681|FG001|Overall Study|Adverse Event|56|||
23772784|NCT00520741|66546680|FG000|Overall Study|Lack of Efficacy|11|||
23772785|NCT00520741|66546681|FG001|Overall Study|Lack of Efficacy|30|||
23772786|NCT00520741|66546680|FG000|Overall Study|Withdrawal by Subject|0|||
23772787|NCT00520741|66546681|FG001|Overall Study|Withdrawal by Subject|11|||
23574931|NCT00219141|65835476|FG000|Overall Study|Lost to Follow-up|2|||
23574932|NCT00219141|65835477|FG001|Overall Study|Lost to Follow-up|4|||
23574933|NCT00219141|65835478|FG002|Overall Study|Lost to Follow-up|1|||
23574934|NCT00219141|65835476|FG000|Overall Study|Protocol Violation|3|||
23574935|NCT00219141|65835477|FG001|Overall Study|Protocol Violation|1|||
23574936|NCT00219141|65835478|FG002|Overall Study|Protocol Violation|1|||
23574937|NCT00219141|65835476|FG000|Overall Study|Withdrawal by Subject|1|||
23574938|NCT00219141|65835477|FG001|Overall Study|Withdrawal by Subject|3|||
23574939|NCT00219141|65835478|FG002|Overall Study|Withdrawal by Subject|5|||
23633631|NCT02870972|66045404|FG004|Overall Study|Adverse Event|0|||
23772788|NCT00520741|66546680|FG000|Overall Study|Protocol Violation|2|||
23833285|NCT00460603|66767904|FG006|Phase 2|Lost to Follow-up|0|||
23833286|NCT00460603|66767905|FG007|Phase 2|Lost to Follow-up|0|||
23833287|NCT00460603|66767906|FG008|Phase 2|Lost to Follow-up|0|||
23833288|NCT00460603|66767907|FG009|Phase 2|Lost to Follow-up|1|||
23833289|NCT00460603|66767908|FG010|Phase 2|Lost to Follow-up|0|||
23833290|NCT00460603|66767909|FG011|Phase 2|Lost to Follow-up|0|||
23833291|NCT00460603|66767898|FG000|Phase 2|Other|0|||
23833292|NCT00460603|66767899|FG001|Phase 2|Other|0|||
23447437|NCT02675231|65380441|FG000|Overall Study|Lost to Follow-up|2|||
23447438|NCT02675231|65380442|FG001|Overall Study|Lost to Follow-up|2|||
23447439|NCT02675231|65380443|FG002|Overall Study|Lost to Follow-up|2|||
23574940|NCT00219141|65835476|FG000|Overall Study|Condition no longer requires study drug|1|||
23574941|NCT00219141|65835477|FG001|Overall Study|Condition no longer requires study drug|0|||
23574942|NCT00219141|65835478|FG002|Overall Study|Condition no longer requires study drug|0|||
23574943|NCT02998528|65835479|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
23574944|NCT02998528|65835480|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
23574945|NCT02998528|65835481|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
23574946|NCT02998528|65835479|FG000|Randomization Period|Participant withdrew consent|0|||
23574947|NCT02998528|65835480|FG001|Randomization Period|Participant withdrew consent|3|||
23574948|NCT02998528|65835481|FG002|Randomization Period|Participant withdrew consent|0|||
23574949|NCT02998528|65835479|FG000|Randomization Period|Participant no longer meets study criteria|1|||
23574950|NCT02998528|65835480|FG001|Randomization Period|Participant no longer meets study criteria|3|||
23574951|NCT02998528|65835481|FG002|Randomization Period|Participant no longer meets study criteria|2|||
23574952|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
23574953|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
23574954|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
23574955|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
23574956|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
23574957|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
23574958|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
23574959|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
23574960|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
23574961|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
23574962|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
23574963|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
23574964|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
23574965|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
23574966|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
23574967|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Death|1|||
23574968|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Death|0|||
23574969|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Death|0|||
23574970|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
23574971|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
23574972|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
23574973|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
23574974|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
23574975|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
23574976|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
23574977|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
23574978|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
23574979|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
23574980|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
23574981|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
23574982|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
23574983|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
23574984|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
23574985|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
23574986|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
23574987|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
23574988|NCT01818700|65835482|FG000|Overall Study|Adverse Event|67|||
23574989|NCT01818700|65835482|FG000|Overall Study|Lack of Efficacy|2|||
23574990|NCT01818700|65835482|FG000|Overall Study|Lost to Follow-up|5|||
23574991|NCT01818700|65835482|FG000|Overall Study|Withdrawal by Subject|27|||
23574992|NCT01818700|65835482|FG000|Overall Study|Protocol Violation|2|||
23574993|NCT01818700|65835482|FG000|Overall Study|Other|1|||
23574994|NCT00972179|65835483|FG000|Overall Study|Noncompliance|1|||
23574995|NCT00972179|65835484|FG001|Overall Study|Noncompliance|0|||
23574996|NCT00972179|65835485|FG002|Overall Study|Noncompliance|0|||
23574997|NCT00972179|65835486|FG003|Overall Study|Noncompliance|0|||
23772789|NCT00520741|66546681|FG001|Overall Study|Protocol Violation|15|||
23772790|NCT00520741|66546680|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
23772791|NCT00520741|66546681|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
23772792|NCT00520741|66546680|FG000|Overall Study|Lost to Follow-up|4|||
23772793|NCT00520741|66546681|FG001|Overall Study|Lost to Follow-up|4|||
23772794|NCT00520741|66546680|FG000|Overall Study|Other reasons for premature termination|0|||
23574998|NCT00972179|65835487|FG004|Overall Study|Noncompliance|1|||
23574999|NCT00972179|65835488|FG005|Overall Study|Noncompliance|0|||
23575000|NCT00972179|65835489|FG006|Overall Study|Noncompliance|1|||
23575001|NCT00972179|65835483|FG000|Overall Study|Withdrawal by Subject|0|||
23575002|NCT00972179|65835484|FG001|Overall Study|Withdrawal by Subject|3|||
23575003|NCT00972179|65835485|FG002|Overall Study|Withdrawal by Subject|0|||
23575004|NCT00972179|65835486|FG003|Overall Study|Withdrawal by Subject|1|||
23575005|NCT00972179|65835487|FG004|Overall Study|Withdrawal by Subject|0|||
23575006|NCT00972179|65835488|FG005|Overall Study|Withdrawal by Subject|0|||
23575007|NCT00972179|65835489|FG006|Overall Study|Withdrawal by Subject|2|||
23575008|NCT00972179|65835483|FG000|Overall Study|Administrative Decision|0|||
23575009|NCT00972179|65835484|FG001|Overall Study|Administrative Decision|0|||
23575010|NCT00972179|65835485|FG002|Overall Study|Administrative Decision|0|||
23575011|NCT00972179|65835486|FG003|Overall Study|Administrative Decision|0|||
23575012|NCT00972179|65835487|FG004|Overall Study|Administrative Decision|1|||
23575013|NCT00972179|65835488|FG005|Overall Study|Administrative Decision|0|||
23575014|NCT00972179|65835489|FG006|Overall Study|Administrative Decision|0|||
23575015|NCT00972179|65835483|FG000|Overall Study|Lost to Follow-up|0|||
23575016|NCT00972179|65835484|FG001|Overall Study|Lost to Follow-up|0|||
23575017|NCT00972179|65835485|FG002|Overall Study|Lost to Follow-up|1|||
23575018|NCT00972179|65835486|FG003|Overall Study|Lost to Follow-up|0|||
23575019|NCT00972179|65835487|FG004|Overall Study|Lost to Follow-up|0|||
23575020|NCT00972179|65835488|FG005|Overall Study|Lost to Follow-up|3|||
23575021|NCT00972179|65835489|FG006|Overall Study|Lost to Follow-up|1|||
23575022|NCT04781647|65835490|FG000|Overall Study|Study terminated by Sponsor|11|||
23575023|NCT04781647|65835491|FG001|Overall Study|Study terminated by Sponsor|9|||
23575024|NCT04781647|65835492|FG002|Overall Study|Study terminated by Sponsor|9|||
23575025|NCT04781647|65835490|FG000|Overall Study|Withdrawal by Subject|1|||
23575026|NCT04781647|65835491|FG001|Overall Study|Withdrawal by Subject|2|||
23575027|NCT04781647|65835492|FG002|Overall Study|Withdrawal by Subject|0|||
23575028|NCT04781647|65835490|FG000|Overall Study|Adverse Event|0|||
23575029|NCT04781647|65835491|FG001|Overall Study|Adverse Event|1|||
23575030|NCT04781647|65835492|FG002|Overall Study|Adverse Event|1|||
23575031|NCT04781647|65835490|FG000|Overall Study|Protocol Violation|1|||
23575032|NCT04781647|65835491|FG001|Overall Study|Protocol Violation|0|||
23575033|NCT04781647|65835492|FG002|Overall Study|Protocol Violation|0|||
23575034|NCT04781647|65835490|FG000|Overall Study|Pregnancy|0|||
23575035|NCT04781647|65835491|FG001|Overall Study|Pregnancy|0|||
23575036|NCT04781647|65835492|FG002|Overall Study|Pregnancy|1|||
23575037|NCT04781647|65835490|FG000|Overall Study|Virology rebounded|1|||
23575038|NCT04781647|65835491|FG001|Overall Study|Virology rebounded|0|||
23575039|NCT04781647|65835492|FG002|Overall Study|Virology rebounded|0|||
23575040|NCT01836458|65835496|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23575041|NCT01836458|65835497|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23575042|NCT01836458|65835498|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23575043|NCT01836458|65835499|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
23575044|NCT04747275|65835500|FG000|Overall Study|Study terminated|0|||
23575045|NCT04747275|65835501|FG001|Overall Study|Study terminated|1|||
23575046|NCT01186328|65835502|FG000|Overall Study|Death|1|||
23575047|NCT01186328|65835503|FG001|Overall Study|Death|0|||
23575048|NCT01186328|65835504|FG002|Overall Study|Death|0|||
23575049|NCT02909101|65835505|FG000|Overall Study|Lost to Follow-up|1|||
23575050|NCT02909101|65835506|FG001|Overall Study|Lost to Follow-up|1|||
23575051|NCT02886728|65835507|FG000|Overall Study|Withdrew Consent|31|||
23575052|NCT02886728|65835508|FG001|Overall Study|Withdrew Consent|13|||
23575053|NCT02886728|65835509|FG002|Overall Study|Withdrew Consent|11|||
23575054|NCT02886728|65835510|FG003|Overall Study|Withdrew Consent|47|||
23575055|NCT02886728|65835507|FG000|Overall Study|Lost to Follow-up|12|||
23575056|NCT02886728|65835508|FG001|Overall Study|Lost to Follow-up|6|||
23575057|NCT02886728|65835509|FG002|Overall Study|Lost to Follow-up|13|||
23575058|NCT02886728|65835510|FG003|Overall Study|Lost to Follow-up|12|||
23772795|NCT00520741|66546681|FG001|Overall Study|Other reasons for premature termination|6|||
23772796|NCT04149964|66546682|FG000|Overall Study|Lost to Follow-up|19|||
23772797|NCT04149964|66546683|FG001|Overall Study|Lost to Follow-up|18|||
23772798|NCT00101582|66546686|FG000|Overall Study|Ineligibility determined|0|||
23772799|NCT00101582|66546687|FG001|Overall Study|Ineligibility determined|1|||
23772800|NCT00101582|66546686|FG000|Overall Study|Adverse Event|1|||
23772801|NCT00101582|66546687|FG001|Overall Study|Adverse Event|4|||
23772802|NCT00101582|66546686|FG000|Overall Study|Withdrawal by Subject|6|||
23575059|NCT02886728|65835507|FG000|Overall Study|Adverse Event|13|||
23575060|NCT02886728|65835508|FG001|Overall Study|Adverse Event|5|||
23772803|NCT00101582|66546687|FG001|Overall Study|Withdrawal by Subject|4|||
23772804|NCT00101582|66546686|FG000|Overall Study|Physician Decision|1|||
23772805|NCT00101582|66546687|FG001|Overall Study|Physician Decision|0|||
23575061|NCT02886728|65835509|FG002|Overall Study|Adverse Event|5|||
23575062|NCT02886728|65835510|FG003|Overall Study|Adverse Event|11|||
23575063|NCT02886728|65835507|FG000|Overall Study|Investigator's Discretion|11|||
23575064|NCT02886728|65835508|FG001|Overall Study|Investigator's Discretion|7|||
23772806|NCT00101582|66546686|FG000|Overall Study|Death|3|||
23575065|NCT02886728|65835509|FG002|Overall Study|Investigator's Discretion|5|||
23772807|NCT00101582|66546687|FG001|Overall Study|Death|5|||
23772808|NCT00101582|66546686|FG000|Overall Study|Other|0|||
23772809|NCT00101582|66546687|FG001|Overall Study|Other|1|||
23772810|NCT02801877|66546692|FG000|Overall Study|Lost to Follow-up|1|||
23772811|NCT02801877|66546693|FG001|Overall Study|Lost to Follow-up|1|||
23833293|NCT00460603|66767900|FG002|Phase 2|Other|0|||
23833294|NCT00460603|66767901|FG003|Phase 2|Other|0|||
23833295|NCT00460603|66767902|FG004|Phase 2|Other|0|||
23833296|NCT00460603|66767903|FG005|Phase 2|Other|0|||
23833297|NCT00460603|66767904|FG006|Phase 2|Other|0|||
23833298|NCT00460603|66767905|FG007|Phase 2|Other|0|||
23833299|NCT00460603|66767906|FG008|Phase 2|Other|0|||
23833300|NCT00460603|66767907|FG009|Phase 2|Other|6|||
23833301|NCT00460603|66767908|FG010|Phase 2|Other|16|||
23833302|NCT00460603|66767909|FG011|Phase 2|Other|7|||
23833303|NCT00460603|66767898|FG000|Phase 2|Objective Progression or Relapse|0|||
23833304|NCT00460603|66767899|FG001|Phase 2|Objective Progression or Relapse|0|||
23833305|NCT00460603|66767900|FG002|Phase 2|Objective Progression or Relapse|0|||
23833306|NCT00460603|66767901|FG003|Phase 2|Objective Progression or Relapse|0|||
23833307|NCT00460603|66767902|FG004|Phase 2|Objective Progression or Relapse|0|||
23833308|NCT00460603|66767903|FG005|Phase 2|Objective Progression or Relapse|0|||
23833309|NCT00460603|66767904|FG006|Phase 2|Objective Progression or Relapse|0|||
23833310|NCT00460603|66767905|FG007|Phase 2|Objective Progression or Relapse|0|||
23833311|NCT00460603|66767906|FG008|Phase 2|Objective Progression or Relapse|0|||
23833312|NCT00460603|66767907|FG009|Phase 2|Objective Progression or Relapse|9|||
23833313|NCT00460603|66767908|FG010|Phase 2|Objective Progression or Relapse|10|||
23833314|NCT00460603|66767909|FG011|Phase 2|Objective Progression or Relapse|17|||
23575066|NCT02886728|65835510|FG003|Overall Study|Investigator's Discretion|11|||
23575067|NCT02886728|65835507|FG000|Overall Study|Death|3|||
23575068|NCT02886728|65835508|FG001|Overall Study|Death|1|||
23575069|NCT02886728|65835509|FG002|Overall Study|Death|0|||
23575070|NCT02886728|65835510|FG003|Overall Study|Death|0|||
23575071|NCT02886728|65835507|FG000|Overall Study|Protocol Violation|0|||
23575072|NCT02886728|65835508|FG001|Overall Study|Protocol Violation|0|||
23575073|NCT02886728|65835509|FG002|Overall Study|Protocol Violation|0|||
23575074|NCT02886728|65835510|FG003|Overall Study|Protocol Violation|4|||
23575075|NCT02886728|65835507|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23772812|NCT02801877|66546694|FG002|Overall Study|Lost to Follow-up|2|||
23772813|NCT02801877|66546695|FG003|Overall Study|Lost to Follow-up|0|||
23833315|NCT00460603|66767898|FG000|Phase 2|Global Deterioration of Health Status|0|||
23833316|NCT00460603|66767899|FG001|Phase 2|Global Deterioration of Health Status|0|||
23833317|NCT00460603|66767900|FG002|Phase 2|Global Deterioration of Health Status|0|||
23833318|NCT00460603|66767901|FG003|Phase 2|Global Deterioration of Health Status|0|||
23833319|NCT00460603|66767902|FG004|Phase 2|Global Deterioration of Health Status|0|||
23833320|NCT00460603|66767903|FG005|Phase 2|Global Deterioration of Health Status|0|||
23833321|NCT00460603|66767904|FG006|Phase 2|Global Deterioration of Health Status|0|||
23833322|NCT00460603|66767905|FG007|Phase 2|Global Deterioration of Health Status|0|||
23575076|NCT02886728|65835508|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23772814|NCT02801877|66546692|FG000|Overall Study|Never Started Treatment|2|||
23772815|NCT02801877|66546693|FG001|Overall Study|Never Started Treatment|0|||
23772816|NCT02801877|66546694|FG002|Overall Study|Never Started Treatment|4|||
23772817|NCT02801877|66546695|FG003|Overall Study|Never Started Treatment|0|||
23772818|NCT00977106|66546696|FG000|Overall Study|Adverse Event|5|||
23772819|NCT00977106|66546697|FG001|Overall Study|Adverse Event|6|||
23772820|NCT00977106|66546696|FG000|Overall Study|Withdrawal by Subject|2|||
23772821|NCT00977106|66546697|FG001|Overall Study|Withdrawal by Subject|2|||
23772822|NCT00977106|66546696|FG000|Overall Study|Lack of Efficacy|2|||
23772823|NCT00977106|66546697|FG001|Overall Study|Lack of Efficacy|2|||
23772824|NCT00977106|66546696|FG000|Overall Study|Protocol Violation|0|||
23772825|NCT00977106|66546697|FG001|Overall Study|Protocol Violation|1|||
23772826|NCT00977106|66546696|FG000|Overall Study|Other|1|||
23772827|NCT00977106|66546697|FG001|Overall Study|Other|0|||
23772828|NCT03401112|66546698|FG000|Overall Study|Adverse Event|1|||
23772829|NCT03401112|66546699|FG001|Overall Study|Adverse Event|2|||
23772830|NCT03401112|66546700|FG002|Overall Study|Adverse Event|3|||
23772831|NCT03401112|66546701|FG003|Overall Study|Adverse Event|2|||
23833323|NCT00460603|66767906|FG008|Phase 2|Global Deterioration of Health Status|0|||
23575077|NCT02886728|65835509|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23833324|NCT00460603|66767907|FG009|Phase 2|Global Deterioration of Health Status|0|||
23833325|NCT00460603|66767908|FG010|Phase 2|Global Deterioration of Health Status|1|||
23833326|NCT00460603|66767909|FG011|Phase 2|Global Deterioration of Health Status|0|||
23575078|NCT02886728|65835510|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23772832|NCT03401112|66546702|FG004|Overall Study|Adverse Event|0|||
23772833|NCT03401112|66546698|FG000|Overall Study|Lost to Follow-up|1|||
23772834|NCT03401112|66546699|FG001|Overall Study|Lost to Follow-up|0|||
23772835|NCT03401112|66546700|FG002|Overall Study|Lost to Follow-up|0|||
23772836|NCT03401112|66546701|FG003|Overall Study|Lost to Follow-up|0|||
23833327|NCT00460603|66767898|FG000|Phase 2|Withdrawal by Subject|0|||
23633632|NCT00233480|66045405|FG000|Overall Study|Underwent status II heart transplant|0|||
23772837|NCT03401112|66546702|FG004|Overall Study|Lost to Follow-up|0|||
23772838|NCT03401112|66546698|FG000|Overall Study|Noncompliance|1|||
23772839|NCT03401112|66546699|FG001|Overall Study|Noncompliance|2|||
23772840|NCT03401112|66546700|FG002|Overall Study|Noncompliance|3|||
23772841|NCT03401112|66546701|FG003|Overall Study|Noncompliance|0|||
23772842|NCT03401112|66546702|FG004|Overall Study|Noncompliance|0|||
23772843|NCT03401112|66546698|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
23772844|NCT03401112|66546699|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
23772845|NCT03401112|66546700|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
23772846|NCT03401112|66546701|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
23772847|NCT03401112|66546702|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
23772848|NCT03401112|66546698|FG000|Overall Study|Withdrawal by Subject|0|||
23772849|NCT03401112|66546699|FG001|Overall Study|Withdrawal by Subject|3|||
23772850|NCT03401112|66546700|FG002|Overall Study|Withdrawal by Subject|2|||
23772851|NCT03401112|66546701|FG003|Overall Study|Withdrawal by Subject|1|||
23772852|NCT03401112|66546702|FG004|Overall Study|Withdrawal by Subject|0|||
23772853|NCT03401112|66546698|FG000|Overall Study|Physician Decision|0|||
23772854|NCT03401112|66546699|FG001|Overall Study|Physician Decision|0|||
23772855|NCT03401112|66546700|FG002|Overall Study|Physician Decision|0|||
23772856|NCT03401112|66546701|FG003|Overall Study|Physician Decision|2|||
23772857|NCT03401112|66546702|FG004|Overall Study|Physician Decision|0|||
23772858|NCT03401112|66546698|FG000|Overall Study|Study was Terminated by Sponsor|0|||
23772859|NCT03401112|66546699|FG001|Overall Study|Study was Terminated by Sponsor|0|||
23772860|NCT03401112|66546700|FG002|Overall Study|Study was Terminated by Sponsor|0|||
23772861|NCT03401112|66546701|FG003|Overall Study|Study was Terminated by Sponsor|1|||
23772862|NCT03401112|66546702|FG004|Overall Study|Study was Terminated by Sponsor|0|||
23772863|NCT03401112|66546698|FG000|Overall Study|Day 1 Assessment not Done|1|||
23772864|NCT03401112|66546699|FG001|Overall Study|Day 1 Assessment not Done|0|||
23772865|NCT03401112|66546700|FG002|Overall Study|Day 1 Assessment not Done|0|||
23772866|NCT03401112|66546701|FG003|Overall Study|Day 1 Assessment not Done|0|||
23772867|NCT03401112|66546702|FG004|Overall Study|Day 1 Assessment not Done|0|||
23772868|NCT03401112|66546698|FG000|Overall Study|Not Dosed|0|||
23772869|NCT03401112|66546699|FG001|Overall Study|Not Dosed|0|||
23772870|NCT03401112|66546700|FG002|Overall Study|Not Dosed|1|||
23772871|NCT03401112|66546701|FG003|Overall Study|Not Dosed|0|||
23772872|NCT03401112|66546702|FG004|Overall Study|Not Dosed|0|||
23772873|NCT03401112|66546698|FG000|Overall Study|Missed Clinical Visit|0|||
23772874|NCT03401112|66546699|FG001|Overall Study|Missed Clinical Visit|0|||
23772875|NCT03401112|66546700|FG002|Overall Study|Missed Clinical Visit|1|||
23772876|NCT03401112|66546701|FG003|Overall Study|Missed Clinical Visit|0|||
23772877|NCT03401112|66546702|FG004|Overall Study|Missed Clinical Visit|0|||
23772878|NCT03401112|66546698|FG000|Overall Study|Missed Doses|0|||
23772879|NCT03401112|66546699|FG001|Overall Study|Missed Doses|0|||
23772880|NCT03401112|66546700|FG002|Overall Study|Missed Doses|1|||
23772881|NCT03401112|66546701|FG003|Overall Study|Missed Doses|0|||
23772882|NCT03401112|66546702|FG004|Overall Study|Missed Doses|0|||
23772883|NCT01273181|66546703|FG000|Phase I, Dose 1|Study termination|1|||
23772884|NCT01273181|66546704|FG001|Phase I, Dose 1|Study termination|0|||
23772885|NCT01273181|66546705|FG002|Phase I, Dose 1|Study termination|0|||
23772886|NCT01273181|66546706|FG003|Phase I, Dose 1|Study termination|0|||
23772887|NCT01273181|66546703|FG000|Phase I, Dose 2|Death during treatment|0|||
23772888|NCT01273181|66546704|FG001|Phase I, Dose 2|Death during treatment|1|||
23772889|NCT01273181|66546705|FG002|Phase I, Dose 2|Death during treatment|0|||
23772890|NCT01273181|66546706|FG003|Phase I, Dose 2|Death during treatment|0|||
23772891|NCT01273181|66546703|FG000|Phase 2, Dose 1|Study termination|0|||
23772892|NCT01273181|66546704|FG001|Phase 2, Dose 1|Study termination|0|||
23772893|NCT01273181|66546705|FG002|Phase 2, Dose 1|Study termination|1|||
23772894|NCT01273181|66546706|FG003|Phase 2, Dose 1|Study termination|0|||
23772895|NCT01273181|66546703|FG000|Phase 2, Dose 2|Death during treatment|0|||
23772896|NCT01273181|66546704|FG001|Phase 2, Dose 2|Death during treatment|0|||
23772897|NCT01273181|66546705|FG002|Phase 2, Dose 2|Death during treatment|0|||
23833328|NCT00460603|66767899|FG001|Phase 2|Withdrawal by Subject|0|||
23633633|NCT00233480|66045406|FG001|Overall Study|Underwent status II heart transplant|1|||
23772898|NCT01273181|66546706|FG003|Phase 2, Dose 2|Death during treatment|1|||
23833329|NCT00460603|66767900|FG002|Phase 2|Withdrawal by Subject|0|||
23772899|NCT03311646|66546709|FG000|Overall Study|Physician Decision|1|||
23772900|NCT03311646|66546709|FG000|Overall Study|Withdrawal by Subject|5|||
23772901|NCT03311646|66546709|FG000|Overall Study|Lost to Follow-up|5|||
23772902|NCT03311646|66546709|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
23772903|NCT00576901|66546710|FG000|Overall Study|Withdrawal by Subject|1|||
23772904|NCT00576901|66546710|FG000|Overall Study|Disease course|1|||
23772905|NCT00576901|66546710|FG000|Overall Study|Protocol Violation|1|||
23772906|NCT00162123|66546712|FG000|Overall Study|Disease progression|27|||
23772907|NCT00162123|66546713|FG001|Overall Study|Disease progression|19|||
23772908|NCT00162123|66546714|FG002|Overall Study|Disease progression|10|||
23772909|NCT00162123|66546715|FG003|Overall Study|Disease progression|4|||
23772910|NCT00162123|66546716|FG004|Overall Study|Disease progression|8|||
23772911|NCT00162123|66546717|FG005|Overall Study|Disease progression|3|||
23772912|NCT00162123|66546718|FG006|Overall Study|Disease progression|1|||
23772913|NCT00162123|66546719|FG007|Overall Study|Disease progression|0|||
23575079|NCT02886728|65835507|FG000|Overall Study|Pregnancy|0|||
23575080|NCT02886728|65835508|FG001|Overall Study|Pregnancy|0|||
23575081|NCT02886728|65835509|FG002|Overall Study|Pregnancy|1|||
23575082|NCT02886728|65835510|FG003|Overall Study|Pregnancy|0|||
23575083|NCT02886728|65835507|FG000|Overall Study|Randomized but Not Dosed|1|||
23772914|NCT00162123|66546712|FG000|Overall Study|Study drug toxicity|6|||
23772915|NCT00162123|66546713|FG001|Overall Study|Study drug toxicity|1|||
23772916|NCT00162123|66546714|FG002|Overall Study|Study drug toxicity|5|||
23772917|NCT00162123|66546715|FG003|Overall Study|Study drug toxicity|0|||
23772918|NCT00162123|66546716|FG004|Overall Study|Study drug toxicity|4|||
23772919|NCT00162123|66546717|FG005|Overall Study|Study drug toxicity|1|||
23772920|NCT00162123|66546718|FG006|Overall Study|Study drug toxicity|1|||
23772921|NCT00162123|66546719|FG007|Overall Study|Study drug toxicity|0|||
23772922|NCT00162123|66546712|FG000|Overall Study|Death|3|||
23772923|NCT00162123|66546713|FG001|Overall Study|Death|3|||
23772924|NCT00162123|66546714|FG002|Overall Study|Death|1|||
23772925|NCT00162123|66546715|FG003|Overall Study|Death|1|||
23772926|NCT00162123|66546716|FG004|Overall Study|Death|1|||
23772927|NCT00162123|66546717|FG005|Overall Study|Death|1|||
23772928|NCT00162123|66546718|FG006|Overall Study|Death|0|||
23772929|NCT00162123|66546719|FG007|Overall Study|Death|0|||
23772930|NCT00162123|66546712|FG000|Overall Study|Withdrawal by Subject|2|||
23772931|NCT00162123|66546713|FG001|Overall Study|Withdrawal by Subject|0|||
23772932|NCT00162123|66546714|FG002|Overall Study|Withdrawal by Subject|2|||
23772933|NCT00162123|66546715|FG003|Overall Study|Withdrawal by Subject|1|||
23772934|NCT00162123|66546716|FG004|Overall Study|Withdrawal by Subject|1|||
23772935|NCT00162123|66546717|FG005|Overall Study|Withdrawal by Subject|2|||
23772936|NCT00162123|66546718|FG006|Overall Study|Withdrawal by Subject|1|||
23772937|NCT00162123|66546719|FG007|Overall Study|Withdrawal by Subject|0|||
23772938|NCT00162123|66546712|FG000|Overall Study|Deterioration without progression|2|||
23772939|NCT00162123|66546713|FG001|Overall Study|Deterioration without progression|2|||
23772940|NCT00162123|66546714|FG002|Overall Study|Deterioration without progression|3|||
23772941|NCT00162123|66546715|FG003|Overall Study|Deterioration without progression|0|||
23772942|NCT00162123|66546716|FG004|Overall Study|Deterioration without progression|1|||
23772943|NCT00162123|66546717|FG005|Overall Study|Deterioration without progression|0|||
23772944|NCT00162123|66546718|FG006|Overall Study|Deterioration without progression|0|||
23772945|NCT00162123|66546719|FG007|Overall Study|Deterioration without progression|0|||
23772946|NCT00162123|66546712|FG000|Overall Study|Adverse Event|1|||
23772947|NCT00162123|66546713|FG001|Overall Study|Adverse Event|2|||
23772948|NCT00162123|66546714|FG002|Overall Study|Adverse Event|0|||
23772949|NCT00162123|66546715|FG003|Overall Study|Adverse Event|2|||
23772950|NCT00162123|66546716|FG004|Overall Study|Adverse Event|1|||
23772951|NCT00162123|66546717|FG005|Overall Study|Adverse Event|0|||
23772952|NCT00162123|66546718|FG006|Overall Study|Adverse Event|0|||
23772953|NCT00162123|66546719|FG007|Overall Study|Adverse Event|0|||
23772954|NCT00162123|66546712|FG000|Overall Study|Not specified (before treatment)|2|||
23772955|NCT00162123|66546713|FG001|Overall Study|Not specified (before treatment)|0|||
23772956|NCT00162123|66546714|FG002|Overall Study|Not specified (before treatment)|0|||
23772957|NCT00162123|66546715|FG003|Overall Study|Not specified (before treatment)|0|||
23772958|NCT00162123|66546716|FG004|Overall Study|Not specified (before treatment)|12|||
23772959|NCT00162123|66546717|FG005|Overall Study|Not specified (before treatment)|1|||
23772960|NCT00162123|66546718|FG006|Overall Study|Not specified (before treatment)|0|||
23772961|NCT00162123|66546719|FG007|Overall Study|Not specified (before treatment)|0|||
23772962|NCT00162123|66546712|FG000|Overall Study|Not specified (after start of treatment)|0|||
23447440|NCT02675231|65380441|FG000|Overall Study|On study treatment/follow up|23|||
23575084|NCT02886728|65835508|FG001|Overall Study|Randomized but Not Dosed|0|||
23772963|NCT00162123|66546713|FG001|Overall Study|Not specified (after start of treatment)|0|||
23772964|NCT00162123|66546714|FG002|Overall Study|Not specified (after start of treatment)|0|||
23772965|NCT00162123|66546715|FG003|Overall Study|Not specified (after start of treatment)|0|||
23772966|NCT00162123|66546716|FG004|Overall Study|Not specified (after start of treatment)|3|||
23772967|NCT00162123|66546717|FG005|Overall Study|Not specified (after start of treatment)|0|||
23772968|NCT00162123|66546718|FG006|Overall Study|Not specified (after start of treatment)|0|||
23772969|NCT00162123|66546719|FG007|Overall Study|Not specified (after start of treatment)|0|||
23772970|NCT00162123|66546712|FG000|Overall Study|Physician Decision|1|||
23575085|NCT02886728|65835509|FG002|Overall Study|Randomized but Not Dosed|0|||
23575086|NCT02886728|65835510|FG003|Overall Study|Randomized but Not Dosed|2|||
23772971|NCT00162123|66546713|FG001|Overall Study|Physician Decision|2|||
23575087|NCT02420327|65835511|FG000|Overall Study|Adverse Event|7|||
23833330|NCT00460603|66767901|FG003|Phase 2|Withdrawal by Subject|0|||
23833331|NCT00460603|66767902|FG004|Phase 2|Withdrawal by Subject|0|||
23833332|NCT00460603|66767903|FG005|Phase 2|Withdrawal by Subject|0|||
23833333|NCT00460603|66767904|FG006|Phase 2|Withdrawal by Subject|0|||
23575088|NCT02420327|65835511|FG000|Overall Study|Pregnancy|1|||
23575089|NCT02420327|65835511|FG000|Overall Study|Withdrawal by Subject|6|||
23575090|NCT02420327|65835511|FG000|Overall Study|Lost to Follow-up|1|||
23575091|NCT02420327|65835511|FG000|Overall Study|Protocol Violation|1|||
23575092|NCT00311155|65835517|FG000|Overall Study|Adverse Event|21|||
23575093|NCT00311155|65835517|FG000|Overall Study|Withdrawal by Subject|17|||
23575094|NCT00311155|65835517|FG000|Overall Study|Did not meet entry criteria|55|||
23575095|NCT01925170|65835525|FG000|Overall Study|Unverified cancer status|53|||
23575096|NCT00614744|65835526|FG000|Overall Study|Lost to Follow-up|5|||
23575097|NCT00614744|65835527|FG001|Overall Study|Lost to Follow-up|4|||
23575098|NCT00614744|65835526|FG000|Overall Study|Incomplete for Behavior Issues|0|||
23575099|NCT00614744|65835527|FG001|Overall Study|Incomplete for Behavior Issues|2|||
23575100|NCT01702428|65835528|FG000|Overall Study|Adverse Event|2|||
23575101|NCT01702428|65835529|FG001|Overall Study|Adverse Event|0|||
23575102|NCT01702428|65835530|FG002|Overall Study|Adverse Event|0|||
23575103|NCT01702428|65835531|FG003|Overall Study|Adverse Event|0|||
23575104|NCT01702428|65835528|FG000|Overall Study|Lost to Follow-up|33|||
23575105|NCT01702428|65835529|FG001|Overall Study|Lost to Follow-up|41|||
23575106|NCT01702428|65835530|FG002|Overall Study|Lost to Follow-up|37|||
23575107|NCT01702428|65835531|FG003|Overall Study|Lost to Follow-up|44|||
23575108|NCT01702428|65835528|FG000|Overall Study|Parents cannot assist to site|1|||
23575109|NCT01702428|65835529|FG001|Overall Study|Parents cannot assist to site|0|||
23575110|NCT01702428|65835530|FG002|Overall Study|Parents cannot assist to site|1|||
23575111|NCT01702428|65835531|FG003|Overall Study|Parents cannot assist to site|0|||
23575112|NCT01702428|65835528|FG000|Overall Study|Lost Coverage|0|||
23575113|NCT01702428|65835529|FG001|Overall Study|Lost Coverage|0|||
23575114|NCT01702428|65835530|FG002|Overall Study|Lost Coverage|0|||
23575115|NCT01702428|65835531|FG003|Overall Study|Lost Coverage|1|||
23575116|NCT01702428|65835528|FG000|Overall Study|Lost Health Plan|3|||
23575117|NCT01702428|65835529|FG001|Overall Study|Lost Health Plan|5|||
23575118|NCT01702428|65835530|FG002|Overall Study|Lost Health Plan|0|||
23575119|NCT01702428|65835531|FG003|Overall Study|Lost Health Plan|2|||
23575120|NCT01702428|65835528|FG000|Overall Study|Mother transferred care|0|||
23575121|NCT01702428|65835529|FG001|Overall Study|Mother transferred care|1|||
23833334|NCT00460603|66767905|FG007|Phase 2|Withdrawal by Subject|0|||
23833335|NCT00460603|66767906|FG008|Phase 2|Withdrawal by Subject|0|||
23833336|NCT00460603|66767907|FG009|Phase 2|Withdrawal by Subject|5|||
23833337|NCT00460603|66767908|FG010|Phase 2|Withdrawal by Subject|4|||
23833338|NCT00460603|66767909|FG011|Phase 2|Withdrawal by Subject|5|||
23833339|NCT00460603|66767898|FG000|Phase 2|Randomized, but not treated|0|||
23833340|NCT00460603|66767899|FG001|Phase 2|Randomized, but not treated|0|||
23833341|NCT00460603|66767900|FG002|Phase 2|Randomized, but not treated|0|||
23833342|NCT00460603|66767901|FG003|Phase 2|Randomized, but not treated|0|||
23833343|NCT00460603|66767902|FG004|Phase 2|Randomized, but not treated|0|||
23833344|NCT00460603|66767903|FG005|Phase 2|Randomized, but not treated|0|||
23833345|NCT00460603|66767904|FG006|Phase 2|Randomized, but not treated|0|||
23575122|NCT01702428|65835530|FG002|Overall Study|Mother transferred care|0|||
23575123|NCT01702428|65835531|FG003|Overall Study|Mother transferred care|0|||
23575124|NCT01702428|65835528|FG000|Overall Study|Parents too busy|1|||
23575125|NCT01702428|65835529|FG001|Overall Study|Parents too busy|0|||
23575126|NCT01702428|65835530|FG002|Overall Study|Parents too busy|0|||
23575127|NCT01702428|65835531|FG003|Overall Study|Parents too busy|0|||
23575128|NCT01702428|65835528|FG000|Overall Study|Protocol Violation|3|||
23575129|NCT01702428|65835529|FG001|Overall Study|Protocol Violation|0|||
23575130|NCT01702428|65835530|FG002|Overall Study|Protocol Violation|1|||
23575131|NCT01702428|65835531|FG003|Overall Study|Protocol Violation|0|||
23575132|NCT01702428|65835528|FG000|Overall Study|Withdrawal by Subject|21|||
23575133|NCT01702428|65835529|FG001|Overall Study|Withdrawal by Subject|23|||
23575134|NCT01702428|65835530|FG002|Overall Study|Withdrawal by Subject|14|||
23833346|NCT00460603|66767905|FG007|Phase 2|Randomized, but not treated|0|||
23833347|NCT00460603|66767906|FG008|Phase 2|Randomized, but not treated|0|||
23833348|NCT00460603|66767907|FG009|Phase 2|Randomized, but not treated|3|||
23833349|NCT00460603|66767908|FG010|Phase 2|Randomized, but not treated|0|||
23833350|NCT00460603|66767909|FG011|Phase 2|Randomized, but not treated|0|||
23447441|NCT02675231|65380442|FG001|Overall Study|On study treatment/follow up|31|||
23833351|NCT03817125|66767917|FG000|Overall Study|Adverse Event|1|||
23575135|NCT01702428|65835531|FG003|Overall Study|Withdrawal by Subject|10|||
23575136|NCT01809210|65835532|FG000|Overall Study|Withdrawal by Subject|0|||
23575137|NCT01809210|65835533|FG001|Overall Study|Withdrawal by Subject|0|||
23575138|NCT01809210|65835534|FG002|Overall Study|Withdrawal by Subject|1|||
23575139|NCT01809210|65835535|FG003|Overall Study|Withdrawal by Subject|1|||
23575140|NCT01809210|65835536|FG004|Overall Study|Withdrawal by Subject|1|||
23833352|NCT03817125|66767918|FG001|Overall Study|Adverse Event|0|||
23833353|NCT03817125|66767917|FG000|Overall Study|Physician Decision|0|||
23833354|NCT03817125|66767918|FG001|Overall Study|Physician Decision|1|||
23833355|NCT03817125|66767917|FG000|Overall Study|Lack of Efficacy|1|||
23833356|NCT03817125|66767918|FG001|Overall Study|Lack of Efficacy|5|||
23833357|NCT01956773|66767919|FG000|Overall Study|Lost to Follow-up|628|||
23833358|NCT01956773|66767920|FG001|Overall Study|Lost to Follow-up|1|||
23833359|NCT00778817|66767925|FG000|Overall Study|Adverse Event|2|||
23833360|NCT00778817|66767925|FG000|Overall Study|Withdrawal by Subject|2|||
23833361|NCT03379727|66767932|FG000|Overall Study|Lack of Efficacy|73|||
23833362|NCT03379727|66767932|FG000|Overall Study|Adverse Event|32|||
23833363|NCT03379727|66767932|FG000|Overall Study|Death|18|||
23833364|NCT03379727|66767932|FG000|Overall Study|Patient/guardian decision|17|||
23833365|NCT03379727|66767932|FG000|Overall Study|Physician Decision|104|||
23833366|NCT03379727|66767932|FG000|Overall Study|Protocol Violation|4|||
23833367|NCT03379727|66767932|FG000|Overall Study|Lost to Follow-up|1|||
23833368|NCT03759392|66767933|FG000|Overall Study|Adverse Event|12|||
23833369|NCT03759392|66767934|FG001|Overall Study|Adverse Event|4|||
23833370|NCT03759392|66767933|FG000|Overall Study|Death|2|||
23833371|NCT03759392|66767934|FG001|Overall Study|Death|1|||
23833372|NCT03759392|66767933|FG000|Overall Study|Withdrawal by Subject|2|||
23833373|NCT03759392|66767934|FG001|Overall Study|Withdrawal by Subject|0|||
23833374|NCT03759392|66767933|FG000|Overall Study|Protocol Violation|2|||
23833375|NCT03759392|66767934|FG001|Overall Study|Protocol Violation|0|||
23833376|NCT03759392|66767933|FG000|Overall Study|Physician Decision|0|||
23833377|NCT03759392|66767934|FG001|Overall Study|Physician Decision|1|||
23833378|NCT03759392|66767933|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
23833379|NCT03759392|66767934|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
23833380|NCT03759392|66767933|FG000|Overall Study|No longer able to take medicines|1|||
23833381|NCT03759392|66767934|FG001|Overall Study|No longer able to take medicines|0|||
23833382|NCT03759392|66767933|FG000|Overall Study|Stopped taking study drug|1|||
23833383|NCT03759392|66767934|FG001|Overall Study|Stopped taking study drug|0|||
23833384|NCT00063934|66767935|FG000|Overall Study|Ineligible|1|||
23833385|NCT00478777|66767936|FG000|Overall Study|Adverse Event|29|||
23833386|NCT00478777|66767936|FG000|Overall Study|Lack of Efficacy|23|||
23833387|NCT00478777|66767936|FG000|Overall Study|Withdrawal by Subject|4|||
23833388|NCT00478777|66767936|FG000|Overall Study|Death|3|||
23833389|NCT00478777|66767936|FG000|Overall Study|Protocol Violation|3|||
23833390|NCT00478777|66767936|FG000|Overall Study|Lost to Follow-up|3|||
23833391|NCT00478777|66767936|FG000|Overall Study|Physician Decision|1|||
23833392|NCT00478777|66767936|FG000|Overall Study|Intolerance of therapy|1|||
23833393|NCT00478777|66767936|FG000|Overall Study|Lack of compliance|1|||
23833394|NCT00478777|66767936|FG000|Overall Study|Lymphocytes infusion|1|||
23833395|NCT00478777|66767936|FG000|Overall Study|End of therapy|2|||
23833396|NCT00478777|66767936|FG000|Overall Study|Not treated with lenalidomide|6|||
23833397|NCT02570308|66767937|FG000|Overall Study|Death|1|||
23833398|NCT02570308|66767938|FG001|Overall Study|Death|5|||
23833399|NCT02570308|66767939|FG002|Overall Study|Death|4|||
23833400|NCT02570308|66767940|FG003|Overall Study|Death|4|||
23833401|NCT02570308|66767941|FG004|Overall Study|Death|69|||
23833402|NCT02570308|66767937|FG000|Overall Study|Lost to Follow-up|0|||
23833403|NCT02570308|66767938|FG001|Overall Study|Lost to Follow-up|0|||
23833404|NCT02570308|66767939|FG002|Overall Study|Lost to Follow-up|0|||
23833405|NCT02570308|66767940|FG003|Overall Study|Lost to Follow-up|0|||
23833406|NCT02570308|66767941|FG004|Overall Study|Lost to Follow-up|2|||
23833407|NCT02570308|66767937|FG000|Overall Study|Withdrawal by Subject|0|||
23772972|NCT00162123|66546714|FG002|Overall Study|Physician Decision|0|||
23772973|NCT00162123|66546715|FG003|Overall Study|Physician Decision|0|||
23772974|NCT00162123|66546716|FG004|Overall Study|Physician Decision|0|||
23772975|NCT00162123|66546717|FG005|Overall Study|Physician Decision|1|||
23772976|NCT00162123|66546718|FG006|Overall Study|Physician Decision|1|||
23772977|NCT00162123|66546719|FG007|Overall Study|Physician Decision|0|||
23772978|NCT00162123|66546712|FG000|Overall Study|Tumor assessment only (not treated)|0|||
23772979|NCT00162123|66546713|FG001|Overall Study|Tumor assessment only (not treated)|0|||
23772980|NCT00162123|66546714|FG002|Overall Study|Tumor assessment only (not treated)|0|||
23772981|NCT00162123|66546715|FG003|Overall Study|Tumor assessment only (not treated)|0|||
23833408|NCT02570308|66767938|FG001|Overall Study|Withdrawal by Subject|0|||
23833409|NCT02570308|66767939|FG002|Overall Study|Withdrawal by Subject|0|||
23833410|NCT02570308|66767940|FG003|Overall Study|Withdrawal by Subject|0|||
23833411|NCT02570308|66767941|FG004|Overall Study|Withdrawal by Subject|1|||
23772982|NCT00162123|66546716|FG004|Overall Study|Tumor assessment only (not treated)|0|||
23772983|NCT00162123|66546717|FG005|Overall Study|Tumor assessment only (not treated)|0|||
23772984|NCT00162123|66546718|FG006|Overall Study|Tumor assessment only (not treated)|0|||
23833412|NCT02570308|66767937|FG000|Overall Study|Other|0|||
23833413|NCT02570308|66767938|FG001|Overall Study|Other|0|||
23772985|NCT00162123|66546719|FG007|Overall Study|Tumor assessment only (not treated)|1|||
23833414|NCT02570308|66767939|FG002|Overall Study|Other|0|||
23833415|NCT02570308|66767940|FG003|Overall Study|Other|0|||
23833416|NCT02570308|66767941|FG004|Overall Study|Other|2|||
23833417|NCT04421131|66767943|FG000|Overall Study|Lost to Follow-up|1|||
23575141|NCT01809210|65835537|FG005|Overall Study|Withdrawal by Subject|0|||
23575142|NCT01809210|65835538|FG006|Overall Study|Withdrawal by Subject|4|||
23575143|NCT01809210|65835532|FG000|Overall Study|Death|1|||
23575144|NCT01809210|65835533|FG001|Overall Study|Death|1|||
23575145|NCT01809210|65835534|FG002|Overall Study|Death|2|||
23575146|NCT01809210|65835535|FG003|Overall Study|Death|0|||
23575147|NCT01809210|65835536|FG004|Overall Study|Death|1|||
23575148|NCT01809210|65835537|FG005|Overall Study|Death|3|||
23575149|NCT01809210|65835538|FG006|Overall Study|Death|1|||
23575150|NCT01349907|65835539|FG000|Overall Study|Adverse Event|37|||
23575151|NCT01349907|65835540|FG001|Overall Study|Adverse Event|11|||
23575152|NCT01349907|65835539|FG000|Overall Study|Treatment failure|13|||
23575153|NCT01349907|65835540|FG001|Overall Study|Treatment failure|4|||
23575154|NCT01349907|65835539|FG000|Overall Study|Lost to Follow-up|25|||
23575155|NCT01349907|65835540|FG001|Overall Study|Lost to Follow-up|6|||
23575156|NCT01349907|65835539|FG000|Overall Study|Withdrawal by Subject|30|||
23575157|NCT01349907|65835540|FG001|Overall Study|Withdrawal by Subject|8|||
23575158|NCT01349907|65835539|FG000|Overall Study|Protocol Violation|33|||
23575159|NCT01349907|65835540|FG001|Overall Study|Protocol Violation|13|||
23575160|NCT01349907|65835539|FG000|Overall Study|Administrative|1|||
23575161|NCT01349907|65835540|FG001|Overall Study|Administrative|1|||
23575162|NCT01010217|65835541|FG000|Overall Study|Lost to Follow-up|4|||
23575163|NCT01010217|65835542|FG001|Overall Study|Lost to Follow-up|5|||
23772986|NCT00162123|66546712|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
23772987|NCT00162123|66546713|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
23633634|NCT01465763|66045407|FG000|Overall Study|Withdrawal by Subject|4|||
23633635|NCT01465763|66045408|FG001|Overall Study|Withdrawal by Subject|0|||
23633636|NCT01465763|66045409|FG002|Overall Study|Withdrawal by Subject|1|||
23633637|NCT01465763|66045407|FG000|Overall Study|Insufficient Clinical Response|11|||
23772988|NCT00162123|66546714|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
23772989|NCT00162123|66546715|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
23772990|NCT00162123|66546716|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
23772991|NCT00162123|66546717|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
23772992|NCT00162123|66546718|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
23833418|NCT04421131|66767943|FG000|Overall Study|Protocol Violation|2|||
23833419|NCT04421131|66767943|FG000|Overall Study|App crashed|5|||
23833420|NCT01537042|66767944|FG000|Overall Study|Adverse Event|0|||
23833421|NCT01537042|66767945|FG001|Overall Study|Adverse Event|2|||
23833422|NCT01537042|66767944|FG000|Overall Study|Lack of Efficacy|0|||
23833423|NCT01537042|66767945|FG001|Overall Study|Lack of Efficacy|1|||
23833424|NCT01537042|66767944|FG000|Overall Study|Protocol Violation|0|||
23833425|NCT01537042|66767945|FG001|Overall Study|Protocol Violation|1|||
23833426|NCT01537042|66767944|FG000|Overall Study|Other|0|||
23833427|NCT01537042|66767945|FG001|Overall Study|Other|1|||
23833428|NCT01882985|66767946|FG000|Overall Study|Lost to Follow-up|1|||
23833429|NCT01882985|66767946|FG000|Overall Study|Withdrawal by Subject|1|||
23833430|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
23833431|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
23833432|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
23833433|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
23833434|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
23833435|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
23833436|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
23833437|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
23833438|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
23833439|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
23833440|NCT03762265|66767947|FG000|BT Period: Weeks 1 to 37|Other|0|||
23833441|NCT03762265|66767948|FG001|BT Period: Weeks 1 to 37|Other|1|||
23833442|NCT03762265|66767947|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
23833443|NCT03762265|66767948|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
23447442|NCT02675231|65380443|FG002|Overall Study|On study treatment/follow up|23|||
23633638|NCT01465763|66045408|FG001|Overall Study|Insufficient Clinical Response|0|||
23633639|NCT01465763|66045409|FG002|Overall Study|Insufficient Clinical Response|1|||
23833444|NCT03762265|66767947|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
23833445|NCT03762265|66767948|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
23833446|NCT03762265|66767947|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
23833447|NCT03762265|66767948|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
23833448|NCT03762265|66767947|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
23833449|NCT03762265|66767948|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
23833450|NCT03762265|66767947|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
23833451|NCT03762265|66767948|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
23833452|NCT03762265|66767947|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
23833453|NCT03762265|66767948|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
23833454|NCT03762265|66767947|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
23447443|NCT00988884|65380444|FG000|Overall Study|Adverse Event|0|||
23447444|NCT00988884|65380445|FG001|Overall Study|Adverse Event|1|||
23447445|NCT00988884|65380444|FG000|Overall Study|Lost to Follow-up|20|||
23447446|NCT00988884|65380445|FG001|Overall Study|Lost to Follow-up|16|||
23447447|NCT00988884|65380444|FG000|Overall Study|Protocol Violation|0|||
23447448|NCT00988884|65380445|FG001|Overall Study|Protocol Violation|1|||
23447449|NCT00988884|65380444|FG000|Overall Study|Withdrawal by Subject|15|||
23447450|NCT00988884|65380445|FG001|Overall Study|Withdrawal by Subject|18|||
23447451|NCT03244917|65380446|FG000|Overall Study|Lost to Follow-up|2|||
23447452|NCT03244917|65380447|FG001|Overall Study|Lost to Follow-up|2|||
23447453|NCT00684996|65380448|FG000|Overall Study|Adverse Event|1|||
23447454|NCT00684996|65380448|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23447455|NCT00684996|65380448|FG000|Overall Study|Progression/relapse|2|||
23447456|NCT00684996|65380448|FG000|Overall Study|Other reasons not protocol specified|1|||
23447457|NCT00700713|65380449|FG000|Overall Study|Protocol Violation|1|||
23447458|NCT00700713|65380450|FG001|Overall Study|Protocol Violation|0|||
23447459|NCT00700713|65380451|FG002|Overall Study|Protocol Violation|1|||
23447460|NCT00700713|65380449|FG000|Overall Study|Withdrawal by Subject|0|||
23447461|NCT00700713|65380450|FG001|Overall Study|Withdrawal by Subject|0|||
23447462|NCT00700713|65380451|FG002|Overall Study|Withdrawal by Subject|1|||
23575164|NCT01010217|65835543|FG002|Overall Study|Lost to Follow-up|1|||
23833455|NCT03762265|66767948|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
23833456|NCT03762265|66767947|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
23833457|NCT03762265|66767948|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
23833458|NCT03762265|66767947|FG000|LTE Period: Weeks 61 to 109|Other|1|||
23833459|NCT03762265|66767948|FG001|LTE Period: Weeks 61 to 109|Other|0|||
23833460|NCT03442751|66770703|FG000|Overall Study|Withdrawal by Subject|3|||
23447463|NCT01859923|65380454|FG000|Overall Study|Adverse Event|0|||
23447464|NCT01859923|65380455|FG001|Overall Study|Adverse Event|0|||
23447465|NCT01859923|65380456|FG002|Overall Study|Adverse Event|1|||
23575165|NCT01010217|65835544|FG003|Overall Study|Lost to Follow-up|0|||
23575166|NCT01010217|65835545|FG004|Overall Study|Lost to Follow-up|0|||
23575167|NCT01010217|65835541|FG000|Overall Study|Withdrawal by Subject|1|||
23575168|NCT01010217|65835542|FG001|Overall Study|Withdrawal by Subject|0|||
23575169|NCT01010217|65835543|FG002|Overall Study|Withdrawal by Subject|0|||
23575170|NCT01010217|65835544|FG003|Overall Study|Withdrawal by Subject|0|||
23575171|NCT01010217|65835545|FG004|Overall Study|Withdrawal by Subject|0|||
23575172|NCT01010217|65835541|FG000|Overall Study|Physician Decision|0|||
23833461|NCT03442751|66770704|FG001|Overall Study|Withdrawal by Subject|1|||
23833462|NCT03442751|66770703|FG000|Overall Study|Lost to Follow-up|3|||
23833463|NCT03442751|66770704|FG001|Overall Study|Lost to Follow-up|0|||
23833464|NCT04231825|66770705|FG000|Overall Study|Protocol Violation|3|||
23575173|NCT01010217|65835542|FG001|Overall Study|Physician Decision|0|||
23575174|NCT01010217|65835543|FG002|Overall Study|Physician Decision|0|||
23575175|NCT01010217|65835544|FG003|Overall Study|Physician Decision|6|||
23575176|NCT01010217|65835545|FG004|Overall Study|Physician Decision|3|||
23575177|NCT03330119|65835547|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
23575178|NCT03330119|65835548|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
23575179|NCT02040090|65835551|FG000|Overall Study|Adverse Event|2|||
23575180|NCT02040090|65835552|FG001|Overall Study|Adverse Event|0|||
23575181|NCT02040090|65835551|FG000|Overall Study|Physician Decision|1|||
23575182|NCT02040090|65835552|FG001|Overall Study|Physician Decision|0|||
23575183|NCT02040090|65835551|FG000|Overall Study|Withdrawal by Subject|0|||
23575184|NCT02040090|65835552|FG001|Overall Study|Withdrawal by Subject|1|||
23575185|NCT02040090|65835551|FG000|Overall Study|Lost to Follow-up|0|||
23575186|NCT02040090|65835552|FG001|Overall Study|Lost to Follow-up|1|||
23575187|NCT00479674|65835556|FG000|Overall Study|Adverse Event|18|||
23575188|NCT00479674|65835556|FG000|Overall Study|Withdrawal by Subject|6|||
23575189|NCT00479674|65835556|FG000|Overall Study|Physician Decision|14|||
23575190|NCT00479674|65835556|FG000|Overall Study|none provided|3|||
23575191|NCT03023332|65835559|FG000|Overall Study|Withdrawal by Subject|10|||
23575192|NCT03023332|65835560|FG001|Overall Study|Withdrawal by Subject|5|||
23575193|NCT03023332|65835561|FG002|Overall Study|Withdrawal by Subject|4|||
23575194|NCT03023332|65835562|FG003|Overall Study|Withdrawal by Subject|7|||
23575195|NCT03023332|65835559|FG000|Overall Study|Lost to Follow-up|13|||
23575196|NCT03023332|65835560|FG001|Overall Study|Lost to Follow-up|16|||
23575197|NCT03023332|65835561|FG002|Overall Study|Lost to Follow-up|8|||
23575198|NCT03023332|65835562|FG003|Overall Study|Lost to Follow-up|13|||
23575199|NCT03023332|65835559|FG000|Overall Study|Death|1|||
23575200|NCT03023332|65835560|FG001|Overall Study|Death|0|||
23575201|NCT03023332|65835561|FG002|Overall Study|Death|0|||
23575202|NCT03023332|65835562|FG003|Overall Study|Death|0|||
23575203|NCT01723826|65835565|FG000|Overall Study|Adverse Event|4|||
23575204|NCT01723826|65835566|FG001|Overall Study|Adverse Event|1|||
23575205|NCT01723826|65835567|FG002|Overall Study|Adverse Event|4|||
23575206|NCT01723826|65835568|FG003|Overall Study|Adverse Event|5|||
23833465|NCT04231825|66770706|FG001|Overall Study|Protocol Violation|3|||
23833466|NCT04231825|66770705|FG000|Overall Study|Lost to Follow-up|0|||
23833467|NCT04231825|66770706|FG001|Overall Study|Lost to Follow-up|1|||
23833468|NCT01173523|66770707|FG000|Overall Study|Clinical Progression|1|||
23575207|NCT01723826|65835565|FG000|Overall Study|Death according to AE eCRF|2|||
23575208|NCT01723826|65835566|FG001|Overall Study|Death according to AE eCRF|3|||
23575209|NCT01723826|65835567|FG002|Overall Study|Death according to AE eCRF|3|||
23575210|NCT01723826|65835568|FG003|Overall Study|Death according to AE eCRF|7|||
23575211|NCT01723826|65835565|FG000|Overall Study|Lost to Follow-up|1|||
23575212|NCT01723826|65835566|FG001|Overall Study|Lost to Follow-up|3|||
23833469|NCT01173523|66770708|FG001|Overall Study|Clinical Progression|1|||
23833470|NCT01173523|66770707|FG000|Overall Study|Progressive Disease|10|||
23833471|NCT01173523|66770708|FG001|Overall Study|Progressive Disease|8|||
23833472|NCT01173523|66770707|FG000|Overall Study|Other|2|||
23833473|NCT01173523|66770708|FG001|Overall Study|Other|3|||
23833474|NCT01408303|66770709|FG000|Overall Study|Adverse Event|3|||
23833475|NCT01408303|66770710|FG001|Overall Study|Adverse Event|7|||
23833476|NCT01408303|66770711|FG002|Overall Study|Adverse Event|2|||
23447466|NCT01859923|65380457|FG003|Overall Study|Adverse Event|1|||
23575213|NCT01723826|65835567|FG002|Overall Study|Lost to Follow-up|1|||
23575214|NCT01723826|65835568|FG003|Overall Study|Lost to Follow-up|1|||
23633640|NCT01465763|66045407|FG000|Overall Study|Adverse Event|9|||
23633641|NCT01465763|66045408|FG001|Overall Study|Adverse Event|0|||
23575215|NCT01723826|65835565|FG000|Overall Study|Non-compliance|0|||
23575216|NCT01723826|65835566|FG001|Overall Study|Non-compliance|1|||
23633642|NCT01465763|66045409|FG002|Overall Study|Adverse Event|1|||
23833477|NCT01408303|66770709|FG000|Overall Study|Lost to Follow-up|0|||
23833478|NCT01408303|66770710|FG001|Overall Study|Lost to Follow-up|1|||
23833479|NCT01408303|66770711|FG002|Overall Study|Lost to Follow-up|2|||
23833480|NCT01408303|66770709|FG000|Overall Study|Withdrawal by Subject|2|||
23833481|NCT01408303|66770710|FG001|Overall Study|Withdrawal by Subject|3|||
23833482|NCT01408303|66770711|FG002|Overall Study|Withdrawal by Subject|1|||
23575217|NCT01723826|65835567|FG002|Overall Study|Non-compliance|3|||
23575218|NCT01723826|65835568|FG003|Overall Study|Non-compliance|3|||
23575219|NCT01723826|65835565|FG000|Overall Study|Non-compliance With Study Drug|0|||
23575220|NCT01723826|65835566|FG001|Overall Study|Non-compliance With Study Drug|1|||
23575221|NCT01723826|65835567|FG002|Overall Study|Non-compliance With Study Drug|0|||
23575222|NCT01723826|65835568|FG003|Overall Study|Non-compliance With Study Drug|0|||
23575223|NCT01723826|65835565|FG000|Overall Study|Other Reason|8|||
23772993|NCT00162123|66546719|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
23772994|NCT03213210|66546720|FG000|Overall Study|Lost to Follow-up|2|||
23772995|NCT03213210|66546720|FG000|Overall Study|Study termination|3|||
23772996|NCT00662025|66549946|FG000|Overall Study|Objective progression or relapse|51|||
23772997|NCT00662025|66549946|FG000|Overall Study|Adverse Event|7|||
23772998|NCT00662025|66549946|FG000|Overall Study|Withdrawal by Subject|1|||
23772999|NCT00662025|66549946|FG000|Overall Study|Results of other clinical study|2|||
23773000|NCT00662025|66549946|FG000|Overall Study|Target lesion cannot be evaluated|1|||
23773001|NCT00662025|66549946|FG000|Overall Study|Domestic circumstances|1|||
23773002|NCT01494506|66549947|FG000|Overall Study|Lack of Efficacy|77|||
23773003|NCT01494506|66549948|FG001|Overall Study|Lack of Efficacy|83|||
23773004|NCT01494506|66549949|FG002|Overall Study|Lack of Efficacy|57|||
23773005|NCT01494506|66549947|FG000|Overall Study|Adverse Event|17|||
23447467|NCT04317040|65380461|FG000|Overall Study|Lost to Follow-up|2|||
23447468|NCT04317040|65380462|FG001|Overall Study|Lost to Follow-up|0|||
23575224|NCT01723826|65835566|FG001|Overall Study|Other Reason|6|||
23575225|NCT01723826|65835567|FG002|Overall Study|Other Reason|12|||
23575226|NCT01723826|65835568|FG003|Overall Study|Other Reason|14|||
23575227|NCT01723826|65835565|FG000|Overall Study|Physician Decision|1|||
23575228|NCT01723826|65835566|FG001|Overall Study|Physician Decision|3|||
23575229|NCT01723826|65835567|FG002|Overall Study|Physician Decision|4|||
23833483|NCT01408303|66770709|FG000|Overall Study|Protocol Violation|0|||
23833484|NCT01408303|66770710|FG001|Overall Study|Protocol Violation|1|||
23833485|NCT01408303|66770711|FG002|Overall Study|Protocol Violation|0|||
23833486|NCT01408303|66770709|FG000|Overall Study|Noncompliance|1|||
23833487|NCT01408303|66770710|FG001|Overall Study|Noncompliance|0|||
23575230|NCT01723826|65835568|FG003|Overall Study|Physician Decision|11|||
23575231|NCT01723826|65835565|FG000|Overall Study|Protocol Violation|1|||
23575232|NCT01723826|65835566|FG001|Overall Study|Protocol Violation|1|||
23575233|NCT01723826|65835567|FG002|Overall Study|Protocol Violation|3|||
23575234|NCT01723826|65835568|FG003|Overall Study|Protocol Violation|1|||
23575235|NCT01723826|65835565|FG000|Overall Study|Withdrawal by Subject|10|||
23575236|NCT01723826|65835566|FG001|Overall Study|Withdrawal by Subject|17|||
23633643|NCT01465763|66045407|FG000|Overall Study|Other|2|||
23833488|NCT01408303|66770711|FG002|Overall Study|Noncompliance|1|||
23833489|NCT03187301|66770712|FG000|Titration Period|Adverse Event|0|||
23575237|NCT01723826|65835567|FG002|Overall Study|Withdrawal by Subject|27|||
23773006|NCT01494506|66549948|FG001|Overall Study|Adverse Event|10|||
23833490|NCT03187301|66770713|FG001|Titration Period|Adverse Event|0|||
23447469|NCT04317040|65380461|FG000|Overall Study|Death|16|||
23773007|NCT01494506|66549949|FG002|Overall Study|Adverse Event|11|||
23773008|NCT01494506|66549947|FG000|Overall Study|Death|9|||
23773009|NCT01494506|66549948|FG001|Overall Study|Death|5|||
23833491|NCT03187301|66770714|FG002|Titration Period|Adverse Event|0|||
23833492|NCT03187301|66770715|FG003|Titration Period|Adverse Event|0|||
23575238|NCT01723826|65835568|FG003|Overall Study|Withdrawal by Subject|48|||
23575239|NCT02091869|65835571|FG000|Overall Study|Withdrawal by Subject|0|||
23575240|NCT02091869|65835572|FG001|Overall Study|Withdrawal by Subject|3|||
23575241|NCT03268590|65835575|FG000|Overall Study|Previously unknown exclusion criteria|1|||
23575242|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
23575243|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
23575244|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
23575245|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
23575246|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
23575247|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
23575248|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
23575249|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
23575250|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
23575251|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
23575252|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
23575253|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
23575254|NCT01237678|65835576|FG000|Phase II|Adverse Event|0|||
23575255|NCT01237678|65835577|FG001|Phase II|Adverse Event|39|||
23575256|NCT01237678|65835578|FG002|Phase II|Adverse Event|9|||
23575257|NCT01237678|65835576|FG000|Phase II|Death|0|||
23575258|NCT01237678|65835577|FG001|Phase II|Death|0|||
23575259|NCT01237678|65835578|FG002|Phase II|Death|2|||
23575260|NCT01237678|65835576|FG000|Phase II|Lack of Efficacy|0|||
23575261|NCT01237678|65835577|FG001|Phase II|Lack of Efficacy|25|||
23575262|NCT01237678|65835578|FG002|Phase II|Lack of Efficacy|3|||
23575263|NCT01237678|65835576|FG000|Phase II|Withdrawal by Subject|0|||
23575264|NCT01237678|65835577|FG001|Phase II|Withdrawal by Subject|1|||
23575265|NCT01237678|65835578|FG002|Phase II|Withdrawal by Subject|5|||
23575266|NCT01237678|65835576|FG000|Phase II|Completed Cycles 4-6|0|||
23575267|NCT01237678|65835577|FG001|Phase II|Completed Cycles 4-6|11|||
23575268|NCT01237678|65835578|FG002|Phase II|Completed Cycles 4-6|21|||
23575269|NCT01237678|65835576|FG000|Phase II|Sponsor Decision/Study Closed|0|||
23575270|NCT01237678|65835577|FG001|Phase II|Sponsor Decision/Study Closed|18|||
23575271|NCT01237678|65835578|FG002|Phase II|Sponsor Decision/Study Closed|7|||
23575272|NCT01237678|65835576|FG000|Phase II|Randomized but were not treated|0|||
23575273|NCT01237678|65835577|FG001|Phase II|Randomized but were not treated|4|||
23575274|NCT01237678|65835578|FG002|Phase II|Randomized but were not treated|3|||
23575275|NCT03615482|65835586|FG000|Overall Study|Death|1|||
23575276|NCT03615482|65835587|FG001|Overall Study|Death|0|||
23575277|NCT03615482|65835586|FG000|Overall Study|Lost to Follow-up|7|||
23575278|NCT03615482|65835587|FG001|Overall Study|Lost to Follow-up|7|||
23575279|NCT03615482|65835586|FG000|Overall Study|Physician Decision|2|||
23575280|NCT03615482|65835587|FG001|Overall Study|Physician Decision|3|||
23575281|NCT03615482|65835586|FG000|Overall Study|Withdrawal by Subject|7|||
23575282|NCT03615482|65835587|FG001|Overall Study|Withdrawal by Subject|7|||
23575283|NCT00197028|65835593|FG000|Overall Study|Adverse Event|2|||
23575284|NCT00197028|65835594|FG001|Overall Study|Adverse Event|2|||
23575285|NCT00197028|65835593|FG000|Overall Study|Protocol Violation|2|||
23575286|NCT00197028|65835594|FG001|Overall Study|Protocol Violation|1|||
23575287|NCT00197028|65835593|FG000|Overall Study|Withdrawal by Subject|8|||
23575288|NCT00197028|65835594|FG001|Overall Study|Withdrawal by Subject|12|||
23575289|NCT00197028|65835593|FG000|Overall Study|Lost to Follow-up|1|||
23575290|NCT00197028|65835594|FG001|Overall Study|Lost to Follow-up|0|||
23575291|NCT00197028|65835593|FG000|Overall Study|Other|3|||
23575292|NCT00197028|65835594|FG001|Overall Study|Other|6|||
23575293|NCT01163149|65835597|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
23575294|NCT01163149|65835598|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23575295|NCT01163149|65835599|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
23575296|NCT01163149|65835597|FG000|Extension Treatment Period|Adverse Event|0|||
23575297|NCT01163149|65835598|FG001|Extension Treatment Period|Adverse Event|1|||
23575298|NCT01163149|65835599|FG002|Extension Treatment Period|Adverse Event|0|||
23633644|NCT01465763|66045408|FG001|Overall Study|Other|0|||
23833493|NCT03187301|66770716|FG004|Titration Period|Adverse Event|0|||
23575299|NCT01163149|65835597|FG000|Extension Treatment Period|Noncompliance|0|||
23575300|NCT01163149|65835598|FG001|Extension Treatment Period|Noncompliance|0|||
23575301|NCT01163149|65835599|FG002|Extension Treatment Period|Noncompliance|1|||
23575302|NCT00007475|65835614|FG000|Overall Study|Withdrawal by Subject|1|||
23575303|NCT00007475|65835615|FG001|Overall Study|Withdrawal by Subject|0|||
23575304|NCT00007475|65835616|FG002|Overall Study|Withdrawal by Subject|0|||
23575305|NCT00007475|65835617|FG003|Overall Study|Withdrawal by Subject|0|||
23575306|NCT00007475|65835614|FG000|Overall Study|Adverse Event|3|||
23575307|NCT00007475|65835615|FG001|Overall Study|Adverse Event|0|||
23575308|NCT00007475|65835616|FG002|Overall Study|Adverse Event|0|||
23633645|NCT01465763|66045409|FG002|Overall Study|Other|0|||
23575309|NCT00007475|65835617|FG003|Overall Study|Adverse Event|0|||
23575310|NCT01619787|65835618|FG000|Overall Study|Lost to Follow-up|5|||
23575311|NCT00619476|65835619|FG000|Overall Study|Adverse Event|12|||
23575312|NCT00619476|65835620|FG001|Overall Study|Adverse Event|6|||
23575313|NCT00619476|65835621|FG002|Overall Study|Adverse Event|12|||
23575314|NCT00619476|65835622|FG003|Overall Study|Adverse Event|16|||
23575315|NCT00619476|65835619|FG000|Overall Study|Lack of Efficacy|6|||
23575316|NCT00619476|65835620|FG001|Overall Study|Lack of Efficacy|1|||
23575317|NCT00619476|65835621|FG002|Overall Study|Lack of Efficacy|1|||
23575318|NCT00619476|65835622|FG003|Overall Study|Lack of Efficacy|4|||
23575319|NCT00619476|65835619|FG000|Overall Study|Protocol Violation|5|||
23575320|NCT00619476|65835620|FG001|Overall Study|Protocol Violation|4|||
23575321|NCT00619476|65835621|FG002|Overall Study|Protocol Violation|4|||
23575322|NCT00619476|65835622|FG003|Overall Study|Protocol Violation|9|||
23575323|NCT00619476|65835619|FG000|Overall Study|Lost to Follow-up|1|||
23575324|NCT00619476|65835620|FG001|Overall Study|Lost to Follow-up|2|||
23575325|NCT00619476|65835621|FG002|Overall Study|Lost to Follow-up|0|||
23575326|NCT00619476|65835622|FG003|Overall Study|Lost to Follow-up|1|||
23575327|NCT00619476|65835619|FG000|Overall Study|Investigator Discretion|2|||
23575328|NCT00619476|65835620|FG001|Overall Study|Investigator Discretion|2|||
23575329|NCT00619476|65835621|FG002|Overall Study|Investigator Discretion|2|||
23575330|NCT00619476|65835622|FG003|Overall Study|Investigator Discretion|0|||
23575331|NCT00619476|65835619|FG000|Overall Study|Withdrawal by Subject|5|||
23575332|NCT00619476|65835620|FG001|Overall Study|Withdrawal by Subject|7|||
23575333|NCT00619476|65835621|FG002|Overall Study|Withdrawal by Subject|5|||
23575334|NCT00619476|65835622|FG003|Overall Study|Withdrawal by Subject|4|||
23575335|NCT00742885|65835623|FG000|Overall Study|Lost to Follow-up|1|||
23773010|NCT01494506|66549949|FG002|Overall Study|Death|2|||
23773011|NCT01494506|66549947|FG000|Overall Study|Physician Decision|7|||
23773012|NCT01494506|66549948|FG001|Overall Study|Physician Decision|5|||
23773013|NCT01494506|66549949|FG002|Overall Study|Physician Decision|4|||
23773014|NCT01494506|66549947|FG000|Overall Study|Withdrawal by Subject|17|||
23773015|NCT01494506|66549948|FG001|Overall Study|Withdrawal by Subject|20|||
23773016|NCT01494506|66549949|FG002|Overall Study|Withdrawal by Subject|14|||
23773017|NCT01494506|66549947|FG000|Overall Study|Clinical Deterioration|21|||
23773018|NCT01494506|66549948|FG001|Overall Study|Clinical Deterioration|17|||
23773019|NCT01494506|66549949|FG002|Overall Study|Clinical Deterioration|13|||
23773020|NCT01494506|66549947|FG000|Overall Study|Sponsor Decision|0|||
23773021|NCT01494506|66549948|FG001|Overall Study|Sponsor Decision|0|||
23773022|NCT01494506|66549949|FG002|Overall Study|Sponsor Decision|1|||
23773023|NCT01494506|66549947|FG000|Overall Study|Other|0|||
23773024|NCT01494506|66549948|FG001|Overall Study|Other|3|||
23773025|NCT01494506|66549949|FG002|Overall Study|Other|1|||
23773026|NCT04625114|66549950|FG000|Overall Study|Adverse Event|3|||
23773027|NCT04625114|66549951|FG001|Overall Study|Adverse Event|1|||
23773028|NCT04625114|66549950|FG000|Overall Study|Withdrawal by Subject|2|||
23773029|NCT04625114|66549951|FG001|Overall Study|Withdrawal by Subject|0|||
23773030|NCT00408902|66549954|FG000|Overall Study|Lack of Efficacy|7|||
23773031|NCT00408902|66549954|FG000|Overall Study|Adverse Event|3|||
23773032|NCT02372409|66549955|FG000|Overall Study|Lost to Follow-up|1|||
23773033|NCT02372409|66549956|FG001|Overall Study|Lost to Follow-up|0|||
23773034|NCT02372409|66549955|FG000|Overall Study|Disease progression|1|||
23773035|NCT02372409|66549956|FG001|Overall Study|Disease progression|1|||
23773036|NCT00560235|66549957|FG000|Phase 1|Discontinued|8|||
23773037|NCT00560235|66549958|FG001|Phase 1|Discontinued|0|||
23773038|NCT00560235|66549959|FG002|Phase 1|Discontinued|0|||
23773039|NCT00560235|66549957|FG000|Phase 1B|Discontinued|0|||
23773040|NCT00560235|66549958|FG001|Phase 1B|Discontinued|19|||
23773041|NCT00560235|66549959|FG002|Phase 1B|Discontinued|0|||
23773042|NCT00560235|66549957|FG000|Phase 2|Discontinued|0|||
23773043|NCT00560235|66549958|FG001|Phase 2|Discontinued|0|||
23773044|NCT00560235|66549959|FG002|Phase 2|Discontinued|96|||
23773045|NCT00560235|66549957|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
23833494|NCT03187301|66770717|FG005|Titration Period|Adverse Event|0|||
23575336|NCT00742885|65835624|FG001|Overall Study|Lost to Follow-up|0|||
23575337|NCT03293485|65835627|FG000|Overall Study|Death|1|||
23575338|NCT03293485|65835627|FG000|Overall Study|Screen Failure|2|||
23575339|NCT03293485|65835627|FG000|Overall Study|Withdrawal by Subject|2|||
23575340|NCT01349829|65835628|FG000|Overall Study|Lost to Follow-up|4|||
23575341|NCT01349829|65835629|FG001|Overall Study|Lost to Follow-up|8|||
23773046|NCT00560235|66549958|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
23773047|NCT00560235|66549959|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
23773048|NCT00436007|66549960|FG000|Overall Study|Withdrawal by Subject|5|||
23773049|NCT00436007|66549961|FG001|Overall Study|Withdrawal by Subject|3|||
23773050|NCT00436007|66549962|FG002|Overall Study|Withdrawal by Subject|4|||
23773051|NCT00436007|66549960|FG000|Overall Study|Lost to Follow-up|14|||
23773052|NCT00436007|66549961|FG001|Overall Study|Lost to Follow-up|10|||
23773053|NCT00436007|66549962|FG002|Overall Study|Lost to Follow-up|13|||
23773054|NCT00436007|66549960|FG000|Overall Study|Physician Decision|0|||
23773055|NCT00436007|66549961|FG001|Overall Study|Physician Decision|0|||
23575342|NCT01349829|65835628|FG000|Overall Study|Consent withdrawal|3|||
23575343|NCT01349829|65835629|FG001|Overall Study|Consent withdrawal|8|||
23575344|NCT01349829|65835628|FG000|Overall Study|Migrated/moved|2|||
23575345|NCT01349829|65835629|FG001|Overall Study|Migrated/moved|7|||
23575346|NCT02839681|65835630|FG000|Overall Study|Death|2|||
23575347|NCT05124899|65835631|FG000|Overall Study|Lost to Follow-up|3|||
23575348|NCT03369951|65838710|FG000|Overall Study|Withdrawal by Subject|3|||
23575349|NCT03369951|65838710|FG000|Overall Study|Death|1|||
23575350|NCT03369951|65838710|FG000|Overall Study|Lost to Follow-up|1|||
23575351|NCT03369951|65838710|FG000|Overall Study|Protocol Violation|1|||
23575352|NCT00683449|65838711|FG000|Overall Study|Lost to Follow-up|0|||
23575353|NCT00683449|65838712|FG001|Overall Study|Lost to Follow-up|1|||
23575354|NCT00683449|65838713|FG002|Overall Study|Lost to Follow-up|0|||
23575355|NCT00683449|65838714|FG003|Overall Study|Lost to Follow-up|0|||
23575356|NCT00683449|65838715|FG004|Overall Study|Lost to Follow-up|0|||
23575357|NCT00062868|65838716|FG000|Dose Level 1|Death|2|||
23575358|NCT00062868|65838717|FG001|Dose Level 1|Death|0|||
23633646|NCT01465763|66045407|FG000|Overall Study|Protocol Violation|4|||
23633647|NCT01465763|66045408|FG001|Overall Study|Protocol Violation|1|||
23833495|NCT03187301|66770718|FG006|Titration Period|Adverse Event|5|||
23833496|NCT03187301|66770712|FG000|Titration Period|Withdrawal by Subject|0|||
23833497|NCT03187301|66770713|FG001|Titration Period|Withdrawal by Subject|0|||
23833498|NCT03187301|66770714|FG002|Titration Period|Withdrawal by Subject|0|||
23833499|NCT03187301|66770715|FG003|Titration Period|Withdrawal by Subject|0|||
23833500|NCT03187301|66770716|FG004|Titration Period|Withdrawal by Subject|0|||
23833501|NCT03187301|66770717|FG005|Titration Period|Withdrawal by Subject|0|||
23833502|NCT03187301|66770718|FG006|Titration Period|Withdrawal by Subject|1|||
23833503|NCT03187301|66770712|FG000|Titration Period|Exclusion Criteria Met|0|||
23833504|NCT03187301|66770713|FG001|Titration Period|Exclusion Criteria Met|0|||
23833505|NCT03187301|66770714|FG002|Titration Period|Exclusion Criteria Met|0|||
23833506|NCT03187301|66770715|FG003|Titration Period|Exclusion Criteria Met|0|||
23833507|NCT03187301|66770716|FG004|Titration Period|Exclusion Criteria Met|0|||
23833508|NCT03187301|66770717|FG005|Titration Period|Exclusion Criteria Met|0|||
23833509|NCT03187301|66770718|FG006|Titration Period|Exclusion Criteria Met|1|||
23833510|NCT03187301|66770712|FG000|Pre-Intervention|Withdrawal by Subject|1|||
23833511|NCT03187301|66770713|FG001|Pre-Intervention|Withdrawal by Subject|0|||
23833512|NCT03187301|66770714|FG002|Pre-Intervention|Withdrawal by Subject|0|||
23833513|NCT03187301|66770715|FG003|Pre-Intervention|Withdrawal by Subject|0|||
23833514|NCT03187301|66770716|FG004|Pre-Intervention|Withdrawal by Subject|0|||
23833515|NCT03187301|66770717|FG005|Pre-Intervention|Withdrawal by Subject|0|||
23833516|NCT03187301|66770718|FG006|Pre-Intervention|Withdrawal by Subject|0|||
23833517|NCT00455403|66770719|FG000|Overall Study|Lost to Follow-up|2|||
23833518|NCT00455403|66770720|FG001|Overall Study|Lost to Follow-up|1|||
23833519|NCT00455403|66770719|FG000|Overall Study|Withdrawal by Subject|1|||
23833520|NCT00455403|66770720|FG001|Overall Study|Withdrawal by Subject|3|||
23833521|NCT00455403|66770719|FG000|Overall Study|Protocol Violation|0|||
23833522|NCT00455403|66770720|FG001|Overall Study|Protocol Violation|2|||
23833523|NCT01164579|66770725|FG000|Overall Study|Lack of Efficacy|0|||
23833524|NCT01164579|66770726|FG001|Overall Study|Lack of Efficacy|0|||
23833525|NCT01164579|66770727|FG002|Overall Study|Lack of Efficacy|6|||
23833526|NCT01164579|66770725|FG000|Overall Study|Lost to Follow-up|1|||
23833527|NCT01164579|66770726|FG001|Overall Study|Lost to Follow-up|1|||
23833528|NCT01164579|66770727|FG002|Overall Study|Lost to Follow-up|0|||
23833529|NCT01164579|66770725|FG000|Overall Study|Withdrawal by Subject|2|||
23833530|NCT01164579|66770726|FG001|Overall Study|Withdrawal by Subject|5|||
23833531|NCT01164579|66770727|FG002|Overall Study|Withdrawal by Subject|3|||
23833532|NCT01164579|66770725|FG000|Overall Study|Protocol Violation|0|||
23833533|NCT01164579|66770726|FG001|Overall Study|Protocol Violation|1|||
23833534|NCT01164579|66770727|FG002|Overall Study|Protocol Violation|2|||
23833535|NCT01164579|66770725|FG000|Overall Study|Adverse Event|4|||
23833536|NCT01164579|66770726|FG001|Overall Study|Adverse Event|2|||
23833537|NCT01164579|66770727|FG002|Overall Study|Adverse Event|5|||
23833538|NCT01164579|66770725|FG000|Overall Study|Reason not specified|1|||
23833539|NCT01164579|66770726|FG001|Overall Study|Reason not specified|0|||
23833540|NCT01164579|66770727|FG002|Overall Study|Reason not specified|0|||
23833541|NCT02362360|66770734|FG000|Period 1|Lack of Efficacy|1|||
23833542|NCT02362360|66770735|FG001|Period 1|Lack of Efficacy|0|||
23833543|NCT02362360|66770734|FG000|Period 1|Withdrawal by Subject|2|||
23447470|NCT04317040|65380462|FG001|Overall Study|Death|18|||
23575359|NCT00062868|65838718|FG002|Dose Level 1|Death|0|||
23833544|NCT02362360|66770735|FG001|Period 1|Withdrawal by Subject|1|||
23575360|NCT00062868|65838719|FG003|Dose Level 1|Death|2|||
23575361|NCT00062868|65838720|FG004|Dose Level 1|Death|0|||
23833545|NCT01420068|66770739|FG000|Overall Study|Administrative problems|1|||
23833546|NCT01420068|66770740|FG001|Overall Study|Administrative problems|3|||
23575362|NCT00062868|65838721|FG005|Dose Level 1|Death|0|||
23575363|NCT00062868|65838722|FG006|Dose Level 1|Death|3|||
23575364|NCT00062868|65838723|FG007|Dose Level 1|Death|0|||
23833547|NCT01420068|66770739|FG000|Overall Study|Withdrawal by Subject|1|||
23833548|NCT01420068|66770740|FG001|Overall Study|Withdrawal by Subject|2|||
23575365|NCT00062868|65838724|FG008|Dose Level 1|Death|0|||
23575366|NCT00062868|65838725|FG009|Dose Level 1|Death|0|||
23575367|NCT00062868|65838726|FG010|Dose Level 1|Death|0|||
23575368|NCT00062868|65838727|FG011|Dose Level 1|Death|0|||
23575369|NCT00062868|65838728|FG012|Dose Level 1|Death|0|||
23575370|NCT00062868|65838729|FG013|Dose Level 1|Death|0|||
23575371|NCT00062868|65838730|FG014|Dose Level 1|Death|0|||
23575372|NCT00062868|65838731|FG015|Dose Level 1|Death|0|||
23575373|NCT00062868|65838732|FG016|Dose Level 1|Death|0|||
23575374|NCT00062868|65838733|FG017|Dose Level 1|Death|0|||
23575375|NCT00062868|65838734|FG018|Dose Level 1|Death|7|||
23773056|NCT00436007|66549962|FG002|Overall Study|Physician Decision|2|||
23575376|NCT00062868|65838735|FG019|Dose Level 1|Death|0|||
23575377|NCT00062868|65838736|FG020|Dose Level 1|Death|1|||
23575378|NCT00062868|65838716|FG000|Dose Level 1|Lost to Follow-up|0|||
23575379|NCT00062868|65838717|FG001|Dose Level 1|Lost to Follow-up|0|||
23773057|NCT00436007|66549960|FG000|Overall Study|Death|0|||
23575380|NCT00062868|65838718|FG002|Dose Level 1|Lost to Follow-up|0|||
23575381|NCT00062868|65838719|FG003|Dose Level 1|Lost to Follow-up|0|||
23575382|NCT00062868|65838720|FG004|Dose Level 1|Lost to Follow-up|0|||
23575383|NCT00062868|65838721|FG005|Dose Level 1|Lost to Follow-up|0|||
23773058|NCT00436007|66549961|FG001|Overall Study|Death|1|||
23773059|NCT00436007|66549962|FG002|Overall Study|Death|3|||
23773060|NCT00436007|66549960|FG000|Overall Study|Other|0|||
23773061|NCT00436007|66549961|FG001|Overall Study|Other|0|||
23773062|NCT00436007|66549962|FG002|Overall Study|Other|1|||
23773063|NCT00760266|66549963|FG000|Overall Study|Adverse Event|13|||
23773064|NCT00760266|66549964|FG001|Overall Study|Adverse Event|7|||
23773065|NCT00760266|66549963|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23833549|NCT00722137|66770743|FG000|Overall Study|Overt Disease Progression|5|||
23833550|NCT00722137|66770744|FG001|Overall Study|Overt Disease Progression|4|||
23575384|NCT00062868|65838722|FG006|Dose Level 1|Lost to Follow-up|0|||
23575385|NCT00062868|65838723|FG007|Dose Level 1|Lost to Follow-up|0|||
23575386|NCT00062868|65838724|FG008|Dose Level 1|Lost to Follow-up|0|||
23575387|NCT00062868|65838725|FG009|Dose Level 1|Lost to Follow-up|0|||
23575388|NCT00062868|65838726|FG010|Dose Level 1|Lost to Follow-up|0|||
23575389|NCT00062868|65838727|FG011|Dose Level 1|Lost to Follow-up|0|||
23575390|NCT00062868|65838728|FG012|Dose Level 1|Lost to Follow-up|1|||
23575391|NCT00062868|65838729|FG013|Dose Level 1|Lost to Follow-up|0|||
23833551|NCT00722137|66770743|FG000|Overall Study|Adverse Event|17|||
23833552|NCT00722137|66770744|FG001|Overall Study|Adverse Event|21|||
23833553|NCT00722137|66770743|FG000|Overall Study|Death|12|||
23833554|NCT00722137|66770744|FG001|Overall Study|Death|7|||
23833555|NCT00722137|66770743|FG000|Overall Study|Withdrawal by Subject|6|||
23575392|NCT00062868|65838730|FG014|Dose Level 1|Lost to Follow-up|0|||
23575393|NCT00062868|65838731|FG015|Dose Level 1|Lost to Follow-up|0|||
23575394|NCT00062868|65838732|FG016|Dose Level 1|Lost to Follow-up|0|||
23575395|NCT00062868|65838733|FG017|Dose Level 1|Lost to Follow-up|0|||
23575396|NCT00062868|65838734|FG018|Dose Level 1|Lost to Follow-up|2|||
23575397|NCT00062868|65838735|FG019|Dose Level 1|Lost to Follow-up|0|||
23575398|NCT00062868|65838736|FG020|Dose Level 1|Lost to Follow-up|1|||
23773066|NCT00760266|66549964|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23773067|NCT00760266|66549963|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23773068|NCT00760266|66549964|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23773069|NCT00760266|66549963|FG000|Overall Study|Lack of Efficacy|2|||
23833556|NCT00722137|66770744|FG001|Overall Study|Withdrawal by Subject|9|||
23833557|NCT00722137|66770743|FG000|Overall Study|Other Reason Unknown|3|||
23833558|NCT00722137|66770744|FG001|Overall Study|Other Reason Unknown|4|||
23833559|NCT00722137|66770743|FG000|Overall Study|Randomized But Not Treated|2|||
23833560|NCT00722137|66770744|FG001|Overall Study|Randomized But Not Treated|3|||
23833561|NCT00314340|66770745|FG000|Overall Study|lost interest|1|||
23833562|NCT01562782|66770746|FG000|Overall Study|Withdrawal by Subject|3|||
23833563|NCT01562782|66770747|FG001|Overall Study|Withdrawal by Subject|3|||
23833564|NCT01562782|66770746|FG000|Overall Study|screen failure|1|||
23833565|NCT01562782|66770747|FG001|Overall Study|screen failure|2|||
23833566|NCT01167140|66770749|FG000|Overall Study|Withdrawal by Subject|1|||
23833567|NCT03817853|66770750|FG000|Induction Phase|Adverse Event|5|||
23833568|NCT03817853|66770751|FG001|Induction Phase|Adverse Event|0|||
23833569|NCT03817853|66770752|FG002|Induction Phase|Adverse Event|0|||
23833570|NCT03817853|66770750|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
23833571|NCT03817853|66770751|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
23833572|NCT03817853|66770752|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
23833573|NCT03817853|66770750|FG000|Induction Phase|Physician Decision|2|||
23833574|NCT03817853|66770751|FG001|Induction Phase|Physician Decision|0|||
23833575|NCT03817853|66770752|FG002|Induction Phase|Physician Decision|0|||
23833576|NCT03817853|66770750|FG000|Induction Phase|Progressive Disease|6|||
23833577|NCT03817853|66770751|FG001|Induction Phase|Progressive Disease|0|||
23833578|NCT03817853|66770752|FG002|Induction Phase|Progressive Disease|0|||
23833579|NCT03817853|66770750|FG000|Induction Phase|Withdrawal by Subject|4|||
23833580|NCT03817853|66770751|FG001|Induction Phase|Withdrawal by Subject|0|||
23833581|NCT03817853|66770752|FG002|Induction Phase|Withdrawal by Subject|0|||
23833582|NCT03817853|66770750|FG000|Maintenance Phase|Adverse Event|0|||
23833583|NCT03817853|66770751|FG001|Maintenance Phase|Adverse Event|8|||
23833584|NCT03817853|66770752|FG002|Maintenance Phase|Adverse Event|0|||
23773070|NCT00760266|66549964|FG001|Overall Study|Lack of Efficacy|2|||
23773071|NCT00760266|66549963|FG000|Overall Study|Protocol deviation|2|||
23773072|NCT00760266|66549964|FG001|Overall Study|Protocol deviation|4|||
23575399|NCT00062868|65838716|FG000|Dose Level 2|Death|0|||
23773073|NCT00760266|66549963|FG000|Overall Study|Patient withdrew consent|3|||
23833585|NCT03817853|66770750|FG000|Maintenance Phase|Death|0|||
23833586|NCT03817853|66770751|FG001|Maintenance Phase|Death|5|||
23833587|NCT03817853|66770752|FG002|Maintenance Phase|Death|0|||
23833588|NCT03817853|66770750|FG000|Maintenance Phase|Progressive Disease|0|||
23833589|NCT03817853|66770751|FG001|Maintenance Phase|Progressive Disease|7|||
23575400|NCT00062868|65838717|FG001|Dose Level 2|Death|3|||
23575401|NCT00062868|65838718|FG002|Dose Level 2|Death|0|||
23575402|NCT00062868|65838719|FG003|Dose Level 2|Death|0|||
23575403|NCT00062868|65838720|FG004|Dose Level 2|Death|2|||
23833590|NCT03817853|66770752|FG002|Maintenance Phase|Progressive Disease|0|||
23833591|NCT03817853|66770750|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23833592|NCT03817853|66770751|FG001|Maintenance Phase|Withdrawal by Subject|2|||
23833593|NCT03817853|66770752|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23833594|NCT03817853|66770750|FG000|Maintenance Phase|Physician Decision|0|||
23833595|NCT03817853|66770751|FG001|Maintenance Phase|Physician Decision|1|||
23833596|NCT03817853|66770752|FG002|Maintenance Phase|Physician Decision|0|||
23833597|NCT03817853|66770750|FG000|Maintenance Phase|Various reasons|0|||
23833598|NCT03817853|66770751|FG001|Maintenance Phase|Various reasons|4|||
23833599|NCT03817853|66770752|FG002|Maintenance Phase|Various reasons|0|||
23833600|NCT03817853|66770750|FG000|Maintenance Phase|Protocol Deviation|0|||
23833601|NCT03817853|66770751|FG001|Maintenance Phase|Protocol Deviation|1|||
23833602|NCT03817853|66770752|FG002|Maintenance Phase|Protocol Deviation|0|||
23833603|NCT03817853|66770750|FG000|Follow-up Phase|Adverse Event|0|||
23833604|NCT03817853|66770751|FG001|Follow-up Phase|Adverse Event|0|||
23833605|NCT03817853|66770752|FG002|Follow-up Phase|Adverse Event|2|||
23833606|NCT03817853|66770750|FG000|Follow-up Phase|Death|0|||
23833607|NCT03817853|66770751|FG001|Follow-up Phase|Death|0|||
23833608|NCT03817853|66770752|FG002|Follow-up Phase|Death|1|||
23833609|NCT03817853|66770750|FG000|Follow-up Phase|Progressive Disease|0|||
23833610|NCT03817853|66770751|FG001|Follow-up Phase|Progressive Disease|0|||
23833611|NCT03817853|66770752|FG002|Follow-up Phase|Progressive Disease|3|||
23833612|NCT03817853|66770750|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23833613|NCT03817853|66770751|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23833614|NCT03817853|66770752|FG002|Follow-up Phase|Withdrawal by Subject|1|||
23833615|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
23833616|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
23833617|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
23833618|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
23833619|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
23833620|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
23833621|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
23833622|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
23833623|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
23833624|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
23833625|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
23833626|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
23833627|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23833628|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23833629|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
23833630|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23833631|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
23833632|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
23833633|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
23833634|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
23833635|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
23833636|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
23833637|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
23833638|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
23833639|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
23833640|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
23833641|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
23833642|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
23833643|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
23833644|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
23833645|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
23575404|NCT00062868|65838721|FG005|Dose Level 2|Death|0|||
23833646|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
23833647|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23833648|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
23833649|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23833650|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23833651|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23833652|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23833653|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23833654|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
23833655|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
23833656|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23833657|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23575405|NCT00062868|65838722|FG006|Dose Level 2|Death|0|||
23575406|NCT00062868|65838723|FG007|Dose Level 2|Death|0|||
23773074|NCT00760266|66549964|FG001|Overall Study|Patient withdrew consent|3|||
23773075|NCT00760266|66549963|FG000|Overall Study|Lost to Follow-up|2|||
23773076|NCT00760266|66549964|FG001|Overall Study|Lost to Follow-up|1|||
23773077|NCT00760266|66549963|FG000|Overall Study|Administrative Problems|0|||
23773078|NCT00760266|66549964|FG001|Overall Study|Administrative Problems|1|||
23773079|NCT03553823|66549965|FG000|Overall Study|Physician Decision|0|||
23773080|NCT03553823|66549966|FG001|Overall Study|Physician Decision|1|||
23773081|NCT03049488|66549967|FG000|Overall Study|Lost to Follow-up|1|||
23773082|NCT03049488|66549968|FG001|Overall Study|Lost to Follow-up|1|||
23773083|NCT03049488|66549969|FG002|Overall Study|Lost to Follow-up|0|||
23773084|NCT03049488|66549970|FG003|Overall Study|Lost to Follow-up|0|||
23773085|NCT03049488|66549971|FG004|Overall Study|Lost to Follow-up|0|||
23773086|NCT03049488|66549972|FG005|Overall Study|Lost to Follow-up|0|||
23773087|NCT03049488|66549967|FG000|Overall Study|Moved from Area|1|||
23773088|NCT03049488|66549968|FG001|Overall Study|Moved from Area|0|||
23773089|NCT03049488|66549969|FG002|Overall Study|Moved from Area|0|||
23773090|NCT03049488|66549970|FG003|Overall Study|Moved from Area|1|||
23773091|NCT03049488|66549971|FG004|Overall Study|Moved from Area|1|||
23773092|NCT03049488|66549972|FG005|Overall Study|Moved from Area|0|||
23773093|NCT03049488|66549967|FG000|Overall Study|Physician Decision|0|||
23773094|NCT03049488|66549968|FG001|Overall Study|Physician Decision|1|||
23773095|NCT03049488|66549969|FG002|Overall Study|Physician Decision|0|||
23773096|NCT03049488|66549970|FG003|Overall Study|Physician Decision|0|||
23773097|NCT03049488|66549971|FG004|Overall Study|Physician Decision|0|||
23773098|NCT03049488|66549972|FG005|Overall Study|Physician Decision|0|||
23773099|NCT03049488|66549967|FG000|Overall Study|Withdrawal by Subject|0|||
23773100|NCT03049488|66549968|FG001|Overall Study|Withdrawal by Subject|0|||
23773101|NCT03049488|66549969|FG002|Overall Study|Withdrawal by Subject|0|||
23773102|NCT03049488|66549970|FG003|Overall Study|Withdrawal by Subject|1|||
23773103|NCT03049488|66549971|FG004|Overall Study|Withdrawal by Subject|1|||
23773104|NCT03049488|66549972|FG005|Overall Study|Withdrawal by Subject|0|||
23773105|NCT00984295|66549975|FG000|Overall Study|Lost to Follow-up|31|||
23773106|NCT00984295|66549976|FG001|Overall Study|Lost to Follow-up|12|||
23773107|NCT00984295|66549977|FG002|Overall Study|Lost to Follow-up|13|||
23773108|NCT00984295|66549975|FG000|Overall Study|Protocol Violation|2|||
23773109|NCT00984295|66549976|FG001|Overall Study|Protocol Violation|1|||
23773110|NCT00984295|66549977|FG002|Overall Study|Protocol Violation|4|||
23773111|NCT00984295|66549975|FG000|Overall Study|Withdrawal by Subject|18|||
23773112|NCT00984295|66549976|FG001|Overall Study|Withdrawal by Subject|9|||
23773113|NCT00984295|66549977|FG002|Overall Study|Withdrawal by Subject|12|||
23773114|NCT00984295|66549975|FG000|Overall Study|CAE - discontinued test vaccine|0|||
23773115|NCT00984295|66549976|FG001|Overall Study|CAE - discontinued test vaccine|1|||
23773116|NCT00984295|66549977|FG002|Overall Study|CAE - discontinued test vaccine|3|||
23773117|NCT00984295|66549975|FG000|Overall Study|Missed one or more blood samplings|3|||
23773118|NCT00984295|66549976|FG001|Overall Study|Missed one or more blood samplings|7|||
23773119|NCT00984295|66549977|FG002|Overall Study|Missed one or more blood samplings|2|||
23773120|NCT00984295|66549975|FG000|Overall Study|Incomplete safety follow-up|11|||
23773121|NCT00984295|66549976|FG001|Overall Study|Incomplete safety follow-up|2|||
23773122|NCT00984295|66549977|FG002|Overall Study|Incomplete safety follow-up|3|||
23773123|NCT03312530|66549980|FG000|Overall Study|Death|5|||
23773124|NCT03312530|66549981|FG001|Overall Study|Death|5|||
23773125|NCT03312530|66549982|FG002|Overall Study|Death|4|||
23773126|NCT03312530|66549983|FG003|Overall Study|Death|10|||
23773127|NCT03312530|66549984|FG004|Overall Study|Death|8|||
23773128|NCT03312530|66549980|FG000|Overall Study|Lost to Follow-up|0|||
23773129|NCT03312530|66549981|FG001|Overall Study|Lost to Follow-up|0|||
23773130|NCT03312530|66549982|FG002|Overall Study|Lost to Follow-up|0|||
23773131|NCT03312530|66549983|FG003|Overall Study|Lost to Follow-up|1|||
23773132|NCT03312530|66549984|FG004|Overall Study|Lost to Follow-up|0|||
23773133|NCT03312530|66549980|FG000|Overall Study|Participant in another sponsor study.|0|||
23773134|NCT03312530|66549981|FG001|Overall Study|Participant in another sponsor study.|0|||
23773135|NCT03312530|66549982|FG002|Overall Study|Participant in another sponsor study.|0|||
23773136|NCT03312530|66549983|FG003|Overall Study|Participant in another sponsor study.|1|||
23773137|NCT03312530|66549984|FG004|Overall Study|Participant in another sponsor study.|0|||
23773138|NCT03312530|66549980|FG000|Overall Study|Study terminated by sponsor|1|||
23773139|NCT03312530|66549981|FG001|Overall Study|Study terminated by sponsor|0|||
23773140|NCT03312530|66549982|FG002|Overall Study|Study terminated by sponsor|2|||
23773141|NCT03312530|66549983|FG003|Overall Study|Study terminated by sponsor|3|||
23773142|NCT03312530|66549984|FG004|Overall Study|Study terminated by sponsor|7|||
23773143|NCT03312530|66549980|FG000|Overall Study|Withdrawal by Subject|0|||
23773144|NCT03312530|66549981|FG001|Overall Study|Withdrawal by Subject|1|||
23773145|NCT03312530|66549982|FG002|Overall Study|Withdrawal by Subject|0|||
23773146|NCT03312530|66549983|FG003|Overall Study|Withdrawal by Subject|0|||
23575407|NCT00062868|65838724|FG008|Dose Level 2|Death|0|||
23773147|NCT03312530|66549984|FG004|Overall Study|Withdrawal by Subject|0|||
23773148|NCT03312530|66549980|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23773149|NCT03312530|66549981|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23773150|NCT03312530|66549982|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23773151|NCT03312530|66549983|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
23773152|NCT03312530|66549984|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23773153|NCT01074554|66549985|FG000|Overall Study|Adverse Event|3|||
23773154|NCT01074554|66549986|FG001|Overall Study|Adverse Event|3|||
23773155|NCT01074554|66549985|FG000|Overall Study|Lost to Follow-up|0|||
23773156|NCT01074554|66549986|FG001|Overall Study|Lost to Follow-up|1|||
23773157|NCT00661999|66549987|FG000|Overall Study|Adverse Event|11|||
23773158|NCT00661999|66549988|FG001|Overall Study|Adverse Event|5|||
23773159|NCT00661999|66549989|FG002|Overall Study|Adverse Event|8|||
23773160|NCT00661999|66549987|FG000|Overall Study|Death|8|||
23773161|NCT00661999|66549988|FG001|Overall Study|Death|6|||
23773162|NCT00661999|66549989|FG002|Overall Study|Death|3|||
23773163|NCT00661999|66549987|FG000|Overall Study|Other Reasons|5|||
23773164|NCT00661999|66549988|FG001|Overall Study|Other Reasons|12|||
23773165|NCT00661999|66549989|FG002|Overall Study|Other Reasons|23|||
23773166|NCT00661999|66549987|FG000|Overall Study|Withdrawal by Subject|30|||
23773167|NCT00661999|66549988|FG001|Overall Study|Withdrawal by Subject|23|||
23773168|NCT00661999|66549989|FG002|Overall Study|Withdrawal by Subject|14|||
23773169|NCT00661999|66549987|FG000|Overall Study|Alternative Treatment|1|||
23773170|NCT00661999|66549988|FG001|Overall Study|Alternative Treatment|0|||
23773171|NCT00661999|66549989|FG002|Overall Study|Alternative Treatment|0|||
23773172|NCT00661999|66549987|FG000|Overall Study|Other Medical Problems|4|||
23773173|NCT00661999|66549988|FG001|Overall Study|Other Medical Problems|4|||
23773174|NCT00661999|66549989|FG002|Overall Study|Other Medical Problems|9|||
23773175|NCT00728949|66549990|FG000|Overall Study|Adverse Event|8|||
23773176|NCT00728949|66549991|FG001|Overall Study|Adverse Event|0|||
23773177|NCT00728949|66549990|FG000|Overall Study|Withdrawal by Subject|2|||
23773178|NCT00728949|66549991|FG001|Overall Study|Withdrawal by Subject|2|||
23773179|NCT00728949|66549990|FG000|Overall Study|Abnormal Lab Results|0|||
23773180|NCT00728949|66549991|FG001|Overall Study|Abnormal Lab Results|2|||
23773181|NCT00728949|66549990|FG000|Overall Study|On treatment at cutoff date|1|||
23773182|NCT00728949|66549991|FG001|Overall Study|On treatment at cutoff date|0|||
23773183|NCT05150964|66549992|FG000|Overall Study|Lost to Follow-up|2|||
23773184|NCT03465904|66549995|FG000|Overall Study|Withdrawal by Subject|9|||
23773185|NCT03465904|66549996|FG001|Overall Study|Withdrawal by Subject|5|||
23773186|NCT03465904|66549995|FG000|Overall Study|Lost to Follow-up|10|||
23773187|NCT03465904|66549996|FG001|Overall Study|Lost to Follow-up|9|||
23773188|NCT03465904|66549995|FG000|Overall Study|Protocol Violation|8|||
23773189|NCT03465904|66549996|FG001|Overall Study|Protocol Violation|5|||
23773190|NCT03465904|66549995|FG000|Overall Study|Ineligible for mITT analysis|62|||
23773191|NCT03465904|66549996|FG001|Overall Study|Ineligible for mITT analysis|47|||
23773192|NCT03340727|66549997|FG000|Overall Study|Death|1|||
23773193|NCT03340727|66549998|FG001|Overall Study|Death|0|||
23773194|NCT03340727|66549997|FG000|Overall Study|Lost to Follow-up|31|||
23773195|NCT03340727|66549998|FG001|Overall Study|Lost to Follow-up|35|||
23773196|NCT03340727|66549997|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
23773197|NCT03340727|66549998|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
23773198|NCT03340727|66549997|FG000|Overall Study|Transferred to another facility|10|||
23773199|NCT03340727|66549998|FG001|Overall Study|Transferred to another facility|7|||
23773200|NCT03340727|66549997|FG000|Overall Study|Withdrawal by Subject|28|||
23773201|NCT03340727|66549998|FG001|Overall Study|Withdrawal by Subject|17|||
23773202|NCT02433678|66550001|FG000|Overall Study|Lost to Follow-up|1|||
23773203|NCT02433678|66550002|FG001|Overall Study|Lost to Follow-up|2|||
23773204|NCT03544138|66550005|FG000|Overall Study|Lost to Follow-up|29|||
23773205|NCT03194464|66550006|FG000|Overall Study|data not usable|2|||
23773206|NCT01919190|66550007|FG000|Overall Study|Intra-op findings, etc.|3|||
23773207|NCT01919190|66550008|FG001|Overall Study|Intra-op findings, etc.|0|||
23773208|NCT01739790|66550009|FG000|Overall Study|Early Trial Termination|2|||
23773209|NCT01739790|66550010|FG001|Overall Study|Early Trial Termination|4|||
23773210|NCT01203878|66550025|FG000|Overall Study|Withdrawal by Subject|0|||
23773211|NCT01203878|66550026|FG001|Overall Study|Withdrawal by Subject|0|||
23773212|NCT01203878|66550027|FG002|Overall Study|Withdrawal by Subject|1|||
23773213|NCT01203878|66550025|FG000|Overall Study|Adverse Event|0|||
23773214|NCT01203878|66550026|FG001|Overall Study|Adverse Event|0|||
23447471|NCT04317040|65380461|FG000|Overall Study|Withdrawal by Subject|0|||
23833658|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23833659|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
23833660|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23833661|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
23773215|NCT01203878|66550027|FG002|Overall Study|Adverse Event|2|||
23773216|NCT01374919|66550030|FG000|Overall Study|Withdrawal by Subject|2|||
23773217|NCT00883090|66550031|FG000|Overall Study|Sponsor's decision|1|||
23773218|NCT00883090|66550031|FG000|Overall Study|Withdrawal by Subject|1|||
23773219|NCT00623779|66550036|FG000|Overall Study|Adverse Event|1|||
23447472|NCT04317040|65380462|FG001|Overall Study|Withdrawal by Subject|1|||
23447473|NCT04317040|65380461|FG000|Overall Study|Incomplete assessments|0|||
23447474|NCT04317040|65380462|FG001|Overall Study|Incomplete assessments|1|||
23447475|NCT04972786|65380463|FG000|First Intervention (1 Day)|Adverse Event|1|||
23447476|NCT04972786|65380464|FG001|First Intervention (1 Day)|Adverse Event|0|||
23447477|NCT02038153|65380465|FG000|Overall Study|Withdrawal by Subject|1|||
23447478|NCT04528641|65380470|FG000|Overall Study|Withdrawal by Subject|0|||
23447479|NCT04528641|65380471|FG001|Overall Study|Withdrawal by Subject|0|||
23447480|NCT04528641|65380472|FG002|Overall Study|Withdrawal by Subject|0|||
23447481|NCT04528641|65380473|FG003|Overall Study|Withdrawal by Subject|1|||
23447482|NCT04528641|65380474|FG004|Overall Study|Withdrawal by Subject|0|||
23447483|NCT04528641|65380475|FG005|Overall Study|Withdrawal by Subject|1|||
23447484|NCT04701333|65380476|FG000|Overall Study|Lost to Follow-up|3|||
23447485|NCT04701333|65380477|FG001|Overall Study|Lost to Follow-up|7|||
23447486|NCT04701333|65380476|FG000|Overall Study|Withdrawal by Subject|0|||
23447487|NCT04701333|65380477|FG001|Overall Study|Withdrawal by Subject|1|||
23447488|NCT04816214|65380480|FG000|Overall Study|Progressive Disease|4|||
23447489|NCT04816214|65380481|FG001|Overall Study|Progressive Disease|0|||
23447490|NCT04816214|65380482|FG002|Overall Study|Progressive Disease|0|||
23447491|NCT04816214|65380480|FG000|Overall Study|Death|1|||
23447492|NCT04816214|65380481|FG001|Overall Study|Death|0|||
23447493|NCT04816214|65380482|FG002|Overall Study|Death|0|||
23447494|NCT04816214|65380480|FG000|Overall Study|Study Terminated by Sponsor|1|||
23447495|NCT04816214|65380481|FG001|Overall Study|Study Terminated by Sponsor|0|||
23447496|NCT04816214|65380482|FG002|Overall Study|Study Terminated by Sponsor|0|||
23447497|NCT02446717|65380488|FG000|Overall Study|Adverse Event|0|||
23447498|NCT02446717|65380489|FG001|Overall Study|Adverse Event|0|||
23447499|NCT02446717|65380490|FG002|Overall Study|Adverse Event|1|||
23447500|NCT02446717|65380491|FG003|Overall Study|Adverse Event|0|||
23447501|NCT02446717|65380492|FG004|Overall Study|Adverse Event|0|||
23447502|NCT02446717|65380488|FG000|Overall Study|Lost to Follow-up|0|||
23447503|NCT02446717|65380489|FG001|Overall Study|Lost to Follow-up|1|||
23447504|NCT02446717|65380490|FG002|Overall Study|Lost to Follow-up|1|||
23447505|NCT02446717|65380491|FG003|Overall Study|Lost to Follow-up|0|||
23447506|NCT02446717|65380492|FG004|Overall Study|Lost to Follow-up|1|||
23773220|NCT00623779|66550037|FG001|Overall Study|Adverse Event|3|||
23773221|NCT00623779|66550038|FG002|Overall Study|Adverse Event|0|||
23773222|NCT00623779|66550036|FG000|Overall Study|Criteria from CSR|2|||
23773223|NCT00623779|66550037|FG001|Overall Study|Criteria from CSR|0|||
23773224|NCT00623779|66550038|FG002|Overall Study|Criteria from CSR|1|||
23773225|NCT00667095|66550039|FG000|Overall Study|Withdrawal by Subject|0|||
23773226|NCT00667095|66550040|FG001|Overall Study|Withdrawal by Subject|1|||
23773227|NCT00683293|66550043|FG000|Overall Study|Withdrawal by Subject|2|||
23773228|NCT00683293|66550044|FG001|Overall Study|Withdrawal by Subject|3|||
23773229|NCT02430870|66550056|FG000|Part 2|Voluntary Withdrawal|0|||
23833662|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
23833663|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23833664|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23833665|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
23833666|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23833667|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Site closed|0|||
23773230|NCT02430870|66550057|FG001|Part 2|Voluntary Withdrawal|0|||
23773231|NCT02430870|66550058|FG002|Part 2|Voluntary Withdrawal|0|||
23773232|NCT02430870|66550059|FG003|Part 2|Voluntary Withdrawal|0|||
23447507|NCT02446717|65380488|FG000|Overall Study|Withdrew consent|0|||
23447508|NCT02446717|65380489|FG001|Overall Study|Withdrew consent|0|||
23447509|NCT02446717|65380490|FG002|Overall Study|Withdrew consent|0|||
23447510|NCT02446717|65380491|FG003|Overall Study|Withdrew consent|1|||
23447511|NCT02446717|65380492|FG004|Overall Study|Withdrew consent|0|||
23773233|NCT02430870|66550060|FG004|Part 2|Voluntary Withdrawal|0|||
23447512|NCT00549640|65380494|FG000|Overall Study|Withdrawal by Subject|6|||
23447513|NCT00549640|65380495|FG001|Overall Study|Withdrawal by Subject|12|||
23447514|NCT00549640|65380494|FG000|Overall Study|Adverse Event|5|||
23447515|NCT00549640|65380495|FG001|Overall Study|Adverse Event|0|||
23447516|NCT00549640|65380494|FG000|Overall Study|Lost to Follow-up|7|||
23447517|NCT00549640|65380495|FG001|Overall Study|Lost to Follow-up|4|||
23447518|NCT02260934|65380500|FG000|Overall Study|Lost to Follow-up|2|||
23447519|NCT02260934|65380501|FG001|Overall Study|Lost to Follow-up|1|||
23447520|NCT02260934|65380500|FG000|Overall Study|Withdrawal by Subject|0|||
23833668|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Site closed|0|||
23833669|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Site closed|1|||
23833670|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Site closed|0|||
23833671|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
23833672|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23833673|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23833674|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23833675|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
23833676|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
23833677|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
23833678|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
23833679|NCT00838903|66770759|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
23833680|NCT00838903|66770760|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23833681|NCT00838903|66770761|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23833682|NCT00838903|66770762|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23833683|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
23833684|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
23833685|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
23833686|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
23833687|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23833688|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
23833689|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
23833690|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
23833691|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
23833692|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
23833693|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
23833694|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
23833695|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
23833696|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
23833697|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
23833698|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
23833699|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
23833700|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
23833701|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
23833702|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
23833703|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
23833704|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
23833705|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
23833706|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
23833707|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
23833708|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23833709|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
23833710|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23833711|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23833712|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
23833713|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23833714|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23833715|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23833716|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
23833717|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23833718|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23833719|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23447521|NCT02260934|65380501|FG001|Overall Study|Withdrawal by Subject|2|||
23447522|NCT02260934|65380500|FG000|Overall Study|Participant Relocated|1|||
23447523|NCT02260934|65380501|FG001|Overall Study|Participant Relocated|0|||
23447524|NCT02260934|65380500|FG000|Overall Study|Site error|0|||
23575408|NCT00062868|65838725|FG009|Dose Level 2|Death|0|||
23833720|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23833721|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23833722|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
23447525|NCT02260934|65380501|FG001|Overall Study|Site error|1|||
23633648|NCT01465763|66045409|FG002|Overall Study|Protocol Violation|1|||
23633649|NCT01465763|66045407|FG000|Overall Study|Death|1|||
23575409|NCT00062868|65838726|FG010|Dose Level 2|Death|1|||
23575410|NCT00062868|65838727|FG011|Dose Level 2|Death|0|||
23633650|NCT01465763|66045408|FG001|Overall Study|Death|0|||
23633651|NCT01465763|66045409|FG002|Overall Study|Death|0|||
23575411|NCT00062868|65838728|FG012|Dose Level 2|Death|0|||
23575412|NCT00062868|65838729|FG013|Dose Level 2|Death|0|||
23575413|NCT00062868|65838730|FG014|Dose Level 2|Death|0|||
23633652|NCT02493062|66045410|FG000|Overall Study|Physician Decision|12|||
23633653|NCT01401153|66045416|FG000|First Test Day|Learning disabilities; illness|1|||
23633654|NCT01401153|66045417|FG001|First Test Day|Learning disabilities; illness|10|||
23575414|NCT00062868|65838731|FG015|Dose Level 2|Death|0|||
23575415|NCT00062868|65838732|FG016|Dose Level 2|Death|2|||
23575416|NCT00062868|65838733|FG017|Dose Level 2|Death|0|||
23575417|NCT00062868|65838734|FG018|Dose Level 2|Death|0|||
23633655|NCT01401153|66045416|FG000|Second Test Day|illness|0|||
23633656|NCT01401153|66045417|FG001|Second Test Day|illness|5|||
23633657|NCT01711853|66045420|FG000|Overall Study|Not treated|3|||
23633658|NCT01088984|66045423|FG000|Phase 1|Death|2|||
23633659|NCT01088984|66045424|FG001|Phase 1|Death|1|||
23633660|NCT01088984|66045423|FG000|Phase 1|Disease Progression|2|||
23633661|NCT01088984|66045424|FG001|Phase 1|Disease Progression|4|||
23633662|NCT01088984|66045423|FG000|Phase 1|Other|1|||
23633663|NCT01088984|66045424|FG001|Phase 1|Other|1|||
23633664|NCT01088984|66045423|FG000|Phase 2|Death|0|||
23633665|NCT01088984|66045424|FG001|Phase 2|Death|5|||
23633666|NCT01088984|66045423|FG000|Phase 2|Withdrawal by Subject|0|||
23633667|NCT01088984|66045424|FG001|Phase 2|Withdrawal by Subject|1|||
23633668|NCT01088984|66045423|FG000|Phase 2|DIsease Progression|0|||
23633669|NCT01088984|66045424|FG001|Phase 2|DIsease Progression|25|||
23633670|NCT01088984|66045423|FG000|Phase 2|Other|0|||
23633671|NCT01088984|66045424|FG001|Phase 2|Other|1|||
23833723|NCT00838903|66770759|FG000|Follow-up Period (8 Weeks)|Missing|1|||
23833724|NCT00838903|66770760|FG001|Follow-up Period (8 Weeks)|Missing|2|||
23833725|NCT00838903|66770761|FG002|Follow-up Period (8 Weeks)|Missing|1|||
23833726|NCT00838903|66770762|FG003|Follow-up Period (8 Weeks)|Missing|1|||
23833727|NCT00866281|66770763|FG000|Overall Study|Adverse Event|1|||
23833728|NCT00866281|66770764|FG001|Overall Study|Adverse Event|0|||
23833729|NCT00866281|66770763|FG000|Overall Study|Withdrawal by participants|3|||
23833730|NCT00866281|66770764|FG001|Overall Study|Withdrawal by participants|0|||
23833731|NCT00866281|66770763|FG000|Overall Study|Disease progression|3|||
23833732|NCT00866281|66770764|FG001|Overall Study|Disease progression|11|||
23833733|NCT00866281|66770763|FG000|Overall Study|New cancer therapy|0|||
23833734|NCT00866281|66770764|FG001|Overall Study|New cancer therapy|4|||
23833735|NCT00288626|66770765|FG000|Overall Study|Death|3|||
23833736|NCT00288626|66770765|FG000|Overall Study|Withdrawal by Subject|4|||
23833737|NCT03660930|66770766|FG000|Overall Study|Adverse Event|0|||
23833738|NCT03660930|66770767|FG001|Overall Study|Adverse Event|0|||
23833739|NCT03660930|66770768|FG002|Overall Study|Adverse Event|0|||
23833740|NCT03660930|66770769|FG003|Overall Study|Adverse Event|2|||
23833741|NCT03660930|66770770|FG004|Overall Study|Adverse Event|0|||
23833742|NCT03660930|66770771|FG005|Overall Study|Adverse Event|1|||
23633672|NCT02947100|66045427|FG000|Overall Study|study terminated early|3|||
23575418|NCT00062868|65838735|FG019|Dose Level 2|Death|0|||
23575419|NCT00062868|65838736|FG020|Dose Level 2|Death|0|||
23633673|NCT02947100|66045427|FG000|Overall Study|did not meet inclusion criteria|1|||
23633674|NCT02688530|66045428|FG000|Overall Study|Withdrawal by Subject|0|||
23633675|NCT02688530|66045429|FG001|Overall Study|Withdrawal by Subject|1|||
23633676|NCT02688530|66045430|FG002|Overall Study|Withdrawal by Subject|0|||
23633677|NCT02688530|66045431|FG003|Overall Study|Withdrawal by Subject|0|||
23833743|NCT03660930|66770772|FG006|Overall Study|Adverse Event|0|||
23833744|NCT03660930|66770773|FG007|Overall Study|Adverse Event|0|||
23575420|NCT00062868|65838716|FG000|Dose Level 2|Lost to Follow-up|0|||
23633678|NCT02688530|66045428|FG000|Overall Study|Lost to Follow-up|0|||
23633679|NCT02688530|66045429|FG001|Overall Study|Lost to Follow-up|0|||
23833745|NCT03660930|66770766|FG000|Overall Study|Withdrawal by Subject|0|||
23833746|NCT03660930|66770767|FG001|Overall Study|Withdrawal by Subject|0|||
23833747|NCT03660930|66770768|FG002|Overall Study|Withdrawal by Subject|0|||
23833748|NCT03660930|66770769|FG003|Overall Study|Withdrawal by Subject|0|||
23833749|NCT03660930|66770770|FG004|Overall Study|Withdrawal by Subject|0|||
23833750|NCT03660930|66770771|FG005|Overall Study|Withdrawal by Subject|1|||
23833751|NCT03660930|66770772|FG006|Overall Study|Withdrawal by Subject|0|||
23833752|NCT03660930|66770773|FG007|Overall Study|Withdrawal by Subject|0|||
23833753|NCT03660930|66770766|FG000|Overall Study|On Treatment|0|||
23833754|NCT03660930|66770767|FG001|Overall Study|On Treatment|0|||
23833755|NCT03660930|66770768|FG002|Overall Study|On Treatment|0|||
23833756|NCT03660930|66770769|FG003|Overall Study|On Treatment|0|||
23833757|NCT03660930|66770770|FG004|Overall Study|On Treatment|0|||
23833758|NCT03660930|66770771|FG005|Overall Study|On Treatment|0|||
23833759|NCT03660930|66770772|FG006|Overall Study|On Treatment|0|||
23833760|NCT03660930|66770773|FG007|Overall Study|On Treatment|1|||
23833761|NCT03660930|66770766|FG000|Overall Study|In Follow-up|0|||
23833762|NCT03660930|66770767|FG001|Overall Study|In Follow-up|0|||
23833763|NCT03660930|66770768|FG002|Overall Study|In Follow-up|0|||
23833764|NCT03660930|66770769|FG003|Overall Study|In Follow-up|0|||
23833765|NCT03660930|66770770|FG004|Overall Study|In Follow-up|0|||
23833766|NCT03660930|66770771|FG005|Overall Study|In Follow-up|0|||
23833767|NCT03660930|66770772|FG006|Overall Study|In Follow-up|1|||
23833768|NCT03660930|66770773|FG007|Overall Study|In Follow-up|2|||
23833769|NCT04570670|66770774|FG000|Overall Study|Withdrawal by Subject|1|||
23833770|NCT04570670|66770775|FG001|Overall Study|Withdrawal by Subject|0|||
23833771|NCT02712554|66770776|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
23833772|NCT02712554|66770777|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
23833773|NCT02712554|66770776|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
23833774|NCT02712554|66770777|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
23833775|NCT02712554|66770776|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
23833776|NCT02712554|66770777|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
23833777|NCT02712554|66770776|FG000|Part B: Qualification Phase|Adverse Event|0|||
23833778|NCT02712554|66770777|FG001|Part B: Qualification Phase|Adverse Event|1|||
23833779|NCT02712554|66770776|FG000|Part B: Treatment Phase|Adverse Event|0|||
23833780|NCT02712554|66770777|FG001|Part B: Treatment Phase|Adverse Event|1|||
23833781|NCT02712554|66770776|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
23833782|NCT02712554|66770777|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
23833783|NCT02712554|66770776|FG000|Part B: Treatment Phase|Other|0|||
23833784|NCT02712554|66770777|FG001|Part B: Treatment Phase|Other|1|||
23833785|NCT01611883|66770778|FG000|Overall Study|Adverse Event|1|||
23833786|NCT01611883|66770779|FG001|Overall Study|Adverse Event|1|||
23833787|NCT03885661|66770780|FG000|Overall Study|Withdrawal by Subject|0|||
23833788|NCT03885661|66770781|FG001|Overall Study|Withdrawal by Subject|1|||
23833789|NCT03885661|66770780|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
23633680|NCT02688530|66045430|FG002|Overall Study|Lost to Follow-up|2|||
23633681|NCT02688530|66045431|FG003|Overall Study|Lost to Follow-up|0|||
23633682|NCT02920970|66045432|FG000|First Intervention|Protocol Violation|0|||
23633683|NCT02920970|66045433|FG001|First Intervention|Protocol Violation|1|||
23633684|NCT02920970|66045432|FG000|First Intervention|Adverse Event|0|||
23633685|NCT02920970|66045433|FG001|First Intervention|Adverse Event|1|||
23633686|NCT02920970|66045432|FG000|Second Intervention|Poor Lens Fit|1|||
23633687|NCT02920970|66045433|FG001|Second Intervention|Poor Lens Fit|0|||
23633688|NCT00527787|66045434|FG000|Overall Study|Adverse Event|14|||
23633689|NCT00527787|66045435|FG001|Overall Study|Adverse Event|24|||
23633690|NCT00527787|66045434|FG000|Overall Study|Withdrawal by Subject|13|||
23633691|NCT00527787|66045435|FG001|Overall Study|Withdrawal by Subject|25|||
23633692|NCT00527787|66045434|FG000|Overall Study|Lost to Follow-up|5|||
23633693|NCT00527787|66045435|FG001|Overall Study|Lost to Follow-up|2|||
23633694|NCT00527787|66045434|FG000|Overall Study|Duodenal Ulcer|1|||
23633695|NCT00527787|66045435|FG001|Overall Study|Duodenal Ulcer|10|||
23833790|NCT03885661|66770781|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
23833791|NCT00848718|66770782|FG000|Overall Study|Adverse Event|2|||
23633696|NCT00527787|66045434|FG000|Overall Study|misc|5|||
23833792|NCT00848718|66770783|FG001|Overall Study|Adverse Event|2|||
23833793|NCT00848718|66770784|FG002|Overall Study|Adverse Event|1|||
23833794|NCT00848718|66770785|FG003|Overall Study|Adverse Event|1|||
23633697|NCT00527787|66045435|FG001|Overall Study|misc|2|||
23575421|NCT00062868|65838717|FG001|Dose Level 2|Lost to Follow-up|0|||
23575422|NCT00062868|65838718|FG002|Dose Level 2|Lost to Follow-up|0|||
23575423|NCT00062868|65838719|FG003|Dose Level 2|Lost to Follow-up|0|||
23575424|NCT00062868|65838720|FG004|Dose Level 2|Lost to Follow-up|0|||
23575425|NCT00062868|65838721|FG005|Dose Level 2|Lost to Follow-up|0|||
23575426|NCT00062868|65838722|FG006|Dose Level 2|Lost to Follow-up|0|||
23575427|NCT00062868|65838723|FG007|Dose Level 2|Lost to Follow-up|0|||
23575428|NCT00062868|65838724|FG008|Dose Level 2|Lost to Follow-up|0|||
23833795|NCT00848718|66770786|FG004|Overall Study|Adverse Event|1|||
23833796|NCT00848718|66770787|FG005|Overall Study|Adverse Event|0|||
23833797|NCT00848718|66770788|FG006|Overall Study|Adverse Event|0|||
23833798|NCT00848718|66770789|FG007|Overall Study|Adverse Event|1|||
23833799|NCT00848718|66770790|FG008|Overall Study|Adverse Event|1|||
23833800|NCT00848718|66770791|FG009|Overall Study|Adverse Event|0|||
23833801|NCT00848718|66770792|FG010|Overall Study|Adverse Event|0|||
23833802|NCT00848718|66770793|FG011|Overall Study|Adverse Event|0|||
23833803|NCT00848718|66770794|FG012|Overall Study|Adverse Event|2|||
23833804|NCT00848718|66770782|FG000|Overall Study|Lack of Efficacy|0|||
23833805|NCT00848718|66770783|FG001|Overall Study|Lack of Efficacy|0|||
23833806|NCT00848718|66770784|FG002|Overall Study|Lack of Efficacy|1|||
23447526|NCT00717249|65380502|FG000|Overall Study|Lens Discomfort|4|||
23447527|NCT00717249|65380503|FG001|Overall Study|Lens Discomfort|1|||
23833807|NCT00848718|66770785|FG003|Overall Study|Lack of Efficacy|0|||
23833808|NCT00848718|66770786|FG004|Overall Study|Lack of Efficacy|0|||
23833809|NCT00848718|66770787|FG005|Overall Study|Lack of Efficacy|0|||
23447528|NCT00717249|65380502|FG000|Overall Study|Unsatisfactory visual Response|0|||
23575429|NCT00062868|65838725|FG009|Dose Level 2|Lost to Follow-up|0|||
23773234|NCT02430870|66550061|FG005|Part 2|Voluntary Withdrawal|0|||
23773235|NCT02430870|66550062|FG006|Part 2|Voluntary Withdrawal|1|||
23773236|NCT02430870|66550063|FG007|Part 2|Voluntary Withdrawal|0|||
23773237|NCT02430870|66550056|FG000|Part 2|Other Reason Not Specified|0|||
23773238|NCT02430870|66550057|FG001|Part 2|Other Reason Not Specified|0|||
23773239|NCT02430870|66550058|FG002|Part 2|Other Reason Not Specified|0|||
23447529|NCT00717249|65380503|FG001|Overall Study|Unsatisfactory visual Response|2|||
23773240|NCT02430870|66550059|FG003|Part 2|Other Reason Not Specified|0|||
23773241|NCT02430870|66550060|FG004|Part 2|Other Reason Not Specified|0|||
23773242|NCT02430870|66550061|FG005|Part 2|Other Reason Not Specified|0|||
23773243|NCT02430870|66550062|FG006|Part 2|Other Reason Not Specified|0|||
23773244|NCT02430870|66550063|FG007|Part 2|Other Reason Not Specified|1|||
23773245|NCT00684671|66550064|FG000|Overall Study|Adverse Event|1|||
23773246|NCT00684671|66550065|FG001|Overall Study|Adverse Event|0|||
23773247|NCT00684671|66550066|FG002|Overall Study|Adverse Event|0|||
23773248|NCT00684671|66550064|FG000|Overall Study|Lost to Follow-up|1|||
23773249|NCT00684671|66550065|FG001|Overall Study|Lost to Follow-up|0|||
23773250|NCT00684671|66550066|FG002|Overall Study|Lost to Follow-up|0|||
23773251|NCT00684671|66550064|FG000|Overall Study|Alcoholic dependance|1|||
23773252|NCT00684671|66550065|FG001|Overall Study|Alcoholic dependance|0|||
23447530|NCT00717249|65380502|FG000|Overall Study|Adverse Event|4|||
23447531|NCT00717249|65380503|FG001|Overall Study|Adverse Event|2|||
23447532|NCT00717249|65380502|FG000|Overall Study|Lost to Follow-up|2|||
23575430|NCT00062868|65838726|FG010|Dose Level 2|Lost to Follow-up|0|||
23575431|NCT00062868|65838727|FG011|Dose Level 2|Lost to Follow-up|0|||
23575432|NCT00062868|65838728|FG012|Dose Level 2|Lost to Follow-up|0|||
23575433|NCT00062868|65838729|FG013|Dose Level 2|Lost to Follow-up|1|||
23575434|NCT00062868|65838730|FG014|Dose Level 2|Lost to Follow-up|0|||
23773253|NCT00684671|66550066|FG002|Overall Study|Alcoholic dependance|0|||
23773254|NCT00264797|66550080|FG000|Overall Study|Withdrawal by Subject|11|||
23773255|NCT00264797|66550081|FG001|Overall Study|Withdrawal by Subject|11|||
23773256|NCT00264797|66550080|FG000|Overall Study|Lost to Follow-up|9|||
23773257|NCT00264797|66550081|FG001|Overall Study|Lost to Follow-up|17|||
23833810|NCT00848718|66770788|FG006|Overall Study|Lack of Efficacy|1|||
23773258|NCT00264797|66550080|FG000|Overall Study|Moved from area|3|||
23773259|NCT00264797|66550081|FG001|Overall Study|Moved from area|1|||
23773260|NCT00264797|66550080|FG000|Overall Study|Practical Problems|2|||
23773261|NCT00264797|66550081|FG001|Overall Study|Practical Problems|3|||
23773262|NCT00264797|66550080|FG000|Overall Study|Incarceration|4|||
23773263|NCT00264797|66550081|FG001|Overall Study|Incarceration|5|||
23773264|NCT00264797|66550080|FG000|Overall Study|Pressure/advice from Outsiders|1|||
23773265|NCT00264797|66550081|FG001|Overall Study|Pressure/advice from Outsiders|1|||
23773266|NCT00264797|66550080|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
23773267|NCT00264797|66550081|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
23773268|NCT00264797|66550080|FG000|Overall Study|Other|3|||
23575435|NCT00062868|65838731|FG015|Dose Level 2|Lost to Follow-up|0|||
23575436|NCT00062868|65838732|FG016|Dose Level 2|Lost to Follow-up|1|||
23575437|NCT00062868|65838733|FG017|Dose Level 2|Lost to Follow-up|0|||
23575438|NCT00062868|65838734|FG018|Dose Level 2|Lost to Follow-up|0|||
23575439|NCT00062868|65838735|FG019|Dose Level 2|Lost to Follow-up|0|||
23575440|NCT00062868|65838736|FG020|Dose Level 2|Lost to Follow-up|0|||
23575441|NCT00062868|65838716|FG000|Dose Level 3|Death|0|||
23575442|NCT00062868|65838717|FG001|Dose Level 3|Death|0|||
23575443|NCT00062868|65838718|FG002|Dose Level 3|Death|0|||
23575444|NCT00062868|65838719|FG003|Dose Level 3|Death|0|||
23575445|NCT00062868|65838720|FG004|Dose Level 3|Death|0|||
23575446|NCT00062868|65838721|FG005|Dose Level 3|Death|0|||
23575447|NCT00062868|65838722|FG006|Dose Level 3|Death|0|||
23575448|NCT00062868|65838723|FG007|Dose Level 3|Death|0|||
23575449|NCT00062868|65838724|FG008|Dose Level 3|Death|0|||
23575450|NCT00062868|65838725|FG009|Dose Level 3|Death|0|||
23575451|NCT00062868|65838726|FG010|Dose Level 3|Death|0|||
23575452|NCT00062868|65838727|FG011|Dose Level 3|Death|1|||
23575453|NCT00062868|65838728|FG012|Dose Level 3|Death|0|||
23575454|NCT00062868|65838729|FG013|Dose Level 3|Death|0|||
23575455|NCT00062868|65838730|FG014|Dose Level 3|Death|0|||
23575456|NCT00062868|65838731|FG015|Dose Level 3|Death|0|||
23575457|NCT00062868|65838732|FG016|Dose Level 3|Death|0|||
23575458|NCT00062868|65838733|FG017|Dose Level 3|Death|1|||
23575459|NCT00062868|65838734|FG018|Dose Level 3|Death|0|||
23773269|NCT00264797|66550081|FG001|Overall Study|Other|4|||
23773270|NCT01505530|66550087|FG000|Overall Study|Progressive Disease|19|||
23773271|NCT01505530|66550088|FG001|Overall Study|Progressive Disease|17|||
23773272|NCT01505530|66550089|FG002|Overall Study|Progressive Disease|18|||
23773273|NCT01505530|66550087|FG000|Overall Study|Adverse Event|1|||
23773274|NCT01505530|66550088|FG001|Overall Study|Adverse Event|1|||
23773275|NCT01505530|66550089|FG002|Overall Study|Adverse Event|0|||
23773276|NCT01505530|66550087|FG000|Overall Study|Withdrawal by Subject|7|||
23773277|NCT01505530|66550088|FG001|Overall Study|Withdrawal by Subject|8|||
23773278|NCT01505530|66550089|FG002|Overall Study|Withdrawal by Subject|6|||
23773279|NCT01505530|66550087|FG000|Overall Study|Physician Decision|6|||
23773280|NCT01505530|66550088|FG001|Overall Study|Physician Decision|2|||
23773281|NCT01505530|66550089|FG002|Overall Study|Physician Decision|5|||
23773282|NCT01505530|66550087|FG000|Overall Study|Sponsor Decision|1|||
23773283|NCT01505530|66550088|FG001|Overall Study|Sponsor Decision|8|||
23773284|NCT01505530|66550089|FG002|Overall Study|Sponsor Decision|7|||
23773285|NCT01505530|66550087|FG000|Overall Study|Death|7|||
23773286|NCT01505530|66550088|FG001|Overall Study|Death|6|||
23773287|NCT01505530|66550089|FG002|Overall Study|Death|5|||
23773288|NCT01505530|66550087|FG000|Overall Study|entry criteria not met|0|||
23773289|NCT01505530|66550088|FG001|Overall Study|entry criteria not met|1|||
23773290|NCT01505530|66550089|FG002|Overall Study|entry criteria not met|0|||
23773291|NCT00727571|66550094|FG000|Overall Study|Ineligibility determined|1|||
23773292|NCT00727571|66550095|FG001|Overall Study|Ineligibility determined|1|||
23773293|NCT00727571|66550096|FG002|Overall Study|Ineligibility determined|1|||
23773294|NCT00727571|66550097|FG003|Overall Study|Ineligibility determined|0|||
23575460|NCT00062868|65838735|FG019|Dose Level 3|Death|0|||
23575461|NCT00062868|65838736|FG020|Dose Level 3|Death|0|||
23575462|NCT00062868|65838716|FG000|Dose Level 3|Lost to Follow-up|0|||
23575463|NCT00062868|65838717|FG001|Dose Level 3|Lost to Follow-up|0|||
23633698|NCT00426127|66045436|FG000|Overall Study|Adverse Event|1|||
23773295|NCT00727571|66550094|FG000|Overall Study|Death|0|||
23773296|NCT00727571|66550095|FG001|Overall Study|Death|19|||
23575464|NCT00062868|65838718|FG002|Dose Level 3|Lost to Follow-up|0|||
23575465|NCT00062868|65838719|FG003|Dose Level 3|Lost to Follow-up|0|||
23575466|NCT00062868|65838720|FG004|Dose Level 3|Lost to Follow-up|0|||
23575467|NCT00062868|65838721|FG005|Dose Level 3|Lost to Follow-up|0|||
23633699|NCT00426127|66045436|FG000|Overall Study|Removed due to disease progression|1|||
23575468|NCT00062868|65838722|FG006|Dose Level 3|Lost to Follow-up|0|||
23575469|NCT00062868|65838723|FG007|Dose Level 3|Lost to Follow-up|0|||
23773297|NCT00727571|66550096|FG002|Overall Study|Death|5|||
23773298|NCT00727571|66550097|FG003|Overall Study|Death|1|||
23773299|NCT00727571|66550094|FG000|Overall Study|Physician Decision|0|||
23773300|NCT00727571|66550095|FG001|Overall Study|Physician Decision|5|||
23773301|NCT00727571|66550096|FG002|Overall Study|Physician Decision|0|||
23773302|NCT00727571|66550097|FG003|Overall Study|Physician Decision|0|||
23773303|NCT00727571|66550094|FG000|Overall Study|Withdrawal by Subject|0|||
23773304|NCT00727571|66550095|FG001|Overall Study|Withdrawal by Subject|10|||
23773305|NCT00727571|66550096|FG002|Overall Study|Withdrawal by Subject|11|||
23773306|NCT00727571|66550097|FG003|Overall Study|Withdrawal by Subject|0|||
23773307|NCT00727571|66550094|FG000|Overall Study|Subject Non Compliance|0|||
23773308|NCT00727571|66550095|FG001|Overall Study|Subject Non Compliance|6|||
23773309|NCT00727571|66550096|FG002|Overall Study|Subject Non Compliance|0|||
23773310|NCT00727571|66550097|FG003|Overall Study|Subject Non Compliance|4|||
23773311|NCT00727571|66550094|FG000|Overall Study|Dismissed from nursing home|0|||
23773312|NCT00727571|66550095|FG001|Overall Study|Dismissed from nursing home|9|||
23773313|NCT00727571|66550096|FG002|Overall Study|Dismissed from nursing home|5|||
23773314|NCT00727571|66550097|FG003|Overall Study|Dismissed from nursing home|0|||
23773315|NCT00727571|66550094|FG000|Overall Study|Hospitalization|0|||
23773316|NCT00727571|66550095|FG001|Overall Study|Hospitalization|1|||
23773317|NCT00727571|66550096|FG002|Overall Study|Hospitalization|0|||
23773318|NCT00727571|66550097|FG003|Overall Study|Hospitalization|1|||
23773319|NCT00727571|66550094|FG000|Overall Study|AE not leading to hospitalization|0|||
23773320|NCT00727571|66550095|FG001|Overall Study|AE not leading to hospitalization|0|||
23773321|NCT00727571|66550096|FG002|Overall Study|AE not leading to hospitalization|2|||
23773322|NCT00727571|66550097|FG003|Overall Study|AE not leading to hospitalization|0|||
23773323|NCT00727571|66550094|FG000|Overall Study|Other|0|||
23773324|NCT00727571|66550095|FG001|Overall Study|Other|4|||
23773325|NCT00727571|66550096|FG002|Overall Study|Other|6|||
23773326|NCT00727571|66550097|FG003|Overall Study|Other|0|||
23773327|NCT04276883|66550111|FG000|Overall Study|Withdrawal by Subject|2|||
23773328|NCT04276883|66550112|FG001|Overall Study|Withdrawal by Subject|3|||
23773329|NCT04276883|66550113|FG002|Overall Study|Withdrawal by Subject|6|||
23773330|NCT04276883|66550111|FG000|Overall Study|Lost to Follow-up|1|||
23773331|NCT04276883|66550112|FG001|Overall Study|Lost to Follow-up|3|||
23773332|NCT04276883|66550113|FG002|Overall Study|Lost to Follow-up|0|||
23773333|NCT04276883|66550111|FG000|Overall Study|Adverse Event|0|||
23773334|NCT04276883|66550112|FG001|Overall Study|Adverse Event|1|||
23773335|NCT04276883|66550113|FG002|Overall Study|Adverse Event|0|||
23773336|NCT04276883|66550111|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
23773337|NCT04276883|66550112|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
23773338|NCT04276883|66550113|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
23773339|NCT01124149|66550114|FG000|Acute Phase|Withdrawal by Subject|22|||
23773340|NCT01124149|66550114|FG000|Acute Phase|Adverse Event|21|||
23575470|NCT00062868|65838724|FG008|Dose Level 3|Lost to Follow-up|0|||
23575471|NCT00062868|65838725|FG009|Dose Level 3|Lost to Follow-up|0|||
23575472|NCT00062868|65838726|FG010|Dose Level 3|Lost to Follow-up|0|||
23575473|NCT00062868|65838727|FG011|Dose Level 3|Lost to Follow-up|0|||
23575474|NCT00062868|65838728|FG012|Dose Level 3|Lost to Follow-up|0|||
23773341|NCT01124149|66550114|FG000|Acute Phase|Lack of Efficacy|17|||
23773342|NCT01124149|66550114|FG000|Acute Phase|Protocol Violation|14|||
23773343|NCT01124149|66550114|FG000|Acute Phase|Lost to Follow-up|2|||
23773344|NCT01124149|66550114|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
23773345|NCT01124149|66550114|FG000|Acute Phase|Sponsor request|1|||
23773346|NCT01124149|66550114|FG000|Acute Phase|UC symptoms not ameliorated|1|||
23773347|NCT01124149|66550114|FG000|Acute Phase|Non-compliance|1|||
23773348|NCT01124149|66550114|FG000|Acute Phase|Low hemoglobin|1|||
23773349|NCT01124149|66550114|FG000|Acute Phase|Travelling to another country|1|||
23773350|NCT01124149|66550114|FG000|Acute Phase|Sponsor decision|1|||
23773351|NCT01124149|66550114|FG000|Maintenance Phase|Lack of Efficacy|40|||
23773352|NCT01124149|66550114|FG000|Maintenance Phase|Adverse Event|24|||
23773353|NCT01124149|66550114|FG000|Maintenance Phase|Lost to Follow-up|15|||
23773354|NCT01124149|66550114|FG000|Maintenance Phase|Withdrawal by Subject|10|||
23773355|NCT01124149|66550114|FG000|Maintenance Phase|Protocol Violation|5|||
23773356|NCT01124149|66550114|FG000|Maintenance Phase|Coordinator error|1|||
23773357|NCT01124149|66550114|FG000|Maintenance Phase|Non-compliance|1|||
23773358|NCT00663871|66550115|FG000|Overall Study|Lost to Follow-up|5|||
23773359|NCT00663871|66550116|FG001|Overall Study|Lost to Follow-up|5|||
23773360|NCT00663871|66550115|FG000|Overall Study|Withdrawal by Subject|5|||
23773361|NCT00663871|66550116|FG001|Overall Study|Withdrawal by Subject|2|||
23773362|NCT00667862|66550117|FG000|Overall Study|Adverse Event|9|||
23773363|NCT00667862|66550117|FG000|Overall Study|Death|1|||
23773364|NCT00667862|66550117|FG000|Overall Study|Disease Progression|22|||
23773365|NCT00667862|66550117|FG000|Overall Study|Withdrawal by Subject|3|||
23773366|NCT02402166|66550118|FG000|Overall Study|Adverse Event|2|||
23773367|NCT02402166|66550118|FG000|Overall Study|Withdrawal by Subject|2|||
23773368|NCT02402166|66550118|FG000|Overall Study|Lost to Follow-up|1|||
23773369|NCT00796510|66550119|FG000|Overall Study|Death|1|||
23773370|NCT00796510|66550120|FG001|Overall Study|Death|0|||
23773371|NCT00796510|66550119|FG000|Overall Study|Study Terminated|2|||
23575475|NCT00062868|65838729|FG013|Dose Level 3|Lost to Follow-up|0|||
23773372|NCT00796510|66550120|FG001|Overall Study|Study Terminated|0|||
23773373|NCT03527745|66550121|FG000|Overall Study|Lost to Follow-up|3|||
23773374|NCT03527745|66550122|FG001|Overall Study|Lost to Follow-up|6|||
23773375|NCT03527745|66550123|FG002|Overall Study|Lost to Follow-up|7|||
23773376|NCT03527745|66550124|FG003|Overall Study|Lost to Follow-up|9|||
23773377|NCT03527745|66550125|FG004|Overall Study|Lost to Follow-up|0|||
23773378|NCT03527745|66550126|FG005|Overall Study|Lost to Follow-up|2|||
23773379|NCT03527745|66550127|FG006|Overall Study|Lost to Follow-up|3|||
23773380|NCT03527745|66550128|FG007|Overall Study|Lost to Follow-up|2|||
23773381|NCT03527745|66550129|FG008|Overall Study|Lost to Follow-up|3|||
23773382|NCT03527745|66550130|FG009|Overall Study|Lost to Follow-up|2|||
23773383|NCT03527745|66550131|FG010|Overall Study|Lost to Follow-up|1|||
23773384|NCT03527745|66550132|FG011|Overall Study|Lost to Follow-up|1|||
23773385|NCT03527745|66550133|FG012|Overall Study|Lost to Follow-up|0|||
23773386|NCT03527745|66550134|FG013|Overall Study|Lost to Follow-up|0|||
23773387|NCT03527745|66550135|FG014|Overall Study|Lost to Follow-up|0|||
23773388|NCT03527745|66550136|FG015|Overall Study|Lost to Follow-up|0|||
23773389|NCT03527745|66550137|FG016|Overall Study|Lost to Follow-up|1|||
23773390|NCT03527745|66550138|FG017|Overall Study|Lost to Follow-up|0|||
23773391|NCT03527745|66550139|FG018|Overall Study|Lost to Follow-up|0|||
23773392|NCT03527745|66550140|FG019|Overall Study|Lost to Follow-up|1|||
23773393|NCT03527745|66550141|FG020|Overall Study|Lost to Follow-up|1|||
23773394|NCT03527745|66550142|FG021|Overall Study|Lost to Follow-up|5|||
23833811|NCT00848718|66770789|FG007|Overall Study|Lack of Efficacy|0|||
23833812|NCT00848718|66770790|FG008|Overall Study|Lack of Efficacy|0|||
23773395|NCT03527745|66550143|FG022|Overall Study|Lost to Follow-up|6|||
23773396|NCT03527745|66550144|FG023|Overall Study|Lost to Follow-up|8|||
23773397|NCT03527745|66550145|FG024|Overall Study|Lost to Follow-up|1|||
23773398|NCT03527745|66550146|FG025|Overall Study|Lost to Follow-up|3|||
23773399|NCT01225146|66550149|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
23773400|NCT01225146|66550150|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
23773401|NCT02143102|66550157|FG000|Overall Study|Lost to Follow-up|11|||
23773402|NCT02143102|66550158|FG001|Overall Study|Lost to Follow-up|0|||
23773403|NCT02146430|66550160|FG000|Overall Study|Protocol Violation|5|||
23773404|NCT02146430|66550161|FG001|Overall Study|Protocol Violation|4|||
23773405|NCT02146430|66550162|FG002|Overall Study|Protocol Violation|8|||
23773406|NCT02146430|66550163|FG003|Overall Study|Protocol Violation|6|||
23773407|NCT02146430|66550160|FG000|Overall Study|Lack of Efficacy|13|||
23773408|NCT02146430|66550161|FG001|Overall Study|Lack of Efficacy|11|||
23773409|NCT02146430|66550162|FG002|Overall Study|Lack of Efficacy|8|||
23773410|NCT02146430|66550163|FG003|Overall Study|Lack of Efficacy|5|||
23773411|NCT02146430|66550160|FG000|Overall Study|Adverse Event|20|||
23773412|NCT02146430|66550161|FG001|Overall Study|Adverse Event|40|||
23773413|NCT02146430|66550162|FG002|Overall Study|Adverse Event|32|||
23773414|NCT02146430|66550163|FG003|Overall Study|Adverse Event|49|||
23773415|NCT02146430|66550160|FG000|Overall Study|Reason missing or not reported|2|||
23773416|NCT02146430|66550161|FG001|Overall Study|Reason missing or not reported|3|||
23773417|NCT02146430|66550162|FG002|Overall Study|Reason missing or not reported|4|||
23773418|NCT02146430|66550163|FG003|Overall Study|Reason missing or not reported|5|||
23773419|NCT02146430|66550160|FG000|Overall Study|Withdrawal by Subject|27|||
23773420|NCT02146430|66550161|FG001|Overall Study|Withdrawal by Subject|29|||
23773421|NCT02146430|66550162|FG002|Overall Study|Withdrawal by Subject|30|||
23773422|NCT02146430|66550163|FG003|Overall Study|Withdrawal by Subject|34|||
23773423|NCT02796664|66550164|FG000|Overall Study|Withdrawal by Subject|0|||
23773424|NCT02796664|66550165|FG001|Overall Study|Withdrawal by Subject|3|||
23773425|NCT02796664|66550164|FG000|Overall Study|Noncompliance|1|||
23773426|NCT02796664|66550165|FG001|Overall Study|Noncompliance|1|||
23773427|NCT02796664|66550164|FG000|Overall Study|Death|0|||
23773428|NCT02796664|66550165|FG001|Overall Study|Death|1|||
23773429|NCT01210001|66550166|FG000|Overall Study|Not treated|1|||
23773430|NCT01210001|66550167|FG001|Overall Study|Not treated|0|||
23773431|NCT01210001|66550168|FG002|Overall Study|Not treated|0|||
23773432|NCT01210001|66550166|FG000|Overall Study|Adverse Event|4|||
23773433|NCT01210001|66550167|FG001|Overall Study|Adverse Event|2|||
23773434|NCT01210001|66550168|FG002|Overall Study|Adverse Event|5|||
23773435|NCT01210001|66550166|FG000|Overall Study|Non compliant with protocol|2|||
23773436|NCT01210001|66550167|FG001|Overall Study|Non compliant with protocol|2|||
23773437|NCT01210001|66550168|FG002|Overall Study|Non compliant with protocol|3|||
23833813|NCT00848718|66770791|FG009|Overall Study|Lack of Efficacy|0|||
23575476|NCT00062868|65838730|FG014|Dose Level 3|Lost to Follow-up|1|||
23575477|NCT00062868|65838731|FG015|Dose Level 3|Lost to Follow-up|0|||
23773438|NCT01210001|66550166|FG000|Overall Study|Lost to Follow-up|4|||
23773439|NCT01210001|66550167|FG001|Overall Study|Lost to Follow-up|3|||
23773440|NCT01210001|66550168|FG002|Overall Study|Lost to Follow-up|2|||
23773441|NCT01210001|66550166|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
23773442|NCT01210001|66550167|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
23773443|NCT01210001|66550168|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
23773444|NCT01210001|66550166|FG000|Overall Study|Other reason not defined above|2|||
23773445|NCT01210001|66550167|FG001|Overall Study|Other reason not defined above|2|||
23773446|NCT01210001|66550168|FG002|Overall Study|Other reason not defined above|1|||
23773447|NCT02016170|66550170|FG000|Overall Study|Adverse Event|1|||
23773448|NCT02016170|66550171|FG001|Overall Study|Adverse Event|1|||
23773449|NCT02016170|66550172|FG002|Overall Study|Adverse Event|0|||
23773450|NCT02016170|66550170|FG000|Overall Study|Protocol Violation|1|||
23773451|NCT02016170|66550171|FG001|Overall Study|Protocol Violation|0|||
23773452|NCT02016170|66550172|FG002|Overall Study|Protocol Violation|0|||
23773453|NCT00051025|66550173|FG000|Overall Study|Progressive Disease|1|||
23773454|NCT00051025|66550174|FG001|Overall Study|Progressive Disease|1|||
23773455|NCT00051025|66550173|FG000|Overall Study|Adverse Event|1|||
23773456|NCT00051025|66550174|FG001|Overall Study|Adverse Event|1|||
23773457|NCT00051025|66550173|FG000|Overall Study|Withdrawal by Subject|0|||
23773458|NCT00051025|66550174|FG001|Overall Study|Withdrawal by Subject|1|||
23773459|NCT00051025|66550173|FG000|Overall Study|Death|0|||
23773460|NCT00051025|66550174|FG001|Overall Study|Death|1|||
23773461|NCT03184441|66550176|FG000|Overall Study|Withdrawal by Subject|1|||
23773462|NCT02906709|66550180|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
23773463|NCT02906709|66550181|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
23773464|NCT02906709|66550180|FG000|Phase A (Week 0 to Week 16)|Death|0|||
23773465|NCT02906709|66550181|FG001|Phase A (Week 0 to Week 16)|Death|1|||
23773466|NCT02906709|66550180|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
23773467|NCT02906709|66550181|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
23773468|NCT02906709|66550180|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
23773469|NCT02906709|66550181|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
23773470|NCT01000337|66550182|FG000|Overall Study|Lost to Follow-up|4|||
23773471|NCT01000337|66550183|FG001|Overall Study|Lost to Follow-up|3|||
23773472|NCT01089647|66550184|FG000|Overall Study|Lost to Follow-up|2|||
23773473|NCT01089647|66550185|FG001|Overall Study|Lost to Follow-up|2|||
23773474|NCT01089647|66550184|FG000|Overall Study|Withdrawal by Subject|2|||
23773475|NCT01089647|66550185|FG001|Overall Study|Withdrawal by Subject|1|||
23773476|NCT01089647|66550184|FG000|Overall Study|Adverse Event|0|||
23773477|NCT01089647|66550185|FG001|Overall Study|Adverse Event|1|||
23773478|NCT02974153|66550192|FG000|Overall Study|Adverse Event|6|||
23773479|NCT02974153|66550193|FG001|Overall Study|Adverse Event|0|||
23773480|NCT02974153|66550194|FG002|Overall Study|Adverse Event|1|||
23773481|NCT02974153|66550192|FG000|Overall Study|Lack of Efficacy|6|||
23773482|NCT02974153|66550193|FG001|Overall Study|Lack of Efficacy|5|||
23773483|NCT02974153|66550194|FG002|Overall Study|Lack of Efficacy|10|||
23773484|NCT02974153|66550192|FG000|Overall Study|Lost to Follow-up|9|||
23773485|NCT02974153|66550193|FG001|Overall Study|Lost to Follow-up|10|||
23773486|NCT02974153|66550194|FG002|Overall Study|Lost to Follow-up|17|||
23773487|NCT02974153|66550192|FG000|Overall Study|Physician Decision|0|||
23773488|NCT02974153|66550193|FG001|Overall Study|Physician Decision|2|||
23773489|NCT02974153|66550194|FG002|Overall Study|Physician Decision|1|||
23773490|NCT02974153|66550192|FG000|Overall Study|Withdrawal by Subject|9|||
23773491|NCT02974153|66550193|FG001|Overall Study|Withdrawal by Subject|16|||
23773492|NCT02974153|66550194|FG002|Overall Study|Withdrawal by Subject|11|||
23773493|NCT02974153|66550192|FG000|Overall Study|Study Burden|8|||
23773494|NCT02974153|66550193|FG001|Overall Study|Study Burden|7|||
23773495|NCT02974153|66550194|FG002|Overall Study|Study Burden|3|||
23773496|NCT02974153|66550192|FG000|Overall Study|Other|14|||
23773497|NCT02974153|66550193|FG001|Overall Study|Other|8|||
23773498|NCT02974153|66550194|FG002|Overall Study|Other|7|||
23773499|NCT00365300|66550195|FG000|Open-label Phase|Adverse Event|4|||
23773500|NCT00365300|66550196|FG001|Open-label Phase|Adverse Event|0|||
23773501|NCT00365300|66550195|FG000|Open-label Phase|Failed to Return|1|||
23773502|NCT00365300|66550196|FG001|Open-label Phase|Failed to Return|0|||
23773503|NCT00365300|66550195|FG000|Open-label Phase|Physician Decision|1|||
23773504|NCT00365300|66550196|FG001|Open-label Phase|Physician Decision|0|||
23773505|NCT00365300|66550195|FG000|Open-label Phase|Noncompliance|9|||
23773506|NCT00365300|66550196|FG001|Open-label Phase|Noncompliance|0|||
23773507|NCT00365300|66550195|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
23773508|NCT00365300|66550196|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
23773509|NCT00365300|66550195|FG000|Open-label Phase|Protocol Violation|1|||
23773510|NCT00365300|66550196|FG001|Open-label Phase|Protocol Violation|0|||
23773511|NCT00365300|66550195|FG000|Open-label Phase|Lack of Efficacy|1|||
23773512|NCT00365300|66550196|FG001|Open-label Phase|Lack of Efficacy|0|||
23773513|NCT00365300|66550195|FG000|Open-label Phase|Patient skipped open label phase|1|||
23773514|NCT00365300|66550196|FG001|Open-label Phase|Patient skipped open label phase|0|||
23773515|NCT00365300|66550195|FG000|Double-blind Phase|Failed to return|1|||
23773516|NCT00365300|66550196|FG001|Double-blind Phase|Failed to return|0|||
23773517|NCT00365300|66550195|FG000|Double-blind Phase|Noncompliance|1|||
23773518|NCT00365300|66550196|FG001|Double-blind Phase|Noncompliance|1|||
23773519|NCT00365300|66550195|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23773520|NCT00365300|66550196|FG001|Double-blind Phase|Withdrawal by Subject|1|||
23773521|NCT00365300|66550195|FG000|Double-blind Phase|Protocol Violation|3|||
23773522|NCT00365300|66550196|FG001|Double-blind Phase|Protocol Violation|1|||
23773523|NCT00365300|66550195|FG000|Double-blind Phase|Lack of Efficacy|6|||
23773524|NCT00365300|66550196|FG001|Double-blind Phase|Lack of Efficacy|6|||
23773525|NCT03500692|66550197|FG000|Overall Study|Death|163|||
23773526|NCT03500692|66550197|FG000|Overall Study|Lost to Follow-up|75|||
23773527|NCT03500692|66550197|FG000|Overall Study|Termination Reasons|3|||
23773528|NCT00688064|66550202|FG000|Overall Study|Protocol Violation|0|||
23773529|NCT00688064|66550203|FG001|Overall Study|Protocol Violation|1|||
23773530|NCT00688064|66550202|FG000|Overall Study|Adverse Event|2|||
23773531|NCT00688064|66550203|FG001|Overall Study|Adverse Event|4|||
23773532|NCT00688064|66550202|FG000|Overall Study|Withdrawal by Subject|7|||
23773533|NCT00688064|66550203|FG001|Overall Study|Withdrawal by Subject|7|||
23773534|NCT00688064|66550202|FG000|Overall Study|Lost to Follow-up|10|||
23773535|NCT00688064|66550203|FG001|Overall Study|Lost to Follow-up|10|||
23773536|NCT00688064|66550202|FG000|Overall Study|Lack of Efficacy|0|||
23773537|NCT00688064|66550203|FG001|Overall Study|Lack of Efficacy|1|||
23773538|NCT00688064|66550202|FG000|Overall Study|Pregnancy|1|||
23773539|NCT00688064|66550203|FG001|Overall Study|Pregnancy|0|||
23773540|NCT00688064|66550202|FG000|Overall Study|Any other reasons|1|||
23773541|NCT00688064|66550203|FG001|Overall Study|Any other reasons|3|||
23773542|NCT02193880|66550204|FG000|Overall Study|patients did not collect enough HPC|3|||
23773543|NCT02227862|66550206|FG000|Overall Study|Protocol Violation|7|||
23773544|NCT02227862|66550207|FG001|Overall Study|Protocol Violation|9|||
23773545|NCT02227862|66550206|FG000|Overall Study|Other|0|||
23773546|NCT02227862|66550207|FG001|Overall Study|Other|2|||
23773547|NCT02227862|66550206|FG000|Overall Study|Adverse Event|4|||
23773548|NCT02227862|66550207|FG001|Overall Study|Adverse Event|3|||
23773549|NCT02227862|66550206|FG000|Overall Study|Withdrawal by Subject|7|||
23773550|NCT02227862|66550207|FG001|Overall Study|Withdrawal by Subject|6|||
23773551|NCT02227862|66550206|FG000|Overall Study|Lost to Follow-up|1|||
23773552|NCT02227862|66550207|FG001|Overall Study|Lost to Follow-up|2|||
23773553|NCT00796822|66550212|FG000|Overall Study|Lost to Follow-up|2|||
23773554|NCT00796822|66550213|FG001|Overall Study|Lost to Follow-up|0|||
23773555|NCT00796822|66550212|FG000|Overall Study|Adverse Event|1|||
23773556|NCT00796822|66550213|FG001|Overall Study|Adverse Event|0|||
23773557|NCT00950807|66550215|FG000|Treatment Period 1|Lack of Efficacy|1|||
23773558|NCT00950807|66550216|FG001|Treatment Period 1|Lack of Efficacy|0|||
23773559|NCT00950807|66550217|FG002|Treatment Period 1|Lack of Efficacy|0|||
23773560|NCT00950807|66550218|FG003|Treatment Period 1|Lack of Efficacy|0|||
23773561|NCT00950807|66550219|FG004|Treatment Period 1|Lack of Efficacy|0|||
23773562|NCT00950807|66550220|FG005|Treatment Period 1|Lack of Efficacy|1|||
23773563|NCT00950807|66550221|FG006|Treatment Period 1|Lack of Efficacy|0|||
23773564|NCT00950807|66550222|FG007|Treatment Period 1|Lack of Efficacy|0|||
23773565|NCT00950807|66550223|FG008|Treatment Period 1|Lack of Efficacy|0|||
23773566|NCT00950807|66550224|FG009|Treatment Period 1|Lack of Efficacy|0|||
23773567|NCT00950807|66550215|FG000|Treatment Period 1|Protocol Violation|1|||
23773568|NCT00950807|66550216|FG001|Treatment Period 1|Protocol Violation|0|||
23773569|NCT00950807|66550217|FG002|Treatment Period 1|Protocol Violation|0|||
23773570|NCT00950807|66550218|FG003|Treatment Period 1|Protocol Violation|0|||
23773571|NCT00950807|66550219|FG004|Treatment Period 1|Protocol Violation|0|||
23773572|NCT00950807|66550220|FG005|Treatment Period 1|Protocol Violation|0|||
23773573|NCT00950807|66550221|FG006|Treatment Period 1|Protocol Violation|0|||
23773574|NCT00950807|66550222|FG007|Treatment Period 1|Protocol Violation|0|||
23773575|NCT00950807|66550223|FG008|Treatment Period 1|Protocol Violation|0|||
23773576|NCT00950807|66550224|FG009|Treatment Period 1|Protocol Violation|0|||
23773577|NCT00950807|66550215|FG000|Treatment Period 1|Lost to Follow-up|0|||
23773578|NCT00950807|66550216|FG001|Treatment Period 1|Lost to Follow-up|0|||
23773579|NCT00950807|66550217|FG002|Treatment Period 1|Lost to Follow-up|1|||
23773580|NCT00950807|66550218|FG003|Treatment Period 1|Lost to Follow-up|0|||
23773581|NCT00950807|66550219|FG004|Treatment Period 1|Lost to Follow-up|0|||
23773582|NCT00950807|66550220|FG005|Treatment Period 1|Lost to Follow-up|0|||
23773583|NCT00950807|66550221|FG006|Treatment Period 1|Lost to Follow-up|0|||
23773584|NCT00950807|66550222|FG007|Treatment Period 1|Lost to Follow-up|0|||
23773585|NCT00950807|66550223|FG008|Treatment Period 1|Lost to Follow-up|0|||
23773586|NCT00950807|66550224|FG009|Treatment Period 1|Lost to Follow-up|0|||
23773587|NCT00950807|66550215|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23773588|NCT00950807|66550216|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23773589|NCT00950807|66550217|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23773590|NCT00950807|66550218|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23773591|NCT00950807|66550219|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23773592|NCT00950807|66550220|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23773593|NCT00950807|66550221|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23773594|NCT00950807|66550222|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23773595|NCT00950807|66550223|FG008|Treatment Period 1|Withdrawal by Subject|1|||
23773596|NCT00950807|66550224|FG009|Treatment Period 1|Withdrawal by Subject|0|||
23773597|NCT00950807|66550215|FG000|Treatment Period 1|Adverse Event|0|||
23773598|NCT00950807|66550216|FG001|Treatment Period 1|Adverse Event|0|||
23773599|NCT00950807|66550217|FG002|Treatment Period 1|Adverse Event|0|||
23773600|NCT00950807|66550218|FG003|Treatment Period 1|Adverse Event|0|||
23773601|NCT00950807|66550219|FG004|Treatment Period 1|Adverse Event|0|||
23773602|NCT00950807|66550220|FG005|Treatment Period 1|Adverse Event|1|||
23773603|NCT00950807|66550221|FG006|Treatment Period 1|Adverse Event|0|||
23773604|NCT00950807|66550222|FG007|Treatment Period 1|Adverse Event|0|||
23773605|NCT00950807|66550223|FG008|Treatment Period 1|Adverse Event|0|||
23773606|NCT00950807|66550224|FG009|Treatment Period 1|Adverse Event|0|||
23773607|NCT00950807|66550215|FG000|Washout Period 1|Lack of Efficacy|0|||
23833814|NCT00848718|66770792|FG010|Overall Study|Lack of Efficacy|0|||
23773608|NCT00950807|66550216|FG001|Washout Period 1|Lack of Efficacy|0|||
23773609|NCT00950807|66550217|FG002|Washout Period 1|Lack of Efficacy|0|||
23773610|NCT00950807|66550218|FG003|Washout Period 1|Lack of Efficacy|0|||
23575478|NCT00062868|65838732|FG016|Dose Level 3|Lost to Follow-up|0|||
23575479|NCT00062868|65838733|FG017|Dose Level 3|Lost to Follow-up|0|||
23575480|NCT00062868|65838734|FG018|Dose Level 3|Lost to Follow-up|0|||
23575481|NCT00062868|65838735|FG019|Dose Level 3|Lost to Follow-up|0|||
23575482|NCT00062868|65838736|FG020|Dose Level 3|Lost to Follow-up|0|||
23575483|NCT00062868|65838716|FG000|Dose Level 3|Withdrew|0|||
23575484|NCT00062868|65838717|FG001|Dose Level 3|Withdrew|0|||
23575485|NCT00062868|65838718|FG002|Dose Level 3|Withdrew|2|||
23575486|NCT00062868|65838719|FG003|Dose Level 3|Withdrew|0|||
23833815|NCT00848718|66770793|FG011|Overall Study|Lack of Efficacy|0|||
23575487|NCT00062868|65838720|FG004|Dose Level 3|Withdrew|0|||
23575488|NCT00062868|65838721|FG005|Dose Level 3|Withdrew|0|||
23575489|NCT00062868|65838722|FG006|Dose Level 3|Withdrew|0|||
23773611|NCT00950807|66550219|FG004|Washout Period 1|Lack of Efficacy|0|||
23773612|NCT00950807|66550220|FG005|Washout Period 1|Lack of Efficacy|0|||
23773613|NCT00950807|66550221|FG006|Washout Period 1|Lack of Efficacy|1|||
23773614|NCT00950807|66550222|FG007|Washout Period 1|Lack of Efficacy|0|||
23773615|NCT00950807|66550223|FG008|Washout Period 1|Lack of Efficacy|0|||
23575490|NCT00062868|65838723|FG007|Dose Level 3|Withdrew|0|||
23773616|NCT00950807|66550224|FG009|Washout Period 1|Lack of Efficacy|0|||
23833816|NCT00848718|66770794|FG012|Overall Study|Lack of Efficacy|0|||
23833817|NCT00848718|66770782|FG000|Overall Study|Physician Decision|0|||
23575491|NCT00062868|65838724|FG008|Dose Level 3|Withdrew|0|||
23773617|NCT00950807|66550215|FG000|Washout Period 1|Withdrawal by Subject|0|||
23773618|NCT00950807|66550216|FG001|Washout Period 1|Withdrawal by Subject|0|||
23773619|NCT00950807|66550217|FG002|Washout Period 1|Withdrawal by Subject|0|||
23773620|NCT00950807|66550218|FG003|Washout Period 1|Withdrawal by Subject|0|||
23773621|NCT00950807|66550219|FG004|Washout Period 1|Withdrawal by Subject|0|||
23773622|NCT00950807|66550220|FG005|Washout Period 1|Withdrawal by Subject|0|||
23773623|NCT00950807|66550221|FG006|Washout Period 1|Withdrawal by Subject|0|||
23773624|NCT00950807|66550222|FG007|Washout Period 1|Withdrawal by Subject|0|||
23773625|NCT00950807|66550223|FG008|Washout Period 1|Withdrawal by Subject|1|||
23773626|NCT00950807|66550224|FG009|Washout Period 1|Withdrawal by Subject|0|||
23773627|NCT00950807|66550215|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
23773628|NCT00950807|66550216|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773629|NCT00950807|66550217|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773630|NCT00950807|66550218|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773631|NCT00950807|66550219|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773632|NCT00950807|66550220|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773633|NCT00950807|66550221|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
23575492|NCT00062868|65838725|FG009|Dose Level 3|Withdrew|0|||
23773634|NCT00950807|66550222|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
23773635|NCT00950807|66550223|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23773636|NCT00950807|66550224|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23833818|NCT00848718|66770783|FG001|Overall Study|Physician Decision|1|||
23833819|NCT00848718|66770784|FG002|Overall Study|Physician Decision|0|||
23833820|NCT00848718|66770785|FG003|Overall Study|Physician Decision|0|||
23833821|NCT00848718|66770786|FG004|Overall Study|Physician Decision|1|||
23633700|NCT04942366|66045440|FG000|Overall Study|Withdrawal by Subject|5|||
23773637|NCT00950807|66550215|FG000|Washout Period 1|Adverse Event|2|||
23773638|NCT00950807|66550216|FG001|Washout Period 1|Adverse Event|0|||
23773639|NCT00950807|66550217|FG002|Washout Period 1|Adverse Event|0|||
23773640|NCT00950807|66550218|FG003|Washout Period 1|Adverse Event|1|||
23833822|NCT00848718|66770787|FG005|Overall Study|Physician Decision|1|||
23833823|NCT00848718|66770788|FG006|Overall Study|Physician Decision|0|||
23575493|NCT00062868|65838726|FG010|Dose Level 3|Withdrew|0|||
23575494|NCT00062868|65838727|FG011|Dose Level 3|Withdrew|0|||
23575495|NCT00062868|65838728|FG012|Dose Level 3|Withdrew|0|||
23575496|NCT00062868|65838729|FG013|Dose Level 3|Withdrew|0|||
23773641|NCT00950807|66550219|FG004|Washout Period 1|Adverse Event|1|||
23773642|NCT00950807|66550220|FG005|Washout Period 1|Adverse Event|0|||
23773643|NCT00950807|66550221|FG006|Washout Period 1|Adverse Event|0|||
23773644|NCT00950807|66550222|FG007|Washout Period 1|Adverse Event|0|||
23773645|NCT00950807|66550223|FG008|Washout Period 1|Adverse Event|0|||
23773646|NCT00950807|66550224|FG009|Washout Period 1|Adverse Event|0|||
23773647|NCT00950807|66550215|FG000|Treatment Period 2|Lack of Efficacy|1|||
23773648|NCT00950807|66550216|FG001|Treatment Period 2|Lack of Efficacy|0|||
23773649|NCT00950807|66550217|FG002|Treatment Period 2|Lack of Efficacy|0|||
23773650|NCT00950807|66550218|FG003|Treatment Period 2|Lack of Efficacy|0|||
23773651|NCT00950807|66550219|FG004|Treatment Period 2|Lack of Efficacy|0|||
23773652|NCT00950807|66550220|FG005|Treatment Period 2|Lack of Efficacy|0|||
23773653|NCT00950807|66550221|FG006|Treatment Period 2|Lack of Efficacy|0|||
23773654|NCT00950807|66550222|FG007|Treatment Period 2|Lack of Efficacy|0|||
23773655|NCT00950807|66550223|FG008|Treatment Period 2|Lack of Efficacy|0|||
23773656|NCT00950807|66550224|FG009|Treatment Period 2|Lack of Efficacy|0|||
23773657|NCT00950807|66550215|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23773658|NCT00950807|66550216|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23773659|NCT00950807|66550217|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23773660|NCT00950807|66550218|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23773661|NCT00950807|66550219|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23773662|NCT00950807|66550220|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23773663|NCT00950807|66550221|FG006|Treatment Period 2|Withdrawal by Subject|1|||
23773664|NCT00950807|66550222|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23773665|NCT00950807|66550223|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23773666|NCT00950807|66550224|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23773667|NCT00950807|66550215|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
23773668|NCT00950807|66550216|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773669|NCT00950807|66550217|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23833824|NCT00848718|66770789|FG007|Overall Study|Physician Decision|0|||
23833825|NCT00848718|66770790|FG008|Overall Study|Physician Decision|1|||
23447533|NCT00717249|65380503|FG001|Overall Study|Lost to Follow-up|0|||
23447534|NCT00717249|65380502|FG000|Overall Study|Withdrawal by Subject|1|||
23773670|NCT00950807|66550218|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773671|NCT00950807|66550219|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773672|NCT00950807|66550220|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773673|NCT00950807|66550221|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23833826|NCT00848718|66770791|FG009|Overall Study|Physician Decision|2|||
23773674|NCT00950807|66550222|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773675|NCT00950807|66550223|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773676|NCT00950807|66550224|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23773677|NCT00950807|66550215|FG000|Treatment Period 2|Adverse Event|0|||
23773678|NCT00950807|66550216|FG001|Treatment Period 2|Adverse Event|1|||
23773679|NCT00950807|66550217|FG002|Treatment Period 2|Adverse Event|0|||
23773680|NCT00950807|66550218|FG003|Treatment Period 2|Adverse Event|1|||
23773681|NCT00950807|66550219|FG004|Treatment Period 2|Adverse Event|0|||
23575497|NCT00062868|65838730|FG014|Dose Level 3|Withdrew|0|||
23575498|NCT00062868|65838731|FG015|Dose Level 3|Withdrew|0|||
23575499|NCT00062868|65838732|FG016|Dose Level 3|Withdrew|0|||
23575500|NCT00062868|65838733|FG017|Dose Level 3|Withdrew|0|||
23773682|NCT00950807|66550220|FG005|Treatment Period 2|Adverse Event|1|||
23773683|NCT00950807|66550221|FG006|Treatment Period 2|Adverse Event|0|||
23773684|NCT00950807|66550222|FG007|Treatment Period 2|Adverse Event|1|||
23773685|NCT00950807|66550223|FG008|Treatment Period 2|Adverse Event|0|||
23773686|NCT00950807|66550224|FG009|Treatment Period 2|Adverse Event|0|||
23773687|NCT00950807|66550215|FG000|Washout Period 2|Lack of Efficacy|1|||
23833827|NCT00848718|66770792|FG010|Overall Study|Physician Decision|0|||
23833828|NCT00848718|66770793|FG011|Overall Study|Physician Decision|0|||
23833829|NCT00848718|66770794|FG012|Overall Study|Physician Decision|1|||
23833830|NCT00848718|66770782|FG000|Overall Study|Progressive disease before treatment|1|||
23833831|NCT00848718|66770783|FG001|Overall Study|Progressive disease before treatment|5|||
23833832|NCT00848718|66770784|FG002|Overall Study|Progressive disease before treatment|1|||
23833833|NCT00848718|66770785|FG003|Overall Study|Progressive disease before treatment|3|||
23833834|NCT00848718|66770786|FG004|Overall Study|Progressive disease before treatment|4|||
23833835|NCT00848718|66770787|FG005|Overall Study|Progressive disease before treatment|4|||
23773688|NCT00950807|66550216|FG001|Washout Period 2|Lack of Efficacy|0|||
23575501|NCT00062868|65838734|FG018|Dose Level 3|Withdrew|0|||
23575502|NCT00062868|65838735|FG019|Dose Level 3|Withdrew|0|||
23773689|NCT00950807|66550217|FG002|Washout Period 2|Lack of Efficacy|0|||
23773690|NCT00950807|66550218|FG003|Washout Period 2|Lack of Efficacy|0|||
23773691|NCT00950807|66550219|FG004|Washout Period 2|Lack of Efficacy|0|||
23773692|NCT00950807|66550220|FG005|Washout Period 2|Lack of Efficacy|0|||
23773693|NCT00950807|66550221|FG006|Washout Period 2|Lack of Efficacy|0|||
23773694|NCT00950807|66550222|FG007|Washout Period 2|Lack of Efficacy|0|||
23773695|NCT00950807|66550223|FG008|Washout Period 2|Lack of Efficacy|0|||
23773696|NCT00950807|66550224|FG009|Washout Period 2|Lack of Efficacy|0|||
23773697|NCT00950807|66550215|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23575503|NCT00062868|65838736|FG020|Dose Level 3|Withdrew|0|||
23773698|NCT00950807|66550216|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23773699|NCT00950807|66550217|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23773700|NCT00950807|66550218|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23773701|NCT00950807|66550219|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23773702|NCT00950807|66550220|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23773703|NCT00950807|66550221|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23773704|NCT00950807|66550222|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23773705|NCT00950807|66550223|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23773706|NCT00950807|66550224|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23773707|NCT00950807|66550215|FG000|Washout Period 2|Adverse Event|3|||
23773708|NCT00950807|66550216|FG001|Washout Period 2|Adverse Event|0|||
23773709|NCT00950807|66550217|FG002|Washout Period 2|Adverse Event|0|||
23773710|NCT00950807|66550218|FG003|Washout Period 2|Adverse Event|1|||
23773711|NCT00950807|66550219|FG004|Washout Period 2|Adverse Event|0|||
23773712|NCT00950807|66550220|FG005|Washout Period 2|Adverse Event|0|||
23773713|NCT00950807|66550221|FG006|Washout Period 2|Adverse Event|0|||
23773714|NCT00950807|66550222|FG007|Washout Period 2|Adverse Event|0|||
23773715|NCT00950807|66550223|FG008|Washout Period 2|Adverse Event|0|||
23773716|NCT00950807|66550224|FG009|Washout Period 2|Adverse Event|0|||
23773717|NCT00950807|66550215|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23773718|NCT00950807|66550216|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23773719|NCT00950807|66550217|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23773720|NCT00950807|66550218|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23773721|NCT00950807|66550219|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23773722|NCT00950807|66550220|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23773723|NCT00950807|66550221|FG006|Treatment Period 3|Withdrawal by Subject|0|||
23773724|NCT00950807|66550222|FG007|Treatment Period 3|Withdrawal by Subject|0|||
23773725|NCT00950807|66550223|FG008|Treatment Period 3|Withdrawal by Subject|0|||
23773726|NCT00950807|66550224|FG009|Treatment Period 3|Withdrawal by Subject|1|||
23773727|NCT00950807|66550215|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23773728|NCT00950807|66550216|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773729|NCT00950807|66550217|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773730|NCT00950807|66550218|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773731|NCT00950807|66550219|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23447535|NCT00717249|65380503|FG001|Overall Study|Withdrawal by Subject|2|||
23447536|NCT00717249|65380502|FG000|Overall Study|Pregnancy|6|||
23447537|NCT00717249|65380503|FG001|Overall Study|Pregnancy|3|||
23447538|NCT00717249|65380502|FG000|Overall Study|Protocol Violation|0|||
23447539|NCT00717249|65380503|FG001|Overall Study|Protocol Violation|2|||
23447540|NCT00717249|65380502|FG000|Overall Study|Subject became Ineligible|1|||
23447541|NCT00717249|65380503|FG001|Overall Study|Subject became Ineligible|1|||
23447542|NCT00717249|65380502|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
23447543|NCT00717249|65380503|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
23447544|NCT00717249|65380502|FG000|Overall Study|Gastric Surgery|0|||
23447545|NCT00717249|65380503|FG001|Overall Study|Gastric Surgery|1|||
23447546|NCT00717249|65380502|FG000|Overall Study|Diagnosed with Diabetes|1|||
23447547|NCT00717249|65380503|FG001|Overall Study|Diagnosed with Diabetes|0|||
23447548|NCT00717249|65380502|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
23447549|NCT00717249|65380503|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
23447550|NCT00717249|65380502|FG000|Overall Study|Subject relocated|1|||
23447551|NCT00717249|65380503|FG001|Overall Study|Subject relocated|0|||
23447552|NCT00717249|65380502|FG000|Overall Study|Headaches|1|||
23447553|NCT00717249|65380503|FG001|Overall Study|Headaches|0|||
23447554|NCT02420093|65380512|FG000|Overall Study|Withdrawal by Subject|1|||
23447555|NCT02420093|65380513|FG001|Overall Study|Withdrawal by Subject|1|||
23447556|NCT02905266|65380514|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
23447557|NCT02905266|65380515|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
23447558|NCT02905266|65380514|FG000|Treatment Phase Part 1|Disease Progression|6|||
23447559|NCT02905266|65380515|FG001|Treatment Phase Part 1|Disease Progression|7|||
23447560|NCT02905266|65380514|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
23447561|NCT02905266|65380515|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
23447562|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
23447563|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
23447564|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
23447565|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
23447566|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
23447567|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
23447568|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Death|0|||
23447569|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Death|1|||
23447570|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
23447571|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
23447572|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
23447573|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
23773732|NCT00950807|66550220|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773733|NCT00950807|66550221|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773734|NCT00950807|66550222|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23773735|NCT00950807|66550223|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773736|NCT00950807|66550224|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23773737|NCT00950807|66550215|FG000|Treatment Period 3|Adverse Event|0|||
23773738|NCT00950807|66550216|FG001|Treatment Period 3|Adverse Event|0|||
23773739|NCT00950807|66550217|FG002|Treatment Period 3|Adverse Event|0|||
23773740|NCT00950807|66550218|FG003|Treatment Period 3|Adverse Event|0|||
23773741|NCT00950807|66550219|FG004|Treatment Period 3|Adverse Event|0|||
23447574|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Disease Progression|9|||
23447575|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Disease Progression|2|||
23447576|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
23575504|NCT03697460|65838737|FG000|Overall Study|Withdrawal by Subject|3|||
23773742|NCT00950807|66550220|FG005|Treatment Period 3|Adverse Event|0|||
23447577|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
23773743|NCT00950807|66550221|FG006|Treatment Period 3|Adverse Event|1|||
23773744|NCT00950807|66550222|FG007|Treatment Period 3|Adverse Event|0|||
23773745|NCT00950807|66550223|FG008|Treatment Period 3|Adverse Event|0|||
23447578|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
23575505|NCT00372528|65838738|FG000|Overall Study|Lack of Efficacy|1|||
23447579|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
23447580|NCT00890825|65380517|FG000|Overall Study|Withdrawal by Subject|1|||
23447581|NCT00890825|65380518|FG001|Overall Study|Withdrawal by Subject|0|||
23447582|NCT00890825|65380517|FG000|Overall Study|Alive at data cut off (DCO)|13|||
23447583|NCT00890825|65380518|FG001|Overall Study|Alive at data cut off (DCO)|14|||
23447584|NCT03187132|65380519|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
23447585|NCT03187132|65380520|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
23447586|NCT03187132|65380519|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
23447587|NCT03187132|65380520|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
23447588|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
23447589|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
23447590|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
23447591|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
23447592|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
23447593|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
23447594|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
23447595|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
23447596|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
23447597|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
23447598|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
23447599|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
23447600|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
23447601|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
23447602|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
23773746|NCT00950807|66550224|FG009|Treatment Period 3|Adverse Event|0|||
23773747|NCT01402947|66550225|FG000|First Intervention|Adverse Event|0|||
23773748|NCT01402947|66550226|FG001|First Intervention|Adverse Event|1|||
23773749|NCT00553280|66550229|FG000|Overall Study|Adverse Event|19|||
23773750|NCT00553280|66550229|FG000|Overall Study|Lack of Efficacy|3|||
23773751|NCT00553280|66550229|FG000|Overall Study|Withdrawal by Subject|3|||
23773752|NCT00553280|66550229|FG000|Overall Study|Physician Decision|1|||
23773753|NCT01984242|66550230|FG000|Overall Study|Death|52|||
23773754|NCT01984242|66550231|FG001|Overall Study|Death|50|||
23773755|NCT01984242|66550232|FG002|Overall Study|Death|52|||
23773756|NCT01984242|66550230|FG000|Overall Study|Withdrawal by Subject|5|||
23773757|NCT01984242|66550231|FG001|Overall Study|Withdrawal by Subject|3|||
23773758|NCT01984242|66550232|FG002|Overall Study|Withdrawal by Subject|10|||
23773759|NCT01984242|66550230|FG000|Overall Study|Physician Decision|0|||
23773760|NCT01984242|66550231|FG001|Overall Study|Physician Decision|0|||
23773761|NCT01984242|66550232|FG002|Overall Study|Physician Decision|1|||
23447603|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
23447604|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
23575506|NCT00372528|65838738|FG000|Overall Study|Adverse Event|1|||
23575507|NCT00372528|65838738|FG000|Overall Study|Study Terminated by Sponsor|18|||
23833836|NCT00848718|66770788|FG006|Overall Study|Progressive disease before treatment|2|||
23447605|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
23447606|NCT02221674|65380523|FG000|Overall Study|Lost to Follow-up|1|||
23773762|NCT01984242|66550230|FG000|Overall Study|Lost to Follow-up|4|||
23773763|NCT01984242|66550231|FG001|Overall Study|Lost to Follow-up|0|||
23447607|NCT02221674|65380524|FG001|Overall Study|Lost to Follow-up|0|||
23447608|NCT02221674|65380525|FG002|Overall Study|Lost to Follow-up|0|||
23447609|NCT02730728|65380526|FG000|Overall Study|Withdrawal by Subject|0|||
23447610|NCT02730728|65380527|FG001|Overall Study|Withdrawal by Subject|1|||
23447611|NCT02730728|65380528|FG002|Overall Study|Withdrawal by Subject|0|||
23447612|NCT02730728|65380526|FG000|Overall Study|Lack of Efficacy|0|||
23447613|NCT02730728|65380527|FG001|Overall Study|Lack of Efficacy|1|||
23447614|NCT02730728|65380528|FG002|Overall Study|Lack of Efficacy|1|||
23447615|NCT00570310|65380539|FG000|Overall Study|Adverse Event|1|||
23447616|NCT00570310|65380540|FG001|Overall Study|Adverse Event|2|||
23447617|NCT00570310|65380539|FG000|Overall Study|Lack of Efficacy|1|||
23447618|NCT00570310|65380540|FG001|Overall Study|Lack of Efficacy|4|||
23447619|NCT00687804|65380547|FG000|Core Study|Adverse Event|5|||
23447620|NCT00687804|65380548|FG001|Core Study|Adverse Event|3|||
23447621|NCT00687804|65380549|FG002|Core Study|Adverse Event|3|||
23447622|NCT00687804|65380547|FG000|Core Study|Abnormal laboratory value(s)|1|||
23447623|NCT00687804|65380548|FG001|Core Study|Abnormal laboratory value(s)|0|||
23575508|NCT00372528|65838738|FG000|Overall Study|Other|1|||
23447624|NCT00687804|65380549|FG002|Core Study|Abnormal laboratory value(s)|0|||
23447625|NCT00687804|65380547|FG000|Core Study|Lack of Efficacy|1|||
23447626|NCT00687804|65380548|FG001|Core Study|Lack of Efficacy|1|||
23447627|NCT00687804|65380549|FG002|Core Study|Lack of Efficacy|1|||
23447628|NCT00687804|65380547|FG000|Core Study|Withdrawal by Subject|4|||
23447629|NCT00687804|65380548|FG001|Core Study|Withdrawal by Subject|7|||
23447630|NCT00687804|65380549|FG002|Core Study|Withdrawal by Subject|7|||
23447631|NCT00687804|65380547|FG000|Core Study|Lost to Follow-up|0|||
23447632|NCT00687804|65380548|FG001|Core Study|Lost to Follow-up|1|||
23447633|NCT00687804|65380549|FG002|Core Study|Lost to Follow-up|0|||
23447634|NCT00687804|65380547|FG000|Core Study|Death|2|||
23575509|NCT00097370|65838739|FG000|Stage 1|Adverse Event|3|||
23575510|NCT00097370|65838739|FG000|Stage 1|Withdrawal by Subject|1|||
23575511|NCT00097370|65838739|FG000|Stage 1|Lack of Efficacy|2|||
23833837|NCT00848718|66770789|FG007|Overall Study|Progressive disease before treatment|1|||
23833838|NCT00848718|66770790|FG008|Overall Study|Progressive disease before treatment|2|||
23833839|NCT00848718|66770791|FG009|Overall Study|Progressive disease before treatment|7|||
23833840|NCT00848718|66770792|FG010|Overall Study|Progressive disease before treatment|3|||
23833841|NCT00848718|66770793|FG011|Overall Study|Progressive disease before treatment|6|||
23833842|NCT00848718|66770794|FG012|Overall Study|Progressive disease before treatment|2|||
23833843|NCT00848718|66770782|FG000|Overall Study|Protocol Violation|0|||
23833844|NCT00848718|66770783|FG001|Overall Study|Protocol Violation|1|||
23833845|NCT00848718|66770784|FG002|Overall Study|Protocol Violation|0|||
23833846|NCT00848718|66770785|FG003|Overall Study|Protocol Violation|0|||
23833847|NCT00848718|66770786|FG004|Overall Study|Protocol Violation|0|||
23833848|NCT00848718|66770787|FG005|Overall Study|Protocol Violation|0|||
23833849|NCT00848718|66770788|FG006|Overall Study|Protocol Violation|0|||
23833850|NCT00848718|66770789|FG007|Overall Study|Protocol Violation|1|||
23833851|NCT00848718|66770790|FG008|Overall Study|Protocol Violation|0|||
23833852|NCT00848718|66770791|FG009|Overall Study|Protocol Violation|0|||
23833853|NCT00848718|66770792|FG010|Overall Study|Protocol Violation|0|||
23833854|NCT00848718|66770793|FG011|Overall Study|Protocol Violation|0|||
23833855|NCT00848718|66770794|FG012|Overall Study|Protocol Violation|1|||
23833856|NCT00848718|66770782|FG000|Overall Study|Withdrawal by Subject|1|||
23833857|NCT00848718|66770783|FG001|Overall Study|Withdrawal by Subject|0|||
23833858|NCT00848718|66770784|FG002|Overall Study|Withdrawal by Subject|0|||
23833859|NCT00848718|66770785|FG003|Overall Study|Withdrawal by Subject|1|||
23833860|NCT00848718|66770786|FG004|Overall Study|Withdrawal by Subject|0|||
23833861|NCT00848718|66770787|FG005|Overall Study|Withdrawal by Subject|0|||
23833862|NCT00848718|66770788|FG006|Overall Study|Withdrawal by Subject|0|||
23833863|NCT00848718|66770789|FG007|Overall Study|Withdrawal by Subject|0|||
23833864|NCT00848718|66770790|FG008|Overall Study|Withdrawal by Subject|0|||
23833865|NCT00848718|66770791|FG009|Overall Study|Withdrawal by Subject|0|||
23833866|NCT00848718|66770792|FG010|Overall Study|Withdrawal by Subject|1|||
23833867|NCT00848718|66770793|FG011|Overall Study|Withdrawal by Subject|0|||
23833868|NCT00848718|66770794|FG012|Overall Study|Withdrawal by Subject|0|||
23447635|NCT00687804|65380548|FG001|Core Study|Death|2|||
23447636|NCT00687804|65380549|FG002|Core Study|Death|2|||
23575512|NCT00097370|65838739|FG000|Stage 2|Adverse Event|5|||
23833869|NCT00848718|66770782|FG000|Overall Study|Progressive disease during treatment|3|||
23833870|NCT00848718|66770783|FG001|Overall Study|Progressive disease during treatment|0|||
23833871|NCT00848718|66770784|FG002|Overall Study|Progressive disease during treatment|3|||
23833872|NCT00848718|66770785|FG003|Overall Study|Progressive disease during treatment|0|||
23833873|NCT00848718|66770786|FG004|Overall Study|Progressive disease during treatment|0|||
23833874|NCT00848718|66770787|FG005|Overall Study|Progressive disease during treatment|0|||
23833875|NCT00848718|66770788|FG006|Overall Study|Progressive disease during treatment|0|||
23447637|NCT00687804|65380547|FG000|Core Study|Protocol Violation|1|||
23447638|NCT00687804|65380548|FG001|Core Study|Protocol Violation|1|||
23575513|NCT00097370|65838739|FG000|Stage 2|Withdrawal by Subject|1|||
23773764|NCT01984242|66550232|FG002|Overall Study|Lost to Follow-up|3|||
23773765|NCT01984242|66550230|FG000|Overall Study|Sponsor Decision|1|||
23773766|NCT01984242|66550231|FG001|Overall Study|Sponsor Decision|0|||
23773767|NCT01984242|66550232|FG002|Overall Study|Sponsor Decision|0|||
23773768|NCT01984242|66550230|FG000|Overall Study|Non-Compliance|1|||
23773769|NCT01984242|66550231|FG001|Overall Study|Non-Compliance|0|||
23773770|NCT01984242|66550232|FG002|Overall Study|Non-Compliance|0|||
23773771|NCT01984242|66550230|FG000|Overall Study|Study terminated by Sponsor|38|||
23773772|NCT01984242|66550231|FG001|Overall Study|Study terminated by Sponsor|50|||
23773773|NCT01984242|66550232|FG002|Overall Study|Study terminated by Sponsor|34|||
23773774|NCT01984242|66550230|FG000|Overall Study|Disease Progression|0|||
23773775|NCT01984242|66550231|FG001|Overall Study|Disease Progression|0|||
23773776|NCT01984242|66550232|FG002|Overall Study|Disease Progression|1|||
23773777|NCT02242201|66550233|FG000|Overall Study|preoperative identified neuropathy|2|||
23773778|NCT02242201|66550234|FG001|Overall Study|preoperative identified neuropathy|0|||
23773779|NCT02242201|66550235|FG002|Overall Study|preoperative identified neuropathy|0|||
23773780|NCT02242201|66550233|FG000|Overall Study|planned post-op anticoagulation|1|||
23773781|NCT02242201|66550234|FG001|Overall Study|planned post-op anticoagulation|0|||
23773782|NCT02242201|66550235|FG002|Overall Study|planned post-op anticoagulation|0|||
23773783|NCT02242201|66550233|FG000|Overall Study|changed surgical procedure|1|||
23773784|NCT02242201|66550234|FG001|Overall Study|changed surgical procedure|0|||
23773785|NCT02242201|66550235|FG002|Overall Study|changed surgical procedure|0|||
23773786|NCT02242201|66550233|FG000|Overall Study|postponed surgery|0|||
23773787|NCT02242201|66550234|FG001|Overall Study|postponed surgery|0|||
23773788|NCT02242201|66550235|FG002|Overall Study|postponed surgery|1|||
23773789|NCT02242201|66550233|FG000|Overall Study|preoperative opioid consumption|0|||
23773790|NCT02242201|66550234|FG001|Overall Study|preoperative opioid consumption|1|||
23773791|NCT02242201|66550235|FG002|Overall Study|preoperative opioid consumption|0|||
23773792|NCT03583606|66550245|FG000|Overall Study|Lost to Follow-up|0|||
23773793|NCT03583606|66550246|FG001|Overall Study|Lost to Follow-up|1|||
23773794|NCT03583606|66550247|FG002|Overall Study|Lost to Follow-up|0|||
23773795|NCT03583606|66550245|FG000|Overall Study|Ineligible at baseline|1|||
23773796|NCT03583606|66550246|FG001|Overall Study|Ineligible at baseline|0|||
23773797|NCT03583606|66550247|FG002|Overall Study|Ineligible at baseline|0|||
23773798|NCT01936948|66550248|FG000|Overall Study|no 30-day follow-up data|0|||
23773799|NCT01936948|66550249|FG001|Overall Study|no 30-day follow-up data|3|||
23773800|NCT01936948|66550250|FG002|Overall Study|no 30-day follow-up data|3|||
23773801|NCT01936948|66550251|FG003|Overall Study|no 30-day follow-up data|3|||
23773802|NCT01287013|66550255|FG000|Overall Study|Non-evaluable|3|||
23773803|NCT01287013|66550256|FG001|Overall Study|Non-evaluable|5|||
23773804|NCT01287013|66550257|FG002|Overall Study|Non-evaluable|21|||
23773805|NCT01469364|66550260|FG000|Overall Study|Adverse Event|1|||
23773806|NCT01469364|66550260|FG000|Overall Study|Withdrawal by Subject|1|||
23773807|NCT01062256|66550267|FG000|Overall Study|Adverse Event|1|||
23773808|NCT01062256|66550268|FG001|Overall Study|Adverse Event|0|||
23773809|NCT01062256|66550269|FG002|Overall Study|Adverse Event|0|||
23773810|NCT01062256|66550267|FG000|Overall Study|Withdrawal by Subject|1|||
23773811|NCT01062256|66550268|FG001|Overall Study|Withdrawal by Subject|1|||
23773812|NCT01062256|66550269|FG002|Overall Study|Withdrawal by Subject|1|||
23773813|NCT01062256|66550267|FG000|Overall Study|Ineligible|1|||
23773814|NCT01062256|66550268|FG001|Overall Study|Ineligible|4|||
23773815|NCT01062256|66550269|FG002|Overall Study|Ineligible|3|||
23773816|NCT01062256|66550267|FG000|Overall Study|Administrative|0|||
23773817|NCT01062256|66550268|FG001|Overall Study|Administrative|2|||
23773818|NCT01062256|66550269|FG002|Overall Study|Administrative|0|||
23773819|NCT01166568|66550270|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
23773820|NCT01166568|66550271|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
23773821|NCT01166568|66550272|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
23833876|NCT00848718|66770789|FG007|Overall Study|Progressive disease during treatment|2|||
23833877|NCT00848718|66770790|FG008|Overall Study|Progressive disease during treatment|0|||
23833878|NCT00848718|66770791|FG009|Overall Study|Progressive disease during treatment|0|||
23833879|NCT00848718|66770792|FG010|Overall Study|Progressive disease during treatment|0|||
23833880|NCT00848718|66770793|FG011|Overall Study|Progressive disease during treatment|0|||
23833881|NCT00848718|66770794|FG012|Overall Study|Progressive disease during treatment|2|||
23833882|NCT02291510|66770797|FG000|Overall Study|Adverse Event|0|||
23833883|NCT02291510|66770798|FG001|Overall Study|Adverse Event|0|||
23833884|NCT02291510|66770799|FG002|Overall Study|Adverse Event|0|||
23833885|NCT02291510|66770800|FG003|Overall Study|Adverse Event|1|||
23773822|NCT01166568|66550270|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
23773823|NCT01166568|66550271|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
23773824|NCT01166568|66550272|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
23773825|NCT01166568|66550270|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
23833886|NCT02268916|66770801|FG000|Overall Study|Lost to Follow-up|1|||
23833887|NCT02268916|66770802|FG001|Overall Study|Lost to Follow-up|1|||
23773826|NCT01166568|66550271|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23773827|NCT01166568|66550272|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
23773828|NCT01735630|66553409|FG000|Overall Study|Adverse Event|8|||
23773829|NCT01735630|66553410|FG001|Overall Study|Adverse Event|7|||
23773830|NCT01735630|66553409|FG000|Overall Study|Lost to Follow-up|1|||
23773831|NCT01735630|66553410|FG001|Overall Study|Lost to Follow-up|0|||
23773832|NCT01735630|66553409|FG000|Overall Study|Physician Decision|0|||
23773833|NCT01735630|66553410|FG001|Overall Study|Physician Decision|1|||
23773834|NCT01735630|66553409|FG000|Overall Study|Sponsor Decision|2|||
23773835|NCT01735630|66553410|FG001|Overall Study|Sponsor Decision|1|||
23773836|NCT01735630|66553409|FG000|Overall Study|Withdrawal by Subject|7|||
23773837|NCT01735630|66553410|FG001|Overall Study|Withdrawal by Subject|9|||
23773838|NCT00220337|66553411|FG000|Overall Study|Adverse Event|70|||
23773839|NCT00220337|66553411|FG000|Overall Study|Lack of Efficacy|17|||
23773840|NCT00220337|66553411|FG000|Overall Study|Withdrawal by Subject|68|||
23773841|NCT00220337|66553411|FG000|Overall Study|Protocol Violation|2|||
23773842|NCT00220337|66553411|FG000|Overall Study|Lost to Follow-up|5|||
23773843|NCT00220337|66553411|FG000|Overall Study|Other|12|||
23773844|NCT00220337|66553411|FG000|Overall Study|Unsatisfactory compliance|5|||
23773845|NCT02480764|66553427|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23773846|NCT02480764|66553428|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23773847|NCT02480764|66553429|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
23773848|NCT02480764|66553427|FG000|Overall Study|Major Protocol Deviation|1|||
23773849|NCT02480764|66553428|FG001|Overall Study|Major Protocol Deviation|4|||
23773850|NCT02480764|66553429|FG002|Overall Study|Major Protocol Deviation|3|||
23773851|NCT02480764|66553427|FG000|Overall Study|Lost to Follow-up|0|||
23773852|NCT02480764|66553428|FG001|Overall Study|Lost to Follow-up|1|||
23773853|NCT02480764|66553429|FG002|Overall Study|Lost to Follow-up|2|||
23773854|NCT02480764|66553427|FG000|Overall Study|Voluntary Withdrawal|6|||
23773855|NCT02480764|66553428|FG001|Overall Study|Voluntary Withdrawal|5|||
23773856|NCT02480764|66553429|FG002|Overall Study|Voluntary Withdrawal|10|||
23773857|NCT02480764|66553427|FG000|Overall Study|Lack of Efficacy|0|||
23773858|NCT02480764|66553428|FG001|Overall Study|Lack of Efficacy|3|||
23773859|NCT02480764|66553429|FG002|Overall Study|Lack of Efficacy|3|||
23773860|NCT02480764|66553427|FG000|Overall Study|Reason not Specified|0|||
23773861|NCT02480764|66553428|FG001|Overall Study|Reason not Specified|1|||
23773862|NCT02480764|66553429|FG002|Overall Study|Reason not Specified|0|||
23773863|NCT03831048|66553430|FG000|Overall Study|Protocol Violation|9|||
23773864|NCT03831048|66553431|FG001|Overall Study|Protocol Violation|3|||
23773865|NCT03831048|66553430|FG000|Overall Study|Death|4|||
23773866|NCT03831048|66553431|FG001|Overall Study|Death|9|||
23773867|NCT03831048|66553430|FG000|Overall Study|Re-transplant|0|||
23773868|NCT03831048|66553431|FG001|Overall Study|Re-transplant|2|||
23773869|NCT03831048|66553430|FG000|Overall Study|Protocol violation and death|1|||
23773870|NCT03831048|66553431|FG001|Overall Study|Protocol violation and death|1|||
23773871|NCT01402908|66553432|FG000|Overall Study|Withdrawal by Subject|30|||
23773872|NCT01402908|66553433|FG001|Overall Study|Withdrawal by Subject|17|||
23773873|NCT01402908|66553432|FG000|Overall Study|Lost to Follow-up|3|||
23773874|NCT01402908|66553433|FG001|Overall Study|Lost to Follow-up|1|||
23773875|NCT01402908|66553432|FG000|Overall Study|Physician Decision|1|||
23773876|NCT01402908|66553433|FG001|Overall Study|Physician Decision|0|||
23773877|NCT02999178|66553434|FG000|Overall Study|Adverse Event|85|||
23773878|NCT02999178|66553435|FG001|Overall Study|Adverse Event|62|||
23773879|NCT02999178|66553434|FG000|Overall Study|Protocol Violation|1|||
23773880|NCT02999178|66553435|FG001|Overall Study|Protocol Violation|2|||
23773881|NCT02999178|66553434|FG000|Overall Study|Lost to Follow-up|0|||
23773882|NCT02999178|66553435|FG001|Overall Study|Lost to Follow-up|2|||
23773883|NCT02999178|66553434|FG000|Overall Study|Withdrawal by Subject|21|||
23773884|NCT02999178|66553435|FG001|Overall Study|Withdrawal by Subject|21|||
23773885|NCT02999178|66553434|FG000|Overall Study|Other reason not defined above|7|||
23447639|NCT00687804|65380549|FG002|Core Study|Protocol Violation|0|||
23773886|NCT02999178|66553435|FG001|Overall Study|Other reason not defined above|13|||
23773887|NCT01370408|66553441|FG000|Overall Study|treatment failure|9|||
23773888|NCT00262223|66553445|FG000|Treatment Phase|Withdrawal by Subject|3|||
23773889|NCT00262223|66553446|FG001|Treatment Phase|Withdrawal by Subject|6|||
23773890|NCT00262223|66553445|FG000|Treatment Phase|Adverse Event|1|||
23773891|NCT00262223|66553446|FG001|Treatment Phase|Adverse Event|2|||
23773892|NCT00262223|66553445|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
23773893|NCT00262223|66553446|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
23773894|NCT00262223|66553445|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
23773895|NCT00262223|66553446|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
23773896|NCT00262223|66553445|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
23773897|NCT00262223|66553446|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
23773898|NCT01335477|66553448|FG000|Overall Study|Adverse Event|30|||
23773899|NCT01335477|66553449|FG001|Overall Study|Adverse Event|42|||
23773900|NCT01335477|66553448|FG000|Overall Study|Non compliant with protocol|0|||
23773901|NCT01335477|66553449|FG001|Overall Study|Non compliant with protocol|2|||
23773902|NCT01335477|66553448|FG000|Overall Study|Lost to Follow-up|1|||
23773903|NCT01335477|66553449|FG001|Overall Study|Lost to Follow-up|2|||
23773904|NCT01335477|66553448|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
23773905|NCT01335477|66553449|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
23773906|NCT01335477|66553448|FG000|Overall Study|Not treated|1|||
23773907|NCT01335477|66553449|FG001|Overall Study|Not treated|2|||
23773908|NCT01335477|66553448|FG000|Overall Study|Reason other than those stated above|2|||
23773909|NCT01335477|66553449|FG001|Overall Study|Reason other than those stated above|2|||
23773910|NCT02353169|66553454|FG000|Overall Study|QTc > 450 msec|1|||
23773911|NCT02353169|66553455|FG001|Overall Study|QTc > 450 msec|1|||
23773912|NCT02353169|66553456|FG002|Overall Study|QTc > 450 msec|1|||
23773913|NCT02353169|66553457|FG003|Overall Study|QTc > 450 msec|1|||
23773914|NCT02353169|66553454|FG000|Overall Study|OR team declined|2|||
23773915|NCT02353169|66553455|FG001|Overall Study|OR team declined|0|||
23773916|NCT02353169|66553456|FG002|Overall Study|OR team declined|0|||
23773917|NCT02353169|66553457|FG003|Overall Study|OR team declined|0|||
23773918|NCT02353169|66553454|FG000|Overall Study|Inhalational induction|0|||
23773919|NCT02353169|66553455|FG001|Overall Study|Inhalational induction|2|||
23773920|NCT02353169|66553456|FG002|Overall Study|Inhalational induction|0|||
23773921|NCT02353169|66553457|FG003|Overall Study|Inhalational induction|0|||
23773922|NCT02353169|66553454|FG000|Overall Study|ECG data error|0|||
23773923|NCT02353169|66553455|FG001|Overall Study|ECG data error|3|||
23773924|NCT02353169|66553456|FG002|Overall Study|ECG data error|2|||
23773925|NCT02353169|66553457|FG003|Overall Study|ECG data error|2|||
23773926|NCT02353169|66553454|FG000|Overall Study|Pre-op medication|0|||
23773927|NCT02353169|66553455|FG001|Overall Study|Pre-op medication|0|||
23773928|NCT02353169|66553456|FG002|Overall Study|Pre-op medication|1|||
23773929|NCT02353169|66553457|FG003|Overall Study|Pre-op medication|0|||
23773930|NCT00552669|66553459|FG000|Overall Study|Death|3|||
23773931|NCT00552669|66553460|FG001|Overall Study|Death|7|||
23773932|NCT01422538|66553461|FG000|Overall Study|Lost to Follow-up|0|||
23773933|NCT01422538|66553462|FG001|Overall Study|Lost to Follow-up|1|||
23773934|NCT01422538|66553463|FG002|Overall Study|Lost to Follow-up|1|||
23773935|NCT01422538|66553461|FG000|Overall Study|Missed visit|0|||
23773936|NCT01422538|66553462|FG001|Overall Study|Missed visit|1|||
23773937|NCT01422538|66553463|FG002|Overall Study|Missed visit|1|||
23773938|NCT04638153|66553464|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23773939|NCT04638153|66553465|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23773940|NCT04638153|66553466|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23773941|NCT04638153|66553464|FG000|Overall Study|Study terminated by sponsor|4|||
23773942|NCT04638153|66553465|FG001|Overall Study|Study terminated by sponsor|2|||
23773943|NCT04638153|66553466|FG002|Overall Study|Study terminated by sponsor|14|||
23773944|NCT05612724|66553468|FG000|Overall Study|Lost to Follow-up|4|||
23773945|NCT00854308|66553475|FG000|Overall Study|Disease progression|42|||
23773946|NCT00854308|66553476|FG001|Overall Study|Disease progression|50|||
23773947|NCT00854308|66553475|FG000|Overall Study|Adverse Event|8|||
23773948|NCT00854308|66553476|FG001|Overall Study|Adverse Event|3|||
23773949|NCT00854308|66553475|FG000|Overall Study|Death|2|||
23773950|NCT00854308|66553476|FG001|Overall Study|Death|5|||
23575514|NCT00097370|65838739|FG000|Stage 2|Lack of Efficacy|3|||
23575515|NCT00097370|65838739|FG000|Stage 2|Pregnancy|1|||
23575516|NCT00097370|65838739|FG000|Stage 2|Sponsor Terminated Study|2|||
23575517|NCT00097370|65838739|FG000|Stage 2|Lost to Follow-up|1|||
23575518|NCT00097370|65838739|FG000|Stage 3|Adverse Event|2|||
23575519|NCT00097370|65838739|FG000|Stage 3|Withdrawal by Subject|3|||
23575520|NCT00097370|65838739|FG000|Stage 3|Lack of Efficacy|1|||
23575521|NCT00097370|65838739|FG000|Stage 3|Sponsor Terminated Study|52|||
23575522|NCT00097370|65838739|FG000|Stage 3|Lost to Follow-up|1|||
23575523|NCT05114590|65838745|FG000|Overall Study|Adverse Event|1|||
23575524|NCT05114590|65838745|FG000|Overall Study|Investigator decision|1|||
23575525|NCT05114590|65838745|FG000|Overall Study|Lost to Follow-up|5|||
23575526|NCT05114590|65838745|FG000|Overall Study|Withdrawal by Subject|5|||
23575527|NCT05114590|65838745|FG000|Overall Study|Other|2|||
23575528|NCT02781506|65838746|FG000|Overall Study|Adverse Event|5|||
23575529|NCT03523871|65838748|FG000|Overall Study|Death|1|||
23575530|NCT01744496|65838749|FG000|Titration Period|Adverse Event|2|||
23575531|NCT01744496|65838750|FG001|Titration Period|Adverse Event|1|||
23575532|NCT01744496|65838749|FG000|Titration Period|Personal reasons|0|||
23575533|NCT01744496|65838750|FG001|Titration Period|Personal reasons|1|||
23575534|NCT01744496|65838749|FG000|Maintenance Period|Adverse Event|1|||
23575535|NCT01744496|65838750|FG001|Maintenance Period|Adverse Event|3|||
23773951|NCT00854308|66553475|FG000|Overall Study|Physician Decision|6|||
23773952|NCT00854308|66553476|FG001|Overall Study|Physician Decision|6|||
23773953|NCT00854308|66553475|FG000|Overall Study|Withdrawal by Subject|4|||
23773954|NCT00854308|66553476|FG001|Overall Study|Withdrawal by Subject|2|||
23773955|NCT00854308|66553475|FG000|Overall Study|Sponsor's decision to terminate study|0|||
23773956|NCT00854308|66553476|FG001|Overall Study|Sponsor's decision to terminate study|1|||
23773957|NCT01536405|66553477|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
23773958|NCT01536405|66553478|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
23773959|NCT01536405|66553477|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
23773960|NCT01536405|66553478|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
23773961|NCT01536405|66553477|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
23773962|NCT01536405|66553478|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
23575536|NCT01744496|65838749|FG000|Maintenance Period|Protocol Violation|1|||
23575537|NCT01744496|65838750|FG001|Maintenance Period|Protocol Violation|0|||
23773963|NCT01536405|66553477|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
23773964|NCT01536405|66553478|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
23447640|NCT00687804|65380547|FG000|Open-Label Extension Study|Adverse Event|2|||
23447641|NCT00687804|65380548|FG001|Open-Label Extension Study|Adverse Event|2|||
23575538|NCT01744496|65838749|FG000|Maintenance Period|Withdrawal by Subject|1|||
23575539|NCT01744496|65838750|FG001|Maintenance Period|Withdrawal by Subject|1|||
23575540|NCT01744496|65838749|FG000|Maintenance Period|Subject left town|1|||
23773965|NCT01536405|66553477|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
23773966|NCT01536405|66553478|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
23773967|NCT01536405|66553477|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
23633701|NCT04942366|66045441|FG001|Overall Study|Withdrawal by Subject|5|||
23633702|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Adverse Event|1|||
23633703|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Adverse Event|1|||
23633704|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Adverse Event|2|||
23773968|NCT01536405|66553478|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
23773969|NCT01536405|66553477|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
23773970|NCT01536405|66553478|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
23773971|NCT01536405|66553477|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
23773972|NCT01536405|66553478|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
23773973|NCT01536405|66553477|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
23773974|NCT01536405|66553478|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
23773975|NCT01536405|66553477|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
23773976|NCT01536405|66553478|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
23773977|NCT01536405|66553477|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
23773978|NCT01536405|66553478|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
23773979|NCT01536405|66553477|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
23773980|NCT01536405|66553478|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
23773981|NCT01536405|66553477|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
23773982|NCT01536405|66553478|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
23773983|NCT00385684|66553481|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
23773984|NCT00385684|66553482|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
23773985|NCT00385684|66553481|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
23773986|NCT00385684|66553482|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
23773987|NCT00385684|66553481|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
23773988|NCT00385684|66553482|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
23773989|NCT02202850|66553485|FG000|Overall Study|Other|2|||
23773990|NCT02202850|66553486|FG001|Overall Study|Other|2|||
23773991|NCT02202850|66553485|FG000|Overall Study|Enbrel treatment discontinued|15|||
23773992|NCT02202850|66553486|FG001|Overall Study|Enbrel treatment discontinued|3|||
23773993|NCT02202850|66553485|FG000|Overall Study|Lost to Follow-up|7|||
23773994|NCT02202850|66553486|FG001|Overall Study|Lost to Follow-up|1|||
23773995|NCT00686959|66553487|FG000|Overall Study|Participants censored (no death events)|124|||
23773996|NCT00686959|66553488|FG001|Overall Study|Participants censored (no death events)|117|||
23773997|NCT02907203|66553494|FG000|Overall Study|Death|1|||
23773998|NCT02907203|66553494|FG000|Overall Study|Lost to Follow-up|3|||
23773999|NCT02907203|66553494|FG000|Overall Study|Withdrawal by Subject|3|||
23774000|NCT02907203|66553494|FG000|Overall Study|Surgical bypass|1|||
23774001|NCT00920140|66553498|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
23774002|NCT00920140|66553499|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
23774003|NCT00920140|66553500|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
23774004|NCT00920140|66553501|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
23774005|NCT00920140|66553502|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
23774006|NCT00920140|66553498|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
23774007|NCT00920140|66553499|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
23774008|NCT00920140|66553500|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23774009|NCT00920140|66553501|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23774010|NCT00920140|66553502|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23774011|NCT00920140|66553498|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23774012|NCT00920140|66553499|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
23774013|NCT00920140|66553500|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23774014|NCT00920140|66553501|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23774015|NCT00920140|66553502|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23774016|NCT00920140|66553498|FG000|Phase 2|Adverse Event|0|||
23774017|NCT00920140|66553499|FG001|Phase 2|Adverse Event|0|||
23447642|NCT00687804|65380549|FG002|Open-Label Extension Study|Adverse Event|2|||
23633705|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Adverse Event|5|||
23633706|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Adverse Event|0|||
23633707|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
23633708|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
23774018|NCT00920140|66553500|FG002|Phase 2|Adverse Event|14|||
23774019|NCT00920140|66553501|FG003|Phase 2|Adverse Event|2|||
23774020|NCT00920140|66553502|FG004|Phase 2|Adverse Event|3|||
23774021|NCT00920140|66553498|FG000|Phase 2|Lack of Efficacy|0|||
23774022|NCT00920140|66553499|FG001|Phase 2|Lack of Efficacy|0|||
23447643|NCT00687804|65380547|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
23447644|NCT00687804|65380548|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
23447645|NCT00687804|65380549|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
23774023|NCT00920140|66553500|FG002|Phase 2|Lack of Efficacy|29|||
23575541|NCT01744496|65838750|FG001|Maintenance Period|Subject left town|0|||
23774024|NCT00920140|66553501|FG003|Phase 2|Lack of Efficacy|14|||
23774025|NCT00920140|66553502|FG004|Phase 2|Lack of Efficacy|5|||
23774026|NCT00920140|66553498|FG000|Phase 2|Lost to Follow-up|0|||
23774027|NCT00920140|66553499|FG001|Phase 2|Lost to Follow-up|0|||
23774028|NCT00920140|66553500|FG002|Phase 2|Lost to Follow-up|0|||
23774029|NCT00920140|66553501|FG003|Phase 2|Lost to Follow-up|1|||
23774030|NCT00920140|66553502|FG004|Phase 2|Lost to Follow-up|0|||
23774031|NCT00920140|66553498|FG000|Phase 2|Physician Decision|0|||
23774032|NCT00920140|66553499|FG001|Phase 2|Physician Decision|0|||
23774033|NCT00920140|66553500|FG002|Phase 2|Physician Decision|3|||
23774034|NCT00920140|66553501|FG003|Phase 2|Physician Decision|3|||
23774035|NCT00920140|66553502|FG004|Phase 2|Physician Decision|2|||
23774036|NCT00920140|66553498|FG000|Phase 2|Withdrawal by Subject|0|||
23774037|NCT00920140|66553499|FG001|Phase 2|Withdrawal by Subject|0|||
23774038|NCT00920140|66553500|FG002|Phase 2|Withdrawal by Subject|4|||
23774039|NCT00920140|66553501|FG003|Phase 2|Withdrawal by Subject|2|||
23575542|NCT00107380|65838753|FG000|Overall Study|Adverse Event|7|||
23575543|NCT00107380|65838753|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
23575544|NCT00107380|65838753|FG000|Overall Study|Progression/relapse|4|||
23575545|NCT00107380|65838753|FG000|Overall Study|Death|3|||
23575546|NCT00107380|65838753|FG000|Overall Study|Other - not protocol specified|7|||
23774040|NCT00920140|66553502|FG004|Phase 2|Withdrawal by Subject|1|||
23774041|NCT01572948|66553503|FG000|Overall Study|Lost to Follow-up|1|||
23774042|NCT01572948|66553504|FG001|Overall Study|Lost to Follow-up|0|||
23774043|NCT01572948|66553503|FG000|Overall Study|unable to contact|0|||
23774044|NCT01572948|66553504|FG001|Overall Study|unable to contact|1|||
23774045|NCT04799158|66553505|FG000|Run-In Period|Adverse Event|6|||
23774046|NCT04799158|66553506|FG001|Run-In Period|Adverse Event|0|||
23774047|NCT04799158|66553507|FG002|Run-In Period|Adverse Event|0|||
23774048|NCT04799158|66553508|FG003|Run-In Period|Adverse Event|0|||
23774049|NCT04799158|66553509|FG004|Run-In Period|Adverse Event|0|||
23774050|NCT04799158|66553505|FG000|Run-In Period|Lost to Follow-up|4|||
23774051|NCT04799158|66553506|FG001|Run-In Period|Lost to Follow-up|0|||
23774052|NCT04799158|66553507|FG002|Run-In Period|Lost to Follow-up|0|||
23833888|NCT02268916|66770801|FG000|Overall Study|Withdrawal by Subject|6|||
23833889|NCT02268916|66770802|FG001|Overall Study|Withdrawal by Subject|5|||
23833890|NCT02268916|66770801|FG000|Overall Study|Participant did not have diabetes|1|||
23833891|NCT02268916|66770802|FG001|Overall Study|Participant did not have diabetes|0|||
23833892|NCT02268916|66770801|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
23833893|NCT02268916|66770802|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
23774053|NCT04799158|66553508|FG003|Run-In Period|Lost to Follow-up|0|||
23774054|NCT04799158|66553509|FG004|Run-In Period|Lost to Follow-up|0|||
23774055|NCT04799158|66553505|FG000|Run-In Period|Significant Protocol Deviation|1|||
23774056|NCT04799158|66553506|FG001|Run-In Period|Significant Protocol Deviation|0|||
23774057|NCT04799158|66553507|FG002|Run-In Period|Significant Protocol Deviation|0|||
23774058|NCT04799158|66553508|FG003|Run-In Period|Significant Protocol Deviation|0|||
23774059|NCT04799158|66553509|FG004|Run-In Period|Significant Protocol Deviation|0|||
23774060|NCT04799158|66553505|FG000|Run-In Period|Withdrawal by Subject|11|||
23774061|NCT04799158|66553506|FG001|Run-In Period|Withdrawal by Subject|0|||
23774062|NCT04799158|66553507|FG002|Run-In Period|Withdrawal by Subject|0|||
23774063|NCT04799158|66553508|FG003|Run-In Period|Withdrawal by Subject|0|||
23774064|NCT04799158|66553509|FG004|Run-In Period|Withdrawal by Subject|0|||
23774065|NCT04799158|66553505|FG000|Run-In Period|Miscellaneous|3|||
23774066|NCT04799158|66553506|FG001|Run-In Period|Miscellaneous|0|||
23774067|NCT04799158|66553507|FG002|Run-In Period|Miscellaneous|0|||
23774068|NCT04799158|66553508|FG003|Run-In Period|Miscellaneous|0|||
23774069|NCT04799158|66553509|FG004|Run-In Period|Miscellaneous|0|||
23774070|NCT04799158|66553505|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
23774071|NCT04799158|66553506|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23774072|NCT04799158|66553507|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23774073|NCT04799158|66553508|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23774074|NCT04799158|66553509|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23575547|NCT00107380|65838753|FG000|Overall Study|Ineligible|2|||
23774075|NCT04799158|66553505|FG000|On-Demand Treatment Period|Adverse Event|0|||
23774076|NCT04799158|66553506|FG001|On-Demand Treatment Period|Adverse Event|1|||
23774077|NCT04799158|66553507|FG002|On-Demand Treatment Period|Adverse Event|0|||
23774078|NCT04799158|66553508|FG003|On-Demand Treatment Period|Adverse Event|0|||
23774079|NCT04799158|66553509|FG004|On-Demand Treatment Period|Adverse Event|1|||
23774080|NCT04799158|66553505|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
23774081|NCT04799158|66553506|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
23774082|NCT04799158|66553507|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
23774083|NCT04799158|66553508|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
23774084|NCT04799158|66553509|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
23774085|NCT04799158|66553505|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23774086|NCT04799158|66553506|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23774087|NCT04799158|66553507|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23774088|NCT04799158|66553508|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
23774089|NCT04799158|66553509|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23774090|NCT04799158|66553505|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
23774091|NCT04799158|66553506|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
23774092|NCT04799158|66553507|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
23774093|NCT04799158|66553508|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
23774094|NCT04799158|66553509|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
23774095|NCT04799158|66553505|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
23774096|NCT04799158|66553506|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
23774097|NCT04799158|66553507|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
23774098|NCT04799158|66553508|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
23774099|NCT04799158|66553509|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
23774100|NCT04799158|66553505|FG000|On-Demand Treatment Period|Miscellaneous|0|||
23774101|NCT04799158|66553506|FG001|On-Demand Treatment Period|Miscellaneous|0|||
23774102|NCT04799158|66553507|FG002|On-Demand Treatment Period|Miscellaneous|0|||
23774103|NCT04799158|66553508|FG003|On-Demand Treatment Period|Miscellaneous|0|||
23774104|NCT04799158|66553509|FG004|On-Demand Treatment Period|Miscellaneous|1|||
23774105|NCT01045096|66553510|FG000|Overall Study|Withdrawal by Subject|2|||
23774106|NCT01045096|66553511|FG001|Overall Study|Withdrawal by Subject|0|||
23774107|NCT01045096|66553512|FG002|Overall Study|Withdrawal by Subject|0|||
23774108|NCT01045096|66553510|FG000|Overall Study|Other|1|||
23774109|NCT01045096|66553511|FG001|Overall Study|Other|0|||
23774110|NCT01045096|66553512|FG002|Overall Study|Other|0|||
23774111|NCT00313703|66553513|FG000|Overall Study|Lost to Follow-up|11|||
23774112|NCT00313703|66553514|FG001|Overall Study|Lost to Follow-up|2|||
23774113|NCT00313703|66553515|FG002|Overall Study|Lost to Follow-up|5|||
23774114|NCT00313703|66553516|FG003|Overall Study|Lost to Follow-up|12|||
23774115|NCT02848326|66553517|FG000|Treatment Period|Adverse Event|5|||
23774116|NCT02848326|66553518|FG001|Treatment Period|Adverse Event|4|||
23774117|NCT02848326|66553519|FG002|Treatment Period|Adverse Event|11|||
23774118|NCT02848326|66553520|FG003|Treatment Period|Adverse Event|6|||
23774119|NCT02848326|66553521|FG004|Treatment Period|Adverse Event|5|||
23774120|NCT02848326|66553522|FG005|Treatment Period|Adverse Event|7|||
23774121|NCT02848326|66553517|FG000|Treatment Period|Withdrawal of Consent|20|||
23774122|NCT02848326|66553518|FG001|Treatment Period|Withdrawal of Consent|6|||
23774123|NCT02848326|66553519|FG002|Treatment Period|Withdrawal of Consent|9|||
23774124|NCT02848326|66553520|FG003|Treatment Period|Withdrawal of Consent|6|||
23774125|NCT02848326|66553521|FG004|Treatment Period|Withdrawal of Consent|9|||
23774126|NCT02848326|66553522|FG005|Treatment Period|Withdrawal of Consent|6|||
23774127|NCT02848326|66553517|FG000|Treatment Period|Lost to Follow-up|5|||
23774128|NCT02848326|66553518|FG001|Treatment Period|Lost to Follow-up|1|||
23774129|NCT02848326|66553519|FG002|Treatment Period|Lost to Follow-up|11|||
23774130|NCT02848326|66553520|FG003|Treatment Period|Lost to Follow-up|7|||
23774131|NCT02848326|66553521|FG004|Treatment Period|Lost to Follow-up|2|||
23774132|NCT02848326|66553522|FG005|Treatment Period|Lost to Follow-up|3|||
23774133|NCT02848326|66553517|FG000|Treatment Period|Pregnancy|0|||
23774134|NCT02848326|66553518|FG001|Treatment Period|Pregnancy|0|||
23774135|NCT02848326|66553519|FG002|Treatment Period|Pregnancy|1|||
23774136|NCT02848326|66553520|FG003|Treatment Period|Pregnancy|1|||
23774137|NCT02848326|66553521|FG004|Treatment Period|Pregnancy|0|||
23447646|NCT00687804|65380547|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
23774138|NCT02848326|66553522|FG005|Treatment Period|Pregnancy|1|||
23774139|NCT02848326|66553517|FG000|Treatment Period|Protocol Violation|4|||
23774140|NCT02848326|66553518|FG001|Treatment Period|Protocol Violation|3|||
23833894|NCT02013817|66770805|FG000|Overall Study|Adverse Event|12|||
23774141|NCT02848326|66553519|FG002|Treatment Period|Protocol Violation|4|||
23774142|NCT02848326|66553520|FG003|Treatment Period|Protocol Violation|2|||
23774143|NCT02848326|66553521|FG004|Treatment Period|Protocol Violation|3|||
23774144|NCT02848326|66553522|FG005|Treatment Period|Protocol Violation|3|||
23774145|NCT02848326|66553517|FG000|Treatment Period|Non-compliance with Study Drug|4|||
23774146|NCT02848326|66553518|FG001|Treatment Period|Non-compliance with Study Drug|0|||
23774147|NCT02848326|66553519|FG002|Treatment Period|Non-compliance with Study Drug|0|||
23774148|NCT02848326|66553520|FG003|Treatment Period|Non-compliance with Study Drug|1|||
23774149|NCT02848326|66553521|FG004|Treatment Period|Non-compliance with Study Drug|0|||
23774150|NCT02848326|66553522|FG005|Treatment Period|Non-compliance with Study Drug|0|||
23774151|NCT02848326|66553517|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
23774152|NCT02848326|66553518|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
23774153|NCT02848326|66553519|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
23447647|NCT00687804|65380548|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
23447648|NCT00687804|65380549|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
23575548|NCT02059161|65838754|FG000|Overall Study|Pregnancy|0|||
23575549|NCT02059161|65838755|FG001|Overall Study|Pregnancy|2|||
23575550|NCT02059161|65838754|FG000|Overall Study|Adverse Event|2|||
23575551|NCT02059161|65838755|FG001|Overall Study|Adverse Event|6|||
23575552|NCT02059161|65838754|FG000|Overall Study|Lost to Follow-up|20|||
23575553|NCT02059161|65838755|FG001|Overall Study|Lost to Follow-up|12|||
23575554|NCT02059161|65838754|FG000|Overall Study|Physician Decision|4|||
23575555|NCT02059161|65838755|FG001|Overall Study|Physician Decision|4|||
23774154|NCT02848326|66553520|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
23774155|NCT02848326|66553521|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
23774156|NCT02848326|66553522|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
23575556|NCT02059161|65838754|FG000|Overall Study|Protocol Violation|1|||
23575557|NCT02059161|65838755|FG001|Overall Study|Protocol Violation|1|||
23774157|NCT02848326|66553517|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
23774158|NCT02848326|66553518|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23774159|NCT02848326|66553519|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
23774160|NCT02848326|66553520|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
23774161|NCT02848326|66553521|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
23774162|NCT02848326|66553522|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
23774163|NCT02495857|66553525|FG000|Overall Study|Adverse Event|5|||
23774164|NCT02495857|66553526|FG001|Overall Study|Adverse Event|0|||
23774165|NCT02495857|66553527|FG002|Overall Study|Adverse Event|1|||
23774166|NCT02495857|66553525|FG000|Overall Study|Withdrawal by Subject|9|||
23774167|NCT02495857|66553526|FG001|Overall Study|Withdrawal by Subject|6|||
23575558|NCT02059161|65838754|FG000|Overall Study|Withdrawal by Subject|16|||
23575559|NCT02059161|65838755|FG001|Overall Study|Withdrawal by Subject|13|||
23774168|NCT02495857|66553527|FG002|Overall Study|Withdrawal by Subject|10|||
23774169|NCT02495857|66553525|FG000|Overall Study|Physician Decision|0|||
23774170|NCT02495857|66553526|FG001|Overall Study|Physician Decision|1|||
23774171|NCT02495857|66553527|FG002|Overall Study|Physician Decision|0|||
23774172|NCT02495857|66553525|FG000|Overall Study|Protocol Violation|1|||
23774173|NCT02495857|66553526|FG001|Overall Study|Protocol Violation|1|||
23774174|NCT02495857|66553527|FG002|Overall Study|Protocol Violation|2|||
23774175|NCT02495857|66553525|FG000|Overall Study|Lost to Follow-up|4|||
23833895|NCT02013817|66770805|FG000|Overall Study|Withdrawal by Subject|4|||
23833896|NCT02013817|66770805|FG000|Overall Study|Death|2|||
23833897|NCT02013817|66770805|FG000|Overall Study|Other|9|||
23833898|NCT02877004|66770806|FG000|Overall Study|Pregnancy|0|||
23833899|NCT02877004|66770807|FG001|Overall Study|Pregnancy|0|||
23833900|NCT02877004|66770808|FG002|Overall Study|Pregnancy|1|||
23833901|NCT01234350|66770809|FG000|Overall Study|Adverse Event|277|||
23833902|NCT01234350|66770810|FG001|Overall Study|Adverse Event|92|||
23833903|NCT01234350|66770809|FG000|Overall Study|Withdrawal by Subject|61|||
23833904|NCT01234350|66770810|FG001|Overall Study|Withdrawal by Subject|36|||
23833905|NCT01234350|66770809|FG000|Overall Study|Lost to Follow-up|115|||
23447649|NCT00687804|65380547|FG000|Open-Label Extension Study|Administrative problems|1|||
23447650|NCT00687804|65380548|FG001|Open-Label Extension Study|Administrative problems|1|||
23447651|NCT00687804|65380549|FG002|Open-Label Extension Study|Administrative problems|0|||
23447652|NCT00687804|65380547|FG000|Open-Label Extension Study|Death|2|||
23447653|NCT00687804|65380548|FG001|Open-Label Extension Study|Death|3|||
23447654|NCT00687804|65380549|FG002|Open-Label Extension Study|Death|3|||
23447655|NCT03956550|65380550|FG000|Overall Study|Sponsor decision|65|||
23447656|NCT03956550|65380551|FG001|Overall Study|Sponsor decision|66|||
23447657|NCT03956550|65380552|FG002|Overall Study|Sponsor decision|64|||
23447658|NCT03956550|65380550|FG000|Overall Study|Adverse Event|0|||
23447659|NCT03956550|65380551|FG001|Overall Study|Adverse Event|1|||
23447660|NCT03956550|65380552|FG002|Overall Study|Adverse Event|0|||
23447661|NCT03956550|65380550|FG000|Overall Study|Withdrawal by Subject|5|||
23447662|NCT03956550|65380551|FG001|Overall Study|Withdrawal by Subject|5|||
23447663|NCT03956550|65380552|FG002|Overall Study|Withdrawal by Subject|6|||
23447664|NCT00799266|65380555|FG000|Overall Study|Adverse Event|0|||
23447665|NCT00799266|65380556|FG001|Overall Study|Adverse Event|1|||
23447666|NCT00799266|65380555|FG000|Overall Study|Subject withdrew consent|3|||
23447667|NCT00799266|65380556|FG001|Overall Study|Subject withdrew consent|0|||
23447668|NCT01426958|65380558|FG000|Overall Study|Adverse Event|2|||
23447669|NCT01546857|65380561|FG000|Overall Study|Withdrawal by Subject|2|||
23447670|NCT01546857|65380562|FG001|Overall Study|Withdrawal by Subject|3|||
23447671|NCT03649074|65380563|FG000|Overall Study|Lost to Follow-up|2|||
23447672|NCT03649074|65380564|FG001|Overall Study|Lost to Follow-up|1|||
23447673|NCT03649074|65380563|FG000|Overall Study|Adverse Event|1|||
23447674|NCT03649074|65380564|FG001|Overall Study|Adverse Event|0|||
23447675|NCT03649074|65380563|FG000|Overall Study|Physician Decision|1|||
23447676|NCT03649074|65380564|FG001|Overall Study|Physician Decision|0|||
23447677|NCT03649074|65380563|FG000|Overall Study|Withdrawal by Subject|0|||
23447678|NCT03649074|65380564|FG001|Overall Study|Withdrawal by Subject|2|||
23447679|NCT03649074|65380563|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23833906|NCT01234350|66770810|FG001|Overall Study|Lost to Follow-up|47|||
23833907|NCT01234350|66770809|FG000|Overall Study|Covers a diverse set of reasons|234|||
23833908|NCT01234350|66770810|FG001|Overall Study|Covers a diverse set of reasons|92|||
23447680|NCT03649074|65380564|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
23447681|NCT03649074|65380563|FG000|Overall Study|Other|1|||
23447682|NCT03649074|65380564|FG001|Overall Study|Other|0|||
23447683|NCT03038126|65380567|FG000|Overall Study|Death|1|||
23447684|NCT03038126|65380568|FG001|Overall Study|Death|1|||
23447685|NCT03038126|65380567|FG000|Overall Study|Withdrawal by Subject|5|||
23833909|NCT01198470|66770811|FG000|Overall Study|Adverse Event|2|||
23833910|NCT02285361|66770812|FG000|Overall Study|Protocol Violation|43|||
23447686|NCT03038126|65380568|FG001|Overall Study|Withdrawal by Subject|0|||
23447687|NCT03038126|65380567|FG000|Overall Study|Lost to Follow-up|0|||
23447688|NCT03038126|65380568|FG001|Overall Study|Lost to Follow-up|1|||
23447689|NCT03038126|65380567|FG000|Overall Study|Long Term Hospitalization|2|||
23447690|NCT03038126|65380568|FG001|Overall Study|Long Term Hospitalization|0|||
23575560|NCT02059161|65838754|FG000|Overall Study|Randomized in error, no study drug|0|||
23575561|NCT02059161|65838755|FG001|Overall Study|Randomized in error, no study drug|1|||
23575562|NCT02059161|65838754|FG000|Overall Study|Non-compliance with study drug|6|||
23575563|NCT02059161|65838755|FG001|Overall Study|Non-compliance with study drug|2|||
23633709|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
23633710|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
23633711|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
23633712|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
23633713|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
23633714|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
23633715|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
23447691|NCT03038126|65380567|FG000|Overall Study|Too Ill to Participate|1|||
23447692|NCT03038126|65380568|FG001|Overall Study|Too Ill to Participate|2|||
23575564|NCT03101592|65838765|FG000|Overall Study|participant files could not be located|111|||
23575565|NCT03101592|65838766|FG001|Overall Study|participant files could not be located|170|||
23575566|NCT03101592|65838767|FG002|Overall Study|participant files could not be located|118|||
23575567|NCT00280293|65838768|FG000|Overall Study|Protocol Violation|3|||
23575568|NCT00280293|65838769|FG001|Overall Study|Protocol Violation|0|||
23575569|NCT00280293|65838768|FG000|Overall Study|Physician Decision|5|||
23575570|NCT00280293|65838769|FG001|Overall Study|Physician Decision|4|||
23575571|NCT00280293|65838768|FG000|Overall Study|Lost to Follow-up|14|||
23575572|NCT00280293|65838769|FG001|Overall Study|Lost to Follow-up|12|||
23575573|NCT00280293|65838768|FG000|Overall Study|Withdrawal by Subject|3|||
23575574|NCT00280293|65838769|FG001|Overall Study|Withdrawal by Subject|5|||
23575575|NCT00280293|65838768|FG000|Overall Study|Incarceration/Legal Reasons|1|||
23575576|NCT00280293|65838769|FG001|Overall Study|Incarceration/Legal Reasons|1|||
23575577|NCT00280293|65838768|FG000|Overall Study|Adverse Event|0|||
23575578|NCT00280293|65838769|FG001|Overall Study|Adverse Event|1|||
23575579|NCT02431533|65838770|FG000|Overall Study|Withdrawal by Subject|1|||
23575580|NCT02431533|65838771|FG001|Overall Study|Withdrawal by Subject|3|||
23575581|NCT02431533|65838770|FG000|Overall Study|Developed Exclusionary criteria|1|||
23575582|NCT02431533|65838771|FG001|Overall Study|Developed Exclusionary criteria|0|||
23575583|NCT00235495|65838772|FG000|Overall Study|Death|52|||
23575584|NCT00235495|65838773|FG001|Overall Study|Death|42|||
23633716|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
23447693|NCT01479868|65380569|FG000|Overall Study|Adverse Event|1|||
23575585|NCT00235495|65838772|FG000|Overall Study|Withdrawal by Subject|5|||
23575586|NCT00235495|65838773|FG001|Overall Study|Withdrawal by Subject|3|||
23575587|NCT00235495|65838772|FG000|Overall Study|Lost to Follow-up|11|||
23575588|NCT00235495|65838773|FG001|Overall Study|Lost to Follow-up|13|||
23575589|NCT00235495|65838772|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
23575590|NCT00235495|65838773|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
23575591|NCT00848211|65838774|FG000|Overall Study|Protocol Violation|0|||
23575592|NCT00848211|65838775|FG001|Overall Study|Protocol Violation|1|||
23575593|NCT00848211|65838776|FG002|Overall Study|Protocol Violation|1|||
23575594|NCT00848211|65838777|FG003|Overall Study|Protocol Violation|0|||
23575595|NCT00848211|65838774|FG000|Overall Study|Adverse Event|0|||
23575596|NCT00848211|65838775|FG001|Overall Study|Adverse Event|0|||
23575597|NCT00848211|65838776|FG002|Overall Study|Adverse Event|0|||
23575598|NCT00848211|65838777|FG003|Overall Study|Adverse Event|0|||
23575599|NCT00057811|65838778|FG000|Overall Study|Lack of Efficacy|1|||
23575600|NCT00057811|65838779|FG001|Overall Study|Lack of Efficacy|4|||
23575601|NCT00057811|65838778|FG000|Overall Study|Physician Decision|1|||
23575602|NCT00057811|65838779|FG001|Overall Study|Physician Decision|0|||
23575603|NCT00057811|65838778|FG000|Overall Study|Withdrawal by Subject|3|||
23575604|NCT00057811|65838779|FG001|Overall Study|Withdrawal by Subject|4|||
23575605|NCT00057811|65838778|FG000|Overall Study|Ineligible|4|||
23575606|NCT00057811|65838779|FG001|Overall Study|Ineligible|2|||
23575607|NCT00057811|65838778|FG000|Overall Study|Inevaluable|1|||
23633717|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23633718|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23633719|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23633720|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
23633721|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23633722|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
23633723|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
23633724|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
23633725|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
23633726|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
23633727|NCT00951015|66045442|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23633728|NCT00951015|66045443|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
23633729|NCT00951015|66045444|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
23774176|NCT02495857|66553526|FG001|Overall Study|Lost to Follow-up|5|||
23774177|NCT02495857|66553527|FG002|Overall Study|Lost to Follow-up|3|||
23774178|NCT02495857|66553525|FG000|Overall Study|Other|3|||
23447694|NCT01479868|65380569|FG000|Overall Study|Lost to Follow-up|4|||
23633730|NCT00951015|66045445|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23633731|NCT00951015|66045446|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
23633732|NCT00951015|66045442|FG000|Open-label Phase|Adverse Event|0|||
23633733|NCT00951015|66045443|FG001|Open-label Phase|Adverse Event|0|||
23633734|NCT00951015|66045444|FG002|Open-label Phase|Adverse Event|0|||
23633735|NCT00951015|66045445|FG003|Open-label Phase|Adverse Event|0|||
23633736|NCT00951015|66045446|FG004|Open-label Phase|Adverse Event|3|||
23633737|NCT00951015|66045442|FG000|Open-label Phase|Lack of Efficacy|0|||
23633738|NCT00951015|66045443|FG001|Open-label Phase|Lack of Efficacy|0|||
23633739|NCT00951015|66045444|FG002|Open-label Phase|Lack of Efficacy|0|||
23633740|NCT00951015|66045445|FG003|Open-label Phase|Lack of Efficacy|0|||
23633741|NCT00951015|66045446|FG004|Open-label Phase|Lack of Efficacy|1|||
23633742|NCT00951015|66045442|FG000|Open-label Phase|Protocol Violation|0|||
23633743|NCT00951015|66045443|FG001|Open-label Phase|Protocol Violation|0|||
23633744|NCT00951015|66045444|FG002|Open-label Phase|Protocol Violation|0|||
23633745|NCT00951015|66045445|FG003|Open-label Phase|Protocol Violation|0|||
23633746|NCT00951015|66045446|FG004|Open-label Phase|Protocol Violation|12|||
23633747|NCT00951015|66045442|FG000|Open-label Phase|Lost to Follow-up|0|||
23633748|NCT00951015|66045443|FG001|Open-label Phase|Lost to Follow-up|0|||
23633749|NCT00951015|66045444|FG002|Open-label Phase|Lost to Follow-up|0|||
23633750|NCT00951015|66045445|FG003|Open-label Phase|Lost to Follow-up|0|||
23633751|NCT00951015|66045446|FG004|Open-label Phase|Lost to Follow-up|12|||
23633752|NCT00951015|66045442|FG000|Open-label Phase|Withdrawal by Subject|0|||
23633753|NCT00951015|66045443|FG001|Open-label Phase|Withdrawal by Subject|0|||
23633754|NCT00951015|66045444|FG002|Open-label Phase|Withdrawal by Subject|0|||
23633755|NCT00951015|66045445|FG003|Open-label Phase|Withdrawal by Subject|0|||
23633756|NCT00951015|66045446|FG004|Open-label Phase|Withdrawal by Subject|14|||
23633757|NCT00951015|66045442|FG000|Open-label Phase|Physician Decision|0|||
23633758|NCT00951015|66045443|FG001|Open-label Phase|Physician Decision|0|||
23633759|NCT00951015|66045444|FG002|Open-label Phase|Physician Decision|0|||
23633760|NCT00951015|66045445|FG003|Open-label Phase|Physician Decision|0|||
23633761|NCT00951015|66045446|FG004|Open-label Phase|Physician Decision|8|||
23633762|NCT00565773|66045447|FG000|Overall Study|Withdrawal by Subject|1|||
23633763|NCT00565773|66045447|FG000|Overall Study|Physician Decision|1|||
23633764|NCT01147536|66045450|FG000|Overall Study|Administrative study close|2|||
23633765|NCT01147536|66045450|FG000|Overall Study|Death|1|||
23633766|NCT05383508|66045455|FG000|Overall Study|Withdrawal by Subject|1|||
23633767|NCT05383508|66045456|FG001|Overall Study|Withdrawal by Subject|0|||
23633768|NCT05383508|66045457|FG002|Overall Study|Withdrawal by Subject|1|||
23633769|NCT05383508|66045458|FG003|Overall Study|Withdrawal by Subject|1|||
23633770|NCT05383508|66045459|FG004|Overall Study|Withdrawal by Subject|2|||
23633771|NCT05383508|66045460|FG005|Overall Study|Withdrawal by Subject|0|||
23633772|NCT00552929|66045461|FG000|Overall Study|Lost to Follow-up|0|||
23633773|NCT00552929|66045462|FG001|Overall Study|Lost to Follow-up|0|||
23633774|NCT00552929|66045463|FG002|Overall Study|Lost to Follow-up|0|||
23633775|NCT00552929|66045464|FG003|Overall Study|Lost to Follow-up|0|||
23633776|NCT00552929|66045465|FG004|Overall Study|Lost to Follow-up|0|||
23633777|NCT00552929|66045466|FG005|Overall Study|Lost to Follow-up|0|||
23633778|NCT00552929|66045467|FG006|Overall Study|Lost to Follow-up|0|||
23633779|NCT00552929|66045468|FG007|Overall Study|Lost to Follow-up|0|||
23633780|NCT00552929|66045469|FG008|Overall Study|Lost to Follow-up|1|||
23633781|NCT00552929|66045470|FG009|Overall Study|Lost to Follow-up|0|||
23633782|NCT00552929|66045461|FG000|Overall Study|Not Eligible|0|||
23633783|NCT00552929|66045462|FG001|Overall Study|Not Eligible|0|||
23633784|NCT00552929|66045463|FG002|Overall Study|Not Eligible|0|||
23633785|NCT00552929|66045464|FG003|Overall Study|Not Eligible|0|||
23633786|NCT00552929|66045465|FG004|Overall Study|Not Eligible|0|||
23633787|NCT00552929|66045466|FG005|Overall Study|Not Eligible|1|||
23633788|NCT00552929|66045467|FG006|Overall Study|Not Eligible|0|||
23633789|NCT00552929|66045468|FG007|Overall Study|Not Eligible|0|||
23633790|NCT00552929|66045469|FG008|Overall Study|Not Eligible|0|||
23633791|NCT00552929|66045470|FG009|Overall Study|Not Eligible|0|||
23633792|NCT01133418|66045471|FG000|Overall Study|Lost to Follow-up|5|||
23633793|NCT01133418|66045472|FG001|Overall Study|Lost to Follow-up|6|||
23633794|NCT02687035|66045477|FG000|Overall Study|Withdrawal by Subject|1|||
23633795|NCT02687035|66045477|FG000|Overall Study|Death|87|||
23633796|NCT02687035|66045477|FG000|Overall Study|Lost to Follow-up|1|||
23633797|NCT02687035|66045477|FG000|Overall Study|Missed Visit|87|||
23633798|NCT02687035|66045477|FG000|Overall Study|Did not receive Study Device|8|||
23633799|NCT01020877|66045478|FG000|Second Intervention|Withdrawal by Subject|1|||
23633800|NCT01020877|66045479|FG001|Second Intervention|Withdrawal by Subject|0|||
23633801|NCT02568397|66045480|FG000|Period 2|Withdrawal by Subject|0|||
23575608|NCT00057811|65838779|FG001|Overall Study|Inevaluable|2|||
23633802|NCT02568397|66045481|FG001|Period 2|Withdrawal by Subject|1|||
23633803|NCT02568397|66045480|FG000|Period 2|Physician Decision|0|||
23633804|NCT02568397|66045481|FG001|Period 2|Physician Decision|1|||
23633805|NCT01850589|66045482|FG000|Overall Study|Withdrawal by Subject|8|||
23633806|NCT01850589|66045483|FG001|Overall Study|Withdrawal by Subject|0|||
23633807|NCT01637077|66045484|FG000|Overall Study|Cancel|1|||
23633808|NCT01637077|66045485|FG001|Overall Study|Cancel|1|||
23633809|NCT01637077|66045484|FG000|Overall Study|Withdrawal by Subject|1|||
23633810|NCT01637077|66045485|FG001|Overall Study|Withdrawal by Subject|0|||
23633811|NCT01637077|66045484|FG000|Overall Study|No cycle 1 questionnaire data|2|||
23633812|NCT01637077|66045485|FG001|Overall Study|No cycle 1 questionnaire data|0|||
23633813|NCT02737826|66045486|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
23575609|NCT00329719|65838787|FG000|Overall Study|Lost to Follow-up|0|||
23575610|NCT00329719|65838788|FG001|Overall Study|Lost to Follow-up|0|||
23575611|NCT00329719|65838789|FG002|Overall Study|Lost to Follow-up|0|||
23575612|NCT00329719|65838790|FG003|Overall Study|Lost to Follow-up|1|||
23575613|NCT00136916|65838793|FG000|Overall Study|Never received study treatment|3|||
23575614|NCT00136916|65838794|FG001|Overall Study|Never received study treatment|5|||
23575615|NCT00136916|65838793|FG000|Overall Study|Death|1|||
23575616|NCT00136916|65838794|FG001|Overall Study|Death|3|||
23633814|NCT02737826|66045487|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
23575617|NCT00136916|65838793|FG000|Overall Study|Adverse Event|27|||
23575618|NCT00136916|65838794|FG001|Overall Study|Adverse Event|8|||
23774179|NCT02495857|66553526|FG001|Overall Study|Other|3|||
23774180|NCT02495857|66553527|FG002|Overall Study|Other|2|||
23774181|NCT01471093|66553531|FG000|Overall Study|Adverse Event|1|||
23774182|NCT01471093|66553532|FG001|Overall Study|Adverse Event|0|||
23774183|NCT01471093|66553533|FG002|Overall Study|Adverse Event|0|||
23774184|NCT01471093|66553534|FG003|Overall Study|Adverse Event|0|||
23575619|NCT00136916|65838793|FG000|Overall Study|Laboratory abnormality|0|||
23575620|NCT00136916|65838794|FG001|Overall Study|Laboratory abnormality|1|||
23575621|NCT00136916|65838793|FG000|Overall Study|Lack of Efficacy|13|||
23575622|NCT00136916|65838794|FG001|Overall Study|Lack of Efficacy|3|||
23575623|NCT00136916|65838793|FG000|Overall Study|Lost to Follow-up|12|||
23575624|NCT00136916|65838794|FG001|Overall Study|Lost to Follow-up|14|||
23774185|NCT02170688|66553539|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
23774186|NCT02170688|66553540|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
23774187|NCT02170688|66553541|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
23774188|NCT02170688|66553542|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
23774189|NCT02170688|66553543|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
23575625|NCT00136916|65838793|FG000|Overall Study|Withdrawal by Subject|44|||
23575626|NCT00136916|65838794|FG001|Overall Study|Withdrawal by Subject|46|||
23575627|NCT00136916|65838793|FG000|Overall Study|Other|22|||
23633815|NCT02737826|66045488|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
23633816|NCT00737698|66045489|FG000|Overall Study|Withdrawal by Subject|6|||
23633817|NCT00737698|66045490|FG001|Overall Study|Withdrawal by Subject|5|||
23633818|NCT00737698|66045491|FG002|Overall Study|Withdrawal by Subject|3|||
23633819|NCT00737698|66045489|FG000|Overall Study|Death|0|||
23774190|NCT02170688|66553539|FG000|Overall Study|Full dose not received|0|||
23774191|NCT02170688|66553540|FG001|Overall Study|Full dose not received|1|||
23774192|NCT02170688|66553541|FG002|Overall Study|Full dose not received|0|||
23774193|NCT02170688|66553542|FG003|Overall Study|Full dose not received|0|||
23774194|NCT02170688|66553543|FG004|Overall Study|Full dose not received|0|||
23774195|NCT02170688|66553539|FG000|Overall Study|Physician Decision|0|||
23774196|NCT02170688|66553540|FG001|Overall Study|Physician Decision|0|||
23774197|NCT02170688|66553541|FG002|Overall Study|Physician Decision|1|||
23447695|NCT01479868|65380569|FG000|Overall Study|Protocol Violation|1|||
23633820|NCT00737698|66045490|FG001|Overall Study|Death|0|||
23633821|NCT00737698|66045491|FG002|Overall Study|Death|1|||
23633822|NCT00387426|66045492|FG000|Overall Study|Lack of Response|7|||
23633823|NCT00387426|66045492|FG000|Overall Study|Toxicities|4|||
23633824|NCT00387426|66045492|FG000|Overall Study|Disease Progression|3|||
23447696|NCT01479868|65380569|FG000|Overall Study|Withdrawal by Subject|1|||
23633825|NCT01793129|66045493|FG000|Overall Study|Lost to Follow-up|3|||
23633826|NCT01793129|66045494|FG001|Overall Study|Lost to Follow-up|7|||
23774198|NCT02170688|66553542|FG003|Overall Study|Physician Decision|0|||
23575628|NCT00136916|65838794|FG001|Overall Study|Other|24|||
23633827|NCT01793129|66045493|FG000|Overall Study|Withdrawal by Subject|0|||
23774199|NCT02170688|66553543|FG004|Overall Study|Physician Decision|0|||
23774200|NCT00958243|66553546|FG000|Overall Study|Withdrawal by Subject|0|||
23774201|NCT00958243|66553547|FG001|Overall Study|Withdrawal by Subject|1|||
23774202|NCT00958243|66553548|FG002|Overall Study|Withdrawal by Subject|3|||
23774203|NCT00958243|66553549|FG003|Overall Study|Withdrawal by Subject|1|||
23774204|NCT00958243|66553550|FG004|Overall Study|Withdrawal by Subject|1|||
23774205|NCT00958243|66553551|FG005|Overall Study|Withdrawal by Subject|5|||
23774206|NCT00958243|66553546|FG000|Overall Study|Lost to Follow-up|2|||
23774207|NCT00958243|66553547|FG001|Overall Study|Lost to Follow-up|5|||
23774208|NCT00958243|66553548|FG002|Overall Study|Lost to Follow-up|11|||
23774209|NCT00958243|66553549|FG003|Overall Study|Lost to Follow-up|2|||
23774210|NCT00958243|66553550|FG004|Overall Study|Lost to Follow-up|8|||
23774211|NCT00958243|66553551|FG005|Overall Study|Lost to Follow-up|5|||
23774212|NCT02924038|66553552|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
23774213|NCT02924038|66553553|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
23774214|NCT00762086|66553554|FG000|Overall Study|Adverse Event|2|||
23774215|NCT00762086|66553555|FG001|Overall Study|Adverse Event|0|||
23774216|NCT00762086|66553554|FG000|Overall Study|Lost to Follow-up|0|||
23774217|NCT00762086|66553555|FG001|Overall Study|Lost to Follow-up|2|||
23774218|NCT00762086|66553554|FG000|Overall Study|Non compliance|1|||
23774219|NCT00762086|66553555|FG001|Overall Study|Non compliance|0|||
23774220|NCT00762086|66553554|FG000|Overall Study|Withdrawal by Subject|2|||
23774221|NCT00762086|66553555|FG001|Overall Study|Withdrawal by Subject|2|||
23774222|NCT00762086|66553554|FG000|Overall Study|Ineligible to participate in the study|1|||
23774223|NCT00762086|66553555|FG001|Overall Study|Ineligible to participate in the study|0|||
23774224|NCT00755196|66553557|FG000|Overall Study|Lost to Follow-up|1|||
23774225|NCT00755196|66553557|FG000|Overall Study|Lack of Efficiency|1|||
23774226|NCT00406848|66553560|FG000|Overall Study|Withdrawal by Subject|27|||
23774227|NCT00406848|66553561|FG001|Overall Study|Withdrawal by Subject|22|||
23774228|NCT00406848|66553560|FG000|Overall Study|Adverse Event|38|||
23774229|NCT00406848|66553561|FG001|Overall Study|Adverse Event|7|||
23774230|NCT00406848|66553560|FG000|Overall Study|Lack of Efficacy|9|||
23774231|NCT00406848|66553561|FG001|Overall Study|Lack of Efficacy|14|||
23774232|NCT00406848|66553560|FG000|Overall Study|Protocol Violation|10|||
23774233|NCT00406848|66553561|FG001|Overall Study|Protocol Violation|6|||
23774234|NCT00406848|66553560|FG000|Overall Study|Lost to Follow-up|6|||
23774235|NCT00406848|66553561|FG001|Overall Study|Lost to Follow-up|2|||
23774236|NCT00406848|66553560|FG000|Overall Study|Physician Decision|2|||
23774237|NCT00406848|66553561|FG001|Overall Study|Physician Decision|2|||
23774238|NCT00406848|66553560|FG000|Overall Study|Sponsor Decision|1|||
23774239|NCT00406848|66553561|FG001|Overall Study|Sponsor Decision|1|||
23575629|NCT00136916|65838793|FG000|Overall Study|Discontinued in follow up period|3|||
23774240|NCT00397488|66553562|FG000|Overall Study|Withdrawal by Subject|3|||
23575630|NCT00136916|65838794|FG001|Overall Study|Discontinued in follow up period|0|||
23575631|NCT01528709|65838795|FG000|Overall Study|Death|2|||
23575632|NCT01528709|65838796|FG001|Overall Study|Death|0|||
23575633|NCT01528709|65838795|FG000|Overall Study|Withdrawal by Subject|10|||
23575634|NCT01528709|65838796|FG001|Overall Study|Withdrawal by Subject|15|||
23575635|NCT01528709|65838795|FG000|Overall Study|allergy|1|||
23633828|NCT01793129|66045494|FG001|Overall Study|Withdrawal by Subject|2|||
23633829|NCT00412607|66045501|FG000|Overall Study|Withdrawal by Subject|9|||
23774241|NCT00397488|66553562|FG000|Overall Study|Adverse Event|3|||
23774242|NCT00397488|66553562|FG000|Overall Study|Death|1|||
23575636|NCT01528709|65838796|FG001|Overall Study|allergy|0|||
23774243|NCT02246920|66553564|FG000|Overall Study|Adverse Event|3|||
23774244|NCT02246920|66553565|FG001|Overall Study|Adverse Event|1|||
23774245|NCT02246920|66553566|FG002|Overall Study|Adverse Event|1|||
23774246|NCT02246920|66553564|FG000|Overall Study|Lost to Follow-up|2|||
23774247|NCT02246920|66553565|FG001|Overall Study|Lost to Follow-up|1|||
23774248|NCT02246920|66553566|FG002|Overall Study|Lost to Follow-up|0|||
23774249|NCT02246920|66553564|FG000|Overall Study|Protocol Violation|2|||
23774250|NCT02246920|66553565|FG001|Overall Study|Protocol Violation|5|||
23833911|NCT02285361|66770812|FG000|Overall Study|Lost to Follow-up|5|||
23575637|NCT00958009|65838797|FG000|Overall Study|Adverse Event|1|||
23774251|NCT02246920|66553566|FG002|Overall Study|Protocol Violation|1|||
23774252|NCT02246920|66553564|FG000|Overall Study|Withdrawal by Subject|0|||
23833912|NCT02285361|66770812|FG000|Overall Study|Not taken GIOTRIF|2|||
23833913|NCT02285361|66770812|FG000|Overall Study|Consented prior to the contract date|1|||
23833914|NCT01082328|66770816|FG000|Overall Study|Adverse Event|1|||
23833915|NCT02801617|66770817|FG000|Overall Study|Protocol Violation|2|||
23633830|NCT00412607|66045501|FG000|Overall Study|Lost to Follow-up|19|||
23774253|NCT02246920|66553565|FG001|Overall Study|Withdrawal by Subject|0|||
23774254|NCT02246920|66553566|FG002|Overall Study|Withdrawal by Subject|1|||
23774255|NCT00064753|66553573|FG000|Overall Study|Death|251|||
23774256|NCT00064753|66553574|FG001|Overall Study|Death|242|||
23774257|NCT00064753|66553573|FG000|Overall Study|Withdrawal by Subject|198|||
23774258|NCT00064753|66553574|FG001|Overall Study|Withdrawal by Subject|171|||
23774259|NCT00064753|66553573|FG000|Overall Study|Lost to Follow-up|225|||
23774260|NCT00064753|66553574|FG001|Overall Study|Lost to Follow-up|235|||
23774261|NCT00304083|66553581|FG000|Overall Study|Withdrawal by Subject|4|||
23774262|NCT00304083|66553582|FG001|Overall Study|Withdrawal by Subject|2|||
23774263|NCT00304083|66553581|FG000|Overall Study|Physician Decision|8|||
23774264|NCT00304083|66553582|FG001|Overall Study|Physician Decision|3|||
23774265|NCT00304083|66553581|FG000|Overall Study|Disease Progression|5|||
23774266|NCT00304083|66553582|FG001|Overall Study|Disease Progression|1|||
23774267|NCT00304083|66553581|FG000|Overall Study|Other|5|||
23774268|NCT00304083|66553582|FG001|Overall Study|Other|2|||
23774269|NCT05593965|66553583|FG000|1st Intervention (1 Day)|Technical error|1|||
23774270|NCT05593965|66553584|FG001|1st Intervention (1 Day)|Technical error|0|||
23774271|NCT00444145|66553592|FG000|Overall Study|Withdrawal by Subject|2|||
23774272|NCT00444145|66553592|FG000|Overall Study|Lost to Follow-up|1|||
23774273|NCT00444145|66553592|FG000|Overall Study|non-compliant|11|||
23774274|NCT00444145|66553592|FG000|Overall Study|Screen Failures|5|||
23774275|NCT04786184|66553594|FG000|Overall Study|Adverse Event|4|||
23774276|NCT04786184|66553595|FG001|Overall Study|Adverse Event|0|||
23774277|NCT04786184|66553594|FG000|Overall Study|Withdrawal by Subject|3|||
23774278|NCT04786184|66553595|FG001|Overall Study|Withdrawal by Subject|1|||
23774279|NCT04786184|66553594|FG000|Overall Study|Lost to Follow-up|4|||
23774280|NCT04786184|66553595|FG001|Overall Study|Lost to Follow-up|2|||
23774281|NCT03338972|66553598|FG000|Overall Study|Death|1|||
23774282|NCT03338972|66553599|FG001|Overall Study|Death|1|||
23774283|NCT03338972|66553600|FG002|Overall Study|Death|0|||
23774284|NCT03338972|66553601|FG003|Overall Study|Death|0|||
23774285|NCT03338972|66553598|FG000|Overall Study|Withdrawal by Subject|1|||
23833916|NCT02801617|66770818|FG001|Overall Study|Protocol Violation|6|||
23833917|NCT01703260|66770819|FG000|Overall Study|Adverse Event|1|||
23833918|NCT01703260|66770820|FG001|Overall Study|Adverse Event|2|||
23833919|NCT01703260|66770821|FG002|Overall Study|Adverse Event|2|||
23833920|NCT01703260|66770819|FG000|Overall Study|Lost to Follow-up|1|||
23833921|NCT01703260|66770820|FG001|Overall Study|Lost to Follow-up|0|||
23833922|NCT01703260|66770821|FG002|Overall Study|Lost to Follow-up|0|||
23833923|NCT01703260|66770819|FG000|Overall Study|Withdrawal by Subject|0|||
23833924|NCT01703260|66770820|FG001|Overall Study|Withdrawal by Subject|0|||
23833925|NCT01703260|66770821|FG002|Overall Study|Withdrawal by Subject|1|||
23833926|NCT01703260|66770819|FG000|Overall Study|Study Termination|1|||
23833927|NCT01703260|66770820|FG001|Overall Study|Study Termination|2|||
23833928|NCT01703260|66770821|FG002|Overall Study|Study Termination|0|||
23833929|NCT01842438|66770822|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
23833930|NCT01842438|66770823|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
23833931|NCT01842438|66770822|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
23833932|NCT01842438|66770823|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
23833933|NCT01842438|66770822|FG000|T2: 6month Follow-up|Death|0|||
23833934|NCT01842438|66770823|FG001|T2: 6month Follow-up|Death|1|||
23833935|NCT01422889|66770827|FG000|Overall Study|No Data Entered for Study Stent|9|||
23833936|NCT02588612|66770828|FG000|Overall Study|Physician Decision|1|||
23833937|NCT02588612|66770828|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
23833938|NCT02588612|66770828|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
23833939|NCT02588612|66770828|FG000|Overall Study|Death prior to T-cell infusion|1|||
23833940|NCT00461630|66770829|FG000|Overall Study|Death|798|||
23833941|NCT00461630|66770830|FG001|Overall Study|Death|732|||
23833942|NCT00461630|66770829|FG000|Overall Study|Lost to Follow-up|108|||
23833943|NCT00461630|66770830|FG001|Overall Study|Lost to Follow-up|95|||
23774286|NCT03338972|66553599|FG001|Overall Study|Withdrawal by Subject|0|||
23774287|NCT03338972|66553600|FG002|Overall Study|Withdrawal by Subject|0|||
23774288|NCT03338972|66553601|FG003|Overall Study|Withdrawal by Subject|0|||
23774289|NCT04091971|66553604|FG000|Overall Study|Withdrawal by Subject|1|||
23774290|NCT04091971|66553604|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
23774291|NCT04091971|66553604|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
23774292|NCT01781637|66553605|FG000|Overall Study|Adverse Event|1|||
23833944|NCT00462709|66770831|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
23833945|NCT00462709|66770831|FG000|Overall Study|Lost to Follow-up|10|||
23447697|NCT01479868|65380569|FG000|Overall Study|Sponsor's Decision|1|||
23447698|NCT01479868|65380569|FG000|Overall Study|Initiation of new HCV Therapy|1|||
23774293|NCT01781637|66553606|FG001|Overall Study|Adverse Event|0|||
23774294|NCT01781637|66553605|FG000|Overall Study|Lack of Efficacy|2|||
23774295|NCT01781637|66553606|FG001|Overall Study|Lack of Efficacy|6|||
23447699|NCT01473732|65380570|FG000|Overall Study|Adverse Event|1|||
23447700|NCT01473732|65380571|FG001|Overall Study|Adverse Event|0|||
23447701|NCT01473732|65380570|FG000|Overall Study|Death|1|||
23447702|NCT01473732|65380571|FG001|Overall Study|Death|0|||
23447703|NCT00836186|65380578|FG000|Overall Study|Blood could not be drawn|1|||
23447704|NCT00108862|65380587|FG000|Overall Study|Death|31|||
23447705|NCT00108862|65380588|FG001|Overall Study|Death|37|||
23447706|NCT00108862|65380587|FG000|Overall Study|Withdrawal by Subject|10|||
23447707|NCT00108862|65380588|FG001|Overall Study|Withdrawal by Subject|6|||
23447708|NCT00108862|65380587|FG000|Overall Study|Lost to Follow-up|27|||
23447709|NCT00108862|65380588|FG001|Overall Study|Lost to Follow-up|19|||
23447710|NCT00801229|65380589|FG000|Signed Consent|Withdrawal by Subject|2|||
23447711|NCT00801229|65380590|FG001|Signed Consent|Withdrawal by Subject|2|||
23447712|NCT00801229|65380589|FG000|Signed Consent|Found Ineligible|1|||
23447713|NCT00801229|65380590|FG001|Signed Consent|Found Ineligible|1|||
23447714|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
23447715|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
23447716|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
23447717|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
23447718|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
23575638|NCT00958009|65838797|FG000|Overall Study|Subject found device difficult to use|1|||
23575639|NCT00738530|65838800|FG000|Overall Study|Death|220|||
23575640|NCT00738530|65838801|FG001|Overall Study|Death|224|||
23575641|NCT00738530|65838800|FG000|Overall Study|Lost to Follow-up|8|||
23774296|NCT01781637|66553605|FG000|Overall Study|Withdrawal by Subject|1|||
23774297|NCT01781637|66553606|FG001|Overall Study|Withdrawal by Subject|0|||
23774298|NCT00755326|66553607|FG000|Overall Study|Lost to Follow-up|2|||
23447719|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
23774299|NCT00755326|66553608|FG001|Overall Study|Lost to Follow-up|3|||
23774300|NCT03730103|66553609|FG000|Overall Study|Did not meet inclusion criteria|0|||
23774301|NCT03730103|66553610|FG001|Overall Study|Did not meet inclusion criteria|5|||
23774302|NCT00175019|66553619|FG000|Overall Study|Adverse Event|54|||
23774303|NCT00175019|66553620|FG001|Overall Study|Adverse Event|22|||
23774304|NCT00175019|66553621|FG002|Overall Study|Adverse Event|2|||
23774305|NCT00175019|66553619|FG000|Overall Study|Protocol Violation|6|||
23774306|NCT00175019|66553620|FG001|Overall Study|Protocol Violation|3|||
23774307|NCT00175019|66553621|FG002|Overall Study|Protocol Violation|3|||
23774308|NCT00175019|66553619|FG000|Overall Study|Lost to Follow-up|42|||
23774309|NCT00175019|66553620|FG001|Overall Study|Lost to Follow-up|39|||
23774310|NCT00175019|66553621|FG002|Overall Study|Lost to Follow-up|9|||
23774311|NCT00175019|66553619|FG000|Overall Study|Did not continue under Amendment 4|1|||
23774312|NCT00175019|66553620|FG001|Overall Study|Did not continue under Amendment 4|1|||
23774313|NCT00175019|66553621|FG002|Overall Study|Did not continue under Amendment 4|2|||
23774314|NCT00175019|66553619|FG000|Overall Study|Personal Reason(s)|39|||
23774315|NCT00175019|66553620|FG001|Overall Study|Personal Reason(s)|31|||
23774316|NCT00175019|66553621|FG002|Overall Study|Personal Reason(s)|8|||
23774317|NCT00175019|66553619|FG000|Overall Study|Therapeutic Failure|10|||
23774318|NCT00175019|66553620|FG001|Overall Study|Therapeutic Failure|38|||
23774319|NCT00175019|66553621|FG002|Overall Study|Therapeutic Failure|22|||
23774320|NCT00175019|66553619|FG000|Overall Study|Gout Flare|2|||
23774321|NCT00175019|66553620|FG001|Overall Study|Gout Flare|3|||
23774322|NCT00175019|66553621|FG002|Overall Study|Gout Flare|0|||
23774323|NCT00175019|66553619|FG000|Overall Study|Reason Not Specified|40|||
23774324|NCT00175019|66553620|FG001|Overall Study|Reason Not Specified|34|||
23833946|NCT00462709|66770831|FG000|Overall Study|Withdrawal by Subject|8|||
23833947|NCT00462709|66770831|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
23833948|NCT00462709|66770831|FG000|Overall Study|Death|2|||
23833949|NCT00462709|66770831|FG000|Overall Study|Logistical reasons|2|||
23833950|NCT00462709|66770831|FG000|Overall Study|Physician Decision|1|||
23833951|NCT00462709|66770831|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
23833952|NCT00191477|66770832|FG000|Overall Study|Tumor Recurrence|49|||
23774325|NCT00175019|66553621|FG002|Overall Study|Reason Not Specified|11|||
23774326|NCT00376623|66553622|FG000|Overall Study|Progressive disease|35|||
23774327|NCT00376623|66553623|FG001|Overall Study|Progressive disease|22|||
23774328|NCT00376623|66553624|FG002|Overall Study|Progressive disease|17|||
23774329|NCT00376623|66553622|FG000|Overall Study|Lost to Follow-up|0|||
23774330|NCT00376623|66553623|FG001|Overall Study|Lost to Follow-up|1|||
23833953|NCT00191477|66770833|FG001|Overall Study|Tumor Recurrence|48|||
23447720|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
23447721|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
23447722|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
23447723|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
23447724|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Adverse Event|1|||
23447725|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Adverse Event|1|||
23447726|NCT00269919|65380591|FG000|Overall Study|Other|26|||
23447727|NCT00269919|65380591|FG000|Overall Study|Started but not treated|1|||
23447728|NCT01569841|65380592|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
23447729|NCT01569841|65380593|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
23447730|NCT04549545|65380594|FG000|Initial Period|Withdrawal by Subject|4|||
23575642|NCT00738530|65838801|FG001|Overall Study|Lost to Follow-up|6|||
23833954|NCT00191477|66770832|FG000|Overall Study|Death, Study Disease|1|||
23833955|NCT00191477|66770833|FG001|Overall Study|Death, Study Disease|1|||
23833956|NCT00191477|66770832|FG000|Overall Study|Death, Other Cause|3|||
23833957|NCT00191477|66770833|FG001|Overall Study|Death, Other Cause|6|||
23833958|NCT00191477|66770832|FG000|Overall Study|Lost to Follow-up|23|||
23833959|NCT00191477|66770833|FG001|Overall Study|Lost to Follow-up|21|||
23833960|NCT00191477|66770832|FG000|Overall Study|Protocol Violation|1|||
23833961|NCT00191477|66770833|FG001|Overall Study|Protocol Violation|1|||
23833962|NCT00191477|66770832|FG000|Overall Study|Treatment Change|2|||
23833963|NCT00191477|66770833|FG001|Overall Study|Treatment Change|0|||
23833964|NCT00191477|66770832|FG000|Overall Study|Withdrawal by Subject|2|||
23833965|NCT00191477|66770833|FG001|Overall Study|Withdrawal by Subject|0|||
23833966|NCT00191477|66770832|FG000|Overall Study|Other|2|||
23833967|NCT00191477|66770833|FG001|Overall Study|Other|0|||
23833968|NCT00191477|66770832|FG000|Overall Study|Not Eligible|41|||
23833969|NCT00191477|66770833|FG001|Overall Study|Not Eligible|38|||
23833970|NCT00191477|66770832|FG000|Overall Study|Pathological Specimen Lost|1|||
23833971|NCT00191477|66770833|FG001|Overall Study|Pathological Specimen Lost|0|||
23833972|NCT00191477|66770832|FG000|Overall Study|Discontinued Prior to Instillation|13|||
23833973|NCT00191477|66770833|FG001|Overall Study|Discontinued Prior to Instillation|14|||
23833974|NCT02929589|66770834|FG000|Overall Study|Withdrawal by Subject|1|||
23833975|NCT02929589|66770835|FG001|Overall Study|Withdrawal by Subject|0|||
23833976|NCT02929589|66770836|FG002|Overall Study|Withdrawal by Subject|0|||
23833977|NCT02929589|66770837|FG003|Overall Study|Withdrawal by Subject|0|||
23833978|NCT02929589|66770834|FG000|Overall Study|Physician Decision|2|||
23833979|NCT02929589|66770835|FG001|Overall Study|Physician Decision|0|||
23833980|NCT02929589|66770836|FG002|Overall Study|Physician Decision|0|||
23833981|NCT02929589|66770837|FG003|Overall Study|Physician Decision|0|||
23833982|NCT02068508|66770838|FG000|Overall Study|Case report forms uncollected|27|||
23833983|NCT02068508|66770838|FG000|Overall Study|Patient did not visit the study site|1|||
23833984|NCT02068508|66770838|FG000|Overall Study|Protocol Violation|4|||
23833985|NCT01367886|66770839|FG000|Overall Study|Lost to Follow-up|4|||
23833986|NCT01367886|66770839|FG000|Overall Study|Lack of Efficacy|2|||
23833987|NCT01367886|66770839|FG000|Overall Study|Death|1|||
23833988|NCT04620746|66770840|FG000|Overall Study|Adverse Event|2|||
23833989|NCT04620746|66770841|FG001|Overall Study|Adverse Event|0|||
23833990|NCT04620746|66770840|FG000|Overall Study|Uniterpretable skin test|1|||
23833991|NCT04620746|66770841|FG001|Overall Study|Uniterpretable skin test|0|||
23833992|NCT04620746|66770840|FG000|Overall Study|Withdrawal by Subject|0|||
23833993|NCT04620746|66770841|FG001|Overall Study|Withdrawal by Subject|1|||
23833994|NCT03776357|66770842|FG000|Overall Study|Lost to Follow-up|3|||
23833995|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
23833996|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
23833997|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
23833998|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
23833999|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
23834000|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
23834001|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
23834002|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
23575643|NCT00738530|65838800|FG000|Overall Study|Withdrawal by Subject|6|||
23575644|NCT00738530|65838801|FG001|Overall Study|Withdrawal by Subject|8|||
23834003|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
23834004|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
23834005|NCT03711786|66770843|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
23834006|NCT03711786|66770844|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
23834007|NCT03511105|66770845|FG000|Overall Study|Adverse Event|1|||
23834008|NCT03511105|66770846|FG001|Overall Study|Adverse Event|0|||
23834009|NCT03511105|66770845|FG000|Overall Study|Withdrew consent|1|||
23834010|NCT03511105|66770846|FG001|Overall Study|Withdrew consent|0|||
23834011|NCT00683618|66770847|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
23575645|NCT03930186|65838808|FG000|Weeks 0 to 16|Adverse Event|6|||
23575646|NCT03930186|65838808|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
23575647|NCT03930186|65838808|FG000|Weeks 16 to 32|Adverse Event|1|||
23834012|NCT00683618|66770848|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
23834013|NCT00683618|66770849|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
23834014|NCT00683618|66770847|FG000|Randomised Treatment Period|Protocol Violation|0|||
23834015|NCT00683618|66770848|FG001|Randomised Treatment Period|Protocol Violation|1|||
23834016|NCT00683618|66770849|FG002|Randomised Treatment Period|Protocol Violation|0|||
23834017|NCT00683618|66770847|FG000|Randomised Treatment Period|Adverse Event|2|||
23834018|NCT00683618|66770848|FG001|Randomised Treatment Period|Adverse Event|0|||
23834019|NCT00683618|66770849|FG002|Randomised Treatment Period|Adverse Event|2|||
23834020|NCT00683618|66770847|FG000|Randomised Treatment Period|Reason not provided|0|||
23834021|NCT00683618|66770848|FG001|Randomised Treatment Period|Reason not provided|0|||
23834022|NCT00683618|66770849|FG002|Randomised Treatment Period|Reason not provided|2|||
23834023|NCT00683618|66770847|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
23834024|NCT00683618|66770848|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23834025|NCT00683618|66770849|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23834026|NCT00683618|66770847|FG000|Extension Treatment Period|Adverse Event|1|||
23834027|NCT00683618|66770848|FG001|Extension Treatment Period|Adverse Event|0|||
23834028|NCT00683618|66770849|FG002|Extension Treatment Period|Adverse Event|0|||
23834029|NCT00683618|66770847|FG000|Extension Treatment Period|Protocol Violation|1|||
23447731|NCT04549545|65380595|FG001|Initial Period|Withdrawal by Subject|0|||
23447732|NCT04549545|65380594|FG000|Initial Period|Additional ENT Procedure|3|||
23447733|NCT04549545|65380595|FG001|Initial Period|Additional ENT Procedure|0|||
23447734|NCT04549545|65380594|FG000|Initial Period|Lost to Follow-up|3|||
23447735|NCT04549545|65380595|FG001|Initial Period|Lost to Follow-up|1|||
23447736|NCT04549545|65380594|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
23447737|NCT04549545|65380595|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
23447738|NCT04549545|65380594|FG000|Crossover Period|Additional ENT Procedure|0|||
23447739|NCT04549545|65380595|FG001|Crossover Period|Additional ENT Procedure|6|||
23447740|NCT04549545|65380594|FG000|Crossover Period|Lost to Follow-up|0|||
23447741|NCT04549545|65380595|FG001|Crossover Period|Lost to Follow-up|1|||
23447742|NCT04549545|65380594|FG000|Crossover Period|Withdrawal by Subject|0|||
23447743|NCT04549545|65380595|FG001|Crossover Period|Withdrawal by Subject|4|||
23447744|NCT02587520|65380596|FG000|Overall Study|Protocol Violation|2|||
23447745|NCT02587520|65380597|FG001|Overall Study|Protocol Violation|0|||
23834030|NCT00683618|66770848|FG001|Extension Treatment Period|Protocol Violation|0|||
23834031|NCT00683618|66770849|FG002|Extension Treatment Period|Protocol Violation|0|||
23834032|NCT02418949|66770850|FG000|Overall Study|Withdrawal by Subject|1|||
23834033|NCT02418949|66770851|FG001|Overall Study|Withdrawal by Subject|0|||
23834034|NCT02418949|66770852|FG002|Overall Study|Withdrawal by Subject|1|||
23834035|NCT02418949|66770853|FG003|Overall Study|Withdrawal by Subject|1|||
23834036|NCT02418949|66770850|FG000|Overall Study|Lost to Follow-up|1|||
23834037|NCT02418949|66770851|FG001|Overall Study|Lost to Follow-up|0|||
23834038|NCT02418949|66770852|FG002|Overall Study|Lost to Follow-up|1|||
23447746|NCT02587520|65380598|FG002|Overall Study|Protocol Violation|0|||
23447747|NCT02587520|65380599|FG003|Overall Study|Protocol Violation|2|||
23834039|NCT02418949|66770853|FG003|Overall Study|Lost to Follow-up|0|||
23447748|NCT02587520|65380600|FG004|Overall Study|Protocol Violation|0|||
23447749|NCT02587520|65380601|FG005|Overall Study|Protocol Violation|1|||
23447750|NCT02587520|65380602|FG006|Overall Study|Protocol Violation|1|||
23447751|NCT02587520|65380603|FG007|Overall Study|Protocol Violation|1|||
23447752|NCT02587520|65380604|FG008|Overall Study|Protocol Violation|3|||
23447753|NCT02587520|65380605|FG009|Overall Study|Protocol Violation|3|||
23447754|NCT02587520|65380606|FG010|Overall Study|Protocol Violation|1|||
23447755|NCT02587520|65380607|FG011|Overall Study|Protocol Violation|2|||
23834040|NCT02418949|66770850|FG000|Overall Study|Physician Decision|1|||
23834041|NCT02418949|66770851|FG001|Overall Study|Physician Decision|1|||
23834042|NCT02418949|66770852|FG002|Overall Study|Physician Decision|1|||
23834043|NCT02418949|66770853|FG003|Overall Study|Physician Decision|0|||
23834044|NCT03743051|66770863|FG000|Overall Study|Adverse Event|5|||
23834045|NCT03743051|66770864|FG001|Overall Study|Adverse Event|9|||
23834046|NCT03743051|66770863|FG000|Overall Study|Death|27|||
23447756|NCT02587520|65380608|FG012|Overall Study|Protocol Violation|0|||
23447757|NCT02587520|65380609|FG013|Overall Study|Protocol Violation|0|||
23447758|NCT02587520|65380610|FG014|Overall Study|Protocol Violation|0|||
23633831|NCT00412607|66045501|FG000|Overall Study|Death|61|||
23774331|NCT00376623|66553624|FG002|Overall Study|Lost to Follow-up|0|||
23774332|NCT00376623|66553622|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
23774333|NCT00376623|66553623|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
23774334|NCT00376623|66553624|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
23774335|NCT00376623|66553622|FG000|Overall Study|Not treated with BI 2536|1|||
23774336|NCT00376623|66553623|FG001|Overall Study|Not treated with BI 2536|0|||
23774337|NCT00376623|66553624|FG002|Overall Study|Not treated with BI 2536|0|||
23774338|NCT00376623|66553622|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
23774339|NCT00376623|66553623|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774340|NCT00376623|66553624|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774341|NCT00376623|66553622|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
23774342|NCT00376623|66553623|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
23774343|NCT00376623|66553624|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
23774344|NCT00376623|66553622|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
23774345|NCT00376623|66553623|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774346|NCT00376623|66553624|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774347|NCT00376623|66553622|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
23774348|NCT00376623|66553623|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
23834047|NCT03743051|66770864|FG001|Overall Study|Death|26|||
23834048|NCT03743051|66770863|FG000|Overall Study|Lost to Follow-up|4|||
23834049|NCT03743051|66770864|FG001|Overall Study|Lost to Follow-up|8|||
23834050|NCT03743051|66770863|FG000|Overall Study|Withdrawal by Subject|32|||
23575648|NCT03930186|65838808|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
23575649|NCT00830947|65838813|FG000|Overall Study|Lost to Follow-up|4|||
23575650|NCT00830947|65838814|FG001|Overall Study|Lost to Follow-up|4|||
23575651|NCT04545619|65838815|FG000|Overall Study|due to equipment challenges|1|||
23575652|NCT00877851|65838816|FG000|Overall Study|Lost to Follow-up|5|||
23575653|NCT00877851|65838817|FG001|Overall Study|Lost to Follow-up|5|||
23575654|NCT00877851|65838816|FG000|Overall Study|computer problem|3|||
23575655|NCT00877851|65838817|FG001|Overall Study|computer problem|0|||
23575656|NCT00877851|65838816|FG000|Overall Study|no longer interested in participating|1|||
23575657|NCT00877851|65838817|FG001|Overall Study|no longer interested in participating|0|||
23575658|NCT01318811|65838820|FG000|Overall Study|Physician Decision|1|||
23575659|NCT01318811|65838821|FG001|Overall Study|Physician Decision|1|||
23575660|NCT01318811|65838820|FG000|Overall Study|CRRT stopped for head CT|0|||
23575661|NCT01318811|65838821|FG001|Overall Study|CRRT stopped for head CT|1|||
23575662|NCT01318811|65838820|FG000|Overall Study|Death|0|||
23575663|NCT01318811|65838821|FG001|Overall Study|Death|1|||
23575664|NCT01318811|65838820|FG000|Overall Study|CRRT stopped for head MRI|0|||
23575665|NCT01318811|65838821|FG001|Overall Study|CRRT stopped for head MRI|1|||
23834051|NCT03743051|66770864|FG001|Overall Study|Withdrawal by Subject|19|||
23575666|NCT02449044|65838822|FG000|Overall Study|Lost to Follow-up|2|||
23575667|NCT02449044|65838822|FG000|Overall Study|Withdrawal by Subject|13|||
23774349|NCT00376623|66553624|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
23774350|NCT00376623|66553622|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774351|NCT00376623|66553623|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23774352|NCT00376623|66553624|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
23774353|NCT00376623|66553622|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
23774354|NCT00376623|66553623|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
23774355|NCT00376623|66553624|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
23774356|NCT00376623|66553622|FG000|Overall Study|Increase of tumour markers|0|||
23774357|NCT00376623|66553623|FG001|Overall Study|Increase of tumour markers|1|||
23774358|NCT00376623|66553624|FG002|Overall Study|Increase of tumour markers|0|||
23774359|NCT00376623|66553622|FG000|Overall Study|Bone metastasis|1|||
23774360|NCT00376623|66553623|FG001|Overall Study|Bone metastasis|0|||
23774361|NCT00376623|66553624|FG002|Overall Study|Bone metastasis|0|||
23774362|NCT02581345|66553631|FG000|Part 1: up to Week 16|Adverse Event|3|||
23774363|NCT02581345|66553632|FG001|Part 1: up to Week 16|Adverse Event|8|||
23774364|NCT02581345|66553633|FG002|Part 1: up to Week 16|Adverse Event|0|||
23774365|NCT02581345|66553634|FG003|Part 1: up to Week 16|Adverse Event|0|||
23774366|NCT02581345|66553631|FG000|Part 1: up to Week 16|Physician Decision|2|||
23774367|NCT02581345|66553632|FG001|Part 1: up to Week 16|Physician Decision|4|||
23774368|NCT02581345|66553633|FG002|Part 1: up to Week 16|Physician Decision|0|||
23774369|NCT02581345|66553634|FG003|Part 1: up to Week 16|Physician Decision|0|||
23774370|NCT02581345|66553631|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
23575668|NCT02449044|65838822|FG000|Overall Study|Adverse Event|30|||
23774371|NCT02581345|66553632|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
23575669|NCT02449044|65838822|FG000|Overall Study|Met Withdrawal Criteria|7|||
23575670|NCT02449044|65838822|FG000|Overall Study|Physician Decision|9|||
23575671|NCT02449044|65838822|FG000|Overall Study|Sponsor Discontinued Trial|3|||
23834052|NCT03743051|66770863|FG000|Overall Study|Physician Decision|10|||
23834053|NCT03743051|66770864|FG001|Overall Study|Physician Decision|15|||
23834054|NCT03743051|66770863|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
23834055|NCT03743051|66770864|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
23834056|NCT02075203|66770865|FG000|Overall Study|Withdrawal by Subject|1|||
23834057|NCT02075203|66770866|FG001|Overall Study|Withdrawal by Subject|0|||
23447759|NCT02587520|65380611|FG015|Overall Study|Protocol Violation|0|||
23774372|NCT02581345|66553633|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
23774373|NCT02581345|66553634|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
23575672|NCT01853254|65838823|FG000|Overall Study|Abnormal Laboratory Test|1|||
23575673|NCT01853254|65838823|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
23575674|NCT01853254|65838823|FG000|Overall Study|Death|1|||
23575675|NCT01853254|65838823|FG000|Overall Study|Failure to Return|43|||
23575676|NCT01853254|65838823|FG000|Overall Study|Insufficient Therapeutic Response|22|||
23575677|NCT01853254|65838823|FG000|Overall Study|Refusal of Treatment|1|||
23575678|NCT01853254|65838823|FG000|Overall Study|Other Protocol Violation|1|||
23575679|NCT01853254|65838823|FG000|Overall Study|Withdrawal of Consent|16|||
23575680|NCT01853254|65838823|FG000|Overall Study|Administrative/Other|16|||
23575681|NCT02956967|65838824|FG000|Overall Study|Adverse Event|3|||
23774374|NCT02581345|66553631|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
23575682|NCT02956967|65838824|FG000|Overall Study|Reason non-related to neutropenia|10|||
23575683|NCT02956967|65838824|FG000|Overall Study|Lost to Follow-up|5|||
23575684|NCT02956967|65838824|FG000|Overall Study|Missing|1|||
23575685|NCT02956967|65838824|FG000|Overall Study|Termination of Nivestim administration|29|||
23774375|NCT02581345|66553632|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
23774376|NCT02581345|66553633|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
23774377|NCT02581345|66553634|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
23774378|NCT02581345|66553631|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
23774379|NCT02581345|66553632|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
23774380|NCT02581345|66553633|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
23774381|NCT02581345|66553634|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
23774382|NCT02581345|66553631|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
23774383|NCT02581345|66553632|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
23774384|NCT02581345|66553633|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
23774385|NCT02581345|66553634|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
23774386|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
23633832|NCT00412607|66045501|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
23633833|NCT01132820|66045503|FG000|Overall Study|Ineligible: wrong cell type|1|||
23774387|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
23834058|NCT02075203|66770867|FG002|Overall Study|Withdrawal by Subject|1|||
23834059|NCT02075203|66770865|FG000|Overall Study|Adverse Event|1|||
23834060|NCT02075203|66770866|FG001|Overall Study|Adverse Event|0|||
23834061|NCT02075203|66770867|FG002|Overall Study|Adverse Event|0|||
23834062|NCT02075203|66770865|FG000|Overall Study|participant refused to use contraception|1|||
23834063|NCT02075203|66770866|FG001|Overall Study|participant refused to use contraception|0|||
23834064|NCT02075203|66770867|FG002|Overall Study|participant refused to use contraception|0|||
23834065|NCT00634803|66770874|FG000|Overall Study|Lost to Follow-up|6|||
23575686|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
23575687|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
23575688|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
23575689|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
23575690|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
23575691|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
23575692|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
23575693|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
23575694|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
23575695|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
23575696|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
23575697|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
23575698|NCT01656759|65838828|FG000|Overall Study|Protocol Violation|2|||
23575699|NCT01656759|65838829|FG001|Overall Study|Protocol Violation|3|||
23575700|NCT02337361|65838830|FG000|3-month Follow-up|Lost to Follow-up|19|||
23575701|NCT02337361|65838831|FG001|3-month Follow-up|Lost to Follow-up|14|||
23575702|NCT02337361|65838830|FG000|6-month Follow-up|Lost to Follow-up|2|||
23575703|NCT02337361|65838831|FG001|6-month Follow-up|Lost to Follow-up|4|||
23575704|NCT00610675|65838832|FG000|Overall Study|Untreated|4|||
23575705|NCT00610675|65838832|FG000|Overall Study|Adverse Event|67|||
23575706|NCT00610675|65838832|FG000|Overall Study|Insufficient Effect|31|||
23575707|NCT00610675|65838832|FG000|Overall Study|Withdrawal by Subject|28|||
23575708|NCT00610675|65838832|FG000|Overall Study|Reasons unrelated to trial|27|||
23575709|NCT00610675|65838832|FG000|Overall Study|Lack of Compliance|7|||
23575710|NCT00610675|65838832|FG000|Overall Study|Lost to Follow-up|31|||
23575711|NCT00610675|65838832|FG000|Overall Study|Other reason (not specified)|25|||
23575712|NCT00801242|65838833|FG000|Overall Study|Adverse Event|10|||
23575713|NCT00801242|65838833|FG000|Overall Study|Withdrawal by Subject|13|||
23575714|NCT00801242|65838833|FG000|Overall Study|Protocol Violation|5|||
23575715|NCT00801242|65838833|FG000|Overall Study|Physician Decision|3|||
23575716|NCT00801242|65838833|FG000|Overall Study|Lost to Follow-up|1|||
23575717|NCT00801242|65838833|FG000|Overall Study|Miscellaneous reasons|20|||
23575718|NCT01628510|65838834|FG000|Overall Study|Withdrawal by Subject|0|||
23575719|NCT01628510|65838835|FG001|Overall Study|Withdrawal by Subject|4|||
23575720|NCT01628510|65838834|FG000|Overall Study|Death|3|||
23575721|NCT01628510|65838835|FG001|Overall Study|Death|1|||
23575722|NCT04285229|65838836|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23575723|NCT04285229|65838837|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575724|NCT04285229|65838838|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23633834|NCT01132820|66045503|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
23633835|NCT01132820|66045503|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
23834066|NCT00634803|66770875|FG001|Overall Study|Lost to Follow-up|7|||
23575725|NCT04285229|65838839|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575726|NCT04285229|65838840|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575727|NCT04285229|65838841|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575728|NCT04285229|65838836|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
23575729|NCT04285229|65838837|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
23575730|NCT04285229|65838838|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
23575731|NCT04285229|65838839|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
23575732|NCT04285229|65838840|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
23575733|NCT04285229|65838841|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
23575734|NCT04285229|65838836|FG000|Extended Treatment Period|Adverse Event|0|||
23575735|NCT04285229|65838837|FG001|Extended Treatment Period|Adverse Event|0|||
23575736|NCT04285229|65838838|FG002|Extended Treatment Period|Adverse Event|0|||
23575737|NCT04285229|65838839|FG003|Extended Treatment Period|Adverse Event|1|||
23575738|NCT04285229|65838840|FG004|Extended Treatment Period|Adverse Event|0|||
23575739|NCT04285229|65838841|FG005|Extended Treatment Period|Adverse Event|0|||
23575740|NCT04285229|65838836|FG000|Extended Treatment Period|Physician Decision|0|||
23575741|NCT04285229|65838837|FG001|Extended Treatment Period|Physician Decision|0|||
23834067|NCT00634803|66770876|FG002|Overall Study|Lost to Follow-up|7|||
23834068|NCT00449865|66770880|FG000|Overall Study|Withdrawal by Subject|110|||
23834069|NCT00449865|66770881|FG001|Overall Study|Withdrawal by Subject|110|||
23834070|NCT00449865|66770880|FG000|Overall Study|Lost to Follow-up|36|||
23834071|NCT00449865|66770881|FG001|Overall Study|Lost to Follow-up|37|||
23834072|NCT00449865|66770880|FG000|Overall Study|Physician Decision|13|||
23834073|NCT00449865|66770881|FG001|Overall Study|Physician Decision|12|||
23834074|NCT00449865|66770880|FG000|Overall Study|Death|31|||
23834075|NCT00449865|66770881|FG001|Overall Study|Death|40|||
23834076|NCT00449865|66770880|FG000|Overall Study|Protocol Violation|8|||
23834077|NCT00449865|66770881|FG001|Overall Study|Protocol Violation|7|||
23834078|NCT00449865|66770880|FG000|Overall Study|Study was stopped|324|||
23834079|NCT00449865|66770881|FG001|Overall Study|Study was stopped|328|||
23834080|NCT02454608|66770885|FG000|Double-Blind Period|Lack of Efficacy|0|||
23834081|NCT02454608|66770886|FG001|Double-Blind Period|Lack of Efficacy|2|||
23834082|NCT02454608|66770887|FG002|Double-Blind Period|Lack of Efficacy|0|||
23834083|NCT02454608|66770885|FG000|Open Label Period|Lost to Follow-up|0|||
23575742|NCT04285229|65838838|FG002|Extended Treatment Period|Physician Decision|1|||
23575743|NCT04285229|65838839|FG003|Extended Treatment Period|Physician Decision|0|||
23575744|NCT04285229|65838840|FG004|Extended Treatment Period|Physician Decision|0|||
23575745|NCT04285229|65838841|FG005|Extended Treatment Period|Physician Decision|0|||
23575746|NCT04285229|65838836|FG000|Follow-up Period|Adverse Event|0|||
23575747|NCT04285229|65838837|FG001|Follow-up Period|Adverse Event|0|||
23575748|NCT04285229|65838838|FG002|Follow-up Period|Adverse Event|0|||
23575749|NCT04285229|65838839|FG003|Follow-up Period|Adverse Event|0|||
23575750|NCT04285229|65838840|FG004|Follow-up Period|Adverse Event|1|||
23575751|NCT04285229|65838841|FG005|Follow-up Period|Adverse Event|4|||
23575752|NCT04285229|65838836|FG000|Follow-up Period|Withdrawal by Subject|0|||
23834084|NCT02454608|66770886|FG001|Open Label Period|Lost to Follow-up|0|||
23834085|NCT02454608|66770887|FG002|Open Label Period|Lost to Follow-up|11|||
23834086|NCT02454608|66770885|FG000|Open Label Period|Withdrawal by Subject|0|||
23834087|NCT02454608|66770886|FG001|Open Label Period|Withdrawal by Subject|0|||
23834088|NCT02454608|66770887|FG002|Open Label Period|Withdrawal by Subject|8|||
23575753|NCT04285229|65838837|FG001|Follow-up Period|Withdrawal by Subject|0|||
23575754|NCT04285229|65838838|FG002|Follow-up Period|Withdrawal by Subject|0|||
23575755|NCT04285229|65838839|FG003|Follow-up Period|Withdrawal by Subject|0|||
23575756|NCT04285229|65838840|FG004|Follow-up Period|Withdrawal by Subject|0|||
23575757|NCT04285229|65838841|FG005|Follow-up Period|Withdrawal by Subject|5|||
23575758|NCT04285229|65838836|FG000|Follow-up Period|Covid-19|0|||
23575759|NCT04285229|65838837|FG001|Follow-up Period|Covid-19|0|||
23575760|NCT04285229|65838838|FG002|Follow-up Period|Covid-19|0|||
23834089|NCT03989102|66770888|FG000|Year 1|Withdrawal by Subject|6|||
23575761|NCT04285229|65838839|FG003|Follow-up Period|Covid-19|0|||
23575762|NCT04285229|65838840|FG004|Follow-up Period|Covid-19|0|||
23575763|NCT04285229|65838841|FG005|Follow-up Period|Covid-19|2|||
23575764|NCT04285229|65838836|FG000|Follow-up Period|Physician Decision|0|||
23575765|NCT04285229|65838837|FG001|Follow-up Period|Physician Decision|0|||
23575766|NCT04285229|65838838|FG002|Follow-up Period|Physician Decision|0|||
23575767|NCT04285229|65838839|FG003|Follow-up Period|Physician Decision|0|||
23575768|NCT04285229|65838840|FG004|Follow-up Period|Physician Decision|0|||
23575769|NCT04285229|65838841|FG005|Follow-up Period|Physician Decision|1|||
23575770|NCT00742274|65838842|FG000|Overall Study|Death|1|||
23575771|NCT00742274|65838843|FG001|Overall Study|Death|0|||
23575772|NCT00742274|65838842|FG000|Overall Study|Withdrawal by Subject|1|||
23575773|NCT00742274|65838843|FG001|Overall Study|Withdrawal by Subject|2|||
23575774|NCT00742274|65838842|FG000|Overall Study|Removed for medical reasons|1|||
23575775|NCT00742274|65838843|FG001|Overall Study|Removed for medical reasons|1|||
23575776|NCT02176928|65838846|FG000|Overall Study|Lost to Follow-up|2|||
23575777|NCT02176928|65838847|FG001|Overall Study|Lost to Follow-up|4|||
23575778|NCT00502996|65838848|FG000|Overall Study|Lost to Follow-up|9|||
23575779|NCT00502996|65838848|FG000|Overall Study|Protocol Violation|2|||
23575780|NCT00502996|65838848|FG000|Overall Study|Treatment failure|25|||
23575781|NCT00502996|65838848|FG000|Overall Study|Withdrawal Informed Consent|6|||
23575782|NCT00502996|65838848|FG000|Overall Study|Adverse Event|2|||
23575783|NCT01627340|65838850|FG000|Overall Study|Adverse Event|1|||
23575784|NCT01627340|65838851|FG001|Overall Study|Adverse Event|0|||
23774388|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
23774389|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
23774390|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
23774391|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
23774392|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
23774393|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
23774394|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
23834090|NCT03989102|66770889|FG001|Year 1|Withdrawal by Subject|2|||
23834091|NCT03989102|66770890|FG002|Year 1|Withdrawal by Subject|7|||
23834092|NCT03989102|66770888|FG000|Year 1|Lost to Follow-up|5|||
23834093|NCT03989102|66770889|FG001|Year 1|Lost to Follow-up|2|||
23834094|NCT03989102|66770890|FG002|Year 1|Lost to Follow-up|5|||
23834095|NCT03989102|66770888|FG000|Year 1|Subject met withdrawal criteria|1|||
23834096|NCT03989102|66770889|FG001|Year 1|Subject met withdrawal criteria|0|||
23834097|NCT03989102|66770890|FG002|Year 1|Subject met withdrawal criteria|1|||
23774395|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
23774396|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
23774397|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
23774398|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
23774399|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
23834098|NCT03989102|66770888|FG000|Year 2|Lost to Follow-up|7|||
23834099|NCT03989102|66770889|FG001|Year 2|Lost to Follow-up|3|||
23834100|NCT03989102|66770890|FG002|Year 2|Lost to Follow-up|4|||
23834101|NCT03989102|66770888|FG000|Year 2|Withdrawal by Subject|3|||
23774400|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
23774401|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
23834102|NCT03989102|66770889|FG001|Year 2|Withdrawal by Subject|1|||
23447760|NCT02587520|65380612|FG016|Overall Study|Protocol Violation|0|||
23575785|NCT01627340|65838850|FG000|Overall Study|Lost to Follow-up|8|||
23575786|NCT01627340|65838851|FG001|Overall Study|Lost to Follow-up|4|||
23575787|NCT01627340|65838850|FG000|Overall Study|Pregnancy|1|||
23575788|NCT01627340|65838851|FG001|Overall Study|Pregnancy|0|||
23575789|NCT01627340|65838850|FG000|Overall Study|Withdrawal by Subject|2|||
23633836|NCT01132820|66045503|FG000|Overall Study|Never treated|1|||
23633837|NCT01132820|66045503|FG000|Overall Study|Inadequate data|1|||
23774402|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
23834103|NCT03989102|66770890|FG002|Year 2|Withdrawal by Subject|2|||
23834104|NCT03989102|66770888|FG000|Year 2|Subject non-compliant|3|||
23575790|NCT01627340|65838851|FG001|Overall Study|Withdrawal by Subject|0|||
23575791|NCT00725010|65838854|FG000|Overall Study|Toxicity|9|||
23575792|NCT00725010|65838854|FG000|Overall Study|Tumor Progression|7|||
23575793|NCT00725010|65838854|FG000|Overall Study|Withdrawal by Subject|2|||
23575794|NCT00725010|65838854|FG000|Overall Study|Death|1|||
23575795|NCT00725010|65838854|FG000|Overall Study|Lost to Follow-up|1|||
23575796|NCT00725010|65838854|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
23575797|NCT00725010|65838854|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
23575798|NCT00725010|65838854|FG000|Overall Study|No further documentation|1|||
23575799|NCT00725010|65838854|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
23774403|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
23447761|NCT02587520|65380613|FG017|Overall Study|Protocol Violation|0|||
23447762|NCT02587520|65380596|FG000|Overall Study|Adverse Event|0|||
23575800|NCT01755689|65838858|FG000|Overall Study|Withdrawal by Subject|1|||
23774404|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
23447763|NCT02587520|65380597|FG001|Overall Study|Adverse Event|0|||
23447764|NCT02587520|65380598|FG002|Overall Study|Adverse Event|0|||
23447765|NCT02587520|65380599|FG003|Overall Study|Adverse Event|0|||
23774405|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
23774406|NCT02581345|66553631|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
23774407|NCT02581345|66553632|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
23774408|NCT02581345|66553633|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
23774409|NCT02581345|66553634|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
23774410|NCT00813293|66553653|FG000|Overall Study|Intercurrent illness|1|||
23774411|NCT00813293|66553654|FG001|Overall Study|Intercurrent illness|0|||
23774412|NCT00813293|66553653|FG000|Overall Study|Adverse Event|0|||
23774413|NCT00813293|66553654|FG001|Overall Study|Adverse Event|1|||
23774414|NCT00854100|66553655|FG000|Overall Study|Inability to complete the study visits|0|||
23774415|NCT00854100|66553656|FG001|Overall Study|Inability to complete the study visits|0|||
23447766|NCT02587520|65380600|FG004|Overall Study|Adverse Event|0|||
23575801|NCT01755689|65838859|FG001|Overall Study|Withdrawal by Subject|3|||
23774416|NCT00854100|66553657|FG002|Overall Study|Inability to complete the study visits|1|||
23774417|NCT00854100|66553655|FG000|Overall Study|Lost to Follow-up|2|||
23774418|NCT00854100|66553656|FG001|Overall Study|Lost to Follow-up|0|||
23575802|NCT01755689|65838860|FG002|Overall Study|Withdrawal by Subject|2|||
23575803|NCT01755689|65838861|FG003|Overall Study|Withdrawal by Subject|1|||
23633838|NCT02628028|66045507|FG000|Dosing Period|Withdrawal by Subject|0|||
23774419|NCT00854100|66553657|FG002|Overall Study|Lost to Follow-up|3|||
23774420|NCT00854100|66553655|FG000|Overall Study|Withdrawal by Subject|3|||
23774421|NCT00854100|66553656|FG001|Overall Study|Withdrawal by Subject|1|||
23774422|NCT00854100|66553657|FG002|Overall Study|Withdrawal by Subject|2|||
23774423|NCT00854100|66553655|FG000|Overall Study|Protocol Violation|2|||
23774424|NCT00854100|66553656|FG001|Overall Study|Protocol Violation|4|||
23774425|NCT00854100|66553657|FG002|Overall Study|Protocol Violation|3|||
23575804|NCT01755689|65838862|FG004|Overall Study|Withdrawal by Subject|1|||
23575805|NCT01755689|65838858|FG000|Overall Study|Migrated/moved from study area|0|||
23575806|NCT01755689|65838859|FG001|Overall Study|Migrated/moved from study area|1|||
23575807|NCT01755689|65838860|FG002|Overall Study|Migrated/moved from study area|1|||
23575808|NCT01755689|65838861|FG003|Overall Study|Migrated/moved from study area|1|||
23575809|NCT01755689|65838862|FG004|Overall Study|Migrated/moved from study area|1|||
23575810|NCT01755689|65838858|FG000|Overall Study|Lost to Follow-up|1|||
23575811|NCT01755689|65838859|FG001|Overall Study|Lost to Follow-up|0|||
23575812|NCT01755689|65838860|FG002|Overall Study|Lost to Follow-up|1|||
23575813|NCT01755689|65838861|FG003|Overall Study|Lost to Follow-up|0|||
23575814|NCT01755689|65838862|FG004|Overall Study|Lost to Follow-up|2|||
23575815|NCT01755689|65838858|FG000|Overall Study|Pregnancy|1|||
23575816|NCT01755689|65838859|FG001|Overall Study|Pregnancy|1|||
23575817|NCT01755689|65838860|FG002|Overall Study|Pregnancy|2|||
23575818|NCT01755689|65838861|FG003|Overall Study|Pregnancy|4|||
23575819|NCT01755689|65838862|FG004|Overall Study|Pregnancy|2|||
23575820|NCT00388362|65838863|FG000|Enrolled|Ineligible|1|||
23575821|NCT00388362|65838863|FG000|Enrolled|Adverse Event|9|||
23575822|NCT00388362|65838863|FG000|Enrolled|Death|1|||
23774426|NCT00854100|66553655|FG000|Overall Study|Adverse Event|2|||
23774427|NCT00854100|66553656|FG001|Overall Study|Adverse Event|1|||
23774428|NCT00854100|66553657|FG002|Overall Study|Adverse Event|2|||
23774429|NCT00154102|66553664|FG000|Overall Study|investigational study phase ongoing|7|||
23575823|NCT00388362|65838863|FG000|Enrolled|Loss insurance|1|||
23575824|NCT00388362|65838863|FG000|Enrolled|Withdrawal by Subject|1|||
23575825|NCT00388362|65838863|FG000|Remained on Study Median of 514 Days|Death|2|||
23575826|NCT01661881|65838868|FG000|Overall Study|Disease Progression|1|||
23575827|NCT00663117|65838869|FG000|Overall Study|Lack of Efficacy|1|||
23575828|NCT00663117|65838870|FG001|Overall Study|Lack of Efficacy|0|||
23575829|NCT02886936|65838871|FG000|Overall Study|Lost to Follow-up|4|||
23575830|NCT02886936|65838872|FG001|Overall Study|Lost to Follow-up|3|||
23575831|NCT02886936|65838873|FG002|Overall Study|Lost to Follow-up|0|||
23774430|NCT00154102|66553665|FG001|Overall Study|investigational study phase ongoing|2|||
23774431|NCT01239121|66553666|FG000|Overall Study|Withdrawal by Subject|2|||
23774432|NCT01239121|66553667|FG001|Overall Study|Withdrawal by Subject|4|||
23774433|NCT01239121|66553668|FG002|Overall Study|Withdrawal by Subject|0|||
23774434|NCT00220701|66553669|FG000|Overall Study|Lost to Follow-up|5|||
23774435|NCT00220701|66553670|FG001|Overall Study|Lost to Follow-up|4|||
23774436|NCT00385593|66553672|FG000|Overall Study|Adverse Event|3|||
23774437|NCT00385593|66553673|FG001|Overall Study|Adverse Event|2|||
23774438|NCT00385593|66553672|FG000|Overall Study|Withdrawal by Subject|17|||
23774439|NCT00385593|66553673|FG001|Overall Study|Withdrawal by Subject|7|||
23774440|NCT00385593|66553672|FG000|Overall Study|Lost to Follow-up|12|||
23774441|NCT00385593|66553673|FG001|Overall Study|Lost to Follow-up|8|||
23774442|NCT00385593|66553672|FG000|Overall Study|Protocol Violation|7|||
23774443|NCT00385593|66553673|FG001|Overall Study|Protocol Violation|4|||
23774444|NCT00385593|66553672|FG000|Overall Study|Several reasons|17|||
23774445|NCT00385593|66553673|FG001|Overall Study|Several reasons|15|||
23774446|NCT00385593|66553672|FG000|Overall Study|Incorrect inclusion|2|||
23774447|NCT00385593|66553673|FG001|Overall Study|Incorrect inclusion|0|||
23774448|NCT00385593|66553672|FG000|Overall Study|Incorrect randomization|0|||
23774449|NCT00385593|66553673|FG001|Overall Study|Incorrect randomization|1|||
23774450|NCT01734772|66553674|FG000|Overall Study|Adverse Event|1|||
23774451|NCT01734772|66553675|FG001|Overall Study|Adverse Event|2|||
23774452|NCT01734772|66553674|FG000|Overall Study|Withdrawal by Subject|0|||
23834105|NCT03989102|66770889|FG001|Year 2|Subject non-compliant|2|||
23575832|NCT00419003|65838874|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
23575833|NCT00419003|65838875|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
23575834|NCT00419003|65838874|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
23575835|NCT00419003|65838875|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
23575836|NCT01880515|65838876|FG000|Overall Study|Lost to Follow-up|3|||
23774453|NCT01734772|66553675|FG001|Overall Study|Withdrawal by Subject|1|||
23774454|NCT02246478|66553676|FG000|Multiple-dose Phase|Protocol Violation|1|||
23575837|NCT01880515|65838877|FG001|Overall Study|Lost to Follow-up|2|||
23575838|NCT01880515|65838876|FG000|Overall Study|Disease Progression|5|||
23575839|NCT01880515|65838877|FG001|Overall Study|Disease Progression|7|||
23575840|NCT03499600|65838878|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
23575841|NCT03499600|65838879|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
23575842|NCT00531011|65838880|FG000|Overall Study|Withdrawal by Subject|2|||
23575843|NCT00531011|65838881|FG001|Overall Study|Withdrawal by Subject|4|||
23575844|NCT00531011|65838880|FG000|Overall Study|Death|1|||
23575845|NCT00531011|65838881|FG001|Overall Study|Death|0|||
23575846|NCT00531011|65838880|FG000|Overall Study|Lost to Follow-up|1|||
23575847|NCT00531011|65838881|FG001|Overall Study|Lost to Follow-up|0|||
23575848|NCT00531011|65838880|FG000|Overall Study|Physician Decision|0|||
23575849|NCT00531011|65838881|FG001|Overall Study|Physician Decision|3|||
23575850|NCT00467142|65838885|FG000|Overall Study|Withdrawal by Subject|1|||
23834106|NCT03989102|66770890|FG002|Year 2|Subject non-compliant|0|||
23575851|NCT00467142|65838885|FG000|Overall Study|Adverse Event|1|||
23575852|NCT00467142|65838885|FG000|Overall Study|Protocol Violation|1|||
23575853|NCT01113463|65838886|FG000|Overall Study|Physician Decision|5|||
23575854|NCT02507219|65838887|FG000|Overall Study|Physician Decision|1|||
23575855|NCT02507219|65838888|FG001|Overall Study|Physician Decision|0|||
23575856|NCT02507219|65838889|FG002|Overall Study|Physician Decision|0|||
23575857|NCT02507219|65838890|FG003|Overall Study|Physician Decision|0|||
23575858|NCT02507219|65838891|FG004|Overall Study|Physician Decision|0|||
23575859|NCT02507219|65838892|FG005|Overall Study|Physician Decision|0|||
23575860|NCT02507219|65838887|FG000|Overall Study|Withdrawal by Subject|0|||
23575861|NCT02507219|65838888|FG001|Overall Study|Withdrawal by Subject|0|||
23575862|NCT02507219|65838889|FG002|Overall Study|Withdrawal by Subject|0|||
23575863|NCT02507219|65838890|FG003|Overall Study|Withdrawal by Subject|0|||
23575864|NCT02507219|65838891|FG004|Overall Study|Withdrawal by Subject|1|||
23834107|NCT03989102|66770888|FG000|Year 2|Travel|1|||
23447767|NCT02587520|65380601|FG005|Overall Study|Adverse Event|0|||
23575865|NCT02507219|65838892|FG005|Overall Study|Withdrawal by Subject|0|||
23575866|NCT01473420|65838893|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
23834108|NCT03989102|66770889|FG001|Year 2|Travel|0|||
23834109|NCT03989102|66770890|FG002|Year 2|Travel|1|||
23834110|NCT03989102|66770888|FG000|Year 2|P16 missing|4|||
23834111|NCT03989102|66770889|FG001|Year 2|P16 missing|2|||
23834112|NCT03989102|66770890|FG002|Year 2|P16 missing|1|||
23834113|NCT03989102|66770888|FG000|Year 2|P11 missing|1|||
23834114|NCT03989102|66770889|FG001|Year 2|P11 missing|3|||
23834115|NCT03989102|66770890|FG002|Year 2|P11 missing|7|||
23834116|NCT03989102|66770888|FG000|Year 2|Definitive displacement outside the study site|0|||
23834117|NCT03989102|66770889|FG001|Year 2|Definitive displacement outside the study site|1|||
23834118|NCT03989102|66770890|FG002|Year 2|Definitive displacement outside the study site|0|||
23834119|NCT03989102|66770888|FG000|Year 2|Subject missed last study visit|0|||
23834120|NCT03989102|66770889|FG001|Year 2|Subject missed last study visit|1|||
23834121|NCT03989102|66770890|FG002|Year 2|Subject missed last study visit|0|||
23834122|NCT03989102|66770888|FG000|Year 2|Death|0|||
23834123|NCT03989102|66770889|FG001|Year 2|Death|1|||
23834124|NCT03989102|66770890|FG002|Year 2|Death|0|||
23834125|NCT03989102|66770888|FG000|Year 2|Subject not reachable|0|||
23834126|NCT03989102|66770889|FG001|Year 2|Subject not reachable|0|||
23834127|NCT03989102|66770890|FG002|Year 2|Subject not reachable|1|||
23834128|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
23834129|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
23834130|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
23834131|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23834132|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23834133|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23834134|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
23834135|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
23834136|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
23834137|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
23834138|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
23834139|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
23834140|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
23834141|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
23834142|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
23834143|NCT03989102|66770888|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
23834144|NCT03989102|66770889|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
23834145|NCT03989102|66770890|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
23834146|NCT04855760|66770891|FG000|Overall Study|Adverse Event|21|||
23834147|NCT04855760|66770891|FG000|Overall Study|Withdrawal by Subject|116|||
23834148|NCT04855760|66770891|FG000|Overall Study|Lack of Efficacy|21|||
23834149|NCT04855760|66770891|FG000|Overall Study|Lost to Follow-up|49|||
23834150|NCT04855760|66770891|FG000|Overall Study|Protocol Violation|2|||
23834151|NCT04855760|66770891|FG000|Overall Study|Physician Decision|5|||
23834152|NCT04855760|66770891|FG000|Overall Study|Pregnancy|1|||
23834153|NCT04855760|66770891|FG000|Overall Study|Non-Compliance with Study Drug|11|||
23834154|NCT04855760|66770891|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
23834155|NCT04855760|66770891|FG000|Overall Study|Study Completed by Sponsor|202|||
23834156|NCT04855760|66770891|FG000|Overall Study|Other|13|||
23834157|NCT05370040|66770892|FG000|Overall Study|Lost to Follow-up|0|||
23834158|NCT05370040|66770893|FG001|Overall Study|Lost to Follow-up|0|||
23834159|NCT05370040|66770894|FG002|Overall Study|Lost to Follow-up|1|||
23834160|NCT05370040|66770895|FG003|Overall Study|Lost to Follow-up|0|||
23834161|NCT05370040|66770896|FG004|Overall Study|Lost to Follow-up|1|||
23834162|NCT05370040|66770897|FG005|Overall Study|Lost to Follow-up|0|||
23834163|NCT00489918|66770913|FG000|Overall Study|Withdrawal by Subject|2|||
23834164|NCT00489918|66770914|FG001|Overall Study|Withdrawal by Subject|1|||
23834165|NCT00489918|66770915|FG002|Overall Study|Withdrawal by Subject|1|||
23834166|NCT00489918|66770916|FG003|Overall Study|Withdrawal by Subject|0|||
23834167|NCT00489918|66770917|FG004|Overall Study|Withdrawal by Subject|1|||
23834168|NCT00489918|66770913|FG000|Overall Study|Adverse Event|0|||
23834169|NCT00489918|66770914|FG001|Overall Study|Adverse Event|1|||
23834170|NCT00489918|66770915|FG002|Overall Study|Adverse Event|1|||
23834171|NCT00489918|66770916|FG003|Overall Study|Adverse Event|0|||
23834172|NCT00489918|66770917|FG004|Overall Study|Adverse Event|0|||
23834173|NCT00489918|66770913|FG000|Overall Study|Lost to Follow-up|0|||
23834174|NCT00489918|66770914|FG001|Overall Study|Lost to Follow-up|0|||
23834175|NCT00489918|66770915|FG002|Overall Study|Lost to Follow-up|1|||
23834176|NCT00489918|66770916|FG003|Overall Study|Lost to Follow-up|1|||
23834177|NCT00489918|66770917|FG004|Overall Study|Lost to Follow-up|0|||
23834178|NCT00489918|66770913|FG000|Overall Study|Physician Decision|0|||
23774455|NCT02246478|66553677|FG001|Multiple-dose Phase|Protocol Violation|0|||
23575867|NCT01473420|65838894|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
23774456|NCT02246478|66553678|FG002|Multiple-dose Phase|Protocol Violation|0|||
23774457|NCT02246478|66553679|FG003|Multiple-dose Phase|Protocol Violation|1|||
23774458|NCT01619800|66553682|FG000|Overall Study|study terminated|2|||
23774459|NCT01619800|66553683|FG001|Overall Study|study terminated|0|||
23774460|NCT03883906|66553691|FG000|Overall Study|Withdrawal by Subject|2|||
23774461|NCT03883906|66553691|FG000|Overall Study|Physician Decision|5|||
23774462|NCT00463606|66553692|FG000|Overall Study|Adverse Event|21|||
23575868|NCT01473420|65838893|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
23575869|NCT01473420|65838894|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
23575870|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
23575871|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
23575872|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
23575873|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
23575874|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
23575875|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
23575876|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
23575877|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
23575878|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
23575879|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
23575880|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
23575881|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
23575882|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
23575883|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
23575884|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
23575885|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
23575886|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
23575887|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
23575888|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
23575889|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
23575890|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
23575891|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
23575892|NCT02400307|65838895|FG000|Overall Study|Enrolled and Never Dosed|1|||
23575893|NCT02400307|65838896|FG001|Overall Study|Enrolled and Never Dosed|0|||
23575894|NCT01767129|65838898|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23575895|NCT01767129|65838899|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23575896|NCT01155726|65838908|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
23575897|NCT01155726|65838909|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
23575898|NCT01155726|65838910|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
23575899|NCT01155726|65838911|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
23575900|NCT01052662|65838912|FG000|Overall Study|Lost to Follow-up|15|||
23575901|NCT01052662|65838913|FG001|Overall Study|Lost to Follow-up|13|||
23575902|NCT01052662|65838914|FG002|Overall Study|Lost to Follow-up|18|||
23575903|NCT01052662|65838912|FG000|Overall Study|Withdrawal by Subject|3|||
23575904|NCT01052662|65838913|FG001|Overall Study|Withdrawal by Subject|2|||
23575905|NCT01052662|65838914|FG002|Overall Study|Withdrawal by Subject|1|||
23575906|NCT01052662|65838912|FG000|Overall Study|Pharmacy issue|1|||
23575907|NCT01052662|65838913|FG001|Overall Study|Pharmacy issue|3|||
23575908|NCT01052662|65838914|FG002|Overall Study|Pharmacy issue|3|||
23575909|NCT01052662|65838912|FG000|Overall Study|Adverse Event|1|||
23575910|NCT01052662|65838913|FG001|Overall Study|Adverse Event|1|||
23575911|NCT01052662|65838914|FG002|Overall Study|Adverse Event|0|||
23575912|NCT01052662|65838912|FG000|Overall Study|Legal Problem|2|||
23575913|NCT01052662|65838913|FG001|Overall Study|Legal Problem|0|||
23575914|NCT01052662|65838914|FG002|Overall Study|Legal Problem|0|||
23575915|NCT01052662|65838912|FG000|Overall Study|Administrative|0|||
23575916|NCT01052662|65838913|FG001|Overall Study|Administrative|3|||
23575917|NCT01052662|65838914|FG002|Overall Study|Administrative|0|||
23575918|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23575919|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
23575920|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23774463|NCT00463606|66553693|FG001|Overall Study|Adverse Event|18|||
23774464|NCT00463606|66553694|FG002|Overall Study|Adverse Event|11|||
23774465|NCT00463606|66553692|FG000|Overall Study|Withdrawal by Subject|11|||
23774466|NCT00463606|66553693|FG001|Overall Study|Withdrawal by Subject|11|||
23774467|NCT00463606|66553694|FG002|Overall Study|Withdrawal by Subject|5|||
23774468|NCT00463606|66553692|FG000|Overall Study|Lost to Follow-up|2|||
23774469|NCT00463606|66553693|FG001|Overall Study|Lost to Follow-up|2|||
23834179|NCT00489918|66770914|FG001|Overall Study|Physician Decision|0|||
23834180|NCT00489918|66770915|FG002|Overall Study|Physician Decision|1|||
23834181|NCT00489918|66770916|FG003|Overall Study|Physician Decision|0|||
23575921|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
23575922|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23575923|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
23575924|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
23575925|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
23575926|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23774470|NCT00463606|66553694|FG002|Overall Study|Lost to Follow-up|3|||
23774471|NCT00463606|66553692|FG000|Overall Study|Subject noncompliance|1|||
23774472|NCT00463606|66553693|FG001|Overall Study|Subject noncompliance|1|||
23834182|NCT00489918|66770917|FG004|Overall Study|Physician Decision|0|||
23834183|NCT01567462|66770918|FG000|Overall Study|Withdrawal by Subject|4|||
23834184|NCT01567462|66770919|FG001|Overall Study|Withdrawal by Subject|7|||
23834185|NCT03749330|66770920|FG000|Overall Study|Clinicians left work in the CICU|0|||
23834186|NCT03749330|66770921|FG001|Overall Study|Clinicians left work in the CICU|2|||
23834187|NCT03749330|66770922|FG002|Overall Study|Clinicians left work in the CICU|0|||
23834188|NCT03749330|66770923|FG003|Overall Study|Clinicians left work in the CICU|0|||
23834189|NCT03749330|66770924|FG004|Overall Study|Clinicians left work in the CICU|0|||
23834190|NCT03749330|66770925|FG005|Overall Study|Clinicians left work in the CICU|0|||
23834191|NCT02861807|66770926|FG000|Overall Study|Lost to Follow-up|7|||
23834192|NCT02861807|66770927|FG001|Overall Study|Lost to Follow-up|6|||
23834193|NCT02861807|66770926|FG000|Overall Study|Withdrawal by Subject|5|||
23834194|NCT02861807|66770927|FG001|Overall Study|Withdrawal by Subject|8|||
23834195|NCT05061693|66770928|FG000|Overall Study|Adverse Event|1|||
23834196|NCT05061693|66770929|FG001|Overall Study|Adverse Event|1|||
23834197|NCT05061693|66770930|FG002|Overall Study|Adverse Event|1|||
23774473|NCT00463606|66553694|FG002|Overall Study|Subject noncompliance|0|||
23774474|NCT00463606|66553692|FG000|Overall Study|Subject moved out of town|1|||
23774475|NCT00463606|66553693|FG001|Overall Study|Subject moved out of town|0|||
23774476|NCT00463606|66553694|FG002|Overall Study|Subject moved out of town|0|||
23834198|NCT05061693|66770931|FG003|Overall Study|Adverse Event|0|||
23834199|NCT05061693|66770928|FG000|Overall Study|Death|0|||
23834200|NCT05061693|66770929|FG001|Overall Study|Death|1|||
23575927|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
23774477|NCT00463606|66553692|FG000|Overall Study|Physician Decision|0|||
23834201|NCT05061693|66770930|FG002|Overall Study|Death|0|||
23834202|NCT05061693|66770931|FG003|Overall Study|Death|0|||
23774478|NCT00463606|66553693|FG001|Overall Study|Physician Decision|1|||
23774479|NCT00463606|66553694|FG002|Overall Study|Physician Decision|0|||
23834203|NCT05061693|66770928|FG000|Overall Study|Lack of Efficacy|1|||
23834204|NCT05061693|66770929|FG001|Overall Study|Lack of Efficacy|0|||
23834205|NCT05061693|66770930|FG002|Overall Study|Lack of Efficacy|0|||
23834206|NCT05061693|66770931|FG003|Overall Study|Lack of Efficacy|0|||
23834207|NCT05061693|66770928|FG000|Overall Study|Lost to Follow-up|0|||
23834208|NCT05061693|66770929|FG001|Overall Study|Lost to Follow-up|0|||
23834209|NCT05061693|66770930|FG002|Overall Study|Lost to Follow-up|1|||
23834210|NCT05061693|66770931|FG003|Overall Study|Lost to Follow-up|0|||
23834211|NCT05061693|66770928|FG000|Overall Study|Protocol Violation|1|||
23834212|NCT05061693|66770929|FG001|Overall Study|Protocol Violation|1|||
23834213|NCT05061693|66770930|FG002|Overall Study|Protocol Violation|1|||
23834214|NCT05061693|66770931|FG003|Overall Study|Protocol Violation|2|||
23575928|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23575929|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
23575930|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23575931|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
23575932|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575933|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575934|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575935|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575936|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
23575937|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575938|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575939|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575940|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575941|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
23575942|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575943|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575944|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575945|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575946|NCT03220737|65838915|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575947|NCT03220737|65838916|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575948|NCT03220737|65838917|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575949|NCT03220737|65838918|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575950|NCT03220737|65838919|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
23575951|NCT03220737|65838920|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575952|NCT03220737|65838921|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575953|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
23575954|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575955|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575956|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575957|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575958|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575959|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575960|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
23575961|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575962|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575963|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575964|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575965|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575966|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575967|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
23575968|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575969|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575970|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23633839|NCT02628028|66045508|FG001|Dosing Period|Withdrawal by Subject|0|||
23633840|NCT02628028|66045509|FG002|Dosing Period|Withdrawal by Subject|1|||
23834215|NCT05061693|66770928|FG000|Overall Study|Withdrawal by Subject|2|||
23834216|NCT05061693|66770929|FG001|Overall Study|Withdrawal by Subject|4|||
23834217|NCT05061693|66770930|FG002|Overall Study|Withdrawal by Subject|2|||
23447768|NCT02587520|65380602|FG006|Overall Study|Adverse Event|0|||
23575971|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575972|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575973|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575974|NCT00003377|65838922|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
23575975|NCT00003377|65838923|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
23575976|NCT00003377|65838924|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
23575977|NCT00003377|65838925|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
23834218|NCT05061693|66770931|FG003|Overall Study|Withdrawal by Subject|2|||
23834219|NCT04762160|66770937|FG000|Overall Study|Study terminated early due to business reasons|5|||
23575978|NCT00003377|65838926|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
23575979|NCT00003377|65838922|FG000|Period II|Ureteral stent complications|0|||
23575980|NCT00003377|65838923|FG001|Period II|Ureteral stent complications|0|||
23575981|NCT00003377|65838924|FG002|Period II|Ureteral stent complications|0|||
23575982|NCT00003377|65838925|FG003|Period II|Ureteral stent complications|0|||
23575983|NCT00003377|65838926|FG004|Period II|Ureteral stent complications|1|||
23575984|NCT03658811|65838927|FG000|Overall Study|Lost to Follow-up|3|||
23575985|NCT01625910|65838928|FG000|Overall Study|Lost to Follow-up|3|||
23575986|NCT01625910|65838929|FG001|Overall Study|Lost to Follow-up|4|||
23575987|NCT00885495|65838930|FG000|Overall Study|Adverse Event|1|||
23575988|NCT00885495|65838931|FG001|Overall Study|Adverse Event|2|||
23575989|NCT00885495|65838930|FG000|Overall Study|Protocol Violation|0|||
23575990|NCT00885495|65838931|FG001|Overall Study|Protocol Violation|1|||
23575991|NCT00885495|65838930|FG000|Overall Study|Withdrawal by Subject|1|||
23575992|NCT00885495|65838931|FG001|Overall Study|Withdrawal by Subject|0|||
23575993|NCT00604721|65838932|FG000|Overall Study|Physician Decision|1|||
23575994|NCT00604721|65838932|FG000|Overall Study|Withdrawal by Subject|1|||
23575995|NCT02234310|65838934|FG000|Overall Study|Physician Decision|1|||
23575996|NCT02234310|65838934|FG000|Overall Study|Adverse Event|1|||
23575997|NCT02234310|65838934|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
23575998|NCT02234310|65838934|FG000|Overall Study|Withdrawal by Subject|2|||
23575999|NCT00163215|65838935|FG000|Overall Study|Lack of Efficacy|3|||
23576000|NCT00163215|65838935|FG000|Overall Study|Withdrawal by Subject|5|||
23576001|NCT00163215|65838935|FG000|Overall Study|Other|7|||
23576002|NCT00900627|65838936|FG000|Overall Study|Condition under investigation worsened|4|||
23576003|NCT00900627|65838937|FG001|Overall Study|Condition under investigation worsened|0|||
23576004|NCT00900627|65838938|FG002|Overall Study|Condition under investigation worsened|5|||
23576005|NCT00900627|65838939|FG003|Overall Study|Condition under investigation worsened|3|||
23576006|NCT00900627|65838940|FG004|Overall Study|Condition under investigation worsened|0|||
23576007|NCT00900627|65838941|FG005|Overall Study|Condition under investigation worsened|0|||
23834220|NCT03922308|66770948|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
23834221|NCT03922308|66770949|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
23834222|NCT03922308|66770950|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
23834223|NCT03922308|66770948|FG000|Overall Study|Lost to Follow-up|1|||
23834224|NCT03922308|66770949|FG001|Overall Study|Lost to Follow-up|0|||
23834225|NCT03922308|66770950|FG002|Overall Study|Lost to Follow-up|0|||
23834226|NCT03922308|66770948|FG000|Overall Study|Reason not Specified|0|||
23834227|NCT03922308|66770949|FG001|Overall Study|Reason not Specified|2|||
23834228|NCT03922308|66770950|FG002|Overall Study|Reason not Specified|1|||
23834229|NCT01415518|66770952|FG000|Overall Study|Withdrawal by Subject|2|||
23834230|NCT01415518|66770953|FG001|Overall Study|Withdrawal by Subject|12|||
23576008|NCT00900627|65838936|FG000|Overall Study|Withdrawal by Subject|1|||
23576009|NCT00900627|65838937|FG001|Overall Study|Withdrawal by Subject|0|||
23576010|NCT00900627|65838938|FG002|Overall Study|Withdrawal by Subject|1|||
23576011|NCT00900627|65838939|FG003|Overall Study|Withdrawal by Subject|0|||
23834231|NCT01415518|66770952|FG000|Overall Study|Protocol Violation|6|||
23834232|NCT01415518|66770953|FG001|Overall Study|Protocol Violation|8|||
23834233|NCT01415518|66770952|FG000|Overall Study|Lost to Follow-up|3|||
23834234|NCT01415518|66770953|FG001|Overall Study|Lost to Follow-up|5|||
23834235|NCT01415518|66770952|FG000|Overall Study|Adverse Event|3|||
23447769|NCT02587520|65380603|FG007|Overall Study|Adverse Event|0|||
23576012|NCT00900627|65838940|FG004|Overall Study|Withdrawal by Subject|1|||
23576013|NCT00900627|65838941|FG005|Overall Study|Withdrawal by Subject|2|||
23576014|NCT00900627|65838936|FG000|Overall Study|Adverse Event|1|||
23576015|NCT00900627|65838937|FG001|Overall Study|Adverse Event|2|||
23576016|NCT00900627|65838938|FG002|Overall Study|Adverse Event|0|||
23576017|NCT00900627|65838939|FG003|Overall Study|Adverse Event|3|||
23576018|NCT00900627|65838940|FG004|Overall Study|Adverse Event|0|||
23834236|NCT01415518|66770953|FG001|Overall Study|Adverse Event|4|||
23834237|NCT01415518|66770952|FG000|Overall Study|Death|1|||
23834238|NCT01415518|66770953|FG001|Overall Study|Death|1|||
23834239|NCT01415518|66770952|FG000|Overall Study|Condition under Investigation Worsened|1|||
23834240|NCT01415518|66770953|FG001|Overall Study|Condition under Investigation Worsened|1|||
23834241|NCT03376789|66770954|FG000|Overall Study|Withdrawal by Subject|3|||
23834242|NCT03376789|66770955|FG001|Overall Study|Withdrawal by Subject|5|||
23834243|NCT03376789|66770954|FG000|Overall Study|Protocol Violation|0|||
23834244|NCT03376789|66770955|FG001|Overall Study|Protocol Violation|1|||
23834245|NCT03376789|66770954|FG000|Overall Study|Adverse Event|0|||
23834246|NCT03376789|66770955|FG001|Overall Study|Adverse Event|1|||
23834247|NCT03376789|66770954|FG000|Overall Study|Lost to Follow-up|1|||
23834248|NCT03376789|66770955|FG001|Overall Study|Lost to Follow-up|1|||
23834249|NCT03376789|66770954|FG000|Overall Study|Per sponsor due to noncompliance|1|||
23834250|NCT03376789|66770955|FG001|Overall Study|Per sponsor due to noncompliance|0|||
23834251|NCT03376789|66770954|FG000|Overall Study|Subject off study medication|0|||
23834252|NCT03376789|66770955|FG001|Overall Study|Subject off study medication|1|||
23834253|NCT01960413|66770956|FG000|Overall Study|Withdrawal by Subject|1|||
23834254|NCT01960413|66770957|FG001|Overall Study|Withdrawal by Subject|1|||
23774480|NCT00463606|66553692|FG000|Overall Study|Sponsor request|0|||
23774481|NCT00463606|66553693|FG001|Overall Study|Sponsor request|1|||
23774482|NCT00463606|66553694|FG002|Overall Study|Sponsor request|0|||
23774483|NCT00463606|66553692|FG000|Overall Study|Exclusion criteria violation|2|||
23774484|NCT00463606|66553693|FG001|Overall Study|Exclusion criteria violation|0|||
23774485|NCT00463606|66553694|FG002|Overall Study|Exclusion criteria violation|0|||
23774486|NCT00463606|66553692|FG000|Overall Study|Coordinator error|1|||
23774487|NCT00463606|66553693|FG001|Overall Study|Coordinator error|0|||
23774488|NCT00463606|66553694|FG002|Overall Study|Coordinator error|0|||
23774489|NCT00463606|66553692|FG000|Overall Study|Patient randomized in error|1|||
23774490|NCT00463606|66553693|FG001|Overall Study|Patient randomized in error|0|||
23774491|NCT00463606|66553694|FG002|Overall Study|Patient randomized in error|0|||
23774492|NCT00463606|66553692|FG000|Overall Study|Participation in another ABT-335 trial|1|||
23774493|NCT00463606|66553693|FG001|Overall Study|Participation in another ABT-335 trial|0|||
23774494|NCT00463606|66553694|FG002|Overall Study|Participation in another ABT-335 trial|0|||
23774495|NCT00463606|66553692|FG000|Overall Study|Protocol Violation|0|||
23774496|NCT00463606|66553693|FG001|Overall Study|Protocol Violation|0|||
23774497|NCT00463606|66553694|FG002|Overall Study|Protocol Violation|1|||
23774498|NCT02166697|66553695|FG000|Overall Study|Protocol Violation|347|||
23774499|NCT00436553|66553696|FG000|Overall Study|Adverse Event|4|||
23774500|NCT00436553|66553697|FG001|Overall Study|Adverse Event|3|||
23774501|NCT00436553|66553698|FG002|Overall Study|Adverse Event|4|||
23774502|NCT00436553|66553696|FG000|Overall Study|Death|3|||
23774503|NCT00436553|66553697|FG001|Overall Study|Death|1|||
23774504|NCT00436553|66553698|FG002|Overall Study|Death|3|||
23834255|NCT01960413|66770956|FG000|Overall Study|Physician Decision|1|||
23834256|NCT01960413|66770957|FG001|Overall Study|Physician Decision|0|||
23576019|NCT00900627|65838941|FG005|Overall Study|Adverse Event|0|||
23576020|NCT00900627|65838936|FG000|Overall Study|Death|0|||
23576021|NCT00900627|65838937|FG001|Overall Study|Death|0|||
23576022|NCT00900627|65838938|FG002|Overall Study|Death|0|||
23576023|NCT00900627|65838939|FG003|Overall Study|Death|0|||
23576024|NCT00900627|65838940|FG004|Overall Study|Death|28|||
23576025|NCT00900627|65838941|FG005|Overall Study|Death|24|||
23576026|NCT01657682|65838942|FG000|Overall Study|Lost to Follow-up|1|||
23576027|NCT01657682|65838943|FG001|Overall Study|Lost to Follow-up|0|||
23576028|NCT01657682|65838944|FG002|Overall Study|Lost to Follow-up|0|||
23576029|NCT01657682|65838942|FG000|Overall Study|Withdrawal by Subject|0|||
23576030|NCT01657682|65838943|FG001|Overall Study|Withdrawal by Subject|1|||
23576031|NCT01657682|65838944|FG002|Overall Study|Withdrawal by Subject|1|||
23576032|NCT01657682|65838942|FG000|Overall Study|Adverse Event|0|||
23576033|NCT01657682|65838943|FG001|Overall Study|Adverse Event|1|||
23576034|NCT01657682|65838944|FG002|Overall Study|Adverse Event|0|||
23576035|NCT02950545|65838945|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576036|NCT02950545|65838946|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576037|NCT02950545|65838947|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576038|NCT02950545|65838948|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576039|NCT02950545|65838949|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576040|NCT02950545|65838950|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
23576041|NCT02950545|65838945|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23774505|NCT00436553|66553696|FG000|Overall Study|Lost to Follow-up|0|||
23774506|NCT00436553|66553697|FG001|Overall Study|Lost to Follow-up|2|||
23774507|NCT00436553|66553698|FG002|Overall Study|Lost to Follow-up|0|||
23774508|NCT00436553|66553696|FG000|Overall Study|Protocol Violation|1|||
23576042|NCT02950545|65838946|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576043|NCT02950545|65838947|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576044|NCT02950545|65838948|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23576045|NCT02950545|65838949|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576046|NCT02950545|65838950|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23774509|NCT00436553|66553697|FG001|Overall Study|Protocol Violation|0|||
23774510|NCT00436553|66553698|FG002|Overall Study|Protocol Violation|0|||
23774511|NCT00436553|66553696|FG000|Overall Study|Withdrawal by Subject|5|||
23774512|NCT00436553|66553697|FG001|Overall Study|Withdrawal by Subject|6|||
23834257|NCT01960413|66770956|FG000|Overall Study|Lost to Follow-up|2|||
23834258|NCT01960413|66770957|FG001|Overall Study|Lost to Follow-up|0|||
23834259|NCT02445248|66770958|FG000|Overall Study|Death|45|||
23834260|NCT02445248|66770959|FG001|Overall Study|Death|12|||
23834261|NCT02445248|66770958|FG000|Overall Study|Progressive disease|13|||
23834262|NCT02445248|66770959|FG001|Overall Study|Progressive disease|1|||
23834263|NCT02445248|66770958|FG000|Overall Study|Subject decision|8|||
23834264|NCT02445248|66770959|FG001|Overall Study|Subject decision|0|||
23834265|NCT02445248|66770958|FG000|Overall Study|Physician Decision|5|||
23834266|NCT02445248|66770959|FG001|Overall Study|Physician Decision|0|||
23834267|NCT02445248|66770958|FG000|Overall Study|Adverse Event|1|||
23834268|NCT02445248|66770959|FG001|Overall Study|Adverse Event|0|||
23834269|NCT02445248|66770958|FG000|Overall Study|Lost to Follow-up|1|||
23834270|NCT02445248|66770959|FG001|Overall Study|Lost to Follow-up|0|||
23834271|NCT03150719|66770960|FG000|Overall Study|Adverse Event|0|||
23834272|NCT03150719|66770961|FG001|Overall Study|Adverse Event|1|||
23834273|NCT03150719|66770960|FG000|Overall Study|Death|0|||
23834274|NCT03150719|66770961|FG001|Overall Study|Death|1|||
23834275|NCT03150719|66770960|FG000|Overall Study|Other|1|||
23834276|NCT03150719|66770961|FG001|Overall Study|Other|0|||
23834277|NCT02996968|66770964|FG000|Overall Study|Withdrawal by Subject|1|||
23834278|NCT02996968|66770965|FG001|Overall Study|Withdrawal by Subject|0|||
23834279|NCT00086684|66770973|FG000|Overall Study|Adverse Event|12|||
23834280|NCT00086684|66770974|FG001|Overall Study|Adverse Event|17|||
23834281|NCT00086684|66770975|FG002|Overall Study|Adverse Event|14|||
23834282|NCT00086684|66770973|FG000|Overall Study|Lack of Efficacy|6|||
23834283|NCT00086684|66770974|FG001|Overall Study|Lack of Efficacy|6|||
23834284|NCT00086684|66770975|FG002|Overall Study|Lack of Efficacy|5|||
23834285|NCT00086684|66770973|FG000|Overall Study|Lost to Follow-up|15|||
23834286|NCT00086684|66770974|FG001|Overall Study|Lost to Follow-up|8|||
23834287|NCT00086684|66770975|FG002|Overall Study|Lost to Follow-up|10|||
23834288|NCT00086684|66770973|FG000|Overall Study|Protocol Violation|8|||
23834289|NCT00086684|66770974|FG001|Overall Study|Protocol Violation|3|||
23834290|NCT00086684|66770975|FG002|Overall Study|Protocol Violation|0|||
23834291|NCT00086684|66770973|FG000|Overall Study|Withdrawal by Subject|0|||
23834292|NCT00086684|66770974|FG001|Overall Study|Withdrawal by Subject|4|||
23834293|NCT00086684|66770975|FG002|Overall Study|Withdrawal by Subject|10|||
23834294|NCT00086684|66770973|FG000|Overall Study|NONCOMPLIANCE|5|||
23834295|NCT00086684|66770974|FG001|Overall Study|NONCOMPLIANCE|7|||
23834296|NCT00086684|66770975|FG002|Overall Study|NONCOMPLIANCE|6|||
23834297|NCT00086684|66770973|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23834298|NCT00086684|66770974|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
23834299|NCT00086684|66770975|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23834300|NCT00086684|66770973|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
23834301|NCT00086684|66770974|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
23834302|NCT00086684|66770975|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
23834303|NCT00086684|66770973|FG000|Overall Study|Other|4|||
23834304|NCT00086684|66770974|FG001|Overall Study|Other|2|||
23834305|NCT00086684|66770975|FG002|Overall Study|Other|3|||
23834306|NCT02898597|66770979|FG000|Overall Study|Protocol Violation|4|||
23834307|NCT02898597|66770980|FG001|Overall Study|Protocol Violation|2|||
23834308|NCT02898597|66770979|FG000|Overall Study|Lost to Follow-up|0|||
23834309|NCT02898597|66770980|FG001|Overall Study|Lost to Follow-up|9|||
23834310|NCT02898597|66770979|FG000|Overall Study|Death|0|||
23834311|NCT02898597|66770980|FG001|Overall Study|Death|1|||
23834312|NCT04615403|66770981|FG000|Overall Study|Death|1|||
23774513|NCT00436553|66553698|FG002|Overall Study|Withdrawal by Subject|3|||
23774514|NCT02017964|66553699|FG000|Overall Study|Patient deemed ineligible|1|||
23774515|NCT01318499|66553700|FG000|Overall Study|Adverse Event|16|||
23774516|NCT01318499|66553701|FG001|Overall Study|Adverse Event|11|||
23774517|NCT01318499|66553702|FG002|Overall Study|Adverse Event|6|||
23774518|NCT01318499|66553700|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
23774519|NCT01318499|66553701|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
23774520|NCT01318499|66553702|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
23774521|NCT01318499|66553700|FG000|Overall Study|Noncompliance|2|||
23774522|NCT01318499|66553701|FG001|Overall Study|Noncompliance|3|||
23774523|NCT01318499|66553702|FG002|Overall Study|Noncompliance|0|||
23774524|NCT01318499|66553700|FG000|Overall Study|Treatment Failure|19|||
23774525|NCT01318499|66553701|FG001|Overall Study|Treatment Failure|19|||
23774526|NCT01318499|66553702|FG002|Overall Study|Treatment Failure|101|||
23774527|NCT01318499|66553700|FG000|Overall Study|Protocol Violation|2|||
23774528|NCT01318499|66553701|FG001|Overall Study|Protocol Violation|4|||
23774529|NCT01318499|66553702|FG002|Overall Study|Protocol Violation|2|||
23774530|NCT01318499|66553700|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
23774531|NCT01318499|66553701|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
23774532|NCT01318499|66553702|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
23774533|NCT01318499|66553700|FG000|Overall Study|Other|7|||
23774534|NCT01318499|66553701|FG001|Overall Study|Other|10|||
23774535|NCT01318499|66553702|FG002|Overall Study|Other|22|||
23774536|NCT03361228|66553703|FG000|Overall Study|Other|1|||
23774537|NCT03361228|66553704|FG001|Overall Study|Other|1|||
23834313|NCT01283464|66770982|FG000|Overall Study|Lost to Follow-up|0|||
23834314|NCT01283464|66770983|FG001|Overall Study|Lost to Follow-up|1|||
23834315|NCT01283464|66770982|FG000|Overall Study|Withdrawal by Subject|1|||
23834316|NCT01283464|66770983|FG001|Overall Study|Withdrawal by Subject|0|||
23834317|NCT01283464|66770982|FG000|Overall Study|Physician Decision|1|||
23834318|NCT01283464|66770983|FG001|Overall Study|Physician Decision|0|||
23774538|NCT03361228|66553703|FG000|Overall Study|Death|3|||
23774539|NCT03361228|66553704|FG001|Overall Study|Death|0|||
23774540|NCT01406795|66553706|FG000|Overall Study|Withdrawal by Subject|1|||
23774541|NCT01139164|66553707|FG000|Overall Study|Withdrawn prior to study start|0|||
23774542|NCT01139164|66553708|FG001|Overall Study|Withdrawn prior to study start|2|||
23774543|NCT01139164|66553709|FG002|Overall Study|Withdrawn prior to study start|0|||
23774544|NCT00352690|66553715|FG000|Overall Study|Determined to be ineligible|2|||
23774545|NCT00352690|66553716|FG001|Overall Study|Determined to be ineligible|0|||
23774546|NCT02116803|66553718|FG000|Overall Study|Adverse Event|2|||
23774547|NCT02116803|66553719|FG001|Overall Study|Adverse Event|1|||
23774548|NCT02116803|66553718|FG000|Overall Study|Physician Decision|1|||
23774549|NCT02116803|66553719|FG001|Overall Study|Physician Decision|0|||
23774550|NCT02116803|66553718|FG000|Overall Study|Progressive disease|4|||
23774551|NCT02116803|66553719|FG001|Overall Study|Progressive disease|0|||
23774552|NCT02116803|66553718|FG000|Overall Study|Study terminated by sponsor|2|||
23774553|NCT02116803|66553719|FG001|Overall Study|Study terminated by sponsor|1|||
23774554|NCT02116803|66553718|FG000|Overall Study|Death|1|||
23774555|NCT02116803|66553719|FG001|Overall Study|Death|0|||
23774556|NCT02194998|66553722|FG000|On-HCV Treatment|Did not pick up study medication|0|||
23774557|NCT02194998|66553723|FG001|On-HCV Treatment|Did not pick up study medication|1|||
23774558|NCT02194998|66553724|FG002|On-HCV Treatment|Did not pick up study medication|0|||
23774559|NCT02194998|66553725|FG003|On-HCV Treatment|Did not pick up study medication|0|||
23774560|NCT02194998|66553722|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
23774561|NCT02194998|66553723|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
23774562|NCT02194998|66553724|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
23774563|NCT02194998|66553725|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
23774564|NCT03127137|66553726|FG000|Overall Study|Requested sedation after consent|1|||
23774565|NCT03127137|66553727|FG001|Overall Study|Requested sedation after consent|0|||
23774566|NCT03127137|66553726|FG000|Overall Study|Malfunction in electronic data collection|1|||
23774567|NCT03127137|66553727|FG001|Overall Study|Malfunction in electronic data collection|0|||
23774568|NCT03127137|66553726|FG000|Overall Study|Post procedure testing could not be obtained|0|||
23774569|NCT03127137|66553727|FG001|Overall Study|Post procedure testing could not be obtained|1|||
23774570|NCT04646109|66553728|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
23774571|NCT04646109|66553729|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
23774572|NCT01790568|66553730|FG000|Overall Study|Progression prior to transplant|0|||
23774573|NCT01790568|66553731|FG001|Overall Study|Progression prior to transplant|1|||
23774574|NCT02946385|66553740|FG000|Overall Study|Lost to Follow-up|0|||
23774575|NCT02946385|66553741|FG001|Overall Study|Lost to Follow-up|0|||
23447770|NCT02587520|65380604|FG008|Overall Study|Adverse Event|0|||
23447771|NCT02587520|65380605|FG009|Overall Study|Adverse Event|0|||
23447772|NCT02587520|65380606|FG010|Overall Study|Adverse Event|0|||
23774576|NCT02946385|66553742|FG002|Overall Study|Lost to Follow-up|3|||
23774577|NCT02946385|66553743|FG003|Overall Study|Lost to Follow-up|0|||
23774578|NCT02946385|66553744|FG004|Overall Study|Lost to Follow-up|2|||
23834319|NCT01591096|66770984|FG000|Overall Study|Adverse Event|1|||
23834320|NCT00958828|66770989|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
23834321|NCT00958828|66770990|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
23834322|NCT00958828|66770989|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
23834323|NCT00958828|66770990|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
23834324|NCT00320710|66770991|FG000|Overall Study|Disease progression|24|||
23834325|NCT00320710|66770992|FG001|Overall Study|Disease progression|19|||
23834326|NCT00320710|66770993|FG002|Overall Study|Disease progression|2|||
23834327|NCT00320710|66770991|FG000|Overall Study|Death|10|||
23774579|NCT02946385|66553745|FG005|Overall Study|Lost to Follow-up|1|||
23774580|NCT00679367|66553752|FG000|Overall Study|Adverse Event|7|||
23774581|NCT00679367|66553752|FG000|Overall Study|inability to swallow oral drugs|1|||
23774582|NCT00679367|66553752|FG000|Overall Study|Lack of Efficacy|3|||
23774583|NCT00679367|66553752|FG000|Overall Study|Withdrawal by Subject|1|||
23774584|NCT00659607|66553753|FG000|Overall Study|No blood pressure recorded|147|||
23774585|NCT00659607|66553753|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
23774586|NCT00659607|66553753|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
23834328|NCT00320710|66770992|FG001|Overall Study|Death|7|||
23576047|NCT02950545|65838945|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576048|NCT02950545|65838946|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576049|NCT02950545|65838947|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576050|NCT02950545|65838948|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576051|NCT02950545|65838949|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
23576052|NCT02950545|65838950|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576053|NCT02950545|65838945|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
23576054|NCT02950545|65838946|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576055|NCT02950545|65838947|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576056|NCT02950545|65838948|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576057|NCT02950545|65838949|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576058|NCT02950545|65838950|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576059|NCT02950545|65838945|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576060|NCT02950545|65838946|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576061|NCT02950545|65838947|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576062|NCT02950545|65838948|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576063|NCT02950545|65838949|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576064|NCT02950545|65838950|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
23576065|NCT02703532|65838951|FG000|Overall Study|Withdrawal by Subject|0|||
23576066|NCT02703532|65838952|FG001|Overall Study|Withdrawal by Subject|1|||
23576067|NCT02703532|65838953|FG002|Overall Study|Withdrawal by Subject|0|||
23576068|NCT02703532|65838954|FG003|Overall Study|Withdrawal by Subject|1|||
23576069|NCT02703532|65838951|FG000|Overall Study|Lost to Follow-up|2|||
23576070|NCT02703532|65838952|FG001|Overall Study|Lost to Follow-up|0|||
23576071|NCT02703532|65838953|FG002|Overall Study|Lost to Follow-up|2|||
23774587|NCT00659607|66553753|FG000|Overall Study|No recorded efficacy data|15|||
23774588|NCT00659607|66553753|FG000|Overall Study|Inconsistent BP measuring date|2|||
23774589|NCT02920996|66553754|FG000|Overall Study|Adverse Event|8|||
23834329|NCT00320710|66770993|FG002|Overall Study|Death|1|||
23834330|NCT00320710|66770991|FG000|Overall Study|Administrative problems|1|||
23834331|NCT00320710|66770992|FG001|Overall Study|Administrative problems|2|||
23834332|NCT00320710|66770993|FG002|Overall Study|Administrative problems|0|||
23834333|NCT00320710|66770991|FG000|Overall Study|Withdrawal by Subject|20|||
23576072|NCT02703532|65838954|FG003|Overall Study|Lost to Follow-up|0|||
23576073|NCT01158378|65838956|FG000|Overall Study|Death|4|||
23576074|NCT01158378|65838957|FG001|Overall Study|Death|5|||
23576075|NCT01158378|65838956|FG000|Overall Study|Lost to Follow-up|2|||
23576076|NCT01158378|65838957|FG001|Overall Study|Lost to Follow-up|4|||
23774590|NCT02920996|66553755|FG001|Overall Study|Adverse Event|0|||
23834334|NCT00320710|66770992|FG001|Overall Study|Withdrawal by Subject|26|||
23834335|NCT00320710|66770993|FG002|Overall Study|Withdrawal by Subject|1|||
23834336|NCT00320710|66770991|FG000|Overall Study|Protocol Violation|6|||
23834337|NCT00320710|66770992|FG001|Overall Study|Protocol Violation|5|||
23834338|NCT00320710|66770993|FG002|Overall Study|Protocol Violation|0|||
23834339|NCT00320710|66770991|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23834340|NCT00320710|66770992|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23834341|NCT00320710|66770993|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23834342|NCT00320710|66770991|FG000|Overall Study|Abnormal laboratory value(s)|12|||
23834343|NCT00320710|66770992|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23834344|NCT00320710|66770993|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23834345|NCT00320710|66770991|FG000|Overall Study|Adverse Event|18|||
23834346|NCT00320710|66770992|FG001|Overall Study|Adverse Event|14|||
23834347|NCT00320710|66770993|FG002|Overall Study|Adverse Event|1|||
23834348|NCT00320710|66770991|FG000|Overall Study|Lost to Follow-up|1|||
23834349|NCT00320710|66770992|FG001|Overall Study|Lost to Follow-up|0|||
23834350|NCT00320710|66770993|FG002|Overall Study|Lost to Follow-up|0|||
23834351|NCT01804946|66770997|FG000|Overall Study|Protocol Violation|1|||
23834352|NCT01804946|66770998|FG001|Overall Study|Protocol Violation|0|||
23834353|NCT01804946|66770997|FG000|Overall Study|Adverse Event|0|||
23834354|NCT01804946|66770998|FG001|Overall Study|Adverse Event|1|||
23834355|NCT01804946|66770997|FG000|Overall Study|Insufficient data available|0|||
23834356|NCT01804946|66770998|FG001|Overall Study|Insufficient data available|1|||
23834357|NCT01804946|66770997|FG000|Overall Study|Do not meet inclusion criteria|1|||
23834358|NCT01804946|66770998|FG001|Overall Study|Do not meet inclusion criteria|2|||
23834359|NCT00767455|66774034|FG000|Overall Study|Investigator error|19|||
23834360|NCT00470704|66774035|FG000|Overall Study|Withdrawal by Subject|4|||
23834361|NCT00470704|66774036|FG001|Overall Study|Withdrawal by Subject|3|||
23834362|NCT00470704|66774035|FG000|Overall Study|Relapse/Progression|37|||
23834363|NCT00470704|66774036|FG001|Overall Study|Relapse/Progression|42|||
23834364|NCT00470704|66774035|FG000|Overall Study|toxicity|0|||
23834365|NCT00470704|66774036|FG001|Overall Study|toxicity|1|||
23834366|NCT04565145|66774037|FG000|Overall Study|Withdrawal by Subject|1|||
23834367|NCT04565145|66774038|FG001|Overall Study|Withdrawal by Subject|1|||
23834368|NCT00463047|66774041|FG000|Titration Period 1|Adverse Event|10|||
23834369|NCT00463047|66774042|FG001|Titration Period 1|Adverse Event|8|||
23834370|NCT00463047|66774041|FG000|Titration Period 1|Lack of Efficacy|10|||
23834371|NCT00463047|66774042|FG001|Titration Period 1|Lack of Efficacy|4|||
23834372|NCT00463047|66774041|FG000|Titration Period 1|Lost to Follow-up|2|||
23834373|NCT00463047|66774042|FG001|Titration Period 1|Lost to Follow-up|0|||
23834374|NCT00463047|66774041|FG000|Titration Period 1|Non-compliance with study medication|3|||
23834375|NCT00463047|66774042|FG001|Titration Period 1|Non-compliance with study medication|5|||
23834376|NCT00463047|66774041|FG000|Titration Period 1|Protocol Violation|5|||
23834377|NCT00463047|66774042|FG001|Titration Period 1|Protocol Violation|5|||
23834378|NCT00463047|66774041|FG000|Titration Period 1|Withdrawal by Subject|3|||
23834379|NCT00463047|66774042|FG001|Titration Period 1|Withdrawal by Subject|5|||
23834380|NCT00463047|66774041|FG000|Titration Period 1|Non-compliance procedures|4|||
23834381|NCT00463047|66774042|FG001|Titration Period 1|Non-compliance procedures|10|||
23834382|NCT00463047|66774041|FG000|Titration Period 1|Other|0|||
23834383|NCT00463047|66774042|FG001|Titration Period 1|Other|2|||
23834384|NCT00463047|66774041|FG000|Titration Period 2|Adverse Event|9|||
23834385|NCT00463047|66774042|FG001|Titration Period 2|Adverse Event|9|||
23834386|NCT00463047|66774041|FG000|Titration Period 2|Lack of Efficacy|6|||
23576077|NCT01158378|65838956|FG000|Overall Study|Withdrawal by Subject|4|||
23834387|NCT00463047|66774042|FG001|Titration Period 2|Lack of Efficacy|4|||
23834388|NCT00463047|66774041|FG000|Titration Period 2|Withdrawal by Subject|1|||
23834389|NCT00463047|66774042|FG001|Titration Period 2|Withdrawal by Subject|0|||
23576078|NCT01158378|65838957|FG001|Overall Study|Withdrawal by Subject|0|||
23834390|NCT00463047|66774041|FG000|Titration Period 2|Protocol Violation|2|||
23834391|NCT00463047|66774042|FG001|Titration Period 2|Protocol Violation|3|||
23834392|NCT00463047|66774041|FG000|Titration Period 2|Lost to Follow-up|1|||
23774591|NCT02920996|66553754|FG000|Overall Study|Physician Decision|1|||
23774592|NCT02920996|66553755|FG001|Overall Study|Physician Decision|0|||
23774593|NCT02920996|66553754|FG000|Overall Study|Death|1|||
23774594|NCT02920996|66553755|FG001|Overall Study|Death|0|||
23774595|NCT02920996|66553754|FG000|Overall Study|Missing|1|||
23576079|NCT00798174|65838961|FG000|Overall Study|inability to implant azygos coil|3|||
23447773|NCT02587520|65380607|FG011|Overall Study|Adverse Event|1|||
23576080|NCT00798174|65838962|FG001|Overall Study|inability to implant azygos coil|3|||
23576081|NCT00798174|65838961|FG000|Overall Study|Inability to sedate for DFT testing|1|||
23576082|NCT00798174|65838962|FG001|Overall Study|Inability to sedate for DFT testing|0|||
23576083|NCT04012814|65838964|FG000|Overall Study|Lost to Follow-up|4|||
23774596|NCT02920996|66553755|FG001|Overall Study|Missing|0|||
23774597|NCT02920996|66553754|FG000|Overall Study|Subject Non-Compliance|1|||
23774598|NCT02920996|66553755|FG001|Overall Study|Subject Non-Compliance|0|||
23774599|NCT02899338|66553756|FG000|Overall Study|Adverse Event|1|||
23774600|NCT02899338|66553757|FG001|Overall Study|Adverse Event|2|||
23774601|NCT02899338|66553756|FG000|Overall Study|Withdrawal by Subject|2|||
23774602|NCT02899338|66553757|FG001|Overall Study|Withdrawal by Subject|0|||
23774603|NCT03830164|66553758|FG000|Overall Study|Adverse Event|0|||
23774604|NCT03830164|66553759|FG001|Overall Study|Adverse Event|2|||
23774605|NCT03830164|66553760|FG002|Overall Study|Adverse Event|0|||
23774606|NCT03830164|66553758|FG000|Overall Study|Lack of Efficacy|1|||
23774607|NCT03830164|66553759|FG001|Overall Study|Lack of Efficacy|5|||
23774608|NCT03830164|66553760|FG002|Overall Study|Lack of Efficacy|0|||
23774609|NCT03830164|66553758|FG000|Overall Study|Lost to Follow-up|0|||
23774610|NCT03830164|66553759|FG001|Overall Study|Lost to Follow-up|1|||
23774611|NCT03830164|66553760|FG002|Overall Study|Lost to Follow-up|0|||
23774612|NCT03830164|66553758|FG000|Overall Study|Withdrawal by Subject|1|||
23774613|NCT03830164|66553759|FG001|Overall Study|Withdrawal by Subject|0|||
23774614|NCT03830164|66553760|FG002|Overall Study|Withdrawal by Subject|0|||
23774615|NCT00117949|66553761|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
23774616|NCT00117949|66553762|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
23774617|NCT00117949|66553763|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
23774618|NCT00117949|66553764|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
23774619|NCT00117949|66553761|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
23774620|NCT00117949|66553762|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
23774621|NCT00117949|66553763|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
23774622|NCT00117949|66553764|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
23774623|NCT00117949|66553761|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
23774624|NCT00117949|66553762|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
23774625|NCT00117949|66553763|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
23774626|NCT00117949|66553764|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
23447774|NCT02587520|65380608|FG012|Overall Study|Adverse Event|0|||
23447775|NCT02587520|65380609|FG013|Overall Study|Adverse Event|0|||
23447776|NCT02587520|65380610|FG014|Overall Study|Adverse Event|0|||
23447777|NCT02587520|65380611|FG015|Overall Study|Adverse Event|0|||
23447778|NCT02587520|65380612|FG016|Overall Study|Adverse Event|0|||
23774627|NCT00117949|66553761|FG000|Overall Study|PSA increase >=10ng/mL|0|||
23774628|NCT00117949|66553762|FG001|Overall Study|PSA increase >=10ng/mL|1|||
23774629|NCT00117949|66553763|FG002|Overall Study|PSA increase >=10ng/mL|1|||
23774630|NCT00117949|66553764|FG003|Overall Study|PSA increase >=10ng/mL|0|||
23774631|NCT00117949|66553761|FG000|Overall Study|PSA reduction <=50%|0|||
23774632|NCT00117949|66553762|FG001|Overall Study|PSA reduction <=50%|2|||
23774633|NCT00117949|66553763|FG002|Overall Study|PSA reduction <=50%|2|||
23774634|NCT00117949|66553764|FG003|Overall Study|PSA reduction <=50%|4|||
23576084|NCT04012814|65838964|FG000|Overall Study|Withdrawal by Subject|2|||
23576085|NCT04012814|65838964|FG000|Overall Study|Protocol Violation|1|||
23576086|NCT04012814|65838964|FG000|Overall Study|Adverse Event|1|||
23774635|NCT00117949|66553761|FG000|Overall Study|Hepatic abnormalities|0|||
23774636|NCT00117949|66553762|FG001|Overall Study|Hepatic abnormalities|1|||
23774637|NCT00117949|66553763|FG002|Overall Study|Hepatic abnormalities|0|||
23774638|NCT00117949|66553764|FG003|Overall Study|Hepatic abnormalities|1|||
23774639|NCT02066922|66553765|FG000|Overall Study|Adverse Event|1|||
23774640|NCT03897088|66553766|FG000|Overall Study|Withdrawal by Subject|12|||
23774641|NCT03897088|66553767|FG001|Overall Study|Withdrawal by Subject|12|||
23774642|NCT03897088|66553766|FG000|Overall Study|Lost to Follow-up|7|||
23774643|NCT03897088|66553767|FG001|Overall Study|Lost to Follow-up|15|||
23774644|NCT03897088|66553766|FG000|Overall Study|Sponsor Decision|1|||
23774645|NCT03897088|66553767|FG001|Overall Study|Sponsor Decision|2|||
23774646|NCT03897088|66553766|FG000|Overall Study|COVID-19|2|||
23774647|NCT03897088|66553767|FG001|Overall Study|COVID-19|0|||
23774648|NCT03897088|66553766|FG000|Overall Study|Other|3|||
23774649|NCT03897088|66553767|FG001|Overall Study|Other|0|||
23774650|NCT03897088|66553766|FG000|Overall Study|Non-compliance with Study Drug|1|||
23774651|NCT03897088|66553767|FG001|Overall Study|Non-compliance with Study Drug|1|||
23774652|NCT03897088|66553766|FG000|Overall Study|Pregnancy|0|||
23774653|NCT03897088|66553767|FG001|Overall Study|Pregnancy|1|||
23774654|NCT01860976|66553768|FG000|Blinded Treatment|Adverse Event|1|||
23774655|NCT01860976|66553769|FG001|Blinded Treatment|Adverse Event|3|||
23774656|NCT01860976|66553768|FG000|Blinded Treatment|Lack of Efficacy|5|||
23774657|NCT01860976|66553769|FG001|Blinded Treatment|Lack of Efficacy|12|||
23774658|NCT01860976|66553768|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
23834393|NCT00463047|66774042|FG001|Titration Period 2|Lost to Follow-up|2|||
23447779|NCT02587520|65380613|FG017|Overall Study|Adverse Event|0|||
23576087|NCT01994720|65838965|FG000|Overall Study|Withdrawal by Subject|46|||
23576088|NCT01994720|65838966|FG001|Overall Study|Withdrawal by Subject|56|||
23834394|NCT00463047|66774041|FG000|Titration Period 2|Non-compliance study medication|4|||
23576089|NCT03300817|65838967|FG000|Overall Study|Withdrawal by Subject|1|||
23576090|NCT03300817|65838967|FG000|Overall Study|Adverse Event|1|||
23576091|NCT03300817|65838967|FG000|Overall Study|Subject Found to be Ineligible|2|||
23576092|NCT00810641|65838968|FG000|Overall Study|Withdrawal by Subject|0|||
23576093|NCT00810641|65838969|FG001|Overall Study|Withdrawal by Subject|1|||
23576094|NCT00810641|65838970|FG002|Overall Study|Withdrawal by Subject|2|||
23576095|NCT04834362|65838971|FG000|Overall Study|Death|1|||
23576096|NCT04834362|65838972|FG001|Overall Study|Death|2|||
23576097|NCT02448719|65838973|FG000|Overall Study|Withdrawal by Subject|0|||
23576098|NCT02448719|65838974|FG001|Overall Study|Withdrawal by Subject|0|||
23576099|NCT02448719|65838975|FG002|Overall Study|Withdrawal by Subject|0|||
23576100|NCT02448719|65838976|FG003|Overall Study|Withdrawal by Subject|0|||
23576101|NCT02448719|65838977|FG004|Overall Study|Withdrawal by Subject|1|||
23576102|NCT02448719|65838978|FG005|Overall Study|Withdrawal by Subject|0|||
23576103|NCT02448719|65838979|FG006|Overall Study|Withdrawal by Subject|0|||
23576104|NCT02448719|65838980|FG007|Overall Study|Withdrawal by Subject|0|||
23576105|NCT02448719|65838981|FG008|Overall Study|Withdrawal by Subject|0|||
23576106|NCT02448719|65838982|FG009|Overall Study|Withdrawal by Subject|0|||
23576107|NCT02448719|65838983|FG010|Overall Study|Withdrawal by Subject|0|||
23774659|NCT01860976|66553769|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
23834395|NCT00463047|66774042|FG001|Titration Period 2|Non-compliance study medication|2|||
23834396|NCT00463047|66774041|FG000|Titration Period 2|Non-compliance procedures|4|||
23834397|NCT00463047|66774042|FG001|Titration Period 2|Non-compliance procedures|1|||
23834398|NCT00463047|66774041|FG000|Titration Period 2|Other|3|||
23834399|NCT00463047|66774042|FG001|Titration Period 2|Other|2|||
23834400|NCT00463047|66774041|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
23834401|NCT00463047|66774042|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
23834402|NCT00463047|66774041|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
23834403|NCT00463047|66774042|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
23834404|NCT00463047|66774041|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
23834405|NCT00463047|66774042|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
23834406|NCT00463047|66774041|FG000|Double-Blind Treatment Period 1|Other|1|||
23834407|NCT00463047|66774042|FG001|Double-Blind Treatment Period 1|Other|0|||
23834408|NCT00463047|66774041|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
23834409|NCT00463047|66774042|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
23834410|NCT00463047|66774041|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23834411|NCT00463047|66774042|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
23834412|NCT00463047|66774041|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
23834413|NCT00463047|66774042|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
23576108|NCT01683994|65838985|FG000|Overall Study|Withdrawal by Subject|1|||
23774660|NCT01860976|66553768|FG000|Blinded Treatment|Withdrawal by Subject|3|||
23774661|NCT01860976|66553769|FG001|Blinded Treatment|Withdrawal by Subject|5|||
23576109|NCT01683994|65838986|FG001|Overall Study|Withdrawal by Subject|0|||
23576110|NCT01683994|65838987|FG002|Overall Study|Withdrawal by Subject|0|||
23576111|NCT01683994|65838988|FG003|Overall Study|Withdrawal by Subject|1|||
23576112|NCT01683994|65838989|FG004|Overall Study|Withdrawal by Subject|0|||
23774662|NCT01860976|66553768|FG000|Blinded Treatment|Subject no longer met criteria|1|||
23774663|NCT01860976|66553769|FG001|Blinded Treatment|Subject no longer met criteria|0|||
23774664|NCT01860976|66553768|FG000|Blinded Treatment|Entered Open-Label in error|0|||
23774665|NCT01860976|66553769|FG001|Blinded Treatment|Entered Open-Label in error|1|||
23774666|NCT01860976|66553768|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
23774667|NCT01860976|66553769|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
23774668|NCT01860976|66553768|FG000|Open-Label|Adverse Event|2|||
23774669|NCT01860976|66553769|FG001|Open-Label|Adverse Event|4|||
23774670|NCT01860976|66553768|FG000|Open-Label|Lack of Efficacy|16|||
23774671|NCT01860976|66553769|FG001|Open-Label|Lack of Efficacy|8|||
23774672|NCT01860976|66553768|FG000|Open-Label|Lost to Follow-up|1|||
23774673|NCT01860976|66553769|FG001|Open-Label|Lost to Follow-up|2|||
23774674|NCT01860976|66553768|FG000|Open-Label|Subject request discontinue treatment|4|||
23774675|NCT01860976|66553769|FG001|Open-Label|Subject request discontinue treatment|3|||
23774676|NCT01860976|66553768|FG000|Open-Label|Withdrawal by Subject|4|||
23774677|NCT01860976|66553769|FG001|Open-Label|Withdrawal by Subject|1|||
23834414|NCT01297517|66774045|FG000|Overall Study|Adverse Event|21|||
23834415|NCT01297517|66774046|FG001|Overall Study|Adverse Event|7|||
23834416|NCT01297517|66774047|FG002|Overall Study|Adverse Event|16|||
23834417|NCT01297517|66774045|FG000|Overall Study|Lost to Follow-up|1|||
23834418|NCT01297517|66774046|FG001|Overall Study|Lost to Follow-up|0|||
23834419|NCT01297517|66774047|FG002|Overall Study|Lost to Follow-up|1|||
23834420|NCT01297517|66774045|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
23834421|NCT01297517|66774046|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
23834422|NCT01297517|66774047|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
23576113|NCT01683994|65838985|FG000|Overall Study|Intercurrent illness|0|||
23576114|NCT01683994|65838986|FG001|Overall Study|Intercurrent illness|0|||
23576115|NCT01683994|65838987|FG002|Overall Study|Intercurrent illness|0|||
23576116|NCT01683994|65838988|FG003|Overall Study|Intercurrent illness|2|||
23576117|NCT01683994|65838989|FG004|Overall Study|Intercurrent illness|1|||
23576118|NCT01782326|65838994|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
23576119|NCT01782326|65838995|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
23576120|NCT01782326|65838994|FG000|Planned Treatment Epoch|Death|29|||
23576121|NCT01782326|65838995|FG001|Planned Treatment Epoch|Death|30|||
23576122|NCT01782326|65838994|FG000|Planned Treatment Epoch|Physician Decision|18|||
23774678|NCT01860976|66553768|FG000|Open-Label|Other Reasons|1|||
23774679|NCT01860976|66553769|FG001|Open-Label|Other Reasons|1|||
23774680|NCT01860976|66553768|FG000|Long Term Extension|Adverse Event|4|||
23774681|NCT01860976|66553769|FG001|Long Term Extension|Adverse Event|0|||
23834423|NCT01297517|66774045|FG000|Overall Study|Noncompliance|1|||
23447780|NCT02587520|65380596|FG000|Overall Study|Withdrawal by Subject|0|||
23447781|NCT02587520|65380597|FG001|Overall Study|Withdrawal by Subject|0|||
23447782|NCT02587520|65380598|FG002|Overall Study|Withdrawal by Subject|1|||
23447783|NCT02587520|65380599|FG003|Overall Study|Withdrawal by Subject|1|||
23447784|NCT02587520|65380600|FG004|Overall Study|Withdrawal by Subject|0|||
23447785|NCT02587520|65380601|FG005|Overall Study|Withdrawal by Subject|1|||
23447786|NCT02587520|65380602|FG006|Overall Study|Withdrawal by Subject|1|||
23447787|NCT02587520|65380603|FG007|Overall Study|Withdrawal by Subject|0|||
23447788|NCT02587520|65380604|FG008|Overall Study|Withdrawal by Subject|0|||
23447789|NCT02587520|65380605|FG009|Overall Study|Withdrawal by Subject|0|||
23447790|NCT02587520|65380606|FG010|Overall Study|Withdrawal by Subject|0|||
23447791|NCT02587520|65380607|FG011|Overall Study|Withdrawal by Subject|0|||
23447792|NCT02587520|65380608|FG012|Overall Study|Withdrawal by Subject|0|||
23447793|NCT02587520|65380609|FG013|Overall Study|Withdrawal by Subject|1|||
23447794|NCT02587520|65380610|FG014|Overall Study|Withdrawal by Subject|0|||
23447795|NCT02587520|65380611|FG015|Overall Study|Withdrawal by Subject|0|||
23447796|NCT02587520|65380612|FG016|Overall Study|Withdrawal by Subject|0|||
23447797|NCT02587520|65380613|FG017|Overall Study|Withdrawal by Subject|0|||
23447798|NCT02587520|65380596|FG000|Overall Study|Lost to Follow-up|0|||
23447799|NCT02587520|65380597|FG001|Overall Study|Lost to Follow-up|2|||
23447800|NCT02587520|65380598|FG002|Overall Study|Lost to Follow-up|0|||
23447801|NCT02587520|65380599|FG003|Overall Study|Lost to Follow-up|2|||
23447802|NCT02587520|65380600|FG004|Overall Study|Lost to Follow-up|0|||
23447803|NCT02587520|65380601|FG005|Overall Study|Lost to Follow-up|1|||
23447804|NCT02587520|65380602|FG006|Overall Study|Lost to Follow-up|1|||
23447805|NCT02587520|65380603|FG007|Overall Study|Lost to Follow-up|1|||
23834424|NCT01297517|66774046|FG001|Overall Study|Noncompliance|0|||
23834425|NCT01297517|66774047|FG002|Overall Study|Noncompliance|0|||
23834426|NCT01297517|66774045|FG000|Overall Study|Protocol Violation|1|||
23834427|NCT01297517|66774046|FG001|Overall Study|Protocol Violation|1|||
23447806|NCT02587520|65380604|FG008|Overall Study|Lost to Follow-up|0|||
23447807|NCT02587520|65380605|FG009|Overall Study|Lost to Follow-up|2|||
23447808|NCT02587520|65380606|FG010|Overall Study|Lost to Follow-up|2|||
23447809|NCT02587520|65380607|FG011|Overall Study|Lost to Follow-up|1|||
23447810|NCT02587520|65380608|FG012|Overall Study|Lost to Follow-up|0|||
23447811|NCT02587520|65380609|FG013|Overall Study|Lost to Follow-up|0|||
23447812|NCT02587520|65380610|FG014|Overall Study|Lost to Follow-up|0|||
23447813|NCT02587520|65380611|FG015|Overall Study|Lost to Follow-up|0|||
23447814|NCT02587520|65380612|FG016|Overall Study|Lost to Follow-up|0|||
23447815|NCT02587520|65380613|FG017|Overall Study|Lost to Follow-up|0|||
23447816|NCT01965704|65380614|FG000|Overall Study|Withdrawal by Subject|2|||
23447817|NCT01965704|65380615|FG001|Overall Study|Withdrawal by Subject|2|||
23447818|NCT01965704|65380616|FG002|Overall Study|Withdrawal by Subject|1|||
23447819|NCT01965704|65380617|FG003|Overall Study|Withdrawal by Subject|1|||
23447820|NCT01965704|65380614|FG000|Overall Study|Delivered at home|1|||
23447821|NCT01965704|65380615|FG001|Overall Study|Delivered at home|1|||
23447822|NCT01965704|65380616|FG002|Overall Study|Delivered at home|0|||
23834428|NCT01297517|66774047|FG002|Overall Study|Protocol Violation|1|||
23834429|NCT01297517|66774045|FG000|Overall Study|Inadequate Control of IOP|1|||
23834430|NCT01297517|66774046|FG001|Overall Study|Inadequate Control of IOP|1|||
23834431|NCT01297517|66774047|FG002|Overall Study|Inadequate Control of IOP|2|||
23447823|NCT01965704|65380617|FG003|Overall Study|Delivered at home|0|||
23447824|NCT01965704|65380614|FG000|Overall Study|Experienced complications|0|||
23447825|NCT01965704|65380615|FG001|Overall Study|Experienced complications|0|||
23447826|NCT01965704|65380616|FG002|Overall Study|Experienced complications|2|||
23447827|NCT01965704|65380617|FG003|Overall Study|Experienced complications|2|||
23447828|NCT01965704|65380614|FG000|Overall Study|Adverse Event|0|||
23447829|NCT01965704|65380615|FG001|Overall Study|Adverse Event|0|||
23447830|NCT01965704|65380616|FG002|Overall Study|Adverse Event|1|||
23447831|NCT01965704|65380617|FG003|Overall Study|Adverse Event|1|||
23834432|NCT03225105|66774048|FG000|Overall Study|Withdrawal by Subject|1|||
23447832|NCT01965704|65380614|FG000|Overall Study|Did not meet inclusion criteria|0|||
23447833|NCT01965704|65380615|FG001|Overall Study|Did not meet inclusion criteria|0|||
23447834|NCT01965704|65380616|FG002|Overall Study|Did not meet inclusion criteria|1|||
23447835|NCT01965704|65380617|FG003|Overall Study|Did not meet inclusion criteria|1|||
23447836|NCT01453140|65380618|FG000|Overall Study|Adverse Event|3|||
23447837|NCT05274958|65380621|FG000|Overall Study|Only completed 1 set of PROMs|22|||
23447838|NCT05274958|65380622|FG001|Overall Study|Only completed 1 set of PROMs|35|||
23447839|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
23447840|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
23447841|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
23447842|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
23447843|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
23447844|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
23447845|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
23447846|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
23447847|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
23447848|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
23447849|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
23447850|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
23447851|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
23447852|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
23576123|NCT01782326|65838995|FG001|Planned Treatment Epoch|Physician Decision|16|||
23576124|NCT01782326|65838994|FG000|Planned Treatment Epoch|Protocol deviation|2|||
23576125|NCT01782326|65838995|FG001|Planned Treatment Epoch|Protocol deviation|3|||
23834433|NCT03225105|66774049|FG001|Overall Study|Withdrawal by Subject|0|||
23774682|NCT01860976|66553768|FG000|Long Term Extension|Lack of Efficacy|2|||
23774683|NCT01860976|66553769|FG001|Long Term Extension|Lack of Efficacy|0|||
23774684|NCT01860976|66553768|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
23774685|NCT01860976|66553769|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
23774686|NCT01860976|66553768|FG000|Long Term Extension|Lost to Follow-up|2|||
23576126|NCT01782326|65838994|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
23834434|NCT03225105|66774050|FG002|Overall Study|Withdrawal by Subject|0|||
23834435|NCT03225105|66774051|FG003|Overall Study|Withdrawal by Subject|0|||
23774687|NCT01860976|66553769|FG001|Long Term Extension|Lost to Follow-up|0|||
23774688|NCT01860976|66553768|FG000|Long Term Extension|subject withdrew consent|7|||
23774689|NCT01860976|66553769|FG001|Long Term Extension|subject withdrew consent|0|||
23774690|NCT00076102|66553770|FG000|Overall Study|Clinical progression|1|||
23774691|NCT00076102|66553770|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
23774692|NCT00076102|66553770|FG000|Overall Study|plexiform neurofibroma surgery|1|||
23774693|NCT00076102|66553770|FG000|Overall Study|refusal of further therapy|2|||
23774694|NCT03048500|66553771|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
23774695|NCT03048500|66553771|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
23774696|NCT03048500|66553771|FG000|Reached 1st Response/Continued Treatment|Death|1|||
23774697|NCT03048500|66553771|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
23834436|NCT03225105|66774048|FG000|Overall Study|Death|0|||
23834437|NCT03225105|66774049|FG001|Overall Study|Death|4|||
23834438|NCT03225105|66774050|FG002|Overall Study|Death|2|||
23834439|NCT03225105|66774051|FG003|Overall Study|Death|0|||
23576127|NCT01782326|65838995|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
23576128|NCT01782326|65838994|FG000|Planned Treatment Epoch|Technical problems|0|||
23576129|NCT01782326|65838995|FG001|Planned Treatment Epoch|Technical problems|4|||
23576130|NCT01782326|65838994|FG000|Double-blind Treatment|Adverse Event|129|||
23834440|NCT03225105|66774048|FG000|Overall Study|Study termination per Sponsor Decision|2|||
23834441|NCT03225105|66774049|FG001|Overall Study|Study termination per Sponsor Decision|0|||
23834442|NCT03225105|66774050|FG002|Overall Study|Study termination per Sponsor Decision|3|||
23834443|NCT03225105|66774051|FG003|Overall Study|Study termination per Sponsor Decision|3|||
23834444|NCT03652051|66774052|FG000|Stage 1|Adverse Event|0|||
23834445|NCT03652051|66774053|FG001|Stage 1|Adverse Event|5|||
23834446|NCT03652051|66774054|FG002|Stage 1|Adverse Event|7|||
23834447|NCT03652051|66774055|FG003|Stage 1|Adverse Event|1|||
23447853|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
23576131|NCT01782326|65838995|FG001|Double-blind Treatment|Adverse Event|145|||
23576132|NCT01782326|65838994|FG000|Double-blind Treatment|Subject/guardian decision|111|||
23774698|NCT03048500|66553771|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
23834448|NCT03652051|66774052|FG000|Stage 1|Withdrawal by Subject|0|||
23834449|NCT03652051|66774053|FG001|Stage 1|Withdrawal by Subject|0|||
23834450|NCT03652051|66774054|FG002|Stage 1|Withdrawal by Subject|1|||
23834451|NCT03652051|66774055|FG003|Stage 1|Withdrawal by Subject|0|||
23834452|NCT03652051|66774052|FG000|Stage 2|Adverse Event|0|||
23576133|NCT01782326|65838995|FG001|Double-blind Treatment|Subject/guardian decision|125|||
23576134|NCT01782326|65838994|FG000|Double-blind Treatment|Lack of Efficacy|17|||
23447854|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
23447855|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
23447856|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
23447857|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
23447858|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
23447859|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
23447860|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
23447861|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
23447862|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
23447863|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
23447864|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
23447865|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
23774699|NCT03048500|66553771|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
23774700|NCT03048500|66553771|FG000|Follow up for 3 Years|Death|12|||
23774701|NCT04188106|66556811|FG000|Overall Study|Lost to Follow-up|5|||
23774702|NCT04188106|66556811|FG000|Overall Study|Non-Compliance|1|||
23774703|NCT02216071|66556812|FG000|Overall Study|Withdrawal by Subject|7|||
23774704|NCT02216071|66556813|FG001|Overall Study|Withdrawal by Subject|2|||
23774705|NCT02216071|66556812|FG000|Overall Study|Lost to Follow-up|3|||
23774706|NCT02216071|66556813|FG001|Overall Study|Lost to Follow-up|3|||
23774707|NCT02216071|66556812|FG000|Overall Study|Protocol Violation|3|||
23774708|NCT02216071|66556813|FG001|Overall Study|Protocol Violation|5|||
23774709|NCT02216071|66556812|FG000|Overall Study|Other|2|||
23774710|NCT02216071|66556813|FG001|Overall Study|Other|2|||
23774711|NCT01449630|66556816|FG000|Period 1|Physician Decision|1|||
23774712|NCT01449630|66556817|FG001|Period 1|Physician Decision|0|||
23774713|NCT01449630|66556818|FG002|Period 1|Physician Decision|0|||
23774714|NCT01449630|66556819|FG003|Period 1|Physician Decision|1|||
23774715|NCT01449630|66556820|FG004|Period 1|Physician Decision|0|||
23774716|NCT01449630|66556821|FG005|Period 1|Physician Decision|0|||
23774717|NCT01449630|66556822|FG006|Period 1|Physician Decision|0|||
23774718|NCT01449630|66556823|FG007|Period 1|Physician Decision|0|||
23774719|NCT01449630|66556824|FG008|Period 1|Physician Decision|0|||
23774720|NCT01449630|66556816|FG000|Period 1|Sponsor Decision|0|||
23774721|NCT01449630|66556817|FG001|Period 1|Sponsor Decision|0|||
23774722|NCT01449630|66556818|FG002|Period 1|Sponsor Decision|0|||
23774723|NCT01449630|66556819|FG003|Period 1|Sponsor Decision|0|||
23774724|NCT01449630|66556820|FG004|Period 1|Sponsor Decision|0|||
23774725|NCT01449630|66556821|FG005|Period 1|Sponsor Decision|1|||
23774726|NCT01449630|66556822|FG006|Period 1|Sponsor Decision|0|||
23774727|NCT01449630|66556823|FG007|Period 1|Sponsor Decision|0|||
23774728|NCT01449630|66556824|FG008|Period 1|Sponsor Decision|0|||
23774729|NCT01449630|66556816|FG000|Period 2|Sponsor Decision|0|||
23774730|NCT01449630|66556817|FG001|Period 2|Sponsor Decision|0|||
23774731|NCT01449630|66556818|FG002|Period 2|Sponsor Decision|0|||
23774732|NCT01449630|66556819|FG003|Period 2|Sponsor Decision|0|||
23774733|NCT01449630|66556820|FG004|Period 2|Sponsor Decision|0|||
23774734|NCT01449630|66556821|FG005|Period 2|Sponsor Decision|0|||
23774735|NCT01449630|66556822|FG006|Period 2|Sponsor Decision|1|||
23774736|NCT01449630|66556823|FG007|Period 2|Sponsor Decision|0|||
23774737|NCT01449630|66556824|FG008|Period 2|Sponsor Decision|0|||
23774738|NCT04657770|66556827|FG000|Overall Study|Withdrawal by Subject|3|||
23774739|NCT04657770|66556827|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
23774740|NCT00048581|66556830|FG000|Double-Blind Period|Adverse Event|9|||
23774741|NCT00048581|66556831|FG001|Double-Blind Period|Adverse Event|5|||
23774742|NCT00048581|66556832|FG002|Double-Blind Period|Adverse Event|0|||
23774743|NCT00048581|66556830|FG000|Double-Blind Period|Lack of Efficacy|14|||
23774744|NCT00048581|66556831|FG001|Double-Blind Period|Lack of Efficacy|27|||
23774745|NCT00048581|66556832|FG002|Double-Blind Period|Lack of Efficacy|0|||
23774746|NCT00048581|66556830|FG000|Double-Blind Period|Lost to Follow-up|5|||
23774747|NCT00048581|66556831|FG001|Double-Blind Period|Lost to Follow-up|0|||
23774748|NCT00048581|66556832|FG002|Double-Blind Period|Lost to Follow-up|0|||
23774749|NCT00048581|66556830|FG000|Double-Blind Period|Withdrawal by Subject|5|||
23774750|NCT00048581|66556831|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23447866|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
23774751|NCT00048581|66556832|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23774752|NCT00048581|66556830|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
23774753|NCT00048581|66556831|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
23774754|NCT00048581|66556832|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
23774755|NCT00048581|66556830|FG000|Double-Blind Period|Investigator Decision|1|||
23774756|NCT00048581|66556831|FG001|Double-Blind Period|Investigator Decision|0|||
23774757|NCT00048581|66556832|FG002|Double-Blind Period|Investigator Decision|0|||
23774758|NCT00048581|66556830|FG000|Open-Label Period|Death|0|||
23774759|NCT00048581|66556831|FG001|Open-Label Period|Death|0|||
23774760|NCT00048581|66556832|FG002|Open-Label Period|Death|4|||
23834453|NCT03652051|66774053|FG001|Stage 2|Adverse Event|2|||
23834454|NCT03652051|66774054|FG002|Stage 2|Adverse Event|1|||
23834455|NCT03652051|66774055|FG003|Stage 2|Adverse Event|0|||
23834456|NCT03652051|66774052|FG000|Stage 2|Protocol Violation|0|||
23834457|NCT03652051|66774053|FG001|Stage 2|Protocol Violation|1|||
23834458|NCT03652051|66774054|FG002|Stage 2|Protocol Violation|6|||
23834459|NCT03652051|66774055|FG003|Stage 2|Protocol Violation|0|||
23834460|NCT03652051|66774052|FG000|Stage 2|Lost to Follow-up|0|||
23834461|NCT03652051|66774053|FG001|Stage 2|Lost to Follow-up|2|||
23834462|NCT03652051|66774054|FG002|Stage 2|Lost to Follow-up|0|||
23834463|NCT03652051|66774055|FG003|Stage 2|Lost to Follow-up|3|||
23834464|NCT03652051|66774052|FG000|Stage 2|Withdrawal by Subject|0|||
23834465|NCT03652051|66774053|FG001|Stage 2|Withdrawal by Subject|11|||
23834466|NCT03652051|66774054|FG002|Stage 2|Withdrawal by Subject|9|||
23834467|NCT03652051|66774055|FG003|Stage 2|Withdrawal by Subject|3|||
23834468|NCT04031846|66774056|FG000|Overall Study|Lost to Follow-up|4|||
23834469|NCT04031846|66774057|FG001|Overall Study|Lost to Follow-up|4|||
23834470|NCT04031846|66774056|FG000|Overall Study|Physician Decision|0|||
23834471|NCT04031846|66774057|FG001|Overall Study|Physician Decision|1|||
23834472|NCT04031846|66774056|FG000|Overall Study|Protocol Violation|1|||
23834473|NCT04031846|66774057|FG001|Overall Study|Protocol Violation|1|||
23834474|NCT04031846|66774056|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
23834475|NCT04031846|66774057|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
23834476|NCT00824772|66774058|FG000|Overall Study|Withdrawal by Subject|8|||
23834477|NCT01790984|66774059|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
23834478|NCT01790984|66774060|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
23834479|NCT01790984|66774061|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
23834480|NCT01790984|66774062|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
23834481|NCT03478644|66774063|FG000|Phase 2|Withdrawal by Subject|2|||
23834482|NCT03478644|66774064|FG001|Phase 2|Withdrawal by Subject|1|||
23834483|NCT03478644|66774063|FG000|Phase 2|Lost to Follow-up|1|||
23834484|NCT03478644|66774064|FG001|Phase 2|Lost to Follow-up|0|||
23834485|NCT04509076|66774069|FG000|Overall Study|Withdrawal by Subject|1|||
23834486|NCT04509076|66774070|FG001|Overall Study|Withdrawal by Subject|2|||
23774761|NCT00048581|66556830|FG000|Open-Label Period|Adverse Event|0|||
23774762|NCT00048581|66556831|FG001|Open-Label Period|Adverse Event|0|||
23774763|NCT00048581|66556832|FG002|Open-Label Period|Adverse Event|37|||
23774764|NCT00048581|66556830|FG000|Open-Label Period|Lack of Efficacy|0|||
23774765|NCT00048581|66556831|FG001|Open-Label Period|Lack of Efficacy|0|||
23774766|NCT00048581|66556832|FG002|Open-Label Period|Lack of Efficacy|69|||
23774767|NCT00048581|66556830|FG000|Open-Label Period|Lost to Follow-up|0|||
23774768|NCT00048581|66556831|FG001|Open-Label Period|Lost to Follow-up|0|||
23774769|NCT00048581|66556832|FG002|Open-Label Period|Lost to Follow-up|14|||
23774770|NCT00048581|66556830|FG000|Open-Label Period|Withdrawal by Subject|0|||
23774771|NCT00048581|66556831|FG001|Open-Label Period|Withdrawal by Subject|0|||
23774772|NCT00048581|66556832|FG002|Open-Label Period|Withdrawal by Subject|20|||
23834487|NCT04509076|66774069|FG000|Overall Study|Lost to Follow-up|1|||
23834488|NCT04509076|66774070|FG001|Overall Study|Lost to Follow-up|2|||
23834489|NCT00921557|66774071|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
23834490|NCT00921557|66774072|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
23834491|NCT00921557|66774073|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
23834492|NCT00921557|66774071|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
23834493|NCT00921557|66774072|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
23834494|NCT00921557|66774073|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
23834495|NCT00921557|66774071|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
23834496|NCT00921557|66774072|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
23834497|NCT00921557|66774073|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
23834498|NCT00921557|66774071|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
23834499|NCT00921557|66774072|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
23576135|NCT01782326|65838995|FG001|Double-blind Treatment|Lack of Efficacy|22|||
23774773|NCT00048581|66556830|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
23774774|NCT00048581|66556831|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
23774775|NCT00048581|66556832|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
23834500|NCT00921557|66774073|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
23834501|NCT00921557|66774071|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
23834502|NCT00921557|66774072|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
23834503|NCT00921557|66774073|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
23834504|NCT01131455|66774078|FG000|Overall Study|Death of PI|6|||
23834505|NCT01131455|66774079|FG001|Overall Study|Death of PI|4|||
23834506|NCT01131455|66774080|FG002|Overall Study|Death of PI|0|||
23576136|NCT01782326|65838994|FG000|Double-blind Treatment|Physician Decision|13|||
23774776|NCT00048581|66556830|FG000|Open-Label Period|Poor/Non-compliance|0|||
23774777|NCT00048581|66556831|FG001|Open-Label Period|Poor/Non-compliance|0|||
23774778|NCT00048581|66556832|FG002|Open-Label Period|Poor/Non-compliance|5|||
23774779|NCT00048581|66556830|FG000|Open-Label Period|Pregnancy|0|||
23774780|NCT00048581|66556831|FG001|Open-Label Period|Pregnancy|0|||
23774781|NCT00048581|66556832|FG002|Open-Label Period|Pregnancy|7|||
23774782|NCT00048581|66556830|FG000|Open-Label Period|Study Site Closure|0|||
23774783|NCT00048581|66556831|FG001|Open-Label Period|Study Site Closure|0|||
23576137|NCT01782326|65838995|FG001|Double-blind Treatment|Physician Decision|16|||
23576138|NCT01782326|65838994|FG000|Double-blind Treatment|Protocol deviation|8|||
23576139|NCT01782326|65838995|FG001|Double-blind Treatment|Protocol deviation|7|||
23576140|NCT01782326|65838994|FG000|Double-blind Treatment|Technical problems|0|||
23576141|NCT01782326|65838995|FG001|Double-blind Treatment|Technical problems|5|||
23576142|NCT00619151|65838996|FG000|Overall Study|Study terminated prior to followup|1|||
23576143|NCT00619151|65838997|FG001|Overall Study|Study terminated prior to followup|0|||
23576144|NCT03018106|65838998|FG000|Overall Study|Lost to Follow-up|0|||
23774784|NCT00048581|66556832|FG002|Open-Label Period|Study Site Closure|2|||
23774785|NCT00048581|66556830|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
23774786|NCT00048581|66556831|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
23774787|NCT00048581|66556832|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
23774788|NCT00048581|66556830|FG000|Open-Label Period|Problem With Transportation To Site|0|||
23774789|NCT00048581|66556831|FG001|Open-Label Period|Problem With Transportation To Site|0|||
23774790|NCT00048581|66556832|FG002|Open-Label Period|Problem With Transportation To Site|1|||
23774791|NCT00048581|66556830|FG000|Open-Label Period|Primary Investigator Retired|0|||
23774792|NCT00048581|66556831|FG001|Open-Label Period|Primary Investigator Retired|0|||
23774793|NCT00048581|66556832|FG002|Open-Label Period|Primary Investigator Retired|2|||
23774794|NCT00048581|66556830|FG000|Open-Label Period|Study Ended By Sponsor|0|||
23774795|NCT00048581|66556831|FG001|Open-Label Period|Study Ended By Sponsor|0|||
23576145|NCT03018106|65838999|FG001|Overall Study|Lost to Follow-up|1|||
23576146|NCT00262743|65839000|FG000|Overall Study|Adverse Event|0|||
23576147|NCT00262743|65839001|FG001|Overall Study|Adverse Event|9|||
23576148|NCT00262743|65839000|FG000|Overall Study|Disease progression|0|||
23576149|NCT00262743|65839001|FG001|Overall Study|Disease progression|3|||
23834507|NCT04090060|66774083|FG000|Overall Study|Lost to Follow-up|76|||
23576150|NCT03283553|65839002|FG000|Patient Participant Flow|Death|5|||
23576151|NCT03283553|65839003|FG001|Patient Participant Flow|Death|10|||
23576152|NCT03283553|65839002|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
23576153|NCT03283553|65839003|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
23576154|NCT03283553|65839002|FG000|Patient Participant Flow|Lost to Follow-up|1|||
23576155|NCT03283553|65839003|FG001|Patient Participant Flow|Lost to Follow-up|1|||
23774796|NCT00048581|66556832|FG002|Open-Label Period|Study Ended By Sponsor|1|||
23834508|NCT04090060|66774084|FG001|Overall Study|Lost to Follow-up|77|||
23576156|NCT03283553|65839002|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
23576157|NCT03283553|65839003|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
23576158|NCT03283553|65839002|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
23576159|NCT03283553|65839003|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
23576160|NCT03283553|65839002|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
23576161|NCT03283553|65839003|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
23576162|NCT02100722|65839004|FG000|Overall Study|Withdrawal pre-procedure|4|||
23576163|NCT02100722|65839005|FG001|Overall Study|Withdrawal pre-procedure|9|||
23633841|NCT02628028|66045510|FG003|Dosing Period|Withdrawal by Subject|0|||
23633842|NCT02628028|66045511|FG004|Dosing Period|Withdrawal by Subject|2|||
23774797|NCT00846495|66556834|FG000|Overall Study|Lost to Follow-up|1|||
23774798|NCT00846495|66556835|FG001|Overall Study|Lost to Follow-up|0|||
23774799|NCT00846495|66556834|FG000|Overall Study|Adverse Event|5|||
23774800|NCT00846495|66556835|FG001|Overall Study|Adverse Event|1|||
23774801|NCT00846495|66556834|FG000|Overall Study|Lack of Efficacy|1|||
23774802|NCT00846495|66556835|FG001|Overall Study|Lack of Efficacy|2|||
23834509|NCT03428152|66774085|FG000|Overall Study|Physician Decision|4|||
23834510|NCT03428152|66774086|FG001|Overall Study|Physician Decision|2|||
23834511|NCT03428152|66774085|FG000|Overall Study|Protocol Violation|3|||
23834512|NCT03428152|66774086|FG001|Overall Study|Protocol Violation|5|||
23834513|NCT03428152|66774085|FG000|Overall Study|Lack of Efficacy|0|||
23834514|NCT03428152|66774086|FG001|Overall Study|Lack of Efficacy|4|||
23834515|NCT00077207|66774087|FG000|Overall Study|Adverse Event|5|||
23834516|NCT00077207|66774087|FG000|Overall Study|Lack of Efficacy|12|||
23834517|NCT00077207|66774087|FG000|Overall Study|Physician Decision|6|||
23834518|NCT00077207|66774087|FG000|Overall Study|Withdrawal by Subject|6|||
23834519|NCT00077207|66774087|FG000|Overall Study|Ineligible|1|||
23774803|NCT00846495|66556834|FG000|Overall Study|Physician Decision|1|||
23774804|NCT00846495|66556835|FG001|Overall Study|Physician Decision|0|||
23774805|NCT03601637|66556842|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
23774806|NCT03601637|66556843|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
23774807|NCT03601637|66556842|FG000|Overall Study|Adverse Event|1|||
23774808|NCT03601637|66556843|FG001|Overall Study|Adverse Event|1|||
23774809|NCT03601637|66556842|FG000|Overall Study|Other|0|||
23774810|NCT03601637|66556843|FG001|Overall Study|Other|1|||
23774811|NCT00950872|66556844|FG000|Overall Study|Withdrawal by Subject|1|||
23774812|NCT00950872|66556844|FG000|Overall Study|Did not have surgery|2|||
23774813|NCT03450070|66556845|FG000|Overall Study|Withdrawal by Subject|8|||
23774814|NCT02032888|66556849|FG000|Treatment Period|Poor compliance/noncompliance|1|||
23774815|NCT02032888|66556850|FG001|Treatment Period|Poor compliance/noncompliance|1|||
23774816|NCT02032888|66556851|FG002|Treatment Period|Poor compliance/noncompliance|0|||
23774817|NCT02032888|66556849|FG000|Treatment Period|Other|1|||
23774818|NCT02032888|66556850|FG001|Treatment Period|Other|1|||
23774819|NCT02032888|66556851|FG002|Treatment Period|Other|0|||
23774820|NCT02032888|66556849|FG000|Follow-up Period|Lost to Follow-up|1|||
23774821|NCT02032888|66556850|FG001|Follow-up Period|Lost to Follow-up|1|||
23774822|NCT02032888|66556851|FG002|Follow-up Period|Lost to Follow-up|0|||
23774823|NCT02032888|66556849|FG000|Follow-up Period|Death|1|||
23834520|NCT02841995|66774088|FG000|Overall Study|Disease progression|5|||
23834521|NCT02841995|66774089|FG001|Overall Study|Disease progression|11|||
23834522|NCT02841995|66774090|FG002|Overall Study|Disease progression|8|||
23834523|NCT02841995|66774088|FG000|Overall Study|Withdrawal by Subject|2|||
23834524|NCT02841995|66774089|FG001|Overall Study|Withdrawal by Subject|4|||
23576164|NCT02100722|65839004|FG000|Overall Study|Withdrawal post-procedure|0|||
23774824|NCT02032888|66556850|FG001|Follow-up Period|Death|1|||
23774825|NCT02032888|66556851|FG002|Follow-up Period|Death|0|||
23774826|NCT02032888|66556849|FG000|Follow-up Period|Other|1|||
23774827|NCT02032888|66556850|FG001|Follow-up Period|Other|0|||
23774828|NCT02032888|66556851|FG002|Follow-up Period|Other|0|||
23774829|NCT00389064|66556861|FG000|Overall Study|Adverse Event|11|||
23774830|NCT00389064|66556862|FG001|Overall Study|Adverse Event|3|||
23774831|NCT00389064|66556861|FG000|Overall Study|Lack of Efficacy|3|||
23774832|NCT00389064|66556862|FG001|Overall Study|Lack of Efficacy|14|||
23774833|NCT00389064|66556861|FG000|Overall Study|Withdrawal by Subject|17|||
23774834|NCT00389064|66556862|FG001|Overall Study|Withdrawal by Subject|27|||
23774835|NCT00389064|66556861|FG000|Overall Study|Physician Decision|2|||
23774836|NCT00389064|66556862|FG001|Overall Study|Physician Decision|2|||
23774837|NCT00389064|66556861|FG000|Overall Study|Lost to Follow-up|1|||
23774838|NCT00389064|66556862|FG001|Overall Study|Lost to Follow-up|2|||
23774839|NCT00389064|66556861|FG000|Overall Study|Protocol Violation|2|||
23774840|NCT00389064|66556862|FG001|Overall Study|Protocol Violation|0|||
23774841|NCT00389064|66556861|FG000|Overall Study|Multiple Reasons|9|||
23774842|NCT00389064|66556862|FG001|Overall Study|Multiple Reasons|11|||
23774843|NCT02626949|66556863|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
23774844|NCT02626949|66556864|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
23774845|NCT02626949|66556863|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
23774846|NCT02626949|66556864|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
23774847|NCT02626949|66556863|FG000|Enrolled|Lost to Follow-up|7|||
23774848|NCT02626949|66556864|FG001|Enrolled|Lost to Follow-up|6|||
23774849|NCT02626949|66556863|FG000|Enrolled|Withdrawal by Subject|3|||
23774850|NCT02626949|66556864|FG001|Enrolled|Withdrawal by Subject|2|||
23774851|NCT00880568|66556865|FG000|Overall Study|Disease progression|3|||
23774852|NCT00880568|66556866|FG001|Overall Study|Disease progression|3|||
23774853|NCT00880568|66556867|FG002|Overall Study|Disease progression|3|||
23774854|NCT00880568|66556868|FG003|Overall Study|Disease progression|1|||
23774855|NCT00880568|66556869|FG004|Overall Study|Disease progression|3|||
23774856|NCT00880568|66556870|FG005|Overall Study|Disease progression|3|||
23774857|NCT00880568|66556871|FG006|Overall Study|Disease progression|5|||
23774858|NCT00880568|66556872|FG007|Overall Study|Disease progression|0|||
23774859|NCT00880568|66556873|FG008|Overall Study|Disease progression|3|||
23774860|NCT00880568|66556865|FG000|Overall Study|Adverse Event|0|||
23774861|NCT00880568|66556866|FG001|Overall Study|Adverse Event|0|||
23774862|NCT00880568|66556867|FG002|Overall Study|Adverse Event|0|||
23834525|NCT02841995|66774090|FG002|Overall Study|Withdrawal by Subject|4|||
23834526|NCT02841995|66774088|FG000|Overall Study|Adverse Event|2|||
23834527|NCT02841995|66774089|FG001|Overall Study|Adverse Event|0|||
23834528|NCT02841995|66774090|FG002|Overall Study|Adverse Event|1|||
23834529|NCT02841995|66774088|FG000|Overall Study|Investigator decision|2|||
23834530|NCT02841995|66774089|FG001|Overall Study|Investigator decision|0|||
23576165|NCT02100722|65839005|FG001|Overall Study|Withdrawal post-procedure|3|||
23576166|NCT02100722|65839004|FG000|Overall Study|Lost to Follow-up|2|||
23576167|NCT02100722|65839005|FG001|Overall Study|Lost to Follow-up|2|||
23576168|NCT02100722|65839004|FG000|Overall Study|Continuing on study|751|||
23576169|NCT02100722|65839005|FG001|Overall Study|Continuing on study|729|||
23576170|NCT03699124|65839006|FG000|Overall Study|Adverse Event|6|||
23576171|NCT03699124|65839007|FG001|Overall Study|Adverse Event|5|||
23576172|NCT03699124|65839008|FG002|Overall Study|Adverse Event|2|||
23576173|NCT03699124|65839006|FG000|Overall Study|Death|0|||
23576174|NCT03699124|65839007|FG001|Overall Study|Death|2|||
23576175|NCT03699124|65839008|FG002|Overall Study|Death|0|||
23774863|NCT00880568|66556868|FG003|Overall Study|Adverse Event|0|||
23447867|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
23447868|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
23447869|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
23774864|NCT00880568|66556869|FG004|Overall Study|Adverse Event|0|||
23774865|NCT00880568|66556870|FG005|Overall Study|Adverse Event|0|||
23774866|NCT00880568|66556871|FG006|Overall Study|Adverse Event|1|||
23774867|NCT00880568|66556872|FG007|Overall Study|Adverse Event|1|||
23834531|NCT02841995|66774090|FG002|Overall Study|Investigator decision|1|||
23834532|NCT02841995|66774088|FG000|Overall Study|Death|0|||
23774868|NCT00880568|66556873|FG008|Overall Study|Adverse Event|0|||
23774869|NCT00880568|66556865|FG000|Overall Study|Withdrawal by Subject|0|||
23774870|NCT00880568|66556866|FG001|Overall Study|Withdrawal by Subject|0|||
23774871|NCT00880568|66556867|FG002|Overall Study|Withdrawal by Subject|0|||
23834533|NCT02841995|66774089|FG001|Overall Study|Death|0|||
23834534|NCT02841995|66774090|FG002|Overall Study|Death|2|||
23576176|NCT03699124|65839006|FG000|Overall Study|Lost to Follow-up|20|||
23576177|NCT03699124|65839007|FG001|Overall Study|Lost to Follow-up|16|||
23576178|NCT03699124|65839008|FG002|Overall Study|Lost to Follow-up|15|||
23774872|NCT00880568|66556868|FG003|Overall Study|Withdrawal by Subject|0|||
23576179|NCT03699124|65839006|FG000|Overall Study|Protocol Violation|1|||
23576180|NCT03699124|65839007|FG001|Overall Study|Protocol Violation|0|||
23576181|NCT03699124|65839008|FG002|Overall Study|Protocol Violation|0|||
23576182|NCT03699124|65839006|FG000|Overall Study|Withdrawal by Subject|13|||
23576183|NCT03699124|65839007|FG001|Overall Study|Withdrawal by Subject|14|||
23576184|NCT03699124|65839008|FG002|Overall Study|Withdrawal by Subject|13|||
23576185|NCT03699124|65839006|FG000|Overall Study|Other reasons|5|||
23576186|NCT03699124|65839007|FG001|Overall Study|Other reasons|3|||
23576187|NCT03699124|65839008|FG002|Overall Study|Other reasons|10|||
23576188|NCT02408549|65839011|FG000|Overall Study|Adverse Event|15|||
23576189|NCT02408549|65839011|FG000|Overall Study|Death|4|||
23576190|NCT02408549|65839011|FG000|Overall Study|Lack of Efficacy|17|||
23576191|NCT02408549|65839011|FG000|Overall Study|Protocol Violation|4|||
23576192|NCT02408549|65839011|FG000|Overall Study|Lost to Follow-up|6|||
23576193|NCT02408549|65839011|FG000|Overall Study|Consent withdrawn|30|||
23576194|NCT02408549|65839011|FG000|Overall Study|Neurology research program closing at site|1|||
23576195|NCT02408549|65839011|FG000|Overall Study|Site closure|1|||
23576196|NCT02408549|65839011|FG000|Overall Study|Pregnancy|1|||
23576197|NCT02408549|65839011|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
23576198|NCT02408549|65839011|FG000|Overall Study|Subject moved to another place, far from site|1|||
23576199|NCT02408549|65839011|FG000|Overall Study|Study terminated at site|1|||
23576200|NCT03029780|65839015|FG000|Overall Study|Disease Progression|20|||
23576201|NCT03029780|65839016|FG001|Overall Study|Disease Progression|22|||
23576202|NCT03029780|65839015|FG000|Overall Study|Study Drug Toxicity|15|||
23576203|NCT03029780|65839016|FG001|Overall Study|Study Drug Toxicity|11|||
23576204|NCT03029780|65839015|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23576205|NCT03029780|65839016|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23576206|NCT03029780|65839015|FG000|Overall Study|Participant request to discontinue study treatment|4|||
23576207|NCT03029780|65839016|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23576208|NCT03029780|65839015|FG000|Overall Study|Maximum clinical benefit|1|||
23576209|NCT03029780|65839016|FG001|Overall Study|Maximum clinical benefit|0|||
23576210|NCT03029780|65839015|FG000|Overall Study|Participant no longer meets study criteria|0|||
23576211|NCT03029780|65839016|FG001|Overall Study|Participant no longer meets study criteria|1|||
23576212|NCT03029780|65839015|FG000|Overall Study|Other reasons|6|||
23576213|NCT03029780|65839016|FG001|Overall Study|Other reasons|6|||
23576214|NCT03029780|65839015|FG000|Overall Study|Not reported|1|||
23576215|NCT03029780|65839016|FG001|Overall Study|Not reported|1|||
23576216|NCT03029780|65839015|FG000|Overall Study|Death|2|||
23576217|NCT03029780|65839016|FG001|Overall Study|Death|6|||
23576218|NCT03055832|65839018|FG000|Week 2|Withdrawal by Subject|1|||
23576219|NCT03055832|65839019|FG001|Week 2|Withdrawal by Subject|0|||
23774873|NCT00880568|66556869|FG004|Overall Study|Withdrawal by Subject|0|||
23774874|NCT00880568|66556870|FG005|Overall Study|Withdrawal by Subject|0|||
23774875|NCT00880568|66556871|FG006|Overall Study|Withdrawal by Subject|0|||
23774876|NCT00880568|66556872|FG007|Overall Study|Withdrawal by Subject|1|||
23774877|NCT00880568|66556873|FG008|Overall Study|Withdrawal by Subject|0|||
23774878|NCT02684578|66556876|FG000|Overall Study|Withdrawal by Subject|10|||
23774879|NCT02684578|66556877|FG001|Overall Study|Withdrawal by Subject|7|||
23774880|NCT02684578|66556876|FG000|Overall Study|Lost to Follow-up|0|||
23774881|NCT02684578|66556877|FG001|Overall Study|Lost to Follow-up|3|||
23774882|NCT02684578|66556876|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
23774883|NCT02684578|66556877|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
23774884|NCT02684578|66556876|FG000|Overall Study|Missing follow-up data|0|||
23774885|NCT02684578|66556877|FG001|Overall Study|Missing follow-up data|1|||
23774886|NCT02365207|66556878|FG000|Overall Study|Withdrawal by Subject|1|||
23774887|NCT02365207|66556878|FG000|Overall Study|Physician Decision|1|||
23774888|NCT00440297|66556883|FG000|Overall Study|Adverse Event|8|||
23774889|NCT00440297|66556884|FG001|Overall Study|Adverse Event|5|||
23834535|NCT02841995|66774088|FG000|Overall Study|Noncompliance to protocol|1|||
23576220|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
23576221|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
23576222|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
23774890|NCT00440297|66556883|FG000|Overall Study|Lost to Follow-up|1|||
23576223|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
23576224|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
23576225|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
23576226|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
23576227|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
23576228|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
23774891|NCT00440297|66556884|FG001|Overall Study|Lost to Follow-up|0|||
23774892|NCT00440297|66556883|FG000|Overall Study|Physician Decision|1|||
23576229|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23576230|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23576231|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23774893|NCT00440297|66556884|FG001|Overall Study|Physician Decision|0|||
23774894|NCT00440297|66556883|FG000|Overall Study|Protocol Violation|11|||
23774895|NCT00440297|66556884|FG001|Overall Study|Protocol Violation|7|||
23774896|NCT00440297|66556883|FG000|Overall Study|Withdrawal by Subject|1|||
23576232|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
23576233|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
23576234|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
23576235|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
23576236|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
23576237|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576238|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576239|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576240|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
23576241|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
23576242|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
23576243|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
23576244|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576245|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576246|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
23633843|NCT02628028|66045512|FG005|Dosing Period|Withdrawal by Subject|4|||
23633844|NCT02628028|66045513|FG006|Dosing Period|Withdrawal by Subject|1|||
23774897|NCT00440297|66556884|FG001|Overall Study|Withdrawal by Subject|6|||
23774898|NCT00440297|66556883|FG000|Overall Study|Randomized by mistake|1|||
23774899|NCT00440297|66556884|FG001|Overall Study|Randomized by mistake|0|||
23774900|NCT02395822|66556887|FG000|Overall Study|Withdrawal by Subject|1|||
23774901|NCT02395822|66556887|FG000|Overall Study|Death|1|||
23774902|NCT03586726|66556888|FG000|Overall Study|Withdrawal by Subject|1|||
23774903|NCT02473640|66556889|FG000|Treatment Period 1|Adverse Event|1|||
23774904|NCT03568461|66556890|FG000|Overall Study|Death|7|||
23774905|NCT03568461|66556890|FG000|Overall Study|Physician Decision|5|||
23774906|NCT03568461|66556890|FG000|Overall Study|Subject decision|5|||
23774907|NCT03568461|66556890|FG000|Overall Study|Lost to Follow-up|1|||
23774908|NCT03561883|66556896|FG000|Overall Study|Adverse Event|10|||
23774909|NCT03561883|66556897|FG001|Overall Study|Adverse Event|13|||
23774910|NCT03561883|66556896|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23774911|NCT03561883|66556897|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23774912|NCT03561883|66556896|FG000|Overall Study|Protocol Violation|2|||
23774913|NCT03561883|66556897|FG001|Overall Study|Protocol Violation|3|||
23774914|NCT03561883|66556896|FG000|Overall Study|Withdrawal by Subject|14|||
23774915|NCT03561883|66556897|FG001|Overall Study|Withdrawal by Subject|6|||
23774916|NCT03561883|66556896|FG000|Overall Study|Lost to Follow-up|2|||
23774917|NCT03561883|66556897|FG001|Overall Study|Lost to Follow-up|6|||
23774918|NCT03561883|66556896|FG000|Overall Study|Study Terminated by Sponsor|12|||
23774919|NCT03561883|66556897|FG001|Overall Study|Study Terminated by Sponsor|11|||
23774920|NCT03561883|66556896|FG000|Overall Study|Physician Decision|1|||
23774921|NCT03561883|66556897|FG001|Overall Study|Physician Decision|0|||
23447870|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
23774922|NCT03561883|66556896|FG000|Overall Study|Randomized by Mistake|1|||
23774923|NCT03561883|66556897|FG001|Overall Study|Randomized by Mistake|0|||
23774924|NCT03561883|66556896|FG000|Overall Study|Other, Not Specified|3|||
23774925|NCT03561883|66556897|FG001|Overall Study|Other, Not Specified|2|||
23774926|NCT02076022|66556902|FG000|Overall Study|Withdrawal by Subject|2|||
23774927|NCT02076022|66556903|FG001|Overall Study|Withdrawal by Subject|0|||
23774928|NCT00912288|66556908|FG000|Overall Study|Death|0|||
23774929|NCT00912288|66556909|FG001|Overall Study|Death|1|||
23774930|NCT00912288|66556908|FG000|Overall Study|Adverse Event|1|||
23774931|NCT00912288|66556909|FG001|Overall Study|Adverse Event|1|||
23774932|NCT00912288|66556908|FG000|Overall Study|Lost to Follow-up|1|||
23774933|NCT00912288|66556909|FG001|Overall Study|Lost to Follow-up|0|||
23576247|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576248|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23774934|NCT00912288|66556908|FG000|Overall Study|Protocol Violation|1|||
23774935|NCT00912288|66556909|FG001|Overall Study|Protocol Violation|0|||
23774936|NCT00912288|66556908|FG000|Overall Study|Withdrawal by Subject|3|||
23774937|NCT00912288|66556909|FG001|Overall Study|Withdrawal by Subject|3|||
23576249|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23576250|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
23576251|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23576252|NCT01653847|65839024|FG000|Overall Study|Withdrawal by Subject|1|||
23576253|NCT01653847|65839025|FG001|Overall Study|Withdrawal by Subject|0|||
23576254|NCT02107443|65839026|FG000|Overall Study|Death|42|||
23576255|NCT02107443|65839027|FG001|Overall Study|Death|30|||
23576256|NCT02107443|65839026|FG000|Overall Study|Study Protocol Violation|3|||
23576257|NCT02107443|65839027|FG001|Overall Study|Study Protocol Violation|1|||
23576258|NCT02107443|65839026|FG000|Overall Study|Registered but Not Eligible|0|||
23774938|NCT00912288|66556908|FG000|Overall Study|Study terminated by sponsor|34|||
23774939|NCT00912288|66556909|FG001|Overall Study|Study terminated by sponsor|35|||
23774940|NCT00912288|66556908|FG000|Overall Study|Other|1|||
23774941|NCT00912288|66556909|FG001|Overall Study|Other|0|||
23774942|NCT00282048|66556911|FG000|Overall Study|Lack of Efficacy|30|||
23774943|NCT00282048|66556911|FG000|Overall Study|Adverse Event|22|||
23774944|NCT00282048|66556911|FG000|Overall Study|Withdrawal by Subject|1|||
23774945|NCT00282048|66556911|FG000|Overall Study|Other|8|||
23774946|NCT00282048|66556911|FG000|Overall Study|Ongoing|1|||
23774947|NCT03227445|66556914|FG000|Period 1 (28 Days)|Adverse Event|1|||
23774948|NCT03227445|66556915|FG001|Period 1 (28 Days)|Adverse Event|2|||
23774949|NCT03227445|66556916|FG002|Period 1 (28 Days)|Adverse Event|0|||
23774950|NCT03227445|66556917|FG003|Period 1 (28 Days)|Adverse Event|1|||
23774951|NCT03227445|66556914|FG000|Period 1 (28 Days)|Protocol Violation|1|||
23774952|NCT03227445|66556915|FG001|Period 1 (28 Days)|Protocol Violation|0|||
23774953|NCT03227445|66556916|FG002|Period 1 (28 Days)|Protocol Violation|0|||
23774954|NCT03227445|66556917|FG003|Period 1 (28 Days)|Protocol Violation|0|||
23774955|NCT03227445|66556914|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
23774956|NCT03227445|66556915|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
23774957|NCT03227445|66556916|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
23774958|NCT03227445|66556917|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
23774959|NCT03227445|66556914|FG000|Period 2 (28 Days)|Adverse Event|1|||
23774960|NCT03227445|66556915|FG001|Period 2 (28 Days)|Adverse Event|0|||
23774961|NCT03227445|66556916|FG002|Period 2 (28 Days)|Adverse Event|2|||
23774962|NCT03227445|66556917|FG003|Period 2 (28 Days)|Adverse Event|1|||
23774963|NCT03227445|66556914|FG000|Period 2 (28 Days)|Protocol Violation|0|||
23774964|NCT03227445|66556915|FG001|Period 2 (28 Days)|Protocol Violation|0|||
23774965|NCT03227445|66556916|FG002|Period 2 (28 Days)|Protocol Violation|0|||
23774966|NCT03227445|66556917|FG003|Period 2 (28 Days)|Protocol Violation|1|||
23774967|NCT03227445|66556914|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
23774968|NCT03227445|66556915|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
23774969|NCT03227445|66556916|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
23774970|NCT03227445|66556917|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
23774971|NCT00591630|66556918|FG000|Overall Study|Death|0|||
23576259|NCT02107443|65839027|FG001|Overall Study|Registered but Not Eligible|1|||
23774972|NCT00591630|66556919|FG001|Overall Study|Death|0|||
23774973|NCT00591630|66556920|FG002|Overall Study|Death|1|||
23774974|NCT00591630|66556921|FG003|Overall Study|Death|0|||
23774975|NCT00095212|66556922|FG000|Overall Study|Withdrawal by Subject|1|||
23774976|NCT00095212|66556923|FG001|Overall Study|Withdrawal by Subject|3|||
23774977|NCT02319148|66556928|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
23774978|NCT02319148|66556929|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
23774979|NCT02319148|66556930|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
23774980|NCT02319148|66556931|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
23774981|NCT02319148|66556928|FG000|Second Intervention Period|No longer willing to participate|0|||
23774982|NCT02319148|66556929|FG001|Second Intervention Period|No longer willing to participate|1|||
23774983|NCT02319148|66556930|FG002|Second Intervention Period|No longer willing to participate|0|||
23774984|NCT02319148|66556931|FG003|Second Intervention Period|No longer willing to participate|0|||
23774985|NCT02319148|66556928|FG000|Second Intervention Period|Other|0|||
23774986|NCT02319148|66556929|FG001|Second Intervention Period|Other|0|||
23774987|NCT02319148|66556930|FG002|Second Intervention Period|Other|0|||
23774988|NCT02319148|66556931|FG003|Second Intervention Period|Other|1|||
23774989|NCT00395226|66556932|FG000|Overall Study|Adverse Event|4|||
23576260|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
23774990|NCT00395226|66556933|FG001|Overall Study|Adverse Event|3|||
23774991|NCT00395226|66556932|FG000|Overall Study|Withdrawal by Subject|0|||
23774992|NCT00395226|66556933|FG001|Overall Study|Withdrawal by Subject|1|||
23774993|NCT00395226|66556932|FG000|Overall Study|Lost to Follow-up|0|||
23834536|NCT02841995|66774089|FG001|Overall Study|Noncompliance to protocol|0|||
23774994|NCT00395226|66556933|FG001|Overall Study|Lost to Follow-up|1|||
23774995|NCT00569374|66556934|FG000|Overall Study|Withdrawal by Subject|4|||
23774996|NCT01703832|66556937|FG000|Overall Study|Withdrawal by Subject|1|||
23774997|NCT01703832|66556938|FG001|Overall Study|Withdrawal by Subject|0|||
23774998|NCT02731157|66556943|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
23774999|NCT05419908|66556944|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
23775000|NCT05419908|66556945|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
23775001|NCT05419908|66556944|FG000|Overall Study|Serious Adverse Event|0|||
23775002|NCT05419908|66556945|FG001|Overall Study|Serious Adverse Event|2|||
23775003|NCT05419908|66556944|FG000|Overall Study|Withdrawal by Subject|2|||
23775004|NCT05419908|66556945|FG001|Overall Study|Withdrawal by Subject|0|||
23775005|NCT05419908|66556944|FG000|Overall Study|Miscellaneous|1|||
23775006|NCT05419908|66556945|FG001|Overall Study|Miscellaneous|1|||
23775007|NCT05097326|66556946|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
23775008|NCT05097326|66556947|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
23834537|NCT02841995|66774090|FG002|Overall Study|Noncompliance to protocol|0|||
23834538|NCT02841995|66774088|FG000|Overall Study|Sponsor decision|1|||
23834539|NCT02841995|66774089|FG001|Overall Study|Sponsor decision|0|||
23834540|NCT02841995|66774090|FG002|Overall Study|Sponsor decision|0|||
23834541|NCT02841995|66774088|FG000|Overall Study|Other|4|||
23834542|NCT02841995|66774089|FG001|Overall Study|Other|1|||
23834543|NCT02841995|66774090|FG002|Overall Study|Other|5|||
23834544|NCT00739661|66774091|FG000|Overall Study|Adverse Event|2|||
23834545|NCT00739661|66774092|FG001|Overall Study|Adverse Event|0|||
23834546|NCT00739661|66774091|FG000|Overall Study|Physician decision to withdraw patient|1|||
23834547|NCT00739661|66774092|FG001|Overall Study|Physician decision to withdraw patient|0|||
23834548|NCT00739661|66774091|FG000|Overall Study|Patient decision to withdraw|9|||
23775009|NCT03661528|66556948|FG000|Overall Study|Death|1|||
23834549|NCT00739661|66774092|FG001|Overall Study|Patient decision to withdraw|4|||
23834550|NCT00739661|66774091|FG000|Overall Study|Disease progression, radiographic|33|||
23834551|NCT00739661|66774092|FG001|Overall Study|Disease progression, radiographic|37|||
23775010|NCT03661528|66556949|FG001|Overall Study|Death|0|||
23775011|NCT03661528|66556948|FG000|Overall Study|Physician Decision|3|||
23775012|NCT03661528|66556949|FG001|Overall Study|Physician Decision|1|||
23775013|NCT03661528|66556948|FG000|Overall Study|Other than Specified|5|||
23775014|NCT03661528|66556949|FG001|Overall Study|Other than Specified|2|||
23775015|NCT03661528|66556948|FG000|Overall Study|Withdrawal by Subject|5|||
23775016|NCT03661528|66556949|FG001|Overall Study|Withdrawal by Subject|3|||
23775017|NCT03661528|66556948|FG000|Overall Study|Disease Progression|8|||
23775018|NCT03661528|66556949|FG001|Overall Study|Disease Progression|13|||
23775019|NCT03661528|66556948|FG000|Overall Study|Adverse Event|61|||
23576261|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
23576262|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
23576263|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
23576264|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Changed Mind|2|||
23576265|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Changed Mind|0|||
23576266|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
23775020|NCT03661528|66556949|FG001|Overall Study|Adverse Event|55|||
23775021|NCT03123471|66556950|FG000|Placebo-controlled Phase|Adverse Event|3|||
23834552|NCT00739661|66774091|FG000|Overall Study|Reason for discontinuation not available|1|||
23834553|NCT00739661|66774092|FG001|Overall Study|Reason for discontinuation not available|1|||
23834554|NCT01930162|66774093|FG000|Overall Study|Abnormal test procedure result(s)|4|||
23834555|NCT01930162|66774093|FG000|Overall Study|Death|1|||
23834556|NCT01966120|66774094|FG000|Overall Study|Withdrawal by Subject|0|||
23834557|NCT01966120|66774095|FG001|Overall Study|Withdrawal by Subject|5|||
23834558|NCT01966120|66774094|FG000|Overall Study|Lost to Follow-up|1|||
23834559|NCT01966120|66774095|FG001|Overall Study|Lost to Follow-up|1|||
23834560|NCT00554515|66774096|FG000|Overall Study|Withdrawal by Subject|3|||
23834561|NCT00554515|66774096|FG000|Overall Study|Disease progression|52|||
23834562|NCT00554515|66774096|FG000|Overall Study|Physician Decision|18|||
23834563|NCT00554515|66774096|FG000|Overall Study|Withdrawal by Subject|11|||
23834564|NCT00554515|66774096|FG000|Overall Study|Adverse Event|9|||
23834565|NCT00554515|66774096|FG000|Overall Study|Death|2|||
23834566|NCT00554515|66774096|FG000|Overall Study|Achieved Stable Disease|7|||
23834567|NCT00554515|66774096|FG000|Overall Study|Other|1|||
23834568|NCT00554515|66774096|FG000|Overall Study|Misc|15|||
23834569|NCT02965573|66774097|FG000|Overall Study|Lack of Efficacy|1|||
23834570|NCT02965573|66774098|FG001|Overall Study|Lack of Efficacy|0|||
23834571|NCT03743415|66774099|FG000|Overall Study|Death|5|||
23834572|NCT03743415|66774100|FG001|Overall Study|Death|3|||
23834573|NCT03743415|66774101|FG002|Overall Study|Death|1|||
23834574|NCT03743415|66774102|FG003|Overall Study|Death|4|||
23834575|NCT03743415|66774103|FG004|Overall Study|Death|0|||
23834576|NCT03743415|66774104|FG005|Overall Study|Death|0|||
23834577|NCT03743415|66774105|FG006|Overall Study|Death|0|||
23834578|NCT03743415|66774106|FG007|Overall Study|Death|0|||
23834579|NCT03743415|66774107|FG008|Overall Study|Death|1|||
23834580|NCT03743415|66774108|FG009|Overall Study|Death|0|||
23834581|NCT03743415|66774099|FG000|Overall Study|Withdrawal by Subject|1|||
23834582|NCT03743415|66774100|FG001|Overall Study|Withdrawal by Subject|0|||
23576267|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
23834583|NCT03743415|66774101|FG002|Overall Study|Withdrawal by Subject|4|||
23576268|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
23775022|NCT03123471|66556951|FG001|Placebo-controlled Phase|Adverse Event|8|||
23834584|NCT03743415|66774102|FG003|Overall Study|Withdrawal by Subject|5|||
23834585|NCT03743415|66774103|FG004|Overall Study|Withdrawal by Subject|5|||
23576269|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
23775023|NCT03123471|66556950|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
23775024|NCT03123471|66556951|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
23834586|NCT03743415|66774104|FG005|Overall Study|Withdrawal by Subject|2|||
23834587|NCT03743415|66774105|FG006|Overall Study|Withdrawal by Subject|2|||
23834588|NCT03743415|66774106|FG007|Overall Study|Withdrawal by Subject|5|||
23775025|NCT03123471|66556950|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
23775026|NCT03123471|66556951|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
23775027|NCT03123471|66556950|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
23775028|NCT03123471|66556951|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
23775029|NCT03123471|66556950|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
23775030|NCT03123471|66556951|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
23775031|NCT03123471|66556950|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
23447871|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
23447872|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
23447873|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
23447874|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
23447875|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
23447876|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
23447877|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
23447878|NCT04854551|65380630|FG000|Overall Study|Withdrawal by Subject|1|||
23447879|NCT04854551|65380631|FG001|Overall Study|Withdrawal by Subject|1|||
23447880|NCT01594931|65380636|FG000|Overall Study|Adverse Event|3|||
23447881|NCT01594931|65380637|FG001|Overall Study|Adverse Event|1|||
23447882|NCT01594931|65380638|FG002|Overall Study|Adverse Event|1|||
23447883|NCT01594931|65380636|FG000|Overall Study|Withdrawal by Subject|2|||
23447884|NCT01594931|65380637|FG001|Overall Study|Withdrawal by Subject|1|||
23447885|NCT01594931|65380638|FG002|Overall Study|Withdrawal by Subject|1|||
23447886|NCT01594931|65380636|FG000|Overall Study|Lack of Efficacy|7|||
23447887|NCT01594931|65380637|FG001|Overall Study|Lack of Efficacy|2|||
23447888|NCT01594931|65380638|FG002|Overall Study|Lack of Efficacy|2|||
23447889|NCT01594931|65380636|FG000|Overall Study|Lost to Follow-up|4|||
23447890|NCT01594931|65380637|FG001|Overall Study|Lost to Follow-up|3|||
23447891|NCT01594931|65380638|FG002|Overall Study|Lost to Follow-up|3|||
23775032|NCT03123471|66556951|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
23775033|NCT03123471|66556950|FG000|Placebo-controlled Phase|Miscellaneous|0|||
23775034|NCT03123471|66556951|FG001|Placebo-controlled Phase|Miscellaneous|1|||
23775035|NCT03123471|66556950|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
23775036|NCT03123471|66556951|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
23775037|NCT03123471|66556950|FG000|Apremilast Extension Phase|Adverse Event|1|||
23775038|NCT03123471|66556951|FG001|Apremilast Extension Phase|Adverse Event|5|||
23775039|NCT03123471|66556950|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
23775040|NCT03123471|66556951|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
23775041|NCT03123471|66556950|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
23775042|NCT03123471|66556951|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
23775043|NCT00860405|66556955|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
23775044|NCT00860405|66556956|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
23775045|NCT01941030|66556957|FG000|Overall Study|Death|3|||
23775046|NCT01941030|66556958|FG001|Overall Study|Death|2|||
23775047|NCT01941030|66556957|FG000|Overall Study|Lost to Follow-up|6|||
23775048|NCT01941030|66556958|FG001|Overall Study|Lost to Follow-up|5|||
23775049|NCT01941030|66556957|FG000|Overall Study|Withdrawal by Subject|4|||
23447892|NCT01594931|65380636|FG000|Overall Study|Protocol Violation|2|||
23447893|NCT01594931|65380637|FG001|Overall Study|Protocol Violation|1|||
23447894|NCT01594931|65380638|FG002|Overall Study|Protocol Violation|0|||
23447895|NCT01594931|65380636|FG000|Overall Study|No defiined|11|||
23447896|NCT01594931|65380637|FG001|Overall Study|No defiined|4|||
23447897|NCT01594931|65380638|FG002|Overall Study|No defiined|7|||
23447898|NCT04950465|65380641|FG000|Overall Study|Lost to Follow-up|1|||
23447899|NCT04950465|65380642|FG001|Overall Study|Lost to Follow-up|0|||
23447900|NCT04950465|65380643|FG002|Overall Study|Lost to Follow-up|0|||
23447901|NCT02763644|65380644|FG000|Overall Study|Patient/guardian decision|1|||
23447902|NCT02763644|65380645|FG001|Overall Study|Patient/guardian decision|0|||
23447903|NCT02763644|65380644|FG000|Overall Study|Death|1|||
23447904|NCT02763644|65380645|FG001|Overall Study|Death|1|||
23447905|NCT02763644|65380644|FG000|Overall Study|Adverse Event|1|||
23447906|NCT02763644|65380645|FG001|Overall Study|Adverse Event|1|||
23447907|NCT02222558|65380646|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
23447908|NCT02222558|65380647|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
23447909|NCT02222558|65380648|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
23447910|NCT02222558|65380649|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
23447911|NCT02222558|65380650|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
23447912|NCT02222558|65380651|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
23447913|NCT02222558|65380646|FG000|Period 3|Withdrawal by Subject|0|||
23447914|NCT02222558|65380647|FG001|Period 3|Withdrawal by Subject|0|||
23447915|NCT02222558|65380648|FG002|Period 3|Withdrawal by Subject|0|||
23447916|NCT02222558|65380649|FG003|Period 3|Withdrawal by Subject|0|||
23447917|NCT02222558|65380650|FG004|Period 3|Withdrawal by Subject|0|||
23447918|NCT02222558|65380651|FG005|Period 3|Withdrawal by Subject|1|||
23775050|NCT01941030|66556958|FG001|Overall Study|Withdrawal by Subject|6|||
23775051|NCT01451762|66556961|FG000|Overall Study|Lost to Follow-up|3|||
23447919|NCT03191630|65380652|FG000|Overall Study|Lost to Follow-up|7|||
23447920|NCT03191630|65380653|FG001|Overall Study|Lost to Follow-up|7|||
23447921|NCT04628780|65380659|FG000|Overall Study|Death|0|||
23447922|NCT04628780|65380660|FG001|Overall Study|Death|1|||
23447923|NCT04628780|65380661|FG002|Overall Study|Death|0|||
23447924|NCT04628780|65380662|FG003|Overall Study|Death|0|||
23447925|NCT04628780|65380663|FG004|Overall Study|Death|1|||
23447926|NCT04628780|65380664|FG005|Overall Study|Death|0|||
23447927|NCT04628780|65380659|FG000|Overall Study|Physician Decision|2|||
23447928|NCT04628780|65380660|FG001|Overall Study|Physician Decision|0|||
23447929|NCT04628780|65380661|FG002|Overall Study|Physician Decision|0|||
23447930|NCT04628780|65380662|FG003|Overall Study|Physician Decision|0|||
23447931|NCT04628780|65380663|FG004|Overall Study|Physician Decision|2|||
23447932|NCT04628780|65380664|FG005|Overall Study|Physician Decision|0|||
23447933|NCT04628780|65380659|FG000|Overall Study|Progressive disease|2|||
23447934|NCT04628780|65380660|FG001|Overall Study|Progressive disease|2|||
23447935|NCT04628780|65380661|FG002|Overall Study|Progressive disease|2|||
23447936|NCT04628780|65380662|FG003|Overall Study|Progressive disease|3|||
23447937|NCT04628780|65380663|FG004|Overall Study|Progressive disease|9|||
23447938|NCT04628780|65380664|FG005|Overall Study|Progressive disease|4|||
23447939|NCT04628780|65380659|FG000|Overall Study|Withdrawal by Subject|0|||
23447940|NCT04628780|65380660|FG001|Overall Study|Withdrawal by Subject|1|||
23447941|NCT04628780|65380661|FG002|Overall Study|Withdrawal by Subject|2|||
23447942|NCT04628780|65380662|FG003|Overall Study|Withdrawal by Subject|0|||
23447943|NCT04628780|65380663|FG004|Overall Study|Withdrawal by Subject|3|||
23447944|NCT04628780|65380664|FG005|Overall Study|Withdrawal by Subject|1|||
23447945|NCT04628780|65380659|FG000|Overall Study|Global deterioration of health status|0|||
23447946|NCT04628780|65380660|FG001|Overall Study|Global deterioration of health status|0|||
23447947|NCT04628780|65380661|FG002|Overall Study|Global deterioration of health status|0|||
23447948|NCT04628780|65380662|FG003|Overall Study|Global deterioration of health status|0|||
23447949|NCT04628780|65380663|FG004|Overall Study|Global deterioration of health status|1|||
23447950|NCT04628780|65380664|FG005|Overall Study|Global deterioration of health status|1|||
23447951|NCT01367834|65380665|FG000|Overall Study|Withdrawal by Subject|2|||
23447952|NCT01367834|65380666|FG001|Overall Study|Withdrawal by Subject|2|||
23447953|NCT01367834|65380665|FG000|Overall Study|Study was ended.|0|||
23447954|NCT01367834|65380666|FG001|Overall Study|Study was ended.|1|||
23447955|NCT04023526|65384466|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
23447956|NCT04023526|65384467|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
23447957|NCT04023526|65384466|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
23447958|NCT04023526|65384467|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
23447959|NCT01855412|65384471|FG000|Overall Study|Death|77|||
23447960|NCT01855412|65384472|FG001|Overall Study|Death|123|||
23447961|NCT01855412|65384473|FG002|Overall Study|Death|30|||
23447962|NCT01855412|65384471|FG000|Overall Study|Lost to Follow-up|28|||
23447963|NCT01855412|65384472|FG001|Overall Study|Lost to Follow-up|46|||
23447964|NCT01855412|65384473|FG002|Overall Study|Lost to Follow-up|15|||
23447965|NCT01855412|65384471|FG000|Overall Study|Withdrawal by Subject|77|||
23447966|NCT01855412|65384472|FG001|Overall Study|Withdrawal by Subject|123|||
23447967|NCT01855412|65384473|FG002|Overall Study|Withdrawal by Subject|24|||
23447968|NCT01855412|65384471|FG000|Overall Study|Physician Decision|25|||
23447969|NCT01855412|65384472|FG001|Overall Study|Physician Decision|31|||
23447970|NCT01855412|65384473|FG002|Overall Study|Physician Decision|3|||
23447971|NCT01855412|65384471|FG000|Overall Study|Site Closure|4|||
23447972|NCT01855412|65384472|FG001|Overall Study|Site Closure|18|||
23447973|NCT01855412|65384473|FG002|Overall Study|Site Closure|1|||
23447974|NCT01855412|65384471|FG000|Overall Study|Reason not Specified|1|||
23447975|NCT01855412|65384472|FG001|Overall Study|Reason not Specified|2|||
23447976|NCT01855412|65384473|FG002|Overall Study|Reason not Specified|3|||
23447977|NCT01693029|65384476|FG000|Overall Study|Withdrawal by Subject|15|||
23447978|NCT01693029|65384477|FG001|Overall Study|Withdrawal by Subject|22|||
23447979|NCT01693029|65384476|FG000|Overall Study|Kidney transplantation|7|||
23447980|NCT01693029|65384477|FG001|Overall Study|Kidney transplantation|7|||
23447981|NCT01693029|65384476|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
23447982|NCT01693029|65384477|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
23447983|NCT01693029|65384476|FG000|Overall Study|Protocol Violation|6|||
23447984|NCT01693029|65384477|FG001|Overall Study|Protocol Violation|7|||
23447985|NCT01693029|65384476|FG000|Overall Study|Change in dialysis modality|2|||
23447986|NCT01693029|65384477|FG001|Overall Study|Change in dialysis modality|1|||
23447987|NCT01693029|65384476|FG000|Overall Study|Physician Decision|0|||
23447988|NCT01693029|65384477|FG001|Overall Study|Physician Decision|2|||
23447989|NCT01693029|65384476|FG000|Overall Study|Lost to Follow-up|0|||
23576270|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
23447990|NCT01693029|65384477|FG001|Overall Study|Lost to Follow-up|1|||
23447991|NCT01693029|65384476|FG000|Overall Study|Adverse Event|1|||
23447992|NCT01693029|65384477|FG001|Overall Study|Adverse Event|6|||
23576271|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
23576272|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
23447993|NCT01693029|65384476|FG000|Overall Study|Death|5|||
23447994|NCT01693029|65384477|FG001|Overall Study|Death|8|||
23447995|NCT01693029|65384476|FG000|Overall Study|Non-compliance|2|||
23447996|NCT01693029|65384477|FG001|Overall Study|Non-compliance|1|||
23447997|NCT00286442|65384478|FG000|Overall Study|Hyperglycemic Rescue|19|||
23447998|NCT00286442|65384479|FG001|Overall Study|Hyperglycemic Rescue|17|||
23447999|NCT00286442|65384480|FG002|Overall Study|Hyperglycemic Rescue|25|||
23448000|NCT00286442|65384478|FG000|Overall Study|Adverse Event|7|||
23448001|NCT00286442|65384479|FG001|Overall Study|Adverse Event|6|||
23448002|NCT00286442|65384480|FG002|Overall Study|Adverse Event|1|||
23448003|NCT00286442|65384478|FG000|Overall Study|Protocol Violation|2|||
23448004|NCT00286442|65384479|FG001|Overall Study|Protocol Violation|4|||
23448005|NCT00286442|65384480|FG002|Overall Study|Protocol Violation|2|||
23448006|NCT00286442|65384478|FG000|Overall Study|Lost to Follow-up|5|||
23448007|NCT00286442|65384479|FG001|Overall Study|Lost to Follow-up|2|||
23448008|NCT00286442|65384480|FG002|Overall Study|Lost to Follow-up|1|||
23448009|NCT00286442|65384478|FG000|Overall Study|Physician Decision|1|||
23448010|NCT00286442|65384479|FG001|Overall Study|Physician Decision|1|||
23448011|NCT00286442|65384480|FG002|Overall Study|Physician Decision|1|||
23448012|NCT00286442|65384478|FG000|Overall Study|Administrative Error|1|||
23448013|NCT00286442|65384479|FG001|Overall Study|Administrative Error|1|||
23448014|NCT00286442|65384480|FG002|Overall Study|Administrative Error|0|||
23448015|NCT00286442|65384478|FG000|Overall Study|Withdrawal by Subject|2|||
23448016|NCT00286442|65384479|FG001|Overall Study|Withdrawal by Subject|14|||
23448017|NCT00286442|65384480|FG002|Overall Study|Withdrawal by Subject|2|||
23448018|NCT00880620|65384481|FG000|Overall Study|Adverse Event|4|||
23448019|NCT00880620|65384482|FG001|Overall Study|Adverse Event|5|||
23448020|NCT00880620|65384483|FG002|Overall Study|Adverse Event|15|||
23448021|NCT00880620|65384484|FG003|Overall Study|Adverse Event|15|||
23448022|NCT00880620|65384481|FG000|Overall Study|Death|0|||
23448023|NCT00880620|65384482|FG001|Overall Study|Death|0|||
23448024|NCT00880620|65384483|FG002|Overall Study|Death|1|||
23448025|NCT00880620|65384484|FG003|Overall Study|Death|0|||
23448026|NCT00880620|65384481|FG000|Overall Study|Lack of Efficacy|12|||
23448027|NCT00880620|65384482|FG001|Overall Study|Lack of Efficacy|4|||
23448028|NCT00880620|65384483|FG002|Overall Study|Lack of Efficacy|0|||
23448029|NCT00880620|65384484|FG003|Overall Study|Lack of Efficacy|1|||
23448030|NCT00880620|65384481|FG000|Overall Study|Lost to Follow-up|0|||
23448031|NCT00880620|65384482|FG001|Overall Study|Lost to Follow-up|1|||
23448032|NCT00880620|65384483|FG002|Overall Study|Lost to Follow-up|1|||
23448033|NCT00880620|65384484|FG003|Overall Study|Lost to Follow-up|0|||
23448034|NCT00880620|65384481|FG000|Overall Study|Protocol Violation|0|||
23448035|NCT00880620|65384482|FG001|Overall Study|Protocol Violation|1|||
23448036|NCT00880620|65384483|FG002|Overall Study|Protocol Violation|0|||
23448037|NCT00880620|65384484|FG003|Overall Study|Protocol Violation|2|||
23448038|NCT00880620|65384481|FG000|Overall Study|Withdrawal by Subject|4|||
23448039|NCT00880620|65384482|FG001|Overall Study|Withdrawal by Subject|3|||
23448040|NCT00880620|65384483|FG002|Overall Study|Withdrawal by Subject|1|||
23448041|NCT00880620|65384484|FG003|Overall Study|Withdrawal by Subject|3|||
23448042|NCT00880620|65384481|FG000|Overall Study|Noncompliance|0|||
23448043|NCT00880620|65384482|FG001|Overall Study|Noncompliance|0|||
23448044|NCT00880620|65384483|FG002|Overall Study|Noncompliance|1|||
23448045|NCT00880620|65384484|FG003|Overall Study|Noncompliance|1|||
23448046|NCT00880620|65384481|FG000|Overall Study|Other|1|||
23448047|NCT00880620|65384482|FG001|Overall Study|Other|1|||
23448048|NCT00880620|65384483|FG002|Overall Study|Other|2|||
23448049|NCT00880620|65384484|FG003|Overall Study|Other|2|||
23448050|NCT01176058|65384485|FG000|Overall Study|Adverse Event|1|||
23448051|NCT01176058|65384486|FG001|Overall Study|Adverse Event|0|||
23448052|NCT01176058|65384485|FG000|Overall Study|Insufficient clinical response|2|||
23448053|NCT01176058|65384486|FG001|Overall Study|Insufficient clinical response|2|||
23448054|NCT01176058|65384485|FG000|Overall Study|Insufficient mycological response|0|||
23448055|NCT01176058|65384486|FG001|Overall Study|Insufficient mycological response|1|||
23448056|NCT01176058|65384485|FG000|Overall Study|Withdrawal by Subject|1|||
23448057|NCT01176058|65384486|FG001|Overall Study|Withdrawal by Subject|0|||
23448058|NCT03275740|65384487|FG000|Overall Study|Adverse Event|0|||
23448059|NCT03275740|65384488|FG001|Overall Study|Adverse Event|0|||
23448060|NCT03275740|65384489|FG002|Overall Study|Adverse Event|0|||
23448061|NCT03275740|65384490|FG003|Overall Study|Adverse Event|0|||
23448062|NCT03275740|65384491|FG004|Overall Study|Adverse Event|1|||
23448063|NCT03275740|65384492|FG005|Overall Study|Adverse Event|0|||
23448064|NCT03275740|65384493|FG006|Overall Study|Adverse Event|0|||
23448065|NCT03275740|65384494|FG007|Overall Study|Adverse Event|0|||
23448066|NCT03275740|65384495|FG008|Overall Study|Adverse Event|0|||
23448067|NCT03275740|65384496|FG009|Overall Study|Adverse Event|0|||
23448068|NCT03275740|65384497|FG010|Overall Study|Adverse Event|0|||
23448069|NCT03275740|65384498|FG011|Overall Study|Adverse Event|0|||
23448070|NCT03275740|65384487|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448071|NCT03275740|65384488|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448072|NCT03275740|65384489|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448073|NCT03275740|65384490|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448074|NCT03275740|65384491|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448075|NCT03275740|65384492|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
23448076|NCT03275740|65384493|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448077|NCT03275740|65384494|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448078|NCT03275740|65384495|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448079|NCT03275740|65384496|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448080|NCT03275740|65384497|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448081|NCT03275740|65384498|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448082|NCT03275740|65384487|FG000|Overall Study|Withdrawal by Subject|0|||
23448083|NCT03275740|65384488|FG001|Overall Study|Withdrawal by Subject|0|||
23448084|NCT03275740|65384489|FG002|Overall Study|Withdrawal by Subject|0|||
23448085|NCT03275740|65384490|FG003|Overall Study|Withdrawal by Subject|0|||
23448086|NCT03275740|65384491|FG004|Overall Study|Withdrawal by Subject|0|||
23448087|NCT03275740|65384492|FG005|Overall Study|Withdrawal by Subject|0|||
23448088|NCT03275740|65384493|FG006|Overall Study|Withdrawal by Subject|0|||
23448089|NCT03275740|65384494|FG007|Overall Study|Withdrawal by Subject|0|||
23448090|NCT03275740|65384495|FG008|Overall Study|Withdrawal by Subject|1|||
23448091|NCT03275740|65384496|FG009|Overall Study|Withdrawal by Subject|1|||
23448092|NCT03275740|65384497|FG010|Overall Study|Withdrawal by Subject|0|||
23448093|NCT03275740|65384498|FG011|Overall Study|Withdrawal by Subject|0|||
23448094|NCT01384734|65384499|FG000|Overall Study|Adverse Event|0|||
23448095|NCT01384734|65384500|FG001|Overall Study|Adverse Event|3|||
23448096|NCT01384734|65384501|FG002|Overall Study|Adverse Event|0|||
23448097|NCT01384734|65384502|FG003|Overall Study|Adverse Event|2|||
23448098|NCT01384734|65384503|FG004|Overall Study|Adverse Event|7|||
23448099|NCT01384734|65384499|FG000|Overall Study|Death|1|||
23448100|NCT01384734|65384500|FG001|Overall Study|Death|0|||
23448101|NCT01384734|65384501|FG002|Overall Study|Death|1|||
23448102|NCT01384734|65384502|FG003|Overall Study|Death|0|||
23448103|NCT01384734|65384503|FG004|Overall Study|Death|0|||
23448104|NCT01384734|65384499|FG000|Overall Study|Continuation criteria not met|0|||
23448105|NCT01384734|65384500|FG001|Overall Study|Continuation criteria not met|0|||
23448106|NCT01384734|65384501|FG002|Overall Study|Continuation criteria not met|1|||
23448107|NCT01384734|65384502|FG003|Overall Study|Continuation criteria not met|1|||
23448108|NCT01384734|65384503|FG004|Overall Study|Continuation criteria not met|0|||
23448109|NCT01384734|65384499|FG000|Overall Study|Lack of Efficacy|3|||
23448110|NCT01384734|65384500|FG001|Overall Study|Lack of Efficacy|7|||
23448111|NCT01384734|65384501|FG002|Overall Study|Lack of Efficacy|4|||
23448112|NCT01384734|65384502|FG003|Overall Study|Lack of Efficacy|4|||
23448113|NCT01384734|65384503|FG004|Overall Study|Lack of Efficacy|2|||
23448114|NCT01384734|65384499|FG000|Overall Study|Lost to Follow-up|5|||
23448115|NCT01384734|65384500|FG001|Overall Study|Lost to Follow-up|3|||
23448116|NCT01384734|65384501|FG002|Overall Study|Lost to Follow-up|3|||
23448117|NCT01384734|65384502|FG003|Overall Study|Lost to Follow-up|8|||
23448118|NCT01384734|65384503|FG004|Overall Study|Lost to Follow-up|5|||
23448119|NCT01384734|65384499|FG000|Overall Study|Non-compliance with study drug|1|||
23448120|NCT01384734|65384500|FG001|Overall Study|Non-compliance with study drug|2|||
23448121|NCT01384734|65384501|FG002|Overall Study|Non-compliance with study drug|6|||
23448122|NCT01384734|65384502|FG003|Overall Study|Non-compliance with study drug|0|||
23448123|NCT01384734|65384503|FG004|Overall Study|Non-compliance with study drug|2|||
23448124|NCT01384734|65384499|FG000|Overall Study|Pregnancy|0|||
23448125|NCT01384734|65384500|FG001|Overall Study|Pregnancy|1|||
23448126|NCT01384734|65384501|FG002|Overall Study|Pregnancy|0|||
23448127|NCT01384734|65384502|FG003|Overall Study|Pregnancy|0|||
23448128|NCT01384734|65384503|FG004|Overall Study|Pregnancy|1|||
23448129|NCT01384734|65384499|FG000|Overall Study|Sponsor terminated|0|||
23448130|NCT01384734|65384500|FG001|Overall Study|Sponsor terminated|0|||
23448131|NCT01384734|65384501|FG002|Overall Study|Sponsor terminated|0|||
23448132|NCT01384734|65384502|FG003|Overall Study|Sponsor terminated|0|||
23448133|NCT01384734|65384503|FG004|Overall Study|Sponsor terminated|1|||
23448134|NCT01384734|65384499|FG000|Overall Study|Withdrawal by Subject|5|||
23448135|NCT01384734|65384500|FG001|Overall Study|Withdrawal by Subject|5|||
23448136|NCT01384734|65384501|FG002|Overall Study|Withdrawal by Subject|6|||
23448137|NCT01384734|65384502|FG003|Overall Study|Withdrawal by Subject|7|||
23448138|NCT01384734|65384503|FG004|Overall Study|Withdrawal by Subject|9|||
23448139|NCT01384734|65384499|FG000|Overall Study|Investigator relocating|0|||
23448140|NCT01384734|65384500|FG001|Overall Study|Investigator relocating|2|||
23448141|NCT01384734|65384501|FG002|Overall Study|Investigator relocating|0|||
23448142|NCT01384734|65384502|FG003|Overall Study|Investigator relocating|3|||
23448143|NCT01384734|65384503|FG004|Overall Study|Investigator relocating|1|||
23448144|NCT01384734|65384499|FG000|Overall Study|Unable to come back for visit|1|||
23448145|NCT01384734|65384500|FG001|Overall Study|Unable to come back for visit|0|||
23448146|NCT01384734|65384501|FG002|Overall Study|Unable to come back for visit|1|||
23448147|NCT01384734|65384502|FG003|Overall Study|Unable to come back for visit|1|||
23448148|NCT01384734|65384503|FG004|Overall Study|Unable to come back for visit|0|||
23448149|NCT01384734|65384499|FG000|Overall Study|Prison|0|||
23448150|NCT01384734|65384500|FG001|Overall Study|Prison|0|||
23448151|NCT01384734|65384501|FG002|Overall Study|Prison|1|||
23448152|NCT01384734|65384502|FG003|Overall Study|Prison|0|||
23448153|NCT01384734|65384503|FG004|Overall Study|Prison|0|||
23448154|NCT01384734|65384499|FG000|Overall Study|As per Exclusion criteria|0|||
23448155|NCT01384734|65384500|FG001|Overall Study|As per Exclusion criteria|1|||
23448156|NCT01384734|65384501|FG002|Overall Study|As per Exclusion criteria|0|||
23448157|NCT01384734|65384502|FG003|Overall Study|As per Exclusion criteria|0|||
23448158|NCT01384734|65384503|FG004|Overall Study|As per Exclusion criteria|0|||
23448159|NCT01384734|65384499|FG000|Overall Study|Missed End of treatment visit|0|||
23448160|NCT01384734|65384500|FG001|Overall Study|Missed End of treatment visit|0|||
23448161|NCT01384734|65384501|FG002|Overall Study|Missed End of treatment visit|0|||
23448162|NCT01384734|65384502|FG003|Overall Study|Missed End of treatment visit|1|||
23448163|NCT01384734|65384503|FG004|Overall Study|Missed End of treatment visit|0|||
23448164|NCT01384734|65384499|FG000|Overall Study|Adhesion problem|0|||
23448165|NCT01384734|65384500|FG001|Overall Study|Adhesion problem|0|||
23448166|NCT01384734|65384501|FG002|Overall Study|Adhesion problem|0|||
23448167|NCT01384734|65384502|FG003|Overall Study|Adhesion problem|1|||
23448168|NCT01384734|65384503|FG004|Overall Study|Adhesion problem|0|||
23448169|NCT01384734|65384499|FG000|Overall Study|Early termination|0|||
23448170|NCT01384734|65384500|FG001|Overall Study|Early termination|0|||
23448171|NCT01384734|65384501|FG002|Overall Study|Early termination|0|||
23775052|NCT01451762|66556962|FG001|Overall Study|Lost to Follow-up|6|||
23775053|NCT01451762|66556963|FG002|Overall Study|Lost to Follow-up|6|||
23775054|NCT01179048|66556964|FG000|Overall Study|Withdrawn - does not allow contact|4|||
23775055|NCT01179048|66556965|FG001|Overall Study|Withdrawn - does not allow contact|8|||
23775056|NCT01179048|66556964|FG000|Overall Study|Lost to Follow-up|8|||
23775057|NCT01179048|66556965|FG001|Overall Study|Lost to Follow-up|9|||
23775058|NCT01179048|66556964|FG000|Overall Study|Alive|127|||
23775059|NCT01179048|66556965|FG001|Overall Study|Alive|142|||
23775060|NCT00366899|66556968|FG000|Infant Series|Withdrawal by Subject|4|||
23775061|NCT00366899|66556969|FG001|Infant Series|Withdrawal by Subject|7|||
23775062|NCT00366899|66556968|FG000|Infant Series|Protocol Violation|2|||
23775063|NCT00366899|66556969|FG001|Infant Series|Protocol Violation|1|||
23775064|NCT00366899|66556968|FG000|Infant Series|Failed to return|1|||
23775065|NCT00366899|66556969|FG001|Infant Series|Failed to return|1|||
23775066|NCT00366899|66556968|FG000|Infant Series|Lost to Follow-up|0|||
23775067|NCT00366899|66556969|FG001|Infant Series|Lost to Follow-up|2|||
23775068|NCT00366899|66556968|FG000|Infant Series|Adverse Event|0|||
23775069|NCT00366899|66556969|FG001|Infant Series|Adverse Event|1|||
23775070|NCT00366899|66556968|FG000|Infant Series|Physician Decision|1|||
23775071|NCT00366899|66556969|FG001|Infant Series|Physician Decision|0|||
23775072|NCT00366899|66556968|FG000|Infant Series|Randomized but not consented|1|||
23775073|NCT00366899|66556969|FG001|Infant Series|Randomized but not consented|0|||
23775074|NCT00366899|66556968|FG000|After Infant Series|Lost to Follow-up|4|||
23775075|NCT00366899|66556969|FG001|After Infant Series|Lost to Follow-up|3|||
23775076|NCT00366899|66556968|FG000|After Infant Series|Withdrawal by Subject|1|||
23775077|NCT00366899|66556969|FG001|After Infant Series|Withdrawal by Subject|4|||
23775078|NCT00366899|66556968|FG000|After Infant Series|Adverse Event|1|||
23448172|NCT01384734|65384502|FG003|Overall Study|Early termination|0|||
23448173|NCT01384734|65384503|FG004|Overall Study|Early termination|1|||
23448174|NCT01384734|65384499|FG000|Overall Study|Physician Decision|1|||
23448175|NCT01384734|65384500|FG001|Overall Study|Physician Decision|0|||
23448176|NCT01384734|65384501|FG002|Overall Study|Physician Decision|0|||
23448177|NCT01384734|65384502|FG003|Overall Study|Physician Decision|0|||
23775079|NCT00366899|66556969|FG001|After Infant Series|Adverse Event|2|||
23775080|NCT00366899|66556968|FG000|After Infant Series|Protocol Violation|1|||
23775081|NCT00366899|66556969|FG001|After Infant Series|Protocol Violation|0|||
23448178|NCT01384734|65384503|FG004|Overall Study|Physician Decision|0|||
23448179|NCT01271725|65384516|FG000|Part A|Progressive disease according to RECIST|8|||
23448180|NCT01271725|65384517|FG001|Part A|Progressive disease according to RECIST|0|||
23448181|NCT01271725|65384516|FG000|Part A|Clinical signs/symptoms of progression|2|||
23448182|NCT01271725|65384517|FG001|Part A|Clinical signs/symptoms of progression|0|||
23448183|NCT01271725|65384516|FG000|Part A|Other Adverse Event|8|||
23448184|NCT01271725|65384517|FG001|Part A|Other Adverse Event|0|||
23448185|NCT01271725|65384516|FG000|Part A|Lost to Follow-up|1|||
23775082|NCT00366899|66556968|FG000|Toddler Dose|Withdrawal by Subject|1|||
23448186|NCT01271725|65384517|FG001|Part A|Lost to Follow-up|0|||
23775083|NCT00366899|66556969|FG001|Toddler Dose|Withdrawal by Subject|1|||
23775084|NCT00366899|66556968|FG000|Toddler Dose|Protocol Violation|1|||
23448187|NCT01271725|65384516|FG000|Part A|Withdrawal by Subject|12|||
23448188|NCT01271725|65384517|FG001|Part A|Withdrawal by Subject|0|||
23448189|NCT01271725|65384516|FG000|Part A|Other than specified|3|||
23448190|NCT01271725|65384517|FG001|Part A|Other than specified|0|||
23448191|NCT01271725|65384516|FG000|Part A|Protocol Violation|1|||
23448192|NCT01271725|65384517|FG001|Part A|Protocol Violation|0|||
23448193|NCT01271725|65384516|FG000|Part B|Other than specified|0|||
23448194|NCT01271725|65384517|FG001|Part B|Other than specified|2|||
23448195|NCT01271725|65384516|FG000|Part B|Clinical signs/symptoms of progression|0|||
23448196|NCT01271725|65384517|FG001|Part B|Clinical signs/symptoms of progression|2|||
23448197|NCT01271725|65384516|FG000|Part B|Other Adverse Event|0|||
23448198|NCT01271725|65384517|FG001|Part B|Other Adverse Event|1|||
23448199|NCT01271725|65384516|FG000|Part B|Protocol Violation|0|||
23448200|NCT01271725|65384517|FG001|Part B|Protocol Violation|1|||
23448201|NCT01271725|65384516|FG000|Part B|Withdrawal by Subject|0|||
23448202|NCT01271725|65384517|FG001|Part B|Withdrawal by Subject|6|||
23448203|NCT02442349|65384518|FG000|Overall Study|Death|14|||
23448204|NCT02442349|65384518|FG000|Overall Study|Withdrawal by Subject|8|||
23448205|NCT02442349|65384518|FG000|Overall Study|On-going Study at Data Cut-off|149|||
23448206|NCT03571204|65384519|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
23448207|NCT03571204|65384520|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
23448208|NCT03571204|65384521|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
23448209|NCT03571204|65384519|FG000|Overall Study|Physician Decision|0|||
23448210|NCT03571204|65384520|FG001|Overall Study|Physician Decision|1|||
23448211|NCT03571204|65384521|FG002|Overall Study|Physician Decision|0|||
23448212|NCT03535974|65384526|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
23448213|NCT03535974|65384527|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
23448214|NCT03535974|65384528|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
23448215|NCT03535974|65384526|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
23448216|NCT03535974|65384527|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
23448217|NCT03535974|65384528|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
23448218|NCT01358825|65384532|FG000|Overall Study|Blood sample not drawn|0|||
23448219|NCT01358825|65384533|FG001|Overall Study|Blood sample not drawn|1|||
23775085|NCT00366899|66556969|FG001|Toddler Dose|Protocol Violation|0|||
23775086|NCT03787680|66556970|FG000|Overall Study|Physician Decision|2|||
23775087|NCT03787680|66556971|FG001|Overall Study|Physician Decision|3|||
23448220|NCT03649217|65384534|FG000|Overall Study|subject had severe ataxia not initially found|1|||
23448221|NCT03649217|65384534|FG000|Overall Study|subject had cognitive issues not initially found|1|||
23448222|NCT02544503|65384541|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
23448223|NCT02544503|65384542|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
23448224|NCT02544503|65384541|FG000|Overall Study|Lost to Follow-up|9|||
23448225|NCT02544503|65384542|FG001|Overall Study|Lost to Follow-up|0|||
23448226|NCT02544503|65384541|FG000|Overall Study|Withdrawal by Subject|1|||
23448227|NCT02544503|65384542|FG001|Overall Study|Withdrawal by Subject|0|||
23448228|NCT00584012|65384547|FG000|Overall Study|Withdrawal by Subject|1|||
23448229|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
23448230|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
23448231|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
23448232|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
23448233|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
23448234|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
23448235|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
23448236|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
23775088|NCT03787680|66556970|FG000|Overall Study|Adverse Event|7|||
23448237|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
23448238|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
23448239|NCT01987102|65384548|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
23448240|NCT01987102|65384549|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
23448241|NCT01400698|65384551|FG000|Overall Study|Lost to Follow-up|2|||
23448242|NCT01400698|65384552|FG001|Overall Study|Lost to Follow-up|5|||
23448243|NCT01400698|65384553|FG002|Overall Study|Lost to Follow-up|2|||
23448244|NCT01400698|65384554|FG003|Overall Study|Lost to Follow-up|1|||
23448245|NCT01400698|65384555|FG004|Overall Study|Lost to Follow-up|4|||
23448246|NCT01400698|65384556|FG005|Overall Study|Lost to Follow-up|3|||
23448247|NCT01400698|65384551|FG000|Overall Study|Withdrawal by Subject|8|||
23448248|NCT01400698|65384552|FG001|Overall Study|Withdrawal by Subject|2|||
23448249|NCT01400698|65384553|FG002|Overall Study|Withdrawal by Subject|0|||
23448250|NCT01400698|65384554|FG003|Overall Study|Withdrawal by Subject|4|||
23448251|NCT01400698|65384555|FG004|Overall Study|Withdrawal by Subject|1|||
23448252|NCT01400698|65384556|FG005|Overall Study|Withdrawal by Subject|3|||
23448253|NCT01400698|65384551|FG000|Overall Study|Protocol Violation|0|||
23448254|NCT01400698|65384552|FG001|Overall Study|Protocol Violation|1|||
23448255|NCT01400698|65384553|FG002|Overall Study|Protocol Violation|0|||
23448256|NCT01400698|65384554|FG003|Overall Study|Protocol Violation|0|||
23448257|NCT01400698|65384555|FG004|Overall Study|Protocol Violation|1|||
23448258|NCT01400698|65384556|FG005|Overall Study|Protocol Violation|0|||
23448259|NCT01400698|65384551|FG000|Overall Study|Non-compliance|0|||
23448260|NCT01400698|65384552|FG001|Overall Study|Non-compliance|1|||
23448261|NCT01400698|65384553|FG002|Overall Study|Non-compliance|0|||
23448262|NCT01400698|65384554|FG003|Overall Study|Non-compliance|1|||
23448263|NCT01400698|65384555|FG004|Overall Study|Non-compliance|0|||
23448264|NCT01400698|65384556|FG005|Overall Study|Non-compliance|0|||
23448265|NCT01400698|65384551|FG000|Overall Study|Adverse Event|1|||
23448266|NCT01400698|65384552|FG001|Overall Study|Adverse Event|0|||
23448267|NCT01400698|65384553|FG002|Overall Study|Adverse Event|0|||
23448268|NCT01400698|65384554|FG003|Overall Study|Adverse Event|0|||
23448269|NCT01400698|65384555|FG004|Overall Study|Adverse Event|0|||
23448270|NCT01400698|65384556|FG005|Overall Study|Adverse Event|0|||
23448271|NCT01400698|65384551|FG000|Overall Study|Other|4|||
23448272|NCT01400698|65384552|FG001|Overall Study|Other|2|||
23448273|NCT01400698|65384553|FG002|Overall Study|Other|0|||
23448274|NCT01400698|65384554|FG003|Overall Study|Other|2|||
23448275|NCT01400698|65384555|FG004|Overall Study|Other|1|||
23448276|NCT01400698|65384556|FG005|Overall Study|Other|0|||
23448277|NCT01879683|65384557|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
23448278|NCT00255190|65384563|FG000|Overall Study|Adverse Event|17|||
23448279|NCT00255190|65384564|FG001|Overall Study|Adverse Event|36|||
23448280|NCT00255190|65384563|FG000|Overall Study|Protocol Violation|2|||
23448281|NCT00255190|65384564|FG001|Overall Study|Protocol Violation|2|||
23448282|NCT00255190|65384563|FG000|Overall Study|Lost to Follow-up|10|||
23576273|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
23576274|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Other Medical|9|||
23576275|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Other Medical|5|||
23576276|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Disease Progression|4|||
23448283|NCT00255190|65384564|FG001|Overall Study|Lost to Follow-up|27|||
23448284|NCT00255190|65384563|FG000|Overall Study|Withdrew Consent|17|||
23448285|NCT00255190|65384564|FG001|Overall Study|Withdrew Consent|48|||
23448286|NCT00255190|65384563|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23448287|NCT00255190|65384564|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23448288|NCT00255190|65384563|FG000|Overall Study|Erosive esophagitis not healed|0|||
23448289|NCT00255190|65384564|FG001|Overall Study|Erosive esophagitis not healed|20|||
23448290|NCT00255190|65384563|FG000|Overall Study|Various|4|||
23448291|NCT00255190|65384564|FG001|Overall Study|Various|23|||
23448292|NCT00619515|65384565|FG000|Overall Study|Study Termination by IRB|73|||
23576277|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Disease Progression|2|||
23448293|NCT00871871|65384567|FG000|Part I|Adverse Event|0|||
23448294|NCT00871871|65384568|FG001|Part I|Adverse Event|2|||
23448295|NCT00871871|65384569|FG002|Part I|Adverse Event|0|||
23448296|NCT00871871|65384570|FG003|Part I|Adverse Event|0|||
23448297|NCT00871871|65384567|FG000|Part I|Withdrawal by Subject|3|||
23448298|NCT00871871|65384568|FG001|Part I|Withdrawal by Subject|0|||
23448299|NCT00871871|65384569|FG002|Part I|Withdrawal by Subject|0|||
23448300|NCT00871871|65384570|FG003|Part I|Withdrawal by Subject|0|||
23448301|NCT00871871|65384567|FG000|Part I|Laboratory abnormality|0|||
23448302|NCT00871871|65384568|FG001|Part I|Laboratory abnormality|1|||
23448303|NCT00871871|65384569|FG002|Part I|Laboratory abnormality|0|||
23448304|NCT00871871|65384570|FG003|Part I|Laboratory abnormality|0|||
23448305|NCT00871871|65384567|FG000|Part II|Lack of Efficacy|0|||
23448306|NCT00871871|65384568|FG001|Part II|Lack of Efficacy|0|||
23448307|NCT00871871|65384569|FG002|Part II|Lack of Efficacy|1|||
23448308|NCT00871871|65384570|FG003|Part II|Lack of Efficacy|0|||
23448309|NCT00871871|65384567|FG000|Part II|Withdrawal by Subject|0|||
23448310|NCT00871871|65384568|FG001|Part II|Withdrawal by Subject|0|||
23448311|NCT00871871|65384569|FG002|Part II|Withdrawal by Subject|2|||
23448312|NCT00871871|65384570|FG003|Part II|Withdrawal by Subject|1|||
23448313|NCT00871871|65384567|FG000|Part II|Adverse Event|0|||
23448314|NCT00871871|65384568|FG001|Part II|Adverse Event|0|||
23448315|NCT00871871|65384569|FG002|Part II|Adverse Event|1|||
23448316|NCT00871871|65384570|FG003|Part II|Adverse Event|2|||
23448317|NCT00871871|65384567|FG000|Part II|Protocol Violation|0|||
23448318|NCT00871871|65384568|FG001|Part II|Protocol Violation|0|||
23448319|NCT00871871|65384569|FG002|Part II|Protocol Violation|0|||
23448320|NCT00871871|65384570|FG003|Part II|Protocol Violation|1|||
23448321|NCT02734693|65384571|FG000|Overall Study|Adverse Event|1|||
23448322|NCT02734693|65384572|FG001|Overall Study|Adverse Event|3|||
23448323|NCT02734693|65384573|FG002|Overall Study|Adverse Event|3|||
23448324|NCT02734693|65384571|FG000|Overall Study|Lack of Efficacy|1|||
23448325|NCT02734693|65384572|FG001|Overall Study|Lack of Efficacy|0|||
23448326|NCT02734693|65384573|FG002|Overall Study|Lack of Efficacy|0|||
23448327|NCT02734693|65384571|FG000|Overall Study|Lost to Follow-up|2|||
23448328|NCT02734693|65384572|FG001|Overall Study|Lost to Follow-up|0|||
23448329|NCT02734693|65384573|FG002|Overall Study|Lost to Follow-up|0|||
23448330|NCT02734693|65384571|FG000|Overall Study|Protocol Violation|1|||
23448331|NCT02734693|65384572|FG001|Overall Study|Protocol Violation|0|||
23448332|NCT02734693|65384573|FG002|Overall Study|Protocol Violation|0|||
23576278|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Personal Issues|0|||
23576279|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Personal Issues|3|||
23576280|NCT00765362|65839028|FG000|Overall Study|Death|9|||
23576281|NCT00765362|65839028|FG000|Overall Study|Adverse Event|2|||
23576282|NCT00765362|65839028|FG000|Overall Study|Protocol Violation|18|||
23576283|NCT00765362|65839028|FG000|Overall Study|Withdrawal by Subject|13|||
23576284|NCT00765362|65839028|FG000|Overall Study|Lost to Follow-up|95|||
23576285|NCT02025205|65839029|FG000|Overall Study|Withdrawal by Subject|1|||
23576286|NCT02025205|65839030|FG001|Overall Study|Withdrawal by Subject|1|||
23576287|NCT02025205|65839029|FG000|Overall Study|Protocol Violation|2|||
23576288|NCT02025205|65839030|FG001|Overall Study|Protocol Violation|1|||
23576289|NCT02025205|65839029|FG000|Overall Study|Death|0|||
23576290|NCT02025205|65839030|FG001|Overall Study|Death|1|||
23576291|NCT03000673|65839031|FG000|Overall Study|Withdrawal by Subject|1|||
23576292|NCT03000673|65839032|FG001|Overall Study|Withdrawal by Subject|0|||
23576293|NCT03000673|65839033|FG002|Overall Study|Withdrawal by Subject|0|||
23576294|NCT03000673|65839034|FG003|Overall Study|Withdrawal by Subject|0|||
23576295|NCT01290094|65843326|FG000|Overall Study|Withdrawal by Subject|1|||
23576296|NCT01290094|65843326|FG000|Overall Study|Lost to Follow-up|5|||
23576297|NCT03212365|65843342|FG000|Overall Study|Discharged prior to Xa level|12|||
23576298|NCT03212365|65843343|FG001|Overall Study|Discharged prior to Xa level|8|||
23576299|NCT03212365|65843342|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
23576300|NCT03212365|65843343|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
23775089|NCT03787680|66556971|FG001|Overall Study|Adverse Event|3|||
23448333|NCT02734693|65384571|FG000|Overall Study|Withdrawal by Subject|1|||
23448334|NCT02734693|65384572|FG001|Overall Study|Withdrawal by Subject|0|||
23448335|NCT02734693|65384573|FG002|Overall Study|Withdrawal by Subject|0|||
23448336|NCT02354235|65384577|FG000|Overall Study|Adverse Event|2|||
23448337|NCT02354235|65384578|FG001|Overall Study|Adverse Event|2|||
23448338|NCT02354235|65384577|FG000|Overall Study|Physician Decision|0|||
23448339|NCT02354235|65384578|FG001|Overall Study|Physician Decision|1|||
23448340|NCT02354235|65384577|FG000|Overall Study|Withdrawal by Subject|1|||
23448341|NCT02354235|65384578|FG001|Overall Study|Withdrawal by Subject|3|||
23448342|NCT02354235|65384577|FG000|Overall Study|Conflict with the stopping criteria|0|||
23448343|NCT02354235|65384578|FG001|Overall Study|Conflict with the stopping criteria|1|||
23834589|NCT03743415|66774107|FG008|Overall Study|Withdrawal by Subject|9|||
23834590|NCT03743415|66774108|FG009|Overall Study|Withdrawal by Subject|10|||
23834591|NCT03743415|66774099|FG000|Overall Study|Lost to Follow-up|2|||
23834592|NCT03743415|66774100|FG001|Overall Study|Lost to Follow-up|0|||
23834593|NCT03743415|66774101|FG002|Overall Study|Lost to Follow-up|2|||
23834594|NCT03743415|66774102|FG003|Overall Study|Lost to Follow-up|1|||
23834595|NCT03743415|66774103|FG004|Overall Study|Lost to Follow-up|1|||
23834596|NCT03743415|66774104|FG005|Overall Study|Lost to Follow-up|0|||
23834597|NCT03743415|66774105|FG006|Overall Study|Lost to Follow-up|1|||
23576301|NCT03212365|65843342|FG000|Overall Study|Refused study medication|3|||
23576302|NCT03212365|65843343|FG001|Overall Study|Refused study medication|0|||
23576303|NCT03212365|65843342|FG000|Overall Study|Initiated heparin infusion on floor|1|||
23576304|NCT03212365|65843343|FG001|Overall Study|Initiated heparin infusion on floor|1|||
23576305|NCT03212365|65843342|FG000|Overall Study|Unexpected return to OR|1|||
23775090|NCT03787680|66556970|FG000|Overall Study|Withdrawal by Subject|2|||
23775091|NCT03787680|66556971|FG001|Overall Study|Withdrawal by Subject|1|||
23775092|NCT00454909|66556972|FG000|Overall Study|Withdrawal by Subject|1|||
23775093|NCT00454909|66556973|FG001|Overall Study|Withdrawal by Subject|0|||
23775094|NCT00454909|66556974|FG002|Overall Study|Withdrawal by Subject|0|||
23775095|NCT00454909|66556972|FG000|Overall Study|Migrated/moved from study area|0|||
23775096|NCT00454909|66556973|FG001|Overall Study|Migrated/moved from study area|0|||
23775097|NCT00454909|66556974|FG002|Overall Study|Migrated/moved from study area|1|||
23775098|NCT00454909|66556972|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
23775099|NCT00454909|66556973|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
23775100|NCT00454909|66556974|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
23775101|NCT00454909|66556972|FG000|Overall Study|Others|1|||
23834598|NCT03743415|66774106|FG007|Overall Study|Lost to Follow-up|4|||
23834599|NCT03743415|66774107|FG008|Overall Study|Lost to Follow-up|13|||
23576306|NCT03212365|65843343|FG001|Overall Study|Unexpected return to OR|1|||
23576307|NCT03212365|65843342|FG000|Overall Study|Medication distribution error|1|||
23576308|NCT03212365|65843343|FG001|Overall Study|Medication distribution error|0|||
23576309|NCT03212365|65843342|FG000|Overall Study|Required epidural placement|1|||
23576310|NCT03212365|65843343|FG001|Overall Study|Required epidural placement|0|||
23576311|NCT03212365|65843342|FG000|Overall Study|Withdrawal by Subject|0|||
23775102|NCT00454909|66556973|FG001|Overall Study|Others|0|||
23775103|NCT00454909|66556974|FG002|Overall Study|Others|0|||
23834600|NCT03743415|66774108|FG009|Overall Study|Lost to Follow-up|13|||
23448344|NCT02366312|65384579|FG000|Overall Study|Lost to Follow-up|0|||
23834601|NCT02510664|66774111|FG000|Overall Study|Transferred Care|9|||
23576312|NCT03212365|65843343|FG001|Overall Study|Withdrawal by Subject|1|||
23576313|NCT03212365|65843342|FG000|Overall Study|developed acute renal failure|0|||
23576314|NCT03212365|65843343|FG001|Overall Study|developed acute renal failure|1|||
23576315|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576316|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
23576317|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
23576318|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
23576319|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
23576320|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
23576321|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576322|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576323|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576324|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576325|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576326|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23448345|NCT02366312|65384580|FG001|Overall Study|Lost to Follow-up|1|||
23775104|NCT02008565|66556975|FG000|Overall Study|Protocol Violation|1|||
23775105|NCT02008565|66556976|FG001|Overall Study|Protocol Violation|1|||
23775106|NCT02008565|66556977|FG002|Overall Study|Protocol Violation|2|||
23775107|NCT02008565|66556978|FG003|Overall Study|Protocol Violation|0|||
23775108|NCT00533273|66556979|FG000|Double-blind|Withdrew consent|0|||
23775109|NCT00533273|66556980|FG001|Double-blind|Withdrew consent|2|||
23775110|NCT00533273|66556979|FG000|Open-label|Withdrawal by Subject|6|||
23775111|NCT00533273|66556980|FG001|Open-label|Withdrawal by Subject|0|||
23775112|NCT02684344|66556986|FG000|Overall Study|Withdrawal by Subject|0|||
23775113|NCT02684344|66556987|FG001|Overall Study|Withdrawal by Subject|1|||
23775114|NCT00105196|66556988|FG000|Overall Study|Lack of Efficacy|2|||
23775115|NCT00105196|66556989|FG001|Overall Study|Lack of Efficacy|3|||
23775116|NCT00105196|66556988|FG000|Overall Study|Adverse Event|11|||
23775117|NCT00105196|66556989|FG001|Overall Study|Adverse Event|3|||
23775118|NCT00105196|66556988|FG000|Overall Study|Withdrawal by Subject|6|||
23775119|NCT00105196|66556989|FG001|Overall Study|Withdrawal by Subject|6|||
23576327|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576328|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
23576329|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
23576330|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576331|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576332|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576333|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576334|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576335|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576336|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576337|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576338|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
23576339|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
23576340|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576341|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23775120|NCT00105196|66556988|FG000|Overall Study|Lost to Follow-up|3|||
23775121|NCT00105196|66556989|FG001|Overall Study|Lost to Follow-up|2|||
23775122|NCT00105196|66556988|FG000|Overall Study|Poor/noncompliance|3|||
23775123|NCT00105196|66556989|FG001|Overall Study|Poor/noncompliance|4|||
23775124|NCT00105196|66556988|FG000|Overall Study|Protocol Violation|5|||
23775125|NCT00105196|66556989|FG001|Overall Study|Protocol Violation|2|||
23775126|NCT00105196|66556988|FG000|Overall Study|pending surgery|0|||
23775127|NCT00105196|66556989|FG001|Overall Study|pending surgery|1|||
23775128|NCT00105196|66556988|FG000|Overall Study|marijuana use|0|||
23775129|NCT00105196|66556989|FG001|Overall Study|marijuana use|1|||
23775130|NCT00105196|66556988|FG000|Overall Study|Subject became unblinded|0|||
23775131|NCT00105196|66556989|FG001|Overall Study|Subject became unblinded|1|||
23775132|NCT01626079|66556991|FG000|Overall Study|Death|167|||
23834602|NCT02510664|66774112|FG001|Overall Study|Transferred Care|9|||
23834603|NCT02510664|66774113|FG002|Overall Study|Transferred Care|0|||
23834604|NCT02510664|66774111|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
23834605|NCT02510664|66774112|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
23834606|NCT02510664|66774113|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
23834607|NCT02510664|66774111|FG000|Overall Study|Time Constraints|1|||
23834608|NCT02510664|66774112|FG001|Overall Study|Time Constraints|1|||
23576342|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23775133|NCT01626079|66556992|FG001|Overall Study|Death|192|||
23775134|NCT01626079|66556993|FG002|Overall Study|Death|39|||
23775135|NCT01626079|66556991|FG000|Overall Study|Withdrawal by Subject|23|||
23834609|NCT02510664|66774113|FG002|Overall Study|Time Constraints|0|||
23834610|NCT01383707|66774116|FG000|Overall Study|Consent withdrawal|6|||
23775136|NCT01626079|66556992|FG001|Overall Study|Withdrawal by Subject|37|||
23834611|NCT01383707|66774116|FG000|Overall Study|Death|19|||
23775137|NCT01626079|66556993|FG002|Overall Study|Withdrawal by Subject|5|||
23775138|NCT01626079|66556991|FG000|Overall Study|Lost to Follow-up|7|||
23834612|NCT01383707|66774116|FG000|Overall Study|Other|8|||
23775139|NCT01626079|66556992|FG001|Overall Study|Lost to Follow-up|4|||
23775140|NCT01626079|66556993|FG002|Overall Study|Lost to Follow-up|2|||
23775141|NCT01626079|66556991|FG000|Overall Study|Missed Visits|1|||
23775142|NCT01626079|66556992|FG001|Overall Study|Missed Visits|4|||
23775143|NCT01626079|66556993|FG002|Overall Study|Missed Visits|6|||
23775144|NCT01648166|66556994|FG000|Overall Study|inadequate toenail samples|53|||
23775145|NCT01648166|66556995|FG001|Overall Study|inadequate toenail samples|100|||
23775146|NCT02079532|66556999|FG000|Overall Study|Adverse Event|7|||
23775147|NCT02079532|66556999|FG000|Overall Study|Additional or changed therapy|2|||
23775148|NCT02079532|66556999|FG000|Overall Study|Lack of Efficacy|9|||
23775149|NCT02079532|66556999|FG000|Overall Study|Protocol Violation|3|||
23775150|NCT02079532|66556999|FG000|Overall Study|Withdrawal by Subject|1|||
23775151|NCT02079532|66556999|FG000|Overall Study|Administrative problems|1|||
23775152|NCT02079532|66556999|FG000|Overall Study|Inclusion into ReFIRST|3|||
23775153|NCT02079532|66556999|FG000|Overall Study|Other|3|||
23775154|NCT00527423|66557007|FG000|Overall Study|Protocol Violation|1|||
23775155|NCT00527423|66557007|FG000|Overall Study|Adverse Event|5|||
23775156|NCT00527423|66557007|FG000|Overall Study|Physician Decision|4|||
23775157|NCT00527423|66557007|FG000|Overall Study|Withdrawal by Subject|10|||
23775158|NCT00527423|66557007|FG000|Overall Study|Lost to Follow-up|4|||
23775159|NCT00527423|66557007|FG000|Overall Study|OTHER|4|||
23775160|NCT00527423|66557007|FG000|Overall Study|Death|9|||
23775161|NCT03262012|66557008|FG000|Overall Study|Withdrawal by Subject|15|||
23775162|NCT03262012|66557009|FG001|Overall Study|Withdrawal by Subject|13|||
23775163|NCT03262012|66557010|FG002|Overall Study|Withdrawal by Subject|8|||
23775164|NCT03262012|66557011|FG003|Overall Study|Withdrawal by Subject|7|||
23775165|NCT03262012|66557008|FG000|Overall Study|Adverse Event|10|||
23775166|NCT03262012|66557009|FG001|Overall Study|Adverse Event|12|||
23775167|NCT03262012|66557010|FG002|Overall Study|Adverse Event|4|||
23775168|NCT03262012|66557011|FG003|Overall Study|Adverse Event|6|||
23775169|NCT03262012|66557008|FG000|Overall Study|Physician Decision|2|||
23775170|NCT03262012|66557009|FG001|Overall Study|Physician Decision|5|||
23775171|NCT03262012|66557010|FG002|Overall Study|Physician Decision|1|||
23775172|NCT03262012|66557011|FG003|Overall Study|Physician Decision|0|||
23775173|NCT03262012|66557008|FG000|Overall Study|Lack of Efficacy|0|||
23775174|NCT03262012|66557009|FG001|Overall Study|Lack of Efficacy|5|||
23775175|NCT03262012|66557010|FG002|Overall Study|Lack of Efficacy|1|||
23775176|NCT03262012|66557011|FG003|Overall Study|Lack of Efficacy|2|||
23775177|NCT03262012|66557008|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
23775178|NCT03262012|66557009|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
23775179|NCT03262012|66557010|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
23775180|NCT03262012|66557011|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
23775181|NCT02272777|66557012|FG000|Overall Study|Adverse Event|0|||
23775182|NCT02272777|66557013|FG001|Overall Study|Adverse Event|1|||
23775183|NCT02272777|66557012|FG000|Overall Study|Withdrawal by Subject|0|||
23775184|NCT02272777|66557013|FG001|Overall Study|Withdrawal by Subject|3|||
23775185|NCT02272777|66557012|FG000|Overall Study|Lost to Follow-up|2|||
23775186|NCT02272777|66557013|FG001|Overall Study|Lost to Follow-up|0|||
23775187|NCT02272777|66557012|FG000|Overall Study|Other|2|||
23775188|NCT02272777|66557013|FG001|Overall Study|Other|0|||
23775189|NCT01223365|66557016|FG000|Open-label Titration Period|Enrolled but not treated|1|||
23775190|NCT01223365|66557016|FG000|Open-label Titration Period|Adverse Event|23|||
23775191|NCT01223365|66557016|FG000|Open-label Titration Period|Lack of Efficacy|3|||
23775192|NCT01223365|66557016|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
23775193|NCT01223365|66557016|FG000|Open-label Titration Period|Protocol Violation|1|||
23775194|NCT01223365|66557016|FG000|Open-label Titration Period|Lost to Follow-up|2|||
23775195|NCT01223365|66557016|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
23775196|NCT01223365|66557016|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
23775197|NCT01223365|66557016|FG000|Open-label Titration Period|Starting physical therapy|1|||
23775198|NCT01223365|66557016|FG000|Open-label Treatment Period|Adverse Event|39|||
23775199|NCT01223365|66557016|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
23775200|NCT01223365|66557016|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
23775201|NCT01223365|66557016|FG000|Open-label Treatment Period|Protocol Violation|15|||
23775202|NCT01223365|66557016|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
23775203|NCT01223365|66557016|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
23775204|NCT01223365|66557016|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
23775205|NCT01223365|66557016|FG000|Open-label Treatment Period|Moved out of area|2|||
23775206|NCT01223365|66557016|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
23775207|NCT01223365|66557016|FG000|Open-label Treatment Period|"Out of window"|1|||
23775208|NCT01223365|66557016|FG000|Open-label Treatment Period|Starting physical therapy|1|||
23775209|NCT01223365|66557016|FG000|Open-label Treatment Period|Physician Decision|2|||
23775210|NCT00414765|66557017|FG000|Overall Study|Adverse Event|5|||
23775211|NCT00414765|66557018|FG001|Overall Study|Adverse Event|9|||
23775212|NCT00414765|66557017|FG000|Overall Study|Withdrawal by Subject|1|||
23834613|NCT01383707|66774116|FG000|Overall Study|Sponsor's decision|2|||
23775213|NCT00414765|66557018|FG001|Overall Study|Withdrawal by Subject|1|||
23775214|NCT00414765|66557017|FG000|Overall Study|Disease Progression|0|||
23576343|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576344|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576345|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
23576346|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576347|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576348|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
23576349|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
23576350|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576351|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23775215|NCT00414765|66557018|FG001|Overall Study|Disease Progression|1|||
23775216|NCT02678286|66557023|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
23775217|NCT02678286|66557024|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
23775218|NCT02678286|66557023|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
23775219|NCT02678286|66557024|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
23775220|NCT02678286|66557023|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
23775221|NCT02678286|66557024|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
23775222|NCT02678286|66557023|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
23775223|NCT02678286|66557024|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
23576352|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23775224|NCT02678286|66557023|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
23775225|NCT02678286|66557024|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
23775226|NCT01259869|66557025|FG000|Overall Study|Duplicated registration|1|||
23775227|NCT01389102|66557027|FG000|Overall Study|Adverse Event|1|||
23775228|NCT01389102|66557028|FG001|Overall Study|Adverse Event|3|||
23775229|NCT01389102|66557029|FG002|Overall Study|Adverse Event|2|||
23775230|NCT01389102|66557030|FG003|Overall Study|Adverse Event|2|||
23834614|NCT01383707|66774116|FG000|Overall Study|Adverse Event|14|||
23834615|NCT01383707|66774116|FG000|Overall Study|Progressive disease|23|||
23633845|NCT02628028|66045514|FG007|Dosing Period|Withdrawal by Subject|1|||
23633846|NCT02628028|66045507|FG000|Dosing Period|Adverse Event|0|||
23775231|NCT01389102|66557031|FG004|Overall Study|Adverse Event|2|||
23834616|NCT02172664|66774119|FG000|Overall Study|Lost to Follow-up|4|||
23775232|NCT01389102|66557032|FG005|Overall Study|Adverse Event|2|||
23775233|NCT01389102|66557027|FG000|Overall Study|Hurricane Katrina|4|||
23775234|NCT01389102|66557028|FG001|Overall Study|Hurricane Katrina|2|||
23775235|NCT01389102|66557029|FG002|Overall Study|Hurricane Katrina|3|||
23576353|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576354|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576355|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576356|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576357|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
23576358|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
23576359|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576360|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576361|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576362|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576363|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576364|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576365|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576366|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576367|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576368|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576369|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
23576370|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576371|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576372|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23775236|NCT01389102|66557030|FG003|Overall Study|Hurricane Katrina|0|||
23775237|NCT01389102|66557031|FG004|Overall Study|Hurricane Katrina|3|||
23775238|NCT01389102|66557032|FG005|Overall Study|Hurricane Katrina|1|||
23775239|NCT01389102|66557027|FG000|Overall Study|Lost to Follow-up|4|||
23775240|NCT01389102|66557028|FG001|Overall Study|Lost to Follow-up|1|||
23775241|NCT01389102|66557029|FG002|Overall Study|Lost to Follow-up|1|||
23775242|NCT01389102|66557030|FG003|Overall Study|Lost to Follow-up|2|||
23775243|NCT01389102|66557031|FG004|Overall Study|Lost to Follow-up|4|||
23775244|NCT01389102|66557032|FG005|Overall Study|Lost to Follow-up|1|||
23775245|NCT01389102|66557027|FG000|Overall Study|Protocol Violation|0|||
23775246|NCT01389102|66557028|FG001|Overall Study|Protocol Violation|0|||
23775247|NCT01389102|66557029|FG002|Overall Study|Protocol Violation|3|||
23775248|NCT01389102|66557030|FG003|Overall Study|Protocol Violation|0|||
23775249|NCT01389102|66557031|FG004|Overall Study|Protocol Violation|1|||
23775250|NCT01389102|66557032|FG005|Overall Study|Protocol Violation|1|||
23775251|NCT01389102|66557027|FG000|Overall Study|Withdrawal by Subject|7|||
23775252|NCT01389102|66557028|FG001|Overall Study|Withdrawal by Subject|4|||
23775253|NCT01389102|66557029|FG002|Overall Study|Withdrawal by Subject|9|||
23775254|NCT01389102|66557030|FG003|Overall Study|Withdrawal by Subject|2|||
23775255|NCT01389102|66557031|FG004|Overall Study|Withdrawal by Subject|3|||
23775256|NCT01389102|66557032|FG005|Overall Study|Withdrawal by Subject|3|||
23775257|NCT01389102|66557027|FG000|Overall Study|Subject Traveling Out of Country|0|||
23775258|NCT01389102|66557028|FG001|Overall Study|Subject Traveling Out of Country|0|||
23775259|NCT01389102|66557029|FG002|Overall Study|Subject Traveling Out of Country|0|||
23775260|NCT01389102|66557030|FG003|Overall Study|Subject Traveling Out of Country|1|||
23775261|NCT01389102|66557031|FG004|Overall Study|Subject Traveling Out of Country|0|||
23775262|NCT01389102|66557032|FG005|Overall Study|Subject Traveling Out of Country|0|||
23775263|NCT01389102|66557027|FG000|Overall Study|Subject Moved|2|||
23775264|NCT01389102|66557028|FG001|Overall Study|Subject Moved|0|||
23775265|NCT01389102|66557029|FG002|Overall Study|Subject Moved|1|||
23775266|NCT01389102|66557030|FG003|Overall Study|Subject Moved|0|||
23775267|NCT01389102|66557031|FG004|Overall Study|Subject Moved|0|||
23775268|NCT01389102|66557032|FG005|Overall Study|Subject Moved|0|||
23576373|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576374|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576375|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576376|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576377|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576378|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
23576379|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
23576380|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
23576381|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576382|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576383|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576384|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576385|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576386|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576387|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576388|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
23576389|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
23576390|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576391|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576392|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576393|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576394|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576395|NCT02018861|65843344|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576396|NCT02018861|65843345|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576397|NCT02018861|65843346|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576398|NCT02018861|65843347|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576399|NCT02018861|65843348|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576400|NCT02018861|65843349|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576401|NCT02018861|65843350|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
23576402|NCT02018861|65843351|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
23576403|NCT02018861|65843352|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576404|NCT02018861|65843353|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576405|NCT02018861|65843344|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576406|NCT02018861|65843345|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576407|NCT02018861|65843346|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576408|NCT02018861|65843347|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576409|NCT02018861|65843348|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576410|NCT02018861|65843349|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576411|NCT02018861|65843350|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
23576412|NCT02018861|65843351|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
23576413|NCT02018861|65843352|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576414|NCT02018861|65843353|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576415|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576416|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576417|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576418|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576419|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576420|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576421|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576422|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576423|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
23576424|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576425|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23633847|NCT02628028|66045508|FG001|Dosing Period|Adverse Event|0|||
23633848|NCT02628028|66045509|FG002|Dosing Period|Adverse Event|0|||
23576426|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576427|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23775269|NCT01389102|66557027|FG000|Overall Study|Unavailable due to husband's illness|0|||
23775270|NCT01389102|66557028|FG001|Overall Study|Unavailable due to husband's illness|1|||
23775271|NCT01389102|66557029|FG002|Overall Study|Unavailable due to husband's illness|0|||
23775272|NCT01389102|66557030|FG003|Overall Study|Unavailable due to husband's illness|0|||
23775273|NCT01389102|66557031|FG004|Overall Study|Unavailable due to husband's illness|0|||
23775274|NCT01389102|66557032|FG005|Overall Study|Unavailable due to husband's illness|0|||
23775275|NCT01389102|66557027|FG000|Overall Study|Investigator Judgement|0|||
23775276|NCT01389102|66557028|FG001|Overall Study|Investigator Judgement|1|||
23775277|NCT01389102|66557029|FG002|Overall Study|Investigator Judgement|0|||
23775278|NCT01389102|66557030|FG003|Overall Study|Investigator Judgement|0|||
23775279|NCT01389102|66557031|FG004|Overall Study|Investigator Judgement|0|||
23775280|NCT01389102|66557032|FG005|Overall Study|Investigator Judgement|0|||
23775281|NCT02458638|66557033|FG000|Overall Study|Death|309|||
23775282|NCT02458638|66557033|FG000|Overall Study|End of Cohort/End of Study|67|||
23775283|NCT02458638|66557033|FG000|Overall Study|Lost to Follow-up|31|||
23775284|NCT02458638|66557033|FG000|Overall Study|Other Reasons|4|||
23775285|NCT02458638|66557033|FG000|Overall Study|Physician Decision|1|||
23576428|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576429|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23775286|NCT02458638|66557033|FG000|Overall Study|Withdrawal by Subject|47|||
23775287|NCT02262377|66557034|FG000|Overall Study|Lost to Follow-up|5|||
23775288|NCT02262377|66557035|FG001|Overall Study|Lost to Follow-up|6|||
23775289|NCT02262377|66557034|FG000|Overall Study|Found ineligible after enrollment|3|||
23775290|NCT02262377|66557035|FG001|Overall Study|Found ineligible after enrollment|0|||
23775291|NCT02262377|66557034|FG000|Overall Study|Withdrawal by Subject|4|||
23775292|NCT02262377|66557035|FG001|Overall Study|Withdrawal by Subject|0|||
23775293|NCT01492400|66557036|FG000|Overall Study|Miscellaneous Reasons|2|||
23775294|NCT01492400|66557037|FG001|Overall Study|Miscellaneous Reasons|3|||
23775295|NCT01492400|66557036|FG000|Overall Study|Personal Reasons|0|||
23775296|NCT01492400|66557037|FG001|Overall Study|Personal Reasons|5|||
23775297|NCT01492400|66557036|FG000|Overall Study|Lost to Follow-up|3|||
23775298|NCT01492400|66557037|FG001|Overall Study|Lost to Follow-up|1|||
23775299|NCT01492400|66557036|FG000|Overall Study|Pregnancy|0|||
23775300|NCT01492400|66557037|FG001|Overall Study|Pregnancy|1|||
23775301|NCT01492400|66557036|FG000|Overall Study|Lack of Efficacy|1|||
23775302|NCT01492400|66557037|FG001|Overall Study|Lack of Efficacy|1|||
23775303|NCT01492400|66557036|FG000|Overall Study|Adverse Event|10|||
23775304|NCT01492400|66557037|FG001|Overall Study|Adverse Event|5|||
23775305|NCT00723528|66557042|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
23834617|NCT02172664|66774120|FG001|Overall Study|Lost to Follow-up|4|||
23834618|NCT02172664|66774119|FG000|Overall Study|Death|1|||
23834619|NCT02172664|66774120|FG001|Overall Study|Death|1|||
23834620|NCT02172664|66774119|FG000|Overall Study|Moved out of area|1|||
23834621|NCT02172664|66774120|FG001|Overall Study|Moved out of area|1|||
23834622|NCT04463251|66774121|FG000|Overall Study|Death|1|||
23834623|NCT04463251|66774122|FG001|Overall Study|Death|0|||
23834624|NCT04463251|66774123|FG002|Overall Study|Death|1|||
23448346|NCT03553758|65384581|FG000|Overall Study|Lost to Follow-up|1|||
23834625|NCT04463251|66774121|FG000|Overall Study|Adverse Event|0|||
23834626|NCT04463251|66774122|FG001|Overall Study|Adverse Event|1|||
23834627|NCT04463251|66774123|FG002|Overall Study|Adverse Event|0|||
23448347|NCT02478463|65384583|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
23576430|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576431|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576432|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576433|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
23576434|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576435|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576436|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576437|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23633849|NCT02628028|66045510|FG003|Dosing Period|Adverse Event|0|||
23834628|NCT04463251|66774121|FG000|Overall Study|Lost to Follow-up|0|||
23834629|NCT04463251|66774122|FG001|Overall Study|Lost to Follow-up|1|||
23834630|NCT04463251|66774123|FG002|Overall Study|Lost to Follow-up|0|||
23834631|NCT04463251|66774121|FG000|Overall Study|Withdrawal by Subject|0|||
23448348|NCT02478463|65384583|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
23633850|NCT02628028|66045511|FG004|Dosing Period|Adverse Event|2|||
23775306|NCT00723528|66557043|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
23775307|NCT00723528|66557044|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
23775308|NCT00723528|66557045|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
23775309|NCT00723528|66557046|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
23775310|NCT00723528|66557047|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
23775311|NCT00723528|66557048|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
23775312|NCT00723528|66557042|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
23834632|NCT04463251|66774122|FG001|Overall Study|Withdrawal by Subject|2|||
23775313|NCT00723528|66557043|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23775314|NCT00723528|66557044|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23775315|NCT00723528|66557045|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23775316|NCT00723528|66557046|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23775317|NCT00723528|66557047|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23576438|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576439|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576440|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576441|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576442|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576443|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
23775318|NCT00723528|66557048|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23775319|NCT00723528|66557042|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775320|NCT00723528|66557043|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775321|NCT00723528|66557044|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
23775322|NCT00723528|66557045|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775323|NCT00723528|66557046|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775324|NCT00723528|66557047|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775325|NCT00723528|66557048|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
23775326|NCT00723528|66557042|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775327|NCT00723528|66557043|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775328|NCT00723528|66557044|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
23775329|NCT00723528|66557045|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775330|NCT00723528|66557046|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775331|NCT00723528|66557047|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775332|NCT00723528|66557048|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23775333|NCT00723528|66557042|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
23775334|NCT00723528|66557043|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23775335|NCT00723528|66557044|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
23775336|NCT00723528|66557045|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23775337|NCT00723528|66557046|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23775338|NCT00723528|66557047|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23775339|NCT00723528|66557048|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23775340|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23576444|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576445|NCT01720797|65843356|FG000|Overall Study|Withdrawal by Subject|3|||
23576446|NCT01720797|65843357|FG001|Overall Study|Withdrawal by Subject|0|||
23576447|NCT00121199|65843359|FG000|Overall Study|Adverse Event|11|||
23576448|NCT00121199|65843359|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23775341|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23775342|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23448349|NCT02478463|65384583|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
23448350|NCT02869633|65384588|FG000|Overall Study|Death|2|||
23576449|NCT00121199|65843359|FG000|Overall Study|Progression/Relapse|1|||
23576450|NCT00121199|65843359|FG000|Overall Study|Death|3|||
23576451|NCT00121199|65843359|FG000|Overall Study|Other - Not Protocol Specified|3|||
23576452|NCT00121199|65843359|FG000|Overall Study|Ineligible|9|||
23576453|NCT02061761|65843362|FG000|Overall Study|Disease progression|2|||
23576454|NCT02061761|65843363|FG001|Overall Study|Disease progression|8|||
23576455|NCT02061761|65843364|FG002|Overall Study|Disease progression|4|||
23576456|NCT02061761|65843365|FG003|Overall Study|Disease progression|5|||
23576457|NCT02061761|65843366|FG004|Overall Study|Disease progression|9|||
23576458|NCT02061761|65843367|FG005|Overall Study|Disease progression|3|||
23576459|NCT02061761|65843368|FG006|Overall Study|Disease progression|1|||
23576460|NCT02061761|65843369|FG007|Overall Study|Disease progression|2|||
23576461|NCT02061761|65843370|FG008|Overall Study|Disease progression|28|||
23576462|NCT02061761|65843362|FG000|Overall Study|Study Drug toxicity|0|||
23576463|NCT02061761|65843363|FG001|Overall Study|Study Drug toxicity|0|||
23576464|NCT02061761|65843364|FG002|Overall Study|Study Drug toxicity|0|||
23775343|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23775344|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23775345|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23775346|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23775347|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775348|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775349|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775350|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775351|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775352|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
23775353|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23775354|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Other|0|||
23775355|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Other|0|||
23576465|NCT02061761|65843365|FG003|Overall Study|Study Drug toxicity|0|||
23576466|NCT02061761|65843366|FG004|Overall Study|Study Drug toxicity|0|||
23576467|NCT02061761|65843367|FG005|Overall Study|Study Drug toxicity|1|||
23775356|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Other|0|||
23775357|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Other|0|||
23775358|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Other|1|||
23775359|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Other|4|||
23775360|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Other|0|||
23775361|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Adverse Event|0|||
23775362|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Adverse Event|0|||
23775363|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Adverse Event|0|||
23775364|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Adverse Event|0|||
23775365|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Adverse Event|1|||
23775366|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Adverse Event|0|||
23775367|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Adverse Event|1|||
23775368|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775369|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775370|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775371|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775372|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775373|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23775374|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
23775375|NCT00723528|66557042|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23775376|NCT00723528|66557043|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23775377|NCT00723528|66557044|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23775378|NCT00723528|66557045|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23448351|NCT02869633|65384589|FG001|Overall Study|Death|1|||
23775379|NCT00723528|66557046|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23775380|NCT00723528|66557047|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23775381|NCT00723528|66557048|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
23775382|NCT04109222|66557049|FG000|Overall Study|Adverse Event|1|||
23775383|NCT04109222|66557050|FG001|Overall Study|Adverse Event|0|||
23775384|NCT04109222|66557051|FG002|Overall Study|Adverse Event|0|||
23775385|NCT01991470|66557052|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
23775386|NCT01991470|66557052|FG000|Enlite 1 Period|Adverse Event|1|||
23448352|NCT02869633|65384588|FG000|Overall Study|Patient refused follow-up|1|||
23576468|NCT02061761|65843368|FG006|Overall Study|Study Drug toxicity|0|||
23576469|NCT02061761|65843369|FG007|Overall Study|Study Drug toxicity|2|||
23576470|NCT02061761|65843370|FG008|Overall Study|Study Drug toxicity|6|||
23576471|NCT02061761|65843362|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
23576472|NCT02061761|65843363|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
23448353|NCT02869633|65384589|FG001|Overall Study|Patient refused follow-up|0|||
23576473|NCT02061761|65843364|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
23576474|NCT02061761|65843365|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
23576475|NCT02061761|65843366|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
23576476|NCT02061761|65843367|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
23576477|NCT02061761|65843368|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
23576478|NCT02061761|65843369|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
23576479|NCT02061761|65843370|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
23576480|NCT02061761|65843362|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23576481|NCT02061761|65843363|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23576482|NCT02061761|65843364|FG002|Overall Study|Participant request to discontinue study treatment|2|||
23576483|NCT02061761|65843365|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23576484|NCT02061761|65843366|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23775387|NCT01991470|66557052|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
23775388|NCT01991470|66557052|FG000|Enlite 3 Period|Lost to Follow-up|1|||
23775389|NCT01991470|66557052|FG000|Enlite 3 Period|Physician Decision|2|||
23775390|NCT01991470|66557052|FG000|Enlite 3 Period|Physician Decision|8|||
23775391|NCT01991470|66557052|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
23775392|NCT01044732|66557055|FG000|Overall Study|Lost to Follow-up|2|||
23775393|NCT01044732|66557056|FG001|Overall Study|Lost to Follow-up|1|||
23775394|NCT01044732|66557055|FG000|Overall Study|Physician Decision|5|||
23775395|NCT01044732|66557056|FG001|Overall Study|Physician Decision|3|||
23775396|NCT01044732|66557055|FG000|Overall Study|Protocol Violation|11|||
23775397|NCT01044732|66557056|FG001|Overall Study|Protocol Violation|12|||
23775398|NCT01044732|66557055|FG000|Overall Study|Withdrawal by Subject|0|||
23775399|NCT01044732|66557056|FG001|Overall Study|Withdrawal by Subject|1|||
23775400|NCT01044732|66557055|FG000|Overall Study|Inadequate bowel preparation|11|||
23775401|NCT01044732|66557056|FG001|Overall Study|Inadequate bowel preparation|17|||
23775402|NCT01044732|66557055|FG000|Overall Study|Inability to reach cecum|5|||
23775403|NCT01044732|66557056|FG001|Overall Study|Inability to reach cecum|2|||
23775404|NCT01044732|66557055|FG000|Overall Study|Technical error or malfunction|15|||
23775405|NCT01044732|66557056|FG001|Overall Study|Technical error or malfunction|14|||
23775406|NCT01052116|66557058|FG000|Overall Study|Lost to Follow-up|11|||
23775407|NCT01052116|66557059|FG001|Overall Study|Lost to Follow-up|17|||
23775408|NCT01052116|66557058|FG000|Overall Study|Withdrawal by Subject|3|||
23775409|NCT01052116|66557059|FG001|Overall Study|Withdrawal by Subject|6|||
23775410|NCT01052116|66557058|FG000|Overall Study|Spirometry not performed|0|||
23775411|NCT01052116|66557059|FG001|Overall Study|Spirometry not performed|4|||
23775412|NCT01993030|66559679|FG000|Overall Study|Adverse Event|0|||
23775413|NCT01993030|66559680|FG001|Overall Study|Adverse Event|4|||
23775414|NCT00995553|66559691|FG000|Overall Study|Withdrawal by Subject|2|||
23775415|NCT00995553|66559692|FG001|Overall Study|Withdrawal by Subject|6|||
23775416|NCT02661295|66559697|FG000|Overall Study|Death|1|||
23775417|NCT02661295|66559697|FG000|Overall Study|Transferred Out|1|||
23775418|NCT02661295|66559697|FG000|Overall Study|Kidney Transplant|1|||
23775419|NCT02661295|66559697|FG000|Overall Study|Withdrawn due to side effects|8|||
23775420|NCT02661295|66559697|FG000|Overall Study|Withdrawn due to access type|1|||
23834633|NCT04463251|66774123|FG002|Overall Study|Withdrawal by Subject|2|||
23834634|NCT00550043|66774124|FG000|Overall Study|Adverse Event|0|||
23834635|NCT00550043|66774125|FG001|Overall Study|Adverse Event|0|||
23834636|NCT00550043|66774126|FG002|Overall Study|Adverse Event|0|||
23834637|NCT00550043|66774127|FG003|Overall Study|Adverse Event|1|||
23834638|NCT00550043|66774128|FG004|Overall Study|Adverse Event|1|||
23834639|NCT00550043|66774124|FG000|Overall Study|Subject Withdrew Consent|0|||
23834640|NCT00550043|66774125|FG001|Overall Study|Subject Withdrew Consent|2|||
23834641|NCT00550043|66774126|FG002|Overall Study|Subject Withdrew Consent|1|||
23834642|NCT00550043|66774127|FG003|Overall Study|Subject Withdrew Consent|0|||
23834643|NCT00550043|66774128|FG004|Overall Study|Subject Withdrew Consent|0|||
23834644|NCT00550043|66774124|FG000|Overall Study|Other Reasons- Unspecified|0|||
23834645|NCT00550043|66774125|FG001|Overall Study|Other Reasons- Unspecified|1|||
23834646|NCT00550043|66774126|FG002|Overall Study|Other Reasons- Unspecified|0|||
23834647|NCT00550043|66774127|FG003|Overall Study|Other Reasons- Unspecified|1|||
23834648|NCT00550043|66774128|FG004|Overall Study|Other Reasons- Unspecified|0|||
23834649|NCT01962103|66774131|FG000|Phase 1|Adverse Event|4|||
23834650|NCT01962103|66774132|FG001|Phase 1|Adverse Event|0|||
23633851|NCT02628028|66045512|FG005|Dosing Period|Adverse Event|1|||
23775421|NCT02661295|66559697|FG000|Overall Study|Withdrawn due to allergies|1|||
23775422|NCT02661295|66559697|FG000|Overall Study|Withdrawn due to non-compliance|1|||
23775423|NCT02661295|66559697|FG000|Overall Study|Withdrawal by Subject|3|||
23775424|NCT02661295|66559697|FG000|Overall Study|Failed screening|2|||
23775425|NCT01434693|66559698|FG000|Overall Study|Adverse Event|1|||
23775426|NCT01434693|66559699|FG001|Overall Study|Adverse Event|0|||
23775427|NCT01434693|66559700|FG002|Overall Study|Adverse Event|0|||
23775428|NCT01434693|66559701|FG003|Overall Study|Adverse Event|0|||
23775429|NCT01434693|66559698|FG000|Overall Study|Withdrawal by Subject|1|||
23775430|NCT01434693|66559699|FG001|Overall Study|Withdrawal by Subject|0|||
23775431|NCT01434693|66559700|FG002|Overall Study|Withdrawal by Subject|1|||
23775432|NCT01434693|66559701|FG003|Overall Study|Withdrawal by Subject|1|||
23775433|NCT01434693|66559698|FG000|Overall Study|Lost to Follow-up|1|||
23775434|NCT01434693|66559699|FG001|Overall Study|Lost to Follow-up|0|||
23775435|NCT01434693|66559700|FG002|Overall Study|Lost to Follow-up|0|||
23775436|NCT01434693|66559701|FG003|Overall Study|Lost to Follow-up|0|||
23775437|NCT03627091|66559702|FG000|Overall Study|Adverse Event|0|||
23775438|NCT03627091|66559703|FG001|Overall Study|Adverse Event|0|||
23775439|NCT03627091|66559704|FG002|Overall Study|Adverse Event|2|||
23775440|NCT03627091|66559702|FG000|Overall Study|Withdrawal by Subject|2|||
23775441|NCT03627091|66559703|FG001|Overall Study|Withdrawal by Subject|0|||
23775442|NCT03627091|66559704|FG002|Overall Study|Withdrawal by Subject|2|||
23775443|NCT03627091|66559702|FG000|Overall Study|Physician Decision|2|||
23775444|NCT03627091|66559703|FG001|Overall Study|Physician Decision|0|||
23775445|NCT03627091|66559704|FG002|Overall Study|Physician Decision|0|||
23775446|NCT03627091|66559702|FG000|Overall Study|Site terminated by sponsor|0|||
23775447|NCT03627091|66559703|FG001|Overall Study|Site terminated by sponsor|1|||
23775448|NCT03627091|66559704|FG002|Overall Study|Site terminated by sponsor|0|||
23834651|NCT01962103|66774133|FG002|Phase 1|Adverse Event|2|||
23576485|NCT02061761|65843367|FG005|Overall Study|Participant request to discontinue study treatment|1|||
23576486|NCT02061761|65843368|FG006|Overall Study|Participant request to discontinue study treatment|0|||
23576487|NCT02061761|65843369|FG007|Overall Study|Participant request to discontinue study treatment|0|||
23576488|NCT02061761|65843370|FG008|Overall Study|Participant request to discontinue study treatment|2|||
23576489|NCT02061761|65843362|FG000|Overall Study|Withdrawal by Subject|0|||
23576490|NCT02061761|65843363|FG001|Overall Study|Withdrawal by Subject|0|||
23576491|NCT02061761|65843364|FG002|Overall Study|Withdrawal by Subject|0|||
23576492|NCT02061761|65843365|FG003|Overall Study|Withdrawal by Subject|0|||
23576493|NCT02061761|65843366|FG004|Overall Study|Withdrawal by Subject|0|||
23775449|NCT03627091|66559702|FG000|Overall Study|Disease relapse|7|||
23775450|NCT03627091|66559703|FG001|Overall Study|Disease relapse|5|||
23775451|NCT03627091|66559704|FG002|Overall Study|Disease relapse|1|||
23775452|NCT03627091|66559702|FG000|Overall Study|Other|1|||
23775453|NCT03627091|66559703|FG001|Overall Study|Other|0|||
23775454|NCT03627091|66559704|FG002|Overall Study|Other|0|||
23775455|NCT00184600|66559705|FG000|Overall Study|Adverse Event|9|||
23775456|NCT00184600|66559706|FG001|Overall Study|Adverse Event|0|||
23775457|NCT00184600|66559707|FG002|Overall Study|Adverse Event|5|||
23775458|NCT00184600|66559705|FG000|Overall Study|Death|3|||
23775459|NCT00184600|66559706|FG001|Overall Study|Death|9|||
23775460|NCT00184600|66559707|FG002|Overall Study|Death|7|||
23775461|NCT00184600|66559705|FG000|Overall Study|Lack of Efficacy|3|||
23775462|NCT00184600|66559706|FG001|Overall Study|Lack of Efficacy|1|||
23775463|NCT00184600|66559707|FG002|Overall Study|Lack of Efficacy|3|||
23775464|NCT00184600|66559705|FG000|Overall Study|Lost to Follow-up|4|||
23775465|NCT00184600|66559706|FG001|Overall Study|Lost to Follow-up|6|||
23775466|NCT00184600|66559707|FG002|Overall Study|Lost to Follow-up|1|||
23775467|NCT00184600|66559705|FG000|Overall Study|Protocol Violation|2|||
23775468|NCT00184600|66559706|FG001|Overall Study|Protocol Violation|2|||
23834652|NCT01962103|66774134|FG003|Phase 1|Adverse Event|1|||
23834653|NCT01962103|66774135|FG004|Phase 1|Adverse Event|2|||
23834654|NCT01962103|66774136|FG005|Phase 1|Adverse Event|2|||
23834655|NCT01962103|66774137|FG006|Phase 1|Adverse Event|0|||
23834656|NCT01962103|66774138|FG007|Phase 1|Adverse Event|0|||
23834657|NCT01962103|66774139|FG008|Phase 1|Adverse Event|0|||
23834658|NCT01962103|66774131|FG000|Phase 1|Progressive Disease|8|||
23576494|NCT02061761|65843367|FG005|Overall Study|Withdrawal by Subject|0|||
23576495|NCT02061761|65843368|FG006|Overall Study|Withdrawal by Subject|0|||
23576496|NCT02061761|65843369|FG007|Overall Study|Withdrawal by Subject|0|||
23775469|NCT00184600|66559707|FG002|Overall Study|Protocol Violation|3|||
23775470|NCT00184600|66559705|FG000|Overall Study|Withdrawal by Subject|20|||
23834659|NCT01962103|66774132|FG001|Phase 1|Progressive Disease|6|||
23576497|NCT02061761|65843370|FG008|Overall Study|Withdrawal by Subject|2|||
23775471|NCT00184600|66559706|FG001|Overall Study|Withdrawal by Subject|28|||
23775472|NCT00184600|66559707|FG002|Overall Study|Withdrawal by Subject|12|||
23775473|NCT00184600|66559705|FG000|Overall Study|Unclassified|4|||
23775474|NCT00184600|66559706|FG001|Overall Study|Unclassified|5|||
23775475|NCT00184600|66559707|FG002|Overall Study|Unclassified|3|||
23775476|NCT02465567|66559709|FG000|Overall Study|Adverse Event|118|||
23775477|NCT02465567|66559710|FG001|Overall Study|Adverse Event|113|||
23775478|NCT02465567|66559711|FG002|Overall Study|Adverse Event|147|||
23834660|NCT01962103|66774133|FG002|Phase 1|Progressive Disease|8|||
23834661|NCT01962103|66774134|FG003|Phase 1|Progressive Disease|4|||
23775479|NCT02465567|66559712|FG003|Overall Study|Adverse Event|138|||
23775480|NCT02465567|66559709|FG000|Overall Study|Lack of Efficacy|103|||
23775481|NCT02465567|66559710|FG001|Overall Study|Lack of Efficacy|102|||
23775482|NCT02465567|66559711|FG002|Overall Study|Lack of Efficacy|171|||
23775483|NCT02465567|66559712|FG003|Overall Study|Lack of Efficacy|135|||
23775484|NCT02465567|66559709|FG000|Overall Study|Withdrawal by Subject|104|||
23775485|NCT02465567|66559710|FG001|Overall Study|Withdrawal by Subject|94|||
23775486|NCT02465567|66559711|FG002|Overall Study|Withdrawal by Subject|123|||
23775487|NCT02465567|66559712|FG003|Overall Study|Withdrawal by Subject|130|||
23775488|NCT02465567|66559709|FG000|Overall Study|Physician Decision|23|||
23775489|NCT02465567|66559710|FG001|Overall Study|Physician Decision|33|||
23775490|NCT02465567|66559711|FG002|Overall Study|Physician Decision|38|||
23775491|NCT02465567|66559712|FG003|Overall Study|Physician Decision|28|||
23775492|NCT02465567|66559709|FG000|Overall Study|Major Protocol Deviation|24|||
23775493|NCT02465567|66559710|FG001|Overall Study|Major Protocol Deviation|26|||
23775494|NCT02465567|66559711|FG002|Overall Study|Major Protocol Deviation|22|||
23775495|NCT02465567|66559712|FG003|Overall Study|Major Protocol Deviation|25|||
23775496|NCT02465567|66559709|FG000|Overall Study|Lost to Follow-up|25|||
23775497|NCT02465567|66559710|FG001|Overall Study|Lost to Follow-up|21|||
23775498|NCT02465567|66559711|FG002|Overall Study|Lost to Follow-up|19|||
23775499|NCT02465567|66559712|FG003|Overall Study|Lost to Follow-up|15|||
23775500|NCT02465567|66559709|FG000|Overall Study|Protocol Specified Criteria|20|||
23775501|NCT02465567|66559710|FG001|Overall Study|Protocol Specified Criteria|10|||
23775502|NCT02465567|66559711|FG002|Overall Study|Protocol Specified Criteria|9|||
23775503|NCT02465567|66559712|FG003|Overall Study|Protocol Specified Criteria|12|||
23775504|NCT02465567|66559709|FG000|Overall Study|Administrative Reasons|12|||
23576498|NCT02061761|65843362|FG000|Overall Study|Maximum clinical benefit|0|||
23775505|NCT02465567|66559710|FG001|Overall Study|Administrative Reasons|9|||
23775506|NCT02465567|66559711|FG002|Overall Study|Administrative Reasons|11|||
23834662|NCT01962103|66774135|FG004|Phase 1|Progressive Disease|5|||
23448354|NCT02869633|65384588|FG000|Overall Study|Provider discretion|1|||
23834663|NCT01962103|66774136|FG005|Phase 1|Progressive Disease|4|||
23834664|NCT01962103|66774137|FG006|Phase 1|Progressive Disease|0|||
23834665|NCT01962103|66774138|FG007|Phase 1|Progressive Disease|0|||
23834666|NCT01962103|66774139|FG008|Phase 1|Progressive Disease|0|||
23834667|NCT01962103|66774131|FG000|Phase 1|Withdrawal by Subject|0|||
23834668|NCT01962103|66774132|FG001|Phase 1|Withdrawal by Subject|0|||
23834669|NCT01962103|66774133|FG002|Phase 1|Withdrawal by Subject|0|||
23834670|NCT01962103|66774134|FG003|Phase 1|Withdrawal by Subject|2|||
23834671|NCT01962103|66774135|FG004|Phase 1|Withdrawal by Subject|0|||
23834672|NCT01962103|66774136|FG005|Phase 1|Withdrawal by Subject|0|||
23834673|NCT01962103|66774137|FG006|Phase 1|Withdrawal by Subject|0|||
23834674|NCT01962103|66774138|FG007|Phase 1|Withdrawal by Subject|0|||
23834675|NCT01962103|66774139|FG008|Phase 1|Withdrawal by Subject|0|||
23834676|NCT01962103|66774131|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
23834677|NCT01962103|66774132|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
23834678|NCT01962103|66774133|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
23834679|NCT01962103|66774134|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
23834680|NCT01962103|66774135|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
23834681|NCT01962103|66774136|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
23834682|NCT01962103|66774137|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
23834683|NCT01962103|66774138|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
23834684|NCT01962103|66774139|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
23834685|NCT01962103|66774131|FG000|Phase 1|Physician Decision|0|||
23834686|NCT01962103|66774132|FG001|Phase 1|Physician Decision|0|||
23834687|NCT01962103|66774133|FG002|Phase 1|Physician Decision|0|||
23834688|NCT01962103|66774134|FG003|Phase 1|Physician Decision|1|||
23576499|NCT02061761|65843363|FG001|Overall Study|Maximum clinical benefit|0|||
23775507|NCT02465567|66559712|FG003|Overall Study|Administrative Reasons|5|||
23775508|NCT02465567|66559709|FG000|Overall Study|Randomized but not treated|1|||
23775509|NCT02465567|66559710|FG001|Overall Study|Randomized but not treated|5|||
23775510|NCT02465567|66559711|FG002|Overall Study|Randomized but not treated|4|||
23775511|NCT02465567|66559712|FG003|Overall Study|Randomized but not treated|5|||
23775512|NCT02465567|66559709|FG000|Overall Study|enrolled in >1 studies|18|||
23775513|NCT02465567|66559710|FG001|Overall Study|enrolled in >1 studies|11|||
23775514|NCT02465567|66559711|FG002|Overall Study|enrolled in >1 studies|19|||
23775515|NCT02465567|66559712|FG003|Overall Study|enrolled in >1 studies|15|||
23775516|NCT02465567|66559709|FG000|Overall Study|missing PI Signature|1|||
23775517|NCT02465567|66559710|FG001|Overall Study|missing PI Signature|0|||
23775518|NCT02465567|66559711|FG002|Overall Study|missing PI Signature|0|||
23448355|NCT02869633|65384589|FG001|Overall Study|Provider discretion|0|||
23448356|NCT02869633|65384588|FG000|Overall Study|Investigator decision|1|||
23448357|NCT02869633|65384589|FG001|Overall Study|Investigator decision|0|||
23448358|NCT02869633|65384588|FG000|Overall Study|Lost to Follow-up|0|||
23448359|NCT02869633|65384589|FG001|Overall Study|Lost to Follow-up|1|||
23775519|NCT02465567|66559712|FG003|Overall Study|missing PI Signature|0|||
23775520|NCT00856388|66559714|FG000|Overall Study|Other|1|||
23775521|NCT03639311|66559715|FG000|Maintenance Phase|Lost to Follow-up|1|||
23775522|NCT03639311|66559716|FG001|Maintenance Phase|Lost to Follow-up|0|||
23775523|NCT03639311|66559717|FG002|Maintenance Phase|Lost to Follow-up|0|||
23775524|NCT03639311|66559715|FG000|Maintenance Phase|Adverse Event|1|||
23775525|NCT03639311|66559716|FG001|Maintenance Phase|Adverse Event|0|||
23448360|NCT02869633|65384588|FG000|Overall Study|Not eligible|6|||
23448361|NCT02869633|65384589|FG001|Overall Study|Not eligible|1|||
23448362|NCT02869633|65384588|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
23448363|NCT02869633|65384589|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
23448364|NCT02869633|65384588|FG000|Overall Study|Withdrawal by Subject|0|||
23448365|NCT02869633|65384589|FG001|Overall Study|Withdrawal by Subject|1|||
23448366|NCT00428948|65384592|FG000|Overall Study|Lost to Follow-up|15|||
23448367|NCT00428948|65384593|FG001|Overall Study|Lost to Follow-up|8|||
23448368|NCT00428948|65384592|FG000|Overall Study|Adverse Event|148|||
23448369|NCT00428948|65384593|FG001|Overall Study|Adverse Event|24|||
23448370|NCT00428948|65384592|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
23576500|NCT02061761|65843364|FG002|Overall Study|Maximum clinical benefit|0|||
23448371|NCT00428948|65384593|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
23448372|NCT00428948|65384592|FG000|Overall Study|Investigator Withdrew Subject|3|||
23775526|NCT03639311|66559717|FG002|Maintenance Phase|Adverse Event|0|||
23775527|NCT03639311|66559715|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
23775528|NCT03639311|66559716|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
23448373|NCT00428948|65384593|FG001|Overall Study|Investigator Withdrew Subject|4|||
23448374|NCT00428948|65384592|FG000|Overall Study|Subject Withdrew Consent|50|||
23448375|NCT00428948|65384593|FG001|Overall Study|Subject Withdrew Consent|30|||
23448376|NCT00428948|65384592|FG000|Overall Study|Protocol Deviation|1|||
23448377|NCT00428948|65384593|FG001|Overall Study|Protocol Deviation|1|||
23448378|NCT00672555|65384594|FG000|Overall Study|Lost to Follow-up|4|||
23448379|NCT00672555|65384594|FG000|Overall Study|Did not want to answer questionnaire|2|||
23448380|NCT05051579|65384596|FG000|Overall Study|Withdrawal by Subject|3|||
23448381|NCT05051579|65384597|FG001|Overall Study|Withdrawal by Subject|5|||
23448382|NCT05051579|65384598|FG002|Overall Study|Withdrawal by Subject|2|||
23448383|NCT05051579|65384599|FG003|Overall Study|Withdrawal by Subject|1|||
23448384|NCT05051579|65384600|FG004|Overall Study|Withdrawal by Subject|4|||
23448385|NCT05051579|65384601|FG005|Overall Study|Withdrawal by Subject|0|||
23448386|NCT05051579|65384602|FG006|Overall Study|Withdrawal by Subject|4|||
23448387|NCT05051579|65384596|FG000|Overall Study|Lost to Follow-up|1|||
23448388|NCT05051579|65384597|FG001|Overall Study|Lost to Follow-up|0|||
23448389|NCT05051579|65384598|FG002|Overall Study|Lost to Follow-up|0|||
23448390|NCT05051579|65384599|FG003|Overall Study|Lost to Follow-up|0|||
23448391|NCT05051579|65384600|FG004|Overall Study|Lost to Follow-up|1|||
23448392|NCT05051579|65384601|FG005|Overall Study|Lost to Follow-up|0|||
23448393|NCT05051579|65384602|FG006|Overall Study|Lost to Follow-up|1|||
23448394|NCT05051579|65384596|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448395|NCT05051579|65384597|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448396|NCT05051579|65384598|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448397|NCT05051579|65384599|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448398|NCT05051579|65384600|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448399|NCT05051579|65384601|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448400|NCT05051579|65384602|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
23448401|NCT05051579|65384596|FG000|Overall Study|Adverse Event|2|||
23448402|NCT05051579|65384597|FG001|Overall Study|Adverse Event|1|||
23448403|NCT05051579|65384598|FG002|Overall Study|Adverse Event|0|||
23448404|NCT05051579|65384599|FG003|Overall Study|Adverse Event|4|||
23448405|NCT05051579|65384600|FG004|Overall Study|Adverse Event|1|||
23448406|NCT05051579|65384601|FG005|Overall Study|Adverse Event|2|||
23448407|NCT05051579|65384602|FG006|Overall Study|Adverse Event|0|||
23448408|NCT05051579|65384596|FG000|Overall Study|Inadvertent Enrollment|0|||
23448409|NCT05051579|65384597|FG001|Overall Study|Inadvertent Enrollment|0|||
23448410|NCT05051579|65384598|FG002|Overall Study|Inadvertent Enrollment|0|||
23448411|NCT05051579|65384599|FG003|Overall Study|Inadvertent Enrollment|0|||
23448412|NCT05051579|65384600|FG004|Overall Study|Inadvertent Enrollment|0|||
23448413|NCT05051579|65384601|FG005|Overall Study|Inadvertent Enrollment|0|||
23448414|NCT05051579|65384602|FG006|Overall Study|Inadvertent Enrollment|1|||
23448415|NCT05051579|65384596|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448416|NCT05051579|65384597|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
23448417|NCT05051579|65384598|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448418|NCT05051579|65384599|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448419|NCT05051579|65384600|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448420|NCT05051579|65384601|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448421|NCT05051579|65384602|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448422|NCT05051579|65384596|FG000|Overall Study|Sponsor Decision|0|||
23448423|NCT05051579|65384597|FG001|Overall Study|Sponsor Decision|0|||
23448424|NCT05051579|65384598|FG002|Overall Study|Sponsor Decision|0|||
23448425|NCT05051579|65384599|FG003|Overall Study|Sponsor Decision|0|||
23448426|NCT05051579|65384600|FG004|Overall Study|Sponsor Decision|1|||
23448427|NCT05051579|65384601|FG005|Overall Study|Sponsor Decision|0|||
23448428|NCT05051579|65384602|FG006|Overall Study|Sponsor Decision|0|||
23448429|NCT05051579|65384596|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448430|NCT05051579|65384597|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448431|NCT05051579|65384598|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448432|NCT05051579|65384599|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448433|NCT05051579|65384600|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
23448434|NCT05051579|65384601|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23633852|NCT02628028|66045513|FG006|Dosing Period|Adverse Event|3|||
23775529|NCT03639311|66559717|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
23775530|NCT03639311|66559715|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
23775531|NCT03639311|66559716|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
23775532|NCT03639311|66559717|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
23775533|NCT03639311|66559715|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
23775534|NCT03639311|66559716|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23775535|NCT03639311|66559717|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23775536|NCT03639311|66559715|FG000|Maintenance Phase|Lack of Efficacy|1|||
23448435|NCT05051579|65384602|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448436|NCT01424501|65384603|FG000|Overall Study|Withdrawal by Subject|1|||
23448437|NCT01424501|65384604|FG001|Overall Study|Withdrawal by Subject|0|||
23448438|NCT01424501|65384605|FG002|Overall Study|Withdrawal by Subject|1|||
23448439|NCT01424501|65384606|FG003|Overall Study|Withdrawal by Subject|0|||
23448440|NCT01424501|65384607|FG004|Overall Study|Withdrawal by Subject|0|||
23448441|NCT01424501|65384608|FG005|Overall Study|Withdrawal by Subject|0|||
23448442|NCT01424501|65384603|FG000|Overall Study|Lost to Follow-up|0|||
23448443|NCT01424501|65384604|FG001|Overall Study|Lost to Follow-up|1|||
23448444|NCT01424501|65384605|FG002|Overall Study|Lost to Follow-up|1|||
23448445|NCT01424501|65384606|FG003|Overall Study|Lost to Follow-up|0|||
23448446|NCT01424501|65384607|FG004|Overall Study|Lost to Follow-up|0|||
23448447|NCT01424501|65384608|FG005|Overall Study|Lost to Follow-up|0|||
23448448|NCT04073186|65384614|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
23775537|NCT03639311|66559716|FG001|Maintenance Phase|Lack of Efficacy|0|||
23775538|NCT03639311|66559717|FG002|Maintenance Phase|Lack of Efficacy|0|||
23775539|NCT03733925|66559718|FG000|Overall Study|Lost to Follow-up|1|||
23448449|NCT04073186|65384614|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
23448450|NCT04073186|65384614|FG000|First Wearing Cycle|Protocol Violation|1|||
23775540|NCT03733925|66559718|FG000|Overall Study|Withdrawal by Subject|2|||
23775541|NCT03733925|66559718|FG000|Overall Study|Adverse Event|2|||
23775542|NCT03733925|66559718|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23775543|NCT00119379|66559719|FG000|Overall Study|Adverse Event|4|||
23775544|NCT00119379|66559720|FG001|Overall Study|Adverse Event|1|||
23633853|NCT02628028|66045514|FG007|Dosing Period|Adverse Event|2|||
23775545|NCT00486837|66559721|FG000|Overall Study|Withdrawal by Subject|1|||
23775546|NCT00486837|66559722|FG001|Overall Study|Withdrawal by Subject|0|||
23775547|NCT00486837|66559721|FG000|Overall Study|Adverse Event|1|||
23775548|NCT00486837|66559722|FG001|Overall Study|Adverse Event|1|||
23775549|NCT00486837|66559721|FG000|Overall Study|Protocol Violation|4|||
23775550|NCT00486837|66559722|FG001|Overall Study|Protocol Violation|2|||
23775551|NCT00486837|66559721|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
23775552|NCT00486837|66559722|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
23775553|NCT01700621|66559723|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
23775554|NCT01700621|66559724|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
23775555|NCT01700621|66559723|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
23775556|NCT01700621|66559724|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
23775557|NCT01700621|66559723|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
23775558|NCT01700621|66559724|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
23775559|NCT00822926|66559725|FG000|Second Injection Visit|Lost to Follow-up|1|||
23775560|NCT00822926|66559726|FG001|Second Injection Visit|Lost to Follow-up|0|||
23775561|NCT00822926|66559725|FG000|Second Injection Visit|Withdrawal by Subject|0|||
23775562|NCT00822926|66559726|FG001|Second Injection Visit|Withdrawal by Subject|1|||
23775563|NCT01399736|66559727|FG000|Overall Study|Withdrawal by Subject|4|||
23775564|NCT01399736|66559728|FG001|Overall Study|Withdrawal by Subject|2|||
23775565|NCT01399736|66559727|FG000|Overall Study|Lost to Follow-up|0|||
23775566|NCT01399736|66559728|FG001|Overall Study|Lost to Follow-up|2|||
23775567|NCT02374853|66559729|FG000|Overall Study|Surgery Cancelled|5|||
23775568|NCT02374853|66559730|FG001|Overall Study|Surgery Cancelled|11|||
23775569|NCT02015390|66559731|FG000|Overall Study|Lost to Follow-up|1|||
23775570|NCT02015390|66559732|FG001|Overall Study|Lost to Follow-up|0|||
23775571|NCT02015390|66559731|FG000|Overall Study|Adverse Event|0|||
23775572|NCT02015390|66559732|FG001|Overall Study|Adverse Event|3|||
23775573|NCT02015390|66559731|FG000|Overall Study|Physician Decision|0|||
23775574|NCT02015390|66559732|FG001|Overall Study|Physician Decision|1|||
23775575|NCT03785548|66559733|FG000|Overall Study|age > 80|1|||
23775576|NCT03785548|66559734|FG001|Overall Study|age > 80|0|||
23775577|NCT03785548|66559733|FG000|Overall Study|no Postop queries|1|||
23775578|NCT03785548|66559734|FG001|Overall Study|no Postop queries|0|||
23775579|NCT03629249|66559735|FG000|Overall Study|Study terminated by sponsor|197|||
23775580|NCT03629249|66559736|FG001|Overall Study|Study terminated by sponsor|197|||
23775581|NCT03629249|66559737|FG002|Overall Study|Study terminated by sponsor|194|||
23775582|NCT03629249|66559735|FG000|Overall Study|Protocol deviation|0|||
23775583|NCT03629249|66559736|FG001|Overall Study|Protocol deviation|2|||
23775584|NCT03629249|66559737|FG002|Overall Study|Protocol deviation|5|||
23775585|NCT03629249|66559735|FG000|Overall Study|Subject decision|1|||
23775586|NCT03629249|66559736|FG001|Overall Study|Subject decision|1|||
23775587|NCT03629249|66559737|FG002|Overall Study|Subject decision|3|||
23775588|NCT03629249|66559735|FG000|Overall Study|Adverse Event|1|||
23775589|NCT03629249|66559736|FG001|Overall Study|Adverse Event|1|||
23775590|NCT03629249|66559737|FG002|Overall Study|Adverse Event|0|||
23775591|NCT03629249|66559735|FG000|Overall Study|Death|1|||
23775592|NCT03629249|66559736|FG001|Overall Study|Death|0|||
23775593|NCT03629249|66559737|FG002|Overall Study|Death|0|||
23775594|NCT03629249|66559735|FG000|Overall Study|Physician Decision|1|||
23775595|NCT03629249|66559736|FG001|Overall Study|Physician Decision|0|||
23775596|NCT03629249|66559737|FG002|Overall Study|Physician Decision|0|||
23775597|NCT01546545|66559738|FG000|Overall Study|Withdrawal by Subject|1|||
23775598|NCT04213326|66559739|FG000|Overall Study|Consent withdrawn|51|||
23775599|NCT04213326|66559740|FG001|Overall Study|Consent withdrawn|241|||
23775600|NCT04213326|66559739|FG000|Overall Study|Lost to Follow-up|50|||
23775601|NCT04213326|66559740|FG001|Overall Study|Lost to Follow-up|902|||
23775602|NCT04213326|66559739|FG000|Overall Study|Protocol Violation|3|||
23775603|NCT04213326|66559740|FG001|Overall Study|Protocol Violation|25|||
23775604|NCT04213326|66559739|FG000|Overall Study|Participant eligibility changed|106|||
23775605|NCT04213326|66559740|FG001|Overall Study|Participant eligibility changed|19|||
23775606|NCT04213326|66559739|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
23775607|NCT04213326|66559740|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
23775608|NCT04213326|66559739|FG000|Overall Study|Incomplete study visit|0|||
23775609|NCT04213326|66559740|FG001|Overall Study|Incomplete study visit|367|||
23775610|NCT01010542|66559746|FG000|Overall Study|Adverse Event|0|||
23775611|NCT01010542|66559747|FG001|Overall Study|Adverse Event|1|||
23775612|NCT01010542|66559748|FG002|Overall Study|Adverse Event|0|||
23775613|NCT01010542|66559746|FG000|Overall Study|Lost to Follow-up|0|||
23775614|NCT01010542|66559747|FG001|Overall Study|Lost to Follow-up|1|||
23775615|NCT01010542|66559748|FG002|Overall Study|Lost to Follow-up|0|||
23775616|NCT01010542|66559746|FG000|Overall Study|Withdrawal by Subject|0|||
23775617|NCT01010542|66559747|FG001|Overall Study|Withdrawal by Subject|3|||
23775618|NCT01010542|66559748|FG002|Overall Study|Withdrawal by Subject|2|||
23775619|NCT02726581|66559749|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23775620|NCT02726581|66559750|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
23775621|NCT02726581|66559751|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23775622|NCT02726581|66559749|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
23775623|NCT02726581|66559750|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
23775624|NCT02726581|66559751|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
23775625|NCT02726581|66559749|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23775626|NCT02726581|66559750|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23775627|NCT02726581|66559751|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23775628|NCT02726581|66559749|FG000|Treatment Period|Disease progression|47|||
23775629|NCT02726581|66559750|FG001|Treatment Period|Disease progression|50|||
23775630|NCT02726581|66559751|FG002|Treatment Period|Disease progression|16|||
23633854|NCT02628028|66045507|FG000|Dosing Period|Death|0|||
23775631|NCT02726581|66559749|FG000|Treatment Period|Other reasons|9|||
23775632|NCT02726581|66559750|FG001|Treatment Period|Other reasons|8|||
23775633|NCT02726581|66559751|FG002|Treatment Period|Other reasons|2|||
23775634|NCT02726581|66559749|FG000|Treatment Period|Study drug toxicity|6|||
23775635|NCT02726581|66559750|FG001|Treatment Period|Study drug toxicity|3|||
23775636|NCT02726581|66559751|FG002|Treatment Period|Study drug toxicity|2|||
23633855|NCT02628028|66045508|FG001|Dosing Period|Death|0|||
23775637|NCT02726581|66559749|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
23834689|NCT01962103|66774135|FG004|Phase 1|Physician Decision|0|||
23834690|NCT01962103|66774136|FG005|Phase 1|Physician Decision|0|||
23834691|NCT01962103|66774137|FG006|Phase 1|Physician Decision|0|||
23834692|NCT01962103|66774138|FG007|Phase 1|Physician Decision|0|||
23834693|NCT01962103|66774139|FG008|Phase 1|Physician Decision|0|||
23834694|NCT01962103|66774131|FG000|Phase 1|Symptomatic Deterioration|3|||
23834695|NCT01962103|66774132|FG001|Phase 1|Symptomatic Deterioration|2|||
23775638|NCT02726581|66559750|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
23775639|NCT02726581|66559751|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
23775640|NCT02726581|66559749|FG000|Treatment Period|Participant withdrew consent|3|||
23775641|NCT02726581|66559750|FG001|Treatment Period|Participant withdrew consent|1|||
23775642|NCT02726581|66559751|FG002|Treatment Period|Participant withdrew consent|1|||
23775643|NCT02726581|66559749|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
23775644|NCT02726581|66559750|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
23775645|NCT02726581|66559751|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
23775646|NCT02726581|66559749|FG000|Treatment Period|Maximum clinical benefit|0|||
23775647|NCT02726581|66559750|FG001|Treatment Period|Maximum clinical benefit|2|||
23775648|NCT02726581|66559751|FG002|Treatment Period|Maximum clinical benefit|0|||
23775649|NCT02726581|66559749|FG000|Treatment Period|Death|1|||
23775650|NCT02726581|66559750|FG001|Treatment Period|Death|0|||
23775651|NCT02726581|66559751|FG002|Treatment Period|Death|0|||
23775652|NCT02726581|66559749|FG000|Treatment Period|Poor/non-compliance|1|||
23775653|NCT02726581|66559750|FG001|Treatment Period|Poor/non-compliance|0|||
23775654|NCT02726581|66559751|FG002|Treatment Period|Poor/non-compliance|0|||
23834696|NCT01962103|66774133|FG002|Phase 1|Symptomatic Deterioration|2|||
23834697|NCT01962103|66774134|FG003|Phase 1|Symptomatic Deterioration|2|||
23834698|NCT01962103|66774135|FG004|Phase 1|Symptomatic Deterioration|1|||
23775655|NCT02726581|66559749|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23775656|NCT02726581|66559750|FG001|Treatment Period|Participant no longer meets study criteria|1|||
23448451|NCT04073186|65384614|FG000|First Wearing Cycle|Lens Discomfort|2|||
23448452|NCT04073186|65384614|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
23448453|NCT04073186|65384614|FG000|Second Wearing Cycle|Adverse Event|1|||
23448454|NCT04024891|65384616|FG000|Overall Study|Pregnancy|0|||
23448455|NCT04024891|65384617|FG001|Overall Study|Pregnancy|1|||
23448456|NCT04112303|65384621|FG000|Overall Study|Death|1|||
23448457|NCT02518971|65384623|FG000|Overall Study|Lost to Follow-up|0|||
23448458|NCT02518971|65384624|FG001|Overall Study|Lost to Follow-up|1|||
23448459|NCT02518971|65384623|FG000|Overall Study|Physician Decision|6|||
23448460|NCT02518971|65384624|FG001|Overall Study|Physician Decision|6|||
23448461|NCT02518971|65384623|FG000|Overall Study|Protocol Violation|6|||
23448462|NCT02518971|65384624|FG001|Overall Study|Protocol Violation|4|||
23448463|NCT02518971|65384623|FG000|Overall Study|Withdrawal by Subject|4|||
23448464|NCT02518971|65384624|FG001|Overall Study|Withdrawal by Subject|5|||
23448465|NCT02518971|65384623|FG000|Overall Study|Side effects|1|||
23775657|NCT02726581|66559751|FG002|Treatment Period|Participant no longer meets study criteria|0|||
23775658|NCT01001208|66559752|FG000|Overall Study|Adverse Event|10|||
23775659|NCT01001208|66559753|FG001|Overall Study|Adverse Event|5|||
23775660|NCT01001208|66559752|FG000|Overall Study|Lost to Follow-up|5|||
23775661|NCT01001208|66559753|FG001|Overall Study|Lost to Follow-up|9|||
23775662|NCT01001208|66559752|FG000|Overall Study|Physician Decision|1|||
23775663|NCT01001208|66559753|FG001|Overall Study|Physician Decision|0|||
23775664|NCT01001208|66559752|FG000|Overall Study|Withdrawal by Subject|4|||
23775665|NCT01001208|66559753|FG001|Overall Study|Withdrawal by Subject|5|||
23775666|NCT01001208|66559752|FG000|Overall Study|Ineligibility Determined|4|||
23775667|NCT01001208|66559753|FG001|Overall Study|Ineligibility Determined|2|||
23775668|NCT01001208|66559752|FG000|Overall Study|Noncompliance|4|||
23775669|NCT01001208|66559753|FG001|Overall Study|Noncompliance|7|||
23775670|NCT01001208|66559752|FG000|Overall Study|Disease Progression|0|||
23775671|NCT01001208|66559753|FG001|Overall Study|Disease Progression|3|||
23775672|NCT01001208|66559752|FG000|Overall Study|Other|0|||
23775673|NCT01001208|66559753|FG001|Overall Study|Other|2|||
23775674|NCT03471078|66559755|FG000|Overall Study|Withdrawal by Subject|9|||
23775675|NCT03471078|66559756|FG001|Overall Study|Withdrawal by Subject|1|||
23775676|NCT03471078|66559755|FG000|Overall Study|Adverse Event|4|||
23775677|NCT03471078|66559756|FG001|Overall Study|Adverse Event|1|||
23775678|NCT03471078|66559755|FG000|Overall Study|Physician Decision|3|||
23775679|NCT03471078|66559756|FG001|Overall Study|Physician Decision|2|||
23775680|NCT03471078|66559755|FG000|Overall Study|Death|2|||
23775681|NCT03471078|66559756|FG001|Overall Study|Death|0|||
23775682|NCT03471078|66559755|FG000|Overall Study|Other|3|||
23775683|NCT03471078|66559756|FG001|Overall Study|Other|2|||
23775684|NCT03122457|66559760|FG000|Overall Study|Withdrawal by Subject|6|||
23775685|NCT01367457|66559762|FG000|Overall Study|Death|2|||
23775686|NCT01367457|66559763|FG001|Overall Study|Death|0|||
23775687|NCT01367457|66559764|FG002|Overall Study|Death|0|||
23775688|NCT01367457|66559762|FG000|Overall Study|Investigator's decision|2|||
23448466|NCT02518971|65384624|FG001|Overall Study|Side effects|0|||
23448467|NCT02518971|65384623|FG000|Overall Study|medication lost in mail|0|||
23448468|NCT02518971|65384624|FG001|Overall Study|medication lost in mail|1|||
23576501|NCT02061761|65843365|FG003|Overall Study|Maximum clinical benefit|1|||
23576502|NCT02061761|65843366|FG004|Overall Study|Maximum clinical benefit|0|||
23448469|NCT02518971|65384623|FG000|Overall Study|eligibility criteria no longer met|6|||
23448470|NCT02518971|65384624|FG001|Overall Study|eligibility criteria no longer met|3|||
23448471|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
23576503|NCT02061761|65843367|FG005|Overall Study|Maximum clinical benefit|0|||
23775689|NCT01367457|66559763|FG001|Overall Study|Investigator's decision|0|||
23775690|NCT01367457|66559764|FG002|Overall Study|Investigator's decision|0|||
23775691|NCT01367457|66559762|FG000|Overall Study|Clinical decline (CD)|2|||
23775692|NCT01367457|66559763|FG001|Overall Study|Clinical decline (CD)|0|||
23775693|NCT01367457|66559764|FG002|Overall Study|Clinical decline (CD)|0|||
23775694|NCT01367457|66559762|FG000|Overall Study|Progression and death|8|||
23775695|NCT01367457|66559763|FG001|Overall Study|Progression and death|0|||
23775696|NCT01367457|66559764|FG002|Overall Study|Progression and death|0|||
23775697|NCT01367457|66559762|FG000|Overall Study|Toxicity|16|||
23448472|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
23448473|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
23448474|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
23448475|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
23448476|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
23448477|NCT01521507|65384625|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
23448478|NCT01521507|65384626|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
23448479|NCT01521507|65384625|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
23448480|NCT01521507|65384626|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
23448481|NCT01521507|65384625|FG000|Stage 2: Observational Design|Physician Decision|1|||
23448482|NCT01521507|65384626|FG001|Stage 2: Observational Design|Physician Decision|0|||
23448483|NCT01125800|65384628|FG000|Phase I|Protocol Violation|0|||
23448484|NCT01125800|65384629|FG001|Phase I|Protocol Violation|3|||
23448485|NCT01125800|65384630|FG002|Phase I|Protocol Violation|1|||
23448486|NCT01125800|65384631|FG003|Phase I|Protocol Violation|1|||
23448487|NCT01125800|65384632|FG004|Phase I|Protocol Violation|0|||
23448488|NCT01125800|65384628|FG000|Phase I|Adverse Event|2|||
23448489|NCT01125800|65384629|FG001|Phase I|Adverse Event|2|||
23448490|NCT01125800|65384630|FG002|Phase I|Adverse Event|1|||
23448491|NCT01125800|65384631|FG003|Phase I|Adverse Event|7|||
23448492|NCT01125800|65384632|FG004|Phase I|Adverse Event|0|||
23448493|NCT01125800|65384628|FG000|Phase I|Administrative problems|1|||
23448494|NCT01125800|65384629|FG001|Phase I|Administrative problems|0|||
23448495|NCT01125800|65384630|FG002|Phase I|Administrative problems|0|||
23448496|NCT01125800|65384631|FG003|Phase I|Administrative problems|0|||
23448497|NCT01125800|65384632|FG004|Phase I|Administrative problems|0|||
23448498|NCT01125800|65384628|FG000|Phase I|Withdrawal by Subject|0|||
23448499|NCT01125800|65384629|FG001|Phase I|Withdrawal by Subject|0|||
23448500|NCT01125800|65384630|FG002|Phase I|Withdrawal by Subject|1|||
23448501|NCT01125800|65384631|FG003|Phase I|Withdrawal by Subject|0|||
23448502|NCT01125800|65384632|FG004|Phase I|Withdrawal by Subject|0|||
23448503|NCT01125800|65384628|FG000|Phase I|Disease progression|5|||
23448504|NCT01125800|65384629|FG001|Phase I|Disease progression|4|||
23448505|NCT01125800|65384630|FG002|Phase I|Disease progression|1|||
23448506|NCT01125800|65384631|FG003|Phase I|Disease progression|3|||
23448507|NCT01125800|65384632|FG004|Phase I|Disease progression|0|||
23448508|NCT01125800|65384628|FG000|Phase II|Protocol Violation|0|||
23448509|NCT01125800|65384629|FG001|Phase II|Protocol Violation|0|||
23448510|NCT01125800|65384630|FG002|Phase II|Protocol Violation|0|||
23448511|NCT01125800|65384631|FG003|Phase II|Protocol Violation|0|||
23448512|NCT01125800|65384632|FG004|Phase II|Protocol Violation|1|||
23448513|NCT01125800|65384628|FG000|Phase II|Adverse Event|0|||
23448514|NCT01125800|65384629|FG001|Phase II|Adverse Event|0|||
23448515|NCT01125800|65384630|FG002|Phase II|Adverse Event|0|||
23448516|NCT01125800|65384631|FG003|Phase II|Adverse Event|0|||
23448517|NCT01125800|65384632|FG004|Phase II|Adverse Event|2|||
23448518|NCT01125800|65384628|FG000|Phase II|Disease progression|0|||
23448519|NCT01125800|65384629|FG001|Phase II|Disease progression|0|||
23448520|NCT01125800|65384630|FG002|Phase II|Disease progression|0|||
23448521|NCT01125800|65384631|FG003|Phase II|Disease progression|1|||
23448522|NCT01125800|65384632|FG004|Phase II|Disease progression|8|||
23448523|NCT00462306|65384633|FG000|Overall Study|insufficient data|0|||
23448524|NCT00462306|65384634|FG001|Overall Study|insufficient data|13|||
23448525|NCT00402168|65384635|FG000|Randomized|Lost to Follow-up|1|||
23448526|NCT00402168|65384636|FG001|Randomized|Lost to Follow-up|0|||
23448527|NCT00402168|65384635|FG000|Randomized|Withdrawal by Subject|0|||
23448528|NCT00402168|65384636|FG001|Randomized|Withdrawal by Subject|1|||
23448529|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|Death|0|||
23448530|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|Death|1|||
23448531|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
23448532|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
23448533|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|non-specified|0|||
23448534|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|non-specified|1|||
23448535|NCT00402168|65384635|FG000|Long Term (LT)|Adverse Event|1|||
23448536|NCT00402168|65384636|FG001|Long Term (LT)|Adverse Event|5|||
23775698|NCT01367457|66559763|FG001|Overall Study|Toxicity|0|||
23775699|NCT01367457|66559764|FG002|Overall Study|Toxicity|0|||
23448537|NCT00402168|65384635|FG000|Long Term (LT)|Withdrawal by Subject|4|||
23448538|NCT00402168|65384636|FG001|Long Term (LT)|Withdrawal by Subject|7|||
23448539|NCT00402168|65384635|FG000|Long Term (LT)|Pregnancy|0|||
23448540|NCT00402168|65384636|FG001|Long Term (LT)|Pregnancy|1|||
23448541|NCT00402168|65384635|FG000|Long Term (LT)|Lost to Follow-up|1|||
23448542|NCT00402168|65384636|FG001|Long Term (LT)|Lost to Follow-up|0|||
23448543|NCT00402168|65384635|FG000|Long Term (LT)|Death|4|||
23448544|NCT00402168|65384636|FG001|Long Term (LT)|Death|0|||
23448545|NCT00402168|65384635|FG000|Long Term (LT)|Lack of Efficacy|0|||
23448546|NCT00402168|65384636|FG001|Long Term (LT)|Lack of Efficacy|2|||
23633856|NCT02628028|66045509|FG002|Dosing Period|Death|0|||
23633857|NCT02628028|66045510|FG003|Dosing Period|Death|0|||
23633858|NCT02628028|66045511|FG004|Dosing Period|Death|0|||
23633859|NCT02628028|66045512|FG005|Dosing Period|Death|0|||
23633860|NCT02628028|66045513|FG006|Dosing Period|Death|0|||
23633861|NCT02628028|66045514|FG007|Dosing Period|Death|1|||
23633862|NCT02628028|66045507|FG000|Dosing Period|Lack of Efficacy|0|||
23633863|NCT02628028|66045508|FG001|Dosing Period|Lack of Efficacy|0|||
23633864|NCT02628028|66045509|FG002|Dosing Period|Lack of Efficacy|0|||
23633865|NCT02628028|66045510|FG003|Dosing Period|Lack of Efficacy|0|||
23633866|NCT02628028|66045511|FG004|Dosing Period|Lack of Efficacy|3|||
23633867|NCT02628028|66045512|FG005|Dosing Period|Lack of Efficacy|0|||
23633868|NCT02628028|66045513|FG006|Dosing Period|Lack of Efficacy|1|||
23633869|NCT02628028|66045514|FG007|Dosing Period|Lack of Efficacy|0|||
23633870|NCT02628028|66045507|FG000|Dosing Period|Study Terminated by Sponsor|0|||
23633871|NCT02628028|66045508|FG001|Dosing Period|Study Terminated by Sponsor|0|||
23633872|NCT02628028|66045509|FG002|Dosing Period|Study Terminated by Sponsor|0|||
23633873|NCT02628028|66045510|FG003|Dosing Period|Study Terminated by Sponsor|0|||
23633874|NCT02628028|66045511|FG004|Dosing Period|Study Terminated by Sponsor|7|||
23633875|NCT02628028|66045512|FG005|Dosing Period|Study Terminated by Sponsor|6|||
23633876|NCT02628028|66045513|FG006|Dosing Period|Study Terminated by Sponsor|7|||
23633877|NCT02628028|66045514|FG007|Dosing Period|Study Terminated by Sponsor|7|||
23633878|NCT02628028|66045507|FG000|Dosing Period|Physician Decision|0|||
23633879|NCT02628028|66045508|FG001|Dosing Period|Physician Decision|0|||
23633880|NCT02628028|66045509|FG002|Dosing Period|Physician Decision|0|||
23633881|NCT02628028|66045510|FG003|Dosing Period|Physician Decision|0|||
23633882|NCT02628028|66045511|FG004|Dosing Period|Physician Decision|0|||
23775700|NCT01367457|66559762|FG000|Overall Study|Progression|137|||
23775701|NCT01367457|66559763|FG001|Overall Study|Progression|0|||
23775702|NCT01367457|66559764|FG002|Overall Study|Progression|0|||
23775703|NCT01367457|66559762|FG000|Overall Study|Patient asks for rest + slow progression|1|||
23775704|NCT01367457|66559763|FG001|Overall Study|Patient asks for rest + slow progression|0|||
23775705|NCT01367457|66559764|FG002|Overall Study|Patient asks for rest + slow progression|0|||
23775706|NCT01367457|66559762|FG000|Overall Study|Investigator's opinion, stable disease|1|||
23775707|NCT01367457|66559763|FG001|Overall Study|Investigator's opinion, stable disease|0|||
23775708|NCT01367457|66559764|FG002|Overall Study|Investigator's opinion, stable disease|0|||
23775709|NCT01367457|66559762|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
23775710|NCT01367457|66559763|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
23775711|NCT01367457|66559764|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
23775712|NCT01367457|66559762|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
23775713|NCT01367457|66559763|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
23775714|NCT01367457|66559764|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
23775715|NCT01367457|66559762|FG000|Overall Study|low grade toxicities + stable disease|1|||
23775716|NCT01367457|66559763|FG001|Overall Study|low grade toxicities + stable disease|0|||
23775717|NCT01367457|66559764|FG002|Overall Study|low grade toxicities + stable disease|0|||
23775718|NCT01367457|66559762|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
23775719|NCT01367457|66559763|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
23775720|NCT01367457|66559764|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
23775721|NCT01367457|66559762|FG000|Overall Study|Withdrawal by Subject|1|||
23775722|NCT01367457|66559763|FG001|Overall Study|Withdrawal by Subject|0|||
23775723|NCT01367457|66559764|FG002|Overall Study|Withdrawal by Subject|0|||
23775724|NCT01367457|66559762|FG000|Overall Study|CD, associated leukaemia|1|||
23775725|NCT01367457|66559763|FG001|Overall Study|CD, associated leukaemia|0|||
23775726|NCT01367457|66559764|FG002|Overall Study|CD, associated leukaemia|0|||
23775727|NCT01367457|66559762|FG000|Overall Study|Uncontrolled pain|1|||
23775728|NCT01367457|66559763|FG001|Overall Study|Uncontrolled pain|0|||
23775729|NCT01367457|66559764|FG002|Overall Study|Uncontrolled pain|0|||
23775730|NCT01367457|66559762|FG000|Overall Study|Overall status worsens to grade 4|1|||
23775731|NCT01367457|66559763|FG001|Overall Study|Overall status worsens to grade 4|0|||
23448547|NCT00402168|65384635|FG000|Long Term (LT)|non-specified|1|||
23448548|NCT00402168|65384636|FG001|Long Term (LT)|non-specified|2|||
23448549|NCT00402168|65384635|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
23448550|NCT00402168|65384636|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
23448551|NCT00402168|65384635|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
23448552|NCT00402168|65384636|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
23448553|NCT00496080|65384637|FG000|Overall Study|Lost to Follow-up|9|||
23633883|NCT02628028|66045512|FG005|Dosing Period|Physician Decision|1|||
23633884|NCT02628028|66045513|FG006|Dosing Period|Physician Decision|0|||
23633885|NCT02628028|66045514|FG007|Dosing Period|Physician Decision|0|||
23633886|NCT02628028|66045507|FG000|Dosing Period|Site Terminated by Sponsor|0|||
23633887|NCT02628028|66045508|FG001|Dosing Period|Site Terminated by Sponsor|0|||
23633888|NCT02628028|66045509|FG002|Dosing Period|Site Terminated by Sponsor|0|||
23775732|NCT01367457|66559764|FG002|Overall Study|Overall status worsens to grade 4|0|||
23775733|NCT01367457|66559762|FG000|Overall Study|Stabilisation + frequent infections|1|||
23448554|NCT00496080|65384637|FG000|Overall Study|Surgical re-intervention|7|||
23448555|NCT00496080|65384637|FG000|Overall Study|Withdrawal by Subject|5|||
23448556|NCT00496080|65384637|FG000|Overall Study|Physician Decision|6|||
23448557|NCT00887549|65384638|FG000|Induction Therapy|Adverse Event|8|||
23448558|NCT00887549|65384638|FG000|Induction Therapy|Physician Decision|1|||
23448559|NCT00887549|65384638|FG000|Induction Therapy|Progressive Disease|13|||
23448560|NCT00887549|65384638|FG000|Induction Therapy|Death due to Study Disease|4|||
23448561|NCT00887549|65384638|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
23448562|NCT00887549|65384638|FG000|Maintenance Therapy|Adverse Event|16|||
23448563|NCT00887549|65384638|FG000|Maintenance Therapy|Physician Decision|1|||
23448564|NCT00887549|65384638|FG000|Maintenance Therapy|Progressive Disease|25|||
23448565|NCT00887549|65384638|FG000|Maintenance Therapy|Death due to adverse event|1|||
23834699|NCT01962103|66774136|FG005|Phase 1|Symptomatic Deterioration|1|||
23834700|NCT01962103|66774137|FG006|Phase 1|Symptomatic Deterioration|0|||
23834701|NCT01962103|66774138|FG007|Phase 1|Symptomatic Deterioration|0|||
23448566|NCT01485094|65384639|FG000|Overall Study|Adverse Event|1|||
23448567|NCT01485094|65384640|FG001|Overall Study|Adverse Event|1|||
23448568|NCT01485094|65384641|FG002|Overall Study|Adverse Event|1|||
23448569|NCT01485094|65384639|FG000|Overall Study|Lost to Follow-up|1|||
23448570|NCT01485094|65384640|FG001|Overall Study|Lost to Follow-up|0|||
23448571|NCT01485094|65384641|FG002|Overall Study|Lost to Follow-up|0|||
23448572|NCT01485094|65384639|FG000|Overall Study|Withdrawal by Subject|1|||
23775734|NCT01367457|66559763|FG001|Overall Study|Stabilisation + frequent infections|0|||
23775735|NCT01367457|66559764|FG002|Overall Study|Stabilisation + frequent infections|0|||
23775736|NCT01367457|66559762|FG000|Overall Study|No clinical benefit|1|||
23775737|NCT01367457|66559763|FG001|Overall Study|No clinical benefit|0|||
23775738|NCT01367457|66559764|FG002|Overall Study|No clinical benefit|0|||
23775739|NCT01367457|66559762|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
23775740|NCT01367457|66559763|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
23775741|NCT01367457|66559764|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
23775742|NCT01367457|66559762|FG000|Overall Study|Overall decline|1|||
23775743|NCT01367457|66559763|FG001|Overall Study|Overall decline|0|||
23775744|NCT01367457|66559764|FG002|Overall Study|Overall decline|0|||
23775745|NCT01367457|66559762|FG000|Overall Study|Rejection of treatment|1|||
23775746|NCT01367457|66559763|FG001|Overall Study|Rejection of treatment|0|||
23448573|NCT01485094|65384640|FG001|Overall Study|Withdrawal by Subject|1|||
23448574|NCT01485094|65384641|FG002|Overall Study|Withdrawal by Subject|0|||
23448575|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
23448576|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
23448577|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Death|1|||
23448578|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Death|2|||
23448579|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
23448580|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
23448581|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
23448582|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
23448583|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
23448584|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
23448585|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
23448586|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
23448587|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
23448588|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
23448589|NCT01794000|65384643|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
23448590|NCT01794000|65384644|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23448591|NCT04014062|65384645|FG000|Period I: Dosing|Medical Grounds|4|||
23448592|NCT04014062|65384646|FG001|Period I: Dosing|Medical Grounds|5|||
23448593|NCT04014062|65384645|FG000|Period I: Dosing|Withdrawal by Subject|3|||
23448594|NCT04014062|65384646|FG001|Period I: Dosing|Withdrawal by Subject|1|||
23448595|NCT01597635|65384647|FG000|Part A|Adverse Event|3|||
23448596|NCT01597635|65384648|FG001|Part A|Adverse Event|0|||
23448597|NCT01597635|65384649|FG002|Part A|Adverse Event|0|||
23448598|NCT01597635|65384647|FG000|Part B|Adverse Event|0|||
23448599|NCT01597635|65384648|FG001|Part B|Adverse Event|0|||
23448600|NCT01597635|65384649|FG002|Part B|Adverse Event|1|||
23448601|NCT01597635|65384647|FG000|Part B|Protocol Violation|0|||
23448602|NCT01597635|65384648|FG001|Part B|Protocol Violation|1|||
23448603|NCT01597635|65384649|FG002|Part B|Protocol Violation|0|||
23448604|NCT01597635|65384647|FG000|Part B|Protocol-defined stopping criteria|0|||
23834702|NCT01962103|66774139|FG008|Phase 1|Symptomatic Deterioration|0|||
23448605|NCT01597635|65384648|FG001|Part B|Protocol-defined stopping criteria|4|||
23448606|NCT01597635|65384649|FG002|Part B|Protocol-defined stopping criteria|3|||
23448607|NCT01597635|65384647|FG000|Part B|Withdrawal by Subject|0|||
23448608|NCT01597635|65384648|FG001|Part B|Withdrawal by Subject|1|||
23448609|NCT01597635|65384649|FG002|Part B|Withdrawal by Subject|0|||
23448610|NCT01061359|65384654|FG000|Overall Study|Death|32|||
23448611|NCT01061359|65384654|FG000|Overall Study|Lost to Follow-up|1072|||
23448612|NCT01061359|65384654|FG000|Overall Study|Relapse|187|||
23834703|NCT01962103|66774131|FG000|Phase 1|Miscellaneous|1|||
23448613|NCT01061359|65384654|FG000|Overall Study|Secondary neoplasm|11|||
23448614|NCT04393493|65384655|FG000|First 4 Days of Intervention|Early improvement|5|||
23448615|NCT04393493|65384656|FG001|First 4 Days of Intervention|Early improvement|7|||
23448616|NCT03137992|65384657|FG000|Washout Period 1|Adverse Event|1|||
23448617|NCT03137992|65384658|FG001|Washout Period 1|Adverse Event|1|||
23448618|NCT03137992|65384659|FG002|Washout Period 1|Adverse Event|0|||
23448619|NCT03137992|65384660|FG003|Washout Period 1|Adverse Event|0|||
23448620|NCT03137992|65384661|FG004|Washout Period 1|Adverse Event|0|||
23448621|NCT03137992|65384662|FG005|Washout Period 1|Adverse Event|1|||
23448622|NCT03137992|65384657|FG000|Washout Period 1|Withdrawal by Subject|0|||
23448623|NCT03137992|65384658|FG001|Washout Period 1|Withdrawal by Subject|1|||
23448624|NCT03137992|65384659|FG002|Washout Period 1|Withdrawal by Subject|1|||
23448625|NCT03137992|65384660|FG003|Washout Period 1|Withdrawal by Subject|0|||
23448626|NCT03137992|65384661|FG004|Washout Period 1|Withdrawal by Subject|0|||
23448627|NCT03137992|65384662|FG005|Washout Period 1|Withdrawal by Subject|0|||
23448628|NCT03137992|65384657|FG000|Washout Period 1|Principal Investigator Discretion|0|||
23448629|NCT03137992|65384658|FG001|Washout Period 1|Principal Investigator Discretion|1|||
23448630|NCT03137992|65384659|FG002|Washout Period 1|Principal Investigator Discretion|0|||
23448631|NCT03137992|65384660|FG003|Washout Period 1|Principal Investigator Discretion|0|||
23448632|NCT03137992|65384661|FG004|Washout Period 1|Principal Investigator Discretion|0|||
23448633|NCT03137992|65384662|FG005|Washout Period 1|Principal Investigator Discretion|0|||
23448634|NCT03137992|65384657|FG000|Washout Period 1|COPD Exacerbation|1|||
23448635|NCT03137992|65384658|FG001|Washout Period 1|COPD Exacerbation|1|||
23448636|NCT03137992|65384659|FG002|Washout Period 1|COPD Exacerbation|1|||
23448637|NCT03137992|65384660|FG003|Washout Period 1|COPD Exacerbation|0|||
23448638|NCT03137992|65384661|FG004|Washout Period 1|COPD Exacerbation|1|||
23448639|NCT03137992|65384662|FG005|Washout Period 1|COPD Exacerbation|1|||
23448640|NCT03137992|65384657|FG000|Washout Period 1|Subject Noncompliance|1|||
23448641|NCT03137992|65384658|FG001|Washout Period 1|Subject Noncompliance|0|||
23448642|NCT03137992|65384659|FG002|Washout Period 1|Subject Noncompliance|0|||
23448643|NCT03137992|65384660|FG003|Washout Period 1|Subject Noncompliance|0|||
23448644|NCT03137992|65384661|FG004|Washout Period 1|Subject Noncompliance|1|||
23448645|NCT03137992|65384662|FG005|Washout Period 1|Subject Noncompliance|0|||
23448646|NCT03137992|65384657|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448647|NCT03137992|65384658|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448648|NCT03137992|65384659|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448649|NCT03137992|65384660|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448650|NCT03137992|65384661|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448651|NCT03137992|65384662|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448652|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
23448653|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448654|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448655|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
23448656|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448657|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
23448658|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Adverse Event|0|||
23448659|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Adverse Event|1|||
23448660|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Adverse Event|0|||
23448661|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Adverse Event|0|||
23448662|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Adverse Event|0|||
23775747|NCT01367457|66559764|FG002|Overall Study|Rejection of treatment|0|||
23775748|NCT01367457|66559762|FG000|Overall Study|Lost to Follow-up|1|||
23775749|NCT01367457|66559763|FG001|Overall Study|Lost to Follow-up|0|||
23775750|NCT01367457|66559764|FG002|Overall Study|Lost to Follow-up|0|||
23448663|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Adverse Event|0|||
23448664|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448665|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
23775751|NCT01367457|66559762|FG000|Overall Study|Death from septic shock|1|||
23775752|NCT01367457|66559763|FG001|Overall Study|Death from septic shock|0|||
23775753|NCT01367457|66559764|FG002|Overall Study|Death from septic shock|0|||
23775754|NCT01367457|66559762|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
23775755|NCT01367457|66559763|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
23775756|NCT01367457|66559764|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
23448666|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448667|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
23448668|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448669|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448670|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448671|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
23448672|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448673|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23775757|NCT01367457|66559762|FG000|Overall Study|Patient's Wish|1|||
23448674|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
23775758|NCT01367457|66559763|FG001|Overall Study|Patient's Wish|0|||
23448675|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448676|NCT03137992|65384657|FG000|Washout Period 2|COPD Exacerbation|1|||
23448677|NCT03137992|65384658|FG001|Washout Period 2|COPD Exacerbation|1|||
23448678|NCT03137992|65384659|FG002|Washout Period 2|COPD Exacerbation|0|||
23448679|NCT03137992|65384660|FG003|Washout Period 2|COPD Exacerbation|0|||
23448680|NCT03137992|65384661|FG004|Washout Period 2|COPD Exacerbation|1|||
23448681|NCT03137992|65384662|FG005|Washout Period 2|COPD Exacerbation|0|||
23448682|NCT03137992|65384657|FG000|Washout Period 2|Subject Non-compliance|0|||
23448683|NCT03137992|65384658|FG001|Washout Period 2|Subject Non-compliance|1|||
23448684|NCT03137992|65384659|FG002|Washout Period 2|Subject Non-compliance|0|||
23448685|NCT03137992|65384660|FG003|Washout Period 2|Subject Non-compliance|0|||
23448686|NCT03137992|65384661|FG004|Washout Period 2|Subject Non-compliance|0|||
23448687|NCT03137992|65384662|FG005|Washout Period 2|Subject Non-compliance|0|||
23448688|NCT03137992|65384657|FG000|Washout Period 2|Adverse Event|0|||
23448689|NCT03137992|65384658|FG001|Washout Period 2|Adverse Event|0|||
23448690|NCT03137992|65384659|FG002|Washout Period 2|Adverse Event|0|||
23448691|NCT03137992|65384660|FG003|Washout Period 2|Adverse Event|1|||
23775759|NCT01367457|66559764|FG002|Overall Study|Patient's Wish|0|||
23775760|NCT01367457|66559762|FG000|Overall Study|Palliative. Overall decline|1|||
23775761|NCT01367457|66559763|FG001|Overall Study|Palliative. Overall decline|0|||
23775762|NCT01367457|66559764|FG002|Overall Study|Palliative. Overall decline|0|||
23775763|NCT01367457|66559762|FG000|Overall Study|Suspected DP/suspected active infection|1|||
23775764|NCT01367457|66559763|FG001|Overall Study|Suspected DP/suspected active infection|0|||
23775765|NCT01367457|66559764|FG002|Overall Study|Suspected DP/suspected active infection|0|||
23775766|NCT01027143|66559765|FG000|Overall Study|Lost to Follow-up|9|||
23775767|NCT01027143|66559766|FG001|Overall Study|Lost to Follow-up|4|||
23775768|NCT01697696|66559767|FG000|Overall Study|Study terminated by sponsor|0|||
23775769|NCT01697696|66559768|FG001|Overall Study|Study terminated by sponsor|3|||
23775770|NCT01697696|66559767|FG000|Overall Study|Protocol deviation|1|||
23775771|NCT01697696|66559768|FG001|Overall Study|Protocol deviation|0|||
23448692|NCT03137992|65384661|FG004|Washout Period 2|Adverse Event|1|||
23448693|NCT03137992|65384662|FG005|Washout Period 2|Adverse Event|0|||
23448694|NCT03137992|65384657|FG000|Washout Period 2|Withdrawal by Subject|1|||
23448695|NCT03137992|65384658|FG001|Washout Period 2|Withdrawal by Subject|0|||
23448696|NCT03137992|65384659|FG002|Washout Period 2|Withdrawal by Subject|0|||
23448697|NCT03137992|65384660|FG003|Washout Period 2|Withdrawal by Subject|0|||
23448698|NCT03137992|65384661|FG004|Washout Period 2|Withdrawal by Subject|1|||
23448699|NCT03137992|65384662|FG005|Washout Period 2|Withdrawal by Subject|0|||
23448700|NCT03137992|65384657|FG000|Washout Period 2|Sponsor Decision|0|||
23448701|NCT03137992|65384658|FG001|Washout Period 2|Sponsor Decision|0|||
23448702|NCT03137992|65384659|FG002|Washout Period 2|Sponsor Decision|0|||
23448703|NCT03137992|65384660|FG003|Washout Period 2|Sponsor Decision|0|||
23448704|NCT03137992|65384661|FG004|Washout Period 2|Sponsor Decision|0|||
23775772|NCT01697696|66559767|FG000|Overall Study|Physician Decision|1|||
23834704|NCT01962103|66774132|FG001|Phase 1|Miscellaneous|0|||
23834705|NCT01962103|66774133|FG002|Phase 1|Miscellaneous|0|||
23448705|NCT03137992|65384662|FG005|Washout Period 2|Sponsor Decision|1|||
23448706|NCT03137992|65384657|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
23448707|NCT03137992|65384658|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
23448708|NCT03137992|65384659|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
23448709|NCT03137992|65384660|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
23448710|NCT03137992|65384661|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
23448711|NCT03137992|65384662|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
23448712|NCT03137992|65384657|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448713|NCT03137992|65384658|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
23448714|NCT03137992|65384659|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
23448715|NCT03137992|65384660|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448716|NCT03137992|65384661|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
23448717|NCT03137992|65384662|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448718|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
23448719|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448720|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
23448721|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448722|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448723|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448724|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448725|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448726|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448727|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
23448728|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23834706|NCT01962103|66774134|FG003|Phase 1|Miscellaneous|0|||
23448729|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23775773|NCT01697696|66559768|FG001|Overall Study|Physician Decision|0|||
23775774|NCT01697696|66559767|FG000|Overall Study|Death|4|||
23834707|NCT01962103|66774135|FG004|Phase 1|Miscellaneous|0|||
23448730|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Per study team|1|||
23448731|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Per study team|0|||
23448732|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Per study team|0|||
23448733|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Per study team|0|||
23448734|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Per study team|0|||
23448735|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Per study team|0|||
23448736|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448737|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448738|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448739|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448740|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448741|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
23448742|NCT04098809|65384665|FG000|Overall Study|Withdrawal by Subject|1|||
23448743|NCT04098809|65384666|FG001|Overall Study|Withdrawal by Subject|3|||
23448744|NCT04098809|65384665|FG000|Overall Study|Physician Decision|2|||
23448745|NCT04098809|65384666|FG001|Overall Study|Physician Decision|1|||
23448746|NCT03863509|65384667|FG000|Overall Study|COVID-19 shutdown period|0|||
23448747|NCT03863509|65384668|FG001|Overall Study|COVID-19 shutdown period|4|||
23448748|NCT03863509|65384669|FG002|Overall Study|COVID-19 shutdown period|0|||
23448749|NCT03863509|65384667|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
23448750|NCT03863509|65384668|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
23448751|NCT03863509|65384669|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
23448752|NCT03863509|65384667|FG000|Overall Study|Lost to Follow-up|8|||
23448753|NCT03863509|65384668|FG001|Overall Study|Lost to Follow-up|0|||
23448754|NCT03863509|65384669|FG002|Overall Study|Lost to Follow-up|2|||
23448755|NCT03863509|65384667|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
23448756|NCT03863509|65384668|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
23448757|NCT03863509|65384669|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
23448758|NCT03863509|65384667|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
23448759|NCT03863509|65384668|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
23448760|NCT03863509|65384669|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
23448761|NCT04378270|65384670|FG000|Overall Study|Lack of Efficacy|1|||
23448762|NCT04378270|65384670|FG000|Overall Study|Withdrawal by Subject|1|||
23448763|NCT04378270|65384670|FG000|Overall Study|Screen Failure|1|||
23448764|NCT04378270|65384670|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
23448765|NCT02614729|65384671|FG000|Overall Study|Withdrawal by Subject|1|||
23448766|NCT02614729|65384672|FG001|Overall Study|Withdrawal by Subject|0|||
23448767|NCT02680665|65384673|FG000|Overall Study|No visit after the first prescription|5|||
23448768|NCT02380287|65384674|FG000|Overall Study|Adverse Event|0|||
23448769|NCT02380287|65384675|FG001|Overall Study|Adverse Event|0|||
23448770|NCT02380287|65384676|FG002|Overall Study|Adverse Event|1|||
23448771|NCT02380287|65384677|FG003|Overall Study|Adverse Event|0|||
23448772|NCT02380287|65384678|FG004|Overall Study|Adverse Event|0|||
23448773|NCT02380287|65384679|FG005|Overall Study|Adverse Event|0|||
23448774|NCT02380287|65384680|FG006|Overall Study|Adverse Event|0|||
23448775|NCT02380287|65384681|FG007|Overall Study|Adverse Event|0|||
23448776|NCT00369577|65384682|FG000|Overall Study|Withdrawal by Subject|0|||
23448777|NCT00369577|65384683|FG001|Overall Study|Withdrawal by Subject|0|||
23448778|NCT00369577|65384684|FG002|Overall Study|Withdrawal by Subject|1|||
23448779|NCT00671034|65384685|FG000|Overall Study|Adverse Event|5|||
23448780|NCT00671034|65384686|FG001|Overall Study|Adverse Event|7|||
23448781|NCT00671034|65384687|FG002|Overall Study|Adverse Event|1|||
23448782|NCT00671034|65384685|FG000|Overall Study|Death|3|||
23448783|NCT00671034|65384686|FG001|Overall Study|Death|2|||
23448784|NCT00671034|65384687|FG002|Overall Study|Death|1|||
23448785|NCT00671034|65384685|FG000|Overall Study|Physician Decision|12|||
23448786|NCT00671034|65384686|FG001|Overall Study|Physician Decision|4|||
23448787|NCT00671034|65384687|FG002|Overall Study|Physician Decision|5|||
23448788|NCT00671034|65384685|FG000|Overall Study|VHR ALL feature|8|||
23448789|NCT00671034|65384686|FG001|Overall Study|VHR ALL feature|3|||
23448790|NCT00671034|65384687|FG002|Overall Study|VHR ALL feature|5|||
23448791|NCT00671034|65384685|FG000|Overall Study|Refusal|5|||
23448792|NCT00671034|65384686|FG001|Overall Study|Refusal|3|||
23448793|NCT00671034|65384687|FG002|Overall Study|Refusal|5|||
23448794|NCT00671034|65384685|FG000|Overall Study|includes Alternative therapy, etc.|6|||
23448795|NCT00671034|65384686|FG001|Overall Study|includes Alternative therapy, etc.|1|||
23448796|NCT00671034|65384687|FG002|Overall Study|includes Alternative therapy, etc.|7|||
23448797|NCT02252146|65384690|FG000|Overall Study|Lack of Efficacy|4|||
23633889|NCT02628028|66045510|FG003|Dosing Period|Site Terminated by Sponsor|0|||
23448798|NCT02252146|65384690|FG000|Overall Study|Entered hospice care|1|||
23633890|NCT02628028|66045511|FG004|Dosing Period|Site Terminated by Sponsor|0|||
23633891|NCT02628028|66045512|FG005|Dosing Period|Site Terminated by Sponsor|1|||
23448799|NCT02252146|65384690|FG000|Overall Study|Inability to travel to study site|1|||
23448800|NCT00601835|65384694|FG000|Overall Study|Withdrawal by Subject|9|||
23448801|NCT00601835|65384695|FG001|Overall Study|Withdrawal by Subject|6|||
23448802|NCT00601835|65384694|FG000|Overall Study|Physician Decision|1|||
23448803|NCT00601835|65384695|FG001|Overall Study|Physician Decision|0|||
23448804|NCT00601835|65384694|FG000|Overall Study|Lost to Follow-up|37|||
23448805|NCT00601835|65384695|FG001|Overall Study|Lost to Follow-up|5|||
23448806|NCT00601835|65384694|FG000|Overall Study|Adverse Event|1|||
23448807|NCT00601835|65384695|FG001|Overall Study|Adverse Event|1|||
23775775|NCT01697696|66559768|FG001|Overall Study|Death|2|||
23775776|NCT01697696|66559767|FG000|Overall Study|Lost to Follow-up|10|||
23775777|NCT01697696|66559768|FG001|Overall Study|Lost to Follow-up|7|||
23775778|NCT01697696|66559767|FG000|Overall Study|Subject/guardian decision|31|||
23775779|NCT01697696|66559768|FG001|Overall Study|Subject/guardian decision|35|||
23775780|NCT00565448|66559769|FG000|Overall Study|Adverse Event|1|||
23775781|NCT00565448|66559770|FG001|Overall Study|Adverse Event|2|||
23448808|NCT00601835|65384694|FG000|Overall Study|Relocate|12|||
23448809|NCT00601835|65384695|FG001|Overall Study|Relocate|2|||
23448810|NCT00354679|65384696|FG000|Overall Study|Patient Not Treated|1|||
23448811|NCT03343626|65384697|FG000|Overall Study|Lost to Follow-up|4|||
23448812|NCT03343626|65384698|FG001|Overall Study|Lost to Follow-up|3|||
23448813|NCT03343626|65384699|FG002|Overall Study|Lost to Follow-up|2|||
23448814|NCT03343626|65384700|FG003|Overall Study|Lost to Follow-up|5|||
23448815|NCT03343626|65384701|FG004|Overall Study|Lost to Follow-up|4|||
23448816|NCT03343626|65384702|FG005|Overall Study|Lost to Follow-up|4|||
23448817|NCT03343626|65384703|FG006|Overall Study|Lost to Follow-up|4|||
23448818|NCT03343626|65384704|FG007|Overall Study|Lost to Follow-up|7|||
23448819|NCT03343626|65384697|FG000|Overall Study|Withdrawal of Consent|2|||
23448820|NCT03343626|65384698|FG001|Overall Study|Withdrawal of Consent|1|||
23448821|NCT03343626|65384699|FG002|Overall Study|Withdrawal of Consent|0|||
23448822|NCT03343626|65384700|FG003|Overall Study|Withdrawal of Consent|3|||
23448823|NCT03343626|65384701|FG004|Overall Study|Withdrawal of Consent|3|||
23448824|NCT03343626|65384702|FG005|Overall Study|Withdrawal of Consent|1|||
23448825|NCT03343626|65384703|FG006|Overall Study|Withdrawal of Consent|1|||
23448826|NCT03343626|65384704|FG007|Overall Study|Withdrawal of Consent|2|||
23448827|NCT03343626|65384697|FG000|Overall Study|Reason not Specified|0|||
23448828|NCT03343626|65384698|FG001|Overall Study|Reason not Specified|1|||
23448829|NCT03343626|65384699|FG002|Overall Study|Reason not Specified|0|||
23448830|NCT03343626|65384700|FG003|Overall Study|Reason not Specified|0|||
23448831|NCT03343626|65384701|FG004|Overall Study|Reason not Specified|0|||
23448832|NCT03343626|65384702|FG005|Overall Study|Reason not Specified|0|||
23448833|NCT03343626|65384703|FG006|Overall Study|Reason not Specified|0|||
23448834|NCT03343626|65384704|FG007|Overall Study|Reason not Specified|1|||
23448835|NCT03343626|65384697|FG000|Overall Study|Data Entry Error|0|||
23448836|NCT03343626|65384698|FG001|Overall Study|Data Entry Error|0|||
23448837|NCT03343626|65384699|FG002|Overall Study|Data Entry Error|0|||
23448838|NCT03343626|65384700|FG003|Overall Study|Data Entry Error|0|||
23448839|NCT03343626|65384701|FG004|Overall Study|Data Entry Error|0|||
23448840|NCT03343626|65384702|FG005|Overall Study|Data Entry Error|0|||
23448841|NCT03343626|65384703|FG006|Overall Study|Data Entry Error|0|||
23448842|NCT03343626|65384704|FG007|Overall Study|Data Entry Error|1|||
23448843|NCT04486235|65384705|FG000|Overall Study|Pregnancy|1|||
23448844|NCT04486235|65384706|FG001|Overall Study|Pregnancy|0|||
23448845|NCT04486235|65384705|FG000|Overall Study|Lost to Follow-up|1|||
23448846|NCT04486235|65384706|FG001|Overall Study|Lost to Follow-up|0|||
23448847|NCT00655629|65384707|FG000|Overall Study|Adverse Event|4|||
23448848|NCT00655629|65384708|FG001|Overall Study|Adverse Event|1|||
23448849|NCT00655629|65384707|FG000|Overall Study|Lack of Efficacy|2|||
23448850|NCT00655629|65384708|FG001|Overall Study|Lack of Efficacy|12|||
23448851|NCT00655629|65384707|FG000|Overall Study|Lost to Follow-up|4|||
23448852|NCT00655629|65384708|FG001|Overall Study|Lost to Follow-up|3|||
23775782|NCT00565448|66559769|FG000|Overall Study|Disease progression|1|||
23448853|NCT00655629|65384707|FG000|Overall Study|Protocol Violation|5|||
23448854|NCT00655629|65384708|FG001|Overall Study|Protocol Violation|3|||
23448855|NCT00655629|65384707|FG000|Overall Study|consent withdrawn|6|||
23448856|NCT00655629|65384708|FG001|Overall Study|consent withdrawn|4|||
23448857|NCT02025179|65384709|FG000|Overall Study|Lost to Follow-up|0|||
23448858|NCT02025179|65384710|FG001|Overall Study|Lost to Follow-up|0|||
23448859|NCT02025179|65384711|FG002|Overall Study|Lost to Follow-up|1|||
23448860|NCT01454596|65384714|FG000|Overall Study|Death|0|||
23448861|NCT01454596|65384715|FG001|Overall Study|Death|0|||
23448862|NCT01454596|65384716|FG002|Overall Study|Death|0|||
23448863|NCT01454596|65384717|FG003|Overall Study|Death|0|||
23448864|NCT01454596|65384718|FG004|Overall Study|Death|0|||
23448865|NCT01454596|65384719|FG005|Overall Study|Death|0|||
23448866|NCT01454596|65384720|FG006|Overall Study|Death|0|||
23448867|NCT01454596|65384721|FG007|Overall Study|Death|0|||
23775783|NCT00565448|66559770|FG001|Overall Study|Disease progression|0|||
23775784|NCT00565448|66559769|FG000|Overall Study|Withdrawal by Subject|1|||
23448868|NCT01454596|65384722|FG008|Overall Study|Death|0|||
23448869|NCT01454596|65384723|FG009|Overall Study|Death|1|||
23448870|NCT01454596|65384724|FG010|Overall Study|Death|1|||
23448871|NCT01454596|65384725|FG011|Overall Study|Death|0|||
23448872|NCT01236521|65384726|FG000|Overall Study|Withdrawal by Subject|12|||
23448873|NCT01236521|65384727|FG001|Overall Study|Withdrawal by Subject|17|||
23448874|NCT01236521|65384726|FG000|Overall Study|Death|2|||
23448875|NCT01236521|65384727|FG001|Overall Study|Death|1|||
23448876|NCT01236521|65384726|FG000|Overall Study|Lost to Follow-up|9|||
23775785|NCT00565448|66559770|FG001|Overall Study|Withdrawal by Subject|0|||
23775786|NCT00001849|66559771|FG000|Overall Study|Death|4|||
23775787|NCT00001849|66559771|FG000|Overall Study|Lost to Follow-up|2|||
23775788|NCT00001849|66559771|FG000|Overall Study|Withdrawal by Subject|2|||
23775789|NCT00001849|66559771|FG000|Overall Study|tumor remained occult|6|||
23775790|NCT01710657|66559775|FG000|Overall Study|Lost to Follow-up|2|||
23775791|NCT01710657|66559776|FG001|Overall Study|Lost to Follow-up|0|||
23775792|NCT01710657|66559777|FG002|Overall Study|Lost to Follow-up|1|||
23775793|NCT01710657|66559775|FG000|Overall Study|Protocol Violation|2|||
23834708|NCT01962103|66774136|FG005|Phase 1|Miscellaneous|0|||
23834709|NCT01962103|66774137|FG006|Phase 1|Miscellaneous|0|||
23834710|NCT01962103|66774138|FG007|Phase 1|Miscellaneous|0|||
23834711|NCT01962103|66774139|FG008|Phase 1|Miscellaneous|0|||
23448877|NCT01236521|65384727|FG001|Overall Study|Lost to Follow-up|7|||
23448878|NCT01486966|65384730|FG000|Overall Study|Adverse Event|0|||
23448879|NCT01486966|65384731|FG001|Overall Study|Adverse Event|1|||
23448880|NCT01486966|65384730|FG000|Overall Study|Withdrawal by Subject|0|||
23448881|NCT01486966|65384731|FG001|Overall Study|Withdrawal by Subject|1|||
23834712|NCT01962103|66774131|FG000|Phase 2|Adverse Event|0|||
23834713|NCT01962103|66774132|FG001|Phase 2|Adverse Event|0|||
23834714|NCT01962103|66774133|FG002|Phase 2|Adverse Event|0|||
23834715|NCT01962103|66774134|FG003|Phase 2|Adverse Event|0|||
23834716|NCT01962103|66774135|FG004|Phase 2|Adverse Event|0|||
23834717|NCT01962103|66774136|FG005|Phase 2|Adverse Event|0|||
23834718|NCT01962103|66774137|FG006|Phase 2|Adverse Event|1|||
23834719|NCT01962103|66774138|FG007|Phase 2|Adverse Event|0|||
23834720|NCT01962103|66774139|FG008|Phase 2|Adverse Event|3|||
23834721|NCT01962103|66774131|FG000|Phase 2|Progressive Disease|0|||
23834722|NCT01962103|66774132|FG001|Phase 2|Progressive Disease|0|||
23834723|NCT01962103|66774133|FG002|Phase 2|Progressive Disease|0|||
23834724|NCT01962103|66774134|FG003|Phase 2|Progressive Disease|0|||
23834725|NCT01962103|66774135|FG004|Phase 2|Progressive Disease|0|||
23834726|NCT01962103|66774136|FG005|Phase 2|Progressive Disease|0|||
23834727|NCT01962103|66774137|FG006|Phase 2|Progressive Disease|11|||
23834728|NCT01962103|66774138|FG007|Phase 2|Progressive Disease|12|||
23834729|NCT01962103|66774139|FG008|Phase 2|Progressive Disease|11|||
23834730|NCT01962103|66774131|FG000|Phase 2|Symptomatic Deterioration|0|||
23834731|NCT01962103|66774132|FG001|Phase 2|Symptomatic Deterioration|0|||
23834732|NCT01962103|66774133|FG002|Phase 2|Symptomatic Deterioration|0|||
23834733|NCT01962103|66774134|FG003|Phase 2|Symptomatic Deterioration|0|||
23834734|NCT01962103|66774135|FG004|Phase 2|Symptomatic Deterioration|0|||
23834735|NCT01962103|66774136|FG005|Phase 2|Symptomatic Deterioration|0|||
23834736|NCT01962103|66774137|FG006|Phase 2|Symptomatic Deterioration|2|||
23834737|NCT01962103|66774138|FG007|Phase 2|Symptomatic Deterioration|2|||
23834738|NCT01962103|66774139|FG008|Phase 2|Symptomatic Deterioration|0|||
23834739|NCT03270657|66774140|FG000|Overall Study|Withdrawal by Subject|1|||
23834740|NCT03570619|66774141|FG000|Overall Study|Adverse Event|2|||
23834741|NCT03570619|66774142|FG001|Overall Study|Adverse Event|0|||
23834742|NCT03570619|66774143|FG002|Overall Study|Adverse Event|1|||
23834743|NCT03570619|66774141|FG000|Overall Study|new diagnosis of new malignancy|1|||
23448882|NCT01799226|65384748|FG000|Overall Study|Withdrawal by Subject|1|||
23448883|NCT01799226|65384749|FG001|Overall Study|Withdrawal by Subject|0|||
23448884|NCT01799226|65384748|FG000|Overall Study|Disqualified at Day 14|1|||
23834744|NCT03570619|66774142|FG001|Overall Study|new diagnosis of new malignancy|0|||
23448885|NCT01799226|65384749|FG001|Overall Study|Disqualified at Day 14|0|||
23576504|NCT02061761|65843368|FG006|Overall Study|Maximum clinical benefit|0|||
23834745|NCT03570619|66774143|FG002|Overall Study|new diagnosis of new malignancy|0|||
23576505|NCT02061761|65843369|FG007|Overall Study|Maximum clinical benefit|0|||
23834746|NCT03570619|66774141|FG000|Overall Study|Physician Decision|1|||
23834747|NCT03570619|66774142|FG001|Overall Study|Physician Decision|1|||
23834748|NCT03570619|66774143|FG002|Overall Study|Physician Decision|0|||
23448886|NCT02576639|65384750|FG000|Overall Study|Withdrawal by Subject|1|||
23448887|NCT02576639|65384751|FG001|Overall Study|Withdrawal by Subject|2|||
23448888|NCT02576639|65384752|FG002|Overall Study|Withdrawal by Subject|1|||
23448889|NCT02576639|65384753|FG003|Overall Study|Withdrawal by Subject|0|||
23448890|NCT02576639|65384754|FG004|Overall Study|Withdrawal by Subject|1|||
23775794|NCT01710657|66559776|FG001|Overall Study|Protocol Violation|2|||
23775795|NCT01710657|66559777|FG002|Overall Study|Protocol Violation|0|||
23834749|NCT03570619|66774141|FG000|Overall Study|Withdrawal by Subject|0|||
23834750|NCT03570619|66774142|FG001|Overall Study|Withdrawal by Subject|2|||
23448891|NCT02576639|65384750|FG000|Overall Study|Adverse Event|1|||
23448892|NCT02576639|65384751|FG001|Overall Study|Adverse Event|0|||
23448893|NCT02576639|65384752|FG002|Overall Study|Adverse Event|1|||
23448894|NCT02576639|65384753|FG003|Overall Study|Adverse Event|1|||
23448895|NCT02576639|65384754|FG004|Overall Study|Adverse Event|2|||
23448896|NCT02576639|65384750|FG000|Overall Study|Physician Decision|0|||
23448897|NCT02576639|65384751|FG001|Overall Study|Physician Decision|0|||
23448898|NCT02576639|65384752|FG002|Overall Study|Physician Decision|0|||
23448899|NCT02576639|65384753|FG003|Overall Study|Physician Decision|0|||
23448900|NCT02576639|65384754|FG004|Overall Study|Physician Decision|1|||
23448901|NCT01980095|65384755|FG000|Overall Study|Lost to Follow-up|6|||
23448902|NCT01980095|65384756|FG001|Overall Study|Lost to Follow-up|7|||
23448903|NCT01980095|65384755|FG000|Overall Study|Withdrawal by Subject|2|||
23448904|NCT01980095|65384756|FG001|Overall Study|Withdrawal by Subject|3|||
23448905|NCT01980095|65384755|FG000|Overall Study|Poor compliance|5|||
23448906|NCT01980095|65384756|FG001|Overall Study|Poor compliance|0|||
23448907|NCT01980095|65384755|FG000|Overall Study|Safety issue|0|||
23448908|NCT01980095|65384756|FG001|Overall Study|Safety issue|1|||
23448909|NCT01980095|65384755|FG000|Overall Study|Study drug discontinued|1|||
23448910|NCT01980095|65384756|FG001|Overall Study|Study drug discontinued|0|||
23448911|NCT01980095|65384755|FG000|Overall Study|Randomized by mistake|1|||
23448912|NCT01980095|65384756|FG001|Overall Study|Randomized by mistake|0|||
23448913|NCT01623115|65384760|FG000|Overall Study|Randomized but not treated|0|||
23448914|NCT01623115|65384761|FG001|Overall Study|Randomized but not treated|1|||
23448915|NCT01623115|65384760|FG000|Overall Study|Physician Decision|1|||
23448916|NCT01623115|65384761|FG001|Overall Study|Physician Decision|0|||
23448917|NCT01623115|65384760|FG000|Overall Study|Participants moved|1|||
23448918|NCT01623115|65384761|FG001|Overall Study|Participants moved|5|||
23448919|NCT01623115|65384760|FG000|Overall Study|Adverse Event|10|||
23448920|NCT01623115|65384761|FG001|Overall Study|Adverse Event|13|||
23834751|NCT03570619|66774143|FG002|Overall Study|Withdrawal by Subject|0|||
23834752|NCT04411810|66774144|FG000|Overall Study|Screen failure|1|||
23576506|NCT02061761|65843370|FG008|Overall Study|Maximum clinical benefit|6|||
23834753|NCT04411810|66774144|FG000|Overall Study|Withdrawal by Subject|1|||
23834754|NCT05000164|66774147|FG000|Overall Study|Adverse Event|1|||
23834755|NCT05000164|66774147|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23834756|NCT05000164|66774147|FG000|Overall Study|Lens Discomfort|3|||
23834757|NCT05000164|66774147|FG000|Overall Study|Withdrew Consent during Study|2|||
23834758|NCT05000164|66774147|FG000|Overall Study|Subject Withdrawn by PI|2|||
23834759|NCT05000164|66774147|FG000|Overall Study|Other Fractured Test Article|1|||
23834760|NCT02569801|66774148|FG000|Overall Study|Withdrawal by Subject|9|||
23834761|NCT02569801|66774149|FG001|Overall Study|Withdrawal by Subject|9|||
23834762|NCT02569801|66774148|FG000|Overall Study|Sponsor Decision|13|||
23448921|NCT01623115|65384760|FG000|Overall Study|Poor compliance to protocol|4|||
23576507|NCT02061761|65843362|FG000|Overall Study|Participant no longer meets study criteria|0|||
23775796|NCT01710657|66559775|FG000|Overall Study|Adverse Event|14|||
23834763|NCT02569801|66774149|FG001|Overall Study|Sponsor Decision|14|||
23834764|NCT02569801|66774148|FG000|Overall Study|Progressive Disease|2|||
23448922|NCT01623115|65384761|FG001|Overall Study|Poor compliance to protocol|10|||
23448923|NCT01623115|65384760|FG000|Overall Study|Consent withdrawn by participant|2|||
23448924|NCT01623115|65384761|FG001|Overall Study|Consent withdrawn by participant|6|||
23448925|NCT01623115|65384760|FG000|Overall Study|Related to study drug administration|0|||
23448926|NCT01623115|65384761|FG001|Overall Study|Related to study drug administration|2|||
23775797|NCT01710657|66559776|FG001|Overall Study|Adverse Event|8|||
23775798|NCT01710657|66559777|FG002|Overall Study|Adverse Event|28|||
23775799|NCT01710657|66559775|FG000|Overall Study|Withdrawal by Subject|0|||
23775800|NCT01710657|66559776|FG001|Overall Study|Withdrawal by Subject|1|||
23775801|NCT01710657|66559777|FG002|Overall Study|Withdrawal by Subject|2|||
23775802|NCT01710657|66559775|FG000|Overall Study|Lack of Efficacy|0|||
23775803|NCT01710657|66559776|FG001|Overall Study|Lack of Efficacy|1|||
23775804|NCT01710657|66559777|FG002|Overall Study|Lack of Efficacy|1|||
23775805|NCT00620022|66559782|FG000|Treatment Period 1|Adverse Event|4|||
23775806|NCT00620022|66559783|FG001|Treatment Period 1|Adverse Event|6|||
23775807|NCT00620022|66559782|FG000|Treatment Period 1|Subject withdrew consent|1|||
23775808|NCT00620022|66559783|FG001|Treatment Period 1|Subject withdrew consent|0|||
23775809|NCT00620022|66559782|FG000|Treatment Period 2|Adverse Event|2|||
23775810|NCT00620022|66559783|FG001|Treatment Period 2|Adverse Event|2|||
23775811|NCT01059903|66559793|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
23775812|NCT01059903|66559794|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
23775813|NCT03480425|66559795|FG000|Overall Study|Force transducer technical failure|1|||
23775814|NCT04419311|66559796|FG000|Overall Study|Lost to Follow-up|1|||
23775815|NCT04419311|66559797|FG001|Overall Study|Lost to Follow-up|0|||
23775816|NCT02100228|66559798|FG000|Overall Study|Other|19|||
23775817|NCT02100228|66559799|FG001|Overall Study|Other|19|||
23775818|NCT02100228|66559798|FG000|Overall Study|Administrative reason|0|||
23775819|NCT02100228|66559799|FG001|Overall Study|Administrative reason|1|||
23775820|NCT02100228|66559798|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
23775821|NCT02100228|66559799|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
23775822|NCT02100228|66559798|FG000|Overall Study|Non-compliance|0|||
23775823|NCT02100228|66559799|FG001|Overall Study|Non-compliance|3|||
23775824|NCT02100228|66559798|FG000|Overall Study|Lost to Follow-up|0|||
23775825|NCT02100228|66559799|FG001|Overall Study|Lost to Follow-up|1|||
23775826|NCT02100228|66559798|FG000|Overall Study|Withdrawal by Subject|27|||
23775827|NCT02100228|66559799|FG001|Overall Study|Withdrawal by Subject|37|||
23834765|NCT02569801|66774149|FG001|Overall Study|Progressive Disease|7|||
23448927|NCT01623115|65384760|FG000|Overall Study|Last visit outside protocol visit window|14|||
23775828|NCT02100228|66559798|FG000|Overall Study|Adverse Event|16|||
23775829|NCT02100228|66559799|FG001|Overall Study|Adverse Event|12|||
23775830|NCT02100228|66559798|FG000|Overall Study|Death|1|||
23775831|NCT02100228|66559799|FG001|Overall Study|Death|1|||
23775832|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Adverse Event|11|||
23775833|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Adverse Event|23|||
23775834|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Adverse Event|29|||
23775835|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Adverse Event|2|||
23775836|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Adverse Event|8|||
23775837|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
23775838|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
23775839|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
23775840|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
23775841|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
23834766|NCT02569801|66774148|FG000|Overall Study|Lost to Follow-up|0|||
23834767|NCT02569801|66774149|FG001|Overall Study|Lost to Follow-up|1|||
23775842|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
23775843|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
23775844|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
23775845|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
23775846|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
23775847|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
23775848|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
23775849|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
23775850|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
23775851|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
23775852|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23775853|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
23775854|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23775855|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23775856|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23775857|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
23775858|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
23775859|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
23775860|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
23775861|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
23775862|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
23775863|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
23775864|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
23775865|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
23775866|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
23775867|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Move|0|||
23775868|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Move|1|||
23775869|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Move|0|||
23775870|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Move|0|||
23775871|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Move|0|||
23775872|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23775873|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23775874|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23775875|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23775876|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
23775877|NCT00318461|66559800|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
23775878|NCT00318461|66559801|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23775879|NCT00318461|66559802|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23775880|NCT00318461|66559803|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
23775881|NCT00318461|66559804|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23775882|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Work commitment|0|||
23775883|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Work commitment|0|||
23775884|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Work commitment|0|||
23775885|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Work commitment|0|||
23775886|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Work commitment|1|||
23775887|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Investigator decision|0|||
23775888|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Investigator decision|0|||
23775889|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Investigator decision|0|||
23775890|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Investigator decision|0|||
23775891|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Investigator decision|1|||
23775892|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Lack of time|1|||
23775893|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Lack of time|0|||
23775894|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Lack of time|0|||
23775895|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Lack of time|0|||
23775896|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Lack of time|0|||
23775897|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23775898|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23775899|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23775900|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23775901|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
23775902|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
23775903|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
23775904|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
23834768|NCT02569801|66774148|FG000|Overall Study|Death|12|||
23834769|NCT02569801|66774149|FG001|Overall Study|Death|4|||
23775905|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
23834770|NCT02042014|66774152|FG000|Overall Study|Adverse Event|1|||
23834771|NCT02042014|66774152|FG000|Overall Study|Physician Decision|7|||
23834772|NCT01609296|66774153|FG000|Overall Study|Death|253|||
23834773|NCT01609296|66774153|FG000|Overall Study|Withdrawal by Subject|151|||
23834774|NCT01609296|66774153|FG000|Overall Study|Lost to Follow-up|21|||
23834775|NCT01609296|66774153|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
23834776|NCT01609296|66774153|FG000|Overall Study|missed visit but known to be alive|28|||
23576508|NCT02061761|65843363|FG001|Overall Study|Participant no longer meets study criteria|0|||
23775906|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
23775907|NCT00318461|66559800|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23775908|NCT00318461|66559801|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23775909|NCT00318461|66559802|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23576509|NCT02061761|65843364|FG002|Overall Study|Participant no longer meets study criteria|0|||
23576510|NCT02061761|65843365|FG003|Overall Study|Participant no longer meets study criteria|0|||
23775910|NCT00318461|66559803|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23775911|NCT00318461|66559804|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
23775912|NCT00318461|66559800|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23775913|NCT00318461|66559801|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
23775914|NCT00318461|66559802|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23775915|NCT00318461|66559803|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23775916|NCT00318461|66559804|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23834777|NCT01662635|66774155|FG000|Overall Study|scarce samples for evaluation|30|||
23834778|NCT01516008|66774156|FG000|Overall Study|Adverse Event|0|||
23834779|NCT01516008|66774157|FG001|Overall Study|Adverse Event|2|||
23834780|NCT01516008|66774158|FG002|Overall Study|Adverse Event|7|||
23576511|NCT02061761|65843366|FG004|Overall Study|Participant no longer meets study criteria|0|||
23576512|NCT02061761|65843367|FG005|Overall Study|Participant no longer meets study criteria|0|||
23576513|NCT02061761|65843368|FG006|Overall Study|Participant no longer meets study criteria|0|||
23576514|NCT02061761|65843369|FG007|Overall Study|Participant no longer meets study criteria|0|||
23576515|NCT02061761|65843370|FG008|Overall Study|Participant no longer meets study criteria|1|||
23576516|NCT02061761|65843362|FG000|Overall Study|Other reasons|0|||
23576517|NCT02061761|65843363|FG001|Overall Study|Other reasons|0|||
23576518|NCT02061761|65843364|FG002|Overall Study|Other reasons|0|||
23576519|NCT02061761|65843365|FG003|Overall Study|Other reasons|0|||
23576520|NCT02061761|65843366|FG004|Overall Study|Other reasons|2|||
23576521|NCT02061761|65843367|FG005|Overall Study|Other reasons|0|||
23576522|NCT02061761|65843368|FG006|Overall Study|Other reasons|0|||
23576523|NCT02061761|65843369|FG007|Overall Study|Other reasons|0|||
23576524|NCT02061761|65843370|FG008|Overall Study|Other reasons|6|||
23576525|NCT01403987|65843371|FG000|Overall Study|Residents forgot their secret PIN|18|||
23576526|NCT01403987|65843372|FG001|Overall Study|Residents forgot their secret PIN|17|||
23576527|NCT01403987|65843373|FG002|Overall Study|Residents forgot their secret PIN|18|||
23576528|NCT02015663|65843377|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
23576529|NCT02015663|65843378|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
23834781|NCT01516008|66774156|FG000|Overall Study|Lack of Efficacy|44|||
23834782|NCT01516008|66774157|FG001|Overall Study|Lack of Efficacy|14|||
23834783|NCT01516008|66774158|FG002|Overall Study|Lack of Efficacy|10|||
23834784|NCT01516008|66774156|FG000|Overall Study|Protocol Violation|1|||
23834785|NCT01516008|66774157|FG001|Overall Study|Protocol Violation|0|||
23834786|NCT01516008|66774158|FG002|Overall Study|Protocol Violation|0|||
23834787|NCT01516008|66774156|FG000|Overall Study|Reason not specified|0|||
23834788|NCT01516008|66774157|FG001|Overall Study|Reason not specified|0|||
23834789|NCT01516008|66774158|FG002|Overall Study|Reason not specified|1|||
23834790|NCT00488644|66774159|FG000|Overall Study|Not Eligible|1|||
23834791|NCT00488644|66774159|FG000|Overall Study|Not Evaluable|1|||
23834792|NCT03259425|66774160|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
23834793|NCT00679211|66774161|FG000|Overall Study|Progressive disease|82|||
23834794|NCT00679211|66774161|FG000|Overall Study|Adverse Event|7|||
23834795|NCT00679211|66774161|FG000|Overall Study|Withdrawal by Subject|2|||
23834796|NCT00679211|66774161|FG000|Overall Study|Physician Decision|5|||
23834797|NCT00679211|66774161|FG000|Overall Study|Refused to undergo protocol procedures|1|||
23834798|NCT00679211|66774161|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
23576530|NCT02015663|65843377|FG000|Overall Study|Withdrawal by Subject|1|||
23576531|NCT02015663|65843378|FG001|Overall Study|Withdrawal by Subject|0|||
23576532|NCT02015663|65843377|FG000|Overall Study|Protocol Violation|0|||
23834799|NCT00679211|66774161|FG000|Overall Study|Other|1|||
23834800|NCT01671007|66774162|FG000|Overall Study|Other reasons than listed|166|||
23834801|NCT01671007|66774163|FG001|Overall Study|Other reasons than listed|373|||
23834802|NCT01671007|66774164|FG002|Overall Study|Other reasons than listed|197|||
23834803|NCT01671007|66774165|FG003|Overall Study|Other reasons than listed|228|||
23576533|NCT02015663|65843378|FG001|Overall Study|Protocol Violation|1|||
23576534|NCT02015663|65843377|FG000|Overall Study|Adverse Event|3|||
23775917|NCT00318461|66559800|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
23775918|NCT00318461|66559801|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
23775919|NCT00318461|66559802|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
23576535|NCT02015663|65843378|FG001|Overall Study|Adverse Event|0|||
23576536|NCT02015663|65843377|FG000|Overall Study|Administrative problems|10|||
23576537|NCT02015663|65843378|FG001|Overall Study|Administrative problems|11|||
23576538|NCT01657032|65843379|FG000|Overall Study|Lost to Follow-up|0|||
23576539|NCT01657032|65843380|FG001|Overall Study|Lost to Follow-up|7|||
23576540|NCT02451930|65843381|FG000|Overall Study|Death|0|||
23775920|NCT00318461|66559803|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
23775921|NCT00318461|66559804|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
23576541|NCT02451930|65843382|FG001|Overall Study|Death|15|||
23576542|NCT02451930|65843381|FG000|Overall Study|Lost to Follow-up|0|||
23576543|NCT02451930|65843382|FG001|Overall Study|Lost to Follow-up|3|||
23576544|NCT02451930|65843381|FG000|Overall Study|Sponsor Decision|2|||
23576545|NCT02451930|65843382|FG001|Overall Study|Sponsor Decision|10|||
23576546|NCT02451930|65843381|FG000|Overall Study|Withdrawal by Subject|0|||
23576547|NCT02451930|65843382|FG001|Overall Study|Withdrawal by Subject|1|||
23576548|NCT02451930|65843381|FG000|Overall Study|Other|0|||
23576549|NCT02451930|65843382|FG001|Overall Study|Other|1|||
23576550|NCT01511536|65843383|FG000|Phase 1|Other|0|||
23576551|NCT01511536|65843384|FG001|Phase 1|Other|1|||
23576552|NCT01511536|65843385|FG002|Phase 1|Other|0|||
23576553|NCT01511536|65843383|FG000|Phase 2|Other|0|||
23576554|NCT01511536|65843384|FG001|Phase 2|Other|0|||
23576555|NCT01511536|65843385|FG002|Phase 2|Other|9|||
23576556|NCT00333138|65843386|FG000|Core Study (6 Months)|Adverse Event|4|||
23576557|NCT00333138|65843387|FG001|Core Study (6 Months)|Adverse Event|5|||
23576558|NCT00333138|65843388|FG002|Core Study (6 Months)|Adverse Event|8|||
23576559|NCT00333138|65843386|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
23576560|NCT00333138|65843387|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
23576561|NCT00333138|65843388|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
23775922|NCT00318461|66559800|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
23775923|NCT00318461|66559801|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
23775924|NCT00318461|66559802|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
23775925|NCT00318461|66559803|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
23775926|NCT00318461|66559804|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
23775927|NCT00318461|66559800|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
23775928|NCT00318461|66559801|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
23775929|NCT00318461|66559802|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
23775930|NCT00318461|66559803|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
23775931|NCT00318461|66559804|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
23775932|NCT00318461|66559800|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
23775933|NCT00318461|66559801|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
23775934|NCT00318461|66559802|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
23775935|NCT00318461|66559803|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
23775936|NCT00318461|66559804|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
23775937|NCT00496964|66559806|FG000|Overall Study|Withdrawal by Subject|0|||
23775938|NCT00496964|66559807|FG001|Overall Study|Withdrawal by Subject|1|||
23775939|NCT00615069|66559809|FG000|Overall Study|Death|10|||
23775940|NCT00615069|66559809|FG000|Overall Study|Physician Decision|2|||
23775941|NCT00615069|66559809|FG000|Overall Study|Withdrawal by Subject|4|||
23775942|NCT02656706|66559818|FG000|Overall Study|Insurance Denial|1|||
23775943|NCT03206177|66559819|FG000|Overall Study|Withdrawal by Subject|1|||
23775944|NCT01387022|66559820|FG000|Overall Study|Death|1|||
23834804|NCT01671007|66774166|FG004|Overall Study|Other reasons than listed|14|||
23576562|NCT00333138|65843386|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
23576563|NCT00333138|65843387|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
23576564|NCT00333138|65843388|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
23576565|NCT00333138|65843386|FG000|Core Study (6 Months)|Protocol Violation|1|||
23576566|NCT00333138|65843387|FG001|Core Study (6 Months)|Protocol Violation|0|||
23576567|NCT00333138|65843388|FG002|Core Study (6 Months)|Protocol Violation|1|||
23775945|NCT01387022|66559821|FG001|Overall Study|Death|1|||
23775946|NCT01387022|66559820|FG000|Overall Study|Lost to Follow-up|0|||
23775947|NCT01387022|66559821|FG001|Overall Study|Lost to Follow-up|3|||
23775948|NCT00604500|66559824|FG000|Overall Study|Adverse Event|2|||
23775949|NCT00604500|66559824|FG000|Overall Study|Protocol Violation|2|||
23775950|NCT00604500|66559824|FG000|Overall Study|Treatment Failure|1|||
23775951|NCT00604500|66559824|FG000|Overall Study|Withdrawal by Subject|4|||
23775952|NCT00604500|66559824|FG000|Overall Study|Administrative|1|||
23775953|NCT00604500|66559824|FG000|Overall Study|Did not meet protocol eligibility|1|||
23775954|NCT01876706|66559833|FG000|Overall Study|BPH Intervention|9|||
23775955|NCT01876706|66559833|FG000|Overall Study|Lost to Follow-up|7|||
23775956|NCT01876706|66559833|FG000|Overall Study|Withdrawals|6|||
23775957|NCT01876706|66559833|FG000|Overall Study|Death|3|||
23775958|NCT01781286|66559839|FG000|Overall Study|Lost to Follow-up|0|||
23775959|NCT01781286|66559840|FG001|Overall Study|Lost to Follow-up|0|||
23775960|NCT01781286|66559841|FG002|Overall Study|Lost to Follow-up|0|||
23775961|NCT01781286|66559842|FG003|Overall Study|Lost to Follow-up|0|||
23775962|NCT01781286|66559843|FG004|Overall Study|Lost to Follow-up|0|||
23775963|NCT01781286|66559844|FG005|Overall Study|Lost to Follow-up|1|||
23775964|NCT01781286|66559839|FG000|Overall Study|Time Constraints|2|||
23775965|NCT01781286|66559840|FG001|Overall Study|Time Constraints|0|||
23775966|NCT01781286|66559841|FG002|Overall Study|Time Constraints|2|||
23775967|NCT01781286|66559842|FG003|Overall Study|Time Constraints|0|||
23775968|NCT01781286|66559843|FG004|Overall Study|Time Constraints|0|||
23775969|NCT01781286|66559844|FG005|Overall Study|Time Constraints|0|||
23775970|NCT01781286|66559839|FG000|Overall Study|Noncompliance|0|||
23775971|NCT01781286|66559840|FG001|Overall Study|Noncompliance|0|||
23775972|NCT01781286|66559841|FG002|Overall Study|Noncompliance|0|||
23775973|NCT01781286|66559842|FG003|Overall Study|Noncompliance|1|||
23775974|NCT01781286|66559843|FG004|Overall Study|Noncompliance|0|||
23775975|NCT01781286|66559844|FG005|Overall Study|Noncompliance|0|||
23775976|NCT01691508|66559851|FG000|Overall Study|Adverse Event|3|||
23775977|NCT01691508|66559852|FG001|Overall Study|Adverse Event|3|||
23775978|NCT01691508|66559851|FG000|Overall Study|Withdrawal by Subject|1|||
23775979|NCT01691508|66559852|FG001|Overall Study|Withdrawal by Subject|0|||
23775980|NCT02637232|66559856|FG000|Overall Study|Lost to Follow-up|42|||
23775981|NCT02637232|66559856|FG000|Overall Study|Adverse Event|11|||
23775982|NCT02637232|66559856|FG000|Overall Study|patient 's decision|2|||
23775983|NCT00259012|66559857|FG000|Overall Study|Adverse Event|0|||
23775984|NCT00259012|66559858|FG001|Overall Study|Adverse Event|1|||
23775985|NCT00259012|66559857|FG000|Overall Study|Withdrawal by Subject|1|||
23775986|NCT00259012|66559858|FG001|Overall Study|Withdrawal by Subject|0|||
23775987|NCT00259012|66559857|FG000|Overall Study|Physician Decision|0|||
23775988|NCT00259012|66559858|FG001|Overall Study|Physician Decision|1|||
23775989|NCT00259012|66559857|FG000|Overall Study|Lost to Follow-up|0|||
23775990|NCT00259012|66559858|FG001|Overall Study|Lost to Follow-up|1|||
23775991|NCT00259012|66559857|FG000|Overall Study|Protocol Violation|1|||
23775992|NCT00259012|66559858|FG001|Overall Study|Protocol Violation|1|||
23775993|NCT02645409|66559859|FG000|Overall Study|Withdrawal by Subject|3|||
23834805|NCT01671007|66774167|FG005|Overall Study|Other reasons than listed|71|||
23576568|NCT00333138|65843386|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
23576569|NCT00333138|65843387|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
23775994|NCT02645409|66559860|FG001|Overall Study|Withdrawal by Subject|0|||
23775995|NCT02645409|66559859|FG000|Overall Study|Physician Decision|1|||
23775996|NCT02645409|66559860|FG001|Overall Study|Physician Decision|0|||
23775997|NCT00694551|66559861|FG000|Overall Study|Disease Progression|1|||
23775998|NCT00694551|66559862|FG001|Overall Study|Disease Progression|0|||
23775999|NCT00694551|66559863|FG002|Overall Study|Disease Progression|1|||
23776000|NCT02109042|66559864|FG000|Overall Study|Sponsor Decision|15|||
23776001|NCT04060147|66559866|FG000|Overall Study|Withdrew consent|1|||
23776002|NCT04611789|66559867|FG000|Overall Study|Lost to Follow-up|1|||
23776003|NCT04611789|66559868|FG001|Overall Study|Lost to Follow-up|0|||
23776004|NCT04611789|66559869|FG002|Overall Study|Lost to Follow-up|0|||
23776005|NCT04274686|66559870|FG000|Overall Study|Physician Decision|1|||
23776006|NCT04274686|66559871|FG001|Overall Study|Physician Decision|0|||
23776007|NCT03546842|66559872|FG000|Overall Study|Protocol Violation|1|||
23776008|NCT03546842|66559872|FG000|Overall Study|Withdrawal by Subject|2|||
23776009|NCT01273805|66559873|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
23776010|NCT01273805|66559874|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
23776011|NCT00324168|66559875|FG000|Overall Study|Lost to Follow-up|19|||
23776012|NCT00324168|66559876|FG001|Overall Study|Lost to Follow-up|18|||
23776013|NCT00324168|66559875|FG000|Overall Study|Death|3|||
23776014|NCT00324168|66559876|FG001|Overall Study|Death|3|||
23776015|NCT00324168|66559875|FG000|Overall Study|Patient did not visit in f/u window|6|||
23776016|NCT00324168|66559876|FG001|Overall Study|Patient did not visit in f/u window|9|||
23776017|NCT01544127|66559877|FG000|Overall Study|Lost to Follow-up|4|||
23776018|NCT01544127|66559878|FG001|Overall Study|Lost to Follow-up|2|||
23776019|NCT01544127|66559879|FG002|Overall Study|Lost to Follow-up|9|||
23776020|NCT01544127|66559877|FG000|Overall Study|Withdrawal by Subject|2|||
23776021|NCT01544127|66559878|FG001|Overall Study|Withdrawal by Subject|2|||
23776022|NCT01544127|66559879|FG002|Overall Study|Withdrawal by Subject|1|||
23776023|NCT01544127|66559877|FG000|Overall Study|Discharged out of catchment area|1|||
23776024|NCT01544127|66559878|FG001|Overall Study|Discharged out of catchment area|1|||
23776025|NCT01544127|66559879|FG002|Overall Study|Discharged out of catchment area|1|||
23776026|NCT01544127|66559877|FG000|Overall Study|Death|1|||
23776027|NCT01544127|66559878|FG001|Overall Study|Death|0|||
23776028|NCT01544127|66559879|FG002|Overall Study|Death|0|||
23776029|NCT01544127|66559877|FG000|Overall Study|Jail or Prison|1|||
23776030|NCT01544127|66559878|FG001|Overall Study|Jail or Prison|1|||
23776031|NCT01544127|66559879|FG002|Overall Study|Jail or Prison|2|||
23776032|NCT01544127|66559877|FG000|Overall Study|Became Psychotic|1|||
23776033|NCT01544127|66559878|FG001|Overall Study|Became Psychotic|0|||
23776034|NCT01544127|66559879|FG002|Overall Study|Became Psychotic|0|||
23776035|NCT01544127|66559877|FG000|Overall Study|Researcher withdrew|1|||
23776036|NCT01544127|66559878|FG001|Overall Study|Researcher withdrew|0|||
23776037|NCT01544127|66559879|FG002|Overall Study|Researcher withdrew|0|||
23776038|NCT01544127|66559877|FG000|Overall Study|Went active duty|0|||
23776039|NCT01544127|66559878|FG001|Overall Study|Went active duty|0|||
23776040|NCT01544127|66559879|FG002|Overall Study|Went active duty|1|||
23776041|NCT02178722|66559880|FG000|Overall Study|Withdrawal by Subject|0|||
23776042|NCT02178722|66559881|FG001|Overall Study|Withdrawal by Subject|0|||
23776043|NCT02178722|66559882|FG002|Overall Study|Withdrawal by Subject|0|||
23776044|NCT02178722|66559883|FG003|Overall Study|Withdrawal by Subject|2|||
23776045|NCT02178722|66559884|FG004|Overall Study|Withdrawal by Subject|33|||
23776046|NCT02178722|66559880|FG000|Overall Study|Death|2|||
23776047|NCT02178722|66559881|FG001|Overall Study|Death|13|||
23776048|NCT02178722|66559882|FG002|Overall Study|Death|12|||
23776049|NCT02178722|66559883|FG003|Overall Study|Death|12|||
23776050|NCT02178722|66559884|FG004|Overall Study|Death|205|||
23776051|NCT02178722|66559880|FG000|Overall Study|Lost to Follow-up|0|||
23776052|NCT02178722|66559881|FG001|Overall Study|Lost to Follow-up|0|||
23776053|NCT02178722|66559882|FG002|Overall Study|Lost to Follow-up|0|||
23776054|NCT02178722|66559883|FG003|Overall Study|Lost to Follow-up|2|||
23776055|NCT02178722|66559884|FG004|Overall Study|Lost to Follow-up|11|||
23776056|NCT02178722|66559880|FG000|Overall Study|Study terminated by Sponsor|2|||
23776057|NCT02178722|66559881|FG001|Overall Study|Study terminated by Sponsor|7|||
23776058|NCT02178722|66559882|FG002|Overall Study|Study terminated by Sponsor|6|||
23776059|NCT02178722|66559883|FG003|Overall Study|Study terminated by Sponsor|4|||
23776060|NCT02178722|66559884|FG004|Overall Study|Study terminated by Sponsor|128|||
23776061|NCT02178722|66559880|FG000|Overall Study|Physician Decision|0|||
23776062|NCT02178722|66559881|FG001|Overall Study|Physician Decision|0|||
23776063|NCT02178722|66559882|FG002|Overall Study|Physician Decision|0|||
23834806|NCT01671007|66774168|FG006|Overall Study|Other reasons than listed|17|||
23776064|NCT02178722|66559883|FG003|Overall Study|Physician Decision|0|||
23776065|NCT02178722|66559884|FG004|Overall Study|Physician Decision|3|||
23776066|NCT02178722|66559880|FG000|Overall Study|Other|0|||
23776067|NCT02178722|66559881|FG001|Overall Study|Other|0|||
23776068|NCT02178722|66559882|FG002|Overall Study|Other|0|||
23776069|NCT02178722|66559883|FG003|Overall Study|Other|0|||
23776070|NCT02178722|66559884|FG004|Overall Study|Other|2|||
23776071|NCT02648347|66559885|FG000|Overall Study|Death|174|||
23776072|NCT02648347|66559886|FG001|Overall Study|Death|167|||
23776073|NCT02648347|66559885|FG000|Overall Study|Withdrawal by Subject|16|||
23776074|NCT02648347|66559886|FG001|Overall Study|Withdrawal by Subject|9|||
23776075|NCT02648347|66559885|FG000|Overall Study|Lost to Follow-up|18|||
23776076|NCT02648347|66559886|FG001|Overall Study|Lost to Follow-up|21|||
23776077|NCT02648347|66559885|FG000|Overall Study|Missing|1|||
23776078|NCT02648347|66559886|FG001|Overall Study|Missing|0|||
23776079|NCT00336479|66559887|FG000|Overall Study|Adverse Event|8|||
23776080|NCT00336479|66559888|FG001|Overall Study|Adverse Event|11|||
23776081|NCT00336479|66559889|FG002|Overall Study|Adverse Event|18|||
23776082|NCT00336479|66559890|FG003|Overall Study|Adverse Event|4|||
23776083|NCT00336479|66559887|FG000|Overall Study|Noncompliant|1|||
23834807|NCT01671007|66774169|FG007|Overall Study|Other reasons than listed|66|||
23834808|NCT01671007|66774170|FG008|Overall Study|Other reasons than listed|0|||
23834809|NCT01671007|66774162|FG000|Overall Study|Withdrawal by Subject|36|||
23834810|NCT01671007|66774163|FG001|Overall Study|Withdrawal by Subject|59|||
23834811|NCT01671007|66774164|FG002|Overall Study|Withdrawal by Subject|53|||
23834812|NCT01671007|66774165|FG003|Overall Study|Withdrawal by Subject|58|||
23834813|NCT01671007|66774166|FG004|Overall Study|Withdrawal by Subject|4|||
23834814|NCT01671007|66774167|FG005|Overall Study|Withdrawal by Subject|15|||
23834815|NCT01671007|66774168|FG006|Overall Study|Withdrawal by Subject|1|||
23776084|NCT00336479|66559888|FG001|Overall Study|Noncompliant|7|||
23776085|NCT00336479|66559889|FG002|Overall Study|Noncompliant|3|||
23776086|NCT00336479|66559890|FG003|Overall Study|Noncompliant|0|||
23834816|NCT01671007|66774169|FG007|Overall Study|Withdrawal by Subject|19|||
23448928|NCT01623115|65384761|FG001|Overall Study|Last visit outside protocol visit window|26|||
23834817|NCT01671007|66774170|FG008|Overall Study|Withdrawal by Subject|0|||
23776087|NCT00336479|66559887|FG000|Overall Study|Physician Decision|2|||
23776088|NCT00336479|66559888|FG001|Overall Study|Physician Decision|3|||
23776089|NCT00336479|66559889|FG002|Overall Study|Physician Decision|1|||
23776090|NCT00336479|66559890|FG003|Overall Study|Physician Decision|0|||
23776091|NCT00336479|66559887|FG000|Overall Study|Lost to Follow-up|3|||
23776092|NCT00336479|66559888|FG001|Overall Study|Lost to Follow-up|2|||
23776093|NCT00336479|66559889|FG002|Overall Study|Lost to Follow-up|0|||
23776094|NCT00336479|66559890|FG003|Overall Study|Lost to Follow-up|0|||
23776095|NCT00336479|66559887|FG000|Overall Study|Withdrawal by Subject|3|||
23776096|NCT00336479|66559888|FG001|Overall Study|Withdrawal by Subject|2|||
23776097|NCT00336479|66559889|FG002|Overall Study|Withdrawal by Subject|3|||
23776098|NCT00336479|66559890|FG003|Overall Study|Withdrawal by Subject|0|||
23776099|NCT00336479|66559887|FG000|Overall Study|Other|0|||
23834818|NCT01671007|66774162|FG000|Overall Study|Lost to Follow-up|93|||
23834819|NCT01671007|66774163|FG001|Overall Study|Lost to Follow-up|142|||
23834820|NCT01671007|66774164|FG002|Overall Study|Lost to Follow-up|91|||
23834821|NCT01671007|66774165|FG003|Overall Study|Lost to Follow-up|63|||
23834822|NCT01671007|66774166|FG004|Overall Study|Lost to Follow-up|7|||
23834823|NCT01671007|66774167|FG005|Overall Study|Lost to Follow-up|20|||
23834824|NCT01671007|66774168|FG006|Overall Study|Lost to Follow-up|2|||
23834825|NCT01671007|66774169|FG007|Overall Study|Lost to Follow-up|28|||
23834826|NCT01671007|66774170|FG008|Overall Study|Lost to Follow-up|0|||
23834827|NCT01671007|66774162|FG000|Overall Study|No end of study case report form|3|||
23834828|NCT01671007|66774163|FG001|Overall Study|No end of study case report form|1|||
23834829|NCT01671007|66774164|FG002|Overall Study|No end of study case report form|0|||
23776100|NCT00336479|66559888|FG001|Overall Study|Other|0|||
23776101|NCT00336479|66559889|FG002|Overall Study|Other|1|||
23776102|NCT00336479|66559890|FG003|Overall Study|Other|0|||
23776103|NCT00336479|66559887|FG000|Overall Study|Virologic Stopping Rule|20|||
23834830|NCT01671007|66774165|FG003|Overall Study|No end of study case report form|2|||
23834831|NCT01671007|66774166|FG004|Overall Study|No end of study case report form|0|||
23776104|NCT00336479|66559888|FG001|Overall Study|Virologic Stopping Rule|0|||
23834832|NCT01671007|66774167|FG005|Overall Study|No end of study case report form|0|||
23776105|NCT00336479|66559889|FG002|Overall Study|Virologic Stopping Rule|0|||
23776106|NCT00336479|66559890|FG003|Overall Study|Virologic Stopping Rule|0|||
23776107|NCT00302952|66559894|FG000|Overall Study|Physician Decision|1|||
23776108|NCT00302952|66559895|FG001|Overall Study|Physician Decision|1|||
23776109|NCT00302952|66559894|FG000|Overall Study|Withdrawal by Subject|2|||
23776110|NCT00302952|66559895|FG001|Overall Study|Withdrawal by Subject|3|||
23776111|NCT00302952|66559894|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
23776112|NCT00302952|66559895|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
23776113|NCT05067647|66559897|FG000|Overall Study|Lost to Follow-up|1|||
23776114|NCT01417078|66559910|FG000|Overall Study|Withdrawal by Subject|1|||
23834833|NCT01671007|66774168|FG006|Overall Study|No end of study case report form|0|||
23834834|NCT01671007|66774169|FG007|Overall Study|No end of study case report form|0|||
23834835|NCT01671007|66774170|FG008|Overall Study|No end of study case report form|0|||
23834836|NCT01671007|66774162|FG000|Overall Study|Not eligible|23|||
23834837|NCT01671007|66774163|FG001|Overall Study|Not eligible|76|||
23834838|NCT01671007|66774164|FG002|Overall Study|Not eligible|25|||
23834839|NCT01671007|66774165|FG003|Overall Study|Not eligible|17|||
23834840|NCT01671007|66774166|FG004|Overall Study|Not eligible|0|||
23834841|NCT01671007|66774167|FG005|Overall Study|Not eligible|6|||
23834842|NCT01671007|66774168|FG006|Overall Study|Not eligible|1|||
23776115|NCT02079766|66559911|FG000|Overall Study|Physician Decision|1|||
23776116|NCT02079766|66559912|FG001|Overall Study|Physician Decision|0|||
23776117|NCT02079766|66559911|FG000|Overall Study|Withdrawal by Subject|1|||
23776118|NCT02079766|66559912|FG001|Overall Study|Withdrawal by Subject|0|||
23834843|NCT01671007|66774169|FG007|Overall Study|Not eligible|19|||
23834844|NCT01671007|66774170|FG008|Overall Study|Not eligible|0|||
23834845|NCT01896128|66774171|FG000|Overall Study|Withdrawal by Subject|3|||
23834846|NCT01896128|66774172|FG001|Overall Study|Withdrawal by Subject|3|||
23448929|NCT01623115|65384760|FG000|Overall Study|Site closure|1|||
23448930|NCT01623115|65384761|FG001|Overall Study|Site closure|7|||
23448931|NCT01623115|65384760|FG000|Overall Study|Death|0|||
23448932|NCT01623115|65384761|FG001|Overall Study|Death|4|||
23448933|NCT01623115|65384760|FG000|Overall Study|Other than specified above|0|||
23448934|NCT01623115|65384761|FG001|Overall Study|Other than specified above|3|||
23448935|NCT00181766|65384767|FG000|Overall Study|Lost to Follow-up|6|||
23448936|NCT00181766|65384767|FG000|Overall Study|Adverse Event|4|||
23448937|NCT00181766|65384767|FG000|Overall Study|non-compliance|2|||
23448938|NCT01508169|65384774|FG000|Overall Study|Adverse Event|1|||
23448939|NCT01508169|65384775|FG001|Overall Study|Adverse Event|0|||
23448940|NCT01508169|65384774|FG000|Overall Study|Withdrawal by Subject|1|||
23448941|NCT01508169|65384775|FG001|Overall Study|Withdrawal by Subject|0|||
23448942|NCT01508169|65384774|FG000|Overall Study|Lost to Follow-up|1|||
23448943|NCT01508169|65384775|FG001|Overall Study|Lost to Follow-up|2|||
23448944|NCT00962208|65384779|FG000|Overall Study|Could not achieve good vision|9|||
23448945|NCT00962208|65384780|FG001|Overall Study|Could not achieve good vision|0|||
23448946|NCT00962208|65384779|FG000|Overall Study|Contraindicated to continue study|5|||
23448947|NCT00962208|65384780|FG001|Overall Study|Contraindicated to continue study|1|||
23448948|NCT00962208|65384779|FG000|Overall Study|Lost to Follow-up|0|||
23448949|NCT00962208|65384780|FG001|Overall Study|Lost to Follow-up|9|||
23448950|NCT02471014|65384784|FG000|Overall Study|Lost to Follow-up|2|||
23448951|NCT02471014|65384785|FG001|Overall Study|Lost to Follow-up|2|||
23448952|NCT01370265|65384786|FG000|First Intervention|Adverse Event|1|||
23448953|NCT01370265|65384787|FG001|First Intervention|Adverse Event|1|||
23448954|NCT01962441|65384788|FG000|Randomized Period|Randomized but Never Treated|4|||
23448955|NCT01962441|65384789|FG001|Randomized Period|Randomized but Never Treated|2|||
23448956|NCT01962441|65384790|FG002|Randomized Period|Randomized but Never Treated|3|||
23448957|NCT01962441|65384788|FG000|Randomized Period|Lost to Follow-up|2|||
23448958|NCT01962441|65384789|FG001|Randomized Period|Lost to Follow-up|4|||
23448959|NCT01962441|65384790|FG002|Randomized Period|Lost to Follow-up|4|||
23448960|NCT01962441|65384788|FG000|Randomized Period|Withdrew Consent|3|||
23448961|NCT01962441|65384789|FG001|Randomized Period|Withdrew Consent|3|||
23448962|NCT01962441|65384790|FG002|Randomized Period|Withdrew Consent|2|||
23448963|NCT01962441|65384788|FG000|Randomized Period|Adverse Event|1|||
23448964|NCT01962441|65384789|FG001|Randomized Period|Adverse Event|1|||
23448965|NCT01962441|65384790|FG002|Randomized Period|Adverse Event|0|||
23448966|NCT01962441|65384788|FG000|Randomized Period|Death|0|||
23448967|NCT01962441|65384789|FG001|Randomized Period|Death|0|||
23448968|NCT01962441|65384790|FG002|Randomized Period|Death|2|||
23448969|NCT01962441|65384788|FG000|Randomized Period|Protocol Violation|0|||
23448970|NCT01962441|65384789|FG001|Randomized Period|Protocol Violation|1|||
23448971|NCT01962441|65384790|FG002|Randomized Period|Protocol Violation|0|||
23448972|NCT01962441|65384788|FG000|Retreatment Substudy|Lack of Efficacy|1|||
23448973|NCT01962441|65384789|FG001|Retreatment Substudy|Lack of Efficacy|0|||
23448974|NCT01962441|65384790|FG002|Retreatment Substudy|Lack of Efficacy|0|||
23448975|NCT01962441|65384788|FG000|Retreatment Substudy|Lost to Follow-up|1|||
23448976|NCT01962441|65384789|FG001|Retreatment Substudy|Lost to Follow-up|0|||
23448977|NCT01962441|65384790|FG002|Retreatment Substudy|Lost to Follow-up|0|||
23448978|NCT01363700|65384791|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448979|NCT01363700|65384792|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
23448980|NCT01363700|65384793|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448981|NCT01363700|65384794|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448982|NCT01363700|65384795|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448983|NCT02098746|65384798|FG000|Overall Study|Changes of Investigator|2|||
23448984|NCT02098746|65384798|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23448985|NCT02098746|65384798|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
23633892|NCT02628028|66045513|FG006|Dosing Period|Site Terminated by Sponsor|1|||
23633893|NCT02628028|66045514|FG007|Dosing Period|Site Terminated by Sponsor|0|||
23576570|NCT00333138|65843388|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
23576571|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
23576572|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
23576573|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
23576574|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
23576575|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
23576576|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
23576577|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
23576578|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
23576579|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
23576580|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
23576581|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
23576582|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
23576583|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
23576584|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
23576585|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
23576586|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
23576587|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
23576588|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
23576589|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
23576590|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
23576591|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
23576592|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
23576593|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
23576594|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
23576595|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Death|0|||
23576596|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Death|1|||
23776119|NCT04646213|66559913|FG000|Overall Study|Physician Decision|3|||
23834847|NCT01286467|66774176|FG000|Overall Study|Death|1|||
23834848|NCT01286467|66774177|FG001|Overall Study|Death|1|||
23834849|NCT01286467|66774178|FG002|Overall Study|Death|1|||
23834850|NCT01286467|66774179|FG003|Overall Study|Death|0|||
23834851|NCT01286467|66774176|FG000|Overall Study|Lost to Follow-up|0|||
23834852|NCT01286467|66774177|FG001|Overall Study|Lost to Follow-up|0|||
23776120|NCT04646213|66559913|FG000|Overall Study|Withdrawal by Subject|2|||
23776121|NCT00862979|66559914|FG000|Overall Study|Adverse Event|6|||
23776122|NCT00862979|66559915|FG001|Overall Study|Adverse Event|3|||
23776123|NCT00862979|66559914|FG000|Overall Study|Protocol Violation|0|||
23776124|NCT00862979|66559915|FG001|Overall Study|Protocol Violation|1|||
23776125|NCT00862979|66559914|FG000|Overall Study|Patient withdrew consent|2|||
23776126|NCT00862979|66559915|FG001|Overall Study|Patient withdrew consent|1|||
23776127|NCT00862979|66559914|FG000|Overall Study|Administrative problems|0|||
23776128|NCT00862979|66559915|FG001|Overall Study|Administrative problems|1|||
23776129|NCT00862979|66559914|FG000|Overall Study|Death|0|||
23576597|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Death|0|||
23576598|NCT00665561|65843391|FG000|Overall Study|Death recorded on subject summary pages|75|||
23633894|NCT02628028|66045507|FG000|Dosing Period|Lost to Follow-up|0|||
23633895|NCT02628028|66045508|FG001|Dosing Period|Lost to Follow-up|0|||
23776130|NCT00862979|66559915|FG001|Overall Study|Death|1|||
23834853|NCT01286467|66774178|FG002|Overall Study|Lost to Follow-up|0|||
23448986|NCT02098746|65384798|FG000|Overall Study|Data Not Available After Treatment|1|||
23633896|NCT02628028|66045509|FG002|Dosing Period|Lost to Follow-up|0|||
23834854|NCT01286467|66774179|FG003|Overall Study|Lost to Follow-up|1|||
23834855|NCT01286467|66774176|FG000|Overall Study|Withdrawal by Subject|0|||
23576599|NCT00665561|65843392|FG001|Overall Study|Death recorded on subject summary pages|75|||
23576600|NCT00665561|65843391|FG000|Overall Study|Does not meet entrance criteria|19|||
23576601|NCT00665561|65843392|FG001|Overall Study|Does not meet entrance criteria|21|||
23576602|NCT00665561|65843391|FG000|Overall Study|Lost to Follow-up|203|||
23576603|NCT00665561|65843392|FG001|Overall Study|Lost to Follow-up|264|||
23576604|NCT00665561|65843391|FG000|Overall Study|Withdrawal by Subject|74|||
23576605|NCT00665561|65843392|FG001|Overall Study|Withdrawal by Subject|65|||
23576606|NCT00665561|65843391|FG000|Overall Study|Other|123|||
23576607|NCT00665561|65843392|FG001|Overall Study|Other|108|||
23576608|NCT00665561|65843391|FG000|Overall Study|Site closed|8|||
23576609|NCT00665561|65843392|FG001|Overall Study|Site closed|0|||
23576610|NCT00665561|65843391|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23576611|NCT00665561|65843392|FG001|Overall Study|Withdrawn due to pregnancy|1|||
23448987|NCT02532517|65384799|FG000|Overall Study|Did not complete 24-Month visit|4|||
23448988|NCT02532517|65384799|FG000|Overall Study|Failed Angiographic eligibility|1|||
23448989|NCT02532517|65384799|FG000|Overall Study|Lost to Follow-up|4|||
23448990|NCT02532517|65384799|FG000|Overall Study|Withdrawal by Subject|4|||
23576612|NCT03073005|65843393|FG000|Overall Study|Death|6|||
23576613|NCT03073005|65843394|FG001|Overall Study|Death|0|||
23576614|NCT03073005|65843395|FG002|Overall Study|Death|7|||
23576615|NCT03073005|65843396|FG003|Overall Study|Death|0|||
23576616|NCT03073005|65843393|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
23576617|NCT03073005|65843394|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
23576618|NCT03073005|65843395|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
23576619|NCT03073005|65843396|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
23576620|NCT03073005|65843393|FG000|Overall Study|Lost to Follow-up|2|||
23576621|NCT03073005|65843394|FG001|Overall Study|Lost to Follow-up|2|||
23576622|NCT03073005|65843395|FG002|Overall Study|Lost to Follow-up|1|||
23576623|NCT03073005|65843396|FG003|Overall Study|Lost to Follow-up|2|||
23576624|NCT03073005|65843393|FG000|Overall Study|Withdrawal by Subject|0|||
23576625|NCT03073005|65843394|FG001|Overall Study|Withdrawal by Subject|4|||
23576626|NCT03073005|65843395|FG002|Overall Study|Withdrawal by Subject|4|||
23576627|NCT03073005|65843396|FG003|Overall Study|Withdrawal by Subject|4|||
23576628|NCT01347645|65843399|FG000|Overall Study|Death|1|||
23576629|NCT01347645|65843400|FG001|Overall Study|Death|5|||
23576630|NCT01347645|65843401|FG002|Overall Study|Death|2|||
23576631|NCT01347645|65843402|FG003|Overall Study|Death|7|||
23576632|NCT01347645|65843403|FG004|Overall Study|Death|7|||
23776131|NCT02587962|66559916|FG000|Overall Study|Adverse Event|0|||
23776132|NCT02587962|66559917|FG001|Overall Study|Adverse Event|0|||
23776133|NCT02587962|66559918|FG002|Overall Study|Adverse Event|1|||
23776134|NCT02587962|66559919|FG003|Overall Study|Adverse Event|0|||
23776135|NCT02587962|66559920|FG004|Overall Study|Adverse Event|0|||
23776136|NCT02587962|66559916|FG000|Overall Study|Withdrawal by Subject|0|||
23448991|NCT02532517|65384799|FG000|Overall Study|Death|4|||
23576633|NCT01347645|65843399|FG000|Overall Study|Lost to Follow-up|1|||
23576634|NCT01347645|65843400|FG001|Overall Study|Lost to Follow-up|1|||
23576635|NCT01347645|65843401|FG002|Overall Study|Lost to Follow-up|0|||
23576636|NCT01347645|65843402|FG003|Overall Study|Lost to Follow-up|1|||
23576637|NCT01347645|65843403|FG004|Overall Study|Lost to Follow-up|1|||
23576638|NCT01347645|65843399|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
23576639|NCT01347645|65843400|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
23576640|NCT01347645|65843401|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
23576641|NCT01347645|65843402|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
23576642|NCT01347645|65843403|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
23576643|NCT01347645|65843399|FG000|Overall Study|Other|1|||
23576644|NCT01347645|65843400|FG001|Overall Study|Other|0|||
23576645|NCT01347645|65843401|FG002|Overall Study|Other|0|||
23834856|NCT01286467|66774177|FG001|Overall Study|Withdrawal by Subject|0|||
23834857|NCT01286467|66774178|FG002|Overall Study|Withdrawal by Subject|1|||
23834858|NCT01286467|66774179|FG003|Overall Study|Withdrawal by Subject|0|||
23834859|NCT01286467|66774176|FG000|Overall Study|Physician Decision|0|||
23834860|NCT01286467|66774177|FG001|Overall Study|Physician Decision|0|||
23834861|NCT01286467|66774178|FG002|Overall Study|Physician Decision|0|||
23834862|NCT01286467|66774179|FG003|Overall Study|Physician Decision|1|||
23834863|NCT01286467|66774176|FG000|Overall Study|Disease progression|3|||
23834864|NCT01286467|66774177|FG001|Overall Study|Disease progression|2|||
23834865|NCT01286467|66774178|FG002|Overall Study|Disease progression|2|||
23834866|NCT01286467|66774179|FG003|Overall Study|Disease progression|3|||
23776137|NCT02587962|66559917|FG001|Overall Study|Withdrawal by Subject|0|||
23776138|NCT02587962|66559918|FG002|Overall Study|Withdrawal by Subject|1|||
23776139|NCT02587962|66559919|FG003|Overall Study|Withdrawal by Subject|1|||
23776140|NCT02587962|66559920|FG004|Overall Study|Withdrawal by Subject|4|||
23776141|NCT02587962|66559916|FG000|Overall Study|Radiological progression|2|||
23776142|NCT02587962|66559917|FG001|Overall Study|Radiological progression|2|||
23776143|NCT02587962|66559918|FG002|Overall Study|Radiological progression|2|||
23776144|NCT02587962|66559919|FG003|Overall Study|Radiological progression|5|||
23776145|NCT02587962|66559920|FG004|Overall Study|Radiological progression|10|||
23776146|NCT02587962|66559916|FG000|Overall Study|Clinical progression|0|||
23576646|NCT01347645|65843402|FG003|Overall Study|Other|0|||
23576647|NCT01347645|65843403|FG004|Overall Study|Other|1|||
23834867|NCT01286467|66774176|FG000|Overall Study|Adverse Event|0|||
23834868|NCT01286467|66774177|FG001|Overall Study|Adverse Event|1|||
23834869|NCT01286467|66774178|FG002|Overall Study|Adverse Event|2|||
23834870|NCT01286467|66774179|FG003|Overall Study|Adverse Event|3|||
23834871|NCT01286467|66774176|FG000|Overall Study|Study drug stop longer than 14 days|0|||
23576648|NCT01347645|65843399|FG000|Overall Study|Withdrawal by Subject|0|||
23576649|NCT01347645|65843400|FG001|Overall Study|Withdrawal by Subject|0|||
23834872|NCT01286467|66774177|FG001|Overall Study|Study drug stop longer than 14 days|0|||
23834873|NCT01286467|66774178|FG002|Overall Study|Study drug stop longer than 14 days|1|||
23834874|NCT01286467|66774179|FG003|Overall Study|Study drug stop longer than 14 days|0|||
23834875|NCT00961350|66774180|FG000|Overall Study|Adverse Event|18|||
23576650|NCT01347645|65843401|FG002|Overall Study|Withdrawal by Subject|0|||
23776147|NCT02587962|66559917|FG001|Overall Study|Clinical progression|1|||
23576651|NCT01347645|65843402|FG003|Overall Study|Withdrawal by Subject|3|||
23576652|NCT01347645|65843403|FG004|Overall Study|Withdrawal by Subject|3|||
23776148|NCT02587962|66559918|FG002|Overall Study|Clinical progression|2|||
23776149|NCT02587962|66559919|FG003|Overall Study|Clinical progression|0|||
23776150|NCT02587962|66559920|FG004|Overall Study|Clinical progression|1|||
23776151|NCT00301366|66559921|FG000|Overall Study|Adverse Event|1|||
23776152|NCT03657160|66559922|FG000|Overall Study|Adverse Event|5|||
23776153|NCT03657160|66559923|FG001|Overall Study|Adverse Event|6|||
23776154|NCT03657160|66559922|FG000|Overall Study|Protocol Deviation|3|||
23576653|NCT01347645|65843399|FG000|Overall Study|Physician Decision|0|||
23576654|NCT01347645|65843400|FG001|Overall Study|Physician Decision|0|||
23576655|NCT01347645|65843401|FG002|Overall Study|Physician Decision|0|||
23776155|NCT03657160|66559923|FG001|Overall Study|Protocol Deviation|0|||
23776156|NCT03657160|66559922|FG000|Overall Study|Withdrawal by Subject|18|||
23776157|NCT03657160|66559923|FG001|Overall Study|Withdrawal by Subject|16|||
23776158|NCT03657160|66559922|FG000|Overall Study|Site Termination|1|||
23834876|NCT00961350|66774181|FG001|Overall Study|Adverse Event|33|||
23576656|NCT01347645|65843402|FG003|Overall Study|Physician Decision|0|||
23834877|NCT00961350|66774180|FG000|Overall Study|Withdrawal by Subject|10|||
23834878|NCT00961350|66774181|FG001|Overall Study|Withdrawal by Subject|10|||
23576657|NCT01347645|65843403|FG004|Overall Study|Physician Decision|1|||
23776159|NCT03657160|66559923|FG001|Overall Study|Site Termination|0|||
23776160|NCT03657160|66559922|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
23776161|NCT03657160|66559923|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
23776162|NCT03657160|66559922|FG000|Overall Study|Death|33|||
23776163|NCT03657160|66559923|FG001|Overall Study|Death|26|||
23633897|NCT02628028|66045510|FG003|Dosing Period|Lost to Follow-up|0|||
23776164|NCT03657160|66559922|FG000|Overall Study|Death (COVID-19-Related)|1|||
23776165|NCT03657160|66559923|FG001|Overall Study|Death (COVID-19-Related)|0|||
23776166|NCT03657160|66559922|FG000|Overall Study|Reason Not Specified|5|||
23776167|NCT03657160|66559923|FG001|Overall Study|Reason Not Specified|5|||
23776168|NCT03657160|66559922|FG000|Overall Study|Other (COVID-19-Related)|0|||
23776169|NCT03657160|66559923|FG001|Overall Study|Other (COVID-19-Related)|1|||
23776170|NCT01079988|66559924|FG000|Overall Study|Lost to Follow-up|0|||
23776171|NCT01079988|66559925|FG001|Overall Study|Lost to Follow-up|0|||
23776172|NCT01079988|66559926|FG002|Overall Study|Lost to Follow-up|0|||
23776173|NCT01079988|66559927|FG003|Overall Study|Lost to Follow-up|1|||
23776174|NCT01079988|66559928|FG004|Overall Study|Lost to Follow-up|0|||
23776175|NCT01079988|66559924|FG000|Overall Study|Lack of Efficacy|1|||
23776176|NCT01079988|66559925|FG001|Overall Study|Lack of Efficacy|0|||
23776177|NCT01079988|66559926|FG002|Overall Study|Lack of Efficacy|0|||
23776178|NCT01079988|66559927|FG003|Overall Study|Lack of Efficacy|0|||
23776179|NCT01079988|66559928|FG004|Overall Study|Lack of Efficacy|0|||
23776180|NCT01079988|66559924|FG000|Overall Study|Other|0|||
23776181|NCT01079988|66559925|FG001|Overall Study|Other|0|||
23776182|NCT01079988|66559926|FG002|Overall Study|Other|0|||
23776183|NCT01079988|66559927|FG003|Overall Study|Other|2|||
23776184|NCT01079988|66559928|FG004|Overall Study|Other|1|||
23776185|NCT00075478|66559929|FG000|Overall Study|not eligible|1|||
23776186|NCT00075478|66559930|FG001|Overall Study|not eligible|0|||
23776187|NCT00075478|66559929|FG000|Overall Study|Physician Decision|0|||
23776188|NCT00075478|66559930|FG001|Overall Study|Physician Decision|1|||
23776189|NCT03952143|66559938|FG000|Lead-In Period|Adverse Event|2|||
23776190|NCT03952143|66559939|FG001|Lead-In Period|Adverse Event|0|||
23776191|NCT03952143|66559940|FG002|Lead-In Period|Adverse Event|0|||
23776192|NCT03952143|66559938|FG000|Lead-In Period|Lack of Efficacy|2|||
23776193|NCT03952143|66559939|FG001|Lead-In Period|Lack of Efficacy|0|||
23776194|NCT03952143|66559940|FG002|Lead-In Period|Lack of Efficacy|0|||
23776195|NCT03952143|66559938|FG000|Lead-In Period|Physician Decision|5|||
23776196|NCT03952143|66559939|FG001|Lead-In Period|Physician Decision|0|||
23776197|NCT03952143|66559940|FG002|Lead-In Period|Physician Decision|0|||
23776198|NCT03952143|66559938|FG000|Lead-In Period|Protocol Violation|5|||
23776199|NCT03952143|66559939|FG001|Lead-In Period|Protocol Violation|0|||
23776200|NCT03952143|66559940|FG002|Lead-In Period|Protocol Violation|0|||
23776201|NCT03952143|66559938|FG000|Lead-In Period|Withdrawal by Subject|19|||
23776202|NCT03952143|66559939|FG001|Lead-In Period|Withdrawal by Subject|0|||
23776203|NCT03952143|66559940|FG002|Lead-In Period|Withdrawal by Subject|0|||
23776204|NCT03952143|66559938|FG000|Treatment Period|Adverse Event|0|||
23776205|NCT03952143|66559939|FG001|Treatment Period|Adverse Event|0|||
23776206|NCT03952143|66559940|FG002|Treatment Period|Adverse Event|1|||
23448992|NCT02362724|65384800|FG000|Overall Study|Withdrawal by Subject|3|||
23448993|NCT02362724|65384801|FG001|Overall Study|Withdrawal by Subject|1|||
23776207|NCT03952143|66559938|FG000|Treatment Period|Lost to Follow-up|0|||
23776208|NCT03952143|66559939|FG001|Treatment Period|Lost to Follow-up|2|||
23776209|NCT03952143|66559940|FG002|Treatment Period|Lost to Follow-up|0|||
23776210|NCT03952143|66559938|FG000|Treatment Period|Physician Decision|0|||
23776211|NCT03952143|66559939|FG001|Treatment Period|Physician Decision|0|||
23776212|NCT03952143|66559940|FG002|Treatment Period|Physician Decision|2|||
23448994|NCT02362724|65384800|FG000|Overall Study|Adverse Event|3|||
23448995|NCT02362724|65384801|FG001|Overall Study|Adverse Event|0|||
23776213|NCT03952143|66559938|FG000|Treatment Period|Protocol Violation|0|||
23776214|NCT03952143|66559939|FG001|Treatment Period|Protocol Violation|0|||
23776215|NCT03952143|66559940|FG002|Treatment Period|Protocol Violation|1|||
23776216|NCT03952143|66559938|FG000|Treatment Period|Withdrawal by Subject|0|||
23776217|NCT03952143|66559939|FG001|Treatment Period|Withdrawal by Subject|5|||
23776218|NCT03952143|66559940|FG002|Treatment Period|Withdrawal by Subject|26|||
23776219|NCT03952143|66559938|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
23776220|NCT03952143|66559939|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
23776221|NCT03952143|66559940|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
23776222|NCT03952143|66559938|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
23776223|NCT03952143|66559939|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
23776224|NCT03952143|66559940|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
23834879|NCT00961350|66774180|FG000|Overall Study|Lost to Follow-up|3|||
23834880|NCT00961350|66774181|FG001|Overall Study|Lost to Follow-up|3|||
23834881|NCT00961350|66774180|FG000|Overall Study|Misc|16|||
23834882|NCT00961350|66774181|FG001|Overall Study|Misc|21|||
23834883|NCT02872714|66774186|FG000|Overall Study|Progressive Disease|1|||
23448996|NCT02871635|65384802|FG000|Overall Study|Primary lack of efficacy|4|||
23834884|NCT02872714|66774187|FG001|Overall Study|Progressive Disease|2|||
23834885|NCT02872714|66774188|FG002|Overall Study|Progressive Disease|0|||
23834886|NCT02872714|66774189|FG003|Overall Study|Progressive Disease|0|||
23834887|NCT02872714|66774190|FG004|Overall Study|Progressive Disease|0|||
23834888|NCT02872714|66774186|FG000|Overall Study|Death|87|||
23834889|NCT02872714|66774187|FG001|Overall Study|Death|36|||
23834890|NCT02872714|66774188|FG002|Overall Study|Death|8|||
23834891|NCT02872714|66774189|FG003|Overall Study|Death|81|||
23834892|NCT02872714|66774190|FG004|Overall Study|Death|2|||
23834893|NCT02872714|66774186|FG000|Overall Study|Lost to Follow-up|2|||
23834894|NCT02872714|66774187|FG001|Overall Study|Lost to Follow-up|1|||
23834895|NCT02872714|66774188|FG002|Overall Study|Lost to Follow-up|0|||
23834896|NCT02872714|66774189|FG003|Overall Study|Lost to Follow-up|3|||
23834897|NCT02872714|66774190|FG004|Overall Study|Lost to Follow-up|0|||
23448997|NCT02871635|65384803|FG001|Overall Study|Primary lack of efficacy|4|||
23448998|NCT02871635|65384802|FG000|Overall Study|Protocol Violation|3|||
23448999|NCT02871635|65384803|FG001|Overall Study|Protocol Violation|1|||
23449000|NCT02871635|65384802|FG000|Overall Study|Lost to Follow-up|1|||
23449001|NCT02871635|65384803|FG001|Overall Study|Lost to Follow-up|2|||
23449002|NCT02871635|65384802|FG000|Overall Study|Pregnancy|0|||
23449003|NCT02871635|65384803|FG001|Overall Study|Pregnancy|2|||
23449004|NCT02871635|65384802|FG000|Overall Study|Physician Decision|1|||
23449005|NCT02871635|65384803|FG001|Overall Study|Physician Decision|1|||
23449006|NCT02871635|65384802|FG000|Overall Study|Withdrawal by Subject|3|||
23449007|NCT02871635|65384803|FG001|Overall Study|Withdrawal by Subject|4|||
23449008|NCT02871635|65384802|FG000|Overall Study|Adverse Event|4|||
23449009|NCT02871635|65384803|FG001|Overall Study|Adverse Event|4|||
23449010|NCT02871635|65384802|FG000|Overall Study|Secondary lack of efficacy|2|||
23776225|NCT03292653|66559942|FG000|Overall Study|Adverse Event|0|||
23834898|NCT02872714|66774186|FG000|Overall Study|Physician Decision|0|||
23449011|NCT02871635|65384803|FG001|Overall Study|Secondary lack of efficacy|1|||
23834899|NCT02872714|66774187|FG001|Overall Study|Physician Decision|0|||
23834900|NCT02872714|66774188|FG002|Overall Study|Physician Decision|0|||
23834901|NCT02872714|66774189|FG003|Overall Study|Physician Decision|1|||
23834902|NCT02872714|66774190|FG004|Overall Study|Physician Decision|0|||
23834903|NCT02872714|66774186|FG000|Overall Study|Withdrawal by Subject|1|||
23449012|NCT02631551|65387861|FG000|Overall Study|Adverse Event|1|||
23449013|NCT02631551|65387862|FG001|Overall Study|Adverse Event|2|||
23449014|NCT02631551|65387863|FG002|Overall Study|Adverse Event|4|||
23449015|NCT02631551|65387864|FG003|Overall Study|Adverse Event|0|||
23449016|NCT02631551|65387861|FG000|Overall Study|Lack of Efficacy|0|||
23834904|NCT02872714|66774187|FG001|Overall Study|Withdrawal by Subject|3|||
23834905|NCT02872714|66774188|FG002|Overall Study|Withdrawal by Subject|0|||
23834906|NCT02872714|66774189|FG003|Overall Study|Withdrawal by Subject|2|||
23834907|NCT02872714|66774190|FG004|Overall Study|Withdrawal by Subject|0|||
23776226|NCT03292653|66559943|FG001|Overall Study|Adverse Event|0|||
23776227|NCT03292653|66559944|FG002|Overall Study|Adverse Event|1|||
23776228|NCT03292653|66559942|FG000|Overall Study|Did not Receive Treatment|1|||
23776229|NCT03292653|66559943|FG001|Overall Study|Did not Receive Treatment|0|||
23776230|NCT03292653|66559944|FG002|Overall Study|Did not Receive Treatment|0|||
23776231|NCT01706536|66559947|FG000|Overall Study|Withdrawal by Subject|1|||
23776232|NCT01706536|66559948|FG001|Overall Study|Withdrawal by Subject|0|||
23776233|NCT01706536|66559949|FG002|Overall Study|Withdrawal by Subject|1|||
23776234|NCT01706536|66559950|FG003|Overall Study|Withdrawal by Subject|0|||
23776235|NCT01706536|66559951|FG004|Overall Study|Withdrawal by Subject|0|||
23776236|NCT01706536|66559947|FG000|Overall Study|Adverse Event|2|||
23776237|NCT01706536|66559948|FG001|Overall Study|Adverse Event|3|||
23776238|NCT01706536|66559949|FG002|Overall Study|Adverse Event|4|||
23776239|NCT01706536|66559950|FG003|Overall Study|Adverse Event|3|||
23776240|NCT01706536|66559951|FG004|Overall Study|Adverse Event|2|||
23776241|NCT01706536|66559947|FG000|Overall Study|Lack of Efficacy|1|||
23776242|NCT01706536|66559948|FG001|Overall Study|Lack of Efficacy|0|||
23776243|NCT01706536|66559949|FG002|Overall Study|Lack of Efficacy|0|||
23776244|NCT01706536|66559950|FG003|Overall Study|Lack of Efficacy|1|||
23576658|NCT01347645|65843399|FG000|Overall Study|Adverse Event|0|||
23576659|NCT01347645|65843400|FG001|Overall Study|Adverse Event|0|||
23576660|NCT01347645|65843401|FG002|Overall Study|Adverse Event|0|||
23576661|NCT01347645|65843402|FG003|Overall Study|Adverse Event|1|||
23576662|NCT01347645|65843403|FG004|Overall Study|Adverse Event|1|||
23576663|NCT03738241|65843408|FG000|Overall Study|Withdrawal by Subject|0|||
23576664|NCT03738241|65843409|FG001|Overall Study|Withdrawal by Subject|0|||
23576665|NCT03738241|65843410|FG002|Overall Study|Withdrawal by Subject|0|||
23576666|NCT03738241|65843411|FG003|Overall Study|Withdrawal by Subject|0|||
23576667|NCT03738241|65843412|FG004|Overall Study|Withdrawal by Subject|0|||
23576668|NCT03738241|65843413|FG005|Overall Study|Withdrawal by Subject|0|||
23576669|NCT03738241|65843414|FG006|Overall Study|Withdrawal by Subject|0|||
23576670|NCT03738241|65843415|FG007|Overall Study|Withdrawal by Subject|0|||
23576671|NCT03738241|65843416|FG008|Overall Study|Withdrawal by Subject|0|||
23576672|NCT03738241|65843417|FG009|Overall Study|Withdrawal by Subject|1|||
23576673|NCT03738241|65843408|FG000|Overall Study|Physician Decision|0|||
23776245|NCT01706536|66559951|FG004|Overall Study|Lack of Efficacy|0|||
23776246|NCT01706536|66559947|FG000|Overall Study|non compliance|0|||
23776247|NCT01706536|66559948|FG001|Overall Study|non compliance|1|||
23776248|NCT01706536|66559949|FG002|Overall Study|non compliance|0|||
23776249|NCT01706536|66559950|FG003|Overall Study|non compliance|0|||
23776250|NCT01706536|66559951|FG004|Overall Study|non compliance|0|||
23776251|NCT02865538|66559954|FG000|Overall Study|Withdrawal by Subject|0|||
23776252|NCT02865538|66559955|FG001|Overall Study|Withdrawal by Subject|0|||
23776253|NCT02865538|66559956|FG002|Overall Study|Withdrawal by Subject|1|||
23776254|NCT02865538|66559957|FG003|Overall Study|Withdrawal by Subject|0|||
23776255|NCT02865538|66559958|FG004|Overall Study|Withdrawal by Subject|0|||
23576674|NCT03738241|65843409|FG001|Overall Study|Physician Decision|0|||
23576675|NCT03738241|65843410|FG002|Overall Study|Physician Decision|0|||
23576676|NCT03738241|65843411|FG003|Overall Study|Physician Decision|0|||
23576677|NCT03738241|65843412|FG004|Overall Study|Physician Decision|0|||
23576678|NCT03738241|65843413|FG005|Overall Study|Physician Decision|0|||
23576679|NCT03738241|65843414|FG006|Overall Study|Physician Decision|0|||
23576680|NCT03738241|65843415|FG007|Overall Study|Physician Decision|0|||
23576681|NCT03738241|65843416|FG008|Overall Study|Physician Decision|1|||
23576682|NCT03738241|65843417|FG009|Overall Study|Physician Decision|0|||
23576683|NCT03738241|65843408|FG000|Overall Study|Adverse Event|1|||
23576684|NCT03738241|65843409|FG001|Overall Study|Adverse Event|0|||
23576685|NCT03738241|65843410|FG002|Overall Study|Adverse Event|0|||
23576686|NCT03738241|65843411|FG003|Overall Study|Adverse Event|0|||
23576687|NCT03738241|65843412|FG004|Overall Study|Adverse Event|0|||
23576688|NCT03738241|65843413|FG005|Overall Study|Adverse Event|0|||
23576689|NCT03738241|65843414|FG006|Overall Study|Adverse Event|0|||
23576690|NCT03738241|65843415|FG007|Overall Study|Adverse Event|0|||
23576691|NCT03738241|65843416|FG008|Overall Study|Adverse Event|0|||
23576692|NCT03738241|65843417|FG009|Overall Study|Adverse Event|0|||
23576693|NCT00131911|65843419|FG000|Overall Study|Withdrawal by Subject|1|||
23576694|NCT00131911|65843420|FG001|Overall Study|Withdrawal by Subject|0|||
23776256|NCT02865538|66559954|FG000|Overall Study|Lost to Follow-up|1|||
23576695|NCT02955277|65843423|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
23776257|NCT02865538|66559955|FG001|Overall Study|Lost to Follow-up|0|||
23776258|NCT02865538|66559956|FG002|Overall Study|Lost to Follow-up|0|||
23776259|NCT02865538|66559957|FG003|Overall Study|Lost to Follow-up|0|||
23776260|NCT02865538|66559958|FG004|Overall Study|Lost to Follow-up|0|||
23776261|NCT03603314|66559967|FG000|Overall Study|Lost to Follow-up|0|||
23776262|NCT03603314|66559968|FG001|Overall Study|Lost to Follow-up|3|||
23576696|NCT02955277|65843424|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
23576697|NCT02955277|65843423|FG000|Post to Follow-up|Lost to Follow-up|8|||
23576698|NCT02955277|65843424|FG001|Post to Follow-up|Lost to Follow-up|11|||
23776263|NCT03603314|66559969|FG002|Overall Study|Lost to Follow-up|0|||
23776264|NCT03603314|66559967|FG000|Overall Study|Protocol Violation|0|||
23576699|NCT03285711|65843428|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
23576700|NCT03285711|65843429|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
23576701|NCT03285711|65843430|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
23576702|NCT03285711|65843431|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
23576703|NCT03285711|65843428|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
23776265|NCT03603314|66559968|FG001|Overall Study|Protocol Violation|1|||
23776266|NCT03603314|66559969|FG002|Overall Study|Protocol Violation|0|||
23776267|NCT03603314|66559967|FG000|Overall Study|Adverse Event|2|||
23776268|NCT03603314|66559968|FG001|Overall Study|Adverse Event|0|||
23776269|NCT03603314|66559969|FG002|Overall Study|Adverse Event|0|||
23776270|NCT03603314|66559967|FG000|Overall Study|Physician Decision|1|||
23776271|NCT03603314|66559968|FG001|Overall Study|Physician Decision|1|||
23776272|NCT03603314|66559969|FG002|Overall Study|Physician Decision|0|||
23776273|NCT03603314|66559967|FG000|Overall Study|Withdrawal by Subject|4|||
23776274|NCT03603314|66559968|FG001|Overall Study|Withdrawal by Subject|5|||
23776275|NCT03603314|66559969|FG002|Overall Study|Withdrawal by Subject|3|||
23776276|NCT03603314|66559967|FG000|Overall Study|Other|0|||
23776277|NCT03603314|66559968|FG001|Overall Study|Other|1|||
23776278|NCT03603314|66559969|FG002|Overall Study|Other|0|||
23776279|NCT01424644|66559970|FG000|Overall Study|Adverse Event|2|||
23776280|NCT01424644|66559971|FG001|Overall Study|Adverse Event|0|||
23776281|NCT01424644|66559970|FG000|Overall Study|Withdrawal by Subject|9|||
23776282|NCT01424644|66559971|FG001|Overall Study|Withdrawal by Subject|12|||
23776283|NCT01424644|66559970|FG000|Overall Study|Lost to Follow-up|16|||
23776284|NCT01424644|66559971|FG001|Overall Study|Lost to Follow-up|12|||
23776285|NCT01424644|66559970|FG000|Overall Study|Protocol Violation|4|||
23776286|NCT01424644|66559971|FG001|Overall Study|Protocol Violation|3|||
23776287|NCT01424644|66559970|FG000|Overall Study|Administrative Reason|1|||
23776288|NCT01424644|66559971|FG001|Overall Study|Administrative Reason|0|||
23776289|NCT01424644|66559970|FG000|Overall Study|Unable to Classify|1|||
23776290|NCT01424644|66559971|FG001|Overall Study|Unable to Classify|0|||
23776291|NCT01404988|66563094|FG000|Overall Study|Death|2|||
23776292|NCT01404988|66563095|FG001|Overall Study|Death|0|||
23776293|NCT01404988|66563096|FG002|Overall Study|Death|2|||
23776294|NCT01404988|66563094|FG000|Overall Study|Adverse Event|1|||
23776295|NCT01404988|66563095|FG001|Overall Study|Adverse Event|0|||
23776296|NCT01404988|66563096|FG002|Overall Study|Adverse Event|0|||
23776297|NCT01404988|66563094|FG000|Overall Study|Withdrawal by Subject|2|||
23776298|NCT01404988|66563095|FG001|Overall Study|Withdrawal by Subject|2|||
23776299|NCT01404988|66563096|FG002|Overall Study|Withdrawal by Subject|0|||
23776300|NCT01404988|66563094|FG000|Overall Study|Lost to Follow-up|1|||
23776301|NCT01404988|66563095|FG001|Overall Study|Lost to Follow-up|2|||
23776302|NCT01404988|66563096|FG002|Overall Study|Lost to Follow-up|1|||
23776303|NCT00635492|66563097|FG000|Overall Study|Death|12|||
23776304|NCT00635492|66563098|FG001|Overall Study|Death|40|||
23776305|NCT00635492|66563097|FG000|Overall Study|Lost to Follow-up|151|||
23776306|NCT00635492|66563098|FG001|Overall Study|Lost to Follow-up|172|||
23776307|NCT00635492|66563097|FG000|Overall Study|Physician Decision|32|||
23776308|NCT00635492|66563098|FG001|Overall Study|Physician Decision|22|||
23776309|NCT00635492|66563097|FG000|Overall Study|Sponsor decision|2|||
23776310|NCT00635492|66563098|FG001|Overall Study|Sponsor decision|3|||
23776311|NCT00635492|66563097|FG000|Overall Study|Withdrawal by Subject|82|||
23776312|NCT00635492|66563098|FG001|Overall Study|Withdrawal by Subject|45|||
23776313|NCT01880593|66563099|FG000|Overall Study|Adverse Event|1|||
23776314|NCT01880593|66563100|FG001|Overall Study|Adverse Event|0|||
23776315|NCT01880593|66563099|FG000|Overall Study|Lack of Efficacy|1|||
23776316|NCT01880593|66563100|FG001|Overall Study|Lack of Efficacy|5|||
23776317|NCT01880593|66563099|FG000|Overall Study|Withdrawal by Subject|6|||
23776318|NCT01880593|66563100|FG001|Overall Study|Withdrawal by Subject|1|||
23776319|NCT00874237|66563101|FG000|Overall Study|Physician Decision|0|||
23776320|NCT00874237|66563102|FG001|Overall Study|Physician Decision|1|||
23776321|NCT00874237|66563103|FG002|Overall Study|Physician Decision|0|||
23776322|NCT00874237|66563104|FG003|Overall Study|Physician Decision|0|||
23776323|NCT00874237|66563105|FG004|Overall Study|Physician Decision|0|||
23633898|NCT02628028|66045511|FG004|Dosing Period|Lost to Follow-up|0|||
23776324|NCT00874237|66563106|FG005|Overall Study|Physician Decision|0|||
23776325|NCT00874237|66563101|FG000|Overall Study|Withdrawal by Subject|0|||
23776326|NCT00874237|66563102|FG001|Overall Study|Withdrawal by Subject|0|||
23576704|NCT03285711|65843429|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23576705|NCT03285711|65843430|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23776327|NCT00874237|66563103|FG002|Overall Study|Withdrawal by Subject|1|||
23776328|NCT00874237|66563104|FG003|Overall Study|Withdrawal by Subject|0|||
23776329|NCT00874237|66563105|FG004|Overall Study|Withdrawal by Subject|0|||
23776330|NCT00874237|66563106|FG005|Overall Study|Withdrawal by Subject|0|||
23776331|NCT00528606|66563107|FG000|Overall Study|Withdrew consent|4|||
23776332|NCT00528606|66563108|FG001|Overall Study|Withdrew consent|3|||
23776333|NCT00528606|66563107|FG000|Overall Study|Lost to Follow-up|4|||
23776334|NCT00528606|66563108|FG001|Overall Study|Lost to Follow-up|1|||
23776335|NCT00528606|66563107|FG000|Overall Study|Adverse Event|3|||
23776336|NCT00528606|66563108|FG001|Overall Study|Adverse Event|0|||
23776337|NCT00528606|66563107|FG000|Overall Study|Other|2|||
23776338|NCT00528606|66563108|FG001|Overall Study|Other|0|||
23776339|NCT02087904|66563110|FG000|Overall Study|Did Not Receive Study Drug|0|||
23776340|NCT02087904|66563111|FG001|Overall Study|Did Not Receive Study Drug|0|||
23776341|NCT02087904|66563112|FG002|Overall Study|Did Not Receive Study Drug|2|||
23776342|NCT02087904|66563113|FG003|Overall Study|Did Not Receive Study Drug|1|||
23776343|NCT02087904|66563110|FG000|Overall Study|Adverse Event|8|||
23776344|NCT02087904|66563111|FG001|Overall Study|Adverse Event|4|||
23776345|NCT02087904|66563112|FG002|Overall Study|Adverse Event|4|||
23776346|NCT02087904|66563113|FG003|Overall Study|Adverse Event|12|||
23776347|NCT02087904|66563110|FG000|Overall Study|Lack of Efficacy|3|||
23776348|NCT02087904|66563111|FG001|Overall Study|Lack of Efficacy|6|||
23776349|NCT02087904|66563112|FG002|Overall Study|Lack of Efficacy|3|||
23776350|NCT02087904|66563113|FG003|Overall Study|Lack of Efficacy|2|||
23776351|NCT02087904|66563110|FG000|Overall Study|Other|6|||
23776352|NCT02087904|66563111|FG001|Overall Study|Other|2|||
23776353|NCT02087904|66563112|FG002|Overall Study|Other|4|||
23776354|NCT02087904|66563113|FG003|Overall Study|Other|4|||
23776355|NCT02087904|66563110|FG000|Overall Study|Withdrawal by Subject|8|||
23776356|NCT02087904|66563111|FG001|Overall Study|Withdrawal by Subject|3|||
23776357|NCT02087904|66563112|FG002|Overall Study|Withdrawal by Subject|7|||
23776358|NCT02087904|66563113|FG003|Overall Study|Withdrawal by Subject|4|||
23776359|NCT02087904|66563110|FG000|Overall Study|Lost to Follow-up|0|||
23776360|NCT02087904|66563111|FG001|Overall Study|Lost to Follow-up|4|||
23776361|NCT02087904|66563112|FG002|Overall Study|Lost to Follow-up|2|||
23776362|NCT02087904|66563113|FG003|Overall Study|Lost to Follow-up|2|||
23776363|NCT01294917|66563115|FG000|Overall Study|Relocation|5|||
23776364|NCT01294917|66563115|FG000|Overall Study|Inconvenience|1|||
23776365|NCT04407806|66563118|FG000|Overall Study|Withdrawal by Subject|1|||
23776366|NCT04407806|66563119|FG001|Overall Study|Withdrawal by Subject|2|||
23776367|NCT00984126|66563122|FG000|Overall Study|Protocol Violation|0|||
23776368|NCT00984126|66563123|FG001|Overall Study|Protocol Violation|0|||
23776369|NCT00984126|66563124|FG002|Overall Study|Protocol Violation|1|||
23776370|NCT00984126|66563125|FG003|Overall Study|Protocol Violation|2|||
23776371|NCT00984126|66563122|FG000|Overall Study|Adverse Event|0|||
23776372|NCT00984126|66563123|FG001|Overall Study|Adverse Event|0|||
23776373|NCT00984126|66563124|FG002|Overall Study|Adverse Event|0|||
23776374|NCT00984126|66563125|FG003|Overall Study|Adverse Event|2|||
23776375|NCT00984126|66563122|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
23776376|NCT00984126|66563123|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
23776377|NCT00984126|66563124|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
23776378|NCT00984126|66563125|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
23776379|NCT00984126|66563122|FG000|Overall Study|Withdrawal criteria|0|||
23776380|NCT00984126|66563123|FG001|Overall Study|Withdrawal criteria|1|||
23776381|NCT00984126|66563124|FG002|Overall Study|Withdrawal criteria|3|||
23776382|NCT00984126|66563125|FG003|Overall Study|Withdrawal criteria|9|||
23776383|NCT01457053|66563126|FG000|Overall Study|Unable to undergo selected treatment|1|||
23776384|NCT01457053|66563127|FG001|Overall Study|Unable to undergo selected treatment|1|||
23776385|NCT04453202|66563128|FG000|Overall Study|Adverse Event|0|||
23776386|NCT04453202|66563129|FG001|Overall Study|Adverse Event|0|||
23776387|NCT04453202|66563130|FG002|Overall Study|Adverse Event|0|||
23776388|NCT04453202|66563131|FG003|Overall Study|Adverse Event|0|||
23776389|NCT04453202|66563132|FG004|Overall Study|Adverse Event|0|||
23776390|NCT04453202|66563133|FG005|Overall Study|Adverse Event|0|||
23776391|NCT04453202|66563134|FG006|Overall Study|Adverse Event|1|||
23776392|NCT04453202|66563135|FG007|Overall Study|Adverse Event|0|||
23776393|NCT04453202|66563136|FG008|Overall Study|Adverse Event|0|||
23776394|NCT04453202|66563137|FG009|Overall Study|Adverse Event|0|||
23776395|NCT04453202|66563138|FG010|Overall Study|Adverse Event|0|||
23776396|NCT04453202|66563128|FG000|Overall Study|Death|0|||
23776397|NCT04453202|66563129|FG001|Overall Study|Death|0|||
23449017|NCT02631551|65387862|FG001|Overall Study|Lack of Efficacy|0|||
23776398|NCT04453202|66563130|FG002|Overall Study|Death|0|||
23449018|NCT02631551|65387863|FG002|Overall Study|Lack of Efficacy|1|||
23776399|NCT04453202|66563131|FG003|Overall Study|Death|0|||
23776400|NCT04453202|66563132|FG004|Overall Study|Death|0|||
23776401|NCT04453202|66563133|FG005|Overall Study|Death|0|||
23776402|NCT04453202|66563134|FG006|Overall Study|Death|0|||
23449019|NCT02631551|65387864|FG003|Overall Study|Lack of Efficacy|0|||
23776403|NCT04453202|66563135|FG007|Overall Study|Death|0|||
23776404|NCT04453202|66563136|FG008|Overall Study|Death|0|||
23776405|NCT04453202|66563137|FG009|Overall Study|Death|1|||
23776406|NCT04453202|66563138|FG010|Overall Study|Death|0|||
23776407|NCT04453202|66563128|FG000|Overall Study|Lost to Follow-up|0|||
23776408|NCT04453202|66563129|FG001|Overall Study|Lost to Follow-up|1|||
23776409|NCT04453202|66563130|FG002|Overall Study|Lost to Follow-up|0|||
23776410|NCT04453202|66563131|FG003|Overall Study|Lost to Follow-up|1|||
23776411|NCT04453202|66563132|FG004|Overall Study|Lost to Follow-up|0|||
23776412|NCT04453202|66563133|FG005|Overall Study|Lost to Follow-up|0|||
23776413|NCT04453202|66563134|FG006|Overall Study|Lost to Follow-up|0|||
23776414|NCT04453202|66563135|FG007|Overall Study|Lost to Follow-up|0|||
23776415|NCT04453202|66563136|FG008|Overall Study|Lost to Follow-up|0|||
23776416|NCT04453202|66563137|FG009|Overall Study|Lost to Follow-up|1|||
23776417|NCT04453202|66563138|FG010|Overall Study|Lost to Follow-up|1|||
23776418|NCT04453202|66563128|FG000|Overall Study|Withdrawal by Subject|1|||
23776419|NCT04453202|66563129|FG001|Overall Study|Withdrawal by Subject|2|||
23776420|NCT04453202|66563130|FG002|Overall Study|Withdrawal by Subject|1|||
23776421|NCT04453202|66563131|FG003|Overall Study|Withdrawal by Subject|2|||
23776422|NCT04453202|66563132|FG004|Overall Study|Withdrawal by Subject|1|||
23776423|NCT04453202|66563133|FG005|Overall Study|Withdrawal by Subject|1|||
23776424|NCT04453202|66563134|FG006|Overall Study|Withdrawal by Subject|0|||
23776425|NCT04453202|66563135|FG007|Overall Study|Withdrawal by Subject|0|||
23776426|NCT04453202|66563136|FG008|Overall Study|Withdrawal by Subject|0|||
23776427|NCT04453202|66563137|FG009|Overall Study|Withdrawal by Subject|1|||
23776428|NCT04453202|66563138|FG010|Overall Study|Withdrawal by Subject|0|||
23449020|NCT02631551|65387861|FG000|Overall Study|Lost to Follow-up|1|||
23576706|NCT03285711|65843431|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23576707|NCT03285711|65843428|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576708|NCT03285711|65843429|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576709|NCT03285711|65843430|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
23576710|NCT03285711|65843431|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576711|NCT03285711|65843428|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576712|NCT03285711|65843429|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
23576713|NCT03285711|65843430|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576714|NCT03285711|65843431|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576715|NCT00901485|65843435|FG000|Overall Study|Lack of Efficacy|0|||
23776429|NCT04453202|66563128|FG000|Overall Study|Adverse Event|0|||
23776430|NCT04453202|66563129|FG001|Overall Study|Adverse Event|0|||
23776431|NCT04453202|66563130|FG002|Overall Study|Adverse Event|0|||
23776432|NCT04453202|66563131|FG003|Overall Study|Adverse Event|0|||
23776433|NCT04453202|66563132|FG004|Overall Study|Adverse Event|0|||
23776434|NCT04453202|66563133|FG005|Overall Study|Adverse Event|1|||
23776435|NCT04453202|66563134|FG006|Overall Study|Adverse Event|0|||
23449021|NCT02631551|65387862|FG001|Overall Study|Lost to Follow-up|2|||
23576716|NCT00901485|65843436|FG001|Overall Study|Lack of Efficacy|2|||
23576717|NCT00901485|65843435|FG000|Overall Study|Withdrawal by Subject|1|||
23576718|NCT00901485|65843436|FG001|Overall Study|Withdrawal by Subject|2|||
23576719|NCT00372567|65843440|FG000|Phase 3 Study|Adverse Event|5|||
23576720|NCT00372567|65843441|FG001|Phase 3 Study|Adverse Event|1|||
23576721|NCT00372567|65843442|FG002|Phase 3 Study|Adverse Event|1|||
23576722|NCT00372567|65843440|FG000|Phase 3 Study|Death|1|||
23576723|NCT00372567|65843441|FG001|Phase 3 Study|Death|1|||
23776436|NCT04453202|66563135|FG007|Overall Study|Adverse Event|0|||
23776437|NCT04453202|66563136|FG008|Overall Study|Adverse Event|0|||
23776438|NCT04453202|66563137|FG009|Overall Study|Adverse Event|0|||
23776439|NCT04453202|66563138|FG010|Overall Study|Adverse Event|0|||
23776440|NCT05017480|66563141|FG000|Stage 1 Study|Withdrawal by Subject|8|||
23776441|NCT05017480|66563142|FG001|Stage 1 Study|Withdrawal by Subject|6|||
23776442|NCT05017480|66563143|FG002|Stage 1 Study|Withdrawal by Subject|0|||
23776443|NCT05017480|66563144|FG003|Stage 1 Study|Withdrawal by Subject|0|||
23776444|NCT05017480|66563145|FG004|Stage 1 Study|Withdrawal by Subject|0|||
23776445|NCT05017480|66563141|FG000|Stage 1 Study|Adverse Event|1|||
23776446|NCT05017480|66563142|FG001|Stage 1 Study|Adverse Event|1|||
23776447|NCT05017480|66563143|FG002|Stage 1 Study|Adverse Event|0|||
23776448|NCT05017480|66563144|FG003|Stage 1 Study|Adverse Event|0|||
23776449|NCT05017480|66563145|FG004|Stage 1 Study|Adverse Event|0|||
23776450|NCT05017480|66563141|FG000|Stage 1 Study|Poor Compliance|1|||
23776451|NCT05017480|66563142|FG001|Stage 1 Study|Poor Compliance|1|||
23776452|NCT05017480|66563143|FG002|Stage 1 Study|Poor Compliance|0|||
23776453|NCT05017480|66563144|FG003|Stage 1 Study|Poor Compliance|0|||
23776454|NCT05017480|66563145|FG004|Stage 1 Study|Poor Compliance|0|||
23776455|NCT05017480|66563141|FG000|Stage 1 Study|Physician Decision|0|||
23776456|NCT05017480|66563142|FG001|Stage 1 Study|Physician Decision|1|||
23776457|NCT05017480|66563143|FG002|Stage 1 Study|Physician Decision|0|||
23776458|NCT05017480|66563144|FG003|Stage 1 Study|Physician Decision|0|||
23776459|NCT05017480|66563145|FG004|Stage 1 Study|Physician Decision|0|||
23776460|NCT05017480|66563141|FG000|Stage 2 Study|Withdrawal by Subject|0|||
23776461|NCT05017480|66563142|FG001|Stage 2 Study|Withdrawal by Subject|0|||
23776462|NCT05017480|66563143|FG002|Stage 2 Study|Withdrawal by Subject|6|||
23776463|NCT05017480|66563144|FG003|Stage 2 Study|Withdrawal by Subject|9|||
23776464|NCT05017480|66563145|FG004|Stage 2 Study|Withdrawal by Subject|11|||
23776465|NCT05017480|66563141|FG000|Stage 2 Study|Lost to Follow-up|0|||
23776466|NCT05017480|66563142|FG001|Stage 2 Study|Lost to Follow-up|0|||
23776467|NCT05017480|66563143|FG002|Stage 2 Study|Lost to Follow-up|0|||
23776468|NCT05017480|66563144|FG003|Stage 2 Study|Lost to Follow-up|2|||
23776469|NCT05017480|66563145|FG004|Stage 2 Study|Lost to Follow-up|1|||
23834908|NCT02872714|66774186|FG000|Overall Study|Captured as Other|2|||
23834909|NCT02872714|66774187|FG001|Overall Study|Captured as Other|0|||
23834910|NCT02872714|66774188|FG002|Overall Study|Captured as Other|0|||
23834911|NCT02872714|66774189|FG003|Overall Study|Captured as Other|1|||
23834912|NCT02872714|66774190|FG004|Overall Study|Captured as Other|0|||
23834913|NCT00611923|66774191|FG000|Overall Study|Withdrawal by Subject|2|||
23834914|NCT00611923|66774192|FG001|Overall Study|Withdrawal by Subject|2|||
23834915|NCT03448419|66774193|FG000|Overall Study|Adverse Event|10|||
23834916|NCT03448419|66774194|FG001|Overall Study|Adverse Event|9|||
23834917|NCT03448419|66774193|FG000|Overall Study|Lost to Follow-up|0|||
23834918|NCT03448419|66774194|FG001|Overall Study|Lost to Follow-up|2|||
23834919|NCT03448419|66774193|FG000|Overall Study|Withdrawal by Subject|3|||
23449022|NCT02631551|65387863|FG002|Overall Study|Lost to Follow-up|0|||
23576724|NCT00372567|65843442|FG002|Phase 3 Study|Death|0|||
23576725|NCT00372567|65843440|FG000|Phase 3 Study|Protocol Violation|0|||
23576726|NCT00372567|65843441|FG001|Phase 3 Study|Protocol Violation|0|||
23576727|NCT00372567|65843442|FG002|Phase 3 Study|Protocol Violation|1|||
23576728|NCT00372567|65843440|FG000|Phase 3 Study|Objective progression or relapse|10|||
23576729|NCT00372567|65843441|FG001|Phase 3 Study|Objective progression or relapse|13|||
23576730|NCT00372567|65843442|FG002|Phase 3 Study|Objective progression or relapse|4|||
23576731|NCT00372567|65843440|FG000|Phase 3 Study|Global deterioration of health status|0|||
23576732|NCT00372567|65843441|FG001|Phase 3 Study|Global deterioration of health status|1|||
23776470|NCT05017480|66563141|FG000|Stage 2 Study|Adverse Event|0|||
23776471|NCT05017480|66563142|FG001|Stage 2 Study|Adverse Event|0|||
23776472|NCT05017480|66563143|FG002|Stage 2 Study|Adverse Event|0|||
23834920|NCT03448419|66774194|FG001|Overall Study|Withdrawal by Subject|1|||
23576733|NCT00372567|65843442|FG002|Phase 3 Study|Global deterioration of health status|0|||
23576734|NCT00372567|65843440|FG000|Phase 3 Study|Other|2|||
23633899|NCT02628028|66045512|FG005|Dosing Period|Lost to Follow-up|0|||
23776473|NCT05017480|66563144|FG003|Stage 2 Study|Adverse Event|1|||
23776474|NCT05017480|66563145|FG004|Stage 2 Study|Adverse Event|0|||
23834921|NCT03448419|66774193|FG000|Overall Study|Not treated|0|||
23834922|NCT03448419|66774194|FG001|Overall Study|Not treated|1|||
23576735|NCT00372567|65843441|FG001|Phase 3 Study|Other|2|||
23633900|NCT02628028|66045513|FG006|Dosing Period|Lost to Follow-up|1|||
23776475|NCT05017480|66563141|FG000|Stage 2 Study|COVID-19|0|||
23776476|NCT05017480|66563142|FG001|Stage 2 Study|COVID-19|0|||
23834923|NCT03448419|66774193|FG000|Overall Study|Patient did not attend all visits|0|||
23834924|NCT03448419|66774194|FG001|Overall Study|Patient did not attend all visits|2|||
23834925|NCT03448419|66774193|FG000|Overall Study|Withdrawn by Sponsor|0|||
23834926|NCT03448419|66774194|FG001|Overall Study|Withdrawn by Sponsor|1|||
23576736|NCT00372567|65843442|FG002|Phase 3 Study|Other|1|||
23576737|NCT00372567|65843440|FG000|Phase 3 Study|study terminated by sponsor|13|||
23576738|NCT00372567|65843441|FG001|Phase 3 Study|study terminated by sponsor|8|||
23576739|NCT00372567|65843442|FG002|Phase 3 Study|study terminated by sponsor|5|||
23576740|NCT02084082|65843445|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
23834927|NCT00347958|66774195|FG000|Overall Study|Adverse Event|1|||
23834928|NCT00347958|66774195|FG000|Overall Study|Protocol Violation|2|||
23834929|NCT00347958|66774195|FG000|Overall Study|Withdrawal by Subject|1|||
23449023|NCT02631551|65387864|FG003|Overall Study|Lost to Follow-up|3|||
23449024|NCT02631551|65387861|FG000|Overall Study|Withdrawal by Subject|2|||
23449025|NCT02631551|65387862|FG001|Overall Study|Withdrawal by Subject|2|||
23449026|NCT02631551|65387863|FG002|Overall Study|Withdrawal by Subject|0|||
23449027|NCT02631551|65387864|FG003|Overall Study|Withdrawal by Subject|5|||
23449028|NCT02631551|65387861|FG000|Overall Study|Protocol deviation|3|||
23449029|NCT02631551|65387862|FG001|Overall Study|Protocol deviation|6|||
23449030|NCT02631551|65387863|FG002|Overall Study|Protocol deviation|3|||
23449031|NCT02631551|65387864|FG003|Overall Study|Protocol deviation|0|||
23449032|NCT02631551|65387861|FG000|Overall Study|Non-compliance with study procedures|0|||
23449033|NCT02631551|65387862|FG001|Overall Study|Non-compliance with study procedures|0|||
23449034|NCT02631551|65387863|FG002|Overall Study|Non-compliance with study procedures|1|||
23449035|NCT02631551|65387864|FG003|Overall Study|Non-compliance with study procedures|1|||
23449036|NCT02631551|65387861|FG000|Overall Study|Non-compliance with study drug|1|||
23449037|NCT02631551|65387862|FG001|Overall Study|Non-compliance with study drug|0|||
23449038|NCT02631551|65387863|FG002|Overall Study|Non-compliance with study drug|0|||
23449039|NCT02631551|65387864|FG003|Overall Study|Non-compliance with study drug|0|||
23449040|NCT02631551|65387861|FG000|Overall Study|Other, specific reasons not collected|5|||
23449041|NCT02631551|65387862|FG001|Overall Study|Other, specific reasons not collected|7|||
23449042|NCT02631551|65387863|FG002|Overall Study|Other, specific reasons not collected|2|||
23449043|NCT02631551|65387864|FG003|Overall Study|Other, specific reasons not collected|2|||
23449044|NCT01702558|65387866|FG000|Overall Study|Withdrawal by Subject|0|||
23449045|NCT01702558|65387867|FG001|Overall Study|Withdrawal by Subject|0|||
23449046|NCT01702558|65387868|FG002|Overall Study|Withdrawal by Subject|0|||
23449047|NCT01702558|65387869|FG003|Overall Study|Withdrawal by Subject|12|||
23449048|NCT01702558|65387870|FG004|Overall Study|Withdrawal by Subject|4|||
23449049|NCT01702558|65387866|FG000|Overall Study|Lost to Follow-up|0|||
23449050|NCT01702558|65387867|FG001|Overall Study|Lost to Follow-up|0|||
23449051|NCT01702558|65387868|FG002|Overall Study|Lost to Follow-up|0|||
23449052|NCT01702558|65387869|FG003|Overall Study|Lost to Follow-up|3|||
23449053|NCT01702558|65387870|FG004|Overall Study|Lost to Follow-up|0|||
23449054|NCT01702558|65387866|FG000|Overall Study|Death|4|||
23449055|NCT01702558|65387867|FG001|Overall Study|Death|3|||
23449056|NCT01702558|65387868|FG002|Overall Study|Death|3|||
23449057|NCT01702558|65387869|FG003|Overall Study|Death|16|||
23449058|NCT01702558|65387870|FG004|Overall Study|Death|20|||
23834930|NCT01706939|66774197|FG000|Pre Randomization|Screen Failure|1|||
23834931|NCT01706939|66774198|FG001|Pre Randomization|Screen Failure|0|||
23834932|NCT01706939|66774199|FG002|Pre Randomization|Screen Failure|0|||
23834933|NCT01706939|66774197|FG000|Pre Randomization|Ineligible for Randomization|1|||
23834934|NCT01706939|66774198|FG001|Pre Randomization|Ineligible for Randomization|0|||
23834935|NCT01706939|66774199|FG002|Pre Randomization|Ineligible for Randomization|0|||
23834936|NCT01706939|66774197|FG000|Pre Randomization|Withdrawal by Subject|1|||
23834937|NCT01706939|66774198|FG001|Pre Randomization|Withdrawal by Subject|0|||
23834938|NCT01706939|66774199|FG002|Pre Randomization|Withdrawal by Subject|0|||
23834939|NCT01706939|66774197|FG000|Randomization|Insufficient QoL survey compliance|0|||
23834940|NCT01706939|66774198|FG001|Randomization|Insufficient QoL survey compliance|1|||
23834941|NCT01706939|66774199|FG002|Randomization|Insufficient QoL survey compliance|1|||
23834942|NCT01706939|66774197|FG000|Randomization|Progression of disease|0|||
23576741|NCT02084082|65843446|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
23576742|NCT02084082|65843447|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
23576743|NCT02084082|65843448|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
23834943|NCT01706939|66774198|FG001|Randomization|Progression of disease|2|||
23834944|NCT01706939|66774199|FG002|Randomization|Progression of disease|1|||
23834945|NCT01346696|66774202|FG000|Overall Study|Death|1|||
23834946|NCT02099110|66774203|FG000|Overall Study|Protocol Violation|2|||
23449059|NCT01702558|65387866|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449060|NCT01702558|65387867|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449061|NCT01702558|65387868|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
23449062|NCT01702558|65387869|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449063|NCT01702558|65387870|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449064|NCT01702558|65387866|FG000|Overall Study|Study Terminated by Sponsor|0|||
23576744|NCT02084082|65843445|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23449065|NCT01702558|65387867|FG001|Overall Study|Study Terminated by Sponsor|1|||
23449066|NCT01702558|65387868|FG002|Overall Study|Study Terminated by Sponsor|0|||
23449067|NCT01702558|65387869|FG003|Overall Study|Study Terminated by Sponsor|0|||
23449068|NCT01702558|65387870|FG004|Overall Study|Study Terminated by Sponsor|1|||
23449069|NCT01702558|65387866|FG000|Overall Study|Other|0|||
23449070|NCT01702558|65387867|FG001|Overall Study|Other|0|||
23449071|NCT01702558|65387868|FG002|Overall Study|Other|0|||
23449072|NCT01702558|65387869|FG003|Overall Study|Other|16|||
23449073|NCT01702558|65387870|FG004|Overall Study|Other|17|||
23449074|NCT00833040|65387871|FG000|Overall Study|Adverse Event|0|||
23449075|NCT00833040|65387872|FG001|Overall Study|Adverse Event|0|||
23449076|NCT00833040|65387873|FG002|Overall Study|Adverse Event|0|||
23449077|NCT00833040|65387874|FG003|Overall Study|Adverse Event|0|||
23449078|NCT00833040|65387875|FG004|Overall Study|Adverse Event|0|||
23449079|NCT00833040|65387876|FG005|Overall Study|Adverse Event|1|||
23449080|NCT03579940|65387877|FG000|Period 2|Withdrawal by Subject|0|||
23449081|NCT03579940|65387878|FG001|Period 2|Withdrawal by Subject|0|||
23449082|NCT03579940|65387879|FG002|Period 2|Withdrawal by Subject|1|||
23449083|NCT03579940|65387880|FG003|Period 2|Withdrawal by Subject|0|||
23449084|NCT03579940|65387881|FG004|Period 2|Withdrawal by Subject|0|||
23449085|NCT03579940|65387882|FG005|Period 2|Withdrawal by Subject|0|||
23449086|NCT03579940|65387883|FG006|Period 2|Withdrawal by Subject|0|||
23449087|NCT03579940|65387884|FG007|Period 2|Withdrawal by Subject|0|||
23449088|NCT03579940|65387885|FG008|Period 2|Withdrawal by Subject|0|||
23449089|NCT03579940|65387886|FG009|Period 2|Withdrawal by Subject|0|||
23449090|NCT03579940|65387887|FG010|Period 2|Withdrawal by Subject|0|||
23449091|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
23449092|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
23449093|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Death|0|||
23449094|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Death|1|||
23449095|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
23449096|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
23449097|NCT02562716|65387892|FG000|Overall Study|Adverse Event|7|||
23449098|NCT02562716|65387893|FG001|Overall Study|Adverse Event|14|||
23449099|NCT02562716|65387892|FG000|Overall Study|Withdrawal unrelated to AE|7|||
23449100|NCT02562716|65387893|FG001|Overall Study|Withdrawal unrelated to AE|1|||
23449101|NCT02562716|65387892|FG000|Overall Study|Progression|8|||
23449102|NCT02562716|65387893|FG001|Overall Study|Progression|10|||
23449103|NCT02562716|65387892|FG000|Overall Study|Death|2|||
23449104|NCT02562716|65387893|FG001|Overall Study|Death|1|||
23449105|NCT02562716|65387892|FG000|Overall Study|Not protocol specified|4|||
23449106|NCT02562716|65387893|FG001|Overall Study|Not protocol specified|2|||
23834947|NCT02099110|66774204|FG001|Overall Study|Protocol Violation|1|||
23834948|NCT02099110|66774205|FG002|Overall Study|Protocol Violation|0|||
23449107|NCT01402817|65387894|FG000|Overall Study|Withdrawal by Subject|3|||
23449108|NCT01402817|65387894|FG000|Overall Study|Study Suspended by FDA|8|||
23449109|NCT00404651|65387897|FG000|Overall Study|Serious Adverse Event|0|||
23449110|NCT00404651|65387898|FG001|Overall Study|Serious Adverse Event|0|||
23449111|NCT00404651|65387899|FG002|Overall Study|Serious Adverse Event|2|||
23449112|NCT00404651|65387900|FG003|Overall Study|Serious Adverse Event|0|||
23449113|NCT00404651|65387897|FG000|Overall Study|Protocol Violation|10|||
23449114|NCT00404651|65387898|FG001|Overall Study|Protocol Violation|5|||
23449115|NCT00404651|65387899|FG002|Overall Study|Protocol Violation|14|||
23449116|NCT00404651|65387900|FG003|Overall Study|Protocol Violation|5|||
23449117|NCT00404651|65387897|FG000|Overall Study|Lost to Follow-up|15|||
23449118|NCT00404651|65387898|FG001|Overall Study|Lost to Follow-up|11|||
23449119|NCT00404651|65387899|FG002|Overall Study|Lost to Follow-up|13|||
23449120|NCT00404651|65387900|FG003|Overall Study|Lost to Follow-up|10|||
23449121|NCT00404651|65387897|FG000|Overall Study|Withdrawal by Subject|14|||
23449122|NCT00404651|65387898|FG001|Overall Study|Withdrawal by Subject|12|||
23449123|NCT00404651|65387899|FG002|Overall Study|Withdrawal by Subject|16|||
23449124|NCT00404651|65387900|FG003|Overall Study|Withdrawal by Subject|6|||
23449125|NCT02524171|65387903|FG000|6-month Follow-up|Lost to Follow-up|53|||
23449126|NCT02524171|65387904|FG001|6-month Follow-up|Lost to Follow-up|45|||
23834949|NCT02099110|66774206|FG003|Overall Study|Protocol Violation|3|||
23834950|NCT02099110|66774207|FG004|Overall Study|Protocol Violation|1|||
23449127|NCT02524171|65387903|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
23449128|NCT02524171|65387904|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
23449129|NCT02913482|65387907|FG000|Overall Study|Death|0|||
23449130|NCT02913482|65387908|FG001|Overall Study|Death|2|||
23449131|NCT02913482|65387909|FG002|Overall Study|Death|2|||
23449132|NCT02913482|65387907|FG000|Overall Study|Progressive Disease|1|||
23449133|NCT02913482|65387908|FG001|Overall Study|Progressive Disease|1|||
23449134|NCT02913482|65387909|FG002|Overall Study|Progressive Disease|1|||
23449135|NCT02913482|65387907|FG000|Overall Study|Reason not specified|0|||
23449136|NCT02913482|65387908|FG001|Overall Study|Reason not specified|0|||
23449137|NCT02913482|65387909|FG002|Overall Study|Reason not specified|1|||
23449138|NCT02913482|65387907|FG000|Overall Study|Withdrawal by Subject|0|||
23449139|NCT02913482|65387908|FG001|Overall Study|Withdrawal by Subject|1|||
23449140|NCT02913482|65387909|FG002|Overall Study|Withdrawal by Subject|1|||
23449141|NCT02611817|65387913|FG000|Open-label Induction Phase|Reason not Specified|9|||
23449142|NCT02611817|65387914|FG001|Open-label Induction Phase|Reason not Specified|0|||
23449143|NCT02611817|65387915|FG002|Open-label Induction Phase|Reason not Specified|0|||
23449144|NCT02611817|65387913|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
23449145|NCT02611817|65387914|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
23449146|NCT02611817|65387915|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
23449147|NCT02611817|65387913|FG000|Open-label Induction Phase|Pregnancy|1|||
23449148|NCT02611817|65387914|FG001|Open-label Induction Phase|Pregnancy|0|||
23449149|NCT02611817|65387915|FG002|Open-label Induction Phase|Pregnancy|0|||
23449150|NCT02611817|65387913|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
23449151|NCT02611817|65387914|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
23449152|NCT02611817|65387915|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
23449153|NCT02611817|65387913|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
23449154|NCT02611817|65387914|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
23449155|NCT02611817|65387915|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
23449156|NCT02611817|65387913|FG000|Open-label Induction Phase|Protocol Violation|5|||
23449157|NCT02611817|65387914|FG001|Open-label Induction Phase|Protocol Violation|0|||
23449158|NCT02611817|65387915|FG002|Open-label Induction Phase|Protocol Violation|0|||
23449159|NCT02611817|65387913|FG000|Open-label Induction Phase|Adverse Event|16|||
23449160|NCT02611817|65387914|FG001|Open-label Induction Phase|Adverse Event|0|||
23449161|NCT02611817|65387915|FG002|Open-label Induction Phase|Adverse Event|0|||
23449162|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
23449163|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
23449164|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
23449165|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
23449166|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
23449167|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
23449168|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
23449169|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
23449170|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
23449171|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
23449172|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
23449173|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
23449174|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
23449175|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
23449176|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
23449177|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
23449178|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
23449179|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
23449180|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
23449181|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
23449182|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
23449183|NCT00730158|65387920|FG000|Overall Study|Withdrawal by Subject|1|||
23449184|NCT00730158|65387921|FG001|Overall Study|Withdrawal by Subject|1|||
23449185|NCT01960140|65387922|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
23449186|NCT01177007|65387923|FG000|Overall Study|Lost to Follow-up|2|||
23449187|NCT01177007|65387923|FG000|Overall Study|Death|4|||
23449188|NCT01177007|65387923|FG000|Overall Study|Entered hospice care|5|||
23449189|NCT01177007|65387923|FG000|Overall Study|Required additional Y90 treatment|6|||
23834951|NCT02099110|66774203|FG000|Overall Study|Participant moved|1|||
23449190|NCT01177007|65387923|FG000|Overall Study|Change in treatment modality|21|||
23449191|NCT00300755|65387924|FG000|Overall Study|Adverse Event|1|||
23449192|NCT00300755|65387925|FG001|Overall Study|Adverse Event|2|||
23449193|NCT00300755|65387926|FG002|Overall Study|Adverse Event|1|||
23449194|NCT00300755|65387924|FG000|Overall Study|Withdrawal by Subject|0|||
23449195|NCT00300755|65387925|FG001|Overall Study|Withdrawal by Subject|2|||
23449196|NCT00300755|65387926|FG002|Overall Study|Withdrawal by Subject|0|||
23834952|NCT02099110|66774204|FG001|Overall Study|Participant moved|1|||
23834953|NCT02099110|66774205|FG002|Overall Study|Participant moved|1|||
23834954|NCT02099110|66774206|FG003|Overall Study|Participant moved|0|||
23834955|NCT02099110|66774207|FG004|Overall Study|Participant moved|2|||
23834956|NCT02099110|66774203|FG000|Overall Study|Withdrawal by Subject|7|||
23834957|NCT02099110|66774204|FG001|Overall Study|Withdrawal by Subject|11|||
23834958|NCT02099110|66774205|FG002|Overall Study|Withdrawal by Subject|13|||
23449197|NCT00300755|65387924|FG000|Overall Study|Protocol Violation|0|||
23449198|NCT00300755|65387925|FG001|Overall Study|Protocol Violation|0|||
23449199|NCT00300755|65387926|FG002|Overall Study|Protocol Violation|1|||
23449200|NCT01096316|65387927|FG000|Overall Study|Lost to Follow-up|15|||
23834959|NCT02099110|66774206|FG003|Overall Study|Withdrawal by Subject|9|||
23449201|NCT01096316|65387928|FG001|Overall Study|Lost to Follow-up|9|||
23449202|NCT02753946|65387935|FG000|Overall Study|Adverse Event|7|||
23449203|NCT02753946|65387936|FG001|Overall Study|Adverse Event|6|||
23449204|NCT02753946|65387935|FG000|Overall Study|Withdrawal by Subject|6|||
23449205|NCT02753946|65387936|FG001|Overall Study|Withdrawal by Subject|1|||
23449206|NCT02753946|65387935|FG000|Overall Study|Lack of Efficacy|1|||
23449207|NCT02753946|65387936|FG001|Overall Study|Lack of Efficacy|0|||
23449208|NCT02753946|65387935|FG000|Overall Study|Physician Decision|0|||
23449209|NCT02753946|65387936|FG001|Overall Study|Physician Decision|2|||
23449210|NCT00764361|65387937|FG000|Overall Study|Withdrawal by Subject|2|||
23449211|NCT00764361|65387938|FG001|Overall Study|Withdrawal by Subject|3|||
23776477|NCT05017480|66563143|FG002|Stage 2 Study|COVID-19|0|||
23776478|NCT05017480|66563144|FG003|Stage 2 Study|COVID-19|1|||
23776479|NCT05017480|66563145|FG004|Stage 2 Study|COVID-19|0|||
23776480|NCT05017480|66563141|FG000|Stage 2 Study|Pregnancy|0|||
23776481|NCT05017480|66563142|FG001|Stage 2 Study|Pregnancy|0|||
23776482|NCT05017480|66563143|FG002|Stage 2 Study|Pregnancy|0|||
23776483|NCT05017480|66563144|FG003|Stage 2 Study|Pregnancy|0|||
23776484|NCT05017480|66563145|FG004|Stage 2 Study|Pregnancy|1|||
23776485|NCT02670525|66563146|FG000|Overall Study|Death|94|||
23776486|NCT02670525|66563147|FG001|Overall Study|Death|14|||
23776487|NCT02670525|66563146|FG000|Overall Study|Lost to Follow-up|4|||
23776488|NCT02670525|66563147|FG001|Overall Study|Lost to Follow-up|1|||
23776489|NCT02670525|66563146|FG000|Overall Study|Subject withdrew consent|1|||
23776490|NCT02670525|66563147|FG001|Overall Study|Subject withdrew consent|0|||
23776491|NCT02670525|66563146|FG000|Overall Study|Unknown, data entry delayed|123|||
23449212|NCT00764361|65387937|FG000|Overall Study|Adverse Event|0|||
23449213|NCT00764361|65387938|FG001|Overall Study|Adverse Event|1|||
23449214|NCT01469221|65387949|FG000|Double Blind Phase|Protocol Violation|1|||
23449215|NCT01469221|65387950|FG001|Double Blind Phase|Protocol Violation|0|||
23449216|NCT01469221|65387951|FG002|Double Blind Phase|Protocol Violation|0|||
23449217|NCT01469221|65387949|FG000|Double Blind Phase|Physician Decision|1|||
23449218|NCT01469221|65387950|FG001|Double Blind Phase|Physician Decision|1|||
23449219|NCT01469221|65387951|FG002|Double Blind Phase|Physician Decision|0|||
23449220|NCT01469221|65387949|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
23449221|NCT01469221|65387950|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
23449222|NCT01469221|65387951|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
23449223|NCT02741635|65387955|FG000|Overall Study|Withdrawal by Subject|1|||
23449224|NCT03827655|65387957|FG000|Overall Study|Death|0|||
23449225|NCT03827655|65387958|FG001|Overall Study|Death|0|||
23449226|NCT03827655|65387959|FG002|Overall Study|Death|0|||
23449227|NCT03827655|65387960|FG003|Overall Study|Death|0|||
23449228|NCT03827655|65387961|FG004|Overall Study|Death|1|||
23449229|NCT03827655|65387957|FG000|Overall Study|Protocol Deviation|1|||
23449230|NCT03827655|65387958|FG001|Overall Study|Protocol Deviation|0|||
23449231|NCT03827655|65387959|FG002|Overall Study|Protocol Deviation|1|||
23449232|NCT03827655|65387960|FG003|Overall Study|Protocol Deviation|1|||
23449233|NCT03827655|65387961|FG004|Overall Study|Protocol Deviation|0|||
23449234|NCT03827655|65387957|FG000|Overall Study|Withdrawal by Subject|3|||
23449235|NCT03827655|65387958|FG001|Overall Study|Withdrawal by Subject|2|||
23449236|NCT03827655|65387959|FG002|Overall Study|Withdrawal by Subject|2|||
23449237|NCT03827655|65387960|FG003|Overall Study|Withdrawal by Subject|0|||
23449238|NCT03827655|65387961|FG004|Overall Study|Withdrawal by Subject|1|||
23449239|NCT03827655|65387957|FG000|Overall Study|Reason not Specified|3|||
23449240|NCT03827655|65387958|FG001|Overall Study|Reason not Specified|1|||
23449241|NCT03827655|65387959|FG002|Overall Study|Reason not Specified|1|||
23449242|NCT03827655|65387960|FG003|Overall Study|Reason not Specified|1|||
23449243|NCT03827655|65387961|FG004|Overall Study|Reason not Specified|1|||
23449244|NCT00836589|65387962|FG000|Overall Study|Lost to Follow-up|246|||
23449245|NCT00836589|65387962|FG000|Overall Study|Death|429|||
23449246|NCT00836589|65387962|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
23449247|NCT00466440|65387963|FG000|Overall Study|Adverse Event|0|||
23449248|NCT00466440|65387964|FG001|Overall Study|Adverse Event|3|||
23449249|NCT00466440|65387965|FG002|Overall Study|Adverse Event|1|||
23449250|NCT00466440|65387963|FG000|Overall Study|Death|1|||
23449251|NCT00466440|65387964|FG001|Overall Study|Death|1|||
23449252|NCT00466440|65387965|FG002|Overall Study|Death|0|||
23449253|NCT00466440|65387963|FG000|Overall Study|Progressive disease|13|||
23449254|NCT00466440|65387964|FG001|Overall Study|Progressive disease|5|||
23449255|NCT00466440|65387965|FG002|Overall Study|Progressive disease|4|||
23449256|NCT00466440|65387963|FG000|Overall Study|Lost to Follow-up|0|||
23776492|NCT02670525|66563147|FG001|Overall Study|Unknown, data entry delayed|78|||
23776493|NCT01458405|66563148|FG000|Phase 1 (up to 12 Months)|Other|0|||
23449257|NCT00466440|65387964|FG001|Overall Study|Lost to Follow-up|1|||
23449258|NCT00466440|65387965|FG002|Overall Study|Lost to Follow-up|0|||
23449259|NCT00466440|65387963|FG000|Overall Study|Physician Decision|0|||
23449260|NCT00466440|65387964|FG001|Overall Study|Physician Decision|1|||
23449261|NCT00466440|65387965|FG002|Overall Study|Physician Decision|2|||
23776494|NCT01458405|66563149|FG001|Phase 1 (up to 12 Months)|Other|1|||
23776495|NCT01458405|66563150|FG002|Phase 1 (up to 12 Months)|Other|0|||
23449262|NCT00466440|65387963|FG000|Overall Study|Protocol entry criteria not met|0|||
23449263|NCT00466440|65387964|FG001|Overall Study|Protocol entry criteria not met|0|||
23449264|NCT00466440|65387965|FG002|Overall Study|Protocol entry criteria not met|4|||
23449265|NCT00466440|65387963|FG000|Overall Study|Withdrawal by Subject|0|||
23449266|NCT00466440|65387964|FG001|Overall Study|Withdrawal by Subject|1|||
23449267|NCT00466440|65387965|FG002|Overall Study|Withdrawal by Subject|0|||
23449268|NCT00466440|65387963|FG000|Overall Study|Sponsor decision|0|||
23449269|NCT00466440|65387964|FG001|Overall Study|Sponsor decision|0|||
23449270|NCT00466440|65387965|FG002|Overall Study|Sponsor decision|1|||
23449271|NCT00411671|65387968|FG000|Overall Study|Adverse Event|15|||
23449272|NCT00411671|65387968|FG000|Overall Study|Death|2|||
23449273|NCT00411671|65387968|FG000|Overall Study|Lost to Follow-up|3|||
23449274|NCT01362348|65387969|FG000|Overall Study|Protocol-defined stopping criteria|9|||
23449275|NCT01362348|65387969|FG000|Overall Study|Study closed/terminated|5|||
23449276|NCT01751984|65387973|FG000|Overall Study|Adverse Event|5|||
23449277|NCT01751984|65387974|FG001|Overall Study|Adverse Event|3|||
23449278|NCT01751984|65387973|FG000|Overall Study|Withdrawal by Subject|0|||
23449279|NCT01751984|65387974|FG001|Overall Study|Withdrawal by Subject|1|||
23449280|NCT01751984|65387973|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
23449281|NCT01751984|65387974|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23449282|NCT04612725|65387980|FG000|Overall Study|Adverse Event|1|||
23449283|NCT04612725|65387981|FG001|Overall Study|Adverse Event|3|||
23449284|NCT04612725|65387982|FG002|Overall Study|Adverse Event|1|||
23449285|NCT04612725|65387983|FG003|Overall Study|Adverse Event|0|||
23449286|NCT04612725|65387984|FG004|Overall Study|Adverse Event|1|||
23449287|NCT04612725|65387980|FG000|Overall Study|Lost to Follow-up|0|||
23449288|NCT04612725|65387981|FG001|Overall Study|Lost to Follow-up|1|||
23449289|NCT04612725|65387982|FG002|Overall Study|Lost to Follow-up|0|||
23449290|NCT04612725|65387983|FG003|Overall Study|Lost to Follow-up|0|||
23449291|NCT04612725|65387984|FG004|Overall Study|Lost to Follow-up|0|||
23449292|NCT04612725|65387980|FG000|Overall Study|Physician Decision|2|||
23449293|NCT04612725|65387981|FG001|Overall Study|Physician Decision|0|||
23449294|NCT04612725|65387982|FG002|Overall Study|Physician Decision|0|||
23449295|NCT04612725|65387983|FG003|Overall Study|Physician Decision|0|||
23449296|NCT04612725|65387984|FG004|Overall Study|Physician Decision|0|||
23449297|NCT04612725|65387980|FG000|Overall Study|Study terminated by sponsor|3|||
23449298|NCT04612725|65387981|FG001|Overall Study|Study terminated by sponsor|1|||
23449299|NCT04612725|65387982|FG002|Overall Study|Study terminated by sponsor|2|||
23449300|NCT04612725|65387983|FG003|Overall Study|Study terminated by sponsor|4|||
23449301|NCT04612725|65387984|FG004|Overall Study|Study terminated by sponsor|5|||
23449302|NCT04612725|65387980|FG000|Overall Study|Withdrawal by Subject|8|||
23449303|NCT04612725|65387981|FG001|Overall Study|Withdrawal by Subject|3|||
23449304|NCT04612725|65387982|FG002|Overall Study|Withdrawal by Subject|5|||
23449305|NCT04612725|65387983|FG003|Overall Study|Withdrawal by Subject|1|||
23449306|NCT04612725|65387984|FG004|Overall Study|Withdrawal by Subject|9|||
23449307|NCT04612725|65387980|FG000|Overall Study|Other|0|||
23449308|NCT04612725|65387981|FG001|Overall Study|Other|0|||
23449309|NCT04612725|65387982|FG002|Overall Study|Other|0|||
23449310|NCT04612725|65387983|FG003|Overall Study|Other|0|||
23449311|NCT04612725|65387984|FG004|Overall Study|Other|1|||
23449312|NCT03066193|65387986|FG000|Overall Study|Withdrawal by Subject|1|||
23449313|NCT02079038|65387987|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
23449314|NCT02079038|65387988|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
23449315|NCT02079038|65387987|FG000|Modified Intent to Treat Population|Death|1|||
23449316|NCT02079038|65387988|FG001|Modified Intent to Treat Population|Death|0|||
23449317|NCT02079038|65387987|FG000|Completed 6 Months|Lost to Follow-up|2|||
23449318|NCT02079038|65387988|FG001|Completed 6 Months|Lost to Follow-up|1|||
23449319|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
23449320|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
23449321|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
23449322|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
23449323|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
23449324|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
23449325|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
23449326|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
23449327|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
23449328|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
23449329|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
23449330|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
23449331|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
23449332|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
23449333|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
23449334|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
23449335|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
23449336|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
23449337|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
23449338|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
23449339|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
23449340|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
23449341|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
23449342|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
23449343|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
23449344|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
23449345|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
23449346|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
23449347|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
23449348|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
23449349|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
23449350|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
23449351|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
23449352|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
23449353|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
23449354|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
23449355|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
23449356|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
23449357|NCT01702025|65387991|FG000|Overall Study|Equipment failure|1|||
23449358|NCT01702025|65387992|FG001|Overall Study|Equipment failure|0|||
23449359|NCT01702025|65387993|FG002|Overall Study|Equipment failure|0|||
23449360|NCT01702025|65387994|FG003|Overall Study|Equipment failure|0|||
23449361|NCT01702025|65387991|FG000|Overall Study|Adverse Event|1|||
23449362|NCT01702025|65387992|FG001|Overall Study|Adverse Event|1|||
23449363|NCT01702025|65387993|FG002|Overall Study|Adverse Event|1|||
23449364|NCT01702025|65387994|FG003|Overall Study|Adverse Event|0|||
23449365|NCT00496015|65387995|FG000|Overall Study|Other|1|||
23449366|NCT00496015|65387996|FG001|Overall Study|Other|0|||
23449367|NCT00496015|65387997|FG002|Overall Study|Other|0|||
23449368|NCT00496015|65387998|FG003|Overall Study|Other|1|||
23449369|NCT00496015|65387999|FG004|Overall Study|Other|0|||
23449370|NCT00844844|65388000|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
23449371|NCT00844844|65388000|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
23449372|NCT00844844|65388000|FG000|Extension Treatment Period|Adverse Event|2|||
23449373|NCT00844844|65388000|FG000|Post Treatment Period|Withdrawal by Subject|1|||
23449374|NCT02055898|65388001|FG000|First Intervention (5 Days)|Physician Decision|2|||
23449375|NCT02055898|65388002|FG001|First Intervention (5 Days)|Physician Decision|0|||
23776496|NCT01458405|66563151|FG003|Phase 1 (up to 12 Months)|Other|0|||
23776497|NCT01458405|66563148|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
23449376|NCT02055898|65388001|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
23449377|NCT02055898|65388002|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
23449378|NCT01946139|65388005|FG000|Overall Study|Withdrawal by Subject|8|||
23449379|NCT01946139|65388005|FG000|Overall Study|ineligible|8|||
23449380|NCT01946139|65388005|FG000|Overall Study|Specimens not available|4|||
23449381|NCT01247324|65388006|FG000|Overall Study|Death|6|||
23576745|NCT02084082|65843446|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23776498|NCT01458405|66563149|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
23776499|NCT01458405|66563150|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
23776500|NCT01458405|66563151|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
23776501|NCT01458405|66563148|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23776502|NCT01458405|66563149|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23776503|NCT01458405|66563150|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23776504|NCT01458405|66563151|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
23776505|NCT01458405|66563148|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23776506|NCT01458405|66563149|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23776507|NCT01458405|66563150|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23776508|NCT01458405|66563151|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
23776509|NCT01263704|66563152|FG000|Overall Study|Progressive disease|18|||
23776510|NCT01263704|66563152|FG000|Overall Study|Adverse Event|3|||
23776511|NCT01263704|66563152|FG000|Overall Study|Death|2|||
23776512|NCT01263704|66563152|FG000|Overall Study|Patient withdrew consent|2|||
23776513|NCT01263704|66563152|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23776514|NCT01263704|66563152|FG000|Overall Study|Lost to Follow-up|1|||
23776515|NCT01263704|66563152|FG000|Overall Study|Colon metastases|1|||
23449382|NCT01247324|65388007|FG001|Overall Study|Death|10|||
23576746|NCT02084082|65843447|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23576747|NCT02084082|65843448|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
23449383|NCT01247324|65388006|FG000|Overall Study|Physician Decision|2|||
23449384|NCT01247324|65388007|FG001|Overall Study|Physician Decision|3|||
23449385|NCT01247324|65388006|FG000|Overall Study|Non-compliance with study drug|3|||
23776516|NCT01263704|66563152|FG000|Overall Study|Principal Investigator (PI) decision|1|||
23776517|NCT01772537|66563153|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
23776518|NCT01772537|66563154|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
23449386|NCT01247324|65388007|FG001|Overall Study|Non-compliance with study drug|0|||
23449387|NCT01247324|65388006|FG000|Overall Study|Lack of Efficacy|24|||
23449388|NCT01247324|65388007|FG001|Overall Study|Lack of Efficacy|14|||
23449389|NCT01247324|65388006|FG000|Overall Study|Non-compliance|3|||
23576748|NCT02427646|65843451|FG000|Overall Study|Lack of Efficacy|2|||
23776519|NCT01772537|66563155|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
23776520|NCT01448057|66563156|FG000|Overall Study|Protocol Violation|3|||
23776521|NCT01448057|66563157|FG001|Overall Study|Protocol Violation|2|||
23776522|NCT01448057|66563156|FG000|Overall Study|Lost to Follow-up|3|||
23776523|NCT01448057|66563157|FG001|Overall Study|Lost to Follow-up|0|||
23776524|NCT01448057|66563156|FG000|Overall Study|Adverse Event|0|||
23776525|NCT01448057|66563157|FG001|Overall Study|Adverse Event|2|||
23776526|NCT01448057|66563156|FG000|Overall Study|Withdrawal by Subject|2|||
23776527|NCT01448057|66563157|FG001|Overall Study|Withdrawal by Subject|0|||
23776528|NCT03482882|66563160|FG000|Overall Study|Adverse Event|3|||
23776529|NCT03482882|66563160|FG000|Overall Study|Lost to Follow-up|1|||
23776530|NCT03482882|66563160|FG000|Overall Study|Protocol Violation|2|||
23776531|NCT03482882|66563160|FG000|Overall Study|Not further specified|1|||
23776532|NCT03497897|66563161|FG000|Overall Study|Adverse Event|1|||
23576749|NCT02427646|65843452|FG001|Overall Study|Lack of Efficacy|3|||
23576750|NCT02427646|65843451|FG000|Overall Study|Physician Decision|1|||
23776533|NCT03497897|66563162|FG001|Overall Study|Adverse Event|1|||
23776534|NCT03497897|66563163|FG002|Overall Study|Adverse Event|1|||
23834960|NCT02099110|66774207|FG004|Overall Study|Withdrawal by Subject|13|||
23834961|NCT02099110|66774203|FG000|Overall Study|Adverse Event|3|||
23834962|NCT02099110|66774204|FG001|Overall Study|Adverse Event|5|||
23834963|NCT02099110|66774205|FG002|Overall Study|Adverse Event|2|||
23834964|NCT02099110|66774206|FG003|Overall Study|Adverse Event|3|||
23834965|NCT02099110|66774207|FG004|Overall Study|Adverse Event|2|||
23834966|NCT02099110|66774203|FG000|Overall Study|Lost to Follow-up|6|||
23834967|NCT02099110|66774204|FG001|Overall Study|Lost to Follow-up|12|||
23834968|NCT02099110|66774205|FG002|Overall Study|Lost to Follow-up|11|||
23834969|NCT02099110|66774206|FG003|Overall Study|Lost to Follow-up|5|||
23834970|NCT02099110|66774207|FG004|Overall Study|Lost to Follow-up|6|||
23834971|NCT02099110|66774203|FG000|Overall Study|Death|0|||
23834972|NCT02099110|66774204|FG001|Overall Study|Death|1|||
23834973|NCT02099110|66774205|FG002|Overall Study|Death|0|||
23834974|NCT02099110|66774206|FG003|Overall Study|Death|0|||
23834975|NCT02099110|66774207|FG004|Overall Study|Death|0|||
23834976|NCT02099110|66774203|FG000|Overall Study|Screen failure|0|||
23834977|NCT02099110|66774204|FG001|Overall Study|Screen failure|0|||
23834978|NCT02099110|66774205|FG002|Overall Study|Screen failure|0|||
23834979|NCT02099110|66774206|FG003|Overall Study|Screen failure|0|||
23834980|NCT02099110|66774207|FG004|Overall Study|Screen failure|1|||
23834981|NCT02099110|66774203|FG000|Overall Study|Non-compliance with study drug|2|||
23834982|NCT02099110|66774204|FG001|Overall Study|Non-compliance with study drug|0|||
23834983|NCT02099110|66774205|FG002|Overall Study|Non-compliance with study drug|0|||
23834984|NCT02099110|66774206|FG003|Overall Study|Non-compliance with study drug|0|||
23834985|NCT02099110|66774207|FG004|Overall Study|Non-compliance with study drug|1|||
23834986|NCT02099110|66774203|FG000|Overall Study|Physician Decision|3|||
23834987|NCT02099110|66774204|FG001|Overall Study|Physician Decision|0|||
23834988|NCT02099110|66774205|FG002|Overall Study|Physician Decision|1|||
23776535|NCT03497897|66563161|FG000|Overall Study|Lost to Follow-up|2|||
23834989|NCT02099110|66774206|FG003|Overall Study|Physician Decision|2|||
23834990|NCT02099110|66774207|FG004|Overall Study|Physician Decision|1|||
23834991|NCT02755103|66774208|FG000|Overall Study|Lost to Follow-up|17|||
23834992|NCT02755103|66774209|FG001|Overall Study|Lost to Follow-up|15|||
23834993|NCT02755103|66774208|FG000|Overall Study|Death|0|||
23834994|NCT02755103|66774209|FG001|Overall Study|Death|1|||
23834995|NCT02755103|66774208|FG000|Overall Study|Physician Decision|0|||
23834996|NCT02755103|66774209|FG001|Overall Study|Physician Decision|1|||
23834997|NCT02755103|66774208|FG000|Overall Study|Pregnancy|0|||
23834998|NCT02755103|66774209|FG001|Overall Study|Pregnancy|1|||
23834999|NCT02755103|66774208|FG000|Overall Study|Withdrawal by Subject|3|||
23835000|NCT02755103|66774209|FG001|Overall Study|Withdrawal by Subject|0|||
23835001|NCT01445730|66774211|FG000|Overall Study|Adverse Event|1|||
23835002|NCT01445730|66774211|FG000|Overall Study|For the advice of a dentist|1|||
23835003|NCT01445730|66774211|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
23835004|NCT01067105|66774214|FG000|Overall Study|Adverse Event|14|||
23835005|NCT01067105|66774214|FG000|Overall Study|Protocol Violation|48|||
23835006|NCT01067105|66774214|FG000|Overall Study|Withdrawal by Subject|36|||
23576751|NCT02427646|65843452|FG001|Overall Study|Physician Decision|4|||
23776536|NCT03497897|66563162|FG001|Overall Study|Lost to Follow-up|0|||
23835007|NCT01067105|66774214|FG000|Overall Study|Lost to Follow-up|6|||
23835008|NCT01067105|66774214|FG000|Overall Study|Physician Decision|6|||
23835009|NCT01067105|66774214|FG000|Overall Study|Other|31|||
23449390|NCT01247324|65388007|FG001|Overall Study|Non-compliance|2|||
23835010|NCT00703157|66774216|FG000|Overall Study|Lost to Follow-up|0|||
23835011|NCT00703157|66774217|FG001|Overall Study|Lost to Follow-up|1|||
23835012|NCT00703157|66774216|FG000|Overall Study|source data permanently lost/ other|4|||
23835013|NCT00703157|66774217|FG001|Overall Study|source data permanently lost/ other|1|||
23835014|NCT02151851|66774220|FG000|Overall Study|Lack of Efficacy|67|||
23835015|NCT02151851|66774221|FG001|Overall Study|Lack of Efficacy|94|||
23576752|NCT02427646|65843451|FG000|Overall Study|Protocol Violation|3|||
23576753|NCT02427646|65843452|FG001|Overall Study|Protocol Violation|3|||
23576754|NCT02427646|65843451|FG000|Overall Study|Bothersome hand weakness|2|||
23576755|NCT02427646|65843452|FG001|Overall Study|Bothersome hand weakness|4|||
23776537|NCT03497897|66563163|FG002|Overall Study|Lost to Follow-up|2|||
23776538|NCT03497897|66563161|FG000|Overall Study|Physician Decision|1|||
23776539|NCT03497897|66563162|FG001|Overall Study|Physician Decision|0|||
23776540|NCT03497897|66563163|FG002|Overall Study|Physician Decision|0|||
23776541|NCT03497897|66563161|FG000|Overall Study|Subject/Guardian Decision|2|||
23776542|NCT03497897|66563162|FG001|Overall Study|Subject/Guardian Decision|1|||
23776543|NCT03497897|66563163|FG002|Overall Study|Subject/Guardian Decision|3|||
23835016|NCT02151851|66774220|FG000|Overall Study|Protocol Violation|0|||
23835017|NCT02151851|66774221|FG001|Overall Study|Protocol Violation|1|||
23576756|NCT00513019|65843454|FG000|Overall Study|Adverse Event|1|||
23576757|NCT00513019|65843455|FG001|Overall Study|Adverse Event|0|||
23576758|NCT00513019|65843454|FG000|Overall Study|Withdrawal by Subject|4|||
23576759|NCT00513019|65843455|FG001|Overall Study|Withdrawal by Subject|5|||
23776544|NCT03018249|66563166|FG000|Overall Study|Withdrawal by Subject|2|||
23835018|NCT02151851|66774220|FG000|Overall Study|Withdrawal by Subject|2|||
23835019|NCT02151851|66774221|FG001|Overall Study|Withdrawal by Subject|5|||
23835020|NCT02151851|66774220|FG000|Overall Study|Medical impairment|1|||
23576760|NCT01770860|65843456|FG000|Overall Study|Withdrawal by Subject|4|||
23576761|NCT01770860|65843456|FG000|Overall Study|Lost to Follow-up|1|||
23835021|NCT02151851|66774221|FG001|Overall Study|Medical impairment|0|||
23576762|NCT01770860|65843456|FG000|Overall Study|Administrative decision made by the PI|1|||
23576763|NCT00605319|65843457|FG000|Overall Study|Adverse Event|6|||
23576764|NCT00983619|65843458|FG000|Overall Study|Lost to Follow-up|0|||
23576765|NCT00983619|65843459|FG001|Overall Study|Lost to Follow-up|1|||
23576766|NCT00983619|65843460|FG002|Overall Study|Lost to Follow-up|0|||
23576767|NCT00983619|65843461|FG003|Overall Study|Lost to Follow-up|0|||
23576768|NCT00983619|65843462|FG004|Overall Study|Lost to Follow-up|0|||
23576769|NCT00983619|65843463|FG005|Overall Study|Lost to Follow-up|2|||
23576770|NCT00983619|65843464|FG006|Overall Study|Lost to Follow-up|0|||
23576771|NCT00983619|65843465|FG007|Overall Study|Lost to Follow-up|0|||
23576772|NCT00983619|65843466|FG008|Overall Study|Lost to Follow-up|0|||
23576773|NCT00983619|65843467|FG009|Overall Study|Lost to Follow-up|0|||
23576774|NCT00983619|65843468|FG010|Overall Study|Lost to Follow-up|0|||
23576775|NCT00983619|65843469|FG011|Overall Study|Lost to Follow-up|2|||
23576776|NCT00983619|65843458|FG000|Overall Study|Withdrawal by Subject|2|||
23576777|NCT00983619|65843459|FG001|Overall Study|Withdrawal by Subject|1|||
23576778|NCT00983619|65843460|FG002|Overall Study|Withdrawal by Subject|1|||
23576779|NCT00983619|65843461|FG003|Overall Study|Withdrawal by Subject|3|||
23576780|NCT00983619|65843462|FG004|Overall Study|Withdrawal by Subject|1|||
23576781|NCT00983619|65843463|FG005|Overall Study|Withdrawal by Subject|23|||
23576782|NCT00983619|65843464|FG006|Overall Study|Withdrawal by Subject|0|||
23576783|NCT00983619|65843465|FG007|Overall Study|Withdrawal by Subject|0|||
23576784|NCT00983619|65843466|FG008|Overall Study|Withdrawal by Subject|0|||
23576785|NCT00983619|65843467|FG009|Overall Study|Withdrawal by Subject|0|||
23576786|NCT00983619|65843468|FG010|Overall Study|Withdrawal by Subject|1|||
23576787|NCT00983619|65843469|FG011|Overall Study|Withdrawal by Subject|1|||
23576788|NCT00983619|65843458|FG000|Overall Study|Death|0|||
23576789|NCT00983619|65843459|FG001|Overall Study|Death|2|||
23576790|NCT00983619|65843460|FG002|Overall Study|Death|2|||
23576791|NCT00983619|65843461|FG003|Overall Study|Death|1|||
23576792|NCT00983619|65843462|FG004|Overall Study|Death|2|||
23576793|NCT00983619|65843463|FG005|Overall Study|Death|30|||
23576794|NCT00983619|65843464|FG006|Overall Study|Death|1|||
23576795|NCT00983619|65843465|FG007|Overall Study|Death|0|||
23576796|NCT00983619|65843466|FG008|Overall Study|Death|1|||
23576797|NCT00983619|65843467|FG009|Overall Study|Death|2|||
23576798|NCT00983619|65843468|FG010|Overall Study|Death|9|||
23576799|NCT00983619|65843469|FG011|Overall Study|Death|8|||
23576800|NCT00983619|65843458|FG000|Overall Study|Other|1|||
23576801|NCT00983619|65843459|FG001|Overall Study|Other|0|||
23576802|NCT00983619|65843460|FG002|Overall Study|Other|0|||
23576803|NCT00983619|65843461|FG003|Overall Study|Other|1|||
23576804|NCT00983619|65843462|FG004|Overall Study|Other|0|||
23576805|NCT00983619|65843463|FG005|Overall Study|Other|12|||
23576806|NCT00983619|65843464|FG006|Overall Study|Other|2|||
23576807|NCT00983619|65843465|FG007|Overall Study|Other|2|||
23576808|NCT00983619|65843466|FG008|Overall Study|Other|0|||
23576809|NCT00983619|65843467|FG009|Overall Study|Other|1|||
23576810|NCT00983619|65843468|FG010|Overall Study|Other|1|||
23576811|NCT00983619|65843469|FG011|Overall Study|Other|0|||
23576812|NCT00691028|65843470|FG000|Open-label Period|Adverse Event|0|||
23576813|NCT00691028|65843471|FG001|Open-label Period|Adverse Event|0|||
23449391|NCT01247324|65388006|FG000|Overall Study|Pregnancy|5|||
23449392|NCT01247324|65388007|FG001|Overall Study|Pregnancy|10|||
23576814|NCT00691028|65843472|FG002|Open-label Period|Adverse Event|0|||
23576815|NCT00691028|65843473|FG003|Open-label Period|Adverse Event|16|||
23576816|NCT00691028|65843470|FG000|Open-label Period|Withdrawal by Subject|0|||
23576817|NCT00691028|65843471|FG001|Open-label Period|Withdrawal by Subject|0|||
23576818|NCT00691028|65843472|FG002|Open-label Period|Withdrawal by Subject|0|||
23576819|NCT00691028|65843473|FG003|Open-label Period|Withdrawal by Subject|3|||
23576820|NCT00691028|65843470|FG000|Open-label Period|not come to a hospital|0|||
23576821|NCT00691028|65843471|FG001|Open-label Period|not come to a hospital|0|||
23576822|NCT00691028|65843472|FG002|Open-label Period|not come to a hospital|0|||
23576823|NCT00691028|65843473|FG003|Open-label Period|not come to a hospital|1|||
23576824|NCT00691028|65843470|FG000|Double-blind Period|Adverse Event|8|||
23576825|NCT00691028|65843471|FG001|Double-blind Period|Adverse Event|9|||
23576826|NCT00691028|65843472|FG002|Double-blind Period|Adverse Event|6|||
23576827|NCT00691028|65843473|FG003|Double-blind Period|Adverse Event|0|||
23576828|NCT00691028|65843470|FG000|Double-blind Period|Lack of Efficacy|4|||
23576829|NCT00691028|65843471|FG001|Double-blind Period|Lack of Efficacy|3|||
23776545|NCT03018249|66563167|FG001|Overall Study|Withdrawal by Subject|2|||
23576830|NCT00691028|65843472|FG002|Double-blind Period|Lack of Efficacy|2|||
23576831|NCT00691028|65843473|FG003|Double-blind Period|Lack of Efficacy|0|||
23576832|NCT00691028|65843470|FG000|Double-blind Period|Withdrawal by Subject|1|||
23576833|NCT00691028|65843471|FG001|Double-blind Period|Withdrawal by Subject|0|||
23576834|NCT00691028|65843472|FG002|Double-blind Period|Withdrawal by Subject|1|||
23576835|NCT00691028|65843473|FG003|Double-blind Period|Withdrawal by Subject|0|||
23576836|NCT00691028|65843470|FG000|Double-blind Period|not come to a hospital.|0|||
23776546|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
23776547|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
23776548|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
23835022|NCT02151851|66774220|FG000|Overall Study|Low compliance to study visits|0|||
23576837|NCT00691028|65843471|FG001|Double-blind Period|not come to a hospital.|1|||
23576838|NCT00691028|65843472|FG002|Double-blind Period|not come to a hospital.|0|||
23576839|NCT00691028|65843473|FG003|Double-blind Period|not come to a hospital.|0|||
23576840|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
23576841|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
23576842|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
23576843|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
23576844|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
23776549|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
23776550|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
23576845|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
23835023|NCT02151851|66774221|FG001|Overall Study|Low compliance to study visits|1|||
23835024|NCT02151851|66774220|FG000|Overall Study|Subject entered into study in error|0|||
23835025|NCT02151851|66774221|FG001|Overall Study|Subject entered into study in error|1|||
23835026|NCT02151851|66774220|FG000|Overall Study|Adverse Event|6|||
23835027|NCT02151851|66774221|FG001|Overall Study|Adverse Event|28|||
23835028|NCT01051791|66774222|FG000|Overall Study|Failed screening|3|||
23576846|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
23776551|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
23776552|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
23776553|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
23776554|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
23776555|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
23776556|NCT00424047|66563174|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
23776557|NCT00424047|66563175|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
23776558|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Adverse Event|22|||
23776559|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Adverse Event|12|||
23776560|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Progression of disease|92|||
23776561|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Progression of disease|128|||
23776562|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
23776563|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
23776564|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
23776565|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
23776566|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Death|11|||
23776567|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Death|11|||
23835029|NCT01051791|66774222|FG000|Overall Study|Withdrawal by Subject|1|||
23835030|NCT03096314|66774223|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
23449393|NCT01247324|65388006|FG000|Overall Study|Protocol Violation|1|||
23449394|NCT01247324|65388007|FG001|Overall Study|Protocol Violation|1|||
23576847|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
23576848|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
23576849|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
23576850|NCT04922021|65843481|FG000|Overall Study|Withdrawal by Subject|4|||
23576851|NCT04922021|65843482|FG001|Overall Study|Withdrawal by Subject|10|||
23576852|NCT04922021|65843481|FG000|Overall Study|Adverse Event|2|||
23576853|NCT04922021|65843482|FG001|Overall Study|Adverse Event|2|||
23576854|NCT04922021|65843481|FG000|Overall Study|Lack of Efficacy|0|||
23576855|NCT04922021|65843482|FG001|Overall Study|Lack of Efficacy|1|||
23576856|NCT04922021|65843481|FG000|Overall Study|Multiple reasons|1|||
23576857|NCT04922021|65843482|FG001|Overall Study|Multiple reasons|0|||
23576858|NCT03712098|65843483|FG000|Overall Study|Lost to Follow-up|3|||
23576859|NCT03712098|65843484|FG001|Overall Study|Lost to Follow-up|7|||
23576860|NCT03712098|65843483|FG000|Overall Study|Withdrawal by Subject|9|||
23576861|NCT03712098|65843484|FG001|Overall Study|Withdrawal by Subject|4|||
23576862|NCT03712098|65843483|FG000|Overall Study|Protocol Violation|2|||
23576863|NCT03712098|65843484|FG001|Overall Study|Protocol Violation|1|||
23576864|NCT02322775|65843490|FG000|Overall Study|Adverse Event|1|||
23576865|NCT02322775|65843491|FG001|Overall Study|Adverse Event|0|||
23576866|NCT02322775|65843490|FG000|Overall Study|Lost to Follow-up|0|||
23576867|NCT02322775|65843491|FG001|Overall Study|Lost to Follow-up|1|||
23576868|NCT02322775|65843490|FG000|Overall Study|Protocol Violation|1|||
23776568|NCT00424047|66563174|FG000|On Study at Time of Unblinding|Other|5|||
23776569|NCT00424047|66563175|FG001|On Study at Time of Unblinding|Other|4|||
23776570|NCT00424047|66563174|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
23776571|NCT00424047|66563175|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
23776572|NCT00424047|66563174|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
23776573|NCT00424047|66563175|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
23776574|NCT00424047|66563174|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
23776575|NCT00424047|66563175|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
23776576|NCT00424047|66563174|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
23776577|NCT00424047|66563175|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
23776578|NCT00424047|66563174|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
23776579|NCT00424047|66563175|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
23776580|NCT03134222|66563176|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
23776581|NCT03134222|66563177|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
23835031|NCT03096314|66774224|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
23835032|NCT03735498|66774226|FG000|Overall Study|Withdrawal by Subject|5|||
23835033|NCT03735498|66774226|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
23835034|NCT01303172|66774227|FG000|Overall Study|Physician Decision|9|||
23835035|NCT01303172|66774228|FG001|Overall Study|Physician Decision|6|||
23835036|NCT01303172|66774227|FG000|Overall Study|Adverse Event|5|||
23835037|NCT01303172|66774228|FG001|Overall Study|Adverse Event|2|||
23835038|NCT01303172|66774227|FG000|Overall Study|Withdrawal by Subject|4|||
23835039|NCT01303172|66774228|FG001|Overall Study|Withdrawal by Subject|2|||
23776582|NCT03134222|66563178|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
23835040|NCT01303172|66774227|FG000|Overall Study|Death|20|||
23835041|NCT01303172|66774228|FG001|Overall Study|Death|7|||
23835042|NCT01303172|66774227|FG000|Overall Study|Lack of Efficacy|25|||
23835043|NCT01303172|66774228|FG001|Overall Study|Lack of Efficacy|17|||
23835044|NCT04909853|66774229|FG000|Part 1|Assigned but not treated|0|||
23576869|NCT02322775|65843491|FG001|Overall Study|Protocol Violation|0|||
23576870|NCT02322775|65843490|FG000|Overall Study|Withdrawal by Subject|3|||
23576871|NCT02322775|65843491|FG001|Overall Study|Withdrawal by Subject|4|||
23576872|NCT02322775|65843490|FG000|Overall Study|Not willing to perform all FU visits|0|||
23776583|NCT03134222|66563179|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
23776584|NCT03134222|66563180|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
23776585|NCT03134222|66563176|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23776586|NCT03134222|66563177|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23776587|NCT03134222|66563178|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23776588|NCT03134222|66563179|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
23776589|NCT03134222|66563180|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
23776590|NCT03134222|66563176|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23776591|NCT03134222|66563177|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
23776592|NCT03134222|66563178|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23776593|NCT03134222|66563179|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23776594|NCT03134222|66563180|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23776595|NCT03134222|66563176|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23776596|NCT03134222|66563177|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
23776597|NCT03134222|66563178|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
23776598|NCT03134222|66563179|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23776599|NCT03134222|66563180|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23835045|NCT04909853|66774230|FG001|Part 1|Assigned but not treated|0|||
23835046|NCT04909853|66774231|FG002|Part 1|Assigned but not treated|1|||
23835047|NCT04909853|66774232|FG003|Part 1|Assigned but not treated|0|||
23835048|NCT04909853|66774229|FG000|Part 2|Adverse Event|0|||
23835049|NCT04909853|66774230|FG001|Part 2|Adverse Event|0|||
23835050|NCT04909853|66774231|FG002|Part 2|Adverse Event|0|||
23835051|NCT04909853|66774232|FG003|Part 2|Adverse Event|1|||
23835052|NCT00734994|66774233|FG000|Overall Study|Withdrawal by Subject|1|||
23835053|NCT03283566|66774236|FG000|Overall Study|Lost to Follow-up|1|||
23835054|NCT03283566|66774237|FG001|Overall Study|Lost to Follow-up|2|||
23835055|NCT00985504|66774238|FG000|Acute Treatment Period|Adverse Event|3|||
23835056|NCT00985504|66774239|FG001|Acute Treatment Period|Adverse Event|4|||
23835057|NCT00985504|66774238|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
23835058|NCT00985504|66774239|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
23835059|NCT00985504|66774238|FG000|Acute Treatment Period|Protocol Violation|2|||
23835060|NCT00985504|66774239|FG001|Acute Treatment Period|Protocol Violation|0|||
23835061|NCT00985504|66774238|FG000|Acute Treatment Period|Sponsor Decision|0|||
23835062|NCT00985504|66774239|FG001|Acute Treatment Period|Sponsor Decision|1|||
23835063|NCT00985504|66774238|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
23835064|NCT00985504|66774239|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
23835065|NCT00985504|66774238|FG000|Optimization Period|Adverse Event|7|||
23835066|NCT00985504|66774239|FG001|Optimization Period|Adverse Event|9|||
23835067|NCT00985504|66774238|FG000|Optimization Period|Death|0|||
23835068|NCT00985504|66774239|FG001|Optimization Period|Death|1|||
23835069|NCT00985504|66774238|FG000|Optimization Period|Lack of Efficacy|5|||
23835070|NCT00985504|66774239|FG001|Optimization Period|Lack of Efficacy|3|||
23835071|NCT00985504|66774238|FG000|Optimization Period|Lost to Follow-up|0|||
23835072|NCT00985504|66774239|FG001|Optimization Period|Lost to Follow-up|1|||
23835073|NCT00985504|66774238|FG000|Optimization Period|Physician Decision|1|||
23835074|NCT00985504|66774239|FG001|Optimization Period|Physician Decision|0|||
23835075|NCT00985504|66774238|FG000|Optimization Period|Protocol Violation|3|||
23835076|NCT00985504|66774239|FG001|Optimization Period|Protocol Violation|1|||
23835077|NCT00985504|66774238|FG000|Optimization Period|Withdrawal by Subject|10|||
23835078|NCT00985504|66774239|FG001|Optimization Period|Withdrawal by Subject|8|||
23835079|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
23835080|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
23835081|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
23835082|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
23835083|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
23835084|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
23835085|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
23835086|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
23835087|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
23835088|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
23835089|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
23835090|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
23835091|NCT03493854|66774246|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
23835092|NCT03493854|66774247|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
23835093|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
23835094|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
23835095|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
23835096|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
23835097|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
23835098|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
23835099|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
23835100|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
23835101|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
23835102|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
23835103|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
23835104|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
23835105|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
23835106|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
23835107|NCT03493854|66774246|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
23835108|NCT03493854|66774247|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
23835109|NCT03493854|66774246|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
23835110|NCT03493854|66774247|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
23835111|NCT03493854|66774246|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
23835112|NCT03493854|66774247|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
23835113|NCT03493854|66774246|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
23835114|NCT03493854|66774247|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
23835115|NCT01074268|66774248|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
23835116|NCT01074268|66774249|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
23835117|NCT01074268|66774248|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
23835118|NCT01074268|66774249|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
23835119|NCT01074268|66774248|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
23835120|NCT01074268|66774249|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
23835121|NCT01074268|66774248|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
23835122|NCT01074268|66774249|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
23776600|NCT03134222|66563176|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23776601|NCT03134222|66563177|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
23776602|NCT03134222|66563178|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23776603|NCT03134222|66563179|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23776604|NCT03134222|66563180|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
23776605|NCT03134222|66563176|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
23776606|NCT03134222|66563177|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23776607|NCT03134222|66563178|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23835123|NCT01074268|66774248|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
23835124|NCT01074268|66774249|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
23835125|NCT01074268|66774248|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
23835126|NCT01074268|66774249|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
23835127|NCT01074268|66774248|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
23835128|NCT01074268|66774249|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
23835129|NCT01074268|66774248|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
23835130|NCT01074268|66774249|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
23835131|NCT01074268|66774248|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
23835132|NCT01074268|66774249|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
23835133|NCT01568892|66774251|FG000|Open-label Phase|Adverse Event|2|||
23835134|NCT01568892|66774252|FG001|Open-label Phase|Adverse Event|0|||
23835135|NCT01568892|66774251|FG000|Open-label Phase|Lack of Efficacy|4|||
23835136|NCT01568892|66774252|FG001|Open-label Phase|Lack of Efficacy|2|||
23633901|NCT02628028|66045514|FG007|Dosing Period|Lost to Follow-up|0|||
23776608|NCT03134222|66563179|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23776609|NCT03134222|66563180|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23776610|NCT03134222|66563176|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23776611|NCT03134222|66563177|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23776612|NCT03134222|66563178|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23776613|NCT03134222|66563179|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
23776614|NCT03134222|66563180|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23776615|NCT03134222|66563176|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23776616|NCT03134222|66563177|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
23776617|NCT03134222|66563178|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23776618|NCT03134222|66563179|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23776619|NCT03134222|66563180|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23776620|NCT01066143|66563181|FG000|Overall Study|ineligible for the study|8|||
23776621|NCT01396278|66563182|FG000|Overall Study|Adverse Event|0|||
23776622|NCT01396278|66563183|FG001|Overall Study|Adverse Event|0|||
23776623|NCT01396278|66563184|FG002|Overall Study|Adverse Event|0|||
23776624|NCT01396278|66563185|FG003|Overall Study|Adverse Event|2|||
23776625|NCT01396278|66563186|FG004|Overall Study|Adverse Event|0|||
23835137|NCT01568892|66774251|FG000|Open-label Phase|Lost to Follow-up|0|||
23835138|NCT01568892|66774252|FG001|Open-label Phase|Lost to Follow-up|1|||
23835139|NCT00386360|66774253|FG000|Overall Study|Adverse Event|4|||
23776626|NCT01396278|66563182|FG000|Overall Study|Withdraw due to trial termination|2|||
23776627|NCT01396278|66563183|FG001|Overall Study|Withdraw due to trial termination|1|||
23776628|NCT01396278|66563184|FG002|Overall Study|Withdraw due to trial termination|1|||
23776629|NCT01396278|66563185|FG003|Overall Study|Withdraw due to trial termination|0|||
23776630|NCT01396278|66563186|FG004|Overall Study|Withdraw due to trial termination|2|||
23776631|NCT02674477|66563187|FG000|Overall Study|Protocol Violation|8|||
23776632|NCT02674477|66563188|FG001|Overall Study|Protocol Violation|2|||
23835140|NCT00386360|66774254|FG001|Overall Study|Adverse Event|2|||
23835141|NCT00386360|66774253|FG000|Overall Study|Physician Decision|2|||
23835142|NCT00386360|66774254|FG001|Overall Study|Physician Decision|2|||
23835143|NCT00386360|66774253|FG000|Overall Study|Lost to Follow-up|0|||
23835144|NCT00386360|66774254|FG001|Overall Study|Lost to Follow-up|2|||
23835145|NCT00386360|66774253|FG000|Overall Study|Protocol Violation|0|||
23835146|NCT00386360|66774254|FG001|Overall Study|Protocol Violation|3|||
23835147|NCT00386360|66774253|FG000|Overall Study|Withdrawal by Subject|3|||
23835148|NCT00386360|66774254|FG001|Overall Study|Withdrawal by Subject|6|||
23835149|NCT00386360|66774253|FG000|Overall Study|Did not take any study medication|0|||
23835150|NCT00386360|66774254|FG001|Overall Study|Did not take any study medication|2|||
23835151|NCT00595920|66774255|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
23835152|NCT02476578|66774264|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
23835153|NCT02476578|66774265|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
23835154|NCT02476578|66774264|FG000|Overall Study|Lost to Follow-up|6|||
23835155|NCT02476578|66774265|FG001|Overall Study|Lost to Follow-up|13|||
23835156|NCT01960257|66774266|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
23835157|NCT01960257|66774267|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
23835158|NCT01960257|66774268|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
23835159|NCT01960257|66774266|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
23835160|NCT01960257|66774267|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
23835161|NCT01960257|66774268|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
23835162|NCT01960257|66774266|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
23835163|NCT01960257|66774267|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
23835164|NCT01960257|66774268|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
23835165|NCT01928472|66774273|FG000|Overall Study|Death|0|||
23835166|NCT01928472|66774274|FG001|Overall Study|Death|0|||
23835167|NCT01928472|66774275|FG002|Overall Study|Death|1|||
23835168|NCT01928472|66774276|FG003|Overall Study|Death|0|||
23835169|NCT01928472|66774273|FG000|Overall Study|Withdrawal by Subject|4|||
23835170|NCT01928472|66774274|FG001|Overall Study|Withdrawal by Subject|4|||
23835171|NCT01928472|66774275|FG002|Overall Study|Withdrawal by Subject|1|||
23835172|NCT01928472|66774276|FG003|Overall Study|Withdrawal by Subject|2|||
23835173|NCT01928472|66774273|FG000|Overall Study|Lost to Follow-up|2|||
23835174|NCT01928472|66774274|FG001|Overall Study|Lost to Follow-up|3|||
23835175|NCT01928472|66774275|FG002|Overall Study|Lost to Follow-up|4|||
23835176|NCT01928472|66774276|FG003|Overall Study|Lost to Follow-up|0|||
23835177|NCT01928472|66774273|FG000|Overall Study|Administrative Reason|2|||
23835178|NCT01928472|66774274|FG001|Overall Study|Administrative Reason|1|||
23835179|NCT01928472|66774275|FG002|Overall Study|Administrative Reason|0|||
23835180|NCT01928472|66774276|FG003|Overall Study|Administrative Reason|0|||
23576873|NCT02322775|65843491|FG001|Overall Study|Not willing to perform all FU visits|1|||
23576874|NCT00946647|65843492|FG000|Phase 1 Part|Adverse Event|2|||
23576875|NCT00946647|65843493|FG001|Phase 1 Part|Adverse Event|5|||
23576876|NCT00946647|65843494|FG002|Phase 1 Part|Adverse Event|3|||
23776633|NCT02475954|66563189|FG000|Overall Study|Withdrawal by Subject|2|||
23835181|NCT01928472|66774273|FG000|Overall Study|Unclassified|0|||
23835182|NCT01928472|66774274|FG001|Overall Study|Unclassified|0|||
23776634|NCT02475954|66563190|FG001|Overall Study|Withdrawal by Subject|2|||
23835183|NCT01928472|66774275|FG002|Overall Study|Unclassified|1|||
23835184|NCT01928472|66774276|FG003|Overall Study|Unclassified|0|||
23835185|NCT01058642|66774277|FG000|Treatment Period 1|Adverse Event|0|||
23835186|NCT01058642|66774278|FG001|Treatment Period 1|Adverse Event|1|||
23835187|NCT01058642|66774279|FG002|Treatment Period 1|Adverse Event|1|||
23449395|NCT01247324|65388006|FG000|Overall Study|Reason not specified|42|||
23835188|NCT01058642|66774280|FG003|Treatment Period 1|Adverse Event|0|||
23576877|NCT00946647|65843495|FG003|Phase 1 Part|Adverse Event|0|||
23449396|NCT01247324|65388007|FG001|Overall Study|Reason not specified|32|||
23449397|NCT01247324|65388006|FG000|Overall Study|Consent withdrawn by participant|41|||
23449398|NCT01247324|65388007|FG001|Overall Study|Consent withdrawn by participant|56|||
23449399|NCT01247324|65388006|FG000|Overall Study|Adverse Event|49|||
23449400|NCT01247324|65388007|FG001|Overall Study|Adverse Event|35|||
23449401|NCT01247324|65388006|FG000|Overall Study|Lost to Follow-up|3|||
23449402|NCT01247324|65388007|FG001|Overall Study|Lost to Follow-up|6|||
23449403|NCT01247324|65388006|FG000|Overall Study|Study Terminated by Sponsor|4|||
23449404|NCT01247324|65388007|FG001|Overall Study|Study Terminated by Sponsor|1|||
23449405|NCT01247324|65388006|FG000|Overall Study|Missing|2|||
23449406|NCT01247324|65388007|FG001|Overall Study|Missing|1|||
23449407|NCT00795535|65388018|FG000|Overall Study|incomplete data and technical problems|20|||
23449408|NCT00479336|65388025|FG000|Overall Study|Adverse Event|1|||
23449409|NCT00479336|65388026|FG001|Overall Study|Adverse Event|1|||
23449410|NCT00479336|65388027|FG002|Overall Study|Adverse Event|1|||
23776635|NCT02475954|66563189|FG000|Overall Study|Lost to Follow-up|11|||
23776636|NCT02475954|66563190|FG001|Overall Study|Lost to Follow-up|9|||
23776637|NCT02475954|66563189|FG000|Overall Study|Death|1|||
23776638|NCT02475954|66563190|FG001|Overall Study|Death|1|||
23776639|NCT03100903|66563191|FG000|Overall Study|Withdrawal by Subject|0|||
23776640|NCT03100903|66563192|FG001|Overall Study|Withdrawal by Subject|0|||
23776641|NCT03100903|66563193|FG002|Overall Study|Withdrawal by Subject|1|||
23776642|NCT00819741|66563194|FG000|Overall Study|Adverse Event|5|||
23776643|NCT00819741|66563195|FG001|Overall Study|Adverse Event|2|||
23776644|NCT00819741|66563194|FG000|Overall Study|Lack of Efficacy|0|||
23776645|NCT00819741|66563195|FG001|Overall Study|Lack of Efficacy|2|||
23776646|NCT00819741|66563194|FG000|Overall Study|Lost to Follow-up|3|||
23776647|NCT00819741|66563195|FG001|Overall Study|Lost to Follow-up|1|||
23776648|NCT00819741|66563194|FG000|Overall Study|Protocol Violation|3|||
23776649|NCT00819741|66563195|FG001|Overall Study|Protocol Violation|4|||
23776650|NCT00819741|66563194|FG000|Overall Study|Withdrawal by Subject|2|||
23776651|NCT00819741|66563195|FG001|Overall Study|Withdrawal by Subject|2|||
23776652|NCT00819741|66563194|FG000|Overall Study|Unclassified|6|||
23776653|NCT00819741|66563195|FG001|Overall Study|Unclassified|0|||
23776654|NCT00819741|66563194|FG000|Overall Study|Reasons unknown|3|||
23776655|NCT00819741|66563195|FG001|Overall Study|Reasons unknown|3|||
23776656|NCT02781727|66563196|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
23776657|NCT02781727|66563197|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
23776658|NCT02781727|66563196|FG000|Treatment Period|Withdrawal by Subject|1|||
23776659|NCT02781727|66563197|FG001|Treatment Period|Withdrawal by Subject|0|||
23776660|NCT02781727|66563196|FG000|Treatment Period|Lost to Follow-up|0|||
23776661|NCT02781727|66563197|FG001|Treatment Period|Lost to Follow-up|1|||
23776662|NCT03351335|66563200|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
23776663|NCT03351335|66563201|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
23776664|NCT03351335|66563202|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
23776665|NCT00419770|66563203|FG000|Overall Study|Withdrawal by Subject|5|||
23776666|NCT00419770|66563204|FG001|Overall Study|Withdrawal by Subject|1|||
23776667|NCT02438722|66563205|FG000|Overall Study|Adverse Event|12|||
23449411|NCT00479336|65388028|FG003|Overall Study|Adverse Event|3|||
23449412|NCT00479336|65388025|FG000|Overall Study|Lack of Efficacy|1|||
23776668|NCT02438722|66563206|FG001|Overall Study|Adverse Event|9|||
23776669|NCT02438722|66563205|FG000|Overall Study|Refusal unrelated to AE|2|||
23449413|NCT00479336|65388026|FG001|Overall Study|Lack of Efficacy|0|||
23776670|NCT02438722|66563206|FG001|Overall Study|Refusal unrelated to AE|5|||
23776671|NCT02438722|66563205|FG000|Overall Study|Disease progression/relapse|46|||
23449414|NCT00479336|65388027|FG002|Overall Study|Lack of Efficacy|0|||
23449415|NCT00479336|65388028|FG003|Overall Study|Lack of Efficacy|0|||
23449416|NCT00479336|65388025|FG000|Overall Study|Protocol Violation|0|||
23449417|NCT00479336|65388026|FG001|Overall Study|Protocol Violation|1|||
23449418|NCT00479336|65388027|FG002|Overall Study|Protocol Violation|0|||
23449419|NCT00479336|65388028|FG003|Overall Study|Protocol Violation|0|||
23449420|NCT00479336|65388025|FG000|Overall Study|Withdrawal by Subject|1|||
23449421|NCT00479336|65388026|FG001|Overall Study|Withdrawal by Subject|2|||
23449422|NCT00479336|65388027|FG002|Overall Study|Withdrawal by Subject|0|||
23449423|NCT00479336|65388028|FG003|Overall Study|Withdrawal by Subject|0|||
23449424|NCT00479336|65388025|FG000|Overall Study|Physician Decision|0|||
23449425|NCT00479336|65388026|FG001|Overall Study|Physician Decision|1|||
23449426|NCT00479336|65388027|FG002|Overall Study|Physician Decision|0|||
23449427|NCT00479336|65388028|FG003|Overall Study|Physician Decision|2|||
23449428|NCT00479336|65388025|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
23449429|NCT00479336|65388026|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
23449430|NCT00479336|65388027|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
23449431|NCT00479336|65388028|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
23449432|NCT01458639|65388036|FG000|Overall Study|Physician Decision|4|||
23449433|NCT01458639|65388036|FG000|Overall Study|Equipment issue|1|||
23449434|NCT01458639|65388036|FG000|Overall Study|Inability to obtain subject blood sample|1|||
23449435|NCT02679755|65388039|FG000|Overall Study|Death|0|||
23449436|NCT02679755|65388040|FG001|Overall Study|Death|3|||
23449437|NCT02679755|65388039|FG000|Overall Study|Global deterioration of health status|1|||
23449438|NCT02679755|65388040|FG001|Overall Study|Global deterioration of health status|8|||
23449439|NCT02679755|65388039|FG000|Overall Study|Lost to Follow-up|1|||
23449440|NCT02679755|65388040|FG001|Overall Study|Lost to Follow-up|0|||
23449441|NCT02679755|65388039|FG000|Overall Study|Objective progression or relapse|24|||
23449442|NCT02679755|65388040|FG001|Overall Study|Objective progression or relapse|83|||
23449443|NCT02679755|65388039|FG000|Overall Study|Not defined|0|||
23449444|NCT02679755|65388040|FG001|Overall Study|Not defined|2|||
23449445|NCT02679755|65388039|FG000|Overall Study|Withdrawal by participant|6|||
23449446|NCT02679755|65388040|FG001|Overall Study|Withdrawal by participant|3|||
23449447|NCT02679755|65388039|FG000|Overall Study|Adverse Event|1|||
23449448|NCT02679755|65388040|FG001|Overall Study|Adverse Event|4|||
23449449|NCT02679755|65388039|FG000|Overall Study|Adverse events not related to study drug|1|||
23449450|NCT02679755|65388040|FG001|Overall Study|Adverse events not related to study drug|2|||
23449451|NCT00796666|65388041|FG000|Overall Study|Death|2|||
23449452|NCT00796666|65388042|FG001|Overall Study|Death|4|||
23449453|NCT00796666|65388041|FG000|Overall Study|Withdrawal by Subject|2|||
23449454|NCT00796666|65388042|FG001|Overall Study|Withdrawal by Subject|0|||
23449455|NCT00796666|65388041|FG000|Overall Study|Adverse Event|7|||
23449456|NCT00796666|65388042|FG001|Overall Study|Adverse Event|5|||
23449457|NCT00796666|65388041|FG000|Overall Study|Protocol Violation|1|||
23449458|NCT00796666|65388042|FG001|Overall Study|Protocol Violation|0|||
23449459|NCT00796666|65388041|FG000|Overall Study|Other|1|||
23449460|NCT00796666|65388042|FG001|Overall Study|Other|0|||
23449461|NCT00796666|65388041|FG000|Overall Study|Terminated by sponsor|53|||
23449462|NCT00796666|65388042|FG001|Overall Study|Terminated by sponsor|55|||
23449463|NCT00796666|65388041|FG000|Overall Study|Randomized and not treated|1|||
23449464|NCT00796666|65388042|FG001|Overall Study|Randomized and not treated|0|||
23449465|NCT00961181|65388045|FG000|Overall Study|Death|2|||
23449466|NCT00961181|65388045|FG000|Overall Study|Withdrawal by Subject|2|||
23449467|NCT00961181|65388045|FG000|Overall Study|Lost to Follow-up|1|||
23449468|NCT00985465|65388046|FG000|Overall Study|Withdrawal by Subject|1|||
23449469|NCT00985465|65388047|FG001|Overall Study|Withdrawal by Subject|2|||
23449470|NCT00985465|65388046|FG000|Overall Study|Considered to be part of the other group|0|||
23449471|NCT00985465|65388047|FG001|Overall Study|Considered to be part of the other group|1|||
23449472|NCT03058692|65388048|FG000|Overall Study|Lost to Follow-up|2|||
23449473|NCT03058692|65388049|FG001|Overall Study|Lost to Follow-up|1|||
23449474|NCT03058692|65388048|FG000|Overall Study|Withdrawal by Subject|1|||
23449475|NCT03058692|65388049|FG001|Overall Study|Withdrawal by Subject|1|||
23449476|NCT02090426|65388050|FG000|Overall Study|Lost to Follow-up|12|||
23449477|NCT02090426|65388051|FG001|Overall Study|Lost to Follow-up|6|||
23449478|NCT00922623|65388052|FG000|Overall Study|Other|4|||
23449479|NCT00922623|65388052|FG000|Overall Study|Lost to Follow-up|1|||
23449480|NCT00948064|65388053|FG000|Phase I|No treatment received|1|||
23449481|NCT00948064|65388054|FG001|Phase I|No treatment received|0|||
23449482|NCT00948064|65388055|FG002|Phase I|No treatment received|0|||
23449483|NCT00948064|65388053|FG000|Phase II|Physician Decision|0|||
23449484|NCT00948064|65388054|FG001|Phase II|Physician Decision|0|||
23449485|NCT00948064|65388055|FG002|Phase II|Physician Decision|1|||
23449486|NCT00948064|65388053|FG000|Phase II|Withdrawal by Subject|0|||
23449487|NCT00948064|65388054|FG001|Phase II|Withdrawal by Subject|1|||
23449488|NCT00948064|65388055|FG002|Phase II|Withdrawal by Subject|0|||
23576878|NCT00946647|65843496|FG004|Phase 1 Part|Adverse Event|0|||
23576879|NCT00946647|65843492|FG000|Phase 1 Part|Disease progression|3|||
23449489|NCT02469623|65388057|FG000|Overall Study|Not consented for long-term follow-up|4|||
23449490|NCT02469623|65388057|FG000|Overall Study|Lost to Follow-up|4|||
23449491|NCT02469623|65388057|FG000|Overall Study|Withdrawal by Subject|2|||
23449492|NCT02469623|65388057|FG000|Overall Study|Death|3|||
23449493|NCT04390243|65388058|FG000|Overall Study|Death|1|||
23449494|NCT04390243|65388058|FG000|Overall Study|Disease Progression|4|||
23449495|NCT04390243|65388058|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
23449496|NCT00556998|65388059|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
23449497|NCT00556998|65388059|FG000|Voriconazole Intravenous (IV)|Other|4|||
23449498|NCT00556998|65388059|FG000|Voriconazole Oral|Adverse Event|1|||
23449499|NCT00556998|65388059|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
23449500|NCT02936635|65388062|FG000|Overall Study|Adverse Event|43|||
23449501|NCT02936635|65388063|FG001|Overall Study|Adverse Event|25|||
23449502|NCT02936635|65388062|FG000|Overall Study|Progressive Disease|10|||
23449503|NCT02936635|65388063|FG001|Overall Study|Progressive Disease|18|||
23449504|NCT02936635|65388062|FG000|Overall Study|Sponsor Discretion|10|||
23449505|NCT02936635|65388063|FG001|Overall Study|Sponsor Discretion|16|||
23449506|NCT02936635|65388062|FG000|Overall Study|Death|9|||
23449507|NCT02936635|65388063|FG001|Overall Study|Death|15|||
23449508|NCT02936635|65388062|FG000|Overall Study|Withdrawal by Subject|8|||
23449509|NCT02936635|65388063|FG001|Overall Study|Withdrawal by Subject|15|||
23449510|NCT02936635|65388062|FG000|Overall Study|Physician Decision|2|||
23449511|NCT02936635|65388063|FG001|Overall Study|Physician Decision|9|||
23449512|NCT02936635|65388062|FG000|Overall Study|Lost to Follow-up|1|||
23449513|NCT02936635|65388063|FG001|Overall Study|Lost to Follow-up|2|||
23449514|NCT02936635|65388062|FG000|Overall Study|Protocol Violation|1|||
23449515|NCT02936635|65388063|FG001|Overall Study|Protocol Violation|0|||
23449516|NCT02936635|65388062|FG000|Overall Study|Lack of effect/Entry into other study|31|||
23449517|NCT02936635|65388063|FG001|Overall Study|Lack of effect/Entry into other study|65|||
23449518|NCT01618669|65388067|FG000|Overall Study|Lost to Follow-up|1|||
23449519|NCT01618669|65388068|FG001|Overall Study|Lost to Follow-up|1|||
23776672|NCT02438722|66563206|FG001|Overall Study|Disease progression/relapse|51|||
23776673|NCT02438722|66563205|FG000|Overall Study|Death|0|||
23776674|NCT02438722|66563206|FG001|Overall Study|Death|3|||
23776675|NCT02438722|66563205|FG000|Overall Study|Physician Decision|2|||
23776676|NCT02438722|66563206|FG001|Overall Study|Physician Decision|2|||
23776677|NCT02438722|66563205|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
23776678|NCT02438722|66563206|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
23776679|NCT02438722|66563205|FG000|Overall Study|Withdrawal by Subject|0|||
23776680|NCT02438722|66563206|FG001|Overall Study|Withdrawal by Subject|1|||
23449520|NCT01618669|65388067|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
23449521|NCT01618669|65388068|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
23449522|NCT01618669|65388067|FG000|Overall Study|Adverse Event|16|||
23449523|NCT01618669|65388068|FG001|Overall Study|Adverse Event|7|||
23449524|NCT01618669|65388067|FG000|Overall Study|Protocol Violation|5|||
23449525|NCT01618669|65388068|FG001|Overall Study|Protocol Violation|3|||
23449526|NCT01618669|65388067|FG000|Overall Study|Withdrawal by Subject|9|||
23449527|NCT01618669|65388068|FG001|Overall Study|Withdrawal by Subject|9|||
23776681|NCT02438722|66563205|FG000|Overall Study|On protocol treatment|15|||
23449528|NCT01618669|65388067|FG000|Overall Study|Miscellaneous Reason|0|||
23449529|NCT01618669|65388068|FG001|Overall Study|Miscellaneous Reason|1|||
23449530|NCT00474955|65388069|FG000|Overall Study|Adverse Event|2|||
23449531|NCT00474955|65388069|FG000|Overall Study|Drug unavailability|1|||
23449532|NCT00474955|65388069|FG000|Overall Study|Personal reasons|5|||
23449533|NCT01290523|65388070|FG000|Overall Study|Death|3|||
23449534|NCT01156480|65388071|FG000|Overall Study|change in diagnosis|0|||
23776682|NCT02438722|66563206|FG001|Overall Study|On protocol treatment|14|||
23776683|NCT02438722|66563205|FG000|Overall Study|Did not receive protocol treatment|5|||
23776684|NCT02438722|66563206|FG001|Overall Study|Did not receive protocol treatment|0|||
23776685|NCT00576056|66563207|FG000|Overall Study|Adverse Event|1|||
23776686|NCT00576056|66563207|FG000|Overall Study|Death|1|||
23776687|NCT00576056|66563207|FG000|Overall Study|Lack of Efficacy|1|||
23776688|NCT00576056|66563207|FG000|Overall Study|Withdrawal by Subject|2|||
23776689|NCT00576056|66563207|FG000|Overall Study|did not meet eligibility criteria|8|||
23776690|NCT00576056|66563207|FG000|Overall Study|Physician Decision|1|||
23776691|NCT03365375|66563208|FG000|Overall Study|Withdrawal by Subject|0|||
23776692|NCT03365375|66563209|FG001|Overall Study|Withdrawal by Subject|1|||
23776693|NCT03365375|66563208|FG000|Overall Study|Lost to Follow-up|0|||
23776694|NCT03365375|66563209|FG001|Overall Study|Lost to Follow-up|4|||
23776695|NCT04088760|66563210|FG000|Overall Study|Physician Decision|1|||
23776696|NCT02924883|66563213|FG000|Overall Study|Death|39|||
23776697|NCT02924883|66563214|FG001|Overall Study|Death|20|||
23776698|NCT02924883|66563213|FG000|Overall Study|Lost to Follow-up|1|||
23776699|NCT02924883|66563214|FG001|Overall Study|Lost to Follow-up|0|||
23776700|NCT02924883|66563213|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
23835189|NCT01058642|66774277|FG000|Treatment Period 1|Physician Decision|0|||
23449535|NCT01156480|65388072|FG001|Overall Study|change in diagnosis|1|||
23449536|NCT03642873|65388073|FG000|Third Intervention (1 Day)|Screen failure|0|||
23449537|NCT03642873|65388074|FG001|Third Intervention (1 Day)|Screen failure|0|||
23449538|NCT03642873|65388075|FG002|Third Intervention (1 Day)|Screen failure|0|||
23449539|NCT03642873|65388076|FG003|Third Intervention (1 Day)|Screen failure|0|||
23449540|NCT03642873|65388077|FG004|Third Intervention (1 Day)|Screen failure|1|||
23449541|NCT03642873|65388078|FG005|Third Intervention (1 Day)|Screen failure|0|||
23835190|NCT01058642|66774278|FG001|Treatment Period 1|Physician Decision|0|||
23835191|NCT01058642|66774279|FG002|Treatment Period 1|Physician Decision|1|||
23835192|NCT01058642|66774280|FG003|Treatment Period 1|Physician Decision|0|||
23835193|NCT01058642|66774277|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23835194|NCT01058642|66774278|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23835195|NCT01058642|66774279|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23835196|NCT01058642|66774280|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23449542|NCT02510001|65388085|FG000|Overall Study|Early disease progression|0|||
23449543|NCT02510001|65388086|FG001|Overall Study|Early disease progression|0|||
23449544|NCT02510001|65388087|FG002|Overall Study|Early disease progression|0|||
23449545|NCT02510001|65388088|FG003|Overall Study|Early disease progression|1|||
23449546|NCT02510001|65388089|FG004|Overall Study|Early disease progression|1|||
23576880|NCT00946647|65843493|FG001|Phase 1 Part|Disease progression|6|||
23576881|NCT00946647|65843494|FG002|Phase 1 Part|Disease progression|1|||
23449547|NCT02510001|65388090|FG005|Overall Study|Early disease progression|1|||
23449548|NCT02510001|65388091|FG006|Overall Study|Early disease progression|0|||
23449549|NCT02510001|65388092|FG007|Overall Study|Early disease progression|0|||
23449550|NCT02510001|65388085|FG000|Overall Study|Adverse Event|0|||
23449551|NCT02510001|65388086|FG001|Overall Study|Adverse Event|0|||
23449552|NCT02510001|65388087|FG002|Overall Study|Adverse Event|0|||
23449553|NCT02510001|65388088|FG003|Overall Study|Adverse Event|1|||
23576882|NCT00946647|65843495|FG003|Phase 1 Part|Disease progression|0|||
23576883|NCT00946647|65843496|FG004|Phase 1 Part|Disease progression|0|||
23576884|NCT00946647|65843492|FG000|Phase 1 Part|Withdrawal by Subject|1|||
23576885|NCT00946647|65843493|FG001|Phase 1 Part|Withdrawal by Subject|4|||
23576886|NCT00946647|65843494|FG002|Phase 1 Part|Withdrawal by Subject|3|||
23576887|NCT00946647|65843495|FG003|Phase 1 Part|Withdrawal by Subject|0|||
23633902|NCT02628028|66045507|FG000|Dosing Period|Other|0|||
23576888|NCT00946647|65843496|FG004|Phase 1 Part|Withdrawal by Subject|0|||
23576889|NCT00946647|65843492|FG000|Phase 1 Part|Abnormal values|0|||
23776701|NCT02924883|66563214|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
23776702|NCT02924883|66563213|FG000|Overall Study|Protocol Violation|1|||
23776703|NCT02924883|66563214|FG001|Overall Study|Protocol Violation|0|||
23776704|NCT02924883|66563213|FG000|Overall Study|Withdrawal by Subject|22|||
23776705|NCT02924883|66563214|FG001|Overall Study|Withdrawal by Subject|16|||
23449554|NCT02510001|65388089|FG004|Overall Study|Adverse Event|2|||
23449555|NCT02510001|65388090|FG005|Overall Study|Adverse Event|1|||
23449556|NCT02510001|65388091|FG006|Overall Study|Adverse Event|2|||
23449557|NCT02510001|65388092|FG007|Overall Study|Adverse Event|5|||
23449558|NCT02510001|65388085|FG000|Overall Study|Physician Decision|0|||
23449559|NCT02510001|65388086|FG001|Overall Study|Physician Decision|0|||
23449560|NCT02510001|65388087|FG002|Overall Study|Physician Decision|0|||
23835197|NCT01058642|66774277|FG000|Treatment Period 1|Lack of Efficacy|0|||
23835198|NCT01058642|66774278|FG001|Treatment Period 1|Lack of Efficacy|0|||
23835199|NCT01058642|66774279|FG002|Treatment Period 1|Lack of Efficacy|0|||
23835200|NCT01058642|66774280|FG003|Treatment Period 1|Lack of Efficacy|1|||
23835201|NCT01058642|66774277|FG000|Treatment Period 1|Protocol Violation|0|||
23835202|NCT01058642|66774278|FG001|Treatment Period 1|Protocol Violation|0|||
23835203|NCT01058642|66774279|FG002|Treatment Period 1|Protocol Violation|0|||
23835204|NCT01058642|66774280|FG003|Treatment Period 1|Protocol Violation|1|||
23835205|NCT01058642|66774277|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
23835206|NCT01058642|66774278|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23835207|NCT01058642|66774279|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23835208|NCT01058642|66774280|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23835209|NCT01611935|66774283|FG000|Overall Study|Family Declined Participation|1|||
23835210|NCT01611935|66774284|FG001|Overall Study|Family Declined Participation|0|||
23835211|NCT03048747|66774286|FG000|Overall Study|Adverse Event|2|||
23835212|NCT03048747|66774286|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
23835213|NCT03048747|66774286|FG000|Overall Study|Physician Decision|1|||
23835214|NCT02484456|66774289|FG000|Washout Period|Withdrawal by Subject|0|||
23835215|NCT02484456|66774290|FG001|Washout Period|Withdrawal by Subject|1|||
23835216|NCT02484456|66774289|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
23835217|NCT02484456|66774290|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
23835218|NCT02484456|66774289|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
23835219|NCT02484456|66774290|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
23835220|NCT02484456|66774289|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
23835221|NCT02484456|66774290|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
23835222|NCT00364923|66774291|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
23835223|NCT00364923|66774291|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
23835224|NCT00420420|66774292|FG000|Overall Study|Adverse Event|5|||
23449561|NCT02510001|65388088|FG003|Overall Study|Physician Decision|0|||
23835225|NCT00420420|66774293|FG001|Overall Study|Adverse Event|3|||
23835226|NCT00420420|66774292|FG000|Overall Study|Protocol Violation|1|||
23449562|NCT02510001|65388089|FG004|Overall Study|Physician Decision|1|||
23449563|NCT02510001|65388090|FG005|Overall Study|Physician Decision|0|||
23449564|NCT02510001|65388091|FG006|Overall Study|Physician Decision|0|||
23449565|NCT02510001|65388092|FG007|Overall Study|Physician Decision|0|||
23449566|NCT02510001|65388085|FG000|Overall Study|Withdrawal by Subject|0|||
23449567|NCT02510001|65388086|FG001|Overall Study|Withdrawal by Subject|0|||
23835227|NCT00420420|66774293|FG001|Overall Study|Protocol Violation|1|||
23835228|NCT00420420|66774292|FG000|Overall Study|Withdrawal by Subject|1|||
23576890|NCT00946647|65843493|FG001|Phase 1 Part|Abnormal values|2|||
23576891|NCT00946647|65843494|FG002|Phase 1 Part|Abnormal values|0|||
23576892|NCT00946647|65843495|FG003|Phase 1 Part|Abnormal values|0|||
23576893|NCT00946647|65843496|FG004|Phase 1 Part|Abnormal values|0|||
23576894|NCT00946647|65843492|FG000|Phase 1 Part|Reason missing|0|||
23576895|NCT00946647|65843493|FG001|Phase 1 Part|Reason missing|1|||
23576896|NCT00946647|65843494|FG002|Phase 1 Part|Reason missing|0|||
23576897|NCT00946647|65843495|FG003|Phase 1 Part|Reason missing|0|||
23835229|NCT00420420|66774293|FG001|Overall Study|Withdrawal by Subject|0|||
23835230|NCT00420420|66774292|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
23835231|NCT00420420|66774293|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
23835232|NCT01532518|66774295|FG000|Overall Study|Withdrawal by Subject|0|||
23835233|NCT01532518|66774296|FG001|Overall Study|Withdrawal by Subject|0|||
23835234|NCT01532518|66774297|FG002|Overall Study|Withdrawal by Subject|1|||
23835235|NCT00603473|66774298|FG000|Overall Study|Adverse Event|4|||
23835236|NCT00603473|66774298|FG000|Overall Study|Lack of Efficacy|4|||
23835237|NCT00603473|66774298|FG000|Overall Study|Protocol Violation|1|||
23835238|NCT02059135|66774302|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
23835239|NCT02059135|66774303|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
23835240|NCT02059135|66774302|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
23835241|NCT02059135|66774303|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
23835242|NCT02059135|66774302|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
23835243|NCT02059135|66774303|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
23835244|NCT02059135|66774302|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
23576898|NCT00946647|65843496|FG004|Phase 1 Part|Reason missing|0|||
23576899|NCT00946647|65843492|FG000|Phase ll Part|Untreated|0|||
23835245|NCT02059135|66774303|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
23576900|NCT00946647|65843493|FG001|Phase ll Part|Untreated|0|||
23576901|NCT00946647|65843494|FG002|Phase ll Part|Untreated|0|||
23576902|NCT00946647|65843495|FG003|Phase ll Part|Untreated|0|||
23576903|NCT00946647|65843496|FG004|Phase ll Part|Untreated|2|||
23576904|NCT00946647|65843492|FG000|Phase ll Part|Adverse Event|0|||
23576905|NCT00946647|65843493|FG001|Phase ll Part|Adverse Event|0|||
23576906|NCT00946647|65843494|FG002|Phase ll Part|Adverse Event|0|||
23576907|NCT00946647|65843495|FG003|Phase ll Part|Adverse Event|10|||
23576908|NCT00946647|65843496|FG004|Phase ll Part|Adverse Event|6|||
23576909|NCT00946647|65843492|FG000|Phase ll Part|Withdrawal by Subject|0|||
23576910|NCT00946647|65843493|FG001|Phase ll Part|Withdrawal by Subject|0|||
23576911|NCT00946647|65843494|FG002|Phase ll Part|Withdrawal by Subject|0|||
23576912|NCT00946647|65843495|FG003|Phase ll Part|Withdrawal by Subject|8|||
23576913|NCT00946647|65843496|FG004|Phase ll Part|Withdrawal by Subject|6|||
23576914|NCT00946647|65843492|FG000|Phase ll Part|Administrative problems|0|||
23576915|NCT00946647|65843493|FG001|Phase ll Part|Administrative problems|0|||
23576916|NCT00946647|65843494|FG002|Phase ll Part|Administrative problems|0|||
23576917|NCT00946647|65843495|FG003|Phase ll Part|Administrative problems|3|||
23576918|NCT00946647|65843496|FG004|Phase ll Part|Administrative problems|8|||
23576919|NCT00946647|65843492|FG000|Phase ll Part|Death|0|||
23576920|NCT00946647|65843493|FG001|Phase ll Part|Death|0|||
23576921|NCT00946647|65843494|FG002|Phase ll Part|Death|0|||
23576922|NCT00946647|65843495|FG003|Phase ll Part|Death|7|||
23576923|NCT00946647|65843496|FG004|Phase ll Part|Death|4|||
23576924|NCT00946647|65843492|FG000|Phase ll Part|Disease progression|0|||
23576925|NCT00946647|65843493|FG001|Phase ll Part|Disease progression|0|||
23576926|NCT00946647|65843494|FG002|Phase ll Part|Disease progression|0|||
23576927|NCT00946647|65843495|FG003|Phase ll Part|Disease progression|6|||
23576928|NCT00946647|65843496|FG004|Phase ll Part|Disease progression|14|||
23835246|NCT02059135|66774302|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
23835247|NCT02059135|66774303|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
23835248|NCT02059135|66774302|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
23835249|NCT02059135|66774303|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
23835250|NCT02059135|66774302|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
23835251|NCT02059135|66774303|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
23835252|NCT02059135|66774302|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
23835253|NCT02059135|66774303|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
23835254|NCT05344560|66777640|FG000|Period 1|Subject out of visit window|1|||
23835255|NCT05344560|66777641|FG001|Period 1|Subject out of visit window|1|||
23835256|NCT05344560|66777640|FG000|Period 2|Covid-19 Related|1|||
23835257|NCT05344560|66777641|FG001|Period 2|Covid-19 Related|0|||
23835258|NCT05344560|66777640|FG000|Period 2|Adverse Event|1|||
23835259|NCT05344560|66777641|FG001|Period 2|Adverse Event|0|||
23835260|NCT05344560|66777640|FG000|Period 2|Subject out of visit window|1|||
23835261|NCT05344560|66777641|FG001|Period 2|Subject out of visit window|1|||
23835262|NCT05344560|66777640|FG000|Period 3|Subject out of visit window|1|||
23835263|NCT05344560|66777641|FG001|Period 3|Subject out of visit window|0|||
23835264|NCT00855894|66777652|FG000|Overall Study|Death|31|||
23835265|NCT00855894|66777652|FG000|Overall Study|Patient's decision|1|||
23835266|NCT00855894|66777652|FG000|Overall Study|Disease progression|1|||
23835267|NCT05506046|66777657|FG000|Overall Study|Lost to Follow-up|89|||
23835268|NCT05506046|66777658|FG001|Overall Study|Lost to Follow-up|101|||
23835269|NCT05506046|66777659|FG002|Overall Study|Lost to Follow-up|102|||
23835270|NCT05506046|66777660|FG003|Overall Study|Lost to Follow-up|99|||
23835271|NCT00318474|66777661|FG000|Overall Study|Adverse Event|1|||
23835272|NCT00318474|66777662|FG001|Overall Study|Adverse Event|1|||
23835273|NCT00318474|66777661|FG000|Overall Study|Lost to Follow-up|0|||
23835274|NCT00318474|66777662|FG001|Overall Study|Lost to Follow-up|1|||
23835275|NCT00318474|66777661|FG000|Overall Study|Pregnancy|0|||
23835276|NCT00318474|66777662|FG001|Overall Study|Pregnancy|2|||
23835277|NCT00318474|66777661|FG000|Overall Study|Protocol Violation|1|||
23835278|NCT00318474|66777662|FG001|Overall Study|Protocol Violation|0|||
23835279|NCT00318474|66777661|FG000|Overall Study|Withdrawal by Subject|3|||
23835280|NCT00318474|66777662|FG001|Overall Study|Withdrawal by Subject|2|||
23835281|NCT00318474|66777661|FG000|Overall Study|Fall in GFR|3|||
23835282|NCT00318474|66777662|FG001|Overall Study|Fall in GFR|3|||
23835283|NCT00318474|66777661|FG000|Overall Study|Post-therapy hyperflycemia|0|||
23835284|NCT00318474|66777662|FG001|Overall Study|Post-therapy hyperflycemia|1|||
23835285|NCT00318474|66777661|FG000|Overall Study|Trial terminated|10|||
23835286|NCT00318474|66777662|FG001|Overall Study|Trial terminated|7|||
23835287|NCT00757042|66777665|FG000|Overall Study|Lost to Follow-up|0|||
23835288|NCT00757042|66777666|FG001|Overall Study|Lost to Follow-up|0|||
23835289|NCT00757042|66777667|FG002|Overall Study|Lost to Follow-up|0|||
23835290|NCT00757042|66777668|FG003|Overall Study|Lost to Follow-up|0|||
23835291|NCT00757042|66777669|FG004|Overall Study|Lost to Follow-up|0|||
23835292|NCT00757042|66777670|FG005|Overall Study|Lost to Follow-up|0|||
23576929|NCT00946647|65843492|FG000|Phase ll Part|Protocol Violation|0|||
23576930|NCT00946647|65843493|FG001|Phase ll Part|Protocol Violation|0|||
23576931|NCT00946647|65843494|FG002|Phase ll Part|Protocol Violation|0|||
23576932|NCT00946647|65843495|FG003|Phase ll Part|Protocol Violation|4|||
23576933|NCT00946647|65843496|FG004|Phase ll Part|Protocol Violation|2|||
23449568|NCT02510001|65388087|FG002|Overall Study|Withdrawal by Subject|0|||
23449569|NCT02510001|65388088|FG003|Overall Study|Withdrawal by Subject|0|||
23576934|NCT00946647|65843492|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
23576935|NCT00946647|65843493|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
23576936|NCT00946647|65843494|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
23576937|NCT00946647|65843495|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
23576938|NCT00946647|65843496|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
23576939|NCT03633903|65843499|FG000|Overall Study|Withdrawal by Subject|1|||
23576940|NCT03633903|65843500|FG001|Overall Study|Withdrawal by Subject|2|||
23576941|NCT03633903|65843499|FG000|Overall Study|Lost to Follow-up|5|||
23576942|NCT03633903|65843500|FG001|Overall Study|Lost to Follow-up|5|||
23576943|NCT02478359|65843501|FG000|Overall Study|Disenrolled from health plan|106|||
23576944|NCT02478359|65843502|FG001|Overall Study|Disenrolled from health plan|65|||
23576945|NCT03660943|65843522|FG000|Overall Study|Adverse Event|5|||
23576946|NCT03660943|65843523|FG001|Overall Study|Adverse Event|3|||
23576947|NCT03660943|65843522|FG000|Overall Study|Death|0|||
23576948|NCT03660943|65843523|FG001|Overall Study|Death|2|||
23576949|NCT03660943|65843522|FG000|Overall Study|Lost to Follow-up|7|||
23576950|NCT03660943|65843523|FG001|Overall Study|Lost to Follow-up|3|||
23576951|NCT03660943|65843522|FG000|Overall Study|Protocol Violation|3|||
23576952|NCT03660943|65843523|FG001|Overall Study|Protocol Violation|5|||
23576953|NCT03660943|65843522|FG000|Overall Study|Withdrawal by Subject|8|||
23576954|NCT03660943|65843523|FG001|Overall Study|Withdrawal by Subject|15|||
23576955|NCT03660943|65843522|FG000|Overall Study|Lack of Efficacy|9|||
23576956|NCT03660943|65843523|FG001|Overall Study|Lack of Efficacy|12|||
23576957|NCT03660943|65843522|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
23576958|NCT03660943|65843523|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
23576959|NCT01871285|65843531|FG000|First Intervention (1 Day)|Adverse Event|1|||
23576960|NCT01871285|65843532|FG001|First Intervention (1 Day)|Adverse Event|0|||
23576961|NCT01871285|65843533|FG002|First Intervention (1 Day)|Adverse Event|0|||
23576962|NCT01871285|65843534|FG003|First Intervention (1 Day)|Adverse Event|0|||
23576963|NCT01871285|65843531|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
23576964|NCT01871285|65843532|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
23576965|NCT01871285|65843533|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
23576966|NCT01871285|65843534|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
23576967|NCT02391038|65843539|FG000|Overall Study|Progressive disease|3|||
23576968|NCT02391038|65843540|FG001|Overall Study|Progressive disease|3|||
23576969|NCT02391038|65843541|FG002|Overall Study|Progressive disease|6|||
23576970|NCT01115998|65843543|FG000|Overall Study|Lost to Follow-up|6|||
23576971|NCT01115998|65843544|FG001|Overall Study|Lost to Follow-up|6|||
23576972|NCT03704298|65843545|FG000|Overall Study|Death|3|||
23576973|NCT03704298|65843546|FG001|Overall Study|Death|1|||
23576974|NCT03704298|65843547|FG002|Overall Study|Death|1|||
23576975|NCT03704298|65843548|FG003|Overall Study|Death|0|||
23576976|NCT03704298|65843545|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
23576977|NCT03704298|65843546|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
23576978|NCT03704298|65843547|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
23576979|NCT03704298|65843548|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
23576980|NCT03704298|65843545|FG000|Overall Study|Withdrawal by Subject|1|||
23576981|NCT03704298|65843546|FG001|Overall Study|Withdrawal by Subject|0|||
23576982|NCT03704298|65843547|FG002|Overall Study|Withdrawal by Subject|0|||
23576983|NCT03704298|65843548|FG003|Overall Study|Withdrawal by Subject|0|||
23576984|NCT03704298|65843545|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576985|NCT03704298|65843546|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
23576986|NCT03704298|65843547|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576987|NCT03704298|65843548|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576988|NCT00593554|65843549|FG000|Overall Study|Death|1|||
23576989|NCT00593554|65843550|FG001|Overall Study|Death|2|||
23576990|NCT00593554|65843549|FG000|Overall Study|Physician Decision|0|||
23576991|NCT00593554|65843550|FG001|Overall Study|Physician Decision|1|||
23576992|NCT00593554|65843549|FG000|Overall Study|Withdrawal by Subject|1|||
23576993|NCT00593554|65843550|FG001|Overall Study|Withdrawal by Subject|0|||
23576994|NCT00593554|65843549|FG000|Overall Study|Disease Progression|1|||
23576995|NCT00593554|65843550|FG001|Overall Study|Disease Progression|2|||
23449570|NCT02510001|65388089|FG004|Overall Study|Withdrawal by Subject|0|||
23576996|NCT01256476|65843551|FG000|Overall Study|Adverse Event|2|||
23576997|NCT01256476|65843552|FG001|Overall Study|Adverse Event|1|||
23449571|NCT02510001|65388090|FG005|Overall Study|Withdrawal by Subject|0|||
23576998|NCT01256476|65843551|FG000|Overall Study|Withdrawal by Subject|2|||
23576999|NCT01256476|65843552|FG001|Overall Study|Withdrawal by Subject|1|||
23577000|NCT01256476|65843551|FG000|Overall Study|Lost to Follow-up|1|||
23577001|NCT01256476|65843552|FG001|Overall Study|Lost to Follow-up|2|||
23633903|NCT02628028|66045508|FG001|Dosing Period|Other|0|||
23633904|NCT02628028|66045509|FG002|Dosing Period|Other|0|||
23633905|NCT02628028|66045510|FG003|Dosing Period|Other|0|||
23633906|NCT02628028|66045511|FG004|Dosing Period|Other|2|||
23633907|NCT02628028|66045512|FG005|Dosing Period|Other|1|||
23633908|NCT02628028|66045513|FG006|Dosing Period|Other|2|||
23633909|NCT02628028|66045514|FG007|Dosing Period|Other|4|||
23633910|NCT02628028|66045507|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
23633911|NCT02628028|66045508|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
23633912|NCT02628028|66045509|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
23633913|NCT02628028|66045510|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
23633914|NCT02628028|66045511|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
23633915|NCT02628028|66045512|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
23633916|NCT02628028|66045513|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
23776706|NCT02924883|66563213|FG000|Overall Study|Progressive Disease|1|||
23776707|NCT02924883|66563214|FG001|Overall Study|Progressive Disease|0|||
23776708|NCT02924883|66563213|FG000|Overall Study|Study Terminated by Sponsor|69|||
23776709|NCT02924883|66563214|FG001|Overall Study|Study Terminated by Sponsor|32|||
23776710|NCT01042522|66563221|FG000|Overall Study|Adverse Event|1|||
23776711|NCT01042522|66563222|FG001|Overall Study|Adverse Event|2|||
23776712|NCT01042522|66563221|FG000|Overall Study|Disease Progression|5|||
23776713|NCT01042522|66563222|FG001|Overall Study|Disease Progression|0|||
23776714|NCT01042522|66563221|FG000|Overall Study|Death|1|||
23776715|NCT01042522|66563222|FG001|Overall Study|Death|0|||
23776716|NCT01042522|66563221|FG000|Overall Study|Patient Refused|0|||
23776717|NCT01042522|66563222|FG001|Overall Study|Patient Refused|3|||
23776718|NCT01042522|66563221|FG000|Overall Study|Withdrawal by Subject|1|||
23776719|NCT01042522|66563222|FG001|Overall Study|Withdrawal by Subject|1|||
23776720|NCT02457520|66563224|FG000|Active Treatment Phase|Adverse Event|10|||
23776721|NCT02457520|66563224|FG000|Active Treatment Phase|Lost to Follow-up|8|||
23776722|NCT02457520|66563224|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
23776723|NCT02457520|66563224|FG000|Active Treatment Phase|other|4|||
23633917|NCT02628028|66045514|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
23633918|NCT02628028|66045507|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23633919|NCT02628028|66045508|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23633920|NCT02628028|66045509|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23776724|NCT02457520|66563224|FG000|Active Treatment Phase|Physician Decision|1|||
23776725|NCT02457520|66563224|FG000|Active Treatment Phase|Protocol Violation|1|||
23776726|NCT02457520|66563224|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
23776727|NCT02457520|66563224|FG000|Post-treatment Period|Other: Retreatment Required|7|||
23776728|NCT02457520|66563224|FG000|Post-treatment Period|Lost to Follow-up|23|||
23633921|NCT02628028|66045510|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23633922|NCT02628028|66045511|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23633923|NCT02628028|66045512|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
23633924|NCT02628028|66045513|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23633925|NCT02628028|66045514|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
23633926|NCT02628028|66045507|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23633927|NCT02628028|66045508|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23633928|NCT02628028|66045509|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23776729|NCT02457520|66563224|FG000|Post-treatment Period|Other|3|||
23776730|NCT02457520|66563224|FG000|Post-treatment Period|Physician Decision|1|||
23776731|NCT02457520|66563224|FG000|Post-treatment Period|Withdrawal by Subject|14|||
23776732|NCT03693430|66563225|FG000|Overall Study|Lost to Follow-up|3|||
23776733|NCT03693430|66563226|FG001|Overall Study|Lost to Follow-up|14|||
23776734|NCT03693430|66563225|FG000|Overall Study|Death|1|||
23776735|NCT03693430|66563226|FG001|Overall Study|Death|0|||
23776736|NCT03693430|66563225|FG000|Overall Study|Withdrawal by Subject|0|||
23776737|NCT03693430|66563226|FG001|Overall Study|Withdrawal by Subject|4|||
23776738|NCT04885296|66563227|FG000|Period 1|Covid-19 Related|1|||
23776739|NCT04885296|66563228|FG001|Period 1|Covid-19 Related|0|||
23776740|NCT04885296|66563227|FG000|Period 1|Adverse Event|0|||
23776741|NCT04885296|66563228|FG001|Period 1|Adverse Event|1|||
23776742|NCT04885296|66563227|FG000|Period 1|Withdrawal by Subject|1|||
23776743|NCT04885296|66563228|FG001|Period 1|Withdrawal by Subject|1|||
23776744|NCT04885296|66563227|FG000|Period 1|Test Article No Longer Available|1|||
23776745|NCT04885296|66563228|FG001|Period 1|Test Article No Longer Available|0|||
23776746|NCT04885296|66563227|FG000|Period 1|Dispensed Study lens in Error|1|||
23776747|NCT04885296|66563228|FG001|Period 1|Dispensed Study lens in Error|0|||
23776748|NCT04885296|66563227|FG000|Period 1|Lost to Follow-up|1|||
23776749|NCT04885296|66563228|FG001|Period 1|Lost to Follow-up|0|||
23776750|NCT04885296|66563227|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23776751|NCT04885296|66563228|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23577002|NCT01256476|65843551|FG000|Overall Study|Persistent ALT or AST elevation|1|||
23577003|NCT01256476|65843552|FG001|Overall Study|Persistent ALT or AST elevation|0|||
23577004|NCT01256476|65843551|FG000|Overall Study|Physician Decision|0|||
23776752|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
23835293|NCT00757042|66777671|FG006|Overall Study|Lost to Follow-up|0|||
23835294|NCT00757042|66777672|FG007|Overall Study|Lost to Follow-up|0|||
23835295|NCT00757042|66777673|FG008|Overall Study|Lost to Follow-up|1|||
23577005|NCT01256476|65843552|FG001|Overall Study|Physician Decision|1|||
23577006|NCT01256476|65843551|FG000|Overall Study|Subject non-compliance|0|||
23577007|NCT01256476|65843552|FG001|Overall Study|Subject non-compliance|1|||
23577008|NCT01256476|65843551|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
23577009|NCT01256476|65843552|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
23577010|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
23577011|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
23577012|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
23577013|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
23577014|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
23577015|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
23577016|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
23577017|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
23577018|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
23577019|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
23577020|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
23577021|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
23577022|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
23577023|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
23633929|NCT02628028|66045510|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23835296|NCT00757042|66777674|FG009|Overall Study|Lost to Follow-up|0|||
23835297|NCT00757042|66777675|FG010|Overall Study|Lost to Follow-up|0|||
23835298|NCT00757042|66777665|FG000|Overall Study|Ineligibility Determined|0|||
23835299|NCT00757042|66777666|FG001|Overall Study|Ineligibility Determined|0|||
23835300|NCT00757042|66777667|FG002|Overall Study|Ineligibility Determined|0|||
23835301|NCT00757042|66777668|FG003|Overall Study|Ineligibility Determined|0|||
23835302|NCT00757042|66777669|FG004|Overall Study|Ineligibility Determined|0|||
23835303|NCT00757042|66777670|FG005|Overall Study|Ineligibility Determined|0|||
23633930|NCT02628028|66045511|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23633931|NCT02628028|66045512|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
23633932|NCT02628028|66045513|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
23835304|NCT00757042|66777671|FG006|Overall Study|Ineligibility Determined|0|||
23835305|NCT00757042|66777672|FG007|Overall Study|Ineligibility Determined|0|||
23835306|NCT00757042|66777673|FG008|Overall Study|Ineligibility Determined|0|||
23835307|NCT00757042|66777674|FG009|Overall Study|Ineligibility Determined|0|||
23835308|NCT00757042|66777675|FG010|Overall Study|Ineligibility Determined|1|||
23835309|NCT00757042|66777665|FG000|Overall Study|Withdrawal by Subject|0|||
23835310|NCT00757042|66777666|FG001|Overall Study|Withdrawal by Subject|0|||
23835311|NCT00757042|66777667|FG002|Overall Study|Withdrawal by Subject|0|||
23835312|NCT00757042|66777668|FG003|Overall Study|Withdrawal by Subject|0|||
23835313|NCT00757042|66777669|FG004|Overall Study|Withdrawal by Subject|0|||
23835314|NCT00757042|66777670|FG005|Overall Study|Withdrawal by Subject|0|||
23835315|NCT00757042|66777671|FG006|Overall Study|Withdrawal by Subject|0|||
23835316|NCT00757042|66777672|FG007|Overall Study|Withdrawal by Subject|0|||
23835317|NCT00757042|66777673|FG008|Overall Study|Withdrawal by Subject|0|||
23835318|NCT00757042|66777674|FG009|Overall Study|Withdrawal by Subject|1|||
23835319|NCT00757042|66777675|FG010|Overall Study|Withdrawal by Subject|0|||
23835320|NCT02576847|66777686|FG000|Overall Study|Adverse Event|27|||
23835321|NCT02576847|66777686|FG000|Overall Study|Lost to Follow-up|22|||
23835322|NCT02576847|66777686|FG000|Overall Study|Physician Decision|1|||
23835323|NCT02576847|66777686|FG000|Overall Study|Pregnancy|1|||
23835324|NCT02576847|66777686|FG000|Overall Study|Protocol Violation|3|||
23835325|NCT02576847|66777686|FG000|Overall Study|Withdrawal by Subject|78|||
23835326|NCT02576847|66777686|FG000|Overall Study|Other|5|||
23835327|NCT00789698|66777687|FG000|Overall Study|Lack of Efficacy|10|||
23835328|NCT00789698|66777688|FG001|Overall Study|Lack of Efficacy|4|||
23835329|NCT00789698|66777689|FG002|Overall Study|Lack of Efficacy|5|||
23835330|NCT00789698|66777690|FG003|Overall Study|Lack of Efficacy|18|||
23835331|NCT00789698|66777687|FG000|Overall Study|Adverse Event|5|||
23835332|NCT00789698|66777688|FG001|Overall Study|Adverse Event|5|||
23835333|NCT00789698|66777689|FG002|Overall Study|Adverse Event|3|||
23835334|NCT00789698|66777690|FG003|Overall Study|Adverse Event|4|||
23835335|NCT00789698|66777687|FG000|Overall Study|Lost to Follow-up|5|||
23835336|NCT00789698|66777688|FG001|Overall Study|Lost to Follow-up|5|||
23835337|NCT00789698|66777689|FG002|Overall Study|Lost to Follow-up|2|||
23835338|NCT00789698|66777690|FG003|Overall Study|Lost to Follow-up|9|||
23835339|NCT00789698|66777687|FG000|Overall Study|Protocol Violation|6|||
23835340|NCT00789698|66777688|FG001|Overall Study|Protocol Violation|1|||
23835341|NCT00789698|66777689|FG002|Overall Study|Protocol Violation|2|||
23835342|NCT00789698|66777690|FG003|Overall Study|Protocol Violation|1|||
23835343|NCT00789698|66777687|FG000|Overall Study|Withdrawal by Subject|14|||
23835344|NCT00789698|66777688|FG001|Overall Study|Withdrawal by Subject|15|||
23835345|NCT00789698|66777689|FG002|Overall Study|Withdrawal by Subject|12|||
23835346|NCT00789698|66777690|FG003|Overall Study|Withdrawal by Subject|19|||
23835347|NCT00789698|66777687|FG000|Overall Study|Administrative|0|||
23835348|NCT00789698|66777688|FG001|Overall Study|Administrative|3|||
23835349|NCT00789698|66777689|FG002|Overall Study|Administrative|3|||
23835350|NCT00789698|66777690|FG003|Overall Study|Administrative|1|||
23835351|NCT03319732|66777693|FG000|Overall Study|Adverse Event|40|||
23835352|NCT03319732|66777693|FG000|Overall Study|Withdrawal by Subject|50|||
23835353|NCT03319732|66777693|FG000|Overall Study|MS relapse|10|||
23835354|NCT03319732|66777693|FG000|Overall Study|reason not specified|5|||
23835355|NCT01139125|66777696|FG000|Overall Study|Withdrawal by Subject|1|||
23835356|NCT01894841|66777701|FG000|Overall Study|Withdrawal by Subject|9|||
23835357|NCT01894841|66777702|FG001|Overall Study|Withdrawal by Subject|4|||
23835358|NCT01894841|66777701|FG000|Overall Study|Withdrawn by investigator|2|||
23835359|NCT01894841|66777702|FG001|Overall Study|Withdrawn by investigator|2|||
23835360|NCT01894841|66777701|FG000|Overall Study|Lost to Follow-up|7|||
23835361|NCT01894841|66777702|FG001|Overall Study|Lost to Follow-up|3|||
23835362|NCT02095691|66777704|FG000|Overall Study|Physician Decision|1|||
23835363|NCT01051960|66777710|FG000|Overall Study|Adverse Event|1|||
23835364|NCT03588910|66777711|FG000|Overall Study|Withdrawal by Subject|1|||
23577024|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
23577025|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
23835365|NCT03588910|66777712|FG001|Overall Study|Withdrawal by Subject|0|||
23835366|NCT03588910|66777711|FG000|Overall Study|Allergy|2|||
23835367|NCT03588910|66777712|FG001|Overall Study|Allergy|0|||
23835368|NCT03588910|66777711|FG000|Overall Study|Protocol Violation|0|||
23835369|NCT03588910|66777712|FG001|Overall Study|Protocol Violation|3|||
23835370|NCT03588910|66777711|FG000|Overall Study|Did not complete Day 1 Survey|5|||
23835371|NCT03588910|66777712|FG001|Overall Study|Did not complete Day 1 Survey|10|||
23835372|NCT03588910|66777711|FG000|Overall Study|Did not complete Day 7 Survey|5|||
23835373|NCT03588910|66777712|FG001|Overall Study|Did not complete Day 7 Survey|2|||
23835374|NCT04227197|66777715|FG000|Randomization|Protocol Violation|1|||
23835375|NCT04227197|66777716|FG001|Randomization|Protocol Violation|0|||
23835376|NCT04227197|66777715|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
23835377|NCT04227197|66777716|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
23835378|NCT04227197|66777715|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
23835379|NCT04227197|66777716|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
23835380|NCT04227197|66777715|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
23835381|NCT04227197|66777716|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
23835382|NCT04227197|66777715|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
23835383|NCT04227197|66777716|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
23835384|NCT04227197|66777715|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
23835385|NCT04227197|66777716|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
23835386|NCT04227197|66777715|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
23835387|NCT04227197|66777716|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
23835388|NCT00171210|66777724|FG000|Overall Study|Adverse Event|16|||
23835389|NCT00171210|66777725|FG001|Overall Study|Adverse Event|27|||
23835390|NCT00171210|66777724|FG000|Overall Study|Abnormal laboratory value(s)|6|||
23835391|NCT00171210|66777725|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23835392|NCT00171210|66777724|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23835393|NCT00171210|66777725|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23835394|NCT00171210|66777724|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
23835395|NCT00171210|66777725|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
23835396|NCT00171210|66777724|FG000|Overall Study|Protocol Violation|0|||
23835397|NCT00171210|66777725|FG001|Overall Study|Protocol Violation|2|||
23835398|NCT00171210|66777724|FG000|Overall Study|Withdrawal by Subject|32|||
23835399|NCT00171210|66777725|FG001|Overall Study|Withdrawal by Subject|30|||
23835400|NCT00171210|66777724|FG000|Overall Study|Lost to Follow-up|1|||
23835401|NCT00171210|66777725|FG001|Overall Study|Lost to Follow-up|0|||
23835402|NCT00171210|66777724|FG000|Overall Study|Administrative problems|1|||
23835403|NCT00171210|66777725|FG001|Overall Study|Administrative problems|1|||
23835404|NCT00171210|66777724|FG000|Overall Study|Death|2|||
23835405|NCT00171210|66777725|FG001|Overall Study|Death|3|||
23577026|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
23577027|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
23577028|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
23835406|NCT00171210|66777724|FG000|Overall Study|Stopped at end of core|0|||
23835407|NCT00171210|66777725|FG001|Overall Study|Stopped at end of core|32|||
23835408|NCT00171210|66777724|FG000|Overall Study|Stopped at end of extension 1|0|||
23835409|NCT00171210|66777725|FG001|Overall Study|Stopped at end of extension 1|1|||
23835410|NCT05027451|66777726|FG000|Overall Study|Lost to Follow-up|1|||
23835411|NCT05027451|66777727|FG001|Overall Study|Lost to Follow-up|1|||
23835412|NCT04075682|66777728|FG000|Overall Study|Lost to Follow-up|5|||
23835413|NCT04075682|66777729|FG001|Overall Study|Lost to Follow-up|5|||
23835414|NCT04075682|66777730|FG002|Overall Study|Lost to Follow-up|2|||
23835415|NCT04075682|66777731|FG003|Overall Study|Lost to Follow-up|2|||
23835416|NCT04075682|66777728|FG000|Overall Study|Withdrawal by Subject|1|||
23835417|NCT04075682|66777729|FG001|Overall Study|Withdrawal by Subject|0|||
23835418|NCT04075682|66777730|FG002|Overall Study|Withdrawal by Subject|1|||
23835419|NCT04075682|66777731|FG003|Overall Study|Withdrawal by Subject|0|||
23835420|NCT04075682|66777728|FG000|Overall Study|Protocol Violation|0|||
23835421|NCT04075682|66777729|FG001|Overall Study|Protocol Violation|1|||
23835422|NCT04075682|66777730|FG002|Overall Study|Protocol Violation|1|||
23835423|NCT04075682|66777731|FG003|Overall Study|Protocol Violation|0|||
23835424|NCT04075682|66777728|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
23835425|NCT04075682|66777729|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
23835426|NCT04075682|66777730|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
23835427|NCT04075682|66777731|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
23835428|NCT04075682|66777728|FG000|Overall Study|Lost study phone the first day of study participation|0|||
23835429|NCT04075682|66777729|FG001|Overall Study|Lost study phone the first day of study participation|1|||
23835430|NCT04075682|66777730|FG002|Overall Study|Lost study phone the first day of study participation|0|||
23835431|NCT04075682|66777731|FG003|Overall Study|Lost study phone the first day of study participation|0|||
23835432|NCT00586820|66777732|FG000|Overall Study|Unsuccessful PCI|1|||
23835433|NCT00586820|66777733|FG001|Overall Study|Unsuccessful PCI|0|||
23835434|NCT00777296|66777734|FG000|Overall Study|Adverse Event|0|||
23835435|NCT00777296|66777735|FG001|Overall Study|Adverse Event|1|||
23835436|NCT00777296|66777736|FG002|Overall Study|Adverse Event|0|||
23835437|NCT00777296|66777737|FG003|Overall Study|Adverse Event|1|||
23835438|NCT00777296|66777734|FG000|Overall Study|Withdrawal by Subject|1|||
23835439|NCT00777296|66777735|FG001|Overall Study|Withdrawal by Subject|0|||
23835440|NCT00777296|66777736|FG002|Overall Study|Withdrawal by Subject|0|||
23835441|NCT00777296|66777737|FG003|Overall Study|Withdrawal by Subject|0|||
23835442|NCT00777296|66777734|FG000|Overall Study|CRF form not completed|0|||
23835443|NCT00777296|66777735|FG001|Overall Study|CRF form not completed|0|||
23835444|NCT00777296|66777736|FG002|Overall Study|CRF form not completed|2|||
23835445|NCT00777296|66777737|FG003|Overall Study|CRF form not completed|0|||
23835446|NCT00684411|66777738|FG000|Overall Study|New Primary Cancer|1|||
23835447|NCT00684411|66777738|FG000|Overall Study|Disease Progression|10|||
23835448|NCT00684411|66777738|FG000|Overall Study|Adverse Event|1|||
23835449|NCT01100086|66777742|FG000|Period 1|Withdrawal by Subject|1|||
23835450|NCT01100086|66777743|FG001|Period 1|Withdrawal by Subject|0|||
23835451|NCT01467713|66777744|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
23835452|NCT01467713|66777745|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23835453|NCT01467713|66777746|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23835454|NCT01467713|66777747|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
23835455|NCT01467713|66777744|FG000|Overall Study|Major Protocol Deviation|2|||
23835456|NCT01467713|66777745|FG001|Overall Study|Major Protocol Deviation|4|||
23835457|NCT01467713|66777746|FG002|Overall Study|Major Protocol Deviation|4|||
23835458|NCT01467713|66777747|FG003|Overall Study|Major Protocol Deviation|1|||
23835459|NCT01467713|66777744|FG000|Overall Study|Lost to Follow-up|9|||
23835460|NCT01467713|66777745|FG001|Overall Study|Lost to Follow-up|12|||
23835461|NCT01467713|66777746|FG002|Overall Study|Lost to Follow-up|6|||
23835462|NCT01467713|66777747|FG003|Overall Study|Lost to Follow-up|9|||
23835463|NCT01467713|66777744|FG000|Overall Study|Voluntary Withdrawal|18|||
23835464|NCT01467713|66777745|FG001|Overall Study|Voluntary Withdrawal|14|||
23835465|NCT01467713|66777746|FG002|Overall Study|Voluntary Withdrawal|21|||
23835466|NCT01467713|66777747|FG003|Overall Study|Voluntary Withdrawal|20|||
23835467|NCT01467713|66777744|FG000|Overall Study|Study Termination|23|||
23835468|NCT01467713|66777745|FG001|Overall Study|Study Termination|33|||
23835469|NCT01467713|66777746|FG002|Overall Study|Study Termination|28|||
23835470|NCT01467713|66777747|FG003|Overall Study|Study Termination|29|||
23835471|NCT01467713|66777744|FG000|Overall Study|Pregnancy|0|||
23835472|NCT01467713|66777745|FG001|Overall Study|Pregnancy|1|||
23835473|NCT01467713|66777746|FG002|Overall Study|Pregnancy|1|||
23835474|NCT01467713|66777747|FG003|Overall Study|Pregnancy|3|||
23633933|NCT02628028|66045514|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
23835475|NCT01467713|66777744|FG000|Overall Study|Relapse|35|||
23835476|NCT01467713|66777745|FG001|Overall Study|Relapse|25|||
23835477|NCT01467713|66777746|FG002|Overall Study|Relapse|28|||
23835478|NCT01467713|66777747|FG003|Overall Study|Relapse|35|||
23835479|NCT01467713|66777744|FG000|Overall Study|Reason not Specified|6|||
23835480|NCT01467713|66777745|FG001|Overall Study|Reason not Specified|11|||
23835481|NCT01467713|66777746|FG002|Overall Study|Reason not Specified|8|||
23835482|NCT01467713|66777747|FG003|Overall Study|Reason not Specified|7|||
23835483|NCT02275819|66777748|FG000|Overall Study|Adverse Event|0|||
23835484|NCT02275819|66777749|FG001|Overall Study|Adverse Event|1|||
23835485|NCT03473925|66777750|FG000|Overall Study|Death|48|||
23835486|NCT03473925|66777751|FG001|Overall Study|Death|44|||
23835487|NCT03473925|66777750|FG000|Overall Study|Sponsor Decision|2|||
23835488|NCT03473925|66777751|FG001|Overall Study|Sponsor Decision|7|||
23835489|NCT03473925|66777750|FG000|Overall Study|Withdrawal by Subject|1|||
23835490|NCT03473925|66777751|FG001|Overall Study|Withdrawal by Subject|3|||
23835491|NCT03473925|66777750|FG000|Overall Study|Not Treated|1|||
23835492|NCT03473925|66777751|FG001|Overall Study|Not Treated|1|||
23835493|NCT00891020|66777752|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
23835494|NCT00891020|66777753|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
23835495|NCT00891020|66777754|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
23835496|NCT00891020|66777752|FG000|24 Week Treatment Period|Death|0|||
23835497|NCT00891020|66777753|FG001|24 Week Treatment Period|Death|2|||
23835498|NCT00891020|66777754|FG002|24 Week Treatment Period|Death|0|||
23835499|NCT00891020|66777752|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
23835500|NCT00891020|66777753|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
23835501|NCT00891020|66777754|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
23835502|NCT00891020|66777752|FG000|24 Week Treatment Period|Failure to return|4|||
23835503|NCT00891020|66777753|FG001|24 Week Treatment Period|Failure to return|5|||
23835504|NCT00891020|66777754|FG002|24 Week Treatment Period|Failure to return|5|||
23835505|NCT00891020|66777752|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
23835506|NCT00891020|66777753|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
23835507|NCT00891020|66777754|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
23835508|NCT00891020|66777752|FG000|24 Week Treatment Period|Other protocol violation|1|||
23835509|NCT00891020|66777753|FG001|24 Week Treatment Period|Other protocol violation|1|||
23835510|NCT00891020|66777754|FG002|24 Week Treatment Period|Other protocol violation|2|||
23835511|NCT00891020|66777752|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
23835512|NCT00891020|66777753|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
23835513|NCT00891020|66777754|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
23835514|NCT00891020|66777752|FG000|24 Week Treatment Period|Withdrew consent|6|||
23633934|NCT02628028|66045507|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23633935|NCT02628028|66045508|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23633936|NCT02628028|66045509|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23633937|NCT02628028|66045510|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23835515|NCT00891020|66777753|FG001|24 Week Treatment Period|Withdrew consent|3|||
23835516|NCT00891020|66777754|FG002|24 Week Treatment Period|Withdrew consent|15|||
23835517|NCT00891020|66777752|FG000|24 Week Treatment Period|Administrative/Other|5|||
23449572|NCT02510001|65388091|FG006|Overall Study|Withdrawal by Subject|0|||
23449573|NCT02510001|65388092|FG007|Overall Study|Withdrawal by Subject|2|||
23449574|NCT00412893|65388096|FG000|Overall Study|Adverse Event|31|||
23449575|NCT00412893|65388097|FG001|Overall Study|Adverse Event|53|||
23449576|NCT00412893|65388096|FG000|Overall Study|Death|17|||
23449577|NCT00412893|65388097|FG001|Overall Study|Death|21|||
23449578|NCT00412893|65388096|FG000|Overall Study|Insufficient Therapeutic Response|39|||
23449579|NCT00412893|65388097|FG001|Overall Study|Insufficient Therapeutic Response|23|||
23449580|NCT00412893|65388096|FG000|Overall Study|Lost to Follow-up|2|||
23449581|NCT00412893|65388097|FG001|Overall Study|Lost to Follow-up|1|||
23449582|NCT00412893|65388096|FG000|Overall Study|Violation of Selection at Entry|17|||
23449583|NCT00412893|65388097|FG001|Overall Study|Violation of Selection at Entry|10|||
23449584|NCT00412893|65388096|FG000|Overall Study|Other Protocol Violation|10|||
23449585|NCT00412893|65388097|FG001|Overall Study|Other Protocol Violation|6|||
23449586|NCT00412893|65388096|FG000|Overall Study|Did Not Cooperate|12|||
23449587|NCT00412893|65388097|FG001|Overall Study|Did Not Cooperate|9|||
23449588|NCT00412893|65388096|FG000|Overall Study|Administrative Reason|12|||
23449589|NCT00412893|65388097|FG001|Overall Study|Administrative Reason|15|||
23449590|NCT00412893|65388096|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
23449591|NCT00412893|65388097|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
23449592|NCT00088530|65388098|FG000|Overall Study|Progressive/Relapsed Disease|28|||
23449593|NCT00088530|65388099|FG001|Overall Study|Progressive/Relapsed Disease|39|||
23449594|NCT00088530|65388098|FG000|Overall Study|Adverse Event|15|||
23449595|NCT00088530|65388099|FG001|Overall Study|Adverse Event|9|||
23449596|NCT00088530|65388098|FG000|Overall Study|Withdrawal by Subject|2|||
23449597|NCT00088530|65388099|FG001|Overall Study|Withdrawal by Subject|5|||
23449598|NCT00088530|65388098|FG000|Overall Study|Lost to Follow-up|2|||
23449599|NCT00088530|65388099|FG001|Overall Study|Lost to Follow-up|0|||
23449600|NCT00088530|65388098|FG000|Overall Study|Physician Decision|2|||
23449601|NCT00088530|65388099|FG001|Overall Study|Physician Decision|0|||
23449602|NCT00088530|65388098|FG000|Overall Study|Sponsor decision|0|||
23577029|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
23577030|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
23577031|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Other|2|||
23577032|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Other|0|||
23577033|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Other|1|||
23577034|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Adverse Event|21|||
23577035|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Adverse Event|26|||
23577036|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Adverse Event|0|||
23577037|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
23577038|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
23577039|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
23577040|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
23577041|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
23577042|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
23577043|NCT02718417|65843575|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
23577044|NCT02718417|65843576|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
23577045|NCT02718417|65843577|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
23577046|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Physician's decision|6|||
23577047|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Physician's decision|7|||
23577048|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Physician's decision|0|||
23577049|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Progressive disease|100|||
23577050|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Progressive disease|88|||
23577051|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Progressive disease|0|||
23577052|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Other|2|||
23577053|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Other|1|||
23577054|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Other|0|||
23577055|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
23577056|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
23577057|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
23577058|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
23577059|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
23577060|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
23577061|NCT02718417|65843575|FG000|Observation Phase (OP)|Adverse Event|0|||
23577062|NCT02718417|65843576|FG001|Observation Phase (OP)|Adverse Event|0|||
23577063|NCT02718417|65843577|FG002|Observation Phase (OP)|Adverse Event|1|||
23577064|NCT02718417|65843575|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
23449603|NCT00088530|65388099|FG001|Overall Study|Sponsor decision|1|||
23577065|NCT02718417|65843576|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
23577066|NCT02718417|65843577|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
23776753|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
23449604|NCT00088530|65388098|FG000|Overall Study|Patient never treated|1|||
23449605|NCT00088530|65388099|FG001|Overall Study|Patient never treated|0|||
23633938|NCT02628028|66045511|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23633939|NCT02628028|66045512|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
23633940|NCT02628028|66045513|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
23633941|NCT02628028|66045514|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
23633942|NCT02628028|66045507|FG000|Long-term Extension (LTE) Period|Other|0|||
23633943|NCT02628028|66045508|FG001|Long-term Extension (LTE) Period|Other|0|||
23633944|NCT02628028|66045509|FG002|Long-term Extension (LTE) Period|Other|0|||
23633945|NCT02628028|66045510|FG003|Long-term Extension (LTE) Period|Other|0|||
23633946|NCT02628028|66045511|FG004|Long-term Extension (LTE) Period|Other|0|||
23633947|NCT02628028|66045512|FG005|Long-term Extension (LTE) Period|Other|3|||
23633948|NCT02628028|66045513|FG006|Long-term Extension (LTE) Period|Other|4|||
23633949|NCT02628028|66045514|FG007|Long-term Extension (LTE) Period|Other|3|||
23633950|NCT01920477|66045515|FG000|Overall Study|Adverse Event|0|||
23633951|NCT01920477|66045516|FG001|Overall Study|Adverse Event|1|||
23633952|NCT01920477|66045515|FG000|Overall Study|Lack of Efficacy|1|||
23835518|NCT00891020|66777753|FG001|24 Week Treatment Period|Administrative/Other|6|||
23835519|NCT00891020|66777754|FG002|24 Week Treatment Period|Administrative/Other|1|||
23835520|NCT00891020|66777752|FG000|Long-term Extension Period|Adverse Event|1|||
23835521|NCT00891020|66777753|FG001|Long-term Extension Period|Adverse Event|11|||
23835522|NCT00891020|66777754|FG002|Long-term Extension Period|Adverse Event|10|||
23835523|NCT00891020|66777752|FG000|Long-term Extension Period|Death|0|||
23835524|NCT00891020|66777753|FG001|Long-term Extension Period|Death|0|||
23835525|NCT00891020|66777754|FG002|Long-term Extension Period|Death|1|||
23835526|NCT00891020|66777752|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
23835527|NCT00891020|66777753|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
23835528|NCT00891020|66777754|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
23449606|NCT00688259|65388105|FG000|Overall Study|Lost to Follow-up|2|||
23449607|NCT00688259|65388106|FG001|Overall Study|Lost to Follow-up|4|||
23449608|NCT00688259|65388105|FG000|Overall Study|Physician Decision|1|||
23449609|NCT00688259|65388106|FG001|Overall Study|Physician Decision|0|||
23449610|NCT00688259|65388105|FG000|Overall Study|Withdrawal by Subject|2|||
23449611|NCT00688259|65388106|FG001|Overall Study|Withdrawal by Subject|0|||
23449612|NCT00688259|65388105|FG000|Overall Study|Declined Interview|2|||
23449613|NCT00688259|65388106|FG001|Overall Study|Declined Interview|3|||
23449614|NCT00688259|65388105|FG000|Overall Study|Hospitalized at Follow-up|0|||
23449615|NCT00688259|65388106|FG001|Overall Study|Hospitalized at Follow-up|1|||
23449616|NCT00580723|65388110|FG000|Overall Study|Did not want to participate in extension|3|||
23449617|NCT00580723|65388110|FG000|Overall Study|Lost to Follow-up|5|||
23449618|NCT00628030|65388111|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
23449619|NCT00628030|65388112|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
23449620|NCT00628030|65388111|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
23449621|NCT00628030|65388112|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
23449622|NCT00628030|65388111|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
23449623|NCT00628030|65388112|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
23449624|NCT02336230|65388114|FG000|Overall Study|Adverse Event|1|||
23449625|NCT02336230|65388114|FG000|Overall Study|Withdrawal of consent|1|||
23449626|NCT02336230|65388114|FG000|Overall Study|Death|9|||
23449627|NCT02336230|65388114|FG000|Overall Study|Dose not received due to shipping delay|1|||
23449628|NCT02336230|65388114|FG000|Overall Study|Discontinuation of MSC infusion|1|||
23449629|NCT01410890|65388121|FG000|Overall Study|Withdrawal by Subject|0|||
23449630|NCT01410890|65388122|FG001|Overall Study|Withdrawal by Subject|1|||
23449631|NCT00615017|65388123|FG000|Overall Study|Adverse Event|0|||
23449632|NCT00615017|65388124|FG001|Overall Study|Adverse Event|1|||
23449633|NCT00615017|65388125|FG002|Overall Study|Adverse Event|2|||
23449634|NCT00615017|65388126|FG003|Overall Study|Adverse Event|0|||
23449635|NCT00615017|65388127|FG004|Overall Study|Adverse Event|0|||
23633953|NCT01920477|66045516|FG001|Overall Study|Lack of Efficacy|0|||
23633954|NCT01920477|66045515|FG000|Overall Study|Study closed/terminated|14|||
23633955|NCT01920477|66045516|FG001|Overall Study|Study closed/terminated|15|||
23449636|NCT00615017|65388128|FG005|Overall Study|Adverse Event|1|||
23449637|NCT00615017|65388123|FG000|Overall Study|Death|0|||
23449638|NCT00615017|65388124|FG001|Overall Study|Death|0|||
23633956|NCT01920477|66045515|FG000|Overall Study|Withdrawal by Subject|0|||
23835529|NCT00891020|66777752|FG000|Long-term Extension Period|Protocol Violation|0|||
23449639|NCT00615017|65388125|FG002|Overall Study|Death|2|||
23449640|NCT00615017|65388126|FG003|Overall Study|Death|0|||
23449641|NCT00615017|65388127|FG004|Overall Study|Death|1|||
23449642|NCT00615017|65388128|FG005|Overall Study|Death|1|||
23449643|NCT00615017|65388123|FG000|Overall Study|Sepsis resolved|0|||
23449644|NCT00615017|65388124|FG001|Overall Study|Sepsis resolved|0|||
23449645|NCT00615017|65388125|FG002|Overall Study|Sepsis resolved|1|||
23449646|NCT00615017|65388126|FG003|Overall Study|Sepsis resolved|0|||
23449647|NCT00615017|65388127|FG004|Overall Study|Sepsis resolved|0|||
23449648|NCT00615017|65388128|FG005|Overall Study|Sepsis resolved|0|||
23449649|NCT00615017|65388123|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
23449650|NCT00615017|65388124|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
23449651|NCT00615017|65388125|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
23449652|NCT00615017|65388126|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
23776754|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
23776755|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
23776756|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
23776757|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
23776758|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
23776759|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
23776760|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
23776761|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
23776762|NCT00056160|66563233|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
23776763|NCT00056160|66563234|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
23776764|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
23776765|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
23776766|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
23776767|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
23776768|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
23776769|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
23776770|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
23776771|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
23776772|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
23776773|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
23776774|NCT00056160|66563233|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
23776775|NCT00056160|66563234|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
23776776|NCT00056160|66563233|FG000|Final Follow-up|Transferred into expanded access study.|3|||
23835530|NCT00891020|66777753|FG001|Long-term Extension Period|Protocol Violation|1|||
23835531|NCT00891020|66777754|FG002|Long-term Extension Period|Protocol Violation|1|||
23835532|NCT00891020|66777752|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
23835533|NCT00891020|66777753|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
23835534|NCT00891020|66777754|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
23835535|NCT00891020|66777752|FG000|Long-term Extension Period|Failure to return|0|||
23835536|NCT00891020|66777753|FG001|Long-term Extension Period|Failure to return|2|||
23835537|NCT00891020|66777754|FG002|Long-term Extension Period|Failure to return|3|||
23835538|NCT00891020|66777752|FG000|Long-term Extension Period|Administrative|1|||
23835539|NCT00891020|66777753|FG001|Long-term Extension Period|Administrative|2|||
23835540|NCT00891020|66777754|FG002|Long-term Extension Period|Administrative|2|||
23835541|NCT02954601|66777755|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
23835542|NCT02954601|66777756|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
23835543|NCT02954601|66777757|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
23835544|NCT02954601|66777758|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
23835545|NCT01743560|66777761|FG000|Overall Study|Disease progression|26|||
23835546|NCT01743560|66777761|FG000|Overall Study|Adverse Event|8|||
23835547|NCT01743560|66777761|FG000|Overall Study|Death|3|||
23835548|NCT01743560|66777761|FG000|Overall Study|Withdrawal by Subject|2|||
23835549|NCT01743560|66777761|FG000|Overall Study|Protocol Violation|1|||
23835550|NCT01743560|66777761|FG000|Overall Study|>1 dose of study drug|3|||
23835551|NCT00984542|66777762|FG000|Overall Study|disease progression|19|||
23835552|NCT00984542|66777762|FG000|Overall Study|toxicity|7|||
23835553|NCT00984542|66777762|FG000|Overall Study|Death|7|||
23449653|NCT00615017|65388127|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
23449654|NCT00615017|65388128|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
23449655|NCT00615017|65388123|FG000|Overall Study|Physician discontinued drug|0|||
23449656|NCT00615017|65388124|FG001|Overall Study|Physician discontinued drug|0|||
23449657|NCT00615017|65388125|FG002|Overall Study|Physician discontinued drug|0|||
23449658|NCT00615017|65388126|FG003|Overall Study|Physician discontinued drug|0|||
23776777|NCT00056160|66563234|FG001|Final Follow-up|Transferred into expanded access study.|0|||
23835554|NCT00984542|66777762|FG000|Overall Study|complicating disease|3|||
23835555|NCT00984542|66777762|FG000|Overall Study|Withdrawal by Subject|3|||
23835556|NCT00984542|66777762|FG000|Overall Study|clinical deterioration|2|||
23835557|NCT00302328|66777763|FG000|Overall Study|Physician Decision|0|||
23835558|NCT00302328|66777764|FG001|Overall Study|Physician Decision|1|||
23449659|NCT00615017|65388127|FG004|Overall Study|Physician discontinued drug|0|||
23835559|NCT00302328|66777765|FG002|Overall Study|Physician Decision|0|||
23835560|NCT02748213|66777767|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
23835561|NCT02748213|66777768|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
23835562|NCT02748213|66777767|FG000|Overall Study|Abnormal Laboratory Test|1|||
23835563|NCT02748213|66777768|FG001|Overall Study|Abnormal Laboratory Test|0|||
23835564|NCT02748213|66777767|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
23835565|NCT02748213|66777768|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
23835566|NCT02748213|66777767|FG000|Overall Study|Death|5|||
23449660|NCT00615017|65388128|FG005|Overall Study|Physician discontinued drug|1|||
23835567|NCT02748213|66777768|FG001|Overall Study|Death|3|||
23449661|NCT00855959|65388129|FG000|Overall Study|Adverse Event|2|||
23577067|NCT02718417|65843575|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
23835568|NCT02748213|66777767|FG000|Overall Study|Insufficient Therapeutic Response|56|||
23835569|NCT02748213|66777768|FG001|Overall Study|Insufficient Therapeutic Response|57|||
23835570|NCT02748213|66777767|FG000|Overall Study|Violation of Selection Criteria|2|||
23835571|NCT02748213|66777768|FG001|Overall Study|Violation of Selection Criteria|0|||
23835572|NCT02748213|66777767|FG000|Overall Study|Protocol Violation|6|||
23835573|NCT02748213|66777768|FG001|Overall Study|Protocol Violation|4|||
23835574|NCT02748213|66777767|FG000|Overall Study|Refused Treatment*|6|||
23835575|NCT02748213|66777768|FG001|Overall Study|Refused Treatment*|6|||
23835576|NCT02748213|66777767|FG000|Overall Study|Failure to Return|1|||
23835577|NCT02748213|66777768|FG001|Overall Study|Failure to Return|0|||
23835578|NCT02748213|66777767|FG000|Overall Study|Other|30|||
23835579|NCT02748213|66777768|FG001|Overall Study|Other|29|||
23835580|NCT02522884|66777780|FG000|Overall Study|Withdrawal by Subject|6|||
23835581|NCT02522884|66777780|FG000|Overall Study|Death|3|||
23835582|NCT02522884|66777780|FG000|Overall Study|Missed 12-month Follow-up|9|||
23835583|NCT04013672|66777781|FG000|Overall Study|Withdrawal by Subject|3|||
23835584|NCT04013672|66777782|FG001|Overall Study|Withdrawal by Subject|0|||
23835585|NCT04013672|66777781|FG000|Overall Study|Death|1|||
23835586|NCT04013672|66777782|FG001|Overall Study|Death|0|||
23835587|NCT04013672|66777781|FG000|Overall Study|Physician Decision|5|||
23835588|NCT04013672|66777782|FG001|Overall Study|Physician Decision|0|||
23835589|NCT03349060|66777784|FG000|Overall Study|Adverse Event|9|||
23835590|NCT03349060|66777785|FG001|Overall Study|Adverse Event|9|||
23835591|NCT03349060|66777786|FG002|Overall Study|Adverse Event|7|||
23835592|NCT03349060|66777784|FG000|Overall Study|Lack of Efficacy|1|||
23835593|NCT03349060|66777785|FG001|Overall Study|Lack of Efficacy|0|||
23835594|NCT03349060|66777786|FG002|Overall Study|Lack of Efficacy|2|||
23835595|NCT03349060|66777784|FG000|Overall Study|Lost to Follow-up|2|||
23835596|NCT03349060|66777785|FG001|Overall Study|Lost to Follow-up|1|||
23835597|NCT03349060|66777786|FG002|Overall Study|Lost to Follow-up|1|||
23835598|NCT03349060|66777784|FG000|Overall Study|Protocol Violation|2|||
23835599|NCT03349060|66777785|FG001|Overall Study|Protocol Violation|2|||
23835600|NCT03349060|66777786|FG002|Overall Study|Protocol Violation|1|||
23835601|NCT03349060|66777784|FG000|Overall Study|Withdrawal by Subject|5|||
23835602|NCT03349060|66777785|FG001|Overall Study|Withdrawal by Subject|3|||
23835603|NCT03349060|66777786|FG002|Overall Study|Withdrawal by Subject|4|||
23835604|NCT03349060|66777784|FG000|Overall Study|Medication error,no linked adverse event|0|||
23835605|NCT03349060|66777785|FG001|Overall Study|Medication error,no linked adverse event|0|||
23835606|NCT03349060|66777786|FG002|Overall Study|Medication error,no linked adverse event|1|||
23835607|NCT03349060|66777784|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23835608|NCT03349060|66777785|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
23835609|NCT03349060|66777786|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
23835610|NCT03349060|66777784|FG000|Overall Study|Other|2|||
23835611|NCT03349060|66777785|FG001|Overall Study|Other|1|||
23835612|NCT03349060|66777786|FG002|Overall Study|Other|0|||
23835613|NCT00403481|66777787|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
23835614|NCT00403481|66777787|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
23577068|NCT02718417|65843576|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
23633957|NCT01920477|66045516|FG001|Overall Study|Withdrawal by Subject|1|||
23633958|NCT02979249|66045517|FG000|Overall Study|Lost to Follow-up|2|||
23633959|NCT02979249|66045517|FG000|Overall Study|Withdrawal by Subject|4|||
23633960|NCT00680992|66045518|FG000|Overall Study|Complete Resection (as per protocol)|25|||
23633961|NCT00680992|66045519|FG001|Overall Study|Complete Resection (as per protocol)|121|||
23633962|NCT00680992|66045520|FG002|Overall Study|Complete Resection (as per protocol)|0|||
23577069|NCT02718417|65843577|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
23577070|NCT02718417|65843575|FG000|Observation Phase (OP)|Physician Decision|0|||
23577071|NCT02718417|65843576|FG001|Observation Phase (OP)|Physician Decision|0|||
23577072|NCT02718417|65843577|FG002|Observation Phase (OP)|Physician Decision|9|||
23577073|NCT02718417|65843575|FG000|Observation Phase (OP)|Progressive disease|0|||
23577074|NCT02718417|65843576|FG001|Observation Phase (OP)|Progressive disease|0|||
23577075|NCT02718417|65843577|FG002|Observation Phase (OP)|Progressive disease|92|||
23577076|NCT02718417|65843575|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
23577077|NCT02718417|65843576|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
23577078|NCT02718417|65843577|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
23577079|NCT02718417|65843575|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
23633963|NCT00680992|66045518|FG000|Overall Study|Administrative Decision|83|||
23633964|NCT00680992|66045519|FG001|Overall Study|Administrative Decision|42|||
23633965|NCT00680992|66045520|FG002|Overall Study|Administrative Decision|5|||
23633966|NCT00680992|66045518|FG000|Overall Study|End of Trial|32|||
23633967|NCT00680992|66045519|FG001|Overall Study|End of Trial|12|||
23633968|NCT00680992|66045520|FG002|Overall Study|End of Trial|3|||
23633969|NCT00680992|66045518|FG000|Overall Study|Withdrawal by Subject|33|||
23633970|NCT00680992|66045519|FG001|Overall Study|Withdrawal by Subject|11|||
23633971|NCT00680992|66045520|FG002|Overall Study|Withdrawal by Subject|1|||
23633972|NCT00680992|66045518|FG000|Overall Study|Adverse Event|21|||
23633973|NCT00680992|66045519|FG001|Overall Study|Adverse Event|19|||
23633974|NCT00680992|66045520|FG002|Overall Study|Adverse Event|1|||
23835615|NCT00403481|66777787|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
23835616|NCT00403481|66777787|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
23835617|NCT00403481|66777787|FG000|Olm 40 mg|Adverse Event|2|||
23835618|NCT00403481|66777787|FG000|Olm 40 mg|Protocol Violation|1|||
23633975|NCT00680992|66045518|FG000|Overall Study|Other|19|||
23633976|NCT00680992|66045519|FG001|Overall Study|Other|14|||
23633977|NCT00680992|66045520|FG002|Overall Study|Other|1|||
23633978|NCT00680992|66045518|FG000|Overall Study|Disease Progression|21|||
23633979|NCT00680992|66045519|FG001|Overall Study|Disease Progression|9|||
23633980|NCT00680992|66045520|FG002|Overall Study|Disease Progression|0|||
23633981|NCT00680992|66045518|FG000|Overall Study|Lost to Follow-up|12|||
23633982|NCT00680992|66045519|FG001|Overall Study|Lost to Follow-up|14|||
23633983|NCT00680992|66045520|FG002|Overall Study|Lost to Follow-up|0|||
23633984|NCT00680992|66045518|FG000|Overall Study|Noncompliance|4|||
23633985|NCT00680992|66045519|FG001|Overall Study|Noncompliance|6|||
23633986|NCT00680992|66045520|FG002|Overall Study|Noncompliance|0|||
23633987|NCT00680992|66045518|FG000|Overall Study|Requirement for Alternative Therapy|8|||
23633988|NCT00680992|66045519|FG001|Overall Study|Requirement for Alternative Therapy|2|||
23633989|NCT00680992|66045520|FG002|Overall Study|Requirement for Alternative Therapy|0|||
23633990|NCT00680992|66045518|FG000|Overall Study|Pregnancy|5|||
23633991|NCT00680992|66045519|FG001|Overall Study|Pregnancy|0|||
23633992|NCT00680992|66045520|FG002|Overall Study|Pregnancy|1|||
23633993|NCT00680992|66045518|FG000|Overall Study|Death|5|||
23633994|NCT00680992|66045519|FG001|Overall Study|Death|1|||
23633995|NCT00680992|66045520|FG002|Overall Study|Death|0|||
23633996|NCT00680992|66045518|FG000|Overall Study|Ineligibility Determined|0|||
23633997|NCT00680992|66045519|FG001|Overall Study|Ineligibility Determined|1|||
23633998|NCT00680992|66045520|FG002|Overall Study|Ineligibility Determined|0|||
23633999|NCT00702962|66045521|FG000|Overall Study|Progressive disease|0|||
23634000|NCT00702962|66045522|FG001|Overall Study|Progressive disease|1|||
23634001|NCT00702962|66045521|FG000|Overall Study|Hospitalized for other health disorder|1|||
23634002|NCT00702962|66045522|FG001|Overall Study|Hospitalized for other health disorder|0|||
23634003|NCT01525238|66045523|FG000|Overall Study|Withdrawal by Subject|1|||
23634004|NCT01525238|66045524|FG001|Overall Study|Withdrawal by Subject|0|||
23634005|NCT01525238|66045525|FG002|Overall Study|Withdrawal by Subject|0|||
23634006|NCT03853551|66045526|FG000|Overall Study|Death|2|||
23835619|NCT00403481|66777787|FG000|Olm 40 mg|Withdrawal by Subject|1|||
23634007|NCT03853551|66045526|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
23634008|NCT04531098|66045527|FG000|Stage I|Adverse Event|0|||
23634009|NCT04531098|66045528|FG001|Stage I|Adverse Event|0|||
23634010|NCT04531098|66045529|FG002|Stage I|Adverse Event|3|||
23634011|NCT04531098|66045527|FG000|Stage I|Protocol Violation|0|||
23634012|NCT04531098|66045528|FG001|Stage I|Protocol Violation|0|||
23634013|NCT04531098|66045529|FG002|Stage I|Protocol Violation|5|||
23634014|NCT04531098|66045527|FG000|Stage I|Withdrawal by Subject|0|||
23835620|NCT00403481|66777787|FG000|Olm 40 mg|Other|1|||
23835621|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
23835622|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
23835623|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
23835624|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
23835625|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
23835626|NCT00403481|66777787|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
23835627|NCT00282113|66777788|FG000|Overall Study|Removed at parents request|1|||
23835628|NCT00282113|66777789|FG001|Overall Study|Removed at parents request|0|||
23835629|NCT00282113|66777790|FG002|Overall Study|Removed at parents request|0|||
23835630|NCT00078767|66777792|FG000|Overall Study|Withdrawal by Subject|1|||
23835631|NCT00078767|66777793|FG001|Overall Study|Withdrawal by Subject|1|||
23835632|NCT04938180|66777794|FG000|Overall Study|Adverse Event|1|||
23835633|NCT03682848|66777797|FG000|Overall Study|Withdrawal by Subject|2|||
23835634|NCT03682848|66777797|FG000|Overall Study|Site closed|5|||
23835635|NCT03682848|66777797|FG000|Overall Study|Protocol Deviation|1|||
23835636|NCT03682848|66777797|FG000|Overall Study|Adverse Event|1|||
23835637|NCT02097745|66777801|FG000|Overall Study|Adverse Event|25|||
23835638|NCT02097745|66777801|FG000|Overall Study|Death|16|||
23835639|NCT02097745|66777801|FG000|Overall Study|Failure to Return|14|||
23835640|NCT02097745|66777801|FG000|Overall Study|Administrative/Other|27|||
23835641|NCT02097745|66777801|FG000|Overall Study|Reason Not Specified|96|||
23835642|NCT01806051|66777802|FG000|Overall Study|Withdrawal by Subject|6|||
23835643|NCT04548193|66777806|FG000|Overall Study|Lost to Follow-up|0|||
23835644|NCT04548193|66777807|FG001|Overall Study|Lost to Follow-up|1|||
23835645|NCT04548193|66777806|FG000|Overall Study|Death|0|||
23835646|NCT04548193|66777807|FG001|Overall Study|Death|1|||
23835647|NCT04548193|66777806|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
23835648|NCT04548193|66777807|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
23835649|NCT04548193|66777806|FG000|Overall Study|Withdrawal by Subject|2|||
23835650|NCT04548193|66777807|FG001|Overall Study|Withdrawal by Subject|2|||
23835651|NCT04387435|66777808|FG000|Overall Study|Physician Decision|1|||
23835652|NCT00031590|66777809|FG000|Overall Study|Adverse Event|1|||
23835653|NCT00031590|66777809|FG000|Overall Study|Withdrawal by parents|2|||
23835654|NCT00030901|66777811|FG000|Initial Registration|Ineligible|167|||
23835655|NCT00030901|66777812|FG001|Initial Registration|Ineligible|0|||
23835656|NCT00030901|66777813|FG002|Initial Registration|Ineligible|0|||
23835657|NCT00030901|66777811|FG000|Randomization|Adverse Event|0|||
23835658|NCT00030901|66777812|FG001|Randomization|Adverse Event|11|||
23835659|NCT00030901|66777813|FG002|Randomization|Adverse Event|7|||
23835660|NCT00030901|66777811|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
23835661|NCT00030901|66777812|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
23835662|NCT00030901|66777813|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
23835663|NCT00030901|66777811|FG000|Randomization|Progression/Relapse|0|||
23835664|NCT00030901|66777812|FG001|Randomization|Progression/Relapse|22|||
23835665|NCT00030901|66777813|FG002|Randomization|Progression/Relapse|21|||
23835666|NCT00030901|66777811|FG000|Randomization|Death|0|||
23835667|NCT00030901|66777812|FG001|Randomization|Death|1|||
23835668|NCT00030901|66777813|FG002|Randomization|Death|3|||
23835669|NCT00030901|66777811|FG000|Randomization|Other|0|||
23835670|NCT00030901|66777812|FG001|Randomization|Other|36|||
23835671|NCT00030901|66777813|FG002|Randomization|Other|33|||
23835672|NCT00030901|66777811|FG000|Randomization|Ineligible|0|||
23835673|NCT00030901|66777812|FG001|Randomization|Ineligible|15|||
23835674|NCT00030901|66777813|FG002|Randomization|Ineligible|14|||
23835675|NCT04176250|66777814|FG000|Overall Study|Adverse Event|0|||
23835676|NCT04176250|66777815|FG001|Overall Study|Adverse Event|1|||
23835677|NCT04176250|66777816|FG002|Overall Study|Adverse Event|0|||
23835678|NCT04176250|66777817|FG003|Overall Study|Adverse Event|1|||
23776778|NCT00056160|66563233|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
23776779|NCT00056160|66563234|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
23776780|NCT00056160|66563233|FG000|Final Follow-up|Adverse Event|1|||
23776781|NCT00056160|66563234|FG001|Final Follow-up|Adverse Event|0|||
23776782|NCT02780687|66563235|FG000|Overall Study|Adverse Event|1|||
23776783|NCT02780687|66563236|FG001|Overall Study|Adverse Event|1|||
23776784|NCT02780687|66563235|FG000|Overall Study|Withdrawal by Subject|2|||
23776785|NCT02780687|66563236|FG001|Overall Study|Withdrawal by Subject|1|||
23776786|NCT02780687|66563235|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
23835679|NCT04176250|66777818|FG004|Overall Study|Adverse Event|0|||
23835680|NCT04176250|66777819|FG005|Overall Study|Adverse Event|1|||
23776787|NCT02780687|66563236|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
23835681|NCT04176250|66777814|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23835682|NCT04176250|66777815|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23835683|NCT04176250|66777816|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
23835684|NCT04176250|66777817|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
23835685|NCT04176250|66777818|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23835686|NCT04176250|66777819|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23835687|NCT04176250|66777814|FG000|Overall Study|Withdrawal by Subject|0|||
23835688|NCT04176250|66777815|FG001|Overall Study|Withdrawal by Subject|0|||
23835689|NCT04176250|66777816|FG002|Overall Study|Withdrawal by Subject|0|||
23835690|NCT04176250|66777817|FG003|Overall Study|Withdrawal by Subject|0|||
23835691|NCT04176250|66777818|FG004|Overall Study|Withdrawal by Subject|0|||
23835692|NCT04176250|66777819|FG005|Overall Study|Withdrawal by Subject|1|||
23835693|NCT04176250|66777814|FG000|Overall Study|Randomized in error|0|||
23835694|NCT04176250|66777815|FG001|Overall Study|Randomized in error|0|||
23835695|NCT04176250|66777816|FG002|Overall Study|Randomized in error|0|||
23835696|NCT04176250|66777817|FG003|Overall Study|Randomized in error|0|||
23835697|NCT04176250|66777818|FG004|Overall Study|Randomized in error|1|||
23835698|NCT04176250|66777819|FG005|Overall Study|Randomized in error|0|||
23835699|NCT00298272|66777820|FG000|Double-blind Phase|Adverse Event|2|||
23634015|NCT04531098|66045528|FG001|Stage I|Withdrawal by Subject|5|||
23634016|NCT04531098|66045529|FG002|Stage I|Withdrawal by Subject|10|||
23634017|NCT04531098|66045527|FG000|Stage II|Adverse Event|1|||
23634018|NCT04531098|66045528|FG001|Stage II|Adverse Event|2|||
23449662|NCT00855959|65388129|FG000|Overall Study|Lost to Follow-up|2|||
23634019|NCT04531098|66045529|FG002|Stage II|Adverse Event|0|||
23634020|NCT04531098|66045527|FG000|Stage II|Protocol Violation|1|||
23634021|NCT04531098|66045528|FG001|Stage II|Protocol Violation|2|||
23634022|NCT04531098|66045529|FG002|Stage II|Protocol Violation|0|||
23634023|NCT04531098|66045527|FG000|Stage II|Withdrawal by Subject|3|||
23634024|NCT04531098|66045528|FG001|Stage II|Withdrawal by Subject|1|||
23634025|NCT04531098|66045529|FG002|Stage II|Withdrawal by Subject|0|||
23634026|NCT04531098|66045527|FG000|Stage II|Moved from study area|8|||
23634027|NCT04531098|66045528|FG001|Stage II|Moved from study area|5|||
23634028|NCT04531098|66045529|FG002|Stage II|Moved from study area|0|||
23634029|NCT03015129|66045530|FG000|Overall Study|Death|2|||
23634030|NCT03015129|66045531|FG001|Overall Study|Death|2|||
23634031|NCT03015129|66045530|FG000|Overall Study|Lost to Follow-up|0|||
23634032|NCT03015129|66045531|FG001|Overall Study|Lost to Follow-up|1|||
23634033|NCT03015129|66045530|FG000|Overall Study|Progression of disease|38|||
23634034|NCT03015129|66045531|FG001|Overall Study|Progression of disease|33|||
23634035|NCT03015129|66045530|FG000|Overall Study|Adverse Event|0|||
23634036|NCT03015129|66045531|FG001|Overall Study|Adverse Event|4|||
23776788|NCT02780687|66563235|FG000|Overall Study|progressive disease|29|||
23776789|NCT02780687|66563236|FG001|Overall Study|progressive disease|6|||
23776790|NCT01496183|66563237|FG000|Overall Study|Physician Decision|3|||
23776791|NCT01496183|66563238|FG001|Overall Study|Physician Decision|1|||
23776792|NCT01496183|66563237|FG000|Overall Study|Withdrawal by Subject|0|||
23776793|NCT01496183|66563238|FG001|Overall Study|Withdrawal by Subject|1|||
23776794|NCT03616106|66563239|FG000|Overall Study|Removed by PI|6|||
23776795|NCT03616106|66563240|FG001|Overall Study|Removed by PI|0|||
23776796|NCT03616106|66563239|FG000|Overall Study|Withdrawal by Subject|1|||
23776797|NCT03616106|66563240|FG001|Overall Study|Withdrawal by Subject|1|||
23776798|NCT03616106|66563239|FG000|Overall Study|Lost to Follow-up|7|||
23776799|NCT03616106|66563240|FG001|Overall Study|Lost to Follow-up|0|||
23776800|NCT02193178|66563242|FG000|Overall Study|Lost to Follow-up|1|||
23776801|NCT02193178|66563242|FG000|Overall Study|Dry eyes|1|||
23776802|NCT01110005|66563243|FG000|Overall Study|ineligible|1|||
23776803|NCT01110005|66563244|FG001|Overall Study|ineligible|2|||
23449663|NCT00855959|65388129|FG000|Overall Study|Withdrawal by Subject|3|||
23634037|NCT00604825|66045532|FG000|Overall Study|Adverse Event|2|||
23634038|NCT00604825|66045533|FG001|Overall Study|Adverse Event|6|||
23634039|NCT00604825|66045534|FG002|Overall Study|Adverse Event|7|||
23776804|NCT01110005|66563243|FG000|Overall Study|missing consent|3|||
23776805|NCT01110005|66563244|FG001|Overall Study|missing consent|2|||
23776806|NCT01110005|66563243|FG000|Overall Study|Withdrawal by Subject|0|||
23577080|NCT02718417|65843576|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
23577081|NCT02718417|65843577|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
23577082|NCT02718417|65843575|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
23577083|NCT02718417|65843576|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
23577084|NCT02718417|65843577|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
23577085|NCT02718417|65843575|FG000|Observation Phase (OP)|Other|0|||
23577086|NCT02718417|65843576|FG001|Observation Phase (OP)|Other|0|||
23577087|NCT02718417|65843577|FG002|Observation Phase (OP)|Other|7|||
23577088|NCT02718417|65843575|FG000|Follow-up Phase|Adverse Event|3|||
23577089|NCT02718417|65843576|FG001|Follow-up Phase|Adverse Event|1|||
23577090|NCT02718417|65843577|FG002|Follow-up Phase|Adverse Event|1|||
23577091|NCT02718417|65843575|FG000|Follow-up Phase|Other|4|||
23577092|NCT02718417|65843576|FG001|Follow-up Phase|Other|6|||
23577093|NCT02718417|65843577|FG002|Follow-up Phase|Other|4|||
23776807|NCT01110005|66563244|FG001|Overall Study|Withdrawal by Subject|1|||
23776808|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
23776809|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
23776810|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
23776811|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
23776812|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
23776813|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
23577094|NCT02718417|65843575|FG000|Follow-up Phase|Withdrawal by Subject|19|||
23577095|NCT02718417|65843576|FG001|Follow-up Phase|Withdrawal by Subject|17|||
23776814|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
23776815|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
23776816|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
23776817|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
23776818|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
23776819|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
23776820|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
23776821|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
23776822|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
23776823|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
23776824|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
23776825|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
23776826|NCT01667679|66563247|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
23776827|NCT01667679|66563248|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
23776828|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
23835700|NCT00298272|66777821|FG001|Double-blind Phase|Adverse Event|0|||
23835701|NCT00298272|66777820|FG000|Double-blind Phase|Failure to Return|2|||
23835702|NCT00298272|66777821|FG001|Double-blind Phase|Failure to Return|0|||
23835703|NCT00298272|66777820|FG000|Double-blind Phase|Protocol Violation|2|||
23835704|NCT00298272|66777821|FG001|Double-blind Phase|Protocol Violation|0|||
23835705|NCT00298272|66777820|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23835706|NCT00298272|66777821|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23835707|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Adverse Event|1|||
23835708|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Adverse Event|2|||
23835709|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
23835710|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
23835711|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Failure to Return|1|||
23835712|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Failure to Return|0|||
23835713|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
23835714|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
23835715|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
23835716|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
23835717|NCT00298272|66777820|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
23835718|NCT00298272|66777821|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
23835719|NCT00298272|66777820|FG000|Safety Follow-up Phase|Failure to Return|1|||
23577096|NCT02718417|65843577|FG002|Follow-up Phase|Withdrawal by Subject|5|||
23577097|NCT02718417|65843575|FG000|Follow-up Phase|Study terminated by sponsor|100|||
23835720|NCT00298272|66777821|FG001|Safety Follow-up Phase|Failure to Return|1|||
23835721|NCT00298272|66777820|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
23835722|NCT00298272|66777821|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
23835723|NCT00298272|66777820|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
23835724|NCT00298272|66777821|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
23835725|NCT01831635|66777826|FG000|Overall Study|Withdrawal by Subject|0|||
23835726|NCT01831635|66777827|FG001|Overall Study|Withdrawal by Subject|2|||
23835727|NCT01831635|66777828|FG002|Overall Study|Withdrawal by Subject|0|||
23835728|NCT02019472|66777831|FG000|Overall Study|Adverse Event|14|||
23835729|NCT02019472|66777832|FG001|Overall Study|Adverse Event|23|||
23835730|NCT02019472|66777833|FG002|Overall Study|Adverse Event|17|||
23835731|NCT02019472|66777831|FG000|Overall Study|Death|0|||
23835732|NCT02019472|66777832|FG001|Overall Study|Death|1|||
23835733|NCT02019472|66777833|FG002|Overall Study|Death|1|||
23835734|NCT02019472|66777831|FG000|Overall Study|Lack of Efficacy|7|||
23449664|NCT00855959|65388129|FG000|Overall Study|Pregnancy|1|||
23449665|NCT00855959|65388129|FG000|Overall Study|Incorrect enrolment|1|||
23634040|NCT00604825|66045535|FG003|Overall Study|Adverse Event|4|||
23634041|NCT00604825|66045532|FG000|Overall Study|Lost to Follow-up|0|||
23776829|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
23776830|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
23776831|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
23776832|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
23776833|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
23634042|NCT00604825|66045533|FG001|Overall Study|Lost to Follow-up|3|||
23634043|NCT00604825|66045534|FG002|Overall Study|Lost to Follow-up|1|||
23634044|NCT00604825|66045535|FG003|Overall Study|Lost to Follow-up|0|||
23634045|NCT00604825|66045532|FG000|Overall Study|Protocol Violation|0|||
23634046|NCT00604825|66045533|FG001|Overall Study|Protocol Violation|1|||
23634047|NCT00604825|66045534|FG002|Overall Study|Protocol Violation|0|||
23634048|NCT00604825|66045535|FG003|Overall Study|Protocol Violation|0|||
23634049|NCT00604825|66045532|FG000|Overall Study|Withdrawal by Subject|4|||
23634050|NCT00604825|66045533|FG001|Overall Study|Withdrawal by Subject|3|||
23634051|NCT00604825|66045534|FG002|Overall Study|Withdrawal by Subject|5|||
23634052|NCT00604825|66045535|FG003|Overall Study|Withdrawal by Subject|5|||
23634053|NCT00604825|66045532|FG000|Overall Study|Lack of Efficacy|3|||
23634054|NCT00604825|66045533|FG001|Overall Study|Lack of Efficacy|2|||
23634055|NCT00604825|66045534|FG002|Overall Study|Lack of Efficacy|1|||
23634056|NCT00604825|66045535|FG003|Overall Study|Lack of Efficacy|0|||
23634057|NCT00604825|66045532|FG000|Overall Study|Did not meet eligibility criteria|0|||
23634058|NCT00604825|66045533|FG001|Overall Study|Did not meet eligibility criteria|0|||
23634059|NCT00604825|66045534|FG002|Overall Study|Did not meet eligibility criteria|2|||
23634060|NCT00604825|66045535|FG003|Overall Study|Did not meet eligibility criteria|0|||
23634061|NCT00604825|66045532|FG000|Overall Study|Physician Decision|0|||
23634062|NCT00604825|66045533|FG001|Overall Study|Physician Decision|0|||
23634063|NCT00604825|66045534|FG002|Overall Study|Physician Decision|0|||
23634064|NCT00604825|66045535|FG003|Overall Study|Physician Decision|1|||
23634065|NCT00604825|66045532|FG000|Overall Study|Exclusion criterion met|0|||
23634066|NCT00604825|66045533|FG001|Overall Study|Exclusion criterion met|0|||
23634067|NCT00604825|66045534|FG002|Overall Study|Exclusion criterion met|0|||
23634068|NCT00604825|66045535|FG003|Overall Study|Exclusion criterion met|1|||
23776834|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
23776835|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
23776836|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
23776837|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
23776838|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
23776839|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
23634069|NCT00607724|66045536|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
23634070|NCT00607724|66045537|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
23776840|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
23776841|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
23835735|NCT02019472|66777832|FG001|Overall Study|Lack of Efficacy|4|||
23835736|NCT02019472|66777833|FG002|Overall Study|Lack of Efficacy|4|||
23634071|NCT00607724|66045538|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
23634072|NCT00607724|66045539|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23634073|NCT00607724|66045540|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23634074|NCT00607724|66045541|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23634075|NCT00607724|66045542|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23634076|NCT00607724|66045536|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
23634077|NCT00607724|66045537|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
23634078|NCT00607724|66045538|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
23776842|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
23776843|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
23776844|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
23776845|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
23776846|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
23776847|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
23776848|NCT01667679|66563247|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
23776849|NCT01667679|66563248|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
23776850|NCT03595657|66563249|FG000|Overall Study|Adverse Event|14|||
23776851|NCT03595657|66563249|FG000|Overall Study|Death|1|||
23776852|NCT03595657|66563249|FG000|Overall Study|Lack of Efficacy|40|||
23776853|NCT03595657|66563249|FG000|Overall Study|Withdrawal by Subject|10|||
23776854|NCT03595657|66563249|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
23776855|NCT03595657|66563249|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
23634079|NCT00607724|66045539|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
23634080|NCT00607724|66045540|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
23634081|NCT00607724|66045541|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
23776856|NCT03136380|66563250|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23634082|NCT00607724|66045542|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
23449666|NCT01392547|65388132|FG000|Overall Study|Adverse Event|2|||
23577098|NCT02718417|65843576|FG001|Follow-up Phase|Study terminated by sponsor|138|||
23577099|NCT02718417|65843577|FG002|Follow-up Phase|Study terminated by sponsor|6|||
23577100|NCT02718417|65843575|FG000|Follow-up Phase|Lost to Follow-up|2|||
23577101|NCT02718417|65843576|FG001|Follow-up Phase|Lost to Follow-up|3|||
23577102|NCT02718417|65843577|FG002|Follow-up Phase|Lost to Follow-up|0|||
23577103|NCT02718417|65843575|FG000|Follow-up Phase|Death leading to discontinuation|7|||
23577104|NCT02718417|65843576|FG001|Follow-up Phase|Death leading to discontinuation|7|||
23577105|NCT02718417|65843577|FG002|Follow-up Phase|Death leading to discontinuation|3|||
23577106|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
23577107|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
23577108|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
23577109|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
23577110|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
23577111|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
23577112|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
23577113|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
23577114|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
23577115|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
23577116|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
23577117|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
23577118|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Other|0|||
23577119|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Other|2|||
23577120|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Other|0|||
23577121|NCT00231894|65843595|FG000|Overall Study|Withdrawal by Subject|1|||
23577122|NCT00231894|65843596|FG001|Overall Study|Withdrawal by Subject|1|||
23577123|NCT00439179|65843601|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577124|NCT00439179|65843602|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
23577125|NCT00439179|65843603|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577126|NCT00439179|65843604|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577127|NCT02325713|65843630|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577128|NCT02325713|65843631|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577129|NCT02325713|65843632|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577130|NCT02325713|65843633|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577131|NCT02325713|65843634|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577132|NCT02325713|65843635|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577133|NCT02325713|65843636|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577134|NCT02325713|65843637|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577135|NCT02325713|65843638|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577136|NCT02325713|65843639|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577137|NCT02325713|65843640|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
23577138|NCT02325713|65843641|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577139|NCT02325713|65843642|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577140|NCT02325713|65843643|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577141|NCT02325713|65843644|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577142|NCT02325713|65843645|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23776857|NCT03136380|66563251|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
23776858|NCT03136380|66563252|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23776859|NCT03136380|66563253|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23449667|NCT01392547|65388132|FG000|Overall Study|Non-compliance|2|||
23449668|NCT01392547|65388132|FG000|Overall Study|Withdrawal criteria|3|||
23577143|NCT02325713|65843630|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
23577144|NCT02325713|65843631|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577145|NCT02325713|65843632|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23634083|NCT00607724|66045536|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23634084|NCT00607724|66045537|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23634085|NCT00607724|66045538|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23634086|NCT00607724|66045539|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
23634087|NCT00607724|66045540|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
23634088|NCT00607724|66045541|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
23634089|NCT00607724|66045542|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
23634090|NCT00607724|66045536|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
23634091|NCT00607724|66045537|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
23634092|NCT00607724|66045538|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
23634093|NCT00607724|66045539|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
23634094|NCT00607724|66045540|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
23634095|NCT00607724|66045541|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
23634096|NCT00607724|66045542|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
23634097|NCT00607724|66045536|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23634098|NCT00607724|66045537|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23577146|NCT02325713|65843633|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577147|NCT02325713|65843634|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577148|NCT02325713|65843635|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577149|NCT02325713|65843636|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577150|NCT02325713|65843637|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577151|NCT02325713|65843638|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577152|NCT02325713|65843639|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577153|NCT02325713|65843640|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577154|NCT02325713|65843641|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577155|NCT02325713|65843642|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577156|NCT02325713|65843643|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577157|NCT02325713|65843644|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577158|NCT02325713|65843645|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577159|NCT02325713|65843630|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577160|NCT02325713|65843631|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577161|NCT02325713|65843632|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577162|NCT02325713|65843633|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577163|NCT02325713|65843634|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577164|NCT02325713|65843635|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23634099|NCT00607724|66045538|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23634100|NCT00607724|66045539|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
23634101|NCT00607724|66045540|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23634102|NCT00607724|66045541|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23634103|NCT00607724|66045542|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23776860|NCT03136380|66563254|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23776861|NCT00863746|66563255|FG000|Treatment|Not treated|4|||
23776862|NCT00863746|66563256|FG001|Treatment|Not treated|2|||
23776863|NCT00863746|66563255|FG000|Treatment|Adverse Event|41|||
23776864|NCT00863746|66563256|FG001|Treatment|Adverse Event|16|||
23776865|NCT00863746|66563255|FG000|Treatment|non-compliant with study medication|4|||
23776866|NCT00863746|66563256|FG001|Treatment|non-compliant with study medication|0|||
23835737|NCT02019472|66777831|FG000|Overall Study|Lost to Follow-up|0|||
23835738|NCT02019472|66777832|FG001|Overall Study|Lost to Follow-up|2|||
23835739|NCT02019472|66777833|FG002|Overall Study|Lost to Follow-up|1|||
23835740|NCT02019472|66777831|FG000|Overall Study|Physician Decision|1|||
23835741|NCT02019472|66777832|FG001|Overall Study|Physician Decision|2|||
23835742|NCT02019472|66777833|FG002|Overall Study|Physician Decision|0|||
23835743|NCT02019472|66777831|FG000|Overall Study|Pregnancy|1|||
23835744|NCT02019472|66777832|FG001|Overall Study|Pregnancy|2|||
23835745|NCT02019472|66777833|FG002|Overall Study|Pregnancy|2|||
23835746|NCT02019472|66777831|FG000|Overall Study|Withdrawal by Subject|11|||
23835747|NCT02019472|66777832|FG001|Overall Study|Withdrawal by Subject|10|||
23835748|NCT02019472|66777833|FG002|Overall Study|Withdrawal by Subject|11|||
23835749|NCT02019472|66777831|FG000|Overall Study|Other|3|||
23835750|NCT02019472|66777832|FG001|Overall Study|Other|8|||
23835751|NCT02019472|66777833|FG002|Overall Study|Other|6|||
23835752|NCT00628212|66777838|FG000|Overall Study|Adverse Event|2|||
23835753|NCT00628212|66777839|FG001|Overall Study|Adverse Event|0|||
23835754|NCT00628212|66777840|FG002|Overall Study|Adverse Event|1|||
23835755|NCT00628212|66777841|FG003|Overall Study|Adverse Event|2|||
23835756|NCT00628212|66777838|FG000|Overall Study|Physician Decision|1|||
23835757|NCT00628212|66777839|FG001|Overall Study|Physician Decision|1|||
23835758|NCT00628212|66777840|FG002|Overall Study|Physician Decision|2|||
23835759|NCT00628212|66777841|FG003|Overall Study|Physician Decision|3|||
23835760|NCT02626026|66777842|FG000|Overall Study|Randomized but Never Treated|0|||
23835761|NCT02626026|66777843|FG001|Overall Study|Randomized but Never Treated|0|||
23835762|NCT02626026|66777844|FG002|Overall Study|Randomized but Never Treated|0|||
23835763|NCT02626026|66777845|FG003|Overall Study|Randomized but Never Treated|0|||
23835764|NCT02626026|66777846|FG004|Overall Study|Randomized but Never Treated|1|||
23835765|NCT02626026|66777847|FG005|Overall Study|Randomized but Never Treated|0|||
23835766|NCT00523848|66777849|FG000|Overall Study|Adverse Event|11|||
23835767|NCT00523848|66777849|FG000|Overall Study|Withdrawal by Subject|2|||
23835768|NCT00523848|66777849|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
23835769|NCT00523848|66777849|FG000|Overall Study|Disease Progression|5|||
23835770|NCT00523848|66777849|FG000|Overall Study|Other, unspecified|4|||
23835771|NCT02968173|66777850|FG000|Overall Study|Withdrawal by Subject|1|||
23835772|NCT01256450|66777851|FG000|Open-label Titration|Adverse Event|39|||
23835773|NCT01256450|66777852|FG001|Open-label Titration|Adverse Event|0|||
23835774|NCT01256450|66777853|FG002|Open-label Titration|Adverse Event|0|||
23835775|NCT01256450|66777851|FG000|Open-label Titration|Lost to Follow-up|7|||
23835776|NCT01256450|66777852|FG001|Open-label Titration|Lost to Follow-up|0|||
23835777|NCT01256450|66777853|FG002|Open-label Titration|Lost to Follow-up|0|||
23835778|NCT01256450|66777851|FG000|Open-label Titration|Lack of analgesic effect|30|||
23835779|NCT01256450|66777852|FG001|Open-label Titration|Lack of analgesic effect|0|||
23835780|NCT01256450|66777853|FG002|Open-label Titration|Lack of analgesic effect|0|||
23835781|NCT01256450|66777851|FG000|Open-label Titration|Non-compliance|9|||
23835782|NCT01256450|66777852|FG001|Open-label Titration|Non-compliance|0|||
23835783|NCT01256450|66777853|FG002|Open-label Titration|Non-compliance|0|||
23835784|NCT01256450|66777851|FG000|Open-label Titration|Screen failure|1|||
23835785|NCT01256450|66777852|FG001|Open-label Titration|Screen failure|0|||
23835786|NCT01256450|66777853|FG002|Open-label Titration|Screen failure|0|||
23835787|NCT01256450|66777851|FG000|Open-label Titration|Other|13|||
23835788|NCT01256450|66777852|FG001|Open-label Titration|Other|0|||
23835789|NCT01256450|66777853|FG002|Open-label Titration|Other|0|||
23835790|NCT01256450|66777851|FG000|Double-blind Treatment|Adverse Event|0|||
23835791|NCT01256450|66777852|FG001|Double-blind Treatment|Adverse Event|8|||
23835792|NCT01256450|66777853|FG002|Double-blind Treatment|Adverse Event|6|||
23835793|NCT01256450|66777851|FG000|Double-blind Treatment|Lost to Follow-up|0|||
23835794|NCT01256450|66777852|FG001|Double-blind Treatment|Lost to Follow-up|1|||
23835795|NCT01256450|66777853|FG002|Double-blind Treatment|Lost to Follow-up|7|||
23835796|NCT01256450|66777851|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
23835797|NCT01256450|66777852|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
23835798|NCT01256450|66777853|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
23835799|NCT01256450|66777851|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
23835800|NCT01256450|66777852|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
23835801|NCT01256450|66777853|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
23835802|NCT01256450|66777851|FG000|Double-blind Treatment|Non-compliance|0|||
23835803|NCT01256450|66777852|FG001|Double-blind Treatment|Non-compliance|5|||
23835804|NCT01256450|66777853|FG002|Double-blind Treatment|Non-compliance|4|||
23835805|NCT01256450|66777851|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
23835806|NCT01256450|66777852|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
23835807|NCT01256450|66777853|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
23835808|NCT01256450|66777851|FG000|Double-blind Treatment|Other|0|||
23835809|NCT01256450|66777852|FG001|Double-blind Treatment|Other|9|||
23835810|NCT01256450|66777853|FG002|Double-blind Treatment|Other|12|||
23835811|NCT00162981|66777854|FG000|Overall Study|Adverse Event|2|||
23835812|NCT00162981|66777855|FG001|Overall Study|Adverse Event|5|||
23835813|NCT00162981|66777854|FG000|Overall Study|Withdrawal by Subject|1|||
23835814|NCT00162981|66777855|FG001|Overall Study|Withdrawal by Subject|1|||
23835815|NCT00162981|66777854|FG000|Overall Study|Physician Decision|1|||
23835816|NCT00162981|66777855|FG001|Overall Study|Physician Decision|0|||
23835817|NCT02572570|66777856|FG000|Overall Study|Study Terminated|27|||
23835818|NCT05966584|66777857|FG000|Overall Study|Lost to Follow-up|1|||
23835819|NCT01209949|66777858|FG000|Overall Study|Lost to Follow-up|3|||
23835820|NCT01321749|66777859|FG000|Overall Study|Lost to Follow-up|4|||
23577165|NCT02325713|65843636|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577166|NCT02325713|65843637|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577167|NCT02325713|65843638|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577168|NCT02325713|65843639|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
23577169|NCT02325713|65843640|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577170|NCT02325713|65843641|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577171|NCT02325713|65843642|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577172|NCT02325713|65843643|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577173|NCT02325713|65843644|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577174|NCT02325713|65843645|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577175|NCT02320721|65843646|FG000|Overall Study|Adverse Event|6|||
23577176|NCT02320721|65843647|FG001|Overall Study|Adverse Event|6|||
23577177|NCT02320721|65843646|FG000|Overall Study|Lack of Efficacy|2|||
23577178|NCT02320721|65843647|FG001|Overall Study|Lack of Efficacy|0|||
23577179|NCT02320721|65843646|FG000|Overall Study|Poor compliance to protocol|3|||
23577180|NCT02320721|65843647|FG001|Overall Study|Poor compliance to protocol|7|||
23577181|NCT02320721|65843646|FG000|Overall Study|Randomized but not treated|0|||
23577182|NCT02320721|65843647|FG001|Overall Study|Randomized but not treated|1|||
23577183|NCT02320721|65843646|FG000|Overall Study|Hypoglycemia|1|||
23577184|NCT02320721|65843647|FG001|Overall Study|Hypoglycemia|0|||
23577185|NCT02320721|65843646|FG000|Overall Study|Other than specified above|15|||
23577186|NCT02320721|65843647|FG001|Overall Study|Other than specified above|20|||
23577187|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Adverse Event|5|||
23577188|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Adverse Event|13|||
23577189|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Adverse Event|0|||
23577190|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
23577191|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
23835821|NCT01321749|66777860|FG001|Overall Study|Lost to Follow-up|11|||
23835822|NCT01321749|66777859|FG000|Overall Study|Protocol Violation|4|||
23835823|NCT01321749|66777860|FG001|Overall Study|Protocol Violation|7|||
23835824|NCT01321749|66777859|FG000|Overall Study|Withdrawal by Subject|5|||
23835825|NCT01321749|66777860|FG001|Overall Study|Withdrawal by Subject|4|||
23835826|NCT01557504|66777862|FG000|Overall Study|Physician Decision|1|||
23835827|NCT01557504|66777863|FG001|Overall Study|Physician Decision|0|||
23835828|NCT03866512|66777864|FG000|Overall Study|Lost to Follow-up|1|||
23835829|NCT03866512|66777865|FG001|Overall Study|Lost to Follow-up|2|||
23835830|NCT03866512|66777866|FG002|Overall Study|Lost to Follow-up|1|||
23835831|NCT03866512|66777864|FG000|Overall Study|Cannulation issues|0|||
23449669|NCT01392547|65388132|FG000|Overall Study|Unclassified|1|||
23449670|NCT01076959|65388136|FG000|Overall Study|Adverse Event|767|||
23449671|NCT01076959|65388136|FG000|Overall Study|Lack of Efficacy|849|||
23449672|NCT01076959|65388136|FG000|Overall Study|Non-compliance|274|||
23449673|NCT01076959|65388136|FG000|Overall Study|Lost to Follow-up|241|||
23449674|NCT01076959|65388136|FG000|Overall Study|Other|119|||
23449675|NCT02420379|65388137|FG000|Overall Study|Withdrawal by Subject|0|||
23577192|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
23577193|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
23577194|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
23577195|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
23835832|NCT03866512|66777865|FG001|Overall Study|Cannulation issues|1|||
23835833|NCT03866512|66777866|FG002|Overall Study|Cannulation issues|2|||
23835834|NCT01483027|66777867|FG000|Overall Study|Administrative Reasons|2|||
23835835|NCT01483027|66777868|FG001|Overall Study|Administrative Reasons|1|||
23835836|NCT01483027|66777867|FG000|Overall Study|Withdrawal by Subject|21|||
23577196|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
23577197|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
23577198|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
23577199|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
23577200|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
23577201|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
23577202|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23577203|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
23577204|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
23577205|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Physician Decision|2|||
23577206|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Physician Decision|3|||
23577207|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Physician Decision|0|||
23577208|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
23577209|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
23577210|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
23577211|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
23577212|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
23577213|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
23577214|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
23634104|NCT04458922|66045547|FG000|Overall Study|Withdrawal by Subject|1|||
23634105|NCT04458922|66045548|FG001|Overall Study|Withdrawal by Subject|0|||
23634106|NCT04458922|66045549|FG002|Overall Study|Withdrawal by Subject|2|||
23634107|NCT04458922|66045547|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
23634108|NCT04458922|66045548|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
23634109|NCT04458922|66045549|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
23634110|NCT04458922|66045547|FG000|Overall Study|Adverse Event|1|||
23634111|NCT04458922|66045548|FG001|Overall Study|Adverse Event|0|||
23634112|NCT04458922|66045549|FG002|Overall Study|Adverse Event|0|||
23634113|NCT04458922|66045547|FG000|Overall Study|Started new study|0|||
23634114|NCT04458922|66045548|FG001|Overall Study|Started new study|0|||
23634115|NCT04458922|66045549|FG002|Overall Study|Started new study|1|||
23634116|NCT04458922|66045547|FG000|Overall Study|Progressive disease|6|||
23634117|NCT04458922|66045548|FG001|Overall Study|Progressive disease|8|||
23634118|NCT04458922|66045549|FG002|Overall Study|Progressive disease|2|||
23634119|NCT04458922|66045547|FG000|Overall Study|Death|1|||
23634120|NCT04458922|66045548|FG001|Overall Study|Death|0|||
23634121|NCT04458922|66045549|FG002|Overall Study|Death|2|||
23634122|NCT04458922|66045547|FG000|Overall Study|Participant started chemotherapy|0|||
23634123|NCT04458922|66045548|FG001|Overall Study|Participant started chemotherapy|1|||
23776867|NCT00863746|66563255|FG000|Treatment|Consent withdrawn|15|||
23776868|NCT00863746|66563256|FG001|Treatment|Consent withdrawn|14|||
23776869|NCT00863746|66563255|FG000|Treatment|Lost to Follow-up|1|||
23776870|NCT00863746|66563256|FG001|Treatment|Lost to Follow-up|0|||
23776871|NCT00863746|66563255|FG000|Treatment|Protocol Violation|5|||
23776872|NCT00863746|66563256|FG001|Treatment|Protocol Violation|3|||
23776873|NCT00863746|66563255|FG000|Treatment|Other|1|||
23776874|NCT00863746|66563256|FG001|Treatment|Other|0|||
23776875|NCT00863746|66563255|FG000|Survival Follow up|Death|244|||
23835837|NCT01483027|66777868|FG001|Overall Study|Withdrawal by Subject|32|||
23835838|NCT01483027|66777867|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
23835839|NCT01483027|66777868|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
23835840|NCT01483027|66777867|FG000|Overall Study|Lost to Follow-up|1|||
23634124|NCT04458922|66045549|FG002|Overall Study|Participant started chemotherapy|0|||
23634125|NCT03149042|66045550|FG000|Overall Study|Invasive FFR not performed|21|||
23634126|NCT03149042|66045550|FG000|Overall Study|Poor CT Image Quality|1|||
23634127|NCT03149042|66045550|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
23634128|NCT05262517|66045555|FG000|Overall Study|Randomized but not treated|5|||
23776876|NCT00863746|66563256|FG001|Survival Follow up|Death|271|||
23776877|NCT00863746|66563255|FG000|Survival Follow up|Lost to Follow-up|2|||
23577215|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
23577216|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
23577217|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
23577218|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
23577219|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
23577220|NCT02276547|65843651|FG000|Overall Study|Death|2|||
23577221|NCT02276547|65843651|FG000|Overall Study|Explant|2|||
23577222|NCT01603121|65843652|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
23577223|NCT01603121|65843653|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
23577224|NCT03619174|65843656|FG000|Overall Study|Lost to Follow-up|3|||
23577225|NCT03619174|65843657|FG001|Overall Study|Lost to Follow-up|0|||
23577226|NCT03619174|65843656|FG000|Overall Study|Withdrawal by Subject|4|||
23577227|NCT03619174|65843657|FG001|Overall Study|Withdrawal by Subject|3|||
23577228|NCT03619174|65843656|FG000|Overall Study|Pregnancy|1|||
23577229|NCT03619174|65843657|FG001|Overall Study|Pregnancy|1|||
23835841|NCT01483027|66777868|FG001|Overall Study|Lost to Follow-up|1|||
23835842|NCT01483027|66777867|FG000|Overall Study|Adverse Event|0|||
23835843|NCT01483027|66777868|FG001|Overall Study|Adverse Event|1|||
23835844|NCT01483027|66777867|FG000|Overall Study|Withdrawal by Subject|0|||
23835845|NCT01483027|66777868|FG001|Overall Study|Withdrawal by Subject|1|||
23835846|NCT00856193|66777871|FG000|Period 2|Abnormal test procedure results|0|||
23835847|NCT00856193|66777872|FG001|Period 2|Abnormal test procedure results|1|||
23835848|NCT00856193|66777871|FG000|Period 2|Lost to Follow-up|0|||
23835849|NCT00856193|66777872|FG001|Period 2|Lost to Follow-up|1|||
23835850|NCT01073605|66777873|FG000|Overall Study|Ongoing at Cutoff Date|1|||
23835851|NCT01073605|66777874|FG001|Overall Study|Ongoing at Cutoff Date|1|||
23835852|NCT01073605|66777875|FG002|Overall Study|Ongoing at Cutoff Date|0|||
23835853|NCT01073605|66777873|FG000|Overall Study|Adverse Event|2|||
23835854|NCT01073605|66777874|FG001|Overall Study|Adverse Event|1|||
23835855|NCT01073605|66777875|FG002|Overall Study|Adverse Event|0|||
23835856|NCT01073605|66777873|FG000|Overall Study|Lost to Follow-up|3|||
23835857|NCT01073605|66777874|FG001|Overall Study|Lost to Follow-up|4|||
23835858|NCT01073605|66777875|FG002|Overall Study|Lost to Follow-up|9|||
23835859|NCT01073605|66777873|FG000|Overall Study|Other|25|||
23835860|NCT01073605|66777874|FG001|Overall Study|Other|21|||
23835861|NCT01073605|66777875|FG002|Overall Study|Other|29|||
23835862|NCT01073605|66777873|FG000|Overall Study|Withdrawal by Subject|31|||
23835863|NCT01073605|66777874|FG001|Overall Study|Withdrawal by Subject|39|||
23835864|NCT01073605|66777875|FG002|Overall Study|Withdrawal by Subject|22|||
23835865|NCT01073605|66777873|FG000|Overall Study|Randomized But Not Treated|0|||
23835866|NCT01073605|66777874|FG001|Overall Study|Randomized But Not Treated|1|||
23835867|NCT01073605|66777875|FG002|Overall Study|Randomized But Not Treated|1|||
23835868|NCT02859337|66777883|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
23835869|NCT02859337|66777884|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
23835870|NCT02859337|66777885|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
23835871|NCT02859337|66777883|FG000|Overall Study|Withdrawal by Subject|3|||
23835872|NCT02859337|66777884|FG001|Overall Study|Withdrawal by Subject|1|||
23835873|NCT02859337|66777885|FG002|Overall Study|Withdrawal by Subject|0|||
23835874|NCT02859337|66777883|FG000|Overall Study|Lost to Follow-up|1|||
23835875|NCT02859337|66777884|FG001|Overall Study|Lost to Follow-up|0|||
23835876|NCT02859337|66777885|FG002|Overall Study|Lost to Follow-up|0|||
23835877|NCT01776840|66777888|FG000|Overall Study|Lost to Follow-up|4|||
23835878|NCT01776840|66777889|FG001|Overall Study|Lost to Follow-up|4|||
23835879|NCT01776840|66777888|FG000|Overall Study|Withdrawal by Subject|42|||
23835880|NCT01776840|66777889|FG001|Overall Study|Withdrawal by Subject|22|||
23835881|NCT01776840|66777888|FG000|Overall Study|Ongoing|112|||
23835882|NCT01776840|66777889|FG001|Overall Study|Ongoing|129|||
23835883|NCT01620138|66777892|FG000|Overall Study|Withdrawal by Subject|3|||
23835884|NCT01620138|66777893|FG001|Overall Study|Withdrawal by Subject|0|||
23835885|NCT01620138|66777892|FG000|Overall Study|Lack of Efficacy|1|||
23835886|NCT01620138|66777893|FG001|Overall Study|Lack of Efficacy|0|||
23577230|NCT03619174|65843656|FG000|Overall Study|Discomfort during treatment|1|||
23835887|NCT01620138|66777892|FG000|Overall Study|Adverse Event|2|||
23835888|NCT01620138|66777893|FG001|Overall Study|Adverse Event|0|||
23835889|NCT00092118|66777895|FG000|Overall Study|Adverse Event|35|||
23835890|NCT00092118|66777896|FG001|Overall Study|Adverse Event|32|||
23835891|NCT00092118|66777895|FG000|Overall Study|Lack of Efficacy|12|||
23835892|NCT00092118|66777896|FG001|Overall Study|Lack of Efficacy|14|||
23835893|NCT00092118|66777895|FG000|Overall Study|Lost to Follow-up|4|||
23835894|NCT00092118|66777896|FG001|Overall Study|Lost to Follow-up|3|||
23835895|NCT00092118|66777895|FG000|Overall Study|Protocol Violation|23|||
23577231|NCT03619174|65843657|FG001|Overall Study|Discomfort during treatment|0|||
23577232|NCT03909165|65843658|FG000|Overall Study|Physician Decision|0|||
23577233|NCT03909165|65843659|FG001|Overall Study|Physician Decision|1|||
23577234|NCT03909165|65843660|FG002|Overall Study|Physician Decision|0|||
23835896|NCT00092118|66777896|FG001|Overall Study|Protocol Violation|25|||
23835897|NCT00092118|66777895|FG000|Overall Study|Withdrawal by Subject|4|||
23449676|NCT02420379|65388138|FG001|Overall Study|Withdrawal by Subject|3|||
23449677|NCT02420379|65388137|FG000|Overall Study|Unable to complete due to schooling|0|||
23449678|NCT02420379|65388138|FG001|Overall Study|Unable to complete due to schooling|1|||
23449679|NCT02420379|65388137|FG000|Overall Study|Transitioned to commercial drug|1|||
23449680|NCT02420379|65388138|FG001|Overall Study|Transitioned to commercial drug|0|||
23449681|NCT01276639|65388139|FG000|Week 0 to 16|Death|1|||
23449682|NCT01276639|65388140|FG001|Week 0 to 16|Death|0|||
23449683|NCT01276639|65388141|FG002|Week 0 to 16|Death|0|||
23449684|NCT01276639|65388142|FG003|Week 0 to 16|Death|0|||
23449685|NCT01276639|65388143|FG004|Week 0 to 16|Death|0|||
23449686|NCT01276639|65388139|FG000|Week 0 to 16|Adverse Event|11|||
23449687|NCT01276639|65388140|FG001|Week 0 to 16|Adverse Event|8|||
23449688|NCT01276639|65388141|FG002|Week 0 to 16|Adverse Event|11|||
23449689|NCT01276639|65388142|FG003|Week 0 to 16|Adverse Event|0|||
23449690|NCT01276639|65388143|FG004|Week 0 to 16|Adverse Event|0|||
23449691|NCT01276639|65388139|FG000|Week 0 to 16|Lack of Efficacy|20|||
23449692|NCT01276639|65388140|FG001|Week 0 to 16|Lack of Efficacy|15|||
23449693|NCT01276639|65388141|FG002|Week 0 to 16|Lack of Efficacy|25|||
23449694|NCT01276639|65388142|FG003|Week 0 to 16|Lack of Efficacy|0|||
23449695|NCT01276639|65388143|FG004|Week 0 to 16|Lack of Efficacy|0|||
23449696|NCT01276639|65388139|FG000|Week 0 to 16|Lost to Follow-up|3|||
23449697|NCT01276639|65388140|FG001|Week 0 to 16|Lost to Follow-up|5|||
23449698|NCT01276639|65388141|FG002|Week 0 to 16|Lost to Follow-up|3|||
23449699|NCT01276639|65388142|FG003|Week 0 to 16|Lost to Follow-up|0|||
23449700|NCT01276639|65388143|FG004|Week 0 to 16|Lost to Follow-up|0|||
23449701|NCT01276639|65388139|FG000|Week 0 to 16|Withdrawal by Subject|8|||
23449702|NCT01276639|65388140|FG001|Week 0 to 16|Withdrawal by Subject|5|||
23449703|NCT01276639|65388141|FG002|Week 0 to 16|Withdrawal by Subject|4|||
23449704|NCT01276639|65388142|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23449705|NCT01276639|65388143|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23449706|NCT01276639|65388139|FG000|Week 0 to 16|Other|7|||
23449707|NCT01276639|65388140|FG001|Week 0 to 16|Other|7|||
23449708|NCT01276639|65388141|FG002|Week 0 to 16|Other|2|||
23449709|NCT01276639|65388142|FG003|Week 0 to 16|Other|0|||
23449710|NCT01276639|65388143|FG004|Week 0 to 16|Other|0|||
23449711|NCT01276639|65388139|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
23449712|NCT01276639|65388140|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
23449713|NCT01276639|65388141|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
23449714|NCT01276639|65388142|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
23577235|NCT03909165|65843661|FG003|Overall Study|Physician Decision|0|||
23577236|NCT03909165|65843662|FG004|Overall Study|Physician Decision|0|||
23577237|NCT03909165|65843658|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577238|NCT03909165|65843659|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577239|NCT03909165|65843660|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577240|NCT03909165|65843661|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577241|NCT03909165|65843662|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23776878|NCT00863746|66563256|FG001|Survival Follow up|Lost to Follow-up|1|||
23776879|NCT00863746|66563255|FG000|Survival Follow up|Consent Withdrawn|7|||
23776880|NCT00863746|66563256|FG001|Survival Follow up|Consent Withdrawn|8|||
23776881|NCT02937701|66563259|FG000|Day 1 to Week 22|Adverse Event|11|||
23449715|NCT01276639|65388143|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
23776882|NCT02937701|66563260|FG001|Day 1 to Week 22|Adverse Event|14|||
23449716|NCT01276639|65388139|FG000|Week 16 to 52|Death|1|||
23449717|NCT01276639|65388140|FG001|Week 16 to 52|Death|0|||
23449718|NCT01276639|65388141|FG002|Week 16 to 52|Death|0|||
23449719|NCT01276639|65388142|FG003|Week 16 to 52|Death|0|||
23577242|NCT03909165|65843658|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23577243|NCT03909165|65843659|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23577244|NCT03909165|65843660|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23577245|NCT03909165|65843661|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
23577246|NCT03909165|65843662|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
23577247|NCT03909165|65843658|FG000|Overall Study|Previous Drug Exposure|0|||
23776883|NCT02937701|66563261|FG002|Day 1 to Week 22|Adverse Event|0|||
23776884|NCT02937701|66563262|FG003|Day 1 to Week 22|Adverse Event|0|||
23776885|NCT02937701|66563263|FG004|Day 1 to Week 22|Adverse Event|0|||
23776886|NCT02937701|66563259|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
23776887|NCT02937701|66563260|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
23776888|NCT02937701|66563261|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
23449720|NCT01276639|65388143|FG004|Week 16 to 52|Death|0|||
23449721|NCT01276639|65388139|FG000|Week 16 to 52|Adverse Event|10|||
23449722|NCT01276639|65388140|FG001|Week 16 to 52|Adverse Event|13|||
23449723|NCT01276639|65388141|FG002|Week 16 to 52|Adverse Event|0|||
23449724|NCT01276639|65388142|FG003|Week 16 to 52|Adverse Event|1|||
23449725|NCT01276639|65388143|FG004|Week 16 to 52|Adverse Event|3|||
23449726|NCT01276639|65388139|FG000|Week 16 to 52|Lack of Efficacy|99|||
23449727|NCT01276639|65388140|FG001|Week 16 to 52|Lack of Efficacy|71|||
23449728|NCT01276639|65388141|FG002|Week 16 to 52|Lack of Efficacy|0|||
23449729|NCT01276639|65388142|FG003|Week 16 to 52|Lack of Efficacy|14|||
23577248|NCT03909165|65843659|FG001|Overall Study|Previous Drug Exposure|0|||
23577249|NCT03909165|65843660|FG002|Overall Study|Previous Drug Exposure|1|||
23577250|NCT03909165|65843661|FG003|Overall Study|Previous Drug Exposure|0|||
23577251|NCT03909165|65843662|FG004|Overall Study|Previous Drug Exposure|0|||
23577252|NCT03909165|65843658|FG000|Overall Study|Early Discharge|1|||
23577253|NCT03909165|65843659|FG001|Overall Study|Early Discharge|0|||
23577254|NCT03909165|65843660|FG002|Overall Study|Early Discharge|0|||
23835898|NCT00092118|66777896|FG001|Overall Study|Withdrawal by Subject|10|||
23835899|NCT00092118|66777895|FG000|Overall Study|Other|6|||
23835900|NCT00092118|66777896|FG001|Overall Study|Other|5|||
23835901|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
23577255|NCT03909165|65843661|FG003|Overall Study|Early Discharge|0|||
23577256|NCT03909165|65843662|FG004|Overall Study|Early Discharge|0|||
23577257|NCT04179461|65843663|FG000|Overall Study|Lost to Follow-up|4|||
23577258|NCT00701311|65843667|FG000|Overall Study|Lack of Efficacy|3|||
23577259|NCT00701311|65843667|FG000|Overall Study|Adverse Event|3|||
23577260|NCT00701311|65843667|FG000|Overall Study|Withdrawal by Subject|2|||
23577261|NCT03785340|65843677|FG000|Overall Study|Lost to Follow-up|2|||
23577262|NCT03785340|65843678|FG001|Overall Study|Lost to Follow-up|0|||
23577263|NCT03785340|65843677|FG000|Overall Study|Adverse Event|1|||
23577264|NCT03785340|65843678|FG001|Overall Study|Adverse Event|0|||
23577265|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
23577266|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
23577267|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
23577268|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
23577269|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
23577270|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
23577271|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
23577272|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
23577273|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
23577274|NCT04707391|65843685|FG000|Overall Study|Adverse Event|5|||
23577275|NCT04707391|65843686|FG001|Overall Study|Adverse Event|8|||
23577276|NCT04707391|65843685|FG000|Overall Study|Lost to Follow-up|44|||
23577277|NCT04707391|65843686|FG001|Overall Study|Lost to Follow-up|31|||
23577278|NCT04707391|65843685|FG000|Overall Study|Protocol Violation|1|||
23634129|NCT05262517|66045556|FG001|Overall Study|Randomized but not treated|11|||
23634130|NCT01677767|66045557|FG000|Overall Study|Adverse Event|1|||
23835902|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
23577279|NCT04707391|65843686|FG001|Overall Study|Protocol Violation|5|||
23577280|NCT04707391|65843685|FG000|Overall Study|Withdrawal by Subject|27|||
23577281|NCT04707391|65843686|FG001|Overall Study|Withdrawal by Subject|25|||
23577282|NCT04707391|65843685|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
23577283|NCT04707391|65843686|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
23577284|NCT04707391|65843685|FG000|Overall Study|Other|0|||
23577285|NCT04707391|65843686|FG001|Overall Study|Other|2|||
23577286|NCT02501811|65843687|FG000|Overall Study|Death|1|||
23577287|NCT02501811|65843688|FG001|Overall Study|Death|3|||
23577288|NCT02501811|65843689|FG002|Overall Study|Death|2|||
23577289|NCT02501811|65843690|FG003|Overall Study|Death|3|||
23577290|NCT02501811|65843687|FG000|Overall Study|Withdrawal by Subject|3|||
23835903|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
23835904|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
23835905|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
23835906|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23835907|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
23835908|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
23835909|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23835910|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23835911|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
23577291|NCT02501811|65843688|FG001|Overall Study|Withdrawal by Subject|3|||
23577292|NCT02501811|65843689|FG002|Overall Study|Withdrawal by Subject|2|||
23577293|NCT02501811|65843690|FG003|Overall Study|Withdrawal by Subject|3|||
23577294|NCT02501811|65843687|FG000|Overall Study|Lost to Follow-up|0|||
23577295|NCT02501811|65843688|FG001|Overall Study|Lost to Follow-up|0|||
23577296|NCT02501811|65843689|FG002|Overall Study|Lost to Follow-up|2|||
23577297|NCT02501811|65843690|FG003|Overall Study|Lost to Follow-up|1|||
23577298|NCT01375959|65843691|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
23577299|NCT01375959|65843692|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
23577300|NCT01375959|65843691|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23577301|NCT01375959|65843692|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
23449730|NCT01276639|65388143|FG004|Week 16 to 52|Lack of Efficacy|13|||
23577302|NCT01375959|65843691|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23577303|NCT01375959|65843692|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
23577304|NCT00737061|65843693|FG000|Waiting Period|Lost to Follow-up|6|||
23577305|NCT00737061|65843693|FG000|Waiting Period|Withdrawal by Subject|1|||
23577306|NCT00737061|65843693|FG000|Waiting Period|Bilateral placement failure|34|||
23577307|NCT00737061|65843693|FG000|Waiting Period|Deemed patent following HSG|26|||
23577308|NCT00737061|65843693|FG000|Waiting Period|Alternative contraception failure|3|||
23577309|NCT00737061|65843693|FG000|Waiting Period|Elected surgical tubal ligation|5|||
23577310|NCT00737061|65843693|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
23577311|NCT00737061|65843693|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
23577312|NCT00737061|65843693|FG000|1 Year Wearing Period|Discontinued reilance|3|||
23577313|NCT00737061|65843693|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
23577314|NCT01232556|65843694|FG000|Overall Study|Withdrawal by Subject|21|||
23577315|NCT01232556|65843695|FG001|Overall Study|Withdrawal by Subject|17|||
23577316|NCT01232556|65843694|FG000|Overall Study|Death|97|||
23577317|NCT01232556|65843695|FG001|Overall Study|Death|97|||
23577318|NCT01232556|65843694|FG000|Overall Study|Lost to Follow-up|0|||
23577319|NCT01232556|65843695|FG001|Overall Study|Lost to Follow-up|2|||
23577320|NCT01232556|65843694|FG000|Overall Study|Terminated by Sponsor|35|||
23577321|NCT01232556|65843695|FG001|Overall Study|Terminated by Sponsor|51|||
23577322|NCT01232556|65843694|FG000|Overall Study|Other|6|||
23577323|NCT01232556|65843695|FG001|Overall Study|Other|4|||
23577324|NCT01575860|65843702|FG000|Overall Study|Withdrawal by Subject|1|||
23577325|NCT01575860|65843702|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
23577326|NCT04004208|65843705|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23577327|NCT04004208|65843706|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23577328|NCT04004208|65843705|FG000|Overall Study|Death|3|||
23577329|NCT04004208|65843706|FG001|Overall Study|Death|0|||
23577330|NCT04004208|65843705|FG000|Overall Study|COVID-19 pandemic|1|||
23577331|NCT04004208|65843706|FG001|Overall Study|COVID-19 pandemic|0|||
23577332|NCT04004208|65843705|FG000|Overall Study|Physician Decision|1|||
23577333|NCT04004208|65843706|FG001|Overall Study|Physician Decision|0|||
23577334|NCT04004208|65843705|FG000|Overall Study|Adverse Event|1|||
23577335|NCT04004208|65843706|FG001|Overall Study|Adverse Event|1|||
23577336|NCT00124982|65843707|FG000|Short-term Period|Death|1|||
23577337|NCT00124982|65843708|FG001|Short-term Period|Death|1|||
23577338|NCT00124982|65843709|FG002|Short-term Period|Death|0|||
23577339|NCT00124982|65843707|FG000|Short-term Period|Adverse Event|17|||
23577340|NCT00124982|65843708|FG001|Short-term Period|Adverse Event|22|||
23577341|NCT00124982|65843709|FG002|Short-term Period|Adverse Event|0|||
23577342|NCT00124982|65843707|FG000|Short-term Period|Lack of Efficacy|32|||
23577343|NCT00124982|65843708|FG001|Short-term Period|Lack of Efficacy|73|||
23577344|NCT00124982|65843709|FG002|Short-term Period|Lack of Efficacy|0|||
23577345|NCT00124982|65843707|FG000|Short-term Period|Lost to Follow-up|8|||
23577346|NCT00124982|65843708|FG001|Short-term Period|Lost to Follow-up|5|||
23577347|NCT00124982|65843709|FG002|Short-term Period|Lost to Follow-up|0|||
23577348|NCT00124982|65843707|FG000|Short-term Period|Withdrawal of Consent|7|||
23577349|NCT00124982|65843708|FG001|Short-term Period|Withdrawal of Consent|9|||
23577350|NCT00124982|65843709|FG002|Short-term Period|Withdrawal of Consent|0|||
23577351|NCT00124982|65843707|FG000|Short-term Period|Poor/Non-compliance|3|||
23577352|NCT00124982|65843708|FG001|Short-term Period|Poor/Non-compliance|1|||
23577353|NCT00124982|65843709|FG002|Short-term Period|Poor/Non-compliance|0|||
23577354|NCT00124982|65843707|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
23577355|NCT00124982|65843708|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
23577356|NCT00124982|65843709|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
23577357|NCT00124982|65843707|FG000|Short-term Period|Participant Decision|1|||
23577358|NCT00124982|65843708|FG001|Short-term Period|Participant Decision|0|||
23577359|NCT00124982|65843709|FG002|Short-term Period|Participant Decision|0|||
23577360|NCT00124982|65843707|FG000|Short-term Period|Participant Chose Own Doctor|0|||
23577361|NCT00124982|65843708|FG001|Short-term Period|Participant Chose Own Doctor|1|||
23776889|NCT02937701|66563262|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
23776890|NCT02937701|66563263|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
23776891|NCT02937701|66563259|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
23776892|NCT02937701|66563260|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
23776893|NCT02937701|66563261|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23776894|NCT02937701|66563262|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23577362|NCT00124982|65843709|FG002|Short-term Period|Participant Chose Own Doctor|0|||
23577363|NCT00124982|65843707|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
23577364|NCT00124982|65843708|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
23577365|NCT00124982|65843709|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
23577366|NCT00124982|65843707|FG000|Short-term Period|Participant Had Lymphopenia|1|||
23577367|NCT00124982|65843708|FG001|Short-term Period|Participant Had Lymphopenia|0|||
23577368|NCT00124982|65843709|FG002|Short-term Period|Participant Had Lymphopenia|0|||
23577369|NCT00124982|65843707|FG000|Long-term Period|Death|0|||
23449731|NCT01276639|65388139|FG000|Week 16 to 52|Lost to Follow-up|3|||
23449732|NCT01276639|65388140|FG001|Week 16 to 52|Lost to Follow-up|1|||
23449733|NCT01276639|65388141|FG002|Week 16 to 52|Lost to Follow-up|0|||
23449734|NCT01276639|65388142|FG003|Week 16 to 52|Lost to Follow-up|0|||
23449735|NCT01276639|65388143|FG004|Week 16 to 52|Lost to Follow-up|1|||
23449736|NCT01276639|65388139|FG000|Week 16 to 52|Withdrawal by Subject|4|||
23776895|NCT02937701|66563263|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23776896|NCT02937701|66563259|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
23776897|NCT02937701|66563260|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
23449737|NCT01276639|65388140|FG001|Week 16 to 52|Withdrawal by Subject|4|||
23449738|NCT01276639|65388141|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23449739|NCT01276639|65388142|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23449740|NCT01276639|65388143|FG004|Week 16 to 52|Withdrawal by Subject|1|||
23449741|NCT01276639|65388139|FG000|Week 16 to 52|Other|10|||
23449742|NCT01276639|65388140|FG001|Week 16 to 52|Other|12|||
23449743|NCT01276639|65388141|FG002|Week 16 to 52|Other|0|||
23449744|NCT01276639|65388142|FG003|Week 16 to 52|Other|1|||
23449745|NCT01276639|65388143|FG004|Week 16 to 52|Other|3|||
23634131|NCT01677767|66045557|FG000|Overall Study|Death|4|||
23634132|NCT01677767|66045557|FG000|Overall Study|Protocol Violation|4|||
23634133|NCT01677767|66045557|FG000|Overall Study|Withdrawal by Subject|10|||
23634134|NCT01677767|66045557|FG000|Overall Study|Non-compliance by the participants|3|||
23634135|NCT00737477|66045562|FG000|Overall Study|Adverse Event|9|||
23634136|NCT00737477|66045562|FG000|Overall Study|Death|9|||
23634137|NCT00737477|66045562|FG000|Overall Study|Treatment Refusal|1|||
23634138|NCT00737477|66045562|FG000|Overall Study|Withdrawal by Subject|1|||
23634139|NCT00737477|66045562|FG000|Overall Study|Renal Transplantation|10|||
23634140|NCT00737477|66045562|FG000|Overall Study|Other|4|||
23634141|NCT01413503|66045567|FG000|Overall Study|Lost to Follow-up|1|||
23634142|NCT01443403|66045568|FG000|Overall Study|Adverse Event|1|||
23634143|NCT01443403|66045569|FG001|Overall Study|Adverse Event|1|||
23634144|NCT01443403|66045570|FG002|Overall Study|Adverse Event|4|||
23634145|NCT01443403|66045571|FG003|Overall Study|Adverse Event|5|||
23634146|NCT01443403|66045568|FG000|Overall Study|Withdrawal by Subject|0|||
23634147|NCT01443403|66045569|FG001|Overall Study|Withdrawal by Subject|1|||
23449746|NCT01620086|65388145|FG000|Overall Study|Withdrawal by Subject|3|||
23449747|NCT01620086|65388146|FG001|Overall Study|Withdrawal by Subject|3|||
23449748|NCT01620086|65388147|FG002|Overall Study|Withdrawal by Subject|0|||
23449749|NCT01620086|65388145|FG000|Overall Study|failed study criteria|1|||
23449750|NCT01620086|65388146|FG001|Overall Study|failed study criteria|4|||
23449751|NCT01620086|65388147|FG002|Overall Study|failed study criteria|0|||
23449752|NCT01620086|65388145|FG000|Overall Study|Physician Decision|1|||
23449753|NCT01620086|65388146|FG001|Overall Study|Physician Decision|0|||
23449754|NCT01620086|65388147|FG002|Overall Study|Physician Decision|0|||
23449755|NCT03683173|65388152|FG000|Completed Follow-up|Unavailable|235|||
23634148|NCT01443403|66045570|FG002|Overall Study|Withdrawal by Subject|2|||
23634149|NCT01443403|66045571|FG003|Overall Study|Withdrawal by Subject|1|||
23634150|NCT01443403|66045568|FG000|Overall Study|Lost to Follow-up|0|||
23776898|NCT02937701|66563261|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
23776899|NCT02937701|66563262|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
23776900|NCT02937701|66563263|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
23776901|NCT02937701|66563259|FG000|Day 1 to Week 22|Death|1|||
23776902|NCT02937701|66563260|FG001|Day 1 to Week 22|Death|1|||
23776903|NCT02937701|66563261|FG002|Day 1 to Week 22|Death|0|||
23776904|NCT02937701|66563262|FG003|Day 1 to Week 22|Death|0|||
23776905|NCT02937701|66563263|FG004|Day 1 to Week 22|Death|0|||
23776906|NCT02937701|66563259|FG000|Day 1 to Week 22|Protocol Violation|1|||
23449756|NCT03683173|65388153|FG001|Completed Follow-up|Unavailable|217|||
23449757|NCT03683173|65388152|FG000|Completed Follow-up|Refused|69|||
23449758|NCT03683173|65388153|FG001|Completed Follow-up|Refused|59|||
23449759|NCT03683173|65388152|FG000|Completed Follow-up|Disconnected phone|65|||
23449760|NCT03683173|65388153|FG001|Completed Follow-up|Disconnected phone|95|||
23449761|NCT03683173|65388152|FG000|Completed Follow-up|Health issue/deceased|10|||
23449762|NCT03683173|65388153|FG001|Completed Follow-up|Health issue/deceased|4|||
23449763|NCT03683173|65388152|FG000|Completed Follow-up|Moved away|8|||
23449764|NCT03683173|65388153|FG001|Completed Follow-up|Moved away|1|||
23776907|NCT02937701|66563260|FG001|Day 1 to Week 22|Protocol Violation|1|||
23776908|NCT02937701|66563261|FG002|Day 1 to Week 22|Protocol Violation|0|||
23776909|NCT02937701|66563262|FG003|Day 1 to Week 22|Protocol Violation|0|||
23776910|NCT02937701|66563263|FG004|Day 1 to Week 22|Protocol Violation|0|||
23449765|NCT01425801|65388162|FG000|Period 1|Withdrawal by Subject|0|||
23634151|NCT01443403|66045569|FG001|Overall Study|Lost to Follow-up|0|||
23634152|NCT01443403|66045570|FG002|Overall Study|Lost to Follow-up|0|||
23634153|NCT01443403|66045571|FG003|Overall Study|Lost to Follow-up|1|||
23634154|NCT01443403|66045568|FG000|Overall Study|Protocol Violation|2|||
23634155|NCT01443403|66045569|FG001|Overall Study|Protocol Violation|1|||
23634156|NCT01443403|66045570|FG002|Overall Study|Protocol Violation|1|||
23776911|NCT02937701|66563259|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
23776912|NCT02937701|66563260|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
23449766|NCT01425801|65388163|FG001|Period 1|Withdrawal by Subject|0|||
23449767|NCT01425801|65388164|FG002|Period 1|Withdrawal by Subject|0|||
23449768|NCT01425801|65388165|FG003|Period 1|Withdrawal by Subject|0|||
23449769|NCT01425801|65388166|FG004|Period 1|Withdrawal by Subject|1|||
23835912|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
23835913|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
23835914|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
23835915|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
23577370|NCT00124982|65843708|FG001|Long-term Period|Death|0|||
23577371|NCT00124982|65843709|FG002|Long-term Period|Death|1|||
23577372|NCT00124982|65843707|FG000|Long-term Period|Adverse Event|0|||
23577373|NCT00124982|65843708|FG001|Long-term Period|Adverse Event|0|||
23577374|NCT00124982|65843709|FG002|Long-term Period|Adverse Event|17|||
23577375|NCT00124982|65843707|FG000|Long-term Period|Lack of Efficacy|0|||
23577376|NCT00124982|65843708|FG001|Long-term Period|Lack of Efficacy|0|||
23577377|NCT00124982|65843709|FG002|Long-term Period|Lack of Efficacy|46|||
23835916|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
23835917|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23835918|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
23835919|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23577378|NCT00124982|65843707|FG000|Long-term Period|Lost to Follow-up|0|||
23577379|NCT00124982|65843708|FG001|Long-term Period|Lost to Follow-up|0|||
23577380|NCT00124982|65843709|FG002|Long-term Period|Lost to Follow-up|4|||
23577381|NCT00124982|65843707|FG000|Long-term Period|Withdrawal by Subject|0|||
23577382|NCT00124982|65843708|FG001|Long-term Period|Withdrawal by Subject|0|||
23835920|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23835921|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23835922|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
23835923|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23835924|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23835925|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23835926|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
23835927|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
23835928|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
23835929|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
23835930|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
23835931|NCT03852472|66777900|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
23835932|NCT03852472|66777901|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
23835933|NCT03852472|66777902|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
23835934|NCT03852472|66777903|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
23835935|NCT03852472|66777904|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
23835936|NCT03852472|66777900|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
23835937|NCT03852472|66777901|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
23835938|NCT03852472|66777902|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
23835939|NCT03852472|66777903|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
23835940|NCT03852472|66777904|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
23835941|NCT03852472|66777900|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
23835942|NCT03852472|66777901|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
23835943|NCT03852472|66777902|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
23577383|NCT00124982|65843709|FG002|Long-term Period|Withdrawal by Subject|16|||
23577384|NCT00124982|65843707|FG000|Long-term Period|Pregnancy|0|||
23577385|NCT00124982|65843708|FG001|Long-term Period|Pregnancy|0|||
23577386|NCT00124982|65843709|FG002|Long-term Period|Pregnancy|1|||
23577387|NCT00124982|65843707|FG000|Long-term Period|Poor/Non-compliance|0|||
23835944|NCT03852472|66777903|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
23835945|NCT03852472|66777904|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
23577388|NCT00124982|65843708|FG001|Long-term Period|Poor/Non-compliance|0|||
23577389|NCT00124982|65843709|FG002|Long-term Period|Poor/Non-compliance|2|||
23835946|NCT03852472|66777900|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
23835947|NCT03852472|66777901|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
23835948|NCT03852472|66777902|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
23835949|NCT03852472|66777903|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
23835950|NCT03852472|66777904|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
23835951|NCT03852472|66777900|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
23835952|NCT03852472|66777901|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
23449770|NCT01425801|65388167|FG005|Period 1|Withdrawal by Subject|0|||
23577390|NCT00124982|65843707|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
23577391|NCT00124982|65843708|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
23577392|NCT00124982|65843709|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
23577393|NCT00124982|65843707|FG000|Long-term Period|Neurologist Recommendation|0|||
23577394|NCT00124982|65843708|FG001|Long-term Period|Neurologist Recommendation|0|||
23776913|NCT02937701|66563261|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
23776914|NCT02937701|66563262|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
23776915|NCT02937701|66563263|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
23776916|NCT02937701|66563259|FG000|Day 1 to Week 22|Physician Decision|2|||
23776917|NCT02937701|66563260|FG001|Day 1 to Week 22|Physician Decision|0|||
23776918|NCT02937701|66563261|FG002|Day 1 to Week 22|Physician Decision|0|||
23776919|NCT02937701|66563262|FG003|Day 1 to Week 22|Physician Decision|0|||
23776920|NCT02937701|66563263|FG004|Day 1 to Week 22|Physician Decision|0|||
23634157|NCT01443403|66045571|FG003|Overall Study|Protocol Violation|1|||
23634158|NCT01443403|66045568|FG000|Overall Study|Use of Prohibited Treatment|2|||
23634159|NCT01443403|66045569|FG001|Overall Study|Use of Prohibited Treatment|3|||
23776921|NCT02937701|66563259|FG000|Day 1 to Week 22|Other|1|||
23776922|NCT02937701|66563260|FG001|Day 1 to Week 22|Other|0|||
23776923|NCT02937701|66563261|FG002|Day 1 to Week 22|Other|0|||
23776924|NCT02937701|66563262|FG003|Day 1 to Week 22|Other|0|||
23776925|NCT02937701|66563263|FG004|Day 1 to Week 22|Other|0|||
23776926|NCT02937701|66563259|FG000|Week 22 to Week 50|Adverse Event|0|||
23776927|NCT02937701|66563260|FG001|Week 22 to Week 50|Adverse Event|0|||
23776928|NCT02937701|66563261|FG002|Week 22 to Week 50|Adverse Event|10|||
23776929|NCT02937701|66563262|FG003|Week 22 to Week 50|Adverse Event|3|||
23776930|NCT02937701|66563263|FG004|Week 22 to Week 50|Adverse Event|3|||
23776931|NCT02937701|66563259|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
23776932|NCT02937701|66563260|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
23776933|NCT02937701|66563261|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
23776934|NCT02937701|66563262|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
23776935|NCT02937701|66563263|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
23776936|NCT02937701|66563259|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
23776937|NCT02937701|66563260|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
23776938|NCT02937701|66563261|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
23634160|NCT01443403|66045570|FG002|Overall Study|Use of Prohibited Treatment|0|||
23776939|NCT02937701|66563262|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
23776940|NCT02937701|66563263|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
23776941|NCT02937701|66563259|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
23776942|NCT02937701|66563260|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
23776943|NCT02937701|66563261|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
23835953|NCT03852472|66777902|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
23449771|NCT01425801|65388162|FG000|Period 2|Withdrawal by Subject|0|||
23449772|NCT01425801|65388163|FG001|Period 2|Withdrawal by Subject|0|||
23449773|NCT01425801|65388164|FG002|Period 2|Withdrawal by Subject|0|||
23449774|NCT01425801|65388165|FG003|Period 2|Withdrawal by Subject|0|||
23449775|NCT01425801|65388166|FG004|Period 2|Withdrawal by Subject|1|||
23449776|NCT01425801|65388167|FG005|Period 2|Withdrawal by Subject|0|||
23449777|NCT01425801|65388162|FG000|Period 3|Stability criteria not fullfilled|0|||
23634161|NCT01443403|66045571|FG003|Overall Study|Use of Prohibited Treatment|0|||
23634162|NCT01443403|66045568|FG000|Overall Study|Other - Miscellaneous|1|||
23634163|NCT01443403|66045569|FG001|Overall Study|Other - Miscellaneous|0|||
23634164|NCT01443403|66045570|FG002|Overall Study|Other - Miscellaneous|0|||
23449778|NCT01425801|65388163|FG001|Period 3|Stability criteria not fullfilled|0|||
23449779|NCT01425801|65388164|FG002|Period 3|Stability criteria not fullfilled|1|||
23449780|NCT01425801|65388165|FG003|Period 3|Stability criteria not fullfilled|0|||
23449781|NCT01425801|65388166|FG004|Period 3|Stability criteria not fullfilled|0|||
23449782|NCT01425801|65388167|FG005|Period 3|Stability criteria not fullfilled|0|||
23449783|NCT01425801|65388162|FG000|Period 4|Not able to maintain visit schedule|0|||
23449784|NCT01425801|65388163|FG001|Period 4|Not able to maintain visit schedule|0|||
23449785|NCT01425801|65388164|FG002|Period 4|Not able to maintain visit schedule|1|||
23449786|NCT01425801|65388165|FG003|Period 4|Not able to maintain visit schedule|0|||
23449787|NCT01425801|65388166|FG004|Period 4|Not able to maintain visit schedule|0|||
23449788|NCT01425801|65388167|FG005|Period 4|Not able to maintain visit schedule|0|||
23449789|NCT01745367|65388168|FG000|Overall Study|Death|1|||
23634165|NCT01443403|66045571|FG003|Overall Study|Other - Miscellaneous|1|||
23634166|NCT00820170|66045581|FG000|Overall Study|Adverse Event|0|||
23634167|NCT00820170|66045582|FG001|Overall Study|Adverse Event|0|||
23634168|NCT00820170|66045583|FG002|Overall Study|Adverse Event|0|||
23776944|NCT02937701|66563262|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
23776945|NCT02937701|66563263|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
23776946|NCT02937701|66563259|FG000|Week 22 to Week 50|Physician Decision|0|||
23776947|NCT02937701|66563260|FG001|Week 22 to Week 50|Physician Decision|0|||
23776948|NCT02937701|66563261|FG002|Week 22 to Week 50|Physician Decision|2|||
23776949|NCT02937701|66563262|FG003|Week 22 to Week 50|Physician Decision|0|||
23634169|NCT00820170|66045584|FG003|Overall Study|Adverse Event|0|||
23634170|NCT00820170|66045585|FG004|Overall Study|Adverse Event|2|||
23634171|NCT00820170|66045581|FG000|Overall Study|Progressive Disease|0|||
23634172|NCT00820170|66045582|FG001|Overall Study|Progressive Disease|0|||
23634173|NCT00820170|66045583|FG002|Overall Study|Progressive Disease|0|||
23634174|NCT00820170|66045584|FG003|Overall Study|Progressive Disease|0|||
23634175|NCT00820170|66045585|FG004|Overall Study|Progressive Disease|2|||
23634176|NCT01696955|66045586|FG000|Main Study|Protocol Violation|1|||
23634177|NCT01696955|66045587|FG001|Main Study|Protocol Violation|0|||
23634178|NCT01696955|66045586|FG000|Main Study|Withdrawal by Subject|1|||
23634179|NCT01696955|66045587|FG001|Main Study|Withdrawal by Subject|1|||
23634180|NCT01016262|66045589|FG000|Double-blind Phase|Adverse Event|0|||
23634181|NCT01016262|66045590|FG001|Double-blind Phase|Adverse Event|0|||
23634182|NCT01016262|66045591|FG002|Double-blind Phase|Adverse Event|1|||
23634183|NCT01016262|66045592|FG003|Double-blind Phase|Adverse Event|0|||
23634184|NCT01016262|66045593|FG004|Double-blind Phase|Adverse Event|0|||
23634185|NCT01016262|66045594|FG005|Double-blind Phase|Adverse Event|0|||
23634186|NCT01016262|66045589|FG000|Double-blind Phase|Lack of Efficacy|1|||
23634187|NCT01016262|66045590|FG001|Double-blind Phase|Lack of Efficacy|0|||
23634188|NCT01016262|66045591|FG002|Double-blind Phase|Lack of Efficacy|5|||
23634189|NCT01016262|66045592|FG003|Double-blind Phase|Lack of Efficacy|0|||
23634190|NCT01016262|66045593|FG004|Double-blind Phase|Lack of Efficacy|0|||
23634191|NCT01016262|66045594|FG005|Double-blind Phase|Lack of Efficacy|0|||
23776950|NCT02937701|66563263|FG004|Week 22 to Week 50|Physician Decision|1|||
23776951|NCT02937701|66563259|FG000|Week 22 to Week 50|Other|0|||
23776952|NCT02937701|66563260|FG001|Week 22 to Week 50|Other|0|||
23776953|NCT02937701|66563261|FG002|Week 22 to Week 50|Other|0|||
23776954|NCT02937701|66563262|FG003|Week 22 to Week 50|Other|0|||
23776955|NCT02937701|66563263|FG004|Week 22 to Week 50|Other|1|||
23776956|NCT01974141|66563268|FG000|Overall Study|Other Reasons|28|||
23776957|NCT01974141|66563269|FG001|Overall Study|Other Reasons|18|||
23776958|NCT01974141|66563268|FG000|Overall Study|Protocol Violation|2|||
23835954|NCT03852472|66777903|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
23449790|NCT01745367|65388169|FG001|Overall Study|Death|0|||
23449791|NCT01745367|65388168|FG000|Overall Study|Withdrawal by Subject|1|||
23449792|NCT01745367|65388169|FG001|Overall Study|Withdrawal by Subject|2|||
23449793|NCT01745367|65388168|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
23634192|NCT01016262|66045589|FG000|Double-blind Phase|Disease Progression|0|||
23634193|NCT01016262|66045590|FG001|Double-blind Phase|Disease Progression|1|||
23634194|NCT01016262|66045591|FG002|Double-blind Phase|Disease Progression|2|||
23634195|NCT01016262|66045592|FG003|Double-blind Phase|Disease Progression|0|||
23634196|NCT01016262|66045593|FG004|Double-blind Phase|Disease Progression|0|||
23634197|NCT01016262|66045594|FG005|Double-blind Phase|Disease Progression|0|||
23634198|NCT01016262|66045589|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
23835955|NCT03852472|66777904|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
23835956|NCT03852472|66777900|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
23634199|NCT01016262|66045590|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
23634200|NCT01016262|66045591|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
23634201|NCT01016262|66045592|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
23634202|NCT01016262|66045593|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
23634203|NCT01016262|66045594|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
23634204|NCT01016262|66045589|FG000|Open-Label Phase|Adverse Event|0|||
23634205|NCT01016262|66045590|FG001|Open-Label Phase|Adverse Event|0|||
23634206|NCT01016262|66045591|FG002|Open-Label Phase|Adverse Event|0|||
23634207|NCT01016262|66045592|FG003|Open-Label Phase|Adverse Event|1|||
23634208|NCT01016262|66045593|FG004|Open-Label Phase|Adverse Event|0|||
23634209|NCT01016262|66045594|FG005|Open-Label Phase|Adverse Event|0|||
23634210|NCT01016262|66045589|FG000|Open-Label Phase|Lost to Follow-up|0|||
23634211|NCT01016262|66045590|FG001|Open-Label Phase|Lost to Follow-up|0|||
23634212|NCT01016262|66045591|FG002|Open-Label Phase|Lost to Follow-up|0|||
23776959|NCT01974141|66563269|FG001|Overall Study|Protocol Violation|6|||
23449794|NCT01745367|65388169|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
23449795|NCT01745367|65388168|FG000|Overall Study|Other Reasons Unspecified|0|||
23449796|NCT01745367|65388169|FG001|Overall Study|Other Reasons Unspecified|2|||
23449797|NCT00718510|65388170|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23449798|NCT00718510|65388171|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23449799|NCT00718510|65388170|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23449800|NCT00718510|65388171|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23449801|NCT00743249|65388172|FG000|Overall Study|Adverse Event|0|||
23449802|NCT00743249|65388173|FG001|Overall Study|Adverse Event|4|||
23449803|NCT00743249|65388172|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
23449804|NCT00743249|65388173|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
23449805|NCT00743249|65388172|FG000|Overall Study|Unsuccessful insertion of stent|2|||
23449806|NCT00743249|65388173|FG001|Overall Study|Unsuccessful insertion of stent|1|||
23449807|NCT01272232|65388182|FG000|Weeks 0-56|Adverse Event|39|||
23449808|NCT01272232|65388183|FG001|Weeks 0-56|Adverse Event|18|||
23449809|NCT01272232|65388184|FG002|Weeks 0-56|Adverse Event|7|||
23449810|NCT01272232|65388182|FG000|Weeks 0-56|Lack of Efficacy|0|||
23634213|NCT01016262|66045592|FG003|Open-Label Phase|Lost to Follow-up|0|||
23634214|NCT01016262|66045593|FG004|Open-Label Phase|Lost to Follow-up|1|||
23776960|NCT01974141|66563268|FG000|Overall Study|Personal Reasons|21|||
23835957|NCT03852472|66777901|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
23835958|NCT03852472|66777902|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
23835959|NCT03852472|66777903|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
23776961|NCT01974141|66563269|FG001|Overall Study|Personal Reasons|20|||
23776962|NCT01974141|66563268|FG000|Overall Study|Lost to Follow-up|38|||
23776963|NCT01974141|66563269|FG001|Overall Study|Lost to Follow-up|29|||
23776964|NCT01974141|66563268|FG000|Overall Study|Pregnancy|3|||
23776965|NCT01974141|66563269|FG001|Overall Study|Pregnancy|3|||
23776966|NCT01974141|66563268|FG000|Overall Study|Lack of Efficacy|0|||
23776967|NCT01974141|66563269|FG001|Overall Study|Lack of Efficacy|1|||
23776968|NCT01974141|66563268|FG000|Overall Study|Adverse Event|4|||
23776969|NCT01974141|66563269|FG001|Overall Study|Adverse Event|5|||
23776970|NCT00995410|66563270|FG000|Overall Study|Adverse Event|51|||
23776971|NCT00995410|66563270|FG000|Overall Study|Withdrawal by Subject|7|||
23776972|NCT00995410|66563270|FG000|Overall Study|Lost to Follow-up|2|||
23449811|NCT01272232|65388183|FG001|Weeks 0-56|Lack of Efficacy|0|||
23634215|NCT01016262|66045594|FG005|Open-Label Phase|Lost to Follow-up|0|||
23634216|NCT01016262|66045589|FG000|Open-Label Phase|Lack of Efficacy|0|||
23634217|NCT01016262|66045590|FG001|Open-Label Phase|Lack of Efficacy|0|||
23634218|NCT01016262|66045591|FG002|Open-Label Phase|Lack of Efficacy|0|||
23634219|NCT01016262|66045592|FG003|Open-Label Phase|Lack of Efficacy|1|||
23634220|NCT01016262|66045593|FG004|Open-Label Phase|Lack of Efficacy|0|||
23634221|NCT01016262|66045594|FG005|Open-Label Phase|Lack of Efficacy|0|||
23634222|NCT01016262|66045589|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
23634223|NCT01016262|66045590|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
23634224|NCT01016262|66045591|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
23634225|NCT01016262|66045592|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
23634226|NCT01016262|66045593|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
23776973|NCT00995410|66563270|FG000|Overall Study|Misc|28|||
23776974|NCT00386009|66563278|FG000|Overall Study|Adverse Event|0|||
23776975|NCT00386009|66563279|FG001|Overall Study|Adverse Event|2|||
23776976|NCT00386009|66563278|FG000|Overall Study|Death|1|||
23776977|NCT00386009|66563279|FG001|Overall Study|Death|0|||
23776978|NCT00386009|66563278|FG000|Overall Study|Entry Criteria Not Met|0|||
23776979|NCT00386009|66563279|FG001|Overall Study|Entry Criteria Not Met|2|||
23835960|NCT03852472|66777904|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
23835961|NCT03852472|66777900|FG000|Period 2 - Week 44|Adverse Event|0|||
23835962|NCT03852472|66777901|FG001|Period 2 - Week 44|Adverse Event|3|||
23835963|NCT03852472|66777902|FG002|Period 2 - Week 44|Adverse Event|1|||
23835964|NCT03852472|66777903|FG003|Period 2 - Week 44|Adverse Event|2|||
23835965|NCT03852472|66777904|FG004|Period 2 - Week 44|Adverse Event|2|||
23776980|NCT00386009|66563278|FG000|Overall Study|Lost to Follow-up|1|||
23776981|NCT00386009|66563279|FG001|Overall Study|Lost to Follow-up|1|||
23776982|NCT00386009|66563278|FG000|Overall Study|Protocol Violation|1|||
23776983|NCT00386009|66563279|FG001|Overall Study|Protocol Violation|0|||
23776984|NCT00386009|66563278|FG000|Overall Study|Sponsor Decision|1|||
23776985|NCT00386009|66563279|FG001|Overall Study|Sponsor Decision|1|||
23776986|NCT00386009|66563278|FG000|Overall Study|Withdrawal by Subject|5|||
23776987|NCT00386009|66563279|FG001|Overall Study|Withdrawal by Subject|4|||
23776988|NCT03025880|66563280|FG000|Overall Study|Adverse Event|1|||
23776989|NCT03025880|66563281|FG001|Overall Study|Adverse Event|0|||
23776990|NCT03025880|66563280|FG000|Overall Study|Death|1|||
23776991|NCT03025880|66563281|FG001|Overall Study|Death|1|||
23776992|NCT03025880|66563280|FG000|Overall Study|Withdrawal by Subject|0|||
23776993|NCT03025880|66563281|FG001|Overall Study|Withdrawal by Subject|1|||
23776994|NCT03025880|66563280|FG000|Overall Study|Physician Decision|0|||
23776995|NCT03025880|66563281|FG001|Overall Study|Physician Decision|1|||
23776996|NCT03025880|66563280|FG000|Overall Study|Progressive Disease|12|||
23835966|NCT03852472|66777900|FG000|Period 2 - Week 44|COVID-19 Related|0|||
23835967|NCT03852472|66777901|FG001|Period 2 - Week 44|COVID-19 Related|0|||
23449812|NCT01272232|65388184|FG002|Weeks 0-56|Lack of Efficacy|3|||
23634227|NCT01016262|66045594|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
23634228|NCT01241604|66045595|FG000|Screening Period|Screen Failure|3|||
23634229|NCT01241604|66045596|FG001|Screening Period|Screen Failure|0|||
23776997|NCT03025880|66563281|FG001|Overall Study|Progressive Disease|19|||
23835968|NCT03852472|66777902|FG002|Period 2 - Week 44|COVID-19 Related|0|||
23835969|NCT03852472|66777903|FG003|Period 2 - Week 44|COVID-19 Related|1|||
23835970|NCT03852472|66777904|FG004|Period 2 - Week 44|COVID-19 Related|0|||
23835971|NCT03852472|66777900|FG000|Period 2 - Week 44|Reason not stated|0|||
23835972|NCT03852472|66777901|FG001|Period 2 - Week 44|Reason not stated|0|||
23835973|NCT03852472|66777902|FG002|Period 2 - Week 44|Reason not stated|0|||
23835974|NCT03852472|66777903|FG003|Period 2 - Week 44|Reason not stated|0|||
23835975|NCT03852472|66777904|FG004|Period 2 - Week 44|Reason not stated|1|||
23835976|NCT02509507|66777905|FG000|Overall Study|Death|21|||
23835977|NCT02509507|66777906|FG001|Overall Study|Death|3|||
23577395|NCT00124982|65843709|FG002|Long-term Period|Neurologist Recommendation|1|||
23577396|NCT01101165|65843710|FG000|Period 1|Adverse Event|1|||
23577397|NCT01101165|65843711|FG001|Period 1|Adverse Event|2|||
23577398|NCT01101165|65843710|FG000|Period 1|Withdrawal by Subject|0|||
23577399|NCT01101165|65843711|FG001|Period 1|Withdrawal by Subject|2|||
23577400|NCT01101165|65843710|FG000|Period 1|Positive Drug Screen|0|||
23577401|NCT01101165|65843711|FG001|Period 1|Positive Drug Screen|1|||
23577402|NCT01101165|65843710|FG000|Period 1|Lost to Follow-up|1|||
23577403|NCT01101165|65843711|FG001|Period 1|Lost to Follow-up|0|||
23577404|NCT01101165|65843710|FG000|Period 2|Withdrawal by Subject|3|||
23577405|NCT01101165|65843711|FG001|Period 2|Withdrawal by Subject|1|||
23577406|NCT01101165|65843710|FG000|Period 2|Adverse Event|1|||
23577407|NCT01101165|65843711|FG001|Period 2|Adverse Event|0|||
23577408|NCT03005288|65843712|FG000|Overall Study|Withdrawal by Subject|7|||
23577409|NCT03005288|65843713|FG001|Overall Study|Withdrawal by Subject|5|||
23577410|NCT03005288|65843712|FG000|Overall Study|Lost to Follow-up|0|||
23835978|NCT02509507|66777907|FG002|Overall Study|Death|22|||
23835979|NCT02509507|66777908|FG003|Overall Study|Death|14|||
23835980|NCT02509507|66777909|FG004|Overall Study|Death|8|||
23835981|NCT02509507|66777910|FG005|Overall Study|Death|12|||
23835982|NCT02509507|66777911|FG006|Overall Study|Death|5|||
23835983|NCT02509507|66777912|FG007|Overall Study|Death|4|||
23835984|NCT02509507|66777913|FG008|Overall Study|Death|8|||
23835985|NCT02509507|66777905|FG000|Overall Study|Lost to Follow-up|0|||
23835986|NCT02509507|66777906|FG001|Overall Study|Lost to Follow-up|1|||
23835987|NCT02509507|66777907|FG002|Overall Study|Lost to Follow-up|0|||
23577411|NCT03005288|65843713|FG001|Overall Study|Lost to Follow-up|1|||
23577412|NCT03005288|65843712|FG000|Overall Study|Adverse Event|5|||
23835988|NCT02509507|66777908|FG003|Overall Study|Lost to Follow-up|0|||
23577413|NCT03005288|65843713|FG001|Overall Study|Adverse Event|0|||
23577414|NCT03005288|65843712|FG000|Overall Study|Protocol deviation|0|||
23577415|NCT03005288|65843713|FG001|Overall Study|Protocol deviation|1|||
23835989|NCT02509507|66777909|FG004|Overall Study|Lost to Follow-up|0|||
23835990|NCT02509507|66777910|FG005|Overall Study|Lost to Follow-up|2|||
23835991|NCT02509507|66777911|FG006|Overall Study|Lost to Follow-up|0|||
23577416|NCT03005288|65843712|FG000|Overall Study|Physician Decision|0|||
23577417|NCT03005288|65843713|FG001|Overall Study|Physician Decision|1|||
23582229|NCT03441984|65862402|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582230|NCT03441984|65862403|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582231|NCT03441984|65862404|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582232|NCT03441984|65862405|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582233|NCT03441984|65862406|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582234|NCT03441984|65862407|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582235|NCT03441984|65862408|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582236|NCT03441984|65862409|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582237|NCT00567879|65862410|FG000|Overall Study|Adverse Event|2|||
23582238|NCT00567879|65862411|FG001|Overall Study|Adverse Event|0|||
23582239|NCT00567879|65862412|FG002|Overall Study|Adverse Event|1|||
23582240|NCT00567879|65862413|FG003|Overall Study|Adverse Event|0|||
23776998|NCT02770820|66563282|FG000|Overall Study|Death|1|||
23582241|NCT00567879|65862414|FG004|Overall Study|Adverse Event|1|||
23582242|NCT00567879|65862415|FG005|Overall Study|Adverse Event|0|||
23835992|NCT02509507|66777912|FG007|Overall Study|Lost to Follow-up|0|||
23835993|NCT02509507|66777913|FG008|Overall Study|Lost to Follow-up|0|||
23835994|NCT02509507|66777905|FG000|Overall Study|Withdrawal by Subject|2|||
23835995|NCT02509507|66777906|FG001|Overall Study|Withdrawal by Subject|0|||
23835996|NCT02509507|66777907|FG002|Overall Study|Withdrawal by Subject|1|||
23835997|NCT02509507|66777908|FG003|Overall Study|Withdrawal by Subject|4|||
23835998|NCT02509507|66777909|FG004|Overall Study|Withdrawal by Subject|1|||
23835999|NCT02509507|66777910|FG005|Overall Study|Withdrawal by Subject|3|||
23836000|NCT02509507|66777911|FG006|Overall Study|Withdrawal by Subject|4|||
23836001|NCT02509507|66777912|FG007|Overall Study|Withdrawal by Subject|0|||
23836002|NCT02509507|66777913|FG008|Overall Study|Withdrawal by Subject|1|||
23836003|NCT01753310|66777914|FG000|Overall Study|Entered into open label extension study|25|||
23836004|NCT01753310|66777915|FG001|Overall Study|Entered into open label extension study|22|||
23836005|NCT01753310|66777914|FG000|Overall Study|Adverse Event|1|||
23836006|NCT01753310|66777915|FG001|Overall Study|Adverse Event|0|||
23836007|NCT01753310|66777914|FG000|Overall Study|Lost to Follow-up|2|||
23836008|NCT01753310|66777915|FG001|Overall Study|Lost to Follow-up|0|||
23836009|NCT01753310|66777914|FG000|Overall Study|Subject decision|2|||
23836010|NCT01753310|66777915|FG001|Overall Study|Subject decision|2|||
23836011|NCT01753310|66777914|FG000|Overall Study|Sponsor decision|1|||
23836012|NCT01753310|66777915|FG001|Overall Study|Sponsor decision|0|||
23836013|NCT01753310|66777914|FG000|Overall Study|Withdrawal by Subject|1|||
23836014|NCT01753310|66777915|FG001|Overall Study|Withdrawal by Subject|0|||
23836015|NCT00687271|66777917|FG000|Overall Study|Adverse Event|1|||
23836016|NCT00687271|66777918|FG001|Overall Study|Adverse Event|3|||
23836017|NCT00687271|66777919|FG002|Overall Study|Adverse Event|1|||
23836018|NCT00687271|66777920|FG003|Overall Study|Adverse Event|0|||
23836019|NCT00687271|66777917|FG000|Overall Study|Lost to Follow-up|0|||
23836020|NCT00687271|66777918|FG001|Overall Study|Lost to Follow-up|1|||
23836021|NCT00687271|66777919|FG002|Overall Study|Lost to Follow-up|0|||
23836022|NCT00687271|66777920|FG003|Overall Study|Lost to Follow-up|0|||
23836023|NCT00687271|66777917|FG000|Overall Study|Protocol Violation|2|||
23836024|NCT00687271|66777918|FG001|Overall Study|Protocol Violation|1|||
23836025|NCT00687271|66777919|FG002|Overall Study|Protocol Violation|1|||
23836026|NCT00687271|66777920|FG003|Overall Study|Protocol Violation|0|||
23577418|NCT02264574|65846804|FG000|Overall Study|Death|21|||
23836027|NCT00687271|66777917|FG000|Overall Study|Withdrawal by Subject|0|||
23836028|NCT00687271|66777918|FG001|Overall Study|Withdrawal by Subject|1|||
23836029|NCT00687271|66777919|FG002|Overall Study|Withdrawal by Subject|3|||
23836030|NCT00687271|66777920|FG003|Overall Study|Withdrawal by Subject|0|||
23836031|NCT02914613|66777921|FG000|Overall Study|Withdrawal by Subject|1|||
23836032|NCT02914613|66777922|FG001|Overall Study|Withdrawal by Subject|2|||
23836033|NCT02914613|66777921|FG000|Overall Study|Adverse Event|1|||
23836034|NCT02914613|66777922|FG001|Overall Study|Adverse Event|0|||
23577419|NCT02264574|65846805|FG001|Overall Study|Death|21|||
23577420|NCT02264574|65846804|FG000|Overall Study|Withdrawal by Subject|8|||
23577421|NCT02264574|65846805|FG001|Overall Study|Withdrawal by Subject|6|||
23836035|NCT03123393|66777923|FG000|Overall Study|Study Terminated by Sponsor|6|||
23836036|NCT03123393|66777924|FG001|Overall Study|Study Terminated by Sponsor|9|||
23836037|NCT03123393|66777923|FG000|Overall Study|Withdrawal by Subject|2|||
23836038|NCT03123393|66777924|FG001|Overall Study|Withdrawal by Subject|1|||
23836039|NCT03123393|66777923|FG000|Overall Study|Reason not Specified|13|||
23836040|NCT03123393|66777924|FG001|Overall Study|Reason not Specified|13|||
23836041|NCT01973439|66777936|FG000|Overall Study|Lost samples from one PK Day|2|||
23836042|NCT01973439|66777936|FG000|Overall Study|Vomiting after commencing once daily|1|||
23836043|NCT01973439|66777936|FG000|Overall Study|PK curve incomplete|2|||
23836044|NCT02395848|66777940|FG000|Overall Study|Lost to Follow-up|2|||
23836045|NCT02431676|66777943|FG000|Overall Study|no lab obtained|0|||
23836046|NCT02431676|66777944|FG001|Overall Study|no lab obtained|1|||
23836047|NCT02431676|66777945|FG002|Overall Study|no lab obtained|2|||
23836048|NCT01778530|66777946|FG000|Overall Study|Progression on study|1|||
23836049|NCT01778530|66777946|FG000|Overall Study|Adverse event/side effect|1|||
23836050|NCT02366689|66777947|FG000|Overall Study|Withdrawal by Subject|1|||
23836051|NCT02366689|66777948|FG001|Overall Study|Withdrawal by Subject|0|||
23836052|NCT02366689|66777949|FG002|Overall Study|Withdrawal by Subject|1|||
23836053|NCT02366689|66777947|FG000|Overall Study|Lost to Follow-up|3|||
23836054|NCT02366689|66777948|FG001|Overall Study|Lost to Follow-up|2|||
23577422|NCT02264574|65846804|FG000|Overall Study|Other, Not Specified|0|||
23577423|NCT02264574|65846805|FG001|Overall Study|Other, Not Specified|3|||
23836055|NCT02366689|66777949|FG002|Overall Study|Lost to Follow-up|0|||
23836056|NCT02366689|66777947|FG000|Overall Study|Pregnancy|0|||
23836057|NCT02366689|66777948|FG001|Overall Study|Pregnancy|1|||
23836058|NCT02366689|66777949|FG002|Overall Study|Pregnancy|1|||
23836059|NCT01479465|66777950|FG000|Overall Study|Disease Progression|9|||
23836060|NCT01479465|66777951|FG001|Overall Study|Disease Progression|61|||
23836061|NCT01479465|66777952|FG002|Overall Study|Disease Progression|65|||
23836062|NCT01479465|66777953|FG003|Overall Study|Disease Progression|70|||
23836063|NCT01479465|66777950|FG000|Overall Study|Study Discontinued by Sponsor|0|||
23836064|NCT01479465|66777951|FG001|Overall Study|Study Discontinued by Sponsor|7|||
23836065|NCT01479465|66777952|FG002|Overall Study|Study Discontinued by Sponsor|5|||
23577424|NCT05177848|65846806|FG000|Overall Study|Lost to Follow-up|1|||
23577425|NCT05177848|65846807|FG001|Overall Study|Lost to Follow-up|4|||
23577426|NCT05177848|65846806|FG000|Overall Study|Discontinued|2|||
23577427|NCT05177848|65846807|FG001|Overall Study|Discontinued|1|||
23577428|NCT04668144|65846808|FG000|Overall Study|Protocol Violation|0|||
23836066|NCT01479465|66777953|FG003|Overall Study|Study Discontinued by Sponsor|3|||
23836067|NCT01479465|66777950|FG000|Overall Study|Adverse Event|0|||
23836068|NCT01479465|66777951|FG001|Overall Study|Adverse Event|3|||
23836069|NCT01479465|66777952|FG002|Overall Study|Adverse Event|6|||
23577429|NCT04668144|65846809|FG001|Overall Study|Protocol Violation|1|||
23577430|NCT04668144|65846810|FG002|Overall Study|Protocol Violation|2|||
23836070|NCT01479465|66777953|FG003|Overall Study|Adverse Event|4|||
23836071|NCT01479465|66777950|FG000|Overall Study|Investigator Discretion|1|||
23836072|NCT01479465|66777951|FG001|Overall Study|Investigator Discretion|4|||
23836073|NCT01479465|66777952|FG002|Overall Study|Investigator Discretion|2|||
23836074|NCT01479465|66777953|FG003|Overall Study|Investigator Discretion|4|||
23836075|NCT01479465|66777950|FG000|Overall Study|Subject Request|1|||
23836076|NCT01479465|66777951|FG001|Overall Study|Subject Request|3|||
23577431|NCT00843882|65846811|FG000|Step 1|Lack of Efficacy|14|||
23577432|NCT00843882|65846812|FG001|Step 1|Lack of Efficacy|10|||
23577433|NCT00843882|65846813|FG002|Step 1|Lack of Efficacy|21|||
23577434|NCT00843882|65846811|FG000|Step 1|Adverse Event|8|||
23577435|NCT00843882|65846812|FG001|Step 1|Adverse Event|17|||
23577436|NCT00843882|65846813|FG002|Step 1|Adverse Event|20|||
23577437|NCT00843882|65846811|FG000|Step 1|Death|1|||
23577438|NCT00843882|65846812|FG001|Step 1|Death|2|||
23577439|NCT00843882|65846813|FG002|Step 1|Death|4|||
23577440|NCT00843882|65846811|FG000|Step 1|Withdrawal by Subject|6|||
23776999|NCT02770820|66563282|FG000|Overall Study|Physician Decision|2|||
23777000|NCT00414466|66563283|FG000|Overall Study|Adverse Event|0|||
23777001|NCT00414466|66563284|FG001|Overall Study|Adverse Event|0|||
23777002|NCT00414466|66563285|FG002|Overall Study|Adverse Event|1|||
23777003|NCT00414466|66563286|FG003|Overall Study|Adverse Event|1|||
23777004|NCT00414466|66563283|FG000|Overall Study|Lack of Efficacy|1|||
23777005|NCT00414466|66563284|FG001|Overall Study|Lack of Efficacy|0|||
23777006|NCT00414466|66563285|FG002|Overall Study|Lack of Efficacy|0|||
23777007|NCT00414466|66563286|FG003|Overall Study|Lack of Efficacy|0|||
23777008|NCT00414466|66563283|FG000|Overall Study|Withdrawn by Sponsor|1|||
23777009|NCT00414466|66563284|FG001|Overall Study|Withdrawn by Sponsor|0|||
23777010|NCT00414466|66563285|FG002|Overall Study|Withdrawn by Sponsor|0|||
23777011|NCT00414466|66563286|FG003|Overall Study|Withdrawn by Sponsor|0|||
23777012|NCT01199861|66563288|FG000|Overall Study|Administrative problems|1|||
23777013|NCT01199861|66563289|FG001|Overall Study|Administrative problems|0|||
23777014|NCT01199861|66563288|FG000|Overall Study|Adverse Event|1|||
23777015|NCT01199861|66563289|FG001|Overall Study|Adverse Event|0|||
23777016|NCT01900730|66563290|FG000|Overall Study|Withdrawal by Subject|1|||
23777017|NCT01900730|66563291|FG001|Overall Study|Withdrawal by Subject|0|||
23777018|NCT01900730|66563290|FG000|Overall Study|Screen Failure|1|||
23777019|NCT01900730|66563291|FG001|Overall Study|Screen Failure|0|||
23777020|NCT02682238|66563293|FG000|Overall Study|Lost to Follow-up|0|||
23777021|NCT02682238|66563294|FG001|Overall Study|Lost to Follow-up|2|||
23777022|NCT02682238|66563293|FG000|Overall Study|Withdrawal by Subject|1|||
23777023|NCT02682238|66563294|FG001|Overall Study|Withdrawal by Subject|0|||
23777024|NCT02682238|66563293|FG000|Overall Study|Adverse Event|1|||
23777025|NCT02682238|66563294|FG001|Overall Study|Adverse Event|0|||
23777026|NCT02682238|66563293|FG000|Overall Study|Non-compliance with Study Drug|1|||
23777027|NCT02682238|66563294|FG001|Overall Study|Non-compliance with Study Drug|0|||
23777028|NCT02682238|66563293|FG000|Overall Study|Non-compliance with Protocol|0|||
23777029|NCT02682238|66563294|FG001|Overall Study|Non-compliance with Protocol|2|||
23777030|NCT00579670|66563295|FG000|Overall Study|Death|1|||
23777031|NCT00579670|66563296|FG001|Overall Study|Death|0|||
23777032|NCT00579670|66563297|FG002|Overall Study|Death|0|||
23777033|NCT00579670|66563298|FG003|Overall Study|Death|0|||
23777034|NCT00579670|66563299|FG004|Overall Study|Death|0|||
23777035|NCT00579670|66563295|FG000|Overall Study|Adverse Event|1|||
23777036|NCT00579670|66563296|FG001|Overall Study|Adverse Event|0|||
23777037|NCT00579670|66563297|FG002|Overall Study|Adverse Event|1|||
23777038|NCT00579670|66563298|FG003|Overall Study|Adverse Event|2|||
23777039|NCT00579670|66563299|FG004|Overall Study|Adverse Event|0|||
23777040|NCT00579670|66563295|FG000|Overall Study|Lack of Efficacy|0|||
23777041|NCT00579670|66563296|FG001|Overall Study|Lack of Efficacy|0|||
23777042|NCT00579670|66563297|FG002|Overall Study|Lack of Efficacy|1|||
23777043|NCT00579670|66563298|FG003|Overall Study|Lack of Efficacy|14|||
23777044|NCT00579670|66563299|FG004|Overall Study|Lack of Efficacy|0|||
23777045|NCT00579670|66563295|FG000|Overall Study|Lost to Follow-up|0|||
23777046|NCT00579670|66563296|FG001|Overall Study|Lost to Follow-up|1|||
23777047|NCT00579670|66563297|FG002|Overall Study|Lost to Follow-up|0|||
23777048|NCT00579670|66563298|FG003|Overall Study|Lost to Follow-up|4|||
23777049|NCT00579670|66563299|FG004|Overall Study|Lost to Follow-up|0|||
23777050|NCT00579670|66563295|FG000|Overall Study|Other|0|||
23777051|NCT00579670|66563296|FG001|Overall Study|Other|0|||
23777052|NCT00579670|66563297|FG002|Overall Study|Other|1|||
23777053|NCT00579670|66563298|FG003|Overall Study|Other|2|||
23836077|NCT01479465|66777952|FG002|Overall Study|Subject Request|4|||
23577441|NCT00843882|65846812|FG001|Step 1|Withdrawal by Subject|12|||
23577442|NCT00843882|65846813|FG002|Step 1|Withdrawal by Subject|9|||
23577443|NCT00843882|65846811|FG000|Step 1|Physician Decision|0|||
23577444|NCT00843882|65846812|FG001|Step 1|Physician Decision|5|||
23577445|NCT00843882|65846813|FG002|Step 1|Physician Decision|1|||
23577446|NCT00843882|65846811|FG000|Step 1|Patient and physician's decision|0|||
23577447|NCT00843882|65846812|FG001|Step 1|Patient and physician's decision|0|||
23777054|NCT00579670|66563299|FG004|Overall Study|Other|0|||
23777055|NCT00579670|66563295|FG000|Overall Study|Withdrawal by Subject|0|||
23777056|NCT00579670|66563296|FG001|Overall Study|Withdrawal by Subject|0|||
23777057|NCT00579670|66563297|FG002|Overall Study|Withdrawal by Subject|1|||
23777058|NCT00579670|66563298|FG003|Overall Study|Withdrawal by Subject|0|||
23777059|NCT00579670|66563299|FG004|Overall Study|Withdrawal by Subject|0|||
23777060|NCT04384978|66563307|FG000|Overall Study|Withdrawal by Subject|4|||
23777061|NCT04384978|66563308|FG001|Overall Study|Withdrawal by Subject|0|||
23836078|NCT01479465|66777953|FG003|Overall Study|Subject Request|2|||
23836079|NCT01479465|66777950|FG000|Overall Study|Subject Withdrew Consent|0|||
23836080|NCT01479465|66777951|FG001|Overall Study|Subject Withdrew Consent|5|||
23836081|NCT01479465|66777952|FG002|Overall Study|Subject Withdrew Consent|2|||
23836082|NCT01479465|66777953|FG003|Overall Study|Subject Withdrew Consent|1|||
23836083|NCT01479465|66777950|FG000|Overall Study|Protocol Violation|0|||
23836084|NCT01479465|66777951|FG001|Overall Study|Protocol Violation|1|||
23836085|NCT01479465|66777952|FG002|Overall Study|Protocol Violation|1|||
23836086|NCT01479465|66777953|FG003|Overall Study|Protocol Violation|0|||
23836087|NCT01479465|66777950|FG000|Overall Study|Death|0|||
23836088|NCT01479465|66777951|FG001|Overall Study|Death|0|||
23836089|NCT01479465|66777952|FG002|Overall Study|Death|0|||
23836090|NCT01479465|66777953|FG003|Overall Study|Death|1|||
23836091|NCT01479465|66777950|FG000|Overall Study|Lost to Follow-up|0|||
23836092|NCT01479465|66777951|FG001|Overall Study|Lost to Follow-up|0|||
23836093|NCT01479465|66777952|FG002|Overall Study|Lost to Follow-up|1|||
23836094|NCT01479465|66777953|FG003|Overall Study|Lost to Follow-up|0|||
23836095|NCT03777436|66777954|FG000|Placebo-controlled Phase|Adverse Event|8|||
23836096|NCT03777436|66777955|FG001|Placebo-controlled Phase|Adverse Event|10|||
23836097|NCT03777436|66777956|FG002|Placebo-controlled Phase|Adverse Event|0|||
23836098|NCT03777436|66777954|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
23836099|NCT03777436|66777955|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
23836100|NCT03777436|66777956|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23836101|NCT03777436|66777954|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
23836102|NCT03777436|66777955|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
23836103|NCT03777436|66777956|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23836104|NCT03777436|66777954|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
23836105|NCT03777436|66777955|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
23836106|NCT03777436|66777956|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
23836107|NCT03777436|66777954|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
23836108|NCT03777436|66777955|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
23836109|NCT03777436|66777956|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23836110|NCT03777436|66777954|FG000|Placebo-controlled Phase|Physician Decision|0|||
23836111|NCT03777436|66777955|FG001|Placebo-controlled Phase|Physician Decision|1|||
23836112|NCT03777436|66777956|FG002|Placebo-controlled Phase|Physician Decision|0|||
23836113|NCT03777436|66777954|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
23836114|NCT03777436|66777955|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
23836115|NCT03777436|66777956|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
23836116|NCT03777436|66777954|FG000|Apremilast Extension Phase|Adverse Event|0|||
23836117|NCT03777436|66777955|FG001|Apremilast Extension Phase|Adverse Event|0|||
23836118|NCT03777436|66777956|FG002|Apremilast Extension Phase|Adverse Event|6|||
23836119|NCT03777436|66777954|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23836120|NCT03777436|66777955|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23836121|NCT03777436|66777956|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
23836122|NCT03777436|66777954|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23836123|NCT03777436|66777955|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23836124|NCT03777436|66777956|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
23836125|NCT03777436|66777954|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23836126|NCT03777436|66777955|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23836127|NCT03777436|66777956|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
23836128|NCT03777436|66777954|FG000|Apremilast Extension Phase|Miscellaneous|0|||
23836129|NCT03777436|66777955|FG001|Apremilast Extension Phase|Miscellaneous|0|||
23836130|NCT03777436|66777956|FG002|Apremilast Extension Phase|Miscellaneous|1|||
23577448|NCT00843882|65846813|FG002|Step 1|Patient and physician's decision|1|||
23577449|NCT00843882|65846811|FG000|Step 1|Other complicating disease|1|||
23577450|NCT00843882|65846812|FG001|Step 1|Other complicating disease|3|||
23577451|NCT00843882|65846813|FG002|Step 1|Other complicating disease|4|||
23577452|NCT00843882|65846811|FG000|Step 1|Alternative therapy|0|||
23577453|NCT00843882|65846812|FG001|Step 1|Alternative therapy|1|||
23577454|NCT00843882|65846813|FG002|Step 1|Alternative therapy|1|||
23577455|NCT00843882|65846811|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
23577456|NCT00843882|65846812|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
23836131|NCT00083759|66777957|FG000|Overall Study|Adverse Event|5|||
23836132|NCT00083759|66777958|FG001|Overall Study|Adverse Event|3|||
23836133|NCT00083759|66777957|FG000|Overall Study|Lost to Follow-up|1|||
23577457|NCT00843882|65846813|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
23577458|NCT00843882|65846811|FG000|Step 1|Off treatment reason unknown|0|||
23577459|NCT00843882|65846812|FG001|Step 1|Off treatment reason unknown|1|||
23577460|NCT00843882|65846813|FG002|Step 1|Off treatment reason unknown|4|||
23577461|NCT00843882|65846811|FG000|Step 1|Never started treatment|2|||
23836134|NCT00083759|66777958|FG001|Overall Study|Lost to Follow-up|0|||
23836135|NCT00083759|66777957|FG000|Overall Study|Death|1|||
23836136|NCT00083759|66777958|FG001|Overall Study|Death|1|||
23836137|NCT00083759|66777957|FG000|Overall Study|Inadequate Therapeutic Response|32|||
23577462|NCT00843882|65846812|FG001|Step 1|Never started treatment|0|||
23577463|NCT00843882|65846813|FG002|Step 1|Never started treatment|0|||
23577464|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
23836138|NCT00083759|66777958|FG001|Overall Study|Inadequate Therapeutic Response|35|||
23836139|NCT00083759|66777957|FG000|Overall Study|Subject Withdrew Consent|2|||
23836140|NCT00083759|66777958|FG001|Overall Study|Subject Withdrew Consent|2|||
23836141|NCT00083759|66777957|FG000|Overall Study|Non-Compliance|1|||
23836142|NCT00083759|66777958|FG001|Overall Study|Non-Compliance|0|||
23836143|NCT00083759|66777957|FG000|Overall Study|Sponsor's Discretion|28|||
23836144|NCT00083759|66777958|FG001|Overall Study|Sponsor's Discretion|29|||
23836145|NCT00083759|66777957|FG000|Overall Study|Other|14|||
23836146|NCT00083759|66777958|FG001|Overall Study|Other|13|||
23836147|NCT00351468|66777959|FG000|Overall Study|Adverse Event|42|||
23836148|NCT00351468|66777959|FG000|Overall Study|Withdrawal by Subject|39|||
23836149|NCT00351468|66777959|FG000|Overall Study|Various -follow up w clinical team|39|||
23836150|NCT00351468|66777959|FG000|Overall Study|Lack of Efficacy|32|||
23836151|NCT00351468|66777959|FG000|Overall Study|Non-compliance|8|||
23836152|NCT00351468|66777959|FG000|Overall Study|Lost to Follow-up|4|||
23836153|NCT00351468|66777959|FG000|Overall Study|Protocol Violation|3|||
23836154|NCT04335123|66777960|FG000|Overall Study|Withdrawal by Subject|2|||
23836155|NCT04335123|66777961|FG001|Overall Study|Withdrawal by Subject|0|||
23836156|NCT04335123|66777960|FG000|Overall Study|Physician Decision|2|||
23836157|NCT04335123|66777961|FG001|Overall Study|Physician Decision|0|||
23836158|NCT02028767|66777962|FG000|Treatment Period 2|Non compliant with protocol|1|||
23836159|NCT02028767|66777963|FG001|Treatment Period 2|Non compliant with protocol|0|||
23836160|NCT02028767|66777962|FG000|Treatment Period 2|Reason other than those specified above|1|||
23836161|NCT02028767|66777963|FG001|Treatment Period 2|Reason other than those specified above|0|||
23836162|NCT00832455|66777964|FG000|Overall Study|Adverse Event|13|||
23836163|NCT00832455|66777964|FG000|Overall Study|Lost to Follow-up|26|||
23836164|NCT00832455|66777964|FG000|Overall Study|Protocol Violation|4|||
23836165|NCT00832455|66777964|FG000|Overall Study|Withdrawal by Subject|17|||
23836166|NCT00832455|66777964|FG000|Overall Study|Screening Failure|2|||
23836167|NCT00832455|66777964|FG000|Overall Study|Stopped Medication|4|||
23836168|NCT00832455|66777964|FG000|Overall Study|Parent misunderstood study|1|||
23836169|NCT00832455|66777964|FG000|Overall Study|Parent dissatisfied|1|||
23836170|NCT00832455|66777964|FG000|Overall Study|No improvement|3|||
23836171|NCT00832455|66777964|FG000|Overall Study|Patient moved|1|||
23836172|NCT01028014|66777965|FG000|Overall Study|Lost to Follow-up|1|||
23836173|NCT01028014|66777966|FG001|Overall Study|Lost to Follow-up|2|||
23836174|NCT01028014|66777967|FG002|Overall Study|Lost to Follow-up|0|||
23836175|NCT01028014|66777968|FG003|Overall Study|Lost to Follow-up|1|||
23836176|NCT01028014|66777969|FG004|Overall Study|Lost to Follow-up|1|||
23577465|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
23577466|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
23577467|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
23577468|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
23577469|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
23577470|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
23577471|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
23577472|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
23577473|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
23836177|NCT01028014|66777970|FG005|Overall Study|Lost to Follow-up|2|||
23836178|NCT01435460|66777971|FG000|Overall Study|Adverse Event|2|||
23836179|NCT01435460|66777972|FG001|Overall Study|Adverse Event|1|||
23836180|NCT01435460|66777971|FG000|Overall Study|Lost to Follow-up|6|||
23836181|NCT01435460|66777972|FG001|Overall Study|Lost to Follow-up|1|||
23836182|NCT01435460|66777971|FG000|Overall Study|Withdrawal by Subject|1|||
23836183|NCT01435460|66777972|FG001|Overall Study|Withdrawal by Subject|3|||
23836184|NCT01435460|66777971|FG000|Overall Study|Protocol Violation|0|||
23577474|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
23577475|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
23577476|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
23836185|NCT01435460|66777972|FG001|Overall Study|Protocol Violation|1|||
23836186|NCT01435460|66777971|FG000|Overall Study|Did not meet eligibility criteria|2|||
23836187|NCT01435460|66777972|FG001|Overall Study|Did not meet eligibility criteria|0|||
23836188|NCT01209520|66777973|FG000|Overall Study|Withdrawal by Subject|3|||
23836189|NCT02195869|66777974|FG000|Overall Study|cGVHD Progression|5|||
23836190|NCT02195869|66777974|FG000|Overall Study|Malignancy Progression/relapse|2|||
23836191|NCT02195869|66777974|FG000|Overall Study|Adverse Event|15|||
23836192|NCT02195869|66777974|FG000|Overall Study|Withdrawal by Subject|7|||
23836193|NCT02195869|66777974|FG000|Overall Study|Physician Decision|4|||
23836194|NCT02195869|66777974|FG000|Overall Study|Study Terminated by Sponsor|7|||
23449813|NCT01272232|65388182|FG000|Weeks 0-56|Protocol Violation|12|||
23577477|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
23634230|NCT01241604|66045597|FG002|Screening Period|Screen Failure|0|||
23836195|NCT02195869|66777974|FG000|Overall Study|Noncompliance with study drug|2|||
23836196|NCT02091089|66777977|FG000|Overall Study|Lost to Follow-up|2|||
23836197|NCT00917852|66777978|FG000|Overall Study|Death|6|||
23836198|NCT02764762|66777979|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23836199|NCT02764762|66777979|FG000|Overall Study|Lost to Follow-up|4|||
23836200|NCT02764762|66777979|FG000|Overall Study|Voluntary Withdrawal|8|||
23836201|NCT02764762|66777979|FG000|Overall Study|Site Termination|1|||
23836202|NCT02764762|66777979|FG000|Overall Study|Lack of Efficacy|16|||
23836203|NCT02764762|66777979|FG000|Overall Study|Reason not Specified|1|||
23836204|NCT02406027|66777981|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23836205|NCT02406027|66777982|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
23836206|NCT02406027|66777983|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
23836207|NCT02406027|66777984|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23836208|NCT02406027|66777985|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23836209|NCT02406027|66777986|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23836210|NCT02406027|66777987|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23836211|NCT02406027|66777981|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
23836212|NCT02406027|66777982|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23836213|NCT02406027|66777983|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
23836214|NCT02406027|66777984|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23836215|NCT02406027|66777985|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23836216|NCT02406027|66777986|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23836217|NCT02406027|66777987|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23836218|NCT02406027|66777981|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
23836219|NCT02406027|66777982|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
23836220|NCT02406027|66777983|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
23836221|NCT02406027|66777984|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23836222|NCT02406027|66777985|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23836223|NCT02406027|66777986|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23836224|NCT02406027|66777987|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23836225|NCT02406027|66777981|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
23836226|NCT02406027|66777982|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23836227|NCT02406027|66777983|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
23836228|NCT02406027|66777984|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23836229|NCT02406027|66777985|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23836230|NCT02406027|66777986|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23836231|NCT02406027|66777987|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23836232|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
23836233|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
23836234|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
23836235|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
23836236|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
23836237|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
23836238|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
23836239|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
23836240|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
23836241|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
23836242|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
23836243|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
23836244|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
23836245|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
23836246|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23836247|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23836248|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23836249|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
23836250|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
23836251|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23836252|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
23836253|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23836254|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23836255|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23836256|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
23836257|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
23836258|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
23836259|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
23836260|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23577478|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
23836261|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23836262|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23836263|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23836264|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23836265|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
23836266|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23836267|NCT02406027|66777981|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836268|NCT02406027|66777982|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836269|NCT02406027|66777983|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836270|NCT02406027|66777984|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836271|NCT02406027|66777985|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
23836272|NCT02406027|66777986|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836273|NCT02406027|66777987|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23836274|NCT00086619|66777988|FG000|Overall Study|Withdrawal by Subject|6|||
23836275|NCT00086619|66777989|FG001|Overall Study|Withdrawal by Subject|6|||
23836276|NCT00086619|66777988|FG000|Overall Study|Adverse Event|8|||
23836277|NCT00086619|66777989|FG001|Overall Study|Adverse Event|10|||
23836278|NCT00086619|66777988|FG000|Overall Study|Protocol Violation|1|||
23836279|NCT00086619|66777989|FG001|Overall Study|Protocol Violation|1|||
23836280|NCT02198664|66777990|FG000|Overall Study|Adverse Event|2|||
23836281|NCT02198664|66777991|FG001|Overall Study|Adverse Event|0|||
23836282|NCT02198664|66777990|FG000|Overall Study|Withdrawal by Subject|11|||
23836283|NCT02198664|66777991|FG001|Overall Study|Withdrawal by Subject|8|||
23836284|NCT02198664|66777990|FG000|Overall Study|Failure to tolerate|2|||
23836285|NCT02198664|66777991|FG001|Overall Study|Failure to tolerate|0|||
23836286|NCT02198664|66777990|FG000|Overall Study|Not stated|1|||
23836287|NCT02198664|66777991|FG001|Overall Study|Not stated|0|||
23836288|NCT00513695|66777992|FG000|Overall Study|Discontinued therapy|2|||
23577479|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
23577480|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
23577481|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
23577482|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
23577483|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
23577484|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
23577485|NCT02790606|65846815|FG000|Overall Study|Death|27|||
23577486|NCT02790606|65846815|FG000|Overall Study|Lost to Follow-up|4|||
23577487|NCT02790606|65846815|FG000|Overall Study|Physician Decision|3|||
23577488|NCT02790606|65846815|FG000|Overall Study|Withdrawal by Subject|1|||
23577489|NCT04796935|65846816|FG000|Overall Study|Withdrawal by Subject|0|||
23577490|NCT04796935|65846817|FG001|Overall Study|Withdrawal by Subject|1|||
23577491|NCT04796935|65846816|FG000|Overall Study|Physician Decision|0|||
23577492|NCT04796935|65846817|FG001|Overall Study|Physician Decision|1|||
23836289|NCT00513695|66777992|FG000|Overall Study|Progression prior to surgery|3|||
23836290|NCT04305327|66777993|FG000|Overall Study|Study early termination|2|||
23836291|NCT04305327|66777994|FG001|Overall Study|Study early termination|5|||
23836292|NCT04305327|66777995|FG002|Overall Study|Study early termination|2|||
23836293|NCT04305327|66777996|FG003|Overall Study|Study early termination|2|||
23836294|NCT04305327|66777993|FG000|Overall Study|Withdrawal by Subject|0|||
23836295|NCT04305327|66777994|FG001|Overall Study|Withdrawal by Subject|1|||
23836296|NCT04305327|66777995|FG002|Overall Study|Withdrawal by Subject|0|||
23836297|NCT04305327|66777996|FG003|Overall Study|Withdrawal by Subject|0|||
23836298|NCT03340454|66777997|FG000|Overall Study|Lost to Follow-up|0|||
23836299|NCT03340454|66777998|FG001|Overall Study|Lost to Follow-up|4|||
23577493|NCT04796935|65846816|FG000|Overall Study|Device not available|1|||
23577494|NCT04796935|65846817|FG001|Overall Study|Device not available|0|||
23577495|NCT04796935|65846816|FG000|Overall Study|Trained provider not available|1|||
23577496|NCT04796935|65846817|FG001|Overall Study|Trained provider not available|0|||
23577497|NCT02711995|65846818|FG000|Washout (90 Days)|Conflicting medication|1|||
23577498|NCT00504348|65846819|FG000|Overall Study|Adverse Event|3|||
23577499|NCT00504348|65846819|FG000|Overall Study|Lack of Efficacy|4|||
23577500|NCT00504348|65846819|FG000|Overall Study|Physician Decision|1|||
23577501|NCT02487446|65846820|FG000|Period 1|Physician Decision|0|||
23836300|NCT04630002|66777999|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
23836301|NCT04630002|66778000|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23836302|NCT04630002|66778001|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23836303|NCT04630002|66777999|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
23577502|NCT02487446|65846821|FG001|Period 1|Physician Decision|1|||
23577503|NCT02487446|65846820|FG000|Period 1|Lack of Efficacy|1|||
23577504|NCT02487446|65846821|FG001|Period 1|Lack of Efficacy|0|||
23577505|NCT02487446|65846820|FG000|Period 1|Protocol deviation|3|||
23577506|NCT02487446|65846821|FG001|Period 1|Protocol deviation|2|||
23577507|NCT02487446|65846820|FG000|Period 1|Lost to Follow-up|2|||
23577508|NCT02487446|65846821|FG001|Period 1|Lost to Follow-up|0|||
23577509|NCT02487446|65846820|FG000|Period 1|Withdrawal by Subject|2|||
23577510|NCT02487446|65846821|FG001|Period 1|Withdrawal by Subject|0|||
23577511|NCT02487446|65846820|FG000|Period 1|Adverse Event|5|||
23577512|NCT02487446|65846821|FG001|Period 1|Adverse Event|5|||
23577513|NCT02487446|65846820|FG000|Washout|Lost to Follow-up|0|||
23577514|NCT02487446|65846821|FG001|Washout|Lost to Follow-up|2|||
23577515|NCT02487446|65846820|FG000|Washout|Withdrawal by Subject|1|||
23577516|NCT02487446|65846821|FG001|Washout|Withdrawal by Subject|4|||
23577517|NCT02487446|65846820|FG000|Washout|Adverse Event|2|||
23577518|NCT02487446|65846821|FG001|Washout|Adverse Event|2|||
23577519|NCT02487446|65846820|FG000|Period 2|Protocol deviation|0|||
23577520|NCT02487446|65846821|FG001|Period 2|Protocol deviation|1|||
23577521|NCT02487446|65846820|FG000|Period 2|Lost to Follow-up|1|||
23577522|NCT02487446|65846821|FG001|Period 2|Lost to Follow-up|1|||
23577523|NCT02487446|65846820|FG000|Period 2|Withdrawal by Subject|1|||
23577524|NCT02487446|65846821|FG001|Period 2|Withdrawal by Subject|1|||
23577525|NCT02487446|65846820|FG000|Period 2|Adverse Event|6|||
23577526|NCT02487446|65846821|FG001|Period 2|Adverse Event|2|||
23577527|NCT00445692|65846823|FG000|Overall Study|Adverse Event|11|||
23577528|NCT00445692|65846823|FG000|Overall Study|Lack of Efficacy|5|||
23577529|NCT01272011|65846824|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
23577530|NCT01272011|65846825|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
23577531|NCT01272011|65846826|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
23449814|NCT01272232|65388183|FG001|Weeks 0-56|Protocol Violation|8|||
23449815|NCT01272232|65388184|FG002|Weeks 0-56|Protocol Violation|13|||
23449816|NCT01272232|65388182|FG000|Weeks 0-56|Withdrawal criteria|32|||
23449817|NCT01272232|65388183|FG001|Weeks 0-56|Withdrawal criteria|14|||
23449818|NCT01272232|65388184|FG002|Weeks 0-56|Withdrawal criteria|37|||
23449819|NCT01272232|65388182|FG000|Weeks 0-56|Unclassified|16|||
23449820|NCT01272232|65388183|FG001|Weeks 0-56|Unclassified|7|||
23449821|NCT01272232|65388184|FG002|Weeks 0-56|Unclassified|12|||
23449822|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
23449823|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
23449824|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
23449825|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
23449826|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
23449827|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
23449828|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
23449829|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
23449830|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
23449831|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
23449832|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
23449833|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
23449834|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
23449835|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
23449836|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
23449837|NCT00657540|65391310|FG000|Overall Study|Lost to Follow-up|1|||
23449838|NCT00657540|65391311|FG001|Overall Study|Lost to Follow-up|4|||
23449839|NCT03836625|65391314|FG000|Overall Study|Lost to Follow-up|9|||
23449840|NCT03836625|65391315|FG001|Overall Study|Lost to Follow-up|9|||
23449841|NCT03836625|65391314|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
23449842|NCT03836625|65391315|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
23577532|NCT03726879|65846835|FG000|Overall Study|Death|6|||
23449843|NCT03836625|65391314|FG000|Overall Study|Death|0|||
23577533|NCT03726879|65846836|FG001|Overall Study|Death|4|||
23577534|NCT03726879|65846835|FG000|Overall Study|Physician Decision|0|||
23577535|NCT03726879|65846836|FG001|Overall Study|Physician Decision|2|||
23577536|NCT03726879|65846835|FG000|Overall Study|Protocol Violation|0|||
23577537|NCT03726879|65846836|FG001|Overall Study|Protocol Violation|1|||
23449844|NCT03836625|65391315|FG001|Overall Study|Death|1|||
23449845|NCT03836625|65391314|FG000|Overall Study|Refused follow-up|0|||
23449846|NCT03836625|65391315|FG001|Overall Study|Refused follow-up|1|||
23577538|NCT03726879|65846835|FG000|Overall Study|Withdrawal by Subject|5|||
23449847|NCT01050634|65391316|FG000|Overall Study|Enrolled, but Not Treated|56|||
23449848|NCT01050634|65391316|FG000|Overall Study|Death|2|||
23577539|NCT03726879|65846836|FG001|Overall Study|Withdrawal by Subject|5|||
23577540|NCT03726879|65846835|FG000|Overall Study|TSH result is unstable|0|||
23577541|NCT03726879|65846836|FG001|Overall Study|TSH result is unstable|1|||
23577542|NCT03726879|65846835|FG000|Overall Study|Continuing on Study|215|||
23577543|NCT03726879|65846836|FG001|Overall Study|Continuing on Study|215|||
23577544|NCT01400893|65846837|FG000|Overall Study|Death|27|||
23577545|NCT01400893|65846838|FG001|Overall Study|Death|21|||
23577546|NCT01400893|65846837|FG000|Overall Study|Lost to Follow-up|0|||
23634231|NCT01638390|66045598|FG000|Overall Study|screening failures|21|||
23634232|NCT01689857|66045599|FG000|Overall Study|Lost to Follow-up|5|||
23634233|NCT01689857|66045600|FG001|Overall Study|Lost to Follow-up|2|||
23634234|NCT00368875|66045601|FG000|Overall Study|Adverse Event|0|||
23634235|NCT00368875|66045602|FG001|Overall Study|Adverse Event|12|||
23634236|NCT00368875|66045601|FG000|Overall Study|Progressive disease|3|||
23634237|NCT00368875|66045602|FG001|Overall Study|Progressive disease|27|||
23777062|NCT00214422|66563309|FG000|Overall Study|Physician Decision|2|||
23777063|NCT00214422|66563310|FG001|Overall Study|Physician Decision|0|||
23777064|NCT00214422|66563311|FG002|Overall Study|Physician Decision|0|||
23777065|NCT00214422|66563309|FG000|Overall Study|Developed esophageal ca|1|||
23777066|NCT00214422|66563310|FG001|Overall Study|Developed esophageal ca|0|||
23777067|NCT00214422|66563311|FG002|Overall Study|Developed esophageal ca|0|||
23777068|NCT00214422|66563309|FG000|Overall Study|Pt taken off study|1|||
23777069|NCT00214422|66563310|FG001|Overall Study|Pt taken off study|1|||
23777070|NCT00214422|66563311|FG002|Overall Study|Pt taken off study|0|||
23777071|NCT00214422|66563309|FG000|Overall Study|Disease progression on study|1|||
23777072|NCT00214422|66563310|FG001|Overall Study|Disease progression on study|0|||
23777073|NCT00214422|66563311|FG002|Overall Study|Disease progression on study|0|||
23777074|NCT00214422|66563309|FG000|Overall Study|Unable to make a radiation treatment|0|||
23777075|NCT00214422|66563310|FG001|Overall Study|Unable to make a radiation treatment|0|||
23777076|NCT00214422|66563311|FG002|Overall Study|Unable to make a radiation treatment|1|||
23777077|NCT00485472|66563313|FG000|Overall Study|Adverse Event|8|||
23777078|NCT00485472|66563314|FG001|Overall Study|Adverse Event|5|||
23777079|NCT00485472|66563313|FG000|Overall Study|Lack of Efficacy|5|||
23777080|NCT00485472|66563314|FG001|Overall Study|Lack of Efficacy|4|||
23777081|NCT00485472|66563313|FG000|Overall Study|Withdrawal by Subject|1|||
23777082|NCT00485472|66563314|FG001|Overall Study|Withdrawal by Subject|0|||
23777083|NCT00485472|66563313|FG000|Overall Study|Protocol Violation|0|||
23777084|NCT00485472|66563314|FG001|Overall Study|Protocol Violation|1|||
23777085|NCT00485472|66563313|FG000|Overall Study|Other|2|||
23777086|NCT00485472|66563314|FG001|Overall Study|Other|1|||
23777087|NCT00485472|66563313|FG000|Overall Study|Lost to Follow-up|0|||
23634238|NCT00368875|66045601|FG000|Overall Study|Withdrawal by Subject|2|||
23777088|NCT00485472|66563314|FG001|Overall Study|Lost to Follow-up|1|||
23777089|NCT00696020|66563318|FG000|Overall Study|Adverse Event|3|||
23777090|NCT00696020|66563319|FG001|Overall Study|Adverse Event|1|||
23777091|NCT00696020|66563320|FG002|Overall Study|Adverse Event|2|||
23777092|NCT00696020|66563321|FG003|Overall Study|Adverse Event|1|||
23634239|NCT00368875|66045602|FG001|Overall Study|Withdrawal by Subject|6|||
23634240|NCT00368875|66045601|FG000|Overall Study|Other Reason|0|||
23634241|NCT00368875|66045602|FG001|Overall Study|Other Reason|2|||
23634242|NCT00368875|66045601|FG000|Overall Study|Alternative Therapy|1|||
23634243|NCT00368875|66045602|FG001|Overall Study|Alternative Therapy|1|||
23634244|NCT02473289|66045606|FG000|Overall Study|Adverse Event|2|||
23634245|NCT02473289|66045607|FG001|Overall Study|Adverse Event|3|||
23634246|NCT02473289|66045606|FG000|Overall Study|Lost to Follow-up|1|||
23634247|NCT02473289|66045607|FG001|Overall Study|Lost to Follow-up|1|||
23836304|NCT04630002|66778000|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23836305|NCT04630002|66778001|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23836306|NCT04630002|66777999|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
23836307|NCT04630002|66778000|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23836308|NCT04630002|66778001|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23836309|NCT04630002|66777999|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23836310|NCT04630002|66778000|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
23836311|NCT04630002|66778001|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23836312|NCT04630002|66777999|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23836313|NCT04630002|66778000|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
23836314|NCT04630002|66778001|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23836315|NCT04630002|66777999|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23836316|NCT04630002|66778000|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
23836317|NCT04630002|66778001|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23836318|NCT04630002|66777999|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
23836319|NCT04630002|66778000|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
23836320|NCT04630002|66778001|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
23836321|NCT04630002|66777999|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
23836322|NCT04630002|66778000|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
23836323|NCT04630002|66778001|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
23836324|NCT03193853|66778002|FG000|Overall Study|Death|6|||
23836325|NCT00558701|66781282|FG000|Overall Study|Protocol Deviations|1|||
23836326|NCT00558701|66781283|FG001|Overall Study|Protocol Deviations|4|||
23836327|NCT04185220|66781284|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
23836328|NCT04185220|66781285|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
23836329|NCT04185220|66781284|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
23836330|NCT04185220|66781285|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
23836331|NCT01314872|66781286|FG000|Treatment Period 1|Protocol Violation|2|||
23836332|NCT01314872|66781287|FG001|Treatment Period 1|Protocol Violation|1|||
23836333|NCT01314872|66781288|FG002|Treatment Period 1|Protocol Violation|1|||
23836334|NCT01314872|66781289|FG003|Treatment Period 1|Protocol Violation|0|||
23836335|NCT01314872|66781290|FG004|Treatment Period 1|Protocol Violation|1|||
23836336|NCT01314872|66781291|FG005|Treatment Period 1|Protocol Violation|0|||
23836337|NCT01314872|66781292|FG006|Treatment Period 1|Protocol Violation|0|||
23836338|NCT01314872|66781293|FG007|Treatment Period 1|Protocol Violation|0|||
23836339|NCT01314872|66781294|FG008|Treatment Period 1|Protocol Violation|0|||
23836340|NCT01314872|66781295|FG009|Treatment Period 1|Protocol Violation|1|||
23836341|NCT01314872|66781296|FG010|Treatment Period 1|Protocol Violation|1|||
23836342|NCT01314872|66781297|FG011|Treatment Period 1|Protocol Violation|0|||
23836343|NCT01314872|66781298|FG012|Treatment Period 1|Protocol Violation|0|||
23836344|NCT01314872|66781299|FG013|Treatment Period 1|Protocol Violation|0|||
23836345|NCT01314872|66781300|FG014|Treatment Period 1|Protocol Violation|0|||
23836346|NCT01314872|66781286|FG000|Treatment Period 1|Physician Decision|0|||
23836347|NCT01314872|66781287|FG001|Treatment Period 1|Physician Decision|1|||
23836348|NCT01314872|66781288|FG002|Treatment Period 1|Physician Decision|0|||
23836349|NCT01314872|66781289|FG003|Treatment Period 1|Physician Decision|1|||
23836350|NCT01314872|66781290|FG004|Treatment Period 1|Physician Decision|0|||
23836351|NCT01314872|66781291|FG005|Treatment Period 1|Physician Decision|0|||
23836352|NCT01314872|66781292|FG006|Treatment Period 1|Physician Decision|0|||
23836353|NCT01314872|66781293|FG007|Treatment Period 1|Physician Decision|0|||
23836354|NCT01314872|66781294|FG008|Treatment Period 1|Physician Decision|0|||
23836355|NCT01314872|66781295|FG009|Treatment Period 1|Physician Decision|1|||
23836356|NCT01314872|66781296|FG010|Treatment Period 1|Physician Decision|0|||
23836357|NCT01314872|66781297|FG011|Treatment Period 1|Physician Decision|0|||
23836358|NCT01314872|66781298|FG012|Treatment Period 1|Physician Decision|0|||
23836359|NCT01314872|66781299|FG013|Treatment Period 1|Physician Decision|0|||
23449849|NCT01050634|65391316|FG000|Overall Study|Adverse Event|42|||
23634248|NCT02473289|66045606|FG000|Overall Study|Protocol Violation|0|||
23634249|NCT02473289|66045607|FG001|Overall Study|Protocol Violation|1|||
23777093|NCT00696020|66563318|FG000|Overall Study|Lack of Efficacy|1|||
23836360|NCT01314872|66781300|FG014|Treatment Period 1|Physician Decision|0|||
23836361|NCT01314872|66781286|FG000|Treatment Period 1|Lack of Efficacy|1|||
23836362|NCT01314872|66781287|FG001|Treatment Period 1|Lack of Efficacy|0|||
23836363|NCT01314872|66781288|FG002|Treatment Period 1|Lack of Efficacy|0|||
23836364|NCT01314872|66781289|FG003|Treatment Period 1|Lack of Efficacy|0|||
23836365|NCT01314872|66781290|FG004|Treatment Period 1|Lack of Efficacy|0|||
23836366|NCT01314872|66781291|FG005|Treatment Period 1|Lack of Efficacy|1|||
23836367|NCT01314872|66781292|FG006|Treatment Period 1|Lack of Efficacy|0|||
23836368|NCT01314872|66781293|FG007|Treatment Period 1|Lack of Efficacy|2|||
23836369|NCT01314872|66781294|FG008|Treatment Period 1|Lack of Efficacy|0|||
23836370|NCT01314872|66781295|FG009|Treatment Period 1|Lack of Efficacy|0|||
23836371|NCT01314872|66781296|FG010|Treatment Period 1|Lack of Efficacy|0|||
23836372|NCT01314872|66781297|FG011|Treatment Period 1|Lack of Efficacy|0|||
23836373|NCT01314872|66781298|FG012|Treatment Period 1|Lack of Efficacy|0|||
23836374|NCT01314872|66781299|FG013|Treatment Period 1|Lack of Efficacy|0|||
23836375|NCT01314872|66781300|FG014|Treatment Period 1|Lack of Efficacy|0|||
23836376|NCT01314872|66781286|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
23836377|NCT01314872|66781287|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
23836378|NCT01314872|66781288|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
23836379|NCT01314872|66781289|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
23836380|NCT01314872|66781290|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
23836381|NCT01314872|66781291|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
23836382|NCT01314872|66781292|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
23836383|NCT01314872|66781293|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
23836384|NCT01314872|66781294|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
23836385|NCT01314872|66781295|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
23836386|NCT01314872|66781296|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
23836387|NCT01314872|66781297|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
23836388|NCT01314872|66781298|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
23836389|NCT01314872|66781299|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
23836390|NCT01314872|66781300|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
23449850|NCT01050634|65391316|FG000|Overall Study|Lost to Follow-up|2|||
23777094|NCT00696020|66563319|FG001|Overall Study|Lack of Efficacy|0|||
23777095|NCT00696020|66563320|FG002|Overall Study|Lack of Efficacy|0|||
23777096|NCT00696020|66563321|FG003|Overall Study|Lack of Efficacy|0|||
23777097|NCT00696020|66563318|FG000|Overall Study|Protocol Violation|0|||
23777098|NCT00696020|66563319|FG001|Overall Study|Protocol Violation|0|||
23777099|NCT00696020|66563320|FG002|Overall Study|Protocol Violation|0|||
23777100|NCT00696020|66563321|FG003|Overall Study|Protocol Violation|1|||
23777101|NCT00696020|66563318|FG000|Overall Study|Withdrawal by Subject|0|||
23777102|NCT00696020|66563319|FG001|Overall Study|Withdrawal by Subject|1|||
23777103|NCT00696020|66563320|FG002|Overall Study|Withdrawal by Subject|0|||
23777104|NCT00696020|66563321|FG003|Overall Study|Withdrawal by Subject|1|||
23777105|NCT00696020|66563318|FG000|Overall Study|Other not stated above|0|||
23777106|NCT00696020|66563319|FG001|Overall Study|Other not stated above|0|||
23836391|NCT01314872|66781286|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23836392|NCT01314872|66781287|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23836393|NCT01314872|66781288|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23836394|NCT01314872|66781289|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23836395|NCT01314872|66781290|FG004|Treatment Period 1|Withdrawal by Subject|3|||
23836396|NCT01314872|66781291|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23836397|NCT01314872|66781292|FG006|Treatment Period 1|Withdrawal by Subject|3|||
23836398|NCT01314872|66781293|FG007|Treatment Period 1|Withdrawal by Subject|2|||
23836399|NCT01314872|66781294|FG008|Treatment Period 1|Withdrawal by Subject|2|||
23836400|NCT01314872|66781295|FG009|Treatment Period 1|Withdrawal by Subject|2|||
23836401|NCT01314872|66781296|FG010|Treatment Period 1|Withdrawal by Subject|1|||
23634250|NCT02473289|66045606|FG000|Overall Study|Withdrawal of consent|6|||
23634251|NCT02473289|66045607|FG001|Overall Study|Withdrawal of consent|7|||
23634252|NCT02473289|66045606|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
23634253|NCT02473289|66045607|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
23634254|NCT02473289|66045606|FG000|Overall Study|Other|2|||
23777107|NCT00696020|66563320|FG002|Overall Study|Other not stated above|1|||
23449851|NCT01050634|65391316|FG000|Overall Study|Other|21|||
23449852|NCT01050634|65391316|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
23449853|NCT01927497|65391317|FG000|Overall Study|Death|0|||
23634255|NCT02473289|66045607|FG001|Overall Study|Other|0|||
23777108|NCT00696020|66563321|FG003|Overall Study|Other not stated above|1|||
23777109|NCT05341622|66563322|FG000|Overall Study|Death|0|||
23777110|NCT05341622|66563323|FG001|Overall Study|Death|0|||
23777111|NCT05341622|66563324|FG002|Overall Study|Death|0|||
23777112|NCT05341622|66563325|FG003|Overall Study|Death|0|||
23777113|NCT05341622|66563326|FG004|Overall Study|Death|1|||
23777114|NCT05341622|66563327|FG005|Overall Study|Death|0|||
23777115|NCT05341622|66563328|FG006|Overall Study|Death|0|||
23777116|NCT05341622|66563329|FG007|Overall Study|Death|1|||
23777117|NCT05341622|66563322|FG000|Overall Study|Invalid Address|0|||
23777118|NCT05341622|66563323|FG001|Overall Study|Invalid Address|1|||
23777119|NCT05341622|66563324|FG002|Overall Study|Invalid Address|0|||
23777120|NCT05341622|66563325|FG003|Overall Study|Invalid Address|0|||
23777121|NCT05341622|66563326|FG004|Overall Study|Invalid Address|0|||
23777122|NCT05341622|66563327|FG005|Overall Study|Invalid Address|0|||
23777123|NCT05341622|66563328|FG006|Overall Study|Invalid Address|0|||
23777124|NCT05341622|66563329|FG007|Overall Study|Invalid Address|0|||
23777125|NCT05341622|66563322|FG000|Overall Study|Ineligible|26|||
23777126|NCT05341622|66563323|FG001|Overall Study|Ineligible|21|||
23777127|NCT05341622|66563324|FG002|Overall Study|Ineligible|28|||
23777128|NCT05341622|66563325|FG003|Overall Study|Ineligible|24|||
23777129|NCT05341622|66563326|FG004|Overall Study|Ineligible|29|||
23777130|NCT05341622|66563327|FG005|Overall Study|Ineligible|31|||
23777131|NCT05341622|66563328|FG006|Overall Study|Ineligible|28|||
23777132|NCT05341622|66563329|FG007|Overall Study|Ineligible|26|||
23777133|NCT02682602|66563331|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
23777134|NCT02682602|66563332|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
23777135|NCT02682602|66563331|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
23777136|NCT02682602|66563332|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
23836402|NCT01314872|66781297|FG011|Treatment Period 1|Withdrawal by Subject|0|||
23777137|NCT02419937|66563333|FG000|Overall Study|Lost to Follow-up|1|||
23777138|NCT02419937|66563334|FG001|Overall Study|Lost to Follow-up|0|||
23777139|NCT05275205|66563335|FG000|Overall Study|Adverse Event|1|||
23777140|NCT05275205|66563336|FG001|Overall Study|Adverse Event|2|||
23777141|NCT05275205|66563335|FG000|Overall Study|Physician Decision|1|||
23577547|NCT01400893|65846838|FG001|Overall Study|Lost to Follow-up|6|||
23577548|NCT03169361|65846842|FG000|Overall Study|Protocol Violation|32|||
23577549|NCT00178256|65846843|FG000|Overall Study|Adverse Event|2|||
23577550|NCT00178256|65846844|FG001|Overall Study|Adverse Event|0|||
23577551|NCT00178256|65846845|FG002|Overall Study|Adverse Event|0|||
23577552|NCT00178256|65846846|FG003|Overall Study|Adverse Event|0|||
23577553|NCT00178256|65846843|FG000|Overall Study|Death|0|||
23577554|NCT00178256|65846844|FG001|Overall Study|Death|1|||
23577555|NCT00178256|65846845|FG002|Overall Study|Death|0|||
23577556|NCT00178256|65846846|FG003|Overall Study|Death|1|||
23836403|NCT01314872|66781298|FG012|Treatment Period 1|Withdrawal by Subject|0|||
23836404|NCT01314872|66781299|FG013|Treatment Period 1|Withdrawal by Subject|0|||
23577557|NCT00178256|65846843|FG000|Overall Study|Cancer progression|2|||
23577558|NCT00178256|65846844|FG001|Overall Study|Cancer progression|0|||
23577559|NCT00178256|65846845|FG002|Overall Study|Cancer progression|0|||
23577560|NCT00178256|65846846|FG003|Overall Study|Cancer progression|1|||
23836405|NCT01314872|66781300|FG014|Treatment Period 1|Withdrawal by Subject|0|||
23836406|NCT01314872|66781286|FG000|Treatment Period 1|Lost to Follow-up|0|||
23836407|NCT01314872|66781287|FG001|Treatment Period 1|Lost to Follow-up|1|||
23836408|NCT01314872|66781288|FG002|Treatment Period 1|Lost to Follow-up|2|||
23836409|NCT01314872|66781289|FG003|Treatment Period 1|Lost to Follow-up|2|||
23836410|NCT01314872|66781290|FG004|Treatment Period 1|Lost to Follow-up|1|||
23836411|NCT01314872|66781291|FG005|Treatment Period 1|Lost to Follow-up|1|||
23836412|NCT01314872|66781292|FG006|Treatment Period 1|Lost to Follow-up|1|||
23836413|NCT01314872|66781293|FG007|Treatment Period 1|Lost to Follow-up|1|||
23836414|NCT01314872|66781294|FG008|Treatment Period 1|Lost to Follow-up|1|||
23836415|NCT01314872|66781295|FG009|Treatment Period 1|Lost to Follow-up|0|||
23836416|NCT01314872|66781296|FG010|Treatment Period 1|Lost to Follow-up|0|||
23836417|NCT01314872|66781297|FG011|Treatment Period 1|Lost to Follow-up|0|||
23836418|NCT01314872|66781298|FG012|Treatment Period 1|Lost to Follow-up|0|||
23836419|NCT01314872|66781299|FG013|Treatment Period 1|Lost to Follow-up|0|||
23836420|NCT01314872|66781300|FG014|Treatment Period 1|Lost to Follow-up|0|||
23836421|NCT01314872|66781286|FG000|Period 2|Protocol Violation|0|||
23836422|NCT01314872|66781287|FG001|Period 2|Protocol Violation|0|||
23836423|NCT01314872|66781288|FG002|Period 2|Protocol Violation|0|||
23836424|NCT01314872|66781289|FG003|Period 2|Protocol Violation|0|||
23836425|NCT01314872|66781290|FG004|Period 2|Protocol Violation|0|||
23577561|NCT00590980|65846847|FG000|Overall Study|Did not meet all inclusion criteria|10|||
23577562|NCT04990440|65846852|FG000|Overall Study|Sponsor's Decision|0|||
23577563|NCT04990440|65846853|FG001|Overall Study|Sponsor's Decision|0|||
23577564|NCT04990440|65846854|FG002|Overall Study|Sponsor's Decision|1|||
23577565|NCT00670540|65846858|FG000|Overall Study|ineligible|17|||
23577566|NCT00670540|65846858|FG000|Overall Study|not living in France|348|||
23577567|NCT00670540|65846858|FG000|Overall Study|refused to participate|189|||
23577568|NCT00670540|65846858|FG000|Overall Study|controls randomised for no follow up|2770|||
23577569|NCT00670540|65846858|FG000|Overall Study|missing information inclusion criteria|1|||
23577570|NCT01536262|65846859|FG000|Overall Study|Adverse Event|6|||
23836426|NCT01314872|66781291|FG005|Period 2|Protocol Violation|0|||
23836427|NCT01314872|66781292|FG006|Period 2|Protocol Violation|0|||
23836428|NCT01314872|66781293|FG007|Period 2|Protocol Violation|0|||
23836429|NCT01314872|66781294|FG008|Period 2|Protocol Violation|0|||
23836430|NCT01314872|66781295|FG009|Period 2|Protocol Violation|0|||
23577571|NCT01536262|65846860|FG001|Overall Study|Adverse Event|1|||
23577572|NCT01536262|65846861|FG002|Overall Study|Adverse Event|2|||
23577573|NCT01536262|65846859|FG000|Overall Study|Withdrawal by Subject|1|||
23577574|NCT01536262|65846860|FG001|Overall Study|Withdrawal by Subject|1|||
23577575|NCT01536262|65846861|FG002|Overall Study|Withdrawal by Subject|0|||
23577576|NCT01536262|65846859|FG000|Overall Study|Other than stated above|1|||
23577577|NCT01536262|65846860|FG001|Overall Study|Other than stated above|0|||
23577578|NCT01536262|65846861|FG002|Overall Study|Other than stated above|0|||
23577579|NCT02414828|65846864|FG000|Overall Study|Lost to Follow-up|0|||
23577580|NCT02414828|65846865|FG001|Overall Study|Lost to Follow-up|1|||
23577581|NCT02414828|65846866|FG002|Overall Study|Lost to Follow-up|1|||
23577582|NCT02414828|65846867|FG003|Overall Study|Lost to Follow-up|2|||
23577583|NCT01244984|65846870|FG000|Overall Study|Adverse Event|2|||
23577584|NCT01244984|65846871|FG001|Overall Study|Adverse Event|11|||
23577585|NCT01244984|65846872|FG002|Overall Study|Adverse Event|2|||
23577586|NCT01244984|65846870|FG000|Overall Study|Protocol Violation|1|||
23577587|NCT01244984|65846871|FG001|Overall Study|Protocol Violation|0|||
23577588|NCT01244984|65846872|FG002|Overall Study|Protocol Violation|0|||
23777142|NCT05275205|66563336|FG001|Overall Study|Physician Decision|1|||
23777143|NCT05275205|66563335|FG000|Overall Study|Withdrawal by Subject|2|||
23777144|NCT05275205|66563336|FG001|Overall Study|Withdrawal by Subject|3|||
23777145|NCT05275205|66563335|FG000|Overall Study|Death|1|||
23777146|NCT05275205|66563336|FG001|Overall Study|Death|0|||
23777147|NCT05275205|66563335|FG000|Overall Study|Patient unable to attend visits|1|||
23777148|NCT05275205|66563336|FG001|Overall Study|Patient unable to attend visits|0|||
23777149|NCT04185909|66563348|FG000|Overall Study|Lost to Follow-up|1|||
23777150|NCT03420300|66563351|FG000|Overall Study|Death|2|||
23777151|NCT03099538|66563352|FG000|Overall Study|Lack of Efficacy|3|||
23777152|NCT02189941|66563359|FG000|Overall Study|Non-compliance|0|||
23777153|NCT02189941|66563360|FG001|Overall Study|Non-compliance|0|||
23777154|NCT02189941|66563361|FG002|Overall Study|Non-compliance|1|||
23777155|NCT01918397|66563365|FG000|Overall Study|Never started treatment|2|||
23577589|NCT01244984|65846870|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
23577590|NCT01244984|65846871|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
23577591|NCT01244984|65846872|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
23777156|NCT01918397|66563366|FG001|Overall Study|Never started treatment|1|||
23777157|NCT01918397|66563367|FG002|Overall Study|Never started treatment|0|||
23577592|NCT01244984|65846870|FG000|Overall Study|Withdrawal by Subject|1|||
23777158|NCT01918397|66563368|FG003|Overall Study|Never started treatment|0|||
23777159|NCT01918397|66563365|FG000|Overall Study|Adverse Event|1|||
23836431|NCT01314872|66781296|FG010|Period 2|Protocol Violation|0|||
23577593|NCT01244984|65846871|FG001|Overall Study|Withdrawal by Subject|2|||
23577594|NCT01244984|65846872|FG002|Overall Study|Withdrawal by Subject|2|||
23577595|NCT00965484|65846873|FG000|Overall Study|Protocol Violation|1|||
23577596|NCT00965484|65846873|FG000|Overall Study|Withdrawal by Subject|1|||
23634256|NCT03361605|66049176|FG000|Overall Study|Analyzable data not available|3|||
23634257|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
23577597|NCT02926937|65846874|FG000|Overall Study|Adverse Event|0|||
23577598|NCT02926937|65846875|FG001|Overall Study|Adverse Event|1|||
23577599|NCT02926937|65846876|FG002|Overall Study|Adverse Event|1|||
23577600|NCT02926937|65846874|FG000|Overall Study|Poor Compliance to Protocol|1|||
23577601|NCT02926937|65846875|FG001|Overall Study|Poor Compliance to Protocol|0|||
23777160|NCT01918397|66563366|FG001|Overall Study|Adverse Event|1|||
23777161|NCT01918397|66563367|FG002|Overall Study|Adverse Event|1|||
23777162|NCT01918397|66563368|FG003|Overall Study|Adverse Event|0|||
23777163|NCT01918397|66563365|FG000|Overall Study|Lack of compliance|2|||
23777164|NCT01918397|66563366|FG001|Overall Study|Lack of compliance|2|||
23777165|NCT01918397|66563367|FG002|Overall Study|Lack of compliance|3|||
23777166|NCT01918397|66563368|FG003|Overall Study|Lack of compliance|0|||
23777167|NCT01918397|66563365|FG000|Overall Study|Pregnancy|0|||
23777168|NCT01918397|66563366|FG001|Overall Study|Pregnancy|1|||
23777169|NCT01918397|66563367|FG002|Overall Study|Pregnancy|0|||
23777170|NCT01918397|66563368|FG003|Overall Study|Pregnancy|0|||
23577602|NCT02926937|65846876|FG002|Overall Study|Poor Compliance to Protocol|0|||
23634258|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
23777171|NCT01918397|66563365|FG000|Overall Study|Rifampin susceptible|0|||
23777172|NCT01918397|66563366|FG001|Overall Study|Rifampin susceptible|0|||
23777173|NCT01918397|66563367|FG002|Overall Study|Rifampin susceptible|0|||
23777174|NCT01918397|66563368|FG003|Overall Study|Rifampin susceptible|2|||
23836432|NCT01314872|66781297|FG011|Period 2|Protocol Violation|3|||
23836433|NCT01314872|66781298|FG012|Period 2|Protocol Violation|3|||
23836434|NCT01314872|66781299|FG013|Period 2|Protocol Violation|2|||
23836435|NCT01314872|66781300|FG014|Period 2|Protocol Violation|0|||
23836436|NCT01314872|66781286|FG000|Period 2|Non-compliance with study drug|0|||
23836437|NCT01314872|66781287|FG001|Period 2|Non-compliance with study drug|0|||
23836438|NCT01314872|66781288|FG002|Period 2|Non-compliance with study drug|0|||
23836439|NCT01314872|66781289|FG003|Period 2|Non-compliance with study drug|0|||
23836440|NCT01314872|66781290|FG004|Period 2|Non-compliance with study drug|0|||
23836441|NCT01314872|66781291|FG005|Period 2|Non-compliance with study drug|0|||
23836442|NCT01314872|66781292|FG006|Period 2|Non-compliance with study drug|0|||
23836443|NCT01314872|66781293|FG007|Period 2|Non-compliance with study drug|0|||
23836444|NCT01314872|66781294|FG008|Period 2|Non-compliance with study drug|0|||
23836445|NCT01314872|66781295|FG009|Period 2|Non-compliance with study drug|0|||
23836446|NCT01314872|66781296|FG010|Period 2|Non-compliance with study drug|0|||
23836447|NCT01314872|66781297|FG011|Period 2|Non-compliance with study drug|3|||
23836448|NCT01314872|66781298|FG012|Period 2|Non-compliance with study drug|3|||
23836449|NCT01314872|66781299|FG013|Period 2|Non-compliance with study drug|1|||
23836450|NCT01314872|66781300|FG014|Period 2|Non-compliance with study drug|2|||
23836451|NCT01314872|66781286|FG000|Period 2|Lack of Efficacy|0|||
23836452|NCT01314872|66781287|FG001|Period 2|Lack of Efficacy|0|||
23836453|NCT01314872|66781288|FG002|Period 2|Lack of Efficacy|0|||
23836454|NCT01314872|66781289|FG003|Period 2|Lack of Efficacy|0|||
23836455|NCT01314872|66781290|FG004|Period 2|Lack of Efficacy|0|||
23836456|NCT01314872|66781291|FG005|Period 2|Lack of Efficacy|0|||
23836457|NCT01314872|66781292|FG006|Period 2|Lack of Efficacy|0|||
23836458|NCT01314872|66781293|FG007|Period 2|Lack of Efficacy|0|||
23836459|NCT01314872|66781294|FG008|Period 2|Lack of Efficacy|0|||
23836460|NCT01314872|66781295|FG009|Period 2|Lack of Efficacy|0|||
23836461|NCT01314872|66781296|FG010|Period 2|Lack of Efficacy|0|||
23836462|NCT01314872|66781297|FG011|Period 2|Lack of Efficacy|7|||
23836463|NCT01314872|66781298|FG012|Period 2|Lack of Efficacy|12|||
23836464|NCT01314872|66781299|FG013|Period 2|Lack of Efficacy|9|||
23836465|NCT01314872|66781300|FG014|Period 2|Lack of Efficacy|2|||
23836466|NCT01314872|66781286|FG000|Period 2|Pregnancy|0|||
23836467|NCT01314872|66781287|FG001|Period 2|Pregnancy|0|||
23836468|NCT01314872|66781288|FG002|Period 2|Pregnancy|0|||
23836469|NCT01314872|66781289|FG003|Period 2|Pregnancy|0|||
23836470|NCT01314872|66781290|FG004|Period 2|Pregnancy|0|||
23836471|NCT01314872|66781291|FG005|Period 2|Pregnancy|0|||
23836472|NCT01314872|66781292|FG006|Period 2|Pregnancy|0|||
23836473|NCT01314872|66781293|FG007|Period 2|Pregnancy|0|||
23836474|NCT01314872|66781294|FG008|Period 2|Pregnancy|0|||
23836475|NCT01314872|66781295|FG009|Period 2|Pregnancy|0|||
23836476|NCT01314872|66781296|FG010|Period 2|Pregnancy|0|||
23836477|NCT01314872|66781297|FG011|Period 2|Pregnancy|0|||
23836478|NCT01314872|66781298|FG012|Period 2|Pregnancy|0|||
23836479|NCT01314872|66781299|FG013|Period 2|Pregnancy|0|||
23836480|NCT01314872|66781300|FG014|Period 2|Pregnancy|1|||
23836481|NCT01314872|66781286|FG000|Period 2|Study terminated by Sponsor|0|||
23836482|NCT01314872|66781287|FG001|Period 2|Study terminated by Sponsor|0|||
23836483|NCT01314872|66781288|FG002|Period 2|Study terminated by Sponsor|0|||
23836484|NCT01314872|66781289|FG003|Period 2|Study terminated by Sponsor|0|||
23836485|NCT01314872|66781290|FG004|Period 2|Study terminated by Sponsor|0|||
23836486|NCT01314872|66781291|FG005|Period 2|Study terminated by Sponsor|0|||
23836487|NCT01314872|66781292|FG006|Period 2|Study terminated by Sponsor|0|||
23836488|NCT01314872|66781293|FG007|Period 2|Study terminated by Sponsor|0|||
23836489|NCT01314872|66781294|FG008|Period 2|Study terminated by Sponsor|0|||
23836490|NCT01314872|66781295|FG009|Period 2|Study terminated by Sponsor|0|||
23836491|NCT01314872|66781296|FG010|Period 2|Study terminated by Sponsor|0|||
23836492|NCT01314872|66781297|FG011|Period 2|Study terminated by Sponsor|2|||
23836493|NCT01314872|66781298|FG012|Period 2|Study terminated by Sponsor|2|||
23836494|NCT01314872|66781299|FG013|Period 2|Study terminated by Sponsor|3|||
23836495|NCT01314872|66781300|FG014|Period 2|Study terminated by Sponsor|0|||
23836496|NCT01314872|66781286|FG000|Period 2|Adverse event, non-fatal|0|||
23836497|NCT01314872|66781287|FG001|Period 2|Adverse event, non-fatal|0|||
23836498|NCT01314872|66781288|FG002|Period 2|Adverse event, non-fatal|0|||
23836499|NCT01314872|66781289|FG003|Period 2|Adverse event, non-fatal|0|||
23836500|NCT01314872|66781290|FG004|Period 2|Adverse event, non-fatal|0|||
23449854|NCT01927497|65391318|FG001|Overall Study|Death|1|||
23449855|NCT01927497|65391317|FG000|Overall Study|Protocol Violation|2|||
23449856|NCT01927497|65391318|FG001|Overall Study|Protocol Violation|0|||
23449857|NCT01339689|65391319|FG000|Overall Study|Adverse Event|1|||
23449858|NCT01339689|65391320|FG001|Overall Study|Adverse Event|2|||
23449859|NCT01339689|65391319|FG000|Overall Study|Lost to Follow-up|9|||
23449860|NCT01339689|65391320|FG001|Overall Study|Lost to Follow-up|3|||
23449861|NCT01339689|65391319|FG000|Overall Study|Withdrawal by Subject|3|||
23449862|NCT01339689|65391320|FG001|Overall Study|Withdrawal by Subject|0|||
23449863|NCT01339689|65391319|FG000|Overall Study|Noncompliance|1|||
23777175|NCT01918397|66563365|FG000|Overall Study|Treatment failure|0|||
23777176|NCT01918397|66563366|FG001|Overall Study|Treatment failure|0|||
23777177|NCT01918397|66563367|FG002|Overall Study|Treatment failure|0|||
23777178|NCT01918397|66563368|FG003|Overall Study|Treatment failure|1|||
23777179|NCT01918397|66563365|FG000|Overall Study|Withdrawal by Subject|3|||
23777180|NCT01918397|66563366|FG001|Overall Study|Withdrawal by Subject|2|||
23777181|NCT01918397|66563367|FG002|Overall Study|Withdrawal by Subject|1|||
23777182|NCT01918397|66563368|FG003|Overall Study|Withdrawal by Subject|1|||
23777183|NCT01918397|66563365|FG000|Overall Study|XDR at baseline|0|||
23777184|NCT01918397|66563366|FG001|Overall Study|XDR at baseline|0|||
23777185|NCT01918397|66563367|FG002|Overall Study|XDR at baseline|1|||
23777186|NCT01918397|66563368|FG003|Overall Study|XDR at baseline|0|||
23777187|NCT01918397|66563365|FG000|Overall Study|Lost to Follow-up|2|||
23777188|NCT01918397|66563366|FG001|Overall Study|Lost to Follow-up|1|||
23777189|NCT01918397|66563367|FG002|Overall Study|Lost to Follow-up|1|||
23777190|NCT01918397|66563368|FG003|Overall Study|Lost to Follow-up|1|||
23777191|NCT01918397|66563365|FG000|Overall Study|Increased QTc|1|||
23777192|NCT01918397|66563366|FG001|Overall Study|Increased QTc|0|||
23777193|NCT01918397|66563367|FG002|Overall Study|Increased QTc|0|||
23777194|NCT01918397|66563368|FG003|Overall Study|Increased QTc|1|||
23777195|NCT01918397|66563365|FG000|Overall Study|Death|0|||
23777196|NCT01918397|66563366|FG001|Overall Study|Death|0|||
23777197|NCT01918397|66563367|FG002|Overall Study|Death|1|||
23777198|NCT01918397|66563368|FG003|Overall Study|Death|0|||
23777199|NCT01918397|66563365|FG000|Overall Study|Involved in another investigative trial|0|||
23777200|NCT01918397|66563366|FG001|Overall Study|Involved in another investigative trial|0|||
23777201|NCT01918397|66563367|FG002|Overall Study|Involved in another investigative trial|0|||
23777202|NCT01918397|66563368|FG003|Overall Study|Involved in another investigative trial|1|||
23777203|NCT04006171|66563370|FG000|Overall Study|Withdrawal by Subject|8|||
23777204|NCT04006171|66563371|FG001|Overall Study|Withdrawal by Subject|7|||
23777205|NCT04006171|66563370|FG000|Overall Study|missing serum samples|2|||
23449864|NCT01339689|65391320|FG001|Overall Study|Noncompliance|0|||
23449865|NCT01339689|65391319|FG000|Overall Study|Relocated out of area|0|||
23449866|NCT01339689|65391320|FG001|Overall Study|Relocated out of area|1|||
23777206|NCT04006171|66563371|FG001|Overall Study|missing serum samples|2|||
23777207|NCT04006171|66563370|FG000|Overall Study|insufficient sample volume|2|||
23777208|NCT04006171|66563371|FG001|Overall Study|insufficient sample volume|3|||
23836501|NCT01314872|66781291|FG005|Period 2|Adverse event, non-fatal|0|||
23836502|NCT01314872|66781292|FG006|Period 2|Adverse event, non-fatal|0|||
23836503|NCT01314872|66781293|FG007|Period 2|Adverse event, non-fatal|0|||
23836504|NCT01314872|66781294|FG008|Period 2|Adverse event, non-fatal|0|||
23836505|NCT01314872|66781295|FG009|Period 2|Adverse event, non-fatal|0|||
23836506|NCT01314872|66781296|FG010|Period 2|Adverse event, non-fatal|0|||
23836507|NCT01314872|66781297|FG011|Period 2|Adverse event, non-fatal|13|||
23836508|NCT01314872|66781298|FG012|Period 2|Adverse event, non-fatal|16|||
23836509|NCT01314872|66781299|FG013|Period 2|Adverse event, non-fatal|24|||
23836510|NCT01314872|66781300|FG014|Period 2|Adverse event, non-fatal|9|||
23836511|NCT01314872|66781286|FG000|Period 2|Withdrawal by Subject|0|||
23836512|NCT01314872|66781287|FG001|Period 2|Withdrawal by Subject|0|||
23836513|NCT01314872|66781288|FG002|Period 2|Withdrawal by Subject|0|||
23836514|NCT01314872|66781289|FG003|Period 2|Withdrawal by Subject|0|||
23836515|NCT01314872|66781290|FG004|Period 2|Withdrawal by Subject|0|||
23836516|NCT01314872|66781291|FG005|Period 2|Withdrawal by Subject|0|||
23836517|NCT01314872|66781292|FG006|Period 2|Withdrawal by Subject|0|||
23836518|NCT01314872|66781293|FG007|Period 2|Withdrawal by Subject|0|||
23836519|NCT01314872|66781294|FG008|Period 2|Withdrawal by Subject|0|||
23836520|NCT01314872|66781295|FG009|Period 2|Withdrawal by Subject|0|||
23836521|NCT01314872|66781296|FG010|Period 2|Withdrawal by Subject|0|||
23836522|NCT01314872|66781297|FG011|Period 2|Withdrawal by Subject|14|||
23836523|NCT01314872|66781298|FG012|Period 2|Withdrawal by Subject|17|||
23836524|NCT01314872|66781299|FG013|Period 2|Withdrawal by Subject|12|||
23836525|NCT01314872|66781300|FG014|Period 2|Withdrawal by Subject|4|||
23836526|NCT01314872|66781286|FG000|Period 2|Lost to Follow-up|0|||
23836527|NCT01314872|66781287|FG001|Period 2|Lost to Follow-up|0|||
23836528|NCT01314872|66781288|FG002|Period 2|Lost to Follow-up|0|||
23836529|NCT01314872|66781289|FG003|Period 2|Lost to Follow-up|0|||
23836530|NCT01314872|66781290|FG004|Period 2|Lost to Follow-up|0|||
23836531|NCT01314872|66781291|FG005|Period 2|Lost to Follow-up|0|||
23836532|NCT01314872|66781292|FG006|Period 2|Lost to Follow-up|0|||
23836533|NCT01314872|66781293|FG007|Period 2|Lost to Follow-up|0|||
23836534|NCT01314872|66781294|FG008|Period 2|Lost to Follow-up|0|||
23836535|NCT01314872|66781295|FG009|Period 2|Lost to Follow-up|0|||
23836536|NCT01314872|66781296|FG010|Period 2|Lost to Follow-up|0|||
23836537|NCT01314872|66781297|FG011|Period 2|Lost to Follow-up|6|||
23836538|NCT01314872|66781298|FG012|Period 2|Lost to Follow-up|7|||
23836539|NCT01314872|66781299|FG013|Period 2|Lost to Follow-up|2|||
23836540|NCT01314872|66781300|FG014|Period 2|Lost to Follow-up|6|||
23836541|NCT01168232|66781301|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
23836542|NCT01168232|66781301|FG000|Overall Study|Ineligible- Wrong cell type|6|||
23836543|NCT01168232|66781301|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
23836544|NCT01749826|66781302|FG000|Overall Study|Study Terminated|20|||
23836545|NCT01749826|66781303|FG001|Overall Study|Study Terminated|0|||
23836546|NCT00507455|66781306|FG000|Overall Study|Adverse Event|3|||
23836547|NCT00507455|66781307|FG001|Overall Study|Adverse Event|3|||
23836548|NCT00507455|66781308|FG002|Overall Study|Adverse Event|6|||
23836549|NCT00507455|66781306|FG000|Overall Study|Withdrawal by Subject|2|||
23836550|NCT00507455|66781307|FG001|Overall Study|Withdrawal by Subject|1|||
23836551|NCT00507455|66781308|FG002|Overall Study|Withdrawal by Subject|2|||
23836552|NCT00507455|66781306|FG000|Overall Study|Protocol Violation|4|||
23836553|NCT00507455|66781307|FG001|Overall Study|Protocol Violation|1|||
23836554|NCT00507455|66781308|FG002|Overall Study|Protocol Violation|1|||
23836555|NCT00507455|66781306|FG000|Overall Study|Lost to Follow-up|2|||
23836556|NCT00507455|66781307|FG001|Overall Study|Lost to Follow-up|0|||
23836557|NCT00507455|66781308|FG002|Overall Study|Lost to Follow-up|2|||
23836558|NCT00507455|66781306|FG000|Overall Study|Lack of Efficacy|0|||
23836559|NCT00507455|66781307|FG001|Overall Study|Lack of Efficacy|1|||
23836560|NCT00507455|66781308|FG002|Overall Study|Lack of Efficacy|0|||
23836561|NCT00507455|66781306|FG000|Overall Study|Other - miscellaneous reason|1|||
23836562|NCT00507455|66781307|FG001|Overall Study|Other - miscellaneous reason|0|||
23836563|NCT00507455|66781308|FG002|Overall Study|Other - miscellaneous reason|1|||
23836564|NCT00789373|66781313|FG000|Induction|Adverse Event|64|||
23836565|NCT00789373|66781314|FG001|Induction|Adverse Event|0|||
23836566|NCT00789373|66781315|FG002|Induction|Adverse Event|0|||
23836567|NCT00789373|66781313|FG000|Induction|Death Due to study disease|24|||
23836568|NCT00789373|66781314|FG001|Induction|Death Due to study disease|0|||
23836569|NCT00789373|66781315|FG002|Induction|Death Due to study disease|0|||
23449867|NCT01339689|65391319|FG000|Overall Study|Other|2|||
23836570|NCT00789373|66781313|FG000|Induction|Death due to adverse event|19|||
23836571|NCT00789373|66781314|FG001|Induction|Death due to adverse event|0|||
23836572|NCT00789373|66781315|FG002|Induction|Death due to adverse event|0|||
23836573|NCT00789373|66781313|FG000|Induction|Death due to toxicity|11|||
23836574|NCT00789373|66781314|FG001|Induction|Death due to toxicity|0|||
23836575|NCT00789373|66781315|FG002|Induction|Death due to toxicity|0|||
23836576|NCT00789373|66781313|FG000|Induction|Death due to procedure|1|||
23836577|NCT00789373|66781314|FG001|Induction|Death due to procedure|0|||
23836578|NCT00789373|66781315|FG002|Induction|Death due to procedure|0|||
23836579|NCT00789373|66781313|FG000|Induction|Investigator decision|7|||
23836580|NCT00789373|66781314|FG001|Induction|Investigator decision|0|||
23836581|NCT00789373|66781315|FG002|Induction|Investigator decision|0|||
23836582|NCT00789373|66781313|FG000|Induction|Protocol entry criteria not met|9|||
23836583|NCT00789373|66781314|FG001|Induction|Protocol entry criteria not met|0|||
23836584|NCT00789373|66781315|FG002|Induction|Protocol entry criteria not met|0|||
23836585|NCT00789373|66781313|FG000|Induction|Lost to Follow-up|6|||
23836586|NCT00789373|66781314|FG001|Induction|Lost to Follow-up|0|||
23836587|NCT00789373|66781315|FG002|Induction|Lost to Follow-up|0|||
23836588|NCT00789373|66781313|FG000|Induction|Protocol Violation|1|||
23836589|NCT00789373|66781314|FG001|Induction|Protocol Violation|0|||
23836590|NCT00789373|66781315|FG002|Induction|Protocol Violation|0|||
23836591|NCT00789373|66781313|FG000|Induction|Progressive Disease|220|||
23836592|NCT00789373|66781314|FG001|Induction|Progressive Disease|0|||
23836593|NCT00789373|66781315|FG002|Induction|Progressive Disease|0|||
23836594|NCT00789373|66781313|FG000|Induction|Withdrawal by Subject|37|||
23836595|NCT00789373|66781314|FG001|Induction|Withdrawal by Subject|0|||
23836596|NCT00789373|66781315|FG002|Induction|Withdrawal by Subject|0|||
23836597|NCT00789373|66781313|FG000|Maintenance|Adverse Event|0|||
23836598|NCT00789373|66781314|FG001|Maintenance|Adverse Event|65|||
23836599|NCT00789373|66781315|FG002|Maintenance|Adverse Event|12|||
23836600|NCT00789373|66781313|FG000|Maintenance|Death due to study disease|0|||
23836601|NCT00789373|66781314|FG001|Maintenance|Death due to study disease|3|||
23577603|NCT02926937|65846874|FG000|Overall Study|Lost to Follow-up|4|||
23577604|NCT02926937|65846875|FG001|Overall Study|Lost to Follow-up|5|||
23577605|NCT02926937|65846876|FG002|Overall Study|Lost to Follow-up|0|||
23577606|NCT02926937|65846874|FG000|Overall Study|At the Participant's own Request|11|||
23577607|NCT02926937|65846875|FG001|Overall Study|At the Participant's own Request|5|||
23577608|NCT02926937|65846876|FG002|Overall Study|At the Participant's own Request|8|||
23577609|NCT02926937|65846874|FG000|Overall Study|Reason not Specified|3|||
23836602|NCT00789373|66781315|FG002|Maintenance|Death due to study disease|1|||
23836603|NCT00789373|66781313|FG000|Maintenance|Death due to adverse event|0|||
23836604|NCT00789373|66781314|FG001|Maintenance|Death due to adverse event|4|||
23836605|NCT00789373|66781315|FG002|Maintenance|Death due to adverse event|1|||
23836606|NCT00789373|66781313|FG000|Maintenance|Death due to toxicity|0|||
23836607|NCT00789373|66781314|FG001|Maintenance|Death due to toxicity|1|||
23836608|NCT00789373|66781315|FG002|Maintenance|Death due to toxicity|2|||
23836609|NCT00789373|66781313|FG000|Maintenance|Investigator Decision|0|||
23836610|NCT00789373|66781314|FG001|Maintenance|Investigator Decision|4|||
23836611|NCT00789373|66781315|FG002|Maintenance|Investigator Decision|2|||
23836612|NCT00789373|66781313|FG000|Maintenance|Protocol entry criteria not met|0|||
23836613|NCT00789373|66781314|FG001|Maintenance|Protocol entry criteria not met|2|||
23836614|NCT00789373|66781315|FG002|Maintenance|Protocol entry criteria not met|0|||
23836615|NCT00789373|66781313|FG000|Maintenance|Lost to Follow-up|0|||
23836616|NCT00789373|66781314|FG001|Maintenance|Lost to Follow-up|2|||
23836617|NCT00789373|66781315|FG002|Maintenance|Lost to Follow-up|0|||
23836618|NCT00789373|66781313|FG000|Maintenance|Progressive Disease|0|||
23836619|NCT00789373|66781314|FG001|Maintenance|Progressive Disease|253|||
23836620|NCT00789373|66781315|FG002|Maintenance|Progressive Disease|152|||
23836621|NCT00789373|66781313|FG000|Maintenance|Withdrawal by Subject|0|||
23836622|NCT00789373|66781314|FG001|Maintenance|Withdrawal by Subject|21|||
23836623|NCT00789373|66781315|FG002|Maintenance|Withdrawal by Subject|8|||
23577610|NCT02926937|65846875|FG001|Overall Study|Reason not Specified|4|||
23577611|NCT02926937|65846876|FG002|Overall Study|Reason not Specified|2|||
23577612|NCT02748512|65846878|FG000|Overall Study|Lost to Follow-up|1|||
23577613|NCT02748512|65846879|FG001|Overall Study|Lost to Follow-up|1|||
23777209|NCT01661686|66563376|FG000|Overall Study|Lost to Follow-up|2|||
23777210|NCT01661686|66563377|FG001|Overall Study|Lost to Follow-up|1|||
23777211|NCT01661686|66563376|FG000|Overall Study|did not receive allocated intervention|0|||
23777212|NCT01661686|66563377|FG001|Overall Study|did not receive allocated intervention|1|||
23777213|NCT02421952|66563378|FG000|Overall Study|Diary Not Returned|93|||
23777214|NCT02421952|66563378|FG000|Overall Study|Failed seriation task|13|||
23777215|NCT02421952|66563378|FG000|Overall Study|Subject uncooperative for baseline test|2|||
23777216|NCT02421952|66563378|FG000|Overall Study|Surgery cancelled|1|||
23777217|NCT03725605|66563379|FG000|Overall Study|Unsuccessful TIL expansion|2|||
23777218|NCT02458469|66563384|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23777219|NCT02458469|66563385|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23777220|NCT02458469|66563386|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23777221|NCT02458469|66563387|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23836624|NCT00789373|66781313|FG000|Maintenance|Sponsor Decision|0|||
23836625|NCT00789373|66781314|FG001|Maintenance|Sponsor Decision|0|||
23577614|NCT01077024|65846880|FG000|Overall Study|Lost to Follow-up|20|||
23577615|NCT01077024|65846881|FG001|Overall Study|Lost to Follow-up|14|||
23577616|NCT01077024|65846880|FG000|Overall Study|Withdrawal by Subject|0|||
23836626|NCT00789373|66781315|FG002|Maintenance|Sponsor Decision|2|||
23836627|NCT00789373|66781313|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
23836628|NCT00789373|66781314|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
23836629|NCT00789373|66781315|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
23836630|NCT00955955|66781316|FG000|Overall Study|Lost to Follow-up|2|||
23836631|NCT00955955|66781317|FG001|Overall Study|Lost to Follow-up|0|||
23836632|NCT00955955|66781318|FG002|Overall Study|Lost to Follow-up|0|||
23836633|NCT01379768|66781319|FG000|Overall Study|Adverse Event|1|||
23836634|NCT01379768|66781320|FG001|Overall Study|Adverse Event|1|||
23836635|NCT01379768|66781321|FG002|Overall Study|Adverse Event|0|||
23836636|NCT01379768|66781319|FG000|Overall Study|Lost to Follow-up|2|||
23836637|NCT01379768|66781320|FG001|Overall Study|Lost to Follow-up|0|||
23836638|NCT01379768|66781321|FG002|Overall Study|Lost to Follow-up|0|||
23836639|NCT03058705|66781325|FG000|Overall Study|Withdrawal by Subject|2|||
23836640|NCT03058705|66781325|FG000|Overall Study|Physician Decision|2|||
23836641|NCT00561392|66781336|FG000|Overall Study|Adverse Event|38|||
23836642|NCT00561392|66781336|FG000|Overall Study|Lack of Efficacy|2|||
23836643|NCT00561392|66781336|FG000|Overall Study|Protocol Violation|1|||
23836644|NCT00561392|66781336|FG000|Overall Study|Withdrawal by Subject|8|||
23836645|NCT00561392|66781336|FG000|Overall Study|Administrative problems|4|||
23836646|NCT00430573|66781341|FG000|Overall Study|Withdrawal by Subject|5|||
23836647|NCT01996241|66781342|FG000|Overall Study|Lost to Follow-up|252|||
23836648|NCT01996241|66781343|FG001|Overall Study|Lost to Follow-up|235|||
23836649|NCT01346059|66781344|FG000|Overall Study|Withdrawal by Subject|1|||
23836650|NCT01346059|66781345|FG001|Overall Study|Withdrawal by Subject|0|||
23836651|NCT04179838|66781350|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23836652|NCT04179838|66781351|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
23836653|NCT04179838|66781350|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
23836654|NCT04179838|66781351|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
23836655|NCT02589639|66781353|FG000|Overall Study|Lost to Follow-up|1|||
23836656|NCT02589639|66781354|FG001|Overall Study|Lost to Follow-up|0|||
23836657|NCT02589639|66781355|FG002|Overall Study|Lost to Follow-up|0|||
23836658|NCT02589639|66781353|FG000|Overall Study|Protocol Violation|1|||
23836659|NCT02589639|66781354|FG001|Overall Study|Protocol Violation|0|||
23836660|NCT02589639|66781355|FG002|Overall Study|Protocol Violation|0|||
23836661|NCT02589639|66781353|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
23836662|NCT02589639|66781354|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
23836663|NCT02589639|66781355|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
23836664|NCT02589639|66781353|FG000|Overall Study|Adverse Event|4|||
23836665|NCT02589639|66781354|FG001|Overall Study|Adverse Event|5|||
23836666|NCT02589639|66781355|FG002|Overall Study|Adverse Event|3|||
23836667|NCT02589639|66781353|FG000|Overall Study|Other reason than specified above|1|||
23836668|NCT02589639|66781354|FG001|Overall Study|Other reason than specified above|2|||
23836669|NCT02589639|66781355|FG002|Overall Study|Other reason than specified above|1|||
23836670|NCT02589639|66781353|FG000|Overall Study|Not Treated|0|||
23836671|NCT02589639|66781354|FG001|Overall Study|Not Treated|3|||
23836672|NCT02589639|66781355|FG002|Overall Study|Not Treated|0|||
23836673|NCT01057810|66781356|FG000|Overall Study|Disease progression|156|||
23836674|NCT01057810|66781357|FG001|Overall Study|Disease progression|197|||
23836675|NCT01057810|66781356|FG000|Overall Study|Study drug toxicity|5|||
23836676|NCT01057810|66781357|FG001|Overall Study|Study drug toxicity|114|||
23836677|NCT01057810|66781356|FG000|Overall Study|Adverse event unrelated to study drug|13|||
23836678|NCT01057810|66781357|FG001|Overall Study|Adverse event unrelated to study drug|29|||
23836679|NCT01057810|66781356|FG000|Overall Study|Withdrawal by Subject|10|||
23836680|NCT01057810|66781357|FG001|Overall Study|Withdrawal by Subject|25|||
23836681|NCT01057810|66781356|FG000|Overall Study|Death|2|||
23836682|NCT01057810|66781357|FG001|Overall Study|Death|12|||
23836683|NCT01057810|66781356|FG000|Overall Study|Maximum clinical benefit|5|||
23836684|NCT01057810|66781357|FG001|Overall Study|Maximum clinical benefit|5|||
23836685|NCT01057810|66781356|FG000|Overall Study|Poor/non-compliance|0|||
23836686|NCT01057810|66781357|FG001|Overall Study|Poor/non-compliance|1|||
23836687|NCT01057810|66781356|FG000|Overall Study|No longer met study criteria|0|||
23836688|NCT01057810|66781357|FG001|Overall Study|No longer met study criteria|1|||
23836689|NCT01057810|66781356|FG000|Overall Study|Other|7|||
23836690|NCT01057810|66781357|FG001|Overall Study|Other|14|||
23836691|NCT02964208|66781358|FG000|Overall Study|Death|103|||
23836692|NCT02964208|66781358|FG000|Overall Study|Withdrawal by Subject|6|||
23836693|NCT02964208|66781358|FG000|Overall Study|Lost to Follow-up|6|||
23836694|NCT02964208|66781358|FG000|Overall Study|Unsuccessful Procedure|5|||
23836695|NCT02964208|66781358|FG000|Overall Study|Device Explant|1|||
23836696|NCT02964208|66781358|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
23836697|NCT02729025|66781359|FG000|Overall Study|Sponsor Decision|0|||
23836698|NCT02729025|66781360|FG001|Overall Study|Sponsor Decision|1|||
23836699|NCT02962648|66781367|FG000|Overall Study|Withdrawal by Subject|3|||
23836700|NCT02962648|66781367|FG000|Overall Study|Lost to Follow-up|3|||
23836701|NCT02962648|66781367|FG000|Overall Study|Physician Decision|1|||
23836702|NCT02962648|66781367|FG000|Overall Study|Subject had problems with transportation|2|||
23836703|NCT03526861|66781368|FG000|Initial Treatment Period|Not dosed|1|||
23836704|NCT03526861|66781369|FG001|Initial Treatment Period|Not dosed|1|||
23836705|NCT03526861|66781370|FG002|Initial Treatment Period|Not dosed|1|||
23836706|NCT03526861|66781371|FG003|Initial Treatment Period|Not dosed|0|||
23836707|NCT03526861|66781372|FG004|Initial Treatment Period|Not dosed|0|||
23836708|NCT03526861|66781373|FG005|Initial Treatment Period|Not dosed|0|||
23836709|NCT03526861|66781374|FG006|Initial Treatment Period|Not dosed|0|||
23836710|NCT03526861|66781375|FG007|Initial Treatment Period|Not dosed|0|||
23836711|NCT03526861|66781376|FG008|Initial Treatment Period|Not dosed|0|||
23836712|NCT03526861|66781368|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
23836713|NCT03526861|66781369|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
23836714|NCT03526861|66781370|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
23836715|NCT03526861|66781371|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836716|NCT03526861|66781372|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23449868|NCT01339689|65391320|FG001|Overall Study|Other|2|||
23577617|NCT01077024|65846881|FG001|Overall Study|Withdrawal by Subject|2|||
23577618|NCT01077024|65846880|FG000|Overall Study|Incarcerated|7|||
23836717|NCT03526861|66781373|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836718|NCT03526861|66781374|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836719|NCT03526861|66781375|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836720|NCT03526861|66781376|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836721|NCT03526861|66781368|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
23836722|NCT03526861|66781369|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
23836723|NCT03526861|66781370|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
23836724|NCT03526861|66781371|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23836725|NCT03526861|66781372|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23836726|NCT03526861|66781373|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23577619|NCT01077024|65846881|FG001|Overall Study|Incarcerated|8|||
23577620|NCT01077024|65846880|FG000|Overall Study|Other|4|||
23836727|NCT03526861|66781374|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23836728|NCT03526861|66781375|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23836729|NCT03526861|66781376|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23836730|NCT03526861|66781368|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836731|NCT03526861|66781369|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836732|NCT03526861|66781370|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836733|NCT03526861|66781371|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23836734|NCT03526861|66781372|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23836735|NCT03526861|66781373|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23577621|NCT01077024|65846881|FG001|Overall Study|Other|4|||
23577622|NCT00322868|65846883|FG000|Overall Study|disease progression|1|||
23577623|NCT01982760|65846886|FG000|Overall Study|Physician Decision|1|||
23577624|NCT01982760|65846887|FG001|Overall Study|Physician Decision|0|||
23836736|NCT03526861|66781374|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23836737|NCT03526861|66781375|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836738|NCT03526861|66781376|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836739|NCT03526861|66781368|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23836740|NCT03526861|66781369|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23836741|NCT03526861|66781370|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23836742|NCT03526861|66781371|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
23836743|NCT03526861|66781372|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
23449869|NCT01339689|65391319|FG000|Overall Study|multiple reasons|1|||
23577625|NCT02554513|65846889|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
23577626|NCT02554513|65846890|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
23836744|NCT03526861|66781373|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
23836745|NCT03526861|66781374|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
23836746|NCT03526861|66781375|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
23836747|NCT03526861|66781376|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23836748|NCT03526861|66781368|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836749|NCT03526861|66781369|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836750|NCT03526861|66781370|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836751|NCT03526861|66781371|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
23836752|NCT03526861|66781372|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836753|NCT03526861|66781373|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836754|NCT03526861|66781374|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836755|NCT03526861|66781375|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836756|NCT03526861|66781376|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836757|NCT03526861|66781368|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836758|NCT03526861|66781369|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836759|NCT03526861|66781370|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836760|NCT03526861|66781371|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836761|NCT03526861|66781372|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836762|NCT03526861|66781373|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836763|NCT03526861|66781374|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836764|NCT03526861|66781375|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23836765|NCT03526861|66781376|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
23836766|NCT03526861|66781368|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836767|NCT03526861|66781369|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836768|NCT03526861|66781370|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836769|NCT03526861|66781371|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836770|NCT03526861|66781372|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836771|NCT03526861|66781373|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836772|NCT03526861|66781374|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836773|NCT03526861|66781375|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23836774|NCT03526861|66781376|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
23836775|NCT03526861|66781368|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836776|NCT03526861|66781369|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23577627|NCT01932996|65846892|FG000|Overall Study|Protocol Violation|2|||
23577628|NCT01932996|65846893|FG001|Overall Study|Protocol Violation|0|||
23836777|NCT03526861|66781370|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836778|NCT03526861|66781371|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836779|NCT03526861|66781372|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836780|NCT03526861|66781373|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836781|NCT03526861|66781374|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23843120|NCT01738503|66805582|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23449870|NCT01339689|65391320|FG001|Overall Study|multiple reasons|1|||
23577629|NCT02687919|65846897|FG000|Overall Study|Withdrawal by Subject|6|||
23577630|NCT02687919|65846898|FG001|Overall Study|Withdrawal by Subject|6|||
23577631|NCT02687919|65846897|FG000|Overall Study|Protocol Violation|2|||
23577632|NCT02687919|65846898|FG001|Overall Study|Protocol Violation|0|||
23577633|NCT00783692|65846903|FG000|Induction Phase|Adverse Event|7|||
23577634|NCT00783692|65846904|FG001|Induction Phase|Adverse Event|9|||
23577635|NCT00783692|65846905|FG002|Induction Phase|Adverse Event|24|||
23577636|NCT00783692|65846906|FG003|Induction Phase|Adverse Event|0|||
23577637|NCT00783692|65846907|FG004|Induction Phase|Adverse Event|0|||
23577638|NCT00783692|65846908|FG005|Induction Phase|Adverse Event|0|||
23577639|NCT00783692|65846909|FG006|Induction Phase|Adverse Event|0|||
23577640|NCT00783692|65846903|FG000|Induction Phase|Protocol Violation|0|||
23577641|NCT00783692|65846904|FG001|Induction Phase|Protocol Violation|0|||
23777222|NCT02458469|66563388|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23577642|NCT00783692|65846905|FG002|Induction Phase|Protocol Violation|1|||
23577643|NCT00783692|65846906|FG003|Induction Phase|Protocol Violation|0|||
23577644|NCT00783692|65846907|FG004|Induction Phase|Protocol Violation|0|||
23777223|NCT02458469|66563389|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23777224|NCT02458469|66563384|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
23777225|NCT02458469|66563385|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
23777226|NCT02458469|66563386|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
23777227|NCT02458469|66563387|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
23777228|NCT02458469|66563388|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
23777229|NCT02458469|66563389|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
23777230|NCT02458469|66563384|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23777231|NCT02458469|66563385|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23777232|NCT02458469|66563386|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23777233|NCT02458469|66563387|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23777234|NCT02458469|66563388|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23777235|NCT02458469|66563389|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
23777236|NCT00617305|66563390|FG000|Overall Study|Adverse Event|4|||
23777237|NCT00617305|66563391|FG001|Overall Study|Adverse Event|0|||
23777238|NCT00617305|66563392|FG002|Overall Study|Adverse Event|0|||
23777239|NCT00617305|66563390|FG000|Overall Study|Death|1|||
23777240|NCT00617305|66563391|FG001|Overall Study|Death|0|||
23777241|NCT00617305|66563392|FG002|Overall Study|Death|0|||
23777242|NCT00617305|66563390|FG000|Overall Study|Physician Decision|1|||
23836782|NCT03526861|66781375|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23836783|NCT03526861|66781376|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
23836784|NCT00427648|66781377|FG000|Overall Study|Protocol Violation|1|||
23836785|NCT00427648|66781378|FG001|Overall Study|Protocol Violation|2|||
23836786|NCT00427648|66781377|FG000|Overall Study|Adverse Event|0|||
23836787|NCT00427648|66781378|FG001|Overall Study|Adverse Event|1|||
23836788|NCT00428246|66781381|FG000|Overall Study|Withdrawal by Subject|0|||
23836789|NCT00428246|66781382|FG001|Overall Study|Withdrawal by Subject|0|||
23836790|NCT00428246|66781383|FG002|Overall Study|Withdrawal by Subject|1|||
23836791|NCT00428246|66781381|FG000|Overall Study|Adverse Event|1|||
23836792|NCT00428246|66781382|FG001|Overall Study|Adverse Event|0|||
23836793|NCT00428246|66781383|FG002|Overall Study|Adverse Event|0|||
23836794|NCT00961571|66781384|FG000|Overall Study|Physician Decision|39|||
23836795|NCT00782626|66781385|FG000|Overall Study|Adverse Event|1|||
23577645|NCT00783692|65846908|FG005|Induction Phase|Protocol Violation|0|||
23577646|NCT00783692|65846909|FG006|Induction Phase|Protocol Violation|0|||
23836796|NCT00782626|66781385|FG000|Overall Study|Progressive Disease|5|||
23836797|NCT00782626|66781385|FG000|Overall Study|Other Complicating Disease|1|||
23449871|NCT00880698|65391321|FG000|Overall Study|Death|0|||
23449872|NCT00880698|65391322|FG001|Overall Study|Death|0|||
23449873|NCT00880698|65391323|FG002|Overall Study|Death|1|||
23449874|NCT00880698|65391324|FG003|Overall Study|Death|2|||
23449875|NCT00880698|65391321|FG000|Overall Study|Lost to Follow-up|1|||
23449876|NCT00880698|65391322|FG001|Overall Study|Lost to Follow-up|3|||
23449877|NCT00880698|65391323|FG002|Overall Study|Lost to Follow-up|0|||
23449878|NCT00880698|65391324|FG003|Overall Study|Lost to Follow-up|1|||
23449879|NCT02738801|65391325|FG000|Overall Study|Adverse Event|1|||
23449880|NCT02738801|65391326|FG001|Overall Study|Adverse Event|1|||
23449881|NCT02738801|65391325|FG000|Overall Study|Withdrawal by Subject|0|||
23449882|NCT02738801|65391326|FG001|Overall Study|Withdrawal by Subject|1|||
23449883|NCT03259555|65391327|FG000|Overall Study|Adverse Event|6|||
23836798|NCT01019694|66781387|FG000|Overall Study|Adverse Event|12|||
23836799|NCT01019694|66781388|FG001|Overall Study|Adverse Event|16|||
23836800|NCT01019694|66781389|FG002|Overall Study|Adverse Event|19|||
23836801|NCT01019694|66781387|FG000|Overall Study|Protocol Violation|2|||
23836802|NCT01019694|66781388|FG001|Overall Study|Protocol Violation|6|||
23836803|NCT01019694|66781389|FG002|Overall Study|Protocol Violation|4|||
23449884|NCT03259555|65391328|FG001|Overall Study|Adverse Event|4|||
23449885|NCT03259555|65391327|FG000|Overall Study|Lack of Efficacy|6|||
23777243|NCT00617305|66563391|FG001|Overall Study|Physician Decision|0|||
23836804|NCT01019694|66781387|FG000|Overall Study|Lost to Follow-up|5|||
23836805|NCT01019694|66781388|FG001|Overall Study|Lost to Follow-up|3|||
23836806|NCT01019694|66781389|FG002|Overall Study|Lost to Follow-up|3|||
23449886|NCT03259555|65391328|FG001|Overall Study|Lack of Efficacy|4|||
23449887|NCT03259555|65391327|FG000|Overall Study|Lost to Follow-up|0|||
23449888|NCT03259555|65391328|FG001|Overall Study|Lost to Follow-up|2|||
23777244|NCT00617305|66563392|FG002|Overall Study|Physician Decision|0|||
23777245|NCT00617305|66563390|FG000|Overall Study|Protocol Violation|1|||
23777246|NCT00617305|66563391|FG001|Overall Study|Protocol Violation|0|||
23777247|NCT00617305|66563392|FG002|Overall Study|Protocol Violation|1|||
23777248|NCT00617305|66563390|FG000|Overall Study|Withdrawal by Subject|1|||
23777249|NCT00617305|66563391|FG001|Overall Study|Withdrawal by Subject|0|||
23777250|NCT00617305|66563392|FG002|Overall Study|Withdrawal by Subject|0|||
23777251|NCT02883452|66563393|FG000|Overall Study|Withdrawal by Subject|1|||
23777252|NCT02883452|66563394|FG001|Overall Study|Withdrawal by Subject|1|||
23777253|NCT02883452|66563395|FG002|Overall Study|Withdrawal by Subject|3|||
23777254|NCT02883452|66563396|FG003|Overall Study|Withdrawal by Subject|0|||
23777255|NCT02883452|66563397|FG004|Overall Study|Withdrawal by Subject|2|||
23777256|NCT02883452|66563398|FG005|Overall Study|Withdrawal by Subject|5|||
23777257|NCT02883452|66563393|FG000|Overall Study|Disease progression|1|||
23777258|NCT02883452|66563394|FG001|Overall Study|Disease progression|0|||
23777259|NCT02883452|66563395|FG002|Overall Study|Disease progression|0|||
23777260|NCT02883452|66563396|FG003|Overall Study|Disease progression|1|||
23777261|NCT02883452|66563397|FG004|Overall Study|Disease progression|4|||
23777262|NCT02883452|66563398|FG005|Overall Study|Disease progression|5|||
23777263|NCT02883452|66563393|FG000|Overall Study|Adverse Event|2|||
23777264|NCT02883452|66563394|FG001|Overall Study|Adverse Event|1|||
23777265|NCT02883452|66563395|FG002|Overall Study|Adverse Event|1|||
23777266|NCT02883452|66563396|FG003|Overall Study|Adverse Event|1|||
23777267|NCT02883452|66563397|FG004|Overall Study|Adverse Event|1|||
23777268|NCT02883452|66563398|FG005|Overall Study|Adverse Event|3|||
23777269|NCT02883452|66563393|FG000|Overall Study|Physician Decision|0|||
23777270|NCT02883452|66563394|FG001|Overall Study|Physician Decision|0|||
23777271|NCT02883452|66563395|FG002|Overall Study|Physician Decision|0|||
23777272|NCT02883452|66563396|FG003|Overall Study|Physician Decision|0|||
23777273|NCT02883452|66563397|FG004|Overall Study|Physician Decision|4|||
23777274|NCT02883452|66563398|FG005|Overall Study|Physician Decision|1|||
23777275|NCT02883452|66563393|FG000|Overall Study|Death|1|||
23777276|NCT02883452|66563394|FG001|Overall Study|Death|0|||
23777277|NCT02883452|66563395|FG002|Overall Study|Death|1|||
23777278|NCT02883452|66563396|FG003|Overall Study|Death|0|||
23777279|NCT02883452|66563397|FG004|Overall Study|Death|0|||
23777280|NCT02883452|66563398|FG005|Overall Study|Death|0|||
23777281|NCT02883452|66563393|FG000|Overall Study|Other|0|||
23777282|NCT02883452|66563394|FG001|Overall Study|Other|0|||
23777283|NCT02883452|66563395|FG002|Overall Study|Other|0|||
23836807|NCT01019694|66781387|FG000|Overall Study|Withdrawal by Subject|4|||
23836808|NCT01019694|66781388|FG001|Overall Study|Withdrawal by Subject|6|||
23449889|NCT03259555|65391327|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23449890|NCT03259555|65391328|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23449891|NCT03259555|65391327|FG000|Overall Study|Progressive Disease|0|||
23449892|NCT03259555|65391328|FG001|Overall Study|Progressive Disease|2|||
23449893|NCT03259555|65391327|FG000|Overall Study|Withdrawal by Subject|19|||
23777284|NCT02883452|66563396|FG003|Overall Study|Other|0|||
23777285|NCT02883452|66563397|FG004|Overall Study|Other|0|||
23777286|NCT02883452|66563398|FG005|Overall Study|Other|1|||
23777287|NCT03555305|66563409|FG000|Period 1|Physician Decision|0|||
23836809|NCT01019694|66781389|FG002|Overall Study|Withdrawal by Subject|12|||
23836810|NCT01019694|66781387|FG000|Overall Study|Not treated|0|||
23836811|NCT01019694|66781388|FG001|Overall Study|Not treated|2|||
23836812|NCT01019694|66781389|FG002|Overall Study|Not treated|3|||
23836813|NCT01019694|66781387|FG000|Overall Study|Other reason (not specified)|1|||
23836814|NCT01019694|66781388|FG001|Overall Study|Other reason (not specified)|5|||
23836815|NCT01019694|66781389|FG002|Overall Study|Other reason (not specified)|6|||
23836816|NCT00502242|66781390|FG000|Overall Study|Lack of Efficacy|1|||
23836817|NCT00502242|66781391|FG001|Overall Study|Lack of Efficacy|11|||
23836818|NCT00502242|66781390|FG000|Overall Study|Adverse Event|31|||
23836819|NCT00502242|66781391|FG001|Overall Study|Adverse Event|20|||
23836820|NCT00502242|66781390|FG000|Overall Study|Physician Decision|2|||
23836821|NCT00502242|66781391|FG001|Overall Study|Physician Decision|3|||
23836822|NCT00502242|66781390|FG000|Overall Study|Other - Unspecified|8|||
23449894|NCT03259555|65391328|FG001|Overall Study|Withdrawal by Subject|16|||
23449895|NCT03259555|65391327|FG000|Overall Study|Physician Decision|1|||
23449896|NCT03259555|65391328|FG001|Overall Study|Physician Decision|2|||
23449897|NCT03259555|65391327|FG000|Overall Study|Other|1|||
23449898|NCT03259555|65391328|FG001|Overall Study|Other|0|||
23777288|NCT03555305|66563410|FG001|Period 1|Physician Decision|1|||
23777289|NCT03555305|66563409|FG000|Period 1|Adverse Event|0|||
23777290|NCT03555305|66563410|FG001|Period 1|Adverse Event|1|||
23777291|NCT01387737|66563412|FG000|Overall Study|Adverse Event|20|||
23777292|NCT01387737|66563413|FG001|Overall Study|Adverse Event|30|||
23777293|NCT01387737|66563412|FG000|Overall Study|Lack of Efficacy|1|||
23777294|NCT01387737|66563413|FG001|Overall Study|Lack of Efficacy|0|||
23777295|NCT01387737|66563412|FG000|Overall Study|Physician Decision|3|||
23777296|NCT01387737|66563413|FG001|Overall Study|Physician Decision|10|||
23777297|NCT01387737|66563412|FG000|Overall Study|Withdrawal by Subject|27|||
23777298|NCT01387737|66563413|FG001|Overall Study|Withdrawal by Subject|31|||
23777299|NCT01387737|66563412|FG000|Overall Study|Clearly not eligible for the study|1|||
23777300|NCT01387737|66563413|FG001|Overall Study|Clearly not eligible for the study|3|||
23777301|NCT03496623|66563417|FG000|Run-In Period (2 Weeks)|Death|1|||
23777302|NCT03496623|66563418|FG001|Run-In Period (2 Weeks)|Death|0|||
23777303|NCT03496623|66563419|FG002|Run-In Period (2 Weeks)|Death|0|||
23777304|NCT03496623|66563420|FG003|Run-In Period (2 Weeks)|Death|0|||
23777305|NCT03496623|66563421|FG004|Run-In Period (2 Weeks)|Death|0|||
23777306|NCT03496623|66563417|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
23777307|NCT03496623|66563418|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23777308|NCT03496623|66563419|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23777309|NCT03496623|66563420|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23777310|NCT03496623|66563421|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23777311|NCT03496623|66563417|FG000|Period 1 (12 Weeks)|Death|0|||
23777312|NCT03496623|66563418|FG001|Period 1 (12 Weeks)|Death|3|||
23777313|NCT03496623|66563419|FG002|Period 1 (12 Weeks)|Death|0|||
23777314|NCT03496623|66563420|FG003|Period 1 (12 Weeks)|Death|0|||
23777315|NCT03496623|66563421|FG004|Period 1 (12 Weeks)|Death|0|||
23777316|NCT03496623|66563417|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23777317|NCT03496623|66563418|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23777318|NCT03496623|66563419|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23777319|NCT03496623|66563420|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
23777320|NCT03496623|66563421|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
23777321|NCT03496623|66563417|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23777322|NCT03496623|66563418|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23836823|NCT00502242|66781391|FG001|Overall Study|Other - Unspecified|14|||
23836824|NCT00502242|66781390|FG000|Overall Study|Protocol Violation|3|||
23777323|NCT03496623|66563419|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23777324|NCT03496623|66563420|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23777325|NCT03496623|66563421|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23836825|NCT00502242|66781391|FG001|Overall Study|Protocol Violation|1|||
23836826|NCT00502242|66781390|FG000|Overall Study|Withdrawal by Subject|6|||
23836827|NCT00502242|66781391|FG001|Overall Study|Withdrawal by Subject|7|||
23836828|NCT02097238|66781398|FG000|Overall Study|Death|1|||
23449923|NCT01135134|65391333|FG000|Overall Study|Adverse Event|1|||
23449924|NCT01135134|65391334|FG001|Overall Study|Adverse Event|1|||
23449925|NCT01135134|65391333|FG000|Overall Study|Did not meet protocol eligibility|1|||
23449926|NCT01135134|65391334|FG001|Overall Study|Did not meet protocol eligibility|0|||
23449927|NCT03546621|65391335|FG000|Overall Study|Withdrawal by Subject|0|||
23449928|NCT03546621|65391336|FG001|Overall Study|Withdrawal by Subject|1|||
23449929|NCT03546621|65391337|FG002|Overall Study|Withdrawal by Subject|2|||
23449930|NCT03546621|65391338|FG003|Overall Study|Withdrawal by Subject|1|||
23449931|NCT03546621|65391335|FG000|Overall Study|Lost to Follow-up|0|||
23449932|NCT03546621|65391336|FG001|Overall Study|Lost to Follow-up|1|||
23449933|NCT03546621|65391337|FG002|Overall Study|Lost to Follow-up|0|||
23449934|NCT03546621|65391338|FG003|Overall Study|Lost to Follow-up|0|||
23449935|NCT03546621|65391335|FG000|Overall Study|Adverse Event|0|||
23449936|NCT03546621|65391336|FG001|Overall Study|Adverse Event|1|||
23449937|NCT03546621|65391337|FG002|Overall Study|Adverse Event|0|||
23449938|NCT03546621|65391338|FG003|Overall Study|Adverse Event|1|||
23449939|NCT03546621|65391335|FG000|Overall Study|Progressive disease|0|||
23449940|NCT03546621|65391336|FG001|Overall Study|Progressive disease|0|||
23449941|NCT03546621|65391337|FG002|Overall Study|Progressive disease|0|||
23449942|NCT03546621|65391338|FG003|Overall Study|Progressive disease|1|||
23449943|NCT03016312|65391340|FG000|Overall Study|discontinued before the treatment started|0|||
23449944|NCT03016312|65391341|FG001|Overall Study|discontinued before the treatment started|1|||
23449945|NCT03016312|65391340|FG000|Overall Study|Withdrawal by Subject|37|||
23449946|NCT03016312|65391341|FG001|Overall Study|Withdrawal by Subject|44|||
23449947|NCT03016312|65391340|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
23449948|NCT03016312|65391341|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
23449949|NCT03016312|65391340|FG000|Overall Study|Physician Decision|1|||
23449950|NCT03016312|65391341|FG001|Overall Study|Physician Decision|3|||
23449951|NCT03016312|65391340|FG000|Overall Study|Lost to Follow-up|12|||
23449952|NCT03016312|65391341|FG001|Overall Study|Lost to Follow-up|12|||
23449953|NCT03016312|65391340|FG000|Overall Study|Death|210|||
23449954|NCT03016312|65391341|FG001|Overall Study|Death|184|||
23449955|NCT03016312|65391340|FG000|Overall Study|loss to contact|1|||
23449956|NCT03016312|65391341|FG001|Overall Study|loss to contact|0|||
23449957|NCT03016312|65391340|FG000|Overall Study|started a new cancer therapy|1|||
23449958|NCT03016312|65391341|FG001|Overall Study|started a new cancer therapy|0|||
23449959|NCT02836652|65391342|FG000|Overall Study|Death|3|||
23449960|NCT02836652|65391343|FG001|Overall Study|Death|3|||
23449961|NCT02836652|65391342|FG000|Overall Study|Transplant/Explant|3|||
23449962|NCT02836652|65391343|FG001|Overall Study|Transplant/Explant|4|||
23449963|NCT02836652|65391342|FG000|Overall Study|Withdrawn|9|||
23449964|NCT02836652|65391343|FG001|Overall Study|Withdrawn|9|||
23449965|NCT02836652|65391342|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
23449966|NCT02836652|65391343|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
23449967|NCT00539994|65391344|FG000|Overall Study|Lost to Follow-up|2|||
23449968|NCT00539994|65391345|FG001|Overall Study|Lost to Follow-up|1|||
23449969|NCT00539994|65391346|FG002|Overall Study|Lost to Follow-up|0|||
23449970|NCT00539994|65391344|FG000|Overall Study|Withdrawal by Subject|1|||
23449971|NCT00539994|65391345|FG001|Overall Study|Withdrawal by Subject|0|||
23449972|NCT00539994|65391346|FG002|Overall Study|Withdrawal by Subject|1|||
23449973|NCT00539994|65391344|FG000|Overall Study|Physician Decision|0|||
23449974|NCT00539994|65391345|FG001|Overall Study|Physician Decision|0|||
23449975|NCT00539994|65391346|FG002|Overall Study|Physician Decision|1|||
23449976|NCT02336607|65391348|FG000|Overall Study|Physician Decision|1|||
23449977|NCT02336607|65391349|FG001|Overall Study|Physician Decision|4|||
23449978|NCT02336607|65391350|FG002|Overall Study|Physician Decision|3|||
23449979|NCT02336607|65391351|FG003|Overall Study|Physician Decision|15|||
23777326|NCT03496623|66563417|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23777327|NCT03496623|66563418|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
23449980|NCT02336607|65391348|FG000|Overall Study|Lack of Efficacy|1|||
23449981|NCT02336607|65391349|FG001|Overall Study|Lack of Efficacy|0|||
23449982|NCT02336607|65391350|FG002|Overall Study|Lack of Efficacy|0|||
23449983|NCT02336607|65391351|FG003|Overall Study|Lack of Efficacy|2|||
23449984|NCT02336607|65391348|FG000|Overall Study|Lost to Follow-up|2|||
23836829|NCT02097238|66781398|FG000|Overall Study|Physician Decision|1|||
23449985|NCT02336607|65391349|FG001|Overall Study|Lost to Follow-up|1|||
23449986|NCT02336607|65391350|FG002|Overall Study|Lost to Follow-up|0|||
23449987|NCT02336607|65391351|FG003|Overall Study|Lost to Follow-up|21|||
23449988|NCT02336607|65391348|FG000|Overall Study|Protocol Violation|0|||
23449989|NCT02336607|65391349|FG001|Overall Study|Protocol Violation|1|||
23449990|NCT02336607|65391350|FG002|Overall Study|Protocol Violation|1|||
23449991|NCT02336607|65391351|FG003|Overall Study|Protocol Violation|3|||
23449992|NCT02336607|65391348|FG000|Overall Study|Adverse Event|0|||
23449993|NCT02336607|65391349|FG001|Overall Study|Adverse Event|2|||
23449994|NCT02336607|65391350|FG002|Overall Study|Adverse Event|2|||
23449995|NCT02336607|65391351|FG003|Overall Study|Adverse Event|26|||
23449996|NCT02336607|65391348|FG000|Overall Study|Withdrawal by Subject|0|||
23449997|NCT02336607|65391349|FG001|Overall Study|Withdrawal by Subject|2|||
23449998|NCT02336607|65391350|FG002|Overall Study|Withdrawal by Subject|0|||
23449999|NCT02336607|65391351|FG003|Overall Study|Withdrawal by Subject|20|||
23450000|NCT03914417|65391352|FG000|Overall Study|Withdrawal by Subject|2|||
23450001|NCT01620060|65391358|FG000|Overall Study|Adverse Event|9|||
23450002|NCT01620060|65391358|FG000|Overall Study|Protocol Violation|1|||
23450003|NCT01620060|65391358|FG000|Overall Study|Withdrawal by Subject|1|||
23836830|NCT02097238|66781398|FG000|Overall Study|Progressive Disease|17|||
23836831|NCT02644668|66781399|FG000|Overall Study|Adverse Event|2|||
23836832|NCT02644668|66781400|FG001|Overall Study|Adverse Event|0|||
23836833|NCT02644668|66781401|FG002|Overall Study|Adverse Event|1|||
23836834|NCT02644668|66781399|FG000|Overall Study|Protocol Violation|0|||
23836835|NCT02644668|66781400|FG001|Overall Study|Protocol Violation|0|||
23836836|NCT02644668|66781401|FG002|Overall Study|Protocol Violation|1|||
23836837|NCT02644668|66781399|FG000|Overall Study|Withdrawal by Subject|0|||
23836838|NCT02644668|66781400|FG001|Overall Study|Withdrawal by Subject|0|||
23836839|NCT02644668|66781401|FG002|Overall Study|Withdrawal by Subject|1|||
23836840|NCT02821754|66781406|FG000|Overall Study|Procedure not required prior to amendment change|13|||
23836841|NCT02821754|66781407|FG001|Overall Study|Procedure not required prior to amendment change|11|||
23836842|NCT02821754|66781408|FG002|Overall Study|Procedure not required prior to amendment change|0|||
23836843|NCT02821754|66781406|FG000|Overall Study|Participant's Clinical status|2|||
23836844|NCT02821754|66781407|FG001|Overall Study|Participant's Clinical status|0|||
23836845|NCT02821754|66781408|FG002|Overall Study|Participant's Clinical status|0|||
23450004|NCT01620060|65391358|FG000|Overall Study|Did not comply with Study Produre|1|||
23450005|NCT01620060|65391358|FG000|Overall Study|Family emergency|1|||
23450006|NCT01620060|65391358|FG000|Overall Study|Per Sponsor Decision|2|||
23450007|NCT04033367|65391359|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
23450008|NCT04033367|65391360|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
23450009|NCT04033367|65391359|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
23450010|NCT04033367|65391360|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
23450011|NCT04033367|65391359|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
23450012|NCT04033367|65391360|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
23450013|NCT04033367|65391359|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
23450014|NCT04033367|65391360|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
23450015|NCT04664153|65391361|FG000|Overall Study|Lack of Efficacy|0|||
23450016|NCT04664153|65391362|FG001|Overall Study|Lack of Efficacy|0|||
23450017|NCT04664153|65391363|FG002|Overall Study|Lack of Efficacy|1|||
23450018|NCT04664153|65391364|FG003|Overall Study|Lack of Efficacy|0|||
23450019|NCT04664153|65391361|FG000|Overall Study|Physician Decision|0|||
23450020|NCT04664153|65391362|FG001|Overall Study|Physician Decision|0|||
23450021|NCT04664153|65391363|FG002|Overall Study|Physician Decision|1|||
23450022|NCT04664153|65391364|FG003|Overall Study|Physician Decision|0|||
23450023|NCT04664153|65391361|FG000|Overall Study|Withdrawal by Subject|3|||
23450024|NCT04664153|65391362|FG001|Overall Study|Withdrawal by Subject|2|||
23450025|NCT04664153|65391363|FG002|Overall Study|Withdrawal by Subject|1|||
23450026|NCT04664153|65391364|FG003|Overall Study|Withdrawal by Subject|2|||
23450027|NCT04664153|65391361|FG000|Overall Study|Other|0|||
23450028|NCT04664153|65391362|FG001|Overall Study|Other|1|||
23450029|NCT04664153|65391363|FG002|Overall Study|Other|0|||
23450030|NCT04664153|65391364|FG003|Overall Study|Other|0|||
23450031|NCT04664153|65391361|FG000|Overall Study|Adverse Event|4|||
23450032|NCT04664153|65391362|FG001|Overall Study|Adverse Event|0|||
23450033|NCT04664153|65391363|FG002|Overall Study|Adverse Event|1|||
23450034|NCT04664153|65391364|FG003|Overall Study|Adverse Event|0|||
23450035|NCT00763386|65391369|FG000|Overall Study|Adverse Event|43|||
23450036|NCT00763386|65391370|FG001|Overall Study|Adverse Event|33|||
23450037|NCT00763386|65391369|FG000|Overall Study|Death|1|||
23450038|NCT00763386|65391370|FG001|Overall Study|Death|2|||
23450039|NCT00763386|65391369|FG000|Overall Study|Lost to Follow-up|3|||
23450040|NCT00763386|65391370|FG001|Overall Study|Lost to Follow-up|3|||
23450041|NCT00763386|65391369|FG000|Overall Study|Withdrawal by Subject|0|||
23450042|NCT00763386|65391370|FG001|Overall Study|Withdrawal by Subject|1|||
23450043|NCT00763386|65391369|FG000|Overall Study|CRF missing|0|||
23450044|NCT00763386|65391370|FG001|Overall Study|CRF missing|1|||
23450045|NCT00763386|65391369|FG000|Overall Study|Study Prosthesis Removed|1|||
23450046|NCT00763386|65391370|FG001|Overall Study|Study Prosthesis Removed|0|||
23836846|NCT02821754|66781406|FG000|Overall Study|Participant removed for noncompliance|1|||
23836847|NCT02821754|66781407|FG001|Overall Study|Participant removed for noncompliance|0|||
23836848|NCT02821754|66781408|FG002|Overall Study|Participant removed for noncompliance|0|||
23450047|NCT00165672|65391371|FG000|Overall Study|Adverse Event|0|||
23450048|NCT00165672|65391372|FG001|Overall Study|Adverse Event|1|||
23450049|NCT03431441|65391378|FG000|Overall Study|Withdrawal by Subject|2|||
23450050|NCT03431441|65391378|FG000|Overall Study|Adverse Event|2|||
23450051|NCT03431441|65391378|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
23450052|NCT00499681|65391381|FG000|Overall Study|toxicity|0|||
23450053|NCT00499681|65391382|FG001|Overall Study|toxicity|1|||
23450054|NCT00499681|65391381|FG000|Overall Study|disease progression|0|||
23450055|NCT00499681|65391382|FG001|Overall Study|disease progression|1|||
23450056|NCT00999544|65391383|FG000|Overall Study|Withdrawal by Subject|1|||
23450057|NCT00667888|65391389|FG000|Overall Study|Death|1|||
23450058|NCT00667888|65391390|FG001|Overall Study|Death|1|||
23450059|NCT00667888|65391389|FG000|Overall Study|Withdrawal by Subject|6|||
23450060|NCT00667888|65391390|FG001|Overall Study|Withdrawal by Subject|3|||
23450061|NCT00667888|65391389|FG000|Overall Study|Proceed with other treatment|3|||
23450062|NCT00667888|65391390|FG001|Overall Study|Proceed with other treatment|3|||
23450063|NCT00667888|65391389|FG000|Overall Study|Ineligible after SIM|0|||
23450064|NCT00667888|65391390|FG001|Overall Study|Ineligible after SIM|2|||
23450065|NCT00330759|65391400|FG000|Overall Study|Death|316|||
23450066|NCT00330759|65391401|FG001|Overall Study|Death|310|||
23450067|NCT00330759|65391400|FG000|Overall Study|Disease progression|104|||
23450068|NCT00330759|65391401|FG001|Overall Study|Disease progression|126|||
23450069|NCT00330759|65391400|FG000|Overall Study|Withdrawal by Subject|143|||
23450070|NCT00330759|65391401|FG001|Overall Study|Withdrawal by Subject|124|||
23450071|NCT00330759|65391400|FG000|Overall Study|Adverse Event|48|||
23450072|NCT00330759|65391401|FG001|Overall Study|Adverse Event|36|||
23450073|NCT00330759|65391400|FG000|Overall Study|Participant request|31|||
23450074|NCT00330759|65391401|FG001|Overall Study|Participant request|22|||
23450075|NCT00330759|65391400|FG000|Overall Study|Lost to Follow-up|16|||
23450076|NCT00330759|65391401|FG001|Overall Study|Lost to Follow-up|22|||
23450077|NCT00330759|65391400|FG000|Overall Study|Noncompliance|15|||
23450078|NCT00330759|65391401|FG001|Overall Study|Noncompliance|17|||
23450079|NCT00330759|65391400|FG000|Overall Study|Physician Decision|1|||
23450080|NCT00330759|65391401|FG001|Overall Study|Physician Decision|2|||
23450081|NCT00330759|65391400|FG000|Overall Study|Protocol deviation|0|||
23450082|NCT00330759|65391401|FG001|Overall Study|Protocol deviation|2|||
23450083|NCT00330759|65391400|FG000|Overall Study|Ineligibility determined|2|||
23450084|NCT00330759|65391401|FG001|Overall Study|Ineligibility determined|1|||
23450085|NCT00330759|65391400|FG000|Overall Study|Other|36|||
23450086|NCT00330759|65391401|FG001|Overall Study|Other|44|||
23450087|NCT00859547|65391406|FG000|Overall Study|Lost to Follow-up|1|||
23450088|NCT00859547|65391406|FG000|Overall Study|Parent withdrew consent|1|||
23450089|NCT03071263|65391407|FG000|Overall Study|Adverse Event|1|||
23450090|NCT03071263|65391408|FG001|Overall Study|Adverse Event|3|||
23450091|NCT03071263|65391407|FG000|Overall Study|Withdrawal by Subject|1|||
23450092|NCT03071263|65391408|FG001|Overall Study|Withdrawal by Subject|3|||
23450093|NCT03071263|65391407|FG000|Overall Study|Physician Decision|1|||
23777328|NCT03496623|66563419|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
23777329|NCT03496623|66563420|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23777330|NCT03496623|66563421|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23777331|NCT03496623|66563417|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23777332|NCT03496623|66563418|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23777333|NCT03496623|66563419|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
23777334|NCT03496623|66563420|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23777335|NCT03496623|66563421|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23777336|NCT03496623|66563417|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23777337|NCT03496623|66563418|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23777338|NCT03496623|66563419|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
23777339|NCT03496623|66563420|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23450094|NCT03071263|65391408|FG001|Overall Study|Physician Decision|0|||
23450095|NCT03071263|65391407|FG000|Overall Study|Participant moved to another city|0|||
23450096|NCT03071263|65391408|FG001|Overall Study|Participant moved to another city|1|||
23450097|NCT02800863|65391409|FG000|Overall Study|Adverse Event|14|||
23450098|NCT02800863|65391409|FG000|Overall Study|Another Device Implanted|1|||
23450099|NCT02800863|65391409|FG000|Overall Study|Device Explanted|1|||
23450100|NCT02800863|65391409|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
23450101|NCT02800863|65391409|FG000|Overall Study|Health Issues|1|||
23450102|NCT02800863|65391409|FG000|Overall Study|Insurance Denial|8|||
23777340|NCT03496623|66563421|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23777341|NCT03496623|66563417|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23450103|NCT02800863|65391409|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
23450104|NCT02800863|65391409|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
23777342|NCT03496623|66563418|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
23450105|NCT02800863|65391409|FG000|Overall Study|Screen Failure|1|||
23450106|NCT02800863|65391409|FG000|Overall Study|Sponsor Request|6|||
23450107|NCT02800863|65391409|FG000|Overall Study|Death|3|||
23577647|NCT00783692|65846903|FG000|Induction Phase|Lack of Efficacy|1|||
23777343|NCT03496623|66563419|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23777344|NCT03496623|66563420|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23777345|NCT03496623|66563421|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23777346|NCT00669942|66566774|FG000|Parts 2 and 3|Adverse Event|0|||
23777347|NCT00669942|66566775|FG001|Parts 2 and 3|Adverse Event|0|||
23777348|NCT00669942|66566776|FG002|Parts 2 and 3|Adverse Event|0|||
23777349|NCT00669942|66566777|FG003|Parts 2 and 3|Adverse Event|0|||
23777350|NCT00669942|66566778|FG004|Parts 2 and 3|Adverse Event|0|||
23777351|NCT00669942|66566779|FG005|Parts 2 and 3|Adverse Event|0|||
23777352|NCT00669942|66566780|FG006|Parts 2 and 3|Adverse Event|0|||
23836849|NCT02821754|66781406|FG000|Overall Study|Drug not available.|0|||
23836850|NCT02821754|66781407|FG001|Overall Study|Drug not available.|0|||
23836851|NCT02821754|66781408|FG002|Overall Study|Drug not available.|1|||
23836852|NCT02821754|66781406|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
23836853|NCT02821754|66781407|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
23836854|NCT02821754|66781408|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
23777353|NCT00669942|66566781|FG007|Parts 2 and 3|Adverse Event|2|||
23777354|NCT00669942|66566782|FG008|Parts 2 and 3|Adverse Event|1|||
23777355|NCT00669942|66566783|FG009|Parts 2 and 3|Adverse Event|0|||
23777356|NCT00669942|66566784|FG010|Parts 2 and 3|Adverse Event|0|||
23777357|NCT00669942|66566785|FG011|Parts 2 and 3|Adverse Event|0|||
23777358|NCT00669942|66566774|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
23836855|NCT04390503|66781413|FG000|Overall Study|Physician Decision|2|||
23836856|NCT04390503|66781414|FG001|Overall Study|Physician Decision|1|||
23836857|NCT04390503|66781413|FG000|Overall Study|Adverse Event|1|||
23777359|NCT00669942|66566775|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
23777360|NCT00669942|66566776|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
23777361|NCT00669942|66566777|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
23777362|NCT00669942|66566778|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
23777363|NCT00669942|66566779|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
23777364|NCT00669942|66566780|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
23777365|NCT00669942|66566781|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
23777366|NCT00669942|66566782|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
23777367|NCT00669942|66566783|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
23777368|NCT00669942|66566784|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
23777369|NCT00669942|66566785|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
23777370|NCT00669942|66566774|FG000|Parts 2 and 3|Protocol Violation|0|||
23777371|NCT00669942|66566775|FG001|Parts 2 and 3|Protocol Violation|0|||
23777372|NCT00669942|66566776|FG002|Parts 2 and 3|Protocol Violation|0|||
23777373|NCT00669942|66566777|FG003|Parts 2 and 3|Protocol Violation|0|||
23777374|NCT00669942|66566778|FG004|Parts 2 and 3|Protocol Violation|0|||
23777375|NCT00669942|66566779|FG005|Parts 2 and 3|Protocol Violation|1|||
23836858|NCT04390503|66781414|FG001|Overall Study|Adverse Event|0|||
23836859|NCT00806403|66781415|FG000|Overall Study|Death|4|||
23836860|NCT00806403|66781416|FG001|Overall Study|Death|3|||
23836861|NCT03103152|66781417|FG000|Overall Study|Physician Decision|5|||
23836862|NCT03103152|66781418|FG001|Overall Study|Physician Decision|2|||
23836863|NCT03103152|66781419|FG002|Overall Study|Physician Decision|6|||
23836864|NCT03103152|66781420|FG003|Overall Study|Physician Decision|3|||
23450108|NCT02800863|65391409|FG000|Overall Study|Subject Implant at Another Facility|1|||
23450109|NCT02800863|65391409|FG000|Overall Study|Lost to Follow-up|26|||
23450110|NCT02800863|65391409|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
23836865|NCT03103152|66781421|FG004|Overall Study|Physician Decision|3|||
23836866|NCT03103152|66781422|FG005|Overall Study|Physician Decision|1|||
23836867|NCT03103152|66781417|FG000|Overall Study|Protocol Violation|2|||
23836868|NCT03103152|66781418|FG001|Overall Study|Protocol Violation|2|||
23836869|NCT03103152|66781419|FG002|Overall Study|Protocol Violation|1|||
23836870|NCT03103152|66781420|FG003|Overall Study|Protocol Violation|2|||
23836871|NCT03103152|66781421|FG004|Overall Study|Protocol Violation|1|||
23836872|NCT03103152|66781422|FG005|Overall Study|Protocol Violation|1|||
23836873|NCT03103152|66781417|FG000|Overall Study|Inter-current illness|0|||
23836874|NCT03103152|66781418|FG001|Overall Study|Inter-current illness|0|||
23836875|NCT03103152|66781419|FG002|Overall Study|Inter-current illness|1|||
23777376|NCT00669942|66566780|FG006|Parts 2 and 3|Protocol Violation|0|||
23777377|NCT00669942|66566781|FG007|Parts 2 and 3|Protocol Violation|0|||
23777378|NCT00669942|66566782|FG008|Parts 2 and 3|Protocol Violation|0|||
23777379|NCT00669942|66566783|FG009|Parts 2 and 3|Protocol Violation|0|||
23777380|NCT00669942|66566784|FG010|Parts 2 and 3|Protocol Violation|0|||
23777381|NCT00669942|66566785|FG011|Parts 2 and 3|Protocol Violation|0|||
23777382|NCT02910037|66566786|FG000|Overall Study|Withdrawal by Subject|4|||
23777383|NCT02910037|66566786|FG000|Overall Study|Lost to Follow-up|6|||
23777384|NCT03880266|66566787|FG000|Overall Study|Withdrawal by Subject|0|||
23836876|NCT03103152|66781420|FG003|Overall Study|Inter-current illness|0|||
23777385|NCT03880266|66566788|FG001|Overall Study|Withdrawal by Subject|1|||
23836877|NCT03103152|66781421|FG004|Overall Study|Inter-current illness|0|||
23836878|NCT03103152|66781422|FG005|Overall Study|Inter-current illness|0|||
23836879|NCT03103152|66781417|FG000|Overall Study|Death|0|||
23836880|NCT03103152|66781418|FG001|Overall Study|Death|1|||
23577648|NCT00783692|65846904|FG001|Induction Phase|Lack of Efficacy|3|||
23577649|NCT00783692|65846905|FG002|Induction Phase|Lack of Efficacy|28|||
23577650|NCT00783692|65846906|FG003|Induction Phase|Lack of Efficacy|0|||
23577651|NCT00783692|65846907|FG004|Induction Phase|Lack of Efficacy|0|||
23577652|NCT00783692|65846908|FG005|Induction Phase|Lack of Efficacy|0|||
23577653|NCT00783692|65846909|FG006|Induction Phase|Lack of Efficacy|0|||
23577654|NCT00783692|65846903|FG000|Induction Phase|Withdrawal by Subject|3|||
23577655|NCT00783692|65846904|FG001|Induction Phase|Withdrawal by Subject|9|||
23577656|NCT00783692|65846905|FG002|Induction Phase|Withdrawal by Subject|16|||
23577657|NCT00783692|65846906|FG003|Induction Phase|Withdrawal by Subject|0|||
23577658|NCT00783692|65846907|FG004|Induction Phase|Withdrawal by Subject|0|||
23577659|NCT00783692|65846908|FG005|Induction Phase|Withdrawal by Subject|0|||
23577660|NCT00783692|65846909|FG006|Induction Phase|Withdrawal by Subject|0|||
23577661|NCT00783692|65846903|FG000|Induction Phase|Lost to Follow-up|0|||
23577662|NCT00783692|65846904|FG001|Induction Phase|Lost to Follow-up|0|||
23577663|NCT00783692|65846905|FG002|Induction Phase|Lost to Follow-up|3|||
23577664|NCT00783692|65846906|FG003|Induction Phase|Lost to Follow-up|0|||
23577665|NCT00783692|65846907|FG004|Induction Phase|Lost to Follow-up|0|||
23577666|NCT00783692|65846908|FG005|Induction Phase|Lost to Follow-up|0|||
23577667|NCT00783692|65846909|FG006|Induction Phase|Lost to Follow-up|0|||
23577668|NCT00783692|65846903|FG000|Induction Phase|Other|0|||
23577669|NCT00783692|65846904|FG001|Induction Phase|Other|0|||
23577670|NCT00783692|65846905|FG002|Induction Phase|Other|2|||
23577671|NCT00783692|65846906|FG003|Induction Phase|Other|0|||
23577672|NCT00783692|65846907|FG004|Induction Phase|Other|0|||
23577673|NCT00783692|65846908|FG005|Induction Phase|Other|0|||
23577674|NCT00783692|65846909|FG006|Induction Phase|Other|0|||
23577675|NCT00783692|65846903|FG000|Maintenance Phase|Adverse Event|7|||
23577676|NCT00783692|65846904|FG001|Maintenance Phase|Adverse Event|0|||
23577677|NCT00783692|65846905|FG002|Maintenance Phase|Adverse Event|0|||
23577678|NCT00783692|65846906|FG003|Maintenance Phase|Adverse Event|15|||
23577679|NCT00783692|65846907|FG004|Maintenance Phase|Adverse Event|12|||
23577680|NCT00783692|65846908|FG005|Maintenance Phase|Adverse Event|9|||
23577681|NCT00783692|65846909|FG006|Maintenance Phase|Adverse Event|38|||
23577682|NCT00783692|65846903|FG000|Maintenance Phase|Protocol Violation|0|||
23577683|NCT00783692|65846904|FG001|Maintenance Phase|Protocol Violation|0|||
23577684|NCT00783692|65846905|FG002|Maintenance Phase|Protocol Violation|0|||
23577685|NCT00783692|65846906|FG003|Maintenance Phase|Protocol Violation|1|||
23577686|NCT00783692|65846907|FG004|Maintenance Phase|Protocol Violation|2|||
23577687|NCT00783692|65846908|FG005|Maintenance Phase|Protocol Violation|3|||
23577688|NCT00783692|65846909|FG006|Maintenance Phase|Protocol Violation|4|||
23577689|NCT00783692|65846903|FG000|Maintenance Phase|Lack of Efficacy|79|||
23577690|NCT00783692|65846904|FG001|Maintenance Phase|Lack of Efficacy|0|||
23577691|NCT00783692|65846905|FG002|Maintenance Phase|Lack of Efficacy|0|||
23577692|NCT00783692|65846906|FG003|Maintenance Phase|Lack of Efficacy|64|||
23577693|NCT00783692|65846907|FG004|Maintenance Phase|Lack of Efficacy|58|||
23577694|NCT00783692|65846908|FG005|Maintenance Phase|Lack of Efficacy|48|||
23577695|NCT00783692|65846909|FG006|Maintenance Phase|Lack of Efficacy|177|||
23577696|NCT00783692|65846903|FG000|Maintenance Phase|Withdrawal by Subject|7|||
23577697|NCT00783692|65846904|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23577698|NCT00783692|65846905|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23577699|NCT00783692|65846906|FG003|Maintenance Phase|Withdrawal by Subject|7|||
23577700|NCT00783692|65846907|FG004|Maintenance Phase|Withdrawal by Subject|6|||
23577701|NCT00783692|65846908|FG005|Maintenance Phase|Withdrawal by Subject|9|||
23577702|NCT00783692|65846909|FG006|Maintenance Phase|Withdrawal by Subject|24|||
23577703|NCT00783692|65846903|FG000|Maintenance Phase|Lost to Follow-up|2|||
23577704|NCT00783692|65846904|FG001|Maintenance Phase|Lost to Follow-up|0|||
23577705|NCT00783692|65846905|FG002|Maintenance Phase|Lost to Follow-up|0|||
23577706|NCT00783692|65846906|FG003|Maintenance Phase|Lost to Follow-up|1|||
23577707|NCT00783692|65846907|FG004|Maintenance Phase|Lost to Follow-up|3|||
23577708|NCT00783692|65846908|FG005|Maintenance Phase|Lost to Follow-up|2|||
23577709|NCT00783692|65846909|FG006|Maintenance Phase|Lost to Follow-up|5|||
23577710|NCT00783692|65846903|FG000|Maintenance Phase|Other|0|||
23577711|NCT00783692|65846904|FG001|Maintenance Phase|Other|0|||
23577712|NCT00783692|65846905|FG002|Maintenance Phase|Other|0|||
23577713|NCT00783692|65846906|FG003|Maintenance Phase|Other|1|||
23577714|NCT00783692|65846907|FG004|Maintenance Phase|Other|0|||
23577715|NCT00783692|65846908|FG005|Maintenance Phase|Other|1|||
23634259|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
23634260|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Death|4|||
23577716|NCT00783692|65846909|FG006|Maintenance Phase|Other|1|||
23577717|NCT01004263|65846910|FG000|Overall Study|Adverse Event|15|||
23577718|NCT01004263|65846910|FG000|Overall Study|Withdrawal by Subject|58|||
23577719|NCT01004263|65846910|FG000|Overall Study|Protocol Violation|10|||
23577720|NCT01004263|65846910|FG000|Overall Study|Lost to Follow-up|64|||
23577721|NCT01004263|65846910|FG000|Overall Study|Lack of Efficacy|13|||
23577722|NCT01004263|65846910|FG000|Overall Study|Pregnancy|2|||
23577723|NCT01004263|65846910|FG000|Overall Study|Physician Decision|15|||
23577724|NCT01004263|65846910|FG000|Overall Study|Lack of Qualifying Event|2|||
23836881|NCT03103152|66781419|FG002|Overall Study|Death|0|||
23836882|NCT03103152|66781420|FG003|Overall Study|Death|0|||
23836883|NCT03103152|66781421|FG004|Overall Study|Death|0|||
23836884|NCT03103152|66781422|FG005|Overall Study|Death|0|||
23836885|NCT03103152|66781417|FG000|Overall Study|Adverse Event|0|||
23836886|NCT03103152|66781418|FG001|Overall Study|Adverse Event|0|||
23836887|NCT03103152|66781419|FG002|Overall Study|Adverse Event|1|||
23836888|NCT03103152|66781420|FG003|Overall Study|Adverse Event|0|||
23836889|NCT03103152|66781421|FG004|Overall Study|Adverse Event|0|||
23836890|NCT03103152|66781422|FG005|Overall Study|Adverse Event|1|||
23836891|NCT03103152|66781417|FG000|Overall Study|Withdrawal by Subject|1|||
23836892|NCT03103152|66781418|FG001|Overall Study|Withdrawal by Subject|0|||
23836893|NCT03103152|66781419|FG002|Overall Study|Withdrawal by Subject|1|||
23836894|NCT03103152|66781420|FG003|Overall Study|Withdrawal by Subject|1|||
23836895|NCT03103152|66781421|FG004|Overall Study|Withdrawal by Subject|1|||
23836896|NCT03103152|66781422|FG005|Overall Study|Withdrawal by Subject|1|||
23836897|NCT03103152|66781417|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
23836898|NCT03103152|66781418|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
23836899|NCT03103152|66781419|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
23836900|NCT03103152|66781420|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
23836901|NCT03103152|66781421|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
23836902|NCT03103152|66781422|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
23836903|NCT03103152|66781417|FG000|Overall Study|Unacceptable side effects|0|||
23836904|NCT03103152|66781418|FG001|Overall Study|Unacceptable side effects|0|||
23836905|NCT03103152|66781419|FG002|Overall Study|Unacceptable side effects|0|||
23836906|NCT03103152|66781420|FG003|Overall Study|Unacceptable side effects|0|||
23836907|NCT03103152|66781421|FG004|Overall Study|Unacceptable side effects|0|||
23836908|NCT03103152|66781422|FG005|Overall Study|Unacceptable side effects|1|||
23836909|NCT03103152|66781417|FG000|Overall Study|Lost to Follow-up|0|||
23836910|NCT03103152|66781418|FG001|Overall Study|Lost to Follow-up|1|||
23836911|NCT03103152|66781419|FG002|Overall Study|Lost to Follow-up|0|||
23836912|NCT03103152|66781420|FG003|Overall Study|Lost to Follow-up|1|||
23836913|NCT03103152|66781421|FG004|Overall Study|Lost to Follow-up|0|||
23836914|NCT03103152|66781422|FG005|Overall Study|Lost to Follow-up|1|||
23836915|NCT03103152|66781417|FG000|Overall Study|Testicular pain|0|||
23836916|NCT03103152|66781418|FG001|Overall Study|Testicular pain|0|||
23836917|NCT03103152|66781419|FG002|Overall Study|Testicular pain|0|||
23836918|NCT03103152|66781420|FG003|Overall Study|Testicular pain|1|||
23836919|NCT03103152|66781421|FG004|Overall Study|Testicular pain|0|||
23836920|NCT03103152|66781422|FG005|Overall Study|Testicular pain|0|||
23836921|NCT03168711|66781424|FG000|Overall Study|Adverse Event|2|||
23836922|NCT03168711|66781425|FG001|Overall Study|Adverse Event|0|||
23836923|NCT03168711|66781424|FG000|Overall Study|Withdrawal by Subject|0|||
23836924|NCT03168711|66781425|FG001|Overall Study|Withdrawal by Subject|1|||
23450111|NCT02800863|65391409|FG000|Overall Study|Subject and/or Family Request|64|||
23450112|NCT02800863|65391409|FG000|Overall Study|Trial Failure|81|||
23450113|NCT02800863|65391409|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
23450114|NCT01601535|65391410|FG000|Phase 1|Adverse Event|1|||
23450115|NCT01601535|65391411|FG001|Phase 1|Adverse Event|0|||
23450116|NCT01601535|65391412|FG002|Phase 1|Adverse Event|2|||
23450117|NCT01601535|65391413|FG003|Phase 1|Adverse Event|1|||
23450118|NCT01601535|65391414|FG004|Phase 1|Adverse Event|0|||
23450119|NCT01601535|65391415|FG005|Phase 1|Adverse Event|0|||
23450120|NCT01601535|65391410|FG000|Phase 1|Withdrawal by Subject|2|||
23450121|NCT01601535|65391411|FG001|Phase 1|Withdrawal by Subject|1|||
23450122|NCT01601535|65391412|FG002|Phase 1|Withdrawal by Subject|1|||
23450123|NCT01601535|65391413|FG003|Phase 1|Withdrawal by Subject|2|||
23450124|NCT01601535|65391414|FG004|Phase 1|Withdrawal by Subject|0|||
23450125|NCT01601535|65391415|FG005|Phase 1|Withdrawal by Subject|0|||
23836925|NCT03168711|66781424|FG000|Overall Study|Death|0|||
23836926|NCT03168711|66781425|FG001|Overall Study|Death|1|||
23836927|NCT02176655|66781426|FG000|Overall Study|Subjects did not treat|6|||
23836928|NCT01031680|66781428|FG000|Overall Study|Adverse Event|8|||
23450126|NCT01601535|65391410|FG000|Phase 1|Progressive Disease|2|||
23450127|NCT01601535|65391411|FG001|Phase 1|Progressive Disease|3|||
23450128|NCT01601535|65391412|FG002|Phase 1|Progressive Disease|2|||
23450129|NCT01601535|65391413|FG003|Phase 1|Progressive Disease|1|||
23450130|NCT01601535|65391414|FG004|Phase 1|Progressive Disease|0|||
23450131|NCT01601535|65391415|FG005|Phase 1|Progressive Disease|0|||
23450132|NCT01601535|65391410|FG000|Phase 1|Started Another Treatment|1|||
23836929|NCT01031680|66781429|FG001|Overall Study|Adverse Event|3|||
23836930|NCT01031680|66781428|FG000|Overall Study|Lost to Follow-up|2|||
23836931|NCT01031680|66781429|FG001|Overall Study|Lost to Follow-up|10|||
23836932|NCT01031680|66781428|FG000|Overall Study|Withdrawal by Subject|12|||
23836933|NCT01031680|66781429|FG001|Overall Study|Withdrawal by Subject|16|||
23836934|NCT01031680|66781428|FG000|Overall Study|Death|2|||
23836935|NCT01031680|66781429|FG001|Overall Study|Death|1|||
23836936|NCT01031680|66781428|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
23836937|NCT01031680|66781429|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
23634261|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Death|2|||
23634262|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Death|3|||
23634263|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
23634264|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
23836938|NCT01031680|66781428|FG000|Overall Study|Poor/Non-compliance|5|||
23836939|NCT01031680|66781429|FG001|Overall Study|Poor/Non-compliance|6|||
23450133|NCT01601535|65391411|FG001|Phase 1|Started Another Treatment|2|||
23836940|NCT01031680|66781428|FG000|Overall Study|Safety|1|||
23836941|NCT01031680|66781429|FG001|Overall Study|Safety|0|||
23836942|NCT01031680|66781428|FG000|Overall Study|Incorrect Enrolment|1|||
23577725|NCT00557505|65846913|FG000|Overall Study|Death|0|||
23577726|NCT00557505|65846914|FG001|Overall Study|Death|0|||
23577727|NCT00557505|65846915|FG002|Overall Study|Death|0|||
23577728|NCT00557505|65846916|FG003|Overall Study|Death|0|||
23577729|NCT00557505|65846917|FG004|Overall Study|Death|0|||
23577730|NCT00557505|65846918|FG005|Overall Study|Death|0|||
23577731|NCT00557505|65846919|FG006|Overall Study|Death|0|||
23836943|NCT01031680|66781429|FG001|Overall Study|Incorrect Enrolment|2|||
23836944|NCT01031680|66781428|FG000|Overall Study|Administrative Reason by Sponsor|0|||
23836945|NCT01031680|66781429|FG001|Overall Study|Administrative Reason by Sponsor|1|||
23836946|NCT01031680|66781428|FG000|Overall Study|Various|0|||
23836947|NCT01031680|66781429|FG001|Overall Study|Various|2|||
23836948|NCT01294696|66781430|FG000|Overall Study|Screening failures|7|||
23836949|NCT01294696|66781430|FG000|Overall Study|Protocol Violation|8|||
23836950|NCT01294696|66781430|FG000|Overall Study|Missing BPI Response|7|||
23836951|NCT01294696|66781430|FG000|Overall Study|Site closure|52|||
23450134|NCT01601535|65391412|FG002|Phase 1|Started Another Treatment|0|||
23577732|NCT00557505|65846920|FG007|Overall Study|Death|0|||
23577733|NCT00557505|65846921|FG008|Overall Study|Death|1|||
23577734|NCT00557505|65846913|FG000|Overall Study|Adverse Event|0|||
23577735|NCT00557505|65846914|FG001|Overall Study|Adverse Event|0|||
23577736|NCT00557505|65846915|FG002|Overall Study|Adverse Event|1|||
23777386|NCT03880266|66566789|FG002|Overall Study|Withdrawal by Subject|1|||
23777387|NCT03880266|66566790|FG003|Overall Study|Withdrawal by Subject|0|||
23777388|NCT03880266|66566791|FG004|Overall Study|Withdrawal by Subject|0|||
23777389|NCT03880266|66566792|FG005|Overall Study|Withdrawal by Subject|0|||
23777390|NCT03880266|66566793|FG006|Overall Study|Withdrawal by Subject|0|||
23777391|NCT03880266|66566794|FG007|Overall Study|Withdrawal by Subject|0|||
23777392|NCT00320112|66566799|FG000|Overall Study|Lost to Follow-up|3|||
23777393|NCT00320112|66566800|FG001|Overall Study|Lost to Follow-up|4|||
23777394|NCT00320112|66566799|FG000|Overall Study|Withdrawal by Subject|3|||
23777395|NCT00320112|66566800|FG001|Overall Study|Withdrawal by Subject|0|||
23777396|NCT00320112|66566799|FG000|Overall Study|Death|2|||
23777397|NCT00320112|66566800|FG001|Overall Study|Death|1|||
23777398|NCT01214850|66566801|FG000|Overall Study|Withdrawal by Subject|38|||
23777399|NCT01214850|66566802|FG001|Overall Study|Withdrawal by Subject|31|||
23777400|NCT01214850|66566803|FG002|Overall Study|Withdrawal by Subject|28|||
23777401|NCT01214850|66566801|FG000|Overall Study|Lost to Follow-up|124|||
23777402|NCT01214850|66566802|FG001|Overall Study|Lost to Follow-up|98|||
23777403|NCT01214850|66566803|FG002|Overall Study|Lost to Follow-up|123|||
23777404|NCT01214850|66566801|FG000|Overall Study|Protocol Violation|5|||
23777405|NCT01214850|66566802|FG001|Overall Study|Protocol Violation|5|||
23777406|NCT01214850|66566803|FG002|Overall Study|Protocol Violation|6|||
23777407|NCT01214850|66566801|FG000|Overall Study|Adverse event or death|11|||
23777408|NCT01214850|66566802|FG001|Overall Study|Adverse event or death|8|||
23777409|NCT01214850|66566803|FG002|Overall Study|Adverse event or death|3|||
23777410|NCT01214850|66566801|FG000|Overall Study|Inappropriate enrollment|2|||
23777411|NCT01214850|66566802|FG001|Overall Study|Inappropriate enrollment|1|||
23777412|NCT01214850|66566803|FG002|Overall Study|Inappropriate enrollment|0|||
23777413|NCT01214850|66566801|FG000|Overall Study|Administrative reason|1|||
23777414|NCT01214850|66566802|FG001|Overall Study|Administrative reason|0|||
23777415|NCT01214850|66566803|FG002|Overall Study|Administrative reason|0|||
23777416|NCT01214850|66566801|FG000|Overall Study|Unable to classify|2|||
23777417|NCT01214850|66566802|FG001|Overall Study|Unable to classify|1|||
23777418|NCT01214850|66566803|FG002|Overall Study|Unable to classify|1|||
23777419|NCT00086996|66566804|FG000|Overall Study|Adverse Event|29|||
23777420|NCT00086996|66566804|FG000|Overall Study|Death|4|||
23777421|NCT00086996|66566804|FG000|Overall Study|progression/relapse|7|||
23777422|NCT00086996|66566804|FG000|Overall Study|Withdrawal by Subject|13|||
23777423|NCT00086996|66566804|FG000|Overall Study|Other|6|||
23777424|NCT00086996|66566804|FG000|Overall Study|not eligible|5|||
23777425|NCT02739997|66566805|FG000|Overall Study|Death|1|||
23777426|NCT02739997|66566805|FG000|Overall Study|Withdrawal by Subject|1|||
23836952|NCT01470248|66781432|FG000|Overall Study|Withdrawal by Subject|1|||
23836953|NCT00765336|66781436|FG000|Overall Study|Protocol Violation|4|||
23836954|NCT00765336|66781437|FG001|Overall Study|Protocol Violation|2|||
23836955|NCT00765336|66781436|FG000|Overall Study|Withdrawal by Subject|6|||
23836956|NCT00765336|66781437|FG001|Overall Study|Withdrawal by Subject|4|||
23577737|NCT00557505|65846916|FG003|Overall Study|Adverse Event|0|||
23577738|NCT00557505|65846917|FG004|Overall Study|Adverse Event|0|||
23577739|NCT00557505|65846918|FG005|Overall Study|Adverse Event|0|||
23577740|NCT00557505|65846919|FG006|Overall Study|Adverse Event|1|||
23777427|NCT00096265|66566806|FG000|Overall Study|Ineligible|1|||
23777428|NCT00096265|66566807|FG001|Overall Study|Ineligible|0|||
23777429|NCT00096265|66566808|FG002|Overall Study|Ineligible|0|||
23777430|NCT00877032|66566809|FG000|Overall Study|Did not meet entrance criteria|0|||
23836957|NCT00765336|66781436|FG000|Overall Study|Lost to Follow-up|7|||
23836958|NCT00765336|66781437|FG001|Overall Study|Lost to Follow-up|9|||
23836959|NCT00765336|66781436|FG000|Overall Study|Adverse Event|2|||
23777431|NCT00877032|66566810|FG001|Overall Study|Did not meet entrance criteria|0|||
23777432|NCT00877032|66566811|FG002|Overall Study|Did not meet entrance criteria|0|||
23777433|NCT00877032|66566812|FG003|Overall Study|Did not meet entrance criteria|1|||
23777434|NCT00877032|66566813|FG004|Overall Study|Did not meet entrance criteria|0|||
23777435|NCT00877032|66566814|FG005|Overall Study|Did not meet entrance criteria|0|||
23777436|NCT00877032|66566815|FG006|Overall Study|Did not meet entrance criteria|2|||
23777437|NCT01722877|66566816|FG000|Overall Study|Death|1|||
23777438|NCT01722877|66566816|FG000|Overall Study|Lost to Follow-up|1|||
23777439|NCT02127281|66566828|FG000|Overall Study|Lost to Follow-up|1|||
23777440|NCT02127281|66566829|FG001|Overall Study|Lost to Follow-up|0|||
23777441|NCT00119015|66566830|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
23777442|NCT00119015|66566831|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
23777443|NCT00119015|66566832|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
23777444|NCT00814463|66566833|FG000|Overall Study|Lost to Follow-up|1|||
23777445|NCT00050778|66566834|FG000|Overall Study|Adverse Event|13|||
23777446|NCT00050778|66566835|FG001|Overall Study|Adverse Event|3|||
23777447|NCT00050778|66566836|FG002|Overall Study|Adverse Event|2|||
23777448|NCT00050778|66566834|FG000|Overall Study|Death|0|||
23777449|NCT00050778|66566835|FG001|Overall Study|Death|1|||
23777450|NCT00050778|66566836|FG002|Overall Study|Death|1|||
23777451|NCT00050778|66566834|FG000|Overall Study|Lack of Efficacy|16|||
23777452|NCT00050778|66566835|FG001|Overall Study|Lack of Efficacy|2|||
23777453|NCT00050778|66566836|FG002|Overall Study|Lack of Efficacy|2|||
23777454|NCT00050778|66566834|FG000|Overall Study|Lost to Follow-up|0|||
23777455|NCT00050778|66566835|FG001|Overall Study|Lost to Follow-up|2|||
23777456|NCT00050778|66566836|FG002|Overall Study|Lost to Follow-up|4|||
23777457|NCT00050778|66566834|FG000|Overall Study|Physician Decision|3|||
23777458|NCT00050778|66566835|FG001|Overall Study|Physician Decision|0|||
23777459|NCT00050778|66566836|FG002|Overall Study|Physician Decision|2|||
23777460|NCT00050778|66566834|FG000|Overall Study|Protocol Violation|2|||
23836960|NCT00765336|66781437|FG001|Overall Study|Adverse Event|1|||
23836961|NCT00135512|66781438|FG000|Overall Study|Adverse Event|56|||
23836962|NCT00135512|66781438|FG000|Overall Study|Lack of Efficacy|25|||
23836963|NCT00135512|66781438|FG000|Overall Study|Other|42|||
23836964|NCT02019264|66781439|FG000|Overall Study|Not treated|6|||
23836965|NCT02019264|66781440|FG001|Overall Study|Not treated|4|||
23777461|NCT00050778|66566835|FG001|Overall Study|Protocol Violation|0|||
23777462|NCT00050778|66566836|FG002|Overall Study|Protocol Violation|1|||
23777463|NCT00050778|66566834|FG000|Overall Study|Withdrawal by Subject|6|||
23777464|NCT00050778|66566835|FG001|Overall Study|Withdrawal by Subject|8|||
23777465|NCT00050778|66566836|FG002|Overall Study|Withdrawal by Subject|4|||
23836966|NCT02019264|66781439|FG000|Overall Study|Lost to Follow-up|50|||
23836967|NCT02019264|66781440|FG001|Overall Study|Lost to Follow-up|47|||
23836968|NCT02019264|66781439|FG000|Overall Study|Withdrawal by Subject|142|||
23777466|NCT00050778|66566834|FG000|Overall Study|Randomized but not treated|4|||
23777467|NCT00050778|66566835|FG001|Overall Study|Randomized but not treated|5|||
23777468|NCT00050778|66566836|FG002|Overall Study|Randomized but not treated|2|||
23777469|NCT00050778|66566834|FG000|Overall Study|Familial and personal reasons|1|||
23577741|NCT00557505|65846920|FG007|Overall Study|Adverse Event|0|||
23577742|NCT00557505|65846921|FG008|Overall Study|Adverse Event|0|||
23577743|NCT00557505|65846913|FG000|Overall Study|Global deterioration of health|1|||
23777470|NCT00050778|66566835|FG001|Overall Study|Familial and personal reasons|0|||
23777471|NCT00050778|66566836|FG002|Overall Study|Familial and personal reasons|0|||
23777472|NCT01511939|66566837|FG000|Overall Study|Withdrawal by Subject|2|||
23577744|NCT00557505|65846914|FG001|Overall Study|Global deterioration of health|0|||
23577745|NCT00557505|65846915|FG002|Overall Study|Global deterioration of health|0|||
23577746|NCT00557505|65846916|FG003|Overall Study|Global deterioration of health|0|||
23577747|NCT00557505|65846917|FG004|Overall Study|Global deterioration of health|0|||
23577748|NCT00557505|65846918|FG005|Overall Study|Global deterioration of health|0|||
23577749|NCT00557505|65846919|FG006|Overall Study|Global deterioration of health|0|||
23577750|NCT00557505|65846920|FG007|Overall Study|Global deterioration of health|0|||
23577751|NCT00557505|65846921|FG008|Overall Study|Global deterioration of health|0|||
23577752|NCT00557505|65846913|FG000|Overall Study|Objective progression or relapse|2|||
23577753|NCT00557505|65846914|FG001|Overall Study|Objective progression or relapse|3|||
23577754|NCT00557505|65846915|FG002|Overall Study|Objective progression or relapse|3|||
23577755|NCT00557505|65846916|FG003|Overall Study|Objective progression or relapse|2|||
23577756|NCT00557505|65846917|FG004|Overall Study|Objective progression or relapse|2|||
23777473|NCT01511939|66566838|FG001|Overall Study|Withdrawal by Subject|1|||
23777474|NCT01511939|66566839|FG002|Overall Study|Withdrawal by Subject|0|||
23777475|NCT04129346|66566843|FG000|Overall Study|Death|1|||
23777476|NCT04129346|66566844|FG001|Overall Study|Death|0|||
23777477|NCT02719522|66566848|FG000|Overall Study|Implant Failure|4|||
23777478|NCT02719522|66566848|FG000|Overall Study|Death|2|||
23777479|NCT02719522|66566848|FG000|Overall Study|Lost to Follow-up|5|||
23777480|NCT04753437|66566852|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23777481|NCT04753437|66566853|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23777482|NCT04753437|66566852|FG000|Overall Study|Liver Function Test Abnormalities|2|||
23777483|NCT04753437|66566853|FG001|Overall Study|Liver Function Test Abnormalities|4|||
23777484|NCT02331394|66566855|FG000|Overall Study|Disease progression|1|||
23777485|NCT00705536|66566856|FG000|Start Period 1|Withdrawal by Subject|0|||
23777486|NCT00705536|66566857|FG001|Start Period 1|Withdrawal by Subject|0|||
23777487|NCT00705536|66566858|FG002|Start Period 1|Withdrawal by Subject|0|||
23777488|NCT00705536|66566859|FG003|Start Period 1|Withdrawal by Subject|1|||
23777489|NCT01185821|66566862|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23777490|NCT01185821|66566863|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23777491|NCT01185821|66566864|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23777492|NCT01185821|66566865|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23777493|NCT01185821|66566866|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23777494|NCT01185821|66566862|FG000|Overall Study|Protocol Violation|0|||
23777495|NCT01185821|66566863|FG001|Overall Study|Protocol Violation|0|||
23777496|NCT01185821|66566864|FG002|Overall Study|Protocol Violation|0|||
23777497|NCT01185821|66566865|FG003|Overall Study|Protocol Violation|1|||
23777498|NCT01185821|66566866|FG004|Overall Study|Protocol Violation|1|||
23777499|NCT01185821|66566862|FG000|Overall Study|Abnormal test procedure result|0|||
23777500|NCT01185821|66566863|FG001|Overall Study|Abnormal test procedure result|0|||
23777501|NCT01185821|66566864|FG002|Overall Study|Abnormal test procedure result|0|||
23777502|NCT01185821|66566865|FG003|Overall Study|Abnormal test procedure result|0|||
23777503|NCT01185821|66566866|FG004|Overall Study|Abnormal test procedure result|1|||
23777504|NCT01185821|66566862|FG000|Overall Study|Death|0|||
23777505|NCT01185821|66566863|FG001|Overall Study|Death|1|||
23777506|NCT01185821|66566864|FG002|Overall Study|Death|0|||
23777507|NCT01185821|66566865|FG003|Overall Study|Death|0|||
23777508|NCT01185821|66566866|FG004|Overall Study|Death|0|||
23777509|NCT01185821|66566862|FG000|Overall Study|Condition no longer required study drug|0|||
23777510|NCT01185821|66566863|FG001|Overall Study|Condition no longer required study drug|0|||
23777511|NCT01185821|66566864|FG002|Overall Study|Condition no longer required study drug|0|||
23777512|NCT01185821|66566865|FG003|Overall Study|Condition no longer required study drug|0|||
23777513|NCT01185821|66566866|FG004|Overall Study|Condition no longer required study drug|1|||
23777514|NCT01185821|66566862|FG000|Overall Study|Adverse Event|2|||
23577757|NCT00557505|65846918|FG005|Overall Study|Objective progression or relapse|3|||
23634265|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
23777515|NCT01185821|66566863|FG001|Overall Study|Adverse Event|3|||
23777516|NCT01185821|66566864|FG002|Overall Study|Adverse Event|1|||
23777517|NCT01185821|66566865|FG003|Overall Study|Adverse Event|2|||
23777518|NCT01185821|66566866|FG004|Overall Study|Adverse Event|5|||
23777519|NCT01185821|66566862|FG000|Overall Study|Lack of Efficacy|0|||
23777520|NCT01185821|66566863|FG001|Overall Study|Lack of Efficacy|0|||
23450135|NCT01601535|65391413|FG003|Phase 1|Started Another Treatment|0|||
23777521|NCT01185821|66566864|FG002|Overall Study|Lack of Efficacy|3|||
23577758|NCT00557505|65846919|FG006|Overall Study|Objective progression or relapse|2|||
23577759|NCT00557505|65846920|FG007|Overall Study|Objective progression or relapse|5|||
23836969|NCT02019264|66781440|FG001|Overall Study|Withdrawal by Subject|117|||
23836970|NCT02019264|66781439|FG000|Overall Study|Administrative reason|36|||
23836971|NCT02019264|66781440|FG001|Overall Study|Administrative reason|28|||
23836972|NCT02019264|66781439|FG000|Overall Study|Missing|14|||
23836973|NCT02019264|66781440|FG001|Overall Study|Missing|11|||
23836974|NCT02525783|66781443|FG000|Overall Study|Lost to Follow-up|10|||
23836975|NCT00454246|66781445|FG000|Overall Study|Adverse Event|2|||
23836976|NCT00454246|66781446|FG001|Overall Study|Adverse Event|2|||
23836977|NCT00454246|66781447|FG002|Overall Study|Adverse Event|0|||
23836978|NCT00454246|66781445|FG000|Overall Study|Violation of selection criteria at entry|6|||
23836979|NCT00454246|66781446|FG001|Overall Study|Violation of selection criteria at entry|0|||
23836980|NCT00454246|66781447|FG002|Overall Study|Violation of selection criteria at entry|0|||
23836981|NCT00454246|66781445|FG000|Overall Study|Protocol Violation|1|||
23836982|NCT00454246|66781446|FG001|Overall Study|Protocol Violation|0|||
23836983|NCT00454246|66781447|FG002|Overall Study|Protocol Violation|0|||
23836984|NCT00454246|66781445|FG000|Overall Study|Refused Treatment|1|||
23836985|NCT00454246|66781446|FG001|Overall Study|Refused Treatment|1|||
23836986|NCT00454246|66781447|FG002|Overall Study|Refused Treatment|0|||
23836987|NCT00454246|66781445|FG000|Overall Study|Failure to return|1|||
23836988|NCT00454246|66781446|FG001|Overall Study|Failure to return|0|||
23836989|NCT00454246|66781447|FG002|Overall Study|Failure to return|0|||
23836990|NCT00454246|66781445|FG000|Overall Study|Early termination of study|62|||
23836991|NCT00454246|66781446|FG001|Overall Study|Early termination of study|26|||
23836992|NCT00454246|66781447|FG002|Overall Study|Early termination of study|9|||
23836993|NCT00957801|66781448|FG000|Overall Study|Withdrawal by Subject|0|||
23836994|NCT00957801|66781449|FG001|Overall Study|Withdrawal by Subject|0|||
23836995|NCT00957801|66781450|FG002|Overall Study|Withdrawal by Subject|0|||
23836996|NCT00957801|66781451|FG003|Overall Study|Withdrawal by Subject|1|||
23836997|NCT02907177|66781452|FG000|Overall Study|Death|0|||
23836998|NCT02907177|66781453|FG001|Overall Study|Death|1|||
23836999|NCT02907177|66781452|FG000|Overall Study|Physician Decision|3|||
23837000|NCT02907177|66781453|FG001|Overall Study|Physician Decision|3|||
23837001|NCT02907177|66781452|FG000|Overall Study|Withdrawal by Subject|15|||
23837002|NCT02907177|66781453|FG001|Overall Study|Withdrawal by Subject|7|||
23837003|NCT02907177|66781452|FG000|Overall Study|Sponsor's Decision|50|||
23577760|NCT00557505|65846921|FG008|Overall Study|Objective progression or relapse|15|||
23577761|NCT00557505|65846913|FG000|Overall Study|Withdrawal by Subject|0|||
23837004|NCT02907177|66781453|FG001|Overall Study|Sponsor's Decision|57|||
23837005|NCT01441765|66781454|FG000|Overall Study|Death|1|||
23837006|NCT01441765|66781455|FG001|Overall Study|Death|0|||
23837007|NCT00425750|66781456|FG000|Overall Study|Death|1|||
23837008|NCT00425750|66781456|FG000|Overall Study|Withdrawal by Subject|3|||
23837009|NCT00425750|66781456|FG000|Overall Study|Adverse Event|3|||
23837010|NCT00425750|66781456|FG000|Overall Study|Progression of disease|18|||
23837011|NCT02792062|66781457|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
23577762|NCT00557505|65846914|FG001|Overall Study|Withdrawal by Subject|0|||
23577763|NCT00557505|65846915|FG002|Overall Study|Withdrawal by Subject|0|||
23577764|NCT00557505|65846916|FG003|Overall Study|Withdrawal by Subject|1|||
23577765|NCT00557505|65846917|FG004|Overall Study|Withdrawal by Subject|0|||
23577766|NCT00557505|65846918|FG005|Overall Study|Withdrawal by Subject|0|||
23577767|NCT00557505|65846919|FG006|Overall Study|Withdrawal by Subject|0|||
23577768|NCT00557505|65846920|FG007|Overall Study|Withdrawal by Subject|0|||
23577769|NCT00557505|65846921|FG008|Overall Study|Withdrawal by Subject|1|||
23577770|NCT02303574|65846922|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577771|NCT02303574|65846923|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577772|NCT02303574|65846924|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
23577773|NCT02303574|65846925|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577774|NCT02303574|65846926|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577775|NCT02303574|65846927|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577776|NCT02303574|65846928|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577777|NCT02303574|65846929|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23837012|NCT02792062|66781458|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23837013|NCT02792062|66781459|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23837014|NCT02792062|66781460|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23837015|NCT02792062|66781461|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23777522|NCT01185821|66566865|FG003|Overall Study|Lack of Efficacy|0|||
23777523|NCT01185821|66566866|FG004|Overall Study|Lack of Efficacy|9|||
23777524|NCT01185821|66566862|FG000|Overall Study|Withdrawal by Subject|3|||
23777525|NCT01185821|66566863|FG001|Overall Study|Withdrawal by Subject|2|||
23777526|NCT01185821|66566864|FG002|Overall Study|Withdrawal by Subject|2|||
23777527|NCT01185821|66566865|FG003|Overall Study|Withdrawal by Subject|1|||
23777528|NCT01185821|66566866|FG004|Overall Study|Withdrawal by Subject|3|||
23777529|NCT01185821|66566862|FG000|Overall Study|Lost to Follow-up|1|||
23777530|NCT01185821|66566863|FG001|Overall Study|Lost to Follow-up|1|||
23777531|NCT01185821|66566864|FG002|Overall Study|Lost to Follow-up|2|||
23777532|NCT01185821|66566865|FG003|Overall Study|Lost to Follow-up|1|||
23777533|NCT01185821|66566866|FG004|Overall Study|Lost to Follow-up|2|||
23777534|NCT01185821|66566862|FG000|Overall Study|Administrative problems|0|||
23777535|NCT01185821|66566863|FG001|Overall Study|Administrative problems|0|||
23777536|NCT01185821|66566864|FG002|Overall Study|Administrative problems|1|||
23777537|NCT01185821|66566865|FG003|Overall Study|Administrative problems|1|||
23450136|NCT01601535|65391414|FG004|Phase 1|Started Another Treatment|0|||
23450137|NCT01601535|65391415|FG005|Phase 1|Started Another Treatment|0|||
23450138|NCT01601535|65391410|FG000|Phase 2|Adverse Event|0|||
23450139|NCT01601535|65391411|FG001|Phase 2|Adverse Event|0|||
23450140|NCT01601535|65391412|FG002|Phase 2|Adverse Event|0|||
23450141|NCT01601535|65391413|FG003|Phase 2|Adverse Event|0|||
23450142|NCT01601535|65391414|FG004|Phase 2|Adverse Event|5|||
23450143|NCT01601535|65391415|FG005|Phase 2|Adverse Event|1|||
23450144|NCT01601535|65391410|FG000|Phase 2|Withdrawal by Subject|0|||
23577778|NCT02303574|65846930|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577779|NCT02303574|65846931|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577780|NCT02303574|65846922|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577781|NCT02303574|65846923|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577782|NCT02303574|65846924|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577783|NCT02303574|65846925|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577784|NCT02303574|65846926|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577785|NCT02303574|65846927|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577786|NCT02303574|65846928|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577787|NCT02303574|65846929|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
23577788|NCT02303574|65846930|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577789|NCT02303574|65846931|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577790|NCT01152554|65846932|FG000|Overall Study|Withdrawal by Subject|73|||
23577791|NCT01152554|65846933|FG001|Overall Study|Withdrawal by Subject|28|||
23577792|NCT01152554|65846932|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
23577793|NCT01152554|65846933|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
23577794|NCT01152554|65846932|FG000|Overall Study|Adverse Event|67|||
23577795|NCT01152554|65846933|FG001|Overall Study|Adverse Event|14|||
23577796|NCT01152554|65846932|FG000|Overall Study|Severe non-compliance to protocol|36|||
23577797|NCT01152554|65846933|FG001|Overall Study|Severe non-compliance to protocol|14|||
23577798|NCT01152554|65846932|FG000|Overall Study|Condition under investigation worsened|5|||
23577799|NCT01152554|65846933|FG001|Overall Study|Condition under investigation worsened|2|||
23577800|NCT01152554|65846932|FG000|Overall Study|Lack of Efficacy|20|||
23577801|NCT01152554|65846933|FG001|Overall Study|Lack of Efficacy|3|||
23577802|NCT01152554|65846932|FG000|Overall Study|Study-specific withdrawal criteria|17|||
23577803|NCT01152554|65846933|FG001|Overall Study|Study-specific withdrawal criteria|8|||
23577804|NCT01152554|65846932|FG000|Overall Study|Lost to Follow-up|87|||
23577805|NCT01152554|65846933|FG001|Overall Study|Lost to Follow-up|32|||
23577806|NCT01152554|65846932|FG000|Overall Study|Other|28|||
23577807|NCT01152554|65846933|FG001|Overall Study|Other|8|||
23577808|NCT01152554|65846932|FG000|Overall Study|Death|1|||
23577809|NCT01152554|65846933|FG001|Overall Study|Death|1|||
23577810|NCT02761629|65846939|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
23577811|NCT02761629|65846940|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
23577812|NCT02761629|65846939|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23577813|NCT02761629|65846940|FG001|Overall Study|Insufficient Therapeutic Response|7|||
23577814|NCT02761629|65846939|FG000|Overall Study|Failure to Return|2|||
23577815|NCT02761629|65846940|FG001|Overall Study|Failure to Return|4|||
23577816|NCT02761629|65846939|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
23577817|NCT02761629|65846940|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
23577818|NCT02761629|65846939|FG000|Overall Study|Protocol Violation|2|||
23577819|NCT02761629|65846940|FG001|Overall Study|Protocol Violation|2|||
23777538|NCT01185821|66566866|FG004|Overall Study|Administrative problems|2|||
23777539|NCT00735904|66566869|FG000|Overall Study|Adverse Event|3|||
23450145|NCT01601535|65391411|FG001|Phase 2|Withdrawal by Subject|0|||
23450146|NCT01601535|65391412|FG002|Phase 2|Withdrawal by Subject|0|||
23777540|NCT00735904|66566869|FG000|Overall Study|Death|20|||
23777541|NCT00735904|66566869|FG000|Overall Study|Protocol Violation|1|||
23777542|NCT00735904|66566869|FG000|Overall Study|Withdrawal by Subject|1|||
23450147|NCT01601535|65391413|FG003|Phase 2|Withdrawal by Subject|0|||
23450148|NCT01601535|65391414|FG004|Phase 2|Withdrawal by Subject|8|||
23577820|NCT02761629|65846939|FG000|Overall Study|Withdrawal by Subject|0|||
23577821|NCT02761629|65846940|FG001|Overall Study|Withdrawal by Subject|3|||
23577822|NCT02761629|65846939|FG000|Overall Study|Other|0|||
23577823|NCT02761629|65846940|FG001|Overall Study|Other|2|||
23577824|NCT02761629|65846939|FG000|Overall Study|Lost to Follow-up|4|||
23577825|NCT02761629|65846940|FG001|Overall Study|Lost to Follow-up|1|||
23577826|NCT02761629|65846939|FG000|Overall Study|Randomized But Not Treated|8|||
23577827|NCT02761629|65846940|FG001|Overall Study|Randomized But Not Treated|4|||
23577828|NCT01822821|65846943|FG000|Overall Study|Eligible surgery cancelled|1|||
23577829|NCT01822821|65846944|FG001|Overall Study|Eligible surgery cancelled|1|||
23577830|NCT01822821|65846943|FG000|Overall Study|Other reasons|1|||
23577831|NCT01822821|65846944|FG001|Overall Study|Other reasons|0|||
23577832|NCT03639675|65846945|FG000|Overall Study|Withdrawal by Subject|1|||
23577833|NCT01154036|65846948|FG000|Phase I|Physician Decision|0|||
23577834|NCT01154036|65846949|FG001|Phase I|Physician Decision|1|||
23577835|NCT01154036|65846950|FG002|Phase I|Physician Decision|0|||
23577836|NCT01154036|65846951|FG003|Phase I|Physician Decision|0|||
23577837|NCT01154036|65846952|FG004|Phase I|Physician Decision|0|||
23577838|NCT01154036|65846953|FG005|Phase I|Physician Decision|0|||
23577839|NCT01154036|65846954|FG006|Phase I|Physician Decision|0|||
23577840|NCT01154036|65846955|FG007|Phase I|Physician Decision|0|||
23577841|NCT01154036|65846948|FG000|Phase I|Lost to Follow-up|0|||
23577842|NCT01154036|65846949|FG001|Phase I|Lost to Follow-up|3|||
23577843|NCT01154036|65846950|FG002|Phase I|Lost to Follow-up|6|||
23577844|NCT01154036|65846951|FG003|Phase I|Lost to Follow-up|0|||
23577845|NCT01154036|65846952|FG004|Phase I|Lost to Follow-up|0|||
23577846|NCT01154036|65846953|FG005|Phase I|Lost to Follow-up|0|||
23577847|NCT01154036|65846954|FG006|Phase I|Lost to Follow-up|0|||
23577848|NCT01154036|65846955|FG007|Phase I|Lost to Follow-up|0|||
23577849|NCT01154036|65846948|FG000|Phase I|Protocol Violation|0|||
23577850|NCT01154036|65846949|FG001|Phase I|Protocol Violation|3|||
23577851|NCT01154036|65846950|FG002|Phase I|Protocol Violation|9|||
23577852|NCT01154036|65846951|FG003|Phase I|Protocol Violation|0|||
23577853|NCT01154036|65846952|FG004|Phase I|Protocol Violation|0|||
23577854|NCT01154036|65846953|FG005|Phase I|Protocol Violation|0|||
23577855|NCT01154036|65846954|FG006|Phase I|Protocol Violation|0|||
23577856|NCT01154036|65846955|FG007|Phase I|Protocol Violation|0|||
23577857|NCT01154036|65846948|FG000|Phase I|Withdrawal by Subject|2|||
23577858|NCT01154036|65846949|FG001|Phase I|Withdrawal by Subject|10|||
23577859|NCT01154036|65846950|FG002|Phase I|Withdrawal by Subject|29|||
23577860|NCT01154036|65846951|FG003|Phase I|Withdrawal by Subject|0|||
23577861|NCT01154036|65846952|FG004|Phase I|Withdrawal by Subject|0|||
23577862|NCT01154036|65846953|FG005|Phase I|Withdrawal by Subject|0|||
23577863|NCT01154036|65846954|FG006|Phase I|Withdrawal by Subject|0|||
23577864|NCT01154036|65846955|FG007|Phase I|Withdrawal by Subject|0|||
23577865|NCT01154036|65846948|FG000|Phase I|Adverse Event|1|||
23577866|NCT01154036|65846949|FG001|Phase I|Adverse Event|11|||
23577867|NCT01154036|65846950|FG002|Phase I|Adverse Event|12|||
23577868|NCT01154036|65846951|FG003|Phase I|Adverse Event|0|||
23577869|NCT01154036|65846952|FG004|Phase I|Adverse Event|0|||
23577870|NCT01154036|65846953|FG005|Phase I|Adverse Event|0|||
23577871|NCT01154036|65846954|FG006|Phase I|Adverse Event|0|||
23577872|NCT01154036|65846955|FG007|Phase I|Adverse Event|0|||
23577873|NCT01154036|65846948|FG000|Phase II|Adverse Event|0|||
23577874|NCT01154036|65846949|FG001|Phase II|Adverse Event|0|||
23777543|NCT00735904|66566869|FG000|Overall Study|Study Terminated by Sponsor|5|||
23777544|NCT00735904|66566869|FG000|Overall Study|Other|8|||
23577875|NCT01154036|65846950|FG002|Phase II|Adverse Event|0|||
23577876|NCT01154036|65846951|FG003|Phase II|Adverse Event|0|||
23777545|NCT02728102|66566870|FG000|Overall Study|Death|3|||
23777546|NCT02728102|66566871|FG001|Overall Study|Death|0|||
23777547|NCT02728102|66566872|FG002|Overall Study|Death|1|||
23777548|NCT02728102|66566870|FG000|Overall Study|Withdrawal by Subject|0|||
23577877|NCT01154036|65846952|FG004|Phase II|Adverse Event|1|||
23577878|NCT01154036|65846953|FG005|Phase II|Adverse Event|1|||
23777549|NCT02728102|66566871|FG001|Overall Study|Withdrawal by Subject|2|||
23777550|NCT02728102|66566872|FG002|Overall Study|Withdrawal by Subject|3|||
23777551|NCT02728102|66566870|FG000|Overall Study|Physician Decision|1|||
23777552|NCT02728102|66566871|FG001|Overall Study|Physician Decision|1|||
23777553|NCT02728102|66566872|FG002|Overall Study|Physician Decision|0|||
23577879|NCT01154036|65846954|FG006|Phase II|Adverse Event|1|||
23577880|NCT01154036|65846955|FG007|Phase II|Adverse Event|1|||
23577881|NCT01154036|65846948|FG000|Phase II|Physician Decision|0|||
23577882|NCT01154036|65846949|FG001|Phase II|Physician Decision|0|||
23577883|NCT01154036|65846950|FG002|Phase II|Physician Decision|0|||
23577884|NCT01154036|65846951|FG003|Phase II|Physician Decision|0|||
23577885|NCT01154036|65846952|FG004|Phase II|Physician Decision|0|||
23577886|NCT01154036|65846953|FG005|Phase II|Physician Decision|0|||
23577887|NCT01154036|65846954|FG006|Phase II|Physician Decision|1|||
23577888|NCT01154036|65846955|FG007|Phase II|Physician Decision|0|||
23577889|NCT01154036|65846948|FG000|Phase II|Lost to Follow-up|0|||
23577890|NCT01154036|65846949|FG001|Phase II|Lost to Follow-up|0|||
23577891|NCT01154036|65846950|FG002|Phase II|Lost to Follow-up|0|||
23577892|NCT01154036|65846951|FG003|Phase II|Lost to Follow-up|1|||
23577893|NCT01154036|65846952|FG004|Phase II|Lost to Follow-up|2|||
23577894|NCT01154036|65846953|FG005|Phase II|Lost to Follow-up|0|||
23577895|NCT01154036|65846954|FG006|Phase II|Lost to Follow-up|2|||
23577896|NCT01154036|65846955|FG007|Phase II|Lost to Follow-up|1|||
23577897|NCT01154036|65846948|FG000|Phase II|Protocol Violation|0|||
23577898|NCT01154036|65846949|FG001|Phase II|Protocol Violation|0|||
23577899|NCT01154036|65846950|FG002|Phase II|Protocol Violation|0|||
23577900|NCT01154036|65846951|FG003|Phase II|Protocol Violation|0|||
23577901|NCT01154036|65846952|FG004|Phase II|Protocol Violation|1|||
23577902|NCT01154036|65846953|FG005|Phase II|Protocol Violation|2|||
23577903|NCT01154036|65846954|FG006|Phase II|Protocol Violation|0|||
23577904|NCT01154036|65846955|FG007|Phase II|Protocol Violation|0|||
23577905|NCT01154036|65846948|FG000|Phase II|Withdrawal by Subject|0|||
23577906|NCT01154036|65846949|FG001|Phase II|Withdrawal by Subject|0|||
23577907|NCT01154036|65846950|FG002|Phase II|Withdrawal by Subject|0|||
23577908|NCT01154036|65846951|FG003|Phase II|Withdrawal by Subject|0|||
23577909|NCT01154036|65846952|FG004|Phase II|Withdrawal by Subject|4|||
23777554|NCT02728102|66566870|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
23777555|NCT02728102|66566871|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
23777556|NCT02728102|66566872|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
23577910|NCT01154036|65846953|FG005|Phase II|Withdrawal by Subject|2|||
23577911|NCT01154036|65846954|FG006|Phase II|Withdrawal by Subject|5|||
23577912|NCT01154036|65846955|FG007|Phase II|Withdrawal by Subject|4|||
23577913|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
23577914|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
23577915|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
23577916|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
23577917|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
23577918|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
23577919|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
23577920|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
23577921|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
23577922|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
23577923|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
23577924|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
23577925|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
23577926|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
23577927|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
23577928|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
23577929|NCT02559817|65846958|FG000|Treatment Period|Adverse Event|1|||
23577930|NCT02559817|65846959|FG001|Treatment Period|Adverse Event|0|||
23577931|NCT02559817|65846960|FG002|Treatment Period|Adverse Event|1|||
23577932|NCT02559817|65846961|FG003|Treatment Period|Adverse Event|0|||
23577933|NCT02559817|65846962|FG004|Treatment Period|Adverse Event|0|||
23577934|NCT02559817|65846958|FG000|Treatment Period|Lack of Efficacy|0|||
23577935|NCT02559817|65846959|FG001|Treatment Period|Lack of Efficacy|1|||
23577936|NCT02559817|65846960|FG002|Treatment Period|Lack of Efficacy|0|||
23577937|NCT02559817|65846961|FG003|Treatment Period|Lack of Efficacy|0|||
23577938|NCT02559817|65846962|FG004|Treatment Period|Lack of Efficacy|0|||
23577939|NCT02559817|65846958|FG000|Treatment Period|Lost to Follow-up|0|||
23577940|NCT02559817|65846959|FG001|Treatment Period|Lost to Follow-up|1|||
23577941|NCT02559817|65846960|FG002|Treatment Period|Lost to Follow-up|0|||
23577942|NCT02559817|65846961|FG003|Treatment Period|Lost to Follow-up|1|||
23577943|NCT02559817|65846962|FG004|Treatment Period|Lost to Follow-up|0|||
23777557|NCT02728102|66566870|FG000|Overall Study|Covid|0|||
23777558|NCT02728102|66566871|FG001|Overall Study|Covid|0|||
23777559|NCT02728102|66566872|FG002|Overall Study|Covid|1|||
23777560|NCT00150462|66566873|FG000|Overall Study|Disease Progression or Relapse|3|||
23777561|NCT00150462|66566874|FG001|Overall Study|Disease Progression or Relapse|1|||
23777562|NCT00150462|66566875|FG002|Overall Study|Disease Progression or Relapse|2|||
23577944|NCT02559817|65846958|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
23577945|NCT02559817|65846959|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
23577946|NCT02559817|65846960|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
23837016|NCT02792062|66781462|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23837017|NCT02556775|66781468|FG000|Overall Study|Withdrawal by Subject|1|||
23577947|NCT02559817|65846961|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
23577948|NCT02559817|65846962|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
23577949|NCT02559817|65846958|FG000|Treatment Period|Protocol Violation|0|||
23837018|NCT02556775|66781469|FG001|Overall Study|Withdrawal by Subject|0|||
23837019|NCT02556775|66781470|FG002|Overall Study|Withdrawal by Subject|1|||
23837020|NCT02556775|66781471|FG003|Overall Study|Withdrawal by Subject|0|||
23837021|NCT02556775|66781468|FG000|Overall Study|Lost to Follow-up|1|||
23837022|NCT02556775|66781469|FG001|Overall Study|Lost to Follow-up|0|||
23837023|NCT02556775|66781470|FG002|Overall Study|Lost to Follow-up|0|||
23837024|NCT02556775|66781471|FG003|Overall Study|Lost to Follow-up|0|||
23450149|NCT01601535|65391415|FG005|Phase 2|Withdrawal by Subject|2|||
23450150|NCT01601535|65391410|FG000|Phase 2|Progressive Disease|0|||
23450151|NCT01601535|65391411|FG001|Phase 2|Progressive Disease|0|||
23450152|NCT01601535|65391412|FG002|Phase 2|Progressive Disease|0|||
23450153|NCT01601535|65391413|FG003|Phase 2|Progressive Disease|0|||
23450154|NCT01601535|65391414|FG004|Phase 2|Progressive Disease|5|||
23450155|NCT01601535|65391415|FG005|Phase 2|Progressive Disease|7|||
23450156|NCT01601535|65391410|FG000|Phase 2|Started Another Treatment|0|||
23577950|NCT02559817|65846959|FG001|Treatment Period|Protocol Violation|0|||
23577951|NCT02559817|65846960|FG002|Treatment Period|Protocol Violation|0|||
23577952|NCT02559817|65846961|FG003|Treatment Period|Protocol Violation|1|||
23577953|NCT02559817|65846962|FG004|Treatment Period|Protocol Violation|0|||
23577954|NCT02034435|65846963|FG000|Overall Study|Withdrawal by Subject|1|||
23577955|NCT02034435|65846964|FG001|Overall Study|Withdrawal by Subject|0|||
23577956|NCT02034435|65846965|FG002|Overall Study|Withdrawal by Subject|0|||
23577957|NCT02034435|65846966|FG003|Overall Study|Withdrawal by Subject|0|||
23577958|NCT02034435|65846963|FG000|Overall Study|Illness|0|||
23577959|NCT02034435|65846964|FG001|Overall Study|Illness|2|||
23450157|NCT01601535|65391411|FG001|Phase 2|Started Another Treatment|0|||
23450158|NCT01601535|65391412|FG002|Phase 2|Started Another Treatment|0|||
23577960|NCT02034435|65846965|FG002|Overall Study|Illness|0|||
23634266|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
23450159|NCT01601535|65391413|FG003|Phase 2|Started Another Treatment|0|||
23634267|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
23837025|NCT02142803|66781472|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23450160|NCT01601535|65391414|FG004|Phase 2|Started Another Treatment|1|||
23577961|NCT02034435|65846966|FG003|Overall Study|Illness|0|||
23577962|NCT02034435|65846963|FG000|Overall Study|Inadequate IV access|1|||
23577963|NCT02034435|65846964|FG001|Overall Study|Inadequate IV access|0|||
23577964|NCT02034435|65846965|FG002|Overall Study|Inadequate IV access|0|||
23577965|NCT02034435|65846966|FG003|Overall Study|Inadequate IV access|1|||
23577966|NCT00373295|65846967|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577967|NCT00373295|65846968|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
23577968|NCT00373295|65846969|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577969|NCT00373295|65846970|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577970|NCT00373295|65846971|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23577971|NCT00373295|65846972|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577972|NCT04212169|65846973|FG000|Overall Study|Adverse Event|0|||
23577973|NCT04212169|65846974|FG001|Overall Study|Adverse Event|0|||
23577974|NCT04212169|65846975|FG002|Overall Study|Adverse Event|0|||
23577975|NCT04212169|65846976|FG003|Overall Study|Adverse Event|2|||
23577976|NCT04212169|65846973|FG000|Overall Study|Lost to Follow-up|1|||
23577977|NCT04212169|65846974|FG001|Overall Study|Lost to Follow-up|0|||
23577978|NCT04212169|65846975|FG002|Overall Study|Lost to Follow-up|0|||
23577979|NCT04212169|65846976|FG003|Overall Study|Lost to Follow-up|2|||
23577980|NCT04212169|65846973|FG000|Overall Study|Withdrawal by Subject|10|||
23577981|NCT04212169|65846974|FG001|Overall Study|Withdrawal by Subject|2|||
23577982|NCT04212169|65846975|FG002|Overall Study|Withdrawal by Subject|5|||
23577983|NCT04212169|65846976|FG003|Overall Study|Withdrawal by Subject|7|||
23577984|NCT04212169|65846973|FG000|Overall Study|Other reason, unspecified|3|||
23577985|NCT04212169|65846974|FG001|Overall Study|Other reason, unspecified|1|||
23577986|NCT04212169|65846975|FG002|Overall Study|Other reason, unspecified|0|||
23450161|NCT01601535|65391415|FG005|Phase 2|Started Another Treatment|2|||
23450162|NCT01290757|65391416|FG000|Overall Study|Adverse Event|1|||
23450163|NCT01290757|65391417|FG001|Overall Study|Adverse Event|0|||
23450164|NCT01290757|65391416|FG000|Overall Study|Protocol Violation|1|||
23450165|NCT01290757|65391417|FG001|Overall Study|Protocol Violation|1|||
23577987|NCT04212169|65846976|FG003|Overall Study|Other reason, unspecified|2|||
23577988|NCT02013687|65846977|FG000|Overall Study|Lost to Follow-up|0|||
23577989|NCT02013687|65846978|FG001|Overall Study|Lost to Follow-up|0|||
23577990|NCT02013687|65846979|FG002|Overall Study|Lost to Follow-up|1|||
23577991|NCT02013687|65846980|FG003|Overall Study|Lost to Follow-up|0|||
23577992|NCT02013687|65846977|FG000|Overall Study|Protocol Violation|0|||
23577993|NCT02013687|65846978|FG001|Overall Study|Protocol Violation|0|||
23634268|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
23634269|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
23777563|NCT00150462|66566876|FG003|Overall Study|Disease Progression or Relapse|1|||
23777564|NCT00150462|66566877|FG004|Overall Study|Disease Progression or Relapse|2|||
23777565|NCT00150462|66566878|FG005|Overall Study|Disease Progression or Relapse|2|||
23777566|NCT00150462|66566879|FG006|Overall Study|Disease Progression or Relapse|3|||
23777567|NCT00150462|66566880|FG007|Overall Study|Disease Progression or Relapse|5|||
23777568|NCT00150462|66566881|FG008|Overall Study|Disease Progression or Relapse|5|||
23777569|NCT00150462|66566882|FG009|Overall Study|Disease Progression or Relapse|3|||
23577994|NCT02013687|65846979|FG002|Overall Study|Protocol Violation|0|||
23577995|NCT02013687|65846980|FG003|Overall Study|Protocol Violation|1|||
23577996|NCT02013687|65846977|FG000|Overall Study|Withdrawal by Subject|0|||
23577997|NCT02013687|65846978|FG001|Overall Study|Withdrawal by Subject|0|||
23577998|NCT02013687|65846979|FG002|Overall Study|Withdrawal by Subject|0|||
23577999|NCT02013687|65846980|FG003|Overall Study|Withdrawal by Subject|1|||
23578000|NCT02013687|65846977|FG000|Overall Study|Missed visits due to patient travel|0|||
23837026|NCT02142803|66781473|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23837027|NCT02142803|66781474|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23837028|NCT02142803|66781475|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
23837029|NCT02356588|66781477|FG000|Overall Study|Lack of Efficacy|4|||
23837030|NCT02356588|66781478|FG001|Overall Study|Lack of Efficacy|10|||
23578001|NCT02013687|65846978|FG001|Overall Study|Missed visits due to patient travel|0|||
23578002|NCT02013687|65846979|FG002|Overall Study|Missed visits due to patient travel|1|||
23578003|NCT02013687|65846980|FG003|Overall Study|Missed visits due to patient travel|0|||
23578004|NCT03290079|65846981|FG000|Overall Study|Death|2|||
23578005|NCT00813488|65846982|FG000|Titration Period 1|Adverse Event|6|||
23578006|NCT00813488|65846983|FG001|Titration Period 1|Adverse Event|1|||
23578007|NCT00813488|65846982|FG000|Titration Period 1|Lack of Efficacy|9|||
23578008|NCT00813488|65846983|FG001|Titration Period 1|Lack of Efficacy|7|||
23578009|NCT00813488|65846982|FG000|Titration Period 1|Withdrawal by Subject|2|||
23578010|NCT00813488|65846983|FG001|Titration Period 1|Withdrawal by Subject|2|||
23578011|NCT00813488|65846982|FG000|Titration Period 1|Protocol Violation|4|||
23578012|NCT00813488|65846983|FG001|Titration Period 1|Protocol Violation|3|||
23578013|NCT00813488|65846982|FG000|Titration Period 1|Non-compliance to study medication|4|||
23578014|NCT00813488|65846983|FG001|Titration Period 1|Non-compliance to study medication|1|||
23578015|NCT00813488|65846982|FG000|Titration Period 1|Non-compliance to study procedures|2|||
23578016|NCT00813488|65846983|FG001|Titration Period 1|Non-compliance to study procedures|2|||
23578017|NCT00813488|65846982|FG000|Titration Period 1|Technical Difficulties|0|||
23578018|NCT00813488|65846983|FG001|Titration Period 1|Technical Difficulties|1|||
23578019|NCT00813488|65846982|FG000|Titration Period 2|Adverse Event|2|||
23578020|NCT00813488|65846983|FG001|Titration Period 2|Adverse Event|3|||
23578021|NCT00813488|65846982|FG000|Titration Period 2|Lack of Efficacy|8|||
23578022|NCT00813488|65846983|FG001|Titration Period 2|Lack of Efficacy|4|||
23578023|NCT00813488|65846982|FG000|Titration Period 2|Protocol Violation|3|||
23578024|NCT00813488|65846983|FG001|Titration Period 2|Protocol Violation|2|||
23578025|NCT00813488|65846982|FG000|Titration Period 2|Lost to Follow-up|1|||
23837031|NCT02356588|66781477|FG000|Overall Study|Adverse Event|0|||
23837032|NCT02356588|66781478|FG001|Overall Study|Adverse Event|2|||
23837033|NCT02356588|66781477|FG000|Overall Study|Withdrawal by Subject|1|||
23837034|NCT02356588|66781478|FG001|Overall Study|Withdrawal by Subject|0|||
23837035|NCT02356588|66781477|FG000|Overall Study|Protocol Violation|0|||
23837036|NCT02356588|66781478|FG001|Overall Study|Protocol Violation|1|||
23837037|NCT02547220|66781479|FG000|Overall Study|Withdrawal by Subject|1|||
23837038|NCT02547220|66781480|FG001|Overall Study|Withdrawal by Subject|0|||
23837039|NCT02547220|66781479|FG000|Overall Study|Study terminated by sponsor|18|||
23837040|NCT02547220|66781480|FG001|Overall Study|Study terminated by sponsor|20|||
23837041|NCT00952068|66781481|FG000|Overall Study|Adverse Event|3|||
23837042|NCT00952068|66781481|FG000|Overall Study|Withdrawal by Subject|4|||
23837043|NCT03051100|66781482|FG000|Overall Study|Withdrawal by Subject|1|||
23837044|NCT03051100|66781483|FG001|Overall Study|Withdrawal by Subject|0|||
23450166|NCT01290757|65391416|FG000|Overall Study|Other|0|||
23450167|NCT01290757|65391417|FG001|Overall Study|Other|1|||
23450168|NCT00113841|65391424|FG000|Overall Study|Disease progression|0|||
23450169|NCT00113841|65391425|FG001|Overall Study|Disease progression|2|||
23450170|NCT00113841|65391424|FG000|Overall Study|Non-compliant|1|||
23450171|NCT00113841|65391425|FG001|Overall Study|Non-compliant|0|||
23450172|NCT01643668|65391426|FG000|Overall Study|Death|1|||
23450173|NCT02807623|65391431|FG000|Overall Study|Lost to Follow-up|23|||
23450174|NCT02807623|65391432|FG001|Overall Study|Lost to Follow-up|18|||
23450175|NCT02807623|65391433|FG002|Overall Study|Lost to Follow-up|22|||
23450176|NCT02807623|65391431|FG000|Overall Study|Drug intolerance|0|||
23450177|NCT02807623|65391432|FG001|Overall Study|Drug intolerance|1|||
23450178|NCT02807623|65391433|FG002|Overall Study|Drug intolerance|0|||
23450179|NCT02807623|65391431|FG000|Overall Study|incomplete blood draw|0|||
23450180|NCT02807623|65391432|FG001|Overall Study|incomplete blood draw|2|||
23450181|NCT02807623|65391433|FG002|Overall Study|incomplete blood draw|1|||
23450182|NCT01176032|65391436|FG000|Overall Study|Adverse Event|1|||
23578026|NCT00813488|65846983|FG001|Titration Period 2|Lost to Follow-up|0|||
23578027|NCT00813488|65846982|FG000|Titration Period 2|Non-compliance with study procedures|2|||
23578028|NCT00813488|65846983|FG001|Titration Period 2|Non-compliance with study procedures|1|||
23578029|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
23837045|NCT03963232|66781485|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23837046|NCT03963232|66781486|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
23837047|NCT03963232|66781485|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23450183|NCT01176032|65391437|FG001|Overall Study|Adverse Event|0|||
23450184|NCT01176032|65391436|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23450185|NCT01176032|65391437|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23578030|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
23837048|NCT03963232|66781486|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23634270|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
23634271|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
23634272|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
23634273|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
23634274|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
23634275|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
23634276|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
23634277|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
23634278|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
23634279|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
23634280|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
23634281|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
23634282|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
23634283|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
23634284|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
23634285|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
23634286|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
23634287|NCT02783573|66049177|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
23634288|NCT02783573|66049178|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
23634289|NCT02783573|66049179|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
23634290|NCT02783573|66049177|FG000|Delayed-Start Period|Sponsor Decision|0|||
23578031|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
23578032|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
23578033|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
23578034|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
23578035|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
23578036|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
23578037|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
23578038|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
23578039|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23578040|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23450186|NCT01176032|65391436|FG000|Overall Study|Protocol Violation|1|||
23450187|NCT01176032|65391437|FG001|Overall Study|Protocol Violation|0|||
23450188|NCT01176032|65391436|FG000|Overall Study|Informed consent withdrawn|3|||
23450189|NCT01176032|65391437|FG001|Overall Study|Informed consent withdrawn|0|||
23450190|NCT01176032|65391436|FG000|Overall Study|Other|1|||
23578041|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
23450191|NCT01176032|65391437|FG001|Overall Study|Other|0|||
23578042|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
23450192|NCT02920892|65391438|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
23450193|NCT02920892|65391439|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
23450194|NCT02920892|65391440|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
23450195|NCT02920892|65391438|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
23450196|NCT02920892|65391439|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
23450197|NCT02920892|65391440|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
23450198|NCT02920892|65391438|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
23450199|NCT02920892|65391439|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
23450200|NCT02920892|65391440|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
23450201|NCT02920892|65391438|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
23450202|NCT02920892|65391439|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
23450203|NCT02920892|65391440|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
23450204|NCT02920892|65391438|FG000|Placebo-Controlled Period|Physician Decision|0|||
23450205|NCT02920892|65391439|FG001|Placebo-Controlled Period|Physician Decision|0|||
23450206|NCT02920892|65391440|FG002|Placebo-Controlled Period|Physician Decision|1|||
23450207|NCT02920892|65391438|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
23450208|NCT02920892|65391439|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
23450209|NCT02920892|65391440|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
23450210|NCT02920892|65391438|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23450211|NCT02920892|65391439|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
23450212|NCT02920892|65391440|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
23450213|NCT02920892|65391438|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
23450214|NCT02920892|65391439|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
23450215|NCT02920892|65391440|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
23450216|NCT01759420|65391441|FG000|Overall Study|Screen failure|5|||
23450217|NCT01759420|65391441|FG000|Overall Study|Inaccurate EKG machine readings|1|||
23450218|NCT01631435|65391442|FG000|Overall Study|Adverse Event|2|||
23450219|NCT01631435|65391442|FG000|Overall Study|Withdrawal by Subject|2|||
23450220|NCT01631435|65391442|FG000|Overall Study|incomplete study procedure|5|||
23450221|NCT01100320|65391443|FG000|Period 1|Withdrawal by Subject|2|||
23450222|NCT01100320|65391444|FG001|Period 1|Withdrawal by Subject|4|||
23450223|NCT01100320|65391443|FG000|Period 1|Positive Drug Screen|1|||
23450224|NCT01100320|65391444|FG001|Period 1|Positive Drug Screen|1|||
23450225|NCT01100320|65391443|FG000|Period 1|Adverse Event|2|||
23450226|NCT01100320|65391444|FG001|Period 1|Adverse Event|2|||
23450227|NCT01100320|65391443|FG000|Period 2|Withdrawal by Subject|1|||
23450228|NCT01100320|65391444|FG001|Period 2|Withdrawal by Subject|1|||
23450229|NCT02542865|65391447|FG000|Overall Study|Identified as screen failure|1|||
23450230|NCT02542865|65391448|FG001|Overall Study|Identified as screen failure|0|||
23450231|NCT02542865|65391447|FG000|Overall Study|Withdrawal by Subject|16|||
23450232|NCT02542865|65391448|FG001|Overall Study|Withdrawal by Subject|0|||
23450233|NCT00604565|65391449|FG000|Overall Study|Study terminated|0|||
23450234|NCT00604565|65391450|FG001|Overall Study|Study terminated|3|||
23450235|NCT00556075|65391456|FG000|Overall Study|Lost to Follow-up|3|||
23450236|NCT00556075|65391457|FG001|Overall Study|Lost to Follow-up|0|||
23450237|NCT00556075|65391458|FG002|Overall Study|Lost to Follow-up|3|||
23450238|NCT00556075|65391456|FG000|Overall Study|Withdrawal by Subject|3|||
23450239|NCT00556075|65391457|FG001|Overall Study|Withdrawal by Subject|3|||
23450240|NCT00556075|65391458|FG002|Overall Study|Withdrawal by Subject|0|||
23450241|NCT00556075|65391456|FG000|Overall Study|Protocol Violation|1|||
23450242|NCT00556075|65391457|FG001|Overall Study|Protocol Violation|1|||
23450243|NCT00556075|65391458|FG002|Overall Study|Protocol Violation|3|||
23450244|NCT00556075|65391456|FG000|Overall Study|Not eligible|1|||
23450245|NCT00556075|65391457|FG001|Overall Study|Not eligible|1|||
23450246|NCT00556075|65391458|FG002|Overall Study|Not eligible|2|||
23450247|NCT00556075|65391456|FG000|Overall Study|Adverse Event|1|||
23450248|NCT00556075|65391457|FG001|Overall Study|Adverse Event|2|||
23450249|NCT00556075|65391458|FG002|Overall Study|Adverse Event|0|||
23450250|NCT00556075|65391456|FG000|Overall Study|Personal issues|4|||
23578043|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Other|1|||
23450251|NCT00556075|65391457|FG001|Overall Study|Personal issues|1|||
23450252|NCT00556075|65391458|FG002|Overall Study|Personal issues|0|||
23450253|NCT00556075|65391456|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
23450254|NCT00556075|65391457|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
23450255|NCT00556075|65391458|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
23450256|NCT01255423|65391459|FG000|Overall Study|Abnormal Laboratory value|3|||
23450257|NCT01255423|65391460|FG001|Overall Study|Abnormal Laboratory value|2|||
23450258|NCT01255423|65391459|FG000|Overall Study|Use of prohibited medications|0|||
23450259|NCT01255423|65391460|FG001|Overall Study|Use of prohibited medications|1|||
23450260|NCT04864639|65391461|FG000|Overall Study|Death|1|||
23450261|NCT04864639|65391461|FG000|Overall Study|Lost to Follow-up|1|||
23578044|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Other|0|||
23450262|NCT04590014|65391463|FG000|Overall Study|Withdrawal by Subject|1|||
23450263|NCT04590014|65391464|FG001|Overall Study|Withdrawal by Subject|0|||
23450264|NCT01488045|65391470|FG000|Overall Study|Withdrawal by Subject|6|||
23450265|NCT01488045|65391471|FG001|Overall Study|Withdrawal by Subject|11|||
23450266|NCT01488045|65391470|FG000|Overall Study|Failure to present for colonoscopy|3|||
23450267|NCT01488045|65391471|FG001|Overall Study|Failure to present for colonoscopy|6|||
23450268|NCT01488045|65391470|FG000|Overall Study|Failure to report exclusion criteria|0|||
23450269|NCT01488045|65391471|FG001|Overall Study|Failure to report exclusion criteria|1|||
23450270|NCT00614575|65391474|FG000|Overall Study|Adverse Event|106|||
23450271|NCT00614575|65391474|FG000|Overall Study|Lost to Follow-up|55|||
23450272|NCT00614575|65391474|FG000|Overall Study|Lack of Efficacy|14|||
23450273|NCT00614575|65391474|FG000|Overall Study|Withdrawal by Subject|6|||
23450274|NCT00614575|65391474|FG000|Overall Study|Death|3|||
23450275|NCT00614575|65391474|FG000|Overall Study|Physician Decision|2|||
23450276|NCT00614575|65391474|FG000|Overall Study|No data were collected.|18|||
23450277|NCT00614575|65391474|FG000|Overall Study|Irregularly enrolled patients|23|||
23450278|NCT00614575|65391474|FG000|Overall Study|No treatment|1|||
23450279|NCT00681629|65391475|FG000|Overall Study|Study termination|4|||
23450280|NCT00681629|65391476|FG001|Overall Study|Study termination|2|||
23450281|NCT00681629|65391475|FG000|Overall Study|Adverse Event|1|||
23450282|NCT00681629|65391476|FG001|Overall Study|Adverse Event|0|||
23450283|NCT00614380|65391479|FG000|Overall Study|Adverse Event|14|||
23450284|NCT00614380|65391480|FG001|Overall Study|Adverse Event|4|||
23450285|NCT00614380|65391481|FG002|Overall Study|Adverse Event|0|||
23450286|NCT00614380|65391482|FG003|Overall Study|Adverse Event|0|||
23450287|NCT00614380|65391479|FG000|Overall Study|Lost to Follow-up|6|||
23450288|NCT00614380|65391480|FG001|Overall Study|Lost to Follow-up|1|||
23450289|NCT00614380|65391481|FG002|Overall Study|Lost to Follow-up|0|||
23450290|NCT00614380|65391482|FG003|Overall Study|Lost to Follow-up|0|||
23450291|NCT00614380|65391479|FG000|Overall Study|Non compliant with the protocol|12|||
23450292|NCT00614380|65391480|FG001|Overall Study|Non compliant with the protocol|2|||
23450293|NCT00614380|65391481|FG002|Overall Study|Non compliant with the protocol|1|||
23450294|NCT00614380|65391482|FG003|Overall Study|Non compliant with the protocol|2|||
23450295|NCT00614380|65391479|FG000|Overall Study|Consent withdrawn|3|||
23450296|NCT00614380|65391480|FG001|Overall Study|Consent withdrawn|1|||
23450297|NCT00614380|65391481|FG002|Overall Study|Consent withdrawn|0|||
23450298|NCT00614380|65391482|FG003|Overall Study|Consent withdrawn|0|||
23450299|NCT05135871|65391483|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
23450300|NCT05135871|65391484|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450301|NCT05135871|65391485|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450302|NCT05135871|65391486|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450303|NCT02519439|65391487|FG000|Overall Study|Study Termination|19|||
23450304|NCT02519439|65391487|FG000|Overall Study|Withdrawal by Subject|1|||
23450305|NCT02519439|65391487|FG000|Overall Study|Adverse Event|1|||
23450306|NCT04737278|65391494|FG000|Overall Study|Lost to Follow-up|1|||
23450307|NCT04737278|65391495|FG001|Overall Study|Lost to Follow-up|1|||
23450308|NCT04737278|65391494|FG000|Overall Study|Withdrawal by Subject|1|||
23450309|NCT04737278|65391495|FG001|Overall Study|Withdrawal by Subject|0|||
23450310|NCT04737278|65391494|FG000|Overall Study|Protocol Violation|1|||
23578045|NCT00813488|65846982|FG000|Open-label Extension|Adverse Event|1|||
23578046|NCT00813488|65846983|FG001|Open-label Extension|Adverse Event|2|||
23578047|NCT00813488|65846982|FG000|Open-label Extension|Lack of Efficacy|3|||
23578048|NCT00813488|65846983|FG001|Open-label Extension|Lack of Efficacy|0|||
23578049|NCT00813488|65846982|FG000|Open-label Extension|Withdrawal by Subject|0|||
23578050|NCT00813488|65846983|FG001|Open-label Extension|Withdrawal by Subject|2|||
23578051|NCT00813488|65846982|FG000|Open-label Extension|Protocol Violation|1|||
23578052|NCT00813488|65846983|FG001|Open-label Extension|Protocol Violation|2|||
23578053|NCT00813488|65846982|FG000|Open-label Extension|Non-compliance study medication|4|||
23578054|NCT00813488|65846983|FG001|Open-label Extension|Non-compliance study medication|0|||
23777570|NCT00150462|66566883|FG010|Overall Study|Disease Progression or Relapse|2|||
23777571|NCT00150462|66566873|FG000|Overall Study|Withdrawal by Subject|0|||
23777572|NCT00150462|66566874|FG001|Overall Study|Withdrawal by Subject|1|||
23450311|NCT04737278|65391495|FG001|Overall Study|Protocol Violation|1|||
23450312|NCT04737278|65391494|FG000|Overall Study|failure to complete questionnaire|1|||
23450313|NCT04737278|65391495|FG001|Overall Study|failure to complete questionnaire|1|||
23450314|NCT00531284|65391496|FG000|Overall Study|Progressive Disease|1|||
23450315|NCT00531284|65391497|FG001|Overall Study|Progressive Disease|3|||
23450316|NCT00531284|65391498|FG002|Overall Study|Progressive Disease|5|||
23450317|NCT00531284|65391499|FG003|Overall Study|Progressive Disease|42|||
23450318|NCT00531284|65391500|FG004|Overall Study|Progressive Disease|4|||
23450319|NCT00531284|65391501|FG005|Overall Study|Progressive Disease|4|||
23450320|NCT00531284|65391502|FG006|Overall Study|Progressive Disease|3|||
23450321|NCT00531284|65391503|FG007|Overall Study|Progressive Disease|8|||
23578055|NCT00813488|65846982|FG000|Open-label Extension|Non-compliance study procedures|2|||
23578056|NCT00813488|65846983|FG001|Open-label Extension|Non-compliance study procedures|1|||
23578057|NCT00813488|65846982|FG000|Open-label Extension|Other|1|||
23837049|NCT03963232|66781485|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
23837050|NCT03963232|66781486|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23837051|NCT03963232|66781485|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
23837052|NCT03963232|66781486|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23837053|NCT03963232|66781485|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
23578058|NCT00813488|65846983|FG001|Open-label Extension|Other|0|||
23578059|NCT01719861|65846990|FG000|Cycle 1|Death|4|||
23578060|NCT01719861|65846990|FG000|Cycle 2|Death|1|||
23578061|NCT04714216|65846994|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
23578062|NCT04714216|65846994|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
23578063|NCT01543685|65846995|FG000|Overall Study|Lack of Efficacy|1|||
23578064|NCT01543685|65846996|FG001|Overall Study|Lack of Efficacy|2|||
23578065|NCT01543685|65846997|FG002|Overall Study|Lack of Efficacy|2|||
23578066|NCT01543685|65846998|FG003|Overall Study|Lack of Efficacy|0|||
23578067|NCT01543685|65846999|FG004|Overall Study|Lack of Efficacy|2|||
23578068|NCT01543685|65846995|FG000|Overall Study|Adverse Event|2|||
23578069|NCT01543685|65846996|FG001|Overall Study|Adverse Event|1|||
23578070|NCT01543685|65846997|FG002|Overall Study|Adverse Event|0|||
23578071|NCT01543685|65846998|FG003|Overall Study|Adverse Event|0|||
23578072|NCT01543685|65846999|FG004|Overall Study|Adverse Event|2|||
23777573|NCT00150462|66566875|FG002|Overall Study|Withdrawal by Subject|1|||
23777574|NCT00150462|66566876|FG003|Overall Study|Withdrawal by Subject|0|||
23777575|NCT00150462|66566877|FG004|Overall Study|Withdrawal by Subject|1|||
23777576|NCT00150462|66566878|FG005|Overall Study|Withdrawal by Subject|2|||
23777577|NCT00150462|66566879|FG006|Overall Study|Withdrawal by Subject|0|||
23777578|NCT00150462|66566880|FG007|Overall Study|Withdrawal by Subject|1|||
23777579|NCT00150462|66566881|FG008|Overall Study|Withdrawal by Subject|0|||
23777580|NCT00150462|66566882|FG009|Overall Study|Withdrawal by Subject|1|||
23777581|NCT00150462|66566883|FG010|Overall Study|Withdrawal by Subject|0|||
23777582|NCT00150462|66566873|FG000|Overall Study|Death|0|||
23777583|NCT00150462|66566874|FG001|Overall Study|Death|1|||
23777584|NCT00150462|66566875|FG002|Overall Study|Death|0|||
23777585|NCT00150462|66566876|FG003|Overall Study|Death|0|||
23777586|NCT00150462|66566877|FG004|Overall Study|Death|0|||
23777587|NCT00150462|66566878|FG005|Overall Study|Death|0|||
23777588|NCT00150462|66566879|FG006|Overall Study|Death|0|||
23777589|NCT00150462|66566880|FG007|Overall Study|Death|0|||
23777590|NCT00150462|66566881|FG008|Overall Study|Death|1|||
23578073|NCT04822298|65847000|FG000|Overall Study|Death|3|||
23578074|NCT03759366|65847001|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
23578075|NCT03759366|65847001|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
23578076|NCT01636362|65847002|FG000|Overall Study|Physician Decision|6|||
23578077|NCT01636362|65847002|FG000|Overall Study|Subject healed, not returning|1|||
23777591|NCT00150462|66566882|FG009|Overall Study|Death|0|||
23777592|NCT00150462|66566883|FG010|Overall Study|Death|0|||
23777593|NCT00150462|66566873|FG000|Overall Study|Adverse Event|0|||
23777594|NCT00150462|66566874|FG001|Overall Study|Adverse Event|0|||
23777595|NCT00150462|66566875|FG002|Overall Study|Adverse Event|0|||
23777596|NCT00150462|66566876|FG003|Overall Study|Adverse Event|1|||
23777597|NCT00150462|66566877|FG004|Overall Study|Adverse Event|0|||
23777598|NCT00150462|66566878|FG005|Overall Study|Adverse Event|0|||
23634291|NCT02783573|66049178|FG001|Delayed-Start Period|Sponsor Decision|17|||
23634292|NCT02783573|66049179|FG002|Delayed-Start Period|Sponsor Decision|12|||
23777599|NCT00150462|66566879|FG006|Overall Study|Adverse Event|0|||
23777600|NCT00150462|66566880|FG007|Overall Study|Adverse Event|2|||
23777601|NCT00150462|66566881|FG008|Overall Study|Adverse Event|0|||
23777602|NCT00150462|66566882|FG009|Overall Study|Adverse Event|1|||
23777603|NCT00150462|66566883|FG010|Overall Study|Adverse Event|0|||
23777604|NCT00150462|66566873|FG000|Overall Study|Physician Decision|0|||
23777605|NCT00150462|66566874|FG001|Overall Study|Physician Decision|0|||
23777606|NCT00150462|66566875|FG002|Overall Study|Physician Decision|1|||
23777607|NCT00150462|66566876|FG003|Overall Study|Physician Decision|1|||
23777608|NCT00150462|66566877|FG004|Overall Study|Physician Decision|0|||
23777609|NCT00150462|66566878|FG005|Overall Study|Physician Decision|0|||
23777610|NCT00150462|66566879|FG006|Overall Study|Physician Decision|0|||
23777611|NCT00150462|66566880|FG007|Overall Study|Physician Decision|0|||
23777612|NCT00150462|66566881|FG008|Overall Study|Physician Decision|0|||
23777613|NCT00150462|66566882|FG009|Overall Study|Physician Decision|0|||
23777614|NCT00150462|66566883|FG010|Overall Study|Physician Decision|0|||
23450322|NCT00531284|65391504|FG008|Overall Study|Progressive Disease|6|||
23578078|NCT01636362|65847002|FG000|Overall Study|Withdrawal by Subject|1|||
23777615|NCT00150462|66566873|FG000|Overall Study|Other|0|||
23777616|NCT00150462|66566874|FG001|Overall Study|Other|0|||
23777617|NCT00150462|66566875|FG002|Overall Study|Other|0|||
23777618|NCT00150462|66566876|FG003|Overall Study|Other|0|||
23450323|NCT00531284|65391505|FG009|Overall Study|Progressive Disease|3|||
23578079|NCT03459729|65847004|FG000|Overall Study|Physician Decision|2|||
23578080|NCT02081391|65847005|FG000|12-hour Treatment|Withdrawal by Subject|3|||
23578081|NCT02081391|65847006|FG001|12-hour Treatment|Withdrawal by Subject|2|||
23578082|NCT02081391|65847007|FG002|12-hour Treatment|Withdrawal by Subject|0|||
23578083|NCT02081391|65847008|FG003|12-hour Treatment|Withdrawal by Subject|0|||
23578084|NCT02081391|65847005|FG000|12-hour Treatment|Physician Decision|4|||
23578085|NCT02081391|65847006|FG001|12-hour Treatment|Physician Decision|1|||
23578086|NCT02081391|65847007|FG002|12-hour Treatment|Physician Decision|0|||
23578087|NCT02081391|65847008|FG003|12-hour Treatment|Physician Decision|0|||
23578088|NCT02081391|65847005|FG000|12-hour Treatment|Lack of Efficacy|3|||
23578089|NCT02081391|65847006|FG001|12-hour Treatment|Lack of Efficacy|0|||
23578090|NCT02081391|65847007|FG002|12-hour Treatment|Lack of Efficacy|0|||
23578091|NCT02081391|65847008|FG003|12-hour Treatment|Lack of Efficacy|0|||
23578092|NCT02081391|65847005|FG000|12-hour Treatment|Adverse Event|4|||
23578093|NCT02081391|65847006|FG001|12-hour Treatment|Adverse Event|2|||
23578094|NCT02081391|65847007|FG002|12-hour Treatment|Adverse Event|0|||
23578095|NCT02081391|65847008|FG003|12-hour Treatment|Adverse Event|0|||
23578096|NCT02081391|65847005|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
23578097|NCT02081391|65847006|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
23578098|NCT02081391|65847007|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
23578099|NCT02081391|65847008|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
23578100|NCT02081391|65847005|FG000|12-hour Treatment|Further reasons|2|||
23578101|NCT02081391|65847006|FG001|12-hour Treatment|Further reasons|1|||
23578102|NCT02081391|65847007|FG002|12-hour Treatment|Further reasons|0|||
23777619|NCT00150462|66566877|FG004|Overall Study|Other|0|||
23578103|NCT02081391|65847008|FG003|12-hour Treatment|Further reasons|0|||
23578104|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
23777620|NCT00150462|66566878|FG005|Overall Study|Other|0|||
23777621|NCT00150462|66566879|FG006|Overall Study|Other|0|||
23837054|NCT03963232|66781486|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
23837055|NCT03963232|66781485|FG000|Open-Label Treatment Phase|Adverse Event|1|||
23837056|NCT03963232|66781486|FG001|Open-Label Treatment Phase|Adverse Event|2|||
23837057|NCT03963232|66781485|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
23634293|NCT05172050|66049180|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
23634294|NCT05172050|66049181|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
23634295|NCT05172050|66049182|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
23634296|NCT05172050|66049180|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
23634297|NCT05172050|66049181|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
23634298|NCT05172050|66049182|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
23634299|NCT05172050|66049180|FG000|Overall Study|Other|2|||
23634300|NCT05172050|66049181|FG001|Overall Study|Other|2|||
23634301|NCT05172050|66049182|FG002|Overall Study|Other|1|||
23634302|NCT00438672|66049185|FG000|Overall Study|Lost to Follow-up|7|||
23634303|NCT00438672|66049186|FG001|Overall Study|Lost to Follow-up|9|||
23450324|NCT00531284|65391506|FG010|Overall Study|Progressive Disease|3|||
23450325|NCT00531284|65391507|FG011|Overall Study|Progressive Disease|14|||
23450326|NCT00531284|65391508|FG012|Overall Study|Progressive Disease|2|||
23450327|NCT00531284|65391509|FG013|Overall Study|Progressive Disease|1|||
23634304|NCT00669877|66049187|FG000|Overall Study|Disease Progression/Death|4|||
23450328|NCT00531284|65391510|FG014|Overall Study|Progressive Disease|2|||
23450329|NCT00531284|65391511|FG015|Overall Study|Progressive Disease|11|||
23634305|NCT02088957|66049188|FG000|Overall Study|Lack of Efficacy|1|||
23837058|NCT03963232|66781486|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
23837059|NCT03963232|66781485|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
23450330|NCT00531284|65391512|FG016|Overall Study|Progressive Disease|5|||
23837060|NCT03963232|66781486|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
23837061|NCT03963232|66781485|FG000|Open-Label Treatment Phase|Pregnancy|1|||
23837062|NCT03963232|66781486|FG001|Open-Label Treatment Phase|Pregnancy|0|||
23837063|NCT03963232|66781485|FG000|Follow-up Phase|Withdrawal by Subject|7|||
23837064|NCT03963232|66781486|FG001|Follow-up Phase|Withdrawal by Subject|5|||
23837065|NCT03963232|66781485|FG000|Follow-up Phase|Protocol Violation|0|||
23837066|NCT03963232|66781486|FG001|Follow-up Phase|Protocol Violation|2|||
23837067|NCT03963232|66781485|FG000|Follow-up Phase|Adverse Event|0|||
23837068|NCT03963232|66781486|FG001|Follow-up Phase|Adverse Event|1|||
23450331|NCT00531284|65391496|FG000|Overall Study|Adverse Event|0|||
23450332|NCT00531284|65391497|FG001|Overall Study|Adverse Event|1|||
23450333|NCT00531284|65391498|FG002|Overall Study|Adverse Event|1|||
23450334|NCT00531284|65391499|FG003|Overall Study|Adverse Event|7|||
23450335|NCT00531284|65391500|FG004|Overall Study|Adverse Event|0|||
23450336|NCT00531284|65391501|FG005|Overall Study|Adverse Event|2|||
23450337|NCT00531284|65391502|FG006|Overall Study|Adverse Event|3|||
23837069|NCT03963232|66781485|FG000|Follow-up Phase|Lost to Follow-up|0|||
23837070|NCT03963232|66781486|FG001|Follow-up Phase|Lost to Follow-up|1|||
23837071|NCT01592786|66781487|FG000|Overall Study|Adverse Event|60|||
23837072|NCT01592786|66781487|FG000|Overall Study|Lack of Efficacy|19|||
23837073|NCT01592786|66781487|FG000|Overall Study|Protocol Violation|14|||
23837074|NCT01592786|66781487|FG000|Overall Study|Withdrawal by Subject|23|||
23837075|NCT01592786|66781487|FG000|Overall Study|Lost to Follow-up|19|||
23837076|NCT01592786|66781487|FG000|Overall Study|Other|3|||
23837077|NCT01284348|66781488|FG000|Overall Study|Death|1|||
23837078|NCT01284348|66781489|FG001|Overall Study|Death|1|||
23837079|NCT01284348|66781488|FG000|Overall Study|Withdrew consent|0|||
23837080|NCT01284348|66781489|FG001|Overall Study|Withdrew consent|1|||
23837081|NCT01284348|66781488|FG000|Overall Study|Status not recorded|9|||
23450338|NCT00531284|65391503|FG007|Overall Study|Adverse Event|2|||
23578105|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
23634306|NCT02088957|66049189|FG001|Overall Study|Lack of Efficacy|0|||
23634307|NCT01934790|66049190|FG000|Treatment|Adverse Event|3|||
23634308|NCT01934790|66049190|FG000|Treatment|Clinical progression|6|||
23634309|NCT01934790|66049190|FG000|Treatment|Radiological progression|4|||
23634310|NCT01934790|66049190|FG000|Treatment|Withdrawal by Subject|2|||
23634311|NCT01934790|66049190|FG000|Treatment|Study drug never administered|1|||
23634312|NCT01934790|66049190|FG000|Active Follow up|Death|20|||
23578106|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
23578107|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
23578108|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
23578109|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
23578110|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
23578111|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
23578112|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
23578113|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578114|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578115|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578116|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
23578117|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
23578118|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
23578119|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
23578120|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
23578121|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
23578122|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
23578123|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
23578124|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
23578125|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
23578126|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
23578127|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
23837082|NCT01284348|66781489|FG001|Overall Study|Status not recorded|10|||
23837083|NCT00110396|66781496|FG000|Overall Study|Adverse Event|15|||
23450339|NCT00531284|65391504|FG008|Overall Study|Adverse Event|3|||
23578128|NCT02531438|65847009|FG000|Overall Study|Adverse Event|7|||
23578129|NCT02531438|65847010|FG001|Overall Study|Adverse Event|9|||
23634313|NCT01934790|66049190|FG000|Active Follow up|Physician Decision|2|||
23634314|NCT01934790|66049190|FG000|Active Follow up|Progressive disease|1|||
23634315|NCT01934790|66049190|FG000|Active Follow up|Other reason|1|||
23450340|NCT00531284|65391505|FG009|Overall Study|Adverse Event|0|||
23837084|NCT00110396|66781496|FG000|Overall Study|Lost to Follow-up|1|||
23837085|NCT00110396|66781496|FG000|Overall Study|Administration of plasmapheresis|1|||
23837086|NCT00110396|66781496|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
23837087|NCT00110396|66781496|FG000|Overall Study|Lack of Efficacy|1|||
23634316|NCT00918879|66049191|FG000|Overall Study|Withdrawal by Subject|4|||
23634317|NCT00918879|66049192|FG001|Overall Study|Withdrawal by Subject|4|||
23634318|NCT00918879|66049191|FG000|Overall Study|Lost to Follow-up|1|||
23634319|NCT00918879|66049192|FG001|Overall Study|Lost to Follow-up|1|||
23634320|NCT00918879|66049191|FG000|Overall Study|Severe non-compliance to protocol|1|||
23634321|NCT00918879|66049192|FG001|Overall Study|Severe non-compliance to protocol|1|||
23634322|NCT00700778|66049196|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
23634323|NCT02591953|66049199|FG000|Overall Study|Lost to Follow-up|6|||
23634324|NCT02591953|66049200|FG001|Overall Study|Lost to Follow-up|6|||
23634325|NCT00945672|66049202|FG000|Overall Study|Withdrawal by Subject|0|||
23634326|NCT00945672|66049203|FG001|Overall Study|Withdrawal by Subject|0|||
23634327|NCT00945672|66049204|FG002|Overall Study|Withdrawal by Subject|0|||
23634328|NCT00945672|66049205|FG003|Overall Study|Withdrawal by Subject|1|||
23634329|NCT02440425|66049206|FG000|Overall Study|Death likely due to disease progression|1|||
23634330|NCT02440425|66049206|FG000|Overall Study|Withdrawal by Subject|2|||
23634331|NCT02440425|66049206|FG000|Overall Study|Adverse Event|1|||
23634332|NCT02440425|66049206|FG000|Overall Study|Adverse Event/Ineligible|1|||
23634333|NCT01299480|66049208|FG000|Overall Study|No longer willing to participate|19|||
23634334|NCT01299480|66049209|FG001|Overall Study|No longer willing to participate|17|||
23634335|NCT01299480|66049210|FG002|Overall Study|No longer willing to participate|14|||
23634336|NCT01299480|66049211|FG003|Overall Study|No longer willing to participate|13|||
23634337|NCT01299480|66049212|FG004|Overall Study|No longer willing to participate|10|||
23634338|NCT01299480|66049208|FG000|Overall Study|Protocol Violation|7|||
23634339|NCT01299480|66049209|FG001|Overall Study|Protocol Violation|5|||
23634340|NCT01299480|66049210|FG002|Overall Study|Protocol Violation|8|||
23634341|NCT01299480|66049211|FG003|Overall Study|Protocol Violation|1|||
23634342|NCT01299480|66049212|FG004|Overall Study|Protocol Violation|1|||
23634343|NCT01299480|66049208|FG000|Overall Study|Withdrawal by Subject|3|||
23634344|NCT01299480|66049209|FG001|Overall Study|Withdrawal by Subject|4|||
23634345|NCT01299480|66049210|FG002|Overall Study|Withdrawal by Subject|7|||
23634346|NCT01299480|66049211|FG003|Overall Study|Withdrawal by Subject|3|||
23634347|NCT01299480|66049212|FG004|Overall Study|Withdrawal by Subject|4|||
23634348|NCT01299480|66049208|FG000|Overall Study|Adverse Event|6|||
23634349|NCT01299480|66049209|FG001|Overall Study|Adverse Event|4|||
23634350|NCT01299480|66049210|FG002|Overall Study|Adverse Event|5|||
23634351|NCT01299480|66049211|FG003|Overall Study|Adverse Event|4|||
23634352|NCT01299480|66049212|FG004|Overall Study|Adverse Event|0|||
23634353|NCT01299480|66049208|FG000|Overall Study|Withdrawal due to pregnancy|0|||
23634354|NCT01299480|66049209|FG001|Overall Study|Withdrawal due to pregnancy|1|||
23634355|NCT01299480|66049210|FG002|Overall Study|Withdrawal due to pregnancy|1|||
23634356|NCT01299480|66049211|FG003|Overall Study|Withdrawal due to pregnancy|0|||
23634357|NCT01299480|66049212|FG004|Overall Study|Withdrawal due to pregnancy|0|||
23634358|NCT01299480|66049208|FG000|Overall Study|Physician Decision|1|||
23634359|NCT01299480|66049209|FG001|Overall Study|Physician Decision|1|||
23634360|NCT01299480|66049210|FG002|Overall Study|Physician Decision|0|||
23634361|NCT01299480|66049211|FG003|Overall Study|Physician Decision|2|||
23634362|NCT01299480|66049212|FG004|Overall Study|Physician Decision|0|||
23634363|NCT01299480|66049208|FG000|Overall Study|Lost to Follow-up|3|||
23777622|NCT00150462|66566880|FG007|Overall Study|Other|0|||
23777623|NCT00150462|66566881|FG008|Overall Study|Other|0|||
23777624|NCT00150462|66566882|FG009|Overall Study|Other|1|||
23777625|NCT00150462|66566883|FG010|Overall Study|Other|1|||
23777626|NCT02373098|66566884|FG000|Overall Study|Lost to Follow-up|1|||
23777627|NCT02373098|66566885|FG001|Overall Study|Lost to Follow-up|0|||
23777628|NCT02373098|66566884|FG000|Overall Study|Protocol Violation|3|||
23777629|NCT02373098|66566885|FG001|Overall Study|Protocol Violation|0|||
23777630|NCT02373098|66566884|FG000|Overall Study|Withdrawal by Subject|5|||
23777631|NCT02373098|66566885|FG001|Overall Study|Withdrawal by Subject|0|||
23777632|NCT02373098|66566884|FG000|Overall Study|Adverse Event|3|||
23777633|NCT02373098|66566885|FG001|Overall Study|Adverse Event|0|||
23450341|NCT00531284|65391506|FG010|Overall Study|Adverse Event|0|||
23634364|NCT01299480|66049209|FG001|Overall Study|Lost to Follow-up|1|||
23634365|NCT01299480|66049210|FG002|Overall Study|Lost to Follow-up|2|||
23634366|NCT01299480|66049211|FG003|Overall Study|Lost to Follow-up|1|||
23634367|NCT01299480|66049212|FG004|Overall Study|Lost to Follow-up|2|||
23634368|NCT01299480|66049208|FG000|Overall Study|Other|3|||
23634369|NCT01299480|66049209|FG001|Overall Study|Other|2|||
23777634|NCT04320849|66566886|FG000|Overall Study|Withdrawal by Subject|4|||
23777635|NCT04320849|66566886|FG000|Overall Study|Imaging data unavailable|2|||
23777636|NCT04320849|66566886|FG000|Overall Study|Incomplete imaging|2|||
23578130|NCT02531438|65847009|FG000|Overall Study|Lost to Follow-up|0|||
23578131|NCT02531438|65847010|FG001|Overall Study|Lost to Follow-up|3|||
23578132|NCT02531438|65847009|FG000|Overall Study|Withdrawal by Subject|7|||
23578133|NCT02531438|65847010|FG001|Overall Study|Withdrawal by Subject|8|||
23578134|NCT02531438|65847009|FG000|Overall Study|Physician Decision|0|||
23578135|NCT02531438|65847010|FG001|Overall Study|Physician Decision|1|||
23578136|NCT02531438|65847009|FG000|Overall Study|Death|6|||
23578137|NCT02531438|65847010|FG001|Overall Study|Death|3|||
23578138|NCT02531438|65847009|FG000|Overall Study|Randomized, but Not Treated|4|||
23578139|NCT02531438|65847010|FG001|Overall Study|Randomized, but Not Treated|0|||
23578140|NCT02531438|65847009|FG000|Overall Study|Missed EOT/PTE Visit|5|||
23578141|NCT02531438|65847010|FG001|Overall Study|Missed EOT/PTE Visit|2|||
23578142|NCT02531438|65847009|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
23578143|NCT02531438|65847010|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
23578144|NCT01866917|65847013|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
23578145|NCT01866917|65847014|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
23578146|NCT00031447|65847035|FG000|Overall Study|Lost to Follow-up|0|||
23777637|NCT01395030|66566887|FG000|Overall Study|Did not complete FCH PET/CT|7|||
23777638|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
23777639|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
23777640|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
23777641|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
23777642|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
23777643|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
23777644|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
23777645|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
23777646|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
23777647|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
23777648|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
23777649|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
23777650|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
23777651|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
23777652|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
23777653|NCT00437658|66566891|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
23777654|NCT00437658|66566892|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
23777655|NCT00437658|66566893|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
23777656|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
23777657|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
23777658|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
23777659|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
23777660|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
23777661|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
23777662|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
23777663|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
23777664|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
23777665|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
23777666|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
23777667|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
23777668|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
23777669|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
23777670|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
23777671|NCT00437658|66566891|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
23777672|NCT00437658|66566892|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
23777673|NCT00437658|66566893|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
23777674|NCT03991494|66566894|FG000|Overall Study|Progressive Disease|4|||
23777675|NCT00441467|66566895|FG000|Overall Study|Adverse Event|6|||
23777676|NCT00441467|66566895|FG000|Overall Study|Withdrawal by Subject|3|||
23777677|NCT00441467|66566895|FG000|Overall Study|Progressive disease|9|||
23777678|NCT02549092|66566896|FG000|Treatment Period|Adverse Event|2|||
23777679|NCT02549092|66566897|FG001|Treatment Period|Adverse Event|2|||
23777680|NCT02549092|66566896|FG000|Treatment Period|Withdrawal by Subject|1|||
23777681|NCT02549092|66566897|FG001|Treatment Period|Withdrawal by Subject|3|||
23777682|NCT02549092|66566896|FG000|Treatment Period|Lack of Efficacy|0|||
23777683|NCT02549092|66566897|FG001|Treatment Period|Lack of Efficacy|2|||
23777684|NCT02549092|66566896|FG000|Extension/Transition Period|Adverse Event|1|||
23578147|NCT00031447|65847036|FG001|Overall Study|Lost to Follow-up|1|||
23578148|NCT00031447|65847035|FG000|Overall Study|Non-compliant|1|||
23578149|NCT00031447|65847036|FG001|Overall Study|Non-compliant|1|||
23777685|NCT02549092|66566897|FG001|Extension/Transition Period|Adverse Event|1|||
23777686|NCT02549092|66566896|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
23777687|NCT02549092|66566897|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
23777688|NCT02549092|66566896|FG000|Extension/Transition Period|Other, Not Specified|4|||
23837088|NCT00110396|66781496|FG000|Overall Study|Decided not to continue treatment|1|||
23837089|NCT00110396|66781496|FG000|Overall Study|Patient non-compliance|1|||
23837090|NCT00110396|66781496|FG000|Overall Study|Patient refused to continue|1|||
23837091|NCT00110396|66781496|FG000|Overall Study|Patient refused to participate|1|||
23837092|NCT00110396|66781496|FG000|Overall Study|Patient will|1|||
23837093|NCT00110396|66781496|FG000|Overall Study|Patient's decision|1|||
23837094|NCT00110396|66781496|FG000|Overall Study|Participation in MS vaccine study|1|||
23837095|NCT00110396|66781496|FG000|Overall Study|Pregnancy|1|||
23837096|NCT00110396|66781496|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
23837097|NCT00110396|66781496|FG000|Overall Study|Protocol Violation|2|||
23837098|NCT00110396|66781496|FG000|Overall Study|Patient refused to come back|1|||
23837099|NCT00110396|66781496|FG000|Overall Study|The patient has refused|2|||
23837100|NCT00110396|66781496|FG000|Overall Study|The patient has refused to visit site|1|||
23837101|NCT00110396|66781496|FG000|Overall Study|Patient is to be administered copaxone|1|||
23578150|NCT00031447|65847035|FG000|Overall Study|Re-activation of Disease|2|||
23578151|NCT00031447|65847036|FG001|Overall Study|Re-activation of Disease|1|||
23837102|NCT02593097|66781497|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
23837103|NCT02593097|66781498|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
23837104|NCT02593097|66781497|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23837105|NCT02593097|66781498|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
23837106|NCT02593097|66781497|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
23837107|NCT02593097|66781498|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
23837108|NCT02593097|66781497|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
23837109|NCT02593097|66781498|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
23837110|NCT02593097|66781497|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
23837111|NCT02593097|66781498|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
23837112|NCT01134107|66781499|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
23837113|NCT01134107|66781500|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
23837114|NCT01134107|66781499|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
23837115|NCT01134107|66781500|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
23837116|NCT01134107|66781499|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
23837117|NCT01134107|66781500|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
23837118|NCT01134107|66781499|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
23837119|NCT01134107|66781500|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
23837120|NCT01134107|66781499|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
23837121|NCT01134107|66781500|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
23837122|NCT01134107|66781499|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
23837123|NCT01134107|66781500|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
23837124|NCT01134107|66781499|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
23837125|NCT01134107|66781500|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
23837126|NCT02134015|66781503|FG000|Overall Study|Protocol Violation|0|||
23837127|NCT02134015|66781504|FG001|Overall Study|Protocol Violation|1|||
23837128|NCT02134015|66781503|FG000|Overall Study|Death|2|||
23837129|NCT02134015|66781504|FG001|Overall Study|Death|1|||
23837130|NCT02134015|66781503|FG000|Overall Study|Reason not provided|1|||
23578152|NCT00031447|65847035|FG000|Overall Study|Disruption of blinded study drug supply|7|||
23837131|NCT02134015|66781504|FG001|Overall Study|Reason not provided|2|||
23837132|NCT02134015|66781503|FG000|Overall Study|Clinical progression|14|||
23837133|NCT02134015|66781504|FG001|Overall Study|Clinical progression|7|||
23837134|NCT02134015|66781503|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
23837135|NCT02134015|66781504|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
23837136|NCT02134015|66781503|FG000|Overall Study|Study terminated by sponsor|2|||
23837137|NCT02134015|66781504|FG001|Overall Study|Study terminated by sponsor|3|||
23837138|NCT02134015|66781503|FG000|Overall Study|Adverse Event|9|||
23837139|NCT02134015|66781504|FG001|Overall Study|Adverse Event|10|||
23837140|NCT02134015|66781503|FG000|Overall Study|Withdrawal by Subject|3|||
23837141|NCT02134015|66781504|FG001|Overall Study|Withdrawal by Subject|7|||
23837142|NCT01464333|66781505|FG000|Overall Study|Adverse Event|34|||
23837143|NCT01464333|66781505|FG000|Overall Study|Lack of Efficacy|72|||
23578153|NCT00031447|65847036|FG001|Overall Study|Disruption of blinded study drug supply|4|||
23837144|NCT01464333|66781505|FG000|Overall Study|Withdrawal by Subject|11|||
23837145|NCT01464333|66781505|FG000|Overall Study|Other|4|||
23837146|NCT01464333|66781505|FG000|Overall Study|No Hospital Visit|42|||
23837147|NCT00558467|66781506|FG000|Overall Study|Adverse Event|1|||
23837148|NCT00558467|66781507|FG001|Overall Study|Adverse Event|2|||
23450342|NCT00531284|65391507|FG011|Overall Study|Adverse Event|5|||
23450343|NCT00531284|65391508|FG012|Overall Study|Adverse Event|0|||
23837149|NCT00558467|66781506|FG000|Overall Study|Lack of Efficacy|0|||
23450344|NCT00531284|65391509|FG013|Overall Study|Adverse Event|1|||
23450345|NCT00531284|65391510|FG014|Overall Study|Adverse Event|1|||
23837150|NCT00558467|66781507|FG001|Overall Study|Lack of Efficacy|1|||
23450346|NCT00531284|65391511|FG015|Overall Study|Adverse Event|0|||
23837151|NCT00558467|66781506|FG000|Overall Study|Patient moving out of state|0|||
23837152|NCT00558467|66781507|FG001|Overall Study|Patient moving out of state|1|||
23837153|NCT01323387|66781508|FG000|Overall Study|Withdrawal by Subject|41|||
23837154|NCT01323387|66781508|FG000|Overall Study|Radiographic Data Unavailable|1|||
23837155|NCT01323387|66781508|FG000|Overall Study|Revision|14|||
23837156|NCT01323387|66781508|FG000|Overall Study|Protocol Violation|12|||
23837157|NCT01323387|66781508|FG000|Overall Study|Randomized but Never Treated|16|||
23837158|NCT02211209|66781509|FG000|Overall Study|Investigator judgment|0|||
23837159|NCT02211209|66781510|FG001|Overall Study|Investigator judgment|1|||
23837160|NCT02211209|66781509|FG000|Overall Study|Voluntary withdrawal|1|||
23837161|NCT02211209|66781510|FG001|Overall Study|Voluntary withdrawal|4|||
23837162|NCT02211209|66781509|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23837163|NCT02211209|66781510|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
23837164|NCT02211209|66781509|FG000|Overall Study|Reason Not Specified|1|||
23837165|NCT02211209|66781510|FG001|Overall Study|Reason Not Specified|0|||
23837166|NCT02062450|66781511|FG000|Overall Study|No follow-up visit|124|||
23837167|NCT00651261|66781513|FG000|Overall Study|Adverse Event|32|||
23837168|NCT00651261|66781514|FG001|Overall Study|Adverse Event|22|||
23837169|NCT00651261|66781513|FG000|Overall Study|Death|18|||
23578154|NCT02300311|65847037|FG000|Overall Study|Other than the reason specified|1|||
23578155|NCT02300311|65847038|FG001|Overall Study|Other than the reason specified|0|||
23837170|NCT00651261|66781514|FG001|Overall Study|Death|18|||
23837171|NCT00651261|66781513|FG000|Overall Study|Withdrawal by Subject|22|||
23837172|NCT00651261|66781514|FG001|Overall Study|Withdrawal by Subject|40|||
23837173|NCT00651261|66781513|FG000|Overall Study|Induction failure|24|||
23837174|NCT00651261|66781514|FG001|Overall Study|Induction failure|35|||
23837175|NCT00651261|66781513|FG000|Overall Study|Disease progression|58|||
23837176|NCT00651261|66781514|FG001|Overall Study|Disease progression|58|||
23837177|NCT00651261|66781513|FG000|Overall Study|Alternative therapy|109|||
23837178|NCT00651261|66781514|FG001|Overall Study|Alternative therapy|107|||
23837179|NCT00651261|66781513|FG000|Overall Study|Other disease or participant decisions|23|||
23837180|NCT00651261|66781514|FG001|Overall Study|Other disease or participant decisions|23|||
23837181|NCT00651261|66781513|FG000|Overall Study|Never treated|5|||
23837182|NCT00651261|66781514|FG001|Overall Study|Never treated|3|||
23837183|NCT00862823|66781515|FG000|First Intervention|Withdrawal by Subject|1|||
23837184|NCT00862823|66781516|FG001|First Intervention|Withdrawal by Subject|1|||
23837185|NCT02088905|66781521|FG000|Overall Study|Withdrawal by Subject|5|||
23837186|NCT02088905|66781522|FG001|Overall Study|Withdrawal by Subject|1|||
23837187|NCT01964222|66781523|FG000|Overall Study|Lost to Follow-up|7|||
23837188|NCT01964222|66781524|FG001|Overall Study|Lost to Follow-up|5|||
23837189|NCT01964222|66781523|FG000|Overall Study|Withdrawal by Subject|6|||
23837190|NCT01964222|66781524|FG001|Overall Study|Withdrawal by Subject|6|||
23837191|NCT01964222|66781523|FG000|Overall Study|Screening Failure|2|||
23837192|NCT01964222|66781524|FG001|Overall Study|Screening Failure|0|||
23837193|NCT01741688|66781530|FG000|Overall Study|Lack of insurance coverage|2|||
23837194|NCT01741688|66781530|FG000|Overall Study|Withdrawal by Subject|1|||
23837195|NCT04707469|66781531|FG000|Overall Study|Site closure|0|||
23837196|NCT04707469|66781532|FG001|Overall Study|Site closure|2|||
23837197|NCT04707469|66781533|FG002|Overall Study|Site closure|0|||
23837198|NCT04707469|66781531|FG000|Overall Study|Physician Decision|2|||
23837199|NCT04707469|66781532|FG001|Overall Study|Physician Decision|2|||
23837200|NCT04707469|66781533|FG002|Overall Study|Physician Decision|2|||
23837201|NCT04707469|66781531|FG000|Overall Study|Death|1|||
23837202|NCT04707469|66781532|FG001|Overall Study|Death|6|||
23837203|NCT04707469|66781533|FG002|Overall Study|Death|2|||
23578156|NCT02300311|65847037|FG000|Overall Study|Refused to continue taking medication|18|||
23578157|NCT02300311|65847038|FG001|Overall Study|Refused to continue taking medication|0|||
23578158|NCT02819479|65847044|FG000|Overall Study|Adverse Event|2|||
23837204|NCT04707469|66781531|FG000|Overall Study|Lost to Follow-up|9|||
23837205|NCT04707469|66781532|FG001|Overall Study|Lost to Follow-up|19|||
23837206|NCT04707469|66781533|FG002|Overall Study|Lost to Follow-up|14|||
23837207|NCT04707469|66781531|FG000|Overall Study|Withdrawal by Subject|17|||
23837208|NCT04707469|66781532|FG001|Overall Study|Withdrawal by Subject|16|||
23837209|NCT04707469|66781533|FG002|Overall Study|Withdrawal by Subject|12|||
23837210|NCT01295827|66781534|FG000|Overall Study|Adverse Event|1|||
23578159|NCT00114959|65847047|FG000|Overall Study|Lack of Efficacy|6|||
23837211|NCT01295827|66781535|FG001|Overall Study|Adverse Event|2|||
23450347|NCT00531284|65391512|FG016|Overall Study|Adverse Event|2|||
23578160|NCT00114959|65847047|FG000|Overall Study|Physician Decision|1|||
23837212|NCT01295827|66781536|FG002|Overall Study|Adverse Event|2|||
23837213|NCT01295827|66781537|FG003|Overall Study|Adverse Event|1|||
23837214|NCT01295827|66781538|FG004|Overall Study|Adverse Event|1|||
23837215|NCT01295827|66781539|FG005|Overall Study|Adverse Event|4|||
23837216|NCT01295827|66781540|FG006|Overall Study|Adverse Event|15|||
23837217|NCT01295827|66781541|FG007|Overall Study|Adverse Event|49|||
23837218|NCT01295827|66781542|FG008|Overall Study|Adverse Event|22|||
23837219|NCT01295827|66781543|FG009|Overall Study|Adverse Event|7|||
23837220|NCT01295827|66781544|FG010|Overall Study|Adverse Event|50|||
23837221|NCT01295827|66781545|FG011|Overall Study|Adverse Event|21|||
23837222|NCT01295827|66781546|FG012|Overall Study|Adverse Event|0|||
23837223|NCT01295827|66781547|FG013|Overall Study|Adverse Event|0|||
23837224|NCT01295827|66781548|FG014|Overall Study|Adverse Event|0|||
23837225|NCT01295827|66781534|FG000|Overall Study|Lost to Follow-up|0|||
23837226|NCT01295827|66781535|FG001|Overall Study|Lost to Follow-up|0|||
23837227|NCT01295827|66781536|FG002|Overall Study|Lost to Follow-up|3|||
23837228|NCT01295827|66781537|FG003|Overall Study|Lost to Follow-up|0|||
23837229|NCT01295827|66781538|FG004|Overall Study|Lost to Follow-up|1|||
23837230|NCT01295827|66781539|FG005|Overall Study|Lost to Follow-up|0|||
23837231|NCT01295827|66781540|FG006|Overall Study|Lost to Follow-up|4|||
23837232|NCT01295827|66781541|FG007|Overall Study|Lost to Follow-up|8|||
23837233|NCT01295827|66781542|FG008|Overall Study|Lost to Follow-up|7|||
23837234|NCT01295827|66781543|FG009|Overall Study|Lost to Follow-up|4|||
23837235|NCT01295827|66781544|FG010|Overall Study|Lost to Follow-up|7|||
23837236|NCT01295827|66781545|FG011|Overall Study|Lost to Follow-up|3|||
23837237|NCT01295827|66781546|FG012|Overall Study|Lost to Follow-up|0|||
23837238|NCT01295827|66781547|FG013|Overall Study|Lost to Follow-up|0|||
23837239|NCT01295827|66781548|FG014|Overall Study|Lost to Follow-up|0|||
23837240|NCT01295827|66781534|FG000|Overall Study|Not Reported|0|||
23837241|NCT01295827|66781535|FG001|Overall Study|Not Reported|0|||
23837242|NCT01295827|66781536|FG002|Overall Study|Not Reported|0|||
23837243|NCT01295827|66781537|FG003|Overall Study|Not Reported|1|||
23837244|NCT01295827|66781538|FG004|Overall Study|Not Reported|0|||
23837245|NCT01295827|66781539|FG005|Overall Study|Not Reported|0|||
23837246|NCT01295827|66781540|FG006|Overall Study|Not Reported|24|||
23837247|NCT01295827|66781541|FG007|Overall Study|Not Reported|58|||
23837248|NCT01295827|66781542|FG008|Overall Study|Not Reported|41|||
23837249|NCT01295827|66781543|FG009|Overall Study|Not Reported|2|||
23837250|NCT01295827|66781544|FG010|Overall Study|Not Reported|23|||
23837251|NCT01295827|66781545|FG011|Overall Study|Not Reported|13|||
23837252|NCT01295827|66781546|FG012|Overall Study|Not Reported|0|||
23837253|NCT01295827|66781547|FG013|Overall Study|Not Reported|0|||
23837254|NCT01295827|66781548|FG014|Overall Study|Not Reported|0|||
23837255|NCT01295827|66781534|FG000|Overall Study|Progressive Disease|2|||
23837256|NCT01295827|66781535|FG001|Overall Study|Progressive Disease|1|||
23837257|NCT01295827|66781536|FG002|Overall Study|Progressive Disease|5|||
23837258|NCT01295827|66781537|FG003|Overall Study|Progressive Disease|2|||
23837259|NCT01295827|66781538|FG004|Overall Study|Progressive Disease|0|||
23837260|NCT01295827|66781539|FG005|Overall Study|Progressive Disease|1|||
23837261|NCT01295827|66781540|FG006|Overall Study|Progressive Disease|87|||
23837262|NCT01295827|66781541|FG007|Overall Study|Progressive Disease|144|||
23837263|NCT01295827|66781542|FG008|Overall Study|Progressive Disease|85|||
23837264|NCT01295827|66781543|FG009|Overall Study|Progressive Disease|40|||
23837265|NCT01295827|66781544|FG010|Overall Study|Progressive Disease|175|||
23837266|NCT01295827|66781545|FG011|Overall Study|Progressive Disease|136|||
23837267|NCT01295827|66781546|FG012|Overall Study|Progressive Disease|0|||
23837268|NCT01295827|66781547|FG013|Overall Study|Progressive Disease|0|||
23837269|NCT01295827|66781548|FG014|Overall Study|Progressive Disease|0|||
23837270|NCT01295827|66781534|FG000|Overall Study|Screen Failure|0|||
23837271|NCT01295827|66781535|FG001|Overall Study|Screen Failure|0|||
23837272|NCT01295827|66781536|FG002|Overall Study|Screen Failure|0|||
23837273|NCT01295827|66781537|FG003|Overall Study|Screen Failure|0|||
23837274|NCT01295827|66781538|FG004|Overall Study|Screen Failure|0|||
23837275|NCT01295827|66781539|FG005|Overall Study|Screen Failure|0|||
23837276|NCT01295827|66781540|FG006|Overall Study|Screen Failure|2|||
23837277|NCT01295827|66781541|FG007|Overall Study|Screen Failure|2|||
23837278|NCT01295827|66781542|FG008|Overall Study|Screen Failure|2|||
23837279|NCT01295827|66781543|FG009|Overall Study|Screen Failure|0|||
23837280|NCT01295827|66781544|FG010|Overall Study|Screen Failure|1|||
23837281|NCT01295827|66781545|FG011|Overall Study|Screen Failure|0|||
23837282|NCT01295827|66781546|FG012|Overall Study|Screen Failure|0|||
23837283|NCT01295827|66781547|FG013|Overall Study|Screen Failure|0|||
23837284|NCT01295827|66781548|FG014|Overall Study|Screen Failure|0|||
23837285|NCT01295827|66781534|FG000|Overall Study|Withdrawal by Subject|1|||
23837286|NCT01295827|66781535|FG001|Overall Study|Withdrawal by Subject|0|||
23837287|NCT01295827|66781536|FG002|Overall Study|Withdrawal by Subject|2|||
23837288|NCT01295827|66781537|FG003|Overall Study|Withdrawal by Subject|0|||
23837289|NCT01295827|66781538|FG004|Overall Study|Withdrawal by Subject|0|||
23837290|NCT01295827|66781539|FG005|Overall Study|Withdrawal by Subject|1|||
23837291|NCT01295827|66781540|FG006|Overall Study|Withdrawal by Subject|13|||
23837292|NCT01295827|66781541|FG007|Overall Study|Withdrawal by Subject|35|||
23837293|NCT01295827|66781542|FG008|Overall Study|Withdrawal by Subject|11|||
23837294|NCT01295827|66781543|FG009|Overall Study|Withdrawal by Subject|2|||
23837295|NCT01295827|66781544|FG010|Overall Study|Withdrawal by Subject|18|||
23837296|NCT01295827|66781545|FG011|Overall Study|Withdrawal by Subject|13|||
23837297|NCT01295827|66781546|FG012|Overall Study|Withdrawal by Subject|0|||
23837298|NCT01295827|66781547|FG013|Overall Study|Withdrawal by Subject|0|||
23837299|NCT01295827|66781548|FG014|Overall Study|Withdrawal by Subject|0|||
23837300|NCT01295827|66781534|FG000|Overall Study|Other|0|||
23837301|NCT01295827|66781535|FG001|Overall Study|Other|0|||
23837302|NCT01295827|66781536|FG002|Overall Study|Other|0|||
23837303|NCT01295827|66781537|FG003|Overall Study|Other|0|||
23837304|NCT01295827|66781538|FG004|Overall Study|Other|0|||
23837305|NCT01295827|66781539|FG005|Overall Study|Other|0|||
23837306|NCT01295827|66781540|FG006|Overall Study|Other|1|||
23837307|NCT01295827|66781541|FG007|Overall Study|Other|1|||
23837308|NCT01295827|66781542|FG008|Overall Study|Other|1|||
23837309|NCT01295827|66781543|FG009|Overall Study|Other|0|||
23837310|NCT01295827|66781544|FG010|Overall Study|Other|2|||
23837311|NCT01295827|66781545|FG011|Overall Study|Other|0|||
23837312|NCT01295827|66781546|FG012|Overall Study|Other|0|||
23837313|NCT01295827|66781547|FG013|Overall Study|Other|0|||
23837314|NCT01295827|66781548|FG014|Overall Study|Other|0|||
23837315|NCT01208974|66781549|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
23837316|NCT01208974|66781550|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23837317|NCT01208974|66781551|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23837318|NCT01208974|66781552|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23837319|NCT01208974|66781549|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
23837320|NCT01208974|66781550|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23837321|NCT01208974|66781551|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23837322|NCT01208974|66781552|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23837323|NCT01208974|66781549|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
23837324|NCT01208974|66781550|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23837325|NCT01208974|66781551|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23837326|NCT01208974|66781552|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23837327|NCT02640664|66781553|FG000|Epoch 1|Withdrawal of informed consent|1|||
23837328|NCT02640664|66781554|FG001|Epoch 1|Withdrawal of informed consent|0|||
23837329|NCT02640664|66781555|FG002|Epoch 1|Withdrawal of informed consent|0|||
23837330|NCT02640664|66781553|FG000|Epoch 1|Death|0|||
23837331|NCT02640664|66781554|FG001|Epoch 1|Death|0|||
23837332|NCT02640664|66781555|FG002|Epoch 1|Death|1|||
23837333|NCT02640664|66781553|FG000|Epoch 2|Withdrawal of informed consent|3|||
23837334|NCT02640664|66781554|FG001|Epoch 2|Withdrawal of informed consent|4|||
23837335|NCT02640664|66781555|FG002|Epoch 2|Withdrawal of informed consent|2|||
23837336|NCT02640664|66781553|FG000|Epoch 2|Subject/guardian decision|0|||
23837337|NCT02640664|66781554|FG001|Epoch 2|Subject/guardian decision|2|||
23837338|NCT02640664|66781555|FG002|Epoch 2|Subject/guardian decision|2|||
23837339|NCT02640664|66781553|FG000|Epoch 2|Lost to Follow-up|3|||
23837340|NCT02640664|66781554|FG001|Epoch 2|Lost to Follow-up|4|||
23837341|NCT02640664|66781555|FG002|Epoch 2|Lost to Follow-up|1|||
23837342|NCT02640664|66781553|FG000|Epoch 2|Death|0|||
23837343|NCT02640664|66781554|FG001|Epoch 2|Death|0|||
23837344|NCT02640664|66781555|FG002|Epoch 2|Death|1|||
23837345|NCT06110494|66781556|FG000|Overall Study|Protocol Violation|2|||
23450348|NCT00531284|65391496|FG000|Overall Study|Withdrawal by Subject|1|||
23634370|NCT01299480|66049210|FG002|Overall Study|Other|3|||
23837346|NCT06110494|66781557|FG001|Overall Study|Protocol Violation|0|||
23837347|NCT06110494|66781558|FG002|Overall Study|Protocol Violation|1|||
23837348|NCT06110494|66781556|FG000|Overall Study|Dixon's test for outlier analysis|1|||
23837349|NCT06110494|66781557|FG001|Overall Study|Dixon's test for outlier analysis|1|||
23837350|NCT06110494|66781558|FG002|Overall Study|Dixon's test for outlier analysis|0|||
23837351|NCT01554527|66781561|FG000|Overall Study|Withdrawal by Subject|1|||
23837352|NCT01554527|66781562|FG001|Overall Study|Withdrawal by Subject|0|||
23837353|NCT01554527|66781563|FG002|Overall Study|Withdrawal by Subject|3|||
23837354|NCT01554527|66781561|FG000|Overall Study|Lost to Follow-up|0|||
23837355|NCT01554527|66781562|FG001|Overall Study|Lost to Follow-up|0|||
23837356|NCT01554527|66781563|FG002|Overall Study|Lost to Follow-up|4|||
23837357|NCT01554527|66781561|FG000|Overall Study|Physician Decision|0|||
23837358|NCT01554527|66781562|FG001|Overall Study|Physician Decision|0|||
23837359|NCT01554527|66781563|FG002|Overall Study|Physician Decision|1|||
23837360|NCT00766636|66784104|FG000|Overall Study|Withdrawal by Subject|1|||
23837361|NCT00766636|66784105|FG001|Overall Study|Withdrawal by Subject|1|||
23837362|NCT00766636|66784104|FG000|Overall Study|Incomplete Treatment|0|||
23837363|NCT00766636|66784105|FG001|Overall Study|Incomplete Treatment|1|||
23837364|NCT00766636|66784104|FG000|Overall Study|Adverse Event|1|||
23837365|NCT00766636|66784105|FG001|Overall Study|Adverse Event|0|||
23837366|NCT00766636|66784104|FG000|Overall Study|Disease Progression|1|||
23837367|NCT00766636|66784105|FG001|Overall Study|Disease Progression|0|||
23837368|NCT01288937|66784106|FG000|Overall Study|Adverse Event|1|||
23837369|NCT01288937|66784107|FG001|Overall Study|Adverse Event|0|||
23837370|NCT02187198|66784108|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
23837371|NCT02187198|66784109|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
23837372|NCT02187198|66784108|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
23837373|NCT02187198|66784109|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
23837374|NCT00154284|66784111|FG000|Overall Study|Adverse Event|6|||
23837375|NCT00154284|66784112|FG001|Overall Study|Adverse Event|9|||
23837376|NCT00154284|66784111|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23837377|NCT00154284|66784112|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23837378|NCT00154284|66784111|FG000|Overall Study|Lack of Efficacy|1|||
23837379|NCT00154284|66784112|FG001|Overall Study|Lack of Efficacy|2|||
23837380|NCT00154284|66784111|FG000|Overall Study|Protocol Violation|0|||
23837381|NCT00154284|66784112|FG001|Overall Study|Protocol Violation|1|||
23837382|NCT00546377|66784118|FG000|Overall Study|Deemed ineligible|1|||
23837383|NCT00546377|66784118|FG000|Overall Study|Adverse Event|6|||
23837384|NCT00245466|66784119|FG000|Overall Study|Adverse Event|2|||
23837385|NCT00245466|66784120|FG001|Overall Study|Adverse Event|8|||
23837386|NCT00245466|66784121|FG002|Overall Study|Adverse Event|4|||
23837387|NCT00245466|66784119|FG000|Overall Study|Low prostate specific antigen suppr|16|||
23837388|NCT00245466|66784120|FG001|Overall Study|Low prostate specific antigen suppr|14|||
23837389|NCT00245466|66784121|FG002|Overall Study|Low prostate specific antigen suppr|5|||
23837390|NCT00245466|66784119|FG000|Overall Study|Insufficient testosterone suppr|12|||
23837391|NCT00245466|66784120|FG001|Overall Study|Insufficient testosterone suppr|12|||
23837392|NCT00245466|66784121|FG002|Overall Study|Insufficient testosterone suppr|21|||
23837393|NCT00245466|66784119|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
23837394|NCT00245466|66784120|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
23837395|NCT00245466|66784121|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
23837396|NCT00245466|66784119|FG000|Overall Study|Withdrawal by Subject|2|||
23837397|NCT00245466|66784120|FG001|Overall Study|Withdrawal by Subject|2|||
23837398|NCT00245466|66784121|FG002|Overall Study|Withdrawal by Subject|1|||
23837399|NCT00245466|66784119|FG000|Overall Study|Lost to Follow-up|3|||
23837400|NCT00245466|66784120|FG001|Overall Study|Lost to Follow-up|0|||
23837401|NCT00245466|66784121|FG002|Overall Study|Lost to Follow-up|0|||
23837402|NCT00245466|66784119|FG000|Overall Study|Disease progression|0|||
23837403|NCT00245466|66784120|FG001|Overall Study|Disease progression|3|||
23837404|NCT00245466|66784121|FG002|Overall Study|Disease progression|1|||
23837405|NCT00245466|66784119|FG000|Overall Study|Protocol Violation|1|||
23837406|NCT00245466|66784120|FG001|Overall Study|Protocol Violation|2|||
23837407|NCT00245466|66784121|FG002|Overall Study|Protocol Violation|2|||
23837408|NCT00245466|66784119|FG000|Overall Study|Death|0|||
23837409|NCT00245466|66784120|FG001|Overall Study|Death|2|||
23837410|NCT00245466|66784121|FG002|Overall Study|Death|0|||
23837411|NCT00245466|66784119|FG000|Overall Study|Administrative reasons|0|||
23450349|NCT00531284|65391497|FG001|Overall Study|Withdrawal by Subject|0|||
23450350|NCT00531284|65391498|FG002|Overall Study|Withdrawal by Subject|0|||
23450351|NCT00531284|65391499|FG003|Overall Study|Withdrawal by Subject|4|||
23450352|NCT00531284|65391500|FG004|Overall Study|Withdrawal by Subject|0|||
23450353|NCT00531284|65391501|FG005|Overall Study|Withdrawal by Subject|0|||
23450354|NCT00531284|65391502|FG006|Overall Study|Withdrawal by Subject|0|||
23450355|NCT00531284|65391503|FG007|Overall Study|Withdrawal by Subject|0|||
23450356|NCT00531284|65391504|FG008|Overall Study|Withdrawal by Subject|0|||
23450357|NCT00531284|65391505|FG009|Overall Study|Withdrawal by Subject|0|||
23837412|NCT00245466|66784120|FG001|Overall Study|Administrative reasons|1|||
23837413|NCT00245466|66784121|FG002|Overall Study|Administrative reasons|0|||
23837414|NCT00912743|66784122|FG000|Overall Study|Adverse Event|3|||
23837415|NCT00912743|66784123|FG001|Overall Study|Adverse Event|1|||
23837416|NCT00912743|66784122|FG000|Overall Study|Lack of Efficacy|9|||
23837417|NCT00912743|66784123|FG001|Overall Study|Lack of Efficacy|18|||
23837418|NCT00912743|66784122|FG000|Overall Study|Toxicity|0|||
23837419|NCT00912743|66784123|FG001|Overall Study|Toxicity|1|||
23450358|NCT00531284|65391506|FG010|Overall Study|Withdrawal by Subject|0|||
23450359|NCT00531284|65391507|FG011|Overall Study|Withdrawal by Subject|3|||
23837420|NCT00912743|66784122|FG000|Overall Study|End of treatment form was not collected|1|||
23837421|NCT00912743|66784123|FG001|Overall Study|End of treatment form was not collected|0|||
23450360|NCT00531284|65391508|FG012|Overall Study|Withdrawal by Subject|0|||
23450361|NCT00531284|65391509|FG013|Overall Study|Withdrawal by Subject|1|||
23450362|NCT00531284|65391510|FG014|Overall Study|Withdrawal by Subject|0|||
23450363|NCT00531284|65391511|FG015|Overall Study|Withdrawal by Subject|1|||
23450364|NCT00531284|65391512|FG016|Overall Study|Withdrawal by Subject|1|||
23450365|NCT00531284|65391496|FG000|Overall Study|Other|1|||
23450366|NCT00531284|65391497|FG001|Overall Study|Other|0|||
23450367|NCT00531284|65391498|FG002|Overall Study|Other|0|||
23450368|NCT00531284|65391499|FG003|Overall Study|Other|10|||
23450369|NCT00531284|65391500|FG004|Overall Study|Other|2|||
23450370|NCT00531284|65391501|FG005|Overall Study|Other|1|||
23450371|NCT00531284|65391502|FG006|Overall Study|Other|0|||
23837422|NCT00931528|66784129|FG000|Overall Study|Protocol Violation|9|||
23837423|NCT00931528|66784130|FG001|Overall Study|Protocol Violation|12|||
23837424|NCT00931528|66784129|FG000|Overall Study|Withdrawal by Subject|4|||
23837425|NCT00931528|66784130|FG001|Overall Study|Withdrawal by Subject|12|||
23837426|NCT00931528|66784129|FG000|Overall Study|Lost to Follow-up|6|||
23837427|NCT00931528|66784130|FG001|Overall Study|Lost to Follow-up|13|||
23837428|NCT00931528|66784129|FG000|Overall Study|Assessment outside of Time Frame|22|||
23837429|NCT00931528|66784130|FG001|Overall Study|Assessment outside of Time Frame|23|||
23837430|NCT03512210|66784132|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
23837431|NCT03512210|66784132|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
23837432|NCT03512210|66784132|FG000|Step 2:Post-MINMON|Death|2|||
23837433|NCT03512210|66784132|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
23837434|NCT03512210|66784132|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
23837435|NCT00927862|66784133|FG000|Overall Study|Missing data needed for endpt analyses|27|||
23837436|NCT00927862|66784134|FG001|Overall Study|Missing data needed for endpt analyses|45|||
23837437|NCT04577404|66784135|FG000|Overall Study|Adverse Event|31|||
23837438|NCT04577404|66784135|FG000|Overall Study|Death|1|||
23837439|NCT04577404|66784135|FG000|Overall Study|Lack of Efficacy|3|||
23837440|NCT04577404|66784135|FG000|Overall Study|Physician Decision|7|||
23837441|NCT04577404|66784135|FG000|Overall Study|Withdrawal by Subject|21|||
23837442|NCT04577404|66784135|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
23837443|NCT01757535|66784136|FG000|Overall Study|Disease Relapse|143|||
23837444|NCT01757535|66784137|FG001|Overall Study|Disease Relapse|180|||
23837445|NCT01757535|66784136|FG000|Overall Study|Adverse Event|29|||
23837446|NCT01757535|66784137|FG001|Overall Study|Adverse Event|11|||
23450372|NCT00531284|65391503|FG007|Overall Study|Other|0|||
23450373|NCT00531284|65391504|FG008|Overall Study|Other|2|||
23450374|NCT00531284|65391505|FG009|Overall Study|Other|1|||
23450375|NCT00531284|65391506|FG010|Overall Study|Other|0|||
23450376|NCT00531284|65391507|FG011|Overall Study|Other|2|||
23450377|NCT00531284|65391508|FG012|Overall Study|Other|0|||
23450378|NCT00531284|65391509|FG013|Overall Study|Other|0|||
23450379|NCT00531284|65391510|FG014|Overall Study|Other|1|||
23450380|NCT00531284|65391511|FG015|Overall Study|Other|0|||
23450381|NCT00531284|65391512|FG016|Overall Study|Other|0|||
23578161|NCT00114959|65847047|FG000|Overall Study|Death|1|||
23578162|NCT01852162|65847050|FG000|Overall Study|Adverse Event|1|||
23777689|NCT02549092|66566897|FG001|Extension/Transition Period|Other, Not Specified|2|||
23777690|NCT02530905|66566898|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
23777691|NCT02530905|66566899|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
23777692|NCT02530905|66566900|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
23777693|NCT02930005|66566901|FG000|Overall Study|Lost to Follow-up|1|||
23777694|NCT02930005|66566902|FG001|Overall Study|Lost to Follow-up|5|||
23777695|NCT02231749|66566903|FG000|Overall Study|Disease progression|229|||
23777696|NCT02231749|66566904|FG001|Overall Study|Disease progression|297|||
23777697|NCT02231749|66566903|FG000|Overall Study|Study Drug Toxicity|134|||
23777698|NCT02231749|66566904|FG001|Overall Study|Study Drug Toxicity|63|||
23777699|NCT02231749|66566903|FG000|Overall Study|Death|1|||
23777700|NCT02231749|66566904|FG001|Overall Study|Death|1|||
23777701|NCT02231749|66566903|FG000|Overall Study|AE unrelated to Study drug|32|||
23837447|NCT01757535|66784136|FG000|Overall Study|Withdrawal by Subject|9|||
23450382|NCT01602224|65391513|FG000|Overall Study|Adverse Event|0|||
23450383|NCT01602224|65391514|FG001|Overall Study|Adverse Event|1|||
23450384|NCT01602224|65391515|FG002|Overall Study|Adverse Event|0|||
23450385|NCT01602224|65391513|FG000|Overall Study|Investigator Decison|1|||
23777702|NCT02231749|66566904|FG001|Overall Study|AE unrelated to Study drug|31|||
23837448|NCT01757535|66784137|FG001|Overall Study|Withdrawal by Subject|13|||
23837449|NCT01757535|66784136|FG000|Overall Study|Miscellaneous|5|||
23837450|NCT01757535|66784137|FG001|Overall Study|Miscellaneous|2|||
23837451|NCT01757535|66784136|FG000|Overall Study|Physician Decision|6|||
23837452|NCT01757535|66784137|FG001|Overall Study|Physician Decision|0|||
23837453|NCT01757535|66784136|FG000|Overall Study|Death|1|||
23450386|NCT01602224|65391514|FG001|Overall Study|Investigator Decison|0|||
23450387|NCT01602224|65391515|FG002|Overall Study|Investigator Decison|0|||
23578163|NCT01852162|65847051|FG001|Overall Study|Adverse Event|0|||
23777703|NCT02231749|66566903|FG000|Overall Study|Participant's request to discontinue|10|||
23777704|NCT02231749|66566904|FG001|Overall Study|Participant's request to discontinue|21|||
23450388|NCT01602224|65391513|FG000|Overall Study|Lost to Follow-up|0|||
23450389|NCT01602224|65391514|FG001|Overall Study|Lost to Follow-up|0|||
23450390|NCT01602224|65391515|FG002|Overall Study|Lost to Follow-up|1|||
23450391|NCT01602224|65391513|FG000|Overall Study|Protocol Violation|0|||
23450392|NCT01602224|65391514|FG001|Overall Study|Protocol Violation|1|||
23450393|NCT01602224|65391515|FG002|Overall Study|Protocol Violation|0|||
23450394|NCT01602224|65391513|FG000|Overall Study|Sponsor Decision|2|||
23450395|NCT01602224|65391514|FG001|Overall Study|Sponsor Decision|3|||
23450396|NCT01602224|65391515|FG002|Overall Study|Sponsor Decision|2|||
23450397|NCT01602224|65391513|FG000|Overall Study|Withdrawal by Subject|5|||
23450398|NCT01602224|65391514|FG001|Overall Study|Withdrawal by Subject|3|||
23450399|NCT01602224|65391515|FG002|Overall Study|Withdrawal by Subject|3|||
23450400|NCT01650558|65391516|FG000|Overall Study|Migration out of study area|61|||
23450401|NCT01650558|65391517|FG001|Overall Study|Migration out of study area|71|||
23450402|NCT01650558|65391518|FG002|Overall Study|Migration out of study area|56|||
23450403|NCT01650558|65391516|FG000|Overall Study|Lost to Follow-up|10|||
23450404|NCT01650558|65391517|FG001|Overall Study|Lost to Follow-up|13|||
23450405|NCT01650558|65391518|FG002|Overall Study|Lost to Follow-up|6|||
23450406|NCT01650558|65391516|FG000|Overall Study|Death|10|||
23450407|NCT01650558|65391517|FG001|Overall Study|Death|6|||
23450408|NCT01650558|65391518|FG002|Overall Study|Death|8|||
23450409|NCT01650558|65391516|FG000|Overall Study|Withdrawal by Subject|1|||
23450410|NCT01650558|65391517|FG001|Overall Study|Withdrawal by Subject|1|||
23450411|NCT01650558|65391518|FG002|Overall Study|Withdrawal by Subject|3|||
23450412|NCT01650558|65391516|FG000|Overall Study|Non-compliant participant|1|||
23450413|NCT01650558|65391517|FG001|Overall Study|Non-compliant participant|0|||
23450414|NCT01650558|65391518|FG002|Overall Study|Non-compliant participant|2|||
23450415|NCT01650558|65391516|FG000|Overall Study|Physician Decision|0|||
23450416|NCT01650558|65391517|FG001|Overall Study|Physician Decision|1|||
23450417|NCT01650558|65391518|FG002|Overall Study|Physician Decision|0|||
23450418|NCT01307319|65391519|FG000|Overall Study|Adverse Event|2|||
23450419|NCT01307319|65391520|FG001|Overall Study|Adverse Event|2|||
23450420|NCT01307319|65391521|FG002|Overall Study|Adverse Event|1|||
23450421|NCT01307319|65391519|FG000|Overall Study|Lost to Follow-up|1|||
23450422|NCT01307319|65391520|FG001|Overall Study|Lost to Follow-up|0|||
23450423|NCT01307319|65391521|FG002|Overall Study|Lost to Follow-up|1|||
23450424|NCT01307319|65391519|FG000|Overall Study|Protocol Violation|1|||
23450425|NCT01307319|65391520|FG001|Overall Study|Protocol Violation|1|||
23450426|NCT01307319|65391521|FG002|Overall Study|Protocol Violation|0|||
23450427|NCT01307319|65391519|FG000|Overall Study|Withdrawal by Subject|0|||
23450428|NCT01307319|65391520|FG001|Overall Study|Withdrawal by Subject|1|||
23450429|NCT01307319|65391521|FG002|Overall Study|Withdrawal by Subject|2|||
23450430|NCT01307319|65391519|FG000|Overall Study|Other|0|||
23450431|NCT01307319|65391520|FG001|Overall Study|Other|4|||
23450432|NCT01307319|65391521|FG002|Overall Study|Other|3|||
23450433|NCT02210000|65391524|FG000|Overall Study|Study Terminated|11|||
23450434|NCT02210000|65391525|FG001|Overall Study|Study Terminated|12|||
23450435|NCT02210000|65391524|FG000|Overall Study|Withdrawal by Subject|7|||
23450436|NCT02210000|65391525|FG001|Overall Study|Withdrawal by Subject|1|||
23450437|NCT02210000|65391524|FG000|Overall Study|Adverse Event|1|||
23450438|NCT02210000|65391525|FG001|Overall Study|Adverse Event|5|||
23450439|NCT02210000|65391524|FG000|Overall Study|Lost to Follow-up|0|||
23450440|NCT02210000|65391525|FG001|Overall Study|Lost to Follow-up|2|||
23450441|NCT02210000|65391524|FG000|Overall Study|Physician Decision|0|||
23450442|NCT02210000|65391525|FG001|Overall Study|Physician Decision|1|||
23450443|NCT03480152|65391526|FG000|Phase I|Signed consent. Died before treatment.|1|||
23578164|NCT01852162|65847050|FG000|Overall Study|Withdrawal by Subject|3|||
23777705|NCT02231749|66566903|FG000|Overall Study|Participant withdrew Consent|8|||
23777706|NCT02231749|66566904|FG001|Overall Study|Participant withdrew Consent|15|||
23777707|NCT02231749|66566903|FG000|Overall Study|Lost to Follow-up|1|||
23777708|NCT02231749|66566904|FG001|Overall Study|Lost to Follow-up|2|||
23777709|NCT02231749|66566903|FG000|Overall Study|Maximum Clinical Benefit|5|||
23777710|NCT02231749|66566904|FG001|Overall Study|Maximum Clinical Benefit|8|||
23777711|NCT02231749|66566903|FG000|Overall Study|Poor/Non-Compliance|0|||
23777712|NCT02231749|66566904|FG001|Overall Study|Poor/Non-Compliance|3|||
23450444|NCT03480152|65391527|FG001|Phase I|Signed consent. Died before treatment.|0|||
23450445|NCT03480152|65391528|FG002|Phase I|Signed consent. Died before treatment.|0|||
23450446|NCT03883581|65391529|FG000|Overall Study|Withdrawal by Subject|4|||
23450447|NCT01421017|65391530|FG000|Overall Study|Withdrawal by Subject|2|||
23450448|NCT01421017|65391531|FG001|Overall Study|Withdrawal by Subject|0|||
23450449|NCT01421017|65391532|FG002|Overall Study|Withdrawal by Subject|0|||
23450450|NCT01421017|65391530|FG000|Overall Study|POD|0|||
23450451|NCT01421017|65391531|FG001|Overall Study|POD|6|||
23450452|NCT01421017|65391532|FG002|Overall Study|POD|3|||
23450453|NCT01121146|65391533|FG000|Overall Study|Death|17|||
23450454|NCT01121146|65391534|FG001|Overall Study|Death|15|||
23450455|NCT01121146|65391533|FG000|Overall Study|Adverse Event|2|||
23450456|NCT01121146|65391534|FG001|Overall Study|Adverse Event|11|||
23450457|NCT01121146|65391533|FG000|Overall Study|Lost to Follow-up|7|||
23777713|NCT02231749|66566903|FG000|Overall Study|Pregnancy|1|||
23450458|NCT01121146|65391534|FG001|Overall Study|Lost to Follow-up|16|||
23450459|NCT04292535|65391541|FG000|Overall Study|Withdrawal by Subject|0|||
23450460|NCT04292535|65391542|FG001|Overall Study|Withdrawal by Subject|0|||
23450461|NCT04292535|65391543|FG002|Overall Study|Withdrawal by Subject|0|||
23450462|NCT04292535|65391544|FG003|Overall Study|Withdrawal by Subject|0|||
23450463|NCT04292535|65391545|FG004|Overall Study|Withdrawal by Subject|0|||
23450464|NCT04292535|65391546|FG005|Overall Study|Withdrawal by Subject|0|||
23450465|NCT04292535|65391547|FG006|Overall Study|Withdrawal by Subject|0|||
23450466|NCT04292535|65391548|FG007|Overall Study|Withdrawal by Subject|1|||
23450467|NCT04292535|65391549|FG008|Overall Study|Withdrawal by Subject|0|||
23450468|NCT04292535|65391550|FG009|Overall Study|Withdrawal by Subject|0|||
23450469|NCT04292535|65391551|FG010|Overall Study|Withdrawal by Subject|0|||
23450470|NCT04292535|65391552|FG011|Overall Study|Withdrawal by Subject|0|||
23450471|NCT04292535|65391553|FG012|Overall Study|Withdrawal by Subject|0|||
23450472|NCT04292535|65391554|FG013|Overall Study|Withdrawal by Subject|0|||
23450473|NCT04292535|65391541|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450474|NCT04292535|65391542|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450475|NCT04292535|65391543|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450476|NCT04292535|65391544|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450477|NCT04292535|65391545|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450478|NCT04292535|65391546|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450479|NCT04292535|65391547|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450480|NCT04292535|65391548|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450481|NCT04292535|65391549|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450482|NCT04292535|65391550|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450483|NCT04292535|65391551|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450484|NCT04292535|65391552|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450485|NCT04292535|65391553|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450486|NCT04292535|65391554|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450487|NCT04292535|65391541|FG000|Overall Study|Report of Dizziness|0|||
23450488|NCT04292535|65391542|FG001|Overall Study|Report of Dizziness|0|||
23450489|NCT04292535|65391543|FG002|Overall Study|Report of Dizziness|0|||
23450490|NCT04292535|65391544|FG003|Overall Study|Report of Dizziness|0|||
23450491|NCT04292535|65391545|FG004|Overall Study|Report of Dizziness|0|||
23450492|NCT04292535|65391546|FG005|Overall Study|Report of Dizziness|0|||
23450493|NCT04292535|65391547|FG006|Overall Study|Report of Dizziness|0|||
23450494|NCT04292535|65391548|FG007|Overall Study|Report of Dizziness|0|||
23450495|NCT04292535|65391549|FG008|Overall Study|Report of Dizziness|0|||
23450496|NCT04292535|65391550|FG009|Overall Study|Report of Dizziness|0|||
23450497|NCT04292535|65391551|FG010|Overall Study|Report of Dizziness|0|||
23450498|NCT04292535|65391552|FG011|Overall Study|Report of Dizziness|0|||
23450499|NCT04292535|65391553|FG012|Overall Study|Report of Dizziness|0|||
23450500|NCT04292535|65391554|FG013|Overall Study|Report of Dizziness|1|||
23450501|NCT04292535|65391541|FG000|Overall Study|Equipment Failure|0|||
23450502|NCT04292535|65391542|FG001|Overall Study|Equipment Failure|0|||
23450503|NCT04292535|65391543|FG002|Overall Study|Equipment Failure|0|||
23450504|NCT04292535|65391544|FG003|Overall Study|Equipment Failure|0|||
23450505|NCT04292535|65391545|FG004|Overall Study|Equipment Failure|0|||
23450506|NCT04292535|65391546|FG005|Overall Study|Equipment Failure|0|||
23450507|NCT04292535|65391547|FG006|Overall Study|Equipment Failure|0|||
23450508|NCT04292535|65391548|FG007|Overall Study|Equipment Failure|0|||
23450509|NCT04292535|65391549|FG008|Overall Study|Equipment Failure|0|||
23450510|NCT04292535|65391550|FG009|Overall Study|Equipment Failure|0|||
23450511|NCT04292535|65391551|FG010|Overall Study|Equipment Failure|0|||
23450512|NCT04292535|65391552|FG011|Overall Study|Equipment Failure|1|||
23450513|NCT04292535|65391553|FG012|Overall Study|Equipment Failure|0|||
23450514|NCT04292535|65391554|FG013|Overall Study|Equipment Failure|0|||
23450515|NCT01929226|65391556|FG000|Overall Study|Lost to Follow-up|4|||
23450516|NCT01929226|65391557|FG001|Overall Study|Lost to Follow-up|0|||
23450517|NCT01929226|65391556|FG000|Overall Study|Withdrawal by Subject|1|||
23450518|NCT01929226|65391557|FG001|Overall Study|Withdrawal by Subject|1|||
23450519|NCT00419393|65391558|FG000|Overall Study|Adverse Event|5|||
23450520|NCT00419393|65391558|FG000|Overall Study|Protocol Violation|5|||
23450521|NCT00419393|65391558|FG000|Overall Study|Withdrawal by Subject|7|||
23450522|NCT00419393|65391558|FG000|Overall Study|Other: Sponsor request|3|||
23450523|NCT00419393|65391558|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
23450524|NCT00419393|65391558|FG000|Overall Study|Other: Site closure|1|||
23450525|NCT00419393|65391558|FG000|Overall Study|Other: Other health problems|1|||
23450526|NCT00419393|65391558|FG000|Overall Study|Other: Investigator decision|1|||
23450527|NCT00100789|65391559|FG000|Overall Study|Adverse Event|10|||
23450528|NCT00100789|65391559|FG000|Overall Study|Withdrawal by Subject|1|||
23450529|NCT00100789|65391559|FG000|Overall Study|Progression/relapse|42|||
23450530|NCT00100789|65391559|FG000|Overall Study|Death|2|||
23450531|NCT00100789|65391559|FG000|Overall Study|Not protocol specified|5|||
23450532|NCT00100789|65391559|FG000|Overall Study|Ineligible|3|||
23450533|NCT00100789|65391559|FG000|Overall Study|Never received treatment|1|||
23450534|NCT01894607|65391561|FG000|Overall Study|Ineligible|1|||
23450535|NCT03309878|65391568|FG000|Overall Study|Adverse Event|1|||
23450536|NCT03309878|65391569|FG001|Overall Study|Adverse Event|0|||
23450537|NCT03309878|65391570|FG002|Overall Study|Adverse Event|0|||
23450538|NCT03309878|65391571|FG003|Overall Study|Adverse Event|0|||
23450539|NCT03309878|65391568|FG000|Overall Study|Did not maintain eligibility|2|||
23450540|NCT03309878|65391569|FG001|Overall Study|Did not maintain eligibility|1|||
23450541|NCT03309878|65391570|FG002|Overall Study|Did not maintain eligibility|0|||
23450542|NCT03309878|65391571|FG003|Overall Study|Did not maintain eligibility|0|||
23450543|NCT03309878|65391568|FG000|Overall Study|Withdrawal by Subject|0|||
23450544|NCT03309878|65391569|FG001|Overall Study|Withdrawal by Subject|1|||
23450545|NCT03309878|65391570|FG002|Overall Study|Withdrawal by Subject|0|||
23450546|NCT03309878|65391571|FG003|Overall Study|Withdrawal by Subject|0|||
23450547|NCT04332107|65391573|FG000|Day 3|Lost to Follow-up|23|||
23450548|NCT04332107|65391574|FG001|Day 3|Lost to Follow-up|14|||
23450549|NCT04332107|65391573|FG000|Day 3|Missing outcome data|3|||
23578165|NCT01852162|65847051|FG001|Overall Study|Withdrawal by Subject|1|||
23578166|NCT00708097|65847058|FG000|Period 1|Protocol Violation|0|||
23777714|NCT02231749|66566904|FG001|Overall Study|Pregnancy|0|||
23777715|NCT02231749|66566903|FG000|Overall Study|other|0|||
23777716|NCT02231749|66566904|FG001|Overall Study|other|8|||
23777717|NCT02231749|66566903|FG000|Overall Study|No longer meets Study Criteria|1|||
23777718|NCT02231749|66566904|FG001|Overall Study|No longer meets Study Criteria|0|||
23777719|NCT01363765|66566905|FG000|Overall Study|non-diagnostic|2621|||
23777720|NCT01363765|66566906|FG001|Overall Study|non-diagnostic|1124|||
23777721|NCT01363765|66566905|FG000|Overall Study|duplicate records|736|||
23777722|NCT01363765|66566906|FG001|Overall Study|duplicate records|3177|||
23777723|NCT01363765|66566905|FG000|Overall Study|non-resident|156|||
23777724|NCT01363765|66566906|FG001|Overall Study|non-resident|76|||
23777725|NCT01363765|66566905|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
23578167|NCT00708097|65847059|FG001|Period 1|Protocol Violation|1|||
23578168|NCT00708097|65847060|FG002|Period 1|Protocol Violation|0|||
23578169|NCT00708097|65847061|FG003|Period 1|Protocol Violation|2|||
23578170|NCT00708097|65847062|FG004|Period 1|Protocol Violation|0|||
23578171|NCT00708097|65847058|FG000|Period 1|Other Reason|0|||
23578172|NCT00708097|65847059|FG001|Period 1|Other Reason|0|||
23578173|NCT00708097|65847060|FG002|Period 1|Other Reason|0|||
23578174|NCT00708097|65847061|FG003|Period 1|Other Reason|0|||
23578175|NCT00708097|65847062|FG004|Period 1|Other Reason|1|||
23578176|NCT00708097|65847058|FG000|Period 2|Protocol Violation|0|||
23578177|NCT00708097|65847059|FG001|Period 2|Protocol Violation|1|||
23578178|NCT00708097|65847060|FG002|Period 2|Protocol Violation|1|||
23578179|NCT00708097|65847061|FG003|Period 2|Protocol Violation|1|||
23578180|NCT00708097|65847062|FG004|Period 2|Protocol Violation|0|||
23578181|NCT03432533|65847064|FG000|Overall Study|Lost to Follow-up|1|||
23634371|NCT01299480|66049211|FG003|Overall Study|Other|0|||
23634372|NCT01299480|66049212|FG004|Overall Study|Other|3|||
23634373|NCT01299480|66049208|FG000|Overall Study|Started, but not vaccinated|0|||
23634374|NCT01299480|66049209|FG001|Overall Study|Started, but not vaccinated|0|||
23634375|NCT01299480|66049210|FG002|Overall Study|Started, but not vaccinated|1|||
23634376|NCT01299480|66049211|FG003|Overall Study|Started, but not vaccinated|1|||
23634377|NCT01299480|66049212|FG004|Overall Study|Started, but not vaccinated|0|||
23777726|NCT01363765|66566906|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
23777727|NCT01363765|66566905|FG000|Overall Study|smear during intervention|2170|||
23777728|NCT01363765|66566906|FG001|Overall Study|smear during intervention|0|||
23837454|NCT01757535|66784137|FG001|Overall Study|Death|2|||
23450550|NCT04332107|65391574|FG001|Day 3|Missing outcome data|6|||
23578182|NCT03432533|65847065|FG001|Overall Study|Lost to Follow-up|2|||
23450551|NCT04332107|65391573|FG000|Day 14|Lost to Follow-up|13|||
23450552|NCT04332107|65391574|FG001|Day 14|Lost to Follow-up|4|||
23450553|NCT04332107|65391573|FG000|Day 14|Missing outcome data|4|||
23450554|NCT04332107|65391574|FG001|Day 14|Missing outcome data|4|||
23578183|NCT03432533|65847064|FG000|Overall Study|Withdrawal by Subject|14|||
23578184|NCT03432533|65847065|FG001|Overall Study|Withdrawal by Subject|9|||
23578185|NCT01833065|65847066|FG000|Overall Study|Adverse Event|6|||
23578186|NCT01833065|65847067|FG001|Overall Study|Adverse Event|1|||
23634378|NCT02071290|66049213|FG000|Overall Study|Death|1|||
23634379|NCT02071290|66049214|FG001|Overall Study|Death|0|||
23777729|NCT02089685|66566907|FG000|Overall Study|Adverse Event|1|||
23777730|NCT02089685|66566908|FG001|Overall Study|Adverse Event|0|||
23777731|NCT02089685|66566909|FG002|Overall Study|Adverse Event|0|||
23777732|NCT02089685|66566910|FG003|Overall Study|Adverse Event|0|||
23777733|NCT02089685|66566911|FG004|Overall Study|Adverse Event|1|||
23777734|NCT02089685|66566912|FG005|Overall Study|Adverse Event|0|||
23450555|NCT04332107|65391573|FG000|Day 21|Lost to Follow-up|10|||
23450556|NCT04332107|65391574|FG001|Day 21|Lost to Follow-up|2|||
23450557|NCT00360412|65391575|FG000|Overall Study|Adverse Event|37|||
23450558|NCT00360412|65391576|FG001|Overall Study|Adverse Event|65|||
23450559|NCT00360412|65391575|FG000|Overall Study|Protocol Violation|2|||
23450560|NCT00360412|65391576|FG001|Overall Study|Protocol Violation|5|||
23450561|NCT00360412|65391575|FG000|Overall Study|Patient withdrew consent|27|||
23450562|NCT00360412|65391576|FG001|Overall Study|Patient withdrew consent|52|||
23450563|NCT00360412|65391575|FG000|Overall Study|Lack of therapeutic efficacy|46|||
23450564|NCT00360412|65391576|FG001|Overall Study|Lack of therapeutic efficacy|61|||
23450565|NCT00360412|65391575|FG000|Overall Study|Physician Decision|2|||
23450566|NCT00360412|65391576|FG001|Overall Study|Physician Decision|4|||
23450567|NCT00360412|65391575|FG000|Overall Study|Other|5|||
23578187|NCT01833065|65847068|FG002|Overall Study|Adverse Event|0|||
23578188|NCT01833065|65847069|FG003|Overall Study|Adverse Event|2|||
23578189|NCT01833065|65847070|FG004|Overall Study|Adverse Event|3|||
23578190|NCT01833065|65847066|FG000|Overall Study|Protocol Violation|1|||
23578191|NCT01833065|65847067|FG001|Overall Study|Protocol Violation|0|||
23578192|NCT01833065|65847068|FG002|Overall Study|Protocol Violation|0|||
23578193|NCT01833065|65847069|FG003|Overall Study|Protocol Violation|0|||
23578194|NCT01833065|65847070|FG004|Overall Study|Protocol Violation|2|||
23578195|NCT01833065|65847066|FG000|Overall Study|Lost to Follow-up|1|||
23578196|NCT01833065|65847067|FG001|Overall Study|Lost to Follow-up|0|||
23578197|NCT01833065|65847068|FG002|Overall Study|Lost to Follow-up|0|||
23578198|NCT01833065|65847069|FG003|Overall Study|Lost to Follow-up|0|||
23578199|NCT01833065|65847070|FG004|Overall Study|Lost to Follow-up|3|||
23578200|NCT01833065|65847066|FG000|Overall Study|Withdrawal by Subject|6|||
23777735|NCT02089685|66566907|FG000|Overall Study|Clinical Progression|4|||
23777736|NCT02089685|66566908|FG001|Overall Study|Clinical Progression|0|||
23777737|NCT02089685|66566909|FG002|Overall Study|Clinical Progression|0|||
23777738|NCT02089685|66566910|FG003|Overall Study|Clinical Progression|5|||
23777739|NCT02089685|66566911|FG004|Overall Study|Clinical Progression|1|||
23777740|NCT02089685|66566912|FG005|Overall Study|Clinical Progression|2|||
23777741|NCT02089685|66566907|FG000|Overall Study|Excluded Medication|1|||
23777742|NCT02089685|66566908|FG001|Overall Study|Excluded Medication|0|||
23578201|NCT01833065|65847067|FG001|Overall Study|Withdrawal by Subject|2|||
23578202|NCT01833065|65847068|FG002|Overall Study|Withdrawal by Subject|4|||
23777743|NCT02089685|66566909|FG002|Overall Study|Excluded Medication|0|||
23777744|NCT02089685|66566910|FG003|Overall Study|Excluded Medication|11|||
23777745|NCT02089685|66566911|FG004|Overall Study|Excluded Medication|2|||
23777746|NCT02089685|66566912|FG005|Overall Study|Excluded Medication|1|||
23777747|NCT02089685|66566907|FG000|Overall Study|Progressive disease|13|||
23777748|NCT02089685|66566908|FG001|Overall Study|Progressive disease|10|||
23777749|NCT02089685|66566909|FG002|Overall Study|Progressive disease|3|||
23777750|NCT02089685|66566910|FG003|Overall Study|Progressive disease|51|||
23777751|NCT02089685|66566911|FG004|Overall Study|Progressive disease|17|||
23777752|NCT02089685|66566912|FG005|Overall Study|Progressive disease|12|||
23777753|NCT02089685|66566907|FG000|Overall Study|Follow up ended by sponsor|2|||
23777754|NCT02089685|66566908|FG001|Overall Study|Follow up ended by sponsor|2|||
23777755|NCT02089685|66566909|FG002|Overall Study|Follow up ended by sponsor|0|||
23777756|NCT02089685|66566910|FG003|Overall Study|Follow up ended by sponsor|70|||
23777757|NCT02089685|66566911|FG004|Overall Study|Follow up ended by sponsor|26|||
23578203|NCT01833065|65847069|FG003|Overall Study|Withdrawal by Subject|3|||
23450568|NCT00360412|65391576|FG001|Overall Study|Other|6|||
23450569|NCT00360412|65391575|FG000|Overall Study|Study termination by Sponsor|214|||
23450570|NCT00360412|65391576|FG001|Overall Study|Study termination by Sponsor|469|||
23450571|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
23777758|NCT02089685|66566912|FG005|Overall Study|Follow up ended by sponsor|26|||
23777759|NCT02089685|66566907|FG000|Overall Study|Withdrawal by Subject|0|||
23578204|NCT01833065|65847070|FG004|Overall Study|Withdrawal by Subject|11|||
23578205|NCT01833065|65847066|FG000|Overall Study|Subject's substantial non-compliance|0|||
23777760|NCT02089685|66566908|FG001|Overall Study|Withdrawal by Subject|2|||
23777761|NCT02089685|66566909|FG002|Overall Study|Withdrawal by Subject|0|||
23777762|NCT02089685|66566910|FG003|Overall Study|Withdrawal by Subject|8|||
23777763|NCT02089685|66566911|FG004|Overall Study|Withdrawal by Subject|1|||
23777764|NCT02089685|66566912|FG005|Overall Study|Withdrawal by Subject|1|||
23777765|NCT02089685|66566907|FG000|Overall Study|Status not recorded|1|||
23578206|NCT01833065|65847067|FG001|Overall Study|Subject's substantial non-compliance|1|||
23578207|NCT01833065|65847068|FG002|Overall Study|Subject's substantial non-compliance|0|||
23777766|NCT02089685|66566908|FG001|Overall Study|Status not recorded|0|||
23578208|NCT01833065|65847069|FG003|Overall Study|Subject's substantial non-compliance|0|||
23578209|NCT01833065|65847070|FG004|Overall Study|Subject's substantial non-compliance|0|||
23578210|NCT01833065|65847066|FG000|Overall Study|Trial terminated by sponsor|8|||
23578211|NCT01833065|65847067|FG001|Overall Study|Trial terminated by sponsor|8|||
23578212|NCT01833065|65847068|FG002|Overall Study|Trial terminated by sponsor|7|||
23578213|NCT01833065|65847069|FG003|Overall Study|Trial terminated by sponsor|3|||
23578214|NCT01833065|65847070|FG004|Overall Study|Trial terminated by sponsor|13|||
23578215|NCT01833065|65847066|FG000|Overall Study|Others|2|||
23578216|NCT01833065|65847067|FG001|Overall Study|Others|1|||
23578217|NCT01833065|65847068|FG002|Overall Study|Others|1|||
23578218|NCT01833065|65847069|FG003|Overall Study|Others|1|||
23578219|NCT01833065|65847070|FG004|Overall Study|Others|4|||
23578220|NCT02652130|65847071|FG000|Overall Study|Death|1|||
23578221|NCT01668147|65847072|FG000|Overall Study|Withdrawal by Subject|6|||
23578222|NCT04296942|65847073|FG000|Overall Study|Study closure by sponsor|1|||
23578223|NCT04296942|65847074|FG001|Overall Study|Study closure by sponsor|0|||
23578224|NCT04296942|65847075|FG002|Overall Study|Study closure by sponsor|0|||
23578225|NCT03677375|65847076|FG000|Overall Study|Incomplete procedure|8|||
23578226|NCT03677375|65847076|FG000|Overall Study|Adverse Event|3|||
23578227|NCT03677375|65847076|FG000|Overall Study|Physician Decision|1|||
23578228|NCT02800928|65847077|FG000|Overall Study|Withdrawal by Subject|1|||
23578229|NCT02800928|65847078|FG001|Overall Study|Withdrawal by Subject|1|||
23578230|NCT02800928|65847077|FG000|Overall Study|Protocol Violation|1|||
23578231|NCT02800928|65847078|FG001|Overall Study|Protocol Violation|1|||
23578232|NCT00231179|65847079|FG000|Overall Study|Lost to Follow-up|21|||
23578233|NCT00231179|65847080|FG001|Overall Study|Lost to Follow-up|21|||
23578234|NCT00231179|65847079|FG000|Overall Study|Withdrawal by Subject|3|||
23578235|NCT00231179|65847080|FG001|Overall Study|Withdrawal by Subject|3|||
23578236|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
23578237|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
23578238|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578239|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578240|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578241|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
23777767|NCT02089685|66566909|FG002|Overall Study|Status not recorded|0|||
23777768|NCT02089685|66566910|FG003|Overall Study|Status not recorded|0|||
23777769|NCT02089685|66566911|FG004|Overall Study|Status not recorded|1|||
23777770|NCT02089685|66566912|FG005|Overall Study|Status not recorded|0|||
23777771|NCT02089685|66566907|FG000|Overall Study|Death|0|||
23777772|NCT02089685|66566908|FG001|Overall Study|Death|0|||
23777773|NCT02089685|66566909|FG002|Overall Study|Death|0|||
23777774|NCT02089685|66566910|FG003|Overall Study|Death|7|||
23777775|NCT02089685|66566911|FG004|Overall Study|Death|2|||
23777776|NCT02089685|66566912|FG005|Overall Study|Death|5|||
23777777|NCT02089685|66566907|FG000|Overall Study|Lost to Follow-up|0|||
23777778|NCT02089685|66566908|FG001|Overall Study|Lost to Follow-up|0|||
23777779|NCT02089685|66566909|FG002|Overall Study|Lost to Follow-up|0|||
23777780|NCT02089685|66566910|FG003|Overall Study|Lost to Follow-up|1|||
23777781|NCT02089685|66566911|FG004|Overall Study|Lost to Follow-up|0|||
23777782|NCT02089685|66566912|FG005|Overall Study|Lost to Follow-up|0|||
23777783|NCT02089685|66566907|FG000|Overall Study|Physician Decision|0|||
23777784|NCT02089685|66566908|FG001|Overall Study|Physician Decision|0|||
23777785|NCT02089685|66566909|FG002|Overall Study|Physician Decision|0|||
23777786|NCT02089685|66566910|FG003|Overall Study|Physician Decision|0|||
23777787|NCT02089685|66566911|FG004|Overall Study|Physician Decision|0|||
23777788|NCT02089685|66566912|FG005|Overall Study|Physician Decision|4|||
23777789|NCT02089685|66566907|FG000|Overall Study|Screen failure|1|||
23777790|NCT02089685|66566908|FG001|Overall Study|Screen failure|0|||
23777791|NCT02089685|66566909|FG002|Overall Study|Screen failure|0|||
23450572|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
23777792|NCT02089685|66566910|FG003|Overall Study|Screen failure|0|||
23777793|NCT02089685|66566911|FG004|Overall Study|Screen failure|0|||
23578242|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
23578243|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
23578244|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578245|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578246|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23777794|NCT02089685|66566912|FG005|Overall Study|Screen failure|0|||
23578247|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578248|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
23777795|NCT01604850|66566916|FG000|Overall Study|Enrolled but never treated|0|||
23837455|NCT01129102|66784142|FG000|Overall Study|No study drug treatment|2|||
23837456|NCT01129102|66784143|FG001|Overall Study|No study drug treatment|3|||
23837457|NCT01129102|66784144|FG002|Overall Study|No study drug treatment|1|||
23837458|NCT01129102|66784142|FG000|Overall Study|Withdrawal by Subject|2|||
23450573|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
23450574|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
23450575|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
23777796|NCT01604850|66566917|FG001|Overall Study|Enrolled but never treated|1|||
23777797|NCT01604850|66566916|FG000|Overall Study|Efficacy Failure|50|||
23777798|NCT01604850|66566917|FG001|Overall Study|Efficacy Failure|29|||
23777799|NCT01604850|66566916|FG000|Overall Study|Lost to Follow-up|1|||
23777800|NCT01604850|66566917|FG001|Overall Study|Lost to Follow-up|0|||
23777801|NCT01604850|66566916|FG000|Overall Study|Subject withdrew consent|1|||
23450576|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
23450577|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
23450578|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
23450579|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
23578249|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
23578250|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23777802|NCT01604850|66566917|FG001|Overall Study|Subject withdrew consent|0|||
23777803|NCT00893464|66566920|FG000|Overall Study|Did not complete therapy/experience PD|0|||
23777804|NCT00893464|66566921|FG001|Overall Study|Did not complete therapy/experience PD|0|||
23777805|NCT00893464|66566922|FG002|Overall Study|Did not complete therapy/experience PD|0|||
23777806|NCT00893464|66566923|FG003|Overall Study|Did not complete therapy/experience PD|0|||
23777807|NCT00893464|66566924|FG004|Overall Study|Did not complete therapy/experience PD|0|||
23777808|NCT00893464|66566925|FG005|Overall Study|Did not complete therapy/experience PD|0|||
23837459|NCT01129102|66784143|FG001|Overall Study|Withdrawal by Subject|0|||
23837460|NCT01129102|66784144|FG002|Overall Study|Withdrawal by Subject|3|||
23450580|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
23777809|NCT00893464|66566926|FG006|Overall Study|Did not complete therapy/experience PD|2|||
23837461|NCT01129102|66784142|FG000|Overall Study|Protocol Violation|0|||
23578251|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578252|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578253|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578254|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578255|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
23578256|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578257|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578258|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578259|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578260|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
23578261|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578262|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578263|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578264|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578265|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578266|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
23578267|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
23578268|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578269|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578270|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578271|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578272|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
23578273|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
23578274|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578275|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578276|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578277|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578278|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
23578279|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
23578280|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578281|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578282|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578283|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578284|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
23578285|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
23578286|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
23578287|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
23578288|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
23837462|NCT01129102|66784143|FG001|Overall Study|Protocol Violation|1|||
23578289|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
23578290|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
23578291|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
23578292|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578293|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578294|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578295|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578296|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578297|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578298|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578299|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
23578300|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
23578301|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23837463|NCT01129102|66784144|FG002|Overall Study|Protocol Violation|1|||
23837464|NCT01129102|66784142|FG000|Overall Study|Pregnancy|0|||
23340866|NCT01936181|64992871|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
23578302|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578303|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23837465|NCT01129102|66784143|FG001|Overall Study|Pregnancy|0|||
23837466|NCT01129102|66784144|FG002|Overall Study|Pregnancy|1|||
23837467|NCT01129102|66784142|FG000|Overall Study|Adverse Event|2|||
23837468|NCT01129102|66784143|FG001|Overall Study|Adverse Event|2|||
23837469|NCT01129102|66784144|FG002|Overall Study|Adverse Event|1|||
23837470|NCT01129102|66784142|FG000|Overall Study|Lost to Follow-up|2|||
23837471|NCT01129102|66784143|FG001|Overall Study|Lost to Follow-up|0|||
23837472|NCT01129102|66784144|FG002|Overall Study|Lost to Follow-up|0|||
23837473|NCT02283268|66784145|FG000|Overall Study|Withdrawal by Subject|1|||
23837474|NCT00728468|66784151|FG000|Overall Study|Enrolled but not treated|1|||
23837475|NCT00728468|66784151|FG000|Overall Study|Death|1|||
23837476|NCT00728468|66784151|FG000|Overall Study|Protocol Violation|4|||
23837477|NCT00728468|66784151|FG000|Overall Study|Objective progression or relapse|9|||
23837478|NCT00728468|66784151|FG000|Overall Study|Study terminated by sponsor|1|||
23837479|NCT00356603|66784152|FG000|Overall Study|Other|6|||
23837480|NCT00356603|66784153|FG001|Overall Study|Other|3|||
23837481|NCT02169271|66784156|FG000|Overall Study|Protocol Violation|1|||
23837482|NCT02169271|66784157|FG001|Overall Study|Protocol Violation|2|||
23837483|NCT00492648|66784158|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
23837484|NCT00492648|66784159|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
23837485|NCT02519348|66784161|FG000|Overall Study|Death|31|||
23837486|NCT02519348|66784162|FG001|Overall Study|Death|74|||
23837487|NCT02519348|66784163|FG002|Overall Study|Death|47|||
23837488|NCT02519348|66784164|FG003|Overall Study|Death|54|||
23837489|NCT02519348|66784165|FG004|Overall Study|Death|63|||
23837490|NCT02519348|66784166|FG005|Overall Study|Death|18|||
23837491|NCT02519348|66784167|FG006|Overall Study|Death|2|||
23837492|NCT02519348|66784168|FG007|Overall Study|Death|5|||
23837493|NCT02519348|66784169|FG008|Overall Study|Death|5|||
23837494|NCT02519348|66784161|FG000|Overall Study|Withdrawal by Subject|4|||
23837495|NCT02519348|66784162|FG001|Overall Study|Withdrawal by Subject|7|||
23837496|NCT02519348|66784163|FG002|Overall Study|Withdrawal by Subject|4|||
23837497|NCT02519348|66784164|FG003|Overall Study|Withdrawal by Subject|3|||
23837498|NCT02519348|66784165|FG004|Overall Study|Withdrawal by Subject|3|||
23837499|NCT02519348|66784166|FG005|Overall Study|Withdrawal by Subject|2|||
23837500|NCT02519348|66784167|FG006|Overall Study|Withdrawal by Subject|0|||
23837501|NCT02519348|66784168|FG007|Overall Study|Withdrawal by Subject|0|||
23578304|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
23578305|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578306|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578307|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578308|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578309|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578310|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578311|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578312|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578313|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578314|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
23578315|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
23578316|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
23578317|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
23837502|NCT02519348|66784169|FG008|Overall Study|Withdrawal by Subject|1|||
23837503|NCT02519348|66784161|FG000|Overall Study|Lost to Follow-up|0|||
23837504|NCT02519348|66784162|FG001|Overall Study|Lost to Follow-up|0|||
23837505|NCT02519348|66784163|FG002|Overall Study|Lost to Follow-up|1|||
23837506|NCT02519348|66784164|FG003|Overall Study|Lost to Follow-up|0|||
23837507|NCT02519348|66784165|FG004|Overall Study|Lost to Follow-up|2|||
23837508|NCT02519348|66784166|FG005|Overall Study|Lost to Follow-up|1|||
23837509|NCT02519348|66784167|FG006|Overall Study|Lost to Follow-up|1|||
23837510|NCT02519348|66784168|FG007|Overall Study|Lost to Follow-up|0|||
23837511|NCT02519348|66784169|FG008|Overall Study|Lost to Follow-up|0|||
23837512|NCT02519348|66784161|FG000|Overall Study|Other|0|||
23837513|NCT02519348|66784162|FG001|Overall Study|Other|3|||
23837514|NCT02519348|66784163|FG002|Overall Study|Other|0|||
23837515|NCT02519348|66784164|FG003|Overall Study|Other|0|||
23837516|NCT02519348|66784165|FG004|Overall Study|Other|1|||
23837517|NCT02519348|66784166|FG005|Overall Study|Other|0|||
23837518|NCT02519348|66784167|FG006|Overall Study|Other|0|||
23837519|NCT02519348|66784168|FG007|Overall Study|Other|0|||
23837520|NCT02519348|66784169|FG008|Overall Study|Other|0|||
23837521|NCT02519348|66784161|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
23837522|NCT02519348|66784162|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
23837523|NCT02519348|66784163|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
23837524|NCT02519348|66784164|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
23837525|NCT02519348|66784165|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
23837526|NCT02519348|66784166|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
23837527|NCT02519348|66784167|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
23837528|NCT02519348|66784168|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
23837529|NCT02519348|66784169|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
23837530|NCT01627574|66784170|FG000|Overall Study|Withdrawal by Subject|8|||
23837531|NCT01627574|66784171|FG001|Overall Study|Withdrawal by Subject|5|||
23837532|NCT01627574|66784170|FG000|Overall Study|Lost to Follow-up|13|||
23837533|NCT01627574|66784171|FG001|Overall Study|Lost to Follow-up|13|||
23837534|NCT04134767|66784172|FG000|Overall Study|Death|0|||
23837535|NCT04134767|66784173|FG001|Overall Study|Death|1|||
23837536|NCT04134767|66784172|FG000|Overall Study|Removed for harassing staff|0|||
23578318|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
23578319|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
23578320|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23578321|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23578322|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
23578323|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23837537|NCT04134767|66784173|FG001|Overall Study|Removed for harassing staff|1|||
23837538|NCT04134767|66784172|FG000|Overall Study|Lost to Follow-up|44|||
23837539|NCT04134767|66784173|FG001|Overall Study|Lost to Follow-up|40|||
23837540|NCT03474731|66784177|FG000|Overall Study|Withdrawal by Subject|36|||
23837541|NCT03474731|66784178|FG001|Overall Study|Withdrawal by Subject|29|||
23837542|NCT03474731|66784179|FG002|Overall Study|Withdrawal by Subject|11|||
23837543|NCT03474731|66784180|FG003|Overall Study|Withdrawal by Subject|27|||
23837544|NCT03474731|66784177|FG000|Overall Study|COVID|0|||
23837545|NCT03474731|66784178|FG001|Overall Study|COVID|23|||
23837546|NCT03474731|66784179|FG002|Overall Study|COVID|0|||
23837547|NCT03474731|66784180|FG003|Overall Study|COVID|0|||
23837548|NCT03474731|66784177|FG000|Overall Study|Participant moved from area|1|||
23837549|NCT03474731|66784178|FG001|Overall Study|Participant moved from area|0|||
23837550|NCT03474731|66784179|FG002|Overall Study|Participant moved from area|0|||
23837551|NCT03474731|66784180|FG003|Overall Study|Participant moved from area|0|||
23837552|NCT03474731|66784177|FG000|Overall Study|Lost to Follow-up|11|||
23837553|NCT03474731|66784178|FG001|Overall Study|Lost to Follow-up|3|||
23578324|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
23578325|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
23837554|NCT03474731|66784179|FG002|Overall Study|Lost to Follow-up|18|||
23837555|NCT03474731|66784180|FG003|Overall Study|Lost to Follow-up|17|||
23837556|NCT03474731|66784177|FG000|Overall Study|Death|0|||
23837557|NCT03474731|66784178|FG001|Overall Study|Death|1|||
23837558|NCT03474731|66784179|FG002|Overall Study|Death|0|||
23837559|NCT03474731|66784180|FG003|Overall Study|Death|0|||
23837560|NCT03474731|66784177|FG000|Overall Study|Participant Removed|0|||
23837561|NCT03474731|66784178|FG001|Overall Study|Participant Removed|0|||
23837562|NCT03474731|66784179|FG002|Overall Study|Participant Removed|0|||
23837563|NCT03474731|66784180|FG003|Overall Study|Participant Removed|1|||
23837564|NCT02504827|66784181|FG000|Overall Study|Could not produce sputum|1|||
23837565|NCT03806933|66784182|FG000|Main Period|Physician Decision|0|||
23837566|NCT03806933|66784183|FG001|Main Period|Physician Decision|0|||
23837567|NCT03806933|66784184|FG002|Main Period|Physician Decision|0|||
23837568|NCT03806933|66784185|FG003|Main Period|Physician Decision|1|||
23837569|NCT03806933|66784182|FG000|Main Period|Pregnancy|0|||
23578326|NCT02056119|65847090|FG000|Overall Study|Death|1|||
23837570|NCT03806933|66784183|FG001|Main Period|Pregnancy|0|||
23837571|NCT03806933|66784184|FG002|Main Period|Pregnancy|1|||
23837572|NCT03806933|66784185|FG003|Main Period|Pregnancy|0|||
23837573|NCT03806933|66784182|FG000|Main Period|Withdrawal by Subject|2|||
23837574|NCT03806933|66784183|FG001|Main Period|Withdrawal by Subject|1|||
23837575|NCT03806933|66784184|FG002|Main Period|Withdrawal by Subject|1|||
23837576|NCT03806933|66784185|FG003|Main Period|Withdrawal by Subject|2|||
23837577|NCT03806933|66784182|FG000|Main Period|Lost to Follow-up|2|||
23837578|NCT03806933|66784183|FG001|Main Period|Lost to Follow-up|2|||
23837579|NCT03806933|66784184|FG002|Main Period|Lost to Follow-up|0|||
23837580|NCT03806933|66784185|FG003|Main Period|Lost to Follow-up|0|||
23837581|NCT03806933|66784182|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23837582|NCT03806933|66784183|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23837583|NCT03806933|66784184|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23837584|NCT03806933|66784185|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
23837585|NCT02858583|66784186|FG000|Overall Study|Declined consent|1|||
23837586|NCT02858583|66784187|FG001|Overall Study|Declined consent|1|||
23837587|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
23837588|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837589|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837590|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837591|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
23837592|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23837593|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23837594|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23837595|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
23837596|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23837597|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23837598|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23837599|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
23837600|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837601|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837602|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837603|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
23837604|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837605|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837606|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837607|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
23837608|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837609|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837610|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837611|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
23578327|NCT02056119|65847091|FG001|Overall Study|Death|2|||
23578328|NCT02056119|65847090|FG000|Overall Study|Intubated for less than 24 hrs|2|||
23578329|NCT02056119|65847091|FG001|Overall Study|Intubated for less than 24 hrs|7|||
23578330|NCT02056119|65847090|FG000|Overall Study|No aerosol treatments were given.|3|||
23578331|NCT02056119|65847091|FG001|Overall Study|No aerosol treatments were given.|2|||
23578332|NCT02056119|65847090|FG000|Overall Study|Received Metaneb treatment|0|||
23578333|NCT02056119|65847091|FG001|Overall Study|Received Metaneb treatment|2|||
23837612|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23837613|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23837614|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23837615|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
23837616|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23837617|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23837618|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23837619|NCT00506415|66784190|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
23837620|NCT00506415|66784191|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23837621|NCT00506415|66784192|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23837622|NCT00506415|66784193|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23837623|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
23837624|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
23837625|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
23837626|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
23837627|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
23837628|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
23837629|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
23837630|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
23837631|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
23837632|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
23634380|NCT02071290|66049213|FG000|Overall Study|Withdrawal by Subject|0|||
23578334|NCT02056119|65847090|FG000|Overall Study|Protocol Violation|4|||
23578335|NCT02056119|65847091|FG001|Overall Study|Protocol Violation|7|||
23837633|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
23837634|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
23837635|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
23837636|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
23837637|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
23837638|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
23837639|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
23578336|NCT00051311|65847092|FG000|Overall Study|Starting new study|0|||
23578337|NCT00051311|65847093|FG001|Overall Study|Starting new study|1|||
23578338|NCT00051311|65847092|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
23578339|NCT00051311|65847093|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
23578340|NCT00051311|65847092|FG000|Overall Study|Death of recipient|8|||
23578341|NCT00051311|65847093|FG001|Overall Study|Death of recipient|8|||
23578342|NCT00051311|65847092|FG000|Overall Study|Recipient taken off study|4|||
23578343|NCT00051311|65847093|FG001|Overall Study|Recipient taken off study|4|||
23578344|NCT02162732|65847094|FG000|Overall Study|Biopsy not performed.|18|||
23578345|NCT02696785|65847095|FG000|Blinded Treatment Period|Adverse Event|0|||
23578346|NCT02696785|65847096|FG001|Blinded Treatment Period|Adverse Event|1|||
23578347|NCT02696785|65847097|FG002|Blinded Treatment Period|Adverse Event|3|||
23578348|NCT02696785|65847098|FG003|Blinded Treatment Period|Adverse Event|0|||
23578349|NCT02696785|65847095|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
23578350|NCT02696785|65847096|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
23578351|NCT02696785|65847097|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
23578352|NCT02696785|65847098|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
23578353|NCT02696785|65847095|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
23578354|NCT02696785|65847096|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
23578355|NCT02696785|65847097|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
23578356|NCT02696785|65847098|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
23578357|NCT02696785|65847095|FG000|Blinded Treatment Period|Screen Failure|1|||
23578358|NCT02696785|65847096|FG001|Blinded Treatment Period|Screen Failure|0|||
23578359|NCT02696785|65847097|FG002|Blinded Treatment Period|Screen Failure|0|||
23837640|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
23837641|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
23837642|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
23837643|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
23578360|NCT02696785|65847098|FG003|Blinded Treatment Period|Screen Failure|0|||
23578361|NCT02696785|65847095|FG000|Washout Period|Withdrawal by Subject|0|||
23578362|NCT02696785|65847096|FG001|Washout Period|Withdrawal by Subject|1|||
23578363|NCT02696785|65847097|FG002|Washout Period|Withdrawal by Subject|0|||
23837644|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
23837645|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
23837646|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
23837647|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
23837648|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
23837649|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
23837650|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
23450581|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
23578364|NCT02696785|65847098|FG003|Washout Period|Withdrawal by Subject|0|||
23578365|NCT02696785|65847095|FG000|Washout Period|Lack of Efficacy|0|||
23578366|NCT02696785|65847096|FG001|Washout Period|Lack of Efficacy|1|||
23578367|NCT02696785|65847097|FG002|Washout Period|Lack of Efficacy|0|||
23578368|NCT02696785|65847098|FG003|Washout Period|Lack of Efficacy|0|||
23578369|NCT02696785|65847095|FG000|Extended Treatment Period|Adverse Event|2|||
23837651|NCT00506415|66784190|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23837652|NCT00506415|66784191|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23837653|NCT00506415|66784192|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
23837654|NCT00506415|66784193|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23837655|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23837656|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23837657|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23837658|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
23837659|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837660|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837661|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23837662|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
23837663|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837664|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837665|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23837666|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
23837667|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837668|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837669|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23837670|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
23837671|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23837672|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23578370|NCT02696785|65847096|FG001|Extended Treatment Period|Adverse Event|3|||
23578371|NCT02696785|65847097|FG002|Extended Treatment Period|Adverse Event|2|||
23837673|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23837674|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
23837675|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837676|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837677|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23837678|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
23837679|NCT00506415|66784190|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23837680|NCT00506415|66784191|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23837681|NCT00506415|66784192|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23837682|NCT00506415|66784193|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
23837683|NCT02155283|66784195|FG000|Overall Study|Lost to Follow-up|3|||
23837684|NCT02155283|66784195|FG000|Overall Study|Withdrawal by Subject|1|||
23837685|NCT02155283|66784195|FG000|Overall Study|Protocol Violation|3|||
23837686|NCT03423173|66784198|FG000|Overall Study|Randomized but not vaccinated|1|||
23837687|NCT03423173|66784199|FG001|Overall Study|Randomized but not vaccinated|0|||
23837688|NCT03423173|66784200|FG002|Overall Study|Randomized but not vaccinated|2|||
23837689|NCT03423173|66784201|FG003|Overall Study|Randomized but not vaccinated|1|||
23837690|NCT03423173|66784198|FG000|Overall Study|Adverse Event|1|||
23837691|NCT03423173|66784199|FG001|Overall Study|Adverse Event|1|||
23837692|NCT03423173|66784200|FG002|Overall Study|Adverse Event|1|||
23837693|NCT03423173|66784201|FG003|Overall Study|Adverse Event|1|||
23837694|NCT03423173|66784198|FG000|Overall Study|Lost to Follow-up|10|||
23837695|NCT03423173|66784199|FG001|Overall Study|Lost to Follow-up|19|||
23578372|NCT02696785|65847098|FG003|Extended Treatment Period|Adverse Event|1|||
23578373|NCT02696785|65847095|FG000|Extended Treatment Period|Lack of Efficacy|0|||
23578374|NCT02696785|65847096|FG001|Extended Treatment Period|Lack of Efficacy|1|||
23578375|NCT02696785|65847097|FG002|Extended Treatment Period|Lack of Efficacy|0|||
23578376|NCT02696785|65847098|FG003|Extended Treatment Period|Lack of Efficacy|0|||
23578377|NCT02696785|65847095|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
23578378|NCT02696785|65847096|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
23578379|NCT02696785|65847097|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
23578380|NCT02696785|65847098|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
23578381|NCT02696785|65847095|FG000|Follow-up Period|Adverse Event|0|||
23578382|NCT02696785|65847096|FG001|Follow-up Period|Adverse Event|0|||
23578383|NCT02696785|65847097|FG002|Follow-up Period|Adverse Event|8|||
23578384|NCT02696785|65847098|FG003|Follow-up Period|Adverse Event|2|||
23578385|NCT02696785|65847095|FG000|Follow-up Period|Lost to Follow-up|0|||
23578386|NCT02696785|65847096|FG001|Follow-up Period|Lost to Follow-up|0|||
23578387|NCT02696785|65847097|FG002|Follow-up Period|Lost to Follow-up|0|||
23578388|NCT02696785|65847098|FG003|Follow-up Period|Lost to Follow-up|1|||
23578389|NCT02696785|65847095|FG000|Follow-up Period|Lack of Efficacy|0|||
23578390|NCT02696785|65847096|FG001|Follow-up Period|Lack of Efficacy|0|||
23578391|NCT02696785|65847097|FG002|Follow-up Period|Lack of Efficacy|0|||
23578392|NCT02696785|65847098|FG003|Follow-up Period|Lack of Efficacy|1|||
23777810|NCT00893464|66566927|FG007|Overall Study|Did not complete therapy/experience PD|2|||
23450582|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
23450583|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
23450584|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
23450585|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
23450586|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
23450587|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
23450588|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
23450589|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
23450590|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
23450591|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
23450592|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
23450593|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Other|6|||
23450594|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Other|8|||
23450595|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
23450596|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
23450597|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
23450598|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
23450599|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
23777811|NCT03329027|66566928|FG000|Overall Study|Lost to Follow-up|1|||
23777812|NCT03329027|66566929|FG001|Overall Study|Lost to Follow-up|0|||
23777813|NCT03329027|66566930|FG002|Overall Study|Lost to Follow-up|1|||
23777814|NCT03329027|66566928|FG000|Overall Study|Protocol Violation|9|||
23777815|NCT03329027|66566929|FG001|Overall Study|Protocol Violation|5|||
23450600|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
23450601|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
23450602|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
23450603|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
23450604|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
23450605|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
23450606|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
23450607|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Death|0|||
23450608|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Death|2|||
23450609|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
23450610|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
23450611|NCT00687401|65391579|FG000|Overall Study|Protocol Violation|7|||
23450612|NCT00687401|65391579|FG000|Overall Study|Adverse Event|6|||
23450613|NCT00687401|65391579|FG000|Overall Study|Lack of Efficacy|6|||
23450614|NCT00687401|65391579|FG000|Overall Study|Withdrawal by Subject|4|||
23450615|NCT00687401|65391579|FG000|Overall Study|Did not return for visit|3|||
23450616|NCT00687401|65391579|FG000|Overall Study|For reasons different from those above|4|||
23578393|NCT02696785|65847095|FG000|Follow-up Period|Withdrawal by Subject|1|||
23634381|NCT02071290|66049214|FG001|Overall Study|Withdrawal by Subject|1|||
23777816|NCT03329027|66566930|FG002|Overall Study|Protocol Violation|7|||
23777817|NCT00550537|66566932|FG000|Overall Study|Death|18|||
23777818|NCT00550537|66566932|FG000|Overall Study|Adverse Event|20|||
23777819|NCT00550537|66566932|FG000|Overall Study|Disease progression before|46|||
23777820|NCT00550537|66566932|FG000|Overall Study|Withdrawal by Subject|7|||
23777821|NCT00550537|66566932|FG000|Overall Study|Change in treatment plan|4|||
23777822|NCT00550537|66566932|FG000|Overall Study|Other complicating ilness|3|||
23777823|NCT00550537|66566932|FG000|Overall Study|Declining performance status|2|||
23777824|NCT00550537|66566932|FG000|Overall Study|Treated closer to home|4|||
23777825|NCT00296647|66566933|FG000|Overall Study|Death|4|||
23450617|NCT01903460|65391581|FG000|Overall Study|Adverse Event|0|||
23450618|NCT01903460|65391582|FG001|Overall Study|Adverse Event|0|||
23578394|NCT02696785|65847096|FG001|Follow-up Period|Withdrawal by Subject|0|||
23777826|NCT00296647|66566934|FG001|Overall Study|Death|1|||
23777827|NCT00296647|66566935|FG002|Overall Study|Death|2|||
23777828|NCT00296647|66566936|FG003|Overall Study|Death|1|||
23777829|NCT00296647|66566937|FG004|Overall Study|Death|1|||
23777830|NCT00296647|66566933|FG000|Overall Study|Withdrawal by Subject|28|||
23634382|NCT02071290|66049213|FG000|Overall Study|Protocol Violation|3|||
23450619|NCT01903460|65391583|FG002|Overall Study|Adverse Event|0|||
23450620|NCT01903460|65391584|FG003|Overall Study|Adverse Event|1|||
23450621|NCT00286494|65391585|FG000|Overall Study|Hyperglycemic rescue|12|||
23837696|NCT03423173|66784200|FG002|Overall Study|Lost to Follow-up|17|||
23837697|NCT03423173|66784201|FG003|Overall Study|Lost to Follow-up|22|||
23837698|NCT03423173|66784198|FG000|Overall Study|Withdrawal of consent|4|||
23837699|NCT03423173|66784199|FG001|Overall Study|Withdrawal of consent|10|||
23837700|NCT03423173|66784200|FG002|Overall Study|Withdrawal of consent|4|||
23837701|NCT03423173|66784201|FG003|Overall Study|Withdrawal of consent|5|||
23837702|NCT03423173|66784198|FG000|Overall Study|Death|1|||
23837703|NCT03423173|66784199|FG001|Overall Study|Death|0|||
23837704|NCT03423173|66784200|FG002|Overall Study|Death|0|||
23837705|NCT03423173|66784201|FG003|Overall Study|Death|0|||
23837706|NCT03423173|66784198|FG000|Overall Study|Reason not Specified|2|||
23837707|NCT03423173|66784199|FG001|Overall Study|Reason not Specified|5|||
23837708|NCT03423173|66784200|FG002|Overall Study|Reason not Specified|3|||
23837709|NCT03423173|66784201|FG003|Overall Study|Reason not Specified|1|||
23837710|NCT01326104|66784222|FG000|Overall Study|progressed prior to vaccine|0|||
23837711|NCT01326104|66784223|FG001|Overall Study|progressed prior to vaccine|2|||
23837712|NCT01326104|66784222|FG000|Overall Study|unable to make vaccine|0|||
23837713|NCT01326104|66784223|FG001|Overall Study|unable to make vaccine|2|||
23837714|NCT00630825|66784226|FG000|Overall Study|Adverse Event|4|||
23837715|NCT00630825|66784227|FG001|Overall Study|Adverse Event|4|||
23837716|NCT00630825|66784228|FG002|Overall Study|Adverse Event|3|||
23837717|NCT00630825|66784229|FG003|Overall Study|Adverse Event|1|||
23837718|NCT00630825|66784226|FG000|Overall Study|Entry Criteria Not Met|1|||
23837719|NCT00630825|66784227|FG001|Overall Study|Entry Criteria Not Met|0|||
23837720|NCT00630825|66784228|FG002|Overall Study|Entry Criteria Not Met|2|||
23837721|NCT00630825|66784229|FG003|Overall Study|Entry Criteria Not Met|1|||
23837722|NCT00630825|66784226|FG000|Overall Study|Lost to Follow-up|1|||
23837723|NCT00630825|66784227|FG001|Overall Study|Lost to Follow-up|1|||
23837724|NCT00630825|66784228|FG002|Overall Study|Lost to Follow-up|1|||
23837725|NCT00630825|66784229|FG003|Overall Study|Lost to Follow-up|1|||
23837726|NCT00630825|66784226|FG000|Overall Study|Physician Decision|1|||
23837727|NCT00630825|66784227|FG001|Overall Study|Physician Decision|0|||
23837728|NCT00630825|66784228|FG002|Overall Study|Physician Decision|0|||
23634383|NCT02071290|66049214|FG001|Overall Study|Protocol Violation|5|||
23634384|NCT02071290|66049213|FG000|Overall Study|Physician Decision|0|||
23634385|NCT02071290|66049214|FG001|Overall Study|Physician Decision|1|||
23634386|NCT03149549|66049217|FG000|Study Discontinuation--Treatment Period|Death|0|||
23634387|NCT03149549|66049218|FG001|Study Discontinuation--Treatment Period|Death|0|||
23634388|NCT03149549|66049219|FG002|Study Discontinuation--Treatment Period|Death|0|||
23634389|NCT03149549|66049220|FG003|Study Discontinuation--Treatment Period|Death|1|||
23634390|NCT03149549|66049221|FG004|Study Discontinuation--Treatment Period|Death|2|||
23837729|NCT00630825|66784229|FG003|Overall Study|Physician Decision|0|||
23837730|NCT00630825|66784226|FG000|Overall Study|Withdrawal by Subject|2|||
23837731|NCT00630825|66784227|FG001|Overall Study|Withdrawal by Subject|2|||
23837732|NCT00630825|66784228|FG002|Overall Study|Withdrawal by Subject|2|||
23837733|NCT00630825|66784229|FG003|Overall Study|Withdrawal by Subject|3|||
23837734|NCT01921101|66784230|FG000|Overall Study|Death|16|||
23837735|NCT01921101|66784231|FG001|Overall Study|Death|6|||
23837736|NCT00072280|66784232|FG000|Treatment|Found ineligible|1|||
23837737|NCT00072280|66784233|FG001|Treatment|Found ineligible|2|||
23837738|NCT00072280|66784232|FG000|Follow-up|Early termination of study|2|||
23837739|NCT00072280|66784233|FG001|Follow-up|Early termination of study|2|||
23837740|NCT00791778|66784236|FG000|Double-blind Treatment|Adverse Event|49|||
23837741|NCT00791778|66784237|FG001|Double-blind Treatment|Adverse Event|9|||
23837742|NCT00791778|66784236|FG000|Double-blind Treatment|Physician Decision|6|||
23837743|NCT00791778|66784237|FG001|Double-blind Treatment|Physician Decision|26|||
23837744|NCT00791778|66784236|FG000|Double-blind Treatment|Protocol Violation|0|||
23837745|NCT00791778|66784237|FG001|Double-blind Treatment|Protocol Violation|4|||
23837746|NCT00791778|66784236|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
23837747|NCT00791778|66784237|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
23837748|NCT00791778|66784236|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
23837749|NCT00791778|66784237|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
23837750|NCT00791778|66784236|FG000|Follow-up|Withdrawal by Subject|3|||
23450622|NCT00286494|65391586|FG001|Overall Study|Hyperglycemic rescue|19|||
23634391|NCT03149549|66049222|FG005|Study Discontinuation--Treatment Period|Death|1|||
23837751|NCT00791778|66784237|FG001|Follow-up|Withdrawal by Subject|0|||
23837752|NCT00791778|66784236|FG000|Follow-up|Lost to Follow-up|2|||
23837753|NCT00791778|66784237|FG001|Follow-up|Lost to Follow-up|1|||
23837754|NCT01120184|66784242|FG000|Overall Study|Adverse Event|0|||
23837755|NCT01120184|66784243|FG001|Overall Study|Adverse Event|1|||
23837756|NCT01120184|66784244|FG002|Overall Study|Adverse Event|0|||
23837757|NCT01120184|66784242|FG000|Overall Study|Lost to Follow-up|13|||
23450623|NCT00286494|65391587|FG002|Overall Study|Hyperglycemic rescue|18|||
23450624|NCT00286494|65391585|FG000|Overall Study|Withdrawal by Subject|2|||
23837758|NCT01120184|66784243|FG001|Overall Study|Lost to Follow-up|13|||
23578395|NCT02696785|65847097|FG002|Follow-up Period|Withdrawal by Subject|5|||
23578396|NCT02696785|65847098|FG003|Follow-up Period|Withdrawal by Subject|4|||
23837759|NCT01120184|66784244|FG002|Overall Study|Lost to Follow-up|11|||
23837760|NCT01120184|66784242|FG000|Overall Study|Physician Decision|9|||
23837761|NCT01120184|66784243|FG001|Overall Study|Physician Decision|1|||
23837762|NCT01120184|66784244|FG002|Overall Study|Physician Decision|3|||
23837763|NCT01120184|66784242|FG000|Overall Study|Reason not Specified|8|||
23837764|NCT01120184|66784243|FG001|Overall Study|Reason not Specified|3|||
23837765|NCT01120184|66784244|FG002|Overall Study|Reason not Specified|12|||
23837766|NCT01120184|66784242|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
23837767|NCT01120184|66784243|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
23837768|NCT01120184|66784244|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
23837769|NCT01120184|66784242|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
23837770|NCT01120184|66784243|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
23837771|NCT01120184|66784244|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
23837772|NCT01120184|66784242|FG000|Overall Study|Death|170|||
23837773|NCT01120184|66784243|FG001|Overall Study|Death|176|||
23837774|NCT01120184|66784244|FG002|Overall Study|Death|169|||
23837775|NCT00686829|66784245|FG000|Overall Study|Adverse Event|5|||
23837776|NCT00686829|66784245|FG000|Overall Study|Lack of Efficacy|6|||
23837777|NCT00686829|66784245|FG000|Overall Study|Lost to Follow-up|4|||
23837778|NCT00686829|66784245|FG000|Overall Study|Withdrawal by Subject|14|||
23837779|NCT00686829|66784245|FG000|Overall Study|Protocol Violation|3|||
23837780|NCT00686829|66784245|FG000|Overall Study|Sponsor discontinued VCV|47|||
23837781|NCT01623310|66784250|FG000|Overall Study|Adverse Event|21|||
23578397|NCT01712685|65847102|FG000|Overall Study|pt declined to participate before trmt|1|||
23578398|NCT00506285|65847103|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
23578399|NCT00506285|65847104|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
23578400|NCT00506285|65847103|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
23578401|NCT00506285|65847104|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
23578402|NCT00506285|65847103|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
23578403|NCT00506285|65847104|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
23578404|NCT00506285|65847103|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
23578405|NCT00506285|65847104|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
23578406|NCT00506285|65847103|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
23578407|NCT00506285|65847104|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
23578408|NCT01394991|65847108|FG000|Overall Study|Adverse Event|0|||
23578409|NCT01394991|65847109|FG001|Overall Study|Adverse Event|4|||
23578410|NCT01394991|65847108|FG000|Overall Study|Lack of Efficacy|5|||
23578411|NCT01394991|65847109|FG001|Overall Study|Lack of Efficacy|7|||
23578412|NCT01394991|65847108|FG000|Overall Study|Lost to Follow-up|6|||
23578413|NCT01394991|65847109|FG001|Overall Study|Lost to Follow-up|8|||
23578414|NCT01394991|65847108|FG000|Overall Study|Physician Decision|1|||
23578415|NCT01394991|65847109|FG001|Overall Study|Physician Decision|3|||
23578416|NCT01394991|65847108|FG000|Overall Study|Protocol Violation|1|||
23578417|NCT01394991|65847109|FG001|Overall Study|Protocol Violation|1|||
23578418|NCT01394991|65847108|FG000|Overall Study|Withdrawal by Subject|20|||
23578419|NCT01394991|65847109|FG001|Overall Study|Withdrawal by Subject|17|||
23578420|NCT01394991|65847108|FG000|Overall Study|Chemotherapy Termination|10|||
23578421|NCT01394991|65847109|FG001|Overall Study|Chemotherapy Termination|15|||
23578422|NCT01394991|65847108|FG000|Overall Study|Disease Progression|7|||
23578423|NCT01394991|65847109|FG001|Overall Study|Disease Progression|7|||
23578424|NCT01394991|65847108|FG000|Overall Study|Prematurely Termination of Trial|9|||
23578425|NCT01394991|65847109|FG001|Overall Study|Prematurely Termination of Trial|10|||
23578426|NCT04562779|65847110|FG000|Overall Study|Lost to Follow-up|7|||
23578427|NCT04562779|65847111|FG001|Overall Study|Lost to Follow-up|5|||
23578428|NCT04562779|65847112|FG002|Overall Study|Lost to Follow-up|10|||
23578429|NCT04562779|65847110|FG000|Overall Study|Protocol Violation|2|||
23578430|NCT04562779|65847111|FG001|Overall Study|Protocol Violation|2|||
23578431|NCT04562779|65847112|FG002|Overall Study|Protocol Violation|0|||
23578432|NCT00087490|65847113|FG000|Overall Study|Death|6|||
23578433|NCT00087490|65847114|FG001|Overall Study|Death|4|||
23578434|NCT00087490|65847113|FG000|Overall Study|Adverse Event|3|||
23837782|NCT01623310|66784250|FG000|Overall Study|Lost to Follow-up|18|||
23837783|NCT01623310|66784250|FG000|Overall Study|Lack of Efficacy|6|||
23837784|NCT01623310|66784250|FG000|Overall Study|Protocol Violation|6|||
23578435|NCT00087490|65847114|FG001|Overall Study|Adverse Event|8|||
23578436|NCT00087490|65847113|FG000|Overall Study|Lack of Efficacy|0|||
23578437|NCT00087490|65847114|FG001|Overall Study|Lack of Efficacy|2|||
23578438|NCT00087490|65847113|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
23578439|NCT00087490|65847114|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
23578440|NCT00087490|65847113|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
23578441|NCT00087490|65847114|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
23578442|NCT00087490|65847113|FG000|Overall Study|Randomized but not treated|7|||
23578443|NCT00087490|65847114|FG001|Overall Study|Randomized but not treated|18|||
23777831|NCT00296647|66566934|FG001|Overall Study|Withdrawal by Subject|27|||
23777832|NCT00296647|66566935|FG002|Overall Study|Withdrawal by Subject|32|||
23777833|NCT00296647|66566936|FG003|Overall Study|Withdrawal by Subject|16|||
23777834|NCT00296647|66566937|FG004|Overall Study|Withdrawal by Subject|19|||
23777835|NCT03164772|66566938|FG000|Overall Study|Death|4|||
23777836|NCT03164772|66566939|FG001|Overall Study|Death|2|||
23777837|NCT03164772|66566938|FG000|Overall Study|Adverse Event|1|||
23450625|NCT00286494|65391586|FG001|Overall Study|Withdrawal by Subject|10|||
23450626|NCT00286494|65391587|FG002|Overall Study|Withdrawal by Subject|9|||
23450627|NCT00286494|65391585|FG000|Overall Study|Adverse Event|3|||
23450628|NCT00286494|65391586|FG001|Overall Study|Adverse Event|8|||
23450629|NCT00286494|65391587|FG002|Overall Study|Adverse Event|6|||
23450630|NCT00286494|65391585|FG000|Overall Study|Physician Decision|5|||
23450631|NCT00286494|65391586|FG001|Overall Study|Physician Decision|5|||
23450632|NCT00286494|65391587|FG002|Overall Study|Physician Decision|1|||
23450633|NCT00286494|65391585|FG000|Overall Study|Lost to Follow-up|3|||
23450634|NCT00286494|65391586|FG001|Overall Study|Lost to Follow-up|1|||
23450635|NCT00286494|65391587|FG002|Overall Study|Lost to Follow-up|3|||
23450636|NCT00286494|65391585|FG000|Overall Study|Protocol Violation|1|||
23450637|NCT00286494|65391586|FG001|Overall Study|Protocol Violation|1|||
23450638|NCT00286494|65391587|FG002|Overall Study|Protocol Violation|2|||
23450639|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Progressive disease|50|||
23450640|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Progressive disease|110|||
23450641|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Progressive disease|0|||
23450642|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Progressive disease|0|||
23450643|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23450644|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
23450645|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23450646|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23450647|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Adverse Event|7|||
23450648|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Adverse Event|7|||
23450649|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23450650|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Adverse Event|0|||
23578444|NCT00681811|65847115|FG000|Overall Study|Adverse Event|1|||
23578445|NCT00681811|65847116|FG001|Overall Study|Adverse Event|1|||
23837785|NCT01623310|66784250|FG000|Overall Study|Withdrawal by Subject|25|||
23837786|NCT01623310|66784250|FG000|Overall Study|Became potentially child-bearing|1|||
23578446|NCT00681811|65847115|FG000|Overall Study|Withdrawal by Subject|2|||
23578447|NCT00681811|65847116|FG001|Overall Study|Withdrawal by Subject|2|||
23578448|NCT00681811|65847115|FG000|Overall Study|Non-compliance|0|||
23578449|NCT00681811|65847116|FG001|Overall Study|Non-compliance|1|||
23578450|NCT01101542|65847118|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
23578451|NCT01101542|65847118|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
23777838|NCT03164772|66566939|FG001|Overall Study|Adverse Event|4|||
23777839|NCT03164772|66566938|FG000|Overall Study|Progressive Disease|11|||
23777840|NCT03164772|66566939|FG001|Overall Study|Progressive Disease|21|||
23777841|NCT03164772|66566938|FG000|Overall Study|Physician Decision|2|||
23777842|NCT03164772|66566939|FG001|Overall Study|Physician Decision|0|||
23777843|NCT03164772|66566938|FG000|Overall Study|Withdrawal by Subject|0|||
23777844|NCT03164772|66566939|FG001|Overall Study|Withdrawal by Subject|4|||
23777845|NCT01921062|66566940|FG000|Overall Study|Withdrawal by Subject|0|||
23777846|NCT01921062|66566941|FG001|Overall Study|Withdrawal by Subject|7|||
23777847|NCT01921062|66566940|FG000|Overall Study|Adverse Event|5|||
23837787|NCT01623310|66784250|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
23837788|NCT01623310|66784250|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
23837789|NCT04578457|66784251|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
23837790|NCT04578457|66784251|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
23837791|NCT04578457|66784251|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
23837792|NCT04578457|66784251|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
23837793|NCT00326716|66784257|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
23837794|NCT00326716|66784258|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
23578452|NCT01101542|65847118|FG000|Year 4 Surveillance Period|Other|287|||
23777848|NCT01921062|66566941|FG001|Overall Study|Adverse Event|6|||
23450651|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Other|1|||
23450652|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Other|3|||
23450653|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Other|0|||
23777849|NCT01921062|66566940|FG000|Overall Study|Protocol Violation|0|||
23777850|NCT01921062|66566941|FG001|Overall Study|Protocol Violation|1|||
23777851|NCT01921062|66566940|FG000|Overall Study|VMIQ score > 72|4|||
23777852|NCT01921062|66566941|FG001|Overall Study|VMIQ score > 72|1|||
23450654|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Other|0|||
23578453|NCT01101542|65847118|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
23578454|NCT01101542|65847118|FG000|Year 5 Surveillance Period|Pregnancy|1|||
23578455|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
23837795|NCT00326716|66784259|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
23837796|NCT00326716|66784260|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
23837797|NCT03850496|66784261|FG000|Overall Study|Withdrawal by Subject|1|||
23777853|NCT01921062|66566940|FG000|Overall Study|Logistic error|0|||
23777854|NCT01921062|66566941|FG001|Overall Study|Logistic error|1|||
23777855|NCT00520130|66566946|FG000|Overall Study|Disease progression on study|4|||
23777856|NCT00520130|66566947|FG001|Overall Study|Disease progression on study|0|||
23777857|NCT00520130|66566946|FG000|Overall Study|Physician Decision|1|||
23777858|NCT00520130|66566947|FG001|Overall Study|Physician Decision|1|||
23777859|NCT00416520|66566952|FG000|Open-label Period|Adverse Event|28|||
23777860|NCT00416520|66566953|FG001|Open-label Period|Adverse Event|10|||
23777861|NCT00416520|66566954|FG002|Open-label Period|Adverse Event|0|||
23777862|NCT00416520|66566955|FG003|Open-label Period|Adverse Event|0|||
23777863|NCT00416520|66566952|FG000|Open-label Period|Death|2|||
23777864|NCT00416520|66566953|FG001|Open-label Period|Death|1|||
23837798|NCT03850496|66784262|FG001|Overall Study|Withdrawal by Subject|0|||
23837799|NCT03850496|66784263|FG002|Overall Study|Withdrawal by Subject|0|||
23837800|NCT03850496|66784261|FG000|Overall Study|Lost to Follow-up|0|||
23450655|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Physician Decision|6|||
23450656|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Physician Decision|3|||
23450657|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Physician Decision|0|||
23338799|NCT00594100|64985966|FG000|Procedure|Technical Failure|9|||
23338800|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
23338801|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
23338802|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
23338803|NCT03689374|64985970|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
23338804|NCT03689374|64985971|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
23338805|NCT03689374|64985972|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
23338806|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
23338807|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
23338808|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
23338809|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
23338810|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
23338811|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
23338812|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Death|0|||
23450658|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Physician Decision|0|||
23338813|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Death|11|||
23338814|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Death|1|||
23338815|NCT00688701|64985978|FG000|Overall Study|Adverse Event|1|||
23338816|NCT00688701|64985979|FG001|Overall Study|Adverse Event|0|||
23338817|NCT00688701|64985980|FG002|Overall Study|Adverse Event|5|||
23338818|NCT00688701|64985981|FG003|Overall Study|Adverse Event|3|||
23338819|NCT00688701|64985978|FG000|Overall Study|Lack of Efficacy|0|||
23338820|NCT00688701|64985979|FG001|Overall Study|Lack of Efficacy|1|||
23338821|NCT00688701|64985980|FG002|Overall Study|Lack of Efficacy|0|||
23338822|NCT00688701|64985981|FG003|Overall Study|Lack of Efficacy|0|||
23338823|NCT00688701|64985978|FG000|Overall Study|Withdrawal by Subject|3|||
23338824|NCT00688701|64985979|FG001|Overall Study|Withdrawal by Subject|3|||
23338825|NCT00688701|64985980|FG002|Overall Study|Withdrawal by Subject|4|||
23338826|NCT00688701|64985981|FG003|Overall Study|Withdrawal by Subject|8|||
23338827|NCT00688701|64985978|FG000|Overall Study|Poor compliance to protocol|0|||
23338828|NCT00688701|64985979|FG001|Overall Study|Poor compliance to protocol|1|||
23578456|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Pregnancy|1|||
23777865|NCT00416520|66566954|FG002|Open-label Period|Death|0|||
23777866|NCT00416520|66566955|FG003|Open-label Period|Death|0|||
23777867|NCT00416520|66566952|FG000|Open-label Period|Lack of Efficacy|8|||
23338829|NCT00688701|64985980|FG002|Overall Study|Poor compliance to protocol|1|||
23338830|NCT00688701|64985981|FG003|Overall Study|Poor compliance to protocol|0|||
23338831|NCT00355147|64985985|FG000|Overall Study|Lost to Follow-up|10|||
23338832|NCT00355147|64985986|FG001|Overall Study|Lost to Follow-up|8|||
23338833|NCT00355147|64985985|FG000|Overall Study|Withdrawal by Subject|8|||
23777868|NCT00416520|66566953|FG001|Open-label Period|Lack of Efficacy|1|||
23777869|NCT00416520|66566954|FG002|Open-label Period|Lack of Efficacy|0|||
23777870|NCT00416520|66566955|FG003|Open-label Period|Lack of Efficacy|0|||
23338834|NCT00355147|64985986|FG001|Overall Study|Withdrawal by Subject|12|||
23338835|NCT05113979|64985987|FG000|Overall Study|Death|2|||
23338836|NCT05113979|64985987|FG000|Overall Study|Lost to Follow-up|1|||
23338837|NCT01421225|64985988|FG000|Overall Study|Withdrawal by Subject|0|||
23338838|NCT01421225|64985989|FG001|Overall Study|Withdrawal by Subject|1|||
23338839|NCT02752165|64985995|FG000|Overall Study|Withdrawal by Subject|6|||
23338840|NCT02752165|64985996|FG001|Overall Study|Withdrawal by Subject|6|||
23338841|NCT02752165|64985995|FG000|Overall Study|Protocol Violation|6|||
23338842|NCT02752165|64985996|FG001|Overall Study|Protocol Violation|5|||
23338843|NCT02752165|64985995|FG000|Overall Study|Lost to Follow-up|33|||
23338844|NCT02752165|64985996|FG001|Overall Study|Lost to Follow-up|38|||
23338845|NCT01817582|64985997|FG000|Overall Study|Withdrawal by Subject|0|||
23338846|NCT01817582|64985998|FG001|Overall Study|Withdrawal by Subject|1|||
23450659|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Death|1|||
23450660|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Death|1|||
23450661|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Death|0|||
23338847|NCT01817582|64985999|FG002|Overall Study|Withdrawal by Subject|0|||
23338848|NCT01817582|64985997|FG000|Overall Study|Participant revealed masked treatment|1|||
23338849|NCT01817582|64985998|FG001|Overall Study|Participant revealed masked treatment|0|||
23338850|NCT01817582|64985999|FG002|Overall Study|Participant revealed masked treatment|0|||
23338851|NCT01817582|64985997|FG000|Overall Study|Randomized but exclusion criteria met|1|||
23338852|NCT01817582|64985998|FG001|Overall Study|Randomized but exclusion criteria met|0|||
23338853|NCT01817582|64985999|FG002|Overall Study|Randomized but exclusion criteria met|0|||
23338854|NCT01108341|64986001|FG000|Overall Study|Death|2|||
23338855|NCT01108341|64986001|FG000|Overall Study|Withdrawal by Subject|1|||
23338856|NCT01108341|64986001|FG000|Overall Study|Lost to Follow-up|1|||
23338857|NCT01108341|64986001|FG000|Overall Study|Other|1|||
23338858|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
23338859|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
23338860|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
23338861|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
23338862|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
23338863|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
23338864|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
23338865|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
23338866|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
23338867|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338868|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338869|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338870|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338871|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
23338872|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338873|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338874|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
23338875|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
23450662|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Death|0|||
23450663|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23837801|NCT03850496|66784262|FG001|Overall Study|Lost to Follow-up|1|||
23837802|NCT03850496|66784263|FG002|Overall Study|Lost to Follow-up|4|||
23837803|NCT01704495|66784270|FG000|Subjects Randomized|Other Reason|3|||
23837804|NCT01704495|66784271|FG001|Subjects Randomized|Other Reason|2|||
23837805|NCT01704495|66784272|FG002|Subjects Randomized|Other Reason|3|||
23837806|NCT01704495|66784273|FG003|Subjects Randomized|Other Reason|2|||
23837807|NCT01704495|66784270|FG000|Subjects Randomized|Discontinuation criteria met|4|||
23837808|NCT01704495|66784271|FG001|Subjects Randomized|Discontinuation criteria met|2|||
23837809|NCT01704495|66784272|FG002|Subjects Randomized|Discontinuation criteria met|2|||
23837810|NCT01704495|66784273|FG003|Subjects Randomized|Discontinuation criteria met|0|||
23837811|NCT01704495|66784270|FG000|Subjects Randomized|Adverse Event|8|||
23837812|NCT01704495|66784271|FG001|Subjects Randomized|Adverse Event|2|||
23837813|NCT01704495|66784272|FG002|Subjects Randomized|Adverse Event|0|||
23837814|NCT01704495|66784273|FG003|Subjects Randomized|Adverse Event|7|||
23837815|NCT01704495|66784270|FG000|Subjects Randomized|Withdrawal by Subject|5|||
23837816|NCT01704495|66784271|FG001|Subjects Randomized|Withdrawal by Subject|5|||
23837817|NCT01704495|66784272|FG002|Subjects Randomized|Withdrawal by Subject|5|||
23837818|NCT01704495|66784273|FG003|Subjects Randomized|Withdrawal by Subject|5|||
23837819|NCT01704495|66784270|FG000|Subjects Randomized|Protocol Violation|1|||
23837820|NCT01704495|66784271|FG001|Subjects Randomized|Protocol Violation|1|||
23837821|NCT01704495|66784272|FG002|Subjects Randomized|Protocol Violation|2|||
23837822|NCT01704495|66784273|FG003|Subjects Randomized|Protocol Violation|0|||
23338876|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
23338877|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
23338878|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Death|0|||
23338879|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Death|0|||
23338880|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Death|1|||
23338881|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Death|0|||
23338882|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338883|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338884|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
23338885|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338886|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
23338887|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
23338888|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
23338889|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
23578457|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
23578458|NCT00997243|65847121|FG000|Overall Study|Early termination of study by sponsor|7|||
23578459|NCT01734811|65850197|FG000|Overall Study|Lost to Follow-up|2|||
23578460|NCT01734811|65850198|FG001|Overall Study|Lost to Follow-up|3|||
23578461|NCT01734811|65850197|FG000|Overall Study|Withdrawal by Subject|2|||
23338890|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23338891|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23578462|NCT01734811|65850198|FG001|Overall Study|Withdrawal by Subject|0|||
23578463|NCT01390857|65850199|FG000|Overall Study|Protocol Violation|2|||
23578464|NCT01390857|65850199|FG000|Overall Study|Lost to Follow-up|1|||
23578465|NCT01390857|65850199|FG000|Overall Study|No Visit after the First Visit|7|||
23578466|NCT02068885|65850205|FG000|Overall Study|Withdrew|3|||
23578467|NCT02068885|65850206|FG001|Overall Study|Withdrew|5|||
23578468|NCT02068885|65850207|FG002|Overall Study|Withdrew|8|||
23578469|NCT01118962|65850208|FG000|Overall Study|Adverse Event|2|||
23578470|NCT01118962|65850208|FG000|Overall Study|Lack of Efficacy|1|||
23578471|NCT01118962|65850208|FG000|Overall Study|Protocol Violation|1|||
23578472|NCT01118962|65850208|FG000|Overall Study|Withdrawal by Subject|4|||
23777871|NCT00416520|66566952|FG000|Open-label Period|Protocol Violation|3|||
23777872|NCT00416520|66566953|FG001|Open-label Period|Protocol Violation|3|||
23338892|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
23338893|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23338894|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
23777873|NCT00416520|66566954|FG002|Open-label Period|Protocol Violation|0|||
23777874|NCT00416520|66566955|FG003|Open-label Period|Protocol Violation|0|||
23777875|NCT00416520|66566952|FG000|Open-label Period|Withdrawal by Subject|16|||
23777876|NCT00416520|66566953|FG001|Open-label Period|Withdrawal by Subject|5|||
23777877|NCT00416520|66566954|FG002|Open-label Period|Withdrawal by Subject|0|||
23777878|NCT00416520|66566955|FG003|Open-label Period|Withdrawal by Subject|0|||
23777879|NCT00416520|66566952|FG000|Open-label Period|Other Reasons|3|||
23777880|NCT00416520|66566953|FG001|Open-label Period|Other Reasons|12|||
23777881|NCT00416520|66566954|FG002|Open-label Period|Other Reasons|0|||
23777882|NCT00416520|66566955|FG003|Open-label Period|Other Reasons|0|||
23777883|NCT00416520|66566952|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23777884|NCT00416520|66566953|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23777885|NCT00416520|66566954|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23777886|NCT00416520|66566955|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
23777887|NCT00416520|66566952|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23777888|NCT00416520|66566953|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23777889|NCT00416520|66566954|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23777890|NCT00416520|66566955|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
23777891|NCT00416520|66566952|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
23777892|NCT00416520|66566953|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
23777893|NCT00416520|66566954|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
23777894|NCT00416520|66566955|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
23777895|NCT00274937|66566965|FG000|Overall Study|Physician Decision|10|||
23777896|NCT00274937|66566965|FG000|Overall Study|Withdrawal by Subject|6|||
23777897|NCT00274937|66566965|FG000|Overall Study|Progressive Disease|4|||
23777898|NCT04869787|66566966|FG000|Screening|Physician Decision|1|||
23777899|NCT04869787|66566966|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
23777900|NCT02996682|66566967|FG000|Overall Study|Death|0|||
23777901|NCT02996682|66566968|FG001|Overall Study|Death|3|||
23777902|NCT01029340|66566970|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
23777903|NCT01029340|66566971|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
23777904|NCT01029340|66566972|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
23578473|NCT01118962|65850208|FG000|Overall Study|Pregnancy|1|||
23777905|NCT01029340|66566973|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
23777906|NCT01029340|66566974|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
23777907|NCT01029340|66566975|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
23338895|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
23578474|NCT01118962|65850208|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
23578475|NCT00530777|65850209|FG000|Overall Study|Lost to Follow-up|0|||
23837823|NCT01704495|66784270|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
23837824|NCT01704495|66784271|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
23837825|NCT01704495|66784272|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
23837826|NCT01704495|66784273|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
23837827|NCT01704495|66784270|FG000|Optional Safety Extension|Adverse Event|0|||
23837828|NCT01704495|66784271|FG001|Optional Safety Extension|Adverse Event|4|||
23837829|NCT01704495|66784272|FG002|Optional Safety Extension|Adverse Event|0|||
23837830|NCT01704495|66784273|FG003|Optional Safety Extension|Adverse Event|1|||
23837831|NCT01704495|66784270|FG000|Optional Safety Extension|Other reason|27|||
23837832|NCT01704495|66784271|FG001|Optional Safety Extension|Other reason|29|||
23837833|NCT01704495|66784272|FG002|Optional Safety Extension|Other reason|30|||
23837834|NCT01704495|66784273|FG003|Optional Safety Extension|Other reason|28|||
23837835|NCT01704495|66784270|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
23837836|NCT01704495|66784271|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
23837837|NCT01704495|66784272|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
23837838|NCT01704495|66784273|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
23837839|NCT05253573|66784279|FG000|Overall Study|Death|1|||
23837840|NCT05253573|66784280|FG001|Overall Study|Death|0|||
23837841|NCT00839800|66784285|FG000|Overall Study|Adverse Event|8|||
23837842|NCT00839800|66784286|FG001|Overall Study|Adverse Event|12|||
23837843|NCT00839800|66784285|FG000|Overall Study|Lost to Follow-up|31|||
23837844|NCT00839800|66784286|FG001|Overall Study|Lost to Follow-up|26|||
23837845|NCT00839800|66784285|FG000|Overall Study|Withdrawal by Subject|28|||
23837846|NCT00839800|66784286|FG001|Overall Study|Withdrawal by Subject|34|||
23837847|NCT00839800|66784285|FG000|Overall Study|Incorrect Enrolment|3|||
23837848|NCT00839800|66784286|FG001|Overall Study|Incorrect Enrolment|3|||
23837849|NCT00839800|66784285|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
23837850|NCT00839800|66784286|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
23837851|NCT00839800|66784285|FG000|Overall Study|Safety Reasons|2|||
23837852|NCT00839800|66784286|FG001|Overall Study|Safety Reasons|1|||
23837853|NCT00839800|66784285|FG000|Overall Study|Other|8|||
23837854|NCT00839800|66784286|FG001|Overall Study|Other|14|||
23837855|NCT00839800|66784285|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
23837856|NCT00839800|66784286|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
23837857|NCT02684097|66784290|FG000|Overall Study|Lack of Efficacy|13|||
23837858|NCT02684097|66784291|FG001|Overall Study|Lack of Efficacy|6|||
23837859|NCT01757184|66784294|FG000|Double-blind Period|Adverse Event|1|||
23837860|NCT01757184|66784295|FG001|Double-blind Period|Adverse Event|0|||
23837861|NCT01757184|66784296|FG002|Double-blind Period|Adverse Event|0|||
23837862|NCT01757184|66784297|FG003|Double-blind Period|Adverse Event|0|||
23837863|NCT01757184|66784294|FG000|Open-label Period|Lost to Follow-up|0|||
23837864|NCT01757184|66784295|FG001|Open-label Period|Lost to Follow-up|0|||
23837865|NCT01757184|66784296|FG002|Open-label Period|Lost to Follow-up|2|||
23837866|NCT01757184|66784297|FG003|Open-label Period|Lost to Follow-up|0|||
23837867|NCT01757184|66784294|FG000|Open-label Period|Withdrawal by Subject|0|||
23837868|NCT01757184|66784295|FG001|Open-label Period|Withdrawal by Subject|0|||
23837869|NCT01757184|66784296|FG002|Open-label Period|Withdrawal by Subject|1|||
23837870|NCT01757184|66784297|FG003|Open-label Period|Withdrawal by Subject|1|||
23837871|NCT01757184|66784294|FG000|Open-label Period|Discontinued by Sponsor|0|||
23837872|NCT01757184|66784295|FG001|Open-label Period|Discontinued by Sponsor|0|||
23837873|NCT01757184|66784296|FG002|Open-label Period|Discontinued by Sponsor|1|||
23837874|NCT01757184|66784297|FG003|Open-label Period|Discontinued by Sponsor|2|||
23837875|NCT00593684|66784301|FG000|Overall Study|Death|2|||
23837876|NCT00593684|66784302|FG001|Overall Study|Death|1|||
23837877|NCT06098339|66784305|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
23837878|NCT06098339|66784306|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
23837879|NCT06098339|66784305|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
23837880|NCT06098339|66784306|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
23837881|NCT00026494|66784307|FG000|Overall Study|Withdrawal by Subject|1|||
23837882|NCT00026494|66784308|FG001|Overall Study|Withdrawal by Subject|0|||
23837883|NCT00026494|66784309|FG002|Overall Study|Withdrawal by Subject|1|||
23578476|NCT00530777|65850210|FG001|Overall Study|Lost to Follow-up|1|||
23837884|NCT00026494|66784310|FG003|Overall Study|Withdrawal by Subject|0|||
23837885|NCT00026494|66784307|FG000|Overall Study|Patient non-compliance|1|||
23578477|NCT00530777|65850209|FG000|Overall Study|Death|1|||
23837886|NCT00026494|66784308|FG001|Overall Study|Patient non-compliance|0|||
23837887|NCT00026494|66784309|FG002|Overall Study|Patient non-compliance|0|||
23837888|NCT00026494|66784310|FG003|Overall Study|Patient non-compliance|0|||
23837889|NCT00026494|66784307|FG000|Overall Study|Patient not treated|0|||
23837890|NCT00026494|66784308|FG001|Overall Study|Patient not treated|0|||
23837891|NCT00026494|66784309|FG002|Overall Study|Patient not treated|2|||
23837892|NCT00026494|66784310|FG003|Overall Study|Patient not treated|0|||
23837893|NCT00026494|66784307|FG000|Overall Study|Clinical progression|0|||
23837894|NCT00026494|66784308|FG001|Overall Study|Clinical progression|0|||
23837895|NCT00026494|66784309|FG002|Overall Study|Clinical progression|3|||
23837896|NCT00026494|66784310|FG003|Overall Study|Clinical progression|0|||
23837897|NCT04168112|66784320|FG000|Overall Study|Lost to Follow-up|1|||
23837898|NCT04168112|66784321|FG001|Overall Study|Lost to Follow-up|0|||
23837899|NCT04168112|66784320|FG000|Overall Study|Withdrawal by Subject|1|||
23837900|NCT04168112|66784321|FG001|Overall Study|Withdrawal by Subject|0|||
23837901|NCT02887183|66784322|FG000|Overall Study|Adverse Event|44|||
23837902|NCT02887183|66784322|FG000|Overall Study|Death|30|||
23837903|NCT02887183|66784322|FG000|Overall Study|Pregnancy|1|||
23338896|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
23338897|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
23338898|NCT03053063|64986008|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
23338899|NCT03053063|64986009|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
23837904|NCT02887183|66784322|FG000|Overall Study|Protocol Violation|6|||
23837905|NCT02887183|66784322|FG000|Overall Study|Technical Problems|2|||
23338900|NCT03053063|64986010|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
23338901|NCT03053063|64986011|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
23338902|NCT03053063|64986008|FG000|Randomized Phase|Withdrew consent|8|||
23338903|NCT03053063|64986009|FG001|Randomized Phase|Withdrew consent|11|||
23338904|NCT03053063|64986010|FG002|Randomized Phase|Withdrew consent|5|||
23338905|NCT03053063|64986011|FG003|Randomized Phase|Withdrew consent|0|||
23338906|NCT03053063|64986008|FG000|Randomized Phase|Investigator's Discretion|8|||
23338907|NCT03053063|64986009|FG001|Randomized Phase|Investigator's Discretion|6|||
23338908|NCT03053063|64986010|FG002|Randomized Phase|Investigator's Discretion|2|||
23338909|NCT03053063|64986011|FG003|Randomized Phase|Investigator's Discretion|0|||
23837906|NCT02887183|66784322|FG000|Overall Study|Lost to Follow-up|13|||
23837907|NCT02887183|66784322|FG000|Overall Study|Physician Decision|10|||
23338910|NCT03053063|64986008|FG000|Randomized Phase|Lost to Follow-up|3|||
23338911|NCT03053063|64986009|FG001|Randomized Phase|Lost to Follow-up|5|||
23338912|NCT03053063|64986010|FG002|Randomized Phase|Lost to Follow-up|1|||
23338913|NCT03053063|64986011|FG003|Randomized Phase|Lost to Follow-up|0|||
23338914|NCT03053063|64986008|FG000|Randomized Phase|Adverse Event|0|||
23338915|NCT03053063|64986009|FG001|Randomized Phase|Adverse Event|1|||
23338916|NCT03053063|64986010|FG002|Randomized Phase|Adverse Event|0|||
23338917|NCT03053063|64986011|FG003|Randomized Phase|Adverse Event|0|||
23338918|NCT03053063|64986008|FG000|Randomized Phase|Randomized but Never Treated|1|||
23338919|NCT03053063|64986009|FG001|Randomized Phase|Randomized but Never Treated|3|||
23338920|NCT03053063|64986010|FG002|Randomized Phase|Randomized but Never Treated|2|||
23338921|NCT03053063|64986011|FG003|Randomized Phase|Randomized but Never Treated|0|||
23837908|NCT02887183|66784322|FG000|Overall Study|Withdrawal by Subject|35|||
23837909|NCT00940823|66784323|FG000|Overall Study|Death|8|||
23338922|NCT03053063|64986008|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
23338923|NCT03053063|64986009|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
23338924|NCT03053063|64986010|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
23338925|NCT03053063|64986011|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
23338926|NCT03053063|64986008|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
23338927|NCT03053063|64986009|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
23338928|NCT03053063|64986010|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
23338929|NCT03053063|64986011|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
23338930|NCT03053063|64986008|FG000|Open-Label Phase|Death|0|||
23338931|NCT03053063|64986009|FG001|Open-Label Phase|Death|0|||
23338932|NCT03053063|64986010|FG002|Open-Label Phase|Death|0|||
23338933|NCT03053063|64986011|FG003|Open-Label Phase|Death|2|||
23338934|NCT03053063|64986008|FG000|Open-Label Phase|Investigator's discretion|0|||
23837910|NCT00940823|66784324|FG001|Overall Study|Death|12|||
23837911|NCT00940823|66784323|FG000|Overall Study|Lost to Follow-up|27|||
23837912|NCT00940823|66784324|FG001|Overall Study|Lost to Follow-up|20|||
23837913|NCT05047211|66784325|FG000|Overall Study|Lost to Follow-up|8|||
23837914|NCT05047211|66784326|FG001|Overall Study|Lost to Follow-up|5|||
23837915|NCT03691207|66784327|FG000|Overall Study|Death|41|||
23837916|NCT03691207|66784328|FG001|Overall Study|Death|26|||
23837917|NCT03691207|66784327|FG000|Overall Study|Lost to Follow-up|1|||
23837918|NCT03691207|66784328|FG001|Overall Study|Lost to Follow-up|1|||
23837919|NCT03691207|66784327|FG000|Overall Study|Withdrawal by Subject|2|||
23837920|NCT03691207|66784328|FG001|Overall Study|Withdrawal by Subject|8|||
23837921|NCT03691207|66784327|FG000|Overall Study|Sponsor decision|1|||
23338935|NCT03053063|64986009|FG001|Open-Label Phase|Investigator's discretion|0|||
23578478|NCT00530777|65850210|FG001|Overall Study|Death|2|||
23578479|NCT00530777|65850209|FG000|Overall Study|Physician Decision|1|||
23837922|NCT03691207|66784328|FG001|Overall Study|Sponsor decision|7|||
23837923|NCT00955409|66784329|FG000|Overall Study|Lack of Efficacy|1|||
23837924|NCT00955409|66784330|FG001|Overall Study|Lack of Efficacy|0|||
23837925|NCT00955409|66784331|FG002|Overall Study|Lack of Efficacy|0|||
23837926|NCT00955409|66784332|FG003|Overall Study|Lack of Efficacy|0|||
23338936|NCT03053063|64986010|FG002|Open-Label Phase|Investigator's discretion|0|||
23338937|NCT03053063|64986011|FG003|Open-Label Phase|Investigator's discretion|2|||
23837927|NCT00955409|66784333|FG004|Overall Study|Lack of Efficacy|0|||
23578480|NCT00530777|65850210|FG001|Overall Study|Physician Decision|0|||
23578481|NCT00530777|65850209|FG000|Overall Study|Withdrawal by Subject|0|||
23578482|NCT00530777|65850210|FG001|Overall Study|Withdrawal by Subject|1|||
23578483|NCT00530777|65850209|FG000|Overall Study|Unable to adhere to visit schedule|5|||
23578484|NCT00530777|65850210|FG001|Overall Study|Unable to adhere to visit schedule|1|||
23578485|NCT00764868|65850215|FG000|Overall Study|Adverse Event|18|||
23578486|NCT00764868|65850215|FG000|Overall Study|Withdrawal by Subject|31|||
23578487|NCT00764868|65850215|FG000|Overall Study|Non-compliance|16|||
23578488|NCT00764868|65850215|FG000|Overall Study|Lost to Follow-up|25|||
23578489|NCT00764868|65850215|FG000|Overall Study|Lack of Efficacy|5|||
23578490|NCT00764868|65850215|FG000|Overall Study|Subject moved|7|||
23578491|NCT00764868|65850215|FG000|Overall Study|Pregnancy|3|||
23578492|NCT00764868|65850215|FG000|Overall Study|Prohibited medication|1|||
23578493|NCT00764868|65850215|FG000|Overall Study|Out of town|1|||
23578494|NCT00764868|65850215|FG000|Overall Study|Misuse and compliance of study drug|1|||
23578495|NCT00764868|65850215|FG000|Overall Study|Subject sent to boarding school|1|||
23578496|NCT00764868|65850215|FG000|Overall Study|Met an exclusion criteria|1|||
23578497|NCT00764868|65850215|FG000|Overall Study|Positive drug screen|2|||
23578498|NCT00764868|65850215|FG000|Overall Study|Sponsor requested withdrawal|1|||
23578499|NCT01348854|65850216|FG000|Overall Study|Lost to Follow-up|2|||
23578500|NCT01348854|65850217|FG001|Overall Study|Lost to Follow-up|1|||
23578501|NCT01348854|65850216|FG000|Overall Study|Withdrawal by Subject|1|||
23578502|NCT01348854|65850217|FG001|Overall Study|Withdrawal by Subject|0|||
23578503|NCT00724061|65850218|FG000|Dose Escalation Phase|Adverse Event|2|||
23578504|NCT00724061|65850218|FG000|Dose Escalation Phase|Disease Progression|3|||
23578505|NCT03670602|65850224|FG000|Overall Study|Lost to Follow-up|1|||
23578506|NCT03670602|65850225|FG001|Overall Study|Lost to Follow-up|0|||
23578507|NCT03670602|65850224|FG000|Overall Study|Withdrawal by Subject|0|||
23578508|NCT03670602|65850225|FG001|Overall Study|Withdrawal by Subject|3|||
23578509|NCT01561079|65850227|FG000|Overall Study|Physician Decision|17|||
23578510|NCT01561079|65850227|FG000|Overall Study|Withdrawal by Subject|59|||
23578511|NCT01561079|65850227|FG000|Overall Study|Protocol Violation|2|||
23578512|NCT03424239|65850228|FG000|Overall Study|Withdrawal by Subject|2|||
23777908|NCT01029340|66566970|FG000|Part B Treatment Period|Protocol Violation|0|||
23777909|NCT01029340|66566971|FG001|Part B Treatment Period|Protocol Violation|0|||
23777910|NCT01029340|66566972|FG002|Part B Treatment Period|Protocol Violation|1|||
23338938|NCT02720744|64986022|FG000|Overall Study|Protocol Violation|0|||
23338939|NCT02720744|64986023|FG001|Overall Study|Protocol Violation|2|||
23338940|NCT02720744|64986022|FG000|Overall Study|Pregnancy|2|||
23338941|NCT02720744|64986023|FG001|Overall Study|Pregnancy|0|||
23338942|NCT02720744|64986022|FG000|Overall Study|Lack of Efficacy|2|||
23338943|NCT02720744|64986023|FG001|Overall Study|Lack of Efficacy|8|||
23338944|NCT02720744|64986022|FG000|Overall Study|Adverse Event|21|||
23338945|NCT02720744|64986023|FG001|Overall Study|Adverse Event|3|||
23338946|NCT02720744|64986022|FG000|Overall Study|Withdrawal by Subject|11|||
23338947|NCT02720744|64986023|FG001|Overall Study|Withdrawal by Subject|11|||
23338948|NCT02720744|64986022|FG000|Overall Study|Lost to follow up|2|||
23777911|NCT01029340|66566973|FG003|Part B Treatment Period|Protocol Violation|0|||
23777912|NCT01029340|66566974|FG004|Part B Treatment Period|Protocol Violation|0|||
23777913|NCT01029340|66566975|FG005|Part B Treatment Period|Protocol Violation|0|||
23777914|NCT01029340|66566970|FG000|Extension Period|Adverse Event|0|||
23777915|NCT01029340|66566971|FG001|Extension Period|Adverse Event|0|||
23777916|NCT01029340|66566972|FG002|Extension Period|Adverse Event|0|||
23777917|NCT01029340|66566973|FG003|Extension Period|Adverse Event|0|||
23777918|NCT01029340|66566974|FG004|Extension Period|Adverse Event|0|||
23777919|NCT01029340|66566975|FG005|Extension Period|Adverse Event|1|||
23777920|NCT01029340|66566970|FG000|Extension Period|starting another study|0|||
23777921|NCT01029340|66566971|FG001|Extension Period|starting another study|0|||
23777922|NCT01029340|66566972|FG002|Extension Period|starting another study|0|||
23777923|NCT01029340|66566973|FG003|Extension Period|starting another study|0|||
23777924|NCT01029340|66566974|FG004|Extension Period|starting another study|0|||
23777925|NCT01029340|66566975|FG005|Extension Period|starting another study|8|||
23777926|NCT01029340|66566970|FG000|Extension Period|non-compliance|0|||
23777927|NCT01029340|66566971|FG001|Extension Period|non-compliance|0|||
23338949|NCT02720744|64986023|FG001|Overall Study|Lost to follow up|0|||
23578513|NCT01143077|65850229|FG000|Overall Study|Lack of Efficacy|0|||
23578514|NCT01143077|65850230|FG001|Overall Study|Lack of Efficacy|2|||
23578515|NCT01143077|65850231|FG002|Overall Study|Lack of Efficacy|1|||
23578516|NCT01143077|65850229|FG000|Overall Study|Adverse Event|5|||
23338950|NCT02720744|64986022|FG000|Overall Study|Non Compliance with Investigational Product|0|||
23578517|NCT01143077|65850230|FG001|Overall Study|Adverse Event|6|||
23578518|NCT01143077|65850231|FG002|Overall Study|Adverse Event|5|||
23578519|NCT01143077|65850229|FG000|Overall Study|Lost to Follow-up|2|||
23338951|NCT02720744|64986023|FG001|Overall Study|Non Compliance with Investigational Product|1|||
23338952|NCT02720744|64986022|FG000|Overall Study|Excluded Concomitant Medication|0|||
23777928|NCT01029340|66566972|FG002|Extension Period|non-compliance|0|||
23777929|NCT01029340|66566973|FG003|Extension Period|non-compliance|0|||
23578520|NCT01143077|65850230|FG001|Overall Study|Lost to Follow-up|3|||
23578521|NCT01143077|65850231|FG002|Overall Study|Lost to Follow-up|4|||
23578522|NCT01143077|65850229|FG000|Overall Study|Protocol Violation|2|||
23578523|NCT01143077|65850230|FG001|Overall Study|Protocol Violation|0|||
23578524|NCT01143077|65850231|FG002|Overall Study|Protocol Violation|0|||
23578525|NCT01143077|65850229|FG000|Overall Study|Withdrawal by Subject|4|||
23578526|NCT01143077|65850230|FG001|Overall Study|Withdrawal by Subject|3|||
23578527|NCT01143077|65850231|FG002|Overall Study|Withdrawal by Subject|3|||
23578528|NCT01143077|65850229|FG000|Overall Study|Non-compliance with study drug|0|||
23578529|NCT01143077|65850230|FG001|Overall Study|Non-compliance with study drug|1|||
23837928|NCT00955409|66784334|FG005|Overall Study|Lack of Efficacy|0|||
23837929|NCT00955409|66784335|FG006|Overall Study|Lack of Efficacy|0|||
23837930|NCT00955409|66784336|FG007|Overall Study|Lack of Efficacy|0|||
23837931|NCT00955409|66784337|FG008|Overall Study|Lack of Efficacy|0|||
23837932|NCT00955409|66784338|FG009|Overall Study|Lack of Efficacy|0|||
23837933|NCT00955409|66784329|FG000|Overall Study|Withdrawal by Subject|1|||
23338953|NCT02720744|64986023|FG001|Overall Study|Excluded Concomitant Medication|1|||
23338954|NCT02656290|64986024|FG000|Overall Study|Lost to Follow-up|1|||
23338955|NCT02656290|64986024|FG000|Overall Study|Reintervention|3|||
23338956|NCT03505593|64986025|FG000|Overall Study|Withdrawal by Subject|1|||
23338957|NCT03505593|64986025|FG000|Overall Study|Died before procedure|1|||
23338958|NCT03505593|64986025|FG000|Overall Study|Anatomical abnormality|1|||
23338959|NCT03505593|64986025|FG000|Overall Study|Unable to pass through esophagus|1|||
23338960|NCT03505593|64986025|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
23338961|NCT00721279|64986027|FG000|Overall Study|Lack of Efficacy|6|||
23338962|NCT00721279|64986028|FG001|Overall Study|Lack of Efficacy|3|||
23338963|NCT00721279|64986027|FG000|Overall Study|Tolerability insufficient|5|||
23338964|NCT00721279|64986028|FG001|Overall Study|Tolerability insufficient|2|||
23338965|NCT00721279|64986027|FG000|Overall Study|Withdrawal by Subject|13|||
23578530|NCT01143077|65850231|FG002|Overall Study|Non-compliance with study drug|1|||
23777930|NCT01029340|66566974|FG004|Extension Period|non-compliance|0|||
23777931|NCT01029340|66566975|FG005|Extension Period|non-compliance|1|||
23777932|NCT01029340|66566970|FG000|Extension Period|Withdrawal by Subject|0|||
23777933|NCT01029340|66566971|FG001|Extension Period|Withdrawal by Subject|0|||
23777934|NCT01029340|66566972|FG002|Extension Period|Withdrawal by Subject|0|||
23777935|NCT01029340|66566973|FG003|Extension Period|Withdrawal by Subject|0|||
23777936|NCT01029340|66566974|FG004|Extension Period|Withdrawal by Subject|0|||
23777937|NCT01029340|66566975|FG005|Extension Period|Withdrawal by Subject|1|||
23777938|NCT01029340|66566970|FG000|Extension Period|Physician Decision|0|||
23777939|NCT01029340|66566971|FG001|Extension Period|Physician Decision|0|||
23777940|NCT01029340|66566972|FG002|Extension Period|Physician Decision|0|||
23777941|NCT01029340|66566973|FG003|Extension Period|Physician Decision|0|||
23777942|NCT01029340|66566974|FG004|Extension Period|Physician Decision|0|||
23777943|NCT01029340|66566975|FG005|Extension Period|Physician Decision|1|||
23777944|NCT03929393|66566976|FG000|Overall Study|Death|1|||
23777945|NCT03929393|66566977|FG001|Overall Study|Death|0|||
23777946|NCT03929393|66566976|FG000|Overall Study|Time Commitment|2|||
23777947|NCT03929393|66566977|FG001|Overall Study|Time Commitment|5|||
23777948|NCT03929393|66566976|FG000|Overall Study|Motor Vehicle Accident|0|||
23777949|NCT03929393|66566977|FG001|Overall Study|Motor Vehicle Accident|1|||
23777950|NCT03929393|66566976|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
23777951|NCT03929393|66566977|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
23777952|NCT03929393|66566976|FG000|Overall Study|Other|1|||
23777953|NCT03929393|66566977|FG001|Overall Study|Other|3|||
23777954|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
23777955|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
23777956|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Death|2|||
23777957|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Death|1|||
23777958|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
23777959|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
23777960|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
23777961|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
23777962|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Other|8|||
23777963|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Other|13|||
23777964|NCT01439880|66566980|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
23777965|NCT01439880|66566981|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
23777966|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
23777967|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
23777968|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
23777969|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
23777970|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Death|3|||
23777971|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Death|13|||
23837934|NCT00955409|66784330|FG001|Overall Study|Withdrawal by Subject|0|||
23837935|NCT00955409|66784331|FG002|Overall Study|Withdrawal by Subject|5|||
23837936|NCT00955409|66784332|FG003|Overall Study|Withdrawal by Subject|2|||
23777972|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
23777973|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
23777974|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Other|14|||
23777975|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Other|31|||
23777976|NCT01439880|66566980|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
23777977|NCT01439880|66566981|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
23777978|NCT01118312|66566986|FG000|Overall Study|Lost to Follow-up|33|||
23777979|NCT01118312|66566987|FG001|Overall Study|Lost to Follow-up|32|||
23837937|NCT00955409|66784333|FG004|Overall Study|Withdrawal by Subject|0|||
23837938|NCT00955409|66784334|FG005|Overall Study|Withdrawal by Subject|0|||
23837939|NCT00955409|66784335|FG006|Overall Study|Withdrawal by Subject|2|||
23837940|NCT00955409|66784336|FG007|Overall Study|Withdrawal by Subject|0|||
23837941|NCT00955409|66784337|FG008|Overall Study|Withdrawal by Subject|1|||
23837942|NCT00955409|66784338|FG009|Overall Study|Withdrawal by Subject|0|||
23338966|NCT00721279|64986028|FG001|Overall Study|Withdrawal by Subject|3|||
23338967|NCT00721279|64986027|FG000|Overall Study|Other|12|||
23338968|NCT00721279|64986028|FG001|Overall Study|Other|16|||
23338969|NCT02288091|64986030|FG000|Overall Study|Lost to Follow-up|1|||
23338970|NCT02288091|64986030|FG000|Overall Study|Screen fail|7|||
23338971|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
23338972|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
23338973|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
23338974|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
23450664|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
23837943|NCT00955409|66784329|FG000|Overall Study|Caregiver Request|2|||
23837944|NCT00955409|66784330|FG001|Overall Study|Caregiver Request|0|||
23837945|NCT00955409|66784331|FG002|Overall Study|Caregiver Request|6|||
23837946|NCT00955409|66784332|FG003|Overall Study|Caregiver Request|5|||
23837947|NCT00955409|66784333|FG004|Overall Study|Caregiver Request|0|||
23837948|NCT00955409|66784334|FG005|Overall Study|Caregiver Request|2|||
23837949|NCT00955409|66784335|FG006|Overall Study|Caregiver Request|3|||
23837950|NCT00955409|66784336|FG007|Overall Study|Caregiver Request|1|||
23837951|NCT00955409|66784337|FG008|Overall Study|Caregiver Request|3|||
23837952|NCT00955409|66784338|FG009|Overall Study|Caregiver Request|0|||
23837953|NCT00955409|66784329|FG000|Overall Study|Investigator Request|0|||
23837954|NCT00955409|66784330|FG001|Overall Study|Investigator Request|0|||
23837955|NCT00955409|66784331|FG002|Overall Study|Investigator Request|1|||
23837956|NCT00955409|66784332|FG003|Overall Study|Investigator Request|0|||
23837957|NCT00955409|66784333|FG004|Overall Study|Investigator Request|0|||
23837958|NCT00955409|66784334|FG005|Overall Study|Investigator Request|0|||
23837959|NCT00955409|66784335|FG006|Overall Study|Investigator Request|0|||
23837960|NCT00955409|66784336|FG007|Overall Study|Investigator Request|0|||
23837961|NCT00955409|66784337|FG008|Overall Study|Investigator Request|0|||
23837962|NCT00955409|66784338|FG009|Overall Study|Investigator Request|0|||
23837963|NCT00955409|66784329|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23837964|NCT00955409|66784330|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23837965|NCT00955409|66784331|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23837966|NCT00955409|66784332|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23837967|NCT00955409|66784333|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23837968|NCT00955409|66784334|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23837969|NCT00955409|66784335|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
23837970|NCT00955409|66784336|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
23837971|NCT00955409|66784337|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
23837972|NCT00955409|66784338|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
23837973|NCT00955409|66784329|FG000|Overall Study|Lost to Follow-up|0|||
23837974|NCT00955409|66784330|FG001|Overall Study|Lost to Follow-up|0|||
23837975|NCT00955409|66784331|FG002|Overall Study|Lost to Follow-up|1|||
23837976|NCT00955409|66784332|FG003|Overall Study|Lost to Follow-up|0|||
23837977|NCT00955409|66784333|FG004|Overall Study|Lost to Follow-up|0|||
23837978|NCT00955409|66784334|FG005|Overall Study|Lost to Follow-up|0|||
23450665|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23450666|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23777980|NCT01118312|66566986|FG000|Overall Study|Withdrawal by Subject|1|||
23837979|NCT00955409|66784335|FG006|Overall Study|Lost to Follow-up|1|||
23837980|NCT00955409|66784336|FG007|Overall Study|Lost to Follow-up|0|||
23837981|NCT00955409|66784337|FG008|Overall Study|Lost to Follow-up|0|||
23837982|NCT00955409|66784338|FG009|Overall Study|Lost to Follow-up|0|||
23837983|NCT00955409|66784329|FG000|Overall Study|Failed to Return|2|||
23837984|NCT00955409|66784330|FG001|Overall Study|Failed to Return|0|||
23837985|NCT00955409|66784331|FG002|Overall Study|Failed to Return|0|||
23578531|NCT01143077|65850229|FG000|Overall Study|Administrative|1|||
23578532|NCT01143077|65850230|FG001|Overall Study|Administrative|0|||
23777981|NCT01118312|66566987|FG001|Overall Study|Withdrawal by Subject|3|||
23837986|NCT00955409|66784332|FG003|Overall Study|Failed to Return|0|||
23837987|NCT00955409|66784333|FG004|Overall Study|Failed to Return|0|||
23837988|NCT00955409|66784334|FG005|Overall Study|Failed to Return|0|||
23837989|NCT00955409|66784335|FG006|Overall Study|Failed to Return|0|||
23450667|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
23450668|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
23777982|NCT00448019|66566990|FG000|Overall Study|Withdrawal by Subject|3|||
23777983|NCT00448019|66566990|FG000|Overall Study|Disease progression|1|||
23777984|NCT00448019|66566990|FG000|Overall Study|Death|2|||
23777985|NCT00448019|66566990|FG000|Overall Study|Insurance Issues|1|||
23777986|NCT03567174|66566991|FG000|Overall Study|Death|24|||
23777987|NCT03567174|66566992|FG001|Overall Study|Death|31|||
23777988|NCT03567174|66566991|FG000|Overall Study|Lost to Follow-up|165|||
23777989|NCT03567174|66566992|FG001|Overall Study|Lost to Follow-up|174|||
23777990|NCT03243630|66566993|FG000|Overall Study|Protocol Violation|1|||
23837990|NCT00955409|66784336|FG007|Overall Study|Failed to Return|2|||
23777991|NCT03243630|66566993|FG000|Overall Study|Physician Decision|1|||
23777992|NCT02760368|66566994|FG000|Overall Study|Withdrawal by Subject|8|||
23777993|NCT02760368|66566995|FG001|Overall Study|Withdrawal by Subject|12|||
23777994|NCT02760368|66566996|FG002|Overall Study|Withdrawal by Subject|9|||
23777995|NCT02760368|66566994|FG000|Overall Study|Screen Failure|0|||
23777996|NCT02760368|66566995|FG001|Overall Study|Screen Failure|0|||
23777997|NCT02760368|66566996|FG002|Overall Study|Screen Failure|1|||
23777998|NCT02760368|66566994|FG000|Overall Study|Death|0|||
23777999|NCT02760368|66566995|FG001|Overall Study|Death|1|||
23778000|NCT02760368|66566996|FG002|Overall Study|Death|0|||
23778001|NCT02760368|66566994|FG000|Overall Study|Withdrawal by Sponsor|0|||
23778002|NCT02760368|66566995|FG001|Overall Study|Withdrawal by Sponsor|0|||
23778003|NCT02760368|66566996|FG002|Overall Study|Withdrawal by Sponsor|1|||
23778004|NCT00328926|66566998|FG000|Overall Study|Pregnancy|2|||
23778005|NCT00328926|66566999|FG001|Overall Study|Pregnancy|1|||
23778006|NCT00328926|66567000|FG002|Overall Study|Pregnancy|0|||
23837991|NCT00955409|66784337|FG008|Overall Study|Failed to Return|0|||
23450669|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
23450670|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
23450671|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
23578533|NCT01143077|65850231|FG002|Overall Study|Administrative|0|||
23338975|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
23338976|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
23338977|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
23338978|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
23338979|NCT01895270|64986035|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
23778007|NCT00328926|66566998|FG000|Overall Study|Lost to Follow-up|0|||
23778008|NCT00328926|66566999|FG001|Overall Study|Lost to Follow-up|1|||
23837992|NCT00955409|66784338|FG009|Overall Study|Failed to Return|0|||
23837993|NCT00955409|66784329|FG000|Overall Study|Adverse Event (AE)|2|||
23837994|NCT00955409|66784330|FG001|Overall Study|Adverse Event (AE)|0|||
23837995|NCT00955409|66784331|FG002|Overall Study|Adverse Event (AE)|0|||
23837996|NCT00955409|66784332|FG003|Overall Study|Adverse Event (AE)|0|||
23837997|NCT00955409|66784333|FG004|Overall Study|Adverse Event (AE)|0|||
23837998|NCT00955409|66784334|FG005|Overall Study|Adverse Event (AE)|1|||
23837999|NCT00955409|66784335|FG006|Overall Study|Adverse Event (AE)|2|||
23838000|NCT00955409|66784336|FG007|Overall Study|Adverse Event (AE)|0|||
23838001|NCT00955409|66784337|FG008|Overall Study|Adverse Event (AE)|2|||
23838002|NCT00955409|66784338|FG009|Overall Study|Adverse Event (AE)|0|||
23838003|NCT00955409|66784329|FG000|Overall Study|Reason not Specified|2|||
23838004|NCT00955409|66784330|FG001|Overall Study|Reason not Specified|1|||
23838005|NCT00955409|66784331|FG002|Overall Study|Reason not Specified|13|||
23838006|NCT00955409|66784332|FG003|Overall Study|Reason not Specified|1|||
23838007|NCT00955409|66784333|FG004|Overall Study|Reason not Specified|2|||
23838008|NCT00955409|66784334|FG005|Overall Study|Reason not Specified|0|||
23838009|NCT00955409|66784335|FG006|Overall Study|Reason not Specified|16|||
23838010|NCT00955409|66784336|FG007|Overall Study|Reason not Specified|0|||
23838011|NCT00955409|66784337|FG008|Overall Study|Reason not Specified|8|||
23838012|NCT00955409|66784338|FG009|Overall Study|Reason not Specified|1|||
23838013|NCT00113763|66784339|FG000|Overall Study|Adverse Event|5|||
23450672|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
23578534|NCT01143077|65850229|FG000|Overall Study|Principal Investigator Decision|2|||
23778009|NCT00328926|66567000|FG002|Overall Study|Lost to Follow-up|0|||
23838014|NCT00113763|66784340|FG001|Overall Study|Adverse Event|2|||
23838015|NCT00113763|66784339|FG000|Overall Study|Disease Progression|28|||
23838016|NCT00113763|66784340|FG001|Overall Study|Disease Progression|14|||
23838017|NCT00113763|66784339|FG000|Overall Study|Lost to Follow-up|10|||
23838018|NCT00113763|66784340|FG001|Overall Study|Lost to Follow-up|0|||
23778010|NCT00328926|66566998|FG000|Overall Study|Death|0|||
23778011|NCT00328926|66566999|FG001|Overall Study|Death|0|||
23778012|NCT00328926|66567000|FG002|Overall Study|Death|1|||
23778013|NCT00328926|66566998|FG000|Overall Study|In vitro fertilization treatment|0|||
23838019|NCT00113763|66784339|FG000|Overall Study|Withdrawal by Subject|1|||
23450673|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
23450674|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
23450675|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
23450676|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
23450677|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
23450678|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
23450679|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Other|0|||
23450680|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Other|0|||
23450681|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Other|4|||
23450682|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Other|7|||
23450683|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
23450684|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
23450685|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
23450686|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
23450687|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Death|0|||
23450688|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Death|0|||
23450689|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Death|2|||
23450690|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Death|7|||
23450691|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450692|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450693|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450694|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
23450695|NCT02201524|65391594|FG000|Overall Study|Adverse Event|0|||
23450696|NCT02201524|65391595|FG001|Overall Study|Adverse Event|2|||
23450697|NCT02201524|65391596|FG002|Overall Study|Adverse Event|1|||
23450698|NCT02201524|65391597|FG003|Overall Study|Adverse Event|0|||
23450699|NCT02201524|65391594|FG000|Overall Study|Insufficient clinical response|1|||
23450700|NCT02201524|65391595|FG001|Overall Study|Insufficient clinical response|0|||
23450701|NCT02201524|65391596|FG002|Overall Study|Insufficient clinical response|0|||
23450702|NCT02201524|65391597|FG003|Overall Study|Insufficient clinical response|0|||
23450703|NCT02201524|65391594|FG000|Overall Study|Lost to Follow-up|0|||
23450704|NCT02201524|65391595|FG001|Overall Study|Lost to Follow-up|0|||
23450705|NCT02201524|65391596|FG002|Overall Study|Lost to Follow-up|2|||
23450706|NCT02201524|65391597|FG003|Overall Study|Lost to Follow-up|0|||
23778014|NCT00328926|66566999|FG001|Overall Study|In vitro fertilization treatment|0|||
23778015|NCT00328926|66567000|FG002|Overall Study|In vitro fertilization treatment|1|||
23778016|NCT00328926|66566998|FG000|Overall Study|Lack of ovarian response|0|||
23778017|NCT00328926|66566999|FG001|Overall Study|Lack of ovarian response|1|||
23778018|NCT00328926|66567000|FG002|Overall Study|Lack of ovarian response|0|||
23778019|NCT04567186|66567001|FG000|Period 1|COVID-19 related|1|||
23338980|NCT01895270|64986036|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
23338981|NCT01895270|64986035|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
23338982|NCT01895270|64986036|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
23338983|NCT01895270|64986035|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
23338984|NCT01895270|64986036|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
23778020|NCT04567186|66567002|FG001|Period 1|COVID-19 related|0|||
23778021|NCT04567186|66567001|FG000|Period 1|Protocol Violation|0|||
23338985|NCT03030989|64986040|FG000|Overall Study|Fever|2|||
23778022|NCT04567186|66567002|FG001|Period 1|Protocol Violation|1|||
23778023|NCT04567186|66567001|FG000|Period 1|Adverse Event|0|||
23778024|NCT04567186|66567002|FG001|Period 1|Adverse Event|2|||
23778025|NCT04567186|66567001|FG000|Period 2|COVID-19 Related|0|||
23778026|NCT04567186|66567002|FG001|Period 2|COVID-19 Related|1|||
23778027|NCT04567186|66567001|FG000|Period 2|Protocol Violation|0|||
23778028|NCT04567186|66567002|FG001|Period 2|Protocol Violation|1|||
23778029|NCT04567186|66567001|FG000|Period 2|Lost to Follow-up|0|||
23778030|NCT04567186|66567002|FG001|Period 2|Lost to Follow-up|1|||
23778031|NCT04567186|66567001|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
23778032|NCT04567186|66567002|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
23778033|NCT03699020|66567006|FG000|Overall Study|Withdrawal by Subject|3|||
23778034|NCT03699020|66567007|FG001|Overall Study|Withdrawal by Subject|2|||
23778035|NCT02327130|66567008|FG000|Overall Study|Discharged in less than 5 days|5|||
23778036|NCT02327130|66567008|FG000|Overall Study|Physician Decision|2|||
23778037|NCT02327130|66567008|FG000|Overall Study|Unable to provide breath sample|1|||
23338986|NCT03030989|64986041|FG001|Overall Study|Fever|2|||
23338987|NCT03030989|64986040|FG000|Overall Study|Rash|2|||
23338988|NCT03030989|64986041|FG001|Overall Study|Rash|1|||
23338989|NCT03030989|64986040|FG000|Overall Study|Fatigue/Overwhelmed|1|||
23450707|NCT02201524|65391594|FG000|Overall Study|No longer meets eligibility criteria|0|||
23778038|NCT02327130|66567008|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
23778039|NCT02327130|66567008|FG000|Overall Study|Met exclusion criteria|3|||
23778040|NCT01838941|66567013|FG000|Overall Study|Adverse Event|1|||
23338990|NCT03030989|64986041|FG001|Overall Study|Fatigue/Overwhelmed|5|||
23778041|NCT01838941|66567013|FG000|Overall Study|Withdrawal by Subject|1|||
23338991|NCT03030989|64986040|FG000|Overall Study|Positive Blood Cultures|2|||
23338992|NCT03030989|64986041|FG001|Overall Study|Positive Blood Cultures|1|||
23338993|NCT03030989|64986040|FG000|Overall Study|Line Removed|0|||
23338994|NCT03030989|64986041|FG001|Overall Study|Line Removed|2|||
23338995|NCT03030989|64986040|FG000|Overall Study|No longer interested|5|||
23338996|NCT03030989|64986041|FG001|Overall Study|No longer interested|3|||
23634392|NCT03149549|66049223|FG006|Study Discontinuation--Treatment Period|Death|1|||
23634393|NCT03149549|66049224|FG007|Study Discontinuation--Treatment Period|Death|2|||
23634394|NCT03149549|66049225|FG008|Study Discontinuation--Treatment Period|Death|4|||
23778042|NCT01403194|66567019|FG000|Overall Study|Screen Failure|2|||
23778043|NCT01403194|66567019|FG000|Overall Study|Lost to Follow-up|8|||
23778044|NCT00537030|66567020|FG000|Overall Study|Physician Decision|2|||
23778045|NCT00537030|66567020|FG000|Overall Study|Withdrawal by Subject|2|||
23778046|NCT00537030|66567020|FG000|Overall Study|≥ Grade 2 allergy|7|||
23778047|NCT00537030|66567020|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
23778048|NCT00537030|66567020|FG000|Overall Study|Ineligible|2|||
23778049|NCT00537030|66567020|FG000|Overall Study|Inevaluable|2|||
23778050|NCT01615198|66567021|FG000|Overall Study|Withdrawal by Subject|5|||
23778051|NCT01615198|66567022|FG001|Overall Study|Withdrawal by Subject|5|||
23778052|NCT01615198|66567021|FG000|Overall Study|Protocol deviation|1|||
23778053|NCT01615198|66567022|FG001|Overall Study|Protocol deviation|1|||
23778054|NCT01615198|66567021|FG000|Overall Study|Physician Decision|5|||
23778055|NCT01615198|66567022|FG001|Overall Study|Physician Decision|1|||
23778056|NCT01615198|66567021|FG000|Overall Study|Lost to Follow-up|1|||
23778057|NCT01615198|66567022|FG001|Overall Study|Lost to Follow-up|1|||
23778058|NCT01615198|66567021|FG000|Overall Study|Lack of Efficacy|1|||
23778059|NCT01615198|66567022|FG001|Overall Study|Lack of Efficacy|6|||
23778060|NCT01615198|66567021|FG000|Overall Study|Adverse Event|11|||
23778061|NCT01615198|66567022|FG001|Overall Study|Adverse Event|5|||
23778062|NCT00323882|66567023|FG000|Overall Study|Adverse Event|2|||
23778063|NCT00323882|66567024|FG001|Overall Study|Adverse Event|1|||
23778064|NCT00323882|66567025|FG002|Overall Study|Adverse Event|1|||
23778065|NCT00323882|66567026|FG003|Overall Study|Adverse Event|1|||
23778066|NCT00323882|66567027|FG004|Overall Study|Adverse Event|3|||
23778067|NCT00323882|66567023|FG000|Overall Study|Disease Progression|6|||
23634395|NCT03149549|66049226|FG009|Study Discontinuation--Treatment Period|Death|1|||
23634396|NCT03149549|66049227|FG010|Study Discontinuation--Treatment Period|Death|0|||
23634397|NCT03149549|66049228|FG011|Study Discontinuation--Treatment Period|Death|0|||
23634398|NCT03149549|66049229|FG012|Study Discontinuation--Treatment Period|Death|1|||
23778068|NCT00323882|66567024|FG001|Overall Study|Disease Progression|4|||
23778069|NCT00323882|66567025|FG002|Overall Study|Disease Progression|10|||
23778070|NCT00323882|66567026|FG003|Overall Study|Disease Progression|5|||
23778071|NCT00323882|66567027|FG004|Overall Study|Disease Progression|22|||
23778072|NCT00323882|66567023|FG000|Overall Study|Death|0|||
23778073|NCT00323882|66567024|FG001|Overall Study|Death|1|||
23778074|NCT00323882|66567025|FG002|Overall Study|Death|1|||
23778075|NCT00323882|66567026|FG003|Overall Study|Death|0|||
23778076|NCT00323882|66567027|FG004|Overall Study|Death|5|||
23778077|NCT00323882|66567023|FG000|Overall Study|Lost to Follow-up|0|||
23778078|NCT00323882|66567024|FG001|Overall Study|Lost to Follow-up|0|||
23778079|NCT00323882|66567025|FG002|Overall Study|Lost to Follow-up|1|||
23778080|NCT00323882|66567026|FG003|Overall Study|Lost to Follow-up|0|||
23778081|NCT00323882|66567027|FG004|Overall Study|Lost to Follow-up|1|||
23634399|NCT03149549|66049217|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634400|NCT03149549|66049218|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634401|NCT03149549|66049219|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634402|NCT03149549|66049220|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23778082|NCT00323882|66567023|FG000|Overall Study|Other|0|||
23339009|NCT00281632|64986051|FG000|Overall Study|Adverse Event|7|||
23339010|NCT00281632|64986051|FG000|Overall Study|Withdrawal by Subject|2|||
23339011|NCT00281632|64986051|FG000|Overall Study|Disease Progression|22|||
23339012|NCT00281632|64986051|FG000|Overall Study|Death|1|||
23778083|NCT00323882|66567024|FG001|Overall Study|Other|0|||
23778084|NCT00323882|66567025|FG002|Overall Study|Other|0|||
23778085|NCT00323882|66567026|FG003|Overall Study|Other|1|||
23778086|NCT00323882|66567027|FG004|Overall Study|Other|1|||
23778087|NCT02024932|66567028|FG000|Overall Study|Adverse Event|2|||
23339013|NCT00281632|64986051|FG000|Overall Study|Physician Decision|1|||
23778088|NCT02024932|66567029|FG001|Overall Study|Adverse Event|3|||
23778089|NCT02024932|66567030|FG002|Overall Study|Adverse Event|0|||
23778090|NCT02024932|66567031|FG003|Overall Study|Adverse Event|0|||
23778091|NCT02024932|66567032|FG004|Overall Study|Adverse Event|2|||
23339014|NCT00281632|64986051|FG000|Overall Study|Ongoing|3|||
23778092|NCT02024932|66567033|FG005|Overall Study|Adverse Event|0|||
23778093|NCT02024932|66567028|FG000|Overall Study|Abnormal laboratory value|0|||
23778094|NCT02024932|66567029|FG001|Overall Study|Abnormal laboratory value|0|||
23339015|NCT00319592|64986052|FG000|Overall Study|Protocol Violation|1|||
23778095|NCT02024932|66567030|FG002|Overall Study|Abnormal laboratory value|0|||
23339016|NCT00319592|64986053|FG001|Overall Study|Protocol Violation|0|||
23339017|NCT00319592|64986052|FG000|Overall Study|Physician Decision|0|||
23339018|NCT00319592|64986053|FG001|Overall Study|Physician Decision|1|||
23339019|NCT00968981|64986056|FG000|Overall Study|Adverse Event|2|||
23339020|NCT00968981|64986057|FG001|Overall Study|Adverse Event|0|||
23339021|NCT00968981|64986058|FG002|Overall Study|Adverse Event|0|||
23339022|NCT00968981|64986056|FG000|Overall Study|Disease Progression|14|||
23339023|NCT00968981|64986057|FG001|Overall Study|Disease Progression|16|||
23339024|NCT00968981|64986058|FG002|Overall Study|Disease Progression|13|||
23339025|NCT00968981|64986056|FG000|Overall Study|Lost to Follow-up|0|||
23339026|NCT00968981|64986057|FG001|Overall Study|Lost to Follow-up|0|||
23339027|NCT00968981|64986058|FG002|Overall Study|Lost to Follow-up|1|||
23339028|NCT00968981|64986056|FG000|Overall Study|Physician Decision|5|||
23339029|NCT00968981|64986057|FG001|Overall Study|Physician Decision|3|||
23339030|NCT00968981|64986058|FG002|Overall Study|Physician Decision|5|||
23339031|NCT00968981|64986056|FG000|Overall Study|Withdrawal by Subject|1|||
23339032|NCT00968981|64986057|FG001|Overall Study|Withdrawal by Subject|3|||
23339033|NCT00968981|64986058|FG002|Overall Study|Withdrawal by Subject|3|||
23339034|NCT01273623|64986059|FG000|Overall Study|did not meet IVUS criteria|29|||
23339035|NCT05723328|64986062|FG000|Overall Study|Investigator's Decision|5|||
23339036|NCT05723328|64986063|FG001|Overall Study|Investigator's Decision|2|||
23339041|NCT01190267|64986072|FG000|Overall Study|Adverse Event|10|||
23339042|NCT01190267|64986073|FG001|Overall Study|Adverse Event|0|||
23339043|NCT01190267|64986072|FG000|Overall Study|Treatment Failure|8|||
23634403|NCT03149549|66049221|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634404|NCT03149549|66049222|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634405|NCT03149549|66049223|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634406|NCT03149549|66049224|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
23634407|NCT03149549|66049225|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23838020|NCT00113763|66784340|FG001|Overall Study|Withdrawal by Subject|4|||
23838021|NCT00113763|66784339|FG000|Overall Study|Other|27|||
23838022|NCT00113763|66784340|FG001|Overall Study|Other|6|||
23838023|NCT00113763|66784339|FG000|Overall Study|Non-compliance|1|||
23838024|NCT00113763|66784340|FG001|Overall Study|Non-compliance|0|||
23838025|NCT00113763|66784339|FG000|Overall Study|Ongoing|1|||
23838026|NCT00113763|66784340|FG001|Overall Study|Ongoing|0|||
23838027|NCT01464164|66784344|FG000|Overall Study|Screen failure|0|||
23838028|NCT01464164|66784345|FG001|Overall Study|Screen failure|1|||
23838029|NCT01464164|66784346|FG002|Overall Study|Screen failure|2|||
23838030|NCT01464164|66784347|FG003|Overall Study|Screen failure|0|||
23838031|NCT01464164|66784348|FG004|Overall Study|Screen failure|0|||
23838032|NCT01464164|66784349|FG005|Overall Study|Screen failure|0|||
23339044|NCT01190267|64986073|FG001|Overall Study|Treatment Failure|2|||
23339045|NCT01190267|64986072|FG000|Overall Study|Lost to Follow-up|2|||
23578535|NCT01143077|65850230|FG001|Overall Study|Principal Investigator Decision|0|||
23578536|NCT01143077|65850231|FG002|Overall Study|Principal Investigator Decision|1|||
23578537|NCT01929993|65850232|FG000|Overall Study|Protocol Violation|4|||
23578538|NCT01929993|65850233|FG001|Overall Study|Protocol Violation|6|||
23578539|NCT01929993|65850232|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
23578540|NCT01929993|65850233|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
23578541|NCT01268059|65850234|FG000|Overall Study|Lost to Follow-up|0|||
23578542|NCT01268059|65850235|FG001|Overall Study|Lost to Follow-up|1|||
23578543|NCT01268059|65850236|FG002|Overall Study|Lost to Follow-up|0|||
23578544|NCT01268059|65850237|FG003|Overall Study|Lost to Follow-up|0|||
23578545|NCT01268059|65850234|FG000|Overall Study|Withdrawal by Subject|7|||
23578546|NCT01268059|65850235|FG001|Overall Study|Withdrawal by Subject|4|||
23578547|NCT01268059|65850236|FG002|Overall Study|Withdrawal by Subject|0|||
23578548|NCT01268059|65850237|FG003|Overall Study|Withdrawal by Subject|0|||
23578549|NCT01268059|65850234|FG000|Overall Study|Death|20|||
23578550|NCT01268059|65850235|FG001|Overall Study|Death|30|||
23578551|NCT01268059|65850236|FG002|Overall Study|Death|3|||
23578552|NCT01268059|65850237|FG003|Overall Study|Death|5|||
23578553|NCT01268059|65850234|FG000|Overall Study|Progression of disease|1|||
23578554|NCT01268059|65850235|FG001|Overall Study|Progression of disease|0|||
23838033|NCT01464164|66784350|FG006|Overall Study|Screen failure|0|||
23339046|NCT01190267|64986073|FG001|Overall Study|Lost to Follow-up|0|||
23339047|NCT01190267|64986072|FG000|Overall Study|Withdrawal by Subject|13|||
23578555|NCT01268059|65850236|FG002|Overall Study|Progression of disease|0|||
23578556|NCT01268059|65850237|FG003|Overall Study|Progression of disease|0|||
23578557|NCT00772928|65850239|FG000|Overall Study|Lost to Follow-up|9|||
23838034|NCT01464164|66784344|FG000|Overall Study|Physician Decision|0|||
23838035|NCT01464164|66784345|FG001|Overall Study|Physician Decision|1|||
23578558|NCT00772928|65850240|FG001|Overall Study|Lost to Follow-up|6|||
23339048|NCT01190267|64986073|FG001|Overall Study|Withdrawal by Subject|1|||
23339049|NCT01190267|64986072|FG000|Overall Study|Protocol Violation|8|||
23339050|NCT01190267|64986073|FG001|Overall Study|Protocol Violation|1|||
23339051|NCT04016779|64986074|FG000|Overall Study|Adverse Event|9|||
23339052|NCT04016779|64986075|FG001|Overall Study|Adverse Event|17|||
23339053|NCT04016779|64986074|FG000|Overall Study|Lack of Efficacy|4|||
23339054|NCT04016779|64986075|FG001|Overall Study|Lack of Efficacy|1|||
23339055|NCT04016779|64986074|FG000|Overall Study|Lost to Follow-up|5|||
23339056|NCT04016779|64986075|FG001|Overall Study|Lost to Follow-up|14|||
23339057|NCT04016779|64986074|FG000|Overall Study|Physician Decision|1|||
23339058|NCT04016779|64986075|FG001|Overall Study|Physician Decision|3|||
23339059|NCT04016779|64986074|FG000|Overall Study|Withdrawal by Subject|6|||
23339060|NCT04016779|64986075|FG001|Overall Study|Withdrawal by Subject|8|||
23339061|NCT04016779|64986074|FG000|Overall Study|Non-compliance with Study Drug|2|||
23339062|NCT04016779|64986075|FG001|Overall Study|Non-compliance with Study Drug|3|||
23339063|NCT04016779|64986074|FG000|Overall Study|Other, Multiple categories|17|||
23339064|NCT04016779|64986075|FG001|Overall Study|Other, Multiple categories|17|||
23339065|NCT04484142|64986076|FG000|Overall Study|Adverse Event|13|||
23339066|NCT04484142|64986076|FG000|Overall Study|Progressive Disease|87|||
23339067|NCT04484142|64986076|FG000|Overall Study|Clinical Progression|10|||
23634408|NCT03149549|66049226|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634409|NCT03149549|66049227|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634410|NCT03149549|66049228|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23634411|NCT03149549|66049229|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
23634412|NCT03149549|66049217|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23634413|NCT03149549|66049218|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23634414|NCT03149549|66049219|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23634415|NCT03149549|66049220|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
23634416|NCT03149549|66049221|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23634417|NCT03149549|66049222|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
23634418|NCT03149549|66049223|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23778096|NCT02024932|66567031|FG003|Overall Study|Abnormal laboratory value|2|||
23339068|NCT04484142|64986076|FG000|Overall Study|Withdrawal by Subject|6|||
23578559|NCT00772928|65850239|FG000|Overall Study|Protocol Violation|10|||
23578560|NCT00772928|65850240|FG001|Overall Study|Protocol Violation|12|||
23578561|NCT00772928|65850239|FG000|Overall Study|Withdrawal by Subject|25|||
23778097|NCT02024932|66567032|FG004|Overall Study|Abnormal laboratory value|0|||
23778098|NCT02024932|66567033|FG005|Overall Study|Abnormal laboratory value|0|||
23778099|NCT00933686|66567034|FG000|Overall Study|Protocol Violation|0|||
23778100|NCT00933686|66567035|FG001|Overall Study|Protocol Violation|1|||
23778101|NCT00933686|66567034|FG000|Overall Study|Lost to Follow-up|2|||
23578562|NCT00772928|65850240|FG001|Overall Study|Withdrawal by Subject|22|||
23578563|NCT00772928|65850239|FG000|Overall Study|Did not receive vaccine|0|||
23578564|NCT00772928|65850240|FG001|Overall Study|Did not receive vaccine|1|||
23578565|NCT00811187|65850241|FG000|Overall Study|Unable to place device / procedure abort|3|||
23578566|NCT00811187|65850242|FG001|Overall Study|Unable to place device / procedure abort|3|||
23634419|NCT03149549|66049224|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23634420|NCT03149549|66049225|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23634421|NCT03149549|66049226|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23778102|NCT00933686|66567035|FG001|Overall Study|Lost to Follow-up|2|||
23778103|NCT00933686|66567034|FG000|Overall Study|Withdrawal by Subject|6|||
23778104|NCT00933686|66567035|FG001|Overall Study|Withdrawal by Subject|5|||
23778105|NCT00933686|66567034|FG000|Overall Study|Adverse Event|1|||
23778106|NCT00933686|66567035|FG001|Overall Study|Adverse Event|1|||
23778107|NCT00933686|66567034|FG000|Overall Study|Physician Decision|1|||
23778108|NCT00933686|66567035|FG001|Overall Study|Physician Decision|0|||
23778109|NCT00933686|66567034|FG000|Overall Study|Failure to show up at endpoint visits|0|||
23778110|NCT00933686|66567035|FG001|Overall Study|Failure to show up at endpoint visits|2|||
23778111|NCT01390844|66567036|FG000|Treatment Phase|Adverse Event|12|||
23778112|NCT01390844|66567037|FG001|Treatment Phase|Adverse Event|2|||
23778113|NCT01390844|66567038|FG002|Treatment Phase|Adverse Event|3|||
23778114|NCT01390844|66567039|FG003|Treatment Phase|Adverse Event|2|||
23778115|NCT01390844|66567036|FG000|Treatment Phase|Treatment Failure|23|||
23778116|NCT01390844|66567037|FG001|Treatment Phase|Treatment Failure|25|||
23778117|NCT01390844|66567038|FG002|Treatment Phase|Treatment Failure|10|||
23578567|NCT00224133|65850243|FG000|Overall Study|Adverse Event|93|||
23578568|NCT00224133|65850243|FG000|Overall Study|Protocol Violation|6|||
23578569|NCT00224133|65850243|FG000|Overall Study|Withdrawal by Subject|33|||
23778118|NCT01390844|66567039|FG003|Treatment Phase|Treatment Failure|13|||
23778119|NCT01390844|66567036|FG000|Treatment Phase|Non-Medical Reasons|5|||
23778120|NCT01390844|66567037|FG001|Treatment Phase|Non-Medical Reasons|1|||
23339069|NCT04484142|64986076|FG000|Overall Study|Physician Decision|1|||
23339070|NCT02549287|64986077|FG000|Overall Study|Lost to Follow-up|65|||
23778121|NCT01390844|66567038|FG002|Treatment Phase|Non-Medical Reasons|8|||
23578570|NCT00224133|65850243|FG000|Overall Study|Lack of Efficacy|58|||
23578571|NCT00224133|65850243|FG000|Overall Study|Lost to Follow-up|21|||
23838036|NCT01464164|66784346|FG002|Overall Study|Physician Decision|0|||
23838037|NCT01464164|66784347|FG003|Overall Study|Physician Decision|0|||
23838038|NCT01464164|66784348|FG004|Overall Study|Physician Decision|0|||
23838039|NCT01464164|66784349|FG005|Overall Study|Physician Decision|0|||
23838040|NCT01464164|66784350|FG006|Overall Study|Physician Decision|2|||
23838041|NCT02612623|66784351|FG000|Overall Study|Withdrawal by Subject|0|||
23838042|NCT02612623|66784352|FG001|Overall Study|Withdrawal by Subject|1|||
23838043|NCT02612623|66784353|FG002|Overall Study|Withdrawal by Subject|0|||
23838044|NCT02612623|66784354|FG003|Overall Study|Withdrawal by Subject|0|||
23838045|NCT02612623|66784351|FG000|Overall Study|Adverse Event|1|||
23838046|NCT02612623|66784352|FG001|Overall Study|Adverse Event|0|||
23838047|NCT02612623|66784353|FG002|Overall Study|Adverse Event|1|||
23838048|NCT02612623|66784354|FG003|Overall Study|Adverse Event|0|||
23838049|NCT00552396|66784355|FG000|Overall Study|protocol withdrawal criteria|3|||
23838050|NCT00552396|66784356|FG001|Overall Study|protocol withdrawal criteria|3|||
23838051|NCT00552396|66784357|FG002|Overall Study|protocol withdrawal criteria|3|||
23838052|NCT00552396|66784358|FG003|Overall Study|protocol withdrawal criteria|6|||
23838053|NCT00552396|66784359|FG004|Overall Study|protocol withdrawal criteria|3|||
23578572|NCT00224133|65850243|FG000|Overall Study|Physician Decision|1|||
23578573|NCT00224133|65850243|FG000|Overall Study|Other|14|||
23578574|NCT02065245|65850244|FG000|Infusion 1|Lost to Follow-up|0|||
23578575|NCT02065245|65850245|FG001|Infusion 1|Lost to Follow-up|0|||
23578576|NCT02065245|65850246|FG002|Infusion 1|Lost to Follow-up|0|||
23578577|NCT02065245|65850247|FG003|Infusion 1|Lost to Follow-up|0|||
23578578|NCT02065245|65850248|FG004|Infusion 1|Lost to Follow-up|0|||
23578579|NCT02065245|65850249|FG005|Infusion 1|Lost to Follow-up|0|||
23578580|NCT02065245|65850250|FG006|Infusion 1|Lost to Follow-up|1|||
23578581|NCT02065245|65850244|FG000|Infusion 1|Death|0|||
23578582|NCT02065245|65850245|FG001|Infusion 1|Death|0|||
23578583|NCT02065245|65850246|FG002|Infusion 1|Death|1|||
23578584|NCT02065245|65850247|FG003|Infusion 1|Death|0|||
23578585|NCT02065245|65850248|FG004|Infusion 1|Death|1|||
23578586|NCT02065245|65850249|FG005|Infusion 1|Death|0|||
23578587|NCT02065245|65850250|FG006|Infusion 1|Death|0|||
23578588|NCT02065245|65850244|FG000|Infusion 2|Death|0|||
23578589|NCT02065245|65850245|FG001|Infusion 2|Death|0|||
23578590|NCT02065245|65850246|FG002|Infusion 2|Death|0|||
23578591|NCT02065245|65850247|FG003|Infusion 2|Death|0|||
23578592|NCT02065245|65850248|FG004|Infusion 2|Death|0|||
23578593|NCT02065245|65850249|FG005|Infusion 2|Death|0|||
23578594|NCT02065245|65850250|FG006|Infusion 2|Death|1|||
23578595|NCT02065245|65850244|FG000|Infusion 3|Lost to Follow-up|1|||
23578596|NCT02065245|65850245|FG001|Infusion 3|Lost to Follow-up|1|||
23578597|NCT02065245|65850246|FG002|Infusion 3|Lost to Follow-up|0|||
23578598|NCT02065245|65850247|FG003|Infusion 3|Lost to Follow-up|0|||
23578599|NCT02065245|65850248|FG004|Infusion 3|Lost to Follow-up|0|||
23578600|NCT02065245|65850249|FG005|Infusion 3|Lost to Follow-up|0|||
23578601|NCT02065245|65850250|FG006|Infusion 3|Lost to Follow-up|0|||
23578602|NCT04088409|65850251|FG000|Part A|Withdrawal by Subject|2|||
23578603|NCT04088409|65850252|FG001|Part A|Withdrawal by Subject|1|||
23578604|NCT04088409|65850251|FG000|Part A|Did Not Meet Randomization Criteria|2|||
23578605|NCT04088409|65850252|FG001|Part A|Did Not Meet Randomization Criteria|0|||
23578606|NCT04088409|65850251|FG000|Part A|Lack of Efficacy|9|||
23578607|NCT04088409|65850252|FG001|Part A|Lack of Efficacy|0|||
23578608|NCT04088409|65850251|FG000|Part A|Lost to Follow-up|1|||
23578609|NCT04088409|65850252|FG001|Part A|Lost to Follow-up|0|||
23578610|NCT04088409|65850251|FG000|Part A|Adverse Event|1|||
23578611|NCT04088409|65850252|FG001|Part A|Adverse Event|0|||
23578612|NCT04088409|65850251|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
23578613|NCT04088409|65850252|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
23578614|NCT04088409|65850251|FG000|Part B|Ongoing Treatment|10|||
23578615|NCT04088409|65850252|FG001|Part B|Ongoing Treatment|0|||
23578616|NCT00783718|65850260|FG000|Induction Phase|Adverse Event|4|||
23838054|NCT00552396|66784360|FG005|Overall Study|protocol withdrawal criteria|3|||
23838055|NCT00552396|66784361|FG006|Overall Study|protocol withdrawal criteria|9|||
23838056|NCT02920008|66784362|FG000|Overall Study|Death|117|||
23838057|NCT02920008|66784363|FG001|Overall Study|Death|127|||
23578617|NCT00783718|65850261|FG001|Induction Phase|Adverse Event|0|||
23578618|NCT00783718|65850262|FG002|Induction Phase|Adverse Event|7|||
23578619|NCT00783718|65850263|FG003|Induction Phase|Adverse Event|0|||
23578620|NCT00783718|65850264|FG004|Induction Phase|Adverse Event|0|||
23838058|NCT02920008|66784362|FG000|Overall Study|Withdrawal by Subject|3|||
23578621|NCT00783718|65850265|FG005|Induction Phase|Adverse Event|0|||
23578622|NCT00783718|65850266|FG006|Induction Phase|Adverse Event|0|||
23578623|NCT00783718|65850260|FG000|Induction Phase|Protocol Violation|1|||
23578624|NCT00783718|65850261|FG001|Induction Phase|Protocol Violation|1|||
23578625|NCT00783718|65850262|FG002|Induction Phase|Protocol Violation|6|||
23578626|NCT00783718|65850263|FG003|Induction Phase|Protocol Violation|0|||
23838059|NCT02920008|66784363|FG001|Overall Study|Withdrawal by Subject|6|||
23838060|NCT02920008|66784362|FG000|Overall Study|Lost to Follow-up|0|||
23838061|NCT02920008|66784363|FG001|Overall Study|Lost to Follow-up|1|||
23838062|NCT02518048|66784367|FG000|Overall Study|Withdrawal by Subject|1|||
23838063|NCT03321968|66787665|FG000|Overall Study|Withdrawal by Subject|1|||
23838064|NCT03321968|66787666|FG001|Overall Study|Withdrawal by Subject|2|||
23838065|NCT03321968|66787667|FG002|Overall Study|Withdrawal by Subject|1|||
23838066|NCT03321968|66787665|FG000|Overall Study|Lost to Follow-up|2|||
23838067|NCT03321968|66787666|FG001|Overall Study|Lost to Follow-up|0|||
23838068|NCT03321968|66787667|FG002|Overall Study|Lost to Follow-up|1|||
23838069|NCT03321968|66787665|FG000|Overall Study|Other than specified|0|||
23838070|NCT03321968|66787666|FG001|Overall Study|Other than specified|0|||
23838071|NCT03321968|66787667|FG002|Overall Study|Other than specified|1|||
23838072|NCT03889418|66787669|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
23838073|NCT03889418|66787670|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838074|NCT03889418|66787671|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838075|NCT03889418|66787672|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23578627|NCT00783718|65850264|FG004|Induction Phase|Protocol Violation|0|||
23578628|NCT00783718|65850265|FG005|Induction Phase|Protocol Violation|0|||
23578629|NCT00783718|65850266|FG006|Induction Phase|Protocol Violation|0|||
23578630|NCT00783718|65850260|FG000|Induction Phase|Lack of Efficacy|5|||
23578631|NCT00783718|65850261|FG001|Induction Phase|Lack of Efficacy|2|||
23578632|NCT00783718|65850262|FG002|Induction Phase|Lack of Efficacy|14|||
23578633|NCT00783718|65850263|FG003|Induction Phase|Lack of Efficacy|0|||
23838076|NCT03889418|66787673|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23339071|NCT02549287|64986078|FG001|Overall Study|Lost to Follow-up|26|||
23578634|NCT00783718|65850264|FG004|Induction Phase|Lack of Efficacy|0|||
23838077|NCT03889418|66787674|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838078|NCT03889418|66787675|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838079|NCT03889418|66787676|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838080|NCT03889418|66787677|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838081|NCT03889418|66787678|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23838082|NCT03889418|66787669|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838083|NCT03889418|66787670|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
23838084|NCT03889418|66787671|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
23838085|NCT03889418|66787672|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838086|NCT03889418|66787673|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838087|NCT03889418|66787674|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23339072|NCT02549287|64986077|FG000|Overall Study|Withdrawal by Subject|15|||
23339073|NCT02549287|64986078|FG001|Overall Study|Withdrawal by Subject|6|||
23778122|NCT01390844|66567039|FG003|Treatment Phase|Non-Medical Reasons|1|||
23778123|NCT01390844|66567036|FG000|Treatment Phase|Non-GCP Compliant|0|||
23778124|NCT01390844|66567037|FG001|Treatment Phase|Non-GCP Compliant|0|||
23778125|NCT01390844|66567038|FG002|Treatment Phase|Non-GCP Compliant|10|||
23778126|NCT01390844|66567039|FG003|Treatment Phase|Non-GCP Compliant|3|||
23778127|NCT01390844|66567036|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
23778128|NCT01390844|66567037|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
23778129|NCT01390844|66567038|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
23778130|NCT01390844|66567039|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
23778131|NCT00268905|66567040|FG000|Overall Study|Adverse Event|3|||
23778132|NCT00268905|66567041|FG001|Overall Study|Adverse Event|0|||
23778133|NCT00268905|66567042|FG002|Overall Study|Adverse Event|4|||
23778134|NCT00268905|66567040|FG000|Overall Study|Lost to Follow-up|0|||
23778135|NCT00268905|66567041|FG001|Overall Study|Lost to Follow-up|1|||
23778136|NCT00268905|66567042|FG002|Overall Study|Lost to Follow-up|0|||
23778137|NCT00268905|66567040|FG000|Overall Study|Withdrawal by Subject|0|||
23778138|NCT00268905|66567041|FG001|Overall Study|Withdrawal by Subject|0|||
23778139|NCT00268905|66567042|FG002|Overall Study|Withdrawal by Subject|3|||
23778140|NCT00268905|66567040|FG000|Overall Study|Progressive Disease|28|||
23778141|NCT00268905|66567041|FG001|Overall Study|Progressive Disease|4|||
23778142|NCT00268905|66567042|FG002|Overall Study|Progressive Disease|3|||
23778143|NCT00268905|66567040|FG000|Overall Study|Physician Decision|3|||
23778144|NCT00268905|66567041|FG001|Overall Study|Physician Decision|0|||
23778145|NCT00268905|66567042|FG002|Overall Study|Physician Decision|1|||
23778146|NCT00268905|66567040|FG000|Overall Study|Clinical Progression|9|||
23838088|NCT03889418|66787675|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838089|NCT03889418|66787676|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23578635|NCT00783718|65850265|FG005|Induction Phase|Lack of Efficacy|0|||
23578636|NCT00783718|65850266|FG006|Induction Phase|Lack of Efficacy|0|||
23778147|NCT00268905|66567041|FG001|Overall Study|Clinical Progression|4|||
23778148|NCT00268905|66567042|FG002|Overall Study|Clinical Progression|1|||
23778149|NCT00263588|66567043|FG000|Overall Study|Death|54|||
23778150|NCT00263588|66567044|FG001|Overall Study|Death|90|||
23778151|NCT00263588|66567043|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
23778152|NCT00263588|66567044|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
23778153|NCT00263588|66567043|FG000|Overall Study|Lost to Follow-up|7|||
23838090|NCT03889418|66787677|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838091|NCT03889418|66787678|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23838092|NCT03889418|66787669|FG000|October-December 2019 (Month 7-9)|Death|0|||
23838093|NCT03889418|66787670|FG001|October-December 2019 (Month 7-9)|Death|0|||
23838094|NCT03889418|66787671|FG002|October-December 2019 (Month 7-9)|Death|0|||
23838095|NCT03889418|66787672|FG003|October-December 2019 (Month 7-9)|Death|0|||
23838096|NCT03889418|66787673|FG004|October-December 2019 (Month 7-9)|Death|0|||
23838097|NCT03889418|66787674|FG005|October-December 2019 (Month 7-9)|Death|0|||
23838098|NCT03889418|66787675|FG006|October-December 2019 (Month 7-9)|Death|0|||
23838099|NCT03889418|66787676|FG007|October-December 2019 (Month 7-9)|Death|0|||
23838100|NCT03889418|66787677|FG008|October-December 2019 (Month 7-9)|Death|1|||
23838101|NCT03889418|66787678|FG009|October-December 2019 (Month 7-9)|Death|0|||
23838102|NCT03889418|66787669|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838103|NCT03889418|66787670|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838104|NCT03889418|66787671|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838105|NCT03889418|66787672|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
23838106|NCT03889418|66787673|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838107|NCT03889418|66787674|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838108|NCT03889418|66787675|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838109|NCT03889418|66787676|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
23838110|NCT03889418|66787677|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838111|NCT03889418|66787678|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23838112|NCT03889418|66787669|FG000|April - June 2020 (Month 13-15)|Death|0|||
23838113|NCT03889418|66787670|FG001|April - June 2020 (Month 13-15)|Death|1|||
23838114|NCT03889418|66787671|FG002|April - June 2020 (Month 13-15)|Death|0|||
23838115|NCT03889418|66787672|FG003|April - June 2020 (Month 13-15)|Death|0|||
23838116|NCT03889418|66787673|FG004|April - June 2020 (Month 13-15)|Death|0|||
23838117|NCT03889418|66787674|FG005|April - June 2020 (Month 13-15)|Death|0|||
23838118|NCT03889418|66787675|FG006|April - June 2020 (Month 13-15)|Death|0|||
23838119|NCT03889418|66787676|FG007|April - June 2020 (Month 13-15)|Death|0|||
23838120|NCT03889418|66787677|FG008|April - June 2020 (Month 13-15)|Death|0|||
23838121|NCT03889418|66787678|FG009|April - June 2020 (Month 13-15)|Death|0|||
23838122|NCT03889418|66787669|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838123|NCT03889418|66787670|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838124|NCT03889418|66787671|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838125|NCT03889418|66787672|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
23838126|NCT03889418|66787673|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838127|NCT03889418|66787674|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838128|NCT03889418|66787675|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23578637|NCT00783718|65850260|FG000|Induction Phase|Withdrawal by Subject|3|||
23578638|NCT00783718|65850261|FG001|Induction Phase|Withdrawal by Subject|4|||
23578639|NCT00783718|65850262|FG002|Induction Phase|Withdrawal by Subject|8|||
23578640|NCT00783718|65850263|FG003|Induction Phase|Withdrawal by Subject|0|||
23578641|NCT00783718|65850264|FG004|Induction Phase|Withdrawal by Subject|0|||
23578642|NCT00783718|65850265|FG005|Induction Phase|Withdrawal by Subject|0|||
23578643|NCT00783718|65850266|FG006|Induction Phase|Withdrawal by Subject|0|||
23578644|NCT00783718|65850260|FG000|Induction Phase|Lost to Follow-up|1|||
23578645|NCT00783718|65850261|FG001|Induction Phase|Lost to Follow-up|0|||
23578646|NCT00783718|65850262|FG002|Induction Phase|Lost to Follow-up|1|||
23578647|NCT00783718|65850263|FG003|Induction Phase|Lost to Follow-up|0|||
23578648|NCT00783718|65850264|FG004|Induction Phase|Lost to Follow-up|0|||
23578649|NCT00783718|65850265|FG005|Induction Phase|Lost to Follow-up|0|||
23578650|NCT00783718|65850266|FG006|Induction Phase|Lost to Follow-up|0|||
23578651|NCT00783718|65850260|FG000|Maintenance Phase|Adverse Event|12|||
23578652|NCT00783718|65850261|FG001|Maintenance Phase|Adverse Event|0|||
23578653|NCT00783718|65850262|FG002|Maintenance Phase|Adverse Event|0|||
23578654|NCT00783718|65850263|FG003|Maintenance Phase|Adverse Event|15|||
23578655|NCT00783718|65850264|FG004|Maintenance Phase|Adverse Event|7|||
23578656|NCT00783718|65850265|FG005|Maintenance Phase|Adverse Event|6|||
23634422|NCT03149549|66049227|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23634423|NCT03149549|66049228|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23838129|NCT03889418|66787676|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838130|NCT03889418|66787677|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23838131|NCT03889418|66787678|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23634424|NCT03149549|66049229|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23838132|NCT03889418|66787669|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
23838133|NCT03889418|66787670|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
23838134|NCT03889418|66787671|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
23838135|NCT03889418|66787672|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
23838136|NCT03889418|66787673|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
23838137|NCT03889418|66787674|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
23578657|NCT00783718|65850266|FG006|Maintenance Phase|Adverse Event|16|||
23578658|NCT00783718|65850260|FG000|Maintenance Phase|Protocol Violation|1|||
23578659|NCT00783718|65850261|FG001|Maintenance Phase|Protocol Violation|0|||
23778154|NCT00263588|66567044|FG001|Overall Study|Lost to Follow-up|10|||
23778155|NCT00263588|66567043|FG000|Overall Study|Withdrawal by Subject|3|||
23778156|NCT00263588|66567044|FG001|Overall Study|Withdrawal by Subject|4|||
23778157|NCT00263588|66567043|FG000|Overall Study|Protocol Violation|0|||
23778158|NCT00263588|66567044|FG001|Overall Study|Protocol Violation|1|||
23778159|NCT00263588|66567043|FG000|Overall Study|Investigator decision|7|||
23778160|NCT00263588|66567044|FG001|Overall Study|Investigator decision|15|||
23778161|NCT00263588|66567043|FG000|Overall Study|Sponsor terminated study|0|||
23778162|NCT00263588|66567044|FG001|Overall Study|Sponsor terminated study|1|||
23778163|NCT02414152|66567045|FG000|Overall Study|Withdrawal by Subject|1|||
23778164|NCT02414152|66567045|FG000|Overall Study|Lack of Efficacy|1|||
23778165|NCT00858845|66567046|FG000|Overall Study|Patient underwent heart transplant.|0|||
23778166|NCT00858845|66567047|FG001|Overall Study|Patient underwent heart transplant.|1|||
23778167|NCT00657553|66567051|FG000|Overall Study|low accrual, no analysis run|5|||
23778168|NCT00657553|66567052|FG001|Overall Study|low accrual, no analysis run|5|||
23778169|NCT01215981|66567053|FG000|Overall Study|Physician Decision|0|||
23778170|NCT01215981|66567054|FG001|Overall Study|Physician Decision|1|||
23778171|NCT01215981|66567053|FG000|Overall Study|Protocol Violation|1|||
23778172|NCT01215981|66567054|FG001|Overall Study|Protocol Violation|0|||
23778173|NCT01215981|66567053|FG000|Overall Study|Withdrawal by Subject|1|||
23778174|NCT01215981|66567054|FG001|Overall Study|Withdrawal by Subject|0|||
23778175|NCT00965185|66567058|FG000|Overall Study|Lost to Follow-up|2|||
23778176|NCT00965185|66567059|FG001|Overall Study|Lost to Follow-up|0|||
23778177|NCT00965185|66567058|FG000|Overall Study|Withdrawal by Subject|0|||
23778178|NCT00965185|66567059|FG001|Overall Study|Withdrawal by Subject|1|||
23778179|NCT01602419|66567062|FG000|Overall Study|Not treated with Wilate|9|||
23778180|NCT01602419|66567062|FG000|Overall Study|Adverse Drug Reaction|4|||
23778181|NCT01602419|66567062|FG000|Overall Study|Insurance issues|3|||
23778182|NCT01602419|66567062|FG000|Overall Study|Changed treatment centre|1|||
23778183|NCT01602419|66567062|FG000|Overall Study|Treatment centre closed|1|||
23778184|NCT01602419|66567062|FG000|Overall Study|Withdrawal by Subject|5|||
23778185|NCT01602419|66567062|FG000|Overall Study|Lost to Follow-up|6|||
23778186|NCT00358449|66567068|FG000|Overall Study|Adverse Event|1|||
23778187|NCT00358449|66567069|FG001|Overall Study|Adverse Event|0|||
23778188|NCT00358449|66567070|FG002|Overall Study|Adverse Event|1|||
23778189|NCT00358449|66567068|FG000|Overall Study|Lost to Follow-up|1|||
23778190|NCT00358449|66567069|FG001|Overall Study|Lost to Follow-up|0|||
23778191|NCT00358449|66567070|FG002|Overall Study|Lost to Follow-up|0|||
23778192|NCT00358449|66567068|FG000|Overall Study|Withdrawal by Subject|2|||
23778193|NCT00358449|66567069|FG001|Overall Study|Withdrawal by Subject|0|||
23778194|NCT00358449|66567070|FG002|Overall Study|Withdrawal by Subject|0|||
23778195|NCT00358449|66567068|FG000|Overall Study|Lack of Efficacy|0|||
23778196|NCT00358449|66567069|FG001|Overall Study|Lack of Efficacy|1|||
23778197|NCT00358449|66567070|FG002|Overall Study|Lack of Efficacy|0|||
23778198|NCT00358449|66567068|FG000|Overall Study|Steriod Inhaler was Increased|0|||
23778199|NCT00358449|66567069|FG001|Overall Study|Steriod Inhaler was Increased|0|||
23778200|NCT00358449|66567070|FG002|Overall Study|Steriod Inhaler was Increased|1|||
23778201|NCT00467896|66567071|FG000|Overall Study|Consent Withdrawal|18|||
23778202|NCT00467896|66567071|FG000|Overall Study|Adverse Event|7|||
23778203|NCT00467896|66567071|FG000|Overall Study|Serious Adverse Event|13|||
23778204|NCT00467896|66567071|FG000|Overall Study|Non-compliance|3|||
23778205|NCT00467896|66567071|FG000|Overall Study|Changed therapy|2|||
23778206|NCT00467896|66567071|FG000|Overall Study|Patient received transplant|2|||
23778207|NCT00467896|66567071|FG000|Overall Study|Patient had atrial septostomy|1|||
23778208|NCT00467896|66567071|FG000|Overall Study|Patient weaned off iloprost|1|||
23778209|NCT00467896|66567071|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
23778210|NCT00467896|66567071|FG000|Overall Study|Started intravenous prostacyclin|1|||
23778211|NCT00467896|66567071|FG000|Overall Study|Started inhaled Remodulin|1|||
23778212|NCT00467896|66567071|FG000|Overall Study|Patient had no improvement|1|||
23778213|NCT01313273|66567072|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
23778214|NCT01313273|66567073|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
23778215|NCT01313273|66567072|FG000|Overall Study|Withdrawal by Subject|1|||
23778216|NCT01313273|66567073|FG001|Overall Study|Withdrawal by Subject|0|||
23778217|NCT01313273|66567072|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
23578660|NCT00783718|65850262|FG002|Maintenance Phase|Protocol Violation|0|||
23578661|NCT00783718|65850263|FG003|Maintenance Phase|Protocol Violation|0|||
23578662|NCT00783718|65850264|FG004|Maintenance Phase|Protocol Violation|0|||
23578663|NCT00783718|65850265|FG005|Maintenance Phase|Protocol Violation|0|||
23578664|NCT00783718|65850266|FG006|Maintenance Phase|Protocol Violation|2|||
23578665|NCT00783718|65850260|FG000|Maintenance Phase|Lack of Efficacy|83|||
23778218|NCT01313273|66567073|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
23778219|NCT03195491|66567075|FG000|Overall Study|Study drug toxicity|25|||
23578666|NCT00783718|65850261|FG001|Maintenance Phase|Lack of Efficacy|0|||
23578667|NCT00783718|65850262|FG002|Maintenance Phase|Lack of Efficacy|0|||
23838138|NCT03889418|66787675|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
23838139|NCT03889418|66787676|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
23838140|NCT03889418|66787677|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
23838141|NCT03889418|66787678|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
23838142|NCT03889418|66787669|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23838143|NCT03889418|66787670|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
23838144|NCT03889418|66787671|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
23838145|NCT03889418|66787672|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
23838146|NCT03889418|66787673|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23838147|NCT03889418|66787674|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23838148|NCT03889418|66787675|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23838149|NCT03889418|66787676|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
23838150|NCT03889418|66787677|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23838151|NCT03889418|66787678|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
23838152|NCT01931475|66787679|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
23838153|NCT01931475|66787680|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
23838154|NCT01931475|66787679|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
23838155|NCT01931475|66787680|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
23838156|NCT01931475|66787679|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
23838157|NCT01931475|66787680|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
23838158|NCT01931475|66787679|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
23838159|NCT01931475|66787680|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
23838160|NCT01931475|66787679|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
23838161|NCT01931475|66787680|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
23838162|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
23838163|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
23838164|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
23838165|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
23838166|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
23838167|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
23838168|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
23838169|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
23838170|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
23838171|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
23838172|NCT01931475|66787679|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
23838173|NCT01931475|66787680|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
23838174|NCT05107492|66787682|FG000|Overall Study|Lost to Follow-up|1|||
23838175|NCT05107492|66787683|FG001|Overall Study|Lost to Follow-up|0|||
23838176|NCT04177095|66787686|FG000|Overall Study|Withdrawal by Subject|3|||
23838177|NCT04177095|66787686|FG000|Overall Study|Screen Failure|3|||
23838178|NCT04177095|66787686|FG000|Overall Study|Problems with the Trugraf assay|1|||
23838179|NCT00410813|66787687|FG000|Overall Study|Adverse Event|6|||
23838180|NCT00410813|66787688|FG001|Overall Study|Adverse Event|11|||
23838181|NCT00410813|66787687|FG000|Overall Study|Progression|32|||
23838182|NCT00410813|66787688|FG001|Overall Study|Progression|21|||
23838183|NCT00410813|66787687|FG000|Overall Study|Not protocol specified|3|||
23838184|NCT00410813|66787688|FG001|Overall Study|Not protocol specified|4|||
23838185|NCT00410813|66787687|FG000|Overall Study|Ineligible|2|||
23838186|NCT00410813|66787688|FG001|Overall Study|Ineligible|4|||
23838187|NCT00410813|66787687|FG000|Overall Study|Death|0|||
23838188|NCT00410813|66787688|FG001|Overall Study|Death|2|||
23838189|NCT00333983|66787689|FG000|Overall Study|Lost to Follow-up|2|||
23838190|NCT00333983|66787690|FG001|Overall Study|Lost to Follow-up|1|||
23838191|NCT00333983|66787691|FG002|Overall Study|Lost to Follow-up|0|||
23838192|NCT00333983|66787689|FG000|Overall Study|Adverse Event|1|||
23838193|NCT00333983|66787690|FG001|Overall Study|Adverse Event|1|||
23838194|NCT00333983|66787691|FG002|Overall Study|Adverse Event|1|||
23838195|NCT00333983|66787689|FG000|Overall Study|Withdrawal by Subject|0|||
23838196|NCT00333983|66787690|FG001|Overall Study|Withdrawal by Subject|3|||
23838197|NCT00333983|66787691|FG002|Overall Study|Withdrawal by Subject|1|||
23838198|NCT00582608|66787692|FG000|Overall Study|Not Treated|7|||
23838199|NCT00582608|66787692|FG000|Overall Study|Patient Ineligible|1|||
23838200|NCT00582608|66787692|FG000|Overall Study|Lack of accrual|4|||
23838201|NCT01732640|66787693|FG000|Overall Study|Adverse Event|0|||
23838202|NCT01732640|66787694|FG001|Overall Study|Adverse Event|1|||
23838203|NCT01732640|66787693|FG000|Overall Study|Death|0|||
23339075|NCT03843541|64986083|FG000|Overall Study|Adverse Event|4|||
23838204|NCT01732640|66787694|FG001|Overall Study|Death|1|||
23838205|NCT01372995|66787695|FG000|Overall Study|Spouse withdrew participant from study|0|||
23838206|NCT01372995|66787696|FG001|Overall Study|Spouse withdrew participant from study|1|||
23838207|NCT01372995|66787697|FG002|Overall Study|Spouse withdrew participant from study|0|||
23838208|NCT01372995|66787695|FG000|Overall Study|Physician Decision|0|||
23838209|NCT01372995|66787696|FG001|Overall Study|Physician Decision|0|||
23339076|NCT03843541|64986084|FG001|Overall Study|Adverse Event|2|||
23339077|NCT03843541|64986085|FG002|Overall Study|Adverse Event|3|||
23339078|NCT03843541|64986083|FG000|Overall Study|Death|1|||
23339079|NCT03843541|64986084|FG001|Overall Study|Death|0|||
23339080|NCT03843541|64986085|FG002|Overall Study|Death|0|||
23339081|NCT03843541|64986083|FG000|Overall Study|Lack of adherence to study medication|0|||
23339082|NCT03843541|64986084|FG001|Overall Study|Lack of adherence to study medication|0|||
23339083|NCT03843541|64986085|FG002|Overall Study|Lack of adherence to study medication|1|||
23339084|NCT03843541|64986083|FG000|Overall Study|Physician Decision|1|||
23838210|NCT01372995|66787697|FG002|Overall Study|Physician Decision|1|||
23339085|NCT03843541|64986084|FG001|Overall Study|Physician Decision|2|||
23339086|NCT03843541|64986085|FG002|Overall Study|Physician Decision|2|||
23450708|NCT02201524|65391595|FG001|Overall Study|No longer meets eligibility criteria|0|||
23450709|NCT02201524|65391596|FG002|Overall Study|No longer meets eligibility criteria|0|||
23838211|NCT02729051|66787702|FG000|Overall Study|Adverse Event|21|||
23838212|NCT02729051|66787703|FG001|Overall Study|Adverse Event|11|||
23838213|NCT02729051|66787702|FG000|Overall Study|Lack of Efficacy|1|||
23838214|NCT02729051|66787703|FG001|Overall Study|Lack of Efficacy|1|||
23838215|NCT02729051|66787702|FG000|Overall Study|Lost to Follow-up|1|||
23838216|NCT02729051|66787703|FG001|Overall Study|Lost to Follow-up|2|||
23838217|NCT02729051|66787702|FG000|Overall Study|Physician Decision|1|||
23838218|NCT02729051|66787703|FG001|Overall Study|Physician Decision|1|||
23838219|NCT02729051|66787702|FG000|Overall Study|Withdrawal by Subject|6|||
23838220|NCT02729051|66787703|FG001|Overall Study|Withdrawal by Subject|17|||
23838221|NCT04112043|66787707|FG000|Overall Study|Withdrawal by Subject|1|||
23838222|NCT04112043|66787708|FG001|Overall Study|Withdrawal by Subject|1|||
23838223|NCT04112043|66787709|FG002|Overall Study|Withdrawal by Subject|1|||
23838224|NCT04112043|66787707|FG000|Overall Study|Taking NR supplement|1|||
23838225|NCT04112043|66787708|FG001|Overall Study|Taking NR supplement|0|||
23838226|NCT04112043|66787709|FG002|Overall Study|Taking NR supplement|0|||
23838227|NCT04112043|66787707|FG000|Overall Study|Adverse Event|0|||
23838228|NCT04112043|66787708|FG001|Overall Study|Adverse Event|1|||
23838229|NCT04112043|66787709|FG002|Overall Study|Adverse Event|0|||
23838230|NCT01996254|66787710|FG000|Overall Study|Change in Eligibility|0|||
23838231|NCT01996254|66787711|FG001|Overall Study|Change in Eligibility|2|||
23838232|NCT01996254|66787712|FG002|Overall Study|Change in Eligibility|0|||
23838233|NCT01996254|66787710|FG000|Overall Study|Withdrawal by Subject|0|||
23838234|NCT01996254|66787711|FG001|Overall Study|Withdrawal by Subject|3|||
23339087|NCT03843541|64986083|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
23339088|NCT03843541|64986084|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
23339089|NCT03843541|64986085|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
23450710|NCT02201524|65391597|FG003|Overall Study|No longer meets eligibility criteria|2|||
23450711|NCT02201524|65391594|FG000|Overall Study|Protocol Violation|0|||
23450712|NCT02201524|65391595|FG001|Overall Study|Protocol Violation|0|||
23450713|NCT02201524|65391596|FG002|Overall Study|Protocol Violation|0|||
23450714|NCT02201524|65391597|FG003|Overall Study|Protocol Violation|1|||
23450715|NCT02201524|65391594|FG000|Overall Study|Withdrawal by Subject|0|||
23450716|NCT02201524|65391595|FG001|Overall Study|Withdrawal by Subject|0|||
23450717|NCT02201524|65391596|FG002|Overall Study|Withdrawal by Subject|1|||
23450718|NCT02201524|65391597|FG003|Overall Study|Withdrawal by Subject|1|||
23450719|NCT02201524|65391594|FG000|Overall Study|Other|1|||
23450720|NCT02201524|65391595|FG001|Overall Study|Other|1|||
23450721|NCT02201524|65391596|FG002|Overall Study|Other|0|||
23450722|NCT02201524|65391597|FG003|Overall Study|Other|0|||
23450723|NCT01721161|65391598|FG000|Overall Study|Adverse Event|2|||
23450724|NCT01721161|65391599|FG001|Overall Study|Adverse Event|3|||
23450725|NCT01721161|65391598|FG000|Overall Study|Lost to Follow-up|1|||
23450726|NCT01721161|65391599|FG001|Overall Study|Lost to Follow-up|2|||
23450727|NCT01721161|65391598|FG000|Overall Study|Withdrawal by Subject|1|||
23450728|NCT01721161|65391599|FG001|Overall Study|Withdrawal by Subject|1|||
23450729|NCT01721161|65391598|FG000|Overall Study|Other|0|||
23450730|NCT01721161|65391599|FG001|Overall Study|Other|1|||
23453640|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
23453641|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
23453642|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453643|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23339090|NCT03843541|64986083|FG000|Overall Study|Withdrawal by Subject|6|||
23453644|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453645|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23838235|NCT01996254|66787712|FG002|Overall Study|Withdrawal by Subject|4|||
23838236|NCT01996254|66787710|FG000|Overall Study|Lost to Follow-up|1|||
23838237|NCT01996254|66787711|FG001|Overall Study|Lost to Follow-up|0|||
23838238|NCT01996254|66787712|FG002|Overall Study|Lost to Follow-up|4|||
23838239|NCT03693612|66787718|FG000|Overall Study|Lost to Follow-up|0|||
23450731|NCT00757237|65394984|FG000|Overall Study|Lost to Follow-up|0|||
23838240|NCT03693612|66787719|FG001|Overall Study|Lost to Follow-up|0|||
23838241|NCT03693612|66787720|FG002|Overall Study|Lost to Follow-up|0|||
23838242|NCT03693612|66787721|FG003|Overall Study|Lost to Follow-up|0|||
23838243|NCT03693612|66787722|FG004|Overall Study|Lost to Follow-up|1|||
23838244|NCT03693612|66787723|FG005|Overall Study|Lost to Follow-up|0|||
23838245|NCT03693612|66787724|FG006|Overall Study|Lost to Follow-up|0|||
23838246|NCT03693612|66787718|FG000|Overall Study|Withdrawal by Subject|0|||
23838247|NCT03693612|66787719|FG001|Overall Study|Withdrawal by Subject|0|||
23838248|NCT03693612|66787720|FG002|Overall Study|Withdrawal by Subject|1|||
23450732|NCT00757237|65394985|FG001|Overall Study|Lost to Follow-up|1|||
23450733|NCT00757237|65394984|FG000|Overall Study|Protocol Violation|0|||
23450734|NCT00757237|65394985|FG001|Overall Study|Protocol Violation|2|||
23450735|NCT00757237|65394984|FG000|Overall Study|Physician Decision|2|||
23450736|NCT00757237|65394985|FG001|Overall Study|Physician Decision|3|||
23450737|NCT00757237|65394984|FG000|Overall Study|Withdrawal by Subject|8|||
23450738|NCT00757237|65394985|FG001|Overall Study|Withdrawal by Subject|12|||
23450739|NCT00757237|65394984|FG000|Overall Study|Safety or Tolerability|3|||
23450740|NCT00757237|65394985|FG001|Overall Study|Safety or Tolerability|5|||
23450741|NCT00757237|65394984|FG000|Overall Study|Other|0|||
23450742|NCT00757237|65394985|FG001|Overall Study|Other|2|||
23450743|NCT00148759|65394987|FG000|Overall Study|Withdrawal by Subject|1|||
23450744|NCT00148759|65394988|FG001|Overall Study|Withdrawal by Subject|1|||
23450745|NCT00148759|65394987|FG000|Overall Study|Lost to Follow-up|1|||
23450746|NCT00148759|65394988|FG001|Overall Study|Lost to Follow-up|0|||
23450747|NCT01664910|65394989|FG000|Overall Study|Adverse Event|0|||
23450748|NCT01664910|65394990|FG001|Overall Study|Adverse Event|0|||
23450749|NCT01664910|65394991|FG002|Overall Study|Adverse Event|1|||
23450750|NCT00721396|65394995|FG000|Overall Study|Adverse Event|4|||
23450751|NCT00721396|65394996|FG001|Overall Study|Adverse Event|7|||
23450752|NCT00721396|65394997|FG002|Overall Study|Adverse Event|2|||
23450753|NCT00721396|65394998|FG003|Overall Study|Adverse Event|0|||
23450754|NCT00721396|65394995|FG000|Overall Study|Withdrawal by Subject|12|||
23450755|NCT00721396|65394996|FG001|Overall Study|Withdrawal by Subject|15|||
23450756|NCT00721396|65394997|FG002|Overall Study|Withdrawal by Subject|3|||
23450757|NCT00721396|65394998|FG003|Overall Study|Withdrawal by Subject|7|||
23450758|NCT00721396|65394995|FG000|Overall Study|Lost to Follow-up|7|||
23450759|NCT00721396|65394996|FG001|Overall Study|Lost to Follow-up|9|||
23450760|NCT00721396|65394997|FG002|Overall Study|Lost to Follow-up|3|||
23450761|NCT00721396|65394998|FG003|Overall Study|Lost to Follow-up|3|||
23450762|NCT00721396|65394995|FG000|Overall Study|Protocol Violation|4|||
23450763|NCT00721396|65394996|FG001|Overall Study|Protocol Violation|3|||
23450764|NCT00721396|65394997|FG002|Overall Study|Protocol Violation|1|||
23450765|NCT00721396|65394998|FG003|Overall Study|Protocol Violation|0|||
23450766|NCT00721396|65394995|FG000|Overall Study|Inappropriate enrollment|0|||
23450767|NCT00721396|65394996|FG001|Overall Study|Inappropriate enrollment|2|||
23778220|NCT03195491|66567076|FG001|Overall Study|Study drug toxicity|3|||
23778221|NCT03195491|66567075|FG000|Overall Study|Maximum clinical benefit|5|||
23778222|NCT03195491|66567076|FG001|Overall Study|Maximum clinical benefit|0|||
23778223|NCT03195491|66567075|FG000|Overall Study|Lost to Follow-up|1|||
23778224|NCT03195491|66567076|FG001|Overall Study|Lost to Follow-up|0|||
23778225|NCT03195491|66567075|FG000|Overall Study|Death|3|||
23778226|NCT03195491|66567076|FG001|Overall Study|Death|0|||
23778227|NCT03195491|66567075|FG000|Overall Study|Adverse event unrelated to study drug|19|||
23778228|NCT03195491|66567076|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23778229|NCT03195491|66567075|FG000|Overall Study|Disease progression|266|||
23778230|NCT03195491|66567076|FG001|Overall Study|Disease progression|8|||
23778231|NCT03195491|66567075|FG000|Overall Study|Other reasons|10|||
23778232|NCT03195491|66567076|FG001|Overall Study|Other reasons|0|||
23778233|NCT03195491|66567075|FG000|Overall Study|Participant withdrew consent|8|||
23778234|NCT03195491|66567076|FG001|Overall Study|Participant withdrew consent|1|||
23778235|NCT03195491|66567075|FG000|Overall Study|Participant no longer meets study criteria|0|||
23778236|NCT03195491|66567076|FG001|Overall Study|Participant no longer meets study criteria|1|||
23778237|NCT03195491|66567075|FG000|Overall Study|Participant request to discontinue study treatment|10|||
23838249|NCT03693612|66787721|FG003|Overall Study|Withdrawal by Subject|0|||
23838250|NCT03693612|66787722|FG004|Overall Study|Withdrawal by Subject|2|||
23450768|NCT00721396|65394997|FG002|Overall Study|Inappropriate enrollment|0|||
23450769|NCT00721396|65394998|FG003|Overall Study|Inappropriate enrollment|0|||
23450770|NCT00721396|65394995|FG000|Overall Study|Administrative reason|3|||
23450771|NCT00721396|65394996|FG001|Overall Study|Administrative reason|0|||
23450772|NCT00721396|65394997|FG002|Overall Study|Administrative reason|1|||
23450773|NCT00721396|65394998|FG003|Overall Study|Administrative reason|0|||
23778238|NCT03195491|66567076|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23838251|NCT03693612|66787723|FG005|Overall Study|Withdrawal by Subject|0|||
23838252|NCT03693612|66787724|FG006|Overall Study|Withdrawal by Subject|0|||
23778239|NCT00624065|66567077|FG000|Overall Study|Adverse Event|5|||
23838253|NCT03693612|66787718|FG000|Overall Study|Study Terminated by Sponsor|0|||
23778240|NCT00624065|66567078|FG001|Overall Study|Adverse Event|6|||
23778241|NCT00624065|66567077|FG000|Overall Study|Lost to Follow-up|4|||
23778242|NCT00624065|66567078|FG001|Overall Study|Lost to Follow-up|1|||
23778243|NCT00624065|66567077|FG000|Overall Study|Consent withdrawn|6|||
23778244|NCT00624065|66567078|FG001|Overall Study|Consent withdrawn|5|||
23778245|NCT00624065|66567077|FG000|Overall Study|Lack of Efficacy|0|||
23778246|NCT00624065|66567078|FG001|Overall Study|Lack of Efficacy|3|||
23778247|NCT00624065|66567077|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
23778248|NCT00624065|66567078|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
23778249|NCT02196675|66567079|FG000|Overall Study|Withdrawal by Subject|1|||
23778250|NCT02196675|66567080|FG001|Overall Study|Withdrawal by Subject|0|||
23778251|NCT02196675|66567081|FG002|Overall Study|Withdrawal by Subject|0|||
23778252|NCT02196675|66567079|FG000|Overall Study|Intra-operative surgical exclusion|1|||
23778253|NCT02196675|66567080|FG001|Overall Study|Intra-operative surgical exclusion|1|||
23778254|NCT02196675|66567081|FG002|Overall Study|Intra-operative surgical exclusion|0|||
23778255|NCT02196675|66567079|FG000|Overall Study|Protocol Violation|0|||
23778256|NCT02196675|66567080|FG001|Overall Study|Protocol Violation|1|||
23778257|NCT02196675|66567081|FG002|Overall Study|Protocol Violation|0|||
23778258|NCT02196675|66567079|FG000|Overall Study|Death|0|||
23778259|NCT02196675|66567080|FG001|Overall Study|Death|0|||
23778260|NCT02196675|66567081|FG002|Overall Study|Death|1|||
23778261|NCT03447262|66567084|FG000|Overall Study|Adverse Event|7|||
23450774|NCT00416624|65394999|FG000|Overall Study|Withdrawal by Subject|1|||
23838254|NCT03693612|66787719|FG001|Overall Study|Study Terminated by Sponsor|1|||
23339091|NCT03843541|64986084|FG001|Overall Study|Withdrawal by Subject|9|||
23450775|NCT00416624|65395000|FG001|Overall Study|Withdrawal by Subject|6|||
23450776|NCT00416624|65395001|FG002|Overall Study|Withdrawal by Subject|4|||
23778262|NCT03447262|66567084|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
23778263|NCT03447262|66567084|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
23450777|NCT00416624|65395002|FG003|Overall Study|Withdrawal by Subject|9|||
23450778|NCT00416624|65394999|FG000|Overall Study|Death|4|||
23450779|NCT00416624|65395000|FG001|Overall Study|Death|7|||
23450780|NCT00416624|65395001|FG002|Overall Study|Death|7|||
23450781|NCT00416624|65395002|FG003|Overall Study|Death|1|||
23450782|NCT00416624|65394999|FG000|Overall Study|Adverse Event|8|||
23450783|NCT00416624|65395000|FG001|Overall Study|Adverse Event|3|||
23450784|NCT00416624|65395001|FG002|Overall Study|Adverse Event|2|||
23450785|NCT00416624|65395002|FG003|Overall Study|Adverse Event|2|||
23450786|NCT00416624|65394999|FG000|Overall Study|Other|8|||
23450787|NCT00416624|65395000|FG001|Overall Study|Other|11|||
23450788|NCT00416624|65395001|FG002|Overall Study|Other|5|||
23450789|NCT00416624|65395002|FG003|Overall Study|Other|5|||
23450790|NCT00416624|65394999|FG000|Overall Study|Cancel|1|||
23450791|NCT00416624|65395000|FG001|Overall Study|Cancel|0|||
23450792|NCT00416624|65395001|FG002|Overall Study|Cancel|0|||
23450793|NCT00416624|65395002|FG003|Overall Study|Cancel|0|||
23450794|NCT02653326|65395005|FG000|Overall Study|Lost to Follow-up|10|||
23450795|NCT02653326|65395006|FG001|Overall Study|Lost to Follow-up|7|||
23450796|NCT01329263|65395007|FG000|Overall Study|Lost to Follow-up|4|||
23450797|NCT01329263|65395008|FG001|Overall Study|Lost to Follow-up|21|||
23450798|NCT01329263|65395007|FG000|Overall Study|Withdrawal by Subject|1|||
23450799|NCT01329263|65395008|FG001|Overall Study|Withdrawal by Subject|2|||
23450800|NCT01141712|65395009|FG000|Overall Study|Disease progression|3|||
23450801|NCT01092728|65395019|FG000|Overall Study|Withdrawal by Subject|2|||
23450802|NCT01092728|65395020|FG001|Overall Study|Withdrawal by Subject|0|||
23450803|NCT01092728|65395019|FG000|Overall Study|Adverse Event|0|||
23450804|NCT01092728|65395020|FG001|Overall Study|Adverse Event|1|||
23450805|NCT01092728|65395019|FG000|Overall Study|Disease Progression|1|||
23450806|NCT01092728|65395020|FG001|Overall Study|Disease Progression|13|||
23450807|NCT01092728|65395019|FG000|Overall Study|Prohibited Concomitant Medications|1|||
23450808|NCT01092728|65395020|FG001|Overall Study|Prohibited Concomitant Medications|0|||
23778264|NCT03447262|66567084|FG000|Overall Study|Death|2|||
23778265|NCT03447262|66567084|FG000|Overall Study|Study Termination by Sponsor|455|||
23450809|NCT00308139|65395022|FG000|Overall Study|Adverse Event|20|||
23450810|NCT00308139|65395023|FG001|Overall Study|Adverse Event|14|||
23450811|NCT00308139|65395022|FG000|Overall Study|Lost to Follow-up|13|||
23450812|NCT00308139|65395023|FG001|Overall Study|Lost to Follow-up|8|||
23450813|NCT00308139|65395022|FG000|Overall Study|Protocol Violation|3|||
23450814|NCT00308139|65395023|FG001|Overall Study|Protocol Violation|2|||
23450815|NCT00308139|65395022|FG000|Overall Study|Withdrawal of Consent|40|||
23450816|NCT00308139|65395023|FG001|Overall Study|Withdrawal of Consent|42|||
23450817|NCT00308139|65395022|FG000|Overall Study|Investigator Decision|11|||
23778266|NCT03447262|66567084|FG000|Overall Study|Other|4|||
23778267|NCT01185548|66567086|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
23778268|NCT00651820|66567093|FG000|Overall Study|Lost to Follow-up|2|||
23778269|NCT02107092|66567096|FG000|Overall Study|Miscellaneous|3|||
23778270|NCT02107092|66567096|FG000|Overall Study|Subject compliance|3|||
23778271|NCT02107092|66567096|FG000|Overall Study|Hypo-or hyperkalemia|2|||
23778272|NCT02107092|66567096|FG000|Overall Study|Met ECG withdrawal criteria|3|||
23450818|NCT00308139|65395023|FG001|Overall Study|Investigator Decision|10|||
23450819|NCT00308139|65395022|FG000|Overall Study|Loss of Glucose Control|5|||
23450820|NCT00308139|65395023|FG001|Overall Study|Loss of Glucose Control|7|||
23450821|NCT00308139|65395022|FG000|Overall Study|Administrative|1|||
23450822|NCT00308139|65395023|FG001|Overall Study|Administrative|4|||
23450823|NCT00308139|65395022|FG000|Overall Study|Other|1|||
23450824|NCT00308139|65395023|FG001|Overall Study|Other|0|||
23450825|NCT01216202|65395027|FG000|Overall Study|Withdrawal by Subject|8|||
23838255|NCT03693612|66787720|FG002|Overall Study|Study Terminated by Sponsor|0|||
23838256|NCT03693612|66787721|FG003|Overall Study|Study Terminated by Sponsor|0|||
23838257|NCT03693612|66787722|FG004|Overall Study|Study Terminated by Sponsor|3|||
23838258|NCT03693612|66787723|FG005|Overall Study|Study Terminated by Sponsor|0|||
23838259|NCT03693612|66787724|FG006|Overall Study|Study Terminated by Sponsor|0|||
23339092|NCT03843541|64986085|FG002|Overall Study|Withdrawal by Subject|7|||
23450826|NCT01216202|65395028|FG001|Overall Study|Withdrawal by Subject|0|||
23578668|NCT00783718|65850263|FG003|Maintenance Phase|Lack of Efficacy|61|||
23578669|NCT00783718|65850264|FG004|Maintenance Phase|Lack of Efficacy|31|||
23778273|NCT02107092|66567096|FG000|Overall Study|Physician Decision|3|||
23778274|NCT02107092|66567096|FG000|Overall Study|Lost to Follow-up|2|||
23778275|NCT02107092|66567096|FG000|Overall Study|Withdrawal by Subject|9|||
23578670|NCT00783718|65850265|FG005|Maintenance Phase|Lack of Efficacy|33|||
23778276|NCT02107092|66567096|FG000|Overall Study|Adverse Event|7|||
23778277|NCT02107092|66567096|FG000|Overall Study|Expected progression of CKD|12|||
23778278|NCT04526210|66567097|FG000|Overall Study|Sponsor decision|7|||
23778279|NCT04526210|66567098|FG001|Overall Study|Sponsor decision|5|||
23778280|NCT04526210|66567097|FG000|Overall Study|Withdrawal by Subject|3|||
23778281|NCT04526210|66567098|FG001|Overall Study|Withdrawal by Subject|2|||
23778282|NCT01675622|66569570|FG000|Overall Study|Withdrawal by Subject|2|||
23778283|NCT01675622|66569571|FG001|Overall Study|Withdrawal by Subject|2|||
23778284|NCT01675622|66569570|FG000|Overall Study|Adverse Event|12|||
23778285|NCT01675622|66569571|FG001|Overall Study|Adverse Event|10|||
23778286|NCT01675622|66569570|FG000|Overall Study|Protocol Violation|4|||
23778287|NCT01675622|66569571|FG001|Overall Study|Protocol Violation|1|||
23778288|NCT01675622|66569570|FG000|Overall Study|Lack of Efficacy|2|||
23778289|NCT01675622|66569571|FG001|Overall Study|Lack of Efficacy|4|||
23778290|NCT01675622|66569570|FG000|Overall Study|Lost to Follow-up|1|||
23778291|NCT01675622|66569571|FG001|Overall Study|Lost to Follow-up|3|||
23778292|NCT01675622|66569570|FG000|Overall Study|Other|5|||
23778293|NCT01675622|66569571|FG001|Overall Study|Other|4|||
23778294|NCT01270503|66569573|FG000|Overall Study|Lost to Follow-up|1|||
23778295|NCT02942264|66569574|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778296|NCT02942264|66569575|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
23778297|NCT02942264|66569576|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778298|NCT02942264|66569577|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778299|NCT02942264|66569578|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778300|NCT02942264|66569579|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778301|NCT02942264|66569580|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
23778302|NCT02942264|66569581|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778303|NCT02942264|66569582|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23778304|NCT02942264|66569574|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778305|NCT02942264|66569575|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778306|NCT02942264|66569576|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778307|NCT02942264|66569577|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778308|NCT02942264|66569578|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778309|NCT02942264|66569579|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778310|NCT02942264|66569580|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778311|NCT02942264|66569581|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23778312|NCT02942264|66569582|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
23778313|NCT00905840|66569587|FG000|Overall Study|Lost to Follow-up|11|||
23778314|NCT00905840|66569587|FG000|Overall Study|Death|3|||
23778315|NCT00905840|66569587|FG000|Overall Study|Withdrawal by Subject|1|||
23339093|NCT03843541|64986083|FG000|Overall Study|Administration of rescue mucolytic|0|||
23450827|NCT01216202|65395027|FG000|Overall Study|Death|0|||
23450828|NCT01216202|65395028|FG001|Overall Study|Death|2|||
23778316|NCT00905840|66569587|FG000|Overall Study|Adverse Event|1|||
23778317|NCT01804270|66569588|FG000|Overall Study|Withdrawal by Subject|1|||
23778318|NCT01804270|66569589|FG001|Overall Study|Withdrawal by Subject|1|||
23778319|NCT01864174|66569590|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
23778320|NCT01864174|66569591|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
23778321|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
23778322|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
23450829|NCT01216202|65395027|FG000|Overall Study|Lost to Follow-up|14|||
23450830|NCT01216202|65395028|FG001|Overall Study|Lost to Follow-up|0|||
23778323|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
23778324|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
23778325|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
23778326|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
23778327|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Death|1|||
23778328|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Death|0|||
23778329|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
23778330|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
23778331|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
23450831|NCT03310723|65395029|FG000|Overall Study|Withdrawal by Subject|0|||
23450832|NCT03310723|65395030|FG001|Overall Study|Withdrawal by Subject|1|||
23450833|NCT03310723|65395029|FG000|Overall Study|Protocol Violation|0|||
23450834|NCT03310723|65395030|FG001|Overall Study|Protocol Violation|2|||
23450835|NCT00468299|65395033|FG000|Overall Study|Withdrawal by Subject|0|||
23450836|NCT00468299|65395034|FG001|Overall Study|Withdrawal by Subject|1|||
23778332|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
23778333|NCT01864174|66569590|FG000|Double Blind - Compliant Randomized|Other|6|||
23450837|NCT02138890|65395039|FG000|Overall Study|Adverse Event|1|||
23778334|NCT01864174|66569591|FG001|Double Blind - Compliant Randomized|Other|10|||
23450838|NCT02138890|65395040|FG001|Overall Study|Adverse Event|0|||
23450839|NCT03007966|65395041|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
23450840|NCT03007966|65395042|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
23450841|NCT03951077|65395049|FG000|Overall Study|Adverse Event|1|||
23450842|NCT03951077|65395050|FG001|Overall Study|Adverse Event|0|||
23450843|NCT03951077|65395051|FG002|Overall Study|Adverse Event|0|||
23450844|NCT03951077|65395052|FG003|Overall Study|Adverse Event|0|||
23450845|NCT03951077|65395053|FG004|Overall Study|Adverse Event|0|||
23450846|NCT03951077|65395054|FG005|Overall Study|Adverse Event|0|||
23450847|NCT03951077|65395049|FG000|Overall Study|Withdrawal by Subject|3|||
23450848|NCT03951077|65395050|FG001|Overall Study|Withdrawal by Subject|3|||
23450849|NCT03951077|65395051|FG002|Overall Study|Withdrawal by Subject|0|||
23450850|NCT03951077|65395052|FG003|Overall Study|Withdrawal by Subject|3|||
23778335|NCT01864174|66569590|FG000|Off Treatment Follow-Up|Other|2|||
23778336|NCT01864174|66569591|FG001|Off Treatment Follow-Up|Other|0|||
23778337|NCT01864174|66569590|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
23778338|NCT01864174|66569591|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
23778339|NCT00746798|66569592|FG000|Overall Study|Protocol Violation|0|||
23778340|NCT00746798|66569593|FG001|Overall Study|Protocol Violation|1|||
23778341|NCT00746798|66569594|FG002|Overall Study|Protocol Violation|0|||
23778342|NCT00746798|66569595|FG003|Overall Study|Protocol Violation|0|||
23778343|NCT00746798|66569592|FG000|Overall Study|Withdrawal by Subject|0|||
23778344|NCT00746798|66569593|FG001|Overall Study|Withdrawal by Subject|1|||
23778345|NCT00746798|66569594|FG002|Overall Study|Withdrawal by Subject|1|||
23778346|NCT00746798|66569595|FG003|Overall Study|Withdrawal by Subject|0|||
23778347|NCT00746798|66569592|FG000|Overall Study|Death|0|||
23778348|NCT00746798|66569593|FG001|Overall Study|Death|0|||
23778349|NCT00746798|66569594|FG002|Overall Study|Death|2|||
23778350|NCT00746798|66569595|FG003|Overall Study|Death|0|||
23778351|NCT00746798|66569592|FG000|Overall Study|Participant unable to return for visit|1|||
23778352|NCT00746798|66569593|FG001|Overall Study|Participant unable to return for visit|0|||
23778353|NCT00746798|66569594|FG002|Overall Study|Participant unable to return for visit|0|||
23778354|NCT00746798|66569595|FG003|Overall Study|Participant unable to return for visit|0|||
23778355|NCT01520909|66569603|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
23778356|NCT01520909|66569604|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
23778357|NCT01520909|66569605|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
23778358|NCT01520909|66569603|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
23778359|NCT01520909|66569604|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
23778360|NCT01520909|66569605|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
23778361|NCT01520909|66569603|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
23778362|NCT01520909|66569604|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
23778363|NCT01520909|66569605|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
23778364|NCT01520909|66569603|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
23778365|NCT01520909|66569604|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
23778366|NCT01520909|66569605|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
23778367|NCT02605928|66569606|FG000|Overall Study|Model tuning phase|28|||
23778368|NCT02605928|66569606|FG000|Overall Study|Lack of Efficacy|5|||
23778369|NCT02188303|66569610|FG000|Overall Study|Adverse Event|0|||
23778370|NCT02188303|66569611|FG001|Overall Study|Adverse Event|0|||
23450851|NCT03951077|65395053|FG004|Overall Study|Withdrawal by Subject|3|||
23450852|NCT03951077|65395054|FG005|Overall Study|Withdrawal by Subject|2|||
23578671|NCT00783718|65850266|FG006|Maintenance Phase|Lack of Efficacy|155|||
23778371|NCT02188303|66569612|FG002|Overall Study|Adverse Event|0|||
23450853|NCT03951077|65395049|FG000|Overall Study|Lost to Follow-up|1|||
23450854|NCT03951077|65395050|FG001|Overall Study|Lost to Follow-up|1|||
23450855|NCT03951077|65395051|FG002|Overall Study|Lost to Follow-up|2|||
23450856|NCT03951077|65395052|FG003|Overall Study|Lost to Follow-up|3|||
23450857|NCT03951077|65395053|FG004|Overall Study|Lost to Follow-up|2|||
23450858|NCT03951077|65395054|FG005|Overall Study|Lost to Follow-up|3|||
23450859|NCT03951077|65395049|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
23450860|NCT03951077|65395050|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
23578672|NCT00783718|65850260|FG000|Maintenance Phase|Withdrawal by Subject|6|||
23578673|NCT00783718|65850261|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23578674|NCT00783718|65850262|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23578675|NCT00783718|65850263|FG003|Maintenance Phase|Withdrawal by Subject|2|||
23578676|NCT00783718|65850264|FG004|Maintenance Phase|Withdrawal by Subject|5|||
23578677|NCT00783718|65850265|FG005|Maintenance Phase|Withdrawal by Subject|2|||
23578678|NCT00783718|65850266|FG006|Maintenance Phase|Withdrawal by Subject|20|||
23578679|NCT00783718|65850260|FG000|Maintenance Phase|Lost to Follow-up|3|||
23578680|NCT00783718|65850261|FG001|Maintenance Phase|Lost to Follow-up|0|||
23578681|NCT00783718|65850262|FG002|Maintenance Phase|Lost to Follow-up|0|||
23578682|NCT00783718|65850263|FG003|Maintenance Phase|Lost to Follow-up|0|||
23578683|NCT00783718|65850264|FG004|Maintenance Phase|Lost to Follow-up|2|||
23578684|NCT00783718|65850265|FG005|Maintenance Phase|Lost to Follow-up|0|||
23578685|NCT00783718|65850266|FG006|Maintenance Phase|Lost to Follow-up|2|||
23578686|NCT02271594|65850267|FG000|Overall Study|Study closed; recruiting failure|19|||
23450861|NCT03951077|65395051|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
23450862|NCT03951077|65395052|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
23578687|NCT02271594|65850268|FG001|Overall Study|Study closed; recruiting failure|12|||
23578688|NCT03033576|65850269|FG000|Overall Study|Ineligible|1|||
23578689|NCT03033576|65850270|FG001|Overall Study|Ineligible|1|||
23578690|NCT03033576|65850269|FG000|Overall Study|Adverse Event|4|||
23578691|NCT03033576|65850270|FG001|Overall Study|Adverse Event|20|||
23578692|NCT03033576|65850269|FG000|Overall Study|Progression/relapse|9|||
23578693|NCT03033576|65850270|FG001|Overall Study|Progression/relapse|36|||
23578694|NCT03033576|65850269|FG000|Overall Study|Death|1|||
23778372|NCT02188303|66569613|FG003|Overall Study|Adverse Event|0|||
23778373|NCT02188303|66569614|FG004|Overall Study|Adverse Event|0|||
23778374|NCT02188303|66569615|FG005|Overall Study|Adverse Event|2|||
23778375|NCT02188303|66569616|FG006|Overall Study|Adverse Event|0|||
23778376|NCT02188303|66569617|FG007|Overall Study|Adverse Event|2|||
23778377|NCT02188303|66569610|FG000|Overall Study|Dose Termination Criteria Met|0|||
23778378|NCT02188303|66569611|FG001|Overall Study|Dose Termination Criteria Met|0|||
23838260|NCT03656068|66787725|FG000|Overall Study|Withdrawal by Subject|4|||
23838261|NCT03656068|66787725|FG000|Overall Study|Adverse Event|1|||
23838262|NCT02875613|66787728|FG000|Overall Study|Withdrawal by Subject|1|||
23838263|NCT02875613|66787728|FG000|Overall Study|Screen Failure|1|||
23838264|NCT03668119|66787729|FG000|Pre-treatment|Disease Progression|1|||
23838265|NCT03668119|66787730|FG001|Pre-treatment|Disease Progression|0|||
23450863|NCT03951077|65395053|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
23450864|NCT03951077|65395054|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
23450865|NCT03951077|65395049|FG000|Overall Study|Other, Not Specified|12|||
23450866|NCT03951077|65395050|FG001|Overall Study|Other, Not Specified|10|||
23450867|NCT03951077|65395051|FG002|Overall Study|Other, Not Specified|10|||
23450868|NCT03951077|65395052|FG003|Overall Study|Other, Not Specified|5|||
23838266|NCT03668119|66787729|FG000|Treatment|Disease Progression|76|||
23838267|NCT03668119|66787730|FG001|Treatment|Disease Progression|57|||
23838268|NCT03668119|66787729|FG000|Treatment|Study drug toxicity|19|||
23838269|NCT03668119|66787730|FG001|Treatment|Study drug toxicity|1|||
23838270|NCT03668119|66787729|FG000|Treatment|Death|3|||
23838271|NCT03668119|66787730|FG001|Treatment|Death|0|||
23838272|NCT03668119|66787729|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
23838273|NCT03668119|66787730|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
23838274|NCT03668119|66787729|FG000|Treatment|Withdrawal by Subject|1|||
23838275|NCT03668119|66787730|FG001|Treatment|Withdrawal by Subject|1|||
23450869|NCT03951077|65395053|FG004|Overall Study|Other, Not Specified|9|||
23578695|NCT03033576|65850270|FG001|Overall Study|Death|1|||
23838276|NCT03668119|66787729|FG000|Treatment|Participant request to discontinue study treatment|3|||
23838277|NCT03668119|66787730|FG001|Treatment|Participant request to discontinue study treatment|1|||
23838278|NCT03668119|66787729|FG000|Treatment|Maximum Clinical Benefit|0|||
23578696|NCT03033576|65850269|FG000|Overall Study|Patient refusal|1|||
23578697|NCT03033576|65850270|FG001|Overall Study|Patient refusal|6|||
23578698|NCT03033576|65850269|FG000|Overall Study|Other, unspecified reasons|0|||
23578699|NCT03033576|65850270|FG001|Overall Study|Other, unspecified reasons|4|||
23578700|NCT03033576|65850269|FG000|Overall Study|Currently on protocol therapy|0|||
23778379|NCT02188303|66569612|FG002|Overall Study|Dose Termination Criteria Met|0|||
23838279|NCT03668119|66787730|FG001|Treatment|Maximum Clinical Benefit|1|||
23838280|NCT03668119|66787729|FG000|Treatment|Participants completed treatment|27|||
23450870|NCT03951077|65395054|FG005|Overall Study|Other, Not Specified|6|||
23838281|NCT03668119|66787730|FG001|Treatment|Participants completed treatment|11|||
23838282|NCT03668119|66787729|FG000|Treatment|Other reasons|2|||
23838283|NCT03668119|66787730|FG001|Treatment|Other reasons|1|||
23838284|NCT01401361|66787733|FG000|Overall Study|Withdrawal by Subject|16|||
23578701|NCT03033576|65850270|FG001|Overall Study|Currently on protocol therapy|2|||
23838285|NCT01401361|66787733|FG000|Overall Study|Lack of Efficacy|6|||
23838286|NCT01401361|66787733|FG000|Overall Study|Physician Decision|1|||
23838287|NCT01401361|66787733|FG000|Overall Study|Lost to Follow-up|3|||
23838288|NCT01401361|66787733|FG000|Overall Study|Subject/family decision post procedure|2|||
23838289|NCT00485732|66787734|FG000|Overall Study|Protocol Violation|1|||
23838290|NCT00485732|66787735|FG001|Overall Study|Protocol Violation|3|||
23838291|NCT00485732|66787734|FG000|Overall Study|Withdrawal by Subject|5|||
23838292|NCT00485732|66787735|FG001|Overall Study|Withdrawal by Subject|4|||
23838293|NCT00485732|66787734|FG000|Overall Study|Lost to Follow-up|2|||
23838294|NCT00485732|66787735|FG001|Overall Study|Lost to Follow-up|2|||
23838295|NCT02596971|66787738|FG000|Overall Study|Death|5|||
23838296|NCT02596971|66787739|FG001|Overall Study|Death|1|||
23838297|NCT02596971|66787740|FG002|Overall Study|Death|5|||
23838298|NCT02596971|66787738|FG000|Overall Study|Withdrawal by Subject|5|||
23838299|NCT02596971|66787739|FG001|Overall Study|Withdrawal by Subject|1|||
23838300|NCT02596971|66787740|FG002|Overall Study|Withdrawal by Subject|4|||
23838301|NCT03878446|66787741|FG000|Overall Study|Withdrawn by parent or guardian|1|||
23838302|NCT03878446|66787742|FG001|Overall Study|Withdrawn by parent or guardian|0|||
23778380|NCT02188303|66569613|FG003|Overall Study|Dose Termination Criteria Met|0|||
23778381|NCT02188303|66569614|FG004|Overall Study|Dose Termination Criteria Met|0|||
23778382|NCT02188303|66569615|FG005|Overall Study|Dose Termination Criteria Met|0|||
23778383|NCT02188303|66569616|FG006|Overall Study|Dose Termination Criteria Met|2|||
23778384|NCT02188303|66569617|FG007|Overall Study|Dose Termination Criteria Met|4|||
23778385|NCT04627038|66569618|FG000|Overall Study|Adverse Event|36|||
23778386|NCT04627038|66569619|FG001|Overall Study|Adverse Event|8|||
23778387|NCT04627038|66569618|FG000|Overall Study|Lost to Follow-up|1|||
23838303|NCT03878446|66787743|FG002|Overall Study|Withdrawn by parent or guardian|0|||
23838304|NCT03878446|66787744|FG003|Overall Study|Withdrawn by parent or guardian|0|||
23838305|NCT03878446|66787745|FG004|Overall Study|Withdrawn by parent or guardian|0|||
23778388|NCT04627038|66569619|FG001|Overall Study|Lost to Follow-up|0|||
23838306|NCT02347774|66787746|FG000|Study Participation|Lost to Follow-up|3|||
23838307|NCT02347774|66787747|FG001|Study Participation|Lost to Follow-up|6|||
23838308|NCT02347774|66787748|FG002|Study Participation|Lost to Follow-up|2|||
23838309|NCT02347774|66787746|FG000|Study Participation|Withdrawal by Subject|8|||
23838310|NCT02347774|66787747|FG001|Study Participation|Withdrawal by Subject|9|||
23838311|NCT02347774|66787748|FG002|Study Participation|Withdrawal by Subject|15|||
23838312|NCT02347774|66787746|FG000|Study Participation|Adverse Event|1|||
23578702|NCT00551213|65850271|FG000|Overall Study|Adverse Event|6|||
23578703|NCT00551213|65850272|FG001|Overall Study|Adverse Event|3|||
23578704|NCT00551213|65850271|FG000|Overall Study|Progressive Disease|41|||
23578705|NCT00551213|65850272|FG001|Overall Study|Progressive Disease|12|||
23578706|NCT00551213|65850271|FG000|Overall Study|Withdrawal by Subject|2|||
23578707|NCT00551213|65850272|FG001|Overall Study|Withdrawal by Subject|0|||
23578708|NCT00551213|65850271|FG000|Overall Study|Not Treated|1|||
23578709|NCT00551213|65850272|FG001|Overall Study|Not Treated|2|||
23578710|NCT05576662|65850273|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
23578711|NCT05576662|65850274|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
23578712|NCT05576662|65850273|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
23578713|NCT05576662|65850274|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
23578714|NCT05576662|65850273|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
23578715|NCT05576662|65850274|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
23578716|NCT05576662|65850273|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
23578717|NCT05576662|65850274|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
23578718|NCT01813422|65850275|FG000|Overall Study|Withdrawal by Subject|14|||
23578719|NCT01813422|65850276|FG001|Overall Study|Withdrawal by Subject|8|||
23578720|NCT01813422|65850275|FG000|Overall Study|Death|2|||
23778389|NCT04627038|66569618|FG000|Overall Study|Physician Decision|0|||
23838313|NCT02347774|66787747|FG001|Study Participation|Adverse Event|4|||
23838314|NCT02347774|66787748|FG002|Study Participation|Adverse Event|6|||
23838315|NCT02347774|66787746|FG000|Study Participation|withdrew consent|1|||
23838316|NCT02347774|66787747|FG001|Study Participation|withdrew consent|1|||
23578721|NCT01813422|65850276|FG001|Overall Study|Death|3|||
23778390|NCT04627038|66569619|FG001|Overall Study|Physician Decision|1|||
23778391|NCT04627038|66569618|FG000|Overall Study|Protocol Violation|3|||
23778392|NCT04627038|66569619|FG001|Overall Study|Protocol Violation|1|||
23838317|NCT02347774|66787748|FG002|Study Participation|withdrew consent|1|||
23838318|NCT02347774|66787746|FG000|Study Participation|Met Prolonged QT criteria|1|||
23838319|NCT02347774|66787747|FG001|Study Participation|Met Prolonged QT criteria|0|||
23838320|NCT02347774|66787748|FG002|Study Participation|Met Prolonged QT criteria|0|||
23838321|NCT02347774|66787746|FG000|Study Participation|non-compliance with study drug|0|||
23838322|NCT02347774|66787747|FG001|Study Participation|non-compliance with study drug|1|||
23778393|NCT04627038|66569618|FG000|Overall Study|Withdrawal by Subject|13|||
23450871|NCT03951077|65395049|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
23578722|NCT01813422|65850275|FG000|Overall Study|Sponsor Decision|2|||
23578723|NCT01813422|65850276|FG001|Overall Study|Sponsor Decision|1|||
23578724|NCT01813422|65850275|FG000|Overall Study|Lost to Follow-up|2|||
23578725|NCT01813422|65850276|FG001|Overall Study|Lost to Follow-up|4|||
23578726|NCT01017120|65850281|FG000|Overall Study|Adverse Event|9|||
23578727|NCT01017120|65850282|FG001|Overall Study|Adverse Event|0|||
23578728|NCT01017120|65850281|FG000|Overall Study|Lost to Follow-up|13|||
23634425|NCT03149549|66049217|FG000|Study Discontinuation--Treatment Period|Other|0|||
23634426|NCT03149549|66049218|FG001|Study Discontinuation--Treatment Period|Other|0|||
23634427|NCT03149549|66049219|FG002|Study Discontinuation--Treatment Period|Other|0|||
23634428|NCT03149549|66049220|FG003|Study Discontinuation--Treatment Period|Other|0|||
23634429|NCT03149549|66049221|FG004|Study Discontinuation--Treatment Period|Other|0|||
23634430|NCT03149549|66049222|FG005|Study Discontinuation--Treatment Period|Other|0|||
23634431|NCT03149549|66049223|FG006|Study Discontinuation--Treatment Period|Other|0|||
23634432|NCT03149549|66049224|FG007|Study Discontinuation--Treatment Period|Other|1|||
23634433|NCT03149549|66049225|FG008|Study Discontinuation--Treatment Period|Other|0|||
23634434|NCT03149549|66049226|FG009|Study Discontinuation--Treatment Period|Other|1|||
23634435|NCT03149549|66049227|FG010|Study Discontinuation--Treatment Period|Other|0|||
23634436|NCT03149549|66049228|FG011|Study Discontinuation--Treatment Period|Other|0|||
23634437|NCT03149549|66049229|FG012|Study Discontinuation--Treatment Period|Other|0|||
23634438|NCT03149549|66049217|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634439|NCT03149549|66049218|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634440|NCT03149549|66049219|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634441|NCT03149549|66049220|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634442|NCT03149549|66049221|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634443|NCT03149549|66049222|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
23634444|NCT03149549|66049223|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
23634445|NCT03149549|66049224|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634446|NCT03149549|66049225|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
23634447|NCT03149549|66049226|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634448|NCT03149549|66049227|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634449|NCT03149549|66049228|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634450|NCT03149549|66049229|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23634451|NCT03149549|66049217|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634452|NCT03149549|66049218|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634453|NCT03149549|66049219|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634454|NCT03149549|66049220|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634455|NCT03149549|66049221|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
23634456|NCT03149549|66049222|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634457|NCT03149549|66049223|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634458|NCT03149549|66049224|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
23634459|NCT03149549|66049225|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
23634460|NCT03149549|66049226|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23778394|NCT04627038|66569619|FG001|Overall Study|Withdrawal by Subject|3|||
23778395|NCT04627038|66569618|FG000|Overall Study|Non-compliance with study drug|0|||
23778396|NCT04627038|66569619|FG001|Overall Study|Non-compliance with study drug|1|||
23778397|NCT04627038|66569618|FG000|Overall Study|Prohibited Concomitant Medication|1|||
23778398|NCT04627038|66569619|FG001|Overall Study|Prohibited Concomitant Medication|0|||
23778399|NCT01839279|66569623|FG000|Overall Study|Adverse Event|4|||
23778400|NCT01839279|66569624|FG001|Overall Study|Adverse Event|1|||
23778401|NCT01839279|66569625|FG002|Overall Study|Adverse Event|1|||
23778402|NCT01839279|66569623|FG000|Overall Study|Withdrawal by Subject|4|||
23778403|NCT01839279|66569624|FG001|Overall Study|Withdrawal by Subject|1|||
23778404|NCT01839279|66569625|FG002|Overall Study|Withdrawal by Subject|1|||
23778405|NCT01839279|66569623|FG000|Overall Study|Classified as 'Other'|5|||
23778406|NCT01839279|66569624|FG001|Overall Study|Classified as 'Other'|0|||
23778407|NCT01839279|66569625|FG002|Overall Study|Classified as 'Other'|0|||
23778408|NCT01035060|66569626|FG000|Overall Study|Lost to Follow-up|0|||
23778409|NCT01035060|66569627|FG001|Overall Study|Lost to Follow-up|7|||
23778410|NCT01035060|66569626|FG000|Overall Study|Did not quality after 2nd screening|14|||
23778411|NCT01035060|66569627|FG001|Overall Study|Did not quality after 2nd screening|1|||
23778412|NCT01035060|66569626|FG000|Overall Study|Withdrawal by Subject|8|||
23578729|NCT01017120|65850282|FG001|Overall Study|Lost to Follow-up|11|||
23578730|NCT01017120|65850281|FG000|Overall Study|Lack of Efficacy|1|||
23778413|NCT01035060|66569627|FG001|Overall Study|Withdrawal by Subject|6|||
23778414|NCT01035060|66569626|FG000|Overall Study|Physician Decision|2|||
23578731|NCT01017120|65850282|FG001|Overall Study|Lack of Efficacy|0|||
23578732|NCT01017120|65850281|FG000|Overall Study|Withdrawal by Subject|39|||
23634461|NCT03149549|66049227|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23634462|NCT03149549|66049228|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
23634463|NCT03149549|66049229|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
23634464|NCT03149549|66049217|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634465|NCT03149549|66049218|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634466|NCT03149549|66049219|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634467|NCT03149549|66049220|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634468|NCT03149549|66049221|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23634469|NCT03149549|66049222|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634470|NCT03149549|66049223|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634471|NCT03149549|66049224|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
23634472|NCT03149549|66049225|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23634473|NCT03149549|66049226|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23634474|NCT03149549|66049227|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
23634475|NCT03149549|66049228|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23634476|NCT03149549|66049229|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23634477|NCT03149549|66049217|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
23634478|NCT03149549|66049218|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
23634479|NCT03149549|66049219|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
23634480|NCT03149549|66049220|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
23578733|NCT01017120|65850282|FG001|Overall Study|Withdrawal by Subject|21|||
23578734|NCT01017120|65850281|FG000|Overall Study|Pregnancy|1|||
23634481|NCT03149549|66049221|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
23634482|NCT03149549|66049222|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
23634483|NCT03149549|66049223|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
23634484|NCT03149549|66049224|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
23634485|NCT03149549|66049225|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
23634486|NCT03149549|66049226|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
23634487|NCT03149549|66049227|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
23634488|NCT03149549|66049228|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
23634489|NCT03149549|66049229|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
23634490|NCT03149549|66049217|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
23578735|NCT01017120|65850282|FG001|Overall Study|Pregnancy|1|||
23578736|NCT01017120|65850281|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23578737|NCT01017120|65850282|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23578738|NCT01017120|65850281|FG000|Overall Study|Relocated Out of Town|0|||
23578739|NCT01017120|65850282|FG001|Overall Study|Relocated Out of Town|2|||
23578740|NCT01017120|65850281|FG000|Overall Study|Protocol Violation|1|||
23634491|NCT03149549|66049218|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
23634492|NCT03149549|66049219|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
23634493|NCT03149549|66049220|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
23634494|NCT03149549|66049221|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
23634495|NCT03149549|66049222|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
23634496|NCT03149549|66049223|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
23778415|NCT01035060|66569627|FG001|Overall Study|Physician Decision|0|||
23778416|NCT00450190|66569635|FG000|Overall Study|Withdrawal by Subject|2|||
23778417|NCT00585689|66569636|FG000|Overall Study|Received different ABI-007 schedule|3|||
23778418|NCT00585689|66569636|FG000|Overall Study|Adverse Event|1|||
23778419|NCT00585689|66569636|FG000|Overall Study|Patient Declined Surgery|1|||
23778420|NCT00585689|66569636|FG000|Overall Study|Patient had unresectable disease|1|||
23778421|NCT00585689|66569636|FG000|Overall Study|Death|1|||
23778422|NCT01353664|66569637|FG000|Overall Study|Other|3|||
23778423|NCT01353664|66569637|FG000|Overall Study|Disease Progression|16|||
23778424|NCT03478397|66569647|FG000|Overall Study|Refused to participate|31|||
23778425|NCT03478397|66569648|FG001|Overall Study|Refused to participate|7|||
23778426|NCT01171989|66569649|FG000|Overall Study|Lost to Follow-up|0|||
23778427|NCT01171989|66569650|FG001|Overall Study|Lost to Follow-up|0|||
23778428|NCT01171989|66569651|FG002|Overall Study|Lost to Follow-up|1|||
23778429|NCT00468286|66569653|FG000|Overall Study|Adverse Event|1|||
23778430|NCT00468286|66569654|FG001|Overall Study|Adverse Event|6|||
23778431|NCT00468286|66569653|FG000|Overall Study|Protocol Violation|2|||
23778432|NCT00468286|66569654|FG001|Overall Study|Protocol Violation|2|||
23778433|NCT00468286|66569653|FG000|Overall Study|Withdrawal by Subject|4|||
23578741|NCT01017120|65850282|FG001|Overall Study|Protocol Violation|0|||
23778434|NCT00468286|66569654|FG001|Overall Study|Withdrawal by Subject|3|||
23778435|NCT00468286|66569653|FG000|Overall Study|Physician Decision|0|||
23778436|NCT00468286|66569654|FG001|Overall Study|Physician Decision|1|||
23778437|NCT02646124|66569657|FG000|Overall Study|Lost to Follow-up|0|||
23778438|NCT02646124|66569658|FG001|Overall Study|Lost to Follow-up|2|||
23450872|NCT03951077|65395050|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
23578742|NCT01017120|65850281|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
23838323|NCT02347774|66787748|FG002|Study Participation|non-compliance with study drug|0|||
23838324|NCT02347774|66787746|FG000|Study Participation|incarceration|1|||
23838325|NCT02347774|66787747|FG001|Study Participation|incarceration|0|||
23838326|NCT02347774|66787748|FG002|Study Participation|incarceration|0|||
23838327|NCT02347774|66787746|FG000|Study Participation|randomized in error|0|||
23838328|NCT02347774|66787747|FG001|Study Participation|randomized in error|0|||
23838329|NCT02347774|66787748|FG002|Study Participation|randomized in error|1|||
23838330|NCT02347774|66787746|FG000|On Study Treatment|Adverse Event|9|||
23578743|NCT01017120|65850282|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
23838331|NCT02347774|66787747|FG001|On Study Treatment|Adverse Event|15|||
23838332|NCT02347774|66787748|FG002|On Study Treatment|Adverse Event|19|||
23838333|NCT02347774|66787746|FG000|On Study Treatment|Lack of Efficacy|3|||
23838334|NCT02347774|66787747|FG001|On Study Treatment|Lack of Efficacy|0|||
23838335|NCT02347774|66787748|FG002|On Study Treatment|Lack of Efficacy|2|||
23838336|NCT02347774|66787746|FG000|On Study Treatment|non-complicance with study medication|0|||
23838337|NCT02347774|66787747|FG001|On Study Treatment|non-complicance with study medication|2|||
23838338|NCT02347774|66787748|FG002|On Study Treatment|non-complicance with study medication|0|||
23838339|NCT02347774|66787746|FG000|On Study Treatment|Protocol Violation|0|||
23838340|NCT02347774|66787747|FG001|On Study Treatment|Protocol Violation|0|||
23339094|NCT03843541|64986084|FG001|Overall Study|Administration of rescue mucolytic|0|||
23339095|NCT03843541|64986085|FG002|Overall Study|Administration of rescue mucolytic|1|||
23578744|NCT00432159|65850283|FG000|Overall Study|Death|0|||
23578745|NCT00432159|65850284|FG001|Overall Study|Death|1|||
23578746|NCT00432159|65850285|FG002|Overall Study|Death|0|||
23578747|NCT00432159|65850286|FG003|Overall Study|Death|0|||
23578748|NCT00432159|65850287|FG004|Overall Study|Death|0|||
23578749|NCT00432159|65850283|FG000|Overall Study|Failure|9|||
23578750|NCT00432159|65850284|FG001|Overall Study|Failure|5|||
23578751|NCT00432159|65850285|FG002|Overall Study|Failure|3|||
23578752|NCT00432159|65850286|FG003|Overall Study|Failure|2|||
23578753|NCT00432159|65850287|FG004|Overall Study|Failure|3|||
23578754|NCT00432159|65850283|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
23578755|NCT00432159|65850284|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
23578756|NCT00432159|65850285|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
23578757|NCT00432159|65850286|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
23578758|NCT00432159|65850287|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
23578759|NCT00329303|65850288|FG000|Overall Study|Lack of Efficacy|1|||
23578760|NCT00329303|65850289|FG001|Overall Study|Lack of Efficacy|0|||
23578761|NCT00329303|65850288|FG000|Overall Study|Decision of the sponsor|0|||
23578762|NCT00329303|65850289|FG001|Overall Study|Decision of the sponsor|1|||
23578763|NCT00329303|65850288|FG000|Overall Study|Patient no longer available|1|||
23578764|NCT00329303|65850289|FG001|Overall Study|Patient no longer available|0|||
23578765|NCT00329303|65850288|FG000|Overall Study|Patient relocated|0|||
23578766|NCT00329303|65850289|FG001|Overall Study|Patient relocated|1|||
23578767|NCT01515319|65850290|FG000|Overall Study|Withdrawal by Subject|0|||
23578768|NCT01515319|65850291|FG001|Overall Study|Withdrawal by Subject|0|||
23578769|NCT01515319|65850292|FG002|Overall Study|Withdrawal by Subject|0|||
23578770|NCT01515319|65850293|FG003|Overall Study|Withdrawal by Subject|0|||
23578771|NCT01515319|65850294|FG004|Overall Study|Withdrawal by Subject|0|||
23578772|NCT01515319|65850295|FG005|Overall Study|Withdrawal by Subject|0|||
23634497|NCT03149549|66049224|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
23634498|NCT03149549|66049225|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
23778439|NCT01576042|66569659|FG000|Overall Study|Physician Decision|2|||
23778440|NCT01576042|66569660|FG001|Overall Study|Physician Decision|0|||
23778441|NCT01401647|66569664|FG000|Overall Study|Withdrawal by Subject|1|||
23778442|NCT01401647|66569665|FG001|Overall Study|Withdrawal by Subject|5|||
23778443|NCT01401647|66569666|FG002|Overall Study|Withdrawal by Subject|2|||
23778444|NCT01401647|66569664|FG000|Overall Study|Lost to Follow-up|3|||
23778445|NCT01401647|66569665|FG001|Overall Study|Lost to Follow-up|3|||
23778446|NCT01401647|66569666|FG002|Overall Study|Lost to Follow-up|1|||
23778447|NCT00855738|66569686|FG000|Overall Study|Lost to Follow-up|2|||
23778448|NCT00855738|66569686|FG000|Overall Study|Adverse Event|1|||
23778449|NCT00855738|66569686|FG000|Overall Study|Subject Defaulted|1|||
23838341|NCT02347774|66787748|FG002|On Study Treatment|Protocol Violation|1|||
23838342|NCT02347774|66787746|FG000|On Study Treatment|withdrew consent|9|||
23838343|NCT02347774|66787747|FG001|On Study Treatment|withdrew consent|8|||
23578773|NCT01515319|65850296|FG006|Overall Study|Withdrawal by Subject|1|||
23838344|NCT02347774|66787748|FG002|On Study Treatment|withdrew consent|12|||
23838345|NCT02347774|66787746|FG000|On Study Treatment|Lost to Follow-up|2|||
23838346|NCT02347774|66787747|FG001|On Study Treatment|Lost to Follow-up|6|||
23578774|NCT01515319|65850297|FG007|Overall Study|Withdrawal by Subject|0|||
23578775|NCT01515319|65850298|FG008|Overall Study|Withdrawal by Subject|0|||
23578776|NCT01515319|65850299|FG009|Overall Study|Withdrawal by Subject|0|||
23778450|NCT00855738|66569686|FG000|Overall Study|Death|1|||
23838347|NCT02347774|66787748|FG002|On Study Treatment|Lost to Follow-up|1|||
23838348|NCT02347774|66787746|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
23634499|NCT03149549|66049226|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
23634500|NCT03149549|66049227|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
23634501|NCT03149549|66049228|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
23634502|NCT03149549|66049229|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
23634503|NCT01370655|66049230|FG000|Period 1|Adverse Event|2|||
23634504|NCT01370655|66049231|FG001|Period 1|Adverse Event|0|||
23634505|NCT01370655|66049232|FG002|Period 1|Adverse Event|0|||
23634506|NCT01370655|66049233|FG003|Period 1|Adverse Event|0|||
23634507|NCT01370655|66049234|FG004|Period 1|Adverse Event|0|||
23634508|NCT01370655|66049235|FG005|Period 1|Adverse Event|0|||
23634509|NCT01370655|66049236|FG006|Period 1|Adverse Event|1|||
23634510|NCT01370655|66049237|FG007|Period 1|Adverse Event|0|||
23634511|NCT01370655|66049238|FG008|Period 1|Adverse Event|0|||
23634512|NCT01370655|66049239|FG009|Period 1|Adverse Event|0|||
23634513|NCT01370655|66049240|FG010|Period 1|Adverse Event|0|||
23634514|NCT01370655|66049241|FG011|Period 1|Adverse Event|0|||
23634515|NCT01370655|66049230|FG000|Period 2|Adverse Event|0|||
23634516|NCT01370655|66049231|FG001|Period 2|Adverse Event|0|||
23634517|NCT01370655|66049232|FG002|Period 2|Adverse Event|1|||
23634518|NCT01370655|66049233|FG003|Period 2|Adverse Event|0|||
23634519|NCT01370655|66049234|FG004|Period 2|Adverse Event|1|||
23634520|NCT01370655|66049235|FG005|Period 2|Adverse Event|0|||
23634521|NCT01370655|66049236|FG006|Period 2|Adverse Event|0|||
23634522|NCT01370655|66049237|FG007|Period 2|Adverse Event|1|||
23634523|NCT01370655|66049238|FG008|Period 2|Adverse Event|0|||
23634524|NCT01370655|66049239|FG009|Period 2|Adverse Event|0|||
23634525|NCT01370655|66049240|FG010|Period 2|Adverse Event|0|||
23778451|NCT02612337|66569687|FG000|Overall Study|Lack of Efficacy|1|||
23578777|NCT01515319|65850290|FG000|Overall Study|Adverse Event|0|||
23578778|NCT01515319|65850291|FG001|Overall Study|Adverse Event|0|||
23578779|NCT01515319|65850292|FG002|Overall Study|Adverse Event|0|||
23578780|NCT01515319|65850293|FG003|Overall Study|Adverse Event|0|||
23578781|NCT01515319|65850294|FG004|Overall Study|Adverse Event|0|||
23578782|NCT01515319|65850295|FG005|Overall Study|Adverse Event|0|||
23578783|NCT01515319|65850296|FG006|Overall Study|Adverse Event|0|||
23578784|NCT01515319|65850297|FG007|Overall Study|Adverse Event|0|||
23578785|NCT01515319|65850298|FG008|Overall Study|Adverse Event|3|||
23578786|NCT01515319|65850299|FG009|Overall Study|Adverse Event|0|||
23578787|NCT01515319|65850290|FG000|Overall Study|Protocol Violation|0|||
23578788|NCT01515319|65850291|FG001|Overall Study|Protocol Violation|0|||
23578789|NCT01515319|65850292|FG002|Overall Study|Protocol Violation|0|||
23578790|NCT01515319|65850293|FG003|Overall Study|Protocol Violation|0|||
23578791|NCT01515319|65850294|FG004|Overall Study|Protocol Violation|0|||
23578792|NCT01515319|65850295|FG005|Overall Study|Protocol Violation|0|||
23578793|NCT01515319|65850296|FG006|Overall Study|Protocol Violation|0|||
23578794|NCT01515319|65850297|FG007|Overall Study|Protocol Violation|0|||
23578795|NCT01515319|65850298|FG008|Overall Study|Protocol Violation|2|||
23634526|NCT01370655|66049241|FG011|Period 2|Adverse Event|0|||
23634527|NCT01370655|66049230|FG000|Period 2|met protocol specified stopping criteria|0|||
23778452|NCT02612337|66569688|FG001|Overall Study|Lack of Efficacy|0|||
23778453|NCT02612337|66569687|FG000|Overall Study|Withdrawal by Subject|2|||
23778454|NCT02612337|66569688|FG001|Overall Study|Withdrawal by Subject|2|||
23778455|NCT02612337|66569687|FG000|Overall Study|Did not receive study drug|0|||
23778456|NCT02612337|66569688|FG001|Overall Study|Did not receive study drug|1|||
23778457|NCT01085045|66569690|FG000|Part A|Withdrawal by Subject|4|||
23778458|NCT01085045|66569690|FG000|Part A|Adverse Event|6|||
23778459|NCT01085045|66569690|FG000|Part A|Protocol Violation|1|||
23778460|NCT01085045|66569690|FG000|Part A|Protocol Specified Criteria|7|||
23778461|NCT01085045|66569690|FG000|Part B|Withdrawal by Subject|2|||
23778462|NCT01085045|66569690|FG000|Part B|Protocol Specified Criteria|6|||
23778463|NCT01085045|66569690|FG000|Part B|Lost to Follow-up|1|||
23778464|NCT01085045|66569690|FG000|Part B|Adverse Event|6|||
23778465|NCT01866319|66569691|FG000|Overall Study|Adverse Event|12|||
23778466|NCT01866319|66569692|FG001|Overall Study|Adverse Event|5|||
23778467|NCT01866319|66569693|FG002|Overall Study|Adverse Event|9|||
23778468|NCT01866319|66569691|FG000|Overall Study|Clinical progression|3|||
23778469|NCT01866319|66569692|FG001|Overall Study|Clinical progression|2|||
23778470|NCT01866319|66569693|FG002|Overall Study|Clinical progression|2|||
23778471|NCT01866319|66569691|FG000|Overall Study|Death|153|||
23778472|NCT01866319|66569692|FG001|Overall Study|Death|154|||
23578796|NCT01515319|65850299|FG009|Overall Study|Protocol Violation|0|||
23578797|NCT02401529|65850300|FG000|Overall Study|Lost to Follow-up|2|||
23578798|NCT02401529|65850301|FG001|Overall Study|Lost to Follow-up|1|||
23578799|NCT02401529|65850300|FG000|Overall Study|Physician Decision|2|||
23634528|NCT01370655|66049231|FG001|Period 2|met protocol specified stopping criteria|0|||
23634529|NCT01370655|66049232|FG002|Period 2|met protocol specified stopping criteria|1|||
23634530|NCT01370655|66049233|FG003|Period 2|met protocol specified stopping criteria|0|||
23634531|NCT01370655|66049234|FG004|Period 2|met protocol specified stopping criteria|0|||
23634532|NCT01370655|66049235|FG005|Period 2|met protocol specified stopping criteria|0|||
23778473|NCT01866319|66569693|FG002|Overall Study|Death|147|||
23778474|NCT01866319|66569691|FG000|Overall Study|Lost to Follow-up|6|||
23578800|NCT02401529|65850301|FG001|Overall Study|Physician Decision|6|||
23578801|NCT02401529|65850300|FG000|Overall Study|Protocol Violation|5|||
23578802|NCT02401529|65850301|FG001|Overall Study|Protocol Violation|0|||
23578803|NCT04523181|65850306|FG000|Overall Study|Withdrawal by Subject|4|||
23578804|NCT04523181|65850307|FG001|Overall Study|Withdrawal by Subject|5|||
23578805|NCT04523181|65850306|FG000|Overall Study|Lost to Follow-up|2|||
23578806|NCT04523181|65850307|FG001|Overall Study|Lost to Follow-up|3|||
23578807|NCT04523181|65850306|FG000|Overall Study|Physician Decision|1|||
23578808|NCT04523181|65850307|FG001|Overall Study|Physician Decision|0|||
23634533|NCT01370655|66049236|FG006|Period 2|met protocol specified stopping criteria|1|||
23634534|NCT01370655|66049237|FG007|Period 2|met protocol specified stopping criteria|0|||
23634535|NCT01370655|66049238|FG008|Period 2|met protocol specified stopping criteria|1|||
23634536|NCT01370655|66049239|FG009|Period 2|met protocol specified stopping criteria|0|||
23634537|NCT01370655|66049240|FG010|Period 2|met protocol specified stopping criteria|1|||
23634538|NCT01370655|66049241|FG011|Period 2|met protocol specified stopping criteria|0|||
23634539|NCT01370655|66049230|FG000|Period 2|Withdrawal by Subject|0|||
23634540|NCT01370655|66049231|FG001|Period 2|Withdrawal by Subject|0|||
23634541|NCT01370655|66049232|FG002|Period 2|Withdrawal by Subject|0|||
23634542|NCT01370655|66049233|FG003|Period 2|Withdrawal by Subject|0|||
23634543|NCT01370655|66049234|FG004|Period 2|Withdrawal by Subject|0|||
23634544|NCT01370655|66049235|FG005|Period 2|Withdrawal by Subject|0|||
23634545|NCT01370655|66049236|FG006|Period 2|Withdrawal by Subject|0|||
23634546|NCT01370655|66049237|FG007|Period 2|Withdrawal by Subject|0|||
23634547|NCT01370655|66049238|FG008|Period 2|Withdrawal by Subject|1|||
23634548|NCT01370655|66049239|FG009|Period 2|Withdrawal by Subject|0|||
23778475|NCT01866319|66569692|FG001|Overall Study|Lost to Follow-up|3|||
23778476|NCT01866319|66569693|FG002|Overall Study|Lost to Follow-up|8|||
23778477|NCT01866319|66569691|FG000|Overall Study|Physician Decision|1|||
23778478|NCT01866319|66569692|FG001|Overall Study|Physician Decision|0|||
23778479|NCT01866319|66569693|FG002|Overall Study|Physician Decision|1|||
23778480|NCT01866319|66569691|FG000|Overall Study|Protocol Violation|0|||
23778481|NCT01866319|66569692|FG001|Overall Study|Protocol Violation|0|||
23778482|NCT01866319|66569693|FG002|Overall Study|Protocol Violation|1|||
23778483|NCT01866319|66569691|FG000|Overall Study|Withdrawal by Subject|32|||
23778484|NCT01866319|66569692|FG001|Overall Study|Withdrawal by Subject|14|||
23778485|NCT01866319|66569693|FG002|Overall Study|Withdrawal by Subject|12|||
23778486|NCT02098876|66569694|FG000|Overall Study|Withdrawal by Subject|5|||
23778487|NCT02098876|66569695|FG001|Overall Study|Withdrawal by Subject|5|||
23778488|NCT02817841|66569696|FG000|Overall Study|Lost to Follow-up|287|||
23778489|NCT02817841|66569696|FG000|Overall Study|Withdrawal by Subject|183|||
23778490|NCT02817841|66569696|FG000|Overall Study|Adverse event not related to bleeding|131|||
23778491|NCT02817841|66569696|FG000|Overall Study|Adverse event related to bleeding|51|||
23778492|NCT02817841|66569696|FG000|Overall Study|Pregnancy|32|||
23778493|NCT02817841|66569696|FG000|Overall Study|Pregnancy wish|17|||
23778494|NCT02817841|66569696|FG000|Overall Study|Other reasons|53|||
23778495|NCT02817841|66569696|FG000|Overall Study|Protocol Violation|94|||
23778496|NCT00864097|66569700|FG000|Overall Study|Death|0|||
23778497|NCT00864097|66569701|FG001|Overall Study|Death|1|||
23778498|NCT00864097|66569702|FG002|Overall Study|Death|0|||
23778499|NCT00864097|66569703|FG003|Overall Study|Death|0|||
23778500|NCT00864097|66569700|FG000|Overall Study|Adverse Event|6|||
23778501|NCT00864097|66569701|FG001|Overall Study|Adverse Event|8|||
23778502|NCT00864097|66569702|FG002|Overall Study|Adverse Event|11|||
23778503|NCT00864097|66569703|FG003|Overall Study|Adverse Event|9|||
23778504|NCT00864097|66569700|FG000|Overall Study|Lack of Efficacy|9|||
23778505|NCT00864097|66569701|FG001|Overall Study|Lack of Efficacy|3|||
23778506|NCT00864097|66569702|FG002|Overall Study|Lack of Efficacy|7|||
23778507|NCT00864097|66569703|FG003|Overall Study|Lack of Efficacy|2|||
23778508|NCT00864097|66569700|FG000|Overall Study|Lost to Follow-up|0|||
23778509|NCT00864097|66569701|FG001|Overall Study|Lost to Follow-up|1|||
23634549|NCT01370655|66049240|FG010|Period 2|Withdrawal by Subject|0|||
23634550|NCT01370655|66049241|FG011|Period 2|Withdrawal by Subject|0|||
23634551|NCT01365481|66049242|FG000|Overall Study|Adverse Event|6|||
23634552|NCT01365481|66049243|FG001|Overall Study|Adverse Event|9|||
23634553|NCT01365481|66049244|FG002|Overall Study|Adverse Event|0|||
23634554|NCT01365481|66049245|FG003|Overall Study|Adverse Event|2|||
23634555|NCT01365481|66049242|FG000|Overall Study|Withdrawal by Subject|0|||
23778510|NCT00864097|66569702|FG002|Overall Study|Lost to Follow-up|0|||
23778511|NCT00864097|66569703|FG003|Overall Study|Lost to Follow-up|1|||
23778512|NCT00864097|66569700|FG000|Overall Study|Withdrawal by Subject|15|||
23578809|NCT04523181|65850306|FG000|Overall Study|Transferred to external facility.|1|||
23634556|NCT01365481|66049243|FG001|Overall Study|Withdrawal by Subject|2|||
23634557|NCT01365481|66049244|FG002|Overall Study|Withdrawal by Subject|1|||
23778513|NCT00864097|66569701|FG001|Overall Study|Withdrawal by Subject|11|||
23578810|NCT04523181|65850307|FG001|Overall Study|Transferred to external facility.|1|||
23778514|NCT00864097|66569702|FG002|Overall Study|Withdrawal by Subject|11|||
23778515|NCT00864097|66569703|FG003|Overall Study|Withdrawal by Subject|12|||
23778516|NCT00864097|66569700|FG000|Overall Study|Protocol Violation|2|||
23778517|NCT00864097|66569701|FG001|Overall Study|Protocol Violation|1|||
23578811|NCT01354938|65850313|FG000|Overall Study|Lost to Follow-up|1|||
23578812|NCT01446003|65850314|FG000|Period 1|Protocol Violation|2|||
23578813|NCT01446003|65850315|FG001|Period 1|Protocol Violation|0|||
23578814|NCT01446003|65850314|FG000|Period 2|Adverse Event|1|||
23578815|NCT01446003|65850315|FG001|Period 2|Adverse Event|0|||
23578816|NCT00953160|65850316|FG000|Overall Study|Lost to Follow-up|23|||
23578817|NCT00953160|65850316|FG000|Overall Study|Withdrawal by Subject|4|||
23578818|NCT02939183|65850317|FG000|Overall Study|Death|0|||
23578819|NCT02939183|65850318|FG001|Overall Study|Death|0|||
23578820|NCT02939183|65850319|FG002|Overall Study|Death|1|||
23578821|NCT02939183|65850320|FG003|Overall Study|Death|0|||
23578822|NCT02939183|65850321|FG004|Overall Study|Death|0|||
23578823|NCT02939183|65850322|FG005|Overall Study|Death|2|||
23578824|NCT02939183|65850323|FG006|Overall Study|Death|1|||
23578825|NCT02939183|65850324|FG007|Overall Study|Death|0|||
23578826|NCT02939183|65850325|FG008|Overall Study|Death|0|||
23578827|NCT02939183|65850317|FG000|Overall Study|Sponsor decision|0|||
23578828|NCT02939183|65850318|FG001|Overall Study|Sponsor decision|1|||
23578829|NCT02939183|65850319|FG002|Overall Study|Sponsor decision|0|||
23578830|NCT02939183|65850320|FG003|Overall Study|Sponsor decision|1|||
23578831|NCT02939183|65850321|FG004|Overall Study|Sponsor decision|2|||
23578832|NCT02939183|65850322|FG005|Overall Study|Sponsor decision|0|||
23578833|NCT02939183|65850323|FG006|Overall Study|Sponsor decision|3|||
23578834|NCT02939183|65850324|FG007|Overall Study|Sponsor decision|1|||
23578835|NCT02939183|65850325|FG008|Overall Study|Sponsor decision|4|||
23578836|NCT02939183|65850317|FG000|Overall Study|Withdrawal by Subject|0|||
23578837|NCT02939183|65850318|FG001|Overall Study|Withdrawal by Subject|2|||
23578838|NCT02939183|65850319|FG002|Overall Study|Withdrawal by Subject|0|||
23578839|NCT02939183|65850320|FG003|Overall Study|Withdrawal by Subject|1|||
23578840|NCT02939183|65850321|FG004|Overall Study|Withdrawal by Subject|0|||
23578841|NCT02939183|65850322|FG005|Overall Study|Withdrawal by Subject|0|||
23578842|NCT02939183|65850323|FG006|Overall Study|Withdrawal by Subject|2|||
23578843|NCT02939183|65850324|FG007|Overall Study|Withdrawal by Subject|2|||
23578844|NCT02939183|65850325|FG008|Overall Study|Withdrawal by Subject|2|||
23578845|NCT02939183|65850317|FG000|Overall Study|Not treated due to adverse event|0|||
23578846|NCT02939183|65850318|FG001|Overall Study|Not treated due to adverse event|0|||
23578847|NCT02939183|65850319|FG002|Overall Study|Not treated due to adverse event|0|||
23578848|NCT02939183|65850320|FG003|Overall Study|Not treated due to adverse event|1|||
23578849|NCT02939183|65850321|FG004|Overall Study|Not treated due to adverse event|0|||
23578850|NCT02939183|65850322|FG005|Overall Study|Not treated due to adverse event|0|||
23578851|NCT02939183|65850323|FG006|Overall Study|Not treated due to adverse event|1|||
23578852|NCT02939183|65850324|FG007|Overall Study|Not treated due to adverse event|0|||
23578853|NCT02939183|65850325|FG008|Overall Study|Not treated due to adverse event|0|||
23578854|NCT03673098|65850328|FG000|Overall Study|Lost to Follow-up|2|||
23578855|NCT03673098|65850329|FG001|Overall Study|Lost to Follow-up|3|||
23578856|NCT03673098|65850328|FG000|Overall Study|Withdrawal by Subject|6|||
23578857|NCT03673098|65850329|FG001|Overall Study|Withdrawal by Subject|1|||
23578858|NCT03673098|65850328|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
23578859|NCT03673098|65850329|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
23578860|NCT02412761|65850330|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578861|NCT02412761|65850331|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578862|NCT02412761|65850332|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578863|NCT02412761|65850333|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578864|NCT02412761|65850334|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578865|NCT02412761|65850335|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578866|NCT00814489|65850340|FG000|Overall Study|Other|2|||
23578867|NCT00814489|65850341|FG001|Overall Study|Other|0|||
23578868|NCT00814489|65850342|FG002|Overall Study|Other|1|||
23578869|NCT00318656|65850346|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
23578870|NCT00318656|65850347|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
23578871|NCT00318656|65850346|FG000|Overall Study|Did not receive any treatment|0|||
23578872|NCT00318656|65850347|FG001|Overall Study|Did not receive any treatment|1|||
23578873|NCT02099539|65850354|FG000|Overall Study|Progressive Disease|3|||
23578874|NCT02099539|65850355|FG001|Overall Study|Progressive Disease|2|||
23778518|NCT00864097|66569702|FG002|Overall Study|Protocol Violation|0|||
23778519|NCT00864097|66569703|FG003|Overall Study|Protocol Violation|1|||
23634558|NCT01365481|66049245|FG003|Overall Study|Withdrawal by Subject|1|||
23778520|NCT00864097|66569700|FG000|Overall Study|Terminated by sponsor|105|||
23778521|NCT00864097|66569701|FG001|Overall Study|Terminated by sponsor|112|||
23578875|NCT02099539|65850356|FG002|Overall Study|Progressive Disease|2|||
23578876|NCT02099539|65850357|FG003|Overall Study|Progressive Disease|1|||
23578877|NCT02099539|65850358|FG004|Overall Study|Progressive Disease|4|||
23578878|NCT02099539|65850359|FG005|Overall Study|Progressive Disease|2|||
23578879|NCT02099539|65850360|FG006|Overall Study|Progressive Disease|0|||
23578880|NCT02099539|65850354|FG000|Overall Study|Adverse Event|0|||
23578881|NCT02099539|65850355|FG001|Overall Study|Adverse Event|0|||
23578882|NCT02099539|65850356|FG002|Overall Study|Adverse Event|1|||
23578883|NCT02099539|65850357|FG003|Overall Study|Adverse Event|1|||
23578884|NCT02099539|65850358|FG004|Overall Study|Adverse Event|0|||
23578885|NCT02099539|65850359|FG005|Overall Study|Adverse Event|0|||
23578886|NCT02099539|65850360|FG006|Overall Study|Adverse Event|0|||
23578887|NCT02099539|65850354|FG000|Overall Study|Physician Decision|0|||
23578888|NCT02099539|65850355|FG001|Overall Study|Physician Decision|0|||
23578889|NCT02099539|65850356|FG002|Overall Study|Physician Decision|0|||
23578890|NCT02099539|65850357|FG003|Overall Study|Physician Decision|0|||
23578891|NCT02099539|65850358|FG004|Overall Study|Physician Decision|0|||
23578892|NCT02099539|65850359|FG005|Overall Study|Physician Decision|1|||
23578893|NCT02099539|65850360|FG006|Overall Study|Physician Decision|0|||
23578894|NCT01222247|65850361|FG000|Overall Study|Lost to Follow-up|2|||
23578895|NCT01222247|65850362|FG001|Overall Study|Lost to Follow-up|2|||
23578896|NCT00924664|65850363|FG000|Overall Study|Adverse Event|23|||
23578897|NCT00924664|65850364|FG001|Overall Study|Adverse Event|39|||
23578898|NCT00924664|65850363|FG000|Overall Study|Lack of Efficacy|10|||
23578899|NCT00924664|65850364|FG001|Overall Study|Lack of Efficacy|15|||
23578900|NCT00924664|65850363|FG000|Overall Study|Lost to Follow-up|10|||
23578901|NCT00924664|65850364|FG001|Overall Study|Lost to Follow-up|12|||
23578902|NCT00924664|65850363|FG000|Overall Study|Withdrawal by Subject|47|||
23578903|NCT00924664|65850364|FG001|Overall Study|Withdrawal by Subject|71|||
23578904|NCT00924664|65850363|FG000|Overall Study|Protocol Violation|2|||
23578905|NCT00924664|65850364|FG001|Overall Study|Protocol Violation|5|||
23578906|NCT00924664|65850363|FG000|Overall Study|Pregnancy|1|||
23578907|NCT00924664|65850364|FG001|Overall Study|Pregnancy|1|||
23578908|NCT00924664|65850363|FG000|Overall Study|Death|0|||
23578909|NCT00924664|65850364|FG001|Overall Study|Death|2|||
23578910|NCT00924664|65850363|FG000|Overall Study|Study terminated by sponsor|199|||
23578911|NCT00924664|65850364|FG001|Overall Study|Study terminated by sponsor|330|||
23578912|NCT00924664|65850363|FG000|Overall Study|Other|29|||
23578913|NCT00924664|65850364|FG001|Overall Study|Other|52|||
23578914|NCT00924664|65850363|FG000|Overall Study|Randomized but not Treated|1|||
23578915|NCT00924664|65850364|FG001|Overall Study|Randomized but not Treated|0|||
23578916|NCT04305912|65850365|FG000|First Intervention|COVID-19 Suspension|2|||
23578917|NCT04305912|65850366|FG001|First Intervention|COVID-19 Suspension|0|||
23578918|NCT04305912|65850365|FG000|First Intervention|Withdrawal by Subject|0|||
23578919|NCT04305912|65850366|FG001|First Intervention|Withdrawal by Subject|1|||
23578920|NCT04305912|65850365|FG000|Second Intervention|Adverse Event|0|||
23578921|NCT04305912|65850366|FG001|Second Intervention|Adverse Event|1|||
23578922|NCT04776213|65850368|FG000|Overall Study|Other|1|||
23578923|NCT04776213|65850368|FG000|Overall Study|Withdrawal by Subject|7|||
23578924|NCT04776213|65850368|FG000|Overall Study|Protocol Violation|1|||
23339096|NCT03843541|64986083|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
23339097|NCT03843541|64986084|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
23838349|NCT02347774|66787747|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
23838350|NCT02347774|66787748|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
23838351|NCT02347774|66787746|FG000|On Study Treatment|ranomized in error|0|||
23838352|NCT02347774|66787747|FG001|On Study Treatment|ranomized in error|0|||
23339098|NCT03843541|64986085|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
23578925|NCT04776213|65850368|FG000|Overall Study|Lost to Follow-up|2|||
23838353|NCT02347774|66787748|FG002|On Study Treatment|ranomized in error|1|||
23838354|NCT03291431|66787750|FG000|Overall Study|Protocol Violation|2|||
23838355|NCT03291431|66787751|FG001|Overall Study|Protocol Violation|1|||
23838356|NCT03291431|66787750|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
23578926|NCT01642186|65850369|FG000|Overall Study|Death|0|||
23578927|NCT01642186|65850370|FG001|Overall Study|Death|2|||
23578928|NCT01642186|65850371|FG002|Overall Study|Death|2|||
23578929|NCT01642186|65850369|FG000|Overall Study|Lost to Follow-up|0|||
23578930|NCT01642186|65850370|FG001|Overall Study|Lost to Follow-up|0|||
23578931|NCT01642186|65850371|FG002|Overall Study|Lost to Follow-up|1|||
23578932|NCT01559090|65850372|FG000|Stage I|Withdrawal by Subject|2|||
23578933|NCT01559090|65850373|FG001|Stage I|Withdrawal by Subject|2|||
23578934|NCT01559090|65850374|FG002|Stage I|Withdrawal by Subject|3|||
23578935|NCT01559090|65850372|FG000|Stage II|Withdrawal by Subject|1|||
23578936|NCT01559090|65850373|FG001|Stage II|Withdrawal by Subject|0|||
23578937|NCT01559090|65850374|FG002|Stage II|Withdrawal by Subject|0|||
23634559|NCT01365481|66049242|FG000|Overall Study|Lost to Follow-up|1|||
23838357|NCT03291431|66787751|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
23578938|NCT03379233|65850375|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
23578939|NCT03379233|65850376|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
23578940|NCT03168438|65850377|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
23578941|NCT03168438|65850378|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
23578942|NCT03523585|65850379|FG000|Overall Study|Progressive Disease|174|||
23578943|NCT03523585|65850380|FG001|Overall Study|Progressive Disease|64|||
23578944|NCT03523585|65850381|FG002|Overall Study|Progressive Disease|77|||
23578945|NCT03523585|65850379|FG000|Overall Study|Adverse Event|74|||
23578946|NCT03523585|65850380|FG001|Overall Study|Adverse Event|5|||
23578947|NCT03523585|65850381|FG002|Overall Study|Adverse Event|9|||
23578948|NCT03523585|65850379|FG000|Overall Study|Withdrawal by Subject|30|||
23578949|NCT03523585|65850380|FG001|Overall Study|Withdrawal by Subject|11|||
23578950|NCT03523585|65850381|FG002|Overall Study|Withdrawal by Subject|6|||
23578951|NCT03523585|65850379|FG000|Overall Study|Clinical Progression|23|||
23578952|NCT03523585|65850380|FG001|Overall Study|Clinical Progression|5|||
23578953|NCT03523585|65850381|FG002|Overall Study|Clinical Progression|10|||
23578954|NCT03523585|65850379|FG000|Overall Study|Death|4|||
23578955|NCT03523585|65850380|FG001|Overall Study|Death|0|||
23578956|NCT03523585|65850381|FG002|Overall Study|Death|1|||
23578957|NCT03523585|65850379|FG000|Overall Study|Physician Decision|2|||
23578958|NCT03523585|65850380|FG001|Overall Study|Physician Decision|1|||
23578959|NCT03523585|65850381|FG002|Overall Study|Physician Decision|0|||
23578960|NCT03523585|65850379|FG000|Overall Study|Lost to Follow-up|1|||
23578961|NCT03523585|65850380|FG001|Overall Study|Lost to Follow-up|0|||
23578962|NCT03523585|65850381|FG002|Overall Study|Lost to Follow-up|0|||
23578963|NCT03523585|65850379|FG000|Overall Study|Miscellaneous|1|||
23578964|NCT03523585|65850380|FG001|Overall Study|Miscellaneous|0|||
23578965|NCT03523585|65850381|FG002|Overall Study|Miscellaneous|0|||
23578966|NCT03523585|65850379|FG000|Overall Study|Protocol Deviation|1|||
23578967|NCT03523585|65850380|FG001|Overall Study|Protocol Deviation|0|||
23578968|NCT03523585|65850381|FG002|Overall Study|Protocol Deviation|1|||
23578969|NCT03523585|65850379|FG000|Overall Study|Randomized But Not Treated|2|||
23578970|NCT03523585|65850380|FG001|Overall Study|Randomized But Not Treated|4|||
23578971|NCT03523585|65850381|FG002|Overall Study|Randomized But Not Treated|3|||
23578972|NCT02015195|65850386|FG000|Overall Study|Adverse Event|0|||
23578973|NCT02015195|65850387|FG001|Overall Study|Adverse Event|0|||
23578974|NCT02015195|65850388|FG002|Overall Study|Adverse Event|0|||
23578975|NCT02015195|65850389|FG003|Overall Study|Adverse Event|1|||
23578976|NCT02015195|65850390|FG004|Overall Study|Adverse Event|0|||
23578977|NCT02015195|65850391|FG005|Overall Study|Adverse Event|0|||
23578978|NCT02015195|65850392|FG006|Overall Study|Adverse Event|0|||
23578979|NCT00945477|65850393|FG000|Overall Study|Adverse Event|3|||
23578980|NCT00945477|65850393|FG000|Overall Study|Lack of Efficacy|2|||
23578981|NCT00945477|65850393|FG000|Overall Study|Withdrawal by Subject|1|||
23578982|NCT01023308|65850394|FG000|Overall Study|Abnormal test proceedure results|3|||
23578983|NCT01023308|65850395|FG001|Overall Study|Abnormal test proceedure results|8|||
23578984|NCT01023308|65850394|FG000|Overall Study|Administrative problems|2|||
23578985|NCT01023308|65850395|FG001|Overall Study|Administrative problems|1|||
23578986|NCT01023308|65850394|FG000|Overall Study|Adverse Event|130|||
23578987|NCT01023308|65850395|FG001|Overall Study|Adverse Event|66|||
23578988|NCT01023308|65850394|FG000|Overall Study|Death|21|||
23578989|NCT01023308|65850395|FG001|Overall Study|Death|17|||
23578990|NCT01023308|65850394|FG000|Overall Study|Disease progression|82|||
23578991|NCT01023308|65850395|FG001|Overall Study|Disease progression|153|||
23578992|NCT01023308|65850394|FG000|Overall Study|New Cancer therapy|4|||
23578993|NCT01023308|65850395|FG001|Overall Study|New Cancer therapy|7|||
23578994|NCT01023308|65850394|FG000|Overall Study|Protocol Violation|3|||
23578995|NCT01023308|65850395|FG001|Overall Study|Protocol Violation|4|||
23578996|NCT01023308|65850394|FG000|Overall Study|Untreated|5|||
23578997|NCT01023308|65850395|FG001|Overall Study|Untreated|5|||
23578998|NCT01023308|65850394|FG000|Overall Study|Lost to Follow-up|1|||
23578999|NCT01023308|65850395|FG001|Overall Study|Lost to Follow-up|0|||
23579000|NCT01023308|65850394|FG000|Overall Study|Withdrawal by Subject|34|||
23579001|NCT01023308|65850395|FG001|Overall Study|Withdrawal by Subject|18|||
23579002|NCT01036087|65850396|FG000|Overall Study|Adverse Event|2|||
23579003|NCT01036087|65850396|FG000|Overall Study|Lack of Efficacy|1|||
23634560|NCT01365481|66049243|FG001|Overall Study|Lost to Follow-up|1|||
23838358|NCT03291431|66787750|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
23838359|NCT03291431|66787751|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
23838360|NCT00356122|66787752|FG000|TREATMENT|Lack of Efficacy|26|||
23579004|NCT01616563|65850400|FG000|Overall Study|Lost to Follow-up|40|||
23579005|NCT04541186|65850404|FG000|Main Study|Adverse Event|0|||
23579006|NCT04541186|65850405|FG001|Main Study|Adverse Event|0|||
23579007|NCT04541186|65850406|FG002|Main Study|Adverse Event|4|||
23579008|NCT04541186|65850407|FG003|Main Study|Adverse Event|0|||
23579009|NCT04541186|65850408|FG004|Main Study|Adverse Event|0|||
23579010|NCT04541186|65850404|FG000|Main Study|Investigator Decision|0|||
23579011|NCT04541186|65850405|FG001|Main Study|Investigator Decision|0|||
23579012|NCT04541186|65850406|FG002|Main Study|Investigator Decision|1|||
23579013|NCT04541186|65850407|FG003|Main Study|Investigator Decision|1|||
23579014|NCT04541186|65850408|FG004|Main Study|Investigator Decision|0|||
23579015|NCT04541186|65850404|FG000|Main Study|Withdrawal by Subject|1|||
23579016|NCT04541186|65850405|FG001|Main Study|Withdrawal by Subject|1|||
23579017|NCT04541186|65850406|FG002|Main Study|Withdrawal by Subject|0|||
23579018|NCT04541186|65850407|FG003|Main Study|Withdrawal by Subject|0|||
23838361|NCT00356122|66787752|FG000|TREATMENT|Adverse Event|10|||
23838362|NCT00356122|66787752|FG000|TREATMENT|Subject's request|4|||
23838363|NCT00356122|66787752|FG000|TREATMENT|Other|4|||
23579019|NCT04541186|65850408|FG004|Main Study|Withdrawal by Subject|0|||
23579020|NCT04541186|65850404|FG000|Main Study|COVID-19-related Dose Interruption|0|||
23579021|NCT04541186|65850405|FG001|Main Study|COVID-19-related Dose Interruption|0|||
23579022|NCT04541186|65850406|FG002|Main Study|COVID-19-related Dose Interruption|0|||
23838364|NCT00356122|66787752|FG000|TREATMENT|Did not receive study medication|1|||
23838365|NCT00356122|66787752|FG000|FOLLOW-UP|Death|37|||
23579023|NCT04541186|65850407|FG003|Main Study|COVID-19-related Dose Interruption|0|||
23579024|NCT04541186|65850408|FG004|Main Study|COVID-19-related Dose Interruption|1|||
23579025|NCT04541186|65850404|FG000|Main Study|Randomized in Error Not Treated|0|||
23579026|NCT04541186|65850405|FG001|Main Study|Randomized in Error Not Treated|0|||
23579027|NCT04541186|65850406|FG002|Main Study|Randomized in Error Not Treated|1|||
23579028|NCT04541186|65850407|FG003|Main Study|Randomized in Error Not Treated|0|||
23579029|NCT04541186|65850408|FG004|Main Study|Randomized in Error Not Treated|0|||
23579030|NCT04541186|65850404|FG000|Fibrate Expansion Study|Other than Specified|0|||
23579031|NCT04541186|65850405|FG001|Fibrate Expansion Study|Other than Specified|0|||
23579032|NCT04541186|65850406|FG002|Fibrate Expansion Study|Other than Specified|0|||
23579033|NCT04541186|65850407|FG003|Fibrate Expansion Study|Other than Specified|0|||
23579034|NCT04541186|65850408|FG004|Fibrate Expansion Study|Other than Specified|1|||
23579035|NCT03772314|65850409|FG000|Overall Study|Adverse Event|7|||
23579036|NCT03772314|65850410|FG001|Overall Study|Adverse Event|2|||
23778522|NCT00864097|66569702|FG002|Overall Study|Terminated by sponsor|102|||
23778523|NCT00864097|66569703|FG003|Overall Study|Terminated by sponsor|99|||
23778524|NCT00864097|66569700|FG000|Overall Study|Randomized but not treated|2|||
23778525|NCT00864097|66569701|FG001|Overall Study|Randomized but not treated|0|||
23838366|NCT00356122|66787752|FG000|FOLLOW-UP|Lost to Follow-up|2|||
23838367|NCT00356122|66787752|FG000|FOLLOW-UP|Other|2|||
23838368|NCT01002989|66787764|FG000|Overall Study|exclusion criteria, no consent|5|||
23838369|NCT03759587|66787765|FG000|Overall Study|Adverse Event|5|||
23838370|NCT03759587|66787765|FG000|Overall Study|Progressive Disease|10|||
23838371|NCT03759587|66787765|FG000|Overall Study|Site Terminated by Sponsor|3|||
23838372|NCT03759587|66787765|FG000|Overall Study|Withdrawal by Subject|1|||
23838373|NCT02955355|66787766|FG000|Overall Study|Adverse Event|4|||
23838374|NCT02955355|66787766|FG000|Overall Study|Death|1|||
23450873|NCT03951077|65395051|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
23579037|NCT05550337|65850411|FG000|Overall Study|Lack of Efficacy|0|||
23579038|NCT05550337|65850412|FG001|Overall Study|Lack of Efficacy|0|||
23778526|NCT00864097|66569702|FG002|Overall Study|Randomized but not treated|1|||
23778527|NCT00864097|66569703|FG003|Overall Study|Randomized but not treated|0|||
23778528|NCT00864097|66569700|FG000|Overall Study|Other|0|||
23778529|NCT00864097|66569701|FG001|Overall Study|Other|0|||
23778530|NCT00864097|66569702|FG002|Overall Study|Other|0|||
23778531|NCT00864097|66569703|FG003|Overall Study|Other|1|||
23778532|NCT01471522|66569705|FG000|Overall Study|Withdrawal by Subject|28|||
23778533|NCT01471522|66569706|FG001|Overall Study|Withdrawal by Subject|22|||
23778534|NCT01471522|66569705|FG000|Overall Study|Lost to Follow-up|36|||
23778535|NCT01471522|66569706|FG001|Overall Study|Lost to Follow-up|26|||
23778536|NCT02511782|66569707|FG000|Overall Study|Withdrawal by Subject|1|||
23778537|NCT02511782|66569708|FG001|Overall Study|Withdrawal by Subject|0|||
23778538|NCT02511782|66569709|FG002|Overall Study|Withdrawal by Subject|0|||
23778539|NCT01391793|66569710|FG000|Overall Study|Ineligible|3|||
23778540|NCT01391793|66569711|FG001|Overall Study|Ineligible|0|||
23778541|NCT01391793|66569710|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
23778542|NCT01391793|66569711|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
23778543|NCT01391793|66569710|FG000|Overall Study|No DMSA|73|||
23778544|NCT01391793|66569711|FG001|Overall Study|No DMSA|57|||
23778545|NCT02732210|66569712|FG000|Overall Study|Site Closed|0|||
23579039|NCT05550337|65850413|FG002|Overall Study|Lack of Efficacy|1|||
23579040|NCT05550337|65850411|FG000|Overall Study|Adverse Event|1|||
23579041|NCT05550337|65850412|FG001|Overall Study|Adverse Event|5|||
23634561|NCT01365481|66049244|FG002|Overall Study|Lost to Follow-up|2|||
23838375|NCT02955355|66787766|FG000|Overall Study|Physician Decision|21|||
23838376|NCT02955355|66787766|FG000|Overall Study|Site Terminated by Sponsor|35|||
23838377|NCT02955355|66787766|FG000|Overall Study|Withdrawal by Subject|19|||
23579042|NCT05550337|65850413|FG002|Overall Study|Adverse Event|0|||
23838378|NCT02955355|66787766|FG000|Overall Study|Reason Not Specified|5|||
23579043|NCT05550337|65850411|FG000|Overall Study|Withdrawal by Subject|8|||
23579044|NCT05550337|65850412|FG001|Overall Study|Withdrawal by Subject|14|||
23579045|NCT05550337|65850413|FG002|Overall Study|Withdrawal by Subject|10|||
23579046|NCT05550337|65850411|FG000|Overall Study|Pregnancy|0|||
23579047|NCT05550337|65850412|FG001|Overall Study|Pregnancy|0|||
23579048|NCT05550337|65850413|FG002|Overall Study|Pregnancy|1|||
23579049|NCT05550337|65850411|FG000|Overall Study|Protocol Violation|1|||
23579050|NCT05550337|65850412|FG001|Overall Study|Protocol Violation|3|||
23579051|NCT05550337|65850413|FG002|Overall Study|Protocol Violation|4|||
23579052|NCT05550337|65850411|FG000|Overall Study|Physician Decision|2|||
23579053|NCT05550337|65850412|FG001|Overall Study|Physician Decision|1|||
23579054|NCT05550337|65850413|FG002|Overall Study|Physician Decision|1|||
23579055|NCT05550337|65850411|FG000|Overall Study|Lost to Follow-up|16|||
23579056|NCT05550337|65850412|FG001|Overall Study|Lost to Follow-up|11|||
23579057|NCT05550337|65850413|FG002|Overall Study|Lost to Follow-up|11|||
23579058|NCT02692235|65850415|FG000|Overall Study|Withdrawal by Subject|2|||
23579059|NCT02692235|65850416|FG001|Overall Study|Withdrawal by Subject|1|||
23579060|NCT02692235|65850415|FG000|Overall Study|Adverse Event|1|||
23579061|NCT02692235|65850416|FG001|Overall Study|Adverse Event|2|||
23579062|NCT00986102|65850417|FG000|Overall Study|Lost to Follow-up|0|||
23579063|NCT00986102|65850418|FG001|Overall Study|Lost to Follow-up|1|||
23579064|NCT00986102|65850419|FG002|Overall Study|Lost to Follow-up|0|||
23579065|NCT00986102|65850420|FG003|Overall Study|Lost to Follow-up|1|||
23579066|NCT00986102|65850417|FG000|Overall Study|Withdrawal by Subject|1|||
23579067|NCT00986102|65850418|FG001|Overall Study|Withdrawal by Subject|1|||
23579068|NCT00986102|65850419|FG002|Overall Study|Withdrawal by Subject|0|||
23579069|NCT00986102|65850420|FG003|Overall Study|Withdrawal by Subject|0|||
23579070|NCT00409708|65850421|FG000|Treatment|Abnormal test procedure result(s)|1|||
23579071|NCT00409708|65850422|FG001|Treatment|Abnormal test procedure result(s)|0|||
23579072|NCT00409708|65850421|FG000|Treatment|Lack of Efficacy|0|||
23579073|NCT00409708|65850422|FG001|Treatment|Lack of Efficacy|1|||
23579074|NCT00409708|65850421|FG000|Treatment|Protocol Violation|6|||
23579075|NCT00409708|65850422|FG001|Treatment|Protocol Violation|2|||
23579076|NCT00409708|65850421|FG000|Treatment|Withdrawal by Subject|3|||
23579077|NCT00409708|65850422|FG001|Treatment|Withdrawal by Subject|8|||
23579078|NCT00409708|65850421|FG000|Treatment|Lost to Follow-up|0|||
23579079|NCT00409708|65850422|FG001|Treatment|Lost to Follow-up|6|||
23579080|NCT00409708|65850421|FG000|Treatment|Administrative problems|5|||
23579081|NCT00409708|65850422|FG001|Treatment|Administrative problems|0|||
23579082|NCT00409708|65850421|FG000|Washout|Lack of Efficacy|9|||
23634562|NCT01365481|66049245|FG003|Overall Study|Lost to Follow-up|3|||
23634563|NCT01365481|66049242|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23778546|NCT02732210|66569713|FG001|Overall Study|Site Closed|11|||
23778547|NCT02732210|66569712|FG000|Overall Study|Study Ended|13|||
23778548|NCT02732210|66569713|FG001|Overall Study|Study Ended|13|||
23778549|NCT02732210|66569712|FG000|Overall Study|Withdrawal by Subject|28|||
23778550|NCT02732210|66569713|FG001|Overall Study|Withdrawal by Subject|87|||
23778551|NCT02732210|66569712|FG000|Overall Study|Lost to Follow-up|5|||
23778552|NCT02732210|66569713|FG001|Overall Study|Lost to Follow-up|57|||
23778553|NCT02732210|66569712|FG000|Overall Study|Death|4|||
23778554|NCT02732210|66569713|FG001|Overall Study|Death|15|||
23778555|NCT02732210|66569712|FG000|Overall Study|Other|35|||
23778556|NCT02732210|66569713|FG001|Overall Study|Other|103|||
23778557|NCT02732210|66569712|FG000|Overall Study|Missing|0|||
23778558|NCT02732210|66569713|FG001|Overall Study|Missing|8|||
23778559|NCT00102440|66569714|FG000|Overall Study|Lost to Follow-up|25|||
23778560|NCT00102440|66569715|FG001|Overall Study|Lost to Follow-up|18|||
23778561|NCT00102440|66569716|FG002|Overall Study|Lost to Follow-up|21|||
23778562|NCT00102440|66569714|FG000|Overall Study|Adverse Event|16|||
23778563|NCT00102440|66569715|FG001|Overall Study|Adverse Event|23|||
23778564|NCT00102440|66569716|FG002|Overall Study|Adverse Event|8|||
23778565|NCT00102440|66569714|FG000|Overall Study|Gout Flare|10|||
23778566|NCT00102440|66569715|FG001|Overall Study|Gout Flare|28|||
23778567|NCT00102440|66569716|FG002|Overall Study|Gout Flare|9|||
23778568|NCT00102440|66569714|FG000|Overall Study|Personal Reason(s)|19|||
23778569|NCT00102440|66569715|FG001|Overall Study|Personal Reason(s)|13|||
23579083|NCT00409708|65850422|FG001|Washout|Lack of Efficacy|1|||
23579084|NCT00409708|65850421|FG000|Washout|Protocol Violation|0|||
23579085|NCT00409708|65850422|FG001|Washout|Protocol Violation|1|||
23579086|NCT00409708|65850421|FG000|Washout|Withdrawal by Subject|11|||
23579087|NCT00409708|65850422|FG001|Washout|Withdrawal by Subject|5|||
23579088|NCT00409708|65850421|FG000|Washout|Lost to Follow-up|1|||
23579089|NCT00409708|65850422|FG001|Washout|Lost to Follow-up|3|||
23579090|NCT01094743|65850423|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
23778570|NCT00102440|66569716|FG002|Overall Study|Personal Reason(s)|13|||
23778571|NCT00102440|66569714|FG000|Overall Study|Other|11|||
23778572|NCT00102440|66569715|FG001|Overall Study|Other|14|||
23778573|NCT00102440|66569716|FG002|Overall Study|Other|14|||
23778574|NCT00102440|66569714|FG000|Overall Study|Protocol Violation|7|||
23778575|NCT00102440|66569715|FG001|Overall Study|Protocol Violation|2|||
23838379|NCT00591565|66787767|FG000|Overall Study|lost follow up, withdrawn|5|||
23838380|NCT03337113|66787770|FG000|Overall Study|Adverse Event|1|||
23838381|NCT03337113|66787771|FG001|Overall Study|Adverse Event|1|||
23450874|NCT03951077|65395052|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
23450875|NCT03951077|65395053|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
23450876|NCT03951077|65395054|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
23450877|NCT02738008|65395058|FG000|Overall Study|Study Terminated by Sponsor|1|||
23450878|NCT02738008|65395059|FG001|Overall Study|Study Terminated by Sponsor|5|||
23450879|NCT02738008|65395060|FG002|Overall Study|Study Terminated by Sponsor|3|||
23450880|NCT02738008|65395058|FG000|Overall Study|Adverse Event|0|||
23450881|NCT02738008|65395059|FG001|Overall Study|Adverse Event|1|||
23579091|NCT00940017|65850424|FG000|Overall Study|did not meet entrance criteria|3|||
23579092|NCT00940017|65850424|FG000|Overall Study|Adverse Event|1|||
23579093|NCT00999661|65850425|FG000|Overall Study|Lost to Follow-up|59|||
23579094|NCT00999661|65850425|FG000|Overall Study|Adverse Event|1|||
23579095|NCT00999661|65850425|FG000|Overall Study|Withdrawal by Subject|1|||
23579096|NCT00999661|65850425|FG000|Overall Study|Not meeting eligibility criteria|9|||
23450882|NCT02738008|65395060|FG002|Overall Study|Adverse Event|2|||
23450883|NCT05579977|65395061|FG000|Treatment Phase|Other|0|||
23450884|NCT05579977|65395062|FG001|Treatment Phase|Other|0|||
23450885|NCT05579977|65395063|FG002|Treatment Phase|Other|0|||
23579097|NCT01167023|65850435|FG000|Overall Study|Lost to Follow-up|0|||
23579098|NCT01167023|65850436|FG001|Overall Study|Lost to Follow-up|1|||
23579099|NCT01167023|65850437|FG002|Overall Study|Lost to Follow-up|1|||
23579100|NCT01167023|65850435|FG000|Overall Study|Screen Failure|0|||
23778576|NCT00102440|66569716|FG002|Overall Study|Protocol Violation|1|||
23778577|NCT02932878|66569717|FG000|Overall Study|Due to Lab Results|2|||
23778578|NCT02932878|66569718|FG001|Overall Study|Due to Lab Results|1|||
23450886|NCT05579977|65395064|FG003|Treatment Phase|Other|2|||
23778579|NCT00473330|66569721|FG000|Core Study|Adverse Event|4|||
23778580|NCT00473330|66569722|FG001|Core Study|Adverse Event|4|||
23778581|NCT00473330|66569723|FG002|Core Study|Adverse Event|1|||
23778582|NCT00473330|66569721|FG000|Core Study|Death|6|||
23450887|NCT05579977|65395065|FG004|Treatment Phase|Other|1|||
23450888|NCT05579977|65395066|FG005|Treatment Phase|Other|2|||
23450889|NCT05579977|65395067|FG006|Treatment Phase|Other|1|||
23450890|NCT05579977|65395068|FG007|Treatment Phase|Other|2|||
23450891|NCT05579977|65395069|FG008|Treatment Phase|Other|2|||
23450892|NCT05579977|65395070|FG009|Treatment Phase|Other|1|||
23450893|NCT05579977|65395071|FG010|Treatment Phase|Other|0|||
23450894|NCT05579977|65395072|FG011|Treatment Phase|Other|0|||
23450895|NCT05579977|65395073|FG012|Treatment Phase|Other|3|||
23450896|NCT05579977|65395061|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
23450897|NCT05579977|65395062|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
23450898|NCT05579977|65395063|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
23450899|NCT05579977|65395064|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
23450900|NCT05579977|65395065|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
23450901|NCT05579977|65395066|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
23450902|NCT05579977|65395067|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
23778583|NCT00473330|66569722|FG001|Core Study|Death|4|||
23778584|NCT00473330|66569723|FG002|Core Study|Death|4|||
23778585|NCT00473330|66569721|FG000|Core Study|Lost to Follow-up|5|||
23778586|NCT00473330|66569722|FG001|Core Study|Lost to Follow-up|5|||
23778587|NCT00473330|66569723|FG002|Core Study|Lost to Follow-up|10|||
23778588|NCT00473330|66569721|FG000|Core Study|Physician Decision|2|||
23778589|NCT00473330|66569722|FG001|Core Study|Physician Decision|1|||
23838382|NCT03337113|66787772|FG002|Overall Study|Adverse Event|0|||
23838383|NCT03337113|66787773|FG003|Overall Study|Adverse Event|1|||
23838384|NCT03337113|66787770|FG000|Overall Study|Physician Decision|0|||
23838385|NCT03337113|66787771|FG001|Overall Study|Physician Decision|2|||
23838386|NCT03337113|66787772|FG002|Overall Study|Physician Decision|0|||
23838387|NCT03337113|66787773|FG003|Overall Study|Physician Decision|1|||
23450903|NCT05579977|65395068|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
23450904|NCT05579977|65395069|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
23450905|NCT05579977|65395070|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
23778590|NCT00473330|66569723|FG002|Core Study|Physician Decision|3|||
23778591|NCT00473330|66569721|FG000|Core Study|Subject Non-compliance|1|||
23838388|NCT03337113|66787770|FG000|Overall Study|Withdrawal by Subject|0|||
23450906|NCT05579977|65395071|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
23579101|NCT01167023|65850436|FG001|Overall Study|Screen Failure|1|||
23579102|NCT01167023|65850437|FG002|Overall Study|Screen Failure|0|||
23778592|NCT00473330|66569722|FG001|Core Study|Subject Non-compliance|2|||
23778593|NCT00473330|66569723|FG002|Core Study|Subject Non-compliance|1|||
23778594|NCT00473330|66569721|FG000|Core Study|Subject Required Other Therapy|0|||
23778595|NCT00473330|66569722|FG001|Core Study|Subject Required Other Therapy|1|||
23838389|NCT03337113|66787771|FG001|Overall Study|Withdrawal by Subject|0|||
23838390|NCT03337113|66787772|FG002|Overall Study|Withdrawal by Subject|1|||
23579103|NCT01167023|65850435|FG000|Overall Study|Sponsor Decision|0|||
23579104|NCT01167023|65850436|FG001|Overall Study|Sponsor Decision|1|||
23579105|NCT01167023|65850437|FG002|Overall Study|Sponsor Decision|0|||
23579106|NCT01167023|65850435|FG000|Overall Study|Withdrawal by Subject|0|||
23579107|NCT01167023|65850436|FG001|Overall Study|Withdrawal by Subject|0|||
23579108|NCT01167023|65850437|FG002|Overall Study|Withdrawal by Subject|1|||
23579109|NCT00495469|65850438|FG000|Overall Study|Adverse Event|0|||
23579110|NCT00495469|65850439|FG001|Overall Study|Adverse Event|1|||
23579111|NCT00495469|65850440|FG002|Overall Study|Adverse Event|3|||
23579112|NCT00495469|65850441|FG003|Overall Study|Adverse Event|0|||
23339121|NCT00890084|64986108|FG000|Overall Study|Adverse Event|16|||
23339122|NCT00890084|64986108|FG000|Overall Study|Lost to Follow-up|126|||
23339123|NCT02759055|64986110|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
23339124|NCT02759055|64986111|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
23339125|NCT02537431|64986114|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
23339126|NCT01867710|64986115|FG000|Overall Study|Death|25|||
23339127|NCT01867710|64986116|FG001|Overall Study|Death|15|||
23339128|NCT01867710|64986117|FG002|Overall Study|Death|27|||
23339129|NCT01867710|64986118|FG003|Overall Study|Death|20|||
23339130|NCT01867710|64986115|FG000|Overall Study|Lost to Follow-up|3|||
23339131|NCT01867710|64986116|FG001|Overall Study|Lost to Follow-up|4|||
23339132|NCT01867710|64986117|FG002|Overall Study|Lost to Follow-up|3|||
23339133|NCT01867710|64986118|FG003|Overall Study|Lost to Follow-up|2|||
23634564|NCT01365481|66049243|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23634565|NCT01365481|66049244|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23634566|NCT01365481|66049245|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23634567|NCT01365481|66049242|FG000|Overall Study|Administrative problems|0|||
23339134|NCT01867710|64986115|FG000|Overall Study|Withdrawal of consent|2|||
23339135|NCT01867710|64986116|FG001|Overall Study|Withdrawal of consent|5|||
23339136|NCT01867710|64986117|FG002|Overall Study|Withdrawal of consent|1|||
23339137|NCT01867710|64986118|FG003|Overall Study|Withdrawal of consent|2|||
23339138|NCT01867710|64986115|FG000|Overall Study|Study Terminated by Sponsor|9|||
23339139|NCT01867710|64986116|FG001|Overall Study|Study Terminated by Sponsor|13|||
23634568|NCT01365481|66049243|FG001|Overall Study|Administrative problems|1|||
23634569|NCT01365481|66049244|FG002|Overall Study|Administrative problems|0|||
23634570|NCT01365481|66049245|FG003|Overall Study|Administrative problems|0|||
23634571|NCT01365481|66049242|FG000|Overall Study|Protocol deviation|0|||
23634572|NCT01365481|66049243|FG001|Overall Study|Protocol deviation|1|||
23634573|NCT01365481|66049244|FG002|Overall Study|Protocol deviation|0|||
23634574|NCT01365481|66049245|FG003|Overall Study|Protocol deviation|1|||
23634575|NCT01365481|66049242|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23634576|NCT01365481|66049243|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23450907|NCT05579977|65395072|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
23450908|NCT05579977|65395073|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
23450909|NCT05579977|65395061|FG000|Treatment Phase|Withdrawal by Subject|2|||
23450910|NCT05579977|65395062|FG001|Treatment Phase|Withdrawal by Subject|0|||
23634577|NCT01365481|66049244|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23634578|NCT01365481|66049245|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23634579|NCT01385748|66049246|FG000|Overall Study|Withdrawal by Subject|7|||
23634580|NCT01385748|66049247|FG001|Overall Study|Withdrawal by Subject|4|||
23634581|NCT01385748|66049248|FG002|Overall Study|Withdrawal by Subject|5|||
23778596|NCT00473330|66569723|FG002|Core Study|Subject Required Other Therapy|3|||
23778597|NCT00473330|66569721|FG000|Core Study|Subject's Decision|9|||
23339140|NCT01867710|64986117|FG002|Overall Study|Study Terminated by Sponsor|8|||
23339141|NCT01867710|64986118|FG003|Overall Study|Study Terminated by Sponsor|16|||
23339142|NCT01867710|64986115|FG000|Overall Study|Biochemical progression|0|||
23339143|NCT01867710|64986116|FG001|Overall Study|Biochemical progression|1|||
23339144|NCT01867710|64986117|FG002|Overall Study|Biochemical progression|0|||
23339145|NCT01867710|64986118|FG003|Overall Study|Biochemical progression|0|||
23579113|NCT00495469|65850442|FG004|Overall Study|Adverse Event|1|||
23634582|NCT01385748|66049246|FG000|Overall Study|Noncompliance|3|||
23634583|NCT01385748|66049247|FG001|Overall Study|Noncompliance|1|||
23339146|NCT01867710|64986115|FG000|Overall Study|Clinical progression|0|||
23339147|NCT01867710|64986116|FG001|Overall Study|Clinical progression|0|||
23579114|NCT00495469|65850443|FG005|Overall Study|Adverse Event|1|||
23579115|NCT00495469|65850444|FG006|Overall Study|Adverse Event|1|||
23450911|NCT05579977|65395063|FG002|Treatment Phase|Withdrawal by Subject|0|||
23450912|NCT05579977|65395064|FG003|Treatment Phase|Withdrawal by Subject|1|||
23450913|NCT05579977|65395065|FG004|Treatment Phase|Withdrawal by Subject|2|||
23450914|NCT05579977|65395066|FG005|Treatment Phase|Withdrawal by Subject|0|||
23450915|NCT05579977|65395067|FG006|Treatment Phase|Withdrawal by Subject|1|||
23450916|NCT05579977|65395068|FG007|Treatment Phase|Withdrawal by Subject|8|||
23450917|NCT05579977|65395069|FG008|Treatment Phase|Withdrawal by Subject|3|||
23450918|NCT05579977|65395070|FG009|Treatment Phase|Withdrawal by Subject|3|||
23450919|NCT05579977|65395071|FG010|Treatment Phase|Withdrawal by Subject|5|||
23450920|NCT05579977|65395072|FG011|Treatment Phase|Withdrawal by Subject|1|||
23450921|NCT05579977|65395073|FG012|Treatment Phase|Withdrawal by Subject|3|||
23339148|NCT01867710|64986117|FG002|Overall Study|Clinical progression|1|||
23339149|NCT01867710|64986118|FG003|Overall Study|Clinical progression|0|||
23339150|NCT01867710|64986115|FG000|Overall Study|Disease progression|1|||
23339151|NCT01867710|64986116|FG001|Overall Study|Disease progression|0|||
23339152|NCT01867710|64986117|FG002|Overall Study|Disease progression|0|||
23339153|NCT01867710|64986118|FG003|Overall Study|Disease progression|0|||
23450922|NCT05579977|65395061|FG000|Treatment Phase|Study terminated by sponsor|70|||
23450923|NCT05579977|65395062|FG001|Treatment Phase|Study terminated by sponsor|70|||
23450924|NCT05579977|65395063|FG002|Treatment Phase|Study terminated by sponsor|61|||
23450925|NCT05579977|65395064|FG003|Treatment Phase|Study terminated by sponsor|59|||
23450926|NCT05579977|65395065|FG004|Treatment Phase|Study terminated by sponsor|63|||
23450927|NCT05579977|65395066|FG005|Treatment Phase|Study terminated by sponsor|53|||
23450928|NCT05579977|65395067|FG006|Treatment Phase|Study terminated by sponsor|66|||
23450929|NCT05579977|65395068|FG007|Treatment Phase|Study terminated by sponsor|48|||
23339154|NCT01867710|64986115|FG000|Overall Study|Patient decision|0|||
23339155|NCT01867710|64986116|FG001|Overall Study|Patient decision|0|||
23339156|NCT01867710|64986117|FG002|Overall Study|Patient decision|0|||
23339157|NCT01867710|64986118|FG003|Overall Study|Patient decision|1|||
23450930|NCT05579977|65395069|FG008|Treatment Phase|Study terminated by sponsor|47|||
23450931|NCT05579977|65395070|FG009|Treatment Phase|Study terminated by sponsor|37|||
23450932|NCT05579977|65395071|FG010|Treatment Phase|Study terminated by sponsor|44|||
23450933|NCT05579977|65395072|FG011|Treatment Phase|Study terminated by sponsor|36|||
23450934|NCT05579977|65395073|FG012|Treatment Phase|Study terminated by sponsor|32|||
23450935|NCT05579977|65395061|FG000|Treatment Phase|Pregnancy|0|||
23450936|NCT05579977|65395062|FG001|Treatment Phase|Pregnancy|0|||
23339158|NCT01867710|64986115|FG000|Overall Study|Patient to follow subsequent treatment|0|||
23339159|NCT01867710|64986116|FG001|Overall Study|Patient to follow subsequent treatment|1|||
23339160|NCT01867710|64986117|FG002|Overall Study|Patient to follow subsequent treatment|0|||
23339161|NCT01867710|64986118|FG003|Overall Study|Patient to follow subsequent treatment|0|||
23450937|NCT05579977|65395063|FG002|Treatment Phase|Pregnancy|0|||
23450938|NCT05579977|65395064|FG003|Treatment Phase|Pregnancy|0|||
23450939|NCT05579977|65395065|FG004|Treatment Phase|Pregnancy|0|||
23450940|NCT05579977|65395066|FG005|Treatment Phase|Pregnancy|0|||
23450941|NCT05579977|65395067|FG006|Treatment Phase|Pregnancy|0|||
23778598|NCT00473330|66569722|FG001|Core Study|Subject's Decision|8|||
23778599|NCT00473330|66569723|FG002|Core Study|Subject's Decision|19|||
23450942|NCT05579977|65395068|FG007|Treatment Phase|Pregnancy|0|||
23450943|NCT05579977|65395069|FG008|Treatment Phase|Pregnancy|0|||
23450944|NCT05579977|65395070|FG009|Treatment Phase|Pregnancy|1|||
23450945|NCT05579977|65395071|FG010|Treatment Phase|Pregnancy|0|||
23579116|NCT00495469|65850438|FG000|Overall Study|Lost to Follow-up|1|||
23579117|NCT00495469|65850439|FG001|Overall Study|Lost to Follow-up|1|||
23778600|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
23778601|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
23339162|NCT01867710|64986115|FG000|Overall Study|Progressive disease|1|||
23339163|NCT01867710|64986116|FG001|Overall Study|Progressive disease|0|||
23339164|NCT01867710|64986117|FG002|Overall Study|Progressive disease|0|||
23579118|NCT00495469|65850440|FG002|Overall Study|Lost to Follow-up|3|||
23579119|NCT00495469|65850441|FG003|Overall Study|Lost to Follow-up|1|||
23579120|NCT00495469|65850442|FG004|Overall Study|Lost to Follow-up|0|||
23778602|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
23778603|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Death|2|||
23778604|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Death|0|||
23339165|NCT01867710|64986118|FG003|Overall Study|Progressive disease|0|||
23339166|NCT01867710|64986115|FG000|Overall Study|Protocol Violation|0|||
23339167|NCT01867710|64986116|FG001|Overall Study|Protocol Violation|0|||
23450946|NCT05579977|65395072|FG011|Treatment Phase|Pregnancy|0|||
23450947|NCT05579977|65395073|FG012|Treatment Phase|Pregnancy|0|||
23450948|NCT05579977|65395061|FG000|Treatment Phase|Physician Decision|0|||
23450949|NCT05579977|65395062|FG001|Treatment Phase|Physician Decision|0|||
23450950|NCT05579977|65395063|FG002|Treatment Phase|Physician Decision|0|||
23450951|NCT05579977|65395064|FG003|Treatment Phase|Physician Decision|0|||
23339168|NCT01867710|64986117|FG002|Overall Study|Protocol Violation|0|||
23579121|NCT00495469|65850443|FG005|Overall Study|Lost to Follow-up|0|||
23579122|NCT00495469|65850444|FG006|Overall Study|Lost to Follow-up|0|||
23579123|NCT00495469|65850438|FG000|Overall Study|Protocol Violation|0|||
23450952|NCT05579977|65395065|FG004|Treatment Phase|Physician Decision|0|||
23450953|NCT05579977|65395066|FG005|Treatment Phase|Physician Decision|0|||
23450954|NCT05579977|65395067|FG006|Treatment Phase|Physician Decision|0|||
23450955|NCT05579977|65395068|FG007|Treatment Phase|Physician Decision|0|||
23450956|NCT05579977|65395069|FG008|Treatment Phase|Physician Decision|0|||
23450957|NCT05579977|65395070|FG009|Treatment Phase|Physician Decision|0|||
23450958|NCT05579977|65395071|FG010|Treatment Phase|Physician Decision|0|||
23450959|NCT05579977|65395072|FG011|Treatment Phase|Physician Decision|1|||
23450960|NCT05579977|65395073|FG012|Treatment Phase|Physician Decision|0|||
23450961|NCT05579977|65395061|FG000|Treatment Phase|Lost to Follow-up|0|||
23450962|NCT05579977|65395062|FG001|Treatment Phase|Lost to Follow-up|0|||
23450963|NCT05579977|65395063|FG002|Treatment Phase|Lost to Follow-up|0|||
23450964|NCT05579977|65395064|FG003|Treatment Phase|Lost to Follow-up|1|||
23450965|NCT05579977|65395065|FG004|Treatment Phase|Lost to Follow-up|1|||
23450966|NCT05579977|65395066|FG005|Treatment Phase|Lost to Follow-up|1|||
23450967|NCT05579977|65395067|FG006|Treatment Phase|Lost to Follow-up|0|||
23450968|NCT05579977|65395068|FG007|Treatment Phase|Lost to Follow-up|1|||
23450969|NCT05579977|65395069|FG008|Treatment Phase|Lost to Follow-up|2|||
23450970|NCT05579977|65395070|FG009|Treatment Phase|Lost to Follow-up|2|||
23450971|NCT05579977|65395071|FG010|Treatment Phase|Lost to Follow-up|1|||
23450972|NCT05579977|65395072|FG011|Treatment Phase|Lost to Follow-up|4|||
23450973|NCT05579977|65395073|FG012|Treatment Phase|Lost to Follow-up|3|||
23450974|NCT05579977|65395061|FG000|Treatment Phase|Death|1|||
23450975|NCT05579977|65395062|FG001|Treatment Phase|Death|0|||
23450976|NCT05579977|65395063|FG002|Treatment Phase|Death|0|||
23450977|NCT05579977|65395064|FG003|Treatment Phase|Death|0|||
23450978|NCT05579977|65395065|FG004|Treatment Phase|Death|0|||
23450979|NCT05579977|65395066|FG005|Treatment Phase|Death|0|||
23450980|NCT05579977|65395067|FG006|Treatment Phase|Death|0|||
23450981|NCT05579977|65395068|FG007|Treatment Phase|Death|0|||
23450982|NCT05579977|65395069|FG008|Treatment Phase|Death|0|||
23450983|NCT05579977|65395070|FG009|Treatment Phase|Death|0|||
23450984|NCT05579977|65395071|FG010|Treatment Phase|Death|0|||
23450985|NCT05579977|65395072|FG011|Treatment Phase|Death|0|||
23450986|NCT05579977|65395073|FG012|Treatment Phase|Death|0|||
23450987|NCT05579977|65395061|FG000|Treatment Phase|Adverse Event|0|||
23450988|NCT05579977|65395062|FG001|Treatment Phase|Adverse Event|3|||
23450989|NCT05579977|65395063|FG002|Treatment Phase|Adverse Event|11|||
23450990|NCT05579977|65395064|FG003|Treatment Phase|Adverse Event|10|||
23450991|NCT05579977|65395065|FG004|Treatment Phase|Adverse Event|5|||
23450992|NCT05579977|65395066|FG005|Treatment Phase|Adverse Event|17|||
23450993|NCT05579977|65395067|FG006|Treatment Phase|Adverse Event|5|||
23450994|NCT05579977|65395068|FG007|Treatment Phase|Adverse Event|5|||
23450995|NCT05579977|65395069|FG008|Treatment Phase|Adverse Event|12|||
23450996|NCT05579977|65395070|FG009|Treatment Phase|Adverse Event|20|||
23450997|NCT05579977|65395071|FG010|Treatment Phase|Adverse Event|15|||
23450998|NCT05579977|65395072|FG011|Treatment Phase|Adverse Event|24|||
23450999|NCT05579977|65395073|FG012|Treatment Phase|Adverse Event|23|||
23451000|NCT05579977|65395061|FG000|Treatment Phase|Randomized not treated|0|||
23451001|NCT05579977|65395062|FG001|Treatment Phase|Randomized not treated|0|||
23451002|NCT05579977|65395063|FG002|Treatment Phase|Randomized not treated|0|||
23451003|NCT05579977|65395064|FG003|Treatment Phase|Randomized not treated|0|||
23451004|NCT05579977|65395065|FG004|Treatment Phase|Randomized not treated|1|||
23451005|NCT05579977|65395066|FG005|Treatment Phase|Randomized not treated|0|||
23451006|NCT05579977|65395067|FG006|Treatment Phase|Randomized not treated|0|||
23451007|NCT05579977|65395068|FG007|Treatment Phase|Randomized not treated|0|||
23451008|NCT05579977|65395069|FG008|Treatment Phase|Randomized not treated|0|||
23451009|NCT05579977|65395070|FG009|Treatment Phase|Randomized not treated|0|||
23451010|NCT05579977|65395071|FG010|Treatment Phase|Randomized not treated|0|||
23451011|NCT05579977|65395072|FG011|Treatment Phase|Randomized not treated|0|||
23634584|NCT01385748|66049248|FG002|Overall Study|Noncompliance|6|||
23634585|NCT01385748|66049246|FG000|Overall Study|Other|1|||
23451012|NCT05579977|65395073|FG012|Treatment Phase|Randomized not treated|0|||
23451013|NCT05579977|65395061|FG000|Follow up|Death|1|||
23451014|NCT05579977|65395062|FG001|Follow up|Death|0|||
23451015|NCT05579977|65395063|FG002|Follow up|Death|0|||
23451016|NCT05579977|65395064|FG003|Follow up|Death|0|||
23451017|NCT05579977|65395065|FG004|Follow up|Death|0|||
23451018|NCT05579977|65395066|FG005|Follow up|Death|0|||
23451019|NCT05579977|65395067|FG006|Follow up|Death|0|||
23451020|NCT05579977|65395068|FG007|Follow up|Death|0|||
23451021|NCT05579977|65395069|FG008|Follow up|Death|0|||
23634586|NCT01385748|66049247|FG001|Overall Study|Other|7|||
23451022|NCT05579977|65395070|FG009|Follow up|Death|0|||
23451023|NCT05579977|65395071|FG010|Follow up|Death|0|||
23451024|NCT05579977|65395072|FG011|Follow up|Death|0|||
23451025|NCT05579977|65395073|FG012|Follow up|Death|0|||
23451026|NCT05579977|65395061|FG000|Follow up|Lost to Follow-up|0|||
23451027|NCT05579977|65395062|FG001|Follow up|Lost to Follow-up|0|||
23451028|NCT05579977|65395063|FG002|Follow up|Lost to Follow-up|0|||
23451029|NCT05579977|65395064|FG003|Follow up|Lost to Follow-up|1|||
23451030|NCT05579977|65395065|FG004|Follow up|Lost to Follow-up|1|||
23634587|NCT01385748|66049248|FG002|Overall Study|Other|1|||
23451031|NCT05579977|65395066|FG005|Follow up|Lost to Follow-up|2|||
23451032|NCT05579977|65395067|FG006|Follow up|Lost to Follow-up|1|||
23451033|NCT05579977|65395068|FG007|Follow up|Lost to Follow-up|1|||
23451034|NCT05579977|65395069|FG008|Follow up|Lost to Follow-up|3|||
23451035|NCT05579977|65395070|FG009|Follow up|Lost to Follow-up|2|||
23451036|NCT05579977|65395071|FG010|Follow up|Lost to Follow-up|2|||
23451037|NCT05579977|65395072|FG011|Follow up|Lost to Follow-up|4|||
23451038|NCT05579977|65395073|FG012|Follow up|Lost to Follow-up|4|||
23451039|NCT05579977|65395061|FG000|Follow up|Withdrawal by Subject|2|||
23451040|NCT05579977|65395062|FG001|Follow up|Withdrawal by Subject|0|||
23451041|NCT05579977|65395063|FG002|Follow up|Withdrawal by Subject|0|||
23451042|NCT05579977|65395064|FG003|Follow up|Withdrawal by Subject|0|||
23451043|NCT05579977|65395065|FG004|Follow up|Withdrawal by Subject|1|||
23451044|NCT05579977|65395066|FG005|Follow up|Withdrawal by Subject|0|||
23451045|NCT05579977|65395067|FG006|Follow up|Withdrawal by Subject|1|||
23451046|NCT05579977|65395068|FG007|Follow up|Withdrawal by Subject|4|||
23451047|NCT05579977|65395069|FG008|Follow up|Withdrawal by Subject|2|||
23451048|NCT05579977|65395070|FG009|Follow up|Withdrawal by Subject|3|||
23451049|NCT05579977|65395071|FG010|Follow up|Withdrawal by Subject|3|||
23451050|NCT05579977|65395072|FG011|Follow up|Withdrawal by Subject|1|||
23451051|NCT05579977|65395073|FG012|Follow up|Withdrawal by Subject|3|||
23451052|NCT04999839|65395074|FG000|Overall Study|Adverse Event|1|||
23451053|NCT04999839|65395075|FG001|Overall Study|Adverse Event|1|||
23451054|NCT04999839|65395076|FG002|Overall Study|Adverse Event|1|||
23451055|NCT04999839|65395077|FG003|Overall Study|Adverse Event|1|||
23451056|NCT04999839|65395078|FG004|Overall Study|Adverse Event|1|||
23451057|NCT04999839|65395074|FG000|Overall Study|Lost to Follow-up|2|||
23451058|NCT04999839|65395075|FG001|Overall Study|Lost to Follow-up|0|||
23451059|NCT04999839|65395076|FG002|Overall Study|Lost to Follow-up|2|||
23451060|NCT04999839|65395077|FG003|Overall Study|Lost to Follow-up|4|||
23451061|NCT04999839|65395078|FG004|Overall Study|Lost to Follow-up|1|||
23451062|NCT04999839|65395074|FG000|Overall Study|Withdrawal by Subject|6|||
23451063|NCT04999839|65395075|FG001|Overall Study|Withdrawal by Subject|5|||
23451064|NCT04999839|65395076|FG002|Overall Study|Withdrawal by Subject|3|||
23451065|NCT04999839|65395077|FG003|Overall Study|Withdrawal by Subject|2|||
23451066|NCT04999839|65395078|FG004|Overall Study|Withdrawal by Subject|2|||
23451067|NCT04999839|65395074|FG000|Overall Study|Lack of Efficacy|0|||
23451068|NCT04999839|65395075|FG001|Overall Study|Lack of Efficacy|1|||
23451069|NCT04999839|65395076|FG002|Overall Study|Lack of Efficacy|0|||
23451070|NCT04999839|65395077|FG003|Overall Study|Lack of Efficacy|0|||
23339169|NCT01867710|64986118|FG003|Overall Study|Protocol Violation|1|||
23339170|NCT01867710|64986115|FG000|Overall Study|PSA-progression|0|||
23339171|NCT01867710|64986116|FG001|Overall Study|PSA-progression|1|||
23339172|NCT01867710|64986117|FG002|Overall Study|PSA-progression|0|||
23339173|NCT01867710|64986118|FG003|Overall Study|PSA-progression|0|||
23451071|NCT04999839|65395078|FG004|Overall Study|Lack of Efficacy|0|||
23451072|NCT04999839|65395074|FG000|Overall Study|Physician Decision|0|||
23579124|NCT00495469|65850439|FG001|Overall Study|Protocol Violation|0|||
23579125|NCT00495469|65850440|FG002|Overall Study|Protocol Violation|0|||
23579126|NCT00495469|65850441|FG003|Overall Study|Protocol Violation|0|||
23579127|NCT00495469|65850442|FG004|Overall Study|Protocol Violation|1|||
23579128|NCT00495469|65850443|FG005|Overall Study|Protocol Violation|2|||
23579129|NCT00495469|65850444|FG006|Overall Study|Protocol Violation|0|||
23579130|NCT00495469|65850438|FG000|Overall Study|Withdrawal by Subject|5|||
23579131|NCT00495469|65850439|FG001|Overall Study|Withdrawal by Subject|3|||
23579132|NCT00495469|65850440|FG002|Overall Study|Withdrawal by Subject|1|||
23579133|NCT00495469|65850441|FG003|Overall Study|Withdrawal by Subject|3|||
23579134|NCT00495469|65850442|FG004|Overall Study|Withdrawal by Subject|3|||
23579135|NCT00495469|65850443|FG005|Overall Study|Withdrawal by Subject|2|||
23579136|NCT00495469|65850444|FG006|Overall Study|Withdrawal by Subject|3|||
23579137|NCT00495469|65850438|FG000|Overall Study|Lack of Efficacy|0|||
23579138|NCT00495469|65850439|FG001|Overall Study|Lack of Efficacy|0|||
23579139|NCT00495469|65850440|FG002|Overall Study|Lack of Efficacy|0|||
23451073|NCT04999839|65395075|FG001|Overall Study|Physician Decision|0|||
23451074|NCT04999839|65395076|FG002|Overall Study|Physician Decision|0|||
23451075|NCT04999839|65395077|FG003|Overall Study|Physician Decision|0|||
23451076|NCT04999839|65395078|FG004|Overall Study|Physician Decision|1|||
23579140|NCT00495469|65850441|FG003|Overall Study|Lack of Efficacy|0|||
23579141|NCT00495469|65850442|FG004|Overall Study|Lack of Efficacy|0|||
23451077|NCT04999839|65395074|FG000|Overall Study|Sponsor request|0|||
23451078|NCT04999839|65395075|FG001|Overall Study|Sponsor request|1|||
23579142|NCT00495469|65850443|FG005|Overall Study|Lack of Efficacy|0|||
23579143|NCT00495469|65850444|FG006|Overall Study|Lack of Efficacy|1|||
23579144|NCT00495469|65850438|FG000|Overall Study|Liver function test abnormality|0|||
23579145|NCT00495469|65850439|FG001|Overall Study|Liver function test abnormality|1|||
23579146|NCT00495469|65850440|FG002|Overall Study|Liver function test abnormality|0|||
23579147|NCT00495469|65850441|FG003|Overall Study|Liver function test abnormality|0|||
23451079|NCT04999839|65395076|FG002|Overall Study|Sponsor request|0|||
23451080|NCT04999839|65395077|FG003|Overall Study|Sponsor request|0|||
23451081|NCT04999839|65395078|FG004|Overall Study|Sponsor request|0|||
23451082|NCT04999839|65395074|FG000|Overall Study|Other|0|||
23451083|NCT04999839|65395075|FG001|Overall Study|Other|0|||
23451084|NCT04999839|65395076|FG002|Overall Study|Other|1|||
23451085|NCT04999839|65395077|FG003|Overall Study|Other|0|||
23451086|NCT04999839|65395078|FG004|Overall Study|Other|0|||
23451087|NCT01300728|65395085|FG000|Overall Study|Withdrawal by Subject|1|||
23451088|NCT01300728|65395086|FG001|Overall Study|Withdrawal by Subject|1|||
23451089|NCT01300728|65395085|FG000|Overall Study|Physician Decision|1|||
23451090|NCT01300728|65395086|FG001|Overall Study|Physician Decision|0|||
23451091|NCT01046565|65395089|FG000|Overall Study|Adverse Event|2|||
23451092|NCT01046565|65395089|FG000|Overall Study|Withdrawal by Subject|7|||
23451093|NCT00960063|65395090|FG000|Overall Study|Adverse Event|1|||
23451094|NCT00960063|65395091|FG001|Overall Study|Adverse Event|0|||
23451095|NCT00960063|65395092|FG002|Overall Study|Adverse Event|0|||
23451096|NCT00960063|65395090|FG000|Overall Study|Progression of Disease|0|||
23451097|NCT00960063|65395091|FG001|Overall Study|Progression of Disease|0|||
23451098|NCT00960063|65395092|FG002|Overall Study|Progression of Disease|3|||
23451099|NCT02610777|65395093|FG000|Overall Study|Lost to Follow-up|1|||
23451100|NCT02610777|65395094|FG001|Overall Study|Lost to Follow-up|0|||
23451101|NCT02610777|65395093|FG000|Overall Study|Site Terminated by Sponsor|9|||
23451102|NCT02610777|65395094|FG001|Overall Study|Site Terminated by Sponsor|8|||
23451103|NCT02610777|65395093|FG000|Overall Study|Withdrawal by Subject|2|||
23451104|NCT02610777|65395094|FG001|Overall Study|Withdrawal by Subject|2|||
23451105|NCT02610777|65395093|FG000|Overall Study|Reason not Specified|0|||
23451106|NCT02610777|65395094|FG001|Overall Study|Reason not Specified|1|||
23451107|NCT02610777|65395093|FG000|Overall Study|Death|50|||
23451108|NCT02610777|65395094|FG001|Overall Study|Death|47|||
23451109|NCT00292942|65395099|FG000|Overall Study|Withdrawal by Subject|0|||
23451110|NCT00292942|65395100|FG001|Overall Study|Withdrawal by Subject|0|||
23451111|NCT00292942|65395101|FG002|Overall Study|Withdrawal by Subject|1|||
23451112|NCT00292942|65395102|FG003|Overall Study|Withdrawal by Subject|0|||
23451113|NCT00292942|65395099|FG000|Overall Study|Adverse Event|0|||
23451114|NCT00292942|65395100|FG001|Overall Study|Adverse Event|0|||
23451115|NCT00292942|65395101|FG002|Overall Study|Adverse Event|0|||
23451116|NCT00292942|65395102|FG003|Overall Study|Adverse Event|1|||
23451117|NCT00527735|65395103|FG000|Overall Study|Disease progression|47|||
23451118|NCT00527735|65395104|FG001|Overall Study|Disease progression|61|||
23451119|NCT00527735|65395105|FG002|Overall Study|Disease progression|53|||
23451120|NCT00527735|65395103|FG000|Overall Study|Death|23|||
23451121|NCT00527735|65395104|FG001|Overall Study|Death|13|||
23451122|NCT00527735|65395105|FG002|Overall Study|Death|15|||
23451123|NCT00527735|65395103|FG000|Overall Study|Completed treatment in treatment phase|14|||
23451124|NCT00527735|65395104|FG001|Overall Study|Completed treatment in treatment phase|13|||
23451125|NCT00527735|65395105|FG002|Overall Study|Completed treatment in treatment phase|18|||
23451126|NCT00527735|65395103|FG000|Overall Study|Adverse Event|10|||
23451127|NCT00527735|65395104|FG001|Overall Study|Adverse Event|6|||
23451128|NCT00527735|65395105|FG002|Overall Study|Adverse Event|7|||
23451129|NCT00527735|65395103|FG000|Overall Study|Not identified|5|||
23451130|NCT00527735|65395104|FG001|Overall Study|Not identified|5|||
23451131|NCT00527735|65395105|FG002|Overall Study|Not identified|5|||
23451132|NCT00527735|65395103|FG000|Overall Study|Withdrawal by Subject|5|||
23451133|NCT00527735|65395104|FG001|Overall Study|Withdrawal by Subject|4|||
23451134|NCT00527735|65395105|FG002|Overall Study|Withdrawal by Subject|3|||
23451135|NCT00527735|65395103|FG000|Overall Study|No longer met study criteria|2|||
23451136|NCT00527735|65395104|FG001|Overall Study|No longer met study criteria|2|||
23451137|NCT00527735|65395105|FG002|Overall Study|No longer met study criteria|1|||
23451138|NCT00527735|65395103|FG000|Overall Study|Lost to Follow-up|0|||
23451139|NCT00527735|65395104|FG001|Overall Study|Lost to Follow-up|0|||
23451140|NCT00527735|65395105|FG002|Overall Study|Lost to Follow-up|3|||
23451141|NCT00527735|65395103|FG000|Overall Study|Poor compliance or noncompliance|0|||
23451142|NCT00527735|65395104|FG001|Overall Study|Poor compliance or noncompliance|1|||
23451143|NCT00527735|65395105|FG002|Overall Study|Poor compliance or noncompliance|1|||
23634588|NCT01385748|66049246|FG000|Overall Study|Adverse Event|4|||
23634589|NCT01385748|66049247|FG001|Overall Study|Adverse Event|2|||
23634590|NCT01385748|66049248|FG002|Overall Study|Adverse Event|1|||
23634591|NCT04129580|66049249|FG000|Overall Study|Lost to Follow-up|14|||
23634592|NCT04129580|66049250|FG001|Overall Study|Lost to Follow-up|25|||
23451144|NCT00527735|65395103|FG000|Overall Study|Completed treatment during maintenance|2|||
23634593|NCT02489968|66049253|FG000|Open-label Treatment Period|Adverse Event|14|||
23778605|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Death|0|||
23451145|NCT00527735|65395104|FG001|Overall Study|Completed treatment during maintenance|2|||
23451146|NCT00527735|65395105|FG002|Overall Study|Completed treatment during maintenance|1|||
23451147|NCT02994108|65395108|FG000|Intervention Messages|Withdrawal by Subject|2|||
23451148|NCT02994108|65395109|FG001|Intervention Messages|Withdrawal by Subject|0|||
23451149|NCT02994108|65395108|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
23634594|NCT02489968|66049254|FG001|Open-label Treatment Period|Adverse Event|7|||
23451150|NCT02994108|65395109|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
23634595|NCT02489968|66049255|FG002|Open-label Treatment Period|Adverse Event|0|||
23634596|NCT02489968|66049256|FG003|Open-label Treatment Period|Adverse Event|0|||
23634597|NCT02489968|66049257|FG004|Open-label Treatment Period|Adverse Event|0|||
23634598|NCT02489968|66049258|FG005|Open-label Treatment Period|Adverse Event|0|||
23634599|NCT02489968|66049253|FG000|Open-label Treatment Period|Protocol Violation|2|||
23634600|NCT02489968|66049254|FG001|Open-label Treatment Period|Protocol Violation|2|||
23634601|NCT02489968|66049255|FG002|Open-label Treatment Period|Protocol Violation|0|||
23634602|NCT02489968|66049256|FG003|Open-label Treatment Period|Protocol Violation|0|||
23634603|NCT02489968|66049257|FG004|Open-label Treatment Period|Protocol Violation|0|||
23634604|NCT02489968|66049258|FG005|Open-label Treatment Period|Protocol Violation|0|||
23634605|NCT02489968|66049253|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23634606|NCT02489968|66049254|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
23634607|NCT02489968|66049255|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23634608|NCT02489968|66049256|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23634609|NCT02489968|66049257|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
23634610|NCT02489968|66049258|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
23634611|NCT02489968|66049253|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
23634612|NCT02489968|66049254|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
23634613|NCT02489968|66049255|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23634614|NCT02489968|66049256|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
23634615|NCT02489968|66049257|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
23634616|NCT02489968|66049258|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
23634617|NCT02489968|66049253|FG000|Open-label Treatment Period|Other than specified above|204|||
23634618|NCT02489968|66049254|FG001|Open-label Treatment Period|Other than specified above|189|||
23634619|NCT02489968|66049255|FG002|Open-label Treatment Period|Other than specified above|0|||
23634620|NCT02489968|66049256|FG003|Open-label Treatment Period|Other than specified above|0|||
23634621|NCT02489968|66049257|FG004|Open-label Treatment Period|Other than specified above|0|||
23634622|NCT02489968|66049258|FG005|Open-label Treatment Period|Other than specified above|0|||
23634623|NCT02489968|66049253|FG000|Double-blind Treatment Period|Adverse Event|0|||
23634624|NCT02489968|66049254|FG001|Double-blind Treatment Period|Adverse Event|0|||
23634625|NCT02489968|66049255|FG002|Double-blind Treatment Period|Adverse Event|2|||
23838391|NCT03337113|66787773|FG003|Overall Study|Withdrawal by Subject|0|||
23838392|NCT04164732|66787779|FG000|Treatment run-in Period|Adverse Event|4|||
23838393|NCT04164732|66787780|FG001|Treatment run-in Period|Adverse Event|0|||
23838394|NCT04164732|66787781|FG002|Treatment run-in Period|Adverse Event|0|||
23838395|NCT04164732|66787779|FG000|Treatment run-in Period|Physician Decision|1|||
23838396|NCT04164732|66787780|FG001|Treatment run-in Period|Physician Decision|0|||
23838397|NCT04164732|66787781|FG002|Treatment run-in Period|Physician Decision|0|||
23838398|NCT04164732|66787779|FG000|Treatment run-in Period|Screen Failure|1|||
23838399|NCT04164732|66787780|FG001|Treatment run-in Period|Screen Failure|0|||
23838400|NCT04164732|66787781|FG002|Treatment run-in Period|Screen Failure|0|||
23838401|NCT04164732|66787779|FG000|Randomized Treatment Period|Adverse Event|0|||
23838402|NCT04164732|66787780|FG001|Randomized Treatment Period|Adverse Event|1|||
23838403|NCT04164732|66787781|FG002|Randomized Treatment Period|Adverse Event|0|||
23838404|NCT04164732|66787779|FG000|Randomized Treatment Period|Protocol Deviation|0|||
23838405|NCT04164732|66787780|FG001|Randomized Treatment Period|Protocol Deviation|1|||
23838406|NCT04164732|66787781|FG002|Randomized Treatment Period|Protocol Deviation|1|||
23838407|NCT04164732|66787779|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
23838408|NCT04164732|66787780|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
23838409|NCT04164732|66787781|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
23838410|NCT00125242|66787782|FG000|Overall Study|did not qualify|7|||
23838411|NCT00125242|66787783|FG001|Overall Study|did not qualify|2|||
23838412|NCT00833105|66787784|FG000|Overall Study|Withdrawal by Subject|1|||
23838413|NCT00833105|66787784|FG000|Overall Study|Adverse Event|2|||
23838414|NCT03515811|66787791|FG000|Overall Study|Lost to Follow-up|2|||
23838415|NCT03515811|66787792|FG001|Overall Study|Lost to Follow-up|1|||
23838416|NCT03515811|66787791|FG000|Overall Study|Protocol Violation|1|||
23838417|NCT03515811|66787792|FG001|Overall Study|Protocol Violation|1|||
23838418|NCT03515811|66787791|FG000|Overall Study|Death|1|||
23838419|NCT03515811|66787792|FG001|Overall Study|Death|1|||
23838420|NCT03515811|66787791|FG000|Overall Study|Withdrawal by Subject|0|||
23838421|NCT03515811|66787792|FG001|Overall Study|Withdrawal by Subject|2|||
23838422|NCT03515811|66787791|FG000|Overall Study|Technical Problems|1|||
23838423|NCT03515811|66787792|FG001|Overall Study|Technical Problems|0|||
23339174|NCT01867710|64986115|FG000|Overall Study|Study medication no longer effective|0|||
23339175|NCT01867710|64986116|FG001|Overall Study|Study medication no longer effective|1|||
23339176|NCT01867710|64986117|FG002|Overall Study|Study medication no longer effective|0|||
23838424|NCT03515811|66787791|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
23838425|NCT03515811|66787792|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
23838426|NCT03515811|66787791|FG000|Overall Study|COVID-19|0|||
23838427|NCT03515811|66787792|FG001|Overall Study|COVID-19|1|||
23838428|NCT02343939|66787797|FG000|Overall Study|Death|0|||
23838429|NCT02343939|66787798|FG001|Overall Study|Death|15|||
23838430|NCT02343939|66787799|FG002|Overall Study|Death|4|||
23838431|NCT02343939|66787800|FG003|Overall Study|Death|2|||
23838432|NCT02343939|66787801|FG004|Overall Study|Death|5|||
23838433|NCT02343939|66787802|FG005|Overall Study|Death|11|||
23838434|NCT02343939|66787803|FG006|Overall Study|Death|8|||
23838435|NCT02343939|66787804|FG007|Overall Study|Death|22|||
23838436|NCT02343939|66787805|FG008|Overall Study|Death|1|||
23838437|NCT02343939|66787797|FG000|Overall Study|Study terminated by sponsor|0|||
23838438|NCT02343939|66787798|FG001|Overall Study|Study terminated by sponsor|27|||
23838439|NCT02343939|66787799|FG002|Overall Study|Study terminated by sponsor|0|||
23339177|NCT01867710|64986118|FG003|Overall Study|Study medication no longer effective|0|||
23579148|NCT00495469|65850442|FG004|Overall Study|Liver function test abnormality|0|||
23579149|NCT00495469|65850443|FG005|Overall Study|Liver function test abnormality|0|||
23579150|NCT00495469|65850444|FG006|Overall Study|Liver function test abnormality|0|||
23579151|NCT00495469|65850438|FG000|Overall Study|ST depression at randomisation in ECG|0|||
23579152|NCT00495469|65850439|FG001|Overall Study|ST depression at randomisation in ECG|1|||
23579153|NCT00495469|65850440|FG002|Overall Study|ST depression at randomisation in ECG|0|||
23579154|NCT00495469|65850441|FG003|Overall Study|ST depression at randomisation in ECG|0|||
23579155|NCT00495469|65850442|FG004|Overall Study|ST depression at randomisation in ECG|0|||
23579156|NCT00495469|65850443|FG005|Overall Study|ST depression at randomisation in ECG|0|||
23579157|NCT00495469|65850444|FG006|Overall Study|ST depression at randomisation in ECG|0|||
23579158|NCT00664521|65850445|FG000|Overall Study|Adverse Event|4|||
23579159|NCT00664521|65850446|FG001|Overall Study|Adverse Event|1|||
23579160|NCT00664521|65850445|FG000|Overall Study|Lost to Follow-up|1|||
23579161|NCT00664521|65850446|FG001|Overall Study|Lost to Follow-up|0|||
23579162|NCT00664521|65850445|FG000|Overall Study|Other|1|||
23579163|NCT00664521|65850446|FG001|Overall Study|Other|0|||
23579164|NCT04096365|65850447|FG000|Overall Study|Adverse Event|1|||
23579165|NCT02688621|65850451|FG000|Overall Study|Pregnancy|1|||
23579166|NCT02688621|65850452|FG001|Overall Study|Pregnancy|3|||
23579167|NCT02688621|65850451|FG000|Overall Study|Lost to Follow-up|38|||
23579168|NCT02688621|65850452|FG001|Overall Study|Lost to Follow-up|15|||
23579169|NCT02688621|65850451|FG000|Overall Study|Withdrawal by Subject|1|||
23579170|NCT02688621|65850452|FG001|Overall Study|Withdrawal by Subject|0|||
23579171|NCT02825043|65850453|FG000|Overall Study|Lost to Follow-up|4|||
23579172|NCT01700530|65850457|FG000|Overall Study|Withdrawal by Subject|0|||
23579173|NCT01700530|65850458|FG001|Overall Study|Withdrawal by Subject|3|||
23579174|NCT01700530|65850459|FG002|Overall Study|Withdrawal by Subject|1|||
23339178|NCT02244463|64986121|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
23339179|NCT02244463|64986122|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339180|NCT02244463|64986123|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339181|NCT02244463|64986124|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339182|NCT02244463|64986125|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339183|NCT02244463|64986126|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339184|NCT02244463|64986121|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
23339185|NCT02244463|64986122|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
23339186|NCT02244463|64986123|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
23339187|NCT02244463|64986124|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
23339188|NCT02244463|64986125|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
23339189|NCT02244463|64986126|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
23339190|NCT02244463|64986121|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339191|NCT02244463|64986122|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
23339192|NCT02244463|64986123|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339193|NCT02244463|64986124|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339194|NCT02244463|64986125|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339195|NCT02244463|64986126|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339196|NCT02244463|64986121|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339197|NCT02244463|64986122|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23579175|NCT01729871|65850460|FG000|Overall Study|Adverse Event|7|||
23579176|NCT01729871|65850461|FG001|Overall Study|Adverse Event|7|||
23339198|NCT02244463|64986123|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
23339199|NCT02244463|64986124|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339200|NCT02244463|64986125|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23579177|NCT01729871|65850460|FG000|Overall Study|Death|0|||
23579178|NCT01729871|65850461|FG001|Overall Study|Death|1|||
23579179|NCT01729871|65850460|FG000|Overall Study|Lack of Efficacy|0|||
23579180|NCT01729871|65850461|FG001|Overall Study|Lack of Efficacy|1|||
23579181|NCT01729871|65850460|FG000|Overall Study|Physician Decision|0|||
23579182|NCT01729871|65850461|FG001|Overall Study|Physician Decision|2|||
23579183|NCT01729871|65850460|FG000|Overall Study|Protocol Violation|1|||
23838440|NCT02343939|66787800|FG003|Overall Study|Study terminated by sponsor|1|||
23838441|NCT02343939|66787801|FG004|Overall Study|Study terminated by sponsor|1|||
23838442|NCT02343939|66787802|FG005|Overall Study|Study terminated by sponsor|5|||
23838443|NCT02343939|66787803|FG006|Overall Study|Study terminated by sponsor|3|||
23339201|NCT02244463|64986126|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339202|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339203|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339204|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339205|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
23339206|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339207|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339208|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339209|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339210|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339211|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
23339212|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339213|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339214|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339215|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339216|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339217|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
23339218|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339219|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339220|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339221|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339222|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339223|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
23339224|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339225|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339226|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339227|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339228|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339229|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
23339230|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339231|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339232|NCT02244463|64986121|FG000|Period 5: Phase II|Disease Progression|0|||
23339233|NCT02244463|64986122|FG001|Period 5: Phase II|Disease Progression|0|||
23339234|NCT02244463|64986123|FG002|Period 5: Phase II|Disease Progression|0|||
23339235|NCT02244463|64986124|FG003|Period 5: Phase II|Disease Progression|0|||
23339236|NCT02244463|64986125|FG004|Period 5: Phase II|Disease Progression|10|||
23339237|NCT02244463|64986126|FG005|Period 5: Phase II|Disease Progression|11|||
23339238|NCT02244463|64986121|FG000|Period 5: Phase II|Physician Decision|0|||
23339239|NCT02244463|64986122|FG001|Period 5: Phase II|Physician Decision|0|||
23339240|NCT02244463|64986123|FG002|Period 5: Phase II|Physician Decision|0|||
23339241|NCT02244463|64986124|FG003|Period 5: Phase II|Physician Decision|0|||
23838444|NCT02343939|66787804|FG007|Overall Study|Study terminated by sponsor|4|||
23838445|NCT02343939|66787805|FG008|Overall Study|Study terminated by sponsor|0|||
23838446|NCT02343939|66787797|FG000|Overall Study|Withdrew consent|3|||
23838447|NCT02343939|66787798|FG001|Overall Study|Withdrew consent|6|||
23838448|NCT02343939|66787799|FG002|Overall Study|Withdrew consent|1|||
23838449|NCT02343939|66787800|FG003|Overall Study|Withdrew consent|2|||
23838450|NCT02343939|66787801|FG004|Overall Study|Withdrew consent|2|||
23838451|NCT02343939|66787802|FG005|Overall Study|Withdrew consent|0|||
23838452|NCT02343939|66787803|FG006|Overall Study|Withdrew consent|0|||
23838453|NCT02343939|66787804|FG007|Overall Study|Withdrew consent|8|||
23838454|NCT02343939|66787805|FG008|Overall Study|Withdrew consent|6|||
23838455|NCT02343939|66787797|FG000|Overall Study|Treatment failure|0|||
23838456|NCT02343939|66787798|FG001|Overall Study|Treatment failure|0|||
23838457|NCT02343939|66787799|FG002|Overall Study|Treatment failure|0|||
23838458|NCT02343939|66787800|FG003|Overall Study|Treatment failure|0|||
23838459|NCT02343939|66787801|FG004|Overall Study|Treatment failure|0|||
23838460|NCT02343939|66787802|FG005|Overall Study|Treatment failure|0|||
23838461|NCT02343939|66787803|FG006|Overall Study|Treatment failure|2|||
23838462|NCT02343939|66787804|FG007|Overall Study|Treatment failure|1|||
23838463|NCT02343939|66787805|FG008|Overall Study|Treatment failure|0|||
23339242|NCT02244463|64986125|FG004|Period 5: Phase II|Physician Decision|3|||
23339243|NCT02244463|64986126|FG005|Period 5: Phase II|Physician Decision|2|||
23339244|NCT02244463|64986121|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
23339245|NCT02244463|64986122|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
23339246|NCT02244463|64986123|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
23838464|NCT02343939|66787797|FG000|Overall Study|Investigator's discretion|0|||
23838465|NCT02343939|66787798|FG001|Overall Study|Investigator's discretion|0|||
23838466|NCT02343939|66787799|FG002|Overall Study|Investigator's discretion|0|||
23838467|NCT02343939|66787800|FG003|Overall Study|Investigator's discretion|1|||
23838468|NCT02343939|66787801|FG004|Overall Study|Investigator's discretion|0|||
23838469|NCT02343939|66787802|FG005|Overall Study|Investigator's discretion|0|||
23339247|NCT02244463|64986124|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
23339248|NCT02244463|64986125|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
23339249|NCT02244463|64986126|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
23339250|NCT02244463|64986121|FG000|Period 5: Phase II|Intercurrent Illness|0|||
23339251|NCT02244463|64986122|FG001|Period 5: Phase II|Intercurrent Illness|0|||
23339252|NCT02244463|64986123|FG002|Period 5: Phase II|Intercurrent Illness|0|||
23339253|NCT02244463|64986124|FG003|Period 5: Phase II|Intercurrent Illness|0|||
23339254|NCT02244463|64986125|FG004|Period 5: Phase II|Intercurrent Illness|2|||
23339255|NCT02244463|64986126|FG005|Period 5: Phase II|Intercurrent Illness|0|||
23339256|NCT02244463|64986121|FG000|Period 5: Phase II|Adverse Event|0|||
23339257|NCT02244463|64986122|FG001|Period 5: Phase II|Adverse Event|0|||
23339258|NCT02244463|64986123|FG002|Period 5: Phase II|Adverse Event|0|||
23339259|NCT02244463|64986124|FG003|Period 5: Phase II|Adverse Event|0|||
23339260|NCT02244463|64986125|FG004|Period 5: Phase II|Adverse Event|0|||
23339261|NCT02244463|64986126|FG005|Period 5: Phase II|Adverse Event|2|||
23339262|NCT02244463|64986121|FG000|Period 5: Phase II|Still On treatment|0|||
23339263|NCT02244463|64986122|FG001|Period 5: Phase II|Still On treatment|0|||
23339264|NCT02244463|64986123|FG002|Period 5: Phase II|Still On treatment|0|||
23339265|NCT02244463|64986124|FG003|Period 5: Phase II|Still On treatment|0|||
23339266|NCT02244463|64986125|FG004|Period 5: Phase II|Still On treatment|0|||
23339267|NCT02244463|64986126|FG005|Period 5: Phase II|Still On treatment|3|||
23339268|NCT01758731|64986130|FG000|Overall Study|Physician Decision|1|||
23339269|NCT01860040|64986131|FG000|Overall Study|Withdrawal by Subject|1|||
23339270|NCT01860040|64986132|FG001|Overall Study|Withdrawal by Subject|0|||
23339271|NCT00729157|64986133|FG000|Overall Study|Withdrawal by Subject|1|||
23339272|NCT01290679|64986136|FG000|Overall Study|Adverse Event|2|||
23339273|NCT01290679|64986137|FG001|Overall Study|Adverse Event|0|||
23339274|NCT01290679|64986136|FG000|Overall Study|Lost to Follow-up|8|||
23339275|NCT01290679|64986137|FG001|Overall Study|Lost to Follow-up|10|||
23339276|NCT01290679|64986136|FG000|Overall Study|Protocol Violation|0|||
23339277|NCT01290679|64986137|FG001|Overall Study|Protocol Violation|1|||
23339278|NCT01290679|64986136|FG000|Overall Study|Withdrawal by Subject|6|||
23339279|NCT01290679|64986137|FG001|Overall Study|Withdrawal by Subject|5|||
23339280|NCT01290679|64986136|FG000|Overall Study|Subject Entered Another Trial|0|||
23339281|NCT01290679|64986137|FG001|Overall Study|Subject Entered Another Trial|5|||
23339282|NCT04672252|64986138|FG000|Overall Study|Protocol Violation|1|||
23339283|NCT04672252|64986139|FG001|Overall Study|Protocol Violation|0|||
23579184|NCT01729871|65850461|FG001|Overall Study|Protocol Violation|0|||
23579185|NCT01729871|65850460|FG000|Overall Study|Withdrawal by Subject|0|||
23579186|NCT01729871|65850461|FG001|Overall Study|Withdrawal by Subject|3|||
23579187|NCT01729871|65850460|FG000|Overall Study|Other|4|||
23579188|NCT01729871|65850461|FG001|Overall Study|Other|9|||
23838470|NCT02343939|66787803|FG006|Overall Study|Investigator's discretion|1|||
23838471|NCT02343939|66787804|FG007|Overall Study|Investigator's discretion|0|||
23838472|NCT02343939|66787805|FG008|Overall Study|Investigator's discretion|0|||
23838473|NCT02343939|66787797|FG000|Overall Study|Adverse Event|0|||
23838474|NCT02343939|66787798|FG001|Overall Study|Adverse Event|0|||
23838475|NCT02343939|66787799|FG002|Overall Study|Adverse Event|0|||
23838476|NCT02343939|66787800|FG003|Overall Study|Adverse Event|0|||
23838477|NCT02343939|66787801|FG004|Overall Study|Adverse Event|0|||
23838478|NCT02343939|66787802|FG005|Overall Study|Adverse Event|1|||
23838479|NCT02343939|66787803|FG006|Overall Study|Adverse Event|0|||
23838480|NCT02343939|66787804|FG007|Overall Study|Adverse Event|0|||
23838481|NCT02343939|66787805|FG008|Overall Study|Adverse Event|0|||
23838482|NCT02343939|66787797|FG000|Overall Study|Never Treated With ENTO|0|||
23838483|NCT02343939|66787798|FG001|Overall Study|Never Treated With ENTO|0|||
23838484|NCT02343939|66787799|FG002|Overall Study|Never Treated With ENTO|0|||
23838485|NCT02343939|66787800|FG003|Overall Study|Never Treated With ENTO|0|||
23838486|NCT02343939|66787801|FG004|Overall Study|Never Treated With ENTO|0|||
23838487|NCT02343939|66787802|FG005|Overall Study|Never Treated With ENTO|0|||
23838488|NCT02343939|66787803|FG006|Overall Study|Never Treated With ENTO|1|||
23339284|NCT01613222|64986140|FG000|Overall Study|Physician Decision|1|||
23339285|NCT01613222|64986140|FG000|Overall Study|Unable to place arterial line|1|||
23339286|NCT01613222|64986140|FG000|Overall Study|Reused disposable sensors|10|||
23339287|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
23339288|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
23339289|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
23339290|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
23339291|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
23339292|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
23339293|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
23579189|NCT00821236|65850462|FG000|Overall Study|Lost to Follow-up|3|||
23838489|NCT02343939|66787804|FG007|Overall Study|Never Treated With ENTO|2|||
23838490|NCT02343939|66787805|FG008|Overall Study|Never Treated With ENTO|0|||
23838491|NCT01735916|66787806|FG000|Overall Study|Subject not eligible to be randomized|11|||
23838492|NCT01735916|66787807|FG001|Overall Study|Subject not eligible to be randomized|0|||
23838493|NCT01735916|66787808|FG002|Overall Study|Subject not eligible to be randomized|0|||
23838494|NCT01735916|66787806|FG000|Overall Study|Early termination of study by sponsor|4|||
23838495|NCT01735916|66787807|FG001|Overall Study|Early termination of study by sponsor|19|||
23838496|NCT01735916|66787808|FG002|Overall Study|Early termination of study by sponsor|7|||
23838497|NCT01735916|66787806|FG000|Overall Study|Withdrawal by Subject|3|||
23838498|NCT01735916|66787807|FG001|Overall Study|Withdrawal by Subject|0|||
23838499|NCT01735916|66787808|FG002|Overall Study|Withdrawal by Subject|0|||
23838500|NCT03876743|66787809|FG000|Overall Study|Lost to Follow-up|6|||
23838501|NCT03876743|66787810|FG001|Overall Study|Lost to Follow-up|4|||
23838502|NCT03876743|66787811|FG002|Overall Study|Lost to Follow-up|4|||
23838503|NCT03876743|66787812|FG003|Overall Study|Lost to Follow-up|7|||
23838504|NCT01091662|66787814|FG000|Overall Study|Adverse Event|1|||
23838505|NCT01091662|66787815|FG001|Overall Study|Adverse Event|9|||
23838506|NCT01091662|66787814|FG000|Overall Study|Physician Decision|1|||
23838507|NCT01091662|66787815|FG001|Overall Study|Physician Decision|1|||
23838508|NCT01091662|66787814|FG000|Overall Study|Withdrawal by Subject|7|||
23838509|NCT01091662|66787815|FG001|Overall Study|Withdrawal by Subject|6|||
23838510|NCT01091662|66787814|FG000|Overall Study|met exit criteria|7|||
23838511|NCT01091662|66787815|FG001|Overall Study|met exit criteria|13|||
23838512|NCT01091662|66787814|FG000|Overall Study|met exclusion criteria|1|||
23838513|NCT01091662|66787815|FG001|Overall Study|met exclusion criteria|0|||
23339294|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
23339295|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
23838514|NCT01091662|66787814|FG000|Overall Study|Lost to Follow-up|0|||
23838515|NCT01091662|66787815|FG001|Overall Study|Lost to Follow-up|1|||
23838516|NCT01091662|66787814|FG000|Overall Study|Pregnancy|0|||
23838517|NCT01091662|66787815|FG001|Overall Study|Pregnancy|1|||
23838518|NCT01091662|66787814|FG000|Overall Study|Protocol Violation|0|||
23838519|NCT01091662|66787815|FG001|Overall Study|Protocol Violation|2|||
23838520|NCT01091662|66787814|FG000|Overall Study|unable to swallow capsule|0|||
23838521|NCT01091662|66787815|FG001|Overall Study|unable to swallow capsule|1|||
23838522|NCT00454363|66787816|FG000|Overall Study|Adverse Event|1|||
23838523|NCT00454363|66787817|FG001|Overall Study|Adverse Event|2|||
23838524|NCT00454363|66787816|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
23838525|NCT00454363|66787817|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
23838526|NCT00179660|66787827|FG000|Overall Study|Adverse Event|7|||
23838527|NCT00179660|66787827|FG000|Overall Study|Lack of therapeutic effect|28|||
23838528|NCT00179660|66787827|FG000|Overall Study|Withdrawal by Subject|2|||
23838529|NCT00179660|66787827|FG000|Overall Study|Lost to Follow-up|1|||
23838530|NCT00179660|66787827|FG000|Overall Study|Death|3|||
23838531|NCT00179660|66787827|FG000|Overall Study|Other - Unspecified|9|||
23838532|NCT04157296|66787828|FG000|Overall Study|Withdrawal by Subject|0|||
23838533|NCT04157296|66787829|FG001|Overall Study|Withdrawal by Subject|1|||
23838534|NCT04157296|66787828|FG000|Overall Study|Did not obtain second fMRI.|0|||
23838535|NCT04157296|66787829|FG001|Overall Study|Did not obtain second fMRI.|1|||
23838536|NCT04157296|66787828|FG000|Overall Study|MRI failed/no second fMRI|0|||
23838537|NCT04157296|66787829|FG001|Overall Study|MRI failed/no second fMRI|1|||
23339296|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
23778606|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23838538|NCT04498182|66787830|FG000|Overall Study|Adverse Event|2|||
23838539|NCT04498182|66787831|FG001|Overall Study|Adverse Event|3|||
23838540|NCT04498182|66787832|FG002|Overall Study|Adverse Event|2|||
23838541|NCT04498182|66787830|FG000|Overall Study|Withdrawal of Consent|3|||
23838542|NCT04498182|66787831|FG001|Overall Study|Withdrawal of Consent|4|||
23838543|NCT04498182|66787832|FG002|Overall Study|Withdrawal of Consent|3|||
23838544|NCT04498182|66787830|FG000|Overall Study|Non-Compliant|1|||
23838545|NCT04498182|66787831|FG001|Overall Study|Non-Compliant|0|||
23838546|NCT04498182|66787832|FG002|Overall Study|Non-Compliant|1|||
23838547|NCT04498182|66787830|FG000|Overall Study|Lost to Follow-up|0|||
23838548|NCT04498182|66787831|FG001|Overall Study|Lost to Follow-up|0|||
23838549|NCT04498182|66787832|FG002|Overall Study|Lost to Follow-up|1|||
23838550|NCT04498182|66787830|FG000|Overall Study|Investigator Decision|0|||
23339297|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23339298|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23838551|NCT04498182|66787831|FG001|Overall Study|Investigator Decision|0|||
23838552|NCT04498182|66787832|FG002|Overall Study|Investigator Decision|1|||
23838553|NCT04498182|66787830|FG000|Overall Study|Protocol Violation|1|||
23838554|NCT04498182|66787831|FG001|Overall Study|Protocol Violation|0|||
23838555|NCT04498182|66787832|FG002|Overall Study|Protocol Violation|2|||
23838556|NCT00740792|66787835|FG000|Overall Study|Adverse Event|3|||
23838557|NCT00740792|66787836|FG001|Overall Study|Adverse Event|1|||
23838558|NCT00740792|66787837|FG002|Overall Study|Adverse Event|1|||
23838559|NCT00740792|66787838|FG003|Overall Study|Adverse Event|3|||
23838560|NCT00740792|66787835|FG000|Overall Study|Lack of Efficacy|1|||
23838561|NCT00740792|66787836|FG001|Overall Study|Lack of Efficacy|1|||
23838562|NCT00740792|66787837|FG002|Overall Study|Lack of Efficacy|0|||
23838563|NCT00740792|66787838|FG003|Overall Study|Lack of Efficacy|3|||
23838564|NCT00740792|66787835|FG000|Overall Study|Lost to Follow-up|2|||
23838565|NCT00740792|66787836|FG001|Overall Study|Lost to Follow-up|1|||
23838566|NCT00740792|66787837|FG002|Overall Study|Lost to Follow-up|0|||
23838567|NCT00740792|66787838|FG003|Overall Study|Lost to Follow-up|0|||
23838568|NCT00740792|66787835|FG000|Overall Study|Protocol Violation|0|||
23838569|NCT00740792|66787836|FG001|Overall Study|Protocol Violation|1|||
23838570|NCT00740792|66787837|FG002|Overall Study|Protocol Violation|0|||
23838571|NCT00740792|66787838|FG003|Overall Study|Protocol Violation|2|||
23838572|NCT00740792|66787835|FG000|Overall Study|Withdrawal by Subject|1|||
23838573|NCT00740792|66787836|FG001|Overall Study|Withdrawal by Subject|1|||
23838574|NCT00740792|66787837|FG002|Overall Study|Withdrawal by Subject|0|||
23838575|NCT00740792|66787838|FG003|Overall Study|Withdrawal by Subject|0|||
23579190|NCT01124617|65850463|FG000|Overall Study|Adverse Event|5|||
23579191|NCT01124617|65850464|FG001|Overall Study|Adverse Event|2|||
23579192|NCT01124617|65850463|FG000|Overall Study|Lack of Efficacy|2|||
23579193|NCT01124617|65850464|FG001|Overall Study|Lack of Efficacy|1|||
23579194|NCT01124617|65850463|FG000|Overall Study|Protocol Violation|1|||
23579195|NCT01124617|65850464|FG001|Overall Study|Protocol Violation|1|||
23579196|NCT01124617|65850463|FG000|Overall Study|Withdrawal by Subject|9|||
23579197|NCT01124617|65850464|FG001|Overall Study|Withdrawal by Subject|1|||
23579198|NCT01124617|65850463|FG000|Overall Study|Other|2|||
23579199|NCT01124617|65850464|FG001|Overall Study|Other|1|||
23579200|NCT02491411|65850467|FG000|Overall Study|Physician Decision|4|||
23579201|NCT03019458|65850468|FG000|Overall Study|Death|0|||
23579202|NCT03019458|65850469|FG001|Overall Study|Death|1|||
23579203|NCT00209027|65850470|FG000|Overall Study|study terminated|10|||
23579204|NCT00209027|65850471|FG001|Overall Study|study terminated|0|||
23579205|NCT02906683|65853291|FG000|Overall Study|Adverse Event|0|||
23579206|NCT02906683|65853292|FG001|Overall Study|Adverse Event|1|||
23579207|NCT02906683|65853293|FG002|Overall Study|Adverse Event|0|||
23579208|NCT02906683|65853291|FG000|Overall Study|Physician Decision|0|||
23778607|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
23778608|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
23778609|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
23778610|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
23778611|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
23778612|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
23778613|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
23838576|NCT00740792|66787835|FG000|Overall Study|administrative|3|||
23451151|NCT02994108|65395108|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
23451152|NCT02994108|65395109|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
23579209|NCT02906683|65853292|FG001|Overall Study|Physician Decision|1|||
23579210|NCT02906683|65853293|FG002|Overall Study|Physician Decision|1|||
23579211|NCT02906683|65853291|FG000|Overall Study|Withdrawal by Subject|0|||
23579212|NCT02906683|65853292|FG001|Overall Study|Withdrawal by Subject|2|||
23579213|NCT02906683|65853293|FG002|Overall Study|Withdrawal by Subject|1|||
23579214|NCT02906683|65853291|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
23579215|NCT02906683|65853292|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
23579216|NCT02906683|65853293|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
23579217|NCT02906683|65853291|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
23579218|NCT02906683|65853292|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
23579219|NCT02906683|65853293|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
23579220|NCT01641861|65853295|FG000|Overall Study|Lost to Follow-up|21|||
23579221|NCT01641861|65853296|FG001|Overall Study|Lost to Follow-up|16|||
23579222|NCT01641861|65853295|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
23579223|NCT01641861|65853296|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
23579224|NCT01641861|65853295|FG000|Overall Study|Died due to drowning|0|||
23579225|NCT01641861|65853296|FG001|Overall Study|Died due to drowning|1|||
23579226|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Death|0|||
23579227|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Death|2|||
23579228|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
23579229|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
23579230|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
23579231|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
23579232|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
23579233|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
23579234|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Death|2|||
23579235|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Death|1|||
23579236|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
23579237|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
23838577|NCT00740792|66787836|FG001|Overall Study|administrative|3|||
23838578|NCT00740792|66787837|FG002|Overall Study|administrative|8|||
23451153|NCT02994108|65395108|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
23838579|NCT00740792|66787838|FG003|Overall Study|administrative|2|||
23838580|NCT00746564|66787839|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
23838581|NCT04478695|66787842|FG000|Overall Study|Death|1|||
23838582|NCT04478695|66787843|FG001|Overall Study|Death|0|||
23838583|NCT03793842|66787844|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
23838584|NCT03793842|66787845|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
23838585|NCT03793842|66787844|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
23838586|NCT03793842|66787845|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
23838587|NCT01436370|66787846|FG000|Overall Study|Lost to Follow-up|0|||
23838588|NCT01436370|66787847|FG001|Overall Study|Lost to Follow-up|0|||
23838589|NCT01436370|66787848|FG002|Overall Study|Lost to Follow-up|0|||
23838590|NCT01436370|66787849|FG003|Overall Study|Lost to Follow-up|0|||
23838591|NCT01436370|66787850|FG004|Overall Study|Lost to Follow-up|1|||
23838592|NCT01436370|66787851|FG005|Overall Study|Lost to Follow-up|0|||
23838593|NCT01436370|66787852|FG006|Overall Study|Lost to Follow-up|0|||
23838594|NCT01436370|66787853|FG007|Overall Study|Lost to Follow-up|0|||
23838595|NCT01876810|66787854|FG000|Overall Study|Physician Decision|0|||
23838596|NCT01876810|66787855|FG001|Overall Study|Physician Decision|1|||
23838597|NCT00831311|66787856|FG000|Overall Study|Definitive Contraindication|3|||
23838598|NCT00831311|66787857|FG001|Overall Study|Definitive Contraindication|3|||
23838599|NCT00831311|66787856|FG000|Overall Study|Lost to Follow-up|3|||
23339299|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
23339300|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23838600|NCT00831311|66787857|FG001|Overall Study|Lost to Follow-up|0|||
23838601|NCT00831311|66787856|FG000|Overall Study|Physician Decision|0|||
23838602|NCT00831311|66787857|FG001|Overall Study|Physician Decision|1|||
23838603|NCT00831311|66787856|FG000|Overall Study|Withdrawal by Subject|6|||
23838604|NCT00831311|66787857|FG001|Overall Study|Withdrawal by Subject|4|||
23838605|NCT00997373|66787858|FG000|Overall Study|Withdrawal by Subject|5|||
23838606|NCT00997373|66787859|FG001|Overall Study|Withdrawal by Subject|0|||
23838607|NCT00997373|66787858|FG000|Overall Study|wrong tumor type|4|||
23838608|NCT00997373|66787859|FG001|Overall Study|wrong tumor type|0|||
23838609|NCT00997373|66787858|FG000|Overall Study|could not have hysterectomy|6|||
23838610|NCT00997373|66787859|FG001|Overall Study|could not have hysterectomy|0|||
23838611|NCT00442897|66787862|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
23838612|NCT00442897|66787863|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
23838613|NCT00442897|66787862|FG000|Base Study (12 Week Follow-up)|Death|0|||
23838614|NCT00442897|66787863|FG001|Base Study (12 Week Follow-up)|Death|1|||
23339301|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
23339302|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Death|0|||
23838615|NCT00442897|66787862|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
23838616|NCT00442897|66787863|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
23838617|NCT00442897|66787862|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
23838618|NCT00442897|66787863|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
23838619|NCT00442897|66787862|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
23838620|NCT00442897|66787863|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
23339303|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Death|0|||
23339304|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Death|1|||
23339305|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Death|2|||
23339306|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Death|7|||
23339307|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
23339308|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
23339309|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
23339310|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
23339311|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
23339312|NCT00941863|64986141|FG000|Continued After PCD|Withdrawal by Subject|0|||
23339313|NCT00941863|64986142|FG001|Continued After PCD|Withdrawal by Subject|0|||
23339314|NCT00941863|64986143|FG002|Continued After PCD|Withdrawal by Subject|0|||
23339315|NCT00941863|64986144|FG003|Continued After PCD|Withdrawal by Subject|0|||
23339316|NCT00941863|64986145|FG004|Continued After PCD|Withdrawal by Subject|1|||
23339317|NCT00941863|64986141|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339318|NCT00941863|64986142|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339319|NCT00941863|64986143|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339320|NCT00941863|64986144|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
23838621|NCT00442897|66787862|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
23838622|NCT00442897|66787863|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
23838623|NCT00442897|66787862|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
23838624|NCT00442897|66787863|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
23838625|NCT00442897|66787862|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
23838626|NCT00442897|66787863|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
23838627|NCT00729612|66787866|FG000|Overall Study|Non evaluable for response|10|||
23838628|NCT02147158|66787867|FG000|Treatment Course 1|Adverse Event|1|||
23838629|NCT02147158|66787868|FG001|Treatment Course 1|Adverse Event|4|||
23838630|NCT02147158|66787869|FG002|Treatment Course 1|Adverse Event|3|||
23838631|NCT02147158|66787870|FG003|Treatment Course 1|Adverse Event|4|||
23838632|NCT02147158|66787871|FG004|Treatment Course 1|Adverse Event|1|||
23838633|NCT02147158|66787872|FG005|Treatment Course 1|Adverse Event|2|||
23838634|NCT02147158|66787867|FG000|Treatment Course 1|Lost to Follow-up|2|||
23838635|NCT02147158|66787868|FG001|Treatment Course 1|Lost to Follow-up|4|||
23838636|NCT02147158|66787869|FG002|Treatment Course 1|Lost to Follow-up|3|||
23838637|NCT02147158|66787870|FG003|Treatment Course 1|Lost to Follow-up|3|||
23838638|NCT02147158|66787871|FG004|Treatment Course 1|Lost to Follow-up|2|||
23838639|NCT02147158|66787872|FG005|Treatment Course 1|Lost to Follow-up|4|||
23838640|NCT02147158|66787867|FG000|Treatment Course 1|Protocol Violation|0|||
23838641|NCT02147158|66787868|FG001|Treatment Course 1|Protocol Violation|0|||
23838642|NCT02147158|66787869|FG002|Treatment Course 1|Protocol Violation|1|||
23838643|NCT02147158|66787870|FG003|Treatment Course 1|Protocol Violation|1|||
23838644|NCT02147158|66787871|FG004|Treatment Course 1|Protocol Violation|0|||
23838645|NCT02147158|66787872|FG005|Treatment Course 1|Protocol Violation|0|||
23838646|NCT02147158|66787867|FG000|Treatment Course 1|Withdrawal of Consent|1|||
23838647|NCT02147158|66787868|FG001|Treatment Course 1|Withdrawal of Consent|1|||
23838648|NCT02147158|66787869|FG002|Treatment Course 1|Withdrawal of Consent|1|||
23838649|NCT02147158|66787870|FG003|Treatment Course 1|Withdrawal of Consent|5|||
23838650|NCT02147158|66787871|FG004|Treatment Course 1|Withdrawal of Consent|3|||
23838651|NCT02147158|66787872|FG005|Treatment Course 1|Withdrawal of Consent|2|||
23838652|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Adverse Event|1|||
23838653|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Adverse Event|0|||
23838654|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Adverse Event|0|||
23838655|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Adverse Event|1|||
23838656|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Adverse Event|0|||
23838657|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Adverse Event|0|||
23838658|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
23838659|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
23838660|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
23838661|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
23838662|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
23838663|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
23838664|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
23838665|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
23838666|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
23838667|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
23838668|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
23339321|NCT00941863|64986145|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
23339322|NCT04533412|64986146|FG000|Overall Study|Withdrawal by Subject|1|||
23339323|NCT04533412|64986147|FG001|Overall Study|Withdrawal by Subject|1|||
23838669|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
23838670|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
23838671|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
23838672|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
23838673|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
23838674|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
23838675|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
23838676|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
23838677|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
23838678|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
23838679|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
23838680|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
23838681|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
23838682|NCT02147158|66787867|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
23579238|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
23579239|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
23838683|NCT02147158|66787868|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23838684|NCT02147158|66787869|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
23838685|NCT02147158|66787870|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
23838686|NCT02147158|66787871|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23838687|NCT02147158|66787872|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23838688|NCT02147158|66787867|FG000|Treatment Course 2|Adverse Event|0|||
23339324|NCT04533412|64986146|FG000|Overall Study|Lost to Follow-up|1|||
23838689|NCT02147158|66787868|FG001|Treatment Course 2|Adverse Event|4|||
23579240|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Death|2|||
23838690|NCT02147158|66787869|FG002|Treatment Course 2|Adverse Event|2|||
23838691|NCT02147158|66787870|FG003|Treatment Course 2|Adverse Event|1|||
23838692|NCT02147158|66787871|FG004|Treatment Course 2|Adverse Event|0|||
23838693|NCT02147158|66787872|FG005|Treatment Course 2|Adverse Event|1|||
23838694|NCT02147158|66787867|FG000|Treatment Course 2|Withdrawal of Consent|0|||
23339325|NCT04533412|64986147|FG001|Overall Study|Lost to Follow-up|4|||
23339326|NCT05483686|64986148|FG000|Overall Study|Lost to Follow-up|5|||
23339327|NCT05483686|64986149|FG001|Overall Study|Lost to Follow-up|7|||
23339328|NCT01163318|64986153|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
23339329|NCT01163318|64986153|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
23339330|NCT01163318|64986153|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
23339331|NCT01163318|64986153|FG000|Overall Study|Participants Without Case Report Form|7|||
23339332|NCT01163318|64986153|FG000|Overall Study|Multiple Reasons Per Participant|224|||
23339333|NCT03301844|64986154|FG000|Overall Study|suspected colon cancer|1|||
23339334|NCT03301844|64986155|FG001|Overall Study|suspected colon cancer|1|||
23339335|NCT01343277|64986156|FG000|Overall Study|Other|3|||
23339336|NCT01343277|64986157|FG001|Overall Study|Other|3|||
23339337|NCT01343277|64986156|FG000|Overall Study|Withdrawal by Subject|18|||
23339338|NCT01343277|64986157|FG001|Overall Study|Withdrawal by Subject|13|||
23339339|NCT01343277|64986156|FG000|Overall Study|Physician Decision|1|||
23451154|NCT02994108|65395109|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
23451155|NCT02300259|65395112|FG000|Period 1|Adverse Event|0|||
23451156|NCT02300259|65395113|FG001|Period 1|Adverse Event|0|||
23451157|NCT02300259|65395114|FG002|Period 1|Adverse Event|1|||
23579241|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Death|0|||
23579242|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
23451158|NCT02300259|65395112|FG000|Period 1|Withdrawal by Subject|0|||
23451159|NCT02300259|65395113|FG001|Period 1|Withdrawal by Subject|0|||
23451160|NCT02300259|65395114|FG002|Period 1|Withdrawal by Subject|1|||
23451161|NCT02300259|65395112|FG000|Period 2|Adverse Event|1|||
23451162|NCT02300259|65395113|FG001|Period 2|Adverse Event|0|||
23451163|NCT02300259|65395114|FG002|Period 2|Adverse Event|0|||
23579243|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
23579244|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
23579245|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
23579246|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
23579247|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
23579248|NCT03176134|65853304|FG000|Overall Study|Lost to Follow-up|0|||
23579249|NCT03176134|65853305|FG001|Overall Study|Lost to Follow-up|2|||
23579250|NCT03176134|65853306|FG002|Overall Study|Lost to Follow-up|0|||
23579251|NCT03176134|65853307|FG003|Overall Study|Lost to Follow-up|0|||
23634626|NCT02489968|66049256|FG003|Double-blind Treatment Period|Adverse Event|6|||
23778614|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
23778615|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
23778616|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
23778617|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
23778618|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
23778619|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
23778620|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
23778621|NCT00473330|66569721|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
23778622|NCT00473330|66569722|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
23778623|NCT00473330|66569723|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
23778624|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
23778625|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
23778626|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
23778627|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Death|2|||
23778628|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Death|2|||
23778629|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Death|1|||
23778630|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
23778631|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
23778632|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
23778633|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
23778634|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
23778635|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
23778636|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
23778637|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
23778638|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
23778639|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
23339340|NCT01343277|64986157|FG001|Overall Study|Physician Decision|2|||
23451164|NCT02300259|65395112|FG000|Period 2|Withdrawal by Subject|0|||
23579252|NCT03176134|65853308|FG004|Overall Study|Lost to Follow-up|0|||
23579253|NCT03176134|65853309|FG005|Overall Study|Lost to Follow-up|0|||
23451165|NCT02300259|65395113|FG001|Period 2|Withdrawal by Subject|0|||
23451166|NCT02300259|65395114|FG002|Period 2|Withdrawal by Subject|1|||
23451167|NCT00659061|65395115|FG000|Overall Study|Migration due to political unrest|21|||
23838695|NCT02147158|66787868|FG001|Treatment Course 2|Withdrawal of Consent|1|||
23838696|NCT02147158|66787869|FG002|Treatment Course 2|Withdrawal of Consent|2|||
23838697|NCT02147158|66787870|FG003|Treatment Course 2|Withdrawal of Consent|3|||
23838698|NCT02147158|66787871|FG004|Treatment Course 2|Withdrawal of Consent|0|||
23838699|NCT02147158|66787872|FG005|Treatment Course 2|Withdrawal of Consent|0|||
23838700|NCT02147158|66787867|FG000|Treatment Course 2|Lost to Follow-up|1|||
23451168|NCT00659061|65395116|FG001|Overall Study|Migration due to political unrest|15|||
23451169|NCT00866177|65395123|FG000|Overall Study|Withdrawal by Subject|1|||
23451170|NCT00866177|65395123|FG000|Overall Study|Not Treated|151|||
23579254|NCT03176134|65853310|FG006|Overall Study|Lost to Follow-up|0|||
23838701|NCT02147158|66787868|FG001|Treatment Course 2|Lost to Follow-up|0|||
23838702|NCT02147158|66787869|FG002|Treatment Course 2|Lost to Follow-up|1|||
23838703|NCT02147158|66787870|FG003|Treatment Course 2|Lost to Follow-up|1|||
23838704|NCT02147158|66787871|FG004|Treatment Course 2|Lost to Follow-up|0|||
23838705|NCT02147158|66787872|FG005|Treatment Course 2|Lost to Follow-up|1|||
23838706|NCT02147158|66787867|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
23838707|NCT02147158|66787868|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
23838708|NCT02147158|66787869|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
23838709|NCT02147158|66787870|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
23838710|NCT02147158|66787871|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
23838711|NCT02147158|66787872|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
23838712|NCT02147158|66787867|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
23838713|NCT02147158|66787868|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
23838714|NCT02147158|66787869|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
23838715|NCT02147158|66787870|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
23838716|NCT02147158|66787871|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
23838717|NCT02147158|66787872|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
23838718|NCT02147158|66787867|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
23838719|NCT02147158|66787868|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
23838720|NCT02147158|66787869|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
23838721|NCT02147158|66787870|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
23838722|NCT02147158|66787871|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
23838723|NCT02147158|66787872|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
23838724|NCT02147158|66787867|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
23838725|NCT02147158|66787868|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
23838726|NCT02147158|66787869|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
23838727|NCT02147158|66787870|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
23838728|NCT02147158|66787871|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
23838729|NCT02147158|66787872|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
23579255|NCT03176134|65853311|FG007|Overall Study|Lost to Follow-up|0|||
23579256|NCT03176134|65853304|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23579257|NCT03176134|65853305|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23579258|NCT03176134|65853306|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23579259|NCT03176134|65853307|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23579260|NCT03176134|65853308|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23579261|NCT03176134|65853309|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23579262|NCT03176134|65853310|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
23579263|NCT03176134|65853311|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
23579264|NCT01417000|65853312|FG000|Overall Study|Death|59|||
23579265|NCT01417000|65853313|FG001|Overall Study|Death|28|||
23579266|NCT01417000|65853312|FG000|Overall Study|Lost to Follow-up|1|||
23579267|NCT01417000|65853313|FG001|Overall Study|Lost to Follow-up|0|||
23579268|NCT01417000|65853312|FG000|Overall Study|Study Terminated by Sponsor|1|||
23579269|NCT01417000|65853313|FG001|Overall Study|Study Terminated by Sponsor|1|||
23579270|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
23579271|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
23579272|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
23579273|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
23579274|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
23579275|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
23579276|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
23579277|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
23579278|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
23838730|NCT02147158|66787867|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
23838731|NCT02147158|66787868|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
23838732|NCT02147158|66787869|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
23838733|NCT02147158|66787870|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
23838734|NCT02147158|66787871|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
23579279|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
23579280|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
23579281|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
23634627|NCT02489968|66049257|FG004|Double-blind Treatment Period|Adverse Event|4|||
23634628|NCT02489968|66049258|FG005|Double-blind Treatment Period|Adverse Event|5|||
23634629|NCT02489968|66049253|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23634630|NCT02489968|66049254|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23634631|NCT02489968|66049255|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23634632|NCT02489968|66049256|FG003|Double-blind Treatment Period|Protocol Violation|0|||
23634633|NCT02489968|66049257|FG004|Double-blind Treatment Period|Protocol Violation|1|||
23634634|NCT02489968|66049258|FG005|Double-blind Treatment Period|Protocol Violation|1|||
23634635|NCT02489968|66049253|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23634636|NCT02489968|66049254|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23634637|NCT02489968|66049255|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23634638|NCT02489968|66049256|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
23634639|NCT02489968|66049257|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23634640|NCT02489968|66049258|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
23634641|NCT02489968|66049253|FG000|Double-blind Treatment Period|Other than specified above|0|||
23634642|NCT02489968|66049254|FG001|Double-blind Treatment Period|Other than specified above|0|||
23634643|NCT02489968|66049255|FG002|Double-blind Treatment Period|Other than specified above|0|||
23634644|NCT02489968|66049256|FG003|Double-blind Treatment Period|Other than specified above|0|||
23634645|NCT02489968|66049257|FG004|Double-blind Treatment Period|Other than specified above|1|||
23634646|NCT02489968|66049258|FG005|Double-blind Treatment Period|Other than specified above|0|||
23634647|NCT03738423|66049259|FG000|Overall Study|Withdrawal by Subject|9|||
23634648|NCT03738423|66049260|FG001|Overall Study|Withdrawal by Subject|12|||
23634649|NCT03738423|66049261|FG002|Overall Study|Withdrawal by Subject|9|||
23634650|NCT03738423|66049262|FG003|Overall Study|Withdrawal by Subject|12|||
23838735|NCT02147158|66787872|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
23838736|NCT01754129|66787873|FG000|Overall Study|Death|13|||
23838737|NCT01754129|66787873|FG000|Overall Study|Duodopa discontinuation|9|||
23838738|NCT01754129|66787873|FG000|Overall Study|Lost to Follow-up|7|||
23579282|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579283|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
23634651|NCT03738423|66049263|FG004|Overall Study|Withdrawal by Subject|10|||
23634652|NCT03738423|66049259|FG000|Overall Study|Lack of Efficacy|3|||
23634653|NCT03738423|66049260|FG001|Overall Study|Lack of Efficacy|1|||
23634654|NCT03738423|66049261|FG002|Overall Study|Lack of Efficacy|1|||
23634655|NCT03738423|66049262|FG003|Overall Study|Lack of Efficacy|1|||
23634656|NCT03738423|66049263|FG004|Overall Study|Lack of Efficacy|2|||
23634657|NCT03738423|66049259|FG000|Overall Study|Lost to Follow-up|1|||
23634658|NCT03738423|66049260|FG001|Overall Study|Lost to Follow-up|0|||
23634659|NCT03738423|66049261|FG002|Overall Study|Lost to Follow-up|1|||
23634660|NCT03738423|66049262|FG003|Overall Study|Lost to Follow-up|1|||
23634661|NCT03738423|66049263|FG004|Overall Study|Lost to Follow-up|0|||
23634662|NCT03738423|66049259|FG000|Overall Study|Protocol Violation|1|||
23579284|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579285|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579286|NCT02851511|65853331|FG000|Phase I|Physician Decision|0|||
23579287|NCT02851511|65853332|FG001|Phase I|Physician Decision|0|||
23634663|NCT03738423|66049260|FG001|Overall Study|Protocol Violation|0|||
23634664|NCT03738423|66049261|FG002|Overall Study|Protocol Violation|0|||
23634665|NCT03738423|66049262|FG003|Overall Study|Protocol Violation|0|||
23634666|NCT03738423|66049263|FG004|Overall Study|Protocol Violation|1|||
23634667|NCT03738423|66049259|FG000|Overall Study|Physician Decision|0|||
23634668|NCT03738423|66049260|FG001|Overall Study|Physician Decision|0|||
23579288|NCT02851511|65853333|FG002|Phase I|Physician Decision|0|||
23579289|NCT02851511|65853334|FG003|Phase I|Physician Decision|1|||
23579290|NCT02851511|65853331|FG000|Phase I|Withdrawal by Subject|2|||
23579291|NCT02851511|65853332|FG001|Phase I|Withdrawal by Subject|1|||
23579292|NCT02851511|65853333|FG002|Phase I|Withdrawal by Subject|0|||
23579293|NCT02851511|65853334|FG003|Phase I|Withdrawal by Subject|3|||
23579294|NCT02851511|65853331|FG000|Phase II|Physician Decision|18|||
23634669|NCT03738423|66049261|FG002|Overall Study|Physician Decision|1|||
23634670|NCT03738423|66049262|FG003|Overall Study|Physician Decision|0|||
23634671|NCT03738423|66049263|FG004|Overall Study|Physician Decision|1|||
23634672|NCT03738423|66049259|FG000|Overall Study|Death|0|||
23634673|NCT03738423|66049260|FG001|Overall Study|Death|0|||
23838739|NCT01754129|66787873|FG000|Overall Study|Withdrew consent|1|||
23579295|NCT02851511|65853332|FG001|Phase II|Physician Decision|16|||
23579296|NCT02851511|65853333|FG002|Phase II|Physician Decision|0|||
23579297|NCT02851511|65853334|FG003|Phase II|Physician Decision|0|||
23634674|NCT03738423|66049261|FG002|Overall Study|Death|0|||
23634675|NCT03738423|66049262|FG003|Overall Study|Death|0|||
23634676|NCT03738423|66049263|FG004|Overall Study|Death|1|||
23634677|NCT03738423|66049259|FG000|Overall Study|Randomized but never treated|0|||
23634678|NCT03738423|66049260|FG001|Overall Study|Randomized but never treated|0|||
23634679|NCT03738423|66049261|FG002|Overall Study|Randomized but never treated|1|||
23579298|NCT02851511|65853331|FG000|Phase II|Withdrawal by Subject|18|||
23634680|NCT03738423|66049262|FG003|Overall Study|Randomized but never treated|1|||
23634681|NCT03738423|66049263|FG004|Overall Study|Randomized but never treated|0|||
23634682|NCT01513330|66049264|FG000|SenSura Mio First,|Adverse Event|2|||
23634683|NCT01513330|66049265|FG001|SenSura Mio First,|Adverse Event|0|||
23634684|NCT01513330|66049264|FG000|SenSura Mio First,|Lack of Efficacy|0|||
23634685|NCT01513330|66049265|FG001|SenSura Mio First,|Lack of Efficacy|1|||
23634686|NCT01513330|66049264|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
23634687|NCT01513330|66049265|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
23634688|NCT01513330|66049264|FG000|SenSura Mio First,|Other|1|||
23634689|NCT01513330|66049265|FG001|SenSura Mio First,|Other|0|||
23634690|NCT01513330|66049264|FG000|Standard Care First,|Lack of Efficacy|2|||
23634691|NCT01513330|66049265|FG001|Standard Care First,|Lack of Efficacy|2|||
23634692|NCT01513330|66049264|FG000|Standard Care First,|Withdrawal by Subject|1|||
23634693|NCT01513330|66049265|FG001|Standard Care First,|Withdrawal by Subject|2|||
23634694|NCT01513330|66049264|FG000|Standard Care First,|Other|1|||
23634695|NCT01513330|66049265|FG001|Standard Care First,|Other|0|||
23634696|NCT01865747|66049268|FG000|Overall Study (ITT)|Adverse Event|32|||
23634697|NCT01865747|66049269|FG001|Overall Study (ITT)|Adverse Event|31|||
23634698|NCT01865747|66049268|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
23634699|NCT01865747|66049269|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
23634700|NCT01865747|66049268|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
23634701|NCT01865747|66049269|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
23634702|NCT01865747|66049268|FG000|Overall Study (ITT)|Protocol Violation|1|||
23634703|NCT01865747|66049269|FG001|Overall Study (ITT)|Protocol Violation|1|||
23579299|NCT02851511|65853332|FG001|Phase II|Withdrawal by Subject|16|||
23579300|NCT02851511|65853333|FG002|Phase II|Withdrawal by Subject|0|||
23634704|NCT01865747|66049268|FG000|Overall Study (ITT)|Physician Decision|5|||
23634705|NCT01865747|66049269|FG001|Overall Study (ITT)|Physician Decision|2|||
23634706|NCT01865747|66049268|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
23778640|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
23579301|NCT02851511|65853334|FG003|Phase II|Withdrawal by Subject|0|||
23778641|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
23579302|NCT02851511|65853331|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
23579303|NCT02851511|65853332|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
23579304|NCT02851511|65853333|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
23579305|NCT02851511|65853334|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
23634707|NCT01865747|66049269|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
23634708|NCT01865747|66049268|FG000|Overall Study (ITT)|Sponsor Decision|0|||
23778642|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
23778643|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
23778644|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
23778645|NCT00473330|66569721|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
23778646|NCT00473330|66569722|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
23778647|NCT00473330|66569723|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
23778648|NCT00625443|66569724|FG000|Overall Study|Adverse Event|1|||
23778649|NCT00625443|66569725|FG001|Overall Study|Adverse Event|4|||
23778650|NCT00625443|66569726|FG002|Overall Study|Adverse Event|0|||
23778651|NCT00625443|66569724|FG000|Overall Study|Non-compliance with protocol|0|||
23778652|NCT00625443|66569725|FG001|Overall Study|Non-compliance with protocol|1|||
23778653|NCT00625443|66569726|FG002|Overall Study|Non-compliance with protocol|0|||
23778654|NCT00625443|66569724|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
23778655|NCT00625443|66569725|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
23778656|NCT00625443|66569726|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
23778657|NCT00625443|66569724|FG000|Overall Study|Withdrawal by Subject|0|||
23778658|NCT00625443|66569725|FG001|Overall Study|Withdrawal by Subject|1|||
23778659|NCT00625443|66569726|FG002|Overall Study|Withdrawal by Subject|2|||
23778660|NCT00625443|66569724|FG000|Overall Study|Physician Decision|0|||
23778661|NCT00625443|66569725|FG001|Overall Study|Physician Decision|4|||
23778662|NCT00625443|66569726|FG002|Overall Study|Physician Decision|2|||
23778663|NCT00625443|66569724|FG000|Overall Study|Other|0|||
23778664|NCT00625443|66569725|FG001|Overall Study|Other|1|||
23778665|NCT00625443|66569726|FG002|Overall Study|Other|1|||
23778666|NCT04605094|66569731|FG000|Overall Study|Adverse Event|2|||
23778667|NCT04605094|66569732|FG001|Overall Study|Adverse Event|2|||
23778668|NCT04605094|66569731|FG000|Overall Study|Lost to Follow-up|1|||
23778669|NCT04605094|66569732|FG001|Overall Study|Lost to Follow-up|4|||
23778670|NCT04605094|66569731|FG000|Overall Study|Physician Decision|2|||
23778671|NCT04605094|66569732|FG001|Overall Study|Physician Decision|2|||
23778672|NCT04605094|66569731|FG000|Overall Study|Study terminated by Sponsor|31|||
23778673|NCT04605094|66569732|FG001|Overall Study|Study terminated by Sponsor|33|||
23579306|NCT02851511|65853331|FG000|Phase II|Lost to Follow-up|0|||
23634709|NCT01865747|66049269|FG001|Overall Study (ITT)|Sponsor Decision|1|||
23634710|NCT01865747|66049268|FG000|Overall Study (ITT)|Progressive Disease|122|||
23579307|NCT02851511|65853332|FG001|Phase II|Lost to Follow-up|1|||
23579308|NCT02851511|65853333|FG002|Phase II|Lost to Follow-up|0|||
23579309|NCT02851511|65853334|FG003|Phase II|Lost to Follow-up|0|||
23579310|NCT00871429|65853335|FG000|Overall Study|Lost to Follow-up|6|||
23579311|NCT00871429|65853335|FG000|Overall Study|Withdrawal by Subject|17|||
23579312|NCT00871429|65853335|FG000|Overall Study|Questionnaire not completed|1|||
23579313|NCT02373813|65853336|FG000|Run-In Period|Other, Not Specified|5|||
23579314|NCT02373813|65853337|FG001|Run-In Period|Other, Not Specified|0|||
23579315|NCT02373813|65853338|FG002|Run-In Period|Other, Not Specified|0|||
23579316|NCT02373813|65853339|FG003|Run-In Period|Other, Not Specified|0|||
23579317|NCT02373813|65853336|FG000|Run-In Period|Withdrawal by Subject|16|||
23634711|NCT01865747|66049269|FG001|Overall Study (ITT)|Progressive Disease|158|||
23634712|NCT01865747|66049268|FG000|Overall Study (ITT)|Reason Not Provided|0|||
23634713|NCT01865747|66049269|FG001|Overall Study (ITT)|Reason Not Provided|1|||
23634714|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
23634715|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
23634716|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
23634717|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
23634718|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
23634719|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
23634720|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
23634721|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
23634722|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
23634723|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
23634724|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
23634725|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
23634726|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
23634727|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
23634728|NCT01865747|66049268|FG000|Primary Intent to Treat (PITT)|Other|0|||
23634729|NCT01865747|66049269|FG001|Primary Intent to Treat (PITT)|Other|1|||
23634730|NCT03117998|66049270|FG000|Overall Study|Adverse Event|1|||
23634731|NCT03117998|66049271|FG001|Overall Study|Adverse Event|0|||
23634732|NCT03117998|66049272|FG002|Overall Study|Adverse Event|0|||
23634733|NCT03117998|66049273|FG003|Overall Study|Adverse Event|0|||
23634734|NCT03117998|66049274|FG004|Overall Study|Adverse Event|0|||
23838740|NCT01754129|66787873|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
23838741|NCT00356148|66787875|FG000|Overall Study|Reoperation within 30 days|2|||
23634735|NCT03117998|66049275|FG005|Overall Study|Adverse Event|0|||
23634736|NCT03117998|66049270|FG000|Overall Study|Withdrawal by Subject|0|||
23634737|NCT03117998|66049271|FG001|Overall Study|Withdrawal by Subject|0|||
23634738|NCT03117998|66049272|FG002|Overall Study|Withdrawal by Subject|2|||
23634739|NCT03117998|66049273|FG003|Overall Study|Withdrawal by Subject|3|||
23634740|NCT03117998|66049274|FG004|Overall Study|Withdrawal by Subject|3|||
23634741|NCT03117998|66049275|FG005|Overall Study|Withdrawal by Subject|0|||
23634742|NCT03117998|66049270|FG000|Overall Study|Physician Decision|0|||
23634743|NCT03117998|66049271|FG001|Overall Study|Physician Decision|1|||
23634744|NCT03117998|66049272|FG002|Overall Study|Physician Decision|1|||
23634745|NCT03117998|66049273|FG003|Overall Study|Physician Decision|0|||
23778674|NCT04605094|66569731|FG000|Overall Study|Withdrawal by Subject|22|||
23778675|NCT04605094|66569732|FG001|Overall Study|Withdrawal by Subject|19|||
23778676|NCT04605094|66569731|FG000|Overall Study|Other|1|||
23778677|NCT04605094|66569732|FG001|Overall Study|Other|1|||
23778678|NCT01355081|66569737|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
23778679|NCT01355081|66569738|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23778680|NCT01355081|66569739|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23778681|NCT01355081|66569737|FG000|Overall Study|Major Protocol Deviation|0|||
23778682|NCT01355081|66569738|FG001|Overall Study|Major Protocol Deviation|1|||
23778683|NCT01355081|66569739|FG002|Overall Study|Major Protocol Deviation|0|||
23778684|NCT01355081|66569737|FG000|Overall Study|Lost to Follow-up|0|||
23778685|NCT01355081|66569738|FG001|Overall Study|Lost to Follow-up|0|||
23778686|NCT01355081|66569739|FG002|Overall Study|Lost to Follow-up|1|||
23778687|NCT01355081|66569737|FG000|Overall Study|Withdrawal of Consent|2|||
23778688|NCT01355081|66569738|FG001|Overall Study|Withdrawal of Consent|3|||
23778689|NCT01355081|66569739|FG002|Overall Study|Withdrawal of Consent|3|||
23838742|NCT00356148|66787876|FG001|Overall Study|Reoperation within 30 days|1|||
23579318|NCT02373813|65853337|FG001|Run-In Period|Withdrawal by Subject|0|||
23579319|NCT02373813|65853338|FG002|Run-In Period|Withdrawal by Subject|0|||
23579320|NCT02373813|65853339|FG003|Run-In Period|Withdrawal by Subject|0|||
23634746|NCT03117998|66049274|FG004|Overall Study|Physician Decision|0|||
23634747|NCT03117998|66049275|FG005|Overall Study|Physician Decision|0|||
23634748|NCT03117998|66049270|FG000|Overall Study|Lost to Follow-up|0|||
23634749|NCT03117998|66049271|FG001|Overall Study|Lost to Follow-up|0|||
23634750|NCT03117998|66049272|FG002|Overall Study|Lost to Follow-up|0|||
23778690|NCT01355081|66569737|FG000|Overall Study|Lack of Efficacy|2|||
23778691|NCT01355081|66569738|FG001|Overall Study|Lack of Efficacy|1|||
23778692|NCT01355081|66569739|FG002|Overall Study|Lack of Efficacy|1|||
23838743|NCT00576420|66787877|FG000|Overall Study|Death|0|||
23838744|NCT00576420|66787878|FG001|Overall Study|Death|0|||
23838745|NCT00576420|66787879|FG002|Overall Study|Death|1|||
23838746|NCT02780713|66787880|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23838747|NCT02780713|66787881|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23838748|NCT02780713|66787882|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
23838749|NCT02780713|66787883|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23838750|NCT02780713|66787884|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23838751|NCT03645395|66787886|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
23838752|NCT03645395|66787887|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
23838753|NCT03645395|66787888|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
23838754|NCT03645395|66787889|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
23838755|NCT03645395|66787886|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
23838756|NCT03645395|66787887|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
23838757|NCT03645395|66787888|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
23838758|NCT03645395|66787889|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
23838759|NCT03645395|66787886|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23838760|NCT03645395|66787887|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23838761|NCT03645395|66787888|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
23838762|NCT03645395|66787889|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23838763|NCT03645395|66787886|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
23838764|NCT03645395|66787887|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
23838765|NCT03645395|66787888|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
23838766|NCT03645395|66787889|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
23838767|NCT02844933|66787896|FG000|Overall Study|Discontinued due to premature termination of study|3|||
23838768|NCT02844933|66787897|FG001|Overall Study|Discontinued due to premature termination of study|2|||
23838769|NCT03809663|66787898|FG000|Overall Study|Decision by sponsor|24|||
23838770|NCT03809663|66787899|FG001|Overall Study|Decision by sponsor|18|||
23838771|NCT03809663|66787900|FG002|Overall Study|Decision by sponsor|20|||
23838772|NCT03809663|66787901|FG003|Overall Study|Decision by sponsor|20|||
23838773|NCT03809663|66787902|FG004|Overall Study|Decision by sponsor|0|||
23838774|NCT03809663|66787903|FG005|Overall Study|Decision by sponsor|0|||
23838775|NCT03809663|66787898|FG000|Overall Study|Withdrawal by Subject|26|||
23838776|NCT03809663|66787899|FG001|Overall Study|Withdrawal by Subject|22|||
23838777|NCT03809663|66787900|FG002|Overall Study|Withdrawal by Subject|27|||
23838778|NCT03809663|66787901|FG003|Overall Study|Withdrawal by Subject|26|||
23838779|NCT03809663|66787902|FG004|Overall Study|Withdrawal by Subject|0|||
23838780|NCT03809663|66787903|FG005|Overall Study|Withdrawal by Subject|0|||
23838781|NCT03809663|66787898|FG000|Overall Study|Lost to Follow-up|1|||
23838782|NCT03809663|66787899|FG001|Overall Study|Lost to Follow-up|4|||
23838783|NCT03809663|66787900|FG002|Overall Study|Lost to Follow-up|1|||
23339341|NCT01343277|64986156|FG000|Overall Study|Death|10|||
23339342|NCT01343277|64986157|FG001|Overall Study|Death|1|||
23339343|NCT01343277|64986156|FG000|Overall Study|Adverse Event|67|||
23339344|NCT01343277|64986157|FG001|Overall Study|Adverse Event|13|||
23339345|NCT01343277|64986156|FG000|Overall Study|Disease progression|270|||
23339346|NCT01343277|64986157|FG001|Overall Study|Disease progression|138|||
23339347|NCT01343277|64986156|FG000|Overall Study|Randomized not treated|6|||
23339348|NCT01343277|64986157|FG001|Overall Study|Randomized not treated|21|||
23339349|NCT01343277|64986156|FG000|Overall Study|Treatment ongoing|8|||
23339350|NCT01343277|64986157|FG001|Overall Study|Treatment ongoing|2|||
23339351|NCT01343277|64986156|FG000|Overall Study|Subsequent anticancer therapy|1|||
23339352|NCT01343277|64986157|FG001|Overall Study|Subsequent anticancer therapy|0|||
23339353|NCT02833844|64986165|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23339354|NCT02833844|64986166|FG001|Double-Blind Period|Withdrawal by Subject|3|||
23339355|NCT02833844|64986165|FG000|Double-Blind Period|Protocol Violation|0|||
23339356|NCT02833844|64986166|FG001|Double-Blind Period|Protocol Violation|4|||
23339357|NCT02833844|64986165|FG000|Open-Label Period|Death|0|||
23579321|NCT02373813|65853336|FG000|Run-In Period|Decision by Sponsor|11|||
23634751|NCT03117998|66049273|FG003|Overall Study|Lost to Follow-up|1|||
23838784|NCT03809663|66787901|FG003|Overall Study|Lost to Follow-up|1|||
23838785|NCT03809663|66787902|FG004|Overall Study|Lost to Follow-up|0|||
23838786|NCT03809663|66787903|FG005|Overall Study|Lost to Follow-up|0|||
23838787|NCT03482453|66787906|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838788|NCT03482453|66787907|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838789|NCT03482453|66787908|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838790|NCT03482453|66787909|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838791|NCT03482453|66787910|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838792|NCT03482453|66787911|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838793|NCT03482453|66787912|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838794|NCT03482453|66787913|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838795|NCT03482453|66787914|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23339358|NCT02833844|64986166|FG001|Open-Label Period|Death|2|||
23339359|NCT02833844|64986165|FG000|Open-Label Period|Lost to Follow-up|1|||
23339360|NCT02833844|64986166|FG001|Open-Label Period|Lost to Follow-up|0|||
23579322|NCT02373813|65853337|FG001|Run-In Period|Decision by Sponsor|0|||
23838796|NCT03482453|66787915|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838797|NCT03482453|66787916|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
23838798|NCT03482453|66787917|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23838799|NCT02530125|66787924|FG000|Completed Treatment|Early termination of study|1|||
23838800|NCT02530125|66787924|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
23838801|NCT00568061|66787925|FG000|Overall Study|Inclusion / exclusion criteria|5|||
23838802|NCT00568061|66787926|FG001|Overall Study|Inclusion / exclusion criteria|1|||
23838803|NCT00568061|66787925|FG000|Overall Study|Adverse Event|0|||
23838804|NCT00568061|66787926|FG001|Overall Study|Adverse Event|1|||
23838805|NCT03476187|66787929|FG000|Overall Study|Protocol Violation|7|||
23838806|NCT03476187|66787929|FG000|Overall Study|Physician Decision|5|||
23838807|NCT01430754|66787930|FG000|Run-In Phase|Circadian Period Ineligible|24|||
23838808|NCT01430754|66787931|FG001|Run-In Phase|Circadian Period Ineligible|0|||
23838809|NCT01430754|66787930|FG000|Run-In Phase|Protocol Violation|6|||
23838810|NCT01430754|66787931|FG001|Run-In Phase|Protocol Violation|0|||
23838811|NCT01430754|66787930|FG000|Run-In Phase|Adverse Event|2|||
23838812|NCT01430754|66787931|FG001|Run-In Phase|Adverse Event|0|||
23838813|NCT01430754|66787930|FG000|Run-In Phase|Other|2|||
23838814|NCT01430754|66787931|FG001|Run-In Phase|Other|0|||
23838815|NCT01430754|66787930|FG000|Run-In Phase|Withdrawal by Subject|2|||
23838816|NCT01430754|66787931|FG001|Run-In Phase|Withdrawal by Subject|0|||
23838817|NCT01430754|66787930|FG000|Run-In Phase|Lost to Follow-up|1|||
23838818|NCT01430754|66787931|FG001|Run-In Phase|Lost to Follow-up|0|||
23838819|NCT01684943|66787936|FG000|Overall Study|Inadequate Venous Access|3|||
23838820|NCT01684943|66787937|FG001|Overall Study|Inadequate Venous Access|0|||
23838821|NCT01684943|66787938|FG002|Overall Study|Inadequate Venous Access|0|||
23838822|NCT01684943|66787936|FG000|Overall Study|Principal Investigator Determination|1|||
23838823|NCT01684943|66787937|FG001|Overall Study|Principal Investigator Determination|0|||
23838824|NCT01684943|66787938|FG002|Overall Study|Principal Investigator Determination|0|||
23838825|NCT01684943|66787936|FG000|Overall Study|Excluded from Analysis|1|||
23838826|NCT01684943|66787937|FG001|Overall Study|Excluded from Analysis|1|||
23838827|NCT01684943|66787938|FG002|Overall Study|Excluded from Analysis|1|||
23838828|NCT01684943|66787936|FG000|Overall Study|Lost to Follow-up|3|||
23838829|NCT01684943|66787937|FG001|Overall Study|Lost to Follow-up|0|||
23838830|NCT01684943|66787938|FG002|Overall Study|Lost to Follow-up|0|||
23838831|NCT01684943|66787936|FG000|Overall Study|Planning Pregnancy|1|||
23838832|NCT01684943|66787937|FG001|Overall Study|Planning Pregnancy|0|||
23838833|NCT01684943|66787938|FG002|Overall Study|Planning Pregnancy|0|||
23838834|NCT03318861|66787955|FG000|Overall Study|Death|2|||
23838835|NCT03318861|66787956|FG001|Overall Study|Death|3|||
23838836|NCT03318861|66787957|FG002|Overall Study|Death|3|||
23838837|NCT03318861|66787958|FG003|Overall Study|Death|2|||
23838838|NCT03318861|66787959|FG004|Overall Study|Death|2|||
23838839|NCT03318861|66787955|FG000|Overall Study|Enrolled But Never Treated|0|||
23838840|NCT03318861|66787956|FG001|Overall Study|Enrolled But Never Treated|1|||
23838841|NCT03318861|66787957|FG002|Overall Study|Enrolled But Never Treated|0|||
23838842|NCT03318861|66787958|FG003|Overall Study|Enrolled But Never Treated|1|||
23838843|NCT03318861|66787959|FG004|Overall Study|Enrolled But Never Treated|1|||
23838844|NCT03318861|66787955|FG000|Overall Study|Informed Consent Withdraw|0|||
23838845|NCT03318861|66787956|FG001|Overall Study|Informed Consent Withdraw|0|||
23838846|NCT03318861|66787957|FG002|Overall Study|Informed Consent Withdraw|0|||
23838847|NCT03318861|66787958|FG003|Overall Study|Informed Consent Withdraw|1|||
23838848|NCT03318861|66787959|FG004|Overall Study|Informed Consent Withdraw|0|||
23838849|NCT03318861|66787955|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
23838850|NCT03318861|66787956|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23838851|NCT03318861|66787957|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23838852|NCT03318861|66787958|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23339361|NCT02833844|64986165|FG000|Open-Label Period|Withdrawal by Subject|1|||
23838853|NCT03318861|66787959|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23838854|NCT01068678|66787960|FG000|Overall Study|Lack of Efficacy|3|||
23838855|NCT01068678|66787961|FG001|Overall Study|Lack of Efficacy|2|||
23838856|NCT01068678|66787960|FG000|Overall Study|Protocol Violation|5|||
23838857|NCT01068678|66787961|FG001|Overall Study|Protocol Violation|1|||
23838858|NCT01068678|66787960|FG000|Overall Study|Withdrawal criteria|12|||
23838859|NCT01068678|66787961|FG001|Overall Study|Withdrawal criteria|6|||
23838860|NCT01068678|66787960|FG000|Overall Study|Unclassified|18|||
23838861|NCT01068678|66787961|FG001|Overall Study|Unclassified|15|||
23838862|NCT03056638|66787962|FG000|Overall Study|Death|1|||
23838863|NCT03056638|66787963|FG001|Overall Study|Death|0|||
23838864|NCT00723008|66787964|FG000|Enrollment|Lost to Follow-up|1|||
23838865|NCT00723008|66787965|FG001|Enrollment|Lost to Follow-up|0|||
23838866|NCT00723008|66787964|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
23838867|NCT00723008|66787965|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
23339362|NCT02833844|64986166|FG001|Open-Label Period|Withdrawal by Subject|0|||
23579323|NCT02373813|65853338|FG002|Run-In Period|Decision by Sponsor|0|||
23838868|NCT00723008|66787964|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
23838869|NCT00723008|66787965|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
23838870|NCT00723008|66787964|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
23838871|NCT00723008|66787965|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
23838872|NCT00723008|66787964|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
23838873|NCT00723008|66787965|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
23838874|NCT00723008|66787964|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
23838875|NCT00723008|66787965|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
23838876|NCT01017874|66787966|FG000|Overall Study|Withdrawal by Subject|23|||
23838877|NCT01017874|66787967|FG001|Overall Study|Withdrawal by Subject|20|||
23838878|NCT01017874|66787966|FG000|Overall Study|Sponsor decision|3|||
23838879|NCT01017874|66787967|FG001|Overall Study|Sponsor decision|1|||
23838880|NCT01017874|66787966|FG000|Overall Study|Lost to Follow-up|3|||
23838881|NCT01017874|66787967|FG001|Overall Study|Lost to Follow-up|2|||
23838882|NCT01017874|66787966|FG000|Overall Study|Physician Decision|1|||
23838883|NCT01017874|66787967|FG001|Overall Study|Physician Decision|3|||
23838884|NCT03887442|66791657|FG000|Overall Study|Adverse Event|1|||
23838885|NCT03887442|66791658|FG001|Overall Study|Adverse Event|0|||
23838886|NCT02040857|66791659|FG000|Overall Study|Adverse Event|14|||
23838887|NCT02040857|66791659|FG000|Overall Study|Physician Decision|5|||
23838888|NCT02040857|66791659|FG000|Overall Study|Withdrawal by Subject|31|||
23838889|NCT02040857|66791659|FG000|Overall Study|patient non-compliance|3|||
23838890|NCT02040857|66791659|FG000|Overall Study|Lost to Follow-up|2|||
23838891|NCT02040857|66791659|FG000|Overall Study|recurrence|4|||
23838892|NCT02040857|66791659|FG000|Overall Study|ineligible|1|||
23838893|NCT02159053|66791661|FG000|Overall Study|Death|2|||
23838894|NCT02159053|66791662|FG001|Overall Study|Death|0|||
23838895|NCT02159053|66791663|FG002|Overall Study|Death|1|||
23838896|NCT02159053|66791661|FG000|Overall Study|Physician Decision|0|||
23838897|NCT02159053|66791662|FG001|Overall Study|Physician Decision|1|||
23838898|NCT02159053|66791663|FG002|Overall Study|Physician Decision|1|||
23838899|NCT02159053|66791661|FG000|Overall Study|Lack of Efficacy|3|||
23838900|NCT02159053|66791662|FG001|Overall Study|Lack of Efficacy|4|||
23838901|NCT02159053|66791663|FG002|Overall Study|Lack of Efficacy|7|||
23838902|NCT02159053|66791661|FG000|Overall Study|Adverse Event|7|||
23838903|NCT02159053|66791662|FG001|Overall Study|Adverse Event|6|||
23838904|NCT02159053|66791663|FG002|Overall Study|Adverse Event|5|||
23339363|NCT01953601|64986167|FG000|Part 1 (Base Study)|Adverse Event|24|||
23339364|NCT01953601|64986168|FG001|Part 1 (Base Study)|Adverse Event|37|||
23339365|NCT01953601|64986169|FG002|Part 1 (Base Study)|Adverse Event|15|||
23339366|NCT01953601|64986167|FG000|Part 1 (Base Study)|Death|2|||
23339367|NCT01953601|64986168|FG001|Part 1 (Base Study)|Death|0|||
23339368|NCT01953601|64986169|FG002|Part 1 (Base Study)|Death|3|||
23339369|NCT01953601|64986167|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
23339370|NCT01953601|64986168|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
23339371|NCT01953601|64986169|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
23339372|NCT01953601|64986167|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
23339373|NCT01953601|64986168|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
23339374|NCT01953601|64986169|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
23339375|NCT01953601|64986167|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
23339376|NCT01953601|64986168|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
23339377|NCT01953601|64986169|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
23339378|NCT01953601|64986167|FG000|Part 1 (Base Study)|Physician Decision|3|||
23339379|NCT01953601|64986168|FG001|Part 1 (Base Study)|Physician Decision|7|||
23339380|NCT01953601|64986169|FG002|Part 1 (Base Study)|Physician Decision|4|||
23838905|NCT02159053|66791661|FG000|Overall Study|Participants/guardian decision|8|||
23838906|NCT02159053|66791662|FG001|Overall Study|Participants/guardian decision|10|||
23838907|NCT02159053|66791663|FG002|Overall Study|Participants/guardian decision|6|||
23838908|NCT02860130|66791664|FG000|Overall Study|Adverse Event|2|||
23838909|NCT02860130|66791665|FG001|Overall Study|Adverse Event|3|||
23838910|NCT02860130|66791664|FG000|Overall Study|Protocol Violation|1|||
23838911|NCT02860130|66791665|FG001|Overall Study|Protocol Violation|1|||
23838912|NCT02860130|66791664|FG000|Overall Study|Withdrawal by Subject|0|||
23838913|NCT02860130|66791665|FG001|Overall Study|Withdrawal by Subject|2|||
23838914|NCT02860130|66791664|FG000|Overall Study|Physician Decision|2|||
23838915|NCT02860130|66791665|FG001|Overall Study|Physician Decision|2|||
23838916|NCT02860130|66791664|FG000|Overall Study|Other|2|||
23838917|NCT02860130|66791665|FG001|Overall Study|Other|1|||
23838918|NCT00708214|66791666|FG000|Overall Study|Other Adverse Event|3|||
23339381|NCT01953601|64986167|FG000|Part 1 (Base Study)|Screen failure|1|||
23339382|NCT01953601|64986168|FG001|Part 1 (Base Study)|Screen failure|0|||
23339383|NCT01953601|64986169|FG002|Part 1 (Base Study)|Screen failure|1|||
23838919|NCT00708214|66791667|FG001|Overall Study|Other Adverse Event|6|||
23838920|NCT00708214|66791668|FG002|Overall Study|Other Adverse Event|2|||
23339384|NCT01953601|64986167|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
23838921|NCT00708214|66791666|FG000|Overall Study|Other|0|||
23838922|NCT00708214|66791667|FG001|Overall Study|Other|1|||
23838923|NCT00708214|66791668|FG002|Overall Study|Other|1|||
23579324|NCT02373813|65853339|FG003|Run-In Period|Decision by Sponsor|0|||
23579325|NCT02373813|65853336|FG000|Run-In Period|Protocol Violation|75|||
23579326|NCT02373813|65853337|FG001|Run-In Period|Protocol Violation|0|||
23579327|NCT02373813|65853338|FG002|Run-In Period|Protocol Violation|0|||
23579328|NCT02373813|65853339|FG003|Run-In Period|Protocol Violation|0|||
23579329|NCT02373813|65853336|FG000|Run-In Period|Lost to Follow-up|2|||
23579330|NCT02373813|65853337|FG001|Run-In Period|Lost to Follow-up|0|||
23579331|NCT02373813|65853338|FG002|Run-In Period|Lost to Follow-up|0|||
23579332|NCT02373813|65853339|FG003|Run-In Period|Lost to Follow-up|0|||
23579333|NCT02373813|65853336|FG000|Run-In Period|Adverse Event|3|||
23778693|NCT01355081|66569737|FG000|Overall Study|Non Compliance with Study Medication|0|||
23778694|NCT01355081|66569738|FG001|Overall Study|Non Compliance with Study Medication|1|||
23778695|NCT01355081|66569739|FG002|Overall Study|Non Compliance with Study Medication|0|||
23778696|NCT02289963|66569742|FG000|Overall Study|Adverse Event|1|||
23778697|NCT02289963|66569743|FG001|Overall Study|Adverse Event|2|||
23778698|NCT02289963|66569742|FG000|Overall Study|Poor compliance to protocol|1|||
23778699|NCT02289963|66569743|FG001|Overall Study|Poor compliance to protocol|0|||
23778700|NCT02289963|66569742|FG000|Overall Study|Withdrawal by Subject|1|||
23778701|NCT02289963|66569743|FG001|Overall Study|Withdrawal by Subject|0|||
23778702|NCT02289963|66569742|FG000|Overall Study|Last injection missed|2|||
23778703|NCT02289963|66569743|FG001|Overall Study|Last injection missed|2|||
23778704|NCT02289963|66569742|FG000|Overall Study|End treatment visit outside visit window|0|||
23778705|NCT02289963|66569743|FG001|Overall Study|End treatment visit outside visit window|4|||
23778706|NCT02289963|66569742|FG000|Overall Study|Other than specified above|0|||
23778707|NCT02289963|66569743|FG001|Overall Study|Other than specified above|2|||
23778708|NCT00794963|66569744|FG000|Overall Study|Withdrawal by Subject|1|||
23778709|NCT00794963|66569745|FG001|Overall Study|Withdrawal by Subject|4|||
23778710|NCT03020615|66569746|FG000|Overall Study|Physician Decision|3|||
23778711|NCT03020615|66569747|FG001|Overall Study|Physician Decision|1|||
23778712|NCT03020615|66569748|FG002|Overall Study|Physician Decision|2|||
23778713|NCT03020615|66569746|FG000|Overall Study|Parent/guardian/patient choice|3|||
23778714|NCT03020615|66569747|FG001|Overall Study|Parent/guardian/patient choice|0|||
23778715|NCT03020615|66569748|FG002|Overall Study|Parent/guardian/patient choice|4|||
23778716|NCT03020615|66569746|FG000|Overall Study|Screen failure|0|||
23778717|NCT03020615|66569747|FG001|Overall Study|Screen failure|0|||
23778718|NCT03020615|66569748|FG002|Overall Study|Screen failure|1|||
23778719|NCT03020615|66569746|FG000|Overall Study|Death|1|||
23778720|NCT03020615|66569747|FG001|Overall Study|Death|0|||
23778721|NCT03020615|66569748|FG002|Overall Study|Death|0|||
23778722|NCT03020615|66569746|FG000|Overall Study|Lost to Follow-up|0|||
23778723|NCT03020615|66569747|FG001|Overall Study|Lost to Follow-up|1|||
23778724|NCT03020615|66569748|FG002|Overall Study|Lost to Follow-up|0|||
23778725|NCT00939003|66569749|FG000|Double-blind Treatment Period|Adverse Event|1|||
23778726|NCT00939003|66569750|FG001|Double-blind Treatment Period|Adverse Event|1|||
23778727|NCT00939003|66569749|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23778728|NCT00939003|66569750|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23778729|NCT00939003|66569749|FG000|Double-blind Treatment Period|Pregnancy|0|||
23778730|NCT00939003|66569750|FG001|Double-blind Treatment Period|Pregnancy|1|||
23778731|NCT00939003|66569749|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
23778732|NCT00939003|66569750|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
23778733|NCT00939003|66569749|FG000|Open-label Treatment Period|Adverse Event|4|||
23778734|NCT00939003|66569750|FG001|Open-label Treatment Period|Adverse Event|8|||
23778735|NCT00939003|66569749|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
23778736|NCT00939003|66569750|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
23778737|NCT00939003|66569749|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
23778738|NCT00939003|66569750|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
23778739|NCT00939003|66569749|FG000|Open-label Treatment Period|Pregnancy|1|||
23778740|NCT00939003|66569750|FG001|Open-label Treatment Period|Pregnancy|1|||
23778741|NCT00939003|66569749|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
23838924|NCT00708214|66791666|FG000|Overall Study|Progressive Disease|4|||
23838925|NCT00708214|66791667|FG001|Overall Study|Progressive Disease|6|||
23838926|NCT00708214|66791668|FG002|Overall Study|Progressive Disease|5|||
23778742|NCT00939003|66569750|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
23778743|NCT00939003|66569749|FG000|Open-label Treatment Period|Site Closure|3|||
23778744|NCT00939003|66569750|FG001|Open-label Treatment Period|Site Closure|4|||
23778745|NCT03752528|66569761|FG000|Part A|Lost to Follow-up|1|||
23838927|NCT02230904|66791672|FG000|Overall Study|Safety follow up could not take place|0|||
23838928|NCT02230904|66791673|FG001|Overall Study|Safety follow up could not take place|1|||
23838929|NCT00984568|66791674|FG000|Overall Study|Withdrawal by Subject|1|||
23579334|NCT02373813|65853337|FG001|Run-In Period|Adverse Event|0|||
23579335|NCT02373813|65853338|FG002|Run-In Period|Adverse Event|0|||
23579336|NCT02373813|65853339|FG003|Run-In Period|Adverse Event|0|||
23579337|NCT02373813|65853336|FG000|Run-In Period|Noncompliance|1|||
23778746|NCT03752528|66569761|FG000|Part A|Protocol Violation|1|||
23778747|NCT03752528|66569761|FG000|Part B|Protocol Violation|1|||
23778748|NCT03752528|66569761|FG000|Part B|Study terminated by sponsor|3|||
23838930|NCT00984568|66791675|FG001|Overall Study|Withdrawal by Subject|2|||
23339385|NCT01953601|64986168|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
23339386|NCT01953601|64986169|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
23339387|NCT01953601|64986167|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
23339388|NCT01953601|64986168|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
23339389|NCT01953601|64986169|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
23339390|NCT01953601|64986167|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
23339391|NCT01953601|64986168|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
23339392|NCT01953601|64986169|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
23339393|NCT01953601|64986167|FG000|Part 1 (Base Study)|Subject moved|2|||
23339394|NCT01953601|64986168|FG001|Part 1 (Base Study)|Subject moved|2|||
23579338|NCT02373813|65853337|FG001|Run-In Period|Noncompliance|0|||
23579339|NCT02373813|65853338|FG002|Run-In Period|Noncompliance|0|||
23339395|NCT01953601|64986169|FG002|Part 1 (Base Study)|Subject moved|1|||
23339396|NCT01953601|64986167|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
23579340|NCT02373813|65853339|FG003|Run-In Period|Noncompliance|0|||
23579341|NCT02373813|65853336|FG000|Run-In Period|Ineligibility Determined|3|||
23339397|NCT01953601|64986168|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
23339398|NCT01953601|64986169|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
23339399|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Adverse Event|1|||
23339400|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Adverse Event|1|||
23339401|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Adverse Event|10|||
23339402|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Death|0|||
23339403|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Death|3|||
23339404|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Death|0|||
23339405|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
23339406|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
23451171|NCT02485691|65395124|FG000|Overall Study|Adverse Event|25|||
23778749|NCT01244126|66569762|FG000|Overall Study|Protocol Violation|3|||
23778750|NCT01244126|66569763|FG001|Overall Study|Protocol Violation|3|||
23778751|NCT01244126|66569764|FG002|Overall Study|Protocol Violation|9|||
23778752|NCT01848938|66569767|FG000|Overall Study|Lost to Follow-up|1|||
23778753|NCT01848938|66569768|FG001|Overall Study|Lost to Follow-up|1|||
23778754|NCT00505622|66569776|FG000|Overall Study|Adverse Event|5|||
23778755|NCT00505622|66569777|FG001|Overall Study|Adverse Event|6|||
23778756|NCT00505622|66569778|FG002|Overall Study|Adverse Event|4|||
23778757|NCT00505622|66569776|FG000|Overall Study|Protocol Violation|1|||
23778758|NCT00505622|66569777|FG001|Overall Study|Protocol Violation|1|||
23778759|NCT00505622|66569778|FG002|Overall Study|Protocol Violation|0|||
23778760|NCT00505622|66569776|FG000|Overall Study|Withdrawal by Subject|0|||
23778761|NCT00505622|66569777|FG001|Overall Study|Withdrawal by Subject|3|||
23778762|NCT00505622|66569778|FG002|Overall Study|Withdrawal by Subject|2|||
23778763|NCT00505622|66569776|FG000|Overall Study|Study termination by sponsor|115|||
23778764|NCT00505622|66569777|FG001|Overall Study|Study termination by sponsor|98|||
23778765|NCT00505622|66569778|FG002|Overall Study|Study termination by sponsor|90|||
23778766|NCT00089661|66569779|FG000|Overall Study|Adverse Event|0|||
23778767|NCT00089661|66569780|FG001|Overall Study|Adverse Event|2|||
23778768|NCT00089661|66569779|FG000|Overall Study|Death|1|||
23778769|NCT00089661|66569780|FG001|Overall Study|Death|0|||
23778770|NCT00089661|66569779|FG000|Overall Study|Lost to Follow-up|0|||
23778771|NCT00089661|66569780|FG001|Overall Study|Lost to Follow-up|3|||
23778772|NCT00089661|66569779|FG000|Overall Study|Withdrawal by Subject|11|||
23778773|NCT00089661|66569780|FG001|Overall Study|Withdrawal by Subject|9|||
23778774|NCT00089661|66569779|FG000|Overall Study|Disease progression|1|||
23778775|NCT00089661|66569780|FG001|Overall Study|Disease progression|3|||
23778776|NCT00089661|66569779|FG000|Overall Study|Ineligibility determined|4|||
23778777|NCT00089661|66569780|FG001|Overall Study|Ineligibility determined|4|||
23778778|NCT00089661|66569779|FG000|Overall Study|Noncompliance|2|||
23778779|NCT00089661|66569780|FG001|Overall Study|Noncompliance|4|||
23778780|NCT00089661|66569779|FG000|Overall Study|Other|2|||
23778781|NCT00089661|66569780|FG001|Overall Study|Other|1|||
23778782|NCT03233724|66569781|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23778783|NCT03233724|66569782|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23778784|NCT03233724|66569783|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23778785|NCT03233724|66569784|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23778786|NCT03233724|66569785|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
23579342|NCT02373813|65853337|FG001|Run-In Period|Ineligibility Determined|0|||
23778787|NCT03233724|66569781|FG000|Phase I Dose Escalation|Best interest of participant|1|||
23778788|NCT03233724|66569782|FG001|Phase I Dose Escalation|Best interest of participant|1|||
23778789|NCT03233724|66569783|FG002|Phase I Dose Escalation|Best interest of participant|1|||
23339407|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
23451172|NCT02485691|65395125|FG001|Overall Study|Adverse Event|11|||
23339408|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
23339409|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
23339410|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
23339411|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Physician Decision|2|||
23339412|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Physician Decision|0|||
23339413|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Physician Decision|2|||
23339414|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
23339415|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
23339416|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
23339417|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
23339418|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
23339419|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
23339420|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
23339421|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
23339422|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
23339423|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Subject moved|0|||
23339424|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Subject moved|0|||
23339425|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Subject moved|1|||
23339426|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
23339427|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
23339428|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
23339429|NCT01893281|64986172|FG000|Overall Study|Adverse Event|1|||
23579343|NCT02373813|65853338|FG002|Run-In Period|Ineligibility Determined|0|||
23579344|NCT02373813|65853339|FG003|Run-In Period|Ineligibility Determined|0|||
23579345|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
23778790|NCT03233724|66569784|FG003|Phase I Dose Escalation|Best interest of participant|0|||
23778791|NCT03233724|66569785|FG004|Phase I Dose Escalation|Best interest of participant|0|||
23778792|NCT03233724|66569781|FG000|Phase I Dose Escalation|Physician Decision|0|||
23778793|NCT03233724|66569782|FG001|Phase I Dose Escalation|Physician Decision|0|||
23778794|NCT03233724|66569783|FG002|Phase I Dose Escalation|Physician Decision|1|||
23778795|NCT03233724|66569784|FG003|Phase I Dose Escalation|Physician Decision|0|||
23778796|NCT03233724|66569785|FG004|Phase I Dose Escalation|Physician Decision|0|||
23778797|NCT03233724|66569781|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23778798|NCT03233724|66569782|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23778799|NCT03233724|66569783|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
23778800|NCT03233724|66569784|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23778801|NCT03233724|66569785|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23778802|NCT01591785|66569786|FG000|Overall Study|worsening condition|1|||
23778803|NCT01591785|66569787|FG001|Overall Study|worsening condition|2|||
23778804|NCT01591785|66569786|FG000|Overall Study|Protocol Violation|2|||
23778805|NCT01591785|66569787|FG001|Overall Study|Protocol Violation|0|||
23778806|NCT01591785|66569786|FG000|Overall Study|Lost to Follow-up|1|||
23778807|NCT01591785|66569787|FG001|Overall Study|Lost to Follow-up|0|||
23778808|NCT03247972|66569788|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
23778809|NCT03247972|66569788|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
23778810|NCT03235739|66569789|FG000|Overall Study|Withdrawal by Subject|2|||
23778811|NCT03235739|66569790|FG001|Overall Study|Withdrawal by Subject|2|||
23778812|NCT03235739|66569789|FG000|Overall Study|Physician Decision|0|||
23778813|NCT03235739|66569790|FG001|Overall Study|Physician Decision|1|||
23778814|NCT01175018|66569791|FG000|Overall Study|Adverse Event|3|||
23778815|NCT01175018|66569792|FG001|Overall Study|Adverse Event|1|||
23778816|NCT02058498|66569793|FG000|Overall Study|Withdrawal by Subject|4|||
23778817|NCT01959672|66569794|FG000|Overall Study|Death|1|||
23778818|NCT02057458|66569795|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
23778819|NCT02057458|66569796|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
23778820|NCT02057458|66569797|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
23778821|NCT02057458|66569795|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
23778822|NCT02057458|66569796|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
23778823|NCT02057458|66569797|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
23778824|NCT02057458|66569795|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
23778825|NCT02057458|66569796|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
23778826|NCT02057458|66569797|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
23778827|NCT01723397|66569798|FG000|Study Period 1|Protocol Violation|0|||
23778828|NCT01723397|66569799|FG001|Study Period 1|Protocol Violation|1|||
23778829|NCT01723397|66569798|FG000|Study Period 2|Protocol Violation|0|||
23778830|NCT01723397|66569799|FG001|Study Period 2|Protocol Violation|1|||
23778831|NCT01248247|66569806|FG000|Overall Study|Adverse Event|2|||
23778832|NCT01248247|66569807|FG001|Overall Study|Adverse Event|4|||
23778833|NCT01248247|66569808|FG002|Overall Study|Adverse Event|4|||
23778834|NCT01248247|66569809|FG003|Overall Study|Adverse Event|2|||
23339430|NCT01893281|64986172|FG000|Overall Study|Protocol Violation|1|||
23451173|NCT02485691|65395124|FG000|Overall Study|Poor compliance to protocol|0|||
23451174|NCT02485691|65395125|FG001|Overall Study|Poor compliance to protocol|1|||
23451175|NCT02485691|65395124|FG000|Overall Study|Disease progression|57|||
23451176|NCT02485691|65395125|FG001|Overall Study|Disease progression|92|||
23451177|NCT02485691|65395124|FG000|Overall Study|Investigator's decision|23|||
23451178|NCT02485691|65395125|FG001|Overall Study|Investigator's decision|5|||
23451179|NCT02485691|65395124|FG000|Overall Study|Participant's request|13|||
23451180|NCT02485691|65395125|FG001|Overall Study|Participant's request|6|||
23451181|NCT02485691|65395124|FG000|Overall Study|Other reason|8|||
23451182|NCT02485691|65395125|FG001|Overall Study|Other reason|9|||
23451183|NCT02485691|65395124|FG000|Overall Study|Randomized and not treated|3|||
23451184|NCT02485691|65395125|FG001|Overall Study|Randomized and not treated|2|||
23451185|NCT00346216|65395127|FG000|Overall Study|Other|181|||
23451186|NCT00346216|65395128|FG001|Overall Study|Other|231|||
23451187|NCT00346216|65395129|FG002|Overall Study|Other|205|||
23451188|NCT00346216|65395127|FG000|Overall Study|No longer willing to participate|600|||
23451189|NCT00346216|65395128|FG001|Overall Study|No longer willing to participate|606|||
23451190|NCT00346216|65395129|FG002|Overall Study|No longer willing to participate|585|||
23451191|NCT00346216|65395127|FG000|Overall Study|Withdrawal by Subject|661|||
23451192|NCT00346216|65395128|FG001|Overall Study|Withdrawal by Subject|692|||
23451193|NCT00346216|65395129|FG002|Overall Study|Withdrawal by Subject|651|||
23451194|NCT00346216|65395127|FG000|Overall Study|Lost to Follow-up|611|||
23451195|NCT00346216|65395128|FG001|Overall Study|Lost to Follow-up|588|||
23451196|NCT00346216|65395129|FG002|Overall Study|Lost to Follow-up|542|||
23451197|NCT00346216|65395127|FG000|Overall Study|Physician Decision|80|||
23451198|NCT00346216|65395128|FG001|Overall Study|Physician Decision|76|||
23451199|NCT00346216|65395129|FG002|Overall Study|Physician Decision|59|||
23451200|NCT00346216|65395127|FG000|Overall Study|Does not meet entrance criteria|13|||
23451201|NCT00346216|65395128|FG001|Overall Study|Does not meet entrance criteria|10|||
23451202|NCT00346216|65395129|FG002|Overall Study|Does not meet entrance criteria|8|||
23451203|NCT00346216|65395127|FG000|Overall Study|Death|189|||
23451204|NCT00346216|65395128|FG001|Overall Study|Death|192|||
23451205|NCT00346216|65395129|FG002|Overall Study|Death|228|||
23451206|NCT00346216|65395127|FG000|Overall Study|Study terminated by sponsor|11|||
23451207|NCT00346216|65395128|FG001|Overall Study|Study terminated by sponsor|4|||
23451208|NCT00346216|65395129|FG002|Overall Study|Study terminated by sponsor|8|||
23451209|NCT00346216|65395127|FG000|Overall Study|Missing Subject Summary Status|62|||
23451210|NCT00346216|65395128|FG001|Overall Study|Missing Subject Summary Status|61|||
23451211|NCT00346216|65395129|FG002|Overall Study|Missing Subject Summary Status|62|||
23451212|NCT02978417|65395132|FG000|Overall Study|Lost to Follow-up|2|||
23451213|NCT02978417|65395133|FG001|Overall Study|Lost to Follow-up|2|||
23451214|NCT01033240|65395134|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
23451215|NCT01033240|65395135|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
23451216|NCT01033240|65395136|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
23451217|NCT01033240|65395134|FG000|Overall Study|Death|2|||
23451218|NCT01033240|65395135|FG001|Overall Study|Death|0|||
23451219|NCT01033240|65395136|FG002|Overall Study|Death|0|||
23451220|NCT01033240|65395134|FG000|Overall Study|Withdrew Consent|2|||
23451221|NCT01033240|65395135|FG001|Overall Study|Withdrew Consent|9|||
23451222|NCT01033240|65395136|FG002|Overall Study|Withdrew Consent|2|||
23451223|NCT01033240|65395134|FG000|Overall Study|Disease Progression|35|||
23451224|NCT01033240|65395135|FG001|Overall Study|Disease Progression|32|||
23451225|NCT01033240|65395136|FG002|Overall Study|Disease Progression|41|||
23451226|NCT01033240|65395134|FG000|Overall Study|Investigator Discretion|0|||
23451227|NCT01033240|65395135|FG001|Overall Study|Investigator Discretion|0|||
23451228|NCT01033240|65395136|FG002|Overall Study|Investigator Discretion|2|||
23451229|NCT01033240|65395134|FG000|Overall Study|Other|0|||
23778835|NCT01248247|66569806|FG000|Overall Study|Death|0|||
23778836|NCT01248247|66569807|FG001|Overall Study|Death|1|||
23778837|NCT01248247|66569808|FG002|Overall Study|Death|4|||
23778838|NCT01248247|66569809|FG003|Overall Study|Death|7|||
23778839|NCT01248247|66569806|FG000|Overall Study|Lost to Follow-up|0|||
23778840|NCT01248247|66569807|FG001|Overall Study|Lost to Follow-up|1|||
23778841|NCT01248247|66569808|FG002|Overall Study|Lost to Follow-up|1|||
23778842|NCT01248247|66569809|FG003|Overall Study|Lost to Follow-up|0|||
23778843|NCT01248247|66569806|FG000|Overall Study|Alternative treatment|0|||
23778844|NCT01248247|66569807|FG001|Overall Study|Alternative treatment|1|||
23778845|NCT01248247|66569808|FG002|Overall Study|Alternative treatment|0|||
23778846|NCT01248247|66569809|FG003|Overall Study|Alternative treatment|0|||
23451230|NCT01033240|65395135|FG001|Overall Study|Other|1|||
23451231|NCT01033240|65395136|FG002|Overall Study|Other|2|||
23451232|NCT02922725|65395137|FG000|Overall Study|Withdrawal by Subject|1|||
23451233|NCT02922725|65395138|FG001|Overall Study|Withdrawal by Subject|0|||
23451234|NCT02922725|65395139|FG002|Overall Study|Withdrawal by Subject|0|||
23451235|NCT02675907|65395140|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
23451236|NCT02675907|65395141|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
23451237|NCT02675907|65395140|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
23451238|NCT02675907|65395141|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
23451239|NCT02675907|65395140|FG000|Study Overall|Lack of Efficacy|1|||
23451240|NCT02675907|65395141|FG001|Study Overall|Lack of Efficacy|0|||
23451241|NCT02675907|65395140|FG000|Study Overall|Withdrawal by Subject|2|||
23451242|NCT02675907|65395141|FG001|Study Overall|Withdrawal by Subject|2|||
23451243|NCT02675907|65395140|FG000|Study Overall|Lost to Follow-up|0|||
23451244|NCT02675907|65395141|FG001|Study Overall|Lost to Follow-up|2|||
23451245|NCT00057863|65395142|FG000|Overall Study|Death|1|||
23451246|NCT00057863|65395142|FG000|Overall Study|Withdrawal by Subject|2|||
23451247|NCT01535807|65395146|FG000|Overall Study|Withdrawal by Subject|1|||
23451248|NCT01535807|65395147|FG001|Overall Study|Withdrawal by Subject|1|||
23451249|NCT01535807|65395146|FG000|Overall Study|Data collection error|1|||
23451250|NCT01535807|65395147|FG001|Overall Study|Data collection error|1|||
23451251|NCT00703924|65395148|FG000|Overall Study|Withdrawal by Subject|1|||
23451252|NCT00703924|65395149|FG001|Overall Study|Withdrawal by Subject|1|||
23451253|NCT00117637|65395150|FG000|First Intervention (Period 1)|Adverse Event|11|||
23451254|NCT00117637|65395151|FG001|First Intervention (Period 1)|Adverse Event|16|||
23451255|NCT00117637|65395150|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
23451256|NCT00117637|65395151|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
23451257|NCT00117637|65395150|FG000|First Intervention (Period 1)|Protocol Violation|1|||
23451258|NCT00117637|65395151|FG001|First Intervention (Period 1)|Protocol Violation|0|||
23451259|NCT00117637|65395150|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
23451260|NCT00117637|65395151|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
23451261|NCT00117637|65395150|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
23451262|NCT00117637|65395151|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
23451263|NCT00117637|65395150|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
23451264|NCT00117637|65395151|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
23451265|NCT00117637|65395150|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
23451266|NCT00117637|65395151|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
23451267|NCT00117637|65395150|FG000|First Intervention (Period 1)|reason not reported|0|||
23451268|NCT00117637|65395151|FG001|First Intervention (Period 1)|reason not reported|1|||
23451269|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Adverse Event|0|||
23451270|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Adverse Event|9|||
23451271|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
23451272|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
23451273|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
23451274|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
23451275|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
23451276|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
23451277|NCT00117637|65395150|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
23451278|NCT00117637|65395151|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
23451279|NCT00117637|65395150|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
23778847|NCT01248247|66569806|FG000|Overall Study|Other|2|||
23778848|NCT01248247|66569807|FG001|Overall Study|Other|8|||
23778849|NCT01248247|66569808|FG002|Overall Study|Other|8|||
23778850|NCT01248247|66569809|FG003|Overall Study|Other|5|||
23778851|NCT01248247|66569806|FG000|Overall Study|Progression|18|||
23778852|NCT01248247|66569807|FG001|Overall Study|Progression|27|||
23778853|NCT01248247|66569808|FG002|Overall Study|Progression|56|||
23778854|NCT01248247|66569809|FG003|Overall Study|Progression|44|||
23778855|NCT01248247|66569806|FG000|Overall Study|Refuse further treatment|0|||
23778856|NCT01248247|66569807|FG001|Overall Study|Refuse further treatment|0|||
23451280|NCT00117637|65395151|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
23579346|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
23579347|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
23579348|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
23579349|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23579350|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
23579351|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
23579352|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
23579353|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23579354|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23579355|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
23579356|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23579357|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23634752|NCT03117998|66049274|FG004|Overall Study|Lost to Follow-up|4|||
23778857|NCT01248247|66569808|FG002|Overall Study|Refuse further treatment|1|||
23451281|NCT00117637|65395150|FG000|Second Intervention (Period 2)|reason not reported|1|||
23634753|NCT03117998|66049275|FG005|Overall Study|Lost to Follow-up|0|||
23778858|NCT01248247|66569809|FG003|Overall Study|Refuse further treatment|2|||
23778859|NCT01248247|66569806|FG000|Overall Study|Complicating disease|0|||
23838931|NCT00984568|66791674|FG000|Overall Study|Lack of Efficacy|2|||
23634754|NCT03117998|66049270|FG000|Overall Study|Subject noncompliance|0|||
23634755|NCT03117998|66049271|FG001|Overall Study|Subject noncompliance|0|||
23634756|NCT03117998|66049272|FG002|Overall Study|Subject noncompliance|1|||
23634757|NCT03117998|66049273|FG003|Overall Study|Subject noncompliance|0|||
23634758|NCT03117998|66049274|FG004|Overall Study|Subject noncompliance|0|||
23634759|NCT03117998|66049275|FG005|Overall Study|Subject noncompliance|2|||
23634760|NCT03117998|66049270|FG000|Overall Study|Protocol Violation|0|||
23634761|NCT03117998|66049271|FG001|Overall Study|Protocol Violation|0|||
23634762|NCT03117998|66049272|FG002|Overall Study|Protocol Violation|0|||
23634763|NCT03117998|66049273|FG003|Overall Study|Protocol Violation|0|||
23634764|NCT03117998|66049274|FG004|Overall Study|Protocol Violation|0|||
23634765|NCT03117998|66049275|FG005|Overall Study|Protocol Violation|1|||
23634766|NCT00581893|66049276|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
23634767|NCT00581893|66049277|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
23634768|NCT00523640|66049278|FG000|Overall Study|Death|1|||
23634769|NCT01969851|66049279|FG000|Overall Study|Adverse Event|0|||
23634770|NCT01969851|66049280|FG001|Overall Study|Adverse Event|0|||
23634771|NCT01969851|66049281|FG002|Overall Study|Adverse Event|3|||
23634772|NCT01969851|66049279|FG000|Overall Study|Lack of Efficacy|0|||
23634773|NCT01969851|66049280|FG001|Overall Study|Lack of Efficacy|3|||
23634774|NCT01969851|66049281|FG002|Overall Study|Lack of Efficacy|1|||
23634775|NCT01969851|66049279|FG000|Overall Study|Withdrawal by Subject|1|||
23634776|NCT01969851|66049280|FG001|Overall Study|Withdrawal by Subject|0|||
23634777|NCT01969851|66049281|FG002|Overall Study|Withdrawal by Subject|1|||
23634778|NCT01969851|66049279|FG000|Overall Study|No effective dose in Titration period|0|||
23634779|NCT01969851|66049280|FG001|Overall Study|No effective dose in Titration period|0|||
23634780|NCT01969851|66049281|FG002|Overall Study|No effective dose in Titration period|1|||
23634781|NCT01969851|66049279|FG000|Overall Study|Sponsor decision|0|||
23634782|NCT01969851|66049280|FG001|Overall Study|Sponsor decision|0|||
23634783|NCT01969851|66049281|FG002|Overall Study|Sponsor decision|1|||
23634784|NCT02242097|66049283|FG000|Ibrutinib Treatment|Adverse Event|16|||
23634785|NCT02242097|66049283|FG000|Ibrutinib Treatment|Physician Decision|1|||
23579358|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
23579359|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23579360|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
23579361|NCT01838551|65853348|FG000|Overall Study|Adverse Event|16|||
23579362|NCT01838551|65853348|FG000|Overall Study|Death|1|||
23579363|NCT01838551|65853348|FG000|Overall Study|Lack of Efficacy|10|||
23579364|NCT01838551|65853348|FG000|Overall Study|Physician Decision|4|||
23579365|NCT01838551|65853348|FG000|Overall Study|Withdrawal by Subject|10|||
23579366|NCT01838551|65853348|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
23634786|NCT02242097|66049283|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
23634787|NCT02242097|66049283|FG000|Ibrutinib Treatment|Death|1|||
23634788|NCT02242097|66049283|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
23634789|NCT02242097|66049283|FG000|Post Therapy Follow Up|Death|3|||
23634790|NCT02242097|66049283|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
23634791|NCT03274895|66049284|FG000|Overall Study|Lack of Efficacy|1|||
23634792|NCT03274895|66049285|FG001|Overall Study|Lack of Efficacy|0|||
23634793|NCT03274895|66049284|FG000|Overall Study|Adverse Event|8|||
23634794|NCT03274895|66049285|FG001|Overall Study|Adverse Event|7|||
23634795|NCT03274895|66049284|FG000|Overall Study|Lost to Follow-up|1|||
23634796|NCT03274895|66049285|FG001|Overall Study|Lost to Follow-up|0|||
23634797|NCT03274895|66049284|FG000|Overall Study|Diagnosis not confirmed|3|||
23634798|NCT03274895|66049285|FG001|Overall Study|Diagnosis not confirmed|4|||
23634799|NCT02389764|66049291|FG000|Overall Study|Lack of Efficacy|9|||
23634800|NCT01110408|66049294|FG000|Overall Study|Protocol Violation|1|||
23634801|NCT01110408|66049295|FG001|Overall Study|Protocol Violation|0|||
23634802|NCT01397422|66049298|FG000|Overall Study|Adverse Event|0|||
23634803|NCT01397422|66049299|FG001|Overall Study|Adverse Event|3|||
23634804|NCT01397422|66049300|FG002|Overall Study|Adverse Event|3|||
23634805|NCT01397422|66049301|FG003|Overall Study|Adverse Event|8|||
23634806|NCT01397422|66049298|FG000|Overall Study|Withdrawal by Subject|1|||
23634807|NCT01397422|66049299|FG001|Overall Study|Withdrawal by Subject|0|||
23634808|NCT01397422|66049300|FG002|Overall Study|Withdrawal by Subject|0|||
23778860|NCT01248247|66569807|FG001|Overall Study|Complicating disease|0|||
23579367|NCT03850444|65853349|FG000|Overall Study|Adverse Event|16|||
23579368|NCT03850444|65853350|FG001|Overall Study|Adverse Event|10|||
23579369|NCT03850444|65853349|FG000|Overall Study|Death|87|||
23634809|NCT01397422|66049301|FG003|Overall Study|Withdrawal by Subject|0|||
23634810|NCT01397422|66049298|FG000|Overall Study|Increased bradykinesia related to PD|1|||
23634811|NCT01397422|66049299|FG001|Overall Study|Increased bradykinesia related to PD|0|||
23634812|NCT01397422|66049300|FG002|Overall Study|Increased bradykinesia related to PD|0|||
23634813|NCT01397422|66049301|FG003|Overall Study|Increased bradykinesia related to PD|0|||
23634814|NCT03433677|66049302|FG000|Period 1|Protocol Violation|1|||
23634815|NCT03433677|66049303|FG001|Period 1|Protocol Violation|0|||
23634816|NCT03433677|66049302|FG000|Period 2|Withdrawal by Subject|1|||
23838932|NCT00984568|66791675|FG001|Overall Study|Lack of Efficacy|0|||
23838933|NCT00984568|66791674|FG000|Overall Study|Adverse Event|2|||
23579370|NCT03850444|65853350|FG001|Overall Study|Death|107|||
23579371|NCT03850444|65853349|FG000|Overall Study|Lost to Follow-up|1|||
23579372|NCT03850444|65853350|FG001|Overall Study|Lost to Follow-up|1|||
23579373|NCT03850444|65853349|FG000|Overall Study|Withdrawal by Subject|1|||
23579374|NCT03850444|65853350|FG001|Overall Study|Withdrawal by Subject|5|||
23579375|NCT03850444|65853349|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
23579376|NCT03850444|65853350|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
23579377|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
23579378|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
23579379|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
23579380|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
23579381|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
23579382|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
23579383|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579384|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579385|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579386|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579387|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
23579388|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579389|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579390|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
23579391|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
23579392|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579393|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579394|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579395|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579396|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
23579397|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
23579398|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579399|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579400|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
23579401|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579402|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579403|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579404|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
23579405|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579406|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
23579407|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
23579408|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
23579409|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
23579410|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579411|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579412|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579413|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
23579414|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
23579415|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
23579416|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
23579417|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
23579418|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
23579419|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579420|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579421|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579422|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
23579423|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
23579424|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
23579425|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
23579426|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
23579427|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
23579428|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
23579429|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
23579430|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
23579431|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579432|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
23634817|NCT03433677|66049303|FG001|Period 2|Withdrawal by Subject|1|||
23579433|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579434|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579435|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
23634818|NCT02310100|66049305|FG000|Overall Study|Physician Decision|3|||
23838934|NCT00984568|66791675|FG001|Overall Study|Adverse Event|0|||
23634819|NCT02310100|66049305|FG000|Overall Study|Withdrawal by Subject|10|||
23634820|NCT02310100|66049305|FG000|Overall Study|Enrollment closure|1|||
23634821|NCT02310100|66049305|FG000|Overall Study|Unapproved ablation operator|1|||
23634822|NCT02310100|66049305|FG000|Overall Study|Visit compliance|1|||
23339431|NCT01893281|64986172|FG000|Overall Study|Withdrawal by Subject|1|||
23339432|NCT02693106|64986179|FG000|Overall Study|No time|3|||
23339433|NCT00102531|64986182|FG000|Overall Study|Adverse Event|0|||
23339434|NCT00102531|64986183|FG001|Overall Study|Adverse Event|1|||
23339435|NCT00102531|64986182|FG000|Overall Study|Disease Progression|5|||
23339436|NCT00102531|64986183|FG001|Overall Study|Disease Progression|9|||
23339437|NCT00102531|64986182|FG000|Overall Study|Physician Decision|0|||
23339438|NCT00102531|64986183|FG001|Overall Study|Physician Decision|1|||
23838935|NCT00984568|66791674|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
23838936|NCT00984568|66791675|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
23838937|NCT00984568|66791674|FG000|Overall Study|Lost to Follow-up|0|||
23339439|NCT01082211|64986185|FG000|Overall Study|Protocol Violation|4|||
23339440|NCT01082211|64986185|FG000|Overall Study|No protocol treatment received|3|||
23339441|NCT00675428|64986187|FG000|Overall Study|Disease Progression|2|||
23339442|NCT00675428|64986188|FG001|Overall Study|Disease Progression|2|||
23339443|NCT00675428|64986187|FG000|Overall Study|No Disease Response After Cycle 6|0|||
23634823|NCT02310100|66049305|FG000|Overall Study|Lost to Follow-up|2|||
23634824|NCT02412735|66049306|FG000|Overall Study|Adverse Event|0|||
23634825|NCT02412735|66049307|FG001|Overall Study|Adverse Event|1|||
23634826|NCT02412735|66049308|FG002|Overall Study|Adverse Event|2|||
23634827|NCT02412735|66049306|FG000|Overall Study|Withdrawal by Subject|23|||
23634828|NCT02412735|66049307|FG001|Overall Study|Withdrawal by Subject|27|||
23634829|NCT02412735|66049308|FG002|Overall Study|Withdrawal by Subject|22|||
23634830|NCT02412735|66049306|FG000|Overall Study|Investigator Decision|3|||
23634831|NCT02412735|66049307|FG001|Overall Study|Investigator Decision|3|||
23634832|NCT02412735|66049308|FG002|Overall Study|Investigator Decision|2|||
23634833|NCT02412735|66049306|FG000|Overall Study|Lost to Follow-up|17|||
23634834|NCT02412735|66049307|FG001|Overall Study|Lost to Follow-up|11|||
23634835|NCT02412735|66049308|FG002|Overall Study|Lost to Follow-up|18|||
23634836|NCT02412735|66049306|FG000|Overall Study|Reason not Specified|3|||
23634837|NCT02412735|66049307|FG001|Overall Study|Reason not Specified|2|||
23634838|NCT02412735|66049308|FG002|Overall Study|Reason not Specified|2|||
23634839|NCT03603639|66049310|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23634840|NCT03603639|66049311|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23634841|NCT03603639|66049312|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23838938|NCT00984568|66791675|FG001|Overall Study|Lost to Follow-up|1|||
23838939|NCT00984568|66791674|FG000|Overall Study|Opportunistic Infection|1|||
23838940|NCT00984568|66791675|FG001|Overall Study|Opportunistic Infection|0|||
23838941|NCT00984568|66791674|FG000|Overall Study|Unknown Reason|1|||
23838942|NCT00984568|66791675|FG001|Overall Study|Unknown Reason|3|||
23838943|NCT01948193|66791676|FG000|Overall Study|Serious event|2|||
23838944|NCT01948193|66791676|FG000|Overall Study|Lost to Follow-up|7|||
23838945|NCT04537234|66791677|FG000|Overall Study|Withdrawal by Subject|2|||
23838946|NCT04537234|66791678|FG001|Overall Study|Withdrawal by Subject|0|||
23838947|NCT02919969|66791679|FG000|Overall Study|Lack of Efficacy|22|||
23838948|NCT02919969|66791679|FG000|Overall Study|Death|4|||
23838949|NCT02919969|66791679|FG000|Overall Study|Physician Decision|3|||
23838950|NCT02919969|66791679|FG000|Overall Study|Withdrawal by Subject|2|||
23838951|NCT02142959|66791680|FG000|Overall Study|Adverse Event|1|||
23838952|NCT02142959|66791681|FG001|Overall Study|Adverse Event|0|||
23838953|NCT02142959|66791682|FG002|Overall Study|Adverse Event|0|||
23838954|NCT02142959|66791680|FG000|Overall Study|Death|0|||
23838955|NCT02142959|66791681|FG001|Overall Study|Death|1|||
23838956|NCT02142959|66791682|FG002|Overall Study|Death|0|||
23838957|NCT02142959|66791680|FG000|Overall Study|Withdrawal by Subject|3|||
23339444|NCT00675428|64986188|FG001|Overall Study|No Disease Response After Cycle 6|1|||
23339445|NCT00675428|64986187|FG000|Overall Study|Physician Decision|1|||
23339446|NCT00675428|64986188|FG001|Overall Study|Physician Decision|0|||
23339447|NCT03180684|64986195|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
23339448|NCT03180684|64986196|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
23339449|NCT03180684|64986195|FG000|Overall Study|Physician Decision|1|||
23634842|NCT03603639|66049313|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
23838958|NCT02142959|66791681|FG001|Overall Study|Withdrawal by Subject|1|||
23838959|NCT02142959|66791682|FG002|Overall Study|Withdrawal by Subject|3|||
23838960|NCT02142959|66791680|FG000|Overall Study|Administrative Reasons|1|||
23838961|NCT02142959|66791681|FG001|Overall Study|Administrative Reasons|0|||
23838962|NCT02142959|66791682|FG002|Overall Study|Administrative Reasons|1|||
23634843|NCT03603639|66049314|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23634844|NCT03603639|66049315|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23339450|NCT03180684|64986196|FG001|Overall Study|Physician Decision|0|||
23339451|NCT03180684|64986195|FG000|Overall Study|Lost to Follow-up|1|||
23339452|NCT03180684|64986196|FG001|Overall Study|Lost to Follow-up|0|||
23838963|NCT02142959|66791680|FG000|Overall Study|Missing|0|||
23838964|NCT02142959|66791681|FG001|Overall Study|Missing|1|||
23451282|NCT00117637|65395151|FG001|Second Intervention (Period 2)|reason not reported|0|||
23451283|NCT00587158|65395158|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
23451284|NCT00587158|65395159|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
23451285|NCT00587158|65395158|FG000|Overall Study|Physician Decision|0|||
23451286|NCT00587158|65395159|FG001|Overall Study|Physician Decision|1|||
23451287|NCT00587158|65395158|FG000|Overall Study|Lost to Follow-up|1|||
23451288|NCT00587158|65395159|FG001|Overall Study|Lost to Follow-up|2|||
23451289|NCT00587158|65395158|FG000|Overall Study|Death|0|||
23451290|NCT00587158|65395159|FG001|Overall Study|Death|1|||
23451291|NCT00587158|65395158|FG000|Overall Study|Subject did not want to take study med|0|||
23451292|NCT00587158|65395159|FG001|Overall Study|Subject did not want to take study med|1|||
23634845|NCT03603639|66049310|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23634846|NCT03603639|66049311|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23634847|NCT03603639|66049312|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23634848|NCT03603639|66049313|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23634849|NCT03603639|66049314|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23778861|NCT01248247|66569808|FG002|Overall Study|Complicating disease|1|||
23778862|NCT01248247|66569809|FG003|Overall Study|Complicating disease|1|||
23838965|NCT02142959|66791682|FG002|Overall Study|Missing|0|||
23634850|NCT03603639|66049315|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23634851|NCT00798590|66049316|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
23634852|NCT00798590|66049317|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
23634853|NCT03686423|66049322|FG000|Overall Study|Withdrawal by Subject|9|||
23634854|NCT03686423|66049322|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
23634855|NCT03995316|66049323|FG000|Overall Study|Lost to Follow-up|10|||
23634856|NCT03995316|66049324|FG001|Overall Study|Lost to Follow-up|3|||
23634857|NCT01609062|66049325|FG000|Extension Phase|Terminated by Sponsor|14|||
23634858|NCT01609062|66049326|FG001|Extension Phase|Terminated by Sponsor|9|||
23778863|NCT00630305|66569811|FG000|Overall Study|Withdrawal by Subject|1|||
23778864|NCT00630305|66569811|FG000|Overall Study|Inability to insert contact lens|1|||
23778865|NCT00433147|66569812|FG000|Overall Study|Adverse Event|0|||
23778866|NCT00433147|66569813|FG001|Overall Study|Adverse Event|1|||
23778867|NCT00433147|66569814|FG002|Overall Study|Adverse Event|0|||
23778868|NCT00433147|66569815|FG003|Overall Study|Adverse Event|0|||
23778869|NCT01383486|66569816|FG000|Overall Study|Lost to Follow-up|10|||
23778870|NCT01383486|66569816|FG000|Overall Study|Incomplete information for analysis|2|||
23778871|NCT01383486|66569816|FG000|Overall Study|Did not take any product|6|||
23778872|NCT03020641|66569819|FG000|Overall Study|Lost to Follow-up|0|||
23778873|NCT03020641|66569820|FG001|Overall Study|Lost to Follow-up|1|||
23778874|NCT03020641|66569819|FG000|Overall Study|Converted to open surgery|2|||
23778875|NCT03020641|66569820|FG001|Overall Study|Converted to open surgery|1|||
23778876|NCT03020641|66569819|FG000|Overall Study|for surgery not performed|0|||
23778877|NCT03020641|66569820|FG001|Overall Study|for surgery not performed|1|||
23778878|NCT02472366|66569821|FG000|Overall Study|Lost to Follow-up|1|||
23778879|NCT02472366|66569822|FG001|Overall Study|Lost to Follow-up|0|||
23778880|NCT00727961|66569825|FG000|Overall Study|Lost to Follow-up|1|||
23778881|NCT00727961|66569825|FG000|Overall Study|Adverse Event|4|||
23778882|NCT00727961|66569825|FG000|Overall Study|Patient's refusal|2|||
23778883|NCT00727961|66569825|FG000|Overall Study|Progression|30|||
23778884|NCT02459951|66569826|FG000|Overall Study|Unable to meet holding requirement|1|||
23778885|NCT01513174|66569827|FG000|Overall Study|Inclusion Error|1|||
23778886|NCT01513174|66569828|FG001|Overall Study|Inclusion Error|7|||
23778887|NCT01513174|66569827|FG000|Overall Study|Not receive study treatment|3|||
23778888|NCT01513174|66569828|FG001|Overall Study|Not receive study treatment|1|||
23778889|NCT02918877|66569831|FG000|Overall Study|Withdrawal by Subject|2|||
23778890|NCT02918877|66569832|FG001|Overall Study|Withdrawal by Subject|2|||
23778891|NCT02918877|66569831|FG000|Overall Study|Surgery cancelled|1|||
23778892|NCT02918877|66569832|FG001|Overall Study|Surgery cancelled|0|||
23778893|NCT02918877|66569831|FG000|Overall Study|Physician Decision|1|||
23778894|NCT02918877|66569832|FG001|Overall Study|Physician Decision|0|||
23778895|NCT02918877|66569831|FG000|Overall Study|Received intraoperative steroids|1|||
23838966|NCT02142959|66791680|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
23838967|NCT02142959|66791681|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
23451293|NCT00296816|65395160|FG000|Overall Study|Disease Progression|37|||
23451294|NCT00296816|65395160|FG000|Overall Study|Adverse Event|18|||
23451295|NCT00296816|65395160|FG000|Overall Study|Investigator/Participant request|5|||
23778896|NCT02918877|66569832|FG001|Overall Study|Received intraoperative steroids|0|||
23778897|NCT02918877|66569831|FG000|Overall Study|Unable to obtain lab samples|1|||
23778898|NCT02918877|66569832|FG001|Overall Study|Unable to obtain lab samples|0|||
23778899|NCT02918877|66569831|FG000|Overall Study|Unsafe to perform BAL|0|||
23778900|NCT02918877|66569832|FG001|Overall Study|Unsafe to perform BAL|1|||
23778901|NCT01037114|66569833|FG000|Year 20|Others|1|||
23451296|NCT00296816|65395160|FG000|Overall Study|Non-compliance|1|||
23778902|NCT03552393|66569836|FG000|Core Period|Kidney Transplant|1|||
23339453|NCT03180684|64986195|FG000|Overall Study|Progressive Disease|1|||
23339454|NCT03180684|64986196|FG001|Overall Study|Progressive Disease|0|||
23339455|NCT05088603|64986211|FG000|Overall Study|Protocol Violation|6|||
23339456|NCT05088603|64986212|FG001|Overall Study|Protocol Violation|1|||
23339457|NCT03348930|64986213|FG000|Washout (1 Week)|Lost to Follow-up|1|||
23339458|NCT03348930|64986214|FG001|Washout (1 Week)|Lost to Follow-up|1|||
23838968|NCT02142959|66791682|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
23838969|NCT02142959|66791680|FG000|Overall Study|Patient didn't complete end of study visit|0|||
23838970|NCT02142959|66791681|FG001|Overall Study|Patient didn't complete end of study visit|0|||
23838971|NCT02142959|66791682|FG002|Overall Study|Patient didn't complete end of study visit|1|||
23838972|NCT00603590|66791687|FG000|Overall Study|Did not attend study clinic|39|||
23838973|NCT00603590|66791688|FG001|Overall Study|Did not attend study clinic|30|||
23838974|NCT00603590|66791687|FG000|Overall Study|Refused blood test|5|||
23339459|NCT02587598|64986215|FG000|Overall Study|Death|4|||
23339460|NCT02587598|64986216|FG001|Overall Study|Death|8|||
23339461|NCT02587598|64986217|FG002|Overall Study|Death|4|||
23339462|NCT02587598|64986218|FG003|Overall Study|Death|16|||
23339463|NCT02587598|64986219|FG004|Overall Study|Death|9|||
23339464|NCT02587598|64986220|FG005|Overall Study|Death|4|||
23339465|NCT02587598|64986221|FG006|Overall Study|Death|6|||
23339466|NCT02587598|64986222|FG007|Overall Study|Death|7|||
23339467|NCT02587598|64986223|FG008|Overall Study|Death|9|||
23339468|NCT02587598|64986224|FG009|Overall Study|Death|1|||
23339469|NCT02587598|64986225|FG010|Overall Study|Death|3|||
23339470|NCT02587598|64986215|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23339471|NCT02587598|64986216|FG001|Overall Study|Study Terminated by the Sponsor|1|||
23339472|NCT02587598|64986217|FG002|Overall Study|Study Terminated by the Sponsor|0|||
23339473|NCT02587598|64986218|FG003|Overall Study|Study Terminated by the Sponsor|3|||
23339474|NCT02587598|64986219|FG004|Overall Study|Study Terminated by the Sponsor|0|||
23339475|NCT02587598|64986220|FG005|Overall Study|Study Terminated by the Sponsor|1|||
23339476|NCT02587598|64986221|FG006|Overall Study|Study Terminated by the Sponsor|0|||
23339477|NCT02587598|64986222|FG007|Overall Study|Study Terminated by the Sponsor|0|||
23339478|NCT02587598|64986223|FG008|Overall Study|Study Terminated by the Sponsor|0|||
23339479|NCT02587598|64986224|FG009|Overall Study|Study Terminated by the Sponsor|1|||
23339480|NCT02587598|64986225|FG010|Overall Study|Study Terminated by the Sponsor|6|||
23339481|NCT02587598|64986215|FG000|Overall Study|Reason for study withdrawal not specified|0|||
23339482|NCT02587598|64986216|FG001|Overall Study|Reason for study withdrawal not specified|1|||
23339483|NCT02587598|64986217|FG002|Overall Study|Reason for study withdrawal not specified|0|||
23339484|NCT02587598|64986218|FG003|Overall Study|Reason for study withdrawal not specified|0|||
23339485|NCT02587598|64986219|FG004|Overall Study|Reason for study withdrawal not specified|0|||
23339486|NCT02587598|64986220|FG005|Overall Study|Reason for study withdrawal not specified|0|||
23339487|NCT02587598|64986221|FG006|Overall Study|Reason for study withdrawal not specified|0|||
23339488|NCT02587598|64986222|FG007|Overall Study|Reason for study withdrawal not specified|0|||
23339489|NCT02587598|64986223|FG008|Overall Study|Reason for study withdrawal not specified|0|||
23339490|NCT02587598|64986224|FG009|Overall Study|Reason for study withdrawal not specified|0|||
23339491|NCT02587598|64986225|FG010|Overall Study|Reason for study withdrawal not specified|0|||
23339492|NCT02587598|64986215|FG000|Overall Study|Withdrawal by Subject|0|||
23339493|NCT02587598|64986216|FG001|Overall Study|Withdrawal by Subject|1|||
23339494|NCT02587598|64986217|FG002|Overall Study|Withdrawal by Subject|0|||
23339495|NCT02587598|64986218|FG003|Overall Study|Withdrawal by Subject|2|||
23339496|NCT02587598|64986219|FG004|Overall Study|Withdrawal by Subject|3|||
23339497|NCT02587598|64986220|FG005|Overall Study|Withdrawal by Subject|1|||
23339498|NCT02587598|64986221|FG006|Overall Study|Withdrawal by Subject|0|||
23339499|NCT02587598|64986222|FG007|Overall Study|Withdrawal by Subject|0|||
23339500|NCT02587598|64986223|FG008|Overall Study|Withdrawal by Subject|0|||
23339501|NCT02587598|64986224|FG009|Overall Study|Withdrawal by Subject|1|||
23339502|NCT02587598|64986225|FG010|Overall Study|Withdrawal by Subject|2|||
23778903|NCT03552393|66569836|FG000|Core Period|Prohibited Medication|1|||
23778904|NCT03552393|66569836|FG000|Safety Extension Period|Kidney Transplant|4|||
23778905|NCT01435265|66573309|FG000|Overall Study|Lost to Follow-up|0|||
23778906|NCT01435265|66573310|FG001|Overall Study|Lost to Follow-up|1|||
23778907|NCT01328093|66573311|FG000|Double-Blind Phase|Adverse Event|78|||
23778908|NCT01328093|66573312|FG001|Double-Blind Phase|Adverse Event|15|||
23778909|NCT01328093|66573311|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
23778910|NCT01328093|66573312|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
23778911|NCT01328093|66573311|FG000|Double-Blind Phase|Lost to Follow-up|39|||
23778912|NCT01328093|66573312|FG001|Double-Blind Phase|Lost to Follow-up|14|||
23778913|NCT01328093|66573311|FG000|Double-Blind Phase|Protocol Violation|30|||
23778914|NCT01328093|66573312|FG001|Double-Blind Phase|Protocol Violation|10|||
23339503|NCT02587598|64986215|FG000|Overall Study|Physician Decision|0|||
23634859|NCT01609062|66049325|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
23778915|NCT01328093|66573311|FG000|Double-Blind Phase|Lack of Efficacy|55|||
23339504|NCT02587598|64986216|FG001|Overall Study|Physician Decision|0|||
23339505|NCT02587598|64986217|FG002|Overall Study|Physician Decision|0|||
23778916|NCT01328093|66573312|FG001|Double-Blind Phase|Lack of Efficacy|13|||
23778917|NCT01328093|66573311|FG000|Double-Blind Phase|Sponsor Decision|17|||
23778918|NCT01328093|66573312|FG001|Double-Blind Phase|Sponsor Decision|3|||
23778919|NCT01328093|66573311|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
23778920|NCT01328093|66573312|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
23778921|NCT01328093|66573311|FG000|Double-Blind Phase|Scheduling conflict|8|||
23778922|NCT01328093|66573312|FG001|Double-Blind Phase|Scheduling conflict|3|||
23778923|NCT01328093|66573311|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
23778924|NCT01328093|66573312|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
23778925|NCT01328093|66573311|FG000|Double-Blind Phase|Death|1|||
23778926|NCT01328093|66573312|FG001|Double-Blind Phase|Death|0|||
23778927|NCT01328093|66573311|FG000|Open-Label Phase|Sponsor Decision|98|||
23778928|NCT01328093|66573312|FG001|Open-Label Phase|Sponsor Decision|34|||
23778929|NCT01328093|66573311|FG000|Open-Label Phase|Protocol Violation|8|||
23778930|NCT01328093|66573312|FG001|Open-Label Phase|Protocol Violation|3|||
23778931|NCT01328093|66573311|FG000|Open-Label Phase|Lost to Follow-up|10|||
23778932|NCT01328093|66573312|FG001|Open-Label Phase|Lost to Follow-up|1|||
23838975|NCT00603590|66791688|FG001|Overall Study|Refused blood test|1|||
23778933|NCT01328093|66573311|FG000|Open-Label Phase|Adverse Event|10|||
23778934|NCT01328093|66573312|FG001|Open-Label Phase|Adverse Event|4|||
23778935|NCT01328093|66573311|FG000|Open-Label Phase|Lack of Efficacy|5|||
23778936|NCT01328093|66573312|FG001|Open-Label Phase|Lack of Efficacy|6|||
23778937|NCT01328093|66573311|FG000|Open-Label Phase|Withdrawal by Subject|4|||
23778938|NCT01328093|66573312|FG001|Open-Label Phase|Withdrawal by Subject|1|||
23778939|NCT01328093|66573311|FG000|Open-Label Phase|Scheduling conflict|2|||
23778940|NCT01328093|66573312|FG001|Open-Label Phase|Scheduling conflict|1|||
23778941|NCT01328093|66573311|FG000|Open-Label Phase|Subject is moving or has moved|2|||
23778942|NCT01328093|66573312|FG001|Open-Label Phase|Subject is moving or has moved|0|||
23634860|NCT01609062|66049326|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
23634861|NCT01609062|66049325|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
23634862|NCT01609062|66049326|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
23634863|NCT00667394|66049327|FG000|Overall Study|Adverse Event|3|||
23634864|NCT00667394|66049328|FG001|Overall Study|Adverse Event|0|||
23634865|NCT00667394|66049327|FG000|Overall Study|Progressive disease|1|||
23634866|NCT00667394|66049328|FG001|Overall Study|Progressive disease|0|||
23634867|NCT03167151|66049331|FG000|Overall Study|Withdrawal by Subject|1|||
23634868|NCT03167151|66049332|FG001|Overall Study|Withdrawal by Subject|0|||
23634869|NCT03167151|66049333|FG002|Overall Study|Withdrawal by Subject|0|||
23634870|NCT03167151|66049331|FG000|Overall Study|No evidence of tumour at surgery|0|||
23634871|NCT03167151|66049332|FG001|Overall Study|No evidence of tumour at surgery|1|||
23634872|NCT03167151|66049333|FG002|Overall Study|No evidence of tumour at surgery|1|||
23778943|NCT01328093|66573311|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
23778944|NCT01328093|66573312|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
23778945|NCT02043132|66573322|FG000|Overall Study|Lost to Follow-up|1|||
23778946|NCT02043132|66573323|FG001|Overall Study|Lost to Follow-up|1|||
23634873|NCT02671500|66049334|FG000|Overall Study|Lack of Efficacy|12|||
23634874|NCT02671500|66049334|FG000|Overall Study|Lost to Follow-up|2|||
23634875|NCT00677534|66049336|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
23634876|NCT00677534|66049336|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
23634877|NCT00677534|66049336|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
23634878|NCT03101462|66049341|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
23634879|NCT03101462|66049342|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
23634880|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
23838976|NCT00603590|66791687|FG000|Overall Study|Patient discontinued study drug|22|||
23838977|NCT00603590|66791688|FG001|Overall Study|Patient discontinued study drug|15|||
23838978|NCT00603590|66791687|FG000|Overall Study|Adverse Event|2|||
23838979|NCT00603590|66791688|FG001|Overall Study|Adverse Event|0|||
23838980|NCT00603590|66791687|FG000|Overall Study|Lost to Follow-up|8|||
23838981|NCT00603590|66791688|FG001|Overall Study|Lost to Follow-up|4|||
23838982|NCT00603590|66791687|FG000|Overall Study|Cardiovascular event|0|||
23838983|NCT00603590|66791688|FG001|Overall Study|Cardiovascular event|1|||
23838984|NCT01841762|66791689|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
23838985|NCT01841762|66791689|FG000|Treatment Period|Adverse Event|16|||
23838986|NCT01841762|66791689|FG000|Treatment Period|Death|1|||
23339506|NCT02587598|64986218|FG003|Overall Study|Physician Decision|0|||
23339507|NCT02587598|64986219|FG004|Overall Study|Physician Decision|0|||
23634881|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
23634882|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23634883|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
23634884|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23634885|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23778947|NCT02043132|66573322|FG000|Overall Study|screen failures|4|||
23778948|NCT02043132|66573323|FG001|Overall Study|screen failures|8|||
23778949|NCT03600805|66573330|FG000|Overall Study|Adverse Event|2|||
23778950|NCT03600805|66573331|FG001|Overall Study|Adverse Event|1|||
23778951|NCT03600805|66573332|FG002|Overall Study|Adverse Event|1|||
23838987|NCT01841762|66791689|FG000|Treatment Period|Withdrawal by Subject|7|||
23838988|NCT01841762|66791689|FG000|Treatment Period|Lost to Follow-up|1|||
23838989|NCT01841762|66791689|FG000|Treatment Period|Physician Decision|2|||
23838990|NCT01841762|66791689|FG000|Treatment Period|Other, including non-compliance|5|||
23838991|NCT01841762|66791689|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
23838992|NCT01841762|66791689|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
23838993|NCT01841762|66791689|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
23838994|NCT01841762|66791689|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
23838995|NCT03831113|66791692|FG000|Overall Study|Withdrawal by Subject|0|||
23838996|NCT03831113|66791693|FG001|Overall Study|Withdrawal by Subject|2|||
23838997|NCT03831113|66791692|FG000|Overall Study|Protocol Violation|0|||
23838998|NCT03831113|66791693|FG001|Overall Study|Protocol Violation|9|||
23838999|NCT03412734|66791698|FG000|Overall Study|Incorrect labeling of samples|2|||
23839000|NCT03412734|66791699|FG001|Overall Study|Incorrect labeling of samples|0|||
23839001|NCT03412734|66791698|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
23839002|NCT03412734|66791699|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
23839003|NCT00458536|66791700|FG000|Overall Study|Disease progression prior to treatment|7|||
23839004|NCT00458536|66791700|FG000|Overall Study|Unable to make vaccine|3|||
23839005|NCT00458536|66791700|FG000|Overall Study|No measurable disease after surgery|2|||
23839006|NCT00458536|66791700|FG000|Overall Study|Did not have renal cell carcinoma|2|||
23839007|NCT00458536|66791700|FG000|Overall Study|Patient did not have surgery|1|||
23839008|NCT00458536|66791700|FG000|Overall Study|Ineligible due to toxicity|1|||
23839009|NCT00458536|66791700|FG000|Overall Study|Withdrawal by Subject|1|||
23839010|NCT00458536|66791700|FG000|Overall Study|Progressive disease during treatment|2|||
23839011|NCT00818766|66791702|FG000|Overall Study|Could not be Contacted on Day 28|11|||
23839012|NCT00818766|66791703|FG001|Overall Study|Could not be Contacted on Day 28|10|||
23839013|NCT00818766|66791702|FG000|Overall Study|Death|1|||
23839014|NCT00818766|66791703|FG001|Overall Study|Death|0|||
23839015|NCT00818766|66791702|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
23579436|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579437|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
23579438|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
23579439|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
23579440|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Death|0|||
23579441|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Death|0|||
23579442|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Death|0|||
23579443|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Death|0|||
23579444|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Death|0|||
23579445|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Death|0|||
23579446|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Death|0|||
23579447|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Death|1|||
23579448|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Death|3|||
23579449|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579450|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579451|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579452|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579453|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23839016|NCT00818766|66791703|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
23839017|NCT02112045|66791709|FG000|Overall Study|Withdrawal by Subject|1|||
23839018|NCT02112045|66791710|FG001|Overall Study|Withdrawal by Subject|0|||
23839019|NCT04087720|66791718|FG000|Overall Study|Withdrawal by Subject|2|||
23839020|NCT04087720|66791718|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
23839021|NCT01560234|66791719|FG000|Overall Study|Lost to Follow-up|3|||
23839022|NCT01560234|66791720|FG001|Overall Study|Lost to Follow-up|0|||
23839023|NCT01560234|66791721|FG002|Overall Study|Lost to Follow-up|1|||
23839024|NCT01560234|66791722|FG003|Overall Study|Lost to Follow-up|0|||
23839025|NCT01560234|66791723|FG004|Overall Study|Lost to Follow-up|0|||
23839026|NCT01560234|66791724|FG005|Overall Study|Lost to Follow-up|2|||
23839027|NCT01560234|66791725|FG006|Overall Study|Lost to Follow-up|0|||
23839028|NCT01560234|66791726|FG007|Overall Study|Lost to Follow-up|2|||
23839029|NCT01106911|66791727|FG000|Overall Study|Physician Decision|2|||
23634886|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23634887|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
23839030|NCT01106911|66791727|FG000|Overall Study|deemed ineligible after screening|3|||
23839031|NCT04654468|66791728|FG000|Overall Study|Death|1|||
23839032|NCT04654468|66791728|FG000|Overall Study|Ongoing in the Study|50|||
23839033|NCT01266291|66791729|FG000|Overall Study|Adverse Event|1|||
23839034|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
23839035|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
23839036|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
23579454|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23839037|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
23839038|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23839039|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23839040|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
23839041|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23839042|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
23839043|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23839044|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23839045|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23839046|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
23839047|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
23839048|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
23839049|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
23839050|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23839051|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
23839052|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23839053|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23839054|NCT00556933|66791730|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23839055|NCT00556933|66791731|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
23839056|NCT00556933|66791732|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23839057|NCT00556933|66791733|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23839058|NCT00556933|66791730|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
23839059|NCT00556933|66791731|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
23839060|NCT00556933|66791732|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
23839061|NCT00556933|66791733|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
23839062|NCT00556933|66791730|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
23839063|NCT00556933|66791731|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
23839064|NCT00556933|66791732|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
23839065|NCT00556933|66791733|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
23839066|NCT00556933|66791730|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
23839067|NCT00556933|66791731|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
23839068|NCT00556933|66791732|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
23839069|NCT00556933|66791733|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
23839070|NCT00556933|66791730|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
23839071|NCT00556933|66791731|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
23839072|NCT00556933|66791732|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
23839073|NCT00556933|66791733|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
23839074|NCT00556933|66791730|FG000|CNI Withdrawal vs. Minimization|Death|0|||
23839075|NCT00556933|66791731|FG001|CNI Withdrawal vs. Minimization|Death|0|||
23839076|NCT00556933|66791732|FG002|CNI Withdrawal vs. Minimization|Death|0|||
23839077|NCT00556933|66791733|FG003|CNI Withdrawal vs. Minimization|Death|1|||
23839078|NCT04657198|66791736|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
23839079|NCT04657198|66791737|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23839080|NCT04657198|66791738|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23839081|NCT00782795|66791739|FG000|Overall Study|Withdrawal by Subject|1|||
23839082|NCT00782795|66791740|FG001|Overall Study|Withdrawal by Subject|2|||
23839083|NCT00379080|66791743|FG000|Overall Study|Withdrawal by Subject|0|||
23634888|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23634889|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23634890|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
23634891|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23634892|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23634893|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
23634894|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23634895|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
23634896|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
23634897|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
23634898|NCT00603525|66049348|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
23634899|NCT00603525|66049349|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
23634900|NCT00603525|66049350|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
23634901|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23634902|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
23634903|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23634904|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23839084|NCT00379080|66791744|FG001|Overall Study|Withdrawal by Subject|4|||
23839085|NCT00379080|66791745|FG002|Overall Study|Withdrawal by Subject|0|||
23634905|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
23839086|NCT01355575|66791746|FG000|Overall Study|Withdrawal by Subject|2|||
23634906|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23634907|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23634908|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
23634909|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23634910|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23634911|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
23634912|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23634913|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23634914|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
23634915|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23634916|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23634917|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
23634918|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23634919|NCT00603525|66049348|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23634920|NCT00603525|66049349|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
23778952|NCT03600805|66573333|FG003|Overall Study|Adverse Event|7|||
23778953|NCT03600805|66573330|FG000|Overall Study|Lack of Efficacy|2|||
23778954|NCT03600805|66573331|FG001|Overall Study|Lack of Efficacy|1|||
23778955|NCT03600805|66573332|FG002|Overall Study|Lack of Efficacy|0|||
23839087|NCT01540487|66791747|FG000|Overall Study|Protocol Violation|1|||
23839088|NCT01540487|66791748|FG001|Overall Study|Protocol Violation|0|||
23839089|NCT03363776|66791749|FG000|Overall Study|Progressive disease|2|||
23839090|NCT03363776|66791750|FG001|Overall Study|Progressive disease|3|||
23839091|NCT03363776|66791751|FG002|Overall Study|Progressive disease|1|||
23839092|NCT03363776|66791749|FG000|Overall Study|Study drug toxicity|0|||
23839093|NCT03363776|66791750|FG001|Overall Study|Study drug toxicity|0|||
23839094|NCT03363776|66791751|FG002|Overall Study|Study drug toxicity|1|||
23839095|NCT03363776|66791749|FG000|Overall Study|Death|1|||
23839096|NCT03363776|66791750|FG001|Overall Study|Death|0|||
23839097|NCT03363776|66791751|FG002|Overall Study|Death|0|||
23839098|NCT00996125|66791752|FG000|Overall Study|Adverse Event|0|||
23839099|NCT00996125|66791753|FG001|Overall Study|Adverse Event|2|||
23839100|NCT00996125|66791752|FG000|Overall Study|Lost to Follow-up|1|||
23839101|NCT00996125|66791753|FG001|Overall Study|Lost to Follow-up|6|||
23839102|NCT00996125|66791752|FG000|Overall Study|Withdrawal by Subject|4|||
23839103|NCT00996125|66791753|FG001|Overall Study|Withdrawal by Subject|3|||
23839104|NCT01014988|66791754|FG000|Overall Study|Adverse Event|20|||
23839105|NCT01014988|66791755|FG001|Overall Study|Adverse Event|0|||
23839106|NCT01014988|66791756|FG002|Overall Study|Adverse Event|1|||
23839107|NCT01014988|66791757|FG003|Overall Study|Adverse Event|0|||
23839108|NCT01014988|66791758|FG004|Overall Study|Adverse Event|1|||
23839109|NCT01014988|66791759|FG005|Overall Study|Adverse Event|3|||
23839110|NCT01014988|66791754|FG000|Overall Study|Lost to Follow-up|1|||
23839111|NCT01014988|66791755|FG001|Overall Study|Lost to Follow-up|0|||
23839112|NCT01014988|66791756|FG002|Overall Study|Lost to Follow-up|1|||
23839113|NCT01014988|66791757|FG003|Overall Study|Lost to Follow-up|0|||
23778956|NCT03600805|66573333|FG003|Overall Study|Lack of Efficacy|0|||
23839114|NCT01014988|66791758|FG004|Overall Study|Lost to Follow-up|0|||
23839115|NCT01014988|66791759|FG005|Overall Study|Lost to Follow-up|0|||
23839116|NCT01014988|66791754|FG000|Overall Study|Physician Decision|1|||
23839117|NCT01014988|66791755|FG001|Overall Study|Physician Decision|0|||
23839118|NCT01014988|66791756|FG002|Overall Study|Physician Decision|0|||
23839119|NCT01014988|66791757|FG003|Overall Study|Physician Decision|0|||
23839120|NCT01014988|66791758|FG004|Overall Study|Physician Decision|0|||
23839121|NCT01014988|66791759|FG005|Overall Study|Physician Decision|0|||
23839122|NCT01014988|66791754|FG000|Overall Study|Withdrawal by Subject|1|||
23839123|NCT01014988|66791755|FG001|Overall Study|Withdrawal by Subject|0|||
23778957|NCT03600805|66573330|FG000|Overall Study|Withdrawal by Subject|1|||
23778958|NCT03600805|66573331|FG001|Overall Study|Withdrawal by Subject|0|||
23778959|NCT03600805|66573332|FG002|Overall Study|Withdrawal by Subject|0|||
23778960|NCT03600805|66573333|FG003|Overall Study|Withdrawal by Subject|1|||
23839124|NCT01014988|66791756|FG002|Overall Study|Withdrawal by Subject|0|||
23839125|NCT01014988|66791757|FG003|Overall Study|Withdrawal by Subject|0|||
23839126|NCT01014988|66791758|FG004|Overall Study|Withdrawal by Subject|0|||
23839127|NCT01014988|66791759|FG005|Overall Study|Withdrawal by Subject|0|||
23839128|NCT01568034|66791762|FG000|Overall Study|Withdrawal by Subject|1|||
23839129|NCT01568034|66791763|FG001|Overall Study|Withdrawal by Subject|0|||
23839130|NCT01568034|66791764|FG002|Overall Study|Withdrawal by Subject|0|||
23839131|NCT01568034|66791765|FG003|Overall Study|Withdrawal by Subject|0|||
23634921|NCT00603525|66049350|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23634922|NCT00603525|66049348|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
23778961|NCT03600805|66573330|FG000|Overall Study|Other unspecified|14|||
23778962|NCT03600805|66573331|FG001|Overall Study|Other unspecified|6|||
23839132|NCT00758485|66791766|FG000|Overall Study|Lost to Follow-up|0|||
23839133|NCT00758485|66791767|FG001|Overall Study|Lost to Follow-up|1|||
23839134|NCT00758485|66791766|FG000|Overall Study|Not Treated|1|||
23839135|NCT00758485|66791767|FG001|Overall Study|Not Treated|2|||
23839136|NCT02222545|66791768|FG000|Overall Study|Adverse Event|1|||
23839137|NCT02222545|66791769|FG001|Overall Study|Adverse Event|0|||
23839138|NCT02222545|66791770|FG002|Overall Study|Adverse Event|2|||
23839139|NCT02222545|66791768|FG000|Overall Study|Death|0|||
23839140|NCT02222545|66791769|FG001|Overall Study|Death|0|||
23839141|NCT02222545|66791770|FG002|Overall Study|Death|9|||
23839142|NCT02222545|66791768|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
23839143|NCT02222545|66791769|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
23839144|NCT02222545|66791770|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
23839145|NCT02222545|66791768|FG000|Overall Study|Withdrawal by Subject|0|||
23839146|NCT02222545|66791769|FG001|Overall Study|Withdrawal by Subject|0|||
23839147|NCT02222545|66791770|FG002|Overall Study|Withdrawal by Subject|3|||
23839148|NCT02222545|66791768|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
23839149|NCT02222545|66791769|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
23839150|NCT02222545|66791770|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
23839151|NCT02042950|66791773|FG000|Overall Study|Progressive Disease|4|||
23839152|NCT04553471|66791776|FG000|Overall Study|Did not start treatment on protocol|3|||
23839153|NCT04553471|66791776|FG000|Overall Study|Death|1|||
23839154|NCT02120833|66791780|FG000|Overall Study|Adverse Event|1|||
23839155|NCT02120833|66791781|FG001|Overall Study|Adverse Event|0|||
23778963|NCT03600805|66573332|FG002|Overall Study|Other unspecified|7|||
23778964|NCT03600805|66573333|FG003|Overall Study|Other unspecified|11|||
23839156|NCT02120833|66791780|FG000|Overall Study|Withdrawal by Subject|2|||
23839157|NCT02120833|66791781|FG001|Overall Study|Withdrawal by Subject|0|||
23839158|NCT02120833|66791780|FG000|Overall Study|Lost to Follow-up|1|||
23839159|NCT02120833|66791781|FG001|Overall Study|Lost to Follow-up|1|||
23839160|NCT03020992|66791782|FG000|Overall Study|Adverse Event|5|||
23839161|NCT03020992|66791782|FG000|Overall Study|Withdrawal by Subject|1|||
23839162|NCT04520997|66791789|FG000|Overall Study|Lost to Follow-up|1|||
23839163|NCT04520997|66791790|FG001|Overall Study|Lost to Follow-up|1|||
23839164|NCT04520997|66791789|FG000|Overall Study|Withdrawal by Subject|1|||
23839165|NCT04520997|66791790|FG001|Overall Study|Withdrawal by Subject|0|||
23839166|NCT04520997|66791789|FG000|Overall Study|Not Treated|0|||
23839167|NCT04520997|66791790|FG001|Overall Study|Not Treated|1|||
23839168|NCT00665431|66791793|FG000|Overall Study|Adverse Event|16|||
23839169|NCT00665431|66791794|FG001|Overall Study|Adverse Event|22|||
23839170|NCT00665431|66791795|FG002|Overall Study|Adverse Event|6|||
23839171|NCT00665431|66791793|FG000|Overall Study|Withdrawal by Subject|17|||
23839172|NCT00665431|66791794|FG001|Overall Study|Withdrawal by Subject|25|||
23839173|NCT00665431|66791795|FG002|Overall Study|Withdrawal by Subject|15|||
23839174|NCT00665431|66791793|FG000|Overall Study|Lost to Follow-up|3|||
23839175|NCT00665431|66791794|FG001|Overall Study|Lost to Follow-up|3|||
23839176|NCT00665431|66791795|FG002|Overall Study|Lost to Follow-up|1|||
23839177|NCT00665431|66791793|FG000|Overall Study|Other|4|||
23839178|NCT00665431|66791794|FG001|Overall Study|Other|7|||
23839179|NCT00665431|66791795|FG002|Overall Study|Other|2|||
23839180|NCT00406367|66791798|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
23839181|NCT00406367|66791799|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23839182|NCT00406367|66791798|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
23839183|NCT00406367|66791799|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
23839184|NCT00406367|66791798|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
23839185|NCT00406367|66791799|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
23839186|NCT00406367|66791798|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
23839187|NCT00406367|66791799|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
23839188|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
23839189|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
23339508|NCT02587598|64986220|FG005|Overall Study|Physician Decision|0|||
23339509|NCT02587598|64986221|FG006|Overall Study|Physician Decision|0|||
23778965|NCT02445339|66573340|FG000|Overall Study|Physician Decision|1|||
23778966|NCT02445339|66573341|FG001|Overall Study|Physician Decision|0|||
23778967|NCT02445339|66573340|FG000|Overall Study|Lost to Follow-up|11|||
23778968|NCT02445339|66573341|FG001|Overall Study|Lost to Follow-up|15|||
23778969|NCT02914600|66573343|FG000|Overall Study|Adverse Event|298|||
23778970|NCT02914600|66573344|FG001|Overall Study|Adverse Event|35|||
23778971|NCT02914600|66573345|FG002|Overall Study|Adverse Event|25|||
23778972|NCT02914600|66573343|FG000|Overall Study|Sponsors decision|287|||
23778973|NCT02914600|66573344|FG001|Overall Study|Sponsors decision|41|||
23778974|NCT02914600|66573345|FG002|Overall Study|Sponsors decision|12|||
23839190|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
23839191|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
23839192|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
23839193|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
23839194|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
23839195|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
23839196|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
23839197|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
23839198|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
23839199|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
23839200|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
23579455|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
23579456|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
23579457|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
23579458|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579459|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579460|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579461|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579462|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579463|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579464|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579465|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
23579466|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
23579467|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579468|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579469|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579470|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579471|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579472|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579473|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
23579474|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
23579475|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
23579476|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579477|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579478|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579479|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579480|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579481|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579482|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
23579483|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
23579484|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
23579485|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579486|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579487|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579488|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579489|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579490|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579491|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
23579492|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
23579493|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
23579494|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Other|0|||
23579495|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Other|0|||
23579496|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Other|0|||
23579497|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Other|0|||
23579498|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Other|0|||
23579499|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Other|0|||
23579500|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Other|110|||
23579501|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Other|9|||
23579502|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Other|17|||
23579503|NCT01474512|65853360|FG000|Induction Period|Adverse Event|6|||
23579504|NCT01474512|65853361|FG001|Induction Period|Adverse Event|10|||
23579505|NCT01474512|65853362|FG002|Induction Period|Adverse Event|10|||
23579506|NCT01474512|65853363|FG003|Induction Period|Adverse Event|0|||
23839201|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
23839202|NCT00406367|66791798|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
23839203|NCT00406367|66791799|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
23839204|NCT04471428|66791800|FG000|Overall Study|Withdrawal by Subject|29|||
23839205|NCT04471428|66791801|FG001|Overall Study|Withdrawal by Subject|1|||
23839206|NCT04471428|66791800|FG000|Overall Study|Physician Decision|0|||
23339510|NCT02587598|64986222|FG007|Overall Study|Physician Decision|0|||
23339511|NCT02587598|64986223|FG008|Overall Study|Physician Decision|0|||
23579507|NCT01474512|65853364|FG004|Induction Period|Adverse Event|0|||
23579508|NCT01474512|65853365|FG005|Induction Period|Adverse Event|0|||
23579509|NCT01474512|65853366|FG006|Induction Period|Adverse Event|0|||
23451297|NCT00296816|65395160|FG000|Overall Study|Missing for end of treatment|4|||
23579510|NCT01474512|65853367|FG007|Induction Period|Adverse Event|0|||
23778975|NCT02914600|66573343|FG000|Overall Study|Withdrawal by Subject|158|||
23778976|NCT02914600|66573344|FG001|Overall Study|Withdrawal by Subject|20|||
23778977|NCT02914600|66573345|FG002|Overall Study|Withdrawal by Subject|18|||
23778978|NCT02914600|66573343|FG000|Overall Study|Investigators discretion|169|||
23778979|NCT02914600|66573344|FG001|Overall Study|Investigators discretion|14|||
23778980|NCT02914600|66573345|FG002|Overall Study|Investigators discretion|13|||
23778981|NCT02914600|66573343|FG000|Overall Study|Lost to Follow-up|10|||
23778982|NCT02914600|66573344|FG001|Overall Study|Lost to Follow-up|4|||
23778983|NCT02914600|66573345|FG002|Overall Study|Lost to Follow-up|0|||
23778984|NCT02914600|66573343|FG000|Overall Study|Pregnancy|8|||
23778985|NCT02914600|66573344|FG001|Overall Study|Pregnancy|0|||
23778986|NCT02914600|66573345|FG002|Overall Study|Pregnancy|0|||
23778987|NCT02914600|66573343|FG000|Overall Study|Protocol Violation|5|||
23778988|NCT02914600|66573344|FG001|Overall Study|Protocol Violation|3|||
23778989|NCT02914600|66573345|FG002|Overall Study|Protocol Violation|0|||
23778990|NCT02914600|66573343|FG000|Overall Study|Non-compliance with study drug|6|||
23778991|NCT02914600|66573344|FG001|Overall Study|Non-compliance with study drug|1|||
23778992|NCT02914600|66573345|FG002|Overall Study|Non-compliance with study drug|0|||
23778993|NCT02914600|66573343|FG000|Overall Study|Death|3|||
23778994|NCT02914600|66573344|FG001|Overall Study|Death|1|||
23778995|NCT02914600|66573345|FG002|Overall Study|Death|1|||
23778996|NCT02914600|66573343|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
23778997|NCT02914600|66573344|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
23778998|NCT02914600|66573345|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
23778999|NCT02914600|66573343|FG000|Overall Study|Enrolled but not treated|1|||
23779000|NCT02914600|66573344|FG001|Overall Study|Enrolled but not treated|0|||
23779001|NCT02914600|66573345|FG002|Overall Study|Enrolled but not treated|0|||
23779002|NCT02622386|66573346|FG000|First Assignment|Withdrawal by Subject|3|||
23779003|NCT02622386|66573347|FG001|First Assignment|Withdrawal by Subject|2|||
23779004|NCT02622386|66573346|FG000|Washout|Withdrawal by Subject|4|||
23779005|NCT02622386|66573347|FG001|Washout|Withdrawal by Subject|4|||
23779006|NCT02622386|66573346|FG000|Second Assignment|Withdrawal by Subject|0|||
23779007|NCT02622386|66573347|FG001|Second Assignment|Withdrawal by Subject|2|||
23779008|NCT01882257|66573351|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
23779009|NCT01882257|66573352|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
23779010|NCT01882257|66573353|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
23779011|NCT01882257|66573351|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
23779012|NCT01882257|66573352|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
23779013|NCT01882257|66573353|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
23779014|NCT02711852|66573354|FG000|Overall Study|Death|5|||
23779015|NCT02711852|66573354|FG000|Overall Study|Lost to Follow-up|1|||
23779016|NCT02711852|66573354|FG000|Overall Study|Completed follow-up|3|||
23779017|NCT02711852|66573354|FG000|Overall Study|Withdrawal by Subject|1|||
23779018|NCT03733730|66573356|FG000|Overall Study|Lost to Follow-up|1|||
23779019|NCT03733730|66573357|FG001|Overall Study|Lost to Follow-up|32|||
23779020|NCT03733730|66573356|FG000|Overall Study|Other|1|||
23779021|NCT03733730|66573357|FG001|Overall Study|Other|0|||
23779022|NCT03733730|66573356|FG000|Overall Study|Adverse Event|0|||
23779023|NCT03733730|66573357|FG001|Overall Study|Adverse Event|4|||
23779024|NCT03733730|66573356|FG000|Overall Study|Death|0|||
23779025|NCT03733730|66573357|FG001|Overall Study|Death|5|||
23779026|NCT03733730|66573356|FG000|Overall Study|Withdrawal by Subject|0|||
23779027|NCT03733730|66573357|FG001|Overall Study|Withdrawal by Subject|8|||
23779028|NCT02077465|66573358|FG000|Overall Study|Withdrew Consent|0|||
23779029|NCT02077465|66573359|FG001|Overall Study|Withdrew Consent|1|||
23779030|NCT02077465|66573358|FG000|Overall Study|Lost to Follow-up|1|||
23779031|NCT02077465|66573359|FG001|Overall Study|Lost to Follow-up|0|||
23779032|NCT00445003|66573360|FG000|Overall Study|Death|1|||
23779033|NCT00445003|66573361|FG001|Overall Study|Death|2|||
23779034|NCT00445003|66573362|FG002|Overall Study|Death|1|||
23779035|NCT00445003|66573360|FG000|Overall Study|Missed Visit|3|||
23779036|NCT00445003|66573361|FG001|Overall Study|Missed Visit|5|||
23779037|NCT00445003|66573362|FG002|Overall Study|Missed Visit|1|||
23579511|NCT01474512|65853368|FG008|Induction Period|Adverse Event|0|||
23779038|NCT00445003|66573360|FG000|Overall Study|Dropped|1|||
23779039|NCT00445003|66573361|FG001|Overall Study|Dropped|3|||
23779040|NCT00445003|66573362|FG002|Overall Study|Dropped|2|||
23779041|NCT03500341|66573363|FG000|Overall Study|Withdrawn prior to Completion|2|||
23779042|NCT02468778|66573364|FG000|Overall Study|Death|2|||
23779043|NCT02468778|66573365|FG001|Overall Study|Death|1|||
23779044|NCT02468778|66573366|FG002|Overall Study|Death|0|||
23779045|NCT02468778|66573364|FG000|Overall Study|Lost to Follow-up|1|||
23779046|NCT02468778|66573365|FG001|Overall Study|Lost to Follow-up|2|||
23779047|NCT02468778|66573366|FG002|Overall Study|Lost to Follow-up|2|||
23779048|NCT02468778|66573364|FG000|Overall Study|Withdrawal by Subject|0|||
23839207|NCT04471428|66791801|FG001|Overall Study|Physician Decision|1|||
23839208|NCT04471428|66791800|FG000|Overall Study|Reason Not Specified|0|||
23839209|NCT04471428|66791801|FG001|Overall Study|Reason Not Specified|2|||
23839210|NCT04471428|66791800|FG000|Overall Study|Death|106|||
23839211|NCT04471428|66791801|FG001|Overall Study|Death|114|||
23579512|NCT01474512|65853369|FG009|Induction Period|Adverse Event|0|||
23579513|NCT01474512|65853370|FG010|Induction Period|Adverse Event|0|||
23579514|NCT01474512|65853371|FG011|Induction Period|Adverse Event|0|||
23579515|NCT01474512|65853372|FG012|Induction Period|Adverse Event|0|||
23579516|NCT01474512|65853373|FG013|Induction Period|Adverse Event|0|||
23579517|NCT01474512|65853374|FG014|Induction Period|Adverse Event|0|||
23579518|NCT01474512|65853375|FG015|Induction Period|Adverse Event|0|||
23579519|NCT01474512|65853376|FG016|Induction Period|Adverse Event|0|||
23839212|NCT04471428|66791800|FG000|Overall Study|Ongoing in the study|45|||
23839213|NCT04471428|66791801|FG001|Overall Study|Ongoing in the study|68|||
23839214|NCT03309943|66791802|FG000|Overall Study|Withdrawal by Subject|0|||
23839215|NCT03309943|66791803|FG001|Overall Study|Withdrawal by Subject|1|||
23839216|NCT03309943|66791802|FG000|Overall Study|Inappropriate behavior towards staff|0|||
23839217|NCT03309943|66791803|FG001|Overall Study|Inappropriate behavior towards staff|1|||
23839218|NCT02308540|66791806|FG000|Overall Study|Lost to Follow-up|0|||
23839219|NCT02308540|66791807|FG001|Overall Study|Lost to Follow-up|0|||
23839220|NCT02308540|66791808|FG002|Overall Study|Lost to Follow-up|0|||
23839221|NCT02308540|66791809|FG003|Overall Study|Lost to Follow-up|0|||
23839222|NCT02308540|66791810|FG004|Overall Study|Lost to Follow-up|0|||
23839223|NCT02308540|66791811|FG005|Overall Study|Lost to Follow-up|1|||
23839224|NCT02492984|66791812|FG000|Overall Study|Adverse Event|1|||
23839225|NCT02492984|66791813|FG001|Overall Study|Adverse Event|0|||
23839226|NCT02492984|66791812|FG000|Overall Study|Protocol Violation|1|||
23839227|NCT02492984|66791813|FG001|Overall Study|Protocol Violation|0|||
23839228|NCT02492984|66791812|FG000|Overall Study|Withdrawal by Subject|1|||
23839229|NCT02492984|66791813|FG001|Overall Study|Withdrawal by Subject|0|||
23839230|NCT01827267|66791814|FG000|Overall Study|Did not receive study drug|1|||
23839231|NCT01827267|66791815|FG001|Overall Study|Did not receive study drug|1|||
23839232|NCT01827267|66791814|FG000|Overall Study|Physician Decision|1|||
23839233|NCT01827267|66791815|FG001|Overall Study|Physician Decision|0|||
23839234|NCT01827267|66791814|FG000|Overall Study|Disease Progression|1|||
23839235|NCT01827267|66791815|FG001|Overall Study|Disease Progression|1|||
23839236|NCT01827267|66791814|FG000|Overall Study|Sponsor Discontinued Study|2|||
23839237|NCT01827267|66791815|FG001|Overall Study|Sponsor Discontinued Study|8|||
23839238|NCT01827267|66791814|FG000|Overall Study|Still on study|0|||
23839239|NCT01827267|66791815|FG001|Overall Study|Still on study|2|||
23839240|NCT01455597|66791816|FG000|Overall Study|Adverse Event|7|||
23839241|NCT01455597|66791817|FG001|Overall Study|Adverse Event|0|||
23579520|NCT01474512|65853377|FG017|Induction Period|Adverse Event|0|||
23579521|NCT01474512|65853360|FG000|Induction Period|Lack of Efficacy|7|||
23579522|NCT01474512|65853361|FG001|Induction Period|Lack of Efficacy|1|||
23579523|NCT01474512|65853362|FG002|Induction Period|Lack of Efficacy|0|||
23779049|NCT02468778|66573365|FG001|Overall Study|Withdrawal by Subject|1|||
23779050|NCT02468778|66573366|FG002|Overall Study|Withdrawal by Subject|1|||
23779051|NCT03351244|66573367|FG000|Overall Study|Adverse Event|7|||
23779052|NCT03351244|66573368|FG001|Overall Study|Adverse Event|11|||
23779053|NCT03351244|66573369|FG002|Overall Study|Adverse Event|12|||
23779054|NCT03351244|66573367|FG000|Overall Study|Investigator's decision|0|||
23779055|NCT03351244|66573368|FG001|Overall Study|Investigator's decision|0|||
23779056|NCT03351244|66573369|FG002|Overall Study|Investigator's decision|2|||
23779057|NCT03351244|66573367|FG000|Overall Study|System error|0|||
23779058|NCT03351244|66573368|FG001|Overall Study|System error|0|||
23779059|NCT03351244|66573369|FG002|Overall Study|System error|2|||
23779060|NCT03351244|66573367|FG000|Overall Study|COVID-19 restrictions|3|||
23779061|NCT03351244|66573368|FG001|Overall Study|COVID-19 restrictions|0|||
23779062|NCT03351244|66573369|FG002|Overall Study|COVID-19 restrictions|1|||
23779063|NCT03351244|66573367|FG000|Overall Study|Non-compliance|2|||
23779064|NCT03351244|66573368|FG001|Overall Study|Non-compliance|5|||
23839242|NCT01455597|66791818|FG002|Overall Study|Adverse Event|5|||
23451298|NCT00296816|65395160|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
23579524|NCT01474512|65853363|FG003|Induction Period|Lack of Efficacy|0|||
23579525|NCT01474512|65853364|FG004|Induction Period|Lack of Efficacy|0|||
23579526|NCT01474512|65853365|FG005|Induction Period|Lack of Efficacy|0|||
23579527|NCT01474512|65853366|FG006|Induction Period|Lack of Efficacy|0|||
23579528|NCT01474512|65853367|FG007|Induction Period|Lack of Efficacy|0|||
23839243|NCT01455597|66791819|FG003|Overall Study|Adverse Event|1|||
23579529|NCT01474512|65853368|FG008|Induction Period|Lack of Efficacy|0|||
23579530|NCT01474512|65853369|FG009|Induction Period|Lack of Efficacy|0|||
23779065|NCT03351244|66573369|FG002|Overall Study|Non-compliance|0|||
23779066|NCT03351244|66573367|FG000|Overall Study|Withdrawal by Subject|11|||
23779067|NCT03351244|66573368|FG001|Overall Study|Withdrawal by Subject|16|||
23839244|NCT01455597|66791816|FG000|Overall Study|Lack of Efficacy|0|||
23839245|NCT01455597|66791817|FG001|Overall Study|Lack of Efficacy|1|||
23839246|NCT01455597|66791818|FG002|Overall Study|Lack of Efficacy|2|||
23579531|NCT01474512|65853370|FG010|Induction Period|Lack of Efficacy|0|||
23579532|NCT01474512|65853371|FG011|Induction Period|Lack of Efficacy|0|||
23579533|NCT01474512|65853372|FG012|Induction Period|Lack of Efficacy|0|||
23579534|NCT01474512|65853373|FG013|Induction Period|Lack of Efficacy|0|||
23579535|NCT01474512|65853374|FG014|Induction Period|Lack of Efficacy|0|||
23579536|NCT01474512|65853375|FG015|Induction Period|Lack of Efficacy|0|||
23579537|NCT01474512|65853376|FG016|Induction Period|Lack of Efficacy|0|||
23579538|NCT01474512|65853377|FG017|Induction Period|Lack of Efficacy|0|||
23579539|NCT01474512|65853360|FG000|Induction Period|Withdrawal by Subject|6|||
23579540|NCT01474512|65853361|FG001|Induction Period|Withdrawal by Subject|6|||
23579541|NCT01474512|65853362|FG002|Induction Period|Withdrawal by Subject|5|||
23579542|NCT01474512|65853363|FG003|Induction Period|Withdrawal by Subject|0|||
23579543|NCT01474512|65853364|FG004|Induction Period|Withdrawal by Subject|0|||
23579544|NCT01474512|65853365|FG005|Induction Period|Withdrawal by Subject|0|||
23579545|NCT01474512|65853366|FG006|Induction Period|Withdrawal by Subject|0|||
23579546|NCT01474512|65853367|FG007|Induction Period|Withdrawal by Subject|0|||
23579547|NCT01474512|65853368|FG008|Induction Period|Withdrawal by Subject|0|||
23579548|NCT01474512|65853369|FG009|Induction Period|Withdrawal by Subject|0|||
23579549|NCT01474512|65853370|FG010|Induction Period|Withdrawal by Subject|0|||
23579550|NCT01474512|65853371|FG011|Induction Period|Withdrawal by Subject|0|||
23579551|NCT01474512|65853372|FG012|Induction Period|Withdrawal by Subject|0|||
23579552|NCT01474512|65853373|FG013|Induction Period|Withdrawal by Subject|0|||
23579553|NCT01474512|65853374|FG014|Induction Period|Withdrawal by Subject|0|||
23579554|NCT01474512|65853375|FG015|Induction Period|Withdrawal by Subject|0|||
23579555|NCT01474512|65853376|FG016|Induction Period|Withdrawal by Subject|0|||
23579556|NCT01474512|65853377|FG017|Induction Period|Withdrawal by Subject|0|||
23579557|NCT01474512|65853360|FG000|Induction Period|Protocol Violation|3|||
23579558|NCT01474512|65853361|FG001|Induction Period|Protocol Violation|6|||
23579559|NCT01474512|65853362|FG002|Induction Period|Protocol Violation|0|||
23579560|NCT01474512|65853363|FG003|Induction Period|Protocol Violation|0|||
23579561|NCT01474512|65853364|FG004|Induction Period|Protocol Violation|0|||
23579562|NCT01474512|65853365|FG005|Induction Period|Protocol Violation|0|||
23579563|NCT01474512|65853366|FG006|Induction Period|Protocol Violation|0|||
23579564|NCT01474512|65853367|FG007|Induction Period|Protocol Violation|0|||
23579565|NCT01474512|65853368|FG008|Induction Period|Protocol Violation|0|||
23579566|NCT01474512|65853369|FG009|Induction Period|Protocol Violation|0|||
23579567|NCT01474512|65853370|FG010|Induction Period|Protocol Violation|0|||
23579568|NCT01474512|65853371|FG011|Induction Period|Protocol Violation|0|||
23579569|NCT01474512|65853372|FG012|Induction Period|Protocol Violation|0|||
23579570|NCT01474512|65853373|FG013|Induction Period|Protocol Violation|0|||
23579571|NCT01474512|65853374|FG014|Induction Period|Protocol Violation|0|||
23579572|NCT01474512|65853375|FG015|Induction Period|Protocol Violation|0|||
23579573|NCT01474512|65853376|FG016|Induction Period|Protocol Violation|0|||
23579574|NCT01474512|65853377|FG017|Induction Period|Protocol Violation|0|||
23579575|NCT01474512|65853360|FG000|Induction Period|Sponsor Decision|1|||
23579576|NCT01474512|65853361|FG001|Induction Period|Sponsor Decision|1|||
23579577|NCT01474512|65853362|FG002|Induction Period|Sponsor Decision|1|||
23579578|NCT01474512|65853363|FG003|Induction Period|Sponsor Decision|0|||
23579579|NCT01474512|65853364|FG004|Induction Period|Sponsor Decision|0|||
23579580|NCT01474512|65853365|FG005|Induction Period|Sponsor Decision|0|||
23579581|NCT01474512|65853366|FG006|Induction Period|Sponsor Decision|0|||
23579582|NCT01474512|65853367|FG007|Induction Period|Sponsor Decision|0|||
23579583|NCT01474512|65853368|FG008|Induction Period|Sponsor Decision|0|||
23579584|NCT01474512|65853369|FG009|Induction Period|Sponsor Decision|0|||
23579585|NCT01474512|65853370|FG010|Induction Period|Sponsor Decision|0|||
23579586|NCT01474512|65853371|FG011|Induction Period|Sponsor Decision|0|||
23579587|NCT01474512|65853372|FG012|Induction Period|Sponsor Decision|0|||
23579588|NCT01474512|65853373|FG013|Induction Period|Sponsor Decision|0|||
23579589|NCT01474512|65853374|FG014|Induction Period|Sponsor Decision|0|||
23579590|NCT01474512|65853375|FG015|Induction Period|Sponsor Decision|0|||
23579591|NCT01474512|65853376|FG016|Induction Period|Sponsor Decision|0|||
23579592|NCT01474512|65853377|FG017|Induction Period|Sponsor Decision|0|||
23579593|NCT01474512|65853360|FG000|Induction Period|Lost to Follow-up|1|||
23579594|NCT01474512|65853361|FG001|Induction Period|Lost to Follow-up|0|||
23579595|NCT01474512|65853362|FG002|Induction Period|Lost to Follow-up|2|||
23579596|NCT01474512|65853363|FG003|Induction Period|Lost to Follow-up|0|||
23579597|NCT01474512|65853364|FG004|Induction Period|Lost to Follow-up|0|||
23579598|NCT01474512|65853365|FG005|Induction Period|Lost to Follow-up|0|||
23579599|NCT01474512|65853366|FG006|Induction Period|Lost to Follow-up|0|||
23579600|NCT01474512|65853367|FG007|Induction Period|Lost to Follow-up|0|||
23579601|NCT01474512|65853368|FG008|Induction Period|Lost to Follow-up|0|||
23579602|NCT01474512|65853369|FG009|Induction Period|Lost to Follow-up|0|||
23579603|NCT01474512|65853370|FG010|Induction Period|Lost to Follow-up|0|||
23579604|NCT01474512|65853371|FG011|Induction Period|Lost to Follow-up|0|||
23579605|NCT01474512|65853372|FG012|Induction Period|Lost to Follow-up|0|||
23579606|NCT01474512|65853373|FG013|Induction Period|Lost to Follow-up|0|||
23579607|NCT01474512|65853374|FG014|Induction Period|Lost to Follow-up|0|||
23579608|NCT01474512|65853375|FG015|Induction Period|Lost to Follow-up|0|||
23579609|NCT01474512|65853376|FG016|Induction Period|Lost to Follow-up|0|||
23579610|NCT01474512|65853377|FG017|Induction Period|Lost to Follow-up|0|||
23579611|NCT01474512|65853360|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579612|NCT01474512|65853361|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579613|NCT01474512|65853362|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579614|NCT01474512|65853363|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
23579615|NCT01474512|65853364|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
23579616|NCT01474512|65853365|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
23579617|NCT01474512|65853366|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
23579618|NCT01474512|65853367|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579619|NCT01474512|65853368|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579620|NCT01474512|65853369|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579621|NCT01474512|65853370|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579622|NCT01474512|65853371|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579623|NCT01474512|65853372|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579624|NCT01474512|65853373|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579625|NCT01474512|65853374|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579626|NCT01474512|65853375|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579627|NCT01474512|65853376|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579628|NCT01474512|65853377|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579629|NCT01474512|65853360|FG000|Maintenance Period|Adverse Event|0|||
23579630|NCT01474512|65853361|FG001|Maintenance Period|Adverse Event|0|||
23579631|NCT01474512|65853362|FG002|Maintenance Period|Adverse Event|0|||
23579632|NCT01474512|65853363|FG003|Maintenance Period|Adverse Event|4|||
23579633|NCT01474512|65853364|FG004|Maintenance Period|Adverse Event|2|||
23579634|NCT01474512|65853365|FG005|Maintenance Period|Adverse Event|7|||
23579635|NCT01474512|65853366|FG006|Maintenance Period|Adverse Event|0|||
23579636|NCT01474512|65853367|FG007|Maintenance Period|Adverse Event|19|||
23579637|NCT01474512|65853368|FG008|Maintenance Period|Adverse Event|1|||
23579638|NCT01474512|65853369|FG009|Maintenance Period|Adverse Event|3|||
23579639|NCT01474512|65853370|FG010|Maintenance Period|Adverse Event|0|||
23579640|NCT01474512|65853371|FG011|Maintenance Period|Adverse Event|0|||
23579641|NCT01474512|65853372|FG012|Maintenance Period|Adverse Event|0|||
23579642|NCT01474512|65853373|FG013|Maintenance Period|Adverse Event|0|||
23579643|NCT01474512|65853374|FG014|Maintenance Period|Adverse Event|0|||
23579644|NCT01474512|65853375|FG015|Maintenance Period|Adverse Event|0|||
23579645|NCT01474512|65853376|FG016|Maintenance Period|Adverse Event|0|||
23579646|NCT01474512|65853377|FG017|Maintenance Period|Adverse Event|0|||
23579647|NCT01474512|65853360|FG000|Maintenance Period|Withdrawal by Subject|0|||
23579648|NCT01474512|65853361|FG001|Maintenance Period|Withdrawal by Subject|0|||
23579649|NCT01474512|65853362|FG002|Maintenance Period|Withdrawal by Subject|0|||
23579650|NCT01474512|65853363|FG003|Maintenance Period|Withdrawal by Subject|6|||
23779068|NCT03351244|66573369|FG002|Overall Study|Withdrawal by Subject|13|||
23779069|NCT03351244|66573367|FG000|Overall Study|Lost to Follow-up|2|||
23579651|NCT01474512|65853364|FG004|Maintenance Period|Withdrawal by Subject|2|||
23579652|NCT01474512|65853365|FG005|Maintenance Period|Withdrawal by Subject|3|||
23579653|NCT01474512|65853366|FG006|Maintenance Period|Withdrawal by Subject|1|||
23579654|NCT01474512|65853367|FG007|Maintenance Period|Withdrawal by Subject|6|||
23579655|NCT01474512|65853368|FG008|Maintenance Period|Withdrawal by Subject|3|||
23579656|NCT01474512|65853369|FG009|Maintenance Period|Withdrawal by Subject|1|||
23579657|NCT01474512|65853370|FG010|Maintenance Period|Withdrawal by Subject|0|||
23579658|NCT01474512|65853371|FG011|Maintenance Period|Withdrawal by Subject|0|||
23579659|NCT01474512|65853372|FG012|Maintenance Period|Withdrawal by Subject|0|||
23579660|NCT01474512|65853373|FG013|Maintenance Period|Withdrawal by Subject|0|||
23579661|NCT01474512|65853374|FG014|Maintenance Period|Withdrawal by Subject|0|||
23579662|NCT01474512|65853375|FG015|Maintenance Period|Withdrawal by Subject|0|||
23579663|NCT01474512|65853376|FG016|Maintenance Period|Withdrawal by Subject|0|||
23579664|NCT01474512|65853377|FG017|Maintenance Period|Withdrawal by Subject|0|||
23579665|NCT01474512|65853360|FG000|Maintenance Period|Lost to Follow-up|0|||
23579666|NCT01474512|65853361|FG001|Maintenance Period|Lost to Follow-up|0|||
23579667|NCT01474512|65853362|FG002|Maintenance Period|Lost to Follow-up|0|||
23579668|NCT01474512|65853363|FG003|Maintenance Period|Lost to Follow-up|3|||
23579669|NCT01474512|65853364|FG004|Maintenance Period|Lost to Follow-up|3|||
23579670|NCT01474512|65853365|FG005|Maintenance Period|Lost to Follow-up|0|||
23339512|NCT02587598|64986224|FG009|Overall Study|Physician Decision|0|||
23579671|NCT01474512|65853366|FG006|Maintenance Period|Lost to Follow-up|0|||
23579672|NCT01474512|65853367|FG007|Maintenance Period|Lost to Follow-up|2|||
23579673|NCT01474512|65853368|FG008|Maintenance Period|Lost to Follow-up|1|||
23579674|NCT01474512|65853369|FG009|Maintenance Period|Lost to Follow-up|1|||
23579675|NCT01474512|65853370|FG010|Maintenance Period|Lost to Follow-up|0|||
23579676|NCT01474512|65853371|FG011|Maintenance Period|Lost to Follow-up|0|||
23579677|NCT01474512|65853372|FG012|Maintenance Period|Lost to Follow-up|0|||
23579678|NCT01474512|65853373|FG013|Maintenance Period|Lost to Follow-up|0|||
23579679|NCT01474512|65853374|FG014|Maintenance Period|Lost to Follow-up|0|||
23579680|NCT01474512|65853375|FG015|Maintenance Period|Lost to Follow-up|0|||
23779070|NCT03351244|66573368|FG001|Overall Study|Lost to Follow-up|6|||
23579681|NCT01474512|65853376|FG016|Maintenance Period|Lost to Follow-up|0|||
23579682|NCT01474512|65853377|FG017|Maintenance Period|Lost to Follow-up|0|||
23579683|NCT01474512|65853360|FG000|Maintenance Period|Death|0|||
23579684|NCT01474512|65853361|FG001|Maintenance Period|Death|0|||
23579685|NCT01474512|65853362|FG002|Maintenance Period|Death|0|||
23579686|NCT01474512|65853363|FG003|Maintenance Period|Death|0|||
23579687|NCT01474512|65853364|FG004|Maintenance Period|Death|0|||
23579688|NCT01474512|65853365|FG005|Maintenance Period|Death|2|||
23579689|NCT01474512|65853366|FG006|Maintenance Period|Death|0|||
23579690|NCT01474512|65853367|FG007|Maintenance Period|Death|0|||
23579691|NCT01474512|65853368|FG008|Maintenance Period|Death|0|||
23579692|NCT01474512|65853369|FG009|Maintenance Period|Death|0|||
23579693|NCT01474512|65853370|FG010|Maintenance Period|Death|0|||
23579694|NCT01474512|65853371|FG011|Maintenance Period|Death|0|||
23579695|NCT01474512|65853372|FG012|Maintenance Period|Death|0|||
23579696|NCT01474512|65853373|FG013|Maintenance Period|Death|0|||
23634923|NCT00603525|66049349|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
23579697|NCT01474512|65853374|FG014|Maintenance Period|Death|0|||
23579698|NCT01474512|65853375|FG015|Maintenance Period|Death|0|||
23579699|NCT01474512|65853376|FG016|Maintenance Period|Death|0|||
23634924|NCT00603525|66049350|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
23579700|NCT01474512|65853377|FG017|Maintenance Period|Death|0|||
23579701|NCT01474512|65853360|FG000|Maintenance Period|Physician Decision|0|||
23579702|NCT01474512|65853361|FG001|Maintenance Period|Physician Decision|0|||
23579703|NCT01474512|65853362|FG002|Maintenance Period|Physician Decision|0|||
23579704|NCT01474512|65853363|FG003|Maintenance Period|Physician Decision|0|||
23579705|NCT01474512|65853364|FG004|Maintenance Period|Physician Decision|0|||
23579706|NCT01474512|65853365|FG005|Maintenance Period|Physician Decision|1|||
23634925|NCT01430468|66049351|FG000|Overall Study|Physician Decision|2|||
23634926|NCT01430468|66049352|FG001|Overall Study|Physician Decision|1|||
23634927|NCT01430468|66049351|FG000|Overall Study|Withdrawal by Subject|5|||
23634928|NCT01430468|66049352|FG001|Overall Study|Withdrawal by Subject|5|||
23779071|NCT03351244|66573369|FG002|Overall Study|Lost to Follow-up|4|||
23779072|NCT03351244|66573367|FG000|Overall Study|Protocol Violation|2|||
23779073|NCT03351244|66573368|FG001|Overall Study|Protocol Violation|2|||
23779074|NCT03351244|66573369|FG002|Overall Study|Protocol Violation|0|||
23779075|NCT02424097|66573376|FG000|Overall Study|Lost to Follow-up|1|||
23779076|NCT02424097|66573377|FG001|Overall Study|Lost to Follow-up|2|||
23779077|NCT02481830|66573387|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
23779078|NCT02481830|66573388|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
23779079|NCT02481830|66573387|FG000|Pre-treatment|Withdrawal by Subject|0|||
23779080|NCT02481830|66573388|FG001|Pre-treatment|Withdrawal by Subject|10|||
23779081|NCT02481830|66573387|FG000|Pre-treatment|Disease Progression|1|||
23779082|NCT02481830|66573388|FG001|Pre-treatment|Disease Progression|1|||
23779083|NCT02481830|66573387|FG000|Pre-treatment|Other reasons|0|||
23779084|NCT02481830|66573388|FG001|Pre-treatment|Other reasons|1|||
23779085|NCT02481830|66573387|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
23839247|NCT01455597|66791819|FG003|Overall Study|Lack of Efficacy|0|||
23839248|NCT01455597|66791816|FG000|Overall Study|Lost to Follow-up|3|||
23839249|NCT01455597|66791817|FG001|Overall Study|Lost to Follow-up|0|||
23839250|NCT01455597|66791818|FG002|Overall Study|Lost to Follow-up|2|||
23839251|NCT01455597|66791819|FG003|Overall Study|Lost to Follow-up|1|||
23839252|NCT01455597|66791816|FG000|Overall Study|Withdrew Consent|6|||
23839253|NCT01455597|66791817|FG001|Overall Study|Withdrew Consent|5|||
23839254|NCT01455597|66791818|FG002|Overall Study|Withdrew Consent|8|||
23839255|NCT01455597|66791819|FG003|Overall Study|Withdrew Consent|5|||
23839256|NCT01455597|66791816|FG000|Overall Study|Reason not Specified|1|||
23839257|NCT01455597|66791817|FG001|Overall Study|Reason not Specified|2|||
23839258|NCT01455597|66791818|FG002|Overall Study|Reason not Specified|3|||
23839259|NCT01455597|66791819|FG003|Overall Study|Reason not Specified|3|||
23579707|NCT01474512|65853366|FG006|Maintenance Period|Physician Decision|0|||
23579708|NCT01474512|65853367|FG007|Maintenance Period|Physician Decision|2|||
23579709|NCT01474512|65853368|FG008|Maintenance Period|Physician Decision|0|||
23579710|NCT01474512|65853369|FG009|Maintenance Period|Physician Decision|0|||
23579711|NCT01474512|65853370|FG010|Maintenance Period|Physician Decision|0|||
23779086|NCT02481830|66573388|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
23779087|NCT02481830|66573387|FG000|Treatment|Disease Progression|233|||
23839260|NCT00300885|66791820|FG000|Treatment|Adverse Event|134|||
23839261|NCT00300885|66791821|FG001|Treatment|Adverse Event|82|||
23839262|NCT00300885|66791820|FG000|Treatment|Death|20|||
23634929|NCT01436253|66049355|FG000|Overall Study|Lost to Follow-up|182|||
23839263|NCT00300885|66791821|FG001|Treatment|Death|7|||
23839264|NCT00300885|66791820|FG000|Treatment|Lack of Efficacy|1|||
23839265|NCT00300885|66791821|FG001|Treatment|Lack of Efficacy|1|||
23579712|NCT01474512|65853371|FG011|Maintenance Period|Physician Decision|0|||
23779088|NCT02481830|66573388|FG001|Treatment|Disease Progression|171|||
23779089|NCT02481830|66573387|FG000|Treatment|Study drug toxicity|18|||
23779090|NCT02481830|66573388|FG001|Treatment|Study drug toxicity|38|||
23839266|NCT00300885|66791820|FG000|Treatment|Lost to Follow-up|3|||
23779091|NCT02481830|66573387|FG000|Treatment|Death|1|||
23779092|NCT02481830|66573388|FG001|Treatment|Death|1|||
23779093|NCT02481830|66573387|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
23779094|NCT02481830|66573388|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
23779095|NCT02481830|66573387|FG000|Treatment|Participants request to discontinue Study treatment|6|||
23779096|NCT02481830|66573388|FG001|Treatment|Participants request to discontinue Study treatment|34|||
23779097|NCT02481830|66573387|FG000|Treatment|Withdrawal by Subject|2|||
23779098|NCT02481830|66573388|FG001|Treatment|Withdrawal by Subject|3|||
23779099|NCT02481830|66573387|FG000|Treatment|Lost to Follow-up|1|||
23779100|NCT02481830|66573388|FG001|Treatment|Lost to Follow-up|0|||
23779101|NCT02481830|66573387|FG000|Treatment|Maximum Clinical Benefit|0|||
23779102|NCT02481830|66573388|FG001|Treatment|Maximum Clinical Benefit|5|||
23779103|NCT02481830|66573387|FG000|Treatment|Administrative reason by sponsor|1|||
23839267|NCT00300885|66791821|FG001|Treatment|Lost to Follow-up|2|||
23839268|NCT00300885|66791820|FG000|Treatment|Physician Decision|4|||
23839269|NCT00300885|66791821|FG001|Treatment|Physician Decision|5|||
23839270|NCT00300885|66791820|FG000|Treatment|Protocol Violation|11|||
23839271|NCT00300885|66791821|FG001|Treatment|Protocol Violation|11|||
23779104|NCT02481830|66573388|FG001|Treatment|Administrative reason by sponsor|1|||
23779105|NCT02481830|66573387|FG000|Treatment|Other reasons|6|||
23779106|NCT02481830|66573388|FG001|Treatment|Other reasons|1|||
23779107|NCT00286754|66573391|FG000|Overall Study|Adverse Event|2|||
23451299|NCT00296816|65395160|FG000|Overall Study|Poor performance status|1|||
23451300|NCT00296816|65395160|FG000|Overall Study|Relocation to Florida|1|||
23451301|NCT00296816|65395160|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
23451302|NCT00296816|65395160|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
23451303|NCT00296816|65395160|FG000|Overall Study|Neuropathy/patient preference|1|||
23451304|NCT00296816|65395160|FG000|Overall Study|Proteinuria|1|||
23451305|NCT00296816|65395160|FG000|Overall Study|ineligibility due to radiation treatment|1|||
23451306|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
23451307|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
23451308|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451309|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451310|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451311|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
23451312|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
23451313|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
23451314|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
23451315|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
23451316|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
23779108|NCT00286754|66573392|FG001|Overall Study|Adverse Event|2|||
23451317|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
23451318|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
23451319|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
23451320|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
23839272|NCT00300885|66791820|FG000|Treatment|Withdrawal by Subject|26|||
23451321|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451322|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
23451323|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23839273|NCT00300885|66791821|FG001|Treatment|Withdrawal by Subject|23|||
23839274|NCT00300885|66791820|FG000|Treatment|Disease progression|171|||
23451324|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451325|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451326|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451327|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
23451328|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451329|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451330|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451331|NCT01329978|65395163|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451332|NCT01329978|65395164|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451333|NCT01329978|65395165|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451334|NCT01329978|65395166|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
23451335|NCT01329978|65395167|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
23451336|NCT01329978|65395163|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23634930|NCT01436253|66049355|FG000|Overall Study|Not meeting all eligibility criteria|117|||
23634931|NCT01643044|66049356|FG000|Overall Study|Lost to Follow-up|1|||
23779109|NCT00286754|66573393|FG002|Overall Study|Adverse Event|3|||
23779110|NCT00286754|66573391|FG000|Overall Study|Withdrawal by Subject|6|||
23779111|NCT00286754|66573392|FG001|Overall Study|Withdrawal by Subject|2|||
23779112|NCT00286754|66573393|FG002|Overall Study|Withdrawal by Subject|0|||
23779113|NCT00286754|66573391|FG000|Overall Study|Lost to Follow-up|12|||
23779114|NCT00286754|66573392|FG001|Overall Study|Lost to Follow-up|14|||
23839275|NCT00300885|66791821|FG001|Treatment|Disease progression|238|||
23451337|NCT01329978|65395164|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451338|NCT01329978|65395165|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451339|NCT01329978|65395166|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451340|NCT01329978|65395167|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
23451341|NCT02796677|65395169|FG000|Overall Study|Adverse Event|11|||
23451342|NCT02796677|65395170|FG001|Overall Study|Adverse Event|22|||
23451343|NCT02796677|65395171|FG002|Overall Study|Adverse Event|14|||
23451344|NCT02796677|65395172|FG003|Overall Study|Adverse Event|14|||
23451345|NCT02796677|65395169|FG000|Overall Study|Protocol Violation|7|||
23451346|NCT02796677|65395170|FG001|Overall Study|Protocol Violation|5|||
23451347|NCT02796677|65395171|FG002|Overall Study|Protocol Violation|4|||
23451348|NCT02796677|65395172|FG003|Overall Study|Protocol Violation|8|||
23779115|NCT00286754|66573393|FG002|Overall Study|Lost to Follow-up|6|||
23779116|NCT00286754|66573391|FG000|Overall Study|Moved out of state|0|||
23779117|NCT00286754|66573392|FG001|Overall Study|Moved out of state|0|||
23779118|NCT00286754|66573393|FG002|Overall Study|Moved out of state|1|||
23779119|NCT02441309|66573394|FG000|Overall Study|Disease progression|2|||
23779120|NCT02441309|66573395|FG001|Overall Study|Disease progression|1|||
23839276|NCT00300885|66791820|FG000|Treatment|Random code broken (subject died)|0|||
23839277|NCT00300885|66791821|FG001|Treatment|Random code broken (subject died)|1|||
23451349|NCT02796677|65395169|FG000|Overall Study|Lost to Follow-up|1|||
23451350|NCT02796677|65395170|FG001|Overall Study|Lost to Follow-up|5|||
23451351|NCT02796677|65395171|FG002|Overall Study|Lost to Follow-up|2|||
23779121|NCT02441309|66573396|FG002|Overall Study|Disease progression|2|||
23779122|NCT02441309|66573394|FG000|Overall Study|Adverse Event|0|||
23779123|NCT02441309|66573395|FG001|Overall Study|Adverse Event|1|||
23779124|NCT02441309|66573396|FG002|Overall Study|Adverse Event|0|||
23779125|NCT02441309|66573394|FG000|Overall Study|Withdrawal by Subject|1|||
23779126|NCT02441309|66573395|FG001|Overall Study|Withdrawal by Subject|0|||
23779127|NCT02441309|66573396|FG002|Overall Study|Withdrawal by Subject|1|||
23779128|NCT03075761|66573398|FG000|Overall Study|Lost to Follow-up|1|||
23779129|NCT03075761|66573399|FG001|Overall Study|Lost to Follow-up|6|||
23779130|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
23779131|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
23779132|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
23779133|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
23779134|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
23779135|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
23779136|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
23779137|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
23779138|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
23779139|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
23779140|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
23779141|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
23779142|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23779143|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23779144|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23779145|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
23779146|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
23779147|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
23779148|NCT01045161|66573400|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
23839278|NCT00300885|66791820|FG000|Treatment|Non-compliant with study medication|3|||
23839279|NCT00300885|66791821|FG001|Treatment|Non-compliant with study medication|4|||
23839280|NCT00300885|66791820|FG000|Follow-up|Death|141|||
23839281|NCT00300885|66791821|FG001|Follow-up|Death|163|||
23839282|NCT00300885|66791820|FG000|Follow-up|Lost to Follow-up|11|||
23839283|NCT00300885|66791821|FG001|Follow-up|Lost to Follow-up|7|||
23839284|NCT00300885|66791820|FG000|Follow-up|Withdrawal by Subject|26|||
23839285|NCT00300885|66791821|FG001|Follow-up|Withdrawal by Subject|25|||
23839286|NCT02278939|66791822|FG000|Overall Study|lack of time|1|||
23839287|NCT02278939|66791823|FG001|Overall Study|lack of time|0|||
23839288|NCT02278939|66791822|FG000|Overall Study|Lost to Follow-up|1|||
23839289|NCT02278939|66791823|FG001|Overall Study|Lost to Follow-up|1|||
23339513|NCT02587598|64986225|FG010|Overall Study|Physician Decision|3|||
23451352|NCT02796677|65395172|FG003|Overall Study|Lost to Follow-up|2|||
23451353|NCT02796677|65395169|FG000|Overall Study|Lack of Efficacy|7|||
23451354|NCT02796677|65395170|FG001|Overall Study|Lack of Efficacy|9|||
23451355|NCT02796677|65395171|FG002|Overall Study|Lack of Efficacy|14|||
23451356|NCT02796677|65395172|FG003|Overall Study|Lack of Efficacy|20|||
23634932|NCT01643044|66049357|FG001|Overall Study|Lost to Follow-up|1|||
23839290|NCT02278939|66791822|FG000|Overall Study|death in family|1|||
23839291|NCT02278939|66791823|FG001|Overall Study|death in family|0|||
23634933|NCT01643044|66049356|FG000|Overall Study|Miscarried baby|2|||
23634934|NCT01643044|66049357|FG001|Overall Study|Miscarried baby|2|||
23634935|NCT01643044|66049356|FG000|Overall Study|Delivered outside of hospital|1|||
23634936|NCT01643044|66049357|FG001|Overall Study|Delivered outside of hospital|2|||
23634937|NCT04577001|66049358|FG000|Overall Study|Subject became ineligible|0|||
23634938|NCT04577001|66049359|FG001|Overall Study|Subject became ineligible|1|||
23634939|NCT01077518|66049361|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
23634940|NCT01077518|66049362|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
23634941|NCT01077518|66049363|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
23634942|NCT01077518|66049361|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
23634943|NCT01077518|66049362|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
23634944|NCT01077518|66049363|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
23634945|NCT01077518|66049361|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
23634946|NCT01077518|66049362|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
23634947|NCT01077518|66049363|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
23634948|NCT01077518|66049361|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
23634949|NCT01077518|66049362|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
23634950|NCT01077518|66049363|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
23634951|NCT01077518|66049361|FG000|Optional Ofa Phase|Physician Decision|0|||
23634952|NCT01077518|66049362|FG001|Optional Ofa Phase|Physician Decision|0|||
23634953|NCT01077518|66049363|FG002|Optional Ofa Phase|Physician Decision|1|||
23634954|NCT01077518|66049361|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
23634955|NCT01077518|66049362|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
23839292|NCT02278939|66791822|FG000|Overall Study|family emergency unable to commit|2|||
23839293|NCT02278939|66791823|FG001|Overall Study|family emergency unable to commit|0|||
23839294|NCT01732458|66791824|FG000|Overall Study|Lost to Follow-up|0|||
23839295|NCT01732458|66791825|FG001|Overall Study|Lost to Follow-up|2|||
23839296|NCT01732458|66791826|FG002|Overall Study|Lost to Follow-up|0|||
23839297|NCT01732458|66791827|FG003|Overall Study|Lost to Follow-up|0|||
23839298|NCT01732458|66791824|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23839299|NCT01732458|66791825|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23839300|NCT01732458|66791826|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23839301|NCT01732458|66791827|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23839302|NCT01732458|66791824|FG000|Overall Study|Physician Decision|1|||
23839303|NCT01732458|66791825|FG001|Overall Study|Physician Decision|2|||
23839304|NCT01732458|66791826|FG002|Overall Study|Physician Decision|2|||
23839305|NCT01732458|66791827|FG003|Overall Study|Physician Decision|0|||
23839306|NCT01732458|66791824|FG000|Overall Study|Protocol Violation|2|||
23839307|NCT01732458|66791825|FG001|Overall Study|Protocol Violation|0|||
23839308|NCT01732458|66791826|FG002|Overall Study|Protocol Violation|0|||
23339514|NCT00435487|64986226|FG000|Overall Study|Death|3|||
23339515|NCT00435487|64986227|FG001|Overall Study|Death|4|||
23339516|NCT00435487|64986226|FG000|Overall Study|Adverse Event|0|||
23339517|NCT00435487|64986227|FG001|Overall Study|Adverse Event|3|||
23339518|NCT00435487|64986226|FG000|Overall Study|Lost to Follow-up|2|||
23339519|NCT00435487|64986227|FG001|Overall Study|Lost to Follow-up|2|||
23339520|NCT00435487|64986226|FG000|Overall Study|Other|5|||
23579713|NCT01474512|65853372|FG012|Maintenance Period|Physician Decision|0|||
23579714|NCT01474512|65853373|FG013|Maintenance Period|Physician Decision|0|||
23579715|NCT01474512|65853374|FG014|Maintenance Period|Physician Decision|0|||
23579716|NCT01474512|65853375|FG015|Maintenance Period|Physician Decision|0|||
23579717|NCT01474512|65853376|FG016|Maintenance Period|Physician Decision|0|||
23579718|NCT01474512|65853377|FG017|Maintenance Period|Physician Decision|0|||
23339521|NCT00435487|64986227|FG001|Overall Study|Other|2|||
23339522|NCT00435487|64986226|FG000|Overall Study|Withdrawal by Subject|2|||
23339523|NCT00435487|64986227|FG001|Overall Study|Withdrawal by Subject|1|||
23339524|NCT00435487|64986226|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
23451357|NCT02796677|65395169|FG000|Overall Study|Withdrawal by Subject|4|||
23579719|NCT01474512|65853360|FG000|Maintenance Period|Clinical Relapse|0|||
23579720|NCT01474512|65853361|FG001|Maintenance Period|Clinical Relapse|0|||
23579721|NCT01474512|65853362|FG002|Maintenance Period|Clinical Relapse|0|||
23579722|NCT01474512|65853363|FG003|Maintenance Period|Clinical Relapse|1|||
23579723|NCT01474512|65853364|FG004|Maintenance Period|Clinical Relapse|0|||
23579724|NCT01474512|65853365|FG005|Maintenance Period|Clinical Relapse|0|||
23579725|NCT01474512|65853366|FG006|Maintenance Period|Clinical Relapse|0|||
23579726|NCT01474512|65853367|FG007|Maintenance Period|Clinical Relapse|0|||
23779149|NCT01045161|66573401|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
23839309|NCT01732458|66791827|FG003|Overall Study|Protocol Violation|2|||
23339525|NCT00435487|64986227|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
23339526|NCT00435487|64986226|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
23451358|NCT02796677|65395170|FG001|Overall Study|Withdrawal by Subject|14|||
23451359|NCT02796677|65395171|FG002|Overall Study|Withdrawal by Subject|6|||
23579727|NCT01474512|65853368|FG008|Maintenance Period|Clinical Relapse|0|||
23839310|NCT01732458|66791824|FG000|Overall Study|Screen Failure|0|||
23839311|NCT01732458|66791825|FG001|Overall Study|Screen Failure|1|||
23839312|NCT01732458|66791826|FG002|Overall Study|Screen Failure|0|||
23839313|NCT01732458|66791827|FG003|Overall Study|Screen Failure|0|||
23339527|NCT00435487|64986227|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
23339528|NCT00330343|64986232|FG000|Overall Study|Lost to Follow-up|5|||
23339529|NCT02475265|64986235|FG000|Overall Study|Physician Decision|1|||
23339530|NCT02475265|64986235|FG000|Overall Study|Withdrawal by Subject|2|||
23339531|NCT03875482|64986238|FG000|Overall Study|Adverse Event|0|||
23339532|NCT03875482|64986239|FG001|Overall Study|Adverse Event|1|||
23339533|NCT03875482|64986238|FG000|Overall Study|Withdrew consent|5|||
23339534|NCT03875482|64986239|FG001|Overall Study|Withdrew consent|6|||
23339535|NCT03875482|64986238|FG000|Overall Study|Lost to Follow-up|8|||
23339536|NCT03875482|64986239|FG001|Overall Study|Lost to Follow-up|2|||
23339537|NCT03875482|64986238|FG000|Overall Study|Lack of Efficacy|0|||
23339538|NCT03875482|64986239|FG001|Overall Study|Lack of Efficacy|11|||
23339539|NCT01931995|64986240|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
23339540|NCT01931995|64986241|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
23779150|NCT01045161|66573402|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
23779151|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
23779152|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
23779153|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
23779154|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
23339541|NCT01931995|64986240|FG000|First Intervention (1 Day)|Physician Decision|1|||
23339542|NCT01931995|64986241|FG001|First Intervention (1 Day)|Physician Decision|1|||
23339543|NCT01931995|64986240|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
23579728|NCT01474512|65853369|FG009|Maintenance Period|Clinical Relapse|0|||
23579729|NCT01474512|65853370|FG010|Maintenance Period|Clinical Relapse|0|||
23579730|NCT01474512|65853371|FG011|Maintenance Period|Clinical Relapse|0|||
23579731|NCT01474512|65853372|FG012|Maintenance Period|Clinical Relapse|0|||
23579732|NCT01474512|65853373|FG013|Maintenance Period|Clinical Relapse|0|||
23579733|NCT01474512|65853374|FG014|Maintenance Period|Clinical Relapse|0|||
23579734|NCT01474512|65853375|FG015|Maintenance Period|Clinical Relapse|0|||
23579735|NCT01474512|65853376|FG016|Maintenance Period|Clinical Relapse|0|||
23579736|NCT01474512|65853377|FG017|Maintenance Period|Clinical Relapse|0|||
23579737|NCT01474512|65853360|FG000|Maintenance Period|Lack of Efficacy|0|||
23579738|NCT01474512|65853361|FG001|Maintenance Period|Lack of Efficacy|0|||
23579739|NCT01474512|65853362|FG002|Maintenance Period|Lack of Efficacy|0|||
23579740|NCT01474512|65853363|FG003|Maintenance Period|Lack of Efficacy|1|||
23579741|NCT01474512|65853364|FG004|Maintenance Period|Lack of Efficacy|0|||
23579742|NCT01474512|65853365|FG005|Maintenance Period|Lack of Efficacy|0|||
23579743|NCT01474512|65853366|FG006|Maintenance Period|Lack of Efficacy|0|||
23579744|NCT01474512|65853367|FG007|Maintenance Period|Lack of Efficacy|11|||
23579745|NCT01474512|65853368|FG008|Maintenance Period|Lack of Efficacy|11|||
23579746|NCT01474512|65853369|FG009|Maintenance Period|Lack of Efficacy|12|||
23579747|NCT01474512|65853370|FG010|Maintenance Period|Lack of Efficacy|0|||
23579748|NCT01474512|65853371|FG011|Maintenance Period|Lack of Efficacy|0|||
23579749|NCT01474512|65853372|FG012|Maintenance Period|Lack of Efficacy|0|||
23579750|NCT01474512|65853373|FG013|Maintenance Period|Lack of Efficacy|0|||
23579751|NCT01474512|65853374|FG014|Maintenance Period|Lack of Efficacy|0|||
23579752|NCT01474512|65853375|FG015|Maintenance Period|Lack of Efficacy|0|||
23579753|NCT01474512|65853376|FG016|Maintenance Period|Lack of Efficacy|0|||
23579754|NCT01474512|65853377|FG017|Maintenance Period|Lack of Efficacy|0|||
23579755|NCT01474512|65853360|FG000|Maintenance Period|Protocol Violation|0|||
23579756|NCT01474512|65853361|FG001|Maintenance Period|Protocol Violation|0|||
23579757|NCT01474512|65853362|FG002|Maintenance Period|Protocol Violation|0|||
23579758|NCT01474512|65853363|FG003|Maintenance Period|Protocol Violation|1|||
23579759|NCT01474512|65853364|FG004|Maintenance Period|Protocol Violation|0|||
23579760|NCT01474512|65853365|FG005|Maintenance Period|Protocol Violation|0|||
23579761|NCT01474512|65853366|FG006|Maintenance Period|Protocol Violation|0|||
23579762|NCT01474512|65853367|FG007|Maintenance Period|Protocol Violation|1|||
23579763|NCT01474512|65853368|FG008|Maintenance Period|Protocol Violation|0|||
23779155|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
23779156|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
23779157|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
23779158|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
23779159|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
23339544|NCT01931995|64986241|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
23339545|NCT04713592|64986250|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23579764|NCT01474512|65853369|FG009|Maintenance Period|Protocol Violation|1|||
23579765|NCT01474512|65853370|FG010|Maintenance Period|Protocol Violation|0|||
23579766|NCT01474512|65853371|FG011|Maintenance Period|Protocol Violation|0|||
23339546|NCT04713592|64986251|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
23579767|NCT01474512|65853372|FG012|Maintenance Period|Protocol Violation|0|||
23339547|NCT04713592|64986252|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23339548|NCT04713592|64986253|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23339549|NCT04713592|64986250|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
23339550|NCT04713592|64986251|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
23339551|NCT04713592|64986252|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
23339552|NCT04713592|64986253|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
23579768|NCT01474512|65853373|FG013|Maintenance Period|Protocol Violation|0|||
23579769|NCT01474512|65853374|FG014|Maintenance Period|Protocol Violation|0|||
23579770|NCT01474512|65853375|FG015|Maintenance Period|Protocol Violation|0|||
23579771|NCT01474512|65853376|FG016|Maintenance Period|Protocol Violation|0|||
23579772|NCT01474512|65853377|FG017|Maintenance Period|Protocol Violation|0|||
23579773|NCT01474512|65853360|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
23579774|NCT01474512|65853361|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
23579775|NCT01474512|65853362|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
23579776|NCT01474512|65853363|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
23579777|NCT01474512|65853364|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
23579778|NCT01474512|65853365|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
23579779|NCT01474512|65853366|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
23579780|NCT01474512|65853367|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
23579781|NCT01474512|65853368|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
23579782|NCT01474512|65853369|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
23579783|NCT01474512|65853370|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
23579784|NCT01474512|65853371|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
23579785|NCT01474512|65853372|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
23579786|NCT01474512|65853373|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
23579787|NCT01474512|65853374|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
23579788|NCT01474512|65853375|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
23579789|NCT01474512|65853376|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
23579790|NCT01474512|65853377|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
23579791|NCT01474512|65853360|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
23579792|NCT01474512|65853361|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
23579793|NCT01474512|65853362|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
23579794|NCT01474512|65853363|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
23579795|NCT01474512|65853364|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
23579796|NCT01474512|65853365|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
23579797|NCT01474512|65853366|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
23579798|NCT01474512|65853367|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
23579799|NCT01474512|65853368|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
23579800|NCT01474512|65853369|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
23579801|NCT01474512|65853370|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
23579802|NCT01474512|65853371|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
23579803|NCT01474512|65853372|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
23579804|NCT01474512|65853373|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
23579805|NCT01474512|65853374|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
23579806|NCT01474512|65853375|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
23579807|NCT01474512|65853376|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
23579808|NCT01474512|65853377|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
23579809|NCT01474512|65853360|FG000|Long-Term Extension Period|Adverse Event|0|||
23579810|NCT01474512|65853361|FG001|Long-Term Extension Period|Adverse Event|0|||
23579811|NCT01474512|65853362|FG002|Long-Term Extension Period|Adverse Event|0|||
23579812|NCT01474512|65853363|FG003|Long-Term Extension Period|Adverse Event|0|||
23579813|NCT01474512|65853364|FG004|Long-Term Extension Period|Adverse Event|0|||
23579814|NCT01474512|65853365|FG005|Long-Term Extension Period|Adverse Event|0|||
23579815|NCT01474512|65853366|FG006|Long-Term Extension Period|Adverse Event|0|||
23579816|NCT01474512|65853367|FG007|Long-Term Extension Period|Adverse Event|0|||
23579817|NCT01474512|65853368|FG008|Long-Term Extension Period|Adverse Event|0|||
23579818|NCT01474512|65853369|FG009|Long-Term Extension Period|Adverse Event|0|||
23579819|NCT01474512|65853370|FG010|Long-Term Extension Period|Adverse Event|0|||
23579820|NCT01474512|65853371|FG011|Long-Term Extension Period|Adverse Event|1|||
23579821|NCT01474512|65853372|FG012|Long-Term Extension Period|Adverse Event|57|||
23579822|NCT01474512|65853373|FG013|Long-Term Extension Period|Adverse Event|58|||
23579823|NCT01474512|65853374|FG014|Long-Term Extension Period|Adverse Event|0|||
23579824|NCT01474512|65853375|FG015|Long-Term Extension Period|Adverse Event|0|||
23579825|NCT01474512|65853376|FG016|Long-Term Extension Period|Adverse Event|0|||
23579826|NCT01474512|65853377|FG017|Long-Term Extension Period|Adverse Event|0|||
23579827|NCT01474512|65853360|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
23579828|NCT01474512|65853361|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
23579829|NCT01474512|65853362|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
23579830|NCT01474512|65853363|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
23579831|NCT01474512|65853364|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
23634956|NCT01077518|66049363|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
23634957|NCT01077518|66049361|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
23634958|NCT01077518|66049362|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
23634959|NCT01077518|66049363|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
23634960|NCT00416195|66049364|FG000|Overall Study|Adverse Event|1|||
23634961|NCT00416195|66049365|FG001|Overall Study|Adverse Event|2|||
23634962|NCT00416195|66049364|FG000|Overall Study|Protocol Violation|1|||
23634963|NCT00416195|66049365|FG001|Overall Study|Protocol Violation|1|||
23634964|NCT00416195|66049364|FG000|Overall Study|Other|0|||
23634965|NCT00416195|66049365|FG001|Overall Study|Other|1|||
23634966|NCT00756457|66049366|FG000|Overall Study|Lost to Follow-up|1|||
23634967|NCT00756457|66049367|FG001|Overall Study|Lost to Follow-up|2|||
23634968|NCT02206061|66049368|FG000|Overall Study|Withdrawal by Subject|4|||
23634969|NCT02206061|66049369|FG001|Overall Study|Withdrawal by Subject|7|||
23634970|NCT02206061|66049370|FG002|Overall Study|Withdrawal by Subject|1|||
23634971|NCT02206061|66049368|FG000|Overall Study|Lost to Follow-up|14|||
23634972|NCT02206061|66049369|FG001|Overall Study|Lost to Follow-up|7|||
23634973|NCT02206061|66049370|FG002|Overall Study|Lost to Follow-up|20|||
23634974|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
23579832|NCT01474512|65853365|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
23634975|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
23634976|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
23634977|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
23634978|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
23634979|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23634980|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23634981|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23634982|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
23634983|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
23634984|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
23634985|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
23634986|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
23634987|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
23634988|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
23634989|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
23634990|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
23634991|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
23634992|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
23451360|NCT02796677|65395172|FG003|Overall Study|Withdrawal by Subject|7|||
23451361|NCT02796677|65395169|FG000|Overall Study|Progressive disease|6|||
23451362|NCT02796677|65395170|FG001|Overall Study|Progressive disease|15|||
23579833|NCT01474512|65853366|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
23579834|NCT01474512|65853367|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
23579835|NCT01474512|65853368|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
23579836|NCT01474512|65853369|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
23579837|NCT01474512|65853370|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
23579838|NCT01474512|65853371|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
23579839|NCT01474512|65853372|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
23579840|NCT01474512|65853373|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
23579841|NCT01474512|65853374|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
23579842|NCT01474512|65853375|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
23579843|NCT01474512|65853376|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
23579844|NCT01474512|65853377|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
23579845|NCT01474512|65853360|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
23579846|NCT01474512|65853361|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
23579847|NCT01474512|65853362|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
23634993|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
23779160|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
23779161|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
23779162|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
23779163|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
23779164|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
23779165|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
23779166|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
23779167|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
23779168|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
23779169|NCT01045161|66573400|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
23779170|NCT01045161|66573401|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
23451363|NCT02796677|65395171|FG002|Overall Study|Progressive disease|13|||
23839314|NCT01868022|66791828|FG000|Overall Study|Withdrawal by Subject|0|||
23839315|NCT01868022|66791829|FG001|Overall Study|Withdrawal by Subject|0|||
23839316|NCT01868022|66791830|FG002|Overall Study|Withdrawal by Subject|1|||
23839317|NCT01868022|66791831|FG003|Overall Study|Withdrawal by Subject|1|||
23839318|NCT01868022|66791832|FG004|Overall Study|Withdrawal by Subject|0|||
23839319|NCT01868022|66791833|FG005|Overall Study|Withdrawal by Subject|0|||
23839320|NCT01868022|66791834|FG006|Overall Study|Withdrawal by Subject|0|||
23839321|NCT01868022|66791835|FG007|Overall Study|Withdrawal by Subject|1|||
23839322|NCT01868022|66791836|FG008|Overall Study|Withdrawal by Subject|0|||
23839323|NCT01868022|66791828|FG000|Overall Study|Adverse Event|0|||
23839324|NCT01868022|66791829|FG001|Overall Study|Adverse Event|0|||
23839325|NCT01868022|66791830|FG002|Overall Study|Adverse Event|0|||
23839326|NCT01868022|66791831|FG003|Overall Study|Adverse Event|0|||
23839327|NCT01868022|66791832|FG004|Overall Study|Adverse Event|2|||
23839328|NCT01868022|66791833|FG005|Overall Study|Adverse Event|0|||
23839329|NCT01868022|66791834|FG006|Overall Study|Adverse Event|0|||
23579848|NCT01474512|65853363|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
23579849|NCT01474512|65853364|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
23634994|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
23839330|NCT01868022|66791835|FG007|Overall Study|Adverse Event|2|||
23839331|NCT01868022|66791836|FG008|Overall Study|Adverse Event|2|||
23579850|NCT01474512|65853365|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
23579851|NCT01474512|65853366|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
23579852|NCT01474512|65853367|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
23579853|NCT01474512|65853368|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
23579854|NCT01474512|65853369|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
23579855|NCT01474512|65853370|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
23579856|NCT01474512|65853371|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
23579857|NCT01474512|65853372|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
23579858|NCT01474512|65853373|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
23579859|NCT01474512|65853374|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
23579860|NCT01474512|65853375|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
23579861|NCT01474512|65853376|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
23579862|NCT01474512|65853377|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
23579863|NCT01474512|65853360|FG000|Long-Term Extension Period|Physician Decision|0|||
23579864|NCT01474512|65853361|FG001|Long-Term Extension Period|Physician Decision|0|||
23579865|NCT01474512|65853362|FG002|Long-Term Extension Period|Physician Decision|0|||
23579866|NCT01474512|65853363|FG003|Long-Term Extension Period|Physician Decision|0|||
23579867|NCT01474512|65853364|FG004|Long-Term Extension Period|Physician Decision|0|||
23579868|NCT01474512|65853365|FG005|Long-Term Extension Period|Physician Decision|0|||
23579869|NCT01474512|65853366|FG006|Long-Term Extension Period|Physician Decision|0|||
23579870|NCT01474512|65853367|FG007|Long-Term Extension Period|Physician Decision|0|||
23579871|NCT01474512|65853368|FG008|Long-Term Extension Period|Physician Decision|0|||
23579872|NCT01474512|65853369|FG009|Long-Term Extension Period|Physician Decision|0|||
23579873|NCT01474512|65853370|FG010|Long-Term Extension Period|Physician Decision|0|||
23579874|NCT01474512|65853371|FG011|Long-Term Extension Period|Physician Decision|0|||
23579875|NCT01474512|65853372|FG012|Long-Term Extension Period|Physician Decision|21|||
23579876|NCT01474512|65853373|FG013|Long-Term Extension Period|Physician Decision|21|||
23579877|NCT01474512|65853374|FG014|Long-Term Extension Period|Physician Decision|0|||
23579878|NCT01474512|65853375|FG015|Long-Term Extension Period|Physician Decision|0|||
23579879|NCT01474512|65853376|FG016|Long-Term Extension Period|Physician Decision|0|||
23579880|NCT01474512|65853377|FG017|Long-Term Extension Period|Physician Decision|0|||
23579881|NCT01474512|65853360|FG000|Long-Term Extension Period|Clinical Relapse|0|||
23579882|NCT01474512|65853361|FG001|Long-Term Extension Period|Clinical Relapse|0|||
23579883|NCT01474512|65853362|FG002|Long-Term Extension Period|Clinical Relapse|0|||
23579884|NCT01474512|65853363|FG003|Long-Term Extension Period|Clinical Relapse|0|||
23579885|NCT01474512|65853364|FG004|Long-Term Extension Period|Clinical Relapse|0|||
23579886|NCT01474512|65853365|FG005|Long-Term Extension Period|Clinical Relapse|0|||
23579887|NCT01474512|65853366|FG006|Long-Term Extension Period|Clinical Relapse|0|||
23579888|NCT01474512|65853367|FG007|Long-Term Extension Period|Clinical Relapse|0|||
23579889|NCT01474512|65853368|FG008|Long-Term Extension Period|Clinical Relapse|0|||
23579890|NCT01474512|65853369|FG009|Long-Term Extension Period|Clinical Relapse|0|||
23579891|NCT01474512|65853370|FG010|Long-Term Extension Period|Clinical Relapse|0|||
23579892|NCT01474512|65853371|FG011|Long-Term Extension Period|Clinical Relapse|0|||
23579893|NCT01474512|65853372|FG012|Long-Term Extension Period|Clinical Relapse|9|||
23579894|NCT01474512|65853373|FG013|Long-Term Extension Period|Clinical Relapse|9|||
23579895|NCT01474512|65853374|FG014|Long-Term Extension Period|Clinical Relapse|0|||
23579896|NCT01474512|65853375|FG015|Long-Term Extension Period|Clinical Relapse|0|||
23579897|NCT01474512|65853376|FG016|Long-Term Extension Period|Clinical Relapse|0|||
23579898|NCT01474512|65853377|FG017|Long-Term Extension Period|Clinical Relapse|0|||
23839332|NCT01868022|66791828|FG000|Overall Study|Physician Decision|0|||
23839333|NCT01868022|66791829|FG001|Overall Study|Physician Decision|0|||
23634995|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
23634996|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
23634997|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
23634998|NCT00479882|66049371|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
23634999|NCT00479882|66049372|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
23635000|NCT00479882|66049373|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
23635001|NCT00479882|66049374|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
23635002|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
23635003|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
23635004|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
23635005|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
23635006|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
23635007|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
23339553|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
23339554|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
23635008|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
23635009|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
23635010|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23635011|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
23635012|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23635013|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23635014|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
23635015|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
23635016|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
23635017|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
23635018|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
23635019|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
23635020|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
23339555|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
23339556|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
23339557|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23339558|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23579899|NCT01474512|65853360|FG000|Long-Term Extension Period|Death|0|||
23579900|NCT01474512|65853361|FG001|Long-Term Extension Period|Death|0|||
23635021|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
23635022|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23635023|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23779171|NCT01045161|66573402|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
23779172|NCT02159183|66573404|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
23579901|NCT01474512|65853362|FG002|Long-Term Extension Period|Death|0|||
23579902|NCT01474512|65853363|FG003|Long-Term Extension Period|Death|0|||
23579903|NCT01474512|65853364|FG004|Long-Term Extension Period|Death|0|||
23579904|NCT01474512|65853365|FG005|Long-Term Extension Period|Death|0|||
23579905|NCT01474512|65853366|FG006|Long-Term Extension Period|Death|0|||
23579906|NCT01474512|65853367|FG007|Long-Term Extension Period|Death|0|||
23579907|NCT01474512|65853368|FG008|Long-Term Extension Period|Death|0|||
23579908|NCT01474512|65853369|FG009|Long-Term Extension Period|Death|0|||
23779173|NCT02159183|66573405|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
23779174|NCT02159183|66573404|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
23339559|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
23339560|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
23339561|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
23451364|NCT02796677|65395172|FG003|Overall Study|Progressive disease|18|||
23451365|NCT02796677|65395169|FG000|Overall Study|Reason not mentioned|2|||
23451366|NCT02796677|65395170|FG001|Overall Study|Reason not mentioned|3|||
23579909|NCT01474512|65853370|FG010|Long-Term Extension Period|Death|0|||
23779175|NCT02159183|66573405|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
23779176|NCT02159183|66573404|FG000|Analysis After the 36 Months Follow-up|Death|0|||
23779177|NCT02159183|66573405|FG001|Analysis After the 36 Months Follow-up|Death|1|||
23779178|NCT02159183|66573404|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
23779179|NCT02159183|66573405|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
23779180|NCT02159183|66573404|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
23779181|NCT02159183|66573405|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
23451367|NCT02796677|65395171|FG002|Overall Study|Reason not mentioned|0|||
23579910|NCT01474512|65853371|FG011|Long-Term Extension Period|Death|0|||
23579911|NCT01474512|65853372|FG012|Long-Term Extension Period|Death|9|||
23579912|NCT01474512|65853373|FG013|Long-Term Extension Period|Death|9|||
23579913|NCT01474512|65853374|FG014|Long-Term Extension Period|Death|0|||
23779182|NCT02847650|66573406|FG000|Overall Study|Adverse Event|2|||
23779183|NCT02847650|66573407|FG001|Overall Study|Adverse Event|4|||
23779184|NCT02847650|66573406|FG000|Overall Study|Lost to Follow-up|1|||
23779185|NCT02847650|66573407|FG001|Overall Study|Lost to Follow-up|0|||
23779186|NCT02847650|66573406|FG000|Overall Study|Protocol Violation|0|||
23779187|NCT02847650|66573407|FG001|Overall Study|Protocol Violation|1|||
23779188|NCT02847650|66573406|FG000|Overall Study|Withdrawal by Subject|1|||
23779189|NCT02847650|66573407|FG001|Overall Study|Withdrawal by Subject|1|||
23779190|NCT01294787|66573408|FG000|Period 1|Adverse Event|0|||
23779191|NCT01294787|66573409|FG001|Period 1|Adverse Event|0|||
23779192|NCT01294787|66573410|FG002|Period 1|Adverse Event|0|||
23779193|NCT01294787|66573411|FG003|Period 1|Adverse Event|0|||
23779194|NCT01294787|66573412|FG004|Period 1|Adverse Event|1|||
23779195|NCT01294787|66573413|FG005|Period 1|Adverse Event|0|||
23779196|NCT01294787|66573408|FG000|Period 1|Withdrawal by Subject|0|||
23779197|NCT01294787|66573409|FG001|Period 1|Withdrawal by Subject|0|||
23779198|NCT01294787|66573410|FG002|Period 1|Withdrawal by Subject|0|||
23779199|NCT01294787|66573411|FG003|Period 1|Withdrawal by Subject|1|||
23779200|NCT01294787|66573412|FG004|Period 1|Withdrawal by Subject|1|||
23839334|NCT01868022|66791830|FG002|Overall Study|Physician Decision|0|||
23839335|NCT01868022|66791831|FG003|Overall Study|Physician Decision|0|||
23839336|NCT01868022|66791832|FG004|Overall Study|Physician Decision|0|||
23839337|NCT01868022|66791833|FG005|Overall Study|Physician Decision|1|||
23839338|NCT01868022|66791834|FG006|Overall Study|Physician Decision|0|||
23839339|NCT01868022|66791835|FG007|Overall Study|Physician Decision|2|||
23839340|NCT01868022|66791836|FG008|Overall Study|Physician Decision|0|||
23839341|NCT01868022|66791828|FG000|Overall Study|Study closed/terminated|0|||
23839342|NCT01868022|66791829|FG001|Overall Study|Study closed/terminated|0|||
23839343|NCT01868022|66791830|FG002|Overall Study|Study closed/terminated|0|||
23839344|NCT01868022|66791831|FG003|Overall Study|Study closed/terminated|0|||
23839345|NCT01868022|66791832|FG004|Overall Study|Study closed/terminated|0|||
23839346|NCT01868022|66791833|FG005|Overall Study|Study closed/terminated|0|||
23839347|NCT01868022|66791834|FG006|Overall Study|Study closed/terminated|0|||
23839348|NCT01868022|66791835|FG007|Overall Study|Study closed/terminated|1|||
23839349|NCT01868022|66791836|FG008|Overall Study|Study closed/terminated|0|||
23839350|NCT01868022|66791828|FG000|Overall Study|Ongoing|0|||
23839351|NCT01868022|66791829|FG001|Overall Study|Ongoing|0|||
23839352|NCT01868022|66791830|FG002|Overall Study|Ongoing|0|||
23839353|NCT01868022|66791831|FG003|Overall Study|Ongoing|0|||
23839354|NCT01868022|66791832|FG004|Overall Study|Ongoing|0|||
23839355|NCT01868022|66791833|FG005|Overall Study|Ongoing|0|||
23839356|NCT01868022|66791834|FG006|Overall Study|Ongoing|0|||
23839357|NCT01868022|66791835|FG007|Overall Study|Ongoing|3|||
23839358|NCT01868022|66791836|FG008|Overall Study|Ongoing|0|||
23839359|NCT00441129|66791841|FG000|Overall Study|Withdrawal by Subject|6|||
23839360|NCT00441129|66791842|FG001|Overall Study|Withdrawal by Subject|14|||
23839361|NCT01842633|66791854|FG000|Overall Study|Screen Failure|1|||
23839362|NCT01842633|66791855|FG001|Overall Study|Screen Failure|0|||
23839363|NCT01842633|66791856|FG002|Overall Study|Screen Failure|0|||
23839364|NCT01842633|66791854|FG000|Overall Study|Adverse Event|1|||
23839365|NCT01842633|66791855|FG001|Overall Study|Adverse Event|1|||
23839366|NCT01842633|66791856|FG002|Overall Study|Adverse Event|0|||
23839367|NCT01842633|66791854|FG000|Overall Study|Withdrawal by Subject|0|||
23839368|NCT01842633|66791855|FG001|Overall Study|Withdrawal by Subject|1|||
23839369|NCT01842633|66791856|FG002|Overall Study|Withdrawal by Subject|0|||
23839370|NCT01842633|66791854|FG000|Overall Study|Technical issues|1|||
23839371|NCT01842633|66791855|FG001|Overall Study|Technical issues|0|||
23839372|NCT01842633|66791856|FG002|Overall Study|Technical issues|0|||
23839373|NCT01609010|66791857|FG000|Overall Study|Stable disease (SD)|22|||
23839374|NCT01609010|66791858|FG001|Overall Study|Stable disease (SD)|16|||
23839375|NCT01609010|66791857|FG000|Overall Study|Progressive disease (PD)|8|||
23839376|NCT01609010|66791858|FG001|Overall Study|Progressive disease (PD)|10|||
23839377|NCT01609010|66791857|FG000|Overall Study|Adverse Event|3|||
23839378|NCT01609010|66791858|FG001|Overall Study|Adverse Event|6|||
23839379|NCT01609010|66791857|FG000|Overall Study|Withdrawal by Subject|2|||
23779201|NCT01294787|66573413|FG005|Period 1|Withdrawal by Subject|1|||
23779202|NCT01294787|66573408|FG000|Period 1|Administrative problem|0|||
23779203|NCT01294787|66573409|FG001|Period 1|Administrative problem|0|||
23839380|NCT01609010|66791858|FG001|Overall Study|Withdrawal by Subject|2|||
23839381|NCT01609010|66791857|FG000|Overall Study|Other|2|||
23839382|NCT01609010|66791858|FG001|Overall Study|Other|0|||
23839383|NCT01609010|66791857|FG000|Overall Study|Other malignancy|1|||
23839384|NCT01609010|66791858|FG001|Overall Study|Other malignancy|0|||
23839385|NCT01609010|66791857|FG000|Overall Study|Pathology review|2|||
23839386|NCT01609010|66791858|FG001|Overall Study|Pathology review|1|||
23839387|NCT01609010|66791857|FG000|Overall Study|Protocol Violation|1|||
23839388|NCT01609010|66791858|FG001|Overall Study|Protocol Violation|1|||
23779204|NCT01294787|66573410|FG002|Period 1|Administrative problem|1|||
23779205|NCT01294787|66573411|FG003|Period 1|Administrative problem|0|||
23839389|NCT01609010|66791857|FG000|Overall Study|New cancer|1|||
23839390|NCT01609010|66791858|FG001|Overall Study|New cancer|0|||
23839391|NCT01609010|66791857|FG000|Overall Study|Lost to Follow-up|1|||
23839392|NCT01609010|66791858|FG001|Overall Study|Lost to Follow-up|1|||
23839393|NCT01177293|66791859|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
23839394|NCT01177293|66791860|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
23339562|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
23339563|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
23339564|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
23339565|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23339566|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23839395|NCT01920958|66791861|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
23839396|NCT02473250|66791862|FG000|Overall Study|Lost to Follow-up|10|||
23839397|NCT02473250|66791862|FG000|Overall Study|Physician Decision|5|||
23839398|NCT02473250|66791862|FG000|Overall Study|Did not tolerate medication washout|3|||
23839399|NCT02473250|66791862|FG000|Overall Study|Antidepressant effect of divalproex|2|||
23839400|NCT01628198|66791869|FG000|Overall Study|Lost to Follow-up|7|||
23839401|NCT01628198|66791869|FG000|Overall Study|Withdrawal by Subject|10|||
23839402|NCT01628198|66791869|FG000|Overall Study|Screen failure|1|||
23339567|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23339568|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23339569|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
23339570|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
23339571|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
23339572|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
23339573|NCT01899742|64986257|FG000|Overall Study|Adverse Event|5|||
23339574|NCT01899742|64986258|FG001|Overall Study|Adverse Event|4|||
23339575|NCT01899742|64986257|FG000|Overall Study|Lack of Efficacy|1|||
23339576|NCT01899742|64986258|FG001|Overall Study|Lack of Efficacy|5|||
23339577|NCT01899742|64986257|FG000|Overall Study|Protocol Violation|2|||
23339578|NCT01899742|64986258|FG001|Overall Study|Protocol Violation|2|||
23339579|NCT01899742|64986257|FG000|Overall Study|Withdrawal by Subject|9|||
23339580|NCT01899742|64986258|FG001|Overall Study|Withdrawal by Subject|5|||
23339581|NCT02225366|64986259|FG000|Overall Study|Lack of Efficacy|1|||
23839403|NCT01582854|66791870|FG000|Overall Study|Death|8|||
23839404|NCT01582854|66791871|FG001|Overall Study|Death|5|||
23839405|NCT01582854|66791870|FG000|Overall Study|Adverse Event|2|||
23839406|NCT01582854|66791871|FG001|Overall Study|Adverse Event|3|||
23839407|NCT01582854|66791870|FG000|Overall Study|Withdrawal by Participant|8|||
23839408|NCT01582854|66791871|FG001|Overall Study|Withdrawal by Participant|11|||
23839409|NCT01582854|66791870|FG000|Overall Study|Lost to Follow-up|1|||
23839410|NCT01582854|66791871|FG001|Overall Study|Lost to Follow-up|2|||
23839411|NCT01582854|66791870|FG000|Overall Study|Physician Decision|0|||
23839412|NCT01582854|66791871|FG001|Overall Study|Physician Decision|1|||
23839413|NCT01582854|66791870|FG000|Overall Study|Recurrent Stroke|13|||
23839414|NCT01582854|66791871|FG001|Overall Study|Recurrent Stroke|8|||
23839415|NCT01582854|66791870|FG000|Overall Study|Disallowed Concomitant Medication|3|||
23839416|NCT01582854|66791871|FG001|Overall Study|Disallowed Concomitant Medication|2|||
23839417|NCT01582854|66791870|FG000|Overall Study|Carotid or Neurosurgery|0|||
23839418|NCT01582854|66791871|FG001|Overall Study|Carotid or Neurosurgery|1|||
23839419|NCT01582854|66791870|FG000|Overall Study|General Anaesthesia|0|||
23839420|NCT01582854|66791871|FG001|Overall Study|General Anaesthesia|1|||
23839421|NCT01582854|66791870|FG000|Overall Study|Other Miscellaneous Reason|1|||
23839422|NCT01582854|66791871|FG001|Overall Study|Other Miscellaneous Reason|0|||
23839423|NCT02490371|66791872|FG000|Overall Study|Lost to Follow-up|1|||
23839424|NCT02490371|66791873|FG001|Overall Study|Lost to Follow-up|1|||
23839425|NCT03055338|66791874|FG000|Overall Study|Lost to Follow-up|9|||
23839426|NCT03055338|66791875|FG001|Overall Study|Lost to Follow-up|2|||
23839427|NCT03055338|66791876|FG002|Overall Study|Lost to Follow-up|3|||
23839428|NCT03055338|66791874|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
23839429|NCT03055338|66791875|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
23839430|NCT03055338|66791876|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
23839431|NCT03055338|66791874|FG000|Overall Study|Physician Decision|0|||
23839432|NCT03055338|66791875|FG001|Overall Study|Physician Decision|0|||
23339582|NCT02225366|64986260|FG001|Overall Study|Lack of Efficacy|0|||
23339583|NCT00954512|64986263|FG000|Overall Study|Withdrawal by Subject|0|||
23451368|NCT02796677|65395172|FG003|Overall Study|Reason not mentioned|5|||
23451369|NCT02748863|65395173|FG000|Treatment Period 1|Adverse Event|0|||
23451370|NCT02748863|65395174|FG001|Treatment Period 1|Adverse Event|1|||
23839433|NCT03055338|66791876|FG002|Overall Study|Physician Decision|2|||
23839434|NCT03055338|66791874|FG000|Overall Study|Withdrawal by Subject|9|||
23451371|NCT02748863|65395175|FG002|Treatment Period 1|Adverse Event|0|||
23451372|NCT02748863|65395176|FG003|Treatment Period 1|Adverse Event|0|||
23839435|NCT03055338|66791875|FG001|Overall Study|Withdrawal by Subject|8|||
23839436|NCT03055338|66791876|FG002|Overall Study|Withdrawal by Subject|7|||
23839437|NCT01986933|66791881|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
23839438|NCT01986933|66791882|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
23839439|NCT01986933|66791883|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
23839440|NCT01986933|66791884|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
23839441|NCT01986933|66791885|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
23839442|NCT01986933|66791881|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
23839443|NCT01986933|66791882|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23839444|NCT01986933|66791883|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23839445|NCT01986933|66791884|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
23839446|NCT01986933|66791885|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23839447|NCT01986933|66791881|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
23839448|NCT01986933|66791882|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
23839449|NCT01986933|66791883|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
23839450|NCT01986933|66791884|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
23839451|NCT01986933|66791885|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
23839452|NCT01986933|66791881|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23839453|NCT01986933|66791882|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
23839454|NCT01986933|66791883|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23839455|NCT01986933|66791884|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
23839456|NCT01986933|66791885|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23839457|NCT01986933|66791881|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23839458|NCT01986933|66791882|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23839459|NCT01986933|66791883|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23839460|NCT01986933|66791884|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23839461|NCT01986933|66791885|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
23839462|NCT01986933|66791881|FG000|Active-to-active (Part B)|Adverse Event|0|||
23839463|NCT01986933|66791882|FG001|Active-to-active (Part B)|Adverse Event|2|||
23839464|NCT01986933|66791883|FG002|Active-to-active (Part B)|Adverse Event|0|||
23839465|NCT01986933|66791884|FG003|Active-to-active (Part B)|Adverse Event|1|||
23839466|NCT01986933|66791885|FG004|Active-to-active (Part B)|Adverse Event|3|||
23839467|NCT01986933|66791881|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
23839468|NCT01986933|66791882|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
23839469|NCT01986933|66791883|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
23839470|NCT01986933|66791884|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
23839471|NCT01986933|66791885|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
23779206|NCT01294787|66573412|FG004|Period 1|Administrative problem|0|||
23779207|NCT01294787|66573413|FG005|Period 1|Administrative problem|1|||
23779208|NCT01294787|66573408|FG000|Period 2|Adverse Event|0|||
23779209|NCT01294787|66573409|FG001|Period 2|Adverse Event|3|||
23779210|NCT01294787|66573410|FG002|Period 2|Adverse Event|0|||
23779211|NCT01294787|66573411|FG003|Period 2|Adverse Event|1|||
23779212|NCT01294787|66573412|FG004|Period 2|Adverse Event|0|||
23779213|NCT01294787|66573413|FG005|Period 2|Adverse Event|0|||
23779214|NCT01294787|66573408|FG000|Period 2|No longer needs study drug|0|||
23779215|NCT01294787|66573409|FG001|Period 2|No longer needs study drug|0|||
23779216|NCT01294787|66573410|FG002|Period 2|No longer needs study drug|0|||
23779217|NCT01294787|66573411|FG003|Period 2|No longer needs study drug|1|||
23779218|NCT01294787|66573412|FG004|Period 2|No longer needs study drug|0|||
23779219|NCT01294787|66573413|FG005|Period 2|No longer needs study drug|0|||
23779220|NCT01294787|66573408|FG000|Period 3|Adverse Event|0|||
23779221|NCT01294787|66573409|FG001|Period 3|Adverse Event|0|||
23779222|NCT01294787|66573410|FG002|Period 3|Adverse Event|0|||
23779223|NCT01294787|66573411|FG003|Period 3|Adverse Event|0|||
23779224|NCT01294787|66573412|FG004|Period 3|Adverse Event|1|||
23839472|NCT01986933|66791881|FG000|Active-to-active (Part B)|Pregnancy|0|||
23839473|NCT01986933|66791882|FG001|Active-to-active (Part B)|Pregnancy|0|||
23839474|NCT01986933|66791883|FG002|Active-to-active (Part B)|Pregnancy|0|||
23339584|NCT00954512|64986264|FG001|Overall Study|Withdrawal by Subject|0|||
23339585|NCT00954512|64986265|FG002|Overall Study|Withdrawal by Subject|0|||
23339586|NCT00954512|64986266|FG003|Overall Study|Withdrawal by Subject|0|||
23339587|NCT00954512|64986267|FG004|Overall Study|Withdrawal by Subject|0|||
23451373|NCT02748863|65395177|FG004|Treatment Period 1|Adverse Event|0|||
23451374|NCT02748863|65395173|FG000|Treatment Period 1|Lack of Efficacy|0|||
23579914|NCT01474512|65853375|FG015|Long-Term Extension Period|Death|0|||
23779225|NCT01294787|66573413|FG005|Period 3|Adverse Event|0|||
23779226|NCT00488774|66573420|FG000|Overall Study|Withdrawal of consent|2|||
23779227|NCT00488774|66573421|FG001|Overall Study|Withdrawal of consent|2|||
23839475|NCT01986933|66791884|FG003|Active-to-active (Part B)|Pregnancy|0|||
23839476|NCT01986933|66791885|FG004|Active-to-active (Part B)|Pregnancy|1|||
23839477|NCT01986933|66791881|FG000|Active-to-active (Part B)|Physician Decision|0|||
23839478|NCT01986933|66791882|FG001|Active-to-active (Part B)|Physician Decision|0|||
23839479|NCT01986933|66791883|FG002|Active-to-active (Part B)|Physician Decision|1|||
23779228|NCT00488774|66573422|FG002|Overall Study|Withdrawal of consent|2|||
23779229|NCT00488774|66573423|FG003|Overall Study|Withdrawal of consent|0|||
23451375|NCT02748863|65395174|FG001|Treatment Period 1|Lack of Efficacy|0|||
23779230|NCT00488774|66573420|FG000|Overall Study|Other|6|||
23339588|NCT00954512|64986268|FG005|Overall Study|Withdrawal by Subject|1|||
23339589|NCT00954512|64986263|FG000|Overall Study|Adverse Event|0|||
23339590|NCT00954512|64986264|FG001|Overall Study|Adverse Event|0|||
23339591|NCT00954512|64986265|FG002|Overall Study|Adverse Event|0|||
23339592|NCT00954512|64986266|FG003|Overall Study|Adverse Event|0|||
23339593|NCT00954512|64986267|FG004|Overall Study|Adverse Event|1|||
23339594|NCT00954512|64986268|FG005|Overall Study|Adverse Event|2|||
23339595|NCT00954512|64986263|FG000|Overall Study|Physician Decision|0|||
23339596|NCT00954512|64986264|FG001|Overall Study|Physician Decision|1|||
23339597|NCT00954512|64986265|FG002|Overall Study|Physician Decision|0|||
23339598|NCT00954512|64986266|FG003|Overall Study|Physician Decision|1|||
23339599|NCT00954512|64986267|FG004|Overall Study|Physician Decision|0|||
23339600|NCT00954512|64986268|FG005|Overall Study|Physician Decision|0|||
23339601|NCT00954512|64986263|FG000|Overall Study|Symptomatic Deterioration|0|||
23339602|NCT00954512|64986264|FG001|Overall Study|Symptomatic Deterioration|1|||
23339603|NCT00954512|64986265|FG002|Overall Study|Symptomatic Deterioration|0|||
23339604|NCT00954512|64986266|FG003|Overall Study|Symptomatic Deterioration|0|||
23339605|NCT00954512|64986267|FG004|Overall Study|Symptomatic Deterioration|2|||
23339606|NCT00954512|64986268|FG005|Overall Study|Symptomatic Deterioration|0|||
23339607|NCT00954512|64986263|FG000|Overall Study|Progression of Disease|2|||
23339608|NCT00954512|64986264|FG001|Overall Study|Progression of Disease|1|||
23339609|NCT00954512|64986265|FG002|Overall Study|Progression of Disease|0|||
23339610|NCT00954512|64986266|FG003|Overall Study|Progression of Disease|1|||
23339611|NCT00954512|64986267|FG004|Overall Study|Progression of Disease|1|||
23339612|NCT00954512|64986268|FG005|Overall Study|Progression of Disease|1|||
23339613|NCT00562302|64986270|FG000|Overall Study|Lost to Follow-up|3|||
23339614|NCT00562302|64986271|FG001|Overall Study|Lost to Follow-up|3|||
23339615|NCT00562302|64986270|FG000|Overall Study|Adverse Event|0|||
23339616|NCT00562302|64986271|FG001|Overall Study|Adverse Event|6|||
23339617|NCT00562302|64986270|FG000|Overall Study|Non-compliance|1|||
23339618|NCT00562302|64986271|FG001|Overall Study|Non-compliance|2|||
23579915|NCT01474512|65853376|FG016|Long-Term Extension Period|Death|0|||
23579916|NCT01474512|65853377|FG017|Long-Term Extension Period|Death|0|||
23839480|NCT01986933|66791884|FG003|Active-to-active (Part B)|Physician Decision|1|||
23839481|NCT01986933|66791885|FG004|Active-to-active (Part B)|Physician Decision|0|||
23839482|NCT01986933|66791881|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
23839483|NCT01986933|66791882|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
23839484|NCT01986933|66791883|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
23839485|NCT01986933|66791884|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
23839486|NCT01986933|66791885|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
23839487|NCT01986933|66791881|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
23839488|NCT01986933|66791882|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
23839489|NCT01986933|66791883|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
23839490|NCT01986933|66791884|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
23839491|NCT01986933|66791885|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
23839492|NCT01986933|66791881|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
23839493|NCT01986933|66791882|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23839494|NCT01986933|66791883|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
23839495|NCT01986933|66791884|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23839496|NCT01986933|66791885|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23839497|NCT01986933|66791881|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
23839498|NCT01986933|66791882|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
23839499|NCT01986933|66791883|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
23839500|NCT01986933|66791884|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
23839501|NCT01986933|66791885|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
23839502|NCT01986933|66791881|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23839503|NCT01986933|66791882|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23839504|NCT01986933|66791883|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23839505|NCT01986933|66791884|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
23839506|NCT01986933|66791885|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23839507|NCT01986933|66791881|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
23839508|NCT01986933|66791882|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
23839509|NCT01986933|66791883|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
23839510|NCT01986933|66791884|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
23339619|NCT00562302|64986270|FG000|Overall Study|Withdrawal by Subject|7|||
23339620|NCT00562302|64986271|FG001|Overall Study|Withdrawal by Subject|8|||
23339621|NCT00562302|64986270|FG000|Overall Study|Death|1|||
23339622|NCT00562302|64986271|FG001|Overall Study|Death|2|||
23839511|NCT01986933|66791885|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
23339623|NCT00562302|64986270|FG000|Overall Study|Lung resection prior to study completion|7|||
23839512|NCT01986933|66791881|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
23839513|NCT01986933|66791882|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
23339624|NCT00562302|64986271|FG001|Overall Study|Lung resection prior to study completion|7|||
23339625|NCT00562302|64986270|FG000|Overall Study|Not stated|1|||
23839514|NCT01986933|66791883|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
23839515|NCT01986933|66791884|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
23839516|NCT01986933|66791885|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
23839517|NCT01986933|66791881|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23579917|NCT01474512|65853360|FG000|Long-Term Extension Period|Sponsor Decision|0|||
23579918|NCT01474512|65853361|FG001|Long-Term Extension Period|Sponsor Decision|0|||
23579919|NCT01474512|65853362|FG002|Long-Term Extension Period|Sponsor Decision|0|||
23779231|NCT00488774|66573421|FG001|Overall Study|Other|3|||
23779232|NCT00488774|66573422|FG002|Overall Study|Other|2|||
23779233|NCT00488774|66573423|FG003|Overall Study|Other|2|||
23779234|NCT00488774|66573420|FG000|Overall Study|Lost to Follow-up|0|||
23779235|NCT00488774|66573421|FG001|Overall Study|Lost to Follow-up|0|||
23779236|NCT00488774|66573422|FG002|Overall Study|Lost to Follow-up|1|||
23779237|NCT00488774|66573423|FG003|Overall Study|Lost to Follow-up|1|||
23779238|NCT01792635|66573428|FG000|Part B|Adverse Event|0|||
23779239|NCT01792635|66573429|FG001|Part B|Adverse Event|0|||
23779240|NCT01792635|66573430|FG002|Part B|Adverse Event|1|||
23779241|NCT01792635|66573428|FG000|Part B|Study terminated|0|||
23779242|NCT01792635|66573429|FG001|Part B|Study terminated|4|||
23779243|NCT01792635|66573430|FG002|Part B|Study terminated|3|||
23779244|NCT01370733|66573434|FG000|Overall Study|Withdrawal by Subject|8|||
23779245|NCT01370733|66573435|FG001|Overall Study|Withdrawal by Subject|8|||
23779246|NCT01370733|66573434|FG000|Overall Study|Lost to Follow-up|3|||
23779247|NCT01370733|66573435|FG001|Overall Study|Lost to Follow-up|0|||
23779248|NCT01370733|66573434|FG000|Overall Study|Adverse Event|2|||
23779249|NCT01370733|66573435|FG001|Overall Study|Adverse Event|4|||
23779250|NCT01370733|66573434|FG000|Overall Study|Lack of Efficacy|3|||
23779251|NCT01370733|66573435|FG001|Overall Study|Lack of Efficacy|5|||
23779252|NCT01370733|66573434|FG000|Overall Study|Physician Decision|0|||
23779253|NCT01370733|66573435|FG001|Overall Study|Physician Decision|2|||
23779254|NCT01370733|66573434|FG000|Overall Study|Protocol Violation|1|||
23779255|NCT01370733|66573435|FG001|Overall Study|Protocol Violation|3|||
23779256|NCT00001703|66573438|FG000|Overall Study|progressed disease|2|||
23779257|NCT00001703|66573438|FG000|Overall Study|No evidence of disease|1|||
23779258|NCT00001703|66573438|FG000|Overall Study|recurrent disease|2|||
23779259|NCT03912337|66573444|FG000|Overall Study|Withdrawal of Consent From Study|1|||
23779260|NCT03912337|66573445|FG001|Overall Study|Withdrawal of Consent From Study|0|||
23779261|NCT03912337|66573444|FG000|Overall Study|Lost to Follow-up|1|||
23779262|NCT03912337|66573445|FG001|Overall Study|Lost to Follow-up|1|||
23779263|NCT00392665|66573446|FG000|Overall Study|Death|16|||
23779264|NCT00392665|66573447|FG001|Overall Study|Death|14|||
23779265|NCT00392665|66573446|FG000|Overall Study|Lost to Follow-up|1|||
23779266|NCT00392665|66573447|FG001|Overall Study|Lost to Follow-up|1|||
23779267|NCT00707161|66573448|FG000|Overall Study|Physician Decision|6|||
23779268|NCT02301975|66573449|FG000|Overall Study|Adverse Event|8|||
23779269|NCT02301975|66573450|FG001|Overall Study|Adverse Event|3|||
23779270|NCT02301975|66573451|FG002|Overall Study|Adverse Event|2|||
23779271|NCT02301975|66573449|FG000|Overall Study|Lack of Efficacy|1|||
23779272|NCT02301975|66573450|FG001|Overall Study|Lack of Efficacy|1|||
23779273|NCT02301975|66573451|FG002|Overall Study|Lack of Efficacy|1|||
23779274|NCT02301975|66573449|FG000|Overall Study|Protocol Violation|3|||
23779275|NCT02301975|66573450|FG001|Overall Study|Protocol Violation|5|||
23779276|NCT02301975|66573451|FG002|Overall Study|Protocol Violation|3|||
23779277|NCT02301975|66573449|FG000|Overall Study|Lost to Follow-up|0|||
23779278|NCT02301975|66573450|FG001|Overall Study|Lost to Follow-up|2|||
23779279|NCT02301975|66573451|FG002|Overall Study|Lost to Follow-up|2|||
23779280|NCT02301975|66573449|FG000|Overall Study|Physician Decision|4|||
23779281|NCT02301975|66573450|FG001|Overall Study|Physician Decision|2|||
23779282|NCT02301975|66573451|FG002|Overall Study|Physician Decision|3|||
23779283|NCT02301975|66573449|FG000|Overall Study|Withdrawal by Subject|15|||
23779284|NCT02301975|66573450|FG001|Overall Study|Withdrawal by Subject|12|||
23779285|NCT02301975|66573451|FG002|Overall Study|Withdrawal by Subject|11|||
23779286|NCT00772941|66573453|FG000|Overall Study|CRFs not available|195|||
23779287|NCT00772941|66573453|FG000|Overall Study|Study not completed|16|||
23779288|NCT00772941|66573453|FG000|Overall Study|Missed Visits|374|||
23779289|NCT00772941|66573453|FG000|Overall Study|Poor Compliance|7|||
23839518|NCT01986933|66791882|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
23779290|NCT00772941|66573453|FG000|Overall Study|GPSP Violation|90|||
23779291|NCT02159950|66573456|FG000|Overall Study|Adverse Event|0|||
23779292|NCT02159950|66573457|FG001|Overall Study|Adverse Event|1|||
23779293|NCT02159950|66573456|FG000|Overall Study|Progression|0|||
23779294|NCT02159950|66573457|FG001|Overall Study|Progression|1|||
23779295|NCT02937870|66573458|FG000|Overall Study|Adverse Event|1|||
23779296|NCT02937870|66573458|FG000|Overall Study|Protocol Deviation|2|||
23779297|NCT00448591|66573462|FG000|Overall Study|Withdrawal by Subject|178|||
23779298|NCT00448591|66573462|FG000|Overall Study|Progressive Disease|1382|||
23779299|NCT00448591|66573462|FG000|Overall Study|Adverse Event|382|||
23779300|NCT00448591|66573462|FG000|Overall Study|Protocol Violation|41|||
23779301|NCT00448591|66573462|FG000|Overall Study|Lost to Follow-up|19|||
23779302|NCT00448591|66573462|FG000|Overall Study|Treatment Regimen Completed|70|||
23839519|NCT01986933|66791883|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23839520|NCT01986933|66791884|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23839521|NCT01986933|66791885|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23839522|NCT01262287|66791886|FG000|Overall Study|Lost to Follow-up|2|||
23839523|NCT01262287|66791887|FG001|Overall Study|Lost to Follow-up|1|||
23839524|NCT00789854|66791888|FG000|Overall Study|Adverse Event|28|||
23839525|NCT00789854|66791889|FG001|Overall Study|Adverse Event|23|||
23839526|NCT00789854|66791890|FG002|Overall Study|Adverse Event|18|||
23839527|NCT00789854|66791888|FG000|Overall Study|Lost to Follow-up|1|||
23839528|NCT00789854|66791889|FG001|Overall Study|Lost to Follow-up|1|||
23839529|NCT00789854|66791890|FG002|Overall Study|Lost to Follow-up|4|||
23839530|NCT00789854|66791888|FG000|Overall Study|Withdrawal by Subject|9|||
23839531|NCT00789854|66791889|FG001|Overall Study|Withdrawal by Subject|6|||
23839532|NCT00789854|66791890|FG002|Overall Study|Withdrawal by Subject|17|||
23839533|NCT00789854|66791888|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23839534|NCT00789854|66791889|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
23839535|NCT00789854|66791890|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23839536|NCT00789854|66791888|FG000|Overall Study|Severe non-compliance to the protocol|3|||
23839537|NCT00789854|66791889|FG001|Overall Study|Severe non-compliance to the protocol|0|||
23839538|NCT00789854|66791890|FG002|Overall Study|Severe non-compliance to the protocol|0|||
23839539|NCT00789854|66791888|FG000|Overall Study|Safety reasons|0|||
23839540|NCT00789854|66791889|FG001|Overall Study|Safety reasons|0|||
23839541|NCT00789854|66791890|FG002|Overall Study|Safety reasons|2|||
23839542|NCT00789854|66791888|FG000|Overall Study|Other|6|||
23839543|NCT00789854|66791889|FG001|Overall Study|Other|0|||
23839544|NCT00789854|66791890|FG002|Overall Study|Other|5|||
23839545|NCT04266795|66791891|FG000|Overall Study|Adverse Event|10|||
23839546|NCT04266795|66791892|FG001|Overall Study|Adverse Event|19|||
23839547|NCT04266795|66791891|FG000|Overall Study|Death|7|||
23839548|NCT04266795|66791892|FG001|Overall Study|Death|8|||
23839549|NCT04266795|66791891|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
23839550|NCT04266795|66791892|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
23839551|NCT04266795|66791891|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
23839552|NCT04266795|66791892|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23839553|NCT04266795|66791891|FG000|Overall Study|Progressive Disease|12|||
23839554|NCT04266795|66791892|FG001|Overall Study|Progressive Disease|9|||
23839555|NCT04266795|66791891|FG000|Overall Study|Withdrawal by Patient|5|||
23839556|NCT04266795|66791892|FG001|Overall Study|Withdrawal by Patient|6|||
23839557|NCT04266795|66791891|FG000|Overall Study|Disease Relapse|3|||
23839558|NCT04266795|66791892|FG001|Overall Study|Disease Relapse|6|||
23839559|NCT04266795|66791891|FG000|Overall Study|Reason not Specified|12|||
23839560|NCT04266795|66791892|FG001|Overall Study|Reason not Specified|10|||
23839561|NCT04266795|66791891|FG000|Overall Study|Participants Ongoing on Treatment|25|||
23839562|NCT04266795|66791892|FG001|Overall Study|Participants Ongoing on Treatment|23|||
23839563|NCT00892151|66791895|FG000|Overall Study|Protocol Violation|1|||
23339626|NCT00562302|64986271|FG001|Overall Study|Not stated|4|||
23451376|NCT02748863|65395175|FG002|Treatment Period 1|Lack of Efficacy|1|||
23579920|NCT01474512|65853363|FG003|Long-Term Extension Period|Sponsor Decision|0|||
23579921|NCT01474512|65853364|FG004|Long-Term Extension Period|Sponsor Decision|0|||
23579922|NCT01474512|65853365|FG005|Long-Term Extension Period|Sponsor Decision|0|||
23579923|NCT01474512|65853366|FG006|Long-Term Extension Period|Sponsor Decision|0|||
23579924|NCT01474512|65853367|FG007|Long-Term Extension Period|Sponsor Decision|0|||
23579925|NCT01474512|65853368|FG008|Long-Term Extension Period|Sponsor Decision|0|||
23579926|NCT01474512|65853369|FG009|Long-Term Extension Period|Sponsor Decision|0|||
23579927|NCT01474512|65853370|FG010|Long-Term Extension Period|Sponsor Decision|0|||
23579928|NCT01474512|65853371|FG011|Long-Term Extension Period|Sponsor Decision|0|||
23579929|NCT01474512|65853372|FG012|Long-Term Extension Period|Sponsor Decision|6|||
23579930|NCT01474512|65853373|FG013|Long-Term Extension Period|Sponsor Decision|6|||
23579931|NCT01474512|65853374|FG014|Long-Term Extension Period|Sponsor Decision|0|||
23579932|NCT01474512|65853375|FG015|Long-Term Extension Period|Sponsor Decision|0|||
23579933|NCT01474512|65853376|FG016|Long-Term Extension Period|Sponsor Decision|0|||
23579934|NCT01474512|65853377|FG017|Long-Term Extension Period|Sponsor Decision|0|||
23579935|NCT01474512|65853360|FG000|Long-Term Extension Period|Protocol Violation|0|||
23579936|NCT01474512|65853361|FG001|Long-Term Extension Period|Protocol Violation|0|||
23839564|NCT02748356|66791896|FG000|Overall Study|Withdrawal by Subject|1|||
23839565|NCT02616146|66791897|FG000|Overall Study|Adverse Event|64|||
23839566|NCT02616146|66791898|FG001|Overall Study|Adverse Event|24|||
23839567|NCT02616146|66791897|FG000|Overall Study|Lost to Follow-up|23|||
23839568|NCT02616146|66791898|FG001|Overall Study|Lost to Follow-up|13|||
23839569|NCT02616146|66791897|FG000|Overall Study|Non-compliance with study protocol|2|||
23839570|NCT02616146|66791898|FG001|Overall Study|Non-compliance with study protocol|0|||
23839571|NCT02616146|66791897|FG000|Overall Study|Non-compliance with study drug|4|||
23839572|NCT02616146|66791898|FG001|Overall Study|Non-compliance with study drug|2|||
23451377|NCT02748863|65395176|FG003|Treatment Period 1|Lack of Efficacy|0|||
23635024|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
23635025|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23635026|NCT00479882|66049371|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23635027|NCT00479882|66049372|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23635028|NCT00479882|66049373|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
23635029|NCT00479882|66049374|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23451378|NCT02748863|65395177|FG004|Treatment Period 1|Lack of Efficacy|0|||
23451379|NCT02748863|65395173|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23451380|NCT02748863|65395174|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23451381|NCT02748863|65395175|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23451382|NCT02748863|65395176|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23451383|NCT02748863|65395177|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23451384|NCT02748863|65395173|FG000|Treatment Period 2|Lost to Follow-up|2|||
23635030|NCT02797522|66049378|FG000|Overall Study|Study Terminated by Sponsor|0|||
23635031|NCT02797522|66049379|FG001|Overall Study|Study Terminated by Sponsor|0|||
23635032|NCT02797522|66049380|FG002|Overall Study|Study Terminated by Sponsor|0|||
23635033|NCT02797522|66049381|FG003|Overall Study|Study Terminated by Sponsor|0|||
23451385|NCT02748863|65395174|FG001|Treatment Period 2|Lost to Follow-up|0|||
23451386|NCT02748863|65395175|FG002|Treatment Period 2|Lost to Follow-up|0|||
23451387|NCT02748863|65395176|FG003|Treatment Period 2|Lost to Follow-up|0|||
23451388|NCT02748863|65395177|FG004|Treatment Period 2|Lost to Follow-up|0|||
23451389|NCT02748863|65395173|FG000|Treatment Period 2|Adverse Event|3|||
23451390|NCT02748863|65395174|FG001|Treatment Period 2|Adverse Event|2|||
23451391|NCT02748863|65395175|FG002|Treatment Period 2|Adverse Event|0|||
23451392|NCT02748863|65395176|FG003|Treatment Period 2|Adverse Event|2|||
23451393|NCT02748863|65395177|FG004|Treatment Period 2|Adverse Event|0|||
23451394|NCT02748863|65395173|FG000|Treatment Period 2|Lack of Efficacy|0|||
23451395|NCT02748863|65395174|FG001|Treatment Period 2|Lack of Efficacy|1|||
23451396|NCT02748863|65395175|FG002|Treatment Period 2|Lack of Efficacy|0|||
23451397|NCT02748863|65395176|FG003|Treatment Period 2|Lack of Efficacy|0|||
23451398|NCT02748863|65395177|FG004|Treatment Period 2|Lack of Efficacy|0|||
23451399|NCT02748863|65395173|FG000|Treatment Period 2|Pregnancy|0|||
23451400|NCT02748863|65395174|FG001|Treatment Period 2|Pregnancy|0|||
23451401|NCT02748863|65395175|FG002|Treatment Period 2|Pregnancy|0|||
23451402|NCT02748863|65395176|FG003|Treatment Period 2|Pregnancy|0|||
23451403|NCT02748863|65395177|FG004|Treatment Period 2|Pregnancy|1|||
23451404|NCT03449758|65395178|FG000|Overall Study|Major protocol deviation|1|||
23451405|NCT03449758|65395178|FG000|Overall Study|Treatment inefficacy|5|||
23451406|NCT03449758|65395178|FG000|Overall Study|Adverse Event|9|||
23451407|NCT03449758|65395178|FG000|Overall Study|Consent withdrawal|1|||
23451408|NCT03449758|65395178|FG000|Overall Study|Other unspecified reason|3|||
23451409|NCT00506350|65395181|FG000|Overall Study|Serious Adverse Event|1|||
23451410|NCT00506350|65395182|FG001|Overall Study|Serious Adverse Event|0|||
23451411|NCT00506350|65395183|FG002|Overall Study|Serious Adverse Event|0|||
23451412|NCT00506350|65395184|FG003|Overall Study|Serious Adverse Event|0|||
23451413|NCT00506350|65395185|FG004|Overall Study|Serious Adverse Event|0|||
23451414|NCT00506350|65395186|FG005|Overall Study|Serious Adverse Event|0|||
23635034|NCT02797522|66049382|FG004|Overall Study|Study Terminated by Sponsor|0|||
23635035|NCT02797522|66049383|FG005|Overall Study|Study Terminated by Sponsor|0|||
23635036|NCT02797522|66049384|FG006|Overall Study|Study Terminated by Sponsor|0|||
23635037|NCT02797522|66049385|FG007|Overall Study|Study Terminated by Sponsor|4|||
23635038|NCT02797522|66049386|FG008|Overall Study|Study Terminated by Sponsor|2|||
23451415|NCT00506350|65395187|FG006|Overall Study|Serious Adverse Event|0|||
23451416|NCT00506350|65395188|FG007|Overall Study|Serious Adverse Event|0|||
23451417|NCT00506350|65395189|FG008|Overall Study|Serious Adverse Event|0|||
23451418|NCT00506350|65395181|FG000|Overall Study|Adverse Event|0|||
23579937|NCT01474512|65853362|FG002|Long-Term Extension Period|Protocol Violation|0|||
23579938|NCT01474512|65853363|FG003|Long-Term Extension Period|Protocol Violation|0|||
23579939|NCT01474512|65853364|FG004|Long-Term Extension Period|Protocol Violation|0|||
23579940|NCT01474512|65853365|FG005|Long-Term Extension Period|Protocol Violation|0|||
23579941|NCT01474512|65853366|FG006|Long-Term Extension Period|Protocol Violation|0|||
23579942|NCT01474512|65853367|FG007|Long-Term Extension Period|Protocol Violation|0|||
23579943|NCT01474512|65853368|FG008|Long-Term Extension Period|Protocol Violation|0|||
23579944|NCT01474512|65853369|FG009|Long-Term Extension Period|Protocol Violation|0|||
23579945|NCT01474512|65853370|FG010|Long-Term Extension Period|Protocol Violation|0|||
23579946|NCT01474512|65853371|FG011|Long-Term Extension Period|Protocol Violation|0|||
23579947|NCT01474512|65853372|FG012|Long-Term Extension Period|Protocol Violation|5|||
23451419|NCT00506350|65395182|FG001|Overall Study|Adverse Event|0|||
23579948|NCT01474512|65853373|FG013|Long-Term Extension Period|Protocol Violation|5|||
23635039|NCT02797522|66049387|FG009|Overall Study|Study Terminated by Sponsor|4|||
23451420|NCT00506350|65395183|FG002|Overall Study|Adverse Event|0|||
23451421|NCT00506350|65395184|FG003|Overall Study|Adverse Event|0|||
23451422|NCT00506350|65395185|FG004|Overall Study|Adverse Event|0|||
23451423|NCT00506350|65395186|FG005|Overall Study|Adverse Event|0|||
23451424|NCT00506350|65395187|FG006|Overall Study|Adverse Event|0|||
23451425|NCT00506350|65395188|FG007|Overall Study|Adverse Event|1|||
23451426|NCT00506350|65395189|FG008|Overall Study|Adverse Event|1|||
23451427|NCT00506350|65395181|FG000|Overall Study|Protocol Violation|0|||
23451428|NCT00506350|65395182|FG001|Overall Study|Protocol Violation|0|||
23451429|NCT00506350|65395183|FG002|Overall Study|Protocol Violation|1|||
23579949|NCT01474512|65853374|FG014|Long-Term Extension Period|Protocol Violation|0|||
23779303|NCT00448591|66573462|FG000|Overall Study|Other|154|||
23779304|NCT00448591|66573462|FG000|Overall Study|Termination of Study|70|||
23779305|NCT01841554|66573463|FG000|Overall Study|Death|7|||
23779306|NCT01841554|66573463|FG000|Overall Study|No Implantation|1|||
23779307|NCT01841554|66573463|FG000|Overall Study|Discontinued Follow Up|5|||
23779308|NCT01841554|66573463|FG000|Overall Study|Study exit due to secondary intervention|6|||
23779309|NCT03161405|66573466|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
23779310|NCT02422264|66573467|FG000|Overall Study|Serious Adverse Event|1|||
23779311|NCT02422264|66573468|FG001|Overall Study|Serious Adverse Event|0|||
23779312|NCT02422264|66573467|FG000|Overall Study|Withdrawal by Subject|1|||
23779313|NCT02422264|66573468|FG001|Overall Study|Withdrawal by Subject|2|||
23779314|NCT02422264|66573467|FG000|Overall Study|Migrated/moved from study area|3|||
23779315|NCT02422264|66573468|FG001|Overall Study|Migrated/moved from study area|1|||
23779316|NCT02422264|66573467|FG000|Overall Study|Subject vaccinated outside of the study|0|||
23839573|NCT02616146|66791897|FG000|Overall Study|Pregnancy|2|||
23839574|NCT02616146|66791898|FG001|Overall Study|Pregnancy|2|||
23839575|NCT02616146|66791897|FG000|Overall Study|Pregnancy wish|3|||
23839576|NCT02616146|66791898|FG001|Overall Study|Pregnancy wish|0|||
23839577|NCT02616146|66791897|FG000|Overall Study|Protocol Violation|6|||
23839578|NCT02616146|66791898|FG001|Overall Study|Protocol Violation|3|||
23839579|NCT02616146|66791897|FG000|Overall Study|Study terminated by sponsor|1372|||
23839580|NCT02616146|66791898|FG001|Overall Study|Study terminated by sponsor|432|||
23839581|NCT02616146|66791897|FG000|Overall Study|Participant moved|4|||
23579950|NCT01474512|65853375|FG015|Long-Term Extension Period|Protocol Violation|0|||
23579951|NCT01474512|65853376|FG016|Long-Term Extension Period|Protocol Violation|0|||
23579952|NCT01474512|65853377|FG017|Long-Term Extension Period|Protocol Violation|0|||
23839582|NCT02616146|66791898|FG001|Overall Study|Participant moved|3|||
23839583|NCT02616146|66791897|FG000|Overall Study|Withdrawal by Subject|30|||
23839584|NCT02616146|66791898|FG001|Overall Study|Withdrawal by Subject|24|||
23839585|NCT02616146|66791897|FG000|Overall Study|Physician Decision|2|||
23839586|NCT02616146|66791898|FG001|Overall Study|Physician Decision|1|||
23339627|NCT01878084|64986272|FG000|Overall Study|Physician Decision|2|||
23339628|NCT02572076|64986273|FG000|Overall Study|Protocol Violation|1|||
23339629|NCT00877071|64986274|FG000|Overall Study|disease progression|2|||
23339630|NCT01023256|64986275|FG000|Overall Study|Protocol Violation|2|||
23339631|NCT01023256|64986276|FG001|Overall Study|Protocol Violation|3|||
23339632|NCT01023256|64986277|FG002|Overall Study|Protocol Violation|0|||
23339633|NCT01023256|64986278|FG003|Overall Study|Protocol Violation|0|||
23339634|NCT01023256|64986275|FG000|Overall Study|Randomized but not treated|1|||
23339635|NCT01023256|64986276|FG001|Overall Study|Randomized but not treated|0|||
23339636|NCT01023256|64986277|FG002|Overall Study|Randomized but not treated|1|||
23451430|NCT00506350|65395184|FG003|Overall Study|Protocol Violation|0|||
23579953|NCT01474512|65853360|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579954|NCT01474512|65853361|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579955|NCT01474512|65853362|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579956|NCT01474512|65853363|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579957|NCT01474512|65853364|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579958|NCT01474512|65853365|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579959|NCT01474512|65853366|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579960|NCT01474512|65853367|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579961|NCT01474512|65853368|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579962|NCT01474512|65853369|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579963|NCT01474512|65853370|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579964|NCT01474512|65853371|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579965|NCT01474512|65853372|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
23579966|NCT01474512|65853373|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
23579967|NCT01474512|65853374|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23779317|NCT02422264|66573468|FG001|Overall Study|Subject vaccinated outside of the study|1|||
23779318|NCT03988803|66573469|FG000|Period 2|Prematurely discontinued from medication|2|||
23779319|NCT03988803|66573469|FG000|Period 2|Adverse Event|1|||
23779320|NCT01629381|66573473|FG000|Overall Study|Withdrawal by Subject|2|||
23839587|NCT00813813|66791902|FG000|Overall Study|Withdrawal by Subject|1|||
23839588|NCT00813813|66791903|FG001|Overall Study|Withdrawal by Subject|1|||
23839589|NCT00813813|66791902|FG000|Overall Study|Lost to Follow-up|2|||
23839590|NCT00813813|66791903|FG001|Overall Study|Lost to Follow-up|7|||
23339637|NCT01023256|64986278|FG003|Overall Study|Randomized but not treated|0|||
23339638|NCT01023256|64986275|FG000|Overall Study|Other|1|||
23339639|NCT01023256|64986276|FG001|Overall Study|Other|0|||
23339640|NCT01023256|64986277|FG002|Overall Study|Other|0|||
23451431|NCT00506350|65395185|FG004|Overall Study|Protocol Violation|0|||
23451432|NCT00506350|65395186|FG005|Overall Study|Protocol Violation|0|||
23451433|NCT00506350|65395187|FG006|Overall Study|Protocol Violation|1|||
23451434|NCT00506350|65395188|FG007|Overall Study|Protocol Violation|0|||
23451435|NCT00506350|65395189|FG008|Overall Study|Protocol Violation|0|||
23451436|NCT00506350|65395181|FG000|Overall Study|Withdrawal by Subject|0|||
23451437|NCT00506350|65395182|FG001|Overall Study|Withdrawal by Subject|1|||
23451438|NCT00506350|65395183|FG002|Overall Study|Withdrawal by Subject|1|||
23451439|NCT00506350|65395184|FG003|Overall Study|Withdrawal by Subject|1|||
23451440|NCT00506350|65395185|FG004|Overall Study|Withdrawal by Subject|4|||
23451441|NCT00506350|65395186|FG005|Overall Study|Withdrawal by Subject|1|||
23451442|NCT00506350|65395187|FG006|Overall Study|Withdrawal by Subject|1|||
23451443|NCT00506350|65395188|FG007|Overall Study|Withdrawal by Subject|2|||
23451444|NCT00506350|65395189|FG008|Overall Study|Withdrawal by Subject|0|||
23451445|NCT00506350|65395181|FG000|Overall Study|Lost to Follow-up|1|||
23451446|NCT00506350|65395182|FG001|Overall Study|Lost to Follow-up|1|||
23451447|NCT00506350|65395183|FG002|Overall Study|Lost to Follow-up|1|||
23451448|NCT00506350|65395184|FG003|Overall Study|Lost to Follow-up|1|||
23451449|NCT00506350|65395185|FG004|Overall Study|Lost to Follow-up|2|||
23451450|NCT00506350|65395186|FG005|Overall Study|Lost to Follow-up|1|||
23451451|NCT00506350|65395187|FG006|Overall Study|Lost to Follow-up|0|||
23451452|NCT00506350|65395188|FG007|Overall Study|Lost to Follow-up|0|||
23451453|NCT00506350|65395189|FG008|Overall Study|Lost to Follow-up|2|||
23451454|NCT00506350|65395181|FG000|Overall Study|Medical Reason|0|||
23451455|NCT00506350|65395182|FG001|Overall Study|Medical Reason|0|||
23451456|NCT00506350|65395183|FG002|Overall Study|Medical Reason|0|||
23451457|NCT00506350|65395184|FG003|Overall Study|Medical Reason|0|||
23451458|NCT00506350|65395185|FG004|Overall Study|Medical Reason|1|||
23451459|NCT00506350|65395186|FG005|Overall Study|Medical Reason|0|||
23451460|NCT00506350|65395187|FG006|Overall Study|Medical Reason|0|||
23451461|NCT00506350|65395188|FG007|Overall Study|Medical Reason|0|||
23451462|NCT00506350|65395189|FG008|Overall Study|Medical Reason|0|||
23451463|NCT00506350|65395181|FG000|Overall Study|Other|1|||
23451464|NCT00506350|65395182|FG001|Overall Study|Other|1|||
23451465|NCT00506350|65395183|FG002|Overall Study|Other|3|||
23451466|NCT00506350|65395184|FG003|Overall Study|Other|0|||
23451467|NCT00506350|65395185|FG004|Overall Study|Other|3|||
23451468|NCT00506350|65395186|FG005|Overall Study|Other|0|||
23451469|NCT00506350|65395187|FG006|Overall Study|Other|0|||
23451470|NCT00506350|65395188|FG007|Overall Study|Other|2|||
23451471|NCT00506350|65395189|FG008|Overall Study|Other|2|||
23451472|NCT02888106|65395190|FG000|Overall Study|Withdrawal by Subject|1|||
23579968|NCT01474512|65853375|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579969|NCT01474512|65853376|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579970|NCT01474512|65853377|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579971|NCT01474512|65853360|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579972|NCT01474512|65853361|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579973|NCT01474512|65853362|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579974|NCT01474512|65853363|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579975|NCT01474512|65853364|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579976|NCT01474512|65853365|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579977|NCT01474512|65853366|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579978|NCT01474512|65853367|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23779321|NCT01629381|66573474|FG001|Overall Study|Withdrawal by Subject|5|||
23779322|NCT02089997|66573475|FG000|Overall Study|Case report forms uncollected|99|||
23779323|NCT02089997|66573475|FG000|Overall Study|Protocol Violation|147|||
23779324|NCT02392000|66573483|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
23779325|NCT02392000|66573483|FG000|Overall Study|Withdrawal by Subject|1|||
23779326|NCT02392000|66573483|FG000|Overall Study|Lost to Follow-up|8|||
23779327|NCT00415363|66573484|FG000|Overall Study|Withdrawal by Subject|4|||
23779328|NCT00415363|66573485|FG001|Overall Study|Withdrawal by Subject|4|||
23779329|NCT00415363|66573484|FG000|Overall Study|Adverse Event|4|||
23779330|NCT00415363|66573485|FG001|Overall Study|Adverse Event|4|||
23779331|NCT00415363|66573484|FG000|Overall Study|Lost to Follow-up|2|||
23779332|NCT00415363|66573485|FG001|Overall Study|Lost to Follow-up|1|||
23779333|NCT00415363|66573484|FG000|Overall Study|Physician Decision|3|||
23779334|NCT00415363|66573485|FG001|Overall Study|Physician Decision|1|||
23779335|NCT00415363|66573484|FG000|Overall Study|Death|16|||
23779336|NCT00415363|66573485|FG001|Overall Study|Death|12|||
23779337|NCT00415363|66573484|FG000|Overall Study|Progressive disease|26|||
23779338|NCT00415363|66573485|FG001|Overall Study|Progressive disease|32|||
23779339|NCT02294604|66573486|FG000|Overall Study|Did not provide samples for culture|0|||
23779340|NCT02294604|66573487|FG001|Overall Study|Did not provide samples for culture|1|||
23451473|NCT02888106|65395191|FG001|Overall Study|Withdrawal by Subject|2|||
23451474|NCT02888106|65395192|FG002|Overall Study|Withdrawal by Subject|0|||
23451475|NCT02888106|65395193|FG003|Overall Study|Withdrawal by Subject|1|||
23579979|NCT01474512|65853368|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23451476|NCT02888106|65395194|FG004|Overall Study|Withdrawal by Subject|0|||
23451477|NCT02888106|65395195|FG005|Overall Study|Withdrawal by Subject|0|||
23451478|NCT02888106|65395190|FG000|Overall Study|Lost to Follow-up|1|||
23451479|NCT02888106|65395191|FG001|Overall Study|Lost to Follow-up|0|||
23451480|NCT02888106|65395192|FG002|Overall Study|Lost to Follow-up|0|||
23451481|NCT02888106|65395193|FG003|Overall Study|Lost to Follow-up|1|||
23451482|NCT02888106|65395194|FG004|Overall Study|Lost to Follow-up|0|||
23451483|NCT02888106|65395195|FG005|Overall Study|Lost to Follow-up|1|||
23451484|NCT02888106|65395190|FG000|Overall Study|Adverse Event|2|||
23451485|NCT02888106|65395191|FG001|Overall Study|Adverse Event|0|||
23451486|NCT02888106|65395192|FG002|Overall Study|Adverse Event|0|||
23451487|NCT02888106|65395193|FG003|Overall Study|Adverse Event|0|||
23451488|NCT02888106|65395194|FG004|Overall Study|Adverse Event|0|||
23451489|NCT02888106|65395195|FG005|Overall Study|Adverse Event|0|||
23779341|NCT02294604|66573488|FG002|Overall Study|Did not provide samples for culture|0|||
23779342|NCT02294604|66573486|FG000|Overall Study|Culture contamination|1|||
23779343|NCT02294604|66573487|FG001|Overall Study|Culture contamination|2|||
23779344|NCT02294604|66573488|FG002|Overall Study|Culture contamination|0|||
23779345|NCT05376319|66573489|FG000|Overall Study|Funding termination|2|||
23779346|NCT05376319|66573490|FG001|Overall Study|Funding termination|4|||
23779347|NCT02943447|66573491|FG000|Blinded Study Phase|Withdrew Consent|1|||
23779348|NCT02943447|66573492|FG001|Blinded Study Phase|Withdrew Consent|2|||
23779349|NCT02943447|66573493|FG002|Blinded Study Phase|Withdrew Consent|1|||
23779350|NCT02943447|66573491|FG000|Blinded Study Phase|Adverse Event|3|||
23779351|NCT02943447|66573492|FG001|Blinded Study Phase|Adverse Event|0|||
23779352|NCT02943447|66573493|FG002|Blinded Study Phase|Adverse Event|0|||
23779353|NCT02943447|66573491|FG000|Blinded Study Phase|Investigator's discretion|1|||
23779354|NCT02943447|66573492|FG001|Blinded Study Phase|Investigator's discretion|0|||
23779355|NCT02943447|66573493|FG002|Blinded Study Phase|Investigator's discretion|0|||
23779356|NCT02943447|66573491|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
23779357|NCT02943447|66573492|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
23779358|NCT02943447|66573493|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
23779359|NCT02943447|66573491|FG000|Open-Label Extension Phase|Adverse Event|4|||
23779360|NCT02943447|66573492|FG001|Open-Label Extension Phase|Adverse Event|7|||
23779361|NCT02943447|66573493|FG002|Open-Label Extension Phase|Adverse Event|3|||
23779362|NCT02943447|66573491|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
23779363|NCT02943447|66573492|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
23779364|NCT02943447|66573493|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
23779365|NCT02943447|66573491|FG000|Open-Label Extension Phase|Withdrew consent|1|||
23779366|NCT02943447|66573492|FG001|Open-Label Extension Phase|Withdrew consent|1|||
23779367|NCT02943447|66573493|FG002|Open-Label Extension Phase|Withdrew consent|1|||
23779368|NCT02943447|66573491|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23779369|NCT02943447|66573492|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23779370|NCT02943447|66573493|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23779371|NCT03041025|66573494|FG000|Overall Study|Adverse Event|0|||
23779372|NCT03041025|66573495|FG001|Overall Study|Adverse Event|0|||
23779373|NCT03041025|66573496|FG002|Overall Study|Adverse Event|1|||
23451490|NCT02888106|65395190|FG000|Overall Study|Withdrawal of consent|0|||
23451491|NCT02888106|65395191|FG001|Overall Study|Withdrawal of consent|0|||
23451492|NCT02888106|65395192|FG002|Overall Study|Withdrawal of consent|0|||
23451493|NCT02888106|65395193|FG003|Overall Study|Withdrawal of consent|0|||
23451494|NCT02888106|65395194|FG004|Overall Study|Withdrawal of consent|1|||
23451495|NCT02888106|65395195|FG005|Overall Study|Withdrawal of consent|0|||
23451496|NCT02888106|65395190|FG000|Overall Study|Pregnancy|1|||
23451497|NCT02888106|65395191|FG001|Overall Study|Pregnancy|0|||
23451498|NCT02888106|65395192|FG002|Overall Study|Pregnancy|0|||
23451499|NCT02888106|65395193|FG003|Overall Study|Pregnancy|0|||
23451500|NCT02888106|65395194|FG004|Overall Study|Pregnancy|0|||
23451501|NCT02888106|65395195|FG005|Overall Study|Pregnancy|0|||
23451502|NCT00430716|65395196|FG000|Double Blind Phase|Death|1|||
23451503|NCT00430716|65395197|FG001|Double Blind Phase|Death|0|||
23451504|NCT00430716|65395198|FG002|Double Blind Phase|Death|0|||
23779374|NCT03041025|66573494|FG000|Overall Study|Lost to Follow-up|1|||
23779375|NCT03041025|66573495|FG001|Overall Study|Lost to Follow-up|0|||
23779376|NCT03041025|66573496|FG002|Overall Study|Lost to Follow-up|0|||
23779377|NCT03041025|66573494|FG000|Overall Study|Withdrawal by Subject|0|||
23779378|NCT03041025|66573495|FG001|Overall Study|Withdrawal by Subject|0|||
23779379|NCT03041025|66573496|FG002|Overall Study|Withdrawal by Subject|1|||
23779380|NCT02794974|66573497|FG000|Overall Study|Physician Decision|0|||
23779381|NCT02794974|66573498|FG001|Overall Study|Physician Decision|1|||
23779382|NCT01136382|66573499|FG000|Overall Study|Other|8|||
23779383|NCT01136382|66573500|FG001|Overall Study|Other|3|||
23779384|NCT01136382|66573499|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
23451505|NCT00430716|65395196|FG000|Double Blind Phase|No longer willing to participate|2|||
23451506|NCT00430716|65395197|FG001|Double Blind Phase|No longer willing to participate|1|||
23451507|NCT00430716|65395198|FG002|Double Blind Phase|No longer willing to participate|1|||
23451508|NCT00430716|65395196|FG000|Double Blind Phase|Other|0|||
23451509|NCT00430716|65395197|FG001|Double Blind Phase|Other|2|||
23451510|NCT00430716|65395198|FG002|Double Blind Phase|Other|0|||
23451511|NCT00430716|65395196|FG000|Double Blind Phase|Study terminated by sponsor|1|||
23779385|NCT01136382|66573500|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
23779386|NCT01136382|66573499|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23779387|NCT01136382|66573500|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23779388|NCT01136382|66573499|FG000|Overall Study|Withdrawal by Subject|4|||
23779389|NCT01136382|66573500|FG001|Overall Study|Withdrawal by Subject|1|||
23779390|NCT03135834|66573501|FG000|Stage 1|Adverse Event|1|||
23779391|NCT03135834|66573502|FG001|Stage 1|Adverse Event|2|||
23779392|NCT03135834|66573503|FG002|Stage 1|Adverse Event|2|||
23779393|NCT03135834|66573504|FG003|Stage 1|Adverse Event|1|||
23779394|NCT03135834|66573501|FG000|Stage 1|Death|1|||
23779395|NCT03135834|66573502|FG001|Stage 1|Death|0|||
23779396|NCT03135834|66573503|FG002|Stage 1|Death|0|||
23779397|NCT03135834|66573504|FG003|Stage 1|Death|0|||
23779398|NCT03135834|66573501|FG000|Stage 1|Lost to Follow-up|17|||
23779399|NCT03135834|66573502|FG001|Stage 1|Lost to Follow-up|24|||
23779400|NCT03135834|66573503|FG002|Stage 1|Lost to Follow-up|21|||
23779401|NCT03135834|66573504|FG003|Stage 1|Lost to Follow-up|38|||
23779402|NCT03135834|66573501|FG000|Stage 1|No longer met eligibility criteria|1|||
23779403|NCT03135834|66573502|FG001|Stage 1|No longer met eligibility criteria|6|||
23779404|NCT03135834|66573503|FG002|Stage 1|No longer met eligibility criteria|2|||
23779405|NCT03135834|66573504|FG003|Stage 1|No longer met eligibility criteria|5|||
23779406|NCT03135834|66573501|FG000|Stage 1|Other|0|||
23779407|NCT03135834|66573502|FG001|Stage 1|Other|2|||
23779408|NCT03135834|66573503|FG002|Stage 1|Other|1|||
23779409|NCT03135834|66573504|FG003|Stage 1|Other|0|||
23779410|NCT03135834|66573501|FG000|Stage 1|Physician Decision|0|||
23779411|NCT03135834|66573502|FG001|Stage 1|Physician Decision|1|||
23779412|NCT03135834|66573503|FG002|Stage 1|Physician Decision|0|||
23779413|NCT03135834|66573504|FG003|Stage 1|Physician Decision|0|||
23779414|NCT03135834|66573501|FG000|Stage 1|Pregnancy|0|||
23779415|NCT03135834|66573502|FG001|Stage 1|Pregnancy|4|||
23779416|NCT03135834|66573503|FG002|Stage 1|Pregnancy|2|||
23779417|NCT03135834|66573504|FG003|Stage 1|Pregnancy|4|||
23779418|NCT03135834|66573501|FG000|Stage 1|Protocol Violation|1|||
23779419|NCT03135834|66573502|FG001|Stage 1|Protocol Violation|1|||
23779420|NCT03135834|66573503|FG002|Stage 1|Protocol Violation|2|||
23779421|NCT03135834|66573504|FG003|Stage 1|Protocol Violation|1|||
23779422|NCT03135834|66573501|FG000|Stage 1|Withdrawal by parent/guardian|2|||
23779423|NCT03135834|66573502|FG001|Stage 1|Withdrawal by parent/guardian|10|||
23779424|NCT03135834|66573503|FG002|Stage 1|Withdrawal by parent/guardian|2|||
23779425|NCT03135834|66573504|FG003|Stage 1|Withdrawal by parent/guardian|1|||
23779426|NCT03135834|66573501|FG000|Stage 1|Withdrawal by Subject|16|||
23779427|NCT03135834|66573502|FG001|Stage 1|Withdrawal by Subject|22|||
23779428|NCT03135834|66573503|FG002|Stage 1|Withdrawal by Subject|7|||
23779429|NCT03135834|66573504|FG003|Stage 1|Withdrawal by Subject|10|||
23779430|NCT03135834|66573501|FG000|Stage 1|Randomized but not Vaccinated|0|||
23779431|NCT03135834|66573502|FG001|Stage 1|Randomized but not Vaccinated|3|||
23779432|NCT03135834|66573503|FG002|Stage 1|Randomized but not Vaccinated|1|||
23779433|NCT03135834|66573504|FG003|Stage 1|Randomized but not Vaccinated|6|||
23779434|NCT03135834|66573501|FG000|Stage 2|Lost to Follow-up|0|||
23779435|NCT03135834|66573502|FG001|Stage 2|Lost to Follow-up|1|||
23779436|NCT03135834|66573503|FG002|Stage 2|Lost to Follow-up|0|||
23779437|NCT03135834|66573504|FG003|Stage 2|Lost to Follow-up|0|||
23779438|NCT03135834|66573501|FG000|Stage 2|Withdrawal by Subject|0|||
23839591|NCT00813813|66791902|FG000|Overall Study|Other|0|||
23839592|NCT00813813|66791903|FG001|Overall Study|Other|1|||
23839593|NCT02122887|66791904|FG000|Overall Study|Withdrawal by Subject|20|||
23839594|NCT02122887|66791905|FG001|Overall Study|Withdrawal by Subject|2|||
23839595|NCT00464490|66791906|FG000|Overall Study|Physician Decision|11|||
23839596|NCT00464490|66791907|FG001|Overall Study|Physician Decision|11|||
23839597|NCT00003830|66791908|FG000|Overall Study|No follow up data|3|||
23839598|NCT00003830|66791909|FG001|Overall Study|No follow up data|0|||
23839599|NCT00003830|66791908|FG000|Overall Study|Sentinel node positive patients|829|||
23839600|NCT00003830|66791909|FG001|Overall Study|Sentinel node positive patients|793|||
23839601|NCT03811093|66791910|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
23779439|NCT03135834|66573502|FG001|Stage 2|Withdrawal by Subject|1|||
23451512|NCT00430716|65395197|FG001|Double Blind Phase|Study terminated by sponsor|1|||
23451513|NCT00430716|65395198|FG002|Double Blind Phase|Study terminated by sponsor|2|||
23779440|NCT03135834|66573503|FG002|Stage 2|Withdrawal by Subject|0|||
23779441|NCT03135834|66573504|FG003|Stage 2|Withdrawal by Subject|0|||
23839602|NCT03811093|66791911|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
23451514|NCT00430716|65395196|FG000|Double Blind Phase|Adverse Event|1|||
23779442|NCT03135834|66573501|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
23779443|NCT03135834|66573502|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
23779444|NCT03135834|66573503|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
23779445|NCT03135834|66573504|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
23779446|NCT03135834|66573501|FG000|Stage 2|Did not receive Booster Vaccination|1|||
23339641|NCT01023256|64986278|FG003|Overall Study|Other|2|||
23339642|NCT01023256|64986275|FG000|Overall Study|Adverse Event|0|||
23339643|NCT01023256|64986276|FG001|Overall Study|Adverse Event|0|||
23339644|NCT01023256|64986277|FG002|Overall Study|Adverse Event|0|||
23339645|NCT01023256|64986278|FG003|Overall Study|Adverse Event|1|||
23339646|NCT01023256|64986275|FG000|Overall Study|Withdrawal by Subject|0|||
23339647|NCT01023256|64986276|FG001|Overall Study|Withdrawal by Subject|0|||
23339648|NCT01023256|64986277|FG002|Overall Study|Withdrawal by Subject|0|||
23451515|NCT00430716|65395197|FG001|Double Blind Phase|Adverse Event|1|||
23451516|NCT00430716|65395198|FG002|Double Blind Phase|Adverse Event|3|||
23451517|NCT00430716|65395196|FG000|Double Blind Phase|Not treated|1|||
23779447|NCT03135834|66573502|FG001|Stage 2|Did not receive Booster Vaccination|1|||
23779448|NCT03135834|66573503|FG002|Stage 2|Did not receive Booster Vaccination|0|||
23451518|NCT00430716|65395197|FG001|Double Blind Phase|Not treated|0|||
23451519|NCT00430716|65395198|FG002|Double Blind Phase|Not treated|0|||
23779449|NCT03135834|66573504|FG003|Stage 2|Did not receive Booster Vaccination|0|||
23779450|NCT01675765|66573505|FG000|Overall Study|Progressive disease|4|||
23779451|NCT01675765|66573506|FG001|Overall Study|Progressive disease|4|||
23779452|NCT01675765|66573505|FG000|Overall Study|Adverse Event|1|||
23779453|NCT01675765|66573506|FG001|Overall Study|Adverse Event|2|||
23339649|NCT01023256|64986278|FG003|Overall Study|Withdrawal by Subject|2|||
23339650|NCT04531462|64986281|FG000|Overall Study|Withdrawal by Subject|3|||
23339651|NCT04531462|64986282|FG001|Overall Study|Withdrawal by Subject|1|||
23339652|NCT04531462|64986281|FG000|Overall Study|Adverse Event|3|||
23339653|NCT04531462|64986282|FG001|Overall Study|Adverse Event|3|||
23339654|NCT00471718|64989227|FG000|Overall Study|Adverse Event|3|||
23339655|NCT00471718|64989227|FG000|Overall Study|other complicating disease|1|||
23339656|NCT00471718|64989227|FG000|Overall Study|disease progression|22|||
23339657|NCT00471718|64989227|FG000|Overall Study|Withdrawal by Subject|1|||
23339658|NCT01489254|64989228|FG000|Double-blind Part|Adverse Event|7|||
23339659|NCT01489254|64989229|FG001|Double-blind Part|Adverse Event|2|||
23339660|NCT01489254|64989230|FG002|Double-blind Part|Adverse Event|2|||
23451520|NCT00430716|65395196|FG000|Open Label Phase|Lost to Follow-up|1|||
23635040|NCT02797522|66049388|FG010|Overall Study|Study Terminated by Sponsor|1|||
23779454|NCT01675765|66573505|FG000|Overall Study|Withdrawal by Subject|2|||
23779455|NCT01675765|66573506|FG001|Overall Study|Withdrawal by Subject|0|||
23779456|NCT01675765|66573505|FG000|Overall Study|Death|1|||
23779457|NCT01675765|66573506|FG001|Overall Study|Death|0|||
23779458|NCT01675765|66573505|FG000|Overall Study|Clinical progression|3|||
23779459|NCT01675765|66573506|FG001|Overall Study|Clinical progression|2|||
23779460|NCT03002077|66573507|FG000|Overall Study|Non-compliance with Study Drug|4|||
23779461|NCT03002077|66573507|FG000|Overall Study|Non-compliance w/Background ADT|1|||
23779462|NCT03002077|66573507|FG000|Overall Study|Study Terminated by Sponsor|257|||
23779463|NCT03002077|66573507|FG000|Overall Study|Site Terminated by Sponsor|5|||
23779464|NCT03002077|66573507|FG000|Overall Study|Miscellaneous Reasons|10|||
23779465|NCT03002077|66573507|FG000|Overall Study|Adverse Event|23|||
23779466|NCT03002077|66573507|FG000|Overall Study|Lack of Efficacy|20|||
23779467|NCT03002077|66573507|FG000|Overall Study|Withdrawal by Subject|72|||
23779468|NCT03002077|66573507|FG000|Overall Study|Lost to Follow-up|21|||
23779469|NCT03002077|66573507|FG000|Overall Study|Pregnancy|4|||
23779470|NCT03002077|66573507|FG000|Overall Study|Protocol Violation|21|||
23779471|NCT02294786|66573512|FG000|Overall Study|Withdrawal by Subject|0|||
23779472|NCT02294786|66573513|FG001|Overall Study|Withdrawal by Subject|1|||
23779473|NCT02294786|66573512|FG000|Overall Study|Physician Decision|6|||
23779474|NCT02294786|66573513|FG001|Overall Study|Physician Decision|7|||
23779475|NCT02294786|66573512|FG000|Overall Study|Lost to Follow-up|1|||
23779476|NCT02294786|66573513|FG001|Overall Study|Lost to Follow-up|2|||
23779477|NCT02294786|66573512|FG000|Overall Study|Protocol Violation|1|||
23779478|NCT02294786|66573513|FG001|Overall Study|Protocol Violation|0|||
23839603|NCT03811093|66791910|FG000|Overall Study|Unable to measure body fat percentage|2|||
23839604|NCT03811093|66791911|FG001|Overall Study|Unable to measure body fat percentage|0|||
23839605|NCT04606394|66791912|FG000|Overall Study|Withdrawal by Subject|3|||
23839606|NCT04606394|66791912|FG000|Overall Study|Exclusion criteria screen failure|12|||
23839607|NCT00022698|66791922|FG000|Overall Study|Adverse Event|5|||
23839608|NCT00022698|66791923|FG001|Overall Study|Adverse Event|9|||
23839609|NCT00022698|66791922|FG000|Overall Study|Death|0|||
23839610|NCT00022698|66791923|FG001|Overall Study|Death|2|||
23839611|NCT00022698|66791922|FG000|Overall Study|Failure to return|0|||
23839612|NCT00022698|66791923|FG001|Overall Study|Failure to return|1|||
23779479|NCT02294786|66573512|FG000|Overall Study|Adverse Event|1|||
23839613|NCT00022698|66791922|FG000|Overall Study|Refused treatment|0|||
23779480|NCT02294786|66573513|FG001|Overall Study|Adverse Event|1|||
23779481|NCT02294786|66573512|FG000|Overall Study|Death|2|||
23339661|NCT01489254|64989231|FG003|Double-blind Part|Adverse Event|0|||
23339662|NCT01489254|64989228|FG000|Double-blind Part|Pregnancy|1|||
23339663|NCT01489254|64989229|FG001|Double-blind Part|Pregnancy|3|||
23339664|NCT01489254|64989230|FG002|Double-blind Part|Pregnancy|0|||
23339665|NCT01489254|64989231|FG003|Double-blind Part|Pregnancy|0|||
23839614|NCT00022698|66791923|FG001|Overall Study|Refused treatment|2|||
23339666|NCT01489254|64989228|FG000|Double-blind Part|Withdrawal by Subject|12|||
23339667|NCT01489254|64989229|FG001|Double-blind Part|Withdrawal by Subject|20|||
23339668|NCT01489254|64989230|FG002|Double-blind Part|Withdrawal by Subject|1|||
23339669|NCT01489254|64989231|FG003|Double-blind Part|Withdrawal by Subject|0|||
23339670|NCT01489254|64989228|FG000|Double-blind Part|Lost to Follow-up|1|||
23339671|NCT01489254|64989229|FG001|Double-blind Part|Lost to Follow-up|2|||
23339672|NCT01489254|64989230|FG002|Double-blind Part|Lost to Follow-up|0|||
23339673|NCT01489254|64989231|FG003|Double-blind Part|Lost to Follow-up|0|||
23339674|NCT01489254|64989228|FG000|Double-blind Part|Other reasons for not completing study|4|||
23339675|NCT01489254|64989229|FG001|Double-blind Part|Other reasons for not completing study|6|||
23339676|NCT01489254|64989230|FG002|Double-blind Part|Other reasons for not completing study|0|||
23339677|NCT01489254|64989231|FG003|Double-blind Part|Other reasons for not completing study|0|||
23339678|NCT01489254|64989228|FG000|Open-label Extension Part|Adverse Event|0|||
23339679|NCT01489254|64989229|FG001|Open-label Extension Part|Adverse Event|0|||
23339680|NCT01489254|64989230|FG002|Open-label Extension Part|Adverse Event|0|||
23339681|NCT01489254|64989231|FG003|Open-label Extension Part|Adverse Event|10|||
23339682|NCT01489254|64989228|FG000|Open-label Extension Part|Pregnancy|0|||
23339683|NCT01489254|64989229|FG001|Open-label Extension Part|Pregnancy|0|||
23339684|NCT01489254|64989230|FG002|Open-label Extension Part|Pregnancy|0|||
23339685|NCT01489254|64989231|FG003|Open-label Extension Part|Pregnancy|3|||
23779482|NCT02294786|66573513|FG001|Overall Study|Death|3|||
23779483|NCT01244620|66573514|FG000|Overall Study|Study terminated|4|||
23779484|NCT01244620|66573515|FG001|Overall Study|Study terminated|4|||
23779485|NCT01244620|66573516|FG002|Overall Study|Study terminated|4|||
23779486|NCT01244620|66573517|FG003|Overall Study|Study terminated|4|||
23779487|NCT01472341|66573522|FG000|Overall Study|Started insulin therapy|55|||
23779488|NCT01472341|66573522|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
23779489|NCT01472341|66573522|FG000|Overall Study|Withdrawal by Subject|39|||
23779490|NCT01472341|66573522|FG000|Overall Study|Lost to Follow-up|52|||
23779491|NCT01472341|66573522|FG000|Overall Study|Laboratory parameters unavailable|25|||
23779492|NCT01472341|66573522|FG000|Overall Study|Death|9|||
23779493|NCT04510285|66573523|FG000|Overall Study|Death|1|||
23779494|NCT00834795|66573531|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
23779495|NCT00834795|66573532|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23779496|NCT00834795|66573531|FG000|Second Intervention|Adverse Event|1|||
23779497|NCT00834795|66573532|FG001|Second Intervention|Adverse Event|0|||
23779498|NCT03203447|66573533|FG000|Overall Study|Withdrawal by Subject|2|||
23779499|NCT03203447|66573534|FG001|Overall Study|Withdrawal by Subject|1|||
23779500|NCT03203447|66573533|FG000|Overall Study|Lost to Follow-up|1|||
23779501|NCT03203447|66573534|FG001|Overall Study|Lost to Follow-up|10|||
23779502|NCT03203447|66573533|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
23779503|NCT03203447|66573534|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
23779504|NCT02336165|66573535|FG000|Overall Study|Death|3|||
23779505|NCT02336165|66573536|FG001|Overall Study|Death|0|||
23779506|NCT02336165|66573537|FG002|Overall Study|Death|0|||
23779507|NCT02336165|66573538|FG003|Overall Study|Death|0|||
23779508|NCT02336165|66573539|FG004|Overall Study|Death|1|||
23779509|NCT02336165|66573535|FG000|Overall Study|Physician Decision|2|||
23779510|NCT02336165|66573536|FG001|Overall Study|Physician Decision|2|||
23779511|NCT02336165|66573537|FG002|Overall Study|Physician Decision|1|||
23779512|NCT02336165|66573538|FG003|Overall Study|Physician Decision|1|||
23779513|NCT02336165|66573539|FG004|Overall Study|Physician Decision|0|||
23779514|NCT02336165|66573535|FG000|Overall Study|Withdrawal by Subject|0|||
23779515|NCT02336165|66573536|FG001|Overall Study|Withdrawal by Subject|0|||
23779516|NCT02336165|66573537|FG002|Overall Study|Withdrawal by Subject|1|||
23779517|NCT02336165|66573538|FG003|Overall Study|Withdrawal by Subject|0|||
23779518|NCT02336165|66573539|FG004|Overall Study|Withdrawal by Subject|1|||
23779519|NCT02336165|66573535|FG000|Overall Study|Adverse Event|4|||
23779520|NCT02336165|66573536|FG001|Overall Study|Adverse Event|1|||
23779521|NCT02336165|66573537|FG002|Overall Study|Adverse Event|2|||
23779522|NCT02336165|66573538|FG003|Overall Study|Adverse Event|4|||
23779523|NCT02336165|66573539|FG004|Overall Study|Adverse Event|1|||
23779524|NCT02336165|66573535|FG000|Overall Study|Progressive disease|23|||
23779525|NCT02336165|66573536|FG001|Overall Study|Progressive disease|22|||
23339686|NCT01489254|64989228|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
23339687|NCT01489254|64989229|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
23635041|NCT00635661|66049389|FG000|Overall Study|Withdrawal by Subject|4|||
23635042|NCT01245140|66049390|FG000|Overall Study|Adverse Event|1|||
23635043|NCT01245140|66049391|FG001|Overall Study|Adverse Event|3|||
23779526|NCT02336165|66573537|FG002|Overall Study|Progressive disease|27|||
23779527|NCT02336165|66573538|FG003|Overall Study|Progressive disease|24|||
23779528|NCT02336165|66573539|FG004|Overall Study|Progressive disease|19|||
23779529|NCT02336165|66573535|FG000|Overall Study|Non-compliance|1|||
23779530|NCT02336165|66573536|FG001|Overall Study|Non-compliance|0|||
23779531|NCT02336165|66573537|FG002|Overall Study|Non-compliance|0|||
23339688|NCT01489254|64989230|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
23779532|NCT02336165|66573538|FG003|Overall Study|Non-compliance|1|||
23339689|NCT01489254|64989231|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
23839615|NCT00022698|66791922|FG000|Overall Study|Insufficient therapeutic response|2|||
23839616|NCT00022698|66791923|FG001|Overall Study|Insufficient therapeutic response|14|||
23839617|NCT00022698|66791922|FG000|Overall Study|Administrative /other|1|||
23839618|NCT00022698|66791923|FG001|Overall Study|Administrative /other|7|||
23839619|NCT02654977|66791924|FG000|Overall Study|Death|1|||
23839620|NCT02654977|66791924|FG000|Overall Study|Lost to Follow-up|1|||
23839621|NCT02654977|66791924|FG000|Overall Study|Adverse Event|1|||
23839622|NCT02654977|66791924|FG000|Overall Study|Withdrawal by Subject|1|||
23839623|NCT02654977|66791924|FG000|Overall Study|Lack of Efficacy|3|||
23839624|NCT00356135|66791925|FG000|Overall Study|Protocol Violation|1|||
23839625|NCT00356135|66791926|FG001|Overall Study|Protocol Violation|0|||
23839626|NCT00356135|66791927|FG002|Overall Study|Protocol Violation|0|||
23839627|NCT00356135|66791925|FG000|Overall Study|Adverse Event|1|||
23839628|NCT00356135|66791926|FG001|Overall Study|Adverse Event|0|||
23839629|NCT00356135|66791927|FG002|Overall Study|Adverse Event|0|||
23839630|NCT00356135|66791925|FG000|Overall Study|Lost to Follow-up|0|||
23839631|NCT00356135|66791926|FG001|Overall Study|Lost to Follow-up|0|||
23839632|NCT00356135|66791927|FG002|Overall Study|Lost to Follow-up|1|||
23839633|NCT00356135|66791925|FG000|Overall Study|Physician Decision|1|||
23839634|NCT00356135|66791926|FG001|Overall Study|Physician Decision|1|||
23839635|NCT00356135|66791927|FG002|Overall Study|Physician Decision|1|||
23339690|NCT01489254|64989228|FG000|Open-label Extension Part|Protocol Violation|0|||
23339691|NCT01489254|64989229|FG001|Open-label Extension Part|Protocol Violation|0|||
23339692|NCT01489254|64989230|FG002|Open-label Extension Part|Protocol Violation|0|||
23635044|NCT01245140|66049390|FG000|Overall Study|Lack of Efficacy|2|||
23779533|NCT02336165|66573539|FG004|Overall Study|Non-compliance|0|||
23779534|NCT02336165|66573535|FG000|Overall Study|Other|1|||
23779535|NCT02336165|66573536|FG001|Overall Study|Other|0|||
23779536|NCT02336165|66573537|FG002|Overall Study|Other|0|||
23779537|NCT02336165|66573538|FG003|Overall Study|Other|1|||
23779538|NCT02336165|66573539|FG004|Overall Study|Other|0|||
23779539|NCT02131129|66573545|FG000|Overall Study|Withdrawal by Subject|1|||
23779540|NCT02131129|66573546|FG001|Overall Study|Withdrawal by Subject|0|||
23779541|NCT01987765|66573547|FG000|Overall Study|Protocol Violation|65|||
23779542|NCT01987765|66573547|FG000|Overall Study|Lost to Follow-up|37|||
23779543|NCT03021018|66573548|FG000|Overall Study|Adverse Event|1|||
23779544|NCT03021018|66573549|FG001|Overall Study|Adverse Event|0|||
23779545|NCT03021018|66573550|FG002|Overall Study|Adverse Event|0|||
23779546|NCT03021018|66573548|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
23779547|NCT03021018|66573549|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
23779548|NCT03021018|66573550|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
23779549|NCT01279486|66573551|FG000|Overall Study|Lost to Follow-up|1|||
23779550|NCT01844375|66573552|FG000|Overall Study|Protocol Violation|1|||
23779551|NCT01844375|66573553|FG001|Overall Study|Protocol Violation|1|||
23779552|NCT00573066|66573554|FG000|Overall Study|Exclusion criteria|18|||
23779553|NCT00573066|66573554|FG000|Overall Study|IV malfunction|1|||
23779554|NCT00573066|66573554|FG000|Overall Study|Postoperative bleeding|1|||
23779555|NCT02909907|66573555|FG000|Overall Study|Withdrawal by Subject|0|||
23779556|NCT02909907|66573556|FG001|Overall Study|Withdrawal by Subject|1|||
23779557|NCT00396279|66573557|FG000|Overall Study|Ongoing in study|26|||
23779558|NCT00396279|66573557|FG000|Overall Study|Disease progression|2|||
23779559|NCT00396279|66573557|FG000|Overall Study|Withdrawal by Subject|1|||
23779560|NCT00396279|66573557|FG000|Overall Study|Physician Decision|1|||
23779561|NCT00239577|66573558|FG000|Primary Phase|Adverse Event|0|||
23779562|NCT00239577|66573559|FG001|Primary Phase|Adverse Event|0|||
23779563|NCT00239577|66573560|FG002|Primary Phase|Adverse Event|1|||
23779564|NCT00239577|66573561|FG003|Primary Phase|Adverse Event|0|||
23779565|NCT00239577|66573558|FG000|Primary Phase|Other|5|||
23779566|NCT00239577|66573559|FG001|Primary Phase|Other|3|||
23779567|NCT00239577|66573560|FG002|Primary Phase|Other|2|||
23779568|NCT00239577|66573561|FG003|Primary Phase|Other|0|||
23779569|NCT01534520|66573562|FG000|Overall Study|Adverse Event|0|||
23779570|NCT01534520|66573563|FG001|Overall Study|Adverse Event|1|||
23779571|NCT02139826|66573564|FG000|Overall Study|Adverse Event|1|||
23779572|NCT00312663|66573565|FG000|Immunization Phase|Adverse Event|0|||
23779573|NCT00312663|66573566|FG001|Immunization Phase|Adverse Event|1|||
23779574|NCT00312663|66573567|FG002|Immunization Phase|Adverse Event|0|||
23779575|NCT00319735|66573581|FG000|Overall Study|Death|2|||
23779576|NCT02193165|66573582|FG000|4 Week Product Use|Lost to Follow-up|1|||
23779577|NCT02193165|66573583|FG001|4 Week Product Use|Lost to Follow-up|1|||
23779578|NCT02193165|66573584|FG002|4 Week Product Use|Lost to Follow-up|1|||
23779579|NCT02193165|66573582|FG000|6 Week Product Use|Lost to Follow-up|0|||
23779580|NCT02193165|66573583|FG001|6 Week Product Use|Lost to Follow-up|1|||
23779581|NCT02193165|66573584|FG002|6 Week Product Use|Lost to Follow-up|0|||
23779582|NCT00003659|66573585|FG000|Overall Study|Withdrawal by Subject|3|||
23839636|NCT00356135|66791925|FG000|Overall Study|Subject non-compliance|1|||
23839637|NCT00356135|66791926|FG001|Overall Study|Subject non-compliance|1|||
23839638|NCT00356135|66791927|FG002|Overall Study|Subject non-compliance|3|||
23839639|NCT02861586|66791930|FG000|Overall Study|Withdrawal by Subject|1|||
23839640|NCT02861586|66791931|FG001|Overall Study|Withdrawal by Subject|2|||
23839641|NCT02861586|66791932|FG002|Overall Study|Withdrawal by Subject|0|||
23839642|NCT02861586|66791933|FG003|Overall Study|Withdrawal by Subject|0|||
23839643|NCT02861586|66791934|FG004|Overall Study|Withdrawal by Subject|0|||
23839644|NCT02861586|66791935|FG005|Overall Study|Withdrawal by Subject|1|||
23839645|NCT02861586|66791936|FG006|Overall Study|Withdrawal by Subject|1|||
23839646|NCT02861586|66791937|FG007|Overall Study|Withdrawal by Subject|0|||
23839647|NCT02861586|66791930|FG000|Overall Study|Lost to Follow-up|3|||
23839648|NCT02861586|66791931|FG001|Overall Study|Lost to Follow-up|1|||
23839649|NCT02861586|66791932|FG002|Overall Study|Lost to Follow-up|1|||
23839650|NCT02861586|66791933|FG003|Overall Study|Lost to Follow-up|0|||
23839651|NCT02861586|66791934|FG004|Overall Study|Lost to Follow-up|0|||
23839652|NCT02861586|66791935|FG005|Overall Study|Lost to Follow-up|3|||
23839653|NCT02861586|66791936|FG006|Overall Study|Lost to Follow-up|0|||
23839654|NCT02861586|66791937|FG007|Overall Study|Lost to Follow-up|0|||
23839655|NCT02861586|66791930|FG000|Overall Study|Adverse Event|0|||
23839656|NCT02861586|66791931|FG001|Overall Study|Adverse Event|0|||
23839657|NCT02861586|66791932|FG002|Overall Study|Adverse Event|0|||
23839658|NCT02861586|66791933|FG003|Overall Study|Adverse Event|0|||
23839659|NCT02861586|66791934|FG004|Overall Study|Adverse Event|0|||
23839660|NCT02861586|66791935|FG005|Overall Study|Adverse Event|1|||
23839661|NCT02861586|66791936|FG006|Overall Study|Adverse Event|0|||
23839662|NCT02861586|66791937|FG007|Overall Study|Adverse Event|0|||
23839663|NCT02073929|66791943|FG000|Overall Study|Lost to Follow-up|2|||
23839664|NCT02073929|66791944|FG001|Overall Study|Lost to Follow-up|1|||
23839665|NCT02073929|66791943|FG000|Overall Study|Adverse Event|2|||
23839666|NCT02073929|66791944|FG001|Overall Study|Adverse Event|1|||
23839667|NCT02073929|66791943|FG000|Overall Study|Withdrawal by Subject|0|||
23839668|NCT02073929|66791944|FG001|Overall Study|Withdrawal by Subject|1|||
23839669|NCT00237458|66791945|FG000|Overall Study|Lack of Efficacy|1|||
23839670|NCT00237458|66791945|FG000|Overall Study|Adverse Event|1|||
23839671|NCT00237458|66791945|FG000|Overall Study|Withdrawal by Subject|1|||
23839672|NCT02058537|66791946|FG000|Overall Study|Withdrawal by Subject|1|||
23839673|NCT02589626|66791947|FG000|Overall Study|Other than the reason specified|1|||
23839674|NCT02589626|66791948|FG001|Overall Study|Other than the reason specified|0|||
23839675|NCT02589626|66791947|FG000|Overall Study|Withdrawal by Subject|1|||
23839676|NCT02589626|66791948|FG001|Overall Study|Withdrawal by Subject|1|||
23839677|NCT02589626|66791947|FG000|Overall Study|Adverse Event|1|||
23839678|NCT02589626|66791948|FG001|Overall Study|Adverse Event|1|||
23839679|NCT02201108|66791949|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
23839680|NCT02201108|66791950|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
23839681|NCT02201108|66791949|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
23839682|NCT02201108|66791950|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
23839683|NCT02201108|66791949|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
23839684|NCT02201108|66791950|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
23839685|NCT02201108|66791949|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
23839686|NCT02201108|66791950|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
23839687|NCT02201108|66791949|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
23839688|NCT02201108|66791950|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
23839689|NCT02201108|66791949|FG000|Open Label Period (up to Week 192)|Other reason|4|||
23839690|NCT02201108|66791950|FG001|Open Label Period (up to Week 192)|Other reason|7|||
23839691|NCT02201108|66791949|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
23839692|NCT02201108|66791950|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
23839693|NCT00471822|66791956|FG000|Overall Study|Protocol Violation|2|||
23839694|NCT00713258|66795267|FG000|Overall Study|Adverse Event|2|||
23839695|NCT00713258|66795268|FG001|Overall Study|Adverse Event|4|||
23839696|NCT00713258|66795267|FG000|Overall Study|Non-Compliance|2|||
23839697|NCT00713258|66795268|FG001|Overall Study|Non-Compliance|1|||
23839698|NCT00713258|66795267|FG000|Overall Study|Other|1|||
23839699|NCT00713258|66795268|FG001|Overall Study|Other|1|||
23839700|NCT00457002|66795272|FG000|Overall Study|Death|40|||
23839701|NCT00457002|66795273|FG001|Overall Study|Death|47|||
23839702|NCT00457002|66795272|FG000|Overall Study|Adverse Event|284|||
23839703|NCT00457002|66795273|FG001|Overall Study|Adverse Event|260|||
23839704|NCT00457002|66795272|FG000|Overall Study|Withdrawal by Subject|299|||
23839705|NCT00457002|66795273|FG001|Overall Study|Withdrawal by Subject|271|||
23839706|NCT00457002|66795272|FG000|Overall Study|Lost to Follow-up|72|||
23839707|NCT00457002|66795273|FG001|Overall Study|Lost to Follow-up|71|||
23839708|NCT00457002|66795272|FG000|Overall Study|Poor/Non-compliance|46|||
23839709|NCT00457002|66795273|FG001|Overall Study|Poor/Non-compliance|33|||
23839710|NCT00457002|66795272|FG000|Overall Study|No longer met criteria|41|||
23839711|NCT00457002|66795273|FG001|Overall Study|No longer met criteria|37|||
23839712|NCT00457002|66795272|FG000|Overall Study|Administrative reason by Sponsor|1|||
23839713|NCT00457002|66795273|FG001|Overall Study|Administrative reason by Sponsor|0|||
23839714|NCT00457002|66795272|FG000|Overall Study|non-specified|29|||
23839715|NCT00457002|66795273|FG001|Overall Study|non-specified|38|||
23839716|NCT00457002|66795272|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
23839717|NCT00457002|66795273|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
23839718|NCT01221272|66795274|FG000|Period 1|Adverse Event|2|||
23839719|NCT01221272|66795275|FG001|Period 1|Adverse Event|0|||
23839720|NCT01221272|66795274|FG000|Period 1|Consent Withdrawal|0|||
23839721|NCT01221272|66795275|FG001|Period 1|Consent Withdrawal|1|||
23839722|NCT01221272|66795274|FG000|Period 1|Significant Dosing Noncompliance|0|||
23839723|NCT01221272|66795275|FG001|Period 1|Significant Dosing Noncompliance|1|||
23839724|NCT01221272|66795274|FG000|Period 2|Adverse Event|0|||
23839725|NCT01221272|66795275|FG001|Period 2|Adverse Event|2|||
23839726|NCT01857583|66795276|FG000|Overall Study|Adverse Event|0|||
23839727|NCT01857583|66795277|FG001|Overall Study|Adverse Event|0|||
23839728|NCT01857583|66795278|FG002|Overall Study|Adverse Event|1|||
23839729|NCT01857583|66795279|FG003|Overall Study|Adverse Event|1|||
23839730|NCT01857583|66795276|FG000|Overall Study|Death|0|||
23839731|NCT01857583|66795277|FG001|Overall Study|Death|1|||
23839732|NCT01857583|66795278|FG002|Overall Study|Death|1|||
23839733|NCT01857583|66795279|FG003|Overall Study|Death|0|||
23839734|NCT01857583|66795276|FG000|Overall Study|Physician Decision|0|||
23839735|NCT01857583|66795277|FG001|Overall Study|Physician Decision|0|||
23839736|NCT01857583|66795278|FG002|Overall Study|Physician Decision|0|||
23839737|NCT01857583|66795279|FG003|Overall Study|Physician Decision|1|||
23839738|NCT01857583|66795276|FG000|Overall Study|Withdrawal by Subject|1|||
23839739|NCT01857583|66795277|FG001|Overall Study|Withdrawal by Subject|0|||
23839740|NCT01857583|66795278|FG002|Overall Study|Withdrawal by Subject|1|||
23839741|NCT01857583|66795279|FG003|Overall Study|Withdrawal by Subject|2|||
23839742|NCT00644917|66795280|FG000|Overall Study|Withdrawal by Subject|2|||
23839743|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
23839744|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
23839745|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
23839746|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
23839747|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
23839748|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
23839749|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
23839750|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
23839751|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
23839752|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
23839753|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
23839754|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
23839755|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
23839756|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
23839757|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
23839758|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
23839759|NCT00491556|66795283|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
23839760|NCT00491556|66795284|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
23839761|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
23839762|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
23839763|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
23839764|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
23839765|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
23839766|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
23839767|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
23839768|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
23839769|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
23839770|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
23839771|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
23839772|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
23839773|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
23839774|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
23839775|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
23839776|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
23839777|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
23839778|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
23839779|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
23839780|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
23839781|NCT00491556|66795283|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
23839782|NCT00491556|66795284|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
23839783|NCT02282631|66795285|FG000|Overall Study|Lost to Follow-up|2|||
23839784|NCT02282631|66795286|FG001|Overall Study|Lost to Follow-up|0|||
23839785|NCT02282813|66795287|FG000|Overall Study|Withdrawal by Subject|4|||
23839786|NCT02282813|66795288|FG001|Overall Study|Withdrawal by Subject|5|||
23839787|NCT02282813|66795289|FG002|Overall Study|Withdrawal by Subject|0|||
23839788|NCT02282813|66795287|FG000|Overall Study|Adverse Event|3|||
23839789|NCT02282813|66795288|FG001|Overall Study|Adverse Event|10|||
23839790|NCT02282813|66795289|FG002|Overall Study|Adverse Event|1|||
23839791|NCT02282813|66795287|FG000|Overall Study|Subject non-compliance|1|||
23839792|NCT02282813|66795288|FG001|Overall Study|Subject non-compliance|4|||
23839793|NCT02282813|66795289|FG002|Overall Study|Subject non-compliance|0|||
23839794|NCT02282813|66795287|FG000|Overall Study|Physician Decision|0|||
23839795|NCT02282813|66795288|FG001|Overall Study|Physician Decision|3|||
23839796|NCT02282813|66795289|FG002|Overall Study|Physician Decision|1|||
23839797|NCT02282813|66795287|FG000|Overall Study|Lost to Follow-up|2|||
23839798|NCT02282813|66795288|FG001|Overall Study|Lost to Follow-up|0|||
23839799|NCT02282813|66795289|FG002|Overall Study|Lost to Follow-up|1|||
23839800|NCT02282813|66795287|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
23839801|NCT02282813|66795288|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
23839802|NCT02282813|66795289|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
23839803|NCT02282813|66795287|FG000|Overall Study|Lack of Efficacy|1|||
23839804|NCT02282813|66795288|FG001|Overall Study|Lack of Efficacy|0|||
23839805|NCT02282813|66795289|FG002|Overall Study|Lack of Efficacy|0|||
23839806|NCT02282813|66795287|FG000|Overall Study|Administrative reasons|0|||
23839807|NCT02282813|66795288|FG001|Overall Study|Administrative reasons|1|||
23839808|NCT02282813|66795289|FG002|Overall Study|Administrative reasons|0|||
23839809|NCT01575834|66795290|FG000|Overall Study|Withdrawal by Subject|352|||
23839810|NCT01575834|66795291|FG001|Overall Study|Withdrawal by Subject|390|||
23839811|NCT01575834|66795290|FG000|Overall Study|Death|81|||
23839812|NCT01575834|66795291|FG001|Overall Study|Death|74|||
23839813|NCT01575834|66795290|FG000|Overall Study|Other|70|||
23839814|NCT01575834|66795291|FG001|Overall Study|Other|70|||
23839815|NCT01575834|66795290|FG000|Overall Study|Adverse Event|63|||
23839816|NCT01575834|66795291|FG001|Overall Study|Adverse Event|61|||
23839817|NCT01575834|66795290|FG000|Overall Study|Lost to Follow-up|55|||
23839818|NCT01575834|66795291|FG001|Overall Study|Lost to Follow-up|68|||
23839819|NCT01575834|66795290|FG000|Overall Study|Noncompliance|52|||
23839820|NCT01575834|66795291|FG001|Overall Study|Noncompliance|27|||
23839821|NCT01575834|66795290|FG000|Overall Study|Administrative decision|15|||
23839822|NCT01575834|66795291|FG001|Overall Study|Administrative decision|33|||
23839823|NCT01575834|66795290|FG000|Overall Study|Ineligibility Determined|5|||
23839824|NCT01575834|66795291|FG001|Overall Study|Ineligibility Determined|8|||
23839825|NCT01575834|66795290|FG000|Overall Study|Protocol Deviation|4|||
23839826|NCT01575834|66795291|FG001|Overall Study|Protocol Deviation|3|||
23839827|NCT01575834|66795290|FG000|Overall Study|Requirement for Alternative Therapy|2|||
23839828|NCT01575834|66795291|FG001|Overall Study|Requirement for Alternative Therapy|4|||
23839829|NCT00347009|66795292|FG000|Overall Study|Death|1|||
23839830|NCT00347009|66795292|FG000|Overall Study|Adverse Event|6|||
23839831|NCT00347009|66795292|FG000|Overall Study|Withdrawal by Subject|3|||
23839832|NCT00347009|66795292|FG000|Overall Study|Physician Decision|5|||
23839833|NCT00347009|66795292|FG000|Overall Study|Lost to Follow-up|4|||
23839834|NCT00347009|66795292|FG000|Overall Study|Protocol Violation|2|||
23839835|NCT00347009|66795292|FG000|Overall Study|Adverse Laboratory Experience|1|||
23839836|NCT00347009|66795292|FG000|Overall Study|Insufficient Viral Suppression|3|||
23839837|NCT00347009|66795292|FG000|Overall Study|Increased ALT/HBV DNA|1|||
23839838|NCT00347009|66795292|FG000|Overall Study|Serious Adverse Event|1|||
23839839|NCT00994461|66795293|FG000|Overall Study|Adverse Event|2|||
23839840|NCT00994461|66795294|FG001|Overall Study|Adverse Event|1|||
23839841|NCT00994461|66795295|FG002|Overall Study|Adverse Event|0|||
23839842|NCT02199795|66795297|FG000|Overall Study|no longer met inclusion criteria|1|||
23839843|NCT02199795|66795298|FG001|Overall Study|no longer met inclusion criteria|0|||
23839844|NCT02199795|66795297|FG000|Overall Study|withdrew due to shoulder pain|1|||
23839845|NCT02199795|66795298|FG001|Overall Study|withdrew due to shoulder pain|0|||
23839846|NCT02027545|66795301|FG000|Overall Study|Failed to sign HIPAA|0|||
23839847|NCT02027545|66795302|FG001|Overall Study|Failed to sign HIPAA|2|||
23839848|NCT02027545|66795301|FG000|Overall Study|Failed to attend study visit|2|||
23839849|NCT02027545|66795302|FG001|Overall Study|Failed to attend study visit|0|||
23839850|NCT02027545|66795301|FG000|Overall Study|Protocol Violation|1|||
23839851|NCT02027545|66795302|FG001|Overall Study|Protocol Violation|0|||
23839852|NCT01081769|66795303|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
23839853|NCT01081769|66795304|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
23839854|NCT01081769|66795303|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
23839855|NCT01081769|66795304|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
23839856|NCT01081769|66795303|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
23839857|NCT01081769|66795304|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
23839858|NCT01081769|66795303|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
23839859|NCT01081769|66795304|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
23839860|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Adverse Event|14|||
23839861|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Adverse Event|11|||
23839862|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Death|1|||
23839863|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Death|1|||
23839864|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
23839865|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
23839866|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
23839867|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
23839868|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Pregnancy|1|||
23839869|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Pregnancy|0|||
23839870|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
23839871|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
23839872|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
23839873|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
23839874|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Other|0|||
23839875|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Other|1|||
23839876|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Ineligibility|3|||
23839877|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Ineligibility|4|||
23839878|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
23839879|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
23839880|NCT01081769|66795303|FG000|CORE Intent-To-Treat|Patient Moved|2|||
23839881|NCT01081769|66795304|FG001|CORE Intent-To-Treat|Patient Moved|2|||
23839882|NCT01868438|66795310|FG000|First Intervention|Withdrawal by Subject|5|||
23839883|NCT01868438|66795311|FG001|First Intervention|Withdrawal by Subject|1|||
23839884|NCT01868438|66795310|FG000|First Intervention|Lost to Follow-up|2|||
23839885|NCT01868438|66795311|FG001|First Intervention|Lost to Follow-up|3|||
23839886|NCT01868438|66795310|FG000|First Intervention|Meeting the non-redosing criteria|0|||
23839887|NCT01868438|66795311|FG001|First Intervention|Meeting the non-redosing criteria|1|||
23839888|NCT01868438|66795310|FG000|Second Intervention|Adverse Event|3|||
23839889|NCT01868438|66795311|FG001|Second Intervention|Adverse Event|3|||
23839890|NCT00423332|66795312|FG000|Overall Study|Adverse Event|6|||
23839891|NCT00423332|66795313|FG001|Overall Study|Adverse Event|2|||
23839892|NCT00423332|66795312|FG000|Overall Study|Withdrawal by Subject|1|||
23839893|NCT00423332|66795313|FG001|Overall Study|Withdrawal by Subject|0|||
23839894|NCT00423332|66795312|FG000|Overall Study|Condition under investigation worsened|1|||
23839895|NCT00423332|66795313|FG001|Overall Study|Condition under investigation worsened|1|||
23839896|NCT00423332|66795312|FG000|Overall Study|Progressive at Week 6|0|||
23839897|NCT00423332|66795313|FG001|Overall Study|Progressive at Week 6|1|||
23839898|NCT00423332|66795312|FG000|Overall Study|Unblinded before 12 weeks|1|||
23839899|NCT00423332|66795313|FG001|Overall Study|Unblinded before 12 weeks|3|||
23839900|NCT01580670|66795314|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
23839901|NCT01580670|66795314|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
23839902|NCT04747886|66795318|FG000|Overall Study|Withdrawal by Subject|1|||
23839903|NCT04747886|66795319|FG001|Overall Study|Withdrawal by Subject|4|||
23839904|NCT05020665|66795320|FG000|Overall Study|Study terminated by Sponsor|5|||
23839905|NCT05020665|66795321|FG001|Overall Study|Study terminated by Sponsor|4|||
23839906|NCT05020665|66795320|FG000|Overall Study|Death|2|||
23839907|NCT05020665|66795321|FG001|Overall Study|Death|1|||
23839908|NCT05020665|66795320|FG000|Overall Study|Physician Decision|0|||
23839909|NCT05020665|66795321|FG001|Overall Study|Physician Decision|1|||
23839910|NCT05020665|66795320|FG000|Overall Study|Withdrawal by Subject|0|||
23839911|NCT05020665|66795321|FG001|Overall Study|Withdrawal by Subject|1|||
23839912|NCT05020665|66795320|FG000|Overall Study|Reason not specified|1|||
23839913|NCT05020665|66795321|FG001|Overall Study|Reason not specified|0|||
23839914|NCT01250873|66795330|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
23839915|NCT01250873|66795330|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
23839916|NCT03278613|66795331|FG000|Overall Study|Lost to Follow-up|3|||
23839917|NCT03278613|66795332|FG001|Overall Study|Lost to Follow-up|1|||
23839918|NCT00468481|66795333|FG000|Overall Study|Adverse Event|13|||
23839919|NCT00468481|66795334|FG001|Overall Study|Adverse Event|3|||
23839920|NCT00468481|66795333|FG000|Overall Study|Lost to Follow-up|25|||
23839921|NCT00468481|66795334|FG001|Overall Study|Lost to Follow-up|8|||
23839922|NCT00468481|66795333|FG000|Overall Study|Pregnancy|2|||
23839923|NCT00468481|66795334|FG001|Overall Study|Pregnancy|0|||
23839924|NCT00468481|66795333|FG000|Overall Study|Protocol Violation|18|||
23839925|NCT00468481|66795334|FG001|Overall Study|Protocol Violation|8|||
23839926|NCT00468481|66795333|FG000|Overall Study|Withdrawal by Subject|12|||
23839927|NCT00468481|66795334|FG001|Overall Study|Withdrawal by Subject|3|||
23839928|NCT00468481|66795333|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
23839929|NCT00468481|66795334|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
23839930|NCT00468481|66795333|FG000|Overall Study|Prohibited Medication|1|||
23839931|NCT00468481|66795334|FG001|Overall Study|Prohibited Medication|1|||
23839932|NCT00468481|66795333|FG000|Overall Study|Egg Donor|1|||
23839933|NCT00468481|66795334|FG001|Overall Study|Egg Donor|0|||
23839934|NCT00468481|66795333|FG000|Overall Study|Moved out of area|4|||
23839935|NCT00468481|66795334|FG001|Overall Study|Moved out of area|1|||
23839936|NCT00468481|66795333|FG000|Overall Study|Non-Compliance|5|||
23839937|NCT00468481|66795334|FG001|Overall Study|Non-Compliance|0|||
23839938|NCT00468481|66795333|FG000|Overall Study|Other|6|||
23839939|NCT00468481|66795334|FG001|Overall Study|Other|0|||
23839940|NCT00402688|66795335|FG000|Overall Study|Adverse Event|12|||
23839941|NCT00402688|66795336|FG001|Overall Study|Adverse Event|9|||
23839942|NCT00402688|66795337|FG002|Overall Study|Adverse Event|3|||
23839943|NCT00402688|66795335|FG000|Overall Study|Withdrawal by Subject|3|||
23839944|NCT00402688|66795336|FG001|Overall Study|Withdrawal by Subject|1|||
23839945|NCT00402688|66795337|FG002|Overall Study|Withdrawal by Subject|1|||
23839946|NCT00402688|66795335|FG000|Overall Study|Physician Decision|0|||
23839947|NCT00402688|66795336|FG001|Overall Study|Physician Decision|0|||
23839948|NCT00402688|66795337|FG002|Overall Study|Physician Decision|1|||
23839949|NCT00402688|66795335|FG000|Overall Study|Lack of Efficacy|4|||
23839950|NCT00402688|66795336|FG001|Overall Study|Lack of Efficacy|4|||
23839951|NCT00402688|66795337|FG002|Overall Study|Lack of Efficacy|5|||
23839952|NCT00402688|66795335|FG000|Overall Study|Protocol Violation|1|||
23839953|NCT00402688|66795336|FG001|Overall Study|Protocol Violation|1|||
23839954|NCT00402688|66795337|FG002|Overall Study|Protocol Violation|1|||
23839955|NCT00402688|66795335|FG000|Overall Study|Lost to Follow-up|1|||
23839956|NCT00402688|66795336|FG001|Overall Study|Lost to Follow-up|0|||
23839957|NCT00402688|66795337|FG002|Overall Study|Lost to Follow-up|2|||
23839958|NCT00402688|66795335|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
23839959|NCT00402688|66795336|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
23839960|NCT00402688|66795337|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
23839961|NCT00402688|66795335|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
23839962|NCT00402688|66795336|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
23839963|NCT00402688|66795337|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
23839964|NCT00402688|66795335|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
23839965|NCT00402688|66795336|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
23839966|NCT00402688|66795337|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
23839967|NCT02285166|66795338|FG000|Overall Study|Case Report Forms Uncollected|564|||
23839968|NCT02285166|66795338|FG000|Overall Study|Protocol Deviation|402|||
23839969|NCT03192306|66795339|FG000|Overall Study|Did not treat cold sore during study|149|||
23839970|NCT03192306|66795340|FG001|Overall Study|Did not treat cold sore during study|143|||
23839971|NCT03192306|66795339|FG000|Overall Study|Withdrawal by Subject|1|||
23839972|NCT03192306|66795340|FG001|Overall Study|Withdrawal by Subject|1|||
23839973|NCT03192306|66795339|FG000|Overall Study|Lost to Follow-up|1|||
23839974|NCT03192306|66795340|FG001|Overall Study|Lost to Follow-up|0|||
23839975|NCT03192306|66795339|FG000|Overall Study|Protocol Violation|1|||
23839976|NCT03192306|66795340|FG001|Overall Study|Protocol Violation|1|||
23839977|NCT00685399|66795346|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23839978|NCT00685399|66795347|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23839979|NCT00685399|66795348|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23839980|NCT00685399|66795349|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23839981|NCT00685399|66795350|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23839982|NCT00685399|66795351|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23839983|NCT00685399|66795352|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23839984|NCT00685399|66795353|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23839985|NCT00685399|66795346|FG000|Treatment Period 1|Protocol Violation|1|||
23839986|NCT00685399|66795347|FG001|Treatment Period 1|Protocol Violation|0|||
23839987|NCT00685399|66795348|FG002|Treatment Period 1|Protocol Violation|0|||
23839988|NCT00685399|66795349|FG003|Treatment Period 1|Protocol Violation|0|||
23839989|NCT00685399|66795350|FG004|Treatment Period 1|Protocol Violation|0|||
23839990|NCT00685399|66795351|FG005|Treatment Period 1|Protocol Violation|0|||
23839991|NCT00685399|66795352|FG006|Treatment Period 1|Protocol Violation|0|||
23839992|NCT00685399|66795353|FG007|Treatment Period 1|Protocol Violation|0|||
23635045|NCT01245140|66049391|FG001|Overall Study|Lack of Efficacy|4|||
23839993|NCT00685399|66795346|FG000|Treatment Period 1|Administrative|2|||
23839994|NCT00685399|66795347|FG001|Treatment Period 1|Administrative|0|||
23839995|NCT00685399|66795348|FG002|Treatment Period 1|Administrative|0|||
23839996|NCT00685399|66795349|FG003|Treatment Period 1|Administrative|0|||
23839997|NCT00685399|66795350|FG004|Treatment Period 1|Administrative|0|||
23839998|NCT00685399|66795351|FG005|Treatment Period 1|Administrative|0|||
23839999|NCT00685399|66795352|FG006|Treatment Period 1|Administrative|0|||
23840000|NCT00685399|66795353|FG007|Treatment Period 1|Administrative|0|||
23840001|NCT00685399|66795346|FG000|Treatment Period 1|Lack of Efficacy|1|||
23840002|NCT00685399|66795347|FG001|Treatment Period 1|Lack of Efficacy|0|||
23840003|NCT00685399|66795348|FG002|Treatment Period 1|Lack of Efficacy|0|||
23840004|NCT00685399|66795349|FG003|Treatment Period 1|Lack of Efficacy|0|||
23840005|NCT00685399|66795350|FG004|Treatment Period 1|Lack of Efficacy|0|||
23840006|NCT00685399|66795351|FG005|Treatment Period 1|Lack of Efficacy|0|||
23840007|NCT00685399|66795352|FG006|Treatment Period 1|Lack of Efficacy|0|||
23840008|NCT00685399|66795353|FG007|Treatment Period 1|Lack of Efficacy|0|||
23840009|NCT00685399|66795346|FG000|Treatment Period 2|Administrative Problems|0|||
23840010|NCT00685399|66795347|FG001|Treatment Period 2|Administrative Problems|2|||
23840011|NCT00685399|66795348|FG002|Treatment Period 2|Administrative Problems|1|||
23840012|NCT00685399|66795349|FG003|Treatment Period 2|Administrative Problems|0|||
23840013|NCT00685399|66795350|FG004|Treatment Period 2|Administrative Problems|0|||
23840014|NCT00685399|66795351|FG005|Treatment Period 2|Administrative Problems|0|||
23840015|NCT00685399|66795352|FG006|Treatment Period 2|Administrative Problems|0|||
23840016|NCT00685399|66795353|FG007|Treatment Period 2|Administrative Problems|0|||
23840017|NCT00685399|66795346|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23840018|NCT00685399|66795347|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23840019|NCT00685399|66795348|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23840020|NCT00685399|66795349|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23840021|NCT00685399|66795350|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23840022|NCT00685399|66795351|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23840023|NCT00685399|66795352|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23840024|NCT00685399|66795353|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23840025|NCT00685399|66795346|FG000|Treatment Period 2|Adverse Event|0|||
23840026|NCT00685399|66795347|FG001|Treatment Period 2|Adverse Event|0|||
23840027|NCT00685399|66795348|FG002|Treatment Period 2|Adverse Event|0|||
23840028|NCT00685399|66795349|FG003|Treatment Period 2|Adverse Event|0|||
23840029|NCT00685399|66795350|FG004|Treatment Period 2|Adverse Event|0|||
23840030|NCT00685399|66795351|FG005|Treatment Period 2|Adverse Event|1|||
23840031|NCT00685399|66795352|FG006|Treatment Period 2|Adverse Event|0|||
23840032|NCT00685399|66795353|FG007|Treatment Period 2|Adverse Event|0|||
23840033|NCT00685399|66795346|FG000|Treatment Period 2|Lack of Efficacy|0|||
23840034|NCT00685399|66795347|FG001|Treatment Period 2|Lack of Efficacy|10|||
23840035|NCT00685399|66795348|FG002|Treatment Period 2|Lack of Efficacy|2|||
23840036|NCT00685399|66795349|FG003|Treatment Period 2|Lack of Efficacy|0|||
23840037|NCT00685399|66795350|FG004|Treatment Period 2|Lack of Efficacy|0|||
23840038|NCT00685399|66795351|FG005|Treatment Period 2|Lack of Efficacy|1|||
23840039|NCT00685399|66795352|FG006|Treatment Period 2|Lack of Efficacy|0|||
23840040|NCT00685399|66795353|FG007|Treatment Period 2|Lack of Efficacy|0|||
23840041|NCT00685399|66795346|FG000|Extension|Administrative Issues|0|||
23840042|NCT00685399|66795347|FG001|Extension|Administrative Issues|0|||
23840043|NCT00685399|66795348|FG002|Extension|Administrative Issues|0|||
23840044|NCT00685399|66795349|FG003|Extension|Administrative Issues|1|||
23840045|NCT00685399|66795350|FG004|Extension|Administrative Issues|0|||
23840046|NCT00685399|66795351|FG005|Extension|Administrative Issues|0|||
23840047|NCT00685399|66795352|FG006|Extension|Administrative Issues|0|||
23840048|NCT00685399|66795353|FG007|Extension|Administrative Issues|0|||
23840049|NCT00685399|66795346|FG000|Extension|Withdrawal by Subject|0|||
23840050|NCT00685399|66795347|FG001|Extension|Withdrawal by Subject|0|||
23840051|NCT00685399|66795348|FG002|Extension|Withdrawal by Subject|0|||
23840052|NCT00685399|66795349|FG003|Extension|Withdrawal by Subject|1|||
23840053|NCT00685399|66795350|FG004|Extension|Withdrawal by Subject|0|||
23840054|NCT00685399|66795351|FG005|Extension|Withdrawal by Subject|0|||
23840055|NCT00685399|66795352|FG006|Extension|Withdrawal by Subject|0|||
23840056|NCT00685399|66795353|FG007|Extension|Withdrawal by Subject|0|||
23840057|NCT00685399|66795346|FG000|Extension|Protocol Violation|0|||
23840058|NCT00685399|66795347|FG001|Extension|Protocol Violation|0|||
23840059|NCT00685399|66795348|FG002|Extension|Protocol Violation|0|||
23840060|NCT00685399|66795349|FG003|Extension|Protocol Violation|1|||
23635046|NCT01245140|66049390|FG000|Overall Study|Protocol Violation|0|||
23635047|NCT01245140|66049391|FG001|Overall Study|Protocol Violation|1|||
23635048|NCT01245140|66049390|FG000|Overall Study|Withdrawal by Subject|0|||
23635049|NCT01245140|66049391|FG001|Overall Study|Withdrawal by Subject|1|||
23635050|NCT01245140|66049390|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
23635051|NCT01245140|66049391|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
23635052|NCT00755105|66049392|FG000|Overall Study|Withdrawal by Subject|9|||
23635053|NCT00755105|66049393|FG001|Overall Study|Withdrawal by Subject|11|||
23635054|NCT00755105|66049394|FG002|Overall Study|Withdrawal by Subject|4|||
23635055|NCT01923467|66049395|FG000|Overall Study|Lost to Follow-up|62|||
23635056|NCT01923467|66049395|FG000|Overall Study|Subject non-interest|479|||
23635057|NCT02597712|66049396|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
23635058|NCT02597712|66049397|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
23635059|NCT02597712|66049396|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
23840061|NCT00685399|66795350|FG004|Extension|Protocol Violation|0|||
23840062|NCT00685399|66795351|FG005|Extension|Protocol Violation|0|||
23840063|NCT00685399|66795352|FG006|Extension|Protocol Violation|0|||
23840064|NCT00685399|66795353|FG007|Extension|Protocol Violation|0|||
23840065|NCT00685399|66795346|FG000|Extension|Lack of Efficacy|0|||
23840066|NCT00685399|66795347|FG001|Extension|Lack of Efficacy|0|||
23840067|NCT00685399|66795348|FG002|Extension|Lack of Efficacy|0|||
23840068|NCT00685399|66795349|FG003|Extension|Lack of Efficacy|2|||
23840069|NCT00685399|66795350|FG004|Extension|Lack of Efficacy|0|||
23840070|NCT00685399|66795351|FG005|Extension|Lack of Efficacy|0|||
23840071|NCT00685399|66795352|FG006|Extension|Lack of Efficacy|0|||
23840072|NCT00685399|66795353|FG007|Extension|Lack of Efficacy|0|||
23840073|NCT00685399|66795346|FG000|Extension|Adverse Event|0|||
23840074|NCT00685399|66795347|FG001|Extension|Adverse Event|0|||
23840075|NCT00685399|66795348|FG002|Extension|Adverse Event|0|||
23779583|NCT02563561|66573587|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
23779584|NCT02563561|66573588|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
23779585|NCT02563561|66573589|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
23779586|NCT02563561|66573587|FG000|Overall Study|Withdrew of Consent|1|||
23840076|NCT00685399|66795349|FG003|Extension|Adverse Event|2|||
23840077|NCT00685399|66795350|FG004|Extension|Adverse Event|0|||
23840078|NCT00685399|66795351|FG005|Extension|Adverse Event|0|||
23840079|NCT00685399|66795352|FG006|Extension|Adverse Event|0|||
23840080|NCT00685399|66795353|FG007|Extension|Adverse Event|0|||
23840081|NCT05326529|66795354|FG000|Overall Study|Lack of Efficacy|0|||
23840082|NCT05326529|66795355|FG001|Overall Study|Lack of Efficacy|1|||
23840083|NCT05326529|66795356|FG002|Overall Study|Lack of Efficacy|0|||
23840084|NCT05326529|66795354|FG000|Overall Study|Physician Decision|0|||
23840085|NCT05326529|66795355|FG001|Overall Study|Physician Decision|0|||
23840086|NCT05326529|66795356|FG002|Overall Study|Physician Decision|2|||
23840087|NCT03003494|66795358|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
23840088|NCT00101166|66795359|FG000|Overall Study|progressive disease|10|||
23840089|NCT02203721|66795370|FG000|Overall Study|Lost to Follow-up|1|||
23840090|NCT02203721|66795371|FG001|Overall Study|Lost to Follow-up|0|||
23840091|NCT02203721|66795370|FG000|Overall Study|Death|0|||
23840092|NCT02203721|66795371|FG001|Overall Study|Death|2|||
23840093|NCT02203721|66795370|FG000|Overall Study|Illness|0|||
23840094|NCT02203721|66795371|FG001|Overall Study|Illness|1|||
23840095|NCT00877487|66795375|FG000|Open-label Treatment Phase|Adverse Event|1|||
23840096|NCT00877487|66795376|FG001|Open-label Treatment Phase|Adverse Event|0|||
23840097|NCT00877487|66795375|FG000|Open-label Treatment Phase|Protocol Violation|3|||
23779587|NCT02563561|66573588|FG001|Overall Study|Withdrew of Consent|1|||
23779588|NCT02563561|66573589|FG002|Overall Study|Withdrew of Consent|2|||
23840098|NCT00877487|66795376|FG001|Open-label Treatment Phase|Protocol Violation|0|||
23840099|NCT00877487|66795375|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
23579980|NCT01474512|65853369|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579981|NCT01474512|65853370|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579982|NCT01474512|65853371|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
23579983|NCT01474512|65853372|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23840100|NCT00877487|66795376|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23840101|NCT00877487|66795375|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
23840102|NCT00877487|66795376|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23840103|NCT00877487|66795375|FG000|Open-label Treatment Phase|Out of country for business|1|||
23840104|NCT00877487|66795376|FG001|Open-label Treatment Phase|Out of country for business|0|||
23840105|NCT00877487|66795375|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
23840106|NCT00877487|66795376|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
23840107|NCT00877487|66795375|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
23840108|NCT00877487|66795376|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
23840109|NCT00877487|66795375|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
23840110|NCT00877487|66795376|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
23840111|NCT00877487|66795375|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
23840112|NCT00877487|66795376|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
23840113|NCT01289639|66795378|FG000|Overall Study|Lost to Follow-up|1|||
23840114|NCT01289639|66795379|FG001|Overall Study|Lost to Follow-up|0|||
23840115|NCT01289639|66795380|FG002|Overall Study|Lost to Follow-up|0|||
23840116|NCT02737930|66795381|FG000|Overall Study|Withdrawal by Subject|0|||
23840117|NCT02737930|66795382|FG001|Overall Study|Withdrawal by Subject|1|||
23840118|NCT01163851|66795383|FG000|Overall Study|Site Closure|0|||
23579984|NCT01474512|65853373|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579985|NCT01474512|65853374|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579986|NCT01474512|65853375|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23779589|NCT02563561|66573587|FG000|Overall Study|Lost to Follow-up|1|||
23779590|NCT02563561|66573588|FG001|Overall Study|Lost to Follow-up|1|||
23779591|NCT02563561|66573589|FG002|Overall Study|Lost to Follow-up|0|||
23779592|NCT02563561|66573587|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
23779593|NCT02563561|66573588|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
23779594|NCT02563561|66573589|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
23779595|NCT02563561|66573587|FG000|Overall Study|Investigator Decision|3|||
23779596|NCT02563561|66573588|FG001|Overall Study|Investigator Decision|4|||
23779597|NCT02563561|66573589|FG002|Overall Study|Investigator Decision|2|||
23779598|NCT02563561|66573587|FG000|Overall Study|Sponsor Decision|5|||
23779599|NCT02563561|66573588|FG001|Overall Study|Sponsor Decision|2|||
23779600|NCT02563561|66573589|FG002|Overall Study|Sponsor Decision|4|||
23779601|NCT02563561|66573587|FG000|Overall Study|Other|1|||
23779602|NCT02563561|66573588|FG001|Overall Study|Other|5|||
23779603|NCT02563561|66573589|FG002|Overall Study|Other|2|||
23779604|NCT04089735|66573590|FG000|Overall Study|Adverse Event|1|||
23779605|NCT04089735|66573591|FG001|Overall Study|Adverse Event|0|||
23779606|NCT04089735|66573592|FG002|Overall Study|Adverse Event|1|||
23840119|NCT01163851|66795384|FG001|Overall Study|Site Closure|1|||
23840120|NCT01163851|66795383|FG000|Overall Study|Enrolled but not treated|1|||
23840121|NCT01163851|66795384|FG001|Overall Study|Enrolled but not treated|0|||
23840122|NCT00975611|66795385|FG000|Overall Study|Screen Fail|16|||
23840123|NCT00975611|66795385|FG000|Overall Study|Physician Decision|1|||
23840124|NCT00178685|66795387|FG000|Overall Study|Death|3|||
23840125|NCT00178685|66795388|FG001|Overall Study|Death|3|||
23840126|NCT00178685|66795389|FG002|Overall Study|Death|6|||
23840127|NCT00178685|66795387|FG000|Overall Study|Lost to Follow-up|100|||
23840128|NCT00178685|66795388|FG001|Overall Study|Lost to Follow-up|187|||
23840129|NCT00178685|66795389|FG002|Overall Study|Lost to Follow-up|183|||
23840130|NCT00178685|66795387|FG000|Overall Study|Withdrawal by Subject|8|||
23840131|NCT00178685|66795388|FG001|Overall Study|Withdrawal by Subject|14|||
23840132|NCT00178685|66795389|FG002|Overall Study|Withdrawal by Subject|7|||
23840133|NCT00443079|66795390|FG000|Overall Study|Lost to Follow-up|0|||
23840134|NCT00443079|66795391|FG001|Overall Study|Lost to Follow-up|1|||
23840135|NCT01862250|66795392|FG000|Overall Study|Adverse Event|4|||
23840136|NCT03491462|66795393|FG000|Overall Study|Lost to Follow-up|2|||
23840137|NCT03491462|66795394|FG001|Overall Study|Lost to Follow-up|0|||
23840138|NCT03491462|66795393|FG000|Overall Study|Adverse Event|11|||
23840139|NCT03491462|66795394|FG001|Overall Study|Adverse Event|1|||
23840140|NCT03491462|66795393|FG000|Overall Study|Physician Decision|3|||
23840141|NCT03491462|66795394|FG001|Overall Study|Physician Decision|0|||
23840142|NCT03491462|66795393|FG000|Overall Study|Withdrawal by Subject|22|||
23840143|NCT03491462|66795394|FG001|Overall Study|Withdrawal by Subject|15|||
23840144|NCT00959374|66795396|FG000|Overall Study|Withdrawal by Subject|2|||
23840145|NCT00959374|66795396|FG000|Overall Study|Lost to Follow-up|14|||
23840146|NCT00959374|66795396|FG000|Overall Study|Death|1|||
23840147|NCT00959374|66795396|FG000|Overall Study|Protocol Violation|1|||
23840148|NCT00959374|66795396|FG000|Overall Study|Implant Removed/Not Replaced|4|||
23840149|NCT00959374|66795396|FG000|Overall Study|Physician Decision|1|||
23840150|NCT03018080|66795400|FG000|Overall Study|Death|12|||
23840151|NCT03018080|66795401|FG001|Overall Study|Death|19|||
23840152|NCT00708552|66795404|FG000|Overall Study|Adverse Event|10|||
23840153|NCT00708552|66795405|FG001|Overall Study|Adverse Event|3|||
23840154|NCT00708552|66795406|FG002|Overall Study|Adverse Event|4|||
23339693|NCT01489254|64989231|FG003|Open-label Extension Part|Protocol Violation|1|||
23339694|NCT01489254|64989228|FG000|Open-label Extension Part|Lost to Follow-up|0|||
23339695|NCT01489254|64989229|FG001|Open-label Extension Part|Lost to Follow-up|0|||
23339696|NCT01489254|64989230|FG002|Open-label Extension Part|Lost to Follow-up|0|||
23339697|NCT01489254|64989231|FG003|Open-label Extension Part|Lost to Follow-up|9|||
23451521|NCT00430716|65395197|FG001|Open Label Phase|Lost to Follow-up|0|||
23451522|NCT00430716|65395198|FG002|Open Label Phase|Lost to Follow-up|1|||
23779607|NCT04089735|66573593|FG003|Overall Study|Adverse Event|1|||
23779608|NCT04089735|66573594|FG004|Overall Study|Adverse Event|0|||
23779609|NCT04089735|66573595|FG005|Overall Study|Adverse Event|0|||
23779610|NCT04089735|66573590|FG000|Overall Study|Physician Decision|0|||
23779611|NCT04089735|66573591|FG001|Overall Study|Physician Decision|3|||
23779612|NCT04089735|66573592|FG002|Overall Study|Physician Decision|0|||
23779613|NCT04089735|66573593|FG003|Overall Study|Physician Decision|0|||
23779614|NCT04089735|66573594|FG004|Overall Study|Physician Decision|0|||
23779615|NCT04089735|66573595|FG005|Overall Study|Physician Decision|0|||
23779616|NCT04089735|66573590|FG000|Overall Study|Withdrawal by Subject|0|||
23779617|NCT04089735|66573591|FG001|Overall Study|Withdrawal by Subject|0|||
23779618|NCT04089735|66573592|FG002|Overall Study|Withdrawal by Subject|1|||
23451523|NCT00430716|65395196|FG000|Open Label Phase|No longer willing to participate|0|||
23579987|NCT01474512|65853376|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23779619|NCT04089735|66573593|FG003|Overall Study|Withdrawal by Subject|0|||
23779620|NCT04089735|66573594|FG004|Overall Study|Withdrawal by Subject|0|||
23779621|NCT04089735|66573595|FG005|Overall Study|Withdrawal by Subject|0|||
23339698|NCT01489254|64989228|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
23339699|NCT01489254|64989229|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
23451524|NCT00430716|65395197|FG001|Open Label Phase|No longer willing to participate|1|||
23579988|NCT01474512|65853377|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579989|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
23579990|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
23840155|NCT00708552|66795407|FG003|Overall Study|Adverse Event|6|||
23840156|NCT00708552|66795404|FG000|Overall Study|Lack of Efficacy|0|||
23840157|NCT00708552|66795405|FG001|Overall Study|Lack of Efficacy|4|||
23840158|NCT00708552|66795406|FG002|Overall Study|Lack of Efficacy|1|||
23840159|NCT00708552|66795407|FG003|Overall Study|Lack of Efficacy|0|||
23339700|NCT01489254|64989230|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
23579991|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
23779622|NCT04089735|66573590|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
23840160|NCT00708552|66795404|FG000|Overall Study|Protocol Violation|0|||
23840161|NCT00708552|66795405|FG001|Overall Study|Protocol Violation|0|||
23840162|NCT00708552|66795406|FG002|Overall Study|Protocol Violation|2|||
23579992|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
23579993|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
23579994|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
23635060|NCT02597712|66049397|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
23635061|NCT02597712|66049396|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
23635062|NCT02597712|66049397|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
23635063|NCT01214642|66049403|FG000|Overall Study|Progressive Disease|3|||
23635064|NCT01214642|66049404|FG001|Overall Study|Progressive Disease|2|||
23635065|NCT01214642|66049405|FG002|Overall Study|Progressive Disease|3|||
23779623|NCT04089735|66573591|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
23779624|NCT04089735|66573592|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
23779625|NCT04089735|66573593|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
23579995|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
23579996|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
23579997|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
23579998|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
23579999|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
23580000|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
23580001|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
23580002|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
23580003|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
23580004|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
23580005|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
23580006|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
23580007|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23635066|NCT01214642|66049406|FG003|Overall Study|Progressive Disease|5|||
23635067|NCT01214642|66049407|FG004|Overall Study|Progressive Disease|5|||
23635068|NCT01214642|66049408|FG005|Overall Study|Progressive Disease|3|||
23779626|NCT04089735|66573594|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
23779627|NCT04089735|66573595|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
23779628|NCT01518972|66573596|FG000|Overall Study|Lost to Follow-up|2|||
23779629|NCT01518972|66573597|FG001|Overall Study|Lost to Follow-up|1|||
23779630|NCT01518972|66573596|FG000|Overall Study|Withdrawal by Subject|1|||
23779631|NCT01518972|66573597|FG001|Overall Study|Withdrawal by Subject|0|||
23779632|NCT01518972|66573596|FG000|Overall Study|Moved from area|1|||
23779633|NCT01518972|66573597|FG001|Overall Study|Moved from area|0|||
23779634|NCT01518972|66573596|FG000|Overall Study|Transportation problems|1|||
23779635|NCT01518972|66573597|FG001|Overall Study|Transportation problems|0|||
23779636|NCT01518972|66573596|FG000|Overall Study|Exclusionary medical condition|1|||
23779637|NCT01518972|66573597|FG001|Overall Study|Exclusionary medical condition|0|||
23779638|NCT01518972|66573596|FG000|Overall Study|Missed safety visits|0|||
23779639|NCT01518972|66573597|FG001|Overall Study|Missed safety visits|1|||
23779640|NCT01518972|66573596|FG000|Overall Study|Exclusionary medication|0|||
23779641|NCT01518972|66573597|FG001|Overall Study|Exclusionary medication|1|||
23779642|NCT01518972|66573596|FG000|Overall Study|Declined medication starting on day 12|0|||
23779643|NCT01518972|66573597|FG001|Overall Study|Declined medication starting on day 12|1|||
23779644|NCT00796653|66573598|FG000|Overall Study|Adverse Event|19|||
23779645|NCT00796653|66573599|FG001|Overall Study|Adverse Event|16|||
23779646|NCT00796653|66573600|FG002|Overall Study|Adverse Event|16|||
23779647|NCT00796653|66573601|FG003|Overall Study|Adverse Event|16|||
23779648|NCT00796653|66573598|FG000|Overall Study|Lost to Follow-up|2|||
23779649|NCT00796653|66573599|FG001|Overall Study|Lost to Follow-up|1|||
23779650|NCT00796653|66573600|FG002|Overall Study|Lost to Follow-up|2|||
23779651|NCT00796653|66573601|FG003|Overall Study|Lost to Follow-up|3|||
23779652|NCT00796653|66573598|FG000|Overall Study|Withdrawal by Subject|16|||
23779653|NCT00796653|66573599|FG001|Overall Study|Withdrawal by Subject|8|||
23779654|NCT00796653|66573600|FG002|Overall Study|Withdrawal by Subject|8|||
23840163|NCT00708552|66795407|FG003|Overall Study|Protocol Violation|4|||
23779655|NCT00796653|66573601|FG003|Overall Study|Withdrawal by Subject|13|||
23779656|NCT00796653|66573598|FG000|Overall Study|Lack of Efficacy|8|||
23779657|NCT00796653|66573599|FG001|Overall Study|Lack of Efficacy|1|||
23779658|NCT00796653|66573600|FG002|Overall Study|Lack of Efficacy|3|||
23339701|NCT01489254|64989231|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
23580008|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580009|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580010|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580011|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23635069|NCT01214642|66049409|FG006|Overall Study|Progressive Disease|5|||
23779659|NCT00796653|66573601|FG003|Overall Study|Lack of Efficacy|2|||
23779660|NCT00796653|66573598|FG000|Overall Study|Non compliance with protocol|2|||
23779661|NCT00796653|66573599|FG001|Overall Study|Non compliance with protocol|2|||
23779662|NCT00796653|66573600|FG002|Overall Study|Non compliance with protocol|0|||
23840164|NCT00708552|66795404|FG000|Overall Study|Lost to Follow-up|4|||
23840165|NCT00708552|66795405|FG001|Overall Study|Lost to Follow-up|2|||
23840166|NCT00708552|66795406|FG002|Overall Study|Lost to Follow-up|0|||
23840167|NCT00708552|66795407|FG003|Overall Study|Lost to Follow-up|1|||
23840168|NCT00708552|66795404|FG000|Overall Study|Physician Decision|1|||
23840169|NCT00708552|66795405|FG001|Overall Study|Physician Decision|2|||
23840170|NCT00708552|66795406|FG002|Overall Study|Physician Decision|0|||
23840171|NCT00708552|66795407|FG003|Overall Study|Physician Decision|0|||
23840172|NCT00708552|66795404|FG000|Overall Study|Withdrawal by Subject|12|||
23840173|NCT00708552|66795405|FG001|Overall Study|Withdrawal by Subject|7|||
23840174|NCT00708552|66795406|FG002|Overall Study|Withdrawal by Subject|8|||
23840175|NCT00708552|66795407|FG003|Overall Study|Withdrawal by Subject|10|||
23840176|NCT02393950|66795408|FG000|Overall Study|Adverse Event|1|||
23840177|NCT02393950|66795409|FG001|Overall Study|Adverse Event|0|||
23840178|NCT02393950|66795408|FG000|Overall Study|Withdrawal by Subject|0|||
23840179|NCT02393950|66795409|FG001|Overall Study|Withdrawal by Subject|1|||
23840180|NCT01681212|66795411|FG000|Overall Study|No longer met study criteria|5|||
23840181|NCT01681212|66795411|FG000|Overall Study|Administrative reason by sponsor|1|||
23840182|NCT00596817|66795412|FG000|Open-label Period|Adverse Event|0|||
23840183|NCT00596817|66795413|FG001|Open-label Period|Adverse Event|49|||
23840184|NCT00596817|66795412|FG000|Open-label Period|Lack of Efficacy|0|||
23840185|NCT00596817|66795413|FG001|Open-label Period|Lack of Efficacy|33|||
23840186|NCT00596817|66795412|FG000|Open-label Period|Other Reasons|0|||
23840187|NCT00596817|66795413|FG001|Open-label Period|Other Reasons|65|||
23840188|NCT00596817|66795412|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
23840189|NCT00596817|66795413|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
23840190|NCT00596817|66795412|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
23840191|NCT00596817|66795413|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
23840192|NCT00596817|66795412|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
23840193|NCT00596817|66795413|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
23840194|NCT00596817|66795412|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
23840195|NCT00596817|66795413|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
23840196|NCT00596817|66795412|FG000|Double-blind Period|Adverse Event|5|||
23840197|NCT00596817|66795413|FG001|Double-blind Period|Adverse Event|16|||
23840198|NCT00596817|66795412|FG000|Double-blind Period|Lack of Efficacy|52|||
23840199|NCT00596817|66795413|FG001|Double-blind Period|Lack of Efficacy|28|||
23840200|NCT00596817|66795412|FG000|Double-blind Period|Non-compliance With Study Product|3|||
23840201|NCT00596817|66795413|FG001|Double-blind Period|Non-compliance With Study Product|4|||
23840202|NCT00596817|66795412|FG000|Double-blind Period|Protocol Violation|11|||
23840203|NCT00596817|66795413|FG001|Double-blind Period|Protocol Violation|8|||
23840204|NCT00596817|66795412|FG000|Double-blind Period|Withdrawal of Consent|7|||
23840205|NCT00596817|66795413|FG001|Double-blind Period|Withdrawal of Consent|3|||
23840206|NCT00596817|66795412|FG000|Double-blind Period|Lost to Follow-up|0|||
23840207|NCT00596817|66795413|FG001|Double-blind Period|Lost to Follow-up|2|||
23840208|NCT00596817|66795412|FG000|Double-blind Period|Other Reasons|10|||
23840209|NCT00596817|66795413|FG001|Double-blind Period|Other Reasons|18|||
23840210|NCT00474045|66795414|FG000|Overall Study|Adverse Event|18|||
23840211|NCT00474045|66795415|FG001|Overall Study|Adverse Event|8|||
23840212|NCT00474045|66795414|FG000|Overall Study|Unclassified|1|||
23840213|NCT00474045|66795415|FG001|Overall Study|Unclassified|3|||
23840214|NCT00474045|66795414|FG000|Overall Study|Lack of Efficacy|0|||
23840215|NCT00474045|66795415|FG001|Overall Study|Lack of Efficacy|9|||
23840216|NCT00474045|66795414|FG000|Overall Study|Lost to Follow-up|1|||
23840217|NCT00474045|66795415|FG001|Overall Study|Lost to Follow-up|1|||
23840218|NCT00474045|66795414|FG000|Overall Study|Protocol Violation|10|||
23840219|NCT00474045|66795415|FG001|Overall Study|Protocol Violation|12|||
23840220|NCT00474045|66795414|FG000|Overall Study|Withdrawal by Subject|16|||
23840221|NCT00474045|66795415|FG001|Overall Study|Withdrawal by Subject|18|||
23840222|NCT00474045|66795414|FG000|Overall Study|Withdrawal criteria|60|||
23840223|NCT00474045|66795415|FG001|Overall Study|Withdrawal criteria|50|||
23840224|NCT01011465|66795426|FG000|Overall Study|Withdrawal by Subject|2|||
23840225|NCT01011465|66795427|FG001|Overall Study|Withdrawal by Subject|1|||
23840226|NCT01011465|66795428|FG002|Overall Study|Withdrawal by Subject|0|||
23840227|NCT01011465|66795429|FG003|Overall Study|Withdrawal by Subject|0|||
23840228|NCT01011465|66795430|FG004|Overall Study|Withdrawal by Subject|1|||
23840229|NCT01011465|66795431|FG005|Overall Study|Withdrawal by Subject|0|||
23840230|NCT01011465|66795432|FG006|Overall Study|Withdrawal by Subject|1|||
23840231|NCT01011465|66795433|FG007|Overall Study|Withdrawal by Subject|0|||
23840232|NCT00977314|66795436|FG000|Overall Study|Withdrawal by Subject|1|||
23840233|NCT00977314|66795437|FG001|Overall Study|Withdrawal by Subject|0|||
23840234|NCT00977314|66795436|FG000|Overall Study|Physician Decision|1|||
23840235|NCT00977314|66795437|FG001|Overall Study|Physician Decision|0|||
23840236|NCT02237196|66795438|FG000|Overall Study|Adverse Event|0|||
23840237|NCT02237196|66795439|FG001|Overall Study|Adverse Event|1|||
23840238|NCT02237196|66795440|FG002|Overall Study|Adverse Event|1|||
23840239|NCT02237196|66795441|FG003|Overall Study|Adverse Event|0|||
23840240|NCT02237196|66795438|FG000|Overall Study|Lost to Follow-up|4|||
23840241|NCT02237196|66795439|FG001|Overall Study|Lost to Follow-up|2|||
23840242|NCT02237196|66795440|FG002|Overall Study|Lost to Follow-up|4|||
23840243|NCT02237196|66795441|FG003|Overall Study|Lost to Follow-up|6|||
23840244|NCT02237196|66795438|FG000|Overall Study|Physician Decision|2|||
23840245|NCT02237196|66795439|FG001|Overall Study|Physician Decision|0|||
23635070|NCT01214642|66049410|FG007|Overall Study|Progressive Disease|3|||
23635071|NCT01214642|66049411|FG008|Overall Study|Progressive Disease|10|||
23580012|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580013|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580014|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580015|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23840246|NCT02237196|66795440|FG002|Overall Study|Physician Decision|0|||
23840247|NCT02237196|66795441|FG003|Overall Study|Physician Decision|1|||
23840248|NCT02237196|66795438|FG000|Overall Study|Pregnancy|0|||
23840249|NCT02237196|66795439|FG001|Overall Study|Pregnancy|0|||
23451525|NCT00430716|65395198|FG002|Open Label Phase|No longer willing to participate|1|||
23580016|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580017|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580018|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580019|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580020|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580021|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
23580022|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
23580023|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
23635072|NCT01214642|66049412|FG009|Overall Study|Progressive Disease|2|||
23635073|NCT01214642|66049413|FG010|Overall Study|Progressive Disease|1|||
23635074|NCT01214642|66049414|FG011|Overall Study|Progressive Disease|4|||
23635075|NCT01214642|66049403|FG000|Overall Study|Adverse Event|0|||
23635076|NCT01214642|66049404|FG001|Overall Study|Adverse Event|1|||
23635077|NCT01214642|66049405|FG002|Overall Study|Adverse Event|0|||
23635078|NCT01214642|66049406|FG003|Overall Study|Adverse Event|0|||
23635079|NCT01214642|66049407|FG004|Overall Study|Adverse Event|0|||
23635080|NCT01214642|66049408|FG005|Overall Study|Adverse Event|0|||
23635081|NCT01214642|66049409|FG006|Overall Study|Adverse Event|1|||
23635082|NCT01214642|66049410|FG007|Overall Study|Adverse Event|0|||
23635083|NCT01214642|66049411|FG008|Overall Study|Adverse Event|0|||
23635084|NCT01214642|66049412|FG009|Overall Study|Adverse Event|1|||
23635085|NCT01214642|66049413|FG010|Overall Study|Adverse Event|1|||
23635086|NCT01214642|66049414|FG011|Overall Study|Adverse Event|0|||
23635087|NCT01214642|66049403|FG000|Overall Study|Death|0|||
23635088|NCT01214642|66049404|FG001|Overall Study|Death|0|||
23635089|NCT01214642|66049405|FG002|Overall Study|Death|1|||
23635090|NCT01214642|66049406|FG003|Overall Study|Death|0|||
23635091|NCT01214642|66049407|FG004|Overall Study|Death|0|||
23635092|NCT01214642|66049408|FG005|Overall Study|Death|0|||
23635093|NCT01214642|66049409|FG006|Overall Study|Death|0|||
23635094|NCT01214642|66049410|FG007|Overall Study|Death|0|||
23635095|NCT01214642|66049411|FG008|Overall Study|Death|0|||
23635096|NCT01214642|66049412|FG009|Overall Study|Death|0|||
23635097|NCT01214642|66049413|FG010|Overall Study|Death|1|||
23635098|NCT01214642|66049414|FG011|Overall Study|Death|0|||
23779663|NCT00796653|66573601|FG003|Overall Study|Non compliance with protocol|2|||
23779664|NCT00796653|66573598|FG000|Overall Study|Other reason not described above|4|||
23779665|NCT00796653|66573599|FG001|Overall Study|Other reason not described above|9|||
23779666|NCT00796653|66573600|FG002|Overall Study|Other reason not described above|7|||
23779667|NCT00796653|66573601|FG003|Overall Study|Other reason not described above|4|||
23779668|NCT03435081|66576203|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
23779669|NCT03435081|66576204|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
23779670|NCT03435081|66576205|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
23779671|NCT03435081|66576203|FG000|Week 0 to Week 16|Adverse Event|2|||
23779672|NCT03435081|66576204|FG001|Week 0 to Week 16|Adverse Event|2|||
23840250|NCT02237196|66795440|FG002|Overall Study|Pregnancy|1|||
23840251|NCT02237196|66795441|FG003|Overall Study|Pregnancy|1|||
23840252|NCT02237196|66795438|FG000|Overall Study|Withdrawal by Subject|1|||
23451526|NCT00430716|65395196|FG000|Open Label Phase|Other|3|||
23635099|NCT01214642|66049403|FG000|Overall Study|Withdrawal by Subject|0|||
23580024|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
23580025|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23635100|NCT01214642|66049404|FG001|Overall Study|Withdrawal by Subject|0|||
23635101|NCT01214642|66049405|FG002|Overall Study|Withdrawal by Subject|1|||
23635102|NCT01214642|66049406|FG003|Overall Study|Withdrawal by Subject|0|||
23635103|NCT01214642|66049407|FG004|Overall Study|Withdrawal by Subject|0|||
23635104|NCT01214642|66049408|FG005|Overall Study|Withdrawal by Subject|0|||
23635105|NCT01214642|66049409|FG006|Overall Study|Withdrawal by Subject|0|||
23635106|NCT01214642|66049410|FG007|Overall Study|Withdrawal by Subject|0|||
23635107|NCT01214642|66049411|FG008|Overall Study|Withdrawal by Subject|3|||
23779673|NCT03435081|66576205|FG002|Week 0 to Week 16|Adverse Event|2|||
23779674|NCT03435081|66576203|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
23779675|NCT03435081|66576204|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
23779676|NCT03435081|66576205|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
23779677|NCT03435081|66576203|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
23779678|NCT03435081|66576204|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
23840253|NCT02237196|66795439|FG001|Overall Study|Withdrawal by Subject|1|||
23840254|NCT02237196|66795440|FG002|Overall Study|Withdrawal by Subject|4|||
23840255|NCT02237196|66795441|FG003|Overall Study|Withdrawal by Subject|1|||
23840256|NCT02237196|66795438|FG000|Overall Study|Site Error|1|||
23840257|NCT02237196|66795439|FG001|Overall Study|Site Error|2|||
23840258|NCT02237196|66795440|FG002|Overall Study|Site Error|0|||
23580026|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580027|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580028|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580029|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580030|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580031|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580032|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580033|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580034|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580035|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580036|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580037|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580038|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580039|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
23580040|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
23580041|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
23580042|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
23580043|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580044|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580045|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580046|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580047|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580048|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580049|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580050|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580051|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580052|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580053|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580054|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580055|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580056|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580057|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580058|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580059|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
23580060|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
23580061|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
23580062|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
23580063|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
23580064|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
23580065|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
23580066|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
23580067|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
23580068|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
23580069|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
23580070|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
23580071|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
23580072|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
23580073|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
23580074|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
23580075|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
23580076|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
23779679|NCT03435081|66576205|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
23840259|NCT02237196|66795441|FG003|Overall Study|Site Error|2|||
23840260|NCT01435018|66795442|FG000|Overall Study|Death|37|||
23580077|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
23580078|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
23580079|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580080|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580081|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
23779680|NCT03435081|66576203|FG000|Week 0 to Week 16|Pregnancy|1|||
23779681|NCT03435081|66576204|FG001|Week 0 to Week 16|Pregnancy|0|||
23840261|NCT01435018|66795443|FG001|Overall Study|Death|18|||
23840262|NCT01435018|66795444|FG002|Overall Study|Death|25|||
23635108|NCT01214642|66049412|FG009|Overall Study|Withdrawal by Subject|1|||
23635109|NCT01214642|66049413|FG010|Overall Study|Withdrawal by Subject|1|||
23635110|NCT01214642|66049414|FG011|Overall Study|Withdrawal by Subject|0|||
23635111|NCT01214642|66049403|FG000|Overall Study|Physician Decision|0|||
23635112|NCT01214642|66049404|FG001|Overall Study|Physician Decision|0|||
23635113|NCT01214642|66049405|FG002|Overall Study|Physician Decision|1|||
23635114|NCT01214642|66049406|FG003|Overall Study|Physician Decision|1|||
23635115|NCT01214642|66049407|FG004|Overall Study|Physician Decision|1|||
23635116|NCT01214642|66049408|FG005|Overall Study|Physician Decision|0|||
23779682|NCT03435081|66576205|FG002|Week 0 to Week 16|Pregnancy|0|||
23779683|NCT03435081|66576203|FG000|Week 0 to Week 16|Non-compliance|1|||
23779684|NCT03435081|66576204|FG001|Week 0 to Week 16|Non-compliance|0|||
23779685|NCT03435081|66576205|FG002|Week 0 to Week 16|Non-compliance|2|||
23779686|NCT03435081|66576203|FG000|Week 0 to Week 16|Inadequate Response|0|||
23779687|NCT03435081|66576204|FG001|Week 0 to Week 16|Inadequate Response|1|||
23779688|NCT03435081|66576205|FG002|Week 0 to Week 16|Inadequate Response|0|||
23635117|NCT01214642|66049409|FG006|Overall Study|Physician Decision|0|||
23635118|NCT01214642|66049410|FG007|Overall Study|Physician Decision|0|||
23635119|NCT01214642|66049411|FG008|Overall Study|Physician Decision|0|||
23635120|NCT01214642|66049412|FG009|Overall Study|Physician Decision|0|||
23635121|NCT01214642|66049413|FG010|Overall Study|Physician Decision|0|||
23779689|NCT03435081|66576203|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
23779690|NCT03435081|66576204|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
23779691|NCT03435081|66576205|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
23779692|NCT03435081|66576203|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
23779693|NCT03435081|66576204|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
23779694|NCT03435081|66576205|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
23779695|NCT03435081|66576203|FG000|Week 16 to Week 104|Adverse Event|1|||
23779696|NCT03435081|66576204|FG001|Week 16 to Week 104|Adverse Event|0|||
23779697|NCT03435081|66576205|FG002|Week 16 to Week 104|Adverse Event|2|||
23779698|NCT03435081|66576203|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
23779699|NCT03435081|66576204|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
23779700|NCT03435081|66576205|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
23580082|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580083|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580084|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580085|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580086|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580087|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580088|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580089|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580090|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580091|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580092|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580093|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580094|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580095|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
23580096|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
23580097|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
23580098|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
23580099|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
23580100|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
23580101|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
23580102|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
23580103|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
23580104|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
23580105|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
23580106|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
23580107|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
23580108|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
23580109|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
23580110|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
23635122|NCT01214642|66049414|FG011|Overall Study|Physician Decision|2|||
23635123|NCT00214019|66049417|FG000|Overall Study|Lost to Follow-up|11|||
23635124|NCT00214019|66049417|FG000|Overall Study|Withdrawal by Subject|2|||
23779701|NCT03435081|66576203|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
23779702|NCT03435081|66576204|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
23779703|NCT03435081|66576205|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
23580111|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
23779704|NCT03435081|66576203|FG000|Week 16 to Week 104|Non--Compliance|0|||
23580112|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
23580113|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
23580114|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
23635125|NCT00214019|66049417|FG000|Overall Study|Screen Failed prior to randomization|17|||
23635126|NCT01706705|66049418|FG000|Overall Study|Death|1|||
23779705|NCT03435081|66576204|FG001|Week 16 to Week 104|Non--Compliance|0|||
23779706|NCT03435081|66576205|FG002|Week 16 to Week 104|Non--Compliance|1|||
23779707|NCT00537979|66576207|FG000|Overall Study|Adverse Event|2|||
23840263|NCT01435018|66795442|FG000|Overall Study|Site is closing|4|||
23840264|NCT01435018|66795443|FG001|Overall Study|Site is closing|9|||
23840265|NCT01435018|66795444|FG002|Overall Study|Site is closing|7|||
23840266|NCT01435018|66795442|FG000|Overall Study|Withdrew consent|0|||
23840267|NCT01435018|66795443|FG001|Overall Study|Withdrew consent|3|||
23840268|NCT01435018|66795444|FG002|Overall Study|Withdrew consent|1|||
23779708|NCT00537979|66576208|FG001|Overall Study|Adverse Event|2|||
23779709|NCT00537979|66576207|FG000|Overall Study|Withdrawal by Subject|1|||
23779710|NCT00537979|66576208|FG001|Overall Study|Withdrawal by Subject|4|||
23779711|NCT00537979|66576207|FG000|Overall Study|Lost to Follow-up|1|||
23779712|NCT00537979|66576208|FG001|Overall Study|Lost to Follow-up|4|||
23779713|NCT00537979|66576207|FG000|Overall Study|Lack of Efficacy|0|||
23779714|NCT00537979|66576208|FG001|Overall Study|Lack of Efficacy|1|||
23779715|NCT00537979|66576207|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
23779716|NCT00537979|66576208|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
23779717|NCT00537979|66576207|FG000|Overall Study|Death|0|||
23779718|NCT00537979|66576208|FG001|Overall Study|Death|3|||
23779719|NCT00537979|66576207|FG000|Overall Study|Kidney transplant|0|||
23779720|NCT00537979|66576208|FG001|Overall Study|Kidney transplant|3|||
23779721|NCT00537979|66576207|FG000|Overall Study|Heart failure|0|||
23779722|NCT00537979|66576208|FG001|Overall Study|Heart failure|1|||
23779723|NCT00609674|66576209|FG000|Overall Study|Adverse Event|1|||
23779724|NCT00609674|66576210|FG001|Overall Study|Adverse Event|1|||
23339702|NCT00833482|64989236|FG000|Days 11-20|Adverse Event|0|||
23580115|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580116|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580117|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580118|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580119|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580120|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580121|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580122|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580123|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580124|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580125|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580126|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580127|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580128|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580129|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
23580130|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580131|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
23580132|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580133|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580134|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580135|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580136|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580137|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580138|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580139|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580140|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580141|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580142|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580143|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580144|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580145|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580146|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580147|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
23580148|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580149|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580150|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
23580151|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Death|0|||
23779725|NCT00609674|66576209|FG000|Overall Study|Protocol Violation|3|||
23779726|NCT00609674|66576210|FG001|Overall Study|Protocol Violation|5|||
23779727|NCT00609674|66576209|FG000|Overall Study|Lost to Follow-up|1|||
23779728|NCT00609674|66576210|FG001|Overall Study|Lost to Follow-up|0|||
23580152|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Death|0|||
23580153|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Death|0|||
23635127|NCT01706705|66049418|FG000|Overall Study|Lack of Efficacy|13|||
23840269|NCT01435018|66795442|FG000|Overall Study|Not willing to adhere to requirements|0|||
23580154|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Death|0|||
23580155|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Death|0|||
23580156|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Death|0|||
23580157|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Death|0|||
23580158|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Death|0|||
23635128|NCT01706705|66049418|FG000|Overall Study|Non-clinical|6|||
23635129|NCT00846807|66049419|FG000|Overall Study|Adverse Event|270|||
23635130|NCT00846807|66049419|FG000|Overall Study|Lost to Follow-up|94|||
23635131|NCT00846807|66049419|FG000|Overall Study|Withdrawal by Subject|56|||
23635132|NCT00846807|66049419|FG000|Overall Study|Non compliant with European label|7|||
23635133|NCT00846807|66049419|FG000|Overall Study|Switch to other anticoagulants|89|||
23635134|NCT00846807|66049419|FG000|Overall Study|No prescription after hospital discharge|56|||
23635135|NCT00846807|66049419|FG000|Overall Study|Other|60|||
23635136|NCT04491877|66049420|FG000|Overall Study|Protocol Deviation|1|||
23635137|NCT04491877|66049421|FG001|Overall Study|Protocol Deviation|0|||
23635138|NCT04491877|66049422|FG002|Overall Study|Protocol Deviation|2|||
23635139|NCT04491877|66049423|FG003|Overall Study|Protocol Deviation|0|||
23635140|NCT04491877|66049424|FG004|Overall Study|Protocol Deviation|0|||
23635141|NCT04491877|66049425|FG005|Overall Study|Protocol Deviation|0|||
23635142|NCT04491877|66049426|FG006|Overall Study|Protocol Deviation|1|||
23635143|NCT04491877|66049427|FG007|Overall Study|Protocol Deviation|1|||
23635144|NCT04491877|66049428|FG008|Overall Study|Protocol Deviation|0|||
23635145|NCT04491877|66049420|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23635146|NCT04491877|66049421|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23635147|NCT04491877|66049422|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23635148|NCT04491877|66049423|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
23635149|NCT04491877|66049424|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23635150|NCT04491877|66049425|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
23779729|NCT00609674|66576209|FG000|Overall Study|Withdrew consent|2|||
23779730|NCT00609674|66576210|FG001|Overall Study|Withdrew consent|1|||
23580159|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Death|0|||
23580160|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Death|0|||
23580161|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Death|0|||
23580162|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Death|0|||
23580163|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Death|0|||
23580164|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Death|0|||
23580165|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Death|0|||
23580166|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Death|0|||
23580167|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Death|1|||
23580168|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Death|0|||
23580169|NCT01653743|65853381|FG000|Overall Study|Withdrawal by Subject|1|||
23580170|NCT01653743|65853382|FG001|Overall Study|Withdrawal by Subject|0|||
23580171|NCT01653743|65853381|FG000|Overall Study|Investigator discretion|3|||
23580172|NCT01653743|65853382|FG001|Overall Study|Investigator discretion|0|||
23580173|NCT02485353|65853385|FG000|Overall Study|Death|1|||
23580174|NCT02485353|65853385|FG000|Overall Study|Disease Progression|1|||
23779731|NCT02246166|66576221|FG000|Overall Study|Protocol Violation|1|||
23779732|NCT02246166|66576222|FG001|Overall Study|Protocol Violation|0|||
23779733|NCT00004562|66576224|FG000|Overall Study|Lost to Follow-up|102|||
23779734|NCT00004562|66576225|FG001|Overall Study|Lost to Follow-up|91|||
23779735|NCT00857623|66576235|FG000|Overall Study|Adverse Event|5|||
23779736|NCT00857623|66576236|FG001|Overall Study|Adverse Event|2|||
23779737|NCT00857623|66576235|FG000|Overall Study|Study-specific discontinuation criteria|5|||
23779738|NCT00857623|66576236|FG001|Overall Study|Study-specific discontinuation criteria|3|||
23779739|NCT00857623|66576235|FG000|Overall Study|Withdrawal by Subject|2|||
23779740|NCT00857623|66576236|FG001|Overall Study|Withdrawal by Subject|1|||
23779741|NCT00857623|66576235|FG000|Overall Study|Lack of Efficacy|1|||
23779742|NCT00857623|66576236|FG001|Overall Study|Lack of Efficacy|1|||
23779743|NCT00857623|66576235|FG000|Overall Study|Severe non-compliance to protocol|1|||
23779744|NCT00857623|66576236|FG001|Overall Study|Severe non-compliance to protocol|1|||
23779745|NCT00857623|66576235|FG000|Overall Study|Intake of prohibited medication|0|||
23779746|NCT00857623|66576236|FG001|Overall Study|Intake of prohibited medication|1|||
23779747|NCT00857623|66576235|FG000|Overall Study|Positive for HEP C|0|||
23779748|NCT00857623|66576236|FG001|Overall Study|Positive for HEP C|1|||
23779749|NCT01981720|66576240|FG000|Overall Study|Adverse Event|1|||
23779750|NCT01981720|66576240|FG000|Overall Study|Withdrawal by Subject|3|||
23779751|NCT01981720|66576240|FG000|Overall Study|Pregnancy|1|||
23779752|NCT01648582|66576241|FG000|Overall Study|Adverse Event|6|||
23779753|NCT01648582|66576242|FG001|Overall Study|Adverse Event|11|||
23339703|NCT00833482|64989237|FG001|Days 11-20|Adverse Event|2|||
23779754|NCT01648582|66576243|FG002|Overall Study|Adverse Event|2|||
23779755|NCT01648582|66576241|FG000|Overall Study|Lost to Follow-up|9|||
23580175|NCT04155424|65853389|FG000|Overall Study|Other than specified|3|||
23635151|NCT04491877|66049426|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
23635152|NCT04491877|66049427|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
23635153|NCT04491877|66049428|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
23635154|NCT04491877|66049420|FG000|Overall Study|Lost to Follow-up|0|||
23580176|NCT04155424|65853389|FG000|Overall Study|Withdrawal by Subject|1|||
23580177|NCT04155424|65853389|FG000|Overall Study|Adverse Event|1|||
23580178|NCT04034238|65853390|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
23779756|NCT01648582|66576242|FG001|Overall Study|Lost to Follow-up|6|||
23779757|NCT01648582|66576243|FG002|Overall Study|Lost to Follow-up|8|||
23840270|NCT01435018|66795443|FG001|Overall Study|Not willing to adhere to requirements|2|||
23779758|NCT01648582|66576241|FG000|Overall Study|Protocol Violation|1|||
23779759|NCT01648582|66576242|FG001|Overall Study|Protocol Violation|2|||
23779760|NCT01648582|66576243|FG002|Overall Study|Protocol Violation|1|||
23840271|NCT01435018|66795444|FG002|Overall Study|Not willing to adhere to requirements|3|||
23840272|NCT01435018|66795442|FG000|Overall Study|Not able to get to clinic|2|||
23840273|NCT01435018|66795443|FG001|Overall Study|Not able to get to clinic|0|||
23840274|NCT01435018|66795444|FG002|Overall Study|Not able to get to clinic|2|||
23840275|NCT01435018|66795442|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23840276|NCT01435018|66795443|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23840277|NCT01435018|66795444|FG002|Overall Study|Severe debilitation, unable to continue|1|||
23840278|NCT01435018|66795442|FG000|Overall Study|Unable to contact participant/parent|1|||
23840279|NCT01435018|66795443|FG001|Overall Study|Unable to contact participant/parent|1|||
23635155|NCT04491877|66049421|FG001|Overall Study|Lost to Follow-up|2|||
23635156|NCT04491877|66049422|FG002|Overall Study|Lost to Follow-up|0|||
23635157|NCT04491877|66049423|FG003|Overall Study|Lost to Follow-up|0|||
23635158|NCT04491877|66049424|FG004|Overall Study|Lost to Follow-up|0|||
23635159|NCT04491877|66049425|FG005|Overall Study|Lost to Follow-up|0|||
23635160|NCT04491877|66049426|FG006|Overall Study|Lost to Follow-up|2|||
23635161|NCT04491877|66049427|FG007|Overall Study|Lost to Follow-up|1|||
23635162|NCT04491877|66049428|FG008|Overall Study|Lost to Follow-up|1|||
23635163|NCT03812029|66049429|FG000|Overall Study|Protocol Violation|1|||
23635164|NCT03812029|66049430|FG001|Overall Study|Protocol Violation|0|||
23635165|NCT03812029|66049431|FG002|Overall Study|Protocol Violation|0|||
23635166|NCT03812029|66049432|FG003|Overall Study|Protocol Violation|1|||
23635167|NCT03812029|66049433|FG004|Overall Study|Protocol Violation|0|||
23635168|NCT03812029|66049429|FG000|Overall Study|Withdrawal by Subject|1|||
23635169|NCT03812029|66049430|FG001|Overall Study|Withdrawal by Subject|0|||
23635170|NCT03812029|66049431|FG002|Overall Study|Withdrawal by Subject|0|||
23635171|NCT03812029|66049432|FG003|Overall Study|Withdrawal by Subject|2|||
23635172|NCT03812029|66049433|FG004|Overall Study|Withdrawal by Subject|2|||
23635173|NCT03812029|66049429|FG000|Overall Study|Stopping rules|0|||
23635174|NCT03812029|66049430|FG001|Overall Study|Stopping rules|1|||
23635175|NCT03812029|66049431|FG002|Overall Study|Stopping rules|0|||
23635176|NCT03812029|66049432|FG003|Overall Study|Stopping rules|0|||
23635177|NCT03812029|66049433|FG004|Overall Study|Stopping rules|0|||
23635178|NCT03812029|66049429|FG000|Overall Study|Adverse Event|0|||
23635179|NCT03812029|66049430|FG001|Overall Study|Adverse Event|9|||
23779761|NCT01648582|66576241|FG000|Overall Study|Withdrawal by Subject|15|||
23779762|NCT01648582|66576242|FG001|Overall Study|Withdrawal by Subject|17|||
23779763|NCT01648582|66576243|FG002|Overall Study|Withdrawal by Subject|17|||
23779764|NCT01648582|66576241|FG000|Overall Study|Physician Decision|0|||
23779765|NCT01648582|66576242|FG001|Overall Study|Physician Decision|1|||
23779766|NCT01648582|66576243|FG002|Overall Study|Physician Decision|3|||
23779767|NCT01648582|66576241|FG000|Overall Study|Death|1|||
23779768|NCT01648582|66576242|FG001|Overall Study|Death|0|||
23779769|NCT01648582|66576243|FG002|Overall Study|Death|0|||
23779770|NCT01648582|66576241|FG000|Overall Study|Sponsor Decision|0|||
23779771|NCT01648582|66576242|FG001|Overall Study|Sponsor Decision|1|||
23779772|NCT01648582|66576243|FG002|Overall Study|Sponsor Decision|1|||
23779773|NCT00440518|66576244|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
23779774|NCT00440518|66576245|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
23779775|NCT00440518|66576246|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
23779776|NCT00440518|66576244|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
23779777|NCT00440518|66576245|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
23840280|NCT01435018|66795444|FG002|Overall Study|Unable to contact participant/parent|1|||
23840281|NCT01435018|66795442|FG000|Overall Study|Enrollment Violation|0|||
23840282|NCT01435018|66795443|FG001|Overall Study|Enrollment Violation|1|||
23840283|NCT01435018|66795444|FG002|Overall Study|Enrollment Violation|0|||
23840284|NCT01435018|66795442|FG000|Overall Study|Never started chemotherapy|3|||
23840285|NCT01435018|66795443|FG001|Overall Study|Never started chemotherapy|0|||
23840286|NCT01435018|66795444|FG002|Overall Study|Never started chemotherapy|1|||
23840287|NCT01077154|66795447|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
23779778|NCT00440518|66576246|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
23779779|NCT00440518|66576244|FG000|Randomized /Titration Period|Protocol Deviation|1|||
23840288|NCT01077154|66795448|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
23635180|NCT03812029|66049431|FG002|Overall Study|Adverse Event|0|||
23635181|NCT03812029|66049432|FG003|Overall Study|Adverse Event|3|||
23635182|NCT03812029|66049433|FG004|Overall Study|Adverse Event|5|||
23635183|NCT03812029|66049429|FG000|Overall Study|Lost to Follow-up|0|||
23635184|NCT03812029|66049430|FG001|Overall Study|Lost to Follow-up|0|||
23635185|NCT03812029|66049431|FG002|Overall Study|Lost to Follow-up|0|||
23635186|NCT03812029|66049432|FG003|Overall Study|Lost to Follow-up|0|||
23635187|NCT03812029|66049433|FG004|Overall Study|Lost to Follow-up|3|||
23635188|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
23635189|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
23635190|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
23635191|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
23779780|NCT00440518|66576245|FG001|Randomized /Titration Period|Protocol Deviation|0|||
23779781|NCT00440518|66576246|FG002|Randomized /Titration Period|Protocol Deviation|0|||
23779782|NCT00440518|66576244|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
23779783|NCT00440518|66576245|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
23779784|NCT00440518|66576246|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
23779785|NCT00440518|66576244|FG000|Randomized /Titration Period|Other|1|||
23779786|NCT00440518|66576245|FG001|Randomized /Titration Period|Other|0|||
23779787|NCT00440518|66576246|FG002|Randomized /Titration Period|Other|0|||
23779788|NCT00440518|66576244|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
23779789|NCT00440518|66576245|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
23779790|NCT00440518|66576246|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
23779791|NCT00440518|66576244|FG000|Randomized /Titration Period|Adverse Event|2|||
23779792|NCT00440518|66576245|FG001|Randomized /Titration Period|Adverse Event|3|||
23779793|NCT00440518|66576246|FG002|Randomized /Titration Period|Adverse Event|0|||
23779794|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
23840289|NCT01077154|66795447|FG000|Overall Study|Withdrawal by Subject|369|||
23840290|NCT01077154|66795448|FG001|Overall Study|Withdrawal by Subject|385|||
23840291|NCT01077154|66795447|FG000|Overall Study|Death|215|||
23840292|NCT01077154|66795448|FG001|Overall Study|Death|214|||
23840293|NCT01077154|66795447|FG000|Overall Study|Lost to Follow-up|43|||
23840294|NCT01077154|66795448|FG001|Overall Study|Lost to Follow-up|35|||
23840295|NCT01077154|66795447|FG000|Overall Study|Noncompliance|22|||
23840296|NCT01077154|66795448|FG001|Overall Study|Noncompliance|20|||
23840297|NCT01077154|66795447|FG000|Overall Study|Disease Progression|18|||
23840298|NCT01077154|66795448|FG001|Overall Study|Disease Progression|20|||
23840299|NCT01077154|66795447|FG000|Overall Study|Ineligibility Determined|10|||
23840300|NCT01077154|66795448|FG001|Overall Study|Ineligibility Determined|14|||
23840301|NCT01077154|66795447|FG000|Overall Study|Other|14|||
23840302|NCT01077154|66795448|FG001|Overall Study|Other|11|||
23840303|NCT01077154|66795447|FG000|Overall Study|Adverse Event|9|||
23840304|NCT01077154|66795448|FG001|Overall Study|Adverse Event|9|||
23840305|NCT01077154|66795447|FG000|Overall Study|Administrative Decision|1|||
23840306|NCT01077154|66795448|FG001|Overall Study|Administrative Decision|6|||
23840307|NCT01077154|66795447|FG000|Overall Study|Protocol Deviation|1|||
23840308|NCT01077154|66795448|FG001|Overall Study|Protocol Deviation|0|||
23840309|NCT03991299|66795450|FG000|Overall Study|Study closed, sponsor decision|3|||
23840310|NCT03991299|66795450|FG000|Overall Study|Withdrawal by Subject|1|||
23840311|NCT04967885|66795451|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
23840312|NCT04967885|66795452|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
23840313|NCT04967885|66795451|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
23840314|NCT04967885|66795452|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
23840315|NCT04967885|66795451|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
23840316|NCT04967885|66795452|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
23840317|NCT04967885|66795451|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
23840318|NCT04967885|66795452|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
23840319|NCT04967885|66795451|FG000|EMI-II Intervention|Lost to Follow-up|14|||
23840320|NCT04967885|66795452|FG001|EMI-II Intervention|Lost to Follow-up|10|||
23840321|NCT02498444|66795453|FG000|Overall Study|Withdrawal by Subject|3|||
23840322|NCT02498444|66795454|FG001|Overall Study|Withdrawal by Subject|0|||
23840323|NCT02498444|66795453|FG000|Overall Study|Physician Decision|1|||
23840324|NCT02498444|66795454|FG001|Overall Study|Physician Decision|0|||
23840325|NCT01029782|66795458|FG000|Overall Study|Lost to Follow-up|2|||
23840326|NCT01029782|66795459|FG001|Overall Study|Lost to Follow-up|2|||
23840327|NCT01029782|66795458|FG000|Overall Study|Diagnosis changed|1|||
23840328|NCT01029782|66795459|FG001|Overall Study|Diagnosis changed|1|||
23840329|NCT01029782|66795458|FG000|Overall Study|Adverse Event|0|||
23840330|NCT01029782|66795459|FG001|Overall Study|Adverse Event|1|||
23840331|NCT01029782|66795458|FG000|Overall Study|Physician Decision|0|||
23840332|NCT01029782|66795459|FG001|Overall Study|Physician Decision|1|||
23840333|NCT01029782|66795458|FG000|Overall Study|Protocol Violation|0|||
23840334|NCT01029782|66795459|FG001|Overall Study|Protocol Violation|2|||
23840335|NCT01029782|66795458|FG000|Overall Study|Withdrawal by Subject|0|||
23840336|NCT01029782|66795459|FG001|Overall Study|Withdrawal by Subject|1|||
23840337|NCT03625466|66795461|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
23840338|NCT03625466|66795462|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
23779795|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
23779796|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
23840339|NCT03625466|66795463|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
23840340|NCT03625466|66795461|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23840341|NCT03625466|66795462|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23451527|NCT00430716|65395197|FG001|Open Label Phase|Other|1|||
23451528|NCT00430716|65395198|FG002|Open Label Phase|Other|1|||
23451529|NCT00430716|65395196|FG000|Open Label Phase|Protocol Violation|1|||
23779797|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
23779798|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
23451530|NCT00430716|65395197|FG001|Open Label Phase|Protocol Violation|0|||
23451531|NCT00430716|65395198|FG002|Open Label Phase|Protocol Violation|0|||
23779799|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
23779800|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
23779801|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
23779802|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
23779803|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
23779804|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
23779805|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
23779806|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
23779807|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
23779808|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
23779809|NCT00440518|66576244|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
23779810|NCT00440518|66576245|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
23779811|NCT00440518|66576246|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
23779812|NCT01473953|66576248|FG000|Overall Study|Other|1|||
23779813|NCT01473953|66576249|FG001|Overall Study|Other|0|||
23779814|NCT01473953|66576250|FG002|Overall Study|Other|0|||
23779815|NCT01473953|66576251|FG003|Overall Study|Other|0|||
23779816|NCT01473953|66576252|FG004|Overall Study|Other|0|||
23779817|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
23779818|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
23779819|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
23779820|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
23779821|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
23779822|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
23779823|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23779824|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23779825|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
23779826|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
23779827|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23779828|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
23779829|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
23779830|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
23779831|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23779832|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23779833|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
23779834|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
23779835|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
23779836|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
23779837|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Death|0|||
23779838|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Death|1|||
23779839|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Death|0|||
23779840|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Death|0|||
23779841|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
23779842|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
23779843|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
23779844|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
23779845|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
23779846|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23779847|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23779848|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23779849|NCT01940341|66576254|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23779850|NCT01940341|66576255|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23779851|NCT01940341|66576256|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23779852|NCT01940341|66576257|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23779853|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23779854|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23779855|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
23779856|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
23779857|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23779858|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23451532|NCT00430716|65395196|FG000|Open Label Phase|Study terminated by sponsor|4|||
23451533|NCT00430716|65395197|FG001|Open Label Phase|Study terminated by sponsor|5|||
23840342|NCT03625466|66795463|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23840343|NCT03625466|66795461|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23840344|NCT03625466|66795462|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23840345|NCT03625466|66795463|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23840346|NCT00267969|66795464|FG000|Controlled Period|Adverse Event|6|||
23840347|NCT00267969|66795465|FG001|Controlled Period|Adverse Event|0|||
23840348|NCT00267969|66795466|FG002|Controlled Period|Adverse Event|2|||
23840349|NCT00267969|66795467|FG003|Controlled Period|Adverse Event|0|||
23840350|NCT00267969|66795468|FG004|Controlled Period|Adverse Event|0|||
23840351|NCT00267969|66795469|FG005|Controlled Period|Adverse Event|0|||
23840352|NCT00267969|66795470|FG006|Controlled Period|Adverse Event|0|||
23779859|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
23779860|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
23779861|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23779862|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23779863|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
23779864|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23779865|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
23779866|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
23779867|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
23779868|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
23779869|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23779870|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23779871|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
23779872|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23779873|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
23779874|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
23779875|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
23779876|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
23779877|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23779878|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23779879|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
23779880|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23779881|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23779882|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23779883|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23779884|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
23779885|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23779886|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23779887|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23779888|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
23779889|NCT01940341|66576254|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23779890|NCT01940341|66576255|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23779891|NCT01940341|66576256|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
23779892|NCT01940341|66576257|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23779893|NCT04533594|66576258|FG000|Overall Study|Death|26|||
23779894|NCT00986245|66576261|FG000|First Intervention|Poor compliance|8|||
23779895|NCT00986245|66576262|FG001|First Intervention|Poor compliance|4|||
23779896|NCT00986245|66576261|FG000|First Intervention|Lack of Efficacy|1|||
23779897|NCT00986245|66576262|FG001|First Intervention|Lack of Efficacy|2|||
23779898|NCT00986245|66576261|FG000|First Intervention|Withdrawal by Subject|0|||
23779899|NCT00986245|66576262|FG001|First Intervention|Withdrawal by Subject|1|||
23779900|NCT00986245|66576261|FG000|First Intervention|Protocol Violation|0|||
23779901|NCT00986245|66576262|FG001|First Intervention|Protocol Violation|1|||
23779902|NCT00986245|66576261|FG000|First Intervention|Out of indication|1|||
23779903|NCT00986245|66576262|FG001|First Intervention|Out of indication|0|||
23779904|NCT00986245|66576261|FG000|Second Intervention|Poor compliance|1|||
23779905|NCT00986245|66576262|FG001|Second Intervention|Poor compliance|0|||
23779906|NCT00986245|66576261|FG000|Second Intervention|Lost to Follow-up|1|||
23779907|NCT00986245|66576262|FG001|Second Intervention|Lost to Follow-up|0|||
23779908|NCT00986245|66576261|FG000|Second Intervention|Protocol Violation|0|||
23779909|NCT00986245|66576262|FG001|Second Intervention|Protocol Violation|1|||
23779910|NCT01536574|66576263|FG000|Overall Study|Adverse Event|4|||
23840353|NCT00267969|66795464|FG000|Controlled Period|Lack of Efficacy|3|||
23840354|NCT00267969|66795465|FG001|Controlled Period|Lack of Efficacy|0|||
23451534|NCT00430716|65395198|FG002|Open Label Phase|Study terminated by sponsor|4|||
23580179|NCT04034238|65853391|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23580180|NCT04034238|65853392|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23580181|NCT04034238|65853393|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23580182|NCT04034238|65853390|FG000|Dose Escalation Phase|Screen failures|0|||
23580183|NCT04034238|65853391|FG001|Dose Escalation Phase|Screen failures|0|||
23580184|NCT04034238|65853392|FG002|Dose Escalation Phase|Screen failures|0|||
23580185|NCT04034238|65853393|FG003|Dose Escalation Phase|Screen failures|2|||
23580186|NCT04034238|65853390|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
23580187|NCT04034238|65853391|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
23580188|NCT04034238|65853392|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
23580189|NCT04034238|65853393|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
23580190|NCT04034238|65853390|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580191|NCT04034238|65853391|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580192|NCT04034238|65853392|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
23580193|NCT04034238|65853393|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580194|NCT03289455|65853394|FG000|Overall Study|Death|1|||
23580195|NCT03289455|65853395|FG001|Overall Study|Death|0|||
23580196|NCT03289455|65853396|FG002|Overall Study|Death|0|||
23580197|NCT03289455|65853394|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
23635192|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635193|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635194|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635195|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635196|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635197|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635198|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635199|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23635200|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
23635201|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
23635202|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
23635203|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
23635204|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635205|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635206|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635207|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635208|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635209|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635210|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635211|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23635212|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
23635213|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
23779911|NCT01536574|66576264|FG001|Overall Study|Adverse Event|5|||
23779912|NCT01536574|66576263|FG000|Overall Study|Withdrawal by Subject|1|||
23779913|NCT01536574|66576264|FG001|Overall Study|Withdrawal by Subject|2|||
23779914|NCT01536574|66576263|FG000|Overall Study|Lack of Efficacy|1|||
23779915|NCT01536574|66576264|FG001|Overall Study|Lack of Efficacy|0|||
23779916|NCT00465270|66576266|FG000|Overall Study|Death|7|||
23779917|NCT00465270|66576267|FG001|Overall Study|Death|11|||
23779918|NCT00465270|66576266|FG000|Overall Study|Withdrawal by Subject|34|||
23779919|NCT00465270|66576267|FG001|Overall Study|Withdrawal by Subject|78|||
23779920|NCT00465270|66576266|FG000|Overall Study|Lost to Follow-up|60|||
23779921|NCT00465270|66576267|FG001|Overall Study|Lost to Follow-up|67|||
23779922|NCT00465270|66576266|FG000|Overall Study|Investigator request|3|||
23779923|NCT00465270|66576267|FG001|Overall Study|Investigator request|4|||
23779924|NCT04405570|66576268|FG000|Overall Study|Adverse Event|0|||
23779925|NCT04405570|66576269|FG001|Overall Study|Adverse Event|1|||
23779926|NCT04405570|66576270|FG002|Overall Study|Adverse Event|1|||
23779927|NCT04405570|66576271|FG003|Overall Study|Adverse Event|1|||
23779928|NCT04405570|66576268|FG000|Overall Study|Lost to Follow-up|0|||
23779929|NCT04405570|66576269|FG001|Overall Study|Lost to Follow-up|1|||
23580198|NCT03289455|65853395|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
23580199|NCT03289455|65853396|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
23635214|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
23635215|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
23779930|NCT04405570|66576270|FG002|Overall Study|Lost to Follow-up|0|||
23779931|NCT04405570|66576271|FG003|Overall Study|Lost to Follow-up|0|||
23779932|NCT04405570|66576268|FG000|Overall Study|Physician Decision|0|||
23779933|NCT04405570|66576269|FG001|Overall Study|Physician Decision|0|||
23779934|NCT04405570|66576270|FG002|Overall Study|Physician Decision|1|||
23779935|NCT04405570|66576271|FG003|Overall Study|Physician Decision|0|||
23779936|NCT04405570|66576268|FG000|Overall Study|Withdrawal by Subject|0|||
23779937|NCT04405570|66576269|FG001|Overall Study|Withdrawal by Subject|1|||
23779938|NCT04405570|66576270|FG002|Overall Study|Withdrawal by Subject|1|||
23779939|NCT04405570|66576271|FG003|Overall Study|Withdrawal by Subject|0|||
23779940|NCT04405570|66576268|FG000|Overall Study|Randomized not dosed|0|||
23779941|NCT04405570|66576269|FG001|Overall Study|Randomized not dosed|2|||
23779942|NCT04405570|66576270|FG002|Overall Study|Randomized not dosed|0|||
23779943|NCT04405570|66576271|FG003|Overall Study|Randomized not dosed|0|||
23779944|NCT03673670|66576275|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
23779945|NCT03673670|66576276|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23779946|NCT03673670|66576277|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23779947|NCT03673670|66576278|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23779948|NCT03673670|66576279|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23779949|NCT03673670|66576280|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23779950|NCT03673670|66576275|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
23779951|NCT03673670|66576276|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
23779952|NCT03673670|66576277|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
23779953|NCT03673670|66576278|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
23779954|NCT03673670|66576279|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
23779955|NCT03673670|66576280|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
23779956|NCT03673670|66576275|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
23779957|NCT03673670|66576276|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
23779958|NCT03673670|66576277|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
23779959|NCT03673670|66576278|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
23779960|NCT03673670|66576279|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
23779961|NCT03673670|66576280|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
23779962|NCT03673670|66576275|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23779963|NCT03673670|66576276|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23779964|NCT03673670|66576277|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23779965|NCT03673670|66576278|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23779966|NCT03673670|66576279|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23779967|NCT03673670|66576280|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
23779968|NCT03673670|66576275|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
23779969|NCT03673670|66576276|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
23779970|NCT03673670|66576277|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
23779971|NCT03673670|66576278|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
23779972|NCT03673670|66576279|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
23779973|NCT03673670|66576280|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
23779974|NCT03673670|66576275|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23779975|NCT03673670|66576276|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23779976|NCT03673670|66576277|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23779977|NCT03673670|66576278|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23779978|NCT03673670|66576279|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
23779979|NCT03673670|66576280|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23779980|NCT03673670|66576275|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
23779981|NCT03673670|66576276|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
23779982|NCT03673670|66576277|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
23779983|NCT03673670|66576278|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
23779984|NCT03673670|66576279|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
23779985|NCT03673670|66576280|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
23779986|NCT03686033|66576284|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
23779987|NCT03686033|66576285|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
23779988|NCT03686033|66576286|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
23779989|NCT03686033|66576287|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
23779990|NCT03686033|66576288|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
23779991|NCT03686033|66576289|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
23779992|NCT01949662|66576290|FG000|Overall Study|Death|9|||
23779993|NCT01949662|66576291|FG001|Overall Study|Death|7|||
23779994|NCT01949662|66576290|FG000|Overall Study|Discharged before an agitation event|8|||
23779995|NCT01949662|66576291|FG001|Overall Study|Discharged before an agitation event|3|||
23779996|NCT01949662|66576290|FG000|Overall Study|Dropped out|1|||
23779997|NCT01949662|66576291|FG001|Overall Study|Dropped out|3|||
23779998|NCT01949662|66576290|FG000|Overall Study|Ineligible|0|||
23779999|NCT01949662|66576291|FG001|Overall Study|Ineligible|1|||
23780000|NCT02409355|66576294|FG000|Overall Study|Withdrawal by Subject|1|||
23780001|NCT02409355|66576295|FG001|Overall Study|Withdrawal by Subject|0|||
23780002|NCT02409355|66576294|FG000|Overall Study|Death|1|||
23780003|NCT02409355|66576295|FG001|Overall Study|Death|1|||
23780004|NCT02409355|66576294|FG000|Overall Study|Study terminated by Sponsor|2|||
23635216|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23780005|NCT02409355|66576295|FG001|Overall Study|Study terminated by Sponsor|3|||
23780006|NCT03620747|66576296|FG000|Overall Study|Participant decision|7|||
23780007|NCT03620747|66576296|FG000|Overall Study|Adverse Event|6|||
23780008|NCT03620747|66576296|FG000|Overall Study|Lack of Efficacy|1|||
23780009|NCT03620747|66576296|FG000|Overall Study|Poor compliance to protocol|2|||
23780010|NCT03620747|66576296|FG000|Overall Study|Other-unspecified|3|||
23780011|NCT02255097|66576298|FG000|Overall Study|Death|151|||
23780012|NCT02255097|66576298|FG000|Overall Study|Lost to Follow-up|5|||
23780013|NCT02255097|66576298|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
23780014|NCT02255097|66576298|FG000|Overall Study|Withdrawal by Subject|7|||
23780015|NCT02255097|66576298|FG000|Overall Study|Allocated but not treated|1|||
23780016|NCT02388191|66576299|FG000|Overall Study|Patient did not receive IUD|1|||
23451535|NCT00849940|65395203|FG000|Overall Study|Physician Decision|4|||
23451536|NCT03798717|65395218|FG000|Overall Study|Failed Screening|0|||
23451537|NCT03798717|65395219|FG001|Overall Study|Failed Screening|0|||
23451538|NCT03798717|65395220|FG002|Overall Study|Failed Screening|0|||
23451539|NCT03798717|65395221|FG003|Overall Study|Failed Screening|0|||
23451540|NCT03798717|65395222|FG004|Overall Study|Failed Screening|0|||
23451541|NCT03798717|65395223|FG005|Overall Study|Failed Screening|1|||
23451542|NCT03798717|65395218|FG000|Overall Study|Physician Decision|1|||
23451543|NCT03798717|65395219|FG001|Overall Study|Physician Decision|0|||
23451544|NCT03798717|65395220|FG002|Overall Study|Physician Decision|1|||
23451545|NCT03798717|65395221|FG003|Overall Study|Physician Decision|0|||
23451546|NCT03798717|65395222|FG004|Overall Study|Physician Decision|0|||
23451547|NCT03798717|65395223|FG005|Overall Study|Physician Decision|0|||
23451548|NCT03798717|65395218|FG000|Overall Study|Withdrawal by Subject|0|||
23451549|NCT03798717|65395219|FG001|Overall Study|Withdrawal by Subject|0|||
23451550|NCT03798717|65395220|FG002|Overall Study|Withdrawal by Subject|0|||
23451551|NCT03798717|65395221|FG003|Overall Study|Withdrawal by Subject|1|||
23451552|NCT03798717|65395222|FG004|Overall Study|Withdrawal by Subject|0|||
23451553|NCT03798717|65395223|FG005|Overall Study|Withdrawal by Subject|0|||
23451554|NCT03798717|65395218|FG000|Overall Study|Lost to Follow-up|1|||
23451555|NCT03798717|65395219|FG001|Overall Study|Lost to Follow-up|0|||
23451556|NCT03798717|65395220|FG002|Overall Study|Lost to Follow-up|0|||
23451557|NCT03798717|65395221|FG003|Overall Study|Lost to Follow-up|1|||
23451558|NCT03798717|65395222|FG004|Overall Study|Lost to Follow-up|0|||
23451559|NCT03798717|65395223|FG005|Overall Study|Lost to Follow-up|0|||
23451560|NCT03798717|65395218|FG000|Overall Study|Adverse Event|0|||
23451561|NCT03798717|65395219|FG001|Overall Study|Adverse Event|1|||
23451562|NCT03798717|65395220|FG002|Overall Study|Adverse Event|0|||
23451563|NCT03798717|65395221|FG003|Overall Study|Adverse Event|0|||
23451564|NCT03798717|65395222|FG004|Overall Study|Adverse Event|0|||
23451565|NCT03798717|65395223|FG005|Overall Study|Adverse Event|0|||
23451566|NCT03798717|65395218|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23780017|NCT02388191|66576300|FG001|Overall Study|Patient did not receive IUD|0|||
23451567|NCT03798717|65395219|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451568|NCT03798717|65395220|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451569|NCT03798717|65395221|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451570|NCT03798717|65395222|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
23451571|NCT03798717|65395223|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451572|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
23451573|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451574|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451575|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451576|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451577|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
23451578|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451579|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451580|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451581|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451582|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
23451583|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451584|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451585|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451586|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23780018|NCT02543203|66576302|FG000|Overall Study|Unpalatable Fragrance|2|||
23780019|NCT02543203|66576303|FG001|Overall Study|Unpalatable Fragrance|2|||
23451587|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
23451588|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451589|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451590|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451591|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451592|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
23780020|NCT02543203|66576302|FG000|Overall Study|Lost to Follow-up|1|||
23780021|NCT02543203|66576303|FG001|Overall Study|Lost to Follow-up|0|||
23339704|NCT00833482|64989238|FG002|Days 11-20|Adverse Event|0|||
23780022|NCT02543203|66576302|FG000|Overall Study|Increased Irritability|1|||
23780023|NCT02543203|66576303|FG001|Overall Study|Increased Irritability|0|||
23780024|NCT02543203|66576302|FG000|Overall Study|Family|1|||
23780025|NCT02543203|66576303|FG001|Overall Study|Family|2|||
23780026|NCT02543203|66576302|FG000|Overall Study|Negative Behavior|1|||
23780027|NCT02543203|66576303|FG001|Overall Study|Negative Behavior|0|||
23780028|NCT02543203|66576302|FG000|Overall Study|Withdrawal by Subject|0|||
23780029|NCT02543203|66576303|FG001|Overall Study|Withdrawal by Subject|1|||
23780030|NCT01182415|66576304|FG000|Overall Study|Lost to Follow-up|1|||
23580200|NCT03289455|65853394|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
23580201|NCT03289455|65853395|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
23780031|NCT00420238|66576305|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
23780032|NCT00420238|66576306|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
23780033|NCT00420238|66576305|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
23780034|NCT00420238|66576306|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
23780035|NCT00420238|66576305|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
23780036|NCT00420238|66576306|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
23780037|NCT00420238|66576305|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
23780038|NCT00420238|66576306|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
23780039|NCT00420238|66576305|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
23780040|NCT00420238|66576306|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
23780041|NCT00420238|66576305|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
23780042|NCT00420238|66576306|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
23780043|NCT00960297|66576307|FG000|Overall Study|Physician Decision|1|||
23780044|NCT00960297|66576307|FG000|Overall Study|Venous port infection|1|||
23780045|NCT00960297|66576307|FG000|Overall Study|Disease progression|1|||
23780046|NCT03128723|66576308|FG000|Overall Study|Withdrawal by Subject|2|||
23780047|NCT00519194|66576313|FG000|Overall Study|Withdrawal by Subject|9|||
23780048|NCT00519194|66576313|FG000|Overall Study|Death|9|||
23780049|NCT00519194|66576313|FG000|Overall Study|Lost to Follow-up|3|||
23780050|NCT01900626|66576314|FG000|Overall Study|study was closed due to low enrollment|1|||
23451593|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23780051|NCT01900626|66576315|FG001|Overall Study|study was closed due to low enrollment|1|||
23780052|NCT01507051|66576316|FG000|Overall Study|Withdrawal by Subject|1|||
23780053|NCT01507051|66576317|FG001|Overall Study|Withdrawal by Subject|3|||
23780054|NCT01507051|66576318|FG002|Overall Study|Withdrawal by Subject|1|||
23780055|NCT01507051|66576319|FG003|Overall Study|Withdrawal by Subject|6|||
23780056|NCT01507051|66576316|FG000|Overall Study|Physician Decision|0|||
23780057|NCT01507051|66576317|FG001|Overall Study|Physician Decision|0|||
23780058|NCT01507051|66576318|FG002|Overall Study|Physician Decision|0|||
23780059|NCT01507051|66576319|FG003|Overall Study|Physician Decision|1|||
23780060|NCT01507051|66576316|FG000|Overall Study|Adverse Event|1|||
23780061|NCT01507051|66576317|FG001|Overall Study|Adverse Event|0|||
23780062|NCT01507051|66576318|FG002|Overall Study|Adverse Event|0|||
23451594|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451595|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451596|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451597|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
23451598|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451599|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451600|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451601|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451602|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
23451603|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451604|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451605|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451606|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451607|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23451608|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
23451609|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
23451610|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
23451611|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
23451612|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23451613|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
23451614|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
23451615|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
23780063|NCT01507051|66576319|FG003|Overall Study|Adverse Event|0|||
23451616|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
23451617|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23780064|NCT01204294|66576320|FG000|Overall Study|Adverse Event|2|||
23580202|NCT03289455|65853396|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
23780065|NCT01204294|66576321|FG001|Overall Study|Adverse Event|6|||
23780066|NCT01204294|66576322|FG002|Overall Study|Adverse Event|0|||
23780067|NCT01204294|66576323|FG003|Overall Study|Adverse Event|7|||
23780068|NCT01204294|66576324|FG004|Overall Study|Adverse Event|1|||
23780069|NCT01204294|66576325|FG005|Overall Study|Adverse Event|4|||
23780070|NCT01204294|66576326|FG006|Overall Study|Adverse Event|0|||
23780071|NCT01204294|66576320|FG000|Overall Study|Protocol Violation|1|||
23780072|NCT01204294|66576321|FG001|Overall Study|Protocol Violation|0|||
23780073|NCT01204294|66576322|FG002|Overall Study|Protocol Violation|2|||
23780074|NCT01204294|66576323|FG003|Overall Study|Protocol Violation|1|||
23780075|NCT01204294|66576324|FG004|Overall Study|Protocol Violation|0|||
23780076|NCT01204294|66576325|FG005|Overall Study|Protocol Violation|0|||
23780077|NCT01204294|66576326|FG006|Overall Study|Protocol Violation|0|||
23780078|NCT01204294|66576320|FG000|Overall Study|Withdrawal by Subject|0|||
23780079|NCT01204294|66576321|FG001|Overall Study|Withdrawal by Subject|2|||
23780080|NCT01204294|66576322|FG002|Overall Study|Withdrawal by Subject|2|||
23580203|NCT03289455|65853394|FG000|Overall Study|Progressive disease|3|||
23580204|NCT03289455|65853395|FG001|Overall Study|Progressive disease|4|||
23580205|NCT03289455|65853396|FG002|Overall Study|Progressive disease|5|||
23580206|NCT04697069|65853399|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
23580207|NCT04697069|65853400|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
23580208|NCT04697069|65853399|FG000|Overall Study|Study termination|2|||
23580209|NCT04697069|65853400|FG001|Overall Study|Study termination|1|||
23580210|NCT00770211|65853401|FG000|Overall Study|Lost to Follow-up|1|||
23580211|NCT00770211|65853402|FG001|Overall Study|Lost to Follow-up|0|||
23580212|NCT00770211|65853401|FG000|Overall Study|Withdrawal by Subject|0|||
23580213|NCT00770211|65853402|FG001|Overall Study|Withdrawal by Subject|2|||
23580214|NCT04236986|65853405|FG000|Overall Study|Withdrawal by Subject|3|||
23580215|NCT04236986|65853406|FG001|Overall Study|Withdrawal by Subject|1|||
23580216|NCT01606189|65853411|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580217|NCT01606189|65853412|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580218|NCT01606189|65853413|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580219|NCT01606189|65853414|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580220|NCT01606189|65853415|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580221|NCT01606189|65853416|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
23580222|NCT01606189|65853411|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23635217|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23635218|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23635219|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23780081|NCT01204294|66576323|FG003|Overall Study|Withdrawal by Subject|1|||
23780082|NCT01204294|66576324|FG004|Overall Study|Withdrawal by Subject|1|||
23780083|NCT01204294|66576325|FG005|Overall Study|Withdrawal by Subject|1|||
23780084|NCT01204294|66576326|FG006|Overall Study|Withdrawal by Subject|2|||
23780085|NCT01204294|66576320|FG000|Overall Study|Lack of Efficacy|0|||
23780086|NCT01204294|66576321|FG001|Overall Study|Lack of Efficacy|0|||
23780087|NCT01204294|66576322|FG002|Overall Study|Lack of Efficacy|0|||
23780088|NCT01204294|66576323|FG003|Overall Study|Lack of Efficacy|2|||
23780089|NCT01204294|66576324|FG004|Overall Study|Lack of Efficacy|0|||
23780090|NCT01204294|66576325|FG005|Overall Study|Lack of Efficacy|0|||
23780091|NCT01204294|66576326|FG006|Overall Study|Lack of Efficacy|0|||
23780092|NCT01204294|66576320|FG000|Overall Study|Other (house moving)|0|||
23780093|NCT01204294|66576321|FG001|Overall Study|Other (house moving)|0|||
23780094|NCT01204294|66576322|FG002|Overall Study|Other (house moving)|1|||
23780095|NCT01204294|66576323|FG003|Overall Study|Other (house moving)|0|||
23780096|NCT01204294|66576324|FG004|Overall Study|Other (house moving)|0|||
23635220|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23635221|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23635222|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23635223|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23780097|NCT01204294|66576325|FG005|Overall Study|Other (house moving)|0|||
23780098|NCT01204294|66576326|FG006|Overall Study|Other (house moving)|0|||
23780099|NCT02979522|66576327|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
23780100|NCT02979522|66576328|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
23780101|NCT02979522|66576327|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
23780102|NCT02979522|66576328|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
23780103|NCT01474551|66576330|FG000|Overall Study|Death|1|||
23780104|NCT05038293|66576331|FG000|Overall Study|device was not operating properly for one subject.|1|||
23780105|NCT05038293|66576332|FG001|Overall Study|device was not operating properly for one subject.|0|||
23780106|NCT05038293|66576331|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
23580223|NCT01606189|65853412|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580224|NCT01606189|65853413|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23780107|NCT05038293|66576332|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
23780108|NCT02956460|66576333|FG000|Lens 1|Lost to Follow-up|1|||
23780109|NCT02956460|66576334|FG001|Lens 1|Lost to Follow-up|0|||
23780110|NCT00365846|66576335|FG000|Overall Study|Lost to Follow-up|1|||
23635224|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
23635225|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
23635226|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
23635227|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
23780111|NCT04175808|66576336|FG000|Part A|Miscellaneous|2|||
23780112|NCT04175808|66576337|FG001|Part A|Miscellaneous|0|||
23780113|NCT04175808|66576338|FG002|Part A|Miscellaneous|0|||
23780114|NCT04175808|66576339|FG003|Part A|Miscellaneous|0|||
23451618|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
23451619|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23451620|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
23451621|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
23635228|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635229|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635230|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635231|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635232|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635233|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635234|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635235|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23635236|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635237|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635238|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
23635239|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
23635240|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635241|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635242|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635243|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635244|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635245|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635246|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635247|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23635248|NCT01646177|66049434|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
23635249|NCT01646177|66049435|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
23635250|NCT01646177|66049436|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
23635251|NCT01646177|66049437|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635252|NCT01646177|66049438|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635253|NCT01646177|66049439|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635254|NCT01646177|66049440|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635255|NCT01646177|66049441|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635256|NCT01646177|66049442|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635257|NCT01646177|66049443|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635258|NCT01646177|66049444|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635259|NCT01646177|66049445|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23635260|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635261|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635262|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635263|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635264|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
23635265|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
23635266|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
23635267|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
23635268|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635269|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635270|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23635271|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23780115|NCT04175808|66576340|FG004|Part A|Miscellaneous|0|||
23840355|NCT00267969|66795466|FG002|Controlled Period|Lack of Efficacy|1|||
23451622|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23635272|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635273|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635274|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635275|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23451623|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23451624|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23451625|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23451626|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23451627|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23451628|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
23451629|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23451630|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
23451631|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23451632|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23451633|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23451634|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
23451635|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
23451636|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
23451637|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451638|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451639|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451640|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23451641|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
23451642|NCT02422498|65395232|FG000|Overall Study|Inevaluable|4|||
23451643|NCT01078441|65395233|FG000|Overall Study|Withdrawal by Subject|1|||
23451644|NCT00217425|65395235|FG000|Overall Study|Never started treatment|2|||
23451645|NCT00217425|65395235|FG000|Overall Study|Patient ineligible|5|||
23451646|NCT00217425|65395235|FG000|Overall Study|Lack of Efficacy|13|||
23451647|NCT00217425|65395235|FG000|Overall Study|Adverse Event|8|||
23451648|NCT00217425|65395235|FG000|Overall Study|Withdrawal by Subject|4|||
23451649|NCT00217425|65395235|FG000|Overall Study|Other complicating disease|1|||
23451650|NCT00217425|65395235|FG000|Overall Study|Other|4|||
23451651|NCT00965081|65395236|FG000|Overall Study|Adverse Event|14|||
23451652|NCT00965081|65395237|FG001|Overall Study|Adverse Event|9|||
23451653|NCT00965081|65395236|FG000|Overall Study|Lack of Efficacy|2|||
23451654|NCT00965081|65395237|FG001|Overall Study|Lack of Efficacy|5|||
23451655|NCT00965081|65395236|FG000|Overall Study|Lost to Follow-up|4|||
23451656|NCT00965081|65395237|FG001|Overall Study|Lost to Follow-up|5|||
23451657|NCT00965081|65395236|FG000|Overall Study|Physician Decision|2|||
23451658|NCT00965081|65395237|FG001|Overall Study|Physician Decision|0|||
23451659|NCT00965081|65395236|FG000|Overall Study|Protocol Violation|2|||
23451660|NCT00965081|65395237|FG001|Overall Study|Protocol Violation|5|||
23451661|NCT00965081|65395236|FG000|Overall Study|Sponsor Decision|1|||
23635276|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
23635277|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
23635278|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
23635279|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
23635280|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635281|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635282|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635283|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23635284|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635285|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635286|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23780116|NCT04175808|66576341|FG005|Part A|Miscellaneous|0|||
23780117|NCT04175808|66576342|FG006|Part A|Miscellaneous|0|||
23780118|NCT01746017|66576345|FG000|Period 1|Withdrawal by Subject|0|||
23780119|NCT01746017|66576346|FG001|Period 1|Withdrawal by Subject|0|||
23780120|NCT01746017|66576347|FG002|Period 1|Withdrawal by Subject|0|||
23780121|NCT01746017|66576348|FG003|Period 1|Withdrawal by Subject|0|||
23780122|NCT01746017|66576349|FG004|Period 1|Withdrawal by Subject|0|||
23780123|NCT01746017|66576350|FG005|Period 1|Withdrawal by Subject|0|||
23780124|NCT01746017|66576351|FG006|Period 1|Withdrawal by Subject|1|||
23780125|NCT01746017|66576352|FG007|Period 1|Withdrawal by Subject|0|||
23780126|NCT01746017|66576353|FG008|Period 1|Withdrawal by Subject|0|||
23780127|NCT01746017|66576354|FG009|Period 1|Withdrawal by Subject|0|||
23780128|NCT01746017|66576355|FG010|Period 1|Withdrawal by Subject|0|||
23451662|NCT00965081|65395237|FG001|Overall Study|Sponsor Decision|0|||
23451663|NCT00965081|65395236|FG000|Overall Study|Withdrawal by Subject|4|||
23451664|NCT00965081|65395237|FG001|Overall Study|Withdrawal by Subject|7|||
23451665|NCT00965081|65395236|FG000|Overall Study|Switched to Rescue Arm|5|||
23451666|NCT00965081|65395237|FG001|Overall Study|Switched to Rescue Arm|12|||
23451667|NCT00227721|65395239|FG000|Overall Study|On study, but never treated.|1|||
23780129|NCT01746017|66576345|FG000|Period 3|Withdrawal by Subject|0|||
23780130|NCT01746017|66576346|FG001|Period 3|Withdrawal by Subject|0|||
23635287|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635288|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
23635289|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
23635290|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
23635291|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
23635292|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635293|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635294|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635295|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23635296|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635297|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635298|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635299|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635300|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
23635301|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
23635302|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
23635303|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
23635304|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635305|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635306|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23635307|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23780131|NCT01746017|66576347|FG002|Period 3|Withdrawal by Subject|0|||
23780132|NCT01746017|66576348|FG003|Period 3|Withdrawal by Subject|0|||
23780133|NCT01746017|66576349|FG004|Period 3|Withdrawal by Subject|0|||
23780134|NCT01746017|66576350|FG005|Period 3|Withdrawal by Subject|1|||
23780135|NCT01746017|66576351|FG006|Period 3|Withdrawal by Subject|0|||
23780136|NCT01746017|66576352|FG007|Period 3|Withdrawal by Subject|0|||
23780137|NCT01746017|66576353|FG008|Period 3|Withdrawal by Subject|0|||
23780138|NCT01746017|66576354|FG009|Period 3|Withdrawal by Subject|0|||
23780139|NCT01746017|66576355|FG010|Period 3|Withdrawal by Subject|0|||
23451668|NCT01467505|65395240|FG000|Overall Study|Adverse Event|1|||
23451669|NCT01467505|65395241|FG001|Overall Study|Adverse Event|0|||
23451670|NCT01467505|65395240|FG000|Overall Study|Withdrawal by Subject|4|||
23451671|NCT01467505|65395241|FG001|Overall Study|Withdrawal by Subject|0|||
23451672|NCT01467505|65395240|FG000|Overall Study|Study Terminated by Sponsor|28|||
23451673|NCT01467505|65395241|FG001|Overall Study|Study Terminated by Sponsor|3|||
23451674|NCT00423657|65395248|FG000|Overall Study|Withdrew consent|10|||
23451675|NCT00423657|65395249|FG001|Overall Study|Withdrew consent|8|||
23451676|NCT00423657|65395248|FG000|Overall Study|Non-compliance|0|||
23451677|NCT00423657|65395249|FG001|Overall Study|Non-compliance|1|||
23451678|NCT00423657|65395248|FG000|Overall Study|Other|15|||
23451679|NCT00423657|65395249|FG001|Overall Study|Other|16|||
23451680|NCT00423657|65395248|FG000|Overall Study|Request of sponsor/investigator|1|||
23451681|NCT00423657|65395249|FG001|Overall Study|Request of sponsor/investigator|0|||
23451682|NCT00702702|65395253|FG000|Overall Study|Study prematurely terminated|56|||
23451683|NCT00443040|65395254|FG000|Overall Study|Withdrawal by Subject|1|||
23451684|NCT00443040|65395255|FG001|Overall Study|Withdrawal by Subject|0|||
23451685|NCT00443040|65395256|FG002|Overall Study|Withdrawal by Subject|0|||
23451686|NCT00443040|65395254|FG000|Overall Study|Converted to an open laparotomy|3|||
23780140|NCT02724462|66576356|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
23780141|NCT02724462|66576357|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
23780142|NCT02724462|66576356|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23780143|NCT02724462|66576357|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23780144|NCT02724462|66576356|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
23780145|NCT02724462|66576357|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
23780146|NCT02724462|66576356|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23780147|NCT02724462|66576357|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23780148|NCT02724462|66576356|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
23780149|NCT02724462|66576357|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
23780150|NCT02724462|66576356|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23780151|NCT02724462|66576357|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23780152|NCT01873586|66576358|FG000|Overall Study|Lost to Follow-up|3|||
23840356|NCT00267969|66795467|FG003|Controlled Period|Lack of Efficacy|0|||
23451687|NCT00443040|65395255|FG001|Overall Study|Converted to an open laparotomy|0|||
23451688|NCT00443040|65395256|FG002|Overall Study|Converted to an open laparotomy|1|||
23840357|NCT00267969|66795468|FG004|Controlled Period|Lack of Efficacy|0|||
23451689|NCT01814527|65395259|FG000|Overall Study|RTP greater than 30 days|6|||
23451690|NCT01814527|65395260|FG001|Overall Study|RTP greater than 30 days|1|||
23451691|NCT00467740|65395263|FG000|Overall Study|Adverse Event|0|||
23635308|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635309|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635310|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635311|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635312|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
23635313|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23635314|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23635315|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23635316|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635317|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23339705|NCT00833482|64989239|FG003|Days 11-20|Adverse Event|0|||
23339706|NCT00833482|64989240|FG004|Days 11-20|Adverse Event|0|||
23339707|NCT00833482|64989241|FG005|Days 11-20|Adverse Event|0|||
23339708|NCT00833482|64989236|FG000|Days 11-20|Withdrawal by Subject|0|||
23339709|NCT00833482|64989237|FG001|Days 11-20|Withdrawal by Subject|1|||
23339710|NCT00833482|64989238|FG002|Days 11-20|Withdrawal by Subject|0|||
23339711|NCT00833482|64989239|FG003|Days 11-20|Withdrawal by Subject|0|||
23339712|NCT00833482|64989240|FG004|Days 11-20|Withdrawal by Subject|0|||
23339713|NCT00833482|64989241|FG005|Days 11-20|Withdrawal by Subject|0|||
23339714|NCT00833482|64989236|FG000|Days 21-30|Adverse Event|0|||
23339715|NCT00833482|64989237|FG001|Days 21-30|Adverse Event|0|||
23451692|NCT00467740|65395264|FG001|Overall Study|Adverse Event|0|||
23635318|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635319|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23635320|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635321|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635322|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635323|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635324|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
23635325|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
23635326|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635327|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
23780153|NCT00467363|66576359|FG000|Overall Study|Lost to Follow-up|80|||
23780154|NCT00467363|66576360|FG001|Overall Study|Lost to Follow-up|70|||
23780155|NCT03236311|66576361|FG000|Overall Study|Study terminated by sponsor|0|||
23780156|NCT03236311|66576362|FG001|Overall Study|Study terminated by sponsor|2|||
23780157|NCT03236311|66576361|FG000|Overall Study|Adverse Event|0|||
23780158|NCT03236311|66576362|FG001|Overall Study|Adverse Event|1|||
23780159|NCT00787254|66576365|FG000|Overall Study|Adverse Event|24|||
23780160|NCT00787254|66576366|FG001|Overall Study|Adverse Event|23|||
23339716|NCT00833482|64989238|FG002|Days 21-30|Adverse Event|1|||
23339717|NCT00833482|64989239|FG003|Days 21-30|Adverse Event|0|||
23451693|NCT00467740|65395265|FG002|Overall Study|Adverse Event|1|||
23451694|NCT00467740|65395266|FG003|Overall Study|Adverse Event|0|||
23635328|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635329|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635330|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635331|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23635332|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635333|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635334|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635335|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635336|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
23635337|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23635338|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23635339|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23635340|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635341|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635342|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23339718|NCT00833482|64989240|FG004|Days 21-30|Adverse Event|0|||
23635343|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23635344|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
23635345|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
23635346|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
23635347|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
23635348|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
23780161|NCT00787254|66576365|FG000|Overall Study|Protocol Violation|26|||
23339719|NCT00833482|64989241|FG005|Days 21-30|Adverse Event|0|||
23339720|NCT00833482|64989236|FG000|Days 21-30|Withdrawal by Subject|0|||
23339721|NCT00833482|64989237|FG001|Days 21-30|Withdrawal by Subject|0|||
23339722|NCT00833482|64989238|FG002|Days 21-30|Withdrawal by Subject|0|||
23635349|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
23635350|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
23635351|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
23635352|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
23635353|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
23635354|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
23339723|NCT00833482|64989239|FG003|Days 21-30|Withdrawal by Subject|0|||
23339724|NCT00833482|64989240|FG004|Days 21-30|Withdrawal by Subject|1|||
23339725|NCT00833482|64989241|FG005|Days 21-30|Withdrawal by Subject|0|||
23451695|NCT00467740|65395267|FG004|Overall Study|Adverse Event|0|||
23635355|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
23635356|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635357|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23780162|NCT00787254|66576366|FG001|Overall Study|Protocol Violation|23|||
23780163|NCT00787254|66576365|FG000|Overall Study|Withdrawal by Subject|16|||
23780164|NCT00787254|66576366|FG001|Overall Study|Withdrawal by Subject|11|||
23780165|NCT00787254|66576365|FG000|Overall Study|Lack of Efficacy|4|||
23780166|NCT00787254|66576366|FG001|Overall Study|Lack of Efficacy|15|||
23780167|NCT00787254|66576365|FG000|Overall Study|NSAIDs discontinuation|1|||
23780168|NCT00787254|66576366|FG001|Overall Study|NSAIDs discontinuation|2|||
23780169|NCT00787254|66576365|FG000|Overall Study|Institution closed|1|||
23780170|NCT00787254|66576366|FG001|Overall Study|Institution closed|0|||
23780171|NCT00787254|66576365|FG000|Overall Study|Physician Decision|4|||
23780172|NCT00787254|66576366|FG001|Overall Study|Physician Decision|8|||
23780173|NCT01061866|66576370|FG000|Overall Study|Adverse Event|2|||
23780174|NCT02624050|66576371|FG000|Overall Study|Physician Decision|4|||
23780175|NCT02624050|66576372|FG001|Overall Study|Physician Decision|0|||
23780176|NCT02624050|66576371|FG000|Overall Study|Protocol Violation|2|||
23780177|NCT02624050|66576372|FG001|Overall Study|Protocol Violation|0|||
23780178|NCT03084471|66576378|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
23780179|NCT03084471|66576378|FG000|Overall Study|Condition under investigation worsened|84|||
23780180|NCT03084471|66576378|FG000|Overall Study|Lack of therapeutic response|2|||
23780181|NCT03084471|66576378|FG000|Overall Study|Protocol Violation|1|||
23780182|NCT03084471|66576378|FG000|Overall Study|Adverse Event|73|||
23780183|NCT03084471|66576378|FG000|Overall Study|Withdrawal by Subject|12|||
23780184|NCT03084471|66576378|FG000|Overall Study|Disease relapse|181|||
23780185|NCT03084471|66576378|FG000|Overall Study|Subjective disease progression|359|||
23780186|NCT03084471|66576378|FG000|Overall Study|Other (as recorded)|33|||
23780187|NCT03084471|66576378|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
23780188|NCT03707912|66576379|FG000|Overall Study|Violation of inclusion criteria|1|||
23780189|NCT03707912|66576380|FG001|Overall Study|Violation of inclusion criteria|0|||
23780190|NCT03290781|66576382|FG000|Overall Study|Adverse Event|5|||
23780191|NCT03290781|66576383|FG001|Overall Study|Adverse Event|7|||
23780192|NCT03290781|66576384|FG002|Overall Study|Adverse Event|4|||
23780193|NCT03290781|66576385|FG003|Overall Study|Adverse Event|1|||
23780194|NCT03290781|66576386|FG004|Overall Study|Adverse Event|0|||
23780195|NCT03290781|66576387|FG005|Overall Study|Adverse Event|0|||
23780196|NCT03290781|66576388|FG006|Overall Study|Adverse Event|0|||
23780197|NCT03290781|66576382|FG000|Overall Study|Death|0|||
23780198|NCT03290781|66576383|FG001|Overall Study|Death|0|||
23780199|NCT03290781|66576384|FG002|Overall Study|Death|1|||
23780200|NCT03290781|66576385|FG003|Overall Study|Death|0|||
23780201|NCT03290781|66576386|FG004|Overall Study|Death|1|||
23780202|NCT03290781|66576387|FG005|Overall Study|Death|0|||
23780203|NCT03290781|66576388|FG006|Overall Study|Death|0|||
23780204|NCT03290781|66576382|FG000|Overall Study|Withdrawal by Subject|6|||
23780205|NCT03290781|66576383|FG001|Overall Study|Withdrawal by Subject|5|||
23780206|NCT03290781|66576384|FG002|Overall Study|Withdrawal by Subject|9|||
23780207|NCT03290781|66576385|FG003|Overall Study|Withdrawal by Subject|10|||
23780208|NCT03290781|66576386|FG004|Overall Study|Withdrawal by Subject|1|||
23780209|NCT03290781|66576387|FG005|Overall Study|Withdrawal by Subject|2|||
23780210|NCT03290781|66576388|FG006|Overall Study|Withdrawal by Subject|0|||
23780211|NCT03290781|66576382|FG000|Overall Study|Physician Decision|0|||
23780212|NCT03290781|66576383|FG001|Overall Study|Physician Decision|1|||
23780213|NCT03290781|66576384|FG002|Overall Study|Physician Decision|0|||
23780214|NCT03290781|66576385|FG003|Overall Study|Physician Decision|0|||
23339726|NCT02278120|64989242|FG000|Treatment Period|Progressive disease|234|||
23451696|NCT00467740|65395263|FG000|Overall Study|Protocol Violation|0|||
23635358|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23780215|NCT03290781|66576386|FG004|Overall Study|Physician Decision|0|||
23780216|NCT03290781|66576387|FG005|Overall Study|Physician Decision|0|||
23780217|NCT03290781|66576388|FG006|Overall Study|Physician Decision|0|||
23780218|NCT03290781|66576382|FG000|Overall Study|Site Terminated by Sponsor|1|||
23780219|NCT03290781|66576383|FG001|Overall Study|Site Terminated by Sponsor|0|||
23780220|NCT03290781|66576384|FG002|Overall Study|Site Terminated by Sponsor|2|||
23780221|NCT03290781|66576385|FG003|Overall Study|Site Terminated by Sponsor|1|||
23451697|NCT00467740|65395264|FG001|Overall Study|Protocol Violation|0|||
23635359|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635360|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23635361|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23635362|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23635363|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
23635364|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635365|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635366|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635367|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23635368|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635369|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635370|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635371|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635372|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635373|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23780222|NCT03290781|66576386|FG004|Overall Study|Site Terminated by Sponsor|0|||
23780223|NCT03290781|66576387|FG005|Overall Study|Site Terminated by Sponsor|0|||
23780224|NCT03290781|66576388|FG006|Overall Study|Site Terminated by Sponsor|0|||
23780225|NCT03290781|66576382|FG000|Overall Study|Lost to Follow-up|0|||
23780226|NCT03290781|66576383|FG001|Overall Study|Lost to Follow-up|0|||
23780227|NCT03290781|66576384|FG002|Overall Study|Lost to Follow-up|0|||
23780228|NCT03290781|66576385|FG003|Overall Study|Lost to Follow-up|1|||
23780229|NCT03290781|66576386|FG004|Overall Study|Lost to Follow-up|0|||
23780230|NCT03290781|66576387|FG005|Overall Study|Lost to Follow-up|0|||
23780231|NCT03290781|66576388|FG006|Overall Study|Lost to Follow-up|0|||
23780232|NCT03290781|66576382|FG000|Overall Study|Protocol Deviation|2|||
23780233|NCT03290781|66576383|FG001|Overall Study|Protocol Deviation|0|||
23780234|NCT03290781|66576384|FG002|Overall Study|Protocol Deviation|0|||
23780235|NCT03290781|66576385|FG003|Overall Study|Protocol Deviation|1|||
23780236|NCT03290781|66576386|FG004|Overall Study|Protocol Deviation|0|||
23780237|NCT03290781|66576387|FG005|Overall Study|Protocol Deviation|0|||
23780238|NCT03290781|66576388|FG006|Overall Study|Protocol Deviation|0|||
23780239|NCT03290781|66576382|FG000|Overall Study|Disease Relapse|32|||
23780240|NCT03290781|66576383|FG001|Overall Study|Disease Relapse|5|||
23780241|NCT03290781|66576384|FG002|Overall Study|Disease Relapse|38|||
23780242|NCT03290781|66576385|FG003|Overall Study|Disease Relapse|7|||
23780243|NCT03290781|66576386|FG004|Overall Study|Disease Relapse|3|||
23780244|NCT03290781|66576387|FG005|Overall Study|Disease Relapse|1|||
23780245|NCT03290781|66576388|FG006|Overall Study|Disease Relapse|4|||
23780246|NCT03290781|66576382|FG000|Overall Study|Other|3|||
23780247|NCT03290781|66576383|FG001|Overall Study|Other|0|||
23780248|NCT03290781|66576384|FG002|Overall Study|Other|2|||
23780249|NCT03290781|66576385|FG003|Overall Study|Other|2|||
23780250|NCT03290781|66576386|FG004|Overall Study|Other|0|||
23780251|NCT03290781|66576387|FG005|Overall Study|Other|0|||
23780252|NCT03290781|66576388|FG006|Overall Study|Other|0|||
23339727|NCT02278120|64989243|FG001|Treatment Period|Progressive disease|260|||
23339728|NCT02278120|64989242|FG000|Treatment Period|Subject/guardian decision|23|||
23339729|NCT02278120|64989243|FG001|Treatment Period|Subject/guardian decision|20|||
23339730|NCT02278120|64989242|FG000|Treatment Period|Adverse Event|16|||
23339731|NCT02278120|64989243|FG001|Treatment Period|Adverse Event|14|||
23339732|NCT02278120|64989242|FG000|Treatment Period|Physician Decision|14|||
23339733|NCT02278120|64989243|FG001|Treatment Period|Physician Decision|27|||
23339734|NCT02278120|64989242|FG000|Treatment Period|Death|3|||
23339735|NCT02278120|64989243|FG001|Treatment Period|Death|3|||
23339736|NCT02278120|64989242|FG000|Treatment Period|Lost to Follow-up|2|||
23339737|NCT02278120|64989243|FG001|Treatment Period|Lost to Follow-up|0|||
23339738|NCT02278120|64989242|FG000|Treatment Period|Protocol deviation|0|||
23339739|NCT02278120|64989243|FG001|Treatment Period|Protocol deviation|2|||
23339740|NCT02278120|64989242|FG000|Treatment Period|Study terminated as per protocol|43|||
23339741|NCT02278120|64989243|FG001|Treatment Period|Study terminated as per protocol|11|||
23339742|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23339743|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23635374|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635375|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
23780253|NCT03503318|66576389|FG000|Overall Study|Death|1|||
23780254|NCT03503318|66576390|FG001|Overall Study|Death|0|||
23780255|NCT03503318|66576391|FG002|Overall Study|Death|4|||
23780256|NCT03503318|66576389|FG000|Overall Study|Adverse Event|3|||
23780257|NCT03503318|66576390|FG001|Overall Study|Adverse Event|4|||
23780258|NCT03503318|66576391|FG002|Overall Study|Adverse Event|2|||
23339744|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23339745|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23340867|NCT01936181|64992872|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
23339746|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
23339747|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
23339748|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
23339749|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
23339750|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23339751|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23339752|NCT00231114|64989244|FG000|Randomized|Withdrawal by Subject|6|||
23339753|NCT00231114|64989245|FG001|Randomized|Withdrawal by Subject|3|||
23339754|NCT00231114|64989244|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
23339755|NCT00231114|64989245|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
23339756|NCT00231114|64989244|FG000|Post-Treatment Period|Lost to Follow-up|6|||
23339757|NCT00231114|64989245|FG001|Post-Treatment Period|Lost to Follow-up|1|||
23339758|NCT00231114|64989244|FG000|Post-Treatment Period|Physician Decision|1|||
23339759|NCT00231114|64989245|FG001|Post-Treatment Period|Physician Decision|0|||
23339760|NCT00231114|64989244|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
23339761|NCT00231114|64989245|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
23780259|NCT03503318|66576389|FG000|Overall Study|Withdrawal by Subject|12|||
23780260|NCT03503318|66576390|FG001|Overall Study|Withdrawal by Subject|17|||
23780261|NCT03503318|66576391|FG002|Overall Study|Withdrawal by Subject|16|||
23780262|NCT03503318|66576389|FG000|Overall Study|Protocol Violation|5|||
23780263|NCT03503318|66576390|FG001|Overall Study|Protocol Violation|0|||
23780264|NCT03503318|66576391|FG002|Overall Study|Protocol Violation|3|||
23780265|NCT03503318|66576389|FG000|Overall Study|Lost to Follow-up|17|||
23780266|NCT03503318|66576390|FG001|Overall Study|Lost to Follow-up|15|||
23339762|NCT02949843|64989246|FG000|Overall Study|Withdrawal by Subject|0|||
23339763|NCT02949843|64989247|FG001|Overall Study|Withdrawal by Subject|1|||
23339764|NCT02949843|64989248|FG002|Overall Study|Withdrawal by Subject|1|||
23339765|NCT00068393|64989250|FG000|Overall Study|Adverse Event|2|||
23339766|NCT00068393|64989250|FG000|Overall Study|Death|3|||
23339767|NCT00068393|64989250|FG000|Overall Study|Withdrawal by Subject|3|||
23339768|NCT00068393|64989250|FG000|Overall Study|Alternative treatment|1|||
23339769|NCT00068393|64989250|FG000|Overall Study|Quality of life worsening|1|||
23339770|NCT03429244|64989253|FG000|Overall Study|Withdrawal by Subject|2|||
23339771|NCT03429244|64989254|FG001|Overall Study|Withdrawal by Subject|1|||
23339772|NCT03429244|64989255|FG002|Overall Study|Withdrawal by Subject|1|||
23339773|NCT00138073|64989256|FG000|Overall Study|lack of resources|55|||
23339774|NCT03075891|64989257|FG000|Overall Study|Withdrawal by Subject|3|||
23339775|NCT03075891|64989258|FG001|Overall Study|Withdrawal by Subject|6|||
23339776|NCT03075891|64989257|FG000|Overall Study|Lost to Follow-up|1|||
23339777|NCT03075891|64989258|FG001|Overall Study|Lost to Follow-up|0|||
23339778|NCT03075891|64989257|FG000|Overall Study|Pregnancy|3|||
23339779|NCT03075891|64989258|FG001|Overall Study|Pregnancy|1|||
23339780|NCT03075891|64989257|FG000|Overall Study|visits not performed (no time)|1|||
23339781|NCT03075891|64989258|FG001|Overall Study|visits not performed (no time)|0|||
23339782|NCT03075891|64989257|FG000|Overall Study|Drug abuse relapse issue|0|||
23339783|NCT03075891|64989258|FG001|Overall Study|Drug abuse relapse issue|1|||
23339784|NCT03075891|64989257|FG000|Overall Study|Participant requiring study withdrawal|0|||
23339785|NCT03075891|64989258|FG001|Overall Study|Participant requiring study withdrawal|1|||
23339786|NCT03075891|64989257|FG000|Overall Study|Adverse event, non-fatal|1|||
23339787|NCT03075891|64989258|FG001|Overall Study|Adverse event, non-fatal|4|||
23339788|NCT01190410|64989259|FG000|Overall Study|Adverse Event|0|||
23339789|NCT01190410|64989260|FG001|Overall Study|Adverse Event|3|||
23339790|NCT01190410|64989259|FG000|Overall Study|Lack of Efficacy|0|||
23339791|NCT01190410|64989260|FG001|Overall Study|Lack of Efficacy|2|||
23339792|NCT01190410|64989259|FG000|Overall Study|Withdrawal by Subject|0|||
23339793|NCT01190410|64989260|FG001|Overall Study|Withdrawal by Subject|2|||
23339794|NCT01190410|64989259|FG000|Overall Study|Administrative decision|1|||
23339795|NCT01190410|64989260|FG001|Overall Study|Administrative decision|0|||
23339796|NCT01190410|64989259|FG000|Overall Study|PI discretion|0|||
23580225|NCT01606189|65853414|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580226|NCT01606189|65853415|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580227|NCT01606189|65853416|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
23780267|NCT03503318|66576391|FG002|Overall Study|Lost to Follow-up|12|||
23780268|NCT03503318|66576389|FG000|Overall Study|Other than specified|1|||
23780269|NCT03503318|66576390|FG001|Overall Study|Other than specified|3|||
23339797|NCT01190410|64989260|FG001|Overall Study|PI discretion|2|||
23339798|NCT00747474|64989261|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339799|NCT00747474|64989262|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339800|NCT00747474|64989263|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339801|NCT00747474|64989264|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339802|NCT00747474|64989265|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339803|NCT00747474|64989266|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23780270|NCT03503318|66576391|FG002|Overall Study|Other than specified|3|||
23780271|NCT01534663|66576392|FG000|Overall Study|Lost to Follow-up|0|||
23780272|NCT01534663|66576393|FG001|Overall Study|Lost to Follow-up|2|||
23780273|NCT01534663|66576392|FG000|Overall Study|Adverse Event|2|||
23780274|NCT01534663|66576393|FG001|Overall Study|Adverse Event|1|||
23780275|NCT00251979|66576394|FG000|Overall Study|Protocol Violation|3|||
23780276|NCT00251979|66576395|FG001|Overall Study|Protocol Violation|5|||
23780277|NCT00251979|66576394|FG000|Overall Study|Adverse Event|11|||
23780278|NCT00251979|66576395|FG001|Overall Study|Adverse Event|17|||
23780279|NCT00251979|66576394|FG000|Overall Study|Withdrawal by Subject|13|||
23780280|NCT00251979|66576395|FG001|Overall Study|Withdrawal by Subject|7|||
23780281|NCT00251979|66576394|FG000|Overall Study|Lost to Follow-up|8|||
23780282|NCT00251979|66576395|FG001|Overall Study|Lost to Follow-up|6|||
23780283|NCT00251979|66576394|FG000|Overall Study|Death|3|||
23780284|NCT00251979|66576395|FG001|Overall Study|Death|5|||
23780285|NCT01519661|66576396|FG000|Overall Study|Protocol deviation|6|||
23780286|NCT01519661|66576396|FG000|Overall Study|Lost to Follow-up|3|||
23780287|NCT01519661|66576396|FG000|Overall Study|Withdrawal by Subject|17|||
23780288|NCT01519661|66576396|FG000|Overall Study|Lack of Efficacy|6|||
23339804|NCT00747474|64989267|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339805|NCT00747474|64989268|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
23339806|NCT00747474|64989269|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339807|NCT00747474|64989270|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23780289|NCT01519661|66576396|FG000|Overall Study|Adverse Event|29|||
23780290|NCT04720664|66576401|FG000|Overall Study|Adverse Event|2|||
23780291|NCT04720664|66576401|FG000|Overall Study|Lack of Efficacy|9|||
23780292|NCT00096447|66576402|FG000|Overall Study|Never treated|1|||
23780293|NCT04349917|66576406|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
23780294|NCT04349917|66576407|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
23780295|NCT04349917|66576406|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
23780296|NCT04349917|66576407|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
23780297|NCT04000815|66576408|FG000|Overall Study|Lost to Follow-up|9|||
23780298|NCT04000815|66576409|FG001|Overall Study|Lost to Follow-up|2|||
23780299|NCT04000815|66576410|FG002|Overall Study|Lost to Follow-up|3|||
23780300|NCT04000815|66576408|FG000|Overall Study|Withdrawal by Subject|4|||
23780301|NCT04000815|66576409|FG001|Overall Study|Withdrawal by Subject|3|||
23780302|NCT04000815|66576410|FG002|Overall Study|Withdrawal by Subject|2|||
23780303|NCT04000815|66576408|FG000|Overall Study|Right ovarian cyst occured|1|||
23780304|NCT04000815|66576409|FG001|Overall Study|Right ovarian cyst occured|0|||
23780305|NCT04000815|66576410|FG002|Overall Study|Right ovarian cyst occured|0|||
23780306|NCT04000815|66576408|FG000|Overall Study|Hypertension occured on follow up|0|||
23780307|NCT04000815|66576409|FG001|Overall Study|Hypertension occured on follow up|0|||
23780308|NCT04000815|66576410|FG002|Overall Study|Hypertension occured on follow up|2|||
23780309|NCT03459807|66576413|FG000|Overall Study|Withdrawal due to transplant|0|||
23780310|NCT03459807|66576414|FG001|Overall Study|Withdrawal due to transplant|1|||
23780311|NCT01171963|66576417|FG000|Overall Study|Adverse Event|10|||
23780312|NCT01171963|66576418|FG001|Overall Study|Adverse Event|15|||
23780313|NCT01171963|66576417|FG000|Overall Study|Lost to Follow-up|23|||
23780314|NCT01171963|66576418|FG001|Overall Study|Lost to Follow-up|24|||
23780315|NCT01171963|66576417|FG000|Overall Study|Other - diarrhoea|1|||
23780316|NCT01171963|66576418|FG001|Overall Study|Other - diarrhoea|0|||
23780317|NCT01171963|66576417|FG000|Overall Study|Withdrawal by Subject|114|||
23780318|NCT01171963|66576418|FG001|Overall Study|Withdrawal by Subject|129|||
23780319|NCT00773253|66576419|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
23780320|NCT00773253|66576420|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
23780321|NCT00163657|66576427|FG000|Overall Study|Death|12|||
23780322|NCT00163657|66576428|FG001|Overall Study|Death|14|||
23780323|NCT00163657|66576429|FG002|Overall Study|Death|19|||
23780324|NCT00163657|66576427|FG000|Overall Study|graft loss|4|||
23780325|NCT00163657|66576428|FG001|Overall Study|graft loss|1|||
23780326|NCT00163657|66576429|FG002|Overall Study|graft loss|2|||
23780327|NCT00163657|66576427|FG000|Overall Study|Withdrawal by Subject|2|||
23780328|NCT00163657|66576428|FG001|Overall Study|Withdrawal by Subject|3|||
23780329|NCT00163657|66576429|FG002|Overall Study|Withdrawal by Subject|2|||
23780330|NCT00163657|66576427|FG000|Overall Study|Physician Decision|0|||
23780331|NCT00163657|66576428|FG001|Overall Study|Physician Decision|1|||
23339808|NCT00747474|64989271|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339809|NCT00747474|64989272|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339810|NCT00073983|64989273|FG000|Overall Study|not evaluable|1|||
23339811|NCT02004886|64989274|FG000|Overall Study|Adverse Event|0|||
23339812|NCT02004886|64989275|FG001|Overall Study|Adverse Event|1|||
23339813|NCT02004886|64989276|FG002|Overall Study|Adverse Event|0|||
23339814|NCT02004886|64989277|FG003|Overall Study|Adverse Event|0|||
23780332|NCT00163657|66576429|FG002|Overall Study|Physician Decision|1|||
23780333|NCT00163657|66576427|FG000|Overall Study|Non Compliance|1|||
23780334|NCT00163657|66576428|FG001|Overall Study|Non Compliance|0|||
23780335|NCT00163657|66576429|FG002|Overall Study|Non Compliance|0|||
23780336|NCT00163657|66576427|FG000|Overall Study|Lost to Follow-up|1|||
23451698|NCT00467740|65395265|FG002|Overall Study|Protocol Violation|1|||
23451699|NCT00467740|65395266|FG003|Overall Study|Protocol Violation|0|||
23451700|NCT00467740|65395267|FG004|Overall Study|Protocol Violation|0|||
23451701|NCT00467740|65395263|FG000|Overall Study|Lost to Follow-up|0|||
23451702|NCT00467740|65395264|FG001|Overall Study|Lost to Follow-up|1|||
23451703|NCT00467740|65395265|FG002|Overall Study|Lost to Follow-up|0|||
23451704|NCT00467740|65395266|FG003|Overall Study|Lost to Follow-up|0|||
23451705|NCT00467740|65395267|FG004|Overall Study|Lost to Follow-up|0|||
23451706|NCT00467740|65395263|FG000|Overall Study|Withdrawal by Subject|1|||
23451707|NCT00467740|65395264|FG001|Overall Study|Withdrawal by Subject|1|||
23451708|NCT00467740|65395265|FG002|Overall Study|Withdrawal by Subject|0|||
23451709|NCT00467740|65395266|FG003|Overall Study|Withdrawal by Subject|1|||
23451710|NCT00467740|65395267|FG004|Overall Study|Withdrawal by Subject|0|||
23780337|NCT00163657|66576428|FG001|Overall Study|Lost to Follow-up|3|||
23780338|NCT00163657|66576429|FG002|Overall Study|Lost to Follow-up|10|||
23451711|NCT00467740|65395263|FG000|Overall Study|Lack of Efficacy|0|||
23451712|NCT00467740|65395264|FG001|Overall Study|Lack of Efficacy|1|||
23780339|NCT00163657|66576427|FG000|Overall Study|Other reason|0|||
23780340|NCT00163657|66576428|FG001|Overall Study|Other reason|1|||
23780341|NCT00163657|66576429|FG002|Overall Study|Other reason|3|||
23451713|NCT00467740|65395265|FG002|Overall Study|Lack of Efficacy|0|||
23451714|NCT00467740|65395266|FG003|Overall Study|Lack of Efficacy|0|||
23451715|NCT00467740|65395267|FG004|Overall Study|Lack of Efficacy|0|||
23780342|NCT00252720|66576433|FG000|Overall Study|Withdrawal by Subject|95|||
23780343|NCT00252720|66576434|FG001|Overall Study|Withdrawal by Subject|97|||
23780344|NCT00252720|66576433|FG000|Overall Study|Death|7|||
23780345|NCT00252720|66576434|FG001|Overall Study|Death|8|||
23780346|NCT00252720|66576433|FG000|Overall Study|Moving|23|||
23780347|NCT00252720|66576434|FG001|Overall Study|Moving|42|||
23780348|NCT00252720|66576433|FG000|Overall Study|Mainly patients lost to follow-up|7|||
23451716|NCT00079040|65395268|FG000|Overall Study|Withdrew before treatment|1|||
23451717|NCT00079040|65395268|FG000|Overall Study|Ineligible|1|||
23451718|NCT01451723|65395270|FG000|Overall Study|study halted|6|||
23451719|NCT01451723|65395271|FG001|Overall Study|study halted|5|||
23451720|NCT01791244|65395272|FG000|Overall Study|Adverse Event|5|||
23451721|NCT01791244|65395273|FG001|Overall Study|Adverse Event|7|||
23451722|NCT01791244|65395272|FG000|Overall Study|Insufficient clinical response|10|||
23451723|NCT01791244|65395273|FG001|Overall Study|Insufficient clinical response|10|||
23451724|NCT01791244|65395272|FG000|Overall Study|Laboratory Abnormality|0|||
23451725|NCT01791244|65395273|FG001|Overall Study|Laboratory Abnormality|1|||
23451726|NCT00857285|65395274|FG000|Overall Study|Adverse Event|4|||
23451727|NCT00857285|65395275|FG001|Overall Study|Adverse Event|2|||
23451728|NCT00857285|65395274|FG000|Overall Study|Lack of Efficacy|0|||
23451729|NCT00857285|65395275|FG001|Overall Study|Lack of Efficacy|2|||
23451730|NCT00857285|65395274|FG000|Overall Study|Protocol Violation|3|||
23451731|NCT00857285|65395275|FG001|Overall Study|Protocol Violation|1|||
23451732|NCT00857285|65395274|FG000|Overall Study|Withdrawal by Subject|4|||
23451733|NCT00857285|65395275|FG001|Overall Study|Withdrawal by Subject|0|||
23451734|NCT00857285|65395274|FG000|Overall Study|Randomization criteria not met|1|||
23451735|NCT00857285|65395275|FG001|Overall Study|Randomization criteria not met|1|||
23451736|NCT02193776|65395276|FG000|Overall Study|Consent withdrawn|1|||
23451737|NCT02193776|65395277|FG001|Overall Study|Consent withdrawn|0|||
23451738|NCT02193776|65395278|FG002|Overall Study|Consent withdrawn|0|||
23451739|NCT02193776|65395279|FG003|Overall Study|Consent withdrawn|0|||
23451740|NCT02193776|65395276|FG000|Overall Study|Failure to comply with protocol|0|||
23451741|NCT02193776|65395277|FG001|Overall Study|Failure to comply with protocol|1|||
23451742|NCT02193776|65395278|FG002|Overall Study|Failure to comply with protocol|0|||
23451743|NCT02193776|65395279|FG003|Overall Study|Failure to comply with protocol|0|||
23580228|NCT00797225|65853418|FG000|Weeks 1 to 12|Adverse Event|0|||
23580229|NCT00797225|65853419|FG001|Weeks 1 to 12|Adverse Event|0|||
23580230|NCT00797225|65853420|FG002|Weeks 1 to 12|Adverse Event|1|||
23580231|NCT00797225|65853421|FG003|Weeks 1 to 12|Adverse Event|0|||
23580232|NCT00797225|65853422|FG004|Weeks 1 to 12|Adverse Event|0|||
23780349|NCT00252720|66576434|FG001|Overall Study|Mainly patients lost to follow-up|18|||
23451744|NCT02193776|65395276|FG000|Overall Study|Investigator/Sponsor decision|1|||
23451745|NCT02193776|65395277|FG001|Overall Study|Investigator/Sponsor decision|1|||
23451746|NCT02193776|65395278|FG002|Overall Study|Investigator/Sponsor decision|0|||
23451747|NCT02193776|65395279|FG003|Overall Study|Investigator/Sponsor decision|0|||
23451748|NCT02193776|65395276|FG000|Overall Study|Death|1|||
23451749|NCT02193776|65395277|FG001|Overall Study|Death|0|||
23451750|NCT02193776|65395278|FG002|Overall Study|Death|0|||
23451751|NCT02193776|65395279|FG003|Overall Study|Death|0|||
23451752|NCT02193776|65395276|FG000|Overall Study|Adverse event/Specific toxicity|5|||
23451753|NCT02193776|65395277|FG001|Overall Study|Adverse event/Specific toxicity|5|||
23451754|NCT02193776|65395278|FG002|Overall Study|Adverse event/Specific toxicity|2|||
23451755|NCT02193776|65395279|FG003|Overall Study|Adverse event/Specific toxicity|2|||
23580233|NCT00797225|65853423|FG005|Weeks 1 to 12|Adverse Event|0|||
23780350|NCT01038856|66576435|FG000|Overall Study|Adverse Event|2|||
23451756|NCT01788566|65395280|FG000|Overall Study|Death|4|||
23451757|NCT01788566|65395280|FG000|Overall Study|Adverse Event|1|||
23451758|NCT01788566|65395280|FG000|Overall Study|Clinical Progressive Disease|3|||
23451759|NCT01884077|65395284|FG000|Overall Study|screen fail|0|||
23451760|NCT01884077|65395285|FG001|Overall Study|screen fail|2|||
23451761|NCT01884077|65395284|FG000|Overall Study|canceled surgery|2|||
23451762|NCT01884077|65395285|FG001|Overall Study|canceled surgery|0|||
23451763|NCT01884077|65395284|FG000|Overall Study|Lost to Follow-up|0|||
23451764|NCT01884077|65395285|FG001|Overall Study|Lost to Follow-up|4|||
23451765|NCT01884077|65395284|FG000|Overall Study|study closed|6|||
23451766|NCT01884077|65395285|FG001|Overall Study|study closed|4|||
23451767|NCT04516746|65395292|FG000|Overall Study|Randomized but not Treated|51|||
23451768|NCT04516746|65395293|FG001|Overall Study|Randomized but not Treated|19|||
23780351|NCT05041361|66576436|FG000|Overall Study|Lost to Follow-up|1|||
23780352|NCT05041361|66576437|FG001|Overall Study|Lost to Follow-up|3|||
23780353|NCT01878292|66576438|FG000|Randomized|Protocol Violation|1|||
23780354|NCT01878292|66576439|FG001|Randomized|Protocol Violation|0|||
23780355|NCT01878292|66576440|FG002|Randomized|Protocol Violation|0|||
23780356|NCT01878292|66576438|FG000|Randomized|Lost to Follow-up|1|||
23780357|NCT01878292|66576439|FG001|Randomized|Lost to Follow-up|0|||
23780358|NCT01878292|66576440|FG002|Randomized|Lost to Follow-up|0|||
23780359|NCT01878292|66576438|FG000|Randomized|Adverse Event|1|||
23780360|NCT01878292|66576439|FG001|Randomized|Adverse Event|0|||
23780361|NCT01878292|66576440|FG002|Randomized|Adverse Event|0|||
23780362|NCT01878292|66576438|FG000|Double-blind Treatment Period|Other Reasons|2|||
23780363|NCT01878292|66576439|FG001|Double-blind Treatment Period|Other Reasons|0|||
23780364|NCT01878292|66576440|FG002|Double-blind Treatment Period|Other Reasons|0|||
23780365|NCT01878292|66576438|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
23780366|NCT01878292|66576439|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
23780367|NCT01878292|66576440|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23780368|NCT01878292|66576438|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
23780369|NCT01878292|66576439|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
23780370|NCT01878292|66576440|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
23780371|NCT01878292|66576438|FG000|Double-blind Treatment Period|Protocol Violation|3|||
23780372|NCT01878292|66576439|FG001|Double-blind Treatment Period|Protocol Violation|4|||
23780373|NCT01878292|66576440|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23780374|NCT01878292|66576438|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
23780375|NCT01878292|66576439|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
23780376|NCT01878292|66576440|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23780377|NCT01878292|66576438|FG000|Double-blind Treatment Period|Adverse Event|4|||
23780378|NCT01878292|66576439|FG001|Double-blind Treatment Period|Adverse Event|9|||
23780379|NCT01878292|66576440|FG002|Double-blind Treatment Period|Adverse Event|8|||
23780380|NCT01878292|66576438|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
23780381|NCT01878292|66576439|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
23780382|NCT01878292|66576440|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
23780383|NCT03966365|66576441|FG000|Overall Study|Protocol Violation|1|||
23780384|NCT03966365|66576442|FG001|Overall Study|Protocol Violation|0|||
23780385|NCT01498120|66576443|FG000|Overall Study|Lost to Follow-up|1|||
23780386|NCT01498120|66576443|FG000|Overall Study|Withdrawal by Subject|5|||
23780387|NCT01498120|66576443|FG000|Overall Study|AE, non-serious non-fatal|3|||
23780388|NCT01498120|66576443|FG000|Overall Study|Other|4|||
23780389|NCT02140060|66576446|FG000|Overall Study|Adverse Event|0|||
23780390|NCT02140060|66576447|FG001|Overall Study|Adverse Event|0|||
23780391|NCT02140060|66576448|FG002|Overall Study|Adverse Event|0|||
23780392|NCT02140060|66576449|FG003|Overall Study|Adverse Event|1|||
23780393|NCT02140060|66576450|FG004|Overall Study|Adverse Event|1|||
23780394|NCT02140060|66576451|FG005|Overall Study|Adverse Event|1|||
23780395|NCT02140060|66576446|FG000|Overall Study|Lack of Efficacy|0|||
23780396|NCT02140060|66576447|FG001|Overall Study|Lack of Efficacy|0|||
23780397|NCT02140060|66576448|FG002|Overall Study|Lack of Efficacy|0|||
23780398|NCT02140060|66576449|FG003|Overall Study|Lack of Efficacy|1|||
23780399|NCT02140060|66576450|FG004|Overall Study|Lack of Efficacy|0|||
23780400|NCT02140060|66576451|FG005|Overall Study|Lack of Efficacy|0|||
23451769|NCT04516746|65395292|FG000|Overall Study|Adverse Event|0|||
23451770|NCT04516746|65395293|FG001|Overall Study|Adverse Event|1|||
23451771|NCT04516746|65395292|FG000|Overall Study|Death|62|||
23451772|NCT04516746|65395293|FG001|Overall Study|Death|32|||
23451773|NCT04516746|65395292|FG000|Overall Study|Lost to Follow-up|3431|||
23451774|NCT04516746|65395293|FG001|Overall Study|Lost to Follow-up|1831|||
23780401|NCT00453362|66576455|FG000|Overall Study|Adverse Event|5|||
23780402|NCT00453362|66576455|FG000|Overall Study|Death|7|||
23780403|NCT00453362|66576455|FG000|Overall Study|Physician Decision|2|||
23780404|NCT00453362|66576455|FG000|Overall Study|Withdrawal by Subject|3|||
23780405|NCT00453362|66576455|FG000|Overall Study|Progression of disease|56|||
23780406|NCT00453362|66576455|FG000|Overall Study|Screening Failure|14|||
23782292|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23782293|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23780407|NCT02017223|66580014|FG000|Overall Study|Algorithm problems|2|||
23780408|NCT03375463|66580015|FG000|Period 1|Lost to Follow-up|0|||
23780409|NCT03375463|66580016|FG001|Period 1|Lost to Follow-up|0|||
23780410|NCT03375463|66580017|FG002|Period 1|Lost to Follow-up|1|||
23780411|NCT03375463|66580018|FG003|Period 1|Lost to Follow-up|0|||
23780412|NCT03375463|66580019|FG004|Period 1|Lost to Follow-up|0|||
23780413|NCT03375463|66580020|FG005|Period 1|Lost to Follow-up|0|||
23780414|NCT03375463|66580015|FG000|Period 1|Adverse Event|0|||
23780415|NCT03375463|66580016|FG001|Period 1|Adverse Event|0|||
23780416|NCT03375463|66580017|FG002|Period 1|Adverse Event|0|||
23780417|NCT03375463|66580018|FG003|Period 1|Adverse Event|0|||
23780418|NCT03375463|66580019|FG004|Period 1|Adverse Event|1|||
23451775|NCT04516746|65395292|FG000|Overall Study|Withdrawal by Subject|1946|||
23451776|NCT04516746|65395293|FG001|Overall Study|Withdrawal by Subject|1696|||
23451777|NCT04516746|65395292|FG000|Overall Study|Physician Decision|10|||
23780419|NCT03375463|66580020|FG005|Period 1|Adverse Event|0|||
23780420|NCT03375463|66580015|FG000|Period 2|Lost to Follow-up|1|||
23780421|NCT03375463|66580016|FG001|Period 2|Lost to Follow-up|1|||
23780422|NCT03375463|66580017|FG002|Period 2|Lost to Follow-up|0|||
23780423|NCT03375463|66580018|FG003|Period 2|Lost to Follow-up|0|||
23780424|NCT03375463|66580019|FG004|Period 2|Lost to Follow-up|0|||
23451778|NCT04516746|65395293|FG001|Overall Study|Physician Decision|8|||
23451779|NCT04516746|65395292|FG000|Overall Study|Other|35|||
23451780|NCT04516746|65395293|FG001|Overall Study|Other|16|||
23451781|NCT02544321|65395305|FG000|Overall Study|Withdrawal by Subject|1|||
23451782|NCT02544321|65395306|FG001|Overall Study|Withdrawal by Subject|2|||
23451783|NCT02544321|65395305|FG000|Overall Study|Adverse Event|1|||
23451784|NCT02544321|65395306|FG001|Overall Study|Adverse Event|1|||
23451785|NCT02544321|65395305|FG000|Overall Study|Protocol Violation|0|||
23451786|NCT02544321|65395306|FG001|Overall Study|Protocol Violation|1|||
23451787|NCT00550953|65395307|FG000|Overall Study|Adverse Event|4|||
23451788|NCT00550953|65395308|FG001|Overall Study|Adverse Event|3|||
23451789|NCT00550953|65395307|FG000|Overall Study|Not able to visit the site|2|||
23451790|NCT00550953|65395308|FG001|Overall Study|Not able to visit the site|3|||
23451791|NCT04537793|65395309|FG000|Part B (24 Weeks)|Adverse Event|0|||
23451792|NCT04537793|65395310|FG001|Part B (24 Weeks)|Adverse Event|1|||
23451793|NCT03206216|65395311|FG000|Overall Study|Withdrawal by Subject|0|||
23451794|NCT03206216|65395312|FG001|Overall Study|Withdrawal by Subject|1|||
23451795|NCT02407223|65395315|FG000|Overall Study|Adverse Event|1|||
23451796|NCT02407223|65395316|FG001|Overall Study|Adverse Event|0|||
23451797|NCT02407223|65395317|FG002|Overall Study|Adverse Event|1|||
23451798|NCT02407223|65395315|FG000|Overall Study|Lack of Efficacy|6|||
23451799|NCT02407223|65395316|FG001|Overall Study|Lack of Efficacy|6|||
23451800|NCT02407223|65395317|FG002|Overall Study|Lack of Efficacy|4|||
23451801|NCT02407223|65395315|FG000|Overall Study|Lost to Follow-up|1|||
23451802|NCT02407223|65395316|FG001|Overall Study|Lost to Follow-up|0|||
23451803|NCT02407223|65395317|FG002|Overall Study|Lost to Follow-up|2|||
23451804|NCT02407223|65395315|FG000|Overall Study|Withdrawal by Subject|2|||
23451805|NCT02407223|65395316|FG001|Overall Study|Withdrawal by Subject|4|||
23451806|NCT02407223|65395317|FG002|Overall Study|Withdrawal by Subject|4|||
23451807|NCT02407223|65395315|FG000|Overall Study|Study Terminated by Sponsor|77|||
23451808|NCT02407223|65395316|FG001|Overall Study|Study Terminated by Sponsor|80|||
23451809|NCT02407223|65395317|FG002|Overall Study|Study Terminated by Sponsor|86|||
23451810|NCT02407223|65395315|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
23451811|NCT02407223|65395316|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
23451812|NCT02407223|65395317|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
23451813|NCT02407223|65395315|FG000|Overall Study|Other|29|||
23451814|NCT02407223|65395316|FG001|Overall Study|Other|27|||
23780425|NCT03375463|66580020|FG005|Period 2|Lost to Follow-up|0|||
23780426|NCT03606174|66580021|FG000|Overall Study|Death|37|||
23780427|NCT03606174|66580022|FG001|Overall Study|Death|15|||
23780428|NCT03606174|66580023|FG002|Overall Study|Death|15|||
23780429|NCT03606174|66580024|FG003|Overall Study|Death|7|||
23780430|NCT03606174|66580025|FG004|Overall Study|Death|35|||
23780431|NCT03606174|66580026|FG005|Overall Study|Death|12|||
23780432|NCT03606174|66580027|FG006|Overall Study|Death|35|||
23451815|NCT02407223|65395317|FG002|Overall Study|Other|25|||
23451816|NCT00377520|65395318|FG000|Overall Study|Ineligible (Prior radiation)|1|||
23451817|NCT02269124|65395319|FG000|Overall Study|Lost to Follow-up|1|||
23451818|NCT02269124|65395320|FG001|Overall Study|Lost to Follow-up|0|||
23451819|NCT02269124|65395319|FG000|Overall Study|Withdrawal by Subject|0|||
23451820|NCT02269124|65395320|FG001|Overall Study|Withdrawal by Subject|2|||
23451821|NCT00399516|65395323|FG000|Overall Study|Lost to Follow-up|2|||
23451822|NCT03550378|65395324|FG000|Overall Study|Death|0|||
23451823|NCT03550378|65395325|FG001|Overall Study|Death|1|||
23451824|NCT01420861|65395330|FG000|Overall Study|Adverse Event|2|||
23451825|NCT01420861|65395330|FG000|Overall Study|Study terminated by Sponsor|7|||
23780433|NCT03606174|66580028|FG007|Overall Study|Death|8|||
23780434|NCT03606174|66580029|FG008|Overall Study|Death|5|||
23780435|NCT03606174|66580030|FG009|Overall Study|Death|3|||
23780436|NCT03606174|66580031|FG010|Overall Study|Death|0|||
23780437|NCT03606174|66580021|FG000|Overall Study|Lost to Follow-up|0|||
23780438|NCT03606174|66580022|FG001|Overall Study|Lost to Follow-up|0|||
23780439|NCT03606174|66580023|FG002|Overall Study|Lost to Follow-up|0|||
23780440|NCT03606174|66580024|FG003|Overall Study|Lost to Follow-up|0|||
23780441|NCT03606174|66580025|FG004|Overall Study|Lost to Follow-up|1|||
23780442|NCT03606174|66580026|FG005|Overall Study|Lost to Follow-up|1|||
23780443|NCT03606174|66580027|FG006|Overall Study|Lost to Follow-up|0|||
23780444|NCT03606174|66580028|FG007|Overall Study|Lost to Follow-up|0|||
23780445|NCT03606174|66580029|FG008|Overall Study|Lost to Follow-up|0|||
23780446|NCT03606174|66580030|FG009|Overall Study|Lost to Follow-up|0|||
23780447|NCT03606174|66580031|FG010|Overall Study|Lost to Follow-up|0|||
23780448|NCT03606174|66580021|FG000|Overall Study|Withdrawal by Subject|6|||
23780449|NCT03606174|66580022|FG001|Overall Study|Withdrawal by Subject|0|||
23780450|NCT03606174|66580023|FG002|Overall Study|Withdrawal by Subject|0|||
23780451|NCT03606174|66580024|FG003|Overall Study|Withdrawal by Subject|1|||
23780452|NCT03606174|66580025|FG004|Overall Study|Withdrawal by Subject|2|||
23780453|NCT03606174|66580026|FG005|Overall Study|Withdrawal by Subject|1|||
23780454|NCT03606174|66580027|FG006|Overall Study|Withdrawal by Subject|4|||
23780455|NCT03606174|66580028|FG007|Overall Study|Withdrawal by Subject|0|||
23780456|NCT03606174|66580029|FG008|Overall Study|Withdrawal by Subject|0|||
23780457|NCT03606174|66580030|FG009|Overall Study|Withdrawal by Subject|0|||
23780458|NCT03606174|66580031|FG010|Overall Study|Withdrawal by Subject|1|||
23780459|NCT03606174|66580021|FG000|Overall Study|Study Terminated by Sponsor|5|||
23780460|NCT03606174|66580022|FG001|Overall Study|Study Terminated by Sponsor|7|||
23780461|NCT03606174|66580023|FG002|Overall Study|Study Terminated by Sponsor|3|||
23780462|NCT03606174|66580024|FG003|Overall Study|Study Terminated by Sponsor|0|||
23780463|NCT03606174|66580025|FG004|Overall Study|Study Terminated by Sponsor|11|||
23780464|NCT03606174|66580026|FG005|Overall Study|Study Terminated by Sponsor|6|||
23780465|NCT03606174|66580027|FG006|Overall Study|Study Terminated by Sponsor|12|||
23780466|NCT03606174|66580028|FG007|Overall Study|Study Terminated by Sponsor|1|||
23780467|NCT03606174|66580029|FG008|Overall Study|Study Terminated by Sponsor|3|||
23780468|NCT03606174|66580030|FG009|Overall Study|Study Terminated by Sponsor|1|||
23780469|NCT03606174|66580031|FG010|Overall Study|Study Terminated by Sponsor|2|||
23780470|NCT03606174|66580021|FG000|Overall Study|Miscellaneous|1|||
23780471|NCT03606174|66580022|FG001|Overall Study|Miscellaneous|1|||
23780472|NCT03606174|66580023|FG002|Overall Study|Miscellaneous|0|||
23780473|NCT03606174|66580024|FG003|Overall Study|Miscellaneous|1|||
23780474|NCT03606174|66580025|FG004|Overall Study|Miscellaneous|4|||
23780475|NCT03606174|66580026|FG005|Overall Study|Miscellaneous|7|||
23780476|NCT03606174|66580027|FG006|Overall Study|Miscellaneous|5|||
23780477|NCT03606174|66580028|FG007|Overall Study|Miscellaneous|0|||
23780478|NCT03606174|66580029|FG008|Overall Study|Miscellaneous|0|||
23780479|NCT03606174|66580030|FG009|Overall Study|Miscellaneous|0|||
23780480|NCT03606174|66580031|FG010|Overall Study|Miscellaneous|1|||
23780481|NCT03956862|66580034|FG000|Overall Study|Lost to Follow-up|1|||
23780482|NCT03956862|66580035|FG001|Overall Study|Lost to Follow-up|1|||
23780483|NCT03956862|66580034|FG000|Overall Study|Withdrawal by Subject|1|||
23780484|NCT03956862|66580035|FG001|Overall Study|Withdrawal by Subject|1|||
23780485|NCT03925532|66580036|FG000|Overall Study|Lost to Follow-up|1|||
23780486|NCT03100344|66580037|FG000|Overall Study|Adverse Event|0|||
23780487|NCT03100344|66580038|FG001|Overall Study|Adverse Event|3|||
23780488|NCT03100344|66580039|FG002|Overall Study|Adverse Event|2|||
23780489|NCT03100344|66580040|FG003|Overall Study|Adverse Event|3|||
23780490|NCT03100344|66580037|FG000|Overall Study|Lack of Efficacy|2|||
23780491|NCT03100344|66580038|FG001|Overall Study|Lack of Efficacy|0|||
23780492|NCT03100344|66580039|FG002|Overall Study|Lack of Efficacy|0|||
23780493|NCT03100344|66580040|FG003|Overall Study|Lack of Efficacy|0|||
23780494|NCT03100344|66580037|FG000|Overall Study|Protocol Violation|1|||
23780495|NCT03100344|66580038|FG001|Overall Study|Protocol Violation|0|||
23780496|NCT03100344|66580039|FG002|Overall Study|Protocol Violation|0|||
23780497|NCT03100344|66580040|FG003|Overall Study|Protocol Violation|0|||
23780498|NCT03100344|66580037|FG000|Overall Study|Withdrawal by Subject|10|||
23780499|NCT03100344|66580038|FG001|Overall Study|Withdrawal by Subject|7|||
23780500|NCT03100344|66580039|FG002|Overall Study|Withdrawal by Subject|4|||
23780501|NCT03100344|66580040|FG003|Overall Study|Withdrawal by Subject|8|||
23780502|NCT03100344|66580037|FG000|Overall Study|Lost to Follow-up|1|||
23780503|NCT03100344|66580038|FG001|Overall Study|Lost to Follow-up|1|||
23780504|NCT03100344|66580039|FG002|Overall Study|Lost to Follow-up|1|||
23780505|NCT03100344|66580040|FG003|Overall Study|Lost to Follow-up|1|||
23580234|NCT00797225|65853424|FG006|Weeks 1 to 12|Adverse Event|0|||
23780506|NCT00837486|66580041|FG000|Blinded-treatment Phase|Physician Decision|1|||
23780507|NCT00837486|66580042|FG001|Blinded-treatment Phase|Physician Decision|0|||
23780508|NCT00837486|66580041|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
23780509|NCT00837486|66580042|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
23780510|NCT00837486|66580041|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
23780511|NCT00837486|66580042|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
23780512|NCT00837486|66580041|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
23451826|NCT01420861|65395330|FG000|Overall Study|Screen failure|7|||
23451827|NCT01420861|65395330|FG000|Overall Study|Randomized not Treated|2|||
23451828|NCT00395746|65398836|FG000|Overall Study|Adverse Event|5|||
23451829|NCT00395746|65398837|FG001|Overall Study|Adverse Event|2|||
23451830|NCT00395746|65398838|FG002|Overall Study|Adverse Event|2|||
23451831|NCT00395746|65398836|FG000|Overall Study|Protocol Violation|0|||
23451832|NCT00395746|65398837|FG001|Overall Study|Protocol Violation|1|||
23451833|NCT00395746|65398838|FG002|Overall Study|Protocol Violation|0|||
23451834|NCT00395746|65398836|FG000|Overall Study|Lack of Efficacy|2|||
23451835|NCT00395746|65398837|FG001|Overall Study|Lack of Efficacy|0|||
23451836|NCT00395746|65398838|FG002|Overall Study|Lack of Efficacy|17|||
23451837|NCT00395746|65398836|FG000|Overall Study|Hypoglycaemia|2|||
23451838|NCT00395746|65398837|FG001|Overall Study|Hypoglycaemia|1|||
23451839|NCT00395746|65398838|FG002|Overall Study|Hypoglycaemia|0|||
23451840|NCT00395746|65398836|FG000|Overall Study|Subject decision|0|||
23451841|NCT00395746|65398837|FG001|Overall Study|Subject decision|0|||
23451842|NCT00395746|65398838|FG002|Overall Study|Subject decision|1|||
23451843|NCT00395746|65398836|FG000|Overall Study|Withdrawal of consent|0|||
23451844|NCT00395746|65398837|FG001|Overall Study|Withdrawal of consent|0|||
23780513|NCT00837486|66580042|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
23780514|NCT01108094|66580043|FG000|Overall Study|Adverse Event|2|||
23780515|NCT01108094|66580044|FG001|Overall Study|Adverse Event|0|||
23780516|NCT01108094|66580045|FG002|Overall Study|Adverse Event|0|||
23780517|NCT01108094|66580046|FG003|Overall Study|Adverse Event|0|||
23780518|NCT01108094|66580043|FG000|Overall Study|Withdrawal by Subject|1|||
23780519|NCT01108094|66580044|FG001|Overall Study|Withdrawal by Subject|0|||
23780520|NCT01108094|66580045|FG002|Overall Study|Withdrawal by Subject|0|||
23780521|NCT01108094|66580046|FG003|Overall Study|Withdrawal by Subject|0|||
23780522|NCT04206332|66580047|FG000|Part A|Lost to Follow-up|0|||
23780523|NCT04206332|66580048|FG001|Part A|Lost to Follow-up|1|||
23780524|NCT04206332|66580049|FG002|Part A|Lost to Follow-up|0|||
23780525|NCT04206332|66580050|FG003|Part A|Lost to Follow-up|0|||
23780526|NCT04206332|66580051|FG004|Part A|Lost to Follow-up|0|||
23780527|NCT04206332|66580052|FG005|Part A|Lost to Follow-up|0|||
23780528|NCT04206332|66580053|FG006|Part A|Lost to Follow-up|0|||
23780529|NCT04206332|66580054|FG007|Part A|Lost to Follow-up|0|||
23780530|NCT04206332|66580055|FG008|Part A|Lost to Follow-up|0|||
23780531|NCT04206332|66580056|FG009|Part A|Lost to Follow-up|0|||
23780532|NCT04206332|66580057|FG010|Part A|Lost to Follow-up|0|||
23780533|NCT04206332|66580058|FG011|Part A|Lost to Follow-up|0|||
23451845|NCT00395746|65398838|FG002|Overall Study|Withdrawal of consent|1|||
23451846|NCT00395746|65398836|FG000|Overall Study|Difficultulty in use of device|0|||
23451847|NCT00395746|65398837|FG001|Overall Study|Difficultulty in use of device|0|||
23451848|NCT00395746|65398838|FG002|Overall Study|Difficultulty in use of device|1|||
23451849|NCT00395746|65398836|FG000|Overall Study|Unable to visit site on schedule|1|||
23780534|NCT04206332|66580059|FG012|Part A|Lost to Follow-up|0|||
23780535|NCT04206332|66580060|FG013|Part A|Lost to Follow-up|0|||
23780536|NCT04206332|66580061|FG014|Part A|Lost to Follow-up|0|||
23780537|NCT04206332|66580062|FG015|Part A|Lost to Follow-up|0|||
23780538|NCT04206332|66580063|FG016|Part A|Lost to Follow-up|0|||
23780539|NCT04206332|66580047|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23451850|NCT00395746|65398837|FG001|Overall Study|Unable to visit site on schedule|0|||
23780540|NCT04206332|66580048|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780541|NCT04206332|66580049|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780542|NCT04206332|66580050|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780543|NCT04206332|66580051|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780544|NCT04206332|66580052|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
23780545|NCT04206332|66580053|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780546|NCT04206332|66580054|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780547|NCT04206332|66580055|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780548|NCT04206332|66580056|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780549|NCT04206332|66580057|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780550|NCT04206332|66580058|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780551|NCT04206332|66580059|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780552|NCT04206332|66580060|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23451851|NCT00395746|65398838|FG002|Overall Study|Unable to visit site on schedule|0|||
23451852|NCT01535040|65398839|FG000|Overall Study|Physician Decision|0|||
23451853|NCT01535040|65398840|FG001|Overall Study|Physician Decision|1|||
23451854|NCT01535040|65398839|FG000|Overall Study|Withdrawal by Subject|13|||
23451855|NCT01535040|65398840|FG001|Overall Study|Withdrawal by Subject|10|||
23451856|NCT01535040|65398839|FG000|Overall Study|Never Started|9|||
23780553|NCT04206332|66580061|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780554|NCT04206332|66580062|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780555|NCT04206332|66580063|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23780556|NCT04206332|66580047|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780557|NCT04206332|66580048|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23782294|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
23451857|NCT01535040|65398840|FG001|Overall Study|Never Started|4|||
23451858|NCT01535040|65398839|FG000|Overall Study|Toxicity|7|||
23451859|NCT01535040|65398840|FG001|Overall Study|Toxicity|5|||
23451860|NCT01535040|65398839|FG000|Overall Study|Multiple Reasons|1|||
23451861|NCT01535040|65398840|FG001|Overall Study|Multiple Reasons|1|||
23451862|NCT00551759|65398841|FG000|Overall Study|Adverse Event|7|||
23451863|NCT00551759|65398841|FG000|Overall Study|Death|5|||
23451864|NCT00551759|65398841|FG000|Overall Study|Ineligible|1|||
23451865|NCT01005251|65398842|FG000|Overall Study|Withdrawal by Subject|2|||
23451866|NCT01005251|65398843|FG001|Overall Study|Withdrawal by Subject|5|||
23451867|NCT01005251|65398844|FG002|Overall Study|Withdrawal by Subject|3|||
23451868|NCT01005251|65398845|FG003|Overall Study|Withdrawal by Subject|4|||
23451869|NCT01005251|65398846|FG004|Overall Study|Withdrawal by Subject|9|||
23451870|NCT01005251|65398842|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
23451871|NCT01005251|65398843|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23451872|NCT01005251|65398844|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
23451873|NCT01005251|65398845|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23451874|NCT01005251|65398846|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23451875|NCT01005251|65398842|FG000|Overall Study|Adverse Event|2|||
23451876|NCT01005251|65398843|FG001|Overall Study|Adverse Event|6|||
23451877|NCT01005251|65398844|FG002|Overall Study|Adverse Event|8|||
23451878|NCT01005251|65398845|FG003|Overall Study|Adverse Event|5|||
23451879|NCT01005251|65398846|FG004|Overall Study|Adverse Event|4|||
23451880|NCT01005251|65398842|FG000|Overall Study|Protocol Violation|1|||
23451881|NCT01005251|65398843|FG001|Overall Study|Protocol Violation|0|||
23451882|NCT01005251|65398844|FG002|Overall Study|Protocol Violation|0|||
23451883|NCT01005251|65398845|FG003|Overall Study|Protocol Violation|0|||
23451884|NCT01005251|65398846|FG004|Overall Study|Protocol Violation|2|||
23451885|NCT01005251|65398842|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
23451886|NCT01005251|65398843|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
23451887|NCT01005251|65398844|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
23451888|NCT01005251|65398845|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
23451889|NCT01005251|65398846|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
23451890|NCT01005251|65398842|FG000|Overall Study|Lost to Follow-up|1|||
23451891|NCT01005251|65398843|FG001|Overall Study|Lost to Follow-up|4|||
23451892|NCT01005251|65398844|FG002|Overall Study|Lost to Follow-up|2|||
23451893|NCT01005251|65398845|FG003|Overall Study|Lost to Follow-up|0|||
23451894|NCT01005251|65398846|FG004|Overall Study|Lost to Follow-up|0|||
23451895|NCT01005251|65398842|FG000|Overall Study|Physician Decision|0|||
23451896|NCT01005251|65398843|FG001|Overall Study|Physician Decision|0|||
23451897|NCT01005251|65398844|FG002|Overall Study|Physician Decision|0|||
23451898|NCT01005251|65398845|FG003|Overall Study|Physician Decision|0|||
23451899|NCT01005251|65398846|FG004|Overall Study|Physician Decision|2|||
23451900|NCT01005251|65398842|FG000|Overall Study|Patient moved|1|||
23451901|NCT01005251|65398843|FG001|Overall Study|Patient moved|0|||
23451902|NCT01005251|65398844|FG002|Overall Study|Patient moved|0|||
23451903|NCT01005251|65398845|FG003|Overall Study|Patient moved|0|||
23451904|NCT01005251|65398846|FG004|Overall Study|Patient moved|0|||
23451905|NCT01005251|65398842|FG000|Overall Study|Wrong drug dispensed|0|||
23451906|NCT01005251|65398843|FG001|Overall Study|Wrong drug dispensed|1|||
23451907|NCT01005251|65398844|FG002|Overall Study|Wrong drug dispensed|0|||
23451908|NCT01005251|65398845|FG003|Overall Study|Wrong drug dispensed|0|||
23451909|NCT01005251|65398846|FG004|Overall Study|Wrong drug dispensed|0|||
23451910|NCT01005251|65398842|FG000|Overall Study|Randomized in error|0|||
23451911|NCT01005251|65398843|FG001|Overall Study|Randomized in error|0|||
23451912|NCT01005251|65398844|FG002|Overall Study|Randomized in error|1|||
23451913|NCT01005251|65398845|FG003|Overall Study|Randomized in error|1|||
23451914|NCT01005251|65398846|FG004|Overall Study|Randomized in error|0|||
23451915|NCT01005251|65398842|FG000|Overall Study|Lack of Efficacy|0|||
23451916|NCT01005251|65398843|FG001|Overall Study|Lack of Efficacy|0|||
23451917|NCT01005251|65398844|FG002|Overall Study|Lack of Efficacy|1|||
23451918|NCT01005251|65398845|FG003|Overall Study|Lack of Efficacy|1|||
23451919|NCT01005251|65398846|FG004|Overall Study|Lack of Efficacy|0|||
23451920|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451921|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451922|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451923|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
23451924|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
23451925|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
23451926|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
23451927|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
23451928|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451929|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
23451930|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451931|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451932|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
23451933|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451934|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451935|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451936|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
23451937|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451938|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451939|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451940|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Death|3|||
23451941|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Death|0|||
23451942|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Death|0|||
23451943|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Death|0|||
23451944|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451945|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
23451946|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451947|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
23451948|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
23451949|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
23451950|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
23451951|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
23451952|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451953|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
23451954|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451955|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451956|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
23451957|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
23451958|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
23451959|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
23451960|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
23451961|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
23451962|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
23451963|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
23451964|NCT00591006|65398856|FG000|Overall Study|Withdrawal by Subject|0|||
23451965|NCT00591006|65398857|FG001|Overall Study|Withdrawal by Subject|0|||
23451966|NCT00591006|65398858|FG002|Overall Study|Withdrawal by Subject|0|||
23451967|NCT00591006|65398859|FG003|Overall Study|Withdrawal by Subject|0|||
23451968|NCT00591006|65398860|FG004|Overall Study|Withdrawal by Subject|0|||
23451969|NCT00591006|65398861|FG005|Overall Study|Withdrawal by Subject|0|||
23451970|NCT00591006|65398862|FG006|Overall Study|Withdrawal by Subject|0|||
23451971|NCT00591006|65398863|FG007|Overall Study|Withdrawal by Subject|0|||
23451972|NCT00591006|65398864|FG008|Overall Study|Withdrawal by Subject|0|||
23451973|NCT00591006|65398865|FG009|Overall Study|Withdrawal by Subject|0|||
23451974|NCT00591006|65398866|FG010|Overall Study|Withdrawal by Subject|0|||
23451975|NCT00591006|65398867|FG011|Overall Study|Withdrawal by Subject|0|||
23451976|NCT00591006|65398868|FG012|Overall Study|Withdrawal by Subject|0|||
23451977|NCT00591006|65398869|FG013|Overall Study|Withdrawal by Subject|0|||
23451978|NCT00591006|65398870|FG014|Overall Study|Withdrawal by Subject|0|||
23451979|NCT00591006|65398871|FG015|Overall Study|Withdrawal by Subject|1|||
23451980|NCT00591006|65398872|FG016|Overall Study|Withdrawal by Subject|0|||
23451981|NCT00591006|65398873|FG017|Overall Study|Withdrawal by Subject|0|||
23451982|NCT00591006|65398874|FG018|Overall Study|Withdrawal by Subject|0|||
23451983|NCT00591006|65398875|FG019|Overall Study|Withdrawal by Subject|0|||
23451984|NCT00591006|65398876|FG020|Overall Study|Withdrawal by Subject|0|||
23451985|NCT00591006|65398877|FG021|Overall Study|Withdrawal by Subject|0|||
23780558|NCT04206332|66580049|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23451986|NCT00591006|65398878|FG022|Overall Study|Withdrawal by Subject|0|||
23451987|NCT00591006|65398879|FG023|Overall Study|Withdrawal by Subject|1|||
23451988|NCT00591006|65398856|FG000|Overall Study|Adverse Event|0|||
23451989|NCT00591006|65398857|FG001|Overall Study|Adverse Event|0|||
23451990|NCT00591006|65398858|FG002|Overall Study|Adverse Event|0|||
23451991|NCT00591006|65398859|FG003|Overall Study|Adverse Event|0|||
23451992|NCT00591006|65398860|FG004|Overall Study|Adverse Event|0|||
23451993|NCT00591006|65398861|FG005|Overall Study|Adverse Event|0|||
23451994|NCT00591006|65398862|FG006|Overall Study|Adverse Event|0|||
23451995|NCT00591006|65398863|FG007|Overall Study|Adverse Event|0|||
23451996|NCT00591006|65398864|FG008|Overall Study|Adverse Event|0|||
23451997|NCT00591006|65398865|FG009|Overall Study|Adverse Event|0|||
23451998|NCT00591006|65398866|FG010|Overall Study|Adverse Event|0|||
23451999|NCT00591006|65398867|FG011|Overall Study|Adverse Event|0|||
23580235|NCT00797225|65853425|FG007|Weeks 1 to 12|Adverse Event|0|||
23580236|NCT00797225|65853418|FG000|Weeks 1 to 12|Non-compliance|0|||
23780559|NCT04206332|66580050|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780560|NCT04206332|66580051|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780561|NCT04206332|66580052|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780562|NCT04206332|66580053|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780563|NCT04206332|66580054|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
23780564|NCT04206332|66580055|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780565|NCT04206332|66580056|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780566|NCT04206332|66580057|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
23780567|NCT04206332|66580058|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780568|NCT04206332|66580059|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780569|NCT04206332|66580060|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780570|NCT04206332|66580061|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780571|NCT04206332|66580062|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780572|NCT04206332|66580063|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780573|NCT04206332|66580047|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780574|NCT04206332|66580048|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780575|NCT04206332|66580049|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780576|NCT04206332|66580050|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780577|NCT04206332|66580051|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780578|NCT04206332|66580052|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780579|NCT04206332|66580053|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780580|NCT04206332|66580054|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780581|NCT04206332|66580055|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780582|NCT04206332|66580056|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780583|NCT04206332|66580057|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780584|NCT04206332|66580058|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780585|NCT04206332|66580059|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780586|NCT04206332|66580060|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780587|NCT04206332|66580061|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23780588|NCT04206332|66580062|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23782295|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23580237|NCT00797225|65853419|FG001|Weeks 1 to 12|Non-compliance|1|||
23580238|NCT00797225|65853420|FG002|Weeks 1 to 12|Non-compliance|0|||
23580239|NCT00797225|65853421|FG003|Weeks 1 to 12|Non-compliance|0|||
23580240|NCT00797225|65853422|FG004|Weeks 1 to 12|Non-compliance|0|||
23580241|NCT00797225|65853423|FG005|Weeks 1 to 12|Non-compliance|0|||
23580242|NCT00797225|65853424|FG006|Weeks 1 to 12|Non-compliance|0|||
23580243|NCT00797225|65853425|FG007|Weeks 1 to 12|Non-compliance|0|||
23580244|NCT00797225|65853418|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
23580245|NCT00797225|65853419|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
23580246|NCT00797225|65853420|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
23580247|NCT00797225|65853421|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
23580248|NCT00797225|65853422|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
23580249|NCT00797225|65853423|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
23580250|NCT00797225|65853424|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
23339815|NCT02004886|64989274|FG000|Overall Study|Unable to attend future visits|1|||
23580251|NCT00797225|65853425|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
23580252|NCT00797225|65853418|FG000|Weeks 1 to 12|Sponsor Decision|1|||
23580253|NCT00797225|65853419|FG001|Weeks 1 to 12|Sponsor Decision|0|||
23452000|NCT00591006|65398868|FG012|Overall Study|Adverse Event|0|||
23580254|NCT00797225|65853420|FG002|Weeks 1 to 12|Sponsor Decision|0|||
23780589|NCT04206332|66580063|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
23780590|NCT04206332|66580047|FG000|Part C|Withdrawal by Subject|0|||
23780591|NCT04206332|66580048|FG001|Part C|Withdrawal by Subject|0|||
23780592|NCT04206332|66580049|FG002|Part C|Withdrawal by Subject|0|||
23780593|NCT04206332|66580050|FG003|Part C|Withdrawal by Subject|0|||
23580255|NCT00797225|65853421|FG003|Weeks 1 to 12|Sponsor Decision|0|||
23580256|NCT00797225|65853422|FG004|Weeks 1 to 12|Sponsor Decision|0|||
23580257|NCT00797225|65853423|FG005|Weeks 1 to 12|Sponsor Decision|0|||
23580258|NCT00797225|65853424|FG006|Weeks 1 to 12|Sponsor Decision|0|||
23580259|NCT00797225|65853425|FG007|Weeks 1 to 12|Sponsor Decision|0|||
23580260|NCT00797225|65853418|FG000|Weeks 13 to 24|Non-compliance|0|||
23580261|NCT00797225|65853419|FG001|Weeks 13 to 24|Non-compliance|2|||
23580262|NCT00797225|65853420|FG002|Weeks 13 to 24|Non-compliance|0|||
23580263|NCT00797225|65853421|FG003|Weeks 13 to 24|Non-compliance|0|||
23580264|NCT00797225|65853422|FG004|Weeks 13 to 24|Non-compliance|0|||
23580265|NCT00797225|65853423|FG005|Weeks 13 to 24|Non-compliance|0|||
23580266|NCT00797225|65853424|FG006|Weeks 13 to 24|Non-compliance|0|||
23580267|NCT00797225|65853425|FG007|Weeks 13 to 24|Non-compliance|0|||
23580268|NCT00797225|65853418|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
23580269|NCT00797225|65853419|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
23580270|NCT00797225|65853420|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
23580271|NCT00797225|65853421|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
23580272|NCT00797225|65853422|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
23580273|NCT00797225|65853423|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
23580274|NCT00797225|65853424|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
23580275|NCT00797225|65853425|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
23580276|NCT00797225|65853418|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
23580277|NCT00797225|65853419|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
23580278|NCT00797225|65853420|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
23580279|NCT00797225|65853421|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
23580280|NCT00797225|65853422|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
23580281|NCT00797225|65853423|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
23580282|NCT00797225|65853424|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
23580283|NCT00797225|65853425|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
23780594|NCT04206332|66580051|FG004|Part C|Withdrawal by Subject|0|||
23780595|NCT04206332|66580052|FG005|Part C|Withdrawal by Subject|0|||
23780596|NCT04206332|66580053|FG006|Part C|Withdrawal by Subject|0|||
23780597|NCT04206332|66580054|FG007|Part C|Withdrawal by Subject|0|||
23780598|NCT04206332|66580055|FG008|Part C|Withdrawal by Subject|0|||
23780599|NCT04206332|66580056|FG009|Part C|Withdrawal by Subject|0|||
23780600|NCT04206332|66580057|FG010|Part C|Withdrawal by Subject|0|||
23780601|NCT04206332|66580058|FG011|Part C|Withdrawal by Subject|0|||
23780602|NCT04206332|66580059|FG012|Part C|Withdrawal by Subject|0|||
23780603|NCT04206332|66580060|FG013|Part C|Withdrawal by Subject|0|||
23780604|NCT04206332|66580061|FG014|Part C|Withdrawal by Subject|2|||
23780605|NCT04206332|66580062|FG015|Part C|Withdrawal by Subject|0|||
23780606|NCT04206332|66580063|FG016|Part C|Withdrawal by Subject|0|||
23780607|NCT00950989|66580064|FG000|Overall Study|Death|0|||
23780608|NCT00950989|66580065|FG001|Overall Study|Death|0|||
23780609|NCT00950989|66580066|FG002|Overall Study|Death|1|||
23780610|NCT00950989|66580067|FG003|Overall Study|Death|0|||
23780611|NCT00950989|66580064|FG000|Overall Study|Administrative Decision|0|||
23580284|NCT00797225|65853418|FG000|Weeks 13 to 24|Adverse Event|0|||
23780612|NCT00950989|66580065|FG001|Overall Study|Administrative Decision|1|||
23780613|NCT00950989|66580066|FG002|Overall Study|Administrative Decision|0|||
23780614|NCT00950989|66580067|FG003|Overall Study|Administrative Decision|0|||
23780615|NCT00950989|66580064|FG000|Overall Study|Disease Progression|0|||
23780616|NCT00950989|66580065|FG001|Overall Study|Disease Progression|0|||
23780617|NCT00950989|66580066|FG002|Overall Study|Disease Progression|1|||
23780618|NCT00950989|66580067|FG003|Overall Study|Disease Progression|0|||
23780619|NCT00950989|66580064|FG000|Overall Study|Withdrawal by Subject|2|||
23780620|NCT00950989|66580065|FG001|Overall Study|Withdrawal by Subject|1|||
23780621|NCT00950989|66580066|FG002|Overall Study|Withdrawal by Subject|0|||
23780622|NCT00950989|66580067|FG003|Overall Study|Withdrawal by Subject|0|||
23780623|NCT00950989|66580064|FG000|Overall Study|Adverse Event|2|||
23780624|NCT00950989|66580065|FG001|Overall Study|Adverse Event|1|||
23780625|NCT00950989|66580066|FG002|Overall Study|Adverse Event|1|||
23780626|NCT00950989|66580067|FG003|Overall Study|Adverse Event|0|||
23780627|NCT00446563|66580070|FG000|Overall Study|Adverse Event|4|||
23780628|NCT00446563|66580071|FG001|Overall Study|Adverse Event|3|||
23580285|NCT00797225|65853419|FG001|Weeks 13 to 24|Adverse Event|1|||
23580286|NCT00797225|65853420|FG002|Weeks 13 to 24|Adverse Event|0|||
23580287|NCT00797225|65853421|FG003|Weeks 13 to 24|Adverse Event|0|||
23580288|NCT00797225|65853422|FG004|Weeks 13 to 24|Adverse Event|0|||
23580289|NCT00797225|65853423|FG005|Weeks 13 to 24|Adverse Event|0|||
23580290|NCT00797225|65853424|FG006|Weeks 13 to 24|Adverse Event|1|||
23580291|NCT00797225|65853425|FG007|Weeks 13 to 24|Adverse Event|0|||
23780629|NCT00446563|66580070|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23780630|NCT00446563|66580071|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23780631|NCT00446563|66580070|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23780632|NCT00446563|66580071|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23780633|NCT00446563|66580070|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23780634|NCT00446563|66580071|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23780635|NCT00446563|66580070|FG000|Overall Study|Withdrawal by Subject|2|||
23780636|NCT00446563|66580071|FG001|Overall Study|Withdrawal by Subject|1|||
23780637|NCT00446563|66580070|FG000|Overall Study|Administrative problems|0|||
23780638|NCT00446563|66580071|FG001|Overall Study|Administrative problems|1|||
23780639|NCT04499963|66580072|FG000|Overall Study|Adverse Event|3|||
23780640|NCT04499963|66580073|FG001|Overall Study|Adverse Event|0|||
23780641|NCT04499963|66580072|FG000|Overall Study|Death|3|||
23780642|NCT04499963|66580073|FG001|Overall Study|Death|0|||
23780643|NCT04499963|66580072|FG000|Overall Study|Lack of Efficacy|7|||
23780644|NCT04499963|66580073|FG001|Overall Study|Lack of Efficacy|0|||
23780645|NCT04499963|66580072|FG000|Overall Study|Lost to Follow-up|2|||
23780646|NCT04499963|66580073|FG001|Overall Study|Lost to Follow-up|0|||
23780647|NCT00359281|66580074|FG000|Overall Study|Adverse Event|1|||
23780648|NCT00359281|66580075|FG001|Overall Study|Adverse Event|0|||
23780649|NCT00359281|66580076|FG002|Overall Study|Adverse Event|0|||
23780650|NCT00359281|66580077|FG003|Overall Study|Adverse Event|0|||
23780651|NCT00359281|66580078|FG004|Overall Study|Adverse Event|0|||
23780652|NCT00359281|66580079|FG005|Overall Study|Adverse Event|0|||
23780653|NCT00359281|66580080|FG006|Overall Study|Adverse Event|1|||
23780654|NCT00359281|66580081|FG007|Overall Study|Adverse Event|0|||
23780655|NCT00359281|66580082|FG008|Overall Study|Adverse Event|0|||
23780656|NCT00359281|66580074|FG000|Overall Study|Withdrawal by Subject|0|||
23780657|NCT00359281|66580075|FG001|Overall Study|Withdrawal by Subject|0|||
23780658|NCT00359281|66580076|FG002|Overall Study|Withdrawal by Subject|0|||
23780659|NCT00359281|66580077|FG003|Overall Study|Withdrawal by Subject|0|||
23780660|NCT00359281|66580078|FG004|Overall Study|Withdrawal by Subject|0|||
23780661|NCT00359281|66580079|FG005|Overall Study|Withdrawal by Subject|0|||
23780662|NCT00359281|66580080|FG006|Overall Study|Withdrawal by Subject|1|||
23780663|NCT00359281|66580081|FG007|Overall Study|Withdrawal by Subject|0|||
23780664|NCT00359281|66580082|FG008|Overall Study|Withdrawal by Subject|0|||
23780665|NCT01929863|66580083|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
23780666|NCT01929863|66580084|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
23580292|NCT00797225|65853418|FG000|Weeks 13 to 24|Sponsor Decision|0|||
23580293|NCT00797225|65853419|FG001|Weeks 13 to 24|Sponsor Decision|0|||
23580294|NCT00797225|65853420|FG002|Weeks 13 to 24|Sponsor Decision|0|||
23580295|NCT00797225|65853421|FG003|Weeks 13 to 24|Sponsor Decision|0|||
23580296|NCT00797225|65853422|FG004|Weeks 13 to 24|Sponsor Decision|0|||
23580297|NCT00797225|65853423|FG005|Weeks 13 to 24|Sponsor Decision|0|||
23580298|NCT00797225|65853424|FG006|Weeks 13 to 24|Sponsor Decision|1|||
23580299|NCT00797225|65853425|FG007|Weeks 13 to 24|Sponsor Decision|0|||
23580300|NCT00795132|65853427|FG000|Overall Study|Death|1|||
23580301|NCT00795132|65853427|FG000|Overall Study|Relapse|2|||
23580302|NCT01304147|65853429|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
23580303|NCT01304147|65853430|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
23580304|NCT04226495|65853431|FG000|Overall Study|Withdrawal by Subject|3|||
23580305|NCT04226495|65853432|FG001|Overall Study|Withdrawal by Subject|3|||
23580306|NCT04226495|65853431|FG000|Overall Study|PI discretion|2|||
23580307|NCT04226495|65853432|FG001|Overall Study|PI discretion|4|||
23580308|NCT04939428|65853433|FG000|Overall Study|Death|0|||
23580309|NCT04939428|65853434|FG001|Overall Study|Death|1|||
23580310|NCT04939428|65853435|FG002|Overall Study|Death|0|||
23580311|NCT04939428|65853433|FG000|Overall Study|Lost to Follow-up|0|||
23780667|NCT01929863|66580083|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
23780668|NCT01929863|66580084|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
23780669|NCT01929863|66580083|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
23780670|NCT01929863|66580084|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
23780671|NCT01190930|66580085|FG000|Induction|Adverse Event|17|||
23780672|NCT01190930|66580086|FG001|Induction|Adverse Event|0|||
23780673|NCT01190930|66580087|FG002|Induction|Adverse Event|0|||
23780674|NCT01190930|66580088|FG003|Induction|Adverse Event|0|||
23780675|NCT01190930|66580089|FG004|Induction|Adverse Event|0|||
23780676|NCT01190930|66580090|FG005|Induction|Adverse Event|0|||
23780677|NCT01190930|66580091|FG006|Induction|Adverse Event|0|||
23780678|NCT01190930|66580092|FG007|Induction|Adverse Event|0|||
23780679|NCT01190930|66580093|FG008|Induction|Adverse Event|0|||
23339816|NCT02004886|64989275|FG001|Overall Study|Unable to attend future visits|0|||
23580312|NCT04939428|65853434|FG001|Overall Study|Lost to Follow-up|5|||
23580313|NCT04939428|65853435|FG002|Overall Study|Lost to Follow-up|0|||
23580314|NCT04939428|65853433|FG000|Overall Study|Physician Decision|1|||
23580315|NCT04939428|65853434|FG001|Overall Study|Physician Decision|0|||
23580316|NCT04939428|65853435|FG002|Overall Study|Physician Decision|0|||
23780680|NCT01190930|66580094|FG009|Induction|Adverse Event|0|||
23780681|NCT01190930|66580085|FG000|Induction|Death|34|||
23780682|NCT01190930|66580086|FG001|Induction|Death|0|||
23780683|NCT01190930|66580087|FG002|Induction|Death|0|||
23580317|NCT04939428|65853433|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23580318|NCT04939428|65853434|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23580319|NCT04939428|65853435|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23580320|NCT04939428|65853433|FG000|Overall Study|Withdrawal by Subject|10|||
23580321|NCT04939428|65853434|FG001|Overall Study|Withdrawal by Subject|11|||
23580322|NCT04939428|65853435|FG002|Overall Study|Withdrawal by Subject|0|||
23780684|NCT01190930|66580088|FG003|Induction|Death|0|||
23780685|NCT01190930|66580089|FG004|Induction|Death|0|||
23780686|NCT01190930|66580090|FG005|Induction|Death|0|||
23780687|NCT01190930|66580091|FG006|Induction|Death|0|||
23780688|NCT01190930|66580092|FG007|Induction|Death|0|||
23780689|NCT01190930|66580093|FG008|Induction|Death|0|||
23780690|NCT01190930|66580094|FG009|Induction|Death|0|||
23780691|NCT01190930|66580085|FG000|Induction|Lost to Follow-up|1|||
23780692|NCT01190930|66580086|FG001|Induction|Lost to Follow-up|0|||
23780693|NCT01190930|66580087|FG002|Induction|Lost to Follow-up|0|||
23580323|NCT04939428|65853433|FG000|Overall Study|Unkown|6|||
23780694|NCT01190930|66580088|FG003|Induction|Lost to Follow-up|0|||
23780695|NCT01190930|66580089|FG004|Induction|Lost to Follow-up|0|||
23780696|NCT01190930|66580090|FG005|Induction|Lost to Follow-up|0|||
23780697|NCT01190930|66580091|FG006|Induction|Lost to Follow-up|0|||
23780698|NCT01190930|66580092|FG007|Induction|Lost to Follow-up|0|||
23780699|NCT01190930|66580093|FG008|Induction|Lost to Follow-up|0|||
23780700|NCT01190930|66580094|FG009|Induction|Lost to Follow-up|0|||
23780701|NCT01190930|66580085|FG000|Induction|Physician Decision|125|||
23780702|NCT01190930|66580086|FG001|Induction|Physician Decision|3|||
23780703|NCT01190930|66580087|FG002|Induction|Physician Decision|0|||
23780704|NCT01190930|66580088|FG003|Induction|Physician Decision|0|||
23780705|NCT01190930|66580089|FG004|Induction|Physician Decision|0|||
23780706|NCT01190930|66580090|FG005|Induction|Physician Decision|0|||
23780707|NCT01190930|66580091|FG006|Induction|Physician Decision|0|||
23780708|NCT01190930|66580092|FG007|Induction|Physician Decision|0|||
23780709|NCT01190930|66580093|FG008|Induction|Physician Decision|0|||
23780710|NCT01190930|66580094|FG009|Induction|Physician Decision|0|||
23780711|NCT01190930|66580085|FG000|Induction|Withdrawal by Subject|9|||
23780712|NCT01190930|66580086|FG001|Induction|Withdrawal by Subject|0|||
23780713|NCT01190930|66580087|FG002|Induction|Withdrawal by Subject|0|||
23780714|NCT01190930|66580088|FG003|Induction|Withdrawal by Subject|0|||
23780715|NCT01190930|66580089|FG004|Induction|Withdrawal by Subject|0|||
23780716|NCT01190930|66580090|FG005|Induction|Withdrawal by Subject|0|||
23780717|NCT01190930|66580091|FG006|Induction|Withdrawal by Subject|0|||
23780718|NCT01190930|66580092|FG007|Induction|Withdrawal by Subject|0|||
23780719|NCT01190930|66580093|FG008|Induction|Withdrawal by Subject|0|||
23780720|NCT01190930|66580094|FG009|Induction|Withdrawal by Subject|0|||
23780721|NCT01190930|66580085|FG000|Induction|Refusal|235|||
23780722|NCT01190930|66580086|FG001|Induction|Refusal|0|||
23780723|NCT01190930|66580087|FG002|Induction|Refusal|0|||
23780724|NCT01190930|66580088|FG003|Induction|Refusal|0|||
23780725|NCT01190930|66580089|FG004|Induction|Refusal|0|||
23780726|NCT01190930|66580090|FG005|Induction|Refusal|0|||
23780727|NCT01190930|66580091|FG006|Induction|Refusal|0|||
23780728|NCT01190930|66580092|FG007|Induction|Refusal|0|||
23780729|NCT01190930|66580093|FG008|Induction|Refusal|0|||
23780730|NCT01190930|66580094|FG009|Induction|Refusal|0|||
23780731|NCT01190930|66580085|FG000|Induction|Inevaluable|23|||
23780732|NCT01190930|66580086|FG001|Induction|Inevaluable|1|||
23780733|NCT01190930|66580087|FG002|Induction|Inevaluable|0|||
23780734|NCT01190930|66580088|FG003|Induction|Inevaluable|0|||
23840358|NCT00267969|66795469|FG005|Controlled Period|Lack of Efficacy|0|||
23840359|NCT00267969|66795470|FG006|Controlled Period|Lack of Efficacy|0|||
23840360|NCT00267969|66795464|FG000|Controlled Period|Lost to Follow-up|1|||
23840361|NCT00267969|66795465|FG001|Controlled Period|Lost to Follow-up|0|||
23580324|NCT04939428|65853434|FG001|Overall Study|Unkown|3|||
23580325|NCT04939428|65853435|FG002|Overall Study|Unkown|0|||
23580326|NCT04939428|65853433|FG000|Overall Study|Discotinued per protocol|0|||
23580327|NCT04939428|65853434|FG001|Overall Study|Discotinued per protocol|0|||
23780735|NCT01190930|66580089|FG004|Induction|Inevaluable|0|||
23780736|NCT01190930|66580090|FG005|Induction|Inevaluable|0|||
23780737|NCT01190930|66580091|FG006|Induction|Inevaluable|0|||
23780738|NCT01190930|66580092|FG007|Induction|Inevaluable|0|||
23780739|NCT01190930|66580093|FG008|Induction|Inevaluable|0|||
23780740|NCT01190930|66580094|FG009|Induction|Inevaluable|0|||
23840362|NCT00267969|66795466|FG002|Controlled Period|Lost to Follow-up|1|||
23780741|NCT01190930|66580085|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
23780742|NCT01190930|66580086|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780743|NCT01190930|66580087|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23580328|NCT04939428|65853435|FG002|Overall Study|Discotinued per protocol|902|||
23780744|NCT01190930|66580088|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780745|NCT01190930|66580089|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780746|NCT01190930|66580090|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780747|NCT01190930|66580091|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780748|NCT01190930|66580092|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780749|NCT01190930|66580093|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23840363|NCT00267969|66795467|FG003|Controlled Period|Lost to Follow-up|0|||
23840364|NCT00267969|66795468|FG004|Controlled Period|Lost to Follow-up|0|||
23840365|NCT00267969|66795469|FG005|Controlled Period|Lost to Follow-up|0|||
23840366|NCT00267969|66795470|FG006|Controlled Period|Lost to Follow-up|0|||
23840367|NCT00267969|66795464|FG000|Controlled Period|Randomized but not treated|0|||
23840368|NCT00267969|66795465|FG001|Controlled Period|Randomized but not treated|0|||
23580329|NCT03085017|65853438|FG000|Overall Study|Death|0|||
23580330|NCT03085017|65853439|FG001|Overall Study|Death|3|||
23580331|NCT00498186|65853440|FG000|Overall Study|Protocol Violation|10|||
23580332|NCT00498186|65853440|FG000|Overall Study|Lack of Efficacy|31|||
23580333|NCT00498186|65853440|FG000|Overall Study|Adverse Event|89|||
23580334|NCT00498186|65853440|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
23580335|NCT00498186|65853440|FG000|Overall Study|Withdrawal by Subject|18|||
23580336|NCT00498186|65853440|FG000|Overall Study|Lost to Follow-up|3|||
23580337|NCT00498186|65853440|FG000|Overall Study|Other|10|||
23580338|NCT05349084|65853441|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
23580339|NCT00630539|65853442|FG000|Overall Study|Adverse Event|1|||
23780750|NCT01190930|66580094|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23780751|NCT01190930|66580085|FG000|Induction|High Risk Downs|80|||
23780752|NCT01190930|66580086|FG001|Induction|High Risk Downs|0|||
23780753|NCT01190930|66580087|FG002|Induction|High Risk Downs|0|||
23780754|NCT01190930|66580088|FG003|Induction|High Risk Downs|0|||
23780755|NCT01190930|66580089|FG004|Induction|High Risk Downs|0|||
23780756|NCT01190930|66580090|FG005|Induction|High Risk Downs|0|||
23780757|NCT01190930|66580091|FG006|Induction|High Risk Downs|0|||
23780758|NCT01190930|66580092|FG007|Induction|High Risk Downs|0|||
23780759|NCT01190930|66580093|FG008|Induction|High Risk Downs|0|||
23780760|NCT01190930|66580094|FG009|Induction|High Risk Downs|0|||
23780761|NCT01190930|66580085|FG000|Induction|Enrollment onto another COG Protocol|1|||
23780762|NCT01190930|66580086|FG001|Induction|Enrollment onto another COG Protocol|0|||
23780763|NCT01190930|66580087|FG002|Induction|Enrollment onto another COG Protocol|0|||
23780764|NCT01190930|66580088|FG003|Induction|Enrollment onto another COG Protocol|0|||
23780765|NCT01190930|66580089|FG004|Induction|Enrollment onto another COG Protocol|0|||
23780766|NCT01190930|66580090|FG005|Induction|Enrollment onto another COG Protocol|0|||
23780767|NCT01190930|66580091|FG006|Induction|Enrollment onto another COG Protocol|0|||
23780768|NCT01190930|66580092|FG007|Induction|Enrollment onto another COG Protocol|0|||
23780769|NCT01190930|66580093|FG008|Induction|Enrollment onto another COG Protocol|0|||
23780770|NCT01190930|66580094|FG009|Induction|Enrollment onto another COG Protocol|0|||
23780771|NCT01190930|66580085|FG000|Induction|Average Risk|1847|||
23780772|NCT01190930|66580086|FG001|Induction|Average Risk|0|||
23780773|NCT01190930|66580087|FG002|Induction|Average Risk|0|||
23780774|NCT01190930|66580088|FG003|Induction|Average Risk|0|||
23780775|NCT01190930|66580089|FG004|Induction|Average Risk|0|||
23780776|NCT01190930|66580090|FG005|Induction|Average Risk|0|||
23780777|NCT01190930|66580091|FG006|Induction|Average Risk|0|||
23780778|NCT01190930|66580092|FG007|Induction|Average Risk|0|||
23780779|NCT01190930|66580093|FG008|Induction|Average Risk|0|||
23780780|NCT01190930|66580094|FG009|Induction|Average Risk|0|||
23780781|NCT01190930|66580085|FG000|Induction|High Risk|1227|||
23780782|NCT01190930|66580086|FG001|Induction|High Risk|0|||
23780783|NCT01190930|66580087|FG002|Induction|High Risk|0|||
23780784|NCT01190930|66580088|FG003|Induction|High Risk|0|||
23780785|NCT01190930|66580089|FG004|Induction|High Risk|0|||
23780786|NCT01190930|66580090|FG005|Induction|High Risk|0|||
23780787|NCT01190930|66580091|FG006|Induction|High Risk|0|||
23780788|NCT01190930|66580092|FG007|Induction|High Risk|0|||
23780789|NCT01190930|66580093|FG008|Induction|High Risk|0|||
23780790|NCT01190930|66580094|FG009|Induction|High Risk|0|||
23780791|NCT01190930|66580085|FG000|Induction|Low Risk|443|||
23780792|NCT01190930|66580086|FG001|Induction|Low Risk|0|||
23780793|NCT01190930|66580087|FG002|Induction|Low Risk|0|||
23780794|NCT01190930|66580088|FG003|Induction|Low Risk|0|||
23780795|NCT01190930|66580089|FG004|Induction|Low Risk|0|||
23780796|NCT01190930|66580090|FG005|Induction|Low Risk|0|||
23840369|NCT00267969|66795466|FG002|Controlled Period|Randomized but not treated|1|||
23339817|NCT02004886|64989276|FG002|Overall Study|Unable to attend future visits|0|||
23780797|NCT01190930|66580091|FG006|Induction|Low Risk|0|||
23780798|NCT01190930|66580092|FG007|Induction|Low Risk|0|||
23780799|NCT01190930|66580093|FG008|Induction|Low Risk|0|||
23780800|NCT01190930|66580094|FG009|Induction|Low Risk|0|||
23780801|NCT01190930|66580085|FG000|Induction|Very High Risk|1012|||
23780802|NCT01190930|66580086|FG001|Induction|Very High Risk|0|||
23780803|NCT01190930|66580087|FG002|Induction|Very High Risk|0|||
23580340|NCT00630539|65853443|FG001|Overall Study|Adverse Event|3|||
23780804|NCT01190930|66580088|FG003|Induction|Very High Risk|0|||
23780805|NCT01190930|66580089|FG004|Induction|Very High Risk|0|||
23780806|NCT01190930|66580090|FG005|Induction|Very High Risk|0|||
23780807|NCT01190930|66580091|FG006|Induction|Very High Risk|0|||
23780808|NCT01190930|66580092|FG007|Induction|Very High Risk|0|||
23780809|NCT01190930|66580093|FG008|Induction|Very High Risk|0|||
23339818|NCT02004886|64989277|FG003|Overall Study|Unable to attend future visits|0|||
23339819|NCT01598090|64989279|FG000|Treatment Period|Poor/non-compliance|0|||
23339820|NCT01598090|64989280|FG001|Treatment Period|Poor/non-compliance|2|||
23339821|NCT01598090|64989281|FG002|Treatment Period|Poor/non-compliance|0|||
23339822|NCT01598090|64989279|FG000|Treatment Period|No longer meet study criteria|0|||
23339823|NCT01598090|64989280|FG001|Treatment Period|No longer meet study criteria|1|||
23780810|NCT01190930|66580094|FG009|Induction|Very High Risk|0|||
23780811|NCT01190930|66580085|FG000|Induction|Philadelphia chromosome-positive|99|||
23780812|NCT01190930|66580086|FG001|Induction|Philadelphia chromosome-positive|0|||
23780813|NCT01190930|66580087|FG002|Induction|Philadelphia chromosome-positive|0|||
23780814|NCT01190930|66580088|FG003|Induction|Philadelphia chromosome-positive|0|||
23780815|NCT01190930|66580089|FG004|Induction|Philadelphia chromosome-positive|0|||
23780816|NCT01190930|66580090|FG005|Induction|Philadelphia chromosome-positive|0|||
23780817|NCT01190930|66580091|FG006|Induction|Philadelphia chromosome-positive|0|||
23840370|NCT00267969|66795467|FG003|Controlled Period|Randomized but not treated|0|||
23840371|NCT00267969|66795468|FG004|Controlled Period|Randomized but not treated|0|||
23840372|NCT00267969|66795469|FG005|Controlled Period|Randomized but not treated|0|||
23339824|NCT01598090|64989281|FG002|Treatment Period|No longer meet study criteria|0|||
23339825|NCT01598090|64989279|FG000|Treatment Period|Lack of Efficacy|5|||
23339826|NCT01598090|64989280|FG001|Treatment Period|Lack of Efficacy|14|||
23452001|NCT00591006|65398869|FG013|Overall Study|Adverse Event|0|||
23339827|NCT01598090|64989281|FG002|Treatment Period|Lack of Efficacy|6|||
23339828|NCT01598090|64989279|FG000|Treatment Period|Adverse Event|2|||
23339829|NCT01598090|64989280|FG001|Treatment Period|Adverse Event|33|||
23339830|NCT01598090|64989281|FG002|Treatment Period|Adverse Event|17|||
23339831|NCT01598090|64989279|FG000|Treatment Period|Other reasons|0|||
23339832|NCT01598090|64989280|FG001|Treatment Period|Other reasons|4|||
23339833|NCT01598090|64989281|FG002|Treatment Period|Other reasons|1|||
23339834|NCT01598090|64989279|FG000|Treatment Period|Withdrawal by Subject|3|||
23339835|NCT01598090|64989280|FG001|Treatment Period|Withdrawal by Subject|13|||
23339836|NCT01598090|64989281|FG002|Treatment Period|Withdrawal by Subject|10|||
23339837|NCT01598090|64989279|FG000|Treatment Period|Lost to Follow-up|1|||
23339838|NCT01598090|64989280|FG001|Treatment Period|Lost to Follow-up|5|||
23339839|NCT01598090|64989281|FG002|Treatment Period|Lost to Follow-up|1|||
23339840|NCT01598090|64989279|FG000|Follow-up Period|Death|0|||
23339841|NCT01598090|64989280|FG001|Follow-up Period|Death|1|||
23339842|NCT01598090|64989281|FG002|Follow-up Period|Death|0|||
23339843|NCT01598090|64989279|FG000|Follow-up Period|No longer required per protocol|1|||
23339844|NCT01598090|64989280|FG001|Follow-up Period|No longer required per protocol|3|||
23339845|NCT01598090|64989281|FG002|Follow-up Period|No longer required per protocol|2|||
23339846|NCT01598090|64989279|FG000|Follow-up Period|Not reported|0|||
23339847|NCT01598090|64989280|FG001|Follow-up Period|Not reported|10|||
23339848|NCT01598090|64989281|FG002|Follow-up Period|Not reported|4|||
23339849|NCT01598090|64989279|FG000|Follow-up Period|Withdrawal by Subject|0|||
23339850|NCT01598090|64989280|FG001|Follow-up Period|Withdrawal by Subject|3|||
23339851|NCT01598090|64989281|FG002|Follow-up Period|Withdrawal by Subject|2|||
23339852|NCT01598090|64989279|FG000|Follow-up Period|Other reasons|2|||
23339853|NCT01598090|64989280|FG001|Follow-up Period|Other reasons|8|||
23339854|NCT01598090|64989281|FG002|Follow-up Period|Other reasons|8|||
23339855|NCT01598090|64989279|FG000|Follow-up Period|Lost to Follow-up|2|||
23339856|NCT01598090|64989280|FG001|Follow-up Period|Lost to Follow-up|10|||
23339857|NCT01598090|64989281|FG002|Follow-up Period|Lost to Follow-up|12|||
23339858|NCT02163447|64989296|FG000|Overall Study|Withdrawal by Subject|2|||
23339859|NCT02163447|64989297|FG001|Overall Study|Withdrawal by Subject|0|||
23339860|NCT02163447|64989298|FG002|Overall Study|Withdrawal by Subject|1|||
23339861|NCT02163447|64989296|FG000|Overall Study|Lost to Follow-up|1|||
23339862|NCT02163447|64989297|FG001|Overall Study|Lost to Follow-up|3|||
23452002|NCT00591006|65398870|FG014|Overall Study|Adverse Event|0|||
23840373|NCT00267969|66795470|FG006|Controlled Period|Randomized but not treated|0|||
23840374|NCT00267969|66795464|FG000|Controlled Period|Other|2|||
23840375|NCT00267969|66795465|FG001|Controlled Period|Other|1|||
23840376|NCT00267969|66795466|FG002|Controlled Period|Other|6|||
23840377|NCT00267969|66795467|FG003|Controlled Period|Other|0|||
23840378|NCT00267969|66795468|FG004|Controlled Period|Other|0|||
23840379|NCT00267969|66795469|FG005|Controlled Period|Other|0|||
23840380|NCT00267969|66795470|FG006|Controlled Period|Other|0|||
23840381|NCT00267969|66795464|FG000|After Controlled Period|Adverse Event|0|||
23452003|NCT00591006|65398871|FG015|Overall Study|Adverse Event|0|||
23452004|NCT00591006|65398872|FG016|Overall Study|Adverse Event|0|||
23780818|NCT01190930|66580092|FG007|Induction|Philadelphia chromosome-positive|0|||
23840382|NCT00267969|66795465|FG001|After Controlled Period|Adverse Event|0|||
23840383|NCT00267969|66795466|FG002|After Controlled Period|Adverse Event|0|||
23840384|NCT00267969|66795467|FG003|After Controlled Period|Adverse Event|7|||
23339863|NCT02163447|64989298|FG002|Overall Study|Lost to Follow-up|0|||
23339864|NCT02163447|64989296|FG000|Overall Study|Moved out of study area|2|||
23339865|NCT02163447|64989297|FG001|Overall Study|Moved out of study area|3|||
23840385|NCT00267969|66795468|FG004|After Controlled Period|Adverse Event|8|||
23339866|NCT02163447|64989298|FG002|Overall Study|Moved out of study area|2|||
23339867|NCT02163447|64989296|FG000|Overall Study|Became HIV infected at time of delivery|1|||
23339868|NCT02163447|64989297|FG001|Overall Study|Became HIV infected at time of delivery|0|||
23339869|NCT02163447|64989298|FG002|Overall Study|Became HIV infected at time of delivery|0|||
23339870|NCT02751450|64989302|FG000|Overall Study|Adverse Event|1|||
23339871|NCT02751450|64989303|FG001|Overall Study|Adverse Event|0|||
23339872|NCT01704651|64989305|FG000|Overall Study|Pre-op withdrawal by subject|1|||
23339873|NCT01704651|64989306|FG001|Overall Study|Pre-op withdrawal by subject|1|||
23339874|NCT01704651|64989305|FG000|Overall Study|Pre-op change in treatment plan|1|||
23339875|NCT01704651|64989306|FG001|Overall Study|Pre-op change in treatment plan|4|||
23339876|NCT01704651|64989305|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
23339877|NCT01704651|64989306|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
23339878|NCT01704651|64989305|FG000|Overall Study|Post-op did not have laparotomy|2|||
23339879|NCT01704651|64989306|FG001|Overall Study|Post-op did not have laparotomy|1|||
23339880|NCT02828124|64989307|FG000|Overall Study|Disease Progression|1|||
23339881|NCT02828124|64989308|FG001|Overall Study|Disease Progression|2|||
23339882|NCT02828124|64989309|FG002|Overall Study|Disease Progression|1|||
23339883|NCT02828124|64989310|FG003|Overall Study|Disease Progression|4|||
23339884|NCT02828124|64989307|FG000|Overall Study|AE Unrelated to Study Drug|0|||
23339885|NCT02828124|64989308|FG001|Overall Study|AE Unrelated to Study Drug|0|||
23339886|NCT02828124|64989309|FG002|Overall Study|AE Unrelated to Study Drug|0|||
23339887|NCT02828124|64989310|FG003|Overall Study|AE Unrelated to Study Drug|1|||
23339888|NCT02828124|64989307|FG000|Overall Study|Subject Withdrew Consent|0|||
23339889|NCT02828124|64989308|FG001|Overall Study|Subject Withdrew Consent|0|||
23339890|NCT02828124|64989309|FG002|Overall Study|Subject Withdrew Consent|0|||
23339891|NCT02828124|64989310|FG003|Overall Study|Subject Withdrew Consent|1|||
23339892|NCT01438294|64989313|FG000|Overall Study|Lost to Follow-up|3|||
23339893|NCT01438294|64989314|FG001|Overall Study|Lost to Follow-up|7|||
23339894|NCT00956592|64989323|FG000|Overall Study|Protocol Violation|1|||
23339895|NCT00956592|64989324|FG001|Overall Study|Protocol Violation|3|||
23339896|NCT02005692|64989332|FG000|Overall Study|Protocol Violation|1|||
23339897|NCT02005692|64989332|FG000|Overall Study|Withdrawal by Subject|1|||
23339898|NCT02005692|64989332|FG000|Overall Study|Discharged earlier than anticipated|5|||
23339899|NCT04413552|64989333|FG000|Overall Study|Adverse Event|0|||
23339900|NCT04413552|64989334|FG001|Overall Study|Adverse Event|0|||
23339901|NCT04413552|64989335|FG002|Overall Study|Adverse Event|0|||
23339902|NCT04413552|64989336|FG003|Overall Study|Adverse Event|0|||
23339903|NCT04413552|64989337|FG004|Overall Study|Adverse Event|0|||
23339904|NCT04413552|64989338|FG005|Overall Study|Adverse Event|0|||
23339905|NCT04413552|64989339|FG006|Overall Study|Adverse Event|1|||
23339906|NCT04413552|64989340|FG007|Overall Study|Adverse Event|0|||
23339907|NCT04413552|64989341|FG008|Overall Study|Adverse Event|0|||
23339908|NCT04413552|64989342|FG009|Overall Study|Adverse Event|0|||
23339909|NCT01925131|64989345|FG000|Overall Study|Death|0|||
23339910|NCT01925131|64989346|FG001|Overall Study|Death|0|||
23339911|NCT01925131|64989347|FG002|Overall Study|Death|1|||
23339912|NCT01925131|64989348|FG003|Overall Study|Death|0|||
23339913|NCT01925131|64989349|FG004|Overall Study|Death|0|||
23339914|NCT01925131|64989350|FG005|Overall Study|Death|0|||
23339915|NCT01925131|64989345|FG000|Overall Study|Progression/Relapse|1|||
23339916|NCT01925131|64989346|FG001|Overall Study|Progression/Relapse|1|||
23339917|NCT01925131|64989347|FG002|Overall Study|Progression/Relapse|4|||
23339918|NCT01925131|64989348|FG003|Overall Study|Progression/Relapse|0|||
23339919|NCT01925131|64989349|FG004|Overall Study|Progression/Relapse|0|||
23339920|NCT01925131|64989350|FG005|Overall Study|Progression/Relapse|1|||
23339921|NCT01925131|64989345|FG000|Overall Study|Patient Refusal|1|||
23339922|NCT01925131|64989346|FG001|Overall Study|Patient Refusal|0|||
23339923|NCT01925131|64989347|FG002|Overall Study|Patient Refusal|0|||
23339924|NCT01925131|64989348|FG003|Overall Study|Patient Refusal|0|||
23452005|NCT00591006|65398873|FG017|Overall Study|Adverse Event|0|||
23580341|NCT00630539|65853444|FG002|Overall Study|Adverse Event|1|||
23580342|NCT00630539|65853445|FG003|Overall Study|Adverse Event|2|||
23580343|NCT00630539|65853442|FG000|Overall Study|Withdrawal by Subject|0|||
23339925|NCT01925131|64989349|FG004|Overall Study|Patient Refusal|0|||
23339926|NCT01925131|64989350|FG005|Overall Study|Patient Refusal|0|||
23339927|NCT01925131|64989345|FG000|Overall Study|Adverse Event|0|||
23339928|NCT01925131|64989346|FG001|Overall Study|Adverse Event|0|||
23339929|NCT01925131|64989347|FG002|Overall Study|Adverse Event|2|||
23339930|NCT01925131|64989348|FG003|Overall Study|Adverse Event|0|||
23580344|NCT00630539|65853443|FG001|Overall Study|Withdrawal by Subject|1|||
23339931|NCT01925131|64989349|FG004|Overall Study|Adverse Event|1|||
23339932|NCT01925131|64989350|FG005|Overall Study|Adverse Event|3|||
23339933|NCT01925131|64989345|FG000|Overall Study|Other - Not Protocol Specified|3|||
23339934|NCT01925131|64989346|FG001|Overall Study|Other - Not Protocol Specified|1|||
23339935|NCT01925131|64989347|FG002|Overall Study|Other - Not Protocol Specified|2|||
23339936|NCT01925131|64989348|FG003|Overall Study|Other - Not Protocol Specified|5|||
23339937|NCT01925131|64989349|FG004|Overall Study|Other - Not Protocol Specified|10|||
23580345|NCT00630539|65853444|FG002|Overall Study|Withdrawal by Subject|0|||
23339938|NCT01925131|64989350|FG005|Overall Study|Other - Not Protocol Specified|6|||
23339939|NCT03919695|64989352|FG000|3-month Follow-up|Death|1|||
23339940|NCT03919695|64989353|FG001|3-month Follow-up|Death|1|||
23339941|NCT03919695|64989352|FG000|3-month Follow-up|unable to contact|0|||
23339942|NCT03919695|64989353|FG001|3-month Follow-up|unable to contact|3|||
23339943|NCT03919695|64989352|FG000|3-month Follow-up|in prison|0|||
23339944|NCT03919695|64989353|FG001|3-month Follow-up|in prison|1|||
23339945|NCT03919695|64989352|FG000|6-month Follow-up|Death|0|||
23339946|NCT03919695|64989353|FG001|6-month Follow-up|Death|1|||
23339947|NCT03919695|64989352|FG000|6-month Follow-up|Lost to Follow-up|1|||
23339948|NCT03919695|64989353|FG001|6-month Follow-up|Lost to Follow-up|2|||
23339949|NCT03919695|64989352|FG000|6-month Follow-up|in prison|0|||
23339950|NCT03919695|64989353|FG001|6-month Follow-up|in prison|2|||
23339951|NCT03919695|64989352|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
23339952|NCT03919695|64989353|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
23339953|NCT03919695|64989352|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
23339954|NCT03919695|64989353|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
23339955|NCT02320058|64989363|FG000|Overall Study|Death|25|||
23339956|NCT02320058|64989364|FG001|Overall Study|Death|10|||
23339957|NCT02320058|64989363|FG000|Overall Study|Lost to Follow-up|4|||
23339958|NCT02320058|64989364|FG001|Overall Study|Lost to Follow-up|0|||
23339959|NCT02320058|64989363|FG000|Overall Study|Other reasons|4|||
23339960|NCT02320058|64989364|FG001|Overall Study|Other reasons|1|||
23339961|NCT02320058|64989363|FG000|Overall Study|Withdrawal by Subject|8|||
23339962|NCT02320058|64989364|FG001|Overall Study|Withdrawal by Subject|2|||
23339963|NCT02320058|64989363|FG000|Overall Study|Not reported|1|||
23339964|NCT02320058|64989364|FG001|Overall Study|Not reported|0|||
23339965|NCT03033602|64989367|FG000|Overall Study|Withdrawal by Subject|11|||
23339966|NCT03033602|64989368|FG001|Overall Study|Withdrawal by Subject|21|||
23339967|NCT03033602|64989367|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
23339968|NCT03033602|64989368|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
23339969|NCT02659514|64989369|FG000|Overall Study|Adverse Event|3|||
23339970|NCT02659514|64989370|FG001|Overall Study|Adverse Event|12|||
23339971|NCT02659514|64989369|FG000|Overall Study|Disease Progression|23|||
23339972|NCT02659514|64989370|FG001|Overall Study|Disease Progression|13|||
23339973|NCT02659514|64989369|FG000|Overall Study|Withdrawal by Subject|0|||
23339974|NCT02659514|64989370|FG001|Overall Study|Withdrawal by Subject|4|||
23339975|NCT02659514|64989369|FG000|Overall Study|Lost to Follow-up|0|||
23339976|NCT02659514|64989370|FG001|Overall Study|Lost to Follow-up|1|||
23339977|NCT02659514|64989369|FG000|Overall Study|Death|6|||
23339978|NCT02659514|64989370|FG001|Overall Study|Death|1|||
23339979|NCT02659514|64989369|FG000|Overall Study|Reason Unspecified|0|||
23339980|NCT02659514|64989370|FG001|Overall Study|Reason Unspecified|3|||
23339981|NCT00160706|64989373|FG000|Overall Study|Adverse Event|53|||
23339982|NCT00160706|64989373|FG000|Overall Study|Adverse Event and Other Reason|105|||
23339983|NCT00160706|64989373|FG000|Overall Study|Protocol Violation|3|||
23339984|NCT00160706|64989373|FG000|Overall Study|Withdrawal by Subject|41|||
23339985|NCT00160706|64989373|FG000|Overall Study|Withdrawal by Subject and Other|12|||
23339986|NCT00160706|64989373|FG000|Overall Study|Physician Decision|10|||
23339987|NCT00160706|64989373|FG000|Overall Study|Physician Decision and Other|3|||
23339988|NCT00160706|64989373|FG000|Overall Study|Lost to Follow-up|4|||
23339989|NCT00160706|64989373|FG000|Overall Study|Lost to Follow-up and Other|1|||
23339990|NCT00160706|64989373|FG000|Overall Study|Lack of Efficacy|42|||
23339991|NCT00160706|64989373|FG000|Overall Study|Lack of Efficacy and Other|1|||
23339992|NCT00160706|64989373|FG000|Overall Study|Other Reason|11|||
23339993|NCT05033262|64989374|FG000|Overall Study|Lost to Follow-up|1|||
23339994|NCT05033262|64989375|FG001|Overall Study|Lost to Follow-up|0|||
23339995|NCT05033262|64989376|FG002|Overall Study|Lost to Follow-up|0|||
23339996|NCT05033262|64989377|FG003|Overall Study|Lost to Follow-up|1|||
23339997|NCT00750139|64989378|FG000|Overall Study|Adverse Event|1|||
23339998|NCT00750139|64989379|FG001|Overall Study|Adverse Event|2|||
23339999|NCT00750139|64989380|FG002|Overall Study|Adverse Event|0|||
23340000|NCT00750139|64989381|FG003|Overall Study|Adverse Event|1|||
23340001|NCT00750139|64989378|FG000|Overall Study|Lost to Follow-up|17|||
23340002|NCT00750139|64989379|FG001|Overall Study|Lost to Follow-up|12|||
23340003|NCT00750139|64989380|FG002|Overall Study|Lost to Follow-up|15|||
23340004|NCT00750139|64989381|FG003|Overall Study|Lost to Follow-up|6|||
23340005|NCT00750139|64989378|FG000|Overall Study|Withdrawal by Subject|3|||
23340006|NCT00750139|64989379|FG001|Overall Study|Withdrawal by Subject|2|||
23340007|NCT00750139|64989380|FG002|Overall Study|Withdrawal by Subject|6|||
23340008|NCT00750139|64989381|FG003|Overall Study|Withdrawal by Subject|2|||
23340009|NCT00750139|64989378|FG000|Overall Study|Physician Decision|1|||
23340010|NCT00750139|64989379|FG001|Overall Study|Physician Decision|1|||
23340011|NCT00750139|64989380|FG002|Overall Study|Physician Decision|0|||
23340012|NCT00750139|64989381|FG003|Overall Study|Physician Decision|0|||
23340013|NCT00750139|64989378|FG000|Overall Study|Non-compliance|1|||
23340014|NCT00750139|64989379|FG001|Overall Study|Non-compliance|0|||
23340015|NCT00750139|64989380|FG002|Overall Study|Non-compliance|1|||
23840386|NCT00267969|66795469|FG005|After Controlled Period|Adverse Event|23|||
23840387|NCT00267969|66795470|FG006|After Controlled Period|Adverse Event|21|||
23840388|NCT00267969|66795464|FG000|After Controlled Period|Death|0|||
23840389|NCT00267969|66795465|FG001|After Controlled Period|Death|0|||
23840390|NCT00267969|66795466|FG002|After Controlled Period|Death|0|||
23840391|NCT00267969|66795467|FG003|After Controlled Period|Death|1|||
23840392|NCT00267969|66795468|FG004|After Controlled Period|Death|2|||
23840393|NCT00267969|66795469|FG005|After Controlled Period|Death|0|||
23840394|NCT00267969|66795470|FG006|After Controlled Period|Death|1|||
23840395|NCT00267969|66795464|FG000|After Controlled Period|Lack of Efficacy|0|||
23840396|NCT00267969|66795465|FG001|After Controlled Period|Lack of Efficacy|0|||
23840397|NCT00267969|66795466|FG002|After Controlled Period|Lack of Efficacy|0|||
23840398|NCT00267969|66795467|FG003|After Controlled Period|Lack of Efficacy|10|||
23840399|NCT00267969|66795468|FG004|After Controlled Period|Lack of Efficacy|6|||
23840400|NCT00267969|66795469|FG005|After Controlled Period|Lack of Efficacy|28|||
23840401|NCT00267969|66795470|FG006|After Controlled Period|Lack of Efficacy|15|||
23840402|NCT00267969|66795464|FG000|After Controlled Period|Lost to Follow-up|0|||
23840403|NCT00267969|66795465|FG001|After Controlled Period|Lost to Follow-up|0|||
23840404|NCT00267969|66795466|FG002|After Controlled Period|Lost to Follow-up|0|||
23840405|NCT00267969|66795467|FG003|After Controlled Period|Lost to Follow-up|5|||
23840406|NCT00267969|66795468|FG004|After Controlled Period|Lost to Follow-up|8|||
23840407|NCT00267969|66795469|FG005|After Controlled Period|Lost to Follow-up|9|||
23840408|NCT00267969|66795470|FG006|After Controlled Period|Lost to Follow-up|10|||
23840409|NCT00267969|66795464|FG000|After Controlled Period|Other|0|||
23840410|NCT00267969|66795465|FG001|After Controlled Period|Other|0|||
23840411|NCT00267969|66795466|FG002|After Controlled Period|Other|0|||
23840412|NCT00267969|66795467|FG003|After Controlled Period|Other|13|||
23840413|NCT00267969|66795468|FG004|After Controlled Period|Other|11|||
23840414|NCT00267969|66795469|FG005|After Controlled Period|Other|22|||
23840415|NCT00267969|66795470|FG006|After Controlled Period|Other|25|||
23840416|NCT01668173|66795471|FG000|Overall Study|Adverse Event|3|||
23840417|NCT01668173|66795471|FG000|Overall Study|Trial suspension|4|||
23840418|NCT03343704|66795472|FG000|Overall Study|Refused to complete follow up|0|||
23840419|NCT03343704|66795473|FG001|Overall Study|Refused to complete follow up|1|||
23840420|NCT03343704|66795472|FG000|Overall Study|Death|0|||
23840421|NCT03343704|66795473|FG001|Overall Study|Death|1|||
23840422|NCT03343704|66795472|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
23840423|NCT03343704|66795473|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
23840424|NCT02411396|66795474|FG000|Overall Study|Lost to Follow-up|31|||
23840425|NCT02411396|66795474|FG000|Overall Study|Death|10|||
23840426|NCT02423343|66795475|FG000|Overall Study|Withdrawal by Subject|0|||
23840427|NCT02423343|66795476|FG001|Overall Study|Withdrawal by Subject|1|||
23840428|NCT02423343|66795477|FG002|Overall Study|Withdrawal by Subject|0|||
23840429|NCT02423343|66795478|FG003|Overall Study|Withdrawal by Subject|0|||
23840430|NCT02423343|66795479|FG004|Overall Study|Withdrawal by Subject|0|||
23840431|NCT02423343|66795480|FG005|Overall Study|Withdrawal by Subject|0|||
23840432|NCT02423343|66795475|FG000|Overall Study|Progressive Disease|0|||
23840433|NCT02423343|66795476|FG001|Overall Study|Progressive Disease|0|||
23840434|NCT02423343|66795477|FG002|Overall Study|Progressive Disease|0|||
23840435|NCT02423343|66795478|FG003|Overall Study|Progressive Disease|0|||
23840436|NCT02423343|66795479|FG004|Overall Study|Progressive Disease|2|||
23840437|NCT02423343|66795480|FG005|Overall Study|Progressive Disease|0|||
23840438|NCT02423343|66795475|FG000|Overall Study|Adverse Event|0|||
23840439|NCT02423343|66795476|FG001|Overall Study|Adverse Event|0|||
23840440|NCT02423343|66795477|FG002|Overall Study|Adverse Event|0|||
23840441|NCT02423343|66795478|FG003|Overall Study|Adverse Event|0|||
23840442|NCT02423343|66795479|FG004|Overall Study|Adverse Event|2|||
23840443|NCT02423343|66795480|FG005|Overall Study|Adverse Event|0|||
23840444|NCT02423343|66795475|FG000|Overall Study|Death|0|||
23840445|NCT02423343|66795476|FG001|Overall Study|Death|0|||
23840446|NCT02423343|66795477|FG002|Overall Study|Death|0|||
23840447|NCT02423343|66795478|FG003|Overall Study|Death|0|||
23840448|NCT02423343|66795479|FG004|Overall Study|Death|1|||
23840449|NCT02423343|66795480|FG005|Overall Study|Death|0|||
23840450|NCT01295671|66795483|FG000|Overall Study|Lost to Follow-up|4|||
23840451|NCT01295671|66795484|FG001|Overall Study|Lost to Follow-up|6|||
23840452|NCT01295671|66795485|FG002|Overall Study|Lost to Follow-up|3|||
23840453|NCT01295671|66795483|FG000|Overall Study|Withdrawal by Subject|3|||
23840454|NCT01295671|66795484|FG001|Overall Study|Withdrawal by Subject|1|||
23840455|NCT01295671|66795485|FG002|Overall Study|Withdrawal by Subject|0|||
23840456|NCT02841280|66795488|FG000|Overall Study|Adverse Event|2|||
23840457|NCT02841280|66795489|FG001|Overall Study|Adverse Event|1|||
23840458|NCT02841280|66795488|FG000|Overall Study|Death|1|||
23840459|NCT02841280|66795489|FG001|Overall Study|Death|0|||
23840460|NCT02841280|66795488|FG000|Overall Study|Lost to Follow-up|2|||
23840461|NCT02841280|66795489|FG001|Overall Study|Lost to Follow-up|2|||
23840462|NCT02841280|66795488|FG000|Overall Study|Withdrawal by Subject|7|||
23840463|NCT02841280|66795489|FG001|Overall Study|Withdrawal by Subject|3|||
23840464|NCT02841280|66795488|FG000|Overall Study|Stop Point: BP above threshold|2|||
23340016|NCT00750139|64989381|FG003|Overall Study|Non-compliance|3|||
23340017|NCT00750139|64989378|FG000|Overall Study|Termination by sponsor|4|||
23340018|NCT00750139|64989379|FG001|Overall Study|Termination by sponsor|0|||
23340019|NCT00750139|64989380|FG002|Overall Study|Termination by sponsor|0|||
23340020|NCT00750139|64989381|FG003|Overall Study|Termination by sponsor|1|||
23340021|NCT00750139|64989378|FG000|Overall Study|Non-specific|62|||
23340022|NCT00750139|64989379|FG001|Overall Study|Non-specific|42|||
23340023|NCT00750139|64989380|FG002|Overall Study|Non-specific|79|||
23340024|NCT00750139|64989381|FG003|Overall Study|Non-specific|33|||
23340025|NCT01880086|64989382|FG000|Overall Study|Lost to Follow-up|1|||
23340026|NCT01880086|64989383|FG001|Overall Study|Lost to Follow-up|1|||
23340027|NCT00631410|64989384|FG000|Overall Study|Adverse Event|1|||
23340028|NCT00631410|64989385|FG001|Overall Study|Adverse Event|3|||
23340029|NCT00631410|64989384|FG000|Overall Study|Objective Progression or Relapse|4|||
23340030|NCT00631410|64989385|FG001|Overall Study|Objective Progression or Relapse|3|||
23340031|NCT00631410|64989384|FG000|Overall Study|Surgery|1|||
23340032|NCT00631410|64989385|FG001|Overall Study|Surgery|0|||
23340033|NCT03483961|64989388|FG000|Overall Study|Lost to Follow-up|7|||
23340034|NCT03483961|64989389|FG001|Overall Study|Lost to Follow-up|6|||
23340035|NCT03483961|64989390|FG002|Overall Study|Lost to Follow-up|6|||
23452006|NCT00591006|65398874|FG018|Overall Study|Adverse Event|0|||
23580346|NCT00630539|65853445|FG003|Overall Study|Withdrawal by Subject|1|||
23580347|NCT01598987|65853448|FG000|Baseline to Month 12|Administrative problems|2|||
23780819|NCT01190930|66580093|FG008|Induction|Philadelphia chromosome-positive|0|||
23780820|NCT01190930|66580094|FG009|Induction|Philadelphia chromosome-positive|0|||
23780821|NCT01190930|66580085|FG000|Induction|Incomplete Induction data|63|||
23780822|NCT01190930|66580086|FG001|Induction|Incomplete Induction data|0|||
23780823|NCT01190930|66580087|FG002|Induction|Incomplete Induction data|0|||
23780824|NCT01190930|66580088|FG003|Induction|Incomplete Induction data|0|||
23780825|NCT01190930|66580089|FG004|Induction|Incomplete Induction data|0|||
23780826|NCT01190930|66580090|FG005|Induction|Incomplete Induction data|0|||
23780827|NCT01190930|66580091|FG006|Induction|Incomplete Induction data|0|||
23780828|NCT01190930|66580092|FG007|Induction|Incomplete Induction data|0|||
23780829|NCT01190930|66580093|FG008|Induction|Incomplete Induction data|0|||
23780830|NCT01190930|66580094|FG009|Induction|Incomplete Induction data|0|||
23780831|NCT01190930|66580085|FG000|Induction|Progressive disease|0|||
23780832|NCT01190930|66580086|FG001|Induction|Progressive disease|1|||
23780833|NCT01190930|66580087|FG002|Induction|Progressive disease|0|||
23780834|NCT01190930|66580088|FG003|Induction|Progressive disease|0|||
23780835|NCT01190930|66580089|FG004|Induction|Progressive disease|0|||
23780836|NCT01190930|66580090|FG005|Induction|Progressive disease|0|||
23780837|NCT01190930|66580091|FG006|Induction|Progressive disease|0|||
23780838|NCT01190930|66580092|FG007|Induction|Progressive disease|0|||
23780839|NCT01190930|66580093|FG008|Induction|Progressive disease|0|||
23780840|NCT01190930|66580094|FG009|Induction|Progressive disease|0|||
23780841|NCT01190930|66580085|FG000|Induction|No treatment|3|||
23780842|NCT01190930|66580086|FG001|Induction|No treatment|0|||
23780843|NCT01190930|66580087|FG002|Induction|No treatment|0|||
23780844|NCT01190930|66580088|FG003|Induction|No treatment|0|||
23780845|NCT01190930|66580089|FG004|Induction|No treatment|0|||
23780846|NCT01190930|66580090|FG005|Induction|No treatment|0|||
23780847|NCT01190930|66580091|FG006|Induction|No treatment|0|||
23780848|NCT01190930|66580092|FG007|Induction|No treatment|0|||
23780849|NCT01190930|66580093|FG008|Induction|No treatment|0|||
23780850|NCT01190930|66580094|FG009|Induction|No treatment|0|||
23780851|NCT01190930|66580085|FG000|Induction|Ineligible|69|||
23780852|NCT01190930|66580086|FG001|Induction|Ineligible|4|||
23780853|NCT01190930|66580087|FG002|Induction|Ineligible|0|||
23340036|NCT03483961|64989391|FG003|Overall Study|Lost to Follow-up|6|||
23580348|NCT01598987|65853448|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
23580349|NCT01598987|65853448|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
23580350|NCT01598987|65853448|FG000|Baseline to 24 Month|Administrative problems|2|||
23580351|NCT01598987|65853448|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
23580352|NCT03976375|65853453|FG000|Overall Study|Death|147|||
23580353|NCT03976375|65853454|FG001|Overall Study|Death|150|||
23580354|NCT03976375|65853455|FG002|Overall Study|Death|38|||
23580355|NCT03976375|65853453|FG000|Overall Study|Lost to Follow-up|1|||
23452007|NCT00591006|65398875|FG019|Overall Study|Adverse Event|0|||
23780854|NCT01190930|66580088|FG003|Induction|Ineligible|0|||
23780855|NCT01190930|66580089|FG004|Induction|Ineligible|0|||
23780856|NCT01190930|66580090|FG005|Induction|Ineligible|0|||
23580356|NCT03976375|65853454|FG001|Overall Study|Lost to Follow-up|1|||
23580357|NCT03976375|65853455|FG002|Overall Study|Lost to Follow-up|1|||
23780857|NCT01190930|66580091|FG006|Induction|Ineligible|0|||
23780858|NCT01190930|66580092|FG007|Induction|Ineligible|0|||
23340037|NCT03483961|64989392|FG004|Overall Study|Lost to Follow-up|6|||
23340038|NCT03483961|64989393|FG005|Overall Study|Lost to Follow-up|4|||
23340039|NCT03483961|64989394|FG006|Overall Study|Lost to Follow-up|4|||
23340040|NCT03483961|64989395|FG007|Overall Study|Lost to Follow-up|11|||
23780859|NCT01190930|66580093|FG008|Induction|Ineligible|0|||
23780860|NCT01190930|66580094|FG009|Induction|Ineligible|0|||
23340041|NCT03483961|64989396|FG008|Overall Study|Lost to Follow-up|1|||
23340042|NCT03483961|64989397|FG009|Overall Study|Lost to Follow-up|0|||
23340043|NCT03483961|64989388|FG000|Overall Study|Withdrawal by Subject|3|||
23340044|NCT03483961|64989389|FG001|Overall Study|Withdrawal by Subject|4|||
23340045|NCT03483961|64989390|FG002|Overall Study|Withdrawal by Subject|5|||
23340046|NCT03483961|64989391|FG003|Overall Study|Withdrawal by Subject|3|||
23340047|NCT03483961|64989392|FG004|Overall Study|Withdrawal by Subject|4|||
23340048|NCT03483961|64989393|FG005|Overall Study|Withdrawal by Subject|2|||
23340049|NCT03483961|64989394|FG006|Overall Study|Withdrawal by Subject|1|||
23635376|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635377|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635378|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635379|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23635380|NCT01646177|66049434|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635381|NCT01646177|66049435|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635382|NCT01646177|66049436|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635383|NCT01646177|66049437|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635384|NCT01646177|66049438|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635385|NCT01646177|66049439|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
23635386|NCT01646177|66049440|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
23635387|NCT01646177|66049441|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
23635388|NCT01646177|66049442|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635389|NCT01646177|66049443|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635390|NCT01646177|66049444|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635391|NCT01646177|66049445|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23635392|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635393|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635394|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635395|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635396|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635397|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635398|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635399|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23635400|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
23635401|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
23635402|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
23635403|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
23635404|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635405|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635406|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635407|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635408|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635409|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23780861|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
23780862|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
23780863|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
23780864|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
23780865|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
23780866|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
23780867|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
23780868|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
23780869|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
23780870|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
23780871|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Death|0|||
23780872|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Death|0|||
23452008|NCT00591006|65398876|FG020|Overall Study|Adverse Event|0|||
23452009|NCT00591006|65398877|FG021|Overall Study|Adverse Event|0|||
23780873|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Death|8|||
23340050|NCT03483961|64989395|FG007|Overall Study|Withdrawal by Subject|2|||
23452010|NCT00591006|65398878|FG022|Overall Study|Adverse Event|1|||
23635410|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635411|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23635412|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
23635413|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
23635414|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
23635415|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
23840465|NCT02841280|66795489|FG001|Overall Study|Stop Point: BP above threshold|0|||
23840466|NCT00489307|66795496|FG000|Overall Study|Death|1|||
23840467|NCT00489307|66795497|FG001|Overall Study|Death|1|||
23840468|NCT00489307|66795496|FG000|Overall Study|Lost to Follow-up|2|||
23840469|NCT00489307|66795497|FG001|Overall Study|Lost to Follow-up|2|||
23840470|NCT00489307|66795496|FG000|Overall Study|Physician Decision|1|||
23840471|NCT00489307|66795497|FG001|Overall Study|Physician Decision|0|||
23340051|NCT03483961|64989396|FG008|Overall Study|Withdrawal by Subject|1|||
23340052|NCT03483961|64989397|FG009|Overall Study|Withdrawal by Subject|0|||
23340053|NCT03483961|64989388|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
23340054|NCT03483961|64989389|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23840472|NCT00489307|66795496|FG000|Overall Study|Withdrawal by Subject|2|||
23840473|NCT00489307|66795497|FG001|Overall Study|Withdrawal by Subject|4|||
23840474|NCT00489307|66795496|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
23840475|NCT00489307|66795497|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
23840476|NCT00489307|66795496|FG000|Overall Study|Surgery after assignment|1|||
23840477|NCT00489307|66795497|FG001|Overall Study|Surgery after assignment|0|||
23840478|NCT00489307|66795496|FG000|Overall Study|Did not fill up the forms|2|||
23840479|NCT00489307|66795497|FG001|Overall Study|Did not fill up the forms|1|||
23840480|NCT00489307|66795496|FG000|Overall Study|Patient or family refusal|5|||
23840481|NCT00489307|66795497|FG001|Overall Study|Patient or family refusal|9|||
23840482|NCT03674112|66795499|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
23840483|NCT03674112|66795500|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
23840484|NCT03674112|66795499|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
23840485|NCT03674112|66795500|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
23840486|NCT03674112|66795499|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
23840487|NCT03674112|66795500|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
23840488|NCT03674112|66795499|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
23840489|NCT03674112|66795500|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
23840490|NCT03674112|66795499|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
23840491|NCT03674112|66795500|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
23840492|NCT03674112|66795499|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
23840493|NCT03674112|66795500|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
23840494|NCT03674112|66795499|FG000|Follow-Up Period (≥3 Years)|Death|2|||
23840495|NCT03674112|66795500|FG001|Follow-Up Period (≥3 Years)|Death|0|||
23840496|NCT03674112|66795499|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
23840497|NCT03674112|66795500|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
23840498|NCT01186692|66795501|FG000|Overall Study|Not Catheterized|11|||
23840499|NCT01186692|66795501|FG000|Overall Study|Futher testing contraindicated implant|19|||
23840500|NCT01186692|66795501|FG000|Overall Study|Adverse Event|2|||
23840501|NCT01894100|66795502|FG000|Overall Study|Lost to Follow-up|0|||
23840502|NCT01894100|66795503|FG001|Overall Study|Lost to Follow-up|1|||
23840503|NCT01894100|66795502|FG000|Overall Study|Withdrawal by Subject|3|||
23840504|NCT01894100|66795503|FG001|Overall Study|Withdrawal by Subject|0|||
23840505|NCT01682226|66795504|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
23840506|NCT01682226|66795504|FG000|Overall Study|Participants did not receive treatment|2|||
23840507|NCT01682226|66795504|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
23840508|NCT00652626|66795507|FG000|Initial Treatment Phase|Adverse Event|0|||
23840509|NCT00652626|66795508|FG001|Initial Treatment Phase|Adverse Event|0|||
23840510|NCT00652626|66795509|FG002|Initial Treatment Phase|Adverse Event|0|||
23840511|NCT00652626|66795510|FG003|Initial Treatment Phase|Adverse Event|0|||
23840512|NCT00652626|66795511|FG004|Initial Treatment Phase|Adverse Event|1|||
23840513|NCT00652626|66795512|FG005|Initial Treatment Phase|Adverse Event|0|||
23840514|NCT00652626|66795513|FG006|Initial Treatment Phase|Adverse Event|0|||
23840515|NCT00652626|66795507|FG000|Initial Treatment Phase|Protocol Violation|0|||
23840516|NCT00652626|66795508|FG001|Initial Treatment Phase|Protocol Violation|0|||
23840517|NCT00652626|66795509|FG002|Initial Treatment Phase|Protocol Violation|0|||
23840518|NCT00652626|66795510|FG003|Initial Treatment Phase|Protocol Violation|1|||
23840519|NCT00652626|66795511|FG004|Initial Treatment Phase|Protocol Violation|0|||
23840520|NCT00652626|66795512|FG005|Initial Treatment Phase|Protocol Violation|0|||
23840521|NCT00652626|66795513|FG006|Initial Treatment Phase|Protocol Violation|0|||
23840522|NCT00652626|66795507|FG000|Initial Treatment Phase|Physician Decision|0|||
23840523|NCT00652626|66795508|FG001|Initial Treatment Phase|Physician Decision|0|||
23840524|NCT00652626|66795509|FG002|Initial Treatment Phase|Physician Decision|0|||
23840525|NCT00652626|66795510|FG003|Initial Treatment Phase|Physician Decision|0|||
23840526|NCT00652626|66795511|FG004|Initial Treatment Phase|Physician Decision|1|||
23840527|NCT00652626|66795512|FG005|Initial Treatment Phase|Physician Decision|0|||
23840528|NCT00652626|66795513|FG006|Initial Treatment Phase|Physician Decision|0|||
23840529|NCT00652626|66795507|FG000|Initial Treatment Phase|Sponsor Request|0|||
23840530|NCT00652626|66795508|FG001|Initial Treatment Phase|Sponsor Request|0|||
23635416|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635417|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635418|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635419|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635420|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635421|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635422|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635423|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23635424|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
23635425|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
23635426|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
23635427|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
23635428|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635429|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635430|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635431|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635432|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635433|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635434|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635435|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23635436|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
23635437|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
23635438|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
23635439|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
23635440|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635441|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635442|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635443|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635444|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635445|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635446|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635447|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23635448|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
23635449|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
23635450|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
23635451|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
23635452|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23780874|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Death|4|||
23780875|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Death|0|||
23780876|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Death|0|||
23780877|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Death|0|||
23780878|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Death|0|||
23780879|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Death|0|||
23780880|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Death|0|||
23780881|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
23780882|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
23780883|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
23780884|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
23780885|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
23780886|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
23780887|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
23780888|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
23780889|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
23780890|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
23780891|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780892|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
23780893|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
23780894|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
23780895|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780896|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780897|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23635453|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635454|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635455|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635456|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635457|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635458|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23840531|NCT00652626|66795509|FG002|Initial Treatment Phase|Sponsor Request|1|||
23840532|NCT00652626|66795510|FG003|Initial Treatment Phase|Sponsor Request|0|||
23840533|NCT00652626|66795511|FG004|Initial Treatment Phase|Sponsor Request|0|||
23840534|NCT00652626|66795512|FG005|Initial Treatment Phase|Sponsor Request|0|||
23840535|NCT00652626|66795513|FG006|Initial Treatment Phase|Sponsor Request|0|||
23840536|NCT00652626|66795507|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
23840537|NCT00652626|66795508|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
23840538|NCT00652626|66795509|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
23840539|NCT00652626|66795510|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
23840540|NCT00652626|66795511|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
23840541|NCT00652626|66795512|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
23840542|NCT00652626|66795513|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
23840543|NCT00652626|66795507|FG000|Extension Phase|Withdrawal by Subject|0|||
23840544|NCT00652626|66795508|FG001|Extension Phase|Withdrawal by Subject|0|||
23840545|NCT00652626|66795509|FG002|Extension Phase|Withdrawal by Subject|0|||
23840546|NCT00652626|66795510|FG003|Extension Phase|Withdrawal by Subject|0|||
23840547|NCT00652626|66795511|FG004|Extension Phase|Withdrawal by Subject|0|||
23840548|NCT00652626|66795512|FG005|Extension Phase|Withdrawal by Subject|2|||
23840549|NCT00652626|66795513|FG006|Extension Phase|Withdrawal by Subject|0|||
23840550|NCT00652626|66795507|FG000|Extension Phase|Adverse Event|0|||
23840551|NCT00652626|66795508|FG001|Extension Phase|Adverse Event|0|||
23840552|NCT00652626|66795509|FG002|Extension Phase|Adverse Event|0|||
23840553|NCT00652626|66795510|FG003|Extension Phase|Adverse Event|0|||
23840554|NCT00652626|66795511|FG004|Extension Phase|Adverse Event|0|||
23840555|NCT00652626|66795512|FG005|Extension Phase|Adverse Event|2|||
23840556|NCT00652626|66795513|FG006|Extension Phase|Adverse Event|1|||
23840557|NCT00652626|66795507|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840558|NCT00652626|66795508|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840559|NCT00652626|66795509|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840560|NCT00652626|66795510|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840561|NCT00652626|66795511|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840562|NCT00652626|66795512|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
23840563|NCT00652626|66795513|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23840564|NCT00652626|66795507|FG000|Extension Phase|Physician Decision|0|||
23840565|NCT00652626|66795508|FG001|Extension Phase|Physician Decision|0|||
23840566|NCT00652626|66795509|FG002|Extension Phase|Physician Decision|0|||
23840567|NCT00652626|66795510|FG003|Extension Phase|Physician Decision|0|||
23840568|NCT00652626|66795511|FG004|Extension Phase|Physician Decision|0|||
23840569|NCT00652626|66795512|FG005|Extension Phase|Physician Decision|1|||
23840570|NCT00652626|66795513|FG006|Extension Phase|Physician Decision|1|||
23840571|NCT00652626|66795507|FG000|Extension Phase|Death|0|||
23840572|NCT00652626|66795508|FG001|Extension Phase|Death|0|||
23840573|NCT00652626|66795509|FG002|Extension Phase|Death|0|||
23840574|NCT00652626|66795510|FG003|Extension Phase|Death|0|||
23840575|NCT00652626|66795511|FG004|Extension Phase|Death|0|||
23840576|NCT00652626|66795512|FG005|Extension Phase|Death|1|||
23840577|NCT00652626|66795513|FG006|Extension Phase|Death|1|||
23840578|NCT02411448|66795514|FG000|Overall Study|Withdrawal by Subject|1|||
23840579|NCT02411448|66795515|FG001|Overall Study|Withdrawal by Subject|14|||
23840580|NCT02411448|66795516|FG002|Overall Study|Withdrawal by Subject|9|||
23840581|NCT02411448|66795514|FG000|Overall Study|Other|0|||
23840582|NCT02411448|66795515|FG001|Overall Study|Other|2|||
23840583|NCT02411448|66795516|FG002|Overall Study|Other|0|||
23840584|NCT02411448|66795514|FG000|Overall Study|Did not receive study treatment|0|||
23840585|NCT02411448|66795515|FG001|Overall Study|Did not receive study treatment|3|||
23840586|NCT02411448|66795516|FG002|Overall Study|Did not receive study treatment|0|||
23840587|NCT02411448|66795514|FG000|Overall Study|Alive on study treatment|3|||
23840588|NCT02411448|66795515|FG001|Overall Study|Alive on study treatment|64|||
23840589|NCT02411448|66795516|FG002|Overall Study|Alive on study treatment|43|||
23840590|NCT02844543|66795529|FG000|Overall Study|Withdrawal by Subject|4|||
23840591|NCT02844543|66795529|FG000|Overall Study|Did not meet eligibility criteria|1|||
23840592|NCT01136356|66795530|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
23840593|NCT01136356|66795531|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
23580358|NCT03976375|65853453|FG000|Overall Study|Withdrawal by Subject|4|||
23580359|NCT03976375|65853454|FG001|Overall Study|Withdrawal by Subject|9|||
23840594|NCT01136356|66795530|FG000|First 18-day Withdrawal|Physician Decision|1|||
23840595|NCT01136356|66795531|FG001|First 18-day Withdrawal|Physician Decision|0|||
23840596|NCT01136356|66795530|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
23840597|NCT01136356|66795531|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
23840598|NCT00656292|66795532|FG000|Overall Study|Withdrawal by Subject|2|||
23840599|NCT00656292|66795533|FG001|Overall Study|Withdrawal by Subject|3|||
23840600|NCT00656292|66795532|FG000|Overall Study|Screen failure|1|||
23840601|NCT00656292|66795533|FG001|Overall Study|Screen failure|2|||
23840602|NCT00977080|66795534|FG000|Overall Study|Adverse Event|2|||
23840603|NCT00977080|66795535|FG001|Overall Study|Adverse Event|7|||
23840604|NCT00977080|66795536|FG002|Overall Study|Adverse Event|7|||
23840605|NCT00977080|66795537|FG003|Overall Study|Adverse Event|7|||
23840606|NCT00977080|66795534|FG000|Overall Study|Withdrawal by Subject|1|||
23840607|NCT00977080|66795535|FG001|Overall Study|Withdrawal by Subject|5|||
23840608|NCT00977080|66795536|FG002|Overall Study|Withdrawal by Subject|1|||
23580360|NCT03976375|65853455|FG002|Overall Study|Withdrawal by Subject|4|||
23580361|NCT03976375|65853453|FG000|Overall Study|Ongoing|33|||
23580362|NCT03976375|65853454|FG001|Overall Study|Ongoing|29|||
23580363|NCT03976375|65853455|FG002|Overall Study|Ongoing|5|||
23580364|NCT00490555|65853458|FG000|Overall Study|noncompliant with drug administration|0|||
23580365|NCT00490555|65853459|FG001|Overall Study|noncompliant with drug administration|0|||
23580366|NCT00490555|65853460|FG002|Overall Study|noncompliant with drug administration|2|||
23580367|NCT00490555|65853461|FG003|Overall Study|noncompliant with drug administration|0|||
23580368|NCT02153788|65853464|FG000|Overall Study|Physician Decision|2|||
23580369|NCT02153788|65853465|FG001|Overall Study|Physician Decision|1|||
23580370|NCT00859014|65853469|FG000|Overall Study|Death|4|||
23580371|NCT00859014|65853469|FG000|Overall Study|Lost to Follow-up|1|||
23580372|NCT01686932|65853475|FG000|Period 1|Adverse Event|1|||
23580373|NCT01686932|65853476|FG001|Period 1|Adverse Event|1|||
23580374|NCT02938442|65853477|FG000|Overall Study|Death|0|||
23580375|NCT02938442|65853478|FG001|Overall Study|Death|1|||
23580376|NCT02938442|65853477|FG000|Overall Study|Lost to Follow-up|0|||
23580377|NCT02938442|65853478|FG001|Overall Study|Lost to Follow-up|1|||
23840609|NCT00977080|66795537|FG003|Overall Study|Withdrawal by Subject|5|||
23840610|NCT00977080|66795534|FG000|Overall Study|Protocol Violation|7|||
23840611|NCT00977080|66795535|FG001|Overall Study|Protocol Violation|3|||
23840612|NCT00977080|66795536|FG002|Overall Study|Protocol Violation|4|||
23840613|NCT00977080|66795537|FG003|Overall Study|Protocol Violation|3|||
23840614|NCT00977080|66795534|FG000|Overall Study|Noncompliance|0|||
23840615|NCT00977080|66795535|FG001|Overall Study|Noncompliance|2|||
23840616|NCT00977080|66795536|FG002|Overall Study|Noncompliance|1|||
23840617|NCT00977080|66795537|FG003|Overall Study|Noncompliance|0|||
23840618|NCT00977080|66795534|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23840619|NCT00977080|66795535|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23840620|NCT00977080|66795536|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23840621|NCT00977080|66795537|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
23840622|NCT00977080|66795534|FG000|Overall Study|Required kidney transplantation|1|||
23840623|NCT00977080|66795535|FG001|Overall Study|Required kidney transplantation|3|||
23840624|NCT00977080|66795536|FG002|Overall Study|Required kidney transplantation|3|||
23840625|NCT00977080|66795537|FG003|Overall Study|Required kidney transplantation|1|||
23840626|NCT00977080|66795534|FG000|Overall Study|Travel for family reasons|1|||
23840627|NCT00977080|66795535|FG001|Overall Study|Travel for family reasons|0|||
23840628|NCT00977080|66795536|FG002|Overall Study|Travel for family reasons|0|||
23840629|NCT00977080|66795537|FG003|Overall Study|Travel for family reasons|0|||
23580378|NCT02938442|65853477|FG000|Overall Study|Physician Decision|0|||
23840630|NCT00566020|66795538|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
23840631|NCT00566020|66795539|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
23840632|NCT00566020|66795538|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
23840633|NCT00566020|66795539|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
23840634|NCT00566020|66795538|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
23840635|NCT00566020|66795539|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
23840636|NCT00566020|66795538|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
23840637|NCT00566020|66795539|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
23840638|NCT00566020|66795538|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
23840639|NCT00566020|66795539|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
23840640|NCT00566020|66795538|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
23840641|NCT00566020|66795539|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
23840642|NCT03670836|66795540|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
23452011|NCT00591006|65398879|FG023|Overall Study|Adverse Event|0|||
23580379|NCT02938442|65853478|FG001|Overall Study|Physician Decision|1|||
23580380|NCT02938442|65853477|FG000|Overall Study|Withdrawal by Subject|2|||
23580381|NCT02938442|65853478|FG001|Overall Study|Withdrawal by Subject|0|||
23840643|NCT03670836|66795541|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
23840644|NCT03670836|66795540|FG000|Per Protocol Population (PP)|Physician Decision|9|||
23840645|NCT03670836|66795541|FG001|Per Protocol Population (PP)|Physician Decision|10|||
23840646|NCT03670836|66795540|FG000|Per Protocol Population (PP)|Physician Decision|4|||
23840647|NCT03670836|66795541|FG001|Per Protocol Population (PP)|Physician Decision|6|||
23840648|NCT03670836|66795540|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
23840649|NCT03670836|66795541|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
23840650|NCT04109391|66795542|FG000|Overall Study|Adverse Event|2|||
23580382|NCT01556243|65853479|FG000|Overall Study|Ineligible|34|||
23452012|NCT03149055|65398880|FG000|Overall Study|Not treated|4|||
23580383|NCT01556243|65853479|FG000|Overall Study|Converted to mastectomy|14|||
23580384|NCT01556243|65853479|FG000|Overall Study|Unable to achieve negative margins|2|||
23840651|NCT04109391|66795543|FG001|Overall Study|Adverse Event|2|||
23840652|NCT04109391|66795544|FG002|Overall Study|Adverse Event|0|||
23840653|NCT04109391|66795542|FG000|Overall Study|Withdrawal by Subject|2|||
23840654|NCT04109391|66795543|FG001|Overall Study|Withdrawal by Subject|0|||
23840655|NCT04109391|66795544|FG002|Overall Study|Withdrawal by Subject|0|||
23840656|NCT04109391|66795542|FG000|Overall Study|Pregnancy|1|||
23840657|NCT04109391|66795543|FG001|Overall Study|Pregnancy|0|||
23840658|NCT04109391|66795544|FG002|Overall Study|Pregnancy|0|||
23840659|NCT04109391|66795542|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
23840660|NCT04109391|66795543|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
23840661|NCT04109391|66795544|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
23840662|NCT04109391|66795542|FG000|Overall Study|Lost to Follow-up|0|||
23840663|NCT04109391|66795543|FG001|Overall Study|Lost to Follow-up|0|||
23840664|NCT04109391|66795544|FG002|Overall Study|Lost to Follow-up|1|||
23840665|NCT04109391|66795542|FG000|Overall Study|Lack of Efficacy|2|||
23840666|NCT04109391|66795543|FG001|Overall Study|Lack of Efficacy|2|||
23840667|NCT04109391|66795544|FG002|Overall Study|Lack of Efficacy|3|||
23840668|NCT02582684|66795545|FG000|Overall Study|Unable to contact subject/parent|4|||
23840669|NCT02582684|66795545|FG000|Overall Study|Subject not able to get to clinic|10|||
23840670|NCT02582684|66795545|FG000|Overall Study|Subject withdrew consent|1|||
23840671|NCT02582684|66795545|FG000|Overall Study|Found to be ineligible after enrollment|2|||
23840672|NCT01500382|66795546|FG000|Washout Period|Study site went out of business|0|||
23580385|NCT01556243|65853479|FG000|Overall Study|Withdrawal by Subject|16|||
23840673|NCT01500382|66795547|FG001|Washout Period|Study site went out of business|0|||
23840674|NCT01500382|66795548|FG002|Washout Period|Study site went out of business|1|||
23840675|NCT01500382|66795549|FG003|Washout Period|Study site went out of business|0|||
23840676|NCT03226769|66795550|FG000|Overall Study|Withdrawal by Subject|0|||
23840677|NCT03226769|66795551|FG001|Overall Study|Withdrawal by Subject|1|||
23840678|NCT01222520|66795553|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
23840679|NCT01222520|66795554|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
23840680|NCT01222520|66795553|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
23840681|NCT01222520|66795554|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
23840682|NCT01222520|66795553|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
23840683|NCT01222520|66795554|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
23840684|NCT01222520|66795553|FG000|Double-blind Period|Adverse Event|0|||
23840685|NCT01222520|66795554|FG001|Double-blind Period|Adverse Event|1|||
23840686|NCT01222520|66795553|FG000|Double-blind Period|Lack of Efficacy|0|||
23840687|NCT01222520|66795554|FG001|Double-blind Period|Lack of Efficacy|1|||
23840688|NCT01222520|66795553|FG000|Double-blind Period|Study medication stolen|1|||
23840689|NCT01222520|66795554|FG001|Double-blind Period|Study medication stolen|0|||
23840690|NCT03656692|66795557|FG000|Overall Study|Worsening of disease activity|2|||
23840691|NCT03656692|66795557|FG000|Overall Study|Physician Decision|1|||
23840692|NCT01068730|66795558|FG000|Period 3|Personal reason|1|||
23840693|NCT01068730|66795559|FG001|Period 3|Personal reason|0|||
23840694|NCT01068730|66795560|FG002|Period 3|Personal reason|0|||
23840695|NCT01068730|66795561|FG003|Period 3|Personal reason|0|||
23840696|NCT01068730|66795558|FG000|Period 4|Family emergency|0|||
23840697|NCT01068730|66795559|FG001|Period 4|Family emergency|1|||
23840698|NCT01068730|66795560|FG002|Period 4|Family emergency|0|||
23840699|NCT01068730|66795561|FG003|Period 4|Family emergency|0|||
23840700|NCT03425396|66798371|FG000|Overall Study|Lost to Follow-up|2|||
23840701|NCT03425396|66798372|FG001|Overall Study|Lost to Follow-up|5|||
23840702|NCT03425396|66798373|FG002|Overall Study|Lost to Follow-up|2|||
23840703|NCT03425396|66798374|FG003|Overall Study|Lost to Follow-up|0|||
23840704|NCT03425396|66798375|FG004|Overall Study|Lost to Follow-up|0|||
23840705|NCT03425396|66798371|FG000|Overall Study|Withdrawal by Subject|0|||
23840706|NCT03425396|66798372|FG001|Overall Study|Withdrawal by Subject|1|||
23580386|NCT00994279|65853482|FG000|Overall Study|Withdrawal by Subject|2|||
23580387|NCT00994279|65853483|FG001|Overall Study|Withdrawal by Subject|2|||
23580388|NCT00994279|65853482|FG000|Overall Study|Toxicity|1|||
23580389|NCT00994279|65853483|FG001|Overall Study|Toxicity|0|||
23580390|NCT00994279|65853482|FG000|Overall Study|Multiple reasons|1|||
23580391|NCT00994279|65853483|FG001|Overall Study|Multiple reasons|3|||
23580392|NCT01192295|65853484|FG000|Overall Study|Adverse Event|3|||
23580393|NCT01192295|65853485|FG001|Overall Study|Adverse Event|7|||
23580394|NCT01192295|65853484|FG000|Overall Study|Withdrawal by Subject|3|||
23580395|NCT01192295|65853485|FG001|Overall Study|Withdrawal by Subject|4|||
23580396|NCT01192295|65853484|FG000|Overall Study|Lost to Follow-up|0|||
23580397|NCT01192295|65853485|FG001|Overall Study|Lost to Follow-up|1|||
23580398|NCT01192295|65853484|FG000|Overall Study|Lack of Efficacy|0|||
23580399|NCT01192295|65853485|FG001|Overall Study|Lack of Efficacy|5|||
23580400|NCT01192295|65853484|FG000|Overall Study|Administrative|4|||
23580401|NCT01192295|65853485|FG001|Overall Study|Administrative|6|||
23580402|NCT02501629|65853486|FG000|Overall Study|Death|0|||
23840707|NCT03425396|66798373|FG002|Overall Study|Withdrawal by Subject|0|||
23580403|NCT02501629|65853487|FG001|Overall Study|Death|1|||
23635459|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23635460|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
23635461|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
23635462|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
23635463|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
23635464|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23452013|NCT02714569|65398891|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
23452014|NCT02714569|65398892|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
23452015|NCT02714569|65398893|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
23452016|NCT02714569|65398894|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
23452017|NCT02714569|65398895|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
23452018|NCT02714569|65398896|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
23452019|NCT02714569|65398897|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
23452020|NCT02714569|65398898|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
23452021|NCT02714569|65398899|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
23452022|NCT02714569|65398900|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
23452023|NCT02714569|65398901|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
23452024|NCT02714569|65398891|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452025|NCT02714569|65398892|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452026|NCT02714569|65398893|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452027|NCT02714569|65398894|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
23452028|NCT02714569|65398895|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23635465|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23452029|NCT02714569|65398896|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23580404|NCT02501629|65853486|FG000|Overall Study|Withdrawn from study by sponsor|1|||
23580405|NCT02501629|65853487|FG001|Overall Study|Withdrawn from study by sponsor|0|||
23580406|NCT02501629|65853486|FG000|Overall Study|Early termination by sponsor|1|||
23580407|NCT02501629|65853487|FG001|Overall Study|Early termination by sponsor|0|||
23580408|NCT02501629|65853486|FG000|Overall Study|Withdrawal by Subject|3|||
23580409|NCT02501629|65853487|FG001|Overall Study|Withdrawal by Subject|5|||
23580410|NCT02501629|65853486|FG000|Overall Study|Subject did not return to site|0|||
23580411|NCT02501629|65853487|FG001|Overall Study|Subject did not return to site|1|||
23580412|NCT02498613|65853488|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
23580413|NCT02498613|65853489|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
23580414|NCT02498613|65853490|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
23580415|NCT02498613|65853491|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
23580416|NCT02498613|65853488|FG000|Overall Study|Withdrawal by Subject|3|||
23580417|NCT02498613|65853489|FG001|Overall Study|Withdrawal by Subject|1|||
23580418|NCT02498613|65853490|FG002|Overall Study|Withdrawal by Subject|0|||
23580419|NCT02498613|65853491|FG003|Overall Study|Withdrawal by Subject|0|||
23635466|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23580420|NCT00630864|65853492|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
23580421|NCT00630864|65853492|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
23580422|NCT00448864|65853493|FG000|Overall Study|Death|1|||
23580423|NCT00448864|65853494|FG001|Overall Study|Death|0|||
23580424|NCT00448864|65853495|FG002|Overall Study|Death|0|||
23580425|NCT00448864|65853493|FG000|Overall Study|Lost to Follow-up|3|||
23580426|NCT00448864|65853494|FG001|Overall Study|Lost to Follow-up|1|||
23580427|NCT00448864|65853495|FG002|Overall Study|Lost to Follow-up|0|||
23580428|NCT00448864|65853493|FG000|Overall Study|Physician Decision|1|||
23580429|NCT00448864|65853494|FG001|Overall Study|Physician Decision|0|||
23580430|NCT00448864|65853495|FG002|Overall Study|Physician Decision|1|||
23580431|NCT00448864|65853493|FG000|Overall Study|Withdrawal by Subject|0|||
23580432|NCT00448864|65853494|FG001|Overall Study|Withdrawal by Subject|2|||
23580433|NCT00448864|65853495|FG002|Overall Study|Withdrawal by Subject|0|||
23580434|NCT00448864|65853493|FG000|Overall Study|Protocol Violation|0|||
23580435|NCT00448864|65853494|FG001|Overall Study|Protocol Violation|2|||
23580436|NCT00448864|65853495|FG002|Overall Study|Protocol Violation|0|||
23580437|NCT03382821|65853498|FG000|Overall Study|Did not receive allocated intervention.|0|||
23580438|NCT03382821|65853499|FG001|Overall Study|Did not receive allocated intervention.|3|||
23635467|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23780898|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780899|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780900|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23780901|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Refusal|0|||
23780902|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Refusal|2|||
23780903|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Refusal|694|||
23780904|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Refusal|4|||
23780905|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Refusal|0|||
23580439|NCT04610684|65853505|FG000|Study Treatment|Withdrawal by Subject|1|||
23580440|NCT04610684|65853505|FG000|Study Treatment|Disease Progression|2|||
23340055|NCT03483961|64989390|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340056|NCT03483961|64989391|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340057|NCT03483961|64989392|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340058|NCT03483961|64989393|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340059|NCT03483961|64989394|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340060|NCT03483961|64989395|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340061|NCT03483961|64989396|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340062|NCT03483961|64989397|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340063|NCT03483961|64989388|FG000|Overall Study|Adverse Event|0|||
23340064|NCT03483961|64989389|FG001|Overall Study|Adverse Event|0|||
23452030|NCT02714569|65398897|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23635468|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23840708|NCT03425396|66798374|FG003|Overall Study|Withdrawal by Subject|1|||
23840709|NCT03425396|66798375|FG004|Overall Study|Withdrawal by Subject|0|||
23840710|NCT03425396|66798371|FG000|Overall Study|Other|0|||
23840711|NCT03425396|66798372|FG001|Overall Study|Other|1|||
23840712|NCT03425396|66798373|FG002|Overall Study|Other|1|||
23840713|NCT03425396|66798374|FG003|Overall Study|Other|0|||
23840714|NCT03425396|66798375|FG004|Overall Study|Other|1|||
23840715|NCT02101736|66798377|FG000|Overall Study|Protocol Violation|3|||
23840716|NCT02101736|66798378|FG001|Overall Study|Protocol Violation|0|||
23840717|NCT02101736|66798377|FG000|Overall Study|Withdrawal by Subject|1|||
23840718|NCT02101736|66798378|FG001|Overall Study|Withdrawal by Subject|1|||
23840719|NCT01339923|66798379|FG000|Overall Study|Adverse Event|1|||
23840720|NCT01339923|66798380|FG001|Overall Study|Adverse Event|1|||
23840721|NCT01339923|66798381|FG002|Overall Study|Adverse Event|1|||
23840722|NCT01339923|66798382|FG003|Overall Study|Adverse Event|0|||
23840723|NCT01339923|66798383|FG004|Overall Study|Adverse Event|0|||
23840724|NCT01339923|66798384|FG005|Overall Study|Adverse Event|0|||
23840725|NCT01339923|66798385|FG006|Overall Study|Adverse Event|1|||
23840726|NCT01339923|66798379|FG000|Overall Study|Inappropriate Enrollment|1|||
23840727|NCT01339923|66798380|FG001|Overall Study|Inappropriate Enrollment|0|||
23840728|NCT01339923|66798381|FG002|Overall Study|Inappropriate Enrollment|0|||
23840729|NCT01339923|66798382|FG003|Overall Study|Inappropriate Enrollment|0|||
23840730|NCT01339923|66798383|FG004|Overall Study|Inappropriate Enrollment|0|||
23840731|NCT01339923|66798384|FG005|Overall Study|Inappropriate Enrollment|1|||
23840732|NCT01339923|66798385|FG006|Overall Study|Inappropriate Enrollment|0|||
23840733|NCT01339923|66798379|FG000|Overall Study|Lost to Follow-up|4|||
23840734|NCT01339923|66798380|FG001|Overall Study|Lost to Follow-up|4|||
23840735|NCT01339923|66798381|FG002|Overall Study|Lost to Follow-up|0|||
23840736|NCT01339923|66798382|FG003|Overall Study|Lost to Follow-up|3|||
23840737|NCT01339923|66798383|FG004|Overall Study|Lost to Follow-up|1|||
23840738|NCT01339923|66798384|FG005|Overall Study|Lost to Follow-up|1|||
23840739|NCT01339923|66798385|FG006|Overall Study|Lost to Follow-up|5|||
23840740|NCT01339923|66798379|FG000|Overall Study|Protocol Violation|0|||
23840741|NCT01339923|66798380|FG001|Overall Study|Protocol Violation|0|||
23840742|NCT01339923|66798381|FG002|Overall Study|Protocol Violation|0|||
23840743|NCT01339923|66798382|FG003|Overall Study|Protocol Violation|0|||
23840744|NCT01339923|66798383|FG004|Overall Study|Protocol Violation|0|||
23840745|NCT01339923|66798384|FG005|Overall Study|Protocol Violation|3|||
23840746|NCT01339923|66798385|FG006|Overall Study|Protocol Violation|1|||
23840747|NCT01339923|66798379|FG000|Overall Study|Unable to Classify|1|||
23840748|NCT01339923|66798380|FG001|Overall Study|Unable to Classify|0|||
23840749|NCT01339923|66798381|FG002|Overall Study|Unable to Classify|1|||
23840750|NCT01339923|66798382|FG003|Overall Study|Unable to Classify|0|||
23840751|NCT01339923|66798383|FG004|Overall Study|Unable to Classify|0|||
23840752|NCT01339923|66798384|FG005|Overall Study|Unable to Classify|1|||
23840753|NCT01339923|66798385|FG006|Overall Study|Unable to Classify|5|||
23840754|NCT01339923|66798379|FG000|Overall Study|Withdrawal by Subject|7|||
23840755|NCT01339923|66798380|FG001|Overall Study|Withdrawal by Subject|11|||
23840756|NCT01339923|66798381|FG002|Overall Study|Withdrawal by Subject|6|||
23635469|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23635470|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23635471|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23840757|NCT01339923|66798382|FG003|Overall Study|Withdrawal by Subject|1|||
23840758|NCT01339923|66798383|FG004|Overall Study|Withdrawal by Subject|4|||
23840759|NCT01339923|66798384|FG005|Overall Study|Withdrawal by Subject|3|||
23840760|NCT01339923|66798385|FG006|Overall Study|Withdrawal by Subject|2|||
23840761|NCT00734162|66798388|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
23840762|NCT00734162|66798389|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
23840763|NCT00734162|66798390|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
23635472|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23635473|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
23635474|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
23635475|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
23635476|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635477|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635478|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635479|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635480|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635481|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635482|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635483|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23340065|NCT03483961|64989390|FG002|Overall Study|Adverse Event|1|||
23340066|NCT03483961|64989391|FG003|Overall Study|Adverse Event|0|||
23340067|NCT03483961|64989392|FG004|Overall Study|Adverse Event|0|||
23340068|NCT03483961|64989393|FG005|Overall Study|Adverse Event|0|||
23340069|NCT03483961|64989394|FG006|Overall Study|Adverse Event|0|||
23340070|NCT03483961|64989395|FG007|Overall Study|Adverse Event|0|||
23340071|NCT03483961|64989396|FG008|Overall Study|Adverse Event|0|||
23340072|NCT03483961|64989397|FG009|Overall Study|Adverse Event|0|||
23340073|NCT02541669|64989402|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23340074|NCT02541669|64989403|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23340075|NCT02541669|64989404|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23340076|NCT02541669|64989405|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23580441|NCT04610684|65853505|FG000|Follow up|Death|2|||
23635484|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23635485|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23635486|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23635487|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23635488|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635489|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635490|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635491|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635492|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635493|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635494|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635495|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635496|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23635497|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23635498|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23635499|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23635500|NCT01646177|66049434|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635501|NCT01646177|66049435|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635502|NCT01646177|66049436|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635503|NCT01646177|66049437|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635504|NCT01646177|66049438|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635505|NCT01646177|66049439|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635506|NCT01646177|66049440|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635507|NCT01646177|66049441|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635508|NCT01646177|66049442|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635509|NCT01646177|66049443|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23635510|NCT01646177|66049444|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
23635511|NCT01646177|66049445|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
23340077|NCT02541669|64989406|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23340078|NCT01089608|64989407|FG000|Overall Study|Adverse Event|0|||
23340079|NCT01089608|64989408|FG001|Overall Study|Adverse Event|4|||
23580442|NCT04610684|65853505|FG000|Follow up|Withdrawal by Subject|1|||
23580443|NCT00335556|65853506|FG000|Overall Study|Death|0|||
23580444|NCT00335556|65853507|FG001|Overall Study|Death|5|||
23580445|NCT00335556|65853508|FG002|Overall Study|Death|0|||
23580446|NCT00335556|65853509|FG003|Overall Study|Death|0|||
23580447|NCT00335556|65853510|FG004|Overall Study|Death|1|||
23580448|NCT00335556|65853511|FG005|Overall Study|Death|0|||
23580449|NCT00335556|65853506|FG000|Overall Study|Lack of Efficacy|0|||
23580450|NCT00335556|65853507|FG001|Overall Study|Lack of Efficacy|19|||
23580451|NCT00335556|65853508|FG002|Overall Study|Lack of Efficacy|3|||
23780906|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Refusal|3|||
23340080|NCT01089608|64989407|FG000|Overall Study|Lost to Follow-up|0|||
23580452|NCT00335556|65853509|FG003|Overall Study|Lack of Efficacy|3|||
23580453|NCT00335556|65853510|FG004|Overall Study|Lack of Efficacy|0|||
23580454|NCT00335556|65853511|FG005|Overall Study|Lack of Efficacy|1|||
23635512|NCT02269423|66049452|FG000|Overall Study|Discontinued due to change in residence|0|||
23635513|NCT02269423|66049453|FG001|Overall Study|Discontinued due to change in residence|1|||
23635514|NCT02269423|66049454|FG002|Overall Study|Discontinued due to change in residence|0|||
23635515|NCT02269423|66049455|FG003|Overall Study|Discontinued due to change in residence|1|||
23635516|NCT00078338|66049456|FG000|Overall Study|Adverse Event|31|||
23635517|NCT00078338|66049457|FG001|Overall Study|Adverse Event|24|||
23635518|NCT00078338|66049456|FG000|Overall Study|Lost to Follow-up|17|||
23635519|NCT00078338|66049457|FG001|Overall Study|Lost to Follow-up|2|||
23635520|NCT00078338|66049456|FG000|Overall Study|Protocol Violation|2|||
23635521|NCT00078338|66049457|FG001|Overall Study|Protocol Violation|2|||
23840764|NCT00734162|66798391|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
23840765|NCT00734162|66798388|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23580455|NCT00335556|65853506|FG000|Overall Study|Physician Decision|0|||
23580456|NCT00335556|65853507|FG001|Overall Study|Physician Decision|6|||
23580457|NCT00335556|65853508|FG002|Overall Study|Physician Decision|2|||
23580458|NCT00335556|65853509|FG003|Overall Study|Physician Decision|1|||
23580459|NCT00335556|65853510|FG004|Overall Study|Physician Decision|0|||
23580460|NCT00335556|65853511|FG005|Overall Study|Physician Decision|0|||
23580461|NCT00335556|65853506|FG000|Overall Study|Ineligible|2|||
23580462|NCT00335556|65853507|FG001|Overall Study|Ineligible|0|||
23580463|NCT00335556|65853508|FG002|Overall Study|Ineligible|0|||
23580464|NCT00335556|65853509|FG003|Overall Study|Ineligible|0|||
23580465|NCT00335556|65853510|FG004|Overall Study|Ineligible|0|||
23580466|NCT00335556|65853511|FG005|Overall Study|Ineligible|0|||
23580467|NCT00335556|65853506|FG000|Overall Study|Refusal of further protocol therapy|0|||
23580468|NCT00335556|65853507|FG001|Overall Study|Refusal of further protocol therapy|4|||
23580469|NCT00335556|65853508|FG002|Overall Study|Refusal of further protocol therapy|0|||
23580470|NCT00335556|65853509|FG003|Overall Study|Refusal of further protocol therapy|1|||
23840766|NCT00734162|66798389|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23840767|NCT00734162|66798390|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23840768|NCT00734162|66798391|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
23840769|NCT00734162|66798388|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
23840770|NCT00734162|66798389|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23840771|NCT00734162|66798390|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23580471|NCT00335556|65853510|FG004|Overall Study|Refusal of further protocol therapy|0|||
23580472|NCT00335556|65853511|FG005|Overall Study|Refusal of further protocol therapy|0|||
23580473|NCT00761774|65853514|FG000|Overall Study|Adverse Event|17|||
23580474|NCT00761774|65853514|FG000|Overall Study|Lack of Efficacy|37|||
23580475|NCT00761774|65853514|FG000|Overall Study|Lost to Follow-up|2|||
23580476|NCT00761774|65853514|FG000|Overall Study|Withdrawal by Subject|9|||
23580477|NCT00761774|65853514|FG000|Overall Study|Non-compliance|4|||
23580478|NCT00761774|65853514|FG000|Overall Study|End of study|2|||
23580479|NCT00761774|65853514|FG000|Overall Study|Reclassification of seizures|1|||
23580480|NCT00761774|65853514|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
23580481|NCT00761774|65853514|FG000|Overall Study|Sponsor decision|1|||
23580482|NCT00761774|65853514|FG000|Overall Study|Investigator clinical judgement|1|||
23580483|NCT00761774|65853514|FG000|Overall Study|Patient moved out of study area|1|||
23580484|NCT00761774|65853514|FG000|Overall Study|Coordinator leaving site|1|||
23580485|NCT00761774|65853514|FG000|Overall Study|Subject IP non-compliance|1|||
23580486|NCT00761774|65853514|FG000|Overall Study|IP stopped by hospital physician|1|||
23840772|NCT00734162|66798391|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23840773|NCT00734162|66798388|FG000|Open-Label Phase|Withdrew Consent|1|||
23840774|NCT00734162|66798389|FG001|Open-Label Phase|Withdrew Consent|0|||
23840775|NCT00734162|66798390|FG002|Open-Label Phase|Withdrew Consent|1|||
23840776|NCT00734162|66798391|FG003|Open-Label Phase|Withdrew Consent|1|||
23840777|NCT00734162|66798388|FG000|Open-Label Phase|Lost to Follow-up|1|||
23840778|NCT00734162|66798389|FG001|Open-Label Phase|Lost to Follow-up|2|||
23840779|NCT00734162|66798390|FG002|Open-Label Phase|Lost to Follow-up|0|||
23840780|NCT00734162|66798391|FG003|Open-Label Phase|Lost to Follow-up|1|||
23840781|NCT00734162|66798388|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23452031|NCT02714569|65398898|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23580487|NCT01555762|65853515|FG000|Overall Study|No information on Bevacizumab intake|11|||
23580488|NCT01555762|65853515|FG000|Overall Study|Missing start date of infusion|8|||
23635522|NCT00078338|66049456|FG000|Overall Study|Disease Progression|4|||
23580489|NCT01555762|65853515|FG000|Overall Study|75 years old or more ticked No|1|||
23580490|NCT01555762|65853515|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
23580491|NCT01555762|65853515|FG000|Overall Study|Death linked to progression of disease|165|||
23580492|NCT01555762|65853515|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
23580493|NCT01555762|65853515|FG000|Overall Study|Investigator's decision|10|||
23580494|NCT01555762|65853515|FG000|Overall Study|Participant not wishing to continue|5|||
23580495|NCT01555762|65853515|FG000|Overall Study|Missing data|1|||
23580496|NCT01555762|65853515|FG000|Overall Study|Death linked to an adverse event|14|||
23840782|NCT00734162|66798389|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23840783|NCT00734162|66798390|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23840784|NCT00734162|66798391|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
23840785|NCT02035202|66798392|FG000|Overall Study|Lost to Follow-up|8|||
23840786|NCT02035202|66798393|FG001|Overall Study|Lost to Follow-up|16|||
23340081|NCT01089608|64989408|FG001|Overall Study|Lost to Follow-up|2|||
23840787|NCT02035202|66798394|FG002|Overall Study|Lost to Follow-up|2|||
23840788|NCT03086967|66798395|FG000|Overall Study|Screen Failure|2|||
23840789|NCT03086967|66798396|FG001|Overall Study|Screen Failure|2|||
23840790|NCT01972438|66798397|FG000|Baseline-Month 3 Crossover Period|Death|1|||
23840791|NCT01972438|66798398|FG001|Baseline-Month 3 Crossover Period|Death|0|||
23840792|NCT01972438|66798397|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
23840793|NCT01972438|66798398|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
23840794|NCT01972438|66798397|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
23840795|NCT01972438|66798398|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
23840796|NCT01972438|66798397|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
23580497|NCT01140347|65853518|FG000|Overall Study|Lost to Follow-up|5|||
23580498|NCT01140347|65853519|FG001|Overall Study|Lost to Follow-up|6|||
23580499|NCT01140347|65853518|FG000|Overall Study|Withdrawal by Subject|13|||
23580500|NCT01140347|65853519|FG001|Overall Study|Withdrawal by Subject|8|||
23580501|NCT03115346|65853522|FG000|Overall Study|Did not have AAA surgery|28|||
23580502|NCT03115346|65853523|FG001|Overall Study|Did not have AAA surgery|15|||
23580503|NCT03115346|65853522|FG000|Overall Study|Death|3|||
23580504|NCT03115346|65853523|FG001|Overall Study|Death|1|||
23580505|NCT03115346|65853522|FG000|Overall Study|Withdrawal by Subject|0|||
23580506|NCT03115346|65853523|FG001|Overall Study|Withdrawal by Subject|3|||
23580507|NCT03115346|65853522|FG000|Overall Study|Lost to Follow-up|0|||
23580508|NCT03115346|65853523|FG001|Overall Study|Lost to Follow-up|3|||
23580509|NCT03251378|65853524|FG000|Overall Study|Death|3|||
23580510|NCT03251378|65853525|FG001|Overall Study|Death|2|||
23580511|NCT03251378|65853526|FG002|Overall Study|Death|3|||
23580512|NCT03251378|65853527|FG003|Overall Study|Death|30|||
23580513|NCT03251378|65853528|FG004|Overall Study|Death|24|||
23840797|NCT01972438|66798398|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
23840798|NCT01972438|66798397|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
23840799|NCT01972438|66798398|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
23840800|NCT01972438|66798397|FG000|Months 6-12 Study Period|Death|1|||
23840801|NCT01972438|66798398|FG001|Months 6-12 Study Period|Death|0|||
23840802|NCT01972438|66798397|FG000|Months 6-12 Study Period|Early Study Closure|2|||
23340082|NCT01790828|64989417|FG000|Overall Study|Other|34|||
23340083|NCT02691013|64989418|FG000|Overall Study|Withdrawal by Subject|3|||
23340084|NCT02691013|64989419|FG001|Overall Study|Withdrawal by Subject|0|||
23840803|NCT01972438|66798398|FG001|Months 6-12 Study Period|Early Study Closure|2|||
23840804|NCT01972438|66798397|FG000|Post Month 12 Study Period|Early Study Closure|3|||
23840805|NCT01972438|66798398|FG001|Post Month 12 Study Period|Early Study Closure|4|||
23840806|NCT00550745|66798399|FG000|Overall Study|Death|20|||
23840807|NCT00550745|66798400|FG001|Overall Study|Death|16|||
23840808|NCT00550745|66798399|FG000|Overall Study|Lost to Follow-up|45|||
23840809|NCT00550745|66798400|FG001|Overall Study|Lost to Follow-up|30|||
23840810|NCT00550745|66798399|FG000|Overall Study|Physician Decision|0|||
23840811|NCT00550745|66798400|FG001|Overall Study|Physician Decision|2|||
23840812|NCT00550745|66798399|FG000|Overall Study|Protocol Violation|4|||
23840813|NCT00550745|66798400|FG001|Overall Study|Protocol Violation|2|||
23840814|NCT00550745|66798399|FG000|Overall Study|Withdrawal by Subject|17|||
23840815|NCT00550745|66798400|FG001|Overall Study|Withdrawal by Subject|10|||
23840816|NCT00550745|66798399|FG000|Overall Study|Screen failure|1|||
23340085|NCT01931956|64989428|FG000|Overall Study|Death|42|||
23580514|NCT03251378|65853529|FG005|Overall Study|Death|12|||
23580515|NCT03251378|65853530|FG006|Overall Study|Death|12|||
23580516|NCT03251378|65853524|FG000|Overall Study|Lost to Follow-up|0|||
23580517|NCT03251378|65853525|FG001|Overall Study|Lost to Follow-up|0|||
23840817|NCT00550745|66798400|FG001|Overall Study|Screen failure|0|||
23840818|NCT03063086|66798401|FG000|Overall Study|technical problems|1|||
23840819|NCT03063086|66798402|FG001|Overall Study|technical problems|0|||
23840820|NCT03063086|66798403|FG002|Overall Study|technical problems|0|||
23840821|NCT03063086|66798404|FG003|Overall Study|technical problems|0|||
23840822|NCT03063086|66798405|FG004|Overall Study|technical problems|0|||
23840823|NCT03063086|66798406|FG005|Overall Study|technical problems|0|||
23840824|NCT03063086|66798401|FG000|Overall Study|Adverse Event|1|||
23840825|NCT03063086|66798402|FG001|Overall Study|Adverse Event|1|||
23840826|NCT03063086|66798403|FG002|Overall Study|Adverse Event|1|||
23340086|NCT01931956|64989429|FG001|Overall Study|Death|7|||
23840827|NCT03063086|66798404|FG003|Overall Study|Adverse Event|1|||
23580518|NCT03251378|65853526|FG002|Overall Study|Lost to Follow-up|1|||
23580519|NCT03251378|65853527|FG003|Overall Study|Lost to Follow-up|3|||
23580520|NCT03251378|65853528|FG004|Overall Study|Lost to Follow-up|0|||
23580521|NCT03251378|65853529|FG005|Overall Study|Lost to Follow-up|0|||
23340087|NCT01931956|64989430|FG002|Overall Study|Death|379|||
23580522|NCT03251378|65853530|FG006|Overall Study|Lost to Follow-up|0|||
23840828|NCT03063086|66798405|FG004|Overall Study|Adverse Event|0|||
23840829|NCT03063086|66798406|FG005|Overall Study|Adverse Event|0|||
23840830|NCT03063086|66798401|FG000|Overall Study|subject/guardian decision|1|||
23840831|NCT03063086|66798402|FG001|Overall Study|subject/guardian decision|0|||
23840832|NCT03063086|66798403|FG002|Overall Study|subject/guardian decision|0|||
23840833|NCT03063086|66798404|FG003|Overall Study|subject/guardian decision|0|||
23840834|NCT03063086|66798405|FG004|Overall Study|subject/guardian decision|0|||
23840835|NCT03063086|66798406|FG005|Overall Study|subject/guardian decision|0|||
23840836|NCT03063086|66798401|FG000|Overall Study|Non-compliance with study treatment|0|||
23840837|NCT03063086|66798402|FG001|Overall Study|Non-compliance with study treatment|0|||
23840838|NCT03063086|66798403|FG002|Overall Study|Non-compliance with study treatment|0|||
23840839|NCT03063086|66798404|FG003|Overall Study|Non-compliance with study treatment|1|||
23840840|NCT03063086|66798405|FG004|Overall Study|Non-compliance with study treatment|0|||
23840841|NCT03063086|66798406|FG005|Overall Study|Non-compliance with study treatment|1|||
23840842|NCT03063086|66798401|FG000|Overall Study|Physician Decision|0|||
23840843|NCT03063086|66798402|FG001|Overall Study|Physician Decision|0|||
23840844|NCT03063086|66798403|FG002|Overall Study|Physician Decision|0|||
23840845|NCT03063086|66798404|FG003|Overall Study|Physician Decision|1|||
23840846|NCT03063086|66798405|FG004|Overall Study|Physician Decision|0|||
23840847|NCT03063086|66798406|FG005|Overall Study|Physician Decision|0|||
23840848|NCT01417156|66798411|FG000|Overall Study|Adverse Event|12|||
23840849|NCT01417156|66798411|FG000|Overall Study|Protocol Violation|2|||
23840850|NCT01377922|66798414|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
23840851|NCT01377922|66798415|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
23840852|NCT02309411|66798416|FG000|Overall Study|Physician Decision|1|||
23840853|NCT02309411|66798417|FG001|Overall Study|Physician Decision|0|||
23452032|NCT02714569|65398899|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23635523|NCT00078338|66049457|FG001|Overall Study|Disease Progression|7|||
23780907|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Refusal|0|||
23780908|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Refusal|0|||
23780909|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Refusal|0|||
23780910|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Refusal|0|||
23780911|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
23780912|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
23780913|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
23780914|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
23780915|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
23780916|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
23780917|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
23780918|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
23780919|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
23780920|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
23780921|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780922|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
23780923|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780924|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780925|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780926|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780927|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780928|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780929|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780930|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23780931|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
23780932|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
23780933|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
23780934|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
23780935|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
23780936|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
23780937|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
23780938|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
23780939|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
23780940|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
23780941|NCT01190930|66580085|FG000|Post Induction Pre-Maintenance|Relapse|0|||
23780942|NCT01190930|66580086|FG001|Post Induction Pre-Maintenance|Relapse|0|||
23780943|NCT01190930|66580087|FG002|Post Induction Pre-Maintenance|Relapse|1|||
23780944|NCT01190930|66580088|FG003|Post Induction Pre-Maintenance|Relapse|0|||
23780945|NCT01190930|66580089|FG004|Post Induction Pre-Maintenance|Relapse|0|||
23780946|NCT01190930|66580090|FG005|Post Induction Pre-Maintenance|Relapse|0|||
23840854|NCT02309411|66798418|FG002|Overall Study|Physician Decision|0|||
23340088|NCT01931956|64989431|FG003|Overall Study|Death|96|||
23340089|NCT01931956|64989428|FG000|Overall Study|Withdrawal by Subject|5|||
23340090|NCT01931956|64989429|FG001|Overall Study|Withdrawal by Subject|0|||
23340091|NCT01931956|64989430|FG002|Overall Study|Withdrawal by Subject|70|||
23340092|NCT01931956|64989431|FG003|Overall Study|Withdrawal by Subject|30|||
23580523|NCT03251378|65853524|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580524|NCT03251378|65853525|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580525|NCT03251378|65853526|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580526|NCT03251378|65853527|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
23780947|NCT01190930|66580091|FG006|Post Induction Pre-Maintenance|Relapse|0|||
23780948|NCT01190930|66580092|FG007|Post Induction Pre-Maintenance|Relapse|0|||
23780949|NCT01190930|66580093|FG008|Post Induction Pre-Maintenance|Relapse|0|||
23780950|NCT01190930|66580094|FG009|Post Induction Pre-Maintenance|Relapse|0|||
23780951|NCT01190930|66580085|FG000|Maintenance|Adverse Event|0|||
23780952|NCT01190930|66580086|FG001|Maintenance|Adverse Event|0|||
23780953|NCT01190930|66580087|FG002|Maintenance|Adverse Event|0|||
23780954|NCT01190930|66580088|FG003|Maintenance|Adverse Event|0|||
23780955|NCT01190930|66580089|FG004|Maintenance|Adverse Event|0|||
23780956|NCT01190930|66580090|FG005|Maintenance|Adverse Event|1|||
23780957|NCT01190930|66580091|FG006|Maintenance|Adverse Event|1|||
23780958|NCT01190930|66580092|FG007|Maintenance|Adverse Event|3|||
23780959|NCT01190930|66580093|FG008|Maintenance|Adverse Event|3|||
23780960|NCT01190930|66580094|FG009|Maintenance|Adverse Event|0|||
23780961|NCT01190930|66580085|FG000|Maintenance|Death|0|||
23780962|NCT01190930|66580086|FG001|Maintenance|Death|0|||
23780963|NCT01190930|66580087|FG002|Maintenance|Death|0|||
23780964|NCT01190930|66580088|FG003|Maintenance|Death|1|||
23780965|NCT01190930|66580089|FG004|Maintenance|Death|0|||
23780966|NCT01190930|66580090|FG005|Maintenance|Death|0|||
23780967|NCT01190930|66580091|FG006|Maintenance|Death|2|||
23780968|NCT01190930|66580092|FG007|Maintenance|Death|2|||
23780969|NCT01190930|66580093|FG008|Maintenance|Death|2|||
23780970|NCT01190930|66580094|FG009|Maintenance|Death|2|||
23780971|NCT01190930|66580085|FG000|Maintenance|Lost to Follow-up|0|||
23780972|NCT01190930|66580086|FG001|Maintenance|Lost to Follow-up|0|||
23780973|NCT01190930|66580087|FG002|Maintenance|Lost to Follow-up|0|||
23780974|NCT01190930|66580088|FG003|Maintenance|Lost to Follow-up|0|||
23780975|NCT01190930|66580089|FG004|Maintenance|Lost to Follow-up|0|||
23780976|NCT01190930|66580090|FG005|Maintenance|Lost to Follow-up|0|||
23780977|NCT01190930|66580091|FG006|Maintenance|Lost to Follow-up|1|||
23780978|NCT01190930|66580092|FG007|Maintenance|Lost to Follow-up|1|||
23780979|NCT01190930|66580093|FG008|Maintenance|Lost to Follow-up|1|||
23780980|NCT01190930|66580094|FG009|Maintenance|Lost to Follow-up|0|||
23780981|NCT01190930|66580085|FG000|Maintenance|Physician Decision|0|||
23780982|NCT01190930|66580086|FG001|Maintenance|Physician Decision|1|||
23780983|NCT01190930|66580087|FG002|Maintenance|Physician Decision|0|||
23780984|NCT01190930|66580088|FG003|Maintenance|Physician Decision|5|||
23780985|NCT01190930|66580089|FG004|Maintenance|Physician Decision|9|||
23780986|NCT01190930|66580090|FG005|Maintenance|Physician Decision|4|||
23780987|NCT01190930|66580091|FG006|Maintenance|Physician Decision|8|||
23780988|NCT01190930|66580092|FG007|Maintenance|Physician Decision|8|||
23780989|NCT01190930|66580093|FG008|Maintenance|Physician Decision|10|||
23780990|NCT01190930|66580094|FG009|Maintenance|Physician Decision|17|||
23780991|NCT01190930|66580085|FG000|Maintenance|Withdrawal by Subject|0|||
23780992|NCT01190930|66580086|FG001|Maintenance|Withdrawal by Subject|0|||
23780993|NCT01190930|66580087|FG002|Maintenance|Withdrawal by Subject|0|||
23780994|NCT01190930|66580088|FG003|Maintenance|Withdrawal by Subject|0|||
23780995|NCT01190930|66580089|FG004|Maintenance|Withdrawal by Subject|0|||
23780996|NCT01190930|66580090|FG005|Maintenance|Withdrawal by Subject|0|||
23780997|NCT01190930|66580091|FG006|Maintenance|Withdrawal by Subject|2|||
23780998|NCT01190930|66580092|FG007|Maintenance|Withdrawal by Subject|1|||
23780999|NCT01190930|66580093|FG008|Maintenance|Withdrawal by Subject|4|||
23781000|NCT01190930|66580094|FG009|Maintenance|Withdrawal by Subject|1|||
23781001|NCT01190930|66580085|FG000|Maintenance|Refusal|0|||
23781002|NCT01190930|66580086|FG001|Maintenance|Refusal|1|||
23781003|NCT01190930|66580087|FG002|Maintenance|Refusal|0|||
23781004|NCT01190930|66580088|FG003|Maintenance|Refusal|2|||
23781005|NCT01190930|66580089|FG004|Maintenance|Refusal|0|||
23781006|NCT01190930|66580090|FG005|Maintenance|Refusal|4|||
23340093|NCT01931956|64989428|FG000|Overall Study|Lost to Follow-up|2|||
23340094|NCT01931956|64989429|FG001|Overall Study|Lost to Follow-up|0|||
23781007|NCT01190930|66580091|FG006|Maintenance|Refusal|5|||
23781008|NCT01190930|66580092|FG007|Maintenance|Refusal|17|||
23781009|NCT01190930|66580093|FG008|Maintenance|Refusal|13|||
23781010|NCT01190930|66580094|FG009|Maintenance|Refusal|6|||
23781011|NCT01190930|66580085|FG000|Maintenance|second malignant neoplasm|0|||
23781012|NCT01190930|66580086|FG001|Maintenance|second malignant neoplasm|0|||
23781013|NCT01190930|66580087|FG002|Maintenance|second malignant neoplasm|0|||
23781014|NCT01190930|66580088|FG003|Maintenance|second malignant neoplasm|1|||
23781015|NCT01190930|66580089|FG004|Maintenance|second malignant neoplasm|0|||
23781016|NCT01190930|66580090|FG005|Maintenance|second malignant neoplasm|1|||
23781017|NCT01190930|66580091|FG006|Maintenance|second malignant neoplasm|0|||
23840855|NCT02309411|66798416|FG000|Overall Study|Withdrawal by Subject|1|||
23840856|NCT02309411|66798417|FG001|Overall Study|Withdrawal by Subject|1|||
23840857|NCT02309411|66798418|FG002|Overall Study|Withdrawal by Subject|0|||
23840858|NCT02111577|66798419|FG000|Overall Study|Protocol Violation|2|||
23840859|NCT02111577|66798420|FG001|Overall Study|Protocol Violation|0|||
23840860|NCT02111577|66798419|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
23840861|NCT02111577|66798420|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
23840862|NCT02111577|66798419|FG000|Overall Study|Failure to produce study treatment|6|||
23840863|NCT02111577|66798420|FG001|Overall Study|Failure to produce study treatment|0|||
23840864|NCT02111577|66798419|FG000|Overall Study|Death|518|||
23840865|NCT02111577|66798420|FG001|Overall Study|Death|254|||
23840866|NCT02111577|66798419|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
23840867|NCT02111577|66798420|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
23580527|NCT03251378|65853528|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
23580528|NCT03251378|65853529|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
23580529|NCT03251378|65853530|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
23840868|NCT02111577|66798419|FG000|Overall Study|Adverse Event|1|||
23840869|NCT02111577|66798420|FG001|Overall Study|Adverse Event|1|||
23840870|NCT02111577|66798419|FG000|Overall Study|Withdrawal by Subject|51|||
23840871|NCT02111577|66798420|FG001|Overall Study|Withdrawal by Subject|23|||
23840872|NCT02111577|66798419|FG000|Overall Study|Disease progression|0|||
23840873|NCT02111577|66798420|FG001|Overall Study|Disease progression|1|||
23840874|NCT02111577|66798419|FG000|Overall Study|Lost to Follow-up|19|||
23840875|NCT02111577|66798420|FG001|Overall Study|Lost to Follow-up|10|||
23580530|NCT03251378|65853524|FG000|Overall Study|Progressive disease|2|||
23580531|NCT03251378|65853525|FG001|Overall Study|Progressive disease|0|||
23580532|NCT03251378|65853526|FG002|Overall Study|Progressive disease|0|||
23580533|NCT03251378|65853527|FG003|Overall Study|Progressive disease|1|||
23840876|NCT01672710|66798421|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
23840877|NCT01672710|66798422|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
23840878|NCT01672710|66798421|FG000|3 Month Follow up|Lost to Follow-up|2|||
23840879|NCT01672710|66798422|FG001|3 Month Follow up|Lost to Follow-up|3|||
23840880|NCT01672710|66798421|FG000|3 Month Follow up|follow up due after termination date|4|||
23840881|NCT01672710|66798422|FG001|3 Month Follow up|follow up due after termination date|1|||
23840882|NCT02424630|66798423|FG000|Overall Study|No rotator cuff tear|1|||
23840883|NCT02424630|66798424|FG001|Overall Study|No rotator cuff tear|2|||
23840884|NCT02424630|66798423|FG000|Overall Study|Open procedure|0|||
23840885|NCT02424630|66798424|FG001|Overall Study|Open procedure|1|||
23840886|NCT00661609|66798433|FG000|Overall Study|Adverse Event|4|||
23840887|NCT00661609|66798433|FG000|Overall Study|Death|20|||
23840888|NCT00661609|66798433|FG000|Overall Study|Withdrawal by Subject|2|||
23840889|NCT00661609|66798433|FG000|Overall Study|PI Decision|1|||
23840890|NCT00661609|66798433|FG000|Overall Study|Survival follow up stage discontinued|11|||
23840891|NCT00661609|66798433|FG000|Overall Study|Disease progression|3|||
23840892|NCT03103321|66798444|FG000|Overall Study|Protocol Violation|1|||
23840893|NCT03103321|66798445|FG001|Overall Study|Protocol Violation|1|||
23840894|NCT03103321|66798446|FG002|Overall Study|Protocol Violation|1|||
23840895|NCT03103321|66798447|FG003|Overall Study|Protocol Violation|0|||
23840896|NCT00794040|66798448|FG000|Overall Study|Withdrawal by Subject|3|||
23840897|NCT00794040|66798449|FG001|Overall Study|Withdrawal by Subject|4|||
23840898|NCT00794040|66798448|FG000|Overall Study|Physician Decision|0|||
23840899|NCT00794040|66798449|FG001|Overall Study|Physician Decision|1|||
23840900|NCT00325156|66798450|FG000|Overall Study|Protocol Violation|8|||
23840901|NCT00325156|66798450|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
23840902|NCT00325156|66798450|FG000|Overall Study|Migrated/moved from study area|12|||
23840903|NCT00325156|66798450|FG000|Overall Study|Adverse event, non-fatal|3|||
23840904|NCT00325156|66798450|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
23840905|NCT00325156|66798450|FG000|Overall Study|Other|1|||
23840906|NCT00325156|66798450|FG000|Overall Study|Withdrawal by Subject|31|||
23840907|NCT02964507|66798452|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
23840908|NCT02964507|66798453|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
23840909|NCT02964507|66798454|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
23840910|NCT02964507|66798455|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
23452033|NCT02714569|65398900|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452034|NCT02714569|65398901|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452035|NCT02714569|65398891|FG000|Part A Third Intervention|Adverse Event|0|||
23580534|NCT03251378|65853528|FG004|Overall Study|Progressive disease|0|||
23580535|NCT03251378|65853529|FG005|Overall Study|Progressive disease|0|||
23580536|NCT03251378|65853530|FG006|Overall Study|Progressive disease|0|||
23580537|NCT03251378|65853524|FG000|Overall Study|Physician Decision|0|||
23840911|NCT02964507|66798456|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
23340095|NCT01931956|64989430|FG002|Overall Study|Lost to Follow-up|11|||
23580538|NCT03251378|65853525|FG001|Overall Study|Physician Decision|2|||
23340096|NCT01931956|64989431|FG003|Overall Study|Lost to Follow-up|7|||
23340097|NCT01931956|64989428|FG000|Overall Study|Expected|2|||
23340098|NCT01931956|64989429|FG001|Overall Study|Expected|0|||
23340099|NCT01931956|64989430|FG002|Overall Study|Expected|6|||
23340100|NCT01931956|64989431|FG003|Overall Study|Expected|0|||
23635524|NCT00078338|66049456|FG000|Overall Study|Other|28|||
23635525|NCT00078338|66049457|FG001|Overall Study|Other|16|||
23635526|NCT00078338|66049456|FG000|Overall Study|Subjects randomized, but not treated|3|||
23635527|NCT00078338|66049457|FG001|Overall Study|Subjects randomized, but not treated|3|||
23635528|NCT01114880|66049459|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
23635529|NCT01114880|66049460|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
23635530|NCT01114880|66049459|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
23635531|NCT01114880|66049460|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
23635532|NCT01114880|66049459|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
23635533|NCT01114880|66049460|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
23635534|NCT01114880|66049459|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
23635535|NCT01114880|66049460|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
23635536|NCT01114880|66049459|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
23781018|NCT01190930|66580092|FG007|Maintenance|second malignant neoplasm|0|||
23781019|NCT01190930|66580093|FG008|Maintenance|second malignant neoplasm|1|||
23781020|NCT01190930|66580094|FG009|Maintenance|second malignant neoplasm|0|||
23781021|NCT01190930|66580085|FG000|Maintenance|Inevaluable|0|||
23781022|NCT01190930|66580086|FG001|Maintenance|Inevaluable|0|||
23781023|NCT01190930|66580087|FG002|Maintenance|Inevaluable|0|||
23781024|NCT01190930|66580088|FG003|Maintenance|Inevaluable|0|||
23781025|NCT01190930|66580089|FG004|Maintenance|Inevaluable|0|||
23781026|NCT01190930|66580090|FG005|Maintenance|Inevaluable|1|||
23781027|NCT01190930|66580091|FG006|Maintenance|Inevaluable|1|||
23781028|NCT01190930|66580092|FG007|Maintenance|Inevaluable|1|||
23781029|NCT01190930|66580093|FG008|Maintenance|Inevaluable|0|||
23781030|NCT01190930|66580094|FG009|Maintenance|Inevaluable|0|||
23781031|NCT01190930|66580085|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
23781032|NCT01190930|66580086|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
23781033|NCT01190930|66580087|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
23781034|NCT01190930|66580088|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
23781035|NCT01190930|66580089|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
23781036|NCT01190930|66580090|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
23781037|NCT01190930|66580091|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
23781038|NCT01190930|66580092|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
23781039|NCT01190930|66580093|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
23781040|NCT01190930|66580094|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
23781041|NCT01190930|66580085|FG000|Maintenance|Relapse|0|||
23781042|NCT01190930|66580086|FG001|Maintenance|Relapse|0|||
23781043|NCT01190930|66580087|FG002|Maintenance|Relapse|0|||
23781044|NCT01190930|66580088|FG003|Maintenance|Relapse|2|||
23781045|NCT01190930|66580089|FG004|Maintenance|Relapse|0|||
23781046|NCT01190930|66580090|FG005|Maintenance|Relapse|1|||
23781047|NCT01190930|66580091|FG006|Maintenance|Relapse|6|||
23781048|NCT01190930|66580092|FG007|Maintenance|Relapse|13|||
23781049|NCT01190930|66580093|FG008|Maintenance|Relapse|11|||
23781050|NCT01190930|66580094|FG009|Maintenance|Relapse|11|||
23781051|NCT01190930|66580085|FG000|Maintenance|Still on therapy|0|||
23781052|NCT01190930|66580086|FG001|Maintenance|Still on therapy|8|||
23781053|NCT01190930|66580087|FG002|Maintenance|Still on therapy|0|||
23781054|NCT01190930|66580088|FG003|Maintenance|Still on therapy|29|||
23781055|NCT01190930|66580089|FG004|Maintenance|Still on therapy|0|||
23781056|NCT01190930|66580090|FG005|Maintenance|Still on therapy|0|||
23781057|NCT01190930|66580091|FG006|Maintenance|Still on therapy|0|||
23781058|NCT01190930|66580092|FG007|Maintenance|Still on therapy|0|||
23781059|NCT01190930|66580093|FG008|Maintenance|Still on therapy|0|||
23781060|NCT01190930|66580094|FG009|Maintenance|Still on therapy|0|||
23781061|NCT00316186|66580095|FG000|Overall Study|Adverse Event|6|||
23781062|NCT00316186|66580095|FG000|Overall Study|Disease Progression|4|||
23781063|NCT00316186|66580095|FG000|Overall Study|Lost to Follow-up|1|||
23781064|NCT00316186|66580095|FG000|Overall Study|Other|1|||
23781065|NCT00113386|66580103|FG000|Overall Study|Withdrawal by Subject|1|||
23781066|NCT00113386|66580104|FG001|Overall Study|Withdrawal by Subject|0|||
23781067|NCT00113386|66580103|FG000|Overall Study|Physician Decision|0|||
23781068|NCT00113386|66580104|FG001|Overall Study|Physician Decision|1|||
23781069|NCT00113386|66580103|FG000|Overall Study|Toxicity|3|||
23781070|NCT00113386|66580104|FG001|Overall Study|Toxicity|0|||
23781071|NCT00113386|66580103|FG000|Overall Study|Ineligible|1|||
23781072|NCT00113386|66580104|FG001|Overall Study|Ineligible|2|||
23340101|NCT01931956|64989428|FG000|Overall Study|Not due|0|||
23781073|NCT00113386|66580103|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
23781074|NCT00113386|66580104|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
23781075|NCT02412852|66580108|FG000|Overall Study|Withdrawal by Subject|0|||
23781076|NCT02412852|66580109|FG001|Overall Study|Withdrawal by Subject|1|||
23781077|NCT02412852|66580110|FG002|Overall Study|Withdrawal by Subject|0|||
23340102|NCT01931956|64989429|FG001|Overall Study|Not due|0|||
23340103|NCT01931956|64989430|FG002|Overall Study|Not due|21|||
23340104|NCT01931956|64989431|FG003|Overall Study|Not due|0|||
23340105|NCT01167881|64989432|FG000|Overall Study|Adverse Event|47|||
23340106|NCT01167881|64989433|FG001|Overall Study|Adverse Event|51|||
23340107|NCT01167881|64989432|FG000|Overall Study|Lack of Efficacy|4|||
23340108|NCT01167881|64989433|FG001|Overall Study|Lack of Efficacy|7|||
23340109|NCT01167881|64989432|FG000|Overall Study|Non compliant with protocol|9|||
23340110|NCT01167881|64989433|FG001|Overall Study|Non compliant with protocol|18|||
23340111|NCT01167881|64989432|FG000|Overall Study|Lost to Follow-up|19|||
23340112|NCT01167881|64989433|FG001|Overall Study|Lost to Follow-up|20|||
23340113|NCT01167881|64989432|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
23340114|NCT01167881|64989433|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
23340115|NCT01167881|64989432|FG000|Overall Study|Not treated|4|||
23340116|NCT01167881|64989433|FG001|Overall Study|Not treated|0|||
23340117|NCT01167881|64989432|FG000|Overall Study|Other not defined above|31|||
23340118|NCT01167881|64989433|FG001|Overall Study|Other not defined above|55|||
23340119|NCT05318092|64989434|FG000|Overall Study|Lost to Follow-up|3|||
23340120|NCT05318092|64989434|FG000|Overall Study|Withdrawal by Subject|1|||
23340121|NCT03315286|64989437|FG000|Overall Study|Lost to Follow-up|0|||
23340122|NCT03315286|64989438|FG001|Overall Study|Lost to Follow-up|3|||
23340123|NCT03315286|64989437|FG000|Overall Study|Withdrawal by Subject|1|||
23340124|NCT03315286|64989438|FG001|Overall Study|Withdrawal by Subject|0|||
23340125|NCT03315286|64989437|FG000|Overall Study|Protocol Violation|0|||
23340126|NCT03315286|64989438|FG001|Overall Study|Protocol Violation|1|||
23340127|NCT01275755|64989439|FG000|Double-blind Treatment Period|Adverse Event|0|||
23340128|NCT01275755|64989440|FG001|Double-blind Treatment Period|Adverse Event|2|||
23340129|NCT01275755|64989439|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23340130|NCT01275755|64989440|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23340131|NCT01275755|64989439|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23340132|NCT01275755|64989440|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23340133|NCT01275755|64989439|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
23340134|NCT01275755|64989440|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
23340135|NCT02162719|64989444|FG000|Overall Study|Death|41|||
23340136|NCT02162719|64989445|FG001|Overall Study|Death|46|||
23340137|NCT02162719|64989444|FG000|Overall Study|Lost to Follow-up|1|||
23340138|NCT02162719|64989445|FG001|Overall Study|Lost to Follow-up|3|||
23340139|NCT02162719|64989444|FG000|Overall Study|Disease Progression|2|||
23340140|NCT02162719|64989445|FG001|Overall Study|Disease Progression|1|||
23340141|NCT02162719|64989444|FG000|Overall Study|Withdrawal by Subject|8|||
23340142|NCT02162719|64989445|FG001|Overall Study|Withdrawal by Subject|2|||
23340143|NCT02162719|64989444|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
23340144|NCT02162719|64989445|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
23340145|NCT03589976|64989448|FG000|Overall Study|Death|5|||
23340146|NCT03589976|64989449|FG001|Overall Study|Death|1|||
23340147|NCT03589976|64989448|FG000|Overall Study|Adverse Event|5|||
23340148|NCT03589976|64989449|FG001|Overall Study|Adverse Event|1|||
23452036|NCT02714569|65398892|FG001|Part A Third Intervention|Adverse Event|0|||
23452037|NCT02714569|65398893|FG002|Part A Third Intervention|Adverse Event|1|||
23452038|NCT02714569|65398894|FG003|Part A Third Intervention|Adverse Event|0|||
23452039|NCT02714569|65398895|FG004|Part A Third Intervention|Adverse Event|0|||
23452040|NCT02714569|65398896|FG005|Part A Third Intervention|Adverse Event|0|||
23452041|NCT02714569|65398897|FG006|Part A Third Intervention|Adverse Event|0|||
23452042|NCT02714569|65398898|FG007|Part A Third Intervention|Adverse Event|0|||
23840912|NCT02964507|66798457|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
23840913|NCT02964507|66798458|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
23840914|NCT02964507|66798459|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
23840915|NCT02964507|66798452|FG000|Overall Study|Study terminated by Sponsor|9|||
23840916|NCT02964507|66798453|FG001|Overall Study|Study terminated by Sponsor|1|||
23840917|NCT02964507|66798454|FG002|Overall Study|Study terminated by Sponsor|9|||
23840918|NCT02964507|66798455|FG003|Overall Study|Study terminated by Sponsor|3|||
23340149|NCT03589976|64989448|FG000|Overall Study|Withdrawal by Subject|4|||
23340150|NCT03589976|64989449|FG001|Overall Study|Withdrawal by Subject|1|||
23340151|NCT03589976|64989448|FG000|Overall Study|Lost to Follow-up|1|||
23340152|NCT03589976|64989449|FG001|Overall Study|Lost to Follow-up|0|||
23452043|NCT02714569|65398899|FG008|Part A Third Intervention|Adverse Event|0|||
23580539|NCT03251378|65853526|FG002|Overall Study|Physician Decision|0|||
23340153|NCT03589976|64989448|FG000|Overall Study|Other|4|||
23452044|NCT02714569|65398900|FG009|Part A Third Intervention|Adverse Event|0|||
23840919|NCT02964507|66798456|FG004|Overall Study|Study terminated by Sponsor|3|||
23452045|NCT02714569|65398901|FG010|Part A Third Intervention|Adverse Event|0|||
23635537|NCT01114880|66049460|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
23340154|NCT03589976|64989449|FG001|Overall Study|Other|3|||
23340155|NCT00150800|64989451|FG000|Overall Study|Adverse Event|89|||
23340156|NCT00150800|64989451|FG000|Overall Study|Death|18|||
23340157|NCT00150800|64989451|FG000|Overall Study|Lack of Efficacy|166|||
23340158|NCT00150800|64989451|FG000|Overall Study|Lost to Follow-up|58|||
23452046|NCT02714569|65398891|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
23452047|NCT02714569|65398892|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452048|NCT02714569|65398893|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452049|NCT02714569|65398894|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452050|NCT02714569|65398895|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452051|NCT02714569|65398896|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
23452052|NCT02714569|65398897|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452053|NCT02714569|65398898|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23580540|NCT03251378|65853527|FG003|Overall Study|Physician Decision|0|||
23580541|NCT03251378|65853528|FG004|Overall Study|Physician Decision|0|||
23840920|NCT02964507|66798457|FG005|Overall Study|Study terminated by Sponsor|2|||
23840921|NCT02964507|66798458|FG006|Overall Study|Study terminated by Sponsor|0|||
23840922|NCT02964507|66798459|FG007|Overall Study|Study terminated by Sponsor|0|||
23840923|NCT02964507|66798452|FG000|Overall Study|Other|3|||
23840924|NCT02964507|66798453|FG001|Overall Study|Other|0|||
23840925|NCT02964507|66798454|FG002|Overall Study|Other|0|||
23840926|NCT02964507|66798455|FG003|Overall Study|Other|0|||
23840927|NCT02964507|66798456|FG004|Overall Study|Other|1|||
23840928|NCT02964507|66798457|FG005|Overall Study|Other|0|||
23840929|NCT02964507|66798458|FG006|Overall Study|Other|0|||
23840930|NCT02964507|66798459|FG007|Overall Study|Other|0|||
23840931|NCT02964507|66798452|FG000|Overall Study|Death|11|||
23840932|NCT02964507|66798453|FG001|Overall Study|Death|9|||
23840933|NCT02964507|66798454|FG002|Overall Study|Death|12|||
23840934|NCT02964507|66798455|FG003|Overall Study|Death|2|||
23840935|NCT02964507|66798456|FG004|Overall Study|Death|10|||
23840936|NCT02964507|66798457|FG005|Overall Study|Death|5|||
23840937|NCT02964507|66798458|FG006|Overall Study|Death|0|||
23580542|NCT03251378|65853529|FG005|Overall Study|Physician Decision|0|||
23580543|NCT03251378|65853530|FG006|Overall Study|Physician Decision|0|||
23840938|NCT02964507|66798459|FG007|Overall Study|Death|0|||
23840939|NCT02964507|66798452|FG000|Overall Study|Withdrawal by Subject|1|||
23840940|NCT02964507|66798453|FG001|Overall Study|Withdrawal by Subject|0|||
23840941|NCT02964507|66798454|FG002|Overall Study|Withdrawal by Subject|1|||
23840942|NCT02964507|66798455|FG003|Overall Study|Withdrawal by Subject|1|||
23840943|NCT02964507|66798456|FG004|Overall Study|Withdrawal by Subject|0|||
23840944|NCT02964507|66798457|FG005|Overall Study|Withdrawal by Subject|1|||
23840945|NCT02964507|66798458|FG006|Overall Study|Withdrawal by Subject|0|||
23840946|NCT02964507|66798459|FG007|Overall Study|Withdrawal by Subject|0|||
23840947|NCT02964507|66798452|FG000|Overall Study|Physician Decision|2|||
23840948|NCT02964507|66798453|FG001|Overall Study|Physician Decision|0|||
23840949|NCT02964507|66798454|FG002|Overall Study|Physician Decision|3|||
23840950|NCT02964507|66798455|FG003|Overall Study|Physician Decision|0|||
23840951|NCT02964507|66798456|FG004|Overall Study|Physician Decision|1|||
23840952|NCT02964507|66798457|FG005|Overall Study|Physician Decision|0|||
23840953|NCT02964507|66798458|FG006|Overall Study|Physician Decision|0|||
23840954|NCT02964507|66798459|FG007|Overall Study|Physician Decision|0|||
23840955|NCT00520533|66798460|FG000|Overall Study|Death|1|||
23840956|NCT00520533|66798460|FG000|Overall Study|Suspension of the study for safety reasons|1|||
23840957|NCT00520533|66798460|FG000|Overall Study|Withdrawal by Subject|1|||
23840958|NCT00520533|66798460|FG000|Overall Study|Physician Decision|1|||
23840959|NCT02609607|66798463|FG000|Overall Study|Lost to Follow-up|0|||
23840960|NCT02609607|66798464|FG001|Overall Study|Lost to Follow-up|1|||
23840961|NCT01194999|66798478|FG000|Overall Study|Lost to Follow-up|17|||
23840962|NCT03508726|66798479|FG000|Overall Study|Withdrawal by Subject|0|||
23840963|NCT03508726|66798480|FG001|Overall Study|Withdrawal by Subject|1|||
23840964|NCT00570141|66798486|FG000|Overall Study|Adverse Event|1|||
23840965|NCT00570141|66798486|FG000|Overall Study|Missed visits|1|||
23840966|NCT00570141|66798486|FG000|Overall Study|Lost to Follow-up|1|||
23840967|NCT00610155|66798487|FG000|Period 1|Withdrawal by Subject|0|||
23840968|NCT00610155|66798488|FG001|Period 1|Withdrawal by Subject|0|||
23840969|NCT00610155|66798489|FG002|Period 1|Withdrawal by Subject|1|||
23840970|NCT00610155|66798490|FG003|Period 1|Withdrawal by Subject|0|||
23840971|NCT00610155|66798491|FG004|Period 1|Withdrawal by Subject|0|||
23840972|NCT00610155|66798492|FG005|Period 1|Withdrawal by Subject|0|||
23580544|NCT03251378|65853524|FG000|Overall Study|Other|2|||
23580545|NCT03251378|65853525|FG001|Overall Study|Other|3|||
23580546|NCT03251378|65853526|FG002|Overall Study|Other|2|||
23840973|NCT00610155|66798487|FG000|Period 3|Adverse Event|1|||
23840974|NCT00610155|66798488|FG001|Period 3|Adverse Event|0|||
23840975|NCT00610155|66798489|FG002|Period 3|Adverse Event|0|||
23840976|NCT00610155|66798490|FG003|Period 3|Adverse Event|0|||
23840977|NCT00610155|66798491|FG004|Period 3|Adverse Event|0|||
23340159|NCT00150800|64989451|FG000|Overall Study|Subject's choice|90|||
23580547|NCT03251378|65853527|FG003|Overall Study|Other|0|||
23840978|NCT00610155|66798492|FG005|Period 3|Adverse Event|0|||
23840979|NCT01344824|66798493|FG000|Overall Study|Adverse Event|15|||
23840980|NCT01344824|66798493|FG000|Overall Study|Withdrawal by Subject|6|||
23840981|NCT01344824|66798493|FG000|Overall Study|Other complicating disease|1|||
23840982|NCT01344824|66798493|FG000|Overall Study|Progression|15|||
23840983|NCT02275546|66798494|FG000|Treatment Period 2|Withdrawal by Subject|2|||
23840984|NCT02275546|66798495|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23840985|NCT02275546|66798494|FG000|Treatment Period 2|Protocol Violation|0|||
23840986|NCT02275546|66798495|FG001|Treatment Period 2|Protocol Violation|1|||
23840987|NCT02418156|66798496|FG000|Overall Study|Lost to Follow-up|12|||
23840988|NCT02418156|66798496|FG000|Overall Study|Death|2|||
23840989|NCT02418156|66798496|FG000|Overall Study|Physician Decision|1|||
23840990|NCT02418156|66798496|FG000|Overall Study|Withdrawal by Subject|1|||
23840991|NCT02418156|66798496|FG000|Overall Study|Subject refused to return|1|||
23340160|NCT00150800|64989451|FG000|Overall Study|No compliance|18|||
23340161|NCT00150800|64989451|FG000|Overall Study|IP misshandling|1|||
23340162|NCT00150800|64989451|FG000|Overall Study|Site closure|24|||
23340163|NCT00150800|64989451|FG000|Overall Study|Protocol non-adherence|2|||
23340164|NCT00150800|64989451|FG000|Overall Study|Nobody to accompany patient|1|||
23340165|NCT00150800|64989451|FG000|Overall Study|Distance too long for patient|1|||
23340166|NCT00150800|64989451|FG000|Overall Study|Neurosurgery|2|||
23840992|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
23840993|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
23840994|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
23840995|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
23840996|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
23840997|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
23840998|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
23840999|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
23841000|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
23841001|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
23841002|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
23841003|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
23841004|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
23841005|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
23841006|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23841007|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23841008|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23841009|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23841010|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
23841011|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
23841012|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
23340167|NCT00150800|64989451|FG000|Overall Study|BRV monotherapy|1|||
23340168|NCT00150800|64989451|FG000|Overall Study|Visit refusal|3|||
23340169|NCT00150800|64989451|FG000|Overall Study|Sponsor's request|2|||
23340170|NCT00150800|64989451|FG000|Overall Study|Generalized Epilepsy|1|||
23340171|NCT00150800|64989451|FG000|Overall Study|Moved from area/country|8|||
23340172|NCT00150800|64989451|FG000|Overall Study|PI retiring|2|||
23340173|NCT00150800|64989451|FG000|Overall Study|PI leaving site|2|||
23340174|NCT00150800|64989451|FG000|Overall Study|Patient insurance|1|||
23340175|NCT00150800|64989451|FG000|Overall Study|Surgical intervention|4|||
23340176|NCT00150800|64989451|FG000|Overall Study|Pregnancy planned|1|||
23340177|NCT00150800|64989451|FG000|Overall Study|PI discontinuation request|1|||
23340178|NCT02111785|64989453|FG000|Overall Study|Death|0|||
23340179|NCT02111785|64989454|FG001|Overall Study|Death|1|||
23340180|NCT02111785|64989455|FG002|Overall Study|Death|0|||
23340181|NCT02111785|64989456|FG003|Overall Study|Death|0|||
23340182|NCT00076752|64989462|FG000|Overall Study|Death|2|||
23340183|NCT00076752|64989462|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
23340184|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
23340185|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340186|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340187|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340188|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340189|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340190|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23452054|NCT02714569|65398899|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452055|NCT02714569|65398900|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23580548|NCT03251378|65853528|FG004|Overall Study|Other|1|||
23580549|NCT03251378|65853529|FG005|Overall Study|Other|1|||
23580550|NCT03251378|65853530|FG006|Overall Study|Other|1|||
23841013|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
23340191|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
23340192|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340868|NCT01936181|64992873|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
23841014|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
23841015|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
23635538|NCT01114880|66049459|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
23635539|NCT01114880|66049460|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
23635540|NCT00586612|66049461|FG000|Primary Phase|Protocol Violation|1|||
23635541|NCT00586612|66049462|FG001|Primary Phase|Protocol Violation|0|||
23635542|NCT00586612|66049461|FG000|Primary Phase|Lost to Follow-up|0|||
23635543|NCT00586612|66049462|FG001|Primary Phase|Lost to Follow-up|1|||
23635544|NCT00586612|66049461|FG000|Primary Phase|Withdrawal by Subject|0|||
23841016|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
23841017|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
23841018|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
23635545|NCT00586612|66049462|FG001|Primary Phase|Withdrawal by Subject|2|||
23781078|NCT02412852|66580111|FG003|Overall Study|Withdrawal by Subject|0|||
23781079|NCT02412852|66580108|FG000|Overall Study|Physician Decision|0|||
23781080|NCT02412852|66580109|FG001|Overall Study|Physician Decision|0|||
23781081|NCT02412852|66580110|FG002|Overall Study|Physician Decision|0|||
23781082|NCT02412852|66580111|FG003|Overall Study|Physician Decision|1|||
23781083|NCT02392195|66580113|FG000|Overall Study|Lost to Follow-up|4|||
23781084|NCT02392195|66580113|FG000|Overall Study|Withdrawal by Subject|4|||
23781085|NCT01030133|66580118|FG000|Overall Study|failed to experience pain at level 7/10|2|||
23781086|NCT01030133|66580119|FG001|Overall Study|failed to experience pain at level 7/10|2|||
23781087|NCT03437265|66580122|FG000|Overall Study|Protocol Violation|6|||
23781088|NCT03649477|66580123|FG000|Overall Study|Adverse Event|2|||
23781089|NCT03649477|66580124|FG001|Overall Study|Adverse Event|0|||
23781090|NCT03649477|66580125|FG002|Overall Study|Adverse Event|0|||
23781091|NCT00678639|66580132|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
23781092|NCT00678639|66580133|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
23781093|NCT01168856|66580134|FG000|Overall Study|Lost to Follow-up|4|||
23781094|NCT01168856|66580135|FG001|Overall Study|Lost to Follow-up|34|||
23781095|NCT01168856|66580134|FG000|Overall Study|Withdrawal by Subject|6|||
23841019|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
23841020|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
23841021|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
23841022|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
23841023|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
23841024|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23635546|NCT00586612|66049461|FG000|Booster Phase|Lost to Follow-up|3|||
23635547|NCT00586612|66049462|FG001|Booster Phase|Lost to Follow-up|1|||
23635548|NCT04617275|66049464|FG000|Treatment Period|Adverse Event|1|||
23635549|NCT04617275|66049465|FG001|Treatment Period|Adverse Event|6|||
23635550|NCT04617275|66049466|FG002|Treatment Period|Adverse Event|4|||
23635551|NCT04617275|66049467|FG003|Treatment Period|Adverse Event|6|||
23635552|NCT04617275|66049468|FG004|Treatment Period|Adverse Event|7|||
23635553|NCT04617275|66049469|FG005|Treatment Period|Adverse Event|8|||
23635554|NCT04617275|66049470|FG006|Treatment Period|Adverse Event|0|||
23635555|NCT04617275|66049471|FG007|Treatment Period|Adverse Event|12|||
23635556|NCT04617275|66049464|FG000|Treatment Period|Lost to Follow-up|0|||
23635557|NCT04617275|66049465|FG001|Treatment Period|Lost to Follow-up|0|||
23635558|NCT04617275|66049466|FG002|Treatment Period|Lost to Follow-up|2|||
23635559|NCT04617275|66049467|FG003|Treatment Period|Lost to Follow-up|0|||
23635560|NCT04617275|66049468|FG004|Treatment Period|Lost to Follow-up|0|||
23635561|NCT04617275|66049469|FG005|Treatment Period|Lost to Follow-up|3|||
23635562|NCT04617275|66049470|FG006|Treatment Period|Lost to Follow-up|0|||
23635563|NCT04617275|66049471|FG007|Treatment Period|Lost to Follow-up|2|||
23635564|NCT04617275|66049464|FG000|Treatment Period|No longer meets eligibility criteria|0|||
23635565|NCT04617275|66049465|FG001|Treatment Period|No longer meets eligibility criteria|0|||
23841025|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23841026|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23841027|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23841028|NCT02016105|66798497|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
23841029|NCT02016105|66798498|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
23841030|NCT02016105|66798499|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23841031|NCT02016105|66798500|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23841032|NCT02016105|66798501|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23841033|NCT02016105|66798502|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23635566|NCT04617275|66049466|FG002|Treatment Period|No longer meets eligibility criteria|0|||
23635567|NCT04617275|66049467|FG003|Treatment Period|No longer meets eligibility criteria|1|||
23635568|NCT04617275|66049468|FG004|Treatment Period|No longer meets eligibility criteria|0|||
23635569|NCT04617275|66049469|FG005|Treatment Period|No longer meets eligibility criteria|0|||
23781096|NCT01168856|66580135|FG001|Overall Study|Withdrawal by Subject|8|||
23781097|NCT01168856|66580134|FG000|Overall Study|Physician Decision|2|||
23781098|NCT01168856|66580135|FG001|Overall Study|Physician Decision|1|||
23781099|NCT01168856|66580134|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
23781100|NCT01168856|66580135|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
23781101|NCT01168856|66580134|FG000|Overall Study|Participant received anti-HCV treatment|1|||
23781102|NCT01168856|66580135|FG001|Overall Study|Participant received anti-HCV treatment|0|||
23841034|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
23841035|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
23841036|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
23841037|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
23841038|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
23841039|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
23841040|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
23841041|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
23580551|NCT03251378|65853524|FG000|Overall Study|Other|0|||
23580552|NCT03251378|65853525|FG001|Overall Study|Other|0|||
23580553|NCT03251378|65853526|FG002|Overall Study|Other|0|||
23580554|NCT03251378|65853527|FG003|Overall Study|Other|4|||
23580555|NCT03251378|65853528|FG004|Overall Study|Other|13|||
23580556|NCT03251378|65853529|FG005|Overall Study|Other|0|||
23580557|NCT03251378|65853530|FG006|Overall Study|Other|0|||
23580558|NCT01251614|65853531|FG000|Overall Study|Adverse Event|1|||
23580559|NCT01251614|65853532|FG001|Overall Study|Adverse Event|0|||
23580560|NCT01251614|65853533|FG002|Overall Study|Adverse Event|1|||
23580561|NCT01251614|65853531|FG000|Overall Study|Lack of Efficacy|1|||
23580562|NCT01251614|65853532|FG001|Overall Study|Lack of Efficacy|9|||
23580563|NCT01251614|65853533|FG002|Overall Study|Lack of Efficacy|4|||
23580564|NCT01251614|65853531|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
23580565|NCT01251614|65853532|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
23580566|NCT01251614|65853533|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
23580567|NCT01251614|65853531|FG000|Overall Study|Pregnancy|0|||
23580568|NCT01251614|65853532|FG001|Overall Study|Pregnancy|0|||
23580569|NCT01251614|65853533|FG002|Overall Study|Pregnancy|2|||
23580570|NCT01251614|65853531|FG000|Overall Study|Loss of Disease Control|0|||
23580571|NCT01251614|65853532|FG001|Overall Study|Loss of Disease Control|1|||
23580572|NCT01251614|65853533|FG002|Overall Study|Loss of Disease Control|0|||
23580573|NCT01251614|65853531|FG000|Overall Study|Withdrawal by Subject|0|||
23580574|NCT01251614|65853532|FG001|Overall Study|Withdrawal by Subject|2|||
23580575|NCT01251614|65853533|FG002|Overall Study|Withdrawal by Subject|1|||
23580576|NCT01251614|65853531|FG000|Overall Study|Lost to Follow-up|0|||
23580577|NCT01251614|65853532|FG001|Overall Study|Lost to Follow-up|1|||
23580578|NCT01251614|65853533|FG002|Overall Study|Lost to Follow-up|0|||
23580579|NCT02049437|65853537|FG000|Period 1|Adverse Event|1|||
23580580|NCT02049437|65853538|FG001|Period 1|Adverse Event|1|||
23580581|NCT02049437|65853537|FG000|Period 1|Adverse Event|1|||
23580582|NCT02049437|65853538|FG001|Period 1|Adverse Event|0|||
23580583|NCT02846415|65853539|FG000|Overall Study|Lost to Follow-up|2|||
23580584|NCT02846415|65853540|FG001|Overall Study|Lost to Follow-up|0|||
23580585|NCT02846415|65853539|FG000|Overall Study|Withdrawal by Subject|1|||
23580586|NCT02846415|65853540|FG001|Overall Study|Withdrawal by Subject|1|||
23580587|NCT00430677|65853541|FG000|Short-term Period|Death|1|||
23580588|NCT00430677|65853542|FG001|Short-term Period|Death|1|||
23580589|NCT00430677|65853543|FG002|Short-term Period|Death|5|||
23580590|NCT00430677|65853541|FG000|Short-term Period|Adverse Event|15|||
23580591|NCT00430677|65853542|FG001|Short-term Period|Adverse Event|13|||
23580592|NCT00430677|65853543|FG002|Short-term Period|Adverse Event|9|||
23580593|NCT00430677|65853541|FG000|Short-term Period|Lack of Efficacy|5|||
23580594|NCT00430677|65853542|FG001|Short-term Period|Lack of Efficacy|6|||
23580595|NCT00430677|65853543|FG002|Short-term Period|Lack of Efficacy|4|||
23580596|NCT00430677|65853541|FG000|Short-term Period|Withdrawal by Subject|1|||
23580597|NCT00430677|65853542|FG001|Short-term Period|Withdrawal by Subject|1|||
23841042|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
23841043|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
23841044|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
23841045|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
23841046|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
23841047|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
23841048|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
23841049|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
23580598|NCT00430677|65853543|FG002|Short-term Period|Withdrawal by Subject|2|||
23580599|NCT00430677|65853541|FG000|Short-term Period|Participant no longer met study criteria|1|||
23841050|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
23841051|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
23580600|NCT00430677|65853542|FG001|Short-term Period|Participant no longer met study criteria|1|||
23580601|NCT00430677|65853543|FG002|Short-term Period|Participant no longer met study criteria|2|||
23580602|NCT00430677|65853541|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
23580603|NCT00430677|65853542|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
23580604|NCT00430677|65853543|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
23580605|NCT00430677|65853541|FG000|Short-term Period|Pregnancy|0|||
23580606|NCT00430677|65853542|FG001|Short-term Period|Pregnancy|2|||
23580607|NCT00430677|65853543|FG002|Short-term Period|Pregnancy|0|||
23580608|NCT00430677|65853541|FG000|Long-term Extension Period|Death|1|||
23580609|NCT00430677|65853542|FG001|Long-term Extension Period|Death|0|||
23580610|NCT00430677|65853543|FG002|Long-term Extension Period|Death|0|||
23841052|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Death|0|||
23841053|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Death|0|||
23841054|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Death|0|||
23841055|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Death|0|||
23841056|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Death|0|||
23841057|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Death|1|||
23841058|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
23841059|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
23841060|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
23841061|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
23841062|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
23841063|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
23841064|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
23841065|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
23841066|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
23841067|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
23841068|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
23841069|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
23841070|NCT02016105|66798497|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23841071|NCT02016105|66798498|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23841072|NCT02016105|66798499|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
23841073|NCT02016105|66798500|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23841074|NCT02016105|66798501|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23841075|NCT02016105|66798502|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
23841076|NCT02016105|66798497|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
23841077|NCT02016105|66798498|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
23841078|NCT02016105|66798499|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
23841079|NCT02016105|66798500|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
23841080|NCT02016105|66798501|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
23841081|NCT02016105|66798502|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
23841082|NCT02016105|66798497|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
23841083|NCT02016105|66798498|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
23841084|NCT02016105|66798499|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
23841085|NCT02016105|66798500|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
23841086|NCT02016105|66798501|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
23841087|NCT02016105|66798502|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
23841088|NCT02016105|66798497|FG000|EXTENSION PERIOD|Adverse Event|0|||
23841089|NCT02016105|66798498|FG001|EXTENSION PERIOD|Adverse Event|0|||
23841090|NCT02016105|66798499|FG002|EXTENSION PERIOD|Adverse Event|2|||
23841091|NCT02016105|66798500|FG003|EXTENSION PERIOD|Adverse Event|0|||
23841092|NCT02016105|66798501|FG004|EXTENSION PERIOD|Adverse Event|1|||
23841093|NCT02016105|66798502|FG005|EXTENSION PERIOD|Adverse Event|0|||
23841094|NCT02016105|66798497|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
23841095|NCT02016105|66798498|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
23841096|NCT02016105|66798499|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
23841097|NCT02016105|66798500|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
23841098|NCT02016105|66798501|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
23841099|NCT02016105|66798502|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
23841100|NCT02016105|66798497|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
23841101|NCT02016105|66798498|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
23841102|NCT02016105|66798499|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
23841103|NCT02016105|66798500|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
23841104|NCT02016105|66798501|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
23841105|NCT02016105|66798502|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
23841106|NCT02016105|66798497|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
23841107|NCT02016105|66798498|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
23841108|NCT02016105|66798499|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
23841109|NCT02016105|66798500|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
23841110|NCT02016105|66798501|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
23841111|NCT02016105|66798502|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
23841112|NCT00471081|66798503|FG000|Active Phase|Protocol Violation|1|||
23841113|NCT00471081|66798504|FG001|Active Phase|Protocol Violation|1|||
23841114|NCT00471081|66798503|FG000|Active Phase|Withdrawal by Subject|0|||
23841115|NCT00471081|66798504|FG001|Active Phase|Withdrawal by Subject|3|||
23841116|NCT00471081|66798503|FG000|Active Phase|Lost to Follow-up|0|||
23841117|NCT00471081|66798504|FG001|Active Phase|Lost to Follow-up|1|||
23841118|NCT00471081|66798503|FG000|Active Phase|Lost health plan/insurance|1|||
23841119|NCT00471081|66798504|FG001|Active Phase|Lost health plan/insurance|8|||
23841120|NCT00471081|66798503|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
23841121|NCT00471081|66798504|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
23841122|NCT00471081|66798503|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
23841123|NCT00471081|66798504|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
23841124|NCT00471081|66798503|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
23841125|NCT00471081|66798504|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
23841126|NCT02527434|66798505|FG000|Overall Study|Lost to Follow-up|2|||
23841127|NCT02527434|66798506|FG001|Overall Study|Lost to Follow-up|2|||
23841128|NCT02527434|66798507|FG002|Overall Study|Lost to Follow-up|0|||
23841129|NCT02527434|66798505|FG000|Overall Study|Death|19|||
23841130|NCT02527434|66798506|FG001|Overall Study|Death|6|||
23841131|NCT02527434|66798507|FG002|Overall Study|Death|17|||
23841132|NCT02527434|66798505|FG000|Overall Study|Withdrawal by Subject|5|||
23841133|NCT02527434|66798506|FG001|Overall Study|Withdrawal by Subject|3|||
23841134|NCT02527434|66798507|FG002|Overall Study|Withdrawal by Subject|3|||
23340193|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23580611|NCT00430677|65853541|FG000|Long-term Extension Period|Adverse Event|3|||
23841135|NCT02527434|66798505|FG000|Overall Study|Reason Not Specified|1|||
23580612|NCT00430677|65853542|FG001|Long-term Extension Period|Adverse Event|2|||
23841136|NCT02527434|66798506|FG001|Overall Study|Reason Not Specified|0|||
23841137|NCT02527434|66798507|FG002|Overall Study|Reason Not Specified|0|||
23841138|NCT02527434|66798505|FG000|Overall Study|Site closure|1|||
23841139|NCT02527434|66798506|FG001|Overall Study|Site closure|0|||
23841140|NCT02527434|66798507|FG002|Overall Study|Site closure|0|||
23841141|NCT01609543|66798508|FG000|Overall Study|Disease Progression|28|||
23841142|NCT01609543|66798508|FG000|Overall Study|Adverse Event|5|||
23841143|NCT01609543|66798508|FG000|Overall Study|Withdrawal by Subject|1|||
23841144|NCT01609543|66798508|FG000|Overall Study|Protocol Violation|1|||
23841145|NCT01609543|66798508|FG000|Overall Study|Death|7|||
23841146|NCT02805660|66798509|FG000|Overall Study|Death|5|||
23841147|NCT02805660|66798510|FG001|Overall Study|Death|2|||
23841148|NCT02805660|66798511|FG002|Overall Study|Death|9|||
23841149|NCT02805660|66798512|FG003|Overall Study|Death|5|||
23841150|NCT02805660|66798513|FG004|Overall Study|Death|0|||
23841151|NCT02805660|66798514|FG005|Overall Study|Death|14|||
23841152|NCT02805660|66798515|FG006|Overall Study|Death|12|||
23841153|NCT02805660|66798509|FG000|Overall Study|Lost to Follow-up|0|||
23841154|NCT02805660|66798510|FG001|Overall Study|Lost to Follow-up|1|||
23841155|NCT02805660|66798511|FG002|Overall Study|Lost to Follow-up|1|||
23841156|NCT02805660|66798512|FG003|Overall Study|Lost to Follow-up|2|||
23841157|NCT02805660|66798513|FG004|Overall Study|Lost to Follow-up|0|||
23841158|NCT02805660|66798514|FG005|Overall Study|Lost to Follow-up|0|||
23841159|NCT02805660|66798515|FG006|Overall Study|Lost to Follow-up|0|||
23841160|NCT02805660|66798509|FG000|Overall Study|Withdrawal by Subject|0|||
23841161|NCT02805660|66798510|FG001|Overall Study|Withdrawal by Subject|0|||
23841162|NCT02805660|66798511|FG002|Overall Study|Withdrawal by Subject|0|||
23841163|NCT02805660|66798512|FG003|Overall Study|Withdrawal by Subject|3|||
23841164|NCT02805660|66798513|FG004|Overall Study|Withdrawal by Subject|1|||
23841165|NCT02805660|66798514|FG005|Overall Study|Withdrawal by Subject|0|||
23841166|NCT02805660|66798515|FG006|Overall Study|Withdrawal by Subject|2|||
23841167|NCT02805660|66798509|FG000|Overall Study|Study terminated by Sponsor|0|||
23841168|NCT02805660|66798510|FG001|Overall Study|Study terminated by Sponsor|0|||
23841169|NCT02805660|66798511|FG002|Overall Study|Study terminated by Sponsor|1|||
23841170|NCT02805660|66798512|FG003|Overall Study|Study terminated by Sponsor|4|||
23841171|NCT02805660|66798513|FG004|Overall Study|Study terminated by Sponsor|2|||
23841172|NCT02805660|66798514|FG005|Overall Study|Study terminated by Sponsor|3|||
23841173|NCT02805660|66798515|FG006|Overall Study|Study terminated by Sponsor|1|||
23841174|NCT02805660|66798509|FG000|Overall Study|Miscellaneous|0|||
23841175|NCT02805660|66798510|FG001|Overall Study|Miscellaneous|1|||
23841176|NCT02805660|66798511|FG002|Overall Study|Miscellaneous|0|||
23841177|NCT02805660|66798512|FG003|Overall Study|Miscellaneous|4|||
23841178|NCT02805660|66798513|FG004|Overall Study|Miscellaneous|0|||
23841179|NCT02805660|66798514|FG005|Overall Study|Miscellaneous|6|||
23841180|NCT02805660|66798515|FG006|Overall Study|Miscellaneous|4|||
23841181|NCT00247611|66798519|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
23841182|NCT00247611|66798520|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
23841183|NCT00247611|66798519|FG000|Baselined|Completed baseline only|9|||
23841184|NCT00247611|66798520|FG001|Baselined|Completed baseline only|8|||
23580613|NCT00430677|65853543|FG002|Long-term Extension Period|Adverse Event|5|||
23841185|NCT02129777|66798521|FG000|Double-Blind Period|Adverse Event|0|||
23841186|NCT02129777|66798522|FG001|Double-Blind Period|Adverse Event|0|||
23580614|NCT00430677|65853541|FG000|Long-term Extension Period|Lack of Efficacy|5|||
23781103|NCT01168856|66580134|FG000|Overall Study|Death|0|||
23841187|NCT02129777|66798523|FG002|Double-Blind Period|Adverse Event|0|||
23841188|NCT02129777|66798524|FG003|Double-Blind Period|Adverse Event|0|||
23841189|NCT02129777|66798525|FG004|Double-Blind Period|Adverse Event|1|||
23841190|NCT02129777|66798526|FG005|Double-Blind Period|Adverse Event|0|||
23841191|NCT02129777|66798527|FG006|Double-Blind Period|Adverse Event|0|||
23841192|NCT02129777|66798521|FG000|Double-Blind Period|Lost to Follow-up|1|||
23841193|NCT02129777|66798522|FG001|Double-Blind Period|Lost to Follow-up|1|||
23841194|NCT02129777|66798523|FG002|Double-Blind Period|Lost to Follow-up|1|||
23781104|NCT01168856|66580135|FG001|Overall Study|Death|2|||
23781105|NCT01168856|66580134|FG000|Overall Study|Other|1|||
23781106|NCT01168856|66580135|FG001|Overall Study|Other|291|||
23781107|NCT01168856|66580134|FG000|Overall Study|Protocol Violation|4|||
23841195|NCT02129777|66798524|FG003|Double-Blind Period|Lost to Follow-up|2|||
23841196|NCT02129777|66798525|FG004|Double-Blind Period|Lost to Follow-up|0|||
23841197|NCT02129777|66798526|FG005|Double-Blind Period|Lost to Follow-up|0|||
23841198|NCT02129777|66798527|FG006|Double-Blind Period|Lost to Follow-up|0|||
23841199|NCT02129777|66798521|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23841200|NCT02129777|66798522|FG001|Double-Blind Period|Withdrawal by Subject|4|||
23841201|NCT02129777|66798523|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23841202|NCT02129777|66798524|FG003|Double-Blind Period|Withdrawal by Subject|2|||
23841203|NCT02129777|66798525|FG004|Double-Blind Period|Withdrawal by Subject|3|||
23841204|NCT02129777|66798526|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23841205|NCT02129777|66798527|FG006|Double-Blind Period|Withdrawal by Subject|0|||
23841206|NCT02129777|66798521|FG000|Double-Blind Period|Pregnancy|0|||
23841207|NCT02129777|66798522|FG001|Double-Blind Period|Pregnancy|0|||
23841208|NCT02129777|66798523|FG002|Double-Blind Period|Pregnancy|0|||
23841209|NCT02129777|66798524|FG003|Double-Blind Period|Pregnancy|0|||
23841210|NCT02129777|66798525|FG004|Double-Blind Period|Pregnancy|1|||
23841211|NCT02129777|66798526|FG005|Double-Blind Period|Pregnancy|0|||
23841212|NCT02129777|66798527|FG006|Double-Blind Period|Pregnancy|0|||
23841213|NCT02129777|66798521|FG000|Double-Blind Period|Lack of Efficacy|3|||
23841214|NCT02129777|66798522|FG001|Double-Blind Period|Lack of Efficacy|1|||
23841215|NCT02129777|66798523|FG002|Double-Blind Period|Lack of Efficacy|0|||
23841216|NCT02129777|66798524|FG003|Double-Blind Period|Lack of Efficacy|3|||
23841217|NCT02129777|66798525|FG004|Double-Blind Period|Lack of Efficacy|2|||
23841218|NCT02129777|66798526|FG005|Double-Blind Period|Lack of Efficacy|0|||
23340194|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340195|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340196|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340197|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340198|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
23340199|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340200|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340201|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340202|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340203|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23580615|NCT00430677|65853542|FG001|Long-term Extension Period|Lack of Efficacy|3|||
23580616|NCT00430677|65853543|FG002|Long-term Extension Period|Lack of Efficacy|8|||
23580617|NCT00430677|65853541|FG000|Long-term Extension Period|Lost to Follow-up|1|||
23580618|NCT00430677|65853542|FG001|Long-term Extension Period|Lost to Follow-up|1|||
23580619|NCT00430677|65853543|FG002|Long-term Extension Period|Lost to Follow-up|1|||
23841219|NCT02129777|66798527|FG006|Double-Blind Period|Lack of Efficacy|0|||
23841220|NCT02129777|66798521|FG000|Double-Blind Period|Other|1|||
23841221|NCT02129777|66798522|FG001|Double-Blind Period|Other|2|||
23841222|NCT02129777|66798523|FG002|Double-Blind Period|Other|0|||
23580620|NCT00430677|65853541|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
23580621|NCT00430677|65853542|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
23580622|NCT00430677|65853543|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
23580623|NCT00430677|65853541|FG000|Long-term Extension Period|Pregnancy|1|||
23580624|NCT00430677|65853542|FG001|Long-term Extension Period|Pregnancy|1|||
23580625|NCT00430677|65853543|FG002|Long-term Extension Period|Pregnancy|0|||
23580626|NCT00430677|65853541|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
23580627|NCT00430677|65853542|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
23580628|NCT00430677|65853543|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
23580629|NCT00430677|65853541|FG000|Long-term Extension Period|Other|2|||
23580630|NCT00430677|65853542|FG001|Long-term Extension Period|Other|1|||
23580631|NCT00430677|65853543|FG002|Long-term Extension Period|Other|1|||
23580632|NCT00430677|65853541|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
23580633|NCT00430677|65853542|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
23580634|NCT00430677|65853543|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
23580635|NCT00519779|65853548|FG000|Overall Study|Withdrawal by Subject|0|||
23580636|NCT00519779|65853549|FG001|Overall Study|Withdrawal by Subject|1|||
23580637|NCT01878890|65853551|FG000|Overall Study|Protocol Violation|0|||
23580638|NCT01878890|65853552|FG001|Overall Study|Protocol Violation|1|||
23580639|NCT01878890|65853553|FG002|Overall Study|Protocol Violation|0|||
23580640|NCT01878890|65853554|FG003|Overall Study|Protocol Violation|0|||
23841223|NCT02129777|66798524|FG003|Double-Blind Period|Other|0|||
23841224|NCT02129777|66798525|FG004|Double-Blind Period|Other|0|||
23841225|NCT02129777|66798526|FG005|Double-Blind Period|Other|0|||
23841226|NCT02129777|66798527|FG006|Double-Blind Period|Other|0|||
23841227|NCT02129777|66798521|FG000|Open-Label Period|Lack of Efficacy|0|||
23841228|NCT02129777|66798522|FG001|Open-Label Period|Lack of Efficacy|0|||
23340204|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340205|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
23340206|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340207|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340208|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340209|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23841229|NCT02129777|66798523|FG002|Open-Label Period|Lack of Efficacy|0|||
23841230|NCT02129777|66798524|FG003|Open-Label Period|Lack of Efficacy|0|||
23841231|NCT02129777|66798525|FG004|Open-Label Period|Lack of Efficacy|0|||
23841232|NCT02129777|66798526|FG005|Open-Label Period|Lack of Efficacy|0|||
23340210|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340211|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340212|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
23340213|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340214|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340215|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340216|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340217|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340218|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340219|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
23340220|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340221|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340222|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340223|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340224|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340225|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340226|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
23340227|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340228|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340229|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340230|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340231|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340232|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340233|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
23841233|NCT02129777|66798527|FG006|Open-Label Period|Lack of Efficacy|5|||
23841234|NCT02129777|66798521|FG000|Open-Label Period|Lost to Follow-up|0|||
23841235|NCT02129777|66798522|FG001|Open-Label Period|Lost to Follow-up|0|||
23841236|NCT02129777|66798523|FG002|Open-Label Period|Lost to Follow-up|0|||
23841237|NCT02129777|66798524|FG003|Open-Label Period|Lost to Follow-up|0|||
23841238|NCT02129777|66798525|FG004|Open-Label Period|Lost to Follow-up|0|||
23841239|NCT02129777|66798526|FG005|Open-Label Period|Lost to Follow-up|1|||
23841240|NCT02129777|66798527|FG006|Open-Label Period|Lost to Follow-up|1|||
23841241|NCT02129777|66798521|FG000|Open-Label Period|Withdrawal by Subject|0|||
23841242|NCT02129777|66798522|FG001|Open-Label Period|Withdrawal by Subject|0|||
23841243|NCT02129777|66798523|FG002|Open-Label Period|Withdrawal by Subject|0|||
23841244|NCT02129777|66798524|FG003|Open-Label Period|Withdrawal by Subject|0|||
23841245|NCT02129777|66798525|FG004|Open-Label Period|Withdrawal by Subject|0|||
23841246|NCT02129777|66798526|FG005|Open-Label Period|Withdrawal by Subject|1|||
23841247|NCT02129777|66798527|FG006|Open-Label Period|Withdrawal by Subject|3|||
23841248|NCT02129777|66798521|FG000|Open-Label Period|Study Termination|0|||
23841249|NCT02129777|66798522|FG001|Open-Label Period|Study Termination|0|||
23841250|NCT02129777|66798523|FG002|Open-Label Period|Study Termination|0|||
23841251|NCT02129777|66798524|FG003|Open-Label Period|Study Termination|0|||
23841252|NCT02129777|66798525|FG004|Open-Label Period|Study Termination|0|||
23841253|NCT02129777|66798526|FG005|Open-Label Period|Study Termination|10|||
23841254|NCT02129777|66798527|FG006|Open-Label Period|Study Termination|39|||
23841255|NCT00570687|66798533|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841256|NCT00570687|66798534|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841257|NCT00570687|66798535|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841258|NCT00570687|66798536|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841259|NCT00570687|66798537|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23841260|NCT00570687|66798538|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23841261|NCT00570687|66798539|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
23841262|NCT00570687|66798540|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23841263|NCT00570687|66798541|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
23841264|NCT00570687|66798542|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23841265|NCT00570687|66798533|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841266|NCT00570687|66798534|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841267|NCT00570687|66798535|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841268|NCT00570687|66798536|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841269|NCT00570687|66798537|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841270|NCT00570687|66798538|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841271|NCT00570687|66798539|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841272|NCT00570687|66798540|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841273|NCT00570687|66798541|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
23841274|NCT00570687|66798542|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841275|NCT00570687|66798533|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841276|NCT00570687|66798534|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841277|NCT00570687|66798535|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841278|NCT00570687|66798536|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841279|NCT00570687|66798537|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841280|NCT00570687|66798538|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841281|NCT00570687|66798539|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
23841282|NCT00570687|66798540|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841283|NCT00570687|66798541|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841284|NCT00570687|66798542|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23841285|NCT02316548|66798543|FG000|Overall Study|Protocol Violation|0|||
23841286|NCT02316548|66798544|FG001|Overall Study|Protocol Violation|1|||
23841287|NCT01102257|66798545|FG000|Overall Study|Adverse Event|1|||
23841288|NCT01102257|66798546|FG001|Overall Study|Adverse Event|0|||
23841289|NCT01102257|66798545|FG000|Overall Study|Adverse Event|1|||
23841290|NCT01102257|66798546|FG001|Overall Study|Adverse Event|0|||
23841291|NCT01340872|66798547|FG000|Double-blind Phase|Adverse Event|6|||
23841292|NCT01340872|66798548|FG001|Double-blind Phase|Adverse Event|4|||
23841293|NCT01340872|66798549|FG002|Double-blind Phase|Adverse Event|0|||
23841294|NCT01340872|66798550|FG003|Double-blind Phase|Adverse Event|0|||
23841295|NCT01340872|66798547|FG000|Double-blind Phase|Withdrawal by Subject|3|||
23841296|NCT01340872|66798548|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23841297|NCT01340872|66798549|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23841298|NCT01340872|66798550|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23841299|NCT01340872|66798547|FG000|Double-blind Phase|Lost to Follow-up|0|||
23841300|NCT01340872|66798548|FG001|Double-blind Phase|Lost to Follow-up|1|||
23841301|NCT01340872|66798549|FG002|Double-blind Phase|Lost to Follow-up|0|||
23841302|NCT01340872|66798550|FG003|Double-blind Phase|Lost to Follow-up|0|||
23841303|NCT01340872|66798547|FG000|Double-blind Phase|Protocol Violation|0|||
23841304|NCT01340872|66798548|FG001|Double-blind Phase|Protocol Violation|1|||
23841305|NCT01340872|66798549|FG002|Double-blind Phase|Protocol Violation|0|||
23841306|NCT01340872|66798550|FG003|Double-blind Phase|Protocol Violation|0|||
23841307|NCT01340872|66798547|FG000|Open-label Phase|Physician Decision|0|||
23841308|NCT01340872|66798548|FG001|Open-label Phase|Physician Decision|0|||
23841309|NCT01340872|66798549|FG002|Open-label Phase|Physician Decision|2|||
23841310|NCT01340872|66798550|FG003|Open-label Phase|Physician Decision|1|||
23841311|NCT01340872|66798547|FG000|Open-label Phase|Pregnancy|0|||
23841312|NCT01340872|66798548|FG001|Open-label Phase|Pregnancy|0|||
23841313|NCT01340872|66798549|FG002|Open-label Phase|Pregnancy|1|||
23841314|NCT01340872|66798550|FG003|Open-label Phase|Pregnancy|0|||
23841315|NCT01340872|66798547|FG000|Open-label Phase|Adverse Event|0|||
23841316|NCT01340872|66798548|FG001|Open-label Phase|Adverse Event|0|||
23841317|NCT01340872|66798549|FG002|Open-label Phase|Adverse Event|8|||
23841318|NCT01340872|66798550|FG003|Open-label Phase|Adverse Event|4|||
23841319|NCT01340872|66798547|FG000|Open-label Phase|Withdrawal by Subject|0|||
23580641|NCT04978363|65853555|FG000|Overall Study|Other medical issues unrelated to the study|0|||
23580642|NCT04978363|65853556|FG001|Overall Study|Other medical issues unrelated to the study|0|||
23580643|NCT04978363|65853557|FG002|Overall Study|Other medical issues unrelated to the study|0|||
23841320|NCT01340872|66798548|FG001|Open-label Phase|Withdrawal by Subject|0|||
23841321|NCT01340872|66798549|FG002|Open-label Phase|Withdrawal by Subject|1|||
23841322|NCT01340872|66798550|FG003|Open-label Phase|Withdrawal by Subject|6|||
23841323|NCT01340872|66798547|FG000|Open-label Phase|Worsening of IBD|0|||
23841324|NCT01340872|66798548|FG001|Open-label Phase|Worsening of IBD|0|||
23841325|NCT01340872|66798549|FG002|Open-label Phase|Worsening of IBD|1|||
23841326|NCT01340872|66798550|FG003|Open-label Phase|Worsening of IBD|0|||
23841327|NCT00667823|66798551|FG000|Overall Study|Lost to Follow-up|5|||
23841328|NCT00667823|66798551|FG000|Overall Study|Adverse Event|7|||
23841329|NCT00667823|66798551|FG000|Overall Study|Death|182|||
23841330|NCT00667823|66798551|FG000|Overall Study|Withdrawal by Subject|12|||
23841331|NCT00667823|66798551|FG000|Overall Study|Other|8|||
23841332|NCT00667823|66798551|FG000|Overall Study|Missing (completion page missing)|2|||
23841333|NCT01046903|66798552|FG000|Overall Study|Lost to Follow-up|16|||
23841334|NCT01046903|66798552|FG000|Overall Study|Adverse Event|4|||
23841335|NCT01046903|66798552|FG000|Overall Study|Withdrawal by Subject|3|||
23841336|NCT01046903|66798552|FG000|Overall Study|Other|5|||
23841337|NCT03436693|66798559|FG000|Overall Study|Adverse Event|22|||
23841338|NCT03436693|66798560|FG001|Overall Study|Adverse Event|10|||
23841339|NCT03436693|66798559|FG000|Overall Study|Physician Decision|3|||
23841340|NCT03436693|66798560|FG001|Overall Study|Physician Decision|3|||
23841341|NCT03436693|66798559|FG000|Overall Study|Withdrawal by Subject|4|||
23841342|NCT03436693|66798560|FG001|Overall Study|Withdrawal by Subject|13|||
23841343|NCT03436693|66798559|FG000|Overall Study|Progressive Disease|1|||
23841344|NCT03436693|66798560|FG001|Overall Study|Progressive Disease|1|||
23841345|NCT00039871|66798561|FG000|Overall Study|Adverse Event|165|||
23841346|NCT00039871|66798561|FG000|Overall Study|Lost to Follow-up|18|||
23841347|NCT00039871|66798561|FG000|Overall Study|Protocol Violation|24|||
23841348|NCT00039871|66798561|FG000|Overall Study|Withdrawal by Subject|97|||
23841349|NCT00039871|66798561|FG000|Overall Study|Did not meet eligibility criteria|11|||
23841350|NCT00039871|66798561|FG000|Overall Study|Administrative|1|||
23841351|NCT00039871|66798561|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
23841352|NCT00039871|66798561|FG000|Overall Study|Never entered follow-up|7|||
23841353|NCT00529308|66798562|FG000|Overall Study|Withdrawal by Subject|1|||
23841354|NCT00529308|66798563|FG001|Overall Study|Withdrawal by Subject|1|||
23841355|NCT01570361|66798569|FG000|Overall Study|Subject discontinued|1|||
23841356|NCT01570361|66798570|FG001|Overall Study|Subject discontinued|2|||
23841357|NCT01570361|66798569|FG000|Overall Study|Sponsor closing the study|51|||
23841358|NCT01570361|66798570|FG001|Overall Study|Sponsor closing the study|50|||
23841359|NCT01570361|66798569|FG000|Overall Study|Subject excluded|5|||
23841360|NCT01570361|66798570|FG001|Overall Study|Subject excluded|3|||
23841361|NCT01570361|66798569|FG000|Overall Study|Subject withdrew consent|14|||
23841362|NCT01570361|66798570|FG001|Overall Study|Subject withdrew consent|9|||
23841363|NCT01570361|66798569|FG000|Overall Study|Adverse Event|2|||
23841364|NCT01570361|66798570|FG001|Overall Study|Adverse Event|1|||
23841365|NCT01570361|66798569|FG000|Overall Study|Lost to Follow-up|4|||
23841366|NCT01570361|66798570|FG001|Overall Study|Lost to Follow-up|4|||
23841367|NCT01570361|66798569|FG000|Overall Study|Death|5|||
23841368|NCT01570361|66798570|FG001|Overall Study|Death|4|||
23841369|NCT01570361|66798569|FG000|Overall Study|Other|0|||
23841370|NCT01570361|66798570|FG001|Overall Study|Other|2|||
23841371|NCT01075256|66798571|FG000|Overall Study|Withdrawal by Subject|1|||
23841372|NCT01075256|66798572|FG001|Overall Study|Withdrawal by Subject|0|||
23841373|NCT01075256|66798573|FG002|Overall Study|Withdrawal by Subject|0|||
23841374|NCT00857896|66798574|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
23841375|NCT01814696|66798585|FG000|Overall Study|Withdrawal by Subject|1|||
23841376|NCT01814696|66798586|FG001|Overall Study|Withdrawal by Subject|0|||
23841377|NCT01814696|66798585|FG000|Overall Study|Randomized to wrong group|1|||
23841378|NCT01814696|66798586|FG001|Overall Study|Randomized to wrong group|0|||
23841379|NCT01508130|66798590|FG000|Overall Study|Adverse Event|81|||
23841380|NCT01508130|66798591|FG001|Overall Study|Adverse Event|28|||
23340234|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340235|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340236|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340237|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340869|NCT01936181|64992870|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
23781108|NCT01168856|66580135|FG001|Overall Study|Protocol Violation|6|||
23841381|NCT01508130|66798590|FG000|Overall Study|Death|3|||
23841382|NCT01508130|66798591|FG001|Overall Study|Death|1|||
23841383|NCT01508130|66798590|FG000|Overall Study|Protocol Violation|2|||
23841384|NCT01508130|66798591|FG001|Overall Study|Protocol Violation|0|||
23841385|NCT01508130|66798590|FG000|Overall Study|Lost to Follow-up|25|||
23841386|NCT01508130|66798591|FG001|Overall Study|Lost to Follow-up|2|||
23841387|NCT01508130|66798590|FG000|Overall Study|Withdrawal by Subject|3|||
23841388|NCT01508130|66798591|FG001|Overall Study|Withdrawal by Subject|3|||
23841389|NCT01508130|66798590|FG000|Overall Study|Subject's substantial non-compliance|25|||
23841390|NCT01508130|66798591|FG001|Overall Study|Subject's substantial non-compliance|9|||
23841391|NCT01508130|66798590|FG000|Overall Study|Insufficient therapeutic response|74|||
23841392|NCT01508130|66798591|FG001|Overall Study|Insufficient therapeutic response|23|||
23841393|NCT01508130|66798590|FG000|Overall Study|Administrative|14|||
23635570|NCT04617275|66049470|FG006|Treatment Period|No longer meets eligibility criteria|0|||
23635571|NCT04617275|66049471|FG007|Treatment Period|No longer meets eligibility criteria|0|||
23635572|NCT04617275|66049464|FG000|Treatment Period|Other|0|||
23635573|NCT04617275|66049465|FG001|Treatment Period|Other|1|||
23635574|NCT04617275|66049466|FG002|Treatment Period|Other|0|||
23635575|NCT04617275|66049467|FG003|Treatment Period|Other|0|||
23635576|NCT04617275|66049468|FG004|Treatment Period|Other|0|||
23635577|NCT04617275|66049469|FG005|Treatment Period|Other|0|||
23635578|NCT04617275|66049470|FG006|Treatment Period|Other|0|||
23635579|NCT04617275|66049471|FG007|Treatment Period|Other|0|||
23635580|NCT04617275|66049464|FG000|Treatment Period|Withdrawal by Subject|2|||
23635581|NCT04617275|66049465|FG001|Treatment Period|Withdrawal by Subject|0|||
23635582|NCT04617275|66049466|FG002|Treatment Period|Withdrawal by Subject|0|||
23635583|NCT04617275|66049467|FG003|Treatment Period|Withdrawal by Subject|2|||
23635584|NCT04617275|66049468|FG004|Treatment Period|Withdrawal by Subject|2|||
23635585|NCT04617275|66049469|FG005|Treatment Period|Withdrawal by Subject|0|||
23781109|NCT00124618|66580136|FG000|Overall Study|Ineligible|1|||
23781110|NCT03772522|66580137|FG000|Pre-intervention|Withdrawal by Subject|3|||
23781111|NCT03772522|66580138|FG001|Pre-intervention|Withdrawal by Subject|4|||
23781112|NCT03772522|66580137|FG000|Intervention|Withdrawal by Subject|1|||
23781113|NCT03772522|66580138|FG001|Intervention|Withdrawal by Subject|0|||
23781114|NCT03772522|66580137|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
23781115|NCT03772522|66580138|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
23781116|NCT02152163|66580139|FG000|Overall Study|Physician Decision|12|||
23781117|NCT02152163|66580140|FG001|Overall Study|Physician Decision|13|||
23781118|NCT01663233|66580141|FG000|Overall Study|Withdrawal by Subject|3|||
23841394|NCT01508130|66798591|FG001|Overall Study|Administrative|3|||
23841395|NCT03287635|66798592|FG000|Overall Study|Lost to Follow-up|5|||
23841396|NCT03287635|66798592|FG000|Overall Study|Withdrawal by Subject|1|||
23841397|NCT03287635|66798592|FG000|Overall Study|Physician Decision|1|||
23781119|NCT01663233|66580142|FG001|Overall Study|Withdrawal by Subject|2|||
23781120|NCT01663233|66580141|FG000|Overall Study|Protocol Deviation|1|||
23781121|NCT01663233|66580142|FG001|Overall Study|Protocol Deviation|4|||
23781122|NCT01663233|66580141|FG000|Overall Study|Lost to Follow-up|0|||
23781123|NCT01663233|66580142|FG001|Overall Study|Lost to Follow-up|1|||
23781124|NCT00833937|66580152|FG000|Washout|Withdrawal by Subject|1|||
23781125|NCT00833937|66580153|FG001|Washout|Withdrawal by Subject|0|||
23781126|NCT03154047|66580154|FG000|Overall Study|Death|1|||
23781127|NCT03154047|66580154|FG000|Overall Study|Study terminated by sponsor|76|||
23781128|NCT03154047|66580154|FG000|Overall Study|Withdrawal by Subject|3|||
23781129|NCT03104374|66580155|FG000|Overall Study|Adverse Event|7|||
23452056|NCT02714569|65398901|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23781130|NCT03104374|66580156|FG001|Overall Study|Adverse Event|6|||
23781131|NCT03104374|66580157|FG002|Overall Study|Adverse Event|12|||
23781132|NCT03104374|66580158|FG003|Overall Study|Adverse Event|15|||
23781133|NCT03104374|66580155|FG000|Overall Study|Withdrawal by Subject|18|||
23781134|NCT03104374|66580156|FG001|Overall Study|Withdrawal by Subject|10|||
23841398|NCT00887315|66798593|FG000|Overall Study|Study termination|7|||
23841399|NCT00887315|66798594|FG001|Overall Study|Study termination|4|||
23841400|NCT04480424|66798596|FG000|Overall Study|Withdrawal by Subject|0|||
23841401|NCT04480424|66798597|FG001|Overall Study|Withdrawal by Subject|2|||
23841402|NCT04480424|66798596|FG000|Overall Study|Lost to Follow-up|3|||
23841403|NCT04480424|66798597|FG001|Overall Study|Lost to Follow-up|3|||
23841404|NCT04480424|66798596|FG000|Overall Study|Death|14|||
23841405|NCT04480424|66798597|FG001|Overall Study|Death|16|||
23841406|NCT04480424|66798596|FG000|Overall Study|Reason not Specified|5|||
23841407|NCT04480424|66798597|FG001|Overall Study|Reason not Specified|5|||
23841408|NCT02049814|66798599|FG000|Overall Study|Reason not Specified|4|||
23841409|NCT02049814|66798600|FG001|Overall Study|Reason not Specified|3|||
23841410|NCT02049814|66798599|FG000|Overall Study|Pregnancy|1|||
23841411|NCT02049814|66798600|FG001|Overall Study|Pregnancy|0|||
23841412|NCT02049814|66798599|FG000|Overall Study|Lost to Follow-up|2|||
23841413|NCT02049814|66798600|FG001|Overall Study|Lost to Follow-up|3|||
23841414|NCT02049814|66798599|FG000|Overall Study|Serious Protocol Violation|5|||
23635586|NCT04617275|66049470|FG006|Treatment Period|Withdrawal by Subject|1|||
23781135|NCT03104374|66580157|FG002|Overall Study|Withdrawal by Subject|10|||
23781136|NCT03104374|66580158|FG003|Overall Study|Withdrawal by Subject|17|||
23781137|NCT03104374|66580155|FG000|Overall Study|Lost to Follow-up|4|||
23841415|NCT02049814|66798600|FG001|Overall Study|Serious Protocol Violation|7|||
23841416|NCT02049814|66798599|FG000|Overall Study|Study Termination|0|||
23841417|NCT02049814|66798600|FG001|Overall Study|Study Termination|1|||
23635587|NCT04617275|66049471|FG007|Treatment Period|Withdrawal by Subject|2|||
23635588|NCT04617275|66049464|FG000|Follow-up Period|Adverse Event|1|||
23635589|NCT04617275|66049465|FG001|Follow-up Period|Adverse Event|1|||
23635590|NCT04617275|66049466|FG002|Follow-up Period|Adverse Event|2|||
23635591|NCT04617275|66049467|FG003|Follow-up Period|Adverse Event|3|||
23781138|NCT03104374|66580156|FG001|Overall Study|Lost to Follow-up|4|||
23781139|NCT03104374|66580157|FG002|Overall Study|Lost to Follow-up|6|||
23841418|NCT02049814|66798599|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
23452057|NCT02714569|65398891|FG000|Part B (Overall)|Lost to Follow-up|0|||
23452058|NCT02714569|65398892|FG001|Part B (Overall)|Lost to Follow-up|0|||
23452059|NCT02714569|65398893|FG002|Part B (Overall)|Lost to Follow-up|0|||
23452060|NCT02714569|65398894|FG003|Part B (Overall)|Lost to Follow-up|0|||
23452061|NCT02714569|65398895|FG004|Part B (Overall)|Lost to Follow-up|0|||
23452062|NCT02714569|65398896|FG005|Part B (Overall)|Lost to Follow-up|0|||
23452063|NCT02714569|65398897|FG006|Part B (Overall)|Lost to Follow-up|1|||
23452064|NCT02714569|65398898|FG007|Part B (Overall)|Lost to Follow-up|0|||
23452065|NCT02714569|65398899|FG008|Part B (Overall)|Lost to Follow-up|0|||
23452066|NCT02714569|65398900|FG009|Part B (Overall)|Lost to Follow-up|0|||
23452067|NCT02714569|65398901|FG010|Part B (Overall)|Lost to Follow-up|0|||
23452068|NCT02714569|65398891|FG000|Part B (Overall)|Withdrawal by Subject|0|||
23452069|NCT02714569|65398892|FG001|Part B (Overall)|Withdrawal by Subject|0|||
23452070|NCT02714569|65398893|FG002|Part B (Overall)|Withdrawal by Subject|0|||
23452071|NCT02714569|65398894|FG003|Part B (Overall)|Withdrawal by Subject|0|||
23452072|NCT02714569|65398895|FG004|Part B (Overall)|Withdrawal by Subject|0|||
23452073|NCT02714569|65398896|FG005|Part B (Overall)|Withdrawal by Subject|0|||
23452074|NCT02714569|65398897|FG006|Part B (Overall)|Withdrawal by Subject|0|||
23452075|NCT02714569|65398898|FG007|Part B (Overall)|Withdrawal by Subject|1|||
23452076|NCT02714569|65398899|FG008|Part B (Overall)|Withdrawal by Subject|0|||
23452077|NCT02714569|65398900|FG009|Part B (Overall)|Withdrawal by Subject|1|||
23452078|NCT02714569|65398901|FG010|Part B (Overall)|Withdrawal by Subject|0|||
23452079|NCT02714569|65398891|FG000|Part B (Overall)|Adverse Event|0|||
23452080|NCT02714569|65398892|FG001|Part B (Overall)|Adverse Event|0|||
23452081|NCT02714569|65398893|FG002|Part B (Overall)|Adverse Event|0|||
23452082|NCT02714569|65398894|FG003|Part B (Overall)|Adverse Event|0|||
23452083|NCT02714569|65398895|FG004|Part B (Overall)|Adverse Event|0|||
23452084|NCT02714569|65398896|FG005|Part B (Overall)|Adverse Event|0|||
23452085|NCT02714569|65398897|FG006|Part B (Overall)|Adverse Event|0|||
23452086|NCT02714569|65398898|FG007|Part B (Overall)|Adverse Event|0|||
23452087|NCT02714569|65398899|FG008|Part B (Overall)|Adverse Event|0|||
23452088|NCT02714569|65398900|FG009|Part B (Overall)|Adverse Event|1|||
23452089|NCT02714569|65398901|FG010|Part B (Overall)|Adverse Event|0|||
23452090|NCT01338818|65398912|FG000|Overall Study|Adverse Event|8|||
23452091|NCT01338818|65398912|FG000|Overall Study|Lack of Efficacy|5|||
23452092|NCT01338818|65398912|FG000|Overall Study|no longer require study drug|1|||
23452093|NCT01338818|65398912|FG000|Overall Study|Withdrawal by Subject|11|||
23452094|NCT01338818|65398912|FG000|Overall Study|Lost to Follow-up|4|||
23452095|NCT01338818|65398912|FG000|Overall Study|Administrative problems|3|||
23452096|NCT01338818|65398912|FG000|Overall Study|Protocol Deviation|4|||
23452097|NCT00248495|65398913|FG000|Overall Study|Withdrawal by Subject|1|||
23781140|NCT03104374|66580158|FG003|Overall Study|Lost to Follow-up|8|||
23781141|NCT03104374|66580155|FG000|Overall Study|Lack of Efficacy|6|||
23452098|NCT01574274|65398914|FG000|Overall Study|Ineligible|0|||
23452099|NCT01574274|65398915|FG001|Overall Study|Ineligible|1|||
23452100|NCT01574274|65398914|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
23452101|NCT01574274|65398915|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
23452102|NCT01574274|65398914|FG000|Overall Study|Ph+ B-ALL|3|||
23452103|NCT01574274|65398915|FG001|Overall Study|Ph+ B-ALL|4|||
23452104|NCT01574274|65398914|FG000|Overall Study|Induction Death|2|||
23452105|NCT01574274|65398915|FG001|Overall Study|Induction Death|0|||
23452106|NCT01574274|65398914|FG000|Overall Study|Induction Failure|4|||
23452107|NCT01574274|65398915|FG001|Overall Study|Induction Failure|1|||
23452108|NCT01574274|65398914|FG000|Overall Study|Adverse Event|16|||
23452109|NCT01574274|65398915|FG001|Overall Study|Adverse Event|13|||
23452110|NCT01574274|65398914|FG000|Overall Study|Remission Death|1|||
23452111|NCT01574274|65398915|FG001|Overall Study|Remission Death|0|||
23452112|NCT01574274|65398914|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
23452113|NCT01574274|65398915|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
23452114|NCT01574274|65398914|FG000|Overall Study|Other, unknown|3|||
23452115|NCT01574274|65398915|FG001|Overall Study|Other, unknown|2|||
23452116|NCT02903160|65398916|FG000|Overall Study|Adverse Event|2|||
23452117|NCT02903160|65398916|FG000|Overall Study|Death|1|||
23452118|NCT02903160|65398916|FG000|Overall Study|Lost to Follow-up|2|||
23452119|NCT02903160|65398916|FG000|Overall Study|Withdrawal by Subject|1|||
23452120|NCT02903160|65398916|FG000|Overall Study|Medical Insurance Barriers|1|||
23580644|NCT04978363|65853558|FG003|Overall Study|Other medical issues unrelated to the study|0|||
23580645|NCT04978363|65853559|FG004|Overall Study|Other medical issues unrelated to the study|1|||
23452121|NCT01724866|65398917|FG000|Overall Study|Adverse Event|0|||
23452122|NCT01724866|65398918|FG001|Overall Study|Adverse Event|0|||
23452123|NCT01724866|65398919|FG002|Overall Study|Adverse Event|1|||
23452124|NCT01724866|65398920|FG003|Overall Study|Adverse Event|1|||
23452125|NCT01724866|65398917|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452126|NCT01724866|65398918|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
23580646|NCT04978363|65853560|FG005|Overall Study|Other medical issues unrelated to the study|0|||
23580647|NCT04978363|65853561|FG006|Overall Study|Other medical issues unrelated to the study|0|||
23452127|NCT01724866|65398919|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452128|NCT01724866|65398920|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452129|NCT01724866|65398917|FG000|Overall Study|Investigator's Discretion|0|||
23452130|NCT01724866|65398918|FG001|Overall Study|Investigator's Discretion|1|||
23452131|NCT01724866|65398919|FG002|Overall Study|Investigator's Discretion|1|||
23452132|NCT01724866|65398920|FG003|Overall Study|Investigator's Discretion|0|||
23452133|NCT01724866|65398917|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
23452134|NCT01724866|65398918|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23635592|NCT04617275|66049468|FG004|Follow-up Period|Adverse Event|4|||
23635593|NCT04617275|66049469|FG005|Follow-up Period|Adverse Event|3|||
23635594|NCT04617275|66049470|FG006|Follow-up Period|Adverse Event|0|||
23452135|NCT01724866|65398919|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23452136|NCT01724866|65398920|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23452137|NCT01724866|65398917|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
23452138|NCT01724866|65398918|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
23635595|NCT04617275|66049471|FG007|Follow-up Period|Adverse Event|3|||
23635596|NCT04617275|66049464|FG000|Follow-up Period|Lost to Follow-up|0|||
23635597|NCT04617275|66049465|FG001|Follow-up Period|Lost to Follow-up|1|||
23452139|NCT01724866|65398919|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
23452140|NCT01724866|65398920|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
23452141|NCT01917747|65398921|FG000|Overall Study|Withdrawal by Subject|1|||
23452142|NCT01917747|65398922|FG001|Overall Study|Withdrawal by Subject|2|||
23452143|NCT01917747|65398921|FG000|Overall Study|Lost to Follow-up|18|||
23452144|NCT01917747|65398922|FG001|Overall Study|Lost to Follow-up|9|||
23452145|NCT00791388|65398925|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452146|NCT00791388|65398926|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
23452147|NCT00791388|65398927|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452148|NCT00791388|65398928|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452149|NCT00791388|65398929|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452150|NCT00791388|65398925|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
23452151|NCT00791388|65398926|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452152|NCT00791388|65398927|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452153|NCT00791388|65398928|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452154|NCT00791388|65398929|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452155|NCT00791388|65398925|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452156|NCT00791388|65398926|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452157|NCT00791388|65398927|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452158|NCT00791388|65398928|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452159|NCT00791388|65398929|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
23452160|NCT00668148|65398932|FG000|Overall Study|Adverse Event|5|||
23452161|NCT00668148|65398932|FG000|Overall Study|Subject Non-compliance|1|||
23452162|NCT00668148|65398932|FG000|Overall Study|Progressive Disease Before Treatment|2|||
23452163|NCT00668148|65398932|FG000|Overall Study|Withdrawal of Consent|2|||
23452164|NCT02349633|65398935|FG000|Overall Study|Death|0|||
23452165|NCT02349633|65398936|FG001|Overall Study|Death|1|||
23452166|NCT02349633|65398937|FG002|Overall Study|Death|0|||
23452167|NCT02349633|65398938|FG003|Overall Study|Death|0|||
23452168|NCT02349633|65398939|FG004|Overall Study|Death|0|||
23452169|NCT02349633|65398940|FG005|Overall Study|Death|1|||
23452170|NCT02349633|65398941|FG006|Overall Study|Death|1|||
23452171|NCT02349633|65398942|FG007|Overall Study|Death|1|||
23452172|NCT02349633|65398943|FG008|Overall Study|Death|0|||
23452173|NCT02349633|65398944|FG009|Overall Study|Death|1|||
23452174|NCT02349633|65398945|FG010|Overall Study|Death|0|||
23452175|NCT02349633|65398946|FG011|Overall Study|Death|0|||
23452176|NCT02349633|65398947|FG012|Overall Study|Death|0|||
23635598|NCT04617275|66049466|FG002|Follow-up Period|Lost to Follow-up|2|||
23635599|NCT04617275|66049467|FG003|Follow-up Period|Lost to Follow-up|0|||
23635600|NCT04617275|66049468|FG004|Follow-up Period|Lost to Follow-up|0|||
23635601|NCT04617275|66049469|FG005|Follow-up Period|Lost to Follow-up|4|||
23635602|NCT04617275|66049470|FG006|Follow-up Period|Lost to Follow-up|0|||
23635603|NCT04617275|66049471|FG007|Follow-up Period|Lost to Follow-up|3|||
23635604|NCT04617275|66049464|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
23635605|NCT04617275|66049465|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
23635606|NCT04617275|66049466|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
23452177|NCT02349633|65398948|FG013|Overall Study|Death|0|||
23452178|NCT02349633|65398935|FG000|Overall Study|Withdrawal by Subject|0|||
23635607|NCT04617275|66049467|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
23635608|NCT04617275|66049468|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
23781142|NCT03104374|66580156|FG001|Overall Study|Lack of Efficacy|7|||
23580648|NCT04978363|65853562|FG007|Overall Study|Other medical issues unrelated to the study|0|||
23580649|NCT04978363|65853563|FG008|Overall Study|Other medical issues unrelated to the study|0|||
23580650|NCT04978363|65853564|FG009|Overall Study|Other medical issues unrelated to the study|0|||
23580651|NCT04978363|65853565|FG010|Overall Study|Other medical issues unrelated to the study|0|||
23580652|NCT04978363|65853555|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
23580653|NCT04978363|65853556|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
23580654|NCT04978363|65853557|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
23580655|NCT04978363|65853558|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
23580656|NCT04978363|65853559|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
23580657|NCT04978363|65853560|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
23580658|NCT04978363|65853561|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
23580659|NCT04978363|65853562|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
23580660|NCT04978363|65853563|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
23580661|NCT04978363|65853564|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
23580662|NCT04978363|65853565|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
23580663|NCT04978363|65853555|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580664|NCT04978363|65853556|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
23580665|NCT04978363|65853557|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580666|NCT04978363|65853558|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580667|NCT04978363|65853559|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580668|NCT04978363|65853560|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580669|NCT04978363|65853561|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580670|NCT04978363|65853562|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580671|NCT04978363|65853563|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580672|NCT04978363|65853564|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580673|NCT04978363|65853565|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580674|NCT00561574|65853571|FG000|Overall Study|Adverse Event|21|||
23580675|NCT00561574|65853572|FG001|Overall Study|Adverse Event|24|||
23580676|NCT00561574|65853571|FG000|Overall Study|Lack of Efficacy|11|||
23580677|NCT00561574|65853572|FG001|Overall Study|Lack of Efficacy|21|||
23580678|NCT00561574|65853571|FG000|Overall Study|Withdrawal by Subject|4|||
23580679|NCT00561574|65853572|FG001|Overall Study|Withdrawal by Subject|4|||
23580680|NCT00561574|65853571|FG000|Overall Study|Reason Unrelated to Trial|6|||
23580681|NCT00561574|65853572|FG001|Overall Study|Reason Unrelated to Trial|2|||
23580682|NCT00561574|65853571|FG000|Overall Study|Lost to Follow-up|1|||
23580683|NCT00561574|65853572|FG001|Overall Study|Lost to Follow-up|0|||
23580684|NCT00561574|65853571|FG000|Overall Study|Other|5|||
23580685|NCT00561574|65853572|FG001|Overall Study|Other|7|||
23580686|NCT01253200|65853575|FG000|Overall Study|Death|1|||
23580687|NCT01253200|65853576|FG001|Overall Study|Death|0|||
23580688|NCT01253200|65853577|FG002|Overall Study|Death|0|||
23580689|NCT01253200|65853578|FG003|Overall Study|Death|0|||
23580690|NCT01253200|65853579|FG004|Overall Study|Death|0|||
23580691|NCT01253200|65853575|FG000|Overall Study|Lost to Follow-up|1|||
23580692|NCT01253200|65853576|FG001|Overall Study|Lost to Follow-up|1|||
23580693|NCT01253200|65853577|FG002|Overall Study|Lost to Follow-up|0|||
23580694|NCT01253200|65853578|FG003|Overall Study|Lost to Follow-up|0|||
23580695|NCT01253200|65853579|FG004|Overall Study|Lost to Follow-up|0|||
23580696|NCT01253200|65853575|FG000|Overall Study|Withdrawal by Subject|2|||
23580697|NCT01253200|65853576|FG001|Overall Study|Withdrawal by Subject|0|||
23580698|NCT01253200|65853577|FG002|Overall Study|Withdrawal by Subject|0|||
23580699|NCT01253200|65853578|FG003|Overall Study|Withdrawal by Subject|0|||
23580700|NCT01253200|65853579|FG004|Overall Study|Withdrawal by Subject|0|||
23580701|NCT01253200|65853575|FG000|Overall Study|Protocol Violation|1|||
23580702|NCT01253200|65853576|FG001|Overall Study|Protocol Violation|4|||
23580703|NCT01253200|65853577|FG002|Overall Study|Protocol Violation|0|||
23580704|NCT01253200|65853578|FG003|Overall Study|Protocol Violation|0|||
23580705|NCT01253200|65853579|FG004|Overall Study|Protocol Violation|5|||
23580706|NCT01253200|65853575|FG000|Overall Study|intents|10|||
23580707|NCT01253200|65853576|FG001|Overall Study|intents|10|||
23580708|NCT01253200|65853577|FG002|Overall Study|intents|1|||
23580709|NCT01253200|65853578|FG003|Overall Study|intents|3|||
23580710|NCT01253200|65853579|FG004|Overall Study|intents|0|||
23781143|NCT03104374|66580157|FG002|Overall Study|Lack of Efficacy|12|||
23781144|NCT03104374|66580158|FG003|Overall Study|Lack of Efficacy|6|||
23580711|NCT01253200|65853575|FG000|Overall Study|Attempts|6|||
23580712|NCT01253200|65853576|FG001|Overall Study|Attempts|4|||
23580713|NCT01253200|65853577|FG002|Overall Study|Attempts|1|||
23580714|NCT01253200|65853578|FG003|Overall Study|Attempts|2|||
23580715|NCT01253200|65853579|FG004|Overall Study|Attempts|0|||
23580716|NCT00601640|65853580|FG000|Overall Study|Withdrawal by Subject|3|||
23580717|NCT00601640|65853581|FG001|Overall Study|Withdrawal by Subject|0|||
23580718|NCT00601640|65853582|FG002|Overall Study|Withdrawal by Subject|7|||
23635609|NCT04617275|66049469|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
23635610|NCT04617275|66049470|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
23635611|NCT04617275|66049471|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
23635612|NCT04617275|66049464|FG000|Follow-up Period|Other|0|||
23635613|NCT04617275|66049465|FG001|Follow-up Period|Other|1|||
23635614|NCT04617275|66049466|FG002|Follow-up Period|Other|0|||
23635615|NCT04617275|66049467|FG003|Follow-up Period|Other|0|||
23635616|NCT04617275|66049468|FG004|Follow-up Period|Other|0|||
23635617|NCT04617275|66049469|FG005|Follow-up Period|Other|0|||
23635618|NCT04617275|66049470|FG006|Follow-up Period|Other|0|||
23635619|NCT04617275|66049471|FG007|Follow-up Period|Other|0|||
23635620|NCT04617275|66049464|FG000|Follow-up Period|Withdrawal by Subject|2|||
23635621|NCT04617275|66049465|FG001|Follow-up Period|Withdrawal by Subject|0|||
23635622|NCT04617275|66049466|FG002|Follow-up Period|Withdrawal by Subject|0|||
23635623|NCT04617275|66049467|FG003|Follow-up Period|Withdrawal by Subject|2|||
23635624|NCT04617275|66049468|FG004|Follow-up Period|Withdrawal by Subject|2|||
23635625|NCT04617275|66049469|FG005|Follow-up Period|Withdrawal by Subject|0|||
23635626|NCT04617275|66049470|FG006|Follow-up Period|Withdrawal by Subject|1|||
23635627|NCT04617275|66049471|FG007|Follow-up Period|Withdrawal by Subject|2|||
23635628|NCT02817906|66049472|FG000|Overall Study|Adverse Event|3|||
23635629|NCT02817906|66049473|FG001|Overall Study|Adverse Event|0|||
23635630|NCT02817906|66049472|FG000|Overall Study|Lack of Efficacy|1|||
23635631|NCT02817906|66049473|FG001|Overall Study|Lack of Efficacy|0|||
23635632|NCT02817906|66049472|FG000|Overall Study|Protocol Violation|1|||
23635633|NCT02817906|66049473|FG001|Overall Study|Protocol Violation|1|||
23635634|NCT02817906|66049472|FG000|Overall Study|Study Terminated by Sponsor|2|||
23635635|NCT02817906|66049473|FG001|Overall Study|Study Terminated by Sponsor|2|||
23635636|NCT02817906|66049472|FG000|Overall Study|Withdrawal by Subject|7|||
23635637|NCT02817906|66049473|FG001|Overall Study|Withdrawal by Subject|0|||
23635638|NCT02817906|66049472|FG000|Overall Study|Other|2|||
23635639|NCT02817906|66049473|FG001|Overall Study|Other|2|||
23635640|NCT01606670|66049474|FG000|Overall Study|Adverse Event|6|||
23781145|NCT03104374|66580155|FG000|Overall Study|Other|2|||
23781146|NCT03104374|66580156|FG001|Overall Study|Other|2|||
23781147|NCT03104374|66580157|FG002|Overall Study|Other|4|||
23580719|NCT00601640|65853580|FG000|Overall Study|Death|1|||
23580720|NCT00601640|65853581|FG001|Overall Study|Death|0|||
23580721|NCT00601640|65853582|FG002|Overall Study|Death|0|||
23580722|NCT00601640|65853580|FG000|Overall Study|Adverse Event|0|||
23580723|NCT00601640|65853581|FG001|Overall Study|Adverse Event|4|||
23580724|NCT00601640|65853582|FG002|Overall Study|Adverse Event|2|||
23580725|NCT00601640|65853580|FG000|Overall Study|intercurrent illness|1|||
23580726|NCT00601640|65853581|FG001|Overall Study|intercurrent illness|0|||
23580727|NCT00601640|65853582|FG002|Overall Study|intercurrent illness|0|||
23580728|NCT00601640|65853580|FG000|Overall Study|change in eligibility status|0|||
23580729|NCT00601640|65853581|FG001|Overall Study|change in eligibility status|1|||
23580730|NCT00601640|65853582|FG002|Overall Study|change in eligibility status|1|||
23580731|NCT00367237|65853583|FG000|Overall Study|Adverse Event|7|||
23580732|NCT00367237|65853584|FG001|Overall Study|Adverse Event|2|||
23580733|NCT00367237|65853583|FG000|Overall Study|Lost to Follow-up|1|||
23580734|NCT00367237|65853584|FG001|Overall Study|Lost to Follow-up|0|||
23580735|NCT00367237|65853583|FG000|Overall Study|Withdrawal by Subject|0|||
23580736|NCT00367237|65853584|FG001|Overall Study|Withdrawal by Subject|4|||
23580737|NCT00367237|65853583|FG000|Overall Study|Protocol Violation|2|||
23580738|NCT00367237|65853584|FG001|Overall Study|Protocol Violation|5|||
23580739|NCT00558753|65853585|FG000|Overall Study|Lost to Follow-up|5|||
23580740|NCT00558753|65853586|FG001|Overall Study|Lost to Follow-up|7|||
23580741|NCT02757885|65853589|FG000|Overall Study|Screen Failures|4|||
23580742|NCT04730947|65853595|FG000|Overall Study|Withdrawal by Subject|0|||
23580743|NCT04730947|65853596|FG001|Overall Study|Withdrawal by Subject|1|||
23580744|NCT01021878|65853597|FG000|Overall Study|Lost to Follow-up|4|||
23580745|NCT01021878|65853598|FG001|Overall Study|Lost to Follow-up|3|||
23580746|NCT01021878|65853597|FG000|Overall Study|Death|0|||
23580747|NCT01021878|65853598|FG001|Overall Study|Death|1|||
23580748|NCT01021878|65853597|FG000|Overall Study|Adverse Event|6|||
23580749|NCT01021878|65853598|FG001|Overall Study|Adverse Event|5|||
23580750|NCT01021878|65853597|FG000|Overall Study|Transplantation|6|||
23580751|NCT01021878|65853598|FG001|Overall Study|Transplantation|1|||
23580752|NCT01268566|65853602|FG000|Overall Study|Lost to Follow-up|1|||
23580753|NCT01268566|65853602|FG000|Overall Study|Withdrawal by Subject|12|||
23635641|NCT01606670|66049474|FG000|Overall Study|Lack of Efficacy|2|||
23635642|NCT01606670|66049474|FG000|Overall Study|Lost to Follow-up|3|||
23635643|NCT01606670|66049474|FG000|Overall Study|Withdrawal by Subject|3|||
23635644|NCT01606670|66049474|FG000|Overall Study|Other Reason|2|||
23635645|NCT02416453|66049476|FG000|Overall Study|Adverse Event|0|||
23635646|NCT02416453|66049477|FG001|Overall Study|Adverse Event|0|||
23635647|NCT02416453|66049478|FG002|Overall Study|Adverse Event|0|||
23635648|NCT02416453|66049479|FG003|Overall Study|Adverse Event|2|||
23635649|NCT02416453|66049480|FG004|Overall Study|Adverse Event|0|||
23635650|NCT02416453|66049481|FG005|Overall Study|Adverse Event|1|||
23580754|NCT01268566|65853602|FG000|Overall Study|Death|30|||
23580755|NCT00162942|65853607|FG000|Overall Study|Adverse Event|10|||
23580756|NCT00162942|65853608|FG001|Overall Study|Adverse Event|6|||
23580757|NCT00162942|65853607|FG000|Overall Study|Death|1|||
23580758|NCT00162942|65853608|FG001|Overall Study|Death|0|||
23580759|NCT00162942|65853607|FG000|Overall Study|Withdrawal by Subject|3|||
23635651|NCT02416453|66049482|FG006|Overall Study|Adverse Event|0|||
23635652|NCT02416453|66049483|FG007|Overall Study|Adverse Event|0|||
23635653|NCT02416453|66049484|FG008|Overall Study|Adverse Event|0|||
23635654|NCT02416453|66049485|FG009|Overall Study|Adverse Event|0|||
23635655|NCT02416453|66049486|FG010|Overall Study|Adverse Event|0|||
23635656|NCT02416453|66049476|FG000|Overall Study|Lost to Follow-up|1|||
23635657|NCT02416453|66049477|FG001|Overall Study|Lost to Follow-up|3|||
23781148|NCT03104374|66580158|FG003|Overall Study|Other|7|||
23781149|NCT00245063|66580159|FG000|Overall Study|Adverse Event|6|||
23781150|NCT00245063|66580160|FG001|Overall Study|Adverse Event|5|||
23781151|NCT00245063|66580159|FG000|Overall Study|Death|1|||
23781152|NCT00245063|66580160|FG001|Overall Study|Death|0|||
23781153|NCT01444378|66580162|FG000|Overall Study|Lost to Follow-up|1|||
23781154|NCT01444378|66580162|FG000|Overall Study|Withdrawal by Subject|1|||
23781155|NCT01444378|66580162|FG000|Overall Study|Death|3|||
23781156|NCT01444378|66580162|FG000|Overall Study|Administrative Closure Of The Study|2|||
23781157|NCT01444378|66580162|FG000|Overall Study|Missed Visits|10|||
23781158|NCT01802320|66580163|FG000|Overall Study|Death|1|||
23841419|NCT02049814|66798600|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
23841420|NCT02049814|66798599|FG000|Overall Study|Voluntary withdrawal|9|||
23580760|NCT00162942|65853608|FG001|Overall Study|Withdrawal by Subject|6|||
23580761|NCT00162942|65853607|FG000|Overall Study|Physician Decision|1|||
23580762|NCT00162942|65853608|FG001|Overall Study|Physician Decision|0|||
23580763|NCT00162942|65853607|FG000|Overall Study|Enter Open-Label Study|76|||
23580764|NCT00162942|65853608|FG001|Overall Study|Enter Open-Label Study|35|||
23580765|NCT00162942|65853607|FG000|Overall Study|Alternate Therapy|6|||
23580766|NCT00162942|65853608|FG001|Overall Study|Alternate Therapy|2|||
23580767|NCT00162942|65853607|FG000|Overall Study|Lack of Efficacy|1|||
23580768|NCT00162942|65853608|FG001|Overall Study|Lack of Efficacy|0|||
23580769|NCT00162942|65853607|FG000|Overall Study|Flare During Active Treatment|7|||
23580770|NCT00162942|65853608|FG001|Overall Study|Flare During Active Treatment|3|||
23580771|NCT00162942|65853607|FG000|Overall Study|2 or more consecutive treatments missed|1|||
23580772|NCT00162942|65853608|FG001|Overall Study|2 or more consecutive treatments missed|0|||
23580773|NCT02424344|65853609|FG000|Overall Study|Lack of Efficacy|0|||
23580774|NCT02424344|65853610|FG001|Overall Study|Lack of Efficacy|1|||
23580775|NCT02424344|65853609|FG000|Overall Study|Withdrawal by Subject|2|||
23580776|NCT02424344|65853610|FG001|Overall Study|Withdrawal by Subject|1|||
23580777|NCT02424344|65853609|FG000|Overall Study|Lost to Follow-up|1|||
23841421|NCT02049814|66798600|FG001|Overall Study|Voluntary withdrawal|8|||
23841422|NCT01515865|66798614|FG000|Part A (Open-label)|Other|3|||
23841423|NCT01515865|66798615|FG001|Part A (Open-label)|Other|0|||
23841424|NCT01515865|66798616|FG002|Part A (Open-label)|Other|0|||
23841425|NCT01515865|66798614|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
23841426|NCT01515865|66798615|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
23841427|NCT01515865|66798616|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
23580778|NCT02424344|65853610|FG001|Overall Study|Lost to Follow-up|0|||
23580779|NCT02424344|65853609|FG000|Overall Study|Adverse Event|4|||
23580780|NCT02424344|65853610|FG001|Overall Study|Adverse Event|8|||
23580781|NCT01890967|65853611|FG000|Overall Study|Adverse Event|3|||
23841428|NCT01515865|66798614|FG000|Part B (Open-label)|Other|1|||
23841429|NCT01515865|66798615|FG001|Part B (Open-label)|Other|0|||
23841430|NCT01515865|66798616|FG002|Part B (Open-label)|Other|0|||
23841431|NCT01053663|66798617|FG000|Overall Study|Death|2|||
23841432|NCT01053663|66798617|FG000|Overall Study|Lost to Follow-up|1|||
23841433|NCT01053663|66798617|FG000|Overall Study|Poor IV Access|1|||
23841434|NCT01053663|66798617|FG000|Overall Study|Transferred to Another Hospital|1|||
23841435|NCT01053663|66798617|FG000|Overall Study|Negative Influenza Diagnosis|1|||
23841436|NCT02993250|66798618|FG000|Overall Study|Lost to Follow-up|0|||
23841437|NCT02993250|66798619|FG001|Overall Study|Lost to Follow-up|1|||
23580782|NCT01890967|65853612|FG001|Overall Study|Adverse Event|3|||
23580783|NCT01890967|65853613|FG002|Overall Study|Adverse Event|3|||
23580784|NCT01890967|65853614|FG003|Overall Study|Adverse Event|2|||
23580785|NCT01890967|65853615|FG004|Overall Study|Adverse Event|1|||
23781159|NCT01802320|66580163|FG000|Overall Study|Withdrawal by Subject|1|||
23841438|NCT03386994|66798622|FG000|Overall Study|Lung transplant|1|||
23841439|NCT03386994|66798622|FG000|Overall Study|Adverse Event|14|||
23841440|NCT03386994|66798622|FG000|Overall Study|Lost to Follow-up|4|||
23841441|NCT03386994|66798622|FG000|Overall Study|Withdrawal by Subject|3|||
23841442|NCT03386994|66798622|FG000|Overall Study|Death|16|||
23580786|NCT01890967|65853616|FG005|Overall Study|Adverse Event|7|||
23580787|NCT01890967|65853611|FG000|Overall Study|Death|1|||
23635658|NCT02416453|66049478|FG002|Overall Study|Lost to Follow-up|0|||
23781160|NCT01745120|66580164|FG000|Overall Study|Investigator decision|1|||
23841443|NCT04740827|66798626|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
23452179|NCT02349633|65398936|FG001|Overall Study|Withdrawal by Subject|0|||
23452180|NCT02349633|65398937|FG002|Overall Study|Withdrawal by Subject|0|||
23452181|NCT02349633|65398938|FG003|Overall Study|Withdrawal by Subject|1|||
23452182|NCT02349633|65398939|FG004|Overall Study|Withdrawal by Subject|0|||
23452183|NCT02349633|65398940|FG005|Overall Study|Withdrawal by Subject|0|||
23452184|NCT02349633|65398941|FG006|Overall Study|Withdrawal by Subject|0|||
23452185|NCT02349633|65398942|FG007|Overall Study|Withdrawal by Subject|2|||
23452186|NCT02349633|65398943|FG008|Overall Study|Withdrawal by Subject|2|||
23452187|NCT02349633|65398944|FG009|Overall Study|Withdrawal by Subject|1|||
23452188|NCT02349633|65398945|FG010|Overall Study|Withdrawal by Subject|0|||
23452189|NCT02349633|65398946|FG011|Overall Study|Withdrawal by Subject|0|||
23452190|NCT02349633|65398947|FG012|Overall Study|Withdrawal by Subject|0|||
23452191|NCT02349633|65398948|FG013|Overall Study|Withdrawal by Subject|0|||
23452192|NCT02349633|65398935|FG000|Overall Study|Withdrawal of informed consent|0|||
23452193|NCT02349633|65398936|FG001|Overall Study|Withdrawal of informed consent|0|||
23452194|NCT02349633|65398937|FG002|Overall Study|Withdrawal of informed consent|0|||
23452195|NCT02349633|65398938|FG003|Overall Study|Withdrawal of informed consent|1|||
23452196|NCT02349633|65398939|FG004|Overall Study|Withdrawal of informed consent|1|||
23452197|NCT02349633|65398940|FG005|Overall Study|Withdrawal of informed consent|0|||
23452198|NCT02349633|65398941|FG006|Overall Study|Withdrawal of informed consent|0|||
23452199|NCT02349633|65398942|FG007|Overall Study|Withdrawal of informed consent|3|||
23452200|NCT02349633|65398943|FG008|Overall Study|Withdrawal of informed consent|0|||
23452201|NCT02349633|65398944|FG009|Overall Study|Withdrawal of informed consent|0|||
23452202|NCT02349633|65398945|FG010|Overall Study|Withdrawal of informed consent|0|||
23452203|NCT02349633|65398946|FG011|Overall Study|Withdrawal of informed consent|0|||
23452204|NCT02349633|65398947|FG012|Overall Study|Withdrawal of informed consent|0|||
23452205|NCT02349633|65398948|FG013|Overall Study|Withdrawal of informed consent|0|||
23452206|NCT02349633|65398935|FG000|Overall Study|Transition to compassionate use|0|||
23452207|NCT02349633|65398936|FG001|Overall Study|Transition to compassionate use|0|||
23452208|NCT02349633|65398937|FG002|Overall Study|Transition to compassionate use|0|||
23781161|NCT01745120|66580165|FG001|Overall Study|Investigator decision|0|||
23781162|NCT00840632|66580170|FG000|First Intervention|Withdrawal by Subject|0|||
23841444|NCT04740827|66798627|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
23841445|NCT04740827|66798626|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
23841446|NCT04740827|66798627|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
23841447|NCT04740827|66798626|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
23841448|NCT04740827|66798627|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
23841449|NCT04740827|66798626|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
23841450|NCT04740827|66798627|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
23841451|NCT04740827|66798626|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
23841452|NCT04740827|66798627|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
23841453|NCT04740827|66798626|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
23841454|NCT04740827|66798627|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
23841455|NCT02632409|66798628|FG000|Randomized|AE unrelated to study Drug|0|||
23841456|NCT02632409|66798629|FG001|Randomized|AE unrelated to study Drug|1|||
23841457|NCT02632409|66798628|FG000|Randomized|Participant withdrew consent|2|||
23841458|NCT02632409|66798629|FG001|Randomized|Participant withdrew consent|1|||
23781163|NCT00840632|66580171|FG001|First Intervention|Withdrawal by Subject|1|||
23781164|NCT00840632|66580170|FG000|Washout|Withdrawal by Subject|1|||
23781165|NCT00840632|66580171|FG001|Washout|Withdrawal by Subject|1|||
23781166|NCT00579345|66580175|FG000|Overall Study|Withdrawal by Subject|2|||
23781167|NCT00579345|66580176|FG001|Overall Study|Withdrawal by Subject|0|||
23781168|NCT00579345|66580177|FG002|Overall Study|Withdrawal by Subject|0|||
23781169|NCT00579345|66580178|FG003|Overall Study|Withdrawal by Subject|0|||
23781170|NCT00579345|66580179|FG004|Overall Study|Withdrawal by Subject|0|||
23781171|NCT00579345|66580180|FG005|Overall Study|Withdrawal by Subject|0|||
23781172|NCT00579345|66580181|FG006|Overall Study|Withdrawal by Subject|0|||
23781173|NCT00579345|66580182|FG007|Overall Study|Withdrawal by Subject|1|||
23781174|NCT00579345|66580175|FG000|Overall Study|Lost to Follow-up|1|||
23781175|NCT00579345|66580176|FG001|Overall Study|Lost to Follow-up|0|||
23841459|NCT02632409|66798628|FG000|Randomized|No Longer meets study criteria|5|||
23841460|NCT02632409|66798629|FG001|Randomized|No Longer meets study criteria|0|||
23452209|NCT02349633|65398938|FG003|Overall Study|Transition to compassionate use|0|||
23452210|NCT02349633|65398939|FG004|Overall Study|Transition to compassionate use|1|||
23452211|NCT02349633|65398940|FG005|Overall Study|Transition to compassionate use|0|||
23452212|NCT02349633|65398941|FG006|Overall Study|Transition to compassionate use|0|||
23452213|NCT02349633|65398942|FG007|Overall Study|Transition to compassionate use|3|||
23452214|NCT02349633|65398943|FG008|Overall Study|Transition to compassionate use|0|||
23452215|NCT02349633|65398944|FG009|Overall Study|Transition to compassionate use|1|||
23781176|NCT00579345|66580177|FG002|Overall Study|Lost to Follow-up|0|||
23781177|NCT00579345|66580178|FG003|Overall Study|Lost to Follow-up|0|||
23781178|NCT00579345|66580179|FG004|Overall Study|Lost to Follow-up|0|||
23841461|NCT02632409|66798628|FG000|Randomized|other reasons|1|||
23841462|NCT02632409|66798629|FG001|Randomized|other reasons|0|||
23841463|NCT02632409|66798628|FG000|Treatment Period|Ongoing Treatment|20|||
23841464|NCT02632409|66798629|FG001|Treatment Period|Ongoing Treatment|21|||
23841465|NCT02632409|66798628|FG000|Treatment Period|Disease Recurrence|147|||
23841466|NCT02632409|66798629|FG001|Treatment Period|Disease Recurrence|90|||
23841467|NCT02632409|66798628|FG000|Treatment Period|Study Drug Toxicity|8|||
23841468|NCT02632409|66798629|FG001|Treatment Period|Study Drug Toxicity|49|||
23841469|NCT02632409|66798628|FG000|Treatment Period|Death|1|||
23841470|NCT02632409|66798629|FG001|Treatment Period|Death|0|||
23841471|NCT02632409|66798628|FG000|Treatment Period|AE unrelated to study drug|15|||
23841472|NCT02632409|66798629|FG001|Treatment Period|AE unrelated to study drug|16|||
23841473|NCT02632409|66798628|FG000|Treatment Period|Request to discontinue treatment|4|||
23841474|NCT02632409|66798629|FG001|Treatment Period|Request to discontinue treatment|19|||
23841475|NCT02632409|66798628|FG000|Treatment Period|Participant withdrew consent|7|||
23781179|NCT00579345|66580180|FG005|Overall Study|Lost to Follow-up|0|||
23781180|NCT00579345|66580181|FG006|Overall Study|Lost to Follow-up|0|||
23781181|NCT00579345|66580182|FG007|Overall Study|Lost to Follow-up|0|||
23781182|NCT00579345|66580175|FG000|Overall Study|Adverse Event|0|||
23580788|NCT01890967|65853612|FG001|Overall Study|Death|0|||
23580789|NCT01890967|65853613|FG002|Overall Study|Death|0|||
23580790|NCT01890967|65853614|FG003|Overall Study|Death|0|||
23580791|NCT01890967|65853615|FG004|Overall Study|Death|0|||
23580792|NCT01890967|65853616|FG005|Overall Study|Death|0|||
23580793|NCT01890967|65853611|FG000|Overall Study|Lost to Follow-up|1|||
23580794|NCT01890967|65853612|FG001|Overall Study|Lost to Follow-up|1|||
23580795|NCT01890967|65853613|FG002|Overall Study|Lost to Follow-up|1|||
23841476|NCT02632409|66798629|FG001|Treatment Period|Participant withdrew consent|5|||
23841477|NCT02632409|66798628|FG000|Treatment Period|Lost to Follow-up|0|||
23841478|NCT02632409|66798629|FG001|Treatment Period|Lost to Follow-up|1|||
23841479|NCT02632409|66798628|FG000|Treatment Period|Maximum clinical benefit|1|||
23841480|NCT02632409|66798629|FG001|Treatment Period|Maximum clinical benefit|0|||
23841481|NCT02632409|66798628|FG000|Treatment Period|No longer meets study criteria|3|||
23841482|NCT02632409|66798629|FG001|Treatment Period|No longer meets study criteria|0|||
23841483|NCT02632409|66798628|FG000|Treatment Period|Administrative Reason by sponsor|0|||
23841484|NCT02632409|66798629|FG001|Treatment Period|Administrative Reason by sponsor|1|||
23841485|NCT02632409|66798628|FG000|Treatment Period|Other Reasons|10|||
23841486|NCT02632409|66798629|FG001|Treatment Period|Other Reasons|6|||
23841487|NCT03039621|66798630|FG000|Overall Study|Violation of inclusion criteria|3|||
23841488|NCT03039621|66798631|FG001|Overall Study|Violation of inclusion criteria|2|||
23841489|NCT03039621|66798630|FG000|Overall Study|Non-compliance with protocol requirement|4|||
23841490|NCT03039621|66798631|FG001|Overall Study|Non-compliance with protocol requirement|5|||
23841491|NCT03039621|66798630|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
23841492|NCT03039621|66798631|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
23841493|NCT03039621|66798630|FG000|Overall Study|Violation of non-inclusion criteria|1|||
23841494|NCT03039621|66798631|FG001|Overall Study|Violation of non-inclusion criteria|2|||
23841495|NCT00712543|66798634|FG000|Day 8-14|Lost to Follow-up|0|||
23580796|NCT01890967|65853614|FG003|Overall Study|Lost to Follow-up|1|||
23580797|NCT01890967|65853615|FG004|Overall Study|Lost to Follow-up|0|||
23781183|NCT00579345|66580176|FG001|Overall Study|Adverse Event|0|||
23781184|NCT00579345|66580177|FG002|Overall Study|Adverse Event|1|||
23781185|NCT00579345|66580178|FG003|Overall Study|Adverse Event|0|||
23781186|NCT00579345|66580179|FG004|Overall Study|Adverse Event|0|||
23781187|NCT00579345|66580180|FG005|Overall Study|Adverse Event|0|||
23781188|NCT00579345|66580181|FG006|Overall Study|Adverse Event|0|||
23781189|NCT00579345|66580182|FG007|Overall Study|Adverse Event|0|||
23781190|NCT00579345|66580175|FG000|Overall Study|Protocol Violation|1|||
23781191|NCT00579345|66580176|FG001|Overall Study|Protocol Violation|0|||
23781192|NCT00579345|66580177|FG002|Overall Study|Protocol Violation|0|||
23781193|NCT00579345|66580178|FG003|Overall Study|Protocol Violation|0|||
23781194|NCT00579345|66580179|FG004|Overall Study|Protocol Violation|0|||
23781195|NCT00579345|66580180|FG005|Overall Study|Protocol Violation|0|||
23841496|NCT00712543|66798635|FG001|Day 8-14|Lost to Follow-up|2|||
23841497|NCT01166438|66798638|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
23841498|NCT01166438|66798639|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
23841499|NCT01166438|66798638|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
23841500|NCT01166438|66798639|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
23580798|NCT01890967|65853616|FG005|Overall Study|Lost to Follow-up|1|||
23781196|NCT00579345|66580181|FG006|Overall Study|Protocol Violation|0|||
23841501|NCT01166438|66798638|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
23841502|NCT01166438|66798639|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
23841503|NCT01166438|66798638|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
23781197|NCT00579345|66580182|FG007|Overall Study|Protocol Violation|1|||
23781198|NCT00579345|66580175|FG000|Overall Study|Death|1|||
23781199|NCT00579345|66580176|FG001|Overall Study|Death|1|||
23781200|NCT00579345|66580177|FG002|Overall Study|Death|1|||
23841504|NCT01166438|66798639|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
23841505|NCT01166438|66798638|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
23841506|NCT01166438|66798639|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
23841507|NCT01166438|66798638|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
23841508|NCT01166438|66798639|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
23841509|NCT00931255|66798640|FG000|Overall Study|Follow up biopsy not done|2|||
23841510|NCT00931255|66798641|FG001|Overall Study|Follow up biopsy not done|3|||
23841511|NCT02257489|66798642|FG000|Overall Study|Withdrawal by Subject|0|||
23841512|NCT02257489|66798643|FG001|Overall Study|Withdrawal by Subject|0|||
23841513|NCT02257489|66798644|FG002|Overall Study|Withdrawal by Subject|0|||
23841514|NCT02257489|66798645|FG003|Overall Study|Withdrawal by Subject|1|||
23841515|NCT02257489|66798646|FG004|Overall Study|Withdrawal by Subject|0|||
23841516|NCT02257489|66798647|FG005|Overall Study|Withdrawal by Subject|0|||
23841517|NCT02257489|66798648|FG006|Overall Study|Withdrawal by Subject|0|||
23841518|NCT02257489|66798649|FG007|Overall Study|Withdrawal by Subject|0|||
23841519|NCT02257489|66798650|FG008|Overall Study|Withdrawal by Subject|0|||
23841520|NCT01252563|66798651|FG000|Overall Study|Contract Deviation|41|||
23841521|NCT01252563|66798651|FG000|Overall Study|Centralized Registration Deviation|30|||
23841522|NCT01252563|66798651|FG000|Overall Study|Lost to Follow-up|161|||
23841523|NCT01252563|66798651|FG000|Overall Study|No visit after first day of treatment|194|||
23841524|NCT01252563|66798651|FG000|Overall Study|No drug administration|6|||
23841525|NCT05486091|66798654|FG000|Overall Study|Withdrawal by Subject|1|||
23841526|NCT05486091|66798654|FG000|Overall Study|Lost to Follow-up|2|||
23841527|NCT00638404|66798655|FG000|Overall Study|Physician Decision|8|||
23841528|NCT00638404|66798656|FG001|Overall Study|Physician Decision|0|||
23841529|NCT00582816|66798659|FG000|Overall Study|Engraftment Failure|3|||
23841530|NCT00820248|66798660|FG000|Overall Study|No treated|4|||
23841531|NCT00820248|66798661|FG001|Overall Study|No treated|1|||
23841532|NCT01718535|66798666|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
23841533|NCT01718535|66798667|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
23841534|NCT01718535|66798668|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
23841535|NCT01718535|66798669|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
23841536|NCT01718535|66798670|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
23841537|NCT01718535|66798671|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
23841538|NCT01718535|66798672|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
23452216|NCT02349633|65398945|FG010|Overall Study|Transition to compassionate use|0|||
23452217|NCT02349633|65398946|FG011|Overall Study|Transition to compassionate use|0|||
23452218|NCT02349633|65398947|FG012|Overall Study|Transition to compassionate use|0|||
23452219|NCT02349633|65398948|FG013|Overall Study|Transition to compassionate use|0|||
23452220|NCT02349633|65398935|FG000|Overall Study|Early termination of survival follow-up|0|||
23452221|NCT02349633|65398936|FG001|Overall Study|Early termination of survival follow-up|0|||
23452222|NCT02349633|65398937|FG002|Overall Study|Early termination of survival follow-up|0|||
23452223|NCT02349633|65398938|FG003|Overall Study|Early termination of survival follow-up|0|||
23452224|NCT02349633|65398939|FG004|Overall Study|Early termination of survival follow-up|0|||
23580799|NCT01890967|65853611|FG000|Overall Study|Protocol Violation|0|||
23580800|NCT01890967|65853612|FG001|Overall Study|Protocol Violation|3|||
23580801|NCT01890967|65853613|FG002|Overall Study|Protocol Violation|3|||
23580802|NCT01890967|65853614|FG003|Overall Study|Protocol Violation|2|||
23580803|NCT01890967|65853615|FG004|Overall Study|Protocol Violation|4|||
23580804|NCT01890967|65853616|FG005|Overall Study|Protocol Violation|1|||
23580805|NCT01890967|65853611|FG000|Overall Study|Sponsor Decision|2|||
23580806|NCT01890967|65853612|FG001|Overall Study|Sponsor Decision|0|||
23580807|NCT01890967|65853613|FG002|Overall Study|Sponsor Decision|1|||
23580808|NCT01890967|65853614|FG003|Overall Study|Sponsor Decision|3|||
23580809|NCT01890967|65853615|FG004|Overall Study|Sponsor Decision|2|||
23580810|NCT01890967|65853616|FG005|Overall Study|Sponsor Decision|3|||
23580811|NCT01890967|65853611|FG000|Overall Study|Withdrawal by Subject|3|||
23580812|NCT01890967|65853612|FG001|Overall Study|Withdrawal by Subject|4|||
23580813|NCT01890967|65853613|FG002|Overall Study|Withdrawal by Subject|2|||
23580814|NCT01890967|65853614|FG003|Overall Study|Withdrawal by Subject|3|||
23580815|NCT01890967|65853615|FG004|Overall Study|Withdrawal by Subject|3|||
23580816|NCT01890967|65853616|FG005|Overall Study|Withdrawal by Subject|1|||
23580817|NCT04476043|65853619|FG000|Overall Study|Withdrawal by Subject|1|||
23580818|NCT04476043|65853620|FG001|Overall Study|Withdrawal by Subject|3|||
23580819|NCT04476043|65853621|FG002|Overall Study|Withdrawal by Subject|4|||
23580820|NCT04476043|65853622|FG003|Overall Study|Withdrawal by Subject|1|||
23580821|NCT04476043|65853619|FG000|Overall Study|Lost to Follow-up|1|||
23580822|NCT04476043|65853620|FG001|Overall Study|Lost to Follow-up|1|||
23580823|NCT04476043|65853621|FG002|Overall Study|Lost to Follow-up|2|||
23841539|NCT01718535|66798673|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
23841540|NCT01718535|66798674|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
23841541|NCT01718535|66798675|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
23452225|NCT02349633|65398940|FG005|Overall Study|Early termination of survival follow-up|0|||
23452226|NCT02349633|65398941|FG006|Overall Study|Early termination of survival follow-up|0|||
23452227|NCT02349633|65398942|FG007|Overall Study|Early termination of survival follow-up|4|||
23452228|NCT02349633|65398943|FG008|Overall Study|Early termination of survival follow-up|0|||
23452229|NCT02349633|65398944|FG009|Overall Study|Early termination of survival follow-up|0|||
23452230|NCT02349633|65398945|FG010|Overall Study|Early termination of survival follow-up|0|||
23452231|NCT02349633|65398946|FG011|Overall Study|Early termination of survival follow-up|0|||
23452232|NCT02349633|65398947|FG012|Overall Study|Early termination of survival follow-up|0|||
23452233|NCT02349633|65398948|FG013|Overall Study|Early termination of survival follow-up|0|||
23452234|NCT02349633|65398935|FG000|Overall Study|Termination by sponsor|0|||
23452235|NCT02349633|65398936|FG001|Overall Study|Termination by sponsor|0|||
23452236|NCT02349633|65398937|FG002|Overall Study|Termination by sponsor|0|||
23452237|NCT02349633|65398938|FG003|Overall Study|Termination by sponsor|0|||
23452238|NCT02349633|65398939|FG004|Overall Study|Termination by sponsor|0|||
23452239|NCT02349633|65398940|FG005|Overall Study|Termination by sponsor|0|||
23580824|NCT04476043|65853622|FG003|Overall Study|Lost to Follow-up|1|||
23580825|NCT04476043|65853619|FG000|Overall Study|Adverse Event|2|||
23580826|NCT04476043|65853620|FG001|Overall Study|Adverse Event|0|||
23580827|NCT04476043|65853621|FG002|Overall Study|Adverse Event|1|||
23580828|NCT04476043|65853622|FG003|Overall Study|Adverse Event|0|||
23580829|NCT04476043|65853619|FG000|Overall Study|Protocol Violation|0|||
23580830|NCT04476043|65853620|FG001|Overall Study|Protocol Violation|1|||
23580831|NCT04476043|65853621|FG002|Overall Study|Protocol Violation|0|||
23580832|NCT04476043|65853622|FG003|Overall Study|Protocol Violation|0|||
23580833|NCT00582790|65853629|FG000|Overall Study|Rapid progression of disease|1|||
23781201|NCT00579345|66580178|FG003|Overall Study|Death|1|||
23781202|NCT00579345|66580179|FG004|Overall Study|Death|0|||
23781203|NCT00579345|66580180|FG005|Overall Study|Death|0|||
23340238|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23781204|NCT00579345|66580181|FG006|Overall Study|Death|0|||
23340239|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340240|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
23340241|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340242|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340243|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340870|NCT01936181|64992871|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
23452240|NCT02349633|65398941|FG006|Overall Study|Termination by sponsor|0|||
23580834|NCT00480441|65853630|FG000|Screening|Not Eligible|37|||
23580835|NCT00480441|65853631|FG001|Screening|Not Eligible|0|||
23580836|NCT00480441|65853632|FG002|Screening|Not Eligible|0|||
23781205|NCT00579345|66580182|FG007|Overall Study|Death|0|||
23781206|NCT02632344|66580183|FG000|Overall Study|Adverse Event|3|||
23781207|NCT02632344|66580183|FG000|Overall Study|Lack of Efficacy|3|||
23781208|NCT02632344|66580183|FG000|Overall Study|Withdrawal by Subject|2|||
23781209|NCT01954394|66580184|FG000|Overall Study|Enrolled but not treated|1|||
23781210|NCT01954394|66580185|FG001|Overall Study|Enrolled but not treated|0|||
23781211|NCT01954394|66580184|FG000|Overall Study|Adverse Event|10|||
23781212|NCT01954394|66580185|FG001|Overall Study|Adverse Event|23|||
23781213|NCT01954394|66580184|FG000|Overall Study|Poor compliance to protocol|7|||
23781214|NCT01954394|66580185|FG001|Overall Study|Poor compliance to protocol|7|||
23781215|NCT01954394|66580184|FG000|Overall Study|Participant Moved|0|||
23781216|NCT01954394|66580185|FG001|Overall Study|Participant Moved|4|||
23781217|NCT01954394|66580184|FG000|Overall Study|Related to Study Drug administration|2|||
23781218|NCT01954394|66580185|FG001|Overall Study|Related to Study Drug administration|2|||
23781219|NCT01954394|66580184|FG000|Overall Study|Other than specified above|10|||
23781220|NCT01954394|66580185|FG001|Overall Study|Other than specified above|21|||
23781221|NCT00312897|66580186|FG000|Overall Study|Adverse Event|1|||
23781222|NCT00312897|66580187|FG001|Overall Study|Adverse Event|0|||
23580837|NCT00480441|65853630|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
23580838|NCT00480441|65853631|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
23635659|NCT02416453|66049479|FG003|Overall Study|Lost to Follow-up|8|||
23781223|NCT00312897|66580186|FG000|Overall Study|Lost to Follow-up|2|||
23781224|NCT00312897|66580187|FG001|Overall Study|Lost to Follow-up|0|||
23781225|NCT00312897|66580186|FG000|Overall Study|Physician Decision|1|||
23781226|NCT00312897|66580187|FG001|Overall Study|Physician Decision|0|||
23781227|NCT00312897|66580186|FG000|Overall Study|Withdrawal by Subject|1|||
23781228|NCT00312897|66580187|FG001|Overall Study|Withdrawal by Subject|3|||
23781229|NCT00312897|66580186|FG000|Overall Study|Pregnancy|1|||
23781230|NCT00312897|66580187|FG001|Overall Study|Pregnancy|0|||
23781231|NCT00312897|66580186|FG000|Overall Study|discontinued prior to getting treatment|0|||
23781232|NCT00312897|66580187|FG001|Overall Study|discontinued prior to getting treatment|3|||
23781233|NCT00640562|66580188|FG000|Overall Study|Adverse Event|8|||
23841542|NCT01680861|66798676|FG000|Early Post-transplant Period|Protocol Violation|1|||
23841543|NCT01680861|66798677|FG001|Early Post-transplant Period|Protocol Violation|1|||
23841544|NCT01062113|66798678|FG000|Overall Study|Adverse Event|1|||
23841545|NCT01062113|66798679|FG001|Overall Study|Adverse Event|0|||
23841546|NCT01062113|66798680|FG002|Overall Study|Adverse Event|0|||
23841547|NCT01062113|66798678|FG000|Overall Study|Lack of Efficacy|38|||
23781234|NCT00640562|66580189|FG001|Overall Study|Adverse Event|5|||
23781235|NCT00640562|66580188|FG000|Overall Study|Lack of Efficacy|1|||
23781236|NCT00640562|66580189|FG001|Overall Study|Lack of Efficacy|4|||
23781237|NCT00640562|66580188|FG000|Overall Study|Protocol Violation|2|||
23781238|NCT00640562|66580189|FG001|Overall Study|Protocol Violation|4|||
23781239|NCT00640562|66580188|FG000|Overall Study|Withdrawal by Subject|6|||
23781240|NCT00640562|66580189|FG001|Overall Study|Withdrawal by Subject|10|||
23781241|NCT00640562|66580188|FG000|Overall Study|Known risperidone intolerance|0|||
23781242|NCT00640562|66580189|FG001|Overall Study|Known risperidone intolerance|1|||
23781243|NCT00640562|66580188|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
23781244|NCT00640562|66580189|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
23781245|NCT00640562|66580188|FG000|Overall Study|Low study drug dose|0|||
23781246|NCT00640562|66580189|FG001|Overall Study|Low study drug dose|1|||
23781247|NCT00640562|66580188|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
23781248|NCT00640562|66580189|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
23781249|NCT01702987|66580190|FG000|Overall Study|Withdrawal by Subject|1|||
23781250|NCT01702987|66580191|FG001|Overall Study|Withdrawal by Subject|0|||
23781251|NCT01768858|66580193|FG000|Overall Study|Lost to Follow-up|9|||
23781252|NCT01768858|66580193|FG000|Overall Study|Lack of Efficacy|8|||
23781253|NCT01768858|66580193|FG000|Overall Study|Serious Adverse Event|1|||
23781254|NCT01768858|66580193|FG000|Overall Study|Participant moved to Germany|1|||
23781255|NCT01768858|66580193|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
23781256|NCT01768858|66580193|FG000|Overall Study|Exanthema|1|||
23781257|NCT01768858|66580193|FG000|Overall Study|Withdrawal by Subject|1|||
23781258|NCT01136174|66580194|FG000|Overall Study|Adverse Event|0|||
23781259|NCT01136174|66580195|FG001|Overall Study|Adverse Event|0|||
23781260|NCT01136174|66580196|FG002|Overall Study|Adverse Event|0|||
23781261|NCT01136174|66580197|FG003|Overall Study|Adverse Event|4|||
23781262|NCT01188681|66580198|FG000|Overall Study|bladder cancer|0|||
23781263|NCT01188681|66580199|FG001|Overall Study|bladder cancer|0|||
23781264|NCT01188681|66580200|FG002|Overall Study|bladder cancer|1|||
23781265|NCT01188681|66580201|FG003|Overall Study|bladder cancer|0|||
23781266|NCT01188681|66580198|FG000|Overall Study|Withdrawal by Subject|0|||
23781267|NCT01188681|66580199|FG001|Overall Study|Withdrawal by Subject|0|||
23781268|NCT01188681|66580200|FG002|Overall Study|Withdrawal by Subject|0|||
23781269|NCT01188681|66580201|FG003|Overall Study|Withdrawal by Subject|1|||
23781270|NCT02453386|66580202|FG000|Overall Study|Adverse Event|22|||
23781271|NCT02453386|66580203|FG001|Overall Study|Adverse Event|30|||
23781272|NCT02453386|66580204|FG002|Overall Study|Adverse Event|15|||
23781273|NCT02453386|66580202|FG000|Overall Study|Protocol Violation|1|||
23781274|NCT02453386|66580203|FG001|Overall Study|Protocol Violation|0|||
23781275|NCT02453386|66580204|FG002|Overall Study|Protocol Violation|1|||
23781276|NCT02453386|66580202|FG000|Overall Study|Withdrawal by Subject|10|||
23781277|NCT02453386|66580203|FG001|Overall Study|Withdrawal by Subject|9|||
23781278|NCT02453386|66580204|FG002|Overall Study|Withdrawal by Subject|9|||
23781279|NCT02453386|66580202|FG000|Overall Study|Sponsor Terminated Study|14|||
23781280|NCT02453386|66580203|FG001|Overall Study|Sponsor Terminated Study|8|||
23781281|NCT02453386|66580204|FG002|Overall Study|Sponsor Terminated Study|11|||
23781282|NCT02453386|66580202|FG000|Overall Study|Subject Terminated by Sponsor|1|||
23781283|NCT02453386|66580203|FG001|Overall Study|Subject Terminated by Sponsor|1|||
23781284|NCT02453386|66580204|FG002|Overall Study|Subject Terminated by Sponsor|1|||
23781285|NCT02453386|66580202|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
23781286|NCT02453386|66580203|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
23781287|NCT02453386|66580204|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
23781288|NCT02453386|66580202|FG000|Overall Study|Lost to Follow-up|0|||
23781289|NCT02453386|66580203|FG001|Overall Study|Lost to Follow-up|0|||
23781290|NCT02453386|66580204|FG002|Overall Study|Lost to Follow-up|1|||
23781291|NCT02453386|66580202|FG000|Overall Study|Other|1|||
23781292|NCT02453386|66580203|FG001|Overall Study|Other|0|||
23781293|NCT02453386|66580204|FG002|Overall Study|Other|1|||
23841548|NCT01062113|66798679|FG001|Overall Study|Lack of Efficacy|22|||
23781294|NCT02865850|66580205|FG000|Overall Study|Death|15|||
23781295|NCT02865850|66580206|FG001|Overall Study|Death|19|||
23781296|NCT02865850|66580205|FG000|Overall Study|Withdrawal by Subject|3|||
23781297|NCT02865850|66580206|FG001|Overall Study|Withdrawal by Subject|2|||
23635660|NCT02416453|66049480|FG004|Overall Study|Lost to Follow-up|0|||
23781298|NCT02865850|66580205|FG000|Overall Study|Lost to Follow-up|3|||
23781299|NCT02865850|66580206|FG001|Overall Study|Lost to Follow-up|2|||
23781300|NCT03173547|66580207|FG000|Overall Study|Adverse Event|2|||
23781301|NCT03173547|66580208|FG001|Overall Study|Adverse Event|0|||
23781302|NCT03173547|66580207|FG000|Overall Study|Withdrawal by Subject|2|||
23841549|NCT01062113|66798680|FG002|Overall Study|Lack of Efficacy|31|||
23841550|NCT01062113|66798678|FG000|Overall Study|Withdrawal by Subject|1|||
23841551|NCT01062113|66798679|FG001|Overall Study|Withdrawal by Subject|0|||
23841552|NCT01062113|66798680|FG002|Overall Study|Withdrawal by Subject|0|||
23841553|NCT01938430|66801240|FG000|Overall Study|Randomized but Not Treated|0|||
23841554|NCT01938430|66801241|FG001|Overall Study|Randomized but Not Treated|0|||
23841555|NCT01938430|66801242|FG002|Overall Study|Randomized but Not Treated|0|||
23841556|NCT01938430|66801243|FG003|Overall Study|Randomized but Not Treated|0|||
23841557|NCT01938430|66801244|FG004|Overall Study|Randomized but Not Treated|0|||
23841558|NCT01938430|66801245|FG005|Overall Study|Randomized but Not Treated|0|||
23841559|NCT01938430|66801246|FG006|Overall Study|Randomized but Not Treated|0|||
23841560|NCT01938430|66801247|FG007|Overall Study|Randomized but Not Treated|0|||
23841561|NCT01938430|66801248|FG008|Overall Study|Randomized but Not Treated|0|||
23841562|NCT01938430|66801249|FG009|Overall Study|Randomized but Not Treated|0|||
23841563|NCT01938430|66801250|FG010|Overall Study|Randomized but Not Treated|1|||
23841564|NCT01938430|66801251|FG011|Overall Study|Randomized but Not Treated|0|||
23841565|NCT01938430|66801252|FG012|Overall Study|Randomized but Not Treated|0|||
23841566|NCT01938430|66801253|FG013|Overall Study|Randomized but Not Treated|1|||
23841567|NCT01938430|66801240|FG000|Overall Study|Adverse Event|0|||
23841568|NCT01938430|66801241|FG001|Overall Study|Adverse Event|0|||
23841569|NCT01938430|66801242|FG002|Overall Study|Adverse Event|0|||
23841570|NCT01938430|66801243|FG003|Overall Study|Adverse Event|0|||
23841571|NCT01938430|66801244|FG004|Overall Study|Adverse Event|0|||
23841572|NCT01938430|66801245|FG005|Overall Study|Adverse Event|0|||
23841573|NCT01938430|66801246|FG006|Overall Study|Adverse Event|1|||
23841574|NCT01938430|66801247|FG007|Overall Study|Adverse Event|0|||
23841575|NCT01938430|66801248|FG008|Overall Study|Adverse Event|0|||
23841576|NCT01938430|66801249|FG009|Overall Study|Adverse Event|0|||
23841577|NCT01938430|66801250|FG010|Overall Study|Adverse Event|0|||
23841578|NCT01938430|66801251|FG011|Overall Study|Adverse Event|0|||
23841579|NCT01938430|66801252|FG012|Overall Study|Adverse Event|0|||
23841580|NCT01938430|66801253|FG013|Overall Study|Adverse Event|0|||
23841581|NCT01938430|66801240|FG000|Overall Study|Death|1|||
23841582|NCT01938430|66801241|FG001|Overall Study|Death|2|||
23841583|NCT01938430|66801242|FG002|Overall Study|Death|2|||
23841584|NCT01938430|66801243|FG003|Overall Study|Death|1|||
23841585|NCT01938430|66801244|FG004|Overall Study|Death|0|||
23841586|NCT01938430|66801245|FG005|Overall Study|Death|0|||
23841587|NCT01938430|66801246|FG006|Overall Study|Death|1|||
23841588|NCT01938430|66801247|FG007|Overall Study|Death|1|||
23841589|NCT01938430|66801248|FG008|Overall Study|Death|2|||
23841590|NCT01938430|66801249|FG009|Overall Study|Death|3|||
23841591|NCT01938430|66801250|FG010|Overall Study|Death|0|||
23841592|NCT01938430|66801251|FG011|Overall Study|Death|0|||
23841593|NCT01938430|66801252|FG012|Overall Study|Death|0|||
23841594|NCT01938430|66801253|FG013|Overall Study|Death|0|||
23841595|NCT01938430|66801240|FG000|Overall Study|Investigator's Discretion|0|||
23841596|NCT01938430|66801241|FG001|Overall Study|Investigator's Discretion|0|||
23841597|NCT01938430|66801242|FG002|Overall Study|Investigator's Discretion|1|||
23841598|NCT01938430|66801243|FG003|Overall Study|Investigator's Discretion|0|||
23841599|NCT01938430|66801244|FG004|Overall Study|Investigator's Discretion|0|||
23841600|NCT01938430|66801245|FG005|Overall Study|Investigator's Discretion|0|||
23841601|NCT01938430|66801246|FG006|Overall Study|Investigator's Discretion|0|||
23841602|NCT01938430|66801247|FG007|Overall Study|Investigator's Discretion|0|||
23841603|NCT01938430|66801248|FG008|Overall Study|Investigator's Discretion|0|||
23841604|NCT01938430|66801249|FG009|Overall Study|Investigator's Discretion|0|||
23841605|NCT01938430|66801250|FG010|Overall Study|Investigator's Discretion|0|||
23841606|NCT01938430|66801251|FG011|Overall Study|Investigator's Discretion|0|||
23841607|NCT01938430|66801252|FG012|Overall Study|Investigator's Discretion|0|||
23841608|NCT01938430|66801253|FG013|Overall Study|Investigator's Discretion|0|||
23841609|NCT01938430|66801240|FG000|Overall Study|Lack of Efficacy|3|||
23841610|NCT01938430|66801241|FG001|Overall Study|Lack of Efficacy|1|||
23841611|NCT01938430|66801242|FG002|Overall Study|Lack of Efficacy|1|||
23841612|NCT01938430|66801243|FG003|Overall Study|Lack of Efficacy|1|||
23841613|NCT01938430|66801244|FG004|Overall Study|Lack of Efficacy|0|||
23841614|NCT01938430|66801245|FG005|Overall Study|Lack of Efficacy|0|||
23841615|NCT01938430|66801246|FG006|Overall Study|Lack of Efficacy|0|||
23841616|NCT01938430|66801247|FG007|Overall Study|Lack of Efficacy|0|||
23841617|NCT01938430|66801248|FG008|Overall Study|Lack of Efficacy|1|||
23841618|NCT01938430|66801249|FG009|Overall Study|Lack of Efficacy|0|||
23841619|NCT01938430|66801250|FG010|Overall Study|Lack of Efficacy|2|||
23841620|NCT01938430|66801251|FG011|Overall Study|Lack of Efficacy|1|||
23841621|NCT01938430|66801252|FG012|Overall Study|Lack of Efficacy|0|||
23841622|NCT01938430|66801253|FG013|Overall Study|Lack of Efficacy|0|||
23841623|NCT01938430|66801240|FG000|Overall Study|Lost to Follow-up|0|||
23841624|NCT01938430|66801241|FG001|Overall Study|Lost to Follow-up|0|||
23841625|NCT01938430|66801242|FG002|Overall Study|Lost to Follow-up|1|||
23841626|NCT01938430|66801243|FG003|Overall Study|Lost to Follow-up|0|||
23841627|NCT01938430|66801244|FG004|Overall Study|Lost to Follow-up|0|||
23841628|NCT01938430|66801245|FG005|Overall Study|Lost to Follow-up|1|||
23841629|NCT01938430|66801246|FG006|Overall Study|Lost to Follow-up|0|||
23841630|NCT01938430|66801247|FG007|Overall Study|Lost to Follow-up|0|||
23841631|NCT01938430|66801248|FG008|Overall Study|Lost to Follow-up|0|||
23841632|NCT01938430|66801249|FG009|Overall Study|Lost to Follow-up|0|||
23841633|NCT01938430|66801250|FG010|Overall Study|Lost to Follow-up|0|||
23841634|NCT01938430|66801251|FG011|Overall Study|Lost to Follow-up|0|||
23841635|NCT01938430|66801252|FG012|Overall Study|Lost to Follow-up|0|||
23841636|NCT01938430|66801253|FG013|Overall Study|Lost to Follow-up|0|||
23841637|NCT01938430|66801240|FG000|Overall Study|Withdrew Consent|0|||
23841638|NCT01938430|66801241|FG001|Overall Study|Withdrew Consent|0|||
23841639|NCT01938430|66801242|FG002|Overall Study|Withdrew Consent|0|||
23841640|NCT01938430|66801243|FG003|Overall Study|Withdrew Consent|0|||
23841641|NCT01938430|66801244|FG004|Overall Study|Withdrew Consent|0|||
23841642|NCT01938430|66801245|FG005|Overall Study|Withdrew Consent|0|||
23841643|NCT01938430|66801246|FG006|Overall Study|Withdrew Consent|0|||
23841644|NCT01938430|66801247|FG007|Overall Study|Withdrew Consent|0|||
23841645|NCT01938430|66801248|FG008|Overall Study|Withdrew Consent|1|||
23841646|NCT01938430|66801249|FG009|Overall Study|Withdrew Consent|0|||
23841647|NCT01938430|66801250|FG010|Overall Study|Withdrew Consent|0|||
23841648|NCT01938430|66801251|FG011|Overall Study|Withdrew Consent|0|||
23841649|NCT01938430|66801252|FG012|Overall Study|Withdrew Consent|0|||
23841650|NCT01938430|66801253|FG013|Overall Study|Withdrew Consent|0|||
23340244|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340245|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340246|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23781303|NCT03173547|66580208|FG001|Overall Study|Withdrawal by Subject|2|||
23781304|NCT03987191|66580209|FG000|Overall Study|COVID-19 related research disruption|0|||
23781305|NCT03987191|66580210|FG001|Overall Study|COVID-19 related research disruption|2|||
23781306|NCT01854047|66580211|FG000|Overall Study|Lack of Efficacy|1|||
23781307|NCT01854047|66580212|FG001|Overall Study|Lack of Efficacy|0|||
23781308|NCT01854047|66580213|FG002|Overall Study|Lack of Efficacy|0|||
23781309|NCT01854047|66580214|FG003|Overall Study|Lack of Efficacy|0|||
23781310|NCT01854047|66580215|FG004|Overall Study|Lack of Efficacy|0|||
23781311|NCT01854047|66580211|FG000|Overall Study|Poor compliance to protocol|3|||
23781312|NCT01854047|66580212|FG001|Overall Study|Poor compliance to protocol|0|||
23781313|NCT01854047|66580213|FG002|Overall Study|Poor compliance to protocol|2|||
23781314|NCT01854047|66580214|FG003|Overall Study|Poor compliance to protocol|0|||
23781315|NCT01854047|66580215|FG004|Overall Study|Poor compliance to protocol|0|||
23781316|NCT01854047|66580211|FG000|Overall Study|Adverse Event|5|||
23781317|NCT01854047|66580212|FG001|Overall Study|Adverse Event|4|||
23781318|NCT01854047|66580213|FG002|Overall Study|Adverse Event|6|||
23781319|NCT01854047|66580214|FG003|Overall Study|Adverse Event|10|||
23781320|NCT01854047|66580215|FG004|Overall Study|Adverse Event|7|||
23781321|NCT01854047|66580211|FG000|Overall Study|Randomized but not treated|0|||
23781322|NCT01854047|66580212|FG001|Overall Study|Randomized but not treated|1|||
23781323|NCT01854047|66580213|FG002|Overall Study|Randomized but not treated|2|||
23781324|NCT01854047|66580214|FG003|Overall Study|Randomized but not treated|0|||
23781325|NCT01854047|66580215|FG004|Overall Study|Randomized but not treated|4|||
23781326|NCT01854047|66580211|FG000|Overall Study|Other than specified above|3|||
23781327|NCT01854047|66580212|FG001|Overall Study|Other than specified above|3|||
23781328|NCT01854047|66580213|FG002|Overall Study|Other than specified above|3|||
23781329|NCT01854047|66580214|FG003|Overall Study|Other than specified above|5|||
23781330|NCT01854047|66580215|FG004|Overall Study|Other than specified above|8|||
23781331|NCT00147498|66580216|FG000|Overall Study|Adverse Event|1|||
23781332|NCT00147498|66580217|FG001|Overall Study|Adverse Event|6|||
23781333|NCT00147498|66580218|FG002|Overall Study|Adverse Event|7|||
23781334|NCT00147498|66580219|FG003|Overall Study|Adverse Event|3|||
23781335|NCT00147498|66580216|FG000|Overall Study|Lack of Efficacy|1|||
23781336|NCT00147498|66580217|FG001|Overall Study|Lack of Efficacy|1|||
23781337|NCT00147498|66580218|FG002|Overall Study|Lack of Efficacy|1|||
23781338|NCT00147498|66580219|FG003|Overall Study|Lack of Efficacy|8|||
23781339|NCT00147498|66580216|FG000|Overall Study|Laboratory abnormality|0|||
23781340|NCT00147498|66580217|FG001|Overall Study|Laboratory abnormality|0|||
23781341|NCT00147498|66580218|FG002|Overall Study|Laboratory abnormality|2|||
23781342|NCT00147498|66580219|FG003|Overall Study|Laboratory abnormality|0|||
23781343|NCT00147498|66580216|FG000|Overall Study|Participant defaulted|0|||
23781344|NCT00147498|66580217|FG001|Overall Study|Participant defaulted|1|||
23781345|NCT00147498|66580218|FG002|Overall Study|Participant defaulted|4|||
23781346|NCT00147498|66580219|FG003|Overall Study|Participant defaulted|3|||
23781347|NCT00147498|66580216|FG000|Overall Study|Other|1|||
23841651|NCT00507819|66801254|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
23841652|NCT00507819|66801255|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23781348|NCT00147498|66580217|FG001|Overall Study|Other|1|||
23841653|NCT00427921|66801256|FG000|Overall Study|Adverse Event|26|||
23841654|NCT00427921|66801256|FG000|Overall Study|Withdrawal by Subject|4|||
23841655|NCT00427921|66801256|FG000|Overall Study|Lost to Follow-up|2|||
23841656|NCT00427921|66801256|FG000|Overall Study|Other reason not specified|10|||
23841657|NCT00427921|66801256|FG000|Overall Study|Adverse Event + Hospitalization|1|||
23841658|NCT00427921|66801256|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
23841659|NCT00427921|66801256|FG000|Overall Study|Adverse Event + No Response|1|||
23841660|NCT00427921|66801256|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
23841661|NCT00427921|66801256|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
23841662|NCT00427921|66801256|FG000|Overall Study|Adverse Event + Lost Response|1|||
23580839|NCT00480441|65853632|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
23580840|NCT00480441|65853630|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
23580841|NCT00480441|65853631|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
23580842|NCT00480441|65853632|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
23580843|NCT00480441|65853630|FG000|Baseline Functional MRI|physical contraindication|4|||
23580844|NCT00480441|65853631|FG001|Baseline Functional MRI|physical contraindication|0|||
23580845|NCT00480441|65853632|FG002|Baseline Functional MRI|physical contraindication|0|||
23580846|NCT00480441|65853630|FG000|Randomization|Lost to Follow-up|0|||
23580847|NCT00480441|65853631|FG001|Randomization|Lost to Follow-up|7|||
23580848|NCT00480441|65853632|FG002|Randomization|Lost to Follow-up|2|||
23635661|NCT02416453|66049481|FG005|Overall Study|Lost to Follow-up|5|||
23635662|NCT02416453|66049482|FG006|Overall Study|Lost to Follow-up|1|||
23635663|NCT02416453|66049483|FG007|Overall Study|Lost to Follow-up|3|||
23635664|NCT02416453|66049484|FG008|Overall Study|Lost to Follow-up|1|||
23635665|NCT02416453|66049485|FG009|Overall Study|Lost to Follow-up|0|||
23781349|NCT00147498|66580218|FG002|Overall Study|Other|3|||
23781350|NCT00147498|66580219|FG003|Overall Study|Other|3|||
23781351|NCT00834340|66580220|FG000|Washout|Adverse Event|1|||
23781352|NCT00834340|66580221|FG001|Washout|Adverse Event|0|||
23781353|NCT00834340|66580220|FG000|Washout|Withdrawal by Subject|1|||
23580849|NCT01582243|65853633|FG000|Overall Study|Withdrawal by Subject|1|||
23580850|NCT01582243|65853633|FG000|Overall Study|Adverse Event|1|||
23580851|NCT01582243|65853633|FG000|Overall Study|Lost to Follow-up|1|||
23580852|NCT02788656|65856733|FG000|Overall Study|Withdrawal by Subject|1|||
23635666|NCT02416453|66049486|FG010|Overall Study|Lost to Follow-up|0|||
23635667|NCT02416453|66049476|FG000|Overall Study|Physician Decision|0|||
23635668|NCT02416453|66049477|FG001|Overall Study|Physician Decision|0|||
23635669|NCT02416453|66049478|FG002|Overall Study|Physician Decision|0|||
23635670|NCT02416453|66049479|FG003|Overall Study|Physician Decision|0|||
23635671|NCT02416453|66049480|FG004|Overall Study|Physician Decision|0|||
23635672|NCT02416453|66049481|FG005|Overall Study|Physician Decision|1|||
23635673|NCT02416453|66049482|FG006|Overall Study|Physician Decision|1|||
23635674|NCT02416453|66049483|FG007|Overall Study|Physician Decision|1|||
23635675|NCT02416453|66049484|FG008|Overall Study|Physician Decision|0|||
23781354|NCT00834340|66580221|FG001|Washout|Withdrawal by Subject|0|||
23781355|NCT00574847|66580222|FG000|Overall Study|Adverse Event|2|||
23781356|NCT00574847|66580223|FG001|Overall Study|Adverse Event|0|||
23841663|NCT00427921|66801256|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
23841664|NCT00427921|66801256|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
23841665|NCT02366637|66801257|FG000|First Intervention Period|Adverse Event|0|||
23635676|NCT02416453|66049485|FG009|Overall Study|Physician Decision|0|||
23635677|NCT02416453|66049486|FG010|Overall Study|Physician Decision|0|||
23841666|NCT02366637|66801258|FG001|First Intervention Period|Adverse Event|1|||
23841667|NCT02366637|66801257|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
23841668|NCT02366637|66801258|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
23841669|NCT02366637|66801257|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
23841670|NCT02366637|66801258|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
23841671|NCT02649439|66801260|FG000|Overall Study|Switched to alternative treatment|6|||
23841672|NCT02649439|66801261|FG001|Overall Study|Switched to alternative treatment|4|||
23841673|NCT02649439|66801260|FG000|Overall Study|Patient decision|1|||
23841674|NCT02649439|66801261|FG001|Overall Study|Patient decision|0|||
23841675|NCT02649439|66801260|FG000|Overall Study|Patient going out of country|1|||
23841676|NCT02649439|66801261|FG001|Overall Study|Patient going out of country|0|||
23841677|NCT02649439|66801260|FG000|Overall Study|To start finasteride|1|||
23580853|NCT02788656|65856734|FG001|Overall Study|Withdrawal by Subject|0|||
23580854|NCT01096056|65856735|FG000|Overall Study|Lost to Follow-up|0|||
23580855|NCT01096056|65856736|FG001|Overall Study|Lost to Follow-up|1|||
23580856|NCT00672256|65856739|FG000|Overall Study|PI dropped, bad data|44|||
23580857|NCT04531540|65856756|FG000|Overall Study|Adverse Event|1|||
23635678|NCT02416453|66049476|FG000|Overall Study|Withdrawal by Subject|2|||
23635679|NCT02416453|66049477|FG001|Overall Study|Withdrawal by Subject|0|||
23635680|NCT02416453|66049478|FG002|Overall Study|Withdrawal by Subject|0|||
23580858|NCT04531540|65856756|FG000|Overall Study|Protocol Violation|3|||
23635681|NCT02416453|66049479|FG003|Overall Study|Withdrawal by Subject|5|||
23635682|NCT02416453|66049480|FG004|Overall Study|Withdrawal by Subject|1|||
23781357|NCT00574847|66580222|FG000|Overall Study|Death|1|||
23781358|NCT00574847|66580223|FG001|Overall Study|Death|0|||
23781359|NCT00574847|66580222|FG000|Overall Study|Withdrawal by Subject|2|||
23841678|NCT02649439|66801261|FG001|Overall Study|To start finasteride|0|||
23841679|NCT02649439|66801260|FG000|Overall Study|Physician Decision|1|||
23841680|NCT02649439|66801261|FG001|Overall Study|Physician Decision|0|||
23452241|NCT02349633|65398942|FG007|Overall Study|Termination by sponsor|1|||
23452242|NCT02349633|65398943|FG008|Overall Study|Termination by sponsor|0|||
23452243|NCT02349633|65398944|FG009|Overall Study|Termination by sponsor|2|||
23452244|NCT02349633|65398945|FG010|Overall Study|Termination by sponsor|0|||
23452245|NCT02349633|65398946|FG011|Overall Study|Termination by sponsor|0|||
23452246|NCT02349633|65398947|FG012|Overall Study|Termination by sponsor|0|||
23452247|NCT02349633|65398948|FG013|Overall Study|Termination by sponsor|0|||
23452248|NCT02349633|65398935|FG000|Overall Study|Other|0|||
23452249|NCT02349633|65398936|FG001|Overall Study|Other|0|||
23452250|NCT02349633|65398937|FG002|Overall Study|Other|0|||
23452251|NCT02349633|65398938|FG003|Overall Study|Other|0|||
23452252|NCT02349633|65398939|FG004|Overall Study|Other|0|||
23452253|NCT02349633|65398940|FG005|Overall Study|Other|0|||
23452254|NCT02349633|65398941|FG006|Overall Study|Other|0|||
23452255|NCT02349633|65398942|FG007|Overall Study|Other|2|||
23452256|NCT02349633|65398943|FG008|Overall Study|Other|0|||
23452257|NCT02349633|65398944|FG009|Overall Study|Other|0|||
23452258|NCT02349633|65398945|FG010|Overall Study|Other|0|||
23452259|NCT02349633|65398946|FG011|Overall Study|Other|0|||
23452260|NCT02349633|65398947|FG012|Overall Study|Other|0|||
23452261|NCT02349633|65398948|FG013|Overall Study|Other|0|||
23452262|NCT03623243|65398954|FG000|Overall Study|Adverse Event|15|||
23452263|NCT03623243|65398954|FG000|Overall Study|Guardian Decision|1|||
23452264|NCT03623243|65398954|FG000|Overall Study|New Therapy for Study Indication|1|||
23452265|NCT03623243|65398954|FG000|Overall Study|Protocol Deviation|3|||
23452266|NCT03623243|65398954|FG000|Overall Study|Physician Decision|4|||
23452267|NCT03623243|65398954|FG000|Overall Study|Patient Decision|15|||
23452268|NCT02552966|65398961|FG000|Overall Study|Lost to Follow-up|2|||
23452269|NCT02552966|65398961|FG000|Overall Study|Withdrawal by Subject|3|||
23452270|NCT00660192|65398962|FG000|Overall Study|Lost to Follow-up|2|||
23452271|NCT00660192|65398963|FG001|Overall Study|Lost to Follow-up|3|||
23452272|NCT03084796|65398964|FG000|Overall Study|Adverse Event|4|||
23452273|NCT03084796|65398965|FG001|Overall Study|Adverse Event|5|||
23452274|NCT03084796|65398966|FG002|Overall Study|Adverse Event|6|||
23452275|NCT03084796|65398967|FG003|Overall Study|Adverse Event|2|||
23452276|NCT03084796|65398968|FG004|Overall Study|Adverse Event|3|||
23452277|NCT03084796|65398969|FG005|Overall Study|Adverse Event|5|||
23452278|NCT03084796|65398964|FG000|Overall Study|Withdrawal by Subject|3|||
23452279|NCT03084796|65398965|FG001|Overall Study|Withdrawal by Subject|5|||
23452280|NCT03084796|65398966|FG002|Overall Study|Withdrawal by Subject|2|||
23452281|NCT03084796|65398967|FG003|Overall Study|Withdrawal by Subject|1|||
23452282|NCT03084796|65398968|FG004|Overall Study|Withdrawal by Subject|3|||
23452283|NCT03084796|65398969|FG005|Overall Study|Withdrawal by Subject|0|||
23452284|NCT03084796|65398964|FG000|Overall Study|Protocol Violation|0|||
23452285|NCT03084796|65398965|FG001|Overall Study|Protocol Violation|0|||
23452286|NCT03084796|65398966|FG002|Overall Study|Protocol Violation|1|||
23452287|NCT03084796|65398967|FG003|Overall Study|Protocol Violation|0|||
23452288|NCT03084796|65398968|FG004|Overall Study|Protocol Violation|1|||
23452289|NCT03084796|65398969|FG005|Overall Study|Protocol Violation|1|||
23452290|NCT03084796|65398964|FG000|Overall Study|Lack of Efficacy|0|||
23580859|NCT04531540|65856756|FG000|Overall Study|Withdrawal by Subject|4|||
23580860|NCT04531540|65856756|FG000|Overall Study|Found to be Ineligible|1|||
23580861|NCT00462943|65856757|FG000|Overall Study|Failure to achieve a response|5|||
23580862|NCT00462943|65856758|FG001|Overall Study|Failure to achieve a response|5|||
23580863|NCT00462943|65856759|FG002|Overall Study|Failure to achieve a response|1|||
23580864|NCT00462943|65856757|FG000|Overall Study|Adverse Event|6|||
23580865|NCT00462943|65856758|FG001|Overall Study|Adverse Event|4|||
23580866|NCT00462943|65856759|FG002|Overall Study|Adverse Event|1|||
23580867|NCT00462943|65856757|FG000|Overall Study|Protocol Violation|1|||
23580868|NCT00462943|65856758|FG001|Overall Study|Protocol Violation|0|||
23580869|NCT00462943|65856759|FG002|Overall Study|Protocol Violation|0|||
23580870|NCT00462943|65856757|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
23580871|NCT00462943|65856758|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
23635683|NCT02416453|66049481|FG005|Overall Study|Withdrawal by Subject|8|||
23635684|NCT02416453|66049482|FG006|Overall Study|Withdrawal by Subject|0|||
23635685|NCT02416453|66049483|FG007|Overall Study|Withdrawal by Subject|8|||
23452291|NCT03084796|65398965|FG001|Overall Study|Lack of Efficacy|0|||
23452292|NCT03084796|65398966|FG002|Overall Study|Lack of Efficacy|1|||
23452293|NCT03084796|65398967|FG003|Overall Study|Lack of Efficacy|0|||
23452294|NCT03084796|65398968|FG004|Overall Study|Lack of Efficacy|1|||
23452295|NCT03084796|65398969|FG005|Overall Study|Lack of Efficacy|0|||
23452296|NCT03084796|65398964|FG000|Overall Study|Lost to Follow-up|0|||
23452297|NCT03084796|65398965|FG001|Overall Study|Lost to Follow-up|0|||
23452298|NCT03084796|65398966|FG002|Overall Study|Lost to Follow-up|1|||
23452299|NCT03084796|65398967|FG003|Overall Study|Lost to Follow-up|1|||
23452300|NCT03084796|65398968|FG004|Overall Study|Lost to Follow-up|3|||
23452301|NCT03084796|65398969|FG005|Overall Study|Lost to Follow-up|1|||
23452302|NCT03084796|65398964|FG000|Overall Study|Randomization error|0|||
23452303|NCT03084796|65398965|FG001|Overall Study|Randomization error|0|||
23452304|NCT03084796|65398966|FG002|Overall Study|Randomization error|1|||
23841681|NCT02649439|66801260|FG000|Overall Study|Disease progression on study|12|||
23841682|NCT02649439|66801261|FG001|Overall Study|Disease progression on study|13|||
23841683|NCT02649439|66801260|FG000|Overall Study|Refused further treatment|1|||
23841684|NCT02649439|66801261|FG001|Overall Study|Refused further treatment|0|||
23841685|NCT02649439|66801260|FG000|Overall Study|Refused further follow up|2|||
23841686|NCT02649439|66801261|FG001|Overall Study|Refused further follow up|7|||
23841687|NCT02649439|66801260|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
23841688|NCT02649439|66801261|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
23340247|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
23340248|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340249|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340250|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340251|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340252|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340253|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340254|NCT04526509|64989469|FG000|Enrolled|Study Terminated by Sponsor|0|||
23340255|NCT04526509|64989470|FG001|Enrolled|Study Terminated by Sponsor|0|||
23340256|NCT04526509|64989471|FG002|Enrolled|Study Terminated by Sponsor|0|||
23340257|NCT04526509|64989472|FG003|Enrolled|Study Terminated by Sponsor|0|||
23340258|NCT04526509|64989473|FG004|Enrolled|Study Terminated by Sponsor|0|||
23340259|NCT04526509|64989474|FG005|Enrolled|Study Terminated by Sponsor|0|||
23340260|NCT04526509|64989475|FG006|Enrolled|Study Terminated by Sponsor|1|||
23340261|NCT04526509|64989469|FG000|Enrolled|Death prior to lymphodepletion|0|||
23340262|NCT04526509|64989470|FG001|Enrolled|Death prior to lymphodepletion|0|||
23340263|NCT04526509|64989471|FG002|Enrolled|Death prior to lymphodepletion|0|||
23340264|NCT04526509|64989472|FG003|Enrolled|Death prior to lymphodepletion|1|||
23340265|NCT04526509|64989473|FG004|Enrolled|Death prior to lymphodepletion|0|||
23340266|NCT04526509|64989474|FG005|Enrolled|Death prior to lymphodepletion|0|||
23340267|NCT04526509|64989475|FG006|Enrolled|Death prior to lymphodepletion|0|||
23340268|NCT04526509|64989469|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340269|NCT04526509|64989470|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340270|NCT04526509|64989471|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340271|NCT04526509|64989472|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
23340272|NCT04526509|64989473|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340273|NCT04526509|64989474|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340274|NCT04526509|64989475|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340275|NCT04526509|64989469|FG000|Enrolled|Physician Decision|0|||
23340276|NCT04526509|64989470|FG001|Enrolled|Physician Decision|1|||
23340277|NCT04526509|64989471|FG002|Enrolled|Physician Decision|0|||
23340278|NCT04526509|64989472|FG003|Enrolled|Physician Decision|0|||
23340279|NCT04526509|64989473|FG004|Enrolled|Physician Decision|0|||
23340280|NCT04526509|64989474|FG005|Enrolled|Physician Decision|0|||
23340281|NCT04526509|64989475|FG006|Enrolled|Physician Decision|0|||
23340282|NCT05174949|64989476|FG000|Overall Study|Physician Decision|1|||
23340283|NCT05174949|64989477|FG001|Overall Study|Physician Decision|2|||
23340284|NCT05174949|64989478|FG002|Overall Study|Physician Decision|0|||
23340285|NCT05174949|64989479|FG003|Overall Study|Physician Decision|1|||
23340286|NCT05174949|64989480|FG004|Overall Study|Physician Decision|0|||
23340287|NCT05174949|64989481|FG005|Overall Study|Physician Decision|0|||
23340288|NCT05174949|64989476|FG000|Overall Study|Withdrawal by Subject|0|||
23340289|NCT05174949|64989477|FG001|Overall Study|Withdrawal by Subject|1|||
23340290|NCT05174949|64989478|FG002|Overall Study|Withdrawal by Subject|0|||
23340291|NCT05174949|64989479|FG003|Overall Study|Withdrawal by Subject|0|||
23340292|NCT05174949|64989480|FG004|Overall Study|Withdrawal by Subject|0|||
23340293|NCT05174949|64989481|FG005|Overall Study|Withdrawal by Subject|0|||
23340294|NCT05174949|64989476|FG000|Overall Study|Lost to Follow-up|0|||
23340295|NCT05174949|64989477|FG001|Overall Study|Lost to Follow-up|0|||
23340296|NCT05174949|64989478|FG002|Overall Study|Lost to Follow-up|0|||
23340297|NCT05174949|64989479|FG003|Overall Study|Lost to Follow-up|1|||
23841689|NCT02649439|66801260|FG000|Overall Study|No treatment, per protocol|1|||
23841690|NCT02649439|66801261|FG001|Overall Study|No treatment, per protocol|0|||
23340298|NCT05174949|64989480|FG004|Overall Study|Lost to Follow-up|0|||
23340299|NCT05174949|64989481|FG005|Overall Study|Lost to Follow-up|0|||
23340300|NCT00727844|64989488|FG000|Initial Randomization|Physician Decision|2|||
23340301|NCT00727844|64989489|FG001|Initial Randomization|Physician Decision|0|||
23452305|NCT03084796|65398967|FG003|Overall Study|Randomization error|0|||
23340302|NCT00727844|64989490|FG002|Initial Randomization|Physician Decision|0|||
23340303|NCT00727844|64989491|FG003|Initial Randomization|Physician Decision|0|||
23452306|NCT03084796|65398968|FG004|Overall Study|Randomization error|0|||
23452307|NCT03084796|65398969|FG005|Overall Study|Randomization error|0|||
23452308|NCT01018030|65398970|FG000|Overall Study|Adverse Event|10|||
23452309|NCT01018030|65398971|FG001|Overall Study|Adverse Event|5|||
23452310|NCT01018030|65398972|FG002|Overall Study|Adverse Event|5|||
23452311|NCT01018030|65398970|FG000|Overall Study|Withdrawal by Subject|2|||
23452312|NCT01018030|65398971|FG001|Overall Study|Withdrawal by Subject|2|||
23452313|NCT01018030|65398972|FG002|Overall Study|Withdrawal by Subject|4|||
23452314|NCT01018030|65398970|FG000|Overall Study|Lost to Follow-up|2|||
23452315|NCT01018030|65398971|FG001|Overall Study|Lost to Follow-up|0|||
23452316|NCT01018030|65398972|FG002|Overall Study|Lost to Follow-up|3|||
23452317|NCT01018030|65398970|FG000|Overall Study|Protocol Violation|2|||
23452318|NCT01018030|65398971|FG001|Overall Study|Protocol Violation|1|||
23452319|NCT01018030|65398972|FG002|Overall Study|Protocol Violation|0|||
23452320|NCT01018030|65398970|FG000|Overall Study|Physician Decision|1|||
23452321|NCT01018030|65398971|FG001|Overall Study|Physician Decision|0|||
23452322|NCT01018030|65398972|FG002|Overall Study|Physician Decision|1|||
23452323|NCT01018030|65398970|FG000|Overall Study|Lack of Efficacy|1|||
23452324|NCT01018030|65398971|FG001|Overall Study|Lack of Efficacy|0|||
23452325|NCT01018030|65398972|FG002|Overall Study|Lack of Efficacy|0|||
23452326|NCT01018030|65398970|FG000|Overall Study|Did Not Receive Study Drug|1|||
23452327|NCT01018030|65398971|FG001|Overall Study|Did Not Receive Study Drug|3|||
23452328|NCT01018030|65398972|FG002|Overall Study|Did Not Receive Study Drug|0|||
23452329|NCT00333775|65398973|FG000|Overall Study|Death|144|||
23452330|NCT00333775|65398974|FG001|Overall Study|Death|149|||
23452331|NCT00333775|65398975|FG002|Overall Study|Death|143|||
23452332|NCT00333775|65398973|FG000|Overall Study|In Follow-up When Study Stopped|87|||
23452333|NCT00333775|65398974|FG001|Overall Study|In Follow-up When Study Stopped|92|||
23452334|NCT00333775|65398975|FG002|Overall Study|In Follow-up When Study Stopped|96|||
23452335|NCT00333775|65398973|FG000|Overall Study|Lost to Follow-up|10|||
23452336|NCT00333775|65398974|FG001|Overall Study|Lost to Follow-up|7|||
23452337|NCT00333775|65398975|FG002|Overall Study|Lost to Follow-up|8|||
23452338|NCT01300234|65398983|FG000|Overall Study|Adverse Event|1|||
23452339|NCT01300234|65398984|FG001|Overall Study|Adverse Event|1|||
23452340|NCT01300234|65398983|FG000|Overall Study|Protocol Violation|2|||
23580872|NCT00462943|65856759|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
23580873|NCT00462943|65856757|FG000|Overall Study|Disease Progression|15|||
23580874|NCT00462943|65856758|FG001|Overall Study|Disease Progression|15|||
23580875|NCT00462943|65856759|FG002|Overall Study|Disease Progression|9|||
23580876|NCT00462943|65856757|FG000|Overall Study|Death|5|||
23580877|NCT00462943|65856758|FG001|Overall Study|Death|2|||
23580878|NCT00462943|65856759|FG002|Overall Study|Death|7|||
23580879|NCT00462943|65856757|FG000|Overall Study|Stem Cell Transplant|1|||
23580880|NCT00462943|65856758|FG001|Overall Study|Stem Cell Transplant|1|||
23580881|NCT00462943|65856759|FG002|Overall Study|Stem Cell Transplant|0|||
23580882|NCT00462943|65856757|FG000|Overall Study|Bone Marrow Transplant|1|||
23580883|NCT00462943|65856758|FG001|Overall Study|Bone Marrow Transplant|0|||
23580884|NCT00462943|65856759|FG002|Overall Study|Bone Marrow Transplant|0|||
23580885|NCT00462943|65856757|FG000|Overall Study|Required Lymphocyte Infusion|1|||
23580886|NCT00462943|65856758|FG001|Overall Study|Required Lymphocyte Infusion|0|||
23580887|NCT00462943|65856759|FG002|Overall Study|Required Lymphocyte Infusion|0|||
23580888|NCT00462943|65856757|FG000|Overall Study|Transplant - not specified|1|||
23580889|NCT00462943|65856758|FG001|Overall Study|Transplant - not specified|0|||
23580890|NCT00462943|65856759|FG002|Overall Study|Transplant - not specified|1|||
23580891|NCT00462943|65856757|FG000|Overall Study|Physician Decision|1|||
23635686|NCT02416453|66049484|FG008|Overall Study|Withdrawal by Subject|4|||
23635687|NCT02416453|66049485|FG009|Overall Study|Withdrawal by Subject|0|||
23580892|NCT00462943|65856758|FG001|Overall Study|Physician Decision|0|||
23580893|NCT00462943|65856759|FG002|Overall Study|Physician Decision|0|||
23580894|NCT00462943|65856757|FG000|Overall Study|Withdrawal by Subject|0|||
23580895|NCT00462943|65856758|FG001|Overall Study|Withdrawal by Subject|1|||
23580896|NCT00462943|65856759|FG002|Overall Study|Withdrawal by Subject|0|||
23635688|NCT02416453|66049486|FG010|Overall Study|Withdrawal by Subject|0|||
23452341|NCT01300234|65398984|FG001|Overall Study|Protocol Violation|3|||
23452342|NCT01300234|65398983|FG000|Overall Study|Withdrawal by Subject|5|||
23452343|NCT01300234|65398984|FG001|Overall Study|Withdrawal by Subject|9|||
23452344|NCT01300234|65398983|FG000|Overall Study|Lost to Follow-up|14|||
23452345|NCT01300234|65398984|FG001|Overall Study|Lost to Follow-up|12|||
23452346|NCT01300234|65398983|FG000|Overall Study|Pregnancy|2|||
23452347|NCT01300234|65398984|FG001|Overall Study|Pregnancy|1|||
23452348|NCT01300234|65398983|FG000|Overall Study|Participant reached stopping critera|2|||
23452349|NCT01300234|65398984|FG001|Overall Study|Participant reached stopping critera|0|||
23452350|NCT01300234|65398983|FG000|Overall Study|Participant stopped medication|1|||
23580897|NCT02347943|65856760|FG000|Overall Study|Study was cancelled|140|||
23580898|NCT02347943|65856761|FG001|Overall Study|Study was cancelled|67|||
23580899|NCT02347943|65856762|FG002|Overall Study|Study was cancelled|45|||
23580900|NCT02335268|65856763|FG000|Overall Study|Physician Decision|5|||
23580901|NCT02335268|65856764|FG001|Overall Study|Physician Decision|1|||
23452351|NCT01300234|65398984|FG001|Overall Study|Participant stopped medication|1|||
23580902|NCT02335268|65856763|FG000|Overall Study|Lack of Efficacy|2|||
23841691|NCT02649439|66801260|FG000|Overall Study|PSA DT makes ineligible|0|||
23841692|NCT02649439|66801261|FG001|Overall Study|PSA DT makes ineligible|1|||
23580903|NCT02335268|65856764|FG001|Overall Study|Lack of Efficacy|1|||
23580904|NCT02335268|65856763|FG000|Overall Study|Adverse Event|5|||
23580905|NCT02335268|65856764|FG001|Overall Study|Adverse Event|2|||
23580906|NCT02335268|65856763|FG000|Overall Study|increase blasts|2|||
23580907|NCT02335268|65856764|FG001|Overall Study|increase blasts|0|||
23580908|NCT02335268|65856763|FG000|Overall Study|Withdrawal by Subject|3|||
23580909|NCT02335268|65856764|FG001|Overall Study|Withdrawal by Subject|2|||
23580910|NCT05355805|65856765|FG000|Overall Study|Lost to Follow-up|6|||
23580911|NCT05355805|65856766|FG001|Overall Study|Lost to Follow-up|5|||
23580912|NCT05355805|65856767|FG002|Overall Study|Lost to Follow-up|6|||
23580913|NCT05355805|65856768|FG003|Overall Study|Lost to Follow-up|2|||
23580914|NCT05355805|65856765|FG000|Overall Study|Decision by Sponsor|0|||
23580915|NCT05355805|65856766|FG001|Overall Study|Decision by Sponsor|0|||
23580916|NCT05355805|65856767|FG002|Overall Study|Decision by Sponsor|0|||
23580917|NCT05355805|65856768|FG003|Overall Study|Decision by Sponsor|1|||
23580918|NCT05355805|65856765|FG000|Overall Study|Withdrawal by Subject|7|||
23580919|NCT05355805|65856766|FG001|Overall Study|Withdrawal by Subject|10|||
23580920|NCT05355805|65856767|FG002|Overall Study|Withdrawal by Subject|9|||
23580921|NCT05355805|65856768|FG003|Overall Study|Withdrawal by Subject|2|||
23580922|NCT05355805|65856765|FG000|Overall Study|Missing|0|||
23580923|NCT05355805|65856766|FG001|Overall Study|Missing|0|||
23580924|NCT05355805|65856767|FG002|Overall Study|Missing|1|||
23580925|NCT05355805|65856768|FG003|Overall Study|Missing|0|||
23580926|NCT05355805|65856765|FG000|Overall Study|Ongoing|0|||
23580927|NCT05355805|65856766|FG001|Overall Study|Ongoing|41|||
23580928|NCT05355805|65856767|FG002|Overall Study|Ongoing|38|||
23580929|NCT05355805|65856768|FG003|Overall Study|Ongoing|48|||
23580930|NCT04159506|65856769|FG000|Overall Study|Lost to Follow-up|2|||
23580931|NCT04159506|65856770|FG001|Overall Study|Lost to Follow-up|5|||
23580932|NCT01141660|65856772|FG000|Overall Study|Physician Decision|0|||
23580933|NCT01141660|65856773|FG001|Overall Study|Physician Decision|12|||
23580934|NCT00410384|65856774|FG000|Overall Study|Withdrawal by Subject|28|||
23580935|NCT00410384|65856775|FG001|Overall Study|Withdrawal by Subject|17|||
23580936|NCT00410384|65856776|FG002|Overall Study|Withdrawal by Subject|20|||
23580937|NCT00410384|65856774|FG000|Overall Study|Adverse Event|23|||
23580938|NCT00410384|65856775|FG001|Overall Study|Adverse Event|18|||
23580939|NCT00410384|65856776|FG002|Overall Study|Adverse Event|23|||
23580940|NCT00410384|65856774|FG000|Overall Study|Lack of Efficacy|20|||
23580941|NCT00410384|65856775|FG001|Overall Study|Lack of Efficacy|12|||
23580942|NCT00410384|65856776|FG002|Overall Study|Lack of Efficacy|17|||
23580943|NCT00410384|65856774|FG000|Overall Study|Lack of Compliance|2|||
23580944|NCT00410384|65856775|FG001|Overall Study|Lack of Compliance|2|||
23580945|NCT00410384|65856776|FG002|Overall Study|Lack of Compliance|2|||
23580946|NCT00410384|65856774|FG000|Overall Study|Lost to Follow-up|4|||
23580947|NCT00410384|65856775|FG001|Overall Study|Lost to Follow-up|6|||
23580948|NCT00410384|65856776|FG002|Overall Study|Lost to Follow-up|6|||
23580949|NCT00410384|65856774|FG000|Overall Study|Protocol Violation|6|||
23580950|NCT00410384|65856775|FG001|Overall Study|Protocol Violation|6|||
23580951|NCT00410384|65856776|FG002|Overall Study|Protocol Violation|6|||
23580952|NCT00410384|65856774|FG000|Overall Study|Physician Decision|3|||
23580953|NCT00410384|65856775|FG001|Overall Study|Physician Decision|3|||
23580954|NCT00410384|65856776|FG002|Overall Study|Physician Decision|4|||
23580955|NCT00410384|65856774|FG000|Overall Study|Other|3|||
23580956|NCT00410384|65856775|FG001|Overall Study|Other|8|||
23841693|NCT02649439|66801260|FG000|Overall Study|Rising PSA No Mets|0|||
23841694|NCT02649439|66801261|FG001|Overall Study|Rising PSA No Mets|1|||
23841695|NCT02649439|66801260|FG000|Overall Study|Rising PSA|0|||
23841696|NCT02649439|66801261|FG001|Overall Study|Rising PSA|1|||
23841697|NCT02649439|66801260|FG000|Overall Study|Signed follow up protocol|0|||
23841698|NCT02649439|66801261|FG001|Overall Study|Signed follow up protocol|1|||
23580957|NCT00410384|65856776|FG002|Overall Study|Other|4|||
23580958|NCT00079937|65856777|FG000|Overall Study|Adverse Event|2|||
23580959|NCT00079937|65856778|FG001|Overall Study|Adverse Event|1|||
23580960|NCT00079937|65856777|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23580961|NCT00079937|65856778|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23580962|NCT00079937|65856777|FG000|Overall Study|Subject no longer requires study drug|3|||
23580963|NCT00079937|65856778|FG001|Overall Study|Subject no longer requires study drug|0|||
23580964|NCT00079937|65856777|FG000|Overall Study|Protocol Violation|8|||
23580965|NCT00079937|65856778|FG001|Overall Study|Protocol Violation|6|||
23580966|NCT00079937|65856777|FG000|Overall Study|Withdrawal by Subject|21|||
23580967|NCT00079937|65856778|FG001|Overall Study|Withdrawal by Subject|7|||
23580968|NCT00079937|65856777|FG000|Overall Study|Lost to Follow-up|12|||
23580969|NCT00079937|65856778|FG001|Overall Study|Lost to Follow-up|5|||
23580970|NCT00079937|65856777|FG000|Overall Study|Administrative problems|22|||
23580971|NCT00079937|65856778|FG001|Overall Study|Administrative problems|11|||
23580972|NCT00832780|65856779|FG000|Overall Study|Death|16|||
23841699|NCT02126579|66801262|FG000|Overall Study|disease progression|0|||
23841700|NCT02126579|66801263|FG001|Overall Study|disease progression|0|||
23841701|NCT02126579|66801264|FG002|Overall Study|disease progression|0|||
23841702|NCT02126579|66801265|FG003|Overall Study|disease progression|1|||
23841703|NCT02126579|66801266|FG004|Overall Study|disease progression|0|||
23841704|NCT02126579|66801267|FG005|Overall Study|disease progression|0|||
23841705|NCT02126579|66801268|FG006|Overall Study|disease progression|1|||
23841706|NCT03233529|66801269|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
23841707|NCT03233529|66801269|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
23841708|NCT01387516|66801273|FG000|Overall Study|Lost to Follow-up|4|||
23452352|NCT01300234|65398983|FG000|Overall Study|Participant refused return to hospital|1|||
23841709|NCT01387516|66801274|FG001|Overall Study|Lost to Follow-up|4|||
23841710|NCT01387516|66801275|FG002|Overall Study|Lost to Follow-up|2|||
23841711|NCT01387516|66801276|FG003|Overall Study|Lost to Follow-up|3|||
23841712|NCT01387516|66801273|FG000|Overall Study|Withdrawal by Subject|1|||
23340304|NCT00174967|64989492|FG000|Overall Study|Adverse Event|1|||
23340305|NCT00174967|64989493|FG001|Overall Study|Adverse Event|2|||
23340306|NCT00174967|64989494|FG002|Overall Study|Adverse Event|2|||
23580973|NCT00832780|65856779|FG000|Overall Study|Lost to Follow-up|4|||
23580974|NCT00832780|65856779|FG000|Overall Study|no reason given|2|||
23580975|NCT00832780|65856779|FG000|Overall Study|other complicating condition|2|||
23580976|NCT00832780|65856779|FG000|Overall Study|Physician Decision|1|||
23580977|NCT02107274|65856781|FG000|Treatment vs. Placebo|Adverse Event|3|||
23580978|NCT02107274|65856782|FG001|Treatment vs. Placebo|Adverse Event|0|||
23580979|NCT02107274|65856781|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
23580980|NCT02107274|65856782|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
23580981|NCT02107274|65856781|FG000|Control Phase|Lost to Follow-up|1|||
23580982|NCT02107274|65856782|FG001|Control Phase|Lost to Follow-up|1|||
23580983|NCT02107274|65856781|FG000|Control Phase|Death|2|||
23580984|NCT02107274|65856782|FG001|Control Phase|Death|0|||
23580985|NCT02107274|65856781|FG000|Control Phase|Adverse Event|0|||
23580986|NCT02107274|65856782|FG001|Control Phase|Adverse Event|1|||
23580987|NCT03582137|65856787|FG000|Overall Study|Adverse Event|1|||
23580988|NCT03582137|65856788|FG001|Overall Study|Adverse Event|0|||
23841713|NCT01387516|66801274|FG001|Overall Study|Withdrawal by Subject|1|||
23841714|NCT01387516|66801275|FG002|Overall Study|Withdrawal by Subject|2|||
23340307|NCT00174967|64989495|FG003|Overall Study|Adverse Event|1|||
23340308|NCT00174967|64989492|FG000|Overall Study|Gout Flare|0|||
23340309|NCT00174967|64989493|FG001|Overall Study|Gout Flare|0|||
23340310|NCT00174967|64989494|FG002|Overall Study|Gout Flare|0|||
23340311|NCT00174967|64989495|FG003|Overall Study|Gout Flare|1|||
23340312|NCT00174967|64989492|FG000|Overall Study|Other|0|||
23340313|NCT00174967|64989493|FG001|Overall Study|Other|1|||
23340314|NCT00174967|64989494|FG002|Overall Study|Other|0|||
23340315|NCT00174967|64989495|FG003|Overall Study|Other|0|||
23340316|NCT01075646|64989498|FG000|Overall Study|Lost to Follow-up|4|||
23340317|NCT01075646|64989499|FG001|Overall Study|Lost to Follow-up|3|||
23340318|NCT01075646|64989500|FG002|Overall Study|Lost to Follow-up|1|||
23340319|NCT01075646|64989501|FG003|Overall Study|Lost to Follow-up|2|||
23340320|NCT03385304|64989502|FG000|Overall Study|Death|19|||
23340321|NCT03385304|64989503|FG001|Overall Study|Death|7|||
23340322|NCT03385304|64989502|FG000|Overall Study|Lost to Follow-up|17|||
23340323|NCT03385304|64989503|FG001|Overall Study|Lost to Follow-up|14|||
23340324|NCT03385304|64989502|FG000|Overall Study|Withdrawal by Subject|3|||
23340325|NCT03385304|64989503|FG001|Overall Study|Withdrawal by Subject|2|||
23340326|NCT03385304|64989502|FG000|Overall Study|Incarceration|2|||
23340327|NCT03385304|64989503|FG001|Overall Study|Incarceration|3|||
23340328|NCT03782298|64989506|FG000|Overall Study|Protocol Deviation|4|||
23340329|NCT02247440|64989511|FG000|Overall Study|Withdrawal by Subject|1|||
23340330|NCT02247440|64989511|FG000|Overall Study|Lack of Efficacy|3|||
23340331|NCT00809471|64989516|FG000|Overall Study|Protocol non-compliance|15|||
23452353|NCT01300234|65398984|FG001|Overall Study|Participant refused return to hospital|0|||
23340332|NCT00809471|64989517|FG001|Overall Study|Protocol non-compliance|15|||
23340333|NCT00809471|64989518|FG002|Overall Study|Protocol non-compliance|6|||
23340334|NCT00809471|64989516|FG000|Overall Study|Lost to Follow-up|4|||
23340335|NCT00809471|64989517|FG001|Overall Study|Lost to Follow-up|2|||
23340336|NCT00809471|64989518|FG002|Overall Study|Lost to Follow-up|9|||
23340337|NCT00809471|64989516|FG000|Overall Study|Adverse Event|0|||
23340338|NCT00809471|64989517|FG001|Overall Study|Adverse Event|2|||
23340339|NCT00809471|64989518|FG002|Overall Study|Adverse Event|2|||
23340340|NCT00809471|64989516|FG000|Overall Study|Requirement for restricted medication|1|||
23452354|NCT02868554|65399002|FG000|Overall Study|Lost to Follow-up|3|||
23580989|NCT03246672|65856789|FG000|Overall Study|Lost to Follow-up|2|||
23580990|NCT04011384|65856790|FG000|Overall Study|Withdrawal by Subject|2|||
23580991|NCT04011384|65856791|FG001|Overall Study|Withdrawal by Subject|0|||
23580992|NCT00088465|65856792|FG000|Overall Study|Withdrawal by Subject|290|||
23580993|NCT00088465|65856792|FG000|Overall Study|Adverse Event|77|||
23580994|NCT00088465|65856792|FG000|Overall Study|Lost to Follow-up|57|||
23841715|NCT01387516|66801276|FG003|Overall Study|Withdrawal by Subject|0|||
23841716|NCT01387516|66801273|FG000|Overall Study|Death|0|||
23841717|NCT01387516|66801274|FG001|Overall Study|Death|0|||
23452355|NCT02868554|65399003|FG001|Overall Study|Lost to Follow-up|0|||
23452356|NCT02868554|65399004|FG002|Overall Study|Lost to Follow-up|1|||
23452357|NCT02313766|65399005|FG000|Overall Study|surgery cancelled|1|||
23452358|NCT02313766|65399006|FG001|Overall Study|surgery cancelled|0|||
23452359|NCT02313766|65399007|FG002|Overall Study|surgery cancelled|0|||
23452360|NCT02313766|65399005|FG000|Overall Study|Lost to Follow-up|0|||
23452361|NCT02313766|65399006|FG001|Overall Study|Lost to Follow-up|2|||
23452362|NCT02313766|65399007|FG002|Overall Study|Lost to Follow-up|0|||
23452363|NCT02313766|65399005|FG000|Overall Study|Adverse Event|0|||
23340341|NCT00809471|64989517|FG001|Overall Study|Requirement for restricted medication|1|||
23340342|NCT00809471|64989518|FG002|Overall Study|Requirement for restricted medication|0|||
23340343|NCT02548351|64989519|FG000|Overall Study|Withdrawal by Subject|149|||
23340344|NCT02548351|64989520|FG001|Overall Study|Withdrawal by Subject|154|||
23340345|NCT02548351|64989521|FG002|Overall Study|Withdrawal by Subject|152|||
23340346|NCT02548351|64989519|FG000|Overall Study|Death|11|||
23340347|NCT02548351|64989520|FG001|Overall Study|Death|15|||
23340348|NCT02548351|64989521|FG002|Overall Study|Death|12|||
23340349|NCT02548351|64989519|FG000|Overall Study|Adverse Event|22|||
23340350|NCT02548351|64989520|FG001|Overall Study|Adverse Event|56|||
23340351|NCT02548351|64989521|FG002|Overall Study|Adverse Event|36|||
23340352|NCT02548351|64989519|FG000|Overall Study|Study Terminated by Sponsor|549|||
23340353|NCT02548351|64989520|FG001|Overall Study|Study Terminated by Sponsor|509|||
23340354|NCT02548351|64989521|FG002|Overall Study|Study Terminated by Sponsor|528|||
23340355|NCT02548351|64989519|FG000|Overall Study|Site Closure|14|||
23340356|NCT02548351|64989520|FG001|Overall Study|Site Closure|5|||
23340357|NCT02548351|64989521|FG002|Overall Study|Site Closure|7|||
23340358|NCT02548351|64989519|FG000|Overall Study|Non-compliance with Study Drug|4|||
23340359|NCT02548351|64989520|FG001|Overall Study|Non-compliance with Study Drug|2|||
23340360|NCT02548351|64989521|FG002|Overall Study|Non-compliance with Study Drug|0|||
23340361|NCT02548351|64989519|FG000|Overall Study|Protocol Violation|2|||
23340362|NCT02548351|64989520|FG001|Overall Study|Protocol Violation|1|||
23340363|NCT02548351|64989521|FG002|Overall Study|Protocol Violation|2|||
23340364|NCT02548351|64989519|FG000|Overall Study|Physician Decision|11|||
23340365|NCT02548351|64989520|FG001|Overall Study|Physician Decision|18|||
23340366|NCT02548351|64989521|FG002|Overall Study|Physician Decision|11|||
23340367|NCT02548351|64989519|FG000|Overall Study|Lost to Follow-up|43|||
23340368|NCT02548351|64989520|FG001|Overall Study|Lost to Follow-up|50|||
23340369|NCT02548351|64989521|FG002|Overall Study|Lost to Follow-up|57|||
23340370|NCT02548351|64989519|FG000|Overall Study|Other|19|||
23340371|NCT02548351|64989520|FG001|Overall Study|Other|16|||
23340372|NCT02548351|64989521|FG002|Overall Study|Other|20|||
23340373|NCT02548351|64989519|FG000|Overall Study|Missing|1|||
23340374|NCT02548351|64989520|FG001|Overall Study|Missing|1|||
23340375|NCT02548351|64989521|FG002|Overall Study|Missing|0|||
23340376|NCT04696354|64989524|FG000|Overall Study|Study termination|6|||
23340377|NCT04696354|64989525|FG001|Overall Study|Study termination|6|||
23340378|NCT01680159|64989531|FG000|Screening Period|Not meet criteria for dose-up period|7|||
23340379|NCT01680159|64989531|FG000|Increased Dose Period|Adverse Event|6|||
23340380|NCT01680159|64989531|FG000|Increased Dose Period|Withdrawal by Subject|2|||
23340381|NCT00256854|64989532|FG000|Overall Study|Withdrawal by Subject|2|||
23340382|NCT00256854|64989533|FG001|Overall Study|Withdrawal by Subject|3|||
23340383|NCT00256854|64989534|FG002|Overall Study|Withdrawal by Subject|0|||
23340384|NCT00256854|64989535|FG003|Overall Study|Withdrawal by Subject|0|||
23340385|NCT00256854|64989536|FG004|Overall Study|Withdrawal by Subject|0|||
23340386|NCT00256854|64989537|FG005|Overall Study|Withdrawal by Subject|0|||
23340387|NCT00256854|64989532|FG000|Overall Study|Lack of Efficacy|1|||
23340388|NCT00256854|64989533|FG001|Overall Study|Lack of Efficacy|0|||
23340389|NCT00256854|64989534|FG002|Overall Study|Lack of Efficacy|0|||
23340390|NCT00256854|64989535|FG003|Overall Study|Lack of Efficacy|0|||
23340391|NCT00256854|64989536|FG004|Overall Study|Lack of Efficacy|0|||
23635689|NCT02416453|66049476|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635690|NCT02416453|66049477|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23841718|NCT01387516|66801275|FG002|Overall Study|Death|0|||
23340392|NCT00256854|64989537|FG005|Overall Study|Lack of Efficacy|0|||
23452364|NCT02313766|65399006|FG001|Overall Study|Adverse Event|1|||
23340393|NCT00256854|64989532|FG000|Overall Study|Protocol Violation|0|||
23340394|NCT00256854|64989533|FG001|Overall Study|Protocol Violation|1|||
23340395|NCT00256854|64989534|FG002|Overall Study|Protocol Violation|1|||
23340396|NCT00256854|64989535|FG003|Overall Study|Protocol Violation|1|||
23340397|NCT00256854|64989536|FG004|Overall Study|Protocol Violation|0|||
23340398|NCT00256854|64989537|FG005|Overall Study|Protocol Violation|0|||
23340399|NCT00256854|64989532|FG000|Overall Study|Adverse Event|0|||
23340400|NCT00256854|64989533|FG001|Overall Study|Adverse Event|0|||
23340401|NCT00256854|64989534|FG002|Overall Study|Adverse Event|2|||
23340402|NCT00256854|64989535|FG003|Overall Study|Adverse Event|2|||
23340403|NCT00256854|64989536|FG004|Overall Study|Adverse Event|0|||
23340404|NCT00256854|64989537|FG005|Overall Study|Adverse Event|1|||
23340405|NCT00256854|64989532|FG000|Overall Study|Not compliant with the study drug|0|||
23340406|NCT00256854|64989533|FG001|Overall Study|Not compliant with the study drug|0|||
23781360|NCT00574847|66580223|FG001|Overall Study|Withdrawal by Subject|2|||
23781361|NCT00574847|66580222|FG000|Overall Study|Physician Decision|1|||
23781362|NCT00574847|66580223|FG001|Overall Study|Physician Decision|0|||
23781363|NCT00574847|66580222|FG000|Overall Study|Did not receive medication (declined)|2|||
23781364|NCT00574847|66580223|FG001|Overall Study|Did not receive medication (declined)|5|||
23781365|NCT00556322|66580224|FG000|Overall Study|Insufficient therapeutic response|158|||
23781366|NCT00556322|66580225|FG001|Overall Study|Insufficient therapeutic response|168|||
23781367|NCT00556322|66580224|FG000|Overall Study|Adverse Event|7|||
23781368|NCT00556322|66580225|FG001|Overall Study|Adverse Event|4|||
23781369|NCT00556322|66580224|FG000|Overall Study|Other|4|||
23781370|NCT00556322|66580225|FG001|Overall Study|Other|1|||
23781371|NCT00556322|66580224|FG000|Overall Study|Lost to Follow-up|5|||
23340407|NCT00256854|64989534|FG002|Overall Study|Not compliant with the study drug|0|||
23340408|NCT00256854|64989535|FG003|Overall Study|Not compliant with the study drug|0|||
23340409|NCT00256854|64989536|FG004|Overall Study|Not compliant with the study drug|1|||
23340410|NCT00256854|64989537|FG005|Overall Study|Not compliant with the study drug|0|||
23340411|NCT00191282|64992748|FG000|Overall Study|Adverse Event|5|||
23340412|NCT00191282|64992749|FG001|Overall Study|Adverse Event|6|||
23340413|NCT00191282|64992748|FG000|Overall Study|Death|51|||
23340414|NCT00191282|64992749|FG001|Overall Study|Death|51|||
23340415|NCT00191282|64992748|FG000|Overall Study|Lack of Efficacy|11|||
23340416|NCT00191282|64992749|FG001|Overall Study|Lack of Efficacy|6|||
23340417|NCT00191282|64992748|FG000|Overall Study|Noncompliance|14|||
23340418|NCT00191282|64992749|FG001|Overall Study|Noncompliance|17|||
23340419|NCT00191282|64992748|FG000|Overall Study|Patient moved|11|||
23340420|NCT00191282|64992749|FG001|Overall Study|Patient moved|14|||
23580995|NCT00088465|65856792|FG000|Overall Study|Physician Decision|45|||
23580996|NCT00088465|65856792|FG000|Overall Study|Sponsor Decision|37|||
23580997|NCT00088465|65856792|FG000|Overall Study|Lack of Efficacy|27|||
23580998|NCT00088465|65856792|FG000|Overall Study|Protocol Violation|17|||
23580999|NCT00088465|65856792|FG000|Overall Study|Death|11|||
23581000|NCT04438785|65856793|FG000|Overall Study|change of weight, give up intervention|2|||
23581001|NCT04438785|65856794|FG001|Overall Study|change of weight, give up intervention|10|||
23581002|NCT00578227|65856795|FG000|Overall Study|Lost to Follow-up|0|||
23581003|NCT00578227|65856796|FG001|Overall Study|Lost to Follow-up|1|||
23581004|NCT00578227|65856797|FG002|Overall Study|Lost to Follow-up|1|||
23581005|NCT00578227|65856795|FG000|Overall Study|Withdrawal by Subject|5|||
23581006|NCT00578227|65856796|FG001|Overall Study|Withdrawal by Subject|1|||
23581007|NCT00578227|65856797|FG002|Overall Study|Withdrawal by Subject|3|||
23581008|NCT00819234|65856798|FG000|Overall Study|Withdrawal by Subject|8|||
23581009|NCT00819234|65856799|FG001|Overall Study|Withdrawal by Subject|13|||
23581010|NCT00819234|65856800|FG002|Overall Study|Withdrawal by Subject|6|||
23581011|NCT00819234|65856801|FG003|Overall Study|Withdrawal by Subject|3|||
23581012|NCT00819234|65856802|FG004|Overall Study|Withdrawal by Subject|0|||
23581013|NCT00819234|65856803|FG005|Overall Study|Withdrawal by Subject|4|||
23581014|NCT00819234|65856804|FG006|Overall Study|Withdrawal by Subject|4|||
23581015|NCT00819234|65856805|FG007|Overall Study|Withdrawal by Subject|8|||
23581016|NCT00819234|65856806|FG008|Overall Study|Withdrawal by Subject|5|||
23581017|NCT00819234|65856807|FG009|Overall Study|Withdrawal by Subject|3|||
23581018|NCT00819234|65856798|FG000|Overall Study|Adverse Event|0|||
23581019|NCT00819234|65856799|FG001|Overall Study|Adverse Event|0|||
23581020|NCT00819234|65856800|FG002|Overall Study|Adverse Event|1|||
23581021|NCT00819234|65856801|FG003|Overall Study|Adverse Event|0|||
23581022|NCT00819234|65856802|FG004|Overall Study|Adverse Event|0|||
23581023|NCT00819234|65856803|FG005|Overall Study|Adverse Event|2|||
23581024|NCT00819234|65856804|FG006|Overall Study|Adverse Event|0|||
23581025|NCT00819234|65856805|FG007|Overall Study|Adverse Event|0|||
23581026|NCT00819234|65856806|FG008|Overall Study|Adverse Event|0|||
23581027|NCT00819234|65856807|FG009|Overall Study|Adverse Event|0|||
23581028|NCT00819234|65856798|FG000|Overall Study|Physician Decision|0|||
23581029|NCT00819234|65856799|FG001|Overall Study|Physician Decision|0|||
23581030|NCT00819234|65856800|FG002|Overall Study|Physician Decision|0|||
23581031|NCT00819234|65856801|FG003|Overall Study|Physician Decision|1|||
23581032|NCT00819234|65856802|FG004|Overall Study|Physician Decision|0|||
23581033|NCT00819234|65856803|FG005|Overall Study|Physician Decision|0|||
23581034|NCT00819234|65856804|FG006|Overall Study|Physician Decision|0|||
23581035|NCT00819234|65856805|FG007|Overall Study|Physician Decision|0|||
23781372|NCT00556322|66580225|FG001|Overall Study|Lost to Follow-up|3|||
23581036|NCT00819234|65856806|FG008|Overall Study|Physician Decision|0|||
23581037|NCT00819234|65856807|FG009|Overall Study|Physician Decision|2|||
23581038|NCT00819234|65856798|FG000|Overall Study|Protocol Violation|0|||
23581039|NCT00819234|65856799|FG001|Overall Study|Protocol Violation|0|||
23581040|NCT00819234|65856800|FG002|Overall Study|Protocol Violation|1|||
23581041|NCT00819234|65856801|FG003|Overall Study|Protocol Violation|0|||
23340421|NCT00191282|64992748|FG000|Overall Study|Withdrawal by Subject|59|||
23581042|NCT00819234|65856802|FG004|Overall Study|Protocol Violation|0|||
23781373|NCT00556322|66580224|FG000|Overall Study|Withdrawal by Subject|19|||
23781374|NCT00556322|66580225|FG001|Overall Study|Withdrawal by Subject|7|||
23841719|NCT01387516|66801276|FG003|Overall Study|Death|1|||
23841720|NCT00886743|66801277|FG000|Overall Study|Adverse Event|3|||
23841721|NCT00886743|66801277|FG000|Overall Study|Other|1|||
23841722|NCT02235077|66801278|FG000|Overall Study|Death|5|||
23841723|NCT02235077|66801279|FG001|Overall Study|Death|7|||
23841724|NCT02235077|66801278|FG000|Overall Study|Lost to Follow-up|5|||
23340422|NCT00191282|64992749|FG001|Overall Study|Withdrawal by Subject|44|||
23340423|NCT00191282|64992748|FG000|Overall Study|Physician Decision|18|||
23340424|NCT00191282|64992749|FG001|Overall Study|Physician Decision|15|||
23340425|NCT00191282|64992748|FG000|Overall Study|Protocol entry criteria not met|14|||
23841725|NCT02235077|66801279|FG001|Overall Study|Lost to Follow-up|6|||
23841726|NCT02235077|66801278|FG000|Overall Study|Withdrawal by Subject|8|||
23841727|NCT02235077|66801279|FG001|Overall Study|Withdrawal by Subject|5|||
23841728|NCT02235077|66801278|FG000|Overall Study|Physician Decision|0|||
23841729|NCT02235077|66801279|FG001|Overall Study|Physician Decision|1|||
23841730|NCT00280397|66801287|FG000|Overall Study|Adverse Event|1|||
23841731|NCT02693002|66801291|FG000|Overall Study|Withdrawal by Subject|1|||
23841732|NCT02693002|66801292|FG001|Overall Study|Withdrawal by Subject|0|||
23841733|NCT02107859|66801302|FG000|Overall Study|Withdrawal by Subject|14|||
23841734|NCT02107859|66801302|FG000|Overall Study|Adverse Event|3|||
23340426|NCT00191282|64992749|FG001|Overall Study|Protocol entry criteria not met|9|||
23581043|NCT00819234|65856803|FG005|Overall Study|Protocol Violation|0|||
23581044|NCT00819234|65856804|FG006|Overall Study|Protocol Violation|0|||
23340427|NCT00191282|64992748|FG000|Overall Study|Protocol Violation|9|||
23340428|NCT00191282|64992749|FG001|Overall Study|Protocol Violation|12|||
23340429|NCT00191282|64992748|FG000|Overall Study|Severity of outcome|2|||
23340430|NCT00191282|64992749|FG001|Overall Study|Severity of outcome|5|||
23581045|NCT00819234|65856805|FG007|Overall Study|Protocol Violation|0|||
23581046|NCT00819234|65856806|FG008|Overall Study|Protocol Violation|0|||
23581047|NCT00819234|65856807|FG009|Overall Study|Protocol Violation|0|||
23581048|NCT00819234|65856798|FG000|Overall Study|Lost to Follow-up|2|||
23581049|NCT00819234|65856799|FG001|Overall Study|Lost to Follow-up|2|||
23581050|NCT00819234|65856800|FG002|Overall Study|Lost to Follow-up|0|||
23581051|NCT00819234|65856801|FG003|Overall Study|Lost to Follow-up|2|||
23581052|NCT00819234|65856802|FG004|Overall Study|Lost to Follow-up|1|||
23581053|NCT00819234|65856803|FG005|Overall Study|Lost to Follow-up|1|||
23581054|NCT00819234|65856804|FG006|Overall Study|Lost to Follow-up|1|||
23581055|NCT00819234|65856805|FG007|Overall Study|Lost to Follow-up|1|||
23581056|NCT00819234|65856806|FG008|Overall Study|Lost to Follow-up|1|||
23581057|NCT00819234|65856807|FG009|Overall Study|Lost to Follow-up|2|||
23581058|NCT00389519|65856808|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
23635691|NCT02416453|66049478|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
23781375|NCT00556322|66580224|FG000|Overall Study|Protocol Violation|5|||
23781376|NCT00556322|66580225|FG001|Overall Study|Protocol Violation|1|||
23781377|NCT00556322|66580224|FG000|Overall Study|Ongoing at data cutoff|3|||
23781378|NCT00556322|66580225|FG001|Overall Study|Ongoing at data cutoff|5|||
23781379|NCT00556322|66580224|FG000|Overall Study|Death|20|||
23781380|NCT00556322|66580225|FG001|Overall Study|Death|14|||
23781381|NCT02146105|66580234|FG000|Overall Study|Adverse Event|1|||
23781382|NCT02146105|66580234|FG000|Overall Study|Withdrawal by Subject|5|||
23781383|NCT00968812|66580235|FG000|Overall Study|Adverse Event|30|||
23781384|NCT00968812|66580236|FG001|Overall Study|Adverse Event|46|||
23781385|NCT00968812|66580237|FG002|Overall Study|Adverse Event|33|||
23781386|NCT00968812|66580235|FG000|Overall Study|Death|2|||
23781387|NCT00968812|66580236|FG001|Overall Study|Death|2|||
23781388|NCT00968812|66580237|FG002|Overall Study|Death|1|||
23781389|NCT00968812|66580235|FG000|Overall Study|Lack of Efficacy|9|||
23781390|NCT00968812|66580236|FG001|Overall Study|Lack of Efficacy|7|||
23781391|NCT00968812|66580237|FG002|Overall Study|Lack of Efficacy|16|||
23781392|NCT00968812|66580235|FG000|Overall Study|Lost to Follow-up|17|||
23781393|NCT00968812|66580236|FG001|Overall Study|Lost to Follow-up|12|||
23781394|NCT00968812|66580237|FG002|Overall Study|Lost to Follow-up|11|||
23781395|NCT00968812|66580235|FG000|Overall Study|Physician Decision|8|||
23781396|NCT00968812|66580236|FG001|Overall Study|Physician Decision|5|||
23781397|NCT00968812|66580237|FG002|Overall Study|Physician Decision|9|||
23841735|NCT02107859|66801302|FG000|Overall Study|Study closure|41|||
23841736|NCT02107859|66801302|FG000|Overall Study|Other than specified|3|||
23841737|NCT02211638|66801303|FG000|Overall Study|Case Report Forms Uncollected|291|||
23581059|NCT00389519|65856809|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
23841738|NCT02211638|66801303|FG000|Overall Study|Protocol Violation|692|||
23841739|NCT02981082|66801304|FG000|Overall Study|Withdrawal by Subject|2|||
23841740|NCT02981082|66801305|FG001|Overall Study|Withdrawal by Subject|0|||
23581060|NCT00389519|65856810|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
23781398|NCT00968812|66580235|FG000|Overall Study|Protocol Violation|7|||
23781399|NCT00968812|66580236|FG001|Overall Study|Protocol Violation|4|||
23781400|NCT00968812|66580237|FG002|Overall Study|Protocol Violation|3|||
23781401|NCT00968812|66580235|FG000|Overall Study|Withdrawal by Subject|17|||
23781402|NCT00968812|66580236|FG001|Overall Study|Withdrawal by Subject|23|||
23781403|NCT00968812|66580237|FG002|Overall Study|Withdrawal by Subject|25|||
23841741|NCT02981082|66801304|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
23841742|NCT02981082|66801305|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
23841743|NCT02981082|66801304|FG000|Overall Study|Adverse Event|0|||
23841744|NCT02981082|66801305|FG001|Overall Study|Adverse Event|1|||
23841745|NCT00533702|66801310|FG000|Overall Study|Withdrawal by Subject|3|||
23841746|NCT00533702|66801311|FG001|Overall Study|Withdrawal by Subject|1|||
23841747|NCT00533702|66801310|FG000|Overall Study|Found ineligible after randomization|2|||
23841748|NCT00533702|66801311|FG001|Overall Study|Found ineligible after randomization|1|||
23841749|NCT00089778|66801312|FG000|Overall Study|Protocol Violation|0|||
23841750|NCT00089778|66801313|FG001|Overall Study|Protocol Violation|0|||
23841751|NCT00089778|66801314|FG002|Overall Study|Protocol Violation|1|||
23841752|NCT03502070|66801317|FG000|Overall Study|Withdrawal by Subject|1|||
23841753|NCT03502070|66801317|FG000|Overall Study|Screen Failure|1|||
23841754|NCT04468347|66801321|FG000|Overall Study|Withdrawal by Subject|0|||
23841755|NCT04468347|66801322|FG001|Overall Study|Withdrawal by Subject|1|||
23841756|NCT04468347|66801323|FG002|Overall Study|Withdrawal by Subject|3|||
23841757|NCT04468347|66801324|FG003|Overall Study|Withdrawal by Subject|3|||
23340431|NCT00191282|64992748|FG000|Overall Study|Sponsor's decision|2|||
23340432|NCT00191282|64992749|FG001|Overall Study|Sponsor's decision|2|||
23841758|NCT04468347|66801321|FG000|Overall Study|Lost to Follow-up|0|||
23841759|NCT04468347|66801322|FG001|Overall Study|Lost to Follow-up|0|||
23841760|NCT04468347|66801323|FG002|Overall Study|Lost to Follow-up|1|||
23841761|NCT04468347|66801324|FG003|Overall Study|Lost to Follow-up|1|||
23841762|NCT04468347|66801321|FG000|Overall Study|Physician Decision|1|||
23841763|NCT04468347|66801322|FG001|Overall Study|Physician Decision|0|||
23841764|NCT04468347|66801323|FG002|Overall Study|Physician Decision|2|||
23841765|NCT04468347|66801324|FG003|Overall Study|Physician Decision|0|||
23841766|NCT04468347|66801321|FG000|Overall Study|Protocol Violation|1|||
23841767|NCT04468347|66801322|FG001|Overall Study|Protocol Violation|0|||
23841768|NCT04468347|66801323|FG002|Overall Study|Protocol Violation|0|||
23841769|NCT04468347|66801324|FG003|Overall Study|Protocol Violation|0|||
23841770|NCT00378508|66801326|FG000|Overall Study|Withdrawal by Subject|1|||
23841771|NCT00378508|66801327|FG001|Overall Study|Withdrawal by Subject|3|||
23841772|NCT00378508|66801326|FG000|Overall Study|Lost to Follow-up|1|||
23841773|NCT00378508|66801327|FG001|Overall Study|Lost to Follow-up|0|||
23841774|NCT01737710|66801330|FG000|Overall Study|Lost to Follow-up|0|||
23841775|NCT01737710|66801331|FG001|Overall Study|Lost to Follow-up|2|||
23841776|NCT01737710|66801332|FG002|Overall Study|Lost to Follow-up|2|||
23841777|NCT01737710|66801333|FG003|Overall Study|Lost to Follow-up|0|||
23841778|NCT01737710|66801334|FG004|Overall Study|Lost to Follow-up|0|||
23841779|NCT01737710|66801330|FG000|Overall Study|Withdrawal by Subject|1|||
23841780|NCT01737710|66801331|FG001|Overall Study|Withdrawal by Subject|1|||
23841781|NCT01737710|66801332|FG002|Overall Study|Withdrawal by Subject|1|||
23841782|NCT01737710|66801333|FG003|Overall Study|Withdrawal by Subject|0|||
23841783|NCT01737710|66801334|FG004|Overall Study|Withdrawal by Subject|0|||
23340433|NCT00191282|64992748|FG000|Overall Study|Lost to Follow-up|24|||
23340434|NCT00191282|64992749|FG001|Overall Study|Lost to Follow-up|31|||
23340435|NCT01493284|64992750|FG000|Overall Study|Death|29|||
23340436|NCT01493284|64992750|FG000|Overall Study|Withdrawal by Subject|32|||
23340437|NCT00381238|64992764|FG000|Overall Study|Adverse Event|3|||
23340438|NCT00381238|64992764|FG000|Overall Study|Protocol Violation|1|||
23340439|NCT00381238|64992764|FG000|Overall Study|Withdrawal by Subject|4|||
23340440|NCT00381238|64992764|FG000|Overall Study|Lack of Efficacy|2|||
23340441|NCT00381238|64992764|FG000|Overall Study|Withdrew by physician|1|||
23340442|NCT00381238|64992764|FG000|Overall Study|Disease progression|1|||
23340443|NCT01701193|64992765|FG000|Overall Study|Withdrawal by Subject|2|||
23340444|NCT01701193|64992766|FG001|Overall Study|Withdrawal by Subject|2|||
23340445|NCT01701193|64992767|FG002|Overall Study|Withdrawal by Subject|1|||
23340446|NCT01701193|64992768|FG003|Overall Study|Withdrawal by Subject|2|||
23340447|NCT01701193|64992765|FG000|Overall Study|Adverse Event|1|||
23340448|NCT01701193|64992766|FG001|Overall Study|Adverse Event|0|||
23340449|NCT01701193|64992767|FG002|Overall Study|Adverse Event|0|||
23340450|NCT01701193|64992768|FG003|Overall Study|Adverse Event|0|||
23340451|NCT03702010|64992771|FG000|Follow-up (30days)|Lack of Efficacy|2|||
23340452|NCT03702010|64992772|FG001|Follow-up (30days)|Lack of Efficacy|2|||
23340453|NCT00157248|64992782|FG000|Overall Study|Adverse Event|36|||
23841784|NCT01737710|66801330|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
23841785|NCT01737710|66801331|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
23340454|NCT00157248|64992783|FG001|Overall Study|Adverse Event|25|||
23340455|NCT00157248|64992784|FG002|Overall Study|Adverse Event|13|||
23340456|NCT00157248|64992785|FG003|Overall Study|Adverse Event|33|||
23340457|NCT00157248|64992782|FG000|Overall Study|Protocol Violation|4|||
23841786|NCT01737710|66801332|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
23841787|NCT01737710|66801333|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
23841788|NCT01737710|66801334|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
23841789|NCT02702388|66801335|FG000|Overall Study|Disease Progression|18|||
23841790|NCT02702388|66801336|FG001|Overall Study|Disease Progression|25|||
23841791|NCT02702388|66801335|FG000|Overall Study|Withdrawal by Subject|9|||
23340458|NCT00157248|64992783|FG001|Overall Study|Protocol Violation|0|||
23340459|NCT00157248|64992784|FG002|Overall Study|Protocol Violation|2|||
23340460|NCT00157248|64992785|FG003|Overall Study|Protocol Violation|2|||
23841792|NCT02702388|66801336|FG001|Overall Study|Withdrawal by Subject|7|||
23841793|NCT02702388|66801335|FG000|Overall Study|Adverse Event|11|||
23841794|NCT02702388|66801336|FG001|Overall Study|Adverse Event|15|||
23841795|NCT02702388|66801335|FG000|Overall Study|Other|2|||
23841796|NCT02702388|66801336|FG001|Overall Study|Other|4|||
23841797|NCT04439214|66801337|FG000|Overall Study|Adverse Event|13|||
23841798|NCT04439214|66801337|FG000|Overall Study|Disease progression|16|||
23841799|NCT04439214|66801337|FG000|Overall Study|Death|1|||
23841800|NCT04439214|66801337|FG000|Overall Study|Withdrawal by Subject|2|||
23841801|NCT04439214|66801337|FG000|Overall Study|Declining health|1|||
23841802|NCT04439214|66801337|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
23841803|NCT04439214|66801337|FG000|Overall Study|Ineligible|5|||
23841804|NCT04105218|66801338|FG000|Overall Study|Withdrawal by Subject|3|||
23841805|NCT04105218|66801339|FG001|Overall Study|Withdrawal by Subject|2|||
23841806|NCT04105218|66801338|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
23841807|NCT04105218|66801339|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
23841808|NCT04105218|66801338|FG000|Overall Study|Failed screening tests|2|||
23841809|NCT04105218|66801339|FG001|Overall Study|Failed screening tests|1|||
23841810|NCT00986921|66801342|FG000|Overall Study|Physician Decision|1|||
23841811|NCT00986921|66801343|FG001|Overall Study|Physician Decision|0|||
23841812|NCT03070002|66801346|FG000|Follow up for 2 Years|Death|1|||
23841813|NCT01866111|66801348|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
23841814|NCT01866111|66801349|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
23841815|NCT01866111|66801350|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
23841816|NCT01866111|66801351|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
23841817|NCT01866111|66801348|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
23841818|NCT01866111|66801349|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
23841819|NCT01866111|66801350|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
23841820|NCT01866111|66801351|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
23841821|NCT02048826|66801356|FG000|Overall Study|Withdrawal by Subject|1|||
23841822|NCT02048826|66801357|FG001|Overall Study|Withdrawal by Subject|0|||
23841823|NCT00596687|66801358|FG000|Overall Study|< 24 hours of insulin treatment|8|||
23841824|NCT00596687|66801359|FG001|Overall Study|< 24 hours of insulin treatment|6|||
23841825|NCT00596687|66801358|FG000|Overall Study|continuous insulin infusion during TPN|2|||
23841826|NCT00596687|66801359|FG001|Overall Study|continuous insulin infusion during TPN|1|||
23841827|NCT00596687|66801358|FG000|Overall Study|Withdrawal by Subject|3|||
23841828|NCT00596687|66801359|FG001|Overall Study|Withdrawal by Subject|1|||
23841829|NCT00596687|66801358|FG000|Overall Study|cancelled surgery|1|||
23841830|NCT00596687|66801359|FG001|Overall Study|cancelled surgery|1|||
23340461|NCT00157248|64992782|FG000|Overall Study|Lost to Follow-up|0|||
23340462|NCT00157248|64992783|FG001|Overall Study|Lost to Follow-up|1|||
23340463|NCT00157248|64992784|FG002|Overall Study|Lost to Follow-up|0|||
23452365|NCT02313766|65399007|FG002|Overall Study|Adverse Event|0|||
23452366|NCT00644358|65399009|FG000|Overall Study|Adverse Event|124|||
23452367|NCT00644358|65399009|FG000|Overall Study|Lost to Follow-up|105|||
23452368|NCT00644358|65399009|FG000|Overall Study|Consent Withdrawal|64|||
23452369|NCT00644358|65399009|FG000|Overall Study|Lack of Effectiveness|39|||
23452370|NCT00644358|65399009|FG000|Overall Study|Protocol Violation|5|||
23452371|NCT00644358|65399009|FG000|Overall Study|Noncompliance|14|||
23452372|NCT00644358|65399009|FG000|Overall Study|Other Unspecified|11|||
23452373|NCT00083889|65399011|FG000|Overall Study|Adverse Event|76|||
23452374|NCT00083889|65399012|FG001|Overall Study|Adverse Event|86|||
23452375|NCT00083889|65399011|FG000|Overall Study|Protocol Violation|2|||
23452376|NCT00083889|65399012|FG001|Overall Study|Protocol Violation|2|||
23841831|NCT01217476|66801360|FG000|Overall Study|Adverse Event|6|||
23841832|NCT01217476|66801361|FG001|Overall Study|Adverse Event|1|||
23841833|NCT01217476|66801360|FG000|Overall Study|Physician Decision|0|||
23841834|NCT01217476|66801361|FG001|Overall Study|Physician Decision|1|||
23841835|NCT01217476|66801360|FG000|Overall Study|Withdrawal by Subject|3|||
23841836|NCT01217476|66801361|FG001|Overall Study|Withdrawal by Subject|3|||
23841837|NCT01217476|66801360|FG000|Overall Study|Surgery on the Target Limb|0|||
23841838|NCT01217476|66801361|FG001|Overall Study|Surgery on the Target Limb|2|||
23841839|NCT01217476|66801360|FG000|Overall Study|Protocol Deviation|1|||
23841840|NCT01217476|66801361|FG001|Overall Study|Protocol Deviation|0|||
23841841|NCT01217476|66801360|FG000|Overall Study|Other|2|||
23841842|NCT01217476|66801361|FG001|Overall Study|Other|0|||
23841843|NCT00526669|66801364|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
23452377|NCT00083889|65399011|FG000|Overall Study|Withdrawal by Subject|22|||
23452378|NCT00083889|65399012|FG001|Overall Study|Withdrawal by Subject|24|||
23452379|NCT00083889|65399011|FG000|Overall Study|Lack of Efficacy|240|||
23452380|NCT00083889|65399012|FG001|Overall Study|Lack of Efficacy|219|||
23452381|NCT00083889|65399011|FG000|Overall Study|Decision of sponsor|32|||
23452382|NCT00083889|65399012|FG001|Overall Study|Decision of sponsor|4|||
23452383|NCT00083889|65399011|FG000|Overall Study|Randomized: did not take study drug|0|||
23452384|NCT00083889|65399012|FG001|Overall Study|Randomized: did not take study drug|15|||
23452385|NCT00083889|65399011|FG000|Overall Study|Completed on marketed sunitinub|3|||
23452386|NCT00083889|65399012|FG001|Overall Study|Completed on marketed sunitinub|0|||
23452387|NCT00083889|65399011|FG000|Overall Study|Crossover to SU011248|0|||
23452388|NCT00083889|65399012|FG001|Overall Study|Crossover to SU011248|25|||
23452389|NCT01352117|65399013|FG000|Overall Study|Death|15|||
23452390|NCT01352117|65399014|FG001|Overall Study|Death|16|||
23452391|NCT01352117|65399013|FG000|Overall Study|Withdrawal by Subject|1|||
23452392|NCT01352117|65399014|FG001|Overall Study|Withdrawal by Subject|0|||
23452393|NCT01352117|65399013|FG000|Overall Study|Lost to Follow-up|2|||
23452394|NCT01352117|65399014|FG001|Overall Study|Lost to Follow-up|7|||
23452395|NCT01352117|65399013|FG000|Overall Study|Non-adherent to study requirements|1|||
23452396|NCT01352117|65399014|FG001|Overall Study|Non-adherent to study requirements|1|||
23452397|NCT01352117|65399013|FG000|Overall Study|Did not initiate study treatment|1|||
23452398|NCT01352117|65399014|FG001|Overall Study|Did not initiate study treatment|0|||
23452399|NCT01352117|65399013|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
23452400|NCT01352117|65399014|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
23452401|NCT01702844|65399016|FG000|Overall Study|Adverse Event|9|||
23452402|NCT01702844|65399016|FG000|Overall Study|Death|1|||
23452403|NCT01702844|65399016|FG000|Overall Study|Withdrawal by Subject|3|||
23452404|NCT01702844|65399016|FG000|Overall Study|Physician Decision|6|||
23452405|NCT01332994|65399017|FG000|Overall Study|Adverse Event|34|||
23452406|NCT01332994|65399017|FG000|Overall Study|Death|1|||
23452407|NCT01332994|65399017|FG000|Overall Study|Lack of Efficacy|1|||
23452408|NCT01332994|65399017|FG000|Overall Study|Lost to Follow-up|4|||
23452409|NCT01332994|65399017|FG000|Overall Study|Protocol Violation|6|||
23452410|NCT01332994|65399017|FG000|Overall Study|Withdrawal by Subject|15|||
23452411|NCT01332994|65399017|FG000|Overall Study|Administrative Problem|2|||
23452412|NCT01332994|65399017|FG000|Overall Study|Other|8|||
23452413|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452414|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
23452415|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452416|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452417|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452418|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
23452419|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
23452420|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452421|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452422|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452423|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
23452424|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
23452425|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452426|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452427|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452428|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
23452429|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
23452430|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452431|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452432|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452433|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
23452434|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
23452435|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23452436|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23452437|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23841844|NCT00526669|66801365|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
23841845|NCT00526669|66801364|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
23841846|NCT00526669|66801365|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
23841847|NCT00526669|66801364|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
23452438|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
23452439|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
23452440|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23452441|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23635692|NCT02416453|66049479|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635693|NCT02416453|66049480|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23340464|NCT00157248|64992785|FG003|Overall Study|Lost to Follow-up|0|||
23452442|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23841848|NCT00526669|66801365|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
23452443|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
23452444|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
23452445|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452446|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452447|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452448|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452449|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
23452450|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452451|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452452|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452453|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452454|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452455|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
23452456|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
23452457|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452458|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452459|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452460|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
23452461|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452462|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452463|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452464|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452465|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
23452466|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
23452467|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452468|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452469|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23841849|NCT00526669|66801364|FG000|Combined Treatment Phase|Death|0|||
23841850|NCT00526669|66801365|FG001|Combined Treatment Phase|Death|2|||
23841851|NCT02693171|66801375|FG000|Overall Study|Adverse Event|1|||
23841852|NCT02693171|66801375|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
23841853|NCT01736397|66801376|FG000|Overall Study|Lack of Efficacy|1|||
23841854|NCT01736397|66801377|FG001|Overall Study|Lack of Efficacy|11|||
23841855|NCT01736397|66801376|FG000|Overall Study|Withdrawal by Subject|6|||
23841856|NCT01736397|66801377|FG001|Overall Study|Withdrawal by Subject|5|||
23841857|NCT01736397|66801376|FG000|Overall Study|Lost to Follow-up|0|||
23841858|NCT01736397|66801377|FG001|Overall Study|Lost to Follow-up|1|||
23841859|NCT01736397|66801376|FG000|Overall Study|Adverse Event|6|||
23841860|NCT01736397|66801377|FG001|Overall Study|Adverse Event|3|||
23841861|NCT01736397|66801376|FG000|Overall Study|Not stated|1|||
23841862|NCT01736397|66801377|FG001|Overall Study|Not stated|4|||
23841863|NCT00619892|66801383|FG000|Overall Study|Adverse Event|3|||
23841864|NCT00619892|66801384|FG001|Overall Study|Adverse Event|0|||
23841865|NCT00619892|66801383|FG000|Overall Study|Lost to Follow-up|0|||
23841866|NCT00619892|66801384|FG001|Overall Study|Lost to Follow-up|1|||
23841867|NCT00619892|66801383|FG000|Overall Study|Intercurrent illness|0|||
23841868|NCT00619892|66801384|FG001|Overall Study|Intercurrent illness|1|||
23841869|NCT01683266|66801385|FG000|Overall Study|Adverse Event|5|||
23841870|NCT01683266|66801386|FG001|Overall Study|Adverse Event|4|||
23841871|NCT01683266|66801385|FG000|Overall Study|Lack of Efficacy|5|||
23841872|NCT01683266|66801386|FG001|Overall Study|Lack of Efficacy|2|||
23841873|NCT01683266|66801385|FG000|Overall Study|Protocol Violation|13|||
23841874|NCT01683266|66801386|FG001|Overall Study|Protocol Violation|6|||
23841875|NCT01683266|66801385|FG000|Overall Study|Personal Reason|17|||
23841876|NCT01683266|66801386|FG001|Overall Study|Personal Reason|25|||
23841877|NCT01683266|66801385|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
23841878|NCT01683266|66801386|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
23841879|NCT01683266|66801385|FG000|Overall Study|Lost to Follow-up|5|||
23841880|NCT01683266|66801386|FG001|Overall Study|Lost to Follow-up|0|||
23841881|NCT01683266|66801385|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
23841882|NCT01683266|66801386|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
23841883|NCT01683266|66801385|FG000|Overall Study|Nonserious Hypoglycemia|0|||
23841884|NCT01683266|66801386|FG001|Overall Study|Nonserious Hypoglycemia|3|||
23841885|NCT01683266|66801385|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23841886|NCT01683266|66801386|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23841887|NCT01683266|66801385|FG000|Overall Study|Possibly Hypoglycemia|1|||
23841888|NCT01683266|66801386|FG001|Overall Study|Possibly Hypoglycemia|0|||
23841889|NCT01683266|66801385|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
23841890|NCT01683266|66801386|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
23452470|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
23452471|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452472|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452473|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23452474|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23452475|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
23635694|NCT02416453|66049481|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635695|NCT02416453|66049482|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635696|NCT02416453|66049483|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635697|NCT02416453|66049484|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635698|NCT02416453|66049485|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635699|NCT02416453|66049486|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23635700|NCT02416453|66049476|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635701|NCT02416453|66049477|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635702|NCT02416453|66049478|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635703|NCT02416453|66049479|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635704|NCT02416453|66049480|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635705|NCT02416453|66049481|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
23635706|NCT02416453|66049482|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635707|NCT02416453|66049483|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635708|NCT02416453|66049484|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635709|NCT02416453|66049485|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635710|NCT02416453|66049486|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23635711|NCT02056626|66049489|FG000|Overall Study|patient did not follow directions|3|||
23635712|NCT02056626|66049490|FG001|Overall Study|patient did not follow directions|1|||
23635713|NCT02056626|66049491|FG002|Overall Study|patient did not follow directions|0|||
23635714|NCT02056626|66049492|FG003|Overall Study|patient did not follow directions|0|||
23635715|NCT02530970|66049493|FG000|Overall Study|Adverse Event|8|||
23635716|NCT02530970|66049493|FG000|Overall Study|Lost to Follow-up|88|||
23635717|NCT02530970|66049493|FG000|Overall Study|Physician Decision|5|||
23635718|NCT02530970|66049493|FG000|Overall Study|Withdrawal by Subject|14|||
23635719|NCT02530970|66049493|FG000|Overall Study|Death|6|||
23635720|NCT02530970|66049493|FG000|Overall Study|Hospitalization|1|||
23635721|NCT02530970|66049493|FG000|Overall Study|Insurance|2|||
23635722|NCT02530970|66049493|FG000|Overall Study|Explant|2|||
23635723|NCT02530970|66049493|FG000|Overall Study|Change in Provider|5|||
23635724|NCT02530970|66049493|FG000|Overall Study|Relocation|3|||
23635725|NCT02233803|66049499|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
23635726|NCT02233803|66049500|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
23635727|NCT02233803|66049499|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
23635728|NCT02233803|66049500|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
23635729|NCT02233803|66049499|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
23635730|NCT02233803|66049500|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
23635731|NCT02233803|66049499|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
23635732|NCT02233803|66049500|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
23635733|NCT02233803|66049499|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
23635734|NCT02233803|66049500|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
23635735|NCT02233803|66049499|FG000|Washout Period (4-Wks)|Physician Decision|1|||
23635736|NCT02233803|66049500|FG001|Washout Period (4-Wks)|Physician Decision|0|||
23635737|NCT02233803|66049499|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
23635738|NCT02233803|66049500|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
23635739|NCT02233803|66049499|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
23635740|NCT02233803|66049500|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
23635741|NCT02233803|66049499|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
23635742|NCT02233803|66049500|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
23635743|NCT00332462|66049503|FG000|Overall Study|Adverse Event|5|||
23635744|NCT00332462|66049503|FG000|Overall Study|Abnormal Lab Value|1|||
23635745|NCT00332462|66049503|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23635746|NCT00332462|66049503|FG000|Overall Study|no longer requires study drug|1|||
23635747|NCT00332462|66049503|FG000|Overall Study|Death|3|||
23635748|NCT00332462|66049503|FG000|Overall Study|Graft Loss|2|||
23635749|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Physician Decision|2|||
23452476|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
23635750|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Physician Decision|0|||
23635751|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Physician Decision|0|||
23635752|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Adverse Event|33|||
23635753|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Adverse Event|0|||
23452477|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23635754|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Adverse Event|0|||
23635755|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
23635756|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23635757|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23635758|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
23635759|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
23841891|NCT01726270|66801392|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
23841892|NCT01726270|66801392|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
23841893|NCT01726270|66801392|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
23452478|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23635760|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
23635761|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
23635762|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23581061|NCT00389519|65856811|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
23581062|NCT00389519|65856808|FG000|Placebo Run-In|Withdrawal by Subject|19|||
23581063|NCT00389519|65856809|FG001|Placebo Run-In|Withdrawal by Subject|0|||
23581064|NCT00389519|65856810|FG002|Placebo Run-In|Withdrawal by Subject|0|||
23581065|NCT00389519|65856811|FG003|Placebo Run-In|Withdrawal by Subject|0|||
23581066|NCT00389519|65856808|FG000|Placebo Run-In|Reason not specified|40|||
23581067|NCT00389519|65856809|FG001|Placebo Run-In|Reason not specified|0|||
23635763|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23635764|NCT01008553|66049504|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
23635765|NCT01008553|66049505|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
23635766|NCT01008553|66049506|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
23635767|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
23635768|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
23635769|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
23635770|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
23635771|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
23635772|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
23635773|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
23635774|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23635775|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23635776|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
23635777|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
23635778|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
23635779|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23635780|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
23781404|NCT00968812|66580235|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
23781405|NCT00968812|66580236|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
23781406|NCT00968812|66580237|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
23781407|NCT00968812|66580235|FG000|Overall Study|Noncompliance with study drug|4|||
23781408|NCT00968812|66580236|FG001|Overall Study|Noncompliance with study drug|1|||
23781409|NCT00968812|66580237|FG002|Overall Study|Noncompliance with study drug|6|||
23781410|NCT00968812|66580235|FG000|Overall Study|Unable to take rescue therapy|12|||
23781411|NCT00968812|66580236|FG001|Overall Study|Unable to take rescue therapy|12|||
23581068|NCT00389519|65856810|FG002|Placebo Run-In|Reason not specified|0|||
23581069|NCT00389519|65856811|FG003|Placebo Run-In|Reason not specified|0|||
23781412|NCT00968812|66580237|FG002|Overall Study|Unable to take rescue therapy|17|||
23781413|NCT00968812|66580235|FG000|Overall Study|Other|25|||
23781414|NCT00968812|66580236|FG001|Overall Study|Other|37|||
23781415|NCT00968812|66580237|FG002|Overall Study|Other|40|||
23781416|NCT00830206|66580240|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23781417|NCT00830206|66580241|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
23781418|NCT00731783|66580242|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
23781419|NCT00731783|66580243|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
23781420|NCT00731783|66580242|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
23781421|NCT00731783|66580243|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
23781422|NCT00731783|66580242|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
23452479|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23452480|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
23452481|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
23452482|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23452483|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23452484|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23452485|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
23452486|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
23452487|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23581070|NCT00389519|65856808|FG000|Randomized|Did not receive study drug|2|||
23581071|NCT00389519|65856809|FG001|Randomized|Did not receive study drug|0|||
23841894|NCT01726270|66801392|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
23635781|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
23635782|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
23635783|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
23635784|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
23635785|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23452488|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452489|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452490|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452491|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452492|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
23452493|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23635786|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23635787|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
23635788|NCT01008553|66049504|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
23581072|NCT00389519|65856810|FG002|Randomized|Did not receive study drug|0|||
23581073|NCT00389519|65856811|FG003|Randomized|Did not receive study drug|0|||
23581074|NCT00389519|65856808|FG000|Treated|Adverse Event|1|||
23581075|NCT00389519|65856809|FG001|Treated|Adverse Event|0|||
23581076|NCT00389519|65856810|FG002|Treated|Adverse Event|0|||
23581077|NCT00389519|65856811|FG003|Treated|Adverse Event|2|||
23581078|NCT00389519|65856808|FG000|Treated|Reason not specified|1|||
23581079|NCT00389519|65856809|FG001|Treated|Reason not specified|1|||
23581080|NCT00389519|65856810|FG002|Treated|Reason not specified|0|||
23581081|NCT00389519|65856811|FG003|Treated|Reason not specified|2|||
23581082|NCT01562743|65856812|FG000|Overall Study|Adverse Event|29|||
23581083|NCT01562743|65856812|FG000|Overall Study|Lack of Efficacy|3|||
23581084|NCT01562743|65856812|FG000|Overall Study|Withdrawal by Subject|13|||
23635789|NCT01008553|66049505|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
23635790|NCT01008553|66049506|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
23635791|NCT01782690|66049510|FG000|Overall Study|Not reported|7|||
23635792|NCT01782690|66049510|FG000|Overall Study|Toxicity of gemcitabine|1|||
23635793|NCT01782690|66049510|FG000|Overall Study|Toxicity of erlotinib|1|||
23635794|NCT01782690|66049510|FG000|Overall Study|Lost to Follow-up|31|||
23635795|NCT01782690|66049510|FG000|Overall Study|Withdrawal of informed consent|2|||
23635796|NCT01782690|66049510|FG000|Overall Study|Absent rash|9|||
23635797|NCT01782690|66049510|FG000|Overall Study|Physician Decision|13|||
23635798|NCT01782690|66049510|FG000|Overall Study|Patient's wish|21|||
23635799|NCT01782690|66049510|FG000|Overall Study|Tumor progression|74|||
23635800|NCT01782690|66049510|FG000|Overall Study|Death|133|||
23635801|NCT01782690|66049510|FG000|Overall Study|Study completion unknown|7|||
23635802|NCT00264303|66049512|FG000|Overall Study|Adverse Event|4|||
23635803|NCT00264303|66049513|FG001|Overall Study|Adverse Event|3|||
23635804|NCT00264303|66049512|FG000|Overall Study|Lack of Efficacy|10|||
23635805|NCT00264303|66049513|FG001|Overall Study|Lack of Efficacy|13|||
23635806|NCT00264303|66049512|FG000|Overall Study|Lost to Follow-up|3|||
23635807|NCT00264303|66049513|FG001|Overall Study|Lost to Follow-up|3|||
23635808|NCT00264303|66049512|FG000|Overall Study|Withdrawal by Subject|2|||
23635809|NCT00264303|66049513|FG001|Overall Study|Withdrawal by Subject|3|||
23635810|NCT00264303|66049512|FG000|Overall Study|Various reasons listed in study report|6|||
23635811|NCT00264303|66049513|FG001|Overall Study|Various reasons listed in study report|7|||
23635812|NCT04276051|66049518|FG000|Overall Study|Lost to Follow-up|0|||
23635813|NCT04276051|66049519|FG001|Overall Study|Lost to Follow-up|1|||
23635814|NCT04276051|66049518|FG000|Overall Study|Physician Decision|0|||
23635815|NCT04276051|66049519|FG001|Overall Study|Physician Decision|1|||
23635816|NCT04276051|66049518|FG000|Overall Study|Withdrawal by Subject|1|||
23635817|NCT04276051|66049519|FG001|Overall Study|Withdrawal by Subject|1|||
23635818|NCT00604708|66052816|FG000|Overall Study|Withdrawal by Subject|9|||
23635819|NCT00604708|66052817|FG001|Overall Study|Withdrawal by Subject|10|||
23452494|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23635820|NCT00604708|66052816|FG000|Overall Study|Protocol Violation|2|||
23635821|NCT00604708|66052817|FG001|Overall Study|Protocol Violation|8|||
23635822|NCT00604708|66052816|FG000|Overall Study|Lost to Follow-up|5|||
23635823|NCT00604708|66052817|FG001|Overall Study|Lost to Follow-up|5|||
23635824|NCT00604708|66052816|FG000|Overall Study|administrative reasons|9|||
23635825|NCT00604708|66052817|FG001|Overall Study|administrative reasons|11|||
23635826|NCT00604708|66052816|FG000|Overall Study|Adverse Event|6|||
23635827|NCT00604708|66052817|FG001|Overall Study|Adverse Event|6|||
23635828|NCT01685229|66052818|FG000|Overall Study|Subjects missing Study Exit form|3|||
23635829|NCT01685229|66052819|FG001|Overall Study|Subjects missing Study Exit form|1|||
23581085|NCT01562743|65856812|FG000|Overall Study|Protocol Violation|1|||
23581086|NCT01562743|65856812|FG000|Overall Study|Discontinuation criteria|2|||
23581087|NCT01562743|65856812|FG000|Overall Study|Lost to Follow-up|2|||
23581088|NCT01562743|65856812|FG000|Overall Study|Physician Decision|2|||
23635830|NCT01685229|66052818|FG000|Overall Study|Lost to Follow-up|16|||
23635831|NCT01685229|66052819|FG001|Overall Study|Lost to Follow-up|10|||
23635832|NCT01685229|66052818|FG000|Overall Study|Withdrawal by Subject|6|||
23635833|NCT01685229|66052819|FG001|Overall Study|Withdrawal by Subject|5|||
23635834|NCT01685229|66052818|FG000|Overall Study|Death|1|||
23581089|NCT00562965|65856813|FG000|Overall Study|Withdrawal by Subject|0|||
23841895|NCT01726270|66801392|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
23841896|NCT01726270|66801392|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
23635835|NCT01685229|66052819|FG001|Overall Study|Death|0|||
23635836|NCT01461811|66052821|FG000|Overall Study|Adverse Event|2|||
23635837|NCT01461811|66052822|FG001|Overall Study|Adverse Event|1|||
23635838|NCT01461811|66052821|FG000|Overall Study|Subject decision unrelated to an AE|1|||
23635839|NCT01461811|66052822|FG001|Overall Study|Subject decision unrelated to an AE|1|||
23581090|NCT00562965|65856814|FG001|Overall Study|Withdrawal by Subject|1|||
23581091|NCT00562965|65856813|FG000|Overall Study|Death|2|||
23581092|NCT00562965|65856814|FG001|Overall Study|Death|4|||
23581093|NCT00562965|65856813|FG000|Overall Study|Lost to Follow-up|1|||
23581094|NCT00562965|65856814|FG001|Overall Study|Lost to Follow-up|0|||
23581095|NCT00562965|65856813|FG000|Overall Study|Other|0|||
23581096|NCT00562965|65856814|FG001|Overall Study|Other|1|||
23581097|NCT01238575|65856815|FG000|Overall Study|Lack of Efficacy|2|||
23581098|NCT01238575|65856816|FG001|Overall Study|Lack of Efficacy|4|||
23581099|NCT01238575|65856815|FG000|Overall Study|Adverse Event|2|||
23581100|NCT01238575|65856816|FG001|Overall Study|Adverse Event|0|||
23452495|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23581101|NCT01772719|65856817|FG000|Overall Study|Withdrawal by Subject|3|||
23581102|NCT01772719|65856817|FG000|Overall Study|Adverse Event|2|||
23581103|NCT01772719|65856817|FG000|Overall Study|Protocol Violation|1|||
23581104|NCT01772719|65856817|FG000|Overall Study|Lost to Follow-up|1|||
23581105|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
23581106|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
23581107|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
23581108|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
23581109|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
23340465|NCT00157248|64992782|FG000|Overall Study|Withdrawal by Subject|1|||
23340466|NCT00157248|64992783|FG001|Overall Study|Withdrawal by Subject|4|||
23340467|NCT00157248|64992784|FG002|Overall Study|Withdrawal by Subject|3|||
23340468|NCT00157248|64992785|FG003|Overall Study|Withdrawal by Subject|3|||
23340469|NCT00157248|64992782|FG000|Overall Study|site closures, subject moving|7|||
23340470|NCT00157248|64992783|FG001|Overall Study|site closures, subject moving|7|||
23340471|NCT00157248|64992784|FG002|Overall Study|site closures, subject moving|3|||
23340472|NCT00157248|64992785|FG003|Overall Study|site closures, subject moving|9|||
23452496|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23635840|NCT01461811|66052821|FG000|Overall Study|Noncompliance|1|||
23635841|NCT01461811|66052822|FG001|Overall Study|Noncompliance|1|||
23635842|NCT03338296|66052824|FG000|Overall Study|Adverse Event|0|||
23635843|NCT03338296|66052825|FG001|Overall Study|Adverse Event|1|||
23635844|NCT03338296|66052824|FG000|Overall Study|Withdrawal by Subject|14|||
23635845|NCT03338296|66052825|FG001|Overall Study|Withdrawal by Subject|13|||
23635846|NCT03338296|66052824|FG000|Overall Study|Lost to Follow-up|10|||
23635847|NCT03338296|66052825|FG001|Overall Study|Lost to Follow-up|10|||
23635848|NCT03338296|66052824|FG000|Overall Study|Study Terminated by Sponsor|77|||
23841897|NCT01397825|66801393|FG000|Overall Study|Progressive Disease|10|||
23841898|NCT01397825|66801394|FG001|Overall Study|Progressive Disease|3|||
23841899|NCT01397825|66801395|FG002|Overall Study|Progressive Disease|11|||
23841900|NCT01397825|66801396|FG003|Overall Study|Progressive Disease|1|||
23841901|NCT01397825|66801397|FG004|Overall Study|Progressive Disease|0|||
23841902|NCT01397825|66801393|FG000|Overall Study|Symptomatic Deterioration|2|||
23452497|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
23452498|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452499|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452500|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23581110|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
23581111|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
23635849|NCT03338296|66052825|FG001|Overall Study|Study Terminated by Sponsor|76|||
23635850|NCT03338296|66052824|FG000|Overall Study|Other|2|||
23635851|NCT03338296|66052825|FG001|Overall Study|Other|7|||
23635852|NCT03338296|66052824|FG000|Overall Study|Missing|0|||
23635853|NCT03338296|66052825|FG001|Overall Study|Missing|1|||
23635854|NCT04860297|66052826|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
23841903|NCT01397825|66801394|FG001|Overall Study|Symptomatic Deterioration|0|||
23581112|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
23581113|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
23635855|NCT04860297|66052827|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
23581114|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
23581115|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
23581116|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
23581117|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
23841904|NCT01397825|66801395|FG002|Overall Study|Symptomatic Deterioration|4|||
23841905|NCT01397825|66801396|FG003|Overall Study|Symptomatic Deterioration|0|||
23841906|NCT01397825|66801397|FG004|Overall Study|Symptomatic Deterioration|0|||
23841907|NCT01397825|66801393|FG000|Overall Study|Adverse Event|0|||
23841908|NCT01397825|66801394|FG001|Overall Study|Adverse Event|1|||
23841909|NCT01397825|66801395|FG002|Overall Study|Adverse Event|5|||
23841910|NCT01397825|66801396|FG003|Overall Study|Adverse Event|1|||
23841911|NCT01397825|66801397|FG004|Overall Study|Adverse Event|0|||
23841912|NCT01397825|66801393|FG000|Overall Study|Withdrawal by Subject|1|||
23841913|NCT01397825|66801394|FG001|Overall Study|Withdrawal by Subject|0|||
23841914|NCT01397825|66801395|FG002|Overall Study|Withdrawal by Subject|5|||
23841915|NCT01397825|66801396|FG003|Overall Study|Withdrawal by Subject|1|||
23841916|NCT01397825|66801397|FG004|Overall Study|Withdrawal by Subject|0|||
23841917|NCT00285207|66801398|FG000|Overall Study|Lost to Follow-up|3|||
23841918|NCT00285207|66801399|FG001|Overall Study|Lost to Follow-up|2|||
23841919|NCT00285207|66801398|FG000|Overall Study|Withdrawal by Subject|5|||
23841920|NCT00285207|66801399|FG001|Overall Study|Withdrawal by Subject|2|||
23841921|NCT00285207|66801398|FG000|Overall Study|Pregnancy|1|||
23841922|NCT00285207|66801399|FG001|Overall Study|Pregnancy|1|||
23841923|NCT00285207|66801398|FG000|Overall Study|non-compliance|0|||
23841924|NCT00285207|66801399|FG001|Overall Study|non-compliance|1|||
23841925|NCT03339726|66801400|FG000|Overall Study|Withdrawal by Subject|1|||
23841926|NCT03339726|66801401|FG001|Overall Study|Withdrawal by Subject|0|||
23841927|NCT03339726|66801402|FG002|Overall Study|Withdrawal by Subject|0|||
23841928|NCT03339726|66801400|FG000|Overall Study|Lost to Follow-up|0|||
23841929|NCT03339726|66801401|FG001|Overall Study|Lost to Follow-up|1|||
23581118|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
23581119|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
23581120|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
23581121|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
23581122|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
23581123|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
23581124|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
23581125|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
23581126|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
23581127|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
23581128|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
23581129|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
23581130|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
23841930|NCT03339726|66801402|FG002|Overall Study|Lost to Follow-up|0|||
23841931|NCT00627445|66801403|FG000|Overall Study|Adverse Event|3|||
23841932|NCT00627445|66801404|FG001|Overall Study|Adverse Event|3|||
23841933|NCT00627445|66801403|FG000|Overall Study|Lack of Efficacy|0|||
23841934|NCT00627445|66801404|FG001|Overall Study|Lack of Efficacy|1|||
23841935|NCT00627445|66801403|FG000|Overall Study|Other|6|||
23841936|NCT00627445|66801404|FG001|Overall Study|Other|8|||
23841937|NCT03865316|66801410|FG000|Overall Study|Procedure Cancelled|4|||
23841938|NCT03865316|66801410|FG000|Overall Study|Equipment failure|4|||
23841939|NCT02055365|66801411|FG000|Overall Study|Prematurely Withdrawn|1|||
23841940|NCT00754234|66801412|FG000|Overall Study|Withdrawal by Subject|3|||
23841941|NCT00930774|66801413|FG000|Overall Study|Withdrawal by Subject|1|||
23841942|NCT00930774|66801414|FG001|Overall Study|Withdrawal by Subject|9|||
23841943|NCT00930774|66801415|FG002|Overall Study|Withdrawal by Subject|2|||
23841944|NCT00930774|66801416|FG003|Overall Study|Withdrawal by Subject|0|||
23841945|NCT04666259|66801417|FG000|Overall Study|ongoing at data cut-off|6|||
23841946|NCT04666259|66801418|FG001|Overall Study|ongoing at data cut-off|14|||
23841947|NCT04666259|66801419|FG002|Overall Study|ongoing at data cut-off|0|||
23841948|NCT04666259|66801417|FG000|Overall Study|Progressive Disease|0|||
23841949|NCT04666259|66801418|FG001|Overall Study|Progressive Disease|1|||
23841950|NCT04666259|66801419|FG002|Overall Study|Progressive Disease|0|||
23581131|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
23841951|NCT04666259|66801417|FG000|Overall Study|Physician Decision|9|||
23841952|NCT04666259|66801418|FG001|Overall Study|Physician Decision|3|||
23841953|NCT04666259|66801419|FG002|Overall Study|Physician Decision|3|||
23841954|NCT04666259|66801417|FG000|Overall Study|Adverse Event|3|||
23841955|NCT04666259|66801418|FG001|Overall Study|Adverse Event|1|||
23841956|NCT04666259|66801419|FG002|Overall Study|Adverse Event|0|||
23841957|NCT04666259|66801417|FG000|Overall Study|Withdrawal by Subject|1|||
23841958|NCT04666259|66801418|FG001|Overall Study|Withdrawal by Subject|2|||
23841959|NCT04666259|66801419|FG002|Overall Study|Withdrawal by Subject|0|||
23841960|NCT04666259|66801417|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
23581132|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
23581133|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
23841961|NCT04666259|66801418|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
23841962|NCT04666259|66801419|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
23841963|NCT00617890|66801420|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
23841964|NCT00617890|66801421|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
23581134|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
23581135|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
23581136|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
23581137|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
23581138|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
23581139|NCT02338609|65856820|FG000|Overall Study|Physician Decision|1|||
23581140|NCT02338609|65856820|FG000|Overall Study|Death|1|||
23581141|NCT03201809|65856821|FG000|Overall Study|Lost to Follow-up|2|||
23581142|NCT03201809|65856822|FG001|Overall Study|Lost to Follow-up|0|||
23581143|NCT00465361|65856823|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
23581144|NCT02368886|65856824|FG000|Overall Study|Cancel|1|||
23581145|NCT02368886|65856825|FG001|Overall Study|Cancel|1|||
23581146|NCT02368886|65856826|FG002|Overall Study|Cancel|1|||
23581147|NCT02368886|65856827|FG003|Overall Study|Cancel|3|||
23581148|NCT02368886|65856824|FG000|Overall Study|Ineligible|0|||
23581149|NCT02368886|65856825|FG001|Overall Study|Ineligible|0|||
23581150|NCT02368886|65856826|FG002|Overall Study|Ineligible|0|||
23581151|NCT02368886|65856827|FG003|Overall Study|Ineligible|1|||
23581152|NCT00797862|65856830|FG000|Overall Study|Adverse Event|86|||
23581153|NCT00797862|65856831|FG001|Overall Study|Adverse Event|44|||
23581154|NCT00797862|65856832|FG002|Overall Study|Adverse Event|58|||
23581155|NCT00797862|65856830|FG000|Overall Study|Abnormal Test Procedure Result|0|||
23581156|NCT00797862|65856831|FG001|Overall Study|Abnormal Test Procedure Result|1|||
23581157|NCT00797862|65856832|FG002|Overall Study|Abnormal Test Procedure Result|1|||
23581158|NCT00797862|65856830|FG000|Overall Study|Lack of Efficacy|1|||
23581159|NCT00797862|65856831|FG001|Overall Study|Lack of Efficacy|7|||
23581160|NCT00797862|65856832|FG002|Overall Study|Lack of Efficacy|6|||
23581161|NCT00797862|65856830|FG000|Overall Study|No longer required study medication|1|||
23581162|NCT00797862|65856831|FG001|Overall Study|No longer required study medication|0|||
23581163|NCT00797862|65856832|FG002|Overall Study|No longer required study medication|0|||
23581164|NCT00797862|65856830|FG000|Overall Study|Withdrawal by Subject|14|||
23581165|NCT00797862|65856831|FG001|Overall Study|Withdrawal by Subject|7|||
23581166|NCT00797862|65856832|FG002|Overall Study|Withdrawal by Subject|7|||
23581167|NCT00797862|65856830|FG000|Overall Study|Lost to Follow-up|11|||
23581168|NCT00797862|65856831|FG001|Overall Study|Lost to Follow-up|0|||
23581169|NCT00797862|65856832|FG002|Overall Study|Lost to Follow-up|5|||
23581170|NCT00797862|65856830|FG000|Overall Study|Administrative Problem|4|||
23581171|NCT00797862|65856831|FG001|Overall Study|Administrative Problem|0|||
23635856|NCT04860297|66052828|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
23635857|NCT04860297|66052829|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
23635858|NCT04860297|66052830|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
23635859|NCT04860297|66052831|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
23581172|NCT00797862|65856832|FG002|Overall Study|Administrative Problem|0|||
23581173|NCT00797862|65856830|FG000|Overall Study|Protocol Violation|4|||
23581174|NCT00797862|65856831|FG001|Overall Study|Protocol Violation|6|||
23841965|NCT00617890|66801422|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
23581175|NCT00797862|65856832|FG002|Overall Study|Protocol Violation|8|||
23581176|NCT00797862|65856830|FG000|Overall Study|Mis-randomized|3|||
23581177|NCT00797862|65856831|FG001|Overall Study|Mis-randomized|3|||
23635860|NCT04860297|66052832|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
23635861|NCT04860297|66052833|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
23635862|NCT04860297|66052826|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
23841966|NCT00617890|66801423|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
23841967|NCT00617890|66801420|FG000|Overall Study|Lack of Efficacy|23|||
23841968|NCT00617890|66801421|FG001|Overall Study|Lack of Efficacy|26|||
23841969|NCT00617890|66801422|FG002|Overall Study|Lack of Efficacy|30|||
23841970|NCT00617890|66801423|FG003|Overall Study|Lack of Efficacy|97|||
23841971|NCT00617890|66801420|FG000|Overall Study|Lost to Follow-up|0|||
23841972|NCT00617890|66801421|FG001|Overall Study|Lost to Follow-up|0|||
23841973|NCT00617890|66801422|FG002|Overall Study|Lost to Follow-up|1|||
23841974|NCT00617890|66801423|FG003|Overall Study|Lost to Follow-up|2|||
23581178|NCT00797862|65856832|FG002|Overall Study|Mis-randomized|1|||
23581179|NCT01244828|65856835|FG000|Overall Study|Adverse Event|37|||
23581180|NCT01244828|65856835|FG000|Overall Study|Withdrawal by Subject|31|||
23841975|NCT00617890|66801420|FG000|Overall Study|Withdrawal by Subject|4|||
23581181|NCT01244828|65856835|FG000|Overall Study|Lack of Efficacy|7|||
23581182|NCT01244828|65856835|FG000|Overall Study|Lost to Follow-up|2|||
23581183|NCT01244828|65856835|FG000|Overall Study|Other reason (not specified)|1|||
23841976|NCT00617890|66801421|FG001|Overall Study|Withdrawal by Subject|1|||
23841977|NCT00617890|66801422|FG002|Overall Study|Withdrawal by Subject|0|||
23581184|NCT04530344|65856838|FG000|Overall Study|Lost to Follow-up|3|||
23581185|NCT04530344|65856839|FG001|Overall Study|Lost to Follow-up|3|||
23581186|NCT04530344|65856840|FG002|Overall Study|Lost to Follow-up|3|||
23581187|NCT04530344|65856841|FG003|Overall Study|Lost to Follow-up|10|||
23581188|NCT04530344|65856838|FG000|Overall Study|Withdrawal by Subject|14|||
23581189|NCT04530344|65856839|FG001|Overall Study|Withdrawal by Subject|5|||
23581190|NCT04530344|65856840|FG002|Overall Study|Withdrawal by Subject|18|||
23581191|NCT04530344|65856841|FG003|Overall Study|Withdrawal by Subject|33|||
23581192|NCT04530344|65856838|FG000|Overall Study|Adverse Event|0|||
23581193|NCT04530344|65856839|FG001|Overall Study|Adverse Event|0|||
23581194|NCT04530344|65856840|FG002|Overall Study|Adverse Event|0|||
23581195|NCT04530344|65856841|FG003|Overall Study|Adverse Event|1|||
23581196|NCT04530344|65856838|FG000|Overall Study|Lack of Efficacy|0|||
23581197|NCT04530344|65856839|FG001|Overall Study|Lack of Efficacy|0|||
23581198|NCT04530344|65856840|FG002|Overall Study|Lack of Efficacy|0|||
23581199|NCT04530344|65856841|FG003|Overall Study|Lack of Efficacy|1|||
23581200|NCT04530344|65856838|FG000|Overall Study|Physician Decision|0|||
23340473|NCT02989649|64992790|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
23340474|NCT02989649|64992790|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
23340475|NCT02989649|64992790|FG000|Overall Study|Lost For Observation During Study|3|||
23340476|NCT02989649|64992790|FG000|Overall Study|Reason Not Specified|13|||
23340477|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
23340478|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
23340479|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
23340480|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
23340481|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23340482|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23340483|NCT01597375|64992791|FG000|Washout (2 Weeks)|Adverse Event|1|||
23340484|NCT01597375|64992792|FG001|Washout (2 Weeks)|Adverse Event|0|||
23340485|NCT01597375|64992791|FG000|Second Intervention|Failed to react at both Aspirin|1|||
23340486|NCT01597375|64992792|FG001|Second Intervention|Failed to react at both Aspirin|1|||
23581201|NCT04530344|65856839|FG001|Overall Study|Physician Decision|0|||
23635863|NCT04860297|66052827|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
23635864|NCT04860297|66052828|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
23635865|NCT04860297|66052829|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
23635866|NCT04860297|66052830|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
23635867|NCT04860297|66052831|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
23635868|NCT04860297|66052832|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
23635869|NCT04860297|66052833|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
23635870|NCT04860297|66052826|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
23635871|NCT04860297|66052827|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
23635872|NCT04860297|66052828|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
23635873|NCT04860297|66052829|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
23635874|NCT04860297|66052830|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
23635875|NCT04860297|66052831|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
23635876|NCT04860297|66052832|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
23635877|NCT04860297|66052833|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
23635878|NCT04860297|66052826|FG000|Part B (Booster Dose)|Other Than Specified|0|||
23635879|NCT04860297|66052827|FG001|Part B (Booster Dose)|Other Than Specified|0|||
23635880|NCT04860297|66052828|FG002|Part B (Booster Dose)|Other Than Specified|0|||
23635881|NCT04860297|66052829|FG003|Part B (Booster Dose)|Other Than Specified|0|||
23635882|NCT04860297|66052830|FG004|Part B (Booster Dose)|Other Than Specified|0|||
23635883|NCT04860297|66052831|FG005|Part B (Booster Dose)|Other Than Specified|1|||
23635884|NCT04860297|66052832|FG006|Part B (Booster Dose)|Other Than Specified|1|||
23635885|NCT04860297|66052833|FG007|Part B (Booster Dose)|Other Than Specified|0|||
23635886|NCT04860297|66052826|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635887|NCT04860297|66052827|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635888|NCT04860297|66052828|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635889|NCT04860297|66052829|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635890|NCT04860297|66052830|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635891|NCT04860297|66052831|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
23635892|NCT04860297|66052832|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
23635893|NCT04860297|66052833|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
23635894|NCT04860297|66052826|FG000|Part B (Booster Dose)|Death|0|||
23581202|NCT04530344|65856840|FG002|Overall Study|Physician Decision|1|||
23581203|NCT04530344|65856841|FG003|Overall Study|Physician Decision|1|||
23581204|NCT04530344|65856838|FG000|Overall Study|Pregnancy|0|||
23635895|NCT04860297|66052827|FG001|Part B (Booster Dose)|Death|0|||
23635896|NCT04860297|66052828|FG002|Part B (Booster Dose)|Death|0|||
23781423|NCT00731783|66580243|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
23340487|NCT01346189|64992793|FG000|Overall Study|Withdrawal by Subject|7|||
23340488|NCT01346189|64992794|FG001|Overall Study|Withdrawal by Subject|5|||
23581205|NCT04530344|65856839|FG001|Overall Study|Pregnancy|0|||
23581206|NCT04530344|65856840|FG002|Overall Study|Pregnancy|2|||
23581207|NCT04530344|65856841|FG003|Overall Study|Pregnancy|1|||
23581208|NCT04530344|65856838|FG000|Overall Study|Protocol Violation|0|||
23581209|NCT04530344|65856839|FG001|Overall Study|Protocol Violation|0|||
23581210|NCT04530344|65856840|FG002|Overall Study|Protocol Violation|0|||
23581211|NCT04530344|65856841|FG003|Overall Study|Protocol Violation|1|||
23581212|NCT04530344|65856838|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
23581213|NCT04530344|65856839|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
23581214|NCT04530344|65856840|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
23581215|NCT04530344|65856841|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
23581216|NCT04530344|65856838|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581217|NCT04530344|65856839|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581218|NCT04530344|65856840|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
23581219|NCT04530344|65856841|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581220|NCT04530344|65856838|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
23581221|NCT04530344|65856839|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
23581222|NCT04530344|65856840|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
23581223|NCT04530344|65856841|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
23841978|NCT00617890|66801423|FG003|Overall Study|Withdrawal by Subject|2|||
23841979|NCT00617890|66801420|FG000|Overall Study|Protocol Violation|2|||
23841980|NCT00617890|66801421|FG001|Overall Study|Protocol Violation|1|||
23841981|NCT00617890|66801422|FG002|Overall Study|Protocol Violation|0|||
23841982|NCT00617890|66801423|FG003|Overall Study|Protocol Violation|0|||
23841983|NCT00617890|66801420|FG000|Overall Study|Adverse Event|1|||
23841984|NCT00617890|66801421|FG001|Overall Study|Adverse Event|0|||
23841985|NCT00617890|66801422|FG002|Overall Study|Adverse Event|3|||
23841986|NCT00617890|66801423|FG003|Overall Study|Adverse Event|8|||
23841987|NCT00617890|66801420|FG000|Overall Study|Not treated|1|||
23841988|NCT00617890|66801421|FG001|Overall Study|Not treated|0|||
23841989|NCT00617890|66801422|FG002|Overall Study|Not treated|1|||
23841990|NCT00617890|66801423|FG003|Overall Study|Not treated|1|||
23841991|NCT01094301|66801424|FG000|Trial Stage|Withdrawal by Subject|1|||
23841992|NCT01094301|66801424|FG000|Implant Stage|Adverse Event|1|||
23841993|NCT01094301|66801424|FG000|Implant Stage|Protocol Violation|1|||
23841994|NCT01094301|66801424|FG000|Implant Stage|Withdrawal by Subject|2|||
23841995|NCT01094301|66801424|FG000|Implant Stage|No return of pain|4|||
23841996|NCT00932373|66801432|FG000|Overall Study|Progressive disease|3|||
23841997|NCT00932373|66801433|FG001|Overall Study|Progressive disease|1|||
23841998|NCT00932373|66801434|FG002|Overall Study|Progressive disease|0|||
23841999|NCT00932373|66801435|FG003|Overall Study|Progressive disease|0|||
23842000|NCT00932373|66801436|FG004|Overall Study|Progressive disease|10|||
23842001|NCT00932373|66801437|FG005|Overall Study|Progressive disease|1|||
23842002|NCT00932373|66801438|FG006|Overall Study|Progressive disease|0|||
23842003|NCT00932373|66801439|FG007|Overall Study|Progressive disease|2|||
23581224|NCT04530344|65856838|FG000|Overall Study|Personal Reasons|0|||
23581225|NCT04530344|65856839|FG001|Overall Study|Personal Reasons|0|||
23581226|NCT04530344|65856840|FG002|Overall Study|Personal Reasons|0|||
23581227|NCT04530344|65856841|FG003|Overall Study|Personal Reasons|1|||
23581228|NCT04530344|65856838|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581229|NCT04530344|65856839|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581230|NCT04530344|65856840|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581231|NCT04530344|65856841|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
23581232|NCT02321540|65856842|FG000|Overall Study|Death|0|||
23581233|NCT02321540|65856843|FG001|Overall Study|Death|1|||
23581234|NCT02321540|65856842|FG000|Overall Study|Progression|3|||
23581235|NCT02321540|65856843|FG001|Overall Study|Progression|9|||
23581236|NCT03971357|65856846|FG000|Overall Study|Lack of Efficacy|0|||
23581237|NCT03971357|65856847|FG001|Overall Study|Lack of Efficacy|1|||
23581238|NCT00852475|65856849|FG000|Overall Study|Lost to Follow-up|3|||
23581239|NCT00852475|65856850|FG001|Overall Study|Lost to Follow-up|4|||
23581240|NCT03836664|65856851|FG000|Overall Study|Didn't complete forms and lost drug|3|||
23581241|NCT03836664|65856852|FG001|Overall Study|Didn't complete forms and lost drug|3|||
23581242|NCT01687270|65856853|FG000|Overall Study|Lack of Efficacy|11|||
23581243|NCT01687270|65856853|FG000|Overall Study|Lost to Follow-up|1|||
23842004|NCT00932373|66801440|FG008|Overall Study|Progressive disease|1|||
23581244|NCT05233085|65856855|FG000|Overall Study|Adverse Event|1|||
23581245|NCT05233085|65856856|FG001|Overall Study|Adverse Event|0|||
23581246|NCT05233085|65856857|FG002|Overall Study|Adverse Event|0|||
23842005|NCT00932373|66801441|FG009|Overall Study|Progressive disease|9|||
23842006|NCT00932373|66801442|FG010|Overall Study|Progressive disease|2|||
23842007|NCT00932373|66801432|FG000|Overall Study|Adverse Event|0|||
23842008|NCT00932373|66801433|FG001|Overall Study|Adverse Event|0|||
23581247|NCT05233085|65856858|FG003|Overall Study|Adverse Event|0|||
23581248|NCT05780047|65856861|FG000|Overall Study|Did not submit baseline urine test kit|226|||
23581249|NCT05780047|65856861|FG000|Overall Study|Lost to Follow-up|34|||
23842009|NCT00932373|66801434|FG002|Overall Study|Adverse Event|0|||
23581250|NCT05780047|65856861|FG000|Overall Study|Did not submit second urine test kit|124|||
23842010|NCT00932373|66801435|FG003|Overall Study|Adverse Event|0|||
23842011|NCT00932373|66801436|FG004|Overall Study|Adverse Event|2|||
23581251|NCT05310084|65856862|FG000|Overall Study|Withdrawal by Subject|2|||
23581252|NCT05310084|65856863|FG001|Overall Study|Withdrawal by Subject|3|||
23581253|NCT05310084|65856862|FG000|Overall Study|Participant availability|0|||
23581254|NCT05310084|65856863|FG001|Overall Study|Participant availability|4|||
23581255|NCT05310084|65856862|FG000|Overall Study|Lost to Follow-up|1|||
23581256|NCT05310084|65856863|FG001|Overall Study|Lost to Follow-up|1|||
23581257|NCT05310084|65856862|FG000|Overall Study|Adverse Event|1|||
23581258|NCT05310084|65856863|FG001|Overall Study|Adverse Event|1|||
23581259|NCT05310084|65856862|FG000|Overall Study|Randomized but not vaccinated|4|||
23581260|NCT05310084|65856863|FG001|Overall Study|Randomized but not vaccinated|2|||
23581261|NCT04550039|65856865|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
23581262|NCT04550039|65856866|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
23581263|NCT04550039|65856865|FG000|Overall Study|patient self-withdrew from study|0|||
23581264|NCT04550039|65856866|FG001|Overall Study|patient self-withdrew from study|1|||
23581265|NCT00751790|65856872|FG000|Overall Study|Lost to Follow-up|1|||
23581266|NCT00751790|65856872|FG000|Overall Study|Death|3|||
23581267|NCT00751790|65856872|FG000|Overall Study|Withdrawal by Subject|1|||
23581268|NCT01645111|65856879|FG000|Overall Study|Did not require Clevidipine|15|||
23581269|NCT00531479|65856884|FG000|Overall Study|Death|68|||
23581270|NCT00531479|65856885|FG001|Overall Study|Death|71|||
23340489|NCT01346189|64992795|FG002|Overall Study|Withdrawal by Subject|3|||
23340490|NCT01346189|64992796|FG003|Overall Study|Withdrawal by Subject|5|||
23340491|NCT01346189|64992793|FG000|Overall Study|Physician Decision|4|||
23340492|NCT01346189|64992794|FG001|Overall Study|Physician Decision|0|||
23340493|NCT01346189|64992795|FG002|Overall Study|Physician Decision|0|||
23340494|NCT01346189|64992796|FG003|Overall Study|Physician Decision|0|||
23581271|NCT00531479|65856884|FG000|Overall Study|Lost to Follow-up|0|||
23581272|NCT00531479|65856885|FG001|Overall Study|Lost to Follow-up|2|||
23581273|NCT00531479|65856884|FG000|Overall Study|Other|0|||
23581274|NCT00531479|65856885|FG001|Overall Study|Other|1|||
23581275|NCT00531479|65856884|FG000|Overall Study|Withdrawal by Subject|6|||
23581276|NCT00531479|65856885|FG001|Overall Study|Withdrawal by Subject|6|||
23581277|NCT00531479|65856884|FG000|Overall Study|Did not receive treatment|2|||
23581278|NCT00531479|65856885|FG001|Overall Study|Did not receive treatment|3|||
23581279|NCT01518257|65856888|FG000|Overall Study|Lost to Follow-up|1|||
23581280|NCT01518257|65856889|FG001|Overall Study|Lost to Follow-up|0|||
23581281|NCT01518257|65856888|FG000|Overall Study|Other Miscellaneous Reason|1|||
23581282|NCT01518257|65856889|FG001|Overall Study|Other Miscellaneous Reason|0|||
23581283|NCT04213846|65856890|FG000|Overall Study|Withdrawal by Subject|7|||
23842012|NCT00932373|66801437|FG005|Overall Study|Adverse Event|1|||
23842013|NCT00932373|66801438|FG006|Overall Study|Adverse Event|0|||
23842014|NCT00932373|66801439|FG007|Overall Study|Adverse Event|1|||
23842015|NCT00932373|66801440|FG008|Overall Study|Adverse Event|0|||
23842016|NCT00932373|66801441|FG009|Overall Study|Adverse Event|2|||
23842017|NCT00932373|66801442|FG010|Overall Study|Adverse Event|1|||
23842018|NCT00932373|66801432|FG000|Overall Study|Physician Decision|0|||
23842019|NCT00932373|66801433|FG001|Overall Study|Physician Decision|0|||
23842020|NCT00932373|66801434|FG002|Overall Study|Physician Decision|1|||
23842021|NCT00932373|66801435|FG003|Overall Study|Physician Decision|0|||
23842022|NCT00932373|66801436|FG004|Overall Study|Physician Decision|2|||
23842023|NCT00932373|66801437|FG005|Overall Study|Physician Decision|0|||
23581284|NCT04213846|65856891|FG001|Overall Study|Withdrawal by Subject|6|||
23581285|NCT04213846|65856890|FG000|Overall Study|Lost to Follow-up|15|||
23581286|NCT04213846|65856891|FG001|Overall Study|Lost to Follow-up|21|||
23581287|NCT02775851|65856894|FG000|Overall Study|Adverse Event|1|||
23340495|NCT01346189|64992793|FG000|Overall Study|Moved|3|||
23340496|NCT01346189|64992794|FG001|Overall Study|Moved|0|||
23340497|NCT01346189|64992795|FG002|Overall Study|Moved|4|||
23340498|NCT01346189|64992796|FG003|Overall Study|Moved|0|||
23340499|NCT01346189|64992793|FG000|Overall Study|Other|2|||
23340500|NCT01346189|64992794|FG001|Overall Study|Other|4|||
23581288|NCT02775851|65856895|FG001|Overall Study|Adverse Event|10|||
23581289|NCT02775851|65856894|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
23340501|NCT01346189|64992795|FG002|Overall Study|Other|7|||
23581290|NCT02775851|65856895|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
23581291|NCT02775851|65856894|FG000|Overall Study|Progression/Relapse|0|||
23581292|NCT02775851|65856895|FG001|Overall Study|Progression/Relapse|4|||
23581293|NCT02775851|65856894|FG000|Overall Study|Other - Not Protocol Specified|0|||
23635897|NCT04860297|66052829|FG003|Part B (Booster Dose)|Death|0|||
23842024|NCT00932373|66801438|FG006|Overall Study|Physician Decision|0|||
23842025|NCT00932373|66801439|FG007|Overall Study|Physician Decision|0|||
23340502|NCT01346189|64992796|FG003|Overall Study|Other|3|||
23340503|NCT01346189|64992793|FG000|Overall Study|Death|0|||
23340504|NCT01346189|64992794|FG001|Overall Study|Death|3|||
23581294|NCT02775851|65856895|FG001|Overall Study|Other - Not Protocol Specified|7|||
23581295|NCT02775851|65856894|FG000|Overall Study|Withdrawal by Subject|1|||
23581296|NCT02775851|65856895|FG001|Overall Study|Withdrawal by Subject|0|||
23842026|NCT00932373|66801440|FG008|Overall Study|Physician Decision|0|||
23842027|NCT00932373|66801441|FG009|Overall Study|Physician Decision|1|||
23842028|NCT00932373|66801442|FG010|Overall Study|Physician Decision|0|||
23842029|NCT00932373|66801432|FG000|Overall Study|Dose limiting toxicity|0|||
23842030|NCT00932373|66801433|FG001|Overall Study|Dose limiting toxicity|0|||
23842031|NCT00932373|66801434|FG002|Overall Study|Dose limiting toxicity|0|||
23842032|NCT00932373|66801435|FG003|Overall Study|Dose limiting toxicity|0|||
23842033|NCT00932373|66801436|FG004|Overall Study|Dose limiting toxicity|0|||
23842034|NCT00932373|66801437|FG005|Overall Study|Dose limiting toxicity|1|||
23635898|NCT04860297|66052830|FG004|Part B (Booster Dose)|Death|1|||
23635899|NCT04860297|66052831|FG005|Part B (Booster Dose)|Death|2|||
23635900|NCT04860297|66052832|FG006|Part B (Booster Dose)|Death|1|||
23635901|NCT04860297|66052833|FG007|Part B (Booster Dose)|Death|0|||
23635902|NCT04860297|66052826|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
23635903|NCT04860297|66052827|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
23842035|NCT00932373|66801438|FG006|Overall Study|Dose limiting toxicity|0|||
23842036|NCT00932373|66801439|FG007|Overall Study|Dose limiting toxicity|0|||
23842037|NCT00932373|66801440|FG008|Overall Study|Dose limiting toxicity|0|||
23842038|NCT00932373|66801441|FG009|Overall Study|Dose limiting toxicity|0|||
23635904|NCT04860297|66052828|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
23635905|NCT04860297|66052829|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
23635906|NCT04860297|66052830|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
23635907|NCT04860297|66052831|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
23635908|NCT04860297|66052832|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
23581297|NCT00577629|65856896|FG000|Treatment Period|Death|1|||
23581298|NCT00577629|65856896|FG000|Long Term Follow-Up|Death|15|||
23581299|NCT00577629|65856896|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
23581300|NCT00577629|65856896|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
23581301|NCT00577629|65856896|FG000|Long Term Follow-Up|Physician Decision|1|||
23581302|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
23581303|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
23581304|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
23581305|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
23635909|NCT04860297|66052833|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
23635910|NCT00964886|66052834|FG000|Overall Study|Lost to Follow-up|2|||
23635911|NCT00964886|66052835|FG001|Overall Study|Lost to Follow-up|2|||
23635912|NCT00964886|66052836|FG002|Overall Study|Lost to Follow-up|6|||
23635913|NCT00964886|66052837|FG003|Overall Study|Lost to Follow-up|4|||
23581306|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
23581307|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
23581308|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
23581309|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
23581310|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
23581311|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
23581312|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
23581313|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
23581314|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
23581315|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
23581316|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
23581317|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
23581318|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
23581319|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
23581320|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
23581321|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
23581322|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
23581323|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
23581324|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
23581325|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
23581326|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581327|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581328|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
23635914|NCT00964886|66052834|FG000|Overall Study|Withdrawal by Subject|6|||
23635915|NCT00964886|66052835|FG001|Overall Study|Withdrawal by Subject|2|||
23635916|NCT00964886|66052836|FG002|Overall Study|Withdrawal by Subject|5|||
23581329|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581330|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
23581331|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
23635917|NCT00964886|66052837|FG003|Overall Study|Withdrawal by Subject|3|||
23635918|NCT00964886|66052834|FG000|Overall Study|Adverse Event|3|||
23635919|NCT00964886|66052835|FG001|Overall Study|Adverse Event|1|||
23842039|NCT00932373|66801442|FG010|Overall Study|Dose limiting toxicity|0|||
23581332|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
23581333|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
23842040|NCT00932373|66801432|FG000|Overall Study|Withdrawal by Subject|0|||
23635920|NCT00964886|66052836|FG002|Overall Study|Adverse Event|5|||
23635921|NCT00964886|66052837|FG003|Overall Study|Adverse Event|2|||
23635922|NCT00964886|66052834|FG000|Overall Study|Protocol Violation|0|||
23635923|NCT00964886|66052835|FG001|Overall Study|Protocol Violation|2|||
23635924|NCT00964886|66052836|FG002|Overall Study|Protocol Violation|0|||
23635925|NCT00964886|66052837|FG003|Overall Study|Protocol Violation|0|||
23635926|NCT03635099|66052838|FG000|Period 1|Adverse Event|1|||
23635927|NCT03635099|66052839|FG001|Period 1|Adverse Event|0|||
23635928|NCT03635099|66052840|FG002|Period 1|Adverse Event|0|||
23635929|NCT03635099|66052841|FG003|Period 1|Adverse Event|1|||
23635930|NCT03635099|66052842|FG004|Period 1|Adverse Event|0|||
23635931|NCT03635099|66052843|FG005|Period 1|Adverse Event|0|||
23635932|NCT03635099|66052844|FG006|Period 1|Adverse Event|0|||
23635933|NCT03635099|66052845|FG007|Period 1|Adverse Event|0|||
23635934|NCT03635099|66052838|FG000|Period 1|Protocol Violation|0|||
23635935|NCT03635099|66052839|FG001|Period 1|Protocol Violation|0|||
23635936|NCT03635099|66052840|FG002|Period 1|Protocol Violation|1|||
23781424|NCT00731783|66580242|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
23781425|NCT00731783|66580243|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
23781426|NCT01566721|66580246|FG000|Treatment Period|Withdrawal by Subject|35|||
23781427|NCT01566721|66580247|FG001|Treatment Period|Withdrawal by Subject|9|||
23781428|NCT01566721|66580246|FG000|Treatment Period|Disease Progression/Recurrence|37|||
23340505|NCT01346189|64992795|FG002|Overall Study|Death|0|||
23340506|NCT01346189|64992796|FG003|Overall Study|Death|0|||
23340507|NCT01346189|64992793|FG000|Overall Study|Non-health system primary care physician|0|||
23340508|NCT01346189|64992794|FG001|Overall Study|Non-health system primary care physician|5|||
23340509|NCT01346189|64992795|FG002|Overall Study|Non-health system primary care physician|0|||
23340510|NCT01346189|64992796|FG003|Overall Study|Non-health system primary care physician|0|||
23340511|NCT01346189|64992793|FG000|Overall Study|Travel|0|||
23340512|NCT01346189|64992794|FG001|Overall Study|Travel|0|||
23340513|NCT01346189|64992795|FG002|Overall Study|Travel|0|||
23340514|NCT01346189|64992796|FG003|Overall Study|Travel|3|||
23340515|NCT02968433|64992797|FG000|Overall Study|Withdrawal by Subject|1|||
23340516|NCT03852628|64992802|FG000|Overall Study|Lost to Follow-up|7|||
23340517|NCT03852628|64992803|FG001|Overall Study|Lost to Follow-up|6|||
23340518|NCT03852628|64992802|FG000|Overall Study|Lack of Efficacy|6|||
23340519|NCT03852628|64992803|FG001|Overall Study|Lack of Efficacy|6|||
23340520|NCT03937908|64992805|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
23340521|NCT03937908|64992806|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
23340522|NCT02847494|64992807|FG000|Overall Study|Lost to Follow-up|8|||
23635937|NCT03635099|66052841|FG003|Period 1|Protocol Violation|0|||
23635938|NCT03635099|66052842|FG004|Period 1|Protocol Violation|0|||
23635939|NCT03635099|66052843|FG005|Period 1|Protocol Violation|0|||
23781429|NCT01566721|66580247|FG001|Treatment Period|Disease Progression/Recurrence|13|||
23781430|NCT01566721|66580246|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
23781431|NCT01566721|66580247|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
23635940|NCT03635099|66052844|FG006|Period 1|Protocol Violation|0|||
23635941|NCT03635099|66052845|FG007|Period 1|Protocol Violation|0|||
23635942|NCT03635099|66052838|FG000|Period 1|Lost to Follow-up|0|||
23635943|NCT03635099|66052839|FG001|Period 1|Lost to Follow-up|0|||
23635944|NCT03635099|66052840|FG002|Period 1|Lost to Follow-up|1|||
23635945|NCT03635099|66052841|FG003|Period 1|Lost to Follow-up|2|||
23635946|NCT03635099|66052842|FG004|Period 1|Lost to Follow-up|1|||
23635947|NCT03635099|66052843|FG005|Period 1|Lost to Follow-up|0|||
23635948|NCT03635099|66052844|FG006|Period 1|Lost to Follow-up|1|||
23635949|NCT03635099|66052845|FG007|Period 1|Lost to Follow-up|2|||
23635950|NCT03635099|66052838|FG000|Period 1|Withdrawal by Subject|3|||
23635951|NCT03635099|66052839|FG001|Period 1|Withdrawal by Subject|3|||
23635952|NCT03635099|66052840|FG002|Period 1|Withdrawal by Subject|5|||
23635953|NCT03635099|66052841|FG003|Period 1|Withdrawal by Subject|2|||
23635954|NCT03635099|66052842|FG004|Period 1|Withdrawal by Subject|2|||
23635955|NCT03635099|66052843|FG005|Period 1|Withdrawal by Subject|0|||
23635956|NCT03635099|66052844|FG006|Period 1|Withdrawal by Subject|3|||
23781432|NCT01566721|66580246|FG000|Treatment Period|Other|13|||
23340523|NCT02847494|64992808|FG001|Overall Study|Lost to Follow-up|5|||
23340524|NCT01967706|64992814|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23340525|NCT01967706|64992815|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23340526|NCT01967706|64992816|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23635957|NCT03635099|66052845|FG007|Period 1|Withdrawal by Subject|0|||
23635958|NCT03635099|66052838|FG000|Period 1|History of suicidal ideation|0|||
23635959|NCT03635099|66052839|FG001|Period 1|History of suicidal ideation|0|||
23635960|NCT03635099|66052840|FG002|Period 1|History of suicidal ideation|1|||
23635961|NCT03635099|66052841|FG003|Period 1|History of suicidal ideation|0|||
23635962|NCT03635099|66052842|FG004|Period 1|History of suicidal ideation|0|||
23635963|NCT03635099|66052843|FG005|Period 1|History of suicidal ideation|0|||
23635964|NCT03635099|66052844|FG006|Period 1|History of suicidal ideation|0|||
23635965|NCT03635099|66052845|FG007|Period 1|History of suicidal ideation|0|||
23781433|NCT01566721|66580247|FG001|Treatment Period|Other|2|||
23452501|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452502|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
23581334|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
23581335|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
23581336|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
23581337|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
23581338|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
23581339|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
23581340|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
23581341|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
23581342|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
23581343|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
23581344|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
23581345|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
23581346|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
23581347|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
23581348|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
23581349|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
23581350|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
23581351|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
23581352|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
23581353|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
23581354|NCT02263885|65856902|FG000|Overall Study|Withdrawal by Subject|7|||
23581355|NCT02263885|65856902|FG000|Overall Study|Alternative Treatment|3|||
23581356|NCT02724020|65856906|FG000|Overall Study|Death|16|||
23581357|NCT02724020|65856907|FG001|Overall Study|Death|18|||
23581358|NCT02724020|65856908|FG002|Overall Study|Death|19|||
23581359|NCT02724020|65856906|FG000|Overall Study|Lost to Follow-up|0|||
23581360|NCT02724020|65856907|FG001|Overall Study|Lost to Follow-up|3|||
23581361|NCT02724020|65856908|FG002|Overall Study|Lost to Follow-up|0|||
23581362|NCT02724020|65856906|FG000|Overall Study|Site Terminated by Sponsor|15|||
23581363|NCT02724020|65856907|FG001|Overall Study|Site Terminated by Sponsor|8|||
23581364|NCT02724020|65856908|FG002|Overall Study|Site Terminated by Sponsor|8|||
23581365|NCT02724020|65856906|FG000|Overall Study|Withdrawal by Subject|1|||
23581366|NCT02724020|65856907|FG001|Overall Study|Withdrawal by Subject|3|||
23581367|NCT02724020|65856908|FG002|Overall Study|Withdrawal by Subject|5|||
23781434|NCT01566721|66580246|FG000|Treatment Period|Lack of Compliance|5|||
23781435|NCT01566721|66580247|FG001|Treatment Period|Lack of Compliance|1|||
23781436|NCT01566721|66580246|FG000|Treatment Period|Adverse Event|100|||
23781437|NCT01566721|66580247|FG001|Treatment Period|Adverse Event|30|||
23781438|NCT01566721|66580246|FG000|Treatment Period|Pregnancy|1|||
23781439|NCT01566721|66580247|FG001|Treatment Period|Pregnancy|0|||
23781440|NCT01566721|66580246|FG000|Safety Follow-up|Physician Decision|6|||
23581392|NCT01388543|65856913|FG000|Day 14|Adverse Event|1|||
23781441|NCT01566721|66580247|FG001|Safety Follow-up|Physician Decision|4|||
23581393|NCT01388543|65856914|FG001|Day 14|Adverse Event|4|||
23581394|NCT02365298|65856917|FG000|Period 2|incorrect Rx dispensed|1|||
23581395|NCT02365298|65856918|FG001|Period 2|incorrect Rx dispensed|0|||
23581396|NCT02365298|65856917|FG000|Period 2|Discontinued at request of Sponsor|1|||
23581397|NCT02365298|65856918|FG001|Period 2|Discontinued at request of Sponsor|0|||
23581398|NCT02365298|65856917|FG000|Period 2|Test Article longer available|0|||
23781442|NCT01566721|66580246|FG000|Safety Follow-up|Lost to Follow-up|101|||
23581399|NCT02365298|65856918|FG001|Period 2|Test Article longer available|1|||
23581400|NCT02365298|65856917|FG000|Period 2|Protocol Violation|0|||
23581401|NCT02365298|65856918|FG001|Period 2|Protocol Violation|1|||
23581402|NCT00184028|65856919|FG000|Overall Study|Death|1|||
23581403|NCT00184028|65856919|FG000|Overall Study|Lack of Efficacy|4|||
23581404|NCT00184028|65856919|FG000|Overall Study|Adverse Event|2|||
23581405|NCT00184028|65856919|FG000|Overall Study|Withdrawal by Subject|1|||
23581406|NCT00184028|65856919|FG000|Overall Study|Non-compliance|2|||
23581407|NCT00594932|65856922|FG000|First 3 Months|Withdrawal by Subject|1|||
23581408|NCT00594932|65856923|FG001|First 3 Months|Withdrawal by Subject|3|||
23581409|NCT00594932|65856922|FG000|Final 3 Months|Withdrawal by Subject|4|||
23581410|NCT00594932|65856923|FG001|Final 3 Months|Withdrawal by Subject|3|||
23581411|NCT02952261|65856928|FG000|Overall Study|Withdrawal by Subject|4|||
23581412|NCT02952261|65856929|FG001|Overall Study|Withdrawal by Subject|5|||
23581413|NCT02952261|65856928|FG000|Overall Study|Protocol Violation|1|||
23581414|NCT02952261|65856929|FG001|Overall Study|Protocol Violation|0|||
23581415|NCT00836810|65856930|FG000|Overall Study|New diagnosis|1|||
23581416|NCT00836810|65856931|FG001|Overall Study|New diagnosis|0|||
23581417|NCT02320253|65856935|FG000|Overall Study|Withdrawal by Subject|3|||
23581418|NCT02320253|65856936|FG001|Overall Study|Withdrawal by Subject|0|||
23581419|NCT02320253|65856937|FG002|Overall Study|Withdrawal by Subject|0|||
23581420|NCT02320253|65856935|FG000|Overall Study|Lost to Follow-up|2|||
23581421|NCT02320253|65856936|FG001|Overall Study|Lost to Follow-up|2|||
23581422|NCT02320253|65856937|FG002|Overall Study|Lost to Follow-up|1|||
23581423|NCT02320253|65856935|FG000|Overall Study|Death|1|||
23340527|NCT01967706|64992817|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23340528|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
23340529|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
23340530|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
23340531|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
23452503|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23635966|NCT03635099|66052838|FG000|Period 1|pursue other treatment options|0|||
23635967|NCT03635099|66052839|FG001|Period 1|pursue other treatment options|0|||
23581424|NCT02320253|65856936|FG001|Overall Study|Death|0|||
23581425|NCT02320253|65856937|FG002|Overall Study|Death|1|||
23581426|NCT01072929|65856938|FG000|Overall Study|Adverse Event|8|||
23581427|NCT01072929|65856939|FG001|Overall Study|Adverse Event|11|||
23581428|NCT01072929|65856940|FG002|Overall Study|Adverse Event|2|||
23581429|NCT01072929|65856938|FG000|Overall Study|Lack of Efficacy|7|||
23581430|NCT01072929|65856939|FG001|Overall Study|Lack of Efficacy|4|||
23581431|NCT01072929|65856940|FG002|Overall Study|Lack of Efficacy|0|||
23581432|NCT01072929|65856938|FG000|Overall Study|Withdrawal by Subject|7|||
23581433|NCT01072929|65856939|FG001|Overall Study|Withdrawal by Subject|15|||
23581434|NCT01072929|65856940|FG002|Overall Study|Withdrawal by Subject|3|||
23581435|NCT01072929|65856938|FG000|Overall Study|Protocol Violation|13|||
23581436|NCT01072929|65856939|FG001|Overall Study|Protocol Violation|11|||
23581437|NCT01072929|65856940|FG002|Overall Study|Protocol Violation|2|||
23581438|NCT01072929|65856938|FG000|Overall Study|Lost to Follow-up|8|||
23581439|NCT01072929|65856939|FG001|Overall Study|Lost to Follow-up|4|||
23581440|NCT01072929|65856940|FG002|Overall Study|Lost to Follow-up|1|||
23581441|NCT01072929|65856938|FG000|Overall Study|Noncompliance with study medication|0|||
23581442|NCT01072929|65856939|FG001|Overall Study|Noncompliance with study medication|3|||
23581443|NCT01072929|65856940|FG002|Overall Study|Noncompliance with study medication|0|||
23581444|NCT01072929|65856938|FG000|Overall Study|Noncompliance with study procedures|1|||
23842041|NCT00932373|66801433|FG001|Overall Study|Withdrawal by Subject|0|||
23842042|NCT00932373|66801434|FG002|Overall Study|Withdrawal by Subject|0|||
23842043|NCT00932373|66801435|FG003|Overall Study|Withdrawal by Subject|0|||
23842044|NCT00932373|66801436|FG004|Overall Study|Withdrawal by Subject|0|||
23842045|NCT00932373|66801437|FG005|Overall Study|Withdrawal by Subject|0|||
23842046|NCT00932373|66801438|FG006|Overall Study|Withdrawal by Subject|0|||
23842047|NCT00932373|66801439|FG007|Overall Study|Withdrawal by Subject|0|||
23842048|NCT00932373|66801440|FG008|Overall Study|Withdrawal by Subject|1|||
23842049|NCT00932373|66801441|FG009|Overall Study|Withdrawal by Subject|0|||
23581445|NCT01072929|65856939|FG001|Overall Study|Noncompliance with study procedures|0|||
23842050|NCT00932373|66801442|FG010|Overall Study|Withdrawal by Subject|0|||
23842051|NCT00932373|66801432|FG000|Overall Study|Clinical progression|0|||
23842052|NCT00932373|66801433|FG001|Overall Study|Clinical progression|0|||
23842053|NCT00932373|66801434|FG002|Overall Study|Clinical progression|0|||
23340532|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23581446|NCT01072929|65856940|FG002|Overall Study|Noncompliance with study procedures|1|||
23581447|NCT01072929|65856938|FG000|Overall Study|Other|0|||
23581448|NCT01072929|65856939|FG001|Overall Study|Other|3|||
23581449|NCT01072929|65856940|FG002|Overall Study|Other|0|||
23581450|NCT02179918|65856947|FG000|Overall Study|Death|0|||
23581451|NCT02179918|65856948|FG001|Overall Study|Death|0|||
23581452|NCT02179918|65856949|FG002|Overall Study|Death|0|||
23581453|NCT02179918|65856950|FG003|Overall Study|Death|1|||
23581454|NCT02179918|65856951|FG004|Overall Study|Death|0|||
23581455|NCT02179918|65856947|FG000|Overall Study|Lost to Follow-up|0|||
23581456|NCT02179918|65856948|FG001|Overall Study|Lost to Follow-up|0|||
23581457|NCT02179918|65856949|FG002|Overall Study|Lost to Follow-up|1|||
23581458|NCT02179918|65856950|FG003|Overall Study|Lost to Follow-up|0|||
23581459|NCT02179918|65856951|FG004|Overall Study|Lost to Follow-up|0|||
23581460|NCT02179918|65856947|FG000|Overall Study|Progressive Disease|4|||
23581461|NCT02179918|65856948|FG001|Overall Study|Progressive Disease|1|||
23581462|NCT02179918|65856949|FG002|Overall Study|Progressive Disease|1|||
23581463|NCT02179918|65856950|FG003|Overall Study|Progressive Disease|2|||
23581464|NCT02179918|65856951|FG004|Overall Study|Progressive Disease|6|||
23581465|NCT02179918|65856947|FG000|Overall Study|Other|0|||
23581466|NCT02179918|65856948|FG001|Overall Study|Other|1|||
23581467|NCT02179918|65856949|FG002|Overall Study|Other|0|||
23581468|NCT02179918|65856950|FG003|Overall Study|Other|0|||
23581469|NCT02179918|65856951|FG004|Overall Study|Other|1|||
23581470|NCT02179918|65856947|FG000|Overall Study|Subject refused further follow-up|0|||
23581471|NCT02179918|65856948|FG001|Overall Study|Subject refused further follow-up|1|||
23581472|NCT02179918|65856949|FG002|Overall Study|Subject refused further follow-up|0|||
23581473|NCT02179918|65856950|FG003|Overall Study|Subject refused further follow-up|0|||
23581474|NCT02179918|65856951|FG004|Overall Study|Subject refused further follow-up|1|||
23635968|NCT03635099|66052840|FG002|Period 1|pursue other treatment options|0|||
23635969|NCT03635099|66052841|FG003|Period 1|pursue other treatment options|0|||
23635970|NCT03635099|66052842|FG004|Period 1|pursue other treatment options|0|||
23635971|NCT03635099|66052843|FG005|Period 1|pursue other treatment options|1|||
23635972|NCT03635099|66052844|FG006|Period 1|pursue other treatment options|0|||
23635973|NCT03635099|66052845|FG007|Period 1|pursue other treatment options|0|||
23581475|NCT01648283|65856955|FG000|Overall Study|Withdrawal by Subject|14|||
23581476|NCT02397889|65856956|FG000|Overall Study|Physician Decision|1|||
23581477|NCT02397889|65856957|FG001|Overall Study|Physician Decision|0|||
23581478|NCT01304706|65856958|FG000|Overall Study|Adverse Event|2|||
23635974|NCT03635099|66052838|FG000|Not Eligible for Period 2|Pregnancy|0|||
23635975|NCT03635099|66052839|FG001|Not Eligible for Period 2|Pregnancy|0|||
23635976|NCT03635099|66052840|FG002|Not Eligible for Period 2|Pregnancy|0|||
23635977|NCT03635099|66052841|FG003|Not Eligible for Period 2|Pregnancy|1|||
23635978|NCT03635099|66052842|FG004|Not Eligible for Period 2|Pregnancy|0|||
23635979|NCT03635099|66052843|FG005|Not Eligible for Period 2|Pregnancy|0|||
23635980|NCT03635099|66052844|FG006|Not Eligible for Period 2|Pregnancy|0|||
23635981|NCT03635099|66052845|FG007|Not Eligible for Period 2|Pregnancy|0|||
23635982|NCT03635099|66052838|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
23781443|NCT01566721|66580247|FG001|Safety Follow-up|Lost to Follow-up|48|||
23781444|NCT01566721|66580246|FG000|Safety Follow-up|Withdrawal by Subject|155|||
23781445|NCT01566721|66580247|FG001|Safety Follow-up|Withdrawal by Subject|49|||
23781446|NCT01566721|66580246|FG000|Safety Follow-up|Death|28|||
23781447|NCT01566721|66580247|FG001|Safety Follow-up|Death|4|||
23781448|NCT01566721|66580246|FG000|Safety Follow-up|Non-compliance|7|||
23781449|NCT01566721|66580247|FG001|Safety Follow-up|Non-compliance|3|||
23781450|NCT01566721|66580246|FG000|Safety Follow-up|Protocol Violation|7|||
23781451|NCT01566721|66580247|FG001|Safety Follow-up|Protocol Violation|0|||
23781452|NCT01566721|66580246|FG000|Safety Follow-up|Site closure|2|||
23781453|NCT01566721|66580247|FG001|Safety Follow-up|Site closure|3|||
23781454|NCT01566721|66580246|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
23781455|NCT01566721|66580247|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
23781456|NCT01566721|66580246|FG000|Safety Follow-up|Missing|7|||
23781457|NCT01566721|66580247|FG001|Safety Follow-up|Missing|2|||
23781458|NCT01566721|66580246|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
23781459|NCT01566721|66580247|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
23781460|NCT01566721|66580246|FG000|Safety Follow-up|Sponsor decision|1|||
23781461|NCT01566721|66580247|FG001|Safety Follow-up|Sponsor decision|0|||
23781462|NCT01566721|66580246|FG000|Safety Follow-up|Adverse Event|8|||
23781463|NCT01566721|66580247|FG001|Safety Follow-up|Adverse Event|4|||
23781464|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Adverse Event|22|||
23781465|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Adverse Event|0|||
23781466|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
23781467|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
23581479|NCT01304706|65856958|FG000|Overall Study|Lack of Efficacy|1|||
23581480|NCT01304706|65856958|FG000|Overall Study|Death|3|||
23581481|NCT01304706|65856958|FG000|Overall Study|Withdrawal by Subject|3|||
23581482|NCT01304706|65856958|FG000|Overall Study|Lost to Follow-up|7|||
23581483|NCT01304706|65856958|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
23581484|NCT02459964|65856960|FG000|Overall Study|Withdrawal by Subject|0|||
23635983|NCT03635099|66052839|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635984|NCT03635099|66052840|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635985|NCT03635099|66052841|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
23781468|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
23781469|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
23635986|NCT03635099|66052842|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635987|NCT03635099|66052843|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635988|NCT03635099|66052844|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635989|NCT03635099|66052845|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
23635990|NCT03635099|66052838|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23635991|NCT03635099|66052839|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23635992|NCT03635099|66052840|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23635993|NCT03635099|66052841|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23635994|NCT03635099|66052842|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23635995|NCT03635099|66052843|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
23635996|NCT03635099|66052844|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
23635997|NCT03635099|66052845|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
23635998|NCT03635099|66052838|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
23635999|NCT03635099|66052839|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
23636000|NCT03635099|66052840|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
23636001|NCT03635099|66052841|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
23636002|NCT03635099|66052842|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23636003|NCT03635099|66052843|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23581485|NCT02459964|65856961|FG001|Overall Study|Withdrawal by Subject|0|||
23581486|NCT02459964|65856962|FG002|Overall Study|Withdrawal by Subject|1|||
23581487|NCT02459964|65856960|FG000|Overall Study|Abnormal EKG changes|0|||
23581488|NCT02459964|65856961|FG001|Overall Study|Abnormal EKG changes|0|||
23636004|NCT03635099|66052844|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23581489|NCT02459964|65856962|FG002|Overall Study|Abnormal EKG changes|1|||
23581490|NCT01033643|65856965|FG000|Overall Study|Withdrew Consent|0|||
23581491|NCT01033643|65856966|FG001|Overall Study|Withdrew Consent|3|||
23581492|NCT01033643|65856967|FG002|Overall Study|Withdrew Consent|0|||
23581493|NCT01033643|65856968|FG003|Overall Study|Withdrew Consent|0|||
23581494|NCT01033643|65856969|FG004|Overall Study|Withdrew Consent|0|||
23581495|NCT01033643|65856970|FG005|Overall Study|Withdrew Consent|1|||
23581496|NCT04391309|65856977|FG000|Overall Study|Death|1|||
23581497|NCT04391309|65856978|FG001|Overall Study|Death|1|||
23581498|NCT04391309|65856977|FG000|Overall Study|Lost to Follow-up|3|||
23581499|NCT04391309|65856978|FG001|Overall Study|Lost to Follow-up|2|||
23581500|NCT04391309|65856977|FG000|Overall Study|Withdrawal by Subject|2|||
23581501|NCT04391309|65856978|FG001|Overall Study|Withdrawal by Subject|2|||
23581502|NCT02138916|65856979|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
23581503|NCT02138916|65856980|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
23581504|NCT02138916|65856981|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
23581505|NCT02138916|65856979|FG000|Overall Study|Death|14|||
23581506|NCT02138916|65856980|FG001|Overall Study|Death|11|||
23581507|NCT02138916|65856981|FG002|Overall Study|Death|12|||
23581508|NCT02138916|65856979|FG000|Overall Study|Withdrawal by Subject|27|||
23581509|NCT02138916|65856980|FG001|Overall Study|Withdrawal by Subject|31|||
23581510|NCT02138916|65856981|FG002|Overall Study|Withdrawal by Subject|32|||
23581511|NCT02138916|65856979|FG000|Overall Study|Study specific withdrawal criteria|0|||
23581512|NCT02138916|65856980|FG001|Overall Study|Study specific withdrawal criteria|0|||
23581513|NCT02138916|65856981|FG002|Overall Study|Study specific withdrawal criteria|1|||
23581514|NCT02138916|65856979|FG000|Overall Study|incorrect enrolment|1|||
23581515|NCT02138916|65856980|FG001|Overall Study|incorrect enrolment|1|||
23581516|NCT02138916|65856981|FG002|Overall Study|incorrect enrolment|0|||
23581517|NCT02138916|65856979|FG000|Overall Study|Severe non-compliance|1|||
23581518|NCT02138916|65856980|FG001|Overall Study|Severe non-compliance|2|||
23581519|NCT02138916|65856981|FG002|Overall Study|Severe non-compliance|1|||
23581520|NCT02138916|65856979|FG000|Overall Study|Lost to Follow-up|4|||
23581521|NCT02138916|65856980|FG001|Overall Study|Lost to Follow-up|2|||
23581522|NCT02138916|65856981|FG002|Overall Study|Lost to Follow-up|3|||
23581523|NCT02138916|65856979|FG000|Overall Study|Adverse Event|4|||
23581524|NCT02138916|65856980|FG001|Overall Study|Adverse Event|4|||
23581525|NCT02138916|65856981|FG002|Overall Study|Adverse Event|3|||
23636005|NCT03635099|66052845|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23636006|NCT03635099|66052838|FG000|Period 2|Adverse Event|0|||
23636007|NCT03635099|66052839|FG001|Period 2|Adverse Event|0|||
23636008|NCT03635099|66052840|FG002|Period 2|Adverse Event|1|||
23636009|NCT03635099|66052841|FG003|Period 2|Adverse Event|0|||
23581526|NCT01872611|65856984|FG000|Overall Study|Adverse Event|3|||
23581527|NCT01872611|65856985|FG001|Overall Study|Adverse Event|1|||
23581528|NCT01872611|65856984|FG000|Overall Study|Adverse Event, prior to treatment|0|||
23581529|NCT01872611|65856985|FG001|Overall Study|Adverse Event, prior to treatment|1|||
23581530|NCT01872611|65856984|FG000|Overall Study|Death|0|||
23581531|NCT01872611|65856985|FG001|Overall Study|Death|1|||
23581532|NCT01872611|65856984|FG000|Overall Study|Death, prior to treatment|0|||
23581533|NCT01872611|65856985|FG001|Overall Study|Death, prior to treatment|1|||
23842054|NCT00932373|66801435|FG003|Overall Study|Clinical progression|0|||
23842055|NCT00932373|66801436|FG004|Overall Study|Clinical progression|0|||
23842056|NCT00932373|66801437|FG005|Overall Study|Clinical progression|0|||
23842057|NCT00932373|66801438|FG006|Overall Study|Clinical progression|1|||
23842058|NCT00932373|66801439|FG007|Overall Study|Clinical progression|0|||
23842059|NCT00932373|66801440|FG008|Overall Study|Clinical progression|0|||
23842060|NCT00932373|66801441|FG009|Overall Study|Clinical progression|0|||
23842061|NCT00932373|66801442|FG010|Overall Study|Clinical progression|0|||
23842062|NCT00932373|66801432|FG000|Overall Study|Lack of Efficacy|0|||
23842063|NCT00932373|66801433|FG001|Overall Study|Lack of Efficacy|0|||
23842064|NCT00932373|66801434|FG002|Overall Study|Lack of Efficacy|0|||
23842065|NCT00932373|66801435|FG003|Overall Study|Lack of Efficacy|0|||
23842066|NCT00932373|66801436|FG004|Overall Study|Lack of Efficacy|0|||
23842067|NCT00932373|66801437|FG005|Overall Study|Lack of Efficacy|0|||
23842068|NCT00932373|66801438|FG006|Overall Study|Lack of Efficacy|0|||
23340533|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340534|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340535|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23581534|NCT01872611|65856984|FG000|Overall Study|Lost to Follow-up|8|||
23581535|NCT01872611|65856985|FG001|Overall Study|Lost to Follow-up|1|||
23581536|NCT01872611|65856984|FG000|Overall Study|Physician Decision|1|||
23581537|NCT01872611|65856985|FG001|Overall Study|Physician Decision|0|||
23581538|NCT01872611|65856984|FG000|Overall Study|Withdrawal by Subject|6|||
23581539|NCT01872611|65856985|FG001|Overall Study|Withdrawal by Subject|1|||
23581540|NCT01872611|65856984|FG000|Overall Study|Reason not provided|6|||
23581541|NCT01872611|65856985|FG001|Overall Study|Reason not provided|6|||
23581542|NCT01876043|65856990|FG000|Overall Study|Death|1|||
23581543|NCT01876043|65856990|FG000|Overall Study|Withdrawal by Subject|1|||
23581544|NCT01656304|65856991|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
23581545|NCT00881335|65858946|FG000|Overall Study|Lost to Follow-up|3|||
23581546|NCT00881335|65858947|FG001|Overall Study|Lost to Follow-up|2|||
23581547|NCT03201757|65858948|FG000|Overall Study|Withdrawal by Subject|133|||
23581548|NCT03201757|65858948|FG000|Overall Study|Adverse Event|44|||
23581549|NCT03201757|65858948|FG000|Overall Study|Lost to Follow-up|37|||
23581550|NCT03201757|65858948|FG000|Overall Study|Pregnancy|2|||
23581551|NCT03201757|65858948|FG000|Overall Study|Lack of Efficacy|1|||
23581552|NCT03201757|65858948|FG000|Overall Study|Protocol Violation|20|||
23581553|NCT03201757|65858948|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
23581554|NCT03201757|65858948|FG000|Overall Study|Not Yet Determined|5|||
23581555|NCT03201757|65858948|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
23581556|NCT03201757|65858948|FG000|Overall Study|Other|20|||
23581557|NCT01240356|65858950|FG000|Overall Study|Withdrawal by Subject|2|||
23581558|NCT01240356|65858951|FG001|Overall Study|Withdrawal by Subject|0|||
23581559|NCT01240356|65858950|FG000|Overall Study|MRI contraindication|1|||
23581560|NCT01240356|65858951|FG001|Overall Study|MRI contraindication|0|||
23581561|NCT02206685|65858952|FG000|Overall Study|Surgery cancelled/changed|2|||
23581562|NCT02206685|65858953|FG001|Overall Study|Surgery cancelled/changed|3|||
23581563|NCT02206685|65858952|FG000|Overall Study|Withdrawal by Subject|1|||
23581564|NCT02206685|65858953|FG001|Overall Study|Withdrawal by Subject|2|||
23581565|NCT02206685|65858952|FG000|Overall Study|Protocol Violation|2|||
23581566|NCT02206685|65858953|FG001|Overall Study|Protocol Violation|2|||
23581567|NCT03771898|65858954|FG000|Overall Study|Adverse Event|1|||
23581568|NCT03771898|65858955|FG001|Overall Study|Adverse Event|0|||
23636010|NCT03635099|66052842|FG004|Period 2|Adverse Event|1|||
23340536|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340537|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340538|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340539|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
23340540|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340541|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
23340542|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
23581569|NCT03771898|65858956|FG002|Overall Study|Adverse Event|0|||
23581570|NCT03771898|65858957|FG003|Overall Study|Adverse Event|0|||
23581571|NCT03771898|65858958|FG004|Overall Study|Adverse Event|0|||
23581572|NCT03771898|65858954|FG000|Overall Study|Lost to Follow-up|1|||
23581573|NCT03771898|65858955|FG001|Overall Study|Lost to Follow-up|1|||
23581574|NCT03771898|65858956|FG002|Overall Study|Lost to Follow-up|1|||
23581575|NCT03771898|65858957|FG003|Overall Study|Lost to Follow-up|0|||
23581576|NCT03771898|65858958|FG004|Overall Study|Lost to Follow-up|0|||
23581577|NCT03771898|65858954|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23636011|NCT03635099|66052843|FG005|Period 2|Adverse Event|0|||
23842069|NCT00932373|66801439|FG007|Overall Study|Lack of Efficacy|0|||
23842070|NCT00932373|66801440|FG008|Overall Study|Lack of Efficacy|0|||
23842071|NCT00932373|66801441|FG009|Overall Study|Lack of Efficacy|1|||
23842072|NCT00932373|66801442|FG010|Overall Study|Lack of Efficacy|0|||
23842073|NCT01750697|66801446|FG000|Overall Study|Transferred Back to Local Hospital|1|||
23340543|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340544|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340545|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340546|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340547|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340548|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23636012|NCT03635099|66052844|FG006|Period 2|Adverse Event|0|||
23636013|NCT03635099|66052845|FG007|Period 2|Adverse Event|0|||
23636014|NCT03635099|66052838|FG000|Period 2|Lost to Follow-up|0|||
23636015|NCT03635099|66052839|FG001|Period 2|Lost to Follow-up|0|||
23781470|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
23781471|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
23340549|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340550|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
23340551|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
23581578|NCT03771898|65858955|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23581579|NCT03771898|65858956|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23581580|NCT03771898|65858957|FG003|Overall Study|Withdrawal by parent/guardian|0|||
23581581|NCT03771898|65858958|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23581582|NCT03771898|65858954|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581583|NCT03771898|65858955|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581584|NCT03771898|65858956|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581585|NCT03771898|65858957|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581586|NCT03771898|65858958|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
23581587|NCT03905135|65858959|FG000|Dose Escalation|Adverse Event|1|||
23581588|NCT03905135|65858960|FG001|Dose Escalation|Adverse Event|1|||
23581589|NCT03905135|65858959|FG000|Dose Escalation|Progressive disease|3|||
23581590|NCT03905135|65858960|FG001|Dose Escalation|Progressive disease|1|||
23581591|NCT03905135|65858959|FG000|Dose Escalation|Intercurrent illness|1|||
23581592|NCT03905135|65858960|FG001|Dose Escalation|Intercurrent illness|0|||
23581593|NCT03178201|65858974|FG000|Overall Study|Off study|5|||
23581594|NCT02042443|65858975|FG000|Overall Study|Adverse Event|2|||
23581595|NCT02042443|65858976|FG001|Overall Study|Adverse Event|1|||
23581596|NCT02042443|65858975|FG000|Overall Study|Withdrawal by Subject|0|||
23581597|NCT02042443|65858976|FG001|Overall Study|Withdrawal by Subject|1|||
23581598|NCT02042443|65858975|FG000|Overall Study|Progression|21|||
23581599|NCT02042443|65858976|FG001|Overall Study|Progression|17|||
23581600|NCT02042443|65858975|FG000|Overall Study|not protocol specified|1|||
23581601|NCT02042443|65858976|FG001|Overall Study|not protocol specified|1|||
23581602|NCT02042443|65858975|FG000|Overall Study|Not eligible/not analyzable|3|||
23581603|NCT02042443|65858976|FG001|Overall Study|Not eligible/not analyzable|6|||
23581604|NCT04091672|65858978|FG000|Overall Study|Death|6|||
23581605|NCT04091672|65858979|FG001|Overall Study|Death|6|||
23581606|NCT04091672|65858978|FG000|Overall Study|Lost to Follow-up|7|||
23581607|NCT04091672|65858979|FG001|Overall Study|Lost to Follow-up|7|||
23581608|NCT04091672|65858978|FG000|Overall Study|Withdrawal by Subject|3|||
23581609|NCT04091672|65858979|FG001|Overall Study|Withdrawal by Subject|3|||
23581610|NCT04091672|65858978|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
23581611|NCT04091672|65858979|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
23581612|NCT00359619|65858980|FG000|Overall Study|Adverse Event|0|||
23581613|NCT00359619|65858981|FG001|Overall Study|Adverse Event|0|||
23581614|NCT00359619|65858982|FG002|Overall Study|Adverse Event|1|||
23581615|NCT00359619|65858983|FG003|Overall Study|Adverse Event|0|||
23581616|NCT00359619|65858984|FG004|Overall Study|Adverse Event|0|||
23581617|NCT00359619|65858985|FG005|Overall Study|Adverse Event|0|||
23581618|NCT00359619|65858986|FG006|Overall Study|Adverse Event|1|||
23636016|NCT03635099|66052840|FG002|Period 2|Lost to Follow-up|1|||
23781472|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
23781473|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
23781474|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
23781475|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
23781476|NCT02493868|66580248|FG000|Induction Phase: DE Participants|Other|8|||
23781477|NCT02493868|66580249|FG001|Induction Phase: DE Participants|Other|0|||
23781478|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
23581619|NCT00359619|65858980|FG000|Overall Study|Withdrawal by Subject|3|||
23581620|NCT00359619|65858981|FG001|Overall Study|Withdrawal by Subject|1|||
23581621|NCT00359619|65858982|FG002|Overall Study|Withdrawal by Subject|4|||
23581622|NCT00359619|65858983|FG003|Overall Study|Withdrawal by Subject|2|||
23581623|NCT00359619|65858984|FG004|Overall Study|Withdrawal by Subject|2|||
23581624|NCT00359619|65858985|FG005|Overall Study|Withdrawal by Subject|0|||
23581625|NCT00359619|65858986|FG006|Overall Study|Withdrawal by Subject|3|||
23636017|NCT03635099|66052841|FG003|Period 2|Lost to Follow-up|0|||
23636018|NCT03635099|66052842|FG004|Period 2|Lost to Follow-up|4|||
23842074|NCT01750697|66801446|FG000|Overall Study|Physician and Family Decision|1|||
23842075|NCT01750697|66801446|FG000|Overall Study|Transferred to Adult Services|5|||
23842076|NCT01750697|66801446|FG000|Overall Study|Physician Decision|1|||
23842077|NCT01750697|66801446|FG000|Overall Study|Withdrawal by Subject|1|||
23842078|NCT02438826|66801447|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
23842079|NCT02438826|66801448|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
23842080|NCT02438826|66801449|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23842081|NCT02438826|66801450|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23842082|NCT02438826|66801447|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
23842083|NCT02438826|66801448|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23842084|NCT02438826|66801449|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23636019|NCT03635099|66052843|FG005|Period 2|Lost to Follow-up|0|||
23842085|NCT02438826|66801450|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23842086|NCT02438826|66801447|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23842087|NCT02438826|66801448|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23842088|NCT02438826|66801449|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23842089|NCT02438826|66801450|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23842090|NCT02438826|66801447|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23842091|NCT02438826|66801448|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
23842092|NCT02438826|66801449|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23842093|NCT02438826|66801450|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23842094|NCT02438826|66801447|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
23842095|NCT02438826|66801448|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
23842096|NCT02438826|66801449|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
23842097|NCT02438826|66801450|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
23842098|NCT02438826|66801447|FG000|Open-Label Treatment Phase|Adverse Event|11|||
23842099|NCT02438826|66801448|FG001|Open-Label Treatment Phase|Adverse Event|6|||
23842100|NCT02438826|66801449|FG002|Open-Label Treatment Phase|Adverse Event|0|||
23842101|NCT02438826|66801450|FG003|Open-Label Treatment Phase|Adverse Event|0|||
23842102|NCT02438826|66801447|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
23842103|NCT02438826|66801448|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
23842104|NCT02438826|66801449|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
23340552|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
23340553|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
23340554|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340555|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340556|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23842105|NCT02438826|66801450|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
23842106|NCT02438826|66801447|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
23842107|NCT02438826|66801448|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
23842108|NCT02438826|66801449|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
23842109|NCT02438826|66801450|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
23842110|NCT02438826|66801447|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
23842111|NCT02438826|66801448|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
23842112|NCT02438826|66801449|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
23842113|NCT02438826|66801450|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
23842114|NCT02438826|66801447|FG000|Post-Treatment Phase|Adverse Event|3|||
23842115|NCT02438826|66801448|FG001|Post-Treatment Phase|Adverse Event|0|||
23842116|NCT02438826|66801449|FG002|Post-Treatment Phase|Adverse Event|0|||
23842117|NCT02438826|66801450|FG003|Post-Treatment Phase|Adverse Event|0|||
23842118|NCT02438826|66801447|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
23842119|NCT02438826|66801448|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
23842120|NCT02438826|66801449|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
23842121|NCT02438826|66801450|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
23842122|NCT02438826|66801447|FG000|Post-Treatment Phase|Physician Decision|1|||
23842123|NCT02438826|66801448|FG001|Post-Treatment Phase|Physician Decision|0|||
23842124|NCT02438826|66801449|FG002|Post-Treatment Phase|Physician Decision|0|||
23842125|NCT02438826|66801450|FG003|Post-Treatment Phase|Physician Decision|0|||
23842126|NCT02438826|66801447|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
23340557|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340558|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340559|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340560|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340561|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
23340562|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
23340563|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
23636020|NCT03635099|66052844|FG006|Period 2|Lost to Follow-up|0|||
23842127|NCT02438826|66801448|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
23842128|NCT02438826|66801449|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
23842129|NCT02438826|66801450|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
23842130|NCT02429778|66801451|FG000|Overall Study|Lost to Follow-up|2|||
23842131|NCT02429778|66801452|FG001|Overall Study|Lost to Follow-up|0|||
23842132|NCT02429778|66801451|FG000|Overall Study|Withdrawal by Subject|5|||
23452504|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452505|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452506|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452507|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
23452508|NCT04842747|65399023|FG000|Overall Study|Withdrawal by Subject|6|||
23452509|NCT04842747|65399024|FG001|Overall Study|Withdrawal by Subject|2|||
23452510|NCT04842747|65399023|FG000|Overall Study|Lost to Follow-up|1|||
23452511|NCT04842747|65399024|FG001|Overall Study|Lost to Follow-up|2|||
23452512|NCT04842747|65399023|FG000|Overall Study|Physician Decision|1|||
23452513|NCT04842747|65399024|FG001|Overall Study|Physician Decision|0|||
23452514|NCT04842747|65399023|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
23452515|NCT04842747|65399024|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
23452516|NCT00475670|65399025|FG000|Overall Study|Death|0|||
23452517|NCT00475670|65399026|FG001|Overall Study|Death|1|||
23452518|NCT00475670|65399025|FG000|Overall Study|Lack of Efficacy|3|||
23452519|NCT00475670|65399026|FG001|Overall Study|Lack of Efficacy|34|||
23452520|NCT00475670|65399025|FG000|Overall Study|Refused treatment|0|||
23452521|NCT00475670|65399026|FG001|Overall Study|Refused treatment|2|||
23452522|NCT00475670|65399025|FG000|Overall Study|Failure to Return|0|||
23452523|NCT00475670|65399026|FG001|Overall Study|Failure to Return|1|||
23452524|NCT00475670|65399025|FG000|Overall Study|Other|0|||
23452525|NCT00475670|65399026|FG001|Overall Study|Other|3|||
23452526|NCT03901144|65399031|FG000|Overall Study|Lost to Follow-up|1|||
23452527|NCT03901144|65399032|FG001|Overall Study|Lost to Follow-up|1|||
23452528|NCT03901144|65399033|FG002|Overall Study|Lost to Follow-up|1|||
23452529|NCT03901144|65399034|FG003|Overall Study|Lost to Follow-up|1|||
23842133|NCT02429778|66801452|FG001|Overall Study|Withdrawal by Subject|0|||
23842134|NCT01696929|66801453|FG000|Overall Study|Physician Decision|1|||
23842135|NCT02760004|66801456|FG000|Overall Study|Lost to Follow-up|13|||
23452530|NCT03353675|65399037|FG000|Overall Study|Adverse Event|4|||
23452531|NCT02539797|65399039|FG000|Overall Study|Lost to Follow-up|0|||
23452532|NCT02539797|65399040|FG001|Overall Study|Lost to Follow-up|1|||
23452533|NCT02539797|65399041|FG002|Overall Study|Lost to Follow-up|0|||
23452534|NCT00539981|65399044|FG000|Overall Study|Adverse events (AE)|3|||
23452535|NCT00539981|65399045|FG001|Overall Study|Adverse events (AE)|3|||
23452536|NCT00539981|65399044|FG000|Overall Study|Lost to Follow-up|260|||
23452537|NCT00539981|65399045|FG001|Overall Study|Lost to Follow-up|251|||
23452538|NCT00539981|65399044|FG000|Overall Study|Withdrew consent|22|||
23452539|NCT00539981|65399045|FG001|Overall Study|Withdrew consent|14|||
23452540|NCT00539981|65399044|FG000|Overall Study|Death|1|||
23452541|NCT00539981|65399045|FG001|Overall Study|Death|1|||
23452542|NCT00539981|65399044|FG000|Overall Study|Other reason-unspecified|9|||
23452543|NCT00539981|65399045|FG001|Overall Study|Other reason-unspecified|13|||
23452544|NCT01277744|65399046|FG000|Overall Study|Physician Decision|2|||
23452545|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
23452546|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
23452547|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
23452548|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
23452549|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
23452550|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
23452551|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
23452552|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
23452553|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
23452554|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
23452555|NCT02960217|65399050|FG000|Open-Label Extension Phase|Adverse Event|1|||
23452556|NCT02960217|65399051|FG001|Open-Label Extension Phase|Adverse Event|0|||
23452557|NCT02960217|65399050|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
23452558|NCT02960217|65399051|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
23452559|NCT02960217|65399050|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
23452560|NCT02960217|65399051|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
23581626|NCT00359619|65858980|FG000|Overall Study|Other|1|||
23581627|NCT00359619|65858981|FG001|Overall Study|Other|0|||
23842136|NCT02760004|66801457|FG001|Overall Study|Lost to Follow-up|22|||
23581628|NCT00359619|65858982|FG002|Overall Study|Other|0|||
23581629|NCT00359619|65858983|FG003|Overall Study|Other|0|||
23452561|NCT02960217|65399050|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
23452562|NCT02960217|65399051|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
23452563|NCT02178995|65399052|FG000|Double Blind|Adverse Event|0|||
23452564|NCT02178995|65399053|FG001|Double Blind|Adverse Event|0|||
23452565|NCT02178995|65399054|FG002|Double Blind|Adverse Event|0|||
23452566|NCT02178995|65399055|FG003|Double Blind|Adverse Event|0|||
23842137|NCT05140382|66801462|FG000|Overall Study|Death|3|||
23452567|NCT02178995|65399056|FG004|Double Blind|Adverse Event|0|||
23452568|NCT02178995|65399057|FG005|Double Blind|Adverse Event|1|||
23452569|NCT02178995|65399058|FG006|Double Blind|Adverse Event|0|||
23452570|NCT02178995|65399059|FG007|Double Blind|Adverse Event|1|||
23452571|NCT02178995|65399060|FG008|Double Blind|Adverse Event|1|||
23452572|NCT02178995|65399052|FG000|Double Blind|Lost to Follow-up|0|||
23452573|NCT02178995|65399053|FG001|Double Blind|Lost to Follow-up|1|||
23452574|NCT02178995|65399054|FG002|Double Blind|Lost to Follow-up|0|||
23452575|NCT02178995|65399055|FG003|Double Blind|Lost to Follow-up|0|||
23452576|NCT02178995|65399056|FG004|Double Blind|Lost to Follow-up|0|||
23452577|NCT02178995|65399057|FG005|Double Blind|Lost to Follow-up|0|||
23452578|NCT02178995|65399058|FG006|Double Blind|Lost to Follow-up|0|||
23452579|NCT02178995|65399059|FG007|Double Blind|Lost to Follow-up|1|||
23452580|NCT02178995|65399060|FG008|Double Blind|Lost to Follow-up|0|||
23452581|NCT02178995|65399052|FG000|Open Label|Adverse Event|2|||
23452582|NCT02178995|65399053|FG001|Open Label|Adverse Event|0|||
23452583|NCT02178995|65399054|FG002|Open Label|Adverse Event|0|||
23452584|NCT02178995|65399055|FG003|Open Label|Adverse Event|0|||
23452585|NCT02178995|65399056|FG004|Open Label|Adverse Event|0|||
23452586|NCT02178995|65399057|FG005|Open Label|Adverse Event|0|||
23452587|NCT02178995|65399058|FG006|Open Label|Adverse Event|0|||
23452588|NCT02178995|65399059|FG007|Open Label|Adverse Event|0|||
23452589|NCT02178995|65399060|FG008|Open Label|Adverse Event|0|||
23452590|NCT02721875|65399062|FG000|Overall Study|Progressive disease/relapse|1|||
23452591|NCT02721875|65399063|FG001|Overall Study|Progressive disease/relapse|0|||
23452592|NCT05470387|65399073|FG000|Overall Study|Protocol Violation|0|||
23452593|NCT05470387|65399074|FG001|Overall Study|Protocol Violation|3|||
23452594|NCT00362648|65399080|FG000|Overall Study|Adverse Event|12|||
23452595|NCT00362648|65399081|FG001|Overall Study|Adverse Event|21|||
23452596|NCT00362648|65399082|FG002|Overall Study|Adverse Event|1|||
23452597|NCT00362648|65399083|FG003|Overall Study|Adverse Event|0|||
23452598|NCT00362648|65399080|FG000|Overall Study|Lost to Follow-up|62|||
23452599|NCT00362648|65399081|FG001|Overall Study|Lost to Follow-up|69|||
23452600|NCT00362648|65399082|FG002|Overall Study|Lost to Follow-up|4|||
23452601|NCT00362648|65399083|FG003|Overall Study|Lost to Follow-up|3|||
23452602|NCT00362648|65399080|FG000|Overall Study|Protocol Violation|4|||
23452603|NCT00362648|65399081|FG001|Overall Study|Protocol Violation|2|||
23452604|NCT00362648|65399082|FG002|Overall Study|Protocol Violation|2|||
23452605|NCT00362648|65399083|FG003|Overall Study|Protocol Violation|2|||
23452606|NCT00362648|65399080|FG000|Overall Study|Withdrawal by Subject|48|||
23452607|NCT00362648|65399081|FG001|Overall Study|Withdrawal by Subject|42|||
23452608|NCT00362648|65399082|FG002|Overall Study|Withdrawal by Subject|2|||
23452609|NCT00362648|65399083|FG003|Overall Study|Withdrawal by Subject|6|||
23452610|NCT00449696|65399084|FG000|Overall Study|Other Treatment Required|6|||
23452611|NCT00449696|65399085|FG001|Overall Study|Other Treatment Required|1|||
23452612|NCT00449696|65399084|FG000|Overall Study|Withdrawal by Subject|5|||
23452613|NCT00449696|65399085|FG001|Overall Study|Withdrawal by Subject|5|||
23452614|NCT00449696|65399084|FG000|Overall Study|Lost to Follow-up|2|||
23452615|NCT00449696|65399085|FG001|Overall Study|Lost to Follow-up|3|||
23452616|NCT00449696|65399084|FG000|Overall Study|Others|7|||
23452617|NCT00449696|65399085|FG001|Overall Study|Others|0|||
23452618|NCT00988598|65399086|FG000|Overall Study|Withdrawal by Subject|2|||
23452619|NCT00988598|65399087|FG001|Overall Study|Withdrawal by Subject|0|||
23452620|NCT01132807|65399088|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
23452621|NCT01132807|65399089|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
23452622|NCT01132807|65399090|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
23452623|NCT01132807|65399088|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
23452624|NCT01132807|65399089|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
23452625|NCT01132807|65399090|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
23452626|NCT02813889|65399091|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
23842138|NCT05140382|66801463|FG001|Overall Study|Death|0|||
23842139|NCT05140382|66801464|FG002|Overall Study|Death|0|||
23842140|NCT05140382|66801462|FG000|Overall Study|Investigator decision|1|||
23842141|NCT05140382|66801463|FG001|Overall Study|Investigator decision|0|||
23842142|NCT05140382|66801464|FG002|Overall Study|Investigator decision|0|||
23636021|NCT03635099|66052845|FG007|Period 2|Lost to Follow-up|0|||
23452627|NCT02813889|65399092|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
23452628|NCT04583280|65399093|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
23452629|NCT04583280|65399094|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
23452630|NCT01389882|65399095|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
23452631|NCT01389882|65399096|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
23452632|NCT01389882|65399095|FG000|Overall Study|Withdrawal by Subject|0|||
23452633|NCT01389882|65399096|FG001|Overall Study|Withdrawal by Subject|1|||
23452634|NCT00990106|65399097|FG000|Overall Study|"too busy to continue"|1|||
23452635|NCT00990106|65399098|FG001|Overall Study|"too busy to continue"|2|||
23452636|NCT00990106|65399097|FG000|Overall Study|Lost to Follow-up|1|||
23452637|NCT00990106|65399098|FG001|Overall Study|Lost to Follow-up|3|||
23842143|NCT05140382|66801462|FG000|Overall Study|Other|4|||
23842144|NCT05140382|66801463|FG001|Overall Study|Other|0|||
23842145|NCT05140382|66801464|FG002|Overall Study|Other|1|||
23842146|NCT05140382|66801462|FG000|Overall Study|Progressive disease|20|||
23842147|NCT05140382|66801463|FG001|Overall Study|Progressive disease|1|||
23842148|NCT05140382|66801464|FG002|Overall Study|Progressive disease|12|||
23842149|NCT05140382|66801462|FG000|Overall Study|Subjective disease progression|2|||
23842150|NCT05140382|66801463|FG001|Overall Study|Subjective disease progression|1|||
23340564|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
23581630|NCT00359619|65858984|FG004|Overall Study|Other|0|||
23581631|NCT00359619|65858985|FG005|Overall Study|Other|0|||
23340565|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340566|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340567|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340568|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340569|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340570|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340571|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340572|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340573|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340574|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340575|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
23340576|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340577|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340578|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340579|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340580|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340581|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340582|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340583|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340584|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340585|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340586|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340587|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
23340588|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
23340589|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
23340590|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340591|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340592|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340593|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
23340594|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340595|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340596|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340597|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340598|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340599|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340600|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340601|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340602|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340603|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
23340604|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340605|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340606|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340607|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340608|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340609|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
23340610|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
23340611|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
23340612|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340613|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
23581632|NCT00359619|65858986|FG006|Overall Study|Other|0|||
23636022|NCT03635099|66052838|FG000|Period 2|Withdrawal by Subject|0|||
23842151|NCT05140382|66801464|FG002|Overall Study|Subjective disease progression|0|||
23842152|NCT05140382|66801462|FG000|Overall Study|Unknown at data cut-off|0|||
23340614|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
23340615|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
23340616|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340617|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340618|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340619|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23842153|NCT05140382|66801463|FG001|Overall Study|Unknown at data cut-off|0|||
23842154|NCT05140382|66801464|FG002|Overall Study|Unknown at data cut-off|1|||
23842155|NCT05140382|66801462|FG000|Overall Study|Withdrawal by Subject|1|||
23842156|NCT05140382|66801463|FG001|Overall Study|Withdrawal by Subject|0|||
23842157|NCT05140382|66801464|FG002|Overall Study|Withdrawal by Subject|4|||
23842158|NCT05140382|66801462|FG000|Overall Study|Withdrawal of consent|0|||
23842159|NCT05140382|66801463|FG001|Overall Study|Withdrawal of consent|0|||
23842160|NCT05140382|66801464|FG002|Overall Study|Withdrawal of consent|1|||
23842161|NCT02865499|66801465|FG000|Baseline|Adverse Event|1|||
23842162|NCT02865499|66801465|FG000|Baseline|Withdrawal by Subject|1|||
23842163|NCT03728426|66801467|FG000|Overall Study|Death|3|||
23842164|NCT01264081|66801468|FG000|Participants Screened|Screening failures|30|||
23842165|NCT01264081|66801468|FG000|Started Treatment|Withdrawal by Subject|1|||
23842166|NCT01264081|66801468|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
23842167|NCT03706430|66801472|FG000|Overall Study|No A-Line placed|5|||
23842168|NCT03706430|66801472|FG000|Overall Study|Subject had gel nail polish|1|||
23842169|NCT03706430|66801472|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
23842170|NCT03706430|66801472|FG000|Overall Study|Cancelled Case|6|||
23842171|NCT03706430|66801472|FG000|Overall Study|Physician Decision|2|||
23842172|NCT01878149|66801473|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
23842173|NCT01878149|66801474|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23842174|NCT03224598|66801477|FG000|Overall Study|Lost to Follow-up|0|||
23842175|NCT03224598|66801478|FG001|Overall Study|Lost to Follow-up|2|||
23842176|NCT03224598|66801479|FG002|Overall Study|Lost to Follow-up|0|||
23842177|NCT03224598|66801477|FG000|Overall Study|Other|0|||
23842178|NCT03224598|66801478|FG001|Overall Study|Other|1|||
23842179|NCT03224598|66801479|FG002|Overall Study|Other|0|||
23842180|NCT00090493|66801480|FG000|Overall Study|Physician Decision|2|||
23842181|NCT01127451|66801485|FG000|Overall Study|Other|2|||
23842182|NCT01127451|66801486|FG001|Overall Study|Other|1|||
23842183|NCT01127451|66801485|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
23842184|NCT01127451|66801486|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
23581633|NCT00359619|65858980|FG000|Overall Study|Lost to Follow-up|4|||
23581634|NCT00359619|65858981|FG001|Overall Study|Lost to Follow-up|4|||
23340620|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
23340621|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
23340622|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
23340623|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
23340624|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
23340625|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
23340626|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
23340627|NCT04064411|64992830|FG000|Overall Study|Adverse Event|29|||
23340628|NCT04064411|64992831|FG001|Overall Study|Adverse Event|19|||
23340629|NCT04064411|64992830|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
23340630|NCT04064411|64992831|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
23340631|NCT04064411|64992830|FG000|Overall Study|Protocol Deviation|0|||
23340632|NCT04064411|64992831|FG001|Overall Study|Protocol Deviation|2|||
23340633|NCT04064411|64992830|FG000|Overall Study|Withdrawal by Subject|25|||
23340634|NCT04064411|64992831|FG001|Overall Study|Withdrawal by Subject|29|||
23340635|NCT04064411|64992830|FG000|Overall Study|Lost to Follow-up|5|||
23452638|NCT00990106|65399097|FG000|Overall Study|Withdrawal by Subject|2|||
23452639|NCT00990106|65399098|FG001|Overall Study|Withdrawal by Subject|1|||
23452640|NCT00990106|65399097|FG000|Overall Study|opted for open label prazosin|1|||
23581635|NCT00359619|65858982|FG002|Overall Study|Lost to Follow-up|2|||
23842185|NCT01127451|66801485|FG000|Overall Study|Death|22|||
23581636|NCT00359619|65858983|FG003|Overall Study|Lost to Follow-up|1|||
23581637|NCT00359619|65858984|FG004|Overall Study|Lost to Follow-up|1|||
23581638|NCT00359619|65858985|FG005|Overall Study|Lost to Follow-up|5|||
23581639|NCT00359619|65858986|FG006|Overall Study|Lost to Follow-up|0|||
23581640|NCT00603447|65859000|FG000|Overall Study|Adverse Event|0|||
23842186|NCT01127451|66801486|FG001|Overall Study|Death|17|||
23842187|NCT01127451|66801485|FG000|Overall Study|Lost to Follow-up|3|||
23842188|NCT01127451|66801486|FG001|Overall Study|Lost to Follow-up|0|||
23842189|NCT01127451|66801485|FG000|Overall Study|Administrative Reason by Sponsor|2|||
23842190|NCT01127451|66801486|FG001|Overall Study|Administrative Reason by Sponsor|2|||
23842191|NCT00900159|66801487|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
23842192|NCT00900159|66801488|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
23842193|NCT02907892|66801489|FG000|Overall Study|Lost to Follow-up|27|||
23842194|NCT02907892|66801490|FG001|Overall Study|Lost to Follow-up|40|||
23842195|NCT02477332|66801493|FG000|Overall Study|Adverse Event|0|||
23842196|NCT02477332|66801494|FG001|Overall Study|Adverse Event|1|||
23842197|NCT02477332|66801495|FG002|Overall Study|Adverse Event|1|||
23842198|NCT02477332|66801496|FG003|Overall Study|Adverse Event|2|||
23842199|NCT02477332|66801497|FG004|Overall Study|Adverse Event|1|||
23842200|NCT02477332|66801498|FG005|Overall Study|Adverse Event|2|||
23842201|NCT02477332|66801493|FG000|Overall Study|Lack of Efficacy|1|||
23842202|NCT02477332|66801494|FG001|Overall Study|Lack of Efficacy|2|||
23842203|NCT02477332|66801495|FG002|Overall Study|Lack of Efficacy|1|||
23842204|NCT02477332|66801496|FG003|Overall Study|Lack of Efficacy|2|||
23842205|NCT02477332|66801497|FG004|Overall Study|Lack of Efficacy|1|||
23842206|NCT02477332|66801498|FG005|Overall Study|Lack of Efficacy|1|||
23842207|NCT02477332|66801493|FG000|Overall Study|Non-compliance with study treatment|0|||
23842208|NCT02477332|66801494|FG001|Overall Study|Non-compliance with study treatment|1|||
23842209|NCT02477332|66801495|FG002|Overall Study|Non-compliance with study treatment|2|||
23842210|NCT02477332|66801496|FG003|Overall Study|Non-compliance with study treatment|0|||
23842211|NCT02477332|66801497|FG004|Overall Study|Non-compliance with study treatment|0|||
23842212|NCT02477332|66801498|FG005|Overall Study|Non-compliance with study treatment|0|||
23842213|NCT02477332|66801493|FG000|Overall Study|Pregnancy|0|||
23842214|NCT02477332|66801494|FG001|Overall Study|Pregnancy|0|||
23842215|NCT02477332|66801495|FG002|Overall Study|Pregnancy|0|||
23842216|NCT02477332|66801496|FG003|Overall Study|Pregnancy|1|||
23842217|NCT02477332|66801497|FG004|Overall Study|Pregnancy|0|||
23842218|NCT02477332|66801498|FG005|Overall Study|Pregnancy|0|||
23842219|NCT02477332|66801493|FG000|Overall Study|Protocol Violation|2|||
23842220|NCT02477332|66801494|FG001|Overall Study|Protocol Violation|0|||
23842221|NCT02477332|66801495|FG002|Overall Study|Protocol Violation|3|||
23842222|NCT02477332|66801496|FG003|Overall Study|Protocol Violation|3|||
23842223|NCT02477332|66801497|FG004|Overall Study|Protocol Violation|1|||
23842224|NCT02477332|66801498|FG005|Overall Study|Protocol Violation|1|||
23581641|NCT00603447|65859001|FG001|Overall Study|Adverse Event|1|||
23581642|NCT00603447|65859002|FG002|Overall Study|Adverse Event|1|||
23581643|NCT00603447|65859003|FG003|Overall Study|Adverse Event|2|||
23581644|NCT00603447|65859004|FG004|Overall Study|Adverse Event|1|||
23842225|NCT02477332|66801493|FG000|Overall Study|Technical problems|0|||
23842226|NCT02477332|66801494|FG001|Overall Study|Technical problems|0|||
23842227|NCT02477332|66801495|FG002|Overall Study|Technical problems|1|||
23842228|NCT02477332|66801496|FG003|Overall Study|Technical problems|0|||
23842229|NCT02477332|66801497|FG004|Overall Study|Technical problems|0|||
23842230|NCT02477332|66801498|FG005|Overall Study|Technical problems|0|||
23842231|NCT02477332|66801493|FG000|Overall Study|Lost to Follow-up|0|||
23842232|NCT02477332|66801494|FG001|Overall Study|Lost to Follow-up|0|||
23842233|NCT02477332|66801495|FG002|Overall Study|Lost to Follow-up|2|||
23842234|NCT02477332|66801496|FG003|Overall Study|Lost to Follow-up|0|||
23842235|NCT02477332|66801497|FG004|Overall Study|Lost to Follow-up|0|||
23842236|NCT02477332|66801498|FG005|Overall Study|Lost to Follow-up|0|||
23581645|NCT00603447|65859005|FG005|Overall Study|Adverse Event|2|||
23581646|NCT00603447|65859006|FG006|Overall Study|Adverse Event|10|||
23581647|NCT00603447|65859000|FG000|Overall Study|Other|0|||
23581648|NCT00603447|65859001|FG001|Overall Study|Other|0|||
23581649|NCT00603447|65859002|FG002|Overall Study|Other|1|||
23581650|NCT00603447|65859003|FG003|Overall Study|Other|0|||
23581651|NCT00603447|65859004|FG004|Overall Study|Other|3|||
23581652|NCT00603447|65859005|FG005|Overall Study|Other|0|||
23581653|NCT00603447|65859006|FG006|Overall Study|Other|13|||
23581654|NCT00603447|65859000|FG000|Overall Study|Withdrew Consent|0|||
23581655|NCT00603447|65859001|FG001|Overall Study|Withdrew Consent|2|||
23581656|NCT00603447|65859002|FG002|Overall Study|Withdrew Consent|0|||
23581657|NCT00603447|65859003|FG003|Overall Study|Withdrew Consent|0|||
23581658|NCT00603447|65859004|FG004|Overall Study|Withdrew Consent|1|||
23581659|NCT00603447|65859005|FG005|Overall Study|Withdrew Consent|0|||
23581660|NCT00603447|65859006|FG006|Overall Study|Withdrew Consent|1|||
23581661|NCT00052962|65859010|FG000|Overall Study|Not evaluable|0|||
23842237|NCT02477332|66801493|FG000|Overall Study|Physician Decision|0|||
23842238|NCT02477332|66801494|FG001|Overall Study|Physician Decision|0|||
23581662|NCT00052962|65859011|FG001|Overall Study|Not evaluable|2|||
23842239|NCT02477332|66801495|FG002|Overall Study|Physician Decision|1|||
23842240|NCT02477332|66801496|FG003|Overall Study|Physician Decision|3|||
23842241|NCT02477332|66801497|FG004|Overall Study|Physician Decision|0|||
23842242|NCT02477332|66801498|FG005|Overall Study|Physician Decision|1|||
23842243|NCT02477332|66801493|FG000|Overall Study|Withdrawal by Subject|0|||
23581663|NCT00052962|65859010|FG000|Overall Study|Not randomized/not evaluable|1|||
23581664|NCT00052962|65859011|FG001|Overall Study|Not randomized/not evaluable|0|||
23581665|NCT00072475|65859014|FG000|Overall Study|Adverse Event|44|||
23581666|NCT00072475|65859014|FG000|Overall Study|Death|3|||
23842244|NCT02477332|66801494|FG001|Overall Study|Withdrawal by Subject|3|||
23842245|NCT02477332|66801495|FG002|Overall Study|Withdrawal by Subject|1|||
23842246|NCT02477332|66801496|FG003|Overall Study|Withdrawal by Subject|2|||
23842247|NCT02477332|66801497|FG004|Overall Study|Withdrawal by Subject|1|||
23842248|NCT02477332|66801498|FG005|Overall Study|Withdrawal by Subject|0|||
23842249|NCT01942486|66801503|FG000|Overall Study|Lost to Follow-up|27|||
23842250|NCT03379753|66801508|FG000|Overall Study|Withdrawal by Subject|2|||
23842251|NCT03379753|66801509|FG001|Overall Study|Withdrawal by Subject|1|||
23842252|NCT03379753|66801508|FG000|Overall Study|not having correct procedure|1|||
23842253|NCT03379753|66801509|FG001|Overall Study|not having correct procedure|2|||
23636023|NCT03635099|66052839|FG001|Period 2|Withdrawal by Subject|0|||
23636024|NCT03635099|66052840|FG002|Period 2|Withdrawal by Subject|7|||
23636025|NCT03635099|66052841|FG003|Period 2|Withdrawal by Subject|4|||
23636026|NCT03635099|66052842|FG004|Period 2|Withdrawal by Subject|7|||
23636027|NCT03635099|66052843|FG005|Period 2|Withdrawal by Subject|0|||
23636028|NCT03635099|66052844|FG006|Period 2|Withdrawal by Subject|0|||
23636029|NCT03635099|66052845|FG007|Period 2|Withdrawal by Subject|0|||
23636030|NCT02175641|66052846|FG000|Overall Study|Death|3|||
23636031|NCT02175641|66052847|FG001|Overall Study|Death|4|||
23636032|NCT02175641|66052846|FG000|Overall Study|Lost to Follow-up|4|||
23636033|NCT02175641|66052847|FG001|Overall Study|Lost to Follow-up|4|||
23636034|NCT02175641|66052846|FG000|Overall Study|Withdrawal by Subject|7|||
23636035|NCT02175641|66052847|FG001|Overall Study|Withdrawal by Subject|4|||
23842254|NCT03379753|66801508|FG000|Overall Study|No primary outcome|12|||
23842255|NCT03379753|66801509|FG001|Overall Study|No primary outcome|22|||
23340636|NCT04064411|64992831|FG001|Overall Study|Lost to Follow-up|2|||
23340637|NCT04064411|64992830|FG000|Overall Study|Other than Specified|4|||
23340638|NCT04064411|64992831|FG001|Overall Study|Other than Specified|1|||
23340639|NCT04064411|64992830|FG000|Overall Study|Death|1|||
23340640|NCT04064411|64992831|FG001|Overall Study|Death|0|||
23340641|NCT02345889|64992832|FG000|Overall Study|Inadequate Bowel Prep|17|||
23340642|NCT02345889|64992833|FG001|Overall Study|Inadequate Bowel Prep|16|||
23340643|NCT02345889|64992834|FG002|Overall Study|Inadequate Bowel Prep|18|||
23340644|NCT02345889|64992835|FG003|Overall Study|Inadequate Bowel Prep|14|||
23340645|NCT02345889|64992832|FG000|Overall Study|Polyposis identified during procedure|1|||
23340646|NCT02345889|64992833|FG001|Overall Study|Polyposis identified during procedure|1|||
23340647|NCT02345889|64992834|FG002|Overall Study|Polyposis identified during procedure|0|||
23340648|NCT02345889|64992835|FG003|Overall Study|Polyposis identified during procedure|1|||
23842256|NCT01258998|66801510|FG000|Overall Study|Ineligible|1|||
23842257|NCT04236141|66801511|FG000|Overall Study|Death|18|||
23842258|NCT04236141|66801512|FG001|Overall Study|Death|10|||
23842259|NCT04236141|66801511|FG000|Overall Study|Withdrawal by Participant|1|||
23842260|NCT04236141|66801512|FG001|Overall Study|Withdrawal by Participant|0|||
23842261|NCT04236141|66801511|FG000|Overall Study|Reason not Specified|1|||
23842262|NCT04236141|66801512|FG001|Overall Study|Reason not Specified|0|||
23842263|NCT04236141|66801511|FG000|Overall Study|Study terminated by Sponsor|8|||
23842264|NCT04236141|66801512|FG001|Overall Study|Study terminated by Sponsor|4|||
23842265|NCT01960907|66801513|FG000|Overall Study|Death|4|||
23842266|NCT01960907|66801514|FG001|Overall Study|Death|3|||
23842267|NCT01960907|66801513|FG000|Overall Study|Withdrawal by Subject|32|||
23842268|NCT01960907|66801514|FG001|Overall Study|Withdrawal by Subject|42|||
23842269|NCT01437995|66801515|FG000|Overall Study|Lost to Follow-up|11|||
23842270|NCT01437995|66801516|FG001|Overall Study|Lost to Follow-up|18|||
23842271|NCT01437995|66801517|FG002|Overall Study|Lost to Follow-up|20|||
23842272|NCT01282372|66805283|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
23842273|NCT01282372|66805283|FG000|Overall Study|Lost to Follow-up|23|||
23842274|NCT01282372|66805283|FG000|Overall Study|Withdrawal by Subject|11|||
23842275|NCT01282372|66805283|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
23842276|NCT01282372|66805283|FG000|Overall Study|Death|1|||
23842277|NCT01282372|66805283|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
23340649|NCT02345889|64992832|FG000|Overall Study|Recognized ineligible post-randomization|1|||
23340650|NCT02345889|64992833|FG001|Overall Study|Recognized ineligible post-randomization|0|||
23340651|NCT02345889|64992834|FG002|Overall Study|Recognized ineligible post-randomization|2|||
23340652|NCT02345889|64992835|FG003|Overall Study|Recognized ineligible post-randomization|1|||
23452641|NCT00990106|65399098|FG001|Overall Study|opted for open label prazosin|1|||
23636036|NCT02175641|66052846|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
23452642|NCT00990106|65399097|FG000|Overall Study|relocation/deployment|4|||
23636037|NCT02175641|66052847|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
23636038|NCT02175641|66052846|FG000|Overall Study|Developed Contraindicated Condition|8|||
23636039|NCT02175641|66052847|FG001|Overall Study|Developed Contraindicated Condition|0|||
23842278|NCT01282372|66805283|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
23842279|NCT01282372|66805283|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
23842280|NCT01282372|66805283|FG000|Overall Study|Adverse Event|12|||
23842281|NCT02651155|66805284|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23842282|NCT02651155|66805285|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23842283|NCT02651155|66805284|FG000|Overall Study|Voluntary Withdrawal|5|||
23842284|NCT02651155|66805285|FG001|Overall Study|Voluntary Withdrawal|0|||
23842285|NCT03089697|66805291|FG000|Overall Study|Adverse Event|1|||
23842286|NCT03089697|66805292|FG001|Overall Study|Adverse Event|2|||
23842287|NCT03089697|66805291|FG000|Overall Study|Withdrawal by Subject|1|||
23842288|NCT03089697|66805292|FG001|Overall Study|Withdrawal by Subject|0|||
23842289|NCT00459290|66805293|FG000|Overall Study|Adverse Event|3|||
23842290|NCT00459290|66805293|FG000|Overall Study|Ineligible|2|||
23842291|NCT02730377|66805294|FG000|Overall Study|Other|5|||
23452643|NCT00990106|65399098|FG001|Overall Study|relocation/deployment|1|||
23842292|NCT02730377|66805295|FG001|Overall Study|Other|4|||
23842293|NCT02730377|66805294|FG000|Overall Study|Death|1|||
23842294|NCT02730377|66805295|FG001|Overall Study|Death|8|||
23842295|NCT02730377|66805294|FG000|Overall Study|Inadequate glycaemic control|368|||
23842296|NCT02730377|66805295|FG001|Overall Study|Inadequate glycaemic control|473|||
23842297|NCT02730377|66805294|FG000|Overall Study|Adverse Event|79|||
23842298|NCT02730377|66805295|FG001|Overall Study|Adverse Event|41|||
23842299|NCT02730377|66805294|FG000|Overall Study|Protocol Violation|23|||
23842300|NCT02730377|66805295|FG001|Overall Study|Protocol Violation|30|||
23842301|NCT02730377|66805294|FG000|Overall Study|Lack of Efficacy|4|||
23842302|NCT02730377|66805295|FG001|Overall Study|Lack of Efficacy|13|||
23842303|NCT02730377|66805294|FG000|Overall Study|Pregnancy|0|||
23842304|NCT02730377|66805295|FG001|Overall Study|Pregnancy|1|||
23581667|NCT00072475|65859014|FG000|Overall Study|Withdrawal by Subject|46|||
23581668|NCT00072475|65859014|FG000|Overall Study|Patient/Investigator Decision|4|||
23581669|NCT00550732|65859015|FG000|Overall Study|Death|4|||
23581670|NCT00550732|65859015|FG000|Overall Study|Withdrawal by Subject|2|||
23581671|NCT00550732|65859015|FG000|Overall Study|Physician Decision|2|||
23581672|NCT00550732|65859015|FG000|Overall Study|Lost to Follow-up|1|||
23581673|NCT00550732|65859015|FG000|Overall Study|Palliative care|1|||
23581674|NCT00550732|65859015|FG000|Overall Study|Adverse Event|1|||
23581675|NCT01939158|65859020|FG000|Overall Study|Adverse Event|1|||
23581676|NCT01939158|65859021|FG001|Overall Study|Adverse Event|0|||
23581677|NCT01939158|65859022|FG002|Overall Study|Adverse Event|0|||
23581678|NCT01939158|65859023|FG003|Overall Study|Adverse Event|0|||
23581679|NCT01939158|65859020|FG000|Overall Study|Withdrawal by Subject|22|||
23581680|NCT01939158|65859021|FG001|Overall Study|Withdrawal by Subject|25|||
23581681|NCT01939158|65859022|FG002|Overall Study|Withdrawal by Subject|15|||
23581682|NCT01939158|65859023|FG003|Overall Study|Withdrawal by Subject|17|||
23581683|NCT01939158|65859020|FG000|Overall Study|Migrated/moved from study area|5|||
23581684|NCT01939158|65859021|FG001|Overall Study|Migrated/moved from study area|7|||
23581685|NCT01939158|65859022|FG002|Overall Study|Migrated/moved from study area|3|||
23581686|NCT01939158|65859023|FG003|Overall Study|Migrated/moved from study area|6|||
23581687|NCT01939158|65859020|FG000|Overall Study|Lost to Follow-up|18|||
23581688|NCT01939158|65859021|FG001|Overall Study|Lost to Follow-up|17|||
23581689|NCT01939158|65859022|FG002|Overall Study|Lost to Follow-up|17|||
23581690|NCT01939158|65859023|FG003|Overall Study|Lost to Follow-up|17|||
23636040|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
23636041|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
23636042|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
23636043|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
23636044|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Death|13|||
23842305|NCT02730377|66805294|FG000|Overall Study|Withdrawal by Subject|45|||
23842306|NCT02730377|66805295|FG001|Overall Study|Withdrawal by Subject|42|||
23842307|NCT02730377|66805294|FG000|Overall Study|Lost to Follow-up|25|||
23842308|NCT02730377|66805295|FG001|Overall Study|Lost to Follow-up|21|||
23842309|NCT01334918|66805298|FG000|Overall Study|Did not receive study drug|6|||
23842310|NCT01334918|66805299|FG001|Overall Study|Did not receive study drug|0|||
23842311|NCT01334918|66805298|FG000|Overall Study|Adverse Event|2|||
23842312|NCT01334918|66805299|FG001|Overall Study|Adverse Event|0|||
23842313|NCT01334918|66805298|FG000|Overall Study|Withdrawal by Subject|0|||
23842314|NCT01334918|66805299|FG001|Overall Study|Withdrawal by Subject|1|||
23452644|NCT00990106|65399097|FG000|Overall Study|started exclusionary medication|0|||
23842315|NCT00803790|66805305|FG000|Period 1|Adverse Event|0|||
23452645|NCT00990106|65399098|FG001|Overall Study|started exclusionary medication|1|||
23581691|NCT01939158|65859020|FG000|Overall Study|Death|0|||
23636045|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Death|12|||
23842316|NCT00803790|66805306|FG001|Period 1|Adverse Event|1|||
23842317|NCT00803790|66805307|FG002|Period 1|Adverse Event|0|||
23842318|NCT00803790|66805308|FG003|Period 1|Adverse Event|0|||
23842319|NCT00803790|66805305|FG000|Period 1|Lost to Follow-up|1|||
23842320|NCT00803790|66805306|FG001|Period 1|Lost to Follow-up|2|||
23842321|NCT00803790|66805307|FG002|Period 1|Lost to Follow-up|0|||
23581692|NCT01939158|65859021|FG001|Overall Study|Death|0|||
23581693|NCT01939158|65859022|FG002|Overall Study|Death|1|||
23581694|NCT01939158|65859023|FG003|Overall Study|Death|1|||
23581695|NCT01939158|65859020|FG000|Overall Study|No longer meets eligibility criteria|0|||
23842322|NCT00803790|66805308|FG003|Period 1|Lost to Follow-up|0|||
23842323|NCT00803790|66805305|FG000|Period 1|Withdrawal by Subject|8|||
23842324|NCT00803790|66805306|FG001|Period 1|Withdrawal by Subject|6|||
23340653|NCT02345889|64992832|FG000|Overall Study|Ulcerative Colitis identified|1|||
23340654|NCT02345889|64992833|FG001|Overall Study|Ulcerative Colitis identified|0|||
23340655|NCT02345889|64992834|FG002|Overall Study|Ulcerative Colitis identified|0|||
23340656|NCT02345889|64992835|FG003|Overall Study|Ulcerative Colitis identified|0|||
23340657|NCT02345889|64992832|FG000|Overall Study|Cecum not intubated|1|||
23340658|NCT02345889|64992833|FG001|Overall Study|Cecum not intubated|0|||
23340659|NCT02345889|64992834|FG002|Overall Study|Cecum not intubated|0|||
23340660|NCT02345889|64992835|FG003|Overall Study|Cecum not intubated|0|||
23340661|NCT02419612|64992836|FG000|Short-term Treatment Period|Adverse Event|1|||
23842325|NCT00803790|66805307|FG002|Period 1|Withdrawal by Subject|0|||
23842326|NCT00803790|66805308|FG003|Period 1|Withdrawal by Subject|0|||
23842327|NCT00803790|66805305|FG000|Period 1|positive drug screen or personal reasons|0|||
23340662|NCT02419612|64992837|FG001|Short-term Treatment Period|Adverse Event|1|||
23340663|NCT02419612|64992836|FG000|Short-term Treatment Period|Death|0|||
23340664|NCT02419612|64992837|FG001|Short-term Treatment Period|Death|2|||
23340665|NCT02419612|64992836|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
23340666|NCT02419612|64992837|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
23340667|NCT02419612|64992836|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
23340668|NCT02419612|64992837|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
23340669|NCT02419612|64992836|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
23340670|NCT02419612|64992837|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
23340671|NCT02419612|64992836|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
23340672|NCT02419612|64992837|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
23340673|NCT02419612|64992836|FG000|Short-term Treatment Period|Worsening of liver function|0|||
23340674|NCT02419612|64992837|FG001|Short-term Treatment Period|Worsening of liver function|1|||
23340675|NCT02419612|64992836|FG000|Short-term Treatment Period|Subject moved out of state|0|||
23340676|NCT02419612|64992837|FG001|Short-term Treatment Period|Subject moved out of state|1|||
23340677|NCT02419612|64992836|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
23340678|NCT02419612|64992837|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
23340679|NCT02419612|64992836|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
23340680|NCT02419612|64992837|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
23340681|NCT02419612|64992836|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
23340682|NCT02419612|64992837|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
23340683|NCT02419612|64992836|FG000|Long-term Treatment Period|Death|0|||
23340684|NCT02419612|64992837|FG001|Long-term Treatment Period|Death|1|||
23340685|NCT02419612|64992836|FG000|Long-term Treatment Period|Adverse Event|0|||
23340686|NCT02419612|64992837|FG001|Long-term Treatment Period|Adverse Event|5|||
23781479|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
23781480|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
23781481|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
23781482|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
23781483|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
23781484|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
23781485|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
23781486|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
23781487|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
23781488|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
23781489|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
23781490|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
23781491|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
23781492|NCT02493868|66580248|FG000|Optimization Phase: DE+TE Participants|Other|10|||
23781493|NCT02493868|66580249|FG001|Optimization Phase: DE+TE Participants|Other|2|||
23781494|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
23781495|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
23781496|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
23781497|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
23781498|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
23781499|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
23781500|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
23781501|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
23781502|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
23781503|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
23781504|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
23781505|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
23781506|NCT02493868|66580248|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
23842328|NCT00803790|66805306|FG001|Period 1|positive drug screen or personal reasons|3|||
23340687|NCT02419612|64992836|FG000|Long-term Treatment Period|Other|4|||
23340688|NCT02419612|64992837|FG001|Long-term Treatment Period|Other|4|||
23452646|NCT00990106|65399097|FG000|Overall Study|planned major surgery|0|||
23452647|NCT00990106|65399098|FG001|Overall Study|planned major surgery|1|||
23452648|NCT00990106|65399097|FG000|Overall Study|scheduling conflicts|0|||
23452649|NCT00990106|65399098|FG001|Overall Study|scheduling conflicts|2|||
23452650|NCT02735239|65399099|FG000|Overall Study|Adverse Event|0|||
23452651|NCT02735239|65399100|FG001|Overall Study|Adverse Event|0|||
23452652|NCT02735239|65399101|FG002|Overall Study|Adverse Event|4|||
23452653|NCT02735239|65399102|FG003|Overall Study|Adverse Event|0|||
23636046|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Progression|257|||
23781507|NCT02493868|66580249|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
23781508|NCT02493868|66580248|FG000|Follow-up Phase|Lost to Follow-up|1|||
23781509|NCT02493868|66580249|FG001|Follow-up Phase|Lost to Follow-up|0|||
23842329|NCT00803790|66805307|FG002|Period 1|positive drug screen or personal reasons|0|||
23842330|NCT00803790|66805308|FG003|Period 1|positive drug screen or personal reasons|4|||
23842331|NCT00803790|66805305|FG000|Period 1|Protocol Violation|0|||
23842332|NCT00803790|66805306|FG001|Period 1|Protocol Violation|0|||
23842333|NCT00803790|66805307|FG002|Period 1|Protocol Violation|1|||
23842334|NCT00803790|66805308|FG003|Period 1|Protocol Violation|0|||
23842335|NCT00803790|66805305|FG000|Period 2|Adverse Event|0|||
23842336|NCT00803790|66805306|FG001|Period 2|Adverse Event|0|||
23842337|NCT00803790|66805307|FG002|Period 2|Adverse Event|1|||
23581696|NCT01939158|65859021|FG001|Overall Study|No longer meets eligibility criteria|0|||
23581697|NCT01939158|65859022|FG002|Overall Study|No longer meets eligibility criteria|1|||
23842338|NCT00803790|66805308|FG003|Period 2|Adverse Event|1|||
23842339|NCT00803790|66805305|FG000|Period 2|Withdrawal by Subject|1|||
23842340|NCT00803790|66805306|FG001|Period 2|Withdrawal by Subject|0|||
23842341|NCT00803790|66805307|FG002|Period 2|Withdrawal by Subject|0|||
23842342|NCT00803790|66805308|FG003|Period 2|Withdrawal by Subject|0|||
23842343|NCT00803790|66805305|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
23452654|NCT02735239|65399103|FG004|Overall Study|Adverse Event|0|||
23452655|NCT02735239|65399104|FG005|Overall Study|Adverse Event|0|||
23452656|NCT02735239|65399099|FG000|Overall Study|Death|1|||
23452657|NCT02735239|65399100|FG001|Overall Study|Death|1|||
23452658|NCT02735239|65399101|FG002|Overall Study|Death|0|||
23452659|NCT02735239|65399102|FG003|Overall Study|Death|0|||
23452660|NCT02735239|65399103|FG004|Overall Study|Death|0|||
23452661|NCT02735239|65399104|FG005|Overall Study|Death|0|||
23452662|NCT02735239|65399099|FG000|Overall Study|Physician Decision|0|||
23452663|NCT02735239|65399100|FG001|Overall Study|Physician Decision|0|||
23452664|NCT02735239|65399101|FG002|Overall Study|Physician Decision|1|||
23452665|NCT02735239|65399102|FG003|Overall Study|Physician Decision|0|||
23452666|NCT02735239|65399103|FG004|Overall Study|Physician Decision|0|||
23452667|NCT02735239|65399104|FG005|Overall Study|Physician Decision|0|||
23452668|NCT02735239|65399099|FG000|Overall Study|Progressive disease|3|||
23781510|NCT02493868|66580248|FG000|Follow-up Phase|Withdrawal by Subject|3|||
23781511|NCT02493868|66580249|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23452669|NCT02735239|65399100|FG001|Overall Study|Progressive disease|1|||
23581698|NCT01939158|65859023|FG003|Overall Study|No longer meets eligibility criteria|0|||
23581699|NCT01939158|65859020|FG000|Overall Study|Other|1|||
23581700|NCT01939158|65859021|FG001|Overall Study|Other|3|||
23581701|NCT01939158|65859022|FG002|Overall Study|Other|4|||
23581702|NCT01939158|65859023|FG003|Overall Study|Other|3|||
23581703|NCT00058058|65859025|FG000|Overall Study|Withdrawal by Subject|4|||
23636047|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Progression|218|||
23636048|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
23636049|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
23781512|NCT02493868|66580248|FG000|Follow-up Phase|Investigator Decision|5|||
23781513|NCT02493868|66580249|FG001|Follow-up Phase|Investigator Decision|1|||
23781514|NCT02493868|66580248|FG000|Follow-up Phase|Other|2|||
23781515|NCT02493868|66580249|FG001|Follow-up Phase|Other|1|||
23781516|NCT03107091|66580252|FG000|Overall Study|Physician Decision|1|||
23781517|NCT00838630|66580259|FG000|First Intervention|Adverse Event|1|||
23781518|NCT00838630|66580260|FG001|First Intervention|Adverse Event|0|||
23842344|NCT00803790|66805306|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
23781519|NCT00838630|66580259|FG000|Washout: 7 Days|Protocol Violation|1|||
23781520|NCT00838630|66580260|FG001|Washout: 7 Days|Protocol Violation|0|||
23842345|NCT00803790|66805307|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
23842346|NCT00803790|66805308|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
23452670|NCT02735239|65399101|FG002|Overall Study|Progressive disease|3|||
23452671|NCT02735239|65399102|FG003|Overall Study|Progressive disease|0|||
23452672|NCT02735239|65399103|FG004|Overall Study|Progressive disease|0|||
23452673|NCT02735239|65399104|FG005|Overall Study|Progressive disease|2|||
23581704|NCT00058058|65859025|FG000|Overall Study|Ineligible|20|||
23452674|NCT02735239|65399099|FG000|Overall Study|Withdrawal by Subject|0|||
23452675|NCT02735239|65399100|FG001|Overall Study|Withdrawal by Subject|1|||
23452676|NCT02735239|65399101|FG002|Overall Study|Withdrawal by Subject|0|||
23581705|NCT00058058|65859025|FG000|Overall Study|Claustrophobic|5|||
23781521|NCT01705574|66580263|FG000|Double-Blind Phase|Lost to Follow-up|12|||
23781522|NCT01705574|66580264|FG001|Double-Blind Phase|Lost to Follow-up|16|||
23452677|NCT02735239|65399102|FG003|Overall Study|Withdrawal by Subject|0|||
23452678|NCT02735239|65399103|FG004|Overall Study|Withdrawal by Subject|0|||
23452679|NCT02735239|65399104|FG005|Overall Study|Withdrawal by Subject|0|||
23452680|NCT01476722|65399107|FG000|Overall Study|Adverse Event|1|||
23452681|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
23452682|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
23452683|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
23452684|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
23452685|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
23452686|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
23452687|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23452688|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
23452689|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
23452690|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
23452691|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
23842347|NCT03485495|66805309|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
23842348|NCT03485495|66805310|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
23842349|NCT03617770|66805318|FG000|Overall Study|Lost to Follow-up|1|||
23452692|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
23452693|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
23452694|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
23452695|NCT00321789|65399112|FG000|Overall Study|Lost to Follow-up|4|||
23452696|NCT00321789|65399113|FG001|Overall Study|Lost to Follow-up|7|||
23452697|NCT00321789|65399112|FG000|Overall Study|Withdrawal by Subject|6|||
23452698|NCT00321789|65399113|FG001|Overall Study|Withdrawal by Subject|6|||
23452699|NCT00321789|65399112|FG000|Overall Study|Protocol Violation|5|||
23452700|NCT00321789|65399113|FG001|Overall Study|Protocol Violation|3|||
23452701|NCT03557970|65399114|FG000|Overall Study|Study closure|1|||
23452702|NCT03557970|65399115|FG001|Overall Study|Study closure|0|||
23452703|NCT03557970|65399114|FG000|Overall Study|Physician Decision|0|||
23452704|NCT03557970|65399115|FG001|Overall Study|Physician Decision|1|||
23452705|NCT03557970|65399114|FG000|Overall Study|Death|0|||
23452706|NCT03557970|65399115|FG001|Overall Study|Death|1|||
23452707|NCT01020786|65399116|FG000|Induction Period|Entry Criteria Not Met|2|||
23452708|NCT01020786|65399116|FG000|Induction Period|Adverse Event|10|||
23452709|NCT01020786|65399116|FG000|Induction Period|Progressive Disease|31|||
23452710|NCT01020786|65399116|FG000|Induction Period|Investigator Decision|3|||
23452711|NCT01020786|65399116|FG000|Induction Period|Withdrawal by Subject|3|||
23452712|NCT01020786|65399116|FG000|Maintenance Period|Adverse Event|8|||
23452713|NCT01020786|65399116|FG000|Maintenance Period|Progressive Disease|43|||
23452714|NCT01020786|65399116|FG000|Maintenance Period|Withdrawal by Subject|8|||
23452715|NCT01020786|65399116|FG000|Maintenance Period|Sponsor Decision|1|||
23452716|NCT02159066|65399117|FG000|Part I|Adverse Event|7|||
23452717|NCT02159066|65399118|FG001|Part I|Adverse Event|5|||
23452718|NCT02159066|65399119|FG002|Part I|Adverse Event|0|||
23452719|NCT02159066|65399120|FG003|Part I|Adverse Event|0|||
23452720|NCT02159066|65399121|FG004|Part I|Adverse Event|0|||
23452721|NCT02159066|65399122|FG005|Part I|Adverse Event|0|||
23452722|NCT02159066|65399117|FG000|Part I|Death|11|||
23452723|NCT02159066|65399118|FG001|Part I|Death|9|||
23452724|NCT02159066|65399119|FG002|Part I|Death|0|||
23452725|NCT02159066|65399120|FG003|Part I|Death|0|||
23452726|NCT02159066|65399121|FG004|Part I|Death|0|||
23452727|NCT02159066|65399122|FG005|Part I|Death|0|||
23452728|NCT02159066|65399117|FG000|Part I|Progressive Disease|37|||
23452729|NCT02159066|65399118|FG001|Part I|Progressive Disease|46|||
23842350|NCT03617770|66805319|FG001|Overall Study|Lost to Follow-up|0|||
23452730|NCT02159066|65399119|FG002|Part I|Progressive Disease|0|||
23452731|NCT02159066|65399120|FG003|Part I|Progressive Disease|0|||
23452732|NCT02159066|65399121|FG004|Part I|Progressive Disease|0|||
23452733|NCT02159066|65399122|FG005|Part I|Progressive Disease|0|||
23452734|NCT02159066|65399117|FG000|Part I|New Therapy for Study Indication|5|||
23452735|NCT02159066|65399118|FG001|Part I|New Therapy for Study Indication|4|||
23452736|NCT02159066|65399119|FG002|Part I|New Therapy for Study Indication|0|||
23452737|NCT02159066|65399120|FG003|Part I|New Therapy for Study Indication|0|||
23842351|NCT01475851|66805326|FG000|Overall Study|Protocol defined stopping criteria|1|||
23340689|NCT02419612|64992836|FG000|Long-term Treatment Period|Subject Decision|2|||
23452738|NCT02159066|65399121|FG004|Part I|New Therapy for Study Indication|0|||
23452739|NCT02159066|65399122|FG005|Part I|New Therapy for Study Indication|0|||
23452740|NCT02159066|65399117|FG000|Part I|Termination of participants from the study|3|||
23452741|NCT02159066|65399118|FG001|Part I|Termination of participants from the study|3|||
23452742|NCT02159066|65399119|FG002|Part I|Termination of participants from the study|0|||
23452743|NCT02159066|65399120|FG003|Part I|Termination of participants from the study|0|||
23452744|NCT02159066|65399121|FG004|Part I|Termination of participants from the study|0|||
23452745|NCT02159066|65399122|FG005|Part I|Termination of participants from the study|0|||
23452746|NCT02159066|65399117|FG000|Part I|Physician Decision|2|||
23452747|NCT02159066|65399118|FG001|Part I|Physician Decision|9|||
23452748|NCT02159066|65399119|FG002|Part I|Physician Decision|0|||
23452749|NCT02159066|65399120|FG003|Part I|Physician Decision|0|||
23452750|NCT02159066|65399121|FG004|Part I|Physician Decision|0|||
23452751|NCT02159066|65399122|FG005|Part I|Physician Decision|0|||
23452752|NCT02159066|65399117|FG000|Part I|Participant/Guardian Decision|9|||
23452753|NCT02159066|65399118|FG001|Part I|Participant/Guardian Decision|3|||
23452754|NCT02159066|65399119|FG002|Part I|Participant/Guardian Decision|0|||
23452755|NCT02159066|65399120|FG003|Part I|Participant/Guardian Decision|0|||
23452756|NCT02159066|65399121|FG004|Part I|Participant/Guardian Decision|0|||
23452757|NCT02159066|65399122|FG005|Part I|Participant/Guardian Decision|0|||
23452758|NCT02159066|65399117|FG000|Part I|Missing Data|1|||
23452759|NCT02159066|65399118|FG001|Part I|Missing Data|0|||
23452760|NCT02159066|65399119|FG002|Part I|Missing Data|0|||
23452761|NCT02159066|65399120|FG003|Part I|Missing Data|0|||
23452762|NCT02159066|65399121|FG004|Part I|Missing Data|0|||
23452763|NCT02159066|65399122|FG005|Part I|Missing Data|0|||
23452764|NCT02159066|65399117|FG000|Part II|Adverse Event|0|||
23452765|NCT02159066|65399118|FG001|Part II|Adverse Event|0|||
23452766|NCT02159066|65399119|FG002|Part II|Adverse Event|1|||
23452767|NCT02159066|65399120|FG003|Part II|Adverse Event|0|||
23452768|NCT02159066|65399121|FG004|Part II|Adverse Event|1|||
23452769|NCT02159066|65399122|FG005|Part II|Adverse Event|1|||
23452770|NCT02159066|65399117|FG000|Part II|Death|0|||
23452771|NCT02159066|65399118|FG001|Part II|Death|0|||
23452772|NCT02159066|65399119|FG002|Part II|Death|1|||
23452773|NCT02159066|65399120|FG003|Part II|Death|0|||
23452774|NCT02159066|65399121|FG004|Part II|Death|2|||
23452775|NCT02159066|65399122|FG005|Part II|Death|1|||
23452776|NCT02159066|65399117|FG000|Part II|Progressive Disease|0|||
23452777|NCT02159066|65399118|FG001|Part II|Progressive Disease|0|||
23452778|NCT02159066|65399119|FG002|Part II|Progressive Disease|35|||
23452779|NCT02159066|65399120|FG003|Part II|Progressive Disease|1|||
23452780|NCT02159066|65399121|FG004|Part II|Progressive Disease|7|||
23452781|NCT02159066|65399122|FG005|Part II|Progressive Disease|4|||
23452782|NCT02159066|65399117|FG000|Part II|New Therapy for Study Indication|0|||
23452783|NCT02159066|65399118|FG001|Part II|New Therapy for Study Indication|0|||
23452784|NCT02159066|65399119|FG002|Part II|New Therapy for Study Indication|0|||
23452785|NCT02159066|65399120|FG003|Part II|New Therapy for Study Indication|0|||
23581706|NCT00058058|65859025|FG000|Overall Study|technical issues|6|||
23636050|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
23636051|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
23636052|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
23636053|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
23636054|NCT01006980|66052848|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
23842352|NCT01475851|66805327|FG001|Overall Study|Protocol defined stopping criteria|0|||
23842353|NCT00384839|66805328|FG000|Overall Study|Adverse Event|4|||
23581707|NCT00058058|65859025|FG000|Overall Study|Poor positioning, illness,pain|3|||
23581708|NCT01008748|65859026|FG000|Overall Study|Lost to Follow-up|80|||
23581709|NCT01008748|65859026|FG000|Overall Study|Other|1|||
23581710|NCT02317705|65859027|FG000|Overall Study|Withdrawal by Subject|3|||
23581711|NCT02317705|65859027|FG000|Overall Study|Physician Decision|1|||
23581712|NCT02317705|65859027|FG000|Overall Study|Drug not usable|1|||
23581713|NCT02256969|65859028|FG000|Overall Study|Screenfailed or withdrew|2|||
23581714|NCT02256969|65859029|FG001|Overall Study|Screenfailed or withdrew|1|||
23581715|NCT02256969|65859030|FG002|Overall Study|Screenfailed or withdrew|1|||
23581716|NCT00093795|65859036|FG000|Overall Study|No follow up data|20|||
23581717|NCT00093795|65859037|FG001|Overall Study|No follow up data|16|||
23581718|NCT00093795|65859038|FG002|Overall Study|No follow up data|17|||
23581719|NCT00477412|65859039|FG000|Overall Study|Death|0|||
23581720|NCT00477412|65859040|FG001|Overall Study|Death|0|||
23636055|NCT01006980|66052849|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
23636056|NCT01006980|66052848|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
23636057|NCT01006980|66052849|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
23636058|NCT01006980|66052848|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
23842354|NCT00384839|66805328|FG000|Overall Study|Investigator Request|1|||
23842355|NCT00384839|66805328|FG000|Overall Study|Patient Request|1|||
23452786|NCT02159066|65399121|FG004|Part II|New Therapy for Study Indication|1|||
23452787|NCT02159066|65399122|FG005|Part II|New Therapy for Study Indication|0|||
23452788|NCT02159066|65399117|FG000|Part II|Physician Decision|0|||
23452789|NCT02159066|65399118|FG001|Part II|Physician Decision|0|||
23452790|NCT02159066|65399119|FG002|Part II|Physician Decision|1|||
23452791|NCT02159066|65399120|FG003|Part II|Physician Decision|0|||
23452792|NCT02159066|65399121|FG004|Part II|Physician Decision|0|||
23452793|NCT02159066|65399122|FG005|Part II|Physician Decision|0|||
23452794|NCT02159066|65399117|FG000|Part II|Participant/Guardian Decision|0|||
23452795|NCT02159066|65399118|FG001|Part II|Participant/Guardian Decision|0|||
23452796|NCT02159066|65399119|FG002|Part II|Participant/Guardian Decision|0|||
23452797|NCT02159066|65399120|FG003|Part II|Participant/Guardian Decision|0|||
23581721|NCT00477412|65859041|FG002|Overall Study|Death|0|||
23452798|NCT02159066|65399121|FG004|Part II|Participant/Guardian Decision|2|||
23452799|NCT02159066|65399122|FG005|Part II|Participant/Guardian Decision|0|||
23452800|NCT02123134|65399125|FG000|Overall Study|Withdrawal of consent|3|||
23452801|NCT02123134|65399126|FG001|Overall Study|Withdrawal of consent|2|||
23452802|NCT02123134|65399125|FG000|Overall Study|Administrative decision|0|||
23452803|NCT02123134|65399126|FG001|Overall Study|Administrative decision|1|||
23452804|NCT02914639|65399127|FG000|Overall Study|Withdrawal by Subject|0|||
23452805|NCT02914639|65399128|FG001|Overall Study|Withdrawal by Subject|2|||
23452806|NCT00101686|65399131|FG000|Overall Study|Progressive Disease|37|||
23452807|NCT00101686|65399132|FG001|Overall Study|Progressive Disease|28|||
23452808|NCT00101686|65399133|FG002|Overall Study|Progressive Disease|37|||
23452809|NCT00101686|65399134|FG003|Overall Study|Progressive Disease|38|||
23452810|NCT00101686|65399135|FG004|Overall Study|Progressive Disease|28|||
23452811|NCT00101686|65399136|FG005|Overall Study|Progressive Disease|25|||
23452812|NCT00101686|65399137|FG006|Overall Study|Progressive Disease|5|||
23452813|NCT00101686|65399138|FG007|Overall Study|Progressive Disease|7|||
23452814|NCT00101686|65399139|FG008|Overall Study|Progressive Disease|10|||
23452815|NCT00101686|65399140|FG009|Overall Study|Progressive Disease|8|||
23452816|NCT00101686|65399131|FG000|Overall Study|initiation other anti-cancer treatment|4|||
23452817|NCT00101686|65399132|FG001|Overall Study|initiation other anti-cancer treatment|3|||
23452818|NCT00101686|65399133|FG002|Overall Study|initiation other anti-cancer treatment|4|||
23452819|NCT00101686|65399134|FG003|Overall Study|initiation other anti-cancer treatment|3|||
23636059|NCT01006980|66052849|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
23636060|NCT01006980|66052848|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
23842356|NCT00384839|66805328|FG000|Overall Study|Ineligible|2|||
23842357|NCT01769508|66805331|FG000|Overall Study|Death|3|||
23842358|NCT01769508|66805331|FG000|Overall Study|Withdrawal by Subject|1|||
23842359|NCT01769508|66805331|FG000|Overall Study|Adverse Event|1|||
23842360|NCT01769508|66805331|FG000|Overall Study|Lost to Follow-up|1|||
23842361|NCT02295020|66805332|FG000|Overall Study|Adverse Event|0|||
23842362|NCT02295020|66805333|FG001|Overall Study|Adverse Event|1|||
23636061|NCT01006980|66052849|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
23636062|NCT01006980|66052848|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
23636063|NCT01006980|66052849|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
23636064|NCT01006980|66052848|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
23636065|NCT01006980|66052849|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
23636066|NCT03752970|66052850|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
23842363|NCT02295020|66805332|FG000|Overall Study|Withdrawal by Subject|3|||
23842364|NCT02295020|66805333|FG001|Overall Study|Withdrawal by Subject|2|||
23842365|NCT01482065|66805336|FG000|Overall Study|Withdrawal by Subject|0|||
23842366|NCT01482065|66805337|FG001|Overall Study|Withdrawal by Subject|1|||
23842367|NCT00679029|66805340|FG000|Overall Study|Adverse Event|3|||
23842368|NCT00679029|66805340|FG000|Overall Study|Withdrawal by Subject|1|||
23842369|NCT00679029|66805340|FG000|Overall Study|Lost to Follow-up|1|||
23842370|NCT02727777|66805341|FG000|Overall Study|Screen Failure|2|||
23842371|NCT02727777|66805342|FG001|Overall Study|Screen Failure|0|||
23842372|NCT02727777|66805343|FG002|Overall Study|Screen Failure|0|||
23842373|NCT02727777|66805341|FG000|Overall Study|Progressive disease|2|||
23842374|NCT02727777|66805342|FG001|Overall Study|Progressive disease|0|||
23636067|NCT03752970|66052851|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
23636068|NCT03752970|66052852|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
23636069|NCT03752970|66052850|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
23842375|NCT02727777|66805343|FG002|Overall Study|Progressive disease|0|||
23842376|NCT02640950|66805344|FG000|Overall Study|Adverse Event|1|||
23842377|NCT02640950|66805344|FG000|Overall Study|Withdrawal by Subject|1|||
23842378|NCT01015131|66805345|FG000|Overall Study|Physician Decision|1|||
23842379|NCT01015131|66805345|FG000|Overall Study|Protocol Violation|1|||
23842380|NCT01015131|66805345|FG000|Overall Study|Withdrawal by Subject|2|||
23842381|NCT01015131|66805345|FG000|Overall Study|Other Protocol Specified Criteria|4|||
23340690|NCT02419612|64992837|FG001|Long-term Treatment Period|Subject Decision|4|||
23340691|NCT02419612|64992836|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
23636070|NCT03752970|66052851|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
23842382|NCT03615144|66805346|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
23842383|NCT03615144|66805347|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
23842384|NCT02714595|66805348|FG000|Overall Study|Lost to Follow-up|1|||
23842385|NCT02714595|66805349|FG001|Overall Study|Lost to Follow-up|0|||
23842386|NCT02714595|66805348|FG000|Overall Study|Withdrawal by Subject|1|||
23842387|NCT02714595|66805349|FG001|Overall Study|Withdrawal by Subject|2|||
23842388|NCT02714595|66805348|FG000|Overall Study|Lack of Efficacy|0|||
23842389|NCT02714595|66805349|FG001|Overall Study|Lack of Efficacy|1|||
23452820|NCT00101686|65399135|FG004|Overall Study|initiation other anti-cancer treatment|1|||
23452821|NCT00101686|65399136|FG005|Overall Study|initiation other anti-cancer treatment|1|||
23452822|NCT00101686|65399137|FG006|Overall Study|initiation other anti-cancer treatment|2|||
23452823|NCT00101686|65399138|FG007|Overall Study|initiation other anti-cancer treatment|2|||
23636071|NCT03752970|66052852|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
23636072|NCT03752970|66052850|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
23636073|NCT03752970|66052851|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
23636074|NCT03752970|66052852|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
23636075|NCT03752970|66052850|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
23636076|NCT03752970|66052851|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
23636077|NCT03752970|66052852|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
23636078|NCT03752970|66052850|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
23636079|NCT03752970|66052851|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
23636080|NCT03752970|66052852|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
23636081|NCT01277887|66052853|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
23636082|NCT01277887|66052854|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
23842390|NCT02714595|66805348|FG000|Overall Study|Death|30|||
23842391|NCT02714595|66805349|FG001|Overall Study|Death|9|||
23842392|NCT02714595|66805348|FG000|Overall Study|Other-Miscellaneous|0|||
23842393|NCT02714595|66805349|FG001|Overall Study|Other-Miscellaneous|1|||
23842394|NCT00002931|66805352|FG000|Overall Study|rapidly progressing disease during|2|||
23842395|NCT02792192|66805353|FG000|Overall Study|Death|1|||
23842396|NCT02792192|66805354|FG001|Overall Study|Death|0|||
23842397|NCT02792192|66805355|FG002|Overall Study|Death|0|||
23842398|NCT02792192|66805356|FG003|Overall Study|Death|0|||
23842399|NCT02792192|66805353|FG000|Overall Study|Informed Consent Withdrawn|4|||
23842400|NCT02792192|66805354|FG001|Overall Study|Informed Consent Withdrawn|0|||
23842401|NCT02792192|66805355|FG002|Overall Study|Informed Consent Withdrawn|0|||
23842402|NCT02792192|66805356|FG003|Overall Study|Informed Consent Withdrawn|0|||
23842403|NCT02792192|66805353|FG000|Overall Study|Physician Decision|1|||
23842404|NCT02792192|66805354|FG001|Overall Study|Physician Decision|0|||
23842405|NCT02792192|66805355|FG002|Overall Study|Physician Decision|0|||
23340692|NCT02419612|64992837|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
23842406|NCT02792192|66805356|FG003|Overall Study|Physician Decision|0|||
23842407|NCT02792192|66805353|FG000|Overall Study|Progressive Disease|0|||
23842408|NCT02792192|66805354|FG001|Overall Study|Progressive Disease|1|||
23842409|NCT02792192|66805355|FG002|Overall Study|Progressive Disease|0|||
23842410|NCT02792192|66805356|FG003|Overall Study|Progressive Disease|0|||
23340693|NCT02256982|64992838|FG000|Overall Study|Disease Progression|0|||
23340694|NCT02256982|64992839|FG001|Overall Study|Disease Progression|1|||
23636083|NCT01277887|66052853|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
23636084|NCT01277887|66052854|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
23636085|NCT01277887|66052853|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
23636086|NCT01277887|66052854|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
23636087|NCT00474526|66052855|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
23636088|NCT00474526|66052856|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
23636089|NCT00474526|66052857|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
23636090|NCT00474526|66052858|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
23781523|NCT01705574|66580265|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23781524|NCT01705574|66580266|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23781525|NCT01705574|66580263|FG000|Double-Blind Phase|Adverse Event|3|||
23781526|NCT01705574|66580264|FG001|Double-Blind Phase|Adverse Event|10|||
23781527|NCT01705574|66580265|FG002|Double-Blind Phase|Adverse Event|0|||
23781528|NCT01705574|66580266|FG003|Double-Blind Phase|Adverse Event|0|||
23781529|NCT01705574|66580263|FG000|Double-Blind Phase|Withdrew Consent|8|||
23842411|NCT02792192|66805353|FG000|Overall Study|Study Terminated By Sponsor|6|||
23340695|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
23340696|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
23340697|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
23340698|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
23452824|NCT00101686|65399139|FG008|Overall Study|initiation other anti-cancer treatment|3|||
23452825|NCT00101686|65399140|FG009|Overall Study|initiation other anti-cancer treatment|3|||
23452826|NCT00101686|65399131|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
23636091|NCT00474526|66052859|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
23636092|NCT00474526|66052860|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
23636093|NCT00474526|66052861|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
23636094|NCT00474526|66052862|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
23781530|NCT01705574|66580264|FG001|Double-Blind Phase|Withdrew Consent|5|||
23781531|NCT01705574|66580265|FG002|Double-Blind Phase|Withdrew Consent|0|||
23781532|NCT01705574|66580266|FG003|Double-Blind Phase|Withdrew Consent|0|||
23842412|NCT02792192|66805354|FG001|Overall Study|Study Terminated By Sponsor|10|||
23842413|NCT02792192|66805355|FG002|Overall Study|Study Terminated By Sponsor|0|||
23842414|NCT02792192|66805356|FG003|Overall Study|Study Terminated By Sponsor|0|||
23842415|NCT02887248|66805364|FG000|Overall Study|Withdrawal by Subject|1|||
23842416|NCT02887248|66805364|FG000|Overall Study|Adverse Event|1|||
23842417|NCT02887248|66805364|FG000|Overall Study|Progressive Disease|1|||
23340699|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Death|0|||
23842418|NCT00761280|66805368|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
23842419|NCT00761280|66805369|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
23842420|NCT00761280|66805368|FG000|Randomization to First Dose|Sponsor decision|1|||
23842421|NCT00761280|66805369|FG001|Randomization to First Dose|Sponsor decision|0|||
23842422|NCT00761280|66805368|FG000|Randomization to First Dose|Other|1|||
23842423|NCT00761280|66805369|FG001|Randomization to First Dose|Other|0|||
23842424|NCT00761280|66805368|FG000|First Dose to End of Study|End of trial|5|||
23340700|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Death|0|||
23340701|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Death|1|||
23842425|NCT00761280|66805369|FG001|First Dose to End of Study|End of trial|5|||
23842426|NCT00761280|66805368|FG000|First Dose to End of Study|Progressive disease|5|||
23842427|NCT00761280|66805369|FG001|First Dose to End of Study|Progressive disease|3|||
23842428|NCT00761280|66805368|FG000|First Dose to End of Study|Sponsor decision|1|||
23842429|NCT00761280|66805369|FG001|First Dose to End of Study|Sponsor decision|2|||
23842430|NCT00761280|66805368|FG000|First Dose to End of Study|Death|1|||
23842431|NCT00761280|66805369|FG001|First Dose to End of Study|Death|0|||
23842432|NCT00761280|66805368|FG000|First Dose to End of Study|Lost to Follow-up|0|||
23842433|NCT00761280|66805369|FG001|First Dose to End of Study|Lost to Follow-up|1|||
23842434|NCT01866657|66805376|FG000|Overall Study|Surgery canceled|2|||
23842435|NCT01866657|66805377|FG001|Overall Study|Surgery canceled|0|||
23842436|NCT01085630|66805380|FG000|Overall Study|Insufficient data|1|||
23842437|NCT01085630|66805381|FG001|Overall Study|Insufficient data|0|||
23842438|NCT01085630|66805380|FG000|Overall Study|Ineligible|3|||
23842439|NCT01085630|66805381|FG001|Overall Study|Ineligible|0|||
23842440|NCT02640677|66805382|FG000|Overall Study|Lost to Follow-up|1|||
23842441|NCT02640677|66805382|FG000|Overall Study|Withdrawal by Subject|1|||
23842442|NCT04481789|66805383|FG000|Period 1|Withdrawal by Subject|1|||
23842443|NCT04481789|66805384|FG001|Period 1|Withdrawal by Subject|0|||
23842444|NCT04481789|66805385|FG002|Period 1|Withdrawal by Subject|0|||
23842445|NCT04481789|66805386|FG003|Period 1|Withdrawal by Subject|0|||
23842446|NCT04481789|66805387|FG004|Period 1|Withdrawal by Subject|0|||
23842447|NCT04481789|66805388|FG005|Period 1|Withdrawal by Subject|0|||
23842448|NCT01263782|66805389|FG000|Overall Study|Death|0|||
23842449|NCT01263782|66805390|FG001|Overall Study|Death|0|||
23636095|NCT00474526|66052863|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
23636096|NCT00474526|66052864|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
23636097|NCT00474526|66052865|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
23636098|NCT00474526|66052866|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
23636099|NCT00474526|66052867|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
23636100|NCT00474526|66052868|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
23636101|NCT00474526|66052869|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
23636102|NCT00474526|66052870|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
23636103|NCT00474526|66052871|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
23636104|NCT00474526|66052855|FG000|Overall Study|Adverse Event|2|||
23636105|NCT00474526|66052856|FG001|Overall Study|Adverse Event|0|||
23636106|NCT00474526|66052857|FG002|Overall Study|Adverse Event|2|||
23636107|NCT00474526|66052858|FG003|Overall Study|Adverse Event|4|||
23636108|NCT00474526|66052859|FG004|Overall Study|Adverse Event|2|||
23781533|NCT01705574|66580263|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
23781534|NCT01705574|66580264|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
23781535|NCT01705574|66580265|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
23781536|NCT01705574|66580266|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
23781537|NCT01705574|66580263|FG000|Double-Blind Phase|Pregnancy|1|||
23781538|NCT01705574|66580264|FG001|Double-Blind Phase|Pregnancy|1|||
23781539|NCT01705574|66580265|FG002|Double-Blind Phase|Pregnancy|0|||
23781540|NCT01705574|66580266|FG003|Double-Blind Phase|Pregnancy|0|||
23781541|NCT01705574|66580263|FG000|Double-Blind Phase|Protocol Violation|1|||
23781542|NCT01705574|66580264|FG001|Double-Blind Phase|Protocol Violation|0|||
23781543|NCT01705574|66580265|FG002|Double-Blind Phase|Protocol Violation|0|||
23781544|NCT01705574|66580266|FG003|Double-Blind Phase|Protocol Violation|0|||
23781545|NCT01705574|66580263|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
23781546|NCT01705574|66580264|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
23781547|NCT01705574|66580265|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
23781548|NCT01705574|66580266|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
23781549|NCT01705574|66580263|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
23842450|NCT01263782|66805391|FG002|Overall Study|Death|1|||
23842451|NCT01263782|66805392|FG003|Overall Study|Death|0|||
23842452|NCT01263782|66805389|FG000|Overall Study|Progressive disease|0|||
23842453|NCT01263782|66805390|FG001|Overall Study|Progressive disease|0|||
23842454|NCT01263782|66805391|FG002|Overall Study|Progressive disease|0|||
23842455|NCT01263782|66805392|FG003|Overall Study|Progressive disease|1|||
23636109|NCT00474526|66052860|FG005|Overall Study|Adverse Event|1|||
23636110|NCT00474526|66052861|FG006|Overall Study|Adverse Event|1|||
23781550|NCT01705574|66580264|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23781551|NCT01705574|66580265|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
23781552|NCT01705574|66580266|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
23781553|NCT01705574|66580263|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
23452827|NCT00101686|65399132|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
23581722|NCT00477412|65859042|FG003|Overall Study|Death|4|||
23781554|NCT01705574|66580264|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
23781555|NCT01705574|66580265|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
23781556|NCT01705574|66580266|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
23781557|NCT01705574|66580263|FG000|Open-Label Extension Phase|Adverse Event|3|||
23781558|NCT01705574|66580264|FG001|Open-Label Extension Phase|Adverse Event|0|||
23781559|NCT01705574|66580265|FG002|Open-Label Extension Phase|Adverse Event|0|||
23781560|NCT01705574|66580266|FG003|Open-Label Extension Phase|Adverse Event|1|||
23781561|NCT01705574|66580263|FG000|Open-Label Extension Phase|Death|2|||
23781562|NCT01705574|66580264|FG001|Open-Label Extension Phase|Death|0|||
23781563|NCT01705574|66580265|FG002|Open-Label Extension Phase|Death|1|||
23781564|NCT01705574|66580266|FG003|Open-Label Extension Phase|Death|0|||
23781565|NCT01705574|66580263|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23842456|NCT01263782|66805389|FG000|Overall Study|Too early|0|||
23842457|NCT01263782|66805390|FG001|Overall Study|Too early|0|||
23842458|NCT01263782|66805391|FG002|Overall Study|Too early|1|||
23842459|NCT01263782|66805392|FG003|Overall Study|Too early|0|||
23842460|NCT01263782|66805389|FG000|Overall Study|Inevaluable|0|||
23842461|NCT01263782|66805390|FG001|Overall Study|Inevaluable|0|||
23842462|NCT01263782|66805391|FG002|Overall Study|Inevaluable|1|||
23842463|NCT01263782|66805392|FG003|Overall Study|Inevaluable|0|||
23842464|NCT03503370|66805393|FG000|Overall Study|Death|3|||
23581723|NCT00477412|65859039|FG000|Overall Study|Lost to Follow-up|0|||
23581724|NCT00477412|65859040|FG001|Overall Study|Lost to Follow-up|0|||
23581725|NCT00477412|65859041|FG002|Overall Study|Lost to Follow-up|0|||
23581726|NCT00477412|65859042|FG003|Overall Study|Lost to Follow-up|1|||
23581727|NCT00477412|65859039|FG000|Overall Study|Withdrawal by Subject|0|||
23581728|NCT00477412|65859040|FG001|Overall Study|Withdrawal by Subject|0|||
23581729|NCT00477412|65859041|FG002|Overall Study|Withdrawal by Subject|0|||
23581730|NCT00477412|65859042|FG003|Overall Study|Withdrawal by Subject|2|||
23581731|NCT00477412|65859039|FG000|Overall Study|Second Malignancy|0|||
23581732|NCT00477412|65859040|FG001|Overall Study|Second Malignancy|0|||
23581733|NCT00477412|65859041|FG002|Overall Study|Second Malignancy|0|||
23581734|NCT00477412|65859042|FG003|Overall Study|Second Malignancy|1|||
23581735|NCT00477412|65859039|FG000|Overall Study|Adverse Event|1|||
23581736|NCT00477412|65859040|FG001|Overall Study|Adverse Event|0|||
23581737|NCT00477412|65859041|FG002|Overall Study|Adverse Event|1|||
23581738|NCT00477412|65859042|FG003|Overall Study|Adverse Event|0|||
23581739|NCT01311648|65859048|FG000|Main Study|Protocol Violation|0|||
23581740|NCT01311648|65859049|FG001|Main Study|Protocol Violation|1|||
23842465|NCT03503370|66805394|FG001|Overall Study|Death|1|||
23842466|NCT02880865|66805395|FG000|Overall Study|Adverse Event|1|||
23842467|NCT02880865|66805396|FG001|Overall Study|Adverse Event|0|||
23842468|NCT02880865|66805395|FG000|Overall Study|Withdrawal by Subject|0|||
23842469|NCT02880865|66805396|FG001|Overall Study|Withdrawal by Subject|2|||
23842470|NCT02880865|66805395|FG000|Overall Study|Physician Decision|0|||
23842471|NCT02880865|66805396|FG001|Overall Study|Physician Decision|1|||
23842472|NCT00812981|66805399|FG000|Overall Study|Other|0|||
23842473|NCT00812981|66805400|FG001|Overall Study|Other|1|||
23842474|NCT00793624|66805401|FG000|Overall Study|Adverse Event|18|||
23842475|NCT00793624|66805402|FG001|Overall Study|Adverse Event|16|||
23581741|NCT01311648|65859048|FG000|Main Study|Adverse Event|0|||
23581742|NCT01311648|65859049|FG001|Main Study|Adverse Event|1|||
23581743|NCT01311648|65859048|FG000|Main Study|Inhibitor management|0|||
23581744|NCT01311648|65859049|FG001|Main Study|Inhibitor management|17|||
23581745|NCT01311648|65859048|FG000|Main Study|Withdrawal by Subject|0|||
23581746|NCT01311648|65859049|FG001|Main Study|Withdrawal by Subject|2|||
23581747|NCT01311648|65859048|FG000|Extension Study|Physician Decision|0|||
23581748|NCT01311648|65859049|FG001|Extension Study|Physician Decision|1|||
23581749|NCT01311648|65859048|FG000|Extension Study|ITI therapy with marketed product|0|||
23581750|NCT01311648|65859049|FG001|Extension Study|ITI therapy with marketed product|1|||
23581751|NCT01311648|65859048|FG000|Extension Study|Incorrect visit planning|0|||
23781566|NCT01705574|66580264|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23781567|NCT01705574|66580265|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
23781568|NCT01705574|66580266|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23842476|NCT00793624|66805403|FG002|Overall Study|Adverse Event|15|||
23842477|NCT00793624|66805404|FG003|Overall Study|Adverse Event|20|||
23581752|NCT01311648|65859049|FG001|Extension Study|Incorrect visit planning|1|||
23581753|NCT01311648|65859048|FG000|Extension Study|Family's decision|0|||
23581754|NCT01311648|65859049|FG001|Extension Study|Family's decision|1|||
23842478|NCT00793624|66805401|FG000|Overall Study|Lost to Follow-up|2|||
23581755|NCT01311648|65859048|FG000|Extension Study|Failure of ITI therapy|0|||
23581756|NCT01311648|65859049|FG001|Extension Study|Failure of ITI therapy|3|||
23842479|NCT00793624|66805402|FG001|Overall Study|Lost to Follow-up|2|||
23842480|NCT00793624|66805403|FG002|Overall Study|Lost to Follow-up|4|||
23581757|NCT01311648|65859048|FG000|Extension Study|Long travel|0|||
23842481|NCT00793624|66805404|FG003|Overall Study|Lost to Follow-up|0|||
23842482|NCT00793624|66805401|FG000|Overall Study|Withdrawal by Subject|20|||
23842483|NCT00793624|66805402|FG001|Overall Study|Withdrawal by Subject|9|||
23842484|NCT00793624|66805403|FG002|Overall Study|Withdrawal by Subject|11|||
23842485|NCT00793624|66805404|FG003|Overall Study|Withdrawal by Subject|14|||
23581758|NCT01311648|65859049|FG001|Extension Study|Long travel|1|||
23581759|NCT01311648|65859048|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
23581760|NCT01311648|65859049|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
23581761|NCT01311648|65859048|FG000|Extension Study|Withdrawal by Subject|0|||
23581762|NCT01311648|65859049|FG001|Extension Study|Withdrawal by Subject|1|||
23581763|NCT01311648|65859048|FG000|Extension Study|Inhibitor management|0|||
23581764|NCT01311648|65859049|FG001|Extension Study|Inhibitor management|2|||
23581765|NCT04172987|65859055|FG000|Lead In Period|Adverse Event|1|||
23581766|NCT04172987|65859055|FG000|Lead In Period|Protocol Violation|1|||
23842486|NCT00793624|66805401|FG000|Overall Study|Lack of Efficacy|9|||
23842487|NCT00793624|66805402|FG001|Overall Study|Lack of Efficacy|2|||
23842488|NCT00793624|66805403|FG002|Overall Study|Lack of Efficacy|1|||
23842489|NCT00793624|66805404|FG003|Overall Study|Lack of Efficacy|3|||
23842490|NCT00793624|66805401|FG000|Overall Study|Non compliance with protocol|2|||
23842491|NCT00793624|66805402|FG001|Overall Study|Non compliance with protocol|3|||
23842492|NCT00793624|66805403|FG002|Overall Study|Non compliance with protocol|2|||
23842493|NCT00793624|66805404|FG003|Overall Study|Non compliance with protocol|3|||
23842494|NCT00793624|66805401|FG000|Overall Study|Other reason not described above|6|||
23842495|NCT00793624|66805402|FG001|Overall Study|Other reason not described above|4|||
23842496|NCT00793624|66805403|FG002|Overall Study|Other reason not described above|6|||
23842497|NCT00793624|66805404|FG003|Overall Study|Other reason not described above|3|||
23842498|NCT00623935|66805413|FG000|Overall Study|Death|1|||
23842499|NCT00623935|66805413|FG000|Overall Study|Patient Declined Transplant|1|||
23842500|NCT02361346|66805414|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
23581767|NCT04172987|65859055|FG000|Period 1|Physician Decision|1|||
23581768|NCT04172987|65859055|FG000|Period 2|Adverse Event|5|||
23581769|NCT04172987|65859055|FG000|Period 2|Dosing Termination by Sponsor|4|||
23581770|NCT00256308|65859063|FG000|Overall Study|Death|2|||
23581771|NCT03095508|65859064|FG000|Overall Study|Adverse Event|0|||
23581772|NCT03095508|65859065|FG001|Overall Study|Adverse Event|1|||
23581773|NCT01941316|65859066|FG000|Overall Study|Adverse Event|0|||
23581774|NCT01941316|65859067|FG001|Overall Study|Adverse Event|1|||
23581775|NCT01941316|65859068|FG002|Overall Study|Adverse Event|0|||
23581776|NCT01941316|65859069|FG003|Overall Study|Adverse Event|7|||
23581777|NCT01941316|65859066|FG000|Overall Study|Progressive Disease|3|||
23581778|NCT01941316|65859067|FG001|Overall Study|Progressive Disease|6|||
23581779|NCT01941316|65859068|FG002|Overall Study|Progressive Disease|2|||
23636111|NCT00474526|66052862|FG007|Overall Study|Adverse Event|0|||
23636112|NCT00474526|66052863|FG008|Overall Study|Adverse Event|0|||
23636113|NCT00474526|66052864|FG009|Overall Study|Adverse Event|0|||
23636114|NCT00474526|66052865|FG010|Overall Study|Adverse Event|0|||
23636115|NCT00474526|66052866|FG011|Overall Study|Adverse Event|0|||
23636116|NCT00474526|66052867|FG012|Overall Study|Adverse Event|0|||
23636117|NCT00474526|66052868|FG013|Overall Study|Adverse Event|0|||
23636118|NCT00474526|66052869|FG014|Overall Study|Adverse Event|1|||
23636119|NCT00474526|66052870|FG015|Overall Study|Adverse Event|1|||
23636120|NCT00474526|66052871|FG016|Overall Study|Adverse Event|0|||
23636121|NCT00474526|66052855|FG000|Overall Study|Death|0|||
23636122|NCT00474526|66052856|FG001|Overall Study|Death|0|||
23636123|NCT00474526|66052857|FG002|Overall Study|Death|0|||
23636124|NCT00474526|66052858|FG003|Overall Study|Death|0|||
23636125|NCT00474526|66052859|FG004|Overall Study|Death|0|||
23636126|NCT00474526|66052860|FG005|Overall Study|Death|0|||
23636127|NCT00474526|66052861|FG006|Overall Study|Death|0|||
23636128|NCT00474526|66052862|FG007|Overall Study|Death|0|||
23636129|NCT00474526|66052863|FG008|Overall Study|Death|0|||
23636130|NCT00474526|66052864|FG009|Overall Study|Death|0|||
23636131|NCT00474526|66052865|FG010|Overall Study|Death|0|||
23636132|NCT00474526|66052866|FG011|Overall Study|Death|0|||
23636133|NCT00474526|66052867|FG012|Overall Study|Death|0|||
23636134|NCT00474526|66052868|FG013|Overall Study|Death|3|||
23636135|NCT00474526|66052869|FG014|Overall Study|Death|0|||
23636136|NCT00474526|66052870|FG015|Overall Study|Death|0|||
23636137|NCT00474526|66052871|FG016|Overall Study|Death|0|||
23842501|NCT02361346|66805415|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
23581780|NCT01941316|65859069|FG003|Overall Study|Progressive Disease|29|||
23581781|NCT01941316|65859066|FG000|Overall Study|Withdrawal by Subject|0|||
23581782|NCT01941316|65859067|FG001|Overall Study|Withdrawal by Subject|2|||
23581783|NCT01941316|65859068|FG002|Overall Study|Withdrawal by Subject|1|||
23636138|NCT00474526|66052855|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636139|NCT00474526|66052856|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
23842502|NCT02361346|66805416|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
23581784|NCT01941316|65859069|FG003|Overall Study|Withdrawal by Subject|8|||
23636140|NCT00474526|66052857|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636141|NCT00474526|66052858|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
23636142|NCT00474526|66052859|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23842503|NCT02361346|66805417|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
23842504|NCT02361346|66805418|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
23842505|NCT02361346|66805419|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
23842506|NCT02361346|66805420|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
23842507|NCT02361346|66805421|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
23842508|NCT02361346|66805422|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
23842509|NCT02361346|66805414|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842510|NCT02361346|66805415|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842511|NCT02361346|66805416|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842512|NCT02361346|66805417|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842513|NCT02361346|66805418|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
23842514|NCT02361346|66805419|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842515|NCT02361346|66805420|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842516|NCT02361346|66805421|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23581785|NCT01941316|65859066|FG000|Overall Study|Death|0|||
23581786|NCT01941316|65859067|FG001|Overall Study|Death|0|||
23581787|NCT01941316|65859068|FG002|Overall Study|Death|0|||
23581788|NCT01941316|65859069|FG003|Overall Study|Death|3|||
23581789|NCT01941316|65859066|FG000|Overall Study|Physician Decision|0|||
23581790|NCT01941316|65859067|FG001|Overall Study|Physician Decision|0|||
23581791|NCT01941316|65859068|FG002|Overall Study|Physician Decision|0|||
23581792|NCT01941316|65859069|FG003|Overall Study|Physician Decision|3|||
23581793|NCT01941316|65859066|FG000|Overall Study|Protocol Violation|0|||
23581794|NCT01941316|65859067|FG001|Overall Study|Protocol Violation|0|||
23581795|NCT01941316|65859068|FG002|Overall Study|Protocol Violation|0|||
23581796|NCT01941316|65859069|FG003|Overall Study|Protocol Violation|3|||
23581797|NCT01941316|65859066|FG000|Overall Study|Intercurrent illness|0|||
23581798|NCT01941316|65859067|FG001|Overall Study|Intercurrent illness|0|||
23581799|NCT01941316|65859068|FG002|Overall Study|Intercurrent illness|0|||
23581800|NCT01941316|65859069|FG003|Overall Study|Intercurrent illness|1|||
23636143|NCT00474526|66052860|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23781569|NCT01705574|66580263|FG000|Open-Label Extension Phase|Physician Decision|0|||
23781570|NCT01705574|66580264|FG001|Open-Label Extension Phase|Physician Decision|0|||
23781571|NCT01705574|66580265|FG002|Open-Label Extension Phase|Physician Decision|2|||
23781572|NCT01705574|66580266|FG003|Open-Label Extension Phase|Physician Decision|0|||
23781573|NCT01705574|66580263|FG000|Open-Label Extension Phase|Pregnancy|0|||
23781574|NCT01705574|66580264|FG001|Open-Label Extension Phase|Pregnancy|0|||
23781575|NCT01705574|66580265|FG002|Open-Label Extension Phase|Pregnancy|1|||
23781576|NCT01705574|66580266|FG003|Open-Label Extension Phase|Pregnancy|1|||
23781577|NCT03031847|66580269|FG000|Overall Study|Death|1|||
23781578|NCT03031847|66580270|FG001|Overall Study|Death|1|||
23781579|NCT03031847|66580271|FG002|Overall Study|Death|2|||
23781580|NCT03031847|66580272|FG003|Overall Study|Death|3|||
23781581|NCT03031847|66580269|FG000|Overall Study|Lost to Follow-up|1|||
23781582|NCT03031847|66580270|FG001|Overall Study|Lost to Follow-up|1|||
23781583|NCT03031847|66580271|FG002|Overall Study|Lost to Follow-up|2|||
23781584|NCT03031847|66580272|FG003|Overall Study|Lost to Follow-up|3|||
23781585|NCT02682784|66580273|FG000|Overall Study|Withdrawal by Subject|0|||
23781586|NCT02682784|66580274|FG001|Overall Study|Withdrawal by Subject|2|||
23781587|NCT02682784|66580275|FG002|Overall Study|Withdrawal by Subject|1|||
23781588|NCT02682784|66580276|FG003|Overall Study|Withdrawal by Subject|2|||
23781589|NCT02682784|66580273|FG000|Overall Study|Physician Decision|1|||
23781590|NCT02682784|66580274|FG001|Overall Study|Physician Decision|0|||
23781591|NCT02682784|66580275|FG002|Overall Study|Physician Decision|1|||
23781592|NCT02682784|66580276|FG003|Overall Study|Physician Decision|1|||
23781593|NCT02880761|66580277|FG000|Overall Study|Death|6|||
23781594|NCT02880761|66580278|FG001|Overall Study|Death|8|||
23781595|NCT02880761|66580277|FG000|Overall Study|Withdrawal by Subject|3|||
23781596|NCT02880761|66580278|FG001|Overall Study|Withdrawal by Subject|6|||
23781597|NCT02880761|66580277|FG000|Overall Study|Protocol Violation|4|||
23781598|NCT02880761|66580278|FG001|Overall Study|Protocol Violation|3|||
23781599|NCT02880761|66580277|FG000|Overall Study|Lost to Follow-up|3|||
23842517|NCT02361346|66805422|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23842518|NCT02361346|66805414|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
23581801|NCT01941316|65859066|FG000|Overall Study|Other, not specified|0|||
23581802|NCT01941316|65859067|FG001|Overall Study|Other, not specified|0|||
23581803|NCT01941316|65859068|FG002|Overall Study|Other, not specified|0|||
23581804|NCT01941316|65859069|FG003|Overall Study|Other, not specified|1|||
23581805|NCT03415022|65859070|FG000|Overall Study|Withdrawal by Subject|1|||
23636144|NCT00474526|66052861|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23781600|NCT02880761|66580278|FG001|Overall Study|Lost to Follow-up|4|||
23781601|NCT00910663|66580279|FG000|Period 1|Withdrawal by Subject|0|||
23781602|NCT00910663|66580280|FG001|Period 1|Withdrawal by Subject|1|||
23781603|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
23781604|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
23781605|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
23781606|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
23842519|NCT02361346|66805415|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
23842520|NCT02361346|66805416|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
23842521|NCT02361346|66805417|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
23842522|NCT02361346|66805418|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
23842523|NCT02361346|66805419|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
23842524|NCT02361346|66805420|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
23842525|NCT02361346|66805421|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
23842526|NCT02361346|66805422|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
23842527|NCT02361346|66805414|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842528|NCT02361346|66805415|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842529|NCT02361346|66805416|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842530|NCT02361346|66805417|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842531|NCT02361346|66805418|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842532|NCT02361346|66805419|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842533|NCT02361346|66805420|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842534|NCT02361346|66805421|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
23842535|NCT02361346|66805422|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23842536|NCT02361346|66805414|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842537|NCT02361346|66805415|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842538|NCT02361346|66805416|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842539|NCT02361346|66805417|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842540|NCT02361346|66805418|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842541|NCT02361346|66805419|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842542|NCT02361346|66805420|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842543|NCT02361346|66805421|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
23842544|NCT02361346|66805422|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23842545|NCT02361346|66805414|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842546|NCT02361346|66805415|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842547|NCT02361346|66805416|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842548|NCT02361346|66805417|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842549|NCT02361346|66805418|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842550|NCT02361346|66805419|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842551|NCT02361346|66805420|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842552|NCT02361346|66805421|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
23842553|NCT02361346|66805422|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23842554|NCT00601172|66805433|FG000|Overall Study|Adverse Event|43|||
23842555|NCT00601172|66805434|FG001|Overall Study|Adverse Event|32|||
23842556|NCT00601172|66805433|FG000|Overall Study|Lack of Efficacy|11|||
23842557|NCT00601172|66805434|FG001|Overall Study|Lack of Efficacy|12|||
23842558|NCT00601172|66805433|FG000|Overall Study|Protocol Violation|2|||
23842559|NCT00601172|66805434|FG001|Overall Study|Protocol Violation|5|||
23842560|NCT00601172|66805433|FG000|Overall Study|Lost to Follow-up|4|||
23842561|NCT00601172|66805434|FG001|Overall Study|Lost to Follow-up|3|||
23842562|NCT00601172|66805433|FG000|Overall Study|Physician Decision|27|||
23636145|NCT00474526|66052862|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636146|NCT00474526|66052863|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636147|NCT00474526|66052864|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636148|NCT00474526|66052865|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636149|NCT00474526|66052866|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636150|NCT00474526|66052867|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636151|NCT00474526|66052868|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23636152|NCT00474526|66052869|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23636153|NCT00474526|66052870|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23842563|NCT00601172|66805434|FG001|Overall Study|Physician Decision|28|||
23842564|NCT00601172|66805433|FG000|Overall Study|Withdrawal by Subject|35|||
23581806|NCT03415022|65859071|FG001|Overall Study|Withdrawal by Subject|2|||
23581807|NCT03415022|65859070|FG000|Overall Study|COVID-19 Suspension|2|||
23581808|NCT03415022|65859071|FG001|Overall Study|COVID-19 Suspension|3|||
23581809|NCT03415022|65859070|FG000|Overall Study|Lost to Follow-up|2|||
23581810|NCT03415022|65859071|FG001|Overall Study|Lost to Follow-up|0|||
23581811|NCT03566680|65859072|FG000|Overall Study|Pregnancy|1|||
23581812|NCT03566680|65859072|FG000|Overall Study|Lost to Follow-up|13|||
23581813|NCT03566680|65859072|FG000|Overall Study|Withdrawal by Subject|3|||
23842565|NCT00601172|66805434|FG001|Overall Study|Withdrawal by Subject|27|||
23842566|NCT00601172|66805433|FG000|Overall Study|Did not meet continuation criteria|19|||
23842567|NCT00601172|66805434|FG001|Overall Study|Did not meet continuation criteria|20|||
23842568|NCT02291601|66805446|FG000|Abdomen|Did not qualify|333|||
23581814|NCT00149630|65859080|FG000|Overall Study|Incarceration|2|||
23581815|NCT00149630|65859081|FG001|Overall Study|Incarceration|0|||
23581816|NCT00149630|65859080|FG000|Overall Study|Treatment Programs|4|||
23636154|NCT00474526|66052871|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23636155|NCT00474526|66052855|FG000|Overall Study|Lost to Follow-up|8|||
23581817|NCT00149630|65859081|FG001|Overall Study|Treatment Programs|5|||
23581818|NCT00149630|65859080|FG000|Overall Study|Adverse Event|2|||
23581819|NCT00149630|65859081|FG001|Overall Study|Adverse Event|0|||
23581820|NCT02724878|65859086|FG000|Overall Study|Still on Active Therapy|15|||
23581821|NCT02724878|65859086|FG000|Overall Study|Disease Progression|31|||
23581822|NCT02724878|65859086|FG000|Overall Study|Toxicity|5|||
23581823|NCT02724878|65859086|FG000|Overall Study|Death|1|||
23581824|NCT02724878|65859086|FG000|Overall Study|Withdrawal by Subject|4|||
23581825|NCT02724878|65859086|FG000|Overall Study|Lost to Follow-up|2|||
23581826|NCT02724878|65859086|FG000|Overall Study|Protocol Violation|1|||
23581827|NCT02724878|65859086|FG000|Overall Study|Ineligible for Study Drug|5|||
23581828|NCT02724878|65859086|FG000|Overall Study|not started|1|||
23581829|NCT01773122|65859091|FG000|Overall Study|Due to amended age eligibility criteria|3|||
23842569|NCT02291601|66805447|FG001|Abdomen|Did not qualify|54|||
23581830|NCT01773122|65859092|FG001|Overall Study|Due to amended age eligibility criteria|1|||
23581831|NCT01773122|65859093|FG002|Overall Study|Due to amended age eligibility criteria|0|||
23581832|NCT01773122|65859094|FG003|Overall Study|Due to amended age eligibility criteria|1|||
23581833|NCT00515086|65859100|FG000|Overall Study|Adverse Event|1|||
23581834|NCT00515086|65859101|FG001|Overall Study|Adverse Event|1|||
23636156|NCT00474526|66052856|FG001|Overall Study|Lost to Follow-up|6|||
23636157|NCT00474526|66052857|FG002|Overall Study|Lost to Follow-up|13|||
23636158|NCT00474526|66052858|FG003|Overall Study|Lost to Follow-up|29|||
23636159|NCT00474526|66052859|FG004|Overall Study|Lost to Follow-up|11|||
23636160|NCT00474526|66052860|FG005|Overall Study|Lost to Follow-up|5|||
23636161|NCT00474526|66052861|FG006|Overall Study|Lost to Follow-up|8|||
23636162|NCT00474526|66052862|FG007|Overall Study|Lost to Follow-up|1|||
23636163|NCT00474526|66052863|FG008|Overall Study|Lost to Follow-up|0|||
23636164|NCT00474526|66052864|FG009|Overall Study|Lost to Follow-up|6|||
23636165|NCT00474526|66052865|FG010|Overall Study|Lost to Follow-up|2|||
23636166|NCT00474526|66052866|FG011|Overall Study|Lost to Follow-up|4|||
23636167|NCT00474526|66052867|FG012|Overall Study|Lost to Follow-up|6|||
23636168|NCT00474526|66052868|FG013|Overall Study|Lost to Follow-up|74|||
23636169|NCT00474526|66052869|FG014|Overall Study|Lost to Follow-up|29|||
23636170|NCT00474526|66052870|FG015|Overall Study|Lost to Follow-up|4|||
23636171|NCT00474526|66052871|FG016|Overall Study|Lost to Follow-up|5|||
23636172|NCT00474526|66052855|FG000|Overall Study|Protocol Violation|2|||
23636173|NCT00474526|66052856|FG001|Overall Study|Protocol Violation|6|||
23842570|NCT02291601|66805448|FG002|Abdomen|Did not qualify|339|||
23842571|NCT02291601|66805446|FG000|Groin|Did not qualify|183|||
23842572|NCT02291601|66805447|FG001|Groin|Did not qualify|30|||
23842573|NCT02291601|66805448|FG002|Groin|Did not qualify|177|||
23842574|NCT00957268|66805449|FG000|Overall Study|Voluntary Withdrawal|0|||
23842575|NCT00957268|66805450|FG001|Overall Study|Voluntary Withdrawal|0|||
23842576|NCT00957268|66805451|FG002|Overall Study|Voluntary Withdrawal|1|||
23842577|NCT00957268|66805452|FG003|Overall Study|Voluntary Withdrawal|0|||
23842578|NCT00957268|66805453|FG004|Overall Study|Voluntary Withdrawal|0|||
23842579|NCT02231879|66805458|FG000|Overall Study|Adverse Event|2|||
23842580|NCT02231879|66805459|FG001|Overall Study|Adverse Event|1|||
23842581|NCT02231879|66805458|FG000|Overall Study|Lack of Efficacy|0|||
23842582|NCT02231879|66805459|FG001|Overall Study|Lack of Efficacy|1|||
23842583|NCT02217410|66805460|FG000|Overall Study|Graft Loss|0|||
23842584|NCT02217410|66805461|FG001|Overall Study|Graft Loss|0|||
23842585|NCT02217410|66805462|FG002|Overall Study|Graft Loss|2|||
23842586|NCT02217410|66805460|FG000|Overall Study|Withdrawal by Subject|0|||
23842587|NCT02217410|66805461|FG001|Overall Study|Withdrawal by Subject|0|||
23842588|NCT02217410|66805462|FG002|Overall Study|Withdrawal by Subject|2|||
23842589|NCT02217410|66805460|FG000|Overall Study|Lost to Follow-up|0|||
23581835|NCT00515086|65859102|FG002|Overall Study|Adverse Event|2|||
23581836|NCT00515086|65859103|FG003|Overall Study|Adverse Event|3|||
23581837|NCT00515086|65859100|FG000|Overall Study|Administrative|1|||
23636174|NCT00474526|66052857|FG002|Overall Study|Protocol Violation|4|||
23581838|NCT00515086|65859101|FG001|Overall Study|Administrative|1|||
23581839|NCT00515086|65859102|FG002|Overall Study|Administrative|0|||
23636175|NCT00474526|66052858|FG003|Overall Study|Protocol Violation|12|||
23636176|NCT00474526|66052859|FG004|Overall Study|Protocol Violation|3|||
23636177|NCT00474526|66052860|FG005|Overall Study|Protocol Violation|1|||
23636178|NCT00474526|66052861|FG006|Overall Study|Protocol Violation|3|||
23636179|NCT00474526|66052862|FG007|Overall Study|Protocol Violation|0|||
23636180|NCT00474526|66052863|FG008|Overall Study|Protocol Violation|0|||
23842590|NCT02217410|66805461|FG001|Overall Study|Lost to Follow-up|0|||
23842591|NCT02217410|66805462|FG002|Overall Study|Lost to Follow-up|1|||
23842592|NCT02217410|66805460|FG000|Overall Study|Lack of Efficacy|0|||
23636181|NCT00474526|66052864|FG009|Overall Study|Protocol Violation|4|||
23842593|NCT02217410|66805461|FG001|Overall Study|Lack of Efficacy|1|||
23842594|NCT02217410|66805462|FG002|Overall Study|Lack of Efficacy|0|||
23636182|NCT00474526|66052865|FG010|Overall Study|Protocol Violation|2|||
23636183|NCT00474526|66052866|FG011|Overall Study|Protocol Violation|2|||
23636184|NCT00474526|66052867|FG012|Overall Study|Protocol Violation|4|||
23636185|NCT00474526|66052868|FG013|Overall Study|Protocol Violation|19|||
23842595|NCT02217410|66805460|FG000|Overall Study|Physician Decision|1|||
23842596|NCT02217410|66805461|FG001|Overall Study|Physician Decision|3|||
23842597|NCT02217410|66805462|FG002|Overall Study|Physician Decision|0|||
23842598|NCT01270464|66805467|FG000|Overall Study|Protocol Violation|4|||
23842599|NCT01270464|66805468|FG001|Overall Study|Protocol Violation|3|||
23842600|NCT01270464|66805469|FG002|Overall Study|Protocol Violation|2|||
23842601|NCT01270464|66805467|FG000|Overall Study|Lack of Efficacy|2|||
23581840|NCT00515086|65859103|FG003|Overall Study|Administrative|0|||
23581841|NCT00515086|65859100|FG000|Overall Study|Withdrawal by Subject|1|||
23581842|NCT00515086|65859101|FG001|Overall Study|Withdrawal by Subject|0|||
23581843|NCT00515086|65859102|FG002|Overall Study|Withdrawal by Subject|0|||
23842602|NCT01270464|66805468|FG001|Overall Study|Lack of Efficacy|3|||
23842603|NCT01270464|66805469|FG002|Overall Study|Lack of Efficacy|1|||
23581844|NCT00515086|65859103|FG003|Overall Study|Withdrawal by Subject|1|||
23581845|NCT00515086|65859100|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23581846|NCT00515086|65859101|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23581847|NCT00515086|65859102|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23581848|NCT00515086|65859103|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23581849|NCT00515086|65859100|FG000|Overall Study|Lost to Follow-up|1|||
23581850|NCT00515086|65859101|FG001|Overall Study|Lost to Follow-up|0|||
23581851|NCT00515086|65859102|FG002|Overall Study|Lost to Follow-up|0|||
23581852|NCT00515086|65859103|FG003|Overall Study|Lost to Follow-up|0|||
23581853|NCT00515086|65859100|FG000|Overall Study|Study drug no longer required|0|||
23581854|NCT00515086|65859101|FG001|Overall Study|Study drug no longer required|1|||
23581855|NCT00515086|65859102|FG002|Overall Study|Study drug no longer required|0|||
23581856|NCT00515086|65859103|FG003|Overall Study|Study drug no longer required|0|||
23581857|NCT00515086|65859100|FG000|Overall Study|Death|2|||
23842604|NCT01270464|66805467|FG000|Overall Study|Adverse Event|9|||
23842605|NCT01270464|66805468|FG001|Overall Study|Adverse Event|1|||
23842606|NCT01270464|66805469|FG002|Overall Study|Adverse Event|7|||
23842607|NCT01270464|66805467|FG000|Overall Study|Withdrawal by Subject|2|||
23842608|NCT01270464|66805468|FG001|Overall Study|Withdrawal by Subject|1|||
23842609|NCT01270464|66805469|FG002|Overall Study|Withdrawal by Subject|4|||
23842610|NCT01270464|66805467|FG000|Overall Study|Lost to Follow-up|2|||
23842611|NCT01270464|66805468|FG001|Overall Study|Lost to Follow-up|3|||
23842612|NCT01270464|66805469|FG002|Overall Study|Lost to Follow-up|1|||
23842613|NCT01270464|66805467|FG000|Overall Study|Other|1|||
23842614|NCT01270464|66805468|FG001|Overall Study|Other|1|||
23842615|NCT01270464|66805469|FG002|Overall Study|Other|3|||
23842616|NCT01684423|66805473|FG000|Overall Study|Withdrawal by Subject|0|||
23842617|NCT01684423|66805474|FG001|Overall Study|Withdrawal by Subject|0|||
23842618|NCT01684423|66805475|FG002|Overall Study|Withdrawal by Subject|1|||
23842619|NCT01684423|66805476|FG003|Overall Study|Withdrawal by Subject|0|||
23842620|NCT01684423|66805477|FG004|Overall Study|Withdrawal by Subject|0|||
23842621|NCT02582242|66805478|FG000|Overall Study|Adverse Event|4|||
23842622|NCT02582242|66805479|FG001|Overall Study|Adverse Event|3|||
23842623|NCT02582242|66805478|FG000|Overall Study|Protocol Violation|3|||
23842624|NCT02582242|66805479|FG001|Overall Study|Protocol Violation|1|||
23842625|NCT02582242|66805478|FG000|Overall Study|Lost to Follow-up|0|||
23842626|NCT02582242|66805479|FG001|Overall Study|Lost to Follow-up|1|||
23842627|NCT02582242|66805478|FG000|Overall Study|Withdrawal by Subject|11|||
23842628|NCT02582242|66805479|FG001|Overall Study|Withdrawal by Subject|11|||
23842629|NCT02582242|66805478|FG000|Overall Study|Unclassified|2|||
23842630|NCT02582242|66805479|FG001|Overall Study|Unclassified|1|||
23842631|NCT00869999|66805484|FG000|Overall Study|Withdrawal by Subject|1|||
23842632|NCT00869999|66805484|FG000|Overall Study|removed prior to starting therapy|1|||
23842633|NCT02778074|66805485|FG000|Overall Study|Lost to Follow-up|7|||
23842634|NCT02778074|66805486|FG001|Overall Study|Lost to Follow-up|10|||
23842635|NCT02782923|66805489|FG000|Overall Study|Lost to Follow-up|15|||
23842636|NCT02276560|66805494|FG000|Overall Study|Adverse Event|1|||
23842637|NCT02276560|66805495|FG001|Overall Study|Adverse Event|0|||
23842638|NCT02276560|66805496|FG002|Overall Study|Adverse Event|0|||
23842639|NCT01122394|66805497|FG000|Overall Study|Withdrawal by Subject|1|||
23842640|NCT01122394|66805498|FG001|Overall Study|Withdrawal by Subject|1|||
23842641|NCT01122394|66805497|FG000|Overall Study|Lost to Follow-up|2|||
23842642|NCT01122394|66805498|FG001|Overall Study|Lost to Follow-up|2|||
23842643|NCT01122394|66805497|FG000|Overall Study|Adverse Event|0|||
23842644|NCT01122394|66805498|FG001|Overall Study|Adverse Event|1|||
23842645|NCT02135107|66805503|FG000|Treatment Period|Withdrawal by Subject|11|||
23842646|NCT02135107|66805504|FG001|Treatment Period|Withdrawal by Subject|0|||
23581858|NCT00515086|65859101|FG001|Overall Study|Death|0|||
23581859|NCT00515086|65859102|FG002|Overall Study|Death|0|||
23581860|NCT00515086|65859103|FG003|Overall Study|Death|0|||
23581861|NCT01720043|65859104|FG000|Overall Study|Withdrawal by Subject|1|||
23581862|NCT04337489|65859105|FG000|Overall Study|Withdrawal by Subject|1|||
23842647|NCT02135107|66805505|FG002|Treatment Period|Withdrawal by Subject|0|||
23842648|NCT02135107|66805506|FG003|Treatment Period|Withdrawal by Subject|0|||
23842649|NCT02135107|66805503|FG000|Treatment Period|Adverse Event|5|||
23842650|NCT02135107|66805504|FG001|Treatment Period|Adverse Event|2|||
23340702|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Death|0|||
23340703|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
23340704|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340705|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340706|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340707|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
23340708|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23340709|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
23340710|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
23340711|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
23340712|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
23340713|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
23340714|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
23340715|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
23340716|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
23340717|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23340718|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
23340719|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
23581863|NCT03782727|65859108|FG000|Overall Study|Lost to Follow-up|32|||
23842651|NCT02135107|66805505|FG002|Treatment Period|Adverse Event|0|||
23842652|NCT02135107|66805506|FG003|Treatment Period|Adverse Event|0|||
23842653|NCT02135107|66805503|FG000|Treatment Period|Pregnancy|1|||
23842654|NCT02135107|66805504|FG001|Treatment Period|Pregnancy|0|||
23842655|NCT02135107|66805505|FG002|Treatment Period|Pregnancy|0|||
23842656|NCT02135107|66805506|FG003|Treatment Period|Pregnancy|0|||
23842657|NCT02135107|66805503|FG000|Treatment Period|Other|115|||
23842658|NCT02135107|66805504|FG001|Treatment Period|Other|24|||
23842659|NCT02135107|66805505|FG002|Treatment Period|Other|0|||
23842660|NCT02135107|66805506|FG003|Treatment Period|Other|0|||
23842661|NCT02135107|66805503|FG000|Maintenance Therapy Period|Adverse Event|0|||
23842662|NCT02135107|66805504|FG001|Maintenance Therapy Period|Adverse Event|0|||
23842663|NCT02135107|66805505|FG002|Maintenance Therapy Period|Adverse Event|3|||
23842664|NCT02135107|66805506|FG003|Maintenance Therapy Period|Adverse Event|7|||
23842665|NCT02135107|66805503|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
23842666|NCT02135107|66805504|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
23842667|NCT02135107|66805505|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
23842668|NCT02135107|66805506|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
23842669|NCT02135107|66805503|FG000|Maintenance Therapy Period|Pregnancy|0|||
23842670|NCT02135107|66805504|FG001|Maintenance Therapy Period|Pregnancy|0|||
23842671|NCT02135107|66805505|FG002|Maintenance Therapy Period|Pregnancy|0|||
23842672|NCT02135107|66805506|FG003|Maintenance Therapy Period|Pregnancy|1|||
23842673|NCT02135107|66805503|FG000|Maintenance Therapy Period|Other|0|||
23842674|NCT02135107|66805504|FG001|Maintenance Therapy Period|Other|0|||
23842675|NCT02135107|66805505|FG002|Maintenance Therapy Period|Other|7|||
23842676|NCT02135107|66805506|FG003|Maintenance Therapy Period|Other|8|||
23842677|NCT00814333|66805517|FG000|Enrollment|Lost to Follow-up|1|||
23842678|NCT00814333|66805518|FG001|Enrollment|Lost to Follow-up|0|||
23842679|NCT01031836|66805521|FG000|Stage I|Adverse Event|1|||
23842680|NCT01031836|66805522|FG001|Stage I|Adverse Event|1|||
23842681|NCT01031836|66805523|FG002|Stage I|Adverse Event|0|||
23842682|NCT01031836|66805524|FG003|Stage I|Adverse Event|0|||
23842683|NCT01031836|66805525|FG004|Stage I|Adverse Event|0|||
23842684|NCT01031836|66805526|FG005|Stage I|Adverse Event|0|||
23842685|NCT01031836|66805521|FG000|Stage I|Other|0|||
23842686|NCT01031836|66805522|FG001|Stage I|Other|1|||
23842687|NCT01031836|66805523|FG002|Stage I|Other|0|||
23842688|NCT01031836|66805524|FG003|Stage I|Other|0|||
23842689|NCT01031836|66805525|FG004|Stage I|Other|0|||
23842690|NCT01031836|66805526|FG005|Stage I|Other|1|||
23842691|NCT01031836|66805521|FG000|Stage II|Adverse Event|0|||
23842692|NCT01031836|66805522|FG001|Stage II|Adverse Event|0|||
23842693|NCT01031836|66805523|FG002|Stage II|Adverse Event|2|||
23842694|NCT01031836|66805524|FG003|Stage II|Adverse Event|2|||
23842695|NCT01031836|66805525|FG004|Stage II|Adverse Event|1|||
23842696|NCT01031836|66805526|FG005|Stage II|Adverse Event|1|||
23581864|NCT03120676|65859110|FG000|Overall Study|Not treated|1|||
23842697|NCT01031836|66805521|FG000|Stage II|Other|2|||
23842698|NCT01031836|66805522|FG001|Stage II|Other|0|||
23842699|NCT01031836|66805523|FG002|Stage II|Other|0|||
23842700|NCT01031836|66805524|FG003|Stage II|Other|1|||
23340720|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23581865|NCT00354029|65859113|FG000|Overall Study|Protocol Violation|4|||
23636186|NCT00474526|66052869|FG014|Overall Study|Protocol Violation|9|||
23842701|NCT01031836|66805525|FG004|Stage II|Other|1|||
23842702|NCT01031836|66805526|FG005|Stage II|Other|0|||
23842703|NCT01399047|66805529|FG000|Overall Study|Withdrawal by Subject|0|||
23842704|NCT01399047|66805530|FG001|Overall Study|Withdrawal by Subject|1|||
23842705|NCT00090220|66805531|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
23340721|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
23340722|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
23340723|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
23340724|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
23340725|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
23340726|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
23340727|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23340728|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
23340729|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23452828|NCT00101686|65399133|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
23636187|NCT00474526|66052870|FG015|Overall Study|Protocol Violation|6|||
23636188|NCT00474526|66052871|FG016|Overall Study|Protocol Violation|2|||
23781607|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781608|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781609|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781610|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781611|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781612|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781613|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781614|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781615|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781616|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781617|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781618|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781619|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781620|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781621|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781622|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781623|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23781624|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
23781625|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
23781626|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
23781627|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
23781628|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781629|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781630|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781631|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781632|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781633|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781634|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781635|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781636|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781637|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781638|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781639|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781640|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781641|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781642|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781643|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781644|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23781645|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
23781646|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
23781647|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
23781648|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
23781649|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781650|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781651|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781652|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781653|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781654|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781655|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781656|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781657|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781658|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781659|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781660|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23842706|NCT00090220|66805532|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
23340730|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23581866|NCT00354029|65859114|FG001|Overall Study|Protocol Violation|2|||
23581867|NCT03303105|65859117|FG000|Overall Study|Adverse Event|0|||
23581868|NCT03303105|65859118|FG001|Overall Study|Adverse Event|2|||
23581869|NCT03303105|65859117|FG000|Overall Study|Lack of Efficacy|1|||
23581870|NCT03303105|65859118|FG001|Overall Study|Lack of Efficacy|0|||
23581871|NCT03303105|65859117|FG000|Overall Study|Protocol Violation|1|||
23581872|NCT03303105|65859118|FG001|Overall Study|Protocol Violation|0|||
23581873|NCT03303105|65859117|FG000|Overall Study|Withdrawal by Subject|0|||
23581874|NCT03303105|65859118|FG001|Overall Study|Withdrawal by Subject|2|||
23581875|NCT05074498|65859123|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581876|NCT05074498|65859124|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581877|NCT05074498|65859125|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581878|NCT05074498|65859126|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
23581879|NCT05074498|65859127|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581880|NCT05074498|65859128|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581881|NCT05074498|65859123|FG000|Part 1 (Upto Day 104)|Other|1|||
23581882|NCT05074498|65859124|FG001|Part 1 (Upto Day 104)|Other|0|||
23581883|NCT05074498|65859125|FG002|Part 1 (Upto Day 104)|Other|0|||
23581884|NCT05074498|65859126|FG003|Part 1 (Upto Day 104)|Other|0|||
23581885|NCT05074498|65859127|FG004|Part 1 (Upto Day 104)|Other|0|||
23581886|NCT05074498|65859128|FG005|Part 1 (Upto Day 104)|Other|0|||
23581887|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581888|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581889|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581890|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581891|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
23581892|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23781661|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781662|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781663|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781664|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781665|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23781666|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
23781667|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
23781668|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
23781669|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781670|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781671|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781672|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781673|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781674|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781675|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781676|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781677|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781678|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781679|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781680|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781681|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781682|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781683|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781684|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781685|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781686|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23781687|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
23781688|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781689|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781690|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
23781691|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781692|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781693|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23340731|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
23581893|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Death|0|||
23581894|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Death|0|||
23581895|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Death|0|||
23581896|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Death|0|||
23581897|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Death|1|||
23581898|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Death|0|||
23581899|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23842707|NCT00090220|66805533|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23842708|NCT00090220|66805534|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23842709|NCT00090220|66805535|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23842710|NCT00090220|66805536|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23842711|NCT00090220|66805531|FG000|Base Study Vaccination Period|Adverse Event|6|||
23842712|NCT00090220|66805532|FG001|Base Study Vaccination Period|Adverse Event|1|||
23842713|NCT00090220|66805533|FG002|Base Study Vaccination Period|Adverse Event|0|||
23842714|NCT00090220|66805534|FG003|Base Study Vaccination Period|Adverse Event|0|||
23842715|NCT00090220|66805535|FG004|Base Study Vaccination Period|Adverse Event|0|||
23842716|NCT00090220|66805536|FG005|Base Study Vaccination Period|Adverse Event|0|||
23842717|NCT00090220|66805531|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
23842718|NCT00090220|66805532|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
23842719|NCT00090220|66805533|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23842720|NCT00090220|66805534|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23842721|NCT00090220|66805535|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23842722|NCT00090220|66805536|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
23842723|NCT00090220|66805531|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
23842724|NCT00090220|66805532|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
23842725|NCT00090220|66805533|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23842726|NCT00090220|66805534|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23636189|NCT00474526|66052855|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
23781694|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781695|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781696|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781697|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781698|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781699|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781700|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781701|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781702|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781703|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781704|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781705|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781706|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781707|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23781708|NCT01597245|66580286|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
23781709|NCT01597245|66580287|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
23781710|NCT01597245|66580288|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
23781711|NCT01597245|66580289|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781712|NCT01597245|66580290|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781713|NCT01597245|66580291|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781714|NCT01597245|66580292|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781715|NCT01597245|66580293|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781716|NCT01597245|66580294|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781717|NCT01597245|66580295|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781718|NCT01597245|66580296|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781719|NCT01597245|66580297|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781720|NCT01597245|66580298|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781721|NCT01597245|66580299|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781722|NCT01597245|66580300|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781723|NCT01597245|66580301|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781724|NCT01597245|66580302|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781725|NCT01597245|66580303|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781726|NCT01597245|66580304|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781727|NCT01597245|66580305|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781728|NCT01597245|66580306|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23781729|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781730|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781731|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781732|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781733|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781734|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
23781735|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
23842727|NCT00090220|66805535|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23842728|NCT00090220|66805536|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
23636190|NCT00474526|66052856|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
23636191|NCT00474526|66052857|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
23636192|NCT00474526|66052858|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
23781736|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781737|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781738|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781739|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781740|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781741|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781742|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781743|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781744|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781745|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781746|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781747|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781748|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781749|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23781750|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781751|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781752|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781753|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781754|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
23781755|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
23781756|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
23781757|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
23781758|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781759|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
23781760|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781761|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781762|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781763|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781764|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781765|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781766|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781767|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781768|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781769|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781770|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23781771|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781772|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781773|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781774|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781775|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781776|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
23781777|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781778|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781779|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
23781780|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781781|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
23781782|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
23781783|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
23781784|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781785|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781786|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781787|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781788|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781789|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781790|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781791|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23781792|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781793|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781794|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781795|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781796|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
23781797|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
23781798|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
23636193|NCT00474526|66052859|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
23452829|NCT00101686|65399134|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
23452830|NCT00101686|65399135|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
23452831|NCT00101686|65399136|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
23452832|NCT00101686|65399137|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
23452833|NCT00101686|65399138|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
23452834|NCT00101686|65399139|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
23581900|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23581901|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23452835|NCT00101686|65399140|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
23452836|NCT00101686|65399131|FG000|Overall Study|unacceptable toxicity|3|||
23452837|NCT00101686|65399132|FG001|Overall Study|unacceptable toxicity|9|||
23452838|NCT00101686|65399133|FG002|Overall Study|unacceptable toxicity|10|||
23452839|NCT00101686|65399134|FG003|Overall Study|unacceptable toxicity|6|||
23452840|NCT00101686|65399135|FG004|Overall Study|unacceptable toxicity|16|||
23452841|NCT00101686|65399136|FG005|Overall Study|unacceptable toxicity|10|||
23452842|NCT00101686|65399137|FG006|Overall Study|unacceptable toxicity|4|||
23452843|NCT00101686|65399138|FG007|Overall Study|unacceptable toxicity|2|||
23452844|NCT00101686|65399139|FG008|Overall Study|unacceptable toxicity|1|||
23452845|NCT00101686|65399140|FG009|Overall Study|unacceptable toxicity|4|||
23452846|NCT00101686|65399131|FG000|Overall Study|Randomized but did not receive treament|1|||
23452847|NCT00101686|65399132|FG001|Overall Study|Randomized but did not receive treament|6|||
23452848|NCT00101686|65399133|FG002|Overall Study|Randomized but did not receive treament|2|||
23452849|NCT00101686|65399134|FG003|Overall Study|Randomized but did not receive treament|2|||
23452850|NCT00101686|65399135|FG004|Overall Study|Randomized but did not receive treament|2|||
23452851|NCT00101686|65399136|FG005|Overall Study|Randomized but did not receive treament|2|||
23452852|NCT00101686|65399137|FG006|Overall Study|Randomized but did not receive treament|0|||
23781799|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
23781800|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
23781801|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
23781802|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
23781803|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
23781804|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
23781805|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23452853|NCT00101686|65399138|FG007|Overall Study|Randomized but did not receive treament|1|||
23452854|NCT00101686|65399139|FG008|Overall Study|Randomized but did not receive treament|0|||
23452855|NCT00101686|65399140|FG009|Overall Study|Randomized but did not receive treament|1|||
23452856|NCT00101686|65399131|FG000|Overall Study|intercurrent non-cancer related illness|0|||
23581902|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23781806|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781807|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781808|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781809|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781810|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781811|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781812|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23781813|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781814|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781815|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781816|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781817|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
23781818|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
23781819|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
23781820|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781821|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
23781822|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
23781823|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
23781824|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
23781825|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
23781826|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23842729|NCT00090220|66805531|FG000|Base Study Vaccination Period|Patient Moved|6|||
23842730|NCT00090220|66805532|FG001|Base Study Vaccination Period|Patient Moved|2|||
23452857|NCT00101686|65399132|FG001|Overall Study|intercurrent non-cancer related illness|0|||
23452858|NCT00101686|65399133|FG002|Overall Study|intercurrent non-cancer related illness|2|||
23452859|NCT00101686|65399134|FG003|Overall Study|intercurrent non-cancer related illness|0|||
23452860|NCT00101686|65399135|FG004|Overall Study|intercurrent non-cancer related illness|1|||
23581903|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
23452861|NCT00101686|65399136|FG005|Overall Study|intercurrent non-cancer related illness|3|||
23452862|NCT00101686|65399137|FG006|Overall Study|intercurrent non-cancer related illness|1|||
23452863|NCT00101686|65399138|FG007|Overall Study|intercurrent non-cancer related illness|0|||
23452864|NCT00101686|65399139|FG008|Overall Study|intercurrent non-cancer related illness|1|||
23452865|NCT00101686|65399140|FG009|Overall Study|intercurrent non-cancer related illness|1|||
23452866|NCT00101686|65399131|FG000|Overall Study|Physician Decision|10|||
23452867|NCT00101686|65399132|FG001|Overall Study|Physician Decision|13|||
23452868|NCT00101686|65399133|FG002|Overall Study|Physician Decision|6|||
23452869|NCT00101686|65399134|FG003|Overall Study|Physician Decision|7|||
23452870|NCT00101686|65399135|FG004|Overall Study|Physician Decision|8|||
23452871|NCT00101686|65399136|FG005|Overall Study|Physician Decision|9|||
23452872|NCT00101686|65399137|FG006|Overall Study|Physician Decision|5|||
23452873|NCT00101686|65399138|FG007|Overall Study|Physician Decision|5|||
23452874|NCT00101686|65399139|FG008|Overall Study|Physician Decision|1|||
23452875|NCT00101686|65399140|FG009|Overall Study|Physician Decision|1|||
23452876|NCT00101686|65399131|FG000|Overall Study|Other|1|||
23452877|NCT00101686|65399132|FG001|Overall Study|Other|4|||
23452878|NCT00101686|65399133|FG002|Overall Study|Other|1|||
23452879|NCT00101686|65399134|FG003|Overall Study|Other|6|||
23452880|NCT00101686|65399135|FG004|Overall Study|Other|2|||
23452881|NCT00101686|65399136|FG005|Overall Study|Other|12|||
23452882|NCT00101686|65399137|FG006|Overall Study|Other|1|||
23452883|NCT00101686|65399138|FG007|Overall Study|Other|5|||
23452884|NCT00101686|65399139|FG008|Overall Study|Other|3|||
23452885|NCT00101686|65399140|FG009|Overall Study|Other|3|||
23452886|NCT00101686|65399131|FG000|Overall Study|Withdrawal by Subject|9|||
23452887|NCT00101686|65399132|FG001|Overall Study|Withdrawal by Subject|8|||
23452888|NCT00101686|65399133|FG002|Overall Study|Withdrawal by Subject|6|||
23452889|NCT00101686|65399134|FG003|Overall Study|Withdrawal by Subject|8|||
23452890|NCT00101686|65399135|FG004|Overall Study|Withdrawal by Subject|8|||
23452891|NCT00101686|65399136|FG005|Overall Study|Withdrawal by Subject|7|||
23452892|NCT00101686|65399137|FG006|Overall Study|Withdrawal by Subject|7|||
23452893|NCT00101686|65399138|FG007|Overall Study|Withdrawal by Subject|7|||
23452894|NCT00101686|65399139|FG008|Overall Study|Withdrawal by Subject|8|||
23452895|NCT00101686|65399140|FG009|Overall Study|Withdrawal by Subject|9|||
23452896|NCT02719171|65399141|FG000|Overall Study|Adverse Event|1|||
23452897|NCT02719171|65399142|FG001|Overall Study|Adverse Event|2|||
23452898|NCT02719171|65399143|FG002|Overall Study|Adverse Event|0|||
23452899|NCT02719171|65399144|FG003|Overall Study|Adverse Event|0|||
23452900|NCT02719171|65399145|FG004|Overall Study|Adverse Event|2|||
23452901|NCT02719171|65399141|FG000|Overall Study|Lost to Follow-up|0|||
23452902|NCT02719171|65399142|FG001|Overall Study|Lost to Follow-up|0|||
23452903|NCT02719171|65399143|FG002|Overall Study|Lost to Follow-up|1|||
23452904|NCT02719171|65399144|FG003|Overall Study|Lost to Follow-up|0|||
23452905|NCT02719171|65399145|FG004|Overall Study|Lost to Follow-up|0|||
23452906|NCT02719171|65399141|FG000|Overall Study|Subject Withdrawal|0|||
23452907|NCT02719171|65399142|FG001|Overall Study|Subject Withdrawal|2|||
23452908|NCT02719171|65399143|FG002|Overall Study|Subject Withdrawal|2|||
23452909|NCT02719171|65399144|FG003|Overall Study|Subject Withdrawal|1|||
23452910|NCT02719171|65399145|FG004|Overall Study|Subject Withdrawal|0|||
23452911|NCT02719171|65399141|FG000|Overall Study|Other|0|||
23452912|NCT02719171|65399142|FG001|Overall Study|Other|0|||
23452913|NCT02719171|65399143|FG002|Overall Study|Other|0|||
23452914|NCT02719171|65399144|FG003|Overall Study|Other|1|||
23452915|NCT02719171|65399145|FG004|Overall Study|Other|0|||
23842731|NCT00090220|66805533|FG002|Base Study Vaccination Period|Patient Moved|0|||
23842732|NCT00090220|66805534|FG003|Base Study Vaccination Period|Patient Moved|0|||
23452916|NCT01945021|65399146|FG000|Overall Study|Adverse Event|1|||
23842733|NCT00090220|66805535|FG004|Base Study Vaccination Period|Patient Moved|0|||
23842734|NCT00090220|66805536|FG005|Base Study Vaccination Period|Patient Moved|0|||
23842735|NCT00090220|66805531|FG000|Base Study Vaccination Period|Other|4|||
23842736|NCT00090220|66805532|FG001|Base Study Vaccination Period|Other|4|||
23452917|NCT01945021|65399146|FG000|Overall Study|Withdrawal of consent|12|||
23452918|NCT01945021|65399146|FG000|Overall Study|Lost to Follow-up|5|||
23452919|NCT01945021|65399146|FG000|Overall Study|Death|65|||
23452920|NCT02898454|65399151|FG000|Overall Study|Adverse Event|4|||
23452921|NCT02898454|65399152|FG001|Overall Study|Adverse Event|1|||
23452922|NCT02898454|65399153|FG002|Overall Study|Adverse Event|2|||
23452923|NCT02898454|65399151|FG000|Overall Study|Protocol Violation|1|||
23452924|NCT02898454|65399152|FG001|Overall Study|Protocol Violation|0|||
23452925|NCT02898454|65399153|FG002|Overall Study|Protocol Violation|1|||
23452926|NCT02898454|65399151|FG000|Overall Study|Lack of Efficacy|4|||
23452927|NCT02898454|65399152|FG001|Overall Study|Lack of Efficacy|1|||
23452928|NCT02898454|65399153|FG002|Overall Study|Lack of Efficacy|0|||
23452929|NCT02898454|65399151|FG000|Overall Study|Withdrawal by Subject|6|||
23452930|NCT02898454|65399152|FG001|Overall Study|Withdrawal by Subject|3|||
23452931|NCT02898454|65399153|FG002|Overall Study|Withdrawal by Subject|3|||
23452932|NCT02898454|65399151|FG000|Overall Study|Lost to Follow-up|1|||
23452933|NCT02898454|65399152|FG001|Overall Study|Lost to Follow-up|0|||
23452934|NCT02898454|65399153|FG002|Overall Study|Lost to Follow-up|0|||
23452935|NCT02898454|65399151|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
23452936|NCT02898454|65399152|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
23452937|NCT02898454|65399153|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
23452938|NCT00960375|65399154|FG000|Overall Study|Lost to Follow-up|20|||
23452939|NCT00960375|65399155|FG001|Overall Study|Lost to Follow-up|22|||
23452940|NCT03186209|65399156|FG000|Overall Study|Withdrawal by Subject|11|||
23452941|NCT03186209|65399157|FG001|Overall Study|Withdrawal by Subject|22|||
23452942|NCT03186209|65399156|FG000|Overall Study|Pregnancy|1|||
23452943|NCT03186209|65399157|FG001|Overall Study|Pregnancy|0|||
23452944|NCT03186209|65399156|FG000|Overall Study|Adverse Event|4|||
23452945|NCT03186209|65399157|FG001|Overall Study|Adverse Event|0|||
23452946|NCT03186209|65399156|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
23452947|NCT03186209|65399157|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
23452948|NCT03186209|65399156|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
23452949|NCT03186209|65399157|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
23452950|NCT03186209|65399156|FG000|Overall Study|Fail to meet randomization criteria|0|||
23452951|NCT03186209|65399157|FG001|Overall Study|Fail to meet randomization criteria|1|||
23452952|NCT03186209|65399156|FG000|Overall Study|Lost to Follow-up|0|||
23452953|NCT03186209|65399157|FG001|Overall Study|Lost to Follow-up|1|||
23452954|NCT00772538|65403176|FG000|Overall Study|Adverse Event|6|||
23452955|NCT00772538|65403177|FG001|Overall Study|Adverse Event|6|||
23452956|NCT00772538|65403176|FG000|Overall Study|Protocol Violation|3|||
23452957|NCT00772538|65403177|FG001|Overall Study|Protocol Violation|3|||
23452958|NCT00772538|65403176|FG000|Overall Study|Lost to Follow-up|1|||
23452959|NCT00772538|65403177|FG001|Overall Study|Lost to Follow-up|1|||
23452960|NCT00772538|65403176|FG000|Overall Study|Withdrawal by Subject|3|||
23452961|NCT00772538|65403177|FG001|Overall Study|Withdrawal by Subject|8|||
23452962|NCT00772538|65403176|FG000|Overall Study|Lack of Efficacy|0|||
23452963|NCT00772538|65403177|FG001|Overall Study|Lack of Efficacy|1|||
23452964|NCT00772538|65403176|FG000|Overall Study|Other|7|||
23452965|NCT00772538|65403177|FG001|Overall Study|Other|7|||
23452966|NCT01924845|65403178|FG000|Overall Study|Adverse Event|3|||
23452967|NCT01924845|65403178|FG000|Overall Study|Withdrawal by Subject|2|||
23452968|NCT01924845|65403178|FG000|Overall Study|Protocol Violation|1|||
23452969|NCT02399215|65403179|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
23452970|NCT02399215|65403179|FG000|Overall Study|Withdrawal by Subject|1|||
23452971|NCT01052493|65403180|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
23452972|NCT01052493|65403181|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
23452973|NCT01052493|65403182|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
23452974|NCT00686777|65403183|FG000|Overall Study|Adverse Event|2|||
23452975|NCT00686777|65403183|FG000|Overall Study|Pregnancy|1|||
23452976|NCT00686777|65403183|FG000|Overall Study|Withdrawal by Subject|2|||
23452977|NCT00686777|65403183|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
23452978|NCT00686777|65403183|FG000|Overall Study|No Visit|1|||
23452979|NCT00774046|65403185|FG000|Screening|Not eligible|56|||
23452980|NCT00774046|65403185|FG000|Enrollment|Desired other therapy/refused|28|||
23636194|NCT00474526|66052860|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
23452981|NCT00774046|65403185|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
23636195|NCT00474526|66052861|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
23636196|NCT00474526|66052862|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
23636197|NCT00474526|66052863|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
23842737|NCT00090220|66805533|FG002|Base Study Vaccination Period|Other|0|||
23452982|NCT01232868|65403186|FG000|Overall Study|Lost to Follow-up|2|||
23452983|NCT01232868|65403187|FG001|Overall Study|Lost to Follow-up|4|||
23452984|NCT03473236|65403188|FG000|Overall Study|Withdrawal by Subject|0|||
23452985|NCT03473236|65403189|FG001|Overall Study|Withdrawal by Subject|0|||
23452986|NCT03473236|65403190|FG002|Overall Study|Withdrawal by Subject|0|||
23452987|NCT03473236|65403191|FG003|Overall Study|Withdrawal by Subject|0|||
23452988|NCT03473236|65403192|FG004|Overall Study|Withdrawal by Subject|0|||
23452989|NCT03473236|65403193|FG005|Overall Study|Withdrawal by Subject|1|||
23452990|NCT03473236|65403194|FG006|Overall Study|Withdrawal by Subject|0|||
23452991|NCT03473236|65403195|FG007|Overall Study|Withdrawal by Subject|0|||
23452992|NCT03473236|65403196|FG008|Overall Study|Withdrawal by Subject|1|||
23452993|NCT03473236|65403197|FG009|Overall Study|Withdrawal by Subject|0|||
23452994|NCT02173769|65403198|FG000|Overall Study|Protocol Violation|4|||
23452995|NCT01405768|65403199|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
23452996|NCT01405768|65403200|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
23452997|NCT01582061|65403204|FG000|Overall Study|Lack of Efficacy|3|||
23452998|NCT01582061|65403205|FG001|Overall Study|Lack of Efficacy|23|||
23452999|NCT01582061|65403204|FG000|Overall Study|Adverse Event|12|||
23453000|NCT01582061|65403205|FG001|Overall Study|Adverse Event|8|||
23453001|NCT01582061|65403204|FG000|Overall Study|Withdrawal by Subject|10|||
23453002|NCT01582061|65403205|FG001|Overall Study|Withdrawal by Subject|4|||
23636198|NCT00474526|66052864|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
23636199|NCT00474526|66052865|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
23636200|NCT00474526|66052866|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
23636201|NCT00474526|66052867|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
23636202|NCT00474526|66052868|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
23636203|NCT00474526|66052869|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
23636204|NCT00474526|66052870|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
23636205|NCT00474526|66052871|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
23636206|NCT00474526|66052855|FG000|Overall Study|Withdrawal by Subject|9|||
23636207|NCT00474526|66052856|FG001|Overall Study|Withdrawal by Subject|24|||
23636208|NCT00474526|66052857|FG002|Overall Study|Withdrawal by Subject|21|||
23636209|NCT00474526|66052858|FG003|Overall Study|Withdrawal by Subject|52|||
23636210|NCT00474526|66052859|FG004|Overall Study|Withdrawal by Subject|38|||
23636211|NCT00474526|66052860|FG005|Overall Study|Withdrawal by Subject|6|||
23636212|NCT00474526|66052861|FG006|Overall Study|Withdrawal by Subject|12|||
23636213|NCT00474526|66052862|FG007|Overall Study|Withdrawal by Subject|4|||
23636214|NCT00474526|66052863|FG008|Overall Study|Withdrawal by Subject|4|||
23636215|NCT00474526|66052864|FG009|Overall Study|Withdrawal by Subject|13|||
23636216|NCT00474526|66052865|FG010|Overall Study|Withdrawal by Subject|5|||
23636217|NCT00474526|66052866|FG011|Overall Study|Withdrawal by Subject|4|||
23636218|NCT00474526|66052867|FG012|Overall Study|Withdrawal by Subject|4|||
23636219|NCT00474526|66052868|FG013|Overall Study|Withdrawal by Subject|37|||
23636220|NCT00474526|66052869|FG014|Overall Study|Withdrawal by Subject|22|||
23636221|NCT00474526|66052870|FG015|Overall Study|Withdrawal by Subject|1|||
23636222|NCT00474526|66052871|FG016|Overall Study|Withdrawal by Subject|1|||
23636223|NCT00747227|66052872|FG000|Overall Study|Death|3|||
23636224|NCT00747227|66052873|FG001|Overall Study|Death|1|||
23842738|NCT00090220|66805534|FG003|Base Study Vaccination Period|Other|0|||
23842739|NCT00090220|66805535|FG004|Base Study Vaccination Period|Other|0|||
23842740|NCT00090220|66805536|FG005|Base Study Vaccination Period|Other|0|||
23842741|NCT00090220|66805531|FG000|Base Study Follow-up Period|Adverse Event|6|||
23453003|NCT01582061|65403204|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23453004|NCT01582061|65403205|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23842742|NCT00090220|66805532|FG001|Base Study Follow-up Period|Adverse Event|1|||
23842743|NCT00090220|66805533|FG002|Base Study Follow-up Period|Adverse Event|0|||
23842744|NCT00090220|66805534|FG003|Base Study Follow-up Period|Adverse Event|0|||
23842745|NCT00090220|66805535|FG004|Base Study Follow-up Period|Adverse Event|0|||
23842746|NCT00090220|66805536|FG005|Base Study Follow-up Period|Adverse Event|0|||
23842747|NCT00090220|66805531|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
23453005|NCT01582061|65403204|FG000|Overall Study|Death|0|||
23453006|NCT01582061|65403205|FG001|Overall Study|Death|1|||
23453007|NCT01582061|65403204|FG000|Overall Study|condition no longer requires study drug|1|||
23453008|NCT01582061|65403205|FG001|Overall Study|condition no longer requires study drug|0|||
23453009|NCT01582061|65403204|FG000|Overall Study|Lost to Follow-up|1|||
23453010|NCT01582061|65403205|FG001|Overall Study|Lost to Follow-up|0|||
23453011|NCT01576341|65403206|FG000|Overall Study|Withdrawal by Subject|24|||
23453012|NCT01576341|65403206|FG000|Overall Study|Adverse Event|10|||
23453013|NCT01576341|65403206|FG000|Overall Study|Death|21|||
23453014|NCT01576341|65403206|FG000|Overall Study|Physician Decision|2|||
23453015|NCT01576341|65403206|FG000|Overall Study|Lost to Follow-up|2|||
23453016|NCT01576341|65403206|FG000|Overall Study|Kidney transplantation|10|||
23453017|NCT01576341|65403206|FG000|Overall Study|Protocol Violation|12|||
23453018|NCT01576341|65403206|FG000|Overall Study|Other|12|||
23453019|NCT04481243|65403207|FG000|Overall Study|Withdrawal by Subject|4|||
23453020|NCT01129622|65403208|FG000|Overall Study|Withdrawal by Subject|2|||
23453021|NCT00525512|65403214|FG000|Double-Blind Phase|Adverse Event|48|||
23453022|NCT00525512|65403215|FG001|Double-Blind Phase|Adverse Event|28|||
23453023|NCT00525512|65403216|FG002|Double-Blind Phase|Adverse Event|0|||
23453024|NCT00525512|65403217|FG003|Double-Blind Phase|Adverse Event|0|||
23453025|NCT00525512|65403214|FG000|Double-Blind Phase|Protocol Violation|3|||
23453026|NCT00525512|65403215|FG001|Double-Blind Phase|Protocol Violation|1|||
23453027|NCT00525512|65403216|FG002|Double-Blind Phase|Protocol Violation|0|||
23453028|NCT00525512|65403217|FG003|Double-Blind Phase|Protocol Violation|0|||
23453029|NCT00525512|65403214|FG000|Double-Blind Phase|Lost to Follow-up|3|||
23636225|NCT00747227|66052872|FG000|Overall Study|Withdrawal by Subject|1|||
23636226|NCT00747227|66052873|FG001|Overall Study|Withdrawal by Subject|0|||
23636227|NCT00747227|66052872|FG000|Overall Study|Lost to Follow-up|1|||
23636228|NCT00747227|66052873|FG001|Overall Study|Lost to Follow-up|2|||
23636229|NCT00747227|66052872|FG000|Overall Study|Illness|1|||
23636230|NCT00747227|66052873|FG001|Overall Study|Illness|1|||
23636231|NCT03026075|66052876|FG000|Overall Study|Physician Decision|1|||
23636232|NCT01730950|66052877|FG000|Overall Study|Protocol Violation|6|||
23636233|NCT01730950|66052878|FG001|Overall Study|Protocol Violation|6|||
23636234|NCT02592876|66052879|FG000|Overall Study|Withdrawal by Subject|3|||
23842748|NCT00090220|66805532|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
23453030|NCT00525512|65403215|FG001|Double-Blind Phase|Lost to Follow-up|7|||
23453031|NCT00525512|65403216|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23636235|NCT02592876|66052880|FG001|Overall Study|Withdrawal by Subject|3|||
23636236|NCT02592876|66052879|FG000|Overall Study|Study Termination by Sponsor|32|||
23842749|NCT00090220|66805533|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
23842750|NCT00090220|66805534|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
23842751|NCT00090220|66805535|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23842752|NCT00090220|66805536|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
23842753|NCT00090220|66805531|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
23842754|NCT00090220|66805532|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
23842755|NCT00090220|66805533|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23842756|NCT00090220|66805534|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23842757|NCT00090220|66805535|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23842758|NCT00090220|66805536|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
23842759|NCT00090220|66805531|FG000|Base Study Follow-up Period|Patient Moved|20|||
23842760|NCT00090220|66805532|FG001|Base Study Follow-up Period|Patient Moved|28|||
23842761|NCT00090220|66805533|FG002|Base Study Follow-up Period|Patient Moved|0|||
23842762|NCT00090220|66805534|FG003|Base Study Follow-up Period|Patient Moved|0|||
23842763|NCT00090220|66805535|FG004|Base Study Follow-up Period|Patient Moved|0|||
23842764|NCT00090220|66805536|FG005|Base Study Follow-up Period|Patient Moved|0|||
23842765|NCT00090220|66805531|FG000|Base Study Follow-up Period|Other|19|||
23842766|NCT00090220|66805532|FG001|Base Study Follow-up Period|Other|21|||
23842767|NCT00090220|66805533|FG002|Base Study Follow-up Period|Other|0|||
23842768|NCT00090220|66805534|FG003|Base Study Follow-up Period|Other|0|||
23842769|NCT00090220|66805535|FG004|Base Study Follow-up Period|Other|0|||
23842770|NCT00090220|66805536|FG005|Base Study Follow-up Period|Other|0|||
23842771|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Adverse Event|0|||
23842772|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Adverse Event|0|||
23842773|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Adverse Event|4|||
23842774|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Adverse Event|0|||
23581904|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
23581905|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Other|0|||
23842775|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Adverse Event|0|||
23842776|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Adverse Event|0|||
23842777|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
23842778|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
23842779|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
23842780|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
23842781|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
23842782|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
23842783|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Moved|0|||
23842784|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Moved|0|||
23842785|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Moved|2|||
23842786|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Moved|1|||
23581906|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Other|0|||
23581907|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Other|0|||
23581908|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Other|0|||
23581909|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Other|1|||
23581910|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Other|0|||
23581911|NCT00748969|65859131|FG000|Overall Study|Withdrawal by Subject|1|||
23581912|NCT00748969|65859132|FG001|Overall Study|Withdrawal by Subject|0|||
23581913|NCT00748969|65859131|FG000|Overall Study|Withdrawal by Subject|0|||
23581914|NCT00748969|65859132|FG001|Overall Study|Withdrawal by Subject|1|||
23581915|NCT04536077|65859133|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
23581916|NCT04536077|65859134|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
23581917|NCT04536077|65859133|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
23581918|NCT04536077|65859134|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
23581919|NCT01414166|65859135|FG000|Overall Study|Adverse Event|10|||
23581920|NCT01414166|65859136|FG001|Overall Study|Adverse Event|2|||
23581921|NCT01414166|65859135|FG000|Overall Study|Lost to Follow-up|4|||
23581922|NCT01414166|65859136|FG001|Overall Study|Lost to Follow-up|1|||
23581923|NCT01414166|65859135|FG000|Overall Study|Non-compliance with study drug|2|||
23581924|NCT01414166|65859136|FG001|Overall Study|Non-compliance with study drug|0|||
23581925|NCT01414166|65859135|FG000|Overall Study|Physician Decision|2|||
23581926|NCT01414166|65859136|FG001|Overall Study|Physician Decision|0|||
23581927|NCT01414166|65859135|FG000|Overall Study|Protocol Violation|2|||
23581928|NCT01414166|65859136|FG001|Overall Study|Protocol Violation|0|||
23581929|NCT01414166|65859135|FG000|Overall Study|Study terminated by Sponsor|68|||
23581930|NCT01414166|65859136|FG001|Overall Study|Study terminated by Sponsor|75|||
23581931|NCT01414166|65859135|FG000|Overall Study|Withdrawal by Subject|3|||
23581932|NCT01414166|65859136|FG001|Overall Study|Withdrawal by Subject|5|||
23842787|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Moved|0|||
23842788|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Moved|0|||
23842789|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23842790|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23842791|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
23842792|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23842793|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23842794|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23781827|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781828|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781829|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781830|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781831|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781832|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781833|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23781834|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781835|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781836|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23453032|NCT00525512|65403217|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23453033|NCT00525512|65403214|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
23453034|NCT00525512|65403215|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
23453035|NCT00525512|65403216|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23453036|NCT00525512|65403217|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23453037|NCT00525512|65403214|FG000|Double-Blind Phase|Lack of Efficacy|13|||
23453038|NCT00525512|65403215|FG001|Double-Blind Phase|Lack of Efficacy|5|||
23453039|NCT00525512|65403216|FG002|Double-Blind Phase|Lack of Efficacy|0|||
23453040|NCT00525512|65403217|FG003|Double-Blind Phase|Lack of Efficacy|0|||
23453041|NCT00525512|65403214|FG000|Double-Blind Phase|Other reason (not specified)|12|||
23453042|NCT00525512|65403215|FG001|Double-Blind Phase|Other reason (not specified)|13|||
23453043|NCT00525512|65403216|FG002|Double-Blind Phase|Other reason (not specified)|0|||
23453044|NCT00525512|65403217|FG003|Double-Blind Phase|Other reason (not specified)|0|||
23453045|NCT00525512|65403214|FG000|Open-Label Phase|Adverse Event|0|||
23453046|NCT00525512|65403215|FG001|Open-Label Phase|Adverse Event|0|||
23453047|NCT00525512|65403216|FG002|Open-Label Phase|Adverse Event|1|||
23453048|NCT00525512|65403217|FG003|Open-Label Phase|Adverse Event|0|||
23453049|NCT00525512|65403214|FG000|Open-Label Phase|Lost to Follow-up|0|||
23453050|NCT00525512|65403215|FG001|Open-Label Phase|Lost to Follow-up|0|||
23453051|NCT00525512|65403216|FG002|Open-Label Phase|Lost to Follow-up|1|||
23453052|NCT00525512|65403217|FG003|Open-Label Phase|Lost to Follow-up|0|||
23453053|NCT00525512|65403214|FG000|Open-Label Phase|Other reason (not specified)|0|||
23581933|NCT01460381|65859139|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
23581934|NCT01460381|65859140|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
23581935|NCT01649427|65859141|FG000|Overall Study|Adverse Event|1|||
23581936|NCT01649427|65859142|FG001|Overall Study|Adverse Event|1|||
23581937|NCT01649427|65859141|FG000|Overall Study|Withdrawal by Subject|8|||
23581938|NCT01649427|65859142|FG001|Overall Study|Withdrawal by Subject|7|||
23581939|NCT01649427|65859141|FG000|Overall Study|Lost to Follow-up|0|||
23581940|NCT01649427|65859142|FG001|Overall Study|Lost to Follow-up|1|||
23581941|NCT01649427|65859141|FG000|Overall Study|Graft loss|0|||
23581942|NCT01649427|65859142|FG001|Overall Study|Graft loss|1|||
23581943|NCT01649427|65859141|FG000|Overall Study|Surgical problems during nephrectomy|2|||
23581944|NCT01649427|65859142|FG001|Overall Study|Surgical problems during nephrectomy|2|||
23581945|NCT04639947|65859143|FG000|Overall Study|Screen fail|1|||
23581946|NCT01257503|65859148|FG000|Overall Study|Lost to Follow-up|7|||
23581947|NCT01257503|65859149|FG001|Overall Study|Lost to Follow-up|10|||
23581948|NCT01257503|65859148|FG000|Overall Study|Over 5 years old at enrollment|0|||
23581949|NCT01257503|65859149|FG001|Overall Study|Over 5 years old at enrollment|1|||
23581950|NCT01257503|65859148|FG000|Overall Study|strep culture positive at enrollment|1|||
23581951|NCT01257503|65859149|FG001|Overall Study|strep culture positive at enrollment|0|||
23581952|NCT01427907|65859150|FG000|Overall Study|Withdrawal by Subject|3|||
23581953|NCT01427907|65859151|FG001|Overall Study|Withdrawal by Subject|4|||
23581954|NCT01744691|65859152|FG000|Overall Study|Progressive Disease|18|||
23581955|NCT01744691|65859152|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
23581956|NCT01744691|65859152|FG000|Overall Study|Withdrawal of consent for treatment|3|||
23581957|NCT01744691|65859152|FG000|Overall Study|Physician Decision|4|||
23581958|NCT03686683|65859153|FG000|Overall Study|Withdrawal by Subject|52|||
23581959|NCT03686683|65859154|FG001|Overall Study|Withdrawal by Subject|32|||
23581960|NCT03686683|65859153|FG000|Overall Study|Lost to Follow-up|23|||
23581961|NCT03686683|65859154|FG001|Overall Study|Lost to Follow-up|19|||
23581962|NCT03686683|65859153|FG000|Overall Study|Adverse Event|1|||
23581963|NCT03686683|65859154|FG001|Overall Study|Adverse Event|0|||
23581964|NCT03686683|65859153|FG000|Overall Study|Death|10|||
23581965|NCT03686683|65859154|FG001|Overall Study|Death|5|||
23581966|NCT03686683|65859153|FG000|Overall Study|Progressive Disease|1|||
23581967|NCT03686683|65859154|FG001|Overall Study|Progressive Disease|1|||
23581968|NCT03686683|65859153|FG000|Overall Study|Noncompliance|1|||
23581969|NCT03686683|65859154|FG001|Overall Study|Noncompliance|0|||
23581970|NCT03686683|65859153|FG000|Overall Study|Physician Decision|1|||
23453054|NCT00525512|65403215|FG001|Open-Label Phase|Other reason (not specified)|0|||
23581971|NCT03686683|65859154|FG001|Overall Study|Physician Decision|1|||
23581972|NCT03686683|65859153|FG000|Overall Study|Screen fail post-randomization|1|||
23581973|NCT03686683|65859154|FG001|Overall Study|Screen fail post-randomization|0|||
23453055|NCT00525512|65403216|FG002|Open-Label Phase|Other reason (not specified)|4|||
23453056|NCT00525512|65403217|FG003|Open-Label Phase|Other reason (not specified)|5|||
23453057|NCT04011540|65403220|FG000|Overall Study|Lost to Follow-up|9|||
23453058|NCT04011540|65403221|FG001|Overall Study|Lost to Follow-up|6|||
23453059|NCT02021565|65403222|FG000|Baseline Through Intervention|Death|0|||
23453060|NCT02021565|65403223|FG001|Baseline Through Intervention|Death|1|||
23453061|NCT02021565|65403222|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
23453062|NCT02021565|65403223|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
23453063|NCT02021565|65403222|FG000|Baseline Through Intervention|Protocol Violation|0|||
23453064|NCT02021565|65403223|FG001|Baseline Through Intervention|Protocol Violation|7|||
23453065|NCT02021565|65403222|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
23453066|NCT02021565|65403223|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
23453067|NCT02021565|65403222|FG000|3-month Follow-up|Death|3|||
23453068|NCT02021565|65403223|FG001|3-month Follow-up|Death|0|||
23453069|NCT02021565|65403222|FG000|3-month Follow-up|Withdrawal by Subject|4|||
23453070|NCT02021565|65403223|FG001|3-month Follow-up|Withdrawal by Subject|0|||
23453071|NCT02021565|65403222|FG000|3-month Follow-up|Protocol Violation|3|||
23453072|NCT02021565|65403223|FG001|3-month Follow-up|Protocol Violation|2|||
23453073|NCT02314052|65403224|FG000|Cycle One|Adverse Event|0|||
23453074|NCT02314052|65403225|FG001|Cycle One|Adverse Event|0|||
23453075|NCT02314052|65403226|FG002|Cycle One|Adverse Event|0|||
23453076|NCT02314052|65403227|FG003|Cycle One|Adverse Event|1|||
23453077|NCT02314052|65403228|FG004|Cycle One|Adverse Event|0|||
23453078|NCT02314052|65403229|FG005|Cycle One|Adverse Event|0|||
23453079|NCT02872116|65403230|FG000|Pre-Treatment|Disease Progression|0|||
23453080|NCT02872116|65403231|FG001|Pre-Treatment|Disease Progression|1|||
23453081|NCT02872116|65403232|FG002|Pre-Treatment|Disease Progression|0|||
23453082|NCT02872116|65403230|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
23453083|NCT02872116|65403231|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
23453084|NCT02872116|65403232|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
23453085|NCT02872116|65403230|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
23453086|NCT02872116|65403231|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
23453087|NCT02872116|65403232|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
23636237|NCT02592876|66052880|FG001|Overall Study|Study Termination by Sponsor|27|||
23636238|NCT02592876|66052879|FG000|Overall Study|Lost to Follow-up|0|||
23636239|NCT02592876|66052880|FG001|Overall Study|Lost to Follow-up|1|||
23636240|NCT02592876|66052879|FG000|Overall Study|Death|6|||
23636241|NCT02592876|66052880|FG001|Overall Study|Death|9|||
23636242|NCT00320528|66052881|FG000|Study Period II|Adverse Event|3|||
23636243|NCT00320528|66052882|FG001|Study Period II|Adverse Event|4|||
23636244|NCT00320528|66052883|FG002|Study Period II|Adverse Event|8|||
23636245|NCT00320528|66052881|FG000|Study Period II|Parent/Caregiver Decision|8|||
23636246|NCT00320528|66052882|FG001|Study Period II|Parent/Caregiver Decision|3|||
23636247|NCT00320528|66052883|FG002|Study Period II|Parent/Caregiver Decision|11|||
23636248|NCT00320528|66052881|FG000|Study Period II|Withdrawal by Subject|0|||
23636249|NCT00320528|66052882|FG001|Study Period II|Withdrawal by Subject|1|||
23636250|NCT00320528|66052883|FG002|Study Period II|Withdrawal by Subject|1|||
23636251|NCT00320528|66052881|FG000|Study Period II|Entry Criteria Exclusion|0|||
23636252|NCT00320528|66052882|FG001|Study Period II|Entry Criteria Exclusion|2|||
23636253|NCT00320528|66052883|FG002|Study Period II|Entry Criteria Exclusion|2|||
23636254|NCT00320528|66052881|FG000|Study Period III|Adverse Event|1|||
23636255|NCT00320528|66052882|FG001|Study Period III|Adverse Event|0|||
23636256|NCT00320528|66052883|FG002|Study Period III|Adverse Event|0|||
23636257|NCT00320528|66052881|FG000|Study Period III|Lost to Follow-up|1|||
23636258|NCT00320528|66052882|FG001|Study Period III|Lost to Follow-up|0|||
23636259|NCT00320528|66052883|FG002|Study Period III|Lost to Follow-up|0|||
23636260|NCT00320528|66052881|FG000|Study Period III|Withdrawal by Subject|1|||
23636261|NCT00320528|66052882|FG001|Study Period III|Withdrawal by Subject|1|||
23636262|NCT00320528|66052883|FG002|Study Period III|Withdrawal by Subject|2|||
23636263|NCT00320528|66052881|FG000|Study Period III|Lack of Efficacy|2|||
23453088|NCT02872116|65403230|FG000|Pre-Treatment|Participant withdrew consent|2|||
23453089|NCT02872116|65403231|FG001|Pre-Treatment|Participant withdrew consent|20|||
23453090|NCT02872116|65403232|FG002|Pre-Treatment|Participant withdrew consent|3|||
23453091|NCT02872116|65403230|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
23453092|NCT02872116|65403231|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
23636264|NCT00320528|66052882|FG001|Study Period III|Lack of Efficacy|0|||
23636265|NCT00320528|66052883|FG002|Study Period III|Lack of Efficacy|0|||
23636266|NCT00320528|66052881|FG000|Study Period III|Parent/Caregiver Decision|14|||
23453093|NCT02872116|65403232|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
23453094|NCT02872116|65403230|FG000|Pre-Treatment|Other reasons|1|||
23636267|NCT00320528|66052882|FG001|Study Period III|Parent/Caregiver Decision|3|||
23636268|NCT00320528|66052883|FG002|Study Period III|Parent/Caregiver Decision|11|||
23636269|NCT00320528|66052881|FG000|Study Period III|Protocol Violation|0|||
23453095|NCT02872116|65403231|FG001|Pre-Treatment|Other reasons|2|||
23453096|NCT02872116|65403232|FG002|Pre-Treatment|Other reasons|2|||
23636270|NCT00320528|66052882|FG001|Study Period III|Protocol Violation|1|||
23636271|NCT00320528|66052883|FG002|Study Period III|Protocol Violation|0|||
23636272|NCT00320528|66052881|FG000|Study Period III|Physician Decision|0|||
23636273|NCT00320528|66052882|FG001|Study Period III|Physician Decision|1|||
23636274|NCT00320528|66052883|FG002|Study Period III|Physician Decision|2|||
23636275|NCT00320528|66052881|FG000|Study Period III|Sponsor Decision|0|||
23636276|NCT00320528|66052882|FG001|Study Period III|Sponsor Decision|0|||
23636277|NCT00320528|66052883|FG002|Study Period III|Sponsor Decision|1|||
23636278|NCT00320528|66052881|FG000|Study Period III|Atomoxetine Commercially Available|68|||
23636279|NCT00320528|66052882|FG001|Study Period III|Atomoxetine Commercially Available|25|||
23636280|NCT00320528|66052883|FG002|Study Period III|Atomoxetine Commercially Available|90|||
23636281|NCT00392925|66052888|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
23636282|NCT00392925|66052889|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23636283|NCT00392925|66052890|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23636284|NCT00392925|66052891|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23636285|NCT00392925|66052888|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
23636286|NCT00392925|66052889|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23636287|NCT00392925|66052890|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23636288|NCT00392925|66052891|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23636289|NCT00392925|66052888|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
23636290|NCT00392925|66052889|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23636291|NCT00392925|66052890|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23636292|NCT00392925|66052891|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23636293|NCT00392925|66052888|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
23842795|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
23842796|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
23842797|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
23842798|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
23842799|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
23842800|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
23842801|NCT00090220|66805531|FG000|Extension 1 (EXT1)|Other reason|0|||
23842802|NCT00090220|66805532|FG001|Extension 1 (EXT1)|Other reason|0|||
23636294|NCT00392925|66052889|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23636295|NCT00392925|66052890|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23842803|NCT00090220|66805533|FG002|Extension 1 (EXT1)|Other reason|2|||
23842804|NCT00090220|66805534|FG003|Extension 1 (EXT1)|Other reason|0|||
23842805|NCT00090220|66805535|FG004|Extension 1 (EXT1)|Other reason|0|||
23842806|NCT00090220|66805536|FG005|Extension 1 (EXT1)|Other reason|0|||
23842807|NCT00090220|66805531|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23842808|NCT00090220|66805532|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23842809|NCT00090220|66805533|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23842810|NCT00090220|66805534|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23842811|NCT00090220|66805535|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
23842812|NCT00090220|66805536|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
23842813|NCT00090220|66805531|FG000|Long-term Follow-up (EXT2)|Death|0|||
23842814|NCT00090220|66805532|FG001|Long-term Follow-up (EXT2)|Death|0|||
23842815|NCT00090220|66805533|FG002|Long-term Follow-up (EXT2)|Death|0|||
23842816|NCT00090220|66805534|FG003|Long-term Follow-up (EXT2)|Death|0|||
23842817|NCT00090220|66805535|FG004|Long-term Follow-up (EXT2)|Death|1|||
23842818|NCT00090220|66805536|FG005|Long-term Follow-up (EXT2)|Death|1|||
23453097|NCT02872116|65403230|FG000|Treatment|Death|122|||
23636296|NCT00392925|66052891|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23636297|NCT00392925|66052888|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
23636298|NCT00392925|66052889|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23636299|NCT00392925|66052890|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23636300|NCT00392925|66052891|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23636301|NCT00392925|66052888|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
23636302|NCT00392925|66052889|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
23636303|NCT00392925|66052890|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
23636304|NCT00392925|66052891|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
23636305|NCT00392925|66052888|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
23636306|NCT00392925|66052889|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
23842819|NCT00090220|66805531|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23842820|NCT00090220|66805532|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23842821|NCT00090220|66805533|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23453098|NCT02872116|65403231|FG001|Treatment|Death|94|||
23453099|NCT02872116|65403232|FG002|Treatment|Death|68|||
23842822|NCT00090220|66805534|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23842823|NCT00090220|66805535|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
23842824|NCT00090220|66805536|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
23842825|NCT00090220|66805531|FG000|Long-term Follow-up (EXT2)|Other|0|||
23636307|NCT00392925|66052890|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
23636308|NCT00392925|66052891|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
23636309|NCT00392925|66052888|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
23636310|NCT00392925|66052889|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
23636311|NCT00392925|66052890|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
23842826|NCT00090220|66805532|FG001|Long-term Follow-up (EXT2)|Other|0|||
23842827|NCT00090220|66805533|FG002|Long-term Follow-up (EXT2)|Other|0|||
23636312|NCT00392925|66052891|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
23636313|NCT00392925|66052888|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
23636314|NCT00392925|66052889|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
23636315|NCT00392925|66052890|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
23842828|NCT00090220|66805534|FG003|Long-term Follow-up (EXT2)|Other|0|||
23842829|NCT00090220|66805535|FG004|Long-term Follow-up (EXT2)|Other|1|||
23842830|NCT00090220|66805536|FG005|Long-term Follow-up (EXT2)|Other|0|||
23842831|NCT02009397|66805537|FG000|Overall Study|Protocol Violation|6|||
23842832|NCT02009397|66805537|FG000|Overall Study|Death|8|||
23842833|NCT02009397|66805537|FG000|Overall Study|Lost to Follow-up|6|||
23842834|NCT00507728|66805538|FG000|Randomization to Month 3|Lost to Follow-up|15|||
23842835|NCT00507728|66805539|FG001|Randomization to Month 3|Lost to Follow-up|14|||
23842836|NCT00507728|66805540|FG002|Randomization to Month 3|Lost to Follow-up|20|||
23842837|NCT00507728|66805538|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
23842838|NCT00507728|66805539|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
23636316|NCT00392925|66052891|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
23636317|NCT03846453|66052892|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
23636318|NCT03846453|66052893|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
23636319|NCT03846453|66052894|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
23636320|NCT03846453|66052892|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
23636321|NCT03846453|66052893|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
23636322|NCT03846453|66052894|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
23636323|NCT03846453|66052892|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
23636324|NCT03846453|66052893|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
23636325|NCT03846453|66052894|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
23636326|NCT03846453|66052892|FG000|Placebo Run-in (14 Days)|Other|2|||
23636327|NCT03846453|66052893|FG001|Placebo Run-in (14 Days)|Other|0|||
23636328|NCT03846453|66052894|FG002|Placebo Run-in (14 Days)|Other|0|||
23636329|NCT03846453|66052892|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
23636330|NCT03846453|66052893|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
23636331|NCT03846453|66052894|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
23636332|NCT03846453|66052892|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
23636333|NCT03846453|66052893|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
23636334|NCT03846453|66052894|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
23636335|NCT03846453|66052892|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
23636336|NCT03846453|66052893|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
23636337|NCT03846453|66052894|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
23636338|NCT03846453|66052892|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
23636339|NCT03846453|66052893|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
23636340|NCT03846453|66052894|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
23636341|NCT03846453|66052892|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
23636342|NCT03846453|66052893|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
23636343|NCT03846453|66052894|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
23636344|NCT01725126|66052898|FG000|Overall Study|Protocol Violation|0|||
23636345|NCT01725126|66052899|FG001|Overall Study|Protocol Violation|1|||
23636346|NCT01725126|66052900|FG002|Overall Study|Protocol Violation|0|||
23636347|NCT01725126|66052901|FG003|Overall Study|Protocol Violation|0|||
23636348|NCT01725126|66052902|FG004|Overall Study|Protocol Violation|0|||
23636349|NCT01725126|66052903|FG005|Overall Study|Protocol Violation|0|||
23636350|NCT01725126|66052898|FG000|Overall Study|Withdrawal by Subject|0|||
23636351|NCT01725126|66052899|FG001|Overall Study|Withdrawal by Subject|0|||
23636352|NCT01725126|66052900|FG002|Overall Study|Withdrawal by Subject|0|||
23636353|NCT01725126|66052901|FG003|Overall Study|Withdrawal by Subject|1|||
23636354|NCT01725126|66052902|FG004|Overall Study|Withdrawal by Subject|0|||
23636355|NCT01725126|66052903|FG005|Overall Study|Withdrawal by Subject|0|||
23636356|NCT01427725|66052906|FG000|Overall Study|Lost to Follow-up|17|||
23636357|NCT01427725|66052906|FG000|Overall Study|Protocol Violation|1|||
23636358|NCT01427725|66052906|FG000|Overall Study|Drug not administered|1|||
23636359|NCT01427725|66052906|FG000|Overall Study|Failure to visit|7|||
23842839|NCT00507728|66805540|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
23842840|NCT02977572|66805541|FG000|Overall Study|Exclusion criterion|2|||
23842841|NCT02977572|66805542|FG001|Overall Study|Exclusion criterion|2|||
23842842|NCT02029989|66805546|FG000|Overall Study|Withdrawal by Subject|1|||
23842843|NCT02029989|66805547|FG001|Overall Study|Withdrawal by Subject|0|||
23636360|NCT01427725|66052906|FG000|Overall Study|Adverse Event|46|||
23636361|NCT01427725|66052906|FG000|Overall Study|Failure to visit after administration|40|||
23636362|NCT01427725|66052906|FG000|Overall Study|Patient's rejection|27|||
23636363|NCT01427725|66052906|FG000|Overall Study|Transfer to a different hospital|17|||
23636364|NCT01427725|66052906|FG000|Overall Study|Lack of Efficacy|8|||
23636365|NCT01427725|66052906|FG000|Overall Study|Death|7|||
23636366|NCT01427725|66052906|FG000|Overall Study|Symptom improvement|6|||
23340732|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
23636367|NCT01427725|66052906|FG000|Overall Study|AE and Patient's rejection|5|||
23636368|NCT01427725|66052906|FG000|Overall Study|Physician Decision|5|||
23781837|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23340733|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
23340734|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
23340735|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
23453100|NCT02872116|65403230|FG000|Treatment|Lost to Follow-up|5|||
23453101|NCT02872116|65403231|FG001|Treatment|Lost to Follow-up|7|||
23453102|NCT02872116|65403232|FG002|Treatment|Lost to Follow-up|3|||
23453103|NCT02872116|65403230|FG000|Treatment|Participant withdrew consent|20|||
23453104|NCT02872116|65403231|FG001|Treatment|Participant withdrew consent|40|||
23453105|NCT02872116|65403232|FG002|Treatment|Participant withdrew consent|8|||
23453106|NCT02872116|65403230|FG000|Treatment|Other reasons|12|||
23453107|NCT02872116|65403231|FG001|Treatment|Other reasons|12|||
23453108|NCT02872116|65403232|FG002|Treatment|Other reasons|5|||
23453109|NCT00141102|65403233|FG000|Overall Study|Adverse Event|233|||
23453110|NCT00141102|65403234|FG001|Overall Study|Adverse Event|305|||
23453111|NCT00141102|65403233|FG000|Overall Study|Laboratory Abnormality|9|||
23453112|NCT00141102|65403234|FG001|Overall Study|Laboratory Abnormality|33|||
23453113|NCT00141102|65403233|FG000|Overall Study|Lack of Efficacy|21|||
23453114|NCT00141102|65403234|FG001|Overall Study|Lack of Efficacy|26|||
23453115|NCT00141102|65403233|FG000|Overall Study|Lost to Follow-up|29|||
23453116|NCT00141102|65403234|FG001|Overall Study|Lost to Follow-up|32|||
23453117|NCT00141102|65403233|FG000|Overall Study|Other|87|||
23453118|NCT00141102|65403234|FG001|Overall Study|Other|76|||
23453119|NCT00141102|65403233|FG000|Overall Study|Withdrawal by Subject|112|||
23453120|NCT00141102|65403234|FG001|Overall Study|Withdrawal by Subject|142|||
23453121|NCT00141102|65403233|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
23453122|NCT00141102|65403234|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
23636369|NCT01427725|66052906|FG000|Overall Study|Exacerbation of underlying disease|5|||
23636370|NCT01427725|66052906|FG000|Overall Study|Oral feeding difficulty|5|||
23636371|NCT01427725|66052906|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
23781838|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23781839|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781840|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781841|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781842|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
23781843|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23781844|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
23781845|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781846|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23781847|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781848|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781849|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781850|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781851|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781852|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781853|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781854|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23781855|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23842844|NCT02029989|66805546|FG000|Overall Study|Withdrawal: Fear of needles|1|||
23842845|NCT02029989|66805547|FG001|Overall Study|Withdrawal: Fear of needles|0|||
23842846|NCT02029989|66805546|FG000|Overall Study|Change of location|2|||
23842847|NCT02029989|66805547|FG001|Overall Study|Change of location|3|||
23842848|NCT02029989|66805546|FG000|Overall Study|Physician Decision|2|||
23842849|NCT02029989|66805547|FG001|Overall Study|Physician Decision|0|||
23842850|NCT02029989|66805546|FG000|Overall Study|Lost to Follow-up|9|||
23842851|NCT02029989|66805547|FG001|Overall Study|Lost to Follow-up|7|||
23453123|NCT00141102|65403233|FG000|Overall Study|Death|2|||
23453124|NCT00141102|65403234|FG001|Overall Study|Death|2|||
23453125|NCT00112736|65403235|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
23453126|NCT00112736|65403236|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
23453127|NCT02051764|65403237|FG000|Overall Study|Study terminated by sponsor|0|||
23842852|NCT02029989|66805546|FG000|Overall Study|Death|0|||
23340736|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
23340737|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
23340738|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
23340739|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Other|8|||
23340740|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Other|14|||
23340741|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Other|8|||
23340742|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Other|23|||
23340743|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
23340744|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
23340745|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
23340746|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
23340747|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23340748|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23581974|NCT03686683|65859153|FG000|Overall Study|Protocol Violation|3|||
23581975|NCT03686683|65859154|FG001|Overall Study|Protocol Violation|0|||
23781856|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23581976|NCT03686683|65859153|FG000|Overall Study|No data available|1|||
23781857|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781858|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781859|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
23781860|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
23781861|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23781862|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781863|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23781864|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23781865|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23781866|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23781867|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23781868|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781869|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781870|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781871|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781872|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781873|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781874|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781875|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23781876|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781877|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781878|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781879|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781880|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781881|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23781882|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781883|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781884|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23781885|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23781886|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23781887|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23781888|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781889|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781890|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781891|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781892|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781893|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781894|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781895|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781896|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23781897|NCT01597245|66580286|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781898|NCT01597245|66580287|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781899|NCT01597245|66580288|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781900|NCT01597245|66580289|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781901|NCT01597245|66580290|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23340749|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
23340750|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
23340751|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Death|0|||
23340752|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Death|0|||
23340753|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23340754|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Death|1|||
23340755|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
23340756|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
23340757|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
23340758|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
23340759|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23340760|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340761|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340762|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340763|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23340764|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
23340765|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23340766|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
23340767|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23340768|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340769|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340770|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340771|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23340772|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
23340773|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
23340774|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23340775|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23340776|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
23340777|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
23340778|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23340779|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340780|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340781|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340782|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23340783|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Other|6|||
23340784|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23340785|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Other|8|||
23340786|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Other|5|||
23340787|NCT00679289|64992844|FG000|Overall Study|Progressive disease|4|||
23340788|NCT00679289|64992845|FG001|Overall Study|Progressive disease|5|||
23453128|NCT02051764|65403238|FG001|Overall Study|Study terminated by sponsor|7|||
23453129|NCT00953667|65403239|FG000|Overall Study|Lost to Follow-up|11|||
23453130|NCT00953667|65403239|FG000|Overall Study|Physician Decision|35|||
23453131|NCT00953667|65403239|FG000|Overall Study|Withdrawal by Subject|63|||
23453132|NCT00953667|65403239|FG000|Overall Study|Adverse Event|10|||
23453133|NCT00953667|65403239|FG000|Overall Study|poor venous access,unable to draw blood|4|||
23453134|NCT01790594|65403240|FG000|Overall Study|Death|1|||
23453135|NCT01790594|65403241|FG001|Overall Study|Death|0|||
23453136|NCT01790594|65403242|FG002|Overall Study|Death|0|||
23453137|NCT01790594|65403240|FG000|Overall Study|Physician Decision|2|||
23453138|NCT01790594|65403241|FG001|Overall Study|Physician Decision|1|||
23453139|NCT01790594|65403242|FG002|Overall Study|Physician Decision|0|||
23453140|NCT01790594|65403240|FG000|Overall Study|Withdrawal by Subject|2|||
23453141|NCT01790594|65403241|FG001|Overall Study|Withdrawal by Subject|0|||
23453142|NCT01790594|65403242|FG002|Overall Study|Withdrawal by Subject|0|||
23453143|NCT01790594|65403240|FG000|Overall Study|Transplant was not done|0|||
23453144|NCT01790594|65403241|FG001|Overall Study|Transplant was not done|0|||
23453145|NCT01790594|65403242|FG002|Overall Study|Transplant was not done|3|||
23453146|NCT01790594|65403240|FG000|Overall Study|Terminated prior to week 76|0|||
23453147|NCT01790594|65403241|FG001|Overall Study|Terminated prior to week 76|2|||
23453148|NCT01790594|65403242|FG002|Overall Study|Terminated prior to week 76|0|||
23453149|NCT01217944|65403243|FG000|Overall Study|Protocol Violation|1|||
23453150|NCT01217944|65403244|FG001|Overall Study|Protocol Violation|1|||
23453151|NCT01217944|65403245|FG002|Overall Study|Protocol Violation|0|||
23453152|NCT01217944|65403243|FG000|Overall Study|Lost to Follow-up|3|||
23340789|NCT00679289|64992846|FG002|Overall Study|Progressive disease|18|||
23340790|NCT00679289|64992844|FG000|Overall Study|Withdrawal by Subject|0|||
23453153|NCT01217944|65403244|FG001|Overall Study|Lost to Follow-up|1|||
23453154|NCT01217944|65403245|FG002|Overall Study|Lost to Follow-up|0|||
23453155|NCT01217944|65403243|FG000|Overall Study|Withdrawal by Subject|1|||
23453156|NCT01217944|65403244|FG001|Overall Study|Withdrawal by Subject|2|||
23453157|NCT01217944|65403245|FG002|Overall Study|Withdrawal by Subject|0|||
23453158|NCT01217944|65403243|FG000|Overall Study|Lack of Efficacy|1|||
23340791|NCT00679289|64992845|FG001|Overall Study|Withdrawal by Subject|1|||
23340792|NCT00679289|64992846|FG002|Overall Study|Withdrawal by Subject|1|||
23340793|NCT00679289|64992844|FG000|Overall Study|Adverse Event|0|||
23340794|NCT00679289|64992845|FG001|Overall Study|Adverse Event|0|||
23340795|NCT00679289|64992846|FG002|Overall Study|Adverse Event|3|||
23340796|NCT00679289|64992844|FG000|Overall Study|Physician Decision|1|||
23340797|NCT00679289|64992845|FG001|Overall Study|Physician Decision|0|||
23340798|NCT00679289|64992846|FG002|Overall Study|Physician Decision|1|||
23340799|NCT01083186|64992847|FG000|Overall Study|Lost to Follow-up|48|||
23340800|NCT01083186|64992847|FG000|Overall Study|Consent Withdrawal|7|||
23340801|NCT01083186|64992847|FG000|Overall Study|Death|3|||
23781902|NCT01597245|66580291|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781903|NCT01597245|66580292|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781904|NCT01597245|66580293|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781905|NCT01597245|66580294|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781906|NCT01597245|66580295|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781907|NCT01597245|66580296|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
23781908|NCT01597245|66580297|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781909|NCT01597245|66580298|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781910|NCT01597245|66580299|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781911|NCT01597245|66580300|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781912|NCT01597245|66580301|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781913|NCT01597245|66580302|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781914|NCT01597245|66580303|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781915|NCT01597245|66580304|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781916|NCT01597245|66580305|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781917|NCT01597245|66580306|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23781918|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781919|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781920|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781921|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781922|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781923|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781924|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781925|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781926|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781927|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781928|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781929|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781930|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781931|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
23781932|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
23781933|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
23781934|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781935|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781936|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781937|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781938|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23781939|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781940|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781941|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781942|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781943|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781944|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781945|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781946|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781947|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781948|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781949|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23340802|NCT01083186|64992847|FG000|Overall Study|Adverse Event|3|||
23581977|NCT03686683|65859154|FG001|Overall Study|No data available|0|||
23581978|NCT02123966|65859158|FG000|Overall Study|Intercurrent Illness|1|||
23340803|NCT01083186|64992847|FG000|Overall Study|Lack of Efficacy|2|||
23581979|NCT01027871|65859159|FG000|Overall Study|Physician Decision|1|||
23581980|NCT01027871|65859160|FG001|Overall Study|Physician Decision|5|||
23581981|NCT01027871|65859161|FG002|Overall Study|Physician Decision|0|||
23581982|NCT01027871|65859159|FG000|Overall Study|Protocol Violation|0|||
23581983|NCT01027871|65859160|FG001|Overall Study|Protocol Violation|2|||
23842853|NCT02029989|66805547|FG001|Overall Study|Death|1|||
23636372|NCT01427725|66052906|FG000|Overall Study|Forgetting prescription|1|||
23636373|NCT01427725|66052906|FG000|Overall Study|Other|2|||
23636374|NCT00468143|66052907|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
23636375|NCT00468143|66052908|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
23636376|NCT00468143|66052907|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
23636377|NCT00468143|66052908|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
23340804|NCT01083186|64992847|FG000|Overall Study|Hemodialysis Initiation|28|||
23453159|NCT01217944|65403244|FG001|Overall Study|Lack of Efficacy|0|||
23453160|NCT01217944|65403245|FG002|Overall Study|Lack of Efficacy|0|||
23581984|NCT01027871|65859161|FG002|Overall Study|Protocol Violation|2|||
23581985|NCT01027871|65859159|FG000|Overall Study|Withdrawal by Subject|1|||
23581986|NCT01027871|65859160|FG001|Overall Study|Withdrawal by Subject|2|||
23581987|NCT01027871|65859161|FG002|Overall Study|Withdrawal by Subject|2|||
23581988|NCT01027871|65859159|FG000|Overall Study|Adverse Event|0|||
23581989|NCT01027871|65859160|FG001|Overall Study|Adverse Event|2|||
23581990|NCT01027871|65859161|FG002|Overall Study|Adverse Event|2|||
23581991|NCT01027871|65859159|FG000|Overall Study|Sponsor Decision|0|||
23581992|NCT01027871|65859160|FG001|Overall Study|Sponsor Decision|2|||
23581993|NCT01027871|65859161|FG002|Overall Study|Sponsor Decision|0|||
23581994|NCT01027871|65859159|FG000|Overall Study|Discontinued Prior to Treatment|0|||
23581995|NCT01027871|65859160|FG001|Overall Study|Discontinued Prior to Treatment|0|||
23581996|NCT01027871|65859161|FG002|Overall Study|Discontinued Prior to Treatment|1|||
23636378|NCT01399697|66052912|FG000|Overall Study|Adverse Event|13|||
23636379|NCT01399697|66052913|FG001|Overall Study|Adverse Event|3|||
23636380|NCT01399697|66052914|FG002|Overall Study|Adverse Event|1|||
23636381|NCT01399697|66052912|FG000|Overall Study|Lost to Follow-up|2|||
23636382|NCT01399697|66052913|FG001|Overall Study|Lost to Follow-up|0|||
23636383|NCT01399697|66052914|FG002|Overall Study|Lost to Follow-up|0|||
23636384|NCT01399697|66052912|FG000|Overall Study|Withdrawal by Subject|8|||
23636385|NCT01399697|66052913|FG001|Overall Study|Withdrawal by Subject|0|||
23636386|NCT01399697|66052914|FG002|Overall Study|Withdrawal by Subject|0|||
23636387|NCT01399697|66052912|FG000|Overall Study|Investigator Decisión|1|||
23636388|NCT01399697|66052913|FG001|Overall Study|Investigator Decisión|0|||
23636389|NCT01399697|66052914|FG002|Overall Study|Investigator Decisión|2|||
23636390|NCT01399697|66052912|FG000|Overall Study|Lack of Efficacy|9|||
23636391|NCT01399697|66052913|FG001|Overall Study|Lack of Efficacy|0|||
23636392|NCT01399697|66052914|FG002|Overall Study|Lack of Efficacy|1|||
23781950|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781951|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781952|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
23781953|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
23781954|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
23781955|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781956|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781957|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781958|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781959|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23781960|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781961|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781962|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781963|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781964|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781965|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781966|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781967|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781968|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781969|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781970|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781971|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781972|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781973|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781974|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
23781975|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
23581997|NCT02289560|65859162|FG000|Overall Study|Lost to Follow-up|6|||
23581998|NCT02289560|65859162|FG000|Overall Study|Alternative Treatment|4|||
23581999|NCT02289560|65859162|FG000|Overall Study|Inadequate Treatment|2|||
23636393|NCT01399697|66052912|FG000|Overall Study|Protocol Violation|2|||
23582000|NCT02289560|65859162|FG000|Overall Study|Withdrawal by Subject|23|||
23636394|NCT01399697|66052913|FG001|Overall Study|Protocol Violation|0|||
23636395|NCT01399697|66052914|FG002|Overall Study|Protocol Violation|0|||
23582001|NCT01684046|65859163|FG000|Period 1, First 30 Days|Adverse Event|0|||
23582002|NCT01684046|65859164|FG001|Period 1, First 30 Days|Adverse Event|2|||
23842854|NCT02029989|66805546|FG000|Overall Study|Protocol Violation|1|||
23842855|NCT02029989|66805547|FG001|Overall Study|Protocol Violation|0|||
23842856|NCT02453334|66805548|FG000|Overall Study|Death|15|||
23582003|NCT00819910|65859165|FG000|Overall Study|Adverse Event|0|||
23636396|NCT01399697|66052912|FG000|Overall Study|Non-Compliant|1|||
23636397|NCT01399697|66052913|FG001|Overall Study|Non-Compliant|0|||
23636398|NCT01399697|66052914|FG002|Overall Study|Non-Compliant|0|||
23636399|NCT01399697|66052912|FG000|Overall Study|Inclusion Error|2|||
23636400|NCT01399697|66052913|FG001|Overall Study|Inclusion Error|0|||
23636401|NCT01399697|66052914|FG002|Overall Study|Inclusion Error|0|||
23636402|NCT01399697|66052912|FG000|Overall Study|Positive result for hepatitis B|1|||
23842857|NCT02453334|66805549|FG001|Overall Study|Death|13|||
23842858|NCT02453334|66805548|FG000|Overall Study|Adverse Event|2|||
23842859|NCT02453334|66805549|FG001|Overall Study|Adverse Event|1|||
23842860|NCT02453334|66805548|FG000|Overall Study|Lost to Follow-up|5|||
23842861|NCT02453334|66805549|FG001|Overall Study|Lost to Follow-up|9|||
23842862|NCT02453334|66805548|FG000|Overall Study|Physician Decision|1|||
23842863|NCT02453334|66805549|FG001|Overall Study|Physician Decision|0|||
23842864|NCT02453334|66805548|FG000|Overall Study|Withdrawal by Subject|17|||
23842865|NCT02453334|66805549|FG001|Overall Study|Withdrawal by Subject|13|||
23842866|NCT02453334|66805548|FG000|Overall Study|Other reason|1|||
23842867|NCT02453334|66805549|FG001|Overall Study|Other reason|4|||
23842868|NCT04590586|66805552|FG000|Overall Study|Death|7|||
23842869|NCT04590586|66805553|FG001|Overall Study|Death|1|||
23842870|NCT04590586|66805554|FG002|Overall Study|Death|37|||
23842871|NCT04590586|66805555|FG003|Overall Study|Death|34|||
23842872|NCT04590586|66805556|FG004|Overall Study|Death|19|||
23842873|NCT04590586|66805557|FG005|Overall Study|Death|3|||
23842874|NCT04590586|66805552|FG000|Overall Study|Lost to Follow-up|3|||
23842875|NCT04590586|66805553|FG001|Overall Study|Lost to Follow-up|0|||
23842876|NCT04590586|66805554|FG002|Overall Study|Lost to Follow-up|11|||
23842877|NCT04590586|66805555|FG003|Overall Study|Lost to Follow-up|11|||
23842878|NCT04590586|66805556|FG004|Overall Study|Lost to Follow-up|6|||
23842879|NCT04590586|66805557|FG005|Overall Study|Lost to Follow-up|0|||
23842880|NCT04590586|66805552|FG000|Overall Study|Withdrawal by Subject|0|||
23842881|NCT04590586|66805553|FG001|Overall Study|Withdrawal by Subject|0|||
23842882|NCT04590586|66805554|FG002|Overall Study|Withdrawal by Subject|6|||
23582004|NCT00819910|65859166|FG001|Overall Study|Adverse Event|0|||
23582005|NCT00819910|65859167|FG002|Overall Study|Adverse Event|2|||
23582006|NCT00819910|65859168|FG003|Overall Study|Adverse Event|1|||
23582007|NCT00819910|65859165|FG000|Overall Study|Withdrawal by Subject|1|||
23582008|NCT00819910|65859166|FG001|Overall Study|Withdrawal by Subject|1|||
23582009|NCT00819910|65859167|FG002|Overall Study|Withdrawal by Subject|1|||
23582010|NCT00819910|65859168|FG003|Overall Study|Withdrawal by Subject|0|||
23582011|NCT00819910|65859165|FG000|Overall Study|Lost to Follow-up|1|||
23582012|NCT00819910|65859166|FG001|Overall Study|Lost to Follow-up|0|||
23582013|NCT00819910|65859167|FG002|Overall Study|Lost to Follow-up|0|||
23582014|NCT00819910|65859168|FG003|Overall Study|Lost to Follow-up|0|||
23582015|NCT04454567|65859170|FG000|Overall Study|Study Terminated by Sponsor|1|||
23582016|NCT04454567|65859171|FG001|Overall Study|Study Terminated by Sponsor|1|||
23582017|NCT01106287|65859172|FG000|Overall Study|Adverse Event|1|||
23582018|NCT01106287|65859173|FG001|Overall Study|Adverse Event|0|||
23582019|NCT01106287|65859174|FG002|Overall Study|Adverse Event|0|||
23582020|NCT01106287|65859175|FG003|Overall Study|Adverse Event|0|||
23582021|NCT01264718|65862278|FG000|Overall Study|Lost to Follow-up|3|||
23582022|NCT01264718|65862279|FG001|Overall Study|Lost to Follow-up|2|||
23582023|NCT01264718|65862278|FG000|Overall Study|Withdrawal by Subject|9|||
23842883|NCT04590586|66805555|FG003|Overall Study|Withdrawal by Subject|0|||
23842884|NCT04590586|66805556|FG004|Overall Study|Withdrawal by Subject|3|||
23842885|NCT04590586|66805557|FG005|Overall Study|Withdrawal by Subject|0|||
23842886|NCT04590586|66805552|FG000|Overall Study|Other|3|||
23842887|NCT04590586|66805553|FG001|Overall Study|Other|0|||
23582024|NCT01264718|65862279|FG001|Overall Study|Withdrawal by Subject|15|||
23582025|NCT01264718|65862278|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
23582026|NCT01264718|65862279|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
23582027|NCT01928940|65862280|FG000|Overall Study|Adverse Event|0|||
23582028|NCT01928940|65862281|FG001|Overall Study|Adverse Event|1|||
23636403|NCT01399697|66052913|FG001|Overall Study|Positive result for hepatitis B|0|||
23636404|NCT01399697|66052914|FG002|Overall Study|Positive result for hepatitis B|0|||
23636405|NCT01399697|66052912|FG000|Overall Study|Clinical RA remission|1|||
23842888|NCT04590586|66805554|FG002|Overall Study|Other|1|||
23842889|NCT04590586|66805555|FG003|Overall Study|Other|1|||
23842890|NCT04590586|66805556|FG004|Overall Study|Other|2|||
23842891|NCT04590586|66805557|FG005|Overall Study|Other|1|||
23842892|NCT00915876|66805558|FG000|Overall Study|Adverse Event|0|||
23842893|NCT00915876|66805559|FG001|Overall Study|Adverse Event|1|||
23842894|NCT03640559|66805560|FG000|Overall Study|Physician Decision|1|||
23842895|NCT03640559|66805561|FG001|Overall Study|Physician Decision|1|||
23636406|NCT01399697|66052913|FG001|Overall Study|Clinical RA remission|0|||
23636407|NCT01399697|66052914|FG002|Overall Study|Clinical RA remission|0|||
23636408|NCT01399697|66052912|FG000|Overall Study|Sponsor Decision|1|||
23636409|NCT01399697|66052913|FG001|Overall Study|Sponsor Decision|0|||
23636410|NCT01399697|66052914|FG002|Overall Study|Sponsor Decision|0|||
23636411|NCT00763451|66052916|FG000|Overall Study|Adverse Event|4|||
23636412|NCT00763451|66052917|FG001|Overall Study|Adverse Event|6|||
23636413|NCT00763451|66052918|FG002|Overall Study|Adverse Event|19|||
23636414|NCT00763451|66052919|FG003|Overall Study|Adverse Event|14|||
23636415|NCT00763451|66052916|FG000|Overall Study|Lack of Efficacy|1|||
23636416|NCT00763451|66052917|FG001|Overall Study|Lack of Efficacy|4|||
23636417|NCT00763451|66052918|FG002|Overall Study|Lack of Efficacy|3|||
23636418|NCT00763451|66052919|FG003|Overall Study|Lack of Efficacy|2|||
23842896|NCT03640559|66805560|FG000|Overall Study|Withdrawal by Subject|1|||
23842897|NCT03640559|66805561|FG001|Overall Study|Withdrawal by Subject|0|||
23842898|NCT04382755|66805562|FG000|Overall Study|Withdrawal by Subject|1|||
23842899|NCT04382755|66805563|FG001|Overall Study|Withdrawal by Subject|0|||
23842900|NCT04382755|66805562|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
23842901|NCT04382755|66805563|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
23842902|NCT04382755|66805562|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
23842903|NCT04382755|66805563|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
23842904|NCT00095238|66805564|FG000|Overall Study|Lack of Efficacy|9|||
23842905|NCT00095238|66805565|FG001|Overall Study|Lack of Efficacy|9|||
23842906|NCT00095238|66805564|FG000|Overall Study|Adverse Event|331|||
23842907|NCT00095238|66805565|FG001|Overall Study|Adverse Event|287|||
23842908|NCT00095238|66805564|FG000|Overall Study|Subject Withdrew Consent|208|||
23842909|NCT00095238|66805565|FG001|Overall Study|Subject Withdrew Consent|223|||
23842910|NCT00095238|66805564|FG000|Overall Study|Death|154|||
23842911|NCT00095238|66805565|FG001|Overall Study|Death|170|||
23842912|NCT00095238|66805564|FG000|Overall Study|Lost to Follow-up|19|||
23842913|NCT00095238|66805565|FG001|Overall Study|Lost to Follow-up|24|||
23842914|NCT00095238|66805564|FG000|Overall Study|Noncompliance|44|||
23842915|NCT00095238|66805565|FG001|Overall Study|Noncompliance|45|||
23842916|NCT00095238|66805564|FG000|Overall Study|No longer met study criteria|4|||
23842917|NCT00095238|66805565|FG001|Overall Study|No longer met study criteria|5|||
23842918|NCT00095238|66805564|FG000|Overall Study|Study terminated by sponsor|0|||
23636419|NCT00763451|66052916|FG000|Overall Study|Withdrawal by Subject|1|||
23636420|NCT00763451|66052917|FG001|Overall Study|Withdrawal by Subject|6|||
23636421|NCT00763451|66052918|FG002|Overall Study|Withdrawal by Subject|9|||
23636422|NCT00763451|66052919|FG003|Overall Study|Withdrawal by Subject|7|||
23636423|NCT00763451|66052916|FG000|Overall Study|Protocol Violation|0|||
23636424|NCT00763451|66052917|FG001|Overall Study|Protocol Violation|0|||
23636425|NCT00763451|66052918|FG002|Overall Study|Protocol Violation|1|||
23636426|NCT00763451|66052919|FG003|Overall Study|Protocol Violation|0|||
23636427|NCT00763451|66052916|FG000|Overall Study|Poor Compliance to Protocol|1|||
23636428|NCT00763451|66052917|FG001|Overall Study|Poor Compliance to Protocol|1|||
23636429|NCT00763451|66052918|FG002|Overall Study|Poor Compliance to Protocol|2|||
23636430|NCT00763451|66052919|FG003|Overall Study|Poor Compliance to Protocol|2|||
23636431|NCT00763451|66052916|FG000|Overall Study|Familial and Personal Reasons|5|||
23636432|NCT00763451|66052917|FG001|Overall Study|Familial and Personal Reasons|3|||
23636433|NCT00763451|66052918|FG002|Overall Study|Familial and Personal Reasons|5|||
23636434|NCT00763451|66052919|FG003|Overall Study|Familial and Personal Reasons|4|||
23636435|NCT00763451|66052916|FG000|Overall Study|Randomized but not Treated|1|||
23636436|NCT00763451|66052917|FG001|Overall Study|Randomized but not Treated|1|||
23636437|NCT00763451|66052918|FG002|Overall Study|Randomized but not Treated|0|||
23636438|NCT00763451|66052919|FG003|Overall Study|Randomized but not Treated|0|||
23636439|NCT00763451|66052916|FG000|Overall Study|Study Site Reason|0|||
23636440|NCT00763451|66052917|FG001|Overall Study|Study Site Reason|1|||
23636441|NCT00763451|66052918|FG002|Overall Study|Study Site Reason|1|||
23636442|NCT00763451|66052919|FG003|Overall Study|Study Site Reason|1|||
23636443|NCT03816761|66052920|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23636444|NCT03816761|66052921|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23636445|NCT03816761|66052922|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23636446|NCT03816761|66052923|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23636447|NCT03816761|66052924|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23636448|NCT03816761|66052925|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
23636449|NCT03816761|66052920|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
23636450|NCT03816761|66052921|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
23636451|NCT03816761|66052922|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
23636452|NCT03816761|66052923|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
23636453|NCT03816761|66052924|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
23842919|NCT00095238|66805565|FG001|Overall Study|Study terminated by sponsor|1|||
23842920|NCT00095238|66805564|FG000|Overall Study|Missing|1|||
23842921|NCT00095238|66805565|FG001|Overall Study|Missing|0|||
23636454|NCT03816761|66052925|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
23636455|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
23636456|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
23636457|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
23636458|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
23636459|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
23636460|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
23636461|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
23636462|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
23636463|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
23636464|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
23636465|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636466|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636467|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
23636468|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
23636469|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636470|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636471|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636472|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23636473|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
23636474|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636475|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636476|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636477|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
23636478|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636479|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636480|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636481|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
23636482|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
23636483|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
23636484|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
23636485|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
23636486|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
23636487|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23636488|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23636489|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23636490|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23636491|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
23781976|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781977|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781978|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781979|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781980|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23781981|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781982|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781983|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23582029|NCT02374957|65862282|FG000|Overall Study|Patient did not complete forms correctly|1|||
23582030|NCT02374957|65862283|FG001|Overall Study|Patient did not complete forms correctly|0|||
23582031|NCT01119703|65862284|FG000|Overall Study|Adverse Event|0|||
23582032|NCT01119703|65862285|FG001|Overall Study|Adverse Event|1|||
23582033|NCT03531905|65862286|FG000|Overall Study|Withdrawal by Subject|3|||
23582034|NCT03531905|65862287|FG001|Overall Study|Withdrawal by Subject|3|||
23582035|NCT03531905|65862288|FG002|Overall Study|Withdrawal by Subject|2|||
23582036|NCT03531905|65862286|FG000|Overall Study|Lost to Follow-up|2|||
23582037|NCT03531905|65862287|FG001|Overall Study|Lost to Follow-up|2|||
23582038|NCT03531905|65862288|FG002|Overall Study|Lost to Follow-up|1|||
23582039|NCT03531905|65862286|FG000|Overall Study|Participant was out of town|1|||
23582040|NCT03531905|65862287|FG001|Overall Study|Participant was out of town|0|||
23582041|NCT03531905|65862288|FG002|Overall Study|Participant was out of town|0|||
23582042|NCT03531905|65862286|FG000|Overall Study|Could not speak with the participant|1|||
23582043|NCT03531905|65862287|FG001|Overall Study|Could not speak with the participant|0|||
23582044|NCT03531905|65862288|FG002|Overall Study|Could not speak with the participant|0|||
23582045|NCT01250002|65862289|FG000|Overall Study|Change to open surgical procedure|4|||
23582046|NCT01250002|65862290|FG001|Overall Study|Change to open surgical procedure|3|||
23582047|NCT02540213|65862291|FG000|Overall Study|Death/adverse event|18|||
23582048|NCT02540213|65862291|FG000|Overall Study|Administrative reasons|3|||
23582049|NCT02540213|65862291|FG000|Overall Study|Kidney transplant|3|||
23636492|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
23636493|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
23636494|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
23636495|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
23453161|NCT03811340|65403248|FG000|Overall Study|subjects did not complete the survey.|90|||
23453162|NCT00001959|65403251|FG000|Overall Study|newly diagnosed colon cancer|1|||
23453163|NCT00001959|65403251|FG000|Overall Study|disabling sedation|1|||
23582050|NCT02540213|65862291|FG000|Overall Study|Lack of Efficacy|6|||
23582051|NCT02540213|65862291|FG000|Overall Study|Consent withdrawn|7|||
23582052|NCT02540213|65862291|FG000|Overall Study|Enrolled but not treated|2|||
23582053|NCT02322216|65862297|FG000|Overall Study|Adverse Event|1|||
23582054|NCT02322216|65862298|FG001|Overall Study|Adverse Event|0|||
23582055|NCT02322216|65862297|FG000|Overall Study|Withdrawal by Subject|1|||
23582056|NCT02322216|65862298|FG001|Overall Study|Withdrawal by Subject|4|||
23582057|NCT02735915|65862299|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
23582058|NCT02735915|65862299|FG000|Overall Study|Withdrawal following SAE|2|||
23582059|NCT02735915|65862299|FG000|Overall Study|Withdrawal by Subject|1|||
23582060|NCT04133363|65862300|FG000|Overall Study|Lost to Follow-up|2|||
23582061|NCT04133363|65862301|FG001|Overall Study|Lost to Follow-up|1|||
23582062|NCT04133363|65862302|FG002|Overall Study|Lost to Follow-up|4|||
23582063|NCT00926393|65862305|FG000|Overall Study|Withdrawal by Subject|1|||
23582064|NCT00926393|65862306|FG001|Overall Study|Withdrawal by Subject|2|||
23582065|NCT00926393|65862305|FG000|Overall Study|Adverse Event|1|||
23582066|NCT00926393|65862306|FG001|Overall Study|Adverse Event|1|||
23582067|NCT00823979|65862308|FG000|Overall Study|Lack of Efficacy|13|||
23781984|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781985|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781986|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781987|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781988|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781989|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781990|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781991|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781992|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781993|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781994|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781995|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
23781996|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
23781997|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781998|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23781999|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23782000|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23782001|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23782002|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782003|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782004|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782005|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782006|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782007|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782008|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782009|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782010|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782011|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782012|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782013|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782014|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782015|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
23782016|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
23782017|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
23782018|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782019|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782020|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782021|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782022|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23782023|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782024|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782025|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782026|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782027|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
23453164|NCT00001959|65403251|FG000|Overall Study|non-compliance|1|||
23582068|NCT00823979|65862309|FG001|Overall Study|Lack of Efficacy|16|||
23582069|NCT00823979|65862310|FG002|Overall Study|Lack of Efficacy|9|||
23636496|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23636497|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23636498|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23636499|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23636500|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
23636501|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
23636502|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
23636503|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
23636504|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
23636505|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
23636506|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
23636507|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
23636508|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
23842922|NCT00095238|66805564|FG000|Overall Study|Other Reasons|87|||
23453165|NCT03057496|65403254|FG000|Overall Study|Withdrawal by Subject|8|||
23453166|NCT03057496|65403254|FG000|Overall Study|Lost to Follow-up|5|||
23453167|NCT03057496|65403254|FG000|Overall Study|Did not use device during home trial|3|||
23453168|NCT03057496|65403254|FG000|Overall Study|Device failure|2|||
23453169|NCT01188772|65403255|FG000|Overall Study|Randomized but Not Treated|0|||
23453170|NCT01188772|65403256|FG001|Overall Study|Randomized but Not Treated|1|||
23453171|NCT01188772|65403257|FG002|Overall Study|Randomized but Not Treated|0|||
23453172|NCT01188772|65403258|FG003|Overall Study|Randomized but Not Treated|0|||
23453173|NCT01188772|65403255|FG000|Overall Study|Adverse Event|0|||
23453174|NCT01188772|65403256|FG001|Overall Study|Adverse Event|1|||
23453175|NCT01188772|65403257|FG002|Overall Study|Adverse Event|2|||
23453176|NCT01188772|65403258|FG003|Overall Study|Adverse Event|0|||
23453177|NCT01188772|65403255|FG000|Overall Study|Lost to Follow-up|4|||
23453178|NCT01188772|65403256|FG001|Overall Study|Lost to Follow-up|1|||
23453179|NCT01188772|65403257|FG002|Overall Study|Lost to Follow-up|1|||
23453180|NCT01188772|65403258|FG003|Overall Study|Lost to Follow-up|1|||
23453181|NCT01188772|65403255|FG000|Overall Study|Non-responder|0|||
23453182|NCT01188772|65403256|FG001|Overall Study|Non-responder|0|||
23453183|NCT01188772|65403257|FG002|Overall Study|Non-responder|3|||
23782028|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782029|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782030|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782031|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
23636509|NCT00477490|66052926|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
23782032|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782033|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782034|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
23453184|NCT01188772|65403258|FG003|Overall Study|Non-responder|0|||
23453185|NCT01188772|65403255|FG000|Overall Study|Physician Decision|0|||
23453186|NCT01188772|65403256|FG001|Overall Study|Physician Decision|0|||
23782035|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782036|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782037|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
23842923|NCT00095238|66805565|FG001|Overall Study|Other Reasons|88|||
23842924|NCT02811861|66805568|FG000|Overall Study|Radiological Disease Progression|123|||
23453187|NCT01188772|65403257|FG002|Overall Study|Physician Decision|1|||
23782038|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
23782039|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782040|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
23842925|NCT02811861|66805569|FG001|Overall Study|Radiological Disease Progression|97|||
23453188|NCT01188772|65403258|FG003|Overall Study|Physician Decision|0|||
23453189|NCT01188772|65403255|FG000|Overall Study|Terminated by Sponsor|0|||
23453190|NCT01188772|65403256|FG001|Overall Study|Terminated by Sponsor|0|||
23582070|NCT00823979|65862308|FG000|Overall Study|Lost to Follow-up|2|||
23582071|NCT00823979|65862309|FG001|Overall Study|Lost to Follow-up|1|||
23582072|NCT00823979|65862310|FG002|Overall Study|Lost to Follow-up|0|||
23582073|NCT00823979|65862308|FG000|Overall Study|Withdrawal by Subject|2|||
23582074|NCT00823979|65862309|FG001|Overall Study|Withdrawal by Subject|3|||
23582075|NCT00823979|65862310|FG002|Overall Study|Withdrawal by Subject|2|||
23582076|NCT00823979|65862308|FG000|Overall Study|Protocol Violation|1|||
23582077|NCT00823979|65862309|FG001|Overall Study|Protocol Violation|1|||
23582078|NCT00823979|65862310|FG002|Overall Study|Protocol Violation|0|||
23582079|NCT00823979|65862308|FG000|Overall Study|Pregnancy|0|||
23582080|NCT00823979|65862309|FG001|Overall Study|Pregnancy|1|||
23582081|NCT00823979|65862310|FG002|Overall Study|Pregnancy|0|||
23582082|NCT00823979|65862308|FG000|Overall Study|Adverse Event|0|||
23582083|NCT00823979|65862309|FG001|Overall Study|Adverse Event|2|||
23582084|NCT00823979|65862310|FG002|Overall Study|Adverse Event|4|||
23582085|NCT00823979|65862308|FG000|Overall Study|Other|2|||
23582086|NCT00823979|65862309|FG001|Overall Study|Other|0|||
23782041|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
23782042|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
23636510|NCT00477490|66052927|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
23636511|NCT00477490|66052928|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
23782043|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
23453191|NCT01188772|65403257|FG002|Overall Study|Terminated by Sponsor|1|||
23453192|NCT01188772|65403258|FG003|Overall Study|Terminated by Sponsor|0|||
23453193|NCT01188772|65403255|FG000|Overall Study|Treatment Failure|0|||
23453194|NCT01188772|65403256|FG001|Overall Study|Treatment Failure|0|||
23453195|NCT01188772|65403257|FG002|Overall Study|Treatment Failure|1|||
23453196|NCT01188772|65403258|FG003|Overall Study|Treatment Failure|0|||
23453197|NCT01188772|65403255|FG000|Overall Study|Virologic Failure|1|||
23453198|NCT01188772|65403256|FG001|Overall Study|Virologic Failure|0|||
23453199|NCT01188772|65403257|FG002|Overall Study|Virologic Failure|0|||
23453200|NCT01188772|65403258|FG003|Overall Study|Virologic Failure|0|||
23453201|NCT01188772|65403255|FG000|Overall Study|Withdrawal by Subject|0|||
23453202|NCT01188772|65403256|FG001|Overall Study|Withdrawal by Subject|0|||
23453203|NCT01188772|65403257|FG002|Overall Study|Withdrawal by Subject|2|||
23453204|NCT01188772|65403258|FG003|Overall Study|Withdrawal by Subject|0|||
23453205|NCT01731912|65403269|FG000|Overall Study|noncompliance|2|||
23453206|NCT00985673|65403272|FG000|Overall Study|Lost to Follow-up|6|||
23453207|NCT00985673|65403273|FG001|Overall Study|Lost to Follow-up|7|||
23453208|NCT00985673|65403274|FG002|Overall Study|Lost to Follow-up|6|||
23453209|NCT00985673|65403275|FG003|Overall Study|Lost to Follow-up|10|||
23453210|NCT00985673|65403276|FG004|Overall Study|Lost to Follow-up|5|||
23453211|NCT00985673|65403277|FG005|Overall Study|Lost to Follow-up|3|||
23453212|NCT00985673|65403272|FG000|Overall Study|Withdrawal by Subject|0|||
23782044|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782045|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782046|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782047|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23453213|NCT00985673|65403273|FG001|Overall Study|Withdrawal by Subject|4|||
23453214|NCT00985673|65403274|FG002|Overall Study|Withdrawal by Subject|5|||
23453215|NCT00985673|65403275|FG003|Overall Study|Withdrawal by Subject|2|||
23453216|NCT00985673|65403276|FG004|Overall Study|Withdrawal by Subject|2|||
23453217|NCT00985673|65403277|FG005|Overall Study|Withdrawal by Subject|3|||
23782048|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782049|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782050|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782051|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782052|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782053|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782054|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782055|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782056|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782057|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782058|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
23782059|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
23782060|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782061|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782062|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782063|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23782064|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23453218|NCT00985673|65403272|FG000|Overall Study|Other|1|||
23453219|NCT00985673|65403273|FG001|Overall Study|Other|0|||
23453220|NCT00985673|65403274|FG002|Overall Study|Other|1|||
23582087|NCT00823979|65862310|FG002|Overall Study|Other|1|||
23582088|NCT00823979|65862308|FG000|Overall Study|Randomized but not Treated|4|||
23582089|NCT00823979|65862309|FG001|Overall Study|Randomized but not Treated|3|||
23582090|NCT00823979|65862310|FG002|Overall Study|Randomized but not Treated|1|||
23582091|NCT00823979|65862308|FG000|Overall Study|Study Terminated by Sponsor|5|||
23582092|NCT00823979|65862309|FG001|Overall Study|Study Terminated by Sponsor|5|||
23582093|NCT00823979|65862310|FG002|Overall Study|Study Terminated by Sponsor|7|||
23582094|NCT02824432|65862311|FG000|Overall Study|Major Protocol Deviation|1|||
23582095|NCT02824432|65862312|FG001|Overall Study|Major Protocol Deviation|0|||
23582096|NCT05349864|65862313|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
23582097|NCT05349864|65862314|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
23582098|NCT02908464|65862321|FG000|Overall Study|Withdrawal by Subject|2|||
23582099|NCT02908464|65862322|FG001|Overall Study|Withdrawal by Subject|1|||
23582100|NCT02908464|65862321|FG000|Overall Study|Found ineligible after randomization|0|||
23582101|NCT02908464|65862322|FG001|Overall Study|Found ineligible after randomization|2|||
23582102|NCT00916006|65862323|FG000|Overall Study|Adverse Event|1|||
23582103|NCT00916006|65862324|FG001|Overall Study|Adverse Event|1|||
23582104|NCT00916006|65862323|FG000|Overall Study|Withdrawal by Subject|2|||
23842926|NCT02811861|66805570|FG002|Overall Study|Radiological Disease Progression|174|||
23842927|NCT02811861|66805568|FG000|Overall Study|Clinical Disease Progression|20|||
23842928|NCT02811861|66805569|FG001|Overall Study|Clinical Disease Progression|19|||
23842929|NCT02811861|66805570|FG002|Overall Study|Clinical Disease Progression|22|||
23842930|NCT02811861|66805568|FG000|Overall Study|Adverse Event|63|||
23842931|NCT02811861|66805569|FG001|Overall Study|Adverse Event|60|||
23842932|NCT02811861|66805570|FG002|Overall Study|Adverse Event|41|||
23842933|NCT02811861|66805568|FG000|Overall Study|Lost to Follow-up|0|||
23842934|NCT02811861|66805569|FG001|Overall Study|Lost to Follow-up|0|||
23842935|NCT02811861|66805570|FG002|Overall Study|Lost to Follow-up|1|||
23842936|NCT02811861|66805568|FG000|Overall Study|Subject Choice|29|||
23453221|NCT00985673|65403275|FG003|Overall Study|Other|0|||
23453222|NCT00985673|65403276|FG004|Overall Study|Other|1|||
23453223|NCT00985673|65403277|FG005|Overall Study|Other|0|||
23636512|NCT00477490|66052929|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
23636513|NCT00477490|66052930|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
23453224|NCT02322281|65403300|FG000|Overall Study|Progressive Disease|42|||
23636514|NCT00477490|66052931|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
23782065|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23453225|NCT02322281|65403301|FG001|Overall Study|Progressive Disease|14|||
23636515|NCT00477490|66052932|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
23782066|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782067|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782068|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782069|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782070|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782071|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782072|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782073|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782074|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782075|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782076|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782077|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782078|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782079|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
23782080|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
23782081|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782082|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782083|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782084|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782085|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23782086|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782087|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782088|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782089|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782090|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782091|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782092|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782093|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782094|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782095|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782096|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782097|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782098|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782099|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782100|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
23782101|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
23782102|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782103|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782104|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782105|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782106|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23782107|NCT01597245|66580286|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782108|NCT01597245|66580287|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782109|NCT01597245|66580288|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782110|NCT01597245|66580289|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782111|NCT01597245|66580290|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782112|NCT01597245|66580291|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782113|NCT01597245|66580292|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782114|NCT01597245|66580293|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782115|NCT01597245|66580294|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23842937|NCT02811861|66805569|FG001|Overall Study|Subject Choice|17|||
23842938|NCT02811861|66805570|FG002|Overall Study|Subject Choice|23|||
23842939|NCT02811861|66805568|FG000|Overall Study|Withdrawal by Subject|4|||
23782116|NCT01597245|66580295|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782117|NCT01597245|66580296|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782118|NCT01597245|66580297|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782119|NCT01597245|66580298|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782120|NCT01597245|66580299|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
23782121|NCT01597245|66580300|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782122|NCT01597245|66580301|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782123|NCT01597245|66580302|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782124|NCT01597245|66580303|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782125|NCT01597245|66580304|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782126|NCT01597245|66580305|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782127|NCT01597245|66580306|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23782128|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782129|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782130|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782131|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782132|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782133|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782134|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782135|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782136|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782137|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782138|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782139|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782140|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782141|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782142|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782143|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23782144|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
23782145|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
23782146|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
23782147|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
23782148|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
23782149|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782150|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782151|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782152|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782153|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782154|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782155|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782156|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782157|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782158|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782159|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782160|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782161|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782162|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782163|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23842940|NCT02811861|66805569|FG001|Overall Study|Withdrawal by Subject|4|||
23842941|NCT02811861|66805570|FG002|Overall Study|Withdrawal by Subject|9|||
23842942|NCT02811861|66805568|FG000|Overall Study|Other|4|||
23842943|NCT02811861|66805569|FG001|Overall Study|Other|13|||
23842944|NCT02811861|66805570|FG002|Overall Study|Other|3|||
23842945|NCT02811861|66805568|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
23842946|NCT02811861|66805569|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
23842947|NCT02811861|66805570|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
23842948|NCT02811861|66805568|FG000|Overall Study|Randomized but not treated|2|||
23453226|NCT02322281|65403302|FG002|Overall Study|Progressive Disease|49|||
23842949|NCT02811861|66805569|FG001|Overall Study|Randomized but not treated|3|||
23340805|NCT01083186|64992847|FG000|Overall Study|Administrative Reasons|2|||
23340806|NCT01083186|64992847|FG000|Overall Study|Non-compliance to Study Treatment|1|||
23340807|NCT03155178|64992850|FG000|Overall Study|Did not meet treatment day baseline|7|||
23340808|NCT03155178|64992851|FG001|Overall Study|Did not meet treatment day baseline|7|||
23340809|NCT03155178|64992852|FG002|Overall Study|Did not meet treatment day baseline|7|||
23340810|NCT03155178|64992853|FG003|Overall Study|Did not meet treatment day baseline|7|||
23340811|NCT01194531|64992854|FG000|Overall Study|Withdrawal by Subject|1|||
23340812|NCT01194531|64992855|FG001|Overall Study|Withdrawal by Subject|0|||
23340813|NCT01194531|64992854|FG000|Overall Study|Protocol Violation|4|||
23340814|NCT01194531|64992855|FG001|Overall Study|Protocol Violation|1|||
23340815|NCT01194531|64992854|FG000|Overall Study|Physician Decision|0|||
23340816|NCT01194531|64992855|FG001|Overall Study|Physician Decision|2|||
23340817|NCT03499899|64992856|FG000|Overall Study|Adverse Event|2|||
23340818|NCT03499899|64992857|FG001|Overall Study|Adverse Event|3|||
23340819|NCT03499899|64992858|FG002|Overall Study|Adverse Event|3|||
23636516|NCT00477490|66052933|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
23636517|NCT00477490|66052934|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
23636518|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
23636519|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
23636520|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
23636521|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
23636522|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
23636523|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
23636524|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
23636525|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
23636526|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
23636527|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
23636528|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
23636529|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
23636530|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23636531|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23636532|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23636533|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23636534|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23636535|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
23636536|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23636537|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
23636538|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
23636539|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23636540|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
23636541|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23636542|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
23636543|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23782164|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782165|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23782166|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
23782167|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
23782168|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
23782169|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
23782170|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782171|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782172|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782173|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782174|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782175|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782176|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782177|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782178|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782179|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782180|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782181|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782182|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782183|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782184|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782185|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782186|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
23340820|NCT03499899|64992856|FG000|Overall Study|Death|0|||
23842950|NCT02811861|66805570|FG002|Overall Study|Randomized but not treated|17|||
23842951|NCT02797080|66805573|FG000|Overall Study|Lost to Follow-up|1|||
23842952|NCT02797080|66805573|FG000|Overall Study|Withdrawal by Subject|1|||
23842953|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
23842954|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
23842955|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
23842956|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
23842957|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
23842958|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
23842959|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
23842960|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
23842961|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
23842962|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
23842963|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
23842964|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
23842965|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
23842966|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
23842967|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
23842968|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
23842969|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
23842970|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
23842971|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
23842972|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
23842973|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
23842974|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
23842975|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
23842976|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
23842977|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
23842978|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
23842979|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
23842980|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
23842981|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23842982|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23842983|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
23842984|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
23842985|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
23842986|NCT00839527|66805575|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
23842987|NCT00839527|66805576|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
23842988|NCT00839527|66805577|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
23842989|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23842990|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
23842991|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23842992|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
23842993|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
23842994|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
23842995|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
23842996|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
23842997|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
23842998|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
23582105|NCT00916006|65862324|FG001|Overall Study|Withdrawal by Subject|5|||
23582106|NCT00916006|65862323|FG000|Overall Study|Protocol Violation|0|||
23582107|NCT00916006|65862324|FG001|Overall Study|Protocol Violation|1|||
23582108|NCT01704846|65862325|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23582109|NCT01704846|65862326|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23582110|NCT00946192|65862330|FG000|Overall Study|Lost to Follow-up|6|||
23582111|NCT00946192|65862331|FG001|Overall Study|Lost to Follow-up|11|||
23582112|NCT00946192|65862332|FG002|Overall Study|Lost to Follow-up|9|||
23582113|NCT00946192|65862330|FG000|Overall Study|Withdrawal by Subject|10|||
23582114|NCT00946192|65862331|FG001|Overall Study|Withdrawal by Subject|7|||
23842999|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
23843000|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
23843001|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
23582115|NCT00946192|65862332|FG002|Overall Study|Withdrawal by Subject|3|||
23582116|NCT00946192|65862330|FG000|Overall Study|Did not start medication|2|||
23582117|NCT00946192|65862331|FG001|Overall Study|Did not start medication|0|||
23582118|NCT00946192|65862332|FG002|Overall Study|Did not start medication|0|||
23582119|NCT02028884|65862333|FG000|Double-blind Period|Adverse Event|5|||
23582120|NCT02028884|65862334|FG001|Double-blind Period|Adverse Event|3|||
23582121|NCT02028884|65862335|FG002|Double-blind Period|Adverse Event|0|||
23843002|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
23843003|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23843004|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
23340821|NCT03499899|64992857|FG001|Overall Study|Death|0|||
23340822|NCT03499899|64992858|FG002|Overall Study|Death|1|||
23340823|NCT03499899|64992856|FG000|Overall Study|Physician Decision|3|||
23340824|NCT03499899|64992857|FG001|Overall Study|Physician Decision|6|||
23340825|NCT03499899|64992858|FG002|Overall Study|Physician Decision|6|||
23340826|NCT03499899|64992856|FG000|Overall Study|Progressive disease|15|||
23843005|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
23843006|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
23843007|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
23843008|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
23843009|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
23453227|NCT02322281|65403300|FG000|Overall Study|Adverse Event|3|||
23453228|NCT02322281|65403301|FG001|Overall Study|Adverse Event|4|||
23453229|NCT02322281|65403302|FG002|Overall Study|Adverse Event|6|||
23453230|NCT02322281|65403300|FG000|Overall Study|Death|3|||
23453231|NCT02322281|65403301|FG001|Overall Study|Death|3|||
23453232|NCT02322281|65403302|FG002|Overall Study|Death|3|||
23453233|NCT02322281|65403300|FG000|Overall Study|Withdrawal by Subject|1|||
23453234|NCT02322281|65403301|FG001|Overall Study|Withdrawal by Subject|1|||
23453235|NCT02322281|65403302|FG002|Overall Study|Withdrawal by Subject|6|||
23453236|NCT02322281|65403300|FG000|Overall Study|Physician Decision|2|||
23453237|NCT02322281|65403301|FG001|Overall Study|Physician Decision|0|||
23453238|NCT02322281|65403302|FG002|Overall Study|Physician Decision|5|||
23453239|NCT02322281|65403300|FG000|Overall Study|Study Terminated by Sponsor|2|||
23453240|NCT02322281|65403301|FG001|Overall Study|Study Terminated by Sponsor|0|||
23453241|NCT02322281|65403302|FG002|Overall Study|Study Terminated by Sponsor|0|||
23453242|NCT02322281|65403300|FG000|Overall Study|Missing|0|||
23453243|NCT02322281|65403301|FG001|Overall Study|Missing|0|||
23453244|NCT02322281|65403302|FG002|Overall Study|Missing|1|||
23453245|NCT02322281|65403300|FG000|Overall Study|Miscellaneous|0|||
23453246|NCT02322281|65403301|FG001|Overall Study|Miscellaneous|0|||
23453247|NCT02322281|65403302|FG002|Overall Study|Miscellaneous|4|||
23453248|NCT01428258|65403308|FG000|Intervention 1|Withdrawal by Subject|2|||
23453249|NCT01428258|65403309|FG001|Intervention 1|Withdrawal by Subject|0|||
23453250|NCT00979901|65403310|FG000|Overall Study|Adverse Event|1|||
23453251|NCT00979901|65403311|FG001|Overall Study|Adverse Event|3|||
23453252|NCT00979901|65403312|FG002|Overall Study|Adverse Event|9|||
23453253|NCT00979901|65403313|FG003|Overall Study|Adverse Event|2|||
23453254|NCT00979901|65403310|FG000|Overall Study|Lack of Efficacy|8|||
23453255|NCT00979901|65403311|FG001|Overall Study|Lack of Efficacy|4|||
23453256|NCT00979901|65403312|FG002|Overall Study|Lack of Efficacy|9|||
23453257|NCT00979901|65403313|FG003|Overall Study|Lack of Efficacy|0|||
23453258|NCT00979901|65403310|FG000|Overall Study|Lost to Follow-up|1|||
23453259|NCT00979901|65403311|FG001|Overall Study|Lost to Follow-up|1|||
23453260|NCT00979901|65403312|FG002|Overall Study|Lost to Follow-up|2|||
23453261|NCT00979901|65403313|FG003|Overall Study|Lost to Follow-up|0|||
23453262|NCT00979901|65403310|FG000|Overall Study|Protocol Violation|2|||
23453263|NCT00979901|65403311|FG001|Overall Study|Protocol Violation|2|||
23453264|NCT00979901|65403312|FG002|Overall Study|Protocol Violation|7|||
23453265|NCT00979901|65403313|FG003|Overall Study|Protocol Violation|1|||
23843010|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
23843011|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
23843012|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
23843013|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
23843014|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
23453266|NCT00979901|65403310|FG000|Overall Study|Withdrawal by Subject|2|||
23453267|NCT00979901|65403311|FG001|Overall Study|Withdrawal by Subject|1|||
23340827|NCT03499899|64992857|FG001|Overall Study|Progressive disease|23|||
23340828|NCT03499899|64992858|FG002|Overall Study|Progressive disease|23|||
23340829|NCT03499899|64992856|FG000|Overall Study|Patient decision|0|||
23453268|NCT00979901|65403312|FG002|Overall Study|Withdrawal by Subject|1|||
23453269|NCT00979901|65403313|FG003|Overall Study|Withdrawal by Subject|1|||
23453270|NCT00979901|65403310|FG000|Overall Study|Noncompliance|1|||
23453271|NCT00979901|65403311|FG001|Overall Study|Noncompliance|0|||
23453272|NCT00979901|65403312|FG002|Overall Study|Noncompliance|0|||
23340830|NCT03499899|64992857|FG001|Overall Study|Patient decision|1|||
23453273|NCT00979901|65403313|FG003|Overall Study|Noncompliance|0|||
23453274|NCT00979901|65403310|FG000|Overall Study|out-of-state|1|||
23453275|NCT00979901|65403311|FG001|Overall Study|out-of-state|0|||
23453276|NCT00979901|65403312|FG002|Overall Study|out-of-state|0|||
23453277|NCT00979901|65403313|FG003|Overall Study|out-of-state|0|||
23453278|NCT00979901|65403310|FG000|Overall Study|vacation|1|||
23453279|NCT00979901|65403311|FG001|Overall Study|vacation|0|||
23453280|NCT00979901|65403312|FG002|Overall Study|vacation|0|||
23340831|NCT03499899|64992858|FG002|Overall Study|Patient decision|1|||
23340832|NCT03499899|64992856|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
23340833|NCT03499899|64992857|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
23340834|NCT03499899|64992858|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
23843015|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
23843016|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
23843017|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
23843018|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
23843019|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
23843020|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
23843021|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
23843022|NCT00839527|66805575|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
23843023|NCT00839527|66805576|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
23843024|NCT00839527|66805577|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
23843025|NCT01322490|66805578|FG000|Treatment Period|Adverse Event|12|||
23843026|NCT01322490|66805579|FG001|Treatment Period|Adverse Event|18|||
23843027|NCT01322490|66805580|FG002|Treatment Period|Adverse Event|15|||
23843028|NCT01322490|66805578|FG000|Treatment Period|Death|5|||
23843029|NCT01322490|66805579|FG001|Treatment Period|Death|7|||
23843030|NCT01322490|66805580|FG002|Treatment Period|Death|3|||
23843031|NCT01322490|66805578|FG000|Treatment Period|Lack of Efficacy|89|||
23843032|NCT01322490|66805579|FG001|Treatment Period|Lack of Efficacy|100|||
23843033|NCT01322490|66805580|FG002|Treatment Period|Lack of Efficacy|112|||
23340835|NCT04114357|64992865|FG000|Baseline-Randomization|Adverse Event|2|||
23340836|NCT04114357|64992866|FG001|Baseline-Randomization|Adverse Event|1|||
23453281|NCT00979901|65403313|FG003|Overall Study|vacation|0|||
23453282|NCT00979901|65403310|FG000|Overall Study|elevated lab values pre-randomization|1|||
23582122|NCT02028884|65862333|FG000|Double-blind Period|Eligibility Violation|1|||
23843034|NCT01322490|66805578|FG000|Treatment Period|Physician Decision|0|||
23843035|NCT01322490|66805579|FG001|Treatment Period|Physician Decision|2|||
23843036|NCT01322490|66805580|FG002|Treatment Period|Physician Decision|1|||
23843037|NCT01322490|66805578|FG000|Treatment Period|Protocol Violation|7|||
23843038|NCT01322490|66805579|FG001|Treatment Period|Protocol Violation|5|||
23843039|NCT01322490|66805580|FG002|Treatment Period|Protocol Violation|4|||
23843040|NCT01322490|66805578|FG000|Treatment Period|Withdrawal by Subject|14|||
23843041|NCT01322490|66805579|FG001|Treatment Period|Withdrawal by Subject|16|||
23843042|NCT01322490|66805580|FG002|Treatment Period|Withdrawal by Subject|11|||
23843043|NCT01322490|66805578|FG000|Treatment Period|Non-compliance with study drug|0|||
23843044|NCT01322490|66805579|FG001|Treatment Period|Non-compliance with study drug|0|||
23843045|NCT01322490|66805580|FG002|Treatment Period|Non-compliance with study drug|1|||
23843046|NCT01322490|66805578|FG000|Treatment Period|Other per report|2|||
23843047|NCT01322490|66805579|FG001|Treatment Period|Other per report|2|||
23843048|NCT01322490|66805580|FG002|Treatment Period|Other per report|1|||
23843049|NCT01322490|66805578|FG000|Treatment Period|Randomized but Not Treated|3|||
23843050|NCT01322490|66805579|FG001|Treatment Period|Randomized but Not Treated|3|||
23843051|NCT01322490|66805580|FG002|Treatment Period|Randomized but Not Treated|5|||
23843052|NCT01322490|66805578|FG000|Long Term Follow-up Period|Death|235|||
23843053|NCT01322490|66805579|FG001|Long Term Follow-up Period|Death|239|||
23843054|NCT01322490|66805580|FG002|Long Term Follow-up Period|Death|236|||
23843055|NCT01322490|66805578|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
23843056|NCT01322490|66805579|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
23843057|NCT01322490|66805580|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
23843058|NCT01322490|66805578|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
23843059|NCT01322490|66805579|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
23340837|NCT04114357|64992865|FG000|Baseline-Randomization|Lost to Follow-up|1|||
23340838|NCT04114357|64992866|FG001|Baseline-Randomization|Lost to Follow-up|1|||
23453283|NCT00979901|65403311|FG001|Overall Study|elevated lab values pre-randomization|0|||
23582123|NCT02028884|65862334|FG001|Double-blind Period|Eligibility Violation|0|||
23782187|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782188|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23782189|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
23782190|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
23782191|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782192|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782193|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782194|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782195|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782196|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23843060|NCT01322490|66805580|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
23843061|NCT01322490|66805578|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
23453284|NCT00979901|65403312|FG002|Overall Study|elevated lab values pre-randomization|0|||
23453285|NCT00979901|65403313|FG003|Overall Study|elevated lab values pre-randomization|0|||
23453286|NCT00979901|65403310|FG000|Overall Study|Discontinued in Error|0|||
23453287|NCT00979901|65403311|FG001|Overall Study|Discontinued in Error|1|||
23453288|NCT00979901|65403312|FG002|Overall Study|Discontinued in Error|0|||
23453289|NCT00979901|65403313|FG003|Overall Study|Discontinued in Error|0|||
23453290|NCT00979901|65403310|FG000|Overall Study|Left Country|0|||
23453291|NCT00979901|65403311|FG001|Overall Study|Left Country|0|||
23453292|NCT00979901|65403312|FG002|Overall Study|Left Country|1|||
23453293|NCT00979901|65403313|FG003|Overall Study|Left Country|0|||
23453294|NCT00979901|65403310|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453295|NCT00979901|65403311|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453296|NCT00979901|65403312|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453297|NCT00979901|65403313|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
23453298|NCT04906499|65403316|FG000|Overall Study|Lack of time|1|||
23453299|NCT01517750|65403320|FG000|Overall Study|Lost to Follow-up|1|||
23453300|NCT01517750|65403321|FG001|Overall Study|Lost to Follow-up|2|||
23453301|NCT01517750|65403322|FG002|Overall Study|Lost to Follow-up|4|||
23453302|NCT01517750|65403323|FG003|Overall Study|Lost to Follow-up|1|||
23453303|NCT01308736|65403324|FG000|Overall Study|Did not attend a single session|6|||
23453304|NCT01308736|65403325|FG001|Overall Study|Did not attend a single session|5|||
23453305|NCT02525471|65403326|FG000|Overall Study|Screen Failure|6|||
23453306|NCT02525471|65403326|FG000|Overall Study|Withdrawal by Subject|4|||
23453307|NCT02525471|65403326|FG000|Overall Study|Death|1|||
23453308|NCT02366195|65403327|FG000|Overall Study|Protocol-specified criteria|3|||
23453309|NCT02366195|65403327|FG000|Overall Study|Withdrawal by Subject|9|||
23453310|NCT02366195|65403327|FG000|Overall Study|Lost to Follow-up|1|||
23453311|NCT02366195|65403327|FG000|Overall Study|Death|41|||
23453312|NCT03935126|65403330|FG000|Overall Study|Study termination by sponsor|3|||
23453313|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453314|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453315|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453316|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453317|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453318|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453319|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453320|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453321|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453322|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453323|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453324|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453325|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453326|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453327|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453328|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453329|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453330|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453331|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453332|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
23453333|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453334|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
23453335|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
23453336|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453337|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453338|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453339|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453340|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453341|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453342|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
23453343|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
23453344|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
23453345|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
23636544|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23453346|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
23453347|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
23453348|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
23453349|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
23453350|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
23453351|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
23582124|NCT02028884|65862335|FG002|Double-blind Period|Eligibility Violation|0|||
23582125|NCT02028884|65862333|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
23453352|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
23453353|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
23453354|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
23453355|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
23453356|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
23453357|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
23453358|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453359|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453360|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23636545|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23636546|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23340839|NCT04114357|64992865|FG000|Cross-over|Adverse Event|0|||
23340840|NCT04114357|64992866|FG001|Cross-over|Adverse Event|1|||
23340841|NCT01936181|64992870|FG000|Randomised, Double-blind|Adverse Event|27|||
23340842|NCT01936181|64992871|FG001|Randomised, Double-blind|Adverse Event|21|||
23340843|NCT01936181|64992872|FG002|Randomised, Double-blind|Adverse Event|0|||
23453361|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453362|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453363|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453364|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453365|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453366|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453367|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453368|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453369|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453370|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453371|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453372|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453373|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453374|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453375|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453376|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453377|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453378|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453379|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453380|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453381|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453382|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453383|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453384|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453385|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453386|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453387|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453388|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453389|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453390|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453391|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
23453392|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453393|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453394|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453395|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453396|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453397|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453398|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
23453399|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453400|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453401|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453402|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23636547|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23340844|NCT01936181|64992873|FG003|Randomised, Double-blind|Adverse Event|0|||
23340845|NCT01936181|64992870|FG000|Randomised, Double-blind|Protocol Violation|1|||
23340846|NCT01936181|64992871|FG001|Randomised, Double-blind|Protocol Violation|5|||
23340847|NCT01936181|64992872|FG002|Randomised, Double-blind|Protocol Violation|0|||
23453403|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453404|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23636548|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23340848|NCT01936181|64992873|FG003|Randomised, Double-blind|Protocol Violation|0|||
23453405|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453406|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453407|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23636549|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23636550|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23782197|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782198|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23636551|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23636552|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23636553|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23636554|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636555|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
23636556|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636557|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636558|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636559|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636560|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636561|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636562|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23636563|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
23636564|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
23636565|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
23636566|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
23636567|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
23636568|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23636569|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23636570|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
23636571|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23636572|NCT00477490|66052926|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636573|NCT00477490|66052927|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
23636574|NCT00477490|66052928|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
23636575|NCT00477490|66052929|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636576|NCT00477490|66052930|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
23636577|NCT00477490|66052931|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636578|NCT00477490|66052932|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636579|NCT00477490|66052933|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636580|NCT00477490|66052934|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23636581|NCT01255631|66052935|FG000|Overall Study|poor enrollment, no data analyzed|9|||
23636582|NCT01255631|66052936|FG001|Overall Study|poor enrollment, no data analyzed|6|||
23636583|NCT04531904|66052937|FG000|Overall Study|Lost to Follow-up|1|||
23636584|NCT04531904|66052937|FG000|Overall Study|Death|14|||
23636585|NCT01607879|66052938|FG000|Overall Study|Death|1|||
23636586|NCT01607879|66052939|FG001|Overall Study|Death|0|||
23636587|NCT01251770|66052940|FG000|Overall Study|Protocol Violation|13|||
23636588|NCT01251770|66052941|FG001|Overall Study|Protocol Violation|7|||
23453408|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453409|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453410|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453411|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453412|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453413|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453414|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23782199|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782200|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782201|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782202|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782203|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782204|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782205|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782206|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782207|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782208|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23782209|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
23782210|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
23636589|NCT02145468|66052942|FG000|Overall Study|Withdrawal by Subject|5|||
23636590|NCT02145468|66052943|FG001|Overall Study|Withdrawal by Subject|8|||
23636591|NCT01498887|66052944|FG000|Overall Study|Administrative problems|1|||
23636592|NCT01498887|66052945|FG001|Overall Study|Administrative problems|0|||
23636593|NCT01498887|66052944|FG000|Overall Study|Lost to Follow-up|1|||
23636594|NCT01498887|66052945|FG001|Overall Study|Lost to Follow-up|1|||
23636595|NCT01498887|66052944|FG000|Overall Study|Withdrawal by Subject|1|||
23636596|NCT01498887|66052945|FG001|Overall Study|Withdrawal by Subject|0|||
23782211|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
23782212|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782213|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782214|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782215|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782216|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23843062|NCT01322490|66805579|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
23843063|NCT01322490|66805580|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
23843064|NCT01322490|66805578|FG000|Long Term Follow-up Period|Other per report|3|||
23843065|NCT01322490|66805579|FG001|Long Term Follow-up Period|Other per report|2|||
23843066|NCT01322490|66805580|FG002|Long Term Follow-up Period|Other per report|2|||
23843067|NCT01322490|66805578|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
23843068|NCT01322490|66805579|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
23843069|NCT01322490|66805580|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
23843070|NCT01738503|66805581|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
23843071|NCT01738503|66805582|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
23843072|NCT01738503|66805583|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
23843073|NCT01738503|66805584|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
23843074|NCT01738503|66805585|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
23843075|NCT01738503|66805586|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
23843076|NCT01738503|66805587|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
23782217|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782218|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782219|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782220|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782221|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782222|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782223|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782224|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782225|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782226|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782227|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782228|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
23782229|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782230|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23782231|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
23782232|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
23782233|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782234|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782235|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782236|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782237|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23782238|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23843077|NCT01738503|66805581|FG000|Treatment Period|Adverse Event|0|||
23843078|NCT01738503|66805582|FG001|Treatment Period|Adverse Event|1|||
23843079|NCT01738503|66805583|FG002|Treatment Period|Adverse Event|0|||
23843080|NCT01738503|66805584|FG003|Treatment Period|Adverse Event|1|||
23843081|NCT01738503|66805585|FG004|Treatment Period|Adverse Event|2|||
23843082|NCT01738503|66805586|FG005|Treatment Period|Adverse Event|2|||
23843083|NCT01738503|66805587|FG006|Treatment Period|Adverse Event|2|||
23843084|NCT01738503|66805581|FG000|Treatment Period|Lost to Follow-up|0|||
23843085|NCT01738503|66805582|FG001|Treatment Period|Lost to Follow-up|0|||
23843086|NCT01738503|66805583|FG002|Treatment Period|Lost to Follow-up|3|||
23843087|NCT01738503|66805584|FG003|Treatment Period|Lost to Follow-up|4|||
23843088|NCT01738503|66805585|FG004|Treatment Period|Lost to Follow-up|1|||
23843089|NCT01738503|66805586|FG005|Treatment Period|Lost to Follow-up|1|||
23843090|NCT01738503|66805587|FG006|Treatment Period|Lost to Follow-up|5|||
23636597|NCT01498887|66052944|FG000|Overall Study|Protocol Violation|1|||
23636598|NCT01498887|66052945|FG001|Overall Study|Protocol Violation|3|||
23636599|NCT01498887|66052944|FG000|Overall Study|Lack of Efficacy|5|||
23782296|NCT01597245|66580286|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782297|NCT01597245|66580287|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782298|NCT01597245|66580288|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782299|NCT01597245|66580289|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782300|NCT01597245|66580290|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782301|NCT01597245|66580291|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782302|NCT01597245|66580292|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782303|NCT01597245|66580293|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782304|NCT01597245|66580294|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782305|NCT01597245|66580295|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782306|NCT01597245|66580296|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782307|NCT01597245|66580297|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782308|NCT01597245|66580298|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782309|NCT01597245|66580299|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782310|NCT01597245|66580300|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782311|NCT01597245|66580301|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782312|NCT01597245|66580302|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782313|NCT01597245|66580303|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782314|NCT01597245|66580304|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782315|NCT01597245|66580305|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
23782316|NCT01597245|66580306|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23782317|NCT03804983|66580307|FG000|Overall Study|Adverse Event|0|||
23782318|NCT03804983|66580308|FG001|Overall Study|Adverse Event|1|||
23782319|NCT03804983|66580307|FG000|Overall Study|Family Obligation|1|||
23782320|NCT03804983|66580308|FG001|Overall Study|Family Obligation|0|||
23782321|NCT02128997|66580309|FG000|Overall Study|Lost to Follow-up|6|||
23782322|NCT02128997|66580310|FG001|Overall Study|Lost to Follow-up|11|||
23782323|NCT02647944|66580312|FG000|Overall Study|Withdrawal by Subject|0|||
23782324|NCT02647944|66580313|FG001|Overall Study|Withdrawal by Subject|3|||
23782325|NCT02647944|66580312|FG000|Overall Study|Adverse Event|2|||
23782326|NCT02647944|66580313|FG001|Overall Study|Adverse Event|0|||
23453646|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453647|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453648|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
23453649|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
23453650|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
23453651|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
23453652|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453653|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453654|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453655|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453656|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453657|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453658|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
23453659|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453660|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
23453661|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
23453662|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453663|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453664|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453665|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453666|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453667|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453668|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
23453669|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453670|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
23453671|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453672|NCT00473434|65403372|FG000|Overall Study|Physician Decision|3|||
23453673|NCT00473434|65403372|FG000|Overall Study|Withdrawal by Subject|9|||
23453674|NCT00473434|65403372|FG000|Overall Study|Compliance|3|||
23453675|NCT00473434|65403372|FG000|Overall Study|Lack of Efficacy|3|||
23453676|NCT00473434|65403372|FG000|Overall Study|Adverse Event|3|||
23453677|NCT00473434|65403372|FG000|Overall Study|Patient was selling medication to others|1|||
23782327|NCT02659150|66580314|FG000|Subject Enrollment|Physician Decision|3|||
23782328|NCT02659150|66580314|FG000|Subject Enrollment|Withdrawal by Subject|2|||
23782329|NCT02659150|66580314|FG000|Baseline Imaging|Withdrawal by Subject|1|||
23453678|NCT00473434|65403372|FG000|Overall Study|Safety evaluation|1|||
23453679|NCT00473434|65403372|FG000|Overall Study|Reason not specified|6|||
23782330|NCT02659150|66580314|FG000|Baseline Imaging|Physician Decision|1|||
23782331|NCT02659150|66580314|FG000|Study Drug Dosing|Adverse Event|1|||
23782332|NCT05652140|66580315|FG000|Overall Study|Lost to Follow-up|7|||
23340871|NCT01936181|64992872|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
23782333|NCT05652140|66580316|FG001|Overall Study|Lost to Follow-up|16|||
23782334|NCT05652140|66580317|FG002|Overall Study|Lost to Follow-up|22|||
23782335|NCT05652140|66580318|FG003|Overall Study|Lost to Follow-up|31|||
23782336|NCT00436163|66580319|FG000|Overall Study|Lost to Follow-up|2|||
23782337|NCT00436163|66580319|FG000|Overall Study|Adverse Event|1|||
23340872|NCT01936181|64992873|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
23340873|NCT01936181|64992870|FG000|Transition-extension|Adverse Event|3|||
23453680|NCT00473434|65403372|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
23453681|NCT00473434|65403372|FG000|Overall Study|Switching to trial medication|1|||
23453682|NCT00473434|65403372|FG000|Overall Study|No longer required|1|||
23453683|NCT00265564|65403373|FG000|Overall Study|Lost to Follow-up|5|||
23453684|NCT00265564|65403374|FG001|Overall Study|Lost to Follow-up|7|||
23453685|NCT00265564|65403373|FG000|Overall Study|met exclusion criteria|5|||
23453686|NCT00265564|65403374|FG001|Overall Study|met exclusion criteria|2|||
23453687|NCT00982735|65403375|FG000|Overall Study|Lost to Follow-up|6|||
23453688|NCT00982735|65403375|FG000|Overall Study|Patient ineligible for trial|224|||
23453689|NCT03489863|65403376|FG000|Overall Study|Withdrawal by Subject|0|||
23453690|NCT03489863|65403377|FG001|Overall Study|Withdrawal by Subject|1|||
23453691|NCT00216671|65403381|FG000|Overall Study|Adverse Event|4|||
23453692|NCT00216671|65403382|FG001|Overall Study|Adverse Event|9|||
23453693|NCT00216671|65403381|FG000|Overall Study|Pregnancy|0|||
23340874|NCT01936181|64992871|FG001|Transition-extension|Adverse Event|0|||
23340875|NCT01936181|64992872|FG002|Transition-extension|Adverse Event|3|||
23340876|NCT01936181|64992873|FG003|Transition-extension|Adverse Event|1|||
23340877|NCT01936181|64992870|FG000|Transition-extension|Lost to Follow-up|3|||
23340878|NCT01936181|64992871|FG001|Transition-extension|Lost to Follow-up|0|||
23340879|NCT01936181|64992872|FG002|Transition-extension|Lost to Follow-up|1|||
23340880|NCT01936181|64992873|FG003|Transition-extension|Lost to Follow-up|2|||
23340881|NCT01936181|64992870|FG000|Transition-extension|Physician Decision|2|||
23340882|NCT01936181|64992871|FG001|Transition-extension|Physician Decision|0|||
23340883|NCT01936181|64992872|FG002|Transition-extension|Physician Decision|0|||
23340884|NCT01936181|64992873|FG003|Transition-extension|Physician Decision|1|||
23340885|NCT01936181|64992870|FG000|Transition-extension|Withdrawal by Subject|7|||
23340886|NCT01936181|64992871|FG001|Transition-extension|Withdrawal by Subject|0|||
23340887|NCT01936181|64992872|FG002|Transition-extension|Withdrawal by Subject|2|||
23340888|NCT01936181|64992873|FG003|Transition-extension|Withdrawal by Subject|1|||
23340889|NCT00519428|64992875|FG000|Overall Study|Adverse Event|5|||
23340890|NCT00519428|64992876|FG001|Overall Study|Adverse Event|2|||
23340891|NCT00519428|64992877|FG002|Overall Study|Adverse Event|10|||
23340892|NCT00519428|64992875|FG000|Overall Study|Lost to Follow-up|7|||
23340893|NCT00519428|64992876|FG001|Overall Study|Lost to Follow-up|7|||
23340894|NCT00519428|64992877|FG002|Overall Study|Lost to Follow-up|6|||
23340895|NCT00519428|64992875|FG000|Overall Study|Withdrawal by Subject|8|||
23340896|NCT00519428|64992876|FG001|Overall Study|Withdrawal by Subject|3|||
23340897|NCT00519428|64992877|FG002|Overall Study|Withdrawal by Subject|7|||
23340898|NCT00519428|64992875|FG000|Overall Study|unstated|1|||
23340899|NCT00519428|64992876|FG001|Overall Study|unstated|3|||
23340900|NCT00519428|64992877|FG002|Overall Study|unstated|2|||
23340901|NCT02163226|64992878|FG000|Overall Study|Death|2|||
23340902|NCT02163226|64992879|FG001|Overall Study|Death|1|||
23340903|NCT02163226|64992878|FG000|Overall Study|Withdrawal by Subject|5|||
23340904|NCT02163226|64992879|FG001|Overall Study|Withdrawal by Subject|2|||
23340905|NCT02163226|64992878|FG000|Overall Study|Returned home, local radiotherapy|3|||
23340906|NCT02163226|64992879|FG001|Overall Study|Returned home, local radiotherapy|0|||
23340907|NCT02163226|64992878|FG000|Overall Study|Repeat imaging showed no disease|2|||
23340908|NCT02163226|64992879|FG001|Overall Study|Repeat imaging showed no disease|0|||
23340909|NCT02163226|64992878|FG000|Overall Study|Incomplete radiotherapy|3|||
23340910|NCT02163226|64992879|FG001|Overall Study|Incomplete radiotherapy|0|||
23340911|NCT02163226|64992878|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
23340912|NCT02163226|64992879|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
23340913|NCT02163226|64992878|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
23340914|NCT02163226|64992879|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
23340915|NCT02163226|64992878|FG000|Overall Study|ineligible|0|||
23340916|NCT02163226|64992879|FG001|Overall Study|ineligible|3|||
23453694|NCT00216671|65403382|FG001|Overall Study|Pregnancy|1|||
23340917|NCT02394340|64992880|FG000|Overall Study|Failed drug screen test|1|||
23340918|NCT02394340|64992880|FG000|Overall Study|Adverse Event|1|||
23340919|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
23340920|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
23453695|NCT00216671|65403381|FG000|Overall Study|Withdrawal by Subject|4|||
23453696|NCT00216671|65403382|FG001|Overall Study|Withdrawal by Subject|2|||
23782338|NCT01882647|66580324|FG000|Overall Study|Lost to Follow-up|2|||
23782339|NCT01882647|66580325|FG001|Overall Study|Lost to Follow-up|2|||
23782340|NCT01882647|66580324|FG000|Overall Study|Withdrawal by Subject|0|||
23782341|NCT01882647|66580325|FG001|Overall Study|Withdrawal by Subject|4|||
23782342|NCT00834522|66580326|FG000|Washout|Adverse Event|1|||
23782343|NCT00834522|66580327|FG001|Washout|Adverse Event|0|||
23782344|NCT00834522|66580326|FG000|Washout|Withdrawal by Subject|2|||
23782345|NCT00834522|66580327|FG001|Washout|Withdrawal by Subject|1|||
23782346|NCT01190865|66580328|FG000|Overall Study|Withdrawal by Subject|1|||
23340921|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
23782347|NCT01190865|66580328|FG000|Overall Study|Non-compliance|2|||
23782348|NCT00610363|66580329|FG000|Overall Study|Non-compliance with protocol|0|||
23782349|NCT00610363|66580330|FG001|Overall Study|Non-compliance with protocol|1|||
23782350|NCT00610363|66580329|FG000|Overall Study|Adverse Event|3|||
23782351|NCT00610363|66580330|FG001|Overall Study|Adverse Event|1|||
23782352|NCT00610363|66580329|FG000|Overall Study|Lack of Efficacy|2|||
23782353|NCT00610363|66580330|FG001|Overall Study|Lack of Efficacy|0|||
23782354|NCT00610363|66580329|FG000|Overall Study|Lost to Follow-up|4|||
23340922|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
23453697|NCT00216671|65403381|FG000|Overall Study|Refused Injections|3|||
23453698|NCT00216671|65403382|FG001|Overall Study|Refused Injections|13|||
23582247|NCT00567879|65862414|FG004|Overall Study|Abnormal test procedure(s)|0|||
23582248|NCT00567879|65862415|FG005|Overall Study|Abnormal test procedure(s)|0|||
23782355|NCT00610363|66580330|FG001|Overall Study|Lost to Follow-up|0|||
23782356|NCT00610363|66580329|FG000|Overall Study|Withdrawal by Subject|1|||
23782357|NCT00610363|66580330|FG001|Overall Study|Withdrawal by Subject|0|||
23782358|NCT00610363|66580329|FG000|Overall Study|Other than specified above|1|||
23782359|NCT00610363|66580330|FG001|Overall Study|Other than specified above|1|||
23782360|NCT05214560|66580331|FG000|Overall Study|Screening Failure|1|||
23782361|NCT05214560|66580331|FG000|Overall Study|Physician Decision|4|||
23782362|NCT05214560|66580331|FG000|Overall Study|Withdrawal by Subject|1|||
23782363|NCT05214560|66580331|FG000|Overall Study|Lost to Follow-up|2|||
23782364|NCT05214560|66580331|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
23782365|NCT05214560|66580331|FG000|Overall Study|Study physician not available for the anesthesia|3|||
23782366|NCT05214560|66580331|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
23782367|NCT05214560|66580331|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
23782368|NCT05214560|66580331|FG000|Overall Study|Surgery not performed|3|||
23782369|NCT04123548|66580333|FG000|Overall Study|Withdrawal by Subject|1|||
23782370|NCT04123548|66580333|FG000|Overall Study|Lost to Follow-up|8|||
23782371|NCT04123548|66580333|FG000|Overall Study|Death|4|||
23782372|NCT04123548|66580333|FG000|Overall Study|Reason Not Specified|1|||
23782373|NCT00934050|66580334|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
23782374|NCT00934050|66580335|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23782375|NCT00934050|66580336|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23782376|NCT00934050|66580337|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
23782377|NCT00934050|66580338|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23782378|NCT00934050|66580339|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23782379|NCT00934050|66580334|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
23340923|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
23340924|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
23340925|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
23340926|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
23340927|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
23340928|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
23340929|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
23340930|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
23340931|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
23782380|NCT00934050|66580335|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
23782381|NCT00934050|66580336|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
23782382|NCT00934050|66580337|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
23782383|NCT00934050|66580338|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
23782384|NCT00934050|66580339|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
23782385|NCT00934050|66580334|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23782386|NCT00934050|66580335|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23340932|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
23582249|NCT00567879|65862410|FG000|Overall Study|Withdrawal by Subject|0|||
23582250|NCT00567879|65862411|FG001|Overall Study|Withdrawal by Subject|0|||
23582251|NCT00567879|65862412|FG002|Overall Study|Withdrawal by Subject|3|||
23582252|NCT00567879|65862413|FG003|Overall Study|Withdrawal by Subject|1|||
23582253|NCT00567879|65862414|FG004|Overall Study|Withdrawal by Subject|0|||
23582254|NCT00567879|65862415|FG005|Overall Study|Withdrawal by Subject|0|||
23782387|NCT00934050|66580336|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
23782388|NCT00934050|66580337|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23782389|NCT00934050|66580338|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23782390|NCT00934050|66580339|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23782391|NCT00934050|66580334|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
23782392|NCT00934050|66580335|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
23782393|NCT00934050|66580336|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
23782394|NCT00934050|66580337|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
23782395|NCT00934050|66580338|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
23782396|NCT00934050|66580339|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
23782397|NCT00934050|66580334|FG000|Enrolled After 15 Dec 2009|Death|0|||
23782398|NCT00934050|66580335|FG001|Enrolled After 15 Dec 2009|Death|0|||
23782399|NCT00934050|66580336|FG002|Enrolled After 15 Dec 2009|Death|0|||
23782400|NCT00934050|66580337|FG003|Enrolled After 15 Dec 2009|Death|0|||
23782401|NCT00934050|66580338|FG004|Enrolled After 15 Dec 2009|Death|0|||
23782402|NCT00934050|66580339|FG005|Enrolled After 15 Dec 2009|Death|1|||
23782403|NCT00934050|66580334|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23782404|NCT00934050|66580335|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23782405|NCT00934050|66580336|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23782406|NCT00934050|66580337|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23782407|NCT00934050|66580338|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23782408|NCT00934050|66580339|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
23782409|NCT00934050|66580334|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23782410|NCT00934050|66580335|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23782411|NCT00934050|66580336|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23782412|NCT00934050|66580337|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23782413|NCT00934050|66580338|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
23782414|NCT00934050|66580339|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
23782415|NCT01139047|66580340|FG000|Overall Study|Withdrawal by Subject|1|||
23782416|NCT02714062|66580341|FG000|Overall Study|Adverse Event|0|||
23782417|NCT02714062|66580342|FG001|Overall Study|Adverse Event|0|||
23782418|NCT02714062|66580343|FG002|Overall Study|Adverse Event|2|||
23782419|NCT02714062|66580341|FG000|Overall Study|Withdrawal by Subject|1|||
23782420|NCT02714062|66580342|FG001|Overall Study|Withdrawal by Subject|0|||
23782421|NCT02714062|66580343|FG002|Overall Study|Withdrawal by Subject|1|||
23782422|NCT02714062|66580341|FG000|Overall Study|Protocol Violation|0|||
23782423|NCT02714062|66580342|FG001|Overall Study|Protocol Violation|1|||
23782424|NCT02714062|66580343|FG002|Overall Study|Protocol Violation|0|||
23782425|NCT01370317|66580344|FG000|Overall Study|Participant withdrew consent|1|||
23782426|NCT01370317|66580345|FG001|Overall Study|Participant withdrew consent|0|||
23782427|NCT01370317|66580344|FG000|Overall Study|Protocol deviation|0|||
23782428|NCT01370317|66580345|FG001|Overall Study|Protocol deviation|1|||
23782429|NCT01778010|66580346|FG000|Overall Study|Withdrawal by Subject|2|||
23782430|NCT01778010|66580346|FG000|Overall Study|abnormal ECG before meds|1|||
23782431|NCT01778010|66580346|FG000|Overall Study|Arrested|1|||
23782432|NCT01778010|66580346|FG000|Overall Study|rash while on placebo|1|||
23782433|NCT03165994|66580347|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
23782434|NCT03165994|66580347|FG000|Overall Study|Death|2|||
23782435|NCT03165994|66580347|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
23782436|NCT03165994|66580347|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
23782437|NCT03165994|66580347|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
23782438|NCT03165994|66580347|FG000|Overall Study|Miscellaneous|1|||
23782439|NCT03600376|66580348|FG000|Overall Study|Adverse Event|1|||
23782440|NCT03600376|66580349|FG001|Overall Study|Adverse Event|1|||
23782441|NCT03600376|66580348|FG000|Overall Study|Transferred to other facility|1|||
23782442|NCT03600376|66580349|FG001|Overall Study|Transferred to other facility|0|||
23782443|NCT03600376|66580348|FG000|Overall Study|Investigator Decision|0|||
23782444|NCT03600376|66580349|FG001|Overall Study|Investigator Decision|4|||
23782445|NCT03600376|66580348|FG000|Overall Study|Determined to be ineligible for study|0|||
23782446|NCT03600376|66580349|FG001|Overall Study|Determined to be ineligible for study|1|||
23782447|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
23782448|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
23782449|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
23782450|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
23782451|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
23782452|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
23782453|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
23782454|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
23782455|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
23782456|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
23340933|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
23340934|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
23340935|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
23402702|NCT03289143|65219984|FG001|Overall Study|Protocol Deviation|1|||
23782457|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
23782458|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
23782459|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
23782460|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
23782461|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
23782462|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
23782463|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
23782464|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
23782465|NCT02009163|66580350|FG000|Open-label Period (Non-randomized)|Other|13|||
23340936|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
23340937|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
23340938|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
23340939|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
23340940|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
23340941|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
23340942|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
23340943|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
23340944|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
23340945|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
23340946|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
23340947|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
23782466|NCT02009163|66580351|FG001|Open-label Period (Non-randomized)|Other|0|||
23782467|NCT02009163|66580352|FG002|Open-label Period (Non-randomized)|Other|0|||
23782468|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
23782469|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
23782470|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
23782471|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
23782472|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
23782473|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
23782474|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Adverse Event|0|||
23340948|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
23340949|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
23340950|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
23340951|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
23340952|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
23340953|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
23340954|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
23340955|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
23340956|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
23340957|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
23340958|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
23340959|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
23340960|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
23340961|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
23340962|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
23340963|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
23340964|NCT02448537|64992884|FG000|Overall Study|Withdrawal by Subject|1|||
23340965|NCT02448537|64992885|FG001|Overall Study|Withdrawal by Subject|1|||
23340966|NCT02448537|64992886|FG002|Overall Study|Withdrawal by Subject|1|||
23340967|NCT01447446|64992891|FG000|Overall Study|Death|6|||
23340968|NCT01447446|64992892|FG001|Overall Study|Death|3|||
23340969|NCT01447446|64992893|FG002|Overall Study|Death|2|||
23340970|NCT01447446|64992894|FG003|Overall Study|Death|1|||
23340971|NCT01447446|64992895|FG004|Overall Study|Death|7|||
23340972|NCT01447446|64992896|FG005|Overall Study|Death|0|||
23340973|NCT01447446|64992891|FG000|Overall Study|Adverse Event|3|||
23340974|NCT01447446|64992892|FG001|Overall Study|Adverse Event|0|||
23340975|NCT01447446|64992893|FG002|Overall Study|Adverse Event|1|||
23340976|NCT01447446|64992894|FG003|Overall Study|Adverse Event|0|||
23340977|NCT01447446|64992895|FG004|Overall Study|Adverse Event|2|||
23340978|NCT01447446|64992896|FG005|Overall Study|Adverse Event|0|||
23340979|NCT01447446|64992891|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
23340980|NCT01447446|64992892|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
23340981|NCT01447446|64992893|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
23340982|NCT01447446|64992894|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
23340983|NCT01447446|64992895|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
23340984|NCT01447446|64992896|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
23340985|NCT01447446|64992891|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
23340986|NCT01447446|64992892|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
23340987|NCT01447446|64992893|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
23402703|NCT03289143|65219985|FG002|Overall Study|Protocol Deviation|3|||
23782475|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Adverse Event|0|||
23453699|NCT00216671|65403381|FG000|Overall Study|No Need to Continue Medication|1|||
23453700|NCT00216671|65403382|FG001|Overall Study|No Need to Continue Medication|1|||
23453701|NCT00216671|65403381|FG000|Overall Study|Insufficient Response|9|||
23453702|NCT00216671|65403382|FG001|Overall Study|Insufficient Response|4|||
23453703|NCT00216671|65403381|FG000|Overall Study|Lost to Follow-up|3|||
23453704|NCT00216671|65403382|FG001|Overall Study|Lost to Follow-up|5|||
23453705|NCT00216671|65403381|FG000|Overall Study|Non compliant|2|||
23453706|NCT00216671|65403382|FG001|Overall Study|Non compliant|2|||
23453707|NCT00216671|65403381|FG000|Overall Study|Ineligible|0|||
23453708|NCT00216671|65403382|FG001|Overall Study|Ineligible|2|||
23453709|NCT00216671|65403381|FG000|Overall Study|Physician Decision|1|||
23453710|NCT00216671|65403382|FG001|Overall Study|Physician Decision|1|||
23453711|NCT00216671|65403381|FG000|Overall Study|Protocol Violation|3|||
23453712|NCT00216671|65403382|FG001|Overall Study|Protocol Violation|5|||
23453713|NCT00216671|65403381|FG000|Overall Study|Relapse|1|||
23453714|NCT00216671|65403382|FG001|Overall Study|Relapse|0|||
23453715|NCT00216671|65403381|FG000|Overall Study|Investigator Illness|0|||
23453716|NCT00216671|65403382|FG001|Overall Study|Investigator Illness|1|||
23453717|NCT00216671|65403381|FG000|Overall Study|Patient Moved|0|||
23453718|NCT00216671|65403382|FG001|Overall Study|Patient Moved|1|||
23453719|NCT00216671|65403381|FG000|Overall Study|Ineligible, no efficacy data|2|||
23453720|NCT00216671|65403382|FG001|Overall Study|Ineligible, no efficacy data|2|||
23453721|NCT00216671|65403381|FG000|Overall Study|Insufficient Response Adverse Event|2|||
23453722|NCT00216671|65403382|FG001|Overall Study|Insufficient Response Adverse Event|1|||
23453723|NCT02694744|65403383|FG000|Overall Study|Adverse Event|2|||
23453724|NCT02694744|65403384|FG001|Overall Study|Adverse Event|1|||
23453725|NCT02694744|65403383|FG000|Overall Study|Withdrawal by Subject|2|||
23453726|NCT02694744|65403384|FG001|Overall Study|Withdrawal by Subject|1|||
23453727|NCT02694744|65403383|FG000|Overall Study|Physician Decision|1|||
23453728|NCT02694744|65403384|FG001|Overall Study|Physician Decision|2|||
23453729|NCT02694744|65403383|FG000|Overall Study|Lost to Follow-up|1|||
23453730|NCT02694744|65403384|FG001|Overall Study|Lost to Follow-up|0|||
23453731|NCT02694744|65403383|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
23453732|NCT02694744|65403384|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
23453733|NCT00768989|65403385|FG000|Prior to Week 24|Withdrawal by Subject|1|||
23453734|NCT00768989|65403386|FG001|Prior to Week 24|Withdrawal by Subject|0|||
23453735|NCT00768989|65403385|FG000|Prior to Week 24|Adverse Event|3|||
23453736|NCT00768989|65403386|FG001|Prior to Week 24|Adverse Event|0|||
23453737|NCT00768989|65403385|FG000|Prior to Week 24|Lost to Follow-up|0|||
23453738|NCT00768989|65403386|FG001|Prior to Week 24|Lost to Follow-up|1|||
23453739|NCT00768989|65403385|FG000|Prior to Week 24|Protocol Violation|0|||
23453740|NCT00768989|65403386|FG001|Prior to Week 24|Protocol Violation|2|||
23453741|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
23453742|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
23453743|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
23453744|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
23453745|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
23453746|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
23636673|NCT00734591|66052957|FG000|Prospective Period|Lost to Follow-up|37|||
23782476|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Adverse Event|6|||
23782477|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
23782478|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
23782479|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
23782480|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
23782481|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
23782482|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
23782483|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Pregnancy|0|||
23782484|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Pregnancy|0|||
23782485|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Pregnancy|2|||
23782486|NCT02009163|66580350|FG000|Randomized-withdrawal Period|Other|0|||
23340988|NCT01447446|64992894|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
23340989|NCT01447446|64992895|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
23453747|NCT00768989|65403385|FG000|On or After Week 36|Lack of Efficacy|1|||
23782487|NCT02009163|66580351|FG001|Randomized-withdrawal Period|Other|9|||
23453748|NCT00768989|65403386|FG001|On or After Week 36|Lack of Efficacy|0|||
23453749|NCT00768989|65403385|FG000|On or After Week 36|Adverse Event|0|||
23453750|NCT00768989|65403386|FG001|On or After Week 36|Adverse Event|1|||
23453751|NCT00768989|65403385|FG000|On or After Week 36|Lost to Follow-up|1|||
23453752|NCT00768989|65403386|FG001|On or After Week 36|Lost to Follow-up|0|||
23782488|NCT02009163|66580352|FG002|Randomized-withdrawal Period|Other|5|||
23453753|NCT00768989|65403385|FG000|On or After Week 36|Poor Compliance|1|||
23453754|NCT00768989|65403386|FG001|On or After Week 36|Poor Compliance|0|||
23453755|NCT00768989|65403385|FG000|On or After Week 36|Protocol Violation|1|||
23453756|NCT00768989|65403386|FG001|On or After Week 36|Protocol Violation|0|||
23636674|NCT00734591|66052958|FG001|Prospective Period|Lost to Follow-up|33|||
23782489|NCT03450057|66580353|FG000|Overall Study|Death|17|||
23782490|NCT03450057|66580353|FG000|Overall Study|ICF withdrawal|4|||
23782491|NCT03450057|66580353|FG000|Overall Study|Lost to Follow-up|2|||
23782492|NCT02655679|66580354|FG000|Overall Study|Adverse Event|0|||
23782493|NCT02655679|66580355|FG001|Overall Study|Adverse Event|1|||
23782494|NCT02655679|66580356|FG002|Overall Study|Adverse Event|0|||
23782495|NCT02655679|66580357|FG003|Overall Study|Adverse Event|0|||
23782496|NCT02655679|66580358|FG004|Overall Study|Adverse Event|0|||
23782497|NCT02655679|66580354|FG000|Overall Study|Withdrawal by Subject|1|||
23782498|NCT02655679|66580355|FG001|Overall Study|Withdrawal by Subject|1|||
23782499|NCT02655679|66580356|FG002|Overall Study|Withdrawal by Subject|0|||
23782500|NCT02655679|66580357|FG003|Overall Study|Withdrawal by Subject|3|||
23782501|NCT02655679|66580358|FG004|Overall Study|Withdrawal by Subject|1|||
23782502|NCT02655679|66580354|FG000|Overall Study|Inability to Comply with the Protocol|1|||
23782503|NCT02655679|66580355|FG001|Overall Study|Inability to Comply with the Protocol|0|||
23782504|NCT02655679|66580356|FG002|Overall Study|Inability to Comply with the Protocol|0|||
23782505|NCT02655679|66580357|FG003|Overall Study|Inability to Comply with the Protocol|0|||
23782506|NCT02655679|66580358|FG004|Overall Study|Inability to Comply with the Protocol|0|||
23782507|NCT02655679|66580354|FG000|Overall Study|Lost to Follow-up|0|||
23782508|NCT02655679|66580355|FG001|Overall Study|Lost to Follow-up|1|||
23782509|NCT02655679|66580356|FG002|Overall Study|Lost to Follow-up|1|||
23782510|NCT02655679|66580357|FG003|Overall Study|Lost to Follow-up|1|||
23782511|NCT02655679|66580358|FG004|Overall Study|Lost to Follow-up|0|||
23782512|NCT02655679|66580354|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23782513|NCT02655679|66580355|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23782514|NCT02655679|66580356|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23782515|NCT02655679|66580357|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23782516|NCT02655679|66580358|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23782517|NCT01149473|66580359|FG000|First Intervention|Adverse Event|1|||
23782518|NCT01149473|66580360|FG001|First Intervention|Adverse Event|1|||
23782519|NCT01149473|66580359|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23782520|NCT01149473|66580360|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23782521|NCT05327491|66580363|FG000|Periods 1 & 2|Miscellaneous|0|||
23782522|NCT05327491|66580364|FG001|Periods 1 & 2|Miscellaneous|1|||
23782523|NCT05327491|66580365|FG002|Periods 1 & 2|Miscellaneous|0|||
23782524|NCT05327491|66580366|FG003|Periods 1 & 2|Miscellaneous|0|||
23782525|NCT05327491|66580363|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
23782526|NCT05327491|66580364|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
23782527|NCT05327491|66580365|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
23782528|NCT05327491|66580366|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
23782529|NCT01963728|66580367|FG000|Overall Study|Study terminated early|0|||
23782530|NCT01963728|66580368|FG001|Overall Study|Study terminated early|1|||
23782531|NCT02158663|66580369|FG000|Overall Study|Withdrawal by Subject|5|||
23782532|NCT02158663|66580370|FG001|Overall Study|Withdrawal by Subject|4|||
23782533|NCT02601560|66580371|FG000|Overall Study|Other|0|||
23782534|NCT02601560|66580372|FG001|Overall Study|Other|0|||
23782535|NCT02601560|66580373|FG002|Overall Study|Other|0|||
23782536|NCT02601560|66580374|FG003|Overall Study|Other|0|||
23782537|NCT02601560|66580375|FG004|Overall Study|Other|0|||
23782538|NCT02601560|66580376|FG005|Overall Study|Other|0|||
23782539|NCT02601560|66580377|FG006|Overall Study|Other|1|||
23782540|NCT02601560|66580378|FG007|Overall Study|Other|0|||
23782541|NCT03197883|66580379|FG000|Overall Study|Adverse Event|1|||
23782542|NCT03197883|66580380|FG001|Overall Study|Adverse Event|1|||
23782543|NCT03197883|66580379|FG000|Overall Study|Lost to Follow-up|1|||
23782544|NCT03197883|66580380|FG001|Overall Study|Lost to Follow-up|0|||
23782545|NCT03197883|66580379|FG000|Overall Study|Protocol Violation|1|||
23782546|NCT03197883|66580380|FG001|Overall Study|Protocol Violation|0|||
23636675|NCT00734591|66052957|FG000|Prospective Period|Study Terminated|1|||
23636676|NCT00734591|66052958|FG001|Prospective Period|Study Terminated|0|||
23636677|NCT00734591|66052957|FG000|Prospective Period|Other|2|||
23636678|NCT00734591|66052958|FG001|Prospective Period|Other|2|||
23636679|NCT00589303|66052966|FG000|Overall Study|Withdrawal by Subject|2|||
23636680|NCT00589303|66052967|FG001|Overall Study|Withdrawal by Subject|1|||
23782547|NCT03197883|66580379|FG000|Overall Study|Other (Not Specified)|0|||
23782548|NCT03197883|66580380|FG001|Overall Study|Other (Not Specified)|5|||
23782549|NCT02514122|66580390|FG000|Overall Study|Withdrawal by Subject|2|||
23782550|NCT02514122|66580391|FG001|Overall Study|Withdrawal by Subject|0|||
23782551|NCT03194217|66580392|FG000|Overall Study|Adverse Event|0|||
23340990|NCT01447446|64992896|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
23782552|NCT03194217|66580393|FG001|Overall Study|Adverse Event|2|||
23782553|NCT03194217|66580394|FG002|Overall Study|Adverse Event|3|||
23636681|NCT00685698|66052968|FG000|Overall Study|Withdrawal by Subject|1|||
23636682|NCT00685698|66052968|FG000|Overall Study|Protocol Violation|6|||
23636683|NCT00685698|66052968|FG000|Overall Study|Adverse Event|3|||
23636684|NCT00685698|66052968|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
23782554|NCT03194217|66580395|FG003|Overall Study|Adverse Event|3|||
23782555|NCT03194217|66580392|FG000|Overall Study|Failure to meet randomisation criteria|0|||
23453757|NCT00768989|65403385|FG000|On or After Week 36|Did not attend termination visit|2|||
23453758|NCT00768989|65403386|FG001|On or After Week 36|Did not attend termination visit|0|||
23453759|NCT00768989|65403385|FG000|On or After Week 36|Sponsor Termination|45|||
23453760|NCT00768989|65403386|FG001|On or After Week 36|Sponsor Termination|26|||
23453761|NCT00837434|65403387|FG000|Overall Study|Physician Decision|3|||
23453762|NCT00837434|65403388|FG001|Overall Study|Physician Decision|0|||
23453763|NCT00837434|65403387|FG000|Overall Study|Lost to Follow-up|1|||
23453764|NCT00837434|65403388|FG001|Overall Study|Lost to Follow-up|1|||
23453765|NCT00837434|65403387|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
23453766|NCT00837434|65403388|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
23453767|NCT00837434|65403387|FG000|Overall Study|Noncompliant|2|||
23453768|NCT00837434|65403388|FG001|Overall Study|Noncompliant|0|||
23453769|NCT00837434|65403387|FG000|Overall Study|Baseline assessments not done in time|1|||
23453770|NCT00837434|65403388|FG001|Overall Study|Baseline assessments not done in time|0|||
23453771|NCT00837434|65403387|FG000|Overall Study|Unable to obtain study drug|1|||
23453772|NCT00837434|65403388|FG001|Overall Study|Unable to obtain study drug|0|||
23453773|NCT05196828|65403389|FG000|Overall Study|Withdrawal by Subject|2|||
23453774|NCT05196828|65403390|FG001|Overall Study|Withdrawal by Subject|0|||
23453775|NCT05196828|65403389|FG000|Overall Study|Lost to Follow-up|0|||
23453776|NCT05196828|65403390|FG001|Overall Study|Lost to Follow-up|4|||
23453777|NCT05196828|65403389|FG000|Overall Study|Adverse Event|1|||
23782556|NCT03194217|66580393|FG001|Overall Study|Failure to meet randomisation criteria|0|||
23782557|NCT03194217|66580394|FG002|Overall Study|Failure to meet randomisation criteria|0|||
23782558|NCT03194217|66580395|FG003|Overall Study|Failure to meet randomisation criteria|1|||
23782559|NCT03194217|66580392|FG000|Overall Study|Other|0|||
23782560|NCT03194217|66580393|FG001|Overall Study|Other|1|||
23782561|NCT03194217|66580394|FG002|Overall Study|Other|1|||
23782562|NCT03194217|66580395|FG003|Overall Study|Other|0|||
23782563|NCT00904215|66583159|FG000|Overall Study|Adverse Event|25|||
23782564|NCT00904215|66583159|FG000|Overall Study|Protocol Violation|10|||
23782565|NCT00904215|66583159|FG000|Overall Study|Lost to Follow-up|63|||
23782566|NCT00904215|66583159|FG000|Overall Study|Withdrawal by Subject|9|||
23782567|NCT00904215|66583159|FG000|Overall Study|Other|28|||
23782568|NCT01686477|66583160|FG000|Feeding Intervention|Death|1|||
23782569|NCT01686477|66583161|FG001|Feeding Intervention|Death|0|||
23782570|NCT01686477|66583162|FG002|Feeding Intervention|Death|1|||
23782571|NCT01686477|66583160|FG000|Feeding Intervention|Withdrawal by Subject|0|||
23782572|NCT01686477|66583161|FG001|Feeding Intervention|Withdrawal by Subject|6|||
23782573|NCT01686477|66583162|FG002|Feeding Intervention|Withdrawal by Subject|0|||
23782574|NCT01686477|66583160|FG000|Feeding Intervention|Physician Decision|1|||
23782575|NCT01686477|66583161|FG001|Feeding Intervention|Physician Decision|2|||
23782576|NCT01686477|66583162|FG002|Feeding Intervention|Physician Decision|0|||
23782577|NCT01686477|66583160|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
23782578|NCT01686477|66583161|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
23782579|NCT01686477|66583162|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
23782580|NCT01686477|66583160|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
23782581|NCT01686477|66583161|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
23782582|NCT01686477|66583162|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
23782583|NCT01686477|66583160|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
23782584|NCT01686477|66583161|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
23782585|NCT01686477|66583162|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
23782586|NCT01686477|66583160|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
23782587|NCT01686477|66583161|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
23782588|NCT01686477|66583162|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
23782589|NCT01686477|66583160|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
23782590|NCT01686477|66583161|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
23453778|NCT05196828|65403390|FG001|Overall Study|Adverse Event|0|||
23782591|NCT01686477|66583162|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
23782592|NCT01686477|66583160|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
23782593|NCT01686477|66583161|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
23782594|NCT01686477|66583162|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
23782595|NCT01686477|66583160|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
23782596|NCT01686477|66583161|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
23782597|NCT01686477|66583162|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
23782598|NCT04400890|66583163|FG000|Overall Study|Withdrawal by Subject|3|||
23782599|NCT04400890|66583164|FG001|Overall Study|Withdrawal by Subject|2|||
23453779|NCT01342913|65403392|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
23453780|NCT01342913|65403393|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23453781|NCT01342913|65403394|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23453782|NCT01342913|65403392|FG000|2-week Run-in Period|Physician Decision|6|||
23453783|NCT01342913|65403393|FG001|2-week Run-in Period|Physician Decision|0|||
23453784|NCT01342913|65403394|FG002|2-week Run-in Period|Physician Decision|0|||
23453785|NCT01342913|65403392|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
23453786|NCT01342913|65403393|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23453787|NCT01342913|65403394|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23453788|NCT01342913|65403392|FG000|2-week Run-in Period|Adverse Event|2|||
23453789|NCT01342913|65403393|FG001|2-week Run-in Period|Adverse Event|0|||
23453790|NCT01342913|65403394|FG002|2-week Run-in Period|Adverse Event|0|||
23453791|NCT01342913|65403392|FG000|2-week Run-in Period|Protocol Violation|5|||
23453792|NCT01342913|65403393|FG001|2-week Run-in Period|Protocol Violation|0|||
23453793|NCT01342913|65403394|FG002|2-week Run-in Period|Protocol Violation|0|||
23453794|NCT01342913|65403392|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
23453795|NCT01342913|65403393|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23453796|NCT01342913|65403394|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23453797|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23782600|NCT02890992|66583165|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782601|NCT02890992|66583166|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
23453798|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Adverse Event|3|||
23453799|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Adverse Event|6|||
23453800|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23453801|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
23453802|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
23453803|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23453804|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
23453805|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
23453806|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23453807|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23453808|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
23453809|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23453810|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Physician Decision|2|||
23453811|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Physician Decision|0|||
23453812|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23453813|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23453814|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23453815|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
23453816|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
23453817|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Disease progression|75|||
23453818|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Disease progression|59|||
23453819|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Adverse Event|16|||
23453820|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Adverse Event|16|||
23453821|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Death|2|||
23453822|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Death|3|||
23453823|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
23453824|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
23453825|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Other|3|||
23453826|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Other|0|||
23453827|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Adverse Event|2|||
23453828|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Adverse Event|3|||
23453829|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Death|1|||
23453830|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Death|3|||
23453831|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
23453832|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
23453833|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
23453834|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
23453835|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Disease progression|103|||
23453836|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Disease progression|122|||
23782602|NCT02890992|66583167|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782603|NCT02890992|66583168|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782604|NCT02890992|66583169|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782605|NCT02890992|66583170|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782606|NCT02890992|66583171|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782607|NCT02890992|66583172|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23782608|NCT02890992|66583165|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23782609|NCT02890992|66583166|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23782610|NCT02890992|66583167|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23453837|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Other|3|||
23453838|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Other|0|||
23453839|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
23453840|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
23453841|NCT00883779|65403397|FG000|Off-study Phase|Death|185|||
23453842|NCT00883779|65403398|FG001|Off-study Phase|Death|174|||
23782611|NCT02890992|66583168|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23782612|NCT02890992|66583169|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23782613|NCT02890992|66583170|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23782614|NCT02890992|66583171|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
23782615|NCT02890992|66583172|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
23782616|NCT02890992|66583165|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782617|NCT02890992|66583166|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
23782618|NCT02890992|66583167|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
23340991|NCT01447446|64992891|FG000|Overall Study|Administrative/Other|34|||
23340992|NCT01447446|64992892|FG001|Overall Study|Administrative/Other|9|||
23340993|NCT01447446|64992893|FG002|Overall Study|Administrative/Other|10|||
23340994|NCT01447446|64992894|FG003|Overall Study|Administrative/Other|2|||
23340995|NCT01447446|64992895|FG004|Overall Study|Administrative/Other|33|||
23340996|NCT01447446|64992896|FG005|Overall Study|Administrative/Other|4|||
23340997|NCT01447446|64992891|FG000|Overall Study|SVR12 Assessment|13|||
23340998|NCT01447446|64992892|FG001|Overall Study|SVR12 Assessment|1|||
23340999|NCT01447446|64992893|FG002|Overall Study|SVR12 Assessment|2|||
23341000|NCT01447446|64992894|FG003|Overall Study|SVR12 Assessment|1|||
23341001|NCT01447446|64992895|FG004|Overall Study|SVR12 Assessment|5|||
23341002|NCT01447446|64992896|FG005|Overall Study|SVR12 Assessment|5|||
23341003|NCT01447446|64992891|FG000|Overall Study|New Treatment Started|8|||
23341004|NCT01447446|64992892|FG001|Overall Study|New Treatment Started|2|||
23341005|NCT01447446|64992893|FG002|Overall Study|New Treatment Started|1|||
23341006|NCT01447446|64992894|FG003|Overall Study|New Treatment Started|0|||
23341007|NCT01447446|64992895|FG004|Overall Study|New Treatment Started|2|||
23341008|NCT01447446|64992896|FG005|Overall Study|New Treatment Started|0|||
23341009|NCT01447446|64992891|FG000|Overall Study|Reason not Specified|1|||
23341010|NCT01447446|64992892|FG001|Overall Study|Reason not Specified|1|||
23341011|NCT01447446|64992893|FG002|Overall Study|Reason not Specified|1|||
23341012|NCT01447446|64992894|FG003|Overall Study|Reason not Specified|1|||
23341013|NCT01447446|64992895|FG004|Overall Study|Reason not Specified|1|||
23341014|NCT01447446|64992896|FG005|Overall Study|Reason not Specified|0|||
23341015|NCT00638443|64992897|FG000|First Intervention|Adverse Event|2|||
23341016|NCT00638443|64992898|FG001|First Intervention|Adverse Event|1|||
23341017|NCT04434469|64992899|FG000|Overall Study|Death|2|||
23341018|NCT04434469|64992900|FG001|Overall Study|Death|3|||
23341019|NCT04434469|64992901|FG002|Overall Study|Death|2|||
23341020|NCT04434469|64992902|FG003|Overall Study|Death|2|||
23341021|NCT04434469|64992903|FG004|Overall Study|Death|2|||
23341022|NCT04434469|64992904|FG005|Overall Study|Death|0|||
23341023|NCT04434469|64992899|FG000|Overall Study|Lost to Follow-up|0|||
23341024|NCT04434469|64992900|FG001|Overall Study|Lost to Follow-up|0|||
23341025|NCT04434469|64992901|FG002|Overall Study|Lost to Follow-up|0|||
23341026|NCT04434469|64992902|FG003|Overall Study|Lost to Follow-up|1|||
23341027|NCT04434469|64992903|FG004|Overall Study|Lost to Follow-up|1|||
23341028|NCT04434469|64992904|FG005|Overall Study|Lost to Follow-up|0|||
23341029|NCT04434469|64992899|FG000|Overall Study|Study terminated by sponsor|1|||
23341030|NCT04434469|64992900|FG001|Overall Study|Study terminated by sponsor|1|||
23341031|NCT04434469|64992901|FG002|Overall Study|Study terminated by sponsor|1|||
23341032|NCT04434469|64992902|FG003|Overall Study|Study terminated by sponsor|2|||
23341033|NCT04434469|64992903|FG004|Overall Study|Study terminated by sponsor|3|||
23341034|NCT04434469|64992904|FG005|Overall Study|Study terminated by sponsor|3|||
23341035|NCT04434469|64992899|FG000|Overall Study|Withdrawal by Subject|0|||
23341036|NCT04434469|64992900|FG001|Overall Study|Withdrawal by Subject|0|||
23341037|NCT04434469|64992901|FG002|Overall Study|Withdrawal by Subject|1|||
23341038|NCT04434469|64992902|FG003|Overall Study|Withdrawal by Subject|0|||
23341039|NCT04434469|64992903|FG004|Overall Study|Withdrawal by Subject|0|||
23341040|NCT04434469|64992904|FG005|Overall Study|Withdrawal by Subject|0|||
23341041|NCT01646021|64992905|FG000|Overall Study|Death|77|||
23341042|NCT01646021|64992906|FG001|Overall Study|Death|83|||
23341043|NCT01646021|64992905|FG000|Overall Study|Study Terminated by Sponsor|50|||
23341044|NCT01646021|64992906|FG001|Overall Study|Study Terminated by Sponsor|41|||
23341045|NCT01646021|64992905|FG000|Overall Study|Lost to Follow-up|2|||
23341046|NCT01646021|64992906|FG001|Overall Study|Lost to Follow-up|2|||
23341047|NCT01646021|64992905|FG000|Overall Study|Withdrawal by Subject|10|||
23341048|NCT01646021|64992906|FG001|Overall Study|Withdrawal by Subject|15|||
23453843|NCT00883779|65403397|FG000|Off-study Phase|Refused treatment|1|||
23341049|NCT03813147|64992907|FG000|Overall Study|Lack of Efficacy|4|||
23341050|NCT03813147|64992908|FG001|Overall Study|Lack of Efficacy|4|||
23341051|NCT03813147|64992907|FG000|Overall Study|Physician Decision|2|||
23582255|NCT00567879|65862410|FG000|Overall Study|New cancer therapy|0|||
23341052|NCT03813147|64992908|FG001|Overall Study|Physician Decision|1|||
23341053|NCT02353442|64992909|FG000|Overall Study|Withdrawal by Subject|3|||
23341054|NCT02353442|64992910|FG001|Overall Study|Withdrawal by Subject|4|||
23341055|NCT01430403|64992911|FG000|Overall Study|Lost to Follow-up|5|||
23341056|NCT01430403|64992912|FG001|Overall Study|Lost to Follow-up|5|||
23782619|NCT02890992|66583168|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782620|NCT02890992|66583169|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782621|NCT02890992|66583170|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782622|NCT02890992|66583171|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782623|NCT02890992|66583172|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
23782624|NCT03965091|66583174|FG000|Overall Study|Adverse Event|0|||
23782625|NCT03965091|66583175|FG001|Overall Study|Adverse Event|2|||
23782626|NCT03965091|66583176|FG002|Overall Study|Adverse Event|3|||
23582256|NCT00567879|65862411|FG001|Overall Study|New cancer therapy|0|||
23582257|NCT00567879|65862412|FG002|Overall Study|New cancer therapy|1|||
23582258|NCT00567879|65862413|FG003|Overall Study|New cancer therapy|0|||
23453844|NCT00883779|65403398|FG001|Off-study Phase|Refused treatment|1|||
23453845|NCT00883779|65403397|FG000|Off-study Phase|Failure to return|5|||
23453846|NCT00883779|65403398|FG001|Off-study Phase|Failure to return|6|||
23453847|NCT00883779|65403397|FG000|Off-study Phase|Other|18|||
23453848|NCT00883779|65403398|FG001|Off-study Phase|Other|21|||
23453849|NCT03812380|65403399|FG000|Overall Study|Protocol Violation|3|||
23453850|NCT03812380|65403400|FG001|Overall Study|Protocol Violation|3|||
23453851|NCT03812380|65403399|FG000|Overall Study|Withdrawal by Subject|5|||
23453852|NCT03812380|65403400|FG001|Overall Study|Withdrawal by Subject|4|||
23453853|NCT03812380|65403399|FG000|Overall Study|Early termination of study|14|||
23453854|NCT03812380|65403400|FG001|Overall Study|Early termination of study|14|||
23453855|NCT01089504|65403402|FG000|Overall Study|Lost to Follow-up|1|||
23453856|NCT01089504|65403403|FG001|Overall Study|Lost to Follow-up|1|||
23453857|NCT01089504|65403402|FG000|Overall Study|Withdrawal by Subject|2|||
23453858|NCT01089504|65403403|FG001|Overall Study|Withdrawal by Subject|0|||
23453859|NCT01667900|65403404|FG000|Part B|Death|0|||
23453860|NCT01667900|65403405|FG001|Part B|Death|0|||
23453861|NCT01667900|65403406|FG002|Part B|Death|0|||
23453862|NCT01667900|65403407|FG003|Part B|Death|0|||
23453863|NCT01667900|65403408|FG004|Part B|Death|0|||
23453864|NCT01667900|65403409|FG005|Part B|Death|0|||
23453865|NCT01667900|65403410|FG006|Part B|Death|0|||
23453866|NCT01667900|65403411|FG007|Part B|Death|0|||
23453867|NCT01667900|65403412|FG008|Part B|Death|0|||
23582259|NCT00567879|65862414|FG004|Overall Study|New cancer therapy|0|||
23582260|NCT00567879|65862415|FG005|Overall Study|New cancer therapy|0|||
23582261|NCT00567879|65862410|FG000|Overall Study|Disease progression|5|||
23582262|NCT00567879|65862411|FG001|Overall Study|Disease progression|7|||
23582263|NCT00567879|65862412|FG002|Overall Study|Disease progression|15|||
23582264|NCT00567879|65862413|FG003|Overall Study|Disease progression|5|||
23582265|NCT00567879|65862414|FG004|Overall Study|Disease progression|11|||
23582266|NCT00567879|65862415|FG005|Overall Study|Disease progression|3|||
23582267|NCT03383887|65862421|FG000|Overall Study|Lost to Follow-up|0|||
23582268|NCT03383887|65862422|FG001|Overall Study|Lost to Follow-up|1|||
23582269|NCT00282438|65862425|FG000|Overall Study|Lack of Efficacy|1|||
23582270|NCT00282438|65862426|FG001|Overall Study|Lack of Efficacy|0|||
23582271|NCT00282438|65862425|FG000|Overall Study|Death|0|||
23582272|NCT00282438|65862426|FG001|Overall Study|Death|1|||
23582273|NCT00349908|65862427|FG000|Overall Study|Withdrawal by Subject|0|||
23582274|NCT00349908|65862428|FG001|Overall Study|Withdrawal by Subject|4|||
23582275|NCT00569946|65862429|FG000|Overall Study|Adverse Event|16|||
23582276|NCT00569946|65862429|FG000|Overall Study|Objective Progression or Relapse|42|||
23582277|NCT00569946|65862429|FG000|Overall Study|Global Deterioration of Health Status|1|||
23582278|NCT01027286|65862431|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
23582279|NCT01027286|65862432|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
23582280|NCT01027286|65862431|FG000|Overall Study|Lost to Follow-up|0|||
23582281|NCT01027286|65862432|FG001|Overall Study|Lost to Follow-up|1|||
23582282|NCT01348087|65862442|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
23582283|NCT01348087|65862442|FG000|Overall Study|Administrative problems|79|||
23582284|NCT01348087|65862442|FG000|Overall Study|protocol deviation|1|||
23582285|NCT01348087|65862442|FG000|Overall Study|Lost to Follow-up|1|||
23582286|NCT01348087|65862442|FG000|Overall Study|Subject withdrew consent|7|||
23582287|NCT01348087|65862442|FG000|Overall Study|Adverse Event|25|||
23582288|NCT00543725|65862443|FG000|Overall Study|Adverse Event|18|||
23582289|NCT00543725|65862444|FG001|Overall Study|Adverse Event|27|||
23782627|NCT03965091|66583174|FG000|Overall Study|Withdrawal by Subject|11|||
23582290|NCT00543725|65862443|FG000|Overall Study|Sponsor's Decision|0|||
23582291|NCT00543725|65862444|FG001|Overall Study|Sponsor's Decision|1|||
23582292|NCT00543725|65862443|FG000|Overall Study|Subject Non-Compliant|4|||
23582293|NCT00543725|65862444|FG001|Overall Study|Subject Non-Compliant|4|||
23705484|NCT03382899|66297516|FG000|Overall Study|Sponsor's decision|31|||
23453868|NCT01667900|65403413|FG009|Part B|Death|0|||
23453869|NCT01667900|65403414|FG010|Part B|Death|0|||
23453870|NCT01667900|65403415|FG011|Part B|Death|0|||
23453871|NCT01667900|65403416|FG012|Part B|Death|0|||
23453872|NCT01667900|65403417|FG013|Part B|Death|0|||
23453873|NCT01667900|65403418|FG014|Part B|Death|0|||
23453874|NCT01667900|65403419|FG015|Part B|Death|0|||
23453875|NCT01667900|65403420|FG016|Part B|Death|1|||
23341057|NCT01430403|64992913|FG002|Overall Study|Lost to Follow-up|3|||
23341058|NCT01430403|64992911|FG000|Overall Study|Physician Decision|1|||
23341059|NCT01430403|64992912|FG001|Overall Study|Physician Decision|0|||
23341060|NCT01430403|64992913|FG002|Overall Study|Physician Decision|0|||
23341061|NCT01430403|64992911|FG000|Overall Study|Protocol Violation|2|||
23341062|NCT01430403|64992912|FG001|Overall Study|Protocol Violation|3|||
23341063|NCT01430403|64992913|FG002|Overall Study|Protocol Violation|2|||
23341064|NCT01430403|64992911|FG000|Overall Study|Withdrawal by Subject|9|||
23341065|NCT01430403|64992912|FG001|Overall Study|Withdrawal by Subject|1|||
23341066|NCT01430403|64992913|FG002|Overall Study|Withdrawal by Subject|3|||
23341067|NCT03200704|64992914|FG000|Overall Study|Withdrawal by Subject|1|||
23341068|NCT04505540|64992915|FG000|Baseline|Protocol Violation|10|||
23341069|NCT04505540|64992915|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
23341070|NCT04505540|64992915|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
23341071|NCT04505540|64992915|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
23341072|NCT04505540|64992915|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
23341073|NCT04505540|64992915|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
23341074|NCT04505540|64992915|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
23341075|NCT04505540|64992915|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
23341076|NCT04505540|64992915|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
23341077|NCT04505540|64992915|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
23341078|NCT04505540|64992915|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
23341079|NCT04505540|64992915|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
23341080|NCT04505540|64992915|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
23341081|NCT04021121|64992916|FG000|Overall Study|Death|3|||
23341082|NCT04021121|64992917|FG001|Overall Study|Death|3|||
23341083|NCT04021121|64992918|FG002|Overall Study|Death|5|||
23341084|NCT04021121|64992919|FG003|Overall Study|Death|4|||
23341085|NCT00976820|64992920|FG000|Overall Study|Lost to Follow-up|5|||
23341086|NCT00976820|64992921|FG001|Overall Study|Lost to Follow-up|16|||
23341087|NCT00976820|64992922|FG002|Overall Study|Lost to Follow-up|2|||
23341088|NCT00976820|64992923|FG003|Overall Study|Lost to Follow-up|3|||
23341089|NCT00976820|64992920|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
23341090|NCT00976820|64992921|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
23341091|NCT00976820|64992922|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
23341092|NCT00976820|64992923|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
23341093|NCT00976820|64992920|FG000|Overall Study|Withdrawal by Subject|2|||
23341094|NCT00976820|64992921|FG001|Overall Study|Withdrawal by Subject|4|||
23341095|NCT00976820|64992922|FG002|Overall Study|Withdrawal by Subject|1|||
23341096|NCT00976820|64992923|FG003|Overall Study|Withdrawal by Subject|4|||
23341097|NCT02892422|64992924|FG000|Overall Study|Enrolled not treated|4|||
23341098|NCT02892422|64992924|FG000|Overall Study|Adverse Event|38|||
23341099|NCT02892422|64992924|FG000|Overall Study|Lack of Efficacy|32|||
23341100|NCT02892422|64992924|FG000|Overall Study|Non-compliance with study drug|11|||
23341101|NCT02892422|64992924|FG000|Overall Study|Protocol Violation|4|||
23341102|NCT02892422|64992924|FG000|Overall Study|Withdrawal by Subject|56|||
23341103|NCT02892422|64992924|FG000|Overall Study|Lost to Follow-up|5|||
23341104|NCT02892422|64992924|FG000|Overall Study|sponsor information 16159A results|21|||
23341105|NCT02892422|64992924|FG000|Overall Study|withdrawal of consent|13|||
23341106|NCT02892422|64992924|FG000|Overall Study|exclusion criteria met|3|||
23341107|NCT02892422|64992924|FG000|Overall Study|moving elsewhere|4|||
23341108|NCT02892422|64992924|FG000|Overall Study|non-compliance|10|||
23341109|NCT02892422|64992924|FG000|Overall Study|patient legally incapable|1|||
23341110|NCT02892422|64992924|FG000|Overall Study|patient decision|7|||
23341111|NCT02892422|64992924|FG000|Overall Study|Investigator decision|1|||
23341112|NCT03843632|64992925|FG000|Overall Study|Withdrawal by Subject|1|||
23341113|NCT03843632|64992926|FG001|Overall Study|Withdrawal by Subject|0|||
23341114|NCT03843632|64992927|FG002|Overall Study|Withdrawal by Subject|0|||
23341115|NCT03843632|64992928|FG003|Overall Study|Withdrawal by Subject|0|||
23341116|NCT04712019|64992929|FG000|Overall Study|Withdrawal by Subject|2|||
23341117|NCT04712019|64992930|FG001|Overall Study|Withdrawal by Subject|2|||
23341118|NCT04712019|64992929|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
23341119|NCT04712019|64992930|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
23341120|NCT05343364|64992931|FG000|Overall Study|Miscellaneous|0|||
23341121|NCT05343364|64992932|FG001|Overall Study|Miscellaneous|1|||
23341122|NCT02031640|64992933|FG000|Screening Period|Adverse Event|1|||
23782628|NCT03965091|66583175|FG001|Overall Study|Withdrawal by Subject|3|||
23341123|NCT02031640|64992934|FG001|Screening Period|Adverse Event|0|||
23341124|NCT02031640|64992935|FG002|Screening Period|Adverse Event|0|||
23341125|NCT02031640|64992936|FG003|Screening Period|Adverse Event|0|||
23341126|NCT02031640|64992937|FG004|Screening Period|Adverse Event|0|||
23341127|NCT02031640|64992938|FG005|Screening Period|Adverse Event|0|||
23341128|NCT02031640|64992933|FG000|Screening Period|Withdrawal by Subject|29|||
23341129|NCT02031640|64992934|FG001|Screening Period|Withdrawal by Subject|0|||
23453876|NCT01667900|65403421|FG017|Part B|Death|0|||
23453877|NCT01667900|65403422|FG018|Part B|Death|0|||
23453878|NCT01667900|65403423|FG019|Part B|Death|0|||
23453879|NCT03050801|65403425|FG000|Experiment 1|Lost to Follow-up|0|||
23453880|NCT03050801|65403426|FG001|Experiment 1|Lost to Follow-up|1|||
23453881|NCT03050801|65403427|FG002|Experiment 1|Lost to Follow-up|0|||
23453882|NCT03050801|65403428|FG003|Experiment 1|Lost to Follow-up|0|||
23453883|NCT03050801|65403429|FG004|Experiment 1|Lost to Follow-up|0|||
23453884|NCT03050801|65403430|FG005|Experiment 1|Lost to Follow-up|0|||
23453885|NCT03050801|65403425|FG000|Experiment 1|Physician Decision|0|||
23453886|NCT03050801|65403426|FG001|Experiment 1|Physician Decision|3|||
23453887|NCT03050801|65403427|FG002|Experiment 1|Physician Decision|0|||
23453888|NCT03050801|65403428|FG003|Experiment 1|Physician Decision|0|||
23453889|NCT03050801|65403429|FG004|Experiment 1|Physician Decision|0|||
23453890|NCT03050801|65403430|FG005|Experiment 1|Physician Decision|0|||
23453891|NCT03050801|65403425|FG000|Experiment 1|Change of experimental design|0|||
23453892|NCT03050801|65403426|FG001|Experiment 1|Change of experimental design|3|||
23453893|NCT03050801|65403427|FG002|Experiment 1|Change of experimental design|0|||
23453894|NCT03050801|65403428|FG003|Experiment 1|Change of experimental design|0|||
23453895|NCT03050801|65403429|FG004|Experiment 1|Change of experimental design|0|||
23453896|NCT03050801|65403430|FG005|Experiment 1|Change of experimental design|0|||
23453897|NCT03050801|65403425|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453898|NCT03050801|65403426|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453899|NCT03050801|65403427|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
23453900|NCT03050801|65403428|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453901|NCT03050801|65403429|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453902|NCT03050801|65403430|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453903|NCT03050801|65403425|FG000|Experiment 2|Lost to Follow-up|0|||
23453904|NCT03050801|65403426|FG001|Experiment 2|Lost to Follow-up|0|||
23453905|NCT03050801|65403427|FG002|Experiment 2|Lost to Follow-up|0|||
23453906|NCT03050801|65403428|FG003|Experiment 2|Lost to Follow-up|1|||
23453907|NCT03050801|65403429|FG004|Experiment 2|Lost to Follow-up|1|||
23453908|NCT03050801|65403430|FG005|Experiment 2|Lost to Follow-up|0|||
23453909|NCT03050801|65403425|FG000|Experiment 2|Physician Decision|0|||
23453910|NCT03050801|65403426|FG001|Experiment 2|Physician Decision|0|||
23453911|NCT03050801|65403427|FG002|Experiment 2|Physician Decision|0|||
23453912|NCT03050801|65403428|FG003|Experiment 2|Physician Decision|0|||
23453913|NCT03050801|65403429|FG004|Experiment 2|Physician Decision|1|||
23453914|NCT03050801|65403430|FG005|Experiment 2|Physician Decision|0|||
23453915|NCT03050801|65403425|FG000|Experiment 2|Pregnancy|0|||
23453916|NCT03050801|65403426|FG001|Experiment 2|Pregnancy|0|||
23453917|NCT03050801|65403427|FG002|Experiment 2|Pregnancy|0|||
23453918|NCT03050801|65403428|FG003|Experiment 2|Pregnancy|0|||
23453919|NCT03050801|65403429|FG004|Experiment 2|Pregnancy|1|||
23782629|NCT03965091|66583176|FG002|Overall Study|Withdrawal by Subject|5|||
23782630|NCT03965091|66583174|FG000|Overall Study|Non-compliance with study drug|0|||
23453920|NCT03050801|65403430|FG005|Experiment 2|Pregnancy|0|||
23453921|NCT03050801|65403425|FG000|Experiment 2|Withdrawal by Subject|0|||
23453922|NCT03050801|65403426|FG001|Experiment 2|Withdrawal by Subject|0|||
23453923|NCT03050801|65403427|FG002|Experiment 2|Withdrawal by Subject|0|||
23453924|NCT03050801|65403428|FG003|Experiment 2|Withdrawal by Subject|1|||
23453925|NCT03050801|65403429|FG004|Experiment 2|Withdrawal by Subject|0|||
23453926|NCT03050801|65403430|FG005|Experiment 2|Withdrawal by Subject|0|||
23453927|NCT03050801|65403425|FG000|Experiment 2|Poor data quality|0|||
23453928|NCT03050801|65403426|FG001|Experiment 2|Poor data quality|0|||
23582294|NCT00543725|65862443|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23582295|NCT00543725|65862444|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
23582296|NCT00543725|65862443|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
23782631|NCT03965091|66583175|FG001|Overall Study|Non-compliance with study drug|0|||
23782632|NCT03965091|66583176|FG002|Overall Study|Non-compliance with study drug|1|||
23782633|NCT03965091|66583174|FG000|Overall Study|Lost to Follow-up|1|||
23782634|NCT03965091|66583175|FG001|Overall Study|Lost to Follow-up|1|||
23782635|NCT03965091|66583176|FG002|Overall Study|Lost to Follow-up|1|||
23782636|NCT03965091|66583174|FG000|Overall Study|Lack of Efficacy|2|||
23453929|NCT03050801|65403427|FG002|Experiment 2|Poor data quality|0|||
23453930|NCT03050801|65403428|FG003|Experiment 2|Poor data quality|4|||
23453931|NCT03050801|65403429|FG004|Experiment 2|Poor data quality|1|||
23453932|NCT03050801|65403430|FG005|Experiment 2|Poor data quality|0|||
23782637|NCT03965091|66583175|FG001|Overall Study|Lack of Efficacy|0|||
23782638|NCT03965091|66583176|FG002|Overall Study|Lack of Efficacy|0|||
23402704|NCT03289143|65219986|FG003|Overall Study|Protocol Deviation|1|||
23453933|NCT03050801|65403425|FG000|Experiment 2|Discomfort during stimulation|0|||
23453934|NCT03050801|65403426|FG001|Experiment 2|Discomfort during stimulation|0|||
23453935|NCT03050801|65403427|FG002|Experiment 2|Discomfort during stimulation|0|||
23453936|NCT03050801|65403428|FG003|Experiment 2|Discomfort during stimulation|0|||
23453937|NCT03050801|65403429|FG004|Experiment 2|Discomfort during stimulation|0|||
23453938|NCT03050801|65403430|FG005|Experiment 2|Discomfort during stimulation|2|||
23582297|NCT00543725|65862444|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
23582298|NCT00543725|65862443|FG000|Overall Study|Protocol Violation|0|||
23453939|NCT01349959|65403431|FG000|Overall Study|Adverse Event|7|||
23453940|NCT00657046|65403432|FG000|Overall Study|Adverse Event|1|||
23453941|NCT00657046|65403433|FG001|Overall Study|Adverse Event|1|||
23453942|NCT00657046|65403434|FG002|Overall Study|Adverse Event|0|||
23453943|NCT00657046|65403432|FG000|Overall Study|Protocol Violation|2|||
23453944|NCT00657046|65403433|FG001|Overall Study|Protocol Violation|2|||
23453945|NCT00657046|65403434|FG002|Overall Study|Protocol Violation|0|||
23453946|NCT00657046|65403432|FG000|Overall Study|Withdrawal by Subject|1|||
23453947|NCT00657046|65403433|FG001|Overall Study|Withdrawal by Subject|0|||
23453948|NCT00657046|65403434|FG002|Overall Study|Withdrawal by Subject|0|||
23453949|NCT00657046|65403432|FG000|Overall Study|Death|0|||
23453950|NCT00657046|65403433|FG001|Overall Study|Death|0|||
23453951|NCT00657046|65403434|FG002|Overall Study|Death|1|||
23453952|NCT00657046|65403432|FG000|Overall Study|Surgery|0|||
23453953|NCT00657046|65403433|FG001|Overall Study|Surgery|0|||
23453954|NCT00657046|65403434|FG002|Overall Study|Surgery|1|||
23453955|NCT01091675|65403437|FG000|Overall Study|Adverse Event|7|||
23453956|NCT01091675|65403437|FG000|Overall Study|Lack of Efficacy|27|||
23453957|NCT02718898|65403438|FG000|Blinded Treatment Period|Adverse Event|5|||
23453958|NCT02718898|65403439|FG001|Blinded Treatment Period|Adverse Event|1|||
23453959|NCT02718898|65403440|FG002|Blinded Treatment Period|Adverse Event|0|||
23453960|NCT02718898|65403441|FG003|Blinded Treatment Period|Adverse Event|0|||
23453961|NCT02718898|65403442|FG004|Blinded Treatment Period|Adverse Event|0|||
23453962|NCT02718898|65403443|FG005|Blinded Treatment Period|Adverse Event|0|||
23453963|NCT02718898|65403444|FG006|Blinded Treatment Period|Adverse Event|0|||
23453964|NCT02718898|65403438|FG000|Blinded Treatment Period|Physician Decision|1|||
23453965|NCT02718898|65403439|FG001|Blinded Treatment Period|Physician Decision|0|||
23453966|NCT02718898|65403440|FG002|Blinded Treatment Period|Physician Decision|0|||
23582299|NCT00543725|65862444|FG001|Overall Study|Protocol Violation|1|||
23582300|NCT00543725|65862443|FG000|Overall Study|Withdrawal by Subject|4|||
23582301|NCT00543725|65862444|FG001|Overall Study|Withdrawal by Subject|13|||
23582302|NCT00543725|65862443|FG000|Overall Study|Lost to Follow-up|15|||
23582303|NCT00543725|65862444|FG001|Overall Study|Lost to Follow-up|11|||
23582304|NCT00543725|65862443|FG000|Overall Study|Other|3|||
23582305|NCT00543725|65862444|FG001|Overall Study|Other|3|||
23582306|NCT02096003|65862446|FG000|Overall Study|Protocol Violation|0|||
23582307|NCT02096003|65862447|FG001|Overall Study|Protocol Violation|2|||
23582308|NCT02096003|65862446|FG000|Overall Study|additional surgery|2|||
23582309|NCT02096003|65862447|FG001|Overall Study|additional surgery|1|||
23582310|NCT03646669|65862449|FG000|Overall Study|Withdrawal by Subject|5|||
23582311|NCT03646669|65862450|FG001|Overall Study|Withdrawal by Subject|0|||
23582312|NCT03055013|65862453|FG000|Overall Study|Adverse Event|78|||
23582313|NCT03055013|65862454|FG001|Overall Study|Adverse Event|0|||
23582314|NCT03055013|65862453|FG000|Overall Study|Death|6|||
23582315|NCT03055013|65862454|FG001|Overall Study|Death|0|||
23582316|NCT03055013|65862453|FG000|Overall Study|Disease relapse|33|||
23582317|NCT03055013|65862454|FG001|Overall Study|Disease relapse|0|||
23582318|NCT03055013|65862453|FG000|Overall Study|Withdrawal by Subject|28|||
23582319|NCT03055013|65862454|FG001|Overall Study|Withdrawal by Subject|0|||
23582320|NCT03055013|65862453|FG000|Overall Study|Other complicating disease|5|||
23582321|NCT03055013|65862454|FG001|Overall Study|Other complicating disease|0|||
23582322|NCT03055013|65862453|FG000|Overall Study|Physician Decision|1|||
23582323|NCT03055013|65862454|FG001|Overall Study|Physician Decision|0|||
23582324|NCT03055013|65862453|FG000|Overall Study|Benign mass/non-RCC|4|||
23582325|NCT03055013|65862454|FG001|Overall Study|Benign mass/non-RCC|0|||
23582326|NCT03055013|65862453|FG000|Overall Study|Enrolled in another trial|1|||
23582327|NCT03055013|65862454|FG001|Overall Study|Enrolled in another trial|0|||
23582328|NCT03055013|65862453|FG000|Overall Study|Non-protocol therapy|1|||
23582329|NCT03055013|65862454|FG001|Overall Study|Non-protocol therapy|0|||
23582330|NCT03055013|65862453|FG000|Overall Study|Incompliance|1|||
23582331|NCT03055013|65862454|FG001|Overall Study|Incompliance|0|||
23582332|NCT03055013|65862453|FG000|Overall Study|Insurance issues|1|||
23582333|NCT03055013|65862454|FG001|Overall Study|Insurance issues|0|||
23582334|NCT03055013|65862453|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
23582335|NCT03055013|65862454|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
23582336|NCT03055013|65862453|FG000|Overall Study|Did not receive nivolumab|10|||
23582337|NCT03055013|65862454|FG001|Overall Study|Did not receive nivolumab|0|||
23582338|NCT03055013|65862453|FG000|Overall Study|Did not receive surgery|0|||
23582339|NCT03055013|65862454|FG001|Overall Study|Did not receive surgery|28|||
23582340|NCT01511250|65862455|FG000|Overall Study|Withdrawal of Consent|1|||
23582341|NCT01511250|65862456|FG001|Overall Study|Withdrawal of Consent|0|||
23582342|NCT01511250|65862457|FG002|Overall Study|Withdrawal of Consent|0|||
23453967|NCT02718898|65403441|FG003|Blinded Treatment Period|Physician Decision|0|||
23453968|NCT02718898|65403442|FG004|Blinded Treatment Period|Physician Decision|0|||
23453969|NCT02718898|65403443|FG005|Blinded Treatment Period|Physician Decision|0|||
23453970|NCT02718898|65403444|FG006|Blinded Treatment Period|Physician Decision|0|||
23636685|NCT00685698|66052968|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
23636686|NCT00685698|66052968|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
23636687|NCT03480932|66052969|FG000|Overall Study|Death|1|||
23636688|NCT03480932|66052970|FG001|Overall Study|Death|1|||
23636689|NCT03480932|66052971|FG002|Overall Study|Death|0|||
23636690|NCT03480932|66052969|FG000|Overall Study|Lost to Follow-up|0|||
23636691|NCT03480932|66052970|FG001|Overall Study|Lost to Follow-up|2|||
23636692|NCT03480932|66052971|FG002|Overall Study|Lost to Follow-up|3|||
23636693|NCT03480932|66052969|FG000|Overall Study|Incarcerated|2|||
23636694|NCT03480932|66052970|FG001|Overall Study|Incarcerated|2|||
23782639|NCT03965091|66583174|FG000|Overall Study|Other than specified|9|||
23782640|NCT03965091|66583175|FG001|Overall Study|Other than specified|11|||
23782641|NCT03965091|66583176|FG002|Overall Study|Other than specified|8|||
23782642|NCT03017885|66583177|FG000|Overall Study|Adverse Event|2|||
23782643|NCT03017885|66583178|FG001|Overall Study|Adverse Event|0|||
23453971|NCT02718898|65403438|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
23453972|NCT02718898|65403439|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
23782644|NCT03017885|66583179|FG002|Overall Study|Adverse Event|0|||
23782645|NCT03017885|66583180|FG003|Overall Study|Adverse Event|0|||
23782646|NCT03017885|66583181|FG004|Overall Study|Adverse Event|0|||
23782647|NCT03017885|66583182|FG005|Overall Study|Adverse Event|0|||
23782648|NCT03017885|66583177|FG000|Overall Study|Progression of disease|4|||
23782649|NCT03017885|66583178|FG001|Overall Study|Progression of disease|3|||
23782650|NCT03017885|66583179|FG002|Overall Study|Progression of disease|4|||
23782651|NCT03017885|66583180|FG003|Overall Study|Progression of disease|0|||
23782652|NCT03017885|66583181|FG004|Overall Study|Progression of disease|0|||
23782653|NCT03017885|66583182|FG005|Overall Study|Progression of disease|0|||
23782654|NCT03017885|66583177|FG000|Overall Study|Other than listed|1|||
23782655|NCT03017885|66583178|FG001|Overall Study|Other than listed|2|||
23782656|NCT03017885|66583179|FG002|Overall Study|Other than listed|1|||
23782657|NCT03017885|66583180|FG003|Overall Study|Other than listed|0|||
23782658|NCT03017885|66583181|FG004|Overall Study|Other than listed|0|||
23782659|NCT03017885|66583182|FG005|Overall Study|Other than listed|0|||
23782660|NCT03017885|66583177|FG000|Overall Study|Lost to Follow-up|2|||
23782661|NCT03017885|66583178|FG001|Overall Study|Lost to Follow-up|0|||
23782662|NCT03017885|66583179|FG002|Overall Study|Lost to Follow-up|3|||
23782663|NCT03017885|66583180|FG003|Overall Study|Lost to Follow-up|0|||
23782664|NCT03017885|66583181|FG004|Overall Study|Lost to Follow-up|0|||
23782665|NCT03017885|66583182|FG005|Overall Study|Lost to Follow-up|0|||
23782666|NCT03017885|66583177|FG000|Overall Study|Change to other anti-cancer therapy|0|||
23782667|NCT03017885|66583178|FG001|Overall Study|Change to other anti-cancer therapy|0|||
23782668|NCT03017885|66583179|FG002|Overall Study|Change to other anti-cancer therapy|1|||
23782669|NCT03017885|66583180|FG003|Overall Study|Change to other anti-cancer therapy|0|||
23782670|NCT03017885|66583181|FG004|Overall Study|Change to other anti-cancer therapy|0|||
23782671|NCT03017885|66583182|FG005|Overall Study|Change to other anti-cancer therapy|0|||
23782672|NCT03522675|66583183|FG000|Overall Study|Screen fail|1|||
23782673|NCT03522675|66583183|FG000|Overall Study|Non-reactive to histamine|1|||
23782674|NCT02865122|66583184|FG000|Overall Study|Adverse Event|1|||
23782675|NCT02865122|66583185|FG001|Overall Study|Adverse Event|0|||
23782676|NCT02865122|66583186|FG002|Overall Study|Adverse Event|0|||
23782677|NCT03514017|66583187|FG000|Overall Study|Death|1|||
23782678|NCT03514017|66583187|FG000|Overall Study|Adverse Event|1|||
23782679|NCT03868891|66583191|FG000|Overall Study|Adverse Event|1|||
23782680|NCT03868891|66583192|FG001|Overall Study|Adverse Event|0|||
23782681|NCT03868891|66583191|FG000|Overall Study|Lost to Follow-up|2|||
23782682|NCT03868891|66583192|FG001|Overall Study|Lost to Follow-up|1|||
23782683|NCT03868891|66583191|FG000|Overall Study|COVID-19 Restrictions|1|||
23782684|NCT03868891|66583192|FG001|Overall Study|COVID-19 Restrictions|2|||
23782685|NCT01265056|66583193|FG000|Initial Study Period|Withdrawal by Subject|1|||
23782686|NCT01265056|66583194|FG001|Initial Study Period|Withdrawal by Subject|1|||
23782687|NCT01265056|66583193|FG000|Initial Study Period|Withdrawal by Subject|1|||
23782688|NCT01265056|66583194|FG001|Initial Study Period|Withdrawal by Subject|1|||
23782689|NCT01265056|66583193|FG000|Follow up|Lost to Follow-up|7|||
23782690|NCT01265056|66583194|FG001|Follow up|Lost to Follow-up|3|||
23782691|NCT01111461|66583195|FG000|Overall Study|Adverse Event|32|||
23782692|NCT01111461|66583195|FG000|Overall Study|Participant choice|11|||
23453973|NCT02718898|65403440|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
23453974|NCT02718898|65403441|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
23782693|NCT01111461|66583195|FG000|Overall Study|Lost to Follow-up|1|||
23453975|NCT02718898|65403442|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
23636695|NCT03480932|66052971|FG002|Overall Study|Incarcerated|2|||
23636696|NCT00037830|66052972|FG000|Overall Study|Adverse Event|2|||
23636697|NCT00037830|66052973|FG001|Overall Study|Adverse Event|0|||
23636698|NCT00037830|66052974|FG002|Overall Study|Adverse Event|0|||
23636699|NCT00037830|66052972|FG000|Overall Study|Withdrawal by Subject|4|||
23636700|NCT00037830|66052973|FG001|Overall Study|Withdrawal by Subject|5|||
23636701|NCT00037830|66052974|FG002|Overall Study|Withdrawal by Subject|1|||
23636702|NCT00037830|66052972|FG000|Overall Study|Protocol Violation|2|||
23341130|NCT02031640|64992935|FG002|Screening Period|Withdrawal by Subject|0|||
23341131|NCT02031640|64992936|FG003|Screening Period|Withdrawal by Subject|0|||
23341132|NCT02031640|64992937|FG004|Screening Period|Withdrawal by Subject|0|||
23341133|NCT02031640|64992938|FG005|Screening Period|Withdrawal by Subject|0|||
23341134|NCT02031640|64992933|FG000|Screening Period|Inclusion criteria not met|312|||
23341135|NCT02031640|64992934|FG001|Screening Period|Inclusion criteria not met|0|||
23341136|NCT02031640|64992935|FG002|Screening Period|Inclusion criteria not met|0|||
23341137|NCT02031640|64992936|FG003|Screening Period|Inclusion criteria not met|0|||
23341138|NCT02031640|64992937|FG004|Screening Period|Inclusion criteria not met|0|||
23341139|NCT02031640|64992938|FG005|Screening Period|Inclusion criteria not met|0|||
23341140|NCT02031640|64992933|FG000|Screening Period|Exclusion criteria met|30|||
23341141|NCT02031640|64992934|FG001|Screening Period|Exclusion criteria met|0|||
23341142|NCT02031640|64992935|FG002|Screening Period|Exclusion criteria met|0|||
23341143|NCT02031640|64992936|FG003|Screening Period|Exclusion criteria met|0|||
23341144|NCT02031640|64992937|FG004|Screening Period|Exclusion criteria met|0|||
23341145|NCT02031640|64992938|FG005|Screening Period|Exclusion criteria met|0|||
23341146|NCT02031640|64992933|FG000|Screening Period|Lost to Follow-up|14|||
23341147|NCT02031640|64992934|FG001|Screening Period|Lost to Follow-up|0|||
23341148|NCT02031640|64992935|FG002|Screening Period|Lost to Follow-up|0|||
23341149|NCT02031640|64992936|FG003|Screening Period|Lost to Follow-up|0|||
23341150|NCT02031640|64992937|FG004|Screening Period|Lost to Follow-up|0|||
23341151|NCT02031640|64992938|FG005|Screening Period|Lost to Follow-up|0|||
23341152|NCT02031640|64992933|FG000|Screening Period|Enrollment closed|26|||
23341153|NCT02031640|64992934|FG001|Screening Period|Enrollment closed|0|||
23341154|NCT02031640|64992935|FG002|Screening Period|Enrollment closed|0|||
23341155|NCT02031640|64992936|FG003|Screening Period|Enrollment closed|0|||
23341156|NCT02031640|64992937|FG004|Screening Period|Enrollment closed|0|||
23341157|NCT02031640|64992938|FG005|Screening Period|Enrollment closed|0|||
23341158|NCT02031640|64992933|FG000|Run-In Period|Adverse Event|4|||
23341159|NCT02031640|64992934|FG001|Run-In Period|Adverse Event|0|||
23341160|NCT02031640|64992935|FG002|Run-In Period|Adverse Event|0|||
23341161|NCT02031640|64992936|FG003|Run-In Period|Adverse Event|0|||
23341162|NCT02031640|64992937|FG004|Run-In Period|Adverse Event|0|||
23341163|NCT02031640|64992938|FG005|Run-In Period|Adverse Event|0|||
23341164|NCT02031640|64992933|FG000|Run-In Period|Withdrawal by Subject|17|||
23341165|NCT02031640|64992934|FG001|Run-In Period|Withdrawal by Subject|0|||
23341166|NCT02031640|64992935|FG002|Run-In Period|Withdrawal by Subject|0|||
23341167|NCT02031640|64992936|FG003|Run-In Period|Withdrawal by Subject|0|||
23341168|NCT02031640|64992937|FG004|Run-In Period|Withdrawal by Subject|0|||
23341169|NCT02031640|64992938|FG005|Run-In Period|Withdrawal by Subject|0|||
23341170|NCT02031640|64992933|FG000|Run-In Period|Inclusion criteria not met|38|||
23341171|NCT02031640|64992934|FG001|Run-In Period|Inclusion criteria not met|0|||
23341172|NCT02031640|64992935|FG002|Run-In Period|Inclusion criteria not met|0|||
23341173|NCT02031640|64992936|FG003|Run-In Period|Inclusion criteria not met|0|||
23341174|NCT02031640|64992937|FG004|Run-In Period|Inclusion criteria not met|0|||
23782694|NCT01111461|66583195|FG000|Overall Study|Withdrawal by Subject|1|||
23782695|NCT01111461|66583195|FG000|Overall Study|Other|6|||
23782696|NCT01313780|66583196|FG000|Overall Study|Lack of Efficacy|4|||
23341175|NCT02031640|64992938|FG005|Run-In Period|Inclusion criteria not met|0|||
23341176|NCT02031640|64992933|FG000|Run-In Period|Exclusion criteria met|8|||
23341177|NCT02031640|64992934|FG001|Run-In Period|Exclusion criteria met|0|||
23341178|NCT02031640|64992935|FG002|Run-In Period|Exclusion criteria met|0|||
23341179|NCT02031640|64992936|FG003|Run-In Period|Exclusion criteria met|0|||
23341180|NCT02031640|64992937|FG004|Run-In Period|Exclusion criteria met|0|||
23341181|NCT02031640|64992938|FG005|Run-In Period|Exclusion criteria met|0|||
23341182|NCT02031640|64992933|FG000|Run-In Period|Randomization criteria not met|85|||
23341183|NCT02031640|64992934|FG001|Run-In Period|Randomization criteria not met|0|||
23341184|NCT02031640|64992935|FG002|Run-In Period|Randomization criteria not met|0|||
23341185|NCT02031640|64992936|FG003|Run-In Period|Randomization criteria not met|0|||
23341186|NCT02031640|64992937|FG004|Run-In Period|Randomization criteria not met|0|||
23341187|NCT02031640|64992938|FG005|Run-In Period|Randomization criteria not met|0|||
23453976|NCT02718898|65403443|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
23341188|NCT02031640|64992933|FG000|Run-In Period|Various administrative reasons|17|||
23341189|NCT02031640|64992934|FG001|Run-In Period|Various administrative reasons|0|||
23341190|NCT02031640|64992935|FG002|Run-In Period|Various administrative reasons|0|||
23341191|NCT02031640|64992936|FG003|Run-In Period|Various administrative reasons|0|||
23341192|NCT02031640|64992937|FG004|Run-In Period|Various administrative reasons|0|||
23341193|NCT02031640|64992938|FG005|Run-In Period|Various administrative reasons|0|||
23582343|NCT01511250|65862458|FG003|Overall Study|Withdrawal of Consent|0|||
23582344|NCT01511250|65862459|FG004|Overall Study|Withdrawal of Consent|0|||
23782697|NCT01313780|66583197|FG001|Overall Study|Lack of Efficacy|2|||
23341194|NCT02031640|64992933|FG000|Double-blind Treatment Period|Protocol deviation|0|||
23341195|NCT02031640|64992934|FG001|Double-blind Treatment Period|Protocol deviation|2|||
23341196|NCT02031640|64992935|FG002|Double-blind Treatment Period|Protocol deviation|0|||
23341197|NCT02031640|64992936|FG003|Double-blind Treatment Period|Protocol deviation|1|||
23341198|NCT02031640|64992937|FG004|Double-blind Treatment Period|Protocol deviation|3|||
23341199|NCT02031640|64992938|FG005|Double-blind Treatment Period|Protocol deviation|1|||
23341200|NCT02031640|64992933|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23341201|NCT02031640|64992934|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
23341202|NCT02031640|64992935|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
23341203|NCT02031640|64992936|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
23341204|NCT02031640|64992937|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
23341205|NCT02031640|64992938|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
23341206|NCT02031640|64992933|FG000|Double-blind Treatment Period|Non-compliance|0|||
23341207|NCT02031640|64992934|FG001|Double-blind Treatment Period|Non-compliance|1|||
23341208|NCT02031640|64992935|FG002|Double-blind Treatment Period|Non-compliance|0|||
23341209|NCT02031640|64992936|FG003|Double-blind Treatment Period|Non-compliance|1|||
23341210|NCT02031640|64992937|FG004|Double-blind Treatment Period|Non-compliance|1|||
23341211|NCT02031640|64992938|FG005|Double-blind Treatment Period|Non-compliance|0|||
23341212|NCT02031640|64992933|FG000|Double-blind Treatment Period|Adverse Event|0|||
23341213|NCT02031640|64992934|FG001|Double-blind Treatment Period|Adverse Event|0|||
23341214|NCT02031640|64992935|FG002|Double-blind Treatment Period|Adverse Event|0|||
23341215|NCT02031640|64992936|FG003|Double-blind Treatment Period|Adverse Event|2|||
23341216|NCT02031640|64992937|FG004|Double-blind Treatment Period|Adverse Event|0|||
23341217|NCT02031640|64992938|FG005|Double-blind Treatment Period|Adverse Event|0|||
23341218|NCT02031640|64992933|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23341219|NCT02031640|64992934|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23341220|NCT02031640|64992935|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
23341221|NCT02031640|64992936|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341222|NCT02031640|64992937|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341223|NCT02031640|64992938|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341224|NCT02031640|64992933|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23341225|NCT02031640|64992934|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
23341226|NCT02031640|64992935|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23341227|NCT02031640|64992936|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23341228|NCT02031640|64992937|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
23341229|NCT02031640|64992938|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
23341230|NCT03214380|64992939|FG000|Lead-in|Adverse Event|3|||
23341231|NCT03214380|64992940|FG001|Lead-in|Adverse Event|0|||
23341232|NCT03214380|64992941|FG002|Lead-in|Adverse Event|0|||
23341233|NCT03214380|64992942|FG003|Lead-in|Adverse Event|1|||
23341234|NCT03214380|64992943|FG004|Lead-in|Adverse Event|0|||
23341235|NCT03214380|64992944|FG005|Lead-in|Adverse Event|0|||
23341236|NCT03214380|64992939|FG000|Lead-in|Lost to Follow-up|4|||
23341237|NCT03214380|64992940|FG001|Lead-in|Lost to Follow-up|0|||
23341238|NCT03214380|64992941|FG002|Lead-in|Lost to Follow-up|0|||
23341239|NCT03214380|64992942|FG003|Lead-in|Lost to Follow-up|1|||
23341240|NCT03214380|64992943|FG004|Lead-in|Lost to Follow-up|0|||
23341241|NCT03214380|64992944|FG005|Lead-in|Lost to Follow-up|0|||
23341242|NCT03214380|64992939|FG000|Lead-in|Eligibility Criteria|3|||
23341243|NCT03214380|64992940|FG001|Lead-in|Eligibility Criteria|0|||
23341244|NCT03214380|64992941|FG002|Lead-in|Eligibility Criteria|0|||
23341245|NCT03214380|64992942|FG003|Lead-in|Eligibility Criteria|0|||
23341246|NCT03214380|64992943|FG004|Lead-in|Eligibility Criteria|0|||
23341247|NCT03214380|64992944|FG005|Lead-in|Eligibility Criteria|0|||
23341248|NCT03214380|64992939|FG000|Lead-in|Physician Decision|6|||
23341249|NCT03214380|64992940|FG001|Lead-in|Physician Decision|0|||
23341250|NCT03214380|64992941|FG002|Lead-in|Physician Decision|0|||
23341251|NCT03214380|64992942|FG003|Lead-in|Physician Decision|0|||
23341252|NCT03214380|64992943|FG004|Lead-in|Physician Decision|0|||
23341253|NCT03214380|64992944|FG005|Lead-in|Physician Decision|0|||
23341254|NCT03214380|64992939|FG000|Lead-in|Protocol Deviation|7|||
23341255|NCT03214380|64992940|FG001|Lead-in|Protocol Deviation|0|||
23341256|NCT03214380|64992941|FG002|Lead-in|Protocol Deviation|0|||
23341257|NCT03214380|64992942|FG003|Lead-in|Protocol Deviation|3|||
23341258|NCT03214380|64992943|FG004|Lead-in|Protocol Deviation|0|||
23341259|NCT03214380|64992944|FG005|Lead-in|Protocol Deviation|0|||
23636703|NCT00037830|66052973|FG001|Overall Study|Protocol Violation|2|||
23341260|NCT03214380|64992939|FG000|Lead-in|Withdrawal by Subject|41|||
23341261|NCT03214380|64992940|FG001|Lead-in|Withdrawal by Subject|0|||
23341262|NCT03214380|64992941|FG002|Lead-in|Withdrawal by Subject|0|||
23341263|NCT03214380|64992942|FG003|Lead-in|Withdrawal by Subject|14|||
23341264|NCT03214380|64992943|FG004|Lead-in|Withdrawal by Subject|0|||
23341265|NCT03214380|64992944|FG005|Lead-in|Withdrawal by Subject|0|||
23341266|NCT03214380|64992939|FG000|Lead-in|Family Emergency|1|||
23341267|NCT03214380|64992940|FG001|Lead-in|Family Emergency|0|||
23341268|NCT03214380|64992941|FG002|Lead-in|Family Emergency|0|||
23341269|NCT03214380|64992942|FG003|Lead-in|Family Emergency|0|||
23341270|NCT03214380|64992943|FG004|Lead-in|Family Emergency|0|||
23341271|NCT03214380|64992944|FG005|Lead-in|Family Emergency|0|||
23636704|NCT00037830|66052974|FG002|Overall Study|Protocol Violation|0|||
23341272|NCT03214380|64992939|FG000|Lead-in|Natural Disaster|9|||
23341273|NCT03214380|64992940|FG001|Lead-in|Natural Disaster|0|||
23341274|NCT03214380|64992941|FG002|Lead-in|Natural Disaster|0|||
23341275|NCT03214380|64992942|FG003|Lead-in|Natural Disaster|0|||
23341276|NCT03214380|64992943|FG004|Lead-in|Natural Disaster|0|||
23341277|NCT03214380|64992944|FG005|Lead-in|Natural Disaster|0|||
23341278|NCT03214380|64992939|FG000|Lead-in|Non Compliance|1|||
23341279|NCT03214380|64992940|FG001|Lead-in|Non Compliance|0|||
23341280|NCT03214380|64992941|FG002|Lead-in|Non Compliance|0|||
23341281|NCT03214380|64992942|FG003|Lead-in|Non Compliance|0|||
23341282|NCT03214380|64992943|FG004|Lead-in|Non Compliance|0|||
23341283|NCT03214380|64992944|FG005|Lead-in|Non Compliance|0|||
23341284|NCT03214380|64992939|FG000|Lead-in|Participant Schedule|2|||
23341285|NCT03214380|64992940|FG001|Lead-in|Participant Schedule|0|||
23341286|NCT03214380|64992941|FG002|Lead-in|Participant Schedule|0|||
23341287|NCT03214380|64992942|FG003|Lead-in|Participant Schedule|0|||
23341288|NCT03214380|64992943|FG004|Lead-in|Participant Schedule|0|||
23341289|NCT03214380|64992944|FG005|Lead-in|Participant Schedule|0|||
23341290|NCT03214380|64992939|FG000|Treatment Period|Adverse Event|0|||
23341291|NCT03214380|64992940|FG001|Treatment Period|Adverse Event|1|||
23341292|NCT03214380|64992941|FG002|Treatment Period|Adverse Event|1|||
23341293|NCT03214380|64992942|FG003|Treatment Period|Adverse Event|0|||
23341294|NCT03214380|64992943|FG004|Treatment Period|Adverse Event|1|||
23341295|NCT03214380|64992944|FG005|Treatment Period|Adverse Event|0|||
23341296|NCT03214380|64992939|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
23341297|NCT03214380|64992940|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
23341298|NCT03214380|64992941|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
23341299|NCT03214380|64992942|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
23341300|NCT03214380|64992943|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
23341301|NCT03214380|64992944|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
23341302|NCT03214380|64992939|FG000|Treatment Period|Withdrawal by Subject|0|||
23341303|NCT03214380|64992940|FG001|Treatment Period|Withdrawal by Subject|10|||
23341304|NCT03214380|64992941|FG002|Treatment Period|Withdrawal by Subject|8|||
23341305|NCT03214380|64992942|FG003|Treatment Period|Withdrawal by Subject|0|||
23341306|NCT03214380|64992943|FG004|Treatment Period|Withdrawal by Subject|7|||
23341307|NCT03214380|64992944|FG005|Treatment Period|Withdrawal by Subject|11|||
23341308|NCT03214380|64992939|FG000|Treatment Period|Death|0|||
23341309|NCT03214380|64992940|FG001|Treatment Period|Death|1|||
23341310|NCT03214380|64992941|FG002|Treatment Period|Death|2|||
23341311|NCT03214380|64992942|FG003|Treatment Period|Death|0|||
23341312|NCT03214380|64992943|FG004|Treatment Period|Death|0|||
23341313|NCT03214380|64992944|FG005|Treatment Period|Death|0|||
23341314|NCT03214380|64992939|FG000|Treatment Period|Lost to Follow-up|0|||
23341315|NCT03214380|64992940|FG001|Treatment Period|Lost to Follow-up|6|||
23341316|NCT03214380|64992941|FG002|Treatment Period|Lost to Follow-up|3|||
23341317|NCT03214380|64992942|FG003|Treatment Period|Lost to Follow-up|0|||
23341318|NCT03214380|64992943|FG004|Treatment Period|Lost to Follow-up|0|||
23341319|NCT03214380|64992944|FG005|Treatment Period|Lost to Follow-up|0|||
23341320|NCT03214380|64992939|FG000|Treatment Period|Participant schedule|0|||
23341321|NCT03214380|64992940|FG001|Treatment Period|Participant schedule|0|||
23341322|NCT03214380|64992941|FG002|Treatment Period|Participant schedule|1|||
23341323|NCT03214380|64992942|FG003|Treatment Period|Participant schedule|0|||
23341324|NCT03214380|64992943|FG004|Treatment Period|Participant schedule|0|||
23341325|NCT03214380|64992944|FG005|Treatment Period|Participant schedule|0|||
23341326|NCT03214380|64992939|FG000|Treatment Period|Treatment Interruption|0|||
23341327|NCT03214380|64992940|FG001|Treatment Period|Treatment Interruption|0|||
23341328|NCT03214380|64992941|FG002|Treatment Period|Treatment Interruption|1|||
23341329|NCT03214380|64992942|FG003|Treatment Period|Treatment Interruption|0|||
23341330|NCT03214380|64992943|FG004|Treatment Period|Treatment Interruption|0|||
23341331|NCT03214380|64992944|FG005|Treatment Period|Treatment Interruption|0|||
23341332|NCT03452488|64992945|FG000|Overall Study|Adverse Event|4|||
23341333|NCT03452488|64992946|FG001|Overall Study|Adverse Event|6|||
23341334|NCT03452488|64992947|FG002|Overall Study|Adverse Event|1|||
23582345|NCT01511250|65862460|FG005|Overall Study|Withdrawal of Consent|0|||
23636705|NCT00037830|66052972|FG000|Overall Study|Unrelated Medical Problem|2|||
23636706|NCT00037830|66052973|FG001|Overall Study|Unrelated Medical Problem|0|||
23636707|NCT00037830|66052974|FG002|Overall Study|Unrelated Medical Problem|0|||
23782698|NCT01313780|66583196|FG000|Overall Study|Adverse Event|6|||
23341335|NCT03452488|64992945|FG000|Overall Study|Death|0|||
23341336|NCT03452488|64992946|FG001|Overall Study|Death|0|||
23341337|NCT03452488|64992947|FG002|Overall Study|Death|1|||
23341338|NCT03452488|64992945|FG000|Overall Study|Lost to Follow-up|1|||
23341339|NCT03452488|64992946|FG001|Overall Study|Lost to Follow-up|2|||
23341340|NCT03452488|64992947|FG002|Overall Study|Lost to Follow-up|0|||
23341341|NCT03452488|64992945|FG000|Overall Study|PI Decision|1|||
23341342|NCT03452488|64992946|FG001|Overall Study|PI Decision|0|||
23341343|NCT03452488|64992947|FG002|Overall Study|PI Decision|0|||
23341344|NCT03452488|64992945|FG000|Overall Study|Withdrew consent|4|||
23636708|NCT00288639|66052977|FG000|Overall Study|Adverse Event|5|||
23636709|NCT00288639|66052977|FG000|Overall Study|Lack of Efficacy|4|||
23341345|NCT03452488|64992946|FG001|Overall Study|Withdrew consent|2|||
23341346|NCT03452488|64992947|FG002|Overall Study|Withdrew consent|2|||
23341347|NCT03452488|64992945|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
23341348|NCT03452488|64992946|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
23341349|NCT03452488|64992947|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
23341350|NCT03452488|64992945|FG000|Overall Study|Other|0|||
23341351|NCT03452488|64992946|FG001|Overall Study|Other|2|||
23341352|NCT03452488|64992947|FG002|Overall Study|Other|2|||
23341353|NCT02272842|64992948|FG000|Overall Study|Lost to Follow-up|8|||
23453977|NCT02718898|65403444|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
23453978|NCT02718898|65403438|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
23582346|NCT01511250|65862461|FG006|Overall Study|Withdrawal of Consent|0|||
23582347|NCT01511250|65862462|FG007|Overall Study|Withdrawal of Consent|1|||
23582348|NCT01511250|65862463|FG008|Overall Study|Withdrawal of Consent|1|||
23582349|NCT01511250|65862464|FG009|Overall Study|Withdrawal of Consent|0|||
23782699|NCT01313780|66583197|FG001|Overall Study|Adverse Event|11|||
23782700|NCT01313780|66583196|FG000|Overall Study|Withdrawal by Subject|2|||
23782701|NCT01313780|66583197|FG001|Overall Study|Withdrawal by Subject|8|||
23782702|NCT01313780|66583196|FG000|Overall Study|Protocol Violation|10|||
23782703|NCT01313780|66583197|FG001|Overall Study|Protocol Violation|4|||
23782704|NCT01313780|66583196|FG000|Overall Study|missing data|3|||
23782705|NCT01313780|66583197|FG001|Overall Study|missing data|3|||
23782706|NCT05099380|66583199|FG000|Overall Study|Subject enrolled in error|1|||
23782707|NCT05099380|66583200|FG001|Overall Study|Subject enrolled in error|0|||
23782708|NCT05099380|66583199|FG000|Overall Study|Study Procedure|1|||
23782709|NCT05099380|66583200|FG001|Overall Study|Study Procedure|0|||
23782710|NCT05099380|66583199|FG000|Overall Study|Protocol Violation|1|||
23782711|NCT05099380|66583200|FG001|Overall Study|Protocol Violation|0|||
23782712|NCT05099380|66583199|FG000|Overall Study|Adverse Event|1|||
23782713|NCT05099380|66583200|FG001|Overall Study|Adverse Event|1|||
23782714|NCT05099380|66583199|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
23782715|NCT05099380|66583200|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
23782716|NCT04278560|66583201|FG000|Overall Study|Adverse Event|1|||
23782717|NCT04278560|66583202|FG001|Overall Study|Adverse Event|2|||
23782718|NCT04278560|66583201|FG000|Overall Study|Withdrawal by Subject|0|||
23782719|NCT04278560|66583202|FG001|Overall Study|Withdrawal by Subject|1|||
23782720|NCT01237054|66583204|FG000|Overall Study|imaging 10C0096|1|||
23782721|NCT03181594|66583212|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
23782722|NCT03181594|66583212|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
23782723|NCT03181594|66583212|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
23782724|NCT03181594|66583212|FG000|Initial Study Protocol (12-month FU)|Death|1|||
23582350|NCT01511250|65862455|FG000|Overall Study|Sponsor/Investigator Decision|1|||
23582351|NCT01511250|65862456|FG001|Overall Study|Sponsor/Investigator Decision|0|||
23582352|NCT01511250|65862457|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23582353|NCT01511250|65862458|FG003|Overall Study|Sponsor/Investigator Decision|0|||
23582354|NCT01511250|65862459|FG004|Overall Study|Sponsor/Investigator Decision|0|||
23582355|NCT01511250|65862460|FG005|Overall Study|Sponsor/Investigator Decision|0|||
23582356|NCT01511250|65862461|FG006|Overall Study|Sponsor/Investigator Decision|0|||
23582357|NCT01511250|65862462|FG007|Overall Study|Sponsor/Investigator Decision|0|||
23582358|NCT01511250|65862463|FG008|Overall Study|Sponsor/Investigator Decision|0|||
23582359|NCT01511250|65862464|FG009|Overall Study|Sponsor/Investigator Decision|0|||
23582360|NCT01511250|65862455|FG000|Overall Study|Lost to Follow-up|7|||
23582361|NCT01511250|65862456|FG001|Overall Study|Lost to Follow-up|3|||
23582362|NCT01511250|65862457|FG002|Overall Study|Lost to Follow-up|3|||
23582363|NCT01511250|65862458|FG003|Overall Study|Lost to Follow-up|3|||
23582364|NCT01511250|65862459|FG004|Overall Study|Lost to Follow-up|0|||
23582365|NCT01511250|65862460|FG005|Overall Study|Lost to Follow-up|0|||
23582366|NCT01511250|65862461|FG006|Overall Study|Lost to Follow-up|2|||
23582367|NCT01511250|65862462|FG007|Overall Study|Lost to Follow-up|3|||
23582368|NCT01511250|65862463|FG008|Overall Study|Lost to Follow-up|13|||
23582369|NCT01511250|65862464|FG009|Overall Study|Lost to Follow-up|5|||
23582370|NCT01511250|65862455|FG000|Overall Study|Protocol Violation|0|||
23582371|NCT01511250|65862456|FG001|Overall Study|Protocol Violation|2|||
23582372|NCT01511250|65862457|FG002|Overall Study|Protocol Violation|1|||
23582373|NCT01511250|65862458|FG003|Overall Study|Protocol Violation|0|||
23782725|NCT03181594|66583212|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
23341354|NCT02272842|64992949|FG001|Overall Study|Lost to Follow-up|8|||
23341355|NCT02272842|64992948|FG000|Overall Study|Withdrawal by Subject|8|||
23341356|NCT02272842|64992949|FG001|Overall Study|Withdrawal by Subject|2|||
23582374|NCT01511250|65862459|FG004|Overall Study|Protocol Violation|0|||
23582375|NCT01511250|65862460|FG005|Overall Study|Protocol Violation|0|||
23582376|NCT01511250|65862461|FG006|Overall Study|Protocol Violation|0|||
23782726|NCT03181594|66583212|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
23782727|NCT00112463|66583213|FG000|Overall Study|Physician Decision|1|||
23782728|NCT00112463|66583213|FG000|Overall Study|Progression|30|||
23782729|NCT00112463|66583213|FG000|Overall Study|Second Primary|1|||
23341357|NCT01820572|64992952|FG000|Randomization|Not Treated|2|||
23341358|NCT01820572|64992953|FG001|Randomization|Not Treated|1|||
23341359|NCT01820572|64992952|FG000|Treatment Period|Adverse Event|12|||
23341360|NCT01820572|64992953|FG001|Treatment Period|Adverse Event|7|||
23341361|NCT01820572|64992952|FG000|Treatment Period|Death|3|||
23341362|NCT01820572|64992953|FG001|Treatment Period|Death|3|||
23341363|NCT01820572|64992952|FG000|Treatment Period|Lack of Efficacy|1|||
23341364|NCT01820572|64992953|FG001|Treatment Period|Lack of Efficacy|0|||
23341365|NCT01820572|64992952|FG000|Treatment Period|poor/non compliance|0|||
23341366|NCT01820572|64992953|FG001|Treatment Period|poor/non compliance|3|||
23341367|NCT01820572|64992952|FG000|Treatment Period|request to discontinue|6|||
23341368|NCT01820572|64992953|FG001|Treatment Period|request to discontinue|11|||
23341369|NCT01820572|64992952|FG000|Treatment Period|No longer meets study criteria|3|||
23341370|NCT01820572|64992953|FG001|Treatment Period|No longer meets study criteria|10|||
23341371|NCT01820572|64992952|FG000|Treatment Period|withdrew consent|1|||
23341372|NCT01820572|64992953|FG001|Treatment Period|withdrew consent|2|||
23341373|NCT01084668|64992957|FG000|Overall Study|Lack of Efficacy|5|||
23341374|NCT01084668|64992957|FG000|Overall Study|Withdrawal by Subject|2|||
23341375|NCT01084668|64992957|FG000|Overall Study|Pregnancy|1|||
23341376|NCT01084668|64992957|FG000|Overall Study|Non-compliance|1|||
23341377|NCT05087966|64992959|FG000|Overall Study|Lost to Follow-up|1|||
23341378|NCT05087966|64992959|FG000|Overall Study|Withdrawal by Subject|5|||
23341379|NCT03613649|64992960|FG000|Second Treatment|Lost to Follow-up|0|||
23341380|NCT03613649|64992961|FG001|Second Treatment|Lost to Follow-up|0|||
23341381|NCT03613649|64992962|FG002|Second Treatment|Lost to Follow-up|1|||
23341382|NCT03613649|64992963|FG003|Second Treatment|Lost to Follow-up|0|||
23341383|NCT03613649|64992964|FG004|Second Treatment|Lost to Follow-up|0|||
23341384|NCT03613649|64992965|FG005|Second Treatment|Lost to Follow-up|0|||
23341385|NCT03613649|64992966|FG006|Second Treatment|Lost to Follow-up|0|||
23782730|NCT00112463|66583213|FG000|Overall Study|Toxicity|3|||
23782731|NCT00112463|66583213|FG000|Overall Study|Withdrawal by Subject|2|||
23782732|NCT00112463|66583213|FG000|Overall Study|Never started treatment|2|||
23782733|NCT03381274|66583214|FG000|Overall Study|Death|2|||
23782734|NCT03381274|66583215|FG001|Overall Study|Death|9|||
23782735|NCT03381274|66583216|FG002|Overall Study|Death|3|||
23782736|NCT03381274|66583217|FG003|Overall Study|Death|2|||
23782737|NCT03381274|66583218|FG004|Overall Study|Death|3|||
23782738|NCT03381274|66583214|FG000|Overall Study|Lost to Follow-up|0|||
23782739|NCT03381274|66583215|FG001|Overall Study|Lost to Follow-up|0|||
23782740|NCT03381274|66583216|FG002|Overall Study|Lost to Follow-up|0|||
23782741|NCT03381274|66583217|FG003|Overall Study|Lost to Follow-up|1|||
23782742|NCT03381274|66583218|FG004|Overall Study|Lost to Follow-up|0|||
23782743|NCT03381274|66583214|FG000|Overall Study|Withdrawal by Subject|2|||
23782744|NCT03381274|66583215|FG001|Overall Study|Withdrawal by Subject|1|||
23782745|NCT03381274|66583216|FG002|Overall Study|Withdrawal by Subject|3|||
23782746|NCT03381274|66583217|FG003|Overall Study|Withdrawal by Subject|1|||
23782747|NCT03381274|66583218|FG004|Overall Study|Withdrawal by Subject|0|||
23782748|NCT03381274|66583214|FG000|Overall Study|Other|1|||
23782749|NCT03381274|66583215|FG001|Overall Study|Other|11|||
23782750|NCT03381274|66583216|FG002|Overall Study|Other|0|||
23782751|NCT03381274|66583217|FG003|Overall Study|Other|2|||
23782752|NCT03381274|66583218|FG004|Overall Study|Other|2|||
23782753|NCT03803774|66583220|FG000|Dose Escalation|Withdrawal by Subject|0|||
23782754|NCT03803774|66583221|FG001|Dose Escalation|Withdrawal by Subject|0|||
23782755|NCT03803774|66583222|FG002|Dose Escalation|Withdrawal by Subject|0|||
23782756|NCT03803774|66583223|FG003|Dose Escalation|Withdrawal by Subject|1|||
23782757|NCT03803774|66583224|FG004|Dose Escalation|Withdrawal by Subject|0|||
23782758|NCT00835991|66583228|FG000|First Intervention|Adverse Event|0|||
23782759|NCT00835991|66583229|FG001|First Intervention|Adverse Event|1|||
23782760|NCT00835991|66583228|FG000|Washout|Protocol Violation|0|||
23782761|NCT00835991|66583229|FG001|Washout|Protocol Violation|2|||
23782762|NCT00835991|66583228|FG000|Washout|Withdrawal by Subject|3|||
23782763|NCT00835991|66583229|FG001|Washout|Withdrawal by Subject|1|||
23782764|NCT00418561|66583230|FG000|Overall Study|Participant's (guardian's) decision|0|||
23782765|NCT00418561|66583231|FG001|Overall Study|Participant's (guardian's) decision|1|||
23782766|NCT00418561|66583232|FG002|Overall Study|Participant's (guardian's) decision|0|||
23341386|NCT03613649|64992967|FG007|Second Treatment|Lost to Follow-up|0|||
23341387|NCT03613649|64992968|FG008|Second Treatment|Lost to Follow-up|0|||
23782767|NCT02822235|66583237|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
23341388|NCT03613649|64992969|FG009|Second Treatment|Lost to Follow-up|0|||
23341389|NCT03613649|64992970|FG010|Second Treatment|Lost to Follow-up|0|||
23341390|NCT03613649|64992971|FG011|Second Treatment|Lost to Follow-up|0|||
23341391|NCT03613649|64992960|FG000|Second Treatment|Withdrawal by Subject|0|||
23782768|NCT02822235|66583238|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
23782769|NCT02822235|66583237|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
23782770|NCT02822235|66583238|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
23782771|NCT02822235|66583237|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
23341392|NCT03613649|64992961|FG001|Second Treatment|Withdrawal by Subject|0|||
23341393|NCT03613649|64992962|FG002|Second Treatment|Withdrawal by Subject|0|||
23341394|NCT03613649|64992963|FG003|Second Treatment|Withdrawal by Subject|0|||
23341395|NCT03613649|64992964|FG004|Second Treatment|Withdrawal by Subject|1|||
23341396|NCT03613649|64992965|FG005|Second Treatment|Withdrawal by Subject|0|||
23341397|NCT03613649|64992966|FG006|Second Treatment|Withdrawal by Subject|0|||
23341398|NCT03613649|64992967|FG007|Second Treatment|Withdrawal by Subject|0|||
23341399|NCT03613649|64992968|FG008|Second Treatment|Withdrawal by Subject|0|||
23341400|NCT03613649|64992969|FG009|Second Treatment|Withdrawal by Subject|0|||
23341401|NCT03613649|64992970|FG010|Second Treatment|Withdrawal by Subject|0|||
23341402|NCT03613649|64992971|FG011|Second Treatment|Withdrawal by Subject|0|||
23341403|NCT03613649|64992960|FG000|Third Treatment|Lost to Follow-up|0|||
23341404|NCT03613649|64992961|FG001|Third Treatment|Lost to Follow-up|0|||
23341405|NCT03613649|64992962|FG002|Third Treatment|Lost to Follow-up|0|||
23341406|NCT03613649|64992963|FG003|Third Treatment|Lost to Follow-up|0|||
23341407|NCT03613649|64992964|FG004|Third Treatment|Lost to Follow-up|1|||
23341408|NCT03613649|64992965|FG005|Third Treatment|Lost to Follow-up|0|||
23341409|NCT03613649|64992966|FG006|Third Treatment|Lost to Follow-up|0|||
23341410|NCT03613649|64992967|FG007|Third Treatment|Lost to Follow-up|0|||
23341411|NCT03613649|64992968|FG008|Third Treatment|Lost to Follow-up|0|||
23341412|NCT03613649|64992969|FG009|Third Treatment|Lost to Follow-up|0|||
23341413|NCT03613649|64992970|FG010|Third Treatment|Lost to Follow-up|0|||
23341414|NCT03613649|64992971|FG011|Third Treatment|Lost to Follow-up|1|||
23341415|NCT03613649|64992960|FG000|Third Treatment|Protocol Violation|0|||
23341416|NCT03613649|64992961|FG001|Third Treatment|Protocol Violation|0|||
23341417|NCT03613649|64992962|FG002|Third Treatment|Protocol Violation|0|||
23341418|NCT03613649|64992963|FG003|Third Treatment|Protocol Violation|0|||
23341419|NCT03613649|64992964|FG004|Third Treatment|Protocol Violation|0|||
23341420|NCT03613649|64992965|FG005|Third Treatment|Protocol Violation|0|||
23341421|NCT03613649|64992966|FG006|Third Treatment|Protocol Violation|1|||
23341422|NCT03613649|64992967|FG007|Third Treatment|Protocol Violation|0|||
23341423|NCT03613649|64992968|FG008|Third Treatment|Protocol Violation|0|||
23341424|NCT03613649|64992969|FG009|Third Treatment|Protocol Violation|0|||
23341425|NCT03613649|64992970|FG010|Third Treatment|Protocol Violation|0|||
23341426|NCT03613649|64992971|FG011|Third Treatment|Protocol Violation|1|||
23341427|NCT03613649|64992960|FG000|Fourth Treatment|Protocol Violation|1|||
23341428|NCT03613649|64992961|FG001|Fourth Treatment|Protocol Violation|0|||
23341429|NCT03613649|64992962|FG002|Fourth Treatment|Protocol Violation|0|||
23341430|NCT03613649|64992963|FG003|Fourth Treatment|Protocol Violation|0|||
23341431|NCT03613649|64992964|FG004|Fourth Treatment|Protocol Violation|1|||
23341432|NCT03613649|64992965|FG005|Fourth Treatment|Protocol Violation|0|||
23341433|NCT03613649|64992966|FG006|Fourth Treatment|Protocol Violation|0|||
23341434|NCT03613649|64992967|FG007|Fourth Treatment|Protocol Violation|0|||
23341435|NCT03613649|64992968|FG008|Fourth Treatment|Protocol Violation|0|||
23341436|NCT03613649|64992969|FG009|Fourth Treatment|Protocol Violation|0|||
23341437|NCT03613649|64992970|FG010|Fourth Treatment|Protocol Violation|0|||
23341438|NCT03613649|64992971|FG011|Fourth Treatment|Protocol Violation|0|||
23341439|NCT03613649|64992960|FG000|Fourth Treatment|Physician Decision|0|||
23341440|NCT03613649|64992961|FG001|Fourth Treatment|Physician Decision|0|||
23341441|NCT03613649|64992962|FG002|Fourth Treatment|Physician Decision|0|||
23341442|NCT03613649|64992963|FG003|Fourth Treatment|Physician Decision|0|||
23341443|NCT03613649|64992964|FG004|Fourth Treatment|Physician Decision|0|||
23341444|NCT03613649|64992965|FG005|Fourth Treatment|Physician Decision|0|||
23341445|NCT03613649|64992966|FG006|Fourth Treatment|Physician Decision|1|||
23341446|NCT03613649|64992967|FG007|Fourth Treatment|Physician Decision|0|||
23341447|NCT03613649|64992968|FG008|Fourth Treatment|Physician Decision|0|||
23341448|NCT03613649|64992969|FG009|Fourth Treatment|Physician Decision|0|||
23341449|NCT03613649|64992970|FG010|Fourth Treatment|Physician Decision|0|||
23341450|NCT03613649|64992971|FG011|Fourth Treatment|Physician Decision|0|||
23341451|NCT03467217|64992974|FG000|Overall Study|Trial stopped early|5|||
23341452|NCT03467217|64992975|FG001|Overall Study|Trial stopped early|2|||
23341453|NCT03467217|64992974|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
23341454|NCT03467217|64992975|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
23341455|NCT03467217|64992974|FG000|Overall Study|Lost to Follow-up|0|||
23341456|NCT03467217|64992975|FG001|Overall Study|Lost to Follow-up|2|||
23341457|NCT00689104|64992976|FG000|Overall Study|Eligibility criterion not met|5|||
23453979|NCT02718898|65403439|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
23453980|NCT02718898|65403440|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
23341458|NCT00689104|64992977|FG001|Overall Study|Eligibility criterion not met|8|||
23341459|NCT00689104|64992978|FG002|Overall Study|Eligibility criterion not met|0|||
23341460|NCT00689104|64992979|FG003|Overall Study|Eligibility criterion not met|4|||
23341461|NCT00689104|64992976|FG000|Overall Study|Adverse Event|13|||
23341462|NCT00689104|64992977|FG001|Overall Study|Adverse Event|25|||
23341463|NCT00689104|64992978|FG002|Overall Study|Adverse Event|16|||
23341464|NCT00689104|64992979|FG003|Overall Study|Adverse Event|24|||
23341465|NCT00689104|64992976|FG000|Overall Study|Lack of Efficacy|5|||
23341466|NCT00689104|64992977|FG001|Overall Study|Lack of Efficacy|6|||
23341467|NCT00689104|64992978|FG002|Overall Study|Lack of Efficacy|2|||
23341468|NCT00689104|64992979|FG003|Overall Study|Lack of Efficacy|3|||
23341469|NCT00689104|64992976|FG000|Overall Study|Withdrawal by Subject|12|||
23341470|NCT00689104|64992977|FG001|Overall Study|Withdrawal by Subject|11|||
23341471|NCT00689104|64992978|FG002|Overall Study|Withdrawal by Subject|18|||
23341472|NCT00689104|64992979|FG003|Overall Study|Withdrawal by Subject|11|||
23341473|NCT00689104|64992976|FG000|Overall Study|Lost to Follow-up|4|||
23341474|NCT00689104|64992977|FG001|Overall Study|Lost to Follow-up|3|||
23341475|NCT00689104|64992978|FG002|Overall Study|Lost to Follow-up|2|||
23341476|NCT00689104|64992979|FG003|Overall Study|Lost to Follow-up|5|||
23341477|NCT00689104|64992976|FG000|Overall Study|Protocol Violation|2|||
23341478|NCT00689104|64992977|FG001|Overall Study|Protocol Violation|3|||
23341479|NCT00689104|64992978|FG002|Overall Study|Protocol Violation|5|||
23341480|NCT00689104|64992979|FG003|Overall Study|Protocol Violation|3|||
23341481|NCT00689104|64992976|FG000|Overall Study|Randomized but never received study drug|2|||
23341482|NCT00689104|64992977|FG001|Overall Study|Randomized but never received study drug|1|||
23341483|NCT00689104|64992978|FG002|Overall Study|Randomized but never received study drug|1|||
23341484|NCT00689104|64992979|FG003|Overall Study|Randomized but never received study drug|0|||
23341485|NCT00689104|64992976|FG000|Overall Study|Physician Decision|1|||
23341486|NCT00689104|64992977|FG001|Overall Study|Physician Decision|0|||
23341487|NCT00689104|64992978|FG002|Overall Study|Physician Decision|0|||
23341488|NCT00689104|64992979|FG003|Overall Study|Physician Decision|0|||
23341489|NCT00689104|64992976|FG000|Overall Study|Non-compliance with study procedures|0|||
23341490|NCT00689104|64992977|FG001|Overall Study|Non-compliance with study procedures|0|||
23341491|NCT00689104|64992978|FG002|Overall Study|Non-compliance with study procedures|1|||
23341492|NCT00689104|64992979|FG003|Overall Study|Non-compliance with study procedures|0|||
23341493|NCT01669174|64992980|FG000|Overall Study|Subject withdrew consent|2|||
23341494|NCT01669174|64992981|FG001|Overall Study|Subject withdrew consent|2|||
23341495|NCT01669174|64992980|FG000|Overall Study|Lost to Follow-up|1|||
23341496|NCT01669174|64992981|FG001|Overall Study|Lost to Follow-up|0|||
23341497|NCT01669174|64992980|FG000|Overall Study|Adverse Event|2|||
23341498|NCT01669174|64992981|FG001|Overall Study|Adverse Event|2|||
23341499|NCT01669174|64992980|FG000|Overall Study|Administrative problems|1|||
23341500|NCT01669174|64992981|FG001|Overall Study|Administrative problems|2|||
23341501|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
23341502|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
23341503|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
23341504|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
23341505|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
23341506|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
23341507|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
23341508|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
23341509|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
23341510|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
23341511|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Death|1|||
23341512|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Death|0|||
23341513|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
23341514|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
23341515|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
23341516|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
23341517|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
23341518|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
23341519|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
23341520|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
23341521|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Adverse Event|2|||
23582377|NCT01511250|65862462|FG007|Overall Study|Protocol Violation|0|||
23582378|NCT01511250|65862463|FG008|Overall Study|Protocol Violation|0|||
23582379|NCT01511250|65862464|FG009|Overall Study|Protocol Violation|0|||
23582380|NCT01120275|65862467|FG000|Overall Study|Adverse Event|3|||
23782772|NCT02822235|66583238|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
23782773|NCT02822235|66583237|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
23782774|NCT02822235|66583238|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
23782775|NCT02822235|66583237|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
23782776|NCT02822235|66583238|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
23782777|NCT02822235|66583237|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
23782778|NCT02822235|66583238|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
23782779|NCT00549718|66583242|FG000|Overall Study|Insufficient clinical response|20|||
23782780|NCT00549718|66583243|FG001|Overall Study|Insufficient clinical response|7|||
23782781|NCT00549718|66583244|FG002|Overall Study|Insufficient clinical response|18|||
23341522|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Adverse Event|6|||
23341523|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
23341524|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
23341525|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Progressive disease|4|||
23341526|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Progressive disease|35|||
23341527|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
23341528|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
23341529|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
23341530|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
23341531|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Death|0|||
23341532|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Death|1|||
23341533|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Other than specified above|9|||
23341534|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Other than specified above|18|||
23341535|NCT01154088|64992984|FG000|Overall Study|Lost to Follow-up|4|||
23341536|NCT01154088|64992985|FG001|Overall Study|Lost to Follow-up|6|||
23341537|NCT01154088|64992986|FG002|Overall Study|Lost to Follow-up|7|||
23341538|NCT02218736|64992987|FG000|Overall Study|Withdrawal by Subject|10|||
23341539|NCT02218736|64992988|FG001|Overall Study|Withdrawal by Subject|9|||
23341540|NCT02218736|64992987|FG000|Overall Study|Protocol Violation|2|||
23341541|NCT02218736|64992988|FG001|Overall Study|Protocol Violation|0|||
23341542|NCT00725608|64992990|FG000|Overall Study|Lost to Follow-up|60|||
23341543|NCT00725608|64992990|FG000|Overall Study|Adverse Event|14|||
23341544|NCT00725608|64992990|FG000|Overall Study|Individual reasons|86|||
23341545|NCT00725608|64992990|FG000|Overall Study|Other|7|||
23341546|NCT02279745|64992991|FG000|Overall Study|Adverse Event|7|||
23341547|NCT02279745|64992991|FG000|Overall Study|Death|6|||
23341548|NCT02279745|64992991|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
23341549|NCT02279745|64992991|FG000|Overall Study|Withdrawal by Subject|2|||
23341550|NCT02279745|64992991|FG000|Overall Study|Pregnancy|1|||
23341551|NCT02279745|64992991|FG000|Overall Study|Study Non-compliance|1|||
23341552|NCT02279745|64992991|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
23341553|NCT01855243|64992993|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
23341554|NCT01855243|64992994|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
23341555|NCT01855243|64992995|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
23341556|NCT00748189|64992996|FG000|Overall Study|Death|99|||
23341557|NCT00748189|64992997|FG001|Overall Study|Death|84|||
23341558|NCT00748189|64992996|FG000|Overall Study|Withdrawal by Subject|23|||
23341559|NCT00748189|64992997|FG001|Overall Study|Withdrawal by Subject|29|||
23341560|NCT00748189|64992996|FG000|Overall Study|Physician Decision|16|||
23341561|NCT00748189|64992997|FG001|Overall Study|Physician Decision|5|||
23341562|NCT00748189|64992996|FG000|Overall Study|Lost to Follow-up|8|||
23341563|NCT00748189|64992997|FG001|Overall Study|Lost to Follow-up|15|||
23341564|NCT00748189|64992996|FG000|Overall Study|Study terminated by Sponsor|70|||
23341565|NCT00748189|64992997|FG001|Overall Study|Study terminated by Sponsor|79|||
23341566|NCT00656851|64992998|FG000|Overall Study|Withdrawal by Subject|0|||
23341567|NCT00656851|64992999|FG001|Overall Study|Withdrawal by Subject|4|||
23341568|NCT00824382|64993008|FG000|Overall Study|Adverse Event|4|||
23341569|NCT00824382|64993009|FG001|Overall Study|Adverse Event|1|||
23341570|NCT00824382|64993010|FG002|Overall Study|Adverse Event|1|||
23341571|NCT00824382|64993011|FG003|Overall Study|Adverse Event|4|||
23341572|NCT00824382|64993008|FG000|Overall Study|Protocol Violation|1|||
23341573|NCT00824382|64993009|FG001|Overall Study|Protocol Violation|0|||
23341574|NCT00824382|64993010|FG002|Overall Study|Protocol Violation|0|||
23341575|NCT00824382|64993011|FG003|Overall Study|Protocol Violation|1|||
23341576|NCT00824382|64993008|FG000|Overall Study|Investigator's decision|0|||
23341577|NCT00824382|64993009|FG001|Overall Study|Investigator's decision|1|||
23341578|NCT00824382|64993010|FG002|Overall Study|Investigator's decision|2|||
23341579|NCT00824382|64993011|FG003|Overall Study|Investigator's decision|0|||
23341580|NCT02738879|64993012|FG000|Overall Study|Adverse Event|1|||
23341581|NCT02738879|64993013|FG001|Overall Study|Adverse Event|1|||
23341582|NCT02738879|64993012|FG000|Overall Study|Death|0|||
23341583|NCT02738879|64993013|FG001|Overall Study|Death|2|||
23341584|NCT02738879|64993012|FG000|Overall Study|Lost to Follow-up|1|||
23341585|NCT02738879|64993013|FG001|Overall Study|Lost to Follow-up|5|||
23341586|NCT02738879|64993012|FG000|Overall Study|Protocol Violation|1|||
23341587|NCT02738879|64993013|FG001|Overall Study|Protocol Violation|3|||
23341588|NCT02738879|64993012|FG000|Overall Study|Physician Decision|3|||
23341589|NCT02738879|64993013|FG001|Overall Study|Physician Decision|4|||
23341590|NCT02738879|64993012|FG000|Overall Study|Pregnancy|0|||
23341591|NCT02738879|64993013|FG001|Overall Study|Pregnancy|1|||
23341592|NCT02738879|64993012|FG000|Overall Study|Screen Failure|1|||
23341593|NCT02738879|64993013|FG001|Overall Study|Screen Failure|2|||
23341594|NCT02738879|64993012|FG000|Overall Study|Site Discontinued Study Participation|1|||
23341595|NCT02738879|64993013|FG001|Overall Study|Site Discontinued Study Participation|0|||
23341596|NCT02738879|64993012|FG000|Overall Study|Withdrawal by Subject|5|||
23341597|NCT02738879|64993013|FG001|Overall Study|Withdrawal by Subject|7|||
23341598|NCT00537316|64993017|FG000|Part 1|Adverse Event|7|||
23341599|NCT00537316|64993018|FG001|Part 1|Adverse Event|11|||
23341600|NCT00537316|64993019|FG002|Part 1|Adverse Event|8|||
23341601|NCT00537316|64993020|FG003|Part 1|Adverse Event|0|||
23341602|NCT00537316|64993021|FG004|Part 1|Adverse Event|0|||
23341603|NCT00537316|64993022|FG005|Part 1|Adverse Event|0|||
23341604|NCT00537316|64993023|FG006|Part 1|Adverse Event|0|||
23341605|NCT00537316|64993017|FG000|Part 1|Protocol defined clinical event|1|||
23341606|NCT00537316|64993018|FG001|Part 1|Protocol defined clinical event|0|||
23341607|NCT00537316|64993019|FG002|Part 1|Protocol defined clinical event|0|||
23341608|NCT00537316|64993020|FG003|Part 1|Protocol defined clinical event|0|||
23341609|NCT00537316|64993021|FG004|Part 1|Protocol defined clinical event|0|||
23341610|NCT00537316|64993022|FG005|Part 1|Protocol defined clinical event|0|||
23341611|NCT00537316|64993023|FG006|Part 1|Protocol defined clinical event|0|||
23341612|NCT00537316|64993017|FG000|Part 1|Lost to Follow-up|1|||
23341613|NCT00537316|64993018|FG001|Part 1|Lost to Follow-up|0|||
23341614|NCT00537316|64993019|FG002|Part 1|Lost to Follow-up|0|||
23341615|NCT00537316|64993020|FG003|Part 1|Lost to Follow-up|0|||
23341616|NCT00537316|64993021|FG004|Part 1|Lost to Follow-up|0|||
23341617|NCT00537316|64993022|FG005|Part 1|Lost to Follow-up|0|||
23341618|NCT00537316|64993023|FG006|Part 1|Lost to Follow-up|0|||
23341619|NCT00537316|64993017|FG000|Part 1|Withdrawal by Subject|3|||
23341620|NCT00537316|64993018|FG001|Part 1|Withdrawal by Subject|8|||
23341621|NCT00537316|64993019|FG002|Part 1|Withdrawal by Subject|4|||
23341622|NCT00537316|64993020|FG003|Part 1|Withdrawal by Subject|0|||
23341623|NCT00537316|64993021|FG004|Part 1|Withdrawal by Subject|0|||
23341624|NCT00537316|64993022|FG005|Part 1|Withdrawal by Subject|0|||
23341625|NCT00537316|64993023|FG006|Part 1|Withdrawal by Subject|0|||
23341626|NCT00537316|64993017|FG000|Part 1|Protocol Violation|1|||
23341627|NCT00537316|64993018|FG001|Part 1|Protocol Violation|5|||
23341628|NCT00537316|64993019|FG002|Part 1|Protocol Violation|1|||
23341629|NCT00537316|64993020|FG003|Part 1|Protocol Violation|0|||
23341630|NCT00537316|64993021|FG004|Part 1|Protocol Violation|0|||
23341631|NCT00537316|64993022|FG005|Part 1|Protocol Violation|0|||
23341632|NCT00537316|64993023|FG006|Part 1|Protocol Violation|0|||
23341633|NCT00537316|64993017|FG000|Part 1|Did not meet protocol eligibility|1|||
23341634|NCT00537316|64993018|FG001|Part 1|Did not meet protocol eligibility|3|||
23341635|NCT00537316|64993019|FG002|Part 1|Did not meet protocol eligibility|2|||
23341636|NCT00537316|64993020|FG003|Part 1|Did not meet protocol eligibility|0|||
23341637|NCT00537316|64993021|FG004|Part 1|Did not meet protocol eligibility|0|||
23341638|NCT00537316|64993022|FG005|Part 1|Did not meet protocol eligibility|0|||
23341639|NCT00537316|64993023|FG006|Part 1|Did not meet protocol eligibility|0|||
23341640|NCT00537316|64993017|FG000|Part 1|Administrative|0|||
23341641|NCT00537316|64993018|FG001|Part 1|Administrative|0|||
23341642|NCT00537316|64993019|FG002|Part 1|Administrative|2|||
23341643|NCT00537316|64993020|FG003|Part 1|Administrative|0|||
23341644|NCT00537316|64993021|FG004|Part 1|Administrative|0|||
23341645|NCT00537316|64993022|FG005|Part 1|Administrative|0|||
23341646|NCT00537316|64993023|FG006|Part 1|Administrative|0|||
23341647|NCT00537316|64993017|FG000|Part 2|Never entered follow-up|0|||
23341648|NCT00537316|64993018|FG001|Part 2|Never entered follow-up|0|||
23341649|NCT00537316|64993019|FG002|Part 2|Never entered follow-up|0|||
23341650|NCT00537316|64993020|FG003|Part 2|Never entered follow-up|0|||
23341651|NCT00537316|64993021|FG004|Part 2|Never entered follow-up|0|||
23341652|NCT00537316|64993022|FG005|Part 2|Never entered follow-up|0|||
23341653|NCT00537316|64993023|FG006|Part 2|Never entered follow-up|1|||
23341654|NCT00537316|64993017|FG000|Part 2|Adverse Event|4|||
23341655|NCT00537316|64993018|FG001|Part 2|Adverse Event|0|||
23341656|NCT00537316|64993019|FG002|Part 2|Adverse Event|2|||
23341657|NCT00537316|64993020|FG003|Part 2|Adverse Event|0|||
23341658|NCT00537316|64993021|FG004|Part 2|Adverse Event|0|||
23341659|NCT00537316|64993022|FG005|Part 2|Adverse Event|0|||
23341660|NCT00537316|64993023|FG006|Part 2|Adverse Event|0|||
23341661|NCT00537316|64993017|FG000|Part 2|Lost to Follow-up|1|||
23341662|NCT00537316|64993018|FG001|Part 2|Lost to Follow-up|0|||
23453981|NCT02718898|65403441|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
23453982|NCT02718898|65403442|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
23453983|NCT02718898|65403443|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
23341663|NCT00537316|64993019|FG002|Part 2|Lost to Follow-up|2|||
23341664|NCT00537316|64993020|FG003|Part 2|Lost to Follow-up|0|||
23341665|NCT00537316|64993021|FG004|Part 2|Lost to Follow-up|0|||
23341666|NCT00537316|64993022|FG005|Part 2|Lost to Follow-up|0|||
23341667|NCT00537316|64993023|FG006|Part 2|Lost to Follow-up|0|||
23341668|NCT00537316|64993017|FG000|Part 2|Withdrawal by Subject|5|||
23341669|NCT00537316|64993018|FG001|Part 2|Withdrawal by Subject|1|||
23341670|NCT00537316|64993019|FG002|Part 2|Withdrawal by Subject|4|||
23341671|NCT00537316|64993020|FG003|Part 2|Withdrawal by Subject|0|||
23341672|NCT00537316|64993021|FG004|Part 2|Withdrawal by Subject|0|||
23341673|NCT00537316|64993022|FG005|Part 2|Withdrawal by Subject|0|||
23341674|NCT00537316|64993023|FG006|Part 2|Withdrawal by Subject|0|||
23341675|NCT00537316|64993017|FG000|Part 2|Administrative|16|||
23341676|NCT00537316|64993018|FG001|Part 2|Administrative|8|||
23341677|NCT00537316|64993019|FG002|Part 2|Administrative|24|||
23453984|NCT02718898|65403444|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
23453985|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453986|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453987|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
23453988|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
23636710|NCT00288639|66052977|FG000|Overall Study|Withdrawal by Subject|2|||
23636711|NCT00288639|66052977|FG000|Overall Study|Other|1|||
23636712|NCT02993523|66052978|FG000|Overall Study|Withdrew Consent|0|||
23636713|NCT02993523|66052979|FG001|Overall Study|Withdrew Consent|0|||
23636714|NCT02993523|66052980|FG002|Overall Study|Withdrew Consent|2|||
23636715|NCT02993523|66052981|FG003|Overall Study|Withdrew Consent|9|||
23636716|NCT02993523|66052982|FG004|Overall Study|Withdrew Consent|0|||
23636717|NCT02993523|66052978|FG000|Overall Study|Lost to Follow-up|0|||
23636718|NCT02993523|66052979|FG001|Overall Study|Lost to Follow-up|0|||
23636719|NCT02993523|66052980|FG002|Overall Study|Lost to Follow-up|3|||
23636720|NCT02993523|66052981|FG003|Overall Study|Lost to Follow-up|6|||
23636721|NCT02993523|66052982|FG004|Overall Study|Lost to Follow-up|0|||
23636722|NCT02993523|66052978|FG000|Overall Study|Death|1|||
23636723|NCT02993523|66052979|FG001|Overall Study|Death|1|||
23636724|NCT02993523|66052980|FG002|Overall Study|Death|138|||
23636725|NCT02993523|66052981|FG003|Overall Study|Death|222|||
23636726|NCT02993523|66052982|FG004|Overall Study|Death|6|||
23636727|NCT02993523|66052978|FG000|Overall Study|Reason not Specified|0|||
23782782|NCT00549718|66583245|FG003|Overall Study|Insufficient clinical response|32|||
23782783|NCT00549718|66583242|FG000|Overall Study|Adverse Event|6|||
23782784|NCT00549718|66583243|FG001|Overall Study|Adverse Event|8|||
23782785|NCT00549718|66583244|FG002|Overall Study|Adverse Event|7|||
23636728|NCT02993523|66052979|FG001|Overall Study|Reason not Specified|0|||
23636729|NCT02993523|66052980|FG002|Overall Study|Reason not Specified|1|||
23636730|NCT02993523|66052981|FG003|Overall Study|Reason not Specified|1|||
23636731|NCT02993523|66052982|FG004|Overall Study|Reason not Specified|0|||
23636732|NCT03192475|66052985|FG000|Overall Study|Death|0|||
23636733|NCT03192475|66052986|FG001|Overall Study|Death|1|||
23636734|NCT03192475|66052985|FG000|Overall Study|Lost to Follow-up|13|||
23636735|NCT03192475|66052986|FG001|Overall Study|Lost to Follow-up|8|||
23636736|NCT00338962|66052989|FG000|Overall Study|Lost to Follow-up|3|||
23636737|NCT00338962|66052990|FG001|Overall Study|Lost to Follow-up|3|||
23636738|NCT00338962|66052991|FG002|Overall Study|Lost to Follow-up|2|||
23636739|NCT00338962|66052992|FG003|Overall Study|Lost to Follow-up|3|||
23636740|NCT00338962|66052989|FG000|Overall Study|Withdrawal by Subject|1|||
23636741|NCT00338962|66052990|FG001|Overall Study|Withdrawal by Subject|0|||
23636742|NCT00338962|66052991|FG002|Overall Study|Withdrawal by Subject|0|||
23636743|NCT00338962|66052992|FG003|Overall Study|Withdrawal by Subject|0|||
23636744|NCT00338962|66052989|FG000|Overall Study|No Transportation|2|||
23636745|NCT00338962|66052990|FG001|Overall Study|No Transportation|0|||
23636746|NCT00338962|66052991|FG002|Overall Study|No Transportation|0|||
23636747|NCT00338962|66052992|FG003|Overall Study|No Transportation|0|||
23782786|NCT00549718|66583245|FG003|Overall Study|Adverse Event|3|||
23453989|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453990|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453991|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23582381|NCT01120275|65862467|FG000|Overall Study|Progression|27|||
23582382|NCT01120275|65862467|FG000|Overall Study|Ineligible|3|||
23582383|NCT01120275|65862467|FG000|Overall Study|Withdrawal by Subject|1|||
23582384|NCT01120275|65862467|FG000|Overall Study|Refusal|1|||
23582385|NCT01120275|65862467|FG000|Overall Study|Not specific|1|||
23582386|NCT01674569|65862469|FG000|Overall Study|Adverse Event|0|||
23582387|NCT01674569|65862470|FG001|Overall Study|Adverse Event|2|||
23582388|NCT01674569|65862471|FG002|Overall Study|Adverse Event|0|||
23582389|NCT01674569|65862472|FG003|Overall Study|Adverse Event|1|||
23582390|NCT01674569|65862473|FG004|Overall Study|Adverse Event|2|||
23582391|NCT01674569|65862474|FG005|Overall Study|Adverse Event|2|||
23582392|NCT01674569|65862469|FG000|Overall Study|Protocol Violation|0|||
23582393|NCT01674569|65862470|FG001|Overall Study|Protocol Violation|1|||
23582394|NCT01674569|65862471|FG002|Overall Study|Protocol Violation|1|||
23582395|NCT01674569|65862472|FG003|Overall Study|Protocol Violation|0|||
23582396|NCT01674569|65862473|FG004|Overall Study|Protocol Violation|0|||
23582397|NCT01674569|65862474|FG005|Overall Study|Protocol Violation|0|||
23636748|NCT00338962|66052989|FG000|Overall Study|Time Constraint|2|||
23636749|NCT00338962|66052990|FG001|Overall Study|Time Constraint|0|||
23636750|NCT00338962|66052991|FG002|Overall Study|Time Constraint|0|||
23636751|NCT00338962|66052992|FG003|Overall Study|Time Constraint|0|||
23636752|NCT00338962|66052989|FG000|Overall Study|Moved|0|||
23636753|NCT00338962|66052990|FG001|Overall Study|Moved|1|||
23636754|NCT00338962|66052991|FG002|Overall Study|Moved|0|||
23636755|NCT00338962|66052992|FG003|Overall Study|Moved|0|||
23636756|NCT00338962|66052989|FG000|Overall Study|Adverse Event|0|||
23636757|NCT00338962|66052990|FG001|Overall Study|Adverse Event|0|||
23636758|NCT00338962|66052991|FG002|Overall Study|Adverse Event|2|||
23636759|NCT00338962|66052992|FG003|Overall Study|Adverse Event|0|||
23341678|NCT00537316|64993020|FG003|Part 2|Administrative|3|||
23341679|NCT00537316|64993021|FG004|Part 2|Administrative|1|||
23341680|NCT00537316|64993022|FG005|Part 2|Administrative|4|||
23341681|NCT00537316|64993023|FG006|Part 2|Administrative|1|||
23341682|NCT05845567|64993029|FG000|Overall Study|Withdrawal by Subject|1|||
23341683|NCT03193801|64993030|FG000|Overall Study|Physician Decision|2|||
23341684|NCT03193801|64993030|FG000|Overall Study|Withdrawal by Subject|1|||
23341685|NCT05148234|64993031|FG000|Phase I|Ineligible|0|||
23341686|NCT05148234|64993032|FG001|Phase I|Ineligible|0|||
23341687|NCT05148234|64993033|FG002|Phase I|Ineligible|0|||
23341688|NCT05148234|64993034|FG003|Phase I|Ineligible|0|||
23341689|NCT05148234|64993035|FG004|Phase I|Ineligible|0|||
23341690|NCT05148234|64993036|FG005|Phase I|Ineligible|0|||
23341691|NCT05148234|64993037|FG006|Phase I|Ineligible|0|||
23341692|NCT05148234|64993038|FG007|Phase I|Ineligible|1|||
23341693|NCT05148234|64993031|FG000|Phase I|Company closed the trial.|0|||
23341694|NCT05148234|64993032|FG001|Phase I|Company closed the trial.|1|||
23341695|NCT05148234|64993033|FG002|Phase I|Company closed the trial.|0|||
23341696|NCT05148234|64993034|FG003|Phase I|Company closed the trial.|0|||
23341697|NCT05148234|64993035|FG004|Phase I|Company closed the trial.|0|||
23341698|NCT05148234|64993036|FG005|Phase I|Company closed the trial.|0|||
23341699|NCT05148234|64993037|FG006|Phase I|Company closed the trial.|0|||
23341700|NCT05148234|64993038|FG007|Phase I|Company closed the trial.|0|||
23341701|NCT02655016|64993039|FG000|Overall Study|Disease progression|6|||
23341702|NCT02655016|64993040|FG001|Overall Study|Disease progression|4|||
23341703|NCT02655016|64993039|FG000|Overall Study|Site closed|0|||
23341704|NCT02655016|64993040|FG001|Overall Study|Site closed|1|||
23341705|NCT02655016|64993039|FG000|Overall Study|Death|30|||
23341706|NCT02655016|64993040|FG001|Overall Study|Death|48|||
23341707|NCT02655016|64993039|FG000|Overall Study|Lost to Follow-up|1|||
23341708|NCT02655016|64993040|FG001|Overall Study|Lost to Follow-up|1|||
23341709|NCT02655016|64993039|FG000|Overall Study|Withdrawal by Subject|18|||
23341710|NCT02655016|64993040|FG001|Overall Study|Withdrawal by Subject|36|||
23341711|NCT05239494|64995898|FG000|Overall Study|Lost to Follow-up|1|||
23341712|NCT02855359|64995899|FG000|Overall Study|Death|2|||
23341713|NCT02855359|64995900|FG001|Overall Study|Death|2|||
23341714|NCT02855359|64995901|FG002|Overall Study|Death|0|||
23341715|NCT02855359|64995902|FG003|Overall Study|Death|0|||
23341716|NCT02855359|64995899|FG000|Overall Study|Study Termination by Sponsor|9|||
23341717|NCT02855359|64995900|FG001|Overall Study|Study Termination by Sponsor|11|||
23341718|NCT02855359|64995901|FG002|Overall Study|Study Termination by Sponsor|0|||
23341719|NCT02855359|64995902|FG003|Overall Study|Study Termination by Sponsor|0|||
23341720|NCT03721835|64995903|FG000|Overall Study|Participant not able to return|1|||
23341721|NCT03721835|64995903|FG000|Overall Study|Lost to Follow-up|1|||
23341722|NCT03721835|64995903|FG000|Overall Study|Revision of the components of the study device|2|||
23341723|NCT03721835|64995903|FG000|Overall Study|Sponsor terminated study|6|||
23341724|NCT03721835|64995903|FG000|Overall Study|Death|1|||
23341725|NCT03721835|64995903|FG000|Overall Study|Sponsor decision|1|||
23341726|NCT01676896|64995904|FG000|Overall Study|Withdrawal by Subject|12|||
23341727|NCT01676896|64995905|FG001|Overall Study|Withdrawal by Subject|7|||
23341728|NCT01676896|64995906|FG002|Overall Study|Withdrawal by Subject|19|||
23341729|NCT02234596|64995907|FG000|Overall Study|Participant not treated|2|||
23341730|NCT03020199|64995910|FG000|Treatment Period|Adverse Event|0|||
23341731|NCT03020199|64995911|FG001|Treatment Period|Adverse Event|2|||
23341732|NCT03020199|64995910|FG000|Treatment Period|Lack of Efficacy|1|||
23341733|NCT03020199|64995911|FG001|Treatment Period|Lack of Efficacy|6|||
23341734|NCT03020199|64995910|FG000|Treatment Period|Lost to Follow-up|1|||
23341735|NCT03020199|64995911|FG001|Treatment Period|Lost to Follow-up|6|||
23341736|NCT03020199|64995910|FG000|Treatment Period|Physician Decision|0|||
23341737|NCT03020199|64995911|FG001|Treatment Period|Physician Decision|1|||
23341738|NCT03020199|64995910|FG000|Treatment Period|Subject/guardian decision|8|||
23341739|NCT03020199|64995911|FG001|Treatment Period|Subject/guardian decision|15|||
23341740|NCT03020199|64995910|FG000|Treatment Period|Subjects not treated|3|||
23341741|NCT03020199|64995911|FG001|Treatment Period|Subjects not treated|4|||
23341742|NCT03020199|64995910|FG000|Follow-up Period|Disease relapse|32|||
23341743|NCT03020199|64995911|FG001|Follow-up Period|Disease relapse|7|||
23582398|NCT01674569|65862469|FG000|Overall Study|Withdrawal by Subject|0|||
23341744|NCT03020199|64995910|FG000|Follow-up Period|Lack of Efficacy|1|||
23341745|NCT03020199|64995911|FG001|Follow-up Period|Lack of Efficacy|2|||
23341746|NCT03020199|64995910|FG000|Follow-up Period|Lost to Follow-up|4|||
23341747|NCT03020199|64995911|FG001|Follow-up Period|Lost to Follow-up|6|||
23341748|NCT03020199|64995910|FG000|Follow-up Period|Physician Decision|2|||
23453992|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341749|NCT03020199|64995911|FG001|Follow-up Period|Physician Decision|2|||
23341750|NCT03020199|64995910|FG000|Follow-up Period|Protocol Violation|1|||
23341751|NCT03020199|64995911|FG001|Follow-up Period|Protocol Violation|2|||
23341752|NCT03020199|64995910|FG000|Follow-up Period|Study terminated by Sponsor|6|||
23341753|NCT03020199|64995911|FG001|Follow-up Period|Study terminated by Sponsor|3|||
23341754|NCT03020199|64995910|FG000|Follow-up Period|Subject/guardian decision|14|||
23341755|NCT03020199|64995911|FG001|Follow-up Period|Subject/guardian decision|9|||
23341756|NCT04083235|64995912|FG000|Overall Study|Death|252|||
23341757|NCT04083235|64995913|FG001|Overall Study|Death|277|||
23341758|NCT04083235|64995912|FG000|Overall Study|Withdrawal by Subject|13|||
23341759|NCT04083235|64995913|FG001|Overall Study|Withdrawal by Subject|17|||
23341760|NCT04083235|64995912|FG000|Overall Study|Lost to Follow-up|1|||
23341761|NCT04083235|64995913|FG001|Overall Study|Lost to Follow-up|1|||
23341762|NCT04083235|64995912|FG000|Overall Study|Does not meet entry criteria|1|||
23341763|NCT04083235|64995913|FG001|Overall Study|Does not meet entry criteria|0|||
23341764|NCT04083235|64995912|FG000|Overall Study|Did not receive treatment|13|||
23341765|NCT04083235|64995913|FG001|Overall Study|Did not receive treatment|8|||
23341766|NCT04083235|64995912|FG000|Overall Study|Ongoing at the time of DCO|44|||
23341767|NCT04083235|64995913|FG001|Overall Study|Ongoing at the time of DCO|7|||
23341768|NCT00380081|64995914|FG000|Overall Study|Withdrawal by Subject|0|||
23341769|NCT00380081|64995915|FG001|Overall Study|Withdrawal by Subject|0|||
23341770|NCT00380081|64995916|FG002|Overall Study|Withdrawal by Subject|0|||
23341771|NCT00380081|64995917|FG003|Overall Study|Withdrawal by Subject|0|||
23341772|NCT00380081|64995918|FG004|Overall Study|Withdrawal by Subject|1|||
23341773|NCT00380081|64995919|FG005|Overall Study|Withdrawal by Subject|0|||
23341774|NCT00380081|64995914|FG000|Overall Study|Family Emergency|0|||
23341775|NCT00380081|64995915|FG001|Overall Study|Family Emergency|0|||
23341776|NCT00380081|64995916|FG002|Overall Study|Family Emergency|0|||
23341777|NCT00380081|64995917|FG003|Overall Study|Family Emergency|0|||
23341778|NCT00380081|64995918|FG004|Overall Study|Family Emergency|0|||
23341779|NCT00380081|64995919|FG005|Overall Study|Family Emergency|1|||
23341780|NCT03201874|64995920|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
23341781|NCT03201874|64995921|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
23341782|NCT03201874|64995920|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
23341783|NCT03201874|64995921|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
23341784|NCT01869699|64995924|FG000|Overall Study|Withdrawal by Subject|1|||
23341785|NCT01869699|64995925|FG001|Overall Study|Withdrawal by Subject|0|||
23341786|NCT02253316|64995928|FG000|Consolidation|Progression|4|||
23341787|NCT02253316|64995929|FG001|Consolidation|Progression|0|||
23341788|NCT02253316|64995930|FG002|Consolidation|Progression|0|||
23341789|NCT02253316|64995928|FG000|Consolidation|Non-Compliance|1|||
23341790|NCT02253316|64995929|FG001|Consolidation|Non-Compliance|0|||
23341791|NCT02253316|64995930|FG002|Consolidation|Non-Compliance|0|||
23341792|NCT02253316|64995928|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
23341793|NCT02253316|64995929|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
23341794|NCT02253316|64995930|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
23341795|NCT02253316|64995928|FG000|Consolidation|Secondary Malignancy|2|||
23341796|NCT02253316|64995929|FG001|Consolidation|Secondary Malignancy|0|||
23341797|NCT02253316|64995930|FG002|Consolidation|Secondary Malignancy|0|||
23341798|NCT02253316|64995928|FG000|Consolidation|Adverse Event|7|||
23341799|NCT02253316|64995929|FG001|Consolidation|Adverse Event|0|||
23341800|NCT02253316|64995930|FG002|Consolidation|Adverse Event|0|||
23341801|NCT02253316|64995928|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
23341802|NCT02253316|64995929|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
23341803|NCT02253316|64995930|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
23341804|NCT02253316|64995928|FG000|Maintenance|Physician Decision|0|||
23341805|NCT02253316|64995929|FG001|Maintenance|Physician Decision|7|||
23341806|NCT02253316|64995930|FG002|Maintenance|Physician Decision|16|||
23341807|NCT02253316|64995928|FG000|Maintenance|Non-Compliance|0|||
23341808|NCT02253316|64995929|FG001|Maintenance|Non-Compliance|1|||
23341809|NCT02253316|64995930|FG002|Maintenance|Non-Compliance|1|||
23453993|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453994|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453995|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
23341810|NCT02253316|64995928|FG000|Maintenance|Secondary Malignancy|0|||
23341811|NCT02253316|64995929|FG001|Maintenance|Secondary Malignancy|2|||
23341812|NCT02253316|64995930|FG002|Maintenance|Secondary Malignancy|6|||
23341813|NCT02253316|64995928|FG000|Maintenance|Adverse Event|0|||
23341814|NCT02253316|64995929|FG001|Maintenance|Adverse Event|8|||
23341815|NCT02253316|64995930|FG002|Maintenance|Adverse Event|12|||
23341816|NCT02253316|64995928|FG000|Maintenance|Still receiving active treatment|0|||
23341817|NCT02253316|64995929|FG001|Maintenance|Still receiving active treatment|5|||
23341818|NCT02253316|64995930|FG002|Maintenance|Still receiving active treatment|0|||
23453996|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341819|NCT00546117|64995931|FG000|Overall Study|Withdrawal by Subject|3|||
23341820|NCT00546117|64995932|FG001|Overall Study|Withdrawal by Subject|0|||
23341821|NCT00546117|64995931|FG000|Overall Study|Inability to schedule follow-up visit|1|||
23341822|NCT00546117|64995932|FG001|Overall Study|Inability to schedule follow-up visit|0|||
23341823|NCT01123941|64995936|FG000|Overall Study|Lost to Follow-up|2|||
23341824|NCT01123941|64995937|FG001|Overall Study|Lost to Follow-up|1|||
23341825|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
23341826|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
23341827|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23341828|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23341829|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
23341830|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
23341831|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23341832|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23341833|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23341834|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
23341835|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23341836|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23341837|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
23341838|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341839|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341840|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341841|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23341842|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23341843|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
23341844|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
23341845|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23341846|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23341847|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
23341848|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
23341849|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Death|0|||
23341850|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Death|0|||
23341851|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Death|1|||
23341852|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Death|1|||
23341853|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341854|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341855|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
23341856|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341857|NCT00614120|64995944|FG000|Overall Study|Adverse Event|9|||
23341858|NCT00614120|64995945|FG001|Overall Study|Adverse Event|22|||
23341859|NCT00614120|64995946|FG002|Overall Study|Adverse Event|30|||
23341860|NCT00614120|64995947|FG003|Overall Study|Adverse Event|3|||
23341861|NCT00614120|64995944|FG000|Overall Study|Lack of Efficacy|3|||
23341862|NCT00614120|64995945|FG001|Overall Study|Lack of Efficacy|3|||
23341863|NCT00614120|64995946|FG002|Overall Study|Lack of Efficacy|2|||
23341864|NCT00614120|64995947|FG003|Overall Study|Lack of Efficacy|2|||
23341865|NCT00614120|64995944|FG000|Overall Study|Protocol Violation|2|||
23341866|NCT00614120|64995945|FG001|Overall Study|Protocol Violation|5|||
23341867|NCT00614120|64995946|FG002|Overall Study|Protocol Violation|3|||
23341868|NCT00614120|64995947|FG003|Overall Study|Protocol Violation|1|||
23341869|NCT00614120|64995944|FG000|Overall Study|Withdrawal criteria|1|||
23341870|NCT00614120|64995945|FG001|Overall Study|Withdrawal criteria|0|||
23341871|NCT00614120|64995946|FG002|Overall Study|Withdrawal criteria|0|||
23341872|NCT00614120|64995947|FG003|Overall Study|Withdrawal criteria|0|||
23341873|NCT00614120|64995944|FG000|Overall Study|Withdrawal by Subject|9|||
23341874|NCT00614120|64995945|FG001|Overall Study|Withdrawal by Subject|10|||
23341875|NCT00614120|64995946|FG002|Overall Study|Withdrawal by Subject|16|||
23341876|NCT00614120|64995947|FG003|Overall Study|Withdrawal by Subject|3|||
23453997|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453998|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341877|NCT00614120|64995944|FG000|Overall Study|Did not meet trial criteria|0|||
23341878|NCT00614120|64995945|FG001|Overall Study|Did not meet trial criteria|1|||
23341879|NCT00614120|64995946|FG002|Overall Study|Did not meet trial criteria|1|||
23341880|NCT00614120|64995947|FG003|Overall Study|Did not meet trial criteria|1|||
23341881|NCT00614120|64995944|FG000|Overall Study|hCG positive (not pregnant)|0|||
23341882|NCT00614120|64995945|FG001|Overall Study|hCG positive (not pregnant)|0|||
23341883|NCT00614120|64995946|FG002|Overall Study|hCG positive (not pregnant)|1|||
23341884|NCT00614120|64995947|FG003|Overall Study|hCG positive (not pregnant)|0|||
23341885|NCT00614120|64995944|FG000|Overall Study|Hypoglycaemia|0|||
23341886|NCT00614120|64995945|FG001|Overall Study|Hypoglycaemia|0|||
23341887|NCT00614120|64995946|FG002|Overall Study|Hypoglycaemia|0|||
23341888|NCT00614120|64995947|FG003|Overall Study|Hypoglycaemia|1|||
23341889|NCT00614120|64995944|FG000|Overall Study|Lack of trial product|3|||
23341890|NCT00614120|64995945|FG001|Overall Study|Lack of trial product|3|||
23341891|NCT00614120|64995946|FG002|Overall Study|Lack of trial product|2|||
23341892|NCT00614120|64995947|FG003|Overall Study|Lack of trial product|0|||
23341893|NCT00614120|64995944|FG000|Overall Study|Late syphilis, latent|1|||
23341894|NCT00614120|64995945|FG001|Overall Study|Late syphilis, latent|0|||
23341895|NCT00614120|64995946|FG002|Overall Study|Late syphilis, latent|0|||
23341896|NCT00614120|64995947|FG003|Overall Study|Late syphilis, latent|0|||
23341897|NCT00614120|64995944|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
23341898|NCT00614120|64995945|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
23341899|NCT00614120|64995946|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
23341900|NCT00614120|64995947|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
23341901|NCT00614120|64995944|FG000|Overall Study|Lost to Follow-up|1|||
23341902|NCT00614120|64995945|FG001|Overall Study|Lost to Follow-up|2|||
23341903|NCT00614120|64995946|FG002|Overall Study|Lost to Follow-up|3|||
23341904|NCT00614120|64995947|FG003|Overall Study|Lost to Follow-up|4|||
23341905|NCT01137110|64995948|FG000|Overall Study|Protocol Violation|1|||
23341906|NCT01137110|64995949|FG001|Overall Study|Protocol Violation|0|||
23341907|NCT00808639|64995955|FG000|Overall Study|Disease progression before surgery.|1|||
23341908|NCT02662764|64995957|FG000|Overall Study|Adverse Event|6|||
23341909|NCT02662764|64995957|FG000|Overall Study|Lack of Efficacy|8|||
23341910|NCT02662764|64995957|FG000|Overall Study|Protocol Violation|1|||
23341911|NCT02662764|64995957|FG000|Overall Study|Withdrawal by Subject|5|||
23341912|NCT02662764|64995957|FG000|Overall Study|Device failure|4|||
23341913|NCT02662764|64995957|FG000|Overall Study|Patient changed treatment|1|||
23341914|NCT02662764|64995957|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
23341915|NCT00759785|64995960|FG000|Overall Study|Participant sample not evaluable|11|||
23341916|NCT00759785|64995961|FG001|Overall Study|Participant sample not evaluable|2|||
23341917|NCT00759785|64995960|FG000|Overall Study|Participant sample lost|0|||
23341918|NCT00759785|64995961|FG001|Overall Study|Participant sample lost|1|||
23341919|NCT00759785|64995960|FG000|Overall Study|Protocol Violation|1|||
23341920|NCT00759785|64995961|FG001|Overall Study|Protocol Violation|0|||
23341921|NCT00759785|64995960|FG000|Overall Study|Physician Decision|0|||
23341922|NCT00759785|64995961|FG001|Overall Study|Physician Decision|1|||
23341923|NCT00759785|64995960|FG000|Overall Study|Withdrawal by Subject|0|||
23341924|NCT00759785|64995961|FG001|Overall Study|Withdrawal by Subject|1|||
23341925|NCT01901653|64995964|FG000|Overall Study|Death|2|||
23341926|NCT01901653|64995965|FG001|Overall Study|Death|1|||
23341927|NCT01901653|64995966|FG002|Overall Study|Death|8|||
23341928|NCT01901653|64995967|FG003|Overall Study|Death|3|||
23341929|NCT01901653|64995968|FG004|Overall Study|Death|2|||
23341930|NCT01901653|64995969|FG005|Overall Study|Death|2|||
23341931|NCT01901653|64995970|FG006|Overall Study|Death|6|||
23341932|NCT01901653|64995971|FG007|Overall Study|Death|9|||
23341933|NCT01901653|64995972|FG008|Overall Study|Death|1|||
23341934|NCT01901653|64995973|FG009|Overall Study|Death|16|||
23341935|NCT01901653|64995974|FG010|Overall Study|Death|2|||
23341936|NCT01901653|64995975|FG011|Overall Study|Death|15|||
23341937|NCT01901653|64995976|FG012|Overall Study|Death|4|||
23341938|NCT01901653|64995964|FG000|Overall Study|Lost to Follow-up|1|||
23341939|NCT01901653|64995965|FG001|Overall Study|Lost to Follow-up|0|||
23341940|NCT01901653|64995966|FG002|Overall Study|Lost to Follow-up|2|||
23341941|NCT01901653|64995967|FG003|Overall Study|Lost to Follow-up|0|||
23341942|NCT01901653|64995968|FG004|Overall Study|Lost to Follow-up|0|||
23341943|NCT01901653|64995969|FG005|Overall Study|Lost to Follow-up|1|||
23341944|NCT01901653|64995970|FG006|Overall Study|Lost to Follow-up|0|||
23341945|NCT01901653|64995971|FG007|Overall Study|Lost to Follow-up|1|||
23341946|NCT01901653|64995972|FG008|Overall Study|Lost to Follow-up|0|||
23341947|NCT01901653|64995973|FG009|Overall Study|Lost to Follow-up|0|||
23341948|NCT01901653|64995974|FG010|Overall Study|Lost to Follow-up|0|||
23341949|NCT01901653|64995975|FG011|Overall Study|Lost to Follow-up|0|||
23341950|NCT01901653|64995976|FG012|Overall Study|Lost to Follow-up|0|||
23341951|NCT01901653|64995964|FG000|Overall Study|Withdrawal by Subject|0|||
23341952|NCT01901653|64995965|FG001|Overall Study|Withdrawal by Subject|0|||
23341953|NCT01901653|64995966|FG002|Overall Study|Withdrawal by Subject|0|||
23341954|NCT01901653|64995967|FG003|Overall Study|Withdrawal by Subject|0|||
23341955|NCT01901653|64995968|FG004|Overall Study|Withdrawal by Subject|0|||
23341956|NCT01901653|64995969|FG005|Overall Study|Withdrawal by Subject|0|||
23341957|NCT01901653|64995970|FG006|Overall Study|Withdrawal by Subject|1|||
23341958|NCT01901653|64995971|FG007|Overall Study|Withdrawal by Subject|0|||
23341959|NCT01901653|64995972|FG008|Overall Study|Withdrawal by Subject|0|||
23341960|NCT01901653|64995973|FG009|Overall Study|Withdrawal by Subject|0|||
23341961|NCT01901653|64995974|FG010|Overall Study|Withdrawal by Subject|0|||
23341962|NCT01901653|64995975|FG011|Overall Study|Withdrawal by Subject|0|||
23341963|NCT01901653|64995976|FG012|Overall Study|Withdrawal by Subject|0|||
23341964|NCT01901653|64995964|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
23341965|NCT01901653|64995965|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
23341966|NCT01901653|64995966|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
23341967|NCT01901653|64995967|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
23341968|NCT01901653|64995968|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
23341969|NCT01901653|64995969|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
23341970|NCT01901653|64995970|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
23341971|NCT01901653|64995971|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
23341972|NCT01901653|64995972|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
23341973|NCT01901653|64995973|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
23341974|NCT01901653|64995974|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
23341975|NCT01901653|64995975|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
23341976|NCT01901653|64995976|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
23341977|NCT04439123|64995978|FG000|Overall Study|Adverse Event|11|||
23341978|NCT04439123|64995978|FG000|Overall Study|Death|1|||
23341979|NCT04439123|64995978|FG000|Overall Study|Disease progression|19|||
23341980|NCT04439123|64995978|FG000|Overall Study|Withdrawal by Subject|2|||
23341981|NCT04439123|64995978|FG000|Overall Study|Still on treatment|2|||
23341982|NCT03533114|64995979|FG000|Overall|Adverse Event|16|||
23341983|NCT03533114|64995980|FG001|Overall|Adverse Event|11|||
23341984|NCT03533114|64995979|FG000|Overall|Consent Withdrawal by Participant|7|||
23341985|NCT03533114|64995980|FG001|Overall|Consent Withdrawal by Participant|6|||
23341986|NCT03533114|64995979|FG000|Overall|Lack of Efficacy|5|||
23341987|NCT03533114|64995980|FG001|Overall|Lack of Efficacy|3|||
23341988|NCT03533114|64995979|FG000|Overall|Lost to Follow-up|1|||
23341989|NCT03533114|64995980|FG001|Overall|Lost to Follow-up|1|||
23341990|NCT03533114|64995979|FG000|Overall|Physician Decision|0|||
23341991|NCT03533114|64995980|FG001|Overall|Physician Decision|2|||
23341992|NCT03533114|64995979|FG000|Overall|Protocol deviation|1|||
23341993|NCT03533114|64995980|FG001|Overall|Protocol deviation|1|||
23341994|NCT03533114|64995979|FG000|Overall|Failure to meet randomization criteria|1|||
23341995|NCT03533114|64995980|FG001|Overall|Failure to meet randomization criteria|2|||
23341996|NCT03533114|64995979|FG000|Overall|Non-Compliance with study drug|0|||
23341997|NCT03533114|64995980|FG001|Overall|Non-Compliance with study drug|1|||
23341998|NCT03533114|64995979|FG000|Overall|Other|0|||
23341999|NCT03533114|64995980|FG001|Overall|Other|1|||
23342000|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Adverse Event|11|||
23342001|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Adverse Event|8|||
23342002|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
23342003|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
23342004|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
23342005|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
23342006|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
23342007|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
23342008|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
23342009|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
23342010|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
23342011|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
23342012|NCT03533114|64995979|FG000|Stable Dose|Adverse Event|0|||
23342013|NCT03533114|64995980|FG001|Stable Dose|Adverse Event|2|||
23342014|NCT03533114|64995979|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
23342015|NCT03533114|64995980|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
23342016|NCT03533114|64995979|FG000|Stable Dose|Lack of Efficacy|1|||
23453999|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454000|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454001|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23454002|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
23454003|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454004|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454005|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454006|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454007|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454008|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
23454009|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
23454010|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454011|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454012|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454013|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454014|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454015|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454016|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
23342017|NCT03533114|64995980|FG001|Stable Dose|Lack of Efficacy|0|||
23342018|NCT03533114|64995979|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
23342019|NCT03533114|64995980|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
23342020|NCT03533114|64995979|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
23342021|NCT03533114|64995980|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
23342022|NCT03533114|64995979|FG000|Open-Label Safety Extension|Adverse Event|3|||
23342023|NCT03533114|64995980|FG001|Open-Label Safety Extension|Adverse Event|0|||
23342024|NCT03533114|64995979|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
23454017|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454018|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454019|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23342025|NCT03533114|64995980|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
23454020|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454021|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454022|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454023|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
23454024|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454025|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454026|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454027|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
23454028|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
23454029|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
23454030|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
23454031|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
23454032|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
23454033|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
23454034|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454035|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454036|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454037|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454038|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
23454039|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
23342026|NCT03533114|64995979|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
23342027|NCT03533114|64995980|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
23342028|NCT03533114|64995979|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
23342029|NCT03533114|64995980|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
23342030|NCT03533114|64995979|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
23342031|NCT03533114|64995980|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
23342032|NCT00782184|64995981|FG000|Overall Study|Adverse Event|1|||
23342033|NCT00782184|64995982|FG001|Overall Study|Adverse Event|2|||
23342034|NCT00782184|64995981|FG000|Overall Study|Protocol Violation|0|||
23342035|NCT00782184|64995982|FG001|Overall Study|Protocol Violation|1|||
23342036|NCT00782184|64995981|FG000|Overall Study|Withdrawal by Subject|3|||
23342037|NCT00782184|64995982|FG001|Overall Study|Withdrawal by Subject|2|||
23454040|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
23454041|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454042|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23782787|NCT00549718|66583242|FG000|Overall Study|Lost to Follow-up|4|||
23782788|NCT00549718|66583243|FG001|Overall Study|Lost to Follow-up|2|||
23782789|NCT00549718|66583244|FG002|Overall Study|Lost to Follow-up|0|||
23782790|NCT00549718|66583245|FG003|Overall Study|Lost to Follow-up|6|||
23782791|NCT00549718|66583242|FG000|Overall Study|Withdrawal by Subject|9|||
23782792|NCT00549718|66583243|FG001|Overall Study|Withdrawal by Subject|18|||
23782793|NCT00549718|66583244|FG002|Overall Study|Withdrawal by Subject|12|||
23782794|NCT00549718|66583245|FG003|Overall Study|Withdrawal by Subject|13|||
23782795|NCT00549718|66583242|FG000|Overall Study|Administrative|2|||
23782796|NCT00549718|66583243|FG001|Overall Study|Administrative|2|||
23782797|NCT00549718|66583244|FG002|Overall Study|Administrative|2|||
23782798|NCT00549718|66583245|FG003|Overall Study|Administrative|1|||
23782799|NCT01725529|66583249|FG000|Overall Study|Adverse Event|1|||
23782800|NCT01725529|66583250|FG001|Overall Study|Adverse Event|0|||
23782801|NCT01725529|66583251|FG002|Overall Study|Adverse Event|0|||
23782802|NCT01725529|66583249|FG000|Overall Study|Lost to Follow-up|2|||
23782803|NCT01725529|66583250|FG001|Overall Study|Lost to Follow-up|1|||
23782804|NCT01725529|66583251|FG002|Overall Study|Lost to Follow-up|1|||
23782805|NCT01725529|66583249|FG000|Overall Study|Protocol Violation|0|||
23782806|NCT01725529|66583250|FG001|Overall Study|Protocol Violation|1|||
23454043|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23782807|NCT01725529|66583251|FG002|Overall Study|Protocol Violation|1|||
23782808|NCT01725529|66583249|FG000|Overall Study|Withdrawal by Subject|12|||
23782809|NCT01725529|66583250|FG001|Overall Study|Withdrawal by Subject|14|||
23342038|NCT01053962|64995983|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23342039|NCT01053962|64995984|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23342040|NCT01053962|64995985|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23782810|NCT01725529|66583251|FG002|Overall Study|Withdrawal by Subject|8|||
23782811|NCT01097577|66583252|FG000|Overall Study|Adverse Event|0|||
23782812|NCT01097577|66583253|FG001|Overall Study|Adverse Event|1|||
23342041|NCT01053962|64995986|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
23342042|NCT01053962|64995987|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
23454044|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454045|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454046|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
23454047|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
23454048|NCT03253393|65403445|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
23454049|NCT03253393|65403446|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
23454050|NCT03253393|65403447|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
23454051|NCT05236270|65403451|FG000|Overall Study|Lost to Follow-up|3|||
23454052|NCT05236270|65403452|FG001|Overall Study|Lost to Follow-up|2|||
23454053|NCT05236270|65403453|FG002|Overall Study|Lost to Follow-up|0|||
23454054|NCT05236270|65403454|FG003|Overall Study|Lost to Follow-up|0|||
23454055|NCT05236270|65403455|FG004|Overall Study|Lost to Follow-up|2|||
23454056|NCT05236270|65403456|FG005|Overall Study|Lost to Follow-up|0|||
23454057|NCT05236270|65403457|FG006|Overall Study|Lost to Follow-up|1|||
23454058|NCT05236270|65403458|FG007|Overall Study|Lost to Follow-up|3|||
23782813|NCT01535222|66583254|FG000|Overall Study|Inclusion/exclusion|0|||
23782814|NCT01535222|66583255|FG001|Overall Study|Inclusion/exclusion|0|||
23782815|NCT01535222|66583256|FG002|Overall Study|Inclusion/exclusion|1|||
23782816|NCT01535222|66583257|FG003|Overall Study|Inclusion/exclusion|0|||
23454059|NCT00499486|65403459|FG000|Overall Study|Withdrawal by Subject|16|||
23454060|NCT02587221|65403460|FG000|Overall Study|Adverse Event|3|||
23454061|NCT02587221|65403461|FG001|Overall Study|Adverse Event|3|||
23342043|NCT01053962|64995983|FG000|Pretreatment Period|Venipuncture Failure|0|||
23342044|NCT01053962|64995984|FG001|Pretreatment Period|Venipuncture Failure|0|||
23342045|NCT01053962|64995985|FG002|Pretreatment Period|Venipuncture Failure|1|||
23342046|NCT01053962|64995986|FG003|Pretreatment Period|Venipuncture Failure|0|||
23454062|NCT02587221|65403460|FG000|Overall Study|Death|33|||
23454063|NCT02587221|65403461|FG001|Overall Study|Death|34|||
23454064|NCT02587221|65403460|FG000|Overall Study|Withdrawal by Subject|66|||
23782817|NCT01535222|66583258|FG004|Overall Study|Inclusion/exclusion|0|||
23782818|NCT01535222|66583259|FG005|Overall Study|Inclusion/exclusion|0|||
23782819|NCT01926119|66583260|FG000|Overall Study|Withdrawal by Subject|1|||
23782820|NCT00850174|66583261|FG000|Washout: One Week|Withdrawal by Subject|0|||
23782821|NCT00850174|66583262|FG001|Washout: One Week|Withdrawal by Subject|2|||
23782822|NCT00850174|66583261|FG000|Second Intervention|Withdrawal by Subject|1|||
23782823|NCT00850174|66583262|FG001|Second Intervention|Withdrawal by Subject|0|||
23782824|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
23782825|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
23782826|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
23782827|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
23782828|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
23782829|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
23782830|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
23782831|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
23782832|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
23782833|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
23782834|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
23782835|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
23782836|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
23454065|NCT02587221|65403461|FG001|Overall Study|Withdrawal by Subject|61|||
23454066|NCT02587221|65403460|FG000|Overall Study|Lost to Follow-up|21|||
23454067|NCT02587221|65403461|FG001|Overall Study|Lost to Follow-up|19|||
23782837|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
23782838|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
23782839|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
23782840|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
23782841|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
23782842|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
23782843|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
23782844|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
23782845|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
23782846|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
23782847|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
23782848|NCT00073307|66583264|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
23454068|NCT02587221|65403460|FG000|Overall Study|Protocol Violation|6|||
23454069|NCT02587221|65403461|FG001|Overall Study|Protocol Violation|5|||
23454070|NCT02587221|65403460|FG000|Overall Study|Other Reason or Unspecified|2|||
23454071|NCT02587221|65403461|FG001|Overall Study|Other Reason or Unspecified|1|||
23454072|NCT00322881|65403462|FG000|Overall Study|Death|2|||
23342047|NCT01053962|64995987|FG004|Pretreatment Period|Venipuncture Failure|0|||
23342048|NCT01053962|64995983|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342049|NCT01053962|64995984|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
23342050|NCT01053962|64995985|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342051|NCT01053962|64995986|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342052|NCT01053962|64995987|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342053|NCT01053962|64995983|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342054|NCT01053962|64995984|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342055|NCT01053962|64995985|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342056|NCT01053962|64995986|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
23342057|NCT01053962|64995987|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23636760|NCT00338962|66052989|FG000|Overall Study|Poor Compliance|0|||
23636761|NCT00338962|66052990|FG001|Overall Study|Poor Compliance|0|||
23636762|NCT00338962|66052991|FG002|Overall Study|Poor Compliance|2|||
23636763|NCT00338962|66052992|FG003|Overall Study|Poor Compliance|0|||
23782849|NCT00073307|66583265|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
23342058|NCT01053962|64995983|FG000|Treatment Period|Lack of Efficacy|0|||
23342059|NCT01053962|64995984|FG001|Treatment Period|Lack of Efficacy|0|||
23342060|NCT01053962|64995985|FG002|Treatment Period|Lack of Efficacy|0|||
23342061|NCT01053962|64995986|FG003|Treatment Period|Lack of Efficacy|0|||
23342062|NCT01053962|64995987|FG004|Treatment Period|Lack of Efficacy|1|||
23342063|NCT01053962|64995983|FG000|Treatment Period|Adverse Event|0|||
23342064|NCT01053962|64995984|FG001|Treatment Period|Adverse Event|0|||
23342065|NCT01053962|64995985|FG002|Treatment Period|Adverse Event|0|||
23342066|NCT01053962|64995986|FG003|Treatment Period|Adverse Event|0|||
23342067|NCT01053962|64995987|FG004|Treatment Period|Adverse Event|1|||
23342068|NCT01053962|64995983|FG000|Treatment Period|Withdrawal by Subject|0|||
23342069|NCT01053962|64995984|FG001|Treatment Period|Withdrawal by Subject|0|||
23342070|NCT01053962|64995985|FG002|Treatment Period|Withdrawal by Subject|0|||
23342071|NCT01053962|64995986|FG003|Treatment Period|Withdrawal by Subject|0|||
23342072|NCT01053962|64995987|FG004|Treatment Period|Withdrawal by Subject|1|||
23342073|NCT01053962|64995983|FG000|Treatment Period|Noncompliance with protocol|1|||
23342074|NCT01053962|64995984|FG001|Treatment Period|Noncompliance with protocol|0|||
23342075|NCT01053962|64995985|FG002|Treatment Period|Noncompliance with protocol|0|||
23342076|NCT01053962|64995986|FG003|Treatment Period|Noncompliance with protocol|0|||
23342077|NCT01053962|64995987|FG004|Treatment Period|Noncompliance with protocol|0|||
23342078|NCT01698879|64995989|FG000|Overall Study|Withdrawal by Subject|1|||
23342079|NCT01698879|64995990|FG001|Overall Study|Withdrawal by Subject|0|||
23342080|NCT01698879|64995991|FG002|Overall Study|Withdrawal by Subject|0|||
23582399|NCT01674569|65862470|FG001|Overall Study|Withdrawal by Subject|0|||
23582400|NCT01674569|65862471|FG002|Overall Study|Withdrawal by Subject|1|||
23582401|NCT01674569|65862472|FG003|Overall Study|Withdrawal by Subject|0|||
23582402|NCT01674569|65862473|FG004|Overall Study|Withdrawal by Subject|0|||
23582403|NCT01674569|65862474|FG005|Overall Study|Withdrawal by Subject|0|||
23582404|NCT02246621|65862475|FG000|Overall Study|Withdrawal by Subject|28|||
23582405|NCT02246621|65862476|FG001|Overall Study|Withdrawal by Subject|16|||
23582406|NCT02246621|65862475|FG000|Overall Study|Lost to Follow-up|1|||
23582407|NCT02246621|65862476|FG001|Overall Study|Lost to Follow-up|0|||
23582408|NCT02246621|65862475|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
23582409|NCT02246621|65862476|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
23582410|NCT03736785|65862477|FG000|Overall Study|Adverse Event|1|||
23582411|NCT03736785|65862478|FG001|Overall Study|Adverse Event|1|||
23582412|NCT03736785|65862479|FG002|Overall Study|Adverse Event|1|||
23582413|NCT03736785|65862477|FG000|Overall Study|Death|1|||
23582414|NCT03736785|65862478|FG001|Overall Study|Death|0|||
23582415|NCT03736785|65862479|FG002|Overall Study|Death|1|||
23582416|NCT03736785|65862477|FG000|Overall Study|Lost to Follow-up|0|||
23582417|NCT03736785|65862478|FG001|Overall Study|Lost to Follow-up|2|||
23582418|NCT03736785|65862479|FG002|Overall Study|Lost to Follow-up|3|||
23582419|NCT03736785|65862477|FG000|Overall Study|Non compliance with study drug|1|||
23782850|NCT00073307|66583266|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
23342081|NCT04351373|64995992|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
23342082|NCT02779855|64995993|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
23582420|NCT03736785|65862478|FG001|Overall Study|Non compliance with study drug|1|||
23582421|NCT03736785|65862479|FG002|Overall Study|Non compliance with study drug|0|||
23342083|NCT02779855|64995994|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
23342084|NCT02779855|64995995|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
23342085|NCT00658775|64995999|FG000|Overall Study|Adverse Event|4|||
23342086|NCT00658775|64996000|FG001|Overall Study|Adverse Event|6|||
23342087|NCT00658775|64995999|FG000|Overall Study|Lost to Follow-up|17|||
23342088|NCT00658775|64996000|FG001|Overall Study|Lost to Follow-up|18|||
23582422|NCT03736785|65862477|FG000|Overall Study|Physician Decision|0|||
23582423|NCT03736785|65862478|FG001|Overall Study|Physician Decision|1|||
23636764|NCT03284203|66053005|FG000|Overall Study|Lost to Follow-up|3|||
23342089|NCT00658775|64995999|FG000|Overall Study|Withdrawal by Subject|6|||
23342090|NCT00658775|64996000|FG001|Overall Study|Withdrawal by Subject|4|||
23342091|NCT00658775|64995999|FG000|Overall Study|Withdrawal of consent|8|||
23342092|NCT00658775|64996000|FG001|Overall Study|Withdrawal of consent|7|||
23342093|NCT00658775|64995999|FG000|Overall Study|Other|7|||
23342094|NCT00658775|64996000|FG001|Overall Study|Other|8|||
23342095|NCT05397171|64996001|FG000|Overall Study|Death|2|||
23342096|NCT05397171|64996002|FG001|Overall Study|Death|3|||
23342097|NCT05397171|64996003|FG002|Overall Study|Death|3|||
23342098|NCT05397171|64996001|FG000|Overall Study|Study Terminated By Sponsor|1|||
23342099|NCT05397171|64996002|FG001|Overall Study|Study Terminated By Sponsor|2|||
23342100|NCT05397171|64996003|FG002|Overall Study|Study Terminated By Sponsor|3|||
23342101|NCT05397171|64996001|FG000|Overall Study|Withdrawal by Subject|0|||
23342102|NCT05397171|64996002|FG001|Overall Study|Withdrawal by Subject|1|||
23342103|NCT05397171|64996003|FG002|Overall Study|Withdrawal by Subject|1|||
23342104|NCT01645891|64996004|FG000|Overall Study|Adverse Event|6|||
23342105|NCT01645891|64996005|FG001|Overall Study|Adverse Event|10|||
23342106|NCT01645891|64996004|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
23342107|NCT01645891|64996005|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
23342108|NCT01645891|64996004|FG000|Overall Study|Withdrawal by Subject|3|||
23342109|NCT01645891|64996005|FG001|Overall Study|Withdrawal by Subject|3|||
23342110|NCT01645891|64996004|FG000|Overall Study|Protocol Violation|4|||
23342111|NCT01645891|64996005|FG001|Overall Study|Protocol Violation|0|||
23342112|NCT01645891|64996004|FG000|Overall Study|Lost to Follow-up|4|||
23342113|NCT01645891|64996005|FG001|Overall Study|Lost to Follow-up|1|||
23342114|NCT01645891|64996004|FG000|Overall Study|Death|0|||
23342115|NCT01645891|64996005|FG001|Overall Study|Death|2|||
23342116|NCT00474786|64996006|FG000|Overall Study|Not Meeting Study Criteria|0|||
23342117|NCT00474786|64996007|FG001|Overall Study|Not Meeting Study Criteria|1|||
23342118|NCT00474786|64996006|FG000|Overall Study|Investigator Request|2|||
23342119|NCT00474786|64996007|FG001|Overall Study|Investigator Request|1|||
23342120|NCT00474786|64996006|FG000|Overall Study|Death|189|||
23342121|NCT00474786|64996007|FG001|Overall Study|Death|170|||
23342122|NCT00474786|64996006|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
23342123|NCT00474786|64996007|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
23342124|NCT00474786|64996006|FG000|Overall Study|Lost to Follow-up|4|||
23342125|NCT00474786|64996007|FG001|Overall Study|Lost to Follow-up|7|||
23342126|NCT00474786|64996006|FG000|Overall Study|Protocol Violation|2|||
23342127|NCT00474786|64996007|FG001|Overall Study|Protocol Violation|0|||
23342128|NCT00474786|64996006|FG000|Overall Study|Withdrawal by Subject|15|||
23342129|NCT00474786|64996007|FG001|Overall Study|Withdrawal by Subject|15|||
23342130|NCT00474786|64996006|FG000|Overall Study|Other|5|||
23342131|NCT00474786|64996007|FG001|Overall Study|Other|0|||
23636765|NCT00678301|66053006|FG000|Overall Study|Non-compliance with study procedures|0|||
23636766|NCT00678301|66053007|FG001|Overall Study|Non-compliance with study procedures|1|||
23582424|NCT03736785|65862479|FG002|Overall Study|Physician Decision|1|||
23582425|NCT03736785|65862477|FG000|Overall Study|Protocol Violation|1|||
23582426|NCT03736785|65862478|FG001|Overall Study|Protocol Violation|4|||
23582427|NCT03736785|65862479|FG002|Overall Study|Protocol Violation|3|||
23582428|NCT03736785|65862477|FG000|Overall Study|Sponsor Decision|1|||
23582429|NCT03736785|65862478|FG001|Overall Study|Sponsor Decision|0|||
23582430|NCT03736785|65862479|FG002|Overall Study|Sponsor Decision|0|||
23782851|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
23782852|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
23782853|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
23782854|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
23782855|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
23782856|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
23342132|NCT03057054|64996013|FG000|Overall Study|Death|4|||
23342133|NCT03057054|64996014|FG001|Overall Study|Death|4|||
23342134|NCT03057054|64996013|FG000|Overall Study|Withdrawal by Subject|6|||
23342135|NCT03057054|64996014|FG001|Overall Study|Withdrawal by Subject|3|||
23342136|NCT03057054|64996013|FG000|Overall Study|Ineligible|1|||
23342137|NCT03057054|64996014|FG001|Overall Study|Ineligible|1|||
23342138|NCT01608087|64996015|FG000|Overall Study|Lost to Follow-up|0|||
23342139|NCT01608087|64996016|FG001|Overall Study|Lost to Follow-up|1|||
23636767|NCT00678301|66053006|FG000|Overall Study|Adverse Event|1|||
23342140|NCT01608087|64996017|FG002|Overall Study|Lost to Follow-up|0|||
23342141|NCT01608087|64996015|FG000|Overall Study|Other Reason|0|||
23636768|NCT00678301|66053007|FG001|Overall Study|Adverse Event|0|||
23342142|NCT01608087|64996016|FG001|Overall Study|Other Reason|1|||
23342143|NCT01608087|64996017|FG002|Overall Study|Other Reason|0|||
23582431|NCT03736785|65862477|FG000|Overall Study|Unknown/Missing data|3|||
23342144|NCT03164564|64996018|FG000|Overall Study|Death|3|||
23342145|NCT03164564|64996019|FG001|Overall Study|Death|0|||
23342146|NCT03164564|64996018|FG000|Overall Study|Withdrawal by Subject|20|||
23582432|NCT03736785|65862478|FG001|Overall Study|Unknown/Missing data|2|||
23636769|NCT00678301|66053006|FG000|Overall Study|Withdrawal by Subject|4|||
23342147|NCT03164564|64996019|FG001|Overall Study|Withdrawal by Subject|15|||
23342148|NCT03164564|64996018|FG000|Overall Study|Lost to Follow-up|2|||
23342149|NCT03164564|64996019|FG001|Overall Study|Lost to Follow-up|0|||
23342150|NCT03164564|64996018|FG000|Overall Study|Physician Decision|0|||
23342151|NCT03164564|64996019|FG001|Overall Study|Physician Decision|1|||
23342152|NCT03164564|64996018|FG000|Overall Study|Adverse Event|0|||
23342153|NCT03164564|64996019|FG001|Overall Study|Adverse Event|1|||
23342154|NCT03164564|64996018|FG000|Overall Study|Ongoing|1586|||
23342155|NCT03164564|64996019|FG001|Overall Study|Ongoing|1586|||
23342156|NCT03430895|64996020|FG000|Overall Study|Not Treated|2|||
23342157|NCT01794793|64996021|FG000|Treatment Period|Withdrawal by Subject|24|||
23782857|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
23782858|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
23342158|NCT01794793|64996021|FG000|Treatment Period|Lack of Efficacy|22|||
23342159|NCT01794793|64996021|FG000|Treatment Period|Adverse Event|17|||
23342160|NCT01794793|64996021|FG000|Treatment Period|Physician Decision|14|||
23342161|NCT01794793|64996021|FG000|Treatment Period|Lost to Follow-up|7|||
23342162|NCT01794793|64996021|FG000|Treatment Period|Death|6|||
23342163|NCT01794793|64996021|FG000|Treatment Period|Protocol Violation|5|||
23782859|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
23782860|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
23782861|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
23782862|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
23782863|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
23782864|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
23454073|NCT00322881|65403462|FG000|Overall Study|Adverse Event|1|||
23454074|NCT00322881|65403462|FG000|Overall Study|Disease Progression|2|||
23782865|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
23782866|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
23782867|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
23782868|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
23782869|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
23782870|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
23782871|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
23782872|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
23782873|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
23782874|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
23782875|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
23782876|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
23782877|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
23454075|NCT00189540|65403463|FG000|Overall Study|Withdrawal by Subject|3|||
23454076|NCT00189540|65403464|FG001|Overall Study|Withdrawal by Subject|0|||
23454077|NCT00189540|65403463|FG000|Overall Study|Death|4|||
23454078|NCT00189540|65403464|FG001|Overall Study|Death|1|||
23454079|NCT02240485|65403465|FG000|3 Months Post-admission|Lost to Follow-up|1|||
23454080|NCT02240485|65403466|FG001|3 Months Post-admission|Lost to Follow-up|5|||
23454081|NCT02240485|65403465|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
23454082|NCT02240485|65403466|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
23454083|NCT02240485|65403465|FG000|9 Months Post-admission|Lost to Follow-up|3|||
23454084|NCT02240485|65403466|FG001|9 Months Post-admission|Lost to Follow-up|1|||
23636770|NCT00678301|66053007|FG001|Overall Study|Withdrawal by Subject|0|||
23636771|NCT00678301|66053006|FG000|Overall Study|Lost to Follow-up|3|||
23782878|NCT00073307|66583264|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
23782879|NCT00073307|66583265|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
23782880|NCT00073307|66583266|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
23782881|NCT01855750|66583267|FG000|Overall Study|Death|78|||
23782882|NCT01855750|66583268|FG001|Overall Study|Death|78|||
23782883|NCT01855750|66583267|FG000|Overall Study|Lost to Follow-up|9|||
23782884|NCT01855750|66583268|FG001|Overall Study|Lost to Follow-up|23|||
23782885|NCT01855750|66583267|FG000|Overall Study|Withdrawal by Subject|35|||
23342164|NCT01794793|64996021|FG000|Treatment Period|administrative problem|3|||
23342165|NCT01794793|64996021|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
23342166|NCT01794793|64996021|FG000|Post-treatment Follow-up|Adverse Event|8|||
23342167|NCT01794793|64996021|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
23342168|NCT01794793|64996021|FG000|Post-treatment Follow-up|administrative problem|5|||
23342169|NCT01794793|64996021|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
23454085|NCT02240485|65403465|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
23454086|NCT02240485|65403466|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
23342170|NCT01794793|64996021|FG000|Post-treatment Follow-up|Protocol Violation|3|||
23636772|NCT00678301|66053007|FG001|Overall Study|Lost to Follow-up|1|||
23782886|NCT01855750|66583268|FG001|Overall Study|Withdrawal by Subject|28|||
23782887|NCT01855750|66583267|FG000|Overall Study|Sponsor ends the study|297|||
23782888|NCT01855750|66583268|FG001|Overall Study|Sponsor ends the study|290|||
23782889|NCT03098394|66583271|FG000|Overall Study|Pregnancy|0|||
23782890|NCT03098394|66583272|FG001|Overall Study|Pregnancy|1|||
23782891|NCT00834756|66583273|FG000|First Intervention|Adverse Event|1|||
23342171|NCT05036668|64996025|FG000|Overall Study|lost to follow Up|0|||
23342172|NCT05036668|64996026|FG001|Overall Study|lost to follow Up|0|||
23342173|NCT05036668|64996027|FG002|Overall Study|lost to follow Up|1|||
23342174|NCT03891862|64996028|FG000|Open-label Period|Adverse Event|2|||
23342175|NCT03891862|64996029|FG001|Open-label Period|Adverse Event|0|||
23342176|NCT03891862|64996030|FG002|Open-label Period|Adverse Event|0|||
23342177|NCT03891862|64996028|FG000|Open-label Period|Protocol Violation|5|||
23342178|NCT03891862|64996029|FG001|Open-label Period|Protocol Violation|0|||
23342179|NCT03891862|64996030|FG002|Open-label Period|Protocol Violation|0|||
23342180|NCT03891862|64996028|FG000|Open-label Period|Withdrawal by Subject|6|||
23342181|NCT03891862|64996029|FG001|Open-label Period|Withdrawal by Subject|0|||
23342182|NCT03891862|64996030|FG002|Open-label Period|Withdrawal by Subject|0|||
23342183|NCT03891862|64996028|FG000|Open-label Period|Death|1|||
23342184|NCT03891862|64996029|FG001|Open-label Period|Death|0|||
23342185|NCT03891862|64996030|FG002|Open-label Period|Death|0|||
23342186|NCT03891862|64996028|FG000|Open-label Period|Lost to Follow-up|2|||
23342187|NCT03891862|64996029|FG001|Open-label Period|Lost to Follow-up|0|||
23342188|NCT03891862|64996030|FG002|Open-label Period|Lost to Follow-up|0|||
23342189|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
23342190|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
23342191|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
23342192|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
23342193|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
23342194|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
23342195|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
23342196|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
23342197|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
23342198|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
23342199|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
23342200|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
23342201|NCT03962790|64996031|FG000|Period 1|Adverse Event|0|||
23342202|NCT03962790|64996032|FG001|Period 1|Adverse Event|1|||
23342203|NCT03962790|64996031|FG000|Period 1|Failed to meet all eligibility criteria|1|||
23342204|NCT03962790|64996032|FG001|Period 1|Failed to meet all eligibility criteria|1|||
23342205|NCT03962790|64996031|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
23342206|NCT03962790|64996032|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
23342207|NCT03962790|64996031|FG000|Period 1|Withdrawal by Subject|1|||
23342208|NCT03962790|64996032|FG001|Period 1|Withdrawal by Subject|0|||
23342209|NCT02850016|64996033|FG000|Overall Study|Withdrawal by Subject|1|||
23342210|NCT02850016|64996034|FG001|Overall Study|Withdrawal by Subject|2|||
23342211|NCT04739722|64996037|FG000|Overall Study|Lost to Follow-up|5301|||
23342212|NCT04739722|64996037|FG000|Overall Study|Withdrawal by Subject|42|||
23342213|NCT04739722|64996037|FG000|Overall Study|Non Average-risk|1157|||
23342214|NCT04725812|64996038|FG000|Overall Study|Withdrawal by Subject|1|||
23342215|NCT01032239|64996041|FG000|Overall Study|Lost to Follow-up|3|||
23342216|NCT01032239|64996042|FG001|Overall Study|Lost to Follow-up|2|||
23342217|NCT01032239|64996041|FG000|Overall Study|Withdrawal by Subject|2|||
23342218|NCT01032239|64996042|FG001|Overall Study|Withdrawal by Subject|3|||
23342219|NCT01032239|64996041|FG000|Overall Study|Death|1|||
23342220|NCT01032239|64996042|FG001|Overall Study|Death|0|||
23342221|NCT01032239|64996041|FG000|Overall Study|Protocol Violation|1|||
23342222|NCT01032239|64996042|FG001|Overall Study|Protocol Violation|0|||
23342223|NCT04143594|64996052|FG000|Overall Study|Withdrew consent|3|||
23342224|NCT04143594|64996053|FG001|Overall Study|Withdrew consent|10|||
23342225|NCT04143594|64996054|FG002|Overall Study|Withdrew consent|3|||
23342226|NCT04143594|64996055|FG003|Overall Study|Withdrew consent|1|||
23342227|NCT04143594|64996052|FG000|Overall Study|Lost to Follow-up|3|||
23342228|NCT04143594|64996053|FG001|Overall Study|Lost to Follow-up|5|||
23342229|NCT04143594|64996054|FG002|Overall Study|Lost to Follow-up|11|||
23342230|NCT04143594|64996055|FG003|Overall Study|Lost to Follow-up|0|||
23342231|NCT04143594|64996052|FG000|Overall Study|Investigator's discretion|2|||
23342232|NCT04143594|64996053|FG001|Overall Study|Investigator's discretion|2|||
23342233|NCT04143594|64996054|FG002|Overall Study|Investigator's discretion|0|||
23342234|NCT04143594|64996055|FG003|Overall Study|Investigator's discretion|0|||
23342235|NCT04143594|64996052|FG000|Overall Study|Randomized but never treated|0|||
23342236|NCT04143594|64996053|FG001|Overall Study|Randomized but never treated|0|||
23342237|NCT04143594|64996054|FG002|Overall Study|Randomized but never treated|0|||
23342238|NCT04143594|64996055|FG003|Overall Study|Randomized but never treated|1|||
23342239|NCT04143594|64996052|FG000|Overall Study|Death|1|||
23782892|NCT00834756|66583274|FG001|First Intervention|Adverse Event|0|||
23342240|NCT04143594|64996053|FG001|Overall Study|Death|0|||
23342241|NCT04143594|64996054|FG002|Overall Study|Death|1|||
23342242|NCT04143594|64996055|FG003|Overall Study|Death|0|||
23342243|NCT04143594|64996052|FG000|Overall Study|Adverse Event|1|||
23342244|NCT04143594|64996053|FG001|Overall Study|Adverse Event|0|||
23342245|NCT04143594|64996054|FG002|Overall Study|Adverse Event|0|||
23342246|NCT04143594|64996055|FG003|Overall Study|Adverse Event|0|||
23342247|NCT04143594|64996052|FG000|Overall Study|Pregnancy|0|||
23342248|NCT04143594|64996053|FG001|Overall Study|Pregnancy|0|||
23342249|NCT04143594|64996054|FG002|Overall Study|Pregnancy|1|||
23782893|NCT00834756|66583273|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23342250|NCT04143594|64996055|FG003|Overall Study|Pregnancy|0|||
23342251|NCT04143594|64996052|FG000|Overall Study|Lack of Efficacy|1|||
23342252|NCT04143594|64996053|FG001|Overall Study|Lack of Efficacy|1|||
23782894|NCT00834756|66583274|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
23782895|NCT00834418|66583277|FG000|Overall Study|Adverse Event|0|||
23782896|NCT00834418|66583278|FG001|Overall Study|Adverse Event|2|||
23782897|NCT02554877|66583286|FG000|Overall Study|Adverse Event|2|||
23782898|NCT02554877|66583287|FG001|Overall Study|Adverse Event|0|||
23782899|NCT02554877|66583288|FG002|Overall Study|Adverse Event|0|||
23782900|NCT02554877|66583289|FG003|Overall Study|Adverse Event|1|||
23782901|NCT02554877|66583286|FG000|Overall Study|Lost to Follow-up|1|||
23782902|NCT02554877|66583287|FG001|Overall Study|Lost to Follow-up|1|||
23782903|NCT02554877|66583288|FG002|Overall Study|Lost to Follow-up|1|||
23782904|NCT02554877|66583289|FG003|Overall Study|Lost to Follow-up|2|||
23782905|NCT02554877|66583286|FG000|Overall Study|Did not meet entrance criteria|0|||
23782906|NCT02554877|66583287|FG001|Overall Study|Did not meet entrance criteria|0|||
23782907|NCT02554877|66583288|FG002|Overall Study|Did not meet entrance criteria|1|||
23782908|NCT02554877|66583289|FG003|Overall Study|Did not meet entrance criteria|0|||
23782909|NCT02554877|66583286|FG000|Overall Study|No longer met eligibility criteria|1|||
23782910|NCT02554877|66583287|FG001|Overall Study|No longer met eligibility criteria|0|||
23782911|NCT02554877|66583288|FG002|Overall Study|No longer met eligibility criteria|1|||
23782912|NCT02554877|66583289|FG003|Overall Study|No longer met eligibility criteria|1|||
23782913|NCT02554877|66583286|FG000|Overall Study|Protocol Violation|3|||
23782914|NCT02554877|66583287|FG001|Overall Study|Protocol Violation|1|||
23782915|NCT02554877|66583288|FG002|Overall Study|Protocol Violation|1|||
23782916|NCT02554877|66583289|FG003|Overall Study|Protocol Violation|0|||
23782917|NCT02554877|66583286|FG000|Overall Study|Other|1|||
23782918|NCT02554877|66583287|FG001|Overall Study|Other|3|||
23782919|NCT02554877|66583288|FG002|Overall Study|Other|0|||
23782920|NCT02554877|66583289|FG003|Overall Study|Other|3|||
23782921|NCT02554877|66583286|FG000|Overall Study|Insufficient clinical response|4|||
23782922|NCT02554877|66583287|FG001|Overall Study|Insufficient clinical response|0|||
23782923|NCT02554877|66583288|FG002|Overall Study|Insufficient clinical response|0|||
23782924|NCT02554877|66583289|FG003|Overall Study|Insufficient clinical response|0|||
23782925|NCT02554877|66583286|FG000|Overall Study|No longer willing to participate|0|||
23782926|NCT02554877|66583287|FG001|Overall Study|No longer willing to participate|2|||
23782927|NCT02554877|66583288|FG002|Overall Study|No longer willing to participate|2|||
23782928|NCT02554877|66583289|FG003|Overall Study|No longer willing to participate|0|||
23782929|NCT04239872|66583291|FG000|Overall Study|Lost to Follow-up|0|||
23782930|NCT04239872|66583292|FG001|Overall Study|Lost to Follow-up|1|||
23782931|NCT03204539|66583296|FG000|Overall Study|Loss of funding|0|||
23782932|NCT03204539|66583297|FG001|Overall Study|Loss of funding|1|||
23782933|NCT01975948|66583298|FG000|Overall Study|Withdrawal by Subject|17|||
23782934|NCT01975948|66583299|FG001|Overall Study|Withdrawal by Subject|21|||
23782935|NCT01975948|66583300|FG002|Overall Study|Withdrawal by Subject|7|||
23782936|NCT01975948|66583301|FG003|Overall Study|Withdrawal by Subject|6|||
23782937|NCT01175135|66583302|FG000|Overall Study|Adverse Event|2|||
23782938|NCT01175135|66583303|FG001|Overall Study|Adverse Event|5|||
23782939|NCT01175135|66583304|FG002|Overall Study|Adverse Event|3|||
23782940|NCT01175135|66583305|FG003|Overall Study|Adverse Event|4|||
23782941|NCT01175135|66583302|FG000|Overall Study|Death|1|||
23782942|NCT01175135|66583303|FG001|Overall Study|Death|0|||
23782943|NCT01175135|66583304|FG002|Overall Study|Death|0|||
23782944|NCT01175135|66583305|FG003|Overall Study|Death|0|||
23782945|NCT01175135|66583302|FG000|Overall Study|Lack of Efficacy|4|||
23342253|NCT04143594|64996054|FG002|Overall Study|Lack of Efficacy|0|||
23782946|NCT01175135|66583303|FG001|Overall Study|Lack of Efficacy|5|||
23782947|NCT01175135|66583304|FG002|Overall Study|Lack of Efficacy|0|||
23342254|NCT04143594|64996055|FG003|Overall Study|Lack of Efficacy|0|||
23342255|NCT04526665|64996056|FG000|Overall Study|Withdrawal by Subject|6|||
23782948|NCT01175135|66583305|FG003|Overall Study|Lack of Efficacy|5|||
23782949|NCT01175135|66583302|FG000|Overall Study|Lost to Follow-up|1|||
23782950|NCT01175135|66583303|FG001|Overall Study|Lost to Follow-up|2|||
23342256|NCT04526665|64996057|FG001|Overall Study|Withdrawal by Subject|3|||
23782951|NCT01175135|66583304|FG002|Overall Study|Lost to Follow-up|0|||
23342257|NCT04526665|64996056|FG000|Overall Study|Adverse Event|4|||
23342258|NCT04526665|64996057|FG001|Overall Study|Adverse Event|1|||
23782952|NCT01175135|66583305|FG003|Overall Study|Lost to Follow-up|0|||
23342259|NCT04526665|64996056|FG000|Overall Study|Physician Decision|2|||
23342260|NCT04526665|64996057|FG001|Overall Study|Physician Decision|2|||
23342261|NCT04526665|64996056|FG000|Overall Study|Death|2|||
23342262|NCT04526665|64996057|FG001|Overall Study|Death|0|||
23342263|NCT04526665|64996056|FG000|Overall Study|Other|0|||
23342264|NCT04526665|64996057|FG001|Overall Study|Other|1|||
23342265|NCT03555565|64996058|FG000|Overall Study|Case Report Forms Uncollected|2|||
23342266|NCT03555565|64996058|FG000|Overall Study|Protocol Deviation|13|||
23342267|NCT01095978|64996059|FG000|Overall Study|Did not take Klacid SR|2|||
23342268|NCT01095978|64996059|FG000|Overall Study|Adverse Event|1|||
23342269|NCT02682823|64996065|FG000|Overall Study|Withdrawal by Subject|0|||
23342270|NCT02682823|64996066|FG001|Overall Study|Withdrawal by Subject|0|||
23342271|NCT02682823|64996067|FG002|Overall Study|Withdrawal by Subject|1|||
23342272|NCT02682823|64996068|FG003|Overall Study|Withdrawal by Subject|0|||
23342273|NCT02682823|64996069|FG004|Overall Study|Withdrawal by Subject|1|||
23342274|NCT02682823|64996065|FG000|Overall Study|Protocol Deviation|0|||
23342275|NCT02682823|64996066|FG001|Overall Study|Protocol Deviation|1|||
23342276|NCT02682823|64996067|FG002|Overall Study|Protocol Deviation|0|||
23342277|NCT02682823|64996068|FG003|Overall Study|Protocol Deviation|0|||
23342278|NCT02682823|64996069|FG004|Overall Study|Protocol Deviation|0|||
23342279|NCT02682823|64996065|FG000|Overall Study|Adverse Event|0|||
23636773|NCT03031496|66053008|FG000|Period 1|Adverse Event|2|||
23636774|NCT03031496|66053009|FG001|Period 1|Adverse Event|0|||
23636775|NCT03031496|66053008|FG000|Period 1|Withdrawal by Subject|0|||
23636776|NCT03031496|66053009|FG001|Period 1|Withdrawal by Subject|2|||
23636777|NCT00953771|66053010|FG000|Overall Study|Death|1|||
23636778|NCT00953771|66053011|FG001|Overall Study|Death|0|||
23636779|NCT01068665|66053014|FG000|Overall Study|Adverse Event|5|||
23636780|NCT01068665|66053015|FG001|Overall Study|Adverse Event|4|||
23636781|NCT01068665|66053014|FG000|Overall Study|Lack of Efficacy|0|||
23636782|NCT01068665|66053015|FG001|Overall Study|Lack of Efficacy|2|||
23636783|NCT01068665|66053014|FG000|Overall Study|Protocol Violation|5|||
23636784|NCT01068665|66053015|FG001|Overall Study|Protocol Violation|2|||
23636785|NCT01068665|66053014|FG000|Overall Study|Withdrawal Criteria|3|||
23636786|NCT01068665|66053015|FG001|Overall Study|Withdrawal Criteria|9|||
23636787|NCT01068665|66053014|FG000|Overall Study|Other|17|||
23636788|NCT01068665|66053015|FG001|Overall Study|Other|12|||
23636789|NCT02815579|66053017|FG000|Overall Study|Non-payment of loan down-payment|16|||
23636790|NCT02815579|66053018|FG001|Overall Study|Non-payment of loan down-payment|0|||
23782953|NCT01175135|66583302|FG000|Overall Study|Protocol Violation|1|||
23636791|NCT02815579|66053017|FG000|Overall Study|Withdrawal by Subject|7|||
23636792|NCT02815579|66053018|FG001|Overall Study|Withdrawal by Subject|1|||
23636793|NCT02815579|66053017|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
23636794|NCT02815579|66053018|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
23782954|NCT01175135|66583303|FG001|Overall Study|Protocol Violation|1|||
23782955|NCT01175135|66583304|FG002|Overall Study|Protocol Violation|0|||
23782956|NCT01175135|66583305|FG003|Overall Study|Protocol Violation|0|||
23782957|NCT01175135|66583302|FG000|Overall Study|Withdrawal by Subject|4|||
23782958|NCT01175135|66583303|FG001|Overall Study|Withdrawal by Subject|8|||
23782959|NCT01175135|66583304|FG002|Overall Study|Withdrawal by Subject|5|||
23782960|NCT01175135|66583305|FG003|Overall Study|Withdrawal by Subject|5|||
23782961|NCT01175135|66583302|FG000|Overall Study|Other|3|||
23782962|NCT01175135|66583303|FG001|Overall Study|Other|1|||
23782963|NCT01175135|66583304|FG002|Overall Study|Other|3|||
23782964|NCT01175135|66583305|FG003|Overall Study|Other|0|||
23782965|NCT01175135|66583302|FG000|Overall Study|Randomized But Not Treated|0|||
23782966|NCT01175135|66583303|FG001|Overall Study|Randomized But Not Treated|0|||
23782967|NCT01175135|66583304|FG002|Overall Study|Randomized But Not Treated|1|||
23782968|NCT01175135|66583305|FG003|Overall Study|Randomized But Not Treated|0|||
23782969|NCT03276754|66583311|FG000|Overall Study|Withdrawal of informed consent|4|||
23782970|NCT03276754|66583311|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
23782971|NCT03276754|66583311|FG000|Overall Study|Lost to Follow-up|27|||
23782972|NCT03276754|66583311|FG000|Overall Study|No data reported at Month 24|31|||
23782973|NCT03276754|66583311|FG000|Overall Study|Death|39|||
23782974|NCT00185458|66583312|FG000|Contraception Phase|Adverse Event|37|||
23782975|NCT00185458|66583312|FG000|Contraception Phase|Lost to Follow-up|10|||
23782976|NCT00185458|66583312|FG000|Contraception Phase|Protocol Violation|2|||
23782977|NCT00185458|66583312|FG000|Contraception Phase|Physician Decision|2|||
23342280|NCT02682823|64996066|FG001|Overall Study|Adverse Event|0|||
23782978|NCT00185458|66583312|FG000|Contraception Phase|Withdrawal by Subject|7|||
23782979|NCT00185458|66583312|FG000|HRT Phase|Adverse Event|18|||
23782980|NCT00185458|66583312|FG000|HRT Phase|Lost to Follow-up|4|||
23342281|NCT02682823|64996067|FG002|Overall Study|Adverse Event|0|||
23342282|NCT02682823|64996068|FG003|Overall Study|Adverse Event|1|||
23342283|NCT02682823|64996069|FG004|Overall Study|Adverse Event|0|||
23636795|NCT02815579|66053017|FG000|Overall Study|Lost to Follow-up|7|||
23636796|NCT02815579|66053018|FG001|Overall Study|Lost to Follow-up|4|||
23636797|NCT02815579|66053017|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
23705485|NCT03382899|66297517|FG001|Overall Study|Sponsor's decision|28|||
23454087|NCT02240485|65403465|FG000|18 Months Post-admission|Lost to Follow-up|1|||
23454088|NCT02240485|65403466|FG001|18 Months Post-admission|Lost to Follow-up|1|||
23454089|NCT02240485|65403465|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
23782981|NCT00185458|66583312|FG000|HRT Phase|Protocol Violation|2|||
23782982|NCT00185458|66583312|FG000|HRT Phase|Withdrawal by Subject|3|||
23782983|NCT01701063|66583313|FG000|Overall Study|Lost to Follow-up|0|||
23782984|NCT01701063|66583314|FG001|Overall Study|Lost to Follow-up|1|||
23782985|NCT01701063|66583315|FG002|Overall Study|Lost to Follow-up|0|||
23782986|NCT01701063|66583313|FG000|Overall Study|Withdrawal by Subject|0|||
23782987|NCT01701063|66583314|FG001|Overall Study|Withdrawal by Subject|0|||
23782988|NCT01701063|66583315|FG002|Overall Study|Withdrawal by Subject|1|||
23782989|NCT01701063|66583313|FG000|Overall Study|Other|0|||
23782990|NCT01701063|66583314|FG001|Overall Study|Other|0|||
23782991|NCT01701063|66583315|FG002|Overall Study|Other|1|||
23782992|NCT01319383|66583316|FG000|Overall Study|No ex vivo or in vivo response|4|||
23782993|NCT01319383|66583317|FG001|Overall Study|No ex vivo or in vivo response|0|||
23782994|NCT01319383|66583316|FG000|Overall Study|Physician Decision|3|||
23782995|NCT01319383|66583317|FG001|Overall Study|Physician Decision|0|||
23782996|NCT01319383|66583316|FG000|Overall Study|Lack of Efficacy|5|||
23782997|NCT01319383|66583317|FG001|Overall Study|Lack of Efficacy|9|||
23782998|NCT01319383|66583316|FG000|Overall Study|No in vivo response to interval doses|0|||
23782999|NCT01319383|66583317|FG001|Overall Study|No in vivo response to interval doses|1|||
23783000|NCT04166630|66583318|FG000|Overall Study|Withdrawal by Subject|0|||
23783001|NCT04166630|66583319|FG001|Overall Study|Withdrawal by Subject|1|||
23783002|NCT01577381|66583332|FG000|Overall Study|Discontinued|2|||
23783003|NCT01577381|66583333|FG001|Overall Study|Discontinued|1|||
23783004|NCT01577381|66583334|FG002|Overall Study|Discontinued|2|||
23783005|NCT01577381|66583335|FG003|Overall Study|Discontinued|2|||
23783006|NCT01577381|66583332|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
23783007|NCT01577381|66583333|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
23783008|NCT01577381|66583334|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
23783009|NCT01577381|66583335|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
23783010|NCT00849901|66583337|FG000|Acute Treatment Phase|Adverse Event|9|||
23783011|NCT00849901|66583338|FG001|Acute Treatment Phase|Adverse Event|1|||
23783012|NCT00849901|66583339|FG002|Acute Treatment Phase|Adverse Event|3|||
23783013|NCT00849901|66583337|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
23783014|NCT00849901|66583338|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
23783015|NCT00849901|66583339|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
23783016|NCT00849901|66583337|FG000|Acute Treatment Phase|Protocol Violation|0|||
23783017|NCT00849901|66583338|FG001|Acute Treatment Phase|Protocol Violation|2|||
23783018|NCT00849901|66583339|FG002|Acute Treatment Phase|Protocol Violation|1|||
23783019|NCT00849901|66583337|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
23783020|NCT00849901|66583338|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
23783021|NCT00849901|66583339|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
23783022|NCT00849901|66583337|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
23783023|NCT00849901|66583338|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
23783024|NCT00849901|66583339|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
23783025|NCT00849901|66583337|FG000|Acute Treatment Phase|Physician Decision|1|||
23783026|NCT00849901|66583338|FG001|Acute Treatment Phase|Physician Decision|1|||
23783027|NCT00849901|66583339|FG002|Acute Treatment Phase|Physician Decision|1|||
23783028|NCT00849901|66583337|FG000|Acute Treatment Phase|Sponsor Decision|1|||
23783029|NCT00849901|66583338|FG001|Acute Treatment Phase|Sponsor Decision|0|||
23783030|NCT00849901|66583339|FG002|Acute Treatment Phase|Sponsor Decision|0|||
23783031|NCT00849901|66583337|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
23783032|NCT00849901|66583338|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
23783033|NCT00849901|66583339|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
23783034|NCT00849901|66583337|FG000|Extension Phase|Adverse Event|2|||
23783035|NCT00849901|66583338|FG001|Extension Phase|Adverse Event|8|||
23783036|NCT00849901|66583339|FG002|Extension Phase|Adverse Event|4|||
23783037|NCT00849901|66583337|FG000|Extension Phase|Lost to Follow-up|3|||
23783038|NCT00849901|66583338|FG001|Extension Phase|Lost to Follow-up|0|||
23783039|NCT00849901|66583339|FG002|Extension Phase|Lost to Follow-up|1|||
23783040|NCT00849901|66583337|FG000|Extension Phase|Protocol Violation|2|||
23783041|NCT00849901|66583338|FG001|Extension Phase|Protocol Violation|2|||
23783042|NCT00849901|66583339|FG002|Extension Phase|Protocol Violation|4|||
23783043|NCT00849901|66583337|FG000|Extension Phase|Withdrawal by Subject|7|||
23783044|NCT00849901|66583338|FG001|Extension Phase|Withdrawal by Subject|6|||
23783045|NCT00849901|66583339|FG002|Extension Phase|Withdrawal by Subject|3|||
23454090|NCT02240485|65403466|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
23454091|NCT03740048|65403469|FG000|Overall Study|Withdrawal by Subject|1|||
23783046|NCT00849901|66583337|FG000|Extension Phase|Parent or Caregiver Decision|10|||
23783047|NCT00849901|66583338|FG001|Extension Phase|Parent or Caregiver Decision|4|||
23783048|NCT00849901|66583339|FG002|Extension Phase|Parent or Caregiver Decision|4|||
23783049|NCT00849901|66583337|FG000|Extension Phase|Physician Decision|1|||
23783050|NCT00849901|66583338|FG001|Extension Phase|Physician Decision|2|||
23783051|NCT00849901|66583339|FG002|Extension Phase|Physician Decision|0|||
23783052|NCT00849901|66583337|FG000|Extension Phase|Lack of Efficacy|2|||
23783053|NCT00849901|66583338|FG001|Extension Phase|Lack of Efficacy|4|||
23783054|NCT00849901|66583339|FG002|Extension Phase|Lack of Efficacy|1|||
23783055|NCT02736721|66583340|FG000|Overall Study|Adverse Event|8|||
23783056|NCT02736721|66583340|FG000|Overall Study|Lost to Follow-up|3|||
23783057|NCT02736721|66583340|FG000|Overall Study|Other|5|||
23783058|NCT04827394|66583341|FG000|Overall Study|Physician Decision|0|||
23783059|NCT04827394|66583342|FG001|Overall Study|Physician Decision|2|||
23783060|NCT03769025|66583343|FG000|Overall Study|Withdrawal by Subject|1|||
23783061|NCT03769025|66583344|FG001|Overall Study|Withdrawal by Subject|1|||
23783062|NCT03769025|66583343|FG000|Overall Study|Lost to Follow-up|4|||
23783063|NCT03769025|66583344|FG001|Overall Study|Lost to Follow-up|3|||
23783064|NCT02321098|66583345|FG000|12 Weeks Treament|Lost to Follow-up|1|||
23783065|NCT02321098|66583346|FG001|12 Weeks Treament|Lost to Follow-up|1|||
23783066|NCT02321098|66583347|FG002|12 Weeks Treament|Lost to Follow-up|0|||
23783067|NCT02321098|66583345|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
23783068|NCT02321098|66583346|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
23783069|NCT02321098|66583347|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
23783070|NCT02321098|66583345|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
23783071|NCT02321098|66583346|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
23783072|NCT02321098|66583347|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
23783073|NCT02321098|66583345|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
23783074|NCT02321098|66583346|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
23783075|NCT02321098|66583347|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
23783076|NCT00207090|66583349|FG000|Overall Study|Study drug toxicity|3|||
23783077|NCT00207090|66583349|FG000|Overall Study|Chest wall mass larger|1|||
23783078|NCT00207090|66583349|FG000|Overall Study|Disease progression/relapse|2|||
23783079|NCT00207090|66583349|FG000|Overall Study|Physician Decision|1|||
23783080|NCT04022954|66583355|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
23783081|NCT04022954|66583355|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
23783082|NCT04022954|66583355|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
23783083|NCT00859430|66583356|FG000|First Intervention|Withdrawal by Subject|0|||
23783084|NCT00859430|66583357|FG001|First Intervention|Withdrawal by Subject|1|||
23783085|NCT01250912|66583358|FG000|Overall Study|Lost to Follow-up|1|||
23783086|NCT00824291|66583359|FG000|Overall Study|Adverse Event|15|||
23783087|NCT00824291|66583360|FG001|Overall Study|Adverse Event|6|||
23783088|NCT00824291|66583359|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23783089|NCT00824291|66583360|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
23783090|NCT00824291|66583359|FG000|Overall Study|Lost to Follow-up|11|||
23783091|NCT00824291|66583360|FG001|Overall Study|Lost to Follow-up|9|||
23783092|NCT00824291|66583359|FG000|Overall Study|Non-compliance|1|||
23783093|NCT00824291|66583360|FG001|Overall Study|Non-compliance|1|||
23843121|NCT01738503|66805583|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23843122|NCT01738503|66805584|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23843123|NCT01738503|66805585|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23843124|NCT01738503|66805586|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
23843125|NCT01738503|66805587|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
23843126|NCT01637922|66805588|FG000|Overall Study|Adverse Event|0|||
23843127|NCT01637922|66805589|FG001|Overall Study|Adverse Event|1|||
23843128|NCT01637922|66805588|FG000|Overall Study|Protocol Violation|0|||
23843129|NCT01637922|66805589|FG001|Overall Study|Protocol Violation|1|||
23843130|NCT01637922|66805588|FG000|Overall Study|Withdrawal by Subject|0|||
23843131|NCT01637922|66805589|FG001|Overall Study|Withdrawal by Subject|3|||
23843132|NCT01637922|66805588|FG000|Overall Study|Lost to Follow-up|2|||
23843133|NCT01637922|66805589|FG001|Overall Study|Lost to Follow-up|0|||
23843134|NCT00626821|66805603|FG000|Overall Study|Adverse Event|44|||
23843135|NCT00626821|66805603|FG000|Overall Study|Protocol Violation|33|||
23843136|NCT00626821|66805603|FG000|Overall Study|Withdrawal by Subject|10|||
23843137|NCT00626821|66805603|FG000|Overall Study|Physician Decision|9|||
23843138|NCT00626821|66805603|FG000|Overall Study|Product dysfunction|21|||
23843139|NCT00626821|66805603|FG000|Overall Study|other/unknown reason|104|||
23843140|NCT02640404|66805604|FG000|Overall Study|Protocol Violation|1|||
23843141|NCT02640404|66805605|FG001|Overall Study|Protocol Violation|0|||
23843142|NCT02640404|66805604|FG000|Overall Study|Withdrawal by Subject|1|||
23843143|NCT02640404|66805605|FG001|Overall Study|Withdrawal by Subject|0|||
23843144|NCT04545567|66805608|FG000|Overall Study|tested positive for SARS-co-V2|1|||
23342284|NCT01905553|64996075|FG000|Period 2|Adverse Event|1|||
23783094|NCT00824291|66583359|FG000|Overall Study|Protocol Violation|4|||
23783095|NCT00824291|66583360|FG001|Overall Study|Protocol Violation|1|||
23843145|NCT04545567|66805609|FG001|Overall Study|tested positive for SARS-co-V2|1|||
23843146|NCT04545567|66805608|FG000|Overall Study|Withdrawal by Subject|0|||
23843147|NCT04545567|66805609|FG001|Overall Study|Withdrawal by Subject|1|||
23843148|NCT02496091|66805612|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23342285|NCT01905553|64996076|FG001|Period 2|Adverse Event|0|||
23342286|NCT02166463|64996077|FG000|Overall Study|Lost to Follow-up|0|||
23342287|NCT02166463|64996078|FG001|Overall Study|Lost to Follow-up|1|||
23342288|NCT02166463|64996077|FG000|Overall Study|Physician Decision|10|||
23342289|NCT02166463|64996078|FG001|Overall Study|Physician Decision|10|||
23342290|NCT02166463|64996077|FG000|Overall Study|Ineligible|11|||
23342291|NCT02166463|64996078|FG001|Overall Study|Ineligible|2|||
23454092|NCT03740048|65403470|FG001|Overall Study|Withdrawal by Subject|1|||
23454093|NCT03740048|65403469|FG000|Overall Study|Death|1|||
23454094|NCT03740048|65403470|FG001|Overall Study|Death|6|||
23454095|NCT03740048|65403469|FG000|Overall Study|Switched to thrice-weekly HD|2|||
23454096|NCT03740048|65403470|FG001|Overall Study|Switched to thrice-weekly HD|0|||
23454097|NCT03740048|65403469|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
23342292|NCT02166463|64996077|FG000|Overall Study|Progressive Disease|9|||
23342293|NCT02166463|64996078|FG001|Overall Study|Progressive Disease|6|||
23342294|NCT02166463|64996077|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
23342295|NCT02166463|64996078|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
23342296|NCT02166463|64996077|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
23342297|NCT02166463|64996078|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
23454098|NCT03740048|65403470|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
23454099|NCT03740048|65403469|FG000|Overall Study|Lost to Follow-up|0|||
23454100|NCT03740048|65403470|FG001|Overall Study|Lost to Follow-up|1|||
23454101|NCT03740048|65403469|FG000|Overall Study|Non-compliance with HD|0|||
23454102|NCT03740048|65403470|FG001|Overall Study|Non-compliance with HD|1|||
23454103|NCT04191616|65403471|FG000|Overall Study|Death|26|||
23582433|NCT03736785|65862479|FG002|Overall Study|Unknown/Missing data|1|||
23582434|NCT03736785|65862477|FG000|Overall Study|Withdrawal by Subject|9|||
23582435|NCT03736785|65862478|FG001|Overall Study|Withdrawal by Subject|6|||
23582436|NCT03736785|65862479|FG002|Overall Study|Withdrawal by Subject|4|||
23342298|NCT02166463|64996077|FG000|Overall Study|Refusal of further protocol therapy|5|||
23454104|NCT04191616|65403471|FG000|Overall Study|Withdrawal by Subject|1|||
23454105|NCT04191616|65403471|FG000|Overall Study|Sponsor decision|2|||
23582437|NCT05489224|65862480|FG000|Treatment Period I|Withdrawal by Subject|6|||
23582438|NCT05489224|65862481|FG001|Treatment Period I|Withdrawal by Subject|5|||
23582439|NCT05489224|65862482|FG002|Treatment Period I|Withdrawal by Subject|0|||
23582440|NCT05489224|65862480|FG000|Treatment Period I|Adverse Event|3|||
23582441|NCT05489224|65862481|FG001|Treatment Period I|Adverse Event|11|||
23582442|NCT05489224|65862482|FG002|Treatment Period I|Adverse Event|0|||
23582443|NCT05489224|65862480|FG000|Treatment Period I|Lost to Follow-up|0|||
23582444|NCT05489224|65862481|FG001|Treatment Period I|Lost to Follow-up|1|||
23582445|NCT05489224|65862482|FG002|Treatment Period I|Lost to Follow-up|0|||
23582446|NCT05489224|65862480|FG000|Treatment Period I|Physician Decision|0|||
23582447|NCT05489224|65862481|FG001|Treatment Period I|Physician Decision|1|||
23582448|NCT05489224|65862482|FG002|Treatment Period I|Physician Decision|0|||
23582449|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Ongoing|222|||
23582450|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Ongoing|107|||
23582451|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Ongoing|107|||
23783096|NCT00824291|66583359|FG000|Overall Study|Withdrawal by Subject|14|||
23783097|NCT00824291|66583360|FG001|Overall Study|Withdrawal by Subject|8|||
23783098|NCT00824291|66583359|FG000|Overall Study|Lack of Efficacy|7|||
23783099|NCT00824291|66583360|FG001|Overall Study|Lack of Efficacy|8|||
23783100|NCT00824291|66583359|FG000|Overall Study|Participant on prohibited medication|1|||
23783101|NCT00824291|66583360|FG001|Overall Study|Participant on prohibited medication|0|||
23783102|NCT00935012|66583363|FG000|Overall Study|Death|19|||
23783103|NCT00935012|66583363|FG000|Overall Study|Withdrawal by Subject|3|||
23783104|NCT00935012|66583363|FG000|Overall Study|Other|5|||
23783105|NCT00935012|66583363|FG000|Overall Study|Adverse Event|2|||
23783106|NCT00477594|66583364|FG000|Year 1 and Year 2|Adverse Event|4|||
23783107|NCT00477594|66583365|FG001|Year 1 and Year 2|Adverse Event|2|||
23783108|NCT00477594|66583364|FG000|Year 1 and Year 2|Physician Decision|2|||
23783109|NCT00477594|66583365|FG001|Year 1 and Year 2|Physician Decision|1|||
23783110|NCT00477594|66583364|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
23783111|NCT00477594|66583365|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
23783112|NCT00477594|66583364|FG000|Year 1 and Year 2|Other|1|||
23783113|NCT00477594|66583365|FG001|Year 1 and Year 2|Other|0|||
23783114|NCT00477594|66583364|FG000|Year 3|Adverse Event|1|||
23783115|NCT00477594|66583365|FG001|Year 3|Adverse Event|0|||
23783116|NCT00477594|66583364|FG000|Year 3|Withdrawal by Subject|1|||
23783117|NCT00477594|66583365|FG001|Year 3|Withdrawal by Subject|0|||
23783118|NCT00477594|66583364|FG000|Follow-up Period|Withdrawal by Subject|2|||
23783119|NCT00477594|66583365|FG001|Follow-up Period|Withdrawal by Subject|1|||
23783120|NCT00477594|66583364|FG000|Follow-up Period|Other|1|||
23783121|NCT00477594|66583365|FG001|Follow-up Period|Other|0|||
23342299|NCT02166463|64996078|FG001|Overall Study|Refusal of further protocol therapy|6|||
23454106|NCT04191616|65403471|FG000|Overall Study|Continuing study|25|||
23454107|NCT01172535|65403472|FG000|Overall Study|Death|3|||
23454108|NCT01172535|65403472|FG000|Overall Study|Withdrawal by Subject|2|||
23454109|NCT01172535|65403472|FG000|Overall Study|Lost to Follow-up|1|||
23454110|NCT01172535|65403472|FG000|Overall Study|Ineligible at study entry|1|||
23454111|NCT01172535|65403472|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23454112|NCT01706458|65403475|FG000|Overall Study|Physician Decision|3|||
23454113|NCT01706458|65403476|FG001|Overall Study|Physician Decision|4|||
23454114|NCT04258423|65403477|FG000|Overall Study|Study Closure|2|||
23454115|NCT04258423|65403478|FG001|Overall Study|Study Closure|2|||
23454116|NCT02859246|65403479|FG000|Overall Study|Screen fails|3|||
23454117|NCT02859246|65403479|FG000|Overall Study|Adverse Event|1|||
23454118|NCT02859246|65403479|FG000|Overall Study|Withdrawal by Subject|1|||
23454119|NCT01600885|65403480|FG000|First Period|Adverse Event|1|||
23454120|NCT01600885|65403481|FG001|First Period|Adverse Event|1|||
23454121|NCT01600885|65403480|FG000|First Period|moved out of area|1|||
23454122|NCT01600885|65403481|FG001|First Period|moved out of area|0|||
23454123|NCT01921205|65403486|FG000|Overall Study|Adverse Event|12|||
23454124|NCT01921205|65403487|FG001|Overall Study|Adverse Event|7|||
23454125|NCT01921205|65403486|FG000|Overall Study|Lack of Efficacy|1|||
23843149|NCT03521115|66805613|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
23843150|NCT03521115|66805614|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
23843151|NCT03521115|66805613|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
23454126|NCT01921205|65403487|FG001|Overall Study|Lack of Efficacy|0|||
23454127|NCT01921205|65403486|FG000|Overall Study|Protocol Violation|1|||
23454128|NCT01921205|65403487|FG001|Overall Study|Protocol Violation|3|||
23454129|NCT01921205|65403486|FG000|Overall Study|Lost to Follow-up|1|||
23454130|NCT01921205|65403487|FG001|Overall Study|Lost to Follow-up|1|||
23454131|NCT01921205|65403486|FG000|Overall Study|Withdrawal by Subject|6|||
23454132|NCT01921205|65403487|FG001|Overall Study|Withdrawal by Subject|5|||
23454133|NCT01921205|65403486|FG000|Overall Study|Use Of Prohibited Medication|0|||
23454134|NCT01921205|65403487|FG001|Overall Study|Use Of Prohibited Medication|1|||
23454135|NCT01921205|65403486|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
23454136|NCT01921205|65403487|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
23454137|NCT01921205|65403486|FG000|Overall Study|Non Compliance Of The Parent|0|||
23454138|NCT01921205|65403487|FG001|Overall Study|Non Compliance Of The Parent|1|||
23454139|NCT01921205|65403486|FG000|Overall Study|Non Compliance Of Child|0|||
23454140|NCT01921205|65403487|FG001|Overall Study|Non Compliance Of Child|1|||
23843152|NCT03521115|66805614|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
23454141|NCT01069484|65403493|FG000|Overall Study|Death-in-near-family|1|||
23454142|NCT01069484|65403494|FG001|Overall Study|Death-in-near-family|0|||
23454143|NCT01069484|65403493|FG000|Overall Study|No specific reason|8|||
23454144|NCT01069484|65403494|FG001|Overall Study|No specific reason|2|||
23454145|NCT01069484|65403493|FG000|Overall Study|Illness mother or child|3|||
23454146|NCT01069484|65403494|FG001|Overall Study|Illness mother or child|1|||
23454147|NCT01506271|65403495|FG000|Overall Study|Progressive disease|0|||
23454148|NCT01506271|65403496|FG001|Overall Study|Progressive disease|1|||
23454149|NCT01506271|65403497|FG002|Overall Study|Progressive disease|0|||
23454150|NCT01506271|65403495|FG000|Overall Study|Protocol Violation|3|||
23454151|NCT01506271|65403496|FG001|Overall Study|Protocol Violation|1|||
23582452|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
23454152|NCT01506271|65403497|FG002|Overall Study|Protocol Violation|0|||
23454153|NCT01506271|65403495|FG000|Overall Study|Death|0|||
23454154|NCT01506271|65403496|FG001|Overall Study|Death|1|||
23454155|NCT01506271|65403497|FG002|Overall Study|Death|0|||
23454156|NCT01506271|65403495|FG000|Overall Study|Adverse Event|0|||
23454157|NCT01506271|65403496|FG001|Overall Study|Adverse Event|2|||
23454158|NCT01506271|65403497|FG002|Overall Study|Adverse Event|0|||
23454159|NCT01506271|65403495|FG000|Overall Study|Insufficient supply of study drug|1|||
23454160|NCT01506271|65403496|FG001|Overall Study|Insufficient supply of study drug|0|||
23454161|NCT01506271|65403497|FG002|Overall Study|Insufficient supply of study drug|0|||
23454162|NCT01506271|65403495|FG000|Overall Study|Withdrawal by Subject|0|||
23454163|NCT01506271|65403496|FG001|Overall Study|Withdrawal by Subject|1|||
23454164|NCT01506271|65403497|FG002|Overall Study|Withdrawal by Subject|1|||
23454165|NCT01506271|65403495|FG000|Overall Study|Lost to Follow-up|0|||
23454166|NCT01506271|65403496|FG001|Overall Study|Lost to Follow-up|1|||
23454167|NCT01506271|65403497|FG002|Overall Study|Lost to Follow-up|2|||
23454168|NCT03261336|65403511|FG000|Overall Study|Adverse Event|1|||
23454169|NCT02559622|65403513|FG000|Overall Study|Progressive disease|0|||
23454170|NCT02559622|65403514|FG001|Overall Study|Progressive disease|1|||
23454171|NCT02559622|65403515|FG002|Overall Study|Progressive disease|0|||
23454172|NCT02559622|65403516|FG003|Overall Study|Progressive disease|0|||
23454173|NCT02559622|65403513|FG000|Overall Study|Adverse Event|0|||
23454174|NCT02559622|65403514|FG001|Overall Study|Adverse Event|2|||
23454175|NCT02559622|65403515|FG002|Overall Study|Adverse Event|2|||
23454176|NCT02559622|65403516|FG003|Overall Study|Adverse Event|2|||
23454177|NCT02559622|65403513|FG000|Overall Study|Patient/guardian decision|1|||
23454178|NCT02559622|65403514|FG001|Overall Study|Patient/guardian decision|2|||
23454179|NCT02559622|65403515|FG002|Overall Study|Patient/guardian decision|0|||
23454180|NCT02559622|65403516|FG003|Overall Study|Patient/guardian decision|1|||
23454181|NCT01446159|65407050|FG000|Overall Study|Withdrawal by Subject|1|||
23454182|NCT01446159|65407051|FG001|Overall Study|Withdrawal by Subject|0|||
23454183|NCT01446159|65407052|FG002|Overall Study|Withdrawal by Subject|14|||
23454184|NCT01446159|65407053|FG003|Overall Study|Withdrawal by Subject|11|||
23454185|NCT01446159|65407050|FG000|Overall Study|Lost to Follow-up|0|||
23454186|NCT01446159|65407051|FG001|Overall Study|Lost to Follow-up|0|||
23454187|NCT01446159|65407052|FG002|Overall Study|Lost to Follow-up|1|||
23454188|NCT01446159|65407053|FG003|Overall Study|Lost to Follow-up|2|||
23454189|NCT01446159|65407050|FG000|Overall Study|Death|2|||
23454190|NCT01446159|65407051|FG001|Overall Study|Death|3|||
23454191|NCT01446159|65407052|FG002|Overall Study|Death|43|||
23454192|NCT01446159|65407053|FG003|Overall Study|Death|36|||
23454193|NCT01446159|65407050|FG000|Overall Study|Other|0|||
23636798|NCT02815579|66053018|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
23636799|NCT02815579|66053017|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
23636800|NCT02815579|66053018|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
23636801|NCT02815579|66053017|FG000|Overall Study|Death|5|||
23636802|NCT02815579|66053018|FG001|Overall Study|Death|4|||
23636803|NCT02815579|66053017|FG000|Overall Study|Imprisoned|0|||
23636804|NCT02815579|66053018|FG001|Overall Study|Imprisoned|2|||
23636805|NCT02815579|66053017|FG000|Overall Study|Did not meet enrollment criteria|0|||
23342300|NCT01253174|64996080|FG000|Period 1|Randomized but not treated|0|||
23454194|NCT01446159|65407051|FG001|Overall Study|Other|0|||
23454195|NCT01446159|65407052|FG002|Overall Study|Other|13|||
23454196|NCT01446159|65407053|FG003|Overall Study|Other|13|||
23454197|NCT00671658|65407054|FG000|Overall Study|Physician Decision|5|||
23454198|NCT03600909|65407055|FG000|Overall Study|Not treated|0|||
23454199|NCT03600909|65407056|FG001|Overall Study|Not treated|3|||
23454200|NCT03600909|65407057|FG002|Overall Study|Not treated|0|||
23454201|NCT02421172|65407058|FG000|Period 1|Adverse Event|1|||
23454202|NCT02421172|65407059|FG001|Period 1|Adverse Event|0|||
23454203|NCT02421172|65407060|FG002|Period 1|Adverse Event|0|||
23454204|NCT02421172|65407061|FG003|Period 1|Adverse Event|0|||
23454205|NCT02421172|65407062|FG004|Period 1|Adverse Event|0|||
23454206|NCT02421172|65407058|FG000|Period 1|Lost to Follow-up|3|||
23454207|NCT02421172|65407059|FG001|Period 1|Lost to Follow-up|1|||
23454208|NCT02421172|65407060|FG002|Period 1|Lost to Follow-up|0|||
23454209|NCT02421172|65407061|FG003|Period 1|Lost to Follow-up|0|||
23636806|NCT02815579|66053018|FG001|Overall Study|Did not meet enrollment criteria|1|||
23636807|NCT03106753|66053019|FG000|Overall Study|Withdrawal by Subject|0|||
23636808|NCT03106753|66053020|FG001|Overall Study|Withdrawal by Subject|1|||
23636809|NCT01228318|66053021|FG000|Overall Study|Clinic no show to receive intervention|1|||
23454210|NCT02421172|65407062|FG004|Period 1|Lost to Follow-up|0|||
23454211|NCT02421172|65407058|FG000|Period 1|Patient/guardian decision|0|||
23454212|NCT02421172|65407059|FG001|Period 1|Patient/guardian decision|1|||
23705870|NCT00740779|66297647|FG001|Overall Study|Lost to Follow-up|3|||
23454213|NCT02421172|65407060|FG002|Period 1|Patient/guardian decision|0|||
23454214|NCT02421172|65407061|FG003|Period 1|Patient/guardian decision|0|||
23454215|NCT02421172|65407062|FG004|Period 1|Patient/guardian decision|0|||
23454216|NCT02421172|65407058|FG000|Period 2|Adverse Event|0|||
23454217|NCT02421172|65407059|FG001|Period 2|Adverse Event|0|||
23454218|NCT02421172|65407060|FG002|Period 2|Adverse Event|4|||
23454219|NCT02421172|65407061|FG003|Period 2|Adverse Event|0|||
23454220|NCT02421172|65407062|FG004|Period 2|Adverse Event|0|||
23454221|NCT02421172|65407058|FG000|Period 2|Lost to Follow-up|0|||
23454222|NCT02421172|65407059|FG001|Period 2|Lost to Follow-up|0|||
23454223|NCT02421172|65407060|FG002|Period 2|Lost to Follow-up|0|||
23454224|NCT02421172|65407061|FG003|Period 2|Lost to Follow-up|1|||
23454225|NCT02421172|65407062|FG004|Period 2|Lost to Follow-up|0|||
23454226|NCT02421172|65407058|FG000|Period 2|Patient/guardian decision|0|||
23454227|NCT02421172|65407059|FG001|Period 2|Patient/guardian decision|0|||
23454228|NCT02421172|65407060|FG002|Period 2|Patient/guardian decision|3|||
23454229|NCT02421172|65407061|FG003|Period 2|Patient/guardian decision|2|||
23454230|NCT02421172|65407062|FG004|Period 2|Patient/guardian decision|1|||
23454231|NCT03289208|65407065|FG000|Overall Study|Adverse Event|1|||
23454232|NCT03289208|65407066|FG001|Overall Study|Adverse Event|0|||
23454233|NCT03289208|65407067|FG002|Overall Study|Adverse Event|0|||
23454234|NCT01075243|65407068|FG000|Overall Study|Lost to Follow-up|5|||
23454235|NCT01075243|65407069|FG001|Overall Study|Lost to Follow-up|2|||
23454236|NCT01075243|65407070|FG002|Overall Study|Lost to Follow-up|0|||
23454237|NCT01075243|65407068|FG000|Overall Study|Withdrawal by Subject|1|||
23454238|NCT01075243|65407069|FG001|Overall Study|Withdrawal by Subject|1|||
23454239|NCT01075243|65407070|FG002|Overall Study|Withdrawal by Subject|0|||
23454240|NCT01710345|65407074|FG000|Overall Study|Adverse Event|0|||
23454241|NCT01710345|65407075|FG001|Overall Study|Adverse Event|2|||
23454242|NCT01710345|65407076|FG002|Overall Study|Adverse Event|0|||
23454243|NCT01710345|65407074|FG000|Overall Study|Lack of Efficacy|2|||
23454244|NCT01710345|65407075|FG001|Overall Study|Lack of Efficacy|3|||
23454245|NCT01710345|65407076|FG002|Overall Study|Lack of Efficacy|1|||
23454246|NCT01710345|65407074|FG000|Overall Study|Drug Dosing Error|1|||
23454247|NCT01710345|65407075|FG001|Overall Study|Drug Dosing Error|0|||
23454248|NCT01710345|65407076|FG002|Overall Study|Drug Dosing Error|0|||
23454249|NCT00472108|65407077|FG000|Overall Study|Lost to Follow-up|0|||
23454250|NCT00472108|65407078|FG001|Overall Study|Lost to Follow-up|1|||
23454251|NCT04564846|65407083|FG000|Overall Study|Withdrawal by Subject|2|||
23454252|NCT04564846|65407084|FG001|Overall Study|Withdrawal by Subject|1|||
23454253|NCT04564846|65407083|FG000|Overall Study|Physician Decision|0|||
23454254|NCT04564846|65407084|FG001|Overall Study|Physician Decision|1|||
23454255|NCT04564846|65407083|FG000|Overall Study|Lost to Follow-up|0|||
23454256|NCT04564846|65407084|FG001|Overall Study|Lost to Follow-up|1|||
23454257|NCT04564846|65407083|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
23454258|NCT04564846|65407084|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
23454259|NCT04564846|65407083|FG000|Overall Study|Subject non-compliance|1|||
23454260|NCT04564846|65407084|FG001|Overall Study|Subject non-compliance|0|||
23454261|NCT03760029|65407087|FG000|Overall Study|Death|1|||
23843153|NCT03190915|66808041|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
23843154|NCT03190915|66808041|FG000|Overall Study|Progressive Disease|3|||
23843155|NCT04267562|66808042|FG000|Assessed for Eligibility|Screen Failure|64|||
23843156|NCT04267562|66808042|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
23843157|NCT04267562|66808042|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
23843158|NCT04267562|66808042|FG000|Assessed for Eligibility|Site closure|6|||
23843159|NCT04267562|66808042|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
23843160|NCT04267562|66808042|FG000|Assessed for Eligibility|Physician Decision|1|||
23342301|NCT01253174|64996081|FG001|Period 1|Randomized but not treated|1|||
23342302|NCT01253174|64996082|FG002|Period 1|Randomized but not treated|1|||
23342303|NCT01253174|64996083|FG003|Period 1|Randomized but not treated|0|||
23342304|NCT01253174|64996084|FG004|Period 1|Randomized but not treated|1|||
23342305|NCT01253174|64996085|FG005|Period 1|Randomized but not treated|0|||
23342306|NCT01253174|64996080|FG000|Period 2|Adverse Event|0|||
23342307|NCT01253174|64996081|FG001|Period 2|Adverse Event|0|||
23342308|NCT01253174|64996082|FG002|Period 2|Adverse Event|1|||
23342309|NCT01253174|64996083|FG003|Period 2|Adverse Event|0|||
23342310|NCT01253174|64996084|FG004|Period 2|Adverse Event|0|||
23342311|NCT01253174|64996085|FG005|Period 2|Adverse Event|0|||
23843161|NCT04267562|66808042|FG000|Month 24|Elective hysterectomy|1|||
23843162|NCT04267562|66808042|FG000|Month 24|Lost to Follow-up|1|||
23843163|NCT04267562|66808042|FG000|Month 36|Elective hysterectomy|2|||
23843164|NCT04267562|66808042|FG000|Month 36|Lost to Follow-up|3|||
23843165|NCT03854370|66808043|FG000|Overall Study|samples not collected|1|||
23843166|NCT03854370|66808044|FG001|Overall Study|samples not collected|1|||
23342312|NCT01253174|64996080|FG000|Period 3|Withdrawal by Subject|0|||
23454262|NCT03760029|65407088|FG001|Overall Study|Death|0|||
23636810|NCT01228318|66053022|FG001|Overall Study|Clinic no show to receive intervention|0|||
23843167|NCT03854370|66808045|FG002|Overall Study|samples not collected|1|||
23454263|NCT03760029|65407089|FG002|Overall Study|Death|0|||
23454264|NCT03760029|65407087|FG000|Overall Study|Lost to Follow-up|0|||
23454265|NCT03760029|65407088|FG001|Overall Study|Lost to Follow-up|2|||
23454266|NCT03760029|65407089|FG002|Overall Study|Lost to Follow-up|1|||
23454267|NCT03760029|65407087|FG000|Overall Study|Withdrawal by Subject|1|||
23454268|NCT03760029|65407088|FG001|Overall Study|Withdrawal by Subject|4|||
23636811|NCT01228318|66053021|FG000|Overall Study|Unable to contact|2|||
23843168|NCT03854370|66808046|FG003|Overall Study|samples not collected|1|||
23342313|NCT01253174|64996081|FG001|Period 3|Withdrawal by Subject|1|||
23342314|NCT01253174|64996082|FG002|Period 3|Withdrawal by Subject|0|||
23342315|NCT01253174|64996083|FG003|Period 3|Withdrawal by Subject|0|||
23843169|NCT03589326|66808048|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
23843170|NCT03589326|66808049|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
23843171|NCT03589326|66808048|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
23843172|NCT03589326|66808049|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
23843173|NCT03589326|66808048|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
23843174|NCT03589326|66808049|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
23843175|NCT03589326|66808048|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
23843176|NCT03589326|66808049|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
23843177|NCT03589326|66808048|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
23843178|NCT03589326|66808049|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
23843179|NCT01940887|66808050|FG000|Year 1|Protocol Violation|0|||
23843180|NCT01940887|66808051|FG001|Year 1|Protocol Violation|1|||
23843181|NCT01940887|66808050|FG000|Year 1|Physician Decision|7|||
23843182|NCT01940887|66808051|FG001|Year 1|Physician Decision|3|||
23843183|NCT01940887|66808050|FG000|Year 1|Death|5|||
23843184|NCT01940887|66808051|FG001|Year 1|Death|3|||
23843185|NCT01940887|66808050|FG000|Year 1|Adverse Event|7|||
23843186|NCT01940887|66808051|FG001|Year 1|Adverse Event|6|||
23843187|NCT01940887|66808050|FG000|Year 1|Withdrawal by Subject|18|||
23843188|NCT01940887|66808051|FG001|Year 1|Withdrawal by Subject|9|||
23843189|NCT01940887|66808050|FG000|Year 1|Lost to Follow-up|2|||
23843190|NCT01940887|66808051|FG001|Year 1|Lost to Follow-up|1|||
23843191|NCT01940887|66808050|FG000|Year 2|Physician Decision|8|||
23843192|NCT01940887|66808051|FG001|Year 2|Physician Decision|1|||
23843193|NCT01940887|66808050|FG000|Year 2|Death|0|||
23843194|NCT01940887|66808051|FG001|Year 2|Death|2|||
23843195|NCT01940887|66808050|FG000|Year 2|Sponsor Decision, early termination|192|||
23843196|NCT01940887|66808051|FG001|Year 2|Sponsor Decision, early termination|203|||
23843197|NCT01940887|66808050|FG000|Year 2|Adverse Event|8|||
23454269|NCT03760029|65407089|FG002|Overall Study|Withdrawal by Subject|1|||
23454270|NCT03760029|65407087|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23454271|NCT03760029|65407088|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23454272|NCT03760029|65407089|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23454273|NCT03760029|65407087|FG000|Overall Study|Other|2|||
23783122|NCT00927069|66583366|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
23783123|NCT00927069|66583367|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
23783124|NCT00927069|66583368|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
23783125|NCT00927069|66583369|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
23783126|NCT00927069|66583366|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
23783127|NCT00927069|66583367|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
23783128|NCT00927069|66583368|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
23783129|NCT00927069|66583369|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
23783130|NCT00927069|66583366|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
23783131|NCT00927069|66583367|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
23783132|NCT00927069|66583368|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
23783133|NCT00927069|66583369|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
23783134|NCT00927069|66583366|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
23783135|NCT00927069|66583367|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
23783136|NCT00927069|66583368|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
23783137|NCT00927069|66583369|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
23783138|NCT00927069|66583366|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
23783139|NCT00927069|66583367|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23783140|NCT00927069|66583368|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23783141|NCT00927069|66583369|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23783142|NCT03872128|66583371|FG000|Overall Study|Dropped out before treatment|1|||
23783143|NCT03872128|66583372|FG001|Overall Study|Dropped out before treatment|0|||
23783144|NCT03872128|66583373|FG002|Overall Study|Dropped out before treatment|4|||
23783145|NCT03872128|66583371|FG000|Overall Study|Lost to Follow-up|2|||
23783146|NCT03872128|66583372|FG001|Overall Study|Lost to Follow-up|5|||
23783147|NCT03872128|66583373|FG002|Overall Study|Lost to Follow-up|8|||
23783148|NCT00244764|66583383|FG000|Overall Study|Adverse Event|37|||
23783149|NCT00244764|66583383|FG000|Overall Study|Lost to Follow-up|23|||
23783150|NCT00244764|66583383|FG000|Overall Study|Withdrawal by Subject|12|||
23783151|NCT00244764|66583383|FG000|Overall Study|Disease Progression|13|||
23783152|NCT00244764|66583383|FG000|Overall Study|Protocol Violation|2|||
23783153|NCT00244764|66583383|FG000|Overall Study|Death|1|||
23783154|NCT00244764|66583383|FG000|Overall Study|Off Study Medication for >21 Days|1|||
23783155|NCT00244764|66583383|FG000|Overall Study|Declining Performance Status|1|||
23783156|NCT00244764|66583383|FG000|Overall Study|Participant was Hospitalized until Death|1|||
23783157|NCT00244764|66583383|FG000|Overall Study|Primary Investigator Discretion|2|||
23783158|NCT00244764|66583383|FG000|Overall Study|Sponsor Terminated Study|2|||
23783159|NCT00244764|66583383|FG000|Overall Study|Developed Secondary Malignancy|1|||
23843198|NCT01940887|66808051|FG001|Year 2|Adverse Event|2|||
23843199|NCT01940887|66808050|FG000|Year 2|Withdrawal by Subject|8|||
23454274|NCT03760029|65407088|FG001|Overall Study|Other|1|||
23454275|NCT03760029|65407089|FG002|Overall Study|Other|0|||
23843200|NCT01940887|66808051|FG001|Year 2|Withdrawal by Subject|8|||
23843201|NCT01940887|66808050|FG000|Year 2|Lost to Follow-up|1|||
23843202|NCT01940887|66808051|FG001|Year 2|Lost to Follow-up|6|||
23843203|NCT01780038|66808053|FG000|Overall Study|Lost to Follow-up|4|||
23843204|NCT01780038|66808054|FG001|Overall Study|Lost to Follow-up|1|||
23843205|NCT03514485|66808055|FG000|Overall Study|Lost to Follow-up|5|||
23843206|NCT03514485|66808056|FG001|Overall Study|Lost to Follow-up|3|||
23843207|NCT03514485|66808057|FG002|Overall Study|Lost to Follow-up|2|||
23843208|NCT03514485|66808058|FG003|Overall Study|Lost to Follow-up|0|||
23843209|NCT03514485|66808059|FG004|Overall Study|Lost to Follow-up|1|||
23843210|NCT03514485|66808060|FG005|Overall Study|Lost to Follow-up|4|||
23843211|NCT03514485|66808055|FG000|Overall Study|Withdrawal by Subject|0|||
23843212|NCT03514485|66808056|FG001|Overall Study|Withdrawal by Subject|1|||
23843213|NCT03514485|66808057|FG002|Overall Study|Withdrawal by Subject|3|||
23843214|NCT03514485|66808058|FG003|Overall Study|Withdrawal by Subject|1|||
23843215|NCT03514485|66808059|FG004|Overall Study|Withdrawal by Subject|2|||
23843216|NCT03514485|66808060|FG005|Overall Study|Withdrawal by Subject|1|||
23843217|NCT04310397|66808061|FG000|Overall Study|Lack of Efficacy|3|||
23843218|NCT04310397|66808061|FG000|Overall Study|Withdrawal by Subject|1|||
23843219|NCT03973918|66808062|FG000|Overall Study|Adverse Event|0|||
23843220|NCT03973918|66808063|FG001|Overall Study|Adverse Event|0|||
23843221|NCT03973918|66808064|FG002|Overall Study|Adverse Event|0|||
23843222|NCT03973918|66808065|FG003|Overall Study|Adverse Event|1|||
23843223|NCT03973918|66808062|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23843224|NCT03973918|66808063|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
23843225|NCT03973918|66808064|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23843226|NCT03973918|66808065|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23843227|NCT03362190|66808066|FG000|Overall Study|Adverse Event|0|||
23843228|NCT03362190|66808067|FG001|Overall Study|Adverse Event|0|||
23843229|NCT03362190|66808068|FG002|Overall Study|Adverse Event|0|||
23843230|NCT03362190|66808069|FG003|Overall Study|Adverse Event|1|||
23843231|NCT03362190|66808066|FG000|Overall Study|Withdrawal by Subject|0|||
23843232|NCT03362190|66808067|FG001|Overall Study|Withdrawal by Subject|0|||
23843233|NCT03362190|66808068|FG002|Overall Study|Withdrawal by Subject|0|||
23843234|NCT03362190|66808069|FG003|Overall Study|Withdrawal by Subject|1|||
23843235|NCT04871711|66808072|FG000|Overall Study|Withdrawal by Subject|11|||
23843236|NCT04871711|66808073|FG001|Overall Study|Withdrawal by Subject|5|||
23843237|NCT04871711|66808072|FG000|Overall Study|Lack of Efficacy|5|||
23843238|NCT04871711|66808073|FG001|Overall Study|Lack of Efficacy|7|||
23843239|NCT04871711|66808072|FG000|Overall Study|Adverse Event|2|||
23843240|NCT04871711|66808073|FG001|Overall Study|Adverse Event|6|||
23843241|NCT04871711|66808072|FG000|Overall Study|Various reasons|2|||
23843242|NCT04871711|66808073|FG001|Overall Study|Various reasons|1|||
23843243|NCT04871711|66808072|FG000|Overall Study|Lost to Follow-up|0|||
23843244|NCT04871711|66808073|FG001|Overall Study|Lost to Follow-up|2|||
23843245|NCT00680901|66808074|FG000|Overall Study|Lost to Follow-up|8|||
23843246|NCT00680901|66808075|FG001|Overall Study|Lost to Follow-up|8|||
23843247|NCT00680901|66808074|FG000|Overall Study|Withdrawal by Subject|4|||
23843248|NCT00680901|66808075|FG001|Overall Study|Withdrawal by Subject|13|||
23843249|NCT00680901|66808074|FG000|Overall Study|Physician Decision|0|||
23843250|NCT00680901|66808075|FG001|Overall Study|Physician Decision|1|||
23843251|NCT00680901|66808074|FG000|Overall Study|Ongoing: On Study Treatment|16|||
23843252|NCT00680901|66808075|FG001|Overall Study|Ongoing: On Study Treatment|13|||
23843253|NCT00680901|66808074|FG000|Overall Study|Ongoing: In Follow Up|45|||
23843254|NCT00680901|66808075|FG001|Overall Study|Ongoing: In Follow Up|41|||
23843255|NCT05338502|66808076|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
23843256|NCT05338502|66808077|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
23843257|NCT05338502|66808078|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
23843258|NCT05338502|66808076|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
23843259|NCT05338502|66808077|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
23843260|NCT05338502|66808078|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
23843261|NCT03092674|66808079|FG000|Overall Study|Adverse Event or Side Effects|1|||
23843262|NCT03092674|66808080|FG001|Overall Study|Adverse Event or Side Effects|4|||
23843263|NCT03092674|66808081|FG002|Overall Study|Adverse Event or Side Effects|4|||
23843264|NCT03092674|66808079|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
23843265|NCT03092674|66808080|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
23843266|NCT03092674|66808081|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
23843267|NCT03092674|66808079|FG000|Overall Study|Progression/Relapse|5|||
23843268|NCT03092674|66808080|FG001|Overall Study|Progression/Relapse|4|||
23843269|NCT03092674|66808081|FG002|Overall Study|Progression/Relapse|8|||
23843270|NCT03092674|66808079|FG000|Overall Study|Death|4|||
23843271|NCT03092674|66808080|FG001|Overall Study|Death|8|||
23843272|NCT03092674|66808081|FG002|Overall Study|Death|2|||
23843273|NCT03092674|66808079|FG000|Overall Study|Other - Not Protocol Specified|11|||
23843274|NCT03092674|66808080|FG001|Overall Study|Other - Not Protocol Specified|8|||
23342316|NCT01253174|64996084|FG004|Period 3|Withdrawal by Subject|1|||
23342317|NCT01253174|64996085|FG005|Period 3|Withdrawal by Subject|0|||
23342318|NCT01253174|64996080|FG000|Period 3|Pregnancy|0|||
23342319|NCT01253174|64996081|FG001|Period 3|Pregnancy|0|||
23342320|NCT01253174|64996082|FG002|Period 3|Pregnancy|1|||
23342321|NCT01253174|64996083|FG003|Period 3|Pregnancy|0|||
23342322|NCT01253174|64996084|FG004|Period 3|Pregnancy|0|||
23342323|NCT01253174|64996085|FG005|Period 3|Pregnancy|0|||
23342324|NCT00567489|64996086|FG000|Overall Study|Adverse Event|6|||
23342325|NCT00567489|64996087|FG001|Overall Study|Adverse Event|14|||
23342326|NCT00567489|64996086|FG000|Overall Study|Physician Decision|0|||
23342327|NCT00567489|64996087|FG001|Overall Study|Physician Decision|4|||
23342328|NCT00567489|64996086|FG000|Overall Study|Withdrawal by Subject|0|||
23342329|NCT00567489|64996087|FG001|Overall Study|Withdrawal by Subject|2|||
23342330|NCT00567489|64996086|FG000|Overall Study|Renal Transplantation|0|||
23342331|NCT00567489|64996087|FG001|Overall Study|Renal Transplantation|3|||
23342332|NCT00567489|64996086|FG000|Overall Study|Other|1|||
23342333|NCT00567489|64996087|FG001|Overall Study|Other|0|||
23342334|NCT03197324|64996088|FG000|Overall Study|Adverse Event|0|||
23342335|NCT03197324|64996089|FG001|Overall Study|Adverse Event|1|||
23342336|NCT01254318|64996098|FG000|Overall Study|Lost to Follow-up|5|||
23342337|NCT01254318|64996098|FG000|Overall Study|Death|47|||
23342338|NCT00348790|64996099|FG000|Completed Treatment|Withdrawal by Subject|4|||
23342339|NCT00348790|64996099|FG000|Completed Treatment|Disease progression|14|||
23342340|NCT00348790|64996099|FG000|Completed Treatment|Adverse Event|4|||
23342341|NCT00348790|64996099|FG000|Completed Treatment|Required surgery|2|||
23342342|NCT00348790|64996099|FG000|Completed Treatment|Unable to travel to study site|1|||
23342343|NCT03687372|64996102|FG000|Overall Study|Lost to Follow-up|12|||
23342344|NCT03687372|64996103|FG001|Overall Study|Lost to Follow-up|21|||
23342345|NCT03687372|64996102|FG000|Overall Study|Withdrawal by Subject|4|||
23342346|NCT03687372|64996103|FG001|Overall Study|Withdrawal by Subject|17|||
23342347|NCT03687372|64996102|FG000|Overall Study|Investigator Decision|1|||
23342348|NCT03687372|64996103|FG001|Overall Study|Investigator Decision|1|||
23342349|NCT04050124|64996104|FG000|Overall Study|Death|1|||
23342350|NCT04050124|64996105|FG001|Overall Study|Death|0|||
23342351|NCT02832375|64996108|FG000|Overall Study|Lost to Follow-up|1|||
23342352|NCT02832375|64996109|FG001|Overall Study|Lost to Follow-up|0|||
23342353|NCT02832375|64996108|FG000|Overall Study|Withdrawal of Consent|1|||
23342354|NCT02832375|64996109|FG001|Overall Study|Withdrawal of Consent|0|||
23342355|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342356|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342357|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342358|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342359|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342360|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342361|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342362|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342363|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342364|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23636812|NCT01228318|66053022|FG001|Overall Study|Unable to contact|5|||
23636813|NCT01228318|66053021|FG000|Overall Study|Moved|0|||
23636814|NCT01228318|66053022|FG001|Overall Study|Moved|2|||
23636815|NCT01228318|66053021|FG000|Overall Study|Incarcerated|1|||
23636816|NCT01228318|66053022|FG001|Overall Study|Incarcerated|0|||
23636817|NCT01023958|66053023|FG000|Overall Study|Progressive disease|48|||
23636818|NCT01023958|66053023|FG000|Overall Study|Other adverse event|1|||
23636819|NCT01023958|66053023|FG000|Overall Study|Refused to continue medication|1|||
23636820|NCT02898077|66053025|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
23636821|NCT02898077|66053026|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
23636822|NCT02898077|66053025|FG000|Overall Study|Lost to Follow-up|4|||
23636823|NCT02898077|66053026|FG001|Overall Study|Lost to Follow-up|3|||
23636824|NCT02898077|66053025|FG000|Overall Study|Physician Decision|0|||
23636825|NCT02898077|66053026|FG001|Overall Study|Physician Decision|2|||
23636826|NCT02898077|66053025|FG000|Overall Study|Sponsor Decision|32|||
23636827|NCT02898077|66053026|FG001|Overall Study|Sponsor Decision|13|||
23636828|NCT02898077|66053025|FG000|Overall Study|Withdrawal by Subject|6|||
23636829|NCT02898077|66053026|FG001|Overall Study|Withdrawal by Subject|3|||
23636830|NCT02898077|66053025|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
23636831|NCT02898077|66053026|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
23342365|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342366|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342367|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342368|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342369|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342370|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23636832|NCT02898077|66053025|FG000|Overall Study|Ended extension period|3|||
23636833|NCT02898077|66053026|FG001|Overall Study|Ended extension period|0|||
23843275|NCT03092674|66808081|FG002|Overall Study|Other - Not Protocol Specified|8|||
23843276|NCT06303167|66808082|FG000|Overall Study|Ineligible|1|||
23843277|NCT06303167|66808082|FG000|Overall Study|Never start protocol therapy|2|||
23843278|NCT06303167|66808082|FG000|Overall Study|Disease progression|16|||
23843279|NCT02387957|66808083|FG000|Overall Study|The study was discontinued|21|||
23843280|NCT02387957|66808084|FG001|Overall Study|The study was discontinued|21|||
23843281|NCT02387957|66808085|FG002|Overall Study|The study was discontinued|20|||
23843282|NCT05481125|66808089|FG000|Overall Study|Adverse Event|1|||
23843283|NCT05481125|66808090|FG001|Overall Study|Adverse Event|0|||
23843284|NCT05481125|66808089|FG000|Overall Study|Lost to Follow-up|0|||
23843285|NCT05481125|66808090|FG001|Overall Study|Lost to Follow-up|1|||
23843286|NCT05481125|66808089|FG000|Overall Study|Withdrawal by Subject|0|||
23843287|NCT05481125|66808090|FG001|Overall Study|Withdrawal by Subject|1|||
23843288|NCT02045862|66808091|FG000|Overall Study|Death|0|||
23843289|NCT02045862|66808092|FG001|Overall Study|Death|0|||
23843290|NCT02045862|66808093|FG002|Overall Study|Death|1|||
23843291|NCT02045862|66808091|FG000|Overall Study|Miscellaneous|5|||
23843292|NCT02045862|66808092|FG001|Overall Study|Miscellaneous|0|||
23843293|NCT02045862|66808093|FG002|Overall Study|Miscellaneous|8|||
23843294|NCT02045862|66808091|FG000|Overall Study|Withdrawal by Patient|18|||
23843295|NCT02045862|66808092|FG001|Overall Study|Withdrawal by Patient|27|||
23843296|NCT02045862|66808093|FG002|Overall Study|Withdrawal by Patient|57|||
23843297|NCT02045862|66808091|FG000|Overall Study|Protocol Violation|0|||
23843298|NCT02045862|66808092|FG001|Overall Study|Protocol Violation|0|||
23843299|NCT02045862|66808093|FG002|Overall Study|Protocol Violation|6|||
23843300|NCT02045862|66808091|FG000|Overall Study|Lack of Efficacy|8|||
23843301|NCT02045862|66808092|FG001|Overall Study|Lack of Efficacy|4|||
23843302|NCT02045862|66808093|FG002|Overall Study|Lack of Efficacy|13|||
23843303|NCT02045862|66808091|FG000|Overall Study|Randomized but not Received Study Drug|0|||
23843304|NCT02045862|66808092|FG001|Overall Study|Randomized but not Received Study Drug|2|||
23843305|NCT02045862|66808093|FG002|Overall Study|Randomized but not Received Study Drug|8|||
23843306|NCT02045862|66808091|FG000|Overall Study|Adverse Event|7|||
23843307|NCT02045862|66808092|FG001|Overall Study|Adverse Event|5|||
23843308|NCT02045862|66808093|FG002|Overall Study|Adverse Event|27|||
23843309|NCT02045862|66808091|FG000|Overall Study|Lost to Follow-up|1|||
23843310|NCT02045862|66808092|FG001|Overall Study|Lost to Follow-up|2|||
23843311|NCT02045862|66808093|FG002|Overall Study|Lost to Follow-up|6|||
23843312|NCT01908829|66808094|FG000|Overall Study|Adverse Event|13|||
23843313|NCT01908829|66808095|FG001|Overall Study|Adverse Event|11|||
23843314|NCT01908829|66808096|FG002|Overall Study|Adverse Event|13|||
23843315|NCT01908829|66808094|FG000|Overall Study|Lost to Follow-up|4|||
23342371|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342372|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342373|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342374|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342375|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342376|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342377|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
23342378|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342379|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342380|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
23342381|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342382|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23843316|NCT01908829|66808095|FG001|Overall Study|Lost to Follow-up|2|||
23843317|NCT01908829|66808096|FG002|Overall Study|Lost to Follow-up|1|||
23843318|NCT01908829|66808094|FG000|Overall Study|Randomized no double-blind drug received|1|||
23843319|NCT01908829|66808095|FG001|Overall Study|Randomized no double-blind drug received|0|||
23843320|NCT01908829|66808096|FG002|Overall Study|Randomized no double-blind drug received|1|||
23843321|NCT01908829|66808094|FG000|Overall Study|Discontinued (no EoT page)|2|||
23454276|NCT01519323|65407094|FG000|Overall Study|Death|3|||
23843322|NCT01908829|66808095|FG001|Overall Study|Discontinued (no EoT page)|0|||
23843323|NCT01908829|66808096|FG002|Overall Study|Discontinued (no EoT page)|0|||
23843324|NCT01908829|66808094|FG000|Overall Study|Miscellaneous|0|||
23843325|NCT01908829|66808095|FG001|Overall Study|Miscellaneous|2|||
23342383|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342384|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342385|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23843326|NCT01908829|66808096|FG002|Overall Study|Miscellaneous|0|||
23342386|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23843327|NCT01908829|66808094|FG000|Overall Study|Protocol Violation|2|||
23843328|NCT01908829|66808095|FG001|Overall Study|Protocol Violation|2|||
23843329|NCT01908829|66808096|FG002|Overall Study|Protocol Violation|0|||
23843330|NCT01908829|66808094|FG000|Overall Study|Lack of Efficacy|1|||
23843331|NCT01908829|66808095|FG001|Overall Study|Lack of Efficacy|3|||
23843332|NCT01908829|66808096|FG002|Overall Study|Lack of Efficacy|2|||
23843333|NCT01908829|66808094|FG000|Overall Study|Withdrawal by Subject|26|||
23843334|NCT01908829|66808095|FG001|Overall Study|Withdrawal by Subject|29|||
23843335|NCT01908829|66808096|FG002|Overall Study|Withdrawal by Subject|22|||
23843336|NCT01385176|66808099|FG000|Randomization Phase|Death|1|||
23843337|NCT01385176|66808100|FG001|Randomization Phase|Death|2|||
23843338|NCT01385176|66808099|FG000|6-18 Month All VNS Active|Death|1|||
23843339|NCT01385176|66808100|FG001|6-18 Month All VNS Active|Death|2|||
23843340|NCT01385176|66808099|FG000|6-18 Month All VNS Active|Physician Decision|0|||
23843341|NCT01385176|66808100|FG001|6-18 Month All VNS Active|Physician Decision|1|||
23843342|NCT01385176|66808099|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
23843343|NCT01385176|66808100|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
23843344|NCT01385176|66808099|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
23843345|NCT01385176|66808100|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
23843346|NCT02208362|66808101|FG000|Overall Study|Participant did not complete treatment|0|||
23843347|NCT02208362|66808102|FG001|Overall Study|Participant did not complete treatment|1|||
23843348|NCT02208362|66808103|FG002|Overall Study|Participant did not complete treatment|0|||
23843349|NCT02208362|66808104|FG003|Overall Study|Participant did not complete treatment|0|||
23843350|NCT02208362|66808105|FG004|Overall Study|Participant did not complete treatment|0|||
23843351|NCT02208362|66808106|FG005|Overall Study|Participant did not complete treatment|0|||
23342387|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342388|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342389|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342390|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342391|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342392|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342393|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342394|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342395|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342396|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342397|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342398|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342399|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342400|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342401|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342402|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342403|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342404|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
23342405|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342406|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342407|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23454277|NCT01519323|65407095|FG001|Overall Study|Death|2|||
23783160|NCT00835536|66583384|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
23783161|NCT00835536|66583385|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
23783162|NCT02545283|66583386|FG000|Overall Study|Lost to Follow-up|2|||
23783163|NCT02545283|66583387|FG001|Overall Study|Lost to Follow-up|4|||
23783164|NCT02545283|66583386|FG000|Overall Study|Withdrawal by Subject|5|||
23783165|NCT02545283|66583387|FG001|Overall Study|Withdrawal by Subject|9|||
23783166|NCT02545283|66583386|FG000|Overall Study|Death|109|||
23783167|NCT02545283|66583387|FG001|Overall Study|Death|211|||
23843352|NCT02208362|66808107|FG006|Overall Study|Participant did not complete treatment|1|||
23454278|NCT01519323|65407094|FG000|Overall Study|Study terminated by sponsor|0|||
23454279|NCT01519323|65407095|FG001|Overall Study|Study terminated by sponsor|1|||
23843353|NCT02208362|66808108|FG007|Overall Study|Participant did not complete treatment|1|||
23843354|NCT02208362|66808109|FG008|Overall Study|Participant did not complete treatment|2|||
23342408|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342409|NCT01943851|64996112|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342410|NCT01943851|64996113|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342411|NCT01943851|64996114|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342412|NCT01943851|64996115|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23454280|NCT02234843|65407096|FG000|Overall Study|Death|1|||
23582453|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
23582454|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
23582455|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
23582456|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
23582457|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
23582458|NCT00991276|65862483|FG000|First Intervention Period|Adverse Event|0|||
23582459|NCT00991276|65862484|FG001|First Intervention Period|Adverse Event|1|||
23582460|NCT00991276|65862485|FG002|First Intervention Period|Adverse Event|0|||
23582461|NCT00991276|65862486|FG003|First Intervention Period|Adverse Event|1|||
23636834|NCT01152814|66053027|FG000|Overall Study|Lost to Follow-up|2|||
23636835|NCT00568178|66053028|FG000|Double Blind Base Study|Adverse Event|0|||
23636836|NCT00568178|66053029|FG001|Double Blind Base Study|Adverse Event|2|||
23843355|NCT02208362|66808110|FG009|Overall Study|Participant did not complete treatment|0|||
23342413|NCT01943851|64996116|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342414|NCT01943851|64996117|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342415|NCT01943851|64996118|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342416|NCT01943851|64996119|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342417|NCT01943851|64996120|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342418|NCT01943851|64996121|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342419|NCT01943851|64996122|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342420|NCT01943851|64996123|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342421|NCT01943851|64996124|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342422|NCT01943851|64996125|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342423|NCT01943851|64996126|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342424|NCT01943851|64996127|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
23342425|NCT01943851|64996128|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342426|NCT01943851|64996129|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342427|NCT01943851|64996112|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342428|NCT01943851|64996113|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342429|NCT01943851|64996114|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342430|NCT01943851|64996115|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342431|NCT01943851|64996116|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342432|NCT01943851|64996117|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342433|NCT01943851|64996118|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342434|NCT01943851|64996119|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342435|NCT01943851|64996120|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342436|NCT01943851|64996121|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342437|NCT01943851|64996122|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342438|NCT01943851|64996123|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342439|NCT01943851|64996124|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342440|NCT01943851|64996125|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342441|NCT01943851|64996126|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342442|NCT01943851|64996127|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
23342443|NCT01943851|64996128|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
23342444|NCT01943851|64996129|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
23342445|NCT01740128|64996130|FG000|Overall Study|Pregnancy|0|||
23342446|NCT01740128|64996131|FG001|Overall Study|Pregnancy|1|||
23342447|NCT01740128|64996130|FG000|Overall Study|Protocol Violation|1|||
23342448|NCT01740128|64996131|FG001|Overall Study|Protocol Violation|2|||
23342449|NCT01740128|64996130|FG000|Overall Study|Lost to Follow-up|2|||
23342450|NCT01740128|64996131|FG001|Overall Study|Lost to Follow-up|2|||
23342451|NCT01740128|64996130|FG000|Overall Study|Withdrawal by Subject|1|||
23342452|NCT01740128|64996131|FG001|Overall Study|Withdrawal by Subject|0|||
23342453|NCT01740128|64996130|FG000|Overall Study|Insufficient protocol compliance|2|||
23342454|NCT01740128|64996131|FG001|Overall Study|Insufficient protocol compliance|2|||
23342455|NCT00655733|64996135|FG000|Overall Study|Lost to Follow-up|2|||
23342456|NCT00655733|64996136|FG001|Overall Study|Lost to Follow-up|2|||
23342457|NCT00655733|64996135|FG000|Overall Study|Adverse Event|2|||
23342458|NCT00655733|64996136|FG001|Overall Study|Adverse Event|2|||
23342459|NCT00655733|64996135|FG000|Overall Study|Withdrawal by Subject|3|||
23342460|NCT00655733|64996136|FG001|Overall Study|Withdrawal by Subject|3|||
23342461|NCT00655733|64996135|FG000|Overall Study|Physician Decision|0|||
23342462|NCT00655733|64996136|FG001|Overall Study|Physician Decision|1|||
23342463|NCT02347891|64996137|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
23843356|NCT02208362|66808111|FG010|Overall Study|Participant did not complete treatment|1|||
23843357|NCT02208362|66808112|FG011|Overall Study|Participant did not complete treatment|0|||
23843358|NCT02208362|66808101|FG000|Overall Study|Participant received disallowed treatment|0|||
23843359|NCT02208362|66808102|FG001|Overall Study|Participant received disallowed treatment|0|||
23843360|NCT02208362|66808103|FG002|Overall Study|Participant received disallowed treatment|0|||
23843361|NCT02208362|66808104|FG003|Overall Study|Participant received disallowed treatment|0|||
23843362|NCT02208362|66808105|FG004|Overall Study|Participant received disallowed treatment|0|||
23843363|NCT02208362|66808106|FG005|Overall Study|Participant received disallowed treatment|0|||
23843364|NCT02208362|66808107|FG006|Overall Study|Participant received disallowed treatment|0|||
23843365|NCT02208362|66808108|FG007|Overall Study|Participant received disallowed treatment|0|||
23843366|NCT02208362|66808109|FG008|Overall Study|Participant received disallowed treatment|1|||
23843367|NCT02208362|66808110|FG009|Overall Study|Participant received disallowed treatment|0|||
23843368|NCT02208362|66808111|FG010|Overall Study|Participant received disallowed treatment|0|||
23843369|NCT02208362|66808112|FG011|Overall Study|Participant received disallowed treatment|0|||
23342464|NCT02347891|64996138|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
23342465|NCT02347891|64996137|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
23342466|NCT02347891|64996138|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
23342467|NCT03361865|64996139|FG000|Overall Study|Death|17|||
23342468|NCT03361865|64996140|FG001|Overall Study|Death|18|||
23342469|NCT03361865|64996139|FG000|Overall Study|Physician Decision|1|||
23843370|NCT05653427|66808113|FG000|Overall Study|Study Terminated by Sponsor|13|||
23843371|NCT04435366|66808114|FG000|Year 1 (12 Months)|Adverse Event|3|||
23843372|NCT04435366|66808115|FG001|Year 1 (12 Months)|Adverse Event|0|||
23843373|NCT04435366|66808116|FG002|Year 1 (12 Months)|Adverse Event|2|||
23843374|NCT04435366|66808114|FG000|Year 1 (12 Months)|Death|2|||
23843375|NCT04435366|66808115|FG001|Year 1 (12 Months)|Death|0|||
23843376|NCT04435366|66808116|FG002|Year 1 (12 Months)|Death|1|||
23843377|NCT04435366|66808114|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
23843378|NCT04435366|66808115|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
23843379|NCT04435366|66808116|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
23342470|NCT03361865|64996140|FG001|Overall Study|Physician Decision|9|||
23342471|NCT03361865|64996139|FG000|Overall Study|Withdrawal by Subject|1|||
23342472|NCT03361865|64996140|FG001|Overall Study|Withdrawal by Subject|0|||
23342473|NCT03814720|64996141|FG000|Overall Study|Lost to Follow-up|0|||
23342474|NCT03814720|64996142|FG001|Overall Study|Lost to Follow-up|1|||
23342475|NCT03814720|64996143|FG002|Overall Study|Lost to Follow-up|0|||
23342476|NCT03814720|64996144|FG003|Overall Study|Lost to Follow-up|0|||
23342477|NCT03814720|64996145|FG004|Overall Study|Lost to Follow-up|0|||
23342478|NCT00965341|64996146|FG000|Overall Study|Withdrew consent|1|||
23342479|NCT00965341|64996147|FG001|Overall Study|Withdrew consent|5|||
23342480|NCT00965341|64996146|FG000|Overall Study|Lost to Follow-up|1|||
23342481|NCT00965341|64996147|FG001|Overall Study|Lost to Follow-up|0|||
23342482|NCT00965341|64996146|FG000|Overall Study|Transportation issues|4|||
23342483|NCT00965341|64996147|FG001|Overall Study|Transportation issues|3|||
23342484|NCT02375555|64996148|FG000|Induction Period|Adverse Event|7|||
23342485|NCT02375555|64996148|FG000|Induction Period|Withdrawal by Subject|2|||
23342486|NCT02375555|64996148|FG000|Induction Period|Other|1|||
23342487|NCT02375555|64996148|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
23342488|NCT02375555|64996148|FG000|Maintenance Period|Adverse Event|2|||
23342489|NCT02375555|64996148|FG000|Maintenance Period|Withdrawal by Subject|4|||
23342490|NCT02375555|64996148|FG000|Maintenance Period|Death|1|||
23342491|NCT02375555|64996148|FG000|Maintenance Period|Disease Progression|5|||
23342492|NCT02375555|64996148|FG000|Maintenance Period|Patient Non-compliance|1|||
23342493|NCT02375555|64996148|FG000|Maintenance Period|Still on maintenance|16|||
23342494|NCT01968707|64996149|FG000|Overall Study|Did not meet treatment day baseline|49|||
23342495|NCT01968707|64996150|FG001|Overall Study|Did not meet treatment day baseline|12|||
23342496|NCT01968707|64996151|FG002|Overall Study|Did not meet treatment day baseline|41|||
23342497|NCT01968707|64996152|FG003|Overall Study|Did not meet treatment day baseline|44|||
23342498|NCT01968707|64996153|FG004|Overall Study|Did not meet treatment day baseline|36|||
23342499|NCT01968707|64996154|FG005|Overall Study|Did not meet treatment day baseline|11|||
23342500|NCT01968707|64996155|FG006|Overall Study|Did not meet treatment day baseline|34|||
23342501|NCT01968707|64996156|FG007|Overall Study|Did not meet treatment day baseline|35|||
23342502|NCT01424514|64996164|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
23342503|NCT01424514|64996165|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
23342504|NCT01424514|64996164|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
23342505|NCT01424514|64996165|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
23342506|NCT03602391|64999626|FG000|Overall Study|COVID-19|7|||
23342507|NCT03602391|64999627|FG001|Overall Study|COVID-19|6|||
23342508|NCT03981900|64999638|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
23342509|NCT03981900|64999638|FG000|Overall Study|Adverse Event|5|||
23342510|NCT03981900|64999638|FG000|Overall Study|Protocol Violation|1|||
23342511|NCT03981900|64999638|FG000|Overall Study|Withdrawal by Subject|7|||
23342512|NCT03981900|64999638|FG000|Overall Study|Lost to Follow-up|46|||
23342513|NCT03981900|64999638|FG000|Overall Study|Decision of the researcher|3|||
23342514|NCT03981900|64999638|FG000|Overall Study|Death|3|||
23342515|NCT03981900|64999638|FG000|Overall Study|Other|5|||
23342516|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342517|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342518|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342519|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342520|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342521|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
23342522|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342523|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342524|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342525|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342526|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342527|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
23342528|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Adverse Event|0|||
23843380|NCT04435366|66808114|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
23843381|NCT04435366|66808115|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
23843382|NCT04435366|66808116|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
23454281|NCT02234843|65407097|FG001|Overall Study|Death|0|||
23843383|NCT04435366|66808114|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
23342529|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Adverse Event|0|||
23342530|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Adverse Event|0|||
23342531|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Adverse Event|0|||
23342532|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Adverse Event|0|||
23342533|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Adverse Event|2|||
23342534|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342535|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342536|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342537|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342538|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342539|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
23342540|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342541|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342542|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342543|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23783168|NCT02545283|66583386|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
23783169|NCT02545283|66583387|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
23783170|NCT02545283|66583386|FG000|Overall Study|Study Terminated By Sponsor|33|||
23783171|NCT02545283|66583387|FG001|Overall Study|Study Terminated By Sponsor|71|||
23783172|NCT00909753|66583388|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
23783173|NCT00909753|66583389|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
23783174|NCT00909753|66583388|FG000|Period: Second Intervention|Protocol Violation|1|||
23783175|NCT00909753|66583389|FG001|Period: Second Intervention|Protocol Violation|0|||
23783176|NCT02963259|66583392|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
23454282|NCT02234843|65407098|FG002|Overall Study|Death|0|||
23454283|NCT02234843|65407099|FG003|Overall Study|Death|0|||
23454284|NCT02234843|65407100|FG004|Overall Study|Death|0|||
23454285|NCT02234843|65407101|FG005|Overall Study|Death|0|||
23454286|NCT02234843|65407102|FG006|Overall Study|Death|0|||
23454287|NCT02234843|65407103|FG007|Overall Study|Death|0|||
23454288|NCT02234843|65407104|FG008|Overall Study|Death|0|||
23454289|NCT02234843|65407105|FG009|Overall Study|Death|0|||
23342544|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342545|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
23342546|NCT03191864|64999639|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342547|NCT03191864|64999640|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342548|NCT03191864|64999641|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
23342549|NCT03191864|64999642|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342550|NCT03191864|64999643|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342551|NCT03191864|64999644|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
23342552|NCT03191864|64999639|FG000|Part 1 - Induction|Adverse Event|0|||
23342553|NCT03191864|64999640|FG001|Part 1 - Induction|Adverse Event|2|||
23342554|NCT03191864|64999641|FG002|Part 1 - Induction|Adverse Event|0|||
23342555|NCT03191864|64999642|FG003|Part 1 - Induction|Adverse Event|1|||
23342556|NCT03191864|64999643|FG004|Part 1 - Induction|Adverse Event|0|||
23342557|NCT03191864|64999644|FG005|Part 1 - Induction|Adverse Event|2|||
23342558|NCT03191864|64999639|FG000|Part 1 - Induction|Randomized but never dosed|0|||
23342559|NCT03191864|64999640|FG001|Part 1 - Induction|Randomized but never dosed|0|||
23454290|NCT02234843|65407096|FG000|Overall Study|Protocol Violation|1|||
23454291|NCT02234843|65407097|FG001|Overall Study|Protocol Violation|0|||
23783177|NCT02963259|66583392|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
23783178|NCT02963259|66583392|FG000|Overall Study|Death|1|||
23783179|NCT02963259|66583392|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
23783180|NCT02039908|66583393|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
23783181|NCT02039908|66583394|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
23783182|NCT02039908|66583395|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
23783183|NCT02039908|66583396|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
23783184|NCT02039908|66583393|FG000|Phase 1-Summer|Protocol Violation|6|||
23783185|NCT02039908|66583394|FG001|Phase 1-Summer|Protocol Violation|0|||
23783186|NCT02039908|66583395|FG002|Phase 1-Summer|Protocol Violation|0|||
23783187|NCT02039908|66583396|FG003|Phase 1-Summer|Protocol Violation|0|||
23342560|NCT03191864|64999641|FG002|Part 1 - Induction|Randomized but never dosed|1|||
23454292|NCT02234843|65407098|FG002|Overall Study|Protocol Violation|1|||
23454293|NCT02234843|65407099|FG003|Overall Study|Protocol Violation|0|||
23454294|NCT02234843|65407100|FG004|Overall Study|Protocol Violation|0|||
23454295|NCT02234843|65407101|FG005|Overall Study|Protocol Violation|0|||
23783188|NCT02039908|66583393|FG000|Phase 2-School Year|Lost to Follow-up|0|||
23636837|NCT00568178|66053030|FG002|Double Blind Base Study|Adverse Event|1|||
23705871|NCT00740779|66297648|FG002|Overall Study|Lost to Follow-up|5|||
23783189|NCT02039908|66583394|FG001|Phase 2-School Year|Lost to Follow-up|0|||
23783190|NCT02039908|66583395|FG002|Phase 2-School Year|Lost to Follow-up|1|||
23783191|NCT02039908|66583396|FG003|Phase 2-School Year|Lost to Follow-up|3|||
23342561|NCT03191864|64999642|FG003|Part 1 - Induction|Randomized but never dosed|0|||
23342562|NCT03191864|64999643|FG004|Part 1 - Induction|Randomized but never dosed|0|||
23342563|NCT03191864|64999644|FG005|Part 1 - Induction|Randomized but never dosed|0|||
23342564|NCT03191864|64999639|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
23342565|NCT03191864|64999640|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
23342566|NCT03191864|64999641|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
23342567|NCT03191864|64999642|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
23342568|NCT03191864|64999643|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
23342569|NCT03191864|64999644|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
23342570|NCT03191864|64999639|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342571|NCT03191864|64999640|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342572|NCT03191864|64999641|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
23342573|NCT03191864|64999642|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342574|NCT03191864|64999643|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342575|NCT03191864|64999644|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342576|NCT03191864|64999639|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
23342577|NCT03191864|64999640|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342578|NCT03191864|64999641|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342579|NCT03191864|64999642|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342580|NCT03191864|64999643|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342581|NCT03191864|64999644|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342582|NCT03191864|64999639|FG000|Part 2 - Maintenance|Physician Decision|1|||
23342583|NCT03191864|64999640|FG001|Part 2 - Maintenance|Physician Decision|0|||
23342584|NCT03191864|64999641|FG002|Part 2 - Maintenance|Physician Decision|0|||
23342585|NCT03191864|64999642|FG003|Part 2 - Maintenance|Physician Decision|0|||
23342586|NCT03191864|64999643|FG004|Part 2 - Maintenance|Physician Decision|0|||
23342587|NCT03191864|64999644|FG005|Part 2 - Maintenance|Physician Decision|0|||
23342588|NCT03191864|64999639|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
23342589|NCT03191864|64999640|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
23342590|NCT03191864|64999641|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
23342591|NCT03191864|64999642|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
23342592|NCT03191864|64999643|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
23342593|NCT03191864|64999644|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
23342594|NCT03191864|64999639|FG000|Part 2 - Maintenance|Adverse Event|0|||
23342595|NCT03191864|64999640|FG001|Part 2 - Maintenance|Adverse Event|0|||
23342596|NCT03191864|64999641|FG002|Part 2 - Maintenance|Adverse Event|0|||
23342597|NCT03191864|64999642|FG003|Part 2 - Maintenance|Adverse Event|0|||
23342598|NCT03191864|64999643|FG004|Part 2 - Maintenance|Adverse Event|1|||
23342599|NCT03191864|64999644|FG005|Part 2 - Maintenance|Adverse Event|0|||
23342600|NCT03191864|64999639|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
23342601|NCT03191864|64999640|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342602|NCT03191864|64999641|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342603|NCT03191864|64999642|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342604|NCT03191864|64999643|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
23342605|NCT03191864|64999644|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342606|NCT03191864|64999639|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342607|NCT03191864|64999640|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342608|NCT03191864|64999641|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342609|NCT03191864|64999642|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342610|NCT03191864|64999643|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
23342611|NCT03191864|64999644|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342612|NCT05178641|64999647|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
23342613|NCT05178641|64999648|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
23342614|NCT05178641|64999647|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
23342615|NCT05178641|64999648|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
23342616|NCT03315754|64999652|FG000|Overall Study|COVID-19 complications leading to death|1|||
23342617|NCT03315754|64999652|FG000|Overall Study|insurance coverage issue|1|||
23342618|NCT04161079|64999653|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
23342619|NCT00459706|64999654|FG000|Overall Study|Adverse Event|19|||
23342620|NCT00459706|64999655|FG001|Overall Study|Adverse Event|13|||
23342621|NCT00459706|64999654|FG000|Overall Study|Withdrawal by Subject|1|||
23342622|NCT00459706|64999655|FG001|Overall Study|Withdrawal by Subject|6|||
23342623|NCT00459706|64999654|FG000|Overall Study|Physician Decision|2|||
23342624|NCT00459706|64999655|FG001|Overall Study|Physician Decision|0|||
23342625|NCT00459706|64999654|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23342626|NCT00459706|64999655|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23342627|NCT00459706|64999654|FG000|Overall Study|Protocol Violation|2|||
23454296|NCT02234843|65407102|FG006|Overall Study|Protocol Violation|0|||
23454297|NCT02234843|65407103|FG007|Overall Study|Protocol Violation|0|||
23843384|NCT04435366|66808115|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
23843385|NCT04435366|66808116|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
23843386|NCT04435366|66808114|FG000|Year 1 (12 Months)|Not treated|0|||
23843387|NCT04435366|66808115|FG001|Year 1 (12 Months)|Not treated|0|||
23843388|NCT04435366|66808116|FG002|Year 1 (12 Months)|Not treated|1|||
23843389|NCT04435366|66808114|FG000|Year 2 (12 Months)|Death|1|||
23843390|NCT04435366|66808115|FG001|Year 2 (12 Months)|Death|4|||
23843391|NCT04435366|66808116|FG002|Year 2 (12 Months)|Death|6|||
23843392|NCT04435366|66808114|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
23843393|NCT04435366|66808115|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
23843394|NCT04435366|66808116|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
23843395|NCT04435366|66808114|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
23843396|NCT04435366|66808115|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
23843397|NCT04435366|66808116|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
23843398|NCT04435366|66808114|FG000|Year 2 (12 Months)|Adverse Event|2|||
23843399|NCT04435366|66808115|FG001|Year 2 (12 Months)|Adverse Event|1|||
23843400|NCT04435366|66808116|FG002|Year 2 (12 Months)|Adverse Event|6|||
23843401|NCT01944839|66808117|FG000|Overall Study|Physician Decision|2|||
23843402|NCT01944839|66808118|FG001|Overall Study|Physician Decision|2|||
23843403|NCT01944839|66808117|FG000|Overall Study|Protocol Violation|0|||
23843404|NCT01944839|66808118|FG001|Overall Study|Protocol Violation|1|||
23843405|NCT01944839|66808117|FG000|Overall Study|Adverse Event|10|||
23843406|NCT01944839|66808118|FG001|Overall Study|Adverse Event|5|||
23843407|NCT01944839|66808117|FG000|Overall Study|Withdrawal by Subject|9|||
23843408|NCT01944839|66808118|FG001|Overall Study|Withdrawal by Subject|17|||
23843409|NCT01944839|66808117|FG000|Overall Study|Lost to Follow-up|1|||
23843410|NCT01944839|66808118|FG001|Overall Study|Lost to Follow-up|0|||
23843411|NCT01944839|66808117|FG000|Overall Study|Subject non-compliance|0|||
23843412|NCT01944839|66808118|FG001|Overall Study|Subject non-compliance|3|||
23843413|NCT02980341|66808119|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23843414|NCT02980341|66808120|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23843415|NCT02980341|66808121|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
23843416|NCT02980341|66808122|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
23843417|NCT02980341|66808123|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23843418|NCT02980341|66808124|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843419|NCT02980341|66808125|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843420|NCT02980341|66808126|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843421|NCT02980341|66808127|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843422|NCT02980341|66808128|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843423|NCT02980341|66808129|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23843424|NCT02980341|66808119|FG000|Dose Escalation|Clinical progression|0|||
23843425|NCT02980341|66808120|FG001|Dose Escalation|Clinical progression|0|||
23843426|NCT02980341|66808121|FG002|Dose Escalation|Clinical progression|2|||
23843427|NCT02980341|66808122|FG003|Dose Escalation|Clinical progression|1|||
23843428|NCT02980341|66808123|FG004|Dose Escalation|Clinical progression|0|||
23843429|NCT02980341|66808124|FG005|Dose Escalation|Clinical progression|0|||
23843430|NCT02980341|66808125|FG006|Dose Escalation|Clinical progression|0|||
23843431|NCT02980341|66808126|FG007|Dose Escalation|Clinical progression|0|||
23843432|NCT02980341|66808127|FG008|Dose Escalation|Clinical progression|0|||
23843433|NCT02980341|66808128|FG009|Dose Escalation|Clinical progression|0|||
23843434|NCT02980341|66808129|FG010|Dose Escalation|Clinical progression|0|||
23843435|NCT02980341|66808119|FG000|Dose Escalation|Adverse Event|0|||
23843436|NCT02980341|66808120|FG001|Dose Escalation|Adverse Event|0|||
23843437|NCT02980341|66808121|FG002|Dose Escalation|Adverse Event|1|||
23843438|NCT02980341|66808122|FG003|Dose Escalation|Adverse Event|2|||
23843439|NCT02980341|66808123|FG004|Dose Escalation|Adverse Event|2|||
23843440|NCT02980341|66808124|FG005|Dose Escalation|Adverse Event|0|||
23843441|NCT02980341|66808125|FG006|Dose Escalation|Adverse Event|0|||
23843442|NCT02980341|66808126|FG007|Dose Escalation|Adverse Event|0|||
23843443|NCT02980341|66808127|FG008|Dose Escalation|Adverse Event|0|||
23843444|NCT02980341|66808128|FG009|Dose Escalation|Adverse Event|0|||
23843445|NCT02980341|66808129|FG010|Dose Escalation|Adverse Event|0|||
23843446|NCT02980341|66808119|FG000|Dose Escalation|Withdrawal by Subject|0|||
23843447|NCT02980341|66808120|FG001|Dose Escalation|Withdrawal by Subject|0|||
23843448|NCT02980341|66808121|FG002|Dose Escalation|Withdrawal by Subject|1|||
23843449|NCT02980341|66808122|FG003|Dose Escalation|Withdrawal by Subject|0|||
23705872|NCT01165021|66297649|FG000|Overall Study|Death|1|||
23843450|NCT02980341|66808123|FG004|Dose Escalation|Withdrawal by Subject|0|||
23342628|NCT00459706|64999655|FG001|Overall Study|Protocol Violation|1|||
23843451|NCT02980341|66808124|FG005|Dose Escalation|Withdrawal by Subject|0|||
23843452|NCT02980341|66808125|FG006|Dose Escalation|Withdrawal by Subject|0|||
23843453|NCT02980341|66808126|FG007|Dose Escalation|Withdrawal by Subject|0|||
23843454|NCT02980341|66808127|FG008|Dose Escalation|Withdrawal by Subject|0|||
23843455|NCT02980341|66808128|FG009|Dose Escalation|Withdrawal by Subject|0|||
23843456|NCT02980341|66808129|FG010|Dose Escalation|Withdrawal by Subject|0|||
23843457|NCT02980341|66808119|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
23342629|NCT00459706|64999654|FG000|Overall Study|Failed to Return|1|||
23342630|NCT00459706|64999655|FG001|Overall Study|Failed to Return|0|||
23342631|NCT00459706|64999654|FG000|Overall Study|Other|0|||
23342632|NCT00459706|64999655|FG001|Overall Study|Other|1|||
23342633|NCT03155997|64999656|FG000|Overall Study|Withdrawal by Subject|119|||
23342634|NCT03155997|64999657|FG001|Overall Study|Withdrawal by Subject|134|||
23342635|NCT03155997|64999656|FG000|Overall Study|Lost to Follow-up|12|||
23342636|NCT03155997|64999657|FG001|Overall Study|Lost to Follow-up|13|||
23342637|NCT03155997|64999656|FG000|Overall Study|Missing disposition data|0|||
23342638|NCT03155997|64999657|FG001|Overall Study|Missing disposition data|1|||
23342639|NCT03155997|64999656|FG000|Overall Study|On study treatment|2027|||
23342640|NCT03155997|64999657|FG001|Overall Study|On study treatment|2074|||
23342641|NCT00834639|64999658|FG000|Second Intervention|Physician Decision|0|||
23342642|NCT00834639|64999659|FG001|Second Intervention|Physician Decision|2|||
23783192|NCT02039908|66583393|FG000|Phase 2-School Year|Protocol Violation|0|||
23342667|NCT01565668|64999666|FG000|Overall Study|Death|2|||
23342668|NCT01565668|64999667|FG001|Overall Study|Death|1|||
23342669|NCT01565668|64999666|FG000|Overall Study|Lack of Efficacy|4|||
23342670|NCT01565668|64999667|FG001|Overall Study|Lack of Efficacy|2|||
23342671|NCT01565668|64999666|FG000|Overall Study|Participant went on Hospice Care|1|||
23342672|NCT01565668|64999667|FG001|Overall Study|Participant went on Hospice Care|0|||
23342673|NCT01565668|64999666|FG000|Overall Study|Adverse Event|6|||
23342674|NCT01565668|64999667|FG001|Overall Study|Adverse Event|1|||
23342675|NCT01565668|64999666|FG000|Overall Study|Randomized, but never received drug|0|||
23342676|NCT01565668|64999667|FG001|Overall Study|Randomized, but never received drug|2|||
23342677|NCT01565668|64999666|FG000|Overall Study|Progressive disease|13|||
23342678|NCT01565668|64999667|FG001|Overall Study|Progressive disease|14|||
23342679|NCT01565668|64999666|FG000|Overall Study|Withdrawal by Subject|1|||
23342680|NCT01565668|64999667|FG001|Overall Study|Withdrawal by Subject|3|||
23342681|NCT01565668|64999666|FG000|Overall Study|HSCT Transplant|11|||
23342682|NCT01565668|64999667|FG001|Overall Study|HSCT Transplant|15|||
23342683|NCT01054300|64999668|FG000|Period 1|Adverse Event|1|||
23342684|NCT01054300|64999669|FG001|Period 1|Adverse Event|0|||
23342685|NCT01054300|64999670|FG002|Period 1|Adverse Event|0|||
23342686|NCT01054300|64999671|FG003|Period 1|Adverse Event|0|||
23342687|NCT01054300|64999668|FG000|Period 2|Withdrawal by Subject|0|||
23342688|NCT01054300|64999669|FG001|Period 2|Withdrawal by Subject|0|||
23454298|NCT02234843|65407104|FG008|Overall Study|Protocol Violation|0|||
23454299|NCT02234843|65407105|FG009|Overall Study|Protocol Violation|0|||
23454300|NCT02234843|65407096|FG000|Overall Study|Efficacy outcome reached|2|||
23454301|NCT02234843|65407097|FG001|Overall Study|Efficacy outcome reached|0|||
23342689|NCT01054300|64999670|FG002|Period 2|Withdrawal by Subject|1|||
23342690|NCT01054300|64999671|FG003|Period 2|Withdrawal by Subject|0|||
23342691|NCT04450407|64999672|FG000|Overall Study|Withdrawal by Subject|10|||
23342692|NCT04450407|64999673|FG001|Overall Study|Withdrawal by Subject|1|||
23342693|NCT04450407|64999674|FG002|Overall Study|Withdrawal by Subject|4|||
23342694|NCT04450407|64999672|FG000|Overall Study|Adverse Event|0|||
23342695|NCT04450407|64999673|FG001|Overall Study|Adverse Event|0|||
23342696|NCT04450407|64999674|FG002|Overall Study|Adverse Event|1|||
23342697|NCT04450407|64999672|FG000|Overall Study|Lost to Follow-up|1|||
23342698|NCT04450407|64999673|FG001|Overall Study|Lost to Follow-up|0|||
23342699|NCT04450407|64999674|FG002|Overall Study|Lost to Follow-up|0|||
23342700|NCT04450407|64999672|FG000|Overall Study|Physician Decision|0|||
23454302|NCT02234843|65407098|FG002|Overall Study|Efficacy outcome reached|0|||
23454303|NCT02234843|65407099|FG003|Overall Study|Efficacy outcome reached|0|||
23454304|NCT02234843|65407100|FG004|Overall Study|Efficacy outcome reached|0|||
23454305|NCT02234843|65407101|FG005|Overall Study|Efficacy outcome reached|2|||
23454306|NCT02234843|65407102|FG006|Overall Study|Efficacy outcome reached|0|||
23454307|NCT02234843|65407103|FG007|Overall Study|Efficacy outcome reached|0|||
23454308|NCT02234843|65407104|FG008|Overall Study|Efficacy outcome reached|0|||
23454309|NCT02234843|65407105|FG009|Overall Study|Efficacy outcome reached|0|||
23454310|NCT02234843|65407096|FG000|Overall Study|Patient convenience|2|||
23454311|NCT02234843|65407097|FG001|Overall Study|Patient convenience|0|||
23454312|NCT02234843|65407098|FG002|Overall Study|Patient convenience|0|||
23454313|NCT02234843|65407099|FG003|Overall Study|Patient convenience|0|||
23454314|NCT02234843|65407100|FG004|Overall Study|Patient convenience|0|||
23454315|NCT02234843|65407101|FG005|Overall Study|Patient convenience|1|||
23454316|NCT02234843|65407102|FG006|Overall Study|Patient convenience|0|||
23454317|NCT02234843|65407103|FG007|Overall Study|Patient convenience|0|||
23454318|NCT02234843|65407104|FG008|Overall Study|Patient convenience|0|||
23454319|NCT02234843|65407105|FG009|Overall Study|Patient convenience|0|||
23454320|NCT02234843|65407096|FG000|Overall Study|Withdrawal by Subject|5|||
23454321|NCT02234843|65407097|FG001|Overall Study|Withdrawal by Subject|1|||
23454322|NCT02234843|65407098|FG002|Overall Study|Withdrawal by Subject|1|||
23454323|NCT02234843|65407099|FG003|Overall Study|Withdrawal by Subject|0|||
23454324|NCT02234843|65407100|FG004|Overall Study|Withdrawal by Subject|0|||
23454325|NCT02234843|65407101|FG005|Overall Study|Withdrawal by Subject|7|||
23454326|NCT02234843|65407102|FG006|Overall Study|Withdrawal by Subject|0|||
23843458|NCT02980341|66808120|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843459|NCT02980341|66808121|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843460|NCT02980341|66808122|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
23843461|NCT02980341|66808123|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843462|NCT02980341|66808124|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843463|NCT02980341|66808125|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843464|NCT02980341|66808126|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843465|NCT02980341|66808127|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843466|NCT02980341|66808128|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843467|NCT02980341|66808129|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
23843468|NCT02980341|66808119|FG000|Dose Escalation|Due to investigator's decision|0|||
23843469|NCT02980341|66808120|FG001|Dose Escalation|Due to investigator's decision|0|||
23843470|NCT02980341|66808121|FG002|Dose Escalation|Due to investigator's decision|0|||
23843471|NCT02980341|66808122|FG003|Dose Escalation|Due to investigator's decision|0|||
23843472|NCT02980341|66808123|FG004|Dose Escalation|Due to investigator's decision|1|||
23843473|NCT02980341|66808124|FG005|Dose Escalation|Due to investigator's decision|0|||
23843474|NCT02980341|66808125|FG006|Dose Escalation|Due to investigator's decision|0|||
23843475|NCT02980341|66808126|FG007|Dose Escalation|Due to investigator's decision|0|||
23843476|NCT02980341|66808127|FG008|Dose Escalation|Due to investigator's decision|0|||
23843477|NCT02980341|66808128|FG009|Dose Escalation|Due to investigator's decision|0|||
23843478|NCT02980341|66808129|FG010|Dose Escalation|Due to investigator's decision|0|||
23843479|NCT02980341|66808119|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843480|NCT02980341|66808120|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843481|NCT02980341|66808121|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843482|NCT02980341|66808122|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843483|NCT02980341|66808123|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843484|NCT02980341|66808124|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
23843485|NCT02980341|66808125|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
23843486|NCT02980341|66808126|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843487|NCT02980341|66808127|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843488|NCT02980341|66808128|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843489|NCT02980341|66808129|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
23843490|NCT02980341|66808119|FG000|Dose Finding|Adverse Event|0|||
23843491|NCT02980341|66808120|FG001|Dose Finding|Adverse Event|0|||
23843492|NCT02980341|66808121|FG002|Dose Finding|Adverse Event|0|||
23843493|NCT02980341|66808122|FG003|Dose Finding|Adverse Event|0|||
23843494|NCT02980341|66808123|FG004|Dose Finding|Adverse Event|0|||
23843495|NCT02980341|66808124|FG005|Dose Finding|Adverse Event|3|||
23843496|NCT02980341|66808125|FG006|Dose Finding|Adverse Event|0|||
23843497|NCT02980341|66808126|FG007|Dose Finding|Adverse Event|0|||
23843498|NCT02980341|66808127|FG008|Dose Finding|Adverse Event|0|||
23843499|NCT02980341|66808128|FG009|Dose Finding|Adverse Event|0|||
23843500|NCT02980341|66808129|FG010|Dose Finding|Adverse Event|0|||
23843501|NCT02980341|66808119|FG000|Dose Finding|Withdrawal by Subject|0|||
23843502|NCT02980341|66808120|FG001|Dose Finding|Withdrawal by Subject|0|||
23843503|NCT02980341|66808121|FG002|Dose Finding|Withdrawal by Subject|0|||
23843504|NCT02980341|66808122|FG003|Dose Finding|Withdrawal by Subject|0|||
23843505|NCT02980341|66808123|FG004|Dose Finding|Withdrawal by Subject|0|||
23843506|NCT02980341|66808124|FG005|Dose Finding|Withdrawal by Subject|1|||
23843507|NCT02980341|66808125|FG006|Dose Finding|Withdrawal by Subject|1|||
23843508|NCT02980341|66808126|FG007|Dose Finding|Withdrawal by Subject|0|||
23843509|NCT02980341|66808127|FG008|Dose Finding|Withdrawal by Subject|0|||
23843510|NCT02980341|66808128|FG009|Dose Finding|Withdrawal by Subject|0|||
23843511|NCT02980341|66808129|FG010|Dose Finding|Withdrawal by Subject|0|||
23843512|NCT02980341|66808119|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843513|NCT02980341|66808120|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843514|NCT02980341|66808121|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843515|NCT02980341|66808122|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843516|NCT02980341|66808123|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843517|NCT02980341|66808124|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843518|NCT02980341|66808125|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23843519|NCT02980341|66808126|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
23843520|NCT02980341|66808127|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
23843521|NCT02980341|66808128|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
23843522|NCT02980341|66808129|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
23342701|NCT04450407|64999673|FG001|Overall Study|Physician Decision|0|||
23342702|NCT04450407|64999674|FG002|Overall Study|Physician Decision|1|||
23342703|NCT04450407|64999672|FG000|Overall Study|Pregnancy|1|||
23843523|NCT02980341|66808119|FG000|Dose Expansion|Clinical progression|0|||
23843524|NCT02980341|66808120|FG001|Dose Expansion|Clinical progression|0|||
23342704|NCT04450407|64999673|FG001|Overall Study|Pregnancy|0|||
23454327|NCT02234843|65407103|FG007|Overall Study|Withdrawal by Subject|0|||
23454328|NCT02234843|65407104|FG008|Overall Study|Withdrawal by Subject|0|||
23454329|NCT02234843|65407105|FG009|Overall Study|Withdrawal by Subject|0|||
23454330|NCT02234843|65407096|FG000|Overall Study|Recovery|1|||
23454331|NCT02234843|65407097|FG001|Overall Study|Recovery|0|||
23843525|NCT02980341|66808121|FG002|Dose Expansion|Clinical progression|0|||
23843526|NCT02980341|66808122|FG003|Dose Expansion|Clinical progression|0|||
23843527|NCT02980341|66808123|FG004|Dose Expansion|Clinical progression|0|||
23843528|NCT02980341|66808124|FG005|Dose Expansion|Clinical progression|0|||
23843529|NCT02980341|66808125|FG006|Dose Expansion|Clinical progression|0|||
23843530|NCT02980341|66808126|FG007|Dose Expansion|Clinical progression|4|||
23843531|NCT02980341|66808127|FG008|Dose Expansion|Clinical progression|3|||
23843532|NCT02980341|66808128|FG009|Dose Expansion|Clinical progression|1|||
23843533|NCT02980341|66808129|FG010|Dose Expansion|Clinical progression|4|||
23843534|NCT02980341|66808119|FG000|Dose Expansion|Adverse Event|0|||
23843535|NCT02980341|66808120|FG001|Dose Expansion|Adverse Event|0|||
23843536|NCT02980341|66808121|FG002|Dose Expansion|Adverse Event|0|||
23843537|NCT02980341|66808122|FG003|Dose Expansion|Adverse Event|0|||
23843538|NCT02980341|66808123|FG004|Dose Expansion|Adverse Event|0|||
23843539|NCT02980341|66808124|FG005|Dose Expansion|Adverse Event|0|||
23843540|NCT02980341|66808125|FG006|Dose Expansion|Adverse Event|0|||
23843541|NCT02980341|66808126|FG007|Dose Expansion|Adverse Event|3|||
23843542|NCT02980341|66808127|FG008|Dose Expansion|Adverse Event|0|||
23843543|NCT02980341|66808128|FG009|Dose Expansion|Adverse Event|1|||
23843544|NCT02980341|66808129|FG010|Dose Expansion|Adverse Event|3|||
23843545|NCT02980341|66808119|FG000|Dose Expansion|Death|0|||
23843546|NCT02980341|66808120|FG001|Dose Expansion|Death|0|||
23843547|NCT02980341|66808121|FG002|Dose Expansion|Death|0|||
23843548|NCT02980341|66808122|FG003|Dose Expansion|Death|0|||
23843549|NCT02980341|66808123|FG004|Dose Expansion|Death|0|||
23843550|NCT02980341|66808124|FG005|Dose Expansion|Death|0|||
23843551|NCT02980341|66808125|FG006|Dose Expansion|Death|0|||
23843552|NCT02980341|66808126|FG007|Dose Expansion|Death|0|||
23843553|NCT02980341|66808127|FG008|Dose Expansion|Death|2|||
23843554|NCT02980341|66808128|FG009|Dose Expansion|Death|1|||
23843555|NCT02980341|66808129|FG010|Dose Expansion|Death|0|||
23843556|NCT02980341|66808119|FG000|Dose Expansion|Withdrawal by Subject|0|||
23843557|NCT02980341|66808120|FG001|Dose Expansion|Withdrawal by Subject|0|||
23843558|NCT02980341|66808121|FG002|Dose Expansion|Withdrawal by Subject|0|||
23843559|NCT02980341|66808122|FG003|Dose Expansion|Withdrawal by Subject|0|||
23843560|NCT02980341|66808123|FG004|Dose Expansion|Withdrawal by Subject|0|||
23843561|NCT02980341|66808124|FG005|Dose Expansion|Withdrawal by Subject|0|||
23843562|NCT02980341|66808125|FG006|Dose Expansion|Withdrawal by Subject|0|||
23843563|NCT02980341|66808126|FG007|Dose Expansion|Withdrawal by Subject|2|||
23843564|NCT02980341|66808127|FG008|Dose Expansion|Withdrawal by Subject|0|||
23843565|NCT02980341|66808128|FG009|Dose Expansion|Withdrawal by Subject|1|||
23843566|NCT02980341|66808129|FG010|Dose Expansion|Withdrawal by Subject|0|||
23843567|NCT02980341|66808119|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843568|NCT02980341|66808120|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843569|NCT02980341|66808121|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843570|NCT02980341|66808122|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843571|NCT02980341|66808123|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843572|NCT02980341|66808124|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843573|NCT02980341|66808125|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843574|NCT02980341|66808126|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
23843575|NCT02980341|66808127|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843576|NCT02980341|66808128|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843577|NCT02980341|66808129|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23843578|NCT02980341|66808119|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843579|NCT02980341|66808120|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843580|NCT02980341|66808121|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843581|NCT02980341|66808122|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843582|NCT02980341|66808123|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843583|NCT02980341|66808124|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843584|NCT02980341|66808125|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23454332|NCT02234843|65407098|FG002|Overall Study|Recovery|0|||
23454333|NCT02234843|65407099|FG003|Overall Study|Recovery|0|||
23454334|NCT02234843|65407100|FG004|Overall Study|Recovery|0|||
23454335|NCT02234843|65407101|FG005|Overall Study|Recovery|0|||
23843585|NCT02980341|66808126|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23342705|NCT04450407|64999674|FG002|Overall Study|Pregnancy|0|||
23342706|NCT04450407|64999672|FG000|Overall Study|Protocol Violation|2|||
23342707|NCT04450407|64999673|FG001|Overall Study|Protocol Violation|0|||
23342708|NCT04450407|64999674|FG002|Overall Study|Protocol Violation|0|||
23342709|NCT04450407|64999672|FG000|Overall Study|Investigational site terminated by sponsor|3|||
23342710|NCT04450407|64999673|FG001|Overall Study|Investigational site terminated by sponsor|0|||
23342711|NCT04450407|64999674|FG002|Overall Study|Investigational site terminated by sponsor|2|||
23342712|NCT02499146|64999677|FG000|Overall Study|Lost to Follow-up|1|||
23342713|NCT02499146|64999677|FG000|Overall Study|Withdrawal by Subject|1|||
23342714|NCT02499146|64999677|FG000|Overall Study|Other|2|||
23342715|NCT02499146|64999677|FG000|Overall Study|Ongoing at date of cut-off|9|||
23342716|NCT02499146|64999677|FG000|Overall Study|Began other treatment/therapy|13|||
23342717|NCT03917472|64999679|FG000|Overall Study|Physician Decision|4|||
23342718|NCT03917472|64999680|FG001|Overall Study|Physician Decision|0|||
23342719|NCT03917472|64999679|FG000|Overall Study|Adverse Event|3|||
23342720|NCT03917472|64999680|FG001|Overall Study|Adverse Event|1|||
23342721|NCT03917472|64999679|FG000|Overall Study|Death|7|||
23342722|NCT03917472|64999680|FG001|Overall Study|Death|5|||
23342723|NCT03917472|64999679|FG000|Overall Study|Withdrawal by Subject|11|||
23342724|NCT03917472|64999680|FG001|Overall Study|Withdrawal by Subject|4|||
23342725|NCT03917472|64999679|FG000|Overall Study|Lost to Follow-up|10|||
23342726|NCT03917472|64999680|FG001|Overall Study|Lost to Follow-up|5|||
23342727|NCT02000622|64999681|FG000|Overall Study|Withdrawal by Subject|5|||
23342728|NCT02000622|64999682|FG001|Overall Study|Withdrawal by Subject|7|||
23454336|NCT02234843|65407102|FG006|Overall Study|Recovery|0|||
23454337|NCT02234843|65407103|FG007|Overall Study|Recovery|0|||
23454338|NCT02234843|65407104|FG008|Overall Study|Recovery|0|||
23454339|NCT02234843|65407105|FG009|Overall Study|Recovery|0|||
23454340|NCT02234843|65407096|FG000|Overall Study|Other|0|||
23454341|NCT02234843|65407097|FG001|Overall Study|Other|2|||
23454342|NCT02234843|65407098|FG002|Overall Study|Other|0|||
23454343|NCT02234843|65407099|FG003|Overall Study|Other|1|||
23454344|NCT02234843|65407100|FG004|Overall Study|Other|0|||
23454345|NCT02234843|65407101|FG005|Overall Study|Other|1|||
23454346|NCT02234843|65407102|FG006|Overall Study|Other|0|||
23454347|NCT02234843|65407103|FG007|Overall Study|Other|1|||
23454348|NCT02234843|65407104|FG008|Overall Study|Other|0|||
23454349|NCT02234843|65407105|FG009|Overall Study|Other|0|||
23454350|NCT02234843|65407096|FG000|Overall Study|Physician Decision|4|||
23454351|NCT02234843|65407097|FG001|Overall Study|Physician Decision|1|||
23454352|NCT02234843|65407098|FG002|Overall Study|Physician Decision|0|||
23454353|NCT02234843|65407099|FG003|Overall Study|Physician Decision|1|||
23454354|NCT02234843|65407100|FG004|Overall Study|Physician Decision|0|||
23454355|NCT02234843|65407101|FG005|Overall Study|Physician Decision|0|||
23454356|NCT02234843|65407102|FG006|Overall Study|Physician Decision|0|||
23454357|NCT02234843|65407103|FG007|Overall Study|Physician Decision|1|||
23454358|NCT02234843|65407104|FG008|Overall Study|Physician Decision|0|||
23454359|NCT02234843|65407105|FG009|Overall Study|Physician Decision|0|||
23454360|NCT02234843|65407096|FG000|Overall Study|Adverse Event|5|||
23454361|NCT02234843|65407097|FG001|Overall Study|Adverse Event|1|||
23843586|NCT02980341|66808127|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
23843587|NCT02980341|66808128|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843588|NCT02980341|66808129|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23843589|NCT02980341|66808119|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843590|NCT02980341|66808120|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843591|NCT02980341|66808121|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843592|NCT02980341|66808122|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843593|NCT02980341|66808123|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843594|NCT02980341|66808124|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23342729|NCT02000622|64999681|FG000|Overall Study|Lost to Follow-up|4|||
23342730|NCT02000622|64999682|FG001|Overall Study|Lost to Follow-up|0|||
23342731|NCT02000622|64999681|FG000|Overall Study|Death|159|||
23342732|NCT02000622|64999682|FG001|Overall Study|Death|73|||
23342733|NCT02000622|64999681|FG000|Overall Study|Withdrawn due to site closure|1|||
23342734|NCT02000622|64999682|FG001|Overall Study|Withdrawn due to site closure|0|||
23342735|NCT01661933|64999684|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
23342736|NCT01661933|64999684|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
23342737|NCT01154296|64999685|FG000|Randomization and Intervention|Decided to decline|1|||
23454362|NCT02234843|65407098|FG002|Overall Study|Adverse Event|1|||
23454363|NCT02234843|65407099|FG003|Overall Study|Adverse Event|3|||
23454364|NCT02234843|65407100|FG004|Overall Study|Adverse Event|2|||
23454365|NCT02234843|65407101|FG005|Overall Study|Adverse Event|1|||
23454366|NCT02234843|65407102|FG006|Overall Study|Adverse Event|0|||
23454367|NCT02234843|65407103|FG007|Overall Study|Adverse Event|0|||
23454368|NCT02234843|65407104|FG008|Overall Study|Adverse Event|1|||
23454369|NCT02234843|65407105|FG009|Overall Study|Adverse Event|0|||
23454370|NCT02234843|65407096|FG000|Overall Study|Non-compliance with study drug|1|||
23454371|NCT02234843|65407097|FG001|Overall Study|Non-compliance with study drug|0|||
23454372|NCT02234843|65407098|FG002|Overall Study|Non-compliance with study drug|0|||
23454373|NCT02234843|65407099|FG003|Overall Study|Non-compliance with study drug|0|||
23454374|NCT02234843|65407100|FG004|Overall Study|Non-compliance with study drug|0|||
23454375|NCT02234843|65407101|FG005|Overall Study|Non-compliance with study drug|1|||
23454376|NCT02234843|65407102|FG006|Overall Study|Non-compliance with study drug|1|||
23454377|NCT02234843|65407103|FG007|Overall Study|Non-compliance with study drug|0|||
23454378|NCT02234843|65407104|FG008|Overall Study|Non-compliance with study drug|0|||
23454379|NCT02234843|65407105|FG009|Overall Study|Non-compliance with study drug|0|||
23454380|NCT02234843|65407096|FG000|Overall Study|Lost to Follow-up|0|||
23454381|NCT02234843|65407097|FG001|Overall Study|Lost to Follow-up|1|||
23454382|NCT02234843|65407098|FG002|Overall Study|Lost to Follow-up|0|||
23454383|NCT02234843|65407099|FG003|Overall Study|Lost to Follow-up|0|||
23454384|NCT02234843|65407100|FG004|Overall Study|Lost to Follow-up|0|||
23454385|NCT02234843|65407101|FG005|Overall Study|Lost to Follow-up|0|||
23454386|NCT02234843|65407102|FG006|Overall Study|Lost to Follow-up|1|||
23454387|NCT02234843|65407103|FG007|Overall Study|Lost to Follow-up|0|||
23454388|NCT02234843|65407104|FG008|Overall Study|Lost to Follow-up|0|||
23454389|NCT02234843|65407105|FG009|Overall Study|Lost to Follow-up|0|||
23454390|NCT01584232|65407108|FG000|Overall Study|Adverse Event|3|||
23454391|NCT01584232|65407109|FG001|Overall Study|Adverse Event|1|||
23454392|NCT01584232|65407108|FG000|Overall Study|Withdrawal by Subject|2|||
23454393|NCT01584232|65407109|FG001|Overall Study|Withdrawal by Subject|1|||
23454394|NCT01584232|65407108|FG000|Overall Study|Physician Decision|2|||
23454395|NCT01584232|65407109|FG001|Overall Study|Physician Decision|1|||
23454396|NCT01584232|65407108|FG000|Overall Study|Lost to Follow-up|1|||
23454397|NCT01584232|65407109|FG001|Overall Study|Lost to Follow-up|0|||
23454398|NCT02520726|65407110|FG000|Overall Study|Lost to Follow-up|3|||
23454399|NCT02520726|65407111|FG001|Overall Study|Lost to Follow-up|2|||
23454400|NCT03634085|65407112|FG000|Overall Study|Adverse Event|1|||
23454401|NCT03634085|65407113|FG001|Overall Study|Adverse Event|0|||
23454402|NCT03634085|65407112|FG000|Overall Study|Withdrawal by Subject|0|||
23454403|NCT03634085|65407113|FG001|Overall Study|Withdrawal by Subject|2|||
23454404|NCT01323582|65407114|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
23454405|NCT01323582|65407115|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
23454406|NCT01323582|65407114|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
23454407|NCT01323582|65407115|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
23454408|NCT01323582|65407114|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
23454409|NCT01323582|65407115|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
23454410|NCT03582215|65407116|FG000|Overall Study|Adverse Event|1|||
23454411|NCT03582215|65407117|FG001|Overall Study|Adverse Event|0|||
23454412|NCT03582215|65407118|FG002|Overall Study|Adverse Event|0|||
23454413|NCT03582215|65407119|FG003|Overall Study|Adverse Event|0|||
23454414|NCT03582215|65407120|FG004|Overall Study|Adverse Event|0|||
23454415|NCT03582215|65407121|FG005|Overall Study|Adverse Event|0|||
23454416|NCT03582215|65407122|FG006|Overall Study|Adverse Event|2|||
23454417|NCT03582215|65407123|FG007|Overall Study|Adverse Event|2|||
23454418|NCT00781768|65407124|FG000|Overall Study|Not transplanted.|0|||
23454419|NCT00781768|65407125|FG001|Overall Study|Not transplanted.|2|||
23454420|NCT00528112|65407126|FG000|Treatment up to 3 Years|Adverse Event|313|||
23454421|NCT00528112|65407127|FG001|Treatment up to 3 Years|Adverse Event|278|||
23454422|NCT00528112|65407126|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
23454423|NCT00528112|65407127|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
23454424|NCT00528112|65407126|FG000|Treatment up to 3 Years|Protocol Violation|16|||
23454425|NCT00528112|65407127|FG001|Treatment up to 3 Years|Protocol Violation|16|||
23454426|NCT00528112|65407126|FG000|Treatment up to 3 Years|Death|0|||
23454427|NCT00528112|65407127|FG001|Treatment up to 3 Years|Death|1|||
23454428|NCT00528112|65407126|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
23454429|NCT00528112|65407127|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
23454430|NCT00528112|65407126|FG000|Treatment up to 3 Years|Pregnancy|9|||
23454431|NCT00528112|65407127|FG001|Treatment up to 3 Years|Pregnancy|10|||
23454432|NCT00528112|65407126|FG000|Treatment up to 3 Years|Other reasons|186|||
23454433|NCT00528112|65407127|FG001|Treatment up to 3 Years|Other reasons|186|||
23454434|NCT00528112|65407126|FG000|Extension Phase|Withdrawal by Subject|0|||
23454435|NCT00528112|65407127|FG001|Extension Phase|Withdrawal by Subject|3|||
23454436|NCT00528112|65407126|FG000|Extension Phase|Other reasons|0|||
23454437|NCT00528112|65407127|FG001|Extension Phase|Other reasons|100|||
23454438|NCT00528112|65407126|FG000|Extension Phase|Pregnancy|0|||
23454439|NCT00528112|65407127|FG001|Extension Phase|Pregnancy|3|||
23454440|NCT00528112|65407126|FG000|Extension Phase|Lost to Follow-up|0|||
23454441|NCT00528112|65407127|FG001|Extension Phase|Lost to Follow-up|12|||
23454442|NCT00528112|65407126|FG000|Extension Phase|Death|0|||
23454443|NCT00528112|65407127|FG001|Extension Phase|Death|1|||
23454444|NCT00528112|65407126|FG000|Extension Phase|Adverse Event|0|||
23454445|NCT00528112|65407127|FG001|Extension Phase|Adverse Event|36|||
23454446|NCT00528112|65407126|FG000|Extension Phase|Protocol Violation|0|||
23454447|NCT00528112|65407127|FG001|Extension Phase|Protocol Violation|2|||
23454448|NCT01453049|65407128|FG000|Overall Study|Protocol Violation|2|||
23454449|NCT01453049|65407129|FG001|Overall Study|Protocol Violation|5|||
23454450|NCT01453049|65407128|FG000|Overall Study|Lost to Follow-up|2|||
23454451|NCT01453049|65407129|FG001|Overall Study|Lost to Follow-up|1|||
23454452|NCT01453049|65407128|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
23454453|NCT01453049|65407129|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
23454454|NCT01453049|65407128|FG000|Overall Study|Withdrawal by Subject|1|||
23454455|NCT01453049|65407129|FG001|Overall Study|Withdrawal by Subject|0|||
23454456|NCT01453049|65407128|FG000|Overall Study|Randomized in Error|1|||
23454457|NCT01453049|65407129|FG001|Overall Study|Randomized in Error|0|||
23454458|NCT00683878|65407130|FG000|Overall Study|Lack of Efficacy|3|||
23454459|NCT00683878|65407131|FG001|Overall Study|Lack of Efficacy|0|||
23454460|NCT00683878|65407132|FG002|Overall Study|Lack of Efficacy|1|||
23454461|NCT00683878|65407130|FG000|Overall Study|Adverse Event|4|||
23454462|NCT00683878|65407131|FG001|Overall Study|Adverse Event|3|||
23454463|NCT00683878|65407132|FG002|Overall Study|Adverse Event|3|||
23454464|NCT00683878|65407130|FG000|Overall Study|Withdrawal by Subject|9|||
23454465|NCT00683878|65407131|FG001|Overall Study|Withdrawal by Subject|8|||
23454466|NCT00683878|65407132|FG002|Overall Study|Withdrawal by Subject|6|||
23454467|NCT00683878|65407130|FG000|Overall Study|Death|0|||
23454468|NCT00683878|65407131|FG001|Overall Study|Death|1|||
23454469|NCT00683878|65407132|FG002|Overall Study|Death|0|||
23454470|NCT00683878|65407130|FG000|Overall Study|Lost to Follow-up|4|||
23454471|NCT00683878|65407131|FG001|Overall Study|Lost to Follow-up|2|||
23454472|NCT00683878|65407132|FG002|Overall Study|Lost to Follow-up|4|||
23454473|NCT00683878|65407130|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
23454474|NCT00683878|65407131|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
23454475|NCT00683878|65407132|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
23454476|NCT00074711|65407136|FG000|Overall Study|Withdrawal by Subject|1|||
23454477|NCT00074711|65407137|FG001|Overall Study|Withdrawal by Subject|1|||
23454478|NCT00074711|65407136|FG000|Overall Study|Lost to Follow-up|10|||
23454479|NCT00074711|65407137|FG001|Overall Study|Lost to Follow-up|8|||
23454480|NCT00074711|65407136|FG000|Overall Study|Participant stopped study drug|4|||
23454481|NCT00074711|65407137|FG001|Overall Study|Participant stopped study drug|6|||
23454482|NCT00510835|65407138|FG000|Overall Study|Withdrawal by Subject|6|||
23454483|NCT00510835|65407139|FG001|Overall Study|Withdrawal by Subject|2|||
23454484|NCT00510835|65407140|FG002|Overall Study|Withdrawal by Subject|2|||
23454485|NCT03790111|65407141|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
23454486|NCT00317473|65407144|FG000|Overall Study|Withdrawal by Subject|2|||
23454487|NCT00317473|65407145|FG001|Overall Study|Withdrawal by Subject|1|||
23454488|NCT00317473|65407146|FG002|Overall Study|Withdrawal by Subject|2|||
23454489|NCT00317473|65407147|FG003|Overall Study|Withdrawal by Subject|1|||
23843595|NCT02980341|66808125|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23454490|NCT00317473|65407148|FG004|Overall Study|Withdrawal by Subject|3|||
23454491|NCT00317473|65407149|FG005|Overall Study|Withdrawal by Subject|1|||
23454492|NCT00317473|65407144|FG000|Overall Study|Relocation|1|||
23454493|NCT00317473|65407145|FG001|Overall Study|Relocation|0|||
23454494|NCT00317473|65407146|FG002|Overall Study|Relocation|1|||
23454495|NCT00317473|65407147|FG003|Overall Study|Relocation|1|||
23454496|NCT00317473|65407148|FG004|Overall Study|Relocation|5|||
23454497|NCT00317473|65407149|FG005|Overall Study|Relocation|2|||
23454498|NCT00317473|65407144|FG000|Overall Study|Death|1|||
23454499|NCT00317473|65407145|FG001|Overall Study|Death|0|||
23454500|NCT00317473|65407146|FG002|Overall Study|Death|0|||
23454501|NCT00317473|65407147|FG003|Overall Study|Death|0|||
23454502|NCT00317473|65407148|FG004|Overall Study|Death|0|||
23454503|NCT00317473|65407149|FG005|Overall Study|Death|0|||
23454504|NCT00317473|65407144|FG000|Overall Study|Other|0|||
23454505|NCT00317473|65407145|FG001|Overall Study|Other|2|||
23454506|NCT00317473|65407146|FG002|Overall Study|Other|0|||
23454507|NCT00317473|65407147|FG003|Overall Study|Other|0|||
23454508|NCT00317473|65407148|FG004|Overall Study|Other|0|||
23454509|NCT00317473|65407149|FG005|Overall Study|Other|0|||
23454510|NCT04002960|65407150|FG000|Overall Study|Withdrawn prior to Completion|2|||
23454511|NCT00651924|65407155|FG000|Overall Study|Withdrawal by PI|0|||
23454512|NCT00651924|65407156|FG001|Overall Study|Withdrawal by PI|2|||
23454513|NCT00651924|65407155|FG000|Overall Study|Withdrawal by Subject|0|||
23454514|NCT00651924|65407156|FG001|Overall Study|Withdrawal by Subject|5|||
23454515|NCT01539759|65407157|FG000|Overall Study|Lost to Follow-up|6|||
23454516|NCT01539759|65407158|FG001|Overall Study|Lost to Follow-up|8|||
23454517|NCT04349072|65407159|FG000|Randomization Period|Found ineligible post enrollment|0|||
23454518|NCT04349072|65407160|FG001|Randomization Period|Found ineligible post enrollment|1|||
23454519|NCT04349072|65407159|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
23454520|NCT04349072|65407160|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
23454521|NCT04349072|65407159|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
23705873|NCT01912768|66297650|FG000|Overall Study|Adverse Event|2|||
23454522|NCT04349072|65407160|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
23454523|NCT04349072|65407159|FG000|Treatment Period|Physician Decision|0|||
23454524|NCT04349072|65407160|FG001|Treatment Period|Physician Decision|1|||
23454525|NCT04349072|65407159|FG000|Treatment Period|Protocol Violation|0|||
23454526|NCT04349072|65407160|FG001|Treatment Period|Protocol Violation|1|||
23454527|NCT04349072|65407159|FG000|Treatment Period|Withdrawal by Subject|1|||
23454528|NCT04349072|65407160|FG001|Treatment Period|Withdrawal by Subject|1|||
23454529|NCT00517296|65407161|FG000|Overall Study|Withdrawal by Subject|1|||
23454530|NCT00517296|65407162|FG001|Overall Study|Withdrawal by Subject|0|||
23454531|NCT00168844|65407164|FG000|Overall Study|Adverse Event|31|||
23454532|NCT00168844|65407165|FG001|Overall Study|Adverse Event|32|||
23454533|NCT00168844|65407166|FG002|Overall Study|Adverse Event|48|||
23454534|NCT00168844|65407164|FG000|Overall Study|Lost to Follow-up|4|||
23454535|NCT00168844|65407165|FG001|Overall Study|Lost to Follow-up|5|||
23454536|NCT00168844|65407166|FG002|Overall Study|Lost to Follow-up|11|||
23454537|NCT00168844|65407164|FG000|Overall Study|Withdrawal by Subject|12|||
23454538|NCT00168844|65407165|FG001|Overall Study|Withdrawal by Subject|9|||
23454539|NCT00168844|65407166|FG002|Overall Study|Withdrawal by Subject|19|||
23454540|NCT00168844|65407164|FG000|Overall Study|Protocol Violation|2|||
23454541|NCT00168844|65407165|FG001|Overall Study|Protocol Violation|2|||
23454542|NCT00168844|65407166|FG002|Overall Study|Protocol Violation|4|||
23454543|NCT00168844|65407164|FG000|Overall Study|Other|6|||
23454544|NCT00168844|65407165|FG001|Overall Study|Other|7|||
23454545|NCT00168844|65407166|FG002|Overall Study|Other|9|||
23454546|NCT00383786|65407177|FG000|Overall Study|Protocol Violation|2|||
23454547|NCT00383786|65407178|FG001|Overall Study|Protocol Violation|6|||
23454548|NCT00383786|65407177|FG000|Overall Study|Withdrawal by Subject|2|||
23454549|NCT00383786|65407178|FG001|Overall Study|Withdrawal by Subject|5|||
23454550|NCT00383786|65407177|FG000|Overall Study|Physician Decision|0|||
23454551|NCT00383786|65407178|FG001|Overall Study|Physician Decision|1|||
23454552|NCT03224130|65407179|FG000|Overall Study|consent issue|0|||
23454553|NCT03224130|65407180|FG001|Overall Study|consent issue|1|||
23843596|NCT02980341|66808126|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843597|NCT02980341|66808127|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
23843598|NCT02980341|66808128|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843599|NCT02980341|66808129|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23843600|NCT02980341|66808119|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843601|NCT02980341|66808120|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843602|NCT02980341|66808121|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843603|NCT02980341|66808122|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843604|NCT02980341|66808123|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843605|NCT02980341|66808124|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23454554|NCT00918385|65407181|FG000|Monotherapy|Adverse Event|1|||
23454555|NCT00918385|65407182|FG001|Monotherapy|Adverse Event|6|||
23342738|NCT01154296|64999686|FG001|Randomization and Intervention|Decided to decline|1|||
23342739|NCT01154296|64999685|FG000|Randomization and Intervention|Declined by staff|1|||
23342740|NCT01154296|64999686|FG001|Randomization and Intervention|Declined by staff|0|||
23342741|NCT01154296|64999685|FG000|Randomization and Intervention|Did not return|1|||
23342742|NCT01154296|64999686|FG001|Randomization and Intervention|Did not return|0|||
23342743|NCT01154296|64999685|FG000|Randomization and Intervention|Left before test|0|||
23342744|NCT01154296|64999686|FG001|Randomization and Intervention|Left before test|1|||
23342745|NCT01154296|64999685|FG000|Randomization and Intervention|Left clinic early|2|||
23342746|NCT01154296|64999686|FG001|Randomization and Intervention|Left clinic early|0|||
23342747|NCT01154296|64999685|FG000|6-month Follow-up|Lost contact|269|||
23342748|NCT01154296|64999686|FG001|6-month Follow-up|Lost contact|275|||
23342749|NCT01154296|64999685|FG000|6-month Follow-up|Incarcerated|37|||
23342750|NCT01154296|64999686|FG001|6-month Follow-up|Incarcerated|32|||
23342751|NCT01154296|64999685|FG000|6-month Follow-up|Withdrew consent|14|||
23342752|NCT01154296|64999686|FG001|6-month Follow-up|Withdrew consent|15|||
23342753|NCT01154296|64999685|FG000|6-month Follow-up|Death|3|||
23342754|NCT01154296|64999686|FG001|6-month Follow-up|Death|2|||
23342755|NCT01154296|64999685|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
23342756|NCT01154296|64999686|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
23342757|NCT03403751|64999687|FG000|Overall Study|Death|5|||
23342758|NCT03403751|64999688|FG001|Overall Study|Death|6|||
23454556|NCT00918385|65407181|FG000|Monotherapy|Complicating illness|1|||
23582462|NCT00991276|65862487|FG004|First Intervention Period|Adverse Event|0|||
23342759|NCT03403751|64999687|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
23454557|NCT00918385|65407182|FG001|Monotherapy|Complicating illness|0|||
23454558|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
23454559|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
23454560|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
23843606|NCT02980341|66808125|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843607|NCT02980341|66808126|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843608|NCT02980341|66808127|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843609|NCT02980341|66808128|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23843610|NCT02980341|66808129|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
23843611|NCT03833427|66808130|FG000|Overall Study|Death|4|||
23342760|NCT03403751|64999688|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
23342761|NCT04017832|64999689|FG000|Overall Study|Withdrawal by Subject|13|||
23454561|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
23454562|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
23454563|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
23454564|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
23454565|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
23454566|NCT00001832|65407183|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
23454567|NCT00001832|65407184|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
23454568|NCT00001832|65407185|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
23454569|NCT00001832|65407186|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
23454570|NCT00001832|65407187|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
23454571|NCT00001832|65407188|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
23454572|NCT00001832|65407189|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
23454573|NCT00001832|65407190|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
23454574|NCT00001832|65407191|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
23454575|NCT00001832|65407192|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
23454576|NCT00001832|65407193|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
23454577|NCT00001832|65407194|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
23454578|NCT00001832|65407195|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
23454579|NCT00001832|65407196|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
23454580|NCT00001832|65407197|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
23454581|NCT00001832|65407183|FG000|Treatment Period|Death during treatment|0|||
23454582|NCT00001832|65407184|FG001|Treatment Period|Death during treatment|0|||
23454583|NCT00001832|65407185|FG002|Treatment Period|Death during treatment|0|||
23454584|NCT00001832|65407186|FG003|Treatment Period|Death during treatment|0|||
23454585|NCT00001832|65407187|FG004|Treatment Period|Death during treatment|0|||
23454586|NCT00001832|65407188|FG005|Treatment Period|Death during treatment|1|||
23454587|NCT00001832|65407189|FG006|Treatment Period|Death during treatment|0|||
23454588|NCT00001832|65407190|FG007|Treatment Period|Death during treatment|0|||
23454589|NCT00001832|65407191|FG008|Treatment Period|Death during treatment|0|||
23454590|NCT00001832|65407192|FG009|Treatment Period|Death during treatment|0|||
23454591|NCT00001832|65407193|FG010|Treatment Period|Death during treatment|0|||
23454592|NCT00001832|65407194|FG011|Treatment Period|Death during treatment|0|||
23454593|NCT00001832|65407195|FG012|Treatment Period|Death during treatment|0|||
23454594|NCT00001832|65407196|FG013|Treatment Period|Death during treatment|0|||
23454595|NCT00001832|65407197|FG014|Treatment Period|Death during treatment|0|||
23454596|NCT00001832|65407183|FG000|Treatment Period|Not treated|0|||
23454597|NCT00001832|65407184|FG001|Treatment Period|Not treated|0|||
23454598|NCT00001832|65407185|FG002|Treatment Period|Not treated|0|||
23454599|NCT00001832|65407186|FG003|Treatment Period|Not treated|0|||
23454600|NCT00001832|65407187|FG004|Treatment Period|Not treated|0|||
23454601|NCT00001832|65407188|FG005|Treatment Period|Not treated|0|||
23454602|NCT00001832|65407189|FG006|Treatment Period|Not treated|0|||
23454603|NCT00001832|65407190|FG007|Treatment Period|Not treated|1|||
23783193|NCT02039908|66583394|FG001|Phase 2-School Year|Protocol Violation|0|||
23783194|NCT02039908|66583395|FG002|Phase 2-School Year|Protocol Violation|3|||
23783195|NCT02039908|66583396|FG003|Phase 2-School Year|Protocol Violation|0|||
23783196|NCT02039908|66583393|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
23783197|NCT02039908|66583394|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
23783198|NCT02039908|66583395|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
23783199|NCT02039908|66583396|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
23783200|NCT04238754|66583401|FG000|Washout - 1 Week|Lost to Follow-up|1|||
23783201|NCT04238754|66583402|FG001|Washout - 1 Week|Lost to Follow-up|0|||
23783202|NCT03663179|66583403|FG000|Overall Study|Withdrawal by Subject|2|||
23783203|NCT03663179|66583404|FG001|Overall Study|Withdrawal by Subject|0|||
23783204|NCT03663179|66583403|FG000|Overall Study|Lost to Follow-up|1|||
23783205|NCT03663179|66583404|FG001|Overall Study|Lost to Follow-up|1|||
23783206|NCT03663179|66583403|FG000|Overall Study|Revealed exclusionary condition|1|||
23783207|NCT03663179|66583404|FG001|Overall Study|Revealed exclusionary condition|0|||
23783208|NCT00834743|66583413|FG000|Second Intervention|Withdrawal by Subject|1|||
23783209|NCT00834743|66583414|FG001|Second Intervention|Withdrawal by Subject|0|||
23783210|NCT02186821|66583418|FG000|Overall Study|Adverse Event|9|||
23783211|NCT02186821|66583418|FG000|Overall Study|Death|2|||
23783212|NCT02186821|66583418|FG000|Overall Study|Disease progression|32|||
23454604|NCT00001832|65407191|FG008|Treatment Period|Not treated|0|||
23454605|NCT00001832|65407192|FG009|Treatment Period|Not treated|0|||
23454606|NCT00001832|65407193|FG010|Treatment Period|Not treated|0|||
23454607|NCT00001832|65407194|FG011|Treatment Period|Not treated|0|||
23454608|NCT00001832|65407195|FG012|Treatment Period|Not treated|0|||
23454609|NCT00001832|65407196|FG013|Treatment Period|Not treated|0|||
23454610|NCT00001832|65407197|FG014|Treatment Period|Not treated|0|||
23783213|NCT02186821|66583418|FG000|Overall Study|Protocol Violation|1|||
23783214|NCT02186821|66583418|FG000|Overall Study|Physician Decision|1|||
23783215|NCT02186821|66583418|FG000|Overall Study|Study terminated by sponsor|2|||
23783216|NCT01056484|66583419|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
23783217|NCT01056484|66583420|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
23783218|NCT01056484|66583419|FG000|Randomized Controlled Trial|Physician Decision|1|||
23783219|NCT01056484|66583420|FG001|Randomized Controlled Trial|Physician Decision|0|||
23783220|NCT01056484|66583419|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
23783221|NCT01056484|66583420|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
23783222|NCT04263649|66583424|FG000|Overall Study|Adverse Event|53|||
23783223|NCT04263649|66583424|FG000|Overall Study|Lost to Follow-up|3|||
23783224|NCT04263649|66583424|FG000|Overall Study|Death|29|||
23783225|NCT04263649|66583424|FG000|Overall Study|Device deficiency|19|||
23783226|NCT04263649|66583424|FG000|Overall Study|other reasons|11|||
23783227|NCT02849457|66586587|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23783228|NCT02849457|66586588|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23783229|NCT02849457|66586589|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
23783230|NCT02849457|66586590|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23783231|NCT01208337|66586591|FG000|Overall Study|Death|3|||
23783232|NCT04173247|66586592|FG000|Overall Study|Withdrawal by Subject|0|||
23783233|NCT04173247|66586593|FG001|Overall Study|Withdrawal by Subject|2|||
23783234|NCT04173247|66586592|FG000|Overall Study|Death|1|||
23783235|NCT04173247|66586593|FG001|Overall Study|Death|0|||
23783236|NCT04173247|66586592|FG000|Overall Study|Physician Decision|1|||
23783237|NCT04173247|66586593|FG001|Overall Study|Physician Decision|0|||
23783238|NCT00365365|66586595|FG000|Overall Study|Randomized but not treated|0|||
23783239|NCT00365365|66586596|FG001|Overall Study|Randomized but not treated|2|||
23783240|NCT00365365|66586597|FG002|Overall Study|Randomized but not treated|0|||
23783241|NCT00365365|66586595|FG000|Overall Study|Poor compliance to protocol|0|||
23783242|NCT00365365|66586596|FG001|Overall Study|Poor compliance to protocol|1|||
23783243|NCT00365365|66586597|FG002|Overall Study|Poor compliance to protocol|0|||
23783244|NCT00365365|66586595|FG000|Overall Study|Lost to Follow-up|3|||
23783245|NCT00365365|66586596|FG001|Overall Study|Lost to Follow-up|3|||
23783246|NCT00365365|66586597|FG002|Overall Study|Lost to Follow-up|3|||
23783247|NCT00365365|66586595|FG000|Overall Study|Death|1|||
23783248|NCT00365365|66586596|FG001|Overall Study|Death|3|||
23783249|NCT00365365|66586597|FG002|Overall Study|Death|0|||
23783250|NCT00365365|66586595|FG000|Overall Study|Subject's request|11|||
23783251|NCT00365365|66586596|FG001|Overall Study|Subject's request|13|||
23843612|NCT03833427|66808131|FG001|Overall Study|Death|2|||
23843613|NCT03833427|66808132|FG002|Overall Study|Death|9|||
23843614|NCT03833427|66808133|FG003|Overall Study|Death|11|||
23843615|NCT03833427|66808134|FG004|Overall Study|Death|0|||
23843616|NCT03833427|66808135|FG005|Overall Study|Death|0|||
23843617|NCT03833427|66808136|FG006|Overall Study|Death|0|||
23843618|NCT03833427|66808130|FG000|Overall Study|Withdrawal by Subject|0|||
23843619|NCT03833427|66808131|FG001|Overall Study|Withdrawal by Subject|1|||
23843620|NCT03833427|66808132|FG002|Overall Study|Withdrawal by Subject|1|||
23843621|NCT03833427|66808133|FG003|Overall Study|Withdrawal by Subject|0|||
23843622|NCT03833427|66808134|FG004|Overall Study|Withdrawal by Subject|0|||
23843623|NCT03833427|66808135|FG005|Overall Study|Withdrawal by Subject|0|||
23843624|NCT03833427|66808136|FG006|Overall Study|Withdrawal by Subject|0|||
23843625|NCT03833427|66808130|FG000|Overall Study|Sponsor Decision|0|||
23843626|NCT03833427|66808131|FG001|Overall Study|Sponsor Decision|0|||
23843627|NCT03833427|66808132|FG002|Overall Study|Sponsor Decision|1|||
23843628|NCT03833427|66808133|FG003|Overall Study|Sponsor Decision|3|||
23843629|NCT03833427|66808134|FG004|Overall Study|Sponsor Decision|0|||
23843630|NCT03833427|66808135|FG005|Overall Study|Sponsor Decision|0|||
23843631|NCT03833427|66808136|FG006|Overall Study|Sponsor Decision|0|||
23454611|NCT00762359|65407202|FG000|Overall Study|Adverse Event|20|||
23454612|NCT00762359|65407203|FG001|Overall Study|Adverse Event|23|||
23843632|NCT05367973|66808137|FG000|Overall Study|Adverse Event|0|||
23454613|NCT00762359|65407202|FG000|Overall Study|Protocol Violation|21|||
23783252|NCT00365365|66586597|FG002|Overall Study|Subject's request|1|||
23783253|NCT00365365|66586595|FG000|Overall Study|Disease progression/relapse|9|||
23783254|NCT00365365|66586596|FG001|Overall Study|Disease progression/relapse|6|||
23843633|NCT05367973|66808138|FG001|Overall Study|Adverse Event|2|||
23843634|NCT04489771|66808139|FG000|Overall Study|Death|27|||
23843635|NCT04489771|66808140|FG001|Overall Study|Death|25|||
23783255|NCT00365365|66586597|FG002|Overall Study|Disease progression/relapse|7|||
23783256|NCT00365365|66586595|FG000|Overall Study|Adverse Event|6|||
23783257|NCT00365365|66586596|FG001|Overall Study|Adverse Event|6|||
23783258|NCT00365365|66586597|FG002|Overall Study|Adverse Event|3|||
23783259|NCT00365365|66586595|FG000|Overall Study|Moved|2|||
23783260|NCT00365365|66586596|FG001|Overall Study|Moved|0|||
23843636|NCT04489771|66808139|FG000|Overall Study|Withdrawal by Subject|1|||
23783261|NCT00365365|66586597|FG002|Overall Study|Moved|0|||
23783262|NCT00365365|66586595|FG000|Overall Study|New cancer|1|||
23783263|NCT00365365|66586596|FG001|Overall Study|New cancer|0|||
23783264|NCT00365365|66586597|FG002|Overall Study|New cancer|0|||
23783265|NCT00365365|66586595|FG000|Overall Study|Withdrew consent|1|||
23783266|NCT00365365|66586596|FG001|Overall Study|Withdrew consent|1|||
23783267|NCT00365365|66586597|FG002|Overall Study|Withdrew consent|0|||
23783268|NCT00365365|66586595|FG000|Overall Study|Second malignancy|0|||
23783269|NCT00365365|66586596|FG001|Overall Study|Second malignancy|1|||
23783270|NCT00365365|66586597|FG002|Overall Study|Second malignancy|0|||
23783271|NCT00365365|66586595|FG000|Overall Study|Patient/physician decision|0|||
23783272|NCT00365365|66586596|FG001|Overall Study|Patient/physician decision|0|||
23843637|NCT04489771|66808140|FG001|Overall Study|Withdrawal by Subject|0|||
23843638|NCT04489771|66808139|FG000|Overall Study|Participants Ongoing in Study|50|||
23843639|NCT04489771|66808140|FG001|Overall Study|Participants Ongoing in Study|51|||
23843640|NCT03526250|66808143|FG000|Overall Study|Adverse Event|4|||
23582463|NCT00991276|65862488|FG005|First Intervention Period|Adverse Event|0|||
23843641|NCT03526250|66808143|FG000|Overall Study|Progressive Disease|16|||
23843642|NCT03526250|66808143|FG000|Overall Study|No Treatment|3|||
23582464|NCT00991276|65862483|FG000|First Intervention Period|Protocol Violation|0|||
23582465|NCT00991276|65862484|FG001|First Intervention Period|Protocol Violation|0|||
23582466|NCT00991276|65862485|FG002|First Intervention Period|Protocol Violation|0|||
23843643|NCT02993146|66808144|FG000|Overall Study|Withdrawal by Subject|0|||
23843644|NCT02993146|66808145|FG001|Overall Study|Withdrawal by Subject|0|||
23843645|NCT02993146|66808146|FG002|Overall Study|Withdrawal by Subject|1|||
23843646|NCT02993146|66808147|FG003|Overall Study|Withdrawal by Subject|1|||
23843647|NCT05413369|66808148|FG000|Overall Study|Adverse Event|1|||
23843648|NCT05413369|66808149|FG001|Overall Study|Adverse Event|1|||
23843649|NCT05413369|66808148|FG000|Overall Study|Withdrawal by Subject|13|||
23843650|NCT05413369|66808149|FG001|Overall Study|Withdrawal by Subject|4|||
23843651|NCT05413369|66808148|FG000|Overall Study|Non-compliance with study schedule|2|||
23843652|NCT05413369|66808149|FG001|Overall Study|Non-compliance with study schedule|1|||
23843653|NCT05413369|66808148|FG000|Overall Study|Other|1|||
23843654|NCT05413369|66808149|FG001|Overall Study|Other|1|||
23843655|NCT01340027|66808150|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
23843656|NCT01340027|66808151|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
23843657|NCT01340027|66808152|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
23843658|NCT01340027|66808153|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
23843659|NCT01340027|66808154|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
23843660|NCT01340027|66808155|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
23843661|NCT01340027|66808156|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
23843662|NCT01340027|66808157|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
23843663|NCT01340027|66808158|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
23843664|NCT01340027|66808159|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
23843665|NCT01340027|66808160|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
23843666|NCT01340027|66808161|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
23843667|NCT01340027|66808150|FG000|Overall Study|Adverse Event|0|||
23843668|NCT01340027|66808151|FG001|Overall Study|Adverse Event|1|||
23582467|NCT00991276|65862486|FG003|First Intervention Period|Protocol Violation|0|||
23582468|NCT00991276|65862487|FG004|First Intervention Period|Protocol Violation|2|||
23582469|NCT00991276|65862488|FG005|First Intervention Period|Protocol Violation|0|||
23582470|NCT00991276|65862483|FG000|First Intervention Period|Insufficient clinical response|0|||
23582471|NCT00991276|65862484|FG001|First Intervention Period|Insufficient clinical response|0|||
23582472|NCT00991276|65862485|FG002|First Intervention Period|Insufficient clinical response|0|||
23783273|NCT00365365|66586597|FG002|Overall Study|Patient/physician decision|1|||
23843669|NCT01340027|66808152|FG002|Overall Study|Adverse Event|2|||
23843670|NCT01340027|66808153|FG003|Overall Study|Adverse Event|0|||
23843671|NCT01340027|66808154|FG004|Overall Study|Adverse Event|1|||
23843672|NCT01340027|66808155|FG005|Overall Study|Adverse Event|2|||
23843673|NCT01340027|66808156|FG006|Overall Study|Adverse Event|2|||
23843674|NCT01340027|66808157|FG007|Overall Study|Adverse Event|1|||
23843675|NCT01340027|66808158|FG008|Overall Study|Adverse Event|4|||
23843676|NCT01340027|66808159|FG009|Overall Study|Adverse Event|1|||
23582473|NCT00991276|65862486|FG003|First Intervention Period|Insufficient clinical response|0|||
23783274|NCT02601625|66586601|FG000|Overall Study|Lost to Follow-up|0|||
23783275|NCT02601625|66586602|FG001|Overall Study|Lost to Follow-up|0|||
23783276|NCT02601625|66586603|FG002|Overall Study|Lost to Follow-up|1|||
23783277|NCT02601625|66586604|FG003|Overall Study|Lost to Follow-up|1|||
23783278|NCT03733444|66586607|FG000|Overall Study|Adverse Event|8|||
23783279|NCT03733444|66586608|FG001|Overall Study|Adverse Event|10|||
23783280|NCT03733444|66586609|FG002|Overall Study|Adverse Event|5|||
23783281|NCT03733444|66586607|FG000|Overall Study|Death|20|||
23783282|NCT03733444|66586608|FG001|Overall Study|Death|19|||
23783283|NCT03733444|66586609|FG002|Overall Study|Death|11|||
23783284|NCT03733444|66586607|FG000|Overall Study|Lost to Follow-up|3|||
23783285|NCT03733444|66586608|FG001|Overall Study|Lost to Follow-up|0|||
23783286|NCT03733444|66586609|FG002|Overall Study|Lost to Follow-up|1|||
23783287|NCT03733444|66586607|FG000|Overall Study|Lack of Efficacy|0|||
23783288|NCT03733444|66586608|FG001|Overall Study|Lack of Efficacy|1|||
23783289|NCT03733444|66586609|FG002|Overall Study|Lack of Efficacy|1|||
23783290|NCT03733444|66586607|FG000|Overall Study|Physician Decision|2|||
23783291|NCT03733444|66586608|FG001|Overall Study|Physician Decision|1|||
23783292|NCT03733444|66586609|FG002|Overall Study|Physician Decision|0|||
23783293|NCT03733444|66586607|FG000|Overall Study|Protocol Violation|2|||
23783294|NCT03733444|66586608|FG001|Overall Study|Protocol Violation|1|||
23783295|NCT03733444|66586609|FG002|Overall Study|Protocol Violation|0|||
23783296|NCT03733444|66586607|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23783297|NCT03733444|66586608|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23783298|NCT03733444|66586609|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
23783299|NCT03733444|66586607|FG000|Overall Study|Study Terminated by Sponsor|203|||
23783300|NCT03733444|66586608|FG001|Overall Study|Study Terminated by Sponsor|209|||
23783301|NCT03733444|66586609|FG002|Overall Study|Study Terminated by Sponsor|221|||
23783302|NCT03733444|66586607|FG000|Overall Study|Withdrawal by Subject|19|||
23783303|NCT03733444|66586608|FG001|Overall Study|Withdrawal by Subject|18|||
23783304|NCT03733444|66586609|FG002|Overall Study|Withdrawal by Subject|16|||
23783305|NCT03733444|66586607|FG000|Overall Study|Miscellaneous|1|||
23783306|NCT03733444|66586608|FG001|Overall Study|Miscellaneous|0|||
23783307|NCT03733444|66586609|FG002|Overall Study|Miscellaneous|1|||
23783308|NCT03733444|66586607|FG000|Overall Study|Not Treated|1|||
23783309|NCT03733444|66586608|FG001|Overall Study|Not Treated|2|||
23783310|NCT03733444|66586609|FG002|Overall Study|Not Treated|1|||
23783311|NCT02558491|66586615|FG000|First Invention|Withdrawal by Subject|3|||
23783312|NCT02558491|66586616|FG001|First Invention|Withdrawal by Subject|1|||
23783313|NCT02558491|66586615|FG000|First Invention|Data collection issues|1|||
23783314|NCT02558491|66586616|FG001|First Invention|Data collection issues|0|||
23783315|NCT02558491|66586615|FG000|First Invention|Stopping criteria|0|||
23783316|NCT02558491|66586616|FG001|First Invention|Stopping criteria|1|||
23783317|NCT02558491|66586615|FG000|First Invention|Changed parameters during trial|1|||
23783318|NCT02558491|66586616|FG001|First Invention|Changed parameters during trial|0|||
23843677|NCT01340027|66808160|FG010|Overall Study|Adverse Event|1|||
23843678|NCT01340027|66808161|FG011|Overall Study|Adverse Event|3|||
23843679|NCT01340027|66808150|FG000|Overall Study|Lack of Efficacy|0|||
23843680|NCT01340027|66808151|FG001|Overall Study|Lack of Efficacy|0|||
23843681|NCT01340027|66808152|FG002|Overall Study|Lack of Efficacy|0|||
23342762|NCT04017832|64999690|FG001|Overall Study|Withdrawal by Subject|12|||
23582474|NCT00991276|65862487|FG004|First Intervention Period|Insufficient clinical response|1|||
23582475|NCT00991276|65862488|FG005|First Intervention Period|Insufficient clinical response|0|||
23783319|NCT02558491|66586615|FG000|Second Intervention|Withdrawal by Subject|1|||
23783320|NCT02558491|66586616|FG001|Second Intervention|Withdrawal by Subject|0|||
23783321|NCT02558491|66586615|FG000|Second Intervention|Stopping Criteria|1|||
23783322|NCT02558491|66586616|FG001|Second Intervention|Stopping Criteria|0|||
23783323|NCT00840411|66586617|FG000|First Intervention|Adverse Event|1|||
23783324|NCT00840411|66586618|FG001|First Intervention|Adverse Event|0|||
23843682|NCT01340027|66808153|FG003|Overall Study|Lack of Efficacy|0|||
23342763|NCT04017832|64999691|FG002|Overall Study|Withdrawal by Subject|21|||
23342764|NCT04017832|64999692|FG003|Overall Study|Withdrawal by Subject|7|||
23582476|NCT00991276|65862483|FG000|First Intervention Period|Other|0|||
23582477|NCT00991276|65862484|FG001|First Intervention Period|Other|0|||
23582478|NCT00991276|65862485|FG002|First Intervention Period|Other|0|||
23582479|NCT00991276|65862486|FG003|First Intervention Period|Other|1|||
23582480|NCT00991276|65862487|FG004|First Intervention Period|Other|1|||
23582481|NCT00991276|65862488|FG005|First Intervention Period|Other|0|||
23582482|NCT00991276|65862483|FG000|First Intervention Period|Withdrawal by Subject|0|||
23582483|NCT00991276|65862484|FG001|First Intervention Period|Withdrawal by Subject|1|||
23582484|NCT00991276|65862485|FG002|First Intervention Period|Withdrawal by Subject|0|||
23783325|NCT00840411|66586617|FG000|Washout|Withdrawal by Subject|1|||
23783326|NCT00840411|66586618|FG001|Washout|Withdrawal by Subject|0|||
23342765|NCT04017832|64999689|FG000|Overall Study|Lost to Follow-up|0|||
23342766|NCT04017832|64999690|FG001|Overall Study|Lost to Follow-up|3|||
23582485|NCT00991276|65862486|FG003|First Intervention Period|Withdrawal by Subject|1|||
23582486|NCT00991276|65862487|FG004|First Intervention Period|Withdrawal by Subject|0|||
23783327|NCT04032977|66586619|FG000|Overall Study|Withdrawal by Subject|6|||
23783328|NCT04032977|66586620|FG001|Overall Study|Withdrawal by Subject|1|||
23783329|NCT04032977|66586619|FG000|Overall Study|Lost to Follow-up|2|||
23783330|NCT04032977|66586620|FG001|Overall Study|Lost to Follow-up|7|||
23843683|NCT01340027|66808154|FG004|Overall Study|Lack of Efficacy|0|||
23783331|NCT04032977|66586619|FG000|Overall Study|Pregnancy|1|||
23783332|NCT04032977|66586620|FG001|Overall Study|Pregnancy|0|||
23783333|NCT03122535|66586623|FG000|Overall Study|Lost to Follow-up|68|||
23783334|NCT03122535|66586624|FG001|Overall Study|Lost to Follow-up|68|||
23342767|NCT04017832|64999691|FG002|Overall Study|Lost to Follow-up|3|||
23342768|NCT04017832|64999692|FG003|Overall Study|Lost to Follow-up|1|||
23342769|NCT04017832|64999689|FG000|Overall Study|Physician Decision|1|||
23342770|NCT04017832|64999690|FG001|Overall Study|Physician Decision|1|||
23342771|NCT04017832|64999691|FG002|Overall Study|Physician Decision|1|||
23342772|NCT04017832|64999692|FG003|Overall Study|Physician Decision|1|||
23342773|NCT04017832|64999689|FG000|Overall Study|Death|2|||
23342774|NCT04017832|64999690|FG001|Overall Study|Death|2|||
23342775|NCT04017832|64999691|FG002|Overall Study|Death|1|||
23582487|NCT00991276|65862488|FG005|First Intervention Period|Withdrawal by Subject|1|||
23582488|NCT00991276|65862483|FG000|First Intervention Period|Lost to Follow-up|0|||
23582489|NCT00991276|65862484|FG001|First Intervention Period|Lost to Follow-up|1|||
23582490|NCT00991276|65862485|FG002|First Intervention Period|Lost to Follow-up|0|||
23582491|NCT00991276|65862486|FG003|First Intervention Period|Lost to Follow-up|1|||
23582492|NCT00991276|65862487|FG004|First Intervention Period|Lost to Follow-up|0|||
23582493|NCT00991276|65862488|FG005|First Intervention Period|Lost to Follow-up|0|||
23582494|NCT00991276|65862483|FG000|Second Intervention Period|Adverse Event|0|||
23582495|NCT00991276|65862484|FG001|Second Intervention Period|Adverse Event|2|||
23582496|NCT00991276|65862485|FG002|Second Intervention Period|Adverse Event|0|||
23582497|NCT00991276|65862486|FG003|Second Intervention Period|Adverse Event|1|||
23582498|NCT00991276|65862487|FG004|Second Intervention Period|Adverse Event|1|||
23582499|NCT00991276|65862488|FG005|Second Intervention Period|Adverse Event|0|||
23582500|NCT00991276|65862483|FG000|Second Intervention Period|Protocol Violation|1|||
23582501|NCT00991276|65862484|FG001|Second Intervention Period|Protocol Violation|0|||
23582502|NCT00991276|65862485|FG002|Second Intervention Period|Protocol Violation|0|||
23582503|NCT00991276|65862486|FG003|Second Intervention Period|Protocol Violation|0|||
23582504|NCT00991276|65862487|FG004|Second Intervention Period|Protocol Violation|0|||
23582505|NCT00991276|65862488|FG005|Second Intervention Period|Protocol Violation|0|||
23582506|NCT00991276|65862483|FG000|Second Intervention Period|Other|0|||
23636838|NCT00568178|66053031|FG003|Double Blind Base Study|Adverse Event|2|||
23636839|NCT00568178|66053032|FG004|Double Blind Base Study|Adverse Event|0|||
23636840|NCT00568178|66053033|FG005|Double Blind Base Study|Adverse Event|0|||
23342776|NCT04017832|64999692|FG003|Overall Study|Death|0|||
23636841|NCT00568178|66053028|FG000|Double Blind Base Study|Lost to Follow-up|1|||
23342777|NCT05835011|64999693|FG000|Overall Study|Study Terminated by the Sponsor|1|||
23342778|NCT05835011|64999693|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
23342779|NCT02567435|64999695|FG000|Overall Study|Death|1|||
23342780|NCT02567435|64999696|FG001|Overall Study|Death|1|||
23342781|NCT02567435|64999697|FG002|Overall Study|Death|0|||
23342782|NCT02567435|64999698|FG003|Overall Study|Death|0|||
23342783|NCT02567435|64999695|FG000|Overall Study|Ineligible|1|||
23342784|NCT02567435|64999696|FG001|Overall Study|Ineligible|3|||
23342785|NCT02567435|64999697|FG002|Overall Study|Ineligible|0|||
23342786|NCT02567435|64999698|FG003|Overall Study|Ineligible|0|||
23342787|NCT02567435|64999695|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
23342788|NCT02567435|64999696|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
23342789|NCT02567435|64999697|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
23342790|NCT02567435|64999698|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
23342791|NCT00738881|64999699|FG000|Overall Study|Withdrawal by Subject|0|||
23342792|NCT00738881|64999700|FG001|Overall Study|Withdrawal by Subject|2|||
23342793|NCT04852679|64999701|FG000|Main Intervention Period|Withdrawal by Subject|3|||
23582507|NCT00991276|65862484|FG001|Second Intervention Period|Other|0|||
23582508|NCT00991276|65862485|FG002|Second Intervention Period|Other|0|||
23636842|NCT00568178|66053029|FG001|Double Blind Base Study|Lost to Follow-up|0|||
23636843|NCT00568178|66053030|FG002|Double Blind Base Study|Lost to Follow-up|0|||
23636844|NCT00568178|66053031|FG003|Double Blind Base Study|Lost to Follow-up|1|||
23636845|NCT00568178|66053032|FG004|Double Blind Base Study|Lost to Follow-up|0|||
23636846|NCT00568178|66053033|FG005|Double Blind Base Study|Lost to Follow-up|0|||
23636847|NCT00568178|66053028|FG000|Double Blind Base Study|Physician Decision|1|||
23783335|NCT03122535|66586623|FG000|Overall Study|Physician Decision|3|||
23783336|NCT03122535|66586624|FG001|Overall Study|Physician Decision|3|||
23582509|NCT00991276|65862486|FG003|Second Intervention Period|Other|1|||
23636848|NCT00568178|66053029|FG001|Double Blind Base Study|Physician Decision|1|||
23705874|NCT01912768|66297651|FG001|Overall Study|Adverse Event|0|||
23843684|NCT01340027|66808155|FG005|Overall Study|Lack of Efficacy|0|||
23342794|NCT04852679|64999701|FG000|Main Intervention Period|Adverse Event|1|||
23342795|NCT04852679|64999701|FG000|Main Intervention Period|Progressive Disease|16|||
23582510|NCT00991276|65862487|FG004|Second Intervention Period|Other|0|||
23342796|NCT04852679|64999701|FG000|Main Intervention Period|Refused study visit|1|||
23342797|NCT04852679|64999701|FG000|Independent Injection Period|Missed study visit|1|||
23582511|NCT00991276|65862488|FG005|Second Intervention Period|Other|1|||
23783337|NCT03122535|66586623|FG000|Overall Study|Withdrawal by Subject|2|||
23843685|NCT01340027|66808156|FG006|Overall Study|Lack of Efficacy|1|||
23843686|NCT01340027|66808157|FG007|Overall Study|Lack of Efficacy|1|||
23843687|NCT01340027|66808158|FG008|Overall Study|Lack of Efficacy|1|||
23843688|NCT01340027|66808159|FG009|Overall Study|Lack of Efficacy|0|||
23843689|NCT01340027|66808160|FG010|Overall Study|Lack of Efficacy|0|||
23843690|NCT01340027|66808161|FG011|Overall Study|Lack of Efficacy|0|||
23843691|NCT01340027|66808150|FG000|Overall Study|Lost to Follow-up|0|||
23843692|NCT01340027|66808151|FG001|Overall Study|Lost to Follow-up|1|||
23843693|NCT01340027|66808152|FG002|Overall Study|Lost to Follow-up|0|||
23843694|NCT01340027|66808153|FG003|Overall Study|Lost to Follow-up|0|||
23843695|NCT01340027|66808154|FG004|Overall Study|Lost to Follow-up|0|||
23843696|NCT01340027|66808155|FG005|Overall Study|Lost to Follow-up|0|||
23843697|NCT01340027|66808156|FG006|Overall Study|Lost to Follow-up|1|||
23843698|NCT01340027|66808157|FG007|Overall Study|Lost to Follow-up|0|||
23843699|NCT01340027|66808158|FG008|Overall Study|Lost to Follow-up|0|||
23843700|NCT01340027|66808159|FG009|Overall Study|Lost to Follow-up|1|||
23843701|NCT01340027|66808160|FG010|Overall Study|Lost to Follow-up|0|||
23843702|NCT01340027|66808161|FG011|Overall Study|Lost to Follow-up|0|||
23843703|NCT01340027|66808150|FG000|Overall Study|Protocol Violation|1|||
23843704|NCT01340027|66808151|FG001|Overall Study|Protocol Violation|2|||
23843705|NCT01340027|66808152|FG002|Overall Study|Protocol Violation|0|||
23843706|NCT01340027|66808153|FG003|Overall Study|Protocol Violation|0|||
23843707|NCT01340027|66808154|FG004|Overall Study|Protocol Violation|6|||
23843708|NCT01340027|66808155|FG005|Overall Study|Protocol Violation|0|||
23843709|NCT01340027|66808156|FG006|Overall Study|Protocol Violation|0|||
23843710|NCT01340027|66808157|FG007|Overall Study|Protocol Violation|1|||
23843711|NCT01340027|66808158|FG008|Overall Study|Protocol Violation|2|||
23843712|NCT01340027|66808159|FG009|Overall Study|Protocol Violation|2|||
23843713|NCT01340027|66808160|FG010|Overall Study|Protocol Violation|0|||
23843714|NCT01340027|66808161|FG011|Overall Study|Protocol Violation|0|||
23843715|NCT01340027|66808150|FG000|Overall Study|Withdrawal by Subject|4|||
23843716|NCT01340027|66808151|FG001|Overall Study|Withdrawal by Subject|3|||
23843717|NCT01340027|66808152|FG002|Overall Study|Withdrawal by Subject|1|||
23843718|NCT01340027|66808153|FG003|Overall Study|Withdrawal by Subject|3|||
23843719|NCT01340027|66808154|FG004|Overall Study|Withdrawal by Subject|3|||
23843720|NCT01340027|66808155|FG005|Overall Study|Withdrawal by Subject|2|||
23843721|NCT01340027|66808156|FG006|Overall Study|Withdrawal by Subject|3|||
23843722|NCT01340027|66808157|FG007|Overall Study|Withdrawal by Subject|4|||
23843723|NCT01340027|66808158|FG008|Overall Study|Withdrawal by Subject|1|||
23843724|NCT01340027|66808159|FG009|Overall Study|Withdrawal by Subject|2|||
23843725|NCT01340027|66808160|FG010|Overall Study|Withdrawal by Subject|0|||
23843726|NCT01340027|66808161|FG011|Overall Study|Withdrawal by Subject|1|||
23843727|NCT01340027|66808150|FG000|Overall Study|Miscellaneous|0|||
23843728|NCT01340027|66808151|FG001|Overall Study|Miscellaneous|0|||
23843729|NCT01340027|66808152|FG002|Overall Study|Miscellaneous|0|||
23843730|NCT01340027|66808153|FG003|Overall Study|Miscellaneous|1|||
23843731|NCT01340027|66808154|FG004|Overall Study|Miscellaneous|0|||
23843732|NCT01340027|66808155|FG005|Overall Study|Miscellaneous|0|||
23843733|NCT01340027|66808156|FG006|Overall Study|Miscellaneous|0|||
23843734|NCT01340027|66808157|FG007|Overall Study|Miscellaneous|0|||
23843735|NCT01340027|66808158|FG008|Overall Study|Miscellaneous|0|||
23843736|NCT01340027|66808159|FG009|Overall Study|Miscellaneous|0|||
23843737|NCT01340027|66808160|FG010|Overall Study|Miscellaneous|1|||
23843738|NCT01340027|66808161|FG011|Overall Study|Miscellaneous|0|||
23843739|NCT04964544|66808166|FG000|Overall Study|Screen failure or other uncategorised|10|||
23843740|NCT04964544|66808166|FG000|Overall Study|Physician Decision|4|||
23843741|NCT04964544|66808166|FG000|Overall Study|Lost to Follow-up|9|||
23843742|NCT04964544|66808166|FG000|Overall Study|Withdrawal by Subject|18|||
23843743|NCT04964544|66808166|FG000|Overall Study|Death|1|||
23843744|NCT04429555|66808167|FG000|Overall Study|Death|0|||
23843745|NCT04429555|66808168|FG001|Overall Study|Death|2|||
23843746|NCT04429555|66808167|FG000|Overall Study|Other|2|||
23843747|NCT04429555|66808168|FG001|Overall Study|Other|0|||
23843748|NCT02294396|66808171|FG000|Overall Study|Adverse Event|26|||
23843749|NCT02294396|66808172|FG001|Overall Study|Adverse Event|25|||
23843750|NCT02294396|66808173|FG002|Overall Study|Adverse Event|21|||
23843751|NCT02294396|66808174|FG003|Overall Study|Adverse Event|24|||
23843752|NCT02294396|66808171|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
23843753|NCT02294396|66808172|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
23843754|NCT02294396|66808173|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
23843755|NCT02294396|66808174|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
23843756|NCT02294396|66808171|FG000|Overall Study|Withdrawal by Subject|8|||
23843757|NCT02294396|66808172|FG001|Overall Study|Withdrawal by Subject|6|||
23843758|NCT02294396|66808173|FG002|Overall Study|Withdrawal by Subject|6|||
23843759|NCT02294396|66808174|FG003|Overall Study|Withdrawal by Subject|8|||
23843760|NCT02294396|66808171|FG000|Overall Study|Lost to Follow-up|0|||
23843761|NCT02294396|66808172|FG001|Overall Study|Lost to Follow-up|0|||
23843762|NCT02294396|66808173|FG002|Overall Study|Lost to Follow-up|1|||
23843763|NCT02294396|66808174|FG003|Overall Study|Lost to Follow-up|1|||
23342798|NCT02733185|64999704|FG000|Overall Study|Withdrawal by Subject|12|||
23342799|NCT02733185|64999705|FG001|Overall Study|Withdrawal by Subject|10|||
23342800|NCT02733185|64999706|FG002|Overall Study|Withdrawal by Subject|17|||
23342801|NCT02733185|64999707|FG003|Overall Study|Withdrawal by Subject|21|||
23342802|NCT02733185|64999704|FG000|Overall Study|Death|46|||
23342803|NCT02733185|64999705|FG001|Overall Study|Death|34|||
23342804|NCT02733185|64999706|FG002|Overall Study|Death|35|||
23342805|NCT02733185|64999707|FG003|Overall Study|Death|43|||
23342806|NCT02733185|64999704|FG000|Overall Study|Lost to Follow-up|17|||
23342807|NCT02733185|64999705|FG001|Overall Study|Lost to Follow-up|18|||
23342808|NCT02733185|64999706|FG002|Overall Study|Lost to Follow-up|16|||
23342809|NCT02733185|64999707|FG003|Overall Study|Lost to Follow-up|11|||
23342813|NCT02680834|64999709|FG000|Overall Study|Physician Decision|5|||
23342814|NCT02680834|64999710|FG001|Overall Study|Physician Decision|2|||
23342815|NCT02680834|64999709|FG000|Overall Study|Withdrawal by Subject|6|||
23342816|NCT02680834|64999710|FG001|Overall Study|Withdrawal by Subject|0|||
23342817|NCT02680834|64999709|FG000|Overall Study|Lost to Follow-up|0|||
23342818|NCT02680834|64999710|FG001|Overall Study|Lost to Follow-up|1|||
23342819|NCT01500187|64999711|FG000|Overall Study|Lost to Follow-up|6|||
23342820|NCT01500187|64999712|FG001|Overall Study|Lost to Follow-up|0|||
23342821|NCT01992653|64999713|FG000|Overall Study|Death|0|||
23342822|NCT01992653|64999714|FG001|Overall Study|Death|0|||
23342823|NCT01992653|64999715|FG002|Overall Study|Death|1|||
23342824|NCT01992653|64999716|FG003|Overall Study|Death|0|||
23342825|NCT01992653|64999717|FG004|Overall Study|Death|1|||
23342826|NCT01992653|64999718|FG005|Overall Study|Death|0|||
23342827|NCT01992653|64999719|FG006|Overall Study|Death|4|||
23342828|NCT01992653|64999720|FG007|Overall Study|Death|2|||
23342829|NCT01992653|64999713|FG000|Overall Study|Lost to Follow-up|0|||
23342830|NCT01992653|64999714|FG001|Overall Study|Lost to Follow-up|0|||
23342831|NCT01992653|64999715|FG002|Overall Study|Lost to Follow-up|0|||
23342832|NCT01992653|64999716|FG003|Overall Study|Lost to Follow-up|0|||
23342833|NCT01992653|64999717|FG004|Overall Study|Lost to Follow-up|0|||
23342834|NCT01992653|64999718|FG005|Overall Study|Lost to Follow-up|0|||
23342835|NCT01992653|64999719|FG006|Overall Study|Lost to Follow-up|0|||
23342836|NCT01992653|64999720|FG007|Overall Study|Lost to Follow-up|1|||
23342837|NCT01992653|64999713|FG000|Overall Study|Study Completed|0|||
23342838|NCT01992653|64999714|FG001|Overall Study|Study Completed|0|||
23342839|NCT01992653|64999715|FG002|Overall Study|Study Completed|0|||
23342840|NCT01992653|64999716|FG003|Overall Study|Study Completed|0|||
23342841|NCT01992653|64999717|FG004|Overall Study|Study Completed|0|||
23342842|NCT01992653|64999718|FG005|Overall Study|Study Completed|0|||
23342843|NCT01992653|64999719|FG006|Overall Study|Study Completed|0|||
23342844|NCT01992653|64999720|FG007|Overall Study|Study Completed|1|||
23342845|NCT01992653|64999713|FG000|Overall Study|Disease Progression|0|||
23342846|NCT01992653|64999714|FG001|Overall Study|Disease Progression|0|||
23342847|NCT01992653|64999715|FG002|Overall Study|Disease Progression|0|||
23783338|NCT03122535|66586624|FG001|Overall Study|Withdrawal by Subject|2|||
23783339|NCT03935880|66586625|FG000|Overall Study|Lost to Follow-up|0|||
23783340|NCT03935880|66586626|FG001|Overall Study|Lost to Follow-up|1|||
23783341|NCT00909610|66586627|FG000|Period: First Intervention|Adverse Event|0|||
23783342|NCT00909610|66586628|FG001|Period: First Intervention|Adverse Event|1|||
23783343|NCT00909610|66586627|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
23783344|NCT00909610|66586628|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
23783345|NCT00909610|66586627|FG000|Period: Second Intervention|Adverse Event|1|||
23783346|NCT00909610|66586628|FG001|Period: Second Intervention|Adverse Event|0|||
23783347|NCT00633594|66586629|FG000|Overall Study|Adverse Event|0|||
23783348|NCT00633594|66586630|FG001|Overall Study|Adverse Event|4|||
23783349|NCT00633594|66586631|FG002|Overall Study|Adverse Event|7|||
23783350|NCT00633594|66586629|FG000|Overall Study|Death|0|||
23783351|NCT00633594|66586630|FG001|Overall Study|Death|1|||
23783352|NCT00633594|66586631|FG002|Overall Study|Death|2|||
23783353|NCT00633594|66586629|FG000|Overall Study|Disease Progression|0|||
23342848|NCT01992653|64999716|FG003|Overall Study|Disease Progression|0|||
23342849|NCT01992653|64999717|FG004|Overall Study|Disease Progression|0|||
23342850|NCT01992653|64999718|FG005|Overall Study|Disease Progression|0|||
23783354|NCT00633594|66586630|FG001|Overall Study|Disease Progression|0|||
23783355|NCT00633594|66586631|FG002|Overall Study|Disease Progression|1|||
23342851|NCT01992653|64999719|FG006|Overall Study|Disease Progression|4|||
23342852|NCT01992653|64999720|FG007|Overall Study|Disease Progression|0|||
23342853|NCT03467763|64999725|FG000|Overall Study|Lost to Follow-up|1|||
23342854|NCT03467763|64999725|FG000|Overall Study|Protocol Violation|2|||
23342855|NCT04934189|64999726|FG000|Overall Study|Lost to Follow-up|4|||
23342856|NCT04934189|64999726|FG000|Overall Study|Withdrawal by Subject|17|||
23342857|NCT02783729|64999727|FG000|Overall Study|Lack of Efficacy|1|||
23342858|NCT02783729|64999728|FG001|Overall Study|Lack of Efficacy|0|||
23342859|NCT02783729|64999729|FG002|Overall Study|Lack of Efficacy|0|||
23783356|NCT01547286|66586639|FG000|Overall Study|Did not meet all eligibility criteria|1|||
23783357|NCT01547286|66586639|FG000|Overall Study|Physician Decision|1|||
23783358|NCT02832063|66586641|FG000|Overall Study|Adverse Event|2|||
23783359|NCT02832063|66586642|FG001|Overall Study|Adverse Event|1|||
23783360|NCT02832063|66586641|FG000|Overall Study|Physician Decision|5|||
23783361|NCT02832063|66586642|FG001|Overall Study|Physician Decision|7|||
23783362|NCT02832063|66586641|FG000|Overall Study|Lost to Follow-up|15|||
23783363|NCT02832063|66586642|FG001|Overall Study|Lost to Follow-up|8|||
23783364|NCT02832063|66586641|FG000|Overall Study|Withdrawal by Subject|10|||
23783365|NCT02832063|66586642|FG001|Overall Study|Withdrawal by Subject|21|||
23783366|NCT02832063|66586641|FG000|Overall Study|Other|2|||
23454614|NCT00762359|65407203|FG001|Overall Study|Protocol Violation|13|||
23783367|NCT02832063|66586642|FG001|Overall Study|Other|1|||
23783368|NCT00777023|66586646|FG000|Overall Study|Adverse Event|15|||
23783369|NCT00777023|66586647|FG001|Overall Study|Adverse Event|21|||
23783370|NCT00777023|66586648|FG002|Overall Study|Adverse Event|8|||
23783371|NCT00777023|66586646|FG000|Overall Study|Lack of Efficacy|1|||
23783372|NCT00777023|66586647|FG001|Overall Study|Lack of Efficacy|0|||
23783373|NCT00777023|66586648|FG002|Overall Study|Lack of Efficacy|14|||
23783374|NCT00777023|66586646|FG000|Overall Study|Protocol Violation|2|||
23783375|NCT00777023|66586647|FG001|Overall Study|Protocol Violation|1|||
23783376|NCT00777023|66586648|FG002|Overall Study|Protocol Violation|1|||
23783377|NCT00777023|66586646|FG000|Overall Study|Lost to Follow-up|2|||
23783378|NCT00777023|66586647|FG001|Overall Study|Lost to Follow-up|3|||
23783379|NCT00777023|66586648|FG002|Overall Study|Lost to Follow-up|3|||
23783380|NCT00777023|66586646|FG000|Overall Study|Death|0|||
23783381|NCT00777023|66586647|FG001|Overall Study|Death|1|||
23783382|NCT00777023|66586648|FG002|Overall Study|Death|0|||
23783383|NCT00777023|66586646|FG000|Overall Study|Withdrawal by Subject|7|||
23783384|NCT00777023|66586647|FG001|Overall Study|Withdrawal by Subject|7|||
23783385|NCT00777023|66586648|FG002|Overall Study|Withdrawal by Subject|8|||
23783386|NCT00777023|66586646|FG000|Overall Study|Missing data|1|||
23783387|NCT00777023|66586647|FG001|Overall Study|Missing data|1|||
23783388|NCT00777023|66586648|FG002|Overall Study|Missing data|0|||
23783389|NCT00777023|66586646|FG000|Overall Study|Reasons not specified|4|||
23783390|NCT00777023|66586647|FG001|Overall Study|Reasons not specified|4|||
23783391|NCT00777023|66586648|FG002|Overall Study|Reasons not specified|2|||
23783392|NCT00777023|66586646|FG000|Overall Study|Last dose date unknown|3|||
23783393|NCT00777023|66586647|FG001|Overall Study|Last dose date unknown|3|||
23783394|NCT00777023|66586648|FG002|Overall Study|Last dose date unknown|1|||
23783395|NCT02178787|66586649|FG000|Overall Study|Lost to Follow-up|1|||
23843764|NCT02294396|66808171|FG000|Overall Study|Protocol Deviation|3|||
23843765|NCT02294396|66808172|FG001|Overall Study|Protocol Deviation|2|||
23843766|NCT02294396|66808173|FG002|Overall Study|Protocol Deviation|2|||
23843767|NCT02294396|66808174|FG003|Overall Study|Protocol Deviation|1|||
23843768|NCT02294396|66808171|FG000|Overall Study|Miscellaneous|2|||
23843769|NCT02294396|66808172|FG001|Overall Study|Miscellaneous|0|||
23843770|NCT02294396|66808173|FG002|Overall Study|Miscellaneous|5|||
23843771|NCT02294396|66808174|FG003|Overall Study|Miscellaneous|2|||
23843772|NCT03881696|66808182|FG000|Overall Study|Adverse Event|2|||
23843773|NCT03881696|66808183|FG001|Overall Study|Adverse Event|0|||
23843774|NCT03881696|66808182|FG000|Overall Study|Withdrawal by Subject|2|||
23843775|NCT03881696|66808183|FG001|Overall Study|Withdrawal by Subject|0|||
23843776|NCT03881696|66808182|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
23843777|NCT03881696|66808183|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
23843778|NCT03881696|66808182|FG000|Overall Study|Failure to meet continuation criteria|1|||
23843779|NCT03881696|66808183|FG001|Overall Study|Failure to meet continuation criteria|0|||
23843780|NCT04432831|66808184|FG000|Overall Study|Withdrawal by Subject|24|||
23843781|NCT04432831|66808185|FG001|Overall Study|Withdrawal by Subject|28|||
23843782|NCT04432831|66808186|FG002|Overall Study|Withdrawal by Subject|21|||
23843783|NCT04432831|66808184|FG000|Overall Study|Death|23|||
23843784|NCT04432831|66808185|FG001|Overall Study|Death|23|||
23843785|NCT04432831|66808186|FG002|Overall Study|Death|17|||
23843786|NCT04432831|66808184|FG000|Overall Study|Lost to Follow-up|15|||
23454615|NCT00762359|65407202|FG000|Overall Study|Withdrawal by Subject|13|||
23454616|NCT00762359|65407203|FG001|Overall Study|Withdrawal by Subject|10|||
23454617|NCT00762359|65407202|FG000|Overall Study|Lack of Efficacy|0|||
23454618|NCT00762359|65407203|FG001|Overall Study|Lack of Efficacy|4|||
23783396|NCT02178787|66586650|FG001|Overall Study|Lost to Follow-up|0|||
23783397|NCT02178787|66586649|FG000|Overall Study|Withdrawal by Subject|0|||
23843787|NCT04432831|66808185|FG001|Overall Study|Lost to Follow-up|15|||
23342860|NCT02783729|64999730|FG003|Overall Study|Lack of Efficacy|0|||
23582512|NCT00991276|65862483|FG000|Third Intervention Period|Protocol Violation|1|||
23783398|NCT02178787|66586650|FG001|Overall Study|Withdrawal by Subject|2|||
23783399|NCT02178787|66586649|FG000|Overall Study|No TCD window|3|||
23783400|NCT02178787|66586650|FG001|Overall Study|No TCD window|7|||
23783401|NCT02178787|66586649|FG000|Overall Study|Physician Decision|1|||
23783402|NCT02178787|66586650|FG001|Overall Study|Physician Decision|0|||
23342861|NCT02783729|64999727|FG000|Overall Study|Adverse Event|2|||
23783403|NCT03238781|66586653|FG000|Overall Study|Adverse Event|1|||
23783404|NCT03238781|66586654|FG001|Overall Study|Adverse Event|1|||
23783405|NCT03238781|66586655|FG002|Overall Study|Adverse Event|2|||
23783406|NCT03238781|66586653|FG000|Overall Study|Lost to Follow-up|2|||
23783407|NCT03238781|66586654|FG001|Overall Study|Lost to Follow-up|1|||
23783408|NCT03238781|66586655|FG002|Overall Study|Lost to Follow-up|2|||
23783409|NCT03238781|66586653|FG000|Overall Study|Withdrawal by Subject|23|||
23783410|NCT03238781|66586654|FG001|Overall Study|Withdrawal by Subject|14|||
23783411|NCT03238781|66586655|FG002|Overall Study|Withdrawal by Subject|16|||
23783412|NCT03238781|66586653|FG000|Overall Study|Decision by sponsor|0|||
23783413|NCT03238781|66586654|FG001|Overall Study|Decision by sponsor|1|||
23783414|NCT03238781|66586655|FG002|Overall Study|Decision by sponsor|0|||
23783415|NCT03792477|66586656|FG000|Overall Study|Adverse Event|0|||
23783416|NCT03792477|66586657|FG001|Overall Study|Adverse Event|0|||
23783417|NCT03792477|66586658|FG002|Overall Study|Adverse Event|0|||
23783418|NCT03792477|66586659|FG003|Overall Study|Adverse Event|1|||
23783419|NCT03792477|66586660|FG004|Overall Study|Adverse Event|0|||
23783420|NCT03792477|66586656|FG000|Overall Study|Lost to Follow-up|0|||
23783421|NCT03792477|66586657|FG001|Overall Study|Lost to Follow-up|0|||
23783422|NCT03792477|66586658|FG002|Overall Study|Lost to Follow-up|2|||
23783423|NCT03792477|66586659|FG003|Overall Study|Lost to Follow-up|0|||
23783424|NCT03792477|66586660|FG004|Overall Study|Lost to Follow-up|0|||
23783425|NCT03792477|66586656|FG000|Overall Study|Other|0|||
23783426|NCT03792477|66586657|FG001|Overall Study|Other|0|||
23454619|NCT00762359|65407202|FG000|Overall Study|Institution closed|2|||
23454620|NCT00762359|65407203|FG001|Overall Study|Institution closed|3|||
23454621|NCT00762359|65407202|FG000|Overall Study|Physician Decision|2|||
23454622|NCT00762359|65407203|FG001|Overall Study|Physician Decision|3|||
23783427|NCT03792477|66586658|FG002|Overall Study|Other|0|||
23783428|NCT03792477|66586659|FG003|Overall Study|Other|0|||
23783429|NCT03792477|66586660|FG004|Overall Study|Other|1|||
23783430|NCT02566850|66586661|FG000|Overall Study|Protocol Violation|1|||
23783431|NCT02576938|66586663|FG000|Overall Study|Adverse Event|5|||
23783432|NCT02576938|66586664|FG001|Overall Study|Adverse Event|3|||
23783433|NCT02576938|66586665|FG002|Overall Study|Adverse Event|6|||
23454623|NCT00762359|65407202|FG000|Overall Study|Removal|0|||
23454624|NCT00762359|65407203|FG001|Overall Study|Removal|1|||
23454625|NCT00762359|65407202|FG000|Overall Study|Withdrew consent|1|||
23454626|NCT00762359|65407203|FG001|Overall Study|Withdrew consent|0|||
23454627|NCT02656017|65407204|FG000|Overall Study|Study burden|3|||
23454628|NCT02656017|65407205|FG001|Overall Study|Study burden|3|||
23454629|NCT02656017|65407204|FG000|Overall Study|Adverse Event|2|||
23454630|NCT02656017|65407205|FG001|Overall Study|Adverse Event|1|||
23454631|NCT02656017|65407204|FG000|Overall Study|Unable/unwilling to take study medication|2|||
23454632|NCT02656017|65407205|FG001|Overall Study|Unable/unwilling to take study medication|1|||
23454633|NCT02656017|65407204|FG000|Overall Study|Began Tolvaptan|1|||
23454634|NCT02656017|65407205|FG001|Overall Study|Began Tolvaptan|1|||
23843788|NCT04432831|66808186|FG002|Overall Study|Lost to Follow-up|12|||
23454635|NCT02656017|65407204|FG000|Overall Study|Withdrawal by Subject|1|||
23454636|NCT02656017|65407205|FG001|Overall Study|Withdrawal by Subject|0|||
23454637|NCT00528957|65407210|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
23454638|NCT00528957|65407211|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
23454639|NCT00528957|65407210|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
23843789|NCT04432831|66808184|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
23342862|NCT02783729|64999728|FG001|Overall Study|Adverse Event|6|||
23342863|NCT02783729|64999729|FG002|Overall Study|Adverse Event|2|||
23454640|NCT00528957|65407211|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
23454641|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
23454642|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
23454643|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
23454644|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
23454645|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
23454646|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
23454647|NCT00528957|65407210|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
23454648|NCT00528957|65407211|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
23454649|NCT00528957|65407210|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
23454650|NCT00528957|65407211|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
23705875|NCT01912768|66297650|FG000|Overall Study|Lost to Follow-up|2|||
23783434|NCT02576938|66586663|FG000|Overall Study|Protocol Violation|1|||
23783435|NCT02576938|66586664|FG001|Overall Study|Protocol Violation|1|||
23783436|NCT02576938|66586665|FG002|Overall Study|Protocol Violation|1|||
23783437|NCT02576938|66586663|FG000|Overall Study|Withdrawal by Subject|3|||
23783438|NCT02576938|66586664|FG001|Overall Study|Withdrawal by Subject|2|||
23783439|NCT02576938|66586665|FG002|Overall Study|Withdrawal by Subject|4|||
23783440|NCT02576938|66586663|FG000|Overall Study|Lack of Efficacy|9|||
23843790|NCT04432831|66808185|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
23783441|NCT02576938|66586664|FG001|Overall Study|Lack of Efficacy|4|||
23783442|NCT02576938|66586665|FG002|Overall Study|Lack of Efficacy|0|||
23783443|NCT02576938|66586663|FG000|Overall Study|Lost to Follow-up|2|||
23783444|NCT02576938|66586664|FG001|Overall Study|Lost to Follow-up|0|||
23783445|NCT02576938|66586665|FG002|Overall Study|Lost to Follow-up|1|||
23454651|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
23454652|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
23454653|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
23454654|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
23582513|NCT00991276|65862484|FG001|Third Intervention Period|Protocol Violation|0|||
23582514|NCT00991276|65862485|FG002|Third Intervention Period|Protocol Violation|0|||
23582515|NCT00991276|65862486|FG003|Third Intervention Period|Protocol Violation|0|||
23454655|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
23454656|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
23454657|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
23454658|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
23454659|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
23783446|NCT02576938|66586663|FG000|Overall Study|Physician Decision|0|||
23454660|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
23454661|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
23454662|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
23454663|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
23454664|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
23454665|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
23454666|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
23454667|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
23454668|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
23454669|NCT00770653|65407214|FG000|Overall Study|Adverse Event|13|||
23454670|NCT00770653|65407215|FG001|Overall Study|Adverse Event|5|||
23454671|NCT00770653|65407214|FG000|Overall Study|Protocol Violation|8|||
23454672|NCT00770653|65407215|FG001|Overall Study|Protocol Violation|6|||
23454673|NCT00770653|65407214|FG000|Overall Study|Withdrawal by Subject|4|||
23454674|NCT00770653|65407215|FG001|Overall Study|Withdrawal by Subject|7|||
23454675|NCT00770653|65407214|FG000|Overall Study|Lack of Compliance|1|||
23454676|NCT00770653|65407215|FG001|Overall Study|Lack of Compliance|4|||
23454677|NCT00770653|65407214|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
23454678|NCT00770653|65407215|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
23454679|NCT00770653|65407214|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
23454680|NCT00770653|65407215|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
23454681|NCT00770653|65407214|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
23454682|NCT00770653|65407215|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
23783447|NCT02576938|66586664|FG001|Overall Study|Physician Decision|1|||
23783448|NCT02576938|66586665|FG002|Overall Study|Physician Decision|0|||
23783449|NCT02576938|66586663|FG000|Overall Study|Met Exclusion Criteria|0|||
23783450|NCT02576938|66586664|FG001|Overall Study|Met Exclusion Criteria|1|||
23783451|NCT02576938|66586665|FG002|Overall Study|Met Exclusion Criteria|0|||
23783452|NCT00813592|66586666|FG000|Overall Study|Disease assessment was not completed per|2|||
23843791|NCT04432831|66808186|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
23454683|NCT00770653|65407214|FG000|Overall Study|Lost to Follow-up|1|||
23454684|NCT00770653|65407215|FG001|Overall Study|Lost to Follow-up|2|||
23454685|NCT00770653|65407214|FG000|Overall Study|Physician Decision|1|||
23454686|NCT00770653|65407215|FG001|Overall Study|Physician Decision|0|||
23454687|NCT02412306|65407216|FG000|Overall Study|Lost to Follow-up|0|||
23582516|NCT00991276|65862487|FG004|Third Intervention Period|Protocol Violation|0|||
23582517|NCT00991276|65862488|FG005|Third Intervention Period|Protocol Violation|0|||
23342864|NCT02783729|64999730|FG003|Overall Study|Adverse Event|3|||
23454688|NCT02412306|65407217|FG001|Overall Study|Lost to Follow-up|1|||
23454689|NCT02412306|65407218|FG002|Overall Study|Lost to Follow-up|0|||
23454690|NCT02412306|65407219|FG003|Overall Study|Lost to Follow-up|0|||
23454691|NCT02412306|65407220|FG004|Overall Study|Lost to Follow-up|0|||
23454692|NCT02412306|65407216|FG000|Overall Study|Withdrawal by Subject|0|||
23454693|NCT02412306|65407217|FG001|Overall Study|Withdrawal by Subject|0|||
23454694|NCT02412306|65407218|FG002|Overall Study|Withdrawal by Subject|1|||
23454695|NCT02412306|65407219|FG003|Overall Study|Withdrawal by Subject|0|||
23454696|NCT02412306|65407220|FG004|Overall Study|Withdrawal by Subject|0|||
23454697|NCT02412306|65407216|FG000|Overall Study|Death|5|||
23783453|NCT01415986|66586667|FG000|Overall Study|Lost to Follow-up|1|||
23783454|NCT04408794|66586671|FG000|Overall Study|Adverse Event|43|||
23783455|NCT04408794|66586671|FG000|Overall Study|Infrequent study drug usage|43|||
23783456|NCT04408794|66586671|FG000|Overall Study|Lack of Efficacy|61|||
23783457|NCT04408794|66586671|FG000|Overall Study|Lost to Follow-up|33|||
23843792|NCT04432831|66808184|FG000|Overall Study|Reason Not Specified|7|||
23582518|NCT00991276|65862483|FG000|Third Intervention Period|Other|0|||
23582519|NCT00991276|65862484|FG001|Third Intervention Period|Other|0|||
23783458|NCT04408794|66586671|FG000|Overall Study|Non-compliance|6|||
23783459|NCT04408794|66586671|FG000|Overall Study|Physician Decision|1|||
23783460|NCT04408794|66586671|FG000|Overall Study|Pregnancy|6|||
23454698|NCT02412306|65407217|FG001|Overall Study|Death|7|||
23454699|NCT02412306|65407218|FG002|Overall Study|Death|15|||
23454700|NCT02412306|65407219|FG003|Overall Study|Death|0|||
23454701|NCT02412306|65407220|FG004|Overall Study|Death|2|||
23454702|NCT00689390|65407221|FG000|Overall Study|Adverse Event|19|||
23454703|NCT00689390|65407222|FG001|Overall Study|Adverse Event|0|||
23454704|NCT00689390|65407221|FG000|Overall Study|Lost to Follow-up|179|||
23454705|NCT00689390|65407222|FG001|Overall Study|Lost to Follow-up|7|||
23454706|NCT00689390|65407221|FG000|Overall Study|Withdrawal by Subject|117|||
23454707|NCT00689390|65407222|FG001|Overall Study|Withdrawal by Subject|3|||
23454708|NCT00689390|65407221|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
23454709|NCT00689390|65407222|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
23454710|NCT00689390|65407221|FG000|Overall Study|Non-Compliance With Protocol|21|||
23454711|NCT00689390|65407222|FG001|Overall Study|Non-Compliance With Protocol|0|||
23582520|NCT00991276|65862485|FG002|Third Intervention Period|Other|0|||
23582521|NCT00991276|65862486|FG003|Third Intervention Period|Other|0|||
23783461|NCT04408794|66586671|FG000|Overall Study|Protocol Deviation|9|||
23783462|NCT04408794|66586671|FG000|Overall Study|Sheehan-STS Result|1|||
23783463|NCT04408794|66586671|FG000|Overall Study|Withdrawal by Subject|57|||
23783464|NCT04408794|66586671|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
23783465|NCT04408794|66586671|FG000|Overall Study|Never Treated Migraine|5|||
23783466|NCT02588339|66586672|FG000|Overall Study|Withdrawal by Subject|1|||
23783467|NCT02588339|66586672|FG000|Overall Study|GVHD Progression prior to treatment|2|||
23783468|NCT00985439|66586673|FG000|Overall Study|Adverse Event|0|||
23783469|NCT00985439|66586674|FG001|Overall Study|Adverse Event|0|||
23783470|NCT00985439|66586675|FG002|Overall Study|Adverse Event|1|||
23783471|NCT00985439|66586676|FG003|Overall Study|Adverse Event|0|||
23783472|NCT00463684|66586679|FG000|Overall Study|Withdrawal by Subject|1|||
23783473|NCT00463684|66586679|FG000|Overall Study|Lost to Follow-up|3|||
23783474|NCT01471353|66586680|FG000|Overall Study|remain on study|3|||
23783475|NCT02699463|66586682|FG000|Overall Study|Lost to Follow-up|11|||
23783476|NCT02699463|66586683|FG001|Overall Study|Lost to Follow-up|8|||
23783477|NCT02699463|66586682|FG000|Overall Study|Withdrawal by Subject|4|||
23783478|NCT02699463|66586683|FG001|Overall Study|Withdrawal by Subject|1|||
23783479|NCT02286739|66586686|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
23783480|NCT02286739|66586687|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
23342865|NCT02783729|64999727|FG000|Overall Study|Other|1|||
23342866|NCT02783729|64999728|FG001|Overall Study|Other|6|||
23342867|NCT02783729|64999729|FG002|Overall Study|Other|2|||
23342868|NCT02783729|64999730|FG003|Overall Study|Other|3|||
23342869|NCT02783729|64999727|FG000|Overall Study|Withdrawal by Subject|2|||
23342870|NCT02783729|64999728|FG001|Overall Study|Withdrawal by Subject|3|||
23342871|NCT02783729|64999729|FG002|Overall Study|Withdrawal by Subject|1|||
23342872|NCT02783729|64999730|FG003|Overall Study|Withdrawal by Subject|2|||
23342873|NCT02783729|64999727|FG000|Overall Study|Participant's choice|2|||
23342874|NCT02783729|64999728|FG001|Overall Study|Participant's choice|1|||
23342875|NCT02783729|64999729|FG002|Overall Study|Participant's choice|2|||
23342876|NCT02783729|64999730|FG003|Overall Study|Participant's choice|1|||
23342877|NCT02783729|64999727|FG000|Overall Study|Lost to Follow-up|2|||
23342878|NCT02783729|64999728|FG001|Overall Study|Lost to Follow-up|1|||
23342879|NCT02783729|64999729|FG002|Overall Study|Lost to Follow-up|1|||
23342880|NCT02783729|64999730|FG003|Overall Study|Lost to Follow-up|0|||
23342881|NCT00791661|64999731|FG000|7 Day Wash-out|Adverse Event|0|||
23342882|NCT00791661|64999732|FG001|7 Day Wash-out|Adverse Event|0|||
23342883|NCT00791661|64999733|FG002|7 Day Wash-out|Adverse Event|1|||
23342884|NCT00791661|64999731|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
23342885|NCT00791661|64999732|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
23342886|NCT00791661|64999733|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
23342887|NCT00381043|64999736|FG000|Overall Study|Lost to Follow-up|8|||
23342888|NCT00381043|64999737|FG001|Overall Study|Lost to Follow-up|6|||
23342889|NCT00381043|64999736|FG000|Overall Study|Withdrawal by Subject|3|||
23342890|NCT00381043|64999737|FG001|Overall Study|Withdrawal by Subject|1|||
23342891|NCT00381043|64999736|FG000|Overall Study|wanted more care|0|||
23342892|NCT00381043|64999737|FG001|Overall Study|wanted more care|1|||
23342893|NCT00381043|64999736|FG000|Overall Study|incarcerated|1|||
23342894|NCT00381043|64999737|FG001|Overall Study|incarcerated|0|||
23783481|NCT02286739|66586686|FG000|Overall Study|No Verasense type documented|0|||
23783482|NCT02286739|66586687|FG001|Overall Study|No Verasense type documented|23|||
23783483|NCT02286739|66586686|FG000|Overall Study|Adverse Event|1|||
23454712|NCT00689390|65407221|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23582522|NCT00991276|65862487|FG004|Third Intervention Period|Other|0|||
23342895|NCT04778059|64999738|FG000|Overall Study|Death|2|||
23342896|NCT04778059|64999739|FG001|Overall Study|Death|2|||
23582523|NCT00991276|65862488|FG005|Third Intervention Period|Other|1|||
23582524|NCT00991276|65862483|FG000|Third Intervention Period|Adverse Event|0|||
23582525|NCT00991276|65862484|FG001|Third Intervention Period|Adverse Event|0|||
23582526|NCT00991276|65862485|FG002|Third Intervention Period|Adverse Event|1|||
23582527|NCT00991276|65862486|FG003|Third Intervention Period|Adverse Event|0|||
23582528|NCT00991276|65862487|FG004|Third Intervention Period|Adverse Event|0|||
23582529|NCT00991276|65862488|FG005|Third Intervention Period|Adverse Event|0|||
23582530|NCT00991276|65862483|FG000|Third Intervention Period|Withdrawal by Subject|0|||
23582531|NCT00991276|65862484|FG001|Third Intervention Period|Withdrawal by Subject|0|||
23636849|NCT00568178|66053030|FG002|Double Blind Base Study|Physician Decision|0|||
23636850|NCT00568178|66053031|FG003|Double Blind Base Study|Physician Decision|1|||
23454713|NCT00689390|65407222|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23454714|NCT00689390|65407221|FG000|Overall Study|Administrative|37|||
23454715|NCT00689390|65407222|FG001|Overall Study|Administrative|0|||
23454716|NCT03525444|65407223|FG000|Overall Study|Adverse Event|0|||
23636851|NCT00568178|66053032|FG004|Double Blind Base Study|Physician Decision|0|||
23636852|NCT00568178|66053033|FG005|Double Blind Base Study|Physician Decision|0|||
23636853|NCT00568178|66053028|FG000|Double Blind Base Study|Protocol Violation|3|||
23636854|NCT00568178|66053029|FG001|Double Blind Base Study|Protocol Violation|2|||
23582532|NCT00991276|65862485|FG002|Third Intervention Period|Withdrawal by Subject|0|||
23582533|NCT00991276|65862486|FG003|Third Intervention Period|Withdrawal by Subject|1|||
23582534|NCT00991276|65862487|FG004|Third Intervention Period|Withdrawal by Subject|0|||
23582535|NCT00991276|65862488|FG005|Third Intervention Period|Withdrawal by Subject|0|||
23582536|NCT01456780|65862489|FG000|Overall Study|Lost to Follow-up|3|||
23636855|NCT00568178|66053030|FG002|Double Blind Base Study|Protocol Violation|0|||
23636856|NCT00568178|66053031|FG003|Double Blind Base Study|Protocol Violation|0|||
23636857|NCT00568178|66053032|FG004|Double Blind Base Study|Protocol Violation|0|||
23636858|NCT00568178|66053033|FG005|Double Blind Base Study|Protocol Violation|0|||
23636859|NCT00568178|66053028|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
23636860|NCT00568178|66053029|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
23636861|NCT00568178|66053030|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
23636862|NCT00568178|66053031|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
23636863|NCT00568178|66053032|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
23636864|NCT00568178|66053033|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
23636865|NCT00568178|66053028|FG000|Double Blind Base Study|Progressive Disease|0|||
23454717|NCT03525444|65407224|FG001|Overall Study|Adverse Event|1|||
23636866|NCT00568178|66053029|FG001|Double Blind Base Study|Progressive Disease|0|||
23636867|NCT00568178|66053030|FG002|Double Blind Base Study|Progressive Disease|0|||
23636868|NCT00568178|66053031|FG003|Double Blind Base Study|Progressive Disease|1|||
23843793|NCT04432831|66808185|FG001|Overall Study|Reason Not Specified|11|||
23843794|NCT04432831|66808186|FG002|Overall Study|Reason Not Specified|9|||
23843795|NCT04432831|66808184|FG000|Overall Study|Adverse Event|7|||
23843796|NCT04432831|66808185|FG001|Overall Study|Adverse Event|7|||
23843797|NCT04432831|66808186|FG002|Overall Study|Adverse Event|7|||
23843798|NCT04432831|66808184|FG000|Overall Study|Physician Decision|1|||
23843799|NCT04432831|66808185|FG001|Overall Study|Physician Decision|3|||
23843800|NCT04432831|66808186|FG002|Overall Study|Physician Decision|6|||
23454718|NCT03525444|65407223|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23454719|NCT03525444|65407224|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
23454720|NCT03525444|65407223|FG000|Overall Study|Other|0|||
23783484|NCT02286739|66586687|FG001|Overall Study|Adverse Event|2|||
23582537|NCT01456780|65862490|FG001|Overall Study|Lost to Follow-up|3|||
23582538|NCT01456780|65862491|FG002|Overall Study|Lost to Follow-up|0|||
23582539|NCT03523091|65862492|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
23783485|NCT02286739|66586686|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
23783486|NCT02286739|66586687|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
23783487|NCT00272779|66586698|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
23783488|NCT00272779|66586699|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
23783489|NCT00272779|66586698|FG000|Baseline Through Week 48|Death before Week 48|4|||
23783490|NCT00272779|66586699|FG001|Baseline Through Week 48|Death before Week 48|4|||
23783491|NCT00272779|66586698|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
23783492|NCT00272779|66586699|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
23783493|NCT00272779|66586698|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
23783494|NCT00272779|66586699|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
23783495|NCT00272779|66586698|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
23783496|NCT00272779|66586699|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
23783497|NCT00272779|66586698|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
23582540|NCT03523091|65862493|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
23843801|NCT04432831|66808184|FG000|Overall Study|Protocol Violation|1|||
23454721|NCT03525444|65407224|FG001|Overall Study|Other|1|||
23582541|NCT03523091|65862492|FG000|Overall Study|Withdrawal by Subject|0|||
23843802|NCT04432831|66808185|FG001|Overall Study|Protocol Violation|0|||
23843803|NCT04432831|66808186|FG002|Overall Study|Protocol Violation|2|||
23783498|NCT00272779|66586699|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
23783499|NCT00272779|66586698|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
23783500|NCT00272779|66586699|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
23783501|NCT00272779|66586698|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
23783502|NCT00272779|66586699|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
23843804|NCT04432831|66808184|FG000|Overall Study|Pregnancy|0|||
23843805|NCT04432831|66808185|FG001|Overall Study|Pregnancy|1|||
23843806|NCT04432831|66808186|FG002|Overall Study|Pregnancy|0|||
23843807|NCT04432831|66808184|FG000|Overall Study|Lack of Efficacy|0|||
23843808|NCT04432831|66808185|FG001|Overall Study|Lack of Efficacy|0|||
23342897|NCT04778059|64999740|FG002|Overall Study|Death|1|||
23636869|NCT00568178|66053032|FG004|Double Blind Base Study|Progressive Disease|0|||
23636870|NCT00568178|66053033|FG005|Double Blind Base Study|Progressive Disease|0|||
23636871|NCT00568178|66053028|FG000|Open Label Extension|Adverse Event|0|||
23636872|NCT00568178|66053029|FG001|Open Label Extension|Adverse Event|0|||
23636873|NCT00568178|66053030|FG002|Open Label Extension|Adverse Event|0|||
23636874|NCT00568178|66053031|FG003|Open Label Extension|Adverse Event|0|||
23636875|NCT00568178|66053032|FG004|Open Label Extension|Adverse Event|11|||
23636876|NCT00568178|66053033|FG005|Open Label Extension|Adverse Event|8|||
23636877|NCT00568178|66053028|FG000|Open Label Extension|Protocol Violation|0|||
23636878|NCT00568178|66053029|FG001|Open Label Extension|Protocol Violation|0|||
23636879|NCT00568178|66053030|FG002|Open Label Extension|Protocol Violation|0|||
23636880|NCT00568178|66053031|FG003|Open Label Extension|Protocol Violation|0|||
23636881|NCT00568178|66053032|FG004|Open Label Extension|Protocol Violation|1|||
23636882|NCT00568178|66053033|FG005|Open Label Extension|Protocol Violation|0|||
23783503|NCT00272779|66586698|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
23783504|NCT00272779|66586699|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
23783505|NCT00272779|66586698|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
23783506|NCT00272779|66586699|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
23783507|NCT00272779|66586698|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
23783508|NCT00272779|66586699|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
23783509|NCT00272779|66586698|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
23783510|NCT00272779|66586699|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
23783511|NCT00272779|66586698|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
23783512|NCT00272779|66586699|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
23783513|NCT00272779|66586698|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
23783514|NCT00272779|66586699|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
23783515|NCT00272779|66586698|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
23783516|NCT00272779|66586699|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
23783517|NCT00272779|66586698|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
23783518|NCT00272779|66586699|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
23783519|NCT00272779|66586698|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
23783520|NCT00272779|66586699|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
23783521|NCT00272779|66586698|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
23783522|NCT00272779|66586699|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
23783523|NCT00272779|66586698|FG000|Baseline Through Week 48|Continuing treatment|385|||
23783524|NCT00272779|66586699|FG001|Baseline Through Week 48|Continuing treatment|368|||
23783525|NCT00272779|66586698|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
23783526|NCT00272779|66586699|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
23783527|NCT00272779|66586698|FG000|Baseline Through Week 48|Never treated|2|||
23783528|NCT00272779|66586699|FG001|Baseline Through Week 48|Never treated|3|||
23783529|NCT00272779|66586698|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
23783530|NCT00272779|66586699|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
23783531|NCT00272779|66586698|FG000|Baseline Through Week 96|Death before Week 96|6|||
23783532|NCT00272779|66586699|FG001|Baseline Through Week 96|Death before Week 96|5|||
23783533|NCT00272779|66586698|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
23783534|NCT00272779|66586699|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
23783535|NCT00272779|66586698|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
23783536|NCT00272779|66586699|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
23783537|NCT00272779|66586698|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
23843809|NCT04432831|66808186|FG002|Overall Study|Lack of Efficacy|2|||
23843810|NCT03005327|66808187|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23636883|NCT00568178|66053028|FG000|Open Label Extension|Lost to Follow-up|0|||
23636884|NCT00568178|66053029|FG001|Open Label Extension|Lost to Follow-up|0|||
23636885|NCT00568178|66053030|FG002|Open Label Extension|Lost to Follow-up|0|||
23636886|NCT00568178|66053031|FG003|Open Label Extension|Lost to Follow-up|0|||
23636887|NCT00568178|66053032|FG004|Open Label Extension|Lost to Follow-up|6|||
23843811|NCT03005327|66808188|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23843812|NCT03005327|66808189|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
23843813|NCT03005327|66808190|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23843814|NCT03005327|66808187|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23843815|NCT03005327|66808188|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23843816|NCT03005327|66808189|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23843817|NCT03005327|66808190|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23843818|NCT03169881|66808191|FG000|Overall Study|Incomplete Follow-up|10|||
23843819|NCT03169881|66808192|FG001|Overall Study|Incomplete Follow-up|15|||
23636888|NCT00568178|66053033|FG005|Open Label Extension|Lost to Follow-up|11|||
23636889|NCT00568178|66053028|FG000|Open Label Extension|Physician Decision|0|||
23843820|NCT03169881|66808191|FG000|Overall Study|Lost to Follow-up|18|||
23843821|NCT03169881|66808192|FG001|Overall Study|Lost to Follow-up|20|||
23582542|NCT03523091|65862493|FG001|Overall Study|Withdrawal by Subject|3|||
23636890|NCT00568178|66053029|FG001|Open Label Extension|Physician Decision|0|||
23636891|NCT00568178|66053030|FG002|Open Label Extension|Physician Decision|0|||
23636892|NCT00568178|66053031|FG003|Open Label Extension|Physician Decision|0|||
23636893|NCT00568178|66053032|FG004|Open Label Extension|Physician Decision|9|||
23636894|NCT00568178|66053033|FG005|Open Label Extension|Physician Decision|8|||
23636895|NCT00568178|66053028|FG000|Open Label Extension|Pregnancy|0|||
23636896|NCT00568178|66053029|FG001|Open Label Extension|Pregnancy|0|||
23636897|NCT00568178|66053030|FG002|Open Label Extension|Pregnancy|0|||
23636898|NCT00568178|66053031|FG003|Open Label Extension|Pregnancy|0|||
23636899|NCT00568178|66053032|FG004|Open Label Extension|Pregnancy|0|||
23636900|NCT00568178|66053033|FG005|Open Label Extension|Pregnancy|1|||
23636901|NCT00568178|66053028|FG000|Open Label Extension|Progressive Disease|0|||
23636902|NCT00568178|66053029|FG001|Open Label Extension|Progressive Disease|0|||
23636903|NCT00568178|66053030|FG002|Open Label Extension|Progressive Disease|0|||
23636904|NCT00568178|66053031|FG003|Open Label Extension|Progressive Disease|0|||
23636905|NCT00568178|66053032|FG004|Open Label Extension|Progressive Disease|3|||
23636906|NCT00568178|66053033|FG005|Open Label Extension|Progressive Disease|1|||
23636907|NCT00568178|66053028|FG000|Open Label Extension|Termination of Trial|0|||
23582543|NCT03523091|65862492|FG000|Overall Study|Increase Botox dose|0|||
23582544|NCT03523091|65862493|FG001|Overall Study|Increase Botox dose|1|||
23636908|NCT00568178|66053029|FG001|Open Label Extension|Termination of Trial|0|||
23636909|NCT00568178|66053030|FG002|Open Label Extension|Termination of Trial|0|||
23636910|NCT00568178|66053031|FG003|Open Label Extension|Termination of Trial|0|||
23636911|NCT00568178|66053032|FG004|Open Label Extension|Termination of Trial|45|||
23636912|NCT00568178|66053033|FG005|Open Label Extension|Termination of Trial|47|||
23636913|NCT00568178|66053028|FG000|Open Label Extension|Withdrawal by Subject|0|||
23636914|NCT00568178|66053029|FG001|Open Label Extension|Withdrawal by Subject|0|||
23636915|NCT00568178|66053030|FG002|Open Label Extension|Withdrawal by Subject|0|||
23636916|NCT00568178|66053031|FG003|Open Label Extension|Withdrawal by Subject|0|||
23636917|NCT00568178|66053032|FG004|Open Label Extension|Withdrawal by Subject|4|||
23636918|NCT00568178|66053033|FG005|Open Label Extension|Withdrawal by Subject|4|||
23636919|NCT02232243|66053034|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
23783538|NCT00272779|66586699|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
23783539|NCT00272779|66586698|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
23783540|NCT00272779|66586699|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
23783541|NCT00272779|66586698|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
23783542|NCT00272779|66586699|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
23783543|NCT00272779|66586698|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
23783544|NCT00272779|66586699|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
23783545|NCT00272779|66586698|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
23342898|NCT04778059|64999741|FG003|Overall Study|Death|1|||
23582545|NCT02095158|65862494|FG000|Overall Study|Adverse Event|14|||
23582546|NCT02095158|65862494|FG000|Overall Study|Lack of Efficacy|3|||
23582547|NCT02095158|65862494|FG000|Overall Study|Pregnancy|1|||
23582548|NCT02095158|65862494|FG000|Overall Study|Lost to Follow-up|20|||
23582549|NCT02095158|65862494|FG000|Overall Study|Personal Reasons|35|||
23582550|NCT02095158|65862494|FG000|Overall Study|Protocol Violation|1|||
23582551|NCT02095158|65862494|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23636920|NCT02232243|66053035|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
23636921|NCT02232243|66053036|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
23636922|NCT02001064|66053037|FG000|Overall Study|Withdrawal by Subject|2|||
23636923|NCT02001064|66053038|FG001|Overall Study|Withdrawal by Subject|1|||
23636924|NCT00515671|66053039|FG000|Overall Study|Lost to Follow-up|13|||
23636925|NCT00515671|66053040|FG001|Overall Study|Lost to Follow-up|10|||
23636926|NCT00515671|66053039|FG000|Overall Study|Withdrawal by Subject|3|||
23636927|NCT00515671|66053040|FG001|Overall Study|Withdrawal by Subject|5|||
23636928|NCT00515671|66053039|FG000|Overall Study|incarcerated|1|||
23636929|NCT00515671|66053040|FG001|Overall Study|incarcerated|2|||
23582552|NCT02974010|65862495|FG000|Overall Study|Lost to Follow-up|3|||
23636930|NCT02546921|66053041|FG000|Overall Study|Adverse Event|0|||
23636931|NCT02546921|66053042|FG001|Overall Study|Adverse Event|5|||
23636932|NCT02546921|66053043|FG002|Overall Study|Adverse Event|2|||
23636933|NCT02546921|66053044|FG003|Overall Study|Adverse Event|0|||
23636934|NCT02546921|66053045|FG004|Overall Study|Adverse Event|0|||
23636935|NCT02546921|66053046|FG005|Overall Study|Adverse Event|0|||
23636936|NCT02546921|66053047|FG006|Overall Study|Adverse Event|0|||
23636937|NCT02546921|66053041|FG000|Overall Study|Evidence of Disease Progression|1|||
23636938|NCT02546921|66053042|FG001|Overall Study|Evidence of Disease Progression|0|||
23636939|NCT02546921|66053043|FG002|Overall Study|Evidence of Disease Progression|0|||
23636940|NCT02546921|66053044|FG003|Overall Study|Evidence of Disease Progression|0|||
23636941|NCT02546921|66053045|FG004|Overall Study|Evidence of Disease Progression|1|||
23783546|NCT00272779|66586699|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
23454722|NCT03370276|65407225|FG000|Overall Study|Death|0|||
23454723|NCT03370276|65407226|FG001|Overall Study|Death|2|||
23454724|NCT03370276|65407227|FG002|Overall Study|Death|5|||
23454725|NCT01751061|65407231|FG000|Overall Study|Death|1|||
23454726|NCT01751061|65407232|FG001|Overall Study|Death|0|||
23454727|NCT01751061|65407231|FG000|Overall Study|patient death|5|||
23454728|NCT01751061|65407232|FG001|Overall Study|patient death|0|||
23454729|NCT01751061|65407231|FG000|Overall Study|Lost to Follow-up|40|||
23454730|NCT01751061|65407232|FG001|Overall Study|Lost to Follow-up|25|||
23454731|NCT01751061|65407231|FG000|Overall Study|patient regained decisional capacity|4|||
23454732|NCT01751061|65407232|FG001|Overall Study|patient regained decisional capacity|8|||
23454733|NCT01751061|65407231|FG000|Overall Study|Withdrawal by Subject|4|||
23454734|NCT01751061|65407232|FG001|Overall Study|Withdrawal by Subject|1|||
23454735|NCT01751061|65407231|FG000|Overall Study|Physician Decision|2|||
23454736|NCT01751061|65407232|FG001|Overall Study|Physician Decision|0|||
23454737|NCT01908426|65407233|FG000|Overall Study|Adverse Event|98|||
23454738|NCT01908426|65407234|FG001|Overall Study|Adverse Event|11|||
23454739|NCT01908426|65407233|FG000|Overall Study|Clinical Deterioration|72|||
23454740|NCT01908426|65407234|FG001|Overall Study|Clinical Deterioration|38|||
23454741|NCT01908426|65407233|FG000|Overall Study|Lack of Efficacy|3|||
23454742|NCT01908426|65407234|FG001|Overall Study|Lack of Efficacy|0|||
23454743|NCT01908426|65407233|FG000|Overall Study|Lost to Follow-up|0|||
23454744|NCT01908426|65407234|FG001|Overall Study|Lost to Follow-up|1|||
23454745|NCT01908426|65407233|FG000|Overall Study|Physician Decision|3|||
23454746|NCT01908426|65407234|FG001|Overall Study|Physician Decision|3|||
23454747|NCT01908426|65407233|FG000|Overall Study|Withdrawal by Subject|11|||
23454748|NCT01908426|65407234|FG001|Overall Study|Withdrawal by Subject|6|||
23454749|NCT01908426|65407233|FG000|Overall Study|Progressive Disease|206|||
23454750|NCT01908426|65407234|FG001|Overall Study|Progressive Disease|152|||
23454751|NCT01908426|65407233|FG000|Overall Study|Protocol Violation|1|||
23454752|NCT01908426|65407234|FG001|Overall Study|Protocol Violation|0|||
23454753|NCT01908426|65407233|FG000|Overall Study|No Study Treatment Given|3|||
23454754|NCT01908426|65407234|FG001|Overall Study|No Study Treatment Given|0|||
23454755|NCT05362487|65407235|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
23454756|NCT03001557|65407236|FG000|Core Phase|Randomized but not treated|0|||
23454757|NCT03001557|65407237|FG001|Core Phase|Randomized but not treated|0|||
23454758|NCT03001557|65407238|FG002|Core Phase|Randomized but not treated|1|||
23454759|NCT03001557|65407239|FG003|Core Phase|Randomized but not treated|0|||
23783547|NCT00272779|66586698|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
23783548|NCT00272779|66586699|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
23783549|NCT00272779|66586698|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
23783550|NCT00272779|66586699|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
23783551|NCT00272779|66586698|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
23783552|NCT00272779|66586699|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
23783553|NCT00272779|66586698|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
23783554|NCT00272779|66586699|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
23783555|NCT00272779|66586698|FG000|Baseline Through Week 96|Never treated|2|||
23783556|NCT00272779|66586699|FG001|Baseline Through Week 96|Never treated|3|||
23783557|NCT00272779|66586698|FG000|Baseline Through Week 96|Continuing on treatment|61|||
23783558|NCT00272779|66586699|FG001|Baseline Through Week 96|Continuing on treatment|38|||
23783559|NCT02378935|66586700|FG000|Overall Study|Lack of Efficacy|10|||
23783560|NCT02378935|66586701|FG001|Overall Study|Lack of Efficacy|0|||
23783561|NCT02378935|66586702|FG002|Overall Study|Lack of Efficacy|2|||
23783562|NCT02378935|66586703|FG003|Overall Study|Lack of Efficacy|6|||
23783563|NCT02378935|66586704|FG004|Overall Study|Lack of Efficacy|0|||
23783564|NCT02378935|66586705|FG005|Overall Study|Lack of Efficacy|0|||
23342899|NCT04778059|64999742|FG004|Overall Study|Death|1|||
23454760|NCT03001557|65407240|FG004|Core Phase|Randomized but not treated|0|||
23454761|NCT03001557|65407241|FG005|Core Phase|Randomized but not treated|0|||
23636942|NCT02546921|66053046|FG005|Overall Study|Evidence of Disease Progression|0|||
23783565|NCT02378935|66586706|FG006|Overall Study|Lack of Efficacy|0|||
23454762|NCT03001557|65407242|FG006|Core Phase|Randomized but not treated|0|||
23454763|NCT03001557|65407243|FG007|Core Phase|Randomized but not treated|0|||
23454764|NCT03001557|65407236|FG000|Extension Phase|Adverse Event|0|||
23342900|NCT04778059|64999738|FG000|Overall Study|Lost to Follow-up|0|||
23342901|NCT04778059|64999739|FG001|Overall Study|Lost to Follow-up|0|||
23342902|NCT04778059|64999740|FG002|Overall Study|Lost to Follow-up|0|||
23342903|NCT04778059|64999741|FG003|Overall Study|Lost to Follow-up|0|||
23342904|NCT04778059|64999742|FG004|Overall Study|Lost to Follow-up|1|||
23342905|NCT04778059|64999738|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342906|NCT04778059|64999739|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342907|NCT04778059|64999740|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342908|NCT04778059|64999741|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342909|NCT04778059|64999742|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
23636943|NCT02546921|66053047|FG006|Overall Study|Evidence of Disease Progression|0|||
23636944|NCT02546921|66053041|FG000|Overall Study|Patient Choice|0|||
23636945|NCT02546921|66053042|FG001|Overall Study|Patient Choice|1|||
23636946|NCT02546921|66053043|FG002|Overall Study|Patient Choice|0|||
23843822|NCT03169881|66808191|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
23843823|NCT03169881|66808192|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
23582553|NCT02974010|65862496|FG001|Overall Study|Lost to Follow-up|1|||
23582554|NCT02974010|65862497|FG002|Overall Study|Lost to Follow-up|0|||
23582555|NCT02974010|65862498|FG003|Overall Study|Lost to Follow-up|0|||
23582556|NCT02974010|65862495|FG000|Overall Study|Withdrawal by Subject|2|||
23582557|NCT02974010|65862496|FG001|Overall Study|Withdrawal by Subject|1|||
23582558|NCT02974010|65862497|FG002|Overall Study|Withdrawal by Subject|0|||
23582559|NCT02974010|65862498|FG003|Overall Study|Withdrawal by Subject|0|||
23582560|NCT02974010|65862495|FG000|Overall Study|Adverse Event|0|||
23636947|NCT02546921|66053044|FG003|Overall Study|Patient Choice|0|||
23843824|NCT05217641|66808193|FG000|Overall Study|Lost to Follow-up|1|||
23843825|NCT05217641|66808194|FG001|Overall Study|Lost to Follow-up|1|||
23843826|NCT05217641|66808195|FG002|Overall Study|Lost to Follow-up|0|||
23342910|NCT02637895|64999745|FG000|Overall Study|Lost to Follow-up|4|||
23843827|NCT05217641|66808196|FG003|Overall Study|Lost to Follow-up|1|||
23843828|NCT05217641|66808197|FG004|Overall Study|Lost to Follow-up|1|||
23843829|NCT05217641|66808198|FG005|Overall Study|Lost to Follow-up|0|||
23843830|NCT05217641|66808193|FG000|Overall Study|Withdrawal by Subject|0|||
23843831|NCT05217641|66808194|FG001|Overall Study|Withdrawal by Subject|0|||
23843832|NCT05217641|66808195|FG002|Overall Study|Withdrawal by Subject|0|||
23843833|NCT05217641|66808196|FG003|Overall Study|Withdrawal by Subject|3|||
23843834|NCT05217641|66808197|FG004|Overall Study|Withdrawal by Subject|1|||
23843835|NCT05217641|66808198|FG005|Overall Study|Withdrawal by Subject|0|||
23843836|NCT05217641|66808193|FG000|Overall Study|Other: participant did not specify reason|0|||
23843837|NCT05217641|66808194|FG001|Overall Study|Other: participant did not specify reason|0|||
23843838|NCT05217641|66808195|FG002|Overall Study|Other: participant did not specify reason|0|||
23843839|NCT05217641|66808196|FG003|Overall Study|Other: participant did not specify reason|0|||
23843840|NCT05217641|66808197|FG004|Overall Study|Other: participant did not specify reason|1|||
23342911|NCT02637895|64999746|FG001|Overall Study|Lost to Follow-up|0|||
23582561|NCT02974010|65862496|FG001|Overall Study|Adverse Event|1|||
23636948|NCT02546921|66053045|FG004|Overall Study|Patient Choice|0|||
23636949|NCT02546921|66053046|FG005|Overall Study|Patient Choice|1|||
23783566|NCT02378935|66586700|FG000|Overall Study|Death|0|||
23783567|NCT02378935|66586701|FG001|Overall Study|Death|0|||
23783568|NCT02378935|66586702|FG002|Overall Study|Death|1|||
23783569|NCT02378935|66586703|FG003|Overall Study|Death|0|||
23783570|NCT02378935|66586704|FG004|Overall Study|Death|0|||
23783571|NCT02378935|66586705|FG005|Overall Study|Death|0|||
23783572|NCT02378935|66586706|FG006|Overall Study|Death|0|||
23783573|NCT00723710|66586707|FG000|Overall Study|Disease progression|48|||
23783574|NCT00723710|66586707|FG000|Overall Study|Adverse Event|88|||
23783575|NCT00723710|66586707|FG000|Overall Study|Withdrawal by Subject|36|||
23783576|NCT00723710|66586707|FG000|Overall Study|Physician Decision|2|||
23783577|NCT01376167|66586714|FG000|Overall Study|Lost to Follow-up|2|||
23783578|NCT01376167|66586715|FG001|Overall Study|Lost to Follow-up|4|||
23783579|NCT01376167|66586716|FG002|Overall Study|Lost to Follow-up|2|||
23783580|NCT01376167|66586714|FG000|Overall Study|Physician Decision|1|||
23783581|NCT01376167|66586715|FG001|Overall Study|Physician Decision|1|||
23783582|NCT01376167|66586716|FG002|Overall Study|Physician Decision|0|||
23783583|NCT01376167|66586714|FG000|Overall Study|Withdrawal by Subject|1|||
23783584|NCT01376167|66586715|FG001|Overall Study|Withdrawal by Subject|5|||
23783585|NCT01376167|66586716|FG002|Overall Study|Withdrawal by Subject|4|||
23783586|NCT03818581|66586719|FG000|Overall Study|Adverse Event|1|||
23783587|NCT03818581|66586720|FG001|Overall Study|Adverse Event|0|||
23783588|NCT03818581|66586721|FG002|Overall Study|Adverse Event|0|||
23843841|NCT05217641|66808198|FG005|Overall Study|Other: participant did not specify reason|0|||
23843842|NCT05217641|66808193|FG000|Overall Study|Extended Follow up|1|||
23582562|NCT02974010|65862497|FG002|Overall Study|Adverse Event|0|||
23783589|NCT03818581|66586722|FG003|Overall Study|Adverse Event|0|||
23843843|NCT05217641|66808194|FG001|Overall Study|Extended Follow up|1|||
23843844|NCT05217641|66808195|FG002|Overall Study|Extended Follow up|0|||
23843845|NCT05217641|66808196|FG003|Overall Study|Extended Follow up|0|||
23843846|NCT05217641|66808197|FG004|Overall Study|Extended Follow up|1|||
23843847|NCT05217641|66808198|FG005|Overall Study|Extended Follow up|0|||
23843848|NCT04815031|66808199|FG000|Overall Study|No adverse event information (missing information)|33|||
23843849|NCT03218826|66808204|FG000|Overall Study|Non-compliance with protocol|1|||
23843850|NCT03218826|66808205|FG001|Overall Study|Non-compliance with protocol|0|||
23843851|NCT03218826|66808206|FG002|Overall Study|Non-compliance with protocol|2|||
23843852|NCT03218826|66808207|FG003|Overall Study|Non-compliance with protocol|1|||
23843853|NCT03218826|66808208|FG004|Overall Study|Non-compliance with protocol|1|||
23843854|NCT04687072|66808209|FG000|Overall Study|Adverse Event|2|||
23843855|NCT04687072|66808210|FG001|Overall Study|Adverse Event|0|||
23843856|NCT04687072|66808209|FG000|Overall Study|Death|1|||
23843857|NCT04687072|66808210|FG001|Overall Study|Death|0|||
23843858|NCT04687072|66808209|FG000|Overall Study|Lack of Efficacy|2|||
23843859|NCT04687072|66808210|FG001|Overall Study|Lack of Efficacy|1|||
23843860|NCT04687072|66808209|FG000|Overall Study|Physician Decision|1|||
23843861|NCT04687072|66808210|FG001|Overall Study|Physician Decision|0|||
23843862|NCT04687072|66808209|FG000|Overall Study|Pregnancy|1|||
23843863|NCT04687072|66808210|FG001|Overall Study|Pregnancy|0|||
23843864|NCT04687072|66808209|FG000|Overall Study|Requires Prohibited Medication|2|||
23843865|NCT04687072|66808210|FG001|Overall Study|Requires Prohibited Medication|0|||
23843866|NCT04687072|66808209|FG000|Overall Study|Withdrawal of Consent|11|||
23843867|NCT04687072|66808210|FG001|Overall Study|Withdrawal of Consent|6|||
23843868|NCT04687072|66808209|FG000|Overall Study|Miscellaneous|4|||
23843869|NCT04687072|66808210|FG001|Overall Study|Miscellaneous|1|||
23843870|NCT05129137|66808211|FG000|Second Period|Adverse Event|1|||
23843871|NCT05129137|66808212|FG001|Second Period|Adverse Event|0|||
23843872|NCT05129137|66808213|FG002|Second Period|Adverse Event|0|||
23843873|NCT05129137|66808214|FG003|Second Period|Adverse Event|0|||
23843874|NCT05129137|66808211|FG000|Second Period|Protocol Violation|0|||
23843875|NCT05129137|66808212|FG001|Second Period|Protocol Violation|0|||
23843876|NCT05129137|66808213|FG002|Second Period|Protocol Violation|0|||
23843877|NCT05129137|66808214|FG003|Second Period|Protocol Violation|1|||
23843878|NCT05129137|66808211|FG000|Third Period|Protocol Violation|0|||
23843879|NCT05129137|66808212|FG001|Third Period|Protocol Violation|0|||
23843880|NCT05129137|66808213|FG002|Third Period|Protocol Violation|0|||
23843881|NCT05129137|66808214|FG003|Third Period|Protocol Violation|1|||
23843882|NCT05129137|66808211|FG000|Forth Period|Protocol Violation|0|||
23843883|NCT05129137|66808212|FG001|Forth Period|Protocol Violation|1|||
23843884|NCT05129137|66808213|FG002|Forth Period|Protocol Violation|0|||
23843885|NCT05129137|66808214|FG003|Forth Period|Protocol Violation|0|||
23843886|NCT05129137|66808211|FG000|Forth Period|Withdrawal by Subject|0|||
23843887|NCT05129137|66808212|FG001|Forth Period|Withdrawal by Subject|0|||
23843888|NCT05129137|66808213|FG002|Forth Period|Withdrawal by Subject|1|||
23843889|NCT05129137|66808214|FG003|Forth Period|Withdrawal by Subject|0|||
23843890|NCT03261674|66808215|FG000|Overall Study|Lost to Follow-up|6|||
23843891|NCT03261674|66808216|FG001|Overall Study|Lost to Follow-up|7|||
23843892|NCT03261674|66808215|FG000|Overall Study|Protocol Violation|1|||
23843893|NCT03261674|66808216|FG001|Overall Study|Protocol Violation|4|||
23843894|NCT03261674|66808215|FG000|Overall Study|Withdrawal by Subject|1|||
23843895|NCT03261674|66808216|FG001|Overall Study|Withdrawal by Subject|4|||
23843896|NCT03261674|66808215|FG000|Overall Study|Physician Decision|1|||
23843897|NCT03261674|66808216|FG001|Overall Study|Physician Decision|0|||
23843898|NCT04720911|66808878|FG000|Overall Study|Withdrawal by Subject|0|||
23843899|NCT04720911|66808879|FG001|Overall Study|Withdrawal by Subject|1|||
23843900|NCT04720911|66808880|FG002|Overall Study|Withdrawal by Subject|0|||
23843901|NCT05238025|66808886|FG000|Overall Study|Adverse Event|2|||
23843902|NCT05238025|66808887|FG001|Overall Study|Adverse Event|2|||
23843903|NCT05238025|66808886|FG000|Overall Study|Lost to Follow-up|334|||
23843904|NCT05238025|66808887|FG001|Overall Study|Lost to Follow-up|339|||
23843905|NCT05238025|66808886|FG000|Overall Study|Withdrawal by Subject|203|||
23843906|NCT05238025|66808887|FG001|Overall Study|Withdrawal by Subject|222|||
23843907|NCT05238025|66808886|FG000|Overall Study|Physician Decision|20|||
23843908|NCT05238025|66808887|FG001|Overall Study|Physician Decision|8|||
23582563|NCT02974010|65862498|FG003|Overall Study|Adverse Event|0|||
23843909|NCT05238025|66808886|FG000|Overall Study|Protocol Violation|6|||
23843910|NCT05238025|66808887|FG001|Overall Study|Protocol Violation|2|||
23843911|NCT05238025|66808886|FG000|Overall Study|Death|38|||
23843912|NCT05238025|66808887|FG001|Overall Study|Death|32|||
23843913|NCT05238025|66808886|FG000|Overall Study|Study terminated by Sponsor|6358|||
23582564|NCT02974010|65862495|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
23843914|NCT05238025|66808887|FG001|Overall Study|Study terminated by Sponsor|6358|||
23843915|NCT05238025|66808886|FG000|Overall Study|Other Reason|669|||
23843916|NCT05238025|66808887|FG001|Overall Study|Other Reason|690|||
23843917|NCT01940900|66808888|FG000|Overall Study|Physician Decision|4|||
23843918|NCT01940900|66808889|FG001|Overall Study|Physician Decision|0|||
23843919|NCT01940900|66808888|FG000|Overall Study|Adverse Event|10|||
23843920|NCT01940900|66808889|FG001|Overall Study|Adverse Event|15|||
23843921|NCT01940900|66808888|FG000|Overall Study|Withdrawal by Subject|11|||
23843922|NCT01940900|66808889|FG001|Overall Study|Withdrawal by Subject|15|||
23342912|NCT02637895|64999745|FG000|Overall Study|Protocol Violation|0|||
23342913|NCT02637895|64999746|FG001|Overall Study|Protocol Violation|1|||
23342914|NCT02637895|64999745|FG000|Overall Study|Lack of Efficacy|1|||
23342915|NCT02637895|64999746|FG001|Overall Study|Lack of Efficacy|0|||
23342916|NCT02637895|64999745|FG000|Overall Study|Withdrawal by Subject|1|||
23342917|NCT02637895|64999746|FG001|Overall Study|Withdrawal by Subject|1|||
23342918|NCT02637895|64999745|FG000|Overall Study|Abnormal baseline lab|0|||
23342919|NCT02637895|64999746|FG001|Overall Study|Abnormal baseline lab|1|||
23342920|NCT03614078|64999751|FG000|Overall Study|Withdrawal by Subject|2|||
23342921|NCT03614078|64999752|FG001|Overall Study|Withdrawal by Subject|2|||
23342922|NCT03614078|64999753|FG002|Overall Study|Withdrawal by Subject|3|||
23342923|NCT03614078|64999751|FG000|Overall Study|Participant Did Not Return for Visit|0|||
23342924|NCT03614078|64999752|FG001|Overall Study|Participant Did Not Return for Visit|1|||
23342925|NCT03614078|64999753|FG002|Overall Study|Participant Did Not Return for Visit|0|||
23342926|NCT03614078|64999751|FG000|Overall Study|High Neutrophils|0|||
23342927|NCT03614078|64999752|FG001|Overall Study|High Neutrophils|0|||
23342928|NCT03614078|64999753|FG002|Overall Study|High Neutrophils|2|||
23342929|NCT03614078|64999751|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
23342930|NCT03614078|64999752|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
23342931|NCT03614078|64999753|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
23342932|NCT03614078|64999751|FG000|Overall Study|Exacerbation of Psoriasis|0|||
23342933|NCT03614078|64999752|FG001|Overall Study|Exacerbation of Psoriasis|1|||
23342934|NCT03614078|64999753|FG002|Overall Study|Exacerbation of Psoriasis|0|||
23342935|NCT03614078|64999751|FG000|Overall Study|Adverse Event|0|||
23342936|NCT03614078|64999752|FG001|Overall Study|Adverse Event|2|||
23342937|NCT03614078|64999753|FG002|Overall Study|Adverse Event|0|||
23342938|NCT03614078|64999751|FG000|Overall Study|Dizziness and Rash|0|||
23342939|NCT03614078|64999752|FG001|Overall Study|Dizziness and Rash|1|||
23342940|NCT03614078|64999753|FG002|Overall Study|Dizziness and Rash|0|||
23582565|NCT02974010|65862496|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
23582566|NCT02974010|65862497|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
23582567|NCT02974010|65862498|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
23582568|NCT02974010|65862495|FG000|Overall Study|Lack of Efficacy|0|||
23582569|NCT02974010|65862496|FG001|Overall Study|Lack of Efficacy|0|||
23582570|NCT02974010|65862497|FG002|Overall Study|Lack of Efficacy|1|||
23342947|NCT00749684|64999761|FG000|Overall Study|Death|1|||
23342948|NCT00749684|64999761|FG000|Overall Study|Adverse Event|27|||
23342949|NCT00749684|64999761|FG000|Overall Study|Participant's Wish|10|||
23342950|NCT00749684|64999761|FG000|Overall Study|Not Documented|1|||
23342951|NCT00749684|64999761|FG000|Overall Study|Progressive Desease|31|||
23342952|NCT00749684|64999761|FG000|Overall Study|Therapy according to protocol + AE|2|||
23342953|NCT00749684|64999761|FG000|Overall Study|AE+discontinuation on participants wish|1|||
23342954|NCT00749684|64999761|FG000|Overall Study|Missing|9|||
23342955|NCT02822573|64999762|FG000|Overall Study|Lost to Follow-up|5|||
23342956|NCT02822573|64999763|FG001|Overall Study|Lost to Follow-up|3|||
23342957|NCT02822573|64999762|FG000|Overall Study|Physician Decision|1|||
23342958|NCT02822573|64999763|FG001|Overall Study|Physician Decision|1|||
23342959|NCT02822573|64999762|FG000|Overall Study|Withdrawal by Subject|9|||
23342960|NCT02822573|64999763|FG001|Overall Study|Withdrawal by Subject|5|||
23342961|NCT02822573|64999762|FG000|Overall Study|Protocol Violation|6|||
23342962|NCT02822573|64999763|FG001|Overall Study|Protocol Violation|4|||
23342963|NCT02822573|64999762|FG000|Overall Study|Too sick or ill|2|||
23342964|NCT02822573|64999763|FG001|Overall Study|Too sick or ill|1|||
23342965|NCT02822573|64999762|FG000|Overall Study|Disease Progression|1|||
23454765|NCT03001557|65407237|FG001|Extension Phase|Adverse Event|0|||
23454766|NCT03001557|65407238|FG002|Extension Phase|Adverse Event|0|||
23454767|NCT03001557|65407239|FG003|Extension Phase|Adverse Event|0|||
23454768|NCT03001557|65407240|FG004|Extension Phase|Adverse Event|0|||
23454769|NCT03001557|65407241|FG005|Extension Phase|Adverse Event|2|||
23454770|NCT03001557|65407242|FG006|Extension Phase|Adverse Event|0|||
23454771|NCT03001557|65407243|FG007|Extension Phase|Adverse Event|0|||
23342966|NCT02822573|64999763|FG001|Overall Study|Disease Progression|1|||
23342967|NCT02822573|64999762|FG000|Overall Study|No reason given|6|||
23342968|NCT02822573|64999763|FG001|Overall Study|No reason given|4|||
23342969|NCT01096589|64999764|FG000|Overall Study|Adverse Event|2|||
23342970|NCT01096589|64999765|FG001|Overall Study|Adverse Event|1|||
23342971|NCT01096589|64999766|FG002|Overall Study|Adverse Event|2|||
23342972|NCT01096589|64999767|FG003|Overall Study|Adverse Event|1|||
23342973|NCT01096589|64999764|FG000|Overall Study|Withdrawal by Subject|2|||
23342974|NCT01096589|64999765|FG001|Overall Study|Withdrawal by Subject|1|||
23342975|NCT01096589|64999766|FG002|Overall Study|Withdrawal by Subject|1|||
23342976|NCT01096589|64999767|FG003|Overall Study|Withdrawal by Subject|1|||
23342977|NCT01096589|64999764|FG000|Overall Study|Compliance with protocol|0|||
23342978|NCT01096589|64999765|FG001|Overall Study|Compliance with protocol|0|||
23342979|NCT01096589|64999766|FG002|Overall Study|Compliance with protocol|1|||
23454772|NCT03001557|65407236|FG000|Extension Phase|Withdrawal by Subject|0|||
23454773|NCT03001557|65407237|FG001|Extension Phase|Withdrawal by Subject|0|||
23454774|NCT03001557|65407238|FG002|Extension Phase|Withdrawal by Subject|0|||
23454775|NCT03001557|65407239|FG003|Extension Phase|Withdrawal by Subject|0|||
23342980|NCT01096589|64999767|FG003|Overall Study|Compliance with protocol|0|||
23342981|NCT01096589|64999764|FG000|Overall Study|found treatment exhausting|0|||
23342982|NCT01096589|64999765|FG001|Overall Study|found treatment exhausting|0|||
23342983|NCT01096589|64999766|FG002|Overall Study|found treatment exhausting|0|||
23342984|NCT01096589|64999767|FG003|Overall Study|found treatment exhausting|1|||
23342985|NCT04756154|64999768|FG000|Overall Study|Did not meet treatment day baseline|30|||
23342986|NCT04756154|64999769|FG001|Overall Study|Did not meet treatment day baseline|28|||
23342987|NCT04756154|64999770|FG002|Overall Study|Did not meet treatment day baseline|7|||
23342988|NCT04756154|64999768|FG000|Overall Study|Did not return for final sample collection|1|||
23342989|NCT04756154|64999769|FG001|Overall Study|Did not return for final sample collection|1|||
23342990|NCT04756154|64999770|FG002|Overall Study|Did not return for final sample collection|0|||
23342991|NCT02017912|64999771|FG000|Overall Study|Withdrawal by Subject|2|||
23342992|NCT02017912|64999772|FG001|Overall Study|Withdrawal by Subject|1|||
23342993|NCT02017912|64999771|FG000|Overall Study|miscellaneous|1|||
23342994|NCT02017912|64999772|FG001|Overall Study|miscellaneous|1|||
23342995|NCT00723255|64999779|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
23342996|NCT00723255|64999779|FG000|Overall Study|Ineligible: Second primary|1|||
23342997|NCT00723255|64999779|FG000|Overall Study|Ineligible: Wrong Primary|2|||
23342998|NCT02520427|64999780|FG000|Overall Study|Decision by sponsor|0|||
23342999|NCT02520427|64999781|FG001|Overall Study|Decision by sponsor|0|||
23343000|NCT02520427|64999782|FG002|Overall Study|Decision by sponsor|0|||
23343001|NCT02520427|64999783|FG003|Overall Study|Decision by sponsor|0|||
23343002|NCT02520427|64999784|FG004|Overall Study|Decision by sponsor|0|||
23343003|NCT02520427|64999785|FG005|Overall Study|Decision by sponsor|0|||
23343004|NCT02520427|64999786|FG006|Overall Study|Decision by sponsor|0|||
23343005|NCT02520427|64999787|FG007|Overall Study|Decision by sponsor|0|||
23343006|NCT02520427|64999788|FG008|Overall Study|Decision by sponsor|1|||
23343007|NCT02520427|64999789|FG009|Overall Study|Decision by sponsor|1|||
23343008|NCT02520427|64999790|FG010|Overall Study|Decision by sponsor|0|||
23343009|NCT02520427|64999791|FG011|Overall Study|Decision by sponsor|0|||
23343010|NCT02520427|64999792|FG012|Overall Study|Decision by sponsor|0|||
23343011|NCT02520427|64999793|FG013|Overall Study|Decision by sponsor|0|||
23343012|NCT02520427|64999794|FG014|Overall Study|Decision by sponsor|0|||
23343013|NCT02520427|64999795|FG015|Overall Study|Decision by sponsor|0|||
23343014|NCT02520427|64999796|FG016|Overall Study|Decision by sponsor|0|||
23343015|NCT02520427|64999797|FG017|Overall Study|Decision by sponsor|0|||
23343016|NCT02520427|64999798|FG018|Overall Study|Decision by sponsor|0|||
23343017|NCT02520427|64999799|FG019|Overall Study|Decision by sponsor|0|||
23343018|NCT02520427|64999800|FG020|Overall Study|Decision by sponsor|0|||
23343019|NCT02520427|64999801|FG021|Overall Study|Decision by sponsor|0|||
23343020|NCT02520427|64999802|FG022|Overall Study|Decision by sponsor|0|||
23343021|NCT02520427|64999803|FG023|Overall Study|Decision by sponsor|0|||
23343022|NCT02520427|64999804|FG024|Overall Study|Decision by sponsor|0|||
23343023|NCT02520427|64999805|FG025|Overall Study|Decision by sponsor|0|||
23343024|NCT02520427|64999780|FG000|Overall Study|Withdrawal by Subject|0|||
23343025|NCT02520427|64999781|FG001|Overall Study|Withdrawal by Subject|0|||
23343026|NCT02520427|64999782|FG002|Overall Study|Withdrawal by Subject|1|||
23343027|NCT02520427|64999783|FG003|Overall Study|Withdrawal by Subject|0|||
23343028|NCT02520427|64999784|FG004|Overall Study|Withdrawal by Subject|0|||
23343029|NCT02520427|64999785|FG005|Overall Study|Withdrawal by Subject|0|||
23343030|NCT02520427|64999786|FG006|Overall Study|Withdrawal by Subject|0|||
23343031|NCT02520427|64999787|FG007|Overall Study|Withdrawal by Subject|0|||
23343032|NCT02520427|64999788|FG008|Overall Study|Withdrawal by Subject|0|||
23343033|NCT02520427|64999789|FG009|Overall Study|Withdrawal by Subject|0|||
23343034|NCT02520427|64999790|FG010|Overall Study|Withdrawal by Subject|0|||
23343035|NCT02520427|64999791|FG011|Overall Study|Withdrawal by Subject|0|||
23343036|NCT02520427|64999792|FG012|Overall Study|Withdrawal by Subject|1|||
23343037|NCT02520427|64999793|FG013|Overall Study|Withdrawal by Subject|1|||
23343038|NCT02520427|64999794|FG014|Overall Study|Withdrawal by Subject|1|||
23343039|NCT02520427|64999795|FG015|Overall Study|Withdrawal by Subject|0|||
23343040|NCT02520427|64999796|FG016|Overall Study|Withdrawal by Subject|1|||
23343041|NCT02520427|64999797|FG017|Overall Study|Withdrawal by Subject|0|||
23343042|NCT02520427|64999798|FG018|Overall Study|Withdrawal by Subject|0|||
23343043|NCT02520427|64999799|FG019|Overall Study|Withdrawal by Subject|3|||
23343044|NCT02520427|64999800|FG020|Overall Study|Withdrawal by Subject|2|||
23343045|NCT02520427|64999801|FG021|Overall Study|Withdrawal by Subject|0|||
23343046|NCT02520427|64999802|FG022|Overall Study|Withdrawal by Subject|0|||
23454776|NCT03001557|65407240|FG004|Extension Phase|Withdrawal by Subject|0|||
23636950|NCT02546921|66053047|FG006|Overall Study|Patient Choice|0|||
23343047|NCT02520427|64999803|FG023|Overall Study|Withdrawal by Subject|0|||
23343048|NCT02520427|64999804|FG024|Overall Study|Withdrawal by Subject|0|||
23343049|NCT02520427|64999805|FG025|Overall Study|Withdrawal by Subject|0|||
23343050|NCT02520427|64999780|FG000|Overall Study|Death|1|||
23343051|NCT02520427|64999781|FG001|Overall Study|Death|0|||
23343052|NCT02520427|64999782|FG002|Overall Study|Death|0|||
23343053|NCT02520427|64999783|FG003|Overall Study|Death|0|||
23343054|NCT02520427|64999784|FG004|Overall Study|Death|0|||
23343055|NCT02520427|64999785|FG005|Overall Study|Death|0|||
23343056|NCT02520427|64999786|FG006|Overall Study|Death|0|||
23343057|NCT02520427|64999787|FG007|Overall Study|Death|0|||
23343058|NCT02520427|64999788|FG008|Overall Study|Death|0|||
23343059|NCT02520427|64999789|FG009|Overall Study|Death|0|||
23343060|NCT02520427|64999790|FG010|Overall Study|Death|0|||
23343061|NCT02520427|64999791|FG011|Overall Study|Death|0|||
23343062|NCT02520427|64999792|FG012|Overall Study|Death|0|||
23343063|NCT02520427|64999793|FG013|Overall Study|Death|0|||
23343064|NCT02520427|64999794|FG014|Overall Study|Death|0|||
23343065|NCT02520427|64999795|FG015|Overall Study|Death|0|||
23343066|NCT02520427|64999796|FG016|Overall Study|Death|2|||
23343067|NCT02520427|64999797|FG017|Overall Study|Death|1|||
23343068|NCT02520427|64999798|FG018|Overall Study|Death|3|||
23343069|NCT02520427|64999799|FG019|Overall Study|Death|2|||
23343070|NCT02520427|64999800|FG020|Overall Study|Death|0|||
23343071|NCT02520427|64999801|FG021|Overall Study|Death|0|||
23343072|NCT02520427|64999802|FG022|Overall Study|Death|1|||
23343073|NCT02520427|64999803|FG023|Overall Study|Death|0|||
23343074|NCT02520427|64999804|FG024|Overall Study|Death|1|||
23343075|NCT02520427|64999805|FG025|Overall Study|Death|0|||
23343076|NCT01471340|64999806|FG000|Overall Study|Death|5|||
23343077|NCT01471340|64999807|FG001|Overall Study|Death|4|||
23343078|NCT01471340|64999806|FG000|Overall Study|Lost to Follow-up|0|||
23343079|NCT01471340|64999807|FG001|Overall Study|Lost to Follow-up|1|||
23343080|NCT01471340|64999806|FG000|Overall Study|Investigational site closure|0|||
23343081|NCT01471340|64999807|FG001|Overall Study|Investigational site closure|1|||
23343082|NCT01471340|64999806|FG000|Overall Study|Invalid informed consent|1|||
23343083|NCT01471340|64999807|FG001|Overall Study|Invalid informed consent|0|||
23343084|NCT01582178|64999809|FG000|Overall Study|Physician Decision|6|||
23343085|NCT01582178|64999810|FG001|Overall Study|Physician Decision|5|||
23343086|NCT02100670|64999814|FG000|Overall Study|Adverse Event|10|||
23343087|NCT02100670|64999815|FG001|Overall Study|Adverse Event|3|||
23343088|NCT02100670|64999816|FG002|Overall Study|Adverse Event|3|||
23343089|NCT02100670|64999817|FG003|Overall Study|Adverse Event|0|||
23343090|NCT02100670|64999814|FG000|Overall Study|Lost to Follow-up|1|||
23343091|NCT02100670|64999815|FG001|Overall Study|Lost to Follow-up|0|||
23343092|NCT02100670|64999816|FG002|Overall Study|Lost to Follow-up|0|||
23343093|NCT02100670|64999817|FG003|Overall Study|Lost to Follow-up|0|||
23343094|NCT02100670|64999814|FG000|Overall Study|Protocol Violation|0|||
23343095|NCT02100670|64999815|FG001|Overall Study|Protocol Violation|1|||
23343096|NCT02100670|64999816|FG002|Overall Study|Protocol Violation|0|||
23343097|NCT02100670|64999817|FG003|Overall Study|Protocol Violation|1|||
23343098|NCT02100670|64999814|FG000|Overall Study|Withdrawal of Consent|0|||
23343099|NCT02100670|64999815|FG001|Overall Study|Withdrawal of Consent|1|||
23343100|NCT02100670|64999816|FG002|Overall Study|Withdrawal of Consent|1|||
23343101|NCT02100670|64999817|FG003|Overall Study|Withdrawal of Consent|0|||
23343102|NCT02100670|64999814|FG000|Overall Study|No swelling no pain|1|||
23343103|NCT02100670|64999815|FG001|Overall Study|No swelling no pain|0|||
23343104|NCT02100670|64999816|FG002|Overall Study|No swelling no pain|0|||
23343105|NCT02100670|64999817|FG003|Overall Study|No swelling no pain|0|||
23343106|NCT02100670|64999814|FG000|Overall Study|Poor Efficacy|0|||
23343107|NCT02100670|64999815|FG001|Overall Study|Poor Efficacy|1|||
23343108|NCT02100670|64999816|FG002|Overall Study|Poor Efficacy|0|||
23343109|NCT02100670|64999817|FG003|Overall Study|Poor Efficacy|0|||
23343110|NCT02100670|64999814|FG000|Overall Study|Physician Decision|0|||
23343111|NCT02100670|64999815|FG001|Overall Study|Physician Decision|1|||
23343112|NCT02100670|64999816|FG002|Overall Study|Physician Decision|0|||
23343113|NCT02100670|64999817|FG003|Overall Study|Physician Decision|0|||
23343114|NCT02100670|64999814|FG000|Overall Study|Withdrawal by Subject|1|||
23343115|NCT02100670|64999815|FG001|Overall Study|Withdrawal by Subject|0|||
23343116|NCT02100670|64999816|FG002|Overall Study|Withdrawal by Subject|0|||
23343117|NCT02100670|64999817|FG003|Overall Study|Withdrawal by Subject|0|||
23343118|NCT00425061|64999825|FG000|Overall Study|Adverse Event|1|||
23343119|NCT00425061|64999826|FG001|Overall Study|Adverse Event|0|||
23343120|NCT00425061|64999827|FG002|Overall Study|Adverse Event|0|||
23343121|NCT00425061|64999828|FG003|Overall Study|Adverse Event|2|||
23343122|NCT00425061|64999829|FG004|Overall Study|Adverse Event|2|||
23343123|NCT00425061|64999830|FG005|Overall Study|Adverse Event|0|||
23343124|NCT00425061|64999831|FG006|Overall Study|Adverse Event|0|||
23343125|NCT00425061|64999825|FG000|Overall Study|Lost to Follow-up|0|||
23343126|NCT00425061|64999826|FG001|Overall Study|Lost to Follow-up|1|||
23343127|NCT00425061|64999827|FG002|Overall Study|Lost to Follow-up|0|||
23343128|NCT00425061|64999828|FG003|Overall Study|Lost to Follow-up|0|||
23343129|NCT00425061|64999829|FG004|Overall Study|Lost to Follow-up|0|||
23343130|NCT00425061|64999830|FG005|Overall Study|Lost to Follow-up|0|||
23343131|NCT00425061|64999831|FG006|Overall Study|Lost to Follow-up|0|||
23343132|NCT00425061|64999825|FG000|Overall Study|Protocol Violation|1|||
23343133|NCT00425061|64999826|FG001|Overall Study|Protocol Violation|0|||
23343134|NCT00425061|64999827|FG002|Overall Study|Protocol Violation|0|||
23343135|NCT00425061|64999828|FG003|Overall Study|Protocol Violation|0|||
23343136|NCT00425061|64999829|FG004|Overall Study|Protocol Violation|0|||
23343137|NCT00425061|64999830|FG005|Overall Study|Protocol Violation|0|||
23343138|NCT00425061|64999831|FG006|Overall Study|Protocol Violation|0|||
23343139|NCT00425061|64999825|FG000|Overall Study|Withdrawal by Subject|0|||
23343140|NCT00425061|64999826|FG001|Overall Study|Withdrawal by Subject|1|||
23343141|NCT00425061|64999827|FG002|Overall Study|Withdrawal by Subject|0|||
23343142|NCT00425061|64999828|FG003|Overall Study|Withdrawal by Subject|0|||
23343143|NCT00425061|64999829|FG004|Overall Study|Withdrawal by Subject|1|||
23343144|NCT00425061|64999830|FG005|Overall Study|Withdrawal by Subject|0|||
23343145|NCT00425061|64999831|FG006|Overall Study|Withdrawal by Subject|3|||
23343146|NCT00425061|64999825|FG000|Overall Study|Sponsor's request|0|||
23343147|NCT00425061|64999826|FG001|Overall Study|Sponsor's request|0|||
23343148|NCT00425061|64999827|FG002|Overall Study|Sponsor's request|0|||
23343149|NCT00425061|64999828|FG003|Overall Study|Sponsor's request|0|||
23343150|NCT00425061|64999829|FG004|Overall Study|Sponsor's request|19|||
23343151|NCT00425061|64999830|FG005|Overall Study|Sponsor's request|4|||
23343152|NCT00425061|64999831|FG006|Overall Study|Sponsor's request|15|||
23343153|NCT00425061|64999825|FG000|Overall Study|Physician Decision|0|||
23343154|NCT00425061|64999826|FG001|Overall Study|Physician Decision|0|||
23343155|NCT00425061|64999827|FG002|Overall Study|Physician Decision|0|||
23343156|NCT00425061|64999828|FG003|Overall Study|Physician Decision|0|||
23343157|NCT00425061|64999829|FG004|Overall Study|Physician Decision|1|||
23343158|NCT00425061|64999830|FG005|Overall Study|Physician Decision|0|||
23343159|NCT00425061|64999831|FG006|Overall Study|Physician Decision|0|||
23343160|NCT00425061|64999825|FG000|Overall Study|Other|0|||
23343161|NCT00425061|64999826|FG001|Overall Study|Other|0|||
23343162|NCT00425061|64999827|FG002|Overall Study|Other|0|||
23343163|NCT00425061|64999828|FG003|Overall Study|Other|0|||
23343164|NCT00425061|64999829|FG004|Overall Study|Other|3|||
23343165|NCT00425061|64999830|FG005|Overall Study|Other|0|||
23343166|NCT00425061|64999831|FG006|Overall Study|Other|1|||
23343167|NCT03634033|64999834|FG000|Overall Study|Did not have a post-assessment|384|||
23343168|NCT03634033|64999835|FG001|Overall Study|Did not have a post-assessment|291|||
23343169|NCT03634033|64999836|FG002|Overall Study|Did not have a post-assessment|114|||
23343170|NCT03634033|64999837|FG003|Overall Study|Did not have a post-assessment|161|||
23343171|NCT03634033|64999838|FG004|Overall Study|Did not have a post-assessment|5|||
23343172|NCT03634033|64999839|FG005|Overall Study|Did not have a post-assessment|0|||
23343173|NCT03634033|64999840|FG006|Overall Study|Did not have a post-assessment|0|||
23343174|NCT03634033|64999834|FG000|Overall Study|Death|0|||
23343175|NCT03634033|64999835|FG001|Overall Study|Death|0|||
23343176|NCT03634033|64999836|FG002|Overall Study|Death|0|||
23343177|NCT03634033|64999837|FG003|Overall Study|Death|0|||
23343178|NCT03634033|64999838|FG004|Overall Study|Death|0|||
23343179|NCT03634033|64999839|FG005|Overall Study|Death|7|||
23343180|NCT03634033|64999840|FG006|Overall Study|Death|7|||
23343181|NCT03634033|64999834|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343182|NCT03634033|64999835|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23582571|NCT02974010|65862498|FG003|Overall Study|Lack of Efficacy|0|||
23582572|NCT00015457|65862499|FG000|First Intervention|Adverse Event|0|||
23582573|NCT00015457|65862500|FG001|First Intervention|Adverse Event|2|||
23582574|NCT00015457|65862499|FG000|First Intervention|Lack of Efficacy|0|||
23582575|NCT00015457|65862500|FG001|First Intervention|Lack of Efficacy|1|||
23582576|NCT00015457|65862499|FG000|Second Intervention|Withdrawal by Subject|1|||
23582577|NCT00015457|65862500|FG001|Second Intervention|Withdrawal by Subject|0|||
23582578|NCT03239210|65862503|FG000|Overall Study|Lost to Follow-up|2|||
23582579|NCT03239210|65862504|FG001|Overall Study|Lost to Follow-up|2|||
23582580|NCT03239210|65862503|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
23582581|NCT03239210|65862504|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
23582582|NCT03239210|65862503|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
23636951|NCT03174431|66053048|FG000|Overall Study|Withdrawal by Subject|14|||
23636952|NCT03174431|66053049|FG001|Overall Study|Withdrawal by Subject|11|||
23636953|NCT03174431|66053048|FG000|Overall Study|alternative treatment|2|||
23343183|NCT03634033|64999836|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343184|NCT03634033|64999837|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23582583|NCT03239210|65862504|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
23582584|NCT03732820|65862505|FG000|Overall Study|Death|168|||
23636954|NCT03174431|66053049|FG001|Overall Study|alternative treatment|0|||
23636955|NCT03174431|66053048|FG000|Overall Study|Lost to Follow-up|1|||
23343185|NCT03634033|64999838|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343186|NCT03634033|64999839|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
23343187|NCT03634033|64999840|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
23343188|NCT03634033|64999834|FG000|Overall Study|Lost to Follow-up|0|||
23343189|NCT03634033|64999835|FG001|Overall Study|Lost to Follow-up|0|||
23343190|NCT03634033|64999836|FG002|Overall Study|Lost to Follow-up|0|||
23343191|NCT03634033|64999837|FG003|Overall Study|Lost to Follow-up|0|||
23343192|NCT03634033|64999838|FG004|Overall Study|Lost to Follow-up|0|||
23582585|NCT03732820|65862506|FG001|Overall Study|Death|203|||
23582586|NCT03732820|65862505|FG000|Overall Study|Other|2|||
23582587|NCT03732820|65862506|FG001|Overall Study|Other|2|||
23582588|NCT03732820|65862505|FG000|Overall Study|Failure to meet randomisation criteria|1|||
23582589|NCT03732820|65862506|FG001|Overall Study|Failure to meet randomisation criteria|1|||
23582590|NCT03732820|65862505|FG000|Overall Study|Patient decision|14|||
23582591|NCT03732820|65862506|FG001|Overall Study|Patient decision|10|||
23582592|NCT03732820|65862505|FG000|Overall Study|Screen failure|0|||
23582593|NCT03732820|65862506|FG001|Overall Study|Screen failure|1|||
23582594|NCT03732820|65862505|FG000|Overall Study|Patients ongoing study at data cut off|210|||
23582595|NCT03732820|65862506|FG001|Overall Study|Patients ongoing study at data cut off|178|||
23582596|NCT03732820|65862505|FG000|Overall Study|Lost to Follow-up|4|||
23582597|NCT03732820|65862506|FG001|Overall Study|Lost to Follow-up|2|||
23582598|NCT03111095|65862507|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
23582599|NCT03111095|65862508|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
23582600|NCT03111095|65862507|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
23582601|NCT03111095|65862508|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
23582602|NCT04995419|65862512|FG000|Overall Study|Withdrawal by Subject|3|||
23582603|NCT04995419|65862512|FG000|Overall Study|Progressive Disease|19|||
23582604|NCT04995419|65862512|FG000|Overall Study|Adverse Event|2|||
23582605|NCT04995419|65862512|FG000|Overall Study|Ongoing|16|||
23582606|NCT02040844|65862517|FG000|Overall Study|Adverse Event|0|||
23582607|NCT02040844|65862518|FG001|Overall Study|Adverse Event|0|||
23582608|NCT02040844|65862519|FG002|Overall Study|Adverse Event|1|||
23582609|NCT02040844|65862517|FG000|Overall Study|Withdrawal by Subject|16|||
23582610|NCT02040844|65862518|FG001|Overall Study|Withdrawal by Subject|22|||
23582611|NCT02040844|65862519|FG002|Overall Study|Withdrawal by Subject|25|||
23582612|NCT02040844|65862517|FG000|Overall Study|Lost to Follow-up|12|||
23582613|NCT02040844|65862518|FG001|Overall Study|Lost to Follow-up|9|||
23582614|NCT02040844|65862519|FG002|Overall Study|Lost to Follow-up|13|||
23582615|NCT02040844|65862517|FG000|Overall Study|Missing|13|||
23582616|NCT02040844|65862518|FG001|Overall Study|Missing|3|||
23582617|NCT02040844|65862519|FG002|Overall Study|Missing|2|||
23582618|NCT02040844|65862517|FG000|Overall Study|Non-specified|8|||
23582619|NCT02040844|65862518|FG001|Overall Study|Non-specified|2|||
23582620|NCT02040844|65862519|FG002|Overall Study|Non-specified|5|||
23582621|NCT02040844|65862517|FG000|Overall Study|Concomitant medication|1|||
23582622|NCT02040844|65862518|FG001|Overall Study|Concomitant medication|3|||
23636956|NCT03174431|66053049|FG001|Overall Study|Lost to Follow-up|5|||
23636957|NCT04157400|66053053|FG000|Overall Study|Withdrawal by Subject|1|||
23636958|NCT04157400|66053053|FG000|Overall Study|Lost to Follow-up|3|||
23636959|NCT01585155|66053054|FG000|Overall Study|Adverse Event|1|||
23636960|NCT01585155|66053054|FG000|Overall Study|Lack of Efficacy|2|||
23636961|NCT01585155|66053054|FG000|Overall Study|Worsening ulcerative colitis|2|||
23636962|NCT00293059|66053057|FG000|Overall Study|Adverse Event|12|||
23636963|NCT00293059|66053058|FG001|Overall Study|Adverse Event|4|||
23636964|NCT00293059|66053057|FG000|Overall Study|Lack of Efficacy|2|||
23636965|NCT00293059|66053058|FG001|Overall Study|Lack of Efficacy|0|||
23636966|NCT00293059|66053057|FG000|Overall Study|Lost to Follow-up|2|||
23636967|NCT00293059|66053058|FG001|Overall Study|Lost to Follow-up|3|||
23636968|NCT00293059|66053057|FG000|Overall Study|Pregnancy|1|||
23636969|NCT00293059|66053058|FG001|Overall Study|Pregnancy|1|||
23636970|NCT00293059|66053057|FG000|Overall Study|Protocol Violation|2|||
23636971|NCT00293059|66053058|FG001|Overall Study|Protocol Violation|0|||
23636972|NCT00293059|66053057|FG000|Overall Study|Withdrawal by Subject|11|||
23636973|NCT00293059|66053058|FG001|Overall Study|Withdrawal by Subject|5|||
23636974|NCT00293059|66053057|FG000|Overall Study|Participant moved out of state|1|||
23636975|NCT00293059|66053058|FG001|Overall Study|Participant moved out of state|0|||
23636976|NCT00293059|66053057|FG000|Overall Study|Participant stopped study drug|1|||
23636977|NCT00293059|66053058|FG001|Overall Study|Participant stopped study drug|0|||
23636978|NCT00293059|66053057|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
23636979|NCT00293059|66053058|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
23636980|NCT00293059|66053057|FG000|Overall Study|missing|3|||
23636981|NCT00293059|66053058|FG001|Overall Study|missing|5|||
23636982|NCT00780559|66053059|FG000|Overall Study|Lost to Follow-up|2|||
23636983|NCT00780559|66053060|FG001|Overall Study|Lost to Follow-up|7|||
23636984|NCT00780559|66053059|FG000|Overall Study|Death|1|||
23636985|NCT00780559|66053060|FG001|Overall Study|Death|0|||
23636986|NCT01232738|66053072|FG000|Overall Study|Death|3|||
23636987|NCT01232738|66053072|FG000|Overall Study|Physician Decision|2|||
23636988|NCT01232738|66053072|FG000|Overall Study|Lost to Follow-up|1|||
23636989|NCT01232738|66053072|FG000|Overall Study|Withdrawal by Subject|2|||
23636990|NCT01232738|66053072|FG000|Overall Study|Adverse Event|5|||
23582623|NCT02040844|65862519|FG002|Overall Study|Concomitant medication|1|||
23582624|NCT00723294|65862521|FG000|Overall Study|Lobular histology|2|||
23582625|NCT00723294|65862521|FG000|Overall Study|>25% intraductal component|1|||
23582626|NCT00723294|65862521|FG000|Overall Study|No MRI tumor enhancement|1|||
23636991|NCT01886287|66053076|FG000|Overall Study|Radiographic disease progression|1|||
23343193|NCT03634033|64999839|FG005|Overall Study|Lost to Follow-up|1|||
23343194|NCT03634033|64999840|FG006|Overall Study|Lost to Follow-up|2|||
23343195|NCT03634033|64999834|FG000|Overall Study|Withdrawal by Subject|0|||
23343196|NCT03634033|64999835|FG001|Overall Study|Withdrawal by Subject|0|||
23343197|NCT03634033|64999836|FG002|Overall Study|Withdrawal by Subject|0|||
23343198|NCT03634033|64999837|FG003|Overall Study|Withdrawal by Subject|0|||
23343199|NCT03634033|64999838|FG004|Overall Study|Withdrawal by Subject|0|||
23343200|NCT03634033|64999839|FG005|Overall Study|Withdrawal by Subject|0|||
23343201|NCT03634033|64999840|FG006|Overall Study|Withdrawal by Subject|1|||
23343202|NCT00978250|64999841|FG000|Overall Study|Late determination of ineligibility|0|||
23343203|NCT00978250|64999842|FG001|Overall Study|Late determination of ineligibility|1|||
23343204|NCT00978250|64999843|FG002|Overall Study|Late determination of ineligibility|0|||
23343205|NCT00978250|64999844|FG003|Overall Study|Late determination of ineligibility|1|||
23343206|NCT05249127|64999846|FG000|Overall Study|Protocol Violation|13|||
23343207|NCT05249127|64999846|FG000|Overall Study|Physician Decision|4|||
23343208|NCT05249127|64999846|FG000|Overall Study|Withdrawal by Subject|2|||
23343209|NCT05249127|64999846|FG000|Overall Study|Participant Non-compliance|1|||
23343210|NCT02589522|64999856|FG000|Overall Study|Physician Decision|1|||
23343211|NCT02589522|64999857|FG001|Overall Study|Physician Decision|2|||
23343212|NCT02589522|64999858|FG002|Overall Study|Physician Decision|0|||
23343213|NCT02589522|64999856|FG000|Overall Study|Did not start treatment|1|||
23343214|NCT02589522|64999857|FG001|Overall Study|Did not start treatment|0|||
23343215|NCT02589522|64999858|FG002|Overall Study|Did not start treatment|0|||
23343216|NCT00514904|64999859|FG000|Overall Study|Withdrawal by Subject|3|||
23343217|NCT00514904|64999860|FG001|Overall Study|Withdrawal by Subject|2|||
23343218|NCT00514904|64999859|FG000|Overall Study|Lost to Follow-up|21|||
23343219|NCT00514904|64999860|FG001|Overall Study|Lost to Follow-up|3|||
23343220|NCT00654875|64999866|FG000|Overall Study|Adverse Event|5|||
23343221|NCT00654875|64999867|FG001|Overall Study|Adverse Event|5|||
23343222|NCT00654875|64999866|FG000|Overall Study|Withdrawal by Subject|4|||
23343223|NCT00654875|64999867|FG001|Overall Study|Withdrawal by Subject|4|||
23343224|NCT00654875|64999866|FG000|Overall Study|Protocol Violation|3|||
23343225|NCT00654875|64999867|FG001|Overall Study|Protocol Violation|3|||
23343226|NCT00654875|64999866|FG000|Overall Study|Lack of Efficacy|2|||
23343227|NCT00654875|64999867|FG001|Overall Study|Lack of Efficacy|2|||
23343228|NCT00654875|64999866|FG000|Overall Study|Lost to Follow-up|1|||
23343229|NCT00654875|64999867|FG001|Overall Study|Lost to Follow-up|3|||
23343230|NCT00654875|64999866|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23343231|NCT00654875|64999867|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23343232|NCT00654875|64999866|FG000|Overall Study|Administrative Problems|1|||
23343233|NCT00654875|64999867|FG001|Overall Study|Administrative Problems|0|||
23343234|NCT04743804|64999868|FG000|Overall Study|Other|1|||
23343235|NCT04743804|64999869|FG001|Overall Study|Other|0|||
23343236|NCT04743804|64999868|FG000|Overall Study|Withdrawal by Subject|0|||
23343237|NCT04743804|64999869|FG001|Overall Study|Withdrawal by Subject|1|||
23343238|NCT04743804|64999868|FG000|Overall Study|Study Terminated by Sponsor|1|||
23343239|NCT04743804|64999869|FG001|Overall Study|Study Terminated by Sponsor|4|||
23343240|NCT04743804|64999868|FG000|Overall Study|Physician Decision|0|||
23343241|NCT04743804|64999869|FG001|Overall Study|Physician Decision|1|||
23343242|NCT04743804|64999868|FG000|Overall Study|Death|3|||
23343243|NCT04743804|64999869|FG001|Overall Study|Death|0|||
23343244|NCT02703272|64999870|FG000|Overall Study|Death|4|||
23343245|NCT02703272|64999871|FG001|Overall Study|Death|9|||
23343246|NCT02703272|64999872|FG002|Overall Study|Death|19|||
23343247|NCT02703272|64999873|FG003|Overall Study|Death|10|||
23343248|NCT02703272|64999870|FG000|Overall Study|Withdrawal by Subject|0|||
23343249|NCT02703272|64999871|FG001|Overall Study|Withdrawal by Subject|0|||
23582627|NCT00723294|65862521|FG000|Overall Study|1.0-Tesla MRI|1|||
23582628|NCT00723294|65862521|FG000|Overall Study|No cryoabalation|2|||
23343250|NCT02703272|64999872|FG002|Overall Study|Withdrawal by Subject|4|||
23343251|NCT02703272|64999873|FG003|Overall Study|Withdrawal by Subject|2|||
23343252|NCT02703272|64999870|FG000|Overall Study|Study Terminated by Sponsor|6|||
23343253|NCT02703272|64999871|FG001|Overall Study|Study Terminated by Sponsor|1|||
23343254|NCT02703272|64999872|FG002|Overall Study|Study Terminated by Sponsor|12|||
23343255|NCT02703272|64999873|FG003|Overall Study|Study Terminated by Sponsor|4|||
23343256|NCT02703272|64999870|FG000|Overall Study|Other|1|||
23343257|NCT02703272|64999871|FG001|Overall Study|Other|0|||
23343258|NCT02703272|64999872|FG002|Overall Study|Other|0|||
23343259|NCT02703272|64999873|FG003|Overall Study|Other|0|||
23343260|NCT04852276|64999876|FG000|Overall Study|Death|2|||
23343261|NCT04852276|64999877|FG001|Overall Study|Death|0|||
23343262|NCT04852276|64999876|FG000|Overall Study|Lost to Follow-up|15|||
23343263|NCT04852276|64999877|FG001|Overall Study|Lost to Follow-up|9|||
23343264|NCT04852276|64999876|FG000|Overall Study|Withdrawal by Subject|26|||
23343265|NCT04852276|64999877|FG001|Overall Study|Withdrawal by Subject|6|||
23343266|NCT04216589|64999878|FG000|Overall Study|Withdrawal by Subject|2|||
23343267|NCT04216589|64999878|FG000|Overall Study|Protocol Violation|1|||
23343268|NCT04216589|64999878|FG000|Overall Study|Incarceration|1|||
23343269|NCT01966068|64999879|FG000|Overall Study|Withdrawal by Subject|57|||
23343270|NCT01966068|64999879|FG000|Overall Study|Lost to Follow-up|81|||
23343271|NCT02883049|64999881|FG000|Induction|Adverse Event|52|||
23343272|NCT02883049|64999882|FG001|Induction|Adverse Event|2|||
23343273|NCT02883049|64999883|FG002|Induction|Adverse Event|0|||
23343274|NCT02883049|64999884|FG003|Induction|Adverse Event|0|||
23343275|NCT02883049|64999885|FG004|Induction|Adverse Event|0|||
23343276|NCT02883049|64999886|FG005|Induction|Adverse Event|0|||
23343277|NCT02883049|64999887|FG006|Induction|Adverse Event|0|||
23343278|NCT02883049|64999888|FG007|Induction|Adverse Event|0|||
23343279|NCT02883049|64999889|FG008|Induction|Adverse Event|0|||
23343280|NCT02883049|64999890|FG009|Induction|Adverse Event|0|||
23343281|NCT02883049|64999891|FG010|Induction|Adverse Event|0|||
23343282|NCT02883049|64999892|FG011|Induction|Adverse Event|0|||
23343283|NCT02883049|64999893|FG012|Induction|Adverse Event|0|||
23343284|NCT02883049|64999894|FG013|Induction|Adverse Event|0|||
23343285|NCT02883049|64999895|FG014|Induction|Adverse Event|0|||
23343286|NCT02883049|64999896|FG015|Induction|Adverse Event|0|||
23343287|NCT02883049|64999881|FG000|Induction|Death|76|||
23343288|NCT02883049|64999882|FG001|Induction|Death|8|||
23343289|NCT02883049|64999883|FG002|Induction|Death|0|||
23343290|NCT02883049|64999884|FG003|Induction|Death|0|||
23343291|NCT02883049|64999885|FG004|Induction|Death|0|||
23343292|NCT02883049|64999886|FG005|Induction|Death|0|||
23343293|NCT02883049|64999887|FG006|Induction|Death|0|||
23343294|NCT02883049|64999888|FG007|Induction|Death|0|||
23343295|NCT02883049|64999889|FG008|Induction|Death|0|||
23343296|NCT02883049|64999890|FG009|Induction|Death|0|||
23343297|NCT02883049|64999891|FG010|Induction|Death|0|||
23343298|NCT02883049|64999892|FG011|Induction|Death|0|||
23343299|NCT02883049|64999893|FG012|Induction|Death|0|||
23343300|NCT02883049|64999894|FG013|Induction|Death|0|||
23343301|NCT02883049|64999895|FG014|Induction|Death|0|||
23343302|NCT02883049|64999896|FG015|Induction|Death|0|||
23343303|NCT02883049|64999881|FG000|Induction|Lost to Follow-up|2|||
23343304|NCT02883049|64999882|FG001|Induction|Lost to Follow-up|0|||
23343305|NCT02883049|64999883|FG002|Induction|Lost to Follow-up|0|||
23343306|NCT02883049|64999884|FG003|Induction|Lost to Follow-up|0|||
23343307|NCT02883049|64999885|FG004|Induction|Lost to Follow-up|0|||
23343308|NCT02883049|64999886|FG005|Induction|Lost to Follow-up|0|||
23343309|NCT02883049|64999887|FG006|Induction|Lost to Follow-up|0|||
23343310|NCT02883049|64999888|FG007|Induction|Lost to Follow-up|0|||
23343311|NCT02883049|64999889|FG008|Induction|Lost to Follow-up|0|||
23343312|NCT02883049|64999890|FG009|Induction|Lost to Follow-up|0|||
23343313|NCT02883049|64999891|FG010|Induction|Lost to Follow-up|0|||
23343314|NCT02883049|64999892|FG011|Induction|Lost to Follow-up|0|||
23343315|NCT02883049|64999893|FG012|Induction|Lost to Follow-up|0|||
23343316|NCT02883049|64999894|FG013|Induction|Lost to Follow-up|0|||
23343317|NCT02883049|64999895|FG014|Induction|Lost to Follow-up|0|||
23343318|NCT02883049|64999896|FG015|Induction|Lost to Follow-up|0|||
23343319|NCT02883049|64999881|FG000|Induction|Physician Decision|1407|||
23343320|NCT02883049|64999882|FG001|Induction|Physician Decision|8|||
23343321|NCT02883049|64999883|FG002|Induction|Physician Decision|0|||
23343322|NCT02883049|64999884|FG003|Induction|Physician Decision|0|||
23343323|NCT02883049|64999885|FG004|Induction|Physician Decision|0|||
23343324|NCT02883049|64999886|FG005|Induction|Physician Decision|0|||
23343325|NCT02883049|64999887|FG006|Induction|Physician Decision|0|||
23343326|NCT02883049|64999888|FG007|Induction|Physician Decision|0|||
23343327|NCT02883049|64999889|FG008|Induction|Physician Decision|0|||
23343328|NCT02883049|64999890|FG009|Induction|Physician Decision|0|||
23343329|NCT02883049|64999891|FG010|Induction|Physician Decision|0|||
23582629|NCT00723294|65862521|FG000|Overall Study|Did not undergo surgery|1|||
23582630|NCT00723294|65862521|FG000|Overall Study|Treated prior to registration|1|||
23343330|NCT02883049|64999892|FG011|Induction|Physician Decision|0|||
23343331|NCT02883049|64999893|FG012|Induction|Physician Decision|0|||
23582631|NCT00723294|65862521|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
23582632|NCT00723294|65862521|FG000|Overall Study|Benign lesion|1|||
23705876|NCT01912768|66297651|FG001|Overall Study|Lost to Follow-up|1|||
23343332|NCT02883049|64999894|FG013|Induction|Physician Decision|0|||
23343333|NCT02883049|64999895|FG014|Induction|Physician Decision|0|||
23343334|NCT02883049|64999896|FG015|Induction|Physician Decision|0|||
23343335|NCT02883049|64999881|FG000|Induction|Protocol Violation|6|||
23343336|NCT02883049|64999882|FG001|Induction|Protocol Violation|0|||
23343337|NCT02883049|64999883|FG002|Induction|Protocol Violation|0|||
23343338|NCT02883049|64999884|FG003|Induction|Protocol Violation|0|||
23343339|NCT02883049|64999885|FG004|Induction|Protocol Violation|0|||
23343340|NCT02883049|64999886|FG005|Induction|Protocol Violation|0|||
23343341|NCT02883049|64999887|FG006|Induction|Protocol Violation|0|||
23343342|NCT02883049|64999888|FG007|Induction|Protocol Violation|0|||
23343343|NCT02883049|64999889|FG008|Induction|Protocol Violation|0|||
23343344|NCT02883049|64999890|FG009|Induction|Protocol Violation|0|||
23343345|NCT02883049|64999891|FG010|Induction|Protocol Violation|0|||
23343346|NCT02883049|64999892|FG011|Induction|Protocol Violation|0|||
23343347|NCT02883049|64999893|FG012|Induction|Protocol Violation|0|||
23343348|NCT02883049|64999894|FG013|Induction|Protocol Violation|0|||
23343349|NCT02883049|64999895|FG014|Induction|Protocol Violation|0|||
23343350|NCT02883049|64999896|FG015|Induction|Protocol Violation|0|||
23343351|NCT02883049|64999881|FG000|Induction|Withdrawal by Subject|6|||
23343352|NCT02883049|64999882|FG001|Induction|Withdrawal by Subject|0|||
23343353|NCT02883049|64999883|FG002|Induction|Withdrawal by Subject|0|||
23343354|NCT02883049|64999884|FG003|Induction|Withdrawal by Subject|0|||
23343355|NCT02883049|64999885|FG004|Induction|Withdrawal by Subject|0|||
23343356|NCT02883049|64999886|FG005|Induction|Withdrawal by Subject|0|||
23343357|NCT02883049|64999887|FG006|Induction|Withdrawal by Subject|0|||
23343358|NCT02883049|64999888|FG007|Induction|Withdrawal by Subject|0|||
23343359|NCT02883049|64999889|FG008|Induction|Withdrawal by Subject|0|||
23343360|NCT02883049|64999890|FG009|Induction|Withdrawal by Subject|0|||
23343361|NCT02883049|64999891|FG010|Induction|Withdrawal by Subject|0|||
23343362|NCT02883049|64999892|FG011|Induction|Withdrawal by Subject|0|||
23343363|NCT02883049|64999893|FG012|Induction|Withdrawal by Subject|0|||
23343364|NCT02883049|64999894|FG013|Induction|Withdrawal by Subject|0|||
23343365|NCT02883049|64999895|FG014|Induction|Withdrawal by Subject|0|||
23343366|NCT02883049|64999896|FG015|Induction|Withdrawal by Subject|0|||
23343367|NCT02883049|64999881|FG000|Induction|Ineligible|35|||
23343368|NCT02883049|64999882|FG001|Induction|Ineligible|1|||
23343369|NCT02883049|64999883|FG002|Induction|Ineligible|0|||
23343370|NCT02883049|64999884|FG003|Induction|Ineligible|0|||
23343371|NCT02883049|64999885|FG004|Induction|Ineligible|0|||
23343372|NCT02883049|64999886|FG005|Induction|Ineligible|0|||
23343373|NCT02883049|64999887|FG006|Induction|Ineligible|0|||
23343374|NCT02883049|64999888|FG007|Induction|Ineligible|0|||
23343375|NCT02883049|64999889|FG008|Induction|Ineligible|0|||
23343376|NCT02883049|64999890|FG009|Induction|Ineligible|0|||
23343377|NCT02883049|64999891|FG010|Induction|Ineligible|0|||
23343378|NCT02883049|64999892|FG011|Induction|Ineligible|0|||
23343379|NCT02883049|64999893|FG012|Induction|Ineligible|0|||
23343380|NCT02883049|64999894|FG013|Induction|Ineligible|0|||
23343381|NCT02883049|64999895|FG014|Induction|Ineligible|0|||
23343382|NCT02883049|64999896|FG015|Induction|Ineligible|0|||
23343383|NCT02883049|64999881|FG000|Induction|Refusal of further protocol therapy|466|||
23343384|NCT02883049|64999882|FG001|Induction|Refusal of further protocol therapy|2|||
23343385|NCT02883049|64999883|FG002|Induction|Refusal of further protocol therapy|0|||
23343386|NCT02883049|64999884|FG003|Induction|Refusal of further protocol therapy|0|||
23343387|NCT02883049|64999885|FG004|Induction|Refusal of further protocol therapy|0|||
23343388|NCT02883049|64999886|FG005|Induction|Refusal of further protocol therapy|0|||
23343389|NCT02883049|64999887|FG006|Induction|Refusal of further protocol therapy|0|||
23343390|NCT02883049|64999888|FG007|Induction|Refusal of further protocol therapy|0|||
23343391|NCT02883049|64999889|FG008|Induction|Refusal of further protocol therapy|0|||
23343392|NCT02883049|64999890|FG009|Induction|Refusal of further protocol therapy|0|||
23343393|NCT02883049|64999891|FG010|Induction|Refusal of further protocol therapy|0|||
23454777|NCT03001557|65407241|FG005|Extension Phase|Withdrawal by Subject|1|||
23454778|NCT03001557|65407242|FG006|Extension Phase|Withdrawal by Subject|5|||
23454779|NCT03001557|65407243|FG007|Extension Phase|Withdrawal by Subject|2|||
23454780|NCT03001557|65407236|FG000|Extension Phase|Lost to Follow-up|0|||
23454781|NCT03001557|65407237|FG001|Extension Phase|Lost to Follow-up|0|||
23454782|NCT03001557|65407238|FG002|Extension Phase|Lost to Follow-up|0|||
23454783|NCT03001557|65407239|FG003|Extension Phase|Lost to Follow-up|0|||
23454784|NCT03001557|65407240|FG004|Extension Phase|Lost to Follow-up|0|||
23454785|NCT03001557|65407241|FG005|Extension Phase|Lost to Follow-up|0|||
23454786|NCT03001557|65407242|FG006|Extension Phase|Lost to Follow-up|2|||
23454787|NCT03001557|65407243|FG007|Extension Phase|Lost to Follow-up|1|||
23454788|NCT03001557|65407236|FG000|Extension Phase|Administrative Reason|0|||
23454789|NCT03001557|65407237|FG001|Extension Phase|Administrative Reason|0|||
23454790|NCT03001557|65407238|FG002|Extension Phase|Administrative Reason|0|||
23454791|NCT03001557|65407239|FG003|Extension Phase|Administrative Reason|0|||
23454792|NCT03001557|65407240|FG004|Extension Phase|Administrative Reason|0|||
23343394|NCT02883049|64999892|FG011|Induction|Refusal of further protocol therapy|0|||
23343395|NCT02883049|64999893|FG012|Induction|Refusal of further protocol therapy|0|||
23343396|NCT02883049|64999894|FG013|Induction|Refusal of further protocol therapy|0|||
23343397|NCT02883049|64999895|FG014|Induction|Refusal of further protocol therapy|0|||
23343398|NCT02883049|64999896|FG015|Induction|Refusal of further protocol therapy|0|||
23343399|NCT02883049|64999881|FG000|Induction|Identified as Ph+ patients|279|||
23343400|NCT02883049|64999882|FG001|Induction|Identified as Ph+ patients|1|||
23343401|NCT02883049|64999883|FG002|Induction|Identified as Ph+ patients|0|||
23343402|NCT02883049|64999884|FG003|Induction|Identified as Ph+ patients|0|||
23343403|NCT02883049|64999885|FG004|Induction|Identified as Ph+ patients|0|||
23343404|NCT02883049|64999886|FG005|Induction|Identified as Ph+ patients|0|||
23343405|NCT02883049|64999887|FG006|Induction|Identified as Ph+ patients|0|||
23454793|NCT03001557|65407241|FG005|Extension Phase|Administrative Reason|1|||
23454794|NCT03001557|65407242|FG006|Extension Phase|Administrative Reason|3|||
23454795|NCT03001557|65407243|FG007|Extension Phase|Administrative Reason|3|||
23343406|NCT02883049|64999888|FG007|Induction|Identified as Ph+ patients|0|||
23343407|NCT02883049|64999889|FG008|Induction|Identified as Ph+ patients|0|||
23343408|NCT02883049|64999890|FG009|Induction|Identified as Ph+ patients|0|||
23343409|NCT02883049|64999891|FG010|Induction|Identified as Ph+ patients|0|||
23343410|NCT02883049|64999892|FG011|Induction|Identified as Ph+ patients|0|||
23343411|NCT02883049|64999893|FG012|Induction|Identified as Ph+ patients|0|||
23343412|NCT02883049|64999894|FG013|Induction|Identified as Ph+ patients|0|||
23343413|NCT02883049|64999895|FG014|Induction|Identified as Ph+ patients|0|||
23343414|NCT02883049|64999896|FG015|Induction|Identified as Ph+ patients|0|||
23343415|NCT02883049|64999881|FG000|Induction|M3 Marrow at Day29|8|||
23343416|NCT02883049|64999882|FG001|Induction|M3 Marrow at Day29|1|||
23343417|NCT02883049|64999883|FG002|Induction|M3 Marrow at Day29|0|||
23343418|NCT02883049|64999884|FG003|Induction|M3 Marrow at Day29|0|||
23343419|NCT02883049|64999885|FG004|Induction|M3 Marrow at Day29|0|||
23343420|NCT02883049|64999886|FG005|Induction|M3 Marrow at Day29|0|||
23343421|NCT02883049|64999887|FG006|Induction|M3 Marrow at Day29|0|||
23343422|NCT02883049|64999888|FG007|Induction|M3 Marrow at Day29|0|||
23343423|NCT02883049|64999889|FG008|Induction|M3 Marrow at Day29|0|||
23343424|NCT02883049|64999890|FG009|Induction|M3 Marrow at Day29|0|||
23343425|NCT02883049|64999891|FG010|Induction|M3 Marrow at Day29|0|||
23343426|NCT02883049|64999892|FG011|Induction|M3 Marrow at Day29|0|||
23343427|NCT02883049|64999893|FG012|Induction|M3 Marrow at Day29|0|||
23343428|NCT02883049|64999894|FG013|Induction|M3 Marrow at Day29|0|||
23343429|NCT02883049|64999895|FG014|Induction|M3 Marrow at Day29|0|||
23343430|NCT02883049|64999896|FG015|Induction|M3 Marrow at Day29|0|||
23343431|NCT02883049|64999881|FG000|Induction|Inevaluable|33|||
23343432|NCT02883049|64999882|FG001|Induction|Inevaluable|1|||
23343433|NCT02883049|64999883|FG002|Induction|Inevaluable|0|||
23454796|NCT03001557|65407236|FG000|Extension Phase|Loss of caregiver|0|||
23636992|NCT01886287|66053076|FG000|Overall Study|Clinical progression due to disease|1|||
23636993|NCT01162863|66053080|FG000|Overall Study|Lack of Efficacy|1|||
23843923|NCT01940900|66808888|FG000|Overall Study|Lost to Follow-up|1|||
23843924|NCT01940900|66808889|FG001|Overall Study|Lost to Follow-up|0|||
23843925|NCT01940900|66808888|FG000|Overall Study|Sponsor Decision|1|||
23843926|NCT01940900|66808889|FG001|Overall Study|Sponsor Decision|0|||
23843927|NCT01940900|66808888|FG000|Overall Study|subject non-compliance|1|||
23843928|NCT01940900|66808889|FG001|Overall Study|subject non-compliance|1|||
23343434|NCT02883049|64999884|FG003|Induction|Inevaluable|0|||
23343435|NCT02883049|64999885|FG004|Induction|Inevaluable|0|||
23343436|NCT02883049|64999886|FG005|Induction|Inevaluable|0|||
23343437|NCT02883049|64999887|FG006|Induction|Inevaluable|0|||
23343438|NCT02883049|64999888|FG007|Induction|Inevaluable|0|||
23343439|NCT02883049|64999889|FG008|Induction|Inevaluable|0|||
23783590|NCT03818581|66586723|FG004|Overall Study|Adverse Event|0|||
23783591|NCT03818581|66586719|FG000|Overall Study|Covid-19|2|||
23783592|NCT03818581|66586720|FG001|Overall Study|Covid-19|0|||
23783593|NCT03818581|66586721|FG002|Overall Study|Covid-19|0|||
23783594|NCT03818581|66586722|FG003|Overall Study|Covid-19|0|||
23783595|NCT03818581|66586723|FG004|Overall Study|Covid-19|1|||
23783596|NCT03818581|66586719|FG000|Overall Study|Withdrawal by Subject|0|||
23783597|NCT03818581|66586720|FG001|Overall Study|Withdrawal by Subject|0|||
23783598|NCT03818581|66586721|FG002|Overall Study|Withdrawal by Subject|0|||
23783599|NCT03818581|66586722|FG003|Overall Study|Withdrawal by Subject|0|||
23783600|NCT03818581|66586723|FG004|Overall Study|Withdrawal by Subject|1|||
23783601|NCT03818581|66586719|FG000|Overall Study|No longer met study criteria|0|||
23783602|NCT03818581|66586720|FG001|Overall Study|No longer met study criteria|0|||
23783603|NCT03818581|66586721|FG002|Overall Study|No longer met study criteria|0|||
23783604|NCT03818581|66586722|FG003|Overall Study|No longer met study criteria|0|||
23783605|NCT03818581|66586723|FG004|Overall Study|No longer met study criteria|1|||
23783606|NCT03325881|66586725|FG000|Overall Study|Protocol Violation|0|||
23783607|NCT03325881|66586726|FG001|Overall Study|Protocol Violation|1|||
23783608|NCT03325881|66586725|FG000|Overall Study|Withdrawal by Subject|0|||
23783609|NCT03325881|66586726|FG001|Overall Study|Withdrawal by Subject|2|||
23783610|NCT03325881|66586725|FG000|Overall Study|Lack of Efficacy|2|||
23783611|NCT03325881|66586726|FG001|Overall Study|Lack of Efficacy|0|||
23783612|NCT03325881|66586725|FG000|Overall Study|Not treated|1|||
23783613|NCT03325881|66586726|FG001|Overall Study|Not treated|0|||
23783614|NCT01380782|66586727|FG000|Overall Study|Adverse Event|0|||
23783615|NCT01380782|66586728|FG001|Overall Study|Adverse Event|1|||
23783616|NCT01380782|66586729|FG002|Overall Study|Adverse Event|0|||
23783617|NCT01380782|66586730|FG003|Overall Study|Adverse Event|0|||
23783618|NCT01380782|66586727|FG000|Overall Study|Death|1|||
23783619|NCT01380782|66586728|FG001|Overall Study|Death|0|||
23783620|NCT01380782|66586729|FG002|Overall Study|Death|0|||
23783621|NCT01380782|66586730|FG003|Overall Study|Death|0|||
23783622|NCT01380782|66586727|FG000|Overall Study|Lack of Efficacy|10|||
23783623|NCT01380782|66586728|FG001|Overall Study|Lack of Efficacy|9|||
23783624|NCT01380782|66586729|FG002|Overall Study|Lack of Efficacy|10|||
23783625|NCT01380782|66586730|FG003|Overall Study|Lack of Efficacy|3|||
23783626|NCT01380782|66586727|FG000|Overall Study|Physician Decision|1|||
23783627|NCT01380782|66586728|FG001|Overall Study|Physician Decision|0|||
23783628|NCT01380782|66586729|FG002|Overall Study|Physician Decision|0|||
23783629|NCT01380782|66586730|FG003|Overall Study|Physician Decision|0|||
23783630|NCT01380782|66586727|FG000|Overall Study|Withdrawal by Subject|0|||
23343440|NCT02883049|64999890|FG009|Induction|Inevaluable|0|||
23343441|NCT02883049|64999891|FG010|Induction|Inevaluable|0|||
23343442|NCT02883049|64999892|FG011|Induction|Inevaluable|0|||
23343443|NCT02883049|64999893|FG012|Induction|Inevaluable|0|||
23343444|NCT02883049|64999894|FG013|Induction|Inevaluable|0|||
23343445|NCT02883049|64999895|FG014|Induction|Inevaluable|0|||
23343446|NCT02883049|64999896|FG015|Induction|Inevaluable|0|||
23343447|NCT02883049|64999881|FG000|Induction|Identified as VHR at end of Induction|244|||
23343448|NCT02883049|64999882|FG001|Induction|Identified as VHR at end of Induction|0|||
23343449|NCT02883049|64999883|FG002|Induction|Identified as VHR at end of Induction|0|||
23343450|NCT02883049|64999884|FG003|Induction|Identified as VHR at end of Induction|0|||
23343451|NCT02883049|64999885|FG004|Induction|Identified as VHR at end of Induction|0|||
23343452|NCT02883049|64999886|FG005|Induction|Identified as VHR at end of Induction|0|||
23343453|NCT02883049|64999887|FG006|Induction|Identified as VHR at end of Induction|0|||
23343454|NCT02883049|64999888|FG007|Induction|Identified as VHR at end of Induction|0|||
23343455|NCT02883049|64999889|FG008|Induction|Identified as VHR at end of Induction|0|||
23343456|NCT02883049|64999890|FG009|Induction|Identified as VHR at end of Induction|0|||
23343457|NCT02883049|64999891|FG010|Induction|Identified as VHR at end of Induction|0|||
23343458|NCT02883049|64999892|FG011|Induction|Identified as VHR at end of Induction|0|||
23343459|NCT02883049|64999893|FG012|Induction|Identified as VHR at end of Induction|0|||
23343460|NCT02883049|64999894|FG013|Induction|Identified as VHR at end of Induction|0|||
23343461|NCT02883049|64999895|FG014|Induction|Identified as VHR at end of Induction|0|||
23343462|NCT02883049|64999896|FG015|Induction|Identified as VHR at end of Induction|0|||
23343463|NCT02883049|64999881|FG000|Induction|Moved to another non-COG institution|3|||
23343464|NCT02883049|64999882|FG001|Induction|Moved to another non-COG institution|0|||
23343465|NCT02883049|64999883|FG002|Induction|Moved to another non-COG institution|0|||
23343466|NCT02883049|64999884|FG003|Induction|Moved to another non-COG institution|0|||
23343467|NCT02883049|64999885|FG004|Induction|Moved to another non-COG institution|0|||
23343468|NCT02883049|64999886|FG005|Induction|Moved to another non-COG institution|0|||
23343469|NCT02883049|64999887|FG006|Induction|Moved to another non-COG institution|0|||
23343470|NCT02883049|64999888|FG007|Induction|Moved to another non-COG institution|0|||
23343471|NCT02883049|64999889|FG008|Induction|Moved to another non-COG institution|0|||
23343472|NCT02883049|64999890|FG009|Induction|Moved to another non-COG institution|0|||
23343473|NCT02883049|64999891|FG010|Induction|Moved to another non-COG institution|0|||
23343474|NCT02883049|64999892|FG011|Induction|Moved to another non-COG institution|0|||
23343475|NCT02883049|64999893|FG012|Induction|Moved to another non-COG institution|0|||
23343476|NCT02883049|64999894|FG013|Induction|Moved to another non-COG institution|0|||
23343477|NCT02883049|64999895|FG014|Induction|Moved to another non-COG institution|0|||
23343478|NCT02883049|64999896|FG015|Induction|Moved to another non-COG institution|0|||
23343479|NCT02883049|64999881|FG000|Induction|Randomization closed|41|||
23343480|NCT02883049|64999882|FG001|Induction|Randomization closed|0|||
23343481|NCT02883049|64999883|FG002|Induction|Randomization closed|0|||
23343482|NCT02883049|64999884|FG003|Induction|Randomization closed|0|||
23343483|NCT02883049|64999885|FG004|Induction|Randomization closed|0|||
23343484|NCT02883049|64999886|FG005|Induction|Randomization closed|0|||
23343485|NCT02883049|64999887|FG006|Induction|Randomization closed|0|||
23343486|NCT02883049|64999888|FG007|Induction|Randomization closed|0|||
23343487|NCT02883049|64999889|FG008|Induction|Randomization closed|0|||
23343488|NCT02883049|64999890|FG009|Induction|Randomization closed|0|||
23343489|NCT02883049|64999891|FG010|Induction|Randomization closed|0|||
23783631|NCT01380782|66586728|FG001|Overall Study|Withdrawal by Subject|0|||
23783632|NCT01380782|66586729|FG002|Overall Study|Withdrawal by Subject|1|||
23783633|NCT01380782|66586730|FG003|Overall Study|Withdrawal by Subject|1|||
23783634|NCT02335658|66586731|FG000|Overall Study|Adverse Event|18|||
23783635|NCT02335658|66586732|FG001|Overall Study|Adverse Event|12|||
23783636|NCT02335658|66586731|FG000|Overall Study|Lack of Efficacy|4|||
23783637|NCT02335658|66586732|FG001|Overall Study|Lack of Efficacy|5|||
23783638|NCT02335658|66586731|FG000|Overall Study|Pregnancy|1|||
23783639|NCT02335658|66586732|FG001|Overall Study|Pregnancy|0|||
23783640|NCT02335658|66586731|FG000|Overall Study|Withdrawal by Subject|13|||
23783641|NCT02335658|66586732|FG001|Overall Study|Withdrawal by Subject|21|||
23783642|NCT02335658|66586731|FG000|Overall Study|non-compliance|2|||
23783643|NCT02335658|66586732|FG001|Overall Study|non-compliance|3|||
23783644|NCT02335658|66586731|FG000|Overall Study|other reason|2|||
23343490|NCT02883049|64999892|FG011|Induction|Randomization closed|0|||
23343491|NCT02883049|64999893|FG012|Induction|Randomization closed|0|||
23343492|NCT02883049|64999894|FG013|Induction|Randomization closed|0|||
23783645|NCT02335658|66586732|FG001|Overall Study|other reason|3|||
23783646|NCT02760927|66586733|FG000|Overall Study|Tube Slippage from Device|1|||
23783647|NCT01348789|66586734|FG000|Overall Study|Protocol Violation|2|||
23783648|NCT01348789|66586734|FG000|Overall Study|Withdrawal by Subject|2|||
23343493|NCT02883049|64999895|FG014|Induction|Randomization closed|0|||
23343494|NCT02883049|64999896|FG015|Induction|Randomization closed|0|||
23343495|NCT02883049|64999881|FG000|Induction|MRD negative|36|||
23343496|NCT02883049|64999882|FG001|Induction|MRD negative|0|||
23783649|NCT01173692|66586735|FG000|Overall Study|Adverse Event|1|||
23843929|NCT01940900|66808888|FG000|Overall Study|other|1|||
23843930|NCT01940900|66808889|FG001|Overall Study|other|0|||
23843931|NCT03124407|66808890|FG000|Overall Study|Lost to Follow-up|1|||
23454797|NCT03001557|65407237|FG001|Extension Phase|Loss of caregiver|0|||
23454798|NCT03001557|65407238|FG002|Extension Phase|Loss of caregiver|0|||
23454799|NCT03001557|65407239|FG003|Extension Phase|Loss of caregiver|0|||
23454800|NCT03001557|65407240|FG004|Extension Phase|Loss of caregiver|0|||
23843932|NCT03124407|66808891|FG001|Overall Study|Lost to Follow-up|0|||
23843933|NCT03124407|66808892|FG002|Overall Study|Lost to Follow-up|0|||
23843934|NCT03124407|66808893|FG003|Overall Study|Lost to Follow-up|0|||
23843935|NCT03124407|66808890|FG000|Overall Study|Adverse Event|0|||
23843936|NCT03124407|66808891|FG001|Overall Study|Adverse Event|0|||
23843937|NCT03124407|66808892|FG002|Overall Study|Adverse Event|1|||
23843938|NCT03124407|66808893|FG003|Overall Study|Adverse Event|0|||
23843939|NCT01116648|66808894|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
23843940|NCT01116648|66808895|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
23343497|NCT02883049|64999883|FG002|Induction|MRD negative|0|||
23343498|NCT02883049|64999884|FG003|Induction|MRD negative|0|||
23343499|NCT02883049|64999885|FG004|Induction|MRD negative|0|||
23343500|NCT02883049|64999886|FG005|Induction|MRD negative|0|||
23343501|NCT02883049|64999887|FG006|Induction|MRD negative|0|||
23454801|NCT03001557|65407241|FG005|Extension Phase|Loss of caregiver|0|||
23343502|NCT02883049|64999888|FG007|Induction|MRD negative|0|||
23343503|NCT02883049|64999889|FG008|Induction|MRD negative|0|||
23343504|NCT02883049|64999890|FG009|Induction|MRD negative|0|||
23343505|NCT02883049|64999891|FG010|Induction|MRD negative|0|||
23343506|NCT02883049|64999892|FG011|Induction|MRD negative|0|||
23343507|NCT02883049|64999893|FG012|Induction|MRD negative|0|||
23343508|NCT02883049|64999894|FG013|Induction|MRD negative|0|||
23343509|NCT02883049|64999895|FG014|Induction|MRD negative|0|||
23343510|NCT02883049|64999896|FG015|Induction|MRD negative|0|||
23343511|NCT02883049|64999881|FG000|Induction|Identified as HR patients|165|||
23343512|NCT02883049|64999882|FG001|Induction|Identified as HR patients|0|||
23454802|NCT03001557|65407242|FG006|Extension Phase|Loss of caregiver|1|||
23454803|NCT03001557|65407243|FG007|Extension Phase|Loss of caregiver|0|||
23454804|NCT03001557|65407236|FG000|Extension Phase|Others|0|||
23454805|NCT03001557|65407237|FG001|Extension Phase|Others|0|||
23454806|NCT03001557|65407238|FG002|Extension Phase|Others|0|||
23454807|NCT03001557|65407239|FG003|Extension Phase|Others|0|||
23454808|NCT03001557|65407240|FG004|Extension Phase|Others|0|||
23454809|NCT03001557|65407241|FG005|Extension Phase|Others|1|||
23454810|NCT03001557|65407242|FG006|Extension Phase|Others|3|||
23454811|NCT03001557|65407243|FG007|Extension Phase|Others|0|||
23454812|NCT03905096|65407244|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
23454813|NCT03905096|65407245|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
23454814|NCT03452540|65407248|FG000|Overall Study|Adverse Event|1|||
23454815|NCT03452540|65407248|FG000|Overall Study|Withdrawal by Subject|1|||
23454816|NCT03452540|65407248|FG000|Overall Study|Other SAE and AE|2|||
23454817|NCT02782676|65407249|FG000|Overall Study|Lost to Follow-up|0|||
23454818|NCT02782676|65407250|FG001|Overall Study|Lost to Follow-up|1|||
23454819|NCT03305666|65407251|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
23454820|NCT03305666|65407252|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
23454821|NCT01808196|65407255|FG000|Overall Study|Lost to Follow-up|1|||
23454822|NCT01350999|65407257|FG000|Overall Study|Adverse Event|4|||
23454823|NCT01350999|65407258|FG001|Overall Study|Adverse Event|9|||
23454824|NCT01350999|65407259|FG002|Overall Study|Adverse Event|10|||
23454825|NCT01350999|65407257|FG000|Overall Study|Voluntary withdrawal|3|||
23454826|NCT01350999|65407258|FG001|Overall Study|Voluntary withdrawal|4|||
23636994|NCT01162863|66053081|FG001|Overall Study|Lack of Efficacy|0|||
23636995|NCT01162863|66053082|FG002|Overall Study|Lack of Efficacy|0|||
23636996|NCT01162863|66053080|FG000|Overall Study|Adverse Event|0|||
23636997|NCT01162863|66053081|FG001|Overall Study|Adverse Event|1|||
23636998|NCT01162863|66053082|FG002|Overall Study|Adverse Event|0|||
23636999|NCT01424813|66053083|FG000|Overall Study|Withdrawal by Subject|3|||
23637000|NCT01424813|66053084|FG001|Overall Study|Withdrawal by Subject|0|||
23637001|NCT01424813|66053083|FG000|Overall Study|Protocol Violation|1|||
23637002|NCT01424813|66053084|FG001|Overall Study|Protocol Violation|0|||
23637003|NCT01424813|66053083|FG000|Overall Study|Other|1|||
23637004|NCT01424813|66053084|FG001|Overall Study|Other|2|||
23843941|NCT01116648|66808896|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
23343513|NCT02883049|64999883|FG002|Induction|Identified as HR patients|0|||
23343514|NCT02883049|64999884|FG003|Induction|Identified as HR patients|0|||
23637005|NCT03381339|66053085|FG000|Overall Study|Protocol Violation|4|||
23343515|NCT02883049|64999885|FG004|Induction|Identified as HR patients|0|||
23343516|NCT02883049|64999886|FG005|Induction|Identified as HR patients|0|||
23454827|NCT01350999|65407259|FG002|Overall Study|Voluntary withdrawal|6|||
23637006|NCT03381339|66053086|FG001|Overall Study|Protocol Violation|3|||
23343517|NCT02883049|64999887|FG006|Induction|Identified as HR patients|0|||
23454828|NCT01350999|65407257|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
23454829|NCT01350999|65407258|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
23454830|NCT01350999|65407259|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
23454831|NCT04924062|65407266|FG000|Overall Study|Death|49|||
23454832|NCT04924062|65407267|FG001|Overall Study|Death|63|||
23454833|NCT04924062|65407266|FG000|Overall Study|Participant On-going|26|||
23454834|NCT04924062|65407267|FG001|Overall Study|Participant On-going|20|||
23454835|NCT00481832|65407268|FG000|Enrollment|Physician Decision|8|||
23454836|NCT00481832|65407268|FG000|Enrollment|Unable to collect enough stem cells|2|||
23843942|NCT01116648|66808897|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
23454837|NCT00481832|65407268|FG000|Inter-transplant Period|Adverse Event|4|||
23454838|NCT00481832|65407268|FG000|Inter-transplant Period|Death|3|||
23454839|NCT00481832|65407268|FG000|Inter-transplant Period|Physician Decision|4|||
23454840|NCT00481832|65407268|FG000|Inter-transplant Period|Disease relapse|11|||
23454841|NCT00481832|65407268|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
23454842|NCT03041038|65407277|FG000|Overall Study|Withdrawal by Subject|4|||
23454843|NCT03041038|65407278|FG001|Overall Study|Withdrawal by Subject|0|||
23454844|NCT03041038|65407277|FG000|Overall Study|Lost to Follow-up|1|||
23454845|NCT03041038|65407278|FG001|Overall Study|Lost to Follow-up|1|||
23454846|NCT03041038|65407277|FG000|Overall Study|Protocol Violation|1|||
23454847|NCT03041038|65407278|FG001|Overall Study|Protocol Violation|1|||
23454848|NCT02285855|65407279|FG000|Overall Study|Withdrawal by Subject|2|||
23454849|NCT02285855|65407280|FG001|Overall Study|Withdrawal by Subject|1|||
23454850|NCT00447226|65407281|FG000|12-Week Open-label Phase|Adverse Event|0|||
23454851|NCT00447226|65407282|FG001|12-Week Open-label Phase|Adverse Event|3|||
23454852|NCT00447226|65407281|FG000|12-Week Open-label Phase|Protocol Violation|0|||
23454853|NCT00447226|65407282|FG001|12-Week Open-label Phase|Protocol Violation|1|||
23454854|NCT00447226|65407281|FG000|12-Week Open-label Phase|Disease Progression|0|||
23454855|NCT00447226|65407282|FG001|12-Week Open-label Phase|Disease Progression|20|||
23454856|NCT00447226|65407281|FG000|12-Week Open-label Phase|Physician Decision|0|||
23454857|NCT00447226|65407282|FG001|12-Week Open-label Phase|Physician Decision|1|||
23454858|NCT00447226|65407281|FG000|Double-blind Phase|Disease Progression|4|||
23454859|NCT00447226|65407282|FG001|Double-blind Phase|Disease Progression|3|||
23454860|NCT00981149|65407284|FG000|Overall Study|Lost to Follow-up|1|||
23454861|NCT00981149|65407285|FG001|Overall Study|Lost to Follow-up|2|||
23454862|NCT00981149|65407284|FG000|Overall Study|Withdrawal by Subject|1|||
23454863|NCT00981149|65407285|FG001|Overall Study|Withdrawal by Subject|1|||
23454864|NCT04725188|65407286|FG000|Overall Study|Death|44|||
23454865|NCT04725188|65407287|FG001|Overall Study|Death|46|||
23454866|NCT04725188|65407288|FG002|Overall Study|Death|48|||
23454867|NCT04725188|65407286|FG000|Overall Study|Lost to Follow-up|0|||
23454868|NCT04725188|65407287|FG001|Overall Study|Lost to Follow-up|0|||
23454869|NCT04725188|65407288|FG002|Overall Study|Lost to Follow-up|1|||
23454870|NCT04725188|65407286|FG000|Overall Study|Withdrawal by Subject|2|||
23454871|NCT04725188|65407287|FG001|Overall Study|Withdrawal by Subject|2|||
23454872|NCT04725188|65407288|FG002|Overall Study|Withdrawal by Subject|1|||
23454873|NCT04725188|65407286|FG000|Overall Study|Participants ongoing in the study|41|||
23454874|NCT04725188|65407287|FG001|Overall Study|Participants ongoing in the study|35|||
23454875|NCT04725188|65407288|FG002|Overall Study|Participants ongoing in the study|35|||
23454876|NCT01381016|65407289|FG000|Overall Study|Lost to Follow-up|1|||
23454877|NCT01381016|65407290|FG001|Overall Study|Lost to Follow-up|1|||
23454878|NCT01381016|65407289|FG000|Overall Study|Screen Failure|2|||
23454879|NCT01381016|65407290|FG001|Overall Study|Screen Failure|2|||
23454880|NCT01381016|65407289|FG000|Overall Study|Withdrawal by Subject|0|||
23783650|NCT01173692|66586736|FG001|Overall Study|Adverse Event|2|||
23783651|NCT01173692|66586735|FG000|Overall Study|Withdrawal by Subject|1|||
23783652|NCT01173692|66586736|FG001|Overall Study|Withdrawal by Subject|3|||
23783653|NCT00561015|66586737|FG000|Overall Study|Adverse Event|0|||
23783654|NCT00561015|66586738|FG001|Overall Study|Adverse Event|0|||
23783655|NCT00561015|66586739|FG002|Overall Study|Adverse Event|0|||
23783656|NCT00561015|66586740|FG003|Overall Study|Adverse Event|0|||
23783657|NCT00561015|66586741|FG004|Overall Study|Adverse Event|1|||
23783658|NCT00561015|66586742|FG005|Overall Study|Adverse Event|0|||
23783659|NCT00561015|66586737|FG000|Overall Study|Lost to Follow-up|2|||
23783660|NCT00561015|66586738|FG001|Overall Study|Lost to Follow-up|0|||
23783661|NCT00561015|66586739|FG002|Overall Study|Lost to Follow-up|0|||
23454881|NCT01381016|65407290|FG001|Overall Study|Withdrawal by Subject|1|||
23454882|NCT01381016|65407289|FG000|Overall Study|Physician Decision|0|||
23454883|NCT01381016|65407290|FG001|Overall Study|Physician Decision|2|||
23454884|NCT04426318|65407293|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
23454885|NCT04426318|65407294|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
23454886|NCT01844765|65407299|FG000|Overall Study|Adverse Event|6|||
23783662|NCT00561015|66586740|FG003|Overall Study|Lost to Follow-up|1|||
23843943|NCT01116648|66808898|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
23783663|NCT00561015|66586741|FG004|Overall Study|Lost to Follow-up|0|||
23454887|NCT01844765|65407300|FG001|Overall Study|Adverse Event|8|||
23454888|NCT01844765|65407299|FG000|Overall Study|Withdrawal by Subject|2|||
23454889|NCT01844765|65407300|FG001|Overall Study|Withdrawal by Subject|3|||
23454890|NCT01844765|65407299|FG000|Overall Study|Disease progression|1|||
23454891|NCT01844765|65407300|FG001|Overall Study|Disease progression|0|||
23454892|NCT01844765|65407299|FG000|Overall Study|Administrative problems|3|||
23582633|NCT00723294|65862521|FG000|Overall Study|Withdrawal by Subject|1|||
23582634|NCT00723294|65862521|FG000|Overall Study|No treatment due to probe failure|1|||
23582635|NCT01097655|65862522|FG000|Overall Study|Withdrawal by Subject|1|||
23582636|NCT01097655|65862522|FG000|Overall Study|Subject Documented Twice|1|||
23843944|NCT01116648|66808899|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
23843945|NCT01116648|66808900|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
23843946|NCT01116648|66808901|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
23843947|NCT01116648|66808902|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
23582637|NCT01097655|65862522|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
23582638|NCT00868231|65862523|FG000|Treatment Period 1|Adverse Event|0|||
23582639|NCT00868231|65862524|FG001|Treatment Period 1|Adverse Event|0|||
23582640|NCT00868231|65862525|FG002|Treatment Period 1|Adverse Event|0|||
23582641|NCT00868231|65862526|FG003|Treatment Period 1|Adverse Event|0|||
23582642|NCT00868231|65862527|FG004|Treatment Period 1|Adverse Event|1|||
23582643|NCT00868231|65862528|FG005|Treatment Period 1|Adverse Event|0|||
23582644|NCT00868231|65862523|FG000|Treatment Period 2|Adverse Event|1|||
23582645|NCT00868231|65862524|FG001|Treatment Period 2|Adverse Event|0|||
23582646|NCT00868231|65862525|FG002|Treatment Period 2|Adverse Event|0|||
23582647|NCT00868231|65862526|FG003|Treatment Period 2|Adverse Event|0|||
23582648|NCT00868231|65862527|FG004|Treatment Period 2|Adverse Event|0|||
23582649|NCT00868231|65862528|FG005|Treatment Period 2|Adverse Event|0|||
23582650|NCT00868231|65862523|FG000|Treatment Period 3|Adverse Event|0|||
23582651|NCT00868231|65862524|FG001|Treatment Period 3|Adverse Event|0|||
23582652|NCT00868231|65862525|FG002|Treatment Period 3|Adverse Event|1|||
23582653|NCT00868231|65862526|FG003|Treatment Period 3|Adverse Event|0|||
23582654|NCT00868231|65862527|FG004|Treatment Period 3|Adverse Event|0|||
23582655|NCT00868231|65862528|FG005|Treatment Period 3|Adverse Event|0|||
23582656|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
23582657|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23582658|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23582659|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23582660|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23582661|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
23582662|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23582663|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
23582664|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
23582665|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
23582666|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23582667|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
23582668|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23582669|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23582670|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582671|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582672|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582673|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23582674|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582675|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582676|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582677|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582678|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
23582679|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582680|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582681|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582682|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582683|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582684|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23582685|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582686|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
23582687|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23582688|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23582689|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23637007|NCT03381339|66053085|FG000|Overall Study|Lost to Follow-up|0|||
23343518|NCT02883049|64999888|FG007|Induction|Identified as HR patients|0|||
23343519|NCT02883049|64999889|FG008|Induction|Identified as HR patients|0|||
23454893|NCT01844765|65407300|FG001|Overall Study|Administrative problems|4|||
23454894|NCT01844765|65407299|FG000|Overall Study|Protocol deviation|2|||
23454895|NCT01844765|65407300|FG001|Overall Study|Protocol deviation|0|||
23582690|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23582691|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23454896|NCT01844765|65407299|FG000|Overall Study|Untreated|1|||
23454897|NCT01844765|65407300|FG001|Overall Study|Untreated|0|||
23454898|NCT01755234|65407303|FG000|Overall Study|Lost to Follow-up|11|||
23454899|NCT01755234|65407304|FG001|Overall Study|Lost to Follow-up|6|||
23454900|NCT01755234|65407303|FG000|Overall Study|Change in surgical case|2|||
23454901|NCT01755234|65407304|FG001|Overall Study|Change in surgical case|1|||
23454902|NCT01755234|65407303|FG000|Overall Study|case cancelled|1|||
23454903|NCT01755234|65407304|FG001|Overall Study|case cancelled|0|||
23454904|NCT01755234|65407303|FG000|Overall Study|Withdrawal by Subject|0|||
23783664|NCT00561015|66586742|FG005|Overall Study|Lost to Follow-up|3|||
23783665|NCT00561015|66586737|FG000|Overall Study|Participant non-compliance|2|||
23783666|NCT00561015|66586738|FG001|Overall Study|Participant non-compliance|0|||
23783667|NCT00561015|66586739|FG002|Overall Study|Participant non-compliance|0|||
23783668|NCT00561015|66586740|FG003|Overall Study|Participant non-compliance|0|||
23783669|NCT00561015|66586741|FG004|Overall Study|Participant non-compliance|0|||
23783670|NCT00561015|66586742|FG005|Overall Study|Participant non-compliance|0|||
23783671|NCT01421277|66586743|FG000|Overall Study|Lack of qualifying event|0|||
23783672|NCT01421277|66586744|FG001|Overall Study|Lack of qualifying event|61|||
23783673|NCT01421277|66586743|FG000|Overall Study|Incomplete baseline data|0|||
23454905|NCT01755234|65407304|FG001|Overall Study|Withdrawal by Subject|1|||
23843948|NCT01116648|66808903|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
23843949|NCT01116648|66808904|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
23843950|NCT01116648|66808905|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
23843951|NCT01116648|66808906|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
23454906|NCT01755234|65407303|FG000|Overall Study|unblinded|1|||
23843952|NCT01116648|66808907|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
23343520|NCT02883049|64999890|FG009|Induction|Identified as HR patients|0|||
23454907|NCT01755234|65407304|FG001|Overall Study|unblinded|0|||
23454908|NCT01611792|65407305|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
23454909|NCT01611792|65407306|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
23582692|NCT01323660|65862530|FG000|Washout Period (14 Days)|Adverse Event|0|||
23582693|NCT01323660|65862531|FG001|Washout Period (14 Days)|Adverse Event|0|||
23582694|NCT01323660|65862532|FG002|Washout Period (14 Days)|Adverse Event|0|||
23582695|NCT01323660|65862533|FG003|Washout Period (14 Days)|Adverse Event|0|||
23582696|NCT01323660|65862534|FG004|Washout Period (14 Days)|Adverse Event|1|||
23582697|NCT01323660|65862535|FG005|Washout Period (14 Days)|Adverse Event|0|||
23582698|NCT01323660|65862530|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
23582699|NCT01323660|65862531|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
23582700|NCT01323660|65862532|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
23582701|NCT01323660|65862533|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
23582702|NCT01323660|65862534|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
23582703|NCT01323660|65862535|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
23582704|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582705|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23582706|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23582707|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582708|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582709|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
23582710|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
23582711|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23582712|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23783674|NCT01421277|66586744|FG001|Overall Study|Incomplete baseline data|31|||
23783675|NCT00682461|66586745|FG000|Overall Study|Adverse Event|5|||
23783676|NCT00682461|66586746|FG001|Overall Study|Adverse Event|7|||
23783677|NCT00682461|66586745|FG000|Overall Study|Lost to Follow-up|8|||
23783678|NCT00682461|66586746|FG001|Overall Study|Lost to Follow-up|5|||
23783679|NCT00682461|66586745|FG000|Overall Study|Withdrawal by Subject|12|||
23783680|NCT00682461|66586746|FG001|Overall Study|Withdrawal by Subject|19|||
23783681|NCT01913405|66586747|FG000|Overall Study|Withdrawal by Subject|1|||
23783682|NCT01913405|66586747|FG000|Overall Study|Adverse Event|1|||
23783683|NCT00851877|66586751|FG000|Phase I-1|Death|1|||
23843953|NCT01116648|66808908|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
23843954|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
23454910|NCT01611792|65407305|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
23454911|NCT01611792|65407306|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
23582713|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23582714|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23582715|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
23582716|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23783684|NCT00851877|66586752|FG001|Phase I-1|Death|0|||
23783685|NCT00851877|66586753|FG002|Phase I-1|Death|0|||
23783686|NCT00851877|66586751|FG000|Phase II|Withdrawal by Subject|0|||
23783687|NCT00851877|66586752|FG001|Phase II|Withdrawal by Subject|0|||
23783688|NCT00851877|66586753|FG002|Phase II|Withdrawal by Subject|3|||
23843955|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
23454912|NCT00474812|65407307|FG000|Overall Study|Withdrawal by Subject|5|||
23843956|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
23843957|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
23843958|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
23843959|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
23843960|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
23843961|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
23843962|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
23843963|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
23637008|NCT03381339|66053086|FG001|Overall Study|Lost to Follow-up|1|||
23637009|NCT04546425|66053087|FG000|Overall Study|Protocol Violation|1|||
23637010|NCT04546425|66053088|FG001|Overall Study|Protocol Violation|1|||
23637011|NCT04546425|66053089|FG002|Overall Study|Protocol Violation|0|||
23637012|NCT04546425|66053090|FG003|Overall Study|Protocol Violation|0|||
23637013|NCT04546425|66053087|FG000|Overall Study|Adverse Event|3|||
23637014|NCT04546425|66053088|FG001|Overall Study|Adverse Event|0|||
23637015|NCT04546425|66053089|FG002|Overall Study|Adverse Event|0|||
23637016|NCT04546425|66053090|FG003|Overall Study|Adverse Event|0|||
23637017|NCT04546425|66053087|FG000|Overall Study|Lost to Follow-up|5|||
23637018|NCT04546425|66053088|FG001|Overall Study|Lost to Follow-up|4|||
23637019|NCT04546425|66053089|FG002|Overall Study|Lost to Follow-up|0|||
23637020|NCT04546425|66053090|FG003|Overall Study|Lost to Follow-up|0|||
23637021|NCT04546425|66053087|FG000|Overall Study|No Longer met eligibility criteria|3|||
23637022|NCT04546425|66053088|FG001|Overall Study|No Longer met eligibility criteria|3|||
23637023|NCT04546425|66053089|FG002|Overall Study|No Longer met eligibility criteria|1|||
23843964|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
23637024|NCT04546425|66053090|FG003|Overall Study|No Longer met eligibility criteria|1|||
23637025|NCT04546425|66053087|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23637026|NCT04546425|66053088|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23637027|NCT04546425|66053089|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23637028|NCT04546425|66053090|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23637029|NCT04927884|66053095|FG000|Overall Study|Progressive Disease|2|||
23637030|NCT03043313|66053096|FG000|Overall Study|Withdrawal by Subject|4|||
23637031|NCT03043313|66053097|FG001|Overall Study|Withdrawal by Subject|1|||
23637032|NCT03043313|66053098|FG002|Overall Study|Withdrawal by Subject|1|||
23637033|NCT03043313|66053096|FG000|Overall Study|Lost to Follow-up|1|||
23637034|NCT03043313|66053097|FG001|Overall Study|Lost to Follow-up|0|||
23637035|NCT03043313|66053098|FG002|Overall Study|Lost to Follow-up|0|||
23637036|NCT03043313|66053096|FG000|Overall Study|Death|26|||
23637037|NCT03043313|66053097|FG001|Overall Study|Death|13|||
23637038|NCT03043313|66053098|FG002|Overall Study|Death|8|||
23637039|NCT03043313|66053096|FG000|Overall Study|On Treatment|7|||
23637040|NCT03043313|66053097|FG001|Overall Study|On Treatment|12|||
23637041|NCT03043313|66053098|FG002|Overall Study|On Treatment|11|||
23637042|NCT03043313|66053096|FG000|Overall Study|In follow up|7|||
23637043|NCT03043313|66053097|FG001|Overall Study|In follow up|15|||
23637044|NCT03043313|66053098|FG002|Overall Study|In follow up|11|||
23637045|NCT03551691|66053099|FG000|Overall Study|Withdrawal by Subject|3|||
23637046|NCT03551691|66053100|FG001|Overall Study|Withdrawal by Subject|3|||
23637047|NCT04307940|66053101|FG000|Overall Study|Adverse Event|1|||
23637048|NCT04307940|66053102|FG001|Overall Study|Adverse Event|0|||
23637049|NCT04307940|66053103|FG002|Overall Study|Adverse Event|0|||
23637050|NCT04307940|66053101|FG000|Overall Study|Withdrawal by Subject|2|||
23637051|NCT04307940|66053102|FG001|Overall Study|Withdrawal by Subject|3|||
23637052|NCT04307940|66053103|FG002|Overall Study|Withdrawal by Subject|1|||
23637053|NCT04307940|66053101|FG000|Overall Study|Lost to Follow-up|2|||
23637054|NCT04307940|66053102|FG001|Overall Study|Lost to Follow-up|0|||
23637055|NCT04307940|66053103|FG002|Overall Study|Lost to Follow-up|1|||
23637056|NCT01038427|66053104|FG000|Overall Study|Lost to follow up|1|||
23637057|NCT01038427|66053105|FG001|Overall Study|Lost to follow up|1|||
23637058|NCT01038427|66053106|FG002|Overall Study|Lost to follow up|0|||
23637059|NCT01038427|66053104|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23637060|NCT01038427|66053105|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23637061|NCT01038427|66053106|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
23637062|NCT01038427|66053104|FG000|Overall Study|Withdrew consent|0|||
23637063|NCT01038427|66053105|FG001|Overall Study|Withdrew consent|0|||
23637064|NCT01038427|66053106|FG002|Overall Study|Withdrew consent|1|||
23637065|NCT01038427|66053104|FG000|Overall Study|Adverse Event|2|||
23637066|NCT01038427|66053105|FG001|Overall Study|Adverse Event|2|||
23637067|NCT01038427|66053106|FG002|Overall Study|Adverse Event|1|||
23637068|NCT01038427|66053104|FG000|Overall Study|Enrolled in error|0|||
23637069|NCT01038427|66053105|FG001|Overall Study|Enrolled in error|1|||
23843965|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
23843966|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
23637070|NCT01038427|66053106|FG002|Overall Study|Enrolled in error|1|||
23637071|NCT01038427|66053104|FG000|Overall Study|Other|0|||
23637072|NCT01038427|66053105|FG001|Overall Study|Other|2|||
23637073|NCT01038427|66053106|FG002|Overall Study|Other|0|||
23843967|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
23843968|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
23843969|NCT02137850|66808909|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
23843970|NCT02137850|66808910|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
23843971|NCT02137850|66808911|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
23843972|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
23843973|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
23843974|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
23637074|NCT00573859|66053107|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
23637075|NCT00573859|66053107|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
23637076|NCT01370590|66053111|FG000|Period 1|Adverse Event|8|||
23637077|NCT01370590|66053112|FG001|Period 1|Adverse Event|4|||
23637078|NCT01370590|66053111|FG000|Period 1|Lost to Follow-up|2|||
23637079|NCT01370590|66053112|FG001|Period 1|Lost to Follow-up|2|||
23637080|NCT01370590|66053111|FG000|Period 1|Protocol Violation|2|||
23637081|NCT01370590|66053112|FG001|Period 1|Protocol Violation|2|||
23637082|NCT01370590|66053111|FG000|Period 1|Withdrawal by Subject|4|||
23637083|NCT01370590|66053112|FG001|Period 1|Withdrawal by Subject|2|||
23637084|NCT01370590|66053111|FG000|Period 1|Could not access randomization system|0|||
23637085|NCT01370590|66053112|FG001|Period 1|Could not access randomization system|1|||
23637086|NCT01370590|66053111|FG000|Crossover Washout Period|Adverse Event|1|||
23637087|NCT01370590|66053112|FG001|Crossover Washout Period|Adverse Event|4|||
23637088|NCT01370590|66053111|FG000|Crossover Washout Period|Lost to Follow-up|2|||
23637089|NCT01370590|66053112|FG001|Crossover Washout Period|Lost to Follow-up|0|||
23637090|NCT01370590|66053111|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
23783689|NCT03719040|66586756|FG000|Overall Study|Withdrawal by Subject|177|||
23783690|NCT03719040|66586756|FG000|Overall Study|Lost to Follow-up|26|||
23783691|NCT03874715|66586757|FG000|Overall Study|Adverse Event|2|||
23783692|NCT03874715|66586758|FG001|Overall Study|Adverse Event|0|||
23783693|NCT03874715|66586757|FG000|Overall Study|Poor compliance to protocol|5|||
23783694|NCT03874715|66586758|FG001|Overall Study|Poor compliance to protocol|1|||
23783695|NCT03874715|66586757|FG000|Overall Study|Withdrawal by Subject|1|||
23843975|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
23843976|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
23843977|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
23843978|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
23843979|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
23843980|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
23843981|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
23843982|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
23343521|NCT02883049|64999891|FG010|Induction|Identified as HR patients|0|||
23637091|NCT01370590|66053112|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
23637092|NCT01370590|66053111|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
23783696|NCT03874715|66586758|FG001|Overall Study|Withdrawal by Subject|0|||
23783697|NCT03874715|66586757|FG000|Overall Study|Other-unspecified|1|||
23783698|NCT03874715|66586758|FG001|Overall Study|Other-unspecified|0|||
23783699|NCT00747565|66586759|FG000|Overall Study|Withdrawal by Subject|10|||
23783700|NCT00747565|66586760|FG001|Overall Study|Withdrawal by Subject|6|||
23783701|NCT00747565|66586759|FG000|Overall Study|Lost to Follow-up|4|||
23783702|NCT00747565|66586760|FG001|Overall Study|Lost to Follow-up|1|||
23783703|NCT03343535|66586761|FG000|Overall Study|Lost to Follow-up|1|||
23783704|NCT03343535|66586761|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
23783705|NCT03343535|66586761|FG000|Overall Study|Death|12|||
23783706|NCT01494532|66586763|FG000|Overall Study|Adverse Event|4|||
23783707|NCT01494532|66586764|FG001|Overall Study|Adverse Event|1|||
23783708|NCT01494532|66586765|FG002|Overall Study|Adverse Event|8|||
23783709|NCT01494532|66586766|FG003|Overall Study|Adverse Event|6|||
23783710|NCT01494532|66586767|FG004|Overall Study|Adverse Event|5|||
23783711|NCT01494532|66586768|FG005|Overall Study|Adverse Event|0|||
23783712|NCT01494532|66586763|FG000|Overall Study|Lack of Efficacy|0|||
23783713|NCT01494532|66586764|FG001|Overall Study|Lack of Efficacy|0|||
23783714|NCT01494532|66586765|FG002|Overall Study|Lack of Efficacy|0|||
23783715|NCT01494532|66586766|FG003|Overall Study|Lack of Efficacy|0|||
23783716|NCT01494532|66586767|FG004|Overall Study|Lack of Efficacy|2|||
23783717|NCT01494532|66586768|FG005|Overall Study|Lack of Efficacy|0|||
23783718|NCT01494532|66586763|FG000|Overall Study|Protocol deviation|2|||
23783719|NCT01494532|66586764|FG001|Overall Study|Protocol deviation|1|||
23783720|NCT01494532|66586765|FG002|Overall Study|Protocol deviation|3|||
23783721|NCT01494532|66586766|FG003|Overall Study|Protocol deviation|2|||
23783722|NCT01494532|66586767|FG004|Overall Study|Protocol deviation|3|||
23783723|NCT01494532|66586768|FG005|Overall Study|Protocol deviation|0|||
23783724|NCT01494532|66586763|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23783725|NCT01494532|66586764|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23843983|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
23637093|NCT01370590|66053112|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
23637094|NCT01370590|66053111|FG000|Period 2|Adverse Event|0|||
23783726|NCT01494532|66586765|FG002|Overall Study|Protocol-defined stopping criteria|1|||
23783727|NCT01494532|66586766|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23783728|NCT01494532|66586767|FG004|Overall Study|Protocol-defined stopping criteria|0|||
23783729|NCT01494532|66586768|FG005|Overall Study|Protocol-defined stopping criteria|0|||
23783730|NCT01494532|66586763|FG000|Overall Study|Lost to Follow-up|1|||
23783731|NCT01494532|66586764|FG001|Overall Study|Lost to Follow-up|0|||
23783732|NCT01494532|66586765|FG002|Overall Study|Lost to Follow-up|0|||
23783733|NCT01494532|66586766|FG003|Overall Study|Lost to Follow-up|2|||
23783734|NCT01494532|66586767|FG004|Overall Study|Lost to Follow-up|0|||
23783735|NCT01494532|66586768|FG005|Overall Study|Lost to Follow-up|0|||
23343522|NCT02883049|64999892|FG011|Induction|Identified as HR patients|0|||
23343523|NCT02883049|64999893|FG012|Induction|Identified as HR patients|0|||
23343524|NCT02883049|64999894|FG013|Induction|Identified as HR patients|0|||
23343525|NCT02883049|64999895|FG014|Induction|Identified as HR patients|0|||
23343526|NCT02883049|64999896|FG015|Induction|Identified as HR patients|0|||
23343527|NCT02883049|64999881|FG000|Induction|Developed SMN|0|||
23343528|NCT02883049|64999882|FG001|Induction|Developed SMN|1|||
23343529|NCT02883049|64999883|FG002|Induction|Developed SMN|0|||
23343530|NCT02883049|64999884|FG003|Induction|Developed SMN|0|||
23343531|NCT02883049|64999885|FG004|Induction|Developed SMN|0|||
23343532|NCT02883049|64999886|FG005|Induction|Developed SMN|0|||
23343533|NCT02883049|64999887|FG006|Induction|Developed SMN|0|||
23343534|NCT02883049|64999888|FG007|Induction|Developed SMN|0|||
23343535|NCT02883049|64999889|FG008|Induction|Developed SMN|0|||
23343536|NCT02883049|64999890|FG009|Induction|Developed SMN|0|||
23343537|NCT02883049|64999891|FG010|Induction|Developed SMN|0|||
23343538|NCT02883049|64999892|FG011|Induction|Developed SMN|0|||
23343539|NCT02883049|64999893|FG012|Induction|Developed SMN|0|||
23343540|NCT02883049|64999894|FG013|Induction|Developed SMN|0|||
23343541|NCT02883049|64999895|FG014|Induction|Developed SMN|0|||
23343542|NCT02883049|64999896|FG015|Induction|Developed SMN|0|||
23343543|NCT02883049|64999881|FG000|Induction|Enrolled onto another COG study|72|||
23343544|NCT02883049|64999882|FG001|Induction|Enrolled onto another COG study|0|||
23343545|NCT02883049|64999883|FG002|Induction|Enrolled onto another COG study|0|||
23343546|NCT02883049|64999884|FG003|Induction|Enrolled onto another COG study|0|||
23343547|NCT02883049|64999885|FG004|Induction|Enrolled onto another COG study|0|||
23343548|NCT02883049|64999886|FG005|Induction|Enrolled onto another COG study|0|||
23343549|NCT02883049|64999887|FG006|Induction|Enrolled onto another COG study|0|||
23343550|NCT02883049|64999888|FG007|Induction|Enrolled onto another COG study|0|||
23343551|NCT02883049|64999889|FG008|Induction|Enrolled onto another COG study|0|||
23343552|NCT02883049|64999890|FG009|Induction|Enrolled onto another COG study|0|||
23343553|NCT02883049|64999891|FG010|Induction|Enrolled onto another COG study|0|||
23343554|NCT02883049|64999892|FG011|Induction|Enrolled onto another COG study|0|||
23343555|NCT02883049|64999893|FG012|Induction|Enrolled onto another COG study|0|||
23343556|NCT02883049|64999894|FG013|Induction|Enrolled onto another COG study|0|||
23343557|NCT02883049|64999895|FG014|Induction|Enrolled onto another COG study|0|||
23343558|NCT02883049|64999896|FG015|Induction|Enrolled onto another COG study|0|||
23343559|NCT02883049|64999881|FG000|Induction|Incomplete induction data|17|||
23343560|NCT02883049|64999882|FG001|Induction|Incomplete induction data|0|||
23343561|NCT02883049|64999883|FG002|Induction|Incomplete induction data|0|||
23843984|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Other|0|||
23343562|NCT02883049|64999884|FG003|Induction|Incomplete induction data|0|||
23343563|NCT02883049|64999885|FG004|Induction|Incomplete induction data|0|||
23343564|NCT02883049|64999886|FG005|Induction|Incomplete induction data|0|||
23454913|NCT00474812|65407307|FG000|Overall Study|No Initiation of treatment|2|||
23454914|NCT00771914|65407308|FG000|Overall Study|Physician Decision|0|||
23582717|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582718|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582719|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582720|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582721|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
23582722|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23582723|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582724|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582725|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582726|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582727|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23582728|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23783736|NCT01494532|66586763|FG000|Overall Study|Physician Decision|0|||
23343565|NCT02883049|64999887|FG006|Induction|Incomplete induction data|0|||
23343566|NCT02883049|64999888|FG007|Induction|Incomplete induction data|0|||
23343567|NCT02883049|64999889|FG008|Induction|Incomplete induction data|0|||
23343568|NCT02883049|64999890|FG009|Induction|Incomplete induction data|0|||
23343569|NCT02883049|64999891|FG010|Induction|Incomplete induction data|0|||
23343570|NCT02883049|64999892|FG011|Induction|Incomplete induction data|0|||
23343571|NCT02883049|64999893|FG012|Induction|Incomplete induction data|0|||
23454915|NCT00771914|65407309|FG001|Overall Study|Physician Decision|0|||
23454916|NCT00771914|65407310|FG002|Overall Study|Physician Decision|0|||
23454917|NCT00771914|65407311|FG003|Overall Study|Physician Decision|1|||
23454918|NCT00771914|65407308|FG000|Overall Study|Lost to Follow-up|0|||
23454919|NCT00771914|65407309|FG001|Overall Study|Lost to Follow-up|0|||
23454920|NCT00771914|65407310|FG002|Overall Study|Lost to Follow-up|0|||
23454921|NCT00771914|65407311|FG003|Overall Study|Lost to Follow-up|1|||
23454922|NCT01045460|65407312|FG000|Overall Study|Physician Decision|3|||
23454923|NCT01045460|65407313|FG001|Overall Study|Physician Decision|2|||
23454924|NCT01045460|65407312|FG000|Overall Study|Lost to Follow-up|0|||
23454925|NCT01045460|65407313|FG001|Overall Study|Lost to Follow-up|1|||
23454926|NCT01045460|65407312|FG000|Overall Study|Lack of Efficacy|3|||
23454927|NCT01045460|65407313|FG001|Overall Study|Lack of Efficacy|0|||
23454928|NCT03253679|65407316|FG000|Overall Study|Screen Failure|1|||
23454929|NCT04233801|65407317|FG000|Overall Study|Other than listed|0|||
23454930|NCT04233801|65407318|FG001|Overall Study|Other than listed|0|||
23454931|NCT04233801|65407319|FG002|Overall Study|Other than listed|1|||
23454932|NCT04233801|65407317|FG000|Overall Study|Withdrawal by Subject|0|||
23454933|NCT04233801|65407318|FG001|Overall Study|Withdrawal by Subject|2|||
23454934|NCT04233801|65407319|FG002|Overall Study|Withdrawal by Subject|3|||
23454935|NCT00928486|65407321|FG000|Overall Study|Adverse Event|2|||
23454936|NCT00928486|65407321|FG000|Overall Study|Disease Progression|7|||
23454937|NCT00928486|65407321|FG000|Overall Study|Withdrawal by Subject|1|||
23454938|NCT00387881|65407322|FG000|Overall Study|Lost to Follow-up|23|||
23454939|NCT00387881|65407323|FG001|Overall Study|Lost to Follow-up|23|||
23454940|NCT00387881|65407322|FG000|Overall Study|Protocol Violation|2|||
23454941|NCT00387881|65407323|FG001|Overall Study|Protocol Violation|12|||
23454942|NCT00387881|65407322|FG000|Overall Study|Withdrawal by Subject|15|||
23454943|NCT00387881|65407323|FG001|Overall Study|Withdrawal by Subject|18|||
23454944|NCT00387881|65407322|FG000|Overall Study|Sponsor terminated Study|0|||
23637095|NCT01370590|66053112|FG001|Period 2|Adverse Event|1|||
23637096|NCT01370590|66053111|FG000|Period 2|Withdrawal by Subject|1|||
23637097|NCT01370590|66053112|FG001|Period 2|Withdrawal by Subject|1|||
23637098|NCT04230122|66053113|FG000|Overall Study|Lost to Follow-up|1|||
23637099|NCT04230122|66053114|FG001|Overall Study|Lost to Follow-up|0|||
23637100|NCT05110690|66053123|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
23637101|NCT05110690|66053123|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
23637102|NCT05110690|66053123|FG000|Completion of Intervention|Lost to Follow-up|1|||
23637103|NCT05110690|66053123|FG000|Completion of Intervention|Death|1|||
23637104|NCT05110690|66053123|FG000|Completion of Intervention|Withdrawal by Subject|2|||
23637105|NCT01200342|66057324|FG000|Overall Study|Disease Progression|1|||
23637106|NCT01374568|66057325|FG000|Overall Study|Lab unable to analyze BTM|0|||
23637107|NCT01374568|66057326|FG001|Overall Study|Lab unable to analyze BTM|2|||
23637108|NCT00415051|66057327|FG000|Overall Study|Protocol Violation|1|||
23637109|NCT01294436|66057328|FG000|Overall Study|Adverse Event|10|||
23637110|NCT01294436|66057329|FG001|Overall Study|Adverse Event|17|||
23637111|NCT01294436|66057328|FG000|Overall Study|Withdrawal by Subject|11|||
23637112|NCT01294436|66057329|FG001|Overall Study|Withdrawal by Subject|28|||
23637113|NCT01294436|66057328|FG000|Overall Study|subject no longer meets study criteria|5|||
23637114|NCT01294436|66057329|FG001|Overall Study|subject no longer meets study criteria|20|||
23637115|NCT01294436|66057328|FG000|Overall Study|poor/non-compliance|2|||
23637116|NCT01294436|66057329|FG001|Overall Study|poor/non-compliance|5|||
23637117|NCT01641159|66057330|FG000|Overall Study|Lost to Follow-up|2|||
23637118|NCT01641159|66057331|FG001|Overall Study|Lost to Follow-up|1|||
23637119|NCT01641159|66057330|FG000|Overall Study|Withdrawal by Subject|0|||
23637120|NCT01641159|66057331|FG001|Overall Study|Withdrawal by Subject|1|||
23637121|NCT03980808|66057332|FG000|Overall Study|Lost to Follow-up|2|||
23637122|NCT03980808|66057333|FG001|Overall Study|Lost to Follow-up|2|||
23637123|NCT01559129|66057336|FG000|Treatment Phase|Adverse Event|0|||
23637124|NCT01559129|66057337|FG001|Treatment Phase|Adverse Event|2|||
23637125|NCT01559129|66057336|FG000|Treatment Phase|Progressive Disease|1|||
23637126|NCT01559129|66057337|FG001|Treatment Phase|Progressive Disease|1|||
23637127|NCT01559129|66057336|FG000|Treatment Phase|Lack of Efficacy|0|||
23454945|NCT00387881|65407323|FG001|Overall Study|Sponsor terminated Study|1|||
23454946|NCT00387881|65407322|FG000|Overall Study|Not eligible|6|||
23454947|NCT00387881|65407323|FG001|Overall Study|Not eligible|7|||
23454948|NCT00387881|65407322|FG000|Overall Study|No opportunity to treat headache|32|||
23454949|NCT00387881|65407323|FG001|Overall Study|No opportunity to treat headache|34|||
23454950|NCT00387881|65407322|FG000|Overall Study|Not otherwise specified|11|||
23454951|NCT00387881|65407323|FG001|Overall Study|Not otherwise specified|7|||
23637128|NCT01559129|66057337|FG001|Treatment Phase|Lack of Efficacy|1|||
23637129|NCT01559129|66057336|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
23454952|NCT00617734|65407324|FG000|Overall Study|Withdrew Consent|2|||
23637130|NCT01559129|66057337|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
23637131|NCT01559129|66057336|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
23637132|NCT01559129|66057337|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
23454953|NCT00617734|65407325|FG001|Overall Study|Withdrew Consent|0|||
23454954|NCT00617734|65407324|FG000|Overall Study|Adverse Event|4|||
23454955|NCT00617734|65407325|FG001|Overall Study|Adverse Event|1|||
23843985|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Other|1|||
23843986|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Other|0|||
23843987|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
23843988|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
23843989|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
23843990|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Early site closure|0|||
23843991|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Early site closure|2|||
23843992|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Early site closure|0|||
23843993|NCT02137850|66808909|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
23843994|NCT02137850|66808910|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
23843995|NCT02137850|66808911|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
23843996|NCT02137850|66808909|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
23843997|NCT02137850|66808910|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
23843998|NCT02137850|66808911|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
23843999|NCT02137850|66808909|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
23844000|NCT02137850|66808910|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
23844001|NCT02137850|66808911|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
23844002|NCT02137850|66808909|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
23844003|NCT02137850|66808910|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
23844004|NCT02137850|66808911|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
23844005|NCT02137850|66808909|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
23844006|NCT02137850|66808910|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
23844007|NCT02137850|66808911|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
23844008|NCT02137850|66808909|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
23844009|NCT02137850|66808910|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
23844010|NCT02137850|66808911|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
23844011|NCT02137850|66808909|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
23844012|NCT02137850|66808910|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
23844013|NCT02137850|66808911|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
23844014|NCT02137850|66808909|FG000|Extension Phase: Prophylaxis|Other|0|||
23844015|NCT02137850|66808910|FG001|Extension Phase: Prophylaxis|Other|1|||
23844016|NCT02137850|66808911|FG002|Extension Phase: Prophylaxis|Other|0|||
23844017|NCT02137850|66808909|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
23844018|NCT02137850|66808910|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
23844019|NCT02137850|66808911|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
23844020|NCT01981954|66808913|FG000|Titration Period|Protocol Deviation|1|||
23844021|NCT01981954|66808913|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
23844022|NCT05569954|66808917|FG000|Overall Study|Lost to Follow-up|3|||
23844023|NCT05569954|66808918|FG001|Overall Study|Lost to Follow-up|4|||
23844024|NCT05569954|66808917|FG000|Overall Study|Protocol Violation|1|||
23844025|NCT05569954|66808918|FG001|Overall Study|Protocol Violation|2|||
23844026|NCT05569954|66808917|FG000|Overall Study|Withdrawal by Subject|4|||
23844027|NCT05569954|66808918|FG001|Overall Study|Withdrawal by Subject|2|||
23844028|NCT04739800|66808919|FG000|Overall Study|Adverse Event|2|||
23844029|NCT04739800|66808920|FG001|Overall Study|Adverse Event|1|||
23844030|NCT04739800|66808921|FG002|Overall Study|Adverse Event|4|||
23844031|NCT04739800|66808922|FG003|Overall Study|Adverse Event|5|||
23844032|NCT04739800|66808919|FG000|Overall Study|Never Treated|2|||
23844033|NCT04739800|66808920|FG001|Overall Study|Never Treated|0|||
23844034|NCT04739800|66808921|FG002|Overall Study|Never Treated|1|||
23844035|NCT04739800|66808922|FG003|Overall Study|Never Treated|1|||
23844036|NCT04739800|66808919|FG000|Overall Study|On Treatment|5|||
23844037|NCT04739800|66808920|FG001|Overall Study|On Treatment|9|||
23844038|NCT04739800|66808921|FG002|Overall Study|On Treatment|9|||
23844039|NCT04739800|66808922|FG003|Overall Study|On Treatment|9|||
23844040|NCT04739800|66808919|FG000|Overall Study|Symptomatic Deterioration|1|||
23844041|NCT04739800|66808920|FG001|Overall Study|Symptomatic Deterioration|1|||
23844042|NCT04739800|66808921|FG002|Overall Study|Symptomatic Deterioration|3|||
23844043|NCT04739800|66808922|FG003|Overall Study|Symptomatic Deterioration|0|||
23844044|NCT04739800|66808919|FG000|Overall Study|Withdrawal by Subject|1|||
23844045|NCT04739800|66808920|FG001|Overall Study|Withdrawal by Subject|2|||
23844046|NCT04739800|66808921|FG002|Overall Study|Withdrawal by Subject|1|||
23844047|NCT04739800|66808922|FG003|Overall Study|Withdrawal by Subject|3|||
23844048|NCT04739800|66808919|FG000|Overall Study|Other Reason|1|||
23844049|NCT04739800|66808920|FG001|Overall Study|Other Reason|3|||
23844050|NCT04739800|66808921|FG002|Overall Study|Other Reason|5|||
23844051|NCT04739800|66808922|FG003|Overall Study|Other Reason|4|||
23844052|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
23844053|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
23844054|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
23844055|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23844056|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23844057|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23343572|NCT02883049|64999894|FG013|Induction|Incomplete induction data|0|||
23343573|NCT02883049|64999895|FG014|Induction|Incomplete induction data|0|||
23343574|NCT02883049|64999896|FG015|Induction|Incomplete induction data|0|||
23343575|NCT02883049|64999881|FG000|Post Induction|Adverse Event|0|||
23343576|NCT02883049|64999882|FG001|Post Induction|Adverse Event|0|||
23343577|NCT02883049|64999883|FG002|Post Induction|Adverse Event|0|||
23343578|NCT02883049|64999884|FG003|Post Induction|Adverse Event|7|||
23343579|NCT02883049|64999885|FG004|Post Induction|Adverse Event|8|||
23343580|NCT02883049|64999886|FG005|Post Induction|Adverse Event|3|||
23343581|NCT02883049|64999887|FG006|Post Induction|Adverse Event|4|||
23343582|NCT02883049|64999888|FG007|Post Induction|Adverse Event|5|||
23343583|NCT02883049|64999889|FG008|Post Induction|Adverse Event|6|||
23343584|NCT02883049|64999890|FG009|Post Induction|Adverse Event|7|||
23343585|NCT02883049|64999891|FG010|Post Induction|Adverse Event|2|||
23343586|NCT02883049|64999892|FG011|Post Induction|Adverse Event|2|||
23343587|NCT02883049|64999893|FG012|Post Induction|Adverse Event|0|||
23343588|NCT02883049|64999894|FG013|Post Induction|Adverse Event|0|||
23343589|NCT02883049|64999895|FG014|Post Induction|Adverse Event|5|||
23343590|NCT02883049|64999896|FG015|Post Induction|Adverse Event|2|||
23343591|NCT02883049|64999881|FG000|Post Induction|Death|0|||
23343592|NCT02883049|64999882|FG001|Post Induction|Death|0|||
23343593|NCT02883049|64999883|FG002|Post Induction|Death|0|||
23343594|NCT02883049|64999884|FG003|Post Induction|Death|9|||
23343595|NCT02883049|64999885|FG004|Post Induction|Death|9|||
23343596|NCT02883049|64999886|FG005|Post Induction|Death|0|||
23343597|NCT02883049|64999887|FG006|Post Induction|Death|1|||
23343598|NCT02883049|64999888|FG007|Post Induction|Death|6|||
23343599|NCT02883049|64999889|FG008|Post Induction|Death|5|||
23343600|NCT02883049|64999890|FG009|Post Induction|Death|3|||
23343601|NCT02883049|64999891|FG010|Post Induction|Death|1|||
23343602|NCT02883049|64999892|FG011|Post Induction|Death|0|||
23343603|NCT02883049|64999893|FG012|Post Induction|Death|1|||
23343604|NCT02883049|64999894|FG013|Post Induction|Death|1|||
23343605|NCT02883049|64999895|FG014|Post Induction|Death|10|||
23343606|NCT02883049|64999896|FG015|Post Induction|Death|2|||
23343607|NCT02883049|64999881|FG000|Post Induction|Lost to Follow-up|0|||
23343608|NCT02883049|64999882|FG001|Post Induction|Lost to Follow-up|0|||
23343609|NCT02883049|64999883|FG002|Post Induction|Lost to Follow-up|0|||
23343610|NCT02883049|64999884|FG003|Post Induction|Lost to Follow-up|0|||
23343611|NCT02883049|64999885|FG004|Post Induction|Lost to Follow-up|1|||
23343612|NCT02883049|64999886|FG005|Post Induction|Lost to Follow-up|1|||
23343613|NCT02883049|64999887|FG006|Post Induction|Lost to Follow-up|0|||
23343614|NCT02883049|64999888|FG007|Post Induction|Lost to Follow-up|0|||
23343615|NCT02883049|64999889|FG008|Post Induction|Lost to Follow-up|3|||
23343616|NCT02883049|64999890|FG009|Post Induction|Lost to Follow-up|0|||
23343617|NCT02883049|64999891|FG010|Post Induction|Lost to Follow-up|1|||
23343618|NCT02883049|64999892|FG011|Post Induction|Lost to Follow-up|0|||
23343619|NCT02883049|64999893|FG012|Post Induction|Lost to Follow-up|0|||
23343620|NCT02883049|64999894|FG013|Post Induction|Lost to Follow-up|0|||
23343621|NCT02883049|64999895|FG014|Post Induction|Lost to Follow-up|0|||
23343622|NCT02883049|64999896|FG015|Post Induction|Lost to Follow-up|0|||
23343623|NCT02883049|64999881|FG000|Post Induction|Physician Decision|0|||
23343624|NCT02883049|64999882|FG001|Post Induction|Physician Decision|0|||
23343625|NCT02883049|64999883|FG002|Post Induction|Physician Decision|0|||
23343626|NCT02883049|64999884|FG003|Post Induction|Physician Decision|27|||
23343627|NCT02883049|64999885|FG004|Post Induction|Physician Decision|27|||
23343628|NCT02883049|64999886|FG005|Post Induction|Physician Decision|23|||
23343629|NCT02883049|64999887|FG006|Post Induction|Physician Decision|30|||
23343630|NCT02883049|64999888|FG007|Post Induction|Physician Decision|56|||
23343631|NCT02883049|64999889|FG008|Post Induction|Physician Decision|85|||
23343632|NCT02883049|64999890|FG009|Post Induction|Physician Decision|12|||
23454956|NCT00617734|65407324|FG000|Overall Study|Protocol Violation|1|||
23454957|NCT00617734|65407325|FG001|Overall Study|Protocol Violation|0|||
23454958|NCT00617734|65407324|FG000|Overall Study|Found Ineligible After Randomization|1|||
23454959|NCT00617734|65407325|FG001|Overall Study|Found Ineligible After Randomization|4|||
23454960|NCT00617734|65407324|FG000|Overall Study|Lost to Follow-up|0|||
23454961|NCT00617734|65407325|FG001|Overall Study|Lost to Follow-up|1|||
23454962|NCT04439136|65407329|FG000|Overall Study|Ineligible|1|||
23637133|NCT01559129|66057336|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
23783737|NCT01494532|66586764|FG001|Overall Study|Physician Decision|1|||
23783738|NCT01494532|66586765|FG002|Overall Study|Physician Decision|1|||
23343633|NCT02883049|64999891|FG010|Post Induction|Physician Decision|5|||
23343634|NCT02883049|64999892|FG011|Post Induction|Physician Decision|14|||
23343635|NCT02883049|64999893|FG012|Post Induction|Physician Decision|1|||
23343636|NCT02883049|64999894|FG013|Post Induction|Physician Decision|11|||
23343637|NCT02883049|64999895|FG014|Post Induction|Physician Decision|19|||
23343638|NCT02883049|64999896|FG015|Post Induction|Physician Decision|5|||
23343639|NCT02883049|64999881|FG000|Post Induction|Protocol Violation|0|||
23343640|NCT02883049|64999882|FG001|Post Induction|Protocol Violation|0|||
23343641|NCT02883049|64999883|FG002|Post Induction|Protocol Violation|0|||
23343642|NCT02883049|64999884|FG003|Post Induction|Protocol Violation|0|||
23343643|NCT02883049|64999885|FG004|Post Induction|Protocol Violation|0|||
23343644|NCT02883049|64999886|FG005|Post Induction|Protocol Violation|0|||
23343645|NCT02883049|64999887|FG006|Post Induction|Protocol Violation|0|||
23343646|NCT02883049|64999888|FG007|Post Induction|Protocol Violation|1|||
23343647|NCT02883049|64999889|FG008|Post Induction|Protocol Violation|0|||
23343648|NCT02883049|64999890|FG009|Post Induction|Protocol Violation|0|||
23343649|NCT02883049|64999891|FG010|Post Induction|Protocol Violation|0|||
23343650|NCT02883049|64999892|FG011|Post Induction|Protocol Violation|0|||
23343651|NCT02883049|64999893|FG012|Post Induction|Protocol Violation|0|||
23343652|NCT02883049|64999894|FG013|Post Induction|Protocol Violation|0|||
23343653|NCT02883049|64999895|FG014|Post Induction|Protocol Violation|0|||
23343654|NCT02883049|64999896|FG015|Post Induction|Protocol Violation|0|||
23343655|NCT02883049|64999881|FG000|Post Induction|Withdrawal by Subject|0|||
23343656|NCT02883049|64999882|FG001|Post Induction|Withdrawal by Subject|0|||
23343657|NCT02883049|64999883|FG002|Post Induction|Withdrawal by Subject|0|||
23343658|NCT02883049|64999884|FG003|Post Induction|Withdrawal by Subject|5|||
23343659|NCT02883049|64999885|FG004|Post Induction|Withdrawal by Subject|2|||
23343660|NCT02883049|64999886|FG005|Post Induction|Withdrawal by Subject|1|||
23343661|NCT02883049|64999887|FG006|Post Induction|Withdrawal by Subject|0|||
23454963|NCT04439136|65407329|FG000|Overall Study|Never Started Treatment|2|||
23454964|NCT04439136|65407329|FG000|Overall Study|Adverse Event|4|||
23454965|NCT04439136|65407329|FG000|Overall Study|Death|3|||
23454966|NCT04439136|65407329|FG000|Overall Study|Disease Progression|27|||
23454967|NCT04439136|65407329|FG000|Overall Study|Alternative Therapy|1|||
23454968|NCT04439136|65407329|FG000|Overall Study|Increased Tumor Burden|1|||
23454969|NCT04439136|65407329|FG000|Overall Study|Symptomatic Detrioration|1|||
23454970|NCT00383552|65407330|FG000|Overall Study|Adverse Event|7|||
23454971|NCT00383552|65407331|FG001|Overall Study|Adverse Event|6|||
23454972|NCT00383552|65407332|FG002|Overall Study|Adverse Event|9|||
23454973|NCT00383552|65407333|FG003|Overall Study|Adverse Event|6|||
23454974|NCT00383552|65407330|FG000|Overall Study|Lack of Efficacy|4|||
23454975|NCT00383552|65407331|FG001|Overall Study|Lack of Efficacy|13|||
23454976|NCT00383552|65407332|FG002|Overall Study|Lack of Efficacy|29|||
23454977|NCT00383552|65407333|FG003|Overall Study|Lack of Efficacy|42|||
23454978|NCT00383552|65407330|FG000|Overall Study|Lost to Follow-up|0|||
23783739|NCT01494532|66586766|FG003|Overall Study|Physician Decision|2|||
23783740|NCT01494532|66586767|FG004|Overall Study|Physician Decision|0|||
23783741|NCT01494532|66586768|FG005|Overall Study|Physician Decision|0|||
23783742|NCT01494532|66586763|FG000|Overall Study|Withdrawal by Subject|3|||
23783743|NCT01494532|66586764|FG001|Overall Study|Withdrawal by Subject|1|||
23783744|NCT01494532|66586765|FG002|Overall Study|Withdrawal by Subject|4|||
23783745|NCT01494532|66586766|FG003|Overall Study|Withdrawal by Subject|3|||
23783746|NCT01494532|66586767|FG004|Overall Study|Withdrawal by Subject|2|||
23783747|NCT01494532|66586768|FG005|Overall Study|Withdrawal by Subject|0|||
23783748|NCT06195579|66586772|FG000|Overall Study|Withdrawal by Subject|1|||
23844058|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23844059|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23844060|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
23844061|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
23844062|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23844063|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23844064|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23844065|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23844066|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
23844067|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
23844068|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23844069|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23844070|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23844071|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23844072|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23844073|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23844074|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
23844075|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23844076|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23844077|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23343662|NCT02883049|64999888|FG007|Post Induction|Withdrawal by Subject|0|||
23343663|NCT02883049|64999889|FG008|Post Induction|Withdrawal by Subject|2|||
23343664|NCT02883049|64999890|FG009|Post Induction|Withdrawal by Subject|0|||
23783749|NCT01309672|66586783|FG000|Overall Study|Lack of Efficacy|20|||
23343665|NCT02883049|64999891|FG010|Post Induction|Withdrawal by Subject|1|||
23343666|NCT02883049|64999892|FG011|Post Induction|Withdrawal by Subject|1|||
23343667|NCT02883049|64999893|FG012|Post Induction|Withdrawal by Subject|0|||
23343668|NCT02883049|64999894|FG013|Post Induction|Withdrawal by Subject|0|||
23783750|NCT01309672|66586783|FG000|Overall Study|Other|9|||
23783751|NCT01309672|66586783|FG000|Overall Study|Adverse Event|5|||
23783752|NCT01309672|66586783|FG000|Overall Study|Withdrawal by Subject|3|||
23783753|NCT02642653|66586784|FG000|Overall Study|Adverse Event|2|||
23783754|NCT02642653|66586785|FG001|Overall Study|Adverse Event|0|||
23343669|NCT02883049|64999895|FG014|Post Induction|Withdrawal by Subject|1|||
23343670|NCT02883049|64999896|FG015|Post Induction|Withdrawal by Subject|0|||
23454979|NCT00383552|65407331|FG001|Overall Study|Lost to Follow-up|1|||
23454980|NCT00383552|65407332|FG002|Overall Study|Lost to Follow-up|5|||
23454981|NCT00383552|65407333|FG003|Overall Study|Lost to Follow-up|1|||
23454982|NCT00383552|65407330|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
23454983|NCT00383552|65407331|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
23454984|NCT00383552|65407332|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
23454985|NCT00383552|65407333|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
23454986|NCT00383552|65407330|FG000|Overall Study|Did not wish to continue (related)|1|||
23454987|NCT00383552|65407331|FG001|Overall Study|Did not wish to continue (related)|0|||
23454988|NCT00383552|65407332|FG002|Overall Study|Did not wish to continue (related)|2|||
23454989|NCT00383552|65407333|FG003|Overall Study|Did not wish to continue (related)|3|||
23454990|NCT00383552|65407330|FG000|Overall Study|Noncompliance with the protocol|11|||
23783755|NCT01247701|66586786|FG000|Overall Study|Death|2|||
23783756|NCT01247701|66586786|FG000|Overall Study|Relapsed|8|||
23783757|NCT01827163|66586791|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
23783758|NCT01827163|66586791|FG000|Overall Study|Adverse Event|9|||
23783759|NCT03913377|66586792|FG000|Period 1|Test Article no longer available|0|||
23783760|NCT03913377|66586793|FG001|Period 1|Test Article no longer available|1|||
23783761|NCT03913377|66586794|FG002|Period 1|Test Article no longer available|0|||
23783762|NCT03913377|66586792|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
23783763|NCT03913377|66586793|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
23783764|NCT03913377|66586794|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
23783765|NCT03114891|66586797|FG000|First Treatment Round|Lost to Follow-up|0|||
23783766|NCT03114891|66586798|FG001|First Treatment Round|Lost to Follow-up|1|||
23783767|NCT03114891|66586799|FG002|First Treatment Round|Lost to Follow-up|1|||
23783768|NCT03114891|66586800|FG003|First Treatment Round|Lost to Follow-up|0|||
23454991|NCT00383552|65407331|FG001|Overall Study|Noncompliance with the protocol|6|||
23454992|NCT00383552|65407332|FG002|Overall Study|Noncompliance with the protocol|8|||
23454993|NCT00383552|65407333|FG003|Overall Study|Noncompliance with the protocol|10|||
23454994|NCT00383552|65407330|FG000|Overall Study|Did not meet protocol eligibility|8|||
23454995|NCT00383552|65407331|FG001|Overall Study|Did not meet protocol eligibility|6|||
23454996|NCT00383552|65407332|FG002|Overall Study|Did not meet protocol eligibility|2|||
23454997|NCT00383552|65407333|FG003|Overall Study|Did not meet protocol eligibility|3|||
23454998|NCT00383552|65407330|FG000|Overall Study|Administrative|1|||
23454999|NCT00383552|65407331|FG001|Overall Study|Administrative|0|||
23455000|NCT00383552|65407332|FG002|Overall Study|Administrative|1|||
23455001|NCT00383552|65407333|FG003|Overall Study|Administrative|1|||
23844078|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23844079|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23844080|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
23844081|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23844082|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
23844083|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23844084|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23844085|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23844086|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23844087|NCT03395184|66808923|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
23844088|NCT03395184|66808924|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
23844089|NCT03395184|66808925|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
23844090|NCT03395184|66808926|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
23844091|NCT03395184|66808927|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
23844092|NCT03395184|66808928|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
23844093|NCT03395184|66808929|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
23844094|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
23844095|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
23844096|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
23844097|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
23844098|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
23844099|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
23637134|NCT01559129|66057337|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
23844100|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
23844101|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23343671|NCT02883049|64999881|FG000|Post Induction|Ineligible|0|||
23783769|NCT03114891|66586797|FG000|First Treatment Round|Withdrawal by Subject|0|||
23783770|NCT03114891|66586798|FG001|First Treatment Round|Withdrawal by Subject|2|||
23582729|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23844102|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23343672|NCT02883049|64999882|FG001|Post Induction|Ineligible|0|||
23343673|NCT02883049|64999883|FG002|Post Induction|Ineligible|2|||
23343674|NCT02883049|64999884|FG003|Post Induction|Ineligible|0|||
23343675|NCT02883049|64999885|FG004|Post Induction|Ineligible|0|||
23343676|NCT02883049|64999886|FG005|Post Induction|Ineligible|0|||
23343677|NCT02883049|64999887|FG006|Post Induction|Ineligible|1|||
23343678|NCT02883049|64999888|FG007|Post Induction|Ineligible|0|||
23343679|NCT02883049|64999889|FG008|Post Induction|Ineligible|0|||
23343680|NCT02883049|64999890|FG009|Post Induction|Ineligible|0|||
23343681|NCT02883049|64999891|FG010|Post Induction|Ineligible|1|||
23343682|NCT02883049|64999892|FG011|Post Induction|Ineligible|0|||
23343683|NCT02883049|64999893|FG012|Post Induction|Ineligible|0|||
23343684|NCT02883049|64999894|FG013|Post Induction|Ineligible|0|||
23343685|NCT02883049|64999895|FG014|Post Induction|Ineligible|0|||
23343686|NCT02883049|64999896|FG015|Post Induction|Ineligible|1|||
23343687|NCT02883049|64999881|FG000|Post Induction|Refusal of further protocol therapy|0|||
23343688|NCT02883049|64999882|FG001|Post Induction|Refusal of further protocol therapy|0|||
23343689|NCT02883049|64999883|FG002|Post Induction|Refusal of further protocol therapy|0|||
23343690|NCT02883049|64999884|FG003|Post Induction|Refusal of further protocol therapy|11|||
23343691|NCT02883049|64999885|FG004|Post Induction|Refusal of further protocol therapy|15|||
23343692|NCT02883049|64999886|FG005|Post Induction|Refusal of further protocol therapy|9|||
23343693|NCT02883049|64999887|FG006|Post Induction|Refusal of further protocol therapy|13|||
23343694|NCT02883049|64999888|FG007|Post Induction|Refusal of further protocol therapy|5|||
23343695|NCT02883049|64999889|FG008|Post Induction|Refusal of further protocol therapy|21|||
23343696|NCT02883049|64999890|FG009|Post Induction|Refusal of further protocol therapy|7|||
23343697|NCT02883049|64999891|FG010|Post Induction|Refusal of further protocol therapy|0|||
23343698|NCT02883049|64999892|FG011|Post Induction|Refusal of further protocol therapy|7|||
23343699|NCT02883049|64999893|FG012|Post Induction|Refusal of further protocol therapy|3|||
23343700|NCT02883049|64999894|FG013|Post Induction|Refusal of further protocol therapy|0|||
23343701|NCT02883049|64999895|FG014|Post Induction|Refusal of further protocol therapy|4|||
23343702|NCT02883049|64999896|FG015|Post Induction|Refusal of further protocol therapy|1|||
23343703|NCT02883049|64999881|FG000|Post Induction|Inevaluable|0|||
23343704|NCT02883049|64999882|FG001|Post Induction|Inevaluable|0|||
23343705|NCT02883049|64999883|FG002|Post Induction|Inevaluable|0|||
23343706|NCT02883049|64999884|FG003|Post Induction|Inevaluable|1|||
23343707|NCT02883049|64999885|FG004|Post Induction|Inevaluable|1|||
23343708|NCT02883049|64999886|FG005|Post Induction|Inevaluable|2|||
23343709|NCT02883049|64999887|FG006|Post Induction|Inevaluable|7|||
23343710|NCT02883049|64999888|FG007|Post Induction|Inevaluable|6|||
23343711|NCT02883049|64999889|FG008|Post Induction|Inevaluable|4|||
23343712|NCT02883049|64999890|FG009|Post Induction|Inevaluable|4|||
23343713|NCT02883049|64999891|FG010|Post Induction|Inevaluable|1|||
23343714|NCT02883049|64999892|FG011|Post Induction|Inevaluable|1|||
23455002|NCT03291067|65407334|FG000|Overall Study|Adverse Event|0|||
23343715|NCT02883049|64999893|FG012|Post Induction|Inevaluable|2|||
23455003|NCT03291067|65407335|FG001|Overall Study|Adverse Event|2|||
23455004|NCT03291067|65407336|FG002|Overall Study|Adverse Event|17|||
23455005|NCT03291067|65407337|FG003|Overall Study|Adverse Event|3|||
23455006|NCT03291067|65407334|FG000|Overall Study|Lost to Follow-up|2|||
23455007|NCT03291067|65407335|FG001|Overall Study|Lost to Follow-up|1|||
23455008|NCT03291067|65407336|FG002|Overall Study|Lost to Follow-up|0|||
23455009|NCT03291067|65407337|FG003|Overall Study|Lost to Follow-up|1|||
23455010|NCT03291067|65407334|FG000|Overall Study|Physician Decision|0|||
23455011|NCT03291067|65407335|FG001|Overall Study|Physician Decision|0|||
23455012|NCT03291067|65407336|FG002|Overall Study|Physician Decision|1|||
23455013|NCT03291067|65407337|FG003|Overall Study|Physician Decision|0|||
23455014|NCT03291067|65407334|FG000|Overall Study|Protocol Violation|5|||
23455015|NCT03291067|65407335|FG001|Overall Study|Protocol Violation|3|||
23455016|NCT03291067|65407336|FG002|Overall Study|Protocol Violation|4|||
23455017|NCT03291067|65407337|FG003|Overall Study|Protocol Violation|2|||
23455018|NCT03291067|65407334|FG000|Overall Study|Withdrawal by Subject|3|||
23455019|NCT03291067|65407335|FG001|Overall Study|Withdrawal by Subject|4|||
23455020|NCT03291067|65407336|FG002|Overall Study|Withdrawal by Subject|7|||
23455021|NCT03291067|65407337|FG003|Overall Study|Withdrawal by Subject|5|||
23455022|NCT03291067|65407334|FG000|Overall Study|Other|0|||
23455023|NCT03291067|65407335|FG001|Overall Study|Other|4|||
23343716|NCT02883049|64999894|FG013|Post Induction|Inevaluable|0|||
23343717|NCT02883049|64999895|FG014|Post Induction|Inevaluable|0|||
23343718|NCT02883049|64999896|FG015|Post Induction|Inevaluable|1|||
23343719|NCT02883049|64999881|FG000|Post Induction|Moved to another non-COG institution|0|||
23343720|NCT02883049|64999882|FG001|Post Induction|Moved to another non-COG institution|0|||
23343721|NCT02883049|64999883|FG002|Post Induction|Moved to another non-COG institution|0|||
23343722|NCT02883049|64999884|FG003|Post Induction|Moved to another non-COG institution|0|||
23343723|NCT02883049|64999885|FG004|Post Induction|Moved to another non-COG institution|0|||
23343724|NCT02883049|64999886|FG005|Post Induction|Moved to another non-COG institution|0|||
23343725|NCT02883049|64999887|FG006|Post Induction|Moved to another non-COG institution|0|||
23455024|NCT03291067|65407336|FG002|Overall Study|Other|4|||
23455025|NCT03291067|65407337|FG003|Overall Study|Other|6|||
23455026|NCT03617172|65407338|FG000|Overall Study|Lost to Follow-up|1|||
23455027|NCT03617172|65407339|FG001|Overall Study|Lost to Follow-up|0|||
23455028|NCT00524485|65409563|FG000|Overall Study|Withdrawal by Subject|5|||
23455029|NCT00231777|65409567|FG000|Overall Study|Lost to Follow-up|3|||
23455030|NCT00231777|65409568|FG001|Overall Study|Lost to Follow-up|0|||
23455031|NCT00231777|65409567|FG000|Overall Study|Other|3|||
23455032|NCT00231777|65409568|FG001|Overall Study|Other|2|||
23455033|NCT02174731|65409571|FG000|Overall Study|Participant decision|67|||
23455034|NCT02174731|65409572|FG001|Overall Study|Participant decision|64|||
23455035|NCT02174731|65409571|FG000|Overall Study|Incorrect enrolment before randomization|0|||
23455036|NCT02174731|65409572|FG001|Overall Study|Incorrect enrolment before randomization|1|||
23455037|NCT02174731|65409571|FG000|Overall Study|Missing|2|||
23455038|NCT02174731|65409572|FG001|Overall Study|Missing|0|||
23455039|NCT00231816|65409585|FG000|Overall Study|Adverse Event|1|||
23455040|NCT00231816|65409586|FG001|Overall Study|Adverse Event|0|||
23783771|NCT03114891|66586799|FG002|First Treatment Round|Withdrawal by Subject|0|||
23783772|NCT03114891|66586800|FG003|First Treatment Round|Withdrawal by Subject|1|||
23783773|NCT03114891|66586797|FG000|3 Week Break|Lost to Follow-up|1|||
23783774|NCT03114891|66586798|FG001|3 Week Break|Lost to Follow-up|0|||
23783775|NCT03114891|66586799|FG002|3 Week Break|Lost to Follow-up|0|||
23783776|NCT03114891|66586800|FG003|3 Week Break|Lost to Follow-up|1|||
23783777|NCT03114891|66586797|FG000|3 Week Break|Withdrawal by Subject|0|||
23783778|NCT03114891|66586798|FG001|3 Week Break|Withdrawal by Subject|1|||
23783779|NCT03114891|66586799|FG002|3 Week Break|Withdrawal by Subject|0|||
23783780|NCT03114891|66586800|FG003|3 Week Break|Withdrawal by Subject|0|||
23783781|NCT03114891|66586797|FG000|Second Treatment Round|Lost to Follow-up|1|||
23783782|NCT03114891|66586798|FG001|Second Treatment Round|Lost to Follow-up|0|||
23783783|NCT03114891|66586799|FG002|Second Treatment Round|Lost to Follow-up|0|||
23783784|NCT03114891|66586800|FG003|Second Treatment Round|Lost to Follow-up|0|||
23783785|NCT03114891|66586797|FG000|Second Treatment Round|Physician Decision|1|||
23783786|NCT03114891|66586798|FG001|Second Treatment Round|Physician Decision|0|||
23783787|NCT03114891|66586799|FG002|Second Treatment Round|Physician Decision|0|||
23783788|NCT03114891|66586800|FG003|Second Treatment Round|Physician Decision|0|||
23783789|NCT01796171|66586801|FG000|Enrolled|Death|0|||
23783790|NCT01796171|66586802|FG001|Enrolled|Death|0|||
23783791|NCT01796171|66586803|FG002|Enrolled|Death|0|||
23783792|NCT01796171|66586804|FG003|Enrolled|Death|0|||
23783793|NCT01796171|66586805|FG004|Enrolled|Death|0|||
23783794|NCT01796171|66586806|FG005|Enrolled|Death|0|||
23783795|NCT01796171|66586807|FG006|Enrolled|Death|0|||
23783796|NCT01796171|66586808|FG007|Enrolled|Death|0|||
23783797|NCT01796171|66586809|FG008|Enrolled|Death|0|||
23783798|NCT01796171|66586810|FG009|Enrolled|Death|0|||
23783799|NCT01796171|66586811|FG010|Enrolled|Death|0|||
23783800|NCT01796171|66586812|FG011|Enrolled|Death|0|||
23783801|NCT01796171|66586813|FG012|Enrolled|Death|0|||
23783802|NCT01796171|66586814|FG013|Enrolled|Death|0|||
23783803|NCT01796171|66586815|FG014|Enrolled|Death|1|||
23783804|NCT01796171|66586801|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
23783805|NCT01796171|66586802|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
23783806|NCT01796171|66586803|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
23783807|NCT01796171|66586804|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
23783808|NCT01796171|66586805|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
23783809|NCT01796171|66586806|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
23783810|NCT01796171|66586807|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
23783811|NCT01796171|66586808|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
23783812|NCT01796171|66586809|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
23783813|NCT01796171|66586810|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
23783814|NCT01796171|66586811|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
23844103|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23844104|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
23343726|NCT02883049|64999888|FG007|Post Induction|Moved to another non-COG institution|2|||
23343727|NCT02883049|64999889|FG008|Post Induction|Moved to another non-COG institution|2|||
23343728|NCT02883049|64999890|FG009|Post Induction|Moved to another non-COG institution|0|||
23343729|NCT02883049|64999891|FG010|Post Induction|Moved to another non-COG institution|0|||
23783815|NCT01796171|66586812|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
23783816|NCT01796171|66586813|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
23783817|NCT01796171|66586814|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
23783818|NCT01796171|66586815|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
23783819|NCT01796171|66586801|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783820|NCT01796171|66586802|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783821|NCT01796171|66586803|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783822|NCT01796171|66586804|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783823|NCT01796171|66586805|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783824|NCT01796171|66586806|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23455041|NCT00231816|65409585|FG000|Overall Study|Lost to Follow-up|8|||
23783825|NCT01796171|66586807|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23455042|NCT00231816|65409586|FG001|Overall Study|Lost to Follow-up|5|||
23455043|NCT00231816|65409585|FG000|Overall Study|Protocol Violation|2|||
23455044|NCT00231816|65409586|FG001|Overall Study|Protocol Violation|3|||
23455045|NCT00231816|65409585|FG000|Overall Study|Withdrawal by Subject|3|||
23455046|NCT00231816|65409586|FG001|Overall Study|Withdrawal by Subject|3|||
23455047|NCT00231816|65409585|FG000|Overall Study|Other|2|||
23455048|NCT00231816|65409586|FG001|Overall Study|Other|1|||
23455049|NCT04124939|65409588|FG000|Overall Study|Lost to Follow-up|1|||
23455050|NCT04124939|65409589|FG001|Overall Study|Lost to Follow-up|3|||
23455051|NCT01358877|65409596|FG000|Overall Study|Death|80|||
23455052|NCT01358877|65409597|FG001|Overall Study|Death|89|||
23455053|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
23455054|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
23455055|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
23455056|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
23455057|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
23455058|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
23455059|NCT01358877|65409596|FG000|Overall Study|Other|142|||
23455060|NCT01358877|65409597|FG001|Overall Study|Other|129|||
23455061|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455062|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455063|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455064|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455065|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455066|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455067|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455068|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455069|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455070|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455071|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455072|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455073|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
23455074|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455075|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455076|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455077|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455078|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
23455079|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455080|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455081|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455082|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455083|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455084|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
23455085|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455086|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
23455087|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455088|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455089|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455090|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455091|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
23455092|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455093|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455094|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455095|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455096|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455097|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455098|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
23455099|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455100|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455101|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
23455102|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455103|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455104|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455105|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
23455106|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455107|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455108|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23783826|NCT01796171|66586808|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23455109|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455110|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455111|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455112|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
23455113|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455114|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455115|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
23455116|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455117|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455118|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455119|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
23455120|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455121|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455122|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
23455123|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455124|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455125|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455126|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455127|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455128|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455129|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23783827|NCT01796171|66586809|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783828|NCT01796171|66586810|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783829|NCT01796171|66586811|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783830|NCT01796171|66586812|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783831|NCT01796171|66586813|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783832|NCT01796171|66586814|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
23783833|NCT01796171|66586815|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23783834|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Progressive disease|0|||
23783835|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Progressive disease|1|||
23783836|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Progressive disease|0|||
23783837|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Progressive disease|0|||
23783838|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Progressive disease|0|||
23783839|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Progressive disease|0|||
23783840|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Progressive disease|0|||
23844105|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
23844106|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
23844107|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
23844108|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23455130|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
23455131|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455132|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455133|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455134|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455135|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455136|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455137|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
23455138|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23844109|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23844110|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23844111|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23844112|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
23844113|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23844114|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23844115|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23455139|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455140|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455141|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455142|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455143|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455144|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
23706032|NCT00718419|66301029|FG000|Overall Study|Sponsor decision|0|||
23844116|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23844117|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23455145|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455146|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455147|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455148|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455149|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455150|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455151|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
23455152|NCT04685798|65409607|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
23455153|NCT00997035|65409608|FG000|3-week Followup Visit|Lost to Follow-up|9|||
23455154|NCT00997035|65409609|FG001|3-week Followup Visit|Lost to Follow-up|6|||
23455155|NCT00997035|65409608|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
23455156|NCT00997035|65409609|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
23455157|NCT03309020|65409610|FG000|Overall Study|Death|1|||
23455158|NCT03309020|65409611|FG001|Overall Study|Death|0|||
23455159|NCT03309020|65409610|FG000|Overall Study|Did not undergo surgery|2|||
23455160|NCT03309020|65409611|FG001|Overall Study|Did not undergo surgery|1|||
23455161|NCT03858049|65409612|FG000|Overall Study|Adverse Event|16|||
23455162|NCT03858049|65409613|FG001|Overall Study|Adverse Event|9|||
23455163|NCT03858049|65409612|FG000|Overall Study|Other|1|||
23455164|NCT03858049|65409613|FG001|Overall Study|Other|1|||
23455165|NCT01045967|65409616|FG000|Second Intervention|Protocol Violation|0|||
23455166|NCT01045967|65409617|FG001|Second Intervention|Protocol Violation|1|||
23455167|NCT05482308|65409618|FG000|Overall Study|Withdrawal by Subject|1|||
23455168|NCT05482308|65409619|FG001|Overall Study|Withdrawal by Subject|0|||
23455169|NCT05482308|65409618|FG000|Overall Study|No longer meets eligibility criteria|0|||
23455170|NCT05482308|65409619|FG001|Overall Study|No longer meets eligibility criteria|1|||
23455171|NCT00904969|65409630|FG000|Overall Study|Lost to Follow-up|4|||
23455172|NCT00904969|65409630|FG000|Overall Study|Withdrawal by Subject|3|||
23455173|NCT00904969|65409630|FG000|Overall Study|Additional Treatments|11|||
23455174|NCT00904969|65409630|FG000|Overall Study|Case Aborted; Subject Exited|1|||
23455175|NCT00107653|65409635|FG000|Overall Study|Adverse Event|24|||
23455176|NCT00107653|65409636|FG001|Overall Study|Adverse Event|43|||
23455177|NCT00107653|65409635|FG000|Overall Study|Insufficient Therapeutic Response|25|||
23455178|NCT00107653|65409636|FG001|Overall Study|Insufficient Therapeutic Response|11|||
23455179|NCT00107653|65409635|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23455180|NCT00107653|65409636|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23455181|NCT00107653|65409635|FG000|Overall Study|Protocol Violation|1|||
23455182|NCT00107653|65409636|FG001|Overall Study|Protocol Violation|0|||
23455183|NCT00107653|65409635|FG000|Overall Study|Withdrawal by Subject|12|||
23455184|NCT00107653|65409636|FG001|Overall Study|Withdrawal by Subject|13|||
23455185|NCT00107653|65409635|FG000|Overall Study|Lost to Follow-up|13|||
23455186|NCT00107653|65409636|FG001|Overall Study|Lost to Follow-up|5|||
23455187|NCT00107653|65409635|FG000|Overall Study|Administrative Reasons|3|||
23455188|NCT00107653|65409636|FG001|Overall Study|Administrative Reasons|3|||
23455189|NCT04366349|65409637|FG000|Overall Study|Withdrawal by Subject|1|||
23455190|NCT04366349|65409638|FG001|Overall Study|Withdrawal by Subject|0|||
23455191|NCT04366349|65409639|FG002|Overall Study|Withdrawal by Subject|0|||
23455192|NCT04366349|65409640|FG003|Overall Study|Withdrawal by Subject|0|||
23455193|NCT04366349|65409641|FG004|Overall Study|Withdrawal by Subject|0|||
23455194|NCT04366349|65409642|FG005|Overall Study|Withdrawal by Subject|0|||
23455195|NCT02219464|65409645|FG000|Overall Study|Withdrawal by Subject|1|||
23455196|NCT02219464|65409646|FG001|Overall Study|Withdrawal by Subject|0|||
23455197|NCT02219464|65409645|FG000|Overall Study|case cancelled|1|||
23455198|NCT02219464|65409646|FG001|Overall Study|case cancelled|0|||
23455199|NCT02219464|65409645|FG000|Overall Study|catheter malfunction|1|||
23455200|NCT02219464|65409646|FG001|Overall Study|catheter malfunction|0|||
23455201|NCT03212326|65409647|FG000|Overall Study|Physician Decision|4|||
23455202|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
23455203|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
23455204|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
23455205|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
23455206|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
23455207|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
23455208|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
23455209|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23455210|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23455211|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
23455212|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23455213|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23455214|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
23455215|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23455216|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23455217|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Other|119|||
23455218|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Other|0|||
23455219|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Other|0|||
23455220|NCT01436149|65409652|FG000|Randomized Phase|Adverse Event|9|||
23455221|NCT01436149|65409653|FG001|Randomized Phase|Adverse Event|10|||
23455222|NCT01436149|65409654|FG002|Randomized Phase|Adverse Event|11|||
23455223|NCT01436149|65409652|FG000|Randomized Phase|Protocol Violation|4|||
23455224|NCT01436149|65409653|FG001|Randomized Phase|Protocol Violation|5|||
23455225|NCT01436149|65409654|FG002|Randomized Phase|Protocol Violation|0|||
23455226|NCT01436149|65409652|FG000|Randomized Phase|Withdrawal by Subject|16|||
23455227|NCT01436149|65409653|FG001|Randomized Phase|Withdrawal by Subject|10|||
23455228|NCT01436149|65409654|FG002|Randomized Phase|Withdrawal by Subject|10|||
23455229|NCT01436149|65409652|FG000|Randomized Phase|Lost to Follow-up|34|||
23455230|NCT01436149|65409653|FG001|Randomized Phase|Lost to Follow-up|5|||
23455231|NCT01436149|65409654|FG002|Randomized Phase|Lost to Follow-up|6|||
23455232|NCT01436149|65409652|FG000|Randomized Phase|Lack of Efficacy|0|||
23455233|NCT01436149|65409653|FG001|Randomized Phase|Lack of Efficacy|0|||
23455234|NCT01436149|65409654|FG002|Randomized Phase|Lack of Efficacy|1|||
23455235|NCT01436149|65409652|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
23455236|NCT01436149|65409653|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
23455237|NCT01436149|65409654|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
23455238|NCT01436149|65409652|FG000|Randomized Phase|Other|12|||
23455239|NCT01436149|65409653|FG001|Randomized Phase|Other|5|||
23455240|NCT01436149|65409654|FG002|Randomized Phase|Other|11|||
23455241|NCT00642356|65409655|FG000|Overall Study|Adverse Event|1|||
23455242|NCT00642356|65409656|FG001|Overall Study|Adverse Event|0|||
23455243|NCT00642356|65409655|FG000|Overall Study|Protocol Violation|0|||
23455244|NCT00642356|65409656|FG001|Overall Study|Protocol Violation|3|||
23455245|NCT00642356|65409655|FG000|Overall Study|Lack of Efficacy|1|||
23455246|NCT00642356|65409656|FG001|Overall Study|Lack of Efficacy|0|||
23455247|NCT03040999|65409657|FG000|Overall Study|Lost to Follow-up|1|||
23455248|NCT03040999|65409658|FG001|Overall Study|Lost to Follow-up|0|||
23455249|NCT03040999|65409657|FG000|Overall Study|Withdrawal by Subject|7|||
23455250|NCT03040999|65409658|FG001|Overall Study|Withdrawal by Subject|12|||
23455251|NCT03040999|65409657|FG000|Overall Study|Death|128|||
23455252|NCT03040999|65409658|FG001|Overall Study|Death|138|||
23455253|NCT03040999|65409657|FG000|Overall Study|Participants Ongoing in Trial|266|||
23455254|NCT03040999|65409658|FG001|Overall Study|Participants Ongoing in Trial|252|||
23455255|NCT03416868|65409662|FG000|Overall Study|Withdrawal by Subject|2|||
23455256|NCT03416868|65409662|FG000|Overall Study|Lost to Follow-up|1|||
23455257|NCT03115359|65409666|FG000|Overall Study|Withdrawal by Subject|29|||
23455258|NCT03115359|65409667|FG001|Overall Study|Withdrawal by Subject|39|||
23455259|NCT03115359|65409666|FG000|Overall Study|Scheduling conflict|25|||
23455260|NCT03115359|65409667|FG001|Overall Study|Scheduling conflict|23|||
23455261|NCT03115359|65409666|FG000|Overall Study|Personal reasons including health|12|||
23455262|NCT03115359|65409667|FG001|Overall Study|Personal reasons including health|9|||
23455263|NCT03115359|65409666|FG000|Overall Study|Transportation barriers|3|||
23455264|NCT03115359|65409667|FG001|Overall Study|Transportation barriers|0|||
23455265|NCT03115359|65409666|FG000|Overall Study|No longer interested|5|||
23455266|NCT03115359|65409667|FG001|Overall Study|No longer interested|4|||
23455267|NCT03115359|65409666|FG000|Overall Study|No reason provided|45|||
23455268|NCT03115359|65409667|FG001|Overall Study|No reason provided|47|||
23455269|NCT01231984|65409668|FG000|Study Period 1|Withdrawal by Subject|0|||
23455270|NCT01231984|65409669|FG001|Study Period 1|Withdrawal by Subject|0|||
23455271|NCT01231984|65409670|FG002|Study Period 1|Withdrawal by Subject|0|||
23455272|NCT01231984|65409671|FG003|Study Period 1|Withdrawal by Subject|1|||
23455273|NCT01231984|65409668|FG000|Study Period 1|Lost to Follow-up|1|||
23455274|NCT01231984|65409669|FG001|Study Period 1|Lost to Follow-up|1|||
23455275|NCT01231984|65409670|FG002|Study Period 1|Lost to Follow-up|1|||
23455276|NCT01231984|65409671|FG003|Study Period 1|Lost to Follow-up|0|||
23455277|NCT01231984|65409668|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455278|NCT01231984|65409669|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455279|NCT01231984|65409670|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455280|NCT01231984|65409671|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455281|NCT01231984|65409668|FG000|Study Period 1|Screen Failure|0|||
23455282|NCT01231984|65409669|FG001|Study Period 1|Screen Failure|0|||
23455283|NCT01231984|65409670|FG002|Study Period 1|Screen Failure|0|||
23455284|NCT01231984|65409671|FG003|Study Period 1|Screen Failure|1|||
23455285|NCT01231984|65409668|FG000|Study Period 1|Non-compliance with study requirements|5|||
23455286|NCT01231984|65409669|FG001|Study Period 1|Non-compliance with study requirements|0|||
23455287|NCT01231984|65409670|FG002|Study Period 1|Non-compliance with study requirements|2|||
23455288|NCT01231984|65409671|FG003|Study Period 1|Non-compliance with study requirements|1|||
23455289|NCT01231984|65409668|FG000|Study Period 1|Protocol Violation|3|||
23455290|NCT01231984|65409669|FG001|Study Period 1|Protocol Violation|4|||
23637135|NCT01559129|66057336|FG000|Open-label Extension Period|Adverse Event|1|||
23637136|NCT01559129|66057337|FG001|Open-label Extension Period|Adverse Event|0|||
23455291|NCT01231984|65409670|FG002|Study Period 1|Protocol Violation|2|||
23455292|NCT01231984|65409671|FG003|Study Period 1|Protocol Violation|3|||
23455293|NCT01231984|65409668|FG000|Study Period 1|Adverse Event|1|||
23455294|NCT01231984|65409669|FG001|Study Period 1|Adverse Event|0|||
23455295|NCT01231984|65409670|FG002|Study Period 1|Adverse Event|0|||
23455296|NCT01231984|65409671|FG003|Study Period 1|Adverse Event|0|||
23455297|NCT01231984|65409668|FG000|Study Period 1|Other|0|||
23455298|NCT01231984|65409669|FG001|Study Period 1|Other|0|||
23455299|NCT01231984|65409670|FG002|Study Period 1|Other|0|||
23455300|NCT01231984|65409671|FG003|Study Period 1|Other|1|||
23455301|NCT01231984|65409668|FG000|Study Period 2|Withdrawal by Subject|1|||
23455302|NCT01231984|65409669|FG001|Study Period 2|Withdrawal by Subject|1|||
23455303|NCT01231984|65409670|FG002|Study Period 2|Withdrawal by Subject|0|||
23455304|NCT01231984|65409671|FG003|Study Period 2|Withdrawal by Subject|0|||
23455305|NCT01231984|65409668|FG000|Study Period 2|Lost to Follow-up|1|||
23455306|NCT01231984|65409669|FG001|Study Period 2|Lost to Follow-up|0|||
23455307|NCT01231984|65409670|FG002|Study Period 2|Lost to Follow-up|0|||
23455308|NCT01231984|65409671|FG003|Study Period 2|Lost to Follow-up|3|||
23455309|NCT01231984|65409668|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455310|NCT01231984|65409669|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455311|NCT01231984|65409670|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
23455312|NCT01231984|65409671|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455313|NCT02343263|65409672|FG000|Overall Study|Physician Decision|5|||
23455314|NCT02343263|65409673|FG001|Overall Study|Physician Decision|3|||
23455315|NCT02343263|65409674|FG002|Overall Study|Physician Decision|1|||
23455316|NCT02177123|65409675|FG000|Overall Study|Lost to Follow-up|6|||
23455317|NCT02177123|65409675|FG000|Overall Study|Withdrawal by Subject|4|||
23455318|NCT02177123|65409675|FG000|Overall Study|Adverse Event|4|||
23455319|NCT02177123|65409675|FG000|Overall Study|Physician Decision|3|||
23455320|NCT02177123|65409675|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
23455321|NCT02177123|65409675|FG000|Overall Study|Excluded for medical reasons|2|||
23455322|NCT02177123|65409675|FG000|Overall Study|Death|1|||
23455323|NCT02177123|65409675|FG000|Overall Study|Other|1|||
23455324|NCT02177123|65409675|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
23455325|NCT00445549|65409676|FG000|Overall Study|progressive disease|12|||
23455326|NCT01393158|65409677|FG000|Overall Study|Adverse Event|1|||
23455327|NCT01393158|65409678|FG001|Overall Study|Adverse Event|0|||
23455328|NCT04606134|65409679|FG000|Overall Study|Adverse Event|0|||
23455329|NCT04606134|65409680|FG001|Overall Study|Adverse Event|1|||
23455330|NCT00981656|65409681|FG000|Overall Study|Protocol Violation|1|||
23455331|NCT00981656|65409681|FG000|Overall Study|Did not start protocol treatment|2|||
23455332|NCT03924622|65409683|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
23455333|NCT03924622|65409684|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455334|NCT03924622|65409685|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455335|NCT03924622|65409686|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
23455336|NCT03924622|65409687|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455337|NCT03924622|65409688|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455338|NCT00894803|65409689|FG000|Overall Study|Death|20|||
23455339|NCT00894803|65409690|FG001|Overall Study|Death|4|||
23455340|NCT00894803|65409689|FG000|Overall Study|Lost to Follow-up|0|||
23455341|NCT00894803|65409690|FG001|Overall Study|Lost to Follow-up|1|||
23455342|NCT04416204|65409694|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455343|NCT04416204|65409695|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
23455344|NCT04416204|65409696|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455345|NCT04416204|65409697|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455346|NCT01690052|65409698|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
23455347|NCT01690052|65409699|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
23455348|NCT03253796|65409700|FG000|Period 1: Run-In|Adverse Event|4|||
23455349|NCT03253796|65409701|FG001|Period 1: Run-In|Adverse Event|0|||
23455350|NCT03253796|65409702|FG002|Period 1: Run-In|Adverse Event|0|||
23455351|NCT03253796|65409703|FG003|Period 1: Run-In|Adverse Event|0|||
23455352|NCT03253796|65409704|FG004|Period 1: Run-In|Adverse Event|0|||
23455353|NCT03253796|65409700|FG000|Period 1: Run-In|Lack of Efficacy|1|||
23455354|NCT03253796|65409701|FG001|Period 1: Run-In|Lack of Efficacy|0|||
23455355|NCT03253796|65409702|FG002|Period 1: Run-In|Lack of Efficacy|0|||
23582730|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23582731|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23582732|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
23455356|NCT03253796|65409703|FG003|Period 1: Run-In|Lack of Efficacy|0|||
23455357|NCT03253796|65409704|FG004|Period 1: Run-In|Lack of Efficacy|0|||
23455358|NCT03253796|65409700|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
23455359|NCT03253796|65409701|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
23455360|NCT03253796|65409702|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
23455361|NCT03253796|65409703|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
23455362|NCT03253796|65409704|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
23455363|NCT03253796|65409700|FG000|Period 1: Run-In|Protocol Violation|5|||
23455364|NCT03253796|65409701|FG001|Period 1: Run-In|Protocol Violation|0|||
23455365|NCT03253796|65409702|FG002|Period 1: Run-In|Protocol Violation|0|||
23783841|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Progressive disease|0|||
23783842|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Progressive disease|0|||
23783843|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Progressive disease|0|||
23783844|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Progressive disease|0|||
23783845|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Progressive disease|0|||
23783846|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Progressive disease|0|||
23455366|NCT03253796|65409703|FG003|Period 1: Run-In|Protocol Violation|0|||
23455367|NCT03253796|65409704|FG004|Period 1: Run-In|Protocol Violation|0|||
23455368|NCT03253796|65409700|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
23455369|NCT03253796|65409701|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
23455370|NCT03253796|65409702|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
23455371|NCT03253796|65409703|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
23455372|NCT03253796|65409704|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
23455373|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455374|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455375|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
23455376|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455377|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455378|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455379|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455380|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
23455381|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455382|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455383|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455384|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455385|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
23455386|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
23455387|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455388|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455389|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23783847|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Progressive disease|0|||
23783848|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Progressive disease|0|||
23783849|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783850|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23637137|NCT01559129|66057336|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
23783851|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783852|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783853|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783854|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783855|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783856|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783857|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23783858|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783859|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23783860|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23783861|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783862|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783863|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23783864|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Physician Decision|0|||
23783865|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Physician Decision|0|||
23783866|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Physician Decision|0|||
23783867|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Physician Decision|0|||
23783868|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Physician Decision|0|||
23783869|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Physician Decision|0|||
23783870|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Physician Decision|0|||
23783871|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Physician Decision|0|||
23343730|NCT02883049|64999892|FG011|Post Induction|Moved to another non-COG institution|1|||
23343731|NCT02883049|64999893|FG012|Post Induction|Moved to another non-COG institution|0|||
23343732|NCT02883049|64999894|FG013|Post Induction|Moved to another non-COG institution|0|||
23455390|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
23582733|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23783872|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Physician Decision|0|||
23783873|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Physician Decision|0|||
23343733|NCT02883049|64999895|FG014|Post Induction|Moved to another non-COG institution|0|||
23455391|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455392|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455393|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
23455394|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
23455395|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
23455396|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
23455397|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
23455398|NCT03253796|65409700|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455399|NCT03253796|65409701|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455400|NCT03253796|65409702|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455401|NCT03253796|65409703|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455402|NCT03253796|65409704|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
23455403|NCT00436332|65409707|FG000|Overall Study|Adverse Event|9|||
23455404|NCT00436332|65409707|FG000|Overall Study|Withdrawal by Subject|2|||
23455405|NCT00436332|65409707|FG000|Overall Study|Progression|59|||
23455406|NCT00436332|65409707|FG000|Overall Study|Death|2|||
23455407|NCT00436332|65409707|FG000|Overall Study|Not Protocol Specified|6|||
23455408|NCT00436332|65409707|FG000|Overall Study|Ineligible|2|||
23455409|NCT00436332|65409707|FG000|Overall Study|Never Received Treatment|3|||
23455410|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
23455411|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
23455412|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
23455413|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
23455414|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Death|1|||
23455415|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Disease progression|2|||
23455416|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
23455417|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
23455418|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
23455419|NCT00062439|65409708|FG000|Surgery|Physician Decision|4|||
23455420|NCT00062439|65409708|FG000|Surgery|Death|1|||
23455421|NCT00062439|65409708|FG000|Surgery|Adverse Event|2|||
23455422|NCT00062439|65409708|FG000|Consolidation Chemotherapy|Adverse Event|2|||
23455423|NCT04050553|65409709|FG000|Period 1|Physician Decision|2|||
23455424|NCT04050553|65409710|FG001|Period 1|Physician Decision|2|||
23455425|NCT04050553|65409709|FG000|Period 1|Adverse Event|1|||
23455426|NCT04050553|65409710|FG001|Period 1|Adverse Event|1|||
23455427|NCT04050553|65409709|FG000|Period 1|Withdrawal by Subject|0|||
23455428|NCT04050553|65409710|FG001|Period 1|Withdrawal by Subject|1|||
23455429|NCT04050553|65409709|FG000|Wash-out|Adverse Event|0|||
23455430|NCT04050553|65409710|FG001|Wash-out|Adverse Event|1|||
23455431|NCT04050553|65409709|FG000|Wash-out|Withdrawal by Subject|0|||
23455432|NCT04050553|65409710|FG001|Wash-out|Withdrawal by Subject|1|||
23455433|NCT00301808|65409711|FG000|Overall Study|Adverse Event|5|||
23455434|NCT00301808|65409711|FG000|Overall Study|Death|3|||
23455435|NCT00301808|65409711|FG000|Overall Study|Lack of Efficacy|4|||
23455436|NCT05473026|65409714|FG000|Overall Study|Lost to Follow-up|5|||
23455437|NCT05473026|65409715|FG001|Overall Study|Lost to Follow-up|2|||
23455438|NCT01009060|65409719|FG000|Overall Study|Adverse Event|1|||
23455439|NCT01009060|65409720|FG001|Overall Study|Adverse Event|2|||
23455440|NCT01009060|65409719|FG000|Overall Study|Protocol Violation|0|||
23455441|NCT01009060|65409720|FG001|Overall Study|Protocol Violation|1|||
23455442|NCT01009060|65409719|FG000|Overall Study|Lost to Follow-up|1|||
23455443|NCT01009060|65409720|FG001|Overall Study|Lost to Follow-up|0|||
23455444|NCT01009060|65409719|FG000|Overall Study|Physician Decision|1|||
23455445|NCT01009060|65409720|FG001|Overall Study|Physician Decision|1|||
23455446|NCT01009060|65409719|FG000|Overall Study|Withdrawal by Subject|1|||
23455447|NCT01009060|65409720|FG001|Overall Study|Withdrawal by Subject|1|||
23455448|NCT02927301|65409725|FG000|Overall Study|Death|39|||
23455449|NCT02927301|65409725|FG000|Overall Study|Lost to Follow-up|8|||
23455450|NCT02927301|65409725|FG000|Overall Study|Physician Decision|2|||
23455451|NCT02927301|65409725|FG000|Overall Study|Withdrawal by Subject|12|||
23455452|NCT02927301|65409725|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
23455453|NCT03337308|65409727|FG000|Overall Study|Adverse Event|2|||
23455454|NCT03337308|65409728|FG001|Overall Study|Adverse Event|3|||
23455455|NCT03337308|65409729|FG002|Overall Study|Adverse Event|3|||
23455456|NCT03337308|65409730|FG003|Overall Study|Adverse Event|1|||
23455457|NCT03337308|65409727|FG000|Overall Study|Lost to Follow-up|1|||
23455458|NCT03337308|65409728|FG001|Overall Study|Lost to Follow-up|2|||
23455459|NCT03337308|65409729|FG002|Overall Study|Lost to Follow-up|0|||
23455460|NCT03337308|65409730|FG003|Overall Study|Lost to Follow-up|0|||
23637138|NCT01559129|66057337|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
23637139|NCT03538938|66057338|FG000|Overall Study|Death|0|||
23637140|NCT03538938|66057339|FG001|Overall Study|Death|0|||
23637141|NCT03538938|66057340|FG002|Overall Study|Death|2|||
23637142|NCT03538938|66057341|FG003|Overall Study|Death|0|||
23637143|NCT03538938|66057342|FG004|Overall Study|Death|0|||
23637144|NCT03538938|66057343|FG005|Overall Study|Death|1|||
23637145|NCT03538938|66057344|FG006|Overall Study|Death|0|||
23637146|NCT03538938|66057345|FG007|Overall Study|Death|1|||
23637147|NCT03538938|66057346|FG008|Overall Study|Death|1|||
23637148|NCT03538938|66057347|FG009|Overall Study|Death|1|||
23637149|NCT03538938|66057348|FG010|Overall Study|Death|0|||
23637150|NCT03538938|66057349|FG011|Overall Study|Death|0|||
23637151|NCT03538938|66057350|FG012|Overall Study|Death|1|||
23637152|NCT03538938|66057351|FG013|Overall Study|Death|1|||
23637153|NCT03538938|66057352|FG014|Overall Study|Death|0|||
23637154|NCT03538938|66057353|FG015|Overall Study|Death|1|||
23637155|NCT03538938|66057338|FG000|Overall Study|Withdrawal by Subject|4|||
23637156|NCT03538938|66057339|FG001|Overall Study|Withdrawal by Subject|6|||
23637157|NCT03538938|66057340|FG002|Overall Study|Withdrawal by Subject|5|||
23637158|NCT03538938|66057341|FG003|Overall Study|Withdrawal by Subject|3|||
23637159|NCT03538938|66057342|FG004|Overall Study|Withdrawal by Subject|0|||
23637160|NCT03538938|66057343|FG005|Overall Study|Withdrawal by Subject|0|||
23637161|NCT03538938|66057344|FG006|Overall Study|Withdrawal by Subject|3|||
23637162|NCT03538938|66057345|FG007|Overall Study|Withdrawal by Subject|1|||
23637163|NCT03538938|66057346|FG008|Overall Study|Withdrawal by Subject|5|||
23637164|NCT03538938|66057347|FG009|Overall Study|Withdrawal by Subject|1|||
23637165|NCT03538938|66057348|FG010|Overall Study|Withdrawal by Subject|2|||
23637166|NCT03538938|66057349|FG011|Overall Study|Withdrawal by Subject|1|||
23637167|NCT03538938|66057350|FG012|Overall Study|Withdrawal by Subject|3|||
23637168|NCT03538938|66057351|FG013|Overall Study|Withdrawal by Subject|0|||
23637169|NCT03538938|66057352|FG014|Overall Study|Withdrawal by Subject|2|||
23637170|NCT03538938|66057353|FG015|Overall Study|Withdrawal by Subject|4|||
23637171|NCT03538938|66057338|FG000|Overall Study|Incarcerated|0|||
23637172|NCT03538938|66057339|FG001|Overall Study|Incarcerated|0|||
23455461|NCT03337308|65409727|FG000|Overall Study|Withdrawal by Subject|2|||
23455462|NCT03337308|65409728|FG001|Overall Study|Withdrawal by Subject|1|||
23455463|NCT03337308|65409729|FG002|Overall Study|Withdrawal by Subject|2|||
23455464|NCT03337308|65409730|FG003|Overall Study|Withdrawal by Subject|1|||
23455465|NCT03337308|65409727|FG000|Overall Study|Protocol Violation|0|||
23455466|NCT03337308|65409728|FG001|Overall Study|Protocol Violation|1|||
23455467|NCT03337308|65409729|FG002|Overall Study|Protocol Violation|0|||
23455468|NCT03337308|65409730|FG003|Overall Study|Protocol Violation|0|||
23455469|NCT02163902|65409731|FG000|Overall Study|Subject's Request|3|||
23455470|NCT02163902|65409732|FG001|Overall Study|Subject's Request|4|||
23455471|NCT02163902|65409731|FG000|Overall Study|Lost to Follow-up|6|||
23455472|NCT02163902|65409732|FG001|Overall Study|Lost to Follow-up|7|||
23455473|NCT02163902|65409731|FG000|Overall Study|Administrative Decision|2|||
23455474|NCT02163902|65409732|FG001|Overall Study|Administrative Decision|2|||
23455475|NCT00453154|65409733|FG000|Double BIind Maintenance|Adverse Event|0|||
23455476|NCT00453154|65409734|FG001|Double BIind Maintenance|Adverse Event|0|||
23455477|NCT00453154|65409735|FG002|Double BIind Maintenance|Adverse Event|3|||
23455478|NCT00453154|65409736|FG003|Double BIind Maintenance|Adverse Event|12|||
23455479|NCT00453154|65409733|FG000|Double BIind Maintenance|Death|0|||
23455480|NCT00453154|65409734|FG001|Double BIind Maintenance|Death|0|||
23455481|NCT00453154|65409735|FG002|Double BIind Maintenance|Death|2|||
23455482|NCT00453154|65409736|FG003|Double BIind Maintenance|Death|1|||
23455483|NCT00453154|65409733|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
23455484|NCT00453154|65409734|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
23455485|NCT00453154|65409735|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
23455486|NCT00453154|65409736|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
23455487|NCT00453154|65409733|FG000|Double BIind Maintenance|Progression|0|||
23455488|NCT00453154|65409734|FG001|Double BIind Maintenance|Progression|0|||
23455489|NCT00453154|65409735|FG002|Double BIind Maintenance|Progression|29|||
23455490|NCT00453154|65409736|FG003|Double BIind Maintenance|Progression|26|||
23455491|NCT00453154|65409733|FG000|Double BIind Maintenance|Medical Issues|0|||
23637173|NCT03538938|66057340|FG002|Overall Study|Incarcerated|0|||
23637174|NCT03538938|66057341|FG003|Overall Study|Incarcerated|0|||
23637175|NCT03538938|66057342|FG004|Overall Study|Incarcerated|0|||
23637176|NCT03538938|66057343|FG005|Overall Study|Incarcerated|0|||
23637177|NCT03538938|66057344|FG006|Overall Study|Incarcerated|0|||
23637178|NCT03538938|66057345|FG007|Overall Study|Incarcerated|0|||
23637179|NCT03538938|66057346|FG008|Overall Study|Incarcerated|0|||
23455492|NCT00453154|65409734|FG001|Double BIind Maintenance|Medical Issues|0|||
23637180|NCT03538938|66057347|FG009|Overall Study|Incarcerated|0|||
23637181|NCT03538938|66057348|FG010|Overall Study|Incarcerated|0|||
23455493|NCT00453154|65409735|FG002|Double BIind Maintenance|Medical Issues|3|||
23637182|NCT03538938|66057349|FG011|Overall Study|Incarcerated|1|||
23637183|NCT03538938|66057350|FG012|Overall Study|Incarcerated|0|||
23844118|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
23844119|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
23455494|NCT00453154|65409736|FG003|Double BIind Maintenance|Medical Issues|1|||
23455495|NCT00453154|65409733|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
23455496|NCT00453154|65409734|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
23455497|NCT00453154|65409735|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
23455498|NCT00453154|65409736|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
23455499|NCT04869982|65409740|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
23455500|NCT04869982|65409741|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
23455501|NCT04869982|65409740|FG000|Overall Study|Migrated / moved from the study area|1|||
23455502|NCT04869982|65409741|FG001|Overall Study|Migrated / moved from the study area|1|||
23455503|NCT04869982|65409740|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
23455504|NCT04869982|65409741|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
23455505|NCT04869982|65409740|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
23582734|NCT01688973|65862536|FG000|Overall Study|Ineligible|2|||
23582735|NCT01688973|65862537|FG001|Overall Study|Ineligible|3|||
23582736|NCT00567164|65862538|FG000|Overall Study|Withdrawal by Subject|171|||
23844120|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
23844121|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
23844122|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23844123|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23844124|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23844125|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
23844126|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23844127|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
23844128|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23844129|NCT03395184|66808923|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23844130|NCT03395184|66808924|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23844131|NCT03395184|66808925|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23844132|NCT03395184|66808926|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
23844133|NCT03395184|66808927|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
23844134|NCT03395184|66808928|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
23844135|NCT03395184|66808929|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
23844136|NCT06586788|66808930|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
23343734|NCT02883049|64999896|FG015|Post Induction|Moved to another non-COG institution|0|||
23455506|NCT04869982|65409741|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
23582737|NCT00567164|65862539|FG001|Overall Study|Withdrawal by Subject|21|||
23582738|NCT00567164|65862540|FG002|Overall Study|Withdrawal by Subject|17|||
23582739|NCT00567164|65862538|FG000|Overall Study|Protocol Violation|23|||
23783874|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Physician Decision|5|||
23783875|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Physician Decision|1|||
23783876|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Physician Decision|1|||
23783877|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Physician Decision|0|||
23783878|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Physician Decision|0|||
23783879|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Death|0|||
23783880|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Death|0|||
23783881|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Death|0|||
23783882|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Death|0|||
23783883|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Death|0|||
23783884|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Death|0|||
23783885|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Death|0|||
23783886|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Death|0|||
23783887|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Death|0|||
23783888|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Death|0|||
23783889|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Death|2|||
23783890|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Death|0|||
23783891|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Death|0|||
23783892|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Death|0|||
23783893|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Death|0|||
23783894|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
23783895|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
23783896|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
23783897|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
23783898|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
23783899|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
23844137|NCT03528369|66808931|FG000|Overall Study|Withdrawal by Subject|2|||
23844138|NCT03528369|66808932|FG001|Overall Study|Withdrawal by Subject|0|||
23582740|NCT00567164|65862539|FG001|Overall Study|Protocol Violation|4|||
23783900|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
23343735|NCT02883049|64999881|FG000|Post Induction|Randomization closed|0|||
23343736|NCT02883049|64999882|FG001|Post Induction|Randomization closed|0|||
23343737|NCT02883049|64999883|FG002|Post Induction|Randomization closed|0|||
23343738|NCT02883049|64999884|FG003|Post Induction|Randomization closed|0|||
23343739|NCT02883049|64999885|FG004|Post Induction|Randomization closed|0|||
23343740|NCT02883049|64999886|FG005|Post Induction|Randomization closed|0|||
23343741|NCT02883049|64999887|FG006|Post Induction|Randomization closed|0|||
23343742|NCT02883049|64999888|FG007|Post Induction|Randomization closed|20|||
23343743|NCT02883049|64999889|FG008|Post Induction|Randomization closed|0|||
23343744|NCT02883049|64999890|FG009|Post Induction|Randomization closed|0|||
23343745|NCT02883049|64999891|FG010|Post Induction|Randomization closed|0|||
23343746|NCT02883049|64999892|FG011|Post Induction|Randomization closed|0|||
23343747|NCT02883049|64999893|FG012|Post Induction|Randomization closed|0|||
23343748|NCT02883049|64999894|FG013|Post Induction|Randomization closed|0|||
23343749|NCT02883049|64999895|FG014|Post Induction|Randomization closed|0|||
23343750|NCT02883049|64999896|FG015|Post Induction|Randomization closed|0|||
23343751|NCT02883049|64999881|FG000|Post Induction|MRD negative|0|||
23455507|NCT04869982|65409740|FG000|Overall Study|Solicited adverse event|2|||
23455508|NCT04869982|65409741|FG001|Overall Study|Solicited adverse event|1|||
23582741|NCT00567164|65862540|FG002|Overall Study|Protocol Violation|2|||
23582742|NCT00567164|65862538|FG000|Overall Study|Adverse Event|92|||
23582743|NCT00567164|65862539|FG001|Overall Study|Adverse Event|13|||
23582744|NCT00567164|65862540|FG002|Overall Study|Adverse Event|9|||
23582745|NCT00567164|65862538|FG000|Overall Study|Death|0|||
23582746|NCT00567164|65862539|FG001|Overall Study|Death|0|||
23582747|NCT00567164|65862540|FG002|Overall Study|Death|1|||
23582748|NCT00567164|65862538|FG000|Overall Study|Lost to Follow-up|202|||
23582749|NCT00567164|65862539|FG001|Overall Study|Lost to Follow-up|23|||
23582750|NCT00567164|65862540|FG002|Overall Study|Lost to Follow-up|21|||
23582751|NCT00567164|65862538|FG000|Overall Study|Pregnancy|20|||
23582752|NCT00567164|65862539|FG001|Overall Study|Pregnancy|4|||
23582753|NCT00567164|65862540|FG002|Overall Study|Pregnancy|6|||
23582754|NCT00567164|65862538|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
23582755|NCT00567164|65862539|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
23582756|NCT00567164|65862540|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
23582757|NCT00567164|65862538|FG000|Overall Study|Missing|1|||
23582758|NCT00567164|65862539|FG001|Overall Study|Missing|0|||
23582759|NCT00567164|65862540|FG002|Overall Study|Missing|0|||
23582760|NCT04984876|65862543|FG000|Overall Study|Subject decision|2|||
23582761|NCT04984876|65862544|FG001|Overall Study|Subject decision|10|||
23582762|NCT04984876|65862545|FG002|Overall Study|Subject decision|3|||
23582763|NCT04984876|65862546|FG003|Overall Study|Subject decision|3|||
23582764|NCT04984876|65862547|FG004|Overall Study|Subject decision|3|||
23582765|NCT04984876|65862548|FG005|Overall Study|Subject decision|0|||
23582766|NCT04984876|65862543|FG000|Overall Study|Guardian decision|0|||
23582767|NCT04984876|65862544|FG001|Overall Study|Guardian decision|1|||
23582768|NCT04984876|65862545|FG002|Overall Study|Guardian decision|0|||
23582769|NCT04984876|65862546|FG003|Overall Study|Guardian decision|2|||
23582770|NCT04984876|65862547|FG004|Overall Study|Guardian decision|0|||
23582771|NCT04984876|65862548|FG005|Overall Study|Guardian decision|1|||
23783901|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
23783902|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
23783903|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
23783904|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
23783905|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
23783906|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
23783907|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
23783908|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
23783909|NCT01796171|66586801|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783910|NCT01796171|66586802|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783911|NCT01796171|66586803|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783912|NCT01796171|66586804|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783913|NCT01796171|66586805|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783914|NCT01796171|66586806|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783915|NCT01796171|66586807|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783916|NCT01796171|66586808|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783917|NCT01796171|66586809|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783918|NCT01796171|66586810|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783919|NCT01796171|66586811|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
23783920|NCT01796171|66586812|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
23783921|NCT01796171|66586813|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23343752|NCT02883049|64999882|FG001|Post Induction|MRD negative|0|||
23343753|NCT02883049|64999883|FG002|Post Induction|MRD negative|0|||
23343754|NCT02883049|64999884|FG003|Post Induction|MRD negative|0|||
23582772|NCT04984876|65862543|FG000|Overall Study|Lost to Follow-up|0|||
23582773|NCT04984876|65862544|FG001|Overall Study|Lost to Follow-up|0|||
23582774|NCT04984876|65862545|FG002|Overall Study|Lost to Follow-up|1|||
23343755|NCT02883049|64999885|FG004|Post Induction|MRD negative|0|||
23343756|NCT02883049|64999886|FG005|Post Induction|MRD negative|0|||
23343757|NCT02883049|64999887|FG006|Post Induction|MRD negative|0|||
23783922|NCT01796171|66586814|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23783923|NCT01796171|66586815|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23343758|NCT02883049|64999888|FG007|Post Induction|MRD negative|11|||
23343759|NCT02883049|64999889|FG008|Post Induction|MRD negative|0|||
23343760|NCT02883049|64999890|FG009|Post Induction|MRD negative|0|||
23343761|NCT02883049|64999891|FG010|Post Induction|MRD negative|0|||
23783924|NCT01796171|66586801|FG000|Follow-up Period|Start of further anticancer therapy|4|||
23783925|NCT01796171|66586802|FG001|Follow-up Period|Start of further anticancer therapy|25|||
23783926|NCT01796171|66586803|FG002|Follow-up Period|Start of further anticancer therapy|2|||
23783927|NCT01796171|66586804|FG003|Follow-up Period|Start of further anticancer therapy|1|||
23783928|NCT01796171|66586805|FG004|Follow-up Period|Start of further anticancer therapy|2|||
23783929|NCT01796171|66586806|FG005|Follow-up Period|Start of further anticancer therapy|2|||
23783930|NCT01796171|66586807|FG006|Follow-up Period|Start of further anticancer therapy|1|||
23343762|NCT02883049|64999892|FG011|Post Induction|MRD negative|0|||
23343763|NCT02883049|64999893|FG012|Post Induction|MRD negative|0|||
23343764|NCT02883049|64999894|FG013|Post Induction|MRD negative|0|||
23582775|NCT04984876|65862546|FG003|Overall Study|Lost to Follow-up|1|||
23582776|NCT04984876|65862547|FG004|Overall Study|Lost to Follow-up|0|||
23343765|NCT02883049|64999895|FG014|Post Induction|MRD negative|0|||
23582777|NCT04984876|65862548|FG005|Overall Study|Lost to Follow-up|0|||
23343766|NCT02883049|64999896|FG015|Post Induction|MRD negative|0|||
23783931|NCT01796171|66586808|FG007|Follow-up Period|Start of further anticancer therapy|15|||
23783932|NCT01796171|66586809|FG008|Follow-up Period|Start of further anticancer therapy|2|||
23343767|NCT02883049|64999881|FG000|Post Induction|Developed SMN|0|||
23343768|NCT02883049|64999882|FG001|Post Induction|Developed SMN|0|||
23343769|NCT02883049|64999883|FG002|Post Induction|Developed SMN|0|||
23343770|NCT02883049|64999884|FG003|Post Induction|Developed SMN|0|||
23343771|NCT02883049|64999885|FG004|Post Induction|Developed SMN|1|||
23343772|NCT02883049|64999886|FG005|Post Induction|Developed SMN|0|||
23343773|NCT02883049|64999887|FG006|Post Induction|Developed SMN|1|||
23343774|NCT02883049|64999888|FG007|Post Induction|Developed SMN|0|||
23783933|NCT01796171|66586810|FG009|Follow-up Period|Start of further anticancer therapy|0|||
23783934|NCT01796171|66586811|FG010|Follow-up Period|Start of further anticancer therapy|0|||
23783935|NCT01796171|66586812|FG011|Follow-up Period|Start of further anticancer therapy|0|||
23783936|NCT01796171|66586813|FG012|Follow-up Period|Start of further anticancer therapy|0|||
23844139|NCT03528369|66808933|FG002|Overall Study|Withdrawal by Subject|0|||
23844140|NCT03528369|66808931|FG000|Overall Study|Lost to Follow-up|1|||
23844141|NCT03528369|66808932|FG001|Overall Study|Lost to Follow-up|0|||
23844142|NCT03528369|66808933|FG002|Overall Study|Lost to Follow-up|0|||
23343775|NCT02883049|64999889|FG008|Post Induction|Developed SMN|0|||
23343776|NCT02883049|64999890|FG009|Post Induction|Developed SMN|0|||
23343777|NCT02883049|64999891|FG010|Post Induction|Developed SMN|1|||
23343778|NCT02883049|64999892|FG011|Post Induction|Developed SMN|1|||
23343779|NCT02883049|64999893|FG012|Post Induction|Developed SMN|0|||
23343780|NCT02883049|64999894|FG013|Post Induction|Developed SMN|0|||
23343781|NCT02883049|64999895|FG014|Post Induction|Developed SMN|1|||
23343782|NCT02883049|64999896|FG015|Post Induction|Developed SMN|0|||
23343783|NCT02883049|64999881|FG000|Post Induction|Enrolled onto another COG study|0|||
23343784|NCT02883049|64999882|FG001|Post Induction|Enrolled onto another COG study|0|||
23343785|NCT02883049|64999883|FG002|Post Induction|Enrolled onto another COG study|0|||
23343786|NCT02883049|64999884|FG003|Post Induction|Enrolled onto another COG study|1|||
23343787|NCT02883049|64999885|FG004|Post Induction|Enrolled onto another COG study|1|||
23783937|NCT01796171|66586814|FG013|Follow-up Period|Start of further anticancer therapy|0|||
23844143|NCT03528369|66808931|FG000|Overall Study|Adverse Event|0|||
23844144|NCT03528369|66808932|FG001|Overall Study|Adverse Event|1|||
23844145|NCT03528369|66808933|FG002|Overall Study|Adverse Event|0|||
23844146|NCT02277444|66808936|FG000|Overall Study|Adverse Event|10|||
23343788|NCT02883049|64999886|FG005|Post Induction|Enrolled onto another COG study|0|||
23343789|NCT02883049|64999887|FG006|Post Induction|Enrolled onto another COG study|0|||
23343790|NCT02883049|64999888|FG007|Post Induction|Enrolled onto another COG study|4|||
23844147|NCT02277444|66808936|FG000|Overall Study|Withdrawal by Subject|3|||
23844148|NCT02277444|66808936|FG000|Overall Study|Other|1|||
23844149|NCT02277444|66808936|FG000|Overall Study|Enrolled and not Treated|3|||
23343791|NCT02883049|64999889|FG008|Post Induction|Enrolled onto another COG study|0|||
23343792|NCT02883049|64999890|FG009|Post Induction|Enrolled onto another COG study|0|||
23343793|NCT02883049|64999891|FG010|Post Induction|Enrolled onto another COG study|0|||
23343794|NCT02883049|64999892|FG011|Post Induction|Enrolled onto another COG study|2|||
23343795|NCT02883049|64999893|FG012|Post Induction|Enrolled onto another COG study|0|||
23343796|NCT02883049|64999894|FG013|Post Induction|Enrolled onto another COG study|1|||
23343797|NCT02883049|64999895|FG014|Post Induction|Enrolled onto another COG study|0|||
23343798|NCT02883049|64999896|FG015|Post Induction|Enrolled onto another COG study|0|||
23582778|NCT04984876|65862543|FG000|Overall Study|Physician Decision|1|||
23783938|NCT01796171|66586815|FG014|Follow-up Period|Start of further anticancer therapy|0|||
23783939|NCT01796171|66586801|FG000|Follow-up Period|Progressive disease|0|||
23783940|NCT01796171|66586802|FG001|Follow-up Period|Progressive disease|1|||
23783941|NCT01796171|66586803|FG002|Follow-up Period|Progressive disease|0|||
23783942|NCT01796171|66586804|FG003|Follow-up Period|Progressive disease|0|||
23783943|NCT01796171|66586805|FG004|Follow-up Period|Progressive disease|0|||
23783944|NCT01796171|66586806|FG005|Follow-up Period|Progressive disease|0|||
23783945|NCT01796171|66586807|FG006|Follow-up Period|Progressive disease|0|||
23343799|NCT02883049|64999881|FG000|Post Induction|Recurrent leukemia|0|||
23343800|NCT02883049|64999882|FG001|Post Induction|Recurrent leukemia|0|||
23343801|NCT02883049|64999883|FG002|Post Induction|Recurrent leukemia|0|||
23343802|NCT02883049|64999884|FG003|Post Induction|Recurrent leukemia|17|||
23343803|NCT02883049|64999885|FG004|Post Induction|Recurrent leukemia|12|||
23844150|NCT02277444|66808936|FG000|Overall Study|Ongoing|113|||
23844151|NCT03800836|66808937|FG000|Overall Study|Other|2|||
23844152|NCT03800836|66808938|FG001|Overall Study|Other|1|||
23844153|NCT03800836|66808939|FG002|Overall Study|Other|0|||
23844154|NCT03800836|66808940|FG003|Overall Study|Other|2|||
23343804|NCT02883049|64999886|FG005|Post Induction|Recurrent leukemia|4|||
23343805|NCT02883049|64999887|FG006|Post Induction|Recurrent leukemia|1|||
23343806|NCT02883049|64999888|FG007|Post Induction|Recurrent leukemia|13|||
23343807|NCT02883049|64999889|FG008|Post Induction|Recurrent leukemia|27|||
23343808|NCT02883049|64999890|FG009|Post Induction|Recurrent leukemia|5|||
23343809|NCT02883049|64999891|FG010|Post Induction|Recurrent leukemia|3|||
23343810|NCT02883049|64999892|FG011|Post Induction|Recurrent leukemia|12|||
23343811|NCT02883049|64999893|FG012|Post Induction|Recurrent leukemia|1|||
23343812|NCT02883049|64999894|FG013|Post Induction|Recurrent leukemia|1|||
23343813|NCT02883049|64999895|FG014|Post Induction|Recurrent leukemia|9|||
23343814|NCT02883049|64999896|FG015|Post Induction|Recurrent leukemia|3|||
23343815|NCT02883049|64999881|FG000|Post Induction|Induction Failure|0|||
23343816|NCT02883049|64999882|FG001|Post Induction|Induction Failure|0|||
23343817|NCT02883049|64999883|FG002|Post Induction|Induction Failure|0|||
23343818|NCT02883049|64999884|FG003|Post Induction|Induction Failure|0|||
23343819|NCT02883049|64999885|FG004|Post Induction|Induction Failure|0|||
23343820|NCT02883049|64999886|FG005|Post Induction|Induction Failure|0|||
23343821|NCT02883049|64999887|FG006|Post Induction|Induction Failure|0|||
23455509|NCT02636699|65409742|FG000|Overall Study|Adverse Event|4|||
23783946|NCT01796171|66586808|FG007|Follow-up Period|Progressive disease|3|||
23783947|NCT01796171|66586809|FG008|Follow-up Period|Progressive disease|0|||
23783948|NCT01796171|66586810|FG009|Follow-up Period|Progressive disease|0|||
23783949|NCT01796171|66586811|FG010|Follow-up Period|Progressive disease|0|||
23783950|NCT01796171|66586812|FG011|Follow-up Period|Progressive disease|0|||
23783951|NCT01796171|66586813|FG012|Follow-up Period|Progressive disease|0|||
23783952|NCT01796171|66586814|FG013|Follow-up Period|Progressive disease|0|||
23783953|NCT01796171|66586815|FG014|Follow-up Period|Progressive disease|0|||
23783954|NCT01796171|66586801|FG000|Follow-up Period|Physician Decision|0|||
23783955|NCT01796171|66586802|FG001|Follow-up Period|Physician Decision|2|||
23783956|NCT01796171|66586803|FG002|Follow-up Period|Physician Decision|0|||
23783957|NCT01796171|66586804|FG003|Follow-up Period|Physician Decision|0|||
23844155|NCT03800836|66808941|FG004|Overall Study|Other|0|||
23844156|NCT03800836|66808942|FG005|Overall Study|Other|1|||
23844157|NCT03800836|66808937|FG000|Overall Study|Lost to Follow-up|2|||
23844158|NCT03800836|66808938|FG001|Overall Study|Lost to Follow-up|0|||
23844159|NCT03800836|66808939|FG002|Overall Study|Lost to Follow-up|1|||
23844160|NCT03800836|66808940|FG003|Overall Study|Lost to Follow-up|1|||
23844161|NCT03800836|66808941|FG004|Overall Study|Lost to Follow-up|3|||
23844162|NCT03800836|66808942|FG005|Overall Study|Lost to Follow-up|0|||
23844163|NCT03800836|66808937|FG000|Overall Study|Withdrawal by Subject|1|||
23844164|NCT03800836|66808938|FG001|Overall Study|Withdrawal by Subject|0|||
23844165|NCT03800836|66808939|FG002|Overall Study|Withdrawal by Subject|0|||
23844166|NCT03800836|66808940|FG003|Overall Study|Withdrawal by Subject|0|||
23844167|NCT03800836|66808941|FG004|Overall Study|Withdrawal by Subject|0|||
23844168|NCT03800836|66808942|FG005|Overall Study|Withdrawal by Subject|0|||
23844169|NCT03800836|66808937|FG000|Overall Study|Physician Decision|31|||
23844170|NCT03800836|66808938|FG001|Overall Study|Physician Decision|3|||
23343822|NCT02883049|64999888|FG007|Post Induction|Induction Failure|2|||
23343823|NCT02883049|64999889|FG008|Post Induction|Induction Failure|2|||
23343824|NCT02883049|64999890|FG009|Post Induction|Induction Failure|0|||
23343825|NCT02883049|64999891|FG010|Post Induction|Induction Failure|0|||
23343826|NCT02883049|64999892|FG011|Post Induction|Induction Failure|0|||
23343827|NCT02883049|64999893|FG012|Post Induction|Induction Failure|0|||
23343828|NCT02883049|64999894|FG013|Post Induction|Induction Failure|2|||
23783958|NCT01796171|66586805|FG004|Follow-up Period|Physician Decision|0|||
23783959|NCT01796171|66586806|FG005|Follow-up Period|Physician Decision|0|||
23783960|NCT01796171|66586807|FG006|Follow-up Period|Physician Decision|0|||
23343829|NCT02883049|64999895|FG014|Post Induction|Induction Failure|0|||
23844171|NCT03800836|66808939|FG002|Overall Study|Physician Decision|6|||
23844172|NCT03800836|66808940|FG003|Overall Study|Physician Decision|4|||
23844173|NCT03800836|66808941|FG004|Overall Study|Physician Decision|4|||
23343830|NCT02883049|64999896|FG015|Post Induction|Induction Failure|0|||
23343831|NCT04506905|64999910|FG000|Overall Study|Lost to Follow-up|1|||
23343832|NCT04506905|64999911|FG001|Overall Study|Lost to Follow-up|0|||
23343833|NCT04506905|64999912|FG002|Overall Study|Lost to Follow-up|0|||
23343834|NCT04506905|64999913|FG003|Overall Study|Lost to Follow-up|1|||
23343835|NCT04506905|64999914|FG004|Overall Study|Lost to Follow-up|0|||
23343836|NCT04506905|64999915|FG005|Overall Study|Lost to Follow-up|0|||
23343837|NCT04506905|64999916|FG006|Overall Study|Lost to Follow-up|0|||
23343838|NCT04506905|64999917|FG007|Overall Study|Lost to Follow-up|0|||
23343839|NCT04506905|64999918|FG008|Overall Study|Lost to Follow-up|0|||
23343840|NCT04506905|64999910|FG000|Overall Study|Withdrawal by Subject|0|||
23343841|NCT04506905|64999911|FG001|Overall Study|Withdrawal by Subject|0|||
23343842|NCT04506905|64999912|FG002|Overall Study|Withdrawal by Subject|0|||
23343843|NCT04506905|64999913|FG003|Overall Study|Withdrawal by Subject|2|||
23343844|NCT04506905|64999914|FG004|Overall Study|Withdrawal by Subject|0|||
23343845|NCT04506905|64999915|FG005|Overall Study|Withdrawal by Subject|0|||
23343846|NCT04506905|64999916|FG006|Overall Study|Withdrawal by Subject|0|||
23343847|NCT04506905|64999917|FG007|Overall Study|Withdrawal by Subject|0|||
23343848|NCT04506905|64999918|FG008|Overall Study|Withdrawal by Subject|0|||
23343849|NCT04776018|64999919|FG000|Overall Study|Death|0|||
23343850|NCT04776018|64999920|FG001|Overall Study|Death|1|||
23343851|NCT04776018|64999921|FG002|Overall Study|Death|4|||
23343852|NCT04776018|64999922|FG003|Overall Study|Death|1|||
23343853|NCT04776018|64999923|FG004|Overall Study|Death|4|||
23343854|NCT04776018|64999924|FG005|Overall Study|Death|0|||
23343855|NCT04776018|64999925|FG006|Overall Study|Death|0|||
23343856|NCT04776018|64999919|FG000|Overall Study|Study terminated by sponsor|2|||
23343857|NCT04776018|64999920|FG001|Overall Study|Study terminated by sponsor|1|||
23343858|NCT04776018|64999921|FG002|Overall Study|Study terminated by sponsor|4|||
23343859|NCT04776018|64999922|FG003|Overall Study|Study terminated by sponsor|0|||
23343860|NCT04776018|64999923|FG004|Overall Study|Study terminated by sponsor|3|||
23343861|NCT04776018|64999924|FG005|Overall Study|Study terminated by sponsor|0|||
23343862|NCT04776018|64999925|FG006|Overall Study|Study terminated by sponsor|0|||
23343863|NCT04776018|64999919|FG000|Overall Study|Withdrawal by Subject|1|||
23343864|NCT04776018|64999920|FG001|Overall Study|Withdrawal by Subject|0|||
23343865|NCT04776018|64999921|FG002|Overall Study|Withdrawal by Subject|0|||
23343866|NCT04776018|64999922|FG003|Overall Study|Withdrawal by Subject|2|||
23343867|NCT04776018|64999923|FG004|Overall Study|Withdrawal by Subject|1|||
23343868|NCT04776018|64999924|FG005|Overall Study|Withdrawal by Subject|0|||
23343869|NCT04776018|64999925|FG006|Overall Study|Withdrawal by Subject|0|||
23343870|NCT04776018|64999919|FG000|Overall Study|Other|0|||
23343871|NCT04776018|64999920|FG001|Overall Study|Other|1|||
23343872|NCT04776018|64999921|FG002|Overall Study|Other|1|||
23343873|NCT04776018|64999922|FG003|Overall Study|Other|0|||
23343874|NCT04776018|64999923|FG004|Overall Study|Other|0|||
23343875|NCT04776018|64999924|FG005|Overall Study|Other|0|||
23343876|NCT04776018|64999925|FG006|Overall Study|Other|0|||
23343877|NCT04776018|64999919|FG000|Overall Study|Lost to Follow-up|0|||
23343878|NCT04776018|64999920|FG001|Overall Study|Lost to Follow-up|0|||
23343879|NCT04776018|64999921|FG002|Overall Study|Lost to Follow-up|1|||
23343880|NCT04776018|64999922|FG003|Overall Study|Lost to Follow-up|0|||
23343881|NCT04776018|64999923|FG004|Overall Study|Lost to Follow-up|0|||
23343882|NCT04776018|64999924|FG005|Overall Study|Lost to Follow-up|0|||
23343883|NCT04776018|64999925|FG006|Overall Study|Lost to Follow-up|0|||
23343884|NCT04696861|65001488|FG000|Overall Study|Death|1|||
23343885|NCT04696861|65001489|FG001|Overall Study|Death|0|||
23343886|NCT04696861|65001488|FG000|Overall Study|Lost to Follow-up|3|||
23343887|NCT04696861|65001489|FG001|Overall Study|Lost to Follow-up|0|||
23343888|NCT01984892|65001490|FG000|Overall Study|Progressive disease|7|||
23343889|NCT01093326|65001494|FG000|Overall Study|Death|0|||
23343890|NCT01093326|65001495|FG001|Overall Study|Death|1|||
23343891|NCT01093326|65001496|FG002|Overall Study|Death|0|||
23343892|NCT01093326|65001494|FG000|Overall Study|Lack of Efficacy|7|||
23343893|NCT01093326|65001495|FG001|Overall Study|Lack of Efficacy|6|||
23343894|NCT01093326|65001496|FG002|Overall Study|Lack of Efficacy|3|||
23343895|NCT01093326|65001494|FG000|Overall Study|Lost to Follow-up|2|||
23343896|NCT01093326|65001495|FG001|Overall Study|Lost to Follow-up|5|||
23343897|NCT01093326|65001496|FG002|Overall Study|Lost to Follow-up|4|||
23343898|NCT01093326|65001494|FG000|Overall Study|Physician Decision|3|||
23343899|NCT01093326|65001495|FG001|Overall Study|Physician Decision|1|||
23343900|NCT01093326|65001496|FG002|Overall Study|Physician Decision|3|||
23343901|NCT01093326|65001494|FG000|Overall Study|Withdrawal by Subject|30|||
23343902|NCT01093326|65001495|FG001|Overall Study|Withdrawal by Subject|27|||
23343903|NCT01093326|65001496|FG002|Overall Study|Withdrawal by Subject|26|||
23343904|NCT01093326|65001494|FG000|Overall Study|Adverse Event|2|||
23343905|NCT01093326|65001495|FG001|Overall Study|Adverse Event|1|||
23343906|NCT01093326|65001496|FG002|Overall Study|Adverse Event|4|||
23343907|NCT01093326|65001494|FG000|Overall Study|Other|0|||
23343908|NCT01093326|65001495|FG001|Overall Study|Other|0|||
23343909|NCT01093326|65001496|FG002|Overall Study|Other|1|||
23343910|NCT05072964|65001500|FG000|Overall Study|Withdrawal by Subject|4|||
23637184|NCT03538938|66057351|FG013|Overall Study|Incarcerated|0|||
23637185|NCT03538938|66057352|FG014|Overall Study|Incarcerated|0|||
23637186|NCT03538938|66057353|FG015|Overall Study|Incarcerated|0|||
23637187|NCT04055090|66057354|FG000|Overall Study|screen failure|1|||
23637188|NCT04055090|66057355|FG001|Overall Study|screen failure|0|||
23783961|NCT01796171|66586808|FG007|Follow-up Period|Physician Decision|0|||
23783962|NCT01796171|66586809|FG008|Follow-up Period|Physician Decision|0|||
23783963|NCT01796171|66586810|FG009|Follow-up Period|Physician Decision|0|||
23783964|NCT01796171|66586811|FG010|Follow-up Period|Physician Decision|5|||
23455510|NCT02636699|65409743|FG001|Overall Study|Adverse Event|0|||
23783965|NCT01796171|66586812|FG011|Follow-up Period|Physician Decision|0|||
23783966|NCT01796171|66586813|FG012|Follow-up Period|Physician Decision|0|||
23783967|NCT01796171|66586814|FG013|Follow-up Period|Physician Decision|0|||
23783968|NCT01796171|66586815|FG014|Follow-up Period|Physician Decision|0|||
23783969|NCT01796171|66586801|FG000|Follow-up Period|Withdrawal by Subject|0|||
23455511|NCT02636699|65409742|FG000|Overall Study|Lost to Follow-up|3|||
23455512|NCT02636699|65409743|FG001|Overall Study|Lost to Follow-up|3|||
23455513|NCT02636699|65409742|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
23455514|NCT02636699|65409743|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
23455515|NCT02636699|65409742|FG000|Overall Study|Physician Decision|0|||
23455516|NCT02636699|65409743|FG001|Overall Study|Physician Decision|1|||
23455517|NCT02636699|65409742|FG000|Overall Study|Withdrawal by Subject|13|||
23455518|NCT02636699|65409743|FG001|Overall Study|Withdrawal by Subject|6|||
23455519|NCT02636699|65409742|FG000|Overall Study|Other|3|||
23455520|NCT02636699|65409743|FG001|Overall Study|Other|1|||
23455521|NCT00388349|65409747|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
23455522|NCT00388349|65409748|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
23455523|NCT02063724|65409749|FG000|Overall Study|Disease progression|1|||
23455524|NCT03259230|65409752|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
23455525|NCT03259230|65409753|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
23455526|NCT00644423|65409754|FG000|Overall Study|Lost to Follow-up|1|||
23455527|NCT00644423|65409755|FG001|Overall Study|Lost to Follow-up|1|||
23455528|NCT03655132|65409756|FG000|Overall Study|Lost to Follow-up|2|||
23455529|NCT03655132|65409757|FG001|Overall Study|Lost to Follow-up|1|||
23455530|NCT03655132|65409756|FG000|Overall Study|Withdrawal by Subject|0|||
23455531|NCT03655132|65409757|FG001|Overall Study|Withdrawal by Subject|1|||
23455532|NCT03655132|65409756|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
23455533|NCT03655132|65409757|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
23455534|NCT00739401|65409761|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
23455535|NCT00739401|65409761|FG000|Overall Study|Death|3|||
23455536|NCT00739401|65409761|FG000|Overall Study|Withdrawal by Subject|4|||
23455537|NCT01680341|65409764|FG000|Overall Study|Adverse Event|3|||
23455538|NCT01680341|65409765|FG001|Overall Study|Adverse Event|2|||
23455539|NCT01680341|65409764|FG000|Overall Study|Unclassified|18|||
23455540|NCT01680341|65409765|FG001|Overall Study|Unclassified|15|||
23455541|NCT06308822|65409766|FG000|Overall Study|Mutation Status Not Confirmed|17|||
23455542|NCT06308822|65409766|FG000|Overall Study|Adverse Event|1|||
23455543|NCT06308822|65409766|FG000|Overall Study|Death|5|||
23455544|NCT06308822|65409766|FG000|Overall Study|Disease progression|8|||
23455545|NCT06308822|65409766|FG000|Overall Study|Withdrawal by Subject|1|||
23455546|NCT06308822|65409766|FG000|Overall Study|Physician Decision|3|||
23455547|NCT02558894|65409767|FG000|Overall Study|Death; any cause, entire study duration|28|||
23455548|NCT02558894|65409768|FG001|Overall Study|Death; any cause, entire study duration|31|||
23455549|NCT02558894|65409767|FG000|Overall Study|Withdrawal by Subject|2|||
23455550|NCT02558894|65409768|FG001|Overall Study|Withdrawal by Subject|1|||
23455551|NCT02558894|65409767|FG000|Overall Study|Closure of Part A|2|||
23455552|NCT02558894|65409768|FG001|Overall Study|Closure of Part A|1|||
23455553|NCT03466658|65409779|FG000|Overall Study|Withdrawal by Subject|3|||
23455554|NCT03341299|65409780|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455555|NCT03341299|65409781|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455556|NCT03341299|65409782|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
23455557|NCT03341299|65409783|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455558|NCT04196686|65409784|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
23455559|NCT04196686|65409785|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
23455560|NCT00435409|65409787|FG000|Overall Study|Protocol Violation|1|||
23455561|NCT00435409|65409788|FG001|Overall Study|Protocol Violation|2|||
23455562|NCT00435409|65409789|FG002|Overall Study|Protocol Violation|0|||
23455563|NCT00435409|65409787|FG000|Overall Study|Lost to Follow-up|1|||
23455564|NCT00435409|65409788|FG001|Overall Study|Lost to Follow-up|2|||
23455565|NCT00435409|65409789|FG002|Overall Study|Lost to Follow-up|0|||
23455566|NCT00435409|65409787|FG000|Overall Study|Death|8|||
23783970|NCT01796171|66586802|FG001|Follow-up Period|Withdrawal by Subject|1|||
23637189|NCT04055090|66057354|FG000|Overall Study|Withdrawal by Subject|1|||
23637190|NCT04055090|66057355|FG001|Overall Study|Withdrawal by Subject|0|||
23783971|NCT01796171|66586803|FG002|Follow-up Period|Withdrawal by Subject|0|||
23455567|NCT00435409|65409788|FG001|Overall Study|Death|6|||
23455568|NCT00435409|65409789|FG002|Overall Study|Death|6|||
23455569|NCT00435409|65409787|FG000|Overall Study|Objective progression or relapse|158|||
23455570|NCT00435409|65409788|FG001|Overall Study|Objective progression or relapse|93|||
23844174|NCT03800836|66808942|FG005|Overall Study|Physician Decision|5|||
23783972|NCT01796171|66586804|FG003|Follow-up Period|Withdrawal by Subject|0|||
23455571|NCT00435409|65409789|FG002|Overall Study|Objective progression or relapse|58|||
23455572|NCT00435409|65409787|FG000|Overall Study|Global deterioration of health status|0|||
23455573|NCT00435409|65409788|FG001|Overall Study|Global deterioration of health status|0|||
23455574|NCT00435409|65409789|FG002|Overall Study|Global deterioration of health status|4|||
23455575|NCT00435409|65409787|FG000|Overall Study|Withdrawal by Subject|8|||
23455576|NCT00435409|65409788|FG001|Overall Study|Withdrawal by Subject|7|||
23455577|NCT00435409|65409789|FG002|Overall Study|Withdrawal by Subject|1|||
23455578|NCT00435409|65409787|FG000|Overall Study|Other|45|||
23455579|NCT00435409|65409788|FG001|Overall Study|Other|30|||
23455580|NCT00435409|65409789|FG002|Overall Study|Other|1|||
23455581|NCT00435409|65409787|FG000|Overall Study|Adverse Event|0|||
23455582|NCT00435409|65409788|FG001|Overall Study|Adverse Event|0|||
23455583|NCT00435409|65409789|FG002|Overall Study|Adverse Event|8|||
23455584|NCT00435409|65409787|FG000|Overall Study|Sponsor decision|0|||
23455585|NCT00435409|65409788|FG001|Overall Study|Sponsor decision|3|||
23455586|NCT00435409|65409789|FG002|Overall Study|Sponsor decision|0|||
23455587|NCT00918281|65409795|FG000|Overall Study|Physician Decision|29|||
23455588|NCT02426580|65409798|FG000|Overall Study|Death|2|||
23455589|NCT02426580|65409799|FG001|Overall Study|Death|2|||
23783973|NCT01796171|66586805|FG004|Follow-up Period|Withdrawal by Subject|0|||
23783974|NCT01796171|66586806|FG005|Follow-up Period|Withdrawal by Subject|1|||
23783975|NCT01796171|66586807|FG006|Follow-up Period|Withdrawal by Subject|0|||
23783976|NCT01796171|66586808|FG007|Follow-up Period|Withdrawal by Subject|0|||
23783977|NCT01796171|66586809|FG008|Follow-up Period|Withdrawal by Subject|0|||
23783978|NCT01796171|66586810|FG009|Follow-up Period|Withdrawal by Subject|0|||
23783979|NCT01796171|66586811|FG010|Follow-up Period|Withdrawal by Subject|3|||
23783980|NCT01796171|66586812|FG011|Follow-up Period|Withdrawal by Subject|1|||
23783981|NCT01796171|66586813|FG012|Follow-up Period|Withdrawal by Subject|0|||
23783982|NCT01796171|66586814|FG013|Follow-up Period|Withdrawal by Subject|0|||
23783983|NCT01796171|66586815|FG014|Follow-up Period|Withdrawal by Subject|0|||
23844175|NCT03800836|66808937|FG000|Overall Study|Death|34|||
23844176|NCT03800836|66808938|FG001|Overall Study|Death|16|||
23844177|NCT03800836|66808939|FG002|Overall Study|Death|5|||
23844178|NCT03800836|66808940|FG003|Overall Study|Death|5|||
23844179|NCT03800836|66808941|FG004|Overall Study|Death|10|||
23844180|NCT03800836|66808942|FG005|Overall Study|Death|0|||
23844181|NCT03800836|66808937|FG000|Overall Study|Symptomatic Deterioration|1|||
23844182|NCT03800836|66808938|FG001|Overall Study|Symptomatic Deterioration|0|||
23844183|NCT03800836|66808939|FG002|Overall Study|Symptomatic Deterioration|1|||
23844184|NCT03800836|66808940|FG003|Overall Study|Symptomatic Deterioration|0|||
23844185|NCT03800836|66808941|FG004|Overall Study|Symptomatic Deterioration|0|||
23844186|NCT03800836|66808942|FG005|Overall Study|Symptomatic Deterioration|0|||
23783984|NCT01796171|66586801|FG000|Follow-up Period|Death|0|||
23783985|NCT01796171|66586802|FG001|Follow-up Period|Death|0|||
23343911|NCT05072964|65001500|FG000|Overall Study|Death|1|||
23783986|NCT01796171|66586803|FG002|Follow-up Period|Death|0|||
23455590|NCT02426580|65409798|FG000|Overall Study|Lost to Follow-up|0|||
23455591|NCT02426580|65409799|FG001|Overall Study|Lost to Follow-up|9|||
23455592|NCT02426580|65409798|FG000|Overall Study|transfer to hemodialysis|5|||
23455593|NCT02426580|65409799|FG001|Overall Study|transfer to hemodialysis|5|||
23783987|NCT01796171|66586804|FG003|Follow-up Period|Death|0|||
23783988|NCT01796171|66586805|FG004|Follow-up Period|Death|0|||
23783989|NCT01796171|66586806|FG005|Follow-up Period|Death|0|||
23783990|NCT01796171|66586807|FG006|Follow-up Period|Death|1|||
23783991|NCT01796171|66586808|FG007|Follow-up Period|Death|0|||
23783992|NCT01796171|66586809|FG008|Follow-up Period|Death|0|||
23783993|NCT01796171|66586810|FG009|Follow-up Period|Death|0|||
23783994|NCT01796171|66586811|FG010|Follow-up Period|Death|17|||
23783995|NCT01796171|66586812|FG011|Follow-up Period|Death|9|||
23783996|NCT01796171|66586813|FG012|Follow-up Period|Death|1|||
23783997|NCT01796171|66586814|FG013|Follow-up Period|Death|0|||
23783998|NCT01796171|66586815|FG014|Follow-up Period|Death|0|||
23783999|NCT01796171|66586801|FG000|Follow-up Period|Patient transferred to other hospital|0|||
23784000|NCT01796171|66586802|FG001|Follow-up Period|Patient transferred to other hospital|1|||
23784001|NCT01796171|66586803|FG002|Follow-up Period|Patient transferred to other hospital|0|||
23784002|NCT01796171|66586804|FG003|Follow-up Period|Patient transferred to other hospital|0|||
23784003|NCT01796171|66586805|FG004|Follow-up Period|Patient transferred to other hospital|0|||
23343912|NCT05619536|65001501|FG000|Overall Study|Withdrawal by Subject|0|||
23343913|NCT05619536|65001502|FG001|Overall Study|Withdrawal by Subject|1|||
23343914|NCT05619536|65001503|FG002|Overall Study|Withdrawal by Subject|0|||
23343915|NCT05619536|65001504|FG003|Overall Study|Withdrawal by Subject|1|||
23343916|NCT05619536|65001501|FG000|Overall Study|Lost to Follow-up|0|||
23455594|NCT02426580|65409798|FG000|Overall Study|Kidney transplant|3|||
23455595|NCT02426580|65409799|FG001|Overall Study|Kidney transplant|0|||
23455596|NCT02426580|65409798|FG000|Overall Study|Allergic to egg white|1|||
23455597|NCT02426580|65409799|FG001|Overall Study|Allergic to egg white|0|||
23455598|NCT04663321|65409800|FG000|Overall Study|Study terminated by Sponsor|2|||
23455599|NCT04663321|65409801|FG001|Overall Study|Study terminated by Sponsor|1|||
23455600|NCT04663321|65409802|FG002|Overall Study|Study terminated by Sponsor|2|||
23455601|NCT04663321|65409800|FG000|Overall Study|Withdrawal by Subject|10|||
23455602|NCT04663321|65409801|FG001|Overall Study|Withdrawal by Subject|3|||
23455603|NCT04663321|65409802|FG002|Overall Study|Withdrawal by Subject|2|||
23455604|NCT04663321|65409800|FG000|Overall Study|Not provided|0|||
23455605|NCT04663321|65409801|FG001|Overall Study|Not provided|0|||
23455606|NCT04663321|65409802|FG002|Overall Study|Not provided|1|||
23455607|NCT03271151|65409805|FG000|Overall Study|Lost to Follow-up|1|||
23455608|NCT03271151|65409806|FG001|Overall Study|Lost to Follow-up|3|||
23784004|NCT01796171|66586806|FG005|Follow-up Period|Patient transferred to other hospital|0|||
23784005|NCT01796171|66586807|FG006|Follow-up Period|Patient transferred to other hospital|0|||
23784006|NCT01796171|66586808|FG007|Follow-up Period|Patient transferred to other hospital|0|||
23784007|NCT01796171|66586809|FG008|Follow-up Period|Patient transferred to other hospital|0|||
23784008|NCT01796171|66586810|FG009|Follow-up Period|Patient transferred to other hospital|0|||
23784009|NCT01796171|66586811|FG010|Follow-up Period|Patient transferred to other hospital|0|||
23784010|NCT01796171|66586812|FG011|Follow-up Period|Patient transferred to other hospital|0|||
23784011|NCT01796171|66586813|FG012|Follow-up Period|Patient transferred to other hospital|0|||
23784012|NCT01796171|66586814|FG013|Follow-up Period|Patient transferred to other hospital|0|||
23784013|NCT01796171|66586815|FG014|Follow-up Period|Patient transferred to other hospital|0|||
23784014|NCT01796171|66586801|FG000|Follow-up Period|Sponsor Decision|0|||
23784015|NCT01796171|66586802|FG001|Follow-up Period|Sponsor Decision|0|||
23784016|NCT01796171|66586803|FG002|Follow-up Period|Sponsor Decision|0|||
23784017|NCT01796171|66586804|FG003|Follow-up Period|Sponsor Decision|0|||
23784018|NCT01796171|66586805|FG004|Follow-up Period|Sponsor Decision|0|||
23784019|NCT01796171|66586806|FG005|Follow-up Period|Sponsor Decision|0|||
23784020|NCT01796171|66586807|FG006|Follow-up Period|Sponsor Decision|0|||
23784021|NCT01796171|66586808|FG007|Follow-up Period|Sponsor Decision|0|||
23784022|NCT01796171|66586809|FG008|Follow-up Period|Sponsor Decision|0|||
23784023|NCT01796171|66586810|FG009|Follow-up Period|Sponsor Decision|0|||
23343917|NCT05619536|65001502|FG001|Overall Study|Lost to Follow-up|1|||
23343918|NCT05619536|65001503|FG002|Overall Study|Lost to Follow-up|1|||
23343919|NCT05619536|65001504|FG003|Overall Study|Lost to Follow-up|0|||
23343920|NCT03205761|65001507|FG000|Overall Study|Withdrawal by Subject|1|||
23455609|NCT03271151|65409805|FG000|Overall Study|Withdrawal by Subject|1|||
23455610|NCT03271151|65409806|FG001|Overall Study|Withdrawal by Subject|0|||
23455611|NCT00713609|65409812|FG000|Overall Study|Adverse Event|2|||
23784024|NCT01796171|66586811|FG010|Follow-up Period|Sponsor Decision|40|||
23784025|NCT01796171|66586812|FG011|Follow-up Period|Sponsor Decision|15|||
23784026|NCT01796171|66586813|FG012|Follow-up Period|Sponsor Decision|7|||
23343921|NCT03205761|65001507|FG000|Overall Study|Progressive Disease|10|||
23784027|NCT01796171|66586814|FG013|Follow-up Period|Sponsor Decision|0|||
23784028|NCT01796171|66586815|FG014|Follow-up Period|Sponsor Decision|0|||
23784029|NCT03249454|66586816|FG000|Overall Study|Withdrawal by Subject|0|||
23784030|NCT03249454|66586817|FG001|Overall Study|Withdrawal by Subject|0|||
23784031|NCT03249454|66586818|FG002|Overall Study|Withdrawal by Subject|0|||
23784032|NCT03249454|66586819|FG003|Overall Study|Withdrawal by Subject|0|||
23784033|NCT03249454|66586820|FG004|Overall Study|Withdrawal by Subject|0|||
23637191|NCT04514510|66057356|FG000|Overall Study|Lost to Follow-up|0|||
23637192|NCT04514510|66057357|FG001|Overall Study|Lost to Follow-up|1|||
23784034|NCT03249454|66586821|FG005|Overall Study|Withdrawal by Subject|0|||
23784035|NCT03249454|66586822|FG006|Overall Study|Withdrawal by Subject|0|||
23784036|NCT03249454|66586823|FG007|Overall Study|Withdrawal by Subject|0|||
23455612|NCT00713609|65409813|FG001|Overall Study|Adverse Event|0|||
23582779|NCT04984876|65862544|FG001|Overall Study|Physician Decision|0|||
23582780|NCT04984876|65862545|FG002|Overall Study|Physician Decision|0|||
23582781|NCT04984876|65862546|FG003|Overall Study|Physician Decision|1|||
23582782|NCT04984876|65862547|FG004|Overall Study|Physician Decision|0|||
23582783|NCT04984876|65862548|FG005|Overall Study|Physician Decision|0|||
23582784|NCT04984876|65862543|FG000|Overall Study|Adverse Event|0|||
23582785|NCT04984876|65862544|FG001|Overall Study|Adverse Event|0|||
23582786|NCT04984876|65862545|FG002|Overall Study|Adverse Event|1|||
23582787|NCT04984876|65862546|FG003|Overall Study|Adverse Event|0|||
23582788|NCT04984876|65862547|FG004|Overall Study|Adverse Event|0|||
23582789|NCT04984876|65862548|FG005|Overall Study|Adverse Event|0|||
23582790|NCT01195675|65862551|FG000|Overall Study|Adverse Event|1|||
23582791|NCT01195675|65862551|FG000|Overall Study|Withdrawal by Subject|2|||
23582792|NCT00248287|65862554|FG000|Overall Study|Adverse Event|11|||
23582793|NCT00248287|65862555|FG001|Overall Study|Adverse Event|10|||
23582794|NCT00248287|65862554|FG000|Overall Study|Death|1|||
23582795|NCT00248287|65862555|FG001|Overall Study|Death|0|||
23582796|NCT00248287|65862554|FG000|Overall Study|Lost to Follow-up|0|||
23582797|NCT00248287|65862555|FG001|Overall Study|Lost to Follow-up|1|||
23582798|NCT00248287|65862554|FG000|Overall Study|Investigator Request|4|||
23582799|NCT00248287|65862555|FG001|Overall Study|Investigator Request|3|||
23582800|NCT00248287|65862554|FG000|Overall Study|Patient Request|5|||
23582801|NCT00248287|65862555|FG001|Overall Study|Patient Request|3|||
23582802|NCT00248287|65862554|FG000|Overall Study|Other|3|||
23582803|NCT00248287|65862555|FG001|Overall Study|Other|2|||
23582804|NCT02469064|65862556|FG000|Overall Study|Request not to receive intervention.|1|||
23582805|NCT02469064|65862557|FG001|Overall Study|Request not to receive intervention.|3|||
23582806|NCT02062827|65862559|FG000|Overall Study|Death|1|||
23582807|NCT02062827|65862560|FG001|Overall Study|Death|0|||
23582808|NCT02062827|65862561|FG002|Overall Study|Death|0|||
23582809|NCT02062827|65862562|FG003|Overall Study|Death|0|||
23582810|NCT02062827|65862563|FG004|Overall Study|Death|0|||
23582811|NCT02062827|65862564|FG005|Overall Study|Death|0|||
23582812|NCT02062827|65862565|FG006|Overall Study|Death|0|||
23582813|NCT02062827|65862566|FG007|Overall Study|Death|0|||
23582814|NCT02062827|65862559|FG000|Overall Study|Withdrawal by Subject|3|||
23582815|NCT02062827|65862560|FG001|Overall Study|Withdrawal by Subject|1|||
23582816|NCT02062827|65862561|FG002|Overall Study|Withdrawal by Subject|1|||
23582817|NCT02062827|65862562|FG003|Overall Study|Withdrawal by Subject|2|||
23582818|NCT02062827|65862563|FG004|Overall Study|Withdrawal by Subject|6|||
23582819|NCT02062827|65862564|FG005|Overall Study|Withdrawal by Subject|0|||
23582820|NCT02062827|65862565|FG006|Overall Study|Withdrawal by Subject|5|||
23582821|NCT02062827|65862566|FG007|Overall Study|Withdrawal by Subject|0|||
23582822|NCT02062827|65862559|FG000|Overall Study|Screen Fail|0|||
23582823|NCT02062827|65862560|FG001|Overall Study|Screen Fail|0|||
23582824|NCT02062827|65862561|FG002|Overall Study|Screen Fail|0|||
23582825|NCT02062827|65862562|FG003|Overall Study|Screen Fail|0|||
23582826|NCT02062827|65862563|FG004|Overall Study|Screen Fail|0|||
23582827|NCT02062827|65862564|FG005|Overall Study|Screen Fail|0|||
23582828|NCT02062827|65862565|FG006|Overall Study|Screen Fail|0|||
23582829|NCT02062827|65862566|FG007|Overall Study|Screen Fail|8|||
23582830|NCT03563053|65865861|FG000|Overall Study|Withdrawal by Subject|17|||
23582831|NCT03563053|65865861|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
23582832|NCT03563053|65865861|FG000|Overall Study|Adverse Event|3|||
23582833|NCT03563053|65865861|FG000|Overall Study|Physician Decision|1|||
23582834|NCT03563053|65865861|FG000|Overall Study|study terminated by sponsor|71|||
23582835|NCT00049517|65865865|FG000|Induction|Disease progression|0|||
23582836|NCT00049517|65865866|FG001|Induction|Disease progression|0|||
23582837|NCT00049517|65865867|FG002|Induction|Disease progression|0|||
23582838|NCT00049517|65865868|FG003|Induction|Disease progression|0|||
23582839|NCT00049517|65865869|FG004|Induction|Disease progression|18|||
23582840|NCT00049517|65865870|FG005|Induction|Disease progression|11|||
23582841|NCT00049517|65865865|FG000|Induction|Adverse Event|0|||
23582842|NCT00049517|65865866|FG001|Induction|Adverse Event|0|||
23582843|NCT00049517|65865867|FG002|Induction|Adverse Event|0|||
23582844|NCT00049517|65865868|FG003|Induction|Adverse Event|0|||
23637193|NCT04514510|66057356|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
23784037|NCT03249454|66586824|FG008|Overall Study|Withdrawal by Subject|0|||
23582845|NCT00049517|65865869|FG004|Induction|Adverse Event|5|||
23582846|NCT00049517|65865870|FG005|Induction|Adverse Event|7|||
23784038|NCT03249454|66586825|FG009|Overall Study|Withdrawal by Subject|1|||
23784039|NCT03249454|66586826|FG010|Overall Study|Withdrawal by Subject|1|||
23784040|NCT01015625|66586830|FG000|Overall Study|Lost to Follow-up|3|||
23784041|NCT01015625|66586831|FG001|Overall Study|Lost to Follow-up|1|||
23784042|NCT01015625|66586830|FG000|Overall Study|Withdrawal by Subject|2|||
23784043|NCT01015625|66586831|FG001|Overall Study|Withdrawal by Subject|3|||
23784044|NCT01015625|66586830|FG000|Overall Study|Physician Decision|2|||
23784045|NCT01015625|66586831|FG001|Overall Study|Physician Decision|0|||
23784046|NCT01015625|66586830|FG000|Overall Study|Death|30|||
23784047|NCT01015625|66586831|FG001|Overall Study|Death|22|||
23784048|NCT00469417|66586832|FG000|Overall Study|Treatment failure all lesions|18|||
23784049|NCT00469417|66586833|FG001|Overall Study|Treatment failure all lesions|11|||
23784050|NCT00469417|66586832|FG000|Overall Study|Consent withdrawn|1|||
23784051|NCT00469417|66586833|FG001|Overall Study|Consent withdrawn|1|||
23784052|NCT00469417|66586832|FG000|Overall Study|Adverse Event|8|||
23784053|NCT00469417|66586833|FG001|Overall Study|Adverse Event|2|||
23784054|NCT00469417|66586832|FG000|Overall Study|Lost to Follow-up|1|||
23784055|NCT00469417|66586833|FG001|Overall Study|Lost to Follow-up|2|||
23784056|NCT00469417|66586832|FG000|Overall Study|Intercurrent disease|0|||
23784057|NCT00469417|66586833|FG001|Overall Study|Intercurrent disease|1|||
23784058|NCT00469417|66586832|FG000|Overall Study|Randomized but not treated|2|||
23784059|NCT00469417|66586833|FG001|Overall Study|Randomized but not treated|0|||
23784060|NCT00829673|66586834|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23784061|NCT00829673|66586835|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23784062|NCT01788423|66586838|FG000|Overall Study|See Comments in Completed (above)|0|||
23784063|NCT01788423|66586839|FG001|Overall Study|See Comments in Completed (above)|4|||
23784064|NCT01788423|66586840|FG002|Overall Study|See Comments in Completed (above)|5|||
23784065|NCT00905346|66586841|FG000|Period 1|Withdrawal by Subject|1|||
23784066|NCT00905346|66586842|FG001|Period 1|Withdrawal by Subject|0|||
23784067|NCT04608188|66586843|FG000|Overall Study|Withdrawal by Subject|4|||
23784068|NCT04608188|66586844|FG001|Overall Study|Withdrawal by Subject|8|||
23784069|NCT03447353|66586845|FG000|Overall Study|Failure at Screening Visit|2|||
23784070|NCT03447353|66586845|FG000|Overall Study|Lost to Follow-up|4|||
23784071|NCT03447353|66586845|FG000|Overall Study|Scheduling Conflicts|3|||
23784072|NCT03447353|66586845|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
23784073|NCT01838681|66586848|FG000|Period A|Adverse Event|39|||
23784074|NCT01838681|66586849|FG001|Period A|Adverse Event|0|||
23784075|NCT01838681|66586850|FG002|Period A|Adverse Event|0|||
23343922|NCT03698994|65001509|FG000|Overall Study|Adverse Event|2|||
23455613|NCT00713609|65409814|FG002|Overall Study|Adverse Event|2|||
23455614|NCT00713609|65409815|FG003|Overall Study|Adverse Event|2|||
23784076|NCT01838681|66586851|FG003|Period A|Adverse Event|0|||
23784077|NCT01838681|66586848|FG000|Period A|Lack of Efficacy|21|||
23784078|NCT01838681|66586849|FG001|Period A|Lack of Efficacy|0|||
23784079|NCT01838681|66586850|FG002|Period A|Lack of Efficacy|0|||
23784080|NCT01838681|66586851|FG003|Period A|Lack of Efficacy|0|||
23784081|NCT01838681|66586848|FG000|Period A|Early response|148|||
23784082|NCT01838681|66586849|FG001|Period A|Early response|0|||
23784083|NCT01838681|66586850|FG002|Period A|Early response|0|||
23784084|NCT01838681|66586851|FG003|Period A|Early response|0|||
23784085|NCT01838681|66586848|FG000|Period A|Withdrawal by Subject|70|||
23784086|NCT01838681|66586849|FG001|Period A|Withdrawal by Subject|0|||
23784087|NCT01838681|66586850|FG002|Period A|Withdrawal by Subject|0|||
23784088|NCT01838681|66586851|FG003|Period A|Withdrawal by Subject|0|||
23784089|NCT01838681|66586848|FG000|Period A|Protocol Violation|16|||
23784090|NCT01838681|66586849|FG001|Period A|Protocol Violation|0|||
23784091|NCT01838681|66586850|FG002|Period A|Protocol Violation|0|||
23784092|NCT01838681|66586851|FG003|Period A|Protocol Violation|0|||
23455615|NCT00713609|65409816|FG004|Overall Study|Adverse Event|3|||
23582847|NCT00049517|65865865|FG000|Induction|Death|0|||
23582848|NCT00049517|65865866|FG001|Induction|Death|0|||
23582849|NCT00049517|65865867|FG002|Induction|Death|0|||
23582850|NCT00049517|65865868|FG003|Induction|Death|0|||
23582851|NCT00049517|65865869|FG004|Induction|Death|9|||
23582852|NCT00049517|65865870|FG005|Induction|Death|6|||
23582853|NCT00049517|65865865|FG000|Induction|Withdrawal by Subject|0|||
23784093|NCT01838681|66586848|FG000|Period A|Non-compliance with IMP|6|||
23784094|NCT01838681|66586849|FG001|Period A|Non-compliance with IMP|0|||
23784095|NCT01838681|66586850|FG002|Period A|Non-compliance with IMP|0|||
23784096|NCT01838681|66586851|FG003|Period A|Non-compliance with IMP|0|||
23784097|NCT01838681|66586848|FG000|Period A|Lost to Follow-up|4|||
23784098|NCT01838681|66586849|FG001|Period A|Lost to Follow-up|0|||
23784099|NCT01838681|66586850|FG002|Period A|Lost to Follow-up|0|||
23784100|NCT01838681|66586851|FG003|Period A|Lost to Follow-up|0|||
23455616|NCT00713609|65409817|FG005|Overall Study|Adverse Event|1|||
23455617|NCT00713609|65409812|FG000|Overall Study|Lost to Follow-up|5|||
23784101|NCT01838681|66586848|FG000|Period A|Withdrawal before treatment|4|||
23784102|NCT01838681|66586849|FG001|Period A|Withdrawal before treatment|0|||
23784103|NCT01838681|66586850|FG002|Period A|Withdrawal before treatment|0|||
23582854|NCT00049517|65865866|FG001|Induction|Withdrawal by Subject|0|||
23582855|NCT00049517|65865867|FG002|Induction|Withdrawal by Subject|0|||
23784104|NCT01838681|66586851|FG003|Period A|Withdrawal before treatment|0|||
23784105|NCT01838681|66586848|FG000|Period A|Administrative or other reasons|17|||
23784106|NCT01838681|66586849|FG001|Period A|Administrative or other reasons|0|||
23784107|NCT01838681|66586850|FG002|Period A|Administrative or other reasons|0|||
23784108|NCT01838681|66586851|FG003|Period A|Administrative or other reasons|0|||
23784109|NCT01838681|66586848|FG000|Period B/A+|Adverse Event|0|||
23784110|NCT01838681|66586849|FG001|Period B/A+|Adverse Event|13|||
23784111|NCT01838681|66586850|FG002|Period B/A+|Adverse Event|27|||
23784112|NCT01838681|66586851|FG003|Period B/A+|Adverse Event|16|||
23784113|NCT01838681|66586848|FG000|Period B/A+|Lack of Efficacy|0|||
23784114|NCT01838681|66586849|FG001|Period B/A+|Lack of Efficacy|9|||
23784115|NCT01838681|66586850|FG002|Period B/A+|Lack of Efficacy|11|||
23784116|NCT01838681|66586851|FG003|Period B/A+|Lack of Efficacy|6|||
23784117|NCT01838681|66586848|FG000|Period B/A+|Withdrawal by Subject|0|||
23343923|NCT03698994|65001509|FG000|Overall Study|Death|1|||
23343924|NCT03698994|65001509|FG000|Overall Study|Physician Decision|1|||
23343925|NCT03698994|65001509|FG000|Overall Study|Withdrawal by Subject|3|||
23343926|NCT03698994|65001509|FG000|Overall Study|Progressive Disease|12|||
23343927|NCT00308087|65001510|FG000|Overall Study|Progressive Disease|19|||
23343928|NCT00308087|65001511|FG001|Overall Study|Progressive Disease|21|||
23343929|NCT00308087|65001510|FG000|Overall Study|Study Closure|11|||
23343930|NCT00308087|65001511|FG001|Overall Study|Study Closure|12|||
23343931|NCT00308087|65001510|FG000|Overall Study|Withdrawal by Subject|2|||
23343932|NCT00308087|65001511|FG001|Overall Study|Withdrawal by Subject|1|||
23343933|NCT00308087|65001510|FG000|Overall Study|Other|4|||
23343934|NCT00308087|65001511|FG001|Overall Study|Other|3|||
23343935|NCT01970475|65001512|FG000|Overall Study|Withdrawal by Subject|11|||
23343936|NCT01970475|65001513|FG001|Overall Study|Withdrawal by Subject|6|||
23343937|NCT01970475|65001512|FG000|Overall Study|Adverse Event|7|||
23343938|NCT01970475|65001513|FG001|Overall Study|Adverse Event|3|||
23784118|NCT01838681|66586849|FG001|Period B/A+|Withdrawal by Subject|28|||
23784119|NCT01838681|66586850|FG002|Period B/A+|Withdrawal by Subject|35|||
23784120|NCT01838681|66586851|FG003|Period B/A+|Withdrawal by Subject|47|||
23784121|NCT01838681|66586848|FG000|Period B/A+|Protocol Violation|0|||
23343939|NCT01970475|65001512|FG000|Overall Study|Lost to Follow-up|2|||
23343940|NCT01970475|65001513|FG001|Overall Study|Lost to Follow-up|2|||
23343941|NCT01970475|65001512|FG000|Overall Study|Protocol Violation|1|||
23343942|NCT01970475|65001513|FG001|Overall Study|Protocol Violation|0|||
23343943|NCT00520481|65001514|FG000|Overall Study|Adverse Event|4|||
23343944|NCT00520481|65001515|FG001|Overall Study|Adverse Event|1|||
23343945|NCT00520481|65001514|FG000|Overall Study|Withdrawal by Subject|3|||
23343946|NCT00520481|65001515|FG001|Overall Study|Withdrawal by Subject|0|||
23343947|NCT01895608|65001521|FG000|Overall Study|change in health status|0|||
23343948|NCT01895608|65001522|FG001|Overall Study|change in health status|1|||
23343949|NCT01895608|65001523|FG002|Overall Study|change in health status|1|||
23343950|NCT01895608|65001524|FG003|Overall Study|change in health status|0|||
23343951|NCT01895608|65001521|FG000|Overall Study|Withdrawal by Subject|0|||
23343952|NCT01895608|65001522|FG001|Overall Study|Withdrawal by Subject|0|||
23343953|NCT01895608|65001523|FG002|Overall Study|Withdrawal by Subject|2|||
23343954|NCT01895608|65001524|FG003|Overall Study|Withdrawal by Subject|0|||
23343955|NCT04325698|65001525|FG000|Overall Study|Study Terminated By Sponsor|1|||
23343956|NCT04325698|65001526|FG001|Overall Study|Study Terminated By Sponsor|1|||
23343957|NCT04325698|65001525|FG000|Overall Study|Withdrawal by Subject|0|||
23343958|NCT04325698|65001526|FG001|Overall Study|Withdrawal by Subject|2|||
23343959|NCT02487771|65001533|FG000|Overall Study|Lost to Follow-up|2|||
23343960|NCT02487771|65001534|FG001|Overall Study|Lost to Follow-up|3|||
23343961|NCT02487771|65001533|FG000|Overall Study|Moved out of area|5|||
23343962|NCT02487771|65001534|FG001|Overall Study|Moved out of area|6|||
23343963|NCT02487771|65001533|FG000|Overall Study|Withdrawal by Subject|3|||
23343964|NCT02487771|65001534|FG001|Overall Study|Withdrawal by Subject|5|||
23343965|NCT02447497|65001535|FG000|Overall Study|Did not meet treatment day baseline.|6|||
23343966|NCT02447497|65001536|FG001|Overall Study|Did not meet treatment day baseline.|5|||
23343967|NCT02447497|65001537|FG002|Overall Study|Did not meet treatment day baseline.|2|||
23343968|NCT02447497|65001538|FG003|Overall Study|Did not meet treatment day baseline.|2|||
23343969|NCT02447497|65001535|FG000|Overall Study|Dressing was compromised|0|||
23343970|NCT02447497|65001536|FG001|Overall Study|Dressing was compromised|1|||
23343971|NCT02447497|65001537|FG002|Overall Study|Dressing was compromised|0|||
23343972|NCT02447497|65001538|FG003|Overall Study|Dressing was compromised|0|||
23343973|NCT06137703|65001539|FG000|Overall Study|Other|0|||
23343974|NCT06137703|65001540|FG001|Overall Study|Other|1|||
23455618|NCT00713609|65409813|FG001|Overall Study|Lost to Follow-up|7|||
23784122|NCT01838681|66586849|FG001|Period B/A+|Protocol Violation|1|||
23784123|NCT01838681|66586850|FG002|Period B/A+|Protocol Violation|4|||
23343975|NCT06137703|65001541|FG002|Overall Study|Other|0|||
23455619|NCT00713609|65409814|FG002|Overall Study|Lost to Follow-up|5|||
23784124|NCT01838681|66586851|FG003|Period B/A+|Protocol Violation|6|||
23343976|NCT06137703|65001542|FG003|Overall Study|Other|0|||
23343977|NCT06137703|65001539|FG000|Overall Study|Adverse Event|0|||
23343978|NCT06137703|65001540|FG001|Overall Study|Adverse Event|0|||
23343979|NCT06137703|65001541|FG002|Overall Study|Adverse Event|1|||
23343980|NCT06137703|65001542|FG003|Overall Study|Adverse Event|0|||
23343981|NCT04464720|65001543|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
23343982|NCT02276053|65001547|FG000|Overall Study|Death|2|||
23343983|NCT02276053|65001547|FG000|Overall Study|Adverse Event|5|||
23343984|NCT02276053|65001547|FG000|Overall Study|Lack of Efficacy|2|||
23343985|NCT02276053|65001547|FG000|Overall Study|Withdrawal by Subject|1|||
23343986|NCT02276053|65001547|FG000|Overall Study|Patient does not meet selection criteria|3|||
23343987|NCT02276053|65001547|FG000|Overall Study|Patient needs to increase baseline AED|1|||
23343988|NCT04323306|65001548|FG000|Overall Study|Physician Decision|1|||
23343989|NCT04323306|65001549|FG001|Overall Study|Physician Decision|0|||
23343990|NCT04323306|65001550|FG002|Overall Study|Physician Decision|0|||
23343991|NCT04323306|65001551|FG003|Overall Study|Physician Decision|0|||
23343992|NCT04323306|65001552|FG004|Overall Study|Physician Decision|0|||
23343993|NCT04323306|65001553|FG005|Overall Study|Physician Decision|0|||
23343994|NCT04323306|65001554|FG006|Overall Study|Physician Decision|0|||
23343995|NCT04323306|65001555|FG007|Overall Study|Physician Decision|0|||
23343996|NCT04323306|65001556|FG008|Overall Study|Physician Decision|0|||
23343997|NCT04323306|65001548|FG000|Overall Study|Withdrawal by Subject|0|||
23343998|NCT04323306|65001549|FG001|Overall Study|Withdrawal by Subject|0|||
23343999|NCT04323306|65001550|FG002|Overall Study|Withdrawal by Subject|0|||
23344000|NCT04323306|65001551|FG003|Overall Study|Withdrawal by Subject|0|||
23344001|NCT04323306|65001552|FG004|Overall Study|Withdrawal by Subject|0|||
23344002|NCT04323306|65001553|FG005|Overall Study|Withdrawal by Subject|1|||
23344003|NCT04323306|65001554|FG006|Overall Study|Withdrawal by Subject|3|||
23344004|NCT04323306|65001555|FG007|Overall Study|Withdrawal by Subject|0|||
23344005|NCT04323306|65001556|FG008|Overall Study|Withdrawal by Subject|1|||
23344006|NCT01806961|65001557|FG000|Overall Study|sponsor decision|16|||
23344007|NCT03861273|65001558|FG000|Screening Phase (3 Weeks)|Other|1|||
23344008|NCT03861273|65001558|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
23344009|NCT03861273|65001558|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
23344010|NCT03861273|65001558|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
23344011|NCT03861273|65001558|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
23344012|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Adverse Event|6|||
23344013|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Adverse Event|14|||
23344014|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Death|3|||
23344015|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Death|1|||
23344016|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
23344017|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
23344018|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
23344019|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
23344020|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
23344021|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
23344022|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
23455620|NCT00713609|65409815|FG003|Overall Study|Lost to Follow-up|5|||
23455621|NCT00713609|65409816|FG004|Overall Study|Lost to Follow-up|7|||
23455622|NCT00713609|65409817|FG005|Overall Study|Lost to Follow-up|0|||
23455623|NCT00713609|65409812|FG000|Overall Study|Lack of Efficacy|1|||
23784125|NCT01838681|66586848|FG000|Period B/A+|Non-compliance with IMP|0|||
23784126|NCT01838681|66586849|FG001|Period B/A+|Non-compliance with IMP|2|||
23784127|NCT01838681|66586850|FG002|Period B/A+|Non-compliance with IMP|3|||
23784128|NCT01838681|66586851|FG003|Period B/A+|Non-compliance with IMP|3|||
23784129|NCT01838681|66586848|FG000|Period B/A+|Lost to Follow-up|0|||
23784130|NCT01838681|66586849|FG001|Period B/A+|Lost to Follow-up|2|||
23784131|NCT01838681|66586850|FG002|Period B/A+|Lost to Follow-up|5|||
23784132|NCT01838681|66586851|FG003|Period B/A+|Lost to Follow-up|11|||
23784133|NCT01838681|66586848|FG000|Period B/A+|Withdrawal before treatment|0|||
23784134|NCT01838681|66586849|FG001|Period B/A+|Withdrawal before treatment|1|||
23784135|NCT01838681|66586850|FG002|Period B/A+|Withdrawal before treatment|0|||
23784136|NCT01838681|66586851|FG003|Period B/A+|Withdrawal before treatment|0|||
23784137|NCT01838681|66586848|FG000|Period B/A+|Administrative or other reasons|0|||
23784138|NCT01838681|66586849|FG001|Period B/A+|Administrative or other reasons|6|||
23784139|NCT01838681|66586850|FG002|Period B/A+|Administrative or other reasons|10|||
23784140|NCT01838681|66586851|FG003|Period B/A+|Administrative or other reasons|28|||
23784141|NCT00620074|66586857|FG000|Overall Study|Adverse Event|1|||
23784142|NCT01757392|66586864|FG000|Overall Study|Withdrawal by Subject|1|||
23784143|NCT01757392|66586864|FG000|Overall Study|Screen Fail|3|||
23784144|NCT00123734|66586870|FG000|Overall Study|Death|3|||
23784145|NCT00123734|66586870|FG000|Overall Study|Lost to Follow-up|3|||
23784146|NCT00123734|66586870|FG000|Overall Study|Dropout|1|||
23784147|NCT00123734|66586870|FG000|Overall Study|Withdrawal by Subject|1|||
23784148|NCT02819518|66586871|FG000|Overall Study|Death|9|||
23784149|NCT02819518|66586872|FG001|Overall Study|Death|11|||
23784150|NCT02819518|66586873|FG002|Overall Study|Death|9|||
23784151|NCT02819518|66586874|FG003|Overall Study|Death|447|||
23784152|NCT02819518|66586875|FG004|Overall Study|Death|233|||
23784153|NCT02819518|66586871|FG000|Overall Study|Withdrawal by Subject|0|||
23784154|NCT02819518|66586872|FG001|Overall Study|Withdrawal by Subject|0|||
23784155|NCT02819518|66586873|FG002|Overall Study|Withdrawal by Subject|0|||
23784156|NCT02819518|66586874|FG003|Overall Study|Withdrawal by Subject|21|||
23784157|NCT02819518|66586875|FG004|Overall Study|Withdrawal by Subject|6|||
23784158|NCT02819518|66586871|FG000|Overall Study|Ongoing in Study|2|||
23784159|NCT02819518|66586872|FG001|Overall Study|Ongoing in Study|3|||
23784160|NCT02819518|66586873|FG002|Overall Study|Ongoing in Study|1|||
23784161|NCT02819518|66586874|FG003|Overall Study|Ongoing in Study|98|||
23784162|NCT02819518|66586875|FG004|Overall Study|Ongoing in Study|42|||
23784163|NCT00443651|66586876|FG000|Overall Study|Death|1|||
23784164|NCT00443651|66586877|FG001|Overall Study|Death|5|||
23784165|NCT00443651|66586876|FG000|Overall Study|Adverse Event|5|||
23784166|NCT00443651|66586877|FG001|Overall Study|Adverse Event|6|||
23784167|NCT00443651|66586876|FG000|Overall Study|Lost to Follow-up|18|||
23784168|NCT00443651|66586877|FG001|Overall Study|Lost to Follow-up|12|||
23784169|NCT00443651|66586876|FG000|Overall Study|Patient's/Guardian's Decision|58|||
23784170|NCT00443651|66586877|FG001|Overall Study|Patient's/Guardian's Decision|30|||
23455624|NCT00713609|65409813|FG001|Overall Study|Lack of Efficacy|3|||
23455625|NCT00713609|65409814|FG002|Overall Study|Lack of Efficacy|0|||
23455626|NCT00713609|65409815|FG003|Overall Study|Lack of Efficacy|0|||
23455627|NCT00713609|65409816|FG004|Overall Study|Lack of Efficacy|1|||
23455628|NCT00713609|65409817|FG005|Overall Study|Lack of Efficacy|0|||
23455629|NCT00713609|65409812|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
23455630|NCT00713609|65409813|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
23455631|NCT00713609|65409814|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
23455632|NCT00713609|65409815|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
23455633|NCT00713609|65409816|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
23784171|NCT00443651|66586876|FG000|Overall Study|Physician Decision|13|||
23784172|NCT00443651|66586877|FG001|Overall Study|Physician Decision|4|||
23784173|NCT00443651|66586876|FG000|Overall Study|Pregnancy|0|||
23784174|NCT00443651|66586877|FG001|Overall Study|Pregnancy|1|||
23784175|NCT00859521|66586878|FG000|Washout|Withdrawal by Subject|0|||
23784176|NCT00859521|66586879|FG001|Washout|Withdrawal by Subject|1|||
23784177|NCT02476994|66586883|FG000|Overall Study|Based on feedback from FDA|1|||
23784178|NCT02476994|66586884|FG001|Overall Study|Based on feedback from FDA|0|||
23784179|NCT03597256|66586892|FG000|Overall Study|Lost to Follow-up|3|||
23784180|NCT03597256|66586893|FG001|Overall Study|Lost to Follow-up|1|||
23784181|NCT03597256|66586892|FG000|Overall Study|Withdrawal by Subject|0|||
23784182|NCT03597256|66586893|FG001|Overall Study|Withdrawal by Subject|1|||
23784183|NCT03597256|66586892|FG000|Overall Study|Could not return for treatment|0|||
23784184|NCT03597256|66586893|FG001|Overall Study|Could not return for treatment|1|||
23784185|NCT03597256|66586892|FG000|Overall Study|Moved from location|0|||
23784186|NCT03597256|66586893|FG001|Overall Study|Moved from location|1|||
23784187|NCT03597256|66586892|FG000|Overall Study|Not accepted the treatment|0|||
23784188|NCT03597256|66586893|FG001|Overall Study|Not accepted the treatment|1|||
23784189|NCT00834067|66586898|FG000|Washout of 21 Days|Protocol Violation|0|||
23784190|NCT00834067|66586899|FG001|Washout of 21 Days|Protocol Violation|1|||
23784191|NCT00984022|66586901|FG000|Overall Study|Lost to Follow-up|10|||
23784192|NCT00984022|66586902|FG001|Overall Study|Lost to Follow-up|14|||
23784193|NCT03138967|66590157|FG000|Overall Study|Death|0|||
23455634|NCT00713609|65409817|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
23455635|NCT00713609|65409812|FG000|Overall Study|Withdrawal by Subject|6|||
23455636|NCT00713609|65409813|FG001|Overall Study|Withdrawal by Subject|1|||
23455637|NCT00713609|65409814|FG002|Overall Study|Withdrawal by Subject|5|||
23455638|NCT00713609|65409815|FG003|Overall Study|Withdrawal by Subject|1|||
23455639|NCT00713609|65409816|FG004|Overall Study|Withdrawal by Subject|5|||
23455640|NCT00713609|65409817|FG005|Overall Study|Withdrawal by Subject|7|||
23455641|NCT00713609|65409812|FG000|Overall Study|Protocol Violation|6|||
23455642|NCT00713609|65409813|FG001|Overall Study|Protocol Violation|3|||
23637194|NCT04514510|66057357|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
23784194|NCT03138967|66590158|FG001|Overall Study|Death|1|||
23784195|NCT03138967|66590157|FG000|Overall Study|Physician Decision|1|||
23784196|NCT03138967|66590158|FG001|Overall Study|Physician Decision|3|||
23784197|NCT00461786|66590159|FG000|Overall Study|Entry Criteria Not Met|2|||
23784198|NCT00461786|66590159|FG000|Overall Study|Inevaluable (Never Treated)|1|||
23784199|NCT00906399|66590160|FG000|Year 1|Randomized But Not Treated|0|||
23784200|NCT00906399|66590161|FG001|Year 1|Randomized But Not Treated|1|||
23784201|NCT00906399|66590162|FG002|Year 1|Randomized But Not Treated|3|||
23784202|NCT00906399|66590163|FG003|Year 1|Randomized But Not Treated|0|||
23784203|NCT00906399|66590164|FG004|Year 1|Randomized But Not Treated|0|||
23784204|NCT00906399|66590165|FG005|Year 1|Randomized But Not Treated|0|||
23784205|NCT00906399|66590166|FG006|Year 1|Randomized But Not Treated|0|||
23455643|NCT00713609|65409814|FG002|Overall Study|Protocol Violation|1|||
23784206|NCT00906399|66590160|FG000|Year 1|Adverse Event|4|||
23784207|NCT00906399|66590161|FG001|Year 1|Adverse Event|22|||
23784208|NCT00906399|66590162|FG002|Year 1|Adverse Event|24|||
23784209|NCT00906399|66590163|FG003|Year 1|Adverse Event|0|||
23784210|NCT00906399|66590164|FG004|Year 1|Adverse Event|0|||
23784211|NCT00906399|66590165|FG005|Year 1|Adverse Event|0|||
23455644|NCT00713609|65409815|FG003|Overall Study|Protocol Violation|1|||
23455645|NCT00713609|65409816|FG004|Overall Study|Protocol Violation|2|||
23455646|NCT00713609|65409817|FG005|Overall Study|Protocol Violation|0|||
23455647|NCT03597347|65409818|FG000|Overall Study|Withdrawal by Subject|1|||
23455648|NCT03597347|65409819|FG001|Overall Study|Withdrawal by Subject|1|||
23455649|NCT03597347|65409820|FG002|Overall Study|Withdrawal by Subject|0|||
23455650|NCT03597347|65409818|FG000|Overall Study|Withdrawal due to Covid-19|3|||
23455651|NCT03597347|65409819|FG001|Overall Study|Withdrawal due to Covid-19|0|||
23455652|NCT03597347|65409820|FG002|Overall Study|Withdrawal due to Covid-19|0|||
23455653|NCT03597347|65409818|FG000|Overall Study|Sponsor decision to terminate study|3|||
23455654|NCT03597347|65409819|FG001|Overall Study|Sponsor decision to terminate study|2|||
23455655|NCT03597347|65409820|FG002|Overall Study|Sponsor decision to terminate study|4|||
23455656|NCT02513563|65409821|FG000|Overall Study|Death|4|||
23455657|NCT02513563|65409821|FG000|Overall Study|Withdrawal by Subject|4|||
23455658|NCT02513563|65409821|FG000|Overall Study|Physician Decision|1|||
23637195|NCT03738475|66057358|FG000|Overall Study|Participant Non-Compliance|1|||
23637196|NCT03738475|66057359|FG001|Overall Study|Participant Non-Compliance|0|||
23455659|NCT04551989|65409824|FG000|Overall Study|Adverse Event|4|||
23455660|NCT04551989|65409824|FG000|Overall Study|Protocol Violation|3|||
23455661|NCT04551989|65409824|FG000|Overall Study|Lost to Follow-up|1|||
23455662|NCT04551989|65409824|FG000|Overall Study|Physician Decision|3|||
23455663|NCT01777308|65409827|FG000|Overall Study|Withdrawal by Subject|5|||
23455664|NCT01777308|65409828|FG001|Overall Study|Withdrawal by Subject|1|||
23455665|NCT01777308|65409827|FG000|Overall Study|Migrated/moved from study area|1|||
23455666|NCT01777308|65409828|FG001|Overall Study|Migrated/moved from study area|0|||
23455667|NCT01777308|65409827|FG000|Overall Study|Lost to Follow-up|7|||
23455668|NCT01777308|65409828|FG001|Overall Study|Lost to Follow-up|2|||
23455669|NCT01777308|65409827|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
23455670|NCT01777308|65409828|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
23455671|NCT03287791|65409829|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23455672|NCT03287791|65409830|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23455673|NCT03287791|65409831|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23455674|NCT03287791|65409829|FG000|Overall Study|Adverse Event|0|||
23455675|NCT03287791|65409830|FG001|Overall Study|Adverse Event|4|||
23455676|NCT03287791|65409831|FG002|Overall Study|Adverse Event|3|||
23784212|NCT00906399|66590166|FG006|Year 1|Adverse Event|0|||
23455677|NCT03287791|65409829|FG000|Overall Study|Withdrawal by Subject|12|||
23455678|NCT03287791|65409830|FG001|Overall Study|Withdrawal by Subject|12|||
23455679|NCT03287791|65409831|FG002|Overall Study|Withdrawal by Subject|17|||
23455680|NCT03287791|65409829|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
23455681|NCT03287791|65409830|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
23582856|NCT00049517|65865868|FG003|Induction|Withdrawal by Subject|0|||
23582857|NCT00049517|65865869|FG004|Induction|Withdrawal by Subject|1|||
23582858|NCT00049517|65865870|FG005|Induction|Withdrawal by Subject|3|||
23582859|NCT00049517|65865865|FG000|Induction|Alternative therapy|0|||
23582860|NCT00049517|65865866|FG001|Induction|Alternative therapy|0|||
23582861|NCT00049517|65865867|FG002|Induction|Alternative therapy|0|||
23582862|NCT00049517|65865868|FG003|Induction|Alternative therapy|0|||
23582863|NCT00049517|65865869|FG004|Induction|Alternative therapy|2|||
23582864|NCT00049517|65865870|FG005|Induction|Alternative therapy|2|||
23582865|NCT00049517|65865865|FG000|Induction|Other complicating disease|0|||
23582866|NCT00049517|65865866|FG001|Induction|Other complicating disease|0|||
23582867|NCT00049517|65865867|FG002|Induction|Other complicating disease|0|||
23582868|NCT00049517|65865868|FG003|Induction|Other complicating disease|0|||
23582869|NCT00049517|65865869|FG004|Induction|Other complicating disease|3|||
23582870|NCT00049517|65865870|FG005|Induction|Other complicating disease|0|||
23582871|NCT00049517|65865865|FG000|Induction|Reasons not reported|0|||
23582872|NCT00049517|65865866|FG001|Induction|Reasons not reported|0|||
23582873|NCT00049517|65865867|FG002|Induction|Reasons not reported|0|||
23582874|NCT00049517|65865868|FG003|Induction|Reasons not reported|0|||
23582875|NCT00049517|65865869|FG004|Induction|Reasons not reported|22|||
23582876|NCT00049517|65865870|FG005|Induction|Reasons not reported|25|||
23582877|NCT00049517|65865865|FG000|Conditioning/Transplant|Disease progression|14|||
23582878|NCT00049517|65865866|FG001|Conditioning/Transplant|Disease progression|6|||
23582879|NCT00049517|65865867|FG002|Conditioning/Transplant|Disease progression|10|||
23455682|NCT03287791|65409831|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
23455683|NCT03287791|65409829|FG000|Overall Study|Lost to Follow-up|8|||
23582880|NCT00049517|65865868|FG003|Conditioning/Transplant|Disease progression|6|||
23455684|NCT03287791|65409830|FG001|Overall Study|Lost to Follow-up|14|||
23455685|NCT03287791|65409831|FG002|Overall Study|Lost to Follow-up|11|||
23455686|NCT03287791|65409829|FG000|Overall Study|Protocol Violation|7|||
23455687|NCT03287791|65409830|FG001|Overall Study|Protocol Violation|2|||
23455688|NCT03287791|65409831|FG002|Overall Study|Protocol Violation|1|||
23637197|NCT01495598|66057365|FG000|Overall Study|Death during follow up period|2|||
23455689|NCT03287791|65409829|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
23582881|NCT00049517|65865869|FG004|Conditioning/Transplant|Disease progression|0|||
23455690|NCT03287791|65409830|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
23455691|NCT03287791|65409831|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
23455692|NCT03287791|65409829|FG000|Overall Study|Too much time between 2 visits|0|||
23455693|NCT03287791|65409830|FG001|Overall Study|Too much time between 2 visits|1|||
23455694|NCT03287791|65409831|FG002|Overall Study|Too much time between 2 visits|0|||
23455695|NCT03287791|65409829|FG000|Overall Study|Non-compliance|0|||
23455696|NCT03287791|65409830|FG001|Overall Study|Non-compliance|1|||
23455697|NCT03287791|65409831|FG002|Overall Study|Non-compliance|0|||
23455698|NCT03287791|65409829|FG000|Overall Study|Did not meet inclusion criteria|1|||
23455699|NCT03287791|65409830|FG001|Overall Study|Did not meet inclusion criteria|0|||
23455700|NCT03287791|65409831|FG002|Overall Study|Did not meet inclusion criteria|0|||
23455701|NCT04890652|65409835|FG000|Overall Study|Withdrawal by Subject|2|||
23455702|NCT02648204|65412724|FG000|Overall Study|Withdrawal by Subject|12|||
23455703|NCT02648204|65412725|FG001|Overall Study|Withdrawal by Subject|8|||
23455704|NCT02648204|65412726|FG002|Overall Study|Withdrawal by Subject|2|||
23455705|NCT02648204|65412727|FG003|Overall Study|Withdrawal by Subject|6|||
23455706|NCT02648204|65412724|FG000|Overall Study|Lost to Follow-up|5|||
23455707|NCT02648204|65412725|FG001|Overall Study|Lost to Follow-up|8|||
23455708|NCT02648204|65412726|FG002|Overall Study|Lost to Follow-up|4|||
23455709|NCT02648204|65412727|FG003|Overall Study|Lost to Follow-up|6|||
23455710|NCT02648204|65412724|FG000|Overall Study|Missing follow-up information|4|||
23455711|NCT02648204|65412725|FG001|Overall Study|Missing follow-up information|4|||
23455712|NCT02648204|65412726|FG002|Overall Study|Missing follow-up information|4|||
23455713|NCT02648204|65412727|FG003|Overall Study|Missing follow-up information|2|||
23455714|NCT02648204|65412724|FG000|Overall Study|Death|1|||
23455715|NCT02648204|65412725|FG001|Overall Study|Death|1|||
23455716|NCT02648204|65412726|FG002|Overall Study|Death|2|||
23455717|NCT02648204|65412727|FG003|Overall Study|Death|2|||
23455718|NCT02648204|65412724|FG000|Overall Study|Adverse Event|0|||
23455719|NCT02648204|65412725|FG001|Overall Study|Adverse Event|0|||
23455720|NCT02648204|65412726|FG002|Overall Study|Adverse Event|1|||
23455721|NCT02648204|65412727|FG003|Overall Study|Adverse Event|0|||
23455722|NCT02246530|65412728|FG000|Overall Study|Lost to Follow-up|4|||
23455723|NCT02246530|65412729|FG001|Overall Study|Lost to Follow-up|0|||
23455724|NCT01743469|65412731|FG000|Active Treatment Phase|Adverse Event|10|||
23455725|NCT01743469|65412732|FG001|Active Treatment Phase|Adverse Event|5|||
23455726|NCT01743469|65412733|FG002|Active Treatment Phase|Adverse Event|8|||
23455727|NCT01743469|65412734|FG003|Active Treatment Phase|Adverse Event|1|||
23455728|NCT01743469|65412731|FG000|Active Treatment Phase|Disease Progression|40|||
23455729|NCT01743469|65412732|FG001|Active Treatment Phase|Disease Progression|47|||
23455730|NCT01743469|65412733|FG002|Active Treatment Phase|Disease Progression|30|||
23455731|NCT01743469|65412734|FG003|Active Treatment Phase|Disease Progression|20|||
23455732|NCT01743469|65412731|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
23455733|NCT01743469|65412732|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
23455734|NCT01743469|65412733|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
23455735|NCT01743469|65412734|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
23455736|NCT01743469|65412731|FG000|Active Treatment Phase|Missing|1|||
23455737|NCT01743469|65412732|FG001|Active Treatment Phase|Missing|0|||
23455738|NCT01743469|65412733|FG002|Active Treatment Phase|Missing|0|||
23455739|NCT01743469|65412734|FG003|Active Treatment Phase|Missing|0|||
23455740|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
23455741|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
23455742|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
23455743|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
23455744|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Death|43|||
23455745|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Death|47|||
23455746|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Death|22|||
23455747|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Death|16|||
23455748|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
23455749|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
23455750|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
23455751|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
23455752|NCT00984256|65412735|FG000|Overall Study|Withdrawal by Subject|0|||
23455753|NCT00984256|65412736|FG001|Overall Study|Withdrawal by Subject|1|||
23455754|NCT00667628|65412739|FG000|Overall Study|Lost to Follow-up|1|||
23455755|NCT00667628|65412740|FG001|Overall Study|Lost to Follow-up|0|||
23455756|NCT00667628|65412739|FG000|Overall Study|Death|6|||
23455757|NCT00667628|65412740|FG001|Overall Study|Death|6|||
23455758|NCT00667628|65412739|FG000|Overall Study|Investigator Considers in Best Interest|1|||
23455759|NCT00667628|65412740|FG001|Overall Study|Investigator Considers in Best Interest|0|||
23455760|NCT00667628|65412739|FG000|Overall Study|Sponsor Terminated Study|17|||
23455761|NCT00667628|65412740|FG001|Overall Study|Sponsor Terminated Study|21|||
23455762|NCT01451606|65412741|FG000|Overall Study|Withdrawal by Subject|4|||
23455763|NCT01451606|65412742|FG001|Overall Study|Withdrawal by Subject|3|||
23455764|NCT03092726|65412747|FG000|Overall Study|Adverse Event|3|||
23455765|NCT03092726|65412748|FG001|Overall Study|Adverse Event|10|||
23455766|NCT03092726|65412747|FG000|Overall Study|Lack of Efficacy|0|||
23455767|NCT03092726|65412748|FG001|Overall Study|Lack of Efficacy|1|||
23455768|NCT03092726|65412747|FG000|Overall Study|Lost to Follow-up|1|||
23637198|NCT01495598|66057365|FG000|Overall Study|Death on study|1|||
23637199|NCT01495598|66057365|FG000|Overall Study|Lost to Follow-up|3|||
23637200|NCT01495598|66057365|FG000|Overall Study|Physician Decision|8|||
23637201|NCT00699153|66057366|FG000|Overall Study|Lost to Follow-up|1|||
23637202|NCT00699153|66057367|FG001|Overall Study|Lost to Follow-up|0|||
23637203|NCT00699153|66057366|FG000|Overall Study|Adverse Event|0|||
23784213|NCT00906399|66590160|FG000|Year 1|Lost to Follow-up|4|||
23455769|NCT03092726|65412748|FG001|Overall Study|Lost to Follow-up|0|||
23582882|NCT00049517|65865870|FG005|Conditioning/Transplant|Disease progression|0|||
23582883|NCT00049517|65865865|FG000|Conditioning/Transplant|Adverse Event|2|||
23582884|NCT00049517|65865866|FG001|Conditioning/Transplant|Adverse Event|1|||
23582885|NCT00049517|65865867|FG002|Conditioning/Transplant|Adverse Event|4|||
23582886|NCT00049517|65865868|FG003|Conditioning/Transplant|Adverse Event|8|||
23455770|NCT03092726|65412747|FG000|Overall Study|Withdrawal by Subject|5|||
23455771|NCT03092726|65412748|FG001|Overall Study|Withdrawal by Subject|3|||
23455772|NCT03759379|65412752|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
23582887|NCT00049517|65865869|FG004|Conditioning/Transplant|Adverse Event|0|||
23582888|NCT00049517|65865870|FG005|Conditioning/Transplant|Adverse Event|0|||
23784214|NCT00906399|66590161|FG001|Year 1|Lost to Follow-up|4|||
23455773|NCT03759379|65412753|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
23455774|NCT03759379|65412752|FG000|Treatment Period|Death|2|||
23455775|NCT03759379|65412753|FG001|Treatment Period|Death|3|||
23455776|NCT03759379|65412752|FG000|Treatment Period|Lost to Follow-up|1|||
23455777|NCT03759379|65412753|FG001|Treatment Period|Lost to Follow-up|0|||
23455778|NCT03759379|65412752|FG000|Treatment Period|Physician Decision|0|||
23455779|NCT03759379|65412753|FG001|Treatment Period|Physician Decision|1|||
23455780|NCT04529083|65412754|FG000|Overall Study|Withdrawal by Subject|3|||
23455781|NCT03633396|65412755|FG000|Overall Study|Withdrawal by Subject|4|||
23455782|NCT03633396|65412756|FG001|Overall Study|Withdrawal by Subject|4|||
23455783|NCT03633396|65412755|FG000|Overall Study|Adverse Event|1|||
23455784|NCT03633396|65412756|FG001|Overall Study|Adverse Event|1|||
23455785|NCT03633396|65412755|FG000|Overall Study|Lack of Efficacy|1|||
23455786|NCT03633396|65412756|FG001|Overall Study|Lack of Efficacy|0|||
23455787|NCT03633396|65412755|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
23455788|NCT03633396|65412756|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
23455789|NCT00764699|65412759|FG000|Overall Study|PI left and study terminated|3|||
23455790|NCT03095651|65412764|FG000|Overall Study|Lost to Follow-up|1|||
23455791|NCT03095651|65412765|FG001|Overall Study|Lost to Follow-up|1|||
23455792|NCT03095651|65412766|FG002|Overall Study|Lost to Follow-up|0|||
23455793|NCT03095651|65412767|FG003|Overall Study|Lost to Follow-up|1|||
23455794|NCT03095651|65412768|FG004|Overall Study|Lost to Follow-up|0|||
23455795|NCT03095651|65412769|FG005|Overall Study|Lost to Follow-up|0|||
23455796|NCT03095651|65412770|FG006|Overall Study|Lost to Follow-up|0|||
23455797|NCT03095651|65412771|FG007|Overall Study|Lost to Follow-up|0|||
23455798|NCT03095651|65412764|FG000|Overall Study|Withdrawal by Subject|0|||
23455799|NCT03095651|65412765|FG001|Overall Study|Withdrawal by Subject|0|||
23455800|NCT03095651|65412766|FG002|Overall Study|Withdrawal by Subject|0|||
23455801|NCT03095651|65412767|FG003|Overall Study|Withdrawal by Subject|0|||
23455802|NCT03095651|65412768|FG004|Overall Study|Withdrawal by Subject|0|||
23455803|NCT03095651|65412769|FG005|Overall Study|Withdrawal by Subject|1|||
23455804|NCT03095651|65412770|FG006|Overall Study|Withdrawal by Subject|0|||
23455805|NCT03095651|65412771|FG007|Overall Study|Withdrawal by Subject|0|||
23784215|NCT00906399|66590162|FG002|Year 1|Lost to Follow-up|2|||
23784216|NCT00906399|66590163|FG003|Year 1|Lost to Follow-up|0|||
23784217|NCT00906399|66590164|FG004|Year 1|Lost to Follow-up|0|||
23784218|NCT00906399|66590165|FG005|Year 1|Lost to Follow-up|0|||
23784219|NCT00906399|66590166|FG006|Year 1|Lost to Follow-up|0|||
23784220|NCT00906399|66590160|FG000|Year 1|Withdrawal by Subject|30|||
23344023|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
23344024|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
23455806|NCT01097668|65412781|FG000|Overall Study|Withdrawal by Subject|1|||
23455807|NCT01097668|65412782|FG001|Overall Study|Withdrawal by Subject|2|||
23455808|NCT01097668|65412781|FG000|Overall Study|Lost to Follow-up|1|||
23582889|NCT00049517|65865865|FG000|Conditioning/Transplant|Death|1|||
23637204|NCT00699153|66057367|FG001|Overall Study|Adverse Event|2|||
23455809|NCT01097668|65412782|FG001|Overall Study|Lost to Follow-up|0|||
23637205|NCT00699153|66057366|FG000|Overall Study|Protocol Violation|1|||
23455810|NCT00625131|65412784|FG000|Overall Study|Lost to Follow-up|3|||
23784221|NCT00906399|66590161|FG001|Year 1|Withdrawal by Subject|32|||
23455811|NCT00625131|65412785|FG001|Overall Study|Lost to Follow-up|2|||
23455812|NCT00625131|65412786|FG002|Overall Study|Lost to Follow-up|0|||
23582890|NCT00049517|65865866|FG001|Conditioning/Transplant|Death|0|||
23582891|NCT00049517|65865867|FG002|Conditioning/Transplant|Death|0|||
23582892|NCT00049517|65865868|FG003|Conditioning/Transplant|Death|2|||
23582893|NCT00049517|65865869|FG004|Conditioning/Transplant|Death|0|||
23582894|NCT00049517|65865870|FG005|Conditioning/Transplant|Death|0|||
23582895|NCT00049517|65865865|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
23582896|NCT00049517|65865866|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
23582897|NCT00049517|65865867|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
23582898|NCT00049517|65865868|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
23582899|NCT00049517|65865869|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
23582900|NCT00049517|65865870|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
23582901|NCT00049517|65865865|FG000|Conditioning/Transplant|Alternative therapy|4|||
23582902|NCT00049517|65865866|FG001|Conditioning/Transplant|Alternative therapy|4|||
23582903|NCT00049517|65865867|FG002|Conditioning/Transplant|Alternative therapy|2|||
23784222|NCT00906399|66590162|FG002|Year 1|Withdrawal by Subject|36|||
23784223|NCT00906399|66590163|FG003|Year 1|Withdrawal by Subject|0|||
23784224|NCT00906399|66590164|FG004|Year 1|Withdrawal by Subject|0|||
23784225|NCT00906399|66590165|FG005|Year 1|Withdrawal by Subject|0|||
23784226|NCT00906399|66590166|FG006|Year 1|Withdrawal by Subject|0|||
23784227|NCT00906399|66590160|FG000|Year 1|Physician Decision|0|||
23784228|NCT00906399|66590161|FG001|Year 1|Physician Decision|1|||
23784229|NCT00906399|66590162|FG002|Year 1|Physician Decision|3|||
23784230|NCT00906399|66590163|FG003|Year 1|Physician Decision|0|||
23784231|NCT00906399|66590164|FG004|Year 1|Physician Decision|0|||
23784232|NCT00906399|66590165|FG005|Year 1|Physician Decision|0|||
23784233|NCT00906399|66590166|FG006|Year 1|Physician Decision|0|||
23784234|NCT00906399|66590160|FG000|Year 1|Death|2|||
23784235|NCT00906399|66590161|FG001|Year 1|Death|1|||
23784236|NCT00906399|66590162|FG002|Year 1|Death|1|||
23784237|NCT00906399|66590163|FG003|Year 1|Death|0|||
23784238|NCT00906399|66590164|FG004|Year 1|Death|0|||
23784239|NCT00906399|66590165|FG005|Year 1|Death|0|||
23784240|NCT00906399|66590166|FG006|Year 1|Death|0|||
23784241|NCT00906399|66590160|FG000|Year 1|Other|4|||
23784242|NCT00906399|66590161|FG001|Year 1|Other|2|||
23784243|NCT00906399|66590162|FG002|Year 1|Other|7|||
23784244|NCT00906399|66590163|FG003|Year 1|Other|0|||
23784245|NCT00906399|66590164|FG004|Year 1|Other|0|||
23784246|NCT00906399|66590165|FG005|Year 1|Other|0|||
23784247|NCT00906399|66590166|FG006|Year 1|Other|0|||
23784248|NCT00906399|66590160|FG000|Year 2|Adverse Event|0|||
23784249|NCT00906399|66590161|FG001|Year 2|Adverse Event|0|||
23784250|NCT00906399|66590162|FG002|Year 2|Adverse Event|0|||
23784251|NCT00906399|66590163|FG003|Year 2|Adverse Event|9|||
23784252|NCT00906399|66590164|FG004|Year 2|Adverse Event|8|||
23784253|NCT00906399|66590165|FG005|Year 2|Adverse Event|11|||
23784254|NCT00906399|66590166|FG006|Year 2|Adverse Event|6|||
23784255|NCT00906399|66590160|FG000|Year 2|Lost to Follow-up|0|||
23784256|NCT00906399|66590161|FG001|Year 2|Lost to Follow-up|0|||
23784257|NCT00906399|66590162|FG002|Year 2|Lost to Follow-up|0|||
23784258|NCT00906399|66590163|FG003|Year 2|Lost to Follow-up|1|||
23784259|NCT00906399|66590164|FG004|Year 2|Lost to Follow-up|4|||
23784260|NCT00906399|66590165|FG005|Year 2|Lost to Follow-up|2|||
23784261|NCT00906399|66590166|FG006|Year 2|Lost to Follow-up|4|||
23582904|NCT00049517|65865868|FG003|Conditioning/Transplant|Alternative therapy|1|||
23582905|NCT00049517|65865869|FG004|Conditioning/Transplant|Alternative therapy|1|||
23582906|NCT00049517|65865870|FG005|Conditioning/Transplant|Alternative therapy|0|||
23582907|NCT00049517|65865865|FG000|Conditioning/Transplant|Other complicating disease|2|||
23582908|NCT00049517|65865866|FG001|Conditioning/Transplant|Other complicating disease|0|||
23582909|NCT00049517|65865867|FG002|Conditioning/Transplant|Other complicating disease|0|||
23582910|NCT00049517|65865868|FG003|Conditioning/Transplant|Other complicating disease|4|||
23582911|NCT00049517|65865869|FG004|Conditioning/Transplant|Other complicating disease|0|||
23582912|NCT00049517|65865870|FG005|Conditioning/Transplant|Other complicating disease|1|||
23582913|NCT00049517|65865865|FG000|Conditioning/Transplant|Reasons not reported|25|||
23582914|NCT00049517|65865866|FG001|Conditioning/Transplant|Reasons not reported|31|||
23455813|NCT00625131|65412784|FG000|Overall Study|Withdrawal by Subject|1|||
23455814|NCT00625131|65412785|FG001|Overall Study|Withdrawal by Subject|0|||
23455815|NCT00625131|65412786|FG002|Overall Study|Withdrawal by Subject|5|||
23455816|NCT00758771|65412787|FG000|Overall Study|Withdrawal by Subject|1|||
23455817|NCT00758771|65412788|FG001|Overall Study|Withdrawal by Subject|1|||
23455818|NCT00758771|65412787|FG000|Overall Study|Did not meet eligibility criteria|2|||
23455819|NCT00758771|65412788|FG001|Overall Study|Did not meet eligibility criteria|4|||
23455820|NCT00521079|65412790|FG000|Overall Study|Adverse Event|7|||
23455821|NCT00521079|65412791|FG001|Overall Study|Adverse Event|1|||
23455822|NCT00521079|65412790|FG000|Overall Study|Lost to Follow-up|2|||
23455823|NCT00521079|65412791|FG001|Overall Study|Lost to Follow-up|1|||
23455824|NCT00521079|65412790|FG000|Overall Study|Withdrawal by Subject|5|||
23455825|NCT00521079|65412791|FG001|Overall Study|Withdrawal by Subject|3|||
23455826|NCT02973100|65412795|FG000|Overall Study|Adverse Event|1|||
23455827|NCT02973100|65412796|FG001|Overall Study|Adverse Event|2|||
23455828|NCT02973100|65412797|FG002|Overall Study|Adverse Event|1|||
23455829|NCT02973100|65412798|FG003|Overall Study|Adverse Event|2|||
23455830|NCT02973100|65412795|FG000|Overall Study|Lost to Follow-up|3|||
23455831|NCT02973100|65412796|FG001|Overall Study|Lost to Follow-up|1|||
23455832|NCT02973100|65412797|FG002|Overall Study|Lost to Follow-up|1|||
23455833|NCT02973100|65412798|FG003|Overall Study|Lost to Follow-up|0|||
23455834|NCT02973100|65412795|FG000|Overall Study|Withdrawal by Subject|3|||
23455835|NCT02973100|65412796|FG001|Overall Study|Withdrawal by Subject|5|||
23455836|NCT02973100|65412797|FG002|Overall Study|Withdrawal by Subject|1|||
23455837|NCT02973100|65412798|FG003|Overall Study|Withdrawal by Subject|4|||
23455838|NCT02973100|65412795|FG000|Overall Study|Notification of change in address|0|||
23455839|NCT02973100|65412796|FG001|Overall Study|Notification of change in address|0|||
23455840|NCT02973100|65412797|FG002|Overall Study|Notification of change in address|0|||
23455841|NCT02973100|65412798|FG003|Overall Study|Notification of change in address|1|||
23455842|NCT02973100|65412795|FG000|Overall Study|Failed to attend Safety followup period|0|||
23455843|NCT02973100|65412796|FG001|Overall Study|Failed to attend Safety followup period|0|||
23455844|NCT02973100|65412797|FG002|Overall Study|Failed to attend Safety followup period|1|||
23455845|NCT02973100|65412798|FG003|Overall Study|Failed to attend Safety followup period|0|||
23455846|NCT00262860|65412800|FG000|Overall Study|Adverse Event|2|||
23455847|NCT00865345|65412801|FG000|Overall Study|Withdrawal by Subject|2|||
23455848|NCT01478971|65412802|FG000|Standard of Care Period|Adverse Event|1|||
23455849|NCT01478971|65412802|FG000|Standard of Care Period|Withdrawal by Subject|3|||
23582915|NCT00049517|65865867|FG002|Conditioning/Transplant|Reasons not reported|18|||
23637206|NCT00699153|66057367|FG001|Overall Study|Protocol Violation|0|||
23637207|NCT00699153|66057366|FG000|Overall Study|Travel Problem|1|||
23637208|NCT00699153|66057367|FG001|Overall Study|Travel Problem|0|||
23784262|NCT00906399|66590160|FG000|Year 2|Withdrawal by Subject|0|||
23784263|NCT00906399|66590161|FG001|Year 2|Withdrawal by Subject|0|||
23455850|NCT01478971|65412802|FG000|Standard of Care Period|Death|8|||
23455851|NCT01478971|65412802|FG000|Standard of Care Period|Lost to Follow-up|9|||
23455852|NCT01478971|65412802|FG000|Standard of Care Period|Other|4|||
23455853|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Adverse Event|1|||
23455854|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
23455855|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Death|4|||
23455856|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
23455857|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Other|4|||
23582916|NCT00049517|65865868|FG003|Conditioning/Transplant|Reasons not reported|15|||
23582917|NCT00049517|65865869|FG004|Conditioning/Transplant|Reasons not reported|5|||
23582918|NCT00049517|65865870|FG005|Conditioning/Transplant|Reasons not reported|5|||
23582919|NCT05419557|65865877|FG000|Overall Study|Lost to Follow-up|11|||
23582920|NCT05419557|65865878|FG001|Overall Study|Lost to Follow-up|4|||
23582921|NCT03722446|65865879|FG000|Overall Study|Protocol Violation|15|||
23582922|NCT03722446|65865880|FG001|Overall Study|Protocol Violation|2|||
23637209|NCT03214640|66057368|FG000|Overall Study|Protocol Violation|1|||
23637210|NCT03214640|66057369|FG001|Overall Study|Protocol Violation|2|||
23637211|NCT03214640|66057370|FG002|Overall Study|Protocol Violation|1|||
23637212|NCT03214640|66057371|FG003|Overall Study|Protocol Violation|4|||
23637213|NCT00299494|66057372|FG000|Overall Study|Withdrawal by Subject|0|||
23455858|NCT03656562|65412805|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
23455859|NCT03656562|65412806|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
23637214|NCT00299494|66057373|FG001|Overall Study|Withdrawal by Subject|0|||
23637215|NCT00299494|66057374|FG002|Overall Study|Withdrawal by Subject|0|||
23637216|NCT00299494|66057375|FG003|Overall Study|Withdrawal by Subject|3|||
23637217|NCT00299494|66057376|FG004|Overall Study|Withdrawal by Subject|1|||
23637218|NCT00299494|66057377|FG005|Overall Study|Withdrawal by Subject|4|||
23637219|NCT00299494|66057372|FG000|Overall Study|Physician Decision|0|||
23637220|NCT00299494|66057373|FG001|Overall Study|Physician Decision|0|||
23637221|NCT00299494|66057374|FG002|Overall Study|Physician Decision|0|||
23637222|NCT00299494|66057375|FG003|Overall Study|Physician Decision|0|||
23637223|NCT00299494|66057376|FG004|Overall Study|Physician Decision|1|||
23637224|NCT00299494|66057377|FG005|Overall Study|Physician Decision|0|||
23637225|NCT00299494|66057372|FG000|Overall Study|Death|3|||
23637226|NCT00299494|66057373|FG001|Overall Study|Death|1|||
23637227|NCT00299494|66057374|FG002|Overall Study|Death|4|||
23637228|NCT00299494|66057375|FG003|Overall Study|Death|6|||
23637229|NCT00299494|66057376|FG004|Overall Study|Death|18|||
23637230|NCT00299494|66057377|FG005|Overall Study|Death|19|||
23637231|NCT00299494|66057372|FG000|Overall Study|Lost to Follow-up|0|||
23637232|NCT00299494|66057373|FG001|Overall Study|Lost to Follow-up|0|||
23637233|NCT00299494|66057374|FG002|Overall Study|Lost to Follow-up|0|||
23637234|NCT00299494|66057375|FG003|Overall Study|Lost to Follow-up|0|||
23637235|NCT00299494|66057376|FG004|Overall Study|Lost to Follow-up|3|||
23637236|NCT00299494|66057377|FG005|Overall Study|Lost to Follow-up|1|||
23637237|NCT00299494|66057372|FG000|Overall Study|Other - Unspecified|0|||
23637238|NCT00299494|66057373|FG001|Overall Study|Other - Unspecified|0|||
23637239|NCT00299494|66057374|FG002|Overall Study|Other - Unspecified|0|||
23637240|NCT00299494|66057375|FG003|Overall Study|Other - Unspecified|0|||
23637241|NCT00299494|66057376|FG004|Overall Study|Other - Unspecified|3|||
23637242|NCT00299494|66057377|FG005|Overall Study|Other - Unspecified|1|||
23637243|NCT00299494|66057372|FG000|Overall Study|Other - site closure|0|||
23637244|NCT00299494|66057373|FG001|Overall Study|Other - site closure|0|||
23637245|NCT00299494|66057374|FG002|Overall Study|Other - site closure|0|||
23637246|NCT00299494|66057375|FG003|Overall Study|Other - site closure|1|||
23637247|NCT00299494|66057376|FG004|Overall Study|Other - site closure|1|||
23637248|NCT00299494|66057377|FG005|Overall Study|Other - site closure|1|||
23637249|NCT01022112|66057378|FG000|Overall Study|Adverse Event|1|||
23637250|NCT01022112|66057379|FG001|Overall Study|Adverse Event|2|||
23637251|NCT01022112|66057380|FG002|Overall Study|Adverse Event|0|||
23637252|NCT01022112|66057381|FG003|Overall Study|Adverse Event|1|||
23637253|NCT01022112|66057382|FG004|Overall Study|Adverse Event|0|||
23637254|NCT01022112|66057378|FG000|Overall Study|Lack of Efficacy|1|||
23637255|NCT01022112|66057379|FG001|Overall Study|Lack of Efficacy|0|||
23637256|NCT01022112|66057380|FG002|Overall Study|Lack of Efficacy|0|||
23637257|NCT01022112|66057381|FG003|Overall Study|Lack of Efficacy|0|||
23637258|NCT01022112|66057382|FG004|Overall Study|Lack of Efficacy|1|||
23637259|NCT01022112|66057378|FG000|Overall Study|Physician Decision|0|||
23784264|NCT00906399|66590162|FG002|Year 2|Withdrawal by Subject|0|||
23455860|NCT03656562|65412807|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
23582923|NCT01474538|65865881|FG000|Treatment Period 1|Death|1|||
23582924|NCT01474538|65865882|FG001|Treatment Period 1|Death|0|||
23637260|NCT01022112|66057379|FG001|Overall Study|Physician Decision|0|||
23637261|NCT01022112|66057380|FG002|Overall Study|Physician Decision|1|||
23637262|NCT01022112|66057381|FG003|Overall Study|Physician Decision|0|||
23637263|NCT01022112|66057382|FG004|Overall Study|Physician Decision|1|||
23637264|NCT01022112|66057378|FG000|Overall Study|Withdrawal by Subject|0|||
23637265|NCT01022112|66057379|FG001|Overall Study|Withdrawal by Subject|1|||
23637266|NCT01022112|66057380|FG002|Overall Study|Withdrawal by Subject|2|||
23637267|NCT01022112|66057381|FG003|Overall Study|Withdrawal by Subject|2|||
23637268|NCT01022112|66057382|FG004|Overall Study|Withdrawal by Subject|1|||
23637269|NCT01022112|66057378|FG000|Overall Study|Fasting plasma glucose level increased|1|||
23637270|NCT01022112|66057379|FG001|Overall Study|Fasting plasma glucose level increased|0|||
23637271|NCT01022112|66057380|FG002|Overall Study|Fasting plasma glucose level increased|0|||
23784265|NCT00906399|66590163|FG003|Year 2|Withdrawal by Subject|17|||
23784266|NCT00906399|66590164|FG004|Year 2|Withdrawal by Subject|18|||
23784267|NCT00906399|66590165|FG005|Year 2|Withdrawal by Subject|27|||
23784268|NCT00906399|66590166|FG006|Year 2|Withdrawal by Subject|13|||
23784269|NCT00906399|66590160|FG000|Year 2|Physician Decision|0|||
23784270|NCT00906399|66590161|FG001|Year 2|Physician Decision|0|||
23784271|NCT00906399|66590162|FG002|Year 2|Physician Decision|0|||
23784272|NCT00906399|66590163|FG003|Year 2|Physician Decision|0|||
23784273|NCT00906399|66590164|FG004|Year 2|Physician Decision|2|||
23784274|NCT00906399|66590165|FG005|Year 2|Physician Decision|6|||
23784275|NCT00906399|66590166|FG006|Year 2|Physician Decision|3|||
23784276|NCT00906399|66590160|FG000|Year 2|Death|0|||
23784277|NCT00906399|66590161|FG001|Year 2|Death|0|||
23784278|NCT00906399|66590162|FG002|Year 2|Death|0|||
23784279|NCT00906399|66590163|FG003|Year 2|Death|1|||
23784280|NCT00906399|66590164|FG004|Year 2|Death|0|||
23784281|NCT00906399|66590165|FG005|Year 2|Death|0|||
23784282|NCT00906399|66590166|FG006|Year 2|Death|3|||
23582925|NCT01474538|65865881|FG000|Treatment Period 1|Physician Decision|1|||
23582926|NCT01474538|65865882|FG001|Treatment Period 1|Physician Decision|0|||
23582927|NCT01474538|65865881|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23582928|NCT01474538|65865882|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23582929|NCT01474538|65865881|FG000|Treatment Period 1|Protocol Violation|0|||
23582930|NCT01474538|65865882|FG001|Treatment Period 1|Protocol Violation|1|||
23582931|NCT01474538|65865881|FG000|Treatment Period 2|Death|1|||
23582932|NCT01474538|65865882|FG001|Treatment Period 2|Death|0|||
23582933|NCT01474538|65865881|FG000|Treatment Period 2|Adverse Event|1|||
23582934|NCT01474538|65865882|FG001|Treatment Period 2|Adverse Event|1|||
23582935|NCT01474538|65865881|FG000|Treatment Period 2|Withdrawal by Subject|2|||
23582936|NCT01474538|65865882|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23582937|NCT01474538|65865881|FG000|Treatment Period 2|Sponsor decision|1|||
23582938|NCT01474538|65865882|FG001|Treatment Period 2|Sponsor decision|0|||
23582939|NCT01474538|65865881|FG000|Treatment Period 2|Physician Decision|0|||
23582940|NCT01474538|65865882|FG001|Treatment Period 2|Physician Decision|1|||
23582941|NCT01474538|65865881|FG000|Treatment Period 2|Protocol Violation|1|||
23582942|NCT01474538|65865882|FG001|Treatment Period 2|Protocol Violation|0|||
23582943|NCT00320489|65865883|FG000|Overall Study|Adverse Event|26|||
23582944|NCT00320489|65865884|FG001|Overall Study|Adverse Event|25|||
23582945|NCT00320489|65865883|FG000|Overall Study|Clinical Relapse|26|||
23582946|NCT00320489|65865884|FG001|Overall Study|Clinical Relapse|20|||
23582947|NCT00320489|65865883|FG000|Overall Study|Death|0|||
23582948|NCT00320489|65865884|FG001|Overall Study|Death|2|||
23582949|NCT00320489|65865883|FG000|Overall Study|Entry Criteria Exclusion|2|||
23784283|NCT00906399|66590160|FG000|Year 2|Other|0|||
23784284|NCT00906399|66590161|FG001|Year 2|Other|0|||
23784285|NCT00906399|66590162|FG002|Year 2|Other|0|||
23784286|NCT00906399|66590163|FG003|Year 2|Other|2|||
23784287|NCT00906399|66590164|FG004|Year 2|Other|3|||
23582950|NCT00320489|65865884|FG001|Overall Study|Entry Criteria Exclusion|4|||
23582951|NCT00320489|65865883|FG000|Overall Study|Lack of Efficacy|16|||
23582952|NCT00320489|65865884|FG001|Overall Study|Lack of Efficacy|7|||
23582953|NCT00320489|65865883|FG000|Overall Study|Lost to Follow-up|21|||
23582954|NCT00320489|65865884|FG001|Overall Study|Lost to Follow-up|22|||
23582955|NCT00320489|65865883|FG000|Overall Study|Physician Decision|8|||
23784288|NCT00906399|66590165|FG005|Year 2|Other|1|||
23784289|NCT00906399|66590166|FG006|Year 2|Other|0|||
23784290|NCT01289262|66590172|FG000|Overall Study|Lost to Follow-up|29|||
23784291|NCT01289262|66590173|FG001|Overall Study|Lost to Follow-up|16|||
23784292|NCT01289262|66590172|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
23784293|NCT01289262|66590173|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
23784294|NCT00679081|66590177|FG000|Overall Study|Lost to Follow-up|1|||
23784295|NCT01900691|66590180|FG000|Overall Study|Death|7|||
23784296|NCT01900691|66590180|FG000|Overall Study|Lost to Follow-up|4|||
23784297|NCT01900691|66590180|FG000|Overall Study|Study Device Not Placed|3|||
23784298|NCT01900691|66590180|FG000|Overall Study|Non study stent placed|2|||
23582956|NCT00320489|65865884|FG001|Overall Study|Physician Decision|8|||
23582957|NCT00320489|65865883|FG000|Overall Study|Protocol Violation|4|||
23582958|NCT00320489|65865884|FG001|Overall Study|Protocol Violation|4|||
23582959|NCT00320489|65865883|FG000|Overall Study|Sponsor Decision|3|||
23582960|NCT00320489|65865884|FG001|Overall Study|Sponsor Decision|3|||
23582961|NCT00320489|65865883|FG000|Overall Study|Withdrawal by Subject|39|||
23582962|NCT00320489|65865884|FG001|Overall Study|Withdrawal by Subject|41|||
23582963|NCT02195479|65865885|FG000|Overall Study|Lost to Follow-up|3|||
23582964|NCT02195479|65865886|FG001|Overall Study|Lost to Follow-up|0|||
23582965|NCT02195479|65865885|FG000|Overall Study|Death|48|||
23582966|NCT02195479|65865886|FG001|Overall Study|Death|45|||
23582967|NCT02195479|65865885|FG000|Overall Study|Physician Decision|1|||
23582968|NCT02195479|65865886|FG001|Overall Study|Physician Decision|0|||
23784299|NCT01900691|66590180|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
23784300|NCT01900691|66590180|FG000|Overall Study|Complete stent migration through digestive tract|1|||
23784301|NCT02436005|66590181|FG000|Second Intervention|Adverse Event|0|||
23784302|NCT02436005|66590182|FG001|Second Intervention|Adverse Event|1|||
23784303|NCT02075463|66590183|FG000|Overall Study|Adverse Event|3|||
23784304|NCT02075463|66590183|FG000|Overall Study|Par. reached stopping criteria|4|||
23784305|NCT02075463|66590183|FG000|Overall Study|Withdrawal by Subject|1|||
23784306|NCT02106156|66590184|FG000|Overall Study|Patient Died|19|||
23784307|NCT02106156|66590185|FG001|Overall Study|Patient Died|0|||
23784308|NCT02106156|66590186|FG002|Overall Study|Patient Died|0|||
23784309|NCT02106156|66590184|FG000|Overall Study|Lack of Tolerability|305|||
23784310|NCT02106156|66590185|FG001|Overall Study|Lack of Tolerability|3|||
23784311|NCT02106156|66590186|FG002|Overall Study|Lack of Tolerability|0|||
23784312|NCT02106156|66590184|FG000|Overall Study|Lack of Virological Response|1044|||
23784313|NCT02106156|66590185|FG001|Overall Study|Lack of Virological Response|8|||
23784314|NCT02106156|66590186|FG002|Overall Study|Lack of Virological Response|0|||
23784315|NCT02106156|66590184|FG000|Overall Study|Concomitant Disease|74|||
23784316|NCT02106156|66590185|FG001|Overall Study|Concomitant Disease|2|||
23784317|NCT02106156|66590186|FG002|Overall Study|Concomitant Disease|0|||
23784318|NCT02106156|66590184|FG000|Overall Study|Lack of Compliance|211|||
23784319|NCT02106156|66590185|FG001|Overall Study|Lack of Compliance|7|||
23784320|NCT02106156|66590186|FG002|Overall Study|Lack of Compliance|0|||
23582969|NCT02195479|65865885|FG000|Overall Study|Withdrawal by Subject|11|||
23582970|NCT02195479|65865886|FG001|Overall Study|Withdrawal by Subject|6|||
23637272|NCT01022112|66057381|FG003|Overall Study|Fasting plasma glucose level increased|0|||
23784321|NCT02106156|66590184|FG000|Overall Study|Patients Request|307|||
23784322|NCT02106156|66590185|FG001|Overall Study|Patients Request|9|||
23784323|NCT02106156|66590186|FG002|Overall Study|Patients Request|0|||
23784324|NCT02106156|66590184|FG000|Overall Study|Lost to Follow-up|451|||
23784325|NCT02106156|66590185|FG001|Overall Study|Lost to Follow-up|8|||
23637273|NCT01022112|66057382|FG004|Overall Study|Fasting plasma glucose level increased|7|||
23637274|NCT03651622|66057383|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
23637275|NCT03651622|66057384|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
23637276|NCT03651622|66057385|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
23784326|NCT02106156|66590186|FG002|Overall Study|Lost to Follow-up|0|||
23784327|NCT02106156|66590184|FG000|Overall Study|Unplanned Event|82|||
23784328|NCT02106156|66590185|FG001|Overall Study|Unplanned Event|2|||
23784329|NCT02106156|66590186|FG002|Overall Study|Unplanned Event|0|||
23784330|NCT02106156|66590184|FG000|Overall Study|Change of Laboratory Parameter|10|||
23784331|NCT02106156|66590185|FG001|Overall Study|Change of Laboratory Parameter|0|||
23784332|NCT02106156|66590186|FG002|Overall Study|Change of Laboratory Parameter|0|||
23784333|NCT02106156|66590184|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
23784334|NCT02106156|66590185|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
23784335|NCT02106156|66590186|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
23784336|NCT02106156|66590184|FG000|Overall Study|Relocation/Change of Physician|40|||
23784337|NCT02106156|66590185|FG001|Overall Study|Relocation/Change of Physician|1|||
23784338|NCT02106156|66590186|FG002|Overall Study|Relocation/Change of Physician|0|||
23784339|NCT00835081|66590190|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23784340|NCT00835081|66590191|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23784341|NCT03769896|66590192|FG000|Open-label Phase|Lack of Efficacy|5|||
23784342|NCT03769896|66590193|FG001|Open-label Phase|Lack of Efficacy|0|||
23784343|NCT03769896|66590192|FG000|Open-label Phase|Adverse Event|3|||
23784344|NCT03769896|66590193|FG001|Open-label Phase|Adverse Event|0|||
23784345|NCT03769896|66590192|FG000|Open-label Phase|Withdrawal by Subject|1|||
23784346|NCT03769896|66590193|FG001|Open-label Phase|Withdrawal by Subject|0|||
23784347|NCT01537887|66590202|FG000|Period 1|Physician Decision|0|||
23784348|NCT01537887|66590203|FG001|Period 1|Physician Decision|0|||
23784349|NCT01537887|66590204|FG002|Period 1|Physician Decision|0|||
23784350|NCT01537887|66590205|FG003|Period 1|Physician Decision|0|||
23784351|NCT01537887|66590206|FG004|Period 1|Physician Decision|1|||
23784352|NCT01537887|66590207|FG005|Period 1|Physician Decision|1|||
23784353|NCT01537887|66590202|FG000|Period 1|Did not receive treatment|0|||
23784354|NCT01537887|66590203|FG001|Period 1|Did not receive treatment|0|||
23784355|NCT01537887|66590204|FG002|Period 1|Did not receive treatment|1|||
23784356|NCT01537887|66590205|FG003|Period 1|Did not receive treatment|0|||
23784357|NCT01537887|66590206|FG004|Period 1|Did not receive treatment|0|||
23784358|NCT01537887|66590207|FG005|Period 1|Did not receive treatment|0|||
23784359|NCT01537887|66590202|FG000|Period 2|Withdrawal by Subject|0|||
23784360|NCT01537887|66590203|FG001|Period 2|Withdrawal by Subject|1|||
23784361|NCT01537887|66590204|FG002|Period 2|Withdrawal by Subject|0|||
23784362|NCT01537887|66590205|FG003|Period 2|Withdrawal by Subject|0|||
23784363|NCT01537887|66590206|FG004|Period 2|Withdrawal by Subject|0|||
23784364|NCT01537887|66590207|FG005|Period 2|Withdrawal by Subject|0|||
23784365|NCT01537887|66590202|FG000|Period 3|Adverse Event|0|||
23784366|NCT01537887|66590203|FG001|Period 3|Adverse Event|0|||
23784367|NCT01537887|66590204|FG002|Period 3|Adverse Event|1|||
23784368|NCT01537887|66590205|FG003|Period 3|Adverse Event|0|||
23784369|NCT01537887|66590206|FG004|Period 3|Adverse Event|0|||
23784370|NCT01537887|66590207|FG005|Period 3|Adverse Event|0|||
23784371|NCT01537887|66590202|FG000|Period 3|Withdrawal by Subject|0|||
23784372|NCT01537887|66590203|FG001|Period 3|Withdrawal by Subject|1|||
23784373|NCT01537887|66590204|FG002|Period 3|Withdrawal by Subject|0|||
23784374|NCT01537887|66590205|FG003|Period 3|Withdrawal by Subject|0|||
23784375|NCT01537887|66590206|FG004|Period 3|Withdrawal by Subject|0|||
23784376|NCT01537887|66590207|FG005|Period 3|Withdrawal by Subject|0|||
23637277|NCT03651622|66057383|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
23784377|NCT00712959|66590210|FG000|Overall Study|Protocol Violation|3|||
23784378|NCT00712959|66590211|FG001|Overall Study|Protocol Violation|1|||
23784379|NCT00712959|66590210|FG000|Overall Study|Lost to Follow-up|13|||
23784380|NCT00712959|66590211|FG001|Overall Study|Lost to Follow-up|2|||
23784381|NCT00712959|66590210|FG000|Overall Study|Withdrawal by Subject|3|||
23784382|NCT00712959|66590211|FG001|Overall Study|Withdrawal by Subject|0|||
23784383|NCT04466111|66590214|FG000|Prior to Trial Phase|Physician Decision|1|||
23784384|NCT00835263|66590219|FG000|Second Intervention|Adverse Event|1|||
23784385|NCT00835263|66590220|FG001|Second Intervention|Adverse Event|0|||
23784386|NCT00840073|66590221|FG000|Second Intervention|Missed 72 hour blood draw|1|||
23784387|NCT00840073|66590222|FG001|Second Intervention|Missed 72 hour blood draw|1|||
23784388|NCT01218867|66590227|FG000|Overall Study|Death during treatment|0|||
23784389|NCT01218867|66590228|FG001|Overall Study|Death during treatment|0|||
23784390|NCT01218867|66590229|FG002|Overall Study|Death during treatment|0|||
23784391|NCT01218867|66590230|FG003|Overall Study|Death during treatment|0|||
23784392|NCT01218867|66590231|FG004|Overall Study|Death during treatment|0|||
23784393|NCT01218867|66590232|FG005|Overall Study|Death during treatment|0|||
23784394|NCT01218867|66590233|FG006|Overall Study|Death during treatment|1|||
23784395|NCT01218867|66590234|FG007|Overall Study|Death during treatment|0|||
23784396|NCT01218867|66590235|FG008|Overall Study|Death during treatment|0|||
23784397|NCT01218867|66590236|FG009|Overall Study|Death during treatment|0|||
23784398|NCT01218867|66590237|FG010|Overall Study|Death during treatment|0|||
23582971|NCT02195479|65865885|FG000|Overall Study|Other|2|||
23582972|NCT02195479|65865886|FG001|Overall Study|Other|2|||
23582973|NCT02195479|65865885|FG000|Overall Study|Ongoing|291|||
23582974|NCT02195479|65865886|FG001|Overall Study|Ongoing|297|||
23582975|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23582976|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
23582977|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Progressive disease|6|||
23582978|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Toxicity|1|||
23784399|NCT02213263|66590240|FG000|Overall Study|Insufficient clinical response|4|||
23784400|NCT02213263|66590241|FG001|Overall Study|Insufficient clinical response|3|||
23784401|NCT02213263|66590240|FG000|Overall Study|Lost to Follow-up|0|||
23784402|NCT02213263|66590241|FG001|Overall Study|Lost to Follow-up|1|||
23784403|NCT02213263|66590240|FG000|Overall Study|No longer willing to participate|3|||
23784404|NCT02213263|66590241|FG001|Overall Study|No longer willing to participate|4|||
23784405|NCT02213263|66590240|FG000|Overall Study|Progressive disease|20|||
23784406|NCT02213263|66590241|FG001|Overall Study|Progressive disease|14|||
23784407|NCT02213263|66590240|FG000|Overall Study|Protocol Violation|0|||
23784408|NCT02213263|66590241|FG001|Overall Study|Protocol Violation|1|||
23784409|NCT02213263|66590240|FG000|Overall Study|Adverse Event|1|||
23784410|NCT02213263|66590241|FG001|Overall Study|Adverse Event|3|||
23455861|NCT03656562|65412808|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
23455862|NCT03656562|65412805|FG000|Overall Study|Physician Decision|1|||
23455863|NCT03656562|65412806|FG001|Overall Study|Physician Decision|2|||
23455864|NCT03656562|65412807|FG002|Overall Study|Physician Decision|0|||
23455865|NCT03656562|65412808|FG003|Overall Study|Physician Decision|0|||
23455866|NCT03656562|65412805|FG000|Overall Study|Subject Decision|3|||
23455867|NCT03656562|65412806|FG001|Overall Study|Subject Decision|5|||
23455868|NCT03656562|65412807|FG002|Overall Study|Subject Decision|0|||
23455869|NCT03656562|65412808|FG003|Overall Study|Subject Decision|2|||
23455870|NCT02435212|65412813|FG000|Core Phase|Adverse Event|8|||
23784411|NCT01249651|66590242|FG000|Overall Study|Withdrawal by Subject|4|||
23784412|NCT01249651|66590242|FG000|Overall Study|Adverse Event|1|||
23784413|NCT01249651|66590242|FG000|Overall Study|Protocol Violation|1|||
23784414|NCT01249651|66590242|FG000|Overall Study|Sponsor Decision|1|||
23784415|NCT01442155|66590245|FG000|Overall Study|Complete remission|35|||
23784416|NCT01442155|66590245|FG000|Overall Study|Recurrence|26|||
23784417|NCT01442155|66590245|FG000|Overall Study|Adverse Event|2|||
23784418|NCT01442155|66590245|FG000|Overall Study|Lost to Follow-up|2|||
23784419|NCT03214952|66590246|FG000|Overall Study|Protocol Deviation|45|||
23784420|NCT03214952|66590246|FG000|Overall Study|Case Report Forms Uncollected|13|||
23344025|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
23344026|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Physician Decision|2|||
23344027|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Physician Decision|4|||
23344028|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Pregnancy|2|||
23344029|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Pregnancy|1|||
23344030|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
23344031|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
23344032|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
23344033|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
23344034|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
23344035|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
23344036|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
23344037|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
23344038|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
23344039|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
23344040|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
23344041|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
23344042|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
23344043|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
23344044|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
23344045|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
23455871|NCT02435212|65412814|FG001|Core Phase|Adverse Event|5|||
23582979|NCT03113487|65865894|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
23637278|NCT03651622|66057384|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
23784421|NCT02269657|66590248|FG000|Overall Study|Protocol Violation|3|||
23784422|NCT05133180|66590249|FG000|Overall Study|Withdrawal of consent|1|||
23784423|NCT05133180|66590250|FG001|Overall Study|Withdrawal of consent|1|||
23344046|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
23344047|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
23455872|NCT02435212|65412813|FG000|Core Phase|Withdrawal by Subject|3|||
23455873|NCT02435212|65412814|FG001|Core Phase|Withdrawal by Subject|0|||
23455874|NCT02435212|65412813|FG000|Core Phase|Withdrawal by parent/guardian|9|||
23344048|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
23344049|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
23344050|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
23344051|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
23344052|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
23344053|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
23344054|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
23344055|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
23344056|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
23344057|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
23344058|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
23344059|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
23344060|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
23344061|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
23344062|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
23344063|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
23344064|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
23344065|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
23344066|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
23344067|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
23344068|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
23344069|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
23344070|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
23344071|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
23344072|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
23344073|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
23344074|NCT03990571|65001569|FG000|Overall Study|Withdrawal by Subject|1|||
23344075|NCT03990571|65001569|FG000|Overall Study|Insurance Issues|3|||
23344076|NCT03990571|65001569|FG000|Overall Study|Covid Restrictions|2|||
23344077|NCT01171898|65001570|FG000|Overall Study|Death|0|||
23344078|NCT01171898|65001571|FG001|Overall Study|Death|0|||
23344079|NCT01171898|65001572|FG002|Overall Study|Death|2|||
23344080|NCT01171898|65001573|FG003|Overall Study|Death|0|||
23344081|NCT01171898|65001570|FG000|Overall Study|Lost to Follow-up|0|||
23344082|NCT01171898|65001571|FG001|Overall Study|Lost to Follow-up|1|||
23344083|NCT01171898|65001572|FG002|Overall Study|Lost to Follow-up|1|||
23344084|NCT01171898|65001573|FG003|Overall Study|Lost to Follow-up|1|||
23344085|NCT01171898|65001570|FG000|Overall Study|Withdrawal by Subject|1|||
23344086|NCT01171898|65001571|FG001|Overall Study|Withdrawal by Subject|4|||
23344087|NCT01171898|65001572|FG002|Overall Study|Withdrawal by Subject|6|||
23344088|NCT01171898|65001573|FG003|Overall Study|Withdrawal by Subject|3|||
23344089|NCT01171898|65001570|FG000|Overall Study|Terminated by Sponsor|1|||
23455875|NCT02435212|65412814|FG001|Core Phase|Withdrawal by parent/guardian|4|||
23455876|NCT02435212|65412813|FG000|Core Phase|Protocol Violation|1|||
23455877|NCT02435212|65412814|FG001|Core Phase|Protocol Violation|2|||
23455878|NCT02435212|65412813|FG000|Core Phase|Physician Decision|3|||
23455879|NCT02435212|65412814|FG001|Core Phase|Physician Decision|0|||
23455880|NCT02435212|65412813|FG000|Core Phase|Lost to Follow-up|0|||
23455881|NCT02435212|65412814|FG001|Core Phase|Lost to Follow-up|1|||
23455882|NCT02435212|65412813|FG000|Core Phase|Lack of Efficacy|0|||
23455883|NCT02435212|65412814|FG001|Core Phase|Lack of Efficacy|1|||
23455884|NCT02435212|65412813|FG000|Core Phase|Recovery|1|||
23344090|NCT01171898|65001571|FG001|Overall Study|Terminated by Sponsor|0|||
23344091|NCT01171898|65001572|FG002|Overall Study|Terminated by Sponsor|0|||
23344092|NCT01171898|65001573|FG003|Overall Study|Terminated by Sponsor|0|||
23344093|NCT01171898|65001570|FG000|Overall Study|Ongoing|1|||
23344094|NCT01171898|65001571|FG001|Overall Study|Ongoing|9|||
23344095|NCT01171898|65001572|FG002|Overall Study|Ongoing|3|||
23344096|NCT01171898|65001573|FG003|Overall Study|Ongoing|0|||
23344097|NCT01171898|65001570|FG000|Overall Study|Other|1|||
23344098|NCT01171898|65001571|FG001|Overall Study|Other|5|||
23344099|NCT01171898|65001572|FG002|Overall Study|Other|0|||
23344100|NCT01171898|65001573|FG003|Overall Study|Other|2|||
23344101|NCT04034251|65001575|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
23344102|NCT04034251|65001576|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
23344103|NCT04034251|65001577|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
23344104|NCT04598451|65001579|FG000|Overall Study|Adverse Event|3|||
23344105|NCT04598451|65001580|FG001|Overall Study|Adverse Event|2|||
23344106|NCT04598451|65001579|FG000|Overall Study|Withdrawal by Subject|3|||
23344107|NCT04598451|65001580|FG001|Overall Study|Withdrawal by Subject|7|||
23344108|NCT04598451|65001579|FG000|Overall Study|Lost to Follow-up|2|||
23344109|NCT04598451|65001580|FG001|Overall Study|Lost to Follow-up|0|||
23344110|NCT04598451|65001579|FG000|Overall Study|Physician Decision|4|||
23344111|NCT04598451|65001580|FG001|Overall Study|Physician Decision|1|||
23344112|NCT04598451|65001579|FG000|Overall Study|Requires Prohibited Medication|1|||
23344113|NCT04598451|65001580|FG001|Overall Study|Requires Prohibited Medication|0|||
23344114|NCT04598451|65001579|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
23344115|NCT04598451|65001580|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
23344116|NCT00504725|65001581|FG000|Overall Study|Protocol Violation|1|||
23344117|NCT00504725|65001582|FG001|Overall Study|Protocol Violation|0|||
23344118|NCT04186806|65001583|FG000|Period 1: 7 Days|Adverse Event|1|||
23344119|NCT04186806|65001584|FG001|Period 1: 7 Days|Adverse Event|0|||
23344120|NCT02963558|65001585|FG000|Overall Study|Withdrawn by investigator|1|||
23784424|NCT05133180|66590249|FG000|Overall Study|Lost to Follow-up|1|||
23784425|NCT05133180|66590250|FG001|Overall Study|Lost to Follow-up|1|||
23784426|NCT05133180|66590249|FG000|Overall Study|Documented disease progression|0|||
23784427|NCT05133180|66590250|FG001|Overall Study|Documented disease progression|1|||
23784428|NCT02151981|66590253|FG000|Overall Study|Death|184|||
23784429|NCT02151981|66590254|FG001|Overall Study|Death|88|||
23784430|NCT02151981|66590253|FG000|Overall Study|Lost to Follow-up|7|||
23784431|NCT02151981|66590254|FG001|Overall Study|Lost to Follow-up|1|||
23784432|NCT02151981|66590253|FG000|Overall Study|Withdrawal by Subject|27|||
23784433|NCT02151981|66590254|FG001|Overall Study|Withdrawal by Subject|21|||
23784434|NCT02151981|66590253|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
23784435|NCT02151981|66590254|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
23784436|NCT02151981|66590253|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23784437|NCT02151981|66590254|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23784438|NCT02151981|66590253|FG000|Overall Study|Patient had no clinical benefit|1|||
23784439|NCT02151981|66590254|FG001|Overall Study|Patient had no clinical benefit|0|||
23784440|NCT02151981|66590253|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
23784441|NCT02151981|66590254|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
23784442|NCT02151981|66590253|FG000|Overall Study|Study terminated|0|||
23784443|NCT02151981|66590254|FG001|Overall Study|Study terminated|1|||
23784444|NCT00624286|66590255|FG000|Overall Study|Protocol Deviation|7|||
23784445|NCT00624286|66590256|FG001|Overall Study|Protocol Deviation|9|||
23784446|NCT00624286|66590255|FG000|Overall Study|Adverse Event|6|||
23784447|NCT00624286|66590256|FG001|Overall Study|Adverse Event|3|||
23784448|NCT00624286|66590255|FG000|Overall Study|Withdrawal by Subject|5|||
23784449|NCT00624286|66590256|FG001|Overall Study|Withdrawal by Subject|4|||
23784450|NCT00624286|66590255|FG000|Overall Study|Lost to Follow-up|3|||
23784451|NCT00624286|66590256|FG001|Overall Study|Lost to Follow-up|2|||
23784452|NCT00624286|66590255|FG000|Overall Study|Administrative problems|3|||
23344121|NCT02963558|65001586|FG001|Overall Study|Withdrawn by investigator|0|||
23637279|NCT03651622|66057385|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
23637280|NCT03651622|66057383|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
23637281|NCT03651622|66057384|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
23637282|NCT03651622|66057385|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
23344122|NCT02963558|65001585|FG000|Overall Study|Withdrawal by Subject|0|||
23637283|NCT03651622|66057383|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
23637284|NCT03651622|66057384|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
23637285|NCT03651622|66057385|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
23637286|NCT03651622|66057383|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
23637287|NCT03651622|66057384|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
23784453|NCT00624286|66590256|FG001|Overall Study|Administrative problems|0|||
23784454|NCT00624286|66590255|FG000|Overall Study|Lack of Efficacy|1|||
23344123|NCT02963558|65001586|FG001|Overall Study|Withdrawal by Subject|1|||
23344124|NCT03091192|65001587|FG000|Overall Study|Study terminated by sponsor|21|||
23344125|NCT03091192|65001588|FG001|Overall Study|Study terminated by sponsor|14|||
23344126|NCT03091192|65001587|FG000|Overall Study|Death|9|||
23344127|NCT03091192|65001588|FG001|Overall Study|Death|13|||
23344128|NCT03091192|65001587|FG000|Overall Study|Withdrawal by Subject|2|||
23344129|NCT03091192|65001588|FG001|Overall Study|Withdrawal by Subject|0|||
23344130|NCT03091192|65001587|FG000|Overall Study|Lost to Follow-up|1|||
23344131|NCT03091192|65001588|FG001|Overall Study|Lost to Follow-up|0|||
23344132|NCT00614523|65001589|FG000|Overall Study|Adverse Event|4|||
23344133|NCT00614523|65001590|FG001|Overall Study|Adverse Event|20|||
23344134|NCT00614523|65001589|FG000|Overall Study|Death|5|||
23344135|NCT00614523|65001590|FG001|Overall Study|Death|8|||
23344136|NCT00614523|65001589|FG000|Overall Study|Lack of Efficacy|9|||
23344137|NCT00614523|65001590|FG001|Overall Study|Lack of Efficacy|11|||
23344138|NCT00614523|65001589|FG000|Overall Study|Lost to Follow-up|0|||
23344139|NCT00614523|65001590|FG001|Overall Study|Lost to Follow-up|1|||
23344140|NCT00614523|65001589|FG000|Overall Study|Protocol Violation|3|||
23637288|NCT03651622|66057385|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
23344141|NCT00614523|65001590|FG001|Overall Study|Protocol Violation|2|||
23344142|NCT00614523|65001589|FG000|Overall Study|Withdrawal by Subject|12|||
23344143|NCT00614523|65001590|FG001|Overall Study|Withdrawal by Subject|22|||
23344144|NCT00614523|65001589|FG000|Overall Study|Other|6|||
23344145|NCT00614523|65001590|FG001|Overall Study|Other|11|||
23344146|NCT00614523|65001589|FG000|Overall Study|Ineligibility Determined|1|||
23344147|NCT00614523|65001590|FG001|Overall Study|Ineligibility Determined|2|||
23344148|NCT00614523|65001589|FG000|Overall Study|Disease Progression|0|||
23344149|NCT00614523|65001590|FG001|Overall Study|Disease Progression|8|||
23344150|NCT00614523|65001589|FG000|Overall Study|Administrative Decision|23|||
23344151|NCT00614523|65001590|FG001|Overall Study|Administrative Decision|46|||
23344152|NCT05177354|65001593|FG000|Implant to 30-day Visit|Physician Decision|1|||
23344153|NCT05177354|65001593|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
23344154|NCT05177354|65001593|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
23344155|NCT05177354|65001593|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
23344156|NCT03581292|65001594|FG000|Overall Study|Physician Decision|9|||
23344157|NCT03581292|65001595|FG001|Overall Study|Physician Decision|5|||
23344158|NCT03581292|65001594|FG000|Overall Study|Withdrawal by Subject|3|||
23344159|NCT03581292|65001595|FG001|Overall Study|Withdrawal by Subject|0|||
23344160|NCT03581292|65001594|FG000|Overall Study|Withdrawal before Therapy Start|1|||
23344161|NCT03581292|65001595|FG001|Overall Study|Withdrawal before Therapy Start|0|||
23344162|NCT01143064|65001596|FG000|Overall Study|Death|109|||
23344163|NCT01143064|65001597|FG001|Overall Study|Death|91|||
23344164|NCT01143064|65001596|FG000|Overall Study|Adverse Event|0|||
23344165|NCT01143064|65001597|FG001|Overall Study|Adverse Event|1|||
23344166|NCT01143064|65001596|FG000|Overall Study|Withdrawal by Subject|7|||
23344167|NCT01143064|65001597|FG001|Overall Study|Withdrawal by Subject|5|||
23344168|NCT01143064|65001596|FG000|Overall Study|Lost to Follow-up|17|||
23344169|NCT01143064|65001597|FG001|Overall Study|Lost to Follow-up|14|||
23455885|NCT02435212|65412814|FG001|Core Phase|Recovery|0|||
23455886|NCT02435212|65412813|FG000|Optional Extension Phase|Adverse Event|3|||
23455887|NCT02435212|65412814|FG001|Optional Extension Phase|Adverse Event|9|||
23455888|NCT02435212|65412813|FG000|Optional Extension Phase|Physician Decision|6|||
23455889|NCT02435212|65412814|FG001|Optional Extension Phase|Physician Decision|8|||
23455890|NCT02435212|65412813|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
23455891|NCT02435212|65412814|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
23455892|NCT02435212|65412813|FG000|Optional Extension Phase|Lack of Efficacy|2|||
23455893|NCT02435212|65412814|FG001|Optional Extension Phase|Lack of Efficacy|3|||
23455894|NCT02435212|65412813|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
23455895|NCT02435212|65412814|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
23455896|NCT02435212|65412813|FG000|Optional Extension Phase|Protocol Violation|0|||
23455897|NCT02435212|65412814|FG001|Optional Extension Phase|Protocol Violation|1|||
23455898|NCT02435212|65412813|FG000|Optional Extension Phase|Recovery|1|||
23455899|NCT02435212|65412814|FG001|Optional Extension Phase|Recovery|1|||
23637289|NCT01125514|66057387|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
23637290|NCT01125514|66057387|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
23344170|NCT01143064|65001596|FG000|Overall Study|Physician Decision|0|||
23344171|NCT01143064|65001597|FG001|Overall Study|Physician Decision|4|||
23344172|NCT03692325|65001601|FG000|Overall Study|Adverse Event|2|||
23344173|NCT03692325|65001601|FG000|Overall Study|Progression/Recurrence|2|||
23344174|NCT00412217|65001604|FG000|Overall Study|Insufficient Data Available|8|||
23344175|NCT00412217|65001605|FG001|Overall Study|Insufficient Data Available|3|||
23344176|NCT00412217|65001604|FG000|Overall Study|Death|5|||
23344177|NCT00412217|65001605|FG001|Overall Study|Death|4|||
23455900|NCT02435212|65412813|FG000|Optional Extension Phase|Death|1|||
23455901|NCT02435212|65412814|FG001|Optional Extension Phase|Death|0|||
23455902|NCT02435212|65412813|FG000|Optional Extension Phase|Technical problems|2|||
23344178|NCT00412217|65001604|FG000|Overall Study|Disease Progression|2|||
23344179|NCT00412217|65001605|FG001|Overall Study|Disease Progression|3|||
23344180|NCT00412217|65001604|FG000|Overall Study|Investigator Decision|1|||
23344181|NCT00412217|65001605|FG001|Overall Study|Investigator Decision|0|||
23344182|NCT00412217|65001604|FG000|Overall Study|Withdrawal by Subject|2|||
23344183|NCT00412217|65001605|FG001|Overall Study|Withdrawal by Subject|0|||
23344184|NCT00412217|65001604|FG000|Overall Study|Lost to Follow-up|1|||
23344185|NCT00412217|65001605|FG001|Overall Study|Lost to Follow-up|4|||
23344186|NCT00412217|65001604|FG000|Overall Study|Study Terminated by Sponsor|26|||
23344187|NCT00412217|65001605|FG001|Overall Study|Study Terminated by Sponsor|33|||
23344188|NCT00412217|65001604|FG000|Overall Study|Other|1|||
23344189|NCT00412217|65001605|FG001|Overall Study|Other|1|||
23344190|NCT03729570|65001608|FG000|Overall Study|Lost to Follow-up|16|||
23344191|NCT03729570|65001609|FG001|Overall Study|Lost to Follow-up|20|||
23344192|NCT03729570|65001608|FG000|Overall Study|Seroconversion|5|||
23344193|NCT03729570|65001609|FG001|Overall Study|Seroconversion|0|||
23344194|NCT03729570|65001608|FG000|Overall Study|Moved out of the city|1|||
23344195|NCT03729570|65001609|FG001|Overall Study|Moved out of the city|0|||
23344196|NCT03729570|65001608|FG000|Overall Study|Time Conflict|1|||
23344197|NCT03729570|65001609|FG001|Overall Study|Time Conflict|0|||
23344198|NCT03729570|65001608|FG000|Overall Study|Time Commitment|2|||
23344199|NCT03729570|65001609|FG001|Overall Study|Time Commitment|0|||
23344200|NCT03729570|65001608|FG000|Overall Study|Bad Experience|0|||
23344201|NCT03729570|65001609|FG001|Overall Study|Bad Experience|1|||
23344202|NCT03729570|65001608|FG000|Overall Study|No reason provided|2|||
23344203|NCT03729570|65001609|FG001|Overall Study|No reason provided|1|||
23344204|NCT03729570|65001608|FG000|Overall Study|Family Conflict|0|||
23344205|NCT03729570|65001609|FG001|Overall Study|Family Conflict|1|||
23344206|NCT03729570|65001608|FG000|Overall Study|Did not want to continue taking medications|0|||
23344207|NCT03729570|65001609|FG001|Overall Study|Did not want to continue taking medications|1|||
23344208|NCT03729570|65001608|FG000|Overall Study|Found another PrEP provider|1|||
23344209|NCT03729570|65001609|FG001|Overall Study|Found another PrEP provider|0|||
23637291|NCT01125514|66057387|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
23344210|NCT03729570|65001608|FG000|Overall Study|Did not enjoy being in the control group|0|||
23344211|NCT03729570|65001609|FG001|Overall Study|Did not enjoy being in the control group|1|||
23344212|NCT04420585|65001616|FG000|Overall Study|Adverse Event|1|||
23344213|NCT04420585|65001616|FG000|Overall Study|Never initiated medication|2|||
23344214|NCT00558896|65003781|FG000|Overall Study|Adverse Event|1|||
23344215|NCT00558896|65003782|FG001|Overall Study|Adverse Event|1|||
23344216|NCT00558896|65003783|FG002|Overall Study|Adverse Event|1|||
23344217|NCT00558896|65003784|FG003|Overall Study|Adverse Event|3|||
23344218|NCT00558896|65003785|FG004|Overall Study|Adverse Event|4|||
23582980|NCT01068249|65865895|FG000|Overall Study|Death|1|||
23784455|NCT00624286|66590256|FG001|Overall Study|Lack of Efficacy|6|||
23784456|NCT00624286|66590255|FG000|Overall Study|Not stated|0|||
23784457|NCT00624286|66590256|FG001|Overall Study|Not stated|1|||
23784458|NCT00624286|66590255|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23784459|NCT00624286|66590256|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23784460|NCT00624286|66590255|FG000|Overall Study|Death|0|||
23784461|NCT00624286|66590256|FG001|Overall Study|Death|1|||
23784462|NCT00829530|66590257|FG000|First Intervention|Adverse Event|0|||
23344219|NCT00558896|65003786|FG005|Overall Study|Adverse Event|10|||
23344220|NCT00558896|65003787|FG006|Overall Study|Adverse Event|3|||
23344221|NCT00558896|65003781|FG000|Overall Study|Death|3|||
23344222|NCT00558896|65003782|FG001|Overall Study|Death|0|||
23344223|NCT00558896|65003783|FG002|Overall Study|Death|2|||
23344224|NCT00558896|65003784|FG003|Overall Study|Death|3|||
23344225|NCT00558896|65003785|FG004|Overall Study|Death|2|||
23344226|NCT00558896|65003786|FG005|Overall Study|Death|2|||
23344227|NCT00558896|65003787|FG006|Overall Study|Death|6|||
23344228|NCT00558896|65003781|FG000|Overall Study|Withdrawal by Subject|2|||
23344229|NCT00558896|65003782|FG001|Overall Study|Withdrawal by Subject|1|||
23344230|NCT00558896|65003783|FG002|Overall Study|Withdrawal by Subject|1|||
23784463|NCT00829530|66590258|FG001|First Intervention|Adverse Event|1|||
23784464|NCT00829530|66590257|FG000|First Intervention|Intolerance to Venopuncture|0|||
23344231|NCT00558896|65003784|FG003|Overall Study|Withdrawal by Subject|1|||
23344232|NCT00558896|65003785|FG004|Overall Study|Withdrawal by Subject|1|||
23344233|NCT00558896|65003786|FG005|Overall Study|Withdrawal by Subject|5|||
23344234|NCT00558896|65003787|FG006|Overall Study|Withdrawal by Subject|5|||
23344235|NCT00558896|65003781|FG000|Overall Study|Alternative Treatment|2|||
23344236|NCT00558896|65003782|FG001|Overall Study|Alternative Treatment|2|||
23344237|NCT00558896|65003783|FG002|Overall Study|Alternative Treatment|0|||
23344238|NCT00558896|65003784|FG003|Overall Study|Alternative Treatment|2|||
23344239|NCT00558896|65003785|FG004|Overall Study|Alternative Treatment|6|||
23344240|NCT00558896|65003786|FG005|Overall Study|Alternative Treatment|7|||
23344241|NCT00558896|65003787|FG006|Overall Study|Alternative Treatment|1|||
23582981|NCT01068249|65865895|FG000|Overall Study|Withdrawal by Subject|3|||
23582982|NCT00712166|65865900|FG000|Overall Study|Noncompliance|0|||
23582983|NCT00712166|65865901|FG001|Overall Study|Noncompliance|1|||
23582984|NCT00906698|65865902|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
23784465|NCT00829530|66590258|FG001|First Intervention|Intolerance to Venopuncture|1|||
23344242|NCT00558896|65003781|FG000|Overall Study|Physician discretion|3|||
23344243|NCT00558896|65003782|FG001|Overall Study|Physician discretion|2|||
23344244|NCT00558896|65003783|FG002|Overall Study|Physician discretion|1|||
23344245|NCT00558896|65003784|FG003|Overall Study|Physician discretion|2|||
23344246|NCT00558896|65003785|FG004|Overall Study|Physician discretion|1|||
23344247|NCT00558896|65003786|FG005|Overall Study|Physician discretion|3|||
23344248|NCT00558896|65003787|FG006|Overall Study|Physician discretion|3|||
23344249|NCT00558896|65003781|FG000|Overall Study|Continues on treatment|10|||
23344250|NCT00558896|65003782|FG001|Overall Study|Continues on treatment|1|||
23344251|NCT00558896|65003783|FG002|Overall Study|Continues on treatment|0|||
23344252|NCT00558896|65003784|FG003|Overall Study|Continues on treatment|1|||
23344253|NCT00558896|65003785|FG004|Overall Study|Continues on treatment|9|||
23344254|NCT00558896|65003786|FG005|Overall Study|Continues on treatment|25|||
23344255|NCT00558896|65003787|FG006|Overall Study|Continues on treatment|6|||
23344256|NCT01647516|65003788|FG000|Induction Period (IP)|Physician Decision|2|||
23344257|NCT01647516|65003789|FG001|Induction Period (IP)|Physician Decision|0|||
23344258|NCT01647516|65003790|FG002|Induction Period (IP)|Physician Decision|0|||
23344259|NCT01647516|65003791|FG003|Induction Period (IP)|Physician Decision|0|||
23344260|NCT01647516|65003792|FG004|Induction Period (IP)|Physician Decision|0|||
23344261|NCT01647516|65003793|FG005|Induction Period (IP)|Physician Decision|0|||
23344262|NCT01647516|65003788|FG000|Induction Period (IP)|Adverse Event|1|||
23344263|NCT01647516|65003789|FG001|Induction Period (IP)|Adverse Event|2|||
23344264|NCT01647516|65003790|FG002|Induction Period (IP)|Adverse Event|0|||
23344265|NCT01647516|65003791|FG003|Induction Period (IP)|Adverse Event|0|||
23344266|NCT01647516|65003792|FG004|Induction Period (IP)|Adverse Event|0|||
23344267|NCT01647516|65003793|FG005|Induction Period (IP)|Adverse Event|0|||
23344268|NCT01647516|65003788|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
23344269|NCT01647516|65003789|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
23344270|NCT01647516|65003790|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
23344271|NCT01647516|65003791|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
23344272|NCT01647516|65003792|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
23344273|NCT01647516|65003793|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
23344274|NCT01647516|65003788|FG000|Induction Period (IP)|Participant Choice|0|||
23344275|NCT01647516|65003789|FG001|Induction Period (IP)|Participant Choice|0|||
23344276|NCT01647516|65003790|FG002|Induction Period (IP)|Participant Choice|1|||
23344277|NCT01647516|65003791|FG003|Induction Period (IP)|Participant Choice|0|||
23344278|NCT01647516|65003792|FG004|Induction Period (IP)|Participant Choice|0|||
23344279|NCT01647516|65003793|FG005|Induction Period (IP)|Participant Choice|0|||
23344280|NCT01647516|65003788|FG000|Induction Period (IP)|Lack of Efficacy|1|||
23344281|NCT01647516|65003789|FG001|Induction Period (IP)|Lack of Efficacy|0|||
23344282|NCT01647516|65003790|FG002|Induction Period (IP)|Lack of Efficacy|0|||
23344283|NCT01647516|65003791|FG003|Induction Period (IP)|Lack of Efficacy|0|||
23344284|NCT01647516|65003792|FG004|Induction Period (IP)|Lack of Efficacy|0|||
23344285|NCT01647516|65003793|FG005|Induction Period (IP)|Lack of Efficacy|0|||
23344286|NCT01647516|65003788|FG000|Induction Period (IP)|No study drug received|1|||
23344287|NCT01647516|65003789|FG001|Induction Period (IP)|No study drug received|1|||
23344288|NCT01647516|65003790|FG002|Induction Period (IP)|No study drug received|0|||
23344289|NCT01647516|65003791|FG003|Induction Period (IP)|No study drug received|0|||
23344290|NCT01647516|65003792|FG004|Induction Period (IP)|No study drug received|0|||
23344291|NCT01647516|65003793|FG005|Induction Period (IP)|No study drug received|0|||
23344292|NCT01647516|65003788|FG000|Maintenance Period (MP)|Adverse Event|2|||
23455903|NCT02435212|65412814|FG001|Optional Extension Phase|Technical problems|0|||
23455904|NCT05106959|65412815|FG000|Overall Study|Lost to Follow-up|1|||
23344293|NCT01647516|65003789|FG001|Maintenance Period (MP)|Adverse Event|1|||
23637292|NCT01125514|66057387|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
23784466|NCT00829530|66590257|FG000|Second Intervention|Intolerance to Venopuncture|1|||
23784467|NCT00829530|66590258|FG001|Second Intervention|Intolerance to Venopuncture|0|||
23784468|NCT02057835|66590259|FG000|Overall Study|Withdrawal by Subject|0|||
23784469|NCT02057835|66590260|FG001|Overall Study|Withdrawal by Subject|2|||
23784470|NCT02057835|66590261|FG002|Overall Study|Withdrawal by Subject|0|||
23784471|NCT02057835|66590262|FG003|Overall Study|Withdrawal by Subject|0|||
23784472|NCT02057835|66590263|FG004|Overall Study|Withdrawal by Subject|0|||
23784473|NCT02057835|66590264|FG005|Overall Study|Withdrawal by Subject|0|||
23784474|NCT02057835|66590265|FG006|Overall Study|Withdrawal by Subject|0|||
23784475|NCT02057835|66590266|FG007|Overall Study|Withdrawal by Subject|0|||
23784476|NCT02057835|66590267|FG008|Overall Study|Withdrawal by Subject|0|||
23784477|NCT02057835|66590268|FG009|Overall Study|Withdrawal by Subject|0|||
23784478|NCT00835575|66590269|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
23784479|NCT00835575|66590270|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
23784480|NCT04594252|66590273|FG000|Overall Study|Adverse Event|0|||
23784481|NCT04594252|66590274|FG001|Overall Study|Adverse Event|2|||
23784482|NCT00373256|66590275|FG000|Overall Study|Adverse Event (AE)|1|||
23784483|NCT00373256|66590276|FG001|Overall Study|Adverse Event (AE)|5|||
23784484|NCT00373256|66590275|FG000|Overall Study|Lost to Follow-up|2|||
23784485|NCT00373256|66590276|FG001|Overall Study|Lost to Follow-up|1|||
23784486|NCT00373256|66590275|FG000|Overall Study|Death|9|||
23784487|NCT00373256|66590276|FG001|Overall Study|Death|8|||
23784488|NCT00373256|66590275|FG000|Overall Study|Objective Progression or Relapse|111|||
23784489|NCT00373256|66590276|FG001|Overall Study|Objective Progression or Relapse|104|||
23784490|NCT00373256|66590275|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
23784491|NCT00373256|66590276|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
23784492|NCT00373256|66590275|FG000|Overall Study|Other|73|||
23784493|NCT00373256|66590276|FG001|Overall Study|Other|107|||
23784494|NCT00373256|66590275|FG000|Overall Study|Protocol Violation|0|||
23784495|NCT00373256|66590276|FG001|Overall Study|Protocol Violation|2|||
23784496|NCT00373256|66590275|FG000|Overall Study|Study Terminated by Sponsor|41|||
23784497|NCT00373256|66590276|FG001|Overall Study|Study Terminated by Sponsor|13|||
23784498|NCT03635320|66590277|FG000|Overall Study|not implanted the device|1|||
23784499|NCT03635320|66590278|FG001|Overall Study|not implanted the device|2|||
23784500|NCT03635320|66590277|FG000|Overall Study|Withdrawal by Subject|11|||
23784501|NCT03635320|66590278|FG001|Overall Study|Withdrawal by Subject|6|||
23784502|NCT00834249|66590279|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23784503|NCT00834249|66590280|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23784504|NCT00834249|66590279|FG000|Second Intervention|Adverse Event|1|||
23784505|NCT00834249|66590280|FG001|Second Intervention|Adverse Event|0|||
23784506|NCT01370083|66590281|FG000|Overall Study|Lost to Follow-up|2|||
23784507|NCT01370083|66590282|FG001|Overall Study|Lost to Follow-up|0|||
23784508|NCT01370083|66590281|FG000|Overall Study|Adverse Event|0|||
23784509|NCT01370083|66590282|FG001|Overall Study|Adverse Event|1|||
23784510|NCT01895335|66590283|FG000|Overall Study|Adverse Event|106|||
23784511|NCT01895335|66590283|FG000|Overall Study|Lack of Efficacy|53|||
23784512|NCT01895335|66590283|FG000|Overall Study|Poor Compliance to Protocol|11|||
23784513|NCT01895335|66590283|FG000|Overall Study|Included But Not treated|1|||
23784514|NCT01895335|66590283|FG000|Overall Study|Other than Specified Above|44|||
23455905|NCT05323084|65412818|FG000|Period 2 - Washout|Lost to Follow-up|0|||
23455906|NCT05323084|65412819|FG001|Period 2 - Washout|Lost to Follow-up|1|||
23455907|NCT04199351|65412820|FG000|Overall Study|Decision by sponsor|0|||
23784515|NCT00942968|66590289|FG000|Overall Study|Adverse Event|60|||
23784516|NCT00942968|66590289|FG000|Overall Study|Death|76|||
23784517|NCT00942968|66590289|FG000|Overall Study|Protocol Violation|9|||
23784518|NCT00942968|66590289|FG000|Overall Study|Lost to Follow-up|4|||
23784519|NCT00942968|66590289|FG000|Overall Study|Withdrawal by Subject|44|||
23784520|NCT00942968|66590289|FG000|Overall Study|Sponsor request|5|||
23784521|NCT00942968|66590289|FG000|Overall Study|Physician Decision|11|||
23784522|NCT00942968|66590289|FG000|Overall Study|Progression of disease|12|||
23784523|NCT00942968|66590289|FG000|Overall Study|Inferior vena cava filter placement|4|||
23784524|NCT00942968|66590289|FG000|Overall Study|Pulmonary embolism (PE)|1|||
23784525|NCT00942968|66590289|FG000|Overall Study|Participant required pancreatic biopsy|1|||
23455908|NCT04199351|65412821|FG001|Overall Study|Decision by sponsor|0|||
23784526|NCT00942968|66590289|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
23784527|NCT00583453|66590290|FG000|Overall Study|discontinued intervention|0|||
23455909|NCT04199351|65412822|FG002|Overall Study|Decision by sponsor|0|||
23455910|NCT04199351|65412823|FG003|Overall Study|Decision by sponsor|2|||
23455911|NCT04199351|65412824|FG004|Overall Study|Decision by sponsor|0|||
23455912|NCT04199351|65412825|FG005|Overall Study|Decision by sponsor|0|||
23455913|NCT04199351|65412826|FG006|Overall Study|Decision by sponsor|0|||
23455914|NCT04199351|65412827|FG007|Overall Study|Decision by sponsor|0|||
23455915|NCT04199351|65412828|FG008|Overall Study|Decision by sponsor|0|||
23455916|NCT04199351|65412829|FG009|Overall Study|Decision by sponsor|6|||
23455917|NCT04199351|65412820|FG000|Overall Study|Lost to Follow-up|0|||
23455918|NCT04199351|65412821|FG001|Overall Study|Lost to Follow-up|0|||
23455919|NCT04199351|65412822|FG002|Overall Study|Lost to Follow-up|1|||
23455920|NCT04199351|65412823|FG003|Overall Study|Lost to Follow-up|0|||
23784528|NCT00583453|66590291|FG001|Overall Study|discontinued intervention|2|||
23784529|NCT01010503|66590294|FG000|Overall Study|Adverse Event|1|||
23784530|NCT01010503|66590294|FG000|Overall Study|Death|1|||
23784531|NCT00835692|66590295|FG000|First Intervention|Withdrawal by Subject|1|||
23784532|NCT00835692|66590296|FG001|First Intervention|Withdrawal by Subject|0|||
23784533|NCT00377260|66590297|FG000|Overall Study|Lost to Follow-up|0|||
23784534|NCT00377260|66590298|FG001|Overall Study|Lost to Follow-up|1|||
23455921|NCT04199351|65412824|FG004|Overall Study|Lost to Follow-up|0|||
23455922|NCT04199351|65412825|FG005|Overall Study|Lost to Follow-up|1|||
23455923|NCT04199351|65412826|FG006|Overall Study|Lost to Follow-up|0|||
23784535|NCT00377260|66590297|FG000|Overall Study|Withdrawal by Subject|2|||
23784536|NCT00377260|66590298|FG001|Overall Study|Withdrawal by Subject|4|||
23784537|NCT01564394|66590299|FG000|Overall Study|Withdrawal by Subject|6|||
23784538|NCT01564394|66590300|FG001|Overall Study|Withdrawal by Subject|10|||
23784539|NCT02820350|66590302|FG000|Overall Study|Withdrawal by Subject|3|||
23455924|NCT04199351|65412827|FG007|Overall Study|Lost to Follow-up|0|||
23455925|NCT04199351|65412828|FG008|Overall Study|Lost to Follow-up|0|||
23455926|NCT04199351|65412829|FG009|Overall Study|Lost to Follow-up|0|||
23455927|NCT04199351|65412820|FG000|Overall Study|Withdrawal by Subject|0|||
23455928|NCT04199351|65412821|FG001|Overall Study|Withdrawal by Subject|1|||
23784540|NCT02820350|66590302|FG000|Overall Study|Death|4|||
23784541|NCT00835666|66590307|FG000|Washout|Protocol Violation|1|||
23455929|NCT04199351|65412822|FG002|Overall Study|Withdrawal by Subject|0|||
23455930|NCT04199351|65412823|FG003|Overall Study|Withdrawal by Subject|0|||
23455931|NCT04199351|65412824|FG004|Overall Study|Withdrawal by Subject|1|||
23455932|NCT04199351|65412825|FG005|Overall Study|Withdrawal by Subject|4|||
23455933|NCT04199351|65412826|FG006|Overall Study|Withdrawal by Subject|2|||
23455934|NCT04199351|65412827|FG007|Overall Study|Withdrawal by Subject|0|||
23455935|NCT04199351|65412828|FG008|Overall Study|Withdrawal by Subject|3|||
23455936|NCT04199351|65412829|FG009|Overall Study|Withdrawal by Subject|0|||
23455937|NCT03363841|65412832|FG000|Overall Study|Adverse Event|1|||
23455938|NCT03363841|65412832|FG000|Overall Study|Withdrawal by Subject|1|||
23455939|NCT03363841|65412832|FG000|Overall Study|Death|7|||
23455940|NCT03363841|65412832|FG000|Overall Study|Physician Decision|1|||
23455941|NCT03040141|65412833|FG000|Overall Study|Death|1|||
23455942|NCT03040141|65412834|FG001|Overall Study|Death|2|||
23455943|NCT03040141|65412835|FG002|Overall Study|Death|3|||
23455944|NCT03040141|65412833|FG000|Overall Study|Withdrawal by Subject|3|||
23455945|NCT03040141|65412834|FG001|Overall Study|Withdrawal by Subject|1|||
23455946|NCT03040141|65412835|FG002|Overall Study|Withdrawal by Subject|1|||
23455947|NCT03040141|65412833|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
23455948|NCT03040141|65412834|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
23455949|NCT03040141|65412835|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
23455950|NCT03040141|65412833|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
23455951|NCT03040141|65412834|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
23455952|NCT03040141|65412835|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
23455953|NCT00360230|65412838|FG000|Overall Study|Withdrawal by Subject|1|||
23455954|NCT00360230|65412839|FG001|Overall Study|Withdrawal by Subject|1|||
23455955|NCT00360230|65412840|FG002|Overall Study|Withdrawal by Subject|0|||
23455956|NCT00360230|65412841|FG003|Overall Study|Withdrawal by Subject|1|||
23455957|NCT00360230|65412842|FG004|Overall Study|Withdrawal by Subject|1|||
23455958|NCT00360230|65412843|FG005|Overall Study|Withdrawal by Subject|1|||
23455959|NCT00360230|65412844|FG006|Overall Study|Withdrawal by Subject|0|||
23455960|NCT00360230|65412838|FG000|Overall Study|Migrated|4|||
23455961|NCT00360230|65412839|FG001|Overall Study|Migrated|1|||
23455962|NCT00360230|65412840|FG002|Overall Study|Migrated|3|||
23455963|NCT00360230|65412841|FG003|Overall Study|Migrated|1|||
23455964|NCT00360230|65412842|FG004|Overall Study|Migrated|4|||
23455965|NCT00360230|65412843|FG005|Overall Study|Migrated|1|||
23455966|NCT00360230|65412844|FG006|Overall Study|Migrated|1|||
23455967|NCT00360230|65412838|FG000|Overall Study|Other|1|||
23455968|NCT00360230|65412839|FG001|Overall Study|Other|0|||
23455969|NCT00360230|65412840|FG002|Overall Study|Other|0|||
23455970|NCT00360230|65412841|FG003|Overall Study|Other|0|||
23455971|NCT00360230|65412842|FG004|Overall Study|Other|0|||
23455972|NCT00360230|65412843|FG005|Overall Study|Other|0|||
23455973|NCT00360230|65412844|FG006|Overall Study|Other|0|||
23455974|NCT00360230|65412838|FG000|Overall Study|Protocol Violation|0|||
23455975|NCT00360230|65412839|FG001|Overall Study|Protocol Violation|0|||
23455976|NCT00360230|65412840|FG002|Overall Study|Protocol Violation|0|||
23455977|NCT00360230|65412841|FG003|Overall Study|Protocol Violation|0|||
23455978|NCT00360230|65412842|FG004|Overall Study|Protocol Violation|0|||
23455979|NCT00360230|65412843|FG005|Overall Study|Protocol Violation|1|||
23455980|NCT00360230|65412844|FG006|Overall Study|Protocol Violation|0|||
23455981|NCT00360230|65412838|FG000|Overall Study|Death|0|||
23455982|NCT00360230|65412839|FG001|Overall Study|Death|1|||
23455983|NCT00360230|65412840|FG002|Overall Study|Death|0|||
23455984|NCT00360230|65412841|FG003|Overall Study|Death|0|||
23455985|NCT00360230|65412842|FG004|Overall Study|Death|0|||
23455986|NCT00360230|65412843|FG005|Overall Study|Death|1|||
23455987|NCT00360230|65412844|FG006|Overall Study|Death|1|||
23455988|NCT02647281|65412853|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455989|NCT02647281|65412854|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455990|NCT02647281|65412855|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455991|NCT02647281|65412856|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455992|NCT02647281|65412857|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455993|NCT02647281|65412858|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455994|NCT02647281|65412859|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455995|NCT02647281|65412860|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455996|NCT02647281|65412861|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
23455997|NCT01285401|65412862|FG000|Overall Study|Prematurely withdrawn from the study|17|||
23455998|NCT01285401|65412863|FG001|Overall Study|Prematurely withdrawn from the study|29|||
23455999|NCT01064440|65412864|FG000|Overall Study|Lost to Follow-up|1|||
23456000|NCT01064440|65412865|FG001|Overall Study|Lost to Follow-up|1|||
23456001|NCT01064440|65412866|FG002|Overall Study|Lost to Follow-up|1|||
23456002|NCT01064440|65412864|FG000|Overall Study|Non-compliance|0|||
23456003|NCT01064440|65412865|FG001|Overall Study|Non-compliance|1|||
23456004|NCT01064440|65412866|FG002|Overall Study|Non-compliance|0|||
23456005|NCT01064440|65412864|FG000|Overall Study|Death|1|||
23456006|NCT01064440|65412865|FG001|Overall Study|Death|0|||
23456007|NCT01064440|65412866|FG002|Overall Study|Death|1|||
23456008|NCT01064440|65412864|FG000|Overall Study|Withdrawal by Subject|0|||
23456009|NCT01064440|65412865|FG001|Overall Study|Withdrawal by Subject|1|||
23456010|NCT01064440|65412866|FG002|Overall Study|Withdrawal by Subject|1|||
23456011|NCT01064440|65412864|FG000|Overall Study|Other: amputation|1|||
23456012|NCT01064440|65412865|FG001|Overall Study|Other: amputation|0|||
23456013|NCT01064440|65412866|FG002|Overall Study|Other: amputation|0|||
23637293|NCT01125514|66057387|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
23637294|NCT01125514|66057387|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
23637295|NCT00667225|66057388|FG000|Overall Study|Subject had no more lesions to treat.|1|||
23637296|NCT00667225|66057389|FG001|Overall Study|Subject had no more lesions to treat.|0|||
23637297|NCT00667225|66057388|FG000|Overall Study|Lost to Follow-up|0|||
23637298|NCT00667225|66057389|FG001|Overall Study|Lost to Follow-up|1|||
23637299|NCT02755818|66057390|FG000|Overall Study|Withdrawal by Subject|0|||
23637300|NCT02755818|66057391|FG001|Overall Study|Withdrawal by Subject|0|||
23344294|NCT01647516|65003790|FG002|Maintenance Period (MP)|Adverse Event|0|||
23344295|NCT01647516|65003791|FG003|Maintenance Period (MP)|Adverse Event|0|||
23344296|NCT01647516|65003792|FG004|Maintenance Period (MP)|Adverse Event|0|||
23344297|NCT01647516|65003793|FG005|Maintenance Period (MP)|Adverse Event|0|||
23344298|NCT01647516|65003788|FG000|Maintenance Period (MP)|Non-compliance|1|||
23344299|NCT01647516|65003789|FG001|Maintenance Period (MP)|Non-compliance|0|||
23456014|NCT00771758|65412867|FG000|Overall Study|Adverse Event|2|||
23637301|NCT02755818|66057392|FG002|Overall Study|Withdrawal by Subject|0|||
23637302|NCT02755818|66057393|FG003|Overall Study|Withdrawal by Subject|2|||
23637303|NCT02755818|66057390|FG000|Overall Study|withdrawal by PI|0|||
23637304|NCT02755818|66057391|FG001|Overall Study|withdrawal by PI|0|||
23637305|NCT02755818|66057392|FG002|Overall Study|withdrawal by PI|1|||
23637306|NCT02755818|66057393|FG003|Overall Study|withdrawal by PI|1|||
23637307|NCT01598662|66057394|FG000|Overall Study|Lost to Follow-up|10|||
23637308|NCT01598662|66057395|FG001|Overall Study|Lost to Follow-up|17|||
23637309|NCT01598662|66057394|FG000|Overall Study|Physician Decision|1|||
23344300|NCT01647516|65003790|FG002|Maintenance Period (MP)|Non-compliance|0|||
23344301|NCT01647516|65003791|FG003|Maintenance Period (MP)|Non-compliance|0|||
23456015|NCT00771758|65412868|FG001|Overall Study|Adverse Event|8|||
23456016|NCT00771758|65412869|FG002|Overall Study|Adverse Event|1|||
23456017|NCT00771758|65412867|FG000|Overall Study|Lack of Efficacy|0|||
23637310|NCT01598662|66057395|FG001|Overall Study|Physician Decision|2|||
23637311|NCT01598662|66057394|FG000|Overall Study|IUD expelled before month 6|0|||
23637312|NCT01598662|66057395|FG001|Overall Study|IUD expelled before month 6|2|||
23637313|NCT02389452|66057396|FG000|Overall Study|Lost to Follow-up|13|||
23637314|NCT02389452|66057396|FG000|Overall Study|Adverse Event|1|||
23637315|NCT02389452|66057396|FG000|Overall Study|Withdrawal by Subject|5|||
23637316|NCT02389452|66057396|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
23637317|NCT01871805|66057407|FG000|Phase I|Death|7|||
23637318|NCT01871805|66057408|FG001|Phase I|Death|4|||
23637319|NCT01871805|66057409|FG002|Phase I|Death|6|||
23637320|NCT01871805|66057410|FG003|Phase I|Death|2|||
23637321|NCT01871805|66057411|FG004|Phase I|Death|9|||
23637322|NCT01871805|66057412|FG005|Phase I|Death|0|||
23637323|NCT01871805|66057407|FG000|Phase I|Alive in Survival Follow-up|0|||
23637324|NCT01871805|66057408|FG001|Phase I|Alive in Survival Follow-up|2|||
23637325|NCT01871805|66057409|FG002|Phase I|Alive in Survival Follow-up|4|||
23637326|NCT01871805|66057410|FG003|Phase I|Alive in Survival Follow-up|5|||
23637327|NCT01871805|66057411|FG004|Phase I|Alive in Survival Follow-up|4|||
23637328|NCT01871805|66057412|FG005|Phase I|Alive in Survival Follow-up|0|||
23637329|NCT01871805|66057407|FG000|Phase I|Lost to Follow-up|0|||
23637330|NCT01871805|66057408|FG001|Phase I|Lost to Follow-up|1|||
23637331|NCT01871805|66057409|FG002|Phase I|Lost to Follow-up|3|||
23637332|NCT01871805|66057410|FG003|Phase I|Lost to Follow-up|0|||
23637333|NCT01871805|66057411|FG004|Phase I|Lost to Follow-up|0|||
23637334|NCT01871805|66057412|FG005|Phase I|Lost to Follow-up|0|||
23456018|NCT00771758|65412868|FG001|Overall Study|Lack of Efficacy|2|||
23637335|NCT01871805|66057407|FG000|Phase II|Death|0|||
23637336|NCT01871805|66057408|FG001|Phase II|Death|0|||
23582985|NCT00906698|65865903|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
23582986|NCT00906698|65865904|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582987|NCT00906698|65865905|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582988|NCT00906698|65865906|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
23582989|NCT00906698|65865907|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582990|NCT00906698|65865902|FG000|Overall Study|Adverse Event|0|||
23582991|NCT00906698|65865903|FG001|Overall Study|Adverse Event|0|||
23582992|NCT00906698|65865904|FG002|Overall Study|Adverse Event|2|||
23637337|NCT01871805|66057409|FG002|Phase II|Death|0|||
23637338|NCT01871805|66057410|FG003|Phase II|Death|0|||
23637339|NCT01871805|66057411|FG004|Phase II|Death|0|||
23637340|NCT01871805|66057412|FG005|Phase II|Death|45|||
23637341|NCT01871805|66057407|FG000|Phase II|Alive in Survival Follow-up|0|||
23637342|NCT01871805|66057408|FG001|Phase II|Alive in Survival Follow-up|0|||
23637343|NCT01871805|66057409|FG002|Phase II|Alive in Survival Follow-up|0|||
23637344|NCT01871805|66057410|FG003|Phase II|Alive in Survival Follow-up|0|||
23637345|NCT01871805|66057411|FG004|Phase II|Alive in Survival Follow-up|0|||
23637346|NCT01871805|66057412|FG005|Phase II|Alive in Survival Follow-up|29|||
23637347|NCT01871805|66057407|FG000|Phase II|Lost to Follow-up|0|||
23637348|NCT01871805|66057408|FG001|Phase II|Lost to Follow-up|0|||
23637349|NCT01871805|66057409|FG002|Phase II|Lost to Follow-up|0|||
23637350|NCT01871805|66057410|FG003|Phase II|Lost to Follow-up|0|||
23637351|NCT01871805|66057411|FG004|Phase II|Lost to Follow-up|0|||
23637352|NCT01871805|66057412|FG005|Phase II|Lost to Follow-up|13|||
23456019|NCT00771758|65412869|FG002|Overall Study|Lack of Efficacy|1|||
23456020|NCT00771758|65412867|FG000|Overall Study|Lost to Follow-up|1|||
23637353|NCT02949362|66057413|FG000|Retrospective Period|Inform consent not signed by participant|4|||
23637354|NCT02949362|66057414|FG001|Retrospective Period|Inform consent not signed by participant|1|||
23637355|NCT02949362|66057415|FG002|Retrospective Period|Inform consent not signed by participant|0|||
23637356|NCT02949362|66057416|FG003|Retrospective Period|Inform consent not signed by participant|0|||
23637357|NCT02949362|66057413|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23637358|NCT02949362|66057414|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23637359|NCT02949362|66057415|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
23637360|NCT02949362|66057416|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23637361|NCT02949362|66057413|FG000|Prospective Period|Other|0|||
23637362|NCT02949362|66057414|FG001|Prospective Period|Other|0|||
23637363|NCT02949362|66057415|FG002|Prospective Period|Other|0|||
23637364|NCT02949362|66057416|FG003|Prospective Period|Other|4|||
23637365|NCT02472145|66057417|FG000|Overall Study|Death|10|||
23637366|NCT02472145|66057418|FG001|Overall Study|Death|101|||
23637367|NCT02472145|66057419|FG002|Overall Study|Death|99|||
23637368|NCT02472145|66057417|FG000|Overall Study|Lost to Follow-up|0|||
23637369|NCT02472145|66057418|FG001|Overall Study|Lost to Follow-up|1|||
23637370|NCT02472145|66057419|FG002|Overall Study|Lost to Follow-up|0|||
23637371|NCT02472145|66057417|FG000|Overall Study|Withdrawal by Subject|0|||
23637372|NCT02472145|66057418|FG001|Overall Study|Withdrawal by Subject|9|||
23637373|NCT02472145|66057419|FG002|Overall Study|Withdrawal by Subject|13|||
23637374|NCT02472145|66057417|FG000|Overall Study|Sponsor decision|0|||
23637375|NCT02472145|66057418|FG001|Overall Study|Sponsor decision|3|||
23637376|NCT02472145|66057419|FG002|Overall Study|Sponsor decision|2|||
23637377|NCT02472145|66057417|FG000|Overall Study|Other|0|||
23637378|NCT02472145|66057418|FG001|Overall Study|Other|45|||
23637379|NCT02472145|66057419|FG002|Overall Study|Other|43|||
23637380|NCT02510040|66057420|FG000|Overall Study|Deemed no longer eligible|18|||
23456021|NCT00771758|65412868|FG001|Overall Study|Lost to Follow-up|0|||
23456022|NCT00771758|65412869|FG002|Overall Study|Lost to Follow-up|0|||
23456023|NCT00771758|65412867|FG000|Overall Study|Protocol Violation|1|||
23456024|NCT00771758|65412868|FG001|Overall Study|Protocol Violation|0|||
23456025|NCT00771758|65412869|FG002|Overall Study|Protocol Violation|0|||
23456026|NCT00771758|65412867|FG000|Overall Study|Withdrawal by Subject|1|||
23456027|NCT00771758|65412868|FG001|Overall Study|Withdrawal by Subject|0|||
23456028|NCT00771758|65412869|FG002|Overall Study|Withdrawal by Subject|0|||
23456029|NCT00771758|65412867|FG000|Overall Study|Other|3|||
23456030|NCT00771758|65412868|FG001|Overall Study|Other|2|||
23456031|NCT00771758|65412869|FG002|Overall Study|Other|0|||
23456032|NCT04349891|65412870|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
23582993|NCT00906698|65865905|FG003|Overall Study|Adverse Event|0|||
23637381|NCT02510040|66057421|FG001|Overall Study|Deemed no longer eligible|3|||
23637382|NCT02510040|66057422|FG002|Overall Study|Deemed no longer eligible|1|||
23637383|NCT01142115|66057423|FG000|First Intervention|Lack of Efficacy|1|||
23637384|NCT01142115|66057424|FG001|First Intervention|Lack of Efficacy|1|||
23637385|NCT01142115|66057423|FG000|First Intervention|Adverse Event|1|||
23637386|NCT01142115|66057424|FG001|First Intervention|Adverse Event|0|||
23637387|NCT01818531|66057429|FG000|Overall Study|Withdrawn for case delay after block|1|||
23456033|NCT04349891|65412871|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
23582994|NCT00906698|65865906|FG004|Overall Study|Adverse Event|4|||
23637388|NCT01818531|66057430|FG001|Overall Study|Withdrawn for case delay after block|0|||
23637389|NCT01818531|66057429|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
23637390|NCT01818531|66057430|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
23784542|NCT00835666|66590308|FG001|Washout|Protocol Violation|0|||
23784543|NCT00835666|66590307|FG000|Washout|Withdrawal by Subject|1|||
23784544|NCT00835666|66590308|FG001|Washout|Withdrawal by Subject|0|||
23784545|NCT03196284|66590309|FG000|Main Part|Withdrawal by Subject|0|||
23784546|NCT03196284|66590310|FG001|Main Part|Withdrawal by Subject|1|||
23784547|NCT03196284|66590311|FG002|Main Part|Withdrawal by Subject|0|||
23784548|NCT03196284|66590309|FG000|Extension Part|Lack of Efficacy|0|||
23784549|NCT03196284|66590310|FG001|Extension Part|Lack of Efficacy|0|||
23784550|NCT03196284|66590311|FG002|Extension Part|Lack of Efficacy|1|||
23784551|NCT03196284|66590309|FG000|Extension Part|Withdrawal by Subject|0|||
23784552|NCT03196284|66590310|FG001|Extension Part|Withdrawal by Subject|0|||
23784553|NCT03196284|66590311|FG002|Extension Part|Withdrawal by Subject|1|||
23784554|NCT03196284|66590309|FG000|Extension Part|Physician Decision|0|||
23784555|NCT03196284|66590310|FG001|Extension Part|Physician Decision|0|||
23582995|NCT00906698|65865907|FG005|Overall Study|Adverse Event|1|||
23582996|NCT00906698|65865902|FG000|Overall Study|Disease progression|3|||
23582997|NCT00906698|65865903|FG001|Overall Study|Disease progression|12|||
23582998|NCT00906698|65865904|FG002|Overall Study|Disease progression|4|||
23582999|NCT00906698|65865905|FG003|Overall Study|Disease progression|4|||
23583000|NCT00906698|65865906|FG004|Overall Study|Disease progression|12|||
23583001|NCT00906698|65865907|FG005|Overall Study|Disease progression|4|||
23583002|NCT00906698|65865902|FG000|Overall Study|Withdrawal by Subject|0|||
23583003|NCT00906698|65865903|FG001|Overall Study|Withdrawal by Subject|0|||
23583004|NCT00906698|65865904|FG002|Overall Study|Withdrawal by Subject|0|||
23583005|NCT00906698|65865905|FG003|Overall Study|Withdrawal by Subject|0|||
23583006|NCT00906698|65865906|FG004|Overall Study|Withdrawal by Subject|1|||
23583007|NCT00906698|65865907|FG005|Overall Study|Withdrawal by Subject|0|||
23583008|NCT00906698|65865902|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
23583009|NCT00906698|65865903|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
23583010|NCT00906698|65865904|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
23583011|NCT00906698|65865905|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
23583012|NCT00906698|65865906|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
23583013|NCT00906698|65865907|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
23583014|NCT01789203|65865914|FG000|Overall Study|Adverse Event|2|||
23583015|NCT01789203|65865915|FG001|Overall Study|Adverse Event|2|||
23637391|NCT01818531|66057429|FG000|Overall Study|Withdrawn for failure to place block|0|||
23637392|NCT01818531|66057430|FG001|Overall Study|Withdrawn for failure to place block|1|||
23637393|NCT01080326|66057431|FG000|Overall Study|Patient deterioration prior to procedure|3|||
23784556|NCT03196284|66590311|FG002|Extension Part|Physician Decision|1|||
23784557|NCT02311361|66590313|FG000|Overall Study|Did not receive treatment|0|||
23784558|NCT02311361|66590314|FG001|Overall Study|Did not receive treatment|1|||
23784559|NCT02311361|66590315|FG002|Overall Study|Did not receive treatment|0|||
23583016|NCT01789203|65865914|FG000|Overall Study|Withdrawal by Subject|1|||
23583017|NCT01789203|65865915|FG001|Overall Study|Withdrawal by Subject|0|||
23583018|NCT01789203|65865914|FG000|Overall Study|Death|1|||
23583019|NCT01789203|65865915|FG001|Overall Study|Death|0|||
23583020|NCT01789203|65865914|FG000|Overall Study|Protocol Violation|2|||
23583021|NCT01789203|65865915|FG001|Overall Study|Protocol Violation|1|||
23583022|NCT01789203|65865914|FG000|Overall Study|Other|1|||
23583023|NCT01789203|65865915|FG001|Overall Study|Other|1|||
23583024|NCT01789203|65865914|FG000|Overall Study|patient non-adherent|2|||
23583025|NCT01789203|65865915|FG001|Overall Study|patient non-adherent|0|||
23583026|NCT02333630|65865917|FG000|Overall Study|Lost to Follow-up|5|||
23583027|NCT02333630|65865918|FG001|Overall Study|Lost to Follow-up|2|||
23583028|NCT00631475|65865919|FG000|Overall Study|Death|18|||
23583029|NCT00631475|65865919|FG000|Overall Study|Adverse Event|14|||
23583030|NCT00631475|65865919|FG000|Overall Study|Withdrew consent|5|||
23583031|NCT00631475|65865919|FG000|Overall Study|Preparation for lung transplant|8|||
23583032|NCT03310983|65865920|FG000|Overall Study|Lost to Follow-up|15|||
23583033|NCT03310983|65865921|FG001|Overall Study|Lost to Follow-up|17|||
23583034|NCT03852433|65865922|FG000|Overall Study|Withdrawal of consent|5|||
23583035|NCT03852433|65865923|FG001|Overall Study|Withdrawal of consent|8|||
23583036|NCT03852433|65865924|FG002|Overall Study|Withdrawal of consent|1|||
23583037|NCT03852433|65865925|FG003|Overall Study|Withdrawal of consent|1|||
23583038|NCT03852433|65865922|FG000|Overall Study|Adverse Event|1|||
23583039|NCT03852433|65865923|FG001|Overall Study|Adverse Event|1|||
23583040|NCT03852433|65865924|FG002|Overall Study|Adverse Event|1|||
23583041|NCT03852433|65865925|FG003|Overall Study|Adverse Event|1|||
23583042|NCT03852433|65865922|FG000|Overall Study|Lost to Follow-up|0|||
23583043|NCT03852433|65865923|FG001|Overall Study|Lost to Follow-up|1|||
23583044|NCT03852433|65865924|FG002|Overall Study|Lost to Follow-up|0|||
23583045|NCT03852433|65865925|FG003|Overall Study|Lost to Follow-up|1|||
23583046|NCT03852433|65865922|FG000|Overall Study|Pregnancy|0|||
23583047|NCT03852433|65865923|FG001|Overall Study|Pregnancy|1|||
23583048|NCT03852433|65865924|FG002|Overall Study|Pregnancy|1|||
23583049|NCT03852433|65865925|FG003|Overall Study|Pregnancy|0|||
23583050|NCT03852433|65865922|FG000|Overall Study|Protocol Violation|0|||
23583051|NCT03852433|65865923|FG001|Overall Study|Protocol Violation|0|||
23583052|NCT03852433|65865924|FG002|Overall Study|Protocol Violation|1|||
23583053|NCT03852433|65865925|FG003|Overall Study|Protocol Violation|1|||
23583054|NCT03852433|65865922|FG000|Overall Study|Death|0|||
23583055|NCT03852433|65865923|FG001|Overall Study|Death|0|||
23583056|NCT03852433|65865924|FG002|Overall Study|Death|1|||
23583057|NCT03852433|65865925|FG003|Overall Study|Death|0|||
23583058|NCT03852433|65865922|FG000|Overall Study|Lack of Efficacy|0|||
23583059|NCT03852433|65865923|FG001|Overall Study|Lack of Efficacy|1|||
23583060|NCT03852433|65865924|FG002|Overall Study|Lack of Efficacy|0|||
23583061|NCT03852433|65865925|FG003|Overall Study|Lack of Efficacy|0|||
23583062|NCT03852433|65865922|FG000|Overall Study|Non-compliance with study drug|0|||
23583063|NCT03852433|65865923|FG001|Overall Study|Non-compliance with study drug|0|||
23583064|NCT03852433|65865924|FG002|Overall Study|Non-compliance with study drug|0|||
23583065|NCT03852433|65865925|FG003|Overall Study|Non-compliance with study drug|1|||
23583066|NCT03852433|65865922|FG000|Overall Study|Physician Decision|1|||
23583067|NCT03852433|65865923|FG001|Overall Study|Physician Decision|0|||
23583068|NCT03852433|65865924|FG002|Overall Study|Physician Decision|0|||
23583069|NCT03852433|65865925|FG003|Overall Study|Physician Decision|0|||
23583070|NCT03852433|65865922|FG000|Overall Study|Randomized but never treated|1|||
23583071|NCT03852433|65865923|FG001|Overall Study|Randomized but never treated|0|||
23583072|NCT03852433|65865924|FG002|Overall Study|Randomized but never treated|0|||
23583073|NCT03852433|65865925|FG003|Overall Study|Randomized but never treated|0|||
23583074|NCT00303303|65865926|FG000|Overall Study|Withdrawal by Subject|0|||
23583075|NCT00303303|65865927|FG001|Overall Study|Withdrawal by Subject|0|||
23583076|NCT00303303|65865928|FG002|Overall Study|Withdrawal by Subject|1|||
23583077|NCT03064074|65865929|FG000|Overall Study|Physician Decision|0|||
23583078|NCT03064074|65865930|FG001|Overall Study|Physician Decision|0|||
23583079|NCT03064074|65865931|FG002|Overall Study|Physician Decision|0|||
23583080|NCT03064074|65865932|FG003|Overall Study|Physician Decision|1|||
23583081|NCT01763047|65865933|FG000|Period 1|Test Article Not Available|4|||
23583082|NCT01763047|65865934|FG001|Period 1|Test Article Not Available|1|||
23583083|NCT01763047|65865933|FG000|Period 1|Protocol Violation|4|||
23583084|NCT01763047|65865934|FG001|Period 1|Protocol Violation|4|||
23583085|NCT01763047|65865933|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
23583086|NCT01763047|65865934|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
23583087|NCT01763047|65865933|FG000|Period 1|Adverse Event|0|||
23583088|NCT01763047|65865934|FG001|Period 1|Adverse Event|1|||
23583089|NCT01763047|65865933|FG000|Period 1|Unsatisfactory Visual Response|0|||
23583090|NCT01763047|65865934|FG001|Period 1|Unsatisfactory Visual Response|3|||
23583091|NCT01763047|65865933|FG000|Period 1|Lens Power Not Available|0|||
23583092|NCT01763047|65865934|FG001|Period 1|Lens Power Not Available|1|||
23583093|NCT01763047|65865933|FG000|Period 1|Study Site office Closed|0|||
23583094|NCT01763047|65865934|FG001|Period 1|Study Site office Closed|1|||
23583095|NCT01763047|65865933|FG000|Period 2|Lens Discomfort|1|||
23583096|NCT01763047|65865934|FG001|Period 2|Lens Discomfort|0|||
23583097|NCT01763047|65865933|FG000|Period 2|No longer meets Eligibility Criteria|1|||
23583098|NCT01763047|65865934|FG001|Period 2|No longer meets Eligibility Criteria|0|||
23583099|NCT01763047|65865933|FG000|Period 2|Study Site office Closed|1|||
23583100|NCT01763047|65865934|FG001|Period 2|Study Site office Closed|1|||
23583101|NCT01763047|65865933|FG000|Period 2|Unsatisfactory Visual Response|1|||
23583102|NCT01763047|65865934|FG001|Period 2|Unsatisfactory Visual Response|1|||
23583103|NCT01763047|65865933|FG000|Period 2|Protocol Violation|0|||
23583104|NCT01763047|65865934|FG001|Period 2|Protocol Violation|2|||
23583105|NCT01763047|65865933|FG000|Period 2|Unsatisfactory lens Fitting|0|||
23583106|NCT01763047|65865934|FG001|Period 2|Unsatisfactory lens Fitting|1|||
23583107|NCT02377362|65865936|FG000|Part A Second Treatment|Protocol Violation|0|||
23583108|NCT02377362|65865937|FG001|Part A Second Treatment|Protocol Violation|0|||
23583109|NCT02377362|65865938|FG002|Part A Second Treatment|Protocol Violation|0|||
23583110|NCT02377362|65865939|FG003|Part A Second Treatment|Protocol Violation|0|||
23583111|NCT02377362|65865940|FG004|Part A Second Treatment|Protocol Violation|1|||
23583112|NCT02377362|65865941|FG005|Part A Second Treatment|Protocol Violation|0|||
23583113|NCT02377362|65865942|FG006|Part A Second Treatment|Protocol Violation|0|||
23583114|NCT02377362|65865943|FG007|Part A Second Treatment|Protocol Violation|0|||
23583115|NCT02377362|65865944|FG008|Part A Second Treatment|Protocol Violation|0|||
23583116|NCT02377362|65865945|FG009|Part A Second Treatment|Protocol Violation|0|||
23583117|NCT02377362|65865946|FG010|Part A Second Treatment|Protocol Violation|0|||
23583118|NCT02377362|65865947|FG011|Part A Second Treatment|Protocol Violation|0|||
23583119|NCT02377362|65865948|FG012|Part A Second Treatment|Protocol Violation|0|||
23583120|NCT02377362|65865936|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583121|NCT02377362|65865937|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583122|NCT02377362|65865938|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583123|NCT02377362|65865939|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
23583124|NCT02377362|65865940|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
23583125|NCT02377362|65865941|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
23583126|NCT02377362|65865942|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583127|NCT02377362|65865943|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583128|NCT02377362|65865944|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583129|NCT02377362|65865945|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583130|NCT02377362|65865946|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583131|NCT02377362|65865947|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583132|NCT02377362|65865948|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583133|NCT02377362|65865936|FG000|Part B Overall|Protocol Violation|0|||
23583134|NCT02377362|65865937|FG001|Part B Overall|Protocol Violation|0|||
23583135|NCT02377362|65865938|FG002|Part B Overall|Protocol Violation|0|||
23583136|NCT02377362|65865939|FG003|Part B Overall|Protocol Violation|0|||
23583137|NCT02377362|65865940|FG004|Part B Overall|Protocol Violation|0|||
23583138|NCT02377362|65865941|FG005|Part B Overall|Protocol Violation|0|||
23583139|NCT02377362|65865942|FG006|Part B Overall|Protocol Violation|0|||
23583140|NCT02377362|65865943|FG007|Part B Overall|Protocol Violation|0|||
23583141|NCT02377362|65865944|FG008|Part B Overall|Protocol Violation|0|||
23583142|NCT02377362|65865945|FG009|Part B Overall|Protocol Violation|1|||
23583143|NCT02377362|65865946|FG010|Part B Overall|Protocol Violation|0|||
23583144|NCT02377362|65865947|FG011|Part B Overall|Protocol Violation|0|||
23583145|NCT02377362|65865948|FG012|Part B Overall|Protocol Violation|0|||
23583146|NCT02377362|65865936|FG000|Part B Overall|Adverse Event|0|||
23583147|NCT02377362|65865937|FG001|Part B Overall|Adverse Event|0|||
23583148|NCT02377362|65865938|FG002|Part B Overall|Adverse Event|0|||
23583149|NCT02377362|65865939|FG003|Part B Overall|Adverse Event|0|||
23583150|NCT02377362|65865940|FG004|Part B Overall|Adverse Event|0|||
23583151|NCT02377362|65865941|FG005|Part B Overall|Adverse Event|0|||
23637394|NCT01080326|66057431|FG000|Overall Study|Surgeon decision|1|||
23637395|NCT03653208|66057438|FG000|Overall Study|Withdrawal by Subject|0|||
23637396|NCT03653208|66057439|FG001|Overall Study|Withdrawal by Subject|0|||
23637397|NCT03653208|66057440|FG002|Overall Study|Withdrawal by Subject|0|||
23637398|NCT03653208|66057441|FG003|Overall Study|Withdrawal by Subject|0|||
23583152|NCT02377362|65865942|FG006|Part B Overall|Adverse Event|1|||
23583153|NCT02377362|65865943|FG007|Part B Overall|Adverse Event|1|||
23583154|NCT02377362|65865944|FG008|Part B Overall|Adverse Event|0|||
23583155|NCT02377362|65865945|FG009|Part B Overall|Adverse Event|0|||
23583156|NCT02377362|65865946|FG010|Part B Overall|Adverse Event|0|||
23583157|NCT02377362|65865947|FG011|Part B Overall|Adverse Event|0|||
23583158|NCT02377362|65865948|FG012|Part B Overall|Adverse Event|0|||
23583159|NCT02377362|65865936|FG000|Part B Overall|Withdrawal by Subject|0|||
23583160|NCT02377362|65865937|FG001|Part B Overall|Withdrawal by Subject|0|||
23583161|NCT02377362|65865938|FG002|Part B Overall|Withdrawal by Subject|0|||
23583162|NCT02377362|65865939|FG003|Part B Overall|Withdrawal by Subject|0|||
23637399|NCT03653208|66057442|FG004|Overall Study|Withdrawal by Subject|1|||
23583163|NCT02377362|65865940|FG004|Part B Overall|Withdrawal by Subject|0|||
23784560|NCT02311361|66590316|FG003|Overall Study|Did not receive treatment|1|||
23784561|NCT04078022|66590317|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
23637400|NCT03653208|66057443|FG005|Overall Study|Withdrawal by Subject|0|||
23637401|NCT03653208|66057444|FG006|Overall Study|Withdrawal by Subject|0|||
23637402|NCT03653208|66057445|FG007|Overall Study|Withdrawal by Subject|1|||
23637403|NCT03653208|66057446|FG008|Overall Study|Withdrawal by Subject|1|||
23583164|NCT02377362|65865941|FG005|Part B Overall|Withdrawal by Subject|0|||
23583165|NCT02377362|65865942|FG006|Part B Overall|Withdrawal by Subject|1|||
23637404|NCT00545753|66057448|FG000|Overall Study|Withdrawal by Subject|0|||
23637405|NCT00545753|66057449|FG001|Overall Study|Withdrawal by Subject|1|||
23637406|NCT00545753|66057450|FG002|Overall Study|Withdrawal by Subject|10|||
23637407|NCT00545753|66057448|FG000|Overall Study|Lost to Follow-up|13|||
23637408|NCT00545753|66057449|FG001|Overall Study|Lost to Follow-up|3|||
23637409|NCT00545753|66057450|FG002|Overall Study|Lost to Follow-up|12|||
23637410|NCT00545753|66057448|FG000|Overall Study|Protocol Violation|3|||
23637411|NCT00545753|66057449|FG001|Overall Study|Protocol Violation|1|||
23637412|NCT00545753|66057450|FG002|Overall Study|Protocol Violation|4|||
23637413|NCT02535091|66057451|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
23637414|NCT02535091|66057452|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
23637415|NCT02535091|66057453|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
23637416|NCT02535091|66057451|FG000|Overall Study|Withdrawal by Subject|14|||
23637417|NCT02535091|66057452|FG001|Overall Study|Withdrawal by Subject|5|||
23637418|NCT02535091|66057453|FG002|Overall Study|Withdrawal by Subject|121|||
23637419|NCT02535091|66057451|FG000|Overall Study|Adverse Event|9|||
23784562|NCT04078022|66590318|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
23344302|NCT01647516|65003792|FG004|Maintenance Period (MP)|Non-compliance|0|||
23344303|NCT01647516|65003793|FG005|Maintenance Period (MP)|Non-compliance|0|||
23583166|NCT02377362|65865943|FG007|Part B Overall|Withdrawal by Subject|0|||
23583167|NCT02377362|65865944|FG008|Part B Overall|Withdrawal by Subject|0|||
23583168|NCT02377362|65865945|FG009|Part B Overall|Withdrawal by Subject|0|||
23583169|NCT02377362|65865946|FG010|Part B Overall|Withdrawal by Subject|0|||
23583170|NCT02377362|65865947|FG011|Part B Overall|Withdrawal by Subject|1|||
23583171|NCT02377362|65865948|FG012|Part B Overall|Withdrawal by Subject|0|||
23583172|NCT03503773|65865949|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
23583173|NCT03503773|65865950|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
23583174|NCT03503773|65865949|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
23583175|NCT03503773|65865950|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
23583176|NCT03503773|65865949|FG000|Overall Study|Not completing the primary ABPM|3|||
23583177|NCT03503773|65865950|FG001|Overall Study|Not completing the primary ABPM|1|||
23583178|NCT03503773|65865949|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23583179|NCT03503773|65865950|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23583180|NCT02857283|65865953|FG000|First Exposure|Withdrawal by Subject|1|||
23583181|NCT02857283|65865954|FG001|First Exposure|Withdrawal by Subject|0|||
23583182|NCT02624778|65865955|FG000|Overall Study|Lost to Follow-up|0|||
23583183|NCT02624778|65865956|FG001|Overall Study|Lost to Follow-up|0|||
23583184|NCT02624778|65865957|FG002|Overall Study|Lost to Follow-up|1|||
23583185|NCT02624778|65865958|FG003|Overall Study|Lost to Follow-up|0|||
23583186|NCT02624778|65865959|FG004|Overall Study|Lost to Follow-up|0|||
23583187|NCT02624778|65865960|FG005|Overall Study|Lost to Follow-up|0|||
23583188|NCT02624778|65865961|FG006|Overall Study|Lost to Follow-up|0|||
23583189|NCT02624778|65865962|FG007|Overall Study|Lost to Follow-up|0|||
23583190|NCT02624778|65865963|FG008|Overall Study|Lost to Follow-up|0|||
23583191|NCT02624778|65865955|FG000|Overall Study|Withdrawal by Subject|0|||
23583192|NCT02624778|65865956|FG001|Overall Study|Withdrawal by Subject|1|||
23583193|NCT02624778|65865957|FG002|Overall Study|Withdrawal by Subject|0|||
23583194|NCT02624778|65865958|FG003|Overall Study|Withdrawal by Subject|0|||
23583195|NCT02624778|65865959|FG004|Overall Study|Withdrawal by Subject|0|||
23583196|NCT02624778|65865960|FG005|Overall Study|Withdrawal by Subject|1|||
23583197|NCT02624778|65865961|FG006|Overall Study|Withdrawal by Subject|1|||
23583198|NCT02624778|65865962|FG007|Overall Study|Withdrawal by Subject|1|||
23583199|NCT02624778|65865963|FG008|Overall Study|Withdrawal by Subject|1|||
23583200|NCT02624778|65865955|FG000|Overall Study|Adverse Event|0|||
23583201|NCT02624778|65865956|FG001|Overall Study|Adverse Event|0|||
23583202|NCT02624778|65865957|FG002|Overall Study|Adverse Event|0|||
23583203|NCT02624778|65865958|FG003|Overall Study|Adverse Event|0|||
23583204|NCT02624778|65865959|FG004|Overall Study|Adverse Event|0|||
23583205|NCT02624778|65865960|FG005|Overall Study|Adverse Event|0|||
23637420|NCT02535091|66057452|FG001|Overall Study|Adverse Event|4|||
23637421|NCT02535091|66057453|FG002|Overall Study|Adverse Event|170|||
23784563|NCT01609257|66590319|FG000|Overall Study|Lost to Follow-up|2|||
23784564|NCT01609257|66590320|FG001|Overall Study|Lost to Follow-up|1|||
23784565|NCT01609257|66590319|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
23583206|NCT02624778|65865961|FG006|Overall Study|Adverse Event|0|||
23583207|NCT02624778|65865962|FG007|Overall Study|Adverse Event|0|||
23583208|NCT02624778|65865963|FG008|Overall Study|Adverse Event|2|||
23583209|NCT02624778|65865955|FG000|Overall Study|Death|0|||
23583210|NCT02624778|65865956|FG001|Overall Study|Death|0|||
23583211|NCT02624778|65865957|FG002|Overall Study|Death|0|||
23583212|NCT02624778|65865958|FG003|Overall Study|Death|0|||
23583213|NCT02624778|65865959|FG004|Overall Study|Death|0|||
23583214|NCT02624778|65865960|FG005|Overall Study|Death|0|||
23583215|NCT02624778|65865961|FG006|Overall Study|Death|1|||
23583216|NCT02624778|65865962|FG007|Overall Study|Death|0|||
23583217|NCT02624778|65865963|FG008|Overall Study|Death|0|||
23583218|NCT02624778|65865955|FG000|Overall Study|Physician Decision|0|||
23583219|NCT02624778|65865956|FG001|Overall Study|Physician Decision|0|||
23583220|NCT02624778|65865957|FG002|Overall Study|Physician Decision|0|||
23583221|NCT02624778|65865958|FG003|Overall Study|Physician Decision|0|||
23583222|NCT02624778|65865959|FG004|Overall Study|Physician Decision|0|||
23583223|NCT02624778|65865960|FG005|Overall Study|Physician Decision|0|||
23583224|NCT02624778|65865961|FG006|Overall Study|Physician Decision|0|||
23583225|NCT02624778|65865962|FG007|Overall Study|Physician Decision|3|||
23583226|NCT02624778|65865963|FG008|Overall Study|Physician Decision|3|||
23583227|NCT04423393|65865964|FG000|Overall Study|Withdrawal by Subject|0|||
23583228|NCT04423393|65865965|FG001|Overall Study|Withdrawal by Subject|0|||
23583229|NCT04423393|65865966|FG002|Overall Study|Withdrawal by Subject|0|||
23583230|NCT04423393|65865967|FG003|Overall Study|Withdrawal by Subject|0|||
23583231|NCT04423393|65865968|FG004|Overall Study|Withdrawal by Subject|0|||
23583232|NCT04423393|65865969|FG005|Overall Study|Withdrawal by Subject|1|||
23583233|NCT04423393|65865970|FG006|Overall Study|Withdrawal by Subject|0|||
23583234|NCT04423393|65865971|FG007|Overall Study|Withdrawal by Subject|0|||
23344304|NCT01647516|65003788|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
23583235|NCT04423393|65865972|FG008|Overall Study|Withdrawal by Subject|0|||
23583236|NCT04423393|65865973|FG009|Overall Study|Withdrawal by Subject|0|||
23583237|NCT04423393|65865974|FG010|Overall Study|Withdrawal by Subject|0|||
23583238|NCT04423393|65865975|FG011|Overall Study|Withdrawal by Subject|0|||
23583239|NCT04423393|65865976|FG012|Overall Study|Withdrawal by Subject|0|||
23583240|NCT04423393|65865977|FG013|Overall Study|Withdrawal by Subject|1|||
23583241|NCT04423393|65865978|FG014|Overall Study|Withdrawal by Subject|0|||
23583242|NCT04423393|65865979|FG015|Overall Study|Withdrawal by Subject|0|||
23583243|NCT04423393|65865980|FG016|Overall Study|Withdrawal by Subject|0|||
23583244|NCT04423393|65865981|FG017|Overall Study|Withdrawal by Subject|0|||
23583245|NCT04423393|65865964|FG000|Overall Study|Sponsor Decision|0|||
23583246|NCT04423393|65865965|FG001|Overall Study|Sponsor Decision|0|||
23583247|NCT04423393|65865966|FG002|Overall Study|Sponsor Decision|0|||
23583248|NCT04423393|65865967|FG003|Overall Study|Sponsor Decision|0|||
23583249|NCT04423393|65865968|FG004|Overall Study|Sponsor Decision|0|||
23583250|NCT04423393|65865969|FG005|Overall Study|Sponsor Decision|0|||
23583251|NCT04423393|65865970|FG006|Overall Study|Sponsor Decision|0|||
23583252|NCT04423393|65865971|FG007|Overall Study|Sponsor Decision|0|||
23583253|NCT04423393|65865972|FG008|Overall Study|Sponsor Decision|0|||
23583254|NCT04423393|65865973|FG009|Overall Study|Sponsor Decision|0|||
23583255|NCT04423393|65865974|FG010|Overall Study|Sponsor Decision|0|||
23583256|NCT04423393|65865975|FG011|Overall Study|Sponsor Decision|0|||
23583257|NCT04423393|65865976|FG012|Overall Study|Sponsor Decision|0|||
23583258|NCT04423393|65865977|FG013|Overall Study|Sponsor Decision|1|||
23583259|NCT04423393|65865978|FG014|Overall Study|Sponsor Decision|0|||
23583260|NCT04423393|65865979|FG015|Overall Study|Sponsor Decision|0|||
23583261|NCT04423393|65865980|FG016|Overall Study|Sponsor Decision|0|||
23583262|NCT04423393|65865981|FG017|Overall Study|Sponsor Decision|0|||
23583263|NCT03829332|65865982|FG000|Overall Study|Death|145|||
23583264|NCT03829332|65865983|FG001|Overall Study|Death|135|||
23583265|NCT03829332|65865982|FG000|Overall Study|Withdrawal by Subject|10|||
23583266|NCT03829332|65865983|FG001|Overall Study|Withdrawal by Subject|4|||
23583267|NCT03829332|65865982|FG000|Overall Study|Ongoing in Study|154|||
23583268|NCT03829332|65865983|FG001|Overall Study|Ongoing in Study|175|||
23583269|NCT00849147|65865986|FG000|Overall Study|Withdrawal by Subject|1|||
23583270|NCT00849147|65865986|FG000|Overall Study|Protocol Violation|2|||
23583271|NCT00849147|65865986|FG000|Overall Study|Disease Relapse/Progression|2|||
23583272|NCT05650333|65865987|FG000|Treatment Period (7 Days)|Adverse Event|1|||
23583273|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
23583274|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
23583275|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
23583276|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
23583277|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
23583278|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
23583279|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583280|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583281|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583282|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
23583283|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
23583284|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583285|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Death|0|||
23583286|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Death|0|||
23583287|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Death|0|||
23583288|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Death|0|||
23583289|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Death|0|||
23583290|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Death|1|||
23583291|NCT04927975|65865990|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
23583292|NCT04927975|65865991|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
23583293|NCT04927975|65865992|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
23583294|NCT04927975|65865993|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
23583295|NCT04927975|65865994|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
23583296|NCT04927975|65865995|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
23583297|NCT04927975|65865990|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
23583298|NCT04927975|65865991|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583299|NCT04927975|65865992|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583300|NCT04927975|65865993|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
23583301|NCT04927975|65865994|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583302|NCT04927975|65865995|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583303|NCT01311713|65865996|FG000|Overall Study|Death|0|||
23344305|NCT01647516|65003789|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
23344306|NCT01647516|65003790|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
23344307|NCT01647516|65003791|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344308|NCT01647516|65003792|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344309|NCT01647516|65003793|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344310|NCT01647516|65003788|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
23344311|NCT01647516|65003789|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
23344312|NCT01647516|65003790|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
23344313|NCT01647516|65003791|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
23344314|NCT01647516|65003792|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
23344315|NCT01647516|65003793|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
23344316|NCT01647516|65003788|FG000|Open-Label Period|Adverse Event|0|||
23344317|NCT01647516|65003789|FG001|Open-Label Period|Adverse Event|0|||
23344318|NCT01647516|65003790|FG002|Open-Label Period|Adverse Event|0|||
23344319|NCT01647516|65003791|FG003|Open-Label Period|Adverse Event|5|||
23344320|NCT01647516|65003792|FG004|Open-Label Period|Adverse Event|6|||
23344321|NCT01647516|65003793|FG005|Open-Label Period|Adverse Event|3|||
23456034|NCT04349891|65412870|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
23456035|NCT04349891|65412871|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
23583304|NCT01311713|65865997|FG001|Overall Study|Death|0|||
23583305|NCT01311713|65865998|FG002|Overall Study|Death|1|||
23583306|NCT01311713|65865999|FG003|Overall Study|Death|1|||
23583307|NCT01311713|65866000|FG004|Overall Study|Death|0|||
23583308|NCT01311713|65866001|FG005|Overall Study|Death|1|||
23583309|NCT01311713|65866002|FG006|Overall Study|Death|0|||
23583310|NCT01311713|65865996|FG000|Overall Study|Adverse Event|0|||
23583311|NCT01311713|65865997|FG001|Overall Study|Adverse Event|1|||
23583312|NCT01311713|65865998|FG002|Overall Study|Adverse Event|0|||
23583313|NCT01311713|65865999|FG003|Overall Study|Adverse Event|2|||
23583314|NCT01311713|65866000|FG004|Overall Study|Adverse Event|0|||
23583315|NCT01311713|65866001|FG005|Overall Study|Adverse Event|0|||
23583316|NCT01311713|65866002|FG006|Overall Study|Adverse Event|2|||
23583317|NCT01311713|65865996|FG000|Overall Study|Withdrawal by Subject|0|||
23583318|NCT01311713|65865997|FG001|Overall Study|Withdrawal by Subject|1|||
23583319|NCT01311713|65865998|FG002|Overall Study|Withdrawal by Subject|1|||
23583320|NCT01311713|65865999|FG003|Overall Study|Withdrawal by Subject|0|||
23583321|NCT01311713|65866000|FG004|Overall Study|Withdrawal by Subject|0|||
23583322|NCT01311713|65866001|FG005|Overall Study|Withdrawal by Subject|1|||
23583323|NCT01311713|65866002|FG006|Overall Study|Withdrawal by Subject|2|||
23583324|NCT01311713|65865996|FG000|Overall Study|Disease progression|3|||
23583325|NCT01311713|65865997|FG001|Overall Study|Disease progression|4|||
23583326|NCT01311713|65865998|FG002|Overall Study|Disease progression|3|||
23583327|NCT01311713|65865999|FG003|Overall Study|Disease progression|2|||
23583328|NCT01311713|65866000|FG004|Overall Study|Disease progression|4|||
23583329|NCT01311713|65866001|FG005|Overall Study|Disease progression|4|||
23583330|NCT01311713|65866002|FG006|Overall Study|Disease progression|5|||
23583331|NCT01311713|65865996|FG000|Overall Study|Lost to Follow-up|0|||
23583332|NCT01311713|65865997|FG001|Overall Study|Lost to Follow-up|0|||
23583333|NCT01311713|65865998|FG002|Overall Study|Lost to Follow-up|1|||
23583334|NCT01311713|65865999|FG003|Overall Study|Lost to Follow-up|0|||
23583335|NCT01311713|65866000|FG004|Overall Study|Lost to Follow-up|0|||
23583336|NCT01311713|65866001|FG005|Overall Study|Lost to Follow-up|0|||
23344322|NCT01647516|65003788|FG000|Open-Label Period|Pregnancy|0|||
23344323|NCT01647516|65003789|FG001|Open-Label Period|Pregnancy|0|||
23344324|NCT01647516|65003790|FG002|Open-Label Period|Pregnancy|0|||
23637422|NCT02535091|66057451|FG000|Overall Study|Other|4|||
23637423|NCT02535091|66057452|FG001|Overall Study|Other|3|||
23637424|NCT02535091|66057453|FG002|Overall Study|Other|81|||
23637425|NCT02535091|66057451|FG000|Overall Study|Lost to Follow-up|0|||
23637426|NCT02535091|66057452|FG001|Overall Study|Lost to Follow-up|1|||
23637427|NCT02535091|66057453|FG002|Overall Study|Lost to Follow-up|19|||
23637428|NCT02535091|66057451|FG000|Overall Study|Protocol Violation|0|||
23637429|NCT02535091|66057452|FG001|Overall Study|Protocol Violation|1|||
23637430|NCT02535091|66057453|FG002|Overall Study|Protocol Violation|11|||
23637431|NCT02535091|66057451|FG000|Overall Study|Pregnancy|0|||
23637432|NCT02535091|66057452|FG001|Overall Study|Pregnancy|0|||
23637433|NCT02535091|66057453|FG002|Overall Study|Pregnancy|7|||
23637434|NCT00941070|66057465|FG000|Overall Study|Patient non-compliant|1|||
23637435|NCT02136134|66057476|FG000|Overall Study|Death|170|||
23637436|NCT02136134|66057477|FG001|Overall Study|Death|148|||
23637437|NCT02136134|66057476|FG000|Overall Study|Withdrawal by Subject|19|||
23637438|NCT02136134|66057477|FG001|Overall Study|Withdrawal by Subject|10|||
23637439|NCT02136134|66057476|FG000|Overall Study|Lost to Follow-up|3|||
23637440|NCT02136134|66057477|FG001|Overall Study|Lost to Follow-up|3|||
23637441|NCT02136134|66057476|FG000|Overall Study|Uspecified|55|||
23637442|NCT02136134|66057477|FG001|Overall Study|Uspecified|90|||
23637443|NCT02202785|66057478|FG000|Overall Study|Study Terminated by Sponsor|1|||
23637444|NCT02202785|66057479|FG001|Overall Study|Study Terminated by Sponsor|6|||
23637445|NCT02202785|66057480|FG002|Overall Study|Study Terminated by Sponsor|4|||
23637446|NCT02202785|66057478|FG000|Overall Study|Withdrawal by Subject|0|||
23637447|NCT02202785|66057479|FG001|Overall Study|Withdrawal by Subject|1|||
23637448|NCT02202785|66057480|FG002|Overall Study|Withdrawal by Subject|0|||
23637449|NCT02202785|66057478|FG000|Overall Study|Lost to Follow-up|0|||
23637450|NCT02202785|66057479|FG001|Overall Study|Lost to Follow-up|1|||
23637451|NCT02202785|66057480|FG002|Overall Study|Lost to Follow-up|0|||
23637452|NCT02202785|66057478|FG000|Overall Study|Reason not Specified|10|||
23637453|NCT02202785|66057479|FG001|Overall Study|Reason not Specified|7|||
23637454|NCT02202785|66057480|FG002|Overall Study|Reason not Specified|13|||
23637455|NCT00324116|66057481|FG000|Overall Study|Adverse Event|5|||
23637456|NCT00324116|66057481|FG000|Overall Study|Lack of Efficacy|17|||
23637457|NCT00324116|66057481|FG000|Overall Study|Withdrawal by Subject|5|||
23637458|NCT00324116|66057481|FG000|Overall Study|Other|5|||
23637459|NCT02179177|66057482|FG000|Overall Study|Lost to Follow-up|1|||
23637460|NCT02179177|66057483|FG001|Overall Study|Lost to Follow-up|1|||
23637461|NCT02179177|66057482|FG000|Overall Study|Withdrawal by Subject|1|||
23637462|NCT02179177|66057483|FG001|Overall Study|Withdrawal by Subject|1|||
23637463|NCT00490490|66057484|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
23637464|NCT00490490|66057484|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
23637465|NCT03775434|66057485|FG000|Overall Study|Adverse Event|2|||
23637466|NCT03775434|66057485|FG000|Overall Study|Withdrawal by Subject|1|||
23637467|NCT02224703|66057486|FG000|Overall Study|Adverse Event|0|||
23637468|NCT02224703|66057487|FG001|Overall Study|Adverse Event|5|||
23637469|NCT02224703|66057488|FG002|Overall Study|Adverse Event|0|||
23637470|NCT02224703|66057486|FG000|Overall Study|Withdrawn by investigator|1|||
23637471|NCT02224703|66057487|FG001|Overall Study|Withdrawn by investigator|0|||
23637472|NCT02224703|66057488|FG002|Overall Study|Withdrawn by investigator|0|||
23637473|NCT02224703|66057486|FG000|Overall Study|Advised by medical monitor|1|||
23637474|NCT02224703|66057487|FG001|Overall Study|Advised by medical monitor|0|||
23637475|NCT02224703|66057488|FG002|Overall Study|Advised by medical monitor|0|||
23637476|NCT02224703|66057486|FG000|Overall Study|Withdrawn by parent/guardian|0|||
23637477|NCT02224703|66057487|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23637478|NCT02224703|66057488|FG002|Overall Study|Withdrawn by parent/guardian|0|||
23637479|NCT02224703|66057486|FG000|Overall Study|Lack of Efficacy|1|||
23637480|NCT02224703|66057487|FG001|Overall Study|Lack of Efficacy|0|||
23637481|NCT02224703|66057488|FG002|Overall Study|Lack of Efficacy|0|||
23637482|NCT02476175|66057492|FG000|Overall Study|Adverse Event|2|||
23637483|NCT00902746|66057493|FG000|Overall Study|Protocol Violation|7|||
23637484|NCT00902746|66057493|FG000|Overall Study|Withdrawal by Subject|16|||
23784566|NCT01609257|66590320|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
23784567|NCT01609257|66590319|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
23784568|NCT01609257|66590320|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
23784569|NCT00838539|66590321|FG000|Overall Study|Disease Progression|2|||
23784570|NCT00838539|66590322|FG001|Overall Study|Disease Progression|4|||
23637485|NCT00902746|66057493|FG000|Overall Study|Adverse Event|8|||
23637486|NCT00902746|66057493|FG000|Overall Study|Lost to Follow-up|3|||
23637487|NCT00902746|66057493|FG000|Overall Study|Physician Decision|2|||
23637488|NCT03596762|66057494|FG000|Overall Study|Protocol Violation|0|||
23637489|NCT03596762|66057495|FG001|Overall Study|Protocol Violation|0|||
23637490|NCT03596762|66057496|FG002|Overall Study|Protocol Violation|0|||
23637491|NCT03596762|66057497|FG003|Overall Study|Protocol Violation|0|||
23637492|NCT03596762|66057498|FG004|Overall Study|Protocol Violation|1|||
23637493|NCT03596762|66057494|FG000|Overall Study|Adverse Event|2|||
23637494|NCT03596762|66057495|FG001|Overall Study|Adverse Event|0|||
23637495|NCT03596762|66057496|FG002|Overall Study|Adverse Event|1|||
23344325|NCT01647516|65003791|FG003|Open-Label Period|Pregnancy|0|||
23344326|NCT01647516|65003792|FG004|Open-Label Period|Pregnancy|0|||
23344327|NCT01647516|65003793|FG005|Open-Label Period|Pregnancy|1|||
23344328|NCT01647516|65003788|FG000|Open-Label Period|Non-compliance|0|||
23344329|NCT01647516|65003789|FG001|Open-Label Period|Non-compliance|0|||
23344330|NCT01647516|65003790|FG002|Open-Label Period|Non-compliance|0|||
23344331|NCT01647516|65003791|FG003|Open-Label Period|Non-compliance|1|||
23344332|NCT01647516|65003792|FG004|Open-Label Period|Non-compliance|0|||
23344333|NCT01647516|65003793|FG005|Open-Label Period|Non-compliance|1|||
23344334|NCT01647516|65003788|FG000|Open-Label Period|Physician Decision|0|||
23344335|NCT01647516|65003789|FG001|Open-Label Period|Physician Decision|0|||
23344336|NCT01647516|65003790|FG002|Open-Label Period|Physician Decision|0|||
23344337|NCT01647516|65003791|FG003|Open-Label Period|Physician Decision|1|||
23344338|NCT01647516|65003792|FG004|Open-Label Period|Physician Decision|1|||
23344339|NCT01647516|65003793|FG005|Open-Label Period|Physician Decision|0|||
23344340|NCT01647516|65003788|FG000|Open-Label Period|Withdrawal by Subject|0|||
23344341|NCT01647516|65003789|FG001|Open-Label Period|Withdrawal by Subject|0|||
23344342|NCT01647516|65003790|FG002|Open-Label Period|Withdrawal by Subject|0|||
23344343|NCT01647516|65003791|FG003|Open-Label Period|Withdrawal by Subject|9|||
23344344|NCT01647516|65003792|FG004|Open-Label Period|Withdrawal by Subject|11|||
23344345|NCT01647516|65003793|FG005|Open-Label Period|Withdrawal by Subject|6|||
23344346|NCT01647516|65003788|FG000|Open-Label Period|Lost to Follow-up|0|||
23344347|NCT01647516|65003789|FG001|Open-Label Period|Lost to Follow-up|0|||
23344348|NCT01647516|65003790|FG002|Open-Label Period|Lost to Follow-up|0|||
23344349|NCT01647516|65003791|FG003|Open-Label Period|Lost to Follow-up|1|||
23344350|NCT01647516|65003792|FG004|Open-Label Period|Lost to Follow-up|0|||
23344351|NCT01647516|65003793|FG005|Open-Label Period|Lost to Follow-up|1|||
23344352|NCT01647516|65003788|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344353|NCT01647516|65003789|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344354|NCT01647516|65003790|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344355|NCT01647516|65003791|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
23344356|NCT01647516|65003792|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
23344357|NCT01647516|65003793|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
23344358|NCT01647516|65003788|FG000|Open-Label Period|Lack of Efficacy|0|||
23344359|NCT01647516|65003789|FG001|Open-Label Period|Lack of Efficacy|0|||
23344360|NCT01647516|65003790|FG002|Open-Label Period|Lack of Efficacy|0|||
23344361|NCT01647516|65003791|FG003|Open-Label Period|Lack of Efficacy|7|||
23344362|NCT01647516|65003792|FG004|Open-Label Period|Lack of Efficacy|9|||
23344363|NCT01647516|65003793|FG005|Open-Label Period|Lack of Efficacy|10|||
23344364|NCT01647516|65003788|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344365|NCT01647516|65003789|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344366|NCT01647516|65003790|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344367|NCT01647516|65003791|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
23344368|NCT01647516|65003792|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
23344369|NCT01647516|65003793|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
23344370|NCT01647516|65003788|FG000|Open-Label Period|No completion / discontinuation visit|0|||
23344371|NCT01647516|65003789|FG001|Open-Label Period|No completion / discontinuation visit|0|||
23344372|NCT01647516|65003790|FG002|Open-Label Period|No completion / discontinuation visit|0|||
23344373|NCT01647516|65003791|FG003|Open-Label Period|No completion / discontinuation visit|0|||
23344374|NCT01647516|65003792|FG004|Open-Label Period|No completion / discontinuation visit|2|||
23344375|NCT01647516|65003793|FG005|Open-Label Period|No completion / discontinuation visit|1|||
23344376|NCT00189306|65003798|FG000|Treatment Period|Withdrawal by Subject|2|||
23344377|NCT00189306|65003798|FG000|Treatment Period|Adverse Event|2|||
23344378|NCT00189306|65003798|FG000|Treatment Period|Protocol Violation|1|||
23344379|NCT00189306|65003798|FG000|Posttreatment Period|Death|1|||
23344380|NCT00189306|65003798|FG000|Posttreatment Period|Withdrawal by Subject|2|||
23344381|NCT00189306|65003798|FG000|Posttreatment Period|Noncompliance|1|||
23344382|NCT00189306|65003798|FG000|Posttreatment Period|Target lesion excised|1|||
23344383|NCT00189306|65003798|FG000|Posttreatment Period|Protocol Violation|1|||
23344384|NCT00189306|65003798|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
23344385|NCT00189306|65003798|FG000|Posttreatment Period|Local skin reaction/sign|1|||
23344386|NCT00189306|65003798|FG000|Long-Term Follow-up|Adverse Event|2|||
23344387|NCT00189306|65003798|FG000|Long-Term Follow-up|Death|4|||
23344388|NCT00189306|65003798|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
23344389|NCT00189306|65003798|FG000|Long-Term Follow-up|Intercurrent disease|2|||
23344390|NCT00189306|65003798|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
23344391|NCT00189306|65003798|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
23344392|NCT02889835|65003799|FG000|Overall Study|Lost to Follow-up|13|||
23344393|NCT02889835|65003800|FG001|Overall Study|Lost to Follow-up|13|||
23344394|NCT02889835|65003801|FG002|Overall Study|Lost to Follow-up|13|||
23344395|NCT02889835|65003799|FG000|Overall Study|Withdrawal by Subject|2|||
23344396|NCT02889835|65003800|FG001|Overall Study|Withdrawal by Subject|2|||
23344397|NCT02889835|65003801|FG002|Overall Study|Withdrawal by Subject|2|||
23784571|NCT00838539|66590323|FG002|Overall Study|Disease Progression|3|||
23784572|NCT00838539|66590324|FG003|Overall Study|Disease Progression|2|||
23784573|NCT00838539|66590325|FG004|Overall Study|Disease Progression|4|||
23784574|NCT00838539|66590326|FG005|Overall Study|Disease Progression|2|||
23784575|NCT00838539|66590327|FG006|Overall Study|Disease Progression|3|||
23784576|NCT00838539|66590328|FG007|Overall Study|Disease Progression|4|||
23784577|NCT00838539|66590329|FG008|Overall Study|Disease Progression|4|||
23784578|NCT00838539|66590330|FG009|Overall Study|Disease Progression|5|||
23784579|NCT00838539|66590331|FG010|Overall Study|Disease Progression|1|||
23784580|NCT00838539|66590332|FG011|Overall Study|Disease Progression|4|||
23784581|NCT00838539|66590321|FG000|Overall Study|Adverse Event|1|||
23784582|NCT00838539|66590322|FG001|Overall Study|Adverse Event|1|||
23784583|NCT00838539|66590323|FG002|Overall Study|Adverse Event|1|||
23784584|NCT00838539|66590324|FG003|Overall Study|Adverse Event|1|||
23784585|NCT00838539|66590325|FG004|Overall Study|Adverse Event|2|||
23784586|NCT00838539|66590326|FG005|Overall Study|Adverse Event|1|||
23784587|NCT00838539|66590327|FG006|Overall Study|Adverse Event|0|||
23784588|NCT00838539|66590328|FG007|Overall Study|Adverse Event|2|||
23784589|NCT00838539|66590329|FG008|Overall Study|Adverse Event|0|||
23784590|NCT00838539|66590330|FG009|Overall Study|Adverse Event|1|||
23784591|NCT00838539|66590331|FG010|Overall Study|Adverse Event|2|||
23456036|NCT04349891|65412870|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
23456037|NCT04349891|65412871|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
23456038|NCT04349891|65412870|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
23784592|NCT00838539|66590332|FG011|Overall Study|Adverse Event|0|||
23456039|NCT04349891|65412871|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
23456040|NCT03624881|65412877|FG000|Overall Study|Screen Failure|14|||
23456041|NCT03624881|65412878|FG001|Overall Study|Screen Failure|0|||
23456042|NCT03624881|65412877|FG000|Overall Study|No Catheter Inserted|6|||
23456043|NCT03624881|65412878|FG001|Overall Study|No Catheter Inserted|1|||
23456044|NCT03624881|65412877|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
23456045|NCT03624881|65412878|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
23456046|NCT03624881|65412877|FG000|Overall Study|Death|2|||
23456047|NCT03624881|65412878|FG001|Overall Study|Death|0|||
23456048|NCT03624881|65412877|FG000|Overall Study|Lost to Follow-up|10|||
23456049|NCT03624881|65412878|FG001|Overall Study|Lost to Follow-up|4|||
23456050|NCT03624881|65412877|FG000|Overall Study|Withdrawal by Subject|12|||
23456051|NCT03624881|65412878|FG001|Overall Study|Withdrawal by Subject|1|||
23456052|NCT00152503|65412879|FG000|Overall Study|Adverse Event|4|||
23456053|NCT01126749|65412880|FG000|Phase 1b|Other|0|||
23456054|NCT01126749|65412881|FG001|Phase 1b|Other|1|||
23456055|NCT01126749|65412882|FG002|Phase 1b|Other|0|||
23456056|NCT01126749|65412883|FG003|Phase 1b|Other|0|||
23456057|NCT01126749|65412880|FG000|Phase 1b|Withdrawal by Subject|0|||
23456058|NCT01126749|65412881|FG001|Phase 1b|Withdrawal by Subject|1|||
23784593|NCT00838539|66590321|FG000|Overall Study|Withdrawal by Subject|0|||
23784594|NCT00838539|66590322|FG001|Overall Study|Withdrawal by Subject|1|||
23784595|NCT00838539|66590323|FG002|Overall Study|Withdrawal by Subject|0|||
23784596|NCT00838539|66590324|FG003|Overall Study|Withdrawal by Subject|0|||
23784597|NCT00838539|66590325|FG004|Overall Study|Withdrawal by Subject|0|||
23784598|NCT00838539|66590326|FG005|Overall Study|Withdrawal by Subject|0|||
23784599|NCT00838539|66590327|FG006|Overall Study|Withdrawal by Subject|0|||
23784600|NCT00838539|66590328|FG007|Overall Study|Withdrawal by Subject|0|||
23784601|NCT00838539|66590329|FG008|Overall Study|Withdrawal by Subject|0|||
23784602|NCT00838539|66590330|FG009|Overall Study|Withdrawal by Subject|1|||
23784603|NCT00838539|66590331|FG010|Overall Study|Withdrawal by Subject|2|||
23784604|NCT00838539|66590332|FG011|Overall Study|Withdrawal by Subject|0|||
23784605|NCT00838539|66590321|FG000|Overall Study|Death|0|||
23784606|NCT00838539|66590322|FG001|Overall Study|Death|0|||
23344398|NCT02889835|65003799|FG000|Overall Study|Protocol Violation|1|||
23344399|NCT02889835|65003800|FG001|Overall Study|Protocol Violation|1|||
23344400|NCT02889835|65003801|FG002|Overall Study|Protocol Violation|1|||
23344401|NCT02889835|65003799|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
23344402|NCT02889835|65003800|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
23344403|NCT02889835|65003801|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
23344404|NCT02889835|65003799|FG000|Overall Study|Death|1|||
23344405|NCT02889835|65003800|FG001|Overall Study|Death|1|||
23344406|NCT02889835|65003801|FG002|Overall Study|Death|1|||
23344407|NCT03652636|65003802|FG000|Overall Study|Withdrawal by Subject|7|||
23344408|NCT01546168|65003803|FG000|Overall Study|Lost to Follow-up|1|||
23344409|NCT01546168|65003804|FG001|Overall Study|Lost to Follow-up|0|||
23344410|NCT01546168|65003803|FG000|Overall Study|Withdrawal by Subject|1|||
23344411|NCT01546168|65003804|FG001|Overall Study|Withdrawal by Subject|0|||
23344412|NCT01546168|65003803|FG000|Overall Study|ineligible after signing consent|2|||
23344413|NCT01546168|65003804|FG001|Overall Study|ineligible after signing consent|0|||
23344414|NCT00336024|65003808|FG000|Overall Study|Death|2|||
23344415|NCT00336024|65003809|FG001|Overall Study|Death|1|||
23344416|NCT00336024|65003808|FG000|Overall Study|Physician Decision|4|||
23344417|NCT00336024|65003809|FG001|Overall Study|Physician Decision|1|||
23344418|NCT00336024|65003808|FG000|Overall Study|Protocol Violation|1|||
23344419|NCT00336024|65003809|FG001|Overall Study|Protocol Violation|0|||
23344420|NCT00336024|65003808|FG000|Overall Study|Withdrawal by Subject|1|||
23344421|NCT00336024|65003809|FG001|Overall Study|Withdrawal by Subject|2|||
23344422|NCT00336024|65003808|FG000|Overall Study|Failure to fulfill consolidation|1|||
23344423|NCT00336024|65003809|FG001|Overall Study|Failure to fulfill consolidation|1|||
23344424|NCT00336024|65003808|FG000|Overall Study|Progressive Disease|4|||
23344425|NCT00336024|65003809|FG001|Overall Study|Progressive Disease|7|||
23344426|NCT00336024|65003808|FG000|Overall Study|Ineligible|7|||
23344427|NCT00336024|65003809|FG001|Overall Study|Ineligible|7|||
23344428|NCT01831596|65003810|FG000|Overall Study|Other|8|||
23344429|NCT01328548|65003815|FG000|Overall Study|Death|3|||
23344430|NCT01328548|65003816|FG001|Overall Study|Death|0|||
23344431|NCT01328548|65003815|FG000|Overall Study|Protocol Violation|1|||
23344432|NCT01328548|65003816|FG001|Overall Study|Protocol Violation|0|||
23344433|NCT02089334|65003821|FG000|Overall Study|Withdrawal by Subject|0|||
23344434|NCT02089334|65003822|FG001|Overall Study|Withdrawal by Subject|0|||
23344435|NCT02089334|65003823|FG002|Overall Study|Withdrawal by Subject|0|||
23344436|NCT02089334|65003824|FG003|Overall Study|Withdrawal by Subject|2|||
23344437|NCT02089334|65003821|FG000|Overall Study|Adverse Event|0|||
23344438|NCT02089334|65003822|FG001|Overall Study|Adverse Event|0|||
23344439|NCT02089334|65003823|FG002|Overall Study|Adverse Event|0|||
23344440|NCT02089334|65003824|FG003|Overall Study|Adverse Event|2|||
23344441|NCT02089334|65003821|FG000|Overall Study|Progressive disease|0|||
23344442|NCT02089334|65003822|FG001|Overall Study|Progressive disease|0|||
23344443|NCT02089334|65003823|FG002|Overall Study|Progressive disease|0|||
23344444|NCT02089334|65003824|FG003|Overall Study|Progressive disease|2|||
23344445|NCT02089334|65003821|FG000|Overall Study|Physician Decision|0|||
23344446|NCT02089334|65003822|FG001|Overall Study|Physician Decision|0|||
23344447|NCT02089334|65003823|FG002|Overall Study|Physician Decision|1|||
23344448|NCT02089334|65003824|FG003|Overall Study|Physician Decision|1|||
23344449|NCT04253782|65003825|FG000|Overall Study|Death|2|||
23344450|NCT04253782|65003826|FG001|Overall Study|Death|0|||
23344451|NCT02344290|65003827|FG000|Overall Study|Withdrawal by Subject|315|||
23344452|NCT02344290|65003828|FG001|Overall Study|Withdrawal by Subject|324|||
23344453|NCT02344290|65003827|FG000|Overall Study|Lost to Follow-up|258|||
23784607|NCT00838539|66590323|FG002|Overall Study|Death|0|||
23784608|NCT00838539|66590324|FG003|Overall Study|Death|0|||
23344454|NCT02344290|65003828|FG001|Overall Study|Lost to Follow-up|249|||
23784609|NCT00838539|66590325|FG004|Overall Study|Death|0|||
23784610|NCT00838539|66590326|FG005|Overall Study|Death|0|||
23784611|NCT00838539|66590327|FG006|Overall Study|Death|1|||
23784612|NCT00838539|66590328|FG007|Overall Study|Death|0|||
23784613|NCT00838539|66590329|FG008|Overall Study|Death|0|||
23784614|NCT00838539|66590330|FG009|Overall Study|Death|0|||
23784615|NCT00838539|66590331|FG010|Overall Study|Death|0|||
23784616|NCT00838539|66590332|FG011|Overall Study|Death|0|||
23784617|NCT00838539|66590321|FG000|Overall Study|Physician Decision|0|||
23784618|NCT00838539|66590322|FG001|Overall Study|Physician Decision|0|||
23784619|NCT00838539|66590323|FG002|Overall Study|Physician Decision|0|||
23784620|NCT00838539|66590324|FG003|Overall Study|Physician Decision|0|||
23344455|NCT02344290|65003827|FG000|Overall Study|Unable to get to clinic|69|||
23344456|NCT02344290|65003828|FG001|Overall Study|Unable to get to clinic|60|||
23344457|NCT02344290|65003827|FG000|Overall Study|Physician Decision|25|||
23344458|NCT02344290|65003828|FG001|Overall Study|Physician Decision|25|||
23344459|NCT02344290|65003827|FG000|Overall Study|Site Closure|15|||
23784621|NCT00838539|66590325|FG004|Overall Study|Physician Decision|0|||
23784622|NCT00838539|66590326|FG005|Overall Study|Physician Decision|0|||
23784623|NCT00838539|66590327|FG006|Overall Study|Physician Decision|0|||
23344460|NCT02344290|65003828|FG001|Overall Study|Site Closure|19|||
23344461|NCT02344290|65003827|FG000|Overall Study|Other|5|||
23344462|NCT02344290|65003828|FG001|Overall Study|Other|3|||
23344463|NCT01258075|65003832|FG000|Overall Study|Adverse Event|8|||
23456059|NCT01126749|65412882|FG002|Phase 1b|Withdrawal by Subject|0|||
23456060|NCT01126749|65412883|FG003|Phase 1b|Withdrawal by Subject|0|||
23456061|NCT01126749|65412880|FG000|Phase 1b|Death|3|||
23784624|NCT00838539|66590328|FG007|Overall Study|Physician Decision|0|||
23784625|NCT00838539|66590329|FG008|Overall Study|Physician Decision|1|||
23784626|NCT00838539|66590330|FG009|Overall Study|Physician Decision|0|||
23344464|NCT01258075|65003833|FG001|Overall Study|Adverse Event|3|||
23344465|NCT01258075|65003832|FG000|Overall Study|Lost to Follow-up|11|||
23344466|NCT01258075|65003833|FG001|Overall Study|Lost to Follow-up|6|||
23344467|NCT01258075|65003832|FG000|Overall Study|Withdrawal by Subject|10|||
23344468|NCT01258075|65003833|FG001|Overall Study|Withdrawal by Subject|7|||
23344469|NCT01258075|65003832|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
23344470|NCT01258075|65003833|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
23344471|NCT01258075|65003832|FG000|Overall Study|Other|12|||
23344472|NCT01258075|65003833|FG001|Overall Study|Other|5|||
23344473|NCT04489381|65003834|FG000|Overall Study|Lost to Follow-up|2|||
23344474|NCT04489381|65003835|FG001|Overall Study|Lost to Follow-up|3|||
23344475|NCT04489381|65003834|FG000|Overall Study|Withdrawal by Subject|1|||
23344476|NCT04489381|65003835|FG001|Overall Study|Withdrawal by Subject|0|||
23344477|NCT05323994|65003836|FG000|Overall Study|Protocol Violation|1|||
23344478|NCT04683939|65003838|FG000|Overall Study|Study termination by the sponsor|0|||
23456062|NCT01126749|65412881|FG001|Phase 1b|Death|4|||
23456063|NCT01126749|65412882|FG002|Phase 1b|Death|0|||
23456064|NCT01126749|65412883|FG003|Phase 1b|Death|0|||
23456065|NCT01126749|65412880|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
23456066|NCT01126749|65412881|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
23456067|NCT01126749|65412882|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
23637496|NCT03596762|66057497|FG003|Overall Study|Adverse Event|0|||
23637497|NCT03596762|66057498|FG004|Overall Study|Adverse Event|5|||
23637498|NCT03596762|66057494|FG000|Overall Study|Withdrawal by Subject|2|||
23637499|NCT03596762|66057495|FG001|Overall Study|Withdrawal by Subject|1|||
23637500|NCT03596762|66057496|FG002|Overall Study|Withdrawal by Subject|0|||
23637501|NCT03596762|66057497|FG003|Overall Study|Withdrawal by Subject|1|||
23637502|NCT03596762|66057498|FG004|Overall Study|Withdrawal by Subject|1|||
23637503|NCT00357110|66057499|FG000|Overall Study|Early study termination|5|||
23637504|NCT00357110|66057500|FG001|Overall Study|Early study termination|5|||
23637505|NCT02460575|66057505|FG000|Overall Study|Lost to Follow-up|1|||
23637506|NCT02460575|66057506|FG001|Overall Study|Lost to Follow-up|0|||
23637507|NCT00368927|66057507|FG000|Overall Study|Lost to Follow-up|2|||
23637508|NCT00368927|66057508|FG001|Overall Study|Lost to Follow-up|0|||
23344479|NCT04683939|65003839|FG001|Overall Study|Study termination by the sponsor|1|||
23456068|NCT01126749|65412883|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
23456069|NCT01126749|65412880|FG000|Phase 2|Study Termination by Sponsor|0|||
23456070|NCT01126749|65412881|FG001|Phase 2|Study Termination by Sponsor|0|||
23456071|NCT01126749|65412882|FG002|Phase 2|Study Termination by Sponsor|12|||
23456072|NCT01126749|65412883|FG003|Phase 2|Study Termination by Sponsor|6|||
23456073|NCT01126749|65412880|FG000|Phase 2|Other|0|||
23456074|NCT01126749|65412881|FG001|Phase 2|Other|0|||
23456075|NCT01126749|65412882|FG002|Phase 2|Other|4|||
23456076|NCT01126749|65412883|FG003|Phase 2|Other|2|||
23456077|NCT01126749|65412880|FG000|Phase 2|Withdrawal by Subject|0|||
23456078|NCT01126749|65412881|FG001|Phase 2|Withdrawal by Subject|0|||
23456079|NCT01126749|65412882|FG002|Phase 2|Withdrawal by Subject|0|||
23456080|NCT01126749|65412883|FG003|Phase 2|Withdrawal by Subject|2|||
23456081|NCT01126749|65412880|FG000|Phase 2|Lost to Follow-up|0|||
23456082|NCT01126749|65412881|FG001|Phase 2|Lost to Follow-up|0|||
23456083|NCT01126749|65412882|FG002|Phase 2|Lost to Follow-up|0|||
23456084|NCT01126749|65412883|FG003|Phase 2|Lost to Follow-up|1|||
23456085|NCT01126749|65412880|FG000|Phase 2|Death|0|||
23456086|NCT01126749|65412881|FG001|Phase 2|Death|0|||
23456087|NCT01126749|65412882|FG002|Phase 2|Death|22|||
23456088|NCT01126749|65412883|FG003|Phase 2|Death|22|||
23456089|NCT01126749|65412880|FG000|Phase 2|Adverse Event|0|||
23456090|NCT01126749|65412881|FG001|Phase 2|Adverse Event|0|||
23456091|NCT01126749|65412882|FG002|Phase 2|Adverse Event|0|||
23456092|NCT01126749|65412883|FG003|Phase 2|Adverse Event|1|||
23456093|NCT03737123|65412884|FG000|Study Treatment|Adverse Event|2|||
23456094|NCT03737123|65412885|FG001|Study Treatment|Adverse Event|0|||
23456095|NCT03737123|65412884|FG000|Study Treatment|Disease Progression|2|||
23456096|NCT03737123|65412885|FG001|Study Treatment|Disease Progression|0|||
23456097|NCT03737123|65412884|FG000|Study Treatment|Withdrawal by Subject|2|||
23456098|NCT03737123|65412885|FG001|Study Treatment|Withdrawal by Subject|0|||
23456099|NCT03737123|65412884|FG000|Follow up|Death|1|||
23637509|NCT00368927|66057507|FG000|Overall Study|Adverse Event|1|||
23637510|NCT00368927|66057508|FG001|Overall Study|Adverse Event|1|||
23637511|NCT00368927|66057507|FG000|Overall Study|Withdrawal by Subject|1|||
23344480|NCT04683939|65003840|FG002|Overall Study|Study termination by the sponsor|2|||
23456100|NCT03737123|65412885|FG001|Follow up|Death|0|||
23344481|NCT04683939|65003841|FG003|Overall Study|Study termination by the sponsor|2|||
23456101|NCT03737123|65412884|FG000|Follow up|Withdrawal by Subject|1|||
23456102|NCT03737123|65412885|FG001|Follow up|Withdrawal by Subject|0|||
23456103|NCT03737123|65412884|FG000|Follow up|Termination of study|4|||
23456104|NCT03737123|65412885|FG001|Follow up|Termination of study|0|||
23637512|NCT00368927|66057508|FG001|Overall Study|Withdrawal by Subject|2|||
23637513|NCT00368927|66057507|FG000|Overall Study|Physician Decision|1|||
23637514|NCT00368927|66057508|FG001|Overall Study|Physician Decision|0|||
23784627|NCT00838539|66590331|FG010|Overall Study|Physician Decision|0|||
23784628|NCT00838539|66590332|FG011|Overall Study|Physician Decision|0|||
23784629|NCT00838539|66590321|FG000|Overall Study|Clinical Progression|0|||
23784630|NCT00838539|66590322|FG001|Overall Study|Clinical Progression|0|||
23784631|NCT00838539|66590323|FG002|Overall Study|Clinical Progression|0|||
23784632|NCT00838539|66590324|FG003|Overall Study|Clinical Progression|0|||
23784633|NCT00838539|66590325|FG004|Overall Study|Clinical Progression|0|||
23784634|NCT00838539|66590326|FG005|Overall Study|Clinical Progression|0|||
23784635|NCT00838539|66590327|FG006|Overall Study|Clinical Progression|1|||
23784636|NCT00838539|66590328|FG007|Overall Study|Clinical Progression|0|||
23784637|NCT00838539|66590329|FG008|Overall Study|Clinical Progression|0|||
23784638|NCT00838539|66590330|FG009|Overall Study|Clinical Progression|0|||
23784639|NCT00838539|66590331|FG010|Overall Study|Clinical Progression|0|||
23784640|NCT00838539|66590332|FG011|Overall Study|Clinical Progression|0|||
23784641|NCT00838539|66590321|FG000|Overall Study|Symptomatic Deterioration|0|||
23784642|NCT00838539|66590322|FG001|Overall Study|Symptomatic Deterioration|0|||
23784643|NCT00838539|66590323|FG002|Overall Study|Symptomatic Deterioration|1|||
23784644|NCT00838539|66590324|FG003|Overall Study|Symptomatic Deterioration|1|||
23784645|NCT00838539|66590325|FG004|Overall Study|Symptomatic Deterioration|0|||
23344482|NCT04683939|65003838|FG000|Overall Study|Death|1|||
23344483|NCT04683939|65003839|FG001|Overall Study|Death|1|||
23344484|NCT04683939|65003840|FG002|Overall Study|Death|2|||
23344485|NCT04683939|65003841|FG003|Overall Study|Death|1|||
23344486|NCT04683939|65003838|FG000|Overall Study|Withdrawal by Subject|1|||
23344487|NCT04683939|65003839|FG001|Overall Study|Withdrawal by Subject|0|||
23344488|NCT04683939|65003840|FG002|Overall Study|Withdrawal by Subject|0|||
23637515|NCT02229851|66057513|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
23637516|NCT02229851|66057514|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
23637517|NCT02229851|66057515|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
23637518|NCT02229851|66057516|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
23637519|NCT02229851|66057517|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
23637520|NCT02229851|66057518|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
23637521|NCT02229851|66057519|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
23637522|NCT02229851|66057513|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23637523|NCT02229851|66057514|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
23637524|NCT02229851|66057515|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23637525|NCT02229851|66057516|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23637526|NCT02229851|66057517|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23784646|NCT00838539|66590326|FG005|Overall Study|Symptomatic Deterioration|1|||
23784647|NCT00838539|66590327|FG006|Overall Study|Symptomatic Deterioration|0|||
23784648|NCT00838539|66590328|FG007|Overall Study|Symptomatic Deterioration|0|||
23784649|NCT00838539|66590329|FG008|Overall Study|Symptomatic Deterioration|0|||
23344489|NCT04683939|65003841|FG003|Overall Study|Withdrawal by Subject|0|||
23583337|NCT01311713|65866002|FG006|Overall Study|Lost to Follow-up|0|||
23784650|NCT00838539|66590330|FG009|Overall Study|Symptomatic Deterioration|1|||
23784651|NCT00838539|66590331|FG010|Overall Study|Symptomatic Deterioration|0|||
23344490|NCT04683939|65003838|FG000|Overall Study|Physician Decision|1|||
23344491|NCT04683939|65003839|FG001|Overall Study|Physician Decision|0|||
23344492|NCT04683939|65003840|FG002|Overall Study|Physician Decision|0|||
23583338|NCT01311713|65865996|FG000|Overall Study|Stopped taking study medication|0|||
23583339|NCT01311713|65865997|FG001|Overall Study|Stopped taking study medication|0|||
23583340|NCT01311713|65865998|FG002|Overall Study|Stopped taking study medication|0|||
23583341|NCT01311713|65865999|FG003|Overall Study|Stopped taking study medication|1|||
23583342|NCT01311713|65866000|FG004|Overall Study|Stopped taking study medication|1|||
23583343|NCT01311713|65866001|FG005|Overall Study|Stopped taking study medication|0|||
23583344|NCT01311713|65866002|FG006|Overall Study|Stopped taking study medication|0|||
23583345|NCT01311713|65865996|FG000|Overall Study|Enrolled but not treated|0|||
23583346|NCT01311713|65865997|FG001|Overall Study|Enrolled but not treated|0|||
23583347|NCT01311713|65865998|FG002|Overall Study|Enrolled but not treated|1|||
23583348|NCT01311713|65865999|FG003|Overall Study|Enrolled but not treated|0|||
23583349|NCT01311713|65866000|FG004|Overall Study|Enrolled but not treated|0|||
23583350|NCT01311713|65866001|FG005|Overall Study|Enrolled but not treated|0|||
23583351|NCT01311713|65866002|FG006|Overall Study|Enrolled but not treated|0|||
23583352|NCT01311713|65865996|FG000|Overall Study|Other than specified|0|||
23583353|NCT01311713|65865997|FG001|Overall Study|Other than specified|1|||
23583354|NCT01311713|65865998|FG002|Overall Study|Other than specified|2|||
23637527|NCT02229851|66057518|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23637528|NCT02229851|66057519|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23637529|NCT02229851|66057513|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
23637530|NCT02229851|66057514|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
23637531|NCT02229851|66057515|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
23637532|NCT02229851|66057516|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23637533|NCT02229851|66057517|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23637534|NCT02229851|66057518|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23637535|NCT02229851|66057519|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23637536|NCT02229851|66057513|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637537|NCT02229851|66057514|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637538|NCT02229851|66057515|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
23583355|NCT01311713|65865999|FG003|Overall Study|Other than specified|0|||
23583356|NCT01311713|65866000|FG004|Overall Study|Other than specified|0|||
23583357|NCT01311713|65866001|FG005|Overall Study|Other than specified|0|||
23583358|NCT01311713|65866002|FG006|Overall Study|Other than specified|0|||
23583359|NCT02027935|65866005|FG000|Overall Study|Death|1|||
23583360|NCT02027935|65866005|FG000|Overall Study|Lack of Efficacy|5|||
23583361|NCT02027935|65866005|FG000|Overall Study|Study Closure|1|||
23583362|NCT02711826|65866008|FG000|Overall Study|Physician Decision|0|||
23583363|NCT02711826|65866009|FG001|Overall Study|Physician Decision|0|||
23583364|NCT02711826|65866010|FG002|Overall Study|Physician Decision|0|||
23583365|NCT02711826|65866011|FG003|Overall Study|Physician Decision|1|||
23583366|NCT02711826|65866012|FG004|Overall Study|Physician Decision|0|||
23583367|NCT02711826|65866008|FG000|Overall Study|Withdrawal by Subject|0|||
23583368|NCT02711826|65866009|FG001|Overall Study|Withdrawal by Subject|1|||
23583369|NCT02711826|65866010|FG002|Overall Study|Withdrawal by Subject|0|||
23583370|NCT02711826|65866011|FG003|Overall Study|Withdrawal by Subject|4|||
23583371|NCT02711826|65866012|FG004|Overall Study|Withdrawal by Subject|0|||
23583372|NCT02711826|65866008|FG000|Overall Study|Failure to manufacture cellular product|0|||
23583373|NCT02711826|65866009|FG001|Overall Study|Failure to manufacture cellular product|0|||
23583374|NCT02711826|65866010|FG002|Overall Study|Failure to manufacture cellular product|5|||
23583375|NCT02711826|65866011|FG003|Overall Study|Failure to manufacture cellular product|0|||
23583376|NCT02711826|65866012|FG004|Overall Study|Failure to manufacture cellular product|0|||
23583377|NCT02711826|65866008|FG000|Overall Study|Infusion canceled for active infection|0|||
23583378|NCT02711826|65866009|FG001|Overall Study|Infusion canceled for active infection|1|||
23583379|NCT02711826|65866010|FG002|Overall Study|Infusion canceled for active infection|0|||
23583380|NCT02711826|65866011|FG003|Overall Study|Infusion canceled for active infection|0|||
23583381|NCT02711826|65866012|FG004|Overall Study|Infusion canceled for active infection|0|||
23583382|NCT02711826|65866008|FG000|Overall Study|Screen failures|0|||
23583383|NCT02711826|65866009|FG001|Overall Study|Screen failures|0|||
23583384|NCT02711826|65866010|FG002|Overall Study|Screen failures|0|||
23583385|NCT02711826|65866011|FG003|Overall Study|Screen failures|4|||
23583386|NCT02711826|65866012|FG004|Overall Study|Screen failures|0|||
23583387|NCT03681691|65866013|FG000|Overall Study|COVID|1|||
23583388|NCT03681691|65866014|FG001|Overall Study|COVID|0|||
23583389|NCT03681691|65866013|FG000|Overall Study|prolonged bleeding|1|||
23583390|NCT03681691|65866014|FG001|Overall Study|prolonged bleeding|0|||
23637539|NCT02229851|66057516|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637540|NCT02229851|66057517|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637541|NCT02229851|66057518|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637542|NCT02229851|66057519|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23637543|NCT02229851|66057513|FG000|Main Phase (Double-blind Phase)|Death|1|||
23637544|NCT02229851|66057514|FG001|Main Phase (Double-blind Phase)|Death|1|||
23637545|NCT02229851|66057515|FG002|Main Phase (Double-blind Phase)|Death|0|||
23637546|NCT02229851|66057516|FG003|Main Phase (Double-blind Phase)|Death|0|||
23637547|NCT02229851|66057517|FG004|Main Phase (Double-blind Phase)|Death|0|||
23637548|NCT02229851|66057518|FG005|Main Phase (Double-blind Phase)|Death|0|||
23637549|NCT02229851|66057519|FG006|Main Phase (Double-blind Phase)|Death|0|||
23637550|NCT02229851|66057513|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23637551|NCT02229851|66057514|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23637552|NCT02229851|66057515|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23637553|NCT02229851|66057516|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23637554|NCT02229851|66057517|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23637555|NCT02229851|66057518|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23637556|NCT02229851|66057519|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23637557|NCT02229851|66057513|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23637558|NCT02229851|66057514|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23637559|NCT02229851|66057515|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23637560|NCT02229851|66057516|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
23637561|NCT02229851|66057517|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
23637562|NCT02229851|66057518|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
23637563|NCT02229851|66057519|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
23637564|NCT02229851|66057513|FG000|Extension Phase (Open-label Phase)|Death|0|||
23637565|NCT02229851|66057514|FG001|Extension Phase (Open-label Phase)|Death|0|||
23637566|NCT02229851|66057515|FG002|Extension Phase (Open-label Phase)|Death|0|||
23637567|NCT02229851|66057516|FG003|Extension Phase (Open-label Phase)|Death|1|||
23637568|NCT02229851|66057517|FG004|Extension Phase (Open-label Phase)|Death|0|||
23637569|NCT02229851|66057518|FG005|Extension Phase (Open-label Phase)|Death|1|||
23637570|NCT02229851|66057519|FG006|Extension Phase (Open-label Phase)|Death|1|||
23637571|NCT00406692|66057520|FG000|Overall Study|Withdrawal by Subject|4|||
23637572|NCT00406692|66057520|FG000|Overall Study|Physician Decision|1|||
23637573|NCT00406692|66057520|FG000|Overall Study|Adverse Event|1|||
23637574|NCT00406692|66057520|FG000|Overall Study|Lack of Efficacy|1|||
23637575|NCT04076943|66057524|FG000|Overall Study|Withdrawal by Subject|12|||
23637576|NCT04076943|66057524|FG000|Overall Study|Adverse Event|1|||
23637577|NCT04076943|66057524|FG000|Overall Study|Progressive Disease|2|||
23637578|NCT04076943|66057524|FG000|Overall Study|Death|13|||
23637579|NCT04076943|66057524|FG000|Overall Study|Other than specified|6|||
23637580|NCT01075958|66057532|FG000|Overall Study|Blood sample could not be obtained|44|||
23637581|NCT01696045|66057537|FG000|Overall Study|Study drug toxicity|1|||
23637582|NCT01696045|66057538|FG001|Overall Study|Study drug toxicity|5|||
23637583|NCT01696045|66057537|FG000|Overall Study|Disease progression|2|||
23637584|NCT01696045|66057538|FG001|Overall Study|Disease progression|2|||
23637585|NCT04043143|66057539|FG000|Overall Study|Lost to Follow-up|5|||
23637586|NCT04043143|66057540|FG001|Overall Study|Lost to Follow-up|5|||
23637587|NCT04043143|66057539|FG000|Overall Study|screen failure|1|||
23637588|NCT04043143|66057540|FG001|Overall Study|screen failure|0|||
23637589|NCT02971761|66057545|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
23637590|NCT03772587|66057547|FG000|Overall Study|COVID-19|0|||
23637591|NCT03772587|66057548|FG001|Overall Study|COVID-19|0|||
23637592|NCT03772587|66057549|FG002|Overall Study|COVID-19|1|||
23637593|NCT03772587|66057550|FG003|Overall Study|COVID-19|1|||
23637594|NCT03772587|66057551|FG004|Overall Study|COVID-19|0|||
23784652|NCT00838539|66590332|FG011|Overall Study|Symptomatic Deterioration|0|||
23784653|NCT04852978|66590334|FG000|Overall Study|Physician Decision|0|||
23784654|NCT04852978|66590335|FG001|Overall Study|Physician Decision|1|||
23784655|NCT04852978|66590336|FG002|Overall Study|Physician Decision|0|||
23784656|NCT04852978|66590337|FG003|Overall Study|Physician Decision|0|||
23784657|NCT04852978|66590338|FG004|Overall Study|Physician Decision|0|||
23784658|NCT04852978|66590339|FG005|Overall Study|Physician Decision|0|||
23784659|NCT04852978|66590340|FG006|Overall Study|Physician Decision|0|||
23784660|NCT04852978|66590341|FG007|Overall Study|Physician Decision|2|||
23784661|NCT04852978|66590342|FG008|Overall Study|Physician Decision|0|||
23784662|NCT04852978|66590334|FG000|Overall Study|Sponsor request|0|||
23637595|NCT03772587|66057547|FG000|Overall Study|Withdrawal by Subject|1|||
23637596|NCT03772587|66057548|FG001|Overall Study|Withdrawal by Subject|0|||
23637597|NCT03772587|66057549|FG002|Overall Study|Withdrawal by Subject|0|||
23784663|NCT04852978|66590335|FG001|Overall Study|Sponsor request|0|||
23784664|NCT04852978|66590336|FG002|Overall Study|Sponsor request|1|||
23784665|NCT04852978|66590337|FG003|Overall Study|Sponsor request|0|||
23637598|NCT03772587|66057550|FG003|Overall Study|Withdrawal by Subject|0|||
23637599|NCT03772587|66057551|FG004|Overall Study|Withdrawal by Subject|0|||
23784666|NCT04852978|66590338|FG004|Overall Study|Sponsor request|0|||
23784667|NCT04852978|66590339|FG005|Overall Study|Sponsor request|0|||
23784668|NCT04852978|66590340|FG006|Overall Study|Sponsor request|0|||
23456105|NCT01690143|65412886|FG000|Overall Study|Withdrawal by Subject|1|||
23456106|NCT04065048|65412887|FG000|Overall Study|Withdrawal by Subject|1|||
23456107|NCT04065048|65412888|FG001|Overall Study|Withdrawal by Subject|2|||
23456108|NCT04065048|65412889|FG002|Overall Study|Withdrawal by Subject|1|||
23456109|NCT04065048|65412890|FG003|Overall Study|Withdrawal by Subject|1|||
23456110|NCT04065048|65412887|FG000|Overall Study|Adverse Event|1|||
23456111|NCT04065048|65412888|FG001|Overall Study|Adverse Event|0|||
23456112|NCT04065048|65412889|FG002|Overall Study|Adverse Event|1|||
23456113|NCT04065048|65412890|FG003|Overall Study|Adverse Event|0|||
23456114|NCT00374140|65412891|FG000|Overall Study|Lost to Follow-up|1|||
23456115|NCT00374140|65412891|FG000|Overall Study|Protocol Violation|1|||
23456116|NCT03796728|65412892|FG000|Overall Study|Lost to Follow-up|8|||
23456117|NCT03796728|65412892|FG000|Overall Study|Reason not Specified|16|||
23456118|NCT04515771|65412893|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
23456119|NCT04515771|65412894|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
23456120|NCT04515771|65412893|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
23456121|NCT04515771|65412894|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
23456122|NCT04515771|65412893|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
23456123|NCT04515771|65412894|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
23456124|NCT04097678|65412897|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
23456125|NCT04097678|65412898|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
23456126|NCT00878501|65412899|FG000|Overall Study|Adverse Event|11|||
23456127|NCT00878501|65412900|FG001|Overall Study|Adverse Event|3|||
23456128|NCT00878501|65412901|FG002|Overall Study|Adverse Event|3|||
23583391|NCT03681691|65866013|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
23583392|NCT03681691|65866014|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
23583393|NCT04886596|65866015|FG000|Overall Study|Adverse Event|73|||
23784669|NCT04852978|66590341|FG007|Overall Study|Sponsor request|0|||
23784670|NCT04852978|66590342|FG008|Overall Study|Sponsor request|0|||
23784671|NCT04852978|66590334|FG000|Overall Study|Death|0|||
23784672|NCT04852978|66590335|FG001|Overall Study|Death|0|||
23784673|NCT04852978|66590336|FG002|Overall Study|Death|0|||
23784674|NCT04852978|66590337|FG003|Overall Study|Death|0|||
23784675|NCT04852978|66590338|FG004|Overall Study|Death|0|||
23784676|NCT04852978|66590339|FG005|Overall Study|Death|0|||
23784677|NCT04852978|66590340|FG006|Overall Study|Death|1|||
23784678|NCT04852978|66590341|FG007|Overall Study|Death|0|||
23784679|NCT04852978|66590342|FG008|Overall Study|Death|0|||
23784680|NCT04852978|66590334|FG000|Overall Study|Lost to Follow-up|3|||
23784681|NCT04852978|66590335|FG001|Overall Study|Lost to Follow-up|2|||
23784682|NCT04852978|66590336|FG002|Overall Study|Lost to Follow-up|2|||
23784683|NCT04852978|66590337|FG003|Overall Study|Lost to Follow-up|0|||
23784684|NCT04852978|66590338|FG004|Overall Study|Lost to Follow-up|2|||
23784685|NCT04852978|66590339|FG005|Overall Study|Lost to Follow-up|4|||
23784686|NCT04852978|66590340|FG006|Overall Study|Lost to Follow-up|1|||
23583394|NCT04886596|65866016|FG001|Overall Study|Adverse Event|78|||
23583395|NCT04886596|65866015|FG000|Overall Study|Lost to Follow-up|104|||
23583396|NCT04886596|65866016|FG001|Overall Study|Lost to Follow-up|104|||
23583397|NCT04886596|65866015|FG000|Overall Study|Ongoing|12095|||
23583398|NCT04886596|65866016|FG001|Overall Study|Ongoing|12107|||
23784687|NCT04852978|66590341|FG007|Overall Study|Lost to Follow-up|2|||
23784688|NCT04852978|66590342|FG008|Overall Study|Lost to Follow-up|2|||
23784689|NCT04852978|66590334|FG000|Overall Study|Withdrawal by Subject|4|||
23784690|NCT04852978|66590335|FG001|Overall Study|Withdrawal by Subject|2|||
23784691|NCT04852978|66590336|FG002|Overall Study|Withdrawal by Subject|2|||
23637600|NCT00224887|66057552|FG000|Overall Study|Pregnancy|6|||
23637601|NCT00224887|66057553|FG001|Overall Study|Pregnancy|6|||
23637602|NCT02922023|66057563|FG000|Overall Study|Lost to Follow-up|2|||
23637603|NCT02922023|66057564|FG001|Overall Study|Lost to Follow-up|0|||
23637604|NCT02842151|66057565|FG000|Overall Study|Adverse Event|1|||
23637605|NCT02842151|66057565|FG000|Overall Study|Subject moved too far away|1|||
23637606|NCT03181789|66057566|FG000|Overall Study|Withdrawal by Subject|0|||
23637607|NCT03181789|66057567|FG001|Overall Study|Withdrawal by Subject|1|||
23637608|NCT03181789|66057568|FG002|Overall Study|Withdrawal by Subject|1|||
23637609|NCT03181789|66057569|FG003|Overall Study|Withdrawal by Subject|0|||
23637610|NCT03181789|66057566|FG000|Overall Study|Lost to Follow-up|7|||
23637611|NCT03181789|66057567|FG001|Overall Study|Lost to Follow-up|1|||
23637612|NCT03181789|66057568|FG002|Overall Study|Lost to Follow-up|0|||
23637613|NCT03181789|66057569|FG003|Overall Study|Lost to Follow-up|0|||
23637614|NCT03181789|66057566|FG000|Overall Study|Participant unable to adhere to visit|0|||
23637615|NCT03181789|66057567|FG001|Overall Study|Participant unable to adhere to visit|1|||
23637616|NCT03181789|66057568|FG002|Overall Study|Participant unable to adhere to visit|0|||
23637617|NCT03181789|66057569|FG003|Overall Study|Participant unable to adhere to visit|0|||
23637618|NCT04546217|66057575|FG000|Overall Study|Withdrawal by Subject|2|||
23637619|NCT04546217|66057576|FG001|Overall Study|Withdrawal by Subject|0|||
23637620|NCT04546217|66057575|FG000|Overall Study|Uncontrolled hypertension|1|||
23637621|NCT04546217|66057576|FG001|Overall Study|Uncontrolled hypertension|0|||
23637622|NCT00128102|66057577|FG000|Overall Study|Site Discontinued|3|||
23637623|NCT00128102|66057578|FG001|Overall Study|Site Discontinued|6|||
23637624|NCT00128102|66057577|FG000|Overall Study|Other|0|||
23637625|NCT00128102|66057578|FG001|Overall Study|Other|1|||
23637626|NCT00128102|66057577|FG000|Overall Study|Progressive Disease|255|||
23637627|NCT00128102|66057578|FG001|Overall Study|Progressive Disease|285|||
23637628|NCT00128102|66057577|FG000|Overall Study|Adverse Event|34|||
23637629|NCT00128102|66057578|FG001|Overall Study|Adverse Event|11|||
23637630|NCT00128102|66057577|FG000|Overall Study|Death|12|||
23637631|NCT00128102|66057578|FG001|Overall Study|Death|13|||
23637632|NCT00128102|66057577|FG000|Overall Study|Physician Decision|3|||
23637633|NCT00128102|66057578|FG001|Overall Study|Physician Decision|3|||
23637634|NCT00128102|66057577|FG000|Overall Study|Withdrawal by Subject|19|||
23637635|NCT00128102|66057578|FG001|Overall Study|Withdrawal by Subject|11|||
23637636|NCT00128102|66057577|FG000|Overall Study|Protocol Violation|2|||
23637637|NCT00128102|66057578|FG001|Overall Study|Protocol Violation|2|||
23784692|NCT04852978|66590337|FG003|Overall Study|Withdrawal by Subject|1|||
23784693|NCT04852978|66590338|FG004|Overall Study|Withdrawal by Subject|5|||
23784694|NCT04852978|66590339|FG005|Overall Study|Withdrawal by Subject|3|||
23784695|NCT04852978|66590340|FG006|Overall Study|Withdrawal by Subject|2|||
23784696|NCT04852978|66590341|FG007|Overall Study|Withdrawal by Subject|2|||
23784697|NCT04852978|66590342|FG008|Overall Study|Withdrawal by Subject|1|||
23784698|NCT01101022|66590343|FG000|Overall Study|Adverse Event|6|||
23784699|NCT01101022|66590344|FG001|Overall Study|Adverse Event|2|||
23784700|NCT01101022|66590343|FG000|Overall Study|Protocol Violation|4|||
23637638|NCT01305239|66057584|FG000|Overall Study|Adverse Event|22|||
23637639|NCT01305239|66057584|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
23637640|NCT00127205|66057590|FG000|Overall Study|Adverse Event|228|||
23637641|NCT00127205|66057591|FG001|Overall Study|Adverse Event|387|||
23637642|NCT00127205|66057592|FG002|Overall Study|Adverse Event|273|||
23637643|NCT00127205|66057590|FG000|Overall Study|Death|8|||
23637644|NCT00127205|66057591|FG001|Overall Study|Death|6|||
23637645|NCT00127205|66057592|FG002|Overall Study|Death|5|||
23637646|NCT00127205|66057590|FG000|Overall Study|Withdrawal by Subject|318|||
23637647|NCT00127205|66057591|FG001|Overall Study|Withdrawal by Subject|310|||
23637648|NCT00127205|66057592|FG002|Overall Study|Withdrawal by Subject|172|||
23637649|NCT00127205|66057590|FG000|Overall Study|Other-non protocol specified|142|||
23784701|NCT01101022|66590344|FG001|Overall Study|Protocol Violation|3|||
23344493|NCT04683939|65003841|FG003|Overall Study|Physician Decision|0|||
23344494|NCT04683939|65003838|FG000|Overall Study|Lost to Follow-up|0|||
23344495|NCT04683939|65003839|FG001|Overall Study|Lost to Follow-up|1|||
23344496|NCT04683939|65003840|FG002|Overall Study|Lost to Follow-up|0|||
23344497|NCT04683939|65003841|FG003|Overall Study|Lost to Follow-up|0|||
23344498|NCT00843037|65003844|FG000|Overall Study|Lost to Follow-up|1|||
23344499|NCT01446237|65003845|FG000|Overall Study|Adverse Event|1|||
23344500|NCT01446237|65003845|FG000|Overall Study|Lost to Follow-up|2|||
23344501|NCT01446237|65003845|FG000|Overall Study|Withdrawal by Subject|7|||
23344502|NCT00970632|65003855|FG000|Overall Study|Adverse Event|2|||
23344503|NCT00970632|65003856|FG001|Overall Study|Adverse Event|2|||
23344504|NCT00970632|65003857|FG002|Overall Study|Adverse Event|1|||
23344505|NCT00970632|65003855|FG000|Overall Study|Lack of Efficacy|3|||
23344506|NCT00970632|65003856|FG001|Overall Study|Lack of Efficacy|0|||
23344507|NCT00970632|65003857|FG002|Overall Study|Lack of Efficacy|0|||
23344508|NCT00970632|65003855|FG000|Overall Study|Lost to Follow-up|3|||
23344509|NCT00970632|65003856|FG001|Overall Study|Lost to Follow-up|0|||
23344510|NCT00970632|65003857|FG002|Overall Study|Lost to Follow-up|2|||
23344511|NCT00970632|65003855|FG000|Overall Study|Protocol Violation|8|||
23344512|NCT00970632|65003856|FG001|Overall Study|Protocol Violation|5|||
23344513|NCT00970632|65003857|FG002|Overall Study|Protocol Violation|8|||
23344514|NCT00970632|65003855|FG000|Overall Study|Withdrawal by Subject|7|||
23344515|NCT00970632|65003856|FG001|Overall Study|Withdrawal by Subject|6|||
23344516|NCT00970632|65003857|FG002|Overall Study|Withdrawal by Subject|4|||
23344517|NCT00970632|65003855|FG000|Overall Study|Entry criteria not met|0|||
23344518|NCT00970632|65003856|FG001|Overall Study|Entry criteria not met|2|||
23344519|NCT00970632|65003857|FG002|Overall Study|Entry criteria not met|2|||
23344520|NCT00970632|65003855|FG000|Overall Study|Sponsor decision|1|||
23344521|NCT00970632|65003856|FG001|Overall Study|Sponsor decision|0|||
23344522|NCT00970632|65003857|FG002|Overall Study|Sponsor decision|1|||
23344523|NCT02908672|65003858|FG000|Overall Study|Death|112|||
23344524|NCT02908672|65003859|FG001|Overall Study|Death|93|||
23344525|NCT02908672|65003858|FG000|Overall Study|Lost to Follow-up|3|||
23344526|NCT02908672|65003859|FG001|Overall Study|Lost to Follow-up|3|||
23344527|NCT02908672|65003858|FG000|Overall Study|Other|2|||
23344528|NCT02908672|65003859|FG001|Overall Study|Other|0|||
23344529|NCT02908672|65003858|FG000|Overall Study|Protocol Violation|1|||
23344530|NCT02908672|65003859|FG001|Overall Study|Protocol Violation|1|||
23344531|NCT02908672|65003858|FG000|Overall Study|Withdrawal by Subject|13|||
23344532|NCT02908672|65003859|FG001|Overall Study|Withdrawal by Subject|18|||
23344533|NCT02908672|65003858|FG000|Overall Study|Study is ongoing|124|||
23344534|NCT02908672|65003859|FG001|Overall Study|Study is ongoing|141|||
23344535|NCT02908672|65003858|FG000|Overall Study|Discontinued the study during run-in|3|||
23344536|NCT02908672|65003859|FG001|Overall Study|Discontinued the study during run-in|0|||
23344537|NCT02278367|65003862|FG000|Overall Study|Physician Decision|5|||
23344538|NCT02278367|65003863|FG001|Overall Study|Physician Decision|0|||
23344539|NCT02278367|65003862|FG000|Overall Study|Withdrawal by Subject|5|||
23344540|NCT02278367|65003863|FG001|Overall Study|Withdrawal by Subject|0|||
23344541|NCT05500274|65003867|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
23344542|NCT05500274|65003868|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
23344543|NCT05500274|65003867|FG000|Overall Study|Lost to Follow-up|86|||
23344544|NCT05500274|65003868|FG001|Overall Study|Lost to Follow-up|93|||
23344545|NCT00637000|65003869|FG000|Overall Study|Withdrawal by Subject|4|||
23344546|NCT00637000|65003870|FG001|Overall Study|Withdrawal by Subject|3|||
23344547|NCT04507256|65003873|FG000|Overall Study|Withdrawal by Subject|1|||
23344548|NCT04507256|65003874|FG001|Overall Study|Withdrawal by Subject|0|||
23344549|NCT04507256|65003875|FG002|Overall Study|Withdrawal by Subject|0|||
23344550|NCT04507256|65003876|FG003|Overall Study|Withdrawal by Subject|1|||
23344551|NCT04507256|65003877|FG004|Overall Study|Withdrawal by Subject|0|||
23344552|NCT04507256|65003878|FG005|Overall Study|Withdrawal by Subject|0|||
23344553|NCT03142334|65003879|FG000|Overall Study|Death|18|||
23344554|NCT03142334|65003880|FG001|Overall Study|Death|33|||
23344555|NCT03142334|65003879|FG000|Overall Study|Withdrawal by Subject|15|||
23344556|NCT03142334|65003880|FG001|Overall Study|Withdrawal by Subject|11|||
23344557|NCT03142334|65003879|FG000|Overall Study|Ongoing on trial follow up|463|||
23344558|NCT03142334|65003880|FG001|Overall Study|Ongoing on trial follow up|454|||
23344559|NCT01149421|65003887|FG000|Overall Study|Adverse Event|22|||
23344560|NCT01149421|65003888|FG001|Overall Study|Adverse Event|6|||
23344561|NCT01149421|65003889|FG002|Overall Study|Adverse Event|11|||
23344562|NCT01149421|65003887|FG000|Overall Study|Withdrawal by Subject|20|||
23344563|NCT01149421|65003888|FG001|Overall Study|Withdrawal by Subject|12|||
23344564|NCT01149421|65003889|FG002|Overall Study|Withdrawal by Subject|13|||
23344565|NCT01149421|65003887|FG000|Overall Study|Sponsor Decision|0|||
23344566|NCT01149421|65003888|FG001|Overall Study|Sponsor Decision|1|||
23344567|NCT01149421|65003889|FG002|Overall Study|Sponsor Decision|1|||
23344568|NCT01149421|65003887|FG000|Overall Study|Lost to Follow-up|2|||
23784702|NCT01101022|66590343|FG000|Overall Study|Withdrawal by Subject|3|||
23784703|NCT01101022|66590344|FG001|Overall Study|Withdrawal by Subject|8|||
23784704|NCT01101022|66590343|FG000|Overall Study|Lost to Follow-up|1|||
23784705|NCT01101022|66590344|FG001|Overall Study|Lost to Follow-up|4|||
23344569|NCT01149421|65003888|FG001|Overall Study|Lost to Follow-up|4|||
23344570|NCT01149421|65003889|FG002|Overall Study|Lost to Follow-up|5|||
23344571|NCT01149421|65003887|FG000|Overall Study|Physician Decision|5|||
23344572|NCT01149421|65003888|FG001|Overall Study|Physician Decision|3|||
23344573|NCT01149421|65003889|FG002|Overall Study|Physician Decision|6|||
23344574|NCT01149421|65003887|FG000|Overall Study|Entry Criteria Not Met|1|||
23344575|NCT01149421|65003888|FG001|Overall Study|Entry Criteria Not Met|1|||
23344576|NCT01149421|65003889|FG002|Overall Study|Entry Criteria Not Met|2|||
23344577|NCT01149421|65003887|FG000|Overall Study|Protocol Violation|2|||
23344578|NCT01149421|65003888|FG001|Overall Study|Protocol Violation|2|||
23344579|NCT01149421|65003889|FG002|Overall Study|Protocol Violation|6|||
23344580|NCT05523323|65003895|FG000|Overall Study|Death|26|||
23784706|NCT01101022|66590343|FG000|Overall Study|Lack of Efficacy|0|||
23344581|NCT05523323|65003896|FG001|Overall Study|Death|21|||
23344582|NCT05523323|65003895|FG000|Overall Study|Ongoing participants|35|||
23344583|NCT05523323|65003896|FG001|Overall Study|Ongoing participants|30|||
23344584|NCT00972816|65003901|FG000|Overall Study|Adverse Event|0|||
23344585|NCT00972816|65003902|FG001|Overall Study|Adverse Event|0|||
23344586|NCT00972816|65003903|FG002|Overall Study|Adverse Event|1|||
23344587|NCT00972816|65003904|FG003|Overall Study|Adverse Event|0|||
23344588|NCT00972816|65003905|FG004|Overall Study|Adverse Event|0|||
23344589|NCT00972816|65003906|FG005|Overall Study|Adverse Event|0|||
23344590|NCT00972816|65003907|FG006|Overall Study|Adverse Event|0|||
23344591|NCT00972816|65003908|FG007|Overall Study|Adverse Event|0|||
23344592|NCT00972816|65003901|FG000|Overall Study|Withdrawal by Subject|4|||
23344593|NCT00972816|65003902|FG001|Overall Study|Withdrawal by Subject|2|||
23344594|NCT00972816|65003903|FG002|Overall Study|Withdrawal by Subject|1|||
23344595|NCT00972816|65003904|FG003|Overall Study|Withdrawal by Subject|3|||
23344596|NCT00972816|65003905|FG004|Overall Study|Withdrawal by Subject|0|||
23344597|NCT00972816|65003906|FG005|Overall Study|Withdrawal by Subject|1|||
23344598|NCT00972816|65003907|FG006|Overall Study|Withdrawal by Subject|1|||
23344599|NCT00972816|65003908|FG007|Overall Study|Withdrawal by Subject|2|||
23344600|NCT00972816|65003901|FG000|Overall Study|Lost to Follow-up|11|||
23344601|NCT00972816|65003902|FG001|Overall Study|Lost to Follow-up|9|||
23344602|NCT00972816|65003903|FG002|Overall Study|Lost to Follow-up|7|||
23784707|NCT01101022|66590344|FG001|Overall Study|Lack of Efficacy|7|||
23344603|NCT00972816|65003904|FG003|Overall Study|Lost to Follow-up|5|||
23344604|NCT00972816|65003905|FG004|Overall Study|Lost to Follow-up|11|||
23344605|NCT00972816|65003906|FG005|Overall Study|Lost to Follow-up|10|||
23344606|NCT00972816|65003907|FG006|Overall Study|Lost to Follow-up|7|||
23344607|NCT00972816|65003908|FG007|Overall Study|Lost to Follow-up|7|||
23344608|NCT00972816|65003901|FG000|Overall Study|Inappropriate enrolment|0|||
23344609|NCT00972816|65003902|FG001|Overall Study|Inappropriate enrolment|0|||
23344610|NCT00972816|65003903|FG002|Overall Study|Inappropriate enrolment|0|||
23344611|NCT00972816|65003904|FG003|Overall Study|Inappropriate enrolment|0|||
23344612|NCT00972816|65003905|FG004|Overall Study|Inappropriate enrolment|0|||
23456129|NCT00878501|65412899|FG000|Overall Study|Lack of Efficacy|2|||
23456130|NCT00878501|65412900|FG001|Overall Study|Lack of Efficacy|1|||
23344613|NCT00972816|65003906|FG005|Overall Study|Inappropriate enrolment|0|||
23344614|NCT00972816|65003907|FG006|Overall Study|Inappropriate enrolment|2|||
23344615|NCT00972816|65003908|FG007|Overall Study|Inappropriate enrolment|0|||
23344616|NCT00972816|65003901|FG000|Overall Study|Unable to classify|2|||
23784708|NCT01101022|66590343|FG000|Overall Study|Sponsor decision|1|||
23344617|NCT00972816|65003902|FG001|Overall Study|Unable to classify|0|||
23344618|NCT00972816|65003903|FG002|Overall Study|Unable to classify|0|||
23344619|NCT00972816|65003904|FG003|Overall Study|Unable to classify|0|||
23344620|NCT00972816|65003905|FG004|Overall Study|Unable to classify|1|||
23344621|NCT00972816|65003906|FG005|Overall Study|Unable to classify|0|||
23344622|NCT00972816|65003907|FG006|Overall Study|Unable to classify|0|||
23344623|NCT00972816|65003908|FG007|Overall Study|Unable to classify|0|||
23344624|NCT02203851|65003909|FG000|Overall Study|Lost to Follow-up|4|||
23344625|NCT02203851|65003909|FG000|Overall Study|Withdrawal by Subject|6|||
23344626|NCT02203851|65003909|FG000|Overall Study|Other|1|||
23344627|NCT04325828|65003910|FG000|Overall Study|Ongoing|26|||
23344628|NCT01482962|65003911|FG000|Overall Study|Progressive Disease|65|||
23344629|NCT01482962|65003912|FG001|Overall Study|Progressive Disease|53|||
23344630|NCT01482962|65003911|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
23344631|NCT01482962|65003912|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
23344632|NCT01482962|65003911|FG000|Overall Study|Adverse Event|18|||
23344633|NCT01482962|65003912|FG001|Overall Study|Adverse Event|22|||
23344634|NCT01482962|65003911|FG000|Overall Study|Withdrawal by Participant|8|||
23344635|NCT01482962|65003912|FG001|Overall Study|Withdrawal by Participant|13|||
23344636|NCT01482962|65003911|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
23456131|NCT00878501|65412901|FG002|Overall Study|Lack of Efficacy|0|||
23784709|NCT01101022|66590344|FG001|Overall Study|Sponsor decision|1|||
23784710|NCT01101022|66590343|FG000|Overall Study|Non-compliance|1|||
23784711|NCT01101022|66590344|FG001|Overall Study|Non-compliance|0|||
23784712|NCT01101022|66590343|FG000|Overall Study|Work schedule|1|||
23784713|NCT01101022|66590344|FG001|Overall Study|Work schedule|1|||
23784714|NCT01101022|66590343|FG000|Overall Study|Vacation|0|||
23784715|NCT01101022|66590344|FG001|Overall Study|Vacation|1|||
23784716|NCT04633564|66590345|FG000|Period 1|Adverse Event|28|||
23784717|NCT04633564|66590346|FG001|Period 1|Adverse Event|19|||
23784718|NCT04633564|66590345|FG000|Period 1|Death|8|||
23784719|NCT04633564|66590346|FG001|Period 1|Death|7|||
23784720|NCT04633564|66590345|FG000|Period 1|Lost to Follow-up|3|||
23784721|NCT04633564|66590346|FG001|Period 1|Lost to Follow-up|5|||
23784722|NCT04633564|66590345|FG000|Period 1|Physician Decision|4|||
23784723|NCT04633564|66590346|FG001|Period 1|Physician Decision|12|||
23784724|NCT04633564|66590345|FG000|Period 1|Protocol Violation|0|||
23784725|NCT04633564|66590346|FG001|Period 1|Protocol Violation|1|||
23784726|NCT04633564|66590345|FG000|Period 1|Withdrawal by Subject|10|||
23784727|NCT04633564|66590346|FG001|Period 1|Withdrawal by Subject|8|||
23784728|NCT04633564|66590345|FG000|Period 1|Progressive disease|47|||
23784729|NCT04633564|66590346|FG001|Period 1|Progressive disease|51|||
23784730|NCT04633564|66590345|FG000|Period 1|Terminated by Sponsor|8|||
23784731|NCT04633564|66590346|FG001|Period 1|Terminated by Sponsor|6|||
23784732|NCT04633564|66590345|FG000|Period 2|Adverse Event|3|||
23784733|NCT04633564|66590346|FG001|Period 2|Adverse Event|4|||
23784734|NCT04633564|66590345|FG000|Period 2|Death|0|||
23784735|NCT04633564|66590346|FG001|Period 2|Death|2|||
23784736|NCT04633564|66590345|FG000|Period 2|Lost to Follow-up|0|||
23784737|NCT04633564|66590346|FG001|Period 2|Lost to Follow-up|1|||
23784738|NCT04633564|66590345|FG000|Period 2|Physician Decision|2|||
23784739|NCT04633564|66590346|FG001|Period 2|Physician Decision|4|||
23784740|NCT04633564|66590345|FG000|Period 2|Withdrawal by Subject|5|||
23784741|NCT04633564|66590346|FG001|Period 2|Withdrawal by Subject|1|||
23784742|NCT04633564|66590345|FG000|Period 2|Progressive Disease|74|||
23784743|NCT04633564|66590346|FG001|Period 2|Progressive Disease|82|||
23456132|NCT00878501|65412899|FG000|Overall Study|Withdrawal by Subject|2|||
23456133|NCT00878501|65412900|FG001|Overall Study|Withdrawal by Subject|1|||
23456134|NCT00878501|65412901|FG002|Overall Study|Withdrawal by Subject|2|||
23456135|NCT00878501|65412899|FG000|Overall Study|Protocol Violation|0|||
23456136|NCT00878501|65412900|FG001|Overall Study|Protocol Violation|0|||
23784744|NCT04633564|66590345|FG000|Period 2|Terminated by Sponsor|9|||
23784745|NCT04633564|66590346|FG001|Period 2|Terminated by Sponsor|3|||
23784746|NCT00834444|66590349|FG000|First Intervention|Adverse Event|1|||
23784747|NCT00834444|66590350|FG001|First Intervention|Adverse Event|0|||
23784748|NCT00834444|66590349|FG000|First Intervention|Intolerance to Venopuncture|0|||
23784749|NCT00834444|66590350|FG001|First Intervention|Intolerance to Venopuncture|1|||
23784750|NCT00834444|66590349|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23784751|NCT00834444|66590350|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23784752|NCT00834444|66590349|FG000|Second Intervention|Adverse Event|1|||
23344637|NCT01482962|65003912|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
23344638|NCT01482962|65003911|FG000|Overall Study|Other Reason|1|||
23344639|NCT01482962|65003912|FG001|Overall Study|Other Reason|5|||
23344640|NCT01482962|65003911|FG000|Overall Study|Study Terminated by Sponsor|5|||
23344641|NCT01482962|65003912|FG001|Overall Study|Study Terminated by Sponsor|2|||
23344642|NCT01482962|65003911|FG000|Overall Study|Did not Receive Study Drug|1|||
23784753|NCT00834444|66590350|FG001|Second Intervention|Adverse Event|0|||
23784754|NCT01200810|66590351|FG000|Overall Study|Physician Decision|1|||
23784755|NCT01200810|66590352|FG001|Overall Study|Physician Decision|0|||
23784756|NCT01200810|66590351|FG000|Overall Study|Withdrawal by Subject|1|||
23784757|NCT01200810|66590352|FG001|Overall Study|Withdrawal by Subject|2|||
23784758|NCT01200810|66590351|FG000|Overall Study|Sponsor stopped making study drug|3|||
23784759|NCT01200810|66590352|FG001|Overall Study|Sponsor stopped making study drug|3|||
23784760|NCT01020474|66590353|FG000|Overall Study|Adverse Event|4|||
23784761|NCT01020474|66590354|FG001|Overall Study|Adverse Event|4|||
23784762|NCT01020474|66590353|FG000|Overall Study|Protocol Violation|0|||
23344643|NCT01482962|65003912|FG001|Overall Study|Did not Receive Study Drug|6|||
23344644|NCT00131365|65003917|FG000|Overall Study|Withdrawal by Subject|1|||
23344645|NCT00131365|65003917|FG000|Overall Study|Alternative treatment|3|||
23583399|NCT04886596|65866015|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
23583400|NCT04886596|65866016|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
23583401|NCT04886596|65866015|FG000|Overall Study|Migrated / Moved from the study area|17|||
23784763|NCT01020474|66590354|FG001|Overall Study|Protocol Violation|2|||
23784764|NCT01020474|66590353|FG000|Overall Study|Withdrawal by Subject|5|||
23784765|NCT01020474|66590354|FG001|Overall Study|Withdrawal by Subject|7|||
23784766|NCT01020474|66590353|FG000|Overall Study|Other Reasons|1|||
23784767|NCT01020474|66590354|FG001|Overall Study|Other Reasons|1|||
23784768|NCT01020474|66590353|FG000|Overall Study|Insufficient Clinical Response|0|||
23784769|NCT01020474|66590354|FG001|Overall Study|Insufficient Clinical Response|3|||
23784770|NCT00881751|66590355|FG000|Overall Study|Physician Decision|0|||
23784771|NCT00881751|66590356|FG001|Overall Study|Physician Decision|1|||
23784772|NCT00881751|66590355|FG000|Overall Study|Adverse Event|0|||
23784773|NCT00881751|66590356|FG001|Overall Study|Adverse Event|2|||
23784774|NCT00881751|66590355|FG000|Overall Study|Withdrawal by Subject|0|||
23784775|NCT00881751|66590356|FG001|Overall Study|Withdrawal by Subject|2|||
23344662|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
23344663|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
23344664|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
23344665|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
23344666|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
23456137|NCT00878501|65412901|FG002|Overall Study|Protocol Violation|1|||
23784776|NCT01531894|66590357|FG000|Overall Study|Physician Decision|8|||
23784777|NCT01531894|66590357|FG000|Overall Study|Death|1|||
23784778|NCT01340495|66590360|FG000|Overall Study|Withdrawal by Subject|1|||
23784779|NCT00829309|66590361|FG000|Washout: 7 Days|Protocol Violation|1|||
23784780|NCT00829309|66590362|FG001|Washout: 7 Days|Protocol Violation|0|||
23784781|NCT01466166|66590365|FG000|Overall Study|Death|1|||
23784782|NCT01466166|66590365|FG000|Overall Study|Lost to Follow-up|7|||
23784783|NCT01466166|66590365|FG000|Overall Study|Infusion Reaction (IR)|27|||
23784784|NCT01466166|66590365|FG000|Overall Study|Adverse Event (Other than IR)|11|||
23784785|NCT01466166|66590365|FG000|Overall Study|Elevated Serum Uric Acid|78|||
23784786|NCT01466166|66590365|FG000|Overall Study|Withdrawal by Subject|13|||
23784787|NCT01466166|66590365|FG000|Overall Study|Sponsor Decision|4|||
23344667|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
23344668|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
23344669|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
23456138|NCT00878501|65412899|FG000|Overall Study|Incorrect enrolment|1|||
23456139|NCT00878501|65412900|FG001|Overall Study|Incorrect enrolment|2|||
23456140|NCT00878501|65412901|FG002|Overall Study|Incorrect enrolment|0|||
23344670|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Death|0|||
23344671|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Death|1|||
23344672|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
23344673|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
23344674|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
23344675|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
23344676|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
23344677|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
23456141|NCT00878501|65412899|FG000|Overall Study|Intake of prohibited concom. medication|0|||
23456142|NCT00878501|65412900|FG001|Overall Study|Intake of prohibited concom. medication|0|||
23456143|NCT00878501|65412901|FG002|Overall Study|Intake of prohibited concom. medication|1|||
23456144|NCT00878501|65412899|FG000|Overall Study|Mis-randomisation of patient|1|||
23456145|NCT00878501|65412900|FG001|Overall Study|Mis-randomisation of patient|0|||
23456146|NCT00878501|65412901|FG002|Overall Study|Mis-randomisation of patient|0|||
23456147|NCT00878501|65412899|FG000|Overall Study|Administrative|0|||
23456148|NCT00878501|65412900|FG001|Overall Study|Administrative|0|||
23456149|NCT00878501|65412901|FG002|Overall Study|Administrative|1|||
23456150|NCT00107198|65412904|FG000|Overall Study|Lack of Efficacy|28|||
23456151|NCT00107198|65412904|FG000|Overall Study|Lost to Follow-up|12|||
23456152|NCT00107198|65412904|FG000|Overall Study|Protocol Violation|1|||
23456153|NCT00107198|65412904|FG000|Overall Study|Withdrawal by Subject|6|||
23456154|NCT00107198|65412904|FG000|Overall Study|Ineligible|5|||
23784788|NCT01466166|66590365|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
23784789|NCT01466166|66590365|FG000|Overall Study|Other|20|||
23784790|NCT04631562|66590366|FG000|Overall Study|Withdrawal by Subject|0|||
23784791|NCT04631562|66590367|FG001|Overall Study|Withdrawal by Subject|0|||
23784792|NCT04631562|66590368|FG002|Overall Study|Withdrawal by Subject|0|||
23784793|NCT04631562|66590369|FG003|Overall Study|Withdrawal by Subject|0|||
23784794|NCT04631562|66590370|FG004|Overall Study|Withdrawal by Subject|0|||
23784795|NCT04631562|66590371|FG005|Overall Study|Withdrawal by Subject|0|||
23784796|NCT04631562|66590372|FG006|Overall Study|Withdrawal by Subject|0|||
23784797|NCT04631562|66590373|FG007|Overall Study|Withdrawal by Subject|1|||
23784798|NCT04631562|66590374|FG008|Overall Study|Withdrawal by Subject|0|||
23784799|NCT04631562|66590366|FG000|Overall Study|Other|0|||
23784800|NCT04631562|66590367|FG001|Overall Study|Other|0|||
23456155|NCT05498649|65412908|FG000|Overall Study|Lost to Follow-up|1|||
23456156|NCT00948246|65412909|FG000|Overall Study|Lost to Follow-up|11|||
23456157|NCT00948246|65412909|FG000|Overall Study|Adverse Event|11|||
23456158|NCT00948246|65412909|FG000|Overall Study|Death|1|||
23456159|NCT00948246|65412909|FG000|Overall Study|Withdrawal by Subject|1|||
23456160|NCT04742556|65412919|FG000|Overall Study|Withdrawal by Subject|0|||
23456161|NCT04742556|65412920|FG001|Overall Study|Withdrawal by Subject|1|||
23456162|NCT04742556|65412921|FG002|Overall Study|Withdrawal by Subject|0|||
23456163|NCT04742556|65412919|FG000|Overall Study|Adverse Event|0|||
23456164|NCT04742556|65412920|FG001|Overall Study|Adverse Event|0|||
23456165|NCT04742556|65412921|FG002|Overall Study|Adverse Event|2|||
23456166|NCT04742556|65412919|FG000|Overall Study|Clinical disease progression|0|||
23456167|NCT04742556|65412920|FG001|Overall Study|Clinical disease progression|1|||
23456168|NCT04742556|65412921|FG002|Overall Study|Clinical disease progression|2|||
23456169|NCT04742556|65412919|FG000|Overall Study|Objective disease progression|3|||
23456170|NCT04742556|65412920|FG001|Overall Study|Objective disease progression|2|||
23456171|NCT04742556|65412921|FG002|Overall Study|Objective disease progression|4|||
23456172|NCT03922581|65412929|FG000|Overall Study|Lost to Follow-up|20|||
23456173|NCT03922581|65412930|FG001|Overall Study|Lost to Follow-up|9|||
23456174|NCT03922581|65412929|FG000|Overall Study|Physician Decision|1|||
23456175|NCT03922581|65412930|FG001|Overall Study|Physician Decision|1|||
23456176|NCT03922581|65412929|FG000|Overall Study|Withdrawal by Subject|1|||
23456177|NCT03922581|65412930|FG001|Overall Study|Withdrawal by Subject|0|||
23456178|NCT02177695|65412931|FG000|ITT Analysis|Ineligible|5|||
23456179|NCT02177695|65412932|FG001|ITT Analysis|Ineligible|5|||
23784801|NCT04631562|66590368|FG002|Overall Study|Other|0|||
23784802|NCT04631562|66590369|FG003|Overall Study|Other|0|||
23456180|NCT02177695|65412931|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
23456181|NCT02177695|65412932|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
23456182|NCT02177695|65412931|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
23456183|NCT02177695|65412932|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
23784803|NCT04631562|66590370|FG004|Overall Study|Other|0|||
23456184|NCT02177695|65412931|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
23456185|NCT02177695|65412932|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
23784804|NCT04631562|66590371|FG005|Overall Study|Other|0|||
23784805|NCT04631562|66590372|FG006|Overall Study|Other|0|||
23784806|NCT04631562|66590373|FG007|Overall Study|Other|0|||
23784807|NCT04631562|66590374|FG008|Overall Study|Other|1|||
23784808|NCT04631562|66590366|FG000|Overall Study|Lost to Follow-up|0|||
23784809|NCT04631562|66590367|FG001|Overall Study|Lost to Follow-up|0|||
23784810|NCT04631562|66590368|FG002|Overall Study|Lost to Follow-up|0|||
23784811|NCT04631562|66590369|FG003|Overall Study|Lost to Follow-up|1|||
23784812|NCT04631562|66590370|FG004|Overall Study|Lost to Follow-up|0|||
23784813|NCT04631562|66590371|FG005|Overall Study|Lost to Follow-up|0|||
23784814|NCT04631562|66590372|FG006|Overall Study|Lost to Follow-up|0|||
23784815|NCT04631562|66590373|FG007|Overall Study|Lost to Follow-up|0|||
23784816|NCT04631562|66590374|FG008|Overall Study|Lost to Follow-up|0|||
23784817|NCT04631562|66590366|FG000|Overall Study|Adverse Event|0|||
23784818|NCT04631562|66590367|FG001|Overall Study|Adverse Event|0|||
23784819|NCT04631562|66590368|FG002|Overall Study|Adverse Event|0|||
23784820|NCT04631562|66590369|FG003|Overall Study|Adverse Event|0|||
23784821|NCT04631562|66590370|FG004|Overall Study|Adverse Event|0|||
23784822|NCT04631562|66590371|FG005|Overall Study|Adverse Event|0|||
23784823|NCT04631562|66590372|FG006|Overall Study|Adverse Event|1|||
23784824|NCT04631562|66590373|FG007|Overall Study|Adverse Event|0|||
23784825|NCT04631562|66590374|FG008|Overall Study|Adverse Event|0|||
23784826|NCT02157974|66590379|FG000|Overall Study|Withdrawal by Subject|0|||
23784827|NCT02157974|66590380|FG001|Overall Study|Withdrawal by Subject|1|||
23784828|NCT02157974|66590381|FG002|Overall Study|Withdrawal by Subject|0|||
23784829|NCT02157974|66590382|FG003|Overall Study|Withdrawal by Subject|0|||
23784830|NCT02157974|66590383|FG004|Overall Study|Withdrawal by Subject|0|||
23784831|NCT02157974|66590379|FG000|Overall Study|Screen Failure|0|||
23784832|NCT02157974|66590380|FG001|Overall Study|Screen Failure|1|||
23784833|NCT02157974|66590381|FG002|Overall Study|Screen Failure|0|||
23784834|NCT02157974|66590382|FG003|Overall Study|Screen Failure|0|||
23784835|NCT02157974|66590383|FG004|Overall Study|Screen Failure|0|||
23784836|NCT02157974|66590379|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23784837|NCT02157974|66590380|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
23784838|NCT02157974|66590381|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23784839|NCT02157974|66590382|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23784840|NCT02157974|66590383|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23784841|NCT00395694|66590387|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
23784842|NCT00395694|66590388|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
23456186|NCT04247347|65412934|FG000|Overall Study|Withdrawal by Subject|2|||
23637650|NCT00127205|66057591|FG001|Overall Study|Other-non protocol specified|129|||
23637651|NCT00127205|66057592|FG002|Overall Study|Other-non protocol specified|77|||
23637652|NCT00127205|66057590|FG000|Overall Study|Data not reported|6|||
23637653|NCT00127205|66057591|FG001|Overall Study|Data not reported|10|||
23637654|NCT00127205|66057592|FG002|Overall Study|Data not reported|1|||
23637655|NCT00127205|66057590|FG000|Overall Study|Progression|127|||
23637656|NCT00127205|66057591|FG001|Overall Study|Progression|131|||
23637657|NCT00127205|66057592|FG002|Overall Study|Progression|84|||
23637658|NCT00790205|66057593|FG000|Overall Study|Lost to Follow-up|61|||
23637659|NCT00790205|66057594|FG001|Overall Study|Lost to Follow-up|71|||
23637660|NCT00790205|66057593|FG000|Overall Study|Withdrawal by Subject|299|||
23637661|NCT00790205|66057594|FG001|Overall Study|Withdrawal by Subject|363|||
23637662|NCT01519089|66057595|FG000|Overall Study|Adverse Event|4|||
23637663|NCT01519089|66057596|FG001|Overall Study|Adverse Event|4|||
23637664|NCT01519089|66057595|FG000|Overall Study|Lack of Efficacy|0|||
23637665|NCT01519089|66057596|FG001|Overall Study|Lack of Efficacy|2|||
23637666|NCT01519089|66057595|FG000|Overall Study|Lost to Follow-up|1|||
23637667|NCT01519089|66057596|FG001|Overall Study|Lost to Follow-up|0|||
23637668|NCT01519089|66057595|FG000|Overall Study|Withdrawal by Subject|0|||
23637669|NCT01519089|66057596|FG001|Overall Study|Withdrawal by Subject|2|||
23637670|NCT01519089|66057595|FG000|Overall Study|Other|2|||
23637671|NCT01519089|66057596|FG001|Overall Study|Other|6|||
23637672|NCT01519089|66057595|FG000|Overall Study|Not received study drug|0|||
23637673|NCT01519089|66057596|FG001|Overall Study|Not received study drug|1|||
23637674|NCT03683823|66057599|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
23637675|NCT03683823|66057600|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
23637676|NCT03683823|66057599|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
23784843|NCT00395694|66590387|FG000|Continuation Phase|Adverse Event|1|||
23456187|NCT04247347|65412935|FG001|Overall Study|Withdrawal by Subject|3|||
23637677|NCT03683823|66057600|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
23637678|NCT03683823|66057599|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
23637679|NCT03683823|66057600|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
23784844|NCT00395694|66590388|FG001|Continuation Phase|Adverse Event|0|||
23784845|NCT00395694|66590387|FG000|Continuation Phase|Lack of Efficacy|12|||
23784846|NCT00395694|66590388|FG001|Continuation Phase|Lack of Efficacy|11|||
23637680|NCT00513305|66057601|FG000|Overall Study|Adverse Event|6|||
23784847|NCT00395694|66590387|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
23784848|NCT00395694|66590388|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
23637681|NCT00513305|66057602|FG001|Overall Study|Adverse Event|2|||
23637682|NCT00513305|66057601|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
23637683|NCT00513305|66057602|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
23784849|NCT00395694|66590387|FG000|Continuation Phase|Poor Compliance|1|||
23784850|NCT00395694|66590388|FG001|Continuation Phase|Poor Compliance|0|||
23784851|NCT00395694|66590387|FG000|Continuation Phase|Withdrawal by Subject|0|||
23784852|NCT00395694|66590388|FG001|Continuation Phase|Withdrawal by Subject|2|||
23784853|NCT00875524|66590390|FG000|Overall Study|Serious adverse event|0|||
23784854|NCT00875524|66590391|FG001|Overall Study|Serious adverse event|1|||
23784855|NCT00875524|66590390|FG000|Overall Study|Protocol Violation|4|||
23784856|NCT00875524|66590391|FG001|Overall Study|Protocol Violation|0|||
23784857|NCT00875524|66590390|FG000|Overall Study|Lost to Follow-up|1|||
23784858|NCT00875524|66590391|FG001|Overall Study|Lost to Follow-up|0|||
23784859|NCT00875524|66590390|FG000|Overall Study|Withdrawal by Subject|3|||
23784860|NCT00875524|66590391|FG001|Overall Study|Withdrawal by Subject|5|||
23784861|NCT00905606|66590392|FG000|Period 1|Adverse Event|0|||
23784862|NCT00905606|66590393|FG001|Period 1|Adverse Event|1|||
23784863|NCT00905606|66590392|FG000|Washout|Withdrawal by Subject|1|||
23784864|NCT00905606|66590393|FG001|Washout|Withdrawal by Subject|0|||
23784865|NCT02334722|66590394|FG000|Overall Study|Lost to Follow-up|4|||
23784866|NCT02334722|66590395|FG001|Overall Study|Lost to Follow-up|0|||
23784867|NCT02334722|66590394|FG000|Overall Study|6 week questionnaire not completed|2|||
23784868|NCT02334722|66590395|FG001|Overall Study|6 week questionnaire not completed|0|||
23784869|NCT02334722|66590394|FG000|Overall Study|Unable to obtain medication|1|||
23784870|NCT02334722|66590395|FG001|Overall Study|Unable to obtain medication|1|||
23784871|NCT02334722|66590394|FG000|Overall Study|Withdrawal by Subject|0|||
23784872|NCT02334722|66590395|FG001|Overall Study|Withdrawal by Subject|3|||
23784873|NCT02334722|66590394|FG000|Overall Study|Adverse Event|0|||
23784874|NCT02334722|66590395|FG001|Overall Study|Adverse Event|2|||
23784875|NCT02334722|66590394|FG000|Overall Study|Physician Decision|0|||
23784876|NCT02334722|66590395|FG001|Overall Study|Physician Decision|1|||
23784877|NCT00798603|66590396|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
23784878|NCT00798603|66590396|FG000|Overall Study|Withdrawal by Subject|10|||
23784879|NCT00798603|66590396|FG000|Overall Study|Adverse Event|22|||
23784880|NCT00798603|66590396|FG000|Overall Study|Physician Decision|1|||
23784881|NCT00798603|66590396|FG000|Overall Study|Lack of insurance coverage|1|||
23344678|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
23344679|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
23344680|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
23344681|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
23344682|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Non compliance|0|||
23344683|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Non compliance|1|||
23637684|NCT00513305|66057601|FG000|Overall Study|Lack of Efficacy|8|||
23344684|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
23344685|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
23344686|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
23344687|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
23344688|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
23344689|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
23344690|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
23344691|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
23344692|NCT00176644|65003926|FG000|Overall Study|Withdrawal by Subject|1|||
23344693|NCT02600845|65003933|FG000|Overall Study|Reason Not Specified|3|||
23344694|NCT02600845|65003933|FG000|Overall Study|Non-compliance with Study Procedures|10|||
23344695|NCT02600845|65003933|FG000|Overall Study|Consent Withdrawal|5|||
23344696|NCT00432276|65003934|FG000|Overall Study|Hyperglycemic Rescue|44|||
23344697|NCT00432276|65003935|FG001|Overall Study|Hyperglycemic Rescue|87|||
23344698|NCT00432276|65003934|FG000|Overall Study|Adverse Event|13|||
23344699|NCT00432276|65003935|FG001|Overall Study|Adverse Event|16|||
23344700|NCT00432276|65003934|FG000|Overall Study|Protocol Violation|25|||
23456188|NCT04247347|65412936|FG002|Overall Study|Withdrawal by Subject|3|||
23344701|NCT00432276|65003935|FG001|Overall Study|Protocol Violation|20|||
23344702|NCT00432276|65003934|FG000|Overall Study|Lost to Follow-up|6|||
23344703|NCT00432276|65003935|FG001|Overall Study|Lost to Follow-up|2|||
23344704|NCT00432276|65003934|FG000|Overall Study|Withdrawal by Subject|25|||
23784882|NCT00829790|66590399|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
23784883|NCT00829790|66590400|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
23784884|NCT02640235|66590401|FG000|Overall Study|Withdrawal by Subject|7|||
23784885|NCT02640235|66590402|FG001|Overall Study|Withdrawal by Subject|6|||
23784886|NCT02640235|66590401|FG000|Overall Study|Lost to Follow-up|4|||
23784887|NCT02640235|66590402|FG001|Overall Study|Lost to Follow-up|3|||
23784888|NCT02640235|66590401|FG000|Overall Study|Death|2|||
23784889|NCT02640235|66590402|FG001|Overall Study|Death|3|||
23344705|NCT00432276|65003935|FG001|Overall Study|Withdrawal by Subject|20|||
23344706|NCT00432276|65003934|FG000|Overall Study|Physician Decision|6|||
23344707|NCT00432276|65003935|FG001|Overall Study|Physician Decision|8|||
23344708|NCT00432276|65003934|FG000|Overall Study|Other|2|||
23344709|NCT00432276|65003935|FG001|Overall Study|Other|3|||
23344710|NCT03244618|65003942|FG000|Overall Study|Lost to Follow-up|3|||
23344711|NCT03244618|65003943|FG001|Overall Study|Lost to Follow-up|4|||
23344712|NCT03244618|65003942|FG000|Overall Study|Protocol Violation|4|||
23344713|NCT03244618|65003943|FG001|Overall Study|Protocol Violation|3|||
23344714|NCT03244618|65003942|FG000|Overall Study|Withdrawal by Subject|0|||
23344715|NCT03244618|65003943|FG001|Overall Study|Withdrawal by Subject|2|||
23344716|NCT03104400|65003950|FG000|Overall Study|Adverse Event|5|||
23344717|NCT03104400|65003951|FG001|Overall Study|Adverse Event|7|||
23456189|NCT04247347|65412934|FG000|Overall Study|Lost to Follow-up|1|||
23344718|NCT03104400|65003952|FG002|Overall Study|Adverse Event|11|||
23344719|NCT03104400|65003953|FG003|Overall Study|Adverse Event|9|||
23344720|NCT03104400|65003954|FG004|Overall Study|Adverse Event|21|||
23344721|NCT03104400|65003950|FG000|Overall Study|Withdrawal by Subject|17|||
23344722|NCT03104400|65003951|FG001|Overall Study|Withdrawal by Subject|19|||
23456190|NCT04247347|65412935|FG001|Overall Study|Lost to Follow-up|1|||
23344723|NCT03104400|65003952|FG002|Overall Study|Withdrawal by Subject|29|||
23344724|NCT03104400|65003953|FG003|Overall Study|Withdrawal by Subject|25|||
23344725|NCT03104400|65003954|FG004|Overall Study|Withdrawal by Subject|24|||
23344726|NCT03104400|65003950|FG000|Overall Study|Lost to Follow-up|4|||
23344727|NCT03104400|65003951|FG001|Overall Study|Lost to Follow-up|1|||
23344728|NCT03104400|65003952|FG002|Overall Study|Lost to Follow-up|4|||
23344729|NCT03104400|65003953|FG003|Overall Study|Lost to Follow-up|8|||
23344730|NCT03104400|65003954|FG004|Overall Study|Lost to Follow-up|7|||
23344731|NCT03104400|65003950|FG000|Overall Study|Lack of Efficacy|6|||
23344732|NCT03104400|65003951|FG001|Overall Study|Lack of Efficacy|3|||
23344733|NCT03104400|65003952|FG002|Overall Study|Lack of Efficacy|8|||
23344734|NCT03104400|65003953|FG003|Overall Study|Lack of Efficacy|2|||
23784890|NCT02640235|66590401|FG000|Overall Study|Other|1|||
23784891|NCT02640235|66590402|FG001|Overall Study|Other|2|||
23784892|NCT00804856|66590405|FG000|Overall Study|Progressive Disease|3|||
23784893|NCT00804856|66590406|FG001|Overall Study|Progressive Disease|2|||
23784894|NCT00804856|66590407|FG002|Overall Study|Progressive Disease|4|||
23784895|NCT00804856|66590408|FG003|Overall Study|Progressive Disease|6|||
23344735|NCT03104400|65003954|FG004|Overall Study|Lack of Efficacy|1|||
23344736|NCT03104400|65003950|FG000|Overall Study|COVID Logistical Restrictions|0|||
23344737|NCT03104400|65003951|FG001|Overall Study|COVID Logistical Restrictions|0|||
23344738|NCT03104400|65003952|FG002|Overall Study|COVID Logistical Restrictions|0|||
23344739|NCT03104400|65003953|FG003|Overall Study|COVID Logistical Restrictions|1|||
23344740|NCT03104400|65003954|FG004|Overall Study|COVID Logistical Restrictions|0|||
23784896|NCT00804856|66590409|FG004|Overall Study|Progressive Disease|4|||
23784897|NCT00804856|66590410|FG005|Overall Study|Progressive Disease|1|||
23784898|NCT00804856|66590411|FG006|Overall Study|Progressive Disease|8|||
23784899|NCT00804856|66590412|FG007|Overall Study|Progressive Disease|2|||
23784900|NCT00804856|66590413|FG008|Overall Study|Progressive Disease|4|||
23784901|NCT00804856|66590414|FG009|Overall Study|Progressive Disease|5|||
23784902|NCT00804856|66590415|FG010|Overall Study|Progressive Disease|12|||
23784903|NCT00804856|66590416|FG011|Overall Study|Progressive Disease|2|||
23784904|NCT00804856|66590417|FG012|Overall Study|Progressive Disease|2|||
23784905|NCT00804856|66590418|FG013|Overall Study|Progressive Disease|26|||
23344741|NCT03104400|65003950|FG000|Overall Study|Other|2|||
23344742|NCT03104400|65003951|FG001|Overall Study|Other|3|||
23344743|NCT03104400|65003952|FG002|Overall Study|Other|7|||
23344744|NCT03104400|65003953|FG003|Overall Study|Other|6|||
23344745|NCT03104400|65003954|FG004|Overall Study|Other|4|||
23344746|NCT03104400|65003950|FG000|Overall Study|Other|0|||
23344747|NCT03104400|65003951|FG001|Overall Study|Other|1|||
23344748|NCT03104400|65003952|FG002|Overall Study|Other|0|||
23784906|NCT00804856|66590419|FG014|Overall Study|Progressive Disease|20|||
23344749|NCT03104400|65003953|FG003|Overall Study|Other|0|||
23784907|NCT00804856|66590405|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784908|NCT00804856|66590406|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784909|NCT00804856|66590407|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784910|NCT00804856|66590408|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784911|NCT00804856|66590409|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23784912|NCT00804856|66590410|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784913|NCT00804856|66590411|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784914|NCT00804856|66590412|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784915|NCT00804856|66590413|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784916|NCT00804856|66590414|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784917|NCT00804856|66590415|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23637685|NCT00513305|66057602|FG001|Overall Study|Lack of Efficacy|13|||
23637686|NCT00513305|66057601|FG000|Overall Study|Withdrawal by Subject|1|||
23637687|NCT00513305|66057602|FG001|Overall Study|Withdrawal by Subject|2|||
23784918|NCT00804856|66590416|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784919|NCT00804856|66590417|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23784920|NCT00804856|66590418|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23344750|NCT03104400|65003954|FG004|Overall Study|Other|0|||
23344751|NCT03535740|65003955|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
23344752|NCT03535740|65003955|FG000|Overall Study|Death|34|||
23344753|NCT03535740|65003955|FG000|Overall Study|Lost to Follow-up|1|||
23344754|NCT03535740|65003955|FG000|Overall Study|Withdrawal by Subject|13|||
23344755|NCT02954653|65003956|FG000|Overall Study|Death|3|||
23344756|NCT02954653|65003957|FG001|Overall Study|Death|1|||
23344757|NCT02954653|65003958|FG002|Overall Study|Death|0|||
23344758|NCT02954653|65003959|FG003|Overall Study|Death|0|||
23344759|NCT02954653|65003960|FG004|Overall Study|Death|0|||
23344760|NCT02954653|65003961|FG005|Overall Study|Death|0|||
23344761|NCT02954653|65003962|FG006|Overall Study|Death|0|||
23344762|NCT02954653|65003963|FG007|Overall Study|Death|0|||
23344763|NCT02954653|65003964|FG008|Overall Study|Death|0|||
23344764|NCT02954653|65003956|FG000|Overall Study|Randomized but did not receive treatment|1|||
23344765|NCT02954653|65003957|FG001|Overall Study|Randomized but did not receive treatment|0|||
23344766|NCT02954653|65003958|FG002|Overall Study|Randomized but did not receive treatment|0|||
23344767|NCT02954653|65003959|FG003|Overall Study|Randomized but did not receive treatment|0|||
23344768|NCT02954653|65003960|FG004|Overall Study|Randomized but did not receive treatment|0|||
23637688|NCT00513305|66057601|FG000|Overall Study|Disease progression|8|||
23637689|NCT00513305|66057602|FG001|Overall Study|Disease progression|5|||
23637690|NCT00513305|66057601|FG000|Overall Study|Eligible for stem cell transplant|1|||
23344769|NCT02954653|65003961|FG005|Overall Study|Randomized but did not receive treatment|0|||
23344770|NCT02954653|65003962|FG006|Overall Study|Randomized but did not receive treatment|0|||
23344771|NCT02954653|65003963|FG007|Overall Study|Randomized but did not receive treatment|0|||
23344772|NCT02954653|65003964|FG008|Overall Study|Randomized but did not receive treatment|0|||
23344773|NCT02954653|65003956|FG000|Overall Study|Started another anti-cancer therapy|0|||
23344774|NCT02954653|65003957|FG001|Overall Study|Started another anti-cancer therapy|1|||
23344775|NCT02954653|65003958|FG002|Overall Study|Started another anti-cancer therapy|0|||
23344776|NCT02954653|65003959|FG003|Overall Study|Started another anti-cancer therapy|0|||
23344777|NCT02954653|65003960|FG004|Overall Study|Started another anti-cancer therapy|0|||
23344778|NCT02954653|65003961|FG005|Overall Study|Started another anti-cancer therapy|0|||
23344779|NCT02954653|65003962|FG006|Overall Study|Started another anti-cancer therapy|0|||
23637691|NCT00513305|66057602|FG001|Overall Study|Eligible for stem cell transplant|0|||
23637692|NCT00513305|66057601|FG000|Overall Study|Hematologic counts did not recover|1|||
23344780|NCT02954653|65003963|FG007|Overall Study|Started another anti-cancer therapy|0|||
23344781|NCT02954653|65003964|FG008|Overall Study|Started another anti-cancer therapy|0|||
23344782|NCT02954653|65003956|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
23344783|NCT02954653|65003957|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
23344784|NCT02954653|65003958|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
23344785|NCT02954653|65003959|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
23344786|NCT02954653|65003960|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
23344787|NCT02954653|65003961|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
23344788|NCT02954653|65003962|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
23344789|NCT02954653|65003963|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
23344790|NCT02954653|65003964|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
23344791|NCT00976209|65003965|FG000|Treatment Period 1|Protocol Violation|1|||
23344792|NCT00976209|65003966|FG001|Treatment Period 1|Protocol Violation|0|||
23344793|NCT00976209|65003965|FG000|Treatment Period 1|Lost to Follow-up|2|||
23344794|NCT00976209|65003966|FG001|Treatment Period 1|Lost to Follow-up|0|||
23344795|NCT00976209|65003965|FG000|Treatment Period 1|Other|0|||
23344796|NCT00976209|65003966|FG001|Treatment Period 1|Other|1|||
23344797|NCT00976209|65003965|FG000|Wash-out Period|Adverse Event|1|||
23344798|NCT00976209|65003966|FG001|Wash-out Period|Adverse Event|2|||
23784921|NCT00804856|66590419|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23784922|NCT00804856|66590405|FG000|Overall Study|Other Adverse Event|1|||
23784923|NCT00804856|66590406|FG001|Overall Study|Other Adverse Event|1|||
23784924|NCT00804856|66590407|FG002|Overall Study|Other Adverse Event|1|||
23784925|NCT00804856|66590408|FG003|Overall Study|Other Adverse Event|2|||
23784926|NCT00804856|66590409|FG004|Overall Study|Other Adverse Event|2|||
23784927|NCT00804856|66590410|FG005|Overall Study|Other Adverse Event|1|||
23784928|NCT00804856|66590411|FG006|Overall Study|Other Adverse Event|3|||
23784929|NCT00804856|66590412|FG007|Overall Study|Other Adverse Event|0|||
23344799|NCT00976209|65003965|FG000|Wash-out Period|Lost to Follow-up|1|||
23344800|NCT00976209|65003966|FG001|Wash-out Period|Lost to Follow-up|0|||
23784930|NCT00804856|66590413|FG008|Overall Study|Other Adverse Event|0|||
23456191|NCT04247347|65412936|FG002|Overall Study|Lost to Follow-up|1|||
23456192|NCT00079417|65412938|FG000|Overall Study|Physician Decision|2|||
23456193|NCT00079417|65412938|FG000|Overall Study|Ineligible|7|||
23456194|NCT02723773|65412939|FG000|Overall Study|Adverse Event|934|||
23456195|NCT02723773|65412940|FG001|Overall Study|Adverse Event|3|||
23456196|NCT02723773|65412941|FG002|Overall Study|Adverse Event|1|||
23456197|NCT02723773|65412942|FG003|Overall Study|Adverse Event|9|||
23456198|NCT02723773|65412939|FG000|Overall Study|Protocol Violation|1|||
23456199|NCT02723773|65412940|FG001|Overall Study|Protocol Violation|0|||
23456200|NCT02723773|65412941|FG002|Overall Study|Protocol Violation|0|||
23456201|NCT02723773|65412942|FG003|Overall Study|Protocol Violation|0|||
23456202|NCT02723773|65412939|FG000|Overall Study|Withdrawal by Subject|360|||
23456203|NCT02723773|65412940|FG001|Overall Study|Withdrawal by Subject|5|||
23456204|NCT02723773|65412941|FG002|Overall Study|Withdrawal by Subject|6|||
23456205|NCT02723773|65412942|FG003|Overall Study|Withdrawal by Subject|10|||
23456206|NCT02723773|65412939|FG000|Overall Study|Migrated/moved from study area|37|||
23456207|NCT02723773|65412940|FG001|Overall Study|Migrated/moved from study area|0|||
23456208|NCT02723773|65412941|FG002|Overall Study|Migrated/moved from study area|0|||
23456209|NCT02723773|65412942|FG003|Overall Study|Migrated/moved from study area|1|||
23456210|NCT02723773|65412939|FG000|Overall Study|Lost to Follow-up|198|||
23456211|NCT02723773|65412940|FG001|Overall Study|Lost to Follow-up|0|||
23456212|NCT02723773|65412941|FG002|Overall Study|Lost to Follow-up|0|||
23456213|NCT02723773|65412942|FG003|Overall Study|Lost to Follow-up|0|||
23456214|NCT02723773|65412939|FG000|Overall Study|Other|189|||
23456215|NCT02723773|65412940|FG001|Overall Study|Other|1|||
23456216|NCT02723773|65412941|FG002|Overall Study|Other|2|||
23456217|NCT02723773|65412942|FG003|Overall Study|Other|2|||
23637693|NCT00513305|66057602|FG001|Overall Study|Hematologic counts did not recover|0|||
23637694|NCT00513305|66057601|FG000|Overall Study|Physician Decision|1|||
23637695|NCT00513305|66057602|FG001|Overall Study|Physician Decision|0|||
23637696|NCT00513305|66057601|FG000|Overall Study|Persistent hypocellularity|0|||
23637697|NCT00513305|66057602|FG001|Overall Study|Persistent hypocellularity|1|||
23637698|NCT00513305|66057601|FG000|Overall Study|Sponsor Decision|0|||
23637699|NCT00513305|66057602|FG001|Overall Study|Sponsor Decision|2|||
23637700|NCT00821587|66057603|FG000|Overall Study|Physician Decision|0|||
23456218|NCT01746368|65412943|FG000|Overall Study|Lost to Follow-up|2|||
23456219|NCT01746368|65412944|FG001|Overall Study|Lost to Follow-up|0|||
23456220|NCT01746368|65412943|FG000|Overall Study|Withdrawal by Subject|0|||
23456221|NCT01746368|65412944|FG001|Overall Study|Withdrawal by Subject|1|||
23456222|NCT03182374|65412945|FG000|Overall Study|Lost to Follow-up|3|||
23456223|NCT03182374|65412946|FG001|Overall Study|Lost to Follow-up|2|||
23456224|NCT03182374|65412945|FG000|Overall Study|Lack of Efficacy|8|||
23456225|NCT03182374|65412946|FG001|Overall Study|Lack of Efficacy|14|||
23456226|NCT03182374|65412945|FG000|Overall Study|Withdrawal by Subject|1|||
23456227|NCT03182374|65412946|FG001|Overall Study|Withdrawal by Subject|1|||
23456228|NCT03182374|65412945|FG000|Overall Study|exit for non-compliance|1|||
23456229|NCT03182374|65412946|FG001|Overall Study|exit for non-compliance|1|||
23456230|NCT03182374|65412945|FG000|Overall Study|one subject was randomized but not treated|1|||
23456231|NCT03182374|65412946|FG001|Overall Study|one subject was randomized but not treated|0|||
23456232|NCT03182374|65412945|FG000|Overall Study|Other reasons|0|||
23456233|NCT03182374|65412946|FG001|Overall Study|Other reasons|3|||
23456234|NCT04388111|65412947|FG000|Overall Study|Lost to Follow-up|5|||
23456235|NCT04388111|65412948|FG001|Overall Study|Lost to Follow-up|3|||
23456236|NCT04388111|65412947|FG000|Overall Study|Adverse Event|1|||
23456237|NCT04388111|65412948|FG001|Overall Study|Adverse Event|1|||
23456238|NCT04388111|65412947|FG000|Overall Study|Protocol Violation|2|||
23456239|NCT04388111|65412948|FG001|Overall Study|Protocol Violation|4|||
23637701|NCT00821587|66057604|FG001|Overall Study|Physician Decision|1|||
23784931|NCT00804856|66590414|FG009|Overall Study|Other Adverse Event|1|||
23784932|NCT00804856|66590415|FG010|Overall Study|Other Adverse Event|5|||
23784933|NCT00804856|66590416|FG011|Overall Study|Other Adverse Event|2|||
23784934|NCT00804856|66590417|FG012|Overall Study|Other Adverse Event|0|||
23784935|NCT00804856|66590418|FG013|Overall Study|Other Adverse Event|6|||
23784936|NCT00804856|66590419|FG014|Overall Study|Other Adverse Event|13|||
23784937|NCT00804856|66590405|FG000|Overall Study|Non compliance with protocol|0|||
23456240|NCT04388111|65412947|FG000|Overall Study|Withdrawal by Subject|1|||
23456241|NCT04388111|65412948|FG001|Overall Study|Withdrawal by Subject|0|||
23456242|NCT03661723|65412949|FG000|Overall Study|Disease Progression|4|||
23456243|NCT03661723|65412950|FG001|Overall Study|Disease Progression|24|||
23456244|NCT03661723|65412951|FG002|Overall Study|Disease Progression|4|||
23456245|NCT03661723|65412952|FG003|Overall Study|Disease Progression|19|||
23637702|NCT04608773|66057621|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
23637703|NCT04608773|66057622|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
23456246|NCT03661723|65412949|FG000|Overall Study|Withdrawal by Subject|1|||
23456247|NCT03661723|65412950|FG001|Overall Study|Withdrawal by Subject|0|||
23456248|NCT03661723|65412951|FG002|Overall Study|Withdrawal by Subject|2|||
23456249|NCT03661723|65412952|FG003|Overall Study|Withdrawal by Subject|4|||
23637704|NCT04608773|66057621|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
23344801|NCT00976209|65003965|FG000|Wash-out Period|Protocol Violation|1|||
23344802|NCT00976209|65003966|FG001|Wash-out Period|Protocol Violation|0|||
23344803|NCT00976209|65003965|FG000|Wash-out Period|Other|1|||
23344804|NCT00976209|65003966|FG001|Wash-out Period|Other|0|||
23344805|NCT00976209|65003965|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23344806|NCT00976209|65003966|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23344807|NCT00976209|65003965|FG000|Treatment Period 2|Lost to Follow-up|0|||
23344808|NCT00976209|65003966|FG001|Treatment Period 2|Lost to Follow-up|1|||
23344809|NCT03875092|65003968|FG000|Overall Study|Adverse Event|2|||
23344810|NCT03875092|65003969|FG001|Overall Study|Adverse Event|5|||
23344811|NCT03875092|65003968|FG000|Overall Study|Death|44|||
23344812|NCT03875092|65003969|FG001|Overall Study|Death|51|||
23344813|NCT03875092|65003968|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
23344814|NCT03875092|65003969|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
23344815|NCT01077739|65003973|FG000|Overall Study|Premature withdrawal|1|||
23344816|NCT01077739|65003974|FG001|Overall Study|Premature withdrawal|3|||
23456250|NCT03661723|65412949|FG000|Overall Study|Physician Decision|1|||
23456251|NCT03661723|65412950|FG001|Overall Study|Physician Decision|0|||
23344817|NCT01077739|65003973|FG000|Overall Study|Withdrawal by Subject|1|||
23344818|NCT01077739|65003974|FG001|Overall Study|Withdrawal by Subject|0|||
23344819|NCT01077739|65003973|FG000|Overall Study|Death|0|||
23456252|NCT03661723|65412951|FG002|Overall Study|Physician Decision|0|||
23456253|NCT03661723|65412952|FG003|Overall Study|Physician Decision|0|||
23456254|NCT03661723|65412949|FG000|Overall Study|Clinical Deterioration|0|||
23456255|NCT03661723|65412950|FG001|Overall Study|Clinical Deterioration|0|||
23456256|NCT03661723|65412951|FG002|Overall Study|Clinical Deterioration|0|||
23456257|NCT03661723|65412952|FG003|Overall Study|Clinical Deterioration|1|||
23456258|NCT03744312|65412955|FG000|Overall Study|Withdrawal by Subject|0|||
23456259|NCT03744312|65412956|FG001|Overall Study|Withdrawal by Subject|1|||
23456260|NCT03744312|65412955|FG000|Overall Study|Screen fail|0|||
23456261|NCT03744312|65412956|FG001|Overall Study|Screen fail|1|||
23456262|NCT02087423|65412962|FG000|Overall Study|Withdrawal by Subject|20|||
23456263|NCT02087423|65412963|FG001|Overall Study|Withdrawal by Subject|20|||
23456264|NCT02087423|65412964|FG002|Overall Study|Withdrawal by Subject|3|||
23456265|NCT02087423|65412962|FG000|Overall Study|Death|68|||
23456266|NCT02087423|65412963|FG001|Overall Study|Death|207|||
23456267|NCT02087423|65412964|FG002|Overall Study|Death|40|||
23456268|NCT02087423|65412962|FG000|Overall Study|Lost to Follow-up|0|||
23456269|NCT02087423|65412963|FG001|Overall Study|Lost to Follow-up|2|||
23456270|NCT02087423|65412964|FG002|Overall Study|Lost to Follow-up|0|||
23456271|NCT02087423|65412962|FG000|Overall Study|Terminated from study at final DCO|23|||
23456272|NCT02087423|65412963|FG001|Overall Study|Terminated from study at final DCO|36|||
23456273|NCT02087423|65412964|FG002|Overall Study|Terminated from study at final DCO|25|||
23456274|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
23456275|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
23456276|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
23456277|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
23456278|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
23456279|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
23456280|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
23456281|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
23456282|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
23784938|NCT00804856|66590406|FG001|Overall Study|Non compliance with protocol|0|||
23456283|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
23456284|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
23456285|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
23456286|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
23456287|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
23456288|NCT00141453|65412971|FG000|Overall Study|Protocol Violation|6|||
23456289|NCT00141453|65412972|FG001|Overall Study|Protocol Violation|5|||
23456290|NCT02336282|65412973|FG000|Overall Study|Unrelated illness|1|||
23456291|NCT02336282|65412973|FG000|Overall Study|Uncomfortable with technology|1|||
23456292|NCT02336282|65412973|FG000|Overall Study|Lost to Follow-up|1|||
23456293|NCT02336282|65412973|FG000|Overall Study|Not enough time to complete sessions|2|||
23456294|NCT01251965|65412977|FG000|Overall Study|Participant/physician decision|1|||
23456295|NCT01251965|65412978|FG001|Overall Study|Participant/physician decision|2|||
23456296|NCT01251965|65412979|FG002|Overall Study|Participant/physician decision|0|||
23456297|NCT01251965|65412977|FG000|Overall Study|Death|0|||
23456298|NCT01251965|65412978|FG001|Overall Study|Death|0|||
23456299|NCT01251965|65412979|FG002|Overall Study|Death|11|||
23456300|NCT01169103|65412980|FG000|Overall Study|Lost to Follow-up|3|||
23456301|NCT01169103|65412981|FG001|Overall Study|Lost to Follow-up|3|||
23456302|NCT01169103|65412980|FG000|Overall Study|Withdrawal by Subject|3|||
23456303|NCT01169103|65412981|FG001|Overall Study|Withdrawal by Subject|1|||
23456304|NCT02016781|65412982|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
23456305|NCT02016781|65412983|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
23456306|NCT02016781|65412982|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
23456307|NCT02016781|65412983|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
23456308|NCT02016781|65412982|FG000|Final Database Lock|Withdrawal by Subject|2|||
23456309|NCT02016781|65412983|FG001|Final Database Lock|Withdrawal by Subject|1|||
23456310|NCT02016781|65412982|FG000|Final Database Lock|Lost to Follow-up|11|||
23456311|NCT02016781|65412983|FG001|Final Database Lock|Lost to Follow-up|4|||
23456312|NCT02016781|65412982|FG000|Final Database Lock|Missing data|0|||
23456313|NCT02016781|65412983|FG001|Final Database Lock|Missing data|3|||
23456314|NCT02183675|65416371|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456315|NCT02183675|65416372|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456316|NCT02183675|65416373|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456317|NCT02183675|65416374|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456318|NCT02183675|65416375|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
23784939|NCT00804856|66590407|FG002|Overall Study|Non compliance with protocol|0|||
23784940|NCT00804856|66590408|FG003|Overall Study|Non compliance with protocol|0|||
23456319|NCT02183675|65416376|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
23456320|NCT03486912|65416377|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456321|NCT03486912|65416378|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
23456322|NCT03486912|65416379|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456323|NCT03486912|65416380|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456324|NCT03486912|65416377|FG000|Treatment Period|Withdrawal by Subject|3|||
23456325|NCT03486912|65416378|FG001|Treatment Period|Withdrawal by Subject|3|||
23456326|NCT03486912|65416379|FG002|Treatment Period|Withdrawal by Subject|3|||
23456327|NCT03486912|65416380|FG003|Treatment Period|Withdrawal by Subject|2|||
23456328|NCT03486912|65416377|FG000|Treatment Period|Other Reasons|0|||
23456329|NCT03486912|65416378|FG001|Treatment Period|Other Reasons|2|||
23456330|NCT03486912|65416379|FG002|Treatment Period|Other Reasons|1|||
23456331|NCT03486912|65416380|FG003|Treatment Period|Other Reasons|1|||
23456332|NCT03486912|65416377|FG000|Treatment Period|Adverse Event|0|||
23456333|NCT03486912|65416378|FG001|Treatment Period|Adverse Event|1|||
23456334|NCT03486912|65416379|FG002|Treatment Period|Adverse Event|1|||
23456335|NCT03486912|65416380|FG003|Treatment Period|Adverse Event|0|||
23456336|NCT03486912|65416377|FG000|Treatment Period|Lost to Follow-up|1|||
23456337|NCT03486912|65416378|FG001|Treatment Period|Lost to Follow-up|0|||
23456338|NCT03486912|65416379|FG002|Treatment Period|Lost to Follow-up|0|||
23456339|NCT03486912|65416380|FG003|Treatment Period|Lost to Follow-up|2|||
23456340|NCT03227757|65416381|FG000|Overall Study|Death|7|||
23456341|NCT03227757|65416381|FG000|Overall Study|Withdrawal|5|||
23456342|NCT03227757|65416381|FG000|Overall Study|Missed visits|4|||
23456343|NCT00784563|65416382|FG000|Years 1 & 2|Withdrawal by Subject|3|||
23456344|NCT00784563|65416383|FG001|Years 1 & 2|Withdrawal by Subject|2|||
23456345|NCT00784563|65416384|FG002|Years 1 & 2|Withdrawal by Subject|0|||
23784941|NCT00804856|66590409|FG004|Overall Study|Non compliance with protocol|0|||
23784942|NCT00804856|66590410|FG005|Overall Study|Non compliance with protocol|0|||
23784943|NCT00804856|66590411|FG006|Overall Study|Non compliance with protocol|0|||
23784944|NCT00804856|66590412|FG007|Overall Study|Non compliance with protocol|0|||
23784945|NCT00804856|66590413|FG008|Overall Study|Non compliance with protocol|0|||
23784946|NCT00804856|66590414|FG009|Overall Study|Non compliance with protocol|0|||
23784947|NCT00804856|66590415|FG010|Overall Study|Non compliance with protocol|0|||
23784948|NCT00804856|66590416|FG011|Overall Study|Non compliance with protocol|0|||
23784949|NCT00804856|66590417|FG012|Overall Study|Non compliance with protocol|0|||
23784950|NCT00804856|66590418|FG013|Overall Study|Non compliance with protocol|2|||
23784951|NCT00804856|66590419|FG014|Overall Study|Non compliance with protocol|0|||
23784952|NCT00804856|66590405|FG000|Overall Study|Refused to continue medication|0|||
23784953|NCT00804856|66590406|FG001|Overall Study|Refused to continue medication|0|||
23784954|NCT00804856|66590407|FG002|Overall Study|Refused to continue medication|0|||
23784955|NCT00804856|66590408|FG003|Overall Study|Refused to continue medication|1|||
23784956|NCT00804856|66590409|FG004|Overall Study|Refused to continue medication|1|||
23784957|NCT00804856|66590410|FG005|Overall Study|Refused to continue medication|0|||
23784958|NCT00804856|66590411|FG006|Overall Study|Refused to continue medication|0|||
23784959|NCT00804856|66590412|FG007|Overall Study|Refused to continue medication|0|||
23784960|NCT00804856|66590413|FG008|Overall Study|Refused to continue medication|0|||
23784961|NCT00804856|66590414|FG009|Overall Study|Refused to continue medication|0|||
23784962|NCT00804856|66590415|FG010|Overall Study|Refused to continue medication|3|||
23784963|NCT00804856|66590416|FG011|Overall Study|Refused to continue medication|0|||
23784964|NCT00804856|66590417|FG012|Overall Study|Refused to continue medication|1|||
23784965|NCT00804856|66590418|FG013|Overall Study|Refused to continue medication|1|||
23784966|NCT00804856|66590419|FG014|Overall Study|Refused to continue medication|5|||
23784967|NCT00804856|66590405|FG000|Overall Study|Other reason than listed above|0|||
23784968|NCT00804856|66590406|FG001|Overall Study|Other reason than listed above|0|||
23784969|NCT00804856|66590407|FG002|Overall Study|Other reason than listed above|0|||
23784970|NCT00804856|66590408|FG003|Overall Study|Other reason than listed above|0|||
23784971|NCT00804856|66590409|FG004|Overall Study|Other reason than listed above|0|||
23784972|NCT00804856|66590410|FG005|Overall Study|Other reason than listed above|1|||
23784973|NCT00804856|66590411|FG006|Overall Study|Other reason than listed above|0|||
23784974|NCT00804856|66590412|FG007|Overall Study|Other reason than listed above|0|||
23784975|NCT00804856|66590413|FG008|Overall Study|Other reason than listed above|1|||
23784976|NCT00804856|66590414|FG009|Overall Study|Other reason than listed above|0|||
23784977|NCT00804856|66590415|FG010|Overall Study|Other reason than listed above|3|||
23784978|NCT00804856|66590416|FG011|Overall Study|Other reason than listed above|1|||
23784979|NCT00804856|66590417|FG012|Overall Study|Other reason than listed above|1|||
23784980|NCT00804856|66590418|FG013|Overall Study|Other reason than listed above|10|||
23784981|NCT00804856|66590419|FG014|Overall Study|Other reason than listed above|3|||
23456346|NCT00784563|65416382|FG000|Years 1 & 2|Adverse Event|0|||
23456347|NCT00784563|65416383|FG001|Years 1 & 2|Adverse Event|3|||
23456348|NCT00784563|65416384|FG002|Years 1 & 2|Adverse Event|0|||
23456349|NCT00784563|65416382|FG000|Year 3|Withdrawal by Subject|0|||
23456350|NCT00784563|65416383|FG001|Year 3|Withdrawal by Subject|0|||
23456351|NCT00784563|65416384|FG002|Year 3|Withdrawal by Subject|2|||
23456352|NCT00784563|65416382|FG000|Year 3|Adverse Event|0|||
23456353|NCT00784563|65416383|FG001|Year 3|Adverse Event|0|||
23784982|NCT02842853|66590420|FG000|Overall Study|Non-compliance with the protocol|3|||
23784983|NCT02842853|66590421|FG001|Overall Study|Non-compliance with the protocol|7|||
23784984|NCT02842853|66590422|FG002|Overall Study|Non-compliance with the protocol|2|||
23784985|NCT02842853|66590423|FG003|Overall Study|Non-compliance with the protocol|5|||
23784986|NCT02842853|66590420|FG000|Overall Study|Subject met exclusion criteria|0|||
23784987|NCT02842853|66590421|FG001|Overall Study|Subject met exclusion criteria|1|||
23784988|NCT02842853|66590422|FG002|Overall Study|Subject met exclusion criteria|0|||
23784989|NCT02842853|66590423|FG003|Overall Study|Subject met exclusion criteria|0|||
23784990|NCT02842853|66590420|FG000|Overall Study|Withdrawal by Subject|11|||
23784991|NCT02842853|66590421|FG001|Overall Study|Withdrawal by Subject|13|||
23784992|NCT02842853|66590422|FG002|Overall Study|Withdrawal by Subject|9|||
23784993|NCT02842853|66590423|FG003|Overall Study|Withdrawal by Subject|8|||
23784994|NCT02842853|66590420|FG000|Overall Study|Lost to Follow-up|9|||
23784995|NCT02842853|66590421|FG001|Overall Study|Lost to Follow-up|13|||
23784996|NCT02842853|66590422|FG002|Overall Study|Lost to Follow-up|10|||
23784997|NCT02842853|66590423|FG003|Overall Study|Lost to Follow-up|11|||
23784998|NCT00745420|66590424|FG000|Overall Study|Ineligible|1|||
23784999|NCT02671435|66590425|FG000|Overall Study|Death|1|||
23785000|NCT02671435|66590426|FG001|Overall Study|Death|3|||
23785001|NCT02671435|66590427|FG002|Overall Study|Death|0|||
23785002|NCT02671435|66590428|FG003|Overall Study|Death|16|||
23785003|NCT02671435|66590429|FG004|Overall Study|Death|14|||
23785004|NCT02671435|66590430|FG005|Overall Study|Death|29|||
23785005|NCT02671435|66590431|FG006|Overall Study|Death|34|||
23785006|NCT02671435|66590432|FG007|Overall Study|Death|28|||
23785007|NCT02671435|66590433|FG008|Overall Study|Death|19|||
23785008|NCT02671435|66590434|FG009|Overall Study|Death|10|||
23456354|NCT00784563|65416384|FG002|Year 3|Adverse Event|1|||
23456355|NCT03585660|65416385|FG000|Overall Study|operator error|1|||
23456356|NCT03585660|65416385|FG000|Overall Study|technical error|2|||
23456357|NCT03585660|65416385|FG000|Overall Study|hip prosthesis|2|||
23456358|NCT03585660|65416385|FG000|Overall Study|did not undergo biopsy|8|||
23456359|NCT03585660|65416385|FG000|Overall Study|scanner problem|2|||
23456360|NCT03391466|65416386|FG000|Overall Study|Death|82|||
23456361|NCT03391466|65416387|FG001|Overall Study|Death|85|||
23456362|NCT03391466|65416386|FG000|Overall Study|Still on study|93|||
23456363|NCT03391466|65416387|FG001|Overall Study|Still on study|74|||
23456364|NCT03391466|65416386|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
23456365|NCT03391466|65416387|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
23456366|NCT03391466|65416386|FG000|Overall Study|Lost to Follow-up|5|||
23456367|NCT03391466|65416387|FG001|Overall Study|Lost to Follow-up|5|||
23456368|NCT03391466|65416386|FG000|Overall Study|Investigator decision|0|||
23456369|NCT03391466|65416387|FG001|Overall Study|Investigator decision|1|||
23456370|NCT03391466|65416386|FG000|Overall Study|Other|0|||
23456371|NCT03391466|65416387|FG001|Overall Study|Other|1|||
23456372|NCT04179500|65416390|FG000|Treatment|Withdrawal by Subject|1|||
23456373|NCT04179500|65416390|FG000|Treatment|Adverse Event|2|||
23456374|NCT04179500|65416390|FG000|Treatment|pyrazinamide resistance|1|||
23456375|NCT00886379|65416391|FG000|Overall Study|Transferred Schools|0|||
23456376|NCT00886379|65416392|FG001|Overall Study|Transferred Schools|0|||
23456377|NCT00886379|65416393|FG002|Overall Study|Transferred Schools|2|||
23456378|NCT00886379|65416394|FG003|Overall Study|Transferred Schools|1|||
23456379|NCT00886379|65416395|FG004|Overall Study|Transferred Schools|1|||
23456380|NCT00886379|65416391|FG000|Overall Study|Final blood draw not obtained|3|||
23456381|NCT00886379|65416392|FG001|Overall Study|Final blood draw not obtained|3|||
23456382|NCT00886379|65416393|FG002|Overall Study|Final blood draw not obtained|4|||
23456383|NCT00886379|65416394|FG003|Overall Study|Final blood draw not obtained|2|||
23456384|NCT00886379|65416395|FG004|Overall Study|Final blood draw not obtained|2|||
23456385|NCT00870740|65416396|FG000|Overall Study|Adverse Event|2|||
23456386|NCT00870740|65416397|FG001|Overall Study|Adverse Event|1|||
23456387|NCT00870740|65416398|FG002|Overall Study|Adverse Event|3|||
23456388|NCT00870740|65416399|FG003|Overall Study|Adverse Event|2|||
23456389|NCT00870740|65416400|FG004|Overall Study|Adverse Event|1|||
23583402|NCT04886596|65866016|FG001|Overall Study|Migrated / Moved from the study area|14|||
23583403|NCT04886596|65866015|FG000|Overall Study|Unknown reason|16|||
23637705|NCT04608773|66057622|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23785009|NCT02671435|66590435|FG010|Overall Study|Death|8|||
23456390|NCT00870740|65416401|FG005|Overall Study|Adverse Event|6|||
23456391|NCT00870740|65416396|FG000|Overall Study|Consent Withdrawn|6|||
23456392|NCT00870740|65416397|FG001|Overall Study|Consent Withdrawn|3|||
23456393|NCT00870740|65416398|FG002|Overall Study|Consent Withdrawn|4|||
23456394|NCT00870740|65416399|FG003|Overall Study|Consent Withdrawn|6|||
23785010|NCT02671435|66590436|FG011|Overall Study|Death|29|||
23456395|NCT00870740|65416400|FG004|Overall Study|Consent Withdrawn|6|||
23456396|NCT00870740|65416401|FG005|Overall Study|Consent Withdrawn|5|||
23456397|NCT00870740|65416396|FG000|Overall Study|Investigator Decision|2|||
23456398|NCT00870740|65416397|FG001|Overall Study|Investigator Decision|0|||
23785011|NCT02671435|66590437|FG012|Overall Study|Death|29|||
23456399|NCT00870740|65416398|FG002|Overall Study|Investigator Decision|1|||
23456400|NCT00870740|65416399|FG003|Overall Study|Investigator Decision|0|||
23456401|NCT00870740|65416400|FG004|Overall Study|Investigator Decision|0|||
23456402|NCT00870740|65416401|FG005|Overall Study|Investigator Decision|0|||
23456403|NCT00870740|65416396|FG000|Overall Study|Subject Non-compliance|0|||
23456404|NCT00870740|65416397|FG001|Overall Study|Subject Non-compliance|0|||
23456405|NCT00870740|65416398|FG002|Overall Study|Subject Non-compliance|0|||
23637706|NCT04608773|66057621|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
23637707|NCT04608773|66057622|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
23637708|NCT04608773|66057621|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
23637709|NCT04608773|66057622|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
23637710|NCT04608773|66057621|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
23785012|NCT02671435|66590438|FG013|Overall Study|Death|29|||
23785013|NCT02671435|66590439|FG014|Overall Study|Death|27|||
23785014|NCT02671435|66590425|FG000|Overall Study|Lost to Follow-up|0|||
23785015|NCT02671435|66590426|FG001|Overall Study|Lost to Follow-up|0|||
23785016|NCT02671435|66590427|FG002|Overall Study|Lost to Follow-up|1|||
23785017|NCT02671435|66590428|FG003|Overall Study|Lost to Follow-up|0|||
23785018|NCT02671435|66590429|FG004|Overall Study|Lost to Follow-up|1|||
23785019|NCT02671435|66590430|FG005|Overall Study|Lost to Follow-up|1|||
23785020|NCT02671435|66590431|FG006|Overall Study|Lost to Follow-up|2|||
23785021|NCT02671435|66590432|FG007|Overall Study|Lost to Follow-up|2|||
23785022|NCT02671435|66590433|FG008|Overall Study|Lost to Follow-up|0|||
23785023|NCT02671435|66590434|FG009|Overall Study|Lost to Follow-up|2|||
23785024|NCT02671435|66590435|FG010|Overall Study|Lost to Follow-up|0|||
23785025|NCT02671435|66590436|FG011|Overall Study|Lost to Follow-up|3|||
23785026|NCT02671435|66590437|FG012|Overall Study|Lost to Follow-up|3|||
23785027|NCT02671435|66590438|FG013|Overall Study|Lost to Follow-up|2|||
23344820|NCT01077739|65003974|FG001|Overall Study|Death|3|||
23344821|NCT01077739|65003973|FG000|Overall Study|Unacceptable toxicity|1|||
23344822|NCT01077739|65003974|FG001|Overall Study|Unacceptable toxicity|2|||
23344823|NCT01077739|65003973|FG000|Overall Study|Other|2|||
23344824|NCT01077739|65003974|FG001|Overall Study|Other|2|||
23344825|NCT02777970|65003977|FG000|Overall Study|Lost to Follow-up|0|||
23344826|NCT02777970|65003978|FG001|Overall Study|Lost to Follow-up|1|||
23344827|NCT02777970|65003979|FG002|Overall Study|Lost to Follow-up|0|||
23344828|NCT02777970|65003977|FG000|Overall Study|Protocol Violation|1|||
23344829|NCT02777970|65003978|FG001|Overall Study|Protocol Violation|0|||
23344830|NCT02777970|65003979|FG002|Overall Study|Protocol Violation|0|||
23344831|NCT03045276|65006636|FG000|Intervention Phase|Withdrawal by Subject|7|||
23344832|NCT03045276|65006637|FG001|Intervention Phase|Withdrawal by Subject|2|||
23344833|NCT03045276|65006638|FG002|Intervention Phase|Withdrawal by Subject|3|||
23344834|NCT03045276|65006639|FG003|Intervention Phase|Withdrawal by Subject|7|||
23344835|NCT03045276|65006636|FG000|Intervention Phase|Developed exclusionary criteria|3|||
23344836|NCT03045276|65006637|FG001|Intervention Phase|Developed exclusionary criteria|3|||
23344837|NCT03045276|65006638|FG002|Intervention Phase|Developed exclusionary criteria|0|||
23344838|NCT03045276|65006639|FG003|Intervention Phase|Developed exclusionary criteria|0|||
23344839|NCT03045276|65006636|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23344840|NCT03045276|65006637|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
23344841|NCT03045276|65006638|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
23344842|NCT03045276|65006639|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
23344843|NCT03045276|65006636|FG000|Follow-Up Phase|Lost to Follow-up|0|||
23344844|NCT03045276|65006637|FG001|Follow-Up Phase|Lost to Follow-up|1|||
23344845|NCT03045276|65006638|FG002|Follow-Up Phase|Lost to Follow-up|0|||
23344846|NCT03045276|65006639|FG003|Follow-Up Phase|Lost to Follow-up|1|||
23344847|NCT03045276|65006636|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
23344848|NCT03045276|65006637|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
23344849|NCT03045276|65006638|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
23344850|NCT03045276|65006639|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
23344851|NCT00712881|65006643|FG000|Overall Study|Adverse Event|3|||
23344852|NCT00712881|65006644|FG001|Overall Study|Adverse Event|3|||
23456406|NCT00870740|65416399|FG003|Overall Study|Subject Non-compliance|0|||
23456407|NCT00870740|65416400|FG004|Overall Study|Subject Non-compliance|0|||
23456408|NCT00870740|65416401|FG005|Overall Study|Subject Non-compliance|1|||
23344853|NCT00712881|65006643|FG000|Overall Study|Withdrawal by Subject|1|||
23344854|NCT00712881|65006644|FG001|Overall Study|Withdrawal by Subject|1|||
23344855|NCT00712881|65006643|FG000|Overall Study|Disease Progression|2|||
23637711|NCT04608773|66057622|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
23344856|NCT00712881|65006644|FG001|Overall Study|Disease Progression|1|||
23344857|NCT00712881|65006643|FG000|Overall Study|Lost to Follow-up|1|||
23344858|NCT00712881|65006644|FG001|Overall Study|Lost to Follow-up|1|||
23785028|NCT02671435|66590439|FG014|Overall Study|Lost to Follow-up|0|||
23785029|NCT02671435|66590425|FG000|Overall Study|Withdrawal by Subject|2|||
23785030|NCT02671435|66590426|FG001|Overall Study|Withdrawal by Subject|0|||
23785031|NCT02671435|66590427|FG002|Overall Study|Withdrawal by Subject|2|||
23456409|NCT00870740|65416396|FG000|Overall Study|Death|0|||
23456410|NCT00870740|65416397|FG001|Overall Study|Death|0|||
23456411|NCT00870740|65416398|FG002|Overall Study|Death|0|||
23456412|NCT00870740|65416399|FG003|Overall Study|Death|0|||
23344859|NCT00712881|65006643|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
23456413|NCT00870740|65416400|FG004|Overall Study|Death|1|||
23456414|NCT00870740|65416401|FG005|Overall Study|Death|0|||
23456415|NCT00870740|65416396|FG000|Overall Study|Other|2|||
23456416|NCT00870740|65416397|FG001|Overall Study|Other|5|||
23456417|NCT00870740|65416398|FG002|Overall Study|Other|2|||
23456418|NCT00870740|65416399|FG003|Overall Study|Other|4|||
23456419|NCT00870740|65416400|FG004|Overall Study|Other|3|||
23456420|NCT00870740|65416401|FG005|Overall Study|Other|5|||
23456421|NCT02953652|65416404|FG000|Overall Study|Adverse Event|18|||
23456422|NCT02953652|65416404|FG000|Overall Study|Withdrawal by Subject|6|||
23456423|NCT02953652|65416404|FG000|Overall Study|Protocol Violation|1|||
23456424|NCT02953652|65416404|FG000|Overall Study|Disease Progression|27|||
23456425|NCT00280917|65416406|FG000|Overall Study|Adverse Event|1|||
23456426|NCT00280917|65416407|FG001|Overall Study|Adverse Event|1|||
23456427|NCT00280917|65416408|FG002|Overall Study|Adverse Event|4|||
23456428|NCT00280917|65416409|FG003|Overall Study|Adverse Event|1|||
23456429|NCT00280917|65416406|FG000|Overall Study|Change Therapy|1|||
23456430|NCT00280917|65416407|FG001|Overall Study|Change Therapy|2|||
23456431|NCT00280917|65416408|FG002|Overall Study|Change Therapy|0|||
23456432|NCT00280917|65416409|FG003|Overall Study|Change Therapy|0|||
23456433|NCT00280917|65416406|FG000|Overall Study|Withdrawal by Subject|0|||
23456434|NCT00280917|65416407|FG001|Overall Study|Withdrawal by Subject|2|||
23456435|NCT00280917|65416408|FG002|Overall Study|Withdrawal by Subject|0|||
23456436|NCT00280917|65416409|FG003|Overall Study|Withdrawal by Subject|1|||
23456437|NCT00280917|65416406|FG000|Overall Study|Noncompliance|0|||
23456438|NCT00280917|65416407|FG001|Overall Study|Noncompliance|1|||
23456439|NCT00280917|65416408|FG002|Overall Study|Noncompliance|2|||
23456440|NCT00280917|65416409|FG003|Overall Study|Noncompliance|0|||
23456441|NCT03409796|65416410|FG000|Overall Study|Adverse Event|2|||
23456442|NCT03409796|65416411|FG001|Overall Study|Adverse Event|0|||
23456443|NCT03409796|65416410|FG000|Overall Study|Other|0|||
23456444|NCT03409796|65416411|FG001|Overall Study|Other|1|||
23456445|NCT00005780|65416412|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
23456446|NCT02731638|65416413|FG000|Overall Study|Lost to Follow-up|6|||
23456447|NCT02731638|65416414|FG001|Overall Study|Lost to Follow-up|9|||
23456448|NCT03379675|65416421|FG000|Overall Study|Lost to Follow-up|0|||
23456449|NCT03379675|65416422|FG001|Overall Study|Lost to Follow-up|1|||
23456450|NCT03379675|65416423|FG002|Overall Study|Lost to Follow-up|0|||
23456451|NCT03379675|65416421|FG000|Overall Study|Adverse Event|2|||
23456452|NCT03379675|65416422|FG001|Overall Study|Adverse Event|0|||
23456453|NCT03379675|65416423|FG002|Overall Study|Adverse Event|0|||
23456454|NCT03379675|65416421|FG000|Overall Study|Withdrawal by Subject|2|||
23456455|NCT03379675|65416422|FG001|Overall Study|Withdrawal by Subject|1|||
23456456|NCT03379675|65416423|FG002|Overall Study|Withdrawal by Subject|2|||
23456457|NCT00468169|65416424|FG000|Overall Study|Withdrawal by Subject|1|||
23583404|NCT04886596|65866016|FG001|Overall Study|Unknown reason|23|||
23583405|NCT03631199|65866019|FG000|Overall Study|Progressive disease|9|||
23785032|NCT02671435|66590428|FG003|Overall Study|Withdrawal by Subject|2|||
23785033|NCT02671435|66590429|FG004|Overall Study|Withdrawal by Subject|2|||
23785034|NCT02671435|66590430|FG005|Overall Study|Withdrawal by Subject|7|||
23785035|NCT02671435|66590431|FG006|Overall Study|Withdrawal by Subject|2|||
23785036|NCT02671435|66590432|FG007|Overall Study|Withdrawal by Subject|7|||
23785037|NCT02671435|66590433|FG008|Overall Study|Withdrawal by Subject|1|||
23785038|NCT02671435|66590434|FG009|Overall Study|Withdrawal by Subject|1|||
23785039|NCT02671435|66590435|FG010|Overall Study|Withdrawal by Subject|2|||
23344860|NCT00712881|65006644|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
23344861|NCT00712881|65006643|FG000|Overall Study|Protocol Violation|1|||
23344862|NCT00712881|65006644|FG001|Overall Study|Protocol Violation|1|||
23344863|NCT00712881|65006643|FG000|Overall Study|Randomized but not treated|1|||
23344864|NCT00712881|65006644|FG001|Overall Study|Randomized but not treated|0|||
23344865|NCT03605849|65006647|FG000|Overall Study|Adverse Event|20|||
23344866|NCT03605849|65006648|FG001|Overall Study|Adverse Event|21|||
23344867|NCT03605849|65006649|FG002|Overall Study|Adverse Event|29|||
23344868|NCT03605849|65006650|FG003|Overall Study|Adverse Event|11|||
23456458|NCT00468169|65416425|FG001|Overall Study|Withdrawal by Subject|0|||
23456459|NCT01345240|65416428|FG000|Overall Study|Adverse Event|3|||
23456460|NCT01345240|65416429|FG001|Overall Study|Adverse Event|5|||
23456461|NCT01345240|65416430|FG002|Overall Study|Adverse Event|4|||
23456462|NCT01345240|65416431|FG003|Overall Study|Adverse Event|2|||
23456463|NCT01345240|65416432|FG004|Overall Study|Adverse Event|1|||
23456464|NCT01345240|65416428|FG000|Overall Study|Lost to Follow-up|8|||
23456465|NCT01345240|65416429|FG001|Overall Study|Lost to Follow-up|9|||
23583406|NCT03631199|65866020|FG001|Overall Study|Progressive disease|5|||
23785040|NCT02671435|66590436|FG011|Overall Study|Withdrawal by Subject|4|||
23456466|NCT01345240|65416430|FG002|Overall Study|Lost to Follow-up|14|||
23456467|NCT01345240|65416431|FG003|Overall Study|Lost to Follow-up|7|||
23456468|NCT01345240|65416432|FG004|Overall Study|Lost to Follow-up|9|||
23456469|NCT02903914|65416433|FG000|Overall Study|Adverse Event|0|||
23456470|NCT02903914|65416434|FG001|Overall Study|Adverse Event|0|||
23456471|NCT02903914|65416435|FG002|Overall Study|Adverse Event|1|||
23456472|NCT02903914|65416436|FG003|Overall Study|Adverse Event|0|||
23456473|NCT02903914|65416437|FG004|Overall Study|Adverse Event|0|||
23456474|NCT02903914|65416438|FG005|Overall Study|Adverse Event|0|||
23456475|NCT02903914|65416439|FG006|Overall Study|Adverse Event|2|||
23456476|NCT02903914|65416440|FG007|Overall Study|Adverse Event|0|||
23456477|NCT02903914|65416433|FG000|Overall Study|Withdrawal by Subject|3|||
23456478|NCT02903914|65416434|FG001|Overall Study|Withdrawal by Subject|1|||
23456479|NCT02903914|65416435|FG002|Overall Study|Withdrawal by Subject|28|||
23456480|NCT02903914|65416436|FG003|Overall Study|Withdrawal by Subject|0|||
23456481|NCT02903914|65416437|FG004|Overall Study|Withdrawal by Subject|1|||
23456482|NCT02903914|65416438|FG005|Overall Study|Withdrawal by Subject|2|||
23456483|NCT02903914|65416439|FG006|Overall Study|Withdrawal by Subject|12|||
23456484|NCT02903914|65416440|FG007|Overall Study|Withdrawal by Subject|0|||
23785041|NCT02671435|66590437|FG012|Overall Study|Withdrawal by Subject|4|||
23785042|NCT02671435|66590438|FG013|Overall Study|Withdrawal by Subject|4|||
23785043|NCT02671435|66590439|FG014|Overall Study|Withdrawal by Subject|2|||
23785044|NCT02671435|66590425|FG000|Overall Study|Un-specified|0|||
23785045|NCT02671435|66590426|FG001|Overall Study|Un-specified|0|||
23785046|NCT02671435|66590427|FG002|Overall Study|Un-specified|0|||
23785047|NCT02671435|66590428|FG003|Overall Study|Un-specified|0|||
23785048|NCT02671435|66590429|FG004|Overall Study|Un-specified|1|||
23785049|NCT02671435|66590430|FG005|Overall Study|Un-specified|3|||
23785050|NCT02671435|66590431|FG006|Overall Study|Un-specified|2|||
23785051|NCT02671435|66590432|FG007|Overall Study|Un-specified|3|||
23785052|NCT02671435|66590433|FG008|Overall Study|Un-specified|0|||
23456485|NCT02903914|65416433|FG000|Overall Study|Progressive Disease|1|||
23785053|NCT02671435|66590434|FG009|Overall Study|Un-specified|5|||
23785054|NCT02671435|66590435|FG010|Overall Study|Un-specified|8|||
23785055|NCT02671435|66590436|FG011|Overall Study|Un-specified|4|||
23785056|NCT02671435|66590437|FG012|Overall Study|Un-specified|5|||
23785057|NCT02671435|66590438|FG013|Overall Study|Un-specified|9|||
23785058|NCT02671435|66590439|FG014|Overall Study|Un-specified|8|||
23785059|NCT00316277|66590442|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
23785060|NCT00316277|66590443|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
23785061|NCT00316277|66590442|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
23456486|NCT02903914|65416434|FG001|Overall Study|Progressive Disease|0|||
23456487|NCT02903914|65416435|FG002|Overall Study|Progressive Disease|4|||
23456488|NCT02903914|65416436|FG003|Overall Study|Progressive Disease|0|||
23456489|NCT02903914|65416437|FG004|Overall Study|Progressive Disease|0|||
23456490|NCT02903914|65416438|FG005|Overall Study|Progressive Disease|0|||
23456491|NCT02903914|65416439|FG006|Overall Study|Progressive Disease|2|||
23456492|NCT02903914|65416440|FG007|Overall Study|Progressive Disease|0|||
23456493|NCT02903914|65416433|FG000|Overall Study|Death|0|||
23456494|NCT02903914|65416434|FG001|Overall Study|Death|0|||
23456495|NCT02903914|65416435|FG002|Overall Study|Death|9|||
23456496|NCT02903914|65416436|FG003|Overall Study|Death|0|||
23456497|NCT02903914|65416437|FG004|Overall Study|Death|1|||
23456498|NCT02903914|65416438|FG005|Overall Study|Death|3|||
23456499|NCT02903914|65416439|FG006|Overall Study|Death|24|||
23456500|NCT02903914|65416440|FG007|Overall Study|Death|2|||
23456501|NCT02903914|65416433|FG000|Overall Study|Lost to Follow-up|0|||
23456502|NCT02903914|65416434|FG001|Overall Study|Lost to Follow-up|1|||
23456503|NCT02903914|65416435|FG002|Overall Study|Lost to Follow-up|0|||
23785062|NCT00316277|66590443|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
23785063|NCT00316277|66590442|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
23456504|NCT02903914|65416436|FG003|Overall Study|Lost to Follow-up|0|||
23456505|NCT02903914|65416437|FG004|Overall Study|Lost to Follow-up|2|||
23456506|NCT02903914|65416438|FG005|Overall Study|Lost to Follow-up|0|||
23456507|NCT02903914|65416439|FG006|Overall Study|Lost to Follow-up|1|||
23456508|NCT02903914|65416440|FG007|Overall Study|Lost to Follow-up|0|||
23456509|NCT02903914|65416433|FG000|Overall Study|Physician Decision|0|||
23456510|NCT02903914|65416434|FG001|Overall Study|Physician Decision|0|||
23456511|NCT02903914|65416435|FG002|Overall Study|Physician Decision|1|||
23456512|NCT02903914|65416436|FG003|Overall Study|Physician Decision|0|||
23456513|NCT02903914|65416437|FG004|Overall Study|Physician Decision|0|||
23785064|NCT00316277|66590443|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
23785065|NCT00316277|66590442|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
23785066|NCT00316277|66590443|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
23456514|NCT02903914|65416438|FG005|Overall Study|Physician Decision|0|||
23456515|NCT02903914|65416439|FG006|Overall Study|Physician Decision|1|||
23456516|NCT02903914|65416440|FG007|Overall Study|Physician Decision|0|||
23456517|NCT02903914|65416433|FG000|Overall Study|Symptomatic Deterioration|0|||
23456518|NCT02903914|65416434|FG001|Overall Study|Symptomatic Deterioration|0|||
23456519|NCT02903914|65416435|FG002|Overall Study|Symptomatic Deterioration|1|||
23456520|NCT02903914|65416436|FG003|Overall Study|Symptomatic Deterioration|0|||
23456521|NCT02903914|65416437|FG004|Overall Study|Symptomatic Deterioration|0|||
23456522|NCT02903914|65416438|FG005|Overall Study|Symptomatic Deterioration|0|||
23456523|NCT02903914|65416439|FG006|Overall Study|Symptomatic Deterioration|0|||
23456524|NCT02903914|65416440|FG007|Overall Study|Symptomatic Deterioration|0|||
23456525|NCT02903914|65416433|FG000|Overall Study|New Cancer Therapy|2|||
23785067|NCT00316277|66590442|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
23785068|NCT00316277|66590443|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
23785069|NCT00836056|66590445|FG000|First Intervention|Adverse Event|1|||
23785070|NCT00836056|66590446|FG001|First Intervention|Adverse Event|0|||
23785071|NCT00829452|66590447|FG000|First Intervention|Withdrawal by Subject|0|||
23785072|NCT00829452|66590448|FG001|First Intervention|Withdrawal by Subject|1|||
23785073|NCT00829452|66590447|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
23785074|NCT00829452|66590448|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
23785075|NCT00829452|66590447|FG000|Second Intervention|Physician Decision|0|||
23785076|NCT00829452|66590448|FG001|Second Intervention|Physician Decision|1|||
23785077|NCT02974621|66590455|FG000|Overall Study|Didn't receive study treatment|1|||
23785078|NCT02974621|66590456|FG001|Overall Study|Didn't receive study treatment|10|||
23785079|NCT00545792|66590457|FG000|Overall Study|Withdrawal by Subject|1|||
23456526|NCT02903914|65416434|FG001|Overall Study|New Cancer Therapy|2|||
23456527|NCT02903914|65416435|FG002|Overall Study|New Cancer Therapy|21|||
23456528|NCT02903914|65416436|FG003|Overall Study|New Cancer Therapy|4|||
23456529|NCT02903914|65416437|FG004|Overall Study|New Cancer Therapy|3|||
23456530|NCT02903914|65416438|FG005|Overall Study|New Cancer Therapy|6|||
23456531|NCT02903914|65416439|FG006|Overall Study|New Cancer Therapy|56|||
23456532|NCT02903914|65416440|FG007|Overall Study|New Cancer Therapy|3|||
23456533|NCT02903914|65416433|FG000|Overall Study|Didn't Return to Site|1|||
23456534|NCT02903914|65416434|FG001|Overall Study|Didn't Return to Site|0|||
23456535|NCT02903914|65416435|FG002|Overall Study|Didn't Return to Site|1|||
23456536|NCT02903914|65416436|FG003|Overall Study|Didn't Return to Site|1|||
23456537|NCT02903914|65416437|FG004|Overall Study|Didn't Return to Site|0|||
23456538|NCT02903914|65416438|FG005|Overall Study|Didn't Return to Site|0|||
23456539|NCT02903914|65416439|FG006|Overall Study|Didn't Return to Site|2|||
23456540|NCT02903914|65416440|FG007|Overall Study|Didn't Return to Site|0|||
23456541|NCT02903914|65416433|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
23456542|NCT02903914|65416434|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
23456543|NCT02903914|65416435|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
23456544|NCT02903914|65416436|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
23456545|NCT02903914|65416437|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
23456546|NCT02903914|65416438|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
23456547|NCT02903914|65416439|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
23456548|NCT02903914|65416440|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
23456549|NCT02903914|65416433|FG000|Overall Study|Follow-up Did Not Occur|0|||
23456550|NCT02903914|65416434|FG001|Overall Study|Follow-up Did Not Occur|1|||
23456551|NCT02903914|65416435|FG002|Overall Study|Follow-up Did Not Occur|1|||
23456552|NCT02903914|65416436|FG003|Overall Study|Follow-up Did Not Occur|0|||
23456553|NCT02903914|65416437|FG004|Overall Study|Follow-up Did Not Occur|2|||
23456554|NCT02903914|65416438|FG005|Overall Study|Follow-up Did Not Occur|0|||
23456555|NCT02903914|65416439|FG006|Overall Study|Follow-up Did Not Occur|8|||
23456556|NCT02903914|65416440|FG007|Overall Study|Follow-up Did Not Occur|0|||
23456557|NCT02903914|65416433|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
23456558|NCT02903914|65416434|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
23456559|NCT02903914|65416435|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
23456560|NCT02903914|65416436|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
23785080|NCT01124175|66590458|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23456561|NCT02903914|65416437|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
23456562|NCT02903914|65416438|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
23583407|NCT03631199|65866021|FG002|Overall Study|Progressive disease|5|||
23785081|NCT01124175|66590459|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
23785082|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Adverse Event|8|||
23785083|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Adverse Event|15|||
23785084|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Adverse Event|25|||
23456563|NCT02903914|65416439|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
23456564|NCT02903914|65416440|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
23456565|NCT02903914|65416433|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456566|NCT02903914|65416434|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
23344869|NCT03605849|65006647|FG000|Overall Study|Lack of Efficacy|4|||
23456567|NCT02903914|65416435|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
23456568|NCT02903914|65416436|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456569|NCT02903914|65416437|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456570|NCT02903914|65416438|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
23456571|NCT02903914|65416439|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456572|NCT02903914|65416440|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456573|NCT02903914|65416433|FG000|Overall Study|Clinical Disease Progression|0|||
23456574|NCT02903914|65416434|FG001|Overall Study|Clinical Disease Progression|0|||
23456575|NCT02903914|65416435|FG002|Overall Study|Clinical Disease Progression|2|||
23456576|NCT02903914|65416436|FG003|Overall Study|Clinical Disease Progression|0|||
23456577|NCT02903914|65416437|FG004|Overall Study|Clinical Disease Progression|0|||
23456578|NCT02903914|65416438|FG005|Overall Study|Clinical Disease Progression|0|||
23456579|NCT02903914|65416439|FG006|Overall Study|Clinical Disease Progression|0|||
23456580|NCT02903914|65416440|FG007|Overall Study|Clinical Disease Progression|0|||
23456581|NCT02903914|65416433|FG000|Overall Study|Completed Follow-up Period|0|||
23456582|NCT02903914|65416434|FG001|Overall Study|Completed Follow-up Period|0|||
23456583|NCT02903914|65416435|FG002|Overall Study|Completed Follow-up Period|6|||
23456584|NCT02903914|65416436|FG003|Overall Study|Completed Follow-up Period|2|||
23456585|NCT02903914|65416437|FG004|Overall Study|Completed Follow-up Period|1|||
23456586|NCT02903914|65416438|FG005|Overall Study|Completed Follow-up Period|0|||
23456587|NCT02903914|65416439|FG006|Overall Study|Completed Follow-up Period|9|||
23456588|NCT02903914|65416440|FG007|Overall Study|Completed Follow-up Period|1|||
23456589|NCT02903914|65416433|FG000|Overall Study|Taken off Treatment per Protocol|0|||
23456590|NCT02903914|65416434|FG001|Overall Study|Taken off Treatment per Protocol|0|||
23456591|NCT02903914|65416435|FG002|Overall Study|Taken off Treatment per Protocol|0|||
23456592|NCT02903914|65416436|FG003|Overall Study|Taken off Treatment per Protocol|0|||
23456593|NCT02903914|65416437|FG004|Overall Study|Taken off Treatment per Protocol|0|||
23456594|NCT02903914|65416438|FG005|Overall Study|Taken off Treatment per Protocol|1|||
23456595|NCT02903914|65416439|FG006|Overall Study|Taken off Treatment per Protocol|0|||
23456596|NCT02903914|65416440|FG007|Overall Study|Taken off Treatment per Protocol|0|||
23456597|NCT02903914|65416433|FG000|Overall Study|Refused Further Treatment/Contact|0|||
23456598|NCT02903914|65416434|FG001|Overall Study|Refused Further Treatment/Contact|0|||
23456599|NCT02903914|65416435|FG002|Overall Study|Refused Further Treatment/Contact|0|||
23456600|NCT02903914|65416436|FG003|Overall Study|Refused Further Treatment/Contact|0|||
23456601|NCT02903914|65416437|FG004|Overall Study|Refused Further Treatment/Contact|0|||
23456602|NCT02903914|65416438|FG005|Overall Study|Refused Further Treatment/Contact|0|||
23456603|NCT02903914|65416439|FG006|Overall Study|Refused Further Treatment/Contact|1|||
23456604|NCT02903914|65416440|FG007|Overall Study|Refused Further Treatment/Contact|0|||
23456605|NCT02903914|65416433|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456606|NCT02903914|65416434|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456607|NCT02903914|65416435|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456608|NCT02903914|65416436|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456609|NCT02903914|65416437|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456610|NCT02903914|65416438|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456611|NCT02903914|65416439|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
23456612|NCT02903914|65416440|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456613|NCT00703014|65416447|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
23456614|NCT00703014|65416448|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
23456615|NCT00703014|65416449|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456616|NCT00703014|65416450|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456617|NCT00703014|65416447|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456618|NCT00703014|65416448|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456619|NCT00703014|65416449|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
23456620|NCT00703014|65416450|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
23456621|NCT04698343|65416451|FG000|Overall Study|Withdrawal by Subject|6|||
23456622|NCT04698343|65416451|FG000|Overall Study|Physician Decision|2|||
23456623|NCT04698343|65416451|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
23456624|NCT04698343|65416451|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
23456625|NCT04698343|65416451|FG000|Overall Study|Personal reasons|3|||
23456626|NCT04698343|65416451|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
23456627|NCT03629886|65416455|FG000|Overall Study|Migrated / moved from the study area|0|||
23637712|NCT00858364|66057623|FG000|Overall Study|Administrative Decision|3|||
23456628|NCT03629886|65416456|FG001|Overall Study|Migrated / moved from the study area|55|||
23456629|NCT03629886|65416455|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
23456630|NCT03629886|65416456|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
23456631|NCT03629886|65416455|FG000|Overall Study|Study vaccine not administrated|0|||
23456632|NCT03629886|65416456|FG001|Overall Study|Study vaccine not administrated|3|||
23456633|NCT03629886|65416455|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
23456634|NCT03629886|65416456|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
23456635|NCT03629886|65416455|FG000|Overall Study|Refused vaccination step of the study|0|||
23456636|NCT03629886|65416456|FG001|Overall Study|Refused vaccination step of the study|44|||
23456637|NCT02163538|65416457|FG000|Overall Study|Protocol Violation|1|||
23456638|NCT02163538|65416458|FG001|Overall Study|Protocol Violation|0|||
23456639|NCT02163538|65416457|FG000|Overall Study|Physician Decision|0|||
23456640|NCT02163538|65416458|FG001|Overall Study|Physician Decision|1|||
23456641|NCT01502293|65416462|FG000|Overall Study|Progressive Disease|20|||
23456642|NCT01502293|65416463|FG001|Overall Study|Progressive Disease|12|||
23456643|NCT01502293|65416464|FG002|Overall Study|Progressive Disease|2|||
23456644|NCT01502293|65416462|FG000|Overall Study|Withdrawal by Subject|3|||
23456645|NCT01502293|65416463|FG001|Overall Study|Withdrawal by Subject|3|||
23456646|NCT01502293|65416464|FG002|Overall Study|Withdrawal by Subject|1|||
23456647|NCT01502293|65416462|FG000|Overall Study|Adverse Event|0|||
23456648|NCT01502293|65416463|FG001|Overall Study|Adverse Event|2|||
23456649|NCT01502293|65416464|FG002|Overall Study|Adverse Event|0|||
23456650|NCT01502293|65416462|FG000|Overall Study|Reason Not Specified|2|||
23456651|NCT01502293|65416463|FG001|Overall Study|Reason Not Specified|0|||
23456652|NCT01502293|65416464|FG002|Overall Study|Reason Not Specified|0|||
23456653|NCT01502293|65416462|FG000|Overall Study|Physician Decision|0|||
23456654|NCT01502293|65416463|FG001|Overall Study|Physician Decision|0|||
23456655|NCT01502293|65416464|FG002|Overall Study|Physician Decision|1|||
23456656|NCT00633477|65416469|FG000|Overall Study|Death|1|||
23456657|NCT00633477|65416470|FG001|Overall Study|Death|0|||
23456658|NCT00633477|65416469|FG000|Overall Study|Randomized but not treated|1|||
23456659|NCT00633477|65416470|FG001|Overall Study|Randomized but not treated|0|||
23456660|NCT03547518|65416471|FG000|Overall Study|Lost to Follow-up|2|||
23344870|NCT03605849|65006648|FG001|Overall Study|Lack of Efficacy|7|||
23456661|NCT03547518|65416472|FG001|Overall Study|Lost to Follow-up|0|||
23456662|NCT02741128|65416473|FG000|Overall Study|Protocol Violation|4|||
23456663|NCT02741128|65416474|FG001|Overall Study|Protocol Violation|1|||
23456664|NCT02741128|65416473|FG000|Overall Study|Withdrawal by Subject|2|||
23456665|NCT02741128|65416474|FG001|Overall Study|Withdrawal by Subject|0|||
23456666|NCT02741128|65416473|FG000|Overall Study|Lost to Follow-up|1|||
23456667|NCT02741128|65416474|FG001|Overall Study|Lost to Follow-up|0|||
23456668|NCT04235140|65416475|FG000|Overall Study|Adverse Event|2|||
23456669|NCT04235140|65416475|FG000|Overall Study|Lost to Follow-up|1|||
23456670|NCT04235140|65416475|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
23456671|NCT04235140|65416475|FG000|Overall Study|Commercial drug is available for participants|7|||
23456672|NCT03724942|65416476|FG000|Overall Study|Adverse Event|20|||
23456673|NCT03724942|65416477|FG001|Overall Study|Adverse Event|14|||
23456674|NCT03724942|65416476|FG000|Overall Study|Lack of Efficacy|0|||
23456675|NCT03724942|65416477|FG001|Overall Study|Lack of Efficacy|1|||
23456676|NCT03724942|65416476|FG000|Overall Study|Physician Decision|5|||
23456677|NCT03724942|65416477|FG001|Overall Study|Physician Decision|2|||
23456678|NCT03724942|65416476|FG000|Overall Study|Protocol Violation|1|||
23456679|NCT03724942|65416477|FG001|Overall Study|Protocol Violation|0|||
23456680|NCT03724942|65416476|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
23456681|NCT03724942|65416477|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
23456682|NCT03724942|65416476|FG000|Overall Study|Withdrawal by Legal Representative|3|||
23456683|NCT03724942|65416477|FG001|Overall Study|Withdrawal by Legal Representative|0|||
23456684|NCT01903356|65416478|FG000|Overall Study|Lost to Follow-up|7|||
23456685|NCT01903356|65416478|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
23456686|NCT01903356|65416478|FG000|Overall Study|Violated the dosage and administration|3|||
23456687|NCT01383928|65416479|FG000|Overall Study|Initiation of ASCT|2|||
23456688|NCT01383928|65416480|FG001|Overall Study|Initiation of ASCT|1|||
23456689|NCT01383928|65416481|FG002|Overall Study|Initiation of ASCT|18|||
23456690|NCT01383928|65416479|FG000|Overall Study|Adverse Event|1|||
23456691|NCT01383928|65416480|FG001|Overall Study|Adverse Event|2|||
23456692|NCT01383928|65416481|FG002|Overall Study|Adverse Event|8|||
23456693|NCT01383928|65416479|FG000|Overall Study|Other|1|||
23456694|NCT01383928|65416480|FG001|Overall Study|Other|3|||
23456695|NCT01383928|65416481|FG002|Overall Study|Other|4|||
23456696|NCT01383928|65416479|FG000|Overall Study|Progressive Disease|1|||
23456697|NCT01383928|65416480|FG001|Overall Study|Progressive Disease|1|||
23456698|NCT01383928|65416481|FG002|Overall Study|Progressive Disease|5|||
23456699|NCT01383928|65416479|FG000|Overall Study|Withdrawal by Subject|0|||
23456700|NCT01383928|65416480|FG001|Overall Study|Withdrawal by Subject|0|||
23456701|NCT01383928|65416481|FG002|Overall Study|Withdrawal by Subject|4|||
23456702|NCT01383928|65416479|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
23456703|NCT01383928|65416480|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23456704|NCT01383928|65416481|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
23456705|NCT01339832|65416482|FG000|Overall Study|Lost to Follow-up|3|||
23456706|NCT01339832|65416482|FG000|Overall Study|Death|11|||
23456707|NCT05543265|65416483|FG000|Overall Study|Lost to Follow-up|3|||
23456708|NCT05543265|65416484|FG001|Overall Study|Lost to Follow-up|3|||
23456709|NCT05543265|65416483|FG000|Overall Study|Withdrawal by Subject|0|||
23456710|NCT05543265|65416484|FG001|Overall Study|Withdrawal by Subject|1|||
23456711|NCT02101775|65416497|FG000|Overall Study|Adverse Event|4|||
23456712|NCT02101775|65416498|FG001|Overall Study|Adverse Event|0|||
23456713|NCT02101775|65416499|FG002|Overall Study|Adverse Event|0|||
23456714|NCT02101775|65416497|FG000|Overall Study|Admission to Hospital|0|||
23456715|NCT02101775|65416498|FG001|Overall Study|Admission to Hospital|1|||
23456716|NCT02101775|65416499|FG002|Overall Study|Admission to Hospital|0|||
23456717|NCT00005906|65416502|FG000|Overall Study|Lack of Efficacy|3|||
23456718|NCT05468814|65416504|FG000|Overall Study|Lost to Follow-up|5|||
23456719|NCT05468814|65416505|FG001|Overall Study|Lost to Follow-up|6|||
23456720|NCT01775501|65416506|FG000|Overall Study|Discontinued prior to treatment|1|||
23456721|NCT04949191|65416512|FG000|Overall Study|Non-compliance with Study Drug|1|||
23456722|NCT04949191|65416513|FG001|Overall Study|Non-compliance with Study Drug|0|||
23456723|NCT04949191|65416514|FG002|Overall Study|Non-compliance with Study Drug|0|||
23456724|NCT04949191|65416515|FG003|Overall Study|Non-compliance with Study Drug|0|||
23456725|NCT04949191|65416512|FG000|Overall Study|Progressive Disease|0|||
23456726|NCT04949191|65416513|FG001|Overall Study|Progressive Disease|1|||
23456727|NCT04949191|65416514|FG002|Overall Study|Progressive Disease|0|||
23456728|NCT04949191|65416515|FG003|Overall Study|Progressive Disease|0|||
23456729|NCT04949191|65416512|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456730|NCT04949191|65416513|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
23456731|NCT04949191|65416514|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456732|NCT04949191|65416515|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456733|NCT04949191|65416512|FG000|Overall Study|Sponsor Terminated Study|0|||
23456734|NCT04949191|65416513|FG001|Overall Study|Sponsor Terminated Study|0|||
23456735|NCT04949191|65416514|FG002|Overall Study|Sponsor Terminated Study|1|||
23456736|NCT04949191|65416515|FG003|Overall Study|Sponsor Terminated Study|1|||
23456737|NCT03770260|65416518|FG000|Overall Study|Disease progression|0|||
23456738|NCT03770260|65416519|FG001|Overall Study|Disease progression|1|||
23456739|NCT03770260|65416520|FG002|Overall Study|Disease progression|0|||
23456740|NCT03770260|65416521|FG003|Overall Study|Disease progression|0|||
23456741|NCT04913610|65416522|FG000|Randomized Participants|Did Not Receive Treatment|0|||
23456742|NCT04913610|65416523|FG001|Randomized Participants|Did Not Receive Treatment|0|||
23456743|NCT04913610|65416524|FG002|Randomized Participants|Did Not Receive Treatment|1|||
23456744|NCT04913610|65416525|FG003|Randomized Participants|Did Not Receive Treatment|1|||
23456745|NCT04913610|65416526|FG004|Randomized Participants|Did Not Receive Treatment|0|||
23456746|NCT04913610|65416522|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
23456747|NCT04913610|65416523|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456748|NCT04913610|65416524|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456749|NCT04913610|65416525|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456750|NCT04913610|65416526|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
23456751|NCT00537394|65416536|FG000|First Year of Follow-up|Death|7|||
23456752|NCT00537394|65416537|FG001|First Year of Follow-up|Death|0|||
23456753|NCT00537394|65416538|FG002|First Year of Follow-up|Death|0|||
23456754|NCT00537394|65416536|FG000|First Year of Follow-up|Severe debilitation|1|||
23456755|NCT00537394|65416537|FG001|First Year of Follow-up|Severe debilitation|0|||
23456756|NCT00537394|65416538|FG002|First Year of Follow-up|Severe debilitation|1|||
23456757|NCT00537394|65416536|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
23456758|NCT00537394|65416537|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
23456759|NCT00537394|65416538|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
23456760|NCT00537394|65416536|FG000|First Year of Follow-up|Lost to Follow-up|1|||
23344871|NCT03605849|65006649|FG002|Overall Study|Lack of Efficacy|9|||
23456761|NCT00537394|65416537|FG001|First Year of Follow-up|Lost to Follow-up|5|||
23456762|NCT00537394|65416538|FG002|First Year of Follow-up|Lost to Follow-up|1|||
23456763|NCT00537394|65416536|FG000|2nd Year of Follow-up|Death|4|||
23456764|NCT00537394|65416537|FG001|2nd Year of Follow-up|Death|1|||
23456765|NCT00537394|65416538|FG002|2nd Year of Follow-up|Death|2|||
23456766|NCT00537394|65416536|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
23456767|NCT00537394|65416537|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
23456768|NCT00537394|65416538|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
23456769|NCT00537394|65416536|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
23456770|NCT00537394|65416537|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
23456771|NCT00537394|65416538|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
23456772|NCT00537394|65416536|FG000|2nd Year of Follow-up|Clinic site closure|1|||
23456773|NCT00537394|65416537|FG001|2nd Year of Follow-up|Clinic site closure|0|||
23456774|NCT00537394|65416538|FG002|2nd Year of Follow-up|Clinic site closure|0|||
23456775|NCT03985761|65416539|FG000|Overall Study|Withdrawal by Subject|2|||
23456776|NCT03985761|65416540|FG001|Overall Study|Withdrawal by Subject|3|||
23456777|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
23456778|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
23456779|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
23456780|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
23456781|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
23456782|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
23456783|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
23456784|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
23456785|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
23456786|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
23456787|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
23456788|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
23456789|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
23456790|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
23456791|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
23456792|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
23456793|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
23456794|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
23456795|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
23456796|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
23456797|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
23456798|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
23456799|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
23456800|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
23456801|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
23456802|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
23456803|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
23456804|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
23456805|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
23456806|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
23456807|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
23456808|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
23456809|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
23456810|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
23456811|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
23456812|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
23456813|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456814|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456815|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456816|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
23456817|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
23456818|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
23456819|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
23456820|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
23456821|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456822|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456823|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
23456824|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456825|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
23456826|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
23456827|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
23456828|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
23456829|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
23456830|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
23456831|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
23456832|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
23456833|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
23456834|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
23456835|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
23456836|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
23583408|NCT03631199|65866022|FG003|Overall Study|Progressive disease|149|||
23583409|NCT03631199|65866023|FG004|Overall Study|Progressive disease|148|||
23456837|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
23456838|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
23456839|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
23456840|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
23456841|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
23456842|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
23456843|NCT03773978|65416552|FG000|DBW Period|Adverse Event|2|||
23456844|NCT03773978|65416553|FG001|DBW Period|Adverse Event|2|||
23456845|NCT03773978|65416552|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
23456846|NCT03773978|65416553|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
23456847|NCT03773978|65416552|FG000|DBW Period|Withdrawal by Subject|2|||
23456848|NCT03773978|65416553|FG001|DBW Period|Withdrawal by Subject|1|||
23456849|NCT03773978|65416552|FG000|DBW Period|Due to epidemic or pandemic|5|||
23456850|NCT03773978|65416553|FG001|DBW Period|Due to epidemic or pandemic|6|||
23456851|NCT03773978|65416552|FG000|DBW Period|Study team decision|1|||
23456852|NCT03773978|65416553|FG001|DBW Period|Study team decision|0|||
23456853|NCT02476617|65416556|FG000|Overall Study|Adverse Event|1|||
23456854|NCT02476617|65416556|FG000|Overall Study|Lost to Follow-up|1|||
23456855|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456856|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456857|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456858|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
23456859|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456860|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
23456861|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456862|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
23456863|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
23456864|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456865|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
23456866|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
23456867|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456868|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
23456869|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456870|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456871|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456872|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456873|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456874|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456875|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456876|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456877|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456878|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456879|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456880|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456881|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456882|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456883|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456884|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
23456885|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456886|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456887|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456888|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456889|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456890|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456891|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
23456892|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456893|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456894|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456895|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456896|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23583410|NCT03631199|65866019|FG000|Overall Study|Physician Decision|0|||
23344872|NCT03605849|65006650|FG003|Overall Study|Lack of Efficacy|2|||
23344873|NCT03605849|65006647|FG000|Overall Study|Lost to Follow-up|8|||
23344874|NCT03605849|65006648|FG001|Overall Study|Lost to Follow-up|8|||
23456897|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456898|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456899|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456900|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456901|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456902|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456903|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456904|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456905|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456906|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23637713|NCT00858364|66057624|FG001|Overall Study|Administrative Decision|2|||
23637714|NCT00858364|66057623|FG000|Overall Study|Adverse Event|5|||
23637715|NCT00858364|66057624|FG001|Overall Study|Adverse Event|2|||
23637716|NCT00858364|66057623|FG000|Overall Study|Withdrawal by Subject|44|||
23637717|NCT00858364|66057624|FG001|Overall Study|Withdrawal by Subject|118|||
23637718|NCT00858364|66057623|FG000|Overall Study|Ineligibility Determined|1|||
23456907|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456908|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456909|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456910|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456911|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456912|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456913|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456914|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
23456915|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456916|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456917|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456918|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456919|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456920|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456921|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456922|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456923|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456924|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
23456925|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
23456926|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
23637719|NCT00858364|66057624|FG001|Overall Study|Ineligibility Determined|10|||
23637720|NCT00858364|66057623|FG000|Overall Study|Lost to Follow-up|24|||
23637721|NCT00858364|66057624|FG001|Overall Study|Lost to Follow-up|54|||
23637722|NCT00858364|66057623|FG000|Overall Study|Noncompliance|3|||
23785085|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
23785086|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
23785087|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
23785088|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
23785089|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
23785090|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
23785091|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
23785092|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
23785093|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
23785094|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23785095|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23785096|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
23785097|NCT01058668|66590460|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
23785098|NCT01058668|66590461|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
23785099|NCT01058668|66590462|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
23785100|NCT03873272|66590463|FG000|Overall Study|Withdrawal by Subject|2|||
23785101|NCT03873272|66590464|FG001|Overall Study|Withdrawal by Subject|0|||
23785102|NCT03873272|66590465|FG002|Overall Study|Withdrawal by Subject|1|||
23785103|NCT03873272|66590463|FG000|Overall Study|Death|0|||
23785104|NCT03873272|66590464|FG001|Overall Study|Death|2|||
23785105|NCT03873272|66590465|FG002|Overall Study|Death|1|||
23456927|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
23583411|NCT03631199|65866020|FG001|Overall Study|Physician Decision|2|||
23637723|NCT00858364|66057624|FG001|Overall Study|Noncompliance|4|||
23785106|NCT02222818|66590466|FG000|Period 1|Eligibility criteria not met|0|||
23785107|NCT02222818|66590467|FG001|Period 1|Eligibility criteria not met|3|||
23785108|NCT02281084|66590468|FG000|Overall Study|Death|21|||
23785109|NCT02281084|66590469|FG001|Overall Study|Death|18|||
23785110|NCT02281084|66590470|FG002|Overall Study|Death|3|||
23637724|NCT00858364|66057623|FG000|Overall Study|Protocol Deviation|0|||
23637725|NCT00858364|66057624|FG001|Overall Study|Protocol Deviation|2|||
23637726|NCT00858364|66057623|FG000|Overall Study|Other|9|||
23637727|NCT00858364|66057624|FG001|Overall Study|Other|17|||
23637728|NCT00858364|66057623|FG000|Overall Study|Missing|1|||
23637729|NCT00858364|66057624|FG001|Overall Study|Missing|1|||
23637730|NCT00858364|66057623|FG000|Overall Study|Still on-study|114|||
23637731|NCT00858364|66057624|FG001|Overall Study|Still on-study|247|||
23637732|NCT02712905|66057625|FG000|Monotherapy|Death|2|||
23637733|NCT02712905|66057626|FG001|Monotherapy|Death|5|||
23637734|NCT02712905|66057627|FG002|Monotherapy|Death|0|||
23637735|NCT02712905|66057628|FG003|Monotherapy|Death|3|||
23637736|NCT02712905|66057629|FG004|Monotherapy|Death|15|||
23785111|NCT02281084|66590471|FG003|Overall Study|Death|5|||
23785112|NCT02281084|66590468|FG000|Overall Study|Adverse Event|1|||
23785113|NCT02281084|66590469|FG001|Overall Study|Adverse Event|0|||
23785114|NCT02281084|66590470|FG002|Overall Study|Adverse Event|0|||
23785115|NCT02281084|66590471|FG003|Overall Study|Adverse Event|0|||
23785116|NCT02281084|66590468|FG000|Overall Study|Withdrawal by Subject|2|||
23456928|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
23785117|NCT02281084|66590469|FG001|Overall Study|Withdrawal by Subject|2|||
23785118|NCT02281084|66590470|FG002|Overall Study|Withdrawal by Subject|0|||
23785119|NCT02281084|66590471|FG003|Overall Study|Withdrawal by Subject|0|||
23344875|NCT03605849|65006649|FG002|Overall Study|Lost to Follow-up|14|||
23456929|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
23456930|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
23456931|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
23456932|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
23456933|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
23456934|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
23456935|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
23456936|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
23456937|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
23456938|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
23456939|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
23456940|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
23456941|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
23456942|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
23456943|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
23456944|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
23456945|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
23456946|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
23456947|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456948|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456949|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456950|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456951|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456952|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456953|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456954|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456955|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
23456956|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456957|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456958|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456959|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456960|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
23456961|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456962|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23583412|NCT03631199|65866021|FG002|Overall Study|Physician Decision|3|||
23637737|NCT02712905|66057630|FG005|Monotherapy|Death|1|||
23344876|NCT03605849|65006650|FG003|Overall Study|Lost to Follow-up|11|||
23637738|NCT02712905|66057631|FG006|Monotherapy|Death|3|||
23637739|NCT02712905|66057632|FG007|Monotherapy|Death|3|||
23785120|NCT02281084|66590468|FG000|Overall Study|Site Closure by Sponsor|5|||
23785121|NCT02281084|66590469|FG001|Overall Study|Site Closure by Sponsor|1|||
23637740|NCT02712905|66057633|FG008|Monotherapy|Death|0|||
23637741|NCT02712905|66057634|FG009|Monotherapy|Death|27|||
23344877|NCT03605849|65006647|FG000|Overall Study|Non-compliance With IMP|6|||
23456963|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456964|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456965|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456966|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456967|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456968|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456969|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456970|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456971|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456972|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23785122|NCT02281084|66590470|FG002|Overall Study|Site Closure by Sponsor|2|||
23785123|NCT02281084|66590471|FG003|Overall Study|Site Closure by Sponsor|0|||
23785124|NCT00218257|66590472|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
23785125|NCT00218257|66590473|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
23785126|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
23785127|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
23785128|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
23456973|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456974|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456975|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
23456976|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456977|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23785129|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
23785130|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
23785131|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
23785132|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
23785133|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
23785134|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
23785135|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
23785136|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
23785137|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
23785138|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
23785139|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
23785140|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
23785141|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
23785142|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
23785143|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
23785144|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
23785145|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
23785146|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
23785147|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
23785148|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
23785149|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
23785150|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
23785151|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
23785152|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
23785153|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
23785154|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
23785155|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
23785156|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
23785157|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
23785158|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
23785159|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
23785160|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
23785161|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
23785162|NCT04194801|66590474|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
23785163|NCT04194801|66590475|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
23785164|NCT04194801|66590476|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
23785165|NCT04194801|66590474|FG000|Part Ib/II End of Study|Death|2|||
23785166|NCT04194801|66590475|FG001|Part Ib/II End of Study|Death|3|||
23785167|NCT04194801|66590476|FG002|Part Ib/II End of Study|Death|3|||
23785168|NCT04194801|66590474|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
23785169|NCT04194801|66590475|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
23785170|NCT04194801|66590476|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
23785171|NCT04194801|66590474|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
23785172|NCT04194801|66590475|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
23785173|NCT04194801|66590476|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
23785174|NCT04194801|66590474|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
23785175|NCT04194801|66590475|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
23785176|NCT04194801|66590476|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
23637742|NCT02712905|66057635|FG010|Monotherapy|Death|2|||
23637743|NCT02712905|66057636|FG011|Monotherapy|Death|5|||
23637744|NCT02712905|66057637|FG012|Monotherapy|Death|0|||
23637745|NCT02712905|66057638|FG013|Monotherapy|Death|0|||
23785177|NCT04194801|66590474|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
23785178|NCT04194801|66590475|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
23785179|NCT04194801|66590476|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
23785180|NCT00838279|66590477|FG000|Washout|Protocol Violation|1|||
23456978|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23785181|NCT00838279|66590478|FG001|Washout|Protocol Violation|0|||
23344878|NCT03605849|65006648|FG001|Overall Study|Non-compliance With IMP|5|||
23344879|NCT03605849|65006649|FG002|Overall Study|Non-compliance With IMP|2|||
23344880|NCT03605849|65006650|FG003|Overall Study|Non-compliance With IMP|1|||
23344881|NCT03605849|65006647|FG000|Overall Study|Protocol Deviation|1|||
23344882|NCT03605849|65006648|FG001|Overall Study|Protocol Deviation|2|||
23344883|NCT03605849|65006649|FG002|Overall Study|Protocol Deviation|1|||
23344884|NCT03605849|65006650|FG003|Overall Study|Protocol Deviation|3|||
23344885|NCT03605849|65006647|FG000|Overall Study|Withdrawal by Subject|33|||
23344886|NCT03605849|65006648|FG001|Overall Study|Withdrawal by Subject|28|||
23344887|NCT03605849|65006649|FG002|Overall Study|Withdrawal by Subject|30|||
23344888|NCT03605849|65006650|FG003|Overall Study|Withdrawal by Subject|28|||
23344889|NCT03605849|65006647|FG000|Overall Study|Site Terminated by Sponsor|0|||
23344890|NCT03605849|65006648|FG001|Overall Study|Site Terminated by Sponsor|0|||
23344891|NCT03605849|65006649|FG002|Overall Study|Site Terminated by Sponsor|0|||
23344892|NCT03605849|65006650|FG003|Overall Study|Site Terminated by Sponsor|1|||
23344893|NCT03605849|65006647|FG000|Overall Study|Physician Decision|2|||
23344894|NCT03605849|65006648|FG001|Overall Study|Physician Decision|1|||
23344895|NCT03605849|65006649|FG002|Overall Study|Physician Decision|2|||
23344896|NCT03605849|65006650|FG003|Overall Study|Physician Decision|1|||
23785182|NCT00838279|66590477|FG000|Washout|Withdrawal by Subject|0|||
23344897|NCT03605849|65006647|FG000|Overall Study|Enrolled, but not Treated|2|||
23344898|NCT03605849|65006648|FG001|Overall Study|Enrolled, but not Treated|2|||
23344899|NCT03605849|65006649|FG002|Overall Study|Enrolled, but not Treated|3|||
23637746|NCT02712905|66057639|FG014|Monotherapy|Death|0|||
23344900|NCT03605849|65006650|FG003|Overall Study|Enrolled, but not Treated|2|||
23344901|NCT03605849|65006647|FG000|Overall Study|Other (COVID-19 Related)|0|||
23344902|NCT03605849|65006648|FG001|Overall Study|Other (COVID-19 Related)|1|||
23344903|NCT03605849|65006649|FG002|Overall Study|Other (COVID-19 Related)|1|||
23344904|NCT03605849|65006650|FG003|Overall Study|Other (COVID-19 Related)|0|||
23637747|NCT02712905|66057640|FG015|Monotherapy|Death|0|||
23785183|NCT00838279|66590478|FG001|Washout|Withdrawal by Subject|1|||
23344905|NCT03605849|65006647|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
23344906|NCT03605849|65006648|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
23344907|NCT03605849|65006649|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
23344908|NCT03605849|65006650|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
23344909|NCT01195844|65006651|FG000|Overall Study|Fecal sample not collected|40|||
23344910|NCT01854879|65006652|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
23344911|NCT01854879|65006652|FG000|Overall Study|screen fail|3|||
23344912|NCT01854879|65006652|FG000|Overall Study|incomplete data set|1|||
23344913|NCT00199797|65006653|FG000|Overall Study|Progressive Disease|1|||
23344914|NCT00199797|65006653|FG000|Overall Study|Adverse Event|1|||
23344915|NCT00199797|65006653|FG000|Overall Study|Physician Decision|1|||
23344916|NCT00595517|65006656|FG000|Overall Study|Adverse Event|6|||
23344917|NCT00595517|65006656|FG000|Overall Study|Withdrawal by Subject|4|||
23344918|NCT00595517|65006656|FG000|Overall Study|Protocol Violation|2|||
23344919|NCT00595517|65006656|FG000|Overall Study|Recurrence of ulcer|5|||
23344920|NCT00595517|65006656|FG000|Overall Study|usage of prohibited treatment|1|||
23344921|NCT00595517|65006656|FG000|Overall Study|No intention to attend regularly|1|||
23344922|NCT06011161|65006657|FG000|Overall Study|Withdrawal by Subject|2|||
23344923|NCT06011161|65006657|FG000|Overall Study|Lost to Follow-up|5|||
23344924|NCT02143791|65006658|FG000|Enrolled|Withdrawal by Subject|4|||
23344925|NCT02143791|65006658|FG000|Trial Stimulation|Lack of Efficacy|21|||
23344926|NCT02143791|65006658|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
23344927|NCT02143791|65006658|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
23344928|NCT02143791|65006658|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
23344929|NCT02143791|65006658|FG000|Any Programming (3-6 Months)|Missing Data|1|||
23344930|NCT02143791|65006658|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
23344931|NCT02691936|65006659|FG000|Overall Study|Withdrawal by Subject|2|||
23344932|NCT02691936|65006660|FG001|Overall Study|Withdrawal by Subject|5|||
23344933|NCT00452673|65006668|FG000|Dose Escalation Period|Disease Progression|6|||
23344934|NCT00452673|65006669|FG001|Dose Escalation Period|Disease Progression|6|||
23344935|NCT00452673|65006670|FG002|Dose Escalation Period|Disease Progression|2|||
23344936|NCT00452673|65006671|FG003|Dose Escalation Period|Disease Progression|6|||
23344937|NCT00452673|65006672|FG004|Dose Escalation Period|Disease Progression|0|||
23344938|NCT00452673|65006668|FG000|Dose Escalation Period|study drug toxicity|1|||
23785184|NCT01948258|66593419|FG000|Overall Study|Pregnancy|41|||
23785185|NCT01948258|66593419|FG000|Overall Study|Did not complete by cut-off date|35|||
23785186|NCT01948258|66593419|FG000|Overall Study|Lost to Follow-up|27|||
23785187|NCT01948258|66593419|FG000|Overall Study|Withdrawal by SPD|8|||
23785188|NCT01948258|66593419|FG000|Overall Study|Withdrawal by Subject|6|||
23785189|NCT01948258|66593419|FG000|Overall Study|Health Care Professional|43|||
23785190|NCT01948258|66593419|FG000|Overall Study|Removed from statistical analysis|2|||
23785191|NCT00420303|66593420|FG000|Overall Study|Serious Adverse Event|1|||
23785192|NCT00420303|66593421|FG001|Overall Study|Serious Adverse Event|0|||
23785193|NCT00420303|66593420|FG000|Overall Study|Lack of Efficacy|0|||
23785194|NCT00420303|66593421|FG001|Overall Study|Lack of Efficacy|3|||
23785195|NCT00420303|66593420|FG000|Overall Study|Physician Decision|0|||
23785196|NCT00420303|66593421|FG001|Overall Study|Physician Decision|1|||
23785197|NCT05093205|66593422|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
23785198|NCT05093205|66593423|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
23785199|NCT05093205|66593424|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
23785200|NCT05093205|66593425|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
23785201|NCT05093205|66593426|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
23344939|NCT00452673|65006669|FG001|Dose Escalation Period|study drug toxicity|3|||
23344940|NCT00452673|65006670|FG002|Dose Escalation Period|study drug toxicity|3|||
23344941|NCT00452673|65006671|FG003|Dose Escalation Period|study drug toxicity|1|||
23344942|NCT00452673|65006672|FG004|Dose Escalation Period|study drug toxicity|0|||
23344943|NCT00452673|65006668|FG000|Dose Escalation Period|Other|0|||
23785202|NCT05093205|66593427|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
23785203|NCT05093205|66593428|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
23785204|NCT05093205|66593429|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
23785205|NCT05093205|66593430|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
23785206|NCT05093205|66593431|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
23785207|NCT05093205|66593432|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
23785208|NCT05093205|66593433|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
23344944|NCT00452673|65006669|FG001|Dose Escalation Period|Other|0|||
23785209|NCT05093205|66593434|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
23785210|NCT05093205|66593422|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23344945|NCT00452673|65006670|FG002|Dose Escalation Period|Other|1|||
23344946|NCT00452673|65006671|FG003|Dose Escalation Period|Other|0|||
23344947|NCT00452673|65006672|FG004|Dose Escalation Period|Other|0|||
23344948|NCT00452673|65006668|FG000|Dose Escalation Period|Adverse Event|0|||
23344949|NCT00452673|65006669|FG001|Dose Escalation Period|Adverse Event|0|||
23344950|NCT00452673|65006670|FG002|Dose Escalation Period|Adverse Event|0|||
23344951|NCT00452673|65006671|FG003|Dose Escalation Period|Adverse Event|1|||
23344952|NCT00452673|65006672|FG004|Dose Escalation Period|Adverse Event|0|||
23344953|NCT00452673|65006668|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
23344954|NCT00452673|65006669|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
23344955|NCT00452673|65006670|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
23344956|NCT00452673|65006671|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
23344957|NCT00452673|65006672|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
23344958|NCT00452673|65006668|FG000|Dose Expansion Period|Disease Progression|0|||
23344959|NCT00452673|65006669|FG001|Dose Expansion Period|Disease Progression|0|||
23344960|NCT00452673|65006670|FG002|Dose Expansion Period|Disease Progression|0|||
23344961|NCT00452673|65006671|FG003|Dose Expansion Period|Disease Progression|0|||
23344962|NCT00452673|65006672|FG004|Dose Expansion Period|Disease Progression|19|||
23344963|NCT00452673|65006668|FG000|Dose Expansion Period|Other|0|||
23344964|NCT00452673|65006669|FG001|Dose Expansion Period|Other|0|||
23344965|NCT00452673|65006670|FG002|Dose Expansion Period|Other|0|||
23344966|NCT00452673|65006671|FG003|Dose Expansion Period|Other|0|||
23344967|NCT00452673|65006672|FG004|Dose Expansion Period|Other|2|||
23344968|NCT01764997|65006673|FG000|Run-in Period|Adverse Event|15|||
23344969|NCT01764997|65006674|FG001|Run-in Period|Adverse Event|0|||
23344970|NCT01764997|65006675|FG002|Run-in Period|Adverse Event|0|||
23344971|NCT01764997|65006676|FG003|Run-in Period|Adverse Event|0|||
23344972|NCT01764997|65006677|FG004|Run-in Period|Adverse Event|0|||
23344973|NCT01764997|65006673|FG000|Run-in Period|Lack of Efficacy|5|||
23344974|NCT01764997|65006674|FG001|Run-in Period|Lack of Efficacy|0|||
23456979|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456980|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23785211|NCT05093205|66593423|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785212|NCT05093205|66593424|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
23785213|NCT05093205|66593425|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785214|NCT05093205|66593426|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785215|NCT05093205|66593427|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785216|NCT05093205|66593428|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785217|NCT05093205|66593429|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785218|NCT05093205|66593430|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785219|NCT05093205|66593431|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785220|NCT05093205|66593432|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785221|NCT05093205|66593433|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23785222|NCT05093205|66593434|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23344975|NCT01764997|65006675|FG002|Run-in Period|Lack of Efficacy|0|||
23785223|NCT05093205|66593422|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
23785224|NCT05093205|66593423|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
23785225|NCT05093205|66593424|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
23785226|NCT05093205|66593425|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
23785227|NCT05093205|66593426|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
23785228|NCT05093205|66593427|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
23344976|NCT01764997|65006676|FG003|Run-in Period|Lack of Efficacy|0|||
23344977|NCT01764997|65006677|FG004|Run-in Period|Lack of Efficacy|0|||
23344978|NCT01764997|65006673|FG000|Run-in Period|Poor compliance to protocol|1|||
23344979|NCT01764997|65006674|FG001|Run-in Period|Poor compliance to protocol|0|||
23344980|NCT01764997|65006675|FG002|Run-in Period|Poor compliance to protocol|0|||
23344981|NCT01764997|65006676|FG003|Run-in Period|Poor compliance to protocol|0|||
23344982|NCT01764997|65006677|FG004|Run-in Period|Poor compliance to protocol|0|||
23785229|NCT05093205|66593428|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
23785230|NCT05093205|66593429|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
23785231|NCT05093205|66593430|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
23785232|NCT05093205|66593431|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
23785233|NCT05093205|66593432|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
23785234|NCT05093205|66593433|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
23785235|NCT05093205|66593434|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
23785236|NCT05093205|66593422|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
23785237|NCT05093205|66593423|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
23785238|NCT05093205|66593424|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
23785239|NCT05093205|66593425|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
23785240|NCT05093205|66593426|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
23785241|NCT05093205|66593427|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
23785242|NCT05093205|66593428|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
23785243|NCT05093205|66593429|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
23344983|NCT01764997|65006673|FG000|Run-in Period|Other than specified above|17|||
23456981|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23785244|NCT05093205|66593430|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
23785245|NCT05093205|66593431|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
23785246|NCT05093205|66593432|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
23785247|NCT05093205|66593433|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
23785248|NCT05093205|66593434|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
23785249|NCT05093205|66593422|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
23785250|NCT05093205|66593423|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
23344984|NCT01764997|65006674|FG001|Run-in Period|Other than specified above|0|||
23344985|NCT01764997|65006675|FG002|Run-in Period|Other than specified above|0|||
23344986|NCT01764997|65006676|FG003|Run-in Period|Other than specified above|0|||
23344987|NCT01764997|65006677|FG004|Run-in Period|Other than specified above|0|||
23344988|NCT01764997|65006673|FG000|Study Drug Treatment Period|Adverse Event|0|||
23785251|NCT05093205|66593424|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
23785252|NCT05093205|66593425|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
23785253|NCT05093205|66593426|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
23785254|NCT05093205|66593427|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
23785255|NCT05093205|66593428|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
23785256|NCT05093205|66593429|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
23344989|NCT01764997|65006674|FG001|Study Drug Treatment Period|Adverse Event|1|||
23344990|NCT01764997|65006675|FG002|Study Drug Treatment Period|Adverse Event|0|||
23344991|NCT01764997|65006676|FG003|Study Drug Treatment Period|Adverse Event|0|||
23344992|NCT01764997|65006677|FG004|Study Drug Treatment Period|Adverse Event|24|||
23344993|NCT01764997|65006673|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
23344994|NCT01764997|65006674|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
23344995|NCT01764997|65006675|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
23344996|NCT01764997|65006676|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
23785257|NCT05093205|66593430|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
23785258|NCT05093205|66593431|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
23785259|NCT05093205|66593432|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
23785260|NCT05093205|66593433|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
23785261|NCT05093205|66593434|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
23785262|NCT05093205|66593422|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
23785263|NCT05093205|66593423|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
23785264|NCT05093205|66593424|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
23785265|NCT05093205|66593425|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
23785266|NCT05093205|66593426|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
23785267|NCT05093205|66593427|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
23785268|NCT05093205|66593428|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
23785269|NCT05093205|66593429|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
23785270|NCT05093205|66593430|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
23785271|NCT05093205|66593431|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
23785272|NCT05093205|66593432|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
23785273|NCT05093205|66593433|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
23785274|NCT05093205|66593434|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
23785275|NCT05093205|66593422|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
23785276|NCT05093205|66593423|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
23785277|NCT05093205|66593424|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
23785278|NCT05093205|66593425|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
23785279|NCT05093205|66593426|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
23344997|NCT01764997|65006677|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
23344998|NCT01764997|65006673|FG000|Study Drug Treatment Period|Other than specified above|0|||
23785280|NCT05093205|66593427|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
23583413|NCT03631199|65866022|FG003|Overall Study|Physician Decision|19|||
23785281|NCT05093205|66593428|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
23785282|NCT05093205|66593429|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
23785283|NCT05093205|66593430|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
23785284|NCT05093205|66593431|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
23785285|NCT05093205|66593432|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
23785286|NCT05093205|66593433|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
23785287|NCT05093205|66593434|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
23785288|NCT05093205|66593422|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
23785289|NCT05093205|66593423|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
23344999|NCT01764997|65006674|FG001|Study Drug Treatment Period|Other than specified above|0|||
23345000|NCT01764997|65006675|FG002|Study Drug Treatment Period|Other than specified above|0|||
23345001|NCT01764997|65006676|FG003|Study Drug Treatment Period|Other than specified above|0|||
23345002|NCT01764997|65006677|FG004|Study Drug Treatment Period|Other than specified above|10|||
23345003|NCT01777295|65006679|FG000|Overall Study|Withdrawal by Subject|2|||
23345004|NCT01777295|65006680|FG001|Overall Study|Withdrawal by Subject|2|||
23345005|NCT01777295|65006679|FG000|Overall Study|Pregnancy|0|||
23345006|NCT01777295|65006680|FG001|Overall Study|Pregnancy|1|||
23345007|NCT01777295|65006679|FG000|Overall Study|Personal problem|1|||
23345008|NCT01777295|65006680|FG001|Overall Study|Personal problem|0|||
23345009|NCT01777295|65006679|FG000|Overall Study|Investigator call for AEs check|1|||
23345010|NCT01777295|65006680|FG001|Overall Study|Investigator call for AEs check|0|||
23345011|NCT01892085|65006681|FG000|Overall Study|Death|4|||
23345012|NCT01892085|65006682|FG001|Overall Study|Death|1|||
23345013|NCT01892085|65006683|FG002|Overall Study|Death|3|||
23345014|NCT01892085|65006681|FG000|Overall Study|Withdrawal by Subject|2|||
23345015|NCT01892085|65006682|FG001|Overall Study|Withdrawal by Subject|0|||
23345016|NCT01892085|65006683|FG002|Overall Study|Withdrawal by Subject|2|||
23785290|NCT05093205|66593424|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
23785291|NCT05093205|66593425|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
23785292|NCT05093205|66593426|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
23785293|NCT05093205|66593427|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
23785294|NCT05093205|66593428|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
23785295|NCT05093205|66593429|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
23785296|NCT05093205|66593430|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
23785297|NCT05093205|66593431|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
23345017|NCT00477750|65006684|FG000|Overall Study|Currently Receiving Treatment|11|||
23345018|NCT02396420|65006693|FG000|Overall Study|Death|1|||
23345019|NCT02333383|65006694|FG000|Overall Study|Adalimumab discontinuation|21|||
23345020|NCT02333383|65006694|FG000|Overall Study|Lost to Follow-up|15|||
23345021|NCT02333383|65006694|FG000|Overall Study|Withdrawal by Subject|3|||
23345022|NCT02333383|65006694|FG000|Overall Study|Transfer to another hospital|2|||
23345023|NCT02474589|65006695|FG000|Overall Study|Adverse Event|6|||
23345024|NCT02474589|65006696|FG001|Overall Study|Adverse Event|2|||
23345025|NCT02474589|65006695|FG000|Overall Study|Lost to Follow-up|6|||
23345026|NCT02474589|65006696|FG001|Overall Study|Lost to Follow-up|1|||
23345027|NCT02474589|65006695|FG000|Overall Study|Protocol Violation|4|||
23345028|NCT02474589|65006696|FG001|Overall Study|Protocol Violation|1|||
23345029|NCT02474589|65006695|FG000|Overall Study|Withdrawal by Subject|4|||
23345030|NCT02474589|65006696|FG001|Overall Study|Withdrawal by Subject|0|||
23456982|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
23785298|NCT05093205|66593432|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
23785299|NCT05093205|66593433|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
23345031|NCT02474589|65006695|FG000|Overall Study|Inability to complete study procedures|5|||
23345032|NCT02474589|65006696|FG001|Overall Study|Inability to complete study procedures|1|||
23345033|NCT02052596|65006697|FG000|Active Phase|Adverse Event|3|||
23345034|NCT02052596|65006698|FG001|Active Phase|Adverse Event|2|||
23345035|NCT02052596|65006697|FG000|Active Phase|Lost to Follow-up|8|||
23345036|NCT02052596|65006698|FG001|Active Phase|Lost to Follow-up|11|||
23345037|NCT02052596|65006697|FG000|Active Phase|Protocol Violation|1|||
23345038|NCT02052596|65006698|FG001|Active Phase|Protocol Violation|2|||
23345039|NCT02052596|65006697|FG000|Active Phase|Withdrawal by Subject|3|||
23345040|NCT02052596|65006698|FG001|Active Phase|Withdrawal by Subject|4|||
23345041|NCT02052596|65006697|FG000|Active Phase|Enrolled in error|1|||
23345042|NCT02052596|65006698|FG001|Active Phase|Enrolled in error|0|||
23345043|NCT02052596|65006697|FG000|Active Phase|Lost due to Crohn's disease|0|||
23345044|NCT02052596|65006698|FG001|Active Phase|Lost due to Crohn's disease|1|||
23345045|NCT02052596|65006697|FG000|Safety Phase|Adverse Event|6|||
23345046|NCT02052596|65006698|FG001|Safety Phase|Adverse Event|3|||
23345047|NCT02052596|65006697|FG000|Safety Phase|Lost to Follow-up|11|||
23345048|NCT02052596|65006698|FG001|Safety Phase|Lost to Follow-up|18|||
23345049|NCT02052596|65006697|FG000|Safety Phase|Protocol Violation|1|||
23345050|NCT02052596|65006698|FG001|Safety Phase|Protocol Violation|2|||
23345051|NCT02052596|65006697|FG000|Safety Phase|Withdrawal by Subject|8|||
23345052|NCT02052596|65006698|FG001|Safety Phase|Withdrawal by Subject|11|||
23637748|NCT02712905|66057641|FG016|Monotherapy|Death|0|||
23637749|NCT02712905|66057642|FG017|Monotherapy|Death|0|||
23345053|NCT02052596|65006697|FG000|Safety Phase|Enrolled in error|1|||
23345054|NCT02052596|65006698|FG001|Safety Phase|Enrolled in error|0|||
23345055|NCT02052596|65006697|FG000|Safety Phase|Lost due to Crohn's disease|0|||
23345056|NCT02052596|65006698|FG001|Safety Phase|Lost due to Crohn's disease|1|||
23345057|NCT00705718|65006699|FG000|Overall Study|Death|6|||
23785300|NCT05093205|66593434|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
23785301|NCT05093205|66593422|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785302|NCT05093205|66593423|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785303|NCT05093205|66593424|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785304|NCT05093205|66593425|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785305|NCT05093205|66593426|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785306|NCT05093205|66593427|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785307|NCT05093205|66593428|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785308|NCT05093205|66593429|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785309|NCT05093205|66593430|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785310|NCT05093205|66593431|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
23345058|NCT00705718|65006700|FG001|Overall Study|Death|6|||
23345059|NCT00705718|65006699|FG000|Overall Study|Not due for Visit|0|||
23345060|NCT00705718|65006700|FG001|Overall Study|Not due for Visit|12|||
23345061|NCT00705718|65006699|FG000|Overall Study|Follow up not done|1|||
23785311|NCT05093205|66593432|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785312|NCT05093205|66593433|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23345062|NCT00705718|65006700|FG001|Overall Study|Follow up not done|4|||
23583414|NCT03631199|65866023|FG004|Overall Study|Physician Decision|13|||
23785313|NCT05093205|66593434|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23785314|NCT05093205|66593422|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
23785315|NCT05093205|66593423|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
23785316|NCT05093205|66593424|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
23785317|NCT05093205|66593425|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
23785318|NCT05093205|66593426|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
23345063|NCT00875433|65006701|FG000|Overall Study|Progressive disease|41|||
23345064|NCT00875433|65006701|FG000|Overall Study|Other Adverse Event|14|||
23345065|NCT00875433|65006701|FG000|Overall Study|Withdrawal by Subject|2|||
23583415|NCT03631199|65866019|FG000|Overall Study|Adverse Event|1|||
23637750|NCT02712905|66057625|FG000|Monotherapy|Lost to Follow-up|0|||
23345066|NCT00875433|65006701|FG000|Overall Study|Other|3|||
23456983|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456984|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456985|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456986|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456987|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456988|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456989|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456990|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456991|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456992|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456993|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456994|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456995|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456996|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456997|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456998|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456999|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457000|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457001|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457002|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457003|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457004|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457005|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457006|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457007|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
23457008|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
23457009|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
23457010|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
23457011|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
23457012|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
23457013|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
23457014|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
23457015|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457016|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457017|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457018|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457019|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457020|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457021|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457022|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457023|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457024|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457025|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457026|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457027|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23345067|NCT02956057|65006702|FG000|Overall Study|Discontinued intervention|14|||
23345068|NCT02956057|65006703|FG001|Overall Study|Discontinued intervention|10|||
23345069|NCT02956057|65006704|FG002|Overall Study|Discontinued intervention|7|||
23345070|NCT02956057|65006705|FG003|Overall Study|Discontinued intervention|14|||
23345071|NCT02956057|65006706|FG004|Overall Study|Discontinued intervention|4|||
23345072|NCT02956057|65006707|FG005|Overall Study|Discontinued intervention|17|||
23345073|NCT02956057|65006702|FG000|Overall Study|Lost to Follow-up|0|||
23345074|NCT02956057|65006703|FG001|Overall Study|Lost to Follow-up|2|||
23345075|NCT02956057|65006704|FG002|Overall Study|Lost to Follow-up|1|||
23345076|NCT02956057|65006705|FG003|Overall Study|Lost to Follow-up|1|||
23345077|NCT02956057|65006706|FG004|Overall Study|Lost to Follow-up|1|||
23345078|NCT02956057|65006707|FG005|Overall Study|Lost to Follow-up|0|||
23345079|NCT00373958|65006709|FG000|Infant Series|Withdrawal by Subject|13|||
23457028|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23345080|NCT00373958|65006710|FG001|Infant Series|Withdrawal by Subject|15|||
23345081|NCT00373958|65006709|FG000|Infant Series|Failed to return|8|||
23345082|NCT00373958|65006710|FG001|Infant Series|Failed to return|13|||
23345083|NCT00373958|65006709|FG000|Infant Series|Lost to Follow-up|6|||
23457029|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457030|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
23457031|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
23457032|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457033|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
23457034|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
23457035|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
23457036|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
23457037|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
23457038|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457039|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457040|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457041|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457042|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457043|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457044|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457045|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457046|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457047|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457048|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457049|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457050|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457051|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457052|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23637751|NCT02712905|66057626|FG001|Monotherapy|Lost to Follow-up|1|||
23637752|NCT02712905|66057627|FG002|Monotherapy|Lost to Follow-up|0|||
23637753|NCT02712905|66057628|FG003|Monotherapy|Lost to Follow-up|1|||
23637754|NCT02712905|66057629|FG004|Monotherapy|Lost to Follow-up|0|||
23637755|NCT02712905|66057630|FG005|Monotherapy|Lost to Follow-up|0|||
23457053|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
23457054|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
23457055|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
23457056|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23637756|NCT02712905|66057631|FG006|Monotherapy|Lost to Follow-up|0|||
23457057|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
23457058|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
23457059|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457060|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457061|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23583416|NCT03631199|65866020|FG001|Overall Study|Adverse Event|1|||
23583417|NCT03631199|65866021|FG002|Overall Study|Adverse Event|0|||
23583418|NCT03631199|65866022|FG003|Overall Study|Adverse Event|28|||
23583419|NCT03631199|65866023|FG004|Overall Study|Adverse Event|29|||
23583420|NCT03631199|65866019|FG000|Overall Study|Death|0|||
23583421|NCT03631199|65866020|FG001|Overall Study|Death|1|||
23583422|NCT03631199|65866021|FG002|Overall Study|Death|0|||
23583423|NCT03631199|65866022|FG003|Overall Study|Death|35|||
23583424|NCT03631199|65866023|FG004|Overall Study|Death|48|||
23583425|NCT03631199|65866019|FG000|Overall Study|Subject decision|0|||
23583426|NCT03631199|65866020|FG001|Overall Study|Subject decision|1|||
23583427|NCT03631199|65866021|FG002|Overall Study|Subject decision|0|||
23583428|NCT03631199|65866022|FG003|Overall Study|Subject decision|12|||
23583429|NCT03631199|65866023|FG004|Overall Study|Subject decision|12|||
23583430|NCT03631199|65866019|FG000|Overall Study|No treated|0|||
23583431|NCT03631199|65866020|FG001|Overall Study|No treated|0|||
23583432|NCT03631199|65866021|FG002|Overall Study|No treated|0|||
23583433|NCT03631199|65866022|FG003|Overall Study|No treated|0|||
23583434|NCT03631199|65866023|FG004|Overall Study|No treated|1|||
23583435|NCT03631199|65866019|FG000|Overall Study|Treatment ongoing|0|||
23583436|NCT03631199|65866020|FG001|Overall Study|Treatment ongoing|1|||
23583437|NCT03631199|65866021|FG002|Overall Study|Treatment ongoing|1|||
23583438|NCT03631199|65866022|FG003|Overall Study|Treatment ongoing|76|||
23583439|NCT03631199|65866023|FG004|Overall Study|Treatment ongoing|71|||
23583440|NCT03631199|65866019|FG000|Overall Study|Guardian decision|0|||
23583441|NCT03631199|65866020|FG001|Overall Study|Guardian decision|0|||
23583442|NCT03631199|65866021|FG002|Overall Study|Guardian decision|0|||
23583443|NCT03631199|65866022|FG003|Overall Study|Guardian decision|1|||
23583444|NCT03631199|65866023|FG004|Overall Study|Guardian decision|1|||
23583445|NCT04011033|65866024|FG000|Overall Study|Physician Decision|2|||
23583446|NCT04011033|65866025|FG001|Overall Study|Physician Decision|3|||
23583447|NCT04011033|65866024|FG000|Overall Study|Withdrawal by Subject|1|||
23457062|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457063|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457064|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457065|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457066|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457067|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457068|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457069|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457070|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457071|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457072|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457073|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457074|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457075|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457076|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
23345084|NCT00373958|65006710|FG001|Infant Series|Lost to Follow-up|5|||
23345085|NCT00373958|65006709|FG000|Infant Series|Protocol Violation|3|||
23345086|NCT00373958|65006710|FG001|Infant Series|Protocol Violation|7|||
23345087|NCT00373958|65006709|FG000|Infant Series|Lost Kaiser coverage|4|||
23345088|NCT00373958|65006710|FG001|Infant Series|Lost Kaiser coverage|0|||
23345089|NCT00373958|65006709|FG000|Infant Series|Child relocated|1|||
23345090|NCT00373958|65006710|FG001|Infant Series|Child relocated|0|||
23345091|NCT00373958|65006709|FG000|Infant Series|Consent was not received|1|||
23345092|NCT00373958|65006710|FG001|Infant Series|Consent was not received|0|||
23345093|NCT00373958|65006709|FG000|Infant Series|Adverse Event|3|||
23345094|NCT00373958|65006710|FG001|Infant Series|Adverse Event|1|||
23345095|NCT00373958|65006709|FG000|Infant Series|Physician Decision|1|||
23345096|NCT00373958|65006710|FG001|Infant Series|Physician Decision|1|||
23345097|NCT00373958|65006709|FG000|Toddler Dose|Lost to Follow-up|5|||
23345098|NCT00373958|65006710|FG001|Toddler Dose|Lost to Follow-up|8|||
23345099|NCT00373958|65006709|FG000|Toddler Dose|Withdrawal by Subject|2|||
23345100|NCT00373958|65006710|FG001|Toddler Dose|Withdrawal by Subject|2|||
23345101|NCT00373958|65006709|FG000|Toddler Dose|Failed to return|1|||
23345102|NCT00373958|65006710|FG001|Toddler Dose|Failed to return|2|||
23345103|NCT00373958|65006709|FG000|Toddler Dose|Protocol Violation|0|||
23345104|NCT00373958|65006710|FG001|Toddler Dose|Protocol Violation|1|||
23345105|NCT00373958|65006709|FG000|Toddler Dose|Withdrawn after infant series|22|||
23345106|NCT00373958|65006710|FG001|Toddler Dose|Withdrawn after infant series|25|||
23345107|NCT00732758|65006713|FG000|Overall Study|Lost to Follow-up|8|||
23345108|NCT00732758|65006714|FG001|Overall Study|Lost to Follow-up|16|||
23345109|NCT00501059|65006715|FG000|Overall Study|Protocol Violation|80|||
23345110|NCT00501059|65006716|FG001|Overall Study|Protocol Violation|69|||
23345111|NCT00501059|65006715|FG000|Overall Study|Death|140|||
23345112|NCT00501059|65006716|FG001|Overall Study|Death|137|||
23345113|NCT00501059|65006715|FG000|Overall Study|Other|236|||
23345114|NCT00501059|65006716|FG001|Overall Study|Other|239|||
23345115|NCT00501059|65006715|FG000|Overall Study|Missing end-of-study page|91|||
23345116|NCT00501059|65006716|FG001|Overall Study|Missing end-of-study page|92|||
23345117|NCT00501059|65006715|FG000|Overall Study|Clinical endpoint reached|110|||
23345118|NCT00501059|65006716|FG001|Overall Study|Clinical endpoint reached|123|||
23345119|NCT00501059|65006715|FG000|Overall Study|Insufficient therapeutic effect|4|||
23345120|NCT00501059|65006716|FG001|Overall Study|Insufficient therapeutic effect|5|||
23345121|NCT00501059|65006715|FG000|Overall Study|Consent withdrawn by subject|817|||
23345122|NCT00501059|65006716|FG001|Overall Study|Consent withdrawn by subject|873|||
23345123|NCT00501059|65006715|FG000|Overall Study|Non-compliant with study treatment|23|||
23345124|NCT00501059|65006716|FG001|Overall Study|Non-compliant with study treatment|16|||
23345125|NCT00501059|65006715|FG000|Overall Study|Reason not given|3|||
23345126|NCT00501059|65006716|FG001|Overall Study|Reason not given|1|||
23345127|NCT00501059|65006715|FG000|Overall Study|Adverse Event|129|||
23345128|NCT00501059|65006716|FG001|Overall Study|Adverse Event|122|||
23637757|NCT02712905|66057632|FG007|Monotherapy|Lost to Follow-up|0|||
23345129|NCT00501059|65006715|FG000|Overall Study|Lost to Follow-up|210|||
23345130|NCT00501059|65006716|FG001|Overall Study|Lost to Follow-up|198|||
23345131|NCT00501059|65006715|FG000|Overall Study|Not treated|25|||
23345132|NCT00501059|65006716|FG001|Overall Study|Not treated|17|||
23345133|NCT01664949|65006717|FG000|Overall Study|Adverse Event|11|||
23345134|NCT01664949|65006718|FG001|Overall Study|Adverse Event|12|||
23345135|NCT01664949|65006717|FG000|Overall Study|Lack of Efficacy|1|||
23345136|NCT01664949|65006718|FG001|Overall Study|Lack of Efficacy|1|||
23345137|NCT01664949|65006717|FG000|Overall Study|Lost to Follow-up|1|||
23345138|NCT01664949|65006718|FG001|Overall Study|Lost to Follow-up|2|||
23345139|NCT01664949|65006717|FG000|Overall Study|Personal Reasons|3|||
23345140|NCT01664949|65006718|FG001|Overall Study|Personal Reasons|4|||
23345141|NCT01664949|65006717|FG000|Overall Study|Protocol Violation|5|||
23457077|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
23457078|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457079|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457080|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23637758|NCT02712905|66057633|FG008|Monotherapy|Lost to Follow-up|0|||
23637759|NCT02712905|66057634|FG009|Monotherapy|Lost to Follow-up|2|||
23637760|NCT02712905|66057635|FG010|Monotherapy|Lost to Follow-up|0|||
23345142|NCT01664949|65006718|FG001|Overall Study|Protocol Violation|5|||
23345143|NCT01664949|65006717|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23457081|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457082|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457083|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457084|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457085|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457086|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457087|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457088|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457089|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457090|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457091|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457092|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457093|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457094|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457095|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457096|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457097|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457098|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457099|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
23457100|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
23457101|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457102|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457103|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457104|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
23457105|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457106|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457107|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457108|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
23457109|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
23457110|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
23457111|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
23457112|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
23457113|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
23457114|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
23457115|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
23457116|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
23457117|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
23457118|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
23457119|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
23457120|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
23457121|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
23457122|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
23457123|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
23457124|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
23457125|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
23457126|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
23457127|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
23457128|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
23457129|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
23457130|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
23457131|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457132|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457133|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457134|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457135|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23637761|NCT02712905|66057636|FG011|Monotherapy|Lost to Follow-up|0|||
23637762|NCT02712905|66057637|FG012|Monotherapy|Lost to Follow-up|0|||
23457136|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457137|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457138|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457139|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457140|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457141|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457142|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457143|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457144|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457145|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457146|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457147|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457148|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457149|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457150|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457151|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457152|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457153|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457154|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457155|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457156|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23345144|NCT01664949|65006718|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23345145|NCT00784238|65006722|FG000|Overall Study|Adverse Event|14|||
23345146|NCT00784238|65006722|FG000|Overall Study|Death|2|||
23345147|NCT00784238|65006722|FG000|Overall Study|Lack of Efficacy|33|||
23345148|NCT00784238|65006722|FG000|Overall Study|Lost to Follow-up|29|||
23457157|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457158|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23637763|NCT02712905|66057638|FG013|Monotherapy|Lost to Follow-up|0|||
23637764|NCT02712905|66057639|FG014|Monotherapy|Lost to Follow-up|0|||
23637765|NCT02712905|66057640|FG015|Monotherapy|Lost to Follow-up|0|||
23637766|NCT02712905|66057641|FG016|Monotherapy|Lost to Follow-up|0|||
23637767|NCT02712905|66057642|FG017|Monotherapy|Lost to Follow-up|0|||
23637768|NCT02712905|66057625|FG000|Monotherapy|Physician Decision|1|||
23785319|NCT05093205|66593427|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
23457159|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23785320|NCT05093205|66593428|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
23785321|NCT05093205|66593429|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
23785322|NCT05093205|66593430|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
23457160|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457161|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457162|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457163|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457164|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457165|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23583448|NCT04011033|65866025|FG001|Overall Study|Withdrawal by Subject|0|||
23583449|NCT00580801|65866026|FG000|Overall Study|Physician Decision|1|||
23785323|NCT05093205|66593431|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
23785324|NCT05093205|66593432|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
23583450|NCT00580801|65866027|FG001|Overall Study|Physician Decision|0|||
23583451|NCT00580801|65866028|FG002|Overall Study|Physician Decision|0|||
23583452|NCT00580801|65866026|FG000|Overall Study|Adverse Event|2|||
23583453|NCT00580801|65866027|FG001|Overall Study|Adverse Event|0|||
23583454|NCT00580801|65866028|FG002|Overall Study|Adverse Event|0|||
23583455|NCT00580801|65866026|FG000|Overall Study|Lost to Follow-up|2|||
23583456|NCT00580801|65866027|FG001|Overall Study|Lost to Follow-up|0|||
23583457|NCT00580801|65866028|FG002|Overall Study|Lost to Follow-up|0|||
23583458|NCT00580801|65866026|FG000|Overall Study|Reached a virologic endpoint|0|||
23583459|NCT00580801|65866027|FG001|Overall Study|Reached a virologic endpoint|1|||
23583460|NCT00580801|65866028|FG002|Overall Study|Reached a virologic endpoint|2|||
23583461|NCT00580801|65866026|FG000|Overall Study|Participant non-compliant|0|||
23583462|NCT00580801|65866027|FG001|Overall Study|Participant non-compliant|0|||
23583463|NCT00580801|65866028|FG002|Overall Study|Participant non-compliant|1|||
23583464|NCT00580801|65866026|FG000|Overall Study|Travel|1|||
23637769|NCT02712905|66057626|FG001|Monotherapy|Physician Decision|0|||
23637770|NCT02712905|66057627|FG002|Monotherapy|Physician Decision|0|||
23637771|NCT02712905|66057628|FG003|Monotherapy|Physician Decision|1|||
23785325|NCT05093205|66593433|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
23583465|NCT00580801|65866027|FG001|Overall Study|Travel|0|||
23583466|NCT00580801|65866028|FG002|Overall Study|Travel|0|||
23583467|NCT04109118|65866029|FG000|Overall Study|Lost to Follow-up|3|||
23583468|NCT02155829|65866030|FG000|Overall Study|Adverse Event|1|||
23785326|NCT05093205|66593434|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
23637772|NCT02712905|66057629|FG004|Monotherapy|Physician Decision|0|||
23457166|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457167|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457168|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457169|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457170|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457171|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457172|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457173|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457174|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457175|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457176|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
23457177|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457178|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457179|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457180|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457181|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23637773|NCT02712905|66057630|FG005|Monotherapy|Physician Decision|0|||
23637774|NCT02712905|66057631|FG006|Monotherapy|Physician Decision|0|||
23785327|NCT05093205|66593422|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785328|NCT05093205|66593423|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785329|NCT05093205|66593424|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785330|NCT05093205|66593425|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785331|NCT05093205|66593426|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785332|NCT05093205|66593427|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785333|NCT05093205|66593428|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785334|NCT05093205|66593429|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785335|NCT05093205|66593430|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785336|NCT05093205|66593431|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785337|NCT05093205|66593432|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
23785338|NCT05093205|66593433|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785339|NCT05093205|66593434|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23785340|NCT05093205|66593422|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785341|NCT05093205|66593423|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785342|NCT05093205|66593424|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785343|NCT05093205|66593425|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785344|NCT05093205|66593426|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785345|NCT05093205|66593427|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785346|NCT05093205|66593428|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785347|NCT05093205|66593429|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785348|NCT05093205|66593430|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23457182|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583469|NCT02155829|65866031|FG001|Overall Study|Adverse Event|0|||
23583470|NCT02155829|65866030|FG000|Overall Study|Withdrawal by Subject|3|||
23583471|NCT02155829|65866031|FG001|Overall Study|Withdrawal by Subject|3|||
23583472|NCT02155829|65866030|FG000|Overall Study|Protocol Violation|2|||
23583473|NCT02155829|65866031|FG001|Overall Study|Protocol Violation|0|||
23583474|NCT01582945|65866032|FG000|Overall Study|Intolerable side-effects|1|||
23583475|NCT01582945|65866032|FG000|Overall Study|Scheduling conflicts|1|||
23583476|NCT02451943|65866036|FG000|Overall Study|On Treatment|4|||
23583477|NCT02451943|65866037|FG001|Overall Study|On Treatment|4|||
23583478|NCT02451943|65866036|FG000|Overall Study|Withdrawal by Subject|13|||
23583479|NCT02451943|65866037|FG001|Overall Study|Withdrawal by Subject|16|||
23583480|NCT02451943|65866036|FG000|Overall Study|Lost to Follow-up|3|||
23583481|NCT02451943|65866037|FG001|Overall Study|Lost to Follow-up|4|||
23583482|NCT02812966|65866040|FG000|Overall Study|Death|1|||
23583483|NCT02812966|65866041|FG001|Overall Study|Death|0|||
23583484|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
23583485|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
23583486|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583487|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583488|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583489|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583490|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583491|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583492|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583493|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583494|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583495|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583496|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583497|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583498|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
23457183|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457184|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457185|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457186|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457187|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457188|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23637775|NCT02712905|66057632|FG007|Monotherapy|Physician Decision|0|||
23637776|NCT02712905|66057633|FG008|Monotherapy|Physician Decision|0|||
23637777|NCT02712905|66057634|FG009|Monotherapy|Physician Decision|1|||
23637778|NCT02712905|66057635|FG010|Monotherapy|Physician Decision|0|||
23637779|NCT02712905|66057636|FG011|Monotherapy|Physician Decision|0|||
23637780|NCT02712905|66057637|FG012|Monotherapy|Physician Decision|0|||
23637781|NCT02712905|66057638|FG013|Monotherapy|Physician Decision|0|||
23637782|NCT02712905|66057639|FG014|Monotherapy|Physician Decision|0|||
23637783|NCT02712905|66057640|FG015|Monotherapy|Physician Decision|0|||
23637784|NCT02712905|66057641|FG016|Monotherapy|Physician Decision|0|||
23637785|NCT02712905|66057642|FG017|Monotherapy|Physician Decision|0|||
23637786|NCT02712905|66057625|FG000|Monotherapy|Study Terminated by Sponsor|0|||
23785349|NCT05093205|66593431|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785350|NCT05093205|66593432|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785351|NCT05093205|66593433|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
23785352|NCT05093205|66593434|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23785353|NCT05093205|66593422|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
23785354|NCT05093205|66593423|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
23637787|NCT02712905|66057626|FG001|Monotherapy|Study Terminated by Sponsor|0|||
23637788|NCT02712905|66057627|FG002|Monotherapy|Study Terminated by Sponsor|0|||
23637789|NCT02712905|66057628|FG003|Monotherapy|Study Terminated by Sponsor|0|||
23637790|NCT02712905|66057629|FG004|Monotherapy|Study Terminated by Sponsor|1|||
23637791|NCT02712905|66057630|FG005|Monotherapy|Study Terminated by Sponsor|0|||
23637792|NCT02712905|66057631|FG006|Monotherapy|Study Terminated by Sponsor|0|||
23637793|NCT02712905|66057632|FG007|Monotherapy|Study Terminated by Sponsor|0|||
23785355|NCT05093205|66593424|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
23785356|NCT05093205|66593425|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
23345149|NCT00784238|65006722|FG000|Overall Study|Pregnancy|1|||
23637794|NCT02712905|66057633|FG008|Monotherapy|Study Terminated by Sponsor|0|||
23785357|NCT05093205|66593426|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
23345150|NCT00784238|65006722|FG000|Overall Study|Withdrawal by Subject|26|||
23345151|NCT00784238|65006722|FG000|Overall Study|Other|14|||
23345152|NCT01044290|65006723|FG000|Follow-up 1|Death|3|||
23345153|NCT01044290|65006724|FG001|Follow-up 1|Death|3|||
23345154|NCT01044290|65006725|FG002|Follow-up 1|Death|1|||
23345155|NCT01044290|65006723|FG000|Follow-up 1|Withdrawal by Subject|2|||
23345156|NCT01044290|65006724|FG001|Follow-up 1|Withdrawal by Subject|2|||
23345157|NCT01044290|65006725|FG002|Follow-up 1|Withdrawal by Subject|0|||
23345158|NCT01044290|65006723|FG000|Follow-Up 2|Death|0|||
23345159|NCT01044290|65006724|FG001|Follow-Up 2|Death|1|||
23345160|NCT01044290|65006725|FG002|Follow-Up 2|Death|1|||
23345161|NCT01044290|65006723|FG000|Follow-Up 2|Withdrawal by Subject|0|||
23345162|NCT01044290|65006724|FG001|Follow-Up 2|Withdrawal by Subject|1|||
23345163|NCT01044290|65006725|FG002|Follow-Up 2|Withdrawal by Subject|1|||
23457189|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457190|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457191|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23785358|NCT05093205|66593427|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
23785359|NCT05093205|66593428|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
23785360|NCT05093205|66593429|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
23457192|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583499|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
23785361|NCT05093205|66593430|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
23785362|NCT05093205|66593431|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
23785363|NCT05093205|66593432|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
23785364|NCT05093205|66593433|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
23785365|NCT05093205|66593434|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
23785366|NCT05093205|66593422|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785367|NCT05093205|66593423|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23345164|NCT00664859|65006726|FG000|Overall Study|Adverse Event|2|||
23345165|NCT00664859|65006727|FG001|Overall Study|Adverse Event|1|||
23345166|NCT00664859|65006728|FG002|Overall Study|Adverse Event|3|||
23345167|NCT00664859|65006726|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
23583500|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583501|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583502|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583503|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583504|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583505|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583506|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583507|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23345168|NCT00664859|65006727|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
23345169|NCT00664859|65006728|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
23345170|NCT00664859|65006726|FG000|Overall Study|Noncompliance with protocol|1|||
23345171|NCT00664859|65006727|FG001|Overall Study|Noncompliance with protocol|0|||
23345172|NCT00664859|65006728|FG002|Overall Study|Noncompliance with protocol|4|||
23345173|NCT00664859|65006726|FG000|Overall Study|Laboratory abnormality|2|||
23345174|NCT00664859|65006727|FG001|Overall Study|Laboratory abnormality|1|||
23345175|NCT00664859|65006728|FG002|Overall Study|Laboratory abnormality|4|||
23637795|NCT02712905|66057634|FG009|Monotherapy|Study Terminated by Sponsor|2|||
23637796|NCT02712905|66057635|FG010|Monotherapy|Study Terminated by Sponsor|0|||
23785368|NCT05093205|66593424|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785369|NCT05093205|66593425|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23345176|NCT00664859|65006726|FG000|Overall Study|Withdrawal by Subject|4|||
23345177|NCT00664859|65006727|FG001|Overall Study|Withdrawal by Subject|1|||
23345178|NCT00664859|65006728|FG002|Overall Study|Withdrawal by Subject|3|||
23345179|NCT00664859|65006726|FG000|Overall Study|Lost to Follow-up|2|||
23345180|NCT00664859|65006727|FG001|Overall Study|Lost to Follow-up|2|||
23345181|NCT00664859|65006728|FG002|Overall Study|Lost to Follow-up|1|||
23345182|NCT00664859|65006726|FG000|Overall Study|Other|0|||
23345183|NCT00664859|65006727|FG001|Overall Study|Other|1|||
23345184|NCT00664859|65006728|FG002|Overall Study|Other|2|||
23345185|NCT03379792|65006729|FG000|Overall Study|Physician Decision|0|||
23345186|NCT03379792|65006730|FG001|Overall Study|Physician Decision|0|||
23345187|NCT03379792|65006731|FG002|Overall Study|Physician Decision|0|||
23345188|NCT03379792|65006732|FG003|Overall Study|Physician Decision|1|||
23345189|NCT03379792|65006733|FG004|Overall Study|Physician Decision|0|||
23345190|NCT03379792|65006734|FG005|Overall Study|Physician Decision|0|||
23345191|NCT03379792|65006729|FG000|Overall Study|Withdrawal by Subject|0|||
23345192|NCT03379792|65006730|FG001|Overall Study|Withdrawal by Subject|0|||
23345193|NCT03379792|65006731|FG002|Overall Study|Withdrawal by Subject|0|||
23345194|NCT03379792|65006732|FG003|Overall Study|Withdrawal by Subject|0|||
23345195|NCT03379792|65006733|FG004|Overall Study|Withdrawal by Subject|1|||
23345196|NCT03379792|65006734|FG005|Overall Study|Withdrawal by Subject|1|||
23345197|NCT01282164|65006735|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
23345198|NCT01282164|65006736|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
23345199|NCT00784550|65006738|FG000|Overall Study|Adverse Event|12|||
23345200|NCT00784550|65006739|FG001|Overall Study|Adverse Event|10|||
23345201|NCT00784550|65006738|FG000|Overall Study|Lack of Efficacy|0|||
23345202|NCT00784550|65006739|FG001|Overall Study|Lack of Efficacy|1|||
23345203|NCT00784550|65006738|FG000|Overall Study|Protocol Violation|10|||
23345204|NCT00784550|65006739|FG001|Overall Study|Protocol Violation|10|||
23345205|NCT00784550|65006738|FG000|Overall Study|Lost to Follow-up|8|||
23345206|NCT00784550|65006739|FG001|Overall Study|Lost to Follow-up|5|||
23345207|NCT00784550|65006738|FG000|Overall Study|Physician Decision|2|||
23345208|NCT00784550|65006739|FG001|Overall Study|Physician Decision|3|||
23785370|NCT05093205|66593426|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23345209|NCT00784550|65006738|FG000|Overall Study|Withdrawal by Subject|4|||
23345210|NCT00784550|65006739|FG001|Overall Study|Withdrawal by Subject|13|||
23345211|NCT00270231|65006740|FG000|First Intervention|Lost to Follow-up|1|||
23345212|NCT00270231|65006741|FG001|First Intervention|Lost to Follow-up|1|||
23345213|NCT00270231|65006740|FG000|Washout Period|Lost to Follow-up|1|||
23345214|NCT00270231|65006741|FG001|Washout Period|Lost to Follow-up|0|||
23345215|NCT00270231|65006740|FG000|Second Intervention|Lost to Follow-up|0|||
23637797|NCT02712905|66057636|FG011|Monotherapy|Study Terminated by Sponsor|0|||
23785371|NCT05093205|66593427|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785372|NCT05093205|66593428|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785373|NCT05093205|66593429|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785374|NCT05093205|66593430|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785375|NCT05093205|66593431|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785376|NCT05093205|66593432|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23785377|NCT05093205|66593433|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
23345216|NCT00270231|65006741|FG001|Second Intervention|Lost to Follow-up|1|||
23345217|NCT02928770|65006742|FG000|Overall Study|Withdrawal by Subject|2|||
23345218|NCT00819780|65006744|FG000|Overall Study|Did not receive study drug|3|||
23345219|NCT00819780|65006745|FG001|Overall Study|Did not receive study drug|4|||
23785378|NCT05093205|66593434|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23345220|NCT00819780|65006744|FG000|Overall Study|Still in treatment|25|||
23345221|NCT00819780|65006745|FG001|Overall Study|Still in treatment|17|||
23345222|NCT02706886|65006746|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
23345223|NCT02706886|65006747|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
23345224|NCT02706886|65006748|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
23345225|NCT02706886|65006749|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
23345226|NCT02706886|65006750|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
23345227|NCT02706886|65006751|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
23345228|NCT02706886|65006752|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
23785379|NCT03364192|66593436|FG000|Overall Study|Ineligible|10|||
23345229|NCT02706886|65006753|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
23345230|NCT02706886|65006754|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
23345231|NCT02062944|65006755|FG000|Overall Study|Lost to Follow-up|1|||
23345232|NCT02062944|65006755|FG000|Overall Study|New hemotological disorder identified|1|||
23345233|NCT02062944|65006755|FG000|Overall Study|Uncontrolled Hypertension|1|||
23345234|NCT02062944|65006755|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
23345235|NCT03417024|65006756|FG000|Overall Study|Study Termination prior to follow-up|11|||
23345236|NCT03417024|65006756|FG000|Overall Study|Physician Decision|2|||
23345237|NCT03673345|65006760|FG000|Overall Study|Lost to Follow-up|1|||
23345238|NCT03673345|65006761|FG001|Overall Study|Lost to Follow-up|0|||
23345239|NCT03673345|65006762|FG002|Overall Study|Lost to Follow-up|3|||
23345240|NCT03673345|65006763|FG003|Overall Study|Lost to Follow-up|3|||
23345241|NCT03673345|65006764|FG004|Overall Study|Lost to Follow-up|2|||
23345242|NCT03673345|65006765|FG005|Overall Study|Lost to Follow-up|1|||
23345243|NCT03673345|65006766|FG006|Overall Study|Lost to Follow-up|0|||
23345244|NCT03673345|65006767|FG007|Overall Study|Lost to Follow-up|0|||
23345245|NCT03673345|65006760|FG000|Overall Study|Withdrawal by Subject|1|||
23345246|NCT03673345|65006761|FG001|Overall Study|Withdrawal by Subject|0|||
23345247|NCT03673345|65006762|FG002|Overall Study|Withdrawal by Subject|4|||
23345248|NCT03673345|65006763|FG003|Overall Study|Withdrawal by Subject|2|||
23345249|NCT03673345|65006764|FG004|Overall Study|Withdrawal by Subject|0|||
23345250|NCT03673345|65006765|FG005|Overall Study|Withdrawal by Subject|0|||
23345251|NCT03673345|65006766|FG006|Overall Study|Withdrawal by Subject|0|||
23345252|NCT03673345|65006767|FG007|Overall Study|Withdrawal by Subject|0|||
23345253|NCT03673345|65006760|FG000|Overall Study|Physician Decision|0|||
23345254|NCT03673345|65006761|FG001|Overall Study|Physician Decision|0|||
23345255|NCT03673345|65006762|FG002|Overall Study|Physician Decision|2|||
23345256|NCT03673345|65006763|FG003|Overall Study|Physician Decision|0|||
23345257|NCT03673345|65006764|FG004|Overall Study|Physician Decision|0|||
23345258|NCT03673345|65006765|FG005|Overall Study|Physician Decision|0|||
23345259|NCT03673345|65006766|FG006|Overall Study|Physician Decision|0|||
23345260|NCT03673345|65006767|FG007|Overall Study|Physician Decision|0|||
23345261|NCT04601103|65006768|FG000|Overall Study|Needed crown & cleaning|0|||
23345262|NCT04601103|65006769|FG001|Overall Study|Needed crown & cleaning|0|||
23345263|NCT04601103|65006770|FG002|Overall Study|Needed crown & cleaning|1|||
23345264|NCT04601103|65006768|FG000|Overall Study|study was terminated|18|||
23345265|NCT04601103|65006769|FG001|Overall Study|study was terminated|18|||
23345266|NCT04601103|65006770|FG002|Overall Study|study was terminated|16|||
23345267|NCT04299048|65006771|FG000|Overall Study|Death|1|||
23345268|NCT04299048|65006771|FG000|Overall Study|Global deterioration of health status|2|||
23345269|NCT04299048|65006771|FG000|Overall Study|Enrolled and not treated|1|||
23345270|NCT04676022|65006782|FG000|Overall Study|Screen Failure/|1|||
23345271|NCT04676022|65006783|FG001|Overall Study|Screen Failure/|1|||
23345272|NCT04676022|65006784|FG002|Overall Study|Screen Failure/|85|||
23345273|NCT04676022|65006782|FG000|Overall Study|Lost to Follow-up|1|||
23345274|NCT04676022|65006783|FG001|Overall Study|Lost to Follow-up|1|||
23345275|NCT04676022|65006784|FG002|Overall Study|Lost to Follow-up|0|||
23345276|NCT04676022|65006782|FG000|Overall Study|Adverse Event|2|||
23345277|NCT04676022|65006783|FG001|Overall Study|Adverse Event|0|||
23345278|NCT04676022|65006784|FG002|Overall Study|Adverse Event|1|||
23345279|NCT04676022|65006782|FG000|Overall Study|Physician Decision|2|||
23345280|NCT04676022|65006783|FG001|Overall Study|Physician Decision|0|||
23345281|NCT04676022|65006784|FG002|Overall Study|Physician Decision|1|||
23345282|NCT04676022|65006782|FG000|Overall Study|Withdrawal by Subject|3|||
23345283|NCT04676022|65006783|FG001|Overall Study|Withdrawal by Subject|1|||
23345284|NCT04676022|65006784|FG002|Overall Study|Withdrawal by Subject|6|||
23345285|NCT04676022|65006782|FG000|Overall Study|Will not move forward with permanent implant|6|||
23345286|NCT04676022|65006783|FG001|Overall Study|Will not move forward with permanent implant|0|||
23345287|NCT04676022|65006784|FG002|Overall Study|Will not move forward with permanent implant|0|||
23345288|NCT04676022|65006782|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
23345289|NCT04676022|65006783|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
23345290|NCT04676022|65006784|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
23345291|NCT03409107|65006785|FG000|Overall Study|Withdrawal by Subject|4|||
23345292|NCT03409107|65006786|FG001|Overall Study|Withdrawal by Subject|2|||
23345293|NCT03409107|65006785|FG000|Overall Study|Physician Decision|1|||
23345294|NCT03409107|65006786|FG001|Overall Study|Physician Decision|0|||
23345295|NCT03409107|65006785|FG000|Overall Study|Lost to Follow-up|7|||
23345296|NCT03409107|65006786|FG001|Overall Study|Lost to Follow-up|2|||
23345297|NCT03409107|65006785|FG000|Overall Study|Adverse Event|5|||
23345298|NCT03409107|65006786|FG001|Overall Study|Adverse Event|3|||
23345299|NCT03671564|65006787|FG000|Overall Study|Progressive Disease|3|||
23345300|NCT03671564|65006788|FG001|Overall Study|Progressive Disease|5|||
23345301|NCT03671564|65006789|FG002|Overall Study|Progressive Disease|3|||
23345302|NCT03671564|65006787|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
23345303|NCT03671564|65006788|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
23345304|NCT03671564|65006789|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
23345305|NCT03671564|65006787|FG000|Overall Study|Withdrawal by Subject|1|||
23345306|NCT03671564|65006788|FG001|Overall Study|Withdrawal by Subject|1|||
23345307|NCT03671564|65006789|FG002|Overall Study|Withdrawal by Subject|0|||
23345308|NCT04392167|65006790|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
23345309|NCT01867294|65006791|FG000|Overall Study|Withdrawal by Subject|1|||
23345310|NCT01867294|65006792|FG001|Overall Study|Withdrawal by Subject|1|||
23345311|NCT01867294|65006793|FG002|Overall Study|Withdrawal by Subject|0|||
23345312|NCT01867294|65006794|FG003|Overall Study|Withdrawal by Subject|0|||
23345313|NCT04521621|65006797|FG000|Overall Study|Death|17|||
23345314|NCT04521621|65006798|FG001|Overall Study|Death|8|||
23345315|NCT04521621|65006799|FG002|Overall Study|Death|8|||
23345316|NCT04521621|65006800|FG003|Overall Study|Death|5|||
23345317|NCT04521621|65006801|FG004|Overall Study|Death|2|||
23345318|NCT04521621|65006802|FG005|Overall Study|Death|7|||
23345319|NCT04521621|65006803|FG006|Overall Study|Death|0|||
23345320|NCT04521621|65006804|FG007|Overall Study|Death|0|||
23345321|NCT04521621|65006797|FG000|Overall Study|Study Terminated by Sponsor|4|||
23345322|NCT04521621|65006798|FG001|Overall Study|Study Terminated by Sponsor|6|||
23345323|NCT04521621|65006799|FG002|Overall Study|Study Terminated by Sponsor|8|||
23345324|NCT04521621|65006800|FG003|Overall Study|Study Terminated by Sponsor|0|||
23345325|NCT04521621|65006801|FG004|Overall Study|Study Terminated by Sponsor|1|||
23345326|NCT04521621|65006802|FG005|Overall Study|Study Terminated by Sponsor|7|||
23345327|NCT04521621|65006803|FG006|Overall Study|Study Terminated by Sponsor|0|||
23345328|NCT04521621|65006804|FG007|Overall Study|Study Terminated by Sponsor|0|||
23345329|NCT04521621|65006797|FG000|Overall Study|Withdrawal by Subject|0|||
23345330|NCT04521621|65006798|FG001|Overall Study|Withdrawal by Subject|0|||
23345331|NCT04521621|65006799|FG002|Overall Study|Withdrawal by Subject|1|||
23345332|NCT04521621|65006800|FG003|Overall Study|Withdrawal by Subject|1|||
23345333|NCT04521621|65006801|FG004|Overall Study|Withdrawal by Subject|0|||
23345334|NCT04521621|65006802|FG005|Overall Study|Withdrawal by Subject|0|||
23345335|NCT04521621|65006803|FG006|Overall Study|Withdrawal by Subject|0|||
23345336|NCT04521621|65006804|FG007|Overall Study|Withdrawal by Subject|0|||
23345337|NCT04521621|65006797|FG000|Overall Study|Allocated in error without study intervention|1|||
23345338|NCT04521621|65006798|FG001|Overall Study|Allocated in error without study intervention|0|||
23345339|NCT04521621|65006799|FG002|Overall Study|Allocated in error without study intervention|0|||
23457193|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583508|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23785380|NCT03364192|66593436|FG000|Overall Study|Withdrawal by Subject|5|||
23785381|NCT03364192|66593436|FG000|Overall Study|Lost to Follow-up|1|||
23785382|NCT03681470|66593437|FG000|Overall Study|Lack of Efficacy|3|||
23785383|NCT03681470|66593437|FG000|Overall Study|Lost to Follow-up|1|||
23785384|NCT03681470|66593437|FG000|Overall Study|Protocol Violation|3|||
23785385|NCT03681470|66593437|FG000|Overall Study|Withdrawal by Subject|1|||
23785386|NCT03406156|66593438|FG000|Overall Study|Death|9|||
23785387|NCT03406156|66593439|FG001|Overall Study|Death|3|||
23785388|NCT03406156|66593438|FG000|Overall Study|Withdrawal by Subject|1|||
23785389|NCT03406156|66593439|FG001|Overall Study|Withdrawal by Subject|2|||
23785390|NCT03406156|66593438|FG000|Overall Study|COVID-19 infection|1|||
23785391|NCT03406156|66593439|FG001|Overall Study|COVID-19 infection|0|||
23785392|NCT03406156|66593438|FG000|Overall Study|Non-compliance with study procedures|1|||
23785393|NCT03406156|66593439|FG001|Overall Study|Non-compliance with study procedures|1|||
23785394|NCT03406156|66593438|FG000|Overall Study|Lost to Follow-up|0|||
23785395|NCT03406156|66593439|FG001|Overall Study|Lost to Follow-up|2|||
23785396|NCT03406156|66593438|FG000|Overall Study|Other, not specified|72|||
23785397|NCT03406156|66593439|FG001|Overall Study|Other, not specified|28|||
23785398|NCT00571064|66593440|FG000|Overall Study|Adverse Event|13|||
23785399|NCT00571064|66593440|FG000|Overall Study|Protocol Violation|4|||
23785400|NCT00571064|66593440|FG000|Overall Study|Withdrawal by Subject|2|||
23785401|NCT00571064|66593440|FG000|Overall Study|Other|2|||
23785402|NCT01735994|66593447|FG000|Overall Study|Withdrawal by Subject|6|||
23785403|NCT01735994|66593448|FG001|Overall Study|Withdrawal by Subject|4|||
23785404|NCT01735994|66593447|FG000|Overall Study|Injury|2|||
23785405|NCT01735994|66593448|FG001|Overall Study|Injury|0|||
23785406|NCT01735994|66593447|FG000|Overall Study|Kicked off team|5|||
23785407|NCT01735994|66593448|FG001|Overall Study|Kicked off team|0|||
23785408|NCT01735994|66593447|FG000|Overall Study|Lost to Follow-up|50|||
23785409|NCT01735994|66593448|FG001|Overall Study|Lost to Follow-up|62|||
23785410|NCT00830258|66593449|FG000|First Intervention|Adverse Event|1|||
23785411|NCT00830258|66593450|FG001|First Intervention|Adverse Event|0|||
23785412|NCT00830258|66593449|FG000|Washout: 7 Days|Protocol Violation|1|||
23785413|NCT00830258|66593450|FG001|Washout: 7 Days|Protocol Violation|0|||
23785414|NCT02902211|66593451|FG000|First Three Months|Withdrawal by Subject|7|||
23785415|NCT02902211|66593452|FG001|First Three Months|Withdrawal by Subject|3|||
23785416|NCT00088829|66593455|FG000|Overall Study|PI left institution and study was close|22|||
23785417|NCT03273153|66593461|FG000|Overall Study|Adverse Event|1|||
23785418|NCT03273153|66593462|FG001|Overall Study|Adverse Event|2|||
23785419|NCT03273153|66593461|FG000|Overall Study|Missing|0|||
23785420|NCT03273153|66593462|FG001|Overall Study|Missing|2|||
23785421|NCT03273153|66593461|FG000|Overall Study|Other|3|||
23785422|NCT03273153|66593462|FG001|Overall Study|Other|2|||
23785423|NCT03273153|66593461|FG000|Overall Study|Symptomatic Deterioration|0|||
23785424|NCT03273153|66593462|FG001|Overall Study|Symptomatic Deterioration|1|||
23785425|NCT03273153|66593461|FG000|Overall Study|Progressive Disease|6|||
23785426|NCT03273153|66593462|FG001|Overall Study|Progressive Disease|5|||
23345340|NCT04521621|65006800|FG003|Overall Study|Allocated in error without study intervention|0|||
23345341|NCT04521621|65006801|FG004|Overall Study|Allocated in error without study intervention|0|||
23706033|NCT00718419|66301030|FG001|Overall Study|Sponsor decision|1|||
23706034|NCT00718419|66301029|FG000|Overall Study|Withdrawal by Subject|0|||
23706035|NCT00718419|66301030|FG001|Overall Study|Withdrawal by Subject|5|||
23706036|NCT00718419|66301029|FG000|Overall Study|Progressive Disease|7|||
23345342|NCT04521621|65006802|FG005|Overall Study|Allocated in error without study intervention|0|||
23345343|NCT04521621|65006803|FG006|Overall Study|Allocated in error without study intervention|0|||
23637798|NCT02712905|66057637|FG012|Monotherapy|Study Terminated by Sponsor|0|||
23637799|NCT02712905|66057638|FG013|Monotherapy|Study Terminated by Sponsor|0|||
23637800|NCT02712905|66057639|FG014|Monotherapy|Study Terminated by Sponsor|0|||
23637801|NCT02712905|66057640|FG015|Monotherapy|Study Terminated by Sponsor|0|||
23637802|NCT02712905|66057641|FG016|Monotherapy|Study Terminated by Sponsor|0|||
23785427|NCT03273153|66593461|FG000|Overall Study|Physician Decision|1|||
23785428|NCT03273153|66593462|FG001|Overall Study|Physician Decision|3|||
23345344|NCT04521621|65006804|FG007|Overall Study|Allocated in error without study intervention|0|||
23345345|NCT04258254|65006807|FG000|Overall Study|Withdrawal by Subject|0|||
23345346|NCT04258254|65006808|FG001|Overall Study|Withdrawal by Subject|1|||
23345347|NCT04258254|65006809|FG002|Overall Study|Withdrawal by Subject|0|||
23345348|NCT04416737|65006810|FG000|Week 1 (First Injection)|Physician Decision|0|||
23345349|NCT04416737|65006811|FG001|Week 1 (First Injection)|Physician Decision|1|||
23345350|NCT00386425|65006813|FG000|Overall Study|Physician Decision|3|||
23345351|NCT00386425|65006814|FG001|Overall Study|Physician Decision|0|||
23345352|NCT00386425|65006815|FG002|Overall Study|Physician Decision|0|||
23345353|NCT00386425|65006813|FG000|Overall Study|Withdrawal by Subject|0|||
23345354|NCT00386425|65006814|FG001|Overall Study|Withdrawal by Subject|1|||
23345355|NCT00386425|65006815|FG002|Overall Study|Withdrawal by Subject|0|||
23345356|NCT02091986|65006816|FG000|Overall Study|7 rand in error 1 patient decision|2|||
23345357|NCT02091986|65006817|FG001|Overall Study|7 rand in error 1 patient decision|3|||
23345358|NCT02091986|65006818|FG002|Overall Study|7 rand in error 1 patient decision|3|||
23345359|NCT02091986|65006816|FG000|Overall Study|Lost to Follow-up|1|||
23785429|NCT03273153|66593461|FG000|Overall Study|Study Terminated by Sponsor|112|||
23785430|NCT03273153|66593462|FG001|Overall Study|Study Terminated by Sponsor|102|||
23785431|NCT03273153|66593461|FG000|Overall Study|Withdrawal by Subject|26|||
23785432|NCT03273153|66593462|FG001|Overall Study|Withdrawal by Subject|25|||
23785433|NCT03273153|66593461|FG000|Overall Study|Protocol Deviation|3|||
23785434|NCT03273153|66593462|FG001|Overall Study|Protocol Deviation|0|||
23785435|NCT03273153|66593461|FG000|Overall Study|Lost to Follow-up|6|||
23345360|NCT02091986|65006817|FG001|Overall Study|Lost to Follow-up|0|||
23345361|NCT02091986|65006818|FG002|Overall Study|Lost to Follow-up|0|||
23345362|NCT02091986|65006816|FG000|Overall Study|Withdrawal by Subject|4|||
23345363|NCT02091986|65006817|FG001|Overall Study|Withdrawal by Subject|8|||
23345364|NCT02091986|65006818|FG002|Overall Study|Withdrawal by Subject|3|||
23345365|NCT02091986|65006816|FG000|Overall Study|Adverse Event|0|||
23345366|NCT02091986|65006817|FG001|Overall Study|Adverse Event|0|||
23345367|NCT02091986|65006818|FG002|Overall Study|Adverse Event|2|||
23345368|NCT01871402|65006819|FG000|Overall Study|Lost to Follow-up|1|||
23345369|NCT01871402|65006820|FG001|Overall Study|Lost to Follow-up|0|||
23345370|NCT01871402|65006819|FG000|Overall Study|Withdrawal by Subject|0|||
23457194|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457195|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457196|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457197|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457198|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457199|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
23785436|NCT03273153|66593462|FG001|Overall Study|Lost to Follow-up|11|||
23785437|NCT03273153|66593461|FG000|Overall Study|Death|66|||
23785438|NCT03273153|66593462|FG001|Overall Study|Death|69|||
23345371|NCT01871402|65006820|FG001|Overall Study|Withdrawal by Subject|2|||
23345372|NCT01871402|65006819|FG000|Overall Study|Non-compliance|0|||
23345373|NCT01871402|65006820|FG001|Overall Study|Non-compliance|1|||
23345374|NCT01306045|65006821|FG000|Met General Eligibility Criteria|Screen failures|193|||
23345375|NCT01306045|65006822|FG001|Met General Eligibility Criteria|Screen failures|11|||
23785439|NCT04345653|66593464|FG000|Overall Study|Withdrawal by Subject|2|||
23637803|NCT02712905|66057642|FG017|Monotherapy|Study Terminated by Sponsor|0|||
23637804|NCT02712905|66057625|FG000|Monotherapy|Withdrawal by Subject|0|||
23637805|NCT02712905|66057626|FG001|Monotherapy|Withdrawal by Subject|0|||
23637806|NCT02712905|66057627|FG002|Monotherapy|Withdrawal by Subject|1|||
23637807|NCT02712905|66057628|FG003|Monotherapy|Withdrawal by Subject|0|||
23637808|NCT02712905|66057629|FG004|Monotherapy|Withdrawal by Subject|2|||
23637809|NCT02712905|66057630|FG005|Monotherapy|Withdrawal by Subject|0|||
23637810|NCT02712905|66057631|FG006|Monotherapy|Withdrawal by Subject|0|||
23637811|NCT02712905|66057632|FG007|Monotherapy|Withdrawal by Subject|0|||
23637812|NCT02712905|66057633|FG008|Monotherapy|Withdrawal by Subject|0|||
23637813|NCT02712905|66057634|FG009|Monotherapy|Withdrawal by Subject|4|||
23637814|NCT02712905|66057635|FG010|Monotherapy|Withdrawal by Subject|1|||
23637815|NCT02712905|66057636|FG011|Monotherapy|Withdrawal by Subject|2|||
23637816|NCT02712905|66057637|FG012|Monotherapy|Withdrawal by Subject|0|||
23637817|NCT02712905|66057638|FG013|Monotherapy|Withdrawal by Subject|0|||
23637818|NCT02712905|66057639|FG014|Monotherapy|Withdrawal by Subject|0|||
23637819|NCT02712905|66057640|FG015|Monotherapy|Withdrawal by Subject|0|||
23637820|NCT02712905|66057641|FG016|Monotherapy|Withdrawal by Subject|0|||
23637821|NCT02712905|66057642|FG017|Monotherapy|Withdrawal by Subject|0|||
23637822|NCT02712905|66057625|FG000|Monotherapy|Started New Cancer Drug|0|||
23637823|NCT02712905|66057626|FG001|Monotherapy|Started New Cancer Drug|0|||
23637824|NCT02712905|66057627|FG002|Monotherapy|Started New Cancer Drug|0|||
23637825|NCT02712905|66057628|FG003|Monotherapy|Started New Cancer Drug|0|||
23637826|NCT02712905|66057629|FG004|Monotherapy|Started New Cancer Drug|0|||
23637827|NCT02712905|66057630|FG005|Monotherapy|Started New Cancer Drug|1|||
23457200|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23637828|NCT02712905|66057631|FG006|Monotherapy|Started New Cancer Drug|0|||
23637829|NCT02712905|66057632|FG007|Monotherapy|Started New Cancer Drug|0|||
23637830|NCT02712905|66057633|FG008|Monotherapy|Started New Cancer Drug|0|||
23637831|NCT02712905|66057634|FG009|Monotherapy|Started New Cancer Drug|0|||
23637832|NCT02712905|66057635|FG010|Monotherapy|Started New Cancer Drug|0|||
23785440|NCT01316055|66593465|FG000|Overall Study|Lost to Follow-up|1|||
23785441|NCT01316055|66593466|FG001|Overall Study|Lost to Follow-up|0|||
23785442|NCT01316055|66593467|FG002|Overall Study|Lost to Follow-up|0|||
23785443|NCT00881569|66593472|FG000|Overall Study|Disease progression|1|||
23785444|NCT00881569|66593473|FG001|Overall Study|Disease progression|1|||
23785445|NCT00840203|66593474|FG000|First Intervention|Protocol Violation|1|||
23785446|NCT00840203|66593475|FG001|First Intervention|Protocol Violation|1|||
23785447|NCT00840203|66593474|FG000|Washout|Protocol Violation|1|||
23785448|NCT00840203|66593475|FG001|Washout|Protocol Violation|0|||
23785449|NCT02718326|66593476|FG000|Overall Study|Adverse Event|4|||
23785450|NCT02718326|66593477|FG001|Overall Study|Adverse Event|9|||
23785451|NCT02718326|66593478|FG002|Overall Study|Adverse Event|0|||
23785452|NCT02718326|66593476|FG000|Overall Study|Death|8|||
23785453|NCT02718326|66593477|FG001|Overall Study|Death|1|||
23785454|NCT02718326|66593478|FG002|Overall Study|Death|2|||
23785455|NCT02718326|66593476|FG000|Overall Study|Withdrawal by Subject|4|||
23785456|NCT02718326|66593477|FG001|Overall Study|Withdrawal by Subject|9|||
23785457|NCT02718326|66593478|FG002|Overall Study|Withdrawal by Subject|6|||
23785458|NCT02718326|66593476|FG000|Overall Study|Lost to Follow-up|18|||
23785459|NCT02718326|66593477|FG001|Overall Study|Lost to Follow-up|5|||
23785460|NCT02718326|66593478|FG002|Overall Study|Lost to Follow-up|14|||
23637833|NCT02712905|66057636|FG011|Monotherapy|Started New Cancer Drug|0|||
23637834|NCT02712905|66057637|FG012|Monotherapy|Started New Cancer Drug|0|||
23637835|NCT02712905|66057638|FG013|Monotherapy|Started New Cancer Drug|0|||
23637836|NCT02712905|66057639|FG014|Monotherapy|Started New Cancer Drug|0|||
23637837|NCT02712905|66057640|FG015|Monotherapy|Started New Cancer Drug|0|||
23785461|NCT02718326|66593476|FG000|Overall Study|Protocol Deviation|1|||
23785462|NCT02718326|66593477|FG001|Overall Study|Protocol Deviation|0|||
23785463|NCT02718326|66593478|FG002|Overall Study|Protocol Deviation|0|||
23785464|NCT02718326|66593476|FG000|Overall Study|Pregnancy|1|||
23785465|NCT02718326|66593477|FG001|Overall Study|Pregnancy|0|||
23785466|NCT02718326|66593478|FG002|Overall Study|Pregnancy|0|||
23785467|NCT01867658|66593481|FG000|Overall Study|Withdrawal by Subject|6|||
23785468|NCT01867658|66593481|FG000|Overall Study|Death|2|||
23785469|NCT01867658|66593481|FG000|Overall Study|Subject could not be contacted|1|||
23637838|NCT02712905|66057641|FG016|Monotherapy|Started New Cancer Drug|0|||
23637839|NCT02712905|66057642|FG017|Monotherapy|Started New Cancer Drug|0|||
23637840|NCT02712905|66057625|FG000|Monotherapy|Adverse Event|0|||
23637841|NCT02712905|66057626|FG001|Monotherapy|Adverse Event|0|||
23345376|NCT01306045|65006823|FG002|Met General Eligibility Criteria|Screen failures|8|||
23345377|NCT02677038|65006824|FG000|Overall Study|Physician Decision|1|||
23345378|NCT02677038|65006824|FG000|Overall Study|Withdrawal by Subject|1|||
23345379|NCT03320850|65006829|FG000|Overall Study|Lost to Follow-up|0|||
23345380|NCT03320850|65006830|FG001|Overall Study|Lost to Follow-up|0|||
23345381|NCT03320850|65006831|FG002|Overall Study|Lost to Follow-up|0|||
23345382|NCT03320850|65006832|FG003|Overall Study|Lost to Follow-up|0|||
23345383|NCT03320850|65006833|FG004|Overall Study|Lost to Follow-up|1|||
23345384|NCT03320850|65006834|FG005|Overall Study|Lost to Follow-up|2|||
23345385|NCT03320850|65006835|FG006|Overall Study|Lost to Follow-up|2|||
23345386|NCT03320850|65006836|FG007|Overall Study|Lost to Follow-up|0|||
23345387|NCT03320850|65006837|FG008|Overall Study|Lost to Follow-up|6|||
23345388|NCT03320850|65006838|FG009|Overall Study|Lost to Follow-up|4|||
23345389|NCT03320850|65006829|FG000|Overall Study|Withdrawal by Subject|0|||
23345390|NCT03320850|65006830|FG001|Overall Study|Withdrawal by Subject|0|||
23345391|NCT03320850|65006831|FG002|Overall Study|Withdrawal by Subject|0|||
23345392|NCT03320850|65006832|FG003|Overall Study|Withdrawal by Subject|0|||
23345393|NCT03320850|65006833|FG004|Overall Study|Withdrawal by Subject|1|||
23345394|NCT03320850|65006834|FG005|Overall Study|Withdrawal by Subject|2|||
23345395|NCT03320850|65006835|FG006|Overall Study|Withdrawal by Subject|4|||
23345396|NCT03320850|65006836|FG007|Overall Study|Withdrawal by Subject|5|||
23345397|NCT03320850|65006837|FG008|Overall Study|Withdrawal by Subject|2|||
23345398|NCT03320850|65006838|FG009|Overall Study|Withdrawal by Subject|1|||
23345399|NCT03320850|65006829|FG000|Overall Study|Lack of Efficacy|0|||
23345400|NCT03320850|65006830|FG001|Overall Study|Lack of Efficacy|0|||
23345401|NCT03320850|65006831|FG002|Overall Study|Lack of Efficacy|0|||
23345402|NCT03320850|65006832|FG003|Overall Study|Lack of Efficacy|1|||
23345403|NCT03320850|65006833|FG004|Overall Study|Lack of Efficacy|0|||
23345404|NCT03320850|65006834|FG005|Overall Study|Lack of Efficacy|1|||
23457201|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23637842|NCT02712905|66057627|FG002|Monotherapy|Adverse Event|0|||
23785470|NCT03256695|66593482|FG000|Overall Study|Adverse Event|8|||
23785471|NCT03256695|66593482|FG000|Overall Study|Death|2|||
23345405|NCT03320850|65006835|FG006|Overall Study|Lack of Efficacy|0|||
23345406|NCT03320850|65006836|FG007|Overall Study|Lack of Efficacy|2|||
23345407|NCT03320850|65006837|FG008|Overall Study|Lack of Efficacy|0|||
23345408|NCT03320850|65006838|FG009|Overall Study|Lack of Efficacy|3|||
23345409|NCT03320850|65006829|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23637843|NCT02712905|66057628|FG003|Monotherapy|Adverse Event|0|||
23637844|NCT02712905|66057629|FG004|Monotherapy|Adverse Event|0|||
23345410|NCT03320850|65006830|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23345411|NCT03320850|65006831|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
23345412|NCT03320850|65006832|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
23345413|NCT03320850|65006833|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
23345414|NCT03320850|65006834|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
23345415|NCT03320850|65006835|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
23345416|NCT03320850|65006836|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
23345417|NCT03320850|65006837|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
23345418|NCT03320850|65006838|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
23345419|NCT03320850|65006829|FG000|Overall Study|Adverse Event|0|||
23345420|NCT03320850|65006830|FG001|Overall Study|Adverse Event|0|||
23345421|NCT03320850|65006831|FG002|Overall Study|Adverse Event|0|||
23345422|NCT03320850|65006832|FG003|Overall Study|Adverse Event|0|||
23345423|NCT03320850|65006833|FG004|Overall Study|Adverse Event|0|||
23345424|NCT03320850|65006834|FG005|Overall Study|Adverse Event|2|||
23345425|NCT03320850|65006835|FG006|Overall Study|Adverse Event|1|||
23345426|NCT03320850|65006836|FG007|Overall Study|Adverse Event|0|||
23345427|NCT03320850|65006837|FG008|Overall Study|Adverse Event|2|||
23345428|NCT03320850|65006838|FG009|Overall Study|Adverse Event|0|||
23345429|NCT03320850|65006829|FG000|Overall Study|Reason Not Specified|0|||
23345430|NCT03320850|65006830|FG001|Overall Study|Reason Not Specified|0|||
23345431|NCT03320850|65006831|FG002|Overall Study|Reason Not Specified|0|||
23345432|NCT03320850|65006832|FG003|Overall Study|Reason Not Specified|0|||
23345433|NCT03320850|65006833|FG004|Overall Study|Reason Not Specified|0|||
23345434|NCT03320850|65006834|FG005|Overall Study|Reason Not Specified|1|||
23345435|NCT03320850|65006835|FG006|Overall Study|Reason Not Specified|0|||
23345436|NCT03320850|65006836|FG007|Overall Study|Reason Not Specified|0|||
23345437|NCT03320850|65006837|FG008|Overall Study|Reason Not Specified|0|||
23345438|NCT03320850|65006838|FG009|Overall Study|Reason Not Specified|1|||
23345439|NCT00348595|65006844|FG000|Overall Study|Adverse Event|5|||
23345440|NCT00348595|65006845|FG001|Overall Study|Adverse Event|8|||
23345441|NCT01732471|65006846|FG000|Overall Study|Withdrawal by Subject|1|||
23345442|NCT00916344|65006847|FG000|Overall Study|Death|2|||
23345443|NCT00916344|65006847|FG000|Overall Study|ICD upgrade|1|||
23345444|NCT00916344|65006847|FG000|Overall Study|Drop-out|5|||
23345445|NCT01801358|65006848|FG000|Overall Study|Adverse Event|0|||
23345446|NCT01801358|65006849|FG001|Overall Study|Adverse Event|2|||
23345447|NCT01801358|65006850|FG002|Overall Study|Adverse Event|1|||
23345448|NCT01801358|65006851|FG003|Overall Study|Adverse Event|0|||
23457202|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457203|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457204|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457205|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457206|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457207|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457208|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457209|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457210|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457211|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457212|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457213|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457214|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457215|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457216|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457217|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457218|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457219|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23583509|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583510|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583511|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23345449|NCT01801358|65006852|FG004|Overall Study|Adverse Event|0|||
23345450|NCT01801358|65006853|FG005|Overall Study|Adverse Event|1|||
23345451|NCT01801358|65006848|FG000|Overall Study|Physician Decision|0|||
23345452|NCT01801358|65006849|FG001|Overall Study|Physician Decision|0|||
23345453|NCT01801358|65006850|FG002|Overall Study|Physician Decision|1|||
23345454|NCT01801358|65006851|FG003|Overall Study|Physician Decision|0|||
23345455|NCT01801358|65006852|FG004|Overall Study|Physician Decision|0|||
23345456|NCT01801358|65006853|FG005|Overall Study|Physician Decision|0|||
23345457|NCT01801358|65006848|FG000|Overall Study|Progressive Disease|6|||
23345458|NCT01801358|65006849|FG001|Overall Study|Progressive Disease|4|||
23345459|NCT01801358|65006850|FG002|Overall Study|Progressive Disease|4|||
23345460|NCT01801358|65006851|FG003|Overall Study|Progressive Disease|5|||
23345461|NCT01801358|65006852|FG004|Overall Study|Progressive Disease|6|||
23345462|NCT01801358|65006853|FG005|Overall Study|Progressive Disease|5|||
23345463|NCT01801358|65006848|FG000|Overall Study|Withdrawal by Subject|0|||
23345464|NCT01801358|65006849|FG001|Overall Study|Withdrawal by Subject|0|||
23345465|NCT01801358|65006850|FG002|Overall Study|Withdrawal by Subject|0|||
23345466|NCT01801358|65006851|FG003|Overall Study|Withdrawal by Subject|1|||
23345467|NCT01801358|65006852|FG004|Overall Study|Withdrawal by Subject|0|||
23457220|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457221|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457222|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
23457223|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457224|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457225|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457226|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457227|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457228|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457229|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457230|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457231|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457232|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457233|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457234|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457235|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457236|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457237|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457238|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457239|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457240|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457241|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457242|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457243|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457244|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457245|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
23457246|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457247|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457248|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457249|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457250|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457251|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457252|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457253|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457254|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457255|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457256|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457257|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457258|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457259|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457260|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457261|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457262|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457263|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457264|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457265|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457266|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457267|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457268|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
23457269|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
23457270|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
23457271|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
23457272|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
23457273|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
23457274|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
23457275|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
23457276|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
23785472|NCT03256695|66593482|FG000|Overall Study|Withdrawal by Subject|14|||
23345468|NCT01801358|65006853|FG005|Overall Study|Withdrawal by Subject|2|||
23345469|NCT05108922|65006856|FG000|Overall Study|Adverse Event|0|||
23345470|NCT05108922|65006857|FG001|Overall Study|Adverse Event|1|||
23345471|NCT05108922|65006856|FG000|Overall Study|Physician Decision|1|||
23345472|NCT05108922|65006857|FG001|Overall Study|Physician Decision|1|||
23345473|NCT05108922|65006856|FG000|Overall Study|Screen Failure|1|||
23345474|NCT05108922|65006857|FG001|Overall Study|Screen Failure|1|||
23345475|NCT05108922|65006856|FG000|Overall Study|Withdrawal by Subject|7|||
23345476|NCT05108922|65006857|FG001|Overall Study|Withdrawal by Subject|4|||
23345477|NCT01104246|65006858|FG000|Overall Study|Withdrawal by Subject|1|||
23345478|NCT01104246|65006858|FG000|Overall Study|did not meet inclusion criteria|4|||
23345479|NCT02429310|65006859|FG000|Overall Study|Lost to Follow-up|1|||
23345480|NCT02429310|65006860|FG001|Overall Study|Lost to Follow-up|2|||
23345481|NCT02429310|65006859|FG000|Overall Study|Protocol Violation|1|||
23345482|NCT02429310|65006860|FG001|Overall Study|Protocol Violation|1|||
23345483|NCT01300338|65006861|FG000|Overall Study|Lost to Follow-up|5|||
23345484|NCT01300338|65006862|FG001|Overall Study|Lost to Follow-up|0|||
23345485|NCT05153148|65006863|FG000|Overall Study|Adverse Event|1|||
23345486|NCT05153148|65006864|FG001|Overall Study|Adverse Event|0|||
23345487|NCT05153148|65006865|FG002|Overall Study|Adverse Event|3|||
23345488|NCT05153148|65006866|FG003|Overall Study|Adverse Event|5|||
23345489|NCT05153148|65006863|FG000|Overall Study|Lost to Follow-up|1|||
23345490|NCT05153148|65006864|FG001|Overall Study|Lost to Follow-up|1|||
23345491|NCT05153148|65006865|FG002|Overall Study|Lost to Follow-up|2|||
23345492|NCT05153148|65006866|FG003|Overall Study|Lost to Follow-up|0|||
23637845|NCT02712905|66057630|FG005|Monotherapy|Adverse Event|0|||
23637846|NCT02712905|66057631|FG006|Monotherapy|Adverse Event|0|||
23637847|NCT02712905|66057632|FG007|Monotherapy|Adverse Event|0|||
23637848|NCT02712905|66057633|FG008|Monotherapy|Adverse Event|1|||
23637849|NCT02712905|66057634|FG009|Monotherapy|Adverse Event|0|||
23637850|NCT02712905|66057635|FG010|Monotherapy|Adverse Event|0|||
23637851|NCT02712905|66057636|FG011|Monotherapy|Adverse Event|0|||
23637852|NCT02712905|66057637|FG012|Monotherapy|Adverse Event|0|||
23637853|NCT02712905|66057638|FG013|Monotherapy|Adverse Event|0|||
23637854|NCT02712905|66057639|FG014|Monotherapy|Adverse Event|0|||
23637855|NCT02712905|66057640|FG015|Monotherapy|Adverse Event|0|||
23637856|NCT02712905|66057641|FG016|Monotherapy|Adverse Event|0|||
23637857|NCT02712905|66057642|FG017|Monotherapy|Adverse Event|0|||
23637858|NCT02712905|66057625|FG000|Combination Therapy|Death|0|||
23637859|NCT02712905|66057626|FG001|Combination Therapy|Death|0|||
23637860|NCT02712905|66057627|FG002|Combination Therapy|Death|0|||
23637861|NCT02712905|66057628|FG003|Combination Therapy|Death|0|||
23637862|NCT02712905|66057629|FG004|Combination Therapy|Death|0|||
23637863|NCT02712905|66057630|FG005|Combination Therapy|Death|0|||
23637864|NCT02712905|66057631|FG006|Combination Therapy|Death|0|||
23637865|NCT02712905|66057632|FG007|Combination Therapy|Death|0|||
23345493|NCT05153148|65006863|FG000|Overall Study|Withdrawal by Subject|6|||
23345494|NCT05153148|65006864|FG001|Overall Study|Withdrawal by Subject|8|||
23345495|NCT05153148|65006865|FG002|Overall Study|Withdrawal by Subject|6|||
23345496|NCT05153148|65006866|FG003|Overall Study|Withdrawal by Subject|8|||
23345497|NCT05153148|65006863|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345498|NCT05153148|65006864|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345499|NCT05153148|65006865|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
23457277|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
23637866|NCT02712905|66057633|FG008|Combination Therapy|Death|0|||
23637867|NCT02712905|66057634|FG009|Combination Therapy|Death|0|||
23637868|NCT02712905|66057635|FG010|Combination Therapy|Death|0|||
23637869|NCT02712905|66057636|FG011|Combination Therapy|Death|0|||
23637870|NCT02712905|66057637|FG012|Combination Therapy|Death|5|||
23637871|NCT02712905|66057638|FG013|Combination Therapy|Death|6|||
23637872|NCT02712905|66057639|FG014|Combination Therapy|Death|1|||
23637873|NCT02712905|66057640|FG015|Combination Therapy|Death|3|||
23637874|NCT02712905|66057641|FG016|Combination Therapy|Death|1|||
23637875|NCT02712905|66057642|FG017|Combination Therapy|Death|3|||
23457278|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
23457279|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
23637876|NCT02712905|66057625|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
23785473|NCT03256695|66593482|FG000|Overall Study|Non-compliance with study drug|1|||
23345500|NCT05153148|65006866|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345501|NCT05153148|65006863|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345502|NCT05153148|65006864|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345503|NCT05153148|65006865|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345504|NCT05153148|65006866|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
23345505|NCT05153148|65006863|FG000|Overall Study|Reason not Specified|1|||
23345506|NCT05153148|65006864|FG001|Overall Study|Reason not Specified|1|||
23345507|NCT05153148|65006865|FG002|Overall Study|Reason not Specified|1|||
23345508|NCT05153148|65006866|FG003|Overall Study|Reason not Specified|1|||
23345509|NCT01362244|65006867|FG000|Overall Study|Adverse Event|3|||
23345510|NCT01362244|65006868|FG001|Overall Study|Adverse Event|5|||
23345511|NCT01362244|65006867|FG000|Overall Study|Lack of Efficacy|5|||
23345512|NCT01362244|65006868|FG001|Overall Study|Lack of Efficacy|11|||
23345513|NCT01362244|65006867|FG000|Overall Study|Lost to Follow-up|0|||
23345514|NCT01362244|65006868|FG001|Overall Study|Lost to Follow-up|2|||
23345515|NCT01362244|65006867|FG000|Overall Study|Protocol Violation|5|||
23345516|NCT01362244|65006868|FG001|Overall Study|Protocol Violation|1|||
23345517|NCT01362244|65006867|FG000|Overall Study|Withdrawal by Subject|2|||
23345518|NCT01362244|65006868|FG001|Overall Study|Withdrawal by Subject|1|||
23345519|NCT01362244|65006867|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
23345520|NCT01362244|65006868|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
23345521|NCT01362244|65006867|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
23345522|NCT01362244|65006868|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
23345523|NCT02658734|65006873|FG000|Overall Study|Adverse Event|2|||
23345524|NCT02658734|65006873|FG000|Overall Study|Death|4|||
23345525|NCT02658734|65006873|FG000|Overall Study|Lost to Follow-up|7|||
23345526|NCT02658734|65006873|FG000|Overall Study|Withdrawal of Consent|16|||
23345527|NCT02658734|65006873|FG000|Overall Study|Disease Progression|28|||
23637877|NCT02712905|66057626|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
23345530|NCT03696108|65006875|FG000|Overall Study|Physician Decision|1|||
23345531|NCT03696108|65006876|FG001|Overall Study|Physician Decision|0|||
23345532|NCT03696108|65006875|FG000|Overall Study|Withdrawal by Subject|3|||
23345533|NCT03696108|65006876|FG001|Overall Study|Withdrawal by Subject|6|||
23345534|NCT01286168|65006877|FG000|Overall Study|Withdrawal by Subject|1|||
23345535|NCT01286168|65006877|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
23345536|NCT04569968|65006883|FG000|Overall Study|Lost to Follow-up|2|||
23345537|NCT04569968|65006884|FG001|Overall Study|Lost to Follow-up|5|||
23345538|NCT04569968|65006883|FG000|Overall Study|Story of head and/or neck surgery|2|||
23345539|NCT04569968|65006884|FG001|Overall Study|Story of head and/or neck surgery|2|||
23345540|NCT04569968|65006883|FG000|Overall Study|Time of stroke onset|8|||
23345541|NCT04569968|65006884|FG001|Overall Study|Time of stroke onset|7|||
23345542|NCT04569968|65006883|FG000|Overall Study|Type of strokr|12|||
23345543|NCT04569968|65006884|FG001|Overall Study|Type of strokr|8|||
23345544|NCT04569968|65006883|FG000|Overall Study|Cooperation|8|||
23345545|NCT04569968|65006884|FG001|Overall Study|Cooperation|8|||
23345546|NCT04569968|65006883|FG000|Overall Study|Age interval|17|||
23345547|NCT04569968|65006884|FG001|Overall Study|Age interval|6|||
23345548|NCT04569968|65006883|FG000|Overall Study|Denial of participation to the study|0|||
23345549|NCT04569968|65006884|FG001|Overall Study|Denial of participation to the study|3|||
23345550|NCT04569968|65006883|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
23345551|NCT04569968|65006884|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
23345552|NCT04569968|65006883|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
23345553|NCT04569968|65006884|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
23345554|NCT04569968|65006883|FG000|Overall Study|Quarantine|1|||
23345555|NCT04569968|65006884|FG001|Overall Study|Quarantine|0|||
23345556|NCT04569968|65006883|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
23345557|NCT04569968|65006884|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
23345558|NCT04569968|65006883|FG000|Overall Study|Repetitive stroke|8|||
23345559|NCT04569968|65006884|FG001|Overall Study|Repetitive stroke|0|||
23345560|NCT04569968|65006883|FG000|Overall Study|Insufficient mastication|1|||
23345561|NCT04569968|65006884|FG001|Overall Study|Insufficient mastication|0|||
23345562|NCT04569968|65006883|FG000|Overall Study|Infection|1|||
23345563|NCT04569968|65006884|FG001|Overall Study|Infection|0|||
23345564|NCT04972968|65006885|FG000|Overall Study|Adverse Event|3|||
23345565|NCT04972968|65006886|FG001|Overall Study|Adverse Event|1|||
23345566|NCT04972968|65006887|FG002|Overall Study|Adverse Event|1|||
23345567|NCT04972968|65006888|FG003|Overall Study|Adverse Event|7|||
23345568|NCT04972968|65006885|FG000|Overall Study|Lack of Efficacy|2|||
23345569|NCT04972968|65006886|FG001|Overall Study|Lack of Efficacy|1|||
23345570|NCT04972968|65006887|FG002|Overall Study|Lack of Efficacy|0|||
23345571|NCT04972968|65006888|FG003|Overall Study|Lack of Efficacy|0|||
23785474|NCT03256695|66593482|FG000|Overall Study|Lost to Follow-up|3|||
23785475|NCT03256695|66593482|FG000|Overall Study|Lack of Efficacy|3|||
23785476|NCT03256695|66593482|FG000|Overall Study|Protocol Violation|5|||
23785477|NCT03256695|66593482|FG000|Overall Study|Other than specified|3|||
23785478|NCT01116739|66593484|FG000|Overall Study|Child had 2 years of HS|110|||
23345572|NCT04972968|65006885|FG000|Overall Study|Withdrawal by Subject|7|||
23785479|NCT01116739|66593485|FG001|Overall Study|Child had 2 years of HS|128|||
23785480|NCT01116739|66593484|FG000|Overall Study|Withdrawal by Subject|6|||
23785481|NCT01116739|66593485|FG001|Overall Study|Withdrawal by Subject|0|||
23785482|NCT01116739|66593484|FG000|Overall Study|child too young|2|||
23785483|NCT01116739|66593485|FG001|Overall Study|child too young|6|||
23785484|NCT01116739|66593484|FG000|Overall Study|child not enrolled in head start|10|||
23785485|NCT01116739|66593485|FG001|Overall Study|child not enrolled in head start|2|||
23785486|NCT01116739|66593484|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
23785487|NCT01116739|66593485|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
23785488|NCT01049334|66593486|FG000|Overall Study|Withdrawal by Subject|5|||
23785489|NCT01049334|66593487|FG001|Overall Study|Withdrawal by Subject|3|||
23785490|NCT01049334|66593486|FG000|Overall Study|Adverse Event|2|||
23785491|NCT01049334|66593487|FG001|Overall Study|Adverse Event|3|||
23785492|NCT01049334|66593486|FG000|Overall Study|Physician Decision|2|||
23785493|NCT01049334|66593487|FG001|Overall Study|Physician Decision|0|||
23345573|NCT04972968|65006886|FG001|Overall Study|Withdrawal by Subject|4|||
23345574|NCT04972968|65006887|FG002|Overall Study|Withdrawal by Subject|3|||
23345575|NCT04972968|65006888|FG003|Overall Study|Withdrawal by Subject|2|||
23345576|NCT04972968|65006885|FG000|Overall Study|Study Terminated by Sponsor|25|||
23345577|NCT04972968|65006886|FG001|Overall Study|Study Terminated by Sponsor|28|||
23345578|NCT04972968|65006887|FG002|Overall Study|Study Terminated by Sponsor|32|||
23345579|NCT04972968|65006888|FG003|Overall Study|Study Terminated by Sponsor|27|||
23345580|NCT04972968|65006885|FG000|Overall Study|Other|1|||
23345581|NCT04972968|65006886|FG001|Overall Study|Other|0|||
23345582|NCT04972968|65006887|FG002|Overall Study|Other|1|||
23345583|NCT04972968|65006888|FG003|Overall Study|Other|1|||
23345584|NCT03605862|65006889|FG000|Overall Study|Withdrawal by Subject|12|||
23345585|NCT03605862|65006890|FG001|Overall Study|Withdrawal by Subject|9|||
23345586|NCT03605862|65006889|FG000|Overall Study|Adverse Event|2|||
23345587|NCT03605862|65006890|FG001|Overall Study|Adverse Event|1|||
23345588|NCT03605862|65006889|FG000|Overall Study|Physician Decision|3|||
23345589|NCT03605862|65006890|FG001|Overall Study|Physician Decision|1|||
23345590|NCT03605862|65006889|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
23345591|NCT03605862|65006890|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
23345592|NCT00900731|65006891|FG000|Overall Study|Adverse Event|31|||
23345593|NCT00900731|65006892|FG001|Overall Study|Adverse Event|27|||
23345594|NCT00900731|65006891|FG000|Overall Study|Withdrawal by Subject|8|||
23345595|NCT00900731|65006892|FG001|Overall Study|Withdrawal by Subject|7|||
23345596|NCT00900731|65006891|FG000|Overall Study|Protocol Deviation|8|||
23345597|NCT00900731|65006892|FG001|Overall Study|Protocol Deviation|11|||
23345598|NCT00900731|65006891|FG000|Overall Study|Administrative Problems|5|||
23345599|NCT00900731|65006892|FG001|Overall Study|Administrative Problems|4|||
23345600|NCT00900731|65006891|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
23345601|NCT00900731|65006892|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23345602|NCT00900731|65006891|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
23345603|NCT00900731|65006892|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
23345604|NCT00900731|65006891|FG000|Overall Study|Lost to Follow-up|2|||
23345605|NCT00900731|65006892|FG001|Overall Study|Lost to Follow-up|3|||
23345606|NCT00900731|65006891|FG000|Overall Study|Lack of Efficacy|1|||
23785494|NCT01049334|66593486|FG000|Overall Study|Protocol Violation|0|||
23785495|NCT01049334|66593487|FG001|Overall Study|Protocol Violation|1|||
23785496|NCT01528696|66593492|FG000|Overall Study|See detailed description|18|||
23345607|NCT00900731|65006892|FG001|Overall Study|Lack of Efficacy|3|||
23785497|NCT01528696|66593493|FG001|Overall Study|See detailed description|19|||
23345608|NCT00900731|65006891|FG000|Overall Study|Death|0|||
23345609|NCT00900731|65006892|FG001|Overall Study|Death|2|||
23345610|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
23345611|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
23457280|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
23457281|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
23457282|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
23457283|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
23457284|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
23457285|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
23457286|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
23457287|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
23457288|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
23457289|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
23457290|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
23457291|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
23457292|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457293|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457294|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457295|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457296|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457297|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457298|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457299|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457300|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457301|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457302|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457303|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457304|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457305|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457306|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457307|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457308|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457309|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457310|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457311|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457312|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457313|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457314|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
23457315|NCT03532542|65416586|FG000|Overall Study|Death|1|||
23457316|NCT03532542|65416587|FG001|Overall Study|Death|0|||
23457317|NCT03532542|65416586|FG000|Overall Study|Study Terminated by Sponsor|41|||
23457318|NCT03532542|65416587|FG001|Overall Study|Study Terminated by Sponsor|65|||
23457319|NCT03532542|65416586|FG000|Overall Study|Withdrawal by Subject|6|||
23457320|NCT03532542|65416587|FG001|Overall Study|Withdrawal by Subject|5|||
23457321|NCT05137041|65416588|FG000|Overall Study|Lost to Follow-up|1|||
23457322|NCT05137041|65416589|FG001|Overall Study|Lost to Follow-up|1|||
23457323|NCT05137041|65416588|FG000|Overall Study|Withdrawal by Subject|0|||
23457324|NCT05137041|65416589|FG001|Overall Study|Withdrawal by Subject|2|||
23457325|NCT05137041|65416588|FG000|Overall Study|Reason not Specified|0|||
23457326|NCT05137041|65416589|FG001|Overall Study|Reason not Specified|1|||
23457327|NCT06271993|65416590|FG000|Overall Study|Not reactive to histamine|5|||
23457328|NCT06271993|65416591|FG001|Overall Study|Not reactive to histamine|5|||
23457329|NCT06271993|65416592|FG002|Overall Study|Not reactive to histamine|5|||
23457330|NCT03346434|65416593|FG000|Overall Study|Randomized in Error|0|||
23457331|NCT03346434|65416594|FG001|Overall Study|Randomized in Error|0|||
23706037|NCT00718419|66301030|FG001|Overall Study|Progressive Disease|25|||
23345612|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
23345613|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
23457332|NCT03346434|65416595|FG002|Overall Study|Randomized in Error|0|||
23457333|NCT03346434|65416596|FG003|Overall Study|Randomized in Error|0|||
23457334|NCT03346434|65416597|FG004|Overall Study|Randomized in Error|1|||
23457335|NCT03346434|65416598|FG005|Overall Study|Randomized in Error|0|||
23457336|NCT03346434|65416593|FG000|Overall Study|Withdrawal by Subject|0|||
23457337|NCT03346434|65416594|FG001|Overall Study|Withdrawal by Subject|0|||
23457338|NCT03346434|65416595|FG002|Overall Study|Withdrawal by Subject|1|||
23457339|NCT03346434|65416596|FG003|Overall Study|Withdrawal by Subject|0|||
23457340|NCT03346434|65416597|FG004|Overall Study|Withdrawal by Subject|1|||
23345614|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
23637878|NCT02712905|66057627|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
23637879|NCT02712905|66057628|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
23637880|NCT02712905|66057629|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
23637881|NCT02712905|66057630|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
23637882|NCT02712905|66057631|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
23637883|NCT02712905|66057632|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
23637884|NCT02712905|66057633|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
23637885|NCT02712905|66057634|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
23637886|NCT02712905|66057635|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
23637887|NCT02712905|66057636|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
23637888|NCT02712905|66057637|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
23637889|NCT02712905|66057638|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
23637890|NCT02712905|66057639|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
23637891|NCT02712905|66057640|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
23637892|NCT02712905|66057641|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
23637893|NCT02712905|66057642|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
23637894|NCT02712905|66057625|FG000|Combination Therapy|Withdrawal by Subject|0|||
23637895|NCT02712905|66057626|FG001|Combination Therapy|Withdrawal by Subject|0|||
23637896|NCT02712905|66057627|FG002|Combination Therapy|Withdrawal by Subject|0|||
23637897|NCT02712905|66057628|FG003|Combination Therapy|Withdrawal by Subject|0|||
23637898|NCT02712905|66057629|FG004|Combination Therapy|Withdrawal by Subject|0|||
23785498|NCT03446768|66593495|FG000|Overall Study|Withdrawal by Subject|0|||
23785499|NCT03446768|66593496|FG001|Overall Study|Withdrawal by Subject|1|||
23785500|NCT00989950|66593500|FG000|Randomized Phase|Protocol Violation|1|||
23785501|NCT00989950|66593501|FG001|Randomized Phase|Protocol Violation|0|||
23785502|NCT00989950|66593502|FG002|Randomized Phase|Protocol Violation|0|||
23785503|NCT00989950|66593503|FG003|Randomized Phase|Protocol Violation|0|||
23785504|NCT00989950|66593500|FG000|Randomized Phase|Adverse Event|0|||
23785505|NCT00989950|66593501|FG001|Randomized Phase|Adverse Event|1|||
23785506|NCT00989950|66593502|FG002|Randomized Phase|Adverse Event|0|||
23785507|NCT00989950|66593503|FG003|Randomized Phase|Adverse Event|0|||
23785508|NCT01527006|66593504|FG000|Core Study|Adverse Event|0|||
23785509|NCT01527006|66593505|FG001|Core Study|Adverse Event|2|||
23785510|NCT01527006|66593504|FG000|Core Study|Lost to Follow-up|0|||
23785511|NCT01527006|66593505|FG001|Core Study|Lost to Follow-up|1|||
23785512|NCT01527006|66593504|FG000|Core Study|Subject Choice|1|||
23785513|NCT01527006|66593505|FG001|Core Study|Subject Choice|0|||
23785514|NCT01527006|66593504|FG000|Core Study|Inadequate Therapeutic Effect|1|||
23785515|NCT01527006|66593505|FG001|Core Study|Inadequate Therapeutic Effect|0|||
23785516|NCT01527006|66593504|FG000|Core Study|Withdrawal by Subject|0|||
23785517|NCT01527006|66593505|FG001|Core Study|Withdrawal by Subject|1|||
23785518|NCT01527006|66593504|FG000|Core Study|Other|0|||
23785519|NCT01527006|66593505|FG001|Core Study|Other|2|||
23785520|NCT01527006|66593504|FG000|Extension Phase|Adverse Event|4|||
23785521|NCT01527006|66593505|FG001|Extension Phase|Adverse Event|2|||
23785522|NCT01527006|66593504|FG000|Extension Phase|Lost to Follow-up|0|||
23637899|NCT02712905|66057630|FG005|Combination Therapy|Withdrawal by Subject|0|||
23637900|NCT02712905|66057631|FG006|Combination Therapy|Withdrawal by Subject|0|||
23785523|NCT01527006|66593505|FG001|Extension Phase|Lost to Follow-up|1|||
23785524|NCT01527006|66593504|FG000|Extension Phase|Subject Choice|1|||
23785525|NCT01527006|66593505|FG001|Extension Phase|Subject Choice|1|||
23785526|NCT01527006|66593504|FG000|Extension Phase|Inadequate therapeutic effect|1|||
23785527|NCT01527006|66593505|FG001|Extension Phase|Inadequate therapeutic effect|1|||
23785528|NCT01527006|66593504|FG000|Extension Phase|Other|0|||
23785529|NCT01527006|66593505|FG001|Extension Phase|Other|3|||
23785530|NCT00418145|66593506|FG000|Overall Study|study terminated|6|||
23785531|NCT00604162|66593511|FG000|Overall Study|Physician Decision|3|||
23785532|NCT00604162|66593511|FG000|Overall Study|Withdrawal by Subject|1|||
23785533|NCT04551066|66593517|FG000|Overall Study|Death|5|||
23785534|NCT04551066|66593518|FG001|Overall Study|Death|3|||
23785535|NCT04551066|66593517|FG000|Overall Study|Lost to Follow-up|1|||
23785536|NCT04551066|66593518|FG001|Overall Study|Lost to Follow-up|0|||
23785537|NCT04551066|66593517|FG000|Overall Study|Sponsor Decision|103|||
23785538|NCT04551066|66593518|FG001|Overall Study|Sponsor Decision|117|||
23785539|NCT04551066|66593517|FG000|Overall Study|Withdrawal by Subject|8|||
23583512|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
23583513|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
23583514|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583515|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583516|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583517|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583518|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583519|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583520|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583521|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583522|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583523|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583524|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583525|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583526|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
23583527|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
23583528|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583529|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583530|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583531|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583532|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583533|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583534|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583535|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583536|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583537|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583538|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583539|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583540|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
23583541|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
23583542|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583543|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583544|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583545|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583546|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583547|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583548|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583549|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583550|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583551|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583552|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583553|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583554|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
23583555|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
23583556|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583557|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583558|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583559|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583560|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583561|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583562|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583563|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583564|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583565|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583566|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583567|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23785540|NCT04551066|66593518|FG001|Overall Study|Withdrawal by Subject|2|||
23785541|NCT04551066|66593517|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
23637901|NCT02712905|66057632|FG007|Combination Therapy|Withdrawal by Subject|0|||
23637902|NCT02712905|66057633|FG008|Combination Therapy|Withdrawal by Subject|0|||
23637903|NCT02712905|66057634|FG009|Combination Therapy|Withdrawal by Subject|0|||
23637904|NCT02712905|66057635|FG010|Combination Therapy|Withdrawal by Subject|0|||
23637905|NCT02712905|66057636|FG011|Combination Therapy|Withdrawal by Subject|0|||
23637906|NCT02712905|66057637|FG012|Combination Therapy|Withdrawal by Subject|0|||
23637907|NCT02712905|66057638|FG013|Combination Therapy|Withdrawal by Subject|0|||
23637908|NCT02712905|66057639|FG014|Combination Therapy|Withdrawal by Subject|0|||
23637909|NCT02712905|66057640|FG015|Combination Therapy|Withdrawal by Subject|1|||
23637910|NCT02712905|66057641|FG016|Combination Therapy|Withdrawal by Subject|0|||
23637911|NCT02712905|66057642|FG017|Combination Therapy|Withdrawal by Subject|2|||
23637912|NCT02712905|66057625|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637913|NCT02712905|66057626|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637914|NCT02712905|66057627|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23345615|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
23345616|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
23345617|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
23345618|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
23345619|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
23345620|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
23345621|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
23345622|NCT02951533|65006893|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
23345623|NCT02951533|65006894|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
23345624|NCT02951533|65006895|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
23345625|NCT02951533|65006893|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
23345626|NCT02951533|65006894|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
23345627|NCT02951533|65006895|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
23345628|NCT02951533|65006893|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
23345629|NCT02951533|65006894|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
23345630|NCT02951533|65006895|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
23345631|NCT02951533|65006893|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
23345632|NCT02951533|65006894|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
23345633|NCT02951533|65006895|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
23345634|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
23345635|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
23345636|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
23345637|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
23345638|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
23345639|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
23345640|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
23345641|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
23345642|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
23345643|NCT02553499|65010829|FG000|Overall Study|Adverse Event|0|||
23345644|NCT02553499|65010830|FG001|Overall Study|Adverse Event|0|||
23345645|NCT02553499|65010831|FG002|Overall Study|Adverse Event|0|||
23345646|NCT02553499|65010832|FG003|Overall Study|Adverse Event|0|||
23583568|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
23637915|NCT02712905|66057628|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23345647|NCT02553499|65010833|FG004|Overall Study|Adverse Event|0|||
23345648|NCT02553499|65010834|FG005|Overall Study|Adverse Event|0|||
23345649|NCT02553499|65010835|FG006|Overall Study|Adverse Event|1|||
23345650|NCT02553499|65010836|FG007|Overall Study|Adverse Event|1|||
23345651|NCT02553499|65010837|FG008|Overall Study|Adverse Event|0|||
23345652|NCT02553499|65010838|FG009|Overall Study|Adverse Event|0|||
23345653|NCT02553499|65010839|FG010|Overall Study|Adverse Event|0|||
23345654|NCT02553499|65010840|FG011|Overall Study|Adverse Event|0|||
23345655|NCT02553499|65010841|FG012|Overall Study|Adverse Event|0|||
23345656|NCT02553499|65010842|FG013|Overall Study|Adverse Event|1|||
23345657|NCT02553499|65010829|FG000|Overall Study|Death|0|||
23345658|NCT02553499|65010830|FG001|Overall Study|Death|1|||
23345659|NCT02553499|65010831|FG002|Overall Study|Death|1|||
23345660|NCT02553499|65010832|FG003|Overall Study|Death|0|||
23345661|NCT02553499|65010833|FG004|Overall Study|Death|1|||
23345662|NCT02553499|65010834|FG005|Overall Study|Death|2|||
23345663|NCT02553499|65010835|FG006|Overall Study|Death|0|||
23637916|NCT02712905|66057629|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637917|NCT02712905|66057630|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637918|NCT02712905|66057631|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637919|NCT02712905|66057632|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23345664|NCT02553499|65010836|FG007|Overall Study|Death|0|||
23345665|NCT02553499|65010837|FG008|Overall Study|Death|0|||
23345666|NCT02553499|65010838|FG009|Overall Study|Death|0|||
23345667|NCT02553499|65010839|FG010|Overall Study|Death|1|||
23345668|NCT02553499|65010840|FG011|Overall Study|Death|0|||
23345669|NCT02553499|65010841|FG012|Overall Study|Death|0|||
23345670|NCT02553499|65010842|FG013|Overall Study|Death|0|||
23345671|NCT02553499|65010829|FG000|Overall Study|Lost to Follow-up|0|||
23345672|NCT02553499|65010830|FG001|Overall Study|Lost to Follow-up|0|||
23345673|NCT02553499|65010831|FG002|Overall Study|Lost to Follow-up|0|||
23345674|NCT02553499|65010832|FG003|Overall Study|Lost to Follow-up|0|||
23345675|NCT02553499|65010833|FG004|Overall Study|Lost to Follow-up|0|||
23345676|NCT02553499|65010834|FG005|Overall Study|Lost to Follow-up|0|||
23345677|NCT02553499|65010835|FG006|Overall Study|Lost to Follow-up|1|||
23345678|NCT02553499|65010836|FG007|Overall Study|Lost to Follow-up|0|||
23345679|NCT02553499|65010837|FG008|Overall Study|Lost to Follow-up|0|||
23345680|NCT02553499|65010838|FG009|Overall Study|Lost to Follow-up|0|||
23345681|NCT02553499|65010839|FG010|Overall Study|Lost to Follow-up|0|||
23345682|NCT02553499|65010840|FG011|Overall Study|Lost to Follow-up|0|||
23345683|NCT02553499|65010841|FG012|Overall Study|Lost to Follow-up|0|||
23345684|NCT02553499|65010842|FG013|Overall Study|Lost to Follow-up|0|||
23345685|NCT02553499|65010829|FG000|Overall Study|Physician Decision|0|||
23345686|NCT02553499|65010830|FG001|Overall Study|Physician Decision|1|||
23345687|NCT02553499|65010831|FG002|Overall Study|Physician Decision|1|||
23345688|NCT02553499|65010832|FG003|Overall Study|Physician Decision|0|||
23345689|NCT02553499|65010833|FG004|Overall Study|Physician Decision|1|||
23345690|NCT02553499|65010834|FG005|Overall Study|Physician Decision|0|||
23345691|NCT02553499|65010835|FG006|Overall Study|Physician Decision|0|||
23345692|NCT02553499|65010836|FG007|Overall Study|Physician Decision|1|||
23345693|NCT02553499|65010837|FG008|Overall Study|Physician Decision|1|||
23345694|NCT02553499|65010838|FG009|Overall Study|Physician Decision|2|||
23345695|NCT02553499|65010839|FG010|Overall Study|Physician Decision|1|||
23345696|NCT02553499|65010840|FG011|Overall Study|Physician Decision|3|||
23345697|NCT02553499|65010841|FG012|Overall Study|Physician Decision|1|||
23345698|NCT02553499|65010842|FG013|Overall Study|Physician Decision|0|||
23345699|NCT02553499|65010829|FG000|Overall Study|Progressive Disease|0|||
23345700|NCT02553499|65010830|FG001|Overall Study|Progressive Disease|0|||
23345701|NCT02553499|65010831|FG002|Overall Study|Progressive Disease|0|||
23345702|NCT02553499|65010832|FG003|Overall Study|Progressive Disease|2|||
23345703|NCT02553499|65010833|FG004|Overall Study|Progressive Disease|1|||
23345704|NCT02553499|65010834|FG005|Overall Study|Progressive Disease|1|||
23345705|NCT02553499|65010835|FG006|Overall Study|Progressive Disease|1|||
23345706|NCT02553499|65010836|FG007|Overall Study|Progressive Disease|0|||
23345707|NCT02553499|65010837|FG008|Overall Study|Progressive Disease|0|||
23345708|NCT02553499|65010838|FG009|Overall Study|Progressive Disease|1|||
23345709|NCT02553499|65010839|FG010|Overall Study|Progressive Disease|0|||
23345710|NCT02553499|65010840|FG011|Overall Study|Progressive Disease|0|||
23345711|NCT02553499|65010841|FG012|Overall Study|Progressive Disease|2|||
23345712|NCT02553499|65010842|FG013|Overall Study|Progressive Disease|1|||
23345713|NCT02553499|65010829|FG000|Overall Study|Study Terminated by Sponsor|0|||
23345714|NCT02553499|65010830|FG001|Overall Study|Study Terminated by Sponsor|0|||
23345715|NCT02553499|65010831|FG002|Overall Study|Study Terminated by Sponsor|0|||
23345716|NCT02553499|65010832|FG003|Overall Study|Study Terminated by Sponsor|0|||
23345717|NCT02553499|65010833|FG004|Overall Study|Study Terminated by Sponsor|0|||
23345718|NCT02553499|65010834|FG005|Overall Study|Study Terminated by Sponsor|0|||
23345719|NCT02553499|65010835|FG006|Overall Study|Study Terminated by Sponsor|0|||
23345720|NCT02553499|65010836|FG007|Overall Study|Study Terminated by Sponsor|0|||
23345721|NCT02553499|65010837|FG008|Overall Study|Study Terminated by Sponsor|1|||
23345722|NCT02553499|65010838|FG009|Overall Study|Study Terminated by Sponsor|0|||
23345723|NCT02553499|65010839|FG010|Overall Study|Study Terminated by Sponsor|0|||
23345724|NCT02553499|65010840|FG011|Overall Study|Study Terminated by Sponsor|0|||
23345725|NCT02553499|65010841|FG012|Overall Study|Study Terminated by Sponsor|0|||
23345726|NCT02553499|65010842|FG013|Overall Study|Study Terminated by Sponsor|0|||
23345727|NCT02553499|65010829|FG000|Overall Study|Withdrawal by Subject|2|||
23345728|NCT02553499|65010830|FG001|Overall Study|Withdrawal by Subject|0|||
23345729|NCT02553499|65010831|FG002|Overall Study|Withdrawal by Subject|0|||
23345730|NCT02553499|65010832|FG003|Overall Study|Withdrawal by Subject|0|||
23345731|NCT02553499|65010833|FG004|Overall Study|Withdrawal by Subject|0|||
23345732|NCT02553499|65010834|FG005|Overall Study|Withdrawal by Subject|0|||
23345733|NCT02553499|65010835|FG006|Overall Study|Withdrawal by Subject|0|||
23345734|NCT02553499|65010836|FG007|Overall Study|Withdrawal by Subject|1|||
23345735|NCT02553499|65010837|FG008|Overall Study|Withdrawal by Subject|1|||
23345736|NCT02553499|65010838|FG009|Overall Study|Withdrawal by Subject|0|||
23345737|NCT02553499|65010839|FG010|Overall Study|Withdrawal by Subject|1|||
23345738|NCT02553499|65010840|FG011|Overall Study|Withdrawal by Subject|0|||
23345739|NCT02553499|65010841|FG012|Overall Study|Withdrawal by Subject|0|||
23345740|NCT02553499|65010842|FG013|Overall Study|Withdrawal by Subject|0|||
23345741|NCT02071706|65010845|FG000|Overall Study|Adverse Event|1|||
23345742|NCT02071706|65010845|FG000|Overall Study|Withdrawal by Subject|2|||
23345743|NCT02059434|65010846|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
23345744|NCT02059434|65010847|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
23345745|NCT02059434|65010848|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
23345746|NCT02059434|65010849|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
23345747|NCT02059434|65010850|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
23345748|NCT02059434|65010851|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
23345749|NCT02059434|65010852|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
23345750|NCT02059434|65010853|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
23785542|NCT04551066|66593518|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
23345751|NCT02059434|65010854|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
23345752|NCT02059434|65010846|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
23345753|NCT02059434|65010847|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
23345754|NCT02059434|65010848|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
23345755|NCT02059434|65010849|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
23345756|NCT02059434|65010850|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
23345757|NCT02059434|65010851|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
23345758|NCT02059434|65010852|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
23345759|NCT02059434|65010853|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
23345760|NCT02059434|65010854|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
23345761|NCT02059434|65010846|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
23345762|NCT02059434|65010847|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
23457341|NCT03346434|65416598|FG005|Overall Study|Withdrawal by Subject|0|||
23637920|NCT02712905|66057633|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637921|NCT02712905|66057634|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637922|NCT02712905|66057635|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637923|NCT02712905|66057636|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637924|NCT02712905|66057637|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637925|NCT02712905|66057638|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637926|NCT02712905|66057639|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637927|NCT02712905|66057640|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
23637928|NCT02712905|66057641|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637929|NCT02712905|66057642|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23637930|NCT01182441|66057648|FG000|Overall Study|Patient Still in Follow-up|152|||
23637931|NCT01182441|66057649|FG001|Overall Study|Patient Still in Follow-up|72|||
23637932|NCT01182441|66057648|FG000|Overall Study|Death|37|||
23637933|NCT01182441|66057649|FG001|Overall Study|Death|25|||
23637934|NCT01182441|66057648|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
23637935|NCT01182441|66057649|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
23637936|NCT01182441|66057648|FG000|Overall Study|Lost to Follow-up|5|||
23637937|NCT01182441|66057649|FG001|Overall Study|Lost to Follow-up|8|||
23637938|NCT01182441|66057648|FG000|Overall Study|Withdrawal by Subject|6|||
23637939|NCT01182441|66057649|FG001|Overall Study|Withdrawal by Subject|13|||
23637940|NCT01182441|66057648|FG000|Overall Study|Implant Not Attempted|4|||
23637941|NCT01182441|66057649|FG001|Overall Study|Implant Not Attempted|0|||
23785543|NCT04551066|66593517|FG000|Overall Study|Adverse Event|2|||
23345763|NCT02059434|65010848|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
23637942|NCT01182441|66057648|FG000|Overall Study|Adverse Event|2|||
23637943|NCT01182441|66057649|FG001|Overall Study|Adverse Event|0|||
23637944|NCT01182441|66057648|FG000|Overall Study|Physician Decision|1|||
23637945|NCT01182441|66057649|FG001|Overall Study|Physician Decision|1|||
23637946|NCT00316602|66057655|FG000|Overall Study|Withdrawal by Subject|3|||
23637947|NCT00316602|66057656|FG001|Overall Study|Withdrawal by Subject|2|||
23637948|NCT00316602|66057655|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
23637949|NCT00316602|66057656|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
23637950|NCT00316602|66057655|FG000|Overall Study|Adverse Event|1|||
23637951|NCT00316602|66057656|FG001|Overall Study|Adverse Event|0|||
23637952|NCT00316602|66057655|FG000|Overall Study|Other|3|||
23637953|NCT00316602|66057656|FG001|Overall Study|Other|6|||
23637954|NCT01137578|66057657|FG000|Overall Study|Participant requested to Discontinue|3|||
23637955|NCT01137578|66057658|FG001|Overall Study|Participant requested to Discontinue|0|||
23637956|NCT01137578|66057659|FG002|Overall Study|Participant requested to Discontinue|0|||
23637957|NCT01137578|66057657|FG000|Overall Study|Withdrawal by Subject|1|||
23637958|NCT01137578|66057658|FG001|Overall Study|Withdrawal by Subject|0|||
23637959|NCT01137578|66057659|FG002|Overall Study|Withdrawal by Subject|0|||
23637960|NCT01137578|66057657|FG000|Overall Study|Other|12|||
23637961|NCT01137578|66057658|FG001|Overall Study|Other|2|||
23637962|NCT01137578|66057659|FG002|Overall Study|Other|6|||
23637963|NCT03248882|66057663|FG000|Overall Study|Adverse Event|3|||
23637964|NCT03248882|66057664|FG001|Overall Study|Adverse Event|3|||
23637965|NCT03248882|66057665|FG002|Overall Study|Adverse Event|2|||
23637966|NCT03248882|66057666|FG003|Overall Study|Adverse Event|6|||
23637967|NCT03248882|66057667|FG004|Overall Study|Adverse Event|9|||
23637968|NCT03248882|66057663|FG000|Overall Study|Lost to Follow-up|0|||
23637969|NCT03248882|66057664|FG001|Overall Study|Lost to Follow-up|0|||
23345764|NCT02059434|65010849|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
23345765|NCT02059434|65010850|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
23345766|NCT02059434|65010851|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
23345767|NCT02059434|65010852|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
23345768|NCT02059434|65010853|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
23345769|NCT02059434|65010854|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
23637970|NCT03248882|66057665|FG002|Overall Study|Lost to Follow-up|0|||
23345770|NCT02059434|65010846|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
23345771|NCT02059434|65010847|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
23345772|NCT02059434|65010848|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
23345773|NCT02059434|65010849|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
23345774|NCT02059434|65010850|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
23345775|NCT02059434|65010851|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
23345776|NCT02059434|65010852|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
23345777|NCT02059434|65010853|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
23345778|NCT02059434|65010854|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
23345779|NCT02059434|65010846|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23637971|NCT03248882|66057666|FG003|Overall Study|Lost to Follow-up|0|||
23785544|NCT04551066|66593518|FG001|Overall Study|Adverse Event|0|||
23345780|NCT02059434|65010847|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345781|NCT02059434|65010848|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345782|NCT02059434|65010849|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345783|NCT02059434|65010850|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345784|NCT02059434|65010851|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345785|NCT02059434|65010852|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345786|NCT02059434|65010853|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345787|NCT02059434|65010854|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
23345788|NCT00460265|65010855|FG000|Overall Study|Lost to Follow-up|14|||
23345789|NCT00460265|65010856|FG001|Overall Study|Lost to Follow-up|15|||
23345790|NCT00460265|65010855|FG000|Overall Study|Physician Decision|1|||
23637972|NCT03248882|66057667|FG004|Overall Study|Lost to Follow-up|1|||
23637973|NCT03248882|66057663|FG000|Overall Study|Protocol Violation|2|||
23785545|NCT04551066|66593517|FG000|Overall Study|Physician Decision|2|||
23785546|NCT04551066|66593518|FG001|Overall Study|Physician Decision|0|||
23785547|NCT04551066|66593517|FG000|Overall Study|Protocol Violation|1|||
23785548|NCT04551066|66593518|FG001|Overall Study|Protocol Violation|0|||
23785549|NCT04551066|66593517|FG000|Overall Study|Lack of Efficacy|0|||
23785550|NCT04551066|66593518|FG001|Overall Study|Lack of Efficacy|1|||
23785551|NCT04551066|66593517|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
23785552|NCT04551066|66593518|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
23637974|NCT03248882|66057664|FG001|Overall Study|Protocol Violation|0|||
23637975|NCT03248882|66057665|FG002|Overall Study|Protocol Violation|2|||
23637976|NCT03248882|66057666|FG003|Overall Study|Protocol Violation|0|||
23637977|NCT03248882|66057667|FG004|Overall Study|Protocol Violation|1|||
23637978|NCT03248882|66057663|FG000|Overall Study|Withdrawal by Subject|2|||
23785553|NCT02267187|66593519|FG000|Overall Study|Physician Decision|2|||
23345791|NCT00460265|65010856|FG001|Overall Study|Physician Decision|2|||
23345792|NCT00460265|65010855|FG000|Overall Study|Withdrawal by Subject|10|||
23345793|NCT00460265|65010856|FG001|Overall Study|Withdrawal by Subject|25|||
23345794|NCT00460265|65010855|FG000|Overall Study|Ongoing|60|||
23345795|NCT00460265|65010856|FG001|Overall Study|Ongoing|47|||
23345796|NCT02847182|65010857|FG000|Overall Study|Withdrawal by Subject|0|||
23345797|NCT02847182|65010858|FG001|Overall Study|Withdrawal by Subject|1|||
23345798|NCT03646305|65010859|FG000|Overall Study|Lost to Follow-up|4|||
23345799|NCT03646305|65010860|FG001|Overall Study|Lost to Follow-up|2|||
23345800|NCT03646305|65010861|FG002|Overall Study|Lost to Follow-up|2|||
23345801|NCT03646305|65010862|FG003|Overall Study|Lost to Follow-up|1|||
23345802|NCT03646305|65010859|FG000|Overall Study|Withdrawal by Subject|1|||
23345803|NCT03646305|65010860|FG001|Overall Study|Withdrawal by Subject|0|||
23345804|NCT03646305|65010861|FG002|Overall Study|Withdrawal by Subject|0|||
23345805|NCT03646305|65010862|FG003|Overall Study|Withdrawal by Subject|1|||
23345806|NCT03521817|65010863|FG000|Overall Study|Protocol Violation|0|||
23345807|NCT03521817|65010864|FG001|Overall Study|Protocol Violation|1|||
23345808|NCT00655681|65010865|FG000|Overall Study|Lost to Follow-up|1|||
23345809|NCT00655681|65010866|FG001|Overall Study|Lost to Follow-up|1|||
23345810|NCT02987972|65010867|FG000|Overall Study|Adverse Event|1|||
23345811|NCT02987972|65010868|FG001|Overall Study|Adverse Event|1|||
23345812|NCT02987972|65010869|FG002|Overall Study|Adverse Event|0|||
23345813|NCT02987972|65010867|FG000|Overall Study|Death|1|||
23345814|NCT02987972|65010868|FG001|Overall Study|Death|0|||
23345815|NCT02987972|65010869|FG002|Overall Study|Death|0|||
23345816|NCT02987972|65010867|FG000|Overall Study|Lack of Efficacy|9|||
23345817|NCT02987972|65010868|FG001|Overall Study|Lack of Efficacy|12|||
23345818|NCT02987972|65010869|FG002|Overall Study|Lack of Efficacy|12|||
23345819|NCT02987972|65010867|FG000|Overall Study|Lost to Follow-up|7|||
23345820|NCT02987972|65010868|FG001|Overall Study|Lost to Follow-up|8|||
23345821|NCT02987972|65010869|FG002|Overall Study|Lost to Follow-up|4|||
23345822|NCT02987972|65010867|FG000|Overall Study|Physician Decision|1|||
23345823|NCT02987972|65010868|FG001|Overall Study|Physician Decision|6|||
23345824|NCT02987972|65010869|FG002|Overall Study|Physician Decision|0|||
23345825|NCT02987972|65010867|FG000|Overall Study|Protocol Violation|2|||
23345826|NCT02987972|65010868|FG001|Overall Study|Protocol Violation|1|||
23345827|NCT02987972|65010869|FG002|Overall Study|Protocol Violation|5|||
23345828|NCT02987972|65010867|FG000|Overall Study|Withdrawal by Subject|22|||
23345829|NCT02987972|65010868|FG001|Overall Study|Withdrawal by Subject|17|||
23345830|NCT02987972|65010869|FG002|Overall Study|Withdrawal by Subject|21|||
23345831|NCT02255552|65010870|FG000|Overall Study|Participants enrolled into another study|0|||
23345832|NCT02255552|65010871|FG001|Overall Study|Participants enrolled into another study|11|||
23345833|NCT02255552|65010870|FG000|Overall Study|Withdrawal by Subject|1|||
23345834|NCT02255552|65010871|FG001|Overall Study|Withdrawal by Subject|4|||
23345835|NCT04829331|65010872|FG000|Overall Study|Lost to Follow-up|1|||
23345836|NCT04829331|65010873|FG001|Overall Study|Lost to Follow-up|0|||
23345837|NCT02091375|65010874|FG000|Overall Study|Adverse Event|8|||
23345838|NCT02091375|65010875|FG001|Overall Study|Adverse Event|1|||
23345839|NCT02091375|65010874|FG000|Overall Study|Lost to Follow-up|0|||
23345840|NCT02091375|65010875|FG001|Overall Study|Lost to Follow-up|1|||
23345841|NCT02091375|65010874|FG000|Overall Study|Withdrawal by Subject|0|||
23345842|NCT02091375|65010875|FG001|Overall Study|Withdrawal by Subject|1|||
23345843|NCT02091375|65010874|FG000|Overall Study|Withdrawn by the investigator|1|||
23345844|NCT02091375|65010875|FG001|Overall Study|Withdrawn by the investigator|0|||
23345845|NCT02284568|65010879|FG000|Overall Study|Adverse Event|2|||
23345846|NCT02284568|65010880|FG001|Overall Study|Adverse Event|9|||
23345847|NCT02284568|65010881|FG002|Overall Study|Adverse Event|4|||
23345848|NCT02284568|65010879|FG000|Overall Study|Withdrawal by Subject|22|||
23345849|NCT02284568|65010880|FG001|Overall Study|Withdrawal by Subject|21|||
23345850|NCT02284568|65010881|FG002|Overall Study|Withdrawal by Subject|1|||
23345851|NCT02284568|65010879|FG000|Overall Study|Noncompliance with study drug admin|1|||
23345852|NCT02284568|65010880|FG001|Overall Study|Noncompliance with study drug admin|2|||
23345853|NCT02284568|65010881|FG002|Overall Study|Noncompliance with study drug admin|0|||
23345854|NCT02284568|65010879|FG000|Overall Study|Noncompliance|1|||
23345855|NCT02284568|65010880|FG001|Overall Study|Noncompliance|0|||
23345856|NCT02284568|65010881|FG002|Overall Study|Noncompliance|0|||
23345857|NCT02284568|65010879|FG000|Overall Study|Protocol Violation|0|||
23345858|NCT02284568|65010880|FG001|Overall Study|Protocol Violation|1|||
23345859|NCT02284568|65010881|FG002|Overall Study|Protocol Violation|0|||
23345860|NCT02284568|65010879|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
23345861|NCT02284568|65010880|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
23345862|NCT02284568|65010881|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
23345863|NCT02284568|65010879|FG000|Overall Study|Lost to Follow-up|0|||
23345864|NCT02284568|65010880|FG001|Overall Study|Lost to Follow-up|3|||
23345865|NCT02284568|65010881|FG002|Overall Study|Lost to Follow-up|0|||
23345866|NCT02284568|65010879|FG000|Overall Study|Lack of Efficacy|4|||
23345867|NCT02284568|65010880|FG001|Overall Study|Lack of Efficacy|7|||
23345868|NCT02284568|65010881|FG002|Overall Study|Lack of Efficacy|0|||
23345869|NCT02284568|65010879|FG000|Overall Study|Other|1|||
23345870|NCT02284568|65010880|FG001|Overall Study|Other|2|||
23345871|NCT02284568|65010881|FG002|Overall Study|Other|0|||
23345872|NCT02284568|65010879|FG000|Overall Study|Withdrew before taking study drug|0|||
23345873|NCT02284568|65010880|FG001|Overall Study|Withdrew before taking study drug|1|||
23345874|NCT02284568|65010881|FG002|Overall Study|Withdrew before taking study drug|0|||
23345875|NCT01846221|65010882|FG000|Overall Study|Catheter Failure|2|||
23345876|NCT01846221|65010883|FG001|Overall Study|Catheter Failure|0|||
23345877|NCT01846221|65010882|FG000|Overall Study|Age Exclusion|1|||
23345878|NCT01846221|65010883|FG001|Overall Study|Age Exclusion|0|||
23345879|NCT01527487|65010884|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
23345880|NCT01527487|65010885|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
23345881|NCT01527487|65010884|FG000|Overall Study|Disease Progression|4|||
23345882|NCT01527487|65010885|FG001|Overall Study|Disease Progression|1|||
23345883|NCT01527487|65010884|FG000|Overall Study|Adverse Event|1|||
23345884|NCT01527487|65010885|FG001|Overall Study|Adverse Event|1|||
23345885|NCT01527487|65010884|FG000|Overall Study|Death|0|||
23345886|NCT01527487|65010885|FG001|Overall Study|Death|1|||
23345887|NCT00829829|65010886|FG000|Overall Study|Protocol Violation|0|||
23345888|NCT00829829|65010887|FG001|Overall Study|Protocol Violation|3|||
23345889|NCT00829829|65010888|FG002|Overall Study|Protocol Violation|0|||
23345890|NCT00829829|65010886|FG000|Overall Study|Adverse Event|4|||
23345891|NCT00829829|65010887|FG001|Overall Study|Adverse Event|4|||
23345892|NCT00829829|65010888|FG002|Overall Study|Adverse Event|3|||
23345893|NCT00829829|65010886|FG000|Overall Study|Withdrawal by Subject|8|||
23345894|NCT00829829|65010887|FG001|Overall Study|Withdrawal by Subject|4|||
23345895|NCT00829829|65010888|FG002|Overall Study|Withdrawal by Subject|2|||
23345896|NCT00829829|65010886|FG000|Overall Study|Decision by the Sponsor|1|||
23345897|NCT00829829|65010887|FG001|Overall Study|Decision by the Sponsor|0|||
23345898|NCT00829829|65010888|FG002|Overall Study|Decision by the Sponsor|2|||
23345899|NCT00829829|65010886|FG000|Overall Study|Lost to Follow-up|7|||
23345900|NCT00829829|65010887|FG001|Overall Study|Lost to Follow-up|3|||
23345901|NCT00829829|65010888|FG002|Overall Study|Lost to Follow-up|3|||
23345902|NCT00829829|65010886|FG000|Overall Study|Other than specified above|2|||
23345903|NCT00829829|65010887|FG001|Overall Study|Other than specified above|2|||
23345904|NCT00829829|65010888|FG002|Overall Study|Other than specified above|1|||
23345905|NCT03168919|65010891|FG000|Overall Study|Withdrawal by Subject|2|||
23345906|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
23345907|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345908|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345909|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345910|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
23345911|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
23345912|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345913|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345914|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345915|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345916|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345917|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345918|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345919|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345920|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345921|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345922|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345923|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345924|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345925|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345926|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345927|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345928|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
23345929|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
23345930|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
23345931|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
23345932|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
23345933|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
23345934|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
23457342|NCT03346434|65416593|FG000|Overall Study|Lost to Follow-up|0|||
23457343|NCT03346434|65416594|FG001|Overall Study|Lost to Follow-up|0|||
23457344|NCT03346434|65416595|FG002|Overall Study|Lost to Follow-up|0|||
23785554|NCT02267187|66593519|FG000|Overall Study|Screen fail|3|||
23785555|NCT00834873|66593520|FG000|First Intervention|Adverse Event|0|||
23785556|NCT00834873|66593521|FG001|First Intervention|Adverse Event|1|||
23785557|NCT00811655|66593522|FG000|Overall Study|Physician Decision|1|||
23785558|NCT00829764|66593527|FG000|First Intervention|Adverse Event|1|||
23785559|NCT00829764|66593528|FG001|First Intervention|Adverse Event|0|||
23785560|NCT00829764|66593527|FG000|First Intervention|Withdrawal by Subject|1|||
23785561|NCT00829764|66593528|FG001|First Intervention|Withdrawal by Subject|1|||
23785562|NCT01634139|66593537|FG000|Overall Study|Non compliant with protocol|1|||
23785563|NCT01634139|66593538|FG001|Overall Study|Non compliant with protocol|0|||
23785564|NCT01634139|66593539|FG002|Overall Study|Non compliant with protocol|0|||
23785565|NCT01634139|66593537|FG000|Overall Study|Consent withdrawn not due to AE|4|||
23785566|NCT01634139|66593538|FG001|Overall Study|Consent withdrawn not due to AE|3|||
23785567|NCT01634139|66593539|FG002|Overall Study|Consent withdrawn not due to AE|2|||
23785568|NCT01634139|66593537|FG000|Overall Study|Other|4|||
23785569|NCT01634139|66593538|FG001|Overall Study|Other|0|||
23785570|NCT01634139|66593539|FG002|Overall Study|Other|3|||
23785571|NCT01634139|66593537|FG000|Overall Study|Lost to Follow-up|0|||
23785572|NCT01634139|66593538|FG001|Overall Study|Lost to Follow-up|2|||
23785573|NCT01634139|66593539|FG002|Overall Study|Lost to Follow-up|0|||
23785574|NCT01634139|66593537|FG000|Overall Study|Not treated|1|||
23785575|NCT01634139|66593538|FG001|Overall Study|Not treated|1|||
23785576|NCT01634139|66593539|FG002|Overall Study|Not treated|0|||
23785577|NCT02875392|66593540|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
23785578|NCT02875392|66593541|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
23785579|NCT02625974|66593542|FG000|Part 1|Lost to Follow-up|9|||
23785580|NCT02625974|66593543|FG001|Part 1|Lost to Follow-up|3|||
23785581|NCT02625974|66593542|FG000|Part 2|Lost to Follow-up|4|||
23457345|NCT03346434|65416596|FG003|Overall Study|Lost to Follow-up|0|||
23457346|NCT03346434|65416597|FG004|Overall Study|Lost to Follow-up|1|||
23785582|NCT02625974|66593543|FG001|Part 2|Lost to Follow-up|6|||
23785583|NCT02625974|66593542|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
23785584|NCT02625974|66593543|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
23785585|NCT01693523|66593544|FG000|Overall Study|Adverse Event|2|||
23457347|NCT03346434|65416598|FG005|Overall Study|Lost to Follow-up|1|||
23457348|NCT03346434|65416593|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457349|NCT03346434|65416594|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457350|NCT03346434|65416595|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457351|NCT03346434|65416596|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457352|NCT03346434|65416597|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
23457353|NCT03346434|65416598|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
23457354|NCT04244253|65416599|FG000|Overall Study|Adverse Event|2|||
23457355|NCT04244253|65416600|FG001|Overall Study|Adverse Event|2|||
23457356|NCT04244253|65416601|FG002|Overall Study|Adverse Event|4|||
23457357|NCT04244253|65416599|FG000|Overall Study|Protocol Violation|1|||
23457358|NCT04244253|65416600|FG001|Overall Study|Protocol Violation|2|||
23457359|NCT04244253|65416601|FG002|Overall Study|Protocol Violation|1|||
23637979|NCT03248882|66057664|FG001|Overall Study|Withdrawal by Subject|2|||
23637980|NCT03248882|66057665|FG002|Overall Study|Withdrawal by Subject|3|||
23637981|NCT03248882|66057666|FG003|Overall Study|Withdrawal by Subject|4|||
23637982|NCT03248882|66057667|FG004|Overall Study|Withdrawal by Subject|2|||
23637983|NCT02992691|66057668|FG000|Overall Study|Adverse Event|2|||
23637984|NCT02992691|66057668|FG000|Overall Study|Withdrawal by Subject|1|||
23637985|NCT04445987|66057672|FG000|Overall Study|Adverse Event|0|||
23637986|NCT04445987|66057673|FG001|Overall Study|Adverse Event|0|||
23637987|NCT04445987|66057674|FG002|Overall Study|Adverse Event|1|||
23637988|NCT04445987|66057675|FG003|Overall Study|Adverse Event|0|||
23637989|NCT04445987|66057676|FG004|Overall Study|Adverse Event|4|||
23637990|NCT04445987|66057677|FG005|Overall Study|Adverse Event|0|||
23785586|NCT01693523|66593545|FG001|Overall Study|Adverse Event|1|||
23637991|NCT04445987|66057672|FG000|Overall Study|Lost to Follow-up|4|||
23637992|NCT04445987|66057673|FG001|Overall Study|Lost to Follow-up|3|||
23637993|NCT04445987|66057674|FG002|Overall Study|Lost to Follow-up|1|||
23637994|NCT04445987|66057675|FG003|Overall Study|Lost to Follow-up|1|||
23457360|NCT04244253|65416599|FG000|Overall Study|Withdrawal by Subject|0|||
23457361|NCT04244253|65416600|FG001|Overall Study|Withdrawal by Subject|1|||
23457362|NCT04244253|65416601|FG002|Overall Study|Withdrawal by Subject|6|||
23457363|NCT04244253|65416599|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23457364|NCT04244253|65416600|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23457365|NCT04244253|65416601|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23457366|NCT05131204|65416603|FG000|Overall Study|Sponsor request|2|||
23457367|NCT05131204|65416604|FG001|Overall Study|Sponsor request|1|||
23457368|NCT05526716|65416609|FG000|Overall Study|Death|1|||
23457369|NCT05526716|65416610|FG001|Overall Study|Death|2|||
23457370|NCT05526716|65416609|FG000|Overall Study|Lost to Follow-up|17|||
23457371|NCT05526716|65416610|FG001|Overall Study|Lost to Follow-up|15|||
23457372|NCT05526716|65416609|FG000|Overall Study|Physician Decision|0|||
23457373|NCT05526716|65416610|FG001|Overall Study|Physician Decision|1|||
23457374|NCT05526716|65416609|FG000|Overall Study|Randomized by mistake without study treatment|0|||
23457375|NCT05526716|65416610|FG001|Overall Study|Randomized by mistake without study treatment|1|||
23457376|NCT05526716|65416609|FG000|Overall Study|Withdrawal by Subject|12|||
23457377|NCT05526716|65416610|FG001|Overall Study|Withdrawal by Subject|12|||
23457378|NCT05526716|65416609|FG000|Overall Study|Not reported|0|||
23457379|NCT05526716|65416610|FG001|Overall Study|Not reported|2|||
23457380|NCT05083351|65416616|FG000|Overall Study|Adverse Event|3|||
23457381|NCT05083351|65416616|FG000|Overall Study|Did not meet data inclusion criteria|8|||
23457382|NCT05083351|65416616|FG000|Overall Study|Did not meet eligibility criteria|19|||
23457383|NCT05083351|65416616|FG000|Overall Study|Study Staff Decision|19|||
23457384|NCT02182895|65416617|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
23457385|NCT02182895|65416618|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
23457386|NCT04423718|65416619|FG000|Overall Study|Adverse Event|6|||
23457387|NCT04423718|65416620|FG001|Overall Study|Adverse Event|2|||
23457388|NCT04423718|65416621|FG002|Overall Study|Adverse Event|5|||
23457389|NCT04423718|65416619|FG000|Overall Study|Physician Decision|1|||
23457390|NCT04423718|65416620|FG001|Overall Study|Physician Decision|4|||
23457391|NCT04423718|65416621|FG002|Overall Study|Physician Decision|1|||
23457392|NCT04423718|65416619|FG000|Overall Study|Protocol Violation|0|||
23457393|NCT04423718|65416620|FG001|Overall Study|Protocol Violation|1|||
23457394|NCT04423718|65416621|FG002|Overall Study|Protocol Violation|1|||
23457395|NCT04423718|65416619|FG000|Overall Study|Lost to Follow-up|1|||
23457396|NCT04423718|65416620|FG001|Overall Study|Lost to Follow-up|1|||
23457397|NCT04423718|65416621|FG002|Overall Study|Lost to Follow-up|2|||
23457398|NCT04423718|65416619|FG000|Overall Study|Lack of Efficacy|2|||
23457399|NCT04423718|65416620|FG001|Overall Study|Lack of Efficacy|0|||
23457400|NCT04423718|65416621|FG002|Overall Study|Lack of Efficacy|0|||
23457401|NCT04423718|65416619|FG000|Overall Study|Withdrawal by Subject|6|||
23457402|NCT04423718|65416620|FG001|Overall Study|Withdrawal by Subject|8|||
23457403|NCT04423718|65416621|FG002|Overall Study|Withdrawal by Subject|14|||
23457404|NCT04423718|65416619|FG000|Overall Study|Death|5|||
23457405|NCT04423718|65416620|FG001|Overall Study|Death|3|||
23457406|NCT04423718|65416621|FG002|Overall Study|Death|2|||
23457407|NCT04423718|65416619|FG000|Overall Study|COVID-19 pandemic|2|||
23457408|NCT04423718|65416620|FG001|Overall Study|COVID-19 pandemic|2|||
23457409|NCT04423718|65416621|FG002|Overall Study|COVID-19 pandemic|2|||
23457410|NCT04423718|65416619|FG000|Overall Study|Other|6|||
23785587|NCT01693523|66593546|FG002|Overall Study|Adverse Event|0|||
23785588|NCT01693523|66593544|FG000|Overall Study|Death|0|||
23785589|NCT01693523|66593545|FG001|Overall Study|Death|1|||
23785590|NCT01693523|66593546|FG002|Overall Study|Death|1|||
23785591|NCT01693523|66593544|FG000|Overall Study|Lost to Follow-up|0|||
23785592|NCT01693523|66593545|FG001|Overall Study|Lost to Follow-up|0|||
23785593|NCT01693523|66593546|FG002|Overall Study|Lost to Follow-up|4|||
23785594|NCT01693523|66593544|FG000|Overall Study|Physician Decision|0|||
23785595|NCT01693523|66593545|FG001|Overall Study|Physician Decision|0|||
23785596|NCT01693523|66593546|FG002|Overall Study|Physician Decision|1|||
23785597|NCT01693523|66593544|FG000|Overall Study|Withdrawal by Subject|1|||
23785598|NCT01693523|66593545|FG001|Overall Study|Withdrawal by Subject|2|||
23785599|NCT01693523|66593546|FG002|Overall Study|Withdrawal by Subject|2|||
23785600|NCT01693523|66593544|FG000|Overall Study|Lack of compliance study medication|1|||
23785601|NCT01693523|66593545|FG001|Overall Study|Lack of compliance study medication|2|||
23785602|NCT01693523|66593546|FG002|Overall Study|Lack of compliance study medication|0|||
23785603|NCT01693523|66593544|FG000|Overall Study|Chemotherapy was held|1|||
23785604|NCT01693523|66593545|FG001|Overall Study|Chemotherapy was held|2|||
23785605|NCT01693523|66593546|FG002|Overall Study|Chemotherapy was held|0|||
23785606|NCT01650194|66593547|FG000|Overall Study|Progressive Disease (PD)|35|||
23785607|NCT01650194|66593547|FG000|Overall Study|Withdrawal by Subject|2|||
23785608|NCT01650194|66593547|FG000|Overall Study|Miscellaneous|10|||
23785609|NCT02025010|66593548|FG000|Overall Study|Symptomatic or radiographic progression|36|||
23785610|NCT02025010|66593548|FG000|Overall Study|Adverse Event|6|||
23457411|NCT04423718|65416620|FG001|Overall Study|Other|2|||
23785611|NCT02025010|66593548|FG000|Overall Study|Physician Decision|7|||
23785612|NCT02025010|66593548|FG000|Overall Study|Withdrawal by Subject|3|||
23345935|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
23345936|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
23345937|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
23345938|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
23345939|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Other|0|||
23457412|NCT04423718|65416621|FG002|Overall Study|Other|2|||
23457413|NCT04423718|65416619|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
23457414|NCT04423718|65416620|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
23457415|NCT04423718|65416621|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
23457416|NCT02140047|65416622|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23457417|NCT02140047|65416623|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23457418|NCT02140047|65416624|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23457419|NCT05789745|65416625|FG000|Overall Study|Withdrawal by Subject|0|||
23457420|NCT05789745|65416626|FG001|Overall Study|Withdrawal by Subject|0|||
23457421|NCT05789745|65416627|FG002|Overall Study|Withdrawal by Subject|0|||
23457422|NCT05789745|65416628|FG003|Overall Study|Withdrawal by Subject|0|||
23457423|NCT05789745|65416629|FG004|Overall Study|Withdrawal by Subject|1|||
23457424|NCT04613362|65416630|FG000|3 Month Follow-up|Lost to Follow-up|1|||
23457425|NCT04613362|65416631|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23457426|NCT04613362|65416630|FG000|6 Month Follow-up|Lost to Follow-up|0|||
23457427|NCT04613362|65416631|FG001|6 Month Follow-up|Lost to Follow-up|1|||
23457428|NCT04218240|65416632|FG000|Overall Study|Withdrawal by Subject|6|||
23457429|NCT04218240|65416633|FG001|Overall Study|Withdrawal by Subject|0|||
23457430|NCT04218240|65416632|FG000|Overall Study|Lack of Efficacy|24|||
23457431|NCT04218240|65416633|FG001|Overall Study|Lack of Efficacy|19|||
23457432|NCT04218240|65416632|FG000|Overall Study|Physician Decision|0|||
23457433|NCT04218240|65416633|FG001|Overall Study|Physician Decision|1|||
23457434|NCT04218240|65416632|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
23457435|NCT04218240|65416633|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
23457436|NCT03524612|65416636|FG000|Overall Study|Lack of Efficacy|10|||
23457437|NCT03524612|65416636|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
23457438|NCT03524612|65416636|FG000|Overall Study|Adverse Event|10|||
23457439|NCT03524612|65416636|FG000|Overall Study|Withdrawal by Subject|7|||
23457440|NCT03524612|65416636|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
23457441|NCT03524612|65416636|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
23457442|NCT03524612|65416636|FG000|Overall Study|New therapy for study indication|6|||
23457443|NCT03524612|65416636|FG000|Overall Study|Death|3|||
23457444|NCT03524612|65416636|FG000|Overall Study|Lost to Follow-up|2|||
23457445|NCT03524612|65416636|FG000|Overall Study|Protocol Violation|1|||
23457446|NCT03755934|65416637|FG000|Overall Study|Adverse Event|4|||
23457447|NCT03755934|65416638|FG001|Overall Study|Adverse Event|1|||
23457448|NCT03755934|65416639|FG002|Overall Study|Adverse Event|1|||
23457449|NCT03755934|65416640|FG003|Overall Study|Adverse Event|3|||
23457450|NCT03755934|65416637|FG000|Overall Study|Physician Decision|2|||
23457451|NCT03755934|65416638|FG001|Overall Study|Physician Decision|0|||
23457452|NCT03755934|65416639|FG002|Overall Study|Physician Decision|0|||
23457453|NCT03755934|65416640|FG003|Overall Study|Physician Decision|1|||
23457454|NCT03755934|65416637|FG000|Overall Study|Withdrawal by Subject|5|||
23457455|NCT03755934|65416638|FG001|Overall Study|Withdrawal by Subject|0|||
23345940|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Other|0|||
23345941|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Other|1|||
23345942|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Other|0|||
23345943|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Other|0|||
23345944|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Other|0|||
23457456|NCT03755934|65416639|FG002|Overall Study|Withdrawal by Subject|0|||
23457457|NCT03755934|65416640|FG003|Overall Study|Withdrawal by Subject|1|||
23457458|NCT03755934|65416637|FG000|Overall Study|Other|3|||
23457459|NCT03755934|65416638|FG001|Overall Study|Other|1|||
23457460|NCT03755934|65416639|FG002|Overall Study|Other|3|||
23457461|NCT03755934|65416640|FG003|Overall Study|Other|1|||
23457462|NCT03459079|65416644|FG000|Overall Study|Adverse Event|4|||
23457463|NCT03459079|65416645|FG001|Overall Study|Adverse Event|2|||
23457464|NCT03459079|65416646|FG002|Overall Study|Adverse Event|0|||
23457465|NCT03459079|65416644|FG000|Overall Study|Withdrawal by Subject|2|||
23457466|NCT03459079|65416645|FG001|Overall Study|Withdrawal by Subject|2|||
23457467|NCT03459079|65416646|FG002|Overall Study|Withdrawal by Subject|0|||
23457468|NCT00627393|65416649|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
23457469|NCT00627393|65416650|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
23457470|NCT00627393|65416649|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
23457471|NCT00627393|65416650|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
23457472|NCT00627393|65416649|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
23457473|NCT00627393|65416650|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
23457474|NCT00627393|65416649|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
23457475|NCT00627393|65416650|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
23457476|NCT00392327|65416651|FG000|Overall Study|Death|1|||
23457477|NCT00392327|65416652|FG001|Overall Study|Death|0|||
23457478|NCT00392327|65416653|FG002|Overall Study|Death|1|||
23457479|NCT00392327|65416654|FG003|Overall Study|Death|0|||
23457480|NCT00392327|65416655|FG004|Overall Study|Death|0|||
23457481|NCT00392327|65416656|FG005|Overall Study|Death|0|||
23457482|NCT00392327|65416657|FG006|Overall Study|Death|0|||
23457483|NCT00392327|65416658|FG007|Overall Study|Death|0|||
23457484|NCT00392327|65416651|FG000|Overall Study|Lack of Efficacy|8|||
23457485|NCT00392327|65416652|FG001|Overall Study|Lack of Efficacy|8|||
23457486|NCT00392327|65416653|FG002|Overall Study|Lack of Efficacy|9|||
23457487|NCT00392327|65416654|FG003|Overall Study|Lack of Efficacy|6|||
23457488|NCT00392327|65416655|FG004|Overall Study|Lack of Efficacy|3|||
23457489|NCT00392327|65416656|FG005|Overall Study|Lack of Efficacy|3|||
23457490|NCT00392327|65416657|FG006|Overall Study|Lack of Efficacy|3|||
23457491|NCT00392327|65416658|FG007|Overall Study|Lack of Efficacy|3|||
23457492|NCT00392327|65416651|FG000|Overall Study|Physician Decision|3|||
23457493|NCT00392327|65416652|FG001|Overall Study|Physician Decision|5|||
23457494|NCT00392327|65416653|FG002|Overall Study|Physician Decision|2|||
23457495|NCT00392327|65416654|FG003|Overall Study|Physician Decision|2|||
23457496|NCT00392327|65416655|FG004|Overall Study|Physician Decision|0|||
23457497|NCT00392327|65416656|FG005|Overall Study|Physician Decision|1|||
23457498|NCT00392327|65416657|FG006|Overall Study|Physician Decision|5|||
23457499|NCT00392327|65416658|FG007|Overall Study|Physician Decision|3|||
23457500|NCT00392327|65416651|FG000|Overall Study|Protocol Violation|0|||
23457501|NCT00392327|65416652|FG001|Overall Study|Protocol Violation|0|||
23457502|NCT00392327|65416653|FG002|Overall Study|Protocol Violation|1|||
23457503|NCT00392327|65416654|FG003|Overall Study|Protocol Violation|0|||
23457504|NCT00392327|65416655|FG004|Overall Study|Protocol Violation|0|||
23457505|NCT00392327|65416656|FG005|Overall Study|Protocol Violation|0|||
23457506|NCT00392327|65416657|FG006|Overall Study|Protocol Violation|0|||
23457507|NCT00392327|65416658|FG007|Overall Study|Protocol Violation|0|||
23457508|NCT00392327|65416651|FG000|Overall Study|Withdrawal by Subject|3|||
23457509|NCT00392327|65416652|FG001|Overall Study|Withdrawal by Subject|2|||
23457510|NCT00392327|65416653|FG002|Overall Study|Withdrawal by Subject|4|||
23457511|NCT00392327|65416654|FG003|Overall Study|Withdrawal by Subject|6|||
23457512|NCT00392327|65416655|FG004|Overall Study|Withdrawal by Subject|0|||
23457513|NCT00392327|65416656|FG005|Overall Study|Withdrawal by Subject|1|||
23457514|NCT00392327|65416657|FG006|Overall Study|Withdrawal by Subject|1|||
23457515|NCT00392327|65416658|FG007|Overall Study|Withdrawal by Subject|5|||
23457516|NCT00392327|65416651|FG000|Overall Study|Ineligible|0|||
23457517|NCT00392327|65416652|FG001|Overall Study|Ineligible|4|||
23457518|NCT00392327|65416653|FG002|Overall Study|Ineligible|3|||
23457519|NCT00392327|65416654|FG003|Overall Study|Ineligible|2|||
23457520|NCT00392327|65416655|FG004|Overall Study|Ineligible|0|||
23457521|NCT00392327|65416656|FG005|Overall Study|Ineligible|0|||
23457522|NCT00392327|65416657|FG006|Overall Study|Ineligible|0|||
23457523|NCT00392327|65416658|FG007|Overall Study|Ineligible|0|||
23345945|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Other|1|||
23457527|NCT01766050|65416660|FG000|Overall Study|Adverse Event|1|||
23457528|NCT01766050|65416660|FG000|Overall Study|Lost to Follow-up|1|||
23457529|NCT01766050|65416660|FG000|Overall Study|Withdrawal by Subject|2|||
23457530|NCT04819945|65416663|FG000|Overall Study|Lost to Follow-up|1|||
23457531|NCT03379818|65416664|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
23457532|NCT03379818|65416665|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
23457533|NCT03379818|65416664|FG000|Overall Study|Withdrawal by Subject|2|||
23457534|NCT03379818|65416665|FG001|Overall Study|Withdrawal by Subject|3|||
23457535|NCT03379818|65416664|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
23457536|NCT03379818|65416665|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
23457537|NCT04408989|65416668|FG000|Overall Study|Lost to Follow-up|0|||
23457538|NCT04408989|65416669|FG001|Overall Study|Lost to Follow-up|0|||
23457539|NCT04408989|65416670|FG002|Overall Study|Lost to Follow-up|1|||
23457540|NCT04408989|65416668|FG000|Overall Study|Withdrawal by Subject|0|||
23457541|NCT04408989|65416669|FG001|Overall Study|Withdrawal by Subject|0|||
23457542|NCT04408989|65416670|FG002|Overall Study|Withdrawal by Subject|2|||
23457543|NCT02814916|65416671|FG000|Overall Study|Withdrawal of consent|0|||
23457544|NCT02814916|65416672|FG001|Overall Study|Withdrawal of consent|2|||
23457545|NCT02814916|65416673|FG002|Overall Study|Withdrawal of consent|0|||
23457546|NCT02814916|65416671|FG000|Overall Study|Lost to Follow-up|0|||
23457547|NCT02814916|65416672|FG001|Overall Study|Lost to Follow-up|1|||
23457548|NCT02814916|65416673|FG002|Overall Study|Lost to Follow-up|0|||
23457549|NCT02814916|65416671|FG000|Overall Study|Other, not specified|0|||
23457550|NCT02814916|65416672|FG001|Overall Study|Other, not specified|1|||
23457551|NCT02814916|65416673|FG002|Overall Study|Other, not specified|0|||
23457552|NCT01280903|65416674|FG000|Overall Study|Lost to Follow-up|23|||
23457553|NCT01280903|65416675|FG001|Overall Study|Lost to Follow-up|16|||
23457554|NCT02384551|65416676|FG000|Overall Study|Lost to Follow-up|13|||
23457555|NCT02384551|65416677|FG001|Overall Study|Lost to Follow-up|14|||
23583569|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
23583570|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583571|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583572|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583573|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583574|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583575|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583576|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583577|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583578|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583579|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583580|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583581|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583582|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
23583583|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
23583584|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583585|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583586|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583587|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583588|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583589|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583590|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583591|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23637995|NCT04445987|66057676|FG004|Overall Study|Lost to Follow-up|29|||
23345946|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Other|0|||
23457556|NCT02384551|65416678|FG002|Overall Study|Lost to Follow-up|14|||
23345947|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Other|0|||
23457557|NCT02384551|65416679|FG003|Overall Study|Lost to Follow-up|14|||
23457558|NCT05121766|65416682|FG000|Overall Study|Covid reinfection|3|||
23457559|NCT05121766|65416683|FG001|Overall Study|Covid reinfection|0|||
23457560|NCT05121766|65416682|FG000|Overall Study|Withdrawal by Subject|3|||
23637996|NCT04445987|66057677|FG005|Overall Study|Lost to Follow-up|0|||
23637997|NCT04445987|66057672|FG000|Overall Study|Physician Decision|0|||
23637998|NCT04445987|66057673|FG001|Overall Study|Physician Decision|0|||
23637999|NCT04445987|66057674|FG002|Overall Study|Physician Decision|0|||
23638000|NCT04445987|66057675|FG003|Overall Study|Physician Decision|0|||
23638001|NCT04445987|66057676|FG004|Overall Study|Physician Decision|1|||
23638002|NCT04445987|66057677|FG005|Overall Study|Physician Decision|0|||
23638003|NCT04445987|66057672|FG000|Overall Study|Protocol Violation|1|||
23638004|NCT04445987|66057673|FG001|Overall Study|Protocol Violation|0|||
23638005|NCT04445987|66057674|FG002|Overall Study|Protocol Violation|0|||
23638006|NCT04445987|66057675|FG003|Overall Study|Protocol Violation|0|||
23638007|NCT04445987|66057676|FG004|Overall Study|Protocol Violation|2|||
23638008|NCT04445987|66057677|FG005|Overall Study|Protocol Violation|0|||
23638009|NCT04445987|66057672|FG000|Overall Study|Withdrawal by Subject|4|||
23638010|NCT04445987|66057673|FG001|Overall Study|Withdrawal by Subject|0|||
23638011|NCT04445987|66057674|FG002|Overall Study|Withdrawal by Subject|1|||
23638012|NCT04445987|66057675|FG003|Overall Study|Withdrawal by Subject|0|||
23638013|NCT04445987|66057676|FG004|Overall Study|Withdrawal by Subject|18|||
23638014|NCT04445987|66057677|FG005|Overall Study|Withdrawal by Subject|1|||
23638015|NCT04445987|66057672|FG000|Overall Study|Other reason|0|||
23638016|NCT04445987|66057673|FG001|Overall Study|Other reason|0|||
23638017|NCT04445987|66057674|FG002|Overall Study|Other reason|1|||
23638018|NCT04445987|66057675|FG003|Overall Study|Other reason|0|||
23638019|NCT04445987|66057676|FG004|Overall Study|Other reason|2|||
23638020|NCT04445987|66057677|FG005|Overall Study|Other reason|0|||
23638021|NCT02559895|66057700|FG000|Overall Study|Adverse Event|3|||
23638022|NCT02559895|66057701|FG001|Overall Study|Adverse Event|3|||
23638023|NCT02559895|66057702|FG002|Overall Study|Adverse Event|2|||
23638024|NCT02559895|66057703|FG003|Overall Study|Adverse Event|1|||
23638025|NCT02559895|66057700|FG000|Overall Study|Lack of Efficacy|2|||
23638026|NCT02559895|66057701|FG001|Overall Study|Lack of Efficacy|3|||
23638027|NCT02559895|66057702|FG002|Overall Study|Lack of Efficacy|2|||
23638028|NCT02559895|66057703|FG003|Overall Study|Lack of Efficacy|8|||
23638029|NCT02559895|66057700|FG000|Overall Study|Lost to Follow-up|22|||
23638030|NCT02559895|66057701|FG001|Overall Study|Lost to Follow-up|16|||
23638031|NCT02559895|66057702|FG002|Overall Study|Lost to Follow-up|12|||
23638032|NCT02559895|66057703|FG003|Overall Study|Lost to Follow-up|17|||
23638033|NCT02559895|66057700|FG000|Overall Study|Physician Decision|1|||
23638034|NCT02559895|66057701|FG001|Overall Study|Physician Decision|1|||
23638035|NCT02559895|66057702|FG002|Overall Study|Physician Decision|3|||
23638036|NCT02559895|66057703|FG003|Overall Study|Physician Decision|0|||
23638037|NCT02559895|66057700|FG000|Overall Study|Withdrawal by Subject|16|||
23638038|NCT02559895|66057701|FG001|Overall Study|Withdrawal by Subject|9|||
23638039|NCT02559895|66057702|FG002|Overall Study|Withdrawal by Subject|20|||
23638040|NCT02559895|66057703|FG003|Overall Study|Withdrawal by Subject|9|||
23638041|NCT02559895|66057700|FG000|Overall Study|Study Burden|10|||
23638042|NCT02559895|66057701|FG001|Overall Study|Study Burden|16|||
23638043|NCT02559895|66057702|FG002|Overall Study|Study Burden|12|||
23638044|NCT02559895|66057703|FG003|Overall Study|Study Burden|22|||
23638045|NCT02559895|66057700|FG000|Overall Study|Other|1|||
23638046|NCT02559895|66057701|FG001|Overall Study|Other|5|||
23638047|NCT02559895|66057702|FG002|Overall Study|Other|3|||
23638048|NCT02559895|66057703|FG003|Overall Study|Other|3|||
23638049|NCT01259089|66060748|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23638050|NCT01259089|66060749|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23785613|NCT02025010|66593548|FG000|Overall Study|Intercurrent illness|3|||
23785614|NCT02025010|66593548|FG000|Overall Study|Patients still on treatment|3|||
23785615|NCT02025010|66593548|FG000|Overall Study|Never initiate the treatment|2|||
23785616|NCT04966741|66593549|FG000|Overall Study|Lost to Follow-up|1|||
23785617|NCT04966741|66593550|FG001|Overall Study|Lost to Follow-up|0|||
23785618|NCT03158727|66593551|FG000|Overall Study|Withdrawal by Subject|2|||
23785619|NCT03158727|66593552|FG001|Overall Study|Withdrawal by Subject|6|||
23638051|NCT01259089|66060750|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23638052|NCT01259089|66060751|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23785620|NCT03158727|66593551|FG000|Overall Study|Death|11|||
23638053|NCT01259089|66060752|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23638054|NCT01259089|66060753|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
23638055|NCT01259089|66060748|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
23638056|NCT01259089|66060749|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
23638057|NCT01259089|66060750|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
23638058|NCT01259089|66060751|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
23638059|NCT01259089|66060752|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
23638060|NCT01259089|66060753|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
23638061|NCT01259089|66060748|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23638062|NCT01259089|66060749|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23785621|NCT03158727|66593552|FG001|Overall Study|Death|12|||
23785622|NCT03158727|66593551|FG000|Overall Study|Lost to Follow-up|1|||
23785623|NCT03158727|66593552|FG001|Overall Study|Lost to Follow-up|0|||
23785624|NCT03158727|66593551|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
23785625|NCT03158727|66593552|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
23785626|NCT03158727|66593551|FG000|Overall Study|Visit 11 not done by mistake|0|||
23785627|NCT03158727|66593552|FG001|Overall Study|Visit 11 not done by mistake|1|||
23785628|NCT03158727|66593551|FG000|Overall Study|Enrolled, not treated|1|||
23785629|NCT03158727|66593552|FG001|Overall Study|Enrolled, not treated|0|||
23785630|NCT01440803|66593558|FG000|Overall Study|Met study stopping rule|2|||
23785631|NCT01440803|66593559|FG001|Overall Study|Met study stopping rule|1|||
23785632|NCT01440803|66593558|FG000|Overall Study|Lost to Follow-up|0|||
23785633|NCT01440803|66593559|FG001|Overall Study|Lost to Follow-up|2|||
23785634|NCT01440803|66593558|FG000|Overall Study|Withdrawal by Subject|0|||
23785635|NCT01440803|66593559|FG001|Overall Study|Withdrawal by Subject|1|||
23785636|NCT00841698|66593562|FG000|First Intervention|Withdrawal by Subject|1|||
23785637|NCT00841698|66593563|FG001|First Intervention|Withdrawal by Subject|0|||
23785638|NCT00819169|66593566|FG000|Overall Study|Withdrawal by Subject|2|||
23785639|NCT00819169|66593567|FG001|Overall Study|Withdrawal by Subject|0|||
23785640|NCT00819169|66593568|FG002|Overall Study|Withdrawal by Subject|0|||
23785641|NCT00819169|66593569|FG003|Overall Study|Withdrawal by Subject|1|||
23785642|NCT00819169|66593570|FG004|Overall Study|Withdrawal by Subject|1|||
23785643|NCT00819169|66593571|FG005|Overall Study|Withdrawal by Subject|1|||
23785644|NCT00819169|66593572|FG006|Overall Study|Withdrawal by Subject|5|||
23785645|NCT00819169|66593573|FG007|Overall Study|Withdrawal by Subject|1|||
23785646|NCT00819169|66593574|FG008|Overall Study|Withdrawal by Subject|4|||
23785647|NCT00819169|66593566|FG000|Overall Study|Lost to Follow-up|0|||
23785648|NCT00819169|66593567|FG001|Overall Study|Lost to Follow-up|2|||
23785649|NCT00819169|66593568|FG002|Overall Study|Lost to Follow-up|0|||
23785650|NCT00819169|66593569|FG003|Overall Study|Lost to Follow-up|1|||
23785651|NCT00819169|66593570|FG004|Overall Study|Lost to Follow-up|0|||
23785652|NCT00819169|66593571|FG005|Overall Study|Lost to Follow-up|6|||
23785653|NCT00819169|66593572|FG006|Overall Study|Lost to Follow-up|2|||
23785654|NCT00819169|66593573|FG007|Overall Study|Lost to Follow-up|2|||
23785655|NCT00819169|66593574|FG008|Overall Study|Lost to Follow-up|1|||
23785656|NCT00819169|66593566|FG000|Overall Study|Death|1|||
23345948|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Other|0|||
23457561|NCT05121766|65416683|FG001|Overall Study|Withdrawal by Subject|1|||
23457562|NCT05121766|65416682|FG000|Overall Study|Adverse Event|2|||
23457563|NCT05121766|65416683|FG001|Overall Study|Adverse Event|4|||
23457564|NCT05121766|65416682|FG000|Overall Study|Lost to Follow-up|0|||
23457565|NCT05121766|65416683|FG001|Overall Study|Lost to Follow-up|1|||
23785657|NCT00819169|66593567|FG001|Overall Study|Death|1|||
23785658|NCT00819169|66593568|FG002|Overall Study|Death|3|||
23785659|NCT00819169|66593569|FG003|Overall Study|Death|8|||
23785660|NCT00819169|66593570|FG004|Overall Study|Death|5|||
23785661|NCT00819169|66593571|FG005|Overall Study|Death|7|||
23785662|NCT00819169|66593572|FG006|Overall Study|Death|9|||
23785663|NCT00819169|66593573|FG007|Overall Study|Death|4|||
23785664|NCT00819169|66593574|FG008|Overall Study|Death|7|||
23785665|NCT00819169|66593566|FG000|Overall Study|Ineligibility determined|0|||
23345949|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Other|0|||
23785666|NCT00819169|66593567|FG001|Overall Study|Ineligibility determined|0|||
23785667|NCT00819169|66593568|FG002|Overall Study|Ineligibility determined|0|||
23345950|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
23785668|NCT00819169|66593569|FG003|Overall Study|Ineligibility determined|2|||
23345951|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345952|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345953|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345954|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345955|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345956|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345957|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
23345958|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
23345959|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
23345960|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
23638063|NCT01259089|66060750|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23785669|NCT00819169|66593570|FG004|Overall Study|Ineligibility determined|0|||
23785670|NCT00819169|66593571|FG005|Overall Study|Ineligibility determined|0|||
23785671|NCT00819169|66593572|FG006|Overall Study|Ineligibility determined|0|||
23785672|NCT00819169|66593573|FG007|Overall Study|Ineligibility determined|0|||
23785673|NCT00819169|66593574|FG008|Overall Study|Ineligibility determined|1|||
23785674|NCT00819169|66593566|FG000|Overall Study|Adverse Event|0|||
23785675|NCT00819169|66593567|FG001|Overall Study|Adverse Event|0|||
23785676|NCT00819169|66593568|FG002|Overall Study|Adverse Event|0|||
23785677|NCT00819169|66593569|FG003|Overall Study|Adverse Event|0|||
23785678|NCT00819169|66593570|FG004|Overall Study|Adverse Event|1|||
23638064|NCT01259089|66060751|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23638065|NCT01259089|66060752|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23638066|NCT01259089|66060753|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
23638067|NCT01259089|66060748|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
23638068|NCT01259089|66060749|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
23638069|NCT01259089|66060750|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
23638070|NCT01259089|66060751|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
23638071|NCT01259089|66060752|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
23638072|NCT01259089|66060753|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
23638073|NCT01259089|66060748|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
23345961|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345962|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345963|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23638074|NCT01259089|66060749|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
23638075|NCT01259089|66060750|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
23638076|NCT01259089|66060751|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
23638077|NCT01259089|66060752|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
23638078|NCT01259089|66060753|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
23638079|NCT01259089|66060748|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
23638080|NCT01259089|66060749|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23638081|NCT01259089|66060750|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23638082|NCT01259089|66060751|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23638083|NCT01259089|66060752|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23638084|NCT01259089|66060753|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23638085|NCT01259089|66060748|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
23638086|NCT01259089|66060749|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
23638087|NCT01259089|66060750|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
23638088|NCT01259089|66060751|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
23638089|NCT01259089|66060752|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
23785679|NCT00819169|66593571|FG005|Overall Study|Adverse Event|0|||
23785680|NCT00819169|66593572|FG006|Overall Study|Adverse Event|0|||
23638090|NCT01259089|66060753|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
23785681|NCT00819169|66593573|FG007|Overall Study|Adverse Event|0|||
23785682|NCT00819169|66593574|FG008|Overall Study|Adverse Event|0|||
23785683|NCT00819169|66593566|FG000|Overall Study|Administrative Decision|0|||
23785684|NCT00819169|66593567|FG001|Overall Study|Administrative Decision|0|||
23457566|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
23457567|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457568|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457569|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
23785685|NCT00819169|66593568|FG002|Overall Study|Administrative Decision|0|||
23785686|NCT00819169|66593569|FG003|Overall Study|Administrative Decision|0|||
23785687|NCT00819169|66593570|FG004|Overall Study|Administrative Decision|1|||
23785688|NCT00819169|66593571|FG005|Overall Study|Administrative Decision|2|||
23785689|NCT00819169|66593572|FG006|Overall Study|Administrative Decision|0|||
23785690|NCT00819169|66593573|FG007|Overall Study|Administrative Decision|2|||
23785691|NCT00819169|66593574|FG008|Overall Study|Administrative Decision|0|||
23785692|NCT02911792|66593576|FG000|Overall Study|Lost to Follow-up|3|||
23785693|NCT02911792|66593577|FG001|Overall Study|Lost to Follow-up|3|||
23785694|NCT02911792|66593578|FG002|Overall Study|Lost to Follow-up|3|||
23785695|NCT02911792|66593579|FG003|Overall Study|Lost to Follow-up|3|||
23785696|NCT00585286|66593580|FG000|Overall Study|Lost to Follow-up|1|||
23785697|NCT01034358|66593581|FG000|Overall Study|Withdrawal by Subject|1|||
23785698|NCT01034358|66593581|FG000|Overall Study|Protocol Violation|1|||
23457570|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457571|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457572|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
23457573|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
23638091|NCT01259089|66060748|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
23638092|NCT01259089|66060749|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
23638093|NCT01259089|66060750|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
23638094|NCT01259089|66060751|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
23638095|NCT01259089|66060752|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
23638096|NCT01259089|66060753|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
23638097|NCT01259089|66060748|FG000|Survival Follow up for Two Years|Death|3|||
23638098|NCT01259089|66060749|FG001|Survival Follow up for Two Years|Death|2|||
23638099|NCT01259089|66060750|FG002|Survival Follow up for Two Years|Death|2|||
23638100|NCT01259089|66060751|FG003|Survival Follow up for Two Years|Death|3|||
23638101|NCT01259089|66060752|FG004|Survival Follow up for Two Years|Death|6|||
23638102|NCT01259089|66060753|FG005|Survival Follow up for Two Years|Death|13|||
23638103|NCT01259089|66060748|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
23638104|NCT01259089|66060749|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
23638105|NCT01259089|66060750|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
23638106|NCT01259089|66060751|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
23638107|NCT01259089|66060752|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
23638108|NCT01259089|66060753|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
23638109|NCT01259089|66060748|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23638110|NCT01259089|66060749|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23638111|NCT01259089|66060750|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23638112|NCT01259089|66060751|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23638113|NCT01259089|66060752|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23638114|NCT01259089|66060753|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
23638115|NCT00126503|66060763|FG000|Overall Study|disease progression|23|||
23638116|NCT00126503|66060764|FG001|Overall Study|disease progression|14|||
23638117|NCT00126503|66060763|FG000|Overall Study|Withdrawal by Subject|0|||
23638118|NCT00126503|66060764|FG001|Overall Study|Withdrawal by Subject|1|||
23638119|NCT00126503|66060763|FG000|Overall Study|alternative therapy|1|||
23638120|NCT00126503|66060764|FG001|Overall Study|alternative therapy|1|||
23638121|NCT00126503|66060763|FG000|Overall Study|other complicating disease|4|||
23638122|NCT00126503|66060764|FG001|Overall Study|other complicating disease|1|||
23638123|NCT00126503|66060763|FG000|Overall Study|Death|3|||
23638124|NCT00126503|66060764|FG001|Overall Study|Death|0|||
23638125|NCT00126503|66060763|FG000|Overall Study|Adverse Event|13|||
23638126|NCT00126503|66060764|FG001|Overall Study|Adverse Event|3|||
23638127|NCT00126503|66060763|FG000|Overall Study|non-compliant|1|||
23638128|NCT00126503|66060764|FG001|Overall Study|non-compliant|0|||
23785699|NCT03499873|66593582|FG000|Overall Study|Withdrawal by Subject|4|||
23785700|NCT03499873|66593583|FG001|Overall Study|Withdrawal by Subject|6|||
23785701|NCT03499873|66593584|FG002|Overall Study|Withdrawal by Subject|1|||
23785702|NCT03499873|66593582|FG000|Overall Study|Subjects condition worsened|0|||
23457574|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
23785703|NCT03499873|66593583|FG001|Overall Study|Subjects condition worsened|3|||
23345964|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23638129|NCT00126503|66060763|FG000|Overall Study|Physician Decision|2|||
23638130|NCT00126503|66060764|FG001|Overall Study|Physician Decision|1|||
23638131|NCT03014011|66060769|FG000|First Intervention|Withdrawal by Subject|1|||
23706185|NCT02234583|66301077|FG000|Overall Study|Lack of Efficacy|58|||
23785704|NCT03499873|66593584|FG002|Overall Study|Subjects condition worsened|11|||
23785705|NCT03499873|66593582|FG000|Overall Study|Adverse Event|8|||
23785706|NCT03499873|66593583|FG001|Overall Study|Adverse Event|3|||
23785707|NCT03499873|66593584|FG002|Overall Study|Adverse Event|6|||
23785708|NCT03499873|66593582|FG000|Overall Study|Physician Decision|1|||
23785709|NCT03499873|66593583|FG001|Overall Study|Physician Decision|0|||
23785710|NCT03499873|66593584|FG002|Overall Study|Physician Decision|0|||
23785711|NCT03499873|66593582|FG000|Overall Study|Administrative reasons|0|||
23785712|NCT03499873|66593583|FG001|Overall Study|Administrative reasons|1|||
23785713|NCT03499873|66593584|FG002|Overall Study|Administrative reasons|0|||
23785714|NCT03499873|66593582|FG000|Overall Study|Concomitant therapy|5|||
23785715|NCT03499873|66593583|FG001|Overall Study|Concomitant therapy|4|||
23638132|NCT03014011|66060770|FG001|First Intervention|Withdrawal by Subject|0|||
23638133|NCT03014011|66060769|FG000|Washout|Withdrawal by Subject|1|||
23638134|NCT03014011|66060770|FG001|Washout|Withdrawal by Subject|0|||
23638135|NCT01099215|66060776|FG000|Overall Study|Withdrawal by Subject|1|||
23638136|NCT01099215|66060777|FG001|Overall Study|Withdrawal by Subject|0|||
23638137|NCT01099215|66060776|FG000|Overall Study|Adverse Event|0|||
23638138|NCT01099215|66060777|FG001|Overall Study|Adverse Event|1|||
23638139|NCT00468559|66060778|FG000|Open-label Treatment Phase|Adverse Event|5|||
23638140|NCT00468559|66060779|FG001|Open-label Treatment Phase|Adverse Event|0|||
23638141|NCT00468559|66060780|FG002|Open-label Treatment Phase|Adverse Event|0|||
23638142|NCT00468559|66060778|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
23638143|NCT00468559|66060779|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
23638144|NCT00468559|66060780|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
23638145|NCT00468559|66060778|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
23638146|NCT00468559|66060779|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23638147|NCT00468559|66060780|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
23638148|NCT00468559|66060778|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
23638149|NCT00468559|66060779|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
23638150|NCT00468559|66060780|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
23638151|NCT00468559|66060778|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
23638152|NCT00468559|66060779|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
23638153|NCT00468559|66060780|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
23638154|NCT02770612|66060788|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
23638155|NCT03284229|66060789|FG000|Overall Study|Lost to Follow-up|3|||
23638156|NCT01638429|66060790|FG000|Overall Study|Withdrawal by Subject|1|||
23638157|NCT00958841|66060793|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23638158|NCT00958841|66060793|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23638159|NCT00958841|66060793|FG000|Overall Study|Administrative problems|1|||
23638160|NCT00958841|66060793|FG000|Overall Study|Adverse Event|8|||
23638161|NCT00958841|66060793|FG000|Overall Study|New cancer therapy|5|||
23638162|NCT00958841|66060793|FG000|Overall Study|Withdrawal by Subject|1|||
23638163|NCT00958841|66060793|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
23638164|NCT00958841|66060793|FG000|Overall Study|Completed M6/did not enter extension|27|||
23638165|NCT00958841|66060793|FG000|Overall Study|Discontinued prior to M*|28|||
23638166|NCT00886795|66060798|FG000|Overall Study|Lack of Efficacy|1|||
23457575|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
23638167|NCT02304705|66060800|FG000|Overall Study|Withdrawal by Subject|2|||
23638168|NCT02304705|66060801|FG001|Overall Study|Withdrawal by Subject|0|||
23638169|NCT02304705|66060800|FG000|Overall Study|Physician Decision|2|||
23638170|NCT02304705|66060801|FG001|Overall Study|Physician Decision|4|||
23638171|NCT02304705|66060800|FG000|Overall Study|Death|0|||
23638172|NCT02304705|66060801|FG001|Overall Study|Death|1|||
23638173|NCT02304705|66060800|FG000|Overall Study|Lost to Follow-up|0|||
23638174|NCT02304705|66060801|FG001|Overall Study|Lost to Follow-up|2|||
23638175|NCT00862719|66060802|FG000|Overall Study|Disease Progression|5|||
23638176|NCT00862719|66060803|FG001|Overall Study|Disease Progression|0|||
23638177|NCT00862719|66060804|FG002|Overall Study|Disease Progression|1|||
23638178|NCT00862719|66060805|FG003|Overall Study|Disease Progression|0|||
23638179|NCT00862719|66060802|FG000|Overall Study|Death|5|||
23638180|NCT00862719|66060803|FG001|Overall Study|Death|6|||
23638181|NCT00862719|66060804|FG002|Overall Study|Death|1|||
23638182|NCT00862719|66060805|FG003|Overall Study|Death|1|||
23638183|NCT00862719|66060802|FG000|Overall Study|Engraftment failure|0|||
23638184|NCT00862719|66060803|FG001|Overall Study|Engraftment failure|0|||
23638185|NCT00862719|66060804|FG002|Overall Study|Engraftment failure|1|||
23638186|NCT00862719|66060805|FG003|Overall Study|Engraftment failure|0|||
23638187|NCT00862719|66060802|FG000|Overall Study|Veno-Occlusive Disease|0|||
23638188|NCT00862719|66060803|FG001|Overall Study|Veno-Occlusive Disease|0|||
23638189|NCT00862719|66060804|FG002|Overall Study|Veno-Occlusive Disease|1|||
23638190|NCT00862719|66060805|FG003|Overall Study|Veno-Occlusive Disease|0|||
23638191|NCT00974259|66060806|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
23638192|NCT00974259|66060807|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
23638193|NCT00742326|66060811|FG000|Overall Study|Physician Decision|0|||
23785716|NCT03499873|66593584|FG002|Overall Study|Concomitant therapy|7|||
23785717|NCT03499873|66593582|FG000|Overall Study|Miscellaneous|1|||
23785718|NCT03499873|66593583|FG001|Overall Study|Miscellaneous|2|||
23785719|NCT03499873|66593584|FG002|Overall Study|Miscellaneous|2|||
23785720|NCT03499873|66593582|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
23785721|NCT03499873|66593583|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
23785722|NCT03499873|66593584|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
23785723|NCT03131895|66593586|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
23345965|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345966|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345967|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345968|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
23785724|NCT03131895|66593587|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
23785725|NCT03131895|66593588|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
23785726|NCT03131895|66593589|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
23638194|NCT00742326|66060812|FG001|Overall Study|Physician Decision|1|||
23638195|NCT01806623|66060816|FG000|Overall Study|Withdrawal by Subject|1|||
23638196|NCT01806623|66060816|FG000|Overall Study|Adverse Event|1|||
23638197|NCT01806623|66060816|FG000|Overall Study|Did not meet the inclusion criteria|56|||
23638198|NCT00772330|66060821|FG000|Overall Study|Lost to Follow-up|3|||
23785727|NCT03131895|66593586|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23785728|NCT03131895|66593587|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
23785729|NCT03131895|66593588|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
23785730|NCT03131895|66593589|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
23785731|NCT03131895|66593586|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23785732|NCT03131895|66593587|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
23345969|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
23345970|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
23345971|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345972|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
23345973|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
23345974|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
23345975|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
23345976|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
23345977|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
23345978|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
23345979|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
23345980|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
23345981|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
23345982|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
23345983|NCT04608344|65010903|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
23345984|NCT04608344|65010904|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
23345985|NCT04608344|65010903|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
23345986|NCT04608344|65010904|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
23345987|NCT02829723|65010905|FG000|Overall Study|Adverse Event|0|||
23345988|NCT02829723|65010906|FG001|Overall Study|Adverse Event|0|||
23345989|NCT02829723|65010907|FG002|Overall Study|Adverse Event|1|||
23345990|NCT02829723|65010908|FG003|Overall Study|Adverse Event|1|||
23345991|NCT02829723|65010909|FG004|Overall Study|Adverse Event|0|||
23345992|NCT02829723|65010910|FG005|Overall Study|Adverse Event|0|||
23345993|NCT02829723|65010911|FG006|Overall Study|Adverse Event|0|||
23345994|NCT02829723|65010912|FG007|Overall Study|Adverse Event|1|||
23638199|NCT02550938|66060824|FG000|Overall Study|Lost to Follow-up|8|||
23785733|NCT03131895|66593588|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23345995|NCT02829723|65010913|FG008|Overall Study|Adverse Event|0|||
23345996|NCT02829723|65010914|FG009|Overall Study|Adverse Event|0|||
23345997|NCT02829723|65010915|FG010|Overall Study|Adverse Event|0|||
23638200|NCT02550938|66060825|FG001|Overall Study|Lost to Follow-up|7|||
23638201|NCT02550938|66060826|FG002|Overall Study|Lost to Follow-up|12|||
23457576|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
23345998|NCT02829723|65010916|FG011|Overall Study|Adverse Event|0|||
23345999|NCT02829723|65010917|FG012|Overall Study|Adverse Event|0|||
23346000|NCT02829723|65010918|FG013|Overall Study|Adverse Event|0|||
23346001|NCT02829723|65010919|FG014|Overall Study|Adverse Event|1|||
23346002|NCT02829723|65010920|FG015|Overall Study|Adverse Event|1|||
23346003|NCT02829723|65010921|FG016|Overall Study|Adverse Event|1|||
23346004|NCT02829723|65010922|FG017|Overall Study|Adverse Event|2|||
23346005|NCT02829723|65010923|FG018|Overall Study|Adverse Event|1|||
23346006|NCT02829723|65010924|FG019|Overall Study|Adverse Event|1|||
23346007|NCT02829723|65010925|FG020|Overall Study|Adverse Event|3|||
23346008|NCT02829723|65010926|FG021|Overall Study|Adverse Event|0|||
23346009|NCT02829723|65010927|FG022|Overall Study|Adverse Event|0|||
23346010|NCT02829723|65010928|FG023|Overall Study|Adverse Event|1|||
23346011|NCT02829723|65010929|FG024|Overall Study|Adverse Event|1|||
23346012|NCT02829723|65010930|FG025|Overall Study|Adverse Event|3|||
23346013|NCT02829723|65010931|FG026|Overall Study|Adverse Event|5|||
23346014|NCT02829723|65010905|FG000|Overall Study|Death|1|||
23346015|NCT02829723|65010906|FG001|Overall Study|Death|0|||
23346016|NCT02829723|65010907|FG002|Overall Study|Death|1|||
23346017|NCT02829723|65010908|FG003|Overall Study|Death|1|||
23346018|NCT02829723|65010909|FG004|Overall Study|Death|0|||
23346019|NCT02829723|65010910|FG005|Overall Study|Death|0|||
23346020|NCT02829723|65010911|FG006|Overall Study|Death|2|||
23346021|NCT02829723|65010912|FG007|Overall Study|Death|0|||
23346022|NCT02829723|65010913|FG008|Overall Study|Death|1|||
23346023|NCT02829723|65010914|FG009|Overall Study|Death|0|||
23346024|NCT02829723|65010915|FG010|Overall Study|Death|0|||
23346025|NCT02829723|65010916|FG011|Overall Study|Death|0|||
23346026|NCT02829723|65010917|FG012|Overall Study|Death|2|||
23346027|NCT02829723|65010918|FG013|Overall Study|Death|1|||
23346028|NCT02829723|65010919|FG014|Overall Study|Death|0|||
23346029|NCT02829723|65010920|FG015|Overall Study|Death|0|||
23346030|NCT02829723|65010921|FG016|Overall Study|Death|0|||
23346031|NCT02829723|65010922|FG017|Overall Study|Death|0|||
23346032|NCT02829723|65010923|FG018|Overall Study|Death|0|||
23346033|NCT02829723|65010924|FG019|Overall Study|Death|0|||
23346034|NCT02829723|65010925|FG020|Overall Study|Death|0|||
23346035|NCT02829723|65010926|FG021|Overall Study|Death|2|||
23346036|NCT02829723|65010927|FG022|Overall Study|Death|0|||
23346037|NCT02829723|65010928|FG023|Overall Study|Death|0|||
23346038|NCT02829723|65010929|FG024|Overall Study|Death|0|||
23346039|NCT02829723|65010930|FG025|Overall Study|Death|1|||
23346040|NCT02829723|65010931|FG026|Overall Study|Death|2|||
23346041|NCT02829723|65010905|FG000|Overall Study|Physician Decision|0|||
23346042|NCT02829723|65010906|FG001|Overall Study|Physician Decision|0|||
23346043|NCT02829723|65010907|FG002|Overall Study|Physician Decision|0|||
23346044|NCT02829723|65010908|FG003|Overall Study|Physician Decision|0|||
23346045|NCT02829723|65010909|FG004|Overall Study|Physician Decision|0|||
23346046|NCT02829723|65010910|FG005|Overall Study|Physician Decision|0|||
23346047|NCT02829723|65010911|FG006|Overall Study|Physician Decision|0|||
23346048|NCT02829723|65010912|FG007|Overall Study|Physician Decision|0|||
23346049|NCT02829723|65010913|FG008|Overall Study|Physician Decision|0|||
23346050|NCT02829723|65010914|FG009|Overall Study|Physician Decision|1|||
23346051|NCT02829723|65010915|FG010|Overall Study|Physician Decision|1|||
23346052|NCT02829723|65010916|FG011|Overall Study|Physician Decision|0|||
23346053|NCT02829723|65010917|FG012|Overall Study|Physician Decision|0|||
23457577|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457578|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457579|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457580|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457581|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23346054|NCT02829723|65010918|FG013|Overall Study|Physician Decision|1|||
23346055|NCT02829723|65010919|FG014|Overall Study|Physician Decision|0|||
23346056|NCT02829723|65010920|FG015|Overall Study|Physician Decision|0|||
23346057|NCT02829723|65010921|FG016|Overall Study|Physician Decision|2|||
23346058|NCT02829723|65010922|FG017|Overall Study|Physician Decision|0|||
23346059|NCT02829723|65010923|FG018|Overall Study|Physician Decision|0|||
23346060|NCT02829723|65010924|FG019|Overall Study|Physician Decision|0|||
23346061|NCT02829723|65010925|FG020|Overall Study|Physician Decision|0|||
23346062|NCT02829723|65010926|FG021|Overall Study|Physician Decision|0|||
23346063|NCT02829723|65010927|FG022|Overall Study|Physician Decision|1|||
23346064|NCT02829723|65010928|FG023|Overall Study|Physician Decision|1|||
23346065|NCT02829723|65010929|FG024|Overall Study|Physician Decision|1|||
23346066|NCT02829723|65010930|FG025|Overall Study|Physician Decision|1|||
23346067|NCT02829723|65010931|FG026|Overall Study|Physician Decision|3|||
23457582|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
23346068|NCT02829723|65010905|FG000|Overall Study|Progressive disease|4|||
23346069|NCT02829723|65010906|FG001|Overall Study|Progressive disease|6|||
23346070|NCT02829723|65010907|FG002|Overall Study|Progressive disease|3|||
23346071|NCT02829723|65010908|FG003|Overall Study|Progressive disease|3|||
23346072|NCT02829723|65010909|FG004|Overall Study|Progressive disease|3|||
23346073|NCT02829723|65010910|FG005|Overall Study|Progressive disease|5|||
23785734|NCT03131895|66593589|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23785735|NCT03131895|66593586|FG000|Washout Period (at Least 5 Days)|Other|0|||
23785736|NCT03131895|66593587|FG001|Washout Period (at Least 5 Days)|Other|0|||
23346074|NCT02829723|65010911|FG006|Overall Study|Progressive disease|4|||
23346075|NCT02829723|65010912|FG007|Overall Study|Progressive disease|6|||
23346076|NCT02829723|65010913|FG008|Overall Study|Progressive disease|8|||
23346077|NCT02829723|65010914|FG009|Overall Study|Progressive disease|4|||
23346078|NCT02829723|65010915|FG010|Overall Study|Progressive disease|9|||
23346079|NCT02829723|65010916|FG011|Overall Study|Progressive disease|0|||
23346080|NCT02829723|65010917|FG012|Overall Study|Progressive disease|3|||
23346081|NCT02829723|65010918|FG013|Overall Study|Progressive disease|4|||
23346082|NCT02829723|65010919|FG014|Overall Study|Progressive disease|2|||
23346083|NCT02829723|65010920|FG015|Overall Study|Progressive disease|4|||
23346084|NCT02829723|65010921|FG016|Overall Study|Progressive disease|5|||
23346085|NCT02829723|65010922|FG017|Overall Study|Progressive disease|3|||
23346086|NCT02829723|65010923|FG018|Overall Study|Progressive disease|4|||
23346087|NCT02829723|65010924|FG019|Overall Study|Progressive disease|4|||
23346088|NCT02829723|65010925|FG020|Overall Study|Progressive disease|7|||
23346089|NCT02829723|65010926|FG021|Overall Study|Progressive disease|6|||
23346090|NCT02829723|65010927|FG022|Overall Study|Progressive disease|3|||
23346091|NCT02829723|65010928|FG023|Overall Study|Progressive disease|3|||
23346092|NCT02829723|65010929|FG024|Overall Study|Progressive disease|3|||
23346093|NCT02829723|65010930|FG025|Overall Study|Progressive disease|16|||
23346094|NCT02829723|65010931|FG026|Overall Study|Progressive disease|10|||
23346095|NCT02829723|65010905|FG000|Overall Study|Subject/guardian decision|0|||
23346096|NCT02829723|65010906|FG001|Overall Study|Subject/guardian decision|1|||
23346097|NCT02829723|65010907|FG002|Overall Study|Subject/guardian decision|0|||
23346098|NCT02829723|65010908|FG003|Overall Study|Subject/guardian decision|1|||
23346099|NCT02829723|65010909|FG004|Overall Study|Subject/guardian decision|0|||
23346100|NCT02829723|65010910|FG005|Overall Study|Subject/guardian decision|0|||
23346101|NCT02829723|65010911|FG006|Overall Study|Subject/guardian decision|0|||
23346102|NCT02829723|65010912|FG007|Overall Study|Subject/guardian decision|1|||
23346103|NCT02829723|65010913|FG008|Overall Study|Subject/guardian decision|0|||
23785737|NCT03131895|66593588|FG002|Washout Period (at Least 5 Days)|Other|2|||
23785738|NCT03131895|66593589|FG003|Washout Period (at Least 5 Days)|Other|0|||
23785739|NCT03131895|66593586|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23785740|NCT03131895|66593587|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
23785741|NCT03131895|66593588|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23785742|NCT03131895|66593589|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23785743|NCT03131895|66593586|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
23346104|NCT02829723|65010914|FG009|Overall Study|Subject/guardian decision|0|||
23346105|NCT02829723|65010915|FG010|Overall Study|Subject/guardian decision|0|||
23346106|NCT02829723|65010916|FG011|Overall Study|Subject/guardian decision|0|||
23346107|NCT02829723|65010917|FG012|Overall Study|Subject/guardian decision|0|||
23785744|NCT03131895|66593587|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23785745|NCT03131895|66593588|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23785746|NCT03131895|66593589|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23785747|NCT05616728|66593590|FG000|Overall Study|Lost to Follow-up|0|||
23785748|NCT05616728|66593591|FG001|Overall Study|Lost to Follow-up|0|||
23785749|NCT05616728|66593592|FG002|Overall Study|Lost to Follow-up|1|||
23785750|NCT05616728|66593590|FG000|Overall Study|Withdrawal by Subject|1|||
23785751|NCT05616728|66593591|FG001|Overall Study|Withdrawal by Subject|1|||
23785752|NCT05616728|66593592|FG002|Overall Study|Withdrawal by Subject|0|||
23346108|NCT02829723|65010918|FG013|Overall Study|Subject/guardian decision|0|||
23346109|NCT02829723|65010919|FG014|Overall Study|Subject/guardian decision|1|||
23346110|NCT02829723|65010920|FG015|Overall Study|Subject/guardian decision|0|||
23346111|NCT02829723|65010921|FG016|Overall Study|Subject/guardian decision|1|||
23457583|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457584|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457585|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
23457586|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457587|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457588|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457589|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457590|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457591|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
23457592|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457593|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457594|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457595|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457596|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457597|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457598|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457599|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
23457600|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457601|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457602|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457603|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457604|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457605|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
23457606|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457607|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457608|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457609|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457610|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457611|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457612|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
23457613|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457614|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457615|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457616|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457617|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457618|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457619|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
23457620|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457621|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457622|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457623|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457624|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457625|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457626|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
23457627|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457628|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457629|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457630|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457631|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457632|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457633|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
23457634|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457635|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457636|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457637|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23583592|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583593|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583594|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583595|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583596|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
23583597|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
23583598|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583599|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583600|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583601|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583602|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23785753|NCT05616728|66593590|FG000|Overall Study|Physician Decision|1|||
23785754|NCT05616728|66593591|FG001|Overall Study|Physician Decision|1|||
23457638|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457639|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457640|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
23457641|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457642|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457643|NCT00687596|65419010|FG000|Overall Study|Adverse Event (AE)|10|||
23457644|NCT00687596|65419011|FG001|Overall Study|Adverse Event (AE)|3|||
23457645|NCT00687596|65419010|FG000|Overall Study|Radiological Disease Progression|6|||
23457646|NCT00687596|65419011|FG001|Overall Study|Radiological Disease Progression|2|||
23457647|NCT00687596|65419010|FG000|Overall Study|Clinical Disease Progression|1|||
23457648|NCT00687596|65419011|FG001|Overall Study|Clinical Disease Progression|3|||
23457649|NCT00687596|65419010|FG000|Overall Study|Investigator Discretion|3|||
23457650|NCT00687596|65419011|FG001|Overall Study|Investigator Discretion|1|||
23457651|NCT00687596|65419010|FG000|Overall Study|Sponsor Terminated Study|6|||
23457652|NCT00687596|65419011|FG001|Overall Study|Sponsor Terminated Study|17|||
23457653|NCT03284710|65419013|FG000|Overall Study|Withdrawal by Subject|1|||
23457654|NCT03284710|65419014|FG001|Overall Study|Withdrawal by Subject|0|||
23457655|NCT03284710|65419015|FG002|Overall Study|Withdrawal by Subject|1|||
23457656|NCT03284710|65419016|FG003|Overall Study|Withdrawal by Subject|6|||
23457657|NCT03284710|65419013|FG000|Overall Study|Lost to Follow-up|3|||
23457658|NCT03284710|65419014|FG001|Overall Study|Lost to Follow-up|3|||
23457659|NCT03284710|65419015|FG002|Overall Study|Lost to Follow-up|1|||
23457660|NCT03284710|65419016|FG003|Overall Study|Lost to Follow-up|0|||
23457661|NCT03284710|65419013|FG000|Overall Study|Physician Decision|1|||
23457662|NCT03284710|65419014|FG001|Overall Study|Physician Decision|0|||
23457663|NCT03284710|65419015|FG002|Overall Study|Physician Decision|0|||
23457664|NCT03284710|65419016|FG003|Overall Study|Physician Decision|0|||
23457665|NCT03284710|65419013|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23457666|NCT03284710|65419014|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23457667|NCT03284710|65419015|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23457668|NCT03284710|65419016|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23457669|NCT03284710|65419013|FG000|Overall Study|HIV Infection|0|||
23457670|NCT03284710|65419014|FG001|Overall Study|HIV Infection|2|||
23457671|NCT03284710|65419015|FG002|Overall Study|HIV Infection|2|||
23457672|NCT03284710|65419016|FG003|Overall Study|HIV Infection|1|||
23457673|NCT04739982|65419017|FG000|Overall Study|Lost to Follow-up|176|||
23457674|NCT04739982|65419018|FG001|Overall Study|Lost to Follow-up|65|||
23457675|NCT04739982|65419017|FG000|Overall Study|Withdrawal by Subject|19|||
23457676|NCT04739982|65419018|FG001|Overall Study|Withdrawal by Subject|0|||
23457677|NCT04739982|65419017|FG000|Overall Study|Protocol Violation|0|||
23457678|NCT04739982|65419018|FG001|Overall Study|Protocol Violation|5|||
23457679|NCT02529852|65419019|FG000|Overall Study|Withdrawal by Subject|2|||
23457680|NCT04617782|65419026|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
23457681|NCT04617782|65419026|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
23457682|NCT04617782|65419026|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
23457683|NCT04617782|65419026|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
23457684|NCT04617782|65419026|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
23457685|NCT04617782|65419026|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
23457686|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
23457687|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
23457688|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
23457689|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457690|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457691|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457692|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457693|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
23457694|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457695|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457696|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457697|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457698|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457699|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23785755|NCT05616728|66593592|FG002|Overall Study|Physician Decision|1|||
23346112|NCT02829723|65010922|FG017|Overall Study|Subject/guardian decision|0|||
23457700|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457701|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
23457702|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23638202|NCT02550938|66060827|FG003|Overall Study|Lost to Follow-up|11|||
23785756|NCT05616728|66593590|FG000|Overall Study|Other|0|||
23346113|NCT02829723|65010923|FG018|Overall Study|Subject/guardian decision|1|||
23785757|NCT05616728|66593591|FG001|Overall Study|Other|2|||
23785758|NCT05616728|66593592|FG002|Overall Study|Other|0|||
23785759|NCT02627963|66593599|FG000|Overall Study|Randomized but not treated|2|||
23785760|NCT02627963|66593600|FG001|Overall Study|Randomized but not treated|6|||
23785761|NCT01642277|66593601|FG000|Overall Study|Adverse Event|10|||
23785762|NCT01642277|66593602|FG001|Overall Study|Adverse Event|0|||
23346114|NCT02829723|65010924|FG019|Overall Study|Subject/guardian decision|0|||
23346115|NCT02829723|65010925|FG020|Overall Study|Subject/guardian decision|1|||
23346116|NCT02829723|65010926|FG021|Overall Study|Subject/guardian decision|0|||
23346117|NCT02829723|65010927|FG022|Overall Study|Subject/guardian decision|0|||
23346118|NCT02829723|65010928|FG023|Overall Study|Subject/guardian decision|1|||
23346119|NCT02829723|65010929|FG024|Overall Study|Subject/guardian decision|0|||
23346120|NCT02829723|65010930|FG025|Overall Study|Subject/guardian decision|1|||
23346121|NCT02829723|65010931|FG026|Overall Study|Subject/guardian decision|1|||
23346122|NCT02829723|65010905|FG000|Overall Study|Study terminated by sponsor|0|||
23346123|NCT02829723|65010906|FG001|Overall Study|Study terminated by sponsor|0|||
23346124|NCT02829723|65010907|FG002|Overall Study|Study terminated by sponsor|0|||
23346125|NCT02829723|65010908|FG003|Overall Study|Study terminated by sponsor|0|||
23346126|NCT02829723|65010909|FG004|Overall Study|Study terminated by sponsor|0|||
23346127|NCT02829723|65010910|FG005|Overall Study|Study terminated by sponsor|0|||
23346128|NCT02829723|65010911|FG006|Overall Study|Study terminated by sponsor|0|||
23346129|NCT02829723|65010912|FG007|Overall Study|Study terminated by sponsor|0|||
23346130|NCT02829723|65010913|FG008|Overall Study|Study terminated by sponsor|0|||
23346131|NCT02829723|65010914|FG009|Overall Study|Study terminated by sponsor|0|||
23346132|NCT02829723|65010915|FG010|Overall Study|Study terminated by sponsor|0|||
23346133|NCT02829723|65010916|FG011|Overall Study|Study terminated by sponsor|0|||
23346134|NCT02829723|65010917|FG012|Overall Study|Study terminated by sponsor|0|||
23346135|NCT02829723|65010918|FG013|Overall Study|Study terminated by sponsor|0|||
23346136|NCT02829723|65010919|FG014|Overall Study|Study terminated by sponsor|0|||
23346137|NCT02829723|65010920|FG015|Overall Study|Study terminated by sponsor|0|||
23346138|NCT02829723|65010921|FG016|Overall Study|Study terminated by sponsor|0|||
23346139|NCT02829723|65010922|FG017|Overall Study|Study terminated by sponsor|0|||
23346140|NCT02829723|65010923|FG018|Overall Study|Study terminated by sponsor|0|||
23346141|NCT02829723|65010924|FG019|Overall Study|Study terminated by sponsor|0|||
23346142|NCT02829723|65010925|FG020|Overall Study|Study terminated by sponsor|0|||
23346143|NCT02829723|65010926|FG021|Overall Study|Study terminated by sponsor|1|||
23346144|NCT02829723|65010927|FG022|Overall Study|Study terminated by sponsor|0|||
23346145|NCT02829723|65010928|FG023|Overall Study|Study terminated by sponsor|0|||
23346146|NCT02829723|65010929|FG024|Overall Study|Study terminated by sponsor|0|||
23346147|NCT02829723|65010930|FG025|Overall Study|Study terminated by sponsor|0|||
23346148|NCT02829723|65010931|FG026|Overall Study|Study terminated by sponsor|0|||
23346149|NCT02294175|65010932|FG000|Overall Study|Withdrawal by Subject|1|||
23346150|NCT02294175|65010933|FG001|Overall Study|Withdrawal by Subject|2|||
23346151|NCT02294175|65010932|FG000|Overall Study|pt taking excluded medication|3|||
23346152|NCT02294175|65010933|FG001|Overall Study|pt taking excluded medication|1|||
23346153|NCT02294175|65010932|FG000|Overall Study|Protocol Violation|1|||
23346154|NCT02294175|65010933|FG001|Overall Study|Protocol Violation|0|||
23346155|NCT02294175|65010932|FG000|Overall Study|Lost to Follow-up|0|||
23785763|NCT01642277|66593601|FG000|Overall Study|Physician Decision|2|||
23785764|NCT01642277|66593602|FG001|Overall Study|Physician Decision|0|||
23785765|NCT01642277|66593601|FG000|Overall Study|Protocol Violation|1|||
23785766|NCT01642277|66593602|FG001|Overall Study|Protocol Violation|0|||
23785767|NCT01642277|66593601|FG000|Overall Study|Withdrawal by Subject|11|||
23785768|NCT01642277|66593602|FG001|Overall Study|Withdrawal by Subject|0|||
23785769|NCT02149420|66593603|FG000|Core Study|Administrative problems|0|||
23785770|NCT02149420|66593604|FG001|Core Study|Administrative problems|1|||
23785771|NCT02149420|66593605|FG002|Core Study|Administrative problems|2|||
23785772|NCT02149420|66593603|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
23785773|NCT02149420|66593604|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
23785774|NCT02149420|66593605|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
23785775|NCT00836472|66593608|FG000|Washout|Adverse Event|1|||
23785776|NCT00836472|66593609|FG001|Washout|Adverse Event|2|||
23785777|NCT00836472|66593608|FG000|Washout|Withdrawal by Subject|1|||
23785778|NCT00836472|66593609|FG001|Washout|Withdrawal by Subject|1|||
23785779|NCT04236596|66593614|FG000|Overall Study|Withdrawal by Subject|1|||
23785780|NCT04236596|66593614|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
23785781|NCT04236596|66593614|FG000|Overall Study|Participants did not receive implant at all|4|||
23785782|NCT04442503|66593620|FG000|Overall Study|Adverse Event|1|||
23785783|NCT04442503|66593621|FG001|Overall Study|Adverse Event|1|||
23785784|NCT04442503|66593620|FG000|Overall Study|Lost to Follow-up|8|||
23785785|NCT04442503|66593621|FG001|Overall Study|Lost to Follow-up|6|||
23785786|NCT04442503|66593620|FG000|Overall Study|Physician Decision|0|||
23785787|NCT04442503|66593621|FG001|Overall Study|Physician Decision|2|||
23785788|NCT04442503|66593620|FG000|Overall Study|Withdrawal by Subject|3|||
23785789|NCT04442503|66593621|FG001|Overall Study|Withdrawal by Subject|4|||
23457703|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457704|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457705|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457706|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457707|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23785790|NCT04442503|66593620|FG000|Overall Study|Reason not Specified|0|||
23785791|NCT04442503|66593621|FG001|Overall Study|Reason not Specified|1|||
23785792|NCT04442503|66593620|FG000|Overall Study|Randomized but not Treated|3|||
23583603|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583604|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23785793|NCT04442503|66593621|FG001|Overall Study|Randomized but not Treated|1|||
23785794|NCT00107991|66593624|FG000|Eligibility Assessment|Disease not severe enough|7|||
23785795|NCT00107991|66593624|FG000|Eligibility Assessment|Unwilling to participate|7|||
23785796|NCT00107991|66593624|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
23785797|NCT00107991|66593624|FG000|Eligibility Assessment|Abnormal labs|2|||
23785798|NCT00107991|66593624|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
23785799|NCT00107991|66593624|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
23785800|NCT00107991|66593624|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
23785801|NCT00107991|66593624|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
23785802|NCT00107991|66593624|FG000|12 Week Treatment Period|Adverse Event|1|||
23785803|NCT00107991|66593624|FG000|12 Week Treatment Period|Protocol Violation|1|||
23785804|NCT00107991|66593624|FG000|12 Week Treatment Period|Incarcerated|1|||
23785805|NCT00107991|66593624|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
23785806|NCT00840216|66593625|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23785807|NCT00840216|66593626|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23785808|NCT03106415|66593627|FG000|Phase 1|Withdrawal by Subject|1|||
23785809|NCT03106415|66593628|FG001|Phase 1|Withdrawal by Subject|0|||
23785810|NCT03106415|66593629|FG002|Phase 1|Withdrawal by Subject|0|||
23785811|NCT03106415|66593627|FG000|Phase 1|Adverse Event|1|||
23785812|NCT03106415|66593628|FG001|Phase 1|Adverse Event|1|||
23785813|NCT03106415|66593629|FG002|Phase 1|Adverse Event|0|||
23785814|NCT03106415|66593627|FG000|Phase 1|Protocol Violation|0|||
23785815|NCT03106415|66593628|FG001|Phase 1|Protocol Violation|1|||
23785816|NCT03106415|66593629|FG002|Phase 1|Protocol Violation|0|||
23785817|NCT00402103|66593630|FG000|Overall Study|Adverse Event|60|||
23785818|NCT00402103|66593631|FG001|Overall Study|Adverse Event|7|||
23785819|NCT00402103|66593630|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23583605|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583606|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583607|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583608|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583609|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23785820|NCT00402103|66593631|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23785821|NCT00402103|66593630|FG000|Overall Study|Condition no longer requires study drug|2|||
23785822|NCT00402103|66593631|FG001|Overall Study|Condition no longer requires study drug|0|||
23785823|NCT00402103|66593630|FG000|Overall Study|Protocol Deviation|8|||
23785824|NCT00402103|66593631|FG001|Overall Study|Protocol Deviation|0|||
23785825|NCT00402103|66593630|FG000|Overall Study|Patient withdrew consent|12|||
23785826|NCT00402103|66593631|FG001|Overall Study|Patient withdrew consent|1|||
23785827|NCT00402103|66593630|FG000|Overall Study|Lost to Follow-up|6|||
23785828|NCT00402103|66593631|FG001|Overall Study|Lost to Follow-up|3|||
23785829|NCT00402103|66593630|FG000|Overall Study|Administrative problems|2|||
23785830|NCT00402103|66593631|FG001|Overall Study|Administrative problems|0|||
23785831|NCT00059332|66593632|FG000|Overall Study|Withdrawal by Subject|2|||
23785832|NCT00059332|66593633|FG001|Overall Study|Withdrawal by Subject|1|||
23785833|NCT00059332|66593632|FG000|Overall Study|Lost to Follow-up|1|||
23583610|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
23583611|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
23583612|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583613|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583614|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583615|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23785834|NCT00059332|66593633|FG001|Overall Study|Lost to Follow-up|1|||
23638203|NCT03231800|66060832|FG000|Overall Study|Lost to Follow-up|0|||
23785835|NCT04887415|66593634|FG000|Overall Study|Lost to Follow-up|2|||
23785836|NCT00455312|66593636|FG000|Overall Study|Death|0|||
23785837|NCT00455312|66593637|FG001|Overall Study|Death|1|||
23785838|NCT00841542|66593638|FG000|Period 1|Adverse Event|1|||
23785839|NCT00841542|66593639|FG001|Period 1|Adverse Event|0|||
23785840|NCT00462345|66593640|FG000|Overall Study|Withdrawal by Subject|2|||
23785841|NCT00462345|66593640|FG000|Overall Study|Did not complete second course|1|||
23785842|NCT02055547|66593643|FG000|Overall Study|Protocol Violation|0|||
23785843|NCT02055547|66593644|FG001|Overall Study|Protocol Violation|0|||
23785844|NCT02055547|66593645|FG002|Overall Study|Protocol Violation|1|||
23785845|NCT02055547|66593646|FG003|Overall Study|Protocol Violation|0|||
23785846|NCT02055547|66593647|FG004|Overall Study|Protocol Violation|0|||
23785847|NCT02055547|66593648|FG005|Overall Study|Protocol Violation|0|||
23785848|NCT02055547|66593649|FG006|Overall Study|Protocol Violation|1|||
23785849|NCT02055547|66593650|FG007|Overall Study|Protocol Violation|0|||
23785850|NCT02055547|66593651|FG008|Overall Study|Protocol Violation|0|||
23785851|NCT02055547|66593652|FG009|Overall Study|Protocol Violation|0|||
23785852|NCT02055547|66593653|FG010|Overall Study|Protocol Violation|0|||
23785853|NCT02055547|66593654|FG011|Overall Study|Protocol Violation|0|||
23785854|NCT02055547|66593655|FG012|Overall Study|Protocol Violation|0|||
23785855|NCT02055547|66593656|FG013|Overall Study|Protocol Violation|0|||
23785856|NCT02055547|66593657|FG014|Overall Study|Protocol Violation|0|||
23785857|NCT02055547|66593658|FG015|Overall Study|Protocol Violation|0|||
23785858|NCT02055547|66593659|FG016|Overall Study|Protocol Violation|0|||
23785859|NCT02055547|66593660|FG017|Overall Study|Protocol Violation|0|||
23785860|NCT02055547|66593661|FG018|Overall Study|Protocol Violation|0|||
23785861|NCT02055547|66593643|FG000|Overall Study|Physician Decision|0|||
23785862|NCT02055547|66593644|FG001|Overall Study|Physician Decision|1|||
23785863|NCT02055547|66593645|FG002|Overall Study|Physician Decision|1|||
23785864|NCT02055547|66593646|FG003|Overall Study|Physician Decision|0|||
23785865|NCT02055547|66593647|FG004|Overall Study|Physician Decision|1|||
23785866|NCT02055547|66593648|FG005|Overall Study|Physician Decision|0|||
23457708|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457709|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
23457710|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457711|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457712|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457713|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457714|NCT05280717|65419027|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457715|NCT05280717|65419028|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457716|NCT05280717|65419029|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457717|NCT05280717|65419030|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457718|NCT05280717|65419031|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457719|NCT05280717|65419032|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
23457720|NCT05280717|65419033|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457721|NCT05280717|65419027|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457722|NCT05280717|65419028|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457723|NCT05280717|65419029|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457724|NCT05280717|65419030|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457725|NCT05280717|65419031|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457726|NCT05280717|65419032|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
23457727|NCT05280717|65419033|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457728|NCT02250326|65419034|FG000|Treatment|Death|1|||
23457729|NCT02250326|65419035|FG001|Treatment|Death|13|||
23457730|NCT02250326|65419036|FG002|Treatment|Death|2|||
23457731|NCT02250326|65419034|FG000|Treatment|Adverse Event|8|||
23457732|NCT02250326|65419035|FG001|Treatment|Adverse Event|8|||
23457733|NCT02250326|65419036|FG002|Treatment|Adverse Event|9|||
23457734|NCT02250326|65419034|FG000|Treatment|Progressive Disease|42|||
23457735|NCT02250326|65419035|FG001|Treatment|Progressive Disease|40|||
23457736|NCT02250326|65419036|FG002|Treatment|Progressive Disease|47|||
23457737|NCT02250326|65419034|FG000|Treatment|Symptomatic Deterioration|9|||
23457738|NCT02250326|65419035|FG001|Treatment|Symptomatic Deterioration|4|||
23457739|NCT02250326|65419036|FG002|Treatment|Symptomatic Deterioration|10|||
23457740|NCT02250326|65419034|FG000|Treatment|Withdrawal by Subject|11|||
23457741|NCT02250326|65419035|FG001|Treatment|Withdrawal by Subject|6|||
23457742|NCT02250326|65419036|FG002|Treatment|Withdrawal by Subject|4|||
23457743|NCT02250326|65419034|FG000|Treatment|Other reasons|8|||
23457744|NCT02250326|65419035|FG001|Treatment|Other reasons|7|||
23457745|NCT02250326|65419036|FG002|Treatment|Other reasons|7|||
23457746|NCT02250326|65419034|FG000|Extension Period|Progressive Disease|0|||
23457747|NCT02250326|65419035|FG001|Extension Period|Progressive Disease|2|||
23457748|NCT02250326|65419036|FG002|Extension Period|Progressive Disease|0|||
23457749|NCT02250326|65419034|FG000|Extension Period|Withdrawal by Subject|0|||
23457750|NCT02250326|65419035|FG001|Extension Period|Withdrawal by Subject|1|||
23457751|NCT02250326|65419036|FG002|Extension Period|Withdrawal by Subject|0|||
23457752|NCT02250326|65419034|FG000|Extension Period|Withdrawal by investigator|0|||
23785867|NCT02055547|66593649|FG006|Overall Study|Physician Decision|0|||
23785868|NCT02055547|66593650|FG007|Overall Study|Physician Decision|0|||
23785869|NCT02055547|66593651|FG008|Overall Study|Physician Decision|0|||
23785870|NCT02055547|66593652|FG009|Overall Study|Physician Decision|1|||
23785871|NCT02055547|66593653|FG010|Overall Study|Physician Decision|1|||
23785872|NCT02055547|66593654|FG011|Overall Study|Physician Decision|0|||
23785873|NCT02055547|66593655|FG012|Overall Study|Physician Decision|0|||
23785874|NCT02055547|66593656|FG013|Overall Study|Physician Decision|0|||
23785875|NCT02055547|66593657|FG014|Overall Study|Physician Decision|0|||
23785876|NCT02055547|66593658|FG015|Overall Study|Physician Decision|0|||
23785877|NCT02055547|66593659|FG016|Overall Study|Physician Decision|0|||
23785878|NCT02055547|66593660|FG017|Overall Study|Physician Decision|0|||
23785879|NCT02055547|66593661|FG018|Overall Study|Physician Decision|0|||
23346156|NCT02294175|65010933|FG001|Overall Study|Lost to Follow-up|1|||
23346157|NCT02294175|65010932|FG000|Overall Study|wound healed|0|||
23346158|NCT02294175|65010933|FG001|Overall Study|wound healed|2|||
23346159|NCT02892513|65010934|FG000|Overall Study|Withdrawal by Subject|0|||
23346160|NCT02892513|65010935|FG001|Overall Study|Withdrawal by Subject|1|||
23346161|NCT01298141|65010936|FG000|Overall Study|Adverse Event|3|||
23346162|NCT01298141|65010936|FG000|Overall Study|Refusal of Required Study Procedures|1|||
23346163|NCT01298141|65010936|FG000|Overall Study|Withdrawal by Subject|6|||
23457753|NCT02250326|65419035|FG001|Extension Period|Withdrawal by investigator|1|||
23457754|NCT02250326|65419036|FG002|Extension Period|Withdrawal by investigator|0|||
23785880|NCT02055547|66593643|FG000|Overall Study|Adverse Event|0|||
23785881|NCT02055547|66593644|FG001|Overall Study|Adverse Event|0|||
23785882|NCT02055547|66593645|FG002|Overall Study|Adverse Event|0|||
23785883|NCT02055547|66593646|FG003|Overall Study|Adverse Event|0|||
23785884|NCT02055547|66593647|FG004|Overall Study|Adverse Event|0|||
23346164|NCT01298141|65010936|FG000|Overall Study|Termination of Study by the Investigator|5|||
23346165|NCT01298141|65010936|FG000|Overall Study|Other|5|||
23346166|NCT01298141|65010936|FG000|Overall Study|Lost to Follow-up|1|||
23346167|NCT01298141|65010936|FG000|Overall Study|Death|6|||
23346168|NCT01298141|65010936|FG000|Overall Study|Not treated|4|||
23346169|NCT00115037|65010943|FG000|Phase1|Lost to Follow-up|16|||
23346170|NCT00115037|65010944|FG001|Phase1|Lost to Follow-up|23|||
23346171|NCT00115037|65010945|FG002|Phase1|Lost to Follow-up|0|||
23346172|NCT00115037|65010946|FG003|Phase1|Lost to Follow-up|0|||
23785885|NCT02055547|66593648|FG005|Overall Study|Adverse Event|0|||
23346173|NCT00115037|65010947|FG004|Phase1|Lost to Follow-up|0|||
23346174|NCT00115037|65010948|FG005|Phase1|Lost to Follow-up|0|||
23346175|NCT00115037|65010943|FG000|Phase1|Withdrawal by Subject|9|||
23346176|NCT00115037|65010944|FG001|Phase1|Withdrawal by Subject|4|||
23346177|NCT00115037|65010945|FG002|Phase1|Withdrawal by Subject|0|||
23346178|NCT00115037|65010946|FG003|Phase1|Withdrawal by Subject|0|||
23346179|NCT00115037|65010947|FG004|Phase1|Withdrawal by Subject|0|||
23346180|NCT00115037|65010948|FG005|Phase1|Withdrawal by Subject|0|||
23785886|NCT02055547|66593649|FG006|Overall Study|Adverse Event|1|||
23785887|NCT02055547|66593650|FG007|Overall Study|Adverse Event|0|||
23785888|NCT02055547|66593651|FG008|Overall Study|Adverse Event|1|||
23785889|NCT02055547|66593652|FG009|Overall Study|Adverse Event|0|||
23785890|NCT02055547|66593653|FG010|Overall Study|Adverse Event|0|||
23785891|NCT02055547|66593654|FG011|Overall Study|Adverse Event|0|||
23785892|NCT02055547|66593655|FG012|Overall Study|Adverse Event|0|||
23785893|NCT02055547|66593656|FG013|Overall Study|Adverse Event|0|||
23785894|NCT02055547|66593657|FG014|Overall Study|Adverse Event|0|||
23785895|NCT02055547|66593658|FG015|Overall Study|Adverse Event|0|||
23785896|NCT02055547|66593659|FG016|Overall Study|Adverse Event|0|||
23785897|NCT02055547|66593660|FG017|Overall Study|Adverse Event|0|||
23785898|NCT02055547|66593661|FG018|Overall Study|Adverse Event|0|||
23785899|NCT02055547|66593643|FG000|Overall Study|Withdrawal by Subject|0|||
23785900|NCT02055547|66593644|FG001|Overall Study|Withdrawal by Subject|0|||
23785901|NCT02055547|66593645|FG002|Overall Study|Withdrawal by Subject|0|||
23785902|NCT02055547|66593646|FG003|Overall Study|Withdrawal by Subject|0|||
23785903|NCT02055547|66593647|FG004|Overall Study|Withdrawal by Subject|0|||
23785904|NCT02055547|66593648|FG005|Overall Study|Withdrawal by Subject|1|||
23785905|NCT02055547|66593649|FG006|Overall Study|Withdrawal by Subject|0|||
23785906|NCT02055547|66593650|FG007|Overall Study|Withdrawal by Subject|0|||
23785907|NCT02055547|66593651|FG008|Overall Study|Withdrawal by Subject|1|||
23785908|NCT02055547|66593652|FG009|Overall Study|Withdrawal by Subject|0|||
23785909|NCT02055547|66593653|FG010|Overall Study|Withdrawal by Subject|0|||
23785910|NCT02055547|66593654|FG011|Overall Study|Withdrawal by Subject|0|||
23785911|NCT02055547|66593655|FG012|Overall Study|Withdrawal by Subject|0|||
23785912|NCT02055547|66593656|FG013|Overall Study|Withdrawal by Subject|1|||
23785913|NCT02055547|66593657|FG014|Overall Study|Withdrawal by Subject|0|||
23785914|NCT02055547|66593658|FG015|Overall Study|Withdrawal by Subject|1|||
23785915|NCT02055547|66593659|FG016|Overall Study|Withdrawal by Subject|0|||
23785916|NCT02055547|66593660|FG017|Overall Study|Withdrawal by Subject|0|||
23785917|NCT02055547|66593661|FG018|Overall Study|Withdrawal by Subject|0|||
23785918|NCT02055547|66593643|FG000|Overall Study|Lost to Follow-up|0|||
23785919|NCT02055547|66593644|FG001|Overall Study|Lost to Follow-up|0|||
23785920|NCT02055547|66593645|FG002|Overall Study|Lost to Follow-up|1|||
23785921|NCT02055547|66593646|FG003|Overall Study|Lost to Follow-up|0|||
23785922|NCT02055547|66593647|FG004|Overall Study|Lost to Follow-up|0|||
23785923|NCT02055547|66593648|FG005|Overall Study|Lost to Follow-up|0|||
23785924|NCT02055547|66593649|FG006|Overall Study|Lost to Follow-up|0|||
23346181|NCT00115037|65010943|FG000|Phase2|Death|0|||
23346182|NCT00115037|65010944|FG001|Phase2|Death|0|||
23346183|NCT00115037|65010945|FG002|Phase2|Death|1|||
23346184|NCT00115037|65010946|FG003|Phase2|Death|0|||
23346185|NCT00115037|65010947|FG004|Phase2|Death|0|||
23346186|NCT00115037|65010948|FG005|Phase2|Death|1|||
23346187|NCT00115037|65010943|FG000|Phase2|Withdrawal by Subject|0|||
23457755|NCT02340026|65419040|FG000|Treatment Phase|Withdrawal by Subject|2|||
23457756|NCT02340026|65419041|FG001|Treatment Phase|Withdrawal by Subject|2|||
23346188|NCT00115037|65010944|FG001|Phase2|Withdrawal by Subject|0|||
23346189|NCT00115037|65010945|FG002|Phase2|Withdrawal by Subject|2|||
23785925|NCT02055547|66593650|FG007|Overall Study|Lost to Follow-up|0|||
23785926|NCT02055547|66593651|FG008|Overall Study|Lost to Follow-up|0|||
23785927|NCT02055547|66593652|FG009|Overall Study|Lost to Follow-up|0|||
23785928|NCT02055547|66593653|FG010|Overall Study|Lost to Follow-up|0|||
23346190|NCT00115037|65010946|FG003|Phase2|Withdrawal by Subject|1|||
23346191|NCT00115037|65010947|FG004|Phase2|Withdrawal by Subject|2|||
23785929|NCT02055547|66593654|FG011|Overall Study|Lost to Follow-up|0|||
23785930|NCT02055547|66593655|FG012|Overall Study|Lost to Follow-up|0|||
23785931|NCT02055547|66593656|FG013|Overall Study|Lost to Follow-up|0|||
23785932|NCT02055547|66593657|FG014|Overall Study|Lost to Follow-up|0|||
23785933|NCT02055547|66593658|FG015|Overall Study|Lost to Follow-up|0|||
23785934|NCT02055547|66593659|FG016|Overall Study|Lost to Follow-up|0|||
23785935|NCT02055547|66593660|FG017|Overall Study|Lost to Follow-up|0|||
23346192|NCT00115037|65010948|FG005|Phase2|Withdrawal by Subject|1|||
23346193|NCT00115037|65010943|FG000|Phase2|Lost to Follow-up|0|||
23346194|NCT00115037|65010944|FG001|Phase2|Lost to Follow-up|0|||
23346195|NCT00115037|65010945|FG002|Phase2|Lost to Follow-up|12|||
23346196|NCT00115037|65010946|FG003|Phase2|Lost to Follow-up|14|||
23346197|NCT00115037|65010947|FG004|Phase2|Lost to Follow-up|4|||
23346198|NCT00115037|65010948|FG005|Phase2|Lost to Follow-up|10|||
23346199|NCT01500213|65010949|FG000|Overall Study|Adverse Event|35|||
23346200|NCT01500213|65010950|FG001|Overall Study|Adverse Event|35|||
23346201|NCT01500213|65010949|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
23346202|NCT01500213|65010950|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
23346203|NCT01500213|65010949|FG000|Overall Study|Withdrawal by Subject|28|||
23346204|NCT01500213|65010950|FG001|Overall Study|Withdrawal by Subject|37|||
23346205|NCT01500213|65010949|FG000|Overall Study|Death|7|||
23346206|NCT01500213|65010950|FG001|Overall Study|Death|3|||
23346207|NCT01500213|65010949|FG000|Overall Study|Disease Progression|13|||
23346208|NCT01500213|65010950|FG001|Overall Study|Disease Progression|21|||
23346209|NCT01500213|65010949|FG000|Overall Study|Protocol Violation|19|||
23346210|NCT01500213|65010950|FG001|Overall Study|Protocol Violation|19|||
23346211|NCT01500213|65010949|FG000|Overall Study|Physician Decision|12|||
23346212|NCT01500213|65010950|FG001|Overall Study|Physician Decision|10|||
23346213|NCT01500213|65010949|FG000|Overall Study|Lack of Efficacy|9|||
23346214|NCT01500213|65010950|FG001|Overall Study|Lack of Efficacy|7|||
23346215|NCT01500213|65010949|FG000|Overall Study|Lost to Follow-up|3|||
23346216|NCT01500213|65010950|FG001|Overall Study|Lost to Follow-up|6|||
23346217|NCT01500213|65010949|FG000|Overall Study|Other Reasons|7|||
23346218|NCT01500213|65010950|FG001|Overall Study|Other Reasons|5|||
23346219|NCT01001598|65010951|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
23346220|NCT01001598|65010951|FG000|Overall Study|Adverse Event|1|||
23457757|NCT02340026|65419040|FG000|Follow-up Phase|Lost to Follow-up|1|||
23457758|NCT02340026|65419041|FG001|Follow-up Phase|Lost to Follow-up|0|||
23346221|NCT00090987|65010952|FG000|Overall Study|Adverse Event|5|||
23346222|NCT00090987|65010952|FG000|Overall Study|Lack of Efficacy|7|||
23346223|NCT00090987|65010952|FG000|Overall Study|Withdrawal by Subject|3|||
23346224|NCT00090987|65010952|FG000|Overall Study|alternative therapy|1|||
23346225|NCT00090987|65010952|FG000|Overall Study|Non-compliance|4|||
23346226|NCT00090987|65010952|FG000|Overall Study|Incarcerated|1|||
23346227|NCT04331067|65010953|FG000|Overall Study|Adverse Event|1|||
23346228|NCT04331067|65010954|FG001|Overall Study|Adverse Event|3|||
23346229|NCT04331067|65010955|FG002|Overall Study|Adverse Event|1|||
23785936|NCT02055547|66593661|FG018|Overall Study|Lost to Follow-up|0|||
23346230|NCT04331067|65010953|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
23346231|NCT04331067|65010954|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
23457759|NCT04038359|65419042|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
23785937|NCT03285594|66593662|FG000|Overall Study|At the Participant's Own Request|10|||
23785938|NCT03285594|66593663|FG001|Overall Study|At the Participant's Own Request|5|||
23785939|NCT03285594|66593664|FG002|Overall Study|At the Participant's Own Request|21|||
23785940|NCT03285594|66593662|FG000|Overall Study|Adverse Event|2|||
23785941|NCT03285594|66593663|FG001|Overall Study|Adverse Event|2|||
23785942|NCT03285594|66593664|FG002|Overall Study|Adverse Event|6|||
23785943|NCT03285594|66593662|FG000|Overall Study|Poor Compliance to Protocol|0|||
23785944|NCT03285594|66593663|FG001|Overall Study|Poor Compliance to Protocol|0|||
23785945|NCT03285594|66593664|FG002|Overall Study|Poor Compliance to Protocol|1|||
23785946|NCT03285594|66593662|FG000|Overall Study|Lost to Follow-up|0|||
23785947|NCT03285594|66593663|FG001|Overall Study|Lost to Follow-up|0|||
23785948|NCT03285594|66593664|FG002|Overall Study|Lost to Follow-up|1|||
23785949|NCT03285594|66593662|FG000|Overall Study|Reason Not Specified|3|||
23785950|NCT03285594|66593663|FG001|Overall Study|Reason Not Specified|4|||
23785951|NCT03285594|66593664|FG002|Overall Study|Reason Not Specified|8|||
23785952|NCT00606281|66593665|FG000|Overall Study|Adverse Event|11|||
23785953|NCT00606281|66593666|FG001|Overall Study|Adverse Event|12|||
23785954|NCT00606281|66593665|FG000|Overall Study|Death|1|||
23785955|NCT00606281|66593666|FG001|Overall Study|Death|0|||
23785956|NCT00606281|66593665|FG000|Overall Study|Lack of Efficacy|28|||
23785957|NCT00606281|66593666|FG001|Overall Study|Lack of Efficacy|35|||
23785958|NCT00606281|66593665|FG000|Overall Study|Physician Decision|0|||
23785959|NCT00606281|66593666|FG001|Overall Study|Physician Decision|1|||
23785960|NCT00606281|66593665|FG000|Overall Study|Protocol Violation|3|||
23785961|NCT00606281|66593666|FG001|Overall Study|Protocol Violation|3|||
23785962|NCT00606281|66593665|FG000|Overall Study|Withdrawal by Subject|11|||
23638204|NCT03231800|66060833|FG001|Overall Study|Lost to Follow-up|2|||
23638205|NCT03231800|66060832|FG000|Overall Study|Protocol Violation|1|||
23638206|NCT03231800|66060833|FG001|Overall Study|Protocol Violation|1|||
23346232|NCT04331067|65010955|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
23346233|NCT00937040|65010956|FG000|Overall Study|Adverse Event|5|||
23346234|NCT00937040|65010957|FG001|Overall Study|Adverse Event|8|||
23346235|NCT00937040|65010956|FG000|Overall Study|Lost to Follow-up|12|||
23346236|NCT00937040|65010957|FG001|Overall Study|Lost to Follow-up|12|||
23346237|NCT00937040|65010956|FG000|Overall Study|Protocol Violation|3|||
23346238|NCT00937040|65010957|FG001|Overall Study|Protocol Violation|0|||
23346239|NCT00937040|65010956|FG000|Overall Study|Withdrawal by Subject|13|||
23346240|NCT00937040|65010957|FG001|Overall Study|Withdrawal by Subject|7|||
23346241|NCT00937040|65010956|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
23346242|NCT00937040|65010957|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
23346243|NCT00937040|65010956|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
23346244|NCT00937040|65010957|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
23346245|NCT02386345|65010958|FG000|Overall Study|Not treated|14|||
23346246|NCT02386345|65010958|FG000|Overall Study|Lost to Follow-up|1|||
23346247|NCT02386345|65010958|FG000|Overall Study|Adverse Event|5|||
23346248|NCT02386345|65010958|FG000|Overall Study|Repeat Procedure|10|||
23346249|NCT02386345|65010958|FG000|Overall Study|Did not complete 12-month follow-up|72|||
23346250|NCT02638259|65010959|FG000|Treatment Period 1|Adverse Event|1|||
23346251|NCT02638259|65010960|FG001|Treatment Period 1|Adverse Event|5|||
23346252|NCT02638259|65010959|FG000|Treatment Period 1|Death|0|||
23346253|NCT02638259|65010960|FG001|Treatment Period 1|Death|1|||
23346254|NCT02638259|65010959|FG000|Treatment Period 1|Lack of Efficacy|0|||
23346255|NCT02638259|65010960|FG001|Treatment Period 1|Lack of Efficacy|1|||
23346256|NCT02638259|65010959|FG000|Treatment Period 1|Protocol Violation|0|||
23346257|NCT02638259|65010960|FG001|Treatment Period 1|Protocol Violation|3|||
23346258|NCT02638259|65010959|FG000|Treatment Period 1|Withdrawal by Subject|4|||
23346259|NCT02638259|65010960|FG001|Treatment Period 1|Withdrawal by Subject|6|||
23346260|NCT02638259|65010959|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
23346261|NCT02638259|65010960|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
23346262|NCT02638259|65010959|FG000|Treatment Period 2|Adverse Event|5|||
23346263|NCT02638259|65010960|FG001|Treatment Period 2|Adverse Event|4|||
23346264|NCT02638259|65010959|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23346265|NCT02638259|65010960|FG001|Treatment Period 2|Withdrawal by Subject|7|||
23346266|NCT03408444|65010961|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
23346267|NCT03408444|65010962|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346268|NCT03408444|65010963|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346269|NCT03408444|65010964|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346270|NCT03408444|65010961|FG000|Overall Study|Lens Discomfort|0|||
23346271|NCT03408444|65010962|FG001|Overall Study|Lens Discomfort|1|||
23346272|NCT03408444|65010963|FG002|Overall Study|Lens Discomfort|0|||
23346273|NCT03408444|65010964|FG003|Overall Study|Lens Discomfort|0|||
23346274|NCT03408444|65010961|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346275|NCT03408444|65010962|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346276|NCT03408444|65010963|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23346277|NCT03408444|65010964|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346278|NCT03408444|65010961|FG000|Overall Study|Withdrawal by Subject|0|||
23346279|NCT03408444|65010962|FG001|Overall Study|Withdrawal by Subject|2|||
23346280|NCT03408444|65010963|FG002|Overall Study|Withdrawal by Subject|3|||
23346281|NCT03408444|65010964|FG003|Overall Study|Withdrawal by Subject|0|||
23346282|NCT03408444|65010961|FG000|Overall Study|Lost to Follow-up|0|||
23346283|NCT03408444|65010962|FG001|Overall Study|Lost to Follow-up|0|||
23346284|NCT03408444|65010963|FG002|Overall Study|Lost to Follow-up|1|||
23346285|NCT03408444|65010964|FG003|Overall Study|Lost to Follow-up|0|||
23346286|NCT03408444|65010961|FG000|Overall Study|Adverse Event|0|||
23346287|NCT03408444|65010962|FG001|Overall Study|Adverse Event|0|||
23346288|NCT03408444|65010963|FG002|Overall Study|Adverse Event|0|||
23346289|NCT03408444|65010964|FG003|Overall Study|Adverse Event|1|||
23346290|NCT03408444|65010961|FG000|Overall Study|Lens Handling Difficulties|0|||
23346291|NCT03408444|65010962|FG001|Overall Study|Lens Handling Difficulties|0|||
23346292|NCT03408444|65010963|FG002|Overall Study|Lens Handling Difficulties|1|||
23346293|NCT03408444|65010964|FG003|Overall Study|Lens Handling Difficulties|0|||
23638207|NCT03231800|66060832|FG000|Overall Study|reason not provided|2|||
23346294|NCT03408444|65010961|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346295|NCT03408444|65010962|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346296|NCT03408444|65010963|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346297|NCT03408444|65010964|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
23346298|NCT00769067|65010967|FG000|Overall Study|Death|89|||
23346299|NCT00769067|65010968|FG001|Overall Study|Death|86|||
23346300|NCT00769067|65010967|FG000|Overall Study|Lost to Follow-up|3|||
23346301|NCT00769067|65010968|FG001|Overall Study|Lost to Follow-up|1|||
23346302|NCT00769067|65010967|FG000|Overall Study|Study terminated by sponsor|1|||
23346303|NCT00769067|65010968|FG001|Overall Study|Study terminated by sponsor|3|||
23346304|NCT00769067|65010967|FG000|Overall Study|Other|1|||
23346305|NCT00769067|65010968|FG001|Overall Study|Other|3|||
23346306|NCT00769067|65010967|FG000|Overall Study|Withdrawal by Subject|0|||
23346307|NCT00769067|65010968|FG001|Overall Study|Withdrawal by Subject|1|||
23346308|NCT01573767|65010969|FG000|Overall Study|Adverse Event|0|||
23346309|NCT01573767|65010970|FG001|Overall Study|Adverse Event|1|||
23346310|NCT01573767|65010971|FG002|Overall Study|Adverse Event|0|||
23346311|NCT01573767|65010972|FG003|Overall Study|Adverse Event|1|||
23346312|NCT01573767|65010969|FG000|Overall Study|Lack of Efficacy|18|||
23346313|NCT01573767|65010970|FG001|Overall Study|Lack of Efficacy|15|||
23346314|NCT01573767|65010971|FG002|Overall Study|Lack of Efficacy|12|||
23346315|NCT01573767|65010972|FG003|Overall Study|Lack of Efficacy|17|||
23346316|NCT01573767|65010969|FG000|Overall Study|Protocol Violation|3|||
23346317|NCT01573767|65010970|FG001|Overall Study|Protocol Violation|1|||
23346318|NCT01573767|65010971|FG002|Overall Study|Protocol Violation|1|||
23346319|NCT01573767|65010972|FG003|Overall Study|Protocol Violation|3|||
23346320|NCT01573767|65010969|FG000|Overall Study|Lost to Follow-up|0|||
23346321|NCT01573767|65010970|FG001|Overall Study|Lost to Follow-up|1|||
23346322|NCT01573767|65010971|FG002|Overall Study|Lost to Follow-up|1|||
23346323|NCT01573767|65010972|FG003|Overall Study|Lost to Follow-up|1|||
23346324|NCT01573767|65010969|FG000|Overall Study|Physician Decision|1|||
23346325|NCT01573767|65010970|FG001|Overall Study|Physician Decision|2|||
23346326|NCT01573767|65010971|FG002|Overall Study|Physician Decision|0|||
23346327|NCT01573767|65010972|FG003|Overall Study|Physician Decision|2|||
23346328|NCT01573767|65010969|FG000|Overall Study|Withdrawal by Subject|0|||
23346329|NCT01573767|65010970|FG001|Overall Study|Withdrawal by Subject|1|||
23346330|NCT01573767|65010971|FG002|Overall Study|Withdrawal by Subject|0|||
23346331|NCT01573767|65010972|FG003|Overall Study|Withdrawal by Subject|0|||
23346332|NCT00835679|65010973|FG000|Overall Study|Withdrawal by Subject|1|||
23346333|NCT00835679|65010974|FG001|Overall Study|Withdrawal by Subject|0|||
23346334|NCT00835679|65010975|FG002|Overall Study|Withdrawal by Subject|0|||
23346335|NCT00835679|65010976|FG003|Overall Study|Withdrawal by Subject|0|||
23346336|NCT00477607|65010977|FG000|Overall Study|Lost to Follow-up|7|||
23346337|NCT00477607|65010978|FG001|Overall Study|Lost to Follow-up|7|||
23346338|NCT00358956|65010979|FG000|Overall Study|Adverse Event|3|||
23346339|NCT00358956|65010979|FG000|Overall Study|condition under investigation worsened|4|||
23346340|NCT00358956|65010979|FG000|Overall Study|Withdrawal by Subject|1|||
23785963|NCT00606281|66593666|FG001|Overall Study|Withdrawal by Subject|13|||
23346341|NCT02543892|65010988|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
23346342|NCT02543892|65010989|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23346343|NCT02543892|65010990|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
23346344|NCT02543892|65010991|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23785964|NCT00606281|66593665|FG000|Overall Study|Progression to depressive phase|1|||
23785965|NCT00606281|66593666|FG001|Overall Study|Progression to depressive phase|1|||
23785966|NCT00606281|66593665|FG000|Overall Study|Change of residence or other commitments|1|||
23346345|NCT02543892|65010992|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23346346|NCT02543892|65010993|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
23346347|NCT02543892|65010994|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
23346348|NCT02543892|65010995|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
23346349|NCT02543892|65010988|FG000|Received Vaccination 2|Physician Decision|0|||
23346350|NCT02543892|65010989|FG001|Received Vaccination 2|Physician Decision|0|||
23346351|NCT02543892|65010990|FG002|Received Vaccination 2|Physician Decision|0|||
23346352|NCT02543892|65010991|FG003|Received Vaccination 2|Physician Decision|0|||
23346353|NCT02543892|65010992|FG004|Received Vaccination 2|Physician Decision|0|||
23346354|NCT02543892|65010993|FG005|Received Vaccination 2|Physician Decision|1|||
23785967|NCT00606281|66593666|FG001|Overall Study|Change of residence or other commitments|1|||
23346355|NCT02543892|65010994|FG006|Received Vaccination 2|Physician Decision|0|||
23346356|NCT02543892|65010995|FG007|Received Vaccination 2|Physician Decision|0|||
23346357|NCT02543892|65010988|FG000|Received Vaccination 2|Adverse Event|0|||
23346358|NCT02543892|65010989|FG001|Received Vaccination 2|Adverse Event|1|||
23346359|NCT02543892|65010990|FG002|Received Vaccination 2|Adverse Event|0|||
23346360|NCT02543892|65010991|FG003|Received Vaccination 2|Adverse Event|0|||
23346361|NCT02543892|65010992|FG004|Received Vaccination 2|Adverse Event|0|||
23346362|NCT02543892|65010993|FG005|Received Vaccination 2|Adverse Event|0|||
23346363|NCT02543892|65010994|FG006|Received Vaccination 2|Adverse Event|0|||
23785968|NCT02854800|66593669|FG000|Overall Study|Protocol Violation|16|||
23346364|NCT02543892|65010995|FG007|Received Vaccination 2|Adverse Event|0|||
23346365|NCT02543892|65010988|FG000|Had Immunology Data|Withdrawal by Subject|0|||
23346366|NCT02543892|65010989|FG001|Had Immunology Data|Withdrawal by Subject|0|||
23346367|NCT02543892|65010990|FG002|Had Immunology Data|Withdrawal by Subject|0|||
23346368|NCT02543892|65010991|FG003|Had Immunology Data|Withdrawal by Subject|0|||
23346369|NCT02543892|65010992|FG004|Had Immunology Data|Withdrawal by Subject|0|||
23346370|NCT02543892|65010993|FG005|Had Immunology Data|Withdrawal by Subject|0|||
23346371|NCT02543892|65010994|FG006|Had Immunology Data|Withdrawal by Subject|1|||
23346372|NCT02543892|65010995|FG007|Had Immunology Data|Withdrawal by Subject|0|||
23346373|NCT01430624|65010996|FG000|Overall Study|Lost to Follow-up|23|||
23346374|NCT01430624|65010997|FG001|Overall Study|Lost to Follow-up|29|||
23346375|NCT01430624|65010998|FG002|Overall Study|Lost to Follow-up|27|||
23346376|NCT01430624|65010996|FG000|Overall Study|technical or eligibility|5|||
23346377|NCT01430624|65010997|FG001|Overall Study|technical or eligibility|5|||
23346378|NCT01430624|65010998|FG002|Overall Study|technical or eligibility|2|||
23346379|NCT00108485|65010999|FG000|Overall Study|Withdrawal by Subject|3|||
23346380|NCT00108485|65011000|FG001|Overall Study|Withdrawal by Subject|0|||
23346381|NCT00108485|65010999|FG000|Overall Study|Lost to Follow-up|0|||
23346382|NCT00108485|65011000|FG001|Overall Study|Lost to Follow-up|2|||
23346383|NCT01097421|65011001|FG000|Overall Study|Adverse Event|8|||
23346384|NCT01097421|65011001|FG000|Overall Study|Protocol Violation|2|||
23346385|NCT01097421|65011001|FG000|Overall Study|Lost to Follow-up|1|||
23346386|NCT01097421|65011001|FG000|Overall Study|Withdrawal by Subject|3|||
23346387|NCT00467961|65011008|FG000|Overall Study|Technical Failures|5|||
23346388|NCT00467961|65011008|FG000|Overall Study|Disease Progression|2|||
23346389|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
23346390|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346391|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
23346392|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
23346393|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346394|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346395|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Other|0|||
23346396|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Other|0|||
23346397|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Other|1|||
23346398|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Other|0|||
23346399|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Other|0|||
23346400|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Other|0|||
23346401|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346402|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
23346403|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346404|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346405|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346406|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346407|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
23346408|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
23346409|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23346410|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
23346411|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23346412|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23583616|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23346413|NCT02122770|65011009|FG000|Part B: Standard of Care|Adverse Event|0|||
23346414|NCT02122770|65011010|FG001|Part B: Standard of Care|Adverse Event|0|||
23346415|NCT02122770|65011011|FG002|Part B: Standard of Care|Adverse Event|0|||
23346416|NCT02122770|65011012|FG003|Part B: Standard of Care|Adverse Event|0|||
23346417|NCT02122770|65011013|FG004|Part B: Standard of Care|Adverse Event|4|||
23346418|NCT02122770|65011014|FG005|Part B: Standard of Care|Adverse Event|1|||
23346419|NCT02122770|65011009|FG000|Part B: Standard of Care|Other|0|||
23346420|NCT02122770|65011010|FG001|Part B: Standard of Care|Other|0|||
23346421|NCT02122770|65011011|FG002|Part B: Standard of Care|Other|0|||
23346422|NCT02122770|65011012|FG003|Part B: Standard of Care|Other|0|||
23346423|NCT02122770|65011013|FG004|Part B: Standard of Care|Other|0|||
23346424|NCT02122770|65011014|FG005|Part B: Standard of Care|Other|2|||
23346425|NCT02122770|65011009|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
23346426|NCT02122770|65011010|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
23346427|NCT02122770|65011011|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
23346428|NCT02122770|65011012|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
23346429|NCT02122770|65011013|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
23346430|NCT02122770|65011014|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
23346431|NCT02122770|65011009|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346432|NCT02122770|65011010|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346433|NCT02122770|65011011|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346434|NCT02122770|65011012|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346435|NCT02122770|65011013|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
23346436|NCT02122770|65011014|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
23785969|NCT02854800|66593670|FG001|Overall Study|Protocol Violation|11|||
23785970|NCT02854800|66593671|FG002|Overall Study|Protocol Violation|3|||
23785971|NCT02854800|66593669|FG000|Overall Study|Withdrawal by Subject|4|||
23785972|NCT02854800|66593670|FG001|Overall Study|Withdrawal by Subject|2|||
23785973|NCT02854800|66593671|FG002|Overall Study|Withdrawal by Subject|3|||
23346437|NCT02122770|65011009|FG000|Part B: Standard of Care|Progressive Disease|0|||
23346438|NCT02122770|65011010|FG001|Part B: Standard of Care|Progressive Disease|0|||
23346439|NCT02122770|65011011|FG002|Part B: Standard of Care|Progressive Disease|0|||
23346440|NCT02122770|65011012|FG003|Part B: Standard of Care|Progressive Disease|0|||
23346441|NCT02122770|65011013|FG004|Part B: Standard of Care|Progressive Disease|10|||
23346442|NCT02122770|65011014|FG005|Part B: Standard of Care|Progressive Disease|8|||
23346443|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
23346444|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
23346445|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
23346446|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
23785974|NCT00573443|66593672|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23785975|NCT00573443|66593673|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23346447|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
23346448|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346449|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346450|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346451|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
23346452|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
23785976|NCT00573443|66593674|FG002|Double-Blind Phase|Lost to Follow-up|2|||
23785977|NCT00573443|66593672|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
23785978|NCT00573443|66593673|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
23785979|NCT00573443|66593674|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
23346453|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
23346454|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
23346455|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Death|0|||
23346456|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Death|0|||
23346457|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Death|1|||
23346458|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Death|0|||
23346459|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346460|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
23346461|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346462|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346463|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
23346464|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
23785980|NCT00573443|66593672|FG000|Double-Blind Phase|Adverse Event|1|||
23785981|NCT00573443|66593673|FG001|Double-Blind Phase|Adverse Event|5|||
23785982|NCT00573443|66593674|FG002|Double-Blind Phase|Adverse Event|0|||
23785983|NCT00573443|66593672|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
23346465|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
23346466|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
23457760|NCT04038359|65419043|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
23638208|NCT03231800|66060833|FG001|Overall Study|reason not provided|0|||
23785984|NCT00573443|66593673|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
23785985|NCT00573443|66593674|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
23785986|NCT00573443|66593672|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
23785987|NCT00573443|66593673|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
23785988|NCT00573443|66593674|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
23785989|NCT00573443|66593672|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23785990|NCT00573443|66593673|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
23785991|NCT00573443|66593674|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
23346467|NCT01179737|65011019|FG000|Extension|The study was terminated|3|||
23346468|NCT01179737|65011020|FG001|Extension|The study was terminated|0|||
23346469|NCT01179737|65011021|FG002|Extension|The study was terminated|0|||
23346470|NCT01179737|65011022|FG003|Extension|The study was terminated|0|||
23346471|NCT01459718|65011023|FG000|Overall Study|Physician Decision|1|||
23346472|NCT01459718|65011023|FG000|Overall Study|Lost to Follow-up|1|||
23785992|NCT00573443|66593672|FG000|Double-Blind Phase|Protocol Violation|0|||
23785993|NCT00573443|66593673|FG001|Double-Blind Phase|Protocol Violation|2|||
23785994|NCT00573443|66593674|FG002|Double-Blind Phase|Protocol Violation|1|||
23785995|NCT00573443|66593672|FG000|Double-Blind Phase|Other|0|||
23785996|NCT00573443|66593673|FG001|Double-Blind Phase|Other|2|||
23785997|NCT00573443|66593674|FG002|Double-Blind Phase|Other|3|||
23785998|NCT00573443|66593672|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
23785999|NCT00573443|66593673|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23786000|NCT00573443|66593674|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23786001|NCT00573443|66593672|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
23786002|NCT00573443|66593673|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
23786003|NCT00573443|66593674|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
23786004|NCT00573443|66593672|FG000|Open-Label Extension Phase|Adverse Event|3|||
23786005|NCT00573443|66593673|FG001|Open-Label Extension Phase|Adverse Event|0|||
23346473|NCT01459718|65011023|FG000|Overall Study|Adverse Event|1|||
23346474|NCT02620384|65011024|FG000|Overall Study|Adverse Event|2|||
23346475|NCT02620384|65011025|FG001|Overall Study|Adverse Event|1|||
23346476|NCT02620384|65011024|FG000|Overall Study|Discharged prior to 2nd dose|2|||
23346477|NCT02620384|65011025|FG001|Overall Study|Discharged prior to 2nd dose|5|||
23346478|NCT02620384|65011024|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
23346479|NCT02620384|65011025|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
23346480|NCT03802565|65011028|FG000|Overall Study|Adverse Event|0|||
23346481|NCT03802565|65011029|FG001|Overall Study|Adverse Event|1|||
23786006|NCT00573443|66593674|FG002|Open-Label Extension Phase|Adverse Event|0|||
23786007|NCT00573443|66593672|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
23786008|NCT00573443|66593673|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
23786009|NCT00573443|66593674|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
23786010|NCT00573443|66593672|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
23786011|NCT00573443|66593673|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
23786012|NCT00573443|66593674|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23786013|NCT00573443|66593672|FG000|Open-Label Extension Phase|Protocol Violation|2|||
23786014|NCT00573443|66593673|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23786015|NCT00573443|66593674|FG002|Open-Label Extension Phase|Protocol Violation|0|||
23786016|NCT00573443|66593672|FG000|Open-Label Extension Phase|Other|2|||
23786017|NCT00573443|66593673|FG001|Open-Label Extension Phase|Other|0|||
23786018|NCT00573443|66593674|FG002|Open-Label Extension Phase|Other|0|||
23786019|NCT01863745|66593675|FG000|Overall Study|Disease Progression|9|||
23786020|NCT01863745|66593675|FG000|Overall Study|Adverse Event|2|||
23786021|NCT01863745|66593675|FG000|Overall Study|Death|1|||
23786022|NCT01863745|66593675|FG000|Overall Study|Withdrawal by Subject|1|||
23786023|NCT05752721|66593676|FG000|Overall Study|Lost to Follow-up|22|||
23786024|NCT05752721|66593677|FG001|Overall Study|Lost to Follow-up|20|||
23786025|NCT05752721|66593676|FG000|Overall Study|Withdrawal by Subject|15|||
23786026|NCT05752721|66593677|FG001|Overall Study|Withdrawal by Subject|12|||
23786027|NCT04079296|66593687|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23786028|NCT04079296|66593688|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23786029|NCT04079296|66593689|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23786030|NCT04079296|66593690|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
23786031|NCT04079296|66593691|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
23786032|NCT04079296|66593687|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23786033|NCT04079296|66593688|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23786034|NCT04079296|66593689|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23786035|NCT04079296|66593690|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
23786036|NCT04079296|66593691|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
23786037|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23786038|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23346482|NCT03802565|65011030|FG002|Overall Study|Adverse Event|2|||
23346483|NCT03802565|65011031|FG003|Overall Study|Adverse Event|1|||
23786039|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23786040|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23786041|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
23786042|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23786043|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23786044|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23786045|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23786046|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
23786047|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23786048|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23346484|NCT03802565|65011032|FG004|Overall Study|Adverse Event|1|||
23786049|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23786050|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
23346485|NCT03802565|65011028|FG000|Overall Study|Withdrawal by Subject|2|||
23786051|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23786052|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23786053|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23786054|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23786055|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
23786056|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
23786057|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23786058|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23786059|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23786060|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
23346486|NCT03802565|65011029|FG001|Overall Study|Withdrawal by Subject|2|||
23346487|NCT03802565|65011030|FG002|Overall Study|Withdrawal by Subject|2|||
23786061|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
23786062|NCT04079296|66593687|FG000|Dose Expansion Phase (168 Days)|Death|0|||
23786063|NCT04079296|66593688|FG001|Dose Expansion Phase (168 Days)|Death|0|||
23786064|NCT04079296|66593689|FG002|Dose Expansion Phase (168 Days)|Death|0|||
23786065|NCT04079296|66593690|FG003|Dose Expansion Phase (168 Days)|Death|1|||
23786066|NCT04079296|66593691|FG004|Dose Expansion Phase (168 Days)|Death|0|||
23786067|NCT02554890|66593692|FG000|Double-blind|Adverse Event|45|||
23786068|NCT02554890|66593693|FG001|Double-blind|Adverse Event|51|||
23786069|NCT02554890|66593692|FG000|Double-blind|Death|6|||
23457761|NCT04038359|65419042|FG000|Overall Study|Death|8|||
23457762|NCT04038359|65419043|FG001|Overall Study|Death|7|||
23457763|NCT04038359|65419042|FG000|Overall Study|Lost to Follow-up|3|||
23457764|NCT04038359|65419043|FG001|Overall Study|Lost to Follow-up|0|||
23457765|NCT04038359|65419042|FG000|Overall Study|Participant Moved|1|||
23457766|NCT04038359|65419043|FG001|Overall Study|Participant Moved|0|||
23346488|NCT03802565|65011031|FG003|Overall Study|Withdrawal by Subject|0|||
23346489|NCT03802565|65011032|FG004|Overall Study|Withdrawal by Subject|1|||
23346490|NCT03802565|65011028|FG000|Overall Study|Protocol Violation|2|||
23346491|NCT03802565|65011029|FG001|Overall Study|Protocol Violation|1|||
23346492|NCT03802565|65011030|FG002|Overall Study|Protocol Violation|4|||
23346493|NCT03802565|65011031|FG003|Overall Study|Protocol Violation|5|||
23346494|NCT03802565|65011032|FG004|Overall Study|Protocol Violation|1|||
23346495|NCT03802565|65011028|FG000|Overall Study|Lost to Follow-up|0|||
23346496|NCT03802565|65011029|FG001|Overall Study|Lost to Follow-up|0|||
23346497|NCT03802565|65011030|FG002|Overall Study|Lost to Follow-up|1|||
23457767|NCT04038359|65419042|FG000|Overall Study|Withdrawal by Subject|4|||
23346498|NCT03802565|65011031|FG003|Overall Study|Lost to Follow-up|0|||
23346499|NCT03802565|65011032|FG004|Overall Study|Lost to Follow-up|0|||
23346500|NCT03802565|65011028|FG000|Overall Study|Subjects Related to Each Other|1|||
23346501|NCT03802565|65011029|FG001|Overall Study|Subjects Related to Each Other|0|||
23346502|NCT03802565|65011030|FG002|Overall Study|Subjects Related to Each Other|0|||
23457768|NCT04038359|65419043|FG001|Overall Study|Withdrawal by Subject|3|||
23786070|NCT02554890|66593693|FG001|Double-blind|Death|4|||
23786071|NCT02554890|66593692|FG000|Double-blind|Protocol Violation|1|||
23786072|NCT02554890|66593693|FG001|Double-blind|Protocol Violation|1|||
23346503|NCT03802565|65011031|FG003|Overall Study|Subjects Related to Each Other|2|||
23346504|NCT03802565|65011032|FG004|Overall Study|Subjects Related to Each Other|1|||
23457769|NCT04038359|65419042|FG000|Overall Study|Physician Decision|3|||
23786073|NCT02554890|66593692|FG000|Double-blind|Physician Decision|4|||
23346505|NCT03802565|65011028|FG000|Overall Study|Elevated Enzymes|0|||
23346506|NCT03802565|65011029|FG001|Overall Study|Elevated Enzymes|0|||
23457770|NCT04038359|65419043|FG001|Overall Study|Physician Decision|2|||
23346507|NCT03802565|65011030|FG002|Overall Study|Elevated Enzymes|0|||
23346508|NCT03802565|65011031|FG003|Overall Study|Elevated Enzymes|0|||
23346509|NCT03802565|65011032|FG004|Overall Study|Elevated Enzymes|2|||
23346510|NCT00070018|65011033|FG000|Overall Study|Adverse Event|2|||
23346511|NCT00070018|65011033|FG000|Overall Study|Lack of Efficacy|1|||
23346512|NCT00070018|65011033|FG000|Overall Study|Withdrawal by Subject|1|||
23457771|NCT04038359|65419042|FG000|Overall Study|Adverse Event|0|||
23457772|NCT04038359|65419043|FG001|Overall Study|Adverse Event|2|||
23457773|NCT04038359|65419042|FG000|Overall Study|Progressive Disease|0|||
23457774|NCT04038359|65419043|FG001|Overall Study|Progressive Disease|1|||
23457775|NCT01084252|65419046|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457776|NCT01084252|65419047|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457777|NCT01084252|65419048|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457778|NCT01084252|65419049|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457779|NCT01084252|65419050|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457780|NCT01084252|65419051|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457781|NCT01084252|65419052|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457782|NCT01084252|65419053|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457783|NCT01084252|65419054|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457784|NCT01084252|65419055|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457785|NCT01084252|65419056|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457786|NCT01084252|65419057|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457787|NCT01084252|65419058|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
23457788|NCT01084252|65419059|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457789|NCT02197234|65419061|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
23457790|NCT02197234|65419061|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
23457791|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
23457792|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
23457793|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
23457794|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
23457795|NCT00626106|65419062|FG000|Overall Study|Withdrawal by Subject|2|||
23457796|NCT00626106|65419063|FG001|Overall Study|Withdrawal by Subject|1|||
23457797|NCT00626106|65419062|FG000|Overall Study|Lost to Follow-up|1|||
23457798|NCT00626106|65419063|FG001|Overall Study|Lost to Follow-up|4|||
23457799|NCT00626106|65419062|FG000|Overall Study|Death|64|||
23457800|NCT00626106|65419063|FG001|Overall Study|Death|19|||
23457801|NCT05176314|65419064|FG000|Overall Study|Lost to Follow-up|2|||
23457802|NCT05176314|65419064|FG000|Overall Study|Physician Decision|1|||
23457803|NCT05176314|65419064|FG000|Overall Study|Adverse Event|1|||
23457804|NCT05291520|65419065|FG000|Overall Study|Lost to Follow-up|0|||
23457805|NCT05291520|65419066|FG001|Overall Study|Lost to Follow-up|0|||
23786074|NCT02554890|66593693|FG001|Double-blind|Physician Decision|3|||
23786075|NCT02554890|66593692|FG000|Double-blind|Subject/Guardian decision|21|||
23786076|NCT02554890|66593693|FG001|Double-blind|Subject/Guardian decision|16|||
23786077|NCT02554890|66593692|FG000|Double-blind|Lost to Follow-up|7|||
23786078|NCT02554890|66593693|FG001|Double-blind|Lost to Follow-up|5|||
23786079|NCT02554890|66593692|FG000|Double-blind|Technical problems|1|||
23786080|NCT02554890|66593693|FG001|Double-blind|Technical problems|0|||
23786081|NCT02554890|66593692|FG000|Double-blind|Withdrawal by Subject|5|||
23786082|NCT02554890|66593693|FG001|Double-blind|Withdrawal by Subject|6|||
23786083|NCT02554890|66593692|FG000|Double-blind|Noncompliance with study treatment|6|||
23346513|NCT02339155|65011034|FG000|Overall Study|Adverse Event|0|||
23346514|NCT02339155|65011035|FG001|Overall Study|Adverse Event|6|||
23457806|NCT05291520|65419067|FG002|Overall Study|Lost to Follow-up|1|||
23457807|NCT03103542|65419068|FG000|Overall Study|Physician Decision|2|||
23457808|NCT03103542|65419068|FG000|Overall Study|Adverse Event|2|||
23457809|NCT03103542|65419068|FG000|Overall Study|Other|2|||
23457810|NCT03103542|65419068|FG000|Overall Study|Withdrawal by Subject|1|||
23457811|NCT02018562|65419069|FG000|Overall Study|Withdrawal by Subject|2|||
23346515|NCT02339155|65011034|FG000|Overall Study|Death|1|||
23346516|NCT02339155|65011035|FG001|Overall Study|Death|1|||
23346517|NCT02339155|65011034|FG000|Overall Study|Lost to Follow-up|8|||
23346518|NCT02339155|65011035|FG001|Overall Study|Lost to Follow-up|9|||
23346519|NCT02339155|65011034|FG000|Overall Study|Physician Decision|2|||
23346520|NCT02339155|65011035|FG001|Overall Study|Physician Decision|1|||
23457812|NCT02018562|65419070|FG001|Overall Study|Withdrawal by Subject|0|||
23786084|NCT02554890|66593693|FG001|Double-blind|Noncompliance with study treatment|5|||
23786085|NCT02554890|66593692|FG000|Open-label|Adverse Event|0|||
23786086|NCT02554890|66593693|FG001|Open-label|Adverse Event|30|||
23786087|NCT02554890|66593692|FG000|Open-label|Death|0|||
23786088|NCT02554890|66593693|FG001|Open-label|Death|1|||
23346521|NCT02339155|65011034|FG000|Overall Study|Withdrawal by Subject|4|||
23346522|NCT02339155|65011035|FG001|Overall Study|Withdrawal by Subject|4|||
23346523|NCT03627416|65011036|FG000|Overall Study|Adverse Event|0|||
23346524|NCT03627416|65011037|FG001|Overall Study|Adverse Event|1|||
23457813|NCT02018562|65419069|FG000|Overall Study|Discharged prior to study completion|1|||
23457814|NCT02018562|65419070|FG001|Overall Study|Discharged prior to study completion|0|||
23457815|NCT04750824|65419073|FG000|Overall Study|Toxicity/intolerability|3|||
23457816|NCT04750824|65419074|FG001|Overall Study|Toxicity/intolerability|1|||
23457817|NCT04750824|65419073|FG000|Overall Study|Death|1|||
23457818|NCT04750824|65419074|FG001|Overall Study|Death|3|||
23583617|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23638209|NCT03965351|66060834|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23786089|NCT02554890|66593692|FG000|Open-label|Physician Decision|0|||
23786090|NCT02554890|66593693|FG001|Open-label|Physician Decision|1|||
23786091|NCT02554890|66593692|FG000|Open-label|Subject/Guardian decision|0|||
23786092|NCT02554890|66593693|FG001|Open-label|Subject/Guardian decision|11|||
23346525|NCT03769675|65011041|FG000|Overall Study|Lost to Follow-up|1|||
23346526|NCT02638129|65011047|FG000|Overall Study|Study terminated|28|||
23346527|NCT02638129|65011048|FG001|Overall Study|Study terminated|30|||
23346528|NCT00984061|65011049|FG000|Clarithromycin Alone|Protocol Violation|1|||
23346529|NCT01935700|65011051|FG000|Overall Study|Withdrawal by Subject|1|||
23346530|NCT01935700|65011052|FG001|Overall Study|Withdrawal by Subject|0|||
23346531|NCT01935700|65011051|FG000|Overall Study|Physician Decision|4|||
23457819|NCT04750824|65419073|FG000|Overall Study|Scheduled duration of therapy complete|1|||
23786093|NCT02554890|66593692|FG000|Open-label|Lost to Follow-up|0|||
23786094|NCT02554890|66593693|FG001|Open-label|Lost to Follow-up|7|||
23786095|NCT02554890|66593692|FG000|Open-label|Technical problems|0|||
23786096|NCT02554890|66593693|FG001|Open-label|Technical problems|1|||
23786097|NCT02554890|66593692|FG000|Open-label|Withdrawal by Subject|0|||
23786098|NCT02554890|66593693|FG001|Open-label|Withdrawal by Subject|1|||
23786099|NCT03199963|66593695|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
23786100|NCT03199963|66593696|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
23786101|NCT03199963|66593695|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
23638210|NCT03965351|66060835|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23638211|NCT03965351|66060834|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
23638212|NCT03965351|66060835|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
23638213|NCT03554629|66060837|FG000|Overall Study|Inadequate data|6|||
23638214|NCT00652327|66060838|FG000|Overall Study|Adverse Event|0|||
23638215|NCT00652327|66060839|FG001|Overall Study|Adverse Event|2|||
23638216|NCT00652327|66060838|FG000|Overall Study|Lost to Follow-up|0|||
23638217|NCT00652327|66060839|FG001|Overall Study|Lost to Follow-up|3|||
23638218|NCT00626197|66060840|FG000|Overall Study|Did not cooperate|2|||
23638219|NCT00626197|66060841|FG001|Overall Study|Did not cooperate|6|||
23638220|NCT00626197|66060842|FG002|Overall Study|Did not cooperate|1|||
23638221|NCT00626197|66060840|FG000|Overall Study|Failure to return|6|||
23638222|NCT00626197|66060841|FG001|Overall Study|Failure to return|5|||
23638223|NCT00626197|66060842|FG002|Overall Study|Failure to return|6|||
23638224|NCT00626197|66060840|FG000|Overall Study|Adverse event, serious fatal|3|||
23638225|NCT00626197|66060841|FG001|Overall Study|Adverse event, serious fatal|6|||
23638226|NCT00626197|66060842|FG002|Overall Study|Adverse event, serious fatal|6|||
23638227|NCT00626197|66060840|FG000|Overall Study|Adverse Event|1|||
23786102|NCT03199963|66593696|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
23786103|NCT03199963|66593695|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
23457820|NCT04750824|65419074|FG001|Overall Study|Scheduled duration of therapy complete|9|||
23583618|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583619|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583620|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583621|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583622|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583623|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583624|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
23638228|NCT00626197|66060841|FG001|Overall Study|Adverse Event|1|||
23638229|NCT00626197|66060842|FG002|Overall Study|Adverse Event|2|||
23638230|NCT00626197|66060840|FG000|Overall Study|Withdrawal by Subject|17|||
23346532|NCT01935700|65011052|FG001|Overall Study|Physician Decision|0|||
23583625|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
23583626|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23346533|NCT02407457|65011055|FG000|1 Month|Death|3|||
23346534|NCT02407457|65011056|FG001|1 Month|Death|0|||
23346535|NCT02407457|65011055|FG000|1 Month|Lost to Follow-up|1|||
23346536|NCT02407457|65011056|FG001|1 Month|Lost to Follow-up|1|||
23346537|NCT02407457|65011055|FG000|1 Month|missed visit|2|||
23346538|NCT02407457|65011056|FG001|1 Month|missed visit|5|||
23346539|NCT02407457|65011055|FG000|6-Month|Death|2|||
23346540|NCT02407457|65011056|FG001|6-Month|Death|8|||
23346541|NCT02407457|65011055|FG000|6-Month|Lost to Follow-up|2|||
23346542|NCT02407457|65011056|FG001|6-Month|Lost to Follow-up|2|||
23346543|NCT02407457|65011055|FG000|6-Month|missed visit|16|||
23346544|NCT02407457|65011056|FG001|6-Month|missed visit|14|||
23346545|NCT02407457|65011055|FG000|6-Month|Open Repair|0|||
23346546|NCT02407457|65011056|FG001|6-Month|Open Repair|1|||
23346547|NCT02407457|65011055|FG000|1 Year|Death|6|||
23346548|NCT02407457|65011056|FG001|1 Year|Death|11|||
23346549|NCT02407457|65011055|FG000|1 Year|Lost to Follow-up|3|||
23346550|NCT02407457|65011056|FG001|1 Year|Lost to Follow-up|2|||
23346551|NCT02407457|65011055|FG000|1 Year|Missed Visit|24|||
23346552|NCT02407457|65011056|FG001|1 Year|Missed Visit|14|||
23346553|NCT02407457|65011055|FG000|1 Year|Open Repair|0|||
23346554|NCT02407457|65011056|FG001|1 Year|Open Repair|1|||
23346555|NCT02407457|65011055|FG000|2-year|Death|14|||
23346556|NCT02407457|65011056|FG001|2-year|Death|8|||
23346557|NCT02407457|65011055|FG000|2-year|Lost to Follow-up|7|||
23346558|NCT02407457|65011056|FG001|2-year|Lost to Follow-up|10|||
23346559|NCT02407457|65011055|FG000|2-year|Missed Visit|13|||
23346560|NCT02407457|65011056|FG001|2-year|Missed Visit|15|||
23346561|NCT02407457|65011055|FG000|2-year|Open Repair|0|||
23346562|NCT02407457|65011056|FG001|2-year|Open Repair|2|||
23346563|NCT02407457|65011055|FG000|3-year|Death|11|||
23346564|NCT02407457|65011056|FG001|3-year|Death|10|||
23346565|NCT02407457|65011055|FG000|3-year|Lost to Follow-up|9|||
23346566|NCT02407457|65011056|FG001|3-year|Lost to Follow-up|10|||
23346567|NCT02407457|65011055|FG000|3-year|Missed Visit|19|||
23346568|NCT02407457|65011056|FG001|3-year|Missed Visit|16|||
23346569|NCT02407457|65011055|FG000|4-year|Death|18|||
23346570|NCT02407457|65011056|FG001|4-year|Death|10|||
23346571|NCT02407457|65011055|FG000|4-year|Lost to Follow-up|10|||
23346572|NCT02407457|65011056|FG001|4-year|Lost to Follow-up|12|||
23346573|NCT02407457|65011055|FG000|4-year|Missed Visit|18|||
23346574|NCT02407457|65011056|FG001|4-year|Missed Visit|16|||
23346575|NCT02407457|65011055|FG000|5-year|Death|10|||
23346576|NCT02407457|65011056|FG001|5-year|Death|3|||
23346577|NCT02407457|65011055|FG000|5-year|Lost to Follow-up|22|||
23346578|NCT02407457|65011056|FG001|5-year|Lost to Follow-up|13|||
23346579|NCT02407457|65011055|FG000|5-year|Missed Visit|9|||
23346580|NCT02407457|65011056|FG001|5-year|Missed Visit|1|||
23346581|NCT03435224|65011057|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
23346582|NCT00866333|65011058|FG000|Overall Study|Withdrawal of consent|0|||
23346583|NCT00866333|65011059|FG001|Overall Study|Withdrawal of consent|1|||
23346584|NCT00866333|65011060|FG002|Overall Study|Withdrawal of consent|2|||
23346585|NCT00866333|65011058|FG000|Overall Study|Reason not Specified|3|||
23346586|NCT00866333|65011059|FG001|Overall Study|Reason not Specified|1|||
23346587|NCT00866333|65011060|FG002|Overall Study|Reason not Specified|1|||
23346588|NCT00866333|65011058|FG000|Overall Study|Study Terminated by Sponsor|2|||
23346589|NCT00866333|65011059|FG001|Overall Study|Study Terminated by Sponsor|5|||
23346590|NCT00866333|65011060|FG002|Overall Study|Study Terminated by Sponsor|9|||
23346591|NCT04063657|65011061|FG000|Overall Study|Lost to Follow-up|1|||
23346592|NCT04063657|65011062|FG001|Overall Study|Lost to Follow-up|0|||
23346593|NCT01796197|65011063|FG000|Overall Study|Lost to Follow-up|1|||
23346594|NCT01796197|65011063|FG000|Overall Study|Lack of Efficacy|1|||
23346595|NCT00878969|65011066|FG000|Overall Study|Physician Decision|5|||
23346596|NCT00878969|65011067|FG001|Overall Study|Physician Decision|3|||
23457821|NCT04750824|65419073|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
23457822|NCT04750824|65419074|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
23786104|NCT03199963|66593696|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
23786105|NCT03199963|66593695|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
23786106|NCT03199963|66593696|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
23786107|NCT03199963|66593695|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
23786108|NCT03199963|66593696|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
23786109|NCT03199963|66593695|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
23786110|NCT03199963|66593696|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
23786111|NCT00354835|66593705|FG000|Overall Study|Death|1|||
23786112|NCT00354835|66593706|FG001|Overall Study|Death|1|||
23786113|NCT00354835|66593705|FG000|Overall Study|Physician Decision|8|||
23786114|NCT00354835|66593706|FG001|Overall Study|Physician Decision|13|||
23786115|NCT00354835|66593705|FG000|Overall Study|Withdrawal by Subject|2|||
23786116|NCT00354835|66593706|FG001|Overall Study|Withdrawal by Subject|1|||
23786117|NCT00354835|66593705|FG000|Overall Study|Ineligible|17|||
23786118|NCT00354835|66593706|FG001|Overall Study|Ineligible|16|||
23786119|NCT00354835|66593705|FG000|Overall Study|Disease progression or relapse|15|||
23786120|NCT00354835|66593706|FG001|Overall Study|Disease progression or relapse|22|||
23786121|NCT00354835|66593705|FG000|Overall Study|Adverse Event|6|||
23786122|NCT00354835|66593706|FG001|Overall Study|Adverse Event|0|||
23786123|NCT00354835|66593705|FG000|Overall Study|Refusal of further therapy|3|||
23786124|NCT00354835|66593706|FG001|Overall Study|Refusal of further therapy|8|||
23786125|NCT00294047|66593707|FG000|Month 48|Adverse Event|28|||
23786126|NCT00294047|66593708|FG001|Month 48|Adverse Event|13|||
23786127|NCT00294047|66593707|FG000|Month 48|Protocol Violation|4|||
23786128|NCT00294047|66593708|FG001|Month 48|Protocol Violation|4|||
23786129|NCT00294047|66593707|FG000|Month 48|Withdrawal by Subject|111|||
23786130|NCT00294047|66593708|FG001|Month 48|Withdrawal by Subject|115|||
23786131|NCT00294047|66593707|FG000|Month 48|Lost to Follow-up|272|||
23786132|NCT00294047|66593708|FG001|Month 48|Lost to Follow-up|287|||
23786133|NCT00294047|66593707|FG000|Month 48|Other|10|||
23786134|NCT00294047|66593708|FG001|Month 48|Other|14|||
23786135|NCT00294047|66593707|FG000|Month 84|Adverse Event|4|||
23786136|NCT00294047|66593708|FG001|Month 84|Adverse Event|2|||
23786137|NCT00294047|66593707|FG000|Month 84|Protocol Violation|1|||
23786138|NCT00294047|66593708|FG001|Month 84|Protocol Violation|1|||
23786139|NCT00294047|66593707|FG000|Month 84|Withdrawal by Subject|33|||
23786140|NCT00294047|66593708|FG001|Month 84|Withdrawal by Subject|31|||
23786141|NCT00294047|66593707|FG000|Month 84|Lost to Follow-up|187|||
23786142|NCT00294047|66593708|FG001|Month 84|Lost to Follow-up|190|||
23786143|NCT00294047|66593707|FG000|Month 84|Absent Cervix|2|||
23786144|NCT00294047|66593708|FG001|Month 84|Absent Cervix|0|||
23786145|NCT00294047|66593707|FG000|Month 84|Work related reasons|4|||
23786146|NCT00294047|66593708|FG001|Month 84|Work related reasons|2|||
23786147|NCT00294047|66593707|FG000|Month 84|Center closed, subject did not transfer|1|||
23786148|NCT00294047|66593708|FG001|Month 84|Center closed, subject did not transfer|0|||
23786149|NCT00294047|66593707|FG000|Month 84|Family problems|2|||
23786150|NCT00294047|66593708|FG001|Month 84|Family problems|2|||
23786151|NCT00294047|66593707|FG000|Month 84|Lack of time|3|||
23786152|NCT00294047|66593708|FG001|Month 84|Lack of time|1|||
23786153|NCT00294047|66593707|FG000|Month 84|Personal reason|2|||
23786154|NCT00294047|66593708|FG001|Month 84|Personal reason|4|||
23786155|NCT00294047|66593707|FG000|Month 84|Subject does not want male physician|1|||
23786156|NCT00294047|66593708|FG001|Month 84|Subject does not want male physician|0|||
23786157|NCT00294047|66593707|FG000|Month 84|Transport reimbursement delayed|0|||
23786158|NCT00294047|66593708|FG001|Month 84|Transport reimbursement delayed|1|||
23786159|NCT00294047|66593707|FG000|Month 84|Unable to reach study site|1|||
23346597|NCT00878969|65011068|FG002|Overall Study|Physician Decision|2|||
23346598|NCT00878969|65011066|FG000|Overall Study|Withdrawal by Subject|1|||
23583627|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23786160|NCT00294047|66593708|FG001|Month 84|Unable to reach study site|0|||
23786161|NCT00294047|66593707|FG000|Month 84|Under investigation locally|1|||
23786162|NCT00294047|66593708|FG001|Month 84|Under investigation locally|0|||
23786163|NCT00294047|66593707|FG000|Month 84|Visit missed|0|||
23786164|NCT00294047|66593708|FG001|Month 84|Visit missed|1|||
23786165|NCT00294047|66593707|FG000|Month 84|No consent for Month 84 Follow-up|731|||
23786166|NCT00294047|66593708|FG001|Month 84|No consent for Month 84 Follow-up|754|||
23786167|NCT03679598|66593709|FG000|Overall Study|Adverse Event|2|||
23786168|NCT03679598|66593710|FG001|Overall Study|Adverse Event|0|||
23786169|NCT02362464|66593711|FG000|Overall Study|Switched to alternative therapy|1|||
23786170|NCT02362464|66593711|FG000|Overall Study|Refused further treatment|1|||
23786171|NCT02362464|66593711|FG000|Overall Study|Physician Decision|4|||
23786172|NCT00829712|66593712|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23786173|NCT00829712|66593713|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23786174|NCT04547192|66597653|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
23786175|NCT04547192|66597654|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
23786176|NCT04547192|66597655|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
23786177|NCT04547192|66597656|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
23786178|NCT04547192|66597653|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
23786179|NCT04547192|66597654|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
23786180|NCT04547192|66597655|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
23786181|NCT04547192|66597656|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
23786182|NCT04547192|66597653|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
23786183|NCT04547192|66597654|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
23786184|NCT04547192|66597655|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
23786185|NCT04547192|66597656|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
23346599|NCT00878969|65011067|FG001|Overall Study|Withdrawal by Subject|6|||
23346600|NCT00878969|65011068|FG002|Overall Study|Withdrawal by Subject|3|||
23346601|NCT00878969|65011066|FG000|Overall Study|kidney transplant|2|||
23346602|NCT00878969|65011067|FG001|Overall Study|kidney transplant|3|||
23346603|NCT00878969|65011068|FG002|Overall Study|kidney transplant|2|||
23346604|NCT00878969|65011066|FG000|Overall Study|Adverse Event|3|||
23346605|NCT00878969|65011067|FG001|Overall Study|Adverse Event|1|||
23346606|NCT00878969|65011068|FG002|Overall Study|Adverse Event|2|||
23346607|NCT00878969|65011066|FG000|Overall Study|Lost to Follow-up|2|||
23346608|NCT00878969|65011067|FG001|Overall Study|Lost to Follow-up|1|||
23346609|NCT00878969|65011068|FG002|Overall Study|Lost to Follow-up|0|||
23346610|NCT00878969|65011066|FG000|Overall Study|Protocol Violation|2|||
23346611|NCT00878969|65011067|FG001|Overall Study|Protocol Violation|0|||
23346612|NCT00878969|65011068|FG002|Overall Study|Protocol Violation|0|||
23346613|NCT00878969|65011066|FG000|Overall Study|Death|0|||
23346614|NCT00878969|65011067|FG001|Overall Study|Death|0|||
23346615|NCT00878969|65011068|FG002|Overall Study|Death|2|||
23346616|NCT00878969|65011066|FG000|Overall Study|Pregnancy|0|||
23346617|NCT00878969|65011067|FG001|Overall Study|Pregnancy|1|||
23346618|NCT00878969|65011068|FG002|Overall Study|Pregnancy|0|||
23346619|NCT02653170|65011077|FG000|Overall Study|Withdrawal by Subject|3|||
23346620|NCT02653170|65011078|FG001|Overall Study|Withdrawal by Subject|8|||
23346621|NCT02653170|65011079|FG002|Overall Study|Withdrawal by Subject|3|||
23346622|NCT02653170|65011077|FG000|Overall Study|withdrawn by study team|2|||
23346623|NCT02653170|65011078|FG001|Overall Study|withdrawn by study team|4|||
23583628|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583629|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583630|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583631|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583632|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583633|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583634|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583635|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23786186|NCT04547192|66597653|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
23786187|NCT04547192|66597654|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
23786188|NCT04547192|66597655|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
23786189|NCT04547192|66597656|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
23786190|NCT04547192|66597653|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
23346624|NCT02653170|65011079|FG002|Overall Study|withdrawn by study team|5|||
23346625|NCT02653170|65011077|FG000|Overall Study|Lost to Follow-up|12|||
23346626|NCT02653170|65011078|FG001|Overall Study|Lost to Follow-up|4|||
23346627|NCT02653170|65011079|FG002|Overall Study|Lost to Follow-up|10|||
23346628|NCT01173055|65011080|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
23346629|NCT01173055|65011081|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
23786191|NCT04547192|66597654|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
23786192|NCT04547192|66597655|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
23786193|NCT04547192|66597656|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
23786194|NCT00772603|66597663|FG000|Overall Study|Withdrawal by Subject|11|||
23786195|NCT00772603|66597664|FG001|Overall Study|Withdrawal by Subject|10|||
23786196|NCT00772603|66597665|FG002|Overall Study|Withdrawal by Subject|6|||
23786197|NCT00772603|66597663|FG000|Overall Study|Adverse Event|37|||
23786198|NCT00772603|66597664|FG001|Overall Study|Adverse Event|18|||
23786199|NCT00772603|66597665|FG002|Overall Study|Adverse Event|10|||
23786200|NCT00772603|66597663|FG000|Overall Study|Subject Non-compliance|1|||
23786201|NCT00772603|66597664|FG001|Overall Study|Subject Non-compliance|6|||
23786202|NCT00772603|66597665|FG002|Overall Study|Subject Non-compliance|4|||
23786203|NCT00772603|66597663|FG000|Overall Study|Protocol Violation|0|||
23786204|NCT00772603|66597664|FG001|Overall Study|Protocol Violation|1|||
23786205|NCT00772603|66597665|FG002|Overall Study|Protocol Violation|1|||
23786206|NCT00772603|66597663|FG000|Overall Study|Lost to Follow-up|1|||
23786207|NCT00772603|66597664|FG001|Overall Study|Lost to Follow-up|5|||
23786208|NCT00772603|66597665|FG002|Overall Study|Lost to Follow-up|2|||
23786209|NCT00772603|66597663|FG000|Overall Study|Physician Decision|0|||
23786210|NCT00772603|66597664|FG001|Overall Study|Physician Decision|0|||
23786211|NCT00772603|66597665|FG002|Overall Study|Physician Decision|1|||
23786212|NCT00772603|66597663|FG000|Overall Study|Other|2|||
23786213|NCT00772603|66597664|FG001|Overall Study|Other|0|||
23786214|NCT00772603|66597665|FG002|Overall Study|Other|2|||
23786215|NCT00672984|66597673|FG000|First Intervention|Adverse Event|5|||
23786216|NCT00672984|66597674|FG001|First Intervention|Adverse Event|0|||
23786217|NCT00672984|66597675|FG002|First Intervention|Adverse Event|0|||
23786218|NCT00672984|66597673|FG000|First Intervention|Withdrawal by Subject|1|||
23786219|NCT00672984|66597674|FG001|First Intervention|Withdrawal by Subject|2|||
23786220|NCT00672984|66597675|FG002|First Intervention|Withdrawal by Subject|2|||
23786221|NCT00672984|66597673|FG000|First Intervention|Sponsor decision|3|||
23786222|NCT00672984|66597674|FG001|First Intervention|Sponsor decision|0|||
23786223|NCT00672984|66597675|FG002|First Intervention|Sponsor decision|0|||
23786224|NCT00672984|66597673|FG000|Second Intervention|Non-compliance with facility policies|0|||
23786225|NCT00672984|66597674|FG001|Second Intervention|Non-compliance with facility policies|2|||
23786226|NCT00672984|66597675|FG002|Second Intervention|Non-compliance with facility policies|0|||
23786227|NCT00672984|66597673|FG000|Second Intervention|Withdrawal by Subject|0|||
23786228|NCT00672984|66597674|FG001|Second Intervention|Withdrawal by Subject|3|||
23786229|NCT00672984|66597675|FG002|Second Intervention|Withdrawal by Subject|0|||
23786230|NCT00672984|66597673|FG000|Second Intervention|Protocol Violation|0|||
23786231|NCT00672984|66597674|FG001|Second Intervention|Protocol Violation|1|||
23786232|NCT00672984|66597675|FG002|Second Intervention|Protocol Violation|1|||
23786233|NCT00672984|66597673|FG000|Third Intervention|Adverse Event|1|||
23786234|NCT00672984|66597674|FG001|Third Intervention|Adverse Event|0|||
23786235|NCT00672984|66597675|FG002|Third Intervention|Adverse Event|1|||
23786236|NCT03193021|66597676|FG000|Overall Study|Lost to Follow-up|1|||
23786237|NCT03193021|66597677|FG001|Overall Study|Lost to Follow-up|1|||
23786238|NCT01983969|66597678|FG000|Overall Study|Disease Progression|0|||
23786239|NCT01983969|66597679|FG001|Overall Study|Disease Progression|1|||
23786240|NCT01983969|66597680|FG002|Overall Study|Disease Progression|0|||
23786241|NCT00903877|66597681|FG000|Overall Study|Did not meet study criteria|33|||
23786242|NCT00903877|66597681|FG000|Overall Study|Withdrawal by Subject|3|||
23786243|NCT00903877|66597681|FG000|Overall Study|Adverse Event|2|||
23786244|NCT00903877|66597681|FG000|Overall Study|Lost to Follow-up|1|||
23786245|NCT00903877|66597681|FG000|Overall Study|Participation put on hold|4|||
23786246|NCT00840879|66597685|FG000|Second Intervention|Withdrawal by Subject|1|||
23786247|NCT00840879|66597686|FG001|Second Intervention|Withdrawal by Subject|0|||
23346630|NCT01173055|65011080|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
23346631|NCT01173055|65011081|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
23457823|NCT01415882|65419081|FG000|Overall Study|Ineligible|1|||
23786248|NCT02316223|66597687|FG000|Overall Study|Lack of Efficacy|0|||
23786249|NCT02316223|66597688|FG001|Overall Study|Lack of Efficacy|1|||
23786250|NCT02316223|66597689|FG002|Overall Study|Lack of Efficacy|1|||
23786251|NCT02316223|66597687|FG000|Overall Study|Lost to Follow-up|27|||
23786252|NCT02316223|66597688|FG001|Overall Study|Lost to Follow-up|34|||
23786253|NCT02316223|66597689|FG002|Overall Study|Lost to Follow-up|36|||
23346632|NCT00710684|65011087|FG000|Overall Study|Adverse Event|11|||
23346633|NCT00710684|65011088|FG001|Overall Study|Adverse Event|19|||
23346634|NCT00710684|65011089|FG002|Overall Study|Adverse Event|16|||
23346635|NCT00710684|65011087|FG000|Overall Study|Lack of Efficacy|4|||
23346636|NCT00710684|65011088|FG001|Overall Study|Lack of Efficacy|3|||
23346637|NCT00710684|65011089|FG002|Overall Study|Lack of Efficacy|5|||
23638231|NCT00626197|66060841|FG001|Overall Study|Withdrawal by Subject|17|||
23638232|NCT00626197|66060842|FG002|Overall Study|Withdrawal by Subject|7|||
23638233|NCT00626197|66060840|FG000|Overall Study|Administrative reasons|15|||
23638234|NCT00626197|66060841|FG001|Overall Study|Administrative reasons|19|||
23638235|NCT00626197|66060842|FG002|Overall Study|Administrative reasons|55|||
23638236|NCT03046121|66060846|FG000|Overall Study|Death|32|||
23638237|NCT03046121|66060847|FG001|Overall Study|Death|60|||
23638238|NCT03046121|66060846|FG000|Overall Study|Withdrawal by Subject|14|||
23638239|NCT03046121|66060847|FG001|Overall Study|Withdrawal by Subject|12|||
23638240|NCT03921723|66060848|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
23638241|NCT03921723|66060848|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
23638242|NCT00095056|66060851|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
23638243|NCT00095056|66060852|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
23638244|NCT00095056|66060851|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
23638245|NCT00095056|66060852|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
23638246|NCT00095056|66060851|FG000|Phase A (Weeks 0-12)|Death|1|||
23638247|NCT00095056|66060852|FG001|Phase A (Weeks 0-12)|Death|0|||
23638248|NCT00095056|66060851|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
23638249|NCT00095056|66060852|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
23638250|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
23638251|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
23638252|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
23638253|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
23638254|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
23638255|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
23638256|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
23638257|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
23638258|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Death|3|||
23786254|NCT02316223|66597687|FG000|Overall Study|COPD Diagnosis|3|||
23786255|NCT02316223|66597688|FG001|Overall Study|COPD Diagnosis|2|||
23786256|NCT02316223|66597689|FG002|Overall Study|COPD Diagnosis|3|||
23786257|NCT02316223|66597687|FG000|Overall Study|Reside outside study area|1|||
23786258|NCT02316223|66597688|FG001|Overall Study|Reside outside study area|1|||
23786259|NCT02316223|66597689|FG002|Overall Study|Reside outside study area|1|||
23786260|NCT02316223|66597687|FG000|Overall Study|No asthma|2|||
23786261|NCT02316223|66597688|FG001|Overall Study|No asthma|0|||
23638259|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Death|1|||
23638260|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
23638261|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
23638262|NCT00095056|66060851|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
23638263|NCT00095056|66060852|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
23638264|NCT03868787|66060853|FG000|Overall Study|Withdrawal by Subject|2|||
23638265|NCT03868787|66060854|FG001|Overall Study|Withdrawal by Subject|1|||
23638266|NCT00506441|66060856|FG000|Period 1; Open-label Period|Adverse Event|21|||
23638267|NCT00506441|66060857|FG001|Period 1; Open-label Period|Adverse Event|0|||
23638268|NCT00506441|66060856|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
23638269|NCT00506441|66060857|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
23638270|NCT00506441|66060856|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
23638271|NCT00506441|66060857|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
23638272|NCT00506441|66060856|FG000|Period 1; Open-label Period|Physician Decision|5|||
23786262|NCT02316223|66597689|FG002|Overall Study|No asthma|0|||
23786263|NCT02316223|66597687|FG000|Overall Study|Discontinued by PI|11|||
23786264|NCT02316223|66597688|FG001|Overall Study|Discontinued by PI|19|||
23346638|NCT00710684|65011087|FG000|Overall Study|Protocol Violation|5|||
23638273|NCT00506441|66060857|FG001|Period 1; Open-label Period|Physician Decision|0|||
23638274|NCT00506441|66060856|FG000|Period 1; Open-label Period|Protocol Violation|9|||
23786265|NCT02316223|66597689|FG002|Overall Study|Discontinued by PI|3|||
23638275|NCT00506441|66060857|FG001|Period 1; Open-label Period|Protocol Violation|0|||
23638276|NCT00506441|66060856|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
23786266|NCT02175095|66597692|FG000|Overall Study|Withdrawal by Subject|3|||
23638277|NCT00506441|66060857|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
23638278|NCT00506441|66060856|FG000|Period 1; Open-label Period|Other Reasons|13|||
23638279|NCT00506441|66060857|FG001|Period 1; Open-label Period|Other Reasons|0|||
23638280|NCT00506441|66060856|FG000|Period 2; Double-blind Period|Adverse Event|0|||
23638281|NCT00506441|66060857|FG001|Period 2; Double-blind Period|Adverse Event|1|||
23786267|NCT02011945|66597697|FG000|Overall Study|Participant requested to Discontinue|0|||
23346639|NCT00710684|65011088|FG001|Overall Study|Protocol Violation|5|||
23346640|NCT00710684|65011089|FG002|Overall Study|Protocol Violation|5|||
23638282|NCT00506441|66060856|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
23457824|NCT01415882|65419082|FG001|Overall Study|Ineligible|0|||
23457825|NCT01415882|65419083|FG002|Overall Study|Ineligible|0|||
23457826|NCT01415882|65419084|FG003|Overall Study|Ineligible|3|||
23457827|NCT01415882|65419085|FG004|Overall Study|Ineligible|0|||
23457828|NCT01415882|65419081|FG000|Overall Study|Withdrawal by Subject|0|||
23457829|NCT01415882|65419082|FG001|Overall Study|Withdrawal by Subject|1|||
23457830|NCT01415882|65419083|FG002|Overall Study|Withdrawal by Subject|0|||
23457831|NCT01415882|65419084|FG003|Overall Study|Withdrawal by Subject|1|||
23457832|NCT01415882|65419085|FG004|Overall Study|Withdrawal by Subject|0|||
23457833|NCT03019406|65419088|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
23457834|NCT03019406|65419089|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
23583636|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23786268|NCT02011945|66597698|FG001|Overall Study|Participant requested to Discontinue|1|||
23786269|NCT02011945|66597699|FG002|Overall Study|Participant requested to Discontinue|1|||
23786270|NCT02011945|66597697|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
23786271|NCT02011945|66597698|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
23786272|NCT02011945|66597699|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
23786273|NCT02011945|66597697|FG000|Overall Study|Study Drug Toxicity|0|||
23786274|NCT02011945|66597698|FG001|Overall Study|Study Drug Toxicity|0|||
23786275|NCT02011945|66597699|FG002|Overall Study|Study Drug Toxicity|1|||
23786276|NCT02011945|66597697|FG000|Overall Study|Treatment Failure|0|||
23786277|NCT02011945|66597698|FG001|Overall Study|Treatment Failure|7|||
23638283|NCT00506441|66060857|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
23638284|NCT00506441|66060856|FG000|Period 2; Double-blind Period|Physician Decision|1|||
23638285|NCT00506441|66060857|FG001|Period 2; Double-blind Period|Physician Decision|1|||
23638286|NCT00506441|66060856|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
23638287|NCT00506441|66060857|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
23638288|NCT00506441|66060856|FG000|Period 2; Double-blind Period|Other Reason|1|||
23638289|NCT00506441|66060857|FG001|Period 2; Double-blind Period|Other Reason|1|||
23638290|NCT01036438|66060858|FG000|Overall Study|Adverse Event|7|||
23638291|NCT01036438|66060859|FG001|Overall Study|Adverse Event|8|||
23638292|NCT01036438|66060858|FG000|Overall Study|Death|0|||
23638293|NCT01036438|66060859|FG001|Overall Study|Death|1|||
23638294|NCT01036438|66060858|FG000|Overall Study|No effect of study treatment|3|||
23583637|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583638|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
23638295|NCT01036438|66060859|FG001|Overall Study|No effect of study treatment|1|||
23638296|NCT02930226|66060860|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
23638297|NCT02930226|66060861|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
23457835|NCT03019406|65419090|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
23583639|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
23583640|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583641|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583642|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583643|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583644|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583645|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23638298|NCT02930226|66060862|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
23638299|NCT02930226|66060863|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
23638300|NCT02930226|66060864|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
23638301|NCT02930226|66060865|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
23638302|NCT00659880|66060866|FG000|Overall Study|Lost to Follow-up|5|||
23786278|NCT02011945|66597699|FG002|Overall Study|Treatment Failure|6|||
23786279|NCT02011945|66597697|FG000|Overall Study|No Longer Meets Study Criteria|1|||
23786280|NCT02011945|66597698|FG001|Overall Study|No Longer Meets Study Criteria|0|||
23786281|NCT02011945|66597699|FG002|Overall Study|No Longer Meets Study Criteria|0|||
23786282|NCT02011945|66597697|FG000|Overall Study|Proceeded to stem cell transplant|0|||
23786283|NCT02011945|66597698|FG001|Overall Study|Proceeded to stem cell transplant|0|||
23786284|NCT02011945|66597699|FG002|Overall Study|Proceeded to stem cell transplant|1|||
23786285|NCT02011945|66597697|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
23786286|NCT02011945|66597698|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
23786287|NCT02011945|66597699|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
23786288|NCT01539239|66597700|FG000|Overall Study|Death|5|||
23786289|NCT01539239|66597701|FG001|Overall Study|Death|5|||
23786290|NCT01539239|66597700|FG000|Overall Study|Lost to Follow-up|7|||
23786291|NCT01539239|66597701|FG001|Overall Study|Lost to Follow-up|12|||
23786292|NCT05387408|66597702|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
23786293|NCT03504085|66597726|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
23786294|NCT03504085|66597727|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
23786295|NCT03504085|66597726|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
23786296|NCT03504085|66597727|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
23786297|NCT03605342|66597728|FG000|Overall Study|Withdrawal by Subject|9|||
23786298|NCT03605342|66597729|FG001|Overall Study|Withdrawal by Subject|7|||
23786299|NCT03605342|66597728|FG000|Overall Study|Lost to Follow-up|1|||
23786300|NCT03605342|66597729|FG001|Overall Study|Lost to Follow-up|1|||
23786301|NCT04994535|66597736|FG000|Overall Study|Lost to Follow-up|7|||
23786302|NCT04994535|66597737|FG001|Overall Study|Lost to Follow-up|7|||
23786303|NCT04994535|66597736|FG000|Overall Study|Withdrawal by Subject|10|||
23786304|NCT04994535|66597737|FG001|Overall Study|Withdrawal by Subject|7|||
23786305|NCT04994535|66597736|FG000|Overall Study|Other|1|||
23786306|NCT04994535|66597737|FG001|Overall Study|Other|1|||
23786307|NCT00319696|66597738|FG000|Overall Study|Adverse Event|36|||
23786308|NCT00319696|66597738|FG000|Overall Study|withdrawal of consent|14|||
23786309|NCT00319696|66597738|FG000|Overall Study|administrative|7|||
23786310|NCT00319696|66597738|FG000|Overall Study|Lost to Follow-up|3|||
23786311|NCT03214588|66597741|FG000|Overall Study|Adverse Event|1|||
23786312|NCT03214588|66597742|FG001|Overall Study|Adverse Event|0|||
23786313|NCT03214588|66597743|FG002|Overall Study|Adverse Event|2|||
23786314|NCT03214588|66597741|FG000|Overall Study|Reason Not Specified|0|||
23457836|NCT03019406|65419091|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
23457837|NCT00976274|65419097|FG000|Overall Study|Lost to Follow-up|5|||
23457838|NCT00976274|65419098|FG001|Overall Study|Lost to Follow-up|5|||
23457839|NCT00976274|65419097|FG000|Overall Study|Withdrawal by Subject|1|||
23457840|NCT00976274|65419098|FG001|Overall Study|Withdrawal by Subject|1|||
23457841|NCT00976274|65419097|FG000|Overall Study|Physician Decision|1|||
23346641|NCT00710684|65011087|FG000|Overall Study|Lost to Follow-up|4|||
23346642|NCT00710684|65011088|FG001|Overall Study|Lost to Follow-up|6|||
23346643|NCT00710684|65011089|FG002|Overall Study|Lost to Follow-up|7|||
23346644|NCT00710684|65011087|FG000|Overall Study|Physician Decision|0|||
23346645|NCT00710684|65011088|FG001|Overall Study|Physician Decision|2|||
23346646|NCT00710684|65011089|FG002|Overall Study|Physician Decision|4|||
23346647|NCT00710684|65011087|FG000|Overall Study|Withdrawal by Subject|24|||
23457842|NCT00976274|65419098|FG001|Overall Study|Physician Decision|2|||
23457843|NCT03919773|65419099|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
23457844|NCT03919773|65419100|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
23346648|NCT00710684|65011088|FG001|Overall Study|Withdrawal by Subject|18|||
23457845|NCT03919773|65419099|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
23457846|NCT03919773|65419100|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
23457847|NCT01527149|65419101|FG000|Overall Study|Death|2|||
23457848|NCT02242942|65419102|FG000|Overall Study|Death|17|||
23457849|NCT02242942|65419103|FG001|Overall Study|Death|20|||
23457850|NCT02242942|65419104|FG002|Overall Study|Death|2|||
23457851|NCT02242942|65419102|FG000|Overall Study|Physician Decision|1|||
23457852|NCT02242942|65419103|FG001|Overall Study|Physician Decision|0|||
23457853|NCT02242942|65419104|FG002|Overall Study|Physician Decision|0|||
23638303|NCT02738853|66060872|FG000|Enrollment|Inclusion/Exclusion not met|21|||
23638304|NCT02738853|66060872|FG000|Enrollment|Withdrawal by Subject|3|||
23786315|NCT03214588|66597742|FG001|Overall Study|Reason Not Specified|1|||
23457854|NCT02242942|65419102|FG000|Overall Study|Withdrawal by Subject|8|||
23457855|NCT02242942|65419103|FG001|Overall Study|Withdrawal by Subject|10|||
23457856|NCT02242942|65419104|FG002|Overall Study|Withdrawal by Subject|0|||
23457857|NCT02242942|65419102|FG000|Overall Study|On-going in Study|190|||
23457858|NCT02242942|65419103|FG001|Overall Study|On-going in Study|186|||
23457859|NCT02242942|65419104|FG002|Overall Study|On-going in Study|11|||
23786316|NCT03214588|66597743|FG002|Overall Study|Reason Not Specified|0|||
23786317|NCT00191815|66597748|FG000|Overall Study|Adverse Event|2|||
23786318|NCT00191815|66597748|FG000|Overall Study|Disease progression or relapse|24|||
23346649|NCT00710684|65011089|FG002|Overall Study|Withdrawal by Subject|11|||
23346650|NCT00710684|65011087|FG000|Overall Study|Missing|1|||
23346651|NCT00710684|65011088|FG001|Overall Study|Missing|0|||
23457860|NCT01506596|65419105|FG000|Overall Study|ineligible pathology|1|||
23457861|NCT00882440|65419106|FG000|Overall Study|Adverse Event|2|||
23457862|NCT00882440|65419107|FG001|Overall Study|Adverse Event|2|||
23457863|NCT00882440|65419108|FG002|Overall Study|Adverse Event|2|||
23457864|NCT00882440|65419109|FG003|Overall Study|Adverse Event|1|||
23457865|NCT00882440|65419110|FG004|Overall Study|Adverse Event|1|||
23457866|NCT00882440|65419111|FG005|Overall Study|Adverse Event|4|||
23457867|NCT00882440|65419112|FG006|Overall Study|Adverse Event|2|||
23457868|NCT00882440|65419106|FG000|Overall Study|Lack of Efficacy|3|||
23457869|NCT00882440|65419107|FG001|Overall Study|Lack of Efficacy|5|||
23457870|NCT00882440|65419108|FG002|Overall Study|Lack of Efficacy|2|||
23457871|NCT00882440|65419109|FG003|Overall Study|Lack of Efficacy|0|||
23786319|NCT00191815|66597748|FG000|Overall Study|Death|2|||
23786320|NCT00191815|66597748|FG000|Overall Study|Protocol Violation|3|||
23786321|NCT00191815|66597748|FG000|Overall Study|Physician Decision|2|||
23786322|NCT00191815|66597748|FG000|Overall Study|Withdrawal by Subject|7|||
23786323|NCT04025021|66597756|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
23786324|NCT04025021|66597757|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
23786325|NCT03808376|66597758|FG000|Overall Study|Withdrawal by Subject|10|||
23786326|NCT00665925|66597761|FG000|Overall Study|Lack of Efficacy|10|||
23786327|NCT00665925|66597762|FG001|Overall Study|Lack of Efficacy|8|||
23786328|NCT00665925|66597763|FG002|Overall Study|Lack of Efficacy|9|||
23786329|NCT00665925|66597764|FG003|Overall Study|Lack of Efficacy|8|||
23786330|NCT00665925|66597761|FG000|Overall Study|Lost to Follow-up|1|||
23457872|NCT00882440|65419110|FG004|Overall Study|Lack of Efficacy|0|||
23457873|NCT00882440|65419111|FG005|Overall Study|Lack of Efficacy|3|||
23457874|NCT00882440|65419112|FG006|Overall Study|Lack of Efficacy|0|||
23457875|NCT00882440|65419106|FG000|Overall Study|Lost to Follow-up|2|||
23457876|NCT00882440|65419107|FG001|Overall Study|Lost to Follow-up|0|||
23457877|NCT00882440|65419108|FG002|Overall Study|Lost to Follow-up|1|||
23457878|NCT00882440|65419109|FG003|Overall Study|Lost to Follow-up|1|||
23457879|NCT00882440|65419110|FG004|Overall Study|Lost to Follow-up|1|||
23457880|NCT00882440|65419111|FG005|Overall Study|Lost to Follow-up|0|||
23457881|NCT00882440|65419112|FG006|Overall Study|Lost to Follow-up|1|||
23457882|NCT00882440|65419106|FG000|Overall Study|Protocol Violation|0|||
23457883|NCT00882440|65419107|FG001|Overall Study|Protocol Violation|0|||
23457884|NCT00882440|65419108|FG002|Overall Study|Protocol Violation|1|||
23457885|NCT00882440|65419109|FG003|Overall Study|Protocol Violation|1|||
23457886|NCT00882440|65419110|FG004|Overall Study|Protocol Violation|1|||
23457887|NCT00882440|65419111|FG005|Overall Study|Protocol Violation|0|||
23457888|NCT00882440|65419112|FG006|Overall Study|Protocol Violation|0|||
23457889|NCT00882440|65419106|FG000|Overall Study|Withdrawal by Subject|2|||
23457890|NCT00882440|65419107|FG001|Overall Study|Withdrawal by Subject|1|||
23457891|NCT00882440|65419108|FG002|Overall Study|Withdrawal by Subject|1|||
23457892|NCT00882440|65419109|FG003|Overall Study|Withdrawal by Subject|0|||
23457893|NCT00882440|65419110|FG004|Overall Study|Withdrawal by Subject|6|||
23457894|NCT00882440|65419111|FG005|Overall Study|Withdrawal by Subject|0|||
23457895|NCT00882440|65419112|FG006|Overall Study|Withdrawal by Subject|1|||
23457896|NCT00882440|65419106|FG000|Overall Study|Patient Uncooperative|2|||
23457897|NCT00882440|65419107|FG001|Overall Study|Patient Uncooperative|0|||
23457898|NCT00882440|65419108|FG002|Overall Study|Patient Uncooperative|0|||
23457899|NCT00882440|65419109|FG003|Overall Study|Patient Uncooperative|0|||
23457900|NCT00882440|65419110|FG004|Overall Study|Patient Uncooperative|1|||
23457901|NCT00882440|65419111|FG005|Overall Study|Patient Uncooperative|0|||
23638305|NCT02738853|66060872|FG000|Enrollment|Subject treated with commercially available device|6|||
23638306|NCT02738853|66060872|FG000|Enrollment|Study Enrollment Closed|3|||
23638307|NCT02738853|66060872|FG000|Procedure|Death|1|||
23638308|NCT02738853|66060872|FG000|1 Month|Death|2|||
23638309|NCT02738853|66060872|FG000|6 Month|Death|4|||
23638310|NCT02738853|66060872|FG000|6 Month|Withdrawal by Subject|2|||
23786331|NCT00665925|66597762|FG001|Overall Study|Lost to Follow-up|2|||
23786332|NCT00665925|66597763|FG002|Overall Study|Lost to Follow-up|2|||
23457902|NCT00882440|65419112|FG006|Overall Study|Patient Uncooperative|0|||
23457903|NCT02230410|65419113|FG000|Overall Study|Screen Failure|3|||
23457904|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
23457905|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
23457906|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
23457907|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
23457908|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Adverse Event|2|||
23583646|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583647|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583648|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583649|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583650|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583651|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23638311|NCT02738853|66060872|FG000|1 Year|Death|6|||
23457909|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Adverse Event|5|||
23786333|NCT00665925|66597764|FG003|Overall Study|Lost to Follow-up|2|||
23786334|NCT00665925|66597761|FG000|Overall Study|Withdrawal by Subject|2|||
23786335|NCT00665925|66597762|FG001|Overall Study|Withdrawal by Subject|2|||
23786336|NCT00665925|66597763|FG002|Overall Study|Withdrawal by Subject|3|||
23786337|NCT00665925|66597764|FG003|Overall Study|Withdrawal by Subject|2|||
23786338|NCT00665925|66597761|FG000|Overall Study|Physician Decision|0|||
23346652|NCT00710684|65011089|FG002|Overall Study|Missing|0|||
23346653|NCT00710684|65011087|FG000|Overall Study|Did not continue after week 24|25|||
23346654|NCT00710684|65011088|FG001|Overall Study|Did not continue after week 24|21|||
23346655|NCT00710684|65011089|FG002|Overall Study|Did not continue after week 24|16|||
23346656|NCT01668966|65011090|FG000|Overall Study|Withdrawal by Subject|1|||
23346657|NCT01668966|65011090|FG000|Overall Study|Death|1|||
23346658|NCT01668966|65011090|FG000|Overall Study|Not treated|2|||
23346659|NCT03126019|65011092|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
23346660|NCT03126019|65011093|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
23346661|NCT03126019|65011092|FG000|Overall Study|Death|2|||
23346662|NCT03126019|65011093|FG001|Overall Study|Death|7|||
23346663|NCT03126019|65011092|FG000|Overall Study|Lost to Follow-up|2|||
23346664|NCT03126019|65011093|FG001|Overall Study|Lost to Follow-up|3|||
23346665|NCT03126019|65011092|FG000|Overall Study|Withdrawal by Participant|1|||
23346666|NCT03126019|65011093|FG001|Overall Study|Withdrawal by Participant|3|||
23346667|NCT03126019|65011092|FG000|Overall Study|Reason not Specified|1|||
23346668|NCT03126019|65011093|FG001|Overall Study|Reason not Specified|3|||
23346669|NCT01037127|65011096|FG000|Overall Study|Lost to Follow-up|2|||
23346670|NCT01037127|65011097|FG001|Overall Study|Lost to Follow-up|4|||
23346671|NCT01037127|65011096|FG000|Overall Study|Physician Decision|1|||
23346672|NCT01037127|65011097|FG001|Overall Study|Physician Decision|0|||
23346673|NCT01037127|65011096|FG000|Overall Study|Study Closed Terminated|2|||
23346674|NCT01037127|65011097|FG001|Overall Study|Study Closed Terminated|17|||
23346675|NCT02609724|65011098|FG000|Overall Study|Death|2|||
23346676|NCT02609724|65011099|FG001|Overall Study|Death|0|||
23346677|NCT02609724|65011100|FG002|Overall Study|Death|1|||
23346678|NCT02609724|65011098|FG000|Overall Study|Withdrawal by Subject|1|||
23346679|NCT02609724|65011099|FG001|Overall Study|Withdrawal by Subject|2|||
23346680|NCT02609724|65011100|FG002|Overall Study|Withdrawal by Subject|3|||
23346681|NCT02609724|65011098|FG000|Overall Study|Illness|2|||
23346682|NCT02609724|65011099|FG001|Overall Study|Illness|1|||
23346683|NCT02609724|65011100|FG002|Overall Study|Illness|0|||
23346684|NCT02002533|65011101|FG000|Overall Study|Withdrawal by Subject|6|||
23346685|NCT02002533|65011102|FG001|Overall Study|Withdrawal by Subject|13|||
23346686|NCT02002533|65011101|FG000|Overall Study|Protocol Violation|0|||
23346687|NCT02002533|65011102|FG001|Overall Study|Protocol Violation|1|||
23346688|NCT02002533|65011101|FG000|Overall Study|Adverse Event|0|||
23346689|NCT02002533|65011102|FG001|Overall Study|Adverse Event|3|||
23346690|NCT02002533|65011101|FG000|Overall Study|Lost to Follow-up|0|||
23346691|NCT02002533|65011102|FG001|Overall Study|Lost to Follow-up|1|||
23346692|NCT01088243|65011103|FG000|Overall Study|Adverse Event|1|||
23346693|NCT01088243|65011104|FG001|Overall Study|Adverse Event|0|||
23346694|NCT02817516|65011105|FG000|Overall Study|Other|0|||
23346695|NCT02817516|65011106|FG001|Overall Study|Other|0|||
23346696|NCT02817516|65011107|FG002|Overall Study|Other|1|||
23346697|NCT02817516|65011108|FG003|Overall Study|Other|0|||
23346698|NCT01793688|65011109|FG000|Overall Study|Protocol Violation|2|||
23346699|NCT02607306|65011110|FG000|Overall Study|Adverse Event|8|||
23346700|NCT02607306|65011111|FG001|Overall Study|Adverse Event|6|||
23346701|NCT02607306|65011112|FG002|Overall Study|Adverse Event|6|||
23346702|NCT02607306|65011110|FG000|Overall Study|Unclassified|1|||
23346703|NCT02607306|65011111|FG001|Overall Study|Unclassified|4|||
23346704|NCT02607306|65011112|FG002|Overall Study|Unclassified|0|||
23346705|NCT02607306|65011110|FG000|Overall Study|Withdrawal by Subject|8|||
23346706|NCT02607306|65011111|FG001|Overall Study|Withdrawal by Subject|10|||
23346707|NCT02607306|65011112|FG002|Overall Study|Withdrawal by Subject|2|||
23346708|NCT02607306|65011110|FG000|Overall Study|Lack of Efficacy|0|||
23346709|NCT02607306|65011111|FG001|Overall Study|Lack of Efficacy|1|||
23346710|NCT02607306|65011112|FG002|Overall Study|Lack of Efficacy|1|||
23346711|NCT02607306|65011110|FG000|Overall Study|Protocol Violation|4|||
23346712|NCT02607306|65011111|FG001|Overall Study|Protocol Violation|2|||
23346713|NCT02607306|65011112|FG002|Overall Study|Protocol Violation|1|||
23786339|NCT00665925|66597762|FG001|Overall Study|Physician Decision|0|||
23346714|NCT02791438|65011113|FG000|Treatment Period|Adverse Event|1|||
23346715|NCT02791438|65011114|FG001|Treatment Period|Adverse Event|0|||
23346716|NCT02791438|65011113|FG000|Treatment Period|Withdrawal by Subject|0|||
23346717|NCT02791438|65011114|FG001|Treatment Period|Withdrawal by Subject|1|||
23346718|NCT02791438|65011113|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
23346719|NCT02791438|65011114|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
23346720|NCT03954041|65011115|FG000|Overall Study|Lost to Follow-up|3|||
23346721|NCT03954041|65011116|FG001|Overall Study|Lost to Follow-up|3|||
23346722|NCT03954041|65011117|FG002|Overall Study|Lost to Follow-up|6|||
23346723|NCT03954041|65011115|FG000|Overall Study|Death|4|||
23346724|NCT03954041|65011116|FG001|Overall Study|Death|0|||
23457910|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Adverse Event|1|||
23457911|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Adverse Event|2|||
23457912|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Death|13|||
23457913|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Death|17|||
23457914|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Death|1|||
23457915|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Death|0|||
23457916|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
23457917|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
23457918|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
23457919|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
23457920|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Disease Progression|2|||
23457921|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Disease Progression|0|||
23457922|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Disease Progression|0|||
23457923|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Disease Progression|0|||
23457924|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
23457925|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
23457926|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
23457927|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
23457928|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
23457929|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
23457930|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
23457931|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
23457932|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
23457933|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
23457934|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
23457935|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
23457936|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Participant Decision|9|||
23457937|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Participant Decision|12|||
23457938|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Participant Decision|1|||
23457939|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Participant Decision|1|||
23457940|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
23457941|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
23457942|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
23457943|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
23457944|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
23457945|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
23457946|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
23457947|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
23457948|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457949|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
23457950|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457951|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457952|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
23457953|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
23457954|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
23457955|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
23457956|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
23457957|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
23457958|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
23457959|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
23457960|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
23457961|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457962|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457963|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457964|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
23457965|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
23457966|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
23457967|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
23457968|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
23457969|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
23457970|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
23457971|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
23457972|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
23457973|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23583652|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23457974|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23457975|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23457976|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
23457977|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
23457978|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
23457979|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
23457980|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
23457981|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457982|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457983|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457984|NCT04780061|65419122|FG000|Overall Study|Withdrawal by Subject|5|||
23457985|NCT04780061|65419123|FG001|Overall Study|Withdrawal by Subject|8|||
23457986|NCT04780061|65419122|FG000|Overall Study|Adverse Event|2|||
23457987|NCT04780061|65419123|FG001|Overall Study|Adverse Event|2|||
23457988|NCT04780061|65419122|FG000|Overall Study|Lost to Follow-up|1|||
23457989|NCT04780061|65419123|FG001|Overall Study|Lost to Follow-up|5|||
23457990|NCT03532451|65419124|FG000|Overall Study|Withdrawal by Subject|0|||
23457991|NCT03532451|65419125|FG001|Overall Study|Withdrawal by Subject|1|||
23457992|NCT03532451|65419124|FG000|Overall Study|Did not undergo surgery|1|||
23457993|NCT03532451|65419125|FG001|Overall Study|Did not undergo surgery|1|||
23457994|NCT05316597|65419126|FG000|First Session|Withdrawal by Subject|0|||
23457995|NCT05316597|65419127|FG001|First Session|Withdrawal by Subject|1|||
23457996|NCT05316597|65419126|FG000|Washout Period|Lost to Follow-up|1|||
23457997|NCT05316597|65419127|FG001|Washout Period|Lost to Follow-up|2|||
23457998|NCT05316597|65419126|FG000|Washout Period|Physician Decision|1|||
23457999|NCT05316597|65419127|FG001|Washout Period|Physician Decision|1|||
23458000|NCT05316597|65419126|FG000|Washout Period|Excluded before second session|1|||
23458001|NCT05316597|65419127|FG001|Washout Period|Excluded before second session|1|||
23458002|NCT05316597|65419126|FG000|Washout Period|Withdrawal by Subject|0|||
23458003|NCT05316597|65419127|FG001|Washout Period|Withdrawal by Subject|4|||
23458004|NCT05720897|65419128|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
23458005|NCT05720897|65419129|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
23458006|NCT01772472|65419130|FG000|Overall Study|Death|56|||
23458007|NCT01772472|65419131|FG001|Overall Study|Death|42|||
23458008|NCT01772472|65419130|FG000|Overall Study|Physician Decision|1|||
23458009|NCT01772472|65419131|FG001|Overall Study|Physician Decision|3|||
23458010|NCT01772472|65419130|FG000|Overall Study|Other|5|||
23458011|NCT01772472|65419131|FG001|Overall Study|Other|5|||
23458012|NCT01772472|65419130|FG000|Overall Study|Lost to Follow-up|12|||
23458013|NCT01772472|65419131|FG001|Overall Study|Lost to Follow-up|8|||
23458014|NCT01772472|65419130|FG000|Overall Study|Withdrawal by Subject|72|||
23458015|NCT01772472|65419131|FG001|Overall Study|Withdrawal by Subject|50|||
23458016|NCT01772472|65419130|FG000|Overall Study|Ongoing|597|||
23458017|NCT01772472|65419131|FG001|Overall Study|Ongoing|635|||
23458018|NCT04825678|65419132|FG000|Overall Study|Decision by Sponsor|2|||
23458019|NCT04825678|65419133|FG001|Overall Study|Decision by Sponsor|3|||
23458020|NCT04825678|65419132|FG000|Overall Study|Withdrawal of Consent From Study|7|||
23458021|NCT04825678|65419133|FG001|Overall Study|Withdrawal of Consent From Study|9|||
23458022|NCT04825678|65419132|FG000|Overall Study|Lost to Follow-up|3|||
23458023|NCT04825678|65419133|FG001|Overall Study|Lost to Follow-up|4|||
23458024|NCT04825678|65419132|FG000|Overall Study|Never Received Investigational Product|1|||
23458025|NCT04825678|65419133|FG001|Overall Study|Never Received Investigational Product|1|||
23458026|NCT05635461|65419136|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458027|NCT05635461|65419137|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458028|NCT05635461|65419138|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458029|NCT05635461|65419139|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458030|NCT05635461|65419140|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
23458031|NCT05635461|65419141|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458032|NCT05635461|65419136|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458033|NCT05635461|65419137|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
23458034|NCT05635461|65419138|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458035|NCT05635461|65419139|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458036|NCT05635461|65419140|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23786340|NCT00665925|66597763|FG002|Overall Study|Physician Decision|1|||
23786341|NCT00665925|66597764|FG003|Overall Study|Physician Decision|2|||
23786342|NCT00665925|66597761|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23786343|NCT00665925|66597762|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
23458037|NCT05635461|65419141|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458038|NCT05635461|65419136|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458039|NCT05635461|65419137|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458040|NCT05635461|65419138|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458041|NCT05635461|65419139|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
23458042|NCT05635461|65419140|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23638312|NCT02738853|66060872|FG000|1 Year|Withdrawal by Subject|1|||
23786344|NCT00665925|66597763|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23786345|NCT00665925|66597764|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
23786346|NCT00665925|66597761|FG000|Overall Study|Adverse Event|1|||
23458043|NCT05635461|65419141|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458044|NCT03279081|65419144|FG000|Overall Study|Withdrawal by Subject|12|||
23458045|NCT03279081|65419145|FG001|Overall Study|Withdrawal by Subject|20|||
23458046|NCT03279081|65419144|FG000|Overall Study|Physician Decision|4|||
23458047|NCT03279081|65419145|FG001|Overall Study|Physician Decision|1|||
23458048|NCT03279081|65419144|FG000|Overall Study|Lost to Follow-up|8|||
23458049|NCT03279081|65419145|FG001|Overall Study|Lost to Follow-up|8|||
23458050|NCT03279081|65419144|FG000|Overall Study|Death|0|||
23458051|NCT03279081|65419145|FG001|Overall Study|Death|1|||
23458052|NCT03279081|65419144|FG000|Overall Study|Adverse Event|1|||
23458053|NCT03279081|65419145|FG001|Overall Study|Adverse Event|0|||
23458054|NCT03279081|65419144|FG000|Overall Study|Reason not Specified|14|||
23458055|NCT03279081|65419145|FG001|Overall Study|Reason not Specified|4|||
23458056|NCT02060721|65419148|FG000|Overall Study|Lost to Follow-up|1|||
23458057|NCT02060721|65419148|FG000|Overall Study|Physician Decision|2|||
23458058|NCT02060721|65419148|FG000|Overall Study|Death|14|||
23458059|NCT02060721|65419148|FG000|Overall Study|Withdrawal by Subject|2|||
23458060|NCT02060721|65419148|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
23458061|NCT05082857|65419149|FG000|Overall Study|participants relocated and could not continue|2|||
23458062|NCT05082857|65419150|FG001|Overall Study|participants relocated and could not continue|1|||
23458063|NCT05082857|65419149|FG000|Overall Study|Lost to Follow-up|1|||
23458064|NCT05082857|65419150|FG001|Overall Study|Lost to Follow-up|3|||
23458065|NCT00581308|65419151|FG000|Pre Discharge|Lost to Follow-up|1|||
23458066|NCT00581308|65419151|FG000|Pre Discharge|Device Removed|1|||
23458067|NCT00581308|65419151|FG000|Month 1|Lost to Follow-up|3|||
23458068|NCT00581308|65419151|FG000|Month 1|Withdrawal by Subject|2|||
23458069|NCT00581308|65419151|FG000|Month 1|Device Removed|2|||
23458070|NCT00581308|65419151|FG000|Month 1|Uknown|1|||
23458071|NCT00581308|65419151|FG000|Month 6|Lost to Follow-up|1|||
23458072|NCT00581308|65419151|FG000|Month 6|Withdrawal by Subject|2|||
23458073|NCT00581308|65419151|FG000|Month 12|Death|1|||
23458074|NCT00581308|65419151|FG000|Month 12|Lost to Follow-up|14|||
23458075|NCT00581308|65419151|FG000|Month 12|Withdrawal by Subject|3|||
23458076|NCT00581308|65419151|FG000|Month 12|Device Removed|1|||
23458077|NCT00581308|65419151|FG000|Month 12|Other|1|||
23458078|NCT04532528|65419155|FG000|Overall Study|Adverse Event|12|||
23458079|NCT04532528|65419156|FG001|Overall Study|Adverse Event|17|||
23458080|NCT04532528|65419155|FG000|Overall Study|Withdrawal of consent|16|||
23458081|NCT04532528|65419156|FG001|Overall Study|Withdrawal of consent|17|||
23458082|NCT04532528|65419155|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
23458083|NCT04532528|65419156|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
23458084|NCT04532528|65419155|FG000|Overall Study|Lost to Follow-up|69|||
23458085|NCT04532528|65419156|FG001|Overall Study|Lost to Follow-up|68|||
23458086|NCT04532528|65419155|FG000|Overall Study|Administrative problems|12|||
23458087|NCT04532528|65419156|FG001|Overall Study|Administrative problems|14|||
23458088|NCT04532528|65419155|FG000|Overall Study|Death|3|||
23458089|NCT04532528|65419156|FG001|Overall Study|Death|3|||
23458090|NCT04532528|65419155|FG000|Overall Study|Other|38|||
23458091|NCT04532528|65419156|FG001|Overall Study|Other|46|||
23458092|NCT05615922|65419162|FG000|Overall Study|Lost to Follow-up|1|||
23458093|NCT03104868|65419163|FG000|6 Week Follow up|Lost to Follow-up|5|||
23458094|NCT03104868|65419164|FG001|6 Week Follow up|Lost to Follow-up|8|||
23458095|NCT03104868|65419163|FG000|6 Week Follow up|Death|1|||
23458096|NCT03104868|65419164|FG001|6 Week Follow up|Death|1|||
23458097|NCT03104868|65419163|FG000|6 Week Follow up|Withdrawal by Subject|7|||
23458098|NCT03104868|65419164|FG001|6 Week Follow up|Withdrawal by Subject|6|||
23458099|NCT03104868|65419163|FG000|6 Week Follow up|Completed Later Timepoint|24|||
23458100|NCT03104868|65419164|FG001|6 Week Follow up|Completed Later Timepoint|22|||
23458101|NCT03104868|65419163|FG000|6 Month Follow up|Lost to Follow-up|2|||
23458102|NCT03104868|65419164|FG001|6 Month Follow up|Lost to Follow-up|2|||
23458103|NCT03104868|65419163|FG000|6 Month Follow up|Death|0|||
23458104|NCT03104868|65419164|FG001|6 Month Follow up|Death|1|||
23458105|NCT03104868|65419163|FG000|6 Month Follow up|Completed Later Timepoint|22|||
23458106|NCT03104868|65419164|FG001|6 Month Follow up|Completed Later Timepoint|32|||
23458107|NCT03104868|65419163|FG000|12 Month Follow up|Lost to Follow-up|1|||
23458108|NCT03104868|65419164|FG001|12 Month Follow up|Lost to Follow-up|2|||
23458109|NCT03104868|65419163|FG000|12 Month Follow up|Death|0|||
23458110|NCT03104868|65419164|FG001|12 Month Follow up|Death|1|||
23458111|NCT03104868|65419163|FG000|12 Month Follow up|Withdrawal by Subject|0|||
23458112|NCT03104868|65419164|FG001|12 Month Follow up|Withdrawal by Subject|3|||
23458113|NCT03104868|65419163|FG000|12 Month Follow up|Completed Later Timepoint|32|||
23458114|NCT03104868|65419164|FG001|12 Month Follow up|Completed Later Timepoint|29|||
23458115|NCT03104868|65419163|FG000|18 Month Follow up|Lost to Follow-up|7|||
23458116|NCT03104868|65419164|FG001|18 Month Follow up|Lost to Follow-up|11|||
23458117|NCT03104868|65419163|FG000|18 Month Follow up|Death|2|||
23458118|NCT03104868|65419164|FG001|18 Month Follow up|Death|1|||
23458119|NCT03104868|65419163|FG000|18 Month Follow up|Withdrawal by Subject|1|||
23458120|NCT03104868|65419164|FG001|18 Month Follow up|Withdrawal by Subject|2|||
23458121|NCT03104868|65419163|FG000|18 Month Follow up|Graft Loss|1|||
23458122|NCT03104868|65419164|FG001|18 Month Follow up|Graft Loss|1|||
23458123|NCT03104868|65419163|FG000|18 Month Follow up|Completed Later Timepoint|19|||
23458124|NCT03104868|65419164|FG001|18 Month Follow up|Completed Later Timepoint|20|||
23458125|NCT03104868|65419163|FG000|24 Month Follow up|Lost to Follow-up|15|||
23458126|NCT03104868|65419164|FG001|24 Month Follow up|Lost to Follow-up|16|||
23458127|NCT03104868|65419163|FG000|24 Month Follow up|Death|3|||
23458128|NCT03104868|65419164|FG001|24 Month Follow up|Death|2|||
23458129|NCT03104868|65419163|FG000|24 Month Follow up|Withdrawal by Subject|1|||
23458130|NCT03104868|65419164|FG001|24 Month Follow up|Withdrawal by Subject|0|||
23458131|NCT03104868|65419163|FG000|24 Month Follow up|Graft Loss|2|||
23458132|NCT03104868|65419164|FG001|24 Month Follow up|Graft Loss|0|||
23458133|NCT04338321|65419165|FG000|Overall Study|Adverse Event|4|||
23786347|NCT00665925|66597762|FG001|Overall Study|Adverse Event|5|||
23786348|NCT00665925|66597763|FG002|Overall Study|Adverse Event|10|||
23786349|NCT00665925|66597764|FG003|Overall Study|Adverse Event|5|||
23786350|NCT00665925|66597761|FG000|Overall Study|Enrolled by mistake|0|||
23786351|NCT00665925|66597762|FG001|Overall Study|Enrolled by mistake|0|||
23786352|NCT00665925|66597763|FG002|Overall Study|Enrolled by mistake|0|||
23786353|NCT00665925|66597764|FG003|Overall Study|Enrolled by mistake|1|||
23786354|NCT00665925|66597761|FG000|Overall Study|Due to exclusion criteria|1|||
23786355|NCT00665925|66597762|FG001|Overall Study|Due to exclusion criteria|0|||
23786356|NCT00665925|66597763|FG002|Overall Study|Due to exclusion criteria|0|||
23786357|NCT00665925|66597764|FG003|Overall Study|Due to exclusion criteria|0|||
23786358|NCT03049748|66597765|FG000|Overall Study|Lost to Follow-up|1|||
23786359|NCT03049748|66597766|FG001|Overall Study|Lost to Follow-up|0|||
23786360|NCT03049748|66597765|FG000|Overall Study|Death|3|||
23786361|NCT03049748|66597766|FG001|Overall Study|Death|0|||
23786362|NCT03049748|66597765|FG000|Overall Study|Withdrawal by Subject|0|||
23786363|NCT03049748|66597766|FG001|Overall Study|Withdrawal by Subject|3|||
23786364|NCT03049748|66597765|FG000|Overall Study|Protocol Violation|0|||
23458134|NCT04338321|65419166|FG001|Overall Study|Adverse Event|10|||
23458135|NCT04338321|65419165|FG000|Overall Study|Death|1|||
23458136|NCT04338321|65419166|FG001|Overall Study|Death|1|||
23458137|NCT04338321|65419165|FG000|Overall Study|Lost to Follow-up|4|||
23458138|NCT04338321|65419166|FG001|Overall Study|Lost to Follow-up|9|||
23786365|NCT03049748|66597766|FG001|Overall Study|Protocol Violation|2|||
23786366|NCT03049748|66597765|FG000|Overall Study|Moved out of state (relocation)|0|||
23458139|NCT04338321|65419165|FG000|Overall Study|Withdrawal by Subject|45|||
23458140|NCT04338321|65419166|FG001|Overall Study|Withdrawal by Subject|69|||
23458141|NCT04338321|65419165|FG000|Overall Study|Physician Decision|5|||
23458142|NCT04338321|65419166|FG001|Overall Study|Physician Decision|9|||
23458143|NCT04338321|65419165|FG000|Overall Study|Other|3|||
23458144|NCT04338321|65419166|FG001|Overall Study|Other|10|||
23458145|NCT03562195|65419169|FG000|Overall Study|Adverse Event|0|||
23458146|NCT03562195|65419170|FG001|Overall Study|Adverse Event|6|||
23458147|NCT03562195|65419169|FG000|Overall Study|Lack of Efficacy|0|||
23458148|NCT03562195|65419170|FG001|Overall Study|Lack of Efficacy|5|||
23458149|NCT03562195|65419169|FG000|Overall Study|Protocol Violation|0|||
23458150|NCT03562195|65419170|FG001|Overall Study|Protocol Violation|1|||
23458151|NCT03562195|65419169|FG000|Overall Study|Lost to Follow-up|0|||
23458152|NCT03562195|65419170|FG001|Overall Study|Lost to Follow-up|1|||
23458153|NCT03562195|65419169|FG000|Overall Study|Physician Decision|1|||
23458154|NCT03562195|65419170|FG001|Overall Study|Physician Decision|0|||
23458155|NCT03562195|65419169|FG000|Overall Study|Withdrawal by Subject|3|||
23458156|NCT03562195|65419170|FG001|Overall Study|Withdrawal by Subject|0|||
23458157|NCT05119569|65419174|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
23458158|NCT05119569|65419175|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
23458159|NCT05119569|65419176|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23638313|NCT02738853|66060872|FG000|2 Year|Death|2|||
23786367|NCT03049748|66597766|FG001|Overall Study|Moved out of state (relocation)|1|||
23458160|NCT05119569|65419177|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23458161|NCT05119569|65419174|FG000|Double Blind Treatment Phase|Adverse Event|6|||
23458162|NCT05119569|65419175|FG001|Double Blind Treatment Phase|Adverse Event|0|||
23458163|NCT05119569|65419176|FG002|Double Blind Treatment Phase|Adverse Event|0|||
23458164|NCT05119569|65419177|FG003|Double Blind Treatment Phase|Adverse Event|0|||
23458165|NCT05119569|65419174|FG000|Open Label Extension Phase|Ongoing in the study|0|||
23458166|NCT05119569|65419175|FG001|Open Label Extension Phase|Ongoing in the study|0|||
23786368|NCT00835705|66597769|FG000|First Intervention|Difficulty with vein|1|||
23786369|NCT00835705|66597770|FG001|First Intervention|Difficulty with vein|0|||
23786370|NCT00835705|66597769|FG000|Second Intervention|Difficulty with vein|1|||
23458167|NCT05119569|65419176|FG002|Open Label Extension Phase|Ongoing in the study|65|||
23458168|NCT05119569|65419177|FG003|Open Label Extension Phase|Ongoing in the study|34|||
23638314|NCT02738853|66060872|FG000|2 Year|Lost to Follow-up|1|||
23786371|NCT00835705|66597770|FG001|Second Intervention|Difficulty with vein|0|||
23786372|NCT04723693|66597773|FG000|Overall Study|Withdrawal by Subject|2|||
23458169|NCT03199976|65419178|FG000|Overall Study|Lack of Efficacy|3|||
23458170|NCT03199976|65419179|FG001|Overall Study|Lack of Efficacy|6|||
23458171|NCT03199976|65419180|FG002|Overall Study|Lack of Efficacy|13|||
23458172|NCT03199976|65419178|FG000|Overall Study|Withdrawal by Subject|1|||
23458173|NCT03199976|65419179|FG001|Overall Study|Withdrawal by Subject|0|||
23458174|NCT03199976|65419180|FG002|Overall Study|Withdrawal by Subject|0|||
23458175|NCT03199976|65419178|FG000|Overall Study|Lost to Follow-up|0|||
23458176|NCT03199976|65419179|FG001|Overall Study|Lost to Follow-up|1|||
23458177|NCT03199976|65419180|FG002|Overall Study|Lost to Follow-up|1|||
23346725|NCT03954041|65011117|FG002|Overall Study|Death|1|||
23346726|NCT03954041|65011115|FG000|Overall Study|Death by neurologic criteria|0|||
23346727|NCT03954041|65011116|FG001|Overall Study|Death by neurologic criteria|0|||
23346728|NCT03954041|65011117|FG002|Overall Study|Death by neurologic criteria|1|||
23346729|NCT03954041|65011115|FG000|Overall Study|Reason not specified|7|||
23346730|NCT03954041|65011116|FG001|Overall Study|Reason not specified|4|||
23346731|NCT03954041|65011117|FG002|Overall Study|Reason not specified|2|||
23346732|NCT03954041|65011115|FG000|Overall Study|Withdrew prior to dosing|4|||
23346733|NCT03954041|65011116|FG001|Overall Study|Withdrew prior to dosing|2|||
23346734|NCT03954041|65011117|FG002|Overall Study|Withdrew prior to dosing|0|||
23458178|NCT05712460|65419181|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458179|NCT05712460|65419182|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23638315|NCT02738853|66060872|FG000|3 Year|Death|2|||
23638316|NCT02738853|66060872|FG000|3 Year|Withdrawal by Subject|1|||
23638317|NCT02738853|66060872|FG000|4 Year|Death|9|||
23638318|NCT02738853|66060872|FG000|5 Year|Lost to Follow-up|4|||
23638319|NCT03014479|66060873|FG000|Overall Study|Adverse Event|0|||
23638320|NCT03014479|66060874|FG001|Overall Study|Adverse Event|1|||
23638321|NCT03014479|66060873|FG000|Overall Study|Voluntary Withdrawal|0|||
23638322|NCT03014479|66060874|FG001|Overall Study|Voluntary Withdrawal|2|||
23638323|NCT03014479|66060873|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
23638324|NCT03014479|66060874|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
23638325|NCT01125046|66060877|FG000|First 6 Months of Treatment|Death|1|||
23638326|NCT01125046|66060877|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
23638327|NCT01125046|66060877|FG000|First 6 Months of Treatment|Non-compliance|1|||
23638328|NCT01125046|66060877|FG000|First 6 Months of Treatment|Surgery|1|||
23638329|NCT01125046|66060877|FG000|First 6 Months of Treatment|Progressive Disease|7|||
23638330|NCT01125046|66060877|FG000|First 6 Months of Treatment|Adverse Event|2|||
23638331|NCT01125046|66060877|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
23638332|NCT01125046|66060877|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
23638333|NCT01125046|66060877|FG000|Follow-up/Data Cut Off Point|Death|29|||
23638334|NCT01125046|66060877|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
23638335|NCT04145700|66060884|FG000|Overall Study|Withdrawal by Subject|8|||
23638336|NCT04145700|66060885|FG001|Overall Study|Withdrawal by Subject|3|||
23638337|NCT03762200|66060886|FG000|Overall Study|Death|2|||
23638338|NCT01669577|66060889|FG000|Overall Study|Death|22|||
23638339|NCT01669577|66060889|FG000|Overall Study|Lost to Follow-up|78|||
23638340|NCT01669577|66060889|FG000|Overall Study|Physician Decision|34|||
23638341|NCT00461981|66060892|FG000|Overall Study|Lost to Follow-up|9|||
23638342|NCT00461981|66060893|FG001|Overall Study|Lost to Follow-up|6|||
23786373|NCT00725322|66597776|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
23786374|NCT00725322|66597777|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
23786375|NCT00725322|66597776|FG000|Washout (28 Days)|Protocol Violation|0|||
23786376|NCT00725322|66597777|FG001|Washout (28 Days)|Protocol Violation|1|||
23786377|NCT05034874|66597781|FG000|Overall Study|Withdrawal by Subject|6|||
23786378|NCT05034874|66597782|FG001|Overall Study|Withdrawal by Subject|6|||
23786379|NCT05034874|66597781|FG000|Overall Study|Lost to Follow-up|18|||
23786380|NCT05034874|66597782|FG001|Overall Study|Lost to Follow-up|8|||
23786381|NCT05034874|66597781|FG000|Overall Study|Physician Decision|0|||
23786382|NCT05034874|66597782|FG001|Overall Study|Physician Decision|1|||
23786383|NCT05034874|66597781|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
23786384|NCT05034874|66597782|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
23786385|NCT00834717|66597787|FG000|First Intervention|Adverse Event|1|||
23786386|NCT00834717|66597788|FG001|First Intervention|Adverse Event|0|||
23786387|NCT00834717|66597787|FG000|First Intervention|Withdrawal by Subject|0|||
23786388|NCT00834717|66597788|FG001|First Intervention|Withdrawal by Subject|1|||
23786389|NCT00841659|66597789|FG000|Washout: 2 Weeks|Protocol Violation|1|||
23786390|NCT00841659|66597790|FG001|Washout: 2 Weeks|Protocol Violation|0|||
23786391|NCT01906372|66597793|FG000|Overall Study|Withdrawal by Subject|2|||
23786392|NCT00594035|66597794|FG000|Overall Study|Lost to Follow-up|1|||
23786393|NCT00594035|66597795|FG001|Overall Study|Lost to Follow-up|1|||
23786394|NCT00594035|66597794|FG000|Overall Study|Withdrawal by Subject|1|||
23786395|NCT00594035|66597795|FG001|Overall Study|Withdrawal by Subject|0|||
23786396|NCT00594035|66597794|FG000|Overall Study|Subject transferred to nursing home|0|||
23786397|NCT00594035|66597795|FG001|Overall Study|Subject transferred to nursing home|1|||
23786398|NCT00594035|66597794|FG000|Overall Study|Subject couldn't return due to job|0|||
23786399|NCT00594035|66597795|FG001|Overall Study|Subject couldn't return due to job|1|||
23786400|NCT00418938|66597796|FG000|Overall Study|Reimbursement|1|||
23346735|NCT00435019|65011128|FG000|Overall Study|Adverse Event|1|||
23638343|NCT00461981|66060892|FG000|Overall Study|Withdrawal by Subject|2|||
23638344|NCT00461981|66060893|FG001|Overall Study|Withdrawal by Subject|3|||
23638345|NCT01283152|66060894|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
23638346|NCT01283152|66060895|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
23638347|NCT01283152|66060894|FG000|Overall Study|Refused HESA|1|||
23638348|NCT01283152|66060895|FG001|Overall Study|Refused HESA|0|||
23638349|NCT01056718|66060896|FG000|Overall Study|Withdrawal by Subject|2|||
23786401|NCT00418938|66597797|FG001|Overall Study|Reimbursement|0|||
23638350|NCT01056718|66060896|FG000|Overall Study|Ischemia on baseline stress test|1|||
23638351|NCT01528345|66060897|FG000|Overall Study|Adverse Event|10|||
23638352|NCT01528345|66060898|FG001|Overall Study|Adverse Event|1|||
23638353|NCT01528345|66060897|FG000|Overall Study|Death|1|||
23638354|NCT01528345|66060898|FG001|Overall Study|Death|1|||
23638355|NCT01528345|66060897|FG000|Overall Study|Non-compliance with study treatment|1|||
23786402|NCT00418938|66597796|FG000|Overall Study|Administrative decision|3|||
23786403|NCT00418938|66597797|FG001|Overall Study|Administrative decision|3|||
23786404|NCT00418938|66597796|FG000|Overall Study|Withdrawal by Subject|16|||
23786405|NCT00418938|66597797|FG001|Overall Study|Withdrawal by Subject|15|||
23346736|NCT00435019|65011129|FG001|Overall Study|Adverse Event|0|||
23346737|NCT00435019|65011128|FG000|Overall Study|Lack of Efficacy|1|||
23346738|NCT00435019|65011129|FG001|Overall Study|Lack of Efficacy|2|||
23346739|NCT00435019|65011128|FG000|Overall Study|Protocol Violation|3|||
23346740|NCT00435019|65011129|FG001|Overall Study|Protocol Violation|1|||
23346741|NCT00435019|65011128|FG000|Overall Study|Personal reasons for withdrawal|8|||
23346742|NCT00435019|65011129|FG001|Overall Study|Personal reasons for withdrawal|7|||
23458180|NCT05712460|65419183|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458181|NCT05712460|65419184|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458182|NCT05712460|65419185|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458183|NCT05712460|65419186|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458184|NCT05712460|65419187|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458185|NCT05712460|65419188|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
23458186|NCT05712460|65419189|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458187|NCT05712460|65419190|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23638356|NCT01528345|66060898|FG001|Overall Study|Non-compliance with study treatment|0|||
23638357|NCT01528345|66060897|FG000|Overall Study|Progressive Disease|26|||
23638358|NCT01528345|66060898|FG001|Overall Study|Progressive Disease|40|||
23638359|NCT01528345|66060897|FG000|Overall Study|Study Terminated by Sponsor|4|||
23638360|NCT01528345|66060898|FG001|Overall Study|Study Terminated by Sponsor|8|||
23638361|NCT01528345|66060897|FG000|Overall Study|Subject/Guardian Decision|5|||
23638362|NCT01528345|66060898|FG001|Overall Study|Subject/Guardian Decision|0|||
23638363|NCT01879553|66060901|FG000|Overall Study|Withdrawal by Subject|1|||
23638364|NCT01879553|66060902|FG001|Overall Study|Withdrawal by Subject|0|||
23638365|NCT02285153|66060904|FG000|Overall Study|Adverse Event|1|||
23638366|NCT02285153|66060905|FG001|Overall Study|Adverse Event|0|||
23638367|NCT01803282|66060908|FG000|Overall Study|Progressive Disease|4|||
23638368|NCT01803282|66060909|FG001|Overall Study|Progressive Disease|3|||
23638369|NCT01803282|66060910|FG002|Overall Study|Progressive Disease|6|||
23638370|NCT01803282|66060911|FG003|Overall Study|Progressive Disease|22|||
23638371|NCT01803282|66060912|FG004|Overall Study|Progressive Disease|5|||
23638372|NCT01803282|66060913|FG005|Overall Study|Progressive Disease|8|||
23638373|NCT01803282|66060914|FG006|Overall Study|Progressive Disease|23|||
23638374|NCT01803282|66060915|FG007|Overall Study|Progressive Disease|24|||
23638375|NCT01803282|66060916|FG008|Overall Study|Progressive Disease|3|||
23638376|NCT01803282|66060917|FG009|Overall Study|Progressive Disease|29|||
23638377|NCT01803282|66060918|FG010|Overall Study|Progressive Disease|6|||
23638378|NCT01803282|66060919|FG011|Overall Study|Progressive Disease|11|||
23638379|NCT01803282|66060908|FG000|Overall Study|Death|0|||
23786406|NCT00418938|66597796|FG000|Overall Study|Lost to Follow-up|1|||
23786407|NCT00418938|66597797|FG001|Overall Study|Lost to Follow-up|3|||
23786408|NCT00418938|66597796|FG000|Overall Study|Adverse Event|1|||
23786409|NCT00418938|66597797|FG001|Overall Study|Adverse Event|1|||
23786410|NCT00418938|66597796|FG000|Overall Study|On-going|1|||
23786411|NCT00418938|66597797|FG001|Overall Study|On-going|1|||
23786412|NCT00418938|66597796|FG000|Overall Study|Ineligibility Determined|1|||
23786413|NCT00418938|66597797|FG001|Overall Study|Ineligibility Determined|0|||
23786414|NCT03966911|66597798|FG000|Overall Study|Adverse Event|1|||
23786415|NCT03966911|66597799|FG001|Overall Study|Adverse Event|1|||
23786416|NCT03966911|66597798|FG000|Overall Study|Withdrawal by Subject|8|||
23786417|NCT03966911|66597799|FG001|Overall Study|Withdrawal by Subject|2|||
23786418|NCT03966911|66597798|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
23786419|NCT03966911|66597799|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
23786420|NCT05169710|66597800|FG000|Overall Study|Adverse Event|1|||
23786421|NCT05169710|66597801|FG001|Overall Study|Adverse Event|2|||
23786422|NCT05169710|66597802|FG002|Overall Study|Adverse Event|2|||
23786423|NCT05169710|66597800|FG000|Overall Study|Lost to Follow-up|0|||
23786424|NCT05169710|66597801|FG001|Overall Study|Lost to Follow-up|0|||
23786425|NCT05169710|66597802|FG002|Overall Study|Lost to Follow-up|1|||
23786426|NCT05169710|66597800|FG000|Overall Study|Withdrawal by Subject|2|||
23786427|NCT05169710|66597801|FG001|Overall Study|Withdrawal by Subject|1|||
23786428|NCT05169710|66597802|FG002|Overall Study|Withdrawal by Subject|0|||
23786429|NCT05169710|66597800|FG000|Overall Study|Other Study Discontinuation Reason|0|||
23638380|NCT01803282|66060909|FG001|Overall Study|Death|0|||
23346743|NCT04984681|65011130|FG000|Overall Study|Lost to Follow-up|3|||
23346744|NCT04984681|65011131|FG001|Overall Study|Lost to Follow-up|1|||
23458188|NCT05712460|65419191|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23638381|NCT01803282|66060910|FG002|Overall Study|Death|0|||
23638382|NCT01803282|66060911|FG003|Overall Study|Death|0|||
23638383|NCT01803282|66060912|FG004|Overall Study|Death|2|||
23786430|NCT05169710|66597801|FG001|Overall Study|Other Study Discontinuation Reason|2|||
23786431|NCT05169710|66597802|FG002|Overall Study|Other Study Discontinuation Reason|0|||
23786432|NCT02905435|66597803|FG000|Overall Study|Death|2|||
23786433|NCT02905435|66597803|FG000|Overall Study|Physician Decision|1|||
23786434|NCT02905435|66597803|FG000|Overall Study|Lost to Follow-up|4|||
23346745|NCT03488225|65011132|FG000|Overall Study|Off Protocol Therapy|2|||
23638384|NCT01803282|66060913|FG005|Overall Study|Death|1|||
23458189|NCT05712460|65419192|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458190|NCT03818256|65419193|FG000|Overall Study|Withdrawal by Subject|2|||
23458191|NCT03818256|65419194|FG001|Overall Study|Withdrawal by Subject|2|||
23458192|NCT03818256|65419193|FG000|Overall Study|Adverse Event|3|||
23458193|NCT03818256|65419194|FG001|Overall Study|Adverse Event|1|||
23458194|NCT03818256|65419193|FG000|Overall Study|Lost to Follow-up|0|||
23458195|NCT03818256|65419194|FG001|Overall Study|Lost to Follow-up|5|||
23458196|NCT03818256|65419193|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
23458197|NCT03818256|65419194|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
23458198|NCT03818256|65419193|FG000|Overall Study|Not reporting for scheduled visits|1|||
23458199|NCT03818256|65419194|FG001|Overall Study|Not reporting for scheduled visits|0|||
23458200|NCT03818256|65419193|FG000|Overall Study|Non-compliant with investigational product|1|||
23458201|NCT03818256|65419194|FG001|Overall Study|Non-compliant with investigational product|0|||
23458202|NCT03804528|65419199|FG000|Overall Study|Time Commitment|18|||
23458203|NCT03804528|65419199|FG000|Overall Study|Health Reasons|5|||
23458204|NCT03988400|65419202|FG000|Overall Study|Adverse Event|1|||
23458205|NCT03988400|65419203|FG001|Overall Study|Adverse Event|0|||
23458206|NCT03988400|65419202|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
23638385|NCT01803282|66060914|FG006|Overall Study|Death|1|||
23638386|NCT01803282|66060915|FG007|Overall Study|Death|5|||
23638387|NCT01803282|66060916|FG008|Overall Study|Death|1|||
23638388|NCT01803282|66060917|FG009|Overall Study|Death|1|||
23638389|NCT01803282|66060918|FG010|Overall Study|Death|0|||
23638390|NCT01803282|66060919|FG011|Overall Study|Death|0|||
23638391|NCT01803282|66060908|FG000|Overall Study|Withdrew Consent|0|||
23638392|NCT01803282|66060909|FG001|Overall Study|Withdrew Consent|0|||
23638393|NCT01803282|66060910|FG002|Overall Study|Withdrew Consent|0|||
23638394|NCT01803282|66060911|FG003|Overall Study|Withdrew Consent|6|||
23638395|NCT01803282|66060912|FG004|Overall Study|Withdrew Consent|1|||
23638396|NCT01803282|66060913|FG005|Overall Study|Withdrew Consent|0|||
23346746|NCT03488225|65011132|FG000|Overall Study|Stem Cell Transplant|2|||
23346747|NCT00328094|65011133|FG000|Overall Study|Physician Decision|3|||
23346748|NCT00328094|65011134|FG001|Overall Study|Physician Decision|3|||
23346749|NCT01214252|65011135|FG000|Overall Study|Not eligible per protocol|82|||
23346750|NCT01783821|65011138|FG000|Overall Study|Screen Failure|1|||
23346751|NCT01783821|65011139|FG001|Overall Study|Screen Failure|1|||
23346752|NCT01524783|65011140|FG000|Blinded Period|Adverse Event|64|||
23346753|NCT01524783|65011141|FG001|Blinded Period|Adverse Event|7|||
23346754|NCT01524783|65011142|FG002|Blinded Period|Adverse Event|0|||
23346755|NCT01524783|65011140|FG000|Blinded Period|Disease Progression|89|||
23346756|NCT01524783|65011141|FG001|Blinded Period|Disease Progression|75|||
23346757|NCT01524783|65011142|FG002|Blinded Period|Disease Progression|0|||
23346758|NCT01524783|65011140|FG000|Blinded Period|Withdrawal by Subject|19|||
23346759|NCT01524783|65011141|FG001|Blinded Period|Withdrawal by Subject|6|||
23346760|NCT01524783|65011142|FG002|Blinded Period|Withdrawal by Subject|0|||
23346761|NCT01524783|65011140|FG000|Blinded Period|Protocol deviation|2|||
23346762|NCT01524783|65011141|FG001|Blinded Period|Protocol deviation|1|||
23346763|NCT01524783|65011142|FG002|Blinded Period|Protocol deviation|0|||
23346764|NCT01524783|65011140|FG000|Blinded Period|Death|5|||
23346765|NCT01524783|65011141|FG001|Blinded Period|Death|2|||
23346766|NCT01524783|65011142|FG002|Blinded Period|Death|0|||
23346767|NCT01524783|65011140|FG000|Open-label Period|Disease progression|13|||
23346768|NCT01524783|65011141|FG001|Open-label Period|Disease progression|0|||
23346769|NCT01524783|65011142|FG002|Open-label Period|Disease progression|2|||
23346770|NCT01524783|65011140|FG000|Open-label Period|Administrative problems|5|||
23346771|NCT01524783|65011141|FG001|Open-label Period|Administrative problems|0|||
23458207|NCT03988400|65419203|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
23458208|NCT03988400|65419202|FG000|Overall Study|Lost to Follow-up|0|||
23638397|NCT01803282|66060914|FG006|Overall Study|Withdrew Consent|8|||
23638398|NCT01803282|66060915|FG007|Overall Study|Withdrew Consent|3|||
23638399|NCT01803282|66060916|FG008|Overall Study|Withdrew Consent|1|||
23786435|NCT01709903|66597804|FG000|Overall Study|administrative problems|2|||
23786436|NCT01709903|66597805|FG001|Overall Study|administrative problems|6|||
23346772|NCT01524783|65011142|FG002|Open-label Period|Administrative problems|2|||
23346773|NCT01524783|65011140|FG000|Open-label Period|Adverse Event|5|||
23346774|NCT01524783|65011141|FG001|Open-label Period|Adverse Event|0|||
23346775|NCT01524783|65011142|FG002|Open-label Period|Adverse Event|1|||
23346776|NCT01524783|65011140|FG000|Open-label Period|Withdrawal by Subject|2|||
23346777|NCT01524783|65011141|FG001|Open-label Period|Withdrawal by Subject|0|||
23346778|NCT01524783|65011142|FG002|Open-label Period|Withdrawal by Subject|1|||
23346779|NCT01524783|65011140|FG000|Open-label Period|Protocol deviation|1|||
23346780|NCT01524783|65011141|FG001|Open-label Period|Protocol deviation|0|||
23346781|NCT01524783|65011142|FG002|Open-label Period|Protocol deviation|0|||
23346782|NCT01632904|65011147|FG000|Overall Study|Adverse Event|4|||
23346783|NCT01632904|65011148|FG001|Overall Study|Adverse Event|1|||
23638400|NCT01803282|66060917|FG009|Overall Study|Withdrew Consent|5|||
23638401|NCT01803282|66060918|FG010|Overall Study|Withdrew Consent|0|||
23346784|NCT01632904|65011147|FG000|Overall Study|Physician Decision|0|||
23346785|NCT01632904|65011148|FG001|Overall Study|Physician Decision|1|||
23346786|NCT01632904|65011147|FG000|Overall Study|Subject decision|3|||
23346787|NCT01632904|65011148|FG001|Overall Study|Subject decision|2|||
23346788|NCT01632904|65011147|FG000|Overall Study|Disease Progression|0|||
23346789|NCT01632904|65011148|FG001|Overall Study|Disease Progression|1|||
23346790|NCT01632904|65011147|FG000|Overall Study|Reason for discontinuation not available|0|||
23346791|NCT01632904|65011148|FG001|Overall Study|Reason for discontinuation not available|1|||
23346792|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
23346793|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
23346794|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
23346795|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
23346796|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
23346797|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
23346798|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346799|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
23346800|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346801|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346802|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346803|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346804|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
23346805|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346806|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346807|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346808|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346809|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
23346810|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346811|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346812|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346813|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
23458209|NCT03988400|65419203|FG001|Overall Study|Lost to Follow-up|1|||
23458210|NCT03995368|65419204|FG000|Overall Study|Lost to Follow-up|1|||
23458211|NCT03995368|65419205|FG001|Overall Study|Lost to Follow-up|4|||
23458212|NCT03995368|65419206|FG002|Overall Study|Lost to Follow-up|1|||
23458213|NCT03995368|65419204|FG000|Overall Study|Did not meet inclusion criteria|1|||
23458214|NCT03995368|65419205|FG001|Overall Study|Did not meet inclusion criteria|6|||
23458215|NCT03995368|65419206|FG002|Overall Study|Did not meet inclusion criteria|3|||
23458216|NCT03995368|65419204|FG000|Overall Study|Withdrawal by Subject|0|||
23458217|NCT03995368|65419205|FG001|Overall Study|Withdrawal by Subject|1|||
23458218|NCT03995368|65419206|FG002|Overall Study|Withdrawal by Subject|1|||
23638402|NCT01803282|66060919|FG011|Overall Study|Withdrew Consent|1|||
23638403|NCT01803282|66060908|FG000|Overall Study|Investigator's Discretion|0|||
23458219|NCT02783690|65421233|FG000|Overall Study|Withdrawal by Subject|3|||
23458220|NCT02783690|65421234|FG001|Overall Study|Withdrawal by Subject|3|||
23458221|NCT05430854|65421235|FG000|Overall Study|Trial terminated by Sponsor|39|||
23458222|NCT05430854|65421236|FG001|Overall Study|Trial terminated by Sponsor|50|||
23458223|NCT05430854|65421237|FG002|Overall Study|Trial terminated by Sponsor|46|||
23346814|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346815|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346816|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23458224|NCT05430854|65421235|FG000|Overall Study|Withdrawal by Subject|0|||
23346817|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346818|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346819|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346820|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346821|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
23346822|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346823|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346824|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346825|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346826|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
23346827|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346828|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346829|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346830|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346831|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
23346832|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
23346833|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
23346834|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
23346835|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
23346836|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
23346837|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346838|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346839|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346840|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346841|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
23346842|NCT02407054|65011156|FG000|Overall Study|Adverse Event|1|||
23346843|NCT02407054|65011157|FG001|Overall Study|Adverse Event|4|||
23346844|NCT02407054|65011158|FG002|Overall Study|Adverse Event|1|||
23346845|NCT02407054|65011156|FG000|Overall Study|Non-compliance with Study|0|||
23346846|NCT02407054|65011157|FG001|Overall Study|Non-compliance with Study|2|||
23346847|NCT02407054|65011158|FG002|Overall Study|Non-compliance with Study|1|||
23346848|NCT02407054|65011156|FG000|Overall Study|Physician Decision|1|||
23346849|NCT02407054|65011157|FG001|Overall Study|Physician Decision|3|||
23346850|NCT02407054|65011158|FG002|Overall Study|Physician Decision|3|||
23346851|NCT02407054|65011156|FG000|Overall Study|Withdrawal by Subject|5|||
23346852|NCT02407054|65011157|FG001|Overall Study|Withdrawal by Subject|9|||
23346853|NCT02407054|65011158|FG002|Overall Study|Withdrawal by Subject|2|||
23583653|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583654|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23638404|NCT01803282|66060909|FG001|Overall Study|Investigator's Discretion|0|||
23638405|NCT01803282|66060910|FG002|Overall Study|Investigator's Discretion|0|||
23638406|NCT01803282|66060911|FG003|Overall Study|Investigator's Discretion|7|||
23638407|NCT01803282|66060912|FG004|Overall Study|Investigator's Discretion|2|||
23638408|NCT01803282|66060913|FG005|Overall Study|Investigator's Discretion|1|||
23638409|NCT01803282|66060914|FG006|Overall Study|Investigator's Discretion|7|||
23638410|NCT01803282|66060915|FG007|Overall Study|Investigator's Discretion|10|||
23638411|NCT01803282|66060916|FG008|Overall Study|Investigator's Discretion|6|||
23346854|NCT01472965|65011159|FG000|Overall Study|Withdrawal by Subject|1|||
23583655|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
23583656|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583657|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583658|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583659|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583660|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583661|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583662|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583663|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583664|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583665|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583666|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583667|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583668|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
23638412|NCT01803282|66060917|FG009|Overall Study|Investigator's Discretion|7|||
23638413|NCT01803282|66060918|FG010|Overall Study|Investigator's Discretion|1|||
23638414|NCT01803282|66060919|FG011|Overall Study|Investigator's Discretion|0|||
23786437|NCT01709903|66597804|FG000|Overall Study|Abnormal test procedure results|1|||
23346855|NCT01472965|65011160|FG001|Overall Study|Withdrawal by Subject|0|||
23346856|NCT02912455|65011161|FG000|Overall Study|Withdrawal by Subject|0|||
23346857|NCT02912455|65011162|FG001|Overall Study|Withdrawal by Subject|1|||
23638415|NCT01803282|66060908|FG000|Overall Study|Adverse Event|0|||
23638416|NCT01803282|66060909|FG001|Overall Study|Adverse Event|0|||
23638417|NCT01803282|66060910|FG002|Overall Study|Adverse Event|0|||
23638418|NCT01803282|66060911|FG003|Overall Study|Adverse Event|0|||
23638419|NCT01803282|66060912|FG004|Overall Study|Adverse Event|0|||
23638420|NCT01803282|66060913|FG005|Overall Study|Adverse Event|0|||
23638421|NCT01803282|66060914|FG006|Overall Study|Adverse Event|1|||
23638422|NCT01803282|66060915|FG007|Overall Study|Adverse Event|2|||
23638423|NCT01803282|66060916|FG008|Overall Study|Adverse Event|0|||
23638424|NCT01803282|66060917|FG009|Overall Study|Adverse Event|1|||
23638425|NCT01803282|66060918|FG010|Overall Study|Adverse Event|0|||
23346858|NCT02912455|65011161|FG000|Overall Study|Lack of Efficacy|0|||
23346859|NCT02912455|65011162|FG001|Overall Study|Lack of Efficacy|1|||
23346860|NCT02912455|65011161|FG000|Overall Study|Lost to Follow-up|2|||
23346861|NCT02912455|65011162|FG001|Overall Study|Lost to Follow-up|1|||
23346862|NCT01447927|65011163|FG000|Overall Study|Adverse Event|4|||
23346863|NCT01447927|65011164|FG001|Overall Study|Adverse Event|3|||
23346864|NCT01447927|65011163|FG000|Overall Study|Withdrawal by Subject|1|||
23346865|NCT01447927|65011164|FG001|Overall Study|Withdrawal by Subject|0|||
23346866|NCT00334802|65011165|FG000|Overall Study|Progressive Disease|2|||
23346867|NCT00334802|65011166|FG001|Overall Study|Progressive Disease|24|||
23346868|NCT00334802|65011165|FG000|Overall Study|Toxicity|1|||
23346869|NCT00334802|65011166|FG001|Overall Study|Toxicity|5|||
23346870|NCT00334802|65011165|FG000|Overall Study|Lack of Efficacy|1|||
23346871|NCT00334802|65011166|FG001|Overall Study|Lack of Efficacy|3|||
23346872|NCT00334802|65011165|FG000|Overall Study|Patient Condition Aggrevated|1|||
23346873|NCT00334802|65011166|FG001|Overall Study|Patient Condition Aggrevated|0|||
23346874|NCT00334802|65011165|FG000|Overall Study|Physician Decision|1|||
23346875|NCT00334802|65011166|FG001|Overall Study|Physician Decision|0|||
23346876|NCT00334802|65011165|FG000|Overall Study|Withdrawal by Subject|0|||
23346877|NCT00334802|65011166|FG001|Overall Study|Withdrawal by Subject|4|||
23346878|NCT00334802|65011165|FG000|Overall Study|Adverse Event|0|||
23346879|NCT00334802|65011166|FG001|Overall Study|Adverse Event|3|||
23583669|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583670|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583671|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583672|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583673|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583674|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583675|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583676|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583677|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583678|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583679|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583680|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23638426|NCT01803282|66060919|FG011|Overall Study|Adverse Event|3|||
23638427|NCT01803282|66060908|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23638428|NCT01803282|66060909|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23638429|NCT01803282|66060910|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23346880|NCT00334802|65011165|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
23346881|NCT00334802|65011166|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
23346882|NCT00616603|65011176|FG000|Overall Study|Physician Decision|2|||
23346883|NCT00616603|65011177|FG001|Overall Study|Physician Decision|0|||
23346884|NCT00616603|65011178|FG002|Overall Study|Physician Decision|2|||
23346885|NCT01552915|65011179|FG000|Overall Study|Adverse Event|3|||
23346886|NCT01552915|65011180|FG001|Overall Study|Adverse Event|14|||
23346887|NCT01552915|65011181|FG002|Overall Study|Adverse Event|3|||
23346888|NCT01552915|65011179|FG000|Overall Study|Lost to Follow-up|4|||
23346889|NCT01552915|65011180|FG001|Overall Study|Lost to Follow-up|6|||
23583681|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583682|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
23583683|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583684|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583685|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583686|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583687|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583688|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583689|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583690|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583691|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583692|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583693|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583694|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23638430|NCT01803282|66060911|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23638431|NCT01803282|66060912|FG004|Overall Study|Non-Compliance with Study Drug|0|||
23583695|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583696|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
23583697|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
23583698|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583699|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583700|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583701|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23638432|NCT01803282|66060913|FG005|Overall Study|Non-Compliance with Study Drug|0|||
23638433|NCT01803282|66060914|FG006|Overall Study|Non-Compliance with Study Drug|0|||
23638434|NCT01803282|66060915|FG007|Overall Study|Non-Compliance with Study Drug|0|||
23638435|NCT01803282|66060916|FG008|Overall Study|Non-Compliance with Study Drug|0|||
23638436|NCT01803282|66060917|FG009|Overall Study|Non-Compliance with Study Drug|0|||
23638437|NCT01803282|66060918|FG010|Overall Study|Non-Compliance with Study Drug|0|||
23786438|NCT01709903|66597805|FG001|Overall Study|Abnormal test procedure results|0|||
23786439|NCT01709903|66597804|FG000|Overall Study|In ability to use device|1|||
23786440|NCT01709903|66597805|FG001|Overall Study|In ability to use device|1|||
23786441|NCT01709903|66597804|FG000|Overall Study|no longer needed study drug|0|||
23786442|NCT01709903|66597805|FG001|Overall Study|no longer needed study drug|1|||
23786443|NCT01709903|66597804|FG000|Overall Study|Lost to Follow-up|0|||
23786444|NCT01709903|66597805|FG001|Overall Study|Lost to Follow-up|2|||
23786445|NCT01709903|66597804|FG000|Overall Study|Death|2|||
23786446|NCT01709903|66597805|FG001|Overall Study|Death|0|||
23786447|NCT01709903|66597804|FG000|Overall Study|Protocol Violation|3|||
23786448|NCT01709903|66597805|FG001|Overall Study|Protocol Violation|2|||
23786449|NCT01709903|66597804|FG000|Overall Study|Lack of Efficacy|3|||
23786450|NCT01709903|66597805|FG001|Overall Study|Lack of Efficacy|3|||
23786451|NCT01709903|66597804|FG000|Overall Study|Withdrawal by Subject|6|||
23786452|NCT01709903|66597805|FG001|Overall Study|Withdrawal by Subject|6|||
23786453|NCT01709903|66597804|FG000|Overall Study|Adverse Event|11|||
23786454|NCT01709903|66597805|FG001|Overall Study|Adverse Event|18|||
23786455|NCT01919112|66597806|FG000|Secondary Analysis-day 30|Death|1|||
23786456|NCT01919112|66597807|FG001|Secondary Analysis-day 30|Death|1|||
23786457|NCT01919112|66597808|FG002|Secondary Analysis-day 30|Death|1|||
23786458|NCT01919112|66597806|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
23786459|NCT01919112|66597807|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
23786460|NCT01919112|66597808|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
23786461|NCT01196390|66597809|FG000|Overall Study|Protocol Violation|4|||
23786462|NCT01196390|66597810|FG001|Overall Study|Protocol Violation|5|||
23786463|NCT02061280|66597811|FG000|Overall Study|Protocol Violation|12|||
23786464|NCT02061280|66597812|FG001|Overall Study|Protocol Violation|8|||
23583702|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23786465|NCT02061280|66597811|FG000|Overall Study|moved out of state|0|||
23786466|NCT02061280|66597812|FG001|Overall Study|moved out of state|1|||
23786467|NCT02061280|66597811|FG000|Overall Study|Withdrawal by Subject|1|||
23786468|NCT02061280|66597812|FG001|Overall Study|Withdrawal by Subject|2|||
23346890|NCT01552915|65011181|FG002|Overall Study|Lost to Follow-up|5|||
23786469|NCT02061280|66597811|FG000|Overall Study|Lost to Follow-up|5|||
23786470|NCT02061280|66597812|FG001|Overall Study|Lost to Follow-up|1|||
23786471|NCT01602380|66597813|FG000|Overall Study|Death|147|||
23786472|NCT01602380|66597814|FG001|Overall Study|Death|145|||
23786473|NCT01602380|66597813|FG000|Overall Study|Withdrawal by Subject|39|||
23786474|NCT01602380|66597814|FG001|Overall Study|Withdrawal by Subject|41|||
23786475|NCT01602380|66597813|FG000|Overall Study|Lost to Follow-up|15|||
23786476|NCT01602380|66597814|FG001|Overall Study|Lost to Follow-up|12|||
23786477|NCT01602380|66597813|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23786478|NCT01602380|66597814|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
23786479|NCT01602380|66597813|FG000|Overall Study|Other|2|||
23786480|NCT01602380|66597814|FG001|Overall Study|Other|0|||
23786481|NCT05239195|66597815|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
23786482|NCT05239195|66597816|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
23786483|NCT00152451|66597818|FG000|Overall Study|Adverse Event|4|||
23786484|NCT01075282|66597821|FG000|Overall Study|Withdrawal by Subject|11|||
23786485|NCT01075282|66597822|FG001|Overall Study|Withdrawal by Subject|7|||
23786486|NCT01075282|66597823|FG002|Overall Study|Withdrawal by Subject|11|||
23786487|NCT01075282|66597821|FG000|Overall Study|Adverse Event|9|||
23786488|NCT01075282|66597822|FG001|Overall Study|Adverse Event|8|||
23786489|NCT01075282|66597823|FG002|Overall Study|Adverse Event|5|||
23786490|NCT01075282|66597821|FG000|Overall Study|Entry Criteria Not Met|3|||
23786491|NCT01075282|66597822|FG001|Overall Study|Entry Criteria Not Met|2|||
23786492|NCT01075282|66597823|FG002|Overall Study|Entry Criteria Not Met|0|||
23786493|NCT01075282|66597821|FG000|Overall Study|Lost to Follow-up|3|||
23786494|NCT01075282|66597822|FG001|Overall Study|Lost to Follow-up|3|||
23786495|NCT01075282|66597823|FG002|Overall Study|Lost to Follow-up|3|||
23786496|NCT01075282|66597821|FG000|Overall Study|Physician Decision|3|||
23786497|NCT01075282|66597822|FG001|Overall Study|Physician Decision|3|||
23786498|NCT01075282|66597823|FG002|Overall Study|Physician Decision|3|||
23786499|NCT01075282|66597821|FG000|Overall Study|Lack of Efficacy|1|||
23786500|NCT01075282|66597822|FG001|Overall Study|Lack of Efficacy|1|||
23786501|NCT01075282|66597823|FG002|Overall Study|Lack of Efficacy|0|||
23786502|NCT01075282|66597821|FG000|Overall Study|Treatment Non-compliance|1|||
23786503|NCT01075282|66597822|FG001|Overall Study|Treatment Non-compliance|2|||
23786504|NCT01075282|66597823|FG002|Overall Study|Treatment Non-compliance|2|||
23786505|NCT01075282|66597821|FG000|Overall Study|Protocol Violation|0|||
23786506|NCT01075282|66597822|FG001|Overall Study|Protocol Violation|2|||
23786507|NCT01075282|66597823|FG002|Overall Study|Protocol Violation|1|||
23786508|NCT01075282|66597821|FG000|Overall Study|Death|0|||
23786509|NCT01075282|66597822|FG001|Overall Study|Death|1|||
23786510|NCT01075282|66597823|FG002|Overall Study|Death|2|||
23786511|NCT03599193|66597824|FG000|Overall Study|Adverse Event|0|||
23786512|NCT03599193|66597825|FG001|Overall Study|Adverse Event|2|||
23786513|NCT03599193|66597824|FG000|Overall Study|Withdrawal by Subject|1|||
23786514|NCT03599193|66597825|FG001|Overall Study|Withdrawal by Subject|0|||
23786515|NCT03599193|66597824|FG000|Overall Study|Protocol Violation|1|||
23786516|NCT03599193|66597825|FG001|Overall Study|Protocol Violation|0|||
23786517|NCT03599193|66597824|FG000|Overall Study|Lost to Follow-up|0|||
23786518|NCT03599193|66597825|FG001|Overall Study|Lost to Follow-up|1|||
23786519|NCT00540423|66597826|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23786520|NCT00540423|66597827|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23786521|NCT00540423|66597828|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23786522|NCT00540423|66597826|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
23786523|NCT00540423|66597827|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23786524|NCT00540423|66597828|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
23786525|NCT05479058|66597829|FG000|Overall Study|Withdrawal by Subject|1|||
23786526|NCT05479058|66597830|FG001|Overall Study|Withdrawal by Subject|1|||
23786527|NCT05479058|66597829|FG000|Overall Study|Study terminated by sponsor|10|||
23786528|NCT05479058|66597830|FG001|Overall Study|Study terminated by sponsor|10|||
23346891|NCT01552915|65011179|FG000|Overall Study|Withdrawal by Subject|6|||
23346892|NCT01552915|65011180|FG001|Overall Study|Withdrawal by Subject|4|||
23346893|NCT01552915|65011181|FG002|Overall Study|Withdrawal by Subject|5|||
23346894|NCT01552915|65011179|FG000|Overall Study|Protocol Violation|0|||
23346895|NCT01552915|65011180|FG001|Overall Study|Protocol Violation|4|||
23346896|NCT01552915|65011181|FG002|Overall Study|Protocol Violation|4|||
23346897|NCT01552915|65011179|FG000|Overall Study|Lack of Efficacy|8|||
23346898|NCT01552915|65011180|FG001|Overall Study|Lack of Efficacy|1|||
23346899|NCT01552915|65011181|FG002|Overall Study|Lack of Efficacy|4|||
23346900|NCT01552915|65011179|FG000|Overall Study|Other|2|||
23346901|NCT01552915|65011180|FG001|Overall Study|Other|0|||
23458225|NCT05430854|65421236|FG001|Overall Study|Withdrawal by Subject|3|||
23458226|NCT05430854|65421237|FG002|Overall Study|Withdrawal by Subject|0|||
23458227|NCT03675126|65421238|FG000|Overall Study|Study Terminated by Sponsor|9|||
23458228|NCT03675126|65421238|FG000|Overall Study|Death|2|||
23458229|NCT03675126|65421238|FG000|Overall Study|Withdrawal by Subject|4|||
23458230|NCT02432703|65421244|FG000|Overall Study|Adverse Event|1|||
23583703|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583704|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583705|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583706|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583707|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583708|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583709|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583710|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583711|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
23583712|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23638438|NCT01803282|66060919|FG011|Overall Study|Non-Compliance with Study Drug|0|||
23638439|NCT01803282|66060908|FG000|Overall Study|Unknown Reason|0|||
23638440|NCT01803282|66060909|FG001|Overall Study|Unknown Reason|0|||
23638441|NCT01803282|66060910|FG002|Overall Study|Unknown Reason|0|||
23638442|NCT01803282|66060911|FG003|Overall Study|Unknown Reason|0|||
23638443|NCT01803282|66060912|FG004|Overall Study|Unknown Reason|0|||
23638444|NCT01803282|66060913|FG005|Overall Study|Unknown Reason|0|||
23638445|NCT01803282|66060914|FG006|Overall Study|Unknown Reason|0|||
23638446|NCT01803282|66060915|FG007|Overall Study|Unknown Reason|1|||
23638447|NCT01803282|66060916|FG008|Overall Study|Unknown Reason|0|||
23638448|NCT01803282|66060917|FG009|Overall Study|Unknown Reason|0|||
23638449|NCT01803282|66060918|FG010|Overall Study|Unknown Reason|0|||
23638450|NCT01803282|66060919|FG011|Overall Study|Unknown Reason|0|||
23638451|NCT01803282|66060908|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
23638452|NCT01803282|66060909|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
23638453|NCT01803282|66060910|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
23638454|NCT01803282|66060911|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
23638455|NCT01803282|66060912|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
23638456|NCT01803282|66060913|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
23638457|NCT01803282|66060914|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
23638458|NCT01803282|66060915|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
23638459|NCT01803282|66060916|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
23786529|NCT00849797|66597837|FG000|First Intervention|bad veins|1|||
23346902|NCT01552915|65011181|FG002|Overall Study|Other|6|||
23346903|NCT00535847|65011182|FG000|Overall Study|Adverse Event|5|||
23346904|NCT00535847|65011183|FG001|Overall Study|Adverse Event|3|||
23786530|NCT00849797|66597838|FG001|First Intervention|bad veins|0|||
23786531|NCT00849797|66597837|FG000|First Intervention|Adverse Event|0|||
23786532|NCT00849797|66597838|FG001|First Intervention|Adverse Event|1|||
23346905|NCT00535847|65011184|FG002|Overall Study|Adverse Event|2|||
23458231|NCT02432703|65421245|FG001|Overall Study|Adverse Event|4|||
23458232|NCT02432703|65421244|FG000|Overall Study|Lack of Efficacy|1|||
23458233|NCT02432703|65421245|FG001|Overall Study|Lack of Efficacy|0|||
23786533|NCT00849797|66597837|FG000|Washout: One Week|Withdrawal by Subject|0|||
23786534|NCT00849797|66597838|FG001|Washout: One Week|Withdrawal by Subject|2|||
23786535|NCT00795821|66597842|FG000|Acute Treatment Phase|Adverse Event|23|||
23786536|NCT00795821|66597843|FG001|Acute Treatment Phase|Adverse Event|4|||
23786537|NCT00795821|66597842|FG000|Acute Treatment Phase|Death|1|||
23786538|NCT00795821|66597843|FG001|Acute Treatment Phase|Death|0|||
23786539|NCT00795821|66597842|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
23786540|NCT00795821|66597843|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
23786541|NCT00795821|66597842|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
23786542|NCT00795821|66597843|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
23786543|NCT00795821|66597842|FG000|Acute Treatment Phase|Physician Decision|1|||
23786544|NCT00795821|66597843|FG001|Acute Treatment Phase|Physician Decision|1|||
23786545|NCT00795821|66597842|FG000|Acute Treatment Phase|Protocol Violation|1|||
23786546|NCT00795821|66597843|FG001|Acute Treatment Phase|Protocol Violation|2|||
23786547|NCT00795821|66597842|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
23786548|NCT00795821|66597843|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
23786549|NCT00795821|66597842|FG000|Long-term Extension Phase|Adverse Event|25|||
23786550|NCT00795821|66597843|FG001|Long-term Extension Phase|Adverse Event|32|||
23346906|NCT00535847|65011182|FG000|Overall Study|Non compliance|1|||
23638460|NCT01803282|66060917|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
23346907|NCT00535847|65011183|FG001|Overall Study|Non compliance|1|||
23346908|NCT00535847|65011184|FG002|Overall Study|Non compliance|0|||
23346909|NCT00535847|65011182|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
23346910|NCT00535847|65011183|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
23346911|NCT00535847|65011184|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
23346912|NCT00778102|65011186|FG000|Overall Study|Adverse Event|8|||
23346913|NCT00778102|65011187|FG001|Overall Study|Adverse Event|5|||
23346914|NCT00778102|65011186|FG000|Overall Study|Death|1|||
23346915|NCT00778102|65011187|FG001|Overall Study|Death|1|||
23346916|NCT00778102|65011186|FG000|Overall Study|Lost to Follow-up|1|||
23346917|NCT00778102|65011187|FG001|Overall Study|Lost to Follow-up|0|||
23346918|NCT00778102|65011186|FG000|Overall Study|Violation of Selection Criteria|1|||
23346919|NCT00778102|65011187|FG001|Overall Study|Violation of Selection Criteria|1|||
23346920|NCT00778102|65011186|FG000|Overall Study|Protocol Violation|0|||
23346921|NCT00778102|65011187|FG001|Overall Study|Protocol Violation|1|||
23346922|NCT00778102|65011186|FG000|Overall Study|Refused Treatment|2|||
23346923|NCT00778102|65011187|FG001|Overall Study|Refused Treatment|3|||
23346924|NCT00778102|65011186|FG000|Overall Study|Withdrawal by Subject|1|||
23346925|NCT00778102|65011187|FG001|Overall Study|Withdrawal by Subject|1|||
23346926|NCT00778102|65011186|FG000|Overall Study|Administrative Reason|7|||
23346927|NCT00778102|65011187|FG001|Overall Study|Administrative Reason|10|||
23346928|NCT01706575|65011189|FG000|Overall Study|Participant Withdrew Consent|4|||
23346929|NCT01706575|65011189|FG000|Overall Study|Lost to Follow-up|2|||
23346930|NCT01706575|65011189|FG000|Overall Study|Started but not Treated|6|||
23346931|NCT02267135|65011190|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
23346932|NCT02267135|65011191|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
23346933|NCT02267135|65011190|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
23346934|NCT02267135|65011191|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
23346935|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
23346936|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
23346937|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
23346938|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
23346939|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
23346940|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
23346941|NCT04250350|65011194|FG000|Overall Study|Withdrawal by Subject|13|||
23346942|NCT04250350|65011194|FG000|Overall Study|Lost to Follow-up|8|||
23346943|NCT04250350|65011194|FG000|Overall Study|Adverse Event|5|||
23346944|NCT04250350|65011194|FG000|Overall Study|Lack of Efficacy|4|||
23346945|NCT04250350|65011194|FG000|Overall Study|Physician Decision|1|||
23346946|NCT04250350|65011194|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
23346947|NCT01534208|65014167|FG000|Overall Study|Lost to Follow-up|19|||
23638461|NCT01803282|66060918|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
23638462|NCT01803282|66060919|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
23638463|NCT01803282|66060908|FG000|Overall Study|Enrolled but Never Treated|0|||
23786551|NCT00795821|66597842|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
23786552|NCT00795821|66597843|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
23786553|NCT00795821|66597842|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
23346948|NCT01534208|65014168|FG001|Overall Study|Lost to Follow-up|14|||
23346949|NCT01534208|65014167|FG000|Overall Study|Withdrawal by Subject|6|||
23346950|NCT01534208|65014168|FG001|Overall Study|Withdrawal by Subject|20|||
23346951|NCT01534208|65014167|FG000|Overall Study|Adverse Event|15|||
23638464|NCT01803282|66060909|FG001|Overall Study|Enrolled but Never Treated|0|||
23346952|NCT01534208|65014168|FG001|Overall Study|Adverse Event|8|||
23458234|NCT02432703|65421244|FG000|Overall Study|Lost to Follow-up|5|||
23458235|NCT02432703|65421245|FG001|Overall Study|Lost to Follow-up|3|||
23458236|NCT02432703|65421244|FG000|Overall Study|Withdrawal by Subject|9|||
23458237|NCT02432703|65421245|FG001|Overall Study|Withdrawal by Subject|6|||
23458238|NCT02432703|65421244|FG000|Overall Study|Other|6|||
23458239|NCT02432703|65421245|FG001|Overall Study|Other|5|||
23458240|NCT01602666|65421246|FG000|Induction Chemotherapy|Death|2|||
23458241|NCT01602666|65421247|FG001|Induction Chemotherapy|Death|1|||
23458242|NCT01602666|65421246|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
23458243|NCT01602666|65421247|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
23458244|NCT01602666|65421246|FG000|Induction Chemotherapy|Physician Decision|12|||
23458245|NCT01602666|65421247|FG001|Induction Chemotherapy|Physician Decision|5|||
23458246|NCT01602666|65421246|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
23458247|NCT01602666|65421247|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
23458248|NCT01602666|65421246|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
23458249|NCT01602666|65421247|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
23458250|NCT01602666|65421246|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
23458251|NCT01602666|65421247|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
23458252|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
23458253|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
23458254|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
23458255|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
23346953|NCT01534208|65014167|FG000|Overall Study|Physician Decision|2|||
23346954|NCT01534208|65014168|FG001|Overall Study|Physician Decision|0|||
23346955|NCT01534208|65014167|FG000|Overall Study|Lack of Efficacy|0|||
23346956|NCT01534208|65014168|FG001|Overall Study|Lack of Efficacy|3|||
23346957|NCT01534208|65014167|FG000|Overall Study|Protocol Violation|2|||
23346958|NCT01534208|65014168|FG001|Overall Study|Protocol Violation|2|||
23346959|NCT01534208|65014167|FG000|Overall Study|Sponsor decision|4|||
23346960|NCT01534208|65014168|FG001|Overall Study|Sponsor decision|1|||
23346961|NCT01534208|65014167|FG000|Overall Study|Subject relocation|2|||
23346962|NCT01534208|65014168|FG001|Overall Study|Subject relocation|0|||
23346963|NCT01534208|65014167|FG000|Overall Study|Lab assessment|2|||
23346964|NCT01534208|65014168|FG001|Overall Study|Lab assessment|1|||
23458256|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
23458257|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
23458258|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
23458259|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
23458260|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
23458261|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
23458262|NCT01263769|65421248|FG000|Overall Study|Non-Compliant with treatment|1|||
23458263|NCT04531176|65421249|FG000|Overall Study|Study was stopped early|24|||
23458264|NCT04531176|65421250|FG001|Overall Study|Study was stopped early|26|||
23458265|NCT04531176|65421251|FG002|Overall Study|Study was stopped early|24|||
23458266|NCT04672239|65421252|FG000|Week 2 Survey|Failed survey check items|1|||
23458267|NCT04672239|65421253|FG001|Week 2 Survey|Failed survey check items|2|||
23458268|NCT04672239|65421254|FG002|Week 2 Survey|Failed survey check items|3|||
23458269|NCT04672239|65421252|FG000|Week 2 Survey|Partially completed survey|7|||
23458270|NCT04672239|65421253|FG001|Week 2 Survey|Partially completed survey|1|||
23458271|NCT04672239|65421254|FG002|Week 2 Survey|Partially completed survey|4|||
23458272|NCT04672239|65421252|FG000|Week 2 Survey|Withdrawal by Subject|0|||
23458273|NCT04672239|65421253|FG001|Week 2 Survey|Withdrawal by Subject|1|||
23458274|NCT04672239|65421254|FG002|Week 2 Survey|Withdrawal by Subject|0|||
23458275|NCT04672239|65421252|FG000|Week 2 Survey|Lost to Follow-up|3|||
23458276|NCT04672239|65421253|FG001|Week 2 Survey|Lost to Follow-up|2|||
23458277|NCT04672239|65421254|FG002|Week 2 Survey|Lost to Follow-up|5|||
23458278|NCT04672239|65421252|FG000|Week 6 Survey|Failed survey check items|2|||
23458279|NCT04672239|65421253|FG001|Week 6 Survey|Failed survey check items|2|||
23458280|NCT04672239|65421254|FG002|Week 6 Survey|Failed survey check items|2|||
23458281|NCT04672239|65421252|FG000|Week 6 Survey|Partially completed survey|3|||
23458282|NCT04672239|65421253|FG001|Week 6 Survey|Partially completed survey|3|||
23458283|NCT04672239|65421254|FG002|Week 6 Survey|Partially completed survey|2|||
23458284|NCT04672239|65421252|FG000|Week 6 Survey|Withdrawal by Subject|1|||
23458285|NCT04672239|65421253|FG001|Week 6 Survey|Withdrawal by Subject|1|||
23458286|NCT04672239|65421254|FG002|Week 6 Survey|Withdrawal by Subject|1|||
23458287|NCT04672239|65421252|FG000|Week 6 Survey|Withdrawn by PI|0|||
23458288|NCT04672239|65421253|FG001|Week 6 Survey|Withdrawn by PI|1|||
23346965|NCT01534208|65014167|FG000|Overall Study|Eligibility error|3|||
23346966|NCT01534208|65014168|FG001|Overall Study|Eligibility error|0|||
23458289|NCT04672239|65421254|FG002|Week 6 Survey|Withdrawn by PI|0|||
23458290|NCT04672239|65421252|FG000|Week 6 Survey|Lost to Follow-up|12|||
23458291|NCT04672239|65421253|FG001|Week 6 Survey|Lost to Follow-up|2|||
23458292|NCT04672239|65421254|FG002|Week 6 Survey|Lost to Follow-up|5|||
23458293|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
23458294|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
23458295|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
23458296|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
23458297|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
23458298|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
23458299|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
23458300|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
23458301|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
23458302|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
23458303|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
23458304|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
23458305|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
23458306|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
23458307|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
23458308|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
23458309|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
23458310|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
23458311|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
23458312|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
23458313|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
23458314|NCT03221556|65421256|FG000|Allocation|post-randomization exclusion|0|||
23458315|NCT03221556|65421257|FG001|Allocation|post-randomization exclusion|1|||
23458316|NCT03221556|65421256|FG000|Follow-Up|Withdrawal by Subject|0|||
23458317|NCT03221556|65421257|FG001|Follow-Up|Withdrawal by Subject|1|||
23458318|NCT03748823|65421269|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
23458319|NCT03748823|65421270|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
23458320|NCT03748823|65421269|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
23458321|NCT03748823|65421270|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
23458322|NCT03748823|65421269|FG000|Extension Period|Withdrawal by Subject|9|||
23458323|NCT03748823|65421270|FG001|Extension Period|Withdrawal by Subject|12|||
23458324|NCT03748823|65421269|FG000|Extension Period|Death|2|||
23458325|NCT03748823|65421270|FG001|Extension Period|Death|2|||
23458326|NCT03748823|65421269|FG000|Extension Period|Other than Specified|0|||
23458327|NCT03748823|65421270|FG001|Extension Period|Other than Specified|1|||
23458328|NCT03748823|65421269|FG000|Extension Period|Protocol Violation|1|||
23458329|NCT03748823|65421270|FG001|Extension Period|Protocol Violation|0|||
23458330|NCT03748823|65421269|FG000|Extension Period|Lost to Follow-up|0|||
23458331|NCT03748823|65421270|FG001|Extension Period|Lost to Follow-up|1|||
23458332|NCT03748823|65421269|FG000|Extension Period|Lack of Efficacy|0|||
23458333|NCT03748823|65421270|FG001|Extension Period|Lack of Efficacy|1|||
23458334|NCT03748823|65421269|FG000|Extension Period|Physician Decision|1|||
23458335|NCT03748823|65421270|FG001|Extension Period|Physician Decision|2|||
23458336|NCT00829426|65421271|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23786554|NCT00795821|66597843|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
23786555|NCT00795821|66597842|FG000|Long-term Extension Phase|Physician Decision|1|||
23786556|NCT00795821|66597843|FG001|Long-term Extension Phase|Physician Decision|2|||
23786557|NCT00795821|66597842|FG000|Long-term Extension Phase|Protocol Violation|3|||
23786558|NCT00795821|66597843|FG001|Long-term Extension Phase|Protocol Violation|5|||
23786559|NCT00795821|66597842|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
23786560|NCT00795821|66597843|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
23786561|NCT00795821|66597842|FG000|Taper Phase|Adverse Event|2|||
23786562|NCT00795821|66597843|FG001|Taper Phase|Adverse Event|0|||
23786563|NCT00795821|66597842|FG000|Taper Phase|Lost to Follow-up|1|||
23786564|NCT00795821|66597843|FG001|Taper Phase|Lost to Follow-up|0|||
23458337|NCT00829426|65421272|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23458338|NCT02004236|65421277|FG000|Overall Study|Lack of Efficacy|0|||
23458339|NCT02004236|65421278|FG001|Overall Study|Lack of Efficacy|0|||
23458340|NCT02004236|65421279|FG002|Overall Study|Lack of Efficacy|16|||
23458341|NCT02129699|65421284|FG000|Overall Study|Did not start treatment|3|||
23458342|NCT02129699|65421285|FG001|Overall Study|Did not start treatment|2|||
23458343|NCT00179621|65421290|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
23638465|NCT01803282|66060910|FG002|Overall Study|Enrolled but Never Treated|0|||
23706186|NCT02234583|66301078|FG001|Overall Study|Lack of Efficacy|103|||
23786565|NCT00795821|66597842|FG000|Taper Phase|Physician Decision|2|||
23786566|NCT00795821|66597843|FG001|Taper Phase|Physician Decision|0|||
23786567|NCT00795821|66597842|FG000|Taper Phase|Withdrawal by Subject|4|||
23458344|NCT00179621|65421291|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
23458345|NCT00179621|65421292|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
23458346|NCT00179621|65421293|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
23458347|NCT00179621|65421290|FG000|Double-Blind Period|Adverse Event|2|||
23458348|NCT00179621|65421291|FG001|Double-Blind Period|Adverse Event|7|||
23458349|NCT00179621|65421292|FG002|Double-Blind Period|Adverse Event|4|||
23458350|NCT00179621|65421293|FG003|Double-Blind Period|Adverse Event|0|||
23458351|NCT00179621|65421290|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23458352|NCT00179621|65421291|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23458353|NCT00179621|65421292|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23458354|NCT00179621|65421293|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23458355|NCT00179621|65421290|FG000|Double-Blind Period|Death|0|||
23458356|NCT00179621|65421291|FG001|Double-Blind Period|Death|1|||
23458357|NCT00179621|65421292|FG002|Double-Blind Period|Death|2|||
23583713|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583714|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583715|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583716|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583717|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583718|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583719|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23786568|NCT00795821|66597843|FG001|Taper Phase|Withdrawal by Subject|0|||
23786569|NCT02450539|66597844|FG000|Overall Study|Withdrawal by Subject|12|||
23786570|NCT02450539|66597845|FG001|Overall Study|Withdrawal by Subject|6|||
23786571|NCT02450539|66597844|FG000|Overall Study|Lost to Follow-up|4|||
23786572|NCT02450539|66597845|FG001|Overall Study|Lost to Follow-up|1|||
23786573|NCT03930732|66597846|FG000|Overall Study|Adverse Event|9|||
23786574|NCT03930732|66597847|FG001|Overall Study|Adverse Event|7|||
23786575|NCT03930732|66597846|FG000|Overall Study|Poor compliance to protocol|0|||
23583720|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583721|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23786576|NCT03930732|66597847|FG001|Overall Study|Poor compliance to protocol|1|||
23786577|NCT03930732|66597846|FG000|Overall Study|Withdrawal by Subject|23|||
23458358|NCT00179621|65421293|FG003|Double-Blind Period|Death|0|||
23458359|NCT00179621|65421290|FG000|Double-Blind Period|Protocol Violation|1|||
23458360|NCT00179621|65421291|FG001|Double-Blind Period|Protocol Violation|0|||
23458361|NCT00179621|65421292|FG002|Double-Blind Period|Protocol Violation|0|||
23458362|NCT00179621|65421293|FG003|Double-Blind Period|Protocol Violation|0|||
23786578|NCT03930732|66597847|FG001|Overall Study|Withdrawal by Subject|11|||
23786579|NCT03930732|66597846|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
23786580|NCT03930732|66597847|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
23786581|NCT03930732|66597846|FG000|Overall Study|Other reason not related to COVID-19|5|||
23786582|NCT03930732|66597847|FG001|Overall Study|Other reason not related to COVID-19|8|||
23786583|NCT00663234|66597848|FG000|Overall Study|Not willing to adhere to requirements|1|||
23786584|NCT05604014|66597851|FG000|Overall Study|Lost to Follow-up|13|||
23786585|NCT00635648|66597852|FG000|Overall Study|Adverse Event|12|||
23786586|NCT00635648|66597852|FG000|Overall Study|Withdrawal by Subject|9|||
23786587|NCT00635648|66597852|FG000|Overall Study|Physician Decision|4|||
23786588|NCT00635648|66597852|FG000|Overall Study|Rapid progression of baseline disease|4|||
23786589|NCT00635648|66597852|FG000|Overall Study|Use of other antifungal agent needed|1|||
23786590|NCT00635648|66597852|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
23786591|NCT00635648|66597852|FG000|Overall Study|Noncompliance with protocol|1|||
23786592|NCT00635648|66597852|FG000|Overall Study|Other reason|2|||
23786593|NCT04035187|66597853|FG000|Overall Study|Withdrawal by Subject|2|||
23786594|NCT04035187|66597854|FG001|Overall Study|Withdrawal by Subject|1|||
23786595|NCT04035187|66597855|FG002|Overall Study|Withdrawal by Subject|0|||
23786596|NCT04035187|66597856|FG003|Overall Study|Withdrawal by Subject|0|||
23786597|NCT04035187|66597853|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
23786598|NCT04035187|66597854|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
23346967|NCT01534208|65014167|FG000|Overall Study|PCP decision|1|||
23786599|NCT04035187|66597855|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
23346968|NCT01534208|65014168|FG001|Overall Study|PCP decision|0|||
23346969|NCT01534208|65014167|FG000|Overall Study|Needed prohibited meds|1|||
23346970|NCT01534208|65014168|FG001|Overall Study|Needed prohibited meds|0|||
23346971|NCT04329091|65014171|FG000|Overall Study|Physician Decision|5|||
23346972|NCT01404208|65014174|FG000|Overall Study|Discontinued|3|||
23346973|NCT01404208|65014175|FG001|Overall Study|Discontinued|0|||
23346974|NCT02919267|65014176|FG000|Overall Study|Protocol Violation|0|||
23346975|NCT02919267|65014177|FG001|Overall Study|Protocol Violation|3|||
23346976|NCT02919267|65014178|FG002|Overall Study|Protocol Violation|3|||
23346977|NCT02919267|65014179|FG003|Overall Study|Protocol Violation|4|||
23346978|NCT04481191|65014186|FG000|Overall Study|Withdrawn by parent/guardian|15|||
23346979|NCT04481191|65014187|FG001|Overall Study|Withdrawn by parent/guardian|10|||
23346980|NCT00597012|65014189|FG000|Overall Study|Death|1|||
23346981|NCT00597012|65014190|FG001|Overall Study|Death|1|||
23346982|NCT00597012|65014189|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
23346983|NCT00597012|65014190|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
23346984|NCT00597012|65014189|FG000|Overall Study|Withdrawal by Subject|7|||
23346985|NCT00597012|65014190|FG001|Overall Study|Withdrawal by Subject|4|||
23346986|NCT00597012|65014189|FG000|Overall Study|Ineligible|2|||
23346987|NCT00597012|65014190|FG001|Overall Study|Ineligible|0|||
23346988|NCT00597012|65014189|FG000|Overall Study|Lost to Follow-up|0|||
23346989|NCT00597012|65014190|FG001|Overall Study|Lost to Follow-up|2|||
23346990|NCT02858180|65014191|FG000|Overall Study|Lost to Follow-up|0|||
23346991|NCT02858180|65014192|FG001|Overall Study|Lost to Follow-up|2|||
23346992|NCT01085136|65014196|FG000|Part A|Other Adverse event|223|||
23346993|NCT01085136|65014197|FG001|Part A|Other Adverse event|0|||
23346994|NCT01085136|65014198|FG002|Part A|Other Adverse event|0|||
23346995|NCT01085136|65014196|FG000|Part A|Protocol Violation|3|||
23346996|NCT01085136|65014197|FG001|Part A|Protocol Violation|0|||
23346997|NCT01085136|65014198|FG002|Part A|Protocol Violation|0|||
23346998|NCT01085136|65014196|FG000|Part A|Lost to Follow-up|3|||
23346999|NCT01085136|65014197|FG001|Part A|Lost to Follow-up|0|||
23347000|NCT01085136|65014198|FG002|Part A|Lost to Follow-up|0|||
23347001|NCT01085136|65014196|FG000|Part A|Refusal to continue trial medication|64|||
23347002|NCT01085136|65014197|FG001|Part A|Refusal to continue trial medication|0|||
23347003|NCT01085136|65014198|FG002|Part A|Refusal to continue trial medication|0|||
23347004|NCT01085136|65014196|FG000|Part A|Other reason not defined above|30|||
23347005|NCT01085136|65014197|FG001|Part A|Other reason not defined above|0|||
23347006|NCT01085136|65014198|FG002|Part A|Other reason not defined above|0|||
23347007|NCT01085136|65014196|FG000|Part B|Other AE|0|||
23347008|NCT01085136|65014197|FG001|Part B|Other AE|29|||
23347009|NCT01085136|65014198|FG002|Part B|Other AE|8|||
23347010|NCT01085136|65014196|FG000|Part B|Refusal to continue trial medication|0|||
23347011|NCT01085136|65014197|FG001|Part B|Refusal to continue trial medication|12|||
23347012|NCT01085136|65014198|FG002|Part B|Refusal to continue trial medication|7|||
23347013|NCT01085136|65014196|FG000|Part B|Not treated|0|||
23347014|NCT01085136|65014197|FG001|Part B|Not treated|4|||
23347015|NCT01085136|65014198|FG002|Part B|Not treated|8|||
23347016|NCT01085136|65014196|FG000|Part B|Other reason not defined above|0|||
23786600|NCT04035187|66597856|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
23347017|NCT01085136|65014197|FG001|Part B|Other reason not defined above|6|||
23347018|NCT01085136|65014198|FG002|Part B|Other reason not defined above|3|||
23347019|NCT00623597|65014199|FG000|Overall Study|Failed to return|1|||
23347020|NCT00623597|65014200|FG001|Overall Study|Failed to return|0|||
23347021|NCT01322035|65014205|FG000|Overall Study|Lost to Follow-up|8|||
23347022|NCT01322035|65014206|FG001|Overall Study|Lost to Follow-up|3|||
23347023|NCT00081731|65014209|FG000|Overall Study|scientific integrity issue|8|||
23347024|NCT00081731|65014210|FG001|Overall Study|scientific integrity issue|8|||
23347025|NCT00767039|65014211|FG000|Overall Study|Death|5|||
23347026|NCT00767039|65014212|FG001|Overall Study|Death|2|||
23347027|NCT03332628|65014213|FG000|Overall Study|Physician Decision|2|||
23458363|NCT00179621|65421290|FG000|Double-Blind Period|Other|0|||
23458364|NCT00179621|65421291|FG001|Double-Blind Period|Other|2|||
23458365|NCT00179621|65421292|FG002|Double-Blind Period|Other|2|||
23638466|NCT01803282|66060911|FG003|Overall Study|Enrolled but Never Treated|0|||
23638467|NCT01803282|66060912|FG004|Overall Study|Enrolled but Never Treated|1|||
23347028|NCT01629823|65014221|FG000|Trial Period|Missed visit|11|||
23347029|NCT01629823|65014222|FG001|Trial Period|Missed visit|9|||
23347030|NCT01629823|65014223|FG002|Trial Period|Missed visit|8|||
23347031|NCT01629823|65014221|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347032|NCT01629823|65014222|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347033|NCT01629823|65014223|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347034|NCT01629823|65014221|FG000|Trial Period|Pregnancy|1|||
23347035|NCT01629823|65014222|FG001|Trial Period|Pregnancy|0|||
23347036|NCT01629823|65014223|FG002|Trial Period|Pregnancy|0|||
23347037|NCT01629823|65014221|FG000|Trial Period|Adverse Event|0|||
23347038|NCT01629823|65014222|FG001|Trial Period|Adverse Event|1|||
23458366|NCT00179621|65421293|FG003|Double-Blind Period|Other|0|||
23347039|NCT01629823|65014223|FG002|Trial Period|Adverse Event|0|||
23347040|NCT01629823|65014221|FG000|Trial Period|Out-of-window visit|0|||
23347041|NCT01629823|65014222|FG001|Trial Period|Out-of-window visit|2|||
23347042|NCT01629823|65014223|FG002|Trial Period|Out-of-window visit|0|||
23347043|NCT01629823|65014221|FG000|Trial Period|Failed to hold medication|0|||
23347044|NCT01629823|65014222|FG001|Trial Period|Failed to hold medication|0|||
23347045|NCT01629823|65014223|FG002|Trial Period|Failed to hold medication|1|||
23347046|NCT01629823|65014221|FG000|Washout Period|Safety|2|||
23347047|NCT01629823|65014222|FG001|Washout Period|Safety|5|||
23347048|NCT01629823|65014223|FG002|Washout Period|Safety|0|||
23347049|NCT01629823|65014221|FG000|Washout Period|Pregnancy|1|||
23347050|NCT01629823|65014222|FG001|Washout Period|Pregnancy|0|||
23347051|NCT01629823|65014223|FG002|Washout Period|Pregnancy|0|||
23347052|NCT01629823|65014221|FG000|Washout Period|Protocol Violation|0|||
23347053|NCT01629823|65014222|FG001|Washout Period|Protocol Violation|1|||
23347054|NCT01629823|65014223|FG002|Washout Period|Protocol Violation|0|||
23347055|NCT00793546|65014224|FG000|Overall Study|Death|3|||
23347056|NCT00793546|65014225|FG001|Overall Study|Death|0|||
23347057|NCT00793546|65014224|FG000|Overall Study|Lost to Follow-up|1|||
23347058|NCT00793546|65014225|FG001|Overall Study|Lost to Follow-up|0|||
23347059|NCT00793546|65014224|FG000|Overall Study|Withdrawal by Subject|1|||
23347060|NCT00793546|65014225|FG001|Overall Study|Withdrawal by Subject|1|||
23347061|NCT00793546|65014224|FG000|Overall Study|Study Terminated by Sponsor|8|||
23786601|NCT02440711|66597857|FG000|Second Intervention|Lost to Follow-up|1|||
23786602|NCT02440711|66597858|FG001|Second Intervention|Lost to Follow-up|0|||
23347062|NCT00793546|65014225|FG001|Overall Study|Study Terminated by Sponsor|27|||
23786603|NCT05394350|66597859|FG000|Overall Study|Death|2|||
23786604|NCT05394350|66597860|FG001|Overall Study|Death|2|||
23786605|NCT05394350|66597861|FG002|Overall Study|Death|4|||
23786606|NCT05394350|66597862|FG003|Overall Study|Death|0|||
23786607|NCT05394350|66597863|FG004|Overall Study|Death|1|||
23786608|NCT05394350|66597864|FG005|Overall Study|Death|0|||
23786609|NCT05394350|66597859|FG000|Overall Study|Study terminated by sponsor|1|||
23347063|NCT00793546|65014224|FG000|Overall Study|Other|1|||
23347064|NCT00793546|65014225|FG001|Overall Study|Other|0|||
23347065|NCT00622336|65014226|FG000|Treatment Phase|Progression of Disease|181|||
23347066|NCT00622336|65014226|FG000|Treatment Phase|Adverse Event|46|||
23347067|NCT00622336|65014226|FG000|Treatment Phase|Other|40|||
23347068|NCT00622336|65014226|FG000|Treatment Phase|Death|14|||
23347069|NCT00622336|65014226|FG000|Treatment Phase|Lack of therapeutic effect|13|||
23347070|NCT00622336|65014226|FG000|Treatment Phase|Withdrawal by Subject|13|||
23347071|NCT00622336|65014226|FG000|Treatment Phase|Lost to Follow-up|2|||
23347072|NCT00622336|65014226|FG000|Extension Phase|Adverse Event|2|||
23347073|NCT00622336|65014226|FG000|Extension Phase|Progressive Disease|6|||
23347074|NCT00622336|65014226|FG000|Extension Phase|Lack of therapeutic effect|2|||
23347075|NCT00622336|65014226|FG000|Extension Phase|Withdrawal by Subject|1|||
23347076|NCT00622336|65014226|FG000|Extension Phase|Lost to Follow-up|1|||
23347077|NCT00622336|65014226|FG000|Extension Phase|Other|9|||
23347078|NCT01730534|65014227|FG000|Overall Study|Withdrawal by Subject|97|||
23347079|NCT01730534|65014228|FG001|Overall Study|Withdrawal by Subject|127|||
23347080|NCT01730534|65014227|FG000|Overall Study|Lost to Follow-up|12|||
23347081|NCT01730534|65014228|FG001|Overall Study|Lost to Follow-up|18|||
23347082|NCT00177307|65014229|FG000|Overall Study|Withdrawal by Subject|1|||
23347083|NCT04007107|65014233|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347084|NCT04007107|65014234|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
23347085|NCT04007107|65014235|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347086|NCT04007107|65014236|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347087|NCT02306694|65014238|FG000|Overall Study|Withdrawal by Subject|3|||
23347088|NCT02306694|65014238|FG000|Overall Study|Lost to Follow-up|1|||
23347089|NCT00157820|65014239|FG000|Randomized|Physician Decision|4|||
23347090|NCT00157820|65014240|FG001|Randomized|Physician Decision|2|||
23347091|NCT00157820|65014241|FG002|Randomized|Physician Decision|3|||
23347092|NCT00157820|65014239|FG000|Randomized|Withdrawal by Subject|1|||
23347093|NCT00157820|65014240|FG001|Randomized|Withdrawal by Subject|2|||
23347094|NCT00157820|65014241|FG002|Randomized|Withdrawal by Subject|3|||
23347095|NCT00157820|65014239|FG000|Randomized|Protocol Violation|2|||
23347096|NCT00157820|65014240|FG001|Randomized|Protocol Violation|1|||
23347097|NCT00157820|65014241|FG002|Randomized|Protocol Violation|2|||
23347098|NCT00157820|65014239|FG000|1st 8 Month|Death|7|||
23347099|NCT00157820|65014240|FG001|1st 8 Month|Death|8|||
23347100|NCT00157820|65014241|FG002|1st 8 Month|Death|3|||
23347101|NCT00157820|65014239|FG000|1st 8 Month|Lost to Follow-up|1|||
23347102|NCT00157820|65014240|FG001|1st 8 Month|Lost to Follow-up|2|||
23347103|NCT00157820|65014241|FG002|1st 8 Month|Lost to Follow-up|1|||
23347104|NCT00157820|65014239|FG000|1st 8 Month|Premature cross-over|0|||
23347105|NCT00157820|65014240|FG001|1st 8 Month|Premature cross-over|2|||
23347106|NCT00157820|65014241|FG002|1st 8 Month|Premature cross-over|2|||
23347107|NCT00157820|65014239|FG000|2nd 8 Months|Death|3|||
23786610|NCT05394350|66597860|FG001|Overall Study|Study terminated by sponsor|1|||
23786611|NCT05394350|66597861|FG002|Overall Study|Study terminated by sponsor|7|||
23786612|NCT05394350|66597862|FG003|Overall Study|Study terminated by sponsor|3|||
23347108|NCT00157820|65014240|FG001|2nd 8 Months|Death|1|||
23347109|NCT00157820|65014241|FG002|2nd 8 Months|Death|3|||
23347110|NCT00157820|65014239|FG000|2nd 8 Months|Lost to Follow-up|1|||
23347111|NCT00157820|65014240|FG001|2nd 8 Months|Lost to Follow-up|5|||
23347112|NCT00157820|65014241|FG002|2nd 8 Months|Lost to Follow-up|2|||
23347113|NCT00157820|65014239|FG000|2nd 8 Months|Premature cross-over|1|||
23347114|NCT00157820|65014240|FG001|2nd 8 Months|Premature cross-over|7|||
23347115|NCT00157820|65014241|FG002|2nd 8 Months|Premature cross-over|9|||
23347116|NCT03199612|65014245|FG000|Overall Study|Adverse Event|1|||
23347117|NCT03199612|65014246|FG001|Overall Study|Adverse Event|0|||
23347118|NCT02071082|65014248|FG000|Overall Study|Enrolled and Never Treated|1|||
23347119|NCT02071082|65014249|FG001|Overall Study|Enrolled and Never Treated|1|||
23347120|NCT02071082|65014248|FG000|Overall Study|Adverse Event|0|||
23347121|NCT02071082|65014249|FG001|Overall Study|Adverse Event|1|||
23347122|NCT02071082|65014248|FG000|Overall Study|Withdrew Consent|0|||
23347123|NCT02071082|65014249|FG001|Overall Study|Withdrew Consent|4|||
23347124|NCT02071082|65014248|FG000|Overall Study|Lost to Follow-up|1|||
23347125|NCT02071082|65014249|FG001|Overall Study|Lost to Follow-up|1|||
23347126|NCT02450552|65014252|FG000|Overall Study|Withdrawal by Subject|4|||
23347127|NCT02450552|65014253|FG001|Overall Study|Withdrawal by Subject|0|||
23347128|NCT02450552|65014254|FG002|Overall Study|Withdrawal by Subject|4|||
23347129|NCT02450552|65014252|FG000|Overall Study|Physician Decision|1|||
23347130|NCT02450552|65014253|FG001|Overall Study|Physician Decision|0|||
23347131|NCT02450552|65014254|FG002|Overall Study|Physician Decision|1|||
23347132|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
23347133|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
23347134|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
23347135|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
23347136|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
23347137|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
23347138|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
23347139|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
23347140|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
23347141|NCT02604550|65014256|FG000|Overall Study|Lost to Follow-up|7|||
23347142|NCT02604550|65014257|FG001|Overall Study|Lost to Follow-up|6|||
23347143|NCT02604550|65014256|FG000|Overall Study|Withdrawal by Subject|0|||
23347144|NCT02604550|65014257|FG001|Overall Study|Withdrawal by Subject|1|||
23347145|NCT02604550|65014256|FG000|Overall Study|Incomplete data using paper journal|18|||
23347146|NCT02604550|65014257|FG001|Overall Study|Incomplete data using paper journal|19|||
23347147|NCT02370667|65014260|FG000|Overall Study|Lost to Follow-up|0|||
23347148|NCT02370667|65014261|FG001|Overall Study|Lost to Follow-up|1|||
23347149|NCT02370667|65014262|FG002|Overall Study|Lost to Follow-up|0|||
23347150|NCT01625689|65014264|FG000|Overall Study|Migration|2|||
23347151|NCT01625689|65014265|FG001|Overall Study|Migration|1|||
23347152|NCT00636194|65014266|FG000|Overall Study|Study related symptoms and complaints|1|||
23347153|NCT00636194|65014267|FG001|Overall Study|Study related symptoms and complaints|0|||
23347154|NCT00636194|65014266|FG000|Overall Study|Protocol Violation|2|||
23347155|NCT00636194|65014267|FG001|Overall Study|Protocol Violation|0|||
23347156|NCT03197870|65014268|FG000|Overall Study|Adverse Event|9|||
23347157|NCT03197870|65014269|FG001|Overall Study|Adverse Event|4|||
23347158|NCT03197870|65014270|FG002|Overall Study|Adverse Event|6|||
23347159|NCT03197870|65014268|FG000|Overall Study|Withdrawal by Subject|2|||
23347160|NCT03197870|65014269|FG001|Overall Study|Withdrawal by Subject|3|||
23347161|NCT03197870|65014270|FG002|Overall Study|Withdrawal by Subject|0|||
23347162|NCT03197870|65014268|FG000|Overall Study|Lost to Follow-up|2|||
23347163|NCT03197870|65014269|FG001|Overall Study|Lost to Follow-up|2|||
23347164|NCT03197870|65014270|FG002|Overall Study|Lost to Follow-up|0|||
23347165|NCT03197870|65014268|FG000|Overall Study|data not available|1|||
23347166|NCT03197870|65014269|FG001|Overall Study|data not available|1|||
23347167|NCT03197870|65014270|FG002|Overall Study|data not available|0|||
23347168|NCT02195427|65014273|FG000|Overall Study|Did not consent to study extension|13|||
23347169|NCT02195427|65014274|FG001|Overall Study|Did not consent to study extension|9|||
23347170|NCT02195427|65014273|FG000|Overall Study|Withdrawal by Subject|4|||
23347171|NCT02195427|65014274|FG001|Overall Study|Withdrawal by Subject|2|||
23347172|NCT02195427|65014273|FG000|Overall Study|Lost to Follow-up|0|||
23347173|NCT02195427|65014274|FG001|Overall Study|Lost to Follow-up|1|||
23347174|NCT02195427|65014273|FG000|Overall Study|Protocol Violation|7|||
23347175|NCT02195427|65014274|FG001|Overall Study|Protocol Violation|14|||
23347176|NCT02195427|65014273|FG000|Overall Study|Conditional re-treatment at W52|2|||
23347177|NCT02195427|65014274|FG001|Overall Study|Conditional re-treatment at W52|1|||
23347178|NCT03782974|65014277|FG000|Overall Study|Withdrawal by Subject|7|||
23347179|NCT03782974|65014278|FG001|Overall Study|Withdrawal by Subject|7|||
23347180|NCT03782974|65014277|FG000|Overall Study|Pregnancy|1|||
23347181|NCT03782974|65014278|FG001|Overall Study|Pregnancy|0|||
23347182|NCT03787303|65014279|FG000|Overall Study|Death|1|||
23347183|NCT03787303|65014279|FG000|Overall Study|Premature Termination of Study|1|||
23347184|NCT01955109|65014283|FG000|Overall Study|Adverse Event|2|||
23347185|NCT01955109|65014284|FG001|Overall Study|Adverse Event|0|||
23347186|NCT01955109|65014283|FG000|Overall Study|Participant unwilling to continue|35|||
23347187|NCT01955109|65014284|FG001|Overall Study|Participant unwilling to continue|7|||
23347188|NCT01955109|65014283|FG000|Overall Study|Physician Decision|2|||
23347189|NCT01955109|65014284|FG001|Overall Study|Physician Decision|0|||
23347190|NCT01955109|65014283|FG000|Overall Study|Lost to Follow-up|3|||
23347191|NCT01955109|65014284|FG001|Overall Study|Lost to Follow-up|1|||
23347192|NCT01955109|65014283|FG000|Overall Study|Non-compliance|3|||
23347193|NCT01955109|65014284|FG001|Overall Study|Non-compliance|1|||
23347194|NCT01844505|65014285|FG000|Overall Study|Disease progression|170|||
23347195|NCT01844505|65014286|FG001|Overall Study|Disease progression|88|||
23347196|NCT01844505|65014287|FG002|Overall Study|Disease progression|224|||
23347197|NCT01844505|65014285|FG000|Overall Study|Study drug toxicity|40|||
23347198|NCT01844505|65014286|FG001|Overall Study|Study drug toxicity|131|||
23347199|NCT01844505|65014287|FG002|Overall Study|Study drug toxicity|50|||
23347200|NCT01844505|65014285|FG000|Overall Study|Death|1|||
23347201|NCT01844505|65014286|FG001|Overall Study|Death|3|||
23347202|NCT01844505|65014287|FG002|Overall Study|Death|1|||
23347203|NCT01844505|65014285|FG000|Overall Study|Adverse event unrelated to study drug|7|||
23347204|NCT01844505|65014286|FG001|Overall Study|Adverse event unrelated to study drug|15|||
23347205|NCT01844505|65014287|FG002|Overall Study|Adverse event unrelated to study drug|6|||
23347206|NCT01844505|65014285|FG000|Overall Study|Subject request discontinue treatment|17|||
23347207|NCT01844505|65014286|FG001|Overall Study|Subject request discontinue treatment|14|||
23347208|NCT01844505|65014287|FG002|Overall Study|Subject request discontinue treatment|8|||
23458367|NCT00179621|65421290|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
23458368|NCT00179621|65421291|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
23458369|NCT00179621|65421292|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
23458370|NCT00179621|65421293|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
23458371|NCT00179621|65421290|FG000|Open-Label Period|Adverse Event|0|||
23458372|NCT00179621|65421291|FG001|Open-Label Period|Adverse Event|6|||
23458373|NCT00179621|65421292|FG002|Open-Label Period|Adverse Event|5|||
23458374|NCT00179621|65421293|FG003|Open-Label Period|Adverse Event|6|||
23458375|NCT00179621|65421290|FG000|Open-Label Period|Withdrawal by Subject|0|||
23458376|NCT00179621|65421291|FG001|Open-Label Period|Withdrawal by Subject|2|||
23786613|NCT05394350|66597863|FG004|Overall Study|Study terminated by sponsor|2|||
23786614|NCT05394350|66597864|FG005|Overall Study|Study terminated by sponsor|4|||
23786615|NCT02028715|66597870|FG000|Overall Study|Adverse Event|2|||
23786616|NCT02028715|66597871|FG001|Overall Study|Adverse Event|2|||
23786617|NCT02028715|66597870|FG000|Overall Study|Physician Decision|1|||
23786618|NCT02028715|66597871|FG001|Overall Study|Physician Decision|0|||
23786619|NCT02028715|66597870|FG000|Overall Study|Did not complete satisfaction surveys|2|||
23786620|NCT02028715|66597871|FG001|Overall Study|Did not complete satisfaction surveys|2|||
23786621|NCT00354159|66597872|FG000|Randomized Study Period|Withdrawal by Subject|5|||
23786622|NCT00354159|66597873|FG001|Randomized Study Period|Withdrawal by Subject|3|||
23786623|NCT00354159|66597872|FG000|Randomized Study Period|Physician Decision|6|||
23786624|NCT00354159|66597873|FG001|Randomized Study Period|Physician Decision|10|||
23786625|NCT00354159|66597872|FG000|Randomized Study Period|Lost to Follow-up|4|||
23786626|NCT00354159|66597873|FG001|Randomized Study Period|Lost to Follow-up|0|||
23786627|NCT00354159|66597872|FG000|Randomized Study Period|Death|7|||
23786628|NCT00354159|66597873|FG001|Randomized Study Period|Death|9|||
23786629|NCT00354159|66597872|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
23786630|NCT00354159|66597873|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
23786631|NCT00354159|66597872|FG000|Long-term Follow-up|Physician Decision|127|||
23786632|NCT00354159|66597873|FG001|Long-term Follow-up|Physician Decision|122|||
23786633|NCT00354159|66597872|FG000|Long-term Follow-up|Lost to Follow-up|1|||
23786634|NCT00354159|66597873|FG001|Long-term Follow-up|Lost to Follow-up|0|||
23786635|NCT00354159|66597872|FG000|Long-term Follow-up|Death|14|||
23786636|NCT00354159|66597873|FG001|Long-term Follow-up|Death|11|||
23786637|NCT00354159|66597872|FG000|Long-term Follow-up|Study Closed|29|||
23786638|NCT00354159|66597873|FG001|Long-term Follow-up|Study Closed|34|||
23786639|NCT01456221|66597874|FG000|Overall Study|Withdrawal by Subject|56|||
23786640|NCT01456221|66597875|FG001|Overall Study|Withdrawal by Subject|49|||
23347209|NCT01844505|65014285|FG000|Overall Study|Withdrawal by Subject|0|||
23347210|NCT01844505|65014286|FG001|Overall Study|Withdrawal by Subject|3|||
23458377|NCT00179621|65421292|FG002|Open-Label Period|Withdrawal by Subject|2|||
23786641|NCT01456221|66597874|FG000|Overall Study|Lost to Follow-up|1|||
23786642|NCT01456221|66597875|FG001|Overall Study|Lost to Follow-up|4|||
23347211|NCT01844505|65014287|FG002|Overall Study|Withdrawal by Subject|0|||
23786643|NCT01456221|66597874|FG000|Overall Study|Received medication|3|||
23786644|NCT01456221|66597875|FG001|Overall Study|Received medication|2|||
23786645|NCT01456221|66597874|FG000|Overall Study|Incomplete data|4|||
23786646|NCT01456221|66597875|FG001|Overall Study|Incomplete data|2|||
23786647|NCT03629054|66597878|FG000|Period 2 (4 Days)|Not treated|0|||
23347212|NCT01844505|65014285|FG000|Overall Study|Lost to Follow-up|1|||
23347213|NCT01844505|65014286|FG001|Overall Study|Lost to Follow-up|0|||
23347214|NCT01844505|65014287|FG002|Overall Study|Lost to Follow-up|0|||
23347215|NCT01844505|65014285|FG000|Overall Study|Maximum clinical benefit|8|||
23458378|NCT00179621|65421293|FG003|Open-Label Period|Withdrawal by Subject|2|||
23583722|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583723|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583724|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
23583725|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
23583726|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583727|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583728|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583729|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583730|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583731|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583732|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583733|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583734|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583735|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583736|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583737|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583738|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583739|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583740|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583741|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583742|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583743|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583744|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
23583745|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583746|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583747|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583748|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583749|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583750|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583751|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583752|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583753|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23638468|NCT01803282|66060913|FG005|Overall Study|Enrolled but Never Treated|0|||
23347216|NCT01844505|65014286|FG001|Overall Study|Maximum clinical benefit|11|||
23347217|NCT01844505|65014287|FG002|Overall Study|Maximum clinical benefit|2|||
23347218|NCT01844505|65014285|FG000|Overall Study|Poor/non-compliance|1|||
23347219|NCT01844505|65014286|FG001|Overall Study|Poor/non-compliance|1|||
23458379|NCT00179621|65421290|FG000|Open-Label Period|Death|0|||
23638469|NCT01803282|66060914|FG006|Overall Study|Enrolled but Never Treated|1|||
23638470|NCT01803282|66060915|FG007|Overall Study|Enrolled but Never Treated|1|||
23638471|NCT01803282|66060916|FG008|Overall Study|Enrolled but Never Treated|0|||
23638472|NCT01803282|66060917|FG009|Overall Study|Enrolled but Never Treated|1|||
23638473|NCT01803282|66060918|FG010|Overall Study|Enrolled but Never Treated|0|||
23786648|NCT03629054|66597879|FG001|Period 2 (4 Days)|Not treated|1|||
23786649|NCT02300103|66597880|FG000|Overall Study|Lack of Efficacy|3|||
23786650|NCT02300103|66597880|FG000|Overall Study|Protocol Violation|1|||
23458380|NCT00179621|65421291|FG001|Open-Label Period|Death|0|||
23458381|NCT00179621|65421292|FG002|Open-Label Period|Death|1|||
23347220|NCT01844505|65014287|FG002|Overall Study|Poor/non-compliance|1|||
23347221|NCT01844505|65014285|FG000|Overall Study|Subject no longer meets criteria|0|||
23347222|NCT01844505|65014286|FG001|Overall Study|Subject no longer meets criteria|1|||
23347223|NCT01844505|65014287|FG002|Overall Study|Subject no longer meets criteria|0|||
23347224|NCT01844505|65014285|FG000|Overall Study|Other Reasons|4|||
23458382|NCT00179621|65421293|FG003|Open-Label Period|Death|2|||
23786651|NCT02300103|66597880|FG000|Overall Study|Withdrew Consent|2|||
23458383|NCT00179621|65421290|FG000|Open-Label Period|Other|0|||
23786652|NCT02272803|66597881|FG000|Overall Study|Disease progression|16|||
23786653|NCT02272803|66597882|FG001|Overall Study|Disease progression|8|||
23786654|NCT02272803|66597881|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
23786655|NCT02272803|66597882|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
23786656|NCT02272803|66597881|FG000|Overall Study|Study drug toxicity|4|||
23786657|NCT02272803|66597882|FG001|Overall Study|Study drug toxicity|9|||
23786658|NCT02272803|66597881|FG000|Overall Study|Participant request to discontinue study treatment|3|||
23786659|NCT02272803|66597882|FG001|Overall Study|Participant request to discontinue study treatment|7|||
23786660|NCT02272803|66597881|FG000|Overall Study|Maximum clinical benefit|4|||
23786661|NCT02272803|66597882|FG001|Overall Study|Maximum clinical benefit|2|||
23786662|NCT02272803|66597881|FG000|Overall Study|Poor/non-compliance|2|||
23786663|NCT02272803|66597882|FG001|Overall Study|Poor/non-compliance|2|||
23786664|NCT02272803|66597881|FG000|Overall Study|Withdrawal by Subject|2|||
23786665|NCT02272803|66597882|FG001|Overall Study|Withdrawal by Subject|1|||
23786666|NCT02272803|66597881|FG000|Overall Study|Death|0|||
23786667|NCT02272803|66597882|FG001|Overall Study|Death|1|||
23786668|NCT02272803|66597881|FG000|Overall Study|Other reasons|1|||
23786669|NCT02272803|66597882|FG001|Overall Study|Other reasons|3|||
23786670|NCT02272803|66597881|FG000|Overall Study|Administrative reason by sponsor|5|||
23786671|NCT02272803|66597882|FG001|Overall Study|Administrative reason by sponsor|4|||
23786672|NCT01911676|66597883|FG000|Period 1 of Study|Withdrawal by Subject|4|||
23786673|NCT01911676|66597884|FG001|Period 1 of Study|Withdrawal by Subject|2|||
23458384|NCT00179621|65421291|FG001|Open-Label Period|Other|1|||
23458385|NCT00179621|65421292|FG002|Open-Label Period|Other|1|||
23458386|NCT00179621|65421293|FG003|Open-Label Period|Other|2|||
23458387|NCT02475681|65421297|FG000|Overall Study|Death|16|||
23458388|NCT02475681|65421298|FG001|Overall Study|Death|6|||
23458389|NCT02475681|65421299|FG002|Overall Study|Death|9|||
23458390|NCT02475681|65421297|FG000|Overall Study|Physician Decision|0|||
23458391|NCT02475681|65421298|FG001|Overall Study|Physician Decision|3|||
23347225|NCT01844505|65014286|FG001|Overall Study|Other Reasons|2|||
23458392|NCT02475681|65421299|FG002|Overall Study|Physician Decision|1|||
23638474|NCT01803282|66060919|FG011|Overall Study|Enrolled but Never Treated|0|||
23786674|NCT01911676|66597885|FG002|Period 1 of Study|Withdrawal by Subject|1|||
23786675|NCT01911676|66597886|FG003|Period 1 of Study|Withdrawal by Subject|2|||
23786676|NCT01911676|66597883|FG000|Period 1 of Study|Physician Decision|2|||
23786677|NCT01911676|66597884|FG001|Period 1 of Study|Physician Decision|0|||
23786678|NCT01911676|66597885|FG002|Period 1 of Study|Physician Decision|0|||
23786679|NCT01911676|66597886|FG003|Period 1 of Study|Physician Decision|1|||
23638475|NCT01011153|66060922|FG000|Overall Study|Less than 78 cases completed|8|||
23458393|NCT02475681|65421297|FG000|Overall Study|Withdrawal by Subject|12|||
23458394|NCT02475681|65421298|FG001|Overall Study|Withdrawal by Subject|6|||
23458395|NCT02475681|65421299|FG002|Overall Study|Withdrawal by Subject|9|||
23458396|NCT02475681|65421297|FG000|Overall Study|Lost to Follow-up|2|||
23458397|NCT02475681|65421298|FG001|Overall Study|Lost to Follow-up|1|||
23458398|NCT02475681|65421299|FG002|Overall Study|Lost to Follow-up|3|||
23458399|NCT02475681|65421297|FG000|Overall Study|Ongoing in Study|0|||
23458400|NCT02475681|65421298|FG001|Overall Study|Ongoing in Study|163|||
23458401|NCT02475681|65421299|FG002|Overall Study|Ongoing in Study|157|||
23458402|NCT02475681|65421297|FG000|Overall Study|Reasons other than above listed|2|||
23458403|NCT02475681|65421298|FG001|Overall Study|Reasons other than above listed|0|||
23458404|NCT02475681|65421299|FG002|Overall Study|Reasons other than above listed|0|||
23458405|NCT01607957|65421300|FG000|Overall Study|Not treated|1|||
23458406|NCT01607957|65421301|FG001|Overall Study|Not treated|1|||
23458407|NCT01607957|65421300|FG000|Overall Study|Death|367|||
23458408|NCT01607957|65421301|FG001|Overall Study|Death|211|||
23458409|NCT01607957|65421300|FG000|Overall Study|Lost to Follow-up|3|||
23458410|NCT01607957|65421301|FG001|Overall Study|Lost to Follow-up|3|||
23458411|NCT01607957|65421300|FG000|Overall Study|Participant refusal|1|||
23458412|NCT01607957|65421301|FG001|Overall Study|Participant refusal|0|||
23458413|NCT03779334|65421302|FG000|Overall Study|Withdrawal by Subject|3|||
23458414|NCT03779334|65421303|FG001|Overall Study|Withdrawal by Subject|0|||
23458415|NCT03779334|65421304|FG002|Overall Study|Withdrawal by Subject|0|||
23458416|NCT03779334|65421302|FG000|Overall Study|Ongoing in Study|5|||
23458417|NCT03779334|65421303|FG001|Overall Study|Ongoing in Study|13|||
23458418|NCT03779334|65421304|FG002|Overall Study|Ongoing in Study|5|||
23458419|NCT05131165|65421307|FG000|Overall Study|Death|1|||
23458420|NCT05131165|65421308|FG001|Overall Study|Death|1|||
23458421|NCT05131165|65421309|FG002|Overall Study|Death|0|||
23458422|NCT05131165|65421307|FG000|Overall Study|Lost to Follow-up|2|||
23458423|NCT05131165|65421308|FG001|Overall Study|Lost to Follow-up|2|||
23458424|NCT05131165|65421309|FG002|Overall Study|Lost to Follow-up|5|||
23458425|NCT05131165|65421307|FG000|Overall Study|Transferred out of clinic|1|||
23458426|NCT05131165|65421308|FG001|Overall Study|Transferred out of clinic|0|||
23458427|NCT05131165|65421309|FG002|Overall Study|Transferred out of clinic|3|||
23458428|NCT05131165|65421307|FG000|Overall Study|Dropped out|1|||
23458429|NCT05131165|65421308|FG001|Overall Study|Dropped out|2|||
23458430|NCT05131165|65421309|FG002|Overall Study|Dropped out|0|||
23458431|NCT02420717|65421310|FG000|Overall Study|Did not receive all study medication|2|||
23458432|NCT02420717|65421311|FG001|Overall Study|Did not receive all study medication|0|||
23458433|NCT02420717|65421312|FG002|Overall Study|Did not receive all study medication|0|||
23458434|NCT04003636|65421315|FG000|Overall Study|Death|409|||
23458435|NCT04003636|65421316|FG001|Overall Study|Death|443|||
23458436|NCT04003636|65421315|FG000|Overall Study|Lost to Follow-up|0|||
23458437|NCT04003636|65421316|FG001|Overall Study|Lost to Follow-up|1|||
23458438|NCT04003636|65421315|FG000|Overall Study|Withdrawal by Subject|5|||
23458439|NCT04003636|65421316|FG001|Overall Study|Withdrawal by Subject|2|||
23458440|NCT04003636|65421315|FG000|Overall Study|Participant On-going|119|||
23458441|NCT04003636|65421316|FG001|Overall Study|Participant On-going|90|||
23458442|NCT01652235|65421317|FG000|Overall Study|Death|9|||
23458443|NCT01652235|65421317|FG000|Overall Study|Lost to Follow-up|5|||
23458444|NCT01652235|65421317|FG000|Overall Study|Withdrawal by Subject|2|||
23458445|NCT05135767|65421318|FG000|Baseline|Lost to Follow-up|1|||
23458446|NCT05135767|65421319|FG001|Baseline|Lost to Follow-up|1|||
23458447|NCT05135767|65421318|FG000|Baseline|Withdrawal by Subject|0|||
23458448|NCT05135767|65421319|FG001|Baseline|Withdrawal by Subject|2|||
23458449|NCT05135767|65421318|FG000|Active Study Phase|Lost to Follow-up|2|||
23458450|NCT05135767|65421319|FG001|Active Study Phase|Lost to Follow-up|0|||
23458451|NCT03453164|65421320|FG000|Overall Study|Lack of Efficacy|16|||
23638476|NCT01011153|66060923|FG001|Overall Study|Less than 78 cases completed|11|||
23638477|NCT01011153|66060924|FG002|Overall Study|Less than 78 cases completed|9|||
23458452|NCT03453164|65421320|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
23458453|NCT03043794|65421325|FG000|Overall Study|Lost to Follow-up|1|||
23458454|NCT02002598|65421326|FG000|Dose Level 1|Withdrawal by Subject|1|||
23458455|NCT02002598|65421327|FG001|Dose Level 1|Withdrawal by Subject|0|||
23458456|NCT02002598|65421328|FG002|Dose Level 1|Withdrawal by Subject|0|||
23458457|NCT02002598|65421329|FG003|Dose Level 1|Withdrawal by Subject|0|||
23458458|NCT02002598|65421330|FG004|Dose Level 1|Withdrawal by Subject|0|||
23458459|NCT05228470|65421336|FG000|Overall Study|Death|6|||
23458460|NCT05228470|65421337|FG001|Overall Study|Death|11|||
23458461|NCT05228470|65421336|FG000|Overall Study|Withdrawal by Subject|1|||
23458462|NCT05228470|65421337|FG001|Overall Study|Withdrawal by Subject|8|||
23458463|NCT05228470|65421336|FG000|Overall Study|Ongoing|1|||
23458464|NCT05228470|65421337|FG001|Overall Study|Ongoing|11|||
23458465|NCT04583618|65421340|FG000|Overall Study|Adverse Event|0|||
23458466|NCT04583618|65421341|FG001|Overall Study|Adverse Event|0|||
23458467|NCT04583618|65421342|FG002|Overall Study|Adverse Event|1|||
23458468|NCT04583618|65421343|FG003|Overall Study|Adverse Event|0|||
23583754|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583755|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583756|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583757|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583758|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
23458469|NCT04583618|65421344|FG004|Overall Study|Adverse Event|0|||
23458470|NCT04583618|65421340|FG000|Overall Study|Protocol deviation|1|||
23458471|NCT04583618|65421341|FG001|Overall Study|Protocol deviation|1|||
23458472|NCT04583618|65421342|FG002|Overall Study|Protocol deviation|1|||
23458473|NCT04583618|65421343|FG003|Overall Study|Protocol deviation|0|||
23458474|NCT04583618|65421344|FG004|Overall Study|Protocol deviation|0|||
23458475|NCT04583618|65421340|FG000|Overall Study|Withdrawal by Subject|2|||
23458476|NCT04583618|65421341|FG001|Overall Study|Withdrawal by Subject|1|||
23458477|NCT04583618|65421342|FG002|Overall Study|Withdrawal by Subject|3|||
23458478|NCT04583618|65421343|FG003|Overall Study|Withdrawal by Subject|1|||
23458479|NCT04583618|65421344|FG004|Overall Study|Withdrawal by Subject|1|||
23458480|NCT04583618|65421340|FG000|Overall Study|Lost to Follow-up|0|||
23458481|NCT04583618|65421341|FG001|Overall Study|Lost to Follow-up|1|||
23458482|NCT04583618|65421342|FG002|Overall Study|Lost to Follow-up|3|||
23458483|NCT04583618|65421343|FG003|Overall Study|Lost to Follow-up|1|||
23458484|NCT04583618|65421344|FG004|Overall Study|Lost to Follow-up|1|||
23458485|NCT02358473|65421345|FG000|Overall Study|Disease Progession|6|||
23458486|NCT02358473|65421345|FG000|Overall Study|Adverse Event|3|||
23458487|NCT02358473|65421345|FG000|Overall Study|Withdrawal by Subject|2|||
23458488|NCT02358473|65421345|FG000|Overall Study|Physician Decision|2|||
23458489|NCT01394016|65421346|FG000|Overall Study|Progressive Disease|2|||
23458490|NCT01394016|65421347|FG001|Overall Study|Progressive Disease|0|||
23458491|NCT01394016|65421348|FG002|Overall Study|Progressive Disease|0|||
23458492|NCT01394016|65421349|FG003|Overall Study|Progressive Disease|0|||
23458493|NCT01394016|65421350|FG004|Overall Study|Progressive Disease|0|||
23458494|NCT01394016|65421351|FG005|Overall Study|Progressive Disease|0|||
23458495|NCT01394016|65421352|FG006|Overall Study|Progressive Disease|0|||
23458496|NCT01394016|65421353|FG007|Overall Study|Progressive Disease|0|||
23458497|NCT01394016|65421354|FG008|Overall Study|Progressive Disease|0|||
23458498|NCT01394016|65421355|FG009|Overall Study|Progressive Disease|0|||
23458499|NCT01394016|65421356|FG010|Overall Study|Progressive Disease|0|||
23458500|NCT01394016|65421357|FG011|Overall Study|Progressive Disease|0|||
23458501|NCT01394016|65421358|FG012|Overall Study|Progressive Disease|0|||
23458502|NCT01394016|65421359|FG013|Overall Study|Progressive Disease|0|||
23458503|NCT01394016|65421360|FG014|Overall Study|Progressive Disease|0|||
23458504|NCT01394016|65421361|FG015|Overall Study|Progressive Disease|0|||
23458505|NCT01394016|65421362|FG016|Overall Study|Progressive Disease|0|||
23458506|NCT01394016|65421363|FG017|Overall Study|Progressive Disease|0|||
23458507|NCT01394016|65421364|FG018|Overall Study|Progressive Disease|0|||
23458508|NCT01394016|65421346|FG000|Overall Study|Withdrawal by Subject|0|||
23458509|NCT01394016|65421347|FG001|Overall Study|Withdrawal by Subject|0|||
23458510|NCT01394016|65421348|FG002|Overall Study|Withdrawal by Subject|0|||
23458511|NCT01394016|65421349|FG003|Overall Study|Withdrawal by Subject|0|||
23458512|NCT01394016|65421350|FG004|Overall Study|Withdrawal by Subject|0|||
23458513|NCT01394016|65421351|FG005|Overall Study|Withdrawal by Subject|0|||
23458514|NCT01394016|65421352|FG006|Overall Study|Withdrawal by Subject|0|||
23458515|NCT01394016|65421353|FG007|Overall Study|Withdrawal by Subject|1|||
23458516|NCT01394016|65421354|FG008|Overall Study|Withdrawal by Subject|1|||
23458517|NCT01394016|65421355|FG009|Overall Study|Withdrawal by Subject|1|||
23458518|NCT01394016|65421356|FG010|Overall Study|Withdrawal by Subject|4|||
23458519|NCT01394016|65421357|FG011|Overall Study|Withdrawal by Subject|0|||
23458520|NCT01394016|65421358|FG012|Overall Study|Withdrawal by Subject|0|||
23458521|NCT01394016|65421359|FG013|Overall Study|Withdrawal by Subject|3|||
23458522|NCT01394016|65421360|FG014|Overall Study|Withdrawal by Subject|1|||
23458523|NCT01394016|65421361|FG015|Overall Study|Withdrawal by Subject|3|||
23458524|NCT01394016|65421362|FG016|Overall Study|Withdrawal by Subject|1|||
23458525|NCT01394016|65421363|FG017|Overall Study|Withdrawal by Subject|1|||
23583759|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583760|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583761|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23638478|NCT03682302|66060925|FG000|Overall Study|Lost to Follow-up|1|||
23458526|NCT01394016|65421364|FG018|Overall Study|Withdrawal by Subject|2|||
23458527|NCT01394016|65421346|FG000|Overall Study|Adverse Event|0|||
23458528|NCT01394016|65421347|FG001|Overall Study|Adverse Event|0|||
23458529|NCT01394016|65421348|FG002|Overall Study|Adverse Event|0|||
23458530|NCT01394016|65421349|FG003|Overall Study|Adverse Event|0|||
23458531|NCT01394016|65421350|FG004|Overall Study|Adverse Event|0|||
23458532|NCT01394016|65421351|FG005|Overall Study|Adverse Event|0|||
23458533|NCT01394016|65421352|FG006|Overall Study|Adverse Event|0|||
23458534|NCT01394016|65421353|FG007|Overall Study|Adverse Event|0|||
23458535|NCT01394016|65421354|FG008|Overall Study|Adverse Event|0|||
23458536|NCT01394016|65421355|FG009|Overall Study|Adverse Event|1|||
23458537|NCT01394016|65421356|FG010|Overall Study|Adverse Event|0|||
23458538|NCT01394016|65421357|FG011|Overall Study|Adverse Event|0|||
23458539|NCT01394016|65421358|FG012|Overall Study|Adverse Event|0|||
23458540|NCT01394016|65421359|FG013|Overall Study|Adverse Event|0|||
23458541|NCT01394016|65421360|FG014|Overall Study|Adverse Event|0|||
23458542|NCT01394016|65421361|FG015|Overall Study|Adverse Event|0|||
23458543|NCT01394016|65421362|FG016|Overall Study|Adverse Event|1|||
23458544|NCT01394016|65421363|FG017|Overall Study|Adverse Event|1|||
23458545|NCT01394016|65421364|FG018|Overall Study|Adverse Event|0|||
23458546|NCT01394016|65421346|FG000|Overall Study|Sponsor Decision|0|||
23458547|NCT01394016|65421347|FG001|Overall Study|Sponsor Decision|0|||
23458548|NCT01394016|65421348|FG002|Overall Study|Sponsor Decision|0|||
23458549|NCT01394016|65421349|FG003|Overall Study|Sponsor Decision|0|||
23458550|NCT01394016|65421350|FG004|Overall Study|Sponsor Decision|0|||
23458551|NCT01394016|65421351|FG005|Overall Study|Sponsor Decision|0|||
23458552|NCT01394016|65421352|FG006|Overall Study|Sponsor Decision|0|||
23458553|NCT01394016|65421353|FG007|Overall Study|Sponsor Decision|0|||
23458554|NCT01394016|65421354|FG008|Overall Study|Sponsor Decision|0|||
23458555|NCT01394016|65421355|FG009|Overall Study|Sponsor Decision|0|||
23458556|NCT01394016|65421356|FG010|Overall Study|Sponsor Decision|0|||
23458557|NCT01394016|65421357|FG011|Overall Study|Sponsor Decision|0|||
23458558|NCT01394016|65421358|FG012|Overall Study|Sponsor Decision|1|||
23458559|NCT01394016|65421359|FG013|Overall Study|Sponsor Decision|0|||
23458560|NCT01394016|65421360|FG014|Overall Study|Sponsor Decision|0|||
23458561|NCT01394016|65421361|FG015|Overall Study|Sponsor Decision|0|||
23458562|NCT01394016|65421362|FG016|Overall Study|Sponsor Decision|0|||
23458563|NCT01394016|65421363|FG017|Overall Study|Sponsor Decision|0|||
23458564|NCT01394016|65421364|FG018|Overall Study|Sponsor Decision|0|||
23458565|NCT01394016|65421346|FG000|Overall Study|Lost to Follow-up|0|||
23458566|NCT01394016|65421347|FG001|Overall Study|Lost to Follow-up|0|||
23458567|NCT01394016|65421348|FG002|Overall Study|Lost to Follow-up|0|||
23458568|NCT01394016|65421349|FG003|Overall Study|Lost to Follow-up|0|||
23458569|NCT01394016|65421350|FG004|Overall Study|Lost to Follow-up|0|||
23458570|NCT01394016|65421351|FG005|Overall Study|Lost to Follow-up|0|||
23458571|NCT01394016|65421352|FG006|Overall Study|Lost to Follow-up|0|||
23458572|NCT01394016|65421353|FG007|Overall Study|Lost to Follow-up|0|||
23458573|NCT01394016|65421354|FG008|Overall Study|Lost to Follow-up|0|||
23458574|NCT01394016|65421355|FG009|Overall Study|Lost to Follow-up|0|||
23458575|NCT01394016|65421356|FG010|Overall Study|Lost to Follow-up|0|||
23458576|NCT01394016|65421357|FG011|Overall Study|Lost to Follow-up|0|||
23458577|NCT01394016|65421358|FG012|Overall Study|Lost to Follow-up|0|||
23458578|NCT01394016|65421359|FG013|Overall Study|Lost to Follow-up|0|||
23458579|NCT01394016|65421360|FG014|Overall Study|Lost to Follow-up|0|||
23458580|NCT01394016|65421361|FG015|Overall Study|Lost to Follow-up|0|||
23458581|NCT01394016|65421362|FG016|Overall Study|Lost to Follow-up|0|||
23458582|NCT01394016|65421363|FG017|Overall Study|Lost to Follow-up|0|||
23458583|NCT01394016|65421364|FG018|Overall Study|Lost to Follow-up|1|||
23458584|NCT02521285|65421367|FG000|Overall Study|Lost to Follow-up|1|||
23458585|NCT02521285|65421368|FG001|Overall Study|Lost to Follow-up|1|||
23458586|NCT02521285|65421367|FG000|Overall Study|Withdrawal by Subject|1|||
23458587|NCT02521285|65421368|FG001|Overall Study|Withdrawal by Subject|1|||
23458588|NCT02521285|65421367|FG000|Overall Study|Adverse Event|0|||
23458589|NCT02521285|65421368|FG001|Overall Study|Adverse Event|1|||
23458590|NCT02546609|65421369|FG000|Overall Study|Withdrawal by Subject|0|||
23458591|NCT02546609|65421370|FG001|Overall Study|Withdrawal by Subject|1|||
23458592|NCT02546609|65421371|FG002|Overall Study|Withdrawal by Subject|2|||
23458593|NCT02546609|65421369|FG000|Overall Study|Adverse Event|0|||
23458594|NCT02546609|65421370|FG001|Overall Study|Adverse Event|6|||
23458595|NCT02546609|65421371|FG002|Overall Study|Adverse Event|1|||
23458596|NCT02546609|65421369|FG000|Overall Study|Protocol Violation|0|||
23458597|NCT02546609|65421370|FG001|Overall Study|Protocol Violation|1|||
23458598|NCT02546609|65421371|FG002|Overall Study|Protocol Violation|1|||
23458599|NCT02546609|65421369|FG000|Overall Study|Lost to Follow-up|2|||
23458600|NCT02546609|65421370|FG001|Overall Study|Lost to Follow-up|3|||
23458601|NCT02546609|65421371|FG002|Overall Study|Lost to Follow-up|1|||
23458602|NCT02546609|65421369|FG000|Overall Study|travel or work schedule restriction|0|||
23458603|NCT02546609|65421370|FG001|Overall Study|travel or work schedule restriction|0|||
23458604|NCT02546609|65421371|FG002|Overall Study|travel or work schedule restriction|2|||
23458605|NCT04629508|65421375|FG000|Overall Study|Adverse Event|1|||
23458606|NCT04629508|65421375|FG000|Overall Study|Death|2|||
23458607|NCT04629508|65421375|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
23458608|NCT04973449|65421380|FG000|Overall Study|Withdrawal by Subject|3|||
23458609|NCT04973449|65421381|FG001|Overall Study|Withdrawal by Subject|3|||
23458610|NCT04973449|65421382|FG002|Overall Study|Withdrawal by Subject|2|||
23458611|NCT04973449|65421383|FG003|Overall Study|Withdrawal by Subject|5|||
23458612|NCT04973449|65421384|FG004|Overall Study|Withdrawal by Subject|5|||
23458613|NCT04973449|65421385|FG005|Overall Study|Withdrawal by Subject|4|||
23458614|NCT04973449|65421386|FG006|Overall Study|Withdrawal by Subject|7|||
23458615|NCT04973449|65421387|FG007|Overall Study|Withdrawal by Subject|5|||
23458616|NCT04973449|65421380|FG000|Overall Study|Lost to Follow-up|15|||
23458617|NCT04973449|65421381|FG001|Overall Study|Lost to Follow-up|16|||
23458618|NCT04973449|65421382|FG002|Overall Study|Lost to Follow-up|16|||
23458619|NCT04973449|65421383|FG003|Overall Study|Lost to Follow-up|13|||
23458620|NCT04973449|65421384|FG004|Overall Study|Lost to Follow-up|5|||
23458621|NCT04973449|65421385|FG005|Overall Study|Lost to Follow-up|6|||
23458622|NCT04973449|65421386|FG006|Overall Study|Lost to Follow-up|10|||
23458623|NCT04973449|65421387|FG007|Overall Study|Lost to Follow-up|6|||
23458624|NCT04973449|65421380|FG000|Overall Study|Death|1|||
23458625|NCT04973449|65421381|FG001|Overall Study|Death|0|||
23458626|NCT04973449|65421382|FG002|Overall Study|Death|0|||
23458627|NCT04973449|65421383|FG003|Overall Study|Death|0|||
23458628|NCT04973449|65421384|FG004|Overall Study|Death|0|||
23458629|NCT04973449|65421385|FG005|Overall Study|Death|1|||
23458630|NCT04973449|65421386|FG006|Overall Study|Death|0|||
23583762|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583763|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583764|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583765|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583766|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583767|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583768|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583769|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583770|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583771|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583772|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
23583773|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583774|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583775|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583776|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583777|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583778|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583779|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583780|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583781|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583782|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583783|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583784|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583785|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583786|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
23583787|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583788|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583789|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583790|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583791|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583792|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583793|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583794|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23638479|NCT03682302|66060926|FG001|Overall Study|Lost to Follow-up|2|||
23638480|NCT03682302|66060927|FG002|Overall Study|Lost to Follow-up|0|||
23638481|NCT03682302|66060928|FG003|Overall Study|Lost to Follow-up|1|||
23638482|NCT03682302|66060925|FG000|Overall Study|Study drug was not administered|0|||
23638483|NCT03682302|66060926|FG001|Overall Study|Study drug was not administered|0|||
23638484|NCT03682302|66060927|FG002|Overall Study|Study drug was not administered|1|||
23638485|NCT03682302|66060928|FG003|Overall Study|Study drug was not administered|1|||
23638486|NCT02574845|66060937|FG000|Overall Study|Consent withdrawn further participation|0|||
23638487|NCT02574845|66060938|FG001|Overall Study|Consent withdrawn further participation|0|||
23638488|NCT02574845|66060939|FG002|Overall Study|Consent withdrawn further participation|0|||
23638489|NCT02574845|66060940|FG003|Overall Study|Consent withdrawn further participation|0|||
23638490|NCT02574845|66060941|FG004|Overall Study|Consent withdrawn further participation|1|||
23638491|NCT02574845|66060942|FG005|Overall Study|Consent withdrawn further participation|0|||
23638492|NCT02574845|66060937|FG000|Overall Study|Adverse Event|0|||
23638493|NCT02574845|66060938|FG001|Overall Study|Adverse Event|1|||
23638494|NCT02574845|66060939|FG002|Overall Study|Adverse Event|0|||
23583795|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23638495|NCT02574845|66060940|FG003|Overall Study|Adverse Event|0|||
23638496|NCT02574845|66060941|FG004|Overall Study|Adverse Event|0|||
23458631|NCT04973449|65421387|FG007|Overall Study|Death|0|||
23638497|NCT02574845|66060942|FG005|Overall Study|Adverse Event|1|||
23458632|NCT04973449|65421380|FG000|Overall Study|Other|1|||
23458633|NCT04973449|65421381|FG001|Overall Study|Other|1|||
23458634|NCT04973449|65421382|FG002|Overall Study|Other|2|||
23458635|NCT04973449|65421383|FG003|Overall Study|Other|1|||
23458636|NCT04973449|65421384|FG004|Overall Study|Other|4|||
23458637|NCT04973449|65421385|FG005|Overall Study|Other|0|||
23458638|NCT04973449|65421386|FG006|Overall Study|Other|2|||
23458639|NCT04973449|65421387|FG007|Overall Study|Other|2|||
23458640|NCT04905134|65421393|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
23583796|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583797|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583798|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583799|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583800|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
23583801|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583802|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583803|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583804|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583805|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583806|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583807|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583808|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583809|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583810|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583811|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
23583812|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583813|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
23583814|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
23583815|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583816|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583817|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583818|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583819|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583820|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583821|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23638498|NCT01012414|66060943|FG000|Overall Study|Withdrawal by Subject|2|||
23458641|NCT04905134|65421393|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
23638499|NCT01012414|66060943|FG000|Overall Study|Lost to Follow-up|1|||
23638500|NCT01012414|66060943|FG000|Overall Study|Trial was stopped before completed|7|||
23458642|NCT04467905|65421394|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
23458643|NCT04467905|65421395|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
23583822|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583823|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583824|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583825|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583826|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583827|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583828|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
23583829|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23786680|NCT01911676|66597883|FG000|Period 2 of Study|Physician Decision|2|||
23638501|NCT00283244|66060948|FG000|Overall Study|Adverse Event|0|||
23347226|NCT01844505|65014287|FG002|Overall Study|Other Reasons|2|||
23458644|NCT04467905|65421396|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
23458645|NCT04467905|65421394|FG000|Overall Study|Conversion to SR|0|||
23458646|NCT04467905|65421395|FG001|Overall Study|Conversion to SR|0|||
23458647|NCT04467905|65421396|FG002|Overall Study|Conversion to SR|3|||
23458648|NCT04467905|65421394|FG000|Overall Study|Technical issue with Holter ECG|0|||
23458649|NCT04467905|65421395|FG001|Overall Study|Technical issue with Holter ECG|0|||
23458650|NCT04467905|65421396|FG002|Overall Study|Technical issue with Holter ECG|3|||
23458651|NCT04467905|65421394|FG000|Overall Study|Hemodynamic instability|0|||
23458652|NCT04467905|65421395|FG001|Overall Study|Hemodynamic instability|0|||
23458653|NCT04467905|65421396|FG002|Overall Study|Hemodynamic instability|1|||
23458654|NCT04467905|65421394|FG000|Overall Study|Site misinterpretation of protocol|0|||
23458655|NCT04467905|65421395|FG001|Overall Study|Site misinterpretation of protocol|0|||
23458656|NCT04467905|65421396|FG002|Overall Study|Site misinterpretation of protocol|1|||
23458657|NCT02023086|65421397|FG000|Overall Study|Withdrawal by Subject|2|||
23458658|NCT02023086|65421398|FG001|Overall Study|Withdrawal by Subject|0|||
23458659|NCT03205423|65421399|FG000|Overall Study|Personal|1|||
23458660|NCT03205423|65421400|FG001|Overall Study|Personal|1|||
23458661|NCT03205423|65421399|FG000|Overall Study|Physician Decision|0|||
23458662|NCT03205423|65421400|FG001|Overall Study|Physician Decision|2|||
23458663|NCT01473134|65421405|FG000|Overall Study|Lost to Follow-up|21|||
23458664|NCT01473134|65421406|FG001|Overall Study|Lost to Follow-up|13|||
23458665|NCT01473134|65421405|FG000|Overall Study|Protocol Violation|32|||
23458666|NCT01473134|65421406|FG001|Overall Study|Protocol Violation|19|||
23458667|NCT01473134|65421405|FG000|Overall Study|Withdrawal by Subject|1|||
23458668|NCT01473134|65421406|FG001|Overall Study|Withdrawal by Subject|2|||
23458669|NCT01473134|65421405|FG000|Overall Study|Death|0|||
23458670|NCT01473134|65421406|FG001|Overall Study|Death|1|||
23458671|NCT01473134|65421405|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
23583830|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583831|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583832|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23458672|NCT01473134|65421406|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
23583833|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23458673|NCT04500158|65421410|FG000|Overall Study|Physician Decision|17|||
23458674|NCT04500158|65421411|FG001|Overall Study|Physician Decision|11|||
23458675|NCT02694185|65421413|FG000|Overall Study|Withdrawal by Subject|45|||
23458676|NCT02694185|65421414|FG001|Overall Study|Withdrawal by Subject|0|||
23458677|NCT00400179|65421415|FG000|Overall Study|Adverse Event|2|||
23458678|NCT00400179|65421416|FG001|Overall Study|Adverse Event|2|||
23458679|NCT00400179|65421415|FG000|Overall Study|Death|1|||
23458680|NCT00400179|65421416|FG001|Overall Study|Death|2|||
23458681|NCT00400179|65421415|FG000|Overall Study|Withdrew Consent|1|||
23458682|NCT00400179|65421416|FG001|Overall Study|Withdrew Consent|5|||
23458683|NCT00400179|65421415|FG000|Overall Study|Disease progression|1|||
23458684|NCT00400179|65421416|FG001|Overall Study|Disease progression|1|||
23458685|NCT00400179|65421415|FG000|Overall Study|Intercurrent illness|0|||
23458686|NCT00400179|65421416|FG001|Overall Study|Intercurrent illness|1|||
23458687|NCT00400179|65421415|FG000|Overall Study|Investigator judgment|0|||
23347227|NCT01844505|65014285|FG000|Overall Study|Not Reported|0|||
23347228|NCT01844505|65014286|FG001|Overall Study|Not Reported|0|||
23347229|NCT01844505|65014287|FG002|Overall Study|Not Reported|1|||
23347230|NCT04068688|65014292|FG000|Overall Study|Lost to Follow-up|1|||
23347231|NCT04068688|65014293|FG001|Overall Study|Lost to Follow-up|1|||
23347232|NCT04068688|65014294|FG002|Overall Study|Lost to Follow-up|0|||
23347233|NCT04068688|65014295|FG003|Overall Study|Lost to Follow-up|0|||
23347234|NCT04068688|65014296|FG004|Overall Study|Lost to Follow-up|5|||
23583834|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583835|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583836|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583837|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583838|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23458688|NCT00400179|65421416|FG001|Overall Study|Investigator judgment|1|||
23458689|NCT00400179|65421415|FG000|Overall Study|Randomization error/patient ineligible|1|||
23458690|NCT00400179|65421416|FG001|Overall Study|Randomization error/patient ineligible|6|||
23458691|NCT01210313|65421423|FG000|Overall Study|Withdrawal by Subject|3|||
23458692|NCT01210313|65421423|FG000|Overall Study|Adverse Event|2|||
23458693|NCT01210313|65421423|FG000|Overall Study|Distant recurrence|4|||
23458694|NCT01210313|65421423|FG000|Overall Study|Non-compliance|7|||
23458695|NCT04179175|65421424|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
23458696|NCT04179175|65421425|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
23458697|NCT04179175|65421426|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
23458698|NCT04179175|65421427|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
23458699|NCT04179175|65421428|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
23458700|NCT04179175|65421429|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
23458701|NCT04179175|65421424|FG000|Overall Study|Adverse Event|5|||
23458702|NCT04179175|65421425|FG001|Overall Study|Adverse Event|3|||
23458703|NCT04179175|65421426|FG002|Overall Study|Adverse Event|3|||
23347235|NCT04068688|65014297|FG005|Overall Study|Lost to Follow-up|5|||
23347236|NCT04068688|65014298|FG006|Overall Study|Lost to Follow-up|0|||
23347237|NCT04068688|65014299|FG007|Overall Study|Lost to Follow-up|0|||
23347238|NCT04068688|65014300|FG008|Overall Study|Lost to Follow-up|1|||
23347239|NCT04068688|65014301|FG009|Overall Study|Lost to Follow-up|0|||
23458704|NCT04179175|65421427|FG003|Overall Study|Adverse Event|4|||
23458705|NCT04179175|65421428|FG004|Overall Study|Adverse Event|6|||
23458706|NCT04179175|65421429|FG005|Overall Study|Adverse Event|6|||
23583839|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
23786681|NCT01911676|66597884|FG001|Period 2 of Study|Physician Decision|0|||
23458707|NCT04179175|65421424|FG000|Overall Study|Lack of Efficacy|5|||
23458708|NCT04179175|65421425|FG001|Overall Study|Lack of Efficacy|1|||
23347240|NCT04068688|65014292|FG000|Overall Study|Withdrawal by Subject|1|||
23347241|NCT04068688|65014293|FG001|Overall Study|Withdrawal by Subject|1|||
23458709|NCT04179175|65421426|FG002|Overall Study|Lack of Efficacy|3|||
23458710|NCT04179175|65421427|FG003|Overall Study|Lack of Efficacy|2|||
23458711|NCT04179175|65421428|FG004|Overall Study|Lack of Efficacy|18|||
23458712|NCT04179175|65421429|FG005|Overall Study|Lack of Efficacy|7|||
23458713|NCT04179175|65421424|FG000|Overall Study|Lost to Follow-up|5|||
23347242|NCT04068688|65014294|FG002|Overall Study|Withdrawal by Subject|0|||
23347243|NCT04068688|65014295|FG003|Overall Study|Withdrawal by Subject|0|||
23583840|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583841|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
23583842|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
23583843|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23347244|NCT04068688|65014296|FG004|Overall Study|Withdrawal by Subject|0|||
23347245|NCT04068688|65014297|FG005|Overall Study|Withdrawal by Subject|0|||
23347246|NCT04068688|65014298|FG006|Overall Study|Withdrawal by Subject|0|||
23347247|NCT04068688|65014299|FG007|Overall Study|Withdrawal by Subject|0|||
23347248|NCT04068688|65014300|FG008|Overall Study|Withdrawal by Subject|0|||
23347249|NCT04068688|65014301|FG009|Overall Study|Withdrawal by Subject|0|||
23347250|NCT04068688|65014292|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
23347251|NCT04068688|65014293|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
23583844|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583845|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583846|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583847|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583848|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583849|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583850|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583851|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583852|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583853|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583854|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583855|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583856|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583857|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
23583858|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
23583859|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
23583860|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
23583861|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
23583862|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583863|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583864|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583865|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583866|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583867|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583868|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583869|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23347252|NCT04068688|65014294|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347253|NCT04068688|65014295|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347254|NCT04068688|65014296|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23583870|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583871|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
23583872|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583873|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23347255|NCT04068688|65014297|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347256|NCT04068688|65014298|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347257|NCT04068688|65014299|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347258|NCT04068688|65014300|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23458714|NCT04179175|65421425|FG001|Overall Study|Lost to Follow-up|3|||
23458715|NCT04179175|65421426|FG002|Overall Study|Lost to Follow-up|2|||
23458716|NCT04179175|65421427|FG003|Overall Study|Lost to Follow-up|2|||
23458717|NCT04179175|65421428|FG004|Overall Study|Lost to Follow-up|4|||
23458718|NCT04179175|65421429|FG005|Overall Study|Lost to Follow-up|5|||
23583874|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23638502|NCT00283244|66060949|FG001|Overall Study|Adverse Event|8|||
23638503|NCT00283244|66060950|FG002|Overall Study|Adverse Event|11|||
23638504|NCT00283244|66060948|FG000|Overall Study|Death|4|||
23638505|NCT00283244|66060949|FG001|Overall Study|Death|3|||
23583875|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583876|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583877|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583878|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583879|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583880|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583881|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583882|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583883|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583884|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583885|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583886|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583887|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583888|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583889|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
23583890|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583891|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583892|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583893|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583894|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583895|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583896|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583897|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583898|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583899|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583900|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
23583901|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
23583902|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
23583903|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583904|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583905|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583906|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583907|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583908|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583909|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583910|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583911|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583912|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583913|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583914|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23638506|NCT00283244|66060950|FG002|Overall Study|Death|2|||
23638507|NCT00283244|66060948|FG000|Overall Study|Lack of Efficacy|8|||
23786682|NCT01911676|66597885|FG002|Period 2 of Study|Physician Decision|0|||
23786683|NCT01911676|66597886|FG003|Period 2 of Study|Physician Decision|1|||
23583915|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583916|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583917|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
23583918|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583919|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583920|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583921|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23638508|NCT00283244|66060949|FG001|Overall Study|Lack of Efficacy|32|||
23583922|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583923|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583924|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583925|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583926|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583927|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583928|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583929|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583930|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
23583931|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
23583932|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23638509|NCT00283244|66060950|FG002|Overall Study|Lack of Efficacy|26|||
23638510|NCT00283244|66060948|FG000|Overall Study|Withdrawal by Subject|1|||
23638511|NCT00283244|66060949|FG001|Overall Study|Withdrawal by Subject|2|||
23786684|NCT01911676|66597883|FG000|Period 2 of Study|Lost to Follow-up|0|||
23347259|NCT04068688|65014301|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347260|NCT01944670|65014302|FG000|Overall Study|Lost to Follow-up|2|||
23347261|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
23347262|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347263|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347264|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347265|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347266|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Death|0|||
23347267|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Death|1|||
23347268|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Death|0|||
23347269|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Death|0|||
23347270|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Death|0|||
23347271|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23347272|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23786685|NCT01911676|66597884|FG001|Period 2 of Study|Lost to Follow-up|0|||
23786686|NCT01911676|66597885|FG002|Period 2 of Study|Lost to Follow-up|0|||
23786687|NCT01911676|66597886|FG003|Period 2 of Study|Lost to Follow-up|1|||
23786688|NCT05755282|66597887|FG000|Overall Study|Protocol Violation|0|||
23786689|NCT05755282|66597888|FG001|Overall Study|Protocol Violation|1|||
23786690|NCT00858780|66597899|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
23786691|NCT00858780|66597900|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23786692|NCT00858780|66597901|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23786693|NCT00858780|66597902|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23786694|NCT00858780|66597903|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23786695|NCT00858780|66597899|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23786696|NCT00858780|66597900|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23786697|NCT00858780|66597901|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
23786698|NCT00858780|66597902|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23786699|NCT00858780|66597903|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23786700|NCT00858780|66597899|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
23786701|NCT00858780|66597900|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23786702|NCT00858780|66597901|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23786703|NCT00858780|66597902|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23786704|NCT00858780|66597903|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
23786705|NCT00858780|66597899|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23786706|NCT00858780|66597900|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
23786707|NCT00858780|66597901|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23786708|NCT00858780|66597902|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23786709|NCT00858780|66597903|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23786710|NCT00858780|66597899|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23786711|NCT00858780|66597900|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23786712|NCT00858780|66597901|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23786713|NCT00858780|66597902|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23786714|NCT00858780|66597903|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
23458719|NCT04179175|65421424|FG000|Overall Study|Physician Decision|2|||
23638512|NCT00283244|66060950|FG002|Overall Study|Withdrawal by Subject|2|||
23638513|NCT00283244|66060948|FG000|Overall Study|Physician Decision|0|||
23786715|NCT00858780|66597899|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
23786716|NCT00858780|66597900|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
23347273|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
23347274|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
23347275|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23786717|NCT00858780|66597901|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
23786718|NCT00858780|66597902|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
23786719|NCT00858780|66597903|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
23786720|NCT03480763|66597904|FG000|Overall Study|Withdrawal by Subject|18|||
23786721|NCT03480763|66597905|FG001|Overall Study|Withdrawal by Subject|10|||
23786722|NCT03480763|66597904|FG000|Overall Study|Lost to Follow-up|4|||
23786723|NCT03480763|66597905|FG001|Overall Study|Lost to Follow-up|7|||
23786724|NCT03480763|66597904|FG000|Overall Study|non-study pneumococcal vaccine|1|||
23786725|NCT03480763|66597905|FG001|Overall Study|non-study pneumococcal vaccine|0|||
23786726|NCT03480763|66597904|FG000|Overall Study|oncological treatment|0|||
23786727|NCT03480763|66597905|FG001|Overall Study|oncological treatment|2|||
23786728|NCT03480763|66597904|FG000|Overall Study|pain with vaccination|1|||
23786729|NCT03480763|66597905|FG001|Overall Study|pain with vaccination|0|||
23786730|NCT00863330|66597914|FG000|Overall Study|study terminated early due to administra|6|||
23786731|NCT04198363|66597917|FG000|Overall Study|Adverse Event|1|||
23786732|NCT04198363|66597918|FG001|Overall Study|Adverse Event|1|||
23786733|NCT04198363|66597917|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
23786734|NCT04198363|66597918|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
23786735|NCT04198363|66597917|FG000|Overall Study|Reason not Specified|1|||
23786736|NCT04198363|66597918|FG001|Overall Study|Reason not Specified|0|||
23786737|NCT03261167|66597919|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
23786738|NCT03261167|66597920|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
23786739|NCT03261167|66597919|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
23786740|NCT03261167|66597920|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
23786741|NCT03261167|66597919|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
23786742|NCT03261167|66597920|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
23786743|NCT03261167|66597919|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
23786744|NCT03261167|66597920|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
23786745|NCT03261167|66597919|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
23786746|NCT03261167|66597920|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
23786747|NCT02072096|66597930|FG000|Overall Study|Lack of Efficacy|18|||
23786748|NCT02072096|66597931|FG001|Overall Study|Lack of Efficacy|29|||
23786749|NCT02072096|66597930|FG000|Overall Study|Protocol Violation|7|||
23786750|NCT02072096|66597931|FG001|Overall Study|Protocol Violation|7|||
23583933|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583934|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23347276|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347277|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
23347278|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347279|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
23347280|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347281|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Death|0|||
23347282|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Death|1|||
23347283|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Death|0|||
23347284|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Death|0|||
23458720|NCT04179175|65421425|FG001|Overall Study|Physician Decision|0|||
23458721|NCT04179175|65421426|FG002|Overall Study|Physician Decision|2|||
23583935|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583936|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23638514|NCT00283244|66060949|FG001|Overall Study|Physician Decision|0|||
23638515|NCT00283244|66060950|FG002|Overall Study|Physician Decision|1|||
23786751|NCT02072096|66597930|FG000|Overall Study|Withdrawal by Subject|5|||
23786752|NCT02072096|66597931|FG001|Overall Study|Withdrawal by Subject|7|||
23786753|NCT02072096|66597930|FG000|Overall Study|Adverse Event|5|||
23786754|NCT02072096|66597931|FG001|Overall Study|Adverse Event|2|||
23786755|NCT02072096|66597930|FG000|Overall Study|No Reason Provided|4|||
23347285|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Death|1|||
23786756|NCT02072096|66597931|FG001|Overall Study|No Reason Provided|2|||
23786757|NCT02072096|66597930|FG000|Overall Study|Death|2|||
23786758|NCT02072096|66597931|FG001|Overall Study|Death|0|||
23786759|NCT02072096|66597930|FG000|Overall Study|Physician Decision|0|||
23786760|NCT02072096|66597931|FG001|Overall Study|Physician Decision|1|||
23786761|NCT02072096|66597930|FG000|Overall Study|Study Terminated by Sponsor|43|||
23786762|NCT02072096|66597931|FG001|Overall Study|Study Terminated by Sponsor|30|||
23786763|NCT02072096|66597930|FG000|Overall Study|Lost to Follow-up|1|||
23786764|NCT02072096|66597931|FG001|Overall Study|Lost to Follow-up|0|||
23786765|NCT02615249|66597933|FG000|Overall Study|Withdrawal by Subject|1|||
23786766|NCT04281472|66597934|FG000|Stage A|Lack of Efficacy|8|||
23786767|NCT04281472|66597935|FG001|Stage A|Lack of Efficacy|0|||
23786768|NCT04281472|66597936|FG002|Stage A|Lack of Efficacy|0|||
23786769|NCT04281472|66597934|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
23786770|NCT04281472|66597935|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23786771|NCT04281472|66597936|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23786772|NCT04281472|66597934|FG000|Stage A|Adverse Event|20|||
23786773|NCT04281472|66597935|FG001|Stage A|Adverse Event|0|||
23786774|NCT04281472|66597936|FG002|Stage A|Adverse Event|0|||
23786775|NCT04281472|66597934|FG000|Stage A|Death|1|||
23786776|NCT04281472|66597935|FG001|Stage A|Death|0|||
23786777|NCT04281472|66597936|FG002|Stage A|Death|0|||
23786778|NCT04281472|66597934|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
23786779|NCT04281472|66597935|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
23786780|NCT04281472|66597936|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
23786781|NCT04281472|66597934|FG000|Stage A|Lost to Follow-up|2|||
23786782|NCT04281472|66597935|FG001|Stage A|Lost to Follow-up|0|||
23458722|NCT04179175|65421427|FG003|Overall Study|Physician Decision|3|||
23786783|NCT04281472|66597936|FG002|Stage A|Lost to Follow-up|0|||
23786784|NCT04281472|66597934|FG000|Stage A|Non-compliance with study drug|1|||
23786785|NCT04281472|66597935|FG001|Stage A|Non-compliance with study drug|0|||
23786786|NCT04281472|66597936|FG002|Stage A|Non-compliance with study drug|0|||
23786787|NCT04281472|66597934|FG000|Stage A|Physician Decision|1|||
23786788|NCT04281472|66597935|FG001|Stage A|Physician Decision|0|||
23786789|NCT04281472|66597936|FG002|Stage A|Physician Decision|0|||
23786790|NCT04281472|66597934|FG000|Stage A|Prohibited medications|2|||
23786791|NCT04281472|66597935|FG001|Stage A|Prohibited medications|0|||
23786792|NCT04281472|66597936|FG002|Stage A|Prohibited medications|0|||
23786793|NCT04281472|66597934|FG000|Stage A|Withdrawal by Subject|11|||
23786794|NCT04281472|66597935|FG001|Stage A|Withdrawal by Subject|0|||
23786795|NCT04281472|66597936|FG002|Stage A|Withdrawal by Subject|0|||
23786796|NCT04281472|66597934|FG000|Stage A|Other|5|||
23786797|NCT04281472|66597935|FG001|Stage A|Other|0|||
23786798|NCT04281472|66597936|FG002|Stage A|Other|0|||
23786799|NCT04281472|66597934|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23786800|NCT04281472|66597935|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
23786801|NCT04281472|66597936|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
23786802|NCT04281472|66597934|FG000|Stage B|Adverse Event|0|||
23786803|NCT04281472|66597935|FG001|Stage B|Adverse Event|3|||
23786804|NCT04281472|66597936|FG002|Stage B|Adverse Event|0|||
23786805|NCT04281472|66597934|FG000|Stage B|Death|0|||
23786806|NCT04281472|66597935|FG001|Stage B|Death|0|||
23786807|NCT04281472|66597936|FG002|Stage B|Death|1|||
23786808|NCT04281472|66597934|FG000|Stage B|Lack of Efficacy|0|||
23786809|NCT04281472|66597935|FG001|Stage B|Lack of Efficacy|0|||
23786810|NCT04281472|66597936|FG002|Stage B|Lack of Efficacy|1|||
23786811|NCT04281472|66597934|FG000|Stage B|Lost to Follow-up|0|||
23786812|NCT04281472|66597935|FG001|Stage B|Lost to Follow-up|0|||
23786813|NCT04281472|66597936|FG002|Stage B|Lost to Follow-up|2|||
23786814|NCT04281472|66597934|FG000|Stage B|Prohibited medications|0|||
23786815|NCT04281472|66597935|FG001|Stage B|Prohibited medications|2|||
23786816|NCT04281472|66597936|FG002|Stage B|Prohibited medications|1|||
23786817|NCT04281472|66597934|FG000|Stage B|Protocol Violation|0|||
23786818|NCT04281472|66597935|FG001|Stage B|Protocol Violation|1|||
23786819|NCT04281472|66597936|FG002|Stage B|Protocol Violation|1|||
23786820|NCT04281472|66597934|FG000|Stage B|Sponsor decision|0|||
23786821|NCT04281472|66597935|FG001|Stage B|Sponsor decision|0|||
23786822|NCT04281472|66597936|FG002|Stage B|Sponsor decision|1|||
23786823|NCT04281472|66597934|FG000|Stage B|Withdrawal by Subject|0|||
23786824|NCT04281472|66597935|FG001|Stage B|Withdrawal by Subject|3|||
23786825|NCT04281472|66597936|FG002|Stage B|Withdrawal by Subject|3|||
23786826|NCT04281472|66597934|FG000|Stage B|Other|0|||
23786827|NCT04281472|66597935|FG001|Stage B|Other|3|||
23786828|NCT04281472|66597936|FG002|Stage B|Other|0|||
23786829|NCT03669250|66597937|FG000|Overall Study|Adverse Event|0|||
23786830|NCT03669250|66597938|FG001|Overall Study|Adverse Event|0|||
23786831|NCT03669250|66597939|FG002|Overall Study|Adverse Event|0|||
23786832|NCT03669250|66597940|FG003|Overall Study|Adverse Event|0|||
23786833|NCT03669250|66597941|FG004|Overall Study|Adverse Event|1|||
23786834|NCT03669250|66597942|FG005|Overall Study|Adverse Event|0|||
23786835|NCT03669250|66597937|FG000|Overall Study|Withdrawal by Subject|0|||
23786836|NCT03669250|66597938|FG001|Overall Study|Withdrawal by Subject|1|||
23786837|NCT03669250|66597939|FG002|Overall Study|Withdrawal by Subject|0|||
23786838|NCT03669250|66597940|FG003|Overall Study|Withdrawal by Subject|1|||
23786839|NCT03669250|66597941|FG004|Overall Study|Withdrawal by Subject|0|||
23786840|NCT03669250|66597942|FG005|Overall Study|Withdrawal by Subject|0|||
23786841|NCT01647828|66597947|FG000|Overall Study|Death|3|||
23458723|NCT04179175|65421428|FG004|Overall Study|Physician Decision|1|||
23706187|NCT02234583|66301077|FG000|Overall Study|Protocol Violation|35|||
23786842|NCT01647828|66597948|FG001|Overall Study|Death|4|||
23786843|NCT01647828|66597949|FG002|Overall Study|Death|4|||
23786844|NCT01647828|66597950|FG003|Overall Study|Death|5|||
23786845|NCT01647828|66597951|FG004|Overall Study|Death|6|||
23786846|NCT01647828|66597952|FG005|Overall Study|Death|3|||
23786847|NCT01647828|66597953|FG006|Overall Study|Death|10|||
23786848|NCT01647828|66597954|FG007|Overall Study|Death|60|||
23786849|NCT01647828|66597955|FG008|Overall Study|Death|71|||
23786850|NCT01647828|66597947|FG000|Overall Study|Withdrawal by Subject|2|||
23786851|NCT01647828|66597948|FG001|Overall Study|Withdrawal by Subject|0|||
23786852|NCT01647828|66597949|FG002|Overall Study|Withdrawal by Subject|0|||
23786853|NCT01647828|66597950|FG003|Overall Study|Withdrawal by Subject|1|||
23786854|NCT01647828|66597951|FG004|Overall Study|Withdrawal by Subject|0|||
23786855|NCT01647828|66597952|FG005|Overall Study|Withdrawal by Subject|0|||
23786856|NCT01647828|66597953|FG006|Overall Study|Withdrawal by Subject|1|||
23786857|NCT01647828|66597954|FG007|Overall Study|Withdrawal by Subject|0|||
23786858|NCT01647828|66597955|FG008|Overall Study|Withdrawal by Subject|2|||
23786859|NCT01647828|66597947|FG000|Overall Study|Study terminated by Sponsor|0|||
23786860|NCT01647828|66597948|FG001|Overall Study|Study terminated by Sponsor|0|||
23786861|NCT01647828|66597949|FG002|Overall Study|Study terminated by Sponsor|0|||
23458724|NCT04179175|65421429|FG005|Overall Study|Physician Decision|1|||
23786862|NCT01647828|66597950|FG003|Overall Study|Study terminated by Sponsor|0|||
23786863|NCT01647828|66597951|FG004|Overall Study|Study terminated by Sponsor|0|||
23786864|NCT01647828|66597952|FG005|Overall Study|Study terminated by Sponsor|0|||
23786865|NCT01647828|66597953|FG006|Overall Study|Study terminated by Sponsor|1|||
23786866|NCT01647828|66597954|FG007|Overall Study|Study terminated by Sponsor|26|||
23786867|NCT01647828|66597955|FG008|Overall Study|Study terminated by Sponsor|16|||
23786868|NCT01647828|66597947|FG000|Overall Study|Lost to Follow-up|0|||
23786869|NCT01647828|66597948|FG001|Overall Study|Lost to Follow-up|0|||
23786870|NCT01647828|66597949|FG002|Overall Study|Lost to Follow-up|0|||
23786871|NCT01647828|66597950|FG003|Overall Study|Lost to Follow-up|0|||
23786872|NCT01647828|66597951|FG004|Overall Study|Lost to Follow-up|0|||
23786873|NCT01647828|66597952|FG005|Overall Study|Lost to Follow-up|0|||
23786874|NCT01647828|66597953|FG006|Overall Study|Lost to Follow-up|0|||
23786875|NCT01647828|66597954|FG007|Overall Study|Lost to Follow-up|2|||
23786876|NCT01647828|66597955|FG008|Overall Study|Lost to Follow-up|0|||
23786877|NCT00669162|66597956|FG000|Overall Study|Withdrawal by Subject|1|||
23786878|NCT00429416|66597958|FG000|Overall Study|Death|1|||
23786879|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
23786880|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
23786881|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
23786882|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
23786883|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
23786884|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
23786885|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Death|9|||
23786886|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Death|7|||
23786887|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Death|14|||
23786888|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Death|7|||
23786889|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Death|0|||
23786890|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Death|0|||
23786891|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
23786892|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
23786893|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
23786894|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
23786895|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
23786896|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
23786897|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Other Event|49|||
23786898|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Other Event|52|||
23786899|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Other Event|41|||
23786900|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Other Event|58|||
23786901|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Other Event|0|||
23786902|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Other Event|0|||
23786903|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
23786904|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
23786905|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
23786906|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
23786907|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
23786908|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
23786909|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
23786910|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
23786911|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
23786912|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
23786913|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
23786914|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
23786915|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
23786916|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
23786917|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
23786918|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
23786919|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
23786920|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
23786921|NCT00205777|66597959|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
23786922|NCT00205777|66597960|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
23786923|NCT00205777|66597961|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
23786924|NCT00205777|66597962|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
23458725|NCT04179175|65421424|FG000|Overall Study|Pregnancy|3|||
23458726|NCT04179175|65421425|FG001|Overall Study|Pregnancy|0|||
23458727|NCT04179175|65421426|FG002|Overall Study|Pregnancy|3|||
23458728|NCT04179175|65421427|FG003|Overall Study|Pregnancy|0|||
23458729|NCT04179175|65421428|FG004|Overall Study|Pregnancy|1|||
23786925|NCT00205777|66597963|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
23786926|NCT00205777|66597964|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
23786927|NCT00205777|66597959|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
23786928|NCT00205777|66597960|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
23786929|NCT00205777|66597961|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
23786930|NCT00205777|66597962|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
23786931|NCT00205777|66597963|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
23786932|NCT00205777|66597964|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
23786933|NCT00205777|66597959|FG000|Completed Core Study, Entered SE I|Other Event|52|||
23458730|NCT04179175|65421429|FG005|Overall Study|Pregnancy|2|||
23786934|NCT00205777|66597960|FG001|Completed Core Study, Entered SE I|Other Event|46|||
23786935|NCT00205777|66597961|FG002|Completed Core Study, Entered SE I|Other Event|47|||
23786936|NCT00205777|66597962|FG003|Completed Core Study, Entered SE I|Other Event|50|||
23786937|NCT00205777|66597963|FG004|Completed Core Study, Entered SE I|Other Event|0|||
23786938|NCT00205777|66597964|FG005|Completed Core Study, Entered SE I|Other Event|0|||
23786939|NCT00205777|66597959|FG000|Study Extension I|Adverse Event|57|||
23786940|NCT00205777|66597960|FG001|Study Extension I|Adverse Event|0|||
23458731|NCT04179175|65421424|FG000|Overall Study|Withdrawal by Subject|22|||
23458732|NCT04179175|65421425|FG001|Overall Study|Withdrawal by Subject|10|||
23458733|NCT04179175|65421426|FG002|Overall Study|Withdrawal by Subject|12|||
23458734|NCT04179175|65421427|FG003|Overall Study|Withdrawal by Subject|8|||
23458735|NCT04179175|65421428|FG004|Overall Study|Withdrawal by Subject|23|||
23458736|NCT04179175|65421429|FG005|Overall Study|Withdrawal by Subject|31|||
23458737|NCT04179175|65421424|FG000|Overall Study|Technical problems|0|||
23458738|NCT04179175|65421425|FG001|Overall Study|Technical problems|0|||
23458739|NCT04179175|65421426|FG002|Overall Study|Technical problems|1|||
23458740|NCT04179175|65421427|FG003|Overall Study|Technical problems|1|||
23458741|NCT04179175|65421428|FG004|Overall Study|Technical problems|0|||
23458742|NCT04179175|65421429|FG005|Overall Study|Technical problems|0|||
23458743|NCT01346358|65421430|FG000|Overall Study|Withdrawal by Subject|1|||
23458744|NCT01346358|65421431|FG001|Overall Study|Withdrawal by Subject|0|||
23458745|NCT01346358|65421432|FG002|Overall Study|Withdrawal by Subject|1|||
23458746|NCT01346358|65421433|FG003|Overall Study|Withdrawal by Subject|1|||
23458747|NCT01346358|65421434|FG004|Overall Study|Withdrawal by Subject|0|||
23458748|NCT01346358|65421435|FG005|Overall Study|Withdrawal by Subject|2|||
23347286|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23458749|NCT01346358|65421436|FG006|Overall Study|Withdrawal by Subject|1|||
23458750|NCT01346358|65421437|FG007|Overall Study|Withdrawal by Subject|1|||
23458751|NCT01346358|65421438|FG008|Overall Study|Withdrawal by Subject|1|||
23458752|NCT01346358|65421430|FG000|Overall Study|Adverse Event|1|||
23458753|NCT01346358|65421431|FG001|Overall Study|Adverse Event|0|||
23458754|NCT01346358|65421432|FG002|Overall Study|Adverse Event|0|||
23458755|NCT01346358|65421433|FG003|Overall Study|Adverse Event|0|||
23458756|NCT01346358|65421434|FG004|Overall Study|Adverse Event|1|||
23458757|NCT01346358|65421435|FG005|Overall Study|Adverse Event|0|||
23458758|NCT01346358|65421436|FG006|Overall Study|Adverse Event|0|||
23458759|NCT01346358|65421437|FG007|Overall Study|Adverse Event|0|||
23458760|NCT01346358|65421438|FG008|Overall Study|Adverse Event|1|||
23458761|NCT01346358|65421430|FG000|Overall Study|Non-Compliance|0|||
23458762|NCT01346358|65421431|FG001|Overall Study|Non-Compliance|0|||
23458763|NCT01346358|65421432|FG002|Overall Study|Non-Compliance|0|||
23458764|NCT01346358|65421433|FG003|Overall Study|Non-Compliance|0|||
23458765|NCT01346358|65421434|FG004|Overall Study|Non-Compliance|0|||
23458766|NCT01346358|65421435|FG005|Overall Study|Non-Compliance|0|||
23458767|NCT01346358|65421436|FG006|Overall Study|Non-Compliance|0|||
23458768|NCT01346358|65421437|FG007|Overall Study|Non-Compliance|2|||
23458769|NCT01346358|65421438|FG008|Overall Study|Non-Compliance|0|||
23458770|NCT01346358|65421430|FG000|Overall Study|Physician Decision|0|||
23458771|NCT01346358|65421431|FG001|Overall Study|Physician Decision|1|||
23458772|NCT01346358|65421432|FG002|Overall Study|Physician Decision|0|||
23458773|NCT01346358|65421433|FG003|Overall Study|Physician Decision|0|||
23458774|NCT01346358|65421434|FG004|Overall Study|Physician Decision|0|||
23458775|NCT01346358|65421435|FG005|Overall Study|Physician Decision|0|||
23458776|NCT01346358|65421436|FG006|Overall Study|Physician Decision|0|||
23458777|NCT01346358|65421437|FG007|Overall Study|Physician Decision|1|||
23458778|NCT01346358|65421438|FG008|Overall Study|Physician Decision|1|||
23458779|NCT05249582|65421439|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
23458780|NCT05249582|65421440|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
23458781|NCT05249582|65421439|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
23458782|NCT05249582|65421440|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
23458783|NCT05249582|65421439|FG000|Overall Study|Declined to use virtual reality headset|1|||
23458784|NCT05249582|65421440|FG001|Overall Study|Declined to use virtual reality headset|0|||
23458785|NCT03668873|65421443|FG000|Overall Study|Lost to Follow-up|6|||
23458786|NCT03668873|65421444|FG001|Overall Study|Lost to Follow-up|3|||
23458787|NCT03164616|65421445|FG000|Overall Study|Death|250|||
23458788|NCT03164616|65421446|FG001|Overall Study|Death|264|||
23458789|NCT03164616|65421447|FG002|Overall Study|Death|279|||
23458790|NCT03164616|65421445|FG000|Overall Study|Lost to Follow-up|2|||
23458791|NCT03164616|65421446|FG001|Overall Study|Lost to Follow-up|2|||
23458792|NCT03164616|65421447|FG002|Overall Study|Lost to Follow-up|2|||
23458793|NCT03164616|65421445|FG000|Overall Study|Withdrawal by Subject|6|||
23458794|NCT03164616|65421446|FG001|Overall Study|Withdrawal by Subject|7|||
23458795|NCT03164616|65421447|FG002|Overall Study|Withdrawal by Subject|16|||
23786941|NCT00205777|66597961|FG002|Study Extension I|Adverse Event|0|||
23786942|NCT00205777|66597962|FG003|Study Extension I|Adverse Event|61|||
23458796|NCT04123470|65421448|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
23458797|NCT04123470|65421449|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
23458798|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
23458799|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
23458800|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
23458801|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
23458802|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
23786943|NCT00205777|66597963|FG004|Study Extension I|Adverse Event|58|||
23786944|NCT00205777|66597964|FG005|Study Extension I|Adverse Event|0|||
23786945|NCT00205777|66597959|FG000|Study Extension I|Death|5|||
23786946|NCT00205777|66597960|FG001|Study Extension I|Death|0|||
23786947|NCT00205777|66597961|FG002|Study Extension I|Death|0|||
23786948|NCT00205777|66597962|FG003|Study Extension I|Death|1|||
23786949|NCT00205777|66597963|FG004|Study Extension I|Death|2|||
23786950|NCT00205777|66597964|FG005|Study Extension I|Death|0|||
23786951|NCT00205777|66597959|FG000|Study Extension I|Withdrawal by Subject|99|||
23786952|NCT00205777|66597960|FG001|Study Extension I|Withdrawal by Subject|0|||
23786953|NCT00205777|66597961|FG002|Study Extension I|Withdrawal by Subject|0|||
23786954|NCT00205777|66597962|FG003|Study Extension I|Withdrawal by Subject|106|||
23786955|NCT00205777|66597963|FG004|Study Extension I|Withdrawal by Subject|89|||
23458803|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
23458804|NCT01231906|65421450|FG000|Overall Study|Lack of Efficacy|75|||
23458805|NCT01231906|65421451|FG001|Overall Study|Lack of Efficacy|68|||
23458806|NCT01231906|65421450|FG000|Overall Study|Lost to Follow-up|1|||
23458807|NCT01231906|65421451|FG001|Overall Study|Lost to Follow-up|0|||
23458808|NCT01231906|65421450|FG000|Overall Study|Physician Decision|34|||
23458809|NCT01231906|65421451|FG001|Overall Study|Physician Decision|24|||
23458810|NCT01231906|65421450|FG000|Overall Study|Withdrawal by Subject|0|||
23458811|NCT01231906|65421451|FG001|Overall Study|Withdrawal by Subject|4|||
23458812|NCT01231906|65421450|FG000|Overall Study|Ineligible|10|||
23458813|NCT01231906|65421451|FG001|Overall Study|Ineligible|3|||
23458814|NCT01231906|65421450|FG000|Overall Study|No treatment|1|||
23458815|NCT01231906|65421451|FG001|Overall Study|No treatment|2|||
23458816|NCT04245111|65421458|FG000|Overall Study|Lost to Follow-up|5|||
23458817|NCT04245111|65421459|FG001|Overall Study|Lost to Follow-up|1|||
23458818|NCT04245111|65421460|FG002|Overall Study|Lost to Follow-up|1|||
23458819|NCT03157830|65421461|FG000|Overall Study|Lost to Follow-up|1|||
23458820|NCT03157830|65421461|FG000|Overall Study|Withdrawal by Subject|1|||
23458821|NCT01864018|65421463|FG000|Overall Study|Ineligible|3|||
23458822|NCT01864018|65421464|FG001|Overall Study|Ineligible|1|||
23458823|NCT03119259|65423519|FG000|Overall Study|Withdrawn as no longer eligible|1|||
23458824|NCT03119259|65423520|FG001|Overall Study|Withdrawn as no longer eligible|0|||
23458825|NCT03119259|65423519|FG000|Overall Study|Withdrawal by Subject|4|||
23458826|NCT03119259|65423520|FG001|Overall Study|Withdrawal by Subject|2|||
23458827|NCT03119259|65423519|FG000|Overall Study|Lost to Follow-up|0|||
23458828|NCT03119259|65423520|FG001|Overall Study|Lost to Follow-up|1|||
23458829|NCT03904693|65423524|FG000|Overall Study|Death|0|||
23458830|NCT03904693|65423525|FG001|Overall Study|Death|0|||
23458831|NCT03904693|65423526|FG002|Overall Study|Death|3|||
23458832|NCT03904693|65423524|FG000|Overall Study|Physician Decision|0|||
23458833|NCT03904693|65423525|FG001|Overall Study|Physician Decision|0|||
23638516|NCT00283244|66060948|FG000|Overall Study|Medical illness (other complicating dz)|4|||
23638517|NCT00283244|66060949|FG001|Overall Study|Medical illness (other complicating dz)|3|||
23786956|NCT00205777|66597964|FG005|Study Extension I|Withdrawal by Subject|0|||
23458834|NCT03904693|65423526|FG002|Overall Study|Physician Decision|2|||
23458835|NCT03904693|65423524|FG000|Overall Study|Withdrawal by Subject|0|||
23458836|NCT03904693|65423525|FG001|Overall Study|Withdrawal by Subject|1|||
23458837|NCT03904693|65423526|FG002|Overall Study|Withdrawal by Subject|4|||
23458838|NCT04439539|65423527|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
23786957|NCT00205777|66597959|FG000|Study Extension I|Protocol Violation|4|||
23786958|NCT00205777|66597960|FG001|Study Extension I|Protocol Violation|0|||
23458839|NCT04439539|65423528|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
23458840|NCT04439539|65423529|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
23458841|NCT04439539|65423527|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
23786959|NCT00205777|66597961|FG002|Study Extension I|Protocol Violation|0|||
23786960|NCT00205777|66597962|FG003|Study Extension I|Protocol Violation|8|||
23458842|NCT04439539|65423528|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
23458843|NCT04439539|65423529|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
23458844|NCT04439539|65423527|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
23458845|NCT04439539|65423528|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
23458846|NCT04439539|65423529|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
23458847|NCT01648751|65423534|FG000|Overall Study|Withdrawal by Subject|2|||
23458848|NCT01648751|65423535|FG001|Overall Study|Withdrawal by Subject|3|||
23458849|NCT04227899|65423536|FG000|Overall Study|Withdrawal by Subject|6|||
23458850|NCT04227899|65423537|FG001|Overall Study|Withdrawal by Subject|3|||
23458851|NCT04227899|65423536|FG000|Overall Study|Death|12|||
23458852|NCT04227899|65423537|FG001|Overall Study|Death|6|||
23458853|NCT04227899|65423536|FG000|Overall Study|Lost to Follow-up|2|||
23458854|NCT04227899|65423537|FG001|Overall Study|Lost to Follow-up|1|||
23458855|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
23458856|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
23458857|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
23458858|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
23458859|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
23458860|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
23458861|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
23458862|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
23458863|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
23458864|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
23458865|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
23458866|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
23458867|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
23458868|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
23458869|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
23458870|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
23458871|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Death|2|||
23458872|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Death|1|||
23458873|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
23458874|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
23458875|NCT03264404|65423540|FG000|Overall Study|Death|2|||
23458876|NCT03264404|65423540|FG000|Overall Study|Physician Decision|1|||
23458877|NCT03264404|65423540|FG000|Overall Study|Disease Progression|28|||
23458878|NCT03264404|65423540|FG000|Overall Study|Adverse Event|1|||
23458879|NCT03264404|65423540|FG000|Overall Study|Off study prior to treatment|2|||
23458880|NCT03497676|65423541|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458881|NCT03497676|65423542|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
23458882|NCT03497676|65423543|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458883|NCT03497676|65423544|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458884|NCT03497676|65423541|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
23458885|NCT03497676|65423542|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
23458886|NCT03497676|65423543|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
23458887|NCT03497676|65423544|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
23786961|NCT00205777|66597963|FG004|Study Extension I|Protocol Violation|8|||
23458888|NCT03497676|65423541|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
23786962|NCT00205777|66597964|FG005|Study Extension I|Protocol Violation|0|||
23786963|NCT00205777|66597959|FG000|Study Extension I|Lack of Efficacy|0|||
23786964|NCT00205777|66597960|FG001|Study Extension I|Lack of Efficacy|0|||
23458889|NCT03497676|65423542|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
23458890|NCT03497676|65423543|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
23458891|NCT03497676|65423544|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
23458892|NCT03497676|65423541|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458893|NCT03497676|65423542|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
23458894|NCT03497676|65423543|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458895|NCT03497676|65423544|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458896|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458897|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458898|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
23458899|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458900|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23458901|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23458902|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
23458903|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23786965|NCT00205777|66597961|FG002|Study Extension I|Lack of Efficacy|0|||
23786966|NCT00205777|66597962|FG003|Study Extension I|Lack of Efficacy|1|||
23638518|NCT00283244|66060950|FG002|Overall Study|Medical illness (other complicating dz)|6|||
23786967|NCT00205777|66597963|FG004|Study Extension I|Lack of Efficacy|2|||
23786968|NCT00205777|66597964|FG005|Study Extension I|Lack of Efficacy|0|||
23786969|NCT00205777|66597959|FG000|Study Extension I|Failed to return|15|||
23786970|NCT00205777|66597960|FG001|Study Extension I|Failed to return|0|||
23786971|NCT00205777|66597961|FG002|Study Extension I|Failed to return|0|||
23786972|NCT00205777|66597962|FG003|Study Extension I|Failed to return|17|||
23786973|NCT00205777|66597963|FG004|Study Extension I|Failed to return|13|||
23786974|NCT00205777|66597964|FG005|Study Extension I|Failed to return|0|||
23786975|NCT00205777|66597959|FG000|Study Extension I|Other Event|34|||
23786976|NCT00205777|66597960|FG001|Study Extension I|Other Event|0|||
23786977|NCT00205777|66597961|FG002|Study Extension I|Other Event|0|||
23786978|NCT00205777|66597962|FG003|Study Extension I|Other Event|34|||
23786979|NCT00205777|66597963|FG004|Study Extension I|Other Event|29|||
23786980|NCT00205777|66597964|FG005|Study Extension I|Other Event|0|||
23786981|NCT00205777|66597959|FG000|Study Extension I|Withdrawn as per protocol|0|||
23786982|NCT00205777|66597960|FG001|Study Extension I|Withdrawn as per protocol|0|||
23786983|NCT00205777|66597961|FG002|Study Extension I|Withdrawn as per protocol|1070|||
23786984|NCT00205777|66597962|FG003|Study Extension I|Withdrawn as per protocol|0|||
23786985|NCT00205777|66597963|FG004|Study Extension I|Withdrawn as per protocol|0|||
23786986|NCT00205777|66597964|FG005|Study Extension I|Withdrawn as per protocol|0|||
23786987|NCT00205777|66597959|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
23786988|NCT00205777|66597960|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23786989|NCT00205777|66597961|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23786990|NCT00205777|66597962|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
23786991|NCT00205777|66597963|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
23786992|NCT00205777|66597964|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23786993|NCT00205777|66597959|FG000|Study Extension II|Adverse Event|0|||
23786994|NCT00205777|66597960|FG001|Study Extension II|Adverse Event|0|||
23786995|NCT00205777|66597961|FG002|Study Extension II|Adverse Event|0|||
23786996|NCT00205777|66597962|FG003|Study Extension II|Adverse Event|14|||
23786997|NCT00205777|66597963|FG004|Study Extension II|Adverse Event|0|||
23786998|NCT00205777|66597964|FG005|Study Extension II|Adverse Event|30|||
23786999|NCT00205777|66597959|FG000|Study Extension II|Death|0|||
23787000|NCT00205777|66597960|FG001|Study Extension II|Death|0|||
23787001|NCT00205777|66597961|FG002|Study Extension II|Death|0|||
23787002|NCT00205777|66597962|FG003|Study Extension II|Death|2|||
23787003|NCT00205777|66597963|FG004|Study Extension II|Death|0|||
23787004|NCT00205777|66597964|FG005|Study Extension II|Death|5|||
23787005|NCT00205777|66597959|FG000|Study Extension II|Withdrawal by Subject|0|||
23787006|NCT00205777|66597960|FG001|Study Extension II|Withdrawal by Subject|0|||
23787007|NCT00205777|66597961|FG002|Study Extension II|Withdrawal by Subject|0|||
23787008|NCT00205777|66597962|FG003|Study Extension II|Withdrawal by Subject|35|||
23787009|NCT00205777|66597963|FG004|Study Extension II|Withdrawal by Subject|0|||
23787010|NCT00205777|66597964|FG005|Study Extension II|Withdrawal by Subject|59|||
23787011|NCT00205777|66597959|FG000|Study Extension II|Protocol Violation|0|||
23787012|NCT00205777|66597960|FG001|Study Extension II|Protocol Violation|0|||
23787013|NCT00205777|66597961|FG002|Study Extension II|Protocol Violation|0|||
23347287|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23347288|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
23347289|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23347290|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
23347291|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347292|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347293|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
23347294|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347295|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
23347296|NCT02461524|65014311|FG000|Overall Study|Death|16|||
23347297|NCT02461524|65014311|FG000|Overall Study|Withdrawal by Subject|4|||
23347298|NCT02461524|65014311|FG000|Overall Study|Device Explanted|5|||
23347299|NCT02461524|65014311|FG000|Overall Study|Missed Visit|6|||
23347300|NCT00197002|65014312|FG000|Overall Study|Adverse Event|0|||
23347301|NCT00197002|65014313|FG001|Overall Study|Adverse Event|1|||
23347302|NCT00197002|65014314|FG002|Overall Study|Adverse Event|0|||
23787014|NCT00205777|66597962|FG003|Study Extension II|Protocol Violation|1|||
23787015|NCT00205777|66597963|FG004|Study Extension II|Protocol Violation|0|||
23787016|NCT00205777|66597964|FG005|Study Extension II|Protocol Violation|10|||
23787017|NCT00205777|66597959|FG000|Study Extension II|Lack of Efficacy|0|||
23787018|NCT00205777|66597960|FG001|Study Extension II|Lack of Efficacy|0|||
23787019|NCT00205777|66597961|FG002|Study Extension II|Lack of Efficacy|0|||
23787020|NCT00205777|66597962|FG003|Study Extension II|Lack of Efficacy|0|||
23787021|NCT00205777|66597963|FG004|Study Extension II|Lack of Efficacy|0|||
23458904|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23458905|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23458906|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
23458907|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23583937|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23787022|NCT00205777|66597964|FG005|Study Extension II|Lack of Efficacy|1|||
23787023|NCT00205777|66597959|FG000|Study Extension II|Failed to return|0|||
23787024|NCT00205777|66597960|FG001|Study Extension II|Failed to return|0|||
23787025|NCT00205777|66597961|FG002|Study Extension II|Failed to return|0|||
23787026|NCT00205777|66597962|FG003|Study Extension II|Failed to return|14|||
23787027|NCT00205777|66597963|FG004|Study Extension II|Failed to return|0|||
23787028|NCT00205777|66597964|FG005|Study Extension II|Failed to return|26|||
23787029|NCT00205777|66597959|FG000|Study Extension II|Other Event|0|||
23787030|NCT00205777|66597960|FG001|Study Extension II|Other Event|0|||
23787031|NCT00205777|66597961|FG002|Study Extension II|Other Event|0|||
23787032|NCT00205777|66597962|FG003|Study Extension II|Other Event|12|||
23787033|NCT00205777|66597963|FG004|Study Extension II|Other Event|0|||
23787034|NCT00205777|66597964|FG005|Study Extension II|Other Event|20|||
23787035|NCT00205777|66597959|FG000|Study Extension II|Enrolled but not treated|0|||
23787036|NCT00205777|66597960|FG001|Study Extension II|Enrolled but not treated|0|||
23787037|NCT00205777|66597961|FG002|Study Extension II|Enrolled but not treated|0|||
23787038|NCT00205777|66597962|FG003|Study Extension II|Enrolled but not treated|71|||
23787039|NCT00205777|66597963|FG004|Study Extension II|Enrolled but not treated|0|||
23787040|NCT00205777|66597964|FG005|Study Extension II|Enrolled but not treated|131|||
23583938|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583939|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583940|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583941|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583942|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583943|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583944|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
23706188|NCT02234583|66301078|FG001|Overall Study|Protocol Violation|42|||
23787041|NCT01015703|66597965|FG000|Overall Study|Withdrawal by Subject|0|||
23787042|NCT01015703|66597966|FG001|Overall Study|Withdrawal by Subject|1|||
23787043|NCT01015703|66597967|FG002|Overall Study|Withdrawal by Subject|0|||
23458908|NCT03497676|65423541|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458909|NCT03497676|65423542|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458910|NCT03497676|65423543|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
23458911|NCT03497676|65423544|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458912|NCT05408429|65423545|FG000|Overall Study|Lost to Follow-up|1|||
23458913|NCT05408429|65423546|FG001|Overall Study|Lost to Follow-up|1|||
23458914|NCT05408429|65423547|FG002|Overall Study|Lost to Follow-up|0|||
23458915|NCT05408429|65423545|FG000|Overall Study|Withdrawal by Subject|5|||
23458916|NCT05408429|65423546|FG001|Overall Study|Withdrawal by Subject|0|||
23458917|NCT05408429|65423547|FG002|Overall Study|Withdrawal by Subject|1|||
23458918|NCT03317405|65423549|FG000|Overall Study|Withdrawal by Subject|1|||
23458919|NCT03317405|65423550|FG001|Overall Study|Withdrawal by Subject|0|||
23787044|NCT01015703|66597968|FG003|Overall Study|Withdrawal by Subject|0|||
23787045|NCT01015703|66597969|FG004|Overall Study|Withdrawal by Subject|0|||
23458920|NCT03317405|65423551|FG002|Overall Study|Withdrawal by Subject|0|||
23458921|NCT03317405|65423549|FG000|Overall Study|Physician Decision|0|||
23458922|NCT03317405|65423550|FG001|Overall Study|Physician Decision|0|||
23458923|NCT03317405|65423551|FG002|Overall Study|Physician Decision|1|||
23458924|NCT03317405|65423549|FG000|Overall Study|Surgery Rescheduled|0|||
23458925|NCT03317405|65423550|FG001|Overall Study|Surgery Rescheduled|1|||
23458926|NCT03317405|65423551|FG002|Overall Study|Surgery Rescheduled|0|||
23458927|NCT05523089|65423554|FG000|Overall Study|Withdrawal by Subject|1|||
23458928|NCT05523089|65423555|FG001|Overall Study|Withdrawal by Subject|0|||
23458929|NCT05523089|65423556|FG002|Overall Study|Withdrawal by Subject|0|||
23458930|NCT05523089|65423554|FG000|Overall Study|Lost to Follow-up|1|||
23458931|NCT05523089|65423555|FG001|Overall Study|Lost to Follow-up|0|||
23458932|NCT05523089|65423556|FG002|Overall Study|Lost to Follow-up|0|||
23458933|NCT04298697|65423557|FG000|Overall Study|Lost to Follow-up|5|||
23458934|NCT04298697|65423558|FG001|Overall Study|Lost to Follow-up|5|||
23458935|NCT04298697|65423559|FG002|Overall Study|Lost to Follow-up|1|||
23458936|NCT04298697|65423560|FG003|Overall Study|Lost to Follow-up|0|||
23458937|NCT04298697|65423557|FG000|Overall Study|Withdrawal by Subject|0|||
23787046|NCT01015703|66597965|FG000|Overall Study|Adverse Event|1|||
23787047|NCT01015703|66597966|FG001|Overall Study|Adverse Event|0|||
23787048|NCT01015703|66597967|FG002|Overall Study|Adverse Event|0|||
23787049|NCT01015703|66597968|FG003|Overall Study|Adverse Event|0|||
23787050|NCT01015703|66597969|FG004|Overall Study|Adverse Event|0|||
23787051|NCT01015703|66597965|FG000|Overall Study|Protocol Violation|1|||
23787052|NCT01015703|66597966|FG001|Overall Study|Protocol Violation|0|||
23787053|NCT01015703|66597967|FG002|Overall Study|Protocol Violation|0|||
23458938|NCT04298697|65423558|FG001|Overall Study|Withdrawal by Subject|3|||
23458939|NCT04298697|65423559|FG002|Overall Study|Withdrawal by Subject|2|||
23458940|NCT04298697|65423560|FG003|Overall Study|Withdrawal by Subject|3|||
23458941|NCT02003924|65423565|FG000|Double-blind Phase|Lost to Follow-up|2|||
23458942|NCT02003924|65423566|FG001|Double-blind Phase|Lost to Follow-up|1|||
23458943|NCT02003924|65423567|FG002|Double-blind Phase|Lost to Follow-up|0|||
23458944|NCT02003924|65423565|FG000|Double-blind Phase|Protocol Violation|1|||
23458945|NCT02003924|65423566|FG001|Double-blind Phase|Protocol Violation|2|||
23458946|NCT02003924|65423567|FG002|Double-blind Phase|Protocol Violation|0|||
23458947|NCT02003924|65423565|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
23458948|NCT02003924|65423566|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
23458949|NCT02003924|65423567|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
23458950|NCT02003924|65423565|FG000|Double-blind Phase|Disease Progression|229|||
23458951|NCT02003924|65423566|FG001|Double-blind Phase|Disease Progression|247|||
23458952|NCT02003924|65423567|FG002|Double-blind Phase|Disease Progression|0|||
23458953|NCT02003924|65423565|FG000|Double-blind Phase|Adverse Event|120|||
23458954|NCT02003924|65423566|FG001|Double-blind Phase|Adverse Event|31|||
23458955|NCT02003924|65423567|FG002|Double-blind Phase|Adverse Event|0|||
23458956|NCT02003924|65423565|FG000|Double-blind Phase|Randomized But not Treated|3|||
23458957|NCT02003924|65423566|FG001|Double-blind Phase|Randomized But not Treated|3|||
23458958|NCT02003924|65423567|FG002|Double-blind Phase|Randomized But not Treated|0|||
23458959|NCT02003924|65423565|FG000|Double-blind Phase|Other|29|||
23458960|NCT02003924|65423566|FG001|Double-blind Phase|Other|50|||
23458961|NCT02003924|65423567|FG002|Double-blind Phase|Other|0|||
23458962|NCT02003924|65423565|FG000|Open-label Phase|Lost to Follow-up|0|||
23458963|NCT02003924|65423566|FG001|Open-label Phase|Lost to Follow-up|0|||
23458964|NCT02003924|65423567|FG002|Open-label Phase|Lost to Follow-up|1|||
23458965|NCT02003924|65423565|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
23458966|NCT02003924|65423566|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
23787054|NCT01015703|66597968|FG003|Overall Study|Protocol Violation|0|||
23787055|NCT01015703|66597969|FG004|Overall Study|Protocol Violation|0|||
23787056|NCT04112823|66597974|FG000|Overall Study|Lost to Follow-up|2|||
23458967|NCT02003924|65423567|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
23458968|NCT02003924|65423565|FG000|Open-label Phase|Disease Progression|59|||
23787057|NCT04112823|66597975|FG001|Overall Study|Lost to Follow-up|3|||
23458969|NCT02003924|65423566|FG001|Open-label Phase|Disease Progression|0|||
23458970|NCT02003924|65423567|FG002|Open-label Phase|Disease Progression|5|||
23458971|NCT02003924|65423565|FG000|Open-label Phase|Adverse Event|25|||
23458972|NCT02003924|65423566|FG001|Open-label Phase|Adverse Event|0|||
23458973|NCT02003924|65423567|FG002|Open-label Phase|Adverse Event|10|||
23458974|NCT02003924|65423565|FG000|Open-label Phase|Other|7|||
23458975|NCT02003924|65423566|FG001|Open-label Phase|Other|0|||
23458976|NCT02003924|65423567|FG002|Open-label Phase|Other|0|||
23458977|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Death|288|||
23458978|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Death|174|||
23458979|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Death|4|||
23458980|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
23458981|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
23458982|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
23458983|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
23458984|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
23458985|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
23458986|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Other|5|||
23458987|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Other|2|||
23458988|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Other|1|||
23458989|NCT03521570|65423568|FG000|Overall Study|Not eligible|11|||
23458990|NCT04914364|65423579|FG000|Overall Study|No longer eligible for study|1|||
23458991|NCT04914364|65423579|FG000|Overall Study|Lost to Follow-up|2|||
23458992|NCT04109547|65423580|FG000|Overall Study|Withdrawal by Subject|3|||
23458993|NCT04109547|65423581|FG001|Overall Study|Withdrawal by Subject|2|||
23458994|NCT04109547|65423582|FG002|Overall Study|Withdrawal by Subject|6|||
23787058|NCT01794845|66597977|FG000|Overall Study|Withdrawal by Subject|1|||
23787059|NCT00467597|66600404|FG000|Overall Study|Withdrawal by Subject|2|||
23787060|NCT00467597|66600405|FG001|Overall Study|Withdrawal by Subject|0|||
23787061|NCT03531827|66600408|FG000|Overall Study|Adverse Event|2|||
23787062|NCT03531827|66600409|FG001|Overall Study|Adverse Event|0|||
23787063|NCT03531827|66600408|FG000|Overall Study|Progressive disease|1|||
23787064|NCT03531827|66600409|FG001|Overall Study|Progressive disease|0|||
23347303|NCT00197002|65014312|FG000|Overall Study|Protocol Violation|1|||
23458995|NCT04109547|65423583|FG003|Overall Study|Withdrawal by Subject|6|||
23458996|NCT04109547|65423580|FG000|Overall Study|Lost to Follow-up|0|||
23458997|NCT04109547|65423581|FG001|Overall Study|Lost to Follow-up|0|||
23458998|NCT04109547|65423582|FG002|Overall Study|Lost to Follow-up|0|||
23458999|NCT04109547|65423583|FG003|Overall Study|Lost to Follow-up|1|||
23459000|NCT04109547|65423580|FG000|Overall Study|Physician Decision|1|||
23583945|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583946|NCT03643211|65866057|FG000|Overall Study|Contract violation/deficiency|12|||
23459001|NCT04109547|65423581|FG001|Overall Study|Physician Decision|2|||
23583947|NCT03643211|65866057|FG000|Overall Study|Invalid registration|3|||
23787065|NCT01958294|66600412|FG000|Overall Study|Clinical Circumstances|2|||
23459002|NCT04109547|65423582|FG002|Overall Study|Physician Decision|0|||
23459003|NCT04109547|65423583|FG003|Overall Study|Physician Decision|0|||
23459004|NCT05058365|65423585|FG000|Overall Study|Migration|1|||
23787066|NCT01186458|66600413|FG000|Overall Study|Adverse Event|1|||
23459005|NCT05058365|65423586|FG001|Overall Study|Migration|1|||
23459006|NCT02603887|65423590|FG000|Stage 1|Adverse Event|4|||
23459007|NCT02603887|65423590|FG000|Stage 1|Disease progression|1|||
23459008|NCT02603887|65423590|FG000|Stage 2|FDA guidance|1|||
23459009|NCT01074970|65423591|FG000|Overall Study|Never Treated|0|||
23459010|NCT01074970|65423592|FG001|Overall Study|Never Treated|0|||
23459011|NCT01074970|65423593|FG002|Overall Study|Never Treated|8|||
23459012|NCT01074970|65423594|FG003|Overall Study|Never Treated|1|||
23459013|NCT01074970|65423591|FG000|Overall Study|Adverse Event|1|||
23459014|NCT01074970|65423592|FG001|Overall Study|Adverse Event|0|||
23459015|NCT01074970|65423593|FG002|Overall Study|Adverse Event|4|||
23459016|NCT01074970|65423594|FG003|Overall Study|Adverse Event|3|||
23459017|NCT01074970|65423591|FG000|Overall Study|Disease progression during treatment|3|||
23459018|NCT01074970|65423592|FG001|Overall Study|Disease progression during treatment|1|||
23459019|NCT01074970|65423593|FG002|Overall Study|Disease progression during treatment|2|||
23459020|NCT01074970|65423594|FG003|Overall Study|Disease progression during treatment|9|||
23459021|NCT01074970|65423591|FG000|Overall Study|Lost to Follow-up|0|||
23459022|NCT01074970|65423592|FG001|Overall Study|Lost to Follow-up|0|||
23459023|NCT01074970|65423593|FG002|Overall Study|Lost to Follow-up|1|||
23459024|NCT01074970|65423594|FG003|Overall Study|Lost to Follow-up|0|||
23459025|NCT01074970|65423591|FG000|Overall Study|Withdrawal by Subject|0|||
23459026|NCT01074970|65423592|FG001|Overall Study|Withdrawal by Subject|0|||
23459027|NCT01074970|65423593|FG002|Overall Study|Withdrawal by Subject|6|||
23459028|NCT01074970|65423594|FG003|Overall Study|Withdrawal by Subject|4|||
23459029|NCT01474317|65423599|FG000|Overall Study|Adverse Event|1|||
23459030|NCT01474317|65423599|FG000|Overall Study|Subject ineligible for study|1|||
23459031|NCT04102098|65423600|FG000|Main Study Period|Ongoing in study|302|||
23459032|NCT04102098|65423601|FG001|Main Study Period|Ongoing in study|291|||
23459033|NCT04102098|65423600|FG000|Main Study Period|Death|20|||
23459034|NCT04102098|65423601|FG001|Main Study Period|Death|27|||
23459035|NCT04102098|65423600|FG000|Main Study Period|Lost to Follow-up|1|||
23459036|NCT04102098|65423601|FG001|Main Study Period|Lost to Follow-up|1|||
23459037|NCT04102098|65423600|FG000|Main Study Period|Physician Decision|0|||
23459038|NCT04102098|65423601|FG001|Main Study Period|Physician Decision|1|||
23459039|NCT04102098|65423600|FG000|Main Study Period|Withdrawal by Subject|11|||
23459040|NCT04102098|65423601|FG001|Main Study Period|Withdrawal by Subject|14|||
23459041|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
23459042|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
23459043|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Death|11|||
23459044|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Death|0|||
23459045|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
23459046|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
23459047|NCT03674411|65423608|FG000|Overall Study|Non-treatment|4|||
23459048|NCT00651742|65423609|FG000|Overall Study|Objective Disease Progression|22|||
23459049|NCT00651742|65423609|FG000|Overall Study|Toxicity|3|||
23459050|NCT00651742|65423609|FG000|Overall Study|Investigator Judgment|1|||
23459051|NCT00651742|65423609|FG000|Overall Study|Withdrawal of Consent|1|||
23459052|NCT00651742|65423609|FG000|Overall Study|Enrolled but not treated|1|||
23459053|NCT00394095|65423610|FG000|Overall Study|Adverse Event|1|||
23459054|NCT00394095|65423611|FG001|Overall Study|Adverse Event|0|||
23459055|NCT03312231|65423614|FG000|Overall Study|Lost to Follow-up|2|||
23459056|NCT03312231|65423615|FG001|Overall Study|Lost to Follow-up|6|||
23459057|NCT03312231|65423616|FG002|Overall Study|Lost to Follow-up|1|||
23459058|NCT03312231|65423617|FG003|Overall Study|Lost to Follow-up|3|||
23459059|NCT03312231|65423618|FG004|Overall Study|Lost to Follow-up|1|||
23459060|NCT03312231|65423614|FG000|Overall Study|Withdrawal by Subject|0|||
23459061|NCT03312231|65423615|FG001|Overall Study|Withdrawal by Subject|3|||
23459062|NCT03312231|65423616|FG002|Overall Study|Withdrawal by Subject|1|||
23459063|NCT03312231|65423617|FG003|Overall Study|Withdrawal by Subject|0|||
23459064|NCT03312231|65423618|FG004|Overall Study|Withdrawal by Subject|0|||
23459065|NCT03312231|65423614|FG000|Overall Study|Death|0|||
23459066|NCT03312231|65423615|FG001|Overall Study|Death|1|||
23459067|NCT03312231|65423616|FG002|Overall Study|Death|1|||
23459068|NCT03312231|65423617|FG003|Overall Study|Death|0|||
23459069|NCT03312231|65423618|FG004|Overall Study|Death|0|||
23459070|NCT03312231|65423614|FG000|Overall Study|Study Vaccination not Received|1|||
23459071|NCT03312231|65423615|FG001|Overall Study|Study Vaccination not Received|1|||
23459072|NCT03312231|65423616|FG002|Overall Study|Study Vaccination not Received|1|||
23459073|NCT03312231|65423617|FG003|Overall Study|Study Vaccination not Received|0|||
23459074|NCT03312231|65423618|FG004|Overall Study|Study Vaccination not Received|0|||
23459075|NCT02589938|65423619|FG000|Overall Study|Withdrawal by Subject|11|||
23459076|NCT02589938|65423620|FG001|Overall Study|Withdrawal by Subject|5|||
23459077|NCT02589938|65423621|FG002|Overall Study|Withdrawal by Subject|6|||
23459078|NCT02589938|65423619|FG000|Overall Study|Lost to Follow-up|3|||
23459079|NCT02589938|65423620|FG001|Overall Study|Lost to Follow-up|3|||
23459080|NCT02589938|65423621|FG002|Overall Study|Lost to Follow-up|3|||
23459081|NCT02589938|65423619|FG000|Overall Study|Death|1|||
23459082|NCT02589938|65423620|FG001|Overall Study|Death|0|||
23459083|NCT02589938|65423621|FG002|Overall Study|Death|1|||
23459084|NCT02589938|65423619|FG000|Overall Study|Protocol Violation|6|||
23459085|NCT02589938|65423620|FG001|Overall Study|Protocol Violation|2|||
23459086|NCT02589938|65423621|FG002|Overall Study|Protocol Violation|3|||
23459087|NCT02589938|65423619|FG000|Overall Study|Physician Decision|1|||
23459088|NCT02589938|65423620|FG001|Overall Study|Physician Decision|0|||
23459089|NCT02589938|65423621|FG002|Overall Study|Physician Decision|0|||
23459090|NCT02589938|65423619|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
23459091|NCT02589938|65423620|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
23459092|NCT02589938|65423621|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
23459093|NCT01838395|65423622|FG000|Overall Study|Withdrawal by Subject|0|||
23459094|NCT01838395|65423623|FG001|Overall Study|Withdrawal by Subject|0|||
23459095|NCT01838395|65423624|FG002|Overall Study|Withdrawal by Subject|0|||
23459096|NCT01838395|65423625|FG003|Overall Study|Withdrawal by Subject|0|||
23459097|NCT01838395|65423626|FG004|Overall Study|Withdrawal by Subject|1|||
23459098|NCT01838395|65423627|FG005|Overall Study|Withdrawal by Subject|0|||
23459099|NCT01838395|65423622|FG000|Overall Study|Death|0|||
23459100|NCT01838395|65423623|FG001|Overall Study|Death|0|||
23459101|NCT01838395|65423624|FG002|Overall Study|Death|1|||
23459102|NCT01838395|65423625|FG003|Overall Study|Death|0|||
23459103|NCT01838395|65423626|FG004|Overall Study|Death|0|||
23459104|NCT01838395|65423627|FG005|Overall Study|Death|0|||
23459105|NCT01838395|65423622|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459106|NCT01838395|65423623|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
23459107|NCT01838395|65423624|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459108|NCT01838395|65423625|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459109|NCT01838395|65423626|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459110|NCT01838395|65423627|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459111|NCT04966013|65423628|FG000|Overall Study|Withdrawal by Subject|0|||
23459112|NCT04966013|65423629|FG001|Overall Study|Withdrawal by Subject|2|||
23459113|NCT04966013|65423630|FG002|Overall Study|Withdrawal by Subject|1|||
23459114|NCT04966013|65423628|FG000|Overall Study|Adverse Event|2|||
23459115|NCT04966013|65423629|FG001|Overall Study|Adverse Event|1|||
23459116|NCT04966013|65423630|FG002|Overall Study|Adverse Event|1|||
23459117|NCT01063751|65423631|FG000|Overall Study|Site terminated|45|||
23459118|NCT01063751|65423631|FG000|Overall Study|Lost to Follow-up|28|||
23583948|NCT03643211|65866057|FG000|Overall Study|No treatment information|2|||
23583949|NCT03643211|65866057|FG000|Overall Study|No adverse event information - No revisit|4|||
23583950|NCT01599325|65866058|FG000|Primary Parent Phase|Adverse Event|5|||
23583951|NCT01599325|65866058|FG000|Primary Parent Phase|Disease Progression|7|||
23583952|NCT01599325|65866058|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
23583953|NCT01599325|65866058|FG000|Primary Parent Phase|Death|13|||
23583954|NCT01599325|65866058|FG000|Primary Parent Phase|Protocol Violation|1|||
23583955|NCT01599325|65866058|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
23583956|NCT01599325|65866058|FG000|Primary Parent Phase|Other|2|||
23583957|NCT01599325|65866058|FG000|Extension Phase|Study Closure|1|||
23583958|NCT01599325|65866058|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
23583959|NCT01599325|65866058|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
23583960|NCT01599325|65866058|FG000|Extension Phase|Disease Progression|1|||
23583961|NCT01599325|65866058|FG000|Extension Phase|Withdrawal by Subject|8|||
23583962|NCT01007149|65866059|FG000|Overall Study|Administrative problems|0|||
23583963|NCT01007149|65866060|FG001|Overall Study|Administrative problems|1|||
23583964|NCT02132702|65866061|FG000|Overall Study|Protocol Violation|2|||
23583965|NCT02132702|65866061|FG000|Overall Study|Adverse Event|3|||
23583966|NCT02132702|65866061|FG000|Overall Study|Withdrawal by Subject|3|||
23583967|NCT02781584|65866064|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
23583968|NCT02781584|65866065|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
23583969|NCT02781584|65866066|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
23583970|NCT02781584|65866067|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
23583971|NCT02781584|65866068|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
23583972|NCT02781584|65866069|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
23583973|NCT02781584|65866070|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
23638519|NCT00283244|66060948|FG000|Overall Study|Clinical deterioration|1|||
23638520|NCT00283244|66060949|FG001|Overall Study|Clinical deterioration|3|||
23583974|NCT02781584|65866071|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
23583975|NCT02781584|65866072|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
23583976|NCT02781584|65866073|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
23583977|NCT02781584|65866074|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
23583978|NCT02781584|65866075|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
23583979|NCT02781584|65866076|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
23583980|NCT02781584|65866064|FG000|Pre-treatment Phase|Adverse Event|0|||
23459119|NCT01063751|65423631|FG000|Overall Study|Withdrawal by Subject|25|||
23459120|NCT01063751|65423631|FG000|Overall Study|Revision|6|||
23459121|NCT01063751|65423631|FG000|Overall Study|Death|12|||
23459122|NCT01063751|65423631|FG000|Overall Study|Physician Decision|4|||
23459123|NCT01063751|65423631|FG000|Overall Study|Active|91|||
23459124|NCT04163341|65423632|FG000|Overall Study|Withdrawal by Subject|2|||
23459125|NCT04163341|65423633|FG001|Overall Study|Withdrawal by Subject|0|||
23459126|NCT04163341|65423632|FG000|Overall Study|Lost to Follow-up|3|||
23459127|NCT04163341|65423633|FG001|Overall Study|Lost to Follow-up|4|||
23459128|NCT03882021|65423634|FG000|Enrollment|Procedure aborted/cancelled|2|||
23459129|NCT03882021|65423634|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
23459130|NCT03882021|65423634|FG000|Enrollment to 3-Month|Death|1|||
23459131|NCT03882021|65423634|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
23638521|NCT00283244|66060950|FG002|Overall Study|Clinical deterioration|3|||
23638522|NCT00350103|66060951|FG000|Overall Study|Adverse Event|12|||
23638523|NCT00350103|66060952|FG001|Overall Study|Adverse Event|29|||
23638524|NCT00350103|66060953|FG002|Overall Study|Adverse Event|17|||
23638525|NCT00350103|66060951|FG000|Overall Study|Lack of Efficacy|5|||
23638526|NCT00350103|66060952|FG001|Overall Study|Lack of Efficacy|1|||
23638527|NCT00350103|66060953|FG002|Overall Study|Lack of Efficacy|3|||
23638528|NCT00350103|66060951|FG000|Overall Study|Withdrawal by Subject|6|||
23638529|NCT00350103|66060952|FG001|Overall Study|Withdrawal by Subject|6|||
23638530|NCT00350103|66060953|FG002|Overall Study|Withdrawal by Subject|8|||
23638531|NCT00350103|66060951|FG000|Overall Study|Protocol Violation|0|||
23638532|NCT00350103|66060952|FG001|Overall Study|Protocol Violation|0|||
23638533|NCT00350103|66060953|FG002|Overall Study|Protocol Violation|1|||
23638534|NCT00350103|66060951|FG000|Overall Study|Unsatisfactory Compliance|2|||
23638535|NCT00350103|66060952|FG001|Overall Study|Unsatisfactory Compliance|2|||
23638536|NCT00350103|66060953|FG002|Overall Study|Unsatisfactory Compliance|1|||
23638537|NCT00350103|66060951|FG000|Overall Study|Investigator´s decision|1|||
23638538|NCT00350103|66060952|FG001|Overall Study|Investigator´s decision|1|||
23787067|NCT00371839|66600414|FG000|Overall Study|Death|4|||
23787068|NCT00371839|66600415|FG001|Overall Study|Death|0|||
23787069|NCT00371839|66600416|FG002|Overall Study|Death|0|||
23787070|NCT00371839|66600414|FG000|Overall Study|Withdrawal by Subject|7|||
23787071|NCT00371839|66600415|FG001|Overall Study|Withdrawal by Subject|4|||
23787072|NCT00371839|66600416|FG002|Overall Study|Withdrawal by Subject|0|||
23787073|NCT00371839|66600414|FG000|Overall Study|Lost to Follow-up|6|||
23787074|NCT00371839|66600415|FG001|Overall Study|Lost to Follow-up|3|||
23787075|NCT00371839|66600416|FG002|Overall Study|Lost to Follow-up|2|||
23787076|NCT05098743|66600419|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
23787077|NCT05098743|66600420|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
23787078|NCT05098743|66600419|FG000|Overall Study|Lost to Follow-up|1|||
23787079|NCT05098743|66600420|FG001|Overall Study|Lost to Follow-up|2|||
23787080|NCT02286466|66600421|FG000|Overall Study|Death|1|||
23459132|NCT03882021|65423634|FG000|Enrollment to 3-Month|Missed Visit|4|||
23459133|NCT03882021|65423634|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
23583981|NCT02781584|65866065|FG001|Pre-treatment Phase|Adverse Event|0|||
23583982|NCT02781584|65866066|FG002|Pre-treatment Phase|Adverse Event|0|||
23583983|NCT02781584|65866067|FG003|Pre-treatment Phase|Adverse Event|0|||
23583984|NCT02781584|65866068|FG004|Pre-treatment Phase|Adverse Event|0|||
23583985|NCT02781584|65866069|FG005|Pre-treatment Phase|Adverse Event|0|||
23583986|NCT02781584|65866070|FG006|Pre-treatment Phase|Adverse Event|0|||
23583987|NCT02781584|65866071|FG007|Pre-treatment Phase|Adverse Event|0|||
23583988|NCT02781584|65866072|FG008|Pre-treatment Phase|Adverse Event|0|||
23583989|NCT02781584|65866073|FG009|Pre-treatment Phase|Adverse Event|0|||
23583990|NCT02781584|65866074|FG010|Pre-treatment Phase|Adverse Event|0|||
23583991|NCT02781584|65866075|FG011|Pre-treatment Phase|Adverse Event|1|||
23583992|NCT02781584|65866076|FG012|Pre-treatment Phase|Adverse Event|0|||
23583993|NCT02781584|65866064|FG000|Treatment Phase|Withdrew Consent|0|||
23583994|NCT02781584|65866065|FG001|Treatment Phase|Withdrew Consent|0|||
23638539|NCT00350103|66060953|FG002|Overall Study|Investigator´s decision|0|||
23638540|NCT00350103|66060951|FG000|Overall Study|Exclusion criteria met|0|||
23638541|NCT00350103|66060952|FG001|Overall Study|Exclusion criteria met|0|||
23638542|NCT00350103|66060953|FG002|Overall Study|Exclusion criteria met|1|||
23347304|NCT00197002|65014313|FG001|Overall Study|Protocol Violation|0|||
23459134|NCT03882021|65423634|FG000|6-Month to 12-Month Visit|Death|1|||
23583995|NCT02781584|65866066|FG002|Treatment Phase|Withdrew Consent|0|||
23583996|NCT02781584|65866067|FG003|Treatment Phase|Withdrew Consent|0|||
23583997|NCT02781584|65866068|FG004|Treatment Phase|Withdrew Consent|0|||
23583998|NCT02781584|65866069|FG005|Treatment Phase|Withdrew Consent|1|||
23583999|NCT02781584|65866070|FG006|Treatment Phase|Withdrew Consent|0|||
23584000|NCT02781584|65866071|FG007|Treatment Phase|Withdrew Consent|0|||
23584001|NCT02781584|65866072|FG008|Treatment Phase|Withdrew Consent|0|||
23584002|NCT02781584|65866073|FG009|Treatment Phase|Withdrew Consent|0|||
23638543|NCT00350103|66060951|FG000|Overall Study|Patient relocated|0|||
23638544|NCT00350103|66060952|FG001|Overall Study|Patient relocated|0|||
23787081|NCT02286466|66600422|FG001|Overall Study|Death|3|||
23347305|NCT00197002|65014314|FG002|Overall Study|Protocol Violation|2|||
23347306|NCT00197002|65014312|FG000|Overall Study|Withdrawal by Subject|9|||
23347307|NCT00197002|65014313|FG001|Overall Study|Withdrawal by Subject|5|||
23347308|NCT00197002|65014314|FG002|Overall Study|Withdrawal by Subject|7|||
23787082|NCT02286466|66600421|FG000|Overall Study|Withdrawal by Subject|5|||
23787083|NCT02286466|66600422|FG001|Overall Study|Withdrawal by Subject|2|||
23787084|NCT02286466|66600421|FG000|Overall Study|Lost to Follow-up|1|||
23787085|NCT02286466|66600422|FG001|Overall Study|Lost to Follow-up|4|||
23347309|NCT00197002|65014312|FG000|Overall Study|Migrated/moved from study area|3|||
23347310|NCT00197002|65014313|FG001|Overall Study|Migrated/moved from study area|5|||
23347311|NCT00197002|65014314|FG002|Overall Study|Migrated/moved from study area|1|||
23347312|NCT00197002|65014312|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
23347313|NCT00197002|65014313|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
23347314|NCT00197002|65014314|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
23347315|NCT00197002|65014312|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
23347316|NCT00197002|65014313|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
23347317|NCT00197002|65014314|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
23347318|NCT00197002|65014312|FG000|Overall Study|Others|3|||
23347319|NCT00197002|65014313|FG001|Overall Study|Others|1|||
23347320|NCT00197002|65014314|FG002|Overall Study|Others|1|||
23347321|NCT02083185|65014315|FG000|Overall Study|Lost to Follow-up|0|||
23347322|NCT02083185|65014316|FG001|Overall Study|Lost to Follow-up|3|||
23347323|NCT02083185|65014317|FG002|Overall Study|Lost to Follow-up|0|||
23347324|NCT02083185|65014315|FG000|Overall Study|Withdrawal by Subject|9|||
23638545|NCT00350103|66060953|FG002|Overall Study|Patient relocated|1|||
23638546|NCT00350103|66060951|FG000|Overall Study|Need for prohibited medication|1|||
23787086|NCT02286466|66600421|FG000|Overall Study|Declined Clinician Assessment|0|||
23787087|NCT02286466|66600422|FG001|Overall Study|Declined Clinician Assessment|1|||
23787088|NCT00268203|66600423|FG000|Overall Study|Lost to Follow-up|92|||
23787089|NCT00268203|66600423|FG000|Overall Study|Withdrawal by Subject|9|||
23787090|NCT00268203|66600423|FG000|Overall Study|Received Other NHL Therapy|7|||
23787091|NCT00268203|66600423|FG000|Overall Study|Progressive Disease|359|||
23787092|NCT00268203|66600423|FG000|Overall Study|Death|84|||
23787093|NCT00268203|66600423|FG000|Overall Study|Reason Not Specified|34|||
23787094|NCT00268203|66600423|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
23787095|NCT03499353|66600424|FG000|Treatment|Adverse Event|3|||
23787096|NCT03499353|66600424|FG000|Treatment|Progressive Disease|10|||
23787097|NCT03499353|66600424|FG000|Treatment|Other|1|||
23787098|NCT03499353|66600424|FG000|Treatment|Withdrawal by Subject|2|||
23787099|NCT03499353|66600424|FG000|Long-Term Follow-up|Death|2|||
23787100|NCT03499353|66600424|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
23787101|NCT03499353|66600424|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
23787102|NCT02635750|66600425|FG000|Part 1, Period 2|Adverse Event|1|||
23787103|NCT02635750|66600426|FG001|Part 1, Period 2|Adverse Event|0|||
23787104|NCT02635750|66600427|FG002|Part 1, Period 2|Adverse Event|0|||
23787105|NCT02441686|66600428|FG000|Induction|Adverse Event|4|||
23787106|NCT02441686|66600428|FG000|Induction|Complicating disease|1|||
23787107|NCT02441686|66600428|FG000|Induction|Physician Decision|1|||
23787108|NCT02441686|66600428|FG000|Induction|Withdrawal by Subject|1|||
23787109|NCT02441686|66600428|FG000|Induction|Did not receive treatment|1|||
23787110|NCT02441686|66600428|FG000|Maintenance|Remaining on Treatment|23|||
23787111|NCT02441686|66600428|FG000|Maintenance|Physician Decision|1|||
23787112|NCT02441686|66600428|FG000|Maintenance|Adverse Event|3|||
23787113|NCT02441686|66600428|FG000|Maintenance|Progressive Disease|10|||
23787114|NCT02441686|66600428|FG000|Maintenance|Withdrawal by Subject|1|||
23787115|NCT00009945|66600430|FG000|Overall Study|no follow up data|7|||
23787116|NCT00009945|66600431|FG001|Overall Study|no follow up data|5|||
23787117|NCT01750294|66600432|FG000|Overall Study|Withdrawal by Subject|1|||
23787118|NCT01750294|66600432|FG000|Overall Study|Safety Endpoint|1|||
23787119|NCT01559363|66600433|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
23347325|NCT02083185|65014316|FG001|Overall Study|Withdrawal by Subject|15|||
23638547|NCT00350103|66060952|FG001|Overall Study|Need for prohibited medication|0|||
23638548|NCT00350103|66060953|FG002|Overall Study|Need for prohibited medication|0|||
23638549|NCT00350103|66060951|FG000|Overall Study|Personal reasons|0|||
23787120|NCT01559363|66600434|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
23787121|NCT01559363|66600435|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
23787122|NCT01559363|66600436|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23787123|NCT01559363|66600437|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23584003|NCT02781584|65866074|FG010|Treatment Phase|Withdrew Consent|1|||
23584004|NCT02781584|65866075|FG011|Treatment Phase|Withdrew Consent|2|||
23584005|NCT02781584|65866076|FG012|Treatment Phase|Withdrew Consent|0|||
23584006|NCT02781584|65866064|FG000|Treatment Phase|Adverse Event|0|||
23584007|NCT02781584|65866065|FG001|Treatment Phase|Adverse Event|0|||
23584008|NCT02781584|65866066|FG002|Treatment Phase|Adverse Event|0|||
23584009|NCT02781584|65866067|FG003|Treatment Phase|Adverse Event|0|||
23584010|NCT02781584|65866068|FG004|Treatment Phase|Adverse Event|0|||
23584011|NCT02781584|65866069|FG005|Treatment Phase|Adverse Event|0|||
23584012|NCT02781584|65866070|FG006|Treatment Phase|Adverse Event|0|||
23584013|NCT02781584|65866071|FG007|Treatment Phase|Adverse Event|1|||
23584014|NCT02781584|65866072|FG008|Treatment Phase|Adverse Event|0|||
23584015|NCT02781584|65866073|FG009|Treatment Phase|Adverse Event|0|||
23584016|NCT02781584|65866074|FG010|Treatment Phase|Adverse Event|0|||
23584017|NCT02781584|65866075|FG011|Treatment Phase|Adverse Event|0|||
23787124|NCT01559363|66600438|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23787125|NCT01559363|66600433|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
23787126|NCT01559363|66600434|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
23787127|NCT01559363|66600435|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
23787128|NCT01559363|66600436|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
23787129|NCT01559363|66600437|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
23787130|NCT01559363|66600438|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
23787131|NCT01559363|66600433|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
23787132|NCT01559363|66600434|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
23787133|NCT01559363|66600435|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23787134|NCT01559363|66600436|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23787135|NCT01559363|66600437|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23787136|NCT01559363|66600438|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23787137|NCT01559363|66600433|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
23787138|NCT01559363|66600434|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23787139|NCT01559363|66600435|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
23787140|NCT01559363|66600436|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23787141|NCT01559363|66600437|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23787142|NCT01559363|66600438|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23787143|NCT01559363|66600433|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23787144|NCT01559363|66600434|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
23787145|NCT01559363|66600435|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23787146|NCT01559363|66600436|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23787147|NCT01559363|66600437|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23787148|NCT01559363|66600438|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23787149|NCT01559363|66600433|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23787150|NCT01559363|66600434|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23787151|NCT01559363|66600435|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23787152|NCT01559363|66600436|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
23787153|NCT01559363|66600437|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
23787154|NCT01559363|66600438|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23584018|NCT02781584|65866076|FG012|Treatment Phase|Adverse Event|0|||
23584019|NCT04858425|65866077|FG000|Overall Study|Adverse Event|2|||
23584020|NCT04858425|65866078|FG001|Overall Study|Adverse Event|2|||
23584021|NCT04858425|65866077|FG000|Overall Study|Withdrawal by Subject|3|||
23787155|NCT01559363|66600433|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23787156|NCT01559363|66600434|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23584022|NCT04858425|65866078|FG001|Overall Study|Withdrawal by Subject|1|||
23347326|NCT02083185|65014317|FG002|Overall Study|Withdrawal by Subject|1|||
23347327|NCT02083185|65014315|FG000|Overall Study|Death|2|||
23347328|NCT02083185|65014316|FG001|Overall Study|Death|2|||
23347329|NCT02083185|65014317|FG002|Overall Study|Death|1|||
23347330|NCT02083185|65014315|FG000|Overall Study|Reason not Specified|9|||
23347331|NCT02083185|65014316|FG001|Overall Study|Reason not Specified|6|||
23347332|NCT02083185|65014317|FG002|Overall Study|Reason not Specified|5|||
23347333|NCT02083185|65014315|FG000|Overall Study|Study Terminated by Sponsor|0|||
23584023|NCT04858425|65866077|FG000|Overall Study|Lost to Follow-up|4|||
23584024|NCT04858425|65866078|FG001|Overall Study|Lost to Follow-up|2|||
23584025|NCT04858425|65866077|FG000|Overall Study|Lost to Follow-up|1|||
23584026|NCT04858425|65866078|FG001|Overall Study|Lost to Follow-up|0|||
23584027|NCT03404843|65866079|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
23584028|NCT03404843|65866080|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
23347334|NCT02083185|65014316|FG001|Overall Study|Study Terminated by Sponsor|1|||
23347335|NCT02083185|65014317|FG002|Overall Study|Study Terminated by Sponsor|0|||
23347336|NCT02083185|65014315|FG000|Overall Study|Did not Receive Study Drug|0|||
23347337|NCT02083185|65014316|FG001|Overall Study|Did not Receive Study Drug|2|||
23347338|NCT02083185|65014317|FG002|Overall Study|Did not Receive Study Drug|0|||
23347339|NCT00860249|65014318|FG000|Overall Study|trial was terminated prior to completion|21|||
23347340|NCT00860249|65014319|FG001|Overall Study|trial was terminated prior to completion|18|||
23347341|NCT00860249|65014320|FG002|Overall Study|trial was terminated prior to completion|21|||
23347342|NCT00990665|65014321|FG000|Overall Study|Unsuccessful Implant|8|||
23347343|NCT00990665|65014321|FG000|Overall Study|Death|29|||
23787157|NCT01559363|66600435|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23787158|NCT01559363|66600436|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
23787159|NCT01559363|66600437|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23787160|NCT01559363|66600438|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23787161|NCT04223791|66600447|FG000|Overall Study|Lost to Follow-up|0|||
23787162|NCT04223791|66600448|FG001|Overall Study|Lost to Follow-up|4|||
23787163|NCT04223791|66600447|FG000|Overall Study|Physician Decision|5|||
23787164|NCT04223791|66600448|FG001|Overall Study|Physician Decision|1|||
23787165|NCT04223791|66600447|FG000|Overall Study|Protocol Violation|1|||
23787166|NCT04223791|66600448|FG001|Overall Study|Protocol Violation|1|||
23347344|NCT00990665|65014321|FG000|Overall Study|Heart Transplant|1|||
23347345|NCT00990665|65014321|FG000|Overall Study|Withdrawal by Subject|6|||
23347346|NCT00990665|65014321|FG000|Overall Study|Lost to Follow-up|1|||
23347347|NCT00990665|65014321|FG000|Overall Study|System Explant|3|||
23347348|NCT02186847|65014322|FG000|Overall Study|Protocol Violation|3|||
23347349|NCT02186847|65014323|FG001|Overall Study|Protocol Violation|0|||
23347350|NCT04326439|65014324|FG000|Overall Study|Withdrawal by Subject|1|||
23347351|NCT04326439|65014325|FG001|Overall Study|Withdrawal by Subject|0|||
23347352|NCT04326439|65014324|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
23347353|NCT04326439|65014325|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
23347354|NCT04326439|65014324|FG000|Overall Study|Relapse after Induction 2|0|||
23347355|NCT04326439|65014325|FG001|Overall Study|Relapse after Induction 2|1|||
23347356|NCT04326439|65014324|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
23347357|NCT04326439|65014325|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
23347358|NCT02678000|65014330|FG000|PART 2|Adverse Event|0|||
23347359|NCT02678000|65014331|FG001|PART 2|Adverse Event|0|||
23584029|NCT03124108|65866081|FG000|Overall Study|Adverse Event|0|||
23584030|NCT03124108|65866082|FG001|Overall Study|Adverse Event|1|||
23584031|NCT03124108|65866083|FG002|Overall Study|Adverse Event|0|||
23584032|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
23584033|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
23584034|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
23787167|NCT04223791|66600447|FG000|Overall Study|Withdrawal by Subject|10|||
23787168|NCT04223791|66600448|FG001|Overall Study|Withdrawal by Subject|12|||
23787169|NCT04223791|66600447|FG000|Overall Study|Pregnancy|1|||
23787170|NCT04223791|66600448|FG001|Overall Study|Pregnancy|1|||
23787171|NCT04223791|66600447|FG000|Overall Study|Ongoing in Study|305|||
23787172|NCT04223791|66600448|FG001|Overall Study|Ongoing in Study|302|||
23584035|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
23787173|NCT03789110|66600449|FG000|Overall Study|Adverse Event|2|||
23787174|NCT03789110|66600449|FG000|Overall Study|Physician Decision|1|||
23787175|NCT03789110|66600449|FG000|Overall Study|Withdrawal by Subject|2|||
23787176|NCT03789110|66600449|FG000|Overall Study|Lack of Efficacy|22|||
23787177|NCT03789110|66600449|FG000|Overall Study|still on treatment|3|||
23347360|NCT02678000|65014332|FG002|PART 2|Adverse Event|2|||
23347361|NCT02678000|65014333|FG003|PART 2|Adverse Event|1|||
23347362|NCT02678000|65014334|FG004|PART 2|Adverse Event|0|||
23347363|NCT02678000|65014330|FG000|PART 2|Withdrawal by Subject|0|||
23347364|NCT02678000|65014331|FG001|PART 2|Withdrawal by Subject|0|||
23347365|NCT02678000|65014332|FG002|PART 2|Withdrawal by Subject|1|||
23787178|NCT00957021|66600450|FG000|Overall Study|Death|5|||
23787179|NCT00957021|66600450|FG000|Overall Study|Lost to Follow-up|8|||
23787180|NCT00957021|66600450|FG000|Overall Study|Withdrawal by Subject|34|||
23787181|NCT00957021|66600450|FG000|Overall Study|No 2 yr ROM data|35|||
23787182|NCT00957021|66600450|FG000|Overall Study|Revised study component by 2 yr visit|8|||
23787183|NCT00957021|66600450|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
23787184|NCT00957021|66600450|FG000|Overall Study|Surgery Cancelled|9|||
23787185|NCT00957021|66600450|FG000|Overall Study|Termination due to language issue|2|||
23787186|NCT00834431|66600451|FG000|First Intervention|Adverse Event|0|||
23787187|NCT00834431|66600452|FG001|First Intervention|Adverse Event|1|||
23787188|NCT00834431|66600451|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23787189|NCT00834431|66600452|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23787190|NCT03502811|66600455|FG000|Overall Study|Death|157|||
23787191|NCT03502811|66600455|FG000|Overall Study|Withdrawal by Subject|105|||
23787192|NCT03502811|66600455|FG000|Overall Study|Lost to Follow-up|26|||
23787193|NCT03502811|66600455|FG000|Overall Study|No Visits (Missed)|31|||
23787194|NCT04089553|66600460|FG000|Overall Study|Death|1|||
23787195|NCT04089553|66600461|FG001|Overall Study|Death|1|||
23787196|NCT04089553|66600460|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
23787197|NCT04089553|66600461|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
23787198|NCT04089553|66600460|FG000|Overall Study|Withdrawal by Subject|3|||
23787199|NCT04089553|66600461|FG001|Overall Study|Withdrawal by Subject|3|||
23787200|NCT04089553|66600460|FG000|Overall Study|Physician Decision|1|||
23787201|NCT04089553|66600461|FG001|Overall Study|Physician Decision|0|||
23787202|NCT04089553|66600460|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
23787203|NCT04089553|66600461|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
23787204|NCT04089553|66600460|FG000|Overall Study|Other|1|||
23787205|NCT04089553|66600461|FG001|Overall Study|Other|0|||
23787206|NCT04089553|66600460|FG000|Overall Study|Adverse Event|1|||
23787207|NCT04089553|66600461|FG001|Overall Study|Adverse Event|1|||
23787208|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
23787209|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
23787210|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
23787211|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
23787212|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|Death|3|||
23787213|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|Death|1|||
23787214|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
23787215|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
23787216|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
23347366|NCT02678000|65014333|FG003|PART 2|Withdrawal by Subject|0|||
23347367|NCT02678000|65014334|FG004|PART 2|Withdrawal by Subject|0|||
23347368|NCT00672841|65014336|FG000|Overall Study|Comfort care|1|||
23347369|NCT00672841|65014337|FG001|Overall Study|Comfort care|4|||
23347370|NCT00672841|65014336|FG000|Overall Study|icteric specimens|0|||
23347371|NCT00672841|65014337|FG001|Overall Study|icteric specimens|3|||
23347372|NCT00672841|65014336|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
23347373|NCT00672841|65014337|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
23347374|NCT00672841|65014336|FG000|Overall Study|Adverse Event|0|||
23347375|NCT00672841|65014337|FG001|Overall Study|Adverse Event|3|||
23347376|NCT00672841|65014336|FG000|Overall Study|Pregnancy|0|||
23347377|NCT00672841|65014337|FG001|Overall Study|Pregnancy|1|||
23347378|NCT03495154|65014338|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
23347379|NCT03495154|65014338|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
23347380|NCT03495154|65014338|FG000|Overall Study|Screen Failures During Surgery|6|||
23347381|NCT03495154|65014338|FG000|Overall Study|Death|2|||
23347382|NCT03495154|65014338|FG000|Overall Study|Lost to Follow-up|16|||
23347383|NCT03495154|65014338|FG000|Overall Study|Withdrawal by Subject|2|||
23347384|NCT03495154|65014338|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
23347385|NCT02054910|65014339|FG000|Overall Study|Lost to Follow-up|4|||
23347386|NCT02054910|65014340|FG001|Overall Study|Lost to Follow-up|1|||
23347387|NCT01382225|65014341|FG000|Overall Study|Adverse Event|3|||
23347388|NCT01382225|65014342|FG001|Overall Study|Adverse Event|2|||
23459135|NCT03882021|65423634|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
23459136|NCT02397096|65423635|FG000|Day 1 to Week 24|Adverse Event|7|||
23787217|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
23787218|NCT00537095|66600464|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
23584036|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Adverse Event|198|||
23584037|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Adverse Event|0|||
23584038|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Adverse Event|0|||
23459137|NCT02397096|65423636|FG001|Day 1 to Week 24|Adverse Event|1|||
23459138|NCT02397096|65423635|FG000|Day 1 to Week 24|Death|1|||
23459139|NCT02397096|65423636|FG001|Day 1 to Week 24|Death|0|||
23459140|NCT02397096|65423635|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
23459141|NCT02397096|65423636|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
23459142|NCT02397096|65423635|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
23459143|NCT02397096|65423636|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
23459144|NCT02397096|65423635|FG000|Day 1 to Week 24|Physician Decision|2|||
23459145|NCT02397096|65423636|FG001|Day 1 to Week 24|Physician Decision|3|||
23459146|NCT02397096|65423635|FG000|Day 1 to Week 24|Protocol Violation|1|||
23459147|NCT02397096|65423636|FG001|Day 1 to Week 24|Protocol Violation|4|||
23459148|NCT02397096|65423635|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
23459149|NCT02397096|65423636|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
23459150|NCT02397096|65423635|FG000|Day 1 to Week 24|Randomized, not treated|3|||
23459151|NCT02397096|65423636|FG001|Day 1 to Week 24|Randomized, not treated|0|||
23459152|NCT02397096|65423635|FG000|Week 24 to Week 48|Adverse Event|6|||
23787219|NCT00537095|66600465|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
23787220|NCT00537095|66600464|FG000|Open-label Period (590 Days)|Adverse Event|2|||
23584039|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Adverse Event|0|||
23584040|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Death|62|||
23584041|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Death|0|||
23584042|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Death|0|||
23584043|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Death|0|||
23584044|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
23584045|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23584046|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23638550|NCT00350103|66060952|FG001|Overall Study|Personal reasons|0|||
23787221|NCT00537095|66600465|FG001|Open-label Period (590 Days)|Adverse Event|11|||
23787222|NCT00537095|66600464|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
23787223|NCT00537095|66600465|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
23787224|NCT00537095|66600464|FG000|Open-label Period (590 Days)|Death|2|||
23787225|NCT00537095|66600465|FG001|Open-label Period (590 Days)|Death|2|||
23787226|NCT00537095|66600464|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
23347389|NCT01382225|65014341|FG000|Overall Study|Protocol Violation|2|||
23459153|NCT02397096|65423636|FG001|Week 24 to Week 48|Adverse Event|2|||
23459154|NCT02397096|65423635|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
23584047|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23638551|NCT00350103|66060953|FG002|Overall Study|Personal reasons|1|||
23347390|NCT01382225|65014342|FG001|Overall Study|Protocol Violation|1|||
23347391|NCT01382225|65014341|FG000|Overall Study|Subject Withdrew Consent|5|||
23459155|NCT02397096|65423636|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
23459156|NCT02397096|65423635|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
23459157|NCT02397096|65423636|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
23459158|NCT02397096|65423635|FG000|Week 24 to Week 48|Physician Decision|2|||
23459159|NCT02397096|65423636|FG001|Week 24 to Week 48|Physician Decision|1|||
23459160|NCT02397096|65423635|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
23459161|NCT02397096|65423636|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
23459162|NCT02397096|65423635|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
23459163|NCT02397096|65423636|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
23459164|NCT02397096|65423635|FG000|Study Extension 1|Adverse Event|7|||
23459165|NCT02397096|65423636|FG001|Study Extension 1|Adverse Event|5|||
23459166|NCT02397096|65423635|FG000|Study Extension 1|Death|1|||
23459167|NCT02397096|65423636|FG001|Study Extension 1|Death|0|||
23459168|NCT02397096|65423635|FG000|Study Extension 1|Lack of Efficacy|2|||
23459169|NCT02397096|65423636|FG001|Study Extension 1|Lack of Efficacy|5|||
23459170|NCT02397096|65423635|FG000|Study Extension 1|Lost to Follow-up|2|||
23459171|NCT02397096|65423636|FG001|Study Extension 1|Lost to Follow-up|3|||
23459172|NCT02397096|65423635|FG000|Study Extension 1|Non-compliance with study drug|3|||
23459173|NCT02397096|65423636|FG001|Study Extension 1|Non-compliance with study drug|0|||
23459174|NCT02397096|65423635|FG000|Study Extension 1|Physician Decision|4|||
23459175|NCT02397096|65423636|FG001|Study Extension 1|Physician Decision|2|||
23459176|NCT02397096|65423635|FG000|Study Extension 1|Pregnancy|1|||
23459177|NCT02397096|65423636|FG001|Study Extension 1|Pregnancy|0|||
23459178|NCT02397096|65423635|FG000|Study Extension 1|Protocol Violation|0|||
23459179|NCT02397096|65423636|FG001|Study Extension 1|Protocol Violation|1|||
23459180|NCT02397096|65423635|FG000|Study Extension 1|Withdrawal by Subject|21|||
23459181|NCT02397096|65423636|FG001|Study Extension 1|Withdrawal by Subject|7|||
23459182|NCT02397096|65423635|FG000|Study Extension 2|Adverse Event|3|||
23459183|NCT02397096|65423636|FG001|Study Extension 2|Adverse Event|3|||
23459184|NCT02397096|65423635|FG000|Study Extension 2|Availability of study medication locally|152|||
23459185|NCT02397096|65423636|FG001|Study Extension 2|Availability of study medication locally|64|||
23459186|NCT02397096|65423635|FG000|Study Extension 2|Death|2|||
23459187|NCT02397096|65423636|FG001|Study Extension 2|Death|0|||
23459188|NCT02397096|65423635|FG000|Study Extension 2|Lack of Efficacy|1|||
23459189|NCT02397096|65423636|FG001|Study Extension 2|Lack of Efficacy|0|||
23459190|NCT02397096|65423635|FG000|Study Extension 2|Lost to Follow-up|2|||
23787227|NCT00537095|66600465|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
23787228|NCT00537095|66600464|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
23787229|NCT00537095|66600465|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
23787230|NCT03961204|66600466|FG000|Overall Study|Withdrawal by Subject|2|||
23347392|NCT01382225|65014342|FG001|Overall Study|Subject Withdrew Consent|2|||
23347393|NCT01382225|65014341|FG000|Overall Study|Other|4|||
23347394|NCT01382225|65014342|FG001|Overall Study|Other|2|||
23347395|NCT00955968|65014349|FG000|Overall Study|Death|2|||
23347396|NCT00955968|65014350|FG001|Overall Study|Death|4|||
23347397|NCT00955968|65014349|FG000|Overall Study|Withdrawal by Subject|35|||
23347398|NCT00955968|65014350|FG001|Overall Study|Withdrawal by Subject|31|||
23347399|NCT00955968|65014349|FG000|Overall Study|Lost to Follow-up|45|||
23347400|NCT00955968|65014350|FG001|Overall Study|Lost to Follow-up|39|||
23347401|NCT00955968|65014349|FG000|Overall Study|Site closed|55|||
23787231|NCT03961204|66600466|FG000|Overall Study|Lost to Follow-up|3|||
23787232|NCT03961204|66600466|FG000|Overall Study|Other|1|||
23787233|NCT03961204|66600466|FG000|Overall Study|Missing|1|||
23787234|NCT05068284|66600474|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
23347402|NCT00955968|65014350|FG001|Overall Study|Site closed|52|||
23347403|NCT04459598|65014360|FG000|Overall Study|Adverse Event|1|||
23347404|NCT04459598|65014361|FG001|Overall Study|Adverse Event|1|||
23347405|NCT00766467|65014362|FG000|Overall Study|Withdrawal by Subject|7|||
23347406|NCT00766467|65014363|FG001|Overall Study|Withdrawal by Subject|2|||
23347407|NCT00766467|65014362|FG000|Overall Study|Adverse Event|1|||
23347408|NCT00766467|65014363|FG001|Overall Study|Adverse Event|1|||
23459191|NCT02397096|65423636|FG001|Study Extension 2|Lost to Follow-up|1|||
23787235|NCT05068284|66600475|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
23787236|NCT05068284|66600476|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23787237|NCT05068284|66600477|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23787238|NCT05068284|66600478|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23787239|NCT05068284|66600479|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23347409|NCT00766467|65014362|FG000|Overall Study|Protocol Violation|2|||
23347410|NCT00766467|65014363|FG001|Overall Study|Protocol Violation|4|||
23347411|NCT00766467|65014362|FG000|Overall Study|Tumor Progression on Study|0|||
23347412|NCT00766467|65014363|FG001|Overall Study|Tumor Progression on Study|1|||
23459192|NCT02397096|65423635|FG000|Study Extension 2|Non-compliance with study drug|1|||
23459193|NCT02397096|65423636|FG001|Study Extension 2|Non-compliance with study drug|0|||
23459194|NCT02397096|65423635|FG000|Study Extension 2|Physician Decision|2|||
23459195|NCT02397096|65423636|FG001|Study Extension 2|Physician Decision|5|||
23459196|NCT02397096|65423635|FG000|Study Extension 2|Pregnancy|1|||
23459197|NCT02397096|65423636|FG001|Study Extension 2|Pregnancy|0|||
23459198|NCT02397096|65423635|FG000|Study Extension 2|Withdrawal by Subject|10|||
23459199|NCT02397096|65423636|FG001|Study Extension 2|Withdrawal by Subject|3|||
23459200|NCT02397096|65423635|FG000|Study Extension 3|Adverse Event|1|||
23459201|NCT02397096|65423636|FG001|Study Extension 3|Adverse Event|0|||
23459202|NCT02397096|65423635|FG000|Study Extension 3|Availability of study medication locally|11|||
23459203|NCT02397096|65423636|FG001|Study Extension 3|Availability of study medication locally|3|||
23459204|NCT02397096|65423635|FG000|Study Extension 3|Lost to Follow-up|1|||
23459205|NCT02397096|65423636|FG001|Study Extension 3|Lost to Follow-up|0|||
23459206|NCT02397096|65423635|FG000|Study Extension 3|Withdrawal by Subject|2|||
23459207|NCT02397096|65423636|FG001|Study Extension 3|Withdrawal by Subject|1|||
23459208|NCT04288089|65423637|FG000|Overall Study|Ongoing Treatment|2|||
23459209|NCT04288089|65423638|FG001|Overall Study|Ongoing Treatment|1|||
23459210|NCT04288089|65423639|FG002|Overall Study|Ongoing Treatment|1|||
23459211|NCT04288089|65423640|FG003|Overall Study|Ongoing Treatment|4|||
23459212|NCT03598036|65423641|FG000|Overall Study|Withdrawal by Subject|1|||
23459213|NCT03598036|65423642|FG001|Overall Study|Withdrawal by Subject|0|||
23459214|NCT02081677|65423645|FG000|Overall Study|Adverse Event|0|||
23459215|NCT02081677|65423646|FG001|Overall Study|Adverse Event|0|||
23459216|NCT02081677|65423647|FG002|Overall Study|Adverse Event|1|||
23459217|NCT02081677|65423648|FG003|Overall Study|Adverse Event|0|||
23459218|NCT02081677|65423645|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23459219|NCT02081677|65423646|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23787240|NCT05068284|66600480|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23787241|NCT05068284|66600481|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23787242|NCT05068284|66600474|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787243|NCT05068284|66600475|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787244|NCT05068284|66600476|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
23787245|NCT05068284|66600477|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787246|NCT05068284|66600478|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787247|NCT05068284|66600479|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787248|NCT05068284|66600480|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787249|NCT05068284|66600481|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23787250|NCT05068284|66600474|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
23787251|NCT05068284|66600475|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
23787252|NCT05068284|66600476|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
23787253|NCT05068284|66600477|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
23787254|NCT05068284|66600478|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
23787255|NCT05068284|66600479|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23787256|NCT05068284|66600480|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23787257|NCT05068284|66600481|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23787258|NCT05068284|66600474|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787259|NCT05068284|66600475|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787260|NCT05068284|66600476|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
23787261|NCT05068284|66600477|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787262|NCT05068284|66600478|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
23787263|NCT05068284|66600479|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787264|NCT05068284|66600480|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787265|NCT05068284|66600481|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23787266|NCT05068284|66600474|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23787267|NCT05068284|66600475|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23787268|NCT05068284|66600476|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23459220|NCT02081677|65423647|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
23459221|NCT02081677|65423648|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23459222|NCT02081677|65423645|FG000|Overall Study|Not comfortable with lens care system|1|||
23459223|NCT02081677|65423646|FG001|Overall Study|Not comfortable with lens care system|0|||
23459224|NCT02081677|65423647|FG002|Overall Study|Not comfortable with lens care system|0|||
23459225|NCT02081677|65423648|FG003|Overall Study|Not comfortable with lens care system|0|||
23459226|NCT02081677|65423645|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23459227|NCT02081677|65423646|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23459228|NCT02081677|65423647|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
23459229|NCT02081677|65423648|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
23459230|NCT02782949|65423649|FG000|Overall Study|Protocol Violation|1|||
23459231|NCT02782949|65423650|FG001|Overall Study|Protocol Violation|0|||
23459232|NCT02782949|65423649|FG000|Overall Study|Withdrawal by Subject|0|||
23459233|NCT02782949|65423650|FG001|Overall Study|Withdrawal by Subject|1|||
23459234|NCT03204188|65423654|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
23459235|NCT03204188|65423654|FG000|Immunotherapy Phase (1 Year)|Death|1|||
23459236|NCT03204188|65423654|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
23459237|NCT03204188|65423654|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
23706189|NCT02234583|66301077|FG000|Overall Study|Other|39|||
23787269|NCT05068284|66600477|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
23787270|NCT05068284|66600478|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23787271|NCT05068284|66600479|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23787272|NCT05068284|66600480|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23787273|NCT05068284|66600481|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23459238|NCT03173560|65423655|FG000|Overall Study|Ongoing on Treatment|38|||
23459239|NCT03173560|65423656|FG001|Overall Study|Ongoing on Treatment|50|||
23459240|NCT03173560|65423655|FG000|Overall Study|Ongoing Survival Follow-up|56|||
23787274|NCT05068284|66600474|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787275|NCT05068284|66600475|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787276|NCT05068284|66600476|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
23787277|NCT05068284|66600477|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
23787278|NCT05068284|66600478|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787279|NCT05068284|66600479|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787280|NCT05068284|66600480|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787281|NCT05068284|66600481|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23787282|NCT05068284|66600474|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787283|NCT05068284|66600475|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787284|NCT05068284|66600476|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
23787285|NCT05068284|66600477|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787286|NCT05068284|66600478|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787287|NCT05068284|66600479|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787288|NCT05068284|66600480|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787289|NCT05068284|66600481|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23787290|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
23787291|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787292|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787293|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787294|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787295|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787296|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787297|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23787298|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
23787299|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23787300|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23787301|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23787302|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23787303|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
23787304|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
23787305|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23787306|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
23347413|NCT00766467|65014362|FG000|Overall Study|Physician Decision|1|||
23459241|NCT03173560|65423656|FG001|Overall Study|Ongoing Survival Follow-up|57|||
23584048|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Complicating disease|13|||
23584049|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Complicating disease|0|||
23584050|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Complicating disease|0|||
23584051|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Complicating disease|0|||
23584052|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
23584053|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
23584054|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
23584055|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
23584056|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
23584057|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23584058|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23584059|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23638552|NCT00350103|66060951|FG000|Overall Study|Patient stopped feeling pain|1|||
23638553|NCT00350103|66060952|FG001|Overall Study|Patient stopped feeling pain|0|||
23638554|NCT00350103|66060953|FG002|Overall Study|Patient stopped feeling pain|0|||
23638555|NCT00350103|66060951|FG000|Overall Study|PR greater than 250ms|0|||
23638556|NCT00350103|66060952|FG001|Overall Study|PR greater than 250ms|0|||
23638557|NCT00350103|66060953|FG002|Overall Study|PR greater than 250ms|1|||
23638558|NCT00350103|66060951|FG000|Overall Study|Wrong calculation of QT interval|0|||
23638559|NCT00350103|66060952|FG001|Overall Study|Wrong calculation of QT interval|0|||
23638560|NCT00350103|66060953|FG002|Overall Study|Wrong calculation of QT interval|1|||
23638561|NCT00350103|66060951|FG000|Overall Study|Sponsor mistake|1|||
23638562|NCT00350103|66060952|FG001|Overall Study|Sponsor mistake|0|||
23638563|NCT00350103|66060953|FG002|Overall Study|Sponsor mistake|0|||
23638564|NCT00350103|66060951|FG000|Overall Study|Randomization mistake|0|||
23638565|NCT00350103|66060952|FG001|Overall Study|Randomization mistake|1|||
23638566|NCT00350103|66060953|FG002|Overall Study|Randomization mistake|1|||
23638567|NCT00350103|66060951|FG000|Overall Study|Sponsor´s decision|0|||
23638568|NCT00350103|66060952|FG001|Overall Study|Sponsor´s decision|1|||
23638569|NCT00350103|66060953|FG002|Overall Study|Sponsor´s decision|0|||
23638570|NCT00350103|66060951|FG000|Overall Study|Lost, Reason unknown|1|||
23638571|NCT00350103|66060952|FG001|Overall Study|Lost, Reason unknown|1|||
23638572|NCT00350103|66060953|FG002|Overall Study|Lost, Reason unknown|0|||
23638573|NCT03258723|66060954|FG000|Overall Study|COVID Interruption of study|54|||
23638574|NCT03258723|66060954|FG000|Overall Study|Lost to Follow-up|8|||
23638575|NCT02180243|66060956|FG000|Overall Study|Withdrawal by Subject|12|||
23638576|NCT02180243|66060957|FG001|Overall Study|Withdrawal by Subject|12|||
23638577|NCT02180243|66060956|FG000|Overall Study|Lost to Follow-up|12|||
23638578|NCT02180243|66060957|FG001|Overall Study|Lost to Follow-up|2|||
23787307|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787308|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787309|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787310|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787311|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787312|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
23787313|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23787314|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
23787315|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787316|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787317|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787318|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787319|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787320|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787321|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23787322|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
23787323|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787324|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787325|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787326|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787327|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23347414|NCT00766467|65014363|FG001|Overall Study|Physician Decision|0|||
23459242|NCT03173560|65423655|FG000|Overall Study|Lost to Follow-up|1|||
23638579|NCT00503139|66060958|FG000|Overall Study|Case Report Forms were not collected|4|||
23638580|NCT00503139|66060958|FG000|Overall Study|Protocol Violation|4|||
23638581|NCT03845140|66060959|FG000|Overall Study|Participant travelled outside study area|0|||
23638582|NCT03845140|66060960|FG001|Overall Study|Participant travelled outside study area|1|||
23638583|NCT03845140|66060961|FG002|Overall Study|Participant travelled outside study area|0|||
23638584|NCT03845140|66060962|FG003|Overall Study|Participant travelled outside study area|0|||
23706190|NCT02234583|66301078|FG001|Overall Study|Other|97|||
23787328|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787329|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23787330|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
23787331|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23787332|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23787333|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23787334|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23787335|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
23787336|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
23787337|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
23787338|NCT05068284|66600474|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787339|NCT05068284|66600475|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
23638585|NCT03845140|66060963|FG004|Overall Study|Participant travelled outside study area|0|||
23638586|NCT03845140|66060964|FG005|Overall Study|Participant travelled outside study area|0|||
23638587|NCT00818779|66060965|FG000|Overall Study|Protocol Violation|1|||
23638588|NCT00818779|66060966|FG001|Overall Study|Protocol Violation|0|||
23638589|NCT00818779|66060965|FG000|Overall Study|Lost to Follow-up|1|||
23638590|NCT00818779|66060966|FG001|Overall Study|Lost to Follow-up|0|||
23638591|NCT00818779|66060965|FG000|Overall Study|Adverse Event|4|||
23638592|NCT00818779|66060966|FG001|Overall Study|Adverse Event|1|||
23638593|NCT02672852|66060967|FG000|Part A1|Disease Worsening|1|||
23638594|NCT02672852|66060968|FG001|Part A1|Disease Worsening|0|||
23638595|NCT02672852|66060969|FG002|Part A1|Disease Worsening|0|||
23638596|NCT02672852|66060970|FG003|Part A1|Disease Worsening|0|||
23638597|NCT02672852|66060971|FG004|Part A1|Disease Worsening|0|||
23638598|NCT02672852|66060972|FG005|Part A1|Disease Worsening|0|||
23638599|NCT02672852|66060973|FG006|Part A1|Disease Worsening|0|||
23638600|NCT02672852|66060967|FG000|Part A1|Adverse Event|0|||
23638601|NCT02672852|66060968|FG001|Part A1|Adverse Event|1|||
23638602|NCT02672852|66060969|FG002|Part A1|Adverse Event|0|||
23638603|NCT02672852|66060970|FG003|Part A1|Adverse Event|0|||
23638604|NCT02672852|66060971|FG004|Part A1|Adverse Event|0|||
23638605|NCT02672852|66060972|FG005|Part A1|Adverse Event|0|||
23638606|NCT02672852|66060973|FG006|Part A1|Adverse Event|0|||
23638607|NCT02672852|66060967|FG000|Part A1|Lost to Follow-up|1|||
23638608|NCT02672852|66060968|FG001|Part A1|Lost to Follow-up|2|||
23638609|NCT02672852|66060969|FG002|Part A1|Lost to Follow-up|0|||
23638610|NCT02672852|66060970|FG003|Part A1|Lost to Follow-up|0|||
23638611|NCT02672852|66060971|FG004|Part A1|Lost to Follow-up|0|||
23638612|NCT02672852|66060972|FG005|Part A1|Lost to Follow-up|0|||
23638613|NCT02672852|66060973|FG006|Part A1|Lost to Follow-up|0|||
23638614|NCT02672852|66060967|FG000|Part A1|Withdrawal by Subject|1|||
23638615|NCT02672852|66060968|FG001|Part A1|Withdrawal by Subject|1|||
23347415|NCT01317797|65014366|FG000|Overall Study|Other|0|||
23347416|NCT01317797|65014367|FG001|Overall Study|Other|1|||
23638616|NCT02672852|66060969|FG002|Part A1|Withdrawal by Subject|0|||
23638617|NCT02672852|66060970|FG003|Part A1|Withdrawal by Subject|0|||
23638618|NCT02672852|66060971|FG004|Part A1|Withdrawal by Subject|0|||
23347417|NCT01317797|65014368|FG002|Overall Study|Other|0|||
23638619|NCT02672852|66060972|FG005|Part A1|Withdrawal by Subject|0|||
23347418|NCT01317797|65014366|FG000|Overall Study|Withdrawal of Patient|0|||
23638620|NCT02672852|66060973|FG006|Part A1|Withdrawal by Subject|0|||
23638621|NCT02672852|66060967|FG000|Part A2|Disease worsening|0|||
23638622|NCT02672852|66060968|FG001|Part A2|Disease worsening|0|||
23638623|NCT02672852|66060969|FG002|Part A2|Disease worsening|1|||
23638624|NCT02672852|66060970|FG003|Part A2|Disease worsening|0|||
23638625|NCT02672852|66060971|FG004|Part A2|Disease worsening|0|||
23638626|NCT02672852|66060972|FG005|Part A2|Disease worsening|0|||
23638627|NCT02672852|66060973|FG006|Part A2|Disease worsening|0|||
23638628|NCT02672852|66060967|FG000|Part A2|Adverse Event|0|||
23638629|NCT02672852|66060968|FG001|Part A2|Adverse Event|0|||
23638630|NCT02672852|66060969|FG002|Part A2|Adverse Event|3|||
23787340|NCT05068284|66600476|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787341|NCT05068284|66600477|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787342|NCT05068284|66600478|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787343|NCT05068284|66600479|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787344|NCT05068284|66600480|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
23787345|NCT05068284|66600481|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
23787346|NCT00736190|66600485|FG000|Overall Study|Pregnancy|1|||
23347419|NCT01317797|65014367|FG001|Overall Study|Withdrawal of Patient|0|||
23347420|NCT01317797|65014368|FG002|Overall Study|Withdrawal of Patient|1|||
23347421|NCT03419598|65014372|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
23347422|NCT00278148|65014373|FG000|Phase II - Expansion Phase|Disease progression|0|||
23347423|NCT00278148|65014374|FG001|Phase II - Expansion Phase|Disease progression|0|||
23347424|NCT00278148|65014375|FG002|Phase II - Expansion Phase|Disease progression|4|||
23347425|NCT00278148|65014373|FG000|Phase II - Expansion Phase|Adverse Event|0|||
23347426|NCT00278148|65014374|FG001|Phase II - Expansion Phase|Adverse Event|0|||
23347427|NCT00278148|65014375|FG002|Phase II - Expansion Phase|Adverse Event|2|||
23347428|NCT00980174|65014376|FG000|Overall Study|Withdrawal by Subject|1|||
23347429|NCT00980174|65014377|FG001|Overall Study|Withdrawal by Subject|4|||
23347430|NCT00980174|65014376|FG000|Overall Study|Adverse Event|0|||
23347431|NCT00980174|65014377|FG001|Overall Study|Adverse Event|3|||
23347432|NCT00980174|65014376|FG000|Overall Study|Ineligibility determined|2|||
23347433|NCT00980174|65014377|FG001|Overall Study|Ineligibility determined|1|||
23347434|NCT00980174|65014376|FG000|Overall Study|Death|1|||
23347435|NCT00980174|65014377|FG001|Overall Study|Death|1|||
23347436|NCT00980174|65014376|FG000|Overall Study|Other|0|||
23347437|NCT00980174|65014377|FG001|Overall Study|Other|1|||
23347438|NCT02998476|65014380|FG000|Overall Study|Lost to Follow-up|1|||
23347439|NCT02998476|65014381|FG001|Overall Study|Lost to Follow-up|0|||
23347440|NCT02998476|65014380|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
23347441|NCT02998476|65014381|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
23347442|NCT02998476|65014380|FG000|Overall Study|Withdrawal by Subject|1|||
23347443|NCT02998476|65014381|FG001|Overall Study|Withdrawal by Subject|2|||
23347444|NCT02998476|65014380|FG000|Overall Study|Death|45|||
23347445|NCT02998476|65014381|FG001|Overall Study|Death|2|||
23347446|NCT02998476|65014380|FG000|Overall Study|Other|6|||
23459243|NCT03173560|65423656|FG001|Overall Study|Lost to Follow-up|4|||
23638631|NCT02672852|66060970|FG003|Part A2|Adverse Event|0|||
23787347|NCT00736190|66600485|FG000|Overall Study|Withdrawal by Subject|1|||
23787348|NCT00736190|66600485|FG000|Overall Study|Adverse Event|1|||
23787349|NCT03497130|66600486|FG000|Overall Study|Lost to Follow-up|1|||
23787350|NCT03497130|66600487|FG001|Overall Study|Lost to Follow-up|1|||
23787351|NCT02125461|66600488|FG000|Overall Study|Withdrawal by Subject|30|||
23787352|NCT02125461|66600489|FG001|Overall Study|Withdrawal by Subject|16|||
23787353|NCT02125461|66600488|FG000|Overall Study|Lost to Follow-up|8|||
23787354|NCT02125461|66600489|FG001|Overall Study|Lost to Follow-up|3|||
23787355|NCT02125461|66600488|FG000|Overall Study|Death|260|||
23787356|NCT02125461|66600489|FG001|Overall Study|Death|149|||
23787357|NCT02125461|66600488|FG000|Overall Study|Missing Termination Reason|0|||
23787358|NCT02125461|66600489|FG001|Overall Study|Missing Termination Reason|1|||
23787359|NCT01811953|66600492|FG000|Overall Study|Adverse Event|0|||
23787360|NCT01811953|66600493|FG001|Overall Study|Adverse Event|0|||
23787361|NCT01811953|66600494|FG002|Overall Study|Adverse Event|0|||
23787362|NCT01811953|66600495|FG003|Overall Study|Adverse Event|1|||
23787363|NCT01811953|66600496|FG004|Overall Study|Adverse Event|0|||
23787364|NCT01811953|66600497|FG005|Overall Study|Adverse Event|1|||
23787365|NCT01811953|66600492|FG000|Overall Study|Protocol Violation|0|||
23787366|NCT01811953|66600493|FG001|Overall Study|Protocol Violation|0|||
23787367|NCT01811953|66600494|FG002|Overall Study|Protocol Violation|0|||
23787368|NCT01811953|66600495|FG003|Overall Study|Protocol Violation|0|||
23347447|NCT02998476|65014381|FG001|Overall Study|Other|1|||
23347448|NCT03806231|65014383|FG000|Overall Study|Physician Decision|1|||
23459244|NCT03173560|65423655|FG000|Overall Study|Withdrawal by Subject|10|||
23638632|NCT02672852|66060971|FG004|Part A2|Adverse Event|0|||
23787369|NCT01811953|66600496|FG004|Overall Study|Protocol Violation|1|||
23638633|NCT02672852|66060972|FG005|Part A2|Adverse Event|0|||
23787370|NCT01811953|66600497|FG005|Overall Study|Protocol Violation|0|||
23787371|NCT03827395|66600503|FG000|Overall Study|Lost to Follow-up|1|||
23347449|NCT03806231|65014384|FG001|Overall Study|Physician Decision|0|||
23347450|NCT03806231|65014383|FG000|Overall Study|Withdrawal by Subject|1|||
23638634|NCT02672852|66060973|FG006|Part A2|Adverse Event|0|||
23787372|NCT03827395|66600504|FG001|Overall Study|Lost to Follow-up|0|||
23787373|NCT03827395|66600503|FG000|Overall Study|Protocol Violation|1|||
23787374|NCT03827395|66600504|FG001|Overall Study|Protocol Violation|0|||
23787375|NCT03827395|66600503|FG000|Overall Study|Became ineligible after enrollment|1|||
23347451|NCT03806231|65014384|FG001|Overall Study|Withdrawal by Subject|0|||
23347452|NCT02342548|65014389|FG000|Overall Study|Adverse Event|12|||
23347453|NCT02342548|65014390|FG001|Overall Study|Adverse Event|17|||
23347454|NCT02342548|65014391|FG002|Overall Study|Adverse Event|13|||
23347455|NCT02342548|65014389|FG000|Overall Study|Lost to Follow-up|0|||
23347456|NCT02342548|65014390|FG001|Overall Study|Lost to Follow-up|1|||
23347457|NCT02342548|65014391|FG002|Overall Study|Lost to Follow-up|0|||
23347458|NCT02342548|65014389|FG000|Overall Study|Study terminated by sponsor|20|||
23347459|NCT02342548|65014390|FG001|Overall Study|Study terminated by sponsor|39|||
23347460|NCT02342548|65014391|FG002|Overall Study|Study terminated by sponsor|25|||
23347461|NCT02342548|65014389|FG000|Overall Study|Protocol Violation|0|||
23347462|NCT02342548|65014390|FG001|Overall Study|Protocol Violation|1|||
23347463|NCT02342548|65014391|FG002|Overall Study|Protocol Violation|0|||
23347464|NCT02342548|65014389|FG000|Overall Study|Withdrawal by Subject|1|||
23347465|NCT02342548|65014390|FG001|Overall Study|Withdrawal by Subject|3|||
23347466|NCT02342548|65014391|FG002|Overall Study|Withdrawal by Subject|4|||
23347467|NCT02342548|65014389|FG000|Overall Study|Other|1|||
23347468|NCT02342548|65014390|FG001|Overall Study|Other|1|||
23347469|NCT02342548|65014391|FG002|Overall Study|Other|1|||
23347470|NCT01041976|65014392|FG000|Overall Study|Withdrawal by Subject|3|||
23347471|NCT01041976|65014393|FG001|Overall Study|Withdrawal by Subject|0|||
23347472|NCT01041976|65014392|FG000|Overall Study|Incarceration|2|||
23347473|NCT01041976|65014393|FG001|Overall Study|Incarceration|0|||
23347474|NCT01041976|65014392|FG000|Overall Study|Death|0|||
23347475|NCT01041976|65014393|FG001|Overall Study|Death|4|||
23347476|NCT00401544|65014395|FG000|Overall Study|Adverse Event|5|||
23347477|NCT00401544|65014396|FG001|Overall Study|Adverse Event|1|||
23347478|NCT00401544|65014397|FG002|Overall Study|Adverse Event|1|||
23347479|NCT00401544|65014398|FG003|Overall Study|Adverse Event|1|||
23347480|NCT00401544|65014395|FG000|Overall Study|Death|3|||
23347481|NCT00401544|65014396|FG001|Overall Study|Death|6|||
23347482|NCT00401544|65014397|FG002|Overall Study|Death|2|||
23347483|NCT00401544|65014398|FG003|Overall Study|Death|5|||
23347484|NCT00401544|65014395|FG000|Overall Study|Lost to Follow-up|2|||
23347485|NCT00401544|65014396|FG001|Overall Study|Lost to Follow-up|0|||
23347486|NCT00401544|65014397|FG002|Overall Study|Lost to Follow-up|1|||
23347487|NCT00401544|65014398|FG003|Overall Study|Lost to Follow-up|1|||
23347488|NCT00401544|65014395|FG000|Overall Study|Withdrawal by Subject|7|||
23347489|NCT00401544|65014396|FG001|Overall Study|Withdrawal by Subject|6|||
23347490|NCT00401544|65014397|FG002|Overall Study|Withdrawal by Subject|6|||
23347491|NCT00401544|65014398|FG003|Overall Study|Withdrawal by Subject|5|||
23347492|NCT00401544|65014395|FG000|Overall Study|Physician Decision|1|||
23347493|NCT00401544|65014396|FG001|Overall Study|Physician Decision|3|||
23347494|NCT00401544|65014397|FG002|Overall Study|Physician Decision|0|||
23347495|NCT00401544|65014398|FG003|Overall Study|Physician Decision|0|||
23347496|NCT00401544|65014395|FG000|Overall Study|Ineligibility determined|0|||
23347497|NCT00401544|65014396|FG001|Overall Study|Ineligibility determined|1|||
23347498|NCT00401544|65014397|FG002|Overall Study|Ineligibility determined|0|||
23347499|NCT00401544|65014398|FG003|Overall Study|Ineligibility determined|2|||
23347500|NCT00401544|65014395|FG000|Overall Study|Disease progression|0|||
23347501|NCT00401544|65014396|FG001|Overall Study|Disease progression|1|||
23347502|NCT00401544|65014397|FG002|Overall Study|Disease progression|0|||
23347503|NCT00401544|65014398|FG003|Overall Study|Disease progression|0|||
23347504|NCT00401544|65014395|FG000|Overall Study|Other|0|||
23347505|NCT00401544|65014396|FG001|Overall Study|Other|0|||
23347506|NCT00401544|65014397|FG002|Overall Study|Other|2|||
23347507|NCT00401544|65014398|FG003|Overall Study|Other|2|||
23347508|NCT01217385|65014399|FG000|Overall Study|Withdrawal by Subject|3|||
23347509|NCT01217385|65014399|FG000|Overall Study|DOSI not performed/not eval|12|||
23347510|NCT01217385|65014399|FG000|Overall Study|Central Path not Available|1|||
23347511|NCT01217385|65014399|FG000|Overall Study|Normal Breast TOI not available|10|||
23347512|NCT01384019|65014400|FG000|Overall Study|Withdrawal by Subject|3|||
23347513|NCT01384019|65014401|FG001|Overall Study|Withdrawal by Subject|0|||
23347514|NCT01384019|65014400|FG000|Overall Study|Death|1|||
23347515|NCT01384019|65014401|FG001|Overall Study|Death|0|||
23347516|NCT01384019|65014400|FG000|Overall Study|MRI refusal|6|||
23347517|NCT01384019|65014401|FG001|Overall Study|MRI refusal|6|||
23347518|NCT03956615|65014403|FG000|Overall Study|No multiple myeloma confirmed|2|||
23347519|NCT03956615|65014403|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
23347520|NCT03956615|65014403|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
23347521|NCT03956615|65014403|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
23347522|NCT01371877|65014406|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
23347523|NCT01371877|65014407|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
23347524|NCT00985959|65014414|FG000|Overall Study|Adverse Event|0|||
23347525|NCT00985959|65014415|FG001|Overall Study|Adverse Event|0|||
23347526|NCT00985959|65014416|FG002|Overall Study|Adverse Event|19|||
23347527|NCT00985959|65014414|FG000|Overall Study|Withdrawal by Subject|0|||
23347528|NCT00985959|65014415|FG001|Overall Study|Withdrawal by Subject|0|||
23347529|NCT00985959|65014416|FG002|Overall Study|Withdrawal by Subject|8|||
23347530|NCT00985959|65014414|FG000|Overall Study|Progressive disease|1|||
23347531|NCT00985959|65014415|FG001|Overall Study|Progressive disease|2|||
23347532|NCT00985959|65014416|FG002|Overall Study|Progressive disease|8|||
23347533|NCT00985959|65014414|FG000|Overall Study|Unrecovered toxicity|0|||
23347534|NCT00985959|65014415|FG001|Overall Study|Unrecovered toxicity|0|||
23347535|NCT00985959|65014416|FG002|Overall Study|Unrecovered toxicity|7|||
23347536|NCT00985959|65014414|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
23347537|NCT00985959|65014415|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
23347538|NCT00985959|65014416|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
23347539|NCT00985959|65014414|FG000|Overall Study|Complete response observed over 2 cycles|0|||
23347540|NCT00985959|65014415|FG001|Overall Study|Complete response observed over 2 cycles|1|||
23347541|NCT00985959|65014416|FG002|Overall Study|Complete response observed over 2 cycles|4|||
23347542|NCT00985959|65014414|FG000|Overall Study|Other|0|||
23347543|NCT00985959|65014415|FG001|Overall Study|Other|0|||
23347544|NCT00985959|65014416|FG002|Overall Study|Other|11|||
23347545|NCT00347919|65014419|FG000|Overall Study|Lost to Follow-up|11|||
23347546|NCT00347919|65014420|FG001|Overall Study|Lost to Follow-up|13|||
23347547|NCT00347919|65014421|FG002|Overall Study|Lost to Follow-up|0|||
23347548|NCT00347919|65014419|FG000|Overall Study|Withdrawal by Subject|6|||
23347549|NCT00347919|65014420|FG001|Overall Study|Withdrawal by Subject|8|||
23347550|NCT00347919|65014421|FG002|Overall Study|Withdrawal by Subject|0|||
23459245|NCT03173560|65423656|FG001|Overall Study|Withdrawal by Subject|5|||
23459246|NCT03173560|65423655|FG000|Overall Study|Other|0|||
23459247|NCT03173560|65423656|FG001|Overall Study|Other|1|||
23787376|NCT03827395|66600504|FG001|Overall Study|Became ineligible after enrollment|2|||
23787377|NCT00840658|66600505|FG000|Overall Study|Death|2|||
23787378|NCT00840658|66600506|FG001|Overall Study|Death|2|||
23787379|NCT00840658|66600507|FG002|Overall Study|Death|3|||
23787380|NCT00840658|66600508|FG003|Overall Study|Death|3|||
23787381|NCT00840658|66600505|FG000|Overall Study|Lost to Follow-up|3|||
23459248|NCT02991768|65423657|FG000|Overall Study|Physician Decision|4|||
23638635|NCT02672852|66060967|FG000|Part A2|Lost to Follow-up|0|||
23787382|NCT00840658|66600506|FG001|Overall Study|Lost to Follow-up|1|||
23787383|NCT00840658|66600507|FG002|Overall Study|Lost to Follow-up|2|||
23787384|NCT00840658|66600508|FG003|Overall Study|Lost to Follow-up|1|||
23787385|NCT02313558|66600509|FG000|Overall Study|Withdrawal by Subject|2|||
23787386|NCT02313558|66600510|FG001|Overall Study|Withdrawal by Subject|0|||
23787387|NCT02313558|66600509|FG000|Overall Study|Lost to Follow-up|4|||
23787388|NCT02313558|66600510|FG001|Overall Study|Lost to Follow-up|4|||
23787389|NCT03807440|66600511|FG000|Overall Study|No documentation of index date 2|320|||
23787390|NCT03807440|66600511|FG000|Overall Study|No informed consent for index date 2|117|||
23787391|NCT01169558|66600514|FG000|Overall Study|Disease progression|98|||
23787392|NCT01169558|66600514|FG000|Overall Study|Adverse Event|25|||
23787393|NCT01169558|66600514|FG000|Overall Study|Withdrawal of Consent|8|||
23787394|NCT01169558|66600514|FG000|Overall Study|Medical Decision|7|||
23787395|NCT01169558|66600514|FG000|Overall Study|Stable Disease|4|||
23787396|NCT01169558|66600514|FG000|Overall Study|Lost to Follow-up|4|||
23638636|NCT02672852|66060968|FG001|Part A2|Lost to Follow-up|0|||
23638637|NCT02672852|66060969|FG002|Part A2|Lost to Follow-up|2|||
23638638|NCT02672852|66060970|FG003|Part A2|Lost to Follow-up|0|||
23638639|NCT02672852|66060971|FG004|Part A2|Lost to Follow-up|0|||
23638640|NCT02672852|66060972|FG005|Part A2|Lost to Follow-up|0|||
23638641|NCT02672852|66060973|FG006|Part A2|Lost to Follow-up|0|||
23638642|NCT02672852|66060967|FG000|Part A2|Withdrawal by Subject|0|||
23638643|NCT02672852|66060968|FG001|Part A2|Withdrawal by Subject|0|||
23638644|NCT02672852|66060969|FG002|Part A2|Withdrawal by Subject|1|||
23638645|NCT02672852|66060970|FG003|Part A2|Withdrawal by Subject|0|||
23638646|NCT02672852|66060971|FG004|Part A2|Withdrawal by Subject|0|||
23638647|NCT02672852|66060972|FG005|Part A2|Withdrawal by Subject|0|||
23638648|NCT02672852|66060973|FG006|Part A2|Withdrawal by Subject|0|||
23638649|NCT02672852|66060967|FG000|Part A2|Other|0|||
23347551|NCT00347919|65014419|FG000|Overall Study|Physician Decision|1|||
23638650|NCT02672852|66060968|FG001|Part A2|Other|0|||
23347552|NCT00347919|65014420|FG001|Overall Study|Physician Decision|1|||
23347553|NCT00347919|65014421|FG002|Overall Study|Physician Decision|0|||
23459249|NCT02205736|65423660|FG000|Overall Study|Lost to Follow-up|106|||
23638651|NCT02672852|66060969|FG002|Part A2|Other|3|||
23638652|NCT02672852|66060970|FG003|Part A2|Other|0|||
23638653|NCT02672852|66060971|FG004|Part A2|Other|0|||
23638654|NCT02672852|66060972|FG005|Part A2|Other|0|||
23787397|NCT01169558|66600514|FG000|Overall Study|Need for Surgery|4|||
23787398|NCT01169558|66600514|FG000|Overall Study|Non-compliance|2|||
23787399|NCT01169558|66600514|FG000|Overall Study|Protocol Violation|2|||
23787400|NCT01169558|66600514|FG000|Overall Study|Partial response|2|||
23787401|NCT00274651|66600515|FG000|Overall Study|Adverse Event|6|||
23787402|NCT00274651|66600516|FG001|Overall Study|Adverse Event|3|||
23347554|NCT00347919|65014419|FG000|Overall Study|Sponsor terminated study|15|||
23347555|NCT00347919|65014420|FG001|Overall Study|Sponsor terminated study|10|||
23347556|NCT00347919|65014421|FG002|Overall Study|Sponsor terminated study|16|||
23347557|NCT00347919|65014419|FG000|Overall Study|Death|35|||
23638655|NCT02672852|66060973|FG006|Part A2|Other|0|||
23638656|NCT02672852|66060967|FG000|Part A2|Not entered in Part B|0|||
23638657|NCT02672852|66060968|FG001|Part A2|Not entered in Part B|0|||
23638658|NCT02672852|66060969|FG002|Part A2|Not entered in Part B|0|||
23459250|NCT03777982|65423661|FG000|Overall Study|Physician Decision|0|||
23459251|NCT03777982|65423662|FG001|Overall Study|Physician Decision|1|||
23459252|NCT01084655|65423664|FG000|Overall Study|Radiographic disease progression|3|||
23459253|NCT01084655|65423665|FG001|Overall Study|Radiographic disease progression|2|||
23459254|NCT01084655|65423666|FG002|Overall Study|Radiographic disease progression|8|||
23459255|NCT01084655|65423664|FG000|Overall Study|Withdrawal by Subject|1|||
23459256|NCT01084655|65423665|FG001|Overall Study|Withdrawal by Subject|0|||
23459257|NCT01084655|65423666|FG002|Overall Study|Withdrawal by Subject|4|||
23459258|NCT01084655|65423664|FG000|Overall Study|Adverse Event|2|||
23459259|NCT01084655|65423665|FG001|Overall Study|Adverse Event|1|||
23459260|NCT01084655|65423666|FG002|Overall Study|Adverse Event|2|||
23459261|NCT01084655|65423664|FG000|Overall Study|Other|0|||
23459262|NCT01084655|65423665|FG001|Overall Study|Other|3|||
23459263|NCT01084655|65423666|FG002|Overall Study|Other|2|||
23459264|NCT01084655|65423664|FG000|Overall Study|Symptomatic deterioration|0|||
23459265|NCT01084655|65423665|FG001|Overall Study|Symptomatic deterioration|0|||
23459266|NCT01084655|65423666|FG002|Overall Study|Symptomatic deterioration|2|||
23459267|NCT01084655|65423664|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
23459268|NCT01084655|65423665|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
23459269|NCT01084655|65423666|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
23638659|NCT02672852|66060970|FG003|Part A2|Not entered in Part B|4|||
23347558|NCT00347919|65014420|FG001|Overall Study|Death|42|||
23638660|NCT02672852|66060971|FG004|Part A2|Not entered in Part B|0|||
23638661|NCT02672852|66060972|FG005|Part A2|Not entered in Part B|0|||
23638662|NCT02672852|66060973|FG006|Part A2|Not entered in Part B|0|||
23638663|NCT02672852|66060967|FG000|Part B|Disease worsening|0|||
23638664|NCT02672852|66060968|FG001|Part B|Disease worsening|0|||
23638665|NCT02672852|66060969|FG002|Part B|Disease worsening|0|||
23638666|NCT02672852|66060970|FG003|Part B|Disease worsening|0|||
23347559|NCT00347919|65014421|FG002|Overall Study|Death|19|||
23347560|NCT00347919|65014419|FG000|Overall Study|Par. Started Other Treatment|1|||
23347561|NCT00347919|65014420|FG001|Overall Study|Par. Started Other Treatment|1|||
23347562|NCT00347919|65014421|FG002|Overall Study|Par. Started Other Treatment|1|||
23347563|NCT00347919|65014419|FG000|Overall Study|Missing|2|||
23638667|NCT02672852|66060971|FG004|Part B|Disease worsening|1|||
23787403|NCT00274651|66600515|FG000|Overall Study|Lack of Efficacy|13|||
23787404|NCT00274651|66600516|FG001|Overall Study|Lack of Efficacy|6|||
23787405|NCT00274651|66600515|FG000|Overall Study|Death|1|||
23638668|NCT02672852|66060972|FG005|Part B|Disease worsening|0|||
23638669|NCT02672852|66060973|FG006|Part B|Disease worsening|1|||
23787406|NCT00274651|66600516|FG001|Overall Study|Death|3|||
23787407|NCT00274651|66600515|FG000|Overall Study|Withdrawal by Subject|0|||
23787408|NCT00274651|66600516|FG001|Overall Study|Withdrawal by Subject|1|||
23787409|NCT00274651|66600515|FG000|Overall Study|Physician Decision|8|||
23787410|NCT00274651|66600516|FG001|Overall Study|Physician Decision|7|||
23787411|NCT03259165|66600517|FG000|Overall Study|COVID 19 pandemic|1|||
23787412|NCT03259165|66600518|FG001|Overall Study|COVID 19 pandemic|1|||
23787413|NCT05740098|66600519|FG000|Overall Study|Lost to Follow-up|26|||
23787414|NCT05740098|66600520|FG001|Overall Study|Lost to Follow-up|17|||
23347564|NCT00347919|65014420|FG001|Overall Study|Missing|1|||
23347565|NCT00347919|65014421|FG002|Overall Study|Missing|2|||
23347566|NCT02360475|65014422|FG000|Overall Study|Lost to Follow-up|4|||
23638670|NCT02672852|66060967|FG000|Part B|Worsening pre-existing condition|0|||
23638671|NCT02672852|66060968|FG001|Part B|Worsening pre-existing condition|0|||
23638672|NCT02672852|66060969|FG002|Part B|Worsening pre-existing condition|0|||
23787415|NCT05740098|66600521|FG002|Overall Study|Lost to Follow-up|21|||
23347567|NCT02360475|65014423|FG001|Overall Study|Lost to Follow-up|12|||
23787416|NCT05315713|66600522|FG000|Overall Study|Death|5|||
23787417|NCT05315713|66600522|FG000|Overall Study|Progressive disease|1|||
23787418|NCT05315713|66600522|FG000|Overall Study|Withdrawal by Subject|1|||
23347568|NCT02360475|65014424|FG002|Overall Study|Lost to Follow-up|6|||
23347569|NCT02360475|65014425|FG003|Overall Study|Lost to Follow-up|4|||
23347570|NCT02360475|65014422|FG000|Overall Study|Withdrawal by Subject|0|||
23347571|NCT02360475|65014423|FG001|Overall Study|Withdrawal by Subject|1|||
23347572|NCT02360475|65014424|FG002|Overall Study|Withdrawal by Subject|2|||
23347573|NCT02360475|65014425|FG003|Overall Study|Withdrawal by Subject|0|||
23347574|NCT02360475|65014422|FG000|Overall Study|Migrated/moved from study area|0|||
23347575|NCT02360475|65014423|FG001|Overall Study|Migrated/moved from study area|0|||
23459285|NCT04659044|65423689|FG000|Induction|Physician Decision|1|||
23459286|NCT04659044|65423689|FG000|Induction|Adverse Event|2|||
23459287|NCT02085460|65423690|FG000|Overall Study|Adverse Event|2|||
23459288|NCT02085460|65423691|FG001|Overall Study|Adverse Event|2|||
23459289|NCT02085460|65423692|FG002|Overall Study|Adverse Event|1|||
23459290|NCT02085460|65423690|FG000|Overall Study|Physician Decision|1|||
23347576|NCT02360475|65014424|FG002|Overall Study|Migrated/moved from study area|0|||
23347577|NCT02360475|65014425|FG003|Overall Study|Migrated/moved from study area|1|||
23347578|NCT02035748|65014426|FG000|Overall Study|Adverse Event|5|||
23347579|NCT02035748|65014426|FG000|Overall Study|Death|3|||
23347580|NCT02035748|65014426|FG000|Overall Study|Lost to Follow-up|2|||
23347581|NCT02035748|65014426|FG000|Overall Study|Physician Decision|3|||
23347582|NCT02035748|65014426|FG000|Overall Study|Withdrawal by Subject|6|||
23347583|NCT02035748|65014426|FG000|Overall Study|Progressive Disease|1|||
23347584|NCT02505334|65014427|FG000|Main Treatment Period|Adverse Event|3|||
23347585|NCT02505334|65014428|FG001|Main Treatment Period|Adverse Event|3|||
23347586|NCT02505334|65014427|FG000|Main Treatment Period|Lack of Efficacy|7|||
23347587|NCT02505334|65014428|FG001|Main Treatment Period|Lack of Efficacy|17|||
23347588|NCT02505334|65014427|FG000|Main Treatment Period|Protocol Violation|0|||
23347589|NCT02505334|65014428|FG001|Main Treatment Period|Protocol Violation|1|||
23347590|NCT02505334|65014427|FG000|Main Treatment Period|Withdrawal by Subject|1|||
23347591|NCT02505334|65014428|FG001|Main Treatment Period|Withdrawal by Subject|8|||
23347592|NCT02505334|65014427|FG000|Main Treatment Period|Unclassified|4|||
23347593|NCT02505334|65014428|FG001|Main Treatment Period|Unclassified|10|||
23347594|NCT02505334|65014427|FG000|Extension Treatment Period|Adverse Event|5|||
23347595|NCT02505334|65014428|FG001|Extension Treatment Period|Adverse Event|0|||
23347596|NCT02505334|65014427|FG000|Extension Treatment Period|Lack of Efficacy|4|||
23347597|NCT02505334|65014428|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23347598|NCT02505334|65014427|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
23347599|NCT02505334|65014428|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23347600|NCT02505334|65014427|FG000|Extension Treatment Period|Unclassified|3|||
23347601|NCT02505334|65014428|FG001|Extension Treatment Period|Unclassified|0|||
23347602|NCT00387010|65014429|FG000|Dose Titration Period|Adverse Event|12|||
23347603|NCT00387010|65014429|FG000|Dose Titration Period|Lack of Efficacy|5|||
23347604|NCT00387010|65014429|FG000|Dose Titration Period|Withdrawal by Subject|3|||
23347605|NCT00387010|65014429|FG000|Dose Titration Period|Protocol Violation|1|||
23347606|NCT00387010|65014429|FG000|Dose Titration Period|Lost to Follow-up|2|||
23347607|NCT00387010|65014429|FG000|Dose Titration Period|Noncompliance with study medication|8|||
23347608|NCT00387010|65014429|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
23347609|NCT00387010|65014429|FG000|Treatment Period|Adverse Event|4|||
23347610|NCT00387010|65014429|FG000|Treatment Period|Withdrawal by Subject|1|||
23347611|NCT00387010|65014429|FG000|Treatment Period|Noncompliance with study medication|2|||
23459291|NCT02085460|65423691|FG001|Overall Study|Physician Decision|1|||
23459292|NCT02085460|65423692|FG002|Overall Study|Physician Decision|2|||
23459293|NCT02085460|65423690|FG000|Overall Study|Withdrawal by Subject|11|||
23787419|NCT05315713|66600522|FG000|Overall Study|Study terminated by sponsor|1|||
23347612|NCT00387010|65014429|FG000|Treatment Period|Noncompliance with study procedures|3|||
23347613|NCT00387010|65014429|FG000|Treatment Period|Participant reported study drug stolen|1|||
23347614|NCT00367484|65014437|FG000|Overall Study|Adverse Event|7|||
23347615|NCT00367484|65014437|FG000|Overall Study|Withdrew informed consent|5|||
23347616|NCT00367484|65014437|FG000|Overall Study|Travel to USA|1|||
23347617|NCT00367484|65014437|FG000|Overall Study|Lost to Follow-up|1|||
23347618|NCT00367484|65014437|FG000|Overall Study|Protocol Violation|1|||
23347619|NCT00367484|65014437|FG000|Overall Study|The choice of the patient|1|||
23347620|NCT00367484|65014437|FG000|Overall Study|Lack of Efficacy|1|||
23347621|NCT00723190|65014438|FG000|Overall Study|Withdrawal by Subject|45|||
23347622|NCT00723190|65014438|FG000|Overall Study|Lost to Follow-up|37|||
23347623|NCT00723190|65014438|FG000|Overall Study|Adverse Event|18|||
23459294|NCT02085460|65423691|FG001|Overall Study|Withdrawal by Subject|5|||
23459295|NCT02085460|65423692|FG002|Overall Study|Withdrawal by Subject|7|||
23459296|NCT02946580|65423698|FG000|Overall Study|Withdrawal by Subject|1|||
23459297|NCT02946580|65423699|FG001|Overall Study|Withdrawal by Subject|2|||
23459298|NCT02946580|65423698|FG000|Overall Study|Adverse Event|0|||
23347624|NCT00723190|65014438|FG000|Overall Study|Lack of Efficacy|16|||
23347625|NCT00723190|65014438|FG000|Overall Study|Protocol Violation|15|||
23347626|NCT00723190|65014438|FG000|Overall Study|Other-Premature Discontinuation|9|||
23347627|NCT00723190|65014438|FG000|Overall Study|Other-Not included in safety population|2|||
23347628|NCT02908074|65014439|FG000|Overall Study|sponsor/ICON decision|0|||
23347629|NCT02908074|65014440|FG001|Overall Study|sponsor/ICON decision|0|||
23347630|NCT02908074|65014441|FG002|Overall Study|sponsor/ICON decision|1|||
23347631|NCT02908074|65014442|FG003|Overall Study|sponsor/ICON decision|0|||
23347632|NCT02908074|65014443|FG004|Overall Study|sponsor/ICON decision|0|||
23347633|NCT02908074|65014444|FG005|Overall Study|sponsor/ICON decision|0|||
23347634|NCT02908074|65014439|FG000|Overall Study|Protocol Violation|0|||
23347635|NCT02908074|65014440|FG001|Overall Study|Protocol Violation|1|||
23347636|NCT02908074|65014441|FG002|Overall Study|Protocol Violation|0|||
23347637|NCT02908074|65014442|FG003|Overall Study|Protocol Violation|0|||
23347638|NCT02908074|65014443|FG004|Overall Study|Protocol Violation|0|||
23347639|NCT02908074|65014444|FG005|Overall Study|Protocol Violation|0|||
23347640|NCT02908074|65014439|FG000|Overall Study|Adverse Event|5|||
23347641|NCT02908074|65014440|FG001|Overall Study|Adverse Event|2|||
23347642|NCT02908074|65014441|FG002|Overall Study|Adverse Event|0|||
23347643|NCT02908074|65014442|FG003|Overall Study|Adverse Event|0|||
23347644|NCT02908074|65014443|FG004|Overall Study|Adverse Event|1|||
23347645|NCT02908074|65014444|FG005|Overall Study|Adverse Event|0|||
23347646|NCT02908074|65014439|FG000|Overall Study|AESI|1|||
23347647|NCT02908074|65014440|FG001|Overall Study|AESI|0|||
23347648|NCT02908074|65014441|FG002|Overall Study|AESI|1|||
23347649|NCT02908074|65014442|FG003|Overall Study|AESI|0|||
23347650|NCT02908074|65014443|FG004|Overall Study|AESI|1|||
23347651|NCT02908074|65014444|FG005|Overall Study|AESI|0|||
23347652|NCT02908074|65014439|FG000|Overall Study|Discontinuation criteria per protocol|0|||
23347653|NCT02908074|65014440|FG001|Overall Study|Discontinuation criteria per protocol|0|||
23347654|NCT02908074|65014441|FG002|Overall Study|Discontinuation criteria per protocol|1|||
23347655|NCT02908074|65014442|FG003|Overall Study|Discontinuation criteria per protocol|0|||
23347656|NCT02908074|65014443|FG004|Overall Study|Discontinuation criteria per protocol|0|||
23347657|NCT02908074|65014444|FG005|Overall Study|Discontinuation criteria per protocol|1|||
23347658|NCT02908074|65014439|FG000|Overall Study|Withdrawal by Subject|3|||
23347659|NCT02908074|65014440|FG001|Overall Study|Withdrawal by Subject|2|||
23347660|NCT02908074|65014441|FG002|Overall Study|Withdrawal by Subject|2|||
23347661|NCT02908074|65014442|FG003|Overall Study|Withdrawal by Subject|2|||
23347662|NCT02908074|65014443|FG004|Overall Study|Withdrawal by Subject|2|||
23347663|NCT02908074|65014444|FG005|Overall Study|Withdrawal by Subject|2|||
23347664|NCT02908074|65014439|FG000|Overall Study|Lost to Follow-up|0|||
23347665|NCT02908074|65014440|FG001|Overall Study|Lost to Follow-up|1|||
23347666|NCT02908074|65014441|FG002|Overall Study|Lost to Follow-up|1|||
23347667|NCT02908074|65014442|FG003|Overall Study|Lost to Follow-up|1|||
23347668|NCT02908074|65014443|FG004|Overall Study|Lost to Follow-up|0|||
23347669|NCT02908074|65014444|FG005|Overall Study|Lost to Follow-up|1|||
23459299|NCT02946580|65423699|FG001|Overall Study|Adverse Event|2|||
23459300|NCT02946580|65423698|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
23459301|NCT02946580|65423699|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
23459302|NCT05232682|65423702|FG000|Overall Study|Lost to Follow-up|2|||
23459303|NCT02855125|65425154|FG000|Overall Study|Withdrawal by Subject|2|||
23459304|NCT02855125|65425155|FG001|Overall Study|Withdrawal by Subject|2|||
23459305|NCT02855125|65425154|FG000|Overall Study|Clinical Disease Progression|5|||
23459306|NCT02855125|65425155|FG001|Overall Study|Clinical Disease Progression|4|||
23459307|NCT02855125|65425154|FG000|Overall Study|Radiologic Disease Progression|36|||
23459308|NCT02855125|65425155|FG001|Overall Study|Radiologic Disease Progression|39|||
23638673|NCT02672852|66060970|FG003|Part B|Worsening pre-existing condition|0|||
23638674|NCT02672852|66060971|FG004|Part B|Worsening pre-existing condition|0|||
23638675|NCT02672852|66060972|FG005|Part B|Worsening pre-existing condition|1|||
23638676|NCT02672852|66060973|FG006|Part B|Worsening pre-existing condition|0|||
23347674|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
23347675|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
23347676|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
23347677|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
23347678|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Death|1|||
23347679|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Death|1|||
23347680|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
23347681|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
23347682|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
23347683|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
23347684|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
23347685|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
23347686|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
23459309|NCT02855125|65425154|FG000|Overall Study|Adverse Event|11|||
23638677|NCT02672852|66060967|FG000|Part B|Other adverse event|0|||
23459310|NCT02855125|65425155|FG001|Overall Study|Adverse Event|7|||
23459311|NCT02855125|65425154|FG000|Overall Study|Physician Decision|1|||
23459312|NCT02855125|65425155|FG001|Overall Study|Physician Decision|0|||
23459313|NCT02855125|65425154|FG000|Overall Study|On Treatment|9|||
23459314|NCT02855125|65425155|FG001|Overall Study|On Treatment|11|||
23459315|NCT02855125|65425154|FG000|Overall Study|Randomized but not treated|0|||
23459316|NCT02855125|65425155|FG001|Overall Study|Randomized but not treated|1|||
23459317|NCT03173248|65425156|FG000|Overall Study|Death|28|||
23459318|NCT03173248|65425157|FG001|Overall Study|Death|46|||
23459319|NCT03173248|65425156|FG000|Overall Study|Lost to Follow-up|0|||
23459320|NCT03173248|65425157|FG001|Overall Study|Lost to Follow-up|1|||
23459321|NCT03173248|65425156|FG000|Overall Study|Withdrawal by Subject|6|||
23459322|NCT03173248|65425157|FG001|Overall Study|Withdrawal by Subject|4|||
23459323|NCT03173248|65425156|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
23459324|NCT03173248|65425157|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
23459325|NCT02796170|65425160|FG000|Overall Study|Lost to Follow-up|3|||
23459326|NCT02796170|65425161|FG001|Overall Study|Lost to Follow-up|0|||
23459327|NCT05567783|65425171|FG000|Overall Study|Death|2|||
23459328|NCT05567783|65425172|FG001|Overall Study|Death|3|||
23459329|NCT05567783|65425173|FG002|Overall Study|Death|0|||
23459330|NCT05567783|65425171|FG000|Overall Study|Lost to Follow-up|25|||
23459331|NCT05567783|65425172|FG001|Overall Study|Lost to Follow-up|19|||
23459332|NCT05567783|65425173|FG002|Overall Study|Lost to Follow-up|17|||
23459333|NCT05567783|65425171|FG000|Overall Study|Physician Decision|10|||
23459334|NCT05567783|65425172|FG001|Overall Study|Physician Decision|7|||
23459335|NCT05567783|65425173|FG002|Overall Study|Physician Decision|9|||
23459336|NCT05567783|65425171|FG000|Overall Study|Study Terminated by Sponsor|924|||
23459337|NCT05567783|65425172|FG001|Overall Study|Study Terminated by Sponsor|937|||
23459338|NCT05567783|65425173|FG002|Overall Study|Study Terminated by Sponsor|941|||
23459339|NCT05567783|65425171|FG000|Overall Study|Withdrawal by Subject|23|||
23459340|NCT05567783|65425172|FG001|Overall Study|Withdrawal by Subject|27|||
23459341|NCT05567783|65425173|FG002|Overall Study|Withdrawal by Subject|24|||
23459342|NCT05567783|65425171|FG000|Overall Study|Incarcerated|1|||
23459343|NCT05567783|65425172|FG001|Overall Study|Incarcerated|0|||
23459344|NCT05567783|65425173|FG002|Overall Study|Incarcerated|0|||
23459345|NCT05567783|65425171|FG000|Overall Study|Participant randomized in error|4|||
23459346|NCT05567783|65425172|FG001|Overall Study|Participant randomized in error|2|||
23459347|NCT05567783|65425173|FG002|Overall Study|Participant randomized in error|2|||
23459348|NCT03425643|65425182|FG000|Overall Study|Withdrawal by Subject|10|||
23459349|NCT03425643|65425183|FG001|Overall Study|Withdrawal by Subject|12|||
23459350|NCT03425643|65425182|FG000|Overall Study|Lost to Follow-up|2|||
23459351|NCT03425643|65425183|FG001|Overall Study|Lost to Follow-up|0|||
23459352|NCT03425643|65425182|FG000|Overall Study|Death|109|||
23459353|NCT03425643|65425183|FG001|Overall Study|Death|141|||
23459354|NCT03425643|65425182|FG000|Overall Study|Ongoing in study|276|||
23459355|NCT03425643|65425183|FG001|Overall Study|Ongoing in study|247|||
23459356|NCT03067077|65425184|FG000|Overall Study|Did not receive surgery|4|||
23459357|NCT03067077|65425185|FG001|Overall Study|Did not receive surgery|5|||
23459358|NCT03067077|65425184|FG000|Overall Study|Lost to Follow-up|3|||
23459359|NCT03067077|65425185|FG001|Overall Study|Lost to Follow-up|2|||
23459360|NCT00762164|65425186|FG000|Overall Study|Lost to Follow-up|1|||
23459361|NCT00762164|65425187|FG001|Overall Study|Lost to Follow-up|1|||
23459362|NCT00762164|65425186|FG000|Overall Study|Discontinued medication|2|||
23459363|NCT00762164|65425187|FG001|Overall Study|Discontinued medication|0|||
23459364|NCT00762164|65425186|FG000|Overall Study|Withdrawal by Subject|0|||
23459365|NCT00762164|65425187|FG001|Overall Study|Withdrawal by Subject|1|||
23459366|NCT01724346|65425190|FG000|Overall Study|Death|42|||
23459367|NCT01724346|65425191|FG001|Overall Study|Death|42|||
23459368|NCT01724346|65425190|FG000|Overall Study|Lost to Follow-up|5|||
23459369|NCT01724346|65425191|FG001|Overall Study|Lost to Follow-up|1|||
23459370|NCT01724346|65425190|FG000|Overall Study|Withdrawal by Subject|27|||
23459371|NCT01724346|65425191|FG001|Overall Study|Withdrawal by Subject|19|||
23459372|NCT01724346|65425190|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
23459373|NCT01724346|65425191|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
23459374|NCT04929249|65425192|FG000|Overall Study|Adverse Event|2|||
23459375|NCT04929249|65425193|FG001|Overall Study|Adverse Event|1|||
23459376|NCT04929249|65425192|FG000|Overall Study|Death|2|||
23459377|NCT04929249|65425193|FG001|Overall Study|Death|1|||
23459378|NCT04929249|65425192|FG000|Overall Study|Lost to Follow-up|3|||
23459379|NCT04929249|65425193|FG001|Overall Study|Lost to Follow-up|11|||
23459380|NCT04929249|65425192|FG000|Overall Study|Technical problems|0|||
23459381|NCT04929249|65425193|FG001|Overall Study|Technical problems|1|||
23459382|NCT04929249|65425192|FG000|Overall Study|Subject decision|6|||
23459383|NCT04929249|65425193|FG001|Overall Study|Subject decision|8|||
23459384|NCT04929249|65425192|FG000|Overall Study|Withdrew consent|0|||
23459385|NCT04929249|65425193|FG001|Overall Study|Withdrew consent|8|||
23459386|NCT01033019|65425196|FG000|Overall Study|Withdrawal by Subject|1|||
23459387|NCT01033019|65425197|FG001|Overall Study|Withdrawal by Subject|0|||
23459388|NCT01967238|65425199|FG000|Overall Study|Adverse Event|1|||
23459389|NCT01967238|65425200|FG001|Overall Study|Adverse Event|1|||
23459390|NCT01967238|65425201|FG002|Overall Study|Adverse Event|0|||
23459391|NCT01967238|65425199|FG000|Overall Study|Lost to Follow-up|1|||
23459392|NCT01967238|65425200|FG001|Overall Study|Lost to Follow-up|0|||
23459393|NCT01967238|65425201|FG002|Overall Study|Lost to Follow-up|1|||
23459394|NCT01967238|65425199|FG000|Overall Study|Withdrawal by Subject|0|||
23459395|NCT01967238|65425200|FG001|Overall Study|Withdrawal by Subject|0|||
23459396|NCT01967238|65425201|FG002|Overall Study|Withdrawal by Subject|1|||
23459397|NCT04025710|65425202|FG000|Overall Study|Death|3|||
23459398|NCT04025710|65425202|FG000|Overall Study|Lost to Follow-up|5|||
23459399|NCT04025710|65425202|FG000|Overall Study|Withdrawal by Subject|1|||
23459400|NCT04025710|65425202|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
23459401|NCT04025710|65425202|FG000|Overall Study|Drop-out according to protocol|34|||
23459402|NCT01285557|65425223|FG000|Overall Study|Death|173|||
23459403|NCT01285557|65425224|FG001|Overall Study|Death|90|||
23459404|NCT01285557|65425223|FG000|Overall Study|Lost to Follow-up|6|||
23459405|NCT01285557|65425224|FG001|Overall Study|Lost to Follow-up|2|||
23459406|NCT01285557|65425223|FG000|Overall Study|Withdrew Consent|6|||
23459407|NCT01285557|65425224|FG001|Overall Study|Withdrew Consent|1|||
23459408|NCT01285557|65425223|FG000|Overall Study|Sponsor Study Termination|23|||
23459409|NCT01285557|65425224|FG001|Overall Study|Sponsor Study Termination|13|||
23459410|NCT01285557|65425223|FG000|Overall Study|Randomized but not treated|1|||
23459411|NCT01285557|65425224|FG001|Overall Study|Randomized but not treated|1|||
23459412|NCT01285557|65425223|FG000|Overall Study|Study follow-up ongoing|28|||
23459413|NCT01285557|65425224|FG001|Overall Study|Study follow-up ongoing|14|||
23459414|NCT01285557|65425223|FG000|Overall Study|Sponsor Decision|2|||
23459415|NCT01285557|65425224|FG001|Overall Study|Sponsor Decision|1|||
23459416|NCT02388269|65425225|FG000|Overall Study|Adverse Event|2|||
23459417|NCT02388269|65425226|FG001|Overall Study|Adverse Event|0|||
23459418|NCT02388269|65425227|FG002|Overall Study|Adverse Event|0|||
23459419|NCT02388269|65425225|FG000|Overall Study|Withdrawal by Subject|1|||
23459420|NCT02388269|65425226|FG001|Overall Study|Withdrawal by Subject|2|||
23459421|NCT02388269|65425227|FG002|Overall Study|Withdrawal by Subject|0|||
23459422|NCT02388269|65425225|FG000|Overall Study|less than 50% stimulations|1|||
23459423|NCT02388269|65425226|FG001|Overall Study|less than 50% stimulations|0|||
23459424|NCT02388269|65425227|FG002|Overall Study|less than 50% stimulations|0|||
23787420|NCT01410227|66600523|FG000|Overall Study|Adverse Event|1|||
23787421|NCT01410227|66600524|FG001|Overall Study|Adverse Event|0|||
23787422|NCT01410227|66600525|FG002|Overall Study|Adverse Event|0|||
23787423|NCT01410227|66600526|FG003|Overall Study|Adverse Event|0|||
23787424|NCT01410227|66600523|FG000|Overall Study|Withdrawal by Subject|3|||
23787425|NCT01410227|66600524|FG001|Overall Study|Withdrawal by Subject|0|||
23787426|NCT01410227|66600525|FG002|Overall Study|Withdrawal by Subject|1|||
23787427|NCT01410227|66600526|FG003|Overall Study|Withdrawal by Subject|0|||
23787428|NCT01410227|66600523|FG000|Overall Study|Pregnancy|0|||
23787429|NCT01410227|66600524|FG001|Overall Study|Pregnancy|0|||
23787430|NCT01410227|66600525|FG002|Overall Study|Pregnancy|0|||
23787431|NCT01410227|66600526|FG003|Overall Study|Pregnancy|1|||
23787432|NCT01410227|66600523|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
23787433|NCT01410227|66600524|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
23787434|NCT01410227|66600525|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
23787435|NCT01410227|66600526|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
23787436|NCT00177164|66600527|FG000|Overall Study|Protocol Violation|0|||
23787437|NCT00177164|66600528|FG001|Overall Study|Protocol Violation|7|||
23787438|NCT00177164|66600527|FG000|Overall Study|Lost to Follow-up|4|||
23787439|NCT00177164|66600528|FG001|Overall Study|Lost to Follow-up|5|||
23787440|NCT00177164|66600527|FG000|Overall Study|increase in alcohol and drug use|1|||
23787441|NCT00177164|66600528|FG001|Overall Study|increase in alcohol and drug use|2|||
23787442|NCT00177164|66600527|FG000|Overall Study|Adverse Event|1|||
23787443|NCT00177164|66600528|FG001|Overall Study|Adverse Event|0|||
23787444|NCT00177164|66600527|FG000|Overall Study|discharge from hospital|1|||
23787445|NCT00177164|66600528|FG001|Overall Study|discharge from hospital|0|||
23787446|NCT00177164|66600527|FG000|Overall Study|Lack of Efficacy|2|||
23787447|NCT00177164|66600528|FG001|Overall Study|Lack of Efficacy|1|||
23787448|NCT00177164|66600527|FG000|Overall Study|Pregnancy|0|||
23459425|NCT02388269|65425225|FG000|Overall Study|no diary data|3|||
23459426|NCT02388269|65425226|FG001|Overall Study|no diary data|0|||
23459427|NCT02388269|65425227|FG002|Overall Study|no diary data|0|||
23459428|NCT02388269|65425225|FG000|Overall Study|Protocol Violation|2|||
23459429|NCT02388269|65425226|FG001|Overall Study|Protocol Violation|0|||
23787449|NCT00177164|66600528|FG001|Overall Study|Pregnancy|1|||
23787450|NCT01117623|66600531|FG000|Overall Study|Adverse Event|0|||
23787451|NCT01117623|66600532|FG001|Overall Study|Adverse Event|2|||
23787452|NCT01117623|66600533|FG002|Overall Study|Adverse Event|4|||
23787453|NCT01117623|66600534|FG003|Overall Study|Adverse Event|0|||
23459430|NCT02388269|65425227|FG002|Overall Study|Protocol Violation|0|||
23459431|NCT02388269|65425225|FG000|Overall Study|Screen Failure|0|||
23459432|NCT02388269|65425226|FG001|Overall Study|Screen Failure|0|||
23459433|NCT02388269|65425227|FG002|Overall Study|Screen Failure|10|||
23459434|NCT02992288|65425228|FG000|Overall Study|Adverse Event|8|||
23459435|NCT02992288|65425229|FG001|Overall Study|Adverse Event|2|||
23459436|NCT02992288|65425230|FG002|Overall Study|Adverse Event|2|||
23459437|NCT02992288|65425231|FG003|Overall Study|Adverse Event|2|||
23459438|NCT02992288|65425232|FG004|Overall Study|Adverse Event|2|||
23459439|NCT02992288|65425233|FG005|Overall Study|Adverse Event|7|||
23459440|NCT02992288|65425228|FG000|Overall Study|Non-compliance with study drug|0|||
23459441|NCT02992288|65425229|FG001|Overall Study|Non-compliance with study drug|1|||
23459442|NCT02992288|65425230|FG002|Overall Study|Non-compliance with study drug|1|||
23459443|NCT02992288|65425231|FG003|Overall Study|Non-compliance with study drug|0|||
23459444|NCT02992288|65425232|FG004|Overall Study|Non-compliance with study drug|1|||
23459445|NCT02992288|65425233|FG005|Overall Study|Non-compliance with study drug|0|||
23459446|NCT02992288|65425228|FG000|Overall Study|Physician Decision|3|||
23459447|NCT02992288|65425229|FG001|Overall Study|Physician Decision|0|||
23459448|NCT02992288|65425230|FG002|Overall Study|Physician Decision|1|||
23459449|NCT02992288|65425231|FG003|Overall Study|Physician Decision|0|||
23459450|NCT02992288|65425232|FG004|Overall Study|Physician Decision|0|||
23459451|NCT02992288|65425233|FG005|Overall Study|Physician Decision|1|||
23459452|NCT02992288|65425228|FG000|Overall Study|Death|2|||
23459453|NCT02992288|65425229|FG001|Overall Study|Death|0|||
23459454|NCT02992288|65425230|FG002|Overall Study|Death|2|||
23459455|NCT02992288|65425231|FG003|Overall Study|Death|1|||
23459456|NCT02992288|65425232|FG004|Overall Study|Death|2|||
23459457|NCT02992288|65425233|FG005|Overall Study|Death|0|||
23459458|NCT02992288|65425228|FG000|Overall Study|Lost to Follow-up|0|||
23459459|NCT02992288|65425229|FG001|Overall Study|Lost to Follow-up|0|||
23459460|NCT02992288|65425230|FG002|Overall Study|Lost to Follow-up|0|||
23459461|NCT02992288|65425231|FG003|Overall Study|Lost to Follow-up|1|||
23459462|NCT02992288|65425232|FG004|Overall Study|Lost to Follow-up|0|||
23459463|NCT02992288|65425233|FG005|Overall Study|Lost to Follow-up|0|||
23459464|NCT02992288|65425228|FG000|Overall Study|Protocol Violation|0|||
23459465|NCT02992288|65425229|FG001|Overall Study|Protocol Violation|0|||
23459466|NCT02992288|65425230|FG002|Overall Study|Protocol Violation|0|||
23638678|NCT02672852|66060968|FG001|Part B|Other adverse event|0|||
23787454|NCT01117623|66600535|FG004|Overall Study|Adverse Event|2|||
23459467|NCT02992288|65425231|FG003|Overall Study|Protocol Violation|0|||
23459468|NCT02992288|65425232|FG004|Overall Study|Protocol Violation|0|||
23459469|NCT02992288|65425233|FG005|Overall Study|Protocol Violation|1|||
23459470|NCT02992288|65425228|FG000|Overall Study|Withdrawal by Subject|4|||
23459471|NCT02992288|65425229|FG001|Overall Study|Withdrawal by Subject|2|||
23459472|NCT02992288|65425230|FG002|Overall Study|Withdrawal by Subject|1|||
23459473|NCT02992288|65425231|FG003|Overall Study|Withdrawal by Subject|5|||
23459474|NCT02992288|65425232|FG004|Overall Study|Withdrawal by Subject|3|||
23459475|NCT02992288|65425233|FG005|Overall Study|Withdrawal by Subject|4|||
23459476|NCT00371150|65425234|FG000|Overall Study|Lost to Follow-up|3|||
23459477|NCT00371150|65425235|FG001|Overall Study|Lost to Follow-up|2|||
23459478|NCT03435211|65425236|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
23459479|NCT05417438|65425239|FG000|Overall Study|Withdrawal by Subject|3|||
23459480|NCT04323124|65425247|FG000|Overall Study|Adverse Event|0|||
23459481|NCT04323124|65425248|FG001|Overall Study|Adverse Event|0|||
23459482|NCT04323124|65425249|FG002|Overall Study|Adverse Event|0|||
23459483|NCT04323124|65425250|FG003|Overall Study|Adverse Event|0|||
23459484|NCT04323124|65425251|FG004|Overall Study|Adverse Event|0|||
23459485|NCT04323124|65425252|FG005|Overall Study|Adverse Event|1|||
23459486|NCT04323124|65425253|FG006|Overall Study|Adverse Event|0|||
23459487|NCT04323124|65425254|FG007|Overall Study|Adverse Event|1|||
23459488|NCT04323124|65425255|FG008|Overall Study|Adverse Event|1|||
23459489|NCT04323124|65425256|FG009|Overall Study|Adverse Event|0|||
23459490|NCT04323124|65425257|FG010|Overall Study|Adverse Event|0|||
23459491|NCT04323124|65425258|FG011|Overall Study|Adverse Event|0|||
23787455|NCT01117623|66600536|FG005|Overall Study|Adverse Event|0|||
23787456|NCT01117623|66600537|FG006|Overall Study|Adverse Event|0|||
23459492|NCT04323124|65425259|FG012|Overall Study|Adverse Event|0|||
23459493|NCT04323124|65425260|FG013|Overall Study|Adverse Event|0|||
23459494|NCT04323124|65425261|FG014|Overall Study|Adverse Event|0|||
23459495|NCT04323124|65425247|FG000|Overall Study|Other|0|||
23459496|NCT04323124|65425248|FG001|Overall Study|Other|0|||
23459497|NCT04323124|65425249|FG002|Overall Study|Other|0|||
23787457|NCT01117623|66600538|FG007|Overall Study|Adverse Event|2|||
23459498|NCT04323124|65425250|FG003|Overall Study|Other|0|||
23459499|NCT04323124|65425251|FG004|Overall Study|Other|1|||
23459500|NCT04323124|65425252|FG005|Overall Study|Other|0|||
23459501|NCT04323124|65425253|FG006|Overall Study|Other|0|||
23459502|NCT04323124|65425254|FG007|Overall Study|Other|0|||
23459503|NCT04323124|65425255|FG008|Overall Study|Other|1|||
23459504|NCT04323124|65425256|FG009|Overall Study|Other|0|||
23459505|NCT04323124|65425257|FG010|Overall Study|Other|0|||
23459506|NCT04323124|65425258|FG011|Overall Study|Other|0|||
23459507|NCT04323124|65425259|FG012|Overall Study|Other|0|||
23459508|NCT04323124|65425260|FG013|Overall Study|Other|0|||
23787458|NCT01117623|66600531|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
23787459|NCT01117623|66600532|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
23787460|NCT01117623|66600533|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
23787461|NCT01117623|66600534|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
23347687|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
23347688|NCT00033657|65014449|FG000|Surgical Resection|not complete resection|0|||
23347689|NCT00033657|65014450|FG001|Surgical Resection|not complete resection|3|||
23347690|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
23347691|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
23347692|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
23347693|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
23787462|NCT01117623|66600535|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
23787463|NCT01117623|66600536|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
23787464|NCT01117623|66600537|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
23787465|NCT01117623|66600538|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
23787466|NCT01117623|66600531|FG000|Overall Study|Withdrawal by Subject|0|||
23347694|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Death|2|||
23347695|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Death|1|||
23347696|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
23347697|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
23347698|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
23347699|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
23347700|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Other|0|||
23347701|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Other|2|||
23347702|NCT03325894|65014451|FG000|Overall Study|Adverse Event|2|||
23347703|NCT03325894|65014452|FG001|Overall Study|Adverse Event|3|||
23347704|NCT03325894|65014451|FG000|Overall Study|Protocol Violation|1|||
23459509|NCT04323124|65425261|FG014|Overall Study|Other|0|||
23459510|NCT04323124|65425247|FG000|Overall Study|Coming from a red zone (COVID)|0|||
23459511|NCT04323124|65425248|FG001|Overall Study|Coming from a red zone (COVID)|0|||
23459512|NCT04323124|65425249|FG002|Overall Study|Coming from a red zone (COVID)|0|||
23787467|NCT01117623|66600532|FG001|Overall Study|Withdrawal by Subject|0|||
23787468|NCT01117623|66600533|FG002|Overall Study|Withdrawal by Subject|2|||
23459513|NCT04323124|65425250|FG003|Overall Study|Coming from a red zone (COVID)|0|||
23459514|NCT04323124|65425251|FG004|Overall Study|Coming from a red zone (COVID)|1|||
23459515|NCT04323124|65425252|FG005|Overall Study|Coming from a red zone (COVID)|1|||
23459516|NCT04323124|65425253|FG006|Overall Study|Coming from a red zone (COVID)|0|||
23584060|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Non-compliance|4|||
23584061|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Non-compliance|0|||
23584062|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Non-compliance|0|||
23584063|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Non-compliance|0|||
23584064|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Pain|4|||
23584065|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Pain|0|||
23584066|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Pain|0|||
23584067|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Pain|0|||
23584068|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
23584069|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
23584070|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
23584071|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
23584072|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Hospice care|1|||
23584073|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Hospice care|0|||
23584074|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Hospice care|0|||
23584075|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Hospice care|0|||
23584076|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Physician Decision|1|||
23584077|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Physician Decision|0|||
23584078|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Physician Decision|0|||
23584079|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Physician Decision|0|||
23584080|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
23584081|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584082|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584083|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584084|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
23584085|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
23584086|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
23787469|NCT01117623|66600534|FG003|Overall Study|Withdrawal by Subject|0|||
23347705|NCT03325894|65014452|FG001|Overall Study|Protocol Violation|2|||
23347706|NCT03325894|65014451|FG000|Overall Study|Withdrawal by Subject|10|||
23347707|NCT03325894|65014452|FG001|Overall Study|Withdrawal by Subject|6|||
23347708|NCT03325894|65014451|FG000|Overall Study|Lost to Follow-up|4|||
23584087|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
23584088|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
23584089|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
23347709|NCT03325894|65014452|FG001|Overall Study|Lost to Follow-up|9|||
23347710|NCT03325894|65014451|FG000|Overall Study|Lack of Efficacy|8|||
23347711|NCT03325894|65014452|FG001|Overall Study|Lack of Efficacy|14|||
23347712|NCT03325894|65014451|FG000|Overall Study|Study Terminated by Sponsor|38|||
23347713|NCT03325894|65014452|FG001|Overall Study|Study Terminated by Sponsor|43|||
23347714|NCT03325894|65014451|FG000|Overall Study|Other (Not received Treatment)|1|||
23347715|NCT03325894|65014452|FG001|Overall Study|Other (Not received Treatment)|0|||
23347716|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
23584090|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
23584091|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
23638679|NCT02672852|66060969|FG002|Part B|Other adverse event|0|||
23638680|NCT02672852|66060970|FG003|Part B|Other adverse event|0|||
23638681|NCT02672852|66060971|FG004|Part B|Other adverse event|3|||
23638682|NCT02672852|66060972|FG005|Part B|Other adverse event|5|||
23584092|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Death|0|||
23584093|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Death|8|||
23584094|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Death|2|||
23584095|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Death|13|||
23584096|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
23584097|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
23584098|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
23584099|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
23584100|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
23584101|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
23787470|NCT01117623|66600535|FG004|Overall Study|Withdrawal by Subject|0|||
23584102|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
23584103|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
23584104|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
23584105|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
23638683|NCT02672852|66060973|FG006|Part B|Other adverse event|1|||
23638684|NCT02672852|66060967|FG000|Part B|Lost to Follow-up|0|||
23638685|NCT02672852|66060968|FG001|Part B|Lost to Follow-up|0|||
23638686|NCT02672852|66060969|FG002|Part B|Lost to Follow-up|0|||
23638687|NCT02672852|66060970|FG003|Part B|Lost to Follow-up|0|||
23638688|NCT02672852|66060971|FG004|Part B|Lost to Follow-up|3|||
23638689|NCT02672852|66060972|FG005|Part B|Lost to Follow-up|4|||
23638690|NCT02672852|66060973|FG006|Part B|Lost to Follow-up|1|||
23638691|NCT02672852|66060967|FG000|Part B|Withdrawal by Subject|0|||
23638692|NCT02672852|66060968|FG001|Part B|Withdrawal by Subject|0|||
23638693|NCT02672852|66060969|FG002|Part B|Withdrawal by Subject|0|||
23638694|NCT02672852|66060970|FG003|Part B|Withdrawal by Subject|0|||
23638695|NCT02672852|66060971|FG004|Part B|Withdrawal by Subject|5|||
23638696|NCT02672852|66060972|FG005|Part B|Withdrawal by Subject|0|||
23638697|NCT02672852|66060973|FG006|Part B|Withdrawal by Subject|7|||
23787471|NCT01117623|66600536|FG005|Overall Study|Withdrawal by Subject|1|||
23787472|NCT01117623|66600537|FG006|Overall Study|Withdrawal by Subject|1|||
23787473|NCT01117623|66600538|FG007|Overall Study|Withdrawal by Subject|1|||
23787474|NCT01117623|66600531|FG000|Overall Study|Non-compliance with study medication|0|||
23787475|NCT01117623|66600532|FG001|Overall Study|Non-compliance with study medication|0|||
23787476|NCT01117623|66600533|FG002|Overall Study|Non-compliance with study medication|0|||
23787477|NCT01117623|66600534|FG003|Overall Study|Non-compliance with study medication|0|||
23787478|NCT01117623|66600535|FG004|Overall Study|Non-compliance with study medication|0|||
23787479|NCT01117623|66600536|FG005|Overall Study|Non-compliance with study medication|0|||
23787480|NCT01117623|66600537|FG006|Overall Study|Non-compliance with study medication|0|||
23787481|NCT01117623|66600538|FG007|Overall Study|Non-compliance with study medication|1|||
23787482|NCT01117623|66600531|FG000|Overall Study|Invest. text: completed all planned txs|0|||
23787483|NCT01117623|66600532|FG001|Overall Study|Invest. text: completed all planned txs|0|||
23787484|NCT01117623|66600533|FG002|Overall Study|Invest. text: completed all planned txs|0|||
23787485|NCT01117623|66600534|FG003|Overall Study|Invest. text: completed all planned txs|0|||
23787486|NCT01117623|66600535|FG004|Overall Study|Invest. text: completed all planned txs|0|||
23787487|NCT01117623|66600536|FG005|Overall Study|Invest. text: completed all planned txs|1|||
23787488|NCT01117623|66600537|FG006|Overall Study|Invest. text: completed all planned txs|0|||
23787489|NCT01117623|66600538|FG007|Overall Study|Invest. text: completed all planned txs|0|||
23787490|NCT02535923|66600541|FG000|Overall Study|Lost to Follow-up|5|||
23787491|NCT02535923|66600542|FG001|Overall Study|Lost to Follow-up|5|||
23584106|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
23638698|NCT02672852|66060967|FG000|Part B|Other|0|||
23347717|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
23584107|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
23638699|NCT02672852|66060968|FG001|Part B|Other|0|||
23638700|NCT02672852|66060969|FG002|Part B|Other|0|||
23638701|NCT02672852|66060970|FG003|Part B|Other|0|||
23638702|NCT02672852|66060971|FG004|Part B|Other|4|||
23638703|NCT02672852|66060972|FG005|Part B|Other|1|||
23638704|NCT02672852|66060973|FG006|Part B|Other|2|||
23638705|NCT02113124|66060976|FG000|Overall Study|Unable to retrieve blood sample|1|||
23638706|NCT02113124|66060977|FG001|Overall Study|Unable to retrieve blood sample|1|||
23638707|NCT01901419|66060981|FG000|Overall Study|Protocol Violation|2|||
23638708|NCT01901419|66060982|FG001|Overall Study|Protocol Violation|6|||
23638709|NCT01901419|66060981|FG000|Overall Study|unavailable researchers|6|||
23787492|NCT02535923|66600541|FG000|Overall Study|Withdrawal by Subject|4|||
23787493|NCT02535923|66600542|FG001|Overall Study|Withdrawal by Subject|3|||
23787494|NCT00645853|66600549|FG000|Overall Study|Adverse Event|18|||
23787495|NCT00645853|66600550|FG001|Overall Study|Adverse Event|7|||
23787496|NCT00645853|66600549|FG000|Overall Study|AZ study closure in Hungary|60|||
23787497|NCT00645853|66600550|FG001|Overall Study|AZ study closure in Hungary|40|||
23787498|NCT00645853|66600549|FG000|Overall Study|Withdrawal by Subject|5|||
23787499|NCT00645853|66600550|FG001|Overall Study|Withdrawal by Subject|2|||
23787500|NCT00645853|66600549|FG000|Overall Study|Protocol Violation|0|||
23459517|NCT04323124|65425254|FG007|Overall Study|Coming from a red zone (COVID)|0|||
23459518|NCT04323124|65425255|FG008|Overall Study|Coming from a red zone (COVID)|0|||
23459519|NCT04323124|65425256|FG009|Overall Study|Coming from a red zone (COVID)|0|||
23459520|NCT04323124|65425257|FG010|Overall Study|Coming from a red zone (COVID)|0|||
23459521|NCT04323124|65425258|FG011|Overall Study|Coming from a red zone (COVID)|0|||
23459522|NCT04323124|65425259|FG012|Overall Study|Coming from a red zone (COVID)|0|||
23459523|NCT04323124|65425260|FG013|Overall Study|Coming from a red zone (COVID)|0|||
23787501|NCT00645853|66600550|FG001|Overall Study|Protocol Violation|2|||
23787502|NCT00645853|66600549|FG000|Overall Study|Discontinuation criteria|2|||
23787503|NCT00645853|66600550|FG001|Overall Study|Discontinuation criteria|2|||
23347718|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
23347719|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
23347720|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
23459524|NCT04323124|65425261|FG014|Overall Study|Coming from a red zone (COVID)|0|||
23459525|NCT04323124|65425247|FG000|Overall Study|No longer meets eligibility criteria|0|||
23459526|NCT04323124|65425248|FG001|Overall Study|No longer meets eligibility criteria|0|||
23787504|NCT00645853|66600549|FG000|Overall Study|recall of ICF, planned operation, death|7|||
23459527|NCT04323124|65425249|FG002|Overall Study|No longer meets eligibility criteria|0|||
23584108|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
23584109|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
23584110|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
23584111|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
23584112|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
23584113|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
23584114|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
23584115|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
23584116|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
23584117|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
23638710|NCT01901419|66060982|FG001|Overall Study|unavailable researchers|3|||
23638711|NCT03139604|66060983|FG000|Overall Study|Other|7|||
23347721|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
23347722|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
23347723|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
23347724|NCT00742508|65014453|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
23347725|NCT00742508|65014454|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
23347726|NCT01537068|65017827|FG000|Overall Study|Lost to Follow-up|2|||
23347727|NCT01537068|65017828|FG001|Overall Study|Lost to Follow-up|1|||
23347728|NCT01537068|65017827|FG000|Overall Study|Adverse Event|0|||
23347729|NCT01537068|65017828|FG001|Overall Study|Adverse Event|1|||
23347730|NCT01537068|65017827|FG000|Overall Study|Withdrawal by Subject|1|||
23347731|NCT01537068|65017828|FG001|Overall Study|Withdrawal by Subject|1|||
23347732|NCT01537068|65017827|FG000|Overall Study|Lack of Efficacy|1|||
23347733|NCT01537068|65017828|FG001|Overall Study|Lack of Efficacy|0|||
23347734|NCT00717275|65017829|FG000|Overall Study|Premature study termination.|3|||
23347735|NCT02474355|65017833|FG000|Overall Study|Other|43|||
23347736|NCT02474355|65017833|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
23347737|NCT02474355|65017833|FG000|Overall Study|Lost to Follow-up|98|||
23347738|NCT02474355|65017833|FG000|Overall Study|Withdrawal by Subject|124|||
23347739|NCT02474355|65017833|FG000|Overall Study|Death|1361|||
23347740|NCT00232596|65017834|FG000|6-Week Titration Phase|Adverse Event|6|||
23347741|NCT00232596|65017835|FG001|6-Week Titration Phase|Adverse Event|19|||
23347742|NCT00232596|65017834|FG000|6-Week Titration Phase|Failed to Return|2|||
23347743|NCT00232596|65017835|FG001|6-Week Titration Phase|Failed to Return|1|||
23347744|NCT00232596|65017834|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
23347745|NCT00232596|65017835|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
23347746|NCT00232596|65017834|FG000|6-Week Titration Phase|Protocol Violation|1|||
23347747|NCT00232596|65017835|FG001|6-Week Titration Phase|Protocol Violation|3|||
23787505|NCT00645853|66600550|FG001|Overall Study|recall of ICF, planned operation, death|4|||
23787506|NCT01075516|66600554|FG000|Overall Study|Death|5|||
23787507|NCT01075516|66600555|FG001|Overall Study|Death|9|||
23787508|NCT01075516|66600554|FG000|Overall Study|Lost to Follow-up|10|||
23787509|NCT01075516|66600555|FG001|Overall Study|Lost to Follow-up|2|||
23787510|NCT01075516|66600554|FG000|Overall Study|Withdrawal by Subject|3|||
23787511|NCT01075516|66600555|FG001|Overall Study|Withdrawal by Subject|5|||
23787512|NCT00830024|66600558|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23787513|NCT00830024|66600559|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23347748|NCT00232596|65017834|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
23347749|NCT00232596|65017835|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
23347750|NCT00232596|65017834|FG000|6-Week Titration Phase|Other|3|||
23347751|NCT00232596|65017835|FG001|6-Week Titration Phase|Other|3|||
23347752|NCT00232596|65017834|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23584118|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
23584119|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
23584120|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
23787514|NCT01576705|66600560|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
23787515|NCT01576705|66600561|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
23787516|NCT01576705|66600562|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
23787517|NCT01576705|66600563|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
23787518|NCT01576705|66600560|FG000|Overall Study|invalid ICF|0|||
23787519|NCT01576705|66600561|FG001|Overall Study|invalid ICF|1|||
23584121|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
23584122|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
23584123|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
23638712|NCT03139604|66060984|FG001|Overall Study|Other|3|||
23638713|NCT03139604|66060983|FG000|Overall Study|Withdrawal by Subject|16|||
23638714|NCT03139604|66060984|FG001|Overall Study|Withdrawal by Subject|17|||
23638715|NCT03139604|66060983|FG000|Overall Study|Physician Decision|1|||
23787520|NCT01576705|66600562|FG002|Overall Study|invalid ICF|0|||
23787521|NCT01576705|66600563|FG003|Overall Study|invalid ICF|0|||
23787522|NCT02294981|66600564|FG000|Overall Study|Lost to Follow-up|1|||
23787523|NCT01087502|66600572|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
23347753|NCT00232596|65017835|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
23347754|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Adverse Event|7|||
23347755|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Adverse Event|22|||
23347756|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
23347757|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
23584124|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
23638716|NCT03139604|66060984|FG001|Overall Study|Physician Decision|2|||
23787524|NCT01087502|66600573|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
23787525|NCT01087502|66600572|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
23347758|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
23347759|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
23787526|NCT01087502|66600573|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
23347760|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Other|1|||
23347761|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Other|3|||
23347762|NCT02470403|65017836|FG000|Overall Study|Adverse Event|1|||
23347763|NCT02470403|65017837|FG001|Overall Study|Adverse Event|0|||
23347764|NCT02470403|65017838|FG002|Overall Study|Adverse Event|0|||
23347765|NCT02470403|65017839|FG003|Overall Study|Adverse Event|0|||
23347766|NCT02470403|65017840|FG004|Overall Study|Adverse Event|0|||
23347767|NCT02470403|65017836|FG000|Overall Study|Lost to Follow-up|0|||
23347768|NCT02470403|65017837|FG001|Overall Study|Lost to Follow-up|1|||
23347769|NCT02470403|65017838|FG002|Overall Study|Lost to Follow-up|0|||
23347770|NCT02470403|65017839|FG003|Overall Study|Lost to Follow-up|0|||
23347771|NCT02470403|65017840|FG004|Overall Study|Lost to Follow-up|0|||
23347772|NCT02470403|65017836|FG000|Overall Study|Subject/guardian decision|1|||
23347773|NCT02470403|65017837|FG001|Overall Study|Subject/guardian decision|0|||
23347774|NCT02470403|65017838|FG002|Overall Study|Subject/guardian decision|0|||
23347775|NCT02470403|65017839|FG003|Overall Study|Subject/guardian decision|4|||
23347776|NCT02470403|65017840|FG004|Overall Study|Subject/guardian decision|0|||
23347777|NCT00106639|65017841|FG000|Overall Study|Adverse Event|3|||
23347778|NCT00106639|65017842|FG001|Overall Study|Adverse Event|4|||
23347779|NCT00106639|65017843|FG002|Overall Study|Adverse Event|1|||
23347780|NCT00106639|65017841|FG000|Overall Study|Protocol Violation|0|||
23347781|NCT00106639|65017842|FG001|Overall Study|Protocol Violation|1|||
23347782|NCT00106639|65017843|FG002|Overall Study|Protocol Violation|0|||
23347783|NCT00106639|65017841|FG000|Overall Study|Withdrawal by Subject|0|||
23347784|NCT00106639|65017842|FG001|Overall Study|Withdrawal by Subject|1|||
23347785|NCT00106639|65017843|FG002|Overall Study|Withdrawal by Subject|0|||
23347786|NCT00106639|65017841|FG000|Overall Study|Participant defaulted|0|||
23347787|NCT00106639|65017842|FG001|Overall Study|Participant defaulted|1|||
23347788|NCT00106639|65017843|FG002|Overall Study|Participant defaulted|1|||
23347789|NCT01917344|65017844|FG000|Overall Study|Withdrawal by Subject|1|||
23347790|NCT01490697|65017849|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
23347791|NCT01490697|65017850|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
23347792|NCT00314132|65017851|FG000|Overall Study|Lost to Follow-up|3|||
23347793|NCT00314132|65017852|FG001|Overall Study|Lost to Follow-up|13|||
23347794|NCT00314132|65017851|FG000|Overall Study|Withdrawal by Subject|3|||
23347795|NCT00314132|65017852|FG001|Overall Study|Withdrawal by Subject|5|||
23347796|NCT00314132|65017851|FG000|Overall Study|Adverse Event|1|||
23347797|NCT00314132|65017852|FG001|Overall Study|Adverse Event|0|||
23347798|NCT00314132|65017851|FG000|Overall Study|Physician Decision|1|||
23347799|NCT00314132|65017852|FG001|Overall Study|Physician Decision|0|||
23347800|NCT01841567|65017853|FG000|Overall Study|Adverse Event|3|||
23347801|NCT01279070|65017857|FG000|Overall Study|Withdrawal by Subject|2|||
23347802|NCT01279070|65017858|FG001|Overall Study|Withdrawal by Subject|3|||
23347803|NCT01279070|65017857|FG000|Overall Study|Acute exacerbation|3|||
23347804|NCT01279070|65017858|FG001|Overall Study|Acute exacerbation|1|||
23347805|NCT00094536|65017859|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
23459528|NCT04323124|65425250|FG003|Overall Study|No longer meets eligibility criteria|0|||
23459529|NCT04323124|65425251|FG004|Overall Study|No longer meets eligibility criteria|0|||
23459530|NCT04323124|65425252|FG005|Overall Study|No longer meets eligibility criteria|0|||
23459531|NCT04323124|65425253|FG006|Overall Study|No longer meets eligibility criteria|0|||
23459532|NCT04323124|65425254|FG007|Overall Study|No longer meets eligibility criteria|1|||
23459533|NCT04323124|65425255|FG008|Overall Study|No longer meets eligibility criteria|0|||
23459534|NCT04323124|65425256|FG009|Overall Study|No longer meets eligibility criteria|0|||
23459535|NCT04323124|65425257|FG010|Overall Study|No longer meets eligibility criteria|0|||
23459536|NCT04323124|65425258|FG011|Overall Study|No longer meets eligibility criteria|0|||
23459537|NCT04323124|65425259|FG012|Overall Study|No longer meets eligibility criteria|0|||
23459538|NCT04323124|65425260|FG013|Overall Study|No longer meets eligibility criteria|1|||
23459539|NCT04323124|65425261|FG014|Overall Study|No longer meets eligibility criteria|1|||
23459540|NCT04323124|65425247|FG000|Overall Study|Study terminated by sponsor|0|||
23347806|NCT00094536|65017859|FG000|Treatment and Follow-up|Adverse Event|4|||
23347807|NCT00094536|65017859|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
23347808|NCT00094536|65017859|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
23347809|NCT00094536|65017859|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
23459541|NCT04323124|65425248|FG001|Overall Study|Study terminated by sponsor|0|||
23347810|NCT00094536|65017859|FG000|Treatment and Follow-up|Subject non-compliance|9|||
23347811|NCT00094536|65017859|FG000|Treatment and Follow-up|Unable to attend visits|1|||
23347812|NCT00430352|65017860|FG000|Overall Study|Disease progression|58|||
23347813|NCT00430352|65017860|FG000|Overall Study|Withdrawal by Subject|11|||
23347814|NCT00430352|65017860|FG000|Overall Study|Adverse Event|16|||
23347815|NCT00430352|65017860|FG000|Overall Study|Death|5|||
23347816|NCT00430352|65017860|FG000|Overall Study|Other|48|||
23347817|NCT03578146|65017861|FG000|Overall Study|Did Not Receive Treatment|1|||
23347818|NCT03578146|65017862|FG001|Overall Study|Did Not Receive Treatment|0|||
23347819|NCT03578146|65017863|FG002|Overall Study|Did Not Receive Treatment|0|||
23347820|NCT03578146|65017864|FG003|Overall Study|Did Not Receive Treatment|0|||
23347821|NCT03578146|65017865|FG004|Overall Study|Did Not Receive Treatment|0|||
23347822|NCT03578146|65017866|FG005|Overall Study|Did Not Receive Treatment|2|||
23347823|NCT03578146|65017861|FG000|Overall Study|Lost to Follow-up|0|||
23347824|NCT03578146|65017862|FG001|Overall Study|Lost to Follow-up|1|||
23347825|NCT03578146|65017863|FG002|Overall Study|Lost to Follow-up|1|||
23347826|NCT03578146|65017864|FG003|Overall Study|Lost to Follow-up|0|||
23347827|NCT03578146|65017865|FG004|Overall Study|Lost to Follow-up|0|||
23347828|NCT03578146|65017866|FG005|Overall Study|Lost to Follow-up|1|||
23347829|NCT01472757|65017875|FG000|Overall Study|Withdrawal by Subject|1|||
23347830|NCT01472757|65017876|FG001|Overall Study|Withdrawal by Subject|2|||
23347831|NCT01472757|65017877|FG002|Overall Study|Withdrawal by Subject|2|||
23347832|NCT01472757|65017878|FG003|Overall Study|Withdrawal by Subject|0|||
23347833|NCT01472757|65017875|FG000|Overall Study|Asthma exacerbation|4|||
23347834|NCT01472757|65017876|FG001|Overall Study|Asthma exacerbation|1|||
23347835|NCT01472757|65017877|FG002|Overall Study|Asthma exacerbation|2|||
23347836|NCT01472757|65017878|FG003|Overall Study|Asthma exacerbation|1|||
23347837|NCT01472757|65017875|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
23347838|NCT01472757|65017876|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
23347839|NCT01472757|65017877|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
23347840|NCT01472757|65017878|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
23347841|NCT01472757|65017875|FG000|Overall Study|Protocol Violation|3|||
23347842|NCT01472757|65017876|FG001|Overall Study|Protocol Violation|2|||
23347843|NCT01472757|65017877|FG002|Overall Study|Protocol Violation|4|||
23347844|NCT01472757|65017878|FG003|Overall Study|Protocol Violation|4|||
23347845|NCT01472757|65017875|FG000|Overall Study|Other reasons|1|||
23347846|NCT01472757|65017876|FG001|Overall Study|Other reasons|0|||
23347847|NCT01472757|65017877|FG002|Overall Study|Other reasons|2|||
23347848|NCT01472757|65017878|FG003|Overall Study|Other reasons|2|||
23347849|NCT03047720|65017880|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
23347850|NCT03047720|65017881|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
23347851|NCT01797081|65017886|FG000|Overall Study|Adverse Event|1|||
23347852|NCT01797081|65017887|FG001|Overall Study|Adverse Event|0|||
23347853|NCT01797081|65017888|FG002|Overall Study|Adverse Event|1|||
23347854|NCT01797081|65017889|FG003|Overall Study|Adverse Event|0|||
23347855|NCT01797081|65017886|FG000|Overall Study|Pregnancy|1|||
23347856|NCT01797081|65017887|FG001|Overall Study|Pregnancy|0|||
23347857|NCT01797081|65017888|FG002|Overall Study|Pregnancy|0|||
23347858|NCT01797081|65017889|FG003|Overall Study|Pregnancy|0|||
23347859|NCT01797081|65017886|FG000|Overall Study|Personal Reasons|12|||
23347860|NCT01797081|65017887|FG001|Overall Study|Personal Reasons|4|||
23347861|NCT01797081|65017888|FG002|Overall Study|Personal Reasons|4|||
23347862|NCT01797081|65017889|FG003|Overall Study|Personal Reasons|8|||
23347863|NCT01797081|65017886|FG000|Overall Study|Protocol Violation|0|||
23347864|NCT01797081|65017887|FG001|Overall Study|Protocol Violation|0|||
23347865|NCT01797081|65017888|FG002|Overall Study|Protocol Violation|0|||
23347866|NCT01797081|65017889|FG003|Overall Study|Protocol Violation|1|||
23347867|NCT01952080|65017890|FG000|Overall Study|Withdrawal by Subject|0|||
23347868|NCT01952080|65017891|FG001|Overall Study|Withdrawal by Subject|0|||
23347869|NCT01952080|65017892|FG002|Overall Study|Withdrawal by Subject|0|||
23347870|NCT01952080|65017893|FG003|Overall Study|Withdrawal by Subject|1|||
23347871|NCT01952080|65017890|FG000|Overall Study|Protocol Non-compliance|0|||
23347872|NCT01952080|65017891|FG001|Overall Study|Protocol Non-compliance|1|||
23347873|NCT01952080|65017892|FG002|Overall Study|Protocol Non-compliance|0|||
23347874|NCT01952080|65017893|FG003|Overall Study|Protocol Non-compliance|0|||
23347875|NCT00574795|65017894|FG000|Infant Series|Withdrawal by Subject|2|||
23347876|NCT00574795|65017894|FG000|Infant Series|Protocol Violation|2|||
23459542|NCT04323124|65425249|FG002|Overall Study|Study terminated by sponsor|0|||
23459543|NCT04323124|65425250|FG003|Overall Study|Study terminated by sponsor|0|||
23459544|NCT04323124|65425251|FG004|Overall Study|Study terminated by sponsor|0|||
23787527|NCT01087502|66600572|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
23787528|NCT01087502|66600573|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
23787529|NCT01087502|66600572|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
23347877|NCT00574795|65017894|FG000|Infant Series|Adverse Event|1|||
23347878|NCT00574795|65017894|FG000|After Infant Series|Withdrawal by Subject|1|||
23347879|NCT00574795|65017894|FG000|After Infant Series|Adverse Event|2|||
23347880|NCT00574795|65017894|FG000|Toddler Dose|Withdrawal by Subject|1|||
23347881|NCT00551161|65017895|FG000|Overall Study|Withdrawal by Subject|1|||
23347882|NCT00248833|65017896|FG000|Overall Study|Adverse Event|2|||
23459545|NCT04323124|65425252|FG005|Overall Study|Study terminated by sponsor|0|||
23347883|NCT00248833|65017897|FG001|Overall Study|Adverse Event|0|||
23347884|NCT00248833|65017898|FG002|Overall Study|Adverse Event|0|||
23347885|NCT00248833|65017896|FG000|Overall Study|Withdrawal by Subject|0|||
23347886|NCT00248833|65017897|FG001|Overall Study|Withdrawal by Subject|1|||
23347887|NCT00248833|65017898|FG002|Overall Study|Withdrawal by Subject|1|||
23347888|NCT00248833|65017896|FG000|Overall Study|Lost to Follow-up|1|||
23347889|NCT00248833|65017897|FG001|Overall Study|Lost to Follow-up|1|||
23459546|NCT04323124|65425253|FG006|Overall Study|Study terminated by sponsor|0|||
23787530|NCT01087502|66600573|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
23347890|NCT00248833|65017898|FG002|Overall Study|Lost to Follow-up|1|||
23347891|NCT00248833|65017896|FG000|Overall Study|Other|0|||
23347892|NCT00248833|65017897|FG001|Overall Study|Other|1|||
23347893|NCT00248833|65017898|FG002|Overall Study|Other|0|||
23347894|NCT02484651|65017902|FG000|Overall Study|Patients' data files were corrupted.|1|||
23347895|NCT02484651|65017903|FG001|Overall Study|Patients' data files were corrupted.|1|||
23347896|NCT02484651|65017902|FG000|Overall Study|BIS monitoring failed.|1|||
23347897|NCT02484651|65017903|FG001|Overall Study|BIS monitoring failed.|1|||
23347898|NCT02484651|65017902|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
23347899|NCT02484651|65017903|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
23347900|NCT00962091|65017906|FG000|Overall Study|Withdrawal by Subject|1|||
23347901|NCT00962091|65017907|FG001|Overall Study|Withdrawal by Subject|2|||
23347902|NCT00962091|65017908|FG002|Overall Study|Withdrawal by Subject|1|||
23347903|NCT00962091|65017909|FG003|Overall Study|Withdrawal by Subject|1|||
23347904|NCT00962091|65017910|FG004|Overall Study|Withdrawal by Subject|0|||
23347905|NCT00962091|65017911|FG005|Overall Study|Withdrawal by Subject|1|||
23347906|NCT00962091|65017912|FG006|Overall Study|Withdrawal by Subject|0|||
23787531|NCT01087502|66600572|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
23347907|NCT00962091|65017906|FG000|Overall Study|Adverse Event|0|||
23347908|NCT00962091|65017907|FG001|Overall Study|Adverse Event|0|||
23347909|NCT00962091|65017908|FG002|Overall Study|Adverse Event|0|||
23347910|NCT00962091|65017909|FG003|Overall Study|Adverse Event|0|||
23347911|NCT00962091|65017910|FG004|Overall Study|Adverse Event|0|||
23347912|NCT00962091|65017911|FG005|Overall Study|Adverse Event|0|||
23787532|NCT01087502|66600573|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
23787533|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
23787534|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
23787535|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
23347913|NCT00962091|65017912|FG006|Overall Study|Adverse Event|1|||
23347914|NCT02939716|65017915|FG000|Overall Study|scanner failure|0|||
23347915|NCT02939716|65017916|FG001|Overall Study|scanner failure|0|||
23347916|NCT02939716|65017917|FG002|Overall Study|scanner failure|0|||
23347917|NCT02939716|65017918|FG003|Overall Study|scanner failure|1|||
23347918|NCT02939716|65017919|FG004|Overall Study|scanner failure|1|||
23347919|NCT02939716|65017920|FG005|Overall Study|scanner failure|1|||
23347920|NCT02879994|65017921|FG000|Overall Study|off treatment early|7|||
23347921|NCT02879994|65017921|FG000|Overall Study|Adverse Event|2|||
23347922|NCT02879994|65017921|FG000|Overall Study|Death|2|||
23347923|NCT01378975|65017923|FG000|Overall Study|Death|77|||
23787536|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
23787537|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
23787538|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
23787539|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
23787540|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
23787541|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
23347924|NCT01378975|65017924|FG001|Overall Study|Death|46|||
23347925|NCT01378975|65017923|FG000|Overall Study|Investigator Request|1|||
23347926|NCT01378975|65017924|FG001|Overall Study|Investigator Request|0|||
23347927|NCT01378975|65017923|FG000|Overall Study|Lost to Follow-up|4|||
23347928|NCT01378975|65017924|FG001|Overall Study|Lost to Follow-up|1|||
23347929|NCT01378975|65017923|FG000|Overall Study|Withdrew Consent|4|||
23787542|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
23347930|NCT01378975|65017924|FG001|Overall Study|Withdrew Consent|3|||
23787543|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
23787544|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
23787545|NCT01087502|66600572|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
23787546|NCT01087502|66600573|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
23787547|NCT00573313|66600574|FG000|Overall Study|Protocol Violation|5|||
23347931|NCT04045132|65017925|FG000|Overall Study|Lost to Follow-up|3|||
23347932|NCT04045132|65017926|FG001|Overall Study|Lost to Follow-up|6|||
23347933|NCT01737268|65017927|FG000|Overall Study|Adverse Event|6|||
23347934|NCT01737268|65017927|FG000|Overall Study|Worsening of Target Disease|2|||
23787548|NCT00573313|66600575|FG001|Overall Study|Protocol Violation|0|||
23787549|NCT00573313|66600576|FG002|Overall Study|Protocol Violation|6|||
23347935|NCT01737268|65017927|FG000|Overall Study|In consideration of the patient's safety|1|||
23787550|NCT00573313|66600577|FG003|Overall Study|Protocol Violation|0|||
23347936|NCT00908076|65017932|FG000|Overall Study|Lack of Efficacy|1|||
23347937|NCT00908076|65017933|FG001|Overall Study|Lack of Efficacy|1|||
23347938|NCT00207727|65017936|FG000|Overall Study|Withdrawal by Subject|0|||
23347939|NCT00207727|65017937|FG001|Overall Study|Withdrawal by Subject|0|||
23347940|NCT00207727|65017938|FG002|Overall Study|Withdrawal by Subject|0|||
23347941|NCT00207727|65017939|FG003|Overall Study|Withdrawal by Subject|0|||
23347942|NCT00207727|65017940|FG004|Overall Study|Withdrawal by Subject|1|||
23347943|NCT00207727|65017936|FG000|Overall Study|Lost to Follow-up|0|||
23787551|NCT04773600|66600581|FG000|Overall Study|Withdrawal by Subject|15|||
23787552|NCT04773600|66600582|FG001|Overall Study|Withdrawal by Subject|9|||
23787553|NCT04773600|66600581|FG000|Overall Study|Lost to Follow-up|10|||
23787554|NCT04773600|66600582|FG001|Overall Study|Lost to Follow-up|6|||
23787555|NCT04773600|66600581|FG000|Overall Study|Adverse Event|8|||
23787556|NCT04773600|66600582|FG001|Overall Study|Adverse Event|2|||
23787557|NCT04773600|66600581|FG000|Overall Study|Lack of Efficacy|2|||
23787558|NCT04773600|66600582|FG001|Overall Study|Lack of Efficacy|3|||
23787559|NCT04773600|66600581|FG000|Overall Study|Noncompliance|2|||
23787560|NCT04773600|66600582|FG001|Overall Study|Noncompliance|0|||
23787561|NCT04773600|66600581|FG000|Overall Study|Protocol Violation|2|||
23787562|NCT04773600|66600582|FG001|Overall Study|Protocol Violation|0|||
23787563|NCT04773600|66600581|FG000|Overall Study|Physician Decision|0|||
23787564|NCT04773600|66600582|FG001|Overall Study|Physician Decision|1|||
23787565|NCT04773600|66600581|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
23787566|NCT04773600|66600582|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
23787567|NCT04773600|66600581|FG000|Overall Study|Emergency Travel Out of Country|1|||
23787568|NCT04773600|66600582|FG001|Overall Study|Emergency Travel Out of Country|0|||
23787569|NCT01442376|66600583|FG000|Overall Study|Adverse Event|0|||
23787570|NCT01442376|66600584|FG001|Overall Study|Adverse Event|3|||
23787571|NCT01442376|66600585|FG002|Overall Study|Adverse Event|2|||
23787572|NCT01442376|66600583|FG000|Overall Study|Death|0|||
23787573|NCT01442376|66600584|FG001|Overall Study|Death|1|||
23787574|NCT01442376|66600585|FG002|Overall Study|Death|1|||
23787575|NCT01442376|66600583|FG000|Overall Study|Withdrawal of consent|0|||
23787576|NCT01442376|66600584|FG001|Overall Study|Withdrawal of consent|0|||
23787577|NCT01442376|66600585|FG002|Overall Study|Withdrawal of consent|1|||
23787578|NCT01442376|66600583|FG000|Overall Study|Patients not treated|2|||
23787579|NCT01442376|66600584|FG001|Overall Study|Patients not treated|3|||
23787580|NCT01442376|66600585|FG002|Overall Study|Patients not treated|1|||
23787581|NCT01442376|66600583|FG000|Overall Study|Not eligible for subsequent cycles|1|||
23787582|NCT01442376|66600584|FG001|Overall Study|Not eligible for subsequent cycles|2|||
23787583|NCT01442376|66600585|FG002|Overall Study|Not eligible for subsequent cycles|0|||
23787584|NCT00700739|66600586|FG000|Overall Study|Lost to Follow-up|4|||
23787585|NCT00700739|66600587|FG001|Overall Study|Lost to Follow-up|4|||
23787586|NCT03644550|66600588|FG000|Overall Study|Withdrawal by Subject|3|||
23787587|NCT03644550|66600588|FG000|Overall Study|Progressive disease|15|||
23787588|NCT00705666|66600589|FG000|Overall Study|No post-treatment questionnaire|279|||
23787589|NCT00705666|66600589|FG000|Overall Study|Withdrawal by Subject|21|||
23787590|NCT00705666|66600589|FG000|Overall Study|Physician Decision|7|||
23787591|NCT00705666|66600589|FG000|Overall Study|Lost to Follow-up|5|||
23787592|NCT00705666|66600589|FG000|Overall Study|Death|1|||
23787593|NCT00705666|66600589|FG000|Overall Study|Adverse Event|4|||
23787594|NCT00705666|66600589|FG000|Overall Study|Other|12|||
23787595|NCT00705666|66600589|FG000|Overall Study|Other|2|||
23787596|NCT00705666|66600589|FG000|Overall Study|Lack of data|3|||
23787597|NCT00705666|66600589|FG000|Overall Study|Untreated|5|||
23787598|NCT01741545|66600591|FG000|Treatment Period|Lack of Efficacy|0|||
23787599|NCT01741545|66600592|FG001|Treatment Period|Lack of Efficacy|1|||
23787600|NCT01741545|66600591|FG000|Treatment Period|Adverse event, non-fatal|1|||
23787601|NCT01741545|66600592|FG001|Treatment Period|Adverse event, non-fatal|3|||
23787602|NCT01741545|66600591|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
23787603|NCT01741545|66600592|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
23787604|NCT01741545|66600591|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23787605|NCT01741545|66600592|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23787606|NCT00446966|66600593|FG000|Overall Study|Lost to Follow-up|10|||
23787607|NCT00446966|66600594|FG001|Overall Study|Lost to Follow-up|7|||
23787608|NCT01456962|66600600|FG000|Overall Study|Lost to Follow-up|2|||
23787609|NCT01456962|66600601|FG001|Overall Study|Lost to Follow-up|1|||
23787610|NCT01660243|66600602|FG000|Overall Study|Adverse Event|1|||
23787611|NCT01660243|66600603|FG001|Overall Study|Adverse Event|0|||
23787612|NCT01660243|66600604|FG002|Overall Study|Adverse Event|1|||
23787613|NCT01660243|66600605|FG003|Overall Study|Adverse Event|0|||
23787614|NCT01660243|66600602|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
23787615|NCT01660243|66600603|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23787616|NCT01660243|66600604|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23787617|NCT01660243|66600605|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23787618|NCT01660243|66600602|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23787619|NCT01660243|66600603|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23787620|NCT01660243|66600604|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
23787621|NCT01660243|66600605|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23787622|NCT01660243|66600602|FG000|Overall Study|Randomization error|0|||
23787623|NCT01660243|66600603|FG001|Overall Study|Randomization error|0|||
23787624|NCT01660243|66600604|FG002|Overall Study|Randomization error|0|||
23787625|NCT01660243|66600605|FG003|Overall Study|Randomization error|1|||
23787626|NCT02648438|66600606|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23787627|NCT02648438|66600607|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23787628|NCT02648438|66600608|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23787629|NCT02648438|66600606|FG000|Overall Study|Protocol Violation|2|||
23787630|NCT02648438|66600607|FG001|Overall Study|Protocol Violation|0|||
23787631|NCT02648438|66600608|FG002|Overall Study|Protocol Violation|0|||
23787632|NCT02648438|66600606|FG000|Overall Study|Withdrawal by Subject|1|||
23787633|NCT02648438|66600607|FG001|Overall Study|Withdrawal by Subject|1|||
23787634|NCT02648438|66600608|FG002|Overall Study|Withdrawal by Subject|0|||
23787635|NCT00227370|66600609|FG000|Overall Study|Withdrawal by Subject|1|||
23787636|NCT00227370|66600610|FG001|Overall Study|Withdrawal by Subject|2|||
23787637|NCT00227370|66600609|FG000|Overall Study|Death|3|||
23787638|NCT00227370|66600610|FG001|Overall Study|Death|4|||
23787639|NCT00227370|66600609|FG000|Overall Study|Adverse Event|6|||
23787640|NCT00227370|66600610|FG001|Overall Study|Adverse Event|11|||
23787641|NCT00227370|66600609|FG000|Overall Study|Physician Decision|9|||
23787642|NCT00227370|66600610|FG001|Overall Study|Physician Decision|6|||
23787643|NCT00227370|66600609|FG000|Overall Study|Other reasons|2|||
23787644|NCT00227370|66600610|FG001|Overall Study|Other reasons|1|||
23787645|NCT02264977|66600619|FG000|Overall Study|Death|3|||
23787646|NCT02264977|66600619|FG000|Overall Study|Physician Decision|1|||
23787647|NCT02264977|66600619|FG000|Overall Study|Refuse to return|1|||
23787648|NCT02658487|66600622|FG000|Overall Study|Death|2|||
23787649|NCT02658487|66600622|FG000|Overall Study|Disease progression|10|||
23787650|NCT02658487|66600622|FG000|Overall Study|Alternative therapy|1|||
23787651|NCT02658487|66600622|FG000|Overall Study|Adverse Event|1|||
23787652|NCT02658487|66600622|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
23787653|NCT02658487|66600622|FG000|Overall Study|Refractory AML|1|||
23787654|NCT00216736|66600623|FG000|Overall Study|Lost to Follow-up|1|||
23787655|NCT00216736|66600624|FG001|Overall Study|Lost to Follow-up|1|||
23787656|NCT00003470|66600625|FG000|Overall Study|Not evaluable|6|||
23787657|NCT00857454|66600626|FG000|Overall Study|Withdrawal by Subject|2|||
23787658|NCT00857454|66600626|FG000|Overall Study|Lost to Follow-up|1|||
23347944|NCT00207727|65017937|FG001|Overall Study|Lost to Follow-up|1|||
23347945|NCT00207727|65017938|FG002|Overall Study|Lost to Follow-up|0|||
23347946|NCT00207727|65017939|FG003|Overall Study|Lost to Follow-up|0|||
23347947|NCT00207727|65017940|FG004|Overall Study|Lost to Follow-up|0|||
23347948|NCT00207727|65017936|FG000|Overall Study|Other|38|||
23347949|NCT00207727|65017937|FG001|Overall Study|Other|41|||
23347950|NCT00207727|65017938|FG002|Overall Study|Other|41|||
23347951|NCT00207727|65017939|FG003|Overall Study|Other|37|||
23459547|NCT04323124|65425254|FG007|Overall Study|Study terminated by sponsor|0|||
23787659|NCT00857454|66600626|FG000|Overall Study|Adverse Event|2|||
23787660|NCT00857454|66600626|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
23787661|NCT00857454|66600626|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
23787662|NCT00857454|66600626|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
23347952|NCT00207727|65017940|FG004|Overall Study|Other|33|||
23787663|NCT02258074|66600627|FG000|Overall Study|Withdrawal by Subject|1|||
23787664|NCT02258074|66600628|FG001|Overall Study|Withdrawal by Subject|0|||
23787665|NCT02258074|66600629|FG002|Overall Study|Withdrawal by Subject|0|||
23787666|NCT02258074|66600630|FG003|Overall Study|Withdrawal by Subject|0|||
23787667|NCT04277507|66600631|FG000|Overall Study|Lost to Follow-up|17|||
23459548|NCT04323124|65425255|FG008|Overall Study|Study terminated by sponsor|0|||
23459549|NCT04323124|65425256|FG009|Overall Study|Study terminated by sponsor|0|||
23459550|NCT04323124|65425257|FG010|Overall Study|Study terminated by sponsor|0|||
23459551|NCT04323124|65425258|FG011|Overall Study|Study terminated by sponsor|2|||
23459552|NCT04323124|65425259|FG012|Overall Study|Study terminated by sponsor|1|||
23459553|NCT04323124|65425260|FG013|Overall Study|Study terminated by sponsor|0|||
23459554|NCT04323124|65425261|FG014|Overall Study|Study terminated by sponsor|0|||
23459555|NCT00551642|65425262|FG000|Treatment Period|Protocol Deviation|6|||
23459556|NCT00551642|65425263|FG001|Treatment Period|Protocol Deviation|11|||
23459557|NCT00551642|65425262|FG000|Treatment Period|Delivery device failure|1|||
23459558|NCT00551642|65425263|FG001|Treatment Period|Delivery device failure|3|||
23459559|NCT00551642|65425262|FG000|Treatment Period|Physician Decision|0|||
23459560|NCT00551642|65425263|FG001|Treatment Period|Physician Decision|1|||
23459561|NCT00551642|65425262|FG000|Treatment Period|Death|33|||
23459562|NCT00551642|65425263|FG001|Treatment Period|Death|31|||
23459563|NCT00551642|65425262|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
23459564|NCT00551642|65425263|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
23459565|NCT00551642|65425262|FG000|Treatment Period|Adverse Event|15|||
23459566|NCT00551642|65425263|FG001|Treatment Period|Adverse Event|12|||
23459567|NCT00551642|65425262|FG000|Treatment Period|Withdrawal by Subject|2|||
23459568|NCT00551642|65425263|FG001|Treatment Period|Withdrawal by Subject|1|||
23459569|NCT03938259|65425264|FG000|Overall Study|unable to establish baseline for ventilation|1|||
23459570|NCT03938259|65425265|FG001|Overall Study|unable to establish baseline for ventilation|1|||
23459571|NCT04272242|65425266|FG000|Overall Study|Withdrawal by Subject|3|||
23459572|NCT04272242|65425266|FG000|Overall Study|Lost to Follow-up|1|||
23459573|NCT04272242|65425266|FG000|Overall Study|Adverse Event|1|||
23459574|NCT01521117|65425267|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
23459575|NCT01521117|65425268|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23459576|NCT01521117|65425267|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
23459577|NCT01521117|65425268|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
23459578|NCT01521117|65425267|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23459579|NCT01521117|65425268|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
23459580|NCT00412984|65425269|FG000|Overall Study|Death|331|||
23459581|NCT00412984|65425270|FG001|Overall Study|Death|349|||
23459582|NCT00412984|65425269|FG000|Overall Study|Adverse Event|679|||
23459583|NCT00412984|65425270|FG001|Overall Study|Adverse Event|738|||
23459584|NCT00412984|65425269|FG000|Overall Study|Withdrawal by Subject|921|||
23459585|NCT00412984|65425270|FG001|Overall Study|Withdrawal by Subject|989|||
23459586|NCT00412984|65425269|FG000|Overall Study|Lost to Follow-up|51|||
23459587|NCT00412984|65425270|FG001|Overall Study|Lost to Follow-up|39|||
23459588|NCT00412984|65425269|FG000|Overall Study|Poor/Noncompliance|57|||
23459589|NCT00412984|65425270|FG001|Overall Study|Poor/Noncompliance|77|||
23459590|NCT00412984|65425269|FG000|Overall Study|Pregnancy|1|||
23459591|NCT00412984|65425270|FG001|Overall Study|Pregnancy|0|||
23459592|NCT00412984|65425269|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
23459593|NCT00412984|65425270|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
23459594|NCT00412984|65425269|FG000|Overall Study|Administrative Reason by Sponsor|11|||
23459595|NCT00412984|65425270|FG001|Overall Study|Administrative Reason by Sponsor|8|||
23459596|NCT00412984|65425269|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
23459597|NCT00412984|65425270|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
23459598|NCT00412984|65425269|FG000|Overall Study|Other Reason|80|||
23459599|NCT00412984|65425270|FG001|Overall Study|Other Reason|92|||
23459600|NCT00412984|65425269|FG000|Overall Study|Not Reported|11|||
23459601|NCT00412984|65425270|FG001|Overall Study|Not Reported|12|||
23459602|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
23459603|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
23459604|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
23459605|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
23459606|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
23459607|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
23459608|NCT00906204|65425271|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
23459609|NCT00906204|65425272|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
23459610|NCT00906204|65425271|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
23459611|NCT00906204|65425272|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
23459612|NCT04558125|65425281|FG000|Overall Study|Death|1|||
23459613|NCT05767749|65425282|FG000|Overall Study|Withdrawal by Subject|0|||
23459614|NCT05767749|65425283|FG001|Overall Study|Withdrawal by Subject|0|||
23459615|NCT05767749|65425284|FG002|Overall Study|Withdrawal by Subject|2|||
23459616|NCT05767749|65425285|FG003|Overall Study|Withdrawal by Subject|2|||
23459617|NCT05767749|65425286|FG004|Overall Study|Withdrawal by Subject|2|||
23459618|NCT05767749|65425287|FG005|Overall Study|Withdrawal by Subject|2|||
23459619|NCT03610269|65425289|FG000|Overall Study|Physician Decision|10|||
23584125|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
23459620|NCT03610269|65425289|FG000|Overall Study|Protocol Violation|1|||
23459621|NCT03610269|65425289|FG000|Overall Study|Unable to draw blood|1|||
23459622|NCT03610269|65425289|FG000|Overall Study|Screen fail|4|||
23459623|NCT04498832|65427779|FG000|Overall Study|Adverse Event|1|||
23459624|NCT04498832|65427780|FG001|Overall Study|Adverse Event|3|||
23459625|NCT04498832|65427779|FG000|Overall Study|Withdrawal by Subject|0|||
23459626|NCT04498832|65427780|FG001|Overall Study|Withdrawal by Subject|1|||
23459627|NCT00696072|65427781|FG000|Overall Study|continuing active treatment|10|||
23459628|NCT00696072|65427782|FG001|Overall Study|continuing active treatment|13|||
23459629|NCT00696072|65427781|FG000|Overall Study|Adverse Event|10|||
23459630|NCT00696072|65427782|FG001|Overall Study|Adverse Event|6|||
23459631|NCT00696072|65427781|FG000|Overall Study|Patient Request|3|||
23459632|NCT00696072|65427782|FG001|Overall Study|Patient Request|7|||
23459633|NCT00696072|65427781|FG000|Overall Study|Investigator Request|1|||
23459634|NCT00696072|65427782|FG001|Overall Study|Investigator Request|4|||
23459635|NCT00696072|65427781|FG000|Overall Study|Sponsor Request|0|||
23459636|NCT00696072|65427782|FG001|Overall Study|Sponsor Request|1|||
23459637|NCT00696072|65427781|FG000|Overall Study|Disease Progression|32|||
23459638|NCT00696072|65427782|FG001|Overall Study|Disease Progression|30|||
23459639|NCT00696072|65427781|FG000|Overall Study|Non-specified|1|||
23459640|NCT00696072|65427782|FG001|Overall Study|Non-specified|2|||
23459641|NCT02638220|65427783|FG000|Overall Study|Lost to Follow-up|6|||
23459642|NCT02638220|65427783|FG000|Overall Study|Withdrawal by Subject|3|||
23459643|NCT02638220|65427783|FG000|Overall Study|Physician Decision|1|||
23459644|NCT02638220|65427783|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
23459645|NCT04639245|65427784|FG000|Overall Study|Death|1|||
23459646|NCT04163016|65427785|FG000|Enrollment|Adverse Event|1|||
23459647|NCT04163016|65427786|FG001|Enrollment|Adverse Event|0|||
23459648|NCT04163016|65427787|FG002|Enrollment|Adverse Event|0|||
23459649|NCT04163016|65427788|FG003|Enrollment|Adverse Event|0|||
23459650|NCT04163016|65427785|FG000|Treatment|Adverse Event|0|||
23459651|NCT04163016|65427786|FG001|Treatment|Adverse Event|1|||
23459652|NCT04163016|65427787|FG002|Treatment|Adverse Event|0|||
23459653|NCT04163016|65427788|FG003|Treatment|Adverse Event|0|||
23459654|NCT04163016|65427785|FG000|Treatment|Withdrawal by Subject|0|||
23459655|NCT04163016|65427786|FG001|Treatment|Withdrawal by Subject|2|||
23459656|NCT04163016|65427787|FG002|Treatment|Withdrawal by Subject|0|||
23459657|NCT04163016|65427788|FG003|Treatment|Withdrawal by Subject|0|||
23459658|NCT04163016|65427785|FG000|Treatment|Indeterminate TB-test|0|||
23459659|NCT04163016|65427786|FG001|Treatment|Indeterminate TB-test|0|||
23459660|NCT04163016|65427787|FG002|Treatment|Indeterminate TB-test|0|||
23459661|NCT04163016|65427788|FG003|Treatment|Indeterminate TB-test|1|||
23459662|NCT04163016|65427785|FG000|Treatment|Participant did not want to continue in study|0|||
23787668|NCT04277507|66600631|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
23459663|NCT04163016|65427786|FG001|Treatment|Participant did not want to continue in study|0|||
23459664|NCT04163016|65427787|FG002|Treatment|Participant did not want to continue in study|0|||
23459665|NCT04163016|65427788|FG003|Treatment|Participant did not want to continue in study|1|||
23459666|NCT04945733|65427797|FG000|Overall Study|Physician Decision|1|||
23459667|NCT04945733|65427798|FG001|Overall Study|Physician Decision|3|||
23459668|NCT04945733|65427799|FG002|Overall Study|Physician Decision|0|||
23459669|NCT04945733|65427797|FG000|Overall Study|Withdrawal by Subject|3|||
23459670|NCT04945733|65427798|FG001|Overall Study|Withdrawal by Subject|3|||
23459671|NCT04945733|65427799|FG002|Overall Study|Withdrawal by Subject|0|||
23459672|NCT03493464|65427801|FG000|Overall Study|Surgery not performed|1|||
23459673|NCT01600326|65427802|FG000|Overall Study|Lost to Follow-up|1|||
23459674|NCT01600326|65427803|FG001|Overall Study|Lost to Follow-up|1|||
23459675|NCT01001221|65427804|FG000|Overall Study|Adverse Event|1|||
23459676|NCT01001221|65427805|FG001|Overall Study|Adverse Event|2|||
23459677|NCT01001221|65427806|FG002|Overall Study|Adverse Event|0|||
23459678|NCT01001221|65427807|FG003|Overall Study|Adverse Event|2|||
23459679|NCT01001221|65427808|FG004|Overall Study|Adverse Event|0|||
23459680|NCT01001221|65427804|FG000|Overall Study|Disease progression|3|||
23459681|NCT01001221|65427805|FG001|Overall Study|Disease progression|2|||
23459682|NCT01001221|65427806|FG002|Overall Study|Disease progression|2|||
23459683|NCT01001221|65427807|FG003|Overall Study|Disease progression|4|||
23459684|NCT01001221|65427808|FG004|Overall Study|Disease progression|0|||
23459685|NCT01001221|65427804|FG000|Overall Study|Other|1|||
23459686|NCT01001221|65427805|FG001|Overall Study|Other|1|||
23459687|NCT01001221|65427806|FG002|Overall Study|Other|0|||
23459688|NCT01001221|65427807|FG003|Overall Study|Other|0|||
23459689|NCT01001221|65427808|FG004|Overall Study|Other|0|||
23459690|NCT01001221|65427804|FG000|Overall Study|Not treated; protocol exclusion|0|||
23459691|NCT01001221|65427805|FG001|Overall Study|Not treated; protocol exclusion|0|||
23459692|NCT01001221|65427806|FG002|Overall Study|Not treated; protocol exclusion|1|||
23459693|NCT01001221|65427807|FG003|Overall Study|Not treated; protocol exclusion|0|||
23459694|NCT01001221|65427808|FG004|Overall Study|Not treated; protocol exclusion|0|||
23459695|NCT02484391|65427809|FG000|Overall Study|Lack of Efficacy|15|||
23459696|NCT02484391|65427810|FG001|Overall Study|Lack of Efficacy|14|||
23459697|NCT02484391|65427811|FG002|Overall Study|Lack of Efficacy|3|||
23459698|NCT02484391|65427809|FG000|Overall Study|Lost to Follow-up|0|||
23459699|NCT02484391|65427810|FG001|Overall Study|Lost to Follow-up|0|||
23459700|NCT02484391|65427811|FG002|Overall Study|Lost to Follow-up|2|||
23459701|NCT02484391|65427809|FG000|Overall Study|Physician Decision|1|||
23459702|NCT02484391|65427810|FG001|Overall Study|Physician Decision|3|||
23459703|NCT02484391|65427811|FG002|Overall Study|Physician Decision|0|||
23459704|NCT02484391|65427809|FG000|Overall Study|Went to Transplant|5|||
23459705|NCT02484391|65427810|FG001|Overall Study|Went to Transplant|3|||
23459706|NCT02484391|65427811|FG002|Overall Study|Went to Transplant|2|||
23459707|NCT02072668|65427812|FG000|Second Intervention|Lost to Follow-up|1|||
23459708|NCT02072668|65427813|FG001|Second Intervention|Lost to Follow-up|0|||
23459709|NCT00726063|65427814|FG000|Overall Study|Adverse Event|9|||
23459710|NCT00726063|65427815|FG001|Overall Study|Adverse Event|7|||
23459711|NCT00456846|65427820|FG000|Overall Study|Adverse Event|2|||
23459712|NCT00456846|65427821|FG001|Overall Study|Adverse Event|15|||
23459713|NCT00456846|65427820|FG000|Overall Study|Physician Decision|11|||
23459714|NCT00456846|65427821|FG001|Overall Study|Physician Decision|6|||
23459715|NCT00456846|65427820|FG000|Overall Study|Protocol Deviation|2|||
23459716|NCT00456846|65427821|FG001|Overall Study|Protocol Deviation|0|||
23459717|NCT00456846|65427820|FG000|Overall Study|Participant Discretion|1|||
23459718|NCT00456846|65427821|FG001|Overall Study|Participant Discretion|5|||
23459719|NCT00456846|65427820|FG000|Overall Study|Other|0|||
23459720|NCT00456846|65427821|FG001|Overall Study|Other|2|||
23459721|NCT01283139|65427822|FG000|Overall Study|Lost to Follow-up|5|||
23459722|NCT01283139|65427823|FG001|Overall Study|Lost to Follow-up|2|||
23459723|NCT01283139|65427824|FG002|Overall Study|Lost to Follow-up|3|||
23459724|NCT01283139|65427825|FG003|Overall Study|Lost to Follow-up|1|||
23459725|NCT01283139|65427822|FG000|Overall Study|Withdrawal by Subject|8|||
23459726|NCT01283139|65427823|FG001|Overall Study|Withdrawal by Subject|8|||
23459727|NCT01283139|65427824|FG002|Overall Study|Withdrawal by Subject|6|||
23459728|NCT01283139|65427825|FG003|Overall Study|Withdrawal by Subject|8|||
23459729|NCT01283139|65427822|FG000|Overall Study|Death|2|||
23459730|NCT01283139|65427823|FG001|Overall Study|Death|0|||
23459731|NCT01283139|65427824|FG002|Overall Study|Death|2|||
23459732|NCT01283139|65427825|FG003|Overall Study|Death|2|||
23459733|NCT01283139|65427822|FG000|Overall Study|Lack of Efficacy|1|||
23459734|NCT01283139|65427823|FG001|Overall Study|Lack of Efficacy|2|||
23459735|NCT01283139|65427824|FG002|Overall Study|Lack of Efficacy|2|||
23459736|NCT01283139|65427825|FG003|Overall Study|Lack of Efficacy|1|||
23459737|NCT01283139|65427822|FG000|Overall Study|Early termination due to AE/SAE|1|||
23459738|NCT01283139|65427823|FG001|Overall Study|Early termination due to AE/SAE|1|||
23459739|NCT01283139|65427824|FG002|Overall Study|Early termination due to AE/SAE|0|||
23459740|NCT01283139|65427825|FG003|Overall Study|Early termination due to AE/SAE|0|||
23459741|NCT01283139|65427822|FG000|Overall Study|Participant's refusal to continue|0|||
23459742|NCT01283139|65427823|FG001|Overall Study|Participant's refusal to continue|3|||
23459743|NCT01283139|65427824|FG002|Overall Study|Participant's refusal to continue|1|||
23459744|NCT01283139|65427825|FG003|Overall Study|Participant's refusal to continue|1|||
23459745|NCT01283139|65427822|FG000|Overall Study|Pregnancy|0|||
23459746|NCT01283139|65427823|FG001|Overall Study|Pregnancy|1|||
23787669|NCT04277507|66600631|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
23787670|NCT04277507|66600631|FG000|Overall Study|Withdrawal by Subject|3|||
23787671|NCT04277507|66600631|FG000|Overall Study|Death due to COVID-19|1|||
23787672|NCT04277507|66600631|FG000|Overall Study|Data missing for full evaluation|5|||
23787673|NCT00243347|66603093|FG000|Overall Study|Lack of Efficacy|4|||
23787674|NCT00243347|66603093|FG000|Overall Study|Adverse Event|2|||
23787675|NCT00243347|66603093|FG000|Overall Study|Death|1|||
23787676|NCT00243347|66603093|FG000|Overall Study|Withdrawal by Subject|5|||
23459747|NCT01283139|65427824|FG002|Overall Study|Pregnancy|1|||
23459748|NCT01283139|65427825|FG003|Overall Study|Pregnancy|0|||
23459749|NCT01283139|65427822|FG000|Overall Study|Missed follow-up visit|0|||
23459750|NCT01283139|65427823|FG001|Overall Study|Missed follow-up visit|1|||
23459751|NCT01283139|65427824|FG002|Overall Study|Missed follow-up visit|2|||
23459752|NCT01283139|65427825|FG003|Overall Study|Missed follow-up visit|2|||
23459753|NCT01283139|65427822|FG000|Overall Study|Participant randomized in error|0|||
23459754|NCT01283139|65427823|FG001|Overall Study|Participant randomized in error|0|||
23459755|NCT01283139|65427824|FG002|Overall Study|Participant randomized in error|1|||
23459756|NCT01283139|65427825|FG003|Overall Study|Participant randomized in error|0|||
23787677|NCT00243347|66603093|FG000|Overall Study|Condition worsened|7|||
23787678|NCT00387153|66603094|FG000|Overall Study|Adverse Event|1|||
23787679|NCT00387153|66603094|FG000|Overall Study|Disease Progression|3|||
23787680|NCT00387153|66603094|FG000|Overall Study|Lack of Response|4|||
23787681|NCT03073798|66603095|FG000|Overall Study|Adverse Event|1|||
23787682|NCT03073798|66603095|FG000|Overall Study|Withdrawal by Subject|1|||
23459757|NCT02603146|65427829|FG000|Overall Study|Lost to Follow-up|5|||
23459758|NCT02603146|65427830|FG001|Overall Study|Lost to Follow-up|6|||
23459759|NCT02603146|65427829|FG000|Overall Study|Withdrawal by Subject|8|||
23459760|NCT02603146|65427830|FG001|Overall Study|Withdrawal by Subject|10|||
23459761|NCT02603146|65427829|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
23459762|NCT02603146|65427830|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
23459763|NCT02603146|65427829|FG000|Overall Study|Participant moved|2|||
23459764|NCT02603146|65427830|FG001|Overall Study|Participant moved|0|||
23459765|NCT02603146|65427829|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
23459766|NCT02603146|65427830|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
23459767|NCT02374450|65427839|FG000|Overall Study|Protocol Violation|0|||
23459768|NCT02374450|65427840|FG001|Overall Study|Protocol Violation|1|||
23459769|NCT02374450|65427841|FG002|Overall Study|Protocol Violation|0|||
23459770|NCT02374450|65427839|FG000|Overall Study|Withdrawal by Subject|91|||
23459771|NCT02374450|65427840|FG001|Overall Study|Withdrawal by Subject|110|||
23459772|NCT02374450|65427841|FG002|Overall Study|Withdrawal by Subject|4|||
23459773|NCT02374450|65427839|FG000|Overall Study|Lost to Follow-up|168|||
23459774|NCT02374450|65427840|FG001|Overall Study|Lost to Follow-up|194|||
23459775|NCT02374450|65427841|FG002|Overall Study|Lost to Follow-up|138|||
23459776|NCT02374450|65427839|FG000|Overall Study|Death|173|||
23459777|NCT02374450|65427840|FG001|Overall Study|Death|185|||
23459778|NCT02374450|65427841|FG002|Overall Study|Death|81|||
23459779|NCT02374450|65427839|FG000|Overall Study|Migrated from the study area|538|||
23459780|NCT02374450|65427840|FG001|Overall Study|Migrated from the study area|648|||
23459781|NCT02374450|65427841|FG002|Overall Study|Migrated from the study area|181|||
23459782|NCT02374450|65427839|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
23459783|NCT02374450|65427840|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
23459784|NCT02374450|65427841|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
23459785|NCT02374450|65427839|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
23459786|NCT02374450|65427840|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
23459787|NCT02374450|65427841|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
23459788|NCT02374450|65427839|FG000|Overall Study|Other|0|||
23459789|NCT02374450|65427840|FG001|Overall Study|Other|21|||
23459790|NCT02374450|65427841|FG002|Overall Study|Other|79|||
23459791|NCT00536744|65427842|FG000|Overall Study|Adverse Event|13|||
23459792|NCT00536744|65427843|FG001|Overall Study|Adverse Event|10|||
23459793|NCT00536744|65427842|FG000|Overall Study|Death|2|||
23459794|NCT00536744|65427843|FG001|Overall Study|Death|1|||
23459795|NCT00536744|65427842|FG000|Overall Study|Physician Decision|3|||
23459796|NCT00536744|65427843|FG001|Overall Study|Physician Decision|1|||
23459797|NCT00536744|65427842|FG000|Overall Study|Lost to Follow-up|3|||
23459798|NCT00536744|65427843|FG001|Overall Study|Lost to Follow-up|5|||
23459799|NCT00536744|65427842|FG000|Overall Study|Withdrawal by Subject|7|||
23459800|NCT00536744|65427843|FG001|Overall Study|Withdrawal by Subject|8|||
23459801|NCT00536744|65427842|FG000|Overall Study|PI tried alternative treatment|1|||
23459802|NCT00536744|65427843|FG001|Overall Study|PI tried alternative treatment|3|||
23459803|NCT03414983|65427844|FG000|Pre-Treatment|Other reasons|1|||
23459804|NCT03414983|65427845|FG001|Pre-Treatment|Other reasons|0|||
23459805|NCT03414983|65427844|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23459806|NCT03414983|65427845|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
23459807|NCT03414983|65427844|FG000|Pre-Treatment|Participant withdrew consent|1|||
23459808|NCT03414983|65427845|FG001|Pre-Treatment|Participant withdrew consent|3|||
23459809|NCT03414983|65427844|FG000|Treatment|Participant withdrew consent|4|||
23459810|NCT03414983|65427845|FG001|Treatment|Participant withdrew consent|3|||
23459811|NCT03414983|65427844|FG000|Treatment|Participant request to discontinue study treatment|8|||
23459812|NCT03414983|65427845|FG001|Treatment|Participant request to discontinue study treatment|10|||
23459813|NCT03414983|65427844|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
23459814|NCT03414983|65427845|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
23459815|NCT03414983|65427844|FG000|Treatment|Death|0|||
23459816|NCT03414983|65427845|FG001|Treatment|Death|1|||
23459817|NCT03414983|65427844|FG000|Treatment|Study Drug Toxicity|10|||
23459818|NCT03414983|65427845|FG001|Treatment|Study Drug Toxicity|5|||
23459819|NCT03414983|65427844|FG000|Treatment|Disease Progression|75|||
23459820|NCT03414983|65427845|FG001|Treatment|Disease Progression|29|||
23459821|NCT03414983|65427844|FG000|Treatment|Not reported|1|||
23459822|NCT03414983|65427845|FG001|Treatment|Not reported|0|||
23459823|NCT03414983|65427844|FG000|Treatment|Other reasons|3|||
23459824|NCT03414983|65427845|FG001|Treatment|Other reasons|2|||
23459825|NCT03414983|65427844|FG000|Treatment|Poor/non-compliance|2|||
23459826|NCT03414983|65427845|FG001|Treatment|Poor/non-compliance|0|||
23459827|NCT03414983|65427844|FG000|Treatment|Maximum clinical benefit|5|||
23459828|NCT03414983|65427845|FG001|Treatment|Maximum clinical benefit|9|||
23459829|NCT03414983|65427844|FG000|Treatment|Lost to Follow-up|0|||
23459830|NCT03414983|65427845|FG001|Treatment|Lost to Follow-up|1|||
23459831|NCT03414983|65427844|FG000|Treatment|Administrative reasons by sponsor|1|||
23459832|NCT03414983|65427845|FG001|Treatment|Administrative reasons by sponsor|0|||
23459833|NCT00089297|65427849|FG000|Overall Study|Adverse Event|9|||
23459834|NCT00089297|65427849|FG000|Overall Study|Death|1|||
23459835|NCT00089297|65427849|FG000|Overall Study|Withdrawal by Subject|12|||
23459836|NCT00089297|65427849|FG000|Overall Study|Disease progression|2|||
23459837|NCT00089297|65427849|FG000|Overall Study|Ineligible|11|||
23459838|NCT00089297|65427849|FG000|Overall Study|Secondary malignancy|1|||
23459839|NCT00089297|65427849|FG000|Overall Study|IRB approval not ready|1|||
23459840|NCT00089297|65427849|FG000|Overall Study|Non-compliance|1|||
23459841|NCT02681523|65427853|FG000|Overall Study|Adverse Event|1|||
23459842|NCT02681523|65427853|FG000|Overall Study|Patient Non-compliance|1|||
23459843|NCT02864394|65427854|FG000|Overall Study|Death|184|||
23459844|NCT02864394|65427855|FG001|Overall Study|Death|189|||
23459845|NCT02864394|65427854|FG000|Overall Study|Lost to Follow-up|0|||
23459846|NCT02864394|65427855|FG001|Overall Study|Lost to Follow-up|2|||
23459847|NCT02864394|65427854|FG000|Overall Study|Sponsor Decision|26|||
23459848|NCT02864394|65427855|FG001|Overall Study|Sponsor Decision|11|||
23459849|NCT02864394|65427854|FG000|Overall Study|Withdrawal by Subject|3|||
23459850|NCT02864394|65427855|FG001|Overall Study|Withdrawal by Subject|10|||
23459851|NCT00926237|65427856|FG000|Overall Study|Withdrawal by Subject|2|||
23787683|NCT02385708|66603109|FG000|Overall Study|Withdrawal by Subject|0|||
23787684|NCT02385708|66603110|FG001|Overall Study|Withdrawal by Subject|2|||
23459852|NCT00926237|65427857|FG001|Overall Study|Withdrawal by Subject|1|||
23459853|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459854|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459855|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
23459856|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
23459857|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459858|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459859|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
23459860|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459861|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459862|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23459863|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23459864|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
23459865|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459866|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459867|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23584126|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
23787685|NCT02385708|66603109|FG000|Overall Study|Withdrawn - surgery canceled|2|||
23787686|NCT02385708|66603110|FG001|Overall Study|Withdrawn - surgery canceled|5|||
23787687|NCT02385708|66603109|FG000|Overall Study|Investigator decision|5|||
23787688|NCT02385708|66603110|FG001|Overall Study|Investigator decision|7|||
23787689|NCT02385708|66603109|FG000|Overall Study|Protocol Violation|1|||
23787690|NCT02385708|66603110|FG001|Overall Study|Protocol Violation|1|||
23787691|NCT04583423|66603111|FG000|Overall Study|Lost to Follow-up|0|||
23787692|NCT04583423|66603112|FG001|Overall Study|Lost to Follow-up|1|||
23787693|NCT04583423|66603113|FG002|Overall Study|Lost to Follow-up|0|||
23787694|NCT04583423|66603114|FG003|Overall Study|Lost to Follow-up|2|||
23787695|NCT04583423|66603111|FG000|Overall Study|Study Terminated by Sponsor|32|||
23787696|NCT04583423|66603112|FG001|Overall Study|Study Terminated by Sponsor|35|||
23787697|NCT04583423|66603113|FG002|Overall Study|Study Terminated by Sponsor|36|||
23787698|NCT04583423|66603114|FG003|Overall Study|Study Terminated by Sponsor|33|||
23787699|NCT04583423|66603111|FG000|Overall Study|Withdrawal by Subject|3|||
23787700|NCT04583423|66603112|FG001|Overall Study|Withdrawal by Subject|1|||
23787701|NCT04583423|66603113|FG002|Overall Study|Withdrawal by Subject|2|||
23787702|NCT04583423|66603114|FG003|Overall Study|Withdrawal by Subject|1|||
23787703|NCT02005276|66603115|FG000|Overall Study|No longer interested|5|||
23787704|NCT02005276|66603116|FG001|Overall Study|No longer interested|2|||
23787705|NCT02005276|66603117|FG002|Overall Study|No longer interested|3|||
23787706|NCT02005276|66603118|FG003|Overall Study|No longer interested|3|||
23787707|NCT01968551|66603120|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
23787708|NCT01968551|66603121|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
23787709|NCT01968551|66603122|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
23787710|NCT01968551|66603120|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
23459868|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23459869|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
23584127|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
23787711|NCT01968551|66603121|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
23787712|NCT01968551|66603122|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
23787713|NCT01968551|66603120|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
23459870|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
23459871|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23459872|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23459873|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23459874|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
23459875|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
23459876|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
23459877|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
23459878|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459879|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459880|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459881|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459882|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459883|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23459884|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459885|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23459886|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459887|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459888|NCT03175367|65427859|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459889|NCT03175367|65427860|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459890|NCT03175367|65427861|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459891|NCT03175367|65427862|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459892|NCT03175367|65427863|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459893|NCT03175367|65427864|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459894|NCT03175367|65427865|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
23459895|NCT03175367|65427859|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459896|NCT03175367|65427860|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459897|NCT03175367|65427861|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459898|NCT03175367|65427862|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459899|NCT03175367|65427863|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459900|NCT03175367|65427864|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
23459901|NCT03175367|65427865|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23459902|NCT02488915|65427866|FG000|Overall Study|Death|21|||
23638717|NCT03139604|66060983|FG000|Overall Study|Lost to Follow-up|3|||
23638718|NCT03139604|66060984|FG001|Overall Study|Lost to Follow-up|1|||
23638719|NCT03139604|66060983|FG000|Overall Study|Death|65|||
23638720|NCT03139604|66060984|FG001|Overall Study|Death|67|||
23638721|NCT03139604|66060983|FG000|Overall Study|Study Terminated by Sponsor|122|||
23638722|NCT03139604|66060984|FG001|Overall Study|Study Terminated by Sponsor|127|||
23638723|NCT03139604|66060983|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
23638724|NCT03139604|66060984|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
23638725|NCT01280357|66060985|FG000|Overall Study|Excluded no internal monitoring|14|||
23638726|NCT01280357|66060985|FG000|Overall Study|IInsufficient data/No data supplied|12|||
23787714|NCT01968551|66603121|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
23787715|NCT01968551|66603122|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
23787716|NCT01968551|66603120|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
23787717|NCT01968551|66603121|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
23638727|NCT05327816|66060988|FG000|Overall Study|Lost to Follow-up|1|||
23638728|NCT05327816|66060989|FG001|Overall Study|Lost to Follow-up|0|||
23638729|NCT05327816|66060990|FG002|Overall Study|Lost to Follow-up|0|||
23638730|NCT05327816|66060991|FG003|Overall Study|Lost to Follow-up|0|||
23638731|NCT05327816|66060992|FG004|Overall Study|Lost to Follow-up|0|||
23638732|NCT05327816|66060993|FG005|Overall Study|Lost to Follow-up|0|||
23638733|NCT05327816|66060994|FG006|Overall Study|Lost to Follow-up|0|||
23787718|NCT01968551|66603122|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
23787719|NCT01968551|66603120|FG000|Extension Phase|Adverse Event|0|||
23787720|NCT01968551|66603121|FG001|Extension Phase|Adverse Event|0|||
23787721|NCT01968551|66603122|FG002|Extension Phase|Adverse Event|2|||
23787722|NCT01968551|66603120|FG000|Extension Phase|Death|0|||
23787723|NCT01968551|66603121|FG001|Extension Phase|Death|1|||
23787724|NCT01968551|66603122|FG002|Extension Phase|Death|0|||
23787725|NCT01968551|66603120|FG000|Extension Phase|Withdrew Consent|0|||
23787726|NCT01968551|66603121|FG001|Extension Phase|Withdrew Consent|0|||
23459903|NCT02488915|65427866|FG000|Overall Study|Lost to Follow-up|4|||
23459904|NCT02488915|65427866|FG000|Overall Study|Withdrawal by Subject|1|||
23459905|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
23638734|NCT05327816|66060995|FG007|Overall Study|Lost to Follow-up|0|||
23638735|NCT05327816|66060996|FG008|Overall Study|Lost to Follow-up|0|||
23787727|NCT01968551|66603122|FG002|Extension Phase|Withdrew Consent|1|||
23787728|NCT01968551|66603120|FG000|Extension Phase|Lost to Follow-up|1|||
23787729|NCT01968551|66603121|FG001|Extension Phase|Lost to Follow-up|0|||
23787730|NCT01968551|66603122|FG002|Extension Phase|Lost to Follow-up|1|||
23787731|NCT00608322|66603123|FG000|Overall Study|Death|2|||
23787732|NCT00608322|66603124|FG001|Overall Study|Death|1|||
23787733|NCT04577651|66603125|FG000|Overall Study|Screen Failure|7|||
23787734|NCT04577651|66603125|FG000|Overall Study|Adverse Event|1|||
23787735|NCT04577651|66603125|FG000|Overall Study|Death|1|||
23787736|NCT04577651|66603125|FG000|Overall Study|Physician Decision|1|||
23787737|NCT04577651|66603125|FG000|Overall Study|Withdrawal by Subject|3|||
23787738|NCT01808651|66603129|FG000|Study Period 1|Lost to Follow-up|1|||
23787739|NCT01808651|66603130|FG001|Study Period 1|Lost to Follow-up|3|||
23787740|NCT01808651|66603131|FG002|Study Period 1|Lost to Follow-up|0|||
23787741|NCT01808651|66603129|FG000|Study Period 1|Protocol Violation|1|||
23787742|NCT01808651|66603130|FG001|Study Period 1|Protocol Violation|0|||
23787743|NCT01808651|66603131|FG002|Study Period 1|Protocol Violation|1|||
23787744|NCT01808651|66603129|FG000|Study Period 1|Physician Decision|3|||
23787745|NCT01808651|66603130|FG001|Study Period 1|Physician Decision|2|||
23787746|NCT01808651|66603131|FG002|Study Period 1|Physician Decision|0|||
23787747|NCT01808651|66603129|FG000|Study Period 1|Lack of Efficacy|2|||
23787748|NCT01808651|66603130|FG001|Study Period 1|Lack of Efficacy|1|||
23787749|NCT01808651|66603131|FG002|Study Period 1|Lack of Efficacy|0|||
23787750|NCT01808651|66603129|FG000|Study Period 1|Adverse Event|10|||
23459906|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
23459907|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
23459908|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
23787751|NCT01808651|66603130|FG001|Study Period 1|Adverse Event|4|||
23787752|NCT01808651|66603131|FG002|Study Period 1|Adverse Event|1|||
23787753|NCT01808651|66603129|FG000|Study Period 1|Participant Decision|9|||
23787754|NCT01808651|66603130|FG001|Study Period 1|Participant Decision|7|||
23787755|NCT01808651|66603131|FG002|Study Period 1|Participant Decision|3|||
23787756|NCT03599362|66603132|FG000|Overall Study|Screen Failure|3|||
23787757|NCT01302548|66603133|FG000|Overall Study|Lost to Follow-up|2|||
23787758|NCT01302548|66603134|FG001|Overall Study|Lost to Follow-up|1|||
23787759|NCT01751087|66603135|FG000|Overall Study|Withdrawal by Subject|1|||
23787760|NCT01751087|66603136|FG001|Overall Study|Withdrawal by Subject|0|||
23787761|NCT01751087|66603137|FG002|Overall Study|Withdrawal by Subject|0|||
23787762|NCT01751087|66603135|FG000|Overall Study|Physician Decision|0|||
23787763|NCT01751087|66603136|FG001|Overall Study|Physician Decision|0|||
23787764|NCT01751087|66603137|FG002|Overall Study|Physician Decision|1|||
23787765|NCT03602339|66603138|FG000|Overall Study|Withdrawal by Subject|9|||
23787766|NCT03602339|66603138|FG000|Overall Study|Physician Decision|2|||
23787767|NCT03602339|66603138|FG000|Overall Study|Other reason|4|||
23787768|NCT00070291|66603139|FG000|Step 1|Withdrawal by Subject|1|||
23787769|NCT00070291|66603139|FG000|Step 1|Adverse Event|1|||
23787770|NCT00070291|66603139|FG000|Step 2|Adverse Event|1|||
23787771|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Refused|1|||
23787772|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Refused|3|||
23787773|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Medical|0|||
23787774|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Medical|1|||
23787775|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
23787776|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
23787777|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
23787778|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
23787779|NCT02054715|66603140|FG000|Baseline/Follow-up 1|No Reason|0|||
23787780|NCT02054715|66603141|FG001|Baseline/Follow-up 1|No Reason|1|||
23787781|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
23787782|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
23787783|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Ineligible|3|||
23787784|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Ineligible|0|||
23638736|NCT05327816|66060997|FG009|Overall Study|Lost to Follow-up|1|||
23638737|NCT05327816|66060998|FG010|Overall Study|Lost to Follow-up|0|||
23638738|NCT05327816|66060988|FG000|Overall Study|Withdrawal by Subject|0|||
23638739|NCT05327816|66060989|FG001|Overall Study|Withdrawal by Subject|0|||
23787785|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Hospitalization|1|||
23638740|NCT05327816|66060990|FG002|Overall Study|Withdrawal by Subject|0|||
23638741|NCT05327816|66060991|FG003|Overall Study|Withdrawal by Subject|0|||
23787786|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Hospitalization|0|||
23787787|NCT02054715|66603140|FG000|Baseline/Follow-up 1|Changed Mind|1|||
23459909|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
23638742|NCT05327816|66060992|FG004|Overall Study|Withdrawal by Subject|1|||
23787788|NCT02054715|66603141|FG001|Baseline/Follow-up 1|Changed Mind|0|||
23787789|NCT02054715|66603140|FG000|Follow-up 2|Lost to Followup|3|||
23787790|NCT02054715|66603141|FG001|Follow-up 2|Lost to Followup|1|||
23347953|NCT03026530|65017942|FG000|Overall Study|Lost to Follow-up|19|||
23787791|NCT02054715|66603140|FG000|Follow-up 2|Refused|3|||
23787792|NCT02054715|66603141|FG001|Follow-up 2|Refused|2|||
23787793|NCT02054715|66603140|FG000|Follow-up 2|Followup Not Completed|3|||
23787794|NCT02054715|66603141|FG001|Follow-up 2|Followup Not Completed|4|||
23787795|NCT02054715|66603140|FG000|Follow-up 2|Ineligible|4|||
23638743|NCT05327816|66060993|FG005|Overall Study|Withdrawal by Subject|1|||
23638744|NCT05327816|66060994|FG006|Overall Study|Withdrawal by Subject|0|||
23584128|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
23787796|NCT02054715|66603141|FG001|Follow-up 2|Ineligible|5|||
23787797|NCT02054715|66603140|FG000|Follow-up 2|Death|3|||
23787798|NCT02054715|66603141|FG001|Follow-up 2|Death|3|||
23787799|NCT02054715|66603140|FG000|Follow-up 2|Hospitalization|0|||
23787800|NCT02054715|66603141|FG001|Follow-up 2|Hospitalization|2|||
23787801|NCT02054715|66603140|FG000|Follow-up 2|Changed MD/Facility|0|||
23787802|NCT02054715|66603141|FG001|Follow-up 2|Changed MD/Facility|1|||
23787803|NCT02054715|66603140|FG000|Follow-up 2|Changed Mind|0|||
23787804|NCT02054715|66603141|FG001|Follow-up 2|Changed Mind|1|||
23787805|NCT02054715|66603140|FG000|Follow-up 2|No Reason|2|||
23787806|NCT02054715|66603141|FG001|Follow-up 2|No Reason|0|||
23787807|NCT02054715|66603140|FG000|Follow-up 2|Treatment Change or Delay|1|||
23787808|NCT02054715|66603141|FG001|Follow-up 2|Treatment Change or Delay|0|||
23787809|NCT01597791|66603142|FG000|Overall Study|Physician Decision|2|||
23787810|NCT01597791|66603143|FG001|Overall Study|Physician Decision|1|||
23787811|NCT01597791|66603142|FG000|Overall Study|Cesarean Section|6|||
23787812|NCT01597791|66603143|FG001|Overall Study|Cesarean Section|7|||
23787813|NCT01597791|66603142|FG000|Overall Study|Subject withdrawal|0|||
23347954|NCT03026530|65017943|FG001|Overall Study|Lost to Follow-up|24|||
23347955|NCT03026530|65017942|FG000|Overall Study|Protocol Violation|2|||
23347956|NCT03026530|65017943|FG001|Overall Study|Protocol Violation|5|||
23347957|NCT02670382|65017944|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
23584129|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
23584130|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
23584131|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
23584132|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
23584133|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
23584134|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
23584135|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
23584136|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Pain|0|||
23584137|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Pain|0|||
23638745|NCT05327816|66060995|FG007|Overall Study|Withdrawal by Subject|0|||
23638746|NCT05327816|66060996|FG008|Overall Study|Withdrawal by Subject|0|||
23638747|NCT05327816|66060997|FG009|Overall Study|Withdrawal by Subject|0|||
23787814|NCT01597791|66603143|FG001|Overall Study|Subject withdrawal|1|||
23787815|NCT01597791|66603142|FG000|Overall Study|Protocol Violation|0|||
23787816|NCT01597791|66603143|FG001|Overall Study|Protocol Violation|1|||
23787817|NCT02452463|66603154|FG000|Overall Study|Death|1|||
23787818|NCT02452463|66603155|FG001|Overall Study|Death|0|||
23787819|NCT02452463|66603156|FG002|Overall Study|Death|0|||
23787820|NCT02452463|66603154|FG000|Overall Study|Study Suspended|1|||
23347958|NCT02670382|65017945|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
23347959|NCT01876979|65017946|FG000|Overall Study|Physician Decision|2|||
23347960|NCT01876979|65017947|FG001|Overall Study|Physician Decision|3|||
23347961|NCT00894790|65017949|FG000|Overall Study|Protocol Violation|0|||
23347962|NCT00894790|65017950|FG001|Overall Study|Protocol Violation|1|||
23347963|NCT00894790|65017949|FG000|Overall Study|Lost to Follow-up|0|||
23347964|NCT00894790|65017950|FG001|Overall Study|Lost to Follow-up|1|||
23347965|NCT00894790|65017949|FG000|Overall Study|Did not meet entrance criteria|1|||
23347966|NCT00894790|65017950|FG001|Overall Study|Did not meet entrance criteria|0|||
23347967|NCT01741792|65017951|FG000|Overall Study|Death|6|||
23347968|NCT01741792|65017952|FG001|Overall Study|Death|1|||
23347969|NCT01741792|65017953|FG002|Overall Study|Death|12|||
23347970|NCT01959698|65017954|FG000|Overall Study|Adverse Event|0|||
23347971|NCT01959698|65017955|FG001|Overall Study|Adverse Event|0|||
23584138|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Pain|0|||
23584139|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Pain|1|||
23638748|NCT05327816|66060998|FG010|Overall Study|Withdrawal by Subject|0|||
23787821|NCT02452463|66603155|FG001|Overall Study|Study Suspended|0|||
23787822|NCT02452463|66603156|FG002|Overall Study|Study Suspended|0|||
23787823|NCT02452463|66603154|FG000|Overall Study|Recommended by DSMB|0|||
23787824|NCT02452463|66603155|FG001|Overall Study|Recommended by DSMB|1|||
23787825|NCT02452463|66603156|FG002|Overall Study|Recommended by DSMB|0|||
23787826|NCT02452463|66603154|FG000|Overall Study|Withdrawal by Subject|0|||
23787827|NCT02452463|66603155|FG001|Overall Study|Withdrawal by Subject|1|||
23787828|NCT02452463|66603156|FG002|Overall Study|Withdrawal by Subject|0|||
23347972|NCT01959698|65017956|FG002|Overall Study|Adverse Event|0|||
23347973|NCT01959698|65017957|FG003|Overall Study|Adverse Event|0|||
23584140|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
23584141|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
23787829|NCT01874535|66603159|FG000|Overall Study|Lost to Follow-up|10|||
23787830|NCT01874535|66603160|FG001|Overall Study|Lost to Follow-up|9|||
23347974|NCT01959698|65017958|FG004|Overall Study|Adverse Event|0|||
23347975|NCT01959698|65017959|FG005|Overall Study|Adverse Event|0|||
23787831|NCT01874535|66603159|FG000|Overall Study|incomplete symptom resolution|45|||
23347976|NCT01959698|65017960|FG006|Overall Study|Adverse Event|1|||
23347977|NCT01959698|65017954|FG000|Overall Study|Physician Decision|1|||
23347978|NCT01959698|65017955|FG001|Overall Study|Physician Decision|0|||
23347979|NCT01959698|65017956|FG002|Overall Study|Physician Decision|1|||
23347980|NCT01959698|65017957|FG003|Overall Study|Physician Decision|2|||
23347981|NCT01959698|65017958|FG004|Overall Study|Physician Decision|0|||
23347982|NCT01959698|65017959|FG005|Overall Study|Physician Decision|3|||
23347983|NCT01959698|65017960|FG006|Overall Study|Physician Decision|3|||
23347984|NCT02240069|65017967|FG000|Overall Study|Withdrawal by Subject|5|||
23347985|NCT02240069|65017968|FG001|Overall Study|Withdrawal by Subject|5|||
23347986|NCT02240069|65017969|FG002|Overall Study|Withdrawal by Subject|2|||
23347987|NCT02179749|65017970|FG000|Overall Study|Adverse Event|0|||
23347988|NCT02179749|65017971|FG001|Overall Study|Adverse Event|0|||
23347989|NCT02179749|65017972|FG002|Overall Study|Adverse Event|1|||
23347990|NCT02179749|65017970|FG000|Overall Study|Withdrawal by Subject|0|||
23347991|NCT02179749|65017971|FG001|Overall Study|Withdrawal by Subject|0|||
23347992|NCT02179749|65017972|FG002|Overall Study|Withdrawal by Subject|1|||
23347993|NCT00628095|65017975|FG000|Overall Study|Adverse Event|5|||
23347994|NCT00628095|65017976|FG001|Overall Study|Adverse Event|3|||
23347995|NCT00628095|65017975|FG000|Overall Study|Lack of Efficacy|0|||
23347996|NCT00628095|65017976|FG001|Overall Study|Lack of Efficacy|3|||
23347997|NCT00628095|65017975|FG000|Overall Study|Withdrawal by Subject|2|||
23638749|NCT05327816|66060988|FG000|Overall Study|Study Terminated by Sponsor|11|||
23638750|NCT05327816|66060989|FG001|Overall Study|Study Terminated by Sponsor|12|||
23638751|NCT05327816|66060990|FG002|Overall Study|Study Terminated by Sponsor|12|||
23638752|NCT05327816|66060991|FG003|Overall Study|Study Terminated by Sponsor|12|||
23638753|NCT05327816|66060992|FG004|Overall Study|Study Terminated by Sponsor|11|||
23638754|NCT05327816|66060993|FG005|Overall Study|Study Terminated by Sponsor|11|||
23638755|NCT05327816|66060994|FG006|Overall Study|Study Terminated by Sponsor|11|||
23638756|NCT05327816|66060995|FG007|Overall Study|Study Terminated by Sponsor|11|||
23638757|NCT05327816|66060996|FG008|Overall Study|Study Terminated by Sponsor|11|||
23638758|NCT05327816|66060997|FG009|Overall Study|Study Terminated by Sponsor|11|||
23787832|NCT01874535|66603160|FG001|Overall Study|incomplete symptom resolution|35|||
23347998|NCT00628095|65017976|FG001|Overall Study|Withdrawal by Subject|0|||
23638759|NCT05327816|66060998|FG010|Overall Study|Study Terminated by Sponsor|12|||
23638760|NCT05327816|66060988|FG000|Overall Study|Randomized but not treated|0|||
23638761|NCT05327816|66060989|FG001|Overall Study|Randomized but not treated|0|||
23787833|NCT01149057|66603161|FG000|Overall Study|Lack of Efficacy|16|||
23787834|NCT01149057|66603161|FG000|Overall Study|Adverse Event|13|||
23347999|NCT00628095|65017975|FG000|Overall Study|Other|0|||
23348000|NCT00628095|65017976|FG001|Overall Study|Other|1|||
23348001|NCT00329641|65017977|FG000|Overall Study|Did not start treatment|1|||
23638762|NCT05327816|66060990|FG002|Overall Study|Randomized but not treated|0|||
23638763|NCT05327816|66060991|FG003|Overall Study|Randomized but not treated|0|||
23638764|NCT05327816|66060992|FG004|Overall Study|Randomized but not treated|0|||
23638765|NCT05327816|66060993|FG005|Overall Study|Randomized but not treated|0|||
23638766|NCT05327816|66060994|FG006|Overall Study|Randomized but not treated|1|||
23638767|NCT05327816|66060995|FG007|Overall Study|Randomized but not treated|1|||
23638768|NCT05327816|66060996|FG008|Overall Study|Randomized but not treated|1|||
23638769|NCT05327816|66060997|FG009|Overall Study|Randomized but not treated|0|||
23638770|NCT05327816|66060998|FG010|Overall Study|Randomized but not treated|0|||
23638771|NCT01202903|66060999|FG000|Overall Study|Administrative Probelms|1|||
23638772|NCT01202903|66061000|FG001|Overall Study|Administrative Probelms|4|||
23638773|NCT01202903|66060999|FG000|Overall Study|Protocol Violation|0|||
23638774|NCT01202903|66061000|FG001|Overall Study|Protocol Violation|1|||
23638775|NCT01202903|66060999|FG000|Overall Study|Death|1|||
23638776|NCT01202903|66061000|FG001|Overall Study|Death|0|||
23638777|NCT01202903|66060999|FG000|Overall Study|Lost to Follow-up|1|||
23638778|NCT01202903|66061000|FG001|Overall Study|Lost to Follow-up|1|||
23638779|NCT01202903|66060999|FG000|Overall Study|Lack of Efficacy|1|||
23638780|NCT01202903|66061000|FG001|Overall Study|Lack of Efficacy|3|||
23638781|NCT01202903|66060999|FG000|Overall Study|Adverse Event|3|||
23638782|NCT01202903|66061000|FG001|Overall Study|Adverse Event|3|||
23638783|NCT01202903|66060999|FG000|Overall Study|Withdrawal by Subject|4|||
23638784|NCT01202903|66061000|FG001|Overall Study|Withdrawal by Subject|4|||
23638785|NCT01531673|66061001|FG000|Overall Study|Non-Compliance|0|||
23348002|NCT00329641|65017977|FG000|Overall Study|Not eligible|1|||
23348003|NCT00329641|65017977|FG000|Overall Study|Adverse Event|3|||
23348004|NCT00329641|65017977|FG000|Overall Study|Other reason, not protocol specified|1|||
23638786|NCT01531673|66061002|FG001|Overall Study|Non-Compliance|0|||
23638787|NCT01531673|66061003|FG002|Overall Study|Non-Compliance|0|||
23638788|NCT01531673|66061004|FG003|Overall Study|Non-Compliance|0|||
23638789|NCT01531673|66061005|FG004|Overall Study|Non-Compliance|0|||
23787835|NCT01149057|66603161|FG000|Overall Study|Withdrawal by Subject|9|||
23348005|NCT02258542|65017980|FG000|Overall Study|eg. not made to the visit|7|||
23348006|NCT02258542|65017981|FG001|Overall Study|eg. not made to the visit|4|||
23638790|NCT01531673|66061006|FG005|Overall Study|Non-Compliance|1|||
23638791|NCT01531673|66061007|FG006|Overall Study|Non-Compliance|0|||
23348007|NCT02258542|65017982|FG002|Overall Study|eg. not made to the visit|0|||
23348008|NCT02258542|65017983|FG003|Overall Study|eg. not made to the visit|1|||
23348009|NCT02258542|65017980|FG000|Overall Study|study specific discount. criteria|1|||
23348010|NCT02258542|65017981|FG001|Overall Study|study specific discount. criteria|1|||
23348011|NCT02258542|65017982|FG002|Overall Study|study specific discount. criteria|0|||
23348012|NCT02258542|65017983|FG003|Overall Study|study specific discount. criteria|0|||
23348013|NCT02258542|65017980|FG000|Overall Study|Withdrawal by Subject|20|||
23348014|NCT02258542|65017981|FG001|Overall Study|Withdrawal by Subject|20|||
23348015|NCT02258542|65017982|FG002|Overall Study|Withdrawal by Subject|7|||
23348016|NCT02258542|65017983|FG003|Overall Study|Withdrawal by Subject|1|||
23348017|NCT02258542|65017980|FG000|Overall Study|Lost to Follow-up|5|||
23348018|NCT02258542|65017981|FG001|Overall Study|Lost to Follow-up|12|||
23348019|NCT02258542|65017982|FG002|Overall Study|Lost to Follow-up|1|||
23348020|NCT02258542|65017983|FG003|Overall Study|Lost to Follow-up|2|||
23348021|NCT02258542|65017980|FG000|Overall Study|Death|5|||
23348022|NCT02258542|65017981|FG001|Overall Study|Death|4|||
23348023|NCT02258542|65017982|FG002|Overall Study|Death|0|||
23348024|NCT02258542|65017983|FG003|Overall Study|Death|1|||
23348025|NCT02258542|65017980|FG000|Overall Study|Adverse Event|3|||
23348026|NCT02258542|65017981|FG001|Overall Study|Adverse Event|4|||
23348027|NCT02258542|65017982|FG002|Overall Study|Adverse Event|0|||
23348028|NCT02258542|65017983|FG003|Overall Study|Adverse Event|0|||
23348029|NCT02258542|65017980|FG000|Overall Study|Protocol Violation|1|||
23348030|NCT02258542|65017981|FG001|Overall Study|Protocol Violation|2|||
23348031|NCT02258542|65017982|FG002|Overall Study|Protocol Violation|0|||
23348032|NCT02258542|65017983|FG003|Overall Study|Protocol Violation|0|||
23348033|NCT02258542|65017980|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23348034|NCT02258542|65017981|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23348035|NCT02258542|65017982|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23348036|NCT02258542|65017983|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
23348037|NCT02258334|65017986|FG000|Overall Study|Adverse Event|1|||
23348038|NCT02258334|65017987|FG001|Overall Study|Adverse Event|0|||
23348039|NCT02258334|65017988|FG002|Overall Study|Adverse Event|0|||
23787836|NCT01149057|66603161|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
23787837|NCT01149057|66603161|FG000|Overall Study|B Cell Depletion|4|||
23787838|NCT01149057|66603161|FG000|Overall Study|Participant Non-Compliance|2|||
23787839|NCT01149057|66603161|FG000|Overall Study|Lost to Follow-up|1|||
23787840|NCT01149057|66603161|FG000|Overall Study|High Parathyroid Hormone Value|1|||
23787841|NCT01149057|66603161|FG000|Overall Study|Other|6|||
23787842|NCT00828321|66603162|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
23787843|NCT00828321|66603163|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
23787844|NCT00828321|66603162|FG000|Second Intervention|Protocol Violation|0|||
23787845|NCT00828321|66603163|FG001|Second Intervention|Protocol Violation|1|||
23787846|NCT01083693|66603166|FG000|Overall Study|Adverse Event|1|||
23787847|NCT01083693|66603167|FG001|Overall Study|Adverse Event|1|||
23348040|NCT02258334|65017989|FG003|Overall Study|Adverse Event|0|||
23348041|NCT00785213|65017993|FG000|Quinine Sulfate Alone|Adverse Event|4|||
23348042|NCT00785213|65017993|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
23348043|NCT02918552|65017994|FG000|Overall Study|Failed Pharmacokinetics|1|||
23348044|NCT02918552|65017995|FG001|Overall Study|Failed Pharmacokinetics|0|||
23348045|NCT02918552|65017994|FG000|Overall Study|Withdrawal by Subject|0|||
23348046|NCT02918552|65017995|FG001|Overall Study|Withdrawal by Subject|1|||
23348047|NCT02918552|65017994|FG000|Overall Study|Lost to Follow-up|0|||
23638792|NCT01531673|66061008|FG007|Overall Study|Non-Compliance|0|||
23787848|NCT01083693|66603168|FG002|Overall Study|Adverse Event|0|||
23348048|NCT02918552|65017995|FG001|Overall Study|Lost to Follow-up|1|||
23348049|NCT02223819|65017996|FG000|Overall Study|Lost to Follow-up|2|||
23348050|NCT02515994|65017997|FG000|Overall Study|Protocol Violation|3|||
23348051|NCT02515994|65017998|FG001|Overall Study|Protocol Violation|5|||
23348052|NCT02515994|65017997|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
23348053|NCT02515994|65017998|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23348054|NCT02515994|65017997|FG000|Overall Study|Adverse Event|3|||
23348055|NCT02515994|65017998|FG001|Overall Study|Adverse Event|1|||
23787849|NCT01083693|66603166|FG000|Overall Study|Lost to Follow-up|2|||
23348056|NCT02515994|65017997|FG000|Overall Study|Withdrawal by Subject|2|||
23348057|NCT02515994|65017998|FG001|Overall Study|Withdrawal by Subject|0|||
23348058|NCT01004406|65017999|FG000|Overall Study|Withdrawal by Subject|2|||
23787850|NCT01083693|66603167|FG001|Overall Study|Lost to Follow-up|0|||
23348059|NCT01004406|65018000|FG001|Overall Study|Withdrawal by Subject|0|||
23348060|NCT01004406|65017999|FG000|Overall Study|Lost to Follow-up|1|||
23348061|NCT01004406|65018000|FG001|Overall Study|Lost to Follow-up|0|||
23348062|NCT03672461|65018001|FG000|Overall Study|COVID Related|4|||
23348063|NCT03672461|65018002|FG001|Overall Study|COVID Related|2|||
23638793|NCT01531673|66061009|FG008|Overall Study|Non-Compliance|0|||
23638794|NCT01531673|66061010|FG009|Overall Study|Non-Compliance|0|||
23787851|NCT01083693|66603168|FG002|Overall Study|Lost to Follow-up|2|||
23787852|NCT01083693|66603166|FG000|Overall Study|Lack of effectiveness|13|||
23787853|NCT01083693|66603167|FG001|Overall Study|Lack of effectiveness|2|||
23787854|NCT01083693|66603168|FG002|Overall Study|Lack of effectiveness|2|||
23787855|NCT01083693|66603166|FG000|Overall Study|Patient Moved|0|||
23787856|NCT01083693|66603167|FG001|Overall Study|Patient Moved|1|||
23787857|NCT01083693|66603168|FG002|Overall Study|Patient Moved|0|||
23787858|NCT01083693|66603166|FG000|Overall Study|Complete remission|0|||
23787859|NCT01083693|66603167|FG001|Overall Study|Complete remission|1|||
23787860|NCT01083693|66603168|FG002|Overall Study|Complete remission|0|||
23787861|NCT01083693|66603166|FG000|Overall Study|Other medical condition/surgery|1|||
23787862|NCT01083693|66603167|FG001|Overall Study|Other medical condition/surgery|1|||
23348064|NCT03672461|65018001|FG000|Overall Study|Adverse Event|2|||
23787863|NCT01083693|66603168|FG002|Overall Study|Other medical condition/surgery|0|||
23787864|NCT01083693|66603166|FG000|Overall Study|Withdrawal by Subject|3|||
23348065|NCT03672461|65018002|FG001|Overall Study|Adverse Event|0|||
23348066|NCT03672461|65018001|FG000|Overall Study|Serious Adverse Event|0|||
23348067|NCT03672461|65018002|FG001|Overall Study|Serious Adverse Event|1|||
23348068|NCT03672461|65018001|FG000|Overall Study|Too Busy|3|||
23348069|NCT03672461|65018002|FG001|Overall Study|Too Busy|1|||
23348070|NCT03672461|65018001|FG000|Overall Study|Lost to Follow-up|1|||
23348071|NCT03672461|65018002|FG001|Overall Study|Lost to Follow-up|2|||
23348072|NCT03672461|65018001|FG000|Overall Study|Family|2|||
23348073|NCT03672461|65018002|FG001|Overall Study|Family|2|||
23348074|NCT03672461|65018001|FG000|Overall Study|No remote technology access|0|||
23348075|NCT03672461|65018002|FG001|Overall Study|No remote technology access|1|||
23348076|NCT03672461|65018001|FG000|Overall Study|Withdrawal by Subject|1|||
23348077|NCT03672461|65018002|FG001|Overall Study|Withdrawal by Subject|0|||
23348078|NCT03672461|65018001|FG000|Overall Study|Cannot tolerate intervention|1|||
23348079|NCT03672461|65018002|FG001|Overall Study|Cannot tolerate intervention|0|||
23348080|NCT03672461|65018001|FG000|Overall Study|Incomplete outcome data|6|||
23348081|NCT03672461|65018002|FG001|Overall Study|Incomplete outcome data|1|||
23348082|NCT01416155|65018005|FG000|Overall Study|Adverse Event|8|||
23348083|NCT01416155|65018005|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
23348084|NCT01416155|65018005|FG000|Overall Study|Withdrawal by Subject|33|||
23348085|NCT01416155|65018005|FG000|Overall Study|Investigator decision|8|||
23348086|NCT01416155|65018005|FG000|Overall Study|Other|7|||
23348087|NCT03535194|65018006|FG000|Induction Period|Adverse Event|2|||
23348088|NCT03535194|65018007|FG001|Induction Period|Adverse Event|2|||
23348089|NCT03535194|65018008|FG002|Induction Period|Adverse Event|1|||
23348090|NCT03535194|65018009|FG003|Induction Period|Adverse Event|3|||
23348091|NCT03535194|65018010|FG004|Induction Period|Adverse Event|0|||
23348092|NCT03535194|65018006|FG000|Induction Period|Death|0|||
23348093|NCT03535194|65018007|FG001|Induction Period|Death|1|||
23348094|NCT03535194|65018008|FG002|Induction Period|Death|0|||
23348095|NCT03535194|65018009|FG003|Induction Period|Death|0|||
23348096|NCT03535194|65018010|FG004|Induction Period|Death|0|||
23348097|NCT03535194|65018006|FG000|Induction Period|Lack of Efficacy|1|||
23348098|NCT03535194|65018007|FG001|Induction Period|Lack of Efficacy|3|||
23348099|NCT03535194|65018008|FG002|Induction Period|Lack of Efficacy|2|||
23348100|NCT03535194|65018009|FG003|Induction Period|Lack of Efficacy|2|||
23348101|NCT03535194|65018010|FG004|Induction Period|Lack of Efficacy|0|||
23348102|NCT03535194|65018006|FG000|Induction Period|Lost to Follow-up|3|||
23348103|NCT03535194|65018007|FG001|Induction Period|Lost to Follow-up|5|||
23348104|NCT03535194|65018008|FG002|Induction Period|Lost to Follow-up|2|||
23348105|NCT03535194|65018009|FG003|Induction Period|Lost to Follow-up|3|||
23348106|NCT03535194|65018010|FG004|Induction Period|Lost to Follow-up|0|||
23348107|NCT03535194|65018006|FG000|Induction Period|Physician Decision|1|||
23348108|NCT03535194|65018007|FG001|Induction Period|Physician Decision|1|||
23348109|NCT03535194|65018008|FG002|Induction Period|Physician Decision|0|||
23348110|NCT03535194|65018009|FG003|Induction Period|Physician Decision|0|||
23348111|NCT03535194|65018010|FG004|Induction Period|Physician Decision|0|||
23348112|NCT03535194|65018006|FG000|Induction Period|Protocol Violation|1|||
23348113|NCT03535194|65018007|FG001|Induction Period|Protocol Violation|0|||
23348114|NCT03535194|65018008|FG002|Induction Period|Protocol Violation|0|||
23348115|NCT03535194|65018009|FG003|Induction Period|Protocol Violation|1|||
23348116|NCT03535194|65018010|FG004|Induction Period|Protocol Violation|0|||
23348117|NCT03535194|65018006|FG000|Induction Period|Screen Failure|0|||
23348118|NCT03535194|65018007|FG001|Induction Period|Screen Failure|1|||
23348119|NCT03535194|65018008|FG002|Induction Period|Screen Failure|0|||
23584142|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
23638795|NCT01531673|66061011|FG010|Overall Study|Non-Compliance|0|||
23638796|NCT01531673|66061012|FG011|Overall Study|Non-Compliance|0|||
23638797|NCT01531673|66061013|FG012|Overall Study|Non-Compliance|0|||
23638798|NCT01531673|66061001|FG000|Overall Study|Adverse Event|0|||
23638799|NCT01531673|66061002|FG001|Overall Study|Adverse Event|1|||
23638800|NCT01531673|66061003|FG002|Overall Study|Adverse Event|0|||
23638801|NCT01531673|66061004|FG003|Overall Study|Adverse Event|0|||
23638802|NCT01531673|66061005|FG004|Overall Study|Adverse Event|0|||
23348120|NCT03535194|65018009|FG003|Induction Period|Screen Failure|0|||
23348121|NCT03535194|65018010|FG004|Induction Period|Screen Failure|0|||
23348122|NCT03535194|65018006|FG000|Induction Period|Withdrawal by Subject|3|||
23348123|NCT03535194|65018007|FG001|Induction Period|Withdrawal by Subject|4|||
23348124|NCT03535194|65018008|FG002|Induction Period|Withdrawal by Subject|3|||
23348125|NCT03535194|65018009|FG003|Induction Period|Withdrawal by Subject|2|||
23348126|NCT03535194|65018010|FG004|Induction Period|Withdrawal by Subject|0|||
23348127|NCT03535194|65018006|FG000|Maintenance Period|Adverse Event|6|||
23584143|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
23584144|NCT05567159|65866088|FG000|Overall Study|Adverse Event|4|||
23638803|NCT01531673|66061006|FG005|Overall Study|Adverse Event|0|||
23348128|NCT03535194|65018007|FG001|Maintenance Period|Adverse Event|5|||
23348129|NCT03535194|65018008|FG002|Maintenance Period|Adverse Event|1|||
23638804|NCT01531673|66061007|FG006|Overall Study|Adverse Event|0|||
23348130|NCT03535194|65018009|FG003|Maintenance Period|Adverse Event|11|||
23348131|NCT03535194|65018010|FG004|Maintenance Period|Adverse Event|4|||
23348132|NCT03535194|65018006|FG000|Maintenance Period|Lack of Efficacy|3|||
23348133|NCT03535194|65018007|FG001|Maintenance Period|Lack of Efficacy|2|||
23348134|NCT03535194|65018008|FG002|Maintenance Period|Lack of Efficacy|5|||
23348135|NCT03535194|65018009|FG003|Maintenance Period|Lack of Efficacy|9|||
23348136|NCT03535194|65018010|FG004|Maintenance Period|Lack of Efficacy|0|||
23787865|NCT01083693|66603167|FG001|Overall Study|Withdrawal by Subject|0|||
23787866|NCT01083693|66603168|FG002|Overall Study|Withdrawal by Subject|2|||
23787867|NCT01083693|66603166|FG000|Overall Study|Reason unknown|0|||
23787868|NCT01083693|66603167|FG001|Overall Study|Reason unknown|0|||
23787869|NCT01083693|66603168|FG002|Overall Study|Reason unknown|1|||
23787870|NCT00472212|66603169|FG000|Overall Study|Lost to Follow-up|6|||
23787871|NCT00472212|66603170|FG001|Overall Study|Lost to Follow-up|4|||
23787872|NCT00807495|66603172|FG000|Overall Study|Adverse Event|6|||
23787873|NCT00807495|66603173|FG001|Overall Study|Adverse Event|3|||
23787874|NCT00807495|66603174|FG002|Overall Study|Adverse Event|1|||
23787875|NCT00807495|66603175|FG003|Overall Study|Adverse Event|1|||
23787876|NCT00807495|66603176|FG004|Overall Study|Adverse Event|2|||
23348137|NCT03535194|65018006|FG000|Maintenance Period|Lost to Follow-up|4|||
23348138|NCT03535194|65018007|FG001|Maintenance Period|Lost to Follow-up|2|||
23348139|NCT03535194|65018008|FG002|Maintenance Period|Lost to Follow-up|1|||
23348140|NCT03535194|65018009|FG003|Maintenance Period|Lost to Follow-up|5|||
23348141|NCT03535194|65018010|FG004|Maintenance Period|Lost to Follow-up|2|||
23348142|NCT03535194|65018006|FG000|Maintenance Period|Other|1|||
23348143|NCT03535194|65018007|FG001|Maintenance Period|Other|2|||
23348144|NCT03535194|65018008|FG002|Maintenance Period|Other|0|||
23348145|NCT03535194|65018009|FG003|Maintenance Period|Other|0|||
23348146|NCT03535194|65018010|FG004|Maintenance Period|Other|0|||
23348147|NCT03535194|65018006|FG000|Maintenance Period|Physician Decision|1|||
23348148|NCT03535194|65018007|FG001|Maintenance Period|Physician Decision|2|||
23348149|NCT03535194|65018008|FG002|Maintenance Period|Physician Decision|0|||
23348150|NCT03535194|65018009|FG003|Maintenance Period|Physician Decision|2|||
23348151|NCT03535194|65018010|FG004|Maintenance Period|Physician Decision|0|||
23348152|NCT03535194|65018006|FG000|Maintenance Period|Pregnancy|0|||
23348153|NCT03535194|65018007|FG001|Maintenance Period|Pregnancy|0|||
23348154|NCT03535194|65018008|FG002|Maintenance Period|Pregnancy|0|||
23348155|NCT03535194|65018009|FG003|Maintenance Period|Pregnancy|2|||
23348156|NCT03535194|65018010|FG004|Maintenance Period|Pregnancy|0|||
23348157|NCT03535194|65018006|FG000|Maintenance Period|Protocol Violation|0|||
23348158|NCT03535194|65018007|FG001|Maintenance Period|Protocol Violation|1|||
23787877|NCT00807495|66603172|FG000|Overall Study|Withdrawal by Patient|2|||
23787878|NCT00807495|66603173|FG001|Overall Study|Withdrawal by Patient|0|||
23787879|NCT00807495|66603174|FG002|Overall Study|Withdrawal by Patient|1|||
23787880|NCT00807495|66603175|FG003|Overall Study|Withdrawal by Patient|0|||
23787881|NCT00807495|66603176|FG004|Overall Study|Withdrawal by Patient|0|||
23787882|NCT00807495|66603172|FG000|Overall Study|Reason Not Specified|0|||
23787883|NCT00807495|66603173|FG001|Overall Study|Reason Not Specified|3|||
23787884|NCT00807495|66603174|FG002|Overall Study|Reason Not Specified|2|||
23787885|NCT00807495|66603175|FG003|Overall Study|Reason Not Specified|0|||
23787886|NCT00807495|66603176|FG004|Overall Study|Reason Not Specified|3|||
23787887|NCT04750239|66603177|FG000|Overall Study|Withdrawal by Subject|2|||
23787888|NCT04750239|66603177|FG000|Overall Study|Trial terminated by sponsor|1|||
23787889|NCT04697173|66603180|FG000|Overall Study|Withdrawal by Subject|34|||
23787890|NCT04697173|66603181|FG001|Overall Study|Withdrawal by Subject|38|||
23348159|NCT03535194|65018008|FG002|Maintenance Period|Protocol Violation|0|||
23348160|NCT03535194|65018009|FG003|Maintenance Period|Protocol Violation|0|||
23787891|NCT03676634|66603184|FG000|Overall Study|Red blood cell loss|1|||
23787892|NCT03676634|66603184|FG000|Overall Study|Out-of-limit pulse|2|||
23787893|NCT00918645|66603185|FG000|Overall Study|Withdrawal by Subject|1|||
23787894|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
23787895|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
23348161|NCT03535194|65018010|FG004|Maintenance Period|Protocol Violation|0|||
23348162|NCT03535194|65018006|FG000|Maintenance Period|Withdrawal by Subject|7|||
23348163|NCT03535194|65018007|FG001|Maintenance Period|Withdrawal by Subject|2|||
23787896|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
23787897|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
23787898|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787899|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787900|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787901|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787902|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787903|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787904|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787905|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787906|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787907|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23787908|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23787909|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23787910|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23787911|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
23787912|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787913|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787914|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787915|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23459910|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459911|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459912|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
23459913|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459914|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459915|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
23459916|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
23459917|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
23459918|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
23459919|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
23459920|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Other|1|||
23459921|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Other|5|||
23459922|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Other|0|||
23459923|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Other|2|||
23459924|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Other|3|||
23459925|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
23459926|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
23459927|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
23459928|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
23459929|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
23459930|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459931|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
23459932|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459933|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
23459934|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459935|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23459936|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
23459937|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
23459938|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23584145|NCT05567159|65866088|FG000|Overall Study|Physician Decision|3|||
23584146|NCT05567159|65866088|FG000|Overall Study|Protocol deviation|1|||
23584147|NCT03425539|65866089|FG000|Overall Study|Randomized but not treated|0|||
23584148|NCT03425539|65866090|FG001|Overall Study|Randomized but not treated|1|||
23584149|NCT03425539|65866089|FG000|Overall Study|Adverse Event|2|||
23584150|NCT03425539|65866090|FG001|Overall Study|Adverse Event|2|||
23584151|NCT03425539|65866089|FG000|Overall Study|Withdrawal by Subject|3|||
23584152|NCT03425539|65866090|FG001|Overall Study|Withdrawal by Subject|0|||
23584153|NCT03425539|65866089|FG000|Overall Study|Lost to Follow-up|0|||
23584154|NCT03425539|65866090|FG001|Overall Study|Lost to Follow-up|1|||
23584155|NCT05526911|65866091|FG000|Overall Study|Adverse Event|2|||
23584156|NCT03368001|65866092|FG000|Allocation|Lost to Pretest|16|||
23638805|NCT01531673|66061008|FG007|Overall Study|Adverse Event|0|||
23787916|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787917|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23459939|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23459940|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
23459941|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
23459942|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
23459943|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
23459944|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
23584157|NCT03368001|65866093|FG001|Allocation|Lost to Pretest|25|||
23584158|NCT03368001|65866092|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
23584159|NCT03368001|65866093|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
23459945|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
23459946|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
23459947|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
23459948|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
23459949|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
23459950|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Other|0|||
23459951|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Other|1|||
23459952|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Other|0|||
23459953|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Other|1|||
23459954|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Other|0|||
23459955|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Not treated|0|||
23459956|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Not treated|0|||
23459957|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Not treated|2|||
23459958|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Not treated|0|||
23459959|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Not treated|0|||
23459960|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
23459961|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
23459962|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
23459963|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
23459964|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
23459965|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
23459966|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
23459967|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
23459968|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
23459969|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
23459970|NCT03467750|65427877|FG000|Overall Study|Surgery canceled|1|||
23459971|NCT03467750|65427878|FG001|Overall Study|Surgery canceled|0|||
23459972|NCT03467750|65427877|FG000|Overall Study|Protocol Violation|1|||
23459973|NCT03467750|65427878|FG001|Overall Study|Protocol Violation|1|||
23459974|NCT03467750|65427877|FG000|Overall Study|Withdrawal by Subject|0|||
23459975|NCT03467750|65427878|FG001|Overall Study|Withdrawal by Subject|1|||
23459976|NCT03094416|65427879|FG000|Run-in|Screening failure|8|||
23459977|NCT03094416|65427879|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
23459978|NCT03094416|65427879|FG000|Run-in|Withdrawal by Subject|3|||
23459979|NCT03094416|65427879|FG000|Treatment Period|Withdrawal by Subject|2|||
23459980|NCT02514083|65427881|FG000|Overall Study|Adverse Event|1|||
23459981|NCT03011099|65427884|FG000|Overall Study|Withdrawal by Subject|0|||
23459982|NCT03011099|65427885|FG001|Overall Study|Withdrawal by Subject|2|||
23459983|NCT01709721|65427901|FG000|Open Label Phase|Withdrawal by Subject|0|||
23459984|NCT01709721|65427902|FG001|Open Label Phase|Withdrawal by Subject|0|||
23459985|NCT01709721|65427903|FG002|Open Label Phase|Withdrawal by Subject|5|||
23459986|NCT01709721|65427901|FG000|Open Label Phase|Adverse Event|0|||
23459987|NCT01709721|65427902|FG001|Open Label Phase|Adverse Event|0|||
23459988|NCT01709721|65427903|FG002|Open Label Phase|Adverse Event|8|||
23459989|NCT01709721|65427901|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
23459990|NCT01709721|65427902|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
23459991|NCT01709721|65427903|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
23459992|NCT01709721|65427901|FG000|Open Label Phase|Investigator Decision|0|||
23459993|NCT01709721|65427902|FG001|Open Label Phase|Investigator Decision|0|||
23459994|NCT01709721|65427903|FG002|Open Label Phase|Investigator Decision|1|||
23459995|NCT01709721|65427901|FG000|Open Label Phase|Sponsor Decision|0|||
23459996|NCT01709721|65427902|FG001|Open Label Phase|Sponsor Decision|0|||
23459997|NCT01709721|65427903|FG002|Open Label Phase|Sponsor Decision|2|||
23459998|NCT01709721|65427901|FG000|Open Label Phase|Protocol Violation|0|||
23459999|NCT01709721|65427902|FG001|Open Label Phase|Protocol Violation|0|||
23460000|NCT01709721|65427903|FG002|Open Label Phase|Protocol Violation|1|||
23460001|NCT01709721|65427901|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
23460002|NCT01709721|65427902|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
23460003|NCT01709721|65427903|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
23460004|NCT01709721|65427901|FG000|Open Label Phase|Inadequate Pain Control|0|||
23460005|NCT01709721|65427902|FG001|Open Label Phase|Inadequate Pain Control|0|||
23460006|NCT01709721|65427903|FG002|Open Label Phase|Inadequate Pain Control|37|||
23460007|NCT01709721|65427901|FG000|Open Label Phase|Other, Specify in text field in database|0|||
23460008|NCT01709721|65427902|FG001|Open Label Phase|Other, Specify in text field in database|0|||
23460009|NCT01709721|65427903|FG002|Open Label Phase|Other, Specify in text field in database|14|||
23460010|NCT01709721|65427901|FG000|Randomized Phase|Adverse Event|0|||
23460011|NCT01709721|65427902|FG001|Randomized Phase|Adverse Event|1|||
23787918|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23460012|NCT01709721|65427903|FG002|Randomized Phase|Adverse Event|0|||
23460013|NCT01709721|65427901|FG000|Randomized Phase|Lost to Follow-up|1|||
23460014|NCT01709721|65427902|FG001|Randomized Phase|Lost to Follow-up|0|||
23460015|NCT01709721|65427903|FG002|Randomized Phase|Lost to Follow-up|0|||
23460016|NCT01709721|65427901|FG000|Randomized Phase|Inadequate Pain Control|1|||
23460017|NCT01709721|65427902|FG001|Randomized Phase|Inadequate Pain Control|2|||
23348164|NCT03535194|65018008|FG002|Maintenance Period|Withdrawal by Subject|1|||
23348165|NCT03535194|65018009|FG003|Maintenance Period|Withdrawal by Subject|8|||
23348166|NCT03535194|65018010|FG004|Maintenance Period|Withdrawal by Subject|0|||
23348167|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Adverse Event|4|||
23348168|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Adverse Event|5|||
23348169|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Adverse Event|1|||
23348170|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Adverse Event|8|||
23348171|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Adverse Event|0|||
23348172|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
23460018|NCT01709721|65427903|FG002|Randomized Phase|Inadequate Pain Control|0|||
23460019|NCT01709721|65427901|FG000|Randomized Phase|Other, Specify text field in database|1|||
23460020|NCT01709721|65427902|FG001|Randomized Phase|Other, Specify text field in database|3|||
23460021|NCT01709721|65427903|FG002|Randomized Phase|Other, Specify text field in database|0|||
23460022|NCT01099267|65427905|FG000|MDS-003 Study|Adverse Event|37|||
23460023|NCT01099267|65427905|FG000|MDS-003 Study|Lack of Efficacy|52|||
23460024|NCT01099267|65427905|FG000|MDS-003 Study|Withdrawal by Subject|8|||
23460025|NCT01099267|65427905|FG000|MDS-003 Study|Lost to Follow-up|1|||
23460026|NCT01099267|65427905|FG000|MDS-003 Study|Death|11|||
23460027|NCT01099267|65427905|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
23460028|NCT01099267|65427905|FG000|MDS-003 Study|Disease Progression|7|||
23460029|NCT01099267|65427905|FG000|MDS-003 Study|Investigator Decision|2|||
23460030|NCT01099267|65427905|FG000|MDS-003 Study|Non-Compliance|2|||
23460031|NCT01099267|65427905|FG000|MDS-003 Study|Loss of Response|1|||
23460032|NCT01099267|65427905|FG000|MDS-003 Study|Secondary Malign Disease|1|||
23460033|NCT04730804|65427911|FG000|Overall Study|Physician Decision|0|||
23460034|NCT04730804|65427912|FG001|Overall Study|Physician Decision|0|||
23460035|NCT04730804|65427913|FG002|Overall Study|Physician Decision|0|||
23460036|NCT04730804|65427914|FG003|Overall Study|Physician Decision|0|||
23460037|NCT04730804|65427915|FG004|Overall Study|Physician Decision|0|||
23460038|NCT04730804|65427916|FG005|Overall Study|Physician Decision|1|||
23460039|NCT04730804|65427911|FG000|Overall Study|Withdrawal by Subject|0|||
23460040|NCT04730804|65427912|FG001|Overall Study|Withdrawal by Subject|0|||
23460041|NCT04730804|65427913|FG002|Overall Study|Withdrawal by Subject|0|||
23460042|NCT04730804|65427914|FG003|Overall Study|Withdrawal by Subject|0|||
23460043|NCT04730804|65427915|FG004|Overall Study|Withdrawal by Subject|1|||
23460044|NCT04730804|65427916|FG005|Overall Study|Withdrawal by Subject|2|||
23460045|NCT00905164|65427917|FG000|Period 1|Protocol Violation|0|||
23460046|NCT00905164|65427918|FG001|Period 1|Protocol Violation|1|||
23460047|NCT03198715|65427919|FG000|Overall Study|Death|0|||
23460048|NCT03198715|65427920|FG001|Overall Study|Death|0|||
23460049|NCT03198715|65427921|FG002|Overall Study|Death|1|||
23460050|NCT03198715|65427922|FG003|Overall Study|Death|0|||
23460051|NCT03198715|65427923|FG004|Overall Study|Death|2|||
23460052|NCT03198715|65427919|FG000|Overall Study|Other|0|||
23460053|NCT03198715|65427920|FG001|Overall Study|Other|1|||
23460054|NCT03198715|65427921|FG002|Overall Study|Other|1|||
23460055|NCT03198715|65427922|FG003|Overall Study|Other|0|||
23460056|NCT03198715|65427923|FG004|Overall Study|Other|0|||
23460057|NCT01615939|65427924|FG000|Overall Study|Lost to Follow-up|5|||
23460058|NCT01615939|65427925|FG001|Overall Study|Lost to Follow-up|0|||
23460059|NCT01614249|65427926|FG000|Overall Study|Lost to Follow-up|11|||
23460060|NCT01614249|65427927|FG001|Overall Study|Lost to Follow-up|23|||
23460061|NCT03361137|65427932|FG000|Overall Study|Reason not specified|1|||
23460062|NCT03361137|65427933|FG001|Overall Study|Reason not specified|0|||
23460063|NCT03361137|65427934|FG002|Overall Study|Reason not specified|0|||
23460064|NCT03361137|65427935|FG003|Overall Study|Reason not specified|0|||
23460065|NCT03361137|65427936|FG004|Overall Study|Reason not specified|0|||
23460066|NCT00307801|65427937|FG000|Overall Study|Adverse Event|12|||
23460067|NCT00307801|65427938|FG001|Overall Study|Adverse Event|4|||
23460068|NCT00307801|65427937|FG000|Overall Study|Withdrawal by Subject|9|||
23460069|NCT00307801|65427938|FG001|Overall Study|Withdrawal by Subject|4|||
23460070|NCT00307801|65427937|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
23460071|NCT00307801|65427938|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
23460072|NCT00307801|65427937|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
23348173|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
23460073|NCT00307801|65427938|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
23460074|NCT00307801|65427937|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
23460075|NCT00307801|65427938|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
23460076|NCT00307801|65427937|FG000|Overall Study|Wrong Randomization|1|||
23460077|NCT00307801|65427938|FG001|Overall Study|Wrong Randomization|0|||
23460078|NCT00307801|65427937|FG000|Overall Study|Lack of Efficacy|0|||
23460079|NCT00307801|65427938|FG001|Overall Study|Lack of Efficacy|2|||
23460080|NCT00307801|65427937|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
23460081|NCT00307801|65427938|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
23460082|NCT00307801|65427937|FG000|Overall Study|Frustration with e-diary|1|||
23460083|NCT00307801|65427938|FG001|Overall Study|Frustration with e-diary|0|||
23348174|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
23348175|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
23348176|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
23348177|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348178|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348179|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348180|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
23348181|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
23460084|NCT00307801|65427937|FG000|Overall Study|Protocol Violation|3|||
23460085|NCT00307801|65427938|FG001|Overall Study|Protocol Violation|2|||
23638806|NCT01531673|66061009|FG008|Overall Study|Adverse Event|0|||
23638807|NCT01531673|66061010|FG009|Overall Study|Adverse Event|0|||
23638808|NCT01531673|66061011|FG010|Overall Study|Adverse Event|0|||
23638809|NCT01531673|66061012|FG011|Overall Study|Adverse Event|0|||
23638810|NCT01531673|66061013|FG012|Overall Study|Adverse Event|0|||
23638811|NCT01531673|66061001|FG000|Overall Study|Lost to Follow-up|0|||
23638812|NCT01531673|66061002|FG001|Overall Study|Lost to Follow-up|0|||
23638813|NCT01531673|66061003|FG002|Overall Study|Lost to Follow-up|0|||
23638814|NCT01531673|66061004|FG003|Overall Study|Lost to Follow-up|0|||
23638815|NCT01531673|66061005|FG004|Overall Study|Lost to Follow-up|1|||
23638816|NCT01531673|66061006|FG005|Overall Study|Lost to Follow-up|0|||
23638817|NCT01531673|66061007|FG006|Overall Study|Lost to Follow-up|0|||
23638818|NCT01531673|66061008|FG007|Overall Study|Lost to Follow-up|0|||
23638819|NCT01531673|66061009|FG008|Overall Study|Lost to Follow-up|0|||
23460086|NCT00307801|65427937|FG000|Overall Study|No reason specified|2|||
23460087|NCT00307801|65427938|FG001|Overall Study|No reason specified|0|||
23460088|NCT00307801|65427937|FG000|Overall Study|Pregnancy|0|||
23460089|NCT00307801|65427938|FG001|Overall Study|Pregnancy|1|||
23460090|NCT02017405|65427940|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460091|NCT02017405|65427941|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460092|NCT02017405|65427942|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460093|NCT02017405|65427943|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460094|NCT02017405|65427944|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460095|NCT02017405|65427945|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
23460096|NCT02017405|65427940|FG000|Open-label Phase|Adverse Event|1|||
23460097|NCT02017405|65427941|FG001|Open-label Phase|Adverse Event|1|||
23460098|NCT02017405|65427942|FG002|Open-label Phase|Adverse Event|0|||
23460099|NCT02017405|65427943|FG003|Open-label Phase|Adverse Event|0|||
23460100|NCT02017405|65427944|FG004|Open-label Phase|Adverse Event|0|||
23460101|NCT02017405|65427945|FG005|Open-label Phase|Adverse Event|0|||
23460102|NCT04106557|65427946|FG000|Overall Study|Physician Decision|0|||
23460103|NCT04106557|65427947|FG001|Overall Study|Physician Decision|1|||
23460104|NCT04106557|65427948|FG002|Overall Study|Physician Decision|0|||
23460105|NCT04106557|65427946|FG000|Overall Study|Protocol Violation|0|||
23460106|NCT04106557|65427947|FG001|Overall Study|Protocol Violation|1|||
23460107|NCT04106557|65427948|FG002|Overall Study|Protocol Violation|0|||
23460108|NCT03448406|65427949|FG000|Overall Study|Noncompliance of scheduled visits|1|||
23460109|NCT03448406|65427950|FG001|Overall Study|Noncompliance of scheduled visits|2|||
23460110|NCT03448406|65427949|FG000|Overall Study|Withdrawal by Subject|1|||
23460111|NCT03448406|65427950|FG001|Overall Study|Withdrawal by Subject|2|||
23460112|NCT03448406|65427949|FG000|Overall Study|Protocol Violation|1|||
23460113|NCT03448406|65427950|FG001|Overall Study|Protocol Violation|0|||
23460114|NCT03448406|65427949|FG000|Overall Study|Adverse Event|8|||
23460115|NCT03448406|65427950|FG001|Overall Study|Adverse Event|9|||
23460116|NCT02151058|65427955|FG000|Overall Study|Withdrawal by Subject|1|||
23460117|NCT02151058|65427956|FG001|Overall Study|Withdrawal by Subject|1|||
23460118|NCT02151058|65427957|FG002|Overall Study|Withdrawal by Subject|3|||
23460119|NCT02151058|65427955|FG000|Overall Study|Lost to Follow-up|1|||
23460120|NCT02151058|65427956|FG001|Overall Study|Lost to Follow-up|0|||
23460121|NCT02151058|65427957|FG002|Overall Study|Lost to Follow-up|2|||
23460122|NCT01419236|65427959|FG000|Overall Study|Adverse Event|1|||
23460123|NCT01419236|65427960|FG001|Overall Study|Adverse Event|0|||
23460124|NCT01419236|65427959|FG000|Overall Study|Lack of Efficacy|0|||
23460125|NCT01419236|65427960|FG001|Overall Study|Lack of Efficacy|1|||
23460126|NCT01419236|65427959|FG000|Overall Study|Lost to Follow-up|1|||
23460127|NCT01419236|65427960|FG001|Overall Study|Lost to Follow-up|0|||
23460128|NCT01419236|65427959|FG000|Overall Study|Physician Decision|1|||
23460129|NCT01419236|65427960|FG001|Overall Study|Physician Decision|0|||
23460130|NCT01419236|65427959|FG000|Overall Study|Withdrawal by Subject|1|||
23460131|NCT01419236|65427960|FG001|Overall Study|Withdrawal by Subject|4|||
23638820|NCT01531673|66061010|FG009|Overall Study|Lost to Follow-up|0|||
23638821|NCT01531673|66061011|FG010|Overall Study|Lost to Follow-up|0|||
23638822|NCT01531673|66061012|FG011|Overall Study|Lost to Follow-up|0|||
23638823|NCT01531673|66061013|FG012|Overall Study|Lost to Follow-up|0|||
23638824|NCT01531673|66061001|FG000|Overall Study|Other|0|||
23460132|NCT01419236|65427959|FG000|Overall Study|Entry Criteria Not Met|1|||
23460133|NCT01419236|65427960|FG001|Overall Study|Entry Criteria Not Met|0|||
23460134|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
23638825|NCT01531673|66061002|FG001|Overall Study|Other|0|||
23460135|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
23460136|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
23460137|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
23460138|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
23460139|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
23638826|NCT01531673|66061003|FG002|Overall Study|Other|0|||
23460140|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
23460141|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
23460142|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
23460143|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
23584160|NCT03368001|65866092|FG000|Posttest|Lost to Posttest|7|||
23584161|NCT03368001|65866093|FG001|Posttest|Lost to Posttest|11|||
23584162|NCT03368001|65866092|FG000|Posttest|Discontinued Intervention|6|||
23787919|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23584163|NCT03368001|65866093|FG001|Posttest|Discontinued Intervention|19|||
23584164|NCT03368001|65866092|FG000|Follow-up|Lost to Follow-up|6|||
23584165|NCT03368001|65866093|FG001|Follow-up|Lost to Follow-up|3|||
23584166|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23584167|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23584168|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23787920|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787921|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23787922|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
23787923|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787924|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
23787925|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787926|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787927|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787928|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787929|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787930|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787931|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787932|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787933|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787934|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787935|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23787936|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
23787937|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
23787938|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
23787939|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787940|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787941|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787942|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787943|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787944|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787945|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787946|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787947|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787948|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787949|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23787950|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
23787951|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787952|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
23787953|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787954|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787955|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787956|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787957|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787958|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787959|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787960|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787961|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787962|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787963|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23787964|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23787965|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787966|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23787967|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787968|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787969|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23584169|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
23584170|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
23638827|NCT01531673|66061004|FG003|Overall Study|Other|1|||
23638828|NCT01531673|66061005|FG004|Overall Study|Other|0|||
23638829|NCT01531673|66061006|FG005|Overall Study|Other|0|||
23638830|NCT01531673|66061007|FG006|Overall Study|Other|0|||
23638831|NCT01531673|66061008|FG007|Overall Study|Other|0|||
23638832|NCT01531673|66061009|FG008|Overall Study|Other|0|||
23638833|NCT01531673|66061010|FG009|Overall Study|Other|1|||
23638834|NCT01531673|66061011|FG010|Overall Study|Other|0|||
23638835|NCT01531673|66061012|FG011|Overall Study|Other|0|||
23638836|NCT01531673|66061013|FG012|Overall Study|Other|0|||
23638837|NCT02706405|66061017|FG000|Overall Study|Death|3|||
23638838|NCT02706405|66061018|FG001|Overall Study|Death|2|||
23638839|NCT02706405|66061019|FG002|Overall Study|Death|0|||
23638840|NCT02706405|66061020|FG003|Overall Study|Death|1|||
23638841|NCT02706405|66061021|FG004|Overall Study|Death|0|||
23638842|NCT02706405|66061022|FG005|Overall Study|Death|0|||
23638843|NCT02706405|66061023|FG006|Overall Study|Death|3|||
23638844|NCT02706405|66061024|FG007|Overall Study|Death|4|||
23638845|NCT02706405|66061017|FG000|Overall Study|Disease progression|0|||
23638846|NCT02706405|66061018|FG001|Overall Study|Disease progression|0|||
23638847|NCT02706405|66061019|FG002|Overall Study|Disease progression|0|||
23638848|NCT02706405|66061020|FG003|Overall Study|Disease progression|0|||
23787970|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787971|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787972|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787973|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787974|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787975|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787976|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787977|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23787978|NCT01695239|66603186|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
23787979|NCT01695239|66603187|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787980|NCT01695239|66603188|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787981|NCT01695239|66603189|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787982|NCT01695239|66603190|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23348182|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Other|1|||
23348183|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Other|0|||
23348184|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Other|0|||
23348185|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Other|5|||
23348186|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Other|0|||
23348187|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Physician Decision|0|||
23348188|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Physician Decision|2|||
23638849|NCT02706405|66061021|FG004|Overall Study|Disease progression|0|||
23638850|NCT02706405|66061022|FG005|Overall Study|Disease progression|0|||
23638851|NCT02706405|66061023|FG006|Overall Study|Disease progression|0|||
23638852|NCT02706405|66061024|FG007|Overall Study|Disease progression|1|||
23638853|NCT02706405|66061017|FG000|Overall Study|Pt moved to new therapy|0|||
23638854|NCT02706405|66061018|FG001|Overall Study|Pt moved to new therapy|0|||
23638855|NCT02706405|66061019|FG002|Overall Study|Pt moved to new therapy|0|||
23638856|NCT02706405|66061020|FG003|Overall Study|Pt moved to new therapy|0|||
23638857|NCT02706405|66061021|FG004|Overall Study|Pt moved to new therapy|0|||
23638858|NCT02706405|66061022|FG005|Overall Study|Pt moved to new therapy|1|||
23638859|NCT02706405|66061023|FG006|Overall Study|Pt moved to new therapy|0|||
23787983|NCT01695239|66603191|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23638860|NCT02706405|66061024|FG007|Overall Study|Pt moved to new therapy|1|||
23638861|NCT02706405|66061017|FG000|Overall Study|Physician Decision|1|||
23787984|NCT01695239|66603192|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787985|NCT01695239|66603193|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787986|NCT01695239|66603194|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787987|NCT01695239|66603195|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787988|NCT01695239|66603196|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787989|NCT01695239|66603197|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23348189|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Physician Decision|1|||
23348190|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Physician Decision|1|||
23787990|NCT01695239|66603198|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787991|NCT01695239|66603199|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23787992|NCT01695239|66603186|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23787993|NCT01695239|66603187|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23787994|NCT01695239|66603188|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23787995|NCT01695239|66603189|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23348191|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Physician Decision|0|||
23348192|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
23348193|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
23348194|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
23348195|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
23348196|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23348197|NCT02603562|65018013|FG000|Overall Study|Lost to Follow-up|1|||
23348198|NCT00803205|65018018|FG000|Overall Study|Adverse Event|7|||
23348199|NCT00803205|65018019|FG001|Overall Study|Adverse Event|2|||
23460144|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
23460145|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
23584171|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584172|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584173|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584174|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584175|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584176|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23460146|NCT01668784|65427963|FG000|Treatment Period|Disease Progression|316|||
23348200|NCT00803205|65018018|FG000|Overall Study|Lost to Follow-up|1|||
23348201|NCT00803205|65018019|FG001|Overall Study|Lost to Follow-up|0|||
23348202|NCT00803205|65018018|FG000|Overall Study|Withdrawal by Subject|9|||
23348203|NCT00803205|65018019|FG001|Overall Study|Withdrawal by Subject|9|||
23348204|NCT00803205|65018018|FG000|Overall Study|Physician Decision|1|||
23348205|NCT00803205|65018019|FG001|Overall Study|Physician Decision|0|||
23348206|NCT00803205|65018018|FG000|Overall Study|Protocol Violation|1|||
23348207|NCT00803205|65018019|FG001|Overall Study|Protocol Violation|1|||
23348208|NCT00803205|65018018|FG000|Overall Study|Medical Monitor Decision|1|||
23348209|NCT00803205|65018019|FG001|Overall Study|Medical Monitor Decision|0|||
23348210|NCT00803205|65018018|FG000|Overall Study|Acquired a Lung Infection|0|||
23348211|NCT00803205|65018019|FG001|Overall Study|Acquired a Lung Infection|1|||
23348212|NCT00803205|65018018|FG000|Overall Study|Sponsor Decision|0|||
23348213|NCT00803205|65018019|FG001|Overall Study|Sponsor Decision|1|||
23348214|NCT02073565|65018022|FG000|Cohort A|Withdrawal by Subject|1|||
23348215|NCT02073565|65018023|FG001|Cohort A|Withdrawal by Subject|0|||
23348216|NCT02073565|65018022|FG000|Cohort B|Withdrawal by Subject|1|||
23638862|NCT02706405|66061018|FG001|Overall Study|Physician Decision|0|||
23638863|NCT02706405|66061019|FG002|Overall Study|Physician Decision|0|||
23638864|NCT02706405|66061020|FG003|Overall Study|Physician Decision|0|||
23638865|NCT02706405|66061021|FG004|Overall Study|Physician Decision|0|||
23638866|NCT02706405|66061022|FG005|Overall Study|Physician Decision|0|||
23638867|NCT02706405|66061023|FG006|Overall Study|Physician Decision|0|||
23638868|NCT02706405|66061024|FG007|Overall Study|Physician Decision|0|||
23638869|NCT01468181|66061025|FG000|Overall Study|Adverse Event|8|||
23638870|NCT01468181|66061026|FG001|Overall Study|Adverse Event|1|||
23638871|NCT01468181|66061027|FG002|Overall Study|Adverse Event|6|||
23638872|NCT01468181|66061028|FG003|Overall Study|Adverse Event|2|||
23638873|NCT01468181|66061029|FG004|Overall Study|Adverse Event|2|||
23638874|NCT01468181|66061025|FG000|Overall Study|Protocol Violation|2|||
23638875|NCT01468181|66061026|FG001|Overall Study|Protocol Violation|0|||
23638876|NCT01468181|66061027|FG002|Overall Study|Protocol Violation|1|||
23638877|NCT01468181|66061028|FG003|Overall Study|Protocol Violation|0|||
23638878|NCT01468181|66061029|FG004|Overall Study|Protocol Violation|1|||
23638879|NCT01468181|66061025|FG000|Overall Study|Physician Decision|0|||
23638880|NCT01468181|66061026|FG001|Overall Study|Physician Decision|0|||
23638881|NCT01468181|66061027|FG002|Overall Study|Physician Decision|0|||
23638882|NCT01468181|66061028|FG003|Overall Study|Physician Decision|1|||
23638883|NCT01468181|66061029|FG004|Overall Study|Physician Decision|1|||
23638884|NCT01468181|66061025|FG000|Overall Study|Lost to Follow-up|0|||
23638885|NCT01468181|66061026|FG001|Overall Study|Lost to Follow-up|0|||
23638886|NCT01468181|66061027|FG002|Overall Study|Lost to Follow-up|1|||
23638887|NCT01468181|66061028|FG003|Overall Study|Lost to Follow-up|0|||
23638888|NCT01468181|66061029|FG004|Overall Study|Lost to Follow-up|1|||
23638889|NCT01468181|66061025|FG000|Overall Study|Withdrawal by Subject|0|||
23638890|NCT01468181|66061026|FG001|Overall Study|Withdrawal by Subject|1|||
23638891|NCT01468181|66061027|FG002|Overall Study|Withdrawal by Subject|0|||
23638892|NCT01468181|66061028|FG003|Overall Study|Withdrawal by Subject|0|||
23638893|NCT01468181|66061029|FG004|Overall Study|Withdrawal by Subject|0|||
23638894|NCT01593787|66061035|FG000|Overall Study|Adverse Event|1|||
23638895|NCT01593787|66061036|FG001|Overall Study|Adverse Event|0|||
23638896|NCT01593787|66061037|FG002|Overall Study|Adverse Event|0|||
23638897|NCT00939822|66061039|FG000|Overall Study|Lost to Follow-up|1|||
23638898|NCT00939822|66061040|FG001|Overall Study|Lost to Follow-up|0|||
23638899|NCT00939822|66061039|FG000|Overall Study|withdrew from study due to busy schedule|1|||
23638900|NCT00939822|66061040|FG001|Overall Study|withdrew from study due to busy schedule|1|||
23638901|NCT00939822|66061039|FG000|Overall Study|Mental health issues|0|||
23638902|NCT00939822|66061040|FG001|Overall Study|Mental health issues|2|||
23638903|NCT01451827|66061042|FG000|Overall Study|Adverse Event|2|||
23638904|NCT01451827|66061043|FG001|Overall Study|Adverse Event|0|||
23638905|NCT01451827|66061044|FG002|Overall Study|Adverse Event|1|||
23348217|NCT02073565|65018023|FG001|Cohort B|Withdrawal by Subject|2|||
23348218|NCT02073565|65018022|FG000|Cohort C|Withdrawal by Subject|0|||
23348219|NCT02073565|65018023|FG001|Cohort C|Withdrawal by Subject|2|||
23348220|NCT02073565|65018022|FG000|Cohort C|Lost to Follow-up|0|||
23348221|NCT02073565|65018023|FG001|Cohort C|Lost to Follow-up|2|||
23348222|NCT00394433|65018024|FG000|Overall Study|Adverse Event|2|||
23348223|NCT00394433|65018024|FG000|Overall Study|Alternative Therapy|1|||
23348224|NCT02134353|65018025|FG000|Overall Study|Adverse Event|10|||
23638906|NCT01451827|66061045|FG003|Overall Study|Adverse Event|1|||
23638907|NCT01451827|66061042|FG000|Overall Study|Protocol deviation|1|||
23638908|NCT01451827|66061043|FG001|Overall Study|Protocol deviation|0|||
23638909|NCT01451827|66061044|FG002|Overall Study|Protocol deviation|0|||
23638910|NCT01451827|66061045|FG003|Overall Study|Protocol deviation|0|||
23638911|NCT01451827|66061042|FG000|Overall Study|Lost to Follow-up|0|||
23638912|NCT01451827|66061043|FG001|Overall Study|Lost to Follow-up|3|||
23638913|NCT01451827|66061044|FG002|Overall Study|Lost to Follow-up|0|||
23638914|NCT01451827|66061045|FG003|Overall Study|Lost to Follow-up|2|||
23706191|NCT01258348|66301081|FG000|Overall Study|Adverse Event|1|||
23638915|NCT01451827|66061042|FG000|Overall Study|Participant met withdrawal criteria|0|||
23638916|NCT01451827|66061043|FG001|Overall Study|Participant met withdrawal criteria|2|||
23638917|NCT01451827|66061044|FG002|Overall Study|Participant met withdrawal criteria|0|||
23638918|NCT01451827|66061045|FG003|Overall Study|Participant met withdrawal criteria|0|||
23638919|NCT01451827|66061042|FG000|Overall Study|Withdrawal by Subject|0|||
23638920|NCT01451827|66061043|FG001|Overall Study|Withdrawal by Subject|0|||
23638921|NCT01451827|66061044|FG002|Overall Study|Withdrawal by Subject|1|||
23638922|NCT01451827|66061045|FG003|Overall Study|Withdrawal by Subject|1|||
23638923|NCT00022659|66061046|FG000|Overall Study|Ineligible: wrong primary|1|||
23638924|NCT00022659|66061046|FG000|Overall Study|Never treated|1|||
23638925|NCT00992225|66061047|FG000|Overall Study|Entry Criteria Not Met|8|||
23638926|NCT00992225|66061047|FG000|Overall Study|Adverse Event|2|||
23638927|NCT00403767|66061048|FG000|Overall Study|Adverse Event|993|||
23638928|NCT00403767|66061049|FG001|Overall Study|Adverse Event|919|||
23638929|NCT00403767|66061048|FG000|Overall Study|Non-compliant with study medication|134|||
23638930|NCT00403767|66061049|FG001|Overall Study|Non-compliant with study medication|164|||
23638931|NCT00403767|66061048|FG000|Overall Study|Consent withdrawn|671|||
23638932|NCT00403767|66061049|FG001|Overall Study|Consent withdrawn|673|||
23638933|NCT00403767|66061048|FG000|Overall Study|Investigator dec./not protocol-related|191|||
23638934|NCT00403767|66061049|FG001|Overall Study|Investigator dec./not protocol-related|178|||
23638935|NCT00403767|66061048|FG000|Overall Study|Lost to Follow-up|6|||
23638936|NCT00403767|66061049|FG001|Overall Study|Lost to Follow-up|8|||
23638937|NCT00403767|66061048|FG000|Overall Study|Protocol Violation|142|||
23638938|NCT00403767|66061049|FG001|Overall Study|Protocol Violation|124|||
23638939|NCT00403767|66061048|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
23638940|NCT00403767|66061049|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
23638941|NCT00403767|66061048|FG000|Overall Study|Study terminated by sponsor|82|||
23638942|NCT00403767|66061049|FG001|Overall Study|Study terminated by sponsor|69|||
23638943|NCT00403767|66061048|FG000|Overall Study|Missing/incomplete data|1|||
23638944|NCT00403767|66061049|FG001|Overall Study|Missing/incomplete data|1|||
23638945|NCT00867308|66061050|FG000|Overall Study|Death|1|||
23638946|NCT00867308|66061051|FG001|Overall Study|Death|0|||
23638947|NCT00867308|66061050|FG000|Overall Study|Adverse Event|1|||
23638948|NCT00867308|66061051|FG001|Overall Study|Adverse Event|4|||
23638949|NCT00867308|66061050|FG000|Overall Study|Lack of Efficacy|6|||
23638950|NCT00867308|66061051|FG001|Overall Study|Lack of Efficacy|12|||
23638951|NCT00867308|66061050|FG000|Overall Study|Withdrawal by Subject|1|||
23638952|NCT00867308|66061051|FG001|Overall Study|Withdrawal by Subject|2|||
23638953|NCT02248818|66064425|FG000|Screening|Protocol Violation|0|||
23638954|NCT02248818|66064426|FG001|Screening|Protocol Violation|0|||
23638955|NCT02248818|66064427|FG002|Screening|Protocol Violation|0|||
23638956|NCT02248818|66064428|FG003|Screening|Protocol Violation|0|||
23638957|NCT02248818|66064429|FG004|Screening|Protocol Violation|0|||
23638958|NCT02248818|66064430|FG005|Screening|Protocol Violation|0|||
23638959|NCT02248818|66064431|FG006|Screening|Protocol Violation|0|||
23638960|NCT02248818|66064432|FG007|Screening|Protocol Violation|0|||
23638961|NCT02248818|66064433|FG008|Screening|Protocol Violation|7|||
23638962|NCT02248818|66064425|FG000|Screening|Study fully enrolled|0|||
23787996|NCT01695239|66603190|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23787997|NCT01695239|66603191|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23787998|NCT01695239|66603192|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23584177|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584178|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
23584179|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
23584180|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
23584181|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
23584182|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584183|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584184|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584185|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584186|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23638963|NCT02248818|66064426|FG001|Screening|Study fully enrolled|0|||
23638964|NCT02248818|66064427|FG002|Screening|Study fully enrolled|0|||
23638965|NCT02248818|66064428|FG003|Screening|Study fully enrolled|0|||
23638966|NCT02248818|66064429|FG004|Screening|Study fully enrolled|0|||
23638967|NCT02248818|66064430|FG005|Screening|Study fully enrolled|0|||
23638968|NCT02248818|66064431|FG006|Screening|Study fully enrolled|0|||
23638969|NCT02248818|66064432|FG007|Screening|Study fully enrolled|0|||
23638970|NCT02248818|66064433|FG008|Screening|Study fully enrolled|14|||
23638971|NCT02248818|66064425|FG000|Screening|Physician Decision|0|||
23638972|NCT02248818|66064426|FG001|Screening|Physician Decision|0|||
23638973|NCT02248818|66064427|FG002|Screening|Physician Decision|0|||
23638974|NCT02248818|66064428|FG003|Screening|Physician Decision|0|||
23638975|NCT02248818|66064429|FG004|Screening|Physician Decision|0|||
23584187|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584188|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584189|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584190|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
23584191|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584192|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
23584193|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584194|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584195|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23638976|NCT02248818|66064430|FG005|Screening|Physician Decision|0|||
23638977|NCT02248818|66064431|FG006|Screening|Physician Decision|0|||
23638978|NCT02248818|66064432|FG007|Screening|Physician Decision|0|||
23638979|NCT02248818|66064433|FG008|Screening|Physician Decision|73|||
23638980|NCT02248818|66064425|FG000|Screening|Withdrawal by Subject|0|||
23638981|NCT02248818|66064426|FG001|Screening|Withdrawal by Subject|0|||
23638982|NCT02248818|66064427|FG002|Screening|Withdrawal by Subject|0|||
23638983|NCT02248818|66064428|FG003|Screening|Withdrawal by Subject|0|||
23638984|NCT02248818|66064429|FG004|Screening|Withdrawal by Subject|0|||
23638985|NCT02248818|66064430|FG005|Screening|Withdrawal by Subject|0|||
23638986|NCT02248818|66064431|FG006|Screening|Withdrawal by Subject|0|||
23638987|NCT02248818|66064432|FG007|Screening|Withdrawal by Subject|0|||
23638988|NCT02248818|66064433|FG008|Screening|Withdrawal by Subject|6|||
23638989|NCT02248818|66064425|FG000|Screening|Lost to Follow-up|0|||
23638990|NCT02248818|66064426|FG001|Screening|Lost to Follow-up|0|||
23638991|NCT02248818|66064427|FG002|Screening|Lost to Follow-up|0|||
23638992|NCT02248818|66064428|FG003|Screening|Lost to Follow-up|0|||
23638993|NCT02248818|66064429|FG004|Screening|Lost to Follow-up|0|||
23638994|NCT02248818|66064430|FG005|Screening|Lost to Follow-up|0|||
23638995|NCT02248818|66064431|FG006|Screening|Lost to Follow-up|0|||
23638996|NCT02248818|66064432|FG007|Screening|Lost to Follow-up|0|||
23638997|NCT02248818|66064433|FG008|Screening|Lost to Follow-up|7|||
23638998|NCT02248818|66064425|FG000|Randomised Study|Administrative - randomization error|0|||
23638999|NCT02248818|66064426|FG001|Randomised Study|Administrative - randomization error|0|||
23639000|NCT02248818|66064427|FG002|Randomised Study|Administrative - randomization error|0|||
23639001|NCT02248818|66064428|FG003|Randomised Study|Administrative - randomization error|0|||
23639002|NCT02248818|66064429|FG004|Randomised Study|Administrative - randomization error|0|||
23639003|NCT02248818|66064430|FG005|Randomised Study|Administrative - randomization error|8|||
23639004|NCT02248818|66064431|FG006|Randomised Study|Administrative - randomization error|0|||
23639005|NCT02248818|66064432|FG007|Randomised Study|Administrative - randomization error|0|||
23639006|NCT02248818|66064433|FG008|Randomised Study|Administrative - randomization error|0|||
23639007|NCT00859222|66064440|FG000|Overall Study|Adverse Event|2|||
23639008|NCT00859222|66064441|FG001|Overall Study|Adverse Event|3|||
23639009|NCT00859222|66064442|FG002|Overall Study|Adverse Event|6|||
23639010|NCT00859222|66064443|FG003|Overall Study|Adverse Event|24|||
23639011|NCT00859222|66064444|FG004|Overall Study|Adverse Event|15|||
23639012|NCT00859222|66064440|FG000|Overall Study|DLT|1|||
23639013|NCT00859222|66064441|FG001|Overall Study|DLT|0|||
23639014|NCT00859222|66064442|FG002|Overall Study|DLT|0|||
23639015|NCT00859222|66064443|FG003|Overall Study|DLT|0|||
23639016|NCT00859222|66064444|FG004|Overall Study|DLT|0|||
23639017|NCT05330676|66064445|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
23639018|NCT05330676|66064446|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
23639019|NCT01262027|66064447|FG000|Overall Study|Adverse Event|1|||
23639020|NCT01262027|66064447|FG000|Overall Study|Withdrawal by Subject|3|||
23348225|NCT02134353|65018026|FG001|Overall Study|Adverse Event|6|||
23639021|NCT01262027|66064447|FG000|Overall Study|Protocol Violation|1|||
23639022|NCT03141905|66064448|FG000|Overall Study|Death|3|||
23639023|NCT03141905|66064449|FG001|Overall Study|Death|2|||
23639024|NCT03141905|66064448|FG000|Overall Study|Withdrawal by Subject|1|||
23639025|NCT03141905|66064449|FG001|Overall Study|Withdrawal by Subject|0|||
23639026|NCT03141905|66064448|FG000|Overall Study|Lost to Follow-up|3|||
23787999|NCT01695239|66603193|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
23639027|NCT03141905|66064449|FG001|Overall Study|Lost to Follow-up|7|||
23639028|NCT03141905|66064448|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
23788000|NCT01695239|66603194|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23788001|NCT01695239|66603195|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23348226|NCT02134353|65018025|FG000|Overall Study|Lost to Follow-up|1|||
23584196|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23639029|NCT03141905|66064449|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
23639030|NCT02075476|66064450|FG000|Overall Study|Death|2|||
23639031|NCT02075476|66064451|FG001|Overall Study|Death|2|||
23639032|NCT02075476|66064450|FG000|Overall Study|Lost to Follow-up|1|||
23639033|NCT02075476|66064451|FG001|Overall Study|Lost to Follow-up|3|||
23639034|NCT00663702|66064456|FG000|Overall Study|Adverse Event|8|||
23639035|NCT00663702|66064457|FG001|Overall Study|Adverse Event|4|||
23348227|NCT02134353|65018026|FG001|Overall Study|Lost to Follow-up|1|||
23788002|NCT01695239|66603196|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23788003|NCT01695239|66603197|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23788004|NCT01695239|66603198|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23788005|NCT01695239|66603199|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23788006|NCT01695239|66603186|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788007|NCT01695239|66603187|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788008|NCT01695239|66603188|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788009|NCT01695239|66603189|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788010|NCT01695239|66603190|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788011|NCT01695239|66603191|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788012|NCT01695239|66603192|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788013|NCT01695239|66603193|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
23788014|NCT01695239|66603194|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788015|NCT01695239|66603195|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788016|NCT01695239|66603196|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788017|NCT01695239|66603197|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788018|NCT01695239|66603198|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788019|NCT01695239|66603199|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23788020|NCT01695239|66603186|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23348228|NCT02134353|65018025|FG000|Overall Study|Lack of Efficacy|2|||
23348229|NCT02134353|65018026|FG001|Overall Study|Lack of Efficacy|1|||
23348230|NCT02134353|65018025|FG000|Overall Study|Withdrawal by Subject|12|||
23348231|NCT02134353|65018026|FG001|Overall Study|Withdrawal by Subject|13|||
23348232|NCT02134353|65018025|FG000|Overall Study|Death|0|||
23348233|NCT02134353|65018026|FG001|Overall Study|Death|1|||
23348234|NCT02134353|65018025|FG000|Overall Study|Pregnancy|0|||
23348235|NCT02134353|65018026|FG001|Overall Study|Pregnancy|1|||
23348236|NCT02134353|65018025|FG000|Overall Study|Relocation|1|||
23706192|NCT01258348|66301082|FG001|Overall Study|Adverse Event|1|||
23348237|NCT02134353|65018026|FG001|Overall Study|Relocation|0|||
23788021|NCT01695239|66603187|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23348238|NCT02134353|65018025|FG000|Overall Study|Other - Patient's Choice|0|||
23348239|NCT02134353|65018026|FG001|Overall Study|Other - Patient's Choice|1|||
23348240|NCT02124759|65018027|FG000|Overall Study|Withdrawal by Subject|3|||
23348241|NCT02124759|65018028|FG001|Overall Study|Withdrawal by Subject|1|||
23348242|NCT02124759|65018029|FG002|Overall Study|Withdrawal by Subject|1|||
23348243|NCT02124759|65018027|FG000|Overall Study|Screen Fail|2|||
23348244|NCT02124759|65018028|FG001|Overall Study|Screen Fail|2|||
23348245|NCT02124759|65018029|FG002|Overall Study|Screen Fail|3|||
23348246|NCT01440569|65018030|FG000|Main Study|Enrolled but not treated|1|||
23348247|NCT01440569|65018031|FG001|Main Study|Enrolled but not treated|0|||
23348248|NCT01440569|65018030|FG000|Main Study|Adverse Event|9|||
23348249|NCT01440569|65018031|FG001|Main Study|Adverse Event|0|||
23348250|NCT01440569|65018030|FG000|Main Study|Pregnancy|1|||
23348251|NCT01440569|65018031|FG001|Main Study|Pregnancy|0|||
23348252|NCT01440569|65018030|FG000|Main Study|Investigator's Discretion|1|||
23348253|NCT01440569|65018031|FG001|Main Study|Investigator's Discretion|1|||
23348254|NCT01440569|65018030|FG000|Main Study|Withdrew Consent|7|||
23348255|NCT01440569|65018031|FG001|Main Study|Withdrew Consent|1|||
23348256|NCT01440569|65018030|FG000|Main Study|Lost to Follow-up|13|||
23348257|NCT01440569|65018031|FG001|Main Study|Lost to Follow-up|2|||
23348258|NCT01440569|65018030|FG000|Main Study|Subject Non-Compliance|3|||
23348259|NCT01440569|65018031|FG001|Main Study|Subject Non-Compliance|0|||
23348260|NCT01440569|65018030|FG000|Main Study|Protocol Violation|1|||
23348261|NCT01440569|65018031|FG001|Main Study|Protocol Violation|0|||
23348262|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Adverse Event|3|||
23348263|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Adverse Event|0|||
23348264|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Pregnancy|1|||
23348265|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Pregnancy|0|||
23348266|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
23348267|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
23348268|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
23348269|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
23348270|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
23348271|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
23348272|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
23348273|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
23348274|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
23348275|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
23348276|NCT01717391|65018032|FG000|Overall Study|Withdrawal by Subject|5|||
23348277|NCT01717391|65018032|FG000|Overall Study|Physician Decision|1|||
23348278|NCT01717391|65018032|FG000|Overall Study|FLT technical failure|3|||
23348279|NCT01606748|65018037|FG000|Overall Study|Adverse Event|1|||
23348280|NCT01606748|65018038|FG001|Overall Study|Adverse Event|0|||
23348281|NCT01606748|65018037|FG000|Overall Study|Progressive Disease|1|||
23348282|NCT01606748|65018038|FG001|Overall Study|Progressive Disease|0|||
23460147|NCT01668784|65427964|FG001|Treatment Period|Disease Progression|293|||
23788022|NCT01695239|66603188|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788023|NCT01695239|66603189|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788024|NCT01695239|66603190|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788025|NCT01695239|66603191|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788026|NCT01695239|66603192|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788027|NCT01695239|66603193|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
23788028|NCT01695239|66603194|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788029|NCT01695239|66603195|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23584197|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23788030|NCT01695239|66603196|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788031|NCT01695239|66603197|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23348283|NCT01606748|65018037|FG000|Overall Study|Withdrawal by Subject|1|||
23348284|NCT01606748|65018038|FG001|Overall Study|Withdrawal by Subject|0|||
23348285|NCT03181503|65018039|FG000|Overall Study|Adverse Event|2|||
23348286|NCT03181503|65018040|FG001|Overall Study|Adverse Event|2|||
23348287|NCT03181503|65018039|FG000|Overall Study|Protocol Violation|1|||
23584198|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584199|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584200|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584201|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584202|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584203|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584204|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584205|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584206|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
23584207|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584208|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584209|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
23584210|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584211|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584212|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584213|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584214|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584215|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
23584216|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
23584217|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584218|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584219|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584220|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
23584221|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584222|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584223|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584224|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584225|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584226|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
23584227|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
23584228|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
23584229|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
23584230|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
23584231|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
23584232|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584233|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584234|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584235|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584236|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584237|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
23584238|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
23584239|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
23584240|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
23584241|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
23584242|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
23584243|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584244|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584245|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584246|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23788032|NCT01695239|66603198|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788033|NCT01695239|66603199|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23788034|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788035|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788036|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788037|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788038|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788039|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788040|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788041|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788042|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
23788043|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
23788044|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788045|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788046|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788047|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23788048|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
23788049|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
23788050|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
23788051|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
23788052|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
23788053|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
23788054|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
23788055|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
23788056|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
23788057|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
23788058|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
23788059|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
23788060|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
23788061|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
23788062|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788063|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788064|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788065|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788066|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788067|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788068|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23348288|NCT03181503|65018040|FG001|Overall Study|Protocol Violation|0|||
23348289|NCT03181503|65018039|FG000|Overall Study|Withdrawal by Subject|3|||
23348290|NCT03181503|65018040|FG001|Overall Study|Withdrawal by Subject|0|||
23348291|NCT03181503|65018039|FG000|Overall Study|Lost to Follow-up|1|||
23348292|NCT03181503|65018040|FG001|Overall Study|Lost to Follow-up|1|||
23348293|NCT03422159|65018044|FG000|Overall Study|Exclusion due to terminal disease|2|||
23348294|NCT03422159|65018045|FG001|Overall Study|Exclusion due to terminal disease|1|||
23348295|NCT04599933|65018047|FG000|Overall Study|Adverse Event|4|||
23584247|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584248|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584249|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
23348296|NCT04599933|65018048|FG001|Overall Study|Adverse Event|1|||
23460148|NCT01668784|65427963|FG000|Treatment Period|Study Drug Toxicity|46|||
23348297|NCT04599933|65018047|FG000|Overall Study|Withdrawal by Subject|4|||
23348298|NCT04599933|65018048|FG001|Overall Study|Withdrawal by Subject|2|||
23348299|NCT04599933|65018047|FG000|Overall Study|Lost to Follow-up|0|||
23348300|NCT04599933|65018048|FG001|Overall Study|Lost to Follow-up|1|||
23348301|NCT04599933|65018047|FG000|Overall Study|Physician Decision|0|||
23348302|NCT04599933|65018048|FG001|Overall Study|Physician Decision|1|||
23348303|NCT04599933|65018047|FG000|Overall Study|Screen Failure|1|||
23348304|NCT04599933|65018048|FG001|Overall Study|Screen Failure|2|||
23348305|NCT02101359|65018049|FG000|Overall Study|Not included|23|||
23348306|NCT02101359|65018050|FG001|Overall Study|Not included|13|||
23348307|NCT02101359|65018049|FG000|Overall Study|Withdrawal by Subject|5|||
23348308|NCT02101359|65018050|FG001|Overall Study|Withdrawal by Subject|4|||
23348309|NCT02101359|65018049|FG000|Overall Study|Lost to Follow-up|1|||
23348310|NCT02101359|65018050|FG001|Overall Study|Lost to Follow-up|0|||
23348311|NCT02101359|65018049|FG000|Overall Study|Protocol Violation|0|||
23348312|NCT02101359|65018050|FG001|Overall Study|Protocol Violation|2|||
23788069|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788070|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
23788071|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
23788072|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788073|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788074|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788075|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23788076|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
23788077|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
23788078|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
23788079|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
23788080|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
23788081|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
23788082|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
23788083|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
23788084|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
23788085|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
23788086|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
23788087|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
23788088|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
23348313|NCT01472939|65018052|FG000|Overall Study|Adverse Event|3|||
23348314|NCT01472939|65018053|FG001|Overall Study|Adverse Event|7|||
23348315|NCT01472939|65018054|FG002|Overall Study|Adverse Event|7|||
23348316|NCT01472939|65018055|FG003|Overall Study|Adverse Event|14|||
23348317|NCT01472939|65018052|FG000|Overall Study|Lack of Efficacy|1|||
23348318|NCT01472939|65018053|FG001|Overall Study|Lack of Efficacy|0|||
23348319|NCT01472939|65018054|FG002|Overall Study|Lack of Efficacy|0|||
23584250|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
23788089|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
23348320|NCT01472939|65018055|FG003|Overall Study|Lack of Efficacy|1|||
23348321|NCT01472939|65018052|FG000|Overall Study|Lost to Follow-up|3|||
23348322|NCT01472939|65018053|FG001|Overall Study|Lost to Follow-up|0|||
23348323|NCT01472939|65018054|FG002|Overall Study|Lost to Follow-up|2|||
23348324|NCT01472939|65018055|FG003|Overall Study|Lost to Follow-up|0|||
23348325|NCT01472939|65018052|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23460149|NCT01668784|65427964|FG001|Treatment Period|Study Drug Toxicity|53|||
23460150|NCT01668784|65427963|FG000|Treatment Period|Death|1|||
23460151|NCT01668784|65427964|FG001|Treatment Period|Death|1|||
23460152|NCT01668784|65427963|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
23460153|NCT01668784|65427964|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
23460154|NCT01668784|65427963|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
23460155|NCT01668784|65427964|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
23460156|NCT01668784|65427963|FG000|Treatment Period|Withdrawal by Subject|5|||
23460157|NCT01668784|65427964|FG001|Treatment Period|Withdrawal by Subject|3|||
23460158|NCT01668784|65427963|FG000|Treatment Period|Maximal Clinical Benefit|3|||
23460159|NCT01668784|65427964|FG001|Treatment Period|Maximal Clinical Benefit|3|||
23460160|NCT01668784|65427963|FG000|Treatment Period|Other|2|||
23460161|NCT01668784|65427964|FG001|Treatment Period|Other|8|||
23460162|NCT01668784|65427963|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
23460163|NCT01668784|65427964|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
23460164|NCT01838694|65427965|FG000|Overall Study|Adverse Event|0|||
23460165|NCT01838694|65427966|FG001|Overall Study|Adverse Event|1|||
23460166|NCT04949490|65427967|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23584251|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
23584252|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
23584253|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584254|NCT02577523|65866114|FG000|Overall Study|Adverse Event|1|||
23584255|NCT02577523|65866115|FG001|Overall Study|Adverse Event|1|||
23788090|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788091|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788092|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788093|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788094|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788095|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788096|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788097|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788098|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
23788099|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
23788100|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788101|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788102|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788103|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23788104|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788105|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788106|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788107|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788108|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788109|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788110|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788111|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788112|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
23584256|NCT02577523|65866114|FG000|Overall Study|Lack of Efficacy|1|||
23584257|NCT02577523|65866115|FG001|Overall Study|Lack of Efficacy|1|||
23584258|NCT02577523|65866114|FG000|Overall Study|Withdrawal by Subject|1|||
23584259|NCT02577523|65866115|FG001|Overall Study|Withdrawal by Subject|0|||
23584260|NCT01565928|65866116|FG000|Overall Study|Adverse Event|3|||
23584261|NCT01565928|65866116|FG000|Overall Study|Other|3|||
23584262|NCT01565928|65866116|FG000|Overall Study|Progressive Disease|13|||
23584263|NCT01565928|65866116|FG000|Overall Study|Withdrawal by Subject|1|||
23584264|NCT01565928|65866116|FG000|Overall Study|Death|2|||
23584265|NCT03834493|65866117|FG000|Overall Study|Participants Ongoing|311|||
23584266|NCT03834493|65866118|FG001|Overall Study|Participants Ongoing|324|||
23584267|NCT03834493|65866117|FG000|Overall Study|Withdrawal by Subject|20|||
23584268|NCT03834493|65866118|FG001|Overall Study|Withdrawal by Subject|17|||
23584269|NCT03834493|65866117|FG000|Overall Study|Physician Decision|1|||
23788113|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
23788114|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788115|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23460167|NCT04949490|65427968|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460168|NCT04949490|65427969|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460169|NCT04949490|65427970|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
23460170|NCT04949490|65427971|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23584270|NCT03834493|65866118|FG001|Overall Study|Physician Decision|0|||
23584271|NCT03834493|65866117|FG000|Overall Study|Death|289|||
23584272|NCT03834493|65866118|FG001|Overall Study|Death|282|||
23584273|NCT02949271|65866119|FG000|Overall Study|Lack of Efficacy|5|||
23788116|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788117|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23788118|NCT01695239|66603186|FG000|Extension Long-Term Extension Periods|Death|0|||
23788119|NCT01695239|66603187|FG001|Extension Long-Term Extension Periods|Death|0|||
23788120|NCT01695239|66603188|FG002|Extension Long-Term Extension Periods|Death|0|||
23788121|NCT01695239|66603189|FG003|Extension Long-Term Extension Periods|Death|0|||
23460171|NCT04949490|65427972|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460172|NCT04949490|65427967|FG000|Group A and Group B|Withdrawal by Subject|0|||
23460173|NCT04949490|65427968|FG001|Group A and Group B|Withdrawal by Subject|0|||
23460174|NCT04949490|65427969|FG002|Group A and Group B|Withdrawal by Subject|1|||
23460175|NCT04949490|65427970|FG003|Group A and Group B|Withdrawal by Subject|0|||
23460176|NCT04949490|65427971|FG004|Group A and Group B|Withdrawal by Subject|0|||
23460177|NCT04949490|65427972|FG005|Group A and Group B|Withdrawal by Subject|0|||
23460178|NCT04949490|65427967|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460179|NCT04949490|65427968|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460180|NCT04949490|65427969|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460181|NCT04949490|65427970|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460182|NCT04949490|65427971|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460183|NCT04949490|65427972|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
23460184|NCT04949490|65427967|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460185|NCT04949490|65427968|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460186|NCT04949490|65427969|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460187|NCT04949490|65427970|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460188|NCT04949490|65427971|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
23348326|NCT01472939|65018053|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23348327|NCT01472939|65018054|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
23348328|NCT01472939|65018055|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23348329|NCT01472939|65018052|FG000|Overall Study|Prohibited Medication|0|||
23348330|NCT01472939|65018053|FG001|Overall Study|Prohibited Medication|1|||
23348331|NCT01472939|65018054|FG002|Overall Study|Prohibited Medication|0|||
23348332|NCT01472939|65018055|FG003|Overall Study|Prohibited Medication|0|||
23348333|NCT01472939|65018052|FG000|Overall Study|Withdrawal By PI|1|||
23348334|NCT01472939|65018053|FG001|Overall Study|Withdrawal By PI|0|||
23348335|NCT01472939|65018054|FG002|Overall Study|Withdrawal By PI|0|||
23348336|NCT01472939|65018055|FG003|Overall Study|Withdrawal By PI|0|||
23348337|NCT01472939|65018052|FG000|Overall Study|Protocol Violation|3|||
23348338|NCT01472939|65018053|FG001|Overall Study|Protocol Violation|3|||
23348339|NCT01472939|65018054|FG002|Overall Study|Protocol Violation|0|||
23348340|NCT01472939|65018055|FG003|Overall Study|Protocol Violation|1|||
23348341|NCT01472939|65018052|FG000|Overall Study|Withdrawal by Subject|9|||
23348342|NCT01472939|65018053|FG001|Overall Study|Withdrawal by Subject|3|||
23348343|NCT01472939|65018054|FG002|Overall Study|Withdrawal by Subject|1|||
23348344|NCT01472939|65018055|FG003|Overall Study|Withdrawal by Subject|4|||
23348345|NCT00401960|65018056|FG000|Overall Study|Lost to Follow-up|3|||
23348346|NCT00401960|65018057|FG001|Overall Study|Lost to Follow-up|0|||
23348347|NCT00401960|65018056|FG000|Overall Study|Death|2|||
23348348|NCT00401960|65018057|FG001|Overall Study|Death|0|||
23348349|NCT03558152|65018058|FG000|Overall Study|Adverse Event|0|||
23348350|NCT03558152|65018059|FG001|Overall Study|Adverse Event|0|||
23348351|NCT03558152|65018060|FG002|Overall Study|Adverse Event|1|||
23348352|NCT03558152|65018061|FG003|Overall Study|Adverse Event|1|||
23348353|NCT03558152|65018062|FG004|Overall Study|Adverse Event|2|||
23348354|NCT03558152|65018063|FG005|Overall Study|Adverse Event|1|||
23348355|NCT03558152|65018064|FG006|Overall Study|Adverse Event|1|||
23348356|NCT03558152|65018065|FG007|Overall Study|Adverse Event|0|||
23348357|NCT03558152|65018058|FG000|Overall Study|Death|0|||
23348358|NCT03558152|65018059|FG001|Overall Study|Death|0|||
23348359|NCT03558152|65018060|FG002|Overall Study|Death|0|||
23348360|NCT03558152|65018061|FG003|Overall Study|Death|0|||
23348361|NCT03558152|65018062|FG004|Overall Study|Death|1|||
23460189|NCT04949490|65427972|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460190|NCT01285323|65427973|FG000|Overall Study|Adverse Event|9|||
23788122|NCT01695239|66603190|FG004|Extension Long-Term Extension Periods|Death|0|||
23348362|NCT03558152|65018063|FG005|Overall Study|Death|0|||
23788123|NCT01695239|66603191|FG005|Extension Long-Term Extension Periods|Death|0|||
23788124|NCT01695239|66603192|FG006|Extension Long-Term Extension Periods|Death|0|||
23788125|NCT01695239|66603193|FG007|Extension Long-Term Extension Periods|Death|0|||
23788126|NCT01695239|66603194|FG008|Extension Long-Term Extension Periods|Death|1|||
23788127|NCT01695239|66603195|FG009|Extension Long-Term Extension Periods|Death|0|||
23348363|NCT03558152|65018064|FG006|Overall Study|Death|0|||
23348364|NCT03558152|65018065|FG007|Overall Study|Death|0|||
23460191|NCT01285323|65427974|FG001|Overall Study|Adverse Event|8|||
23460192|NCT01285323|65427973|FG000|Overall Study|Lack of Efficacy|4|||
23460193|NCT01285323|65427974|FG001|Overall Study|Lack of Efficacy|2|||
23460194|NCT01285323|65427973|FG000|Overall Study|Withdrawal by Subject|15|||
23460195|NCT01285323|65427974|FG001|Overall Study|Withdrawal by Subject|11|||
23460196|NCT01285323|65427973|FG000|Overall Study|Protocol Violation|1|||
23460197|NCT01285323|65427974|FG001|Overall Study|Protocol Violation|2|||
23460198|NCT01285323|65427973|FG000|Overall Study|Non-compliance with study procedures|2|||
23460199|NCT01285323|65427974|FG001|Overall Study|Non-compliance with study procedures|3|||
23460200|NCT01285323|65427973|FG000|Overall Study|Lost to Follow-up|1|||
23460201|NCT01285323|65427974|FG001|Overall Study|Lost to Follow-up|1|||
23460202|NCT01285323|65427973|FG000|Overall Study|Other|1|||
23460203|NCT01285323|65427974|FG001|Overall Study|Other|3|||
23460204|NCT05530252|65427985|FG000|Overall Study|Lost to Follow-up|1|||
23460205|NCT05530252|65427986|FG001|Overall Study|Lost to Follow-up|1|||
23460206|NCT05530252|65427987|FG002|Overall Study|Lost to Follow-up|1|||
23460207|NCT04456504|65427988|FG000|Overall Study|Lost to Follow-up|2|||
23460208|NCT00541658|65427989|FG000|Overall Study|Adverse Event|28|||
23460209|NCT00541658|65427990|FG001|Overall Study|Adverse Event|37|||
23460210|NCT00541658|65427991|FG002|Overall Study|Adverse Event|25|||
23460211|NCT00541658|65427989|FG000|Overall Study|Physician Decision|0|||
23460212|NCT00541658|65427990|FG001|Overall Study|Physician Decision|0|||
23460213|NCT00541658|65427991|FG002|Overall Study|Physician Decision|4|||
23460214|NCT00541658|65427989|FG000|Overall Study|Lost to Follow-up|3|||
23460215|NCT00541658|65427990|FG001|Overall Study|Lost to Follow-up|3|||
23460216|NCT00541658|65427991|FG002|Overall Study|Lost to Follow-up|6|||
23460217|NCT00541658|65427989|FG000|Overall Study|Protocol Violation|0|||
23460218|NCT00541658|65427990|FG001|Overall Study|Protocol Violation|1|||
23460219|NCT00541658|65427991|FG002|Overall Study|Protocol Violation|1|||
23460220|NCT00541658|65427989|FG000|Overall Study|Withdrawal by Subject|28|||
23460221|NCT00541658|65427990|FG001|Overall Study|Withdrawal by Subject|32|||
23460222|NCT00541658|65427991|FG002|Overall Study|Withdrawal by Subject|32|||
23460223|NCT00541658|65427989|FG000|Overall Study|Took No Study Drug|1|||
23460224|NCT00541658|65427990|FG001|Overall Study|Took No Study Drug|0|||
23460225|NCT00541658|65427991|FG002|Overall Study|Took No Study Drug|0|||
23460226|NCT01409707|65427992|FG000|Overall Study|Withdrawal by Subject|5|||
23460227|NCT01409707|65427993|FG001|Overall Study|Withdrawal by Subject|17|||
23460228|NCT01409707|65427994|FG002|Overall Study|Withdrawal by Subject|16|||
23460229|NCT00911170|65427995|FG000|Treatment Period|Randomized in error|1|||
23460230|NCT00911170|65427996|FG001|Treatment Period|Randomized in error|1|||
23460231|NCT00911170|65427995|FG000|Treatment Period|Ineligibility determined|1|||
23460232|NCT00911170|65427996|FG001|Treatment Period|Ineligibility determined|3|||
23460233|NCT00911170|65427995|FG000|Treatment Period|Protocol deviation|1|||
23348365|NCT03558152|65018058|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
23460234|NCT00911170|65427996|FG001|Treatment Period|Protocol deviation|2|||
23460235|NCT00911170|65427995|FG000|Treatment Period|Adverse Event|9|||
23788128|NCT01695239|66603196|FG010|Extension Long-Term Extension Periods|Death|0|||
23788129|NCT01695239|66603197|FG011|Extension Long-Term Extension Periods|Death|0|||
23788130|NCT01695239|66603198|FG012|Extension Long-Term Extension Periods|Death|0|||
23788131|NCT01695239|66603199|FG013|Extension Long-Term Extension Periods|Death|0|||
23788132|NCT01695239|66603186|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23460236|NCT00911170|65427996|FG001|Treatment Period|Adverse Event|10|||
23460237|NCT00911170|65427995|FG000|Treatment Period|Withdrawal by Subject|4|||
23460238|NCT00911170|65427996|FG001|Treatment Period|Withdrawal by Subject|4|||
23584274|NCT02949271|65866120|FG001|Overall Study|Lack of Efficacy|4|||
23584275|NCT02949271|65866119|FG000|Overall Study|Lost to Follow-up|3|||
23788133|NCT01695239|66603187|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788134|NCT01695239|66603188|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788135|NCT01695239|66603189|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23460239|NCT00911170|65427995|FG000|Treatment Period|Disease progression|0|||
23460240|NCT00911170|65427996|FG001|Treatment Period|Disease progression|2|||
23460241|NCT00911170|65427995|FG000|Treatment Period|Physician Decision|5|||
23460242|NCT00911170|65427996|FG001|Treatment Period|Physician Decision|5|||
23460243|NCT00911170|65427995|FG000|Treatment Period|Lost to Follow-up|0|||
23584276|NCT02949271|65866120|FG001|Overall Study|Lost to Follow-up|6|||
23584277|NCT02949271|65866119|FG000|Overall Study|Physician Decision|5|||
23584278|NCT02949271|65866120|FG001|Overall Study|Physician Decision|5|||
23584279|NCT02949271|65866119|FG000|Overall Study|Protocol Violation|6|||
23584280|NCT02949271|65866120|FG001|Overall Study|Protocol Violation|3|||
23584281|NCT02949271|65866119|FG000|Overall Study|Withdrawal by Subject|1|||
23584282|NCT02949271|65866120|FG001|Overall Study|Withdrawal by Subject|0|||
23788136|NCT01695239|66603190|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23584283|NCT02949271|65866119|FG000|Overall Study|Delivered prior to intervention|7|||
23460244|NCT00911170|65427996|FG001|Treatment Period|Lost to Follow-up|1|||
23460245|NCT00911170|65427995|FG000|Treatment Period|Death|6|||
23460246|NCT00911170|65427996|FG001|Treatment Period|Death|9|||
23460247|NCT00911170|65427995|FG000|Long Term Follow-Up|Continuing in study|274|||
23460248|NCT00911170|65427996|FG001|Long Term Follow-Up|Continuing in study|269|||
23460249|NCT00911170|65427995|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
23460250|NCT00911170|65427996|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
23788137|NCT01695239|66603191|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788138|NCT01695239|66603192|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788139|NCT01695239|66603193|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788140|NCT01695239|66603194|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788141|NCT01695239|66603195|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788142|NCT01695239|66603196|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23788143|NCT01695239|66603197|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23788144|NCT01695239|66603198|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
23460251|NCT00911170|65427995|FG000|Long Term Follow-Up|Physician Decision|5|||
23460252|NCT00911170|65427996|FG001|Long Term Follow-Up|Physician Decision|4|||
23460253|NCT00911170|65427995|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
23460254|NCT00911170|65427996|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
23460255|NCT00911170|65427995|FG000|Long Term Follow-Up|Death|116|||
23460256|NCT00911170|65427996|FG001|Long Term Follow-Up|Death|121|||
23460257|NCT00385671|65427997|FG000|Overall Study|Adverse Event|14|||
23460258|NCT00385671|65427998|FG001|Overall Study|Adverse Event|27|||
23460259|NCT00385671|65427999|FG002|Overall Study|Adverse Event|18|||
23460260|NCT00385671|65427997|FG000|Overall Study|Lack of Efficacy|5|||
23460261|NCT00385671|65427998|FG001|Overall Study|Lack of Efficacy|9|||
23460262|NCT00385671|65427999|FG002|Overall Study|Lack of Efficacy|5|||
23460263|NCT00385671|65427997|FG000|Overall Study|Lost to Follow-up|6|||
23460264|NCT00385671|65427998|FG001|Overall Study|Lost to Follow-up|6|||
23460265|NCT00385671|65427999|FG002|Overall Study|Lost to Follow-up|5|||
23460266|NCT00385671|65427997|FG000|Overall Study|Physician Decision|2|||
23460267|NCT00385671|65427998|FG001|Overall Study|Physician Decision|1|||
23460268|NCT00385671|65427999|FG002|Overall Study|Physician Decision|2|||
23584284|NCT02949271|65866120|FG001|Overall Study|Delivered prior to intervention|9|||
23584285|NCT02949271|65866119|FG000|Overall Study|Outside the window for cervical dilation|2|||
23584286|NCT02949271|65866120|FG001|Overall Study|Outside the window for cervical dilation|3|||
23584287|NCT01119950|65866128|FG000|Overall Study|Adverse Event|25|||
23584288|NCT01119950|65866128|FG000|Overall Study|Withdrawal by Subject|9|||
23584289|NCT01119950|65866128|FG000|Overall Study|Protocol Violation|5|||
23584290|NCT01119950|65866128|FG000|Overall Study|Lost to Follow-up|4|||
23584291|NCT01119950|65866128|FG000|Overall Study|Administrative|2|||
23584292|NCT01119950|65866128|FG000|Overall Study|Abnormal lab value|1|||
23584293|NCT01119950|65866128|FG000|Overall Study|Death|1|||
23584294|NCT01516892|65866129|FG000|Overall Study|Adverse Event|25|||
23584295|NCT01516892|65866129|FG000|Overall Study|Lack of Efficacy|35|||
23460269|NCT00385671|65427997|FG000|Overall Study|Protocol Violation|5|||
23460270|NCT00385671|65427998|FG001|Overall Study|Protocol Violation|2|||
23460271|NCT00385671|65427999|FG002|Overall Study|Protocol Violation|1|||
23460272|NCT00385671|65427997|FG000|Overall Study|Sponsor Decision|2|||
23460273|NCT00385671|65427998|FG001|Overall Study|Sponsor Decision|2|||
23584296|NCT01516892|65866129|FG000|Overall Study|Pregnancy|5|||
23639036|NCT00663702|66064456|FG000|Overall Study|Withdrawal by Subject|3|||
23460274|NCT00385671|65427999|FG002|Overall Study|Sponsor Decision|1|||
23460275|NCT00385671|65427997|FG000|Overall Study|Withdrawal by Subject|4|||
23639037|NCT00663702|66064457|FG001|Overall Study|Withdrawal by Subject|1|||
23348366|NCT03558152|65018059|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348367|NCT03558152|65018060|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348368|NCT03558152|65018061|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348369|NCT03558152|65018062|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348370|NCT03558152|65018063|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348371|NCT03558152|65018064|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348372|NCT03558152|65018065|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348373|NCT03558152|65018058|FG000|Overall Study|Miscalculation in mmcs|0|||
23348374|NCT03558152|65018059|FG001|Overall Study|Miscalculation in mmcs|0|||
23348375|NCT03558152|65018060|FG002|Overall Study|Miscalculation in mmcs|0|||
23348376|NCT03558152|65018061|FG003|Overall Study|Miscalculation in mmcs|0|||
23348377|NCT03558152|65018062|FG004|Overall Study|Miscalculation in mmcs|0|||
23348378|NCT03558152|65018063|FG005|Overall Study|Miscalculation in mmcs|0|||
23348379|NCT03558152|65018064|FG006|Overall Study|Miscalculation in mmcs|1|||
23639038|NCT00663702|66064456|FG000|Overall Study|Pregnancy|0|||
23639039|NCT00663702|66064457|FG001|Overall Study|Pregnancy|1|||
23639040|NCT00663702|66064456|FG000|Overall Study|Lost to Follow-up|3|||
23639041|NCT00663702|66064457|FG001|Overall Study|Lost to Follow-up|0|||
23639042|NCT00663702|66064456|FG000|Overall Study|Death|1|||
23639043|NCT00663702|66064457|FG001|Overall Study|Death|1|||
23639044|NCT00663702|66064456|FG000|Overall Study|Lack of Efficacy|3|||
23639045|NCT00663702|66064457|FG001|Overall Study|Lack of Efficacy|3|||
23639046|NCT01517295|66064458|FG000|Overall Study|Physician Decision|1|||
23348380|NCT03558152|65018065|FG007|Overall Study|Miscalculation in mmcs|0|||
23348381|NCT03558152|65018058|FG000|Overall Study|Mistake in calculation|0|||
23348382|NCT03558152|65018059|FG001|Overall Study|Mistake in calculation|0|||
23348383|NCT03558152|65018060|FG002|Overall Study|Mistake in calculation|0|||
23639047|NCT01517295|66064459|FG001|Overall Study|Physician Decision|0|||
23639048|NCT00929110|66064460|FG000|Overall Study|Adverse Event|40|||
23639049|NCT00929110|66064461|FG001|Overall Study|Adverse Event|29|||
23460276|NCT00385671|65427998|FG001|Overall Study|Withdrawal by Subject|4|||
23460277|NCT00385671|65427999|FG002|Overall Study|Withdrawal by Subject|4|||
23639050|NCT00929110|66064462|FG002|Overall Study|Adverse Event|18|||
23639051|NCT00929110|66064460|FG000|Overall Study|Subject withdrew consent|40|||
23639052|NCT00929110|66064461|FG001|Overall Study|Subject withdrew consent|23|||
23639053|NCT00929110|66064462|FG002|Overall Study|Subject withdrew consent|26|||
23639054|NCT00929110|66064460|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
23639055|NCT00929110|66064461|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
23639056|NCT00929110|66064462|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23639057|NCT00929110|66064460|FG000|Overall Study|Lost to Follow-up|7|||
23348384|NCT03558152|65018061|FG003|Overall Study|Mistake in calculation|1|||
23348385|NCT03558152|65018062|FG004|Overall Study|Mistake in calculation|0|||
23348386|NCT03558152|65018063|FG005|Overall Study|Mistake in calculation|0|||
23348387|NCT03558152|65018064|FG006|Overall Study|Mistake in calculation|0|||
23348388|NCT03558152|65018065|FG007|Overall Study|Mistake in calculation|0|||
23348389|NCT03558152|65018058|FG000|Overall Study|Mistake in evaluation of disease status|0|||
23348390|NCT03558152|65018059|FG001|Overall Study|Mistake in evaluation of disease status|0|||
23348391|NCT03558152|65018060|FG002|Overall Study|Mistake in evaluation of disease status|0|||
23348392|NCT03558152|65018061|FG003|Overall Study|Mistake in evaluation of disease status|0|||
23348393|NCT03558152|65018062|FG004|Overall Study|Mistake in evaluation of disease status|0|||
23348394|NCT03558152|65018063|FG005|Overall Study|Mistake in evaluation of disease status|0|||
23348395|NCT03558152|65018064|FG006|Overall Study|Mistake in evaluation of disease status|0|||
23348396|NCT03558152|65018065|FG007|Overall Study|Mistake in evaluation of disease status|1|||
23788145|NCT01695239|66603199|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23788146|NCT01695239|66603186|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788147|NCT01695239|66603187|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788148|NCT01695239|66603188|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788149|NCT01695239|66603189|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788150|NCT01695239|66603190|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788151|NCT01695239|66603191|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788152|NCT01695239|66603192|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788153|NCT01695239|66603193|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788154|NCT01695239|66603194|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788155|NCT01695239|66603195|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788156|NCT01695239|66603196|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23788157|NCT01695239|66603197|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23348397|NCT03558152|65018058|FG000|Overall Study|Physician Decision|0|||
23348398|NCT03558152|65018059|FG001|Overall Study|Physician Decision|0|||
23788158|NCT01695239|66603198|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23788159|NCT01695239|66603199|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23788160|NCT01695239|66603186|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
23348399|NCT03558152|65018060|FG002|Overall Study|Physician Decision|0|||
23348400|NCT03558152|65018061|FG003|Overall Study|Physician Decision|0|||
23348401|NCT03558152|65018062|FG004|Overall Study|Physician Decision|0|||
23348402|NCT03558152|65018063|FG005|Overall Study|Physician Decision|0|||
23348403|NCT03558152|65018064|FG006|Overall Study|Physician Decision|1|||
23348404|NCT03558152|65018065|FG007|Overall Study|Physician Decision|0|||
23348405|NCT03558152|65018058|FG000|Overall Study|Withdrawal by Subject|2|||
23348406|NCT03558152|65018059|FG001|Overall Study|Withdrawal by Subject|3|||
23348407|NCT03558152|65018060|FG002|Overall Study|Withdrawal by Subject|2|||
23348408|NCT03558152|65018061|FG003|Overall Study|Withdrawal by Subject|1|||
23348409|NCT03558152|65018062|FG004|Overall Study|Withdrawal by Subject|1|||
23348410|NCT03558152|65018063|FG005|Overall Study|Withdrawal by Subject|1|||
23348411|NCT03558152|65018064|FG006|Overall Study|Withdrawal by Subject|3|||
23348412|NCT03558152|65018065|FG007|Overall Study|Withdrawal by Subject|2|||
23348413|NCT03558152|65018058|FG000|Overall Study|Lack of Efficacy|11|||
23348414|NCT03558152|65018059|FG001|Overall Study|Lack of Efficacy|11|||
23348415|NCT03558152|65018060|FG002|Overall Study|Lack of Efficacy|10|||
23348416|NCT03558152|65018061|FG003|Overall Study|Lack of Efficacy|11|||
23348417|NCT03558152|65018062|FG004|Overall Study|Lack of Efficacy|14|||
23348418|NCT03558152|65018063|FG005|Overall Study|Lack of Efficacy|12|||
23348419|NCT03558152|65018064|FG006|Overall Study|Lack of Efficacy|14|||
23348420|NCT03558152|65018065|FG007|Overall Study|Lack of Efficacy|13|||
23348421|NCT03558152|65018058|FG000|Overall Study|Protocol Violation|1|||
23348422|NCT03558152|65018059|FG001|Overall Study|Protocol Violation|1|||
23348423|NCT03558152|65018060|FG002|Overall Study|Protocol Violation|0|||
23348424|NCT03558152|65018061|FG003|Overall Study|Protocol Violation|1|||
23348425|NCT03558152|65018062|FG004|Overall Study|Protocol Violation|1|||
23348426|NCT03558152|65018063|FG005|Overall Study|Protocol Violation|0|||
23348427|NCT03558152|65018064|FG006|Overall Study|Protocol Violation|2|||
23348428|NCT03558152|65018065|FG007|Overall Study|Protocol Violation|0|||
23348429|NCT00415597|65018066|FG000|Enrollment|Withdrawal by Subject|1|||
23348430|NCT00415597|65018066|FG000|Enrollment|Protocol Violation|1|||
23348431|NCT00415597|65018066|FG000|Treatment|Adverse Event|110|||
23348432|NCT00415597|65018066|FG000|Treatment|Lack of Efficacy|39|||
23348433|NCT00415597|65018066|FG000|Treatment|Protocol Violation|67|||
23348434|NCT00415597|65018066|FG000|Treatment|Physician Decision|3|||
23348435|NCT00415597|65018066|FG000|Treatment|Withdrawal by Subject|51|||
23348436|NCT00415597|65018066|FG000|Treatment|Lost to Follow-up|28|||
23348437|NCT00415597|65018066|FG000|Treatment|Drug Screen|2|||
23348438|NCT00415597|65018066|FG000|Treatment|Administrative|3|||
23348439|NCT00415597|65018066|FG000|Treatment|Sponsor Decision|1|||
23348440|NCT00415597|65018066|FG000|Treatment|Multiple Reasons|1|||
23348441|NCT00844480|65018074|FG000|Overall Study|Withdrawal by Subject|2|||
23348442|NCT00844480|65018075|FG001|Overall Study|Withdrawal by Subject|3|||
23348443|NCT01333956|65018076|FG000|Overall Study|Lost to Follow-up|1|||
23348444|NCT01333956|65018077|FG001|Overall Study|Lost to Follow-up|2|||
23584297|NCT01516892|65866129|FG000|Overall Study|Lost to Follow-up|82|||
23584298|NCT01516892|65866129|FG000|Overall Study|Subject Withdrew Consent|92|||
23584299|NCT01516892|65866129|FG000|Overall Study|Protocol Violation|60|||
23584300|NCT01516892|65866129|FG000|Overall Study|Other Miscellaneous Reasons|43|||
23584301|NCT01516892|65866129|FG000|Overall Study|Missing|1|||
23584302|NCT01769391|65866130|FG000|Overall Study|Death|10|||
23584303|NCT01769391|65866131|FG001|Overall Study|Death|1|||
23348445|NCT01333956|65018078|FG002|Overall Study|Lost to Follow-up|0|||
23348446|NCT01333956|65018079|FG003|Overall Study|Lost to Follow-up|1|||
23348447|NCT01333956|65018076|FG000|Overall Study|Unable to complete study procedure|1|||
23348448|NCT01333956|65018077|FG001|Overall Study|Unable to complete study procedure|0|||
23348449|NCT01333956|65018078|FG002|Overall Study|Unable to complete study procedure|0|||
23348450|NCT01333956|65018079|FG003|Overall Study|Unable to complete study procedure|1|||
23348451|NCT01333956|65018076|FG000|Overall Study|Withdrawal by Subject|0|||
23348452|NCT01333956|65018077|FG001|Overall Study|Withdrawal by Subject|2|||
23348453|NCT01333956|65018078|FG002|Overall Study|Withdrawal by Subject|1|||
23584304|NCT01769391|65866130|FG000|Overall Study|Adverse Event|0|||
23348454|NCT01333956|65018079|FG003|Overall Study|Withdrawal by Subject|0|||
23348455|NCT00603382|65018082|FG000|Overall Study|Adverse Event|0|||
23348456|NCT00603382|65018083|FG001|Overall Study|Adverse Event|1|||
23348457|NCT00603382|65018084|FG002|Overall Study|Adverse Event|1|||
23348458|NCT00603382|65018085|FG003|Overall Study|Adverse Event|2|||
23584305|NCT01769391|65866131|FG001|Overall Study|Adverse Event|3|||
23348459|NCT00603382|65018086|FG004|Overall Study|Adverse Event|1|||
23584306|NCT01769391|65866130|FG000|Overall Study|Progressive Disease|1|||
23584307|NCT01769391|65866131|FG001|Overall Study|Progressive Disease|2|||
23348460|NCT00603382|65018087|FG005|Overall Study|Adverse Event|2|||
23348461|NCT00603382|65018082|FG000|Overall Study|Lack of Efficacy|14|||
23348462|NCT00603382|65018083|FG001|Overall Study|Lack of Efficacy|9|||
23348463|NCT00603382|65018084|FG002|Overall Study|Lack of Efficacy|3|||
23348464|NCT00603382|65018085|FG003|Overall Study|Lack of Efficacy|6|||
23348465|NCT00603382|65018086|FG004|Overall Study|Lack of Efficacy|6|||
23348466|NCT00603382|65018087|FG005|Overall Study|Lack of Efficacy|11|||
23348467|NCT00603382|65018082|FG000|Overall Study|Protocol Violation|1|||
23348468|NCT00603382|65018083|FG001|Overall Study|Protocol Violation|0|||
23348469|NCT00603382|65018084|FG002|Overall Study|Protocol Violation|1|||
23348470|NCT00603382|65018085|FG003|Overall Study|Protocol Violation|2|||
23348471|NCT00603382|65018086|FG004|Overall Study|Protocol Violation|1|||
23348472|NCT00603382|65018087|FG005|Overall Study|Protocol Violation|0|||
23348473|NCT00603382|65018082|FG000|Overall Study|Lost to Follow-up|0|||
23348474|NCT00603382|65018083|FG001|Overall Study|Lost to Follow-up|1|||
23348475|NCT00603382|65018084|FG002|Overall Study|Lost to Follow-up|1|||
23348476|NCT00603382|65018085|FG003|Overall Study|Lost to Follow-up|1|||
23348477|NCT00603382|65018086|FG004|Overall Study|Lost to Follow-up|0|||
23348478|NCT00603382|65018087|FG005|Overall Study|Lost to Follow-up|1|||
23348479|NCT00603382|65018082|FG000|Overall Study|Physician Decision|0|||
23348480|NCT00603382|65018083|FG001|Overall Study|Physician Decision|0|||
23348481|NCT00603382|65018084|FG002|Overall Study|Physician Decision|2|||
23348482|NCT00603382|65018085|FG003|Overall Study|Physician Decision|0|||
23348483|NCT00603382|65018086|FG004|Overall Study|Physician Decision|1|||
23348484|NCT00603382|65018087|FG005|Overall Study|Physician Decision|3|||
23348485|NCT00603382|65018082|FG000|Overall Study|Withdrawal by Subject|3|||
23348486|NCT00603382|65018083|FG001|Overall Study|Withdrawal by Subject|3|||
23348487|NCT00603382|65018084|FG002|Overall Study|Withdrawal by Subject|1|||
23348488|NCT00603382|65018085|FG003|Overall Study|Withdrawal by Subject|1|||
23348489|NCT00603382|65018086|FG004|Overall Study|Withdrawal by Subject|0|||
23348490|NCT00603382|65018087|FG005|Overall Study|Withdrawal by Subject|1|||
23348491|NCT01069419|65018091|FG000|Overall Study|Adverse Event|233|||
23348492|NCT01069419|65018091|FG000|Overall Study|Lack of Efficacy|332|||
23348493|NCT01069419|65018091|FG000|Overall Study|Lost to Follow-up|49|||
23348494|NCT01069419|65018091|FG000|Overall Study|Remission of disease|11|||
23348495|NCT01069419|65018091|FG000|Overall Study|Withdrawal by Subject|34|||
23348496|NCT01069419|65018091|FG000|Overall Study|Other Reason|43|||
23348497|NCT01069419|65018091|FG000|Overall Study|Missing termination information|13|||
23348498|NCT00987402|65018092|FG000|Overall Study|Insufficient data entry|86|||
23348499|NCT00987402|65018093|FG001|Overall Study|Insufficient data entry|98|||
23348500|NCT00904839|65018094|FG000|Overall Study|Adverse Event|0|||
23348501|NCT00904839|65018095|FG001|Overall Study|Adverse Event|5|||
23348502|NCT00904839|65018096|FG002|Overall Study|Adverse Event|4|||
23348503|NCT00904839|65018094|FG000|Overall Study|Protocol Violation|0|||
23348504|NCT00904839|65018095|FG001|Overall Study|Protocol Violation|1|||
23348505|NCT00904839|65018096|FG002|Overall Study|Protocol Violation|1|||
23348506|NCT00904839|65018094|FG000|Overall Study|Lost to Follow-up|0|||
23460283|NCT03350672|65430684|FG000|Overall Study|Withdrawal by Subject|7|||
23460284|NCT03350672|65430685|FG001|Overall Study|Withdrawal by Subject|0|||
23460285|NCT03350672|65430686|FG002|Overall Study|Withdrawal by Subject|0|||
23788161|NCT01695239|66603187|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788162|NCT01695239|66603188|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788163|NCT01695239|66603189|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788164|NCT01695239|66603190|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788165|NCT01695239|66603191|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788166|NCT01695239|66603192|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788167|NCT01695239|66603193|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788168|NCT01695239|66603194|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788169|NCT01695239|66603195|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788170|NCT01695239|66603196|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788171|NCT01695239|66603197|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
23788172|NCT01695239|66603198|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
23788173|NCT01695239|66603199|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
23348507|NCT00904839|65018095|FG001|Overall Study|Lost to Follow-up|1|||
23348508|NCT00904839|65018096|FG002|Overall Study|Lost to Follow-up|2|||
23348509|NCT00904839|65018094|FG000|Overall Study|Withdrawal by Subject|0|||
23348510|NCT00904839|65018095|FG001|Overall Study|Withdrawal by Subject|2|||
23348511|NCT00904839|65018096|FG002|Overall Study|Withdrawal by Subject|0|||
23348512|NCT00904839|65018094|FG000|Overall Study|Not treated|1|||
23460286|NCT03219723|65430687|FG000|Overall Study|Case Report Forms Uncollected|6|||
23460287|NCT03219723|65430687|FG000|Overall Study|Protocol Deviation|4|||
23348513|NCT00904839|65018095|FG001|Overall Study|Not treated|0|||
23348514|NCT00904839|65018096|FG002|Overall Study|Not treated|1|||
23348515|NCT00904839|65018094|FG000|Overall Study|Other than above|0|||
23348516|NCT00904839|65018095|FG001|Overall Study|Other than above|9|||
23348517|NCT00904839|65018096|FG002|Overall Study|Other than above|7|||
23348518|NCT03760458|65018098|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
23348519|NCT03760458|65018099|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
23348520|NCT03760458|65018100|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23348521|NCT03760458|65018101|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23348522|NCT03760458|65018102|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23348523|NCT02044874|65018103|FG000|Overall Study|Adverse Event|5|||
23348524|NCT02044874|65018104|FG001|Overall Study|Adverse Event|6|||
23348525|NCT02044874|65018105|FG002|Overall Study|Adverse Event|6|||
23348526|NCT02044874|65018103|FG000|Overall Study|Withdrawal by Subject|8|||
23348527|NCT02044874|65018104|FG001|Overall Study|Withdrawal by Subject|16|||
23348528|NCT02044874|65018105|FG002|Overall Study|Withdrawal by Subject|23|||
23348529|NCT02044874|65018103|FG000|Overall Study|Physician Decision|0|||
23348530|NCT02044874|65018104|FG001|Overall Study|Physician Decision|2|||
23348531|NCT02044874|65018105|FG002|Overall Study|Physician Decision|1|||
23348532|NCT02044874|65018103|FG000|Overall Study|Lost to Follow-up|10|||
23348533|NCT02044874|65018104|FG001|Overall Study|Lost to Follow-up|27|||
23348534|NCT02044874|65018105|FG002|Overall Study|Lost to Follow-up|21|||
23348535|NCT02044874|65018103|FG000|Overall Study|Sponsor Decision|0|||
23348536|NCT02044874|65018104|FG001|Overall Study|Sponsor Decision|1|||
23348537|NCT02044874|65018105|FG002|Overall Study|Sponsor Decision|1|||
23348538|NCT02044874|65018103|FG000|Overall Study|Other|7|||
23348539|NCT02044874|65018104|FG001|Overall Study|Other|3|||
23348540|NCT02044874|65018105|FG002|Overall Study|Other|8|||
23348541|NCT00932451|65018107|FG000|Overall Study|Withdrawal by Subject|69|||
23348542|NCT00932451|65018107|FG000|Overall Study|Lost to Follow-up|22|||
23348543|NCT00932451|65018107|FG000|Overall Study|Death|726|||
23348544|NCT00932451|65018107|FG000|Overall Study|Other reasons|5|||
23348545|NCT00787917|65018110|FG000|Blinded Treatment|Adverse Event|1|||
23348546|NCT00787917|65018111|FG001|Blinded Treatment|Adverse Event|0|||
23348547|NCT00787917|65018110|FG000|Blinded Treatment|Lack of Efficacy|1|||
23460288|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
23460289|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
23460290|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
23460291|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
23348548|NCT00787917|65018111|FG001|Blinded Treatment|Lack of Efficacy|0|||
23348549|NCT00787917|65018110|FG000|Blinded Treatment|Administrative problems|3|||
23348550|NCT00787917|65018111|FG001|Blinded Treatment|Administrative problems|2|||
23348551|NCT00787917|65018110|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
23348552|NCT00787917|65018111|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
23348553|NCT00787917|65018110|FG000|Open Label|Administrative problems|3|||
23348554|NCT00787917|65018111|FG001|Open Label|Administrative problems|0|||
23348555|NCT02945254|65018112|FG000|Overall Study|Lost to Follow-up|1|||
23348556|NCT02945254|65018113|FG001|Overall Study|Lost to Follow-up|0|||
23348557|NCT02945254|65018112|FG000|Overall Study|Withdrawal by Subject|1|||
23348558|NCT02945254|65018113|FG001|Overall Study|Withdrawal by Subject|0|||
23348559|NCT01210144|65018119|FG000|Overall Study|Lack of ovarian response|1|||
23348560|NCT01210144|65018120|FG001|Overall Study|Lack of ovarian response|0|||
23348561|NCT01210144|65018119|FG000|Overall Study|No fertilization|1|||
23348562|NCT01210144|65018120|FG001|Overall Study|No fertilization|0|||
23348563|NCT01210144|65018119|FG000|Overall Study|No transfer|1|||
23348564|NCT01210144|65018120|FG001|Overall Study|No transfer|0|||
23348565|NCT02614131|65018121|FG000|Overall Study|Withdrawal by Subject|1|||
23348566|NCT02614131|65018122|FG001|Overall Study|Withdrawal by Subject|0|||
23788174|NCT01695239|66603186|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788175|NCT01695239|66603187|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788176|NCT01695239|66603188|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788177|NCT01695239|66603189|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788178|NCT01695239|66603190|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788179|NCT01695239|66603191|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788180|NCT01695239|66603192|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23348567|NCT02614131|65018123|FG002|Overall Study|Withdrawal by Subject|0|||
23348568|NCT02614131|65018124|FG003|Overall Study|Withdrawal by Subject|0|||
23348569|NCT02614131|65018125|FG004|Overall Study|Withdrawal by Subject|0|||
23348570|NCT02614131|65018126|FG005|Overall Study|Withdrawal by Subject|0|||
23348571|NCT02614131|65018127|FG006|Overall Study|Withdrawal by Subject|0|||
23348572|NCT02614131|65018121|FG000|Overall Study|Adverse Event|0|||
23348573|NCT02614131|65018122|FG001|Overall Study|Adverse Event|0|||
23348574|NCT02614131|65018123|FG002|Overall Study|Adverse Event|0|||
23348575|NCT02614131|65018124|FG003|Overall Study|Adverse Event|0|||
23348576|NCT02614131|65018125|FG004|Overall Study|Adverse Event|0|||
23348577|NCT02614131|65018126|FG005|Overall Study|Adverse Event|0|||
23348578|NCT02614131|65018127|FG006|Overall Study|Adverse Event|1|||
23348579|NCT00526331|65018129|FG000|Overall Study|Sponsor Termination|55|||
23348580|NCT02631746|65018132|FG000|Overall Study|Lack of Efficacy|3|||
23348581|NCT02552888|65018133|FG000|Overall Study|Lost to Follow-up|1|||
23348582|NCT02552888|65018134|FG001|Overall Study|Lost to Follow-up|1|||
23348583|NCT03172364|65018135|FG000|Overall Study|Adverse Event|1|||
23348584|NCT03172364|65018136|FG001|Overall Study|Adverse Event|1|||
23348585|NCT03172364|65018135|FG000|Overall Study|Protocol Violation|1|||
23348586|NCT03172364|65018136|FG001|Overall Study|Protocol Violation|0|||
23348587|NCT01603407|65018137|FG000|Overall Study|Adverse Event|1|||
23348588|NCT01603407|65018138|FG001|Overall Study|Adverse Event|1|||
23348589|NCT01603407|65018139|FG002|Overall Study|Adverse Event|1|||
23348590|NCT01603407|65018137|FG000|Overall Study|Protocol Violation|2|||
23348591|NCT01603407|65018138|FG001|Overall Study|Protocol Violation|2|||
23348592|NCT01603407|65018139|FG002|Overall Study|Protocol Violation|0|||
23348593|NCT01603407|65018137|FG000|Overall Study|Withdrawal by Subject|8|||
23348594|NCT01603407|65018138|FG001|Overall Study|Withdrawal by Subject|5|||
23348595|NCT01603407|65018139|FG002|Overall Study|Withdrawal by Subject|7|||
23348596|NCT01603407|65018137|FG000|Overall Study|Lost to Follow-up|0|||
23348597|NCT01603407|65018138|FG001|Overall Study|Lost to Follow-up|3|||
23348598|NCT01603407|65018139|FG002|Overall Study|Lost to Follow-up|2|||
23348599|NCT00856843|65021567|FG000|Overall Study|Withdrawal by Subject|1|||
23348600|NCT00856843|65021568|FG001|Overall Study|Withdrawal by Subject|5|||
23348601|NCT00856843|65021567|FG000|Overall Study|Lack of Efficacy|1|||
23348602|NCT00856843|65021568|FG001|Overall Study|Lack of Efficacy|0|||
23348603|NCT02012959|65021569|FG000|Treatment Phase A|Adverse Event|2|||
23348604|NCT02012959|65021570|FG001|Treatment Phase A|Adverse Event|0|||
23348605|NCT02012959|65021571|FG002|Treatment Phase A|Adverse Event|0|||
23348606|NCT02012959|65021572|FG003|Treatment Phase A|Adverse Event|0|||
23348607|NCT02012959|65021573|FG004|Treatment Phase A|Adverse Event|0|||
23348608|NCT01280682|65021574|FG000|Overall Study|Lost to Follow-up|0|||
23348609|NCT01280682|65021575|FG001|Overall Study|Lost to Follow-up|6|||
23348610|NCT01280682|65021574|FG000|Overall Study|Withdrawal by Subject|0|||
23348611|NCT01280682|65021575|FG001|Overall Study|Withdrawal by Subject|7|||
23348612|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
23348613|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
23348614|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
23348615|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
23348616|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
23348617|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
23348618|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
23348619|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
23348620|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
23348621|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
23348622|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
23348623|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
23348624|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
23348625|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
23348626|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
23348627|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
23348628|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
23460292|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
23460293|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
23460294|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
23460295|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
23460296|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
23460297|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460298|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460299|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460300|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
23460301|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
23460302|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
23460303|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
23460304|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
23460305|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
23460306|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
23460307|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
23460308|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
23460309|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
23460310|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
23460311|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
23460312|NCT03962491|65430696|FG000|Overall Study|Lost to Follow-up|4|||
23460313|NCT03962491|65430697|FG001|Overall Study|Lost to Follow-up|5|||
23460314|NCT00425269|65430699|FG000|Overall Study|Pregnancy|5|||
23460315|NCT00425269|65430700|FG001|Overall Study|Pregnancy|7|||
23460316|NCT00425269|65430699|FG000|Overall Study|Lost to Follow-up|9|||
23460317|NCT00425269|65430700|FG001|Overall Study|Lost to Follow-up|9|||
23460318|NCT00425269|65430699|FG000|Overall Study|moved or medical reason|5|||
23460319|NCT00425269|65430700|FG001|Overall Study|moved or medical reason|4|||
23788181|NCT01695239|66603193|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788182|NCT01695239|66603194|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788183|NCT01695239|66603195|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788184|NCT01695239|66603196|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788185|NCT01695239|66603197|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23788186|NCT01695239|66603198|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23460320|NCT02059278|65430701|FG000|Overall Study|Adverse Event|1|||
23460321|NCT02059278|65430702|FG001|Overall Study|Adverse Event|1|||
23460322|NCT02059278|65430701|FG000|Overall Study|Lost to Follow-up|1|||
23460323|NCT02059278|65430702|FG001|Overall Study|Lost to Follow-up|0|||
23460324|NCT02059278|65430701|FG000|Overall Study|Withdrawal by Subject|0|||
23460325|NCT02059278|65430702|FG001|Overall Study|Withdrawal by Subject|3|||
23460326|NCT02059278|65430701|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
23639058|NCT00929110|66064461|FG001|Overall Study|Lost to Follow-up|7|||
23788187|NCT01695239|66603199|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
23788188|NCT01686438|66603200|FG000|Overall Study|Lost to Follow-up|8|||
23788189|NCT01686438|66603201|FG001|Overall Study|Lost to Follow-up|9|||
23788190|NCT01686438|66603202|FG002|Overall Study|Lost to Follow-up|10|||
23788191|NCT01686438|66603200|FG000|Overall Study|Adverse Event|0|||
23788192|NCT01686438|66603201|FG001|Overall Study|Adverse Event|0|||
23788193|NCT01686438|66603202|FG002|Overall Study|Adverse Event|1|||
23788194|NCT01686438|66603200|FG000|Overall Study|Protocol Violation|0|||
23788195|NCT01686438|66603201|FG001|Overall Study|Protocol Violation|0|||
23788196|NCT01686438|66603202|FG002|Overall Study|Protocol Violation|1|||
23788197|NCT01686438|66603200|FG000|Overall Study|Withdrawal by Subject|0|||
23788198|NCT01686438|66603201|FG001|Overall Study|Withdrawal by Subject|0|||
23788199|NCT01686438|66603202|FG002|Overall Study|Withdrawal by Subject|1|||
23788200|NCT02911701|66603203|FG000|Overall Study|Withdrawal by Subject|2|||
23788201|NCT02911701|66603204|FG001|Overall Study|Withdrawal by Subject|4|||
23788202|NCT02911701|66603203|FG000|Overall Study|Adverse Event|1|||
23788203|NCT02911701|66603204|FG001|Overall Study|Adverse Event|0|||
23788204|NCT00474058|66603205|FG000|Overall Study|Adverse Event|11|||
23460327|NCT02059278|65430702|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
23788205|NCT00474058|66603206|FG001|Overall Study|Adverse Event|6|||
23788206|NCT00474058|66603205|FG000|Overall Study|Lack of Efficacy|0|||
23788207|NCT00474058|66603206|FG001|Overall Study|Lack of Efficacy|4|||
23788208|NCT00474058|66603205|FG000|Overall Study|Withdrawal by Subject|11|||
23788209|NCT00474058|66603206|FG001|Overall Study|Withdrawal by Subject|7|||
23788210|NCT00474058|66603205|FG000|Overall Study|Other|2|||
23788211|NCT00474058|66603206|FG001|Overall Study|Other|0|||
23460328|NCT01499355|65430714|FG000|Run-In Period|Study Termination|15|||
23460329|NCT01499355|65430715|FG001|Run-In Period|Study Termination|0|||
23460330|NCT01499355|65430716|FG002|Run-In Period|Study Termination|0|||
23460331|NCT01499355|65430717|FG003|Run-In Period|Study Termination|0|||
23460332|NCT01499355|65430714|FG000|Run-In Period|Other|3|||
23460333|NCT01499355|65430715|FG001|Run-In Period|Other|0|||
23460334|NCT01499355|65430716|FG002|Run-In Period|Other|0|||
23460335|NCT01499355|65430717|FG003|Run-In Period|Other|0|||
23460336|NCT01499355|65430714|FG000|Run-In Period|Death|2|||
23460337|NCT01499355|65430715|FG001|Run-In Period|Death|0|||
23460338|NCT01499355|65430716|FG002|Run-In Period|Death|0|||
23460339|NCT01499355|65430717|FG003|Run-In Period|Death|0|||
23460340|NCT01499355|65430714|FG000|Run-In Period|Investigator Decision|2|||
23460341|NCT01499355|65430715|FG001|Run-In Period|Investigator Decision|0|||
23460342|NCT01499355|65430716|FG002|Run-In Period|Investigator Decision|0|||
23460343|NCT01499355|65430717|FG003|Run-In Period|Investigator Decision|0|||
23460344|NCT01499355|65430714|FG000|Run-In Period|Consent Withdrawn|1|||
23460345|NCT01499355|65430715|FG001|Run-In Period|Consent Withdrawn|0|||
23460346|NCT01499355|65430716|FG002|Run-In Period|Consent Withdrawn|0|||
23460347|NCT01499355|65430717|FG003|Run-In Period|Consent Withdrawn|0|||
23460348|NCT01499355|65430714|FG000|Run-In Period|Adverse Event|8|||
23460349|NCT01499355|65430715|FG001|Run-In Period|Adverse Event|0|||
23460350|NCT01499355|65430716|FG002|Run-In Period|Adverse Event|0|||
23460351|NCT01499355|65430717|FG003|Run-In Period|Adverse Event|0|||
23460352|NCT01499355|65430714|FG000|Double-Blind Period|Adverse Event|0|||
23460353|NCT01499355|65430715|FG001|Double-Blind Period|Adverse Event|2|||
23460354|NCT01499355|65430716|FG002|Double-Blind Period|Adverse Event|3|||
23460355|NCT01499355|65430717|FG003|Double-Blind Period|Adverse Event|2|||
23460356|NCT01499355|65430714|FG000|Double-Blind Period|Study Termination|0|||
23460357|NCT01499355|65430715|FG001|Double-Blind Period|Study Termination|18|||
23460358|NCT01499355|65430716|FG002|Double-Blind Period|Study Termination|16|||
23460359|NCT01499355|65430717|FG003|Double-Blind Period|Study Termination|14|||
23460360|NCT01499355|65430714|FG000|Double-Blind Period|Other|0|||
23460361|NCT01499355|65430715|FG001|Double-Blind Period|Other|1|||
23460362|NCT01499355|65430716|FG002|Double-Blind Period|Other|2|||
23460363|NCT01499355|65430717|FG003|Double-Blind Period|Other|2|||
23788212|NCT04692155|66603208|FG000|Overall Study|Death|1|||
23788213|NCT03366428|66603219|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
23788214|NCT03366428|66603219|FG000|Overall Study|Adverse Event|12|||
23788215|NCT03366428|66603219|FG000|Overall Study|Clinical progression|2|||
23788216|NCT03366428|66603219|FG000|Overall Study|Withdrawal by Subject|4|||
23788217|NCT02654145|66603220|FG000|Overall Study|Lack of Efficacy|1|||
23460364|NCT01499355|65430714|FG000|Double-Blind Period|Death|0|||
23460365|NCT01499355|65430715|FG001|Double-Blind Period|Death|1|||
23460366|NCT01499355|65430716|FG002|Double-Blind Period|Death|0|||
23460367|NCT01499355|65430717|FG003|Double-Blind Period|Death|0|||
23460368|NCT01499355|65430714|FG000|Double-Blind Period|Investigator Decision|0|||
23460369|NCT01499355|65430715|FG001|Double-Blind Period|Investigator Decision|0|||
23460370|NCT01499355|65430716|FG002|Double-Blind Period|Investigator Decision|3|||
23460371|NCT01499355|65430717|FG003|Double-Blind Period|Investigator Decision|3|||
23460372|NCT01499355|65430714|FG000|Double-Blind Period|Consent Withdrawn|0|||
23460373|NCT01499355|65430715|FG001|Double-Blind Period|Consent Withdrawn|0|||
23460374|NCT01499355|65430716|FG002|Double-Blind Period|Consent Withdrawn|1|||
23460375|NCT01499355|65430717|FG003|Double-Blind Period|Consent Withdrawn|2|||
23460376|NCT01499355|65430714|FG000|Double-Blind Period|Lost to Follow-up|0|||
23460377|NCT01499355|65430715|FG001|Double-Blind Period|Lost to Follow-up|1|||
23460378|NCT01499355|65430716|FG002|Double-Blind Period|Lost to Follow-up|0|||
23460379|NCT01499355|65430717|FG003|Double-Blind Period|Lost to Follow-up|0|||
23460380|NCT00092417|65430718|FG000|Overall Study|Lost to Follow-up|2|||
23460381|NCT00092417|65430719|FG001|Overall Study|Lost to Follow-up|0|||
23460382|NCT00092417|65430718|FG000|Overall Study|Withdrawal by Subject|2|||
23460383|NCT00092417|65430719|FG001|Overall Study|Withdrawal by Subject|1|||
23460384|NCT00092417|65430718|FG000|Overall Study|Other|1|||
23460385|NCT00092417|65430719|FG001|Overall Study|Other|0|||
23460386|NCT02120898|65430721|FG000|Overall Study|Withdrawal by Subject|4|||
23460387|NCT02120898|65430722|FG001|Overall Study|Withdrawal by Subject|2|||
23788218|NCT02654145|66603220|FG000|Overall Study|Protocol Violation|1|||
23788219|NCT02654145|66603220|FG000|Overall Study|Withdrawal by Subject|5|||
23348629|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
23348630|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Other|3|||
23460388|NCT02120898|65430723|FG002|Overall Study|Withdrawal by Subject|2|||
23460389|NCT02120898|65430721|FG000|Overall Study|Non-compliance with study drug|3|||
23460390|NCT02120898|65430722|FG001|Overall Study|Non-compliance with study drug|0|||
23460391|NCT02120898|65430723|FG002|Overall Study|Non-compliance with study drug|0|||
23460392|NCT02120898|65430721|FG000|Overall Study|Adverse Event|1|||
23460393|NCT02120898|65430722|FG001|Overall Study|Adverse Event|2|||
23460394|NCT02120898|65430723|FG002|Overall Study|Adverse Event|1|||
23460395|NCT02120898|65430721|FG000|Overall Study|Protocol Violation|1|||
23460396|NCT02120898|65430722|FG001|Overall Study|Protocol Violation|2|||
23460397|NCT02120898|65430723|FG002|Overall Study|Protocol Violation|0|||
23460398|NCT02120898|65430721|FG000|Overall Study|Lost to Follow-up|0|||
23460399|NCT02120898|65430722|FG001|Overall Study|Lost to Follow-up|0|||
23460400|NCT02120898|65430723|FG002|Overall Study|Lost to Follow-up|1|||
23460401|NCT00888173|65430724|FG000|Overall Study|Wrong Primary|1|||
23460402|NCT00888173|65430724|FG000|Overall Study|Ineligible: required test not done|1|||
23460403|NCT00734149|65430743|FG000|Overall Study|Withdrawal by Subject|1|||
23460404|NCT01131507|65430744|FG000|Overall Study|Adverse Event|1|||
23460405|NCT01131507|65430744|FG000|Overall Study|Lost to Follow-up|1|||
23460406|NCT01131507|65430744|FG000|Overall Study|Withdrawal by Subject|1|||
23460407|NCT01815918|65430745|FG000|Overall Study|Patient samples not analyzable|3|||
23460408|NCT01815918|65430746|FG001|Overall Study|Patient samples not analyzable|4|||
23460409|NCT01815918|65430745|FG000|Overall Study|Lack of Efficacy|15|||
23460410|NCT01815918|65430746|FG001|Overall Study|Lack of Efficacy|15|||
23460411|NCT01292486|65430749|FG000|Overall Study|Protocol Violation|2|||
23460412|NCT01292486|65430749|FG000|Overall Study|Did not meet screening criteria|2|||
23460413|NCT01292486|65430749|FG000|Overall Study|Adverse Event|1|||
23460414|NCT01292486|65430749|FG000|Overall Study|Physician Decision|1|||
23460415|NCT01056822|65430750|FG000|Overall Study|Adverse Event|0|||
23460416|NCT01056822|65430751|FG001|Overall Study|Adverse Event|1|||
23460417|NCT01056822|65430750|FG000|Overall Study|Protocol Violation|6|||
23460418|NCT01056822|65430751|FG001|Overall Study|Protocol Violation|5|||
23460419|NCT01056822|65430750|FG000|Overall Study|Withdrawal by Subject|1|||
23460420|NCT01056822|65430751|FG001|Overall Study|Withdrawal by Subject|1|||
23460421|NCT01056822|65430750|FG000|Overall Study|Lost to Follow-up|1|||
23460422|NCT01056822|65430751|FG001|Overall Study|Lost to Follow-up|0|||
23460423|NCT03155841|65430755|FG000|Overall Study|Protocol Violation|3|||
23460424|NCT03155841|65430756|FG001|Overall Study|Protocol Violation|4|||
23460425|NCT00787644|65430761|FG000|Overall Study|Lost to Follow-up|1|||
23460426|NCT00787644|65430762|FG001|Overall Study|Lost to Follow-up|1|||
23460427|NCT00787644|65430761|FG000|Overall Study|Withdrawal by Subject|1|||
23460428|NCT00787644|65430762|FG001|Overall Study|Withdrawal by Subject|1|||
23460429|NCT00935584|65430764|FG000|Overall Study|Withdrawal by Subject|9|||
23460430|NCT00935584|65430765|FG001|Overall Study|Withdrawal by Subject|0|||
23460431|NCT00935584|65430764|FG000|Overall Study|Death|3|||
23460432|NCT00935584|65430765|FG001|Overall Study|Death|0|||
23460433|NCT00935584|65430764|FG000|Overall Study|Lost to Follow-up|8|||
23460434|NCT00935584|65430765|FG001|Overall Study|Lost to Follow-up|0|||
23460435|NCT00935584|65430764|FG000|Overall Study|No show|9|||
23460436|NCT00935584|65430765|FG001|Overall Study|No show|0|||
23460437|NCT00935584|65430764|FG000|Overall Study|Relocated|3|||
23460438|NCT00935584|65430765|FG001|Overall Study|Relocated|0|||
23460439|NCT00935584|65430764|FG000|Overall Study|Patient changed provider|3|||
23460440|NCT00935584|65430765|FG001|Overall Study|Patient changed provider|0|||
23460441|NCT00935584|65430764|FG000|Overall Study|Provider dropped out of study|14|||
23460442|NCT00935584|65430765|FG001|Overall Study|Provider dropped out of study|4|||
23460443|NCT00459316|65430768|FG000|Steps 1 & 2|Other eligibility failure|1|||
23460444|NCT00459316|65430769|FG001|Steps 1 & 2|Other eligibility failure|1|||
23460445|NCT00459316|65430770|FG002|Steps 1 & 2|Other eligibility failure|0|||
23460446|NCT00459316|65430768|FG000|Steps 1 & 2|Death|1|||
23460447|NCT00459316|65430769|FG001|Steps 1 & 2|Death|1|||
23460448|NCT00459316|65430770|FG002|Steps 1 & 2|Death|0|||
23460449|NCT00459316|65430768|FG000|Steps 1 & 2|Not able to get to clinic|7|||
23460450|NCT00459316|65430769|FG001|Steps 1 & 2|Not able to get to clinic|4|||
23460451|NCT00459316|65430770|FG002|Steps 1 & 2|Not able to get to clinic|0|||
23460452|NCT00459316|65430768|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
23460453|NCT00459316|65430769|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
23460454|NCT00459316|65430770|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
23460455|NCT00459316|65430768|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
23460456|NCT00459316|65430769|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
23460457|NCT00459316|65430770|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
23460458|NCT00459316|65430768|FG000|Steps 1 & 2|Lost to Follow-up|5|||
23460459|NCT00459316|65430769|FG001|Steps 1 & 2|Lost to Follow-up|0|||
23460460|NCT00459316|65430770|FG002|Steps 1 & 2|Lost to Follow-up|2|||
23460461|NCT00459316|65430768|FG000|Step 3|Withdrawal by Subject|3|||
23460462|NCT00459316|65430769|FG001|Step 3|Withdrawal by Subject|0|||
23460463|NCT00459316|65430770|FG002|Step 3|Withdrawal by Subject|1|||
23460464|NCT00992108|65430771|FG000|Overall Study|Lost to Follow-up|0|||
23460465|NCT00992108|65430772|FG001|Overall Study|Lost to Follow-up|1|||
23460466|NCT02613507|65430773|FG000|Overall Study|Disease Progression|237|||
23460467|NCT02613507|65430774|FG001|Overall Study|Disease Progression|109|||
23460468|NCT02613507|65430773|FG000|Overall Study|Study Drug Toxicity|15|||
23460469|NCT02613507|65430774|FG001|Overall Study|Study Drug Toxicity|14|||
23460470|NCT02613507|65430773|FG000|Overall Study|Death|3|||
23460471|NCT02613507|65430774|FG001|Overall Study|Death|0|||
23460472|NCT02613507|65430773|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
23460473|NCT02613507|65430774|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23460474|NCT02613507|65430773|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
23460475|NCT02613507|65430774|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
23639059|NCT00929110|66064462|FG002|Overall Study|Lost to Follow-up|3|||
23460476|NCT02613507|65430773|FG000|Overall Study|Participant Withdrew Consent|0|||
23460477|NCT02613507|65430774|FG001|Overall Study|Participant Withdrew Consent|2|||
23460478|NCT02613507|65430773|FG000|Overall Study|Lost to Follow-up|1|||
23460479|NCT02613507|65430774|FG001|Overall Study|Lost to Follow-up|0|||
23460480|NCT02613507|65430773|FG000|Overall Study|Maximum Clinical Benefit|4|||
23460481|NCT02613507|65430774|FG001|Overall Study|Maximum Clinical Benefit|10|||
23460482|NCT02613507|65430773|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
23460483|NCT02613507|65430774|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
23460484|NCT02613507|65430773|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
23460485|NCT02613507|65430774|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
23460486|NCT02613507|65430773|FG000|Overall Study|Randomized but not Treated|1|||
23460487|NCT02613507|65430774|FG001|Overall Study|Randomized but not Treated|10|||
23460488|NCT00684021|65430775|FG000|Overall Study|MRI Contraindicated|1|||
23460489|NCT00684021|65430776|FG001|Overall Study|MRI Contraindicated|1|||
23460490|NCT00684021|65430777|FG002|Overall Study|MRI Contraindicated|1|||
23460491|NCT00684021|65430778|FG003|Overall Study|MRI Contraindicated|0|||
23460492|NCT00684021|65430775|FG000|Overall Study|MRI not performed|0|||
23460493|NCT00684021|65430776|FG001|Overall Study|MRI not performed|1|||
23460494|NCT00684021|65430777|FG002|Overall Study|MRI not performed|1|||
23460495|NCT00684021|65430778|FG003|Overall Study|MRI not performed|2|||
23788220|NCT00876265|66603221|FG000|Overall Study|Miscellaneous reasons|4|||
23788221|NCT00876265|66603221|FG000|Overall Study|Lost to Follow-up|6|||
23788222|NCT00876265|66603221|FG000|Overall Study|Withdrawal by Subject|2|||
23788223|NCT02241551|66603224|FG000|Overall Study|Adverse Event|1|||
23788224|NCT02241551|66603225|FG001|Overall Study|Adverse Event|0|||
23788225|NCT00714051|66603226|FG000|Overall Study|Withdrawal by Subject|1|||
23788226|NCT00714051|66603227|FG001|Overall Study|Withdrawal by Subject|0|||
23788227|NCT00714051|66603226|FG000|Overall Study|Death|0|||
23788228|NCT00714051|66603227|FG001|Overall Study|Death|1|||
23788229|NCT03707587|66603231|FG000|Overall Study|Death|0|||
23788230|NCT03707587|66603232|FG001|Overall Study|Death|1|||
23788231|NCT04411680|66603233|FG000|Treatment Period|Adverse Event|3|||
23460496|NCT00684021|65430775|FG000|Overall Study|Death|1|||
23460497|NCT00684021|65430776|FG001|Overall Study|Death|0|||
23460498|NCT00684021|65430777|FG002|Overall Study|Death|0|||
23460499|NCT00684021|65430778|FG003|Overall Study|Death|0|||
23460500|NCT02220920|65430779|FG000|Overall Study|Adverse Event|1|||
23460501|NCT02220920|65430780|FG001|Overall Study|Adverse Event|0|||
23460502|NCT02220920|65430779|FG000|Overall Study|Lack of Efficacy|0|||
23460503|NCT02220920|65430780|FG001|Overall Study|Lack of Efficacy|1|||
23460504|NCT02220920|65430779|FG000|Overall Study|Withdrawal by Subject|1|||
23460505|NCT02220920|65430780|FG001|Overall Study|Withdrawal by Subject|0|||
23460506|NCT02220920|65430779|FG000|Overall Study|Conflict with the stopping criteria|1|||
23460507|NCT02220920|65430780|FG001|Overall Study|Conflict with the stopping criteria|2|||
23460508|NCT02691507|65430783|FG000|Overall Study|Missed Visit 3|0|||
23460509|NCT02691507|65430784|FG001|Overall Study|Missed Visit 3|1|||
23460510|NCT04177823|65430785|FG000|Overall Study|Physician Decision|1|||
23460511|NCT04177823|65430785|FG000|Overall Study|Withdrawal by Subject|1|||
23460512|NCT00474487|65430786|FG000|Overall Study|Withdrawal by Subject|6|||
23460513|NCT00474487|65430787|FG001|Overall Study|Withdrawal by Subject|0|||
23460514|NCT00474487|65430788|FG002|Overall Study|Withdrawal by Subject|0|||
23460515|NCT00474487|65430789|FG003|Overall Study|Withdrawal by Subject|0|||
23460516|NCT00474487|65430786|FG000|Overall Study|Lost to Follow-up|20|||
23460517|NCT00474487|65430787|FG001|Overall Study|Lost to Follow-up|1|||
23460518|NCT00474487|65430788|FG002|Overall Study|Lost to Follow-up|7|||
23460519|NCT00474487|65430789|FG003|Overall Study|Lost to Follow-up|0|||
23460520|NCT00474487|65430786|FG000|Overall Study|Inappropriate enrollment|4|||
23460521|NCT00474487|65430787|FG001|Overall Study|Inappropriate enrollment|0|||
23460522|NCT00474487|65430788|FG002|Overall Study|Inappropriate enrollment|7|||
23788232|NCT04411680|66603234|FG001|Treatment Period|Adverse Event|0|||
23788233|NCT04411680|66603233|FG000|Treatment Period|Discharged from hospital|18|||
23788234|NCT04411680|66603234|FG001|Treatment Period|Discharged from hospital|7|||
23460523|NCT00474487|65430789|FG003|Overall Study|Inappropriate enrollment|0|||
23460524|NCT00474487|65430786|FG000|Overall Study|Death|0|||
23460525|NCT00474487|65430787|FG001|Overall Study|Death|1|||
23460526|NCT00474487|65430788|FG002|Overall Study|Death|0|||
23460527|NCT00474487|65430789|FG003|Overall Study|Death|0|||
23460528|NCT00910650|65430794|FG000|Overall Study|Death|2|||
23460529|NCT00283296|65430795|FG000|Overall Study|in-home trial not completed|5|||
23788235|NCT04411680|66603233|FG000|Treatment Period|Missed 1 or more doses|8|||
23460530|NCT04774094|65430796|FG000|Overall Study|Other|2|||
23460531|NCT04774094|65430796|FG000|Overall Study|Withdrawal by Subject|9|||
23460532|NCT04774094|65430796|FG000|Overall Study|Lost to Follow-up|7|||
23788236|NCT04411680|66603234|FG001|Treatment Period|Missed 1 or more doses|0|||
23788237|NCT04411680|66603233|FG000|Treatment Period|Transferred to another hospital|0|||
23460533|NCT04774094|65430796|FG000|Overall Study|Lack of Efficacy|5|||
23460534|NCT04774094|65430796|FG000|Overall Study|Death|17|||
23460535|NCT04774094|65430796|FG000|Overall Study|Adverse Event|4|||
23460536|NCT03278249|65430797|FG000|Overall Study|Withdrawal by Subject|2|||
23460537|NCT03278249|65430797|FG000|Overall Study|Lost to Follow-up|1|||
23460538|NCT02158546|65430798|FG000|Overall Study|Physician Decision|0|||
23460539|NCT02158546|65430799|FG001|Overall Study|Physician Decision|1|||
23460540|NCT02158546|65430800|FG002|Overall Study|Physician Decision|0|||
23460541|NCT02158546|65430801|FG003|Overall Study|Physician Decision|0|||
23788238|NCT04411680|66603234|FG001|Treatment Period|Transferred to another hospital|1|||
23788239|NCT04411680|66603233|FG000|Follow up Period|Withdrawal by Subject|2|||
23788240|NCT04411680|66603234|FG001|Follow up Period|Withdrawal by Subject|0|||
23788241|NCT04411680|66603233|FG000|Follow up Period|Lost to Follow-up|5|||
23788242|NCT04411680|66603234|FG001|Follow up Period|Lost to Follow-up|6|||
23788243|NCT04411680|66603233|FG000|Follow up Period|Death|11|||
23788244|NCT04411680|66603234|FG001|Follow up Period|Death|8|||
23788245|NCT01378962|66603235|FG000|Overall Study|Death|14|||
23788246|NCT01378962|66603235|FG000|Overall Study|Lost to Follow-up|1|||
23788247|NCT01378962|66603235|FG000|Overall Study|Other|2|||
23788248|NCT03415308|66603236|FG000|Overall Study|Lost to Follow-up|0|||
23788249|NCT03415308|66603237|FG001|Overall Study|Lost to Follow-up|0|||
23788250|NCT03415308|66603238|FG002|Overall Study|Lost to Follow-up|1|||
23788251|NCT03415308|66603236|FG000|Overall Study|Scheduling Conflicts|0|||
23788252|NCT03415308|66603237|FG001|Overall Study|Scheduling Conflicts|0|||
23788253|NCT03415308|66603238|FG002|Overall Study|Scheduling Conflicts|7|||
23788254|NCT04474405|66603239|FG000|Overall Study|Withdrawal by Subject|0|||
23788255|NCT04474405|66603240|FG001|Overall Study|Withdrawal by Subject|0|||
23788256|NCT04474405|66603241|FG002|Overall Study|Withdrawal by Subject|1|||
23788257|NCT04474405|66603242|FG003|Overall Study|Withdrawal by Subject|0|||
23788258|NCT04474405|66603243|FG004|Overall Study|Withdrawal by Subject|1|||
23788259|NCT04474405|66603244|FG005|Overall Study|Withdrawal by Subject|0|||
23788260|NCT04474405|66603239|FG000|Overall Study|Other|0|||
23788261|NCT04474405|66603240|FG001|Overall Study|Other|0|||
23788262|NCT04474405|66603241|FG002|Overall Study|Other|0|||
23788263|NCT04474405|66603242|FG003|Overall Study|Other|0|||
23788264|NCT04474405|66603243|FG004|Overall Study|Other|3|||
23788265|NCT04474405|66603244|FG005|Overall Study|Other|0|||
23788266|NCT00730691|66603247|FG000|Overall Study|Adverse Event|4|||
23788267|NCT00730691|66603248|FG001|Overall Study|Adverse Event|8|||
23788268|NCT00730691|66603249|FG002|Overall Study|Adverse Event|11|||
23788269|NCT00730691|66603250|FG003|Overall Study|Adverse Event|11|||
23788270|NCT00730691|66603251|FG004|Overall Study|Adverse Event|23|||
23788271|NCT00730691|66603247|FG000|Overall Study|Lack of Efficacy|4|||
23788272|NCT00730691|66603248|FG001|Overall Study|Lack of Efficacy|4|||
23460542|NCT02158546|65430798|FG000|Overall Study|Non-compliance|0|||
23460543|NCT02158546|65430799|FG001|Overall Study|Non-compliance|1|||
23460544|NCT02158546|65430800|FG002|Overall Study|Non-compliance|0|||
23460545|NCT02158546|65430801|FG003|Overall Study|Non-compliance|1|||
23460546|NCT02158546|65430798|FG000|Overall Study|Failure to meet eligibility criteria|0|||
23460547|NCT02158546|65430799|FG001|Overall Study|Failure to meet eligibility criteria|1|||
23460548|NCT02158546|65430800|FG002|Overall Study|Failure to meet eligibility criteria|0|||
23584308|NCT01769391|65866130|FG000|Overall Study|Withdrawal by Subject|4|||
23788273|NCT00730691|66603249|FG002|Overall Study|Lack of Efficacy|2|||
23788274|NCT00730691|66603250|FG003|Overall Study|Lack of Efficacy|1|||
23788275|NCT00730691|66603251|FG004|Overall Study|Lack of Efficacy|1|||
23788276|NCT00730691|66603247|FG000|Overall Study|Non-compliance with Study Drug|6|||
23788277|NCT00730691|66603248|FG001|Overall Study|Non-compliance with Study Drug|1|||
23788278|NCT00730691|66603249|FG002|Overall Study|Non-compliance with Study Drug|6|||
23788279|NCT00730691|66603250|FG003|Overall Study|Non-compliance with Study Drug|3|||
23788280|NCT00730691|66603251|FG004|Overall Study|Non-compliance with Study Drug|3|||
23788281|NCT00730691|66603247|FG000|Overall Study|Protocol Deviations|3|||
23788282|NCT00730691|66603248|FG001|Overall Study|Protocol Deviations|5|||
23460549|NCT02158546|65430801|FG003|Overall Study|Failure to meet eligibility criteria|0|||
23460550|NCT02158546|65430798|FG000|Overall Study|Lack of Efficacy|1|||
23584309|NCT01769391|65866131|FG001|Overall Study|Withdrawal by Subject|3|||
23788283|NCT00730691|66603249|FG002|Overall Study|Protocol Deviations|3|||
23788284|NCT00730691|66603250|FG003|Overall Study|Protocol Deviations|7|||
23788285|NCT00730691|66603251|FG004|Overall Study|Protocol Deviations|5|||
23788286|NCT00730691|66603247|FG000|Overall Study|Withdrawal of Consent|7|||
23460551|NCT02158546|65430799|FG001|Overall Study|Lack of Efficacy|1|||
23584310|NCT01769391|65866130|FG000|Overall Study|Investigator Decision|2|||
23788287|NCT00730691|66603248|FG001|Overall Study|Withdrawal of Consent|9|||
23788288|NCT00730691|66603249|FG002|Overall Study|Withdrawal of Consent|3|||
23788289|NCT00730691|66603250|FG003|Overall Study|Withdrawal of Consent|6|||
23788290|NCT00730691|66603251|FG004|Overall Study|Withdrawal of Consent|3|||
23788291|NCT00730691|66603247|FG000|Overall Study|Lost to Follow-up|11|||
23788292|NCT00730691|66603248|FG001|Overall Study|Lost to Follow-up|8|||
23788293|NCT00730691|66603249|FG002|Overall Study|Lost to Follow-up|13|||
23788294|NCT00730691|66603250|FG003|Overall Study|Lost to Follow-up|15|||
23788295|NCT00730691|66603251|FG004|Overall Study|Lost to Follow-up|13|||
23788296|NCT00730691|66603247|FG000|Overall Study|Other|1|||
23460552|NCT02158546|65430800|FG002|Overall Study|Lack of Efficacy|0|||
23460553|NCT02158546|65430801|FG003|Overall Study|Lack of Efficacy|0|||
23788297|NCT00730691|66603248|FG001|Overall Study|Other|1|||
23788298|NCT00730691|66603249|FG002|Overall Study|Other|1|||
23788299|NCT00730691|66603250|FG003|Overall Study|Other|2|||
23788300|NCT00730691|66603251|FG004|Overall Study|Other|2|||
23788301|NCT01993186|66603254|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
23788302|NCT01993186|66603255|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
23788303|NCT01993186|66603254|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
23460554|NCT02158546|65430798|FG000|Overall Study|Adverse Event|2|||
23460555|NCT02158546|65430799|FG001|Overall Study|Adverse Event|2|||
23460556|NCT02158546|65430800|FG002|Overall Study|Adverse Event|0|||
23460557|NCT02158546|65430801|FG003|Overall Study|Adverse Event|0|||
23460558|NCT02158546|65430798|FG000|Overall Study|Withdrawal by Subject|6|||
23460559|NCT02158546|65430799|FG001|Overall Study|Withdrawal by Subject|2|||
23460560|NCT02158546|65430800|FG002|Overall Study|Withdrawal by Subject|1|||
23460561|NCT02158546|65430801|FG003|Overall Study|Withdrawal by Subject|0|||
23460562|NCT02158546|65430798|FG000|Overall Study|Lost to Follow-up|5|||
23460563|NCT02158546|65430799|FG001|Overall Study|Lost to Follow-up|4|||
23460564|NCT02158546|65430800|FG002|Overall Study|Lost to Follow-up|0|||
23460565|NCT02158546|65430801|FG003|Overall Study|Lost to Follow-up|1|||
23460566|NCT02158546|65430798|FG000|Overall Study|Site Excluded|5|||
23460567|NCT02158546|65430799|FG001|Overall Study|Site Excluded|5|||
23460568|NCT02158546|65430800|FG002|Overall Study|Site Excluded|3|||
23460569|NCT02158546|65430801|FG003|Overall Study|Site Excluded|4|||
23460570|NCT00423579|65430802|FG000|Overall Study|Lost to Follow-up|3|||
23460571|NCT00423579|65430803|FG001|Overall Study|Lost to Follow-up|0|||
23460572|NCT00423579|65430802|FG000|Overall Study|Protocol Violation|1|||
23584311|NCT01769391|65866131|FG001|Overall Study|Investigator Decision|0|||
23584312|NCT02465359|65866132|FG000|Overall Study|Lack of Efficacy|1|||
23584313|NCT02465359|65866132|FG000|Overall Study|Withdrawal by Subject|1|||
23460573|NCT00423579|65430803|FG001|Overall Study|Protocol Violation|3|||
23460574|NCT00423579|65430802|FG000|Overall Study|Diagnosis of diabetes|0|||
23460575|NCT00423579|65430803|FG001|Overall Study|Diagnosis of diabetes|1|||
23460576|NCT01194830|65430805|FG000|Overall Study|Adverse Event|3|||
23460577|NCT01194830|65430806|FG001|Overall Study|Adverse Event|2|||
23460578|NCT01194830|65430805|FG000|Overall Study|Protocol Violation|5|||
23788304|NCT01993186|66603255|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23788305|NCT01993186|66603254|FG000|Open-Label Extension Period|Other, Not Specified|0|||
23460579|NCT01194830|65430806|FG001|Overall Study|Protocol Violation|4|||
23460580|NCT01194830|65430805|FG000|Overall Study|Lost to Follow-up|9|||
23460581|NCT01194830|65430806|FG001|Overall Study|Lost to Follow-up|7|||
23460582|NCT01194830|65430805|FG000|Overall Study|Withdrawal by Subject|2|||
23460583|NCT01194830|65430806|FG001|Overall Study|Withdrawal by Subject|1|||
23460584|NCT01194830|65430805|FG000|Overall Study|Lack of Efficacy|1|||
23460585|NCT01194830|65430806|FG001|Overall Study|Lack of Efficacy|1|||
23460586|NCT01194830|65430805|FG000|Overall Study|Non-compliance issues|4|||
23460587|NCT01194830|65430806|FG001|Overall Study|Non-compliance issues|4|||
23460588|NCT01194830|65430805|FG000|Overall Study|Other Reason|12|||
23460589|NCT01194830|65430806|FG001|Overall Study|Other Reason|8|||
23460590|NCT02749422|65430812|FG000|Overall Study|Lost to Follow-up|0|||
23460591|NCT02749422|65430813|FG001|Overall Study|Lost to Follow-up|2|||
23460592|NCT02749422|65430812|FG000|Overall Study|Ineligible|0|||
23460593|NCT02749422|65430813|FG001|Overall Study|Ineligible|1|||
23460594|NCT00389610|65430814|FG000|Overall Study|Disease Progression|0|||
23460595|NCT00389610|65430815|FG001|Overall Study|Disease Progression|19|||
23460596|NCT00389610|65430814|FG000|Overall Study|Death|0|||
23460597|NCT00389610|65430815|FG001|Overall Study|Death|1|||
23460598|NCT00389610|65430814|FG000|Overall Study|Physician Decision|0|||
23460599|NCT00389610|65430815|FG001|Overall Study|Physician Decision|1|||
23460600|NCT00389610|65430814|FG000|Overall Study|Withdrawal by Subject|0|||
23460601|NCT00389610|65430815|FG001|Overall Study|Withdrawal by Subject|1|||
23460602|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
23460603|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
23460604|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
23460605|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
23460606|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
23460607|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
23460608|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
23460609|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
23460610|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
23460611|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Other|0|||
23460612|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Other|1|||
23460613|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Other|0|||
23460614|NCT00174187|65430818|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
23460615|NCT00174187|65430819|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
23460616|NCT00174187|65430820|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
23460617|NCT00174187|65430818|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
23460618|NCT00174187|65430819|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
23460619|NCT00174187|65430820|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
23460620|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
23460621|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
23460622|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
23460623|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
23460624|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
23460625|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
23460626|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Other|0|||
23460627|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Other|0|||
23460628|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Other|5|||
23460629|NCT03299166|65430821|FG000|Overall Study|Adverse Event|9|||
23460630|NCT03299166|65430822|FG001|Overall Study|Adverse Event|4|||
23460631|NCT03299166|65430821|FG000|Overall Study|Withdrawal by Subject|6|||
23460632|NCT03299166|65430822|FG001|Overall Study|Withdrawal by Subject|5|||
23460633|NCT03299166|65430821|FG000|Overall Study|Physician Decision|1|||
23460634|NCT03299166|65430822|FG001|Overall Study|Physician Decision|1|||
23584314|NCT02465359|65866132|FG000|Overall Study|Adverse Event|1|||
23788306|NCT01993186|66603255|FG001|Open-Label Extension Period|Other, Not Specified|1|||
23788307|NCT01993186|66603254|FG000|Open-Label Extension Period|Adverse Event|1|||
23788308|NCT01993186|66603255|FG001|Open-Label Extension Period|Adverse Event|0|||
23788309|NCT01993186|66603254|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
23788310|NCT01993186|66603255|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
23788311|NCT01993186|66603254|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
23348631|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Other|2|||
23460635|NCT03299166|65430821|FG000|Overall Study|Sponsor Decision|3|||
23460636|NCT03299166|65430822|FG001|Overall Study|Sponsor Decision|0|||
23460637|NCT03299166|65430821|FG000|Overall Study|Lost to Follow-up|2|||
23460638|NCT03299166|65430822|FG001|Overall Study|Lost to Follow-up|4|||
23460639|NCT03299166|65430821|FG000|Overall Study|Randomization Error|0|||
23460640|NCT03299166|65430822|FG001|Overall Study|Randomization Error|1|||
23460641|NCT03299166|65430821|FG000|Overall Study|Subject unable to return due to COVID|1|||
23460642|NCT03299166|65430822|FG001|Overall Study|Subject unable to return due to COVID|0|||
23460643|NCT03299166|65430821|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
23788312|NCT01993186|66603255|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
23788313|NCT01993186|66603254|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
23788314|NCT01993186|66603255|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
23788315|NCT01205035|66603256|FG000|Overall Study|Withdrawal by Subject|1|||
23788316|NCT01205035|66603257|FG001|Overall Study|Withdrawal by Subject|0|||
23788317|NCT01205035|66603256|FG000|Overall Study|Physician Decision|1|||
23460644|NCT03299166|65430822|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
23460645|NCT04634253|65430823|FG000|Overall Study|Adverse Event|1|||
23460646|NCT04634253|65430824|FG001|Overall Study|Adverse Event|1|||
23460647|NCT04634253|65430825|FG002|Overall Study|Adverse Event|0|||
23584315|NCT02775435|65866136|FG000|Overall Study|Adverse Event|32|||
23348632|NCT02949908|65021592|FG000|Overall Study|Study termination|2|||
23348633|NCT03003000|65021595|FG000|Overall Study|Adverse Event|1|||
23348634|NCT03003000|65021596|FG001|Overall Study|Adverse Event|2|||
23584316|NCT02775435|65866137|FG001|Overall Study|Adverse Event|27|||
23584317|NCT02775435|65866136|FG000|Overall Study|Lost to Follow-up|2|||
23788318|NCT01205035|66603257|FG001|Overall Study|Physician Decision|0|||
23788319|NCT00965757|66603258|FG000|Double-blind Phase|Progression of concomitant disease|1|||
23788320|NCT00965757|66603259|FG001|Double-blind Phase|Progression of concomitant disease|2|||
23788321|NCT00965757|66603260|FG002|Double-blind Phase|Progression of concomitant disease|0|||
23788322|NCT00965757|66603261|FG003|Double-blind Phase|Progression of concomitant disease|0|||
23788323|NCT00965757|66603258|FG000|Double-blind Phase|Adverse drug reaction|2|||
23788324|NCT00965757|66603259|FG001|Double-blind Phase|Adverse drug reaction|1|||
23788325|NCT00965757|66603260|FG002|Double-blind Phase|Adverse drug reaction|0|||
23788326|NCT00965757|66603261|FG003|Double-blind Phase|Adverse drug reaction|0|||
23584318|NCT02775435|65866137|FG001|Overall Study|Lost to Follow-up|2|||
23584319|NCT02775435|65866136|FG000|Overall Study|Sponsor decision|44|||
23584320|NCT02775435|65866137|FG001|Overall Study|Sponsor decision|19|||
23584321|NCT02775435|65866136|FG000|Overall Study|Withdrawal by Subject|4|||
23584322|NCT02775435|65866137|FG001|Overall Study|Withdrawal by Subject|9|||
23584323|NCT02775435|65866136|FG000|Overall Study|Death|196|||
23584324|NCT02775435|65866137|FG001|Overall Study|Death|224|||
23584325|NCT01174550|65866138|FG000|Overall Study|Death|75|||
23584326|NCT01174550|65866139|FG001|Overall Study|Death|74|||
23584327|NCT01174550|65866138|FG000|Overall Study|Lost to Follow-up|652|||
23584328|NCT01174550|65866139|FG001|Overall Study|Lost to Follow-up|510|||
23584329|NCT01174550|65866138|FG000|Overall Study|Withdrawal by Subject|543|||
23584330|NCT01174550|65866139|FG001|Overall Study|Withdrawal by Subject|289|||
23584331|NCT03396913|65866146|FG000|Overall Study|Lost to Follow-up|0|||
23584332|NCT03396913|65866147|FG001|Overall Study|Lost to Follow-up|6|||
23584333|NCT03523962|65866150|FG000|Closed Fractures|Death|86|||
23788327|NCT00965757|66603258|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
23348635|NCT03003000|65021597|FG002|Overall Study|Adverse Event|3|||
23584334|NCT03523962|65866151|FG001|Closed Fractures|Death|71|||
23584335|NCT03523962|65866152|FG002|Closed Fractures|Death|0|||
23584336|NCT03523962|65866153|FG003|Closed Fractures|Death|0|||
23584337|NCT03523962|65866150|FG000|Closed Fractures|Lost to Follow-up|62|||
23788328|NCT00965757|66603259|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
23348636|NCT03003000|65021595|FG000|Overall Study|Lack of Efficacy|1|||
23460648|NCT04634253|65430823|FG000|Overall Study|Physician Decision|0|||
23584338|NCT03523962|65866151|FG001|Closed Fractures|Lost to Follow-up|36|||
23348637|NCT03003000|65021596|FG001|Overall Study|Lack of Efficacy|0|||
23348638|NCT03003000|65021597|FG002|Overall Study|Lack of Efficacy|0|||
23348639|NCT03003000|65021595|FG000|Overall Study|Non-compliant with protocol|0|||
23348640|NCT03003000|65021596|FG001|Overall Study|Non-compliant with protocol|1|||
23348641|NCT03003000|65021597|FG002|Overall Study|Non-compliant with protocol|1|||
23348642|NCT03003000|65021595|FG000|Overall Study|Refused to continue medication|2|||
23348643|NCT03003000|65021596|FG001|Overall Study|Refused to continue medication|0|||
23348644|NCT03003000|65021597|FG002|Overall Study|Refused to continue medication|0|||
23348645|NCT03003000|65021595|FG000|Overall Study|Other than listed|1|||
23348646|NCT03003000|65021596|FG001|Overall Study|Other than listed|1|||
23348647|NCT03003000|65021597|FG002|Overall Study|Other than listed|1|||
23348648|NCT00505661|65021598|FG000|Overall Study|Not Eligible|4|||
23348649|NCT02079636|65021599|FG000|Overall Study|Death|2|||
23584339|NCT03523962|65866152|FG002|Closed Fractures|Lost to Follow-up|0|||
23584340|NCT03523962|65866153|FG003|Closed Fractures|Lost to Follow-up|0|||
23584341|NCT03523962|65866150|FG000|Closed Fractures|Withdrawal by Subject|19|||
23584342|NCT03523962|65866151|FG001|Closed Fractures|Withdrawal by Subject|29|||
23584343|NCT03523962|65866152|FG002|Closed Fractures|Withdrawal by Subject|0|||
23584344|NCT03523962|65866153|FG003|Closed Fractures|Withdrawal by Subject|0|||
23584345|NCT03523962|65866150|FG000|Closed Fractures|Incarceration|1|||
23584346|NCT03523962|65866151|FG001|Closed Fractures|Incarceration|4|||
23584347|NCT03523962|65866152|FG002|Closed Fractures|Incarceration|0|||
23584348|NCT03523962|65866153|FG003|Closed Fractures|Incarceration|0|||
23584349|NCT03523962|65866150|FG000|Open Fractures|Death|0|||
23584350|NCT03523962|65866151|FG001|Open Fractures|Death|0|||
23584351|NCT03523962|65866152|FG002|Open Fractures|Death|11|||
23584352|NCT03523962|65866153|FG003|Open Fractures|Death|6|||
23584353|NCT03523962|65866150|FG000|Open Fractures|Lost to Follow-up|0|||
23348650|NCT02079636|65021600|FG001|Overall Study|Death|1|||
23584354|NCT03523962|65866151|FG001|Open Fractures|Lost to Follow-up|0|||
23584355|NCT03523962|65866152|FG002|Open Fractures|Lost to Follow-up|15|||
23348651|NCT02079636|65021601|FG002|Overall Study|Death|0|||
23584356|NCT03523962|65866153|FG003|Open Fractures|Lost to Follow-up|8|||
23584357|NCT03523962|65866150|FG000|Open Fractures|Withdrawal by Subject|0|||
23584358|NCT03523962|65866151|FG001|Open Fractures|Withdrawal by Subject|0|||
23639060|NCT00929110|66064460|FG000|Overall Study|Protocol deviation|5|||
23788329|NCT00965757|66603260|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
23788330|NCT00965757|66603261|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
23788331|NCT00965757|66603258|FG000|Double-blind Phase|Lack of Efficacy|7|||
23788332|NCT00965757|66603259|FG001|Double-blind Phase|Lack of Efficacy|11|||
23788333|NCT00965757|66603260|FG002|Double-blind Phase|Lack of Efficacy|0|||
23788334|NCT00965757|66603261|FG003|Double-blind Phase|Lack of Efficacy|0|||
23788335|NCT00965757|66603258|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
23788336|NCT00965757|66603259|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23788337|NCT00965757|66603260|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23348652|NCT02079636|65021602|FG003|Overall Study|Death|5|||
23348653|NCT02079636|65021603|FG004|Overall Study|Death|1|||
23348654|NCT02079636|65021604|FG005|Overall Study|Death|2|||
23348655|NCT02079636|65021605|FG006|Overall Study|Death|1|||
23348656|NCT02079636|65021606|FG007|Overall Study|Death|0|||
23348657|NCT02079636|65021607|FG008|Overall Study|Death|0|||
23348658|NCT02079636|65021608|FG009|Overall Study|Death|0|||
23348659|NCT02079636|65021609|FG010|Overall Study|Death|0|||
23348660|NCT02079636|65021610|FG011|Overall Study|Death|1|||
23348661|NCT02079636|65021611|FG012|Overall Study|Death|1|||
23348662|NCT02079636|65021612|FG013|Overall Study|Death|0|||
23348663|NCT02079636|65021613|FG014|Overall Study|Death|2|||
23584359|NCT03523962|65866152|FG002|Open Fractures|Withdrawal by Subject|6|||
23584360|NCT03523962|65866153|FG003|Open Fractures|Withdrawal by Subject|2|||
23584361|NCT03523962|65866150|FG000|Open Fractures|Incarceration|0|||
23584362|NCT03523962|65866151|FG001|Open Fractures|Incarceration|0|||
23584363|NCT03523962|65866152|FG002|Open Fractures|Incarceration|1|||
23584364|NCT03523962|65866153|FG003|Open Fractures|Incarceration|0|||
23584365|NCT03568162|65866154|FG000|Overall Study|Adverse Event|0|||
23584366|NCT03568162|65866155|FG001|Overall Study|Adverse Event|1|||
23584367|NCT03568162|65866156|FG002|Overall Study|Adverse Event|2|||
23584368|NCT03568162|65866157|FG003|Overall Study|Adverse Event|0|||
23584369|NCT03568162|65866158|FG004|Overall Study|Adverse Event|0|||
23584370|NCT03568162|65866159|FG005|Overall Study|Adverse Event|1|||
23584371|NCT03568162|65866154|FG000|Overall Study|Death|0|||
23584372|NCT03568162|65866155|FG001|Overall Study|Death|0|||
23584373|NCT03568162|65866156|FG002|Overall Study|Death|0|||
23584374|NCT03568162|65866157|FG003|Overall Study|Death|0|||
23584375|NCT03568162|65866158|FG004|Overall Study|Death|1|||
23584376|NCT03568162|65866159|FG005|Overall Study|Death|0|||
23584377|NCT03568162|65866154|FG000|Overall Study|Lost to Follow-up|3|||
23584378|NCT03568162|65866155|FG001|Overall Study|Lost to Follow-up|2|||
23584379|NCT03568162|65866156|FG002|Overall Study|Lost to Follow-up|4|||
23584380|NCT03568162|65866157|FG003|Overall Study|Lost to Follow-up|2|||
23584381|NCT03568162|65866158|FG004|Overall Study|Lost to Follow-up|3|||
23584382|NCT03568162|65866159|FG005|Overall Study|Lost to Follow-up|2|||
23584383|NCT03568162|65866154|FG000|Overall Study|Physician Decision|0|||
23584384|NCT03568162|65866155|FG001|Overall Study|Physician Decision|1|||
23584385|NCT03568162|65866156|FG002|Overall Study|Physician Decision|1|||
23584386|NCT03568162|65866157|FG003|Overall Study|Physician Decision|0|||
23584387|NCT03568162|65866158|FG004|Overall Study|Physician Decision|1|||
23584388|NCT03568162|65866159|FG005|Overall Study|Physician Decision|0|||
23584389|NCT03568162|65866154|FG000|Overall Study|Pregnancy|0|||
23584390|NCT03568162|65866155|FG001|Overall Study|Pregnancy|0|||
23584391|NCT03568162|65866156|FG002|Overall Study|Pregnancy|0|||
23584392|NCT03568162|65866157|FG003|Overall Study|Pregnancy|1|||
23584393|NCT03568162|65866158|FG004|Overall Study|Pregnancy|0|||
23584394|NCT03568162|65866159|FG005|Overall Study|Pregnancy|0|||
23584395|NCT03568162|65866154|FG000|Overall Study|Protocol Violation|1|||
23584396|NCT03568162|65866155|FG001|Overall Study|Protocol Violation|0|||
23584397|NCT03568162|65866156|FG002|Overall Study|Protocol Violation|1|||
23584398|NCT03568162|65866157|FG003|Overall Study|Protocol Violation|1|||
23584399|NCT03568162|65866158|FG004|Overall Study|Protocol Violation|1|||
23584400|NCT03568162|65866159|FG005|Overall Study|Protocol Violation|1|||
23584401|NCT03568162|65866154|FG000|Overall Study|Withdrawal by Subject|15|||
23584402|NCT03568162|65866155|FG001|Overall Study|Withdrawal by Subject|15|||
23584403|NCT03568162|65866156|FG002|Overall Study|Withdrawal by Subject|26|||
23584404|NCT03568162|65866157|FG003|Overall Study|Withdrawal by Subject|22|||
23584405|NCT03568162|65866158|FG004|Overall Study|Withdrawal by Subject|6|||
23584406|NCT03568162|65866159|FG005|Overall Study|Withdrawal by Subject|9|||
23584407|NCT03568162|65866154|FG000|Overall Study|Others|3|||
23584408|NCT03568162|65866155|FG001|Overall Study|Others|4|||
23348664|NCT02079636|65021599|FG000|Overall Study|Adverse Event|1|||
23348665|NCT02079636|65021600|FG001|Overall Study|Adverse Event|1|||
23584409|NCT03568162|65866156|FG002|Overall Study|Others|1|||
23584410|NCT03568162|65866157|FG003|Overall Study|Others|4|||
23584411|NCT03568162|65866158|FG004|Overall Study|Others|2|||
23584412|NCT03568162|65866159|FG005|Overall Study|Others|1|||
23584413|NCT03538054|65866160|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
23584414|NCT03538054|65866160|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
23584415|NCT03538054|65866160|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
23639061|NCT00929110|66064461|FG001|Overall Study|Protocol deviation|2|||
23639062|NCT00929110|66064462|FG002|Overall Study|Protocol deviation|4|||
23639063|NCT00929110|66064460|FG000|Overall Study|Administrative problems|4|||
23639064|NCT00929110|66064461|FG001|Overall Study|Administrative problems|1|||
23639065|NCT00929110|66064462|FG002|Overall Study|Administrative problems|2|||
23639066|NCT00929110|66064460|FG000|Overall Study|Death|2|||
23639067|NCT00929110|66064461|FG001|Overall Study|Death|2|||
23788338|NCT00965757|66603261|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23788339|NCT00965757|66603258|FG000|Double-blind Phase|Lost to Follow-up|0|||
23788340|NCT00965757|66603259|FG001|Double-blind Phase|Lost to Follow-up|1|||
23788341|NCT00965757|66603260|FG002|Double-blind Phase|Lost to Follow-up|0|||
23788342|NCT00965757|66603261|FG003|Double-blind Phase|Lost to Follow-up|0|||
23639068|NCT00929110|66064462|FG002|Overall Study|Death|2|||
23639069|NCT00929110|66064460|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23639070|NCT00929110|66064461|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23639071|NCT00929110|66064462|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23788343|NCT00965757|66603258|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
23788344|NCT00965757|66603259|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
23788345|NCT00965757|66603260|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
23788346|NCT00965757|66603261|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
23788347|NCT00965757|66603258|FG000|Double-blind Phase|Other|1|||
23788348|NCT00965757|66603259|FG001|Double-blind Phase|Other|0|||
23788349|NCT00965757|66603260|FG002|Double-blind Phase|Other|0|||
23788350|NCT00965757|66603261|FG003|Double-blind Phase|Other|0|||
23788351|NCT00965757|66603258|FG000|Extension Phase|Progression of concomitant disease|0|||
23788352|NCT00965757|66603259|FG001|Extension Phase|Progression of concomitant disease|0|||
23788353|NCT00965757|66603260|FG002|Extension Phase|Progression of concomitant disease|4|||
23788354|NCT00965757|66603261|FG003|Extension Phase|Progression of concomitant disease|2|||
23788355|NCT00965757|66603258|FG000|Extension Phase|Adverse drug reaction|0|||
23788356|NCT00965757|66603259|FG001|Extension Phase|Adverse drug reaction|0|||
23788357|NCT00965757|66603260|FG002|Extension Phase|Adverse drug reaction|6|||
23788358|NCT00965757|66603261|FG003|Extension Phase|Adverse drug reaction|3|||
23788359|NCT00965757|66603258|FG000|Extension Phase|Abnormal Laboratory Value|0|||
23788360|NCT00965757|66603259|FG001|Extension Phase|Abnormal Laboratory Value|0|||
23788361|NCT00965757|66603260|FG002|Extension Phase|Abnormal Laboratory Value|6|||
23788362|NCT00965757|66603261|FG003|Extension Phase|Abnormal Laboratory Value|1|||
23788363|NCT00965757|66603258|FG000|Extension Phase|Lack of Efficacy|0|||
23788364|NCT00965757|66603259|FG001|Extension Phase|Lack of Efficacy|0|||
23788365|NCT00965757|66603260|FG002|Extension Phase|Lack of Efficacy|8|||
23788366|NCT00965757|66603261|FG003|Extension Phase|Lack of Efficacy|12|||
23788367|NCT00965757|66603258|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23788368|NCT00965757|66603259|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23788369|NCT00965757|66603260|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
23639072|NCT00929110|66064460|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23639073|NCT00929110|66064461|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23639074|NCT00929110|66064462|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23788370|NCT00965757|66603261|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23788371|NCT00965757|66603258|FG000|Extension Phase|Lost to Follow-up|0|||
23788372|NCT00965757|66603259|FG001|Extension Phase|Lost to Follow-up|0|||
23788373|NCT00965757|66603260|FG002|Extension Phase|Lost to Follow-up|0|||
23788374|NCT00965757|66603261|FG003|Extension Phase|Lost to Follow-up|1|||
23788375|NCT00965757|66603258|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
23788376|NCT00965757|66603259|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
23788377|NCT00965757|66603260|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
23788378|NCT00965757|66603261|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
23788379|NCT00965757|66603258|FG000|Extension Phase|Protocol Violation|0|||
23788380|NCT00965757|66603259|FG001|Extension Phase|Protocol Violation|0|||
23788381|NCT00965757|66603260|FG002|Extension Phase|Protocol Violation|0|||
23788382|NCT00965757|66603261|FG003|Extension Phase|Protocol Violation|1|||
23788383|NCT00965757|66603258|FG000|Extension Phase|Other|0|||
23788384|NCT00965757|66603259|FG001|Extension Phase|Other|0|||
23788385|NCT00965757|66603260|FG002|Extension Phase|Other|2|||
23788386|NCT00965757|66603261|FG003|Extension Phase|Other|1|||
23788387|NCT00533507|66603266|FG000|Overall Study|Withdrawal by Subject|1|||
23788388|NCT02473393|66603269|FG000|Overall Study|Adverse Event|0|||
23460649|NCT04634253|65430824|FG001|Overall Study|Physician Decision|1|||
23460650|NCT04634253|65430825|FG002|Overall Study|Physician Decision|0|||
23460651|NCT04634253|65430823|FG000|Overall Study|Withdrawal by Subject|1|||
23460652|NCT04634253|65430824|FG001|Overall Study|Withdrawal by Subject|0|||
23584416|NCT04889664|65866161|FG000|Screen|Lost to Follow-up|1|||
23584417|NCT04889664|65866161|FG000|Screen|Failed to meet screening criteria|1|||
23639075|NCT00929110|66064460|FG000|Overall Study|Patient inability to use the device|0|||
23460653|NCT04634253|65430825|FG002|Overall Study|Withdrawal by Subject|3|||
23348666|NCT02079636|65021601|FG002|Overall Study|Adverse Event|0|||
23460654|NCT02863419|65430829|FG000|Overall Study|Lost to Follow-up|0|||
23460655|NCT02863419|65430830|FG001|Overall Study|Lost to Follow-up|1|||
23460656|NCT02863419|65430831|FG002|Overall Study|Lost to Follow-up|4|||
23460657|NCT02863419|65430829|FG000|Overall Study|Withdrawal by Subject|5|||
23460658|NCT02863419|65430830|FG001|Overall Study|Withdrawal by Subject|5|||
23460659|NCT02863419|65430831|FG002|Overall Study|Withdrawal by Subject|3|||
23348667|NCT02079636|65021602|FG003|Overall Study|Adverse Event|1|||
23348668|NCT02079636|65021603|FG004|Overall Study|Adverse Event|1|||
23348669|NCT02079636|65021604|FG005|Overall Study|Adverse Event|2|||
23348670|NCT02079636|65021605|FG006|Overall Study|Adverse Event|0|||
23348671|NCT02079636|65021606|FG007|Overall Study|Adverse Event|0|||
23348672|NCT02079636|65021607|FG008|Overall Study|Adverse Event|0|||
23348673|NCT02079636|65021608|FG009|Overall Study|Adverse Event|0|||
23348674|NCT02079636|65021609|FG010|Overall Study|Adverse Event|0|||
23348675|NCT02079636|65021610|FG011|Overall Study|Adverse Event|0|||
23348676|NCT02079636|65021611|FG012|Overall Study|Adverse Event|0|||
23348677|NCT02079636|65021612|FG013|Overall Study|Adverse Event|0|||
23348678|NCT02079636|65021613|FG014|Overall Study|Adverse Event|0|||
23348679|NCT02079636|65021599|FG000|Overall Study|Progressive disease|0|||
23348680|NCT02079636|65021600|FG001|Overall Study|Progressive disease|0|||
23348681|NCT02079636|65021601|FG002|Overall Study|Progressive disease|0|||
23348682|NCT02079636|65021602|FG003|Overall Study|Progressive disease|2|||
23348683|NCT02079636|65021603|FG004|Overall Study|Progressive disease|0|||
23348684|NCT02079636|65021604|FG005|Overall Study|Progressive disease|0|||
23348685|NCT02079636|65021605|FG006|Overall Study|Progressive disease|0|||
23348686|NCT02079636|65021606|FG007|Overall Study|Progressive disease|0|||
23348687|NCT02079636|65021607|FG008|Overall Study|Progressive disease|0|||
23348688|NCT02079636|65021608|FG009|Overall Study|Progressive disease|0|||
23348689|NCT02079636|65021609|FG010|Overall Study|Progressive disease|0|||
23348690|NCT02079636|65021610|FG011|Overall Study|Progressive disease|0|||
23348691|NCT02079636|65021611|FG012|Overall Study|Progressive disease|1|||
23348692|NCT02079636|65021612|FG013|Overall Study|Progressive disease|0|||
23348693|NCT02079636|65021613|FG014|Overall Study|Progressive disease|0|||
23348694|NCT02079636|65021599|FG000|Overall Study|Withdrawal by Subject|0|||
23348695|NCT02079636|65021600|FG001|Overall Study|Withdrawal by Subject|0|||
23348696|NCT02079636|65021601|FG002|Overall Study|Withdrawal by Subject|0|||
23348697|NCT02079636|65021602|FG003|Overall Study|Withdrawal by Subject|4|||
23348698|NCT02079636|65021603|FG004|Overall Study|Withdrawal by Subject|0|||
23348699|NCT02079636|65021604|FG005|Overall Study|Withdrawal by Subject|1|||
23348700|NCT02079636|65021605|FG006|Overall Study|Withdrawal by Subject|0|||
23348701|NCT02079636|65021606|FG007|Overall Study|Withdrawal by Subject|0|||
23348702|NCT02079636|65021607|FG008|Overall Study|Withdrawal by Subject|0|||
23348703|NCT02079636|65021608|FG009|Overall Study|Withdrawal by Subject|2|||
23348704|NCT02079636|65021609|FG010|Overall Study|Withdrawal by Subject|1|||
23348705|NCT02079636|65021610|FG011|Overall Study|Withdrawal by Subject|1|||
23348706|NCT02079636|65021611|FG012|Overall Study|Withdrawal by Subject|1|||
23348707|NCT02079636|65021612|FG013|Overall Study|Withdrawal by Subject|0|||
23348708|NCT02079636|65021613|FG014|Overall Study|Withdrawal by Subject|2|||
23348709|NCT02079636|65021599|FG000|Overall Study|Physician Decision|0|||
23348710|NCT02079636|65021600|FG001|Overall Study|Physician Decision|0|||
23348711|NCT02079636|65021601|FG002|Overall Study|Physician Decision|0|||
23348712|NCT02079636|65021602|FG003|Overall Study|Physician Decision|0|||
23348713|NCT02079636|65021603|FG004|Overall Study|Physician Decision|0|||
23348714|NCT02079636|65021604|FG005|Overall Study|Physician Decision|1|||
23348715|NCT02079636|65021605|FG006|Overall Study|Physician Decision|0|||
23348716|NCT02079636|65021606|FG007|Overall Study|Physician Decision|0|||
23348717|NCT02079636|65021607|FG008|Overall Study|Physician Decision|0|||
23348718|NCT02079636|65021608|FG009|Overall Study|Physician Decision|1|||
23348719|NCT02079636|65021609|FG010|Overall Study|Physician Decision|1|||
23348720|NCT02079636|65021610|FG011|Overall Study|Physician Decision|0|||
23348721|NCT02079636|65021611|FG012|Overall Study|Physician Decision|0|||
23460660|NCT02863419|65430829|FG000|Overall Study|Died|3|||
23348722|NCT02079636|65021612|FG013|Overall Study|Physician Decision|0|||
23348723|NCT02079636|65021613|FG014|Overall Study|Physician Decision|1|||
23460661|NCT02863419|65430830|FG001|Overall Study|Died|4|||
23788389|NCT02473393|66603270|FG001|Overall Study|Adverse Event|0|||
23348724|NCT02079636|65021599|FG000|Overall Study|Lost to Follow-up|0|||
23348725|NCT02079636|65021600|FG001|Overall Study|Lost to Follow-up|0|||
23348726|NCT02079636|65021601|FG002|Overall Study|Lost to Follow-up|0|||
23348727|NCT02079636|65021602|FG003|Overall Study|Lost to Follow-up|0|||
23348728|NCT02079636|65021603|FG004|Overall Study|Lost to Follow-up|0|||
23348729|NCT02079636|65021604|FG005|Overall Study|Lost to Follow-up|0|||
23348730|NCT02079636|65021605|FG006|Overall Study|Lost to Follow-up|0|||
23460662|NCT02863419|65430831|FG002|Overall Study|Died|1|||
23460663|NCT02443688|65430832|FG000|Overall Study|Adverse Event|2|||
23460664|NCT02443688|65430833|FG001|Overall Study|Adverse Event|3|||
23348731|NCT02079636|65021606|FG007|Overall Study|Lost to Follow-up|1|||
23348732|NCT02079636|65021607|FG008|Overall Study|Lost to Follow-up|0|||
23348733|NCT02079636|65021608|FG009|Overall Study|Lost to Follow-up|0|||
23348734|NCT02079636|65021609|FG010|Overall Study|Lost to Follow-up|0|||
23348735|NCT02079636|65021610|FG011|Overall Study|Lost to Follow-up|0|||
23348736|NCT02079636|65021611|FG012|Overall Study|Lost to Follow-up|0|||
23348737|NCT02079636|65021612|FG013|Overall Study|Lost to Follow-up|0|||
23348738|NCT02079636|65021613|FG014|Overall Study|Lost to Follow-up|0|||
23348739|NCT00250458|65021614|FG000|Overall Study|Lost to Follow-up|4|||
23348740|NCT00250458|65021615|FG001|Overall Study|Lost to Follow-up|2|||
23348741|NCT00250458|65021614|FG000|Overall Study|Protocol Violation|0|||
23348742|NCT00250458|65021615|FG001|Overall Study|Protocol Violation|1|||
23348743|NCT00250458|65021614|FG000|Overall Study|Withdrawal by Subject|4|||
23348744|NCT00250458|65021615|FG001|Overall Study|Withdrawal by Subject|2|||
23348745|NCT00250458|65021614|FG000|Overall Study|Lack of Migraine Attack|20|||
23348746|NCT00250458|65021615|FG001|Overall Study|Lack of Migraine Attack|9|||
23348747|NCT00250458|65021614|FG000|Overall Study|Qualifying migraine but did not treat|3|||
23348748|NCT00250458|65021615|FG001|Overall Study|Qualifying migraine but did not treat|3|||
23348749|NCT00250458|65021614|FG000|Overall Study|Other|1|||
23348750|NCT00250458|65021615|FG001|Overall Study|Other|0|||
23348751|NCT01731470|65021622|FG000|Overall Study|Withdrawal by Subject|1|||
23348752|NCT01731470|65021622|FG000|Overall Study|Did not meet study criteria|1|||
23348753|NCT01606202|65021636|FG000|Overall Study|Adverse Event|5|||
23348754|NCT01606202|65021637|FG001|Overall Study|Adverse Event|0|||
23348755|NCT01606202|65021636|FG000|Overall Study|Withdrawal by Subject|2|||
23348756|NCT01606202|65021637|FG001|Overall Study|Withdrawal by Subject|1|||
23348757|NCT01606202|65021636|FG000|Overall Study|Personal problems|0|||
23348758|NCT01606202|65021637|FG001|Overall Study|Personal problems|1|||
23348759|NCT01606202|65021636|FG000|Overall Study|Problems with administration|0|||
23348760|NCT01606202|65021637|FG001|Overall Study|Problems with administration|1|||
23348761|NCT02839876|65021640|FG000|Overall Study|Protocol Violation|10|||
23348762|NCT02839876|65021641|FG001|Overall Study|Protocol Violation|11|||
23348763|NCT00503997|65021642|FG000|Overall Study|disease progression|1|||
23348764|NCT00503997|65021642|FG000|Overall Study|Adverse Event|5|||
23348765|NCT00503997|65021642|FG000|Overall Study|Death|1|||
23460665|NCT02443688|65430834|FG002|Overall Study|Adverse Event|2|||
23460666|NCT02443688|65430832|FG000|Overall Study|Lost to Follow-up|1|||
23639076|NCT00929110|66064461|FG001|Overall Study|Patient inability to use the device|1|||
23639077|NCT00929110|66064462|FG002|Overall Study|Patient inability to use the device|0|||
23348766|NCT00503997|65021642|FG000|Overall Study|Withdrawal by Subject|1|||
23348767|NCT01156051|65021647|FG000|Overall Study|Lost to Follow-up|1|||
23348768|NCT01156051|65021648|FG001|Overall Study|Lost to Follow-up|0|||
23348769|NCT01156051|65021647|FG000|Overall Study|patient not compliant with protocol|0|||
23460667|NCT02443688|65430833|FG001|Overall Study|Lost to Follow-up|0|||
23348770|NCT01156051|65021648|FG001|Overall Study|patient not compliant with protocol|1|||
23348771|NCT01211483|65021657|FG000|Phase 1b|Death|6|||
23348772|NCT01211483|65021658|FG001|Phase 1b|Death|0|||
23348773|NCT01211483|65021659|FG002|Phase 1b|Death|0|||
23348774|NCT01211483|65021660|FG003|Phase 1b|Death|0|||
23348775|NCT01211483|65021657|FG000|Phase 1b|Withdrawal by Subject|1|||
23348776|NCT01211483|65021658|FG001|Phase 1b|Withdrawal by Subject|0|||
23348777|NCT01211483|65021659|FG002|Phase 1b|Withdrawal by Subject|0|||
23348778|NCT01211483|65021660|FG003|Phase 1b|Withdrawal by Subject|0|||
23348779|NCT01211483|65021657|FG000|Phase 2|Lost to Follow-up|0|||
23348780|NCT01211483|65021658|FG001|Phase 2|Lost to Follow-up|1|||
23348781|NCT01211483|65021659|FG002|Phase 2|Lost to Follow-up|1|||
23348782|NCT01211483|65021660|FG003|Phase 2|Lost to Follow-up|2|||
23348783|NCT01211483|65021657|FG000|Phase 2|Death|0|||
23348784|NCT01211483|65021658|FG001|Phase 2|Death|64|||
23348785|NCT01211483|65021659|FG002|Phase 2|Death|53|||
23348786|NCT01211483|65021660|FG003|Phase 2|Death|53|||
23348787|NCT01211483|65021657|FG000|Phase 2|Withdrawal by Subject|0|||
23348788|NCT01211483|65021658|FG001|Phase 2|Withdrawal by Subject|1|||
23348789|NCT01211483|65021659|FG002|Phase 2|Withdrawal by Subject|10|||
23348790|NCT01211483|65021660|FG003|Phase 2|Withdrawal by Subject|5|||
23348791|NCT01211483|65021657|FG000|Phase 2|Study terminated by Sponsor|0|||
23348792|NCT01211483|65021658|FG001|Phase 2|Study terminated by Sponsor|6|||
23348793|NCT01211483|65021659|FG002|Phase 2|Study terminated by Sponsor|8|||
23348794|NCT01211483|65021660|FG003|Phase 2|Study terminated by Sponsor|11|||
23348795|NCT01904903|65021667|FG000|Overall Study|Withdrawal by Subject|1|||
23788390|NCT02473393|66603271|FG002|Overall Study|Adverse Event|1|||
23788391|NCT02473393|66603272|FG003|Overall Study|Adverse Event|0|||
23788392|NCT02473393|66603269|FG000|Overall Study|Withdrawal by Subject|0|||
23788393|NCT02473393|66603270|FG001|Overall Study|Withdrawal by Subject|0|||
23788394|NCT02473393|66603271|FG002|Overall Study|Withdrawal by Subject|1|||
23788395|NCT02473393|66603272|FG003|Overall Study|Withdrawal by Subject|1|||
23788396|NCT01943435|66603273|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
23788397|NCT01943435|66603274|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
23788398|NCT01943435|66603275|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
23788399|NCT01943435|66603273|FG000|Intervention Period|Withdrawal by Subject|3|||
23788400|NCT01943435|66603274|FG001|Intervention Period|Withdrawal by Subject|3|||
23348796|NCT01634659|65021668|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
23584418|NCT04889664|65866161|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
23584419|NCT00831792|65869170|FG000|Overall Study|Not Eligible|3|||
23584420|NCT00831792|65869170|FG000|Overall Study|Adverse Event|1|||
23584421|NCT00831792|65869170|FG000|Overall Study|Death|1|||
23584422|NCT00831792|65869170|FG000|Overall Study|Lack of Efficacy|1|||
23584423|NCT00613301|65869171|FG000|Overall Study|Adverse Event|49|||
23584424|NCT00613301|65869171|FG000|Overall Study|Lost to Follow-up|88|||
23584425|NCT00613301|65869171|FG000|Overall Study|Withdrawal by Subject|5|||
23584426|NCT00613301|65869171|FG000|Overall Study|Death|6|||
23584427|NCT00613301|65869171|FG000|Overall Study|Lack of Efficacy|13|||
23584428|NCT00613301|65869171|FG000|Overall Study|Physician Decision|2|||
23584429|NCT00613301|65869171|FG000|Overall Study|No data was collected|53|||
23584430|NCT00613301|65869171|FG000|Overall Study|Irregularly enrolled patients|12|||
23584431|NCT01839877|65869186|FG000|Overall Study|Protocol Violation|1|||
23584432|NCT05567952|65869187|FG000|Overall Study|Lost to Follow-up|3|||
23584433|NCT05567952|65869188|FG001|Overall Study|Lost to Follow-up|2|||
23584434|NCT05567952|65869187|FG000|Overall Study|Withdrawal by Subject|6|||
23584435|NCT05567952|65869188|FG001|Overall Study|Withdrawal by Subject|3|||
23584436|NCT05567952|65869187|FG000|Overall Study|Other|3|||
23584437|NCT05567952|65869188|FG001|Overall Study|Other|1|||
23584438|NCT01450943|65869189|FG000|Overall Study|Screen failure, loss to follow-up|2|||
23584439|NCT01450943|65869190|FG001|Overall Study|Screen failure, loss to follow-up|7|||
23584440|NCT01450943|65869191|FG002|Overall Study|Screen failure, loss to follow-up|6|||
23584441|NCT01249092|65869195|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
23584442|NCT01249092|65869195|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
23584443|NCT03781804|65869196|FG000|Overall Study|Adverse Event|2|||
23584444|NCT03781804|65869197|FG001|Overall Study|Adverse Event|2|||
23584445|NCT03781804|65869198|FG002|Overall Study|Adverse Event|3|||
23788401|NCT01943435|66603275|FG002|Intervention Period|Withdrawal by Subject|4|||
23788402|NCT01943435|66603273|FG000|2 Month Follow up|Lost to Follow-up|2|||
23584446|NCT03781804|65869196|FG000|Overall Study|Lost to Follow-up|1|||
23584447|NCT03781804|65869197|FG001|Overall Study|Lost to Follow-up|1|||
23584448|NCT03781804|65869198|FG002|Overall Study|Lost to Follow-up|2|||
23584449|NCT03781804|65869196|FG000|Overall Study|Lack of Efficacy|4|||
23584450|NCT03781804|65869197|FG001|Overall Study|Lack of Efficacy|2|||
23348797|NCT01634659|65021669|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
23348798|NCT01634659|65021668|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
23348799|NCT01634659|65021669|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
23788403|NCT01943435|66603274|FG001|2 Month Follow up|Lost to Follow-up|3|||
23348800|NCT00335959|65021674|FG000|Overall Study|Adverse Event|2|||
23348801|NCT00335959|65021674|FG000|Overall Study|Ineligible|1|||
23348802|NCT03304184|65021675|FG000|Overall Study|Withdrawal by Subject|1|||
23348803|NCT03304184|65021676|FG001|Overall Study|Withdrawal by Subject|2|||
23348804|NCT00904917|65021679|FG000|Overall Study|Lost to Follow-up|2|||
23348805|NCT00904917|65021680|FG001|Overall Study|Lost to Follow-up|2|||
23348806|NCT00904917|65021681|FG002|Overall Study|Lost to Follow-up|2|||
23348807|NCT00904917|65021682|FG003|Overall Study|Lost to Follow-up|2|||
23348808|NCT04495816|65021687|FG000|Overall Study|Lost to Follow-up|10|||
23348809|NCT04495816|65021688|FG001|Overall Study|Lost to Follow-up|4|||
23348810|NCT04495816|65021687|FG000|Overall Study|Withdrawal by Subject|3|||
23348811|NCT04495816|65021688|FG001|Overall Study|Withdrawal by Subject|5|||
23348812|NCT00334295|65021689|FG000|Overall Study|Patients received fewer than 3 injection|5|||
23348813|NCT00426660|65021693|FG000|Overall Study|Death|14|||
23348814|NCT00426660|65021693|FG000|Overall Study|Adverse Event|23|||
23348815|NCT00426660|65021693|FG000|Overall Study|Insufficient Clinical Response|22|||
23348816|NCT00426660|65021693|FG000|Overall Study|Lost to Follow-up|15|||
23348817|NCT00426660|65021693|FG000|Overall Study|Other|23|||
23348818|NCT00426660|65021693|FG000|Overall Study|Withdrawal by Subject|18|||
23348819|NCT00426660|65021693|FG000|Overall Study|Protocol Violation|1|||
23348820|NCT00426660|65021693|FG000|Overall Study|Enrolled Not Treated|15|||
23348821|NCT01249833|65021694|FG000|Overall Study|Lost to Follow-up|0|||
23348822|NCT01249833|65021695|FG001|Overall Study|Lost to Follow-up|1|||
23460668|NCT02443688|65430834|FG002|Overall Study|Lost to Follow-up|0|||
23460669|NCT02443688|65430832|FG000|Overall Study|Physician Decision|3|||
23788404|NCT01943435|66603275|FG002|2 Month Follow up|Lost to Follow-up|0|||
23788405|NCT01943435|66603273|FG000|6 Month Follow up|Lost to Follow-up|12|||
23788406|NCT01943435|66603274|FG001|6 Month Follow up|Lost to Follow-up|7|||
23788407|NCT01943435|66603275|FG002|6 Month Follow up|Lost to Follow-up|15|||
23788408|NCT02010060|66603276|FG000|Overall Study|Lost to Follow-up|1|||
23788409|NCT02010060|66603277|FG001|Overall Study|Lost to Follow-up|2|||
23788410|NCT02010060|66603278|FG002|Overall Study|Lost to Follow-up|2|||
23788411|NCT02010060|66603276|FG000|Overall Study|Injury|0|||
23788412|NCT02010060|66603277|FG001|Overall Study|Injury|1|||
23348823|NCT03611582|65021696|FG000|Overall Study|Adverse Event|26|||
23348824|NCT03611582|65021697|FG001|Overall Study|Adverse Event|6|||
23348825|NCT03611582|65021696|FG000|Overall Study|Protocol Violation|0|||
23460670|NCT02443688|65430833|FG001|Overall Study|Physician Decision|0|||
23639078|NCT00925353|66064463|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
23460671|NCT02443688|65430834|FG002|Overall Study|Physician Decision|1|||
23639079|NCT04313608|66064464|FG000|Overall Study|Death|12|||
23639080|NCT04313608|66064465|FG001|Overall Study|Death|3|||
23639081|NCT02311673|66064466|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23788413|NCT02010060|66603278|FG002|Overall Study|Injury|0|||
23788414|NCT03086460|66603279|FG000|Study Participants|Lost to Follow-up|2|||
23348826|NCT03611582|65021697|FG001|Overall Study|Protocol Violation|1|||
23348827|NCT03611582|65021696|FG000|Overall Study|Pregnancy|1|||
23460672|NCT02443688|65430832|FG000|Overall Study|Pregnancy|0|||
23706193|NCT01258348|66301083|FG002|Overall Study|Adverse Event|3|||
23788415|NCT03086460|66603279|FG000|Study Participants|Protocol Violation|1|||
23788416|NCT03086460|66603279|FG000|Study Participants|Withdrawal by Subject|6|||
23788417|NCT03086460|66603279|FG000|Treatment A|Lost to Follow-up|1|||
23348828|NCT03611582|65021697|FG001|Overall Study|Pregnancy|2|||
23348829|NCT03611582|65021696|FG000|Overall Study|Lack of Efficacy|0|||
23348830|NCT03611582|65021697|FG001|Overall Study|Lack of Efficacy|1|||
23348831|NCT03611582|65021696|FG000|Overall Study|At the discretion of the investigator|1|||
23348832|NCT03611582|65021697|FG001|Overall Study|At the discretion of the investigator|0|||
23348833|NCT03611582|65021696|FG000|Overall Study|Safety concern as judged by the investigator|1|||
23460673|NCT02443688|65430833|FG001|Overall Study|Pregnancy|0|||
23460674|NCT02443688|65430834|FG002|Overall Study|Pregnancy|1|||
23584451|NCT03781804|65869198|FG002|Overall Study|Lack of Efficacy|9|||
23788418|NCT03086460|66603279|FG000|Treatment A|Protocol Violation|1|||
23788419|NCT03086460|66603279|FG000|Treatment A|Withdrawal by Subject|2|||
23788420|NCT03086460|66603279|FG000|Treatment C|Withdrawal by Subject|2|||
23788421|NCT03086460|66603279|FG000|Treatment E|Lost to Follow-up|1|||
23788422|NCT03086460|66603279|FG000|Treatment E|Withdrawal by Subject|3|||
23788423|NCT00834613|66603280|FG000|First Intervention|Protocol Violation|1|||
23788424|NCT00834613|66603281|FG001|First Intervention|Protocol Violation|0|||
23788425|NCT00081653|66603282|FG000|Overall Study|Adverse Event|23|||
23788426|NCT00081653|66603283|FG001|Overall Study|Adverse Event|17|||
23788427|NCT00081653|66603282|FG000|Overall Study|Lost to Follow-up|2|||
23788428|NCT00081653|66603283|FG001|Overall Study|Lost to Follow-up|4|||
23788429|NCT00081653|66603282|FG000|Overall Study|Refused Treatment|18|||
23788430|NCT00081653|66603283|FG001|Overall Study|Refused Treatment|14|||
23788431|NCT00081653|66603282|FG000|Overall Study|Low bone mineral density|1|||
23788432|NCT00081653|66603283|FG001|Overall Study|Low bone mineral density|0|||
23788433|NCT00081653|66603282|FG000|Overall Study|Bone loss|2|||
23788434|NCT00081653|66603283|FG001|Overall Study|Bone loss|0|||
23788435|NCT00081653|66603282|FG000|Overall Study|Participant leaving country|1|||
23788436|NCT00081653|66603283|FG001|Overall Study|Participant leaving country|0|||
23788437|NCT00081653|66603282|FG000|Overall Study|Loss of bone mass|0|||
23788438|NCT00081653|66603283|FG001|Overall Study|Loss of bone mass|2|||
23788439|NCT00425308|66603284|FG000|Overall Study|Adverse Event|2|||
23788440|NCT00425308|66603285|FG001|Overall Study|Adverse Event|1|||
23788441|NCT00425308|66603284|FG000|Overall Study|Withdrawal by Subject|1|||
23788442|NCT00425308|66603285|FG001|Overall Study|Withdrawal by Subject|0|||
23788443|NCT00425308|66603284|FG000|Overall Study|Death|1|||
23788444|NCT00425308|66603285|FG001|Overall Study|Death|0|||
23788445|NCT00295490|66603286|FG000|Overall Study|Protocol Violation|0|||
23788446|NCT00295490|66603287|FG001|Overall Study|Protocol Violation|0|||
23788447|NCT00295490|66603288|FG002|Overall Study|Protocol Violation|3|||
23788448|NCT00295490|66603289|FG003|Overall Study|Protocol Violation|3|||
23788449|NCT00295490|66603286|FG000|Overall Study|Withdrawal by Subject|0|||
23788450|NCT00295490|66603287|FG001|Overall Study|Withdrawal by Subject|2|||
23788451|NCT00295490|66603288|FG002|Overall Study|Withdrawal by Subject|0|||
23584452|NCT03781804|65869196|FG000|Overall Study|Protocol Violation|0|||
23788452|NCT00295490|66603289|FG003|Overall Study|Withdrawal by Subject|1|||
23788453|NCT00295490|66603286|FG000|Overall Study|Lost to Follow-up|0|||
23788454|NCT00295490|66603287|FG001|Overall Study|Lost to Follow-up|0|||
23788455|NCT00295490|66603288|FG002|Overall Study|Lost to Follow-up|1|||
23788456|NCT00295490|66603289|FG003|Overall Study|Lost to Follow-up|0|||
23788457|NCT00295490|66603286|FG000|Overall Study|Adverse Event|1|||
23788458|NCT00295490|66603287|FG001|Overall Study|Adverse Event|0|||
23348834|NCT03611582|65021697|FG001|Overall Study|Safety concern as judged by the investigator|2|||
23460675|NCT02443688|65430832|FG000|Overall Study|Withdrawal by Subject|3|||
23788459|NCT00295490|66603288|FG002|Overall Study|Adverse Event|0|||
23788460|NCT00295490|66603289|FG003|Overall Study|Adverse Event|0|||
23788461|NCT00295490|66603286|FG000|Overall Study|Other|0|||
23348835|NCT03611582|65021696|FG000|Overall Study|Withdrawal by Subject|4|||
23348836|NCT03611582|65021697|FG001|Overall Study|Withdrawal by Subject|3|||
23348837|NCT03611582|65021696|FG000|Overall Study|Lost to Follow-up|18|||
23348838|NCT03611582|65021697|FG001|Overall Study|Lost to Follow-up|7|||
23348839|NCT03611582|65021696|FG000|Overall Study|other|17|||
23348840|NCT03611582|65021697|FG001|Overall Study|other|16|||
23348841|NCT01790516|65021698|FG000|Overall Study|Physician Decision|1|||
23348842|NCT01790516|65021699|FG001|Overall Study|Physician Decision|0|||
23348843|NCT02772276|65021700|FG000|Overall Study|Lost to Follow-up|0|||
23348844|NCT02772276|65021701|FG001|Overall Study|Lost to Follow-up|0|||
23348845|NCT02772276|65021702|FG002|Overall Study|Lost to Follow-up|0|||
23348846|NCT02772276|65021703|FG003|Overall Study|Lost to Follow-up|0|||
23348847|NCT02772276|65021704|FG004|Overall Study|Lost to Follow-up|0|||
23348848|NCT02772276|65021705|FG005|Overall Study|Lost to Follow-up|0|||
23348849|NCT02772276|65021706|FG006|Overall Study|Lost to Follow-up|1|||
23348850|NCT02772276|65021707|FG007|Overall Study|Lost to Follow-up|0|||
23348851|NCT02772276|65021708|FG008|Overall Study|Lost to Follow-up|0|||
23348852|NCT02772276|65021709|FG009|Overall Study|Lost to Follow-up|0|||
23348853|NCT02772276|65021710|FG010|Overall Study|Lost to Follow-up|0|||
23348854|NCT02772276|65021711|FG011|Overall Study|Lost to Follow-up|0|||
23348855|NCT02772276|65021712|FG012|Overall Study|Lost to Follow-up|0|||
23348856|NCT02772276|65021700|FG000|Overall Study|Withdrew consent|0|||
23348857|NCT02772276|65021701|FG001|Overall Study|Withdrew consent|0|||
23348858|NCT02772276|65021702|FG002|Overall Study|Withdrew consent|0|||
23348859|NCT02772276|65021703|FG003|Overall Study|Withdrew consent|0|||
23348860|NCT02772276|65021704|FG004|Overall Study|Withdrew consent|0|||
23348861|NCT02772276|65021705|FG005|Overall Study|Withdrew consent|0|||
23460676|NCT02443688|65430833|FG001|Overall Study|Withdrawal by Subject|3|||
23788462|NCT00295490|66603287|FG001|Overall Study|Other|2|||
23788463|NCT00295490|66603288|FG002|Overall Study|Other|0|||
23788464|NCT00295490|66603289|FG003|Overall Study|Other|1|||
23788465|NCT00627016|66603290|FG000|Overall Study|Adverse Event|1|||
23788466|NCT00627016|66603291|FG001|Overall Study|Adverse Event|1|||
23788467|NCT00627016|66603290|FG000|Overall Study|Protocol Violation|0|||
23788468|NCT00627016|66603291|FG001|Overall Study|Protocol Violation|2|||
23788469|NCT00627016|66603290|FG000|Overall Study|Lost to Follow-up|0|||
23788470|NCT00627016|66603291|FG001|Overall Study|Lost to Follow-up|1|||
23788471|NCT00627016|66603290|FG000|Overall Study|Withdrawal by Subject|2|||
23788472|NCT00627016|66603291|FG001|Overall Study|Withdrawal by Subject|1|||
23788473|NCT00627016|66603290|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23788474|NCT00627016|66603291|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
23788475|NCT00627016|66603290|FG000|Overall Study|Lack of Efficacy|1|||
23788476|NCT00627016|66603291|FG001|Overall Study|Lack of Efficacy|0|||
23788477|NCT00627016|66603290|FG000|Overall Study|Placed on Excluded Drugs|1|||
23788478|NCT00627016|66603291|FG001|Overall Study|Placed on Excluded Drugs|0|||
23788479|NCT00627016|66603290|FG000|Overall Study|Pregnancy|1|||
23788480|NCT00627016|66603291|FG001|Overall Study|Pregnancy|0|||
23788481|NCT02611687|66603292|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
23788482|NCT02611687|66603293|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
23788483|NCT01215721|66603294|FG000|Overall Study|Adverse Event|2|||
23788484|NCT01484912|66603295|FG000|Overall Study|Withdrawal by Subject|1|||
23788485|NCT01484912|66603296|FG001|Overall Study|Withdrawal by Subject|0|||
23788486|NCT01484912|66603295|FG000|Overall Study|Physician Decision|0|||
23788487|NCT01484912|66603296|FG001|Overall Study|Physician Decision|1|||
23788488|NCT03637764|66603299|FG000|Overall Study|Adverse Event|2|||
23788489|NCT03637764|66603300|FG001|Overall Study|Adverse Event|0|||
23788490|NCT03637764|66603301|FG002|Overall Study|Adverse Event|0|||
23788491|NCT03637764|66603302|FG003|Overall Study|Adverse Event|1|||
23788492|NCT03637764|66603299|FG000|Overall Study|Progressive Disease|23|||
23788493|NCT03637764|66603300|FG001|Overall Study|Progressive Disease|23|||
23788494|NCT03637764|66603301|FG002|Overall Study|Progressive Disease|18|||
23788495|NCT03637764|66603302|FG003|Overall Study|Progressive Disease|31|||
23788496|NCT03637764|66603299|FG000|Overall Study|Withdrawal by Subject|1|||
23788497|NCT03637764|66603300|FG001|Overall Study|Withdrawal by Subject|3|||
23788498|NCT03637764|66603301|FG002|Overall Study|Withdrawal by Subject|0|||
23788499|NCT03637764|66603302|FG003|Overall Study|Withdrawal by Subject|1|||
23788500|NCT01960296|66603305|FG000|Overall Study|Postponed surgery|1|||
23788501|NCT01960296|66603306|FG001|Overall Study|Postponed surgery|0|||
23788502|NCT01960296|66603305|FG000|Overall Study|Received different procedure|1|||
23788503|NCT01960296|66603306|FG001|Overall Study|Received different procedure|3|||
23348862|NCT02772276|65021706|FG006|Overall Study|Withdrew consent|0|||
23348863|NCT02772276|65021707|FG007|Overall Study|Withdrew consent|1|||
23348864|NCT02772276|65021708|FG008|Overall Study|Withdrew consent|0|||
23348865|NCT02772276|65021709|FG009|Overall Study|Withdrew consent|0|||
23348866|NCT02772276|65021710|FG010|Overall Study|Withdrew consent|0|||
23348867|NCT02772276|65021711|FG011|Overall Study|Withdrew consent|0|||
23348868|NCT02772276|65021712|FG012|Overall Study|Withdrew consent|0|||
23348869|NCT01362517|65021713|FG000|Overall Study|Protocol Violation|1|||
23788504|NCT04060251|66603307|FG000|Overall Study|Study terminated due to low enrollment.|7|||
23348870|NCT01362517|65021713|FG000|Overall Study|Lost to Follow-up|1|||
23348871|NCT02774005|65021714|FG000|Overall Study|Adverse Event|8|||
23348872|NCT02774005|65021714|FG000|Overall Study|Withdrawal by Subject|23|||
23348873|NCT02774005|65021714|FG000|Overall Study|Lost to Follow-up|7|||
23348874|NCT02774005|65021714|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
23348875|NCT02774005|65021714|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
23348876|NCT02774005|65021714|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
23348877|NCT02774005|65021714|FG000|Overall Study|Death|1|||
23348878|NCT02774005|65021714|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
23348879|NCT02774005|65021714|FG000|Overall Study|Lack of compliance with study medication|4|||
23348880|NCT02774005|65021714|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
23348881|NCT02774005|65021714|FG000|Overall Study|another study|1|||
23348882|NCT02774005|65021714|FG000|Overall Study|cardiologist imposed travel restriction|1|||
23348883|NCT03054064|65021715|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
23348884|NCT03054064|65021715|FG000|Overall Study|Investigator Decision|2|||
23348885|NCT03054064|65021715|FG000|Overall Study|Bladder Issue|1|||
23348886|NCT03054064|65021715|FG000|Overall Study|High Blood Pressure|1|||
23348887|NCT03054064|65021715|FG000|Overall Study|Change in Status|1|||
23348888|NCT01283334|65021716|FG000|Overall Study|Withdrawal by Subject|1|||
23348889|NCT01283334|65021716|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
23348890|NCT01283334|65021716|FG000|Overall Study|Adverse Event|4|||
23348891|NCT01283334|65021716|FG000|Overall Study|Physician Decision|1|||
23348892|NCT01346540|65021718|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
23348893|NCT01346540|65021719|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
23348894|NCT01346540|65021718|FG000|Overall Study|Adverse Event|0|||
23348895|NCT01346540|65021719|FG001|Overall Study|Adverse Event|4|||
23348896|NCT02686658|65021721|FG000|Overall Study|Adverse Event|0|||
23348897|NCT02686658|65021722|FG001|Overall Study|Adverse Event|0|||
23348898|NCT02686658|65021723|FG002|Overall Study|Adverse Event|1|||
23348899|NCT02686658|65021724|FG003|Overall Study|Adverse Event|1|||
23348900|NCT02686658|65021725|FG004|Overall Study|Adverse Event|2|||
23348901|NCT02686658|65021726|FG005|Overall Study|Adverse Event|1|||
23348902|NCT02686658|65021721|FG000|Overall Study|Investigator decision|0|||
23348903|NCT02686658|65021722|FG001|Overall Study|Investigator decision|0|||
23348904|NCT02686658|65021723|FG002|Overall Study|Investigator decision|0|||
23348905|NCT02686658|65021724|FG003|Overall Study|Investigator decision|1|||
23348906|NCT02686658|65021725|FG004|Overall Study|Investigator decision|2|||
23348907|NCT02686658|65021726|FG005|Overall Study|Investigator decision|1|||
23348908|NCT02686658|65021721|FG000|Overall Study|Sponsor decision|1|||
23348909|NCT02686658|65021722|FG001|Overall Study|Sponsor decision|2|||
23348910|NCT02686658|65021723|FG002|Overall Study|Sponsor decision|1|||
23348911|NCT02686658|65021724|FG003|Overall Study|Sponsor decision|5|||
23348912|NCT02686658|65021725|FG004|Overall Study|Sponsor decision|13|||
23348913|NCT02686658|65021726|FG005|Overall Study|Sponsor decision|2|||
23348914|NCT02686658|65021721|FG000|Overall Study|Lost to Follow-up|0|||
23348915|NCT02686658|65021722|FG001|Overall Study|Lost to Follow-up|0|||
23348916|NCT02686658|65021723|FG002|Overall Study|Lost to Follow-up|2|||
23348917|NCT02686658|65021724|FG003|Overall Study|Lost to Follow-up|0|||
23348918|NCT02686658|65021725|FG004|Overall Study|Lost to Follow-up|0|||
23348919|NCT02686658|65021726|FG005|Overall Study|Lost to Follow-up|1|||
23348920|NCT02686658|65021721|FG000|Overall Study|Death|1|||
23348921|NCT02686658|65021722|FG001|Overall Study|Death|0|||
23348922|NCT02686658|65021723|FG002|Overall Study|Death|0|||
23348923|NCT02686658|65021724|FG003|Overall Study|Death|1|||
23348924|NCT02686658|65021725|FG004|Overall Study|Death|1|||
23348925|NCT02686658|65021726|FG005|Overall Study|Death|1|||
23348926|NCT02686658|65021721|FG000|Overall Study|Withdrawal by Subject|2|||
23348927|NCT02686658|65021722|FG001|Overall Study|Withdrawal by Subject|5|||
23348928|NCT02686658|65021723|FG002|Overall Study|Withdrawal by Subject|4|||
23348929|NCT02686658|65021724|FG003|Overall Study|Withdrawal by Subject|4|||
23348930|NCT02686658|65021725|FG004|Overall Study|Withdrawal by Subject|17|||
23348931|NCT02686658|65021726|FG005|Overall Study|Withdrawal by Subject|8|||
23348932|NCT02686658|65021721|FG000|Overall Study|Placed in hospice care|0|||
23348933|NCT02686658|65021722|FG001|Overall Study|Placed in hospice care|0|||
23348934|NCT02686658|65021723|FG002|Overall Study|Placed in hospice care|1|||
23348935|NCT02686658|65021724|FG003|Overall Study|Placed in hospice care|0|||
23584453|NCT03781804|65869197|FG001|Overall Study|Protocol Violation|0|||
23348936|NCT02686658|65021725|FG004|Overall Study|Placed in hospice care|0|||
23348937|NCT02686658|65021726|FG005|Overall Study|Placed in hospice care|0|||
23348938|NCT02686658|65021721|FG000|Overall Study|Participant non-compliance|0|||
23348939|NCT02686658|65021722|FG001|Overall Study|Participant non-compliance|0|||
23348940|NCT02686658|65021723|FG002|Overall Study|Participant non-compliance|0|||
23584454|NCT03781804|65869198|FG002|Overall Study|Protocol Violation|1|||
23348941|NCT02686658|65021724|FG003|Overall Study|Participant non-compliance|0|||
23348942|NCT02686658|65021725|FG004|Overall Study|Participant non-compliance|0|||
23348943|NCT02686658|65021726|FG005|Overall Study|Participant non-compliance|1|||
23348944|NCT02686658|65021721|FG000|Overall Study|Concern over coronavirus disease care|0|||
23348945|NCT02686658|65021722|FG001|Overall Study|Concern over coronavirus disease care|0|||
23348946|NCT02686658|65021723|FG002|Overall Study|Concern over coronavirus disease care|0|||
23348947|NCT02686658|65021724|FG003|Overall Study|Concern over coronavirus disease care|0|||
23348948|NCT02686658|65021725|FG004|Overall Study|Concern over coronavirus disease care|2|||
23348949|NCT02686658|65021726|FG005|Overall Study|Concern over coronavirus disease care|1|||
23348950|NCT01432275|65021727|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
23348951|NCT01432275|65021728|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
23348952|NCT01432275|65021727|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
23348953|NCT01432275|65021728|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
23348954|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
23348955|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
23348956|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
23348957|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
23348958|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
23348959|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
23348960|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
23348961|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
23348962|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
23348963|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
23348964|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
23348965|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
23348966|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
23348967|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
23348968|NCT01185509|65021732|FG000|Overall Study|Progression/Relapse|9|||
23348969|NCT01185509|65021733|FG001|Overall Study|Progression/Relapse|15|||
23348970|NCT01185509|65021732|FG000|Overall Study|Physician Decision|2|||
23348971|NCT01185509|65021733|FG001|Overall Study|Physician Decision|2|||
23348972|NCT01185509|65021732|FG000|Overall Study|Withdrawal by Subject|0|||
23348973|NCT01185509|65021733|FG001|Overall Study|Withdrawal by Subject|1|||
23348974|NCT01185509|65021732|FG000|Overall Study|Death|0|||
23348975|NCT01185509|65021733|FG001|Overall Study|Death|1|||
23348976|NCT01185509|65021732|FG000|Overall Study|Intercurrent Illness|0|||
23348977|NCT01185509|65021733|FG001|Overall Study|Intercurrent Illness|1|||
23348978|NCT01542034|65021740|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
23348979|NCT01542034|65021741|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
23348980|NCT01542034|65021740|FG000|Overall Study|Administrative decision|0|||
23348981|NCT01542034|65021741|FG001|Overall Study|Administrative decision|3|||
23348982|NCT01542034|65021740|FG000|Overall Study|Subject Noncompliance|1|||
23348983|NCT01542034|65021741|FG001|Overall Study|Subject Noncompliance|0|||
23348984|NCT01542034|65021740|FG000|Overall Study|Adverse Event|2|||
23348985|NCT01542034|65021741|FG001|Overall Study|Adverse Event|2|||
23348986|NCT01542034|65021740|FG000|Overall Study|Lost to Follow-up|7|||
23348987|NCT01542034|65021741|FG001|Overall Study|Lost to Follow-up|6|||
23348988|NCT00581542|65021742|FG000|Overall Study|they met an exclusion criteria|2|||
23348989|NCT00581542|65021743|FG001|Overall Study|they met an exclusion criteria|2|||
23348990|NCT00581542|65021742|FG000|Overall Study|Lost to Follow-up|9|||
23348991|NCT00581542|65021743|FG001|Overall Study|Lost to Follow-up|21|||
23348992|NCT03515629|65021744|FG000|Overall Study|Death|0|||
23460677|NCT02443688|65430834|FG002|Overall Study|Withdrawal by Subject|4|||
23460678|NCT02443688|65430832|FG000|Overall Study|Non-compliance with study drug|1|||
23460679|NCT02443688|65430833|FG001|Overall Study|Non-compliance with study drug|2|||
23584455|NCT03781804|65869196|FG000|Overall Study|Withdrawal by Subject|0|||
23584456|NCT03781804|65869197|FG001|Overall Study|Withdrawal by Subject|1|||
23348993|NCT03515629|65021745|FG001|Overall Study|Death|1|||
23348994|NCT03515629|65021746|FG002|Overall Study|Death|1|||
23348995|NCT03515629|65021744|FG000|Overall Study|Progressive disease|0|||
23348996|NCT03515629|65021745|FG001|Overall Study|Progressive disease|1|||
23348997|NCT03515629|65021746|FG002|Overall Study|Progressive disease|0|||
23348998|NCT03426436|65021747|FG000|Overall Study|Incorrect lead placement|12|||
23348999|NCT03426436|65021747|FG000|Overall Study|Withdrawal by Subject|2|||
23349000|NCT03426436|65021747|FG000|Overall Study|Consent issue|1|||
23349001|NCT03426436|65021747|FG000|Overall Study|ECGs not saved|4|||
23349002|NCT03427268|65021748|FG000|Overall Study|Progressive disease|25|||
23349003|NCT03427268|65021748|FG000|Overall Study|Never treated|2|||
23349004|NCT03427268|65021748|FG000|Overall Study|Compassionate use|1|||
23349005|NCT03427268|65021748|FG000|Overall Study|Withdrawal by Subject|1|||
23788505|NCT04060251|66603308|FG001|Overall Study|Study terminated due to low enrollment.|5|||
23788506|NCT04060251|66603309|FG002|Overall Study|Study terminated due to low enrollment.|7|||
23788507|NCT04060251|66603307|FG000|Overall Study|Adverse Event|1|||
23788508|NCT04060251|66603308|FG001|Overall Study|Adverse Event|1|||
23788509|NCT04060251|66603309|FG002|Overall Study|Adverse Event|0|||
23788510|NCT02255149|66603310|FG000|Overall Study|Lost to Follow-up|2|||
23788511|NCT02255149|66603310|FG000|Overall Study|Withdrawal by Subject|1|||
23788512|NCT02255149|66603310|FG000|Overall Study|Withdrawal by PI|1|||
23788513|NCT02255149|66603310|FG000|Overall Study|Implant Failure|1|||
23349006|NCT03427268|65021748|FG000|Overall Study|Adverse Event|3|||
23349007|NCT00980655|65021749|FG000|Overall Study|Adverse Event|13|||
23349008|NCT00980655|65021750|FG001|Overall Study|Adverse Event|31|||
23349009|NCT00980655|65021749|FG000|Overall Study|Death|0|||
23349010|NCT00980655|65021750|FG001|Overall Study|Death|7|||
23349011|NCT00980655|65021749|FG000|Overall Study|Protocol Violation|2|||
23349012|NCT00980655|65021750|FG001|Overall Study|Protocol Violation|7|||
23349013|NCT00980655|65021749|FG000|Overall Study|Withdrawal by Subject|0|||
23349014|NCT00980655|65021750|FG001|Overall Study|Withdrawal by Subject|4|||
23349015|NCT00980655|65021749|FG000|Overall Study|Lost to Follow-up|0|||
23349016|NCT00980655|65021750|FG001|Overall Study|Lost to Follow-up|1|||
23349017|NCT00980655|65021749|FG000|Overall Study|Parent/legal guardian request|1|||
23349018|NCT00980655|65021750|FG001|Overall Study|Parent/legal guardian request|0|||
23349019|NCT00980655|65021749|FG000|Overall Study|Other|0|||
23788514|NCT03167606|66603314|FG000|Overall Study|Lost to Follow-up|73|||
23584457|NCT03781804|65869198|FG002|Overall Study|Withdrawal by Subject|1|||
23788515|NCT03167606|66603315|FG001|Overall Study|Lost to Follow-up|64|||
23349020|NCT00980655|65021750|FG001|Overall Study|Other|1|||
23584458|NCT03781804|65869196|FG000|Overall Study|Reason not provided|2|||
23349021|NCT01886781|65021751|FG000|Overall Study|Protocol Violation|5|||
23349022|NCT01886781|65021752|FG001|Overall Study|Protocol Violation|0|||
23349023|NCT01886781|65021751|FG000|Overall Study|Adverse Event|1|||
23349024|NCT01886781|65021752|FG001|Overall Study|Adverse Event|0|||
23349025|NCT01886781|65021751|FG000|Overall Study|Lost to Follow-up|5|||
23349026|NCT01886781|65021752|FG001|Overall Study|Lost to Follow-up|0|||
23349027|NCT01886781|65021751|FG000|Overall Study|Withdrawal by Subject|2|||
23349028|NCT01886781|65021752|FG001|Overall Study|Withdrawal by Subject|1|||
23349029|NCT01886781|65021751|FG000|Overall Study|Worsening of symptoms|1|||
23349030|NCT01886781|65021752|FG001|Overall Study|Worsening of symptoms|1|||
23349031|NCT04245202|65021753|FG000|Overall Study|Lack of Efficacy|10|||
23349032|NCT04245202|65021754|FG001|Overall Study|Lack of Efficacy|1|||
23349033|NCT00980018|65021755|FG000|Overall Study|Adverse Event|8|||
23349034|NCT00980018|65021755|FG000|Overall Study|Patient withdrew consent|3|||
23349035|NCT00980018|65021755|FG000|Overall Study|Lost to Follow-up|1|||
23349036|NCT01210495|65021758|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
23349037|NCT01210495|65021759|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
23349038|NCT01210495|65021760|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
23349039|NCT01210495|65021761|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
23349040|NCT01210495|65021758|FG000|Overall Study|Death|14|||
23349041|NCT01210495|65021759|FG001|Overall Study|Death|7|||
23349042|NCT01210495|65021760|FG002|Overall Study|Death|112|||
23349043|NCT01210495|65021761|FG003|Overall Study|Death|54|||
23349044|NCT01210495|65021758|FG000|Overall Study|Study Terminated by Sponsor|0|||
23349045|NCT01210495|65021759|FG001|Overall Study|Study Terminated by Sponsor|0|||
23349046|NCT01210495|65021760|FG002|Overall Study|Study Terminated by Sponsor|4|||
23349047|NCT01210495|65021761|FG003|Overall Study|Study Terminated by Sponsor|11|||
23349048|NCT01210495|65021758|FG000|Overall Study|Lost to Follow-up|0|||
23349049|NCT01210495|65021759|FG001|Overall Study|Lost to Follow-up|0|||
23349050|NCT01210495|65021760|FG002|Overall Study|Lost to Follow-up|1|||
23349051|NCT01210495|65021761|FG003|Overall Study|Lost to Follow-up|1|||
23349052|NCT01210495|65021758|FG000|Overall Study|Other unspecified|0|||
23349053|NCT01210495|65021759|FG001|Overall Study|Other unspecified|0|||
23460680|NCT02443688|65430834|FG002|Overall Study|Non-compliance with study drug|4|||
23460681|NCT02443688|65430832|FG000|Overall Study|Sponsor Request|2|||
23460682|NCT02443688|65430833|FG001|Overall Study|Sponsor Request|1|||
23788516|NCT03167606|66603314|FG000|Overall Study|Withdrawal by Subject|6|||
23788517|NCT03167606|66603315|FG001|Overall Study|Withdrawal by Subject|5|||
23788518|NCT03167606|66603314|FG000|Overall Study|Withdrawal by Investigator|0|||
23788519|NCT03167606|66603315|FG001|Overall Study|Withdrawal by Investigator|2|||
23788520|NCT00239005|66603318|FG000|Overall Study|Adverse Event|6|||
23788521|NCT00239005|66603319|FG001|Overall Study|Adverse Event|6|||
23349054|NCT01210495|65021760|FG002|Overall Study|Other unspecified|6|||
23349055|NCT01210495|65021761|FG003|Overall Study|Other unspecified|0|||
23349056|NCT03434249|65021767|FG000|Overall Study|Adverse Event|1|||
23349057|NCT03434249|65021768|FG001|Overall Study|Adverse Event|0|||
23349058|NCT03434249|65021767|FG000|Overall Study|Lost to Follow-up|0|||
23349059|NCT03434249|65021768|FG001|Overall Study|Lost to Follow-up|1|||
23349060|NCT03434249|65021767|FG000|Overall Study|Non-compliance of family|2|||
23788522|NCT00239005|66603318|FG000|Overall Study|Withdrawal by Subject|3|||
23788523|NCT00239005|66603319|FG001|Overall Study|Withdrawal by Subject|4|||
23788524|NCT00239005|66603318|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
23788525|NCT00239005|66603319|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
23788526|NCT00239005|66603318|FG000|Overall Study|Protocol Violation|1|||
23788527|NCT00239005|66603319|FG001|Overall Study|Protocol Violation|0|||
23788528|NCT00239005|66603318|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
23788529|NCT00239005|66603319|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
23788530|NCT00239005|66603318|FG000|Overall Study|Lost to Follow-up|0|||
23788531|NCT00239005|66603319|FG001|Overall Study|Lost to Follow-up|1|||
23788532|NCT02451358|66603320|FG000|Overall Study|Withdrawal by Subject|1|||
23788533|NCT02451358|66603321|FG001|Overall Study|Withdrawal by Subject|1|||
23788534|NCT02451358|66603322|FG002|Overall Study|Withdrawal by Subject|0|||
23788535|NCT02451358|66603323|FG003|Overall Study|Withdrawal by Subject|0|||
23788536|NCT02451358|66603320|FG000|Overall Study|Protocol Violation|0|||
23788537|NCT02451358|66603321|FG001|Overall Study|Protocol Violation|1|||
23788538|NCT02451358|66603322|FG002|Overall Study|Protocol Violation|1|||
23788539|NCT02451358|66603323|FG003|Overall Study|Protocol Violation|0|||
23788540|NCT04183335|66603324|FG000|Overall Study|Adverse Event|1|||
23788541|NCT04183335|66603325|FG001|Overall Study|Adverse Event|0|||
23788542|NCT04183335|66603324|FG000|Overall Study|Withdrawal by Subject|12|||
23788543|NCT04183335|66603325|FG001|Overall Study|Withdrawal by Subject|3|||
23788544|NCT01103713|66603326|FG000|Overall Study|Lost to Follow-up|2|||
23349061|NCT03434249|65021768|FG001|Overall Study|Non-compliance of family|1|||
23349062|NCT03434249|65021767|FG000|Overall Study|Difficulties in completing daily diary|2|||
23349063|NCT03434249|65021768|FG001|Overall Study|Difficulties in completing daily diary|1|||
23349064|NCT04394624|65021769|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
23460683|NCT02443688|65430834|FG002|Overall Study|Sponsor Request|0|||
23349065|NCT04394624|65021769|FG000|Overall Study|Adverse Event|5|||
23349066|NCT04394624|65021769|FG000|Overall Study|Progressive disease|20|||
23349067|NCT01047332|65021770|FG000|Overall Study|SEMS Obstruction|11|||
23349068|NCT01047332|65021771|FG001|Overall Study|SEMS Obstruction|20|||
23349069|NCT01047332|65021770|FG000|Overall Study|Died Unobstructed|38|||
23349070|NCT01047332|65021771|FG001|Overall Study|Died Unobstructed|41|||
23349071|NCT01047332|65021770|FG000|Overall Study|Lost to Follow-up|8|||
23349072|NCT01047332|65021771|FG001|Overall Study|Lost to Follow-up|3|||
23349073|NCT02248974|65021772|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
23349074|NCT02248974|65021773|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
23788545|NCT01103713|66603326|FG000|Overall Study|Withdrawal by Subject|8|||
23788546|NCT01103713|66603326|FG000|Overall Study|Study terminated by sponsor|2|||
23788547|NCT01103713|66603326|FG000|Overall Study|Other|1|||
23349075|NCT02248974|65021772|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
23349076|NCT02248974|65021773|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
23349077|NCT02248974|65021772|FG000|1-Day Follow-Up|Enrolled in another study|1|||
23349078|NCT02248974|65021773|FG001|1-Day Follow-Up|Enrolled in another study|0|||
23788548|NCT03801707|66603331|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
23788549|NCT00466167|66603333|FG000|Overall Study|Adverse Event|8|||
23788550|NCT00466167|66603334|FG001|Overall Study|Adverse Event|8|||
23349079|NCT02248974|65021772|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
23349080|NCT02248974|65021773|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
23349081|NCT02248974|65021772|FG000|1-Week Follow-Up|Enrolled in another study|1|||
23349082|NCT02248974|65021773|FG001|1-Week Follow-Up|Enrolled in another study|1|||
23349083|NCT02248974|65021772|FG000|1-Week Follow-Up|Transferred to another facility|1|||
23349084|NCT02248974|65021773|FG001|1-Week Follow-Up|Transferred to another facility|0|||
23349085|NCT02248974|65021772|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
23349086|NCT02248974|65021773|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
23349087|NCT02248974|65021772|FG000|1-Week Follow-Up|Death|1|||
23349088|NCT02248974|65021773|FG001|1-Week Follow-Up|Death|1|||
23349089|NCT02248974|65021772|FG000|1-Week Follow-Up|Excluded because of age|0|||
23349090|NCT02248974|65021773|FG001|1-Week Follow-Up|Excluded because of age|1|||
23349091|NCT02248974|65021772|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
23788551|NCT00466167|66603335|FG002|Overall Study|Adverse Event|7|||
23788552|NCT00466167|66603333|FG000|Overall Study|Lack of Efficacy|2|||
23349092|NCT02248974|65021773|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
23349093|NCT02248974|65021772|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
23349094|NCT02248974|65021773|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
23584459|NCT03781804|65869197|FG001|Overall Study|Reason not provided|2|||
23349095|NCT02248974|65021772|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
23349096|NCT02248974|65021773|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
23349097|NCT02248974|65021772|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
23788553|NCT00466167|66603334|FG001|Overall Study|Lack of Efficacy|0|||
23788554|NCT00466167|66603335|FG002|Overall Study|Lack of Efficacy|3|||
23349098|NCT02248974|65021773|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
23349099|NCT02248974|65021772|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
23349100|NCT02248974|65021773|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
23349101|NCT00306787|65021774|FG000|Overall Study|Discontinued without taking study drug|208|||
23349102|NCT00306787|65021775|FG001|Overall Study|Discontinued without taking study drug|215|||
23349103|NCT00306787|65021774|FG000|Overall Study|Adverse Event|1|||
23349104|NCT00306787|65021775|FG001|Overall Study|Adverse Event|1|||
23349105|NCT00306787|65021774|FG000|Overall Study|Lack of Efficacy|1|||
23349106|NCT00306787|65021775|FG001|Overall Study|Lack of Efficacy|0|||
23349107|NCT00306787|65021774|FG000|Overall Study|Protocol Violation|8|||
23349108|NCT00306787|65021775|FG001|Overall Study|Protocol Violation|10|||
23349109|NCT00306787|65021774|FG000|Overall Study|Withdrawal by Subject|2|||
23349110|NCT00306787|65021775|FG001|Overall Study|Withdrawal by Subject|9|||
23349111|NCT00306787|65021774|FG000|Overall Study|Lost to Follow-up|9|||
23349112|NCT00306787|65021775|FG001|Overall Study|Lost to Follow-up|6|||
23349113|NCT00306787|65021774|FG000|Overall Study|Administrative problems|4|||
23349114|NCT00306787|65021775|FG001|Overall Study|Administrative problems|0|||
23349115|NCT00306787|65021774|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23349116|NCT00306787|65021775|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23349117|NCT01458951|65021776|FG000|Overall Study|Other|1|||
23349118|NCT01458951|65021777|FG001|Overall Study|Other|0|||
23460684|NCT01499940|65430835|FG000|Overall Study|Study was withdrawn before completion.|9|||
23788555|NCT00466167|66603333|FG000|Overall Study|Protocol Violation|1|||
23788556|NCT00466167|66603334|FG001|Overall Study|Protocol Violation|1|||
23788557|NCT00466167|66603335|FG002|Overall Study|Protocol Violation|2|||
23788558|NCT00466167|66603333|FG000|Overall Study|Lost to Follow-up|3|||
23788559|NCT00466167|66603334|FG001|Overall Study|Lost to Follow-up|2|||
23788560|NCT00466167|66603335|FG002|Overall Study|Lost to Follow-up|2|||
23788561|NCT00466167|66603333|FG000|Overall Study|Withdrawal by Subject|4|||
23788562|NCT00466167|66603334|FG001|Overall Study|Withdrawal by Subject|1|||
23788563|NCT00466167|66603335|FG002|Overall Study|Withdrawal by Subject|6|||
23788564|NCT00466167|66603333|FG000|Overall Study|patient did not meet inclusion criteria|1|||
23788565|NCT00466167|66603334|FG001|Overall Study|patient did not meet inclusion criteria|0|||
23788566|NCT00466167|66603335|FG002|Overall Study|patient did not meet inclusion criteria|1|||
23788567|NCT00466167|66603333|FG000|Overall Study|Not treated|1|||
23788568|NCT00466167|66603334|FG001|Overall Study|Not treated|0|||
23788569|NCT00466167|66603335|FG002|Overall Study|Not treated|0|||
23788570|NCT03552484|66603336|FG000|Overall Study|Death|6|||
23788571|NCT03552484|66603337|FG001|Overall Study|Death|4|||
23788572|NCT03552484|66603336|FG000|Overall Study|Lost to Follow-up|0|||
23788573|NCT03552484|66603337|FG001|Overall Study|Lost to Follow-up|16|||
23788574|NCT00367133|66603338|FG000|2 Years|Death|20|||
23788575|NCT00367133|66603339|FG001|2 Years|Death|12|||
23788576|NCT00367133|66603340|FG002|2 Years|Death|12|||
23788577|NCT00367133|66603338|FG000|2 Years|Dropped|34|||
23788578|NCT00367133|66603339|FG001|2 Years|Dropped|19|||
23788579|NCT00367133|66603340|FG002|2 Years|Dropped|33|||
23788580|NCT00367133|66603338|FG000|2 Years|Missed visit|4|||
23788581|NCT00367133|66603339|FG001|2 Years|Missed visit|5|||
23788582|NCT00367133|66603340|FG002|2 Years|Missed visit|4|||
23788583|NCT00848536|66603341|FG000|Overall Study|Adverse Event|2|||
23788584|NCT00848536|66603342|FG001|Overall Study|Adverse Event|2|||
23788585|NCT00848536|66603341|FG000|Overall Study|Withdrawal by Subject|0|||
23788586|NCT00848536|66603342|FG001|Overall Study|Withdrawal by Subject|1|||
23788587|NCT00848536|66603341|FG000|Overall Study|Protocol Violation|0|||
23788588|NCT00848536|66603342|FG001|Overall Study|Protocol Violation|1|||
23788589|NCT00848536|66603341|FG000|Overall Study|Noncompliance|1|||
23788590|NCT00848536|66603342|FG001|Overall Study|Noncompliance|0|||
23788591|NCT00848536|66603341|FG000|Overall Study|Inadequate Control of IOP|1|||
23788592|NCT00848536|66603342|FG001|Overall Study|Inadequate Control of IOP|1|||
23349119|NCT01458951|65021778|FG002|Overall Study|Other|0|||
23349120|NCT01458951|65021776|FG000|Overall Study|Protocol Violation|5|||
23349121|NCT01458951|65021777|FG001|Overall Study|Protocol Violation|1|||
23349122|NCT01458951|65021778|FG002|Overall Study|Protocol Violation|0|||
23349123|NCT01458951|65021776|FG000|Overall Study|Withdrawal by Subject|2|||
23460685|NCT00751296|65430836|FG000|Overall Study|Adverse Event|2|||
23349124|NCT01458951|65021777|FG001|Overall Study|Withdrawal by Subject|0|||
23349125|NCT01458951|65021778|FG002|Overall Study|Withdrawal by Subject|2|||
23788593|NCT00848536|66603341|FG000|Overall Study|Patient Moved|0|||
23788594|NCT00848536|66603342|FG001|Overall Study|Patient Moved|2|||
23788595|NCT03067987|66603343|FG000|Overall Study|Lost to Follow-up|7|||
23788596|NCT03067987|66603344|FG001|Overall Study|Lost to Follow-up|10|||
23788597|NCT03067987|66603343|FG000|Overall Study|Protocol Violation|1|||
23349126|NCT01458951|65021776|FG000|Overall Study|Adverse Event|7|||
23349127|NCT01458951|65021777|FG001|Overall Study|Adverse Event|0|||
23460686|NCT02606643|65430840|FG000|Overall Study|did not meet inclusion criteria|1|||
23788598|NCT03067987|66603344|FG001|Overall Study|Protocol Violation|2|||
23788599|NCT03067987|66603343|FG000|Overall Study|Withdrawal by Subject|2|||
23460687|NCT02606643|65430841|FG001|Overall Study|did not meet inclusion criteria|3|||
23460688|NCT00836693|65430842|FG000|Overall Study|Adverse Event|4|||
23460689|NCT00836693|65430843|FG001|Overall Study|Adverse Event|1|||
23460690|NCT00836693|65430842|FG000|Overall Study|Sponsor Decision|0|||
23460691|NCT00836693|65430843|FG001|Overall Study|Sponsor Decision|1|||
23460692|NCT00836693|65430842|FG000|Overall Study|Physician Decision|2|||
23460693|NCT00836693|65430843|FG001|Overall Study|Physician Decision|0|||
23460694|NCT00836693|65430842|FG000|Overall Study|Withdrawal by Subject|9|||
23460695|NCT00836693|65430843|FG001|Overall Study|Withdrawal by Subject|4|||
23460696|NCT00836693|65430842|FG000|Overall Study|Protocol Violation|1|||
23460697|NCT00836693|65430843|FG001|Overall Study|Protocol Violation|0|||
23460698|NCT00836693|65430842|FG000|Overall Study|Lost to Follow-up|1|||
23460699|NCT00836693|65430843|FG001|Overall Study|Lost to Follow-up|0|||
23460700|NCT03722238|65430844|FG000|Overall Study|Protocol Violation|1|||
23460701|NCT03722238|65430845|FG001|Overall Study|Protocol Violation|0|||
23349128|NCT01458951|65021778|FG002|Overall Study|Adverse Event|2|||
23349129|NCT01458951|65021776|FG000|Overall Study|Insufficient Clinical Response|17|||
23349130|NCT01458951|65021777|FG001|Overall Study|Insufficient Clinical Response|0|||
23349131|NCT01458951|65021778|FG002|Overall Study|Insufficient Clinical Response|11|||
23349132|NCT02637713|65021779|FG000|Overall Study|Screen Failure|2|||
23349133|NCT03738800|65021780|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
23349134|NCT03738800|65021781|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23349135|NCT03738800|65021782|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23349136|NCT03738800|65021780|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
23349137|NCT03738800|65021781|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
23349138|NCT03738800|65021782|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
23349139|NCT03738800|65021780|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
23349140|NCT03738800|65021781|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23349141|NCT03738800|65021782|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23349142|NCT01592292|65021783|FG000|Overall Study|Follow-up loss|3|||
23349143|NCT01592292|65021784|FG001|Overall Study|Follow-up loss|3|||
23349144|NCT01592292|65021785|FG002|Overall Study|Follow-up loss|1|||
23349145|NCT01592292|65021786|FG003|Overall Study|Follow-up loss|0|||
23349146|NCT01592292|65021783|FG000|Overall Study|Withdrew consent|2|||
23460702|NCT03722238|65430844|FG000|Overall Study|Physician Decision|1|||
23460703|NCT03722238|65430845|FG001|Overall Study|Physician Decision|0|||
23460704|NCT03722238|65430844|FG000|Overall Study|Death|1|||
23460705|NCT03722238|65430845|FG001|Overall Study|Death|0|||
23460706|NCT03722238|65430844|FG000|Overall Study|Lost to Follow-up|6|||
23460707|NCT03722238|65430845|FG001|Overall Study|Lost to Follow-up|0|||
23460708|NCT03722238|65430844|FG000|Overall Study|Partial missing data|44|||
23460709|NCT03722238|65430845|FG001|Overall Study|Partial missing data|1|||
23460710|NCT03722238|65430844|FG000|Overall Study|Withdrawal by Subject|2|||
23460711|NCT03722238|65430845|FG001|Overall Study|Withdrawal by Subject|0|||
23460712|NCT03722238|65430844|FG000|Overall Study|Other|4|||
23460713|NCT03722238|65430845|FG001|Overall Study|Other|0|||
23460714|NCT03722238|65430844|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
23460715|NCT03722238|65430845|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
23460716|NCT03722238|65430844|FG000|Overall Study|Did not meet risk classification group criteria|90|||
23460717|NCT03722238|65430845|FG001|Overall Study|Did not meet risk classification group criteria|0|||
23460718|NCT03722238|65430844|FG000|Overall Study|Did not sign consent|17|||
23460719|NCT03722238|65430845|FG001|Overall Study|Did not sign consent|0|||
23460720|NCT03722238|65430844|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
23460721|NCT03722238|65430845|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
23460722|NCT03722238|65430844|FG000|Overall Study|Not willing to purchase study medication|142|||
23460723|NCT03722238|65430845|FG001|Overall Study|Not willing to purchase study medication|0|||
23460724|NCT03722238|65430844|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
23460725|NCT03722238|65430845|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
23349147|NCT01592292|65021784|FG001|Overall Study|Withdrew consent|1|||
23349148|NCT01592292|65021785|FG002|Overall Study|Withdrew consent|0|||
23349149|NCT01592292|65021786|FG003|Overall Study|Withdrew consent|0|||
23349150|NCT01592292|65021783|FG000|Overall Study|Other|1|||
23349151|NCT01592292|65021784|FG001|Overall Study|Other|1|||
23349152|NCT01592292|65021785|FG002|Overall Study|Other|2|||
23460726|NCT04682366|65430846|FG000|Overall Study|Lost to Follow-up|1|||
23460727|NCT04682366|65430847|FG001|Overall Study|Lost to Follow-up|1|||
23460728|NCT02954536|65430851|FG000|Overall Study|Adverse Event|2|||
23460729|NCT02954536|65430851|FG000|Overall Study|Death|12|||
23349153|NCT01592292|65021786|FG003|Overall Study|Other|1|||
23460730|NCT03387085|65430852|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
23460731|NCT01256788|65430855|FG000|Overall Study|Lost to Follow-up|5|||
23460732|NCT01256788|65430856|FG001|Overall Study|Lost to Follow-up|8|||
23460733|NCT01256788|65430857|FG002|Overall Study|Lost to Follow-up|3|||
23460734|NCT01744977|65430858|FG000|Overall Study|Withdrawal by Subject|1|||
23460735|NCT01744977|65430859|FG001|Overall Study|Withdrawal by Subject|2|||
23460736|NCT01744977|65430858|FG000|Overall Study|Death|2|||
23460737|NCT01744977|65430859|FG001|Overall Study|Death|3|||
23460738|NCT01744977|65430858|FG000|Overall Study|Lost to Follow-up|2|||
23460739|NCT01744977|65430859|FG001|Overall Study|Lost to Follow-up|0|||
23460740|NCT01744977|65430858|FG000|Overall Study|No longer meets inclusion|6|||
23460741|NCT01744977|65430859|FG001|Overall Study|No longer meets inclusion|0|||
23460742|NCT04030143|65430860|FG000|Overall Study|Adverse Event|5|||
23460743|NCT04030143|65430861|FG001|Overall Study|Adverse Event|10|||
23460744|NCT04030143|65430860|FG000|Overall Study|Lost to Follow-up|3|||
23460745|NCT04030143|65430861|FG001|Overall Study|Lost to Follow-up|7|||
23460746|NCT04030143|65430860|FG000|Overall Study|Protocol Deviation|2|||
23460747|NCT04030143|65430861|FG001|Overall Study|Protocol Deviation|2|||
23460748|NCT04030143|65430860|FG000|Overall Study|Withdrawal by Subject|16|||
23460749|NCT04030143|65430861|FG001|Overall Study|Withdrawal by Subject|18|||
23460750|NCT04030143|65430860|FG000|Overall Study|Physician Decision|1|||
23460751|NCT04030143|65430861|FG001|Overall Study|Physician Decision|1|||
23460752|NCT04030143|65430860|FG000|Overall Study|Due to Covid-19|2|||
23460753|NCT04030143|65430861|FG001|Overall Study|Due to Covid-19|3|||
23460754|NCT04030143|65430860|FG000|Overall Study|Not Due to Covid-19|1|||
23460755|NCT04030143|65430861|FG001|Overall Study|Not Due to Covid-19|1|||
23460756|NCT00791934|65430862|FG000|Overall Study|Withdrawal by Subject|2|||
23460757|NCT00791934|65430862|FG000|Overall Study|Did not consent for extended follow-up|13|||
23460758|NCT00453206|65430863|FG000|Overall Study|Death|1|||
23460759|NCT02326155|65430867|FG000|Overall Study|Adverse Event|21|||
23460760|NCT02326155|65430868|FG001|Overall Study|Adverse Event|5|||
23460761|NCT02326155|65430867|FG000|Overall Study|Death|3|||
23460762|NCT02326155|65430868|FG001|Overall Study|Death|0|||
23460763|NCT02326155|65430867|FG000|Overall Study|Lack of Efficacy|49|||
23460764|NCT02326155|65430868|FG001|Overall Study|Lack of Efficacy|5|||
23460765|NCT02326155|65430867|FG000|Overall Study|Lost to Follow-up|14|||
23460766|NCT02326155|65430868|FG001|Overall Study|Lost to Follow-up|3|||
23460767|NCT02326155|65430867|FG000|Overall Study|Protocol Violation|2|||
23460768|NCT02326155|65430868|FG001|Overall Study|Protocol Violation|0|||
23460769|NCT02326155|65430867|FG000|Overall Study|Withdrawal by Subject|34|||
23460770|NCT02326155|65430868|FG001|Overall Study|Withdrawal by Subject|11|||
23460771|NCT02326155|65430867|FG000|Overall Study|Disease progression|37|||
23460772|NCT02326155|65430868|FG001|Overall Study|Disease progression|4|||
23460773|NCT02326155|65430867|FG000|Overall Study|Study close|188|||
23460774|NCT02326155|65430868|FG001|Overall Study|Study close|21|||
23788600|NCT03067987|66603344|FG001|Overall Study|Withdrawal by Subject|1|||
23788601|NCT00506831|66603357|FG000|Overall Study|Death|1|||
23788602|NCT00506831|66603357|FG000|Overall Study|Withdrawal by Subject|1|||
23788603|NCT02105272|66606131|FG000|Overall Study|Adverse Event|1|||
23788604|NCT02105272|66606132|FG001|Overall Study|Adverse Event|2|||
23788605|NCT02105272|66606131|FG000|Overall Study|Physician Decision|0|||
23788606|NCT02105272|66606132|FG001|Overall Study|Physician Decision|1|||
23788607|NCT02105272|66606131|FG000|Overall Study|Protocol Violation|2|||
23788608|NCT02105272|66606132|FG001|Overall Study|Protocol Violation|0|||
23460775|NCT02326155|65430867|FG000|Overall Study|except for study close|46|||
23460776|NCT02326155|65430868|FG001|Overall Study|except for study close|13|||
23460777|NCT01553084|65430869|FG000|Overall Study|Withdrawal by Subject|15|||
23460778|NCT01553084|65430870|FG001|Overall Study|Withdrawal by Subject|13|||
23460779|NCT01553084|65430871|FG002|Overall Study|Withdrawal by Subject|35|||
23460780|NCT02536976|65430872|FG000|Overall Study|Physician Decision|0|||
23460781|NCT02536976|65430873|FG001|Overall Study|Physician Decision|1|||
23460782|NCT01458392|65430876|FG000|Overall Study|Death|2|||
23460783|NCT01458392|65430877|FG001|Overall Study|Death|11|||
23460784|NCT01458392|65430878|FG002|Overall Study|Death|22|||
23460785|NCT01458392|65430876|FG000|Overall Study|At the discretion of the sponsor|0|||
23460786|NCT01458392|65430877|FG001|Overall Study|At the discretion of the sponsor|2|||
23788609|NCT02105272|66606131|FG000|Overall Study|Withdrawal by Subject|2|||
23460787|NCT01458392|65430878|FG002|Overall Study|At the discretion of the sponsor|7|||
23460788|NCT01458392|65430876|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
23460789|NCT01458392|65430877|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
23460790|NCT01458392|65430878|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
23639082|NCT02311673|66064467|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23639083|NCT02311673|66064468|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
23788610|NCT02105272|66606132|FG001|Overall Study|Withdrawal by Subject|0|||
23788611|NCT02358538|66606133|FG000|Through Week 26|Adverse Event|0|||
23349154|NCT00741091|65021789|FG000|Overall Study|Death|13|||
23460791|NCT00928408|65430879|FG000|Overall Study|Other|2|||
23460792|NCT00928408|65430879|FG000|Overall Study|Withdrawal by Subject|4|||
23460793|NCT00928408|65430879|FG000|Overall Study|Death|5|||
23460794|NCT00928408|65430879|FG000|Overall Study|Lost to Follow-up|12|||
23460795|NCT03051178|65430880|FG000|Overall Study|Withdrawal by Subject|5|||
23460796|NCT00260533|65430882|FG000|Overall Study|Other|3|||
23460797|NCT00260533|65430883|FG001|Overall Study|Other|3|||
23460798|NCT01352715|65430884|FG000|Overall Study|Death|3|||
23460799|NCT01352715|65430885|FG001|Overall Study|Death|3|||
23460800|NCT01352715|65430884|FG000|Overall Study|Lost to Follow-up|5|||
23460801|NCT01352715|65430885|FG001|Overall Study|Lost to Follow-up|7|||
23460802|NCT01352715|65430884|FG000|Overall Study|Withdrawal by Subject|4|||
23460803|NCT01352715|65430885|FG001|Overall Study|Withdrawal by Subject|8|||
23460804|NCT01352715|65430884|FG000|Overall Study|site closure|16|||
23460805|NCT01352715|65430885|FG001|Overall Study|site closure|15|||
23460806|NCT01352715|65430884|FG000|Overall Study|no final visit in closeout period|15|||
23460807|NCT01352715|65430885|FG001|Overall Study|no final visit in closeout period|12|||
23460808|NCT01352715|65430884|FG000|Overall Study|major ineligibility|2|||
23460809|NCT01352715|65430885|FG001|Overall Study|major ineligibility|1|||
23460810|NCT00904982|65430889|FG000|Overall Study|Withdrawal by Subject|2|||
23788612|NCT02358538|66606134|FG001|Through Week 26|Adverse Event|1|||
23788613|NCT02358538|66606135|FG002|Through Week 26|Adverse Event|1|||
23460811|NCT00904982|65430890|FG001|Overall Study|Withdrawal by Subject|0|||
23460812|NCT00904982|65430891|FG002|Overall Study|Withdrawal by Subject|0|||
23460813|NCT00904982|65430892|FG003|Overall Study|Withdrawal by Subject|0|||
23460814|NCT01710501|65430893|FG000|Overall Study|Lost to Follow-up|2|||
23460815|NCT01710501|65430894|FG001|Overall Study|Lost to Follow-up|0|||
23460816|NCT01710501|65430895|FG002|Overall Study|Lost to Follow-up|0|||
23460817|NCT00830440|65430896|FG000|Overall Study|Protocol Violation|1|||
23460818|NCT00830440|65430897|FG001|Overall Study|Protocol Violation|0|||
23460819|NCT00830440|65430896|FG000|Overall Study|Withdrawal by Subject|1|||
23460820|NCT00830440|65430897|FG001|Overall Study|Withdrawal by Subject|0|||
23460821|NCT00830440|65430896|FG000|Overall Study|unsuccessful procedure|4|||
23460822|NCT00830440|65430897|FG001|Overall Study|unsuccessful procedure|0|||
23460823|NCT00830440|65430896|FG000|Overall Study|Adverse Event|2|||
23460824|NCT00830440|65430897|FG001|Overall Study|Adverse Event|0|||
23460825|NCT03873116|65430898|FG000|Part 1|Study drug discontinuation due to rash|0|||
23460826|NCT03873116|65430899|FG001|Part 1|Study drug discontinuation due to rash|0|||
23460827|NCT03873116|65430900|FG002|Part 1|Study drug discontinuation due to rash|0|||
23460828|NCT03873116|65430901|FG003|Part 1|Study drug discontinuation due to rash|0|||
23460829|NCT03873116|65430902|FG004|Part 1|Study drug discontinuation due to rash|0|||
23460830|NCT03873116|65430903|FG005|Part 1|Study drug discontinuation due to rash|1|||
23460831|NCT03873116|65430898|FG000|Part 2|Withdrawal by Subject|0|||
23460832|NCT03873116|65430899|FG001|Part 2|Withdrawal by Subject|0|||
23460833|NCT03873116|65430900|FG002|Part 2|Withdrawal by Subject|1|||
23460834|NCT03873116|65430901|FG003|Part 2|Withdrawal by Subject|0|||
23460835|NCT03873116|65430902|FG004|Part 2|Withdrawal by Subject|0|||
23460836|NCT03873116|65430903|FG005|Part 2|Withdrawal by Subject|0|||
23460837|NCT03873116|65430898|FG000|Part 2|Lab abnormality or AE|0|||
23460838|NCT03873116|65430899|FG001|Part 2|Lab abnormality or AE|0|||
23460839|NCT03873116|65430900|FG002|Part 2|Lab abnormality or AE|0|||
23460840|NCT03873116|65430901|FG003|Part 2|Lab abnormality or AE|0|||
23460841|NCT03873116|65430902|FG004|Part 2|Lab abnormality or AE|1|||
23460842|NCT03873116|65430903|FG005|Part 2|Lab abnormality or AE|0|||
23460843|NCT03873116|65430898|FG000|Part 3|Withdrawal by Subject|0|||
23460844|NCT03873116|65430899|FG001|Part 3|Withdrawal by Subject|0|||
23460845|NCT03873116|65430900|FG002|Part 3|Withdrawal by Subject|0|||
23460846|NCT03873116|65430901|FG003|Part 3|Withdrawal by Subject|0|||
23460847|NCT03873116|65430902|FG004|Part 3|Withdrawal by Subject|1|||
23460848|NCT03873116|65430903|FG005|Part 3|Withdrawal by Subject|0|||
23460849|NCT01149096|65430905|FG000|Overall Study|Lost to Follow-up|0|||
23460850|NCT01149096|65430906|FG001|Overall Study|Lost to Follow-up|1|||
23460851|NCT00248625|65430907|FG000|Overall Study|Withdrawal by Subject|0|||
23460852|NCT00248625|65430908|FG001|Overall Study|Withdrawal by Subject|2|||
23788614|NCT02358538|66606136|FG003|Through Week 26|Adverse Event|2|||
23788615|NCT02358538|66606133|FG000|Through Week 26|Lack of Efficacy|1|||
23788616|NCT02358538|66606134|FG001|Through Week 26|Lack of Efficacy|1|||
23788617|NCT02358538|66606135|FG002|Through Week 26|Lack of Efficacy|3|||
23788618|NCT02358538|66606136|FG003|Through Week 26|Lack of Efficacy|3|||
23788619|NCT02358538|66606133|FG000|Through Week 26|Withdrawal by Subject|1|||
23788620|NCT02358538|66606134|FG001|Through Week 26|Withdrawal by Subject|0|||
23788621|NCT02358538|66606135|FG002|Through Week 26|Withdrawal by Subject|0|||
23788622|NCT02358538|66606136|FG003|Through Week 26|Withdrawal by Subject|0|||
23460853|NCT02379728|65430909|FG000|Overall Study|Lost to Follow-up|1|||
23460854|NCT02379728|65430910|FG001|Overall Study|Lost to Follow-up|0|||
23460855|NCT02379728|65430911|FG002|Overall Study|Lost to Follow-up|3|||
23460856|NCT02379728|65430912|FG003|Overall Study|Lost to Follow-up|0|||
23460857|NCT02379728|65430909|FG000|Overall Study|Withdrawal by Subject|5|||
23460858|NCT02379728|65430910|FG001|Overall Study|Withdrawal by Subject|0|||
23460859|NCT02379728|65430911|FG002|Overall Study|Withdrawal by Subject|5|||
23460860|NCT02379728|65430912|FG003|Overall Study|Withdrawal by Subject|3|||
23460861|NCT02379728|65430909|FG000|Overall Study|Protocol Violation|0|||
23460862|NCT02379728|65430910|FG001|Overall Study|Protocol Violation|0|||
23788623|NCT02358538|66606133|FG000|Through Week 26|Non-Compliance|0|||
23788624|NCT02358538|66606134|FG001|Through Week 26|Non-Compliance|0|||
23788625|NCT02358538|66606135|FG002|Through Week 26|Non-Compliance|1|||
23788626|NCT02358538|66606136|FG003|Through Week 26|Non-Compliance|0|||
23788627|NCT02358538|66606133|FG000|Through Week 26|Family did not see benefit from IP|1|||
23788628|NCT02358538|66606134|FG001|Through Week 26|Family did not see benefit from IP|0|||
23788629|NCT02358538|66606135|FG002|Through Week 26|Family did not see benefit from IP|0|||
23788630|NCT02358538|66606136|FG003|Through Week 26|Family did not see benefit from IP|0|||
23788631|NCT02358538|66606133|FG000|52 Week Extension Period|Lack of Efficacy|0|||
23788632|NCT02358538|66606134|FG001|52 Week Extension Period|Lack of Efficacy|0|||
23788633|NCT02358538|66606135|FG002|52 Week Extension Period|Lack of Efficacy|2|||
23788634|NCT02358538|66606136|FG003|52 Week Extension Period|Lack of Efficacy|4|||
23788635|NCT00728754|66606137|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
23788636|NCT00728754|66606138|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
23788637|NCT00728754|66606137|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
23788638|NCT00728754|66606138|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
23788639|NCT00728754|66606137|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
23788640|NCT00728754|66606138|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
23788641|NCT00731939|66606140|FG000|Overall Study|Adverse Event|6|||
23788642|NCT00731939|66606140|FG000|Overall Study|Lost to Follow-up|15|||
23788643|NCT00731939|66606140|FG000|Overall Study|Not implanted with study device|9|||
23788644|NCT00731939|66606140|FG000|Overall Study|Withdrawal by Subject|2|||
23788645|NCT00731939|66606140|FG000|Overall Study|Did not meet enrollment criteria|2|||
23788646|NCT04002648|66606141|FG000|Overall Study|Lost to Follow-up|2|||
23788647|NCT04002648|66606142|FG001|Overall Study|Lost to Follow-up|0|||
23788648|NCT01490190|66606144|FG000|Overall Study|Withdrawal by Subject|9|||
23788649|NCT01490190|66606144|FG000|Overall Study|Adverse Event|17|||
23788650|NCT01490190|66606144|FG000|Overall Study|Protocol Violation|5|||
23639084|NCT02311673|66064469|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23639085|NCT01163292|66064470|FG000|Overall Study|Lack of Efficacy|9|||
23639086|NCT01163292|66064471|FG001|Overall Study|Lack of Efficacy|0|||
23639087|NCT01163292|66064470|FG000|Overall Study|Adverse Event|6|||
23639088|NCT01163292|66064471|FG001|Overall Study|Adverse Event|0|||
23639089|NCT01163292|66064470|FG000|Overall Study|Initiation of biological therapy|0|||
23639090|NCT01163292|66064471|FG001|Overall Study|Initiation of biological therapy|15|||
23639091|NCT01163292|66064470|FG000|Overall Study|Sufficient response to adalimumab|8|||
23639092|NCT01163292|66064471|FG001|Overall Study|Sufficient response to adalimumab|0|||
23639093|NCT01163292|66064470|FG000|Overall Study|Refusal to receive adalimumab|7|||
23639094|NCT01163292|66064471|FG001|Overall Study|Refusal to receive adalimumab|0|||
23639095|NCT01163292|66064470|FG000|Overall Study|Economic reasons|6|||
23639096|NCT01163292|66064471|FG001|Overall Study|Economic reasons|0|||
23639097|NCT01163292|66064470|FG000|Overall Study|No further visits|5|||
23788651|NCT01490190|66606144|FG000|Overall Study|Lost to Follow-up|13|||
23788652|NCT01490190|66606144|FG000|Overall Study|Relocation|1|||
23788653|NCT01490190|66606144|FG000|Overall Study|Inconvenience|1|||
23788654|NCT01490190|66606144|FG000|Overall Study|Ring expulsion|2|||
23788655|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Subject request|8|||
23788656|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Subject request|11|||
23788657|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
23788658|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
23788659|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
23788660|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
23788661|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
23788662|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
23788663|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
23788664|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
23349155|NCT00741091|65021789|FG000|Overall Study|Lost to Follow-up|16|||
23460863|NCT02379728|65430911|FG002|Overall Study|Protocol Violation|2|||
23639098|NCT01163292|66064471|FG001|Overall Study|No further visits|7|||
23788665|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
23788666|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
23788667|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Death|1|||
23788668|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Death|0|||
23788669|NCT00521586|66606145|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
23788670|NCT00521586|66606146|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
23788671|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
23788672|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
23788673|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
23788674|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
23788675|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
23788676|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
23788677|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
23639099|NCT04655027|66064472|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
23639100|NCT04655027|66064473|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
23639101|NCT01076647|66064479|FG000|Overall Study|Adverse Event|4|||
23639102|NCT01076647|66064480|FG001|Overall Study|Adverse Event|1|||
23639103|NCT01076647|66064479|FG000|Overall Study|Lack of Efficacy|0|||
23639104|NCT01076647|66064480|FG001|Overall Study|Lack of Efficacy|1|||
23639105|NCT01076647|66064479|FG000|Overall Study|Protocol Violation|7|||
23639106|NCT01076647|66064480|FG001|Overall Study|Protocol Violation|9|||
23639107|NCT01076647|66064479|FG000|Overall Study|Withdrawal criteria|2|||
23639108|NCT01076647|66064480|FG001|Overall Study|Withdrawal criteria|2|||
23639109|NCT01076647|66064479|FG000|Overall Study|Unclassified|12|||
23639110|NCT01076647|66064480|FG001|Overall Study|Unclassified|12|||
23639111|NCT03507777|66064481|FG000|Overall Study|Lost to Follow-up|5|||
23639112|NCT03507777|66064482|FG001|Overall Study|Lost to Follow-up|7|||
23639113|NCT03507777|66064481|FG000|Overall Study|Withdrawal by Subject|6|||
23639114|NCT03507777|66064482|FG001|Overall Study|Withdrawal by Subject|11|||
23639115|NCT03507777|66064481|FG000|Overall Study|Death|30|||
23639116|NCT03507777|66064482|FG001|Overall Study|Death|44|||
23639117|NCT03507777|66064481|FG000|Overall Study|Other Reasons|3|||
23639118|NCT03507777|66064482|FG001|Overall Study|Other Reasons|8|||
23639119|NCT00727311|66064483|FG000|Overall Study|Did not receive drug|316|||
23639120|NCT00727311|66064483|FG000|Overall Study|Missing end of therapy data|205|||
23639121|NCT00727311|66064483|FG000|Overall Study|Adverse Event|58|||
23639122|NCT00727311|66064483|FG000|Overall Study|Lack of Efficacy|242|||
23639123|NCT00727311|66064483|FG000|Overall Study|Lost to Follow-up|73|||
23639124|NCT00727311|66064483|FG000|Overall Study|Withdrawal by Subject|77|||
23639125|NCT00727311|66064483|FG000|Overall Study|Other|97|||
23639126|NCT00727311|66064483|FG000|Overall Study|Multiple reasons|39|||
23639127|NCT04664400|66064484|FG000|Overall Study|Withdrawal by Subject|2|||
23639128|NCT01253018|66064485|FG000|Overall Study|Lost to Follow-up|1|||
23639129|NCT01253018|66064486|FG001|Overall Study|Lost to Follow-up|1|||
23639130|NCT01253018|66064485|FG000|Overall Study|Robot Repair Issues|2|||
23788678|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
23349156|NCT00741091|65021789|FG000|Overall Study|Withdrawal by Subject|6|||
23584460|NCT03781804|65869198|FG002|Overall Study|Reason not provided|0|||
23584461|NCT04555044|65869199|FG000|Overall Study|Adverse Event|0|||
23584462|NCT04555044|65869200|FG001|Overall Study|Adverse Event|1|||
23584463|NCT05487703|65869205|FG000|Overall Study|Other|19|||
23584464|NCT05487703|65869205|FG000|Overall Study|Participant not well|5|||
23584465|NCT05487703|65869205|FG000|Overall Study|Insurance Reasons|6|||
23584466|NCT05487703|65869205|FG000|Overall Study|Physician Decision|19|||
23584467|NCT05487703|65869205|FG000|Overall Study|Lack of Efficacy|60|||
23584468|NCT03302156|65869206|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
23584469|NCT03302156|65869207|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
23584470|NCT03302156|65869208|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
23584471|NCT01306331|65869209|FG000|Overall Study|Adverse Event|28|||
23584472|NCT01306331|65869210|FG001|Overall Study|Adverse Event|25|||
23584473|NCT01306331|65869209|FG000|Overall Study|Lost to Follow-up|321|||
23584474|NCT01306331|65869210|FG001|Overall Study|Lost to Follow-up|323|||
23584475|NCT01306331|65869209|FG000|Overall Study|Physician Decision|26|||
23584476|NCT01306331|65869210|FG001|Overall Study|Physician Decision|22|||
23584477|NCT01306331|65869209|FG000|Overall Study|Pregnancy|136|||
23584478|NCT01306331|65869210|FG001|Overall Study|Pregnancy|151|||
23584479|NCT01306331|65869209|FG000|Overall Study|Protocol Violation|154|||
23584480|NCT01306331|65869210|FG001|Overall Study|Protocol Violation|124|||
23584481|NCT01306331|65869209|FG000|Overall Study|Withdrawal by Subject|163|||
23584482|NCT01306331|65869210|FG001|Overall Study|Withdrawal by Subject|152|||
23639131|NCT01253018|66064486|FG001|Overall Study|Robot Repair Issues|0|||
23584483|NCT01306331|65869209|FG000|Overall Study|Not sexually active|29|||
23639132|NCT01253018|66064485|FG000|Overall Study|Withdrawal by Subject|1|||
23639133|NCT01253018|66064486|FG001|Overall Study|Withdrawal by Subject|1|||
23639134|NCT00548262|66064487|FG000|Overall Study|Death|21|||
23639135|NCT00548262|66064487|FG000|Overall Study|Adverse Event|2|||
23639136|NCT00548262|66064487|FG000|Overall Study|Lack of Efficacy|4|||
23639137|NCT00548262|66064487|FG000|Overall Study|Lost to Follow-up|1|||
23639138|NCT00548262|66064487|FG000|Overall Study|Other|3|||
23639139|NCT00548262|66064487|FG000|Overall Study|Withdrawal by Subject|1|||
23639140|NCT01123070|66064488|FG000|Part B Double Blind Period|Protocol Violation|0|||
23639141|NCT01123070|66064489|FG001|Part B Double Blind Period|Protocol Violation|0|||
23639142|NCT01123070|66064490|FG002|Part B Double Blind Period|Protocol Violation|0|||
23639143|NCT01123070|66064491|FG003|Part B Double Blind Period|Protocol Violation|1|||
23639144|NCT01123070|66064488|FG000|Part B Double Blind Period|Adverse Event|0|||
23639145|NCT01123070|66064489|FG001|Part B Double Blind Period|Adverse Event|0|||
23639146|NCT01123070|66064490|FG002|Part B Double Blind Period|Adverse Event|2|||
23639147|NCT01123070|66064491|FG003|Part B Double Blind Period|Adverse Event|0|||
23639148|NCT01123070|66064488|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
23639149|NCT01123070|66064489|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
23639150|NCT01123070|66064490|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
23639151|NCT01123070|66064491|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
23639152|NCT00132873|66064492|FG000|Overall Study|Adverse Event|3|||
23639153|NCT00132873|66064492|FG000|Overall Study|Lost to Follow-up|1|||
23639154|NCT00132873|66064492|FG000|Overall Study|Lack of Efficacy|1|||
23639155|NCT00132873|66064492|FG000|Overall Study|Withdrawal by Subject|3|||
23639156|NCT00132873|66064492|FG000|Overall Study|Planned Pregnancy|1|||
23460864|NCT02379728|65430912|FG003|Overall Study|Protocol Violation|0|||
23460865|NCT01527370|65430920|FG000|Overall Study|Withdrawal by Subject|4|||
23460866|NCT01527370|65430920|FG000|Overall Study|Physician Decision|1|||
23460867|NCT01527370|65430920|FG000|Overall Study|Death|1|||
23460868|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23584484|NCT01306331|65869210|FG001|Overall Study|Not sexually active|28|||
23639157|NCT02643303|66064493|FG000|Overall Study|Progressive Disease|4|||
23639158|NCT02643303|66064494|FG001|Overall Study|Progressive Disease|4|||
23639159|NCT02643303|66064495|FG002|Overall Study|Progressive Disease|1|||
23639160|NCT02643303|66064496|FG003|Overall Study|Progressive Disease|12|||
23639161|NCT02643303|66064497|FG004|Overall Study|Progressive Disease|6|||
23639162|NCT02643303|66064498|FG005|Overall Study|Progressive Disease|4|||
23639163|NCT02643303|66064499|FG006|Overall Study|Progressive Disease|8|||
23639164|NCT02643303|66064500|FG007|Overall Study|Progressive Disease|2|||
23788679|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
23584485|NCT01306331|65869209|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
23584486|NCT01306331|65869210|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
23584487|NCT01306331|65869209|FG000|Overall Study|Other|34|||
23584488|NCT01306331|65869210|FG001|Overall Study|Other|32|||
23584489|NCT01837641|65869213|FG000|Overall Study|Sponsor decision|1|||
23584490|NCT01837641|65869214|FG001|Overall Study|Sponsor decision|0|||
23584491|NCT01837641|65869215|FG002|Overall Study|Sponsor decision|0|||
23584492|NCT01837641|65869216|FG003|Overall Study|Sponsor decision|0|||
23584493|NCT01837641|65869217|FG004|Overall Study|Sponsor decision|0|||
23584494|NCT01837641|65869218|FG005|Overall Study|Sponsor decision|1|||
23584495|NCT01837641|65869219|FG006|Overall Study|Sponsor decision|0|||
23584496|NCT01837641|65869220|FG007|Overall Study|Sponsor decision|0|||
23584497|NCT01837641|65869213|FG000|Overall Study|Adverse Event|0|||
23584498|NCT01837641|65869214|FG001|Overall Study|Adverse Event|0|||
23584499|NCT01837641|65869215|FG002|Overall Study|Adverse Event|0|||
23584500|NCT01837641|65869216|FG003|Overall Study|Adverse Event|0|||
23584501|NCT01837641|65869217|FG004|Overall Study|Adverse Event|0|||
23584502|NCT01837641|65869218|FG005|Overall Study|Adverse Event|1|||
23584503|NCT01837641|65869219|FG006|Overall Study|Adverse Event|0|||
23584504|NCT01837641|65869220|FG007|Overall Study|Adverse Event|0|||
23584505|NCT01837641|65869213|FG000|Overall Study|Withdrawal by Subject|0|||
23584506|NCT01837641|65869214|FG001|Overall Study|Withdrawal by Subject|0|||
23584507|NCT01837641|65869215|FG002|Overall Study|Withdrawal by Subject|0|||
23584508|NCT01837641|65869216|FG003|Overall Study|Withdrawal by Subject|0|||
23584509|NCT01837641|65869217|FG004|Overall Study|Withdrawal by Subject|1|||
23584510|NCT01837641|65869218|FG005|Overall Study|Withdrawal by Subject|0|||
23584511|NCT01837641|65869219|FG006|Overall Study|Withdrawal by Subject|1|||
23639165|NCT02643303|66064501|FG008|Overall Study|Progressive Disease|6|||
23639166|NCT02643303|66064493|FG000|Overall Study|Adverse Event|0|||
23639167|NCT02643303|66064494|FG001|Overall Study|Adverse Event|1|||
23639168|NCT02643303|66064495|FG002|Overall Study|Adverse Event|0|||
23788680|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
23584512|NCT01837641|65869220|FG007|Overall Study|Withdrawal by Subject|0|||
23639169|NCT02643303|66064496|FG003|Overall Study|Adverse Event|0|||
23639170|NCT02643303|66064497|FG004|Overall Study|Adverse Event|1|||
23788681|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
23584513|NCT05052983|65869221|FG000|Overall Study|Lack of Efficacy|3|||
23584514|NCT05052983|65869222|FG001|Overall Study|Lack of Efficacy|12|||
23639171|NCT02643303|66064498|FG005|Overall Study|Adverse Event|0|||
23639172|NCT02643303|66064499|FG006|Overall Study|Adverse Event|0|||
23639173|NCT02643303|66064500|FG007|Overall Study|Adverse Event|0|||
23639174|NCT02643303|66064501|FG008|Overall Study|Adverse Event|0|||
23639175|NCT02643303|66064493|FG000|Overall Study|Withdrawal by Subject|0|||
23639176|NCT02643303|66064494|FG001|Overall Study|Withdrawal by Subject|0|||
23639177|NCT02643303|66064495|FG002|Overall Study|Withdrawal by Subject|0|||
23639178|NCT02643303|66064496|FG003|Overall Study|Withdrawal by Subject|1|||
23639179|NCT02643303|66064497|FG004|Overall Study|Withdrawal by Subject|0|||
23639180|NCT02643303|66064498|FG005|Overall Study|Withdrawal by Subject|0|||
23639181|NCT02643303|66064499|FG006|Overall Study|Withdrawal by Subject|1|||
23639182|NCT02643303|66064500|FG007|Overall Study|Withdrawal by Subject|1|||
23639183|NCT02643303|66064501|FG008|Overall Study|Withdrawal by Subject|1|||
23639184|NCT02735577|66064503|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
23639185|NCT02735577|66064503|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
23639186|NCT01253304|66064506|FG000|Overall Study|Adverse Event|0|||
23639187|NCT01253304|66064507|FG001|Overall Study|Adverse Event|0|||
23639188|NCT01253304|66064508|FG002|Overall Study|Adverse Event|0|||
23639189|NCT01253304|66064509|FG003|Overall Study|Adverse Event|1|||
23639190|NCT03208036|66064512|FG000|Baseline Assessment|Withdrawal by Subject|1|||
23639191|NCT03208036|66064513|FG001|Baseline Assessment|Withdrawal by Subject|1|||
23639192|NCT03208036|66064512|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
23639193|NCT03208036|66064513|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
23639194|NCT03208036|66064512|FG000|Intervention|Withdrawal by Subject|3|||
23639195|NCT03208036|66064513|FG001|Intervention|Withdrawal by Subject|2|||
23639196|NCT03208036|66064512|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
23639197|NCT03208036|66064513|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
23639198|NCT00770029|66064518|FG000|Overall Study|Lost to Follow-up|2|||
23639199|NCT00770029|66064519|FG001|Overall Study|Lost to Follow-up|0|||
23639200|NCT00770029|66064518|FG000|Overall Study|Withdrawal by Subject|3|||
23639201|NCT00770029|66064519|FG001|Overall Study|Withdrawal by Subject|3|||
23639202|NCT00770029|66064518|FG000|Overall Study|Adverse Event|1|||
23639203|NCT00770029|66064519|FG001|Overall Study|Adverse Event|0|||
23639204|NCT01213524|66064524|FG000|Baseline|Withdrawal by Subject|5|||
23639205|NCT01213524|66064524|FG000|Baseline|high breath alcohol levels|1|||
23639206|NCT01213524|66064524|FG000|Baseline|Physician Decision|1|||
23639207|NCT01213524|66064524|FG000|Session 2|Withdrawal by Subject|5|||
23639208|NCT01213524|66064524|FG000|Session 3|Withdrawal by Subject|4|||
23639209|NCT01213524|66064524|FG000|Session 4|Physician Decision|1|||
23639210|NCT01213524|66064524|FG000|Session 4|Withdrawal by Subject|2|||
23639211|NCT01758900|66064525|FG000|Overall Study|difficulty for further intubation|7|||
23639212|NCT01758900|66064526|FG001|Overall Study|difficulty for further intubation|8|||
23639213|NCT02141620|66064531|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
23639214|NCT02141620|66064532|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
23639215|NCT03896152|66064536|FG000|Overall Study|Patient/guardian decision|1|||
23639216|NCT03896152|66064537|FG001|Overall Study|Patient/guardian decision|1|||
23639217|NCT03896152|66064536|FG000|Overall Study|Adverse Event|0|||
23639218|NCT03896152|66064537|FG001|Overall Study|Adverse Event|1|||
23639219|NCT03896152|66064536|FG000|Overall Study|Physician Decision|1|||
23639220|NCT03896152|66064537|FG001|Overall Study|Physician Decision|0|||
23639221|NCT03896152|66064536|FG000|Overall Study|Technical problems|1|||
23639222|NCT03896152|66064537|FG001|Overall Study|Technical problems|0|||
23349157|NCT00741091|65021789|FG000|Overall Study|Missed Visit|22|||
23349158|NCT04500769|65021790|FG000|Overall Study|Withdrawal by Subject|5|||
23349159|NCT03217968|65021793|FG000|Overall Study|Withdrawal by Subject|4|||
23349160|NCT03217968|65021793|FG000|Overall Study|Lost to Follow-up|1|||
23639223|NCT00490724|66064538|FG000|Period I|Physician Decision|0|||
23639224|NCT00490724|66064539|FG001|Period I|Physician Decision|0|||
23639225|NCT00490724|66064540|FG002|Period I|Physician Decision|1|||
23639226|NCT00490724|66064538|FG000|Period II|Treatment Discontinuation|3|||
23639227|NCT00490724|66064539|FG001|Period II|Treatment Discontinuation|1|||
23349161|NCT03217968|65021793|FG000|Overall Study|Protocol Violation|6|||
23639228|NCT00490724|66064540|FG002|Period II|Treatment Discontinuation|3|||
23639229|NCT01014208|66064541|FG000|Overall Study|Lost to Follow-up|2|||
23639230|NCT01014208|66064542|FG001|Overall Study|Lost to Follow-up|5|||
23639231|NCT01014208|66064541|FG000|Overall Study|Participant Withdrew Consent|12|||
23639232|NCT01014208|66064542|FG001|Overall Study|Participant Withdrew Consent|12|||
23639233|NCT01014208|66064541|FG000|Overall Study|Did Not Receive Study Drug|2|||
23788682|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
23349162|NCT00725101|65021797|FG000|Overall Study|Death|3|||
23639234|NCT01014208|66064542|FG001|Overall Study|Did Not Receive Study Drug|0|||
23639235|NCT01014208|66064541|FG000|Overall Study|Study Closed/terminated|78|||
23639236|NCT01014208|66064542|FG001|Overall Study|Study Closed/terminated|83|||
23639237|NCT01940939|66064543|FG000|Overall Study|Withdrawal by Subject|2|||
23639238|NCT01940939|66064544|FG001|Overall Study|Withdrawal by Subject|8|||
23639239|NCT04400487|66064545|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23349163|NCT00725101|65021797|FG000|Overall Study|Lost to Follow-up|353|||
23639240|NCT04400487|66064545|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
23639241|NCT04400487|66064545|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
23639242|NCT00436605|66064546|FG000|Overall Study|Protocol Violation|3|||
23639243|NCT02580305|66064547|FG000|Overall Study|Adverse Event|15|||
23639244|NCT02580305|66064548|FG001|Overall Study|Adverse Event|19|||
23349164|NCT00725101|65021797|FG000|Overall Study|Protocol Violation|1|||
23349165|NCT00725101|65021797|FG000|Overall Study|Withdrawal by Subject|127|||
23639245|NCT02580305|66064549|FG002|Overall Study|Adverse Event|10|||
23639246|NCT02580305|66064547|FG000|Overall Study|Lack of Efficacy|5|||
23349166|NCT00725101|65021797|FG000|Overall Study|not specified/no reason given|11|||
23349167|NCT00090584|65021798|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
23349168|NCT00090584|65021799|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
23349169|NCT00090584|65021798|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
23349170|NCT00090584|65021799|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
23349171|NCT01549041|65021800|FG000|Overall Study|Lack of Efficacy|2|||
23349172|NCT01549041|65021801|FG001|Overall Study|Lack of Efficacy|4|||
23349173|NCT01549041|65021800|FG000|Overall Study|Adverse Event|0|||
23349174|NCT01549041|65021801|FG001|Overall Study|Adverse Event|4|||
23349175|NCT02719353|65021806|FG000|First Intervention|Physician Decision|0|||
23349176|NCT02719353|65021807|FG001|First Intervention|Physician Decision|1|||
23349177|NCT00900757|65021815|FG000|Overall Study|screen failure|19|||
23349178|NCT03085238|65021816|FG000|Overall Study|Adverse Event|2|||
23639247|NCT02580305|66064548|FG001|Overall Study|Lack of Efficacy|0|||
23639248|NCT02580305|66064549|FG002|Overall Study|Lack of Efficacy|2|||
23639249|NCT02580305|66064547|FG000|Overall Study|Protocol Violation|4|||
23639250|NCT02580305|66064548|FG001|Overall Study|Protocol Violation|9|||
23639251|NCT02580305|66064549|FG002|Overall Study|Protocol Violation|6|||
23639252|NCT02580305|66064547|FG000|Overall Study|Lost to Follow-up|4|||
23639253|NCT02580305|66064548|FG001|Overall Study|Lost to Follow-up|4|||
23639254|NCT02580305|66064549|FG002|Overall Study|Lost to Follow-up|2|||
23639255|NCT02580305|66064547|FG000|Overall Study|Withdrawal by Subject|11|||
23639256|NCT02580305|66064548|FG001|Overall Study|Withdrawal by Subject|9|||
23639257|NCT02580305|66064549|FG002|Overall Study|Withdrawal by Subject|7|||
23639258|NCT02580305|66064547|FG000|Overall Study|Randomized in error and never treated|4|||
23639259|NCT02580305|66064548|FG001|Overall Study|Randomized in error and never treated|8|||
23639260|NCT02580305|66064549|FG002|Overall Study|Randomized in error and never treated|5|||
23639261|NCT03541200|66064552|FG000|Overall Study|Adverse Event|19|||
23639262|NCT03541200|66064552|FG000|Overall Study|Death|1|||
23639263|NCT03541200|66064552|FG000|Overall Study|Lost to Follow-up|10|||
23639264|NCT03541200|66064552|FG000|Overall Study|Physician Decision|1|||
23639265|NCT03541200|66064552|FG000|Overall Study|Protocol Violation|51|||
23639266|NCT03541200|66064552|FG000|Overall Study|Withdrawal by Subject|23|||
23639267|NCT03541200|66064552|FG000|Overall Study|other|8|||
23639268|NCT00591851|66064554|FG000|Overall Study|Withdrawal by Subject|3|||
23639269|NCT00591851|66064554|FG000|Overall Study|Adverse Event|2|||
23639270|NCT00591851|66064554|FG000|Overall Study|Progressive Disease|1|||
23639271|NCT00635427|66064557|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23639272|NCT00635427|66064558|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23639273|NCT00635427|66064559|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
23639274|NCT00635427|66064560|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23639275|NCT00635427|66064561|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23639276|NCT00635427|66064557|FG000|Overall Study|Death|0|||
23639277|NCT00635427|66064558|FG001|Overall Study|Death|0|||
23639278|NCT00635427|66064559|FG002|Overall Study|Death|0|||
23639279|NCT00635427|66064560|FG003|Overall Study|Death|1|||
23349179|NCT03085238|65021816|FG000|Overall Study|Death|2|||
23349180|NCT01314105|65021824|FG000|Overall Study|Progressive Disease|6|||
23349181|NCT01314105|65021825|FG001|Overall Study|Progressive Disease|10|||
23349182|NCT01314105|65021824|FG000|Overall Study|Refused to continue taking medication|0|||
23349183|NCT01314105|65021825|FG001|Overall Study|Refused to continue taking medication|1|||
23639280|NCT00635427|66064561|FG004|Overall Study|Death|0|||
23639281|NCT00635427|66064557|FG000|Overall Study|Termination Of Study By Sponsor|12|||
23639282|NCT00635427|66064558|FG001|Overall Study|Termination Of Study By Sponsor|6|||
23639283|NCT00635427|66064559|FG002|Overall Study|Termination Of Study By Sponsor|10|||
23639284|NCT00635427|66064560|FG003|Overall Study|Termination Of Study By Sponsor|6|||
23639285|NCT00635427|66064561|FG004|Overall Study|Termination Of Study By Sponsor|6|||
23639286|NCT00635427|66064557|FG000|Overall Study|Withdrawal Of Consent|0|||
23639287|NCT00635427|66064558|FG001|Overall Study|Withdrawal Of Consent|0|||
23639288|NCT00635427|66064559|FG002|Overall Study|Withdrawal Of Consent|0|||
23639289|NCT00635427|66064560|FG003|Overall Study|Withdrawal Of Consent|2|||
23349184|NCT01314105|65021824|FG000|Overall Study|Other Adverse Event|1|||
23639290|NCT00635427|66064561|FG004|Overall Study|Withdrawal Of Consent|2|||
23639291|NCT01302080|66064562|FG000|Overall Study|Withdrew Consent|92|||
23639292|NCT01302080|66064563|FG001|Overall Study|Withdrew Consent|39|||
23639293|NCT01302080|66064562|FG000|Overall Study|Patient/Family Moved|28|||
23639294|NCT01302080|66064563|FG001|Overall Study|Patient/Family Moved|3|||
23639295|NCT01302080|66064562|FG000|Overall Study|Lost to Follow-up|192|||
23639296|NCT01302080|66064563|FG001|Overall Study|Lost to Follow-up|93|||
23639297|NCT01302080|66064562|FG000|Overall Study|Death|1|||
23639298|NCT01302080|66064563|FG001|Overall Study|Death|0|||
23639299|NCT01302080|66064562|FG000|Overall Study|Other|52|||
23639300|NCT01302080|66064563|FG001|Overall Study|Other|8|||
23639301|NCT01302080|66064562|FG000|Overall Study|Reason Missing For Discontinuation|1|||
23639302|NCT01302080|66064563|FG001|Overall Study|Reason Missing For Discontinuation|0|||
23639303|NCT01977677|66064564|FG000|Overall Study|Unrelated Adverse Event|0|||
23639304|NCT01977677|66064565|FG001|Overall Study|Unrelated Adverse Event|0|||
23639305|NCT01977677|66064566|FG002|Overall Study|Unrelated Adverse Event|1|||
23639306|NCT01499303|66064567|FG000|Overall Study|Ongoing|2|||
23639307|NCT01499303|66064568|FG001|Overall Study|Ongoing|1|||
23639308|NCT01499303|66064567|FG000|Overall Study|Withdrawal by Subject|0|||
23639309|NCT01499303|66064568|FG001|Overall Study|Withdrawal by Subject|1|||
23639310|NCT01499303|66064567|FG000|Overall Study|Adverse Event|1|||
23639311|NCT01499303|66064568|FG001|Overall Study|Adverse Event|4|||
23639312|NCT01499303|66064567|FG000|Overall Study|Other|0|||
23639313|NCT01499303|66064568|FG001|Overall Study|Other|1|||
23639314|NCT01283516|66064569|FG000|Overall Study|Adverse Event|0|||
23639315|NCT01283516|66064570|FG001|Overall Study|Adverse Event|0|||
23639316|NCT01283516|66064571|FG002|Overall Study|Adverse Event|0|||
23639317|NCT01283516|66064572|FG003|Overall Study|Adverse Event|0|||
23639318|NCT01283516|66064573|FG004|Overall Study|Adverse Event|0|||
23639319|NCT01283516|66064574|FG005|Overall Study|Adverse Event|0|||
23639320|NCT01283516|66064575|FG006|Overall Study|Adverse Event|2|||
23639321|NCT01283516|66064576|FG007|Overall Study|Adverse Event|0|||
23639322|NCT01283516|66064577|FG008|Overall Study|Adverse Event|28|||
23639323|NCT01283516|66064569|FG000|Overall Study|Death|0|||
23639324|NCT01283516|66064570|FG001|Overall Study|Death|0|||
23639325|NCT01283516|66064571|FG002|Overall Study|Death|0|||
23639326|NCT01283516|66064572|FG003|Overall Study|Death|0|||
23639327|NCT01283516|66064573|FG004|Overall Study|Death|0|||
23639328|NCT01283516|66064574|FG005|Overall Study|Death|1|||
23639329|NCT01283516|66064575|FG006|Overall Study|Death|0|||
23639330|NCT01283516|66064576|FG007|Overall Study|Death|1|||
23639331|NCT01283516|66064577|FG008|Overall Study|Death|12|||
23639332|NCT01283516|66064569|FG000|Overall Study|Disease Progression|2|||
23639333|NCT01283516|66064570|FG001|Overall Study|Disease Progression|2|||
23639334|NCT01283516|66064571|FG002|Overall Study|Disease Progression|3|||
23639335|NCT01283516|66064572|FG003|Overall Study|Disease Progression|3|||
23639336|NCT01283516|66064573|FG004|Overall Study|Disease Progression|13|||
23639337|NCT01283516|66064574|FG005|Overall Study|Disease Progression|8|||
23639338|NCT01283516|66064575|FG006|Overall Study|Disease Progression|6|||
23639339|NCT01283516|66064576|FG007|Overall Study|Disease Progression|3|||
23639340|NCT01283516|66064577|FG008|Overall Study|Disease Progression|139|||
23639341|NCT01283516|66064569|FG000|Overall Study|Withdrawal by Subject|0|||
23639342|NCT01283516|66064570|FG001|Overall Study|Withdrawal by Subject|0|||
23639343|NCT01283516|66064571|FG002|Overall Study|Withdrawal by Subject|0|||
23639344|NCT01283516|66064572|FG003|Overall Study|Withdrawal by Subject|0|||
23639345|NCT01283516|66064573|FG004|Overall Study|Withdrawal by Subject|1|||
23639346|NCT01283516|66064574|FG005|Overall Study|Withdrawal by Subject|0|||
23639347|NCT01283516|66064575|FG006|Overall Study|Withdrawal by Subject|1|||
23639348|NCT01283516|66064576|FG007|Overall Study|Withdrawal by Subject|0|||
23639349|NCT01283516|66064577|FG008|Overall Study|Withdrawal by Subject|36|||
23639350|NCT01283516|66064569|FG000|Overall Study|Administrative problems|0|||
23788683|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
23788684|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
23788685|NCT00521586|66606145|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
23788686|NCT00521586|66606146|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
23788687|NCT00521586|66606145|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
23788688|NCT00521586|66606146|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
23639351|NCT01283516|66064570|FG001|Overall Study|Administrative problems|0|||
23639352|NCT01283516|66064571|FG002|Overall Study|Administrative problems|0|||
23639353|NCT01283516|66064572|FG003|Overall Study|Administrative problems|0|||
23639354|NCT01283516|66064573|FG004|Overall Study|Administrative problems|0|||
23639355|NCT01283516|66064574|FG005|Overall Study|Administrative problems|1|||
23639356|NCT01283516|66064575|FG006|Overall Study|Administrative problems|1|||
23639357|NCT01283516|66064576|FG007|Overall Study|Administrative problems|1|||
23639358|NCT01283516|66064577|FG008|Overall Study|Administrative problems|39|||
23639359|NCT01283516|66064569|FG000|Overall Study|Lost to Follow-up|0|||
23639360|NCT01283516|66064570|FG001|Overall Study|Lost to Follow-up|0|||
23639361|NCT01283516|66064571|FG002|Overall Study|Lost to Follow-up|0|||
23639362|NCT01283516|66064572|FG003|Overall Study|Lost to Follow-up|0|||
23639363|NCT01283516|66064573|FG004|Overall Study|Lost to Follow-up|0|||
23639364|NCT01283516|66064574|FG005|Overall Study|Lost to Follow-up|0|||
23639365|NCT01283516|66064575|FG006|Overall Study|Lost to Follow-up|0|||
23639366|NCT01283516|66064576|FG007|Overall Study|Lost to Follow-up|0|||
23639367|NCT01283516|66064577|FG008|Overall Study|Lost to Follow-up|1|||
23349185|NCT01314105|65021825|FG001|Overall Study|Other Adverse Event|1|||
23349186|NCT02570750|65021826|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
23349187|NCT02570750|65021827|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
23349188|NCT02570750|65021826|FG000|Overall Study|Protocol deviation|4|||
23349189|NCT02570750|65021827|FG001|Overall Study|Protocol deviation|2|||
23349190|NCT02570750|65021826|FG000|Overall Study|Withdrawal by Subject|5|||
23349191|NCT02570750|65021827|FG001|Overall Study|Withdrawal by Subject|0|||
23349192|NCT02570750|65021826|FG000|Overall Study|Lost to Follow-up|2|||
23349193|NCT02570750|65021827|FG001|Overall Study|Lost to Follow-up|2|||
23349194|NCT02570750|65021826|FG000|Overall Study|Adverse Event|2|||
23349195|NCT02570750|65021827|FG001|Overall Study|Adverse Event|1|||
23349196|NCT00597506|65021828|FG000|Overall Study|Subject is being followed for survival|1|||
23349197|NCT00380718|65021831|FG000|Overall Study|Adverse Event|1|||
23349198|NCT00380718|65021831|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
23349199|NCT01294371|65021832|FG000|Overall Study|Adverse Event|1|||
23349200|NCT01294371|65021832|FG000|Overall Study|Withdrawal by Subject|12|||
23349201|NCT01294371|65021832|FG000|Overall Study|Lost to Follow-up|6|||
23349202|NCT01294371|65021832|FG000|Overall Study|Administrative Reason|1|||
23349203|NCT01294371|65021832|FG000|Overall Study|Other|14|||
23349204|NCT03840148|65021835|FG000|Study Drug Disposition|Adverse Event|13|||
23349205|NCT03840148|65021836|FG001|Study Drug Disposition|Adverse Event|2|||
23788689|NCT00521586|66606145|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
23349206|NCT03840148|65021835|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
23349207|NCT03840148|65021836|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
23349208|NCT03840148|65021835|FG000|Study Drug Disposition|Lack of Efficacy|3|||
23349209|NCT03840148|65021836|FG001|Study Drug Disposition|Lack of Efficacy|0|||
23349210|NCT03840148|65021835|FG000|Study Drug Disposition|Physician Decision|2|||
23349211|NCT03840148|65021836|FG001|Study Drug Disposition|Physician Decision|0|||
23349212|NCT03840148|65021835|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
23349213|NCT03840148|65021836|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
23788690|NCT00521586|66606146|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
23788691|NCT00521586|66606145|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
23788692|NCT00521586|66606146|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
23788693|NCT01492439|66606147|FG000|Overall Study|Withdrew from RTE|4|||
23788694|NCT01492439|66606148|FG001|Overall Study|Withdrew from RTE|9|||
23788695|NCT01698554|66606149|FG000|Overall Study|Adverse Event|2|||
23788696|NCT01698554|66606150|FG001|Overall Study|Adverse Event|5|||
23788697|NCT01698554|66606151|FG002|Overall Study|Adverse Event|0|||
23788698|NCT01698554|66606152|FG003|Overall Study|Adverse Event|1|||
23788699|NCT01698554|66606149|FG000|Overall Study|Lost to Follow-up|1|||
23788700|NCT01698554|66606150|FG001|Overall Study|Lost to Follow-up|0|||
23788701|NCT01698554|66606151|FG002|Overall Study|Lost to Follow-up|0|||
23349214|NCT03840148|65021835|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
23349215|NCT03840148|65021836|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
23349216|NCT03840148|65021835|FG000|Study Completion Disposition|Physician Decision|2|||
23788702|NCT01698554|66606152|FG003|Overall Study|Lost to Follow-up|0|||
23788703|NCT01698554|66606149|FG000|Overall Study|Personal Reasons|0|||
23788704|NCT01698554|66606150|FG001|Overall Study|Personal Reasons|5|||
23788705|NCT01698554|66606151|FG002|Overall Study|Personal Reasons|1|||
23788706|NCT01698554|66606152|FG003|Overall Study|Personal Reasons|1|||
23788707|NCT01698554|66606149|FG000|Overall Study|Protocol Violation|2|||
23788708|NCT01698554|66606150|FG001|Overall Study|Protocol Violation|0|||
23788709|NCT01698554|66606151|FG002|Overall Study|Protocol Violation|1|||
23788710|NCT01698554|66606152|FG003|Overall Study|Protocol Violation|0|||
23349217|NCT03840148|65021836|FG001|Study Completion Disposition|Physician Decision|0|||
23349218|NCT03840148|65021835|FG000|Study Completion Disposition|Covid-19 related|2|||
23349219|NCT03840148|65021836|FG001|Study Completion Disposition|Covid-19 related|0|||
23349220|NCT03840148|65021835|FG000|Study Completion Disposition|Lost to Follow-up|1|||
23349221|NCT03840148|65021836|FG001|Study Completion Disposition|Lost to Follow-up|1|||
23349222|NCT03840148|65021835|FG000|Study Completion Disposition|Death|1|||
23584515|NCT05052983|65869221|FG000|Overall Study|Adverse Event|1|||
23584516|NCT05052983|65869222|FG001|Overall Study|Adverse Event|0|||
23584517|NCT05460663|65869223|FG000|Overall Study|Withdrawal by Subject|2|||
23584518|NCT05460663|65869224|FG001|Overall Study|Withdrawal by Subject|5|||
23584519|NCT05305040|65869225|FG000|Overall Study|Not Dosed|37|||
23584520|NCT05305040|65869226|FG001|Overall Study|Not Dosed|37|||
23584521|NCT05305040|65869225|FG000|Overall Study|Study Closure|34|||
23584522|NCT05305040|65869226|FG001|Overall Study|Study Closure|46|||
23788711|NCT01698554|66606149|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23349223|NCT03840148|65021836|FG001|Study Completion Disposition|Death|0|||
23402705|NCT03289143|65219983|FG000|Overall Study|Study Terminated By Sponsor|101|||
23584523|NCT05305040|65869225|FG000|Overall Study|Death|14|||
23584524|NCT05305040|65869226|FG001|Overall Study|Death|13|||
23788712|NCT01698554|66606150|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23788713|NCT01698554|66606151|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23788714|NCT01698554|66606152|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23788715|NCT01566435|66606153|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
23788716|NCT03980522|66606154|FG000|Treatment Period|Adverse Event|1|||
23788717|NCT03980522|66606155|FG001|Treatment Period|Adverse Event|0|||
23349224|NCT03840148|65021835|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
23349225|NCT03840148|65021836|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
23349226|NCT02483572|65021837|FG000|Overall Study|Withdrawal by Subject|1|||
23788718|NCT03980522|66606156|FG002|Treatment Period|Adverse Event|0|||
23788719|NCT03980522|66606157|FG003|Treatment Period|Adverse Event|0|||
23788720|NCT03980522|66606158|FG004|Treatment Period|Adverse Event|0|||
23788721|NCT01024855|66606160|FG000|Overall Study|Inclusion/exclusion criteria|1|||
23788722|NCT00867360|66606164|FG000|Overall Study|Withdrawal by Subject|1|||
23788723|NCT00867360|66606165|FG001|Overall Study|Withdrawal by Subject|0|||
23788724|NCT00867360|66606164|FG000|Overall Study|Physician Decision|0|||
23788725|NCT00867360|66606165|FG001|Overall Study|Physician Decision|1|||
23788726|NCT00902538|66606168|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
23788727|NCT00902538|66606169|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23788728|NCT00902538|66606170|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23788729|NCT00902538|66606171|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23788730|NCT00902538|66606172|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23788731|NCT00902538|66606173|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23788732|NCT00902538|66606168|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
23788733|NCT00902538|66606169|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23788734|NCT00902538|66606170|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23788735|NCT00902538|66606171|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23788736|NCT00902538|66606172|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23788737|NCT00902538|66606173|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23788738|NCT00902538|66606168|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
23788739|NCT00902538|66606169|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23788740|NCT00902538|66606170|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23788741|NCT00902538|66606171|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23788742|NCT00902538|66606172|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23788743|NCT00902538|66606173|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23788744|NCT00902538|66606168|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
23788745|NCT00902538|66606169|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23788746|NCT00902538|66606170|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23788747|NCT00902538|66606171|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23788748|NCT00902538|66606172|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23788749|NCT00902538|66606173|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23788750|NCT00902538|66606168|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
23788751|NCT00902538|66606169|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23788752|NCT00902538|66606170|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23788753|NCT00902538|66606171|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23788754|NCT00902538|66606172|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23788755|NCT00902538|66606173|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23788756|NCT00902538|66606168|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
23788757|NCT00902538|66606169|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
23788758|NCT00902538|66606170|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
23788759|NCT00902538|66606171|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23788760|NCT00902538|66606172|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23788761|NCT00902538|66606173|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23788762|NCT00902538|66606168|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
23788763|NCT00902538|66606169|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
23788764|NCT00902538|66606170|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
23788765|NCT00902538|66606171|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23788766|NCT00902538|66606172|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23788767|NCT00902538|66606173|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23788768|NCT00902538|66606168|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
23788769|NCT00902538|66606169|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23788770|NCT00902538|66606170|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
23788771|NCT00902538|66606171|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23349227|NCT02483572|65021838|FG001|Overall Study|Withdrawal by Subject|0|||
23349228|NCT02483572|65021837|FG000|Overall Study|Lost to Follow-up|1|||
23788772|NCT00902538|66606172|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23349229|NCT02483572|65021838|FG001|Overall Study|Lost to Follow-up|0|||
23349230|NCT02483572|65021837|FG000|Overall Study|Physician Decision|0|||
23349231|NCT02483572|65021838|FG001|Overall Study|Physician Decision|1|||
23349232|NCT00394771|65021839|FG000|Overall Study|Did not meet protocol requirements|1|||
23349233|NCT00394771|65021840|FG001|Overall Study|Did not meet protocol requirements|0|||
23349234|NCT00394771|65021841|FG002|Overall Study|Did not meet protocol requirements|2|||
23349235|NCT00394771|65021842|FG003|Overall Study|Did not meet protocol requirements|0|||
23349236|NCT00394771|65021839|FG000|Overall Study|Protocol Violation|2|||
23349237|NCT00394771|65021840|FG001|Overall Study|Protocol Violation|4|||
23349238|NCT00394771|65021841|FG002|Overall Study|Protocol Violation|9|||
23349239|NCT00394771|65021842|FG003|Overall Study|Protocol Violation|7|||
23349240|NCT00394771|65021839|FG000|Overall Study|Withdrawal by Subject|10|||
23349241|NCT00394771|65021840|FG001|Overall Study|Withdrawal by Subject|6|||
23349242|NCT00394771|65021841|FG002|Overall Study|Withdrawal by Subject|8|||
23349243|NCT00394771|65021842|FG003|Overall Study|Withdrawal by Subject|12|||
23349244|NCT00394771|65021839|FG000|Overall Study|Adverse Event|10|||
23349245|NCT00394771|65021840|FG001|Overall Study|Adverse Event|5|||
23349246|NCT00394771|65021841|FG002|Overall Study|Adverse Event|12|||
23349247|NCT00394771|65021842|FG003|Overall Study|Adverse Event|8|||
23349248|NCT00394771|65021839|FG000|Overall Study|Participant pregnant|0|||
23349249|NCT00394771|65021840|FG001|Overall Study|Participant pregnant|1|||
23349250|NCT00394771|65021841|FG002|Overall Study|Participant pregnant|2|||
23349251|NCT00394771|65021842|FG003|Overall Study|Participant pregnant|2|||
23349252|NCT00394771|65021839|FG000|Overall Study|Lost to Follow-up|15|||
23349253|NCT00394771|65021840|FG001|Overall Study|Lost to Follow-up|15|||
23349254|NCT00394771|65021841|FG002|Overall Study|Lost to Follow-up|13|||
23349255|NCT00394771|65021842|FG003|Overall Study|Lost to Follow-up|10|||
23349256|NCT00394771|65021839|FG000|Overall Study|Other|3|||
23349257|NCT00394771|65021840|FG001|Overall Study|Other|3|||
23349258|NCT00394771|65021841|FG002|Overall Study|Other|1|||
23349259|NCT00394771|65021842|FG003|Overall Study|Other|0|||
23349260|NCT00659776|65021848|FG000|Overall Study|Withdrawal by Subject|12|||
23349261|NCT00659776|65021849|FG001|Overall Study|Withdrawal by Subject|2|||
23349262|NCT00659776|65021850|FG002|Overall Study|Withdrawal by Subject|0|||
23349263|NCT02685072|65021852|FG000|Treatment Period|Lost to Follow-up|12|||
23349264|NCT02685072|65021853|FG001|Treatment Period|Lost to Follow-up|6|||
23349265|NCT02685072|65021852|FG000|Treatment Period|Withdrawal by Subject|1|||
23349266|NCT02685072|65021853|FG001|Treatment Period|Withdrawal by Subject|3|||
23349267|NCT02685072|65021852|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
23349268|NCT02685072|65021853|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
23349269|NCT02382796|65021861|FG000|Overall Study|Global deterioration of health status|1|||
23349270|NCT02382796|65021861|FG000|Overall Study|Objective progression or relapse|3|||
23349271|NCT02382796|65021861|FG000|Overall Study|Commercial dacomitinib became available|3|||
23349272|NCT00423189|65021862|FG000|Overall Study|Death|0|||
23349273|NCT00423189|65021863|FG001|Overall Study|Death|1|||
23349274|NCT00423189|65021864|FG002|Overall Study|Death|0|||
23349275|NCT03301740|65021865|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
23349276|NCT03301740|65021866|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
23349277|NCT03301740|65021865|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
23349278|NCT03301740|65021866|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
23349279|NCT04150068|65021867|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
23349280|NCT04150068|65021868|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
23349281|NCT04150068|65021869|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
23349282|NCT04150068|65021867|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
23349283|NCT04150068|65021868|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
23349284|NCT04150068|65021869|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
23349285|NCT00084318|65021871|FG000|Overall Study|Withdrawal by Subject|5|||
23349286|NCT00084318|65021872|FG001|Overall Study|Withdrawal by Subject|2|||
23349287|NCT00084318|65021871|FG000|Overall Study|Protocol Violation|15|||
23349288|NCT00084318|65021872|FG001|Overall Study|Protocol Violation|11|||
23349289|NCT00084318|65021871|FG000|Overall Study|No protocol treatment|2|||
23349290|NCT00084318|65021872|FG001|Overall Study|No protocol treatment|0|||
23349291|NCT02667626|65021877|FG000|Overall Study|Withdrawal by Subject|0|||
23349292|NCT02667626|65021878|FG001|Overall Study|Withdrawal by Subject|1|||
23349293|NCT03536949|65021879|FG000|Overall Study|Adverse Event|4|||
23349294|NCT03536949|65021880|FG001|Overall Study|Adverse Event|0|||
23349295|NCT03536949|65021879|FG000|Overall Study|Lost to Follow-up|2|||
23349296|NCT03536949|65021880|FG001|Overall Study|Lost to Follow-up|1|||
23349297|NCT03536949|65021879|FG000|Overall Study|Withdrawal by Subject|6|||
23349298|NCT03536949|65021880|FG001|Overall Study|Withdrawal by Subject|0|||
23349299|NCT03536949|65021879|FG000|Overall Study|Non-compliance|2|||
23460869|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
23349300|NCT03536949|65021880|FG001|Overall Study|Non-compliance|1|||
23349301|NCT03673501|65021881|FG000|Overall Study|Participants ongoing.|36|||
23349302|NCT03673501|65021882|FG001|Overall Study|Participants ongoing.|24|||
23349303|NCT02669082|65021883|FG000|Overall Study|Adverse Event|1|||
23460870|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23460871|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23460872|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
23460873|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
23460874|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
23460875|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
23460876|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460877|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
23460878|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460879|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460880|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
23460881|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
23460882|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
23460883|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
23460884|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Death|0|||
23460885|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Death|0|||
23460886|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Death|43|||
23460887|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Death|44|||
23460888|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460889|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460890|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
23460891|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460892|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
23460893|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
23460894|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
23460895|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
23460896|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
23460897|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
23460898|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
23460899|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
23460900|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460901|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460902|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460903|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
23460904|NCT00561925|65430927|FG000|14 Day Lead-In Period|Adverse Event|38|||
23460905|NCT00561925|65430928|FG001|14 Day Lead-In Period|Adverse Event|0|||
23460906|NCT00561925|65430929|FG002|14 Day Lead-In Period|Adverse Event|0|||
23460907|NCT00561925|65430930|FG003|14 Day Lead-In Period|Adverse Event|0|||
23460908|NCT00561925|65430931|FG004|14 Day Lead-In Period|Adverse Event|0|||
23460909|NCT00561925|65430927|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
23460910|NCT00561925|65430928|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460911|NCT00561925|65430929|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460912|NCT00561925|65430930|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460913|NCT00561925|65430931|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460914|NCT00561925|65430927|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
23460915|NCT00561925|65430928|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
23460916|NCT00561925|65430929|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
23460917|NCT00561925|65430930|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
23460918|NCT00561925|65430931|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
23460919|NCT00561925|65430927|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
23460920|NCT00561925|65430928|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
23460921|NCT00561925|65430929|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
23584525|NCT05305040|65869225|FG000|Overall Study|Withdrawal by Subject|15|||
23584526|NCT05305040|65869226|FG001|Overall Study|Withdrawal by Subject|10|||
23460922|NCT00561925|65430930|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
23460923|NCT00561925|65430931|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
23349304|NCT05385224|65021884|FG000|Overall Study|Unable to swallow capsule|2|||
23349305|NCT05385224|65021884|FG000|Overall Study|Withdrawal by Subject|2|||
23349306|NCT05385224|65021884|FG000|Overall Study|Did not meet study criteria|1|||
23460924|NCT00561925|65430927|FG000|14 Day Lead-In Period|Other|5|||
23460925|NCT00561925|65430928|FG001|14 Day Lead-In Period|Other|0|||
23460926|NCT00561925|65430929|FG002|14 Day Lead-In Period|Other|0|||
23460927|NCT00561925|65430930|FG003|14 Day Lead-In Period|Other|0|||
23460928|NCT00561925|65430931|FG004|14 Day Lead-In Period|Other|0|||
23460929|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
23460930|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
23460931|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
23460932|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
23460933|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
23349307|NCT00561470|65021885|FG000|Overall Study|Adverse Event|74|||
23349308|NCT00561470|65021886|FG001|Overall Study|Adverse Event|163|||
23349309|NCT00561470|65021885|FG000|Overall Study|Disease progression|437|||
23460934|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460935|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
23460936|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
23460937|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460938|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460939|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23460940|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
23349310|NCT00561470|65021886|FG001|Overall Study|Disease progression|305|||
23349311|NCT00561470|65021885|FG000|Overall Study|poor compliance to protocol|4|||
23639368|NCT02636725|66064578|FG000|Overall Study|Adverse Event|1|||
23639369|NCT01205152|66064579|FG000|Overall Study|Death|1|||
23639370|NCT02601300|66064585|FG000|Induction Phase|Lack of Efficacy|2|||
23639371|NCT02601300|66064585|FG000|Induction Phase|Protocol Violation|1|||
23639372|NCT02601300|66064585|FG000|Extension Phase|Withdrawal by Subject|3|||
23639373|NCT02601300|66064585|FG000|Extension Phase|Adverse Event|4|||
23639374|NCT02601300|66064585|FG000|Extension Phase|Lack of Efficacy|10|||
23349312|NCT00561470|65021886|FG001|Overall Study|poor compliance to protocol|4|||
23349313|NCT00561470|65021885|FG000|Overall Study|Lost to Follow-up|2|||
23639375|NCT00436852|66064588|FG000|Overall Study|Death|23|||
23639376|NCT00436852|66064589|FG001|Overall Study|Death|34|||
23639377|NCT00436852|66064588|FG000|Overall Study|Lack of Efficacy|9|||
23639378|NCT00436852|66064589|FG001|Overall Study|Lack of Efficacy|7|||
23639379|NCT00436852|66064588|FG000|Overall Study|Withdrawal by Subject|2|||
23639380|NCT00436852|66064589|FG001|Overall Study|Withdrawal by Subject|4|||
23639381|NCT00436852|66064588|FG000|Overall Study|Ineligible|1|||
23639382|NCT00436852|66064589|FG001|Overall Study|Ineligible|0|||
23639383|NCT02235311|66064591|FG000|Overall Study|Lost to Follow-up|0|||
23639384|NCT02235311|66064592|FG001|Overall Study|Lost to Follow-up|1|||
23639385|NCT02235311|66064591|FG000|Overall Study|Protocol Violation|0|||
23639386|NCT02235311|66064592|FG001|Overall Study|Protocol Violation|1|||
23639387|NCT01796548|66064593|FG000|Overall Study|Lost to Follow-up|1|||
23639388|NCT01796548|66064593|FG000|Overall Study|Other|2|||
23639389|NCT01552603|66064596|FG000|Overall Study|Physician Decision|1|||
23639390|NCT01920932|66064597|FG000|Overall Study|Death|1|||
23639391|NCT01920932|66064597|FG000|Overall Study|Withdrawal of consent|1|||
23788773|NCT00902538|66606173|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23788774|NCT00902538|66606168|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
23788775|NCT00902538|66606169|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
23788776|NCT00902538|66606170|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
23788777|NCT00902538|66606171|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
23788778|NCT00902538|66606172|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
23788779|NCT00902538|66606173|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
23788780|NCT00902538|66606168|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
23788781|NCT00902538|66606169|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
23788782|NCT00902538|66606170|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
23788783|NCT00902538|66606171|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23788784|NCT00902538|66606172|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23788785|NCT00902538|66606173|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23788786|NCT00902538|66606168|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
23788787|NCT00902538|66606169|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
23788788|NCT00902538|66606170|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
23788789|NCT00902538|66606171|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
23788790|NCT00902538|66606172|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
23788791|NCT00902538|66606173|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
23788792|NCT00902538|66606168|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
23788793|NCT00902538|66606169|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
23788794|NCT00902538|66606170|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
23788795|NCT00902538|66606171|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
23788796|NCT00902538|66606172|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
23788797|NCT00902538|66606173|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
23788798|NCT00902538|66606168|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23788799|NCT00902538|66606169|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
23788800|NCT00902538|66606170|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23788801|NCT00902538|66606171|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23788802|NCT00902538|66606172|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23788803|NCT00902538|66606173|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23788804|NCT00902538|66606168|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23788805|NCT00902538|66606169|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
23788806|NCT00902538|66606170|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23788807|NCT00902538|66606171|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23460941|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
23460942|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23639392|NCT04155047|66064600|FG000|Overall Study|Adverse Event|1|||
23639393|NCT04155047|66064601|FG001|Overall Study|Adverse Event|0|||
23349314|NCT00561470|65021886|FG001|Overall Study|Lost to Follow-up|0|||
23349315|NCT00561470|65021885|FG000|Overall Study|Physician Decision|21|||
23349316|NCT00561470|65021886|FG001|Overall Study|Physician Decision|20|||
23349317|NCT00561470|65021885|FG000|Overall Study|Consent Withdrawn|2|||
23349318|NCT00561470|65021886|FG001|Overall Study|Consent Withdrawn|6|||
23349319|NCT00561470|65021885|FG000|Overall Study|Subject request|43|||
23349320|NCT00561470|65021886|FG001|Overall Study|Subject request|77|||
23349321|NCT00561470|65021885|FG000|Overall Study|Metastatic surgery|10|||
23349322|NCT00561470|65021886|FG001|Overall Study|Metastatic surgery|12|||
23349323|NCT00561470|65021885|FG000|Overall Study|Unauthorized procedure|3|||
23349324|NCT00561470|65021886|FG001|Overall Study|Unauthorized procedure|1|||
23349325|NCT00561470|65021885|FG000|Overall Study|Randomized but not treated|5|||
23349326|NCT00561470|65021886|FG001|Overall Study|Randomized but not treated|5|||
23349327|NCT00561470|65021885|FG000|Overall Study|Missed visit window|1|||
23349328|NCT00561470|65021886|FG001|Overall Study|Missed visit window|4|||
23349329|NCT00561470|65021885|FG000|Overall Study|Planning surgery|1|||
23349330|NCT00561470|65021886|FG001|Overall Study|Planning surgery|1|||
23349331|NCT00561470|65021885|FG000|Overall Study|Ongoing Treatment|11|||
23349332|NCT00561470|65021886|FG001|Overall Study|Ongoing Treatment|14|||
23349333|NCT02147067|65021887|FG000|Overall Study|Withdrawal by Subject|2|||
23349334|NCT02147067|65021888|FG001|Overall Study|Withdrawal by Subject|2|||
23349335|NCT01420679|65021889|FG000|Overall Study|Disease Progression|3|||
23349336|NCT01420679|65021890|FG001|Overall Study|Disease Progression|2|||
23349337|NCT01420679|65021889|FG000|Overall Study|Adverse Event|4|||
23349338|NCT01420679|65021890|FG001|Overall Study|Adverse Event|0|||
23349339|NCT01420679|65021889|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
23349340|NCT01420679|65021890|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
23349341|NCT01420679|65021889|FG000|Overall Study|Patient Decision|1|||
23349342|NCT01420679|65021890|FG001|Overall Study|Patient Decision|0|||
23349343|NCT01420679|65021889|FG000|Overall Study|Investigator Decision|1|||
23349344|NCT01420679|65021890|FG001|Overall Study|Investigator Decision|2|||
23639394|NCT04155047|66064600|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
23639395|NCT04155047|66064601|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
23639396|NCT04276415|66064602|FG000|Overall Study|Adverse Event|0|||
23639397|NCT04276415|66064603|FG001|Overall Study|Adverse Event|0|||
23639398|NCT04276415|66064604|FG002|Overall Study|Adverse Event|0|||
23639399|NCT04276415|66064605|FG003|Overall Study|Adverse Event|3|||
23639400|NCT04276415|66064606|FG004|Overall Study|Adverse Event|0|||
23639401|NCT04276415|66064607|FG005|Overall Study|Adverse Event|0|||
23639402|NCT04276415|66064602|FG000|Overall Study|Clinical progression|1|||
23639403|NCT04276415|66064603|FG001|Overall Study|Clinical progression|1|||
23639404|NCT04276415|66064604|FG002|Overall Study|Clinical progression|0|||
23639405|NCT04276415|66064605|FG003|Overall Study|Clinical progression|0|||
23639406|NCT04276415|66064606|FG004|Overall Study|Clinical progression|1|||
23639407|NCT04276415|66064607|FG005|Overall Study|Clinical progression|0|||
23639408|NCT04276415|66064602|FG000|Overall Study|Other|0|||
23639409|NCT04276415|66064603|FG001|Overall Study|Other|0|||
23639410|NCT04276415|66064604|FG002|Overall Study|Other|0|||
23639411|NCT04276415|66064605|FG003|Overall Study|Other|1|||
23349345|NCT01420679|65021889|FG000|Overall Study|Sponsor Decision|3|||
23639412|NCT04276415|66064606|FG004|Overall Study|Other|0|||
23639413|NCT04276415|66064607|FG005|Overall Study|Other|0|||
23788808|NCT00902538|66606172|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23788809|NCT00902538|66606173|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23788810|NCT00902538|66606168|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23788811|NCT00902538|66606169|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23788812|NCT00902538|66606170|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23788813|NCT00902538|66606171|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
23788814|NCT00902538|66606172|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
23788815|NCT00902538|66606173|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
23788816|NCT00902538|66606168|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23349346|NCT01420679|65021890|FG001|Overall Study|Sponsor Decision|3|||
23349347|NCT01420679|65021889|FG000|Overall Study|Other|1|||
23639414|NCT04276415|66064602|FG000|Overall Study|Physician Decision|0|||
23349348|NCT01420679|65021890|FG001|Overall Study|Other|0|||
23349349|NCT02923245|65021891|FG000|Overall Study|ultrasound order was cancelled|2|||
23349350|NCT02923245|65021892|FG001|Overall Study|ultrasound order was cancelled|1|||
23349351|NCT02607280|65021893|FG000|Overall Study|Adverse Event|4|||
23349352|NCT02607280|65021894|FG001|Overall Study|Adverse Event|0|||
23349353|NCT02607280|65021893|FG000|Overall Study|Decrease in CrCl <15|0|||
23639415|NCT04276415|66064603|FG001|Overall Study|Physician Decision|0|||
23639416|NCT04276415|66064604|FG002|Overall Study|Physician Decision|1|||
23349354|NCT02607280|65021894|FG001|Overall Study|Decrease in CrCl <15|1|||
23349355|NCT01877382|65021899|FG000|Dose Escalation|Progressive disease|2|||
23639417|NCT04276415|66064605|FG003|Overall Study|Physician Decision|3|||
23639418|NCT04276415|66064606|FG004|Overall Study|Physician Decision|2|||
23639419|NCT04276415|66064607|FG005|Overall Study|Physician Decision|0|||
23639420|NCT04276415|66064602|FG000|Overall Study|Progressive disease|3|||
23460943|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23460944|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23460945|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
23460946|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
23460947|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23460948|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23584527|NCT05305040|65869225|FG000|Overall Study|Other|13|||
23584528|NCT05305040|65869226|FG001|Overall Study|Other|10|||
23584529|NCT05305040|65869225|FG000|Overall Study|Primary Malignancy Relapse|3|||
23584530|NCT05305040|65869226|FG001|Overall Study|Primary Malignancy Relapse|4|||
23584531|NCT05305040|65869225|FG000|Overall Study|Adverse Event|3|||
23584532|NCT05305040|65869226|FG001|Overall Study|Adverse Event|3|||
23584533|NCT05305040|65869225|FG000|Overall Study|Lost to Follow-up|2|||
23584534|NCT05305040|65869226|FG001|Overall Study|Lost to Follow-up|1|||
23584535|NCT05305040|65869225|FG000|Overall Study|Graft versus host disease|2|||
23584536|NCT05305040|65869226|FG001|Overall Study|Graft versus host disease|0|||
23584537|NCT05305040|65869225|FG000|Overall Study|Investigator's Decision|1|||
23584538|NCT05305040|65869226|FG001|Overall Study|Investigator's Decision|1|||
23584539|NCT05305040|65869225|FG000|Overall Study|COVID-19 Reasons|1|||
23584540|NCT05305040|65869226|FG001|Overall Study|COVID-19 Reasons|0|||
23584541|NCT01972152|65869227|FG000|First Treatment Visit|Lost to Follow-up|0|||
23584542|NCT01972152|65869228|FG001|First Treatment Visit|Lost to Follow-up|1|||
23584543|NCT01972152|65869229|FG002|First Treatment Visit|Lost to Follow-up|0|||
23584544|NCT01972152|65869230|FG003|First Treatment Visit|Lost to Follow-up|0|||
23584545|NCT01972152|65869231|FG004|First Treatment Visit|Lost to Follow-up|0|||
23584546|NCT01972152|65869232|FG005|First Treatment Visit|Lost to Follow-up|0|||
23584547|NCT01972152|65869227|FG000|Second Treatment Visit|Protocol Violation|0|||
23584548|NCT01972152|65869228|FG001|Second Treatment Visit|Protocol Violation|1|||
23584549|NCT01972152|65869229|FG002|Second Treatment Visit|Protocol Violation|0|||
23584550|NCT01972152|65869230|FG003|Second Treatment Visit|Protocol Violation|0|||
23584551|NCT01972152|65869231|FG004|Second Treatment Visit|Protocol Violation|0|||
23584552|NCT01972152|65869232|FG005|Second Treatment Visit|Protocol Violation|0|||
23584553|NCT02499328|65869236|FG000|Overall Study|Withdrawal by Subject|1|||
23584554|NCT02499328|65869237|FG001|Overall Study|Withdrawal by Subject|1|||
23584555|NCT02499328|65869238|FG002|Overall Study|Withdrawal by Subject|5|||
23584556|NCT02499328|65869239|FG003|Overall Study|Withdrawal by Subject|3|||
23584557|NCT02499328|65869240|FG004|Overall Study|Withdrawal by Subject|5|||
23584558|NCT02499328|65869241|FG005|Overall Study|Withdrawal by Subject|0|||
23584559|NCT02499328|65869242|FG006|Overall Study|Withdrawal by Subject|0|||
23584560|NCT02499328|65869243|FG007|Overall Study|Withdrawal by Subject|0|||
23584561|NCT02499328|65869244|FG008|Overall Study|Withdrawal by Subject|2|||
23584562|NCT02499328|65869245|FG009|Overall Study|Withdrawal by Subject|2|||
23584563|NCT02499328|65869246|FG010|Overall Study|Withdrawal by Subject|0|||
23584564|NCT02499328|65869247|FG011|Overall Study|Withdrawal by Subject|3|||
23584565|NCT02499328|65869248|FG012|Overall Study|Withdrawal by Subject|7|||
23584566|NCT02499328|65869249|FG013|Overall Study|Withdrawal by Subject|3|||
23584567|NCT02499328|65869250|FG014|Overall Study|Withdrawal by Subject|1|||
23584568|NCT02499328|65869251|FG015|Overall Study|Withdrawal by Subject|0|||
23584569|NCT02499328|65869252|FG016|Overall Study|Withdrawal by Subject|0|||
23584570|NCT02499328|65869253|FG017|Overall Study|Withdrawal by Subject|3|||
23584571|NCT02499328|65869254|FG018|Overall Study|Withdrawal by Subject|0|||
23584572|NCT02499328|65869236|FG000|Overall Study|Lost to Follow-up|0|||
23584573|NCT02499328|65869237|FG001|Overall Study|Lost to Follow-up|1|||
23584574|NCT02499328|65869238|FG002|Overall Study|Lost to Follow-up|1|||
23584575|NCT02499328|65869239|FG003|Overall Study|Lost to Follow-up|2|||
23584576|NCT02499328|65869240|FG004|Overall Study|Lost to Follow-up|0|||
23584577|NCT02499328|65869241|FG005|Overall Study|Lost to Follow-up|0|||
23584578|NCT02499328|65869242|FG006|Overall Study|Lost to Follow-up|0|||
23584579|NCT02499328|65869243|FG007|Overall Study|Lost to Follow-up|2|||
23584580|NCT02499328|65869244|FG008|Overall Study|Lost to Follow-up|3|||
23788817|NCT00902538|66606169|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23788818|NCT00902538|66606170|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23788819|NCT00902538|66606171|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
23788820|NCT00902538|66606172|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
23788821|NCT00902538|66606173|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23788822|NCT00902538|66606168|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23788823|NCT00902538|66606169|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23788824|NCT00902538|66606170|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23584581|NCT02499328|65869245|FG009|Overall Study|Lost to Follow-up|0|||
23584582|NCT02499328|65869246|FG010|Overall Study|Lost to Follow-up|0|||
23584583|NCT02499328|65869247|FG011|Overall Study|Lost to Follow-up|0|||
23584584|NCT02499328|65869248|FG012|Overall Study|Lost to Follow-up|0|||
23349356|NCT01877382|65021900|FG001|Dose Escalation|Progressive disease|0|||
23349357|NCT01877382|65021901|FG002|Dose Escalation|Progressive disease|1|||
23349358|NCT01877382|65021902|FG003|Dose Escalation|Progressive disease|6|||
23349359|NCT01877382|65021903|FG004|Dose Escalation|Progressive disease|1|||
23349360|NCT01877382|65021904|FG005|Dose Escalation|Progressive disease|0|||
23349361|NCT01877382|65021905|FG006|Dose Escalation|Progressive disease|3|||
23349362|NCT01877382|65021906|FG007|Dose Escalation|Progressive disease|10|||
23349363|NCT01877382|65021907|FG008|Dose Escalation|Progressive disease|4|||
23349364|NCT01877382|65021908|FG009|Dose Escalation|Progressive disease|2|||
23349365|NCT01877382|65021909|FG010|Dose Escalation|Progressive disease|3|||
23349366|NCT01877382|65021910|FG011|Dose Escalation|Progressive disease|3|||
23349367|NCT01877382|65021911|FG012|Dose Escalation|Progressive disease|13|||
23349368|NCT01877382|65021912|FG013|Dose Escalation|Progressive disease|1|||
23349369|NCT01877382|65021913|FG014|Dose Escalation|Progressive disease|0|||
23349370|NCT01877382|65021899|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349371|NCT01877382|65021900|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349372|NCT01877382|65021901|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349373|NCT01877382|65021902|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349374|NCT01877382|65021903|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349375|NCT01877382|65021904|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349376|NCT01877382|65021905|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349377|NCT01877382|65021906|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349378|NCT01877382|65021907|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349379|NCT01877382|65021908|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349380|NCT01877382|65021909|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349381|NCT01877382|65021910|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349382|NCT01877382|65021911|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349383|NCT01877382|65021912|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349384|NCT01877382|65021913|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349385|NCT01877382|65021899|FG000|Dose Escalation|Clinical progression|0|||
23349386|NCT01877382|65021900|FG001|Dose Escalation|Clinical progression|1|||
23349387|NCT01877382|65021901|FG002|Dose Escalation|Clinical progression|0|||
23349388|NCT01877382|65021902|FG003|Dose Escalation|Clinical progression|2|||
23349389|NCT01877382|65021903|FG004|Dose Escalation|Clinical progression|0|||
23349390|NCT01877382|65021904|FG005|Dose Escalation|Clinical progression|0|||
23349391|NCT01877382|65021905|FG006|Dose Escalation|Clinical progression|1|||
23788825|NCT00902538|66606171|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
23788826|NCT00902538|66606172|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23788827|NCT00902538|66606173|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23788828|NCT00660660|66606174|FG000|Overall Study|Adverse Event|1|||
23788829|NCT00660660|66606175|FG001|Overall Study|Adverse Event|0|||
23788830|NCT00660660|66606174|FG000|Overall Study|Lost to Follow-up|0|||
23788831|NCT00660660|66606175|FG001|Overall Study|Lost to Follow-up|6|||
23788832|NCT00660660|66606174|FG000|Overall Study|Lack of Efficacy|0|||
23788833|NCT00660660|66606175|FG001|Overall Study|Lack of Efficacy|2|||
23788834|NCT00660660|66606174|FG000|Overall Study|Withdrawal by Subject|3|||
23788835|NCT00660660|66606175|FG001|Overall Study|Withdrawal by Subject|0|||
23788836|NCT00660660|66606174|FG000|Overall Study|Incorrect enrollment and other|0|||
23788837|NCT00660660|66606175|FG001|Overall Study|Incorrect enrollment and other|1|||
23788838|NCT00660660|66606174|FG000|Overall Study|New medication after randomization|1|||
23349392|NCT01877382|65021906|FG007|Dose Escalation|Clinical progression|0|||
23349393|NCT01877382|65021907|FG008|Dose Escalation|Clinical progression|0|||
23349394|NCT01877382|65021908|FG009|Dose Escalation|Clinical progression|1|||
23349395|NCT01877382|65021909|FG010|Dose Escalation|Clinical progression|0|||
23349396|NCT01877382|65021910|FG011|Dose Escalation|Clinical progression|0|||
23349397|NCT01877382|65021911|FG012|Dose Escalation|Clinical progression|2|||
23349398|NCT01877382|65021912|FG013|Dose Escalation|Clinical progression|1|||
23349399|NCT01877382|65021913|FG014|Dose Escalation|Clinical progression|0|||
23349400|NCT01877382|65021899|FG000|Dose Escalation|Adverse Event|0|||
23788839|NCT00660660|66606175|FG001|Overall Study|New medication after randomization|0|||
23788840|NCT01528735|66606180|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
23584585|NCT02499328|65869249|FG013|Overall Study|Lost to Follow-up|0|||
23584586|NCT02499328|65869250|FG014|Overall Study|Lost to Follow-up|0|||
23584587|NCT02499328|65869251|FG015|Overall Study|Lost to Follow-up|0|||
23584588|NCT02499328|65869252|FG016|Overall Study|Lost to Follow-up|0|||
23584589|NCT02499328|65869253|FG017|Overall Study|Lost to Follow-up|0|||
23584590|NCT02499328|65869254|FG018|Overall Study|Lost to Follow-up|1|||
23584591|NCT02499328|65869236|FG000|Overall Study|Death|0|||
23584592|NCT02499328|65869237|FG001|Overall Study|Death|3|||
23584593|NCT02499328|65869238|FG002|Overall Study|Death|3|||
23584594|NCT02499328|65869239|FG003|Overall Study|Death|2|||
23584595|NCT02499328|65869240|FG004|Overall Study|Death|4|||
23584596|NCT02499328|65869241|FG005|Overall Study|Death|7|||
23584597|NCT02499328|65869242|FG006|Overall Study|Death|3|||
23584598|NCT02499328|65869243|FG007|Overall Study|Death|0|||
23584599|NCT02499328|65869244|FG008|Overall Study|Death|2|||
23584600|NCT02499328|65869245|FG009|Overall Study|Death|6|||
23584601|NCT02499328|65869246|FG010|Overall Study|Death|6|||
23584602|NCT02499328|65869247|FG011|Overall Study|Death|20|||
23584603|NCT02499328|65869248|FG012|Overall Study|Death|9|||
23584604|NCT02499328|65869249|FG013|Overall Study|Death|7|||
23584605|NCT02499328|65869250|FG014|Overall Study|Death|3|||
23584606|NCT02499328|65869251|FG015|Overall Study|Death|1|||
23584607|NCT02499328|65869252|FG016|Overall Study|Death|1|||
23584608|NCT02499328|65869253|FG017|Overall Study|Death|16|||
23584609|NCT02499328|65869254|FG018|Overall Study|Death|5|||
23584610|NCT02499328|65869236|FG000|Overall Study|"Other"|2|||
23584611|NCT02499328|65869237|FG001|Overall Study|"Other"|2|||
23584612|NCT02499328|65869238|FG002|Overall Study|"Other"|1|||
23584613|NCT02499328|65869239|FG003|Overall Study|"Other"|3|||
23584614|NCT02499328|65869240|FG004|Overall Study|"Other"|6|||
23639421|NCT04276415|66064603|FG001|Overall Study|Progressive disease|3|||
23639422|NCT04276415|66064604|FG002|Overall Study|Progressive disease|4|||
23639423|NCT04276415|66064605|FG003|Overall Study|Progressive disease|5|||
23639424|NCT04276415|66064606|FG004|Overall Study|Progressive disease|1|||
23639425|NCT04276415|66064607|FG005|Overall Study|Progressive disease|2|||
23639426|NCT04276415|66064602|FG000|Overall Study|Withdrawal by patient|0|||
23639427|NCT04276415|66064603|FG001|Overall Study|Withdrawal by patient|0|||
23639428|NCT04276415|66064604|FG002|Overall Study|Withdrawal by patient|0|||
23788841|NCT01528735|66606181|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
23788842|NCT01528735|66606180|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
23788843|NCT01528735|66606181|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
23788844|NCT01183884|66606182|FG000|Overall Study|Progressive Disease|26|||
23788845|NCT01183884|66606182|FG000|Overall Study|Adverse Event|3|||
23788846|NCT01183884|66606182|FG000|Overall Study|Withdrawal by Subject|1|||
23788847|NCT01183884|66606182|FG000|Overall Study|Other Complicating Disease|3|||
23788848|NCT01183884|66606182|FG000|Overall Study|Not Treated|1|||
23788849|NCT01183884|66606182|FG000|Overall Study|Other|4|||
23788850|NCT02653664|66606184|FG000|Post-Treatment|Withdrawal by Subject|6|||
23788851|NCT02653664|66606185|FG001|Post-Treatment|Withdrawal by Subject|5|||
23788852|NCT02653664|66606186|FG002|Post-Treatment|Withdrawal by Subject|7|||
23788853|NCT02653664|66606184|FG000|Post-Treatment|Lost to Follow-up|8|||
23788854|NCT02653664|66606185|FG001|Post-Treatment|Lost to Follow-up|1|||
23788855|NCT02653664|66606186|FG002|Post-Treatment|Lost to Follow-up|7|||
23639429|NCT04276415|66064605|FG003|Overall Study|Withdrawal by patient|1|||
23639430|NCT04276415|66064606|FG004|Overall Study|Withdrawal by patient|2|||
23639431|NCT04276415|66064607|FG005|Overall Study|Withdrawal by patient|0|||
23584615|NCT02499328|65869241|FG005|Overall Study|"Other"|2|||
23584616|NCT02499328|65869242|FG006|Overall Study|"Other"|3|||
23584617|NCT02499328|65869243|FG007|Overall Study|"Other"|4|||
23584618|NCT02499328|65869244|FG008|Overall Study|"Other"|6|||
23584619|NCT02499328|65869245|FG009|Overall Study|"Other"|16|||
23639432|NCT01253135|66064608|FG000|Original Protocol|Protocol Amendment|15|||
23788856|NCT02653664|66606184|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
23788857|NCT02653664|66606185|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
23788858|NCT02653664|66606186|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
23788859|NCT02653664|66606184|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
23788860|NCT02653664|66606185|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
23788861|NCT02653664|66606186|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
23788862|NCT02653664|66606184|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23788863|NCT02653664|66606185|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
23788864|NCT02653664|66606186|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23788865|NCT02653664|66606184|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
23788866|NCT02653664|66606185|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
23349401|NCT01877382|65021900|FG001|Dose Escalation|Adverse Event|0|||
23349402|NCT01877382|65021901|FG002|Dose Escalation|Adverse Event|0|||
23349403|NCT01877382|65021902|FG003|Dose Escalation|Adverse Event|4|||
23349404|NCT01877382|65021903|FG004|Dose Escalation|Adverse Event|1|||
23349405|NCT01877382|65021904|FG005|Dose Escalation|Adverse Event|2|||
23788867|NCT02653664|66606186|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
23788868|NCT02653664|66606184|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
23788869|NCT02653664|66606185|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
23788870|NCT02653664|66606186|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
23788871|NCT02653664|66606184|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
23788872|NCT02653664|66606185|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
23788873|NCT02653664|66606186|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
23788874|NCT02653664|66606184|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23788875|NCT02653664|66606185|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
23788876|NCT02653664|66606186|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23788877|NCT02653664|66606184|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
23788878|NCT02653664|66606185|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
23788879|NCT02653664|66606186|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
23788880|NCT03123094|66606187|FG000|Overall Study|Withdrawal by Subject|0|||
23788881|NCT03123094|66606188|FG001|Overall Study|Withdrawal by Subject|2|||
23788882|NCT03123094|66606189|FG002|Overall Study|Withdrawal by Subject|1|||
23788883|NCT03123094|66606190|FG003|Overall Study|Withdrawal by Subject|0|||
23788884|NCT03123094|66606191|FG004|Overall Study|Withdrawal by Subject|1|||
23788885|NCT00487695|66606192|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
23788886|NCT00487695|66606193|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
23788887|NCT00487695|66606192|FG000|First Procedure|active wheezing (did not have procedure)|1|||
23788888|NCT00487695|66606193|FG001|First Procedure|active wheezing (did not have procedure)|0|||
23788889|NCT00487695|66606192|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
23788890|NCT00487695|66606193|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
23788891|NCT00487695|66606192|FG000|Second Procedure|active wheezing|0|||
23788892|NCT00487695|66606193|FG001|Second Procedure|active wheezing|1|||
23788893|NCT00487695|66606192|FG000|Second Procedure|Withdrawal by Subject|1|||
23788894|NCT00487695|66606193|FG001|Second Procedure|Withdrawal by Subject|2|||
23788895|NCT02462837|66606196|FG000|Overall Study|pt developed hives|1|||
23788896|NCT02462837|66606197|FG001|Overall Study|pt developed hives|0|||
23349406|NCT01877382|65021905|FG006|Dose Escalation|Adverse Event|1|||
23349407|NCT01877382|65021906|FG007|Dose Escalation|Adverse Event|2|||
23349408|NCT01877382|65021907|FG008|Dose Escalation|Adverse Event|0|||
23349409|NCT01877382|65021908|FG009|Dose Escalation|Adverse Event|0|||
23349410|NCT01877382|65021909|FG010|Dose Escalation|Adverse Event|0|||
23349411|NCT01877382|65021910|FG011|Dose Escalation|Adverse Event|0|||
23788897|NCT02462837|66606196|FG000|Overall Study|Withdrawal by Subject|1|||
23349412|NCT01877382|65021911|FG012|Dose Escalation|Adverse Event|1|||
23349413|NCT01877382|65021912|FG013|Dose Escalation|Adverse Event|0|||
23349414|NCT01877382|65021913|FG014|Dose Escalation|Adverse Event|0|||
23788898|NCT02462837|66606197|FG001|Overall Study|Withdrawal by Subject|0|||
23349415|NCT01877382|65021899|FG000|Dose Escalation|Withdrawal by Subject|0|||
23349416|NCT01877382|65021900|FG001|Dose Escalation|Withdrawal by Subject|0|||
23349417|NCT01877382|65021901|FG002|Dose Escalation|Withdrawal by Subject|0|||
23349418|NCT01877382|65021902|FG003|Dose Escalation|Withdrawal by Subject|0|||
23349419|NCT01877382|65021903|FG004|Dose Escalation|Withdrawal by Subject|0|||
23349420|NCT01877382|65021904|FG005|Dose Escalation|Withdrawal by Subject|3|||
23349421|NCT01877382|65021905|FG006|Dose Escalation|Withdrawal by Subject|2|||
23349422|NCT01877382|65021906|FG007|Dose Escalation|Withdrawal by Subject|1|||
23349423|NCT01877382|65021907|FG008|Dose Escalation|Withdrawal by Subject|1|||
23349424|NCT01877382|65021908|FG009|Dose Escalation|Withdrawal by Subject|0|||
23349425|NCT01877382|65021909|FG010|Dose Escalation|Withdrawal by Subject|0|||
23349426|NCT01877382|65021910|FG011|Dose Escalation|Withdrawal by Subject|0|||
23349427|NCT01877382|65021911|FG012|Dose Escalation|Withdrawal by Subject|0|||
23349428|NCT01877382|65021912|FG013|Dose Escalation|Withdrawal by Subject|0|||
23349429|NCT01877382|65021913|FG014|Dose Escalation|Withdrawal by Subject|0|||
23349430|NCT01877382|65021899|FG000|Dose Escalation|Protocol Violation|0|||
23349431|NCT01877382|65021900|FG001|Dose Escalation|Protocol Violation|0|||
23349432|NCT01877382|65021901|FG002|Dose Escalation|Protocol Violation|0|||
23349433|NCT01877382|65021902|FG003|Dose Escalation|Protocol Violation|0|||
23349434|NCT01877382|65021903|FG004|Dose Escalation|Protocol Violation|0|||
23349435|NCT01877382|65021904|FG005|Dose Escalation|Protocol Violation|0|||
23349436|NCT01877382|65021905|FG006|Dose Escalation|Protocol Violation|1|||
23349437|NCT01877382|65021906|FG007|Dose Escalation|Protocol Violation|0|||
23349438|NCT01877382|65021907|FG008|Dose Escalation|Protocol Violation|0|||
23349439|NCT01877382|65021908|FG009|Dose Escalation|Protocol Violation|0|||
23349440|NCT01877382|65021909|FG010|Dose Escalation|Protocol Violation|0|||
23349441|NCT01877382|65021910|FG011|Dose Escalation|Protocol Violation|0|||
23349442|NCT01877382|65021911|FG012|Dose Escalation|Protocol Violation|0|||
23349443|NCT01877382|65021912|FG013|Dose Escalation|Protocol Violation|0|||
23349444|NCT01877382|65021913|FG014|Dose Escalation|Protocol Violation|0|||
23349445|NCT01877382|65021899|FG000|Dose Escalation|Study terminated by sponsor|0|||
23349446|NCT01877382|65021900|FG001|Dose Escalation|Study terminated by sponsor|0|||
23349447|NCT01877382|65021901|FG002|Dose Escalation|Study terminated by sponsor|0|||
23349448|NCT01877382|65021902|FG003|Dose Escalation|Study terminated by sponsor|0|||
23349449|NCT01877382|65021903|FG004|Dose Escalation|Study terminated by sponsor|0|||
23788899|NCT01395017|66606198|FG000|Overall Study|Lost to Follow-up|1|||
23788900|NCT01395017|66606199|FG001|Overall Study|Lost to Follow-up|0|||
23788901|NCT01395017|66606198|FG000|Overall Study|Adverse Event|26|||
23788902|NCT01395017|66606199|FG001|Overall Study|Adverse Event|12|||
23788903|NCT01395017|66606198|FG000|Overall Study|Physician Decision|11|||
23788904|NCT01395017|66606199|FG001|Overall Study|Physician Decision|15|||
23788905|NCT01395017|66606198|FG000|Overall Study|Withdrawal by Subject|14|||
23788906|NCT01395017|66606199|FG001|Overall Study|Withdrawal by Subject|8|||
23788907|NCT01395017|66606198|FG000|Overall Study|Protocol deviation|1|||
23788908|NCT01395017|66606199|FG001|Overall Study|Protocol deviation|2|||
23788909|NCT01395017|66606198|FG000|Overall Study|Death|4|||
23788910|NCT01395017|66606199|FG001|Overall Study|Death|3|||
23349450|NCT01877382|65021904|FG005|Dose Escalation|Study terminated by sponsor|0|||
23349451|NCT01877382|65021905|FG006|Dose Escalation|Study terminated by sponsor|0|||
23349452|NCT01877382|65021906|FG007|Dose Escalation|Study terminated by sponsor|1|||
23349453|NCT01877382|65021907|FG008|Dose Escalation|Study terminated by sponsor|1|||
23460949|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23788911|NCT01395017|66606198|FG000|Overall Study|Disease progression|42|||
23349454|NCT01877382|65021908|FG009|Dose Escalation|Study terminated by sponsor|0|||
23349455|NCT01877382|65021909|FG010|Dose Escalation|Study terminated by sponsor|0|||
23349456|NCT01877382|65021910|FG011|Dose Escalation|Study terminated by sponsor|0|||
23349457|NCT01877382|65021911|FG012|Dose Escalation|Study terminated by sponsor|3|||
23349458|NCT01877382|65021912|FG013|Dose Escalation|Study terminated by sponsor|0|||
23349459|NCT01877382|65021913|FG014|Dose Escalation|Study terminated by sponsor|0|||
23349460|NCT01877382|65021899|FG000|Dose Escalation|Death|0|||
23349461|NCT01877382|65021900|FG001|Dose Escalation|Death|0|||
23349462|NCT01877382|65021901|FG002|Dose Escalation|Death|0|||
23349463|NCT01877382|65021902|FG003|Dose Escalation|Death|0|||
23349464|NCT01877382|65021903|FG004|Dose Escalation|Death|0|||
23349465|NCT01877382|65021904|FG005|Dose Escalation|Death|0|||
23349466|NCT01877382|65021905|FG006|Dose Escalation|Death|0|||
23349467|NCT01877382|65021906|FG007|Dose Escalation|Death|1|||
23349468|NCT01877382|65021907|FG008|Dose Escalation|Death|0|||
23349469|NCT01877382|65021908|FG009|Dose Escalation|Death|0|||
23349470|NCT01877382|65021909|FG010|Dose Escalation|Death|0|||
23349471|NCT01877382|65021910|FG011|Dose Escalation|Death|0|||
23788912|NCT01395017|66606199|FG001|Overall Study|Disease progression|58|||
23788913|NCT01395017|66606198|FG000|Overall Study|Sponsor discontinued study|1|||
23788914|NCT01395017|66606199|FG001|Overall Study|Sponsor discontinued study|4|||
23349472|NCT01877382|65021911|FG012|Dose Escalation|Death|1|||
23788915|NCT01499043|66606200|FG000|Overall Study|Progressive disease (radiographic)|2|||
23788916|NCT01499043|66606200|FG000|Overall Study|Progressive disease (clinical)|1|||
23788917|NCT01499043|66606200|FG000|Overall Study|Withdrawal by Subject|2|||
23788918|NCT01499043|66606200|FG000|Overall Study|Adverse Event|1|||
23788919|NCT01986647|66606201|FG000|Overall Study|Lost to Follow-up|4|||
23788920|NCT01986647|66606202|FG001|Overall Study|Lost to Follow-up|1|||
23788921|NCT01986647|66606203|FG002|Overall Study|Lost to Follow-up|4|||
23788922|NCT01986647|66606204|FG003|Overall Study|Lost to Follow-up|4|||
23788923|NCT01986647|66606201|FG000|Overall Study|Withdrawal by Subject|1|||
23788924|NCT01986647|66606202|FG001|Overall Study|Withdrawal by Subject|3|||
23788925|NCT01986647|66606203|FG002|Overall Study|Withdrawal by Subject|2|||
23788926|NCT01986647|66606204|FG003|Overall Study|Withdrawal by Subject|3|||
23788927|NCT01986647|66606201|FG000|Overall Study|Health|5|||
23788928|NCT01986647|66606202|FG001|Overall Study|Health|3|||
23788929|NCT01986647|66606203|FG002|Overall Study|Health|6|||
23788930|NCT01986647|66606204|FG003|Overall Study|Health|4|||
23788931|NCT02471807|66606208|FG000|Overall Study|Death|14|||
23788932|NCT02471807|66606208|FG000|Overall Study|Withdrawal by Subject|2|||
23349473|NCT01877382|65021912|FG013|Dose Escalation|Death|1|||
23788933|NCT02471807|66606208|FG000|Overall Study|Explant|5|||
23788934|NCT02471807|66606208|FG000|Overall Study|Lost to Follow-up|1|||
23788935|NCT04388787|66606209|FG000|Blinded Period|Patient could not follow instructions|1|||
23788936|NCT04388787|66606209|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
23788937|NCT03889639|66606221|FG000|Overall Study|Withdrawal by Subject|0|||
23349474|NCT01877382|65021913|FG014|Dose Escalation|Death|0|||
23349475|NCT01877382|65021899|FG000|Dose Expansion|Progressive disease|0|||
23349476|NCT01877382|65021900|FG001|Dose Expansion|Progressive disease|0|||
23349477|NCT01877382|65021901|FG002|Dose Expansion|Progressive disease|0|||
23349478|NCT01877382|65021902|FG003|Dose Expansion|Progressive disease|0|||
23349479|NCT01877382|65021903|FG004|Dose Expansion|Progressive disease|0|||
23349480|NCT01877382|65021904|FG005|Dose Expansion|Progressive disease|0|||
23349481|NCT01877382|65021905|FG006|Dose Expansion|Progressive disease|0|||
23349482|NCT01877382|65021906|FG007|Dose Expansion|Progressive disease|0|||
23349483|NCT01877382|65021907|FG008|Dose Expansion|Progressive disease|0|||
23349484|NCT01877382|65021908|FG009|Dose Expansion|Progressive disease|0|||
23349485|NCT01877382|65021909|FG010|Dose Expansion|Progressive disease|0|||
23349486|NCT01877382|65021910|FG011|Dose Expansion|Progressive disease|0|||
23349487|NCT01877382|65021911|FG012|Dose Expansion|Progressive disease|0|||
23349488|NCT01877382|65021912|FG013|Dose Expansion|Progressive disease|0|||
23460950|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
23460951|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
23460952|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23460953|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23460954|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460955|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
23460956|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
23460957|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460958|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460959|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Death|0|||
23460960|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Death|6|||
23460961|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Death|3|||
23460962|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Death|0|||
23460963|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Death|0|||
23460964|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460965|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
23584620|NCT02499328|65869246|FG010|Overall Study|"Other"|13|||
23584621|NCT02499328|65869247|FG011|Overall Study|"Other"|31|||
23584622|NCT02499328|65869248|FG012|Overall Study|"Other"|8|||
23584623|NCT02499328|65869249|FG013|Overall Study|"Other"|7|||
23584624|NCT02499328|65869250|FG014|Overall Study|"Other"|6|||
23584625|NCT02499328|65869251|FG015|Overall Study|"Other"|0|||
23584626|NCT02499328|65869252|FG016|Overall Study|"Other"|0|||
23584627|NCT02499328|65869253|FG017|Overall Study|"Other"|34|||
23584628|NCT02499328|65869254|FG018|Overall Study|"Other"|43|||
23584629|NCT02499328|65869236|FG000|Overall Study|Disease Progression|0|||
23584630|NCT02499328|65869237|FG001|Overall Study|Disease Progression|0|||
23584631|NCT02499328|65869238|FG002|Overall Study|Disease Progression|0|||
23584632|NCT02499328|65869239|FG003|Overall Study|Disease Progression|0|||
23584633|NCT02499328|65869240|FG004|Overall Study|Disease Progression|0|||
23584634|NCT02499328|65869241|FG005|Overall Study|Disease Progression|0|||
23584635|NCT02499328|65869242|FG006|Overall Study|Disease Progression|1|||
23584636|NCT02499328|65869243|FG007|Overall Study|Disease Progression|0|||
23584637|NCT02499328|65869244|FG008|Overall Study|Disease Progression|1|||
23584638|NCT02499328|65869245|FG009|Overall Study|Disease Progression|0|||
23584639|NCT02499328|65869246|FG010|Overall Study|Disease Progression|1|||
23584640|NCT02499328|65869247|FG011|Overall Study|Disease Progression|0|||
23584641|NCT02499328|65869248|FG012|Overall Study|Disease Progression|0|||
23584642|NCT02499328|65869249|FG013|Overall Study|Disease Progression|0|||
23788938|NCT03889639|66606222|FG001|Overall Study|Withdrawal by Subject|0|||
23788939|NCT03889639|66606223|FG002|Overall Study|Withdrawal by Subject|0|||
23788940|NCT03889639|66606224|FG003|Overall Study|Withdrawal by Subject|0|||
23788941|NCT03889639|66606225|FG004|Overall Study|Withdrawal by Subject|0|||
23788942|NCT03889639|66606226|FG005|Overall Study|Withdrawal by Subject|0|||
23788943|NCT03889639|66606227|FG006|Overall Study|Withdrawal by Subject|0|||
23788944|NCT03889639|66606228|FG007|Overall Study|Withdrawal by Subject|1|||
23788945|NCT02997176|66606231|FG000|Overall Study|Adverse Event|0|||
23788946|NCT02997176|66606232|FG001|Overall Study|Adverse Event|0|||
23788947|NCT02997176|66606233|FG002|Overall Study|Adverse Event|0|||
23788948|NCT02997176|66606234|FG003|Overall Study|Adverse Event|8|||
23788949|NCT02997176|66606231|FG000|Overall Study|Progressive Disease|1|||
23788950|NCT02997176|66606232|FG001|Overall Study|Progressive Disease|0|||
23788951|NCT02997176|66606233|FG002|Overall Study|Progressive Disease|1|||
23788952|NCT02997176|66606234|FG003|Overall Study|Progressive Disease|1|||
23788953|NCT02997176|66606231|FG000|Overall Study|Death|0|||
23460966|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23584643|NCT02499328|65869250|FG014|Overall Study|Disease Progression|0|||
23584644|NCT02499328|65869251|FG015|Overall Study|Disease Progression|0|||
23584645|NCT02499328|65869252|FG016|Overall Study|Disease Progression|0|||
23788954|NCT02997176|66606232|FG001|Overall Study|Death|0|||
23788955|NCT02997176|66606233|FG002|Overall Study|Death|1|||
23460967|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460968|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460969|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Other|0|||
23460970|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Other|8|||
23460971|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Other|11|||
23460972|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Other|0|||
23460973|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Other|0|||
23460974|NCT00561925|65430927|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
23460975|NCT00561925|65430928|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
23460976|NCT00561925|65430929|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
23460977|NCT00561925|65430930|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
23460978|NCT00561925|65430931|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
23460979|NCT04314284|65430934|FG000|Overall Study|Withdrawal by Subject|4|||
23460980|NCT04314284|65430935|FG001|Overall Study|Withdrawal by Subject|7|||
23460981|NCT04314284|65430934|FG000|Overall Study|Consented but did not complete survey|0|||
23460982|NCT04314284|65430935|FG001|Overall Study|Consented but did not complete survey|6|||
23460983|NCT00087152|65430936|FG000|Overall Study|Ineligible|6|||
23460984|NCT01761877|65430937|FG000|Overall Study|Adverse Event|7|||
23460985|NCT01761877|65430938|FG001|Overall Study|Adverse Event|0|||
23460986|NCT01761877|65430937|FG000|Overall Study|Withdrawal by Subject|6|||
23460987|NCT01761877|65430938|FG001|Overall Study|Withdrawal by Subject|4|||
23460988|NCT01761877|65430937|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
23460989|NCT01761877|65430938|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
23460990|NCT01761877|65430937|FG000|Overall Study|Death|0|||
23460991|NCT01761877|65430938|FG001|Overall Study|Death|1|||
23460992|NCT01761877|65430937|FG000|Overall Study|MRI intolerant|1|||
23460993|NCT01761877|65430938|FG001|Overall Study|MRI intolerant|6|||
23460994|NCT02351817|65430939|FG000|Period 1|Adverse Event|1|||
23460995|NCT02351817|65430940|FG001|Period 1|Adverse Event|2|||
23460996|NCT02351817|65430939|FG000|Period 1|Lack of Efficacy|0|||
23460997|NCT02351817|65430940|FG001|Period 1|Lack of Efficacy|1|||
23460998|NCT02351817|65430939|FG000|Period 2|Adverse Event|0|||
23460999|NCT02351817|65430940|FG001|Period 2|Adverse Event|2|||
23461000|NCT02351817|65430939|FG000|Period 2|Protocol Violation|1|||
23461001|NCT02351817|65430940|FG001|Period 2|Protocol Violation|0|||
23461002|NCT02345070|65430943|FG000|Overall Study|Adverse Event|12|||
23461003|NCT02345070|65430944|FG001|Overall Study|Adverse Event|8|||
23461004|NCT02345070|65430945|FG002|Overall Study|Adverse Event|16|||
23461005|NCT02345070|65430943|FG000|Overall Study|Poor compliance to protocol|2|||
23461006|NCT02345070|65430944|FG001|Overall Study|Poor compliance to protocol|0|||
23461007|NCT02345070|65430945|FG002|Overall Study|Poor compliance to protocol|0|||
23461008|NCT02345070|65430943|FG000|Overall Study|Other than specified above|6|||
23461009|NCT02345070|65430944|FG001|Overall Study|Other than specified above|3|||
23461010|NCT02345070|65430945|FG002|Overall Study|Other than specified above|7|||
23461011|NCT01389596|65434737|FG000|Overall Study|Protocol Violation|3|||
23461012|NCT01389596|65434738|FG001|Overall Study|Protocol Violation|4|||
23461013|NCT01389596|65434739|FG002|Overall Study|Protocol Violation|3|||
23461014|NCT01389596|65434737|FG000|Overall Study|Withdrawal by Subject|1|||
23461015|NCT01389596|65434738|FG001|Overall Study|Withdrawal by Subject|2|||
23461016|NCT01389596|65434739|FG002|Overall Study|Withdrawal by Subject|2|||
23461017|NCT01389596|65434737|FG000|Overall Study|Insufficient Clinical Response|3|||
23461018|NCT01389596|65434738|FG001|Overall Study|Insufficient Clinical Response|4|||
23461019|NCT01389596|65434739|FG002|Overall Study|Insufficient Clinical Response|5|||
23461020|NCT01389596|65434737|FG000|Overall Study|Adverse Event|1|||
23461021|NCT01389596|65434738|FG001|Overall Study|Adverse Event|4|||
23461022|NCT01389596|65434739|FG002|Overall Study|Adverse Event|0|||
23461023|NCT01389596|65434737|FG000|Overall Study|Death|0|||
23461024|NCT01389596|65434738|FG001|Overall Study|Death|1|||
23349489|NCT01877382|65021913|FG014|Dose Expansion|Progressive disease|11|||
23349490|NCT01877382|65021899|FG000|Dose Expansion|Clinical progression|0|||
23349491|NCT01877382|65021900|FG001|Dose Expansion|Clinical progression|0|||
23349492|NCT01877382|65021901|FG002|Dose Expansion|Clinical progression|0|||
23349493|NCT01877382|65021902|FG003|Dose Expansion|Clinical progression|0|||
23349494|NCT01877382|65021903|FG004|Dose Expansion|Clinical progression|0|||
23349495|NCT01877382|65021904|FG005|Dose Expansion|Clinical progression|0|||
23349496|NCT01877382|65021905|FG006|Dose Expansion|Clinical progression|0|||
23349497|NCT01877382|65021906|FG007|Dose Expansion|Clinical progression|0|||
23349498|NCT01877382|65021907|FG008|Dose Expansion|Clinical progression|0|||
23461025|NCT01389596|65434739|FG002|Overall Study|Death|0|||
23461026|NCT01389596|65434737|FG000|Overall Study|Other Unspecified|2|||
23461027|NCT01389596|65434738|FG001|Overall Study|Other Unspecified|1|||
23461028|NCT01389596|65434739|FG002|Overall Study|Other Unspecified|0|||
23461029|NCT03413891|65434742|FG000|Overall Study|Lost to Follow-up|2|||
23461030|NCT03413891|65434743|FG001|Overall Study|Lost to Follow-up|1|||
23349499|NCT01877382|65021908|FG009|Dose Expansion|Clinical progression|0|||
23349500|NCT01877382|65021909|FG010|Dose Expansion|Clinical progression|0|||
23349501|NCT01877382|65021910|FG011|Dose Expansion|Clinical progression|0|||
23349502|NCT01877382|65021911|FG012|Dose Expansion|Clinical progression|0|||
23461031|NCT03413891|65434742|FG000|Overall Study|Protocol Violation|0|||
23461032|NCT03413891|65434743|FG001|Overall Study|Protocol Violation|1|||
23461033|NCT01586364|65434744|FG000|Overall Study|Withdrawal by Subject|40|||
23461034|NCT01586364|65434744|FG000|Overall Study|Adverse Event|37|||
23461035|NCT01586364|65434744|FG000|Overall Study|Lost to Follow-up|17|||
23461036|NCT01586364|65434744|FG000|Overall Study|Protocol Violation|16|||
23461037|NCT01586364|65434744|FG000|Overall Study|Lack of Efficacy|1|||
23461038|NCT01586364|65434744|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
23461039|NCT01586364|65434744|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
23461040|NCT01586364|65434744|FG000|Overall Study|Other-Site closure due to PI illness|1|||
23461041|NCT01586364|65434744|FG000|Overall Study|Other-PI discretion, site closing|2|||
23461042|NCT01586364|65434744|FG000|Overall Study|Other-Not specified|1|||
23461043|NCT03137381|65434749|FG000|Overall Study|Adverse Event|3|||
23461044|NCT03137381|65434750|FG001|Overall Study|Adverse Event|0|||
23461045|NCT03137381|65434751|FG002|Overall Study|Adverse Event|2|||
23461046|NCT03137381|65434752|FG003|Overall Study|Adverse Event|0|||
23461047|NCT03137381|65434749|FG000|Overall Study|Lost to Follow-up|2|||
23461048|NCT03137381|65434750|FG001|Overall Study|Lost to Follow-up|1|||
23461049|NCT03137381|65434751|FG002|Overall Study|Lost to Follow-up|1|||
23461050|NCT03137381|65434752|FG003|Overall Study|Lost to Follow-up|0|||
23461051|NCT03137381|65434749|FG000|Overall Study|Protocol deviation|1|||
23461052|NCT03137381|65434750|FG001|Overall Study|Protocol deviation|1|||
23461053|NCT03137381|65434751|FG002|Overall Study|Protocol deviation|0|||
23461054|NCT03137381|65434752|FG003|Overall Study|Protocol deviation|1|||
23461055|NCT03137381|65434749|FG000|Overall Study|Withdrawal by Investigator|0|||
23461056|NCT03137381|65434750|FG001|Overall Study|Withdrawal by Investigator|1|||
23461057|NCT03137381|65434751|FG002|Overall Study|Withdrawal by Investigator|1|||
23461058|NCT03137381|65434752|FG003|Overall Study|Withdrawal by Investigator|0|||
23461059|NCT03137381|65434749|FG000|Overall Study|Withdrawal by Subject|3|||
23461060|NCT03137381|65434750|FG001|Overall Study|Withdrawal by Subject|4|||
23461061|NCT03137381|65434751|FG002|Overall Study|Withdrawal by Subject|3|||
23461062|NCT03137381|65434752|FG003|Overall Study|Withdrawal by Subject|0|||
23461063|NCT03137381|65434749|FG000|Overall Study|Pregnancy|0|||
23461064|NCT03137381|65434750|FG001|Overall Study|Pregnancy|0|||
23461065|NCT03137381|65434751|FG002|Overall Study|Pregnancy|1|||
23461066|NCT03137381|65434752|FG003|Overall Study|Pregnancy|0|||
23461067|NCT00966654|65434753|FG000|Overall Study|Study was terminated,PI left institution|12|||
23461068|NCT02557139|65434754|FG000|Overall Study|Significant liver elevation|1|||
23461069|NCT02557139|65434755|FG001|Overall Study|Significant liver elevation|0|||
23461070|NCT02557139|65434756|FG002|Overall Study|Significant liver elevation|1|||
23461071|NCT02557139|65434754|FG000|Overall Study|Withdrawal by Subject|1|||
23461072|NCT02557139|65434755|FG001|Overall Study|Withdrawal by Subject|0|||
23461073|NCT02557139|65434756|FG002|Overall Study|Withdrawal by Subject|0|||
23461074|NCT02557139|65434754|FG000|Overall Study|Illness of prohibited medication|0|||
23461075|NCT02557139|65434755|FG001|Overall Study|Illness of prohibited medication|0|||
23461076|NCT02557139|65434756|FG002|Overall Study|Illness of prohibited medication|1|||
23461077|NCT00812708|65434760|FG000|Overall Study|Device could not be implanted|2|||
23461078|NCT00812708|65434760|FG000|Overall Study|Lack of medical insurance|1|||
23461079|NCT00812708|65434760|FG000|Overall Study|Switched to another study|1|||
23461080|NCT00812708|65434760|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
23461081|NCT00812708|65434760|FG000|Overall Study|Signed consent but later withdrew|3|||
23461082|NCT05038982|65434764|FG000|Overall Study|Withdrawal by Subject|0|||
23461083|NCT05038982|65434765|FG001|Overall Study|Withdrawal by Subject|2|||
23461084|NCT05050318|65434770|FG000|Overall Study|Protocol Deviation|1|||
23461085|NCT05050318|65434771|FG001|Overall Study|Protocol Deviation|0|||
23461086|NCT05050318|65434772|FG002|Overall Study|Protocol Deviation|0|||
23461087|NCT03592186|65434773|FG000|Overall Study|Withdrawal by Subject|1|||
23461088|NCT03592186|65434774|FG001|Overall Study|Withdrawal by Subject|0|||
23461089|NCT03592186|65434773|FG000|Overall Study|Lost to Follow-up|16|||
23461090|NCT03592186|65434774|FG001|Overall Study|Lost to Follow-up|11|||
23788956|NCT02997176|66606234|FG003|Overall Study|Death|1|||
23788957|NCT02997176|66606231|FG000|Overall Study|Withdrawal by Subject|0|||
23788958|NCT02997176|66606232|FG001|Overall Study|Withdrawal by Subject|2|||
23788959|NCT02997176|66606233|FG002|Overall Study|Withdrawal by Subject|0|||
23788960|NCT02997176|66606234|FG003|Overall Study|Withdrawal by Subject|1|||
23788961|NCT01046084|66606235|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
23788962|NCT01046084|66606236|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
23788963|NCT05274763|66606237|FG000|Overall Study|Lost to Follow-up|1|||
23461091|NCT00630838|65434777|FG000|Overall Study|Death|0|||
23461092|NCT00630838|65434778|FG001|Overall Study|Death|1|||
23461093|NCT00630838|65434777|FG000|Overall Study|Lost to Follow-up|0|||
23461094|NCT00630838|65434778|FG001|Overall Study|Lost to Follow-up|1|||
23461095|NCT01198795|65434779|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
23461096|NCT01198795|65434779|FG000|Overall Study|Withdrawal by Subject|17|||
23461097|NCT01198795|65434779|FG000|Overall Study|Lost to Follow-up|15|||
23788964|NCT03248128|66606246|FG000|Overall Study|Lost to Follow-up|1|||
23788965|NCT03248128|66606247|FG001|Overall Study|Lost to Follow-up|0|||
23349503|NCT01877382|65021912|FG013|Dose Expansion|Clinical progression|0|||
23349504|NCT01877382|65021913|FG014|Dose Expansion|Clinical progression|6|||
23349505|NCT01877382|65021899|FG000|Dose Expansion|Adverse Event|0|||
23349506|NCT01877382|65021900|FG001|Dose Expansion|Adverse Event|0|||
23349507|NCT01877382|65021901|FG002|Dose Expansion|Adverse Event|0|||
23349508|NCT01877382|65021902|FG003|Dose Expansion|Adverse Event|0|||
23349509|NCT01877382|65021903|FG004|Dose Expansion|Adverse Event|0|||
23349510|NCT01877382|65021904|FG005|Dose Expansion|Adverse Event|0|||
23349511|NCT01877382|65021905|FG006|Dose Expansion|Adverse Event|0|||
23349512|NCT01877382|65021906|FG007|Dose Expansion|Adverse Event|0|||
23349513|NCT01877382|65021907|FG008|Dose Expansion|Adverse Event|0|||
23349514|NCT01877382|65021908|FG009|Dose Expansion|Adverse Event|0|||
23349515|NCT01877382|65021909|FG010|Dose Expansion|Adverse Event|0|||
23349516|NCT01877382|65021910|FG011|Dose Expansion|Adverse Event|0|||
23349517|NCT01877382|65021911|FG012|Dose Expansion|Adverse Event|0|||
23349518|NCT01877382|65021912|FG013|Dose Expansion|Adverse Event|0|||
23349519|NCT01877382|65021913|FG014|Dose Expansion|Adverse Event|1|||
23349520|NCT01877382|65021899|FG000|Dose Expansion|Death|0|||
23349521|NCT01877382|65021900|FG001|Dose Expansion|Death|0|||
23349522|NCT01877382|65021901|FG002|Dose Expansion|Death|0|||
23349523|NCT01877382|65021902|FG003|Dose Expansion|Death|0|||
23349524|NCT01877382|65021903|FG004|Dose Expansion|Death|0|||
23349525|NCT01877382|65021904|FG005|Dose Expansion|Death|0|||
23788966|NCT03248128|66606246|FG000|Overall Study|Withdrawal by Subject|16|||
23788967|NCT03248128|66606247|FG001|Overall Study|Withdrawal by Subject|14|||
23788968|NCT03248128|66606246|FG000|Overall Study|Site Closed|4|||
23788969|NCT03248128|66606247|FG001|Overall Study|Site Closed|3|||
23788970|NCT03248128|66606246|FG000|Overall Study|Randomized, but did not receive treatment|1|||
23788971|NCT03248128|66606247|FG001|Overall Study|Randomized, but did not receive treatment|3|||
23788972|NCT03246503|66606252|FG000|Overall Study|Lost to Follow-up|23|||
23788973|NCT03246503|66606252|FG000|Overall Study|Withdrawal by Subject|20|||
23788974|NCT03246503|66606252|FG000|Overall Study|Physician Decision|5|||
23788975|NCT03246503|66606252|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
23788976|NCT02911025|66606253|FG000|Overall Study|Lost to Follow-up|3|||
23788977|NCT01158118|66606254|FG000|Overall Study|Screen failure|1|||
23788978|NCT01158118|66606255|FG001|Overall Study|Screen failure|0|||
23788979|NCT01158118|66606254|FG000|Overall Study|Donor match was a screen failure|0|||
23788980|NCT01158118|66606255|FG001|Overall Study|Donor match was a screen failure|1|||
23788981|NCT01158118|66606254|FG000|Overall Study|Suffered stroke prior to transplant|0|||
23788982|NCT01158118|66606255|FG001|Overall Study|Suffered stroke prior to transplant|1|||
23788983|NCT01158118|66606254|FG000|Overall Study|Death|0|||
23788984|NCT01158118|66606255|FG001|Overall Study|Death|1|||
23788985|NCT03314857|66606256|FG000|Overall Study|Death|4|||
23788986|NCT03314857|66606256|FG000|Overall Study|Physician Decision|1|||
23788987|NCT01592240|66606257|FG000|Overall Study|Adverse Event|1|||
23788988|NCT01592240|66606258|FG001|Overall Study|Adverse Event|0|||
23349526|NCT01877382|65021905|FG006|Dose Expansion|Death|0|||
23349527|NCT01877382|65021906|FG007|Dose Expansion|Death|0|||
23349528|NCT01877382|65021907|FG008|Dose Expansion|Death|0|||
23349529|NCT01877382|65021908|FG009|Dose Expansion|Death|0|||
23349530|NCT01877382|65021909|FG010|Dose Expansion|Death|0|||
23349531|NCT01877382|65021910|FG011|Dose Expansion|Death|0|||
23349532|NCT01877382|65021911|FG012|Dose Expansion|Death|0|||
23349533|NCT01877382|65021912|FG013|Dose Expansion|Death|0|||
23349534|NCT01877382|65021913|FG014|Dose Expansion|Death|1|||
23584646|NCT02499328|65869253|FG017|Overall Study|Disease Progression|2|||
23788989|NCT01592240|66606259|FG002|Overall Study|Adverse Event|0|||
23788990|NCT01592240|66606260|FG003|Overall Study|Adverse Event|1|||
23788991|NCT01592240|66606261|FG004|Overall Study|Adverse Event|1|||
23788992|NCT01592240|66606262|FG005|Overall Study|Adverse Event|0|||
23788993|NCT01592240|66606263|FG006|Overall Study|Adverse Event|0|||
23788994|NCT01592240|66606257|FG000|Overall Study|Death|0|||
23788995|NCT01592240|66606258|FG001|Overall Study|Death|1|||
23788996|NCT01592240|66606259|FG002|Overall Study|Death|0|||
23788997|NCT01592240|66606260|FG003|Overall Study|Death|0|||
23788998|NCT01592240|66606261|FG004|Overall Study|Death|0|||
23788999|NCT01592240|66606262|FG005|Overall Study|Death|0|||
23789000|NCT01592240|66606263|FG006|Overall Study|Death|0|||
23789001|NCT01592240|66606257|FG000|Overall Study|Lost to Follow-up|1|||
23789002|NCT01592240|66606258|FG001|Overall Study|Lost to Follow-up|3|||
23789003|NCT01592240|66606259|FG002|Overall Study|Lost to Follow-up|1|||
23789004|NCT01592240|66606260|FG003|Overall Study|Lost to Follow-up|0|||
23789005|NCT01592240|66606261|FG004|Overall Study|Lost to Follow-up|3|||
23789006|NCT01592240|66606262|FG005|Overall Study|Lost to Follow-up|2|||
23789007|NCT01592240|66606263|FG006|Overall Study|Lost to Follow-up|0|||
23789008|NCT01592240|66606257|FG000|Overall Study|Protocol Violation|0|||
23789009|NCT01592240|66606258|FG001|Overall Study|Protocol Violation|0|||
23789010|NCT01592240|66606259|FG002|Overall Study|Protocol Violation|0|||
23789011|NCT01592240|66606260|FG003|Overall Study|Protocol Violation|0|||
23789012|NCT01592240|66606261|FG004|Overall Study|Protocol Violation|0|||
23789013|NCT01592240|66606262|FG005|Overall Study|Protocol Violation|1|||
23789014|NCT01592240|66606263|FG006|Overall Study|Protocol Violation|0|||
23789015|NCT01592240|66606257|FG000|Overall Study|Withdrawal by Subject|0|||
23789016|NCT01592240|66606258|FG001|Overall Study|Withdrawal by Subject|4|||
23789017|NCT01592240|66606259|FG002|Overall Study|Withdrawal by Subject|4|||
23789018|NCT01592240|66606260|FG003|Overall Study|Withdrawal by Subject|1|||
23789019|NCT01592240|66606261|FG004|Overall Study|Withdrawal by Subject|3|||
23789020|NCT01592240|66606262|FG005|Overall Study|Withdrawal by Subject|0|||
23789021|NCT01592240|66606263|FG006|Overall Study|Withdrawal by Subject|2|||
23789022|NCT01592240|66606257|FG000|Overall Study|Other|0|||
23789023|NCT01592240|66606258|FG001|Overall Study|Other|3|||
23789024|NCT01592240|66606259|FG002|Overall Study|Other|1|||
23789025|NCT01592240|66606260|FG003|Overall Study|Other|1|||
23789026|NCT01592240|66606261|FG004|Overall Study|Other|0|||
23789027|NCT01592240|66606262|FG005|Overall Study|Other|0|||
23789028|NCT01592240|66606263|FG006|Overall Study|Other|1|||
23789029|NCT01592240|66606257|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23789030|NCT01592240|66606258|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23789031|NCT01592240|66606259|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
23584647|NCT02499328|65869254|FG018|Overall Study|Disease Progression|0|||
23584648|NCT02499328|65869236|FG000|Overall Study|Adverse Event|1|||
23584649|NCT02499328|65869237|FG001|Overall Study|Adverse Event|0|||
23584650|NCT02499328|65869238|FG002|Overall Study|Adverse Event|0|||
23584651|NCT02499328|65869239|FG003|Overall Study|Adverse Event|1|||
23584652|NCT02499328|65869240|FG004|Overall Study|Adverse Event|0|||
23584653|NCT02499328|65869241|FG005|Overall Study|Adverse Event|0|||
23584654|NCT02499328|65869242|FG006|Overall Study|Adverse Event|0|||
23584655|NCT02499328|65869243|FG007|Overall Study|Adverse Event|0|||
23789032|NCT01592240|66606260|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
23789033|NCT01592240|66606261|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
23789034|NCT01592240|66606262|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
23789035|NCT01592240|66606263|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
23789036|NCT04567329|66606265|FG000|Overall Study|Withdrawal by Subject|5|||
23789037|NCT04567329|66606266|FG001|Overall Study|Withdrawal by Subject|6|||
23789038|NCT04567329|66606265|FG000|Overall Study|Protocol Violation|2|||
23789039|NCT04567329|66606266|FG001|Overall Study|Protocol Violation|3|||
23789040|NCT04567329|66606265|FG000|Overall Study|Discontinued|2|||
23584656|NCT02499328|65869244|FG008|Overall Study|Adverse Event|0|||
23789041|NCT04567329|66606266|FG001|Overall Study|Discontinued|2|||
23789042|NCT04567329|66606265|FG000|Overall Study|Lost to Follow-up|0|||
23789043|NCT04567329|66606266|FG001|Overall Study|Lost to Follow-up|1|||
23584657|NCT02499328|65869245|FG009|Overall Study|Adverse Event|0|||
23584658|NCT02499328|65869246|FG010|Overall Study|Adverse Event|0|||
23584659|NCT02499328|65869247|FG011|Overall Study|Adverse Event|0|||
23584660|NCT02499328|65869248|FG012|Overall Study|Adverse Event|1|||
23584661|NCT02499328|65869249|FG013|Overall Study|Adverse Event|0|||
23584662|NCT02499328|65869250|FG014|Overall Study|Adverse Event|0|||
23584663|NCT02499328|65869251|FG015|Overall Study|Adverse Event|0|||
23789044|NCT04567329|66606265|FG000|Overall Study|Lack of Efficacy|0|||
23789045|NCT04567329|66606266|FG001|Overall Study|Lack of Efficacy|1|||
23789046|NCT01252953|66606267|FG000|Overall Study|Withdrawal by Subject|16|||
23789047|NCT01252953|66606268|FG001|Overall Study|Withdrawal by Subject|17|||
23789048|NCT01252953|66606267|FG000|Overall Study|Lost to Follow-up|22|||
23789049|NCT01252953|66606268|FG001|Overall Study|Lost to Follow-up|21|||
23789050|NCT04203667|66606269|FG000|Overall Study|Withdrawal by Subject|1|||
23789051|NCT04203667|66606269|FG000|Overall Study|Lost to Follow-up|1|||
23789052|NCT04203667|66606269|FG000|Overall Study|Death|1|||
23789053|NCT04203667|66606269|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
23789054|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
23789055|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
23789056|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
23789057|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
23789058|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
23461098|NCT01198795|65434779|FG000|Overall Study|Adverse Event|9|||
23461099|NCT01198795|65434779|FG000|Overall Study|Lack of Efficacy|5|||
23461100|NCT01198795|65434779|FG000|Overall Study|Protocol Violation|2|||
23461101|NCT01198795|65434779|FG000|Overall Study|Other Reason|4|||
23461102|NCT03558737|65434780|FG000|Overall Study|Death|1|||
23461103|NCT03558737|65434781|FG001|Overall Study|Death|1|||
23461104|NCT00744497|65434782|FG000|Overall Study|Withdrawal by Subject|21|||
23461105|NCT00744497|65434783|FG001|Overall Study|Withdrawal by Subject|18|||
23461106|NCT00744497|65434782|FG000|Overall Study|Death|11|||
23461107|NCT00744497|65434783|FG001|Overall Study|Death|9|||
23461108|NCT00744497|65434782|FG000|Overall Study|Lost to Follow-up|4|||
23461109|NCT00744497|65434783|FG001|Overall Study|Lost to Follow-up|2|||
23461110|NCT00744497|65434782|FG000|Overall Study|Poor compliance/noncompliance|9|||
23461111|NCT00744497|65434783|FG001|Overall Study|Poor compliance/noncompliance|5|||
23461112|NCT00744497|65434782|FG000|Overall Study|No longer meets study criteria|7|||
23461113|NCT00744497|65434783|FG001|Overall Study|No longer meets study criteria|3|||
23461114|NCT00744497|65434782|FG000|Overall Study|Administrative Reason By Sponsor|25|||
23461115|NCT00744497|65434783|FG001|Overall Study|Administrative Reason By Sponsor|8|||
23461116|NCT00744497|65434782|FG000|Overall Study|Disease progression|312|||
23461117|NCT00744497|65434783|FG001|Overall Study|Disease progression|219|||
23461118|NCT00744497|65434782|FG000|Overall Study|Study drug toxicity|68|||
23461119|NCT00744497|65434783|FG001|Overall Study|Study drug toxicity|141|||
23461120|NCT00744497|65434782|FG000|Overall Study|Adverse event unrelated to study drug|78|||
23461121|NCT00744497|65434783|FG001|Overall Study|Adverse event unrelated to study drug|122|||
23584664|NCT02499328|65869252|FG016|Overall Study|Adverse Event|0|||
23789059|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
23789060|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
23789061|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
23789062|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
23789063|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
23789064|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
23789065|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
23789066|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
23789067|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
23789068|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
23789069|NCT01139762|66606274|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
23789070|NCT01139762|66606275|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
23789071|NCT01139762|66606276|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
23789072|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
23789073|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
23789074|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
23789075|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Death|0|||
23584665|NCT02499328|65869253|FG017|Overall Study|Adverse Event|0|||
23584666|NCT02499328|65869254|FG018|Overall Study|Adverse Event|0|||
23461122|NCT00744497|65434782|FG000|Overall Study|Patient requested to stop study drug|65|||
23584667|NCT00975806|65869255|FG000|Overall Study|Adverse Event|2|||
23789076|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Death|1|||
23349535|NCT01877382|65021899|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349536|NCT01877382|65021900|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349537|NCT01877382|65021901|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349538|NCT01877382|65021902|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349539|NCT01877382|65021903|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349540|NCT01877382|65021904|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349541|NCT01877382|65021905|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349542|NCT01877382|65021906|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349543|NCT01877382|65021907|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349544|NCT01877382|65021908|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349545|NCT01877382|65021909|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349546|NCT01877382|65021910|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349547|NCT01877382|65021911|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349548|NCT01877382|65021912|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349549|NCT01877382|65021913|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349550|NCT01712334|65021914|FG000|Treatment Period 1|Randomized in Error|0|||
23349551|NCT01712334|65021915|FG001|Treatment Period 1|Randomized in Error|2|||
23789077|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Death|1|||
23789078|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
23789079|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
23789080|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
23789081|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
23789082|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
23789083|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
23789084|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
23789085|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
23789086|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
23349552|NCT02655419|65021916|FG000|Overall Study|Enrolled but not treated|1|||
23349553|NCT02655419|65021917|FG001|Overall Study|Enrolled but not treated|5|||
23461123|NCT00744497|65434783|FG001|Overall Study|Patient requested to stop study drug|80|||
23461124|NCT00744497|65434782|FG000|Overall Study|Maximum clinical benefit|141|||
23461125|NCT00744497|65434783|FG001|Overall Study|Maximum clinical benefit|142|||
23461126|NCT00744497|65434782|FG000|Overall Study|Not defined|19|||
23461127|NCT00744497|65434783|FG001|Overall Study|Not defined|13|||
23461128|NCT01457703|65434796|FG000|Overall Study|Screen Failure|5|||
23461129|NCT01457703|65434797|FG001|Overall Study|Screen Failure|7|||
23461130|NCT01457703|65434796|FG000|Overall Study|Withdrawal by Subject|1|||
23461131|NCT01457703|65434797|FG001|Overall Study|Withdrawal by Subject|4|||
23461132|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
23461133|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
23461134|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
23461135|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
23461136|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
23461137|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
23461138|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
23461139|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
23461140|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
23461141|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
23461142|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
23461143|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
23461144|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
23461145|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
23461146|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
23461147|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
23461148|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
23461149|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
23461150|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
23461151|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
23461152|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
23461153|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
23461154|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
23461155|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
23461156|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
23461157|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
23461158|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
23461159|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
23461160|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461161|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461162|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461163|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461164|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461165|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461166|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
23461167|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461168|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461169|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461170|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461171|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461172|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461173|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461174|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Transplant|0|||
23461175|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Transplant|1|||
23461176|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Transplant|0|||
23461177|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Transplant|0|||
23461178|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Transplant|0|||
23461179|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Transplant|1|||
23461180|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Transplant|0|||
23461181|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Transplant|0|||
23461182|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Transplant|0|||
23461183|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Transplant|0|||
23461184|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Transplant|0|||
23461185|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Transplant|0|||
23461186|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Transplant|0|||
23461187|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Transplant|0|||
23461188|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
23461189|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
23461190|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
23461191|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
23461192|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
23461193|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
23461194|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
23461195|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
23461196|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
23461197|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
23461198|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
23461199|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
23461200|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
23461201|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
23461202|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
23461203|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
23461204|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
23461205|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
23461206|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
23461207|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
23461208|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
23461209|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
23461210|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
23461211|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
23461212|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
23461213|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
23461214|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
23461215|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
23461216|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
23461217|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
23461218|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
23461219|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
23461220|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
23461221|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
23461222|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
23461223|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
23461224|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
23461225|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
23461226|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
23461227|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
23461228|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
23461229|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
23461230|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
23461231|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
23461232|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
23461233|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
23461234|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
23461235|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
23461236|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
23461237|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
23461238|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
23461239|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
23461240|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
23461241|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
23461242|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
23461243|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
23461244|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
23584668|NCT00975806|65869256|FG001|Overall Study|Adverse Event|1|||
23584669|NCT00975806|65869257|FG002|Overall Study|Adverse Event|2|||
23584670|NCT00975806|65869255|FG000|Overall Study|Disease Progression|1|||
23461245|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461246|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461247|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461248|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461249|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461250|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461251|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
23461252|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461253|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
23461254|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
23461255|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461256|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461257|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461258|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461259|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461260|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461261|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23584671|NCT00975806|65869256|FG001|Overall Study|Disease Progression|5|||
23584672|NCT00975806|65869257|FG002|Overall Study|Disease Progression|1|||
23349554|NCT02655419|65021916|FG000|Overall Study|Withdrawal by Subject|4|||
23349555|NCT02655419|65021917|FG001|Overall Study|Withdrawal by Subject|1|||
23349556|NCT02655419|65021916|FG000|Overall Study|Other|0|||
23349557|NCT02655419|65021917|FG001|Overall Study|Other|1|||
23402706|NCT03289143|65219984|FG001|Overall Study|Study Terminated By Sponsor|75|||
23402707|NCT03289143|65219985|FG002|Overall Study|Study Terminated By Sponsor|100|||
23402708|NCT03289143|65219986|FG003|Overall Study|Study Terminated By Sponsor|69|||
23402709|NCT03289143|65219983|FG000|Overall Study|Withdrawal by Subject|14|||
23402710|NCT03289143|65219984|FG001|Overall Study|Withdrawal by Subject|6|||
23402711|NCT03289143|65219985|FG002|Overall Study|Withdrawal by Subject|14|||
23402712|NCT03289143|65219986|FG003|Overall Study|Withdrawal by Subject|12|||
23402713|NCT03289143|65219983|FG000|Overall Study|Adverse Event|10|||
23402714|NCT03289143|65219984|FG001|Overall Study|Adverse Event|7|||
23402715|NCT03289143|65219985|FG002|Overall Study|Adverse Event|6|||
23402716|NCT03289143|65219986|FG003|Overall Study|Adverse Event|5|||
23402717|NCT03289143|65219983|FG000|Overall Study|Death|2|||
23402718|NCT03289143|65219984|FG001|Overall Study|Death|0|||
23402719|NCT03289143|65219985|FG002|Overall Study|Death|2|||
23402720|NCT03289143|65219986|FG003|Overall Study|Death|1|||
23402721|NCT03289143|65219983|FG000|Overall Study|Lost to Follow-up|2|||
23402722|NCT03289143|65219984|FG001|Overall Study|Lost to Follow-up|1|||
23402723|NCT03289143|65219985|FG002|Overall Study|Lost to Follow-up|1|||
23402724|NCT03289143|65219986|FG003|Overall Study|Lost to Follow-up|0|||
23402725|NCT03289143|65219983|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
23402726|NCT03289143|65219984|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
23402727|NCT03289143|65219985|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
23402728|NCT03289143|65219986|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
23402729|NCT03289143|65219983|FG000|Overall Study|Withdrawal by Caregiver|0|||
23402730|NCT03289143|65219984|FG001|Overall Study|Withdrawal by Caregiver|1|||
23402731|NCT03289143|65219985|FG002|Overall Study|Withdrawal by Caregiver|0|||
23402732|NCT03289143|65219986|FG003|Overall Study|Withdrawal by Caregiver|0|||
23402733|NCT03289143|65219983|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402734|NCT03289143|65219984|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402735|NCT03289143|65219985|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
23402736|NCT03289143|65219986|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402737|NCT03289143|65219983|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402738|NCT03289143|65219984|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402739|NCT03289143|65219985|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402740|NCT03289143|65219986|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
23402741|NCT01724216|65219987|FG000|Overall Study|Scan was not completed|1|||
23402742|NCT01459666|65219989|FG000|Overall Study|PI left institution|5|||
23402743|NCT01459666|65219990|FG001|Overall Study|PI left institution|4|||
23402744|NCT03745768|65219991|FG000|Overall Study|discontinued study|2|||
23402745|NCT03745768|65219992|FG001|Overall Study|discontinued study|0|||
23402746|NCT01669902|65219993|FG000|Overall Study|Adverse Event|11|||
23349558|NCT02612610|65025241|FG000|Overall Study|Withdrawal by Subject|1|||
23349559|NCT02612610|65025242|FG001|Overall Study|Withdrawal by Subject|1|||
23349560|NCT02612610|65025243|FG002|Overall Study|Withdrawal by Subject|0|||
23349561|NCT02612610|65025244|FG003|Overall Study|Withdrawal by Subject|2|||
23349562|NCT02612610|65025241|FG000|Overall Study|Adverse Event|2|||
23349563|NCT02612610|65025242|FG001|Overall Study|Adverse Event|2|||
23461262|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461263|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461264|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461265|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
23461266|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461267|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
23461268|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461269|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461270|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461271|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461272|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461273|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461274|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461275|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461276|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461277|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461278|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461279|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
23461280|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461281|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461282|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461283|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461284|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461285|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461286|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Transplant|0|||
23461287|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Transplant|0|||
23461288|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Transplant|0|||
23461289|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Transplant|0|||
23461290|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Transplant|0|||
23461291|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Transplant|0|||
23461292|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Transplant|0|||
23584673|NCT00975806|65869255|FG000|Overall Study|Withdrawal by Subject|1|||
23584674|NCT00975806|65869256|FG001|Overall Study|Withdrawal by Subject|0|||
23789087|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
23789088|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
23789089|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
23789090|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
23789091|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
23789092|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
23789093|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
23789094|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
23789095|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
23789096|NCT01139762|66606274|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
23789097|NCT01139762|66606275|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
23789098|NCT01139762|66606276|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
23789099|NCT05004649|66606284|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
23789100|NCT05004649|66606284|FG000|Overall Study|Lost to Follow-up|1|||
23789101|NCT05004649|66606284|FG000|Overall Study|Withdrawal by Subject|2|||
23789102|NCT05004649|66606284|FG000|Overall Study|COVID-19|1|||
23789103|NCT02280863|66606287|FG000|Integrated Platform|Met stopping criteria|0|||
23789104|NCT02280863|66606288|FG001|Integrated Platform|Met stopping criteria|1|||
23789105|NCT00924638|66606290|FG000|Overall Study|Death|3|||
23789106|NCT00924638|66606291|FG001|Overall Study|Death|2|||
23789107|NCT00924638|66606290|FG000|Overall Study|Lost to Follow-up|1|||
23789108|NCT00924638|66606291|FG001|Overall Study|Lost to Follow-up|1|||
23789109|NCT00924638|66606290|FG000|Overall Study|Withdrawal by Subject|5|||
23789110|NCT00924638|66606291|FG001|Overall Study|Withdrawal by Subject|7|||
23789111|NCT00924638|66606290|FG000|Overall Study|Physician Decision|3|||
23789112|NCT00924638|66606291|FG001|Overall Study|Physician Decision|3|||
23349564|NCT02612610|65025243|FG002|Overall Study|Adverse Event|3|||
23584675|NCT00975806|65869257|FG002|Overall Study|Withdrawal by Subject|0|||
23461293|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Transplant|0|||
23461294|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Transplant|0|||
23789113|NCT03888235|66606292|FG000|Overall Study|Lost to Follow-up|1|||
23789114|NCT03888235|66606293|FG001|Overall Study|Lost to Follow-up|1|||
23789115|NCT03888235|66606294|FG002|Overall Study|Lost to Follow-up|0|||
23349565|NCT02612610|65025244|FG003|Overall Study|Adverse Event|10|||
23349566|NCT02612610|65025241|FG000|Overall Study|Lost to Follow-up|0|||
23349567|NCT02612610|65025242|FG001|Overall Study|Lost to Follow-up|1|||
23349568|NCT02612610|65025243|FG002|Overall Study|Lost to Follow-up|0|||
23789116|NCT04892147|66606295|FG000|Overall Study|Withdrawal by Subject|2|||
23789117|NCT04892147|66606296|FG001|Overall Study|Withdrawal by Subject|0|||
23789118|NCT01558635|66606297|FG000|Overall Study|Death|1|||
23789119|NCT01558635|66606297|FG000|Overall Study|Withdrawal by Subject|2|||
23789120|NCT01558635|66606297|FG000|Overall Study|Physician Decision|1|||
23789121|NCT01558635|66606297|FG000|Overall Study|Subject received other treatment|1|||
23789122|NCT01558635|66606297|FG000|Overall Study|Reveal XT was explanted|1|||
23789123|NCT00438633|66606298|FG000|Overall Study|Withdrawal by Subject|1|||
23789124|NCT00438633|66606299|FG001|Overall Study|Withdrawal by Subject|0|||
23789125|NCT00438633|66606298|FG000|Overall Study|Lost to Follow-up|15|||
23789126|NCT00438633|66606299|FG001|Overall Study|Lost to Follow-up|17|||
23789127|NCT01513239|66606302|FG000|Period 1: Main Phase|Adverse Event|1|||
23789128|NCT01513239|66606303|FG001|Period 1: Main Phase|Adverse Event|1|||
23789129|NCT01513239|66606304|FG002|Period 1: Main Phase|Adverse Event|2|||
23789130|NCT01513239|66606305|FG003|Period 1: Main Phase|Adverse Event|0|||
23789131|NCT01513239|66606306|FG004|Period 1: Main Phase|Adverse Event|0|||
23789132|NCT01513239|66606307|FG005|Period 1: Main Phase|Adverse Event|0|||
23789133|NCT01513239|66606302|FG000|Period 1: Main Phase|Death|29|||
23789134|NCT01513239|66606303|FG001|Period 1: Main Phase|Death|22|||
23789135|NCT01513239|66606304|FG002|Period 1: Main Phase|Death|32|||
23789136|NCT01513239|66606305|FG003|Period 1: Main Phase|Death|0|||
23789137|NCT01513239|66606306|FG004|Period 1: Main Phase|Death|0|||
23789138|NCT01513239|66606307|FG005|Period 1: Main Phase|Death|0|||
23789139|NCT01513239|66606302|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
23789140|NCT01513239|66606303|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
23789141|NCT01513239|66606304|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
23789142|NCT01513239|66606305|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
23789143|NCT01513239|66606306|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
23789144|NCT01513239|66606307|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
23789145|NCT01513239|66606302|FG000|Period 1: Main Phase|Physician Decision|4|||
23789146|NCT01513239|66606303|FG001|Period 1: Main Phase|Physician Decision|4|||
23789147|NCT01513239|66606304|FG002|Period 1: Main Phase|Physician Decision|4|||
23789148|NCT01513239|66606305|FG003|Period 1: Main Phase|Physician Decision|0|||
23789149|NCT01513239|66606306|FG004|Period 1: Main Phase|Physician Decision|0|||
23789150|NCT01513239|66606307|FG005|Period 1: Main Phase|Physician Decision|0|||
23789151|NCT01513239|66606302|FG000|Period 1: Main Phase|Protocol Violation|2|||
23789152|NCT01513239|66606303|FG001|Period 1: Main Phase|Protocol Violation|2|||
23789153|NCT01513239|66606304|FG002|Period 1: Main Phase|Protocol Violation|2|||
23789154|NCT01513239|66606305|FG003|Period 1: Main Phase|Protocol Violation|0|||
23789155|NCT01513239|66606306|FG004|Period 1: Main Phase|Protocol Violation|0|||
23789156|NCT01513239|66606307|FG005|Period 1: Main Phase|Protocol Violation|0|||
23789157|NCT01513239|66606302|FG000|Period 1: Main Phase|Technical Problems|1|||
23789158|NCT01513239|66606303|FG001|Period 1: Main Phase|Technical Problems|2|||
23789159|NCT01513239|66606304|FG002|Period 1: Main Phase|Technical Problems|0|||
23789160|NCT01513239|66606305|FG003|Period 1: Main Phase|Technical Problems|0|||
23789161|NCT01513239|66606306|FG004|Period 1: Main Phase|Technical Problems|0|||
23349569|NCT02612610|65025244|FG003|Overall Study|Lost to Follow-up|0|||
23349570|NCT02612610|65025241|FG000|Overall Study|Protocol Violation|0|||
23789162|NCT01513239|66606307|FG005|Period 1: Main Phase|Technical Problems|0|||
23789163|NCT01513239|66606302|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
23789164|NCT01513239|66606303|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
23349571|NCT02612610|65025242|FG001|Overall Study|Protocol Violation|1|||
23349572|NCT02612610|65025243|FG002|Overall Study|Protocol Violation|1|||
23349573|NCT02612610|65025244|FG003|Overall Study|Protocol Violation|0|||
23349574|NCT02612610|65025241|FG000|Overall Study|Lack of Efficacy|1|||
23349575|NCT02612610|65025242|FG001|Overall Study|Lack of Efficacy|2|||
23349576|NCT02612610|65025243|FG002|Overall Study|Lack of Efficacy|0|||
23349577|NCT02612610|65025244|FG003|Overall Study|Lack of Efficacy|1|||
23349578|NCT02612610|65025241|FG000|Overall Study|Physician Decision|0|||
23349579|NCT02612610|65025242|FG001|Overall Study|Physician Decision|1|||
23349580|NCT02612610|65025243|FG002|Overall Study|Physician Decision|0|||
23789165|NCT01513239|66606304|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
23349581|NCT02612610|65025244|FG003|Overall Study|Physician Decision|0|||
23789166|NCT01513239|66606305|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
23789167|NCT01513239|66606306|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
23789168|NCT01513239|66606307|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
23789169|NCT01513239|66606302|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23789170|NCT01513239|66606303|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23789171|NCT01513239|66606304|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23789172|NCT01513239|66606305|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
23789173|NCT01513239|66606306|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
23789174|NCT01513239|66606307|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
23789175|NCT01513239|66606302|FG000|Period 2: 9 Month Extension Phase|Death|0|||
23789176|NCT01513239|66606303|FG001|Period 2: 9 Month Extension Phase|Death|0|||
23789177|NCT01513239|66606304|FG002|Period 2: 9 Month Extension Phase|Death|0|||
23789178|NCT01513239|66606305|FG003|Period 2: 9 Month Extension Phase|Death|2|||
23789179|NCT01513239|66606306|FG004|Period 2: 9 Month Extension Phase|Death|5|||
23789180|NCT01513239|66606307|FG005|Period 2: 9 Month Extension Phase|Death|2|||
23789181|NCT01513239|66606302|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23789182|NCT01513239|66606303|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23789183|NCT01513239|66606304|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23789184|NCT01513239|66606305|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
23789185|NCT01513239|66606306|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
23349582|NCT02612610|65025241|FG000|Overall Study|Noncompliance|1|||
23349583|NCT02612610|65025242|FG001|Overall Study|Noncompliance|0|||
23349584|NCT02612610|65025243|FG002|Overall Study|Noncompliance|0|||
23349585|NCT02612610|65025244|FG003|Overall Study|Noncompliance|0|||
23349586|NCT02612610|65025241|FG000|Overall Study|Cough Improvement|0|||
23349587|NCT02612610|65025242|FG001|Overall Study|Cough Improvement|0|||
23349588|NCT02612610|65025243|FG002|Overall Study|Cough Improvement|1|||
23349589|NCT02612610|65025244|FG003|Overall Study|Cough Improvement|0|||
23349590|NCT00738062|65025245|FG000|Open Label Treatment|Lack of Efficacy|5|||
23349591|NCT00738062|65025246|FG001|Open Label Treatment|Lack of Efficacy|0|||
23349592|NCT00738062|65025247|FG002|Open Label Treatment|Lack of Efficacy|0|||
23349593|NCT00738062|65025245|FG000|Open Label Treatment|Adverse Event|11|||
23349594|NCT00738062|65025246|FG001|Open Label Treatment|Adverse Event|0|||
23349595|NCT00738062|65025247|FG002|Open Label Treatment|Adverse Event|0|||
23349596|NCT00738062|65025245|FG000|Open Label Treatment|Protocol Violation|2|||
23349597|NCT00738062|65025246|FG001|Open Label Treatment|Protocol Violation|0|||
23349598|NCT00738062|65025247|FG002|Open Label Treatment|Protocol Violation|0|||
23349599|NCT00738062|65025245|FG000|Open Label Treatment|Withdrawal by Subject|9|||
23349600|NCT00738062|65025246|FG001|Open Label Treatment|Withdrawal by Subject|0|||
23349601|NCT00738062|65025247|FG002|Open Label Treatment|Withdrawal by Subject|0|||
23349602|NCT00738062|65025245|FG000|Open Label Treatment|Investigator Decision|1|||
23349603|NCT00738062|65025246|FG001|Open Label Treatment|Investigator Decision|0|||
23349604|NCT00738062|65025247|FG002|Open Label Treatment|Investigator Decision|0|||
23349605|NCT00738062|65025245|FG000|Open-Label Extension|Adverse Event|5|||
23349606|NCT00738062|65025246|FG001|Open-Label Extension|Adverse Event|0|||
23349607|NCT00738062|65025247|FG002|Open-Label Extension|Adverse Event|0|||
23349608|NCT00738062|65025245|FG000|Open-Label Extension|Physician Decision|1|||
23349609|NCT00738062|65025246|FG001|Open-Label Extension|Physician Decision|0|||
23349610|NCT00738062|65025247|FG002|Open-Label Extension|Physician Decision|0|||
23349611|NCT00738062|65025245|FG000|Open-Label Extension|Lack of Efficacy|2|||
23349612|NCT00738062|65025246|FG001|Open-Label Extension|Lack of Efficacy|0|||
23349613|NCT00738062|65025247|FG002|Open-Label Extension|Lack of Efficacy|0|||
23349614|NCT00738062|65025245|FG000|Open-Label Extension|Withdrawal by Subject|6|||
23349615|NCT00738062|65025246|FG001|Open-Label Extension|Withdrawal by Subject|0|||
23349616|NCT00738062|65025247|FG002|Open-Label Extension|Withdrawal by Subject|0|||
23349617|NCT00738062|65025245|FG000|Open-Label Extension|Protocol Violation|1|||
23349618|NCT00738062|65025246|FG001|Open-Label Extension|Protocol Violation|0|||
23349619|NCT00738062|65025247|FG002|Open-Label Extension|Protocol Violation|0|||
23789186|NCT01513239|66606307|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23349620|NCT00738062|65025245|FG000|Open-Label Extension|Study Terminated|2|||
23349621|NCT00738062|65025246|FG001|Open-Label Extension|Study Terminated|0|||
23349622|NCT00738062|65025247|FG002|Open-Label Extension|Study Terminated|0|||
23349623|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23349624|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23349625|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23584676|NCT00975806|65869255|FG000|Overall Study|Death|0|||
23584677|NCT00975806|65869256|FG001|Overall Study|Death|1|||
23584678|NCT00975806|65869257|FG002|Overall Study|Death|0|||
23584679|NCT00975806|65869255|FG000|Overall Study|Physician decision and disease related|1|||
23584680|NCT00975806|65869256|FG001|Overall Study|Physician decision and disease related|0|||
23584681|NCT00975806|65869257|FG002|Overall Study|Physician decision and disease related|1|||
23584682|NCT00777556|65869258|FG000|Overall Study|Inappropriate self-selection|34|||
23584683|NCT00777556|65869258|FG000|Overall Study|Dispensed but did not use product|12|||
23639433|NCT01253135|66064608|FG000|Amended Protocol|Non-compliance|1|||
23639434|NCT00777088|66064609|FG000|Overall Study|PED Treatment not attempted|1|||
23639435|NCT03525392|66064610|FG000|Overall Study|Adverse Event|1|||
23639436|NCT03525392|66064611|FG001|Overall Study|Adverse Event|0|||
23639437|NCT03525392|66064612|FG002|Overall Study|Adverse Event|2|||
23639438|NCT03525392|66064613|FG003|Overall Study|Adverse Event|0|||
23639439|NCT03525392|66064614|FG004|Overall Study|Adverse Event|0|||
23639440|NCT03525392|66064610|FG000|Overall Study|Progressive disease|0|||
23639441|NCT03525392|66064611|FG001|Overall Study|Progressive disease|1|||
23789187|NCT01513239|66606302|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23789188|NCT01513239|66606303|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23789189|NCT01513239|66606304|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23789190|NCT01513239|66606305|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
23789191|NCT01513239|66606306|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23789192|NCT01513239|66606307|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23789193|NCT01513239|66606302|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23789194|NCT01513239|66606303|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23789195|NCT01513239|66606304|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23789196|NCT01513239|66606305|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23584684|NCT00777556|65869258|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
23639442|NCT03525392|66064612|FG002|Overall Study|Progressive disease|1|||
23349626|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
23349627|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
23349628|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
23349629|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349630|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
23349631|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349632|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349633|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349634|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349635|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
23349636|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
23349637|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23349638|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23349639|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23789197|NCT01513239|66606306|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
23789198|NCT01513239|66606307|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
23789199|NCT04768114|66606308|FG000|Overall Study|Lost to Follow-up|5|||
23789200|NCT04768114|66606309|FG001|Overall Study|Lost to Follow-up|10|||
23789201|NCT04768114|66606308|FG000|Overall Study|Withdrawal by Subject|0|||
23789202|NCT04768114|66606309|FG001|Overall Study|Withdrawal by Subject|1|||
23789203|NCT02786953|66606313|FG000|Overall Study|Withdrawal by Subject|3|||
23789204|NCT02786953|66606314|FG001|Overall Study|Withdrawal by Subject|0|||
23789205|NCT02786953|66606313|FG000|Overall Study|Physician Decision|0|||
23789206|NCT02786953|66606314|FG001|Overall Study|Physician Decision|1|||
23789207|NCT03439085|66606315|FG000|Overall Study|Death|2|||
23789208|NCT03439085|66606315|FG000|Overall Study|Screen Failure|20|||
23789209|NCT00702507|66606317|FG000|Initial Treatment Phase|Adverse Event|2|||
23789210|NCT00702507|66606317|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
23789211|NCT00702507|66606317|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
23789212|NCT00702507|66606317|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
23349640|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
23349641|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
23349642|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349643|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
23349644|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349645|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349646|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
23461295|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Transplant|4|||
23461296|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Transplant|2|||
23461297|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Transplant|0|||
23584685|NCT01784068|65869262|FG000|NTCS Phase|Adverse Event|5|||
23789213|NCT00702507|66606317|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
23789214|NCT00702507|66606317|FG000|Follow-up Phase|Protocol Violation|2|||
23639443|NCT03525392|66064613|FG003|Overall Study|Progressive disease|3|||
23639444|NCT03525392|66064614|FG004|Overall Study|Progressive disease|1|||
23639445|NCT00789360|66064619|FG000|Overall Study|Protocol Violation|3|||
23639446|NCT00789360|66064620|FG001|Overall Study|Protocol Violation|1|||
23639447|NCT01892540|66064621|FG000|Overall Study|Did not complete PET/MRI|0|||
23639448|NCT01892540|66064622|FG001|Overall Study|Did not complete PET/MRI|0|||
23639449|NCT01892540|66064623|FG002|Overall Study|Did not complete PET/MRI|2|||
23639450|NCT01892540|66064621|FG000|Overall Study|Did not fit in scanner|0|||
23639451|NCT01892540|66064622|FG001|Overall Study|Did not fit in scanner|0|||
23639452|NCT01892540|66064623|FG002|Overall Study|Did not fit in scanner|1|||
23639453|NCT01258595|66064626|FG000|Overall Study|Lost to Follow-up|1|||
23639454|NCT01258595|66064627|FG001|Overall Study|Lost to Follow-up|0|||
23639455|NCT01258595|66064626|FG000|Overall Study|Withdrawal by Subject|0|||
23639456|NCT01258595|66064627|FG001|Overall Study|Withdrawal by Subject|1|||
23639457|NCT02334423|66064628|FG000|Overall Study|Protocol Violation|10|||
23639458|NCT02334423|66064629|FG001|Overall Study|Protocol Violation|3|||
23639459|NCT01008410|66064630|FG000|Overall Study|Adverse Event|13|||
23639460|NCT01008410|66064631|FG001|Overall Study|Adverse Event|7|||
23639461|NCT01008410|66064630|FG000|Overall Study|Withdrawal by Subject|6|||
23639462|NCT01008410|66064631|FG001|Overall Study|Withdrawal by Subject|2|||
23639463|NCT01008410|66064630|FG000|Overall Study|Lost to Follow-up|1|||
23639464|NCT01008410|66064631|FG001|Overall Study|Lost to Follow-up|0|||
23639465|NCT01008410|66064630|FG000|Overall Study|Noncompliance|1|||
23639466|NCT01008410|66064631|FG001|Overall Study|Noncompliance|0|||
23349647|NCT01752634|65025250|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
23584686|NCT01784068|65869263|FG001|NTCS Phase|Adverse Event|0|||
23584687|NCT01784068|65869262|FG000|NTCS Phase|Physician Decision|2|||
23584688|NCT01784068|65869263|FG001|NTCS Phase|Physician Decision|0|||
23584689|NCT01784068|65869262|FG000|NTCS Phase|Patient/guardian decision|3|||
23584690|NCT01784068|65869263|FG001|NTCS Phase|Patient/guardian decision|0|||
23584691|NCT01784068|65869262|FG000|NTCS Phase|Death|2|||
23584692|NCT01784068|65869263|FG001|NTCS Phase|Death|0|||
23584693|NCT01784068|65869262|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
23584694|NCT01784068|65869263|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
23584695|NCT01784068|65869262|FG000|TFR Phase|Physician Decision|0|||
23584696|NCT01784068|65869263|FG001|TFR Phase|Physician Decision|1|||
23584697|NCT01784068|65869262|FG000|TFR Phase|Patient/guardian decision|0|||
23584698|NCT01784068|65869263|FG001|TFR Phase|Patient/guardian decision|3|||
23584699|NCT01784068|65869262|FG000|TFR Phase|Death|0|||
23584700|NCT01784068|65869263|FG001|TFR Phase|Death|1|||
23584701|NCT01784068|65869262|FG000|TFR Phase|Lack of Efficacy|0|||
23584702|NCT01784068|65869263|FG001|TFR Phase|Lack of Efficacy|88|||
23639467|NCT01008410|66064630|FG000|Overall Study|Low Cortisol|2|||
23639468|NCT01008410|66064631|FG001|Overall Study|Low Cortisol|0|||
23639469|NCT01008410|66064630|FG000|Overall Study|Lack of Efficacy|2|||
23789215|NCT00702507|66606317|FG000|Follow-up Phase|Lost to Follow-up|23|||
23789216|NCT00702507|66606317|FG000|Follow-up Phase|Late Enrollment|1|||
23789217|NCT00999687|66606318|FG000|First Intervention|Withdrawal by Subject|1|||
23789218|NCT00999687|66606318|FG000|Second Intervention|Withdrawal by Subject|2|||
23789219|NCT00999687|66606318|FG000|Second Intervention|Lack of Efficacy|1|||
23789220|NCT02957942|66606323|FG000|Overall Study|Withdrawal by Subject|0|||
23789221|NCT02957942|66606324|FG001|Overall Study|Withdrawal by Subject|1|||
23789222|NCT02957942|66606323|FG000|Overall Study|Practicing experiment protocol|0|||
23789223|NCT02957942|66606324|FG001|Overall Study|Practicing experiment protocol|6|||
23789224|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
23789225|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
23789226|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
23789227|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
23789228|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
23789229|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
23789230|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
23789231|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
23789232|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
23789233|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
23584703|NCT01333514|65869264|FG000|Overall Study|Withdrawal by Subject|1|||
23639470|NCT01008410|66064631|FG001|Overall Study|Lack of Efficacy|6|||
23639471|NCT01008410|66064630|FG000|Overall Study|Met Exclusion Criterion|0|||
23639472|NCT01008410|66064631|FG001|Overall Study|Met Exclusion Criterion|1|||
23639473|NCT03339245|66064634|FG000|Overall Study|Adverse Event|1|||
23639474|NCT03339245|66064635|FG001|Overall Study|Adverse Event|1|||
23639475|NCT03339245|66064634|FG000|Overall Study|Withdrawal by Subject|1|||
23639476|NCT03339245|66064635|FG001|Overall Study|Withdrawal by Subject|0|||
23639477|NCT02383940|66064640|FG000|Overall Study|Adverse Event|1|||
23639478|NCT02383940|66064641|FG001|Overall Study|Adverse Event|0|||
23639479|NCT02383940|66064640|FG000|Overall Study|Lost to Follow-up|2|||
23639480|NCT02383940|66064641|FG001|Overall Study|Lost to Follow-up|2|||
23639481|NCT02383940|66064640|FG000|Overall Study|Physician Decision|2|||
23639482|NCT02383940|66064641|FG001|Overall Study|Physician Decision|0|||
23639483|NCT02383940|66064640|FG000|Overall Study|Withdrawal by Subject|1|||
23639484|NCT02383940|66064641|FG001|Overall Study|Withdrawal by Subject|1|||
23639485|NCT02383940|66064640|FG000|Overall Study|Randomized but not treated|2|||
23639486|NCT02383940|66064641|FG001|Overall Study|Randomized but not treated|0|||
23639487|NCT02383940|66064640|FG000|Overall Study|Other than specified above|1|||
23789234|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
23789235|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
23789236|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
23789237|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
23789238|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
23789239|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
23789240|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
23789241|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
23789242|NCT00950300|66606325|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
23789243|NCT00950300|66606326|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
23789244|NCT00950300|66606325|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
23789245|NCT00950300|66606326|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
23789246|NCT00950300|66606325|FG000|TFFU Period|Death|4|||
23789247|NCT00950300|66606326|FG001|TFFU Period|Death|1|||
23789248|NCT00950300|66606325|FG000|TFFU Period|Refused Treatment|10|||
23789249|NCT00950300|66606326|FG001|TFFU Period|Refused Treatment|11|||
23789250|NCT00950300|66606325|FG000|TFFU Period|Failure to Return|16|||
23789251|NCT00950300|66606326|FG001|TFFU Period|Failure to Return|16|||
23789252|NCT00950300|66606325|FG000|TFFU Period|Recurrence of Disease|63|||
23789253|NCT00950300|66606326|FG001|TFFU Period|Recurrence of Disease|72|||
23789254|NCT00950300|66606325|FG000|TFFU Period|Other|4|||
23789255|NCT00950300|66606326|FG001|TFFU Period|Other|3|||
23789256|NCT00950300|66606325|FG000|SFU Period|Death|44|||
23789257|NCT00950300|66606326|FG001|SFU Period|Death|42|||
23789258|NCT00950300|66606325|FG000|SFU Period|Lost to Follow-up|30|||
23789259|NCT00950300|66606326|FG001|SFU Period|Lost to Follow-up|28|||
23789260|NCT00950300|66606325|FG000|SFU Period|Withdrawal by Subject|4|||
23402747|NCT01669902|65219993|FG000|Overall Study|Lack of Efficacy|10|||
23789261|NCT00950300|66606326|FG001|SFU Period|Withdrawal by Subject|8|||
23639488|NCT02383940|66064641|FG001|Overall Study|Other than specified above|0|||
23639489|NCT00710021|66064642|FG000|Overall Study|Lost to Follow-up|1|||
23349648|NCT01752634|65025251|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
23349649|NCT01752634|65025252|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
23349650|NCT01752634|65025253|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
23349651|NCT01752634|65025254|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
23349652|NCT01752634|65025255|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
23461298|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Transplant|0|||
23461299|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Transplant|0|||
23461300|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
23461301|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
23461302|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
23461303|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
23461304|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
23461305|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
23461306|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
23461307|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
23461308|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
23461309|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
23461310|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
23461311|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
23461312|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
23461313|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
23461314|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
23461315|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
23461316|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
23461317|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
23461318|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
23461319|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
23461320|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
23461321|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
23461322|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
23461323|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
23461324|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
23461325|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
23461326|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
23461327|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
23461328|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461329|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461330|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461331|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461332|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461333|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461334|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461335|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461336|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461337|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461338|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461339|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
23461340|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461341|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461342|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461343|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461344|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461345|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461346|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461347|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461348|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461349|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461350|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461351|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461352|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461353|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
23461354|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461355|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461356|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23584704|NCT01333514|65869265|FG001|Overall Study|Withdrawal by Subject|0|||
23584705|NCT02534896|65869266|FG000|Overall Study|Adverse Event|2|||
23789262|NCT02651987|66606335|FG000|Overall Study|Adverse Event|2|||
23789263|NCT02651987|66606336|FG001|Overall Study|Adverse Event|2|||
23789264|NCT02651987|66606335|FG000|Overall Study|Consent Withdrawn|2|||
23789265|NCT02651987|66606336|FG001|Overall Study|Consent Withdrawn|0|||
23789266|NCT02651987|66606335|FG000|Overall Study|Local PD|0|||
23789267|NCT02651987|66606336|FG001|Overall Study|Local PD|2|||
23789268|NCT02651987|66606335|FG000|Overall Study|Investigator Decision|1|||
23349653|NCT01752634|65025250|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
23461357|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461358|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461359|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461360|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461361|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461362|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461363|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461364|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461365|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461366|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461367|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
23461368|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23639490|NCT00710021|66064643|FG001|Overall Study|Lost to Follow-up|0|||
23639491|NCT00710021|66064644|FG002|Overall Study|Lost to Follow-up|0|||
23639492|NCT00710021|66064642|FG000|Overall Study|Subject's Decision|0|||
23639493|NCT00710021|66064643|FG001|Overall Study|Subject's Decision|1|||
23639494|NCT00710021|66064644|FG002|Overall Study|Subject's Decision|0|||
23639495|NCT00710021|66064642|FG000|Overall Study|Subject misrandomized|0|||
23639496|NCT00710021|66064643|FG001|Overall Study|Subject misrandomized|1|||
23639497|NCT00710021|66064644|FG002|Overall Study|Subject misrandomized|1|||
23639498|NCT00710021|66064642|FG000|Overall Study|Physician Decision|0|||
23639499|NCT00710021|66064643|FG001|Overall Study|Physician Decision|1|||
23639500|NCT00710021|66064644|FG002|Overall Study|Physician Decision|0|||
23639501|NCT02624791|66064645|FG000|Overall Study|Withdrawal by Subject|2|||
23639502|NCT02624791|66064646|FG001|Overall Study|Withdrawal by Subject|0|||
23639503|NCT02624791|66064647|FG002|Overall Study|Withdrawal by Subject|0|||
23639504|NCT02624791|66064648|FG003|Overall Study|Withdrawal by Subject|0|||
23639505|NCT02624791|66064649|FG004|Overall Study|Withdrawal by Subject|0|||
23639506|NCT02624791|66064650|FG005|Overall Study|Withdrawal by Subject|0|||
23639507|NCT01853475|66064651|FG000|Overall Study|Withdrawal by Subject|0|||
23639508|NCT01853475|66064652|FG001|Overall Study|Withdrawal by Subject|1|||
23639509|NCT01853475|66064653|FG002|Overall Study|Withdrawal by Subject|0|||
23639510|NCT02703259|66064658|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
23639511|NCT02703259|66064659|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
23639512|NCT02703259|66064658|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
23639513|NCT02703259|66064659|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
23639514|NCT02703259|66064658|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
23639515|NCT02703259|66064659|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
23639516|NCT01281839|66064660|FG000|Overall Study|Lost to Follow-up|6|||
23639517|NCT01281839|66064661|FG001|Overall Study|Lost to Follow-up|3|||
23639518|NCT01281839|66064660|FG000|Overall Study|Withdrawal by Subject|4|||
23639519|NCT01281839|66064661|FG001|Overall Study|Withdrawal by Subject|10|||
23639520|NCT01281839|66064660|FG000|Overall Study|Reason not specified|0|||
23639521|NCT01281839|66064661|FG001|Overall Study|Reason not specified|1|||
23639522|NCT01964924|66064665|FG000|Trametinib Monotherapy|Progression|19|||
23639523|NCT01964924|66064666|FG001|Trametinib Monotherapy|Progression|0|||
23639524|NCT05032872|66064667|FG000|Overall Study|Adverse Event|1|||
23639525|NCT05032872|66064668|FG001|Overall Study|Adverse Event|0|||
23639526|NCT05032872|66064667|FG000|Overall Study|Lost to Follow-up|2|||
23639527|NCT05032872|66064668|FG001|Overall Study|Lost to Follow-up|4|||
23639528|NCT05032872|66064667|FG000|Overall Study|Withdrawal by Subject|4|||
23639529|NCT05032872|66064668|FG001|Overall Study|Withdrawal by Subject|3|||
23639530|NCT01332630|66064669|FG000|Overall Study|Withdrawal by Subject|3|||
23639531|NCT01361594|66064670|FG000|Overall Study|Withdrawal by Subject|1|||
23639532|NCT01361594|66064671|FG001|Overall Study|Withdrawal by Subject|2|||
23639533|NCT03274687|66064672|FG000|Overall Study|Protocol Violation|1|||
23639534|NCT03274687|66064673|FG001|Overall Study|Protocol Violation|1|||
23639535|NCT01484431|66064678|FG000|Period 1: High Dose|Physician Decision|0|||
23639536|NCT01484431|66064679|FG001|Period 1: High Dose|Physician Decision|1|||
23639537|NCT01484431|66064680|FG002|Period 1: High Dose|Physician Decision|0|||
23639538|NCT01484431|66064678|FG000|Period 2|Death|0|||
23639539|NCT01484431|66064679|FG001|Period 2|Death|1|||
23789269|NCT02651987|66606336|FG001|Overall Study|Investigator Decision|1|||
23789270|NCT02704091|66606337|FG000|Overall Study|Adverse Event|4|||
23789271|NCT02704091|66606338|FG001|Overall Study|Adverse Event|3|||
23789272|NCT02704091|66606337|FG000|Overall Study|Protocol Violation|5|||
23789273|NCT02704091|66606338|FG001|Overall Study|Protocol Violation|3|||
23639540|NCT01484431|66064680|FG002|Period 2|Death|1|||
23639541|NCT01484431|66064678|FG000|Period 2|Physician Decision|0|||
23639542|NCT01484431|66064679|FG001|Period 2|Physician Decision|0|||
23461369|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461370|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
23461371|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
23461372|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
23639543|NCT01484431|66064680|FG002|Period 2|Physician Decision|1|||
23461373|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
23461374|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
23461375|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
23461376|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
23461377|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
23461378|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
23461379|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
23461380|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
23461381|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
23461382|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
23461383|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
23461384|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461385|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461386|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461387|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461388|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461389|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461390|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461391|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461392|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461393|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461394|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461395|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461396|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
23461397|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461398|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461399|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461400|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461401|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461402|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461403|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461404|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461405|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461406|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461407|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461408|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461409|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461410|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
23461411|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
23461412|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461413|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461414|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461415|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461416|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461417|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461418|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461419|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461420|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461421|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461422|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461423|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461424|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
23461425|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
23461426|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461427|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461428|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584706|NCT02534896|65869267|FG001|Overall Study|Adverse Event|1|||
23461429|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461430|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461431|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461432|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461433|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461434|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584707|NCT02534896|65869268|FG002|Overall Study|Adverse Event|1|||
23461435|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461436|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461437|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584708|NCT02534896|65869266|FG000|Overall Study|Insufficient therapeutic response|2|||
23639544|NCT01484431|66064678|FG000|Period 2|Non-Compliance with Study Drug|1|||
23639545|NCT01484431|66064679|FG001|Period 2|Non-Compliance with Study Drug|0|||
23639546|NCT01484431|66064680|FG002|Period 2|Non-Compliance with Study Drug|0|||
23461438|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
23461439|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
23461440|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461441|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461442|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461443|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461444|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461445|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461446|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461447|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461448|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461449|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461450|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461451|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461452|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
23461453|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461454|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461455|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461456|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461457|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461458|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461459|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461460|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461461|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461462|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461463|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461464|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461465|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461466|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
23461467|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461468|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461469|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461470|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461471|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461472|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461473|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461474|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461475|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461476|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461477|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461478|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461479|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461480|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
23461481|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461482|NCT02612779|65434815|FG000|Overall Study|Administrative reason by sponsor|4|||
23461483|NCT02612779|65434816|FG001|Overall Study|Administrative reason by sponsor|1|||
23461484|NCT02612779|65434815|FG000|Overall Study|No longer meet study criteria|0|||
23461485|NCT02612779|65434816|FG001|Overall Study|No longer meet study criteria|1|||
23461486|NCT02612779|65434815|FG000|Overall Study|Disease progression|29|||
23461487|NCT02612779|65434816|FG001|Overall Study|Disease progression|2|||
23461488|NCT02612779|65434815|FG000|Overall Study|Study drug toxicity|10|||
23461489|NCT02612779|65434816|FG001|Overall Study|Study drug toxicity|1|||
23461490|NCT02612779|65434815|FG000|Overall Study|Death|1|||
23461491|NCT02612779|65434816|FG001|Overall Study|Death|0|||
23461492|NCT02612779|65434815|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23461493|NCT02612779|65434816|FG001|Overall Study|Adverse event unrelated to study drug|0|||
23461494|NCT02612779|65434815|FG000|Overall Study|Participant withdrew consent|4|||
23461495|NCT02612779|65434816|FG001|Overall Study|Participant withdrew consent|0|||
23461496|NCT02612779|65434815|FG000|Overall Study|Lost to Follow-up|1|||
23461497|NCT02612779|65434816|FG001|Overall Study|Lost to Follow-up|0|||
23461498|NCT02612779|65434815|FG000|Overall Study|Maximum clinical benefit|10|||
23639547|NCT00515853|66064681|FG000|Overall Study|Lost to Follow-up|9|||
23461499|NCT02612779|65434816|FG001|Overall Study|Maximum clinical benefit|1|||
23461500|NCT02612779|65434815|FG000|Overall Study|Other reasons|4|||
23461501|NCT02612779|65434816|FG001|Overall Study|Other reasons|0|||
23639548|NCT00515853|66064682|FG001|Overall Study|Lost to Follow-up|13|||
23639549|NCT00515853|66064681|FG000|Overall Study|Withdrawal by Subject|6|||
23461502|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
23461503|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
23461504|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
23461505|NCT00335777|65434820|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
23461506|NCT00335777|65434820|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
23461507|NCT04944992|65434823|FG000|Overall Study|Lost to Follow-up|1|||
23461508|NCT04944992|65434824|FG001|Overall Study|Lost to Follow-up|1|||
23461509|NCT04944992|65434823|FG000|Overall Study|Physician Decision|1|||
23461510|NCT04944992|65434824|FG001|Overall Study|Physician Decision|0|||
23461511|NCT04944992|65434823|FG000|Overall Study|Withdrawal by Subject|6|||
23461512|NCT04944992|65434824|FG001|Overall Study|Withdrawal by Subject|1|||
23461513|NCT02491684|65434825|FG000|Treatment Phase|Adverse Event|2|||
23461514|NCT02491684|65434826|FG001|Treatment Phase|Adverse Event|2|||
23461515|NCT02491684|65434825|FG000|Treatment Phase|Incorrect randomisation|1|||
23461516|NCT02491684|65434826|FG001|Treatment Phase|Incorrect randomisation|0|||
23461517|NCT02491684|65434825|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
23461518|NCT02491684|65434826|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
23461519|NCT01748292|65434827|FG000|Overall Study|Adverse Event|2|||
23461520|NCT01748292|65434828|FG001|Overall Study|Adverse Event|4|||
23461521|NCT01748292|65434827|FG000|Overall Study|Lost to Follow-up|0|||
23461522|NCT01748292|65434828|FG001|Overall Study|Lost to Follow-up|3|||
23461523|NCT01748292|65434827|FG000|Overall Study|Death|0|||
23461524|NCT01748292|65434828|FG001|Overall Study|Death|3|||
23461525|NCT01748292|65434827|FG000|Overall Study|Withdrawal by Subject|0|||
23461526|NCT01748292|65434828|FG001|Overall Study|Withdrawal by Subject|2|||
23461527|NCT04154904|65434829|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
23461528|NCT04154904|65434830|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
23789274|NCT02704091|66606337|FG000|Overall Study|Consent withdrawn|4|||
23461529|NCT04154904|65434831|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
23461530|NCT03058146|65434832|FG000|Overall Study|Withdrawal by Subject|4|||
23461531|NCT03058146|65434833|FG001|Overall Study|Withdrawal by Subject|1|||
23461532|NCT03058146|65434832|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
23461533|NCT03058146|65434833|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
23461534|NCT00303069|65434834|FG000|Overall Study|Lost to Follow-up|1|||
23461535|NCT00303069|65434835|FG001|Overall Study|Lost to Follow-up|0|||
23461536|NCT00303069|65434836|FG002|Overall Study|Lost to Follow-up|0|||
23461537|NCT00303069|65434837|FG003|Overall Study|Lost to Follow-up|2|||
23461538|NCT00303069|65434834|FG000|Overall Study|subject moved|1|||
23461539|NCT00303069|65434835|FG001|Overall Study|subject moved|0|||
23461540|NCT00303069|65434836|FG002|Overall Study|subject moved|0|||
23461541|NCT00303069|65434837|FG003|Overall Study|subject moved|0|||
23461542|NCT00303069|65434834|FG000|Overall Study|Recruitment into Army Reserves|0|||
23461543|NCT00303069|65434835|FG001|Overall Study|Recruitment into Army Reserves|0|||
23461544|NCT00303069|65434836|FG002|Overall Study|Recruitment into Army Reserves|1|||
23461545|NCT00303069|65434837|FG003|Overall Study|Recruitment into Army Reserves|0|||
23461546|NCT00091949|65434838|FG000|Overall Study|Withdrawal by Subject|117|||
23461547|NCT00091949|65434839|FG001|Overall Study|Withdrawal by Subject|110|||
23461548|NCT00091949|65434838|FG000|Overall Study|Lost to Follow-up|58|||
23461549|NCT00091949|65434839|FG001|Overall Study|Lost to Follow-up|41|||
23461550|NCT02144610|65434840|FG000|Overall Study|Physician Decision|1|||
23461551|NCT02144610|65434841|FG001|Overall Study|Physician Decision|0|||
23461552|NCT02144610|65434840|FG000|Overall Study|Withdrawal by Subject|1|||
23461553|NCT02144610|65434841|FG001|Overall Study|Withdrawal by Subject|5|||
23461554|NCT02144610|65434840|FG000|Overall Study|Death|2|||
23461555|NCT02144610|65434841|FG001|Overall Study|Death|2|||
23461556|NCT02144610|65434840|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
23461557|NCT02144610|65434841|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
23461558|NCT02144610|65434840|FG000|Overall Study|Other|0|||
23461559|NCT02144610|65434841|FG001|Overall Study|Other|1|||
23789275|NCT02704091|66606338|FG001|Overall Study|Consent withdrawn|4|||
23461560|NCT00004563|65434845|FG000|Overall Study|Withdrawal by Subject|20|||
23461561|NCT00004563|65434846|FG001|Overall Study|Withdrawal by Subject|16|||
23461562|NCT00004563|65434845|FG000|Overall Study|Lack of Efficacy|3|||
23461563|NCT00004563|65434846|FG001|Overall Study|Lack of Efficacy|5|||
23461564|NCT00004563|65434845|FG000|Overall Study|Death|2|||
23461565|NCT00004563|65434846|FG001|Overall Study|Death|3|||
23461566|NCT04313244|65434847|FG000|Overall Study|Withdrawal of Consent|3|||
23461567|NCT04313244|65434848|FG001|Overall Study|Withdrawal of Consent|3|||
23461568|NCT04313244|65434847|FG000|Overall Study|Met Exclusion Criteria|1|||
23461569|NCT04313244|65434848|FG001|Overall Study|Met Exclusion Criteria|0|||
23461570|NCT04313244|65434847|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
23461571|NCT04313244|65434848|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
23461572|NCT01217229|65434850|FG000|Overall Study|Adverse Event|1|||
23461573|NCT01217229|65434850|FG000|Overall Study|Disease progression, deterioration|2|||
23461574|NCT01217229|65434850|FG000|Overall Study|Disease progression, Cheson criteria|14|||
23461575|NCT01217229|65434850|FG000|Overall Study|Protocol Violation|1|||
23461576|NCT01217229|65434850|FG000|Overall Study|Disease progression not confirmed|2|||
23461577|NCT00318643|65434853|FG000|Overall Study|Adverse Event|0|||
23461578|NCT00318643|65434854|FG001|Overall Study|Adverse Event|0|||
23461579|NCT00318643|65434855|FG002|Overall Study|Adverse Event|0|||
23461580|NCT00318643|65434856|FG003|Overall Study|Adverse Event|0|||
23461581|NCT00318643|65434857|FG004|Overall Study|Adverse Event|1|||
23461582|NCT00318643|65434853|FG000|Overall Study|Participant's Decision|0|||
23461583|NCT00318643|65434854|FG001|Overall Study|Participant's Decision|0|||
23461584|NCT00318643|65434855|FG002|Overall Study|Participant's Decision|0|||
23461585|NCT00318643|65434856|FG003|Overall Study|Participant's Decision|0|||
23461586|NCT00318643|65434857|FG004|Overall Study|Participant's Decision|1|||
23461587|NCT00318643|65434853|FG000|Overall Study|Investigator's Decision|0|||
23461588|NCT00318643|65434854|FG001|Overall Study|Investigator's Decision|0|||
23461589|NCT00318643|65434855|FG002|Overall Study|Investigator's Decision|0|||
23461590|NCT00318643|65434856|FG003|Overall Study|Investigator's Decision|0|||
23461591|NCT00318643|65434857|FG004|Overall Study|Investigator's Decision|1|||
23461592|NCT00949702|65434858|FG000|Overall Study|Death|40|||
23461593|NCT00949702|65434858|FG000|Overall Study|Disease progression|7|||
23461594|NCT00949702|65434858|FG000|Overall Study|Withdrawal of consent|1|||
23461595|NCT03112603|65434859|FG000|End of Randomization Period|Lost to Follow-up|3|||
23461596|NCT03112603|65434860|FG001|End of Randomization Period|Lost to Follow-up|0|||
23461597|NCT03112603|65434861|FG002|End of Randomization Period|Lost to Follow-up|0|||
23461598|NCT03112603|65434859|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
23461599|NCT03112603|65434860|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
23461600|NCT03112603|65434861|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
23461601|NCT03112603|65434859|FG000|End of Randomization Period|Physician Decision|43|||
23461602|NCT03112603|65434860|FG001|End of Randomization Period|Physician Decision|18|||
23461603|NCT03112603|65434861|FG002|End of Randomization Period|Physician Decision|0|||
23461604|NCT03112603|65434859|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
23461605|NCT03112603|65434860|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
23461606|NCT03112603|65434861|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
23461607|NCT03112603|65434859|FG000|End of Randomization Period|Death|10|||
23461608|NCT03112603|65434860|FG001|End of Randomization Period|Death|7|||
23461609|NCT03112603|65434861|FG002|End of Randomization Period|Death|0|||
23461610|NCT03112603|65434859|FG000|End of Randomization Period|Disease Relapse|12|||
23461611|NCT03112603|65434860|FG001|End of Randomization Period|Disease Relapse|7|||
23461612|NCT03112603|65434861|FG002|End of Randomization Period|Disease Relapse|0|||
23461613|NCT03112603|65434859|FG000|End of Randomization Period|Lack of Efficacy|25|||
23461614|NCT03112603|65434860|FG001|End of Randomization Period|Lack of Efficacy|77|||
23461615|NCT03112603|65434861|FG002|End of Randomization Period|Lack of Efficacy|0|||
23461616|NCT03112603|65434859|FG000|End of Randomization Period|Adverse Event|32|||
23461617|NCT03112603|65434860|FG001|End of Randomization Period|Adverse Event|12|||
23461618|NCT03112603|65434861|FG002|End of Randomization Period|Adverse Event|0|||
23461619|NCT03112603|65434859|FG000|End of Cross Over Period|Death|0|||
23461620|NCT03112603|65434860|FG001|End of Cross Over Period|Death|0|||
23461621|NCT03112603|65434861|FG002|End of Cross Over Period|Death|2|||
23461622|NCT03112603|65434859|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
23461623|NCT03112603|65434860|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
23461624|NCT03112603|65434861|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
23461625|NCT03112603|65434859|FG000|End of Cross Over Period|Physician Decision|0|||
23461626|NCT03112603|65434860|FG001|End of Cross Over Period|Physician Decision|0|||
23789276|NCT02704091|66606337|FG000|Overall Study|Lost to Follow-up|13|||
23789277|NCT02704091|66606338|FG001|Overall Study|Lost to Follow-up|5|||
23789278|NCT02704091|66606337|FG000|Overall Study|Other|2|||
23789279|NCT02704091|66606338|FG001|Overall Study|Other|8|||
23789280|NCT02167594|66606339|FG000|Overall Study|Withdrawal by Subject|2|||
23789281|NCT02167594|66606340|FG001|Overall Study|Withdrawal by Subject|0|||
23789282|NCT02167594|66606341|FG002|Overall Study|Withdrawal by Subject|0|||
23461627|NCT03112603|65434861|FG002|End of Cross Over Period|Physician Decision|29|||
23584709|NCT02534896|65869267|FG001|Overall Study|Insufficient therapeutic response|0|||
23584710|NCT02534896|65869268|FG002|Overall Study|Insufficient therapeutic response|0|||
23584711|NCT03768206|65869269|FG000|Overall Study|Lost to Follow-up|2|||
23584712|NCT03768206|65869270|FG001|Overall Study|Lost to Follow-up|1|||
23789283|NCT02167594|66606339|FG000|Overall Study|Death|0|||
23789284|NCT02167594|66606340|FG001|Overall Study|Death|1|||
23789285|NCT02167594|66606341|FG002|Overall Study|Death|0|||
23789286|NCT03694197|66606342|FG000|Overall Study|Adverse Event|9|||
23789287|NCT03694197|66606342|FG000|Overall Study|Protocol became inconvenient to participate|1|||
23461628|NCT03112603|65434859|FG000|End of Cross Over Period|Lack of Efficacy|0|||
23461629|NCT03112603|65434860|FG001|End of Cross Over Period|Lack of Efficacy|0|||
23461630|NCT03112603|65434861|FG002|End of Cross Over Period|Lack of Efficacy|8|||
23789288|NCT03694197|66606342|FG000|Overall Study|Physician Decision|4|||
23789289|NCT03694197|66606342|FG000|Overall Study|Study terminated by sponsor|1350|||
23789290|NCT03694197|66606342|FG000|Overall Study|Participant moved|5|||
23789291|NCT03694197|66606342|FG000|Overall Study|Participant withdrew consent|10|||
23789292|NCT03694197|66606342|FG000|Overall Study|Related to IMP administration|1|||
23789293|NCT03694197|66606342|FG000|Overall Study|Not disclosed|5|||
23789294|NCT01120028|66606343|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23789295|NCT01120028|66606344|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
23461631|NCT03112603|65434859|FG000|End of Cross Over Period|Adverse Event|0|||
23461632|NCT03112603|65434860|FG001|End of Cross Over Period|Adverse Event|0|||
23461633|NCT03112603|65434861|FG002|End of Cross Over Period|Adverse Event|6|||
23461634|NCT03112603|65434859|FG000|End of Cross Over Period|Disease Relapse|0|||
23461635|NCT03112603|65434860|FG001|End of Cross Over Period|Disease Relapse|0|||
23461636|NCT03112603|65434861|FG002|End of Cross Over Period|Disease Relapse|2|||
23461637|NCT02121535|65434862|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
23461638|NCT02121535|65434863|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
23461639|NCT02121535|65434862|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
23461640|NCT02121535|65434863|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
23461641|NCT01393821|65434866|FG000|Overall Study|Cancel|1|||
23461642|NCT01393821|65434867|FG001|Overall Study|Cancel|1|||
23461643|NCT01393821|65434866|FG000|Overall Study|not evaluable for primary endpoint|4|||
23461644|NCT01393821|65434867|FG001|Overall Study|not evaluable for primary endpoint|2|||
23461645|NCT01907854|65434868|FG000|Overall Study|Protocol Violation|1|||
23461646|NCT01907854|65434869|FG001|Overall Study|Protocol Violation|1|||
23461647|NCT01907854|65434868|FG000|Overall Study|Withdrawal by Subject|9|||
23461648|NCT01907854|65434869|FG001|Overall Study|Withdrawal by Subject|7|||
23461649|NCT01907854|65434868|FG000|Overall Study|Lost to Follow-up|2|||
23461650|NCT01907854|65434869|FG001|Overall Study|Lost to Follow-up|2|||
23461651|NCT01907854|65434868|FG000|Overall Study|Unclassified|4|||
23461652|NCT01907854|65434869|FG001|Overall Study|Unclassified|3|||
23461653|NCT01310777|65434872|FG000|Overall Study|Adverse Event|23|||
23461654|NCT01310777|65434873|FG001|Overall Study|Adverse Event|1|||
23461655|NCT01310777|65434874|FG002|Overall Study|Adverse Event|15|||
23461656|NCT01310777|65434872|FG000|Overall Study|Lost to Follow-up|0|||
23461657|NCT01310777|65434873|FG001|Overall Study|Lost to Follow-up|4|||
23461658|NCT01310777|65434874|FG002|Overall Study|Lost to Follow-up|1|||
23461659|NCT01310777|65434872|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
23461660|NCT01310777|65434873|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
23461661|NCT01310777|65434874|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
23461662|NCT01310777|65434872|FG000|Overall Study|Inadequate Control of IOP|5|||
23461663|NCT01310777|65434873|FG001|Overall Study|Inadequate Control of IOP|7|||
23461664|NCT01310777|65434874|FG002|Overall Study|Inadequate Control of IOP|10|||
23461665|NCT01310777|65434872|FG000|Overall Study|Other|4|||
23461666|NCT01310777|65434873|FG001|Overall Study|Other|1|||
23461667|NCT01310777|65434874|FG002|Overall Study|Other|2|||
23461668|NCT03591406|65434875|FG000|Overall Study|Adverse Event|5|||
23461669|NCT03591406|65434876|FG001|Overall Study|Adverse Event|3|||
23789296|NCT01120028|66606345|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23789297|NCT01120028|66606346|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23789298|NCT01120028|66606343|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
23789299|NCT01120028|66606344|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
23789300|NCT01120028|66606345|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
23789301|NCT01120028|66606346|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
23789302|NCT00101439|66606347|FG000|Period 2|Withdrawal by Subject|0|||
23789303|NCT00101439|66606348|FG001|Period 2|Withdrawal by Subject|2|||
23789304|NCT04133311|66606349|FG000|Period 1 Double Masked Treatment Period|Death|1|||
23789305|NCT04133311|66606350|FG001|Period 1 Double Masked Treatment Period|Death|0|||
23789306|NCT04133311|66606351|FG002|Period 1 Double Masked Treatment Period|Death|0|||
23789307|NCT04133311|66606352|FG003|Period 1 Double Masked Treatment Period|Death|0|||
23789308|NCT04133311|66606349|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
23789309|NCT04133311|66606350|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
23789310|NCT04133311|66606351|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
23789311|NCT04133311|66606352|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
23461670|NCT03591406|65434875|FG000|Overall Study|Protocol Violation|2|||
23461671|NCT03591406|65434876|FG001|Overall Study|Protocol Violation|1|||
23461672|NCT03591406|65434875|FG000|Overall Study|Withdrawal by Subject|0|||
23461673|NCT03591406|65434876|FG001|Overall Study|Withdrawal by Subject|5|||
23461674|NCT00687193|65434877|FG000|Overall Study|Adverse Event|0|||
23461675|NCT00687193|65434878|FG001|Overall Study|Adverse Event|1|||
23461676|NCT00687193|65434879|FG002|Overall Study|Adverse Event|2|||
23461677|NCT00687193|65434880|FG003|Overall Study|Adverse Event|3|||
23461678|NCT00687193|65434881|FG004|Overall Study|Adverse Event|0|||
23461679|NCT00687193|65434882|FG005|Overall Study|Adverse Event|2|||
23461680|NCT00687193|65434877|FG000|Overall Study|Lack of Efficacy|1|||
23461681|NCT00687193|65434878|FG001|Overall Study|Lack of Efficacy|1|||
23461682|NCT00687193|65434879|FG002|Overall Study|Lack of Efficacy|0|||
23461683|NCT00687193|65434880|FG003|Overall Study|Lack of Efficacy|0|||
23461684|NCT00687193|65434881|FG004|Overall Study|Lack of Efficacy|0|||
23461685|NCT00687193|65434882|FG005|Overall Study|Lack of Efficacy|2|||
23461686|NCT00687193|65434877|FG000|Overall Study|Protocol Violation|1|||
23461687|NCT00687193|65434878|FG001|Overall Study|Protocol Violation|2|||
23461688|NCT00687193|65434879|FG002|Overall Study|Protocol Violation|0|||
23461689|NCT00687193|65434880|FG003|Overall Study|Protocol Violation|1|||
23461690|NCT00687193|65434881|FG004|Overall Study|Protocol Violation|2|||
23461691|NCT00687193|65434882|FG005|Overall Study|Protocol Violation|0|||
23461692|NCT01959503|65434883|FG000|Overall Study|Death|2|||
23461693|NCT01959503|65434884|FG001|Overall Study|Death|1|||
23461694|NCT01959503|65434883|FG000|Overall Study|Randomized but not treated|1|||
23461695|NCT01959503|65434884|FG001|Overall Study|Randomized but not treated|1|||
23461696|NCT00914849|65434885|FG000|Overall Study|Withdrawal by Subject|1|||
23461697|NCT00914849|65434886|FG001|Overall Study|Withdrawal by Subject|0|||
23461698|NCT00914849|65434885|FG000|Overall Study|Not eligible|0|||
23461699|NCT00914849|65434886|FG001|Overall Study|Not eligible|1|||
23461700|NCT01046396|65434888|FG000|Overall Study|Withdrawal by Subject|5|||
23461701|NCT01294553|65434889|FG000|Overall Study|Duplicated Participants|1|||
23461702|NCT01294553|65434889|FG000|Overall Study|Protocol Violation|268|||
23461703|NCT02420821|65434890|FG000|Overall Study|Lost to Follow-up|6|||
23461704|NCT02420821|65434891|FG001|Overall Study|Lost to Follow-up|6|||
23461705|NCT02420821|65434890|FG000|Overall Study|Non-compliance|0|||
23461706|NCT02420821|65434891|FG001|Overall Study|Non-compliance|2|||
23461707|NCT02420821|65434890|FG000|Overall Study|Physician Decision|6|||
23461708|NCT02420821|65434891|FG001|Overall Study|Physician Decision|2|||
23461709|NCT02420821|65434890|FG000|Overall Study|Withdrawal by Subject|32|||
23461710|NCT02420821|65434891|FG001|Overall Study|Withdrawal by Subject|25|||
23461711|NCT02420821|65434890|FG000|Overall Study|Death|270|||
23461712|NCT02420821|65434891|FG001|Overall Study|Death|263|||
23461713|NCT02420821|65434890|FG000|Overall Study|Study Terminated By Sponsor|145|||
23789312|NCT04133311|66606349|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
23789313|NCT04133311|66606350|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
23461714|NCT02420821|65434891|FG001|Overall Study|Study Terminated By Sponsor|149|||
23461715|NCT02420821|65434890|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
23461716|NCT02420821|65434891|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
23461717|NCT02420821|65434890|FG000|Overall Study|Adverse Event|0|||
23461718|NCT02420821|65434891|FG001|Overall Study|Adverse Event|1|||
23461719|NCT02420821|65434890|FG000|Overall Study|Protinuria|0|||
23461720|NCT02420821|65434891|FG001|Overall Study|Protinuria|1|||
23461721|NCT02420821|65434890|FG000|Overall Study|Progressive Disease|1|||
23461722|NCT02420821|65434891|FG001|Overall Study|Progressive Disease|1|||
23461723|NCT02420821|65434890|FG000|Overall Study|Disease Progression|0|||
23461724|NCT02420821|65434891|FG001|Overall Study|Disease Progression|1|||
23461725|NCT02420821|65434890|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
23461726|NCT02420821|65434891|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
23461727|NCT00763035|65434895|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
23461728|NCT00763035|65434896|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
23461729|NCT00763035|65434895|FG000|First Intervention|Adverse Event|0|||
23461730|NCT00763035|65434896|FG001|First Intervention|Adverse Event|1|||
23461731|NCT00763035|65434895|FG000|Second Intervention|Adverse Event|1|||
23461732|NCT00763035|65434896|FG001|Second Intervention|Adverse Event|0|||
23461733|NCT00763035|65434895|FG000|Second Intervention|Physician Decision|2|||
23461734|NCT00763035|65434896|FG001|Second Intervention|Physician Decision|0|||
23461735|NCT02158442|65434897|FG000|Overall Study|Withdrawal by Subject|1|||
23461736|NCT02158442|65434898|FG001|Overall Study|Withdrawal by Subject|0|||
23461737|NCT02158442|65434897|FG000|Overall Study|Perfusion staff not available|1|||
23461738|NCT02158442|65434898|FG001|Overall Study|Perfusion staff not available|0|||
23461739|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
23461740|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
23461741|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
23461742|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461743|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461744|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461745|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
23584713|NCT03768206|65869269|FG000|Overall Study|Withdrawal by Subject|0|||
23789314|NCT04133311|66606351|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
23461746|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461747|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23706194|NCT01258348|66301084|FG003|Overall Study|Adverse Event|2|||
23461748|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461749|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461750|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23584714|NCT03768206|65869270|FG001|Overall Study|Withdrawal by Subject|1|||
23461751|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
23461752|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461753|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461754|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461755|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461756|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461757|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
23639550|NCT00515853|66064682|FG001|Overall Study|Withdrawal by Subject|4|||
23639551|NCT01195948|66064683|FG000|Overall Study|Lost to Follow-up|0|||
23639552|NCT01195948|66064684|FG001|Overall Study|Lost to Follow-up|1|||
23639553|NCT01195948|66064685|FG002|Overall Study|Lost to Follow-up|2|||
23789315|NCT04133311|66606352|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
23789316|NCT04133311|66606349|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23789317|NCT04133311|66606350|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
23461758|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
23461759|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
23461760|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461761|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461762|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461763|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461764|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
23461765|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461766|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461767|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461768|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461769|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461770|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
23461771|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461772|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461773|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461774|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461775|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461776|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461777|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461778|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
23461779|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461780|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461781|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461782|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461783|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461784|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
23461785|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
23461786|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
23461787|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461788|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461789|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461790|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
23461791|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
23461792|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
23461793|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461794|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461795|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461796|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
23461797|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
23461798|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461799|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23461800|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23639554|NCT03377699|66064686|FG000|Overall Study|Withdrawal by Subject|2|||
23639555|NCT03377699|66064687|FG001|Overall Study|Withdrawal by Subject|9|||
23789318|NCT04133311|66606351|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23789319|NCT04133311|66606352|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23789320|NCT04133311|66606349|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
23789321|NCT04133311|66606350|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
23349654|NCT01752634|65025251|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
23349655|NCT01752634|65025252|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
23461801|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23461802|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
23461803|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
23461804|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
23461805|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461806|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461807|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461808|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
23461809|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461810|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461811|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461812|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461813|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461814|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
23461815|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461816|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461817|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461818|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461819|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461820|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461821|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461822|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
23461823|NCT05375760|65434908|FG000|Overall Study|Adverse Event|1|||
23461824|NCT05375760|65434909|FG001|Overall Study|Adverse Event|0|||
23461825|NCT05375760|65434908|FG000|Overall Study|Death|0|||
23461826|NCT05375760|65434909|FG001|Overall Study|Death|1|||
23461827|NCT05375760|65434908|FG000|Overall Study|Lost to Follow-up|6|||
23461828|NCT05375760|65434909|FG001|Overall Study|Lost to Follow-up|6|||
23461829|NCT05375760|65434908|FG000|Overall Study|Withdrawal by Subject|17|||
23461830|NCT05375760|65434909|FG001|Overall Study|Withdrawal by Subject|19|||
23461831|NCT05375760|65434908|FG000|Overall Study|Dosing halted by FDA|96|||
23461832|NCT05375760|65434909|FG001|Overall Study|Dosing halted by FDA|100|||
23461833|NCT05375760|65434908|FG000|Overall Study|Not compliant with study visit|2|||
23461834|NCT05375760|65434909|FG001|Overall Study|Not compliant with study visit|0|||
23461835|NCT05375760|65434908|FG000|Overall Study|Physician Decision|1|||
23461836|NCT05375760|65434909|FG001|Overall Study|Physician Decision|0|||
23461837|NCT05375760|65434908|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
23461838|NCT05375760|65434909|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
23461839|NCT05375760|65434908|FG000|Overall Study|Participant moved|1|||
23461840|NCT05375760|65434909|FG001|Overall Study|Participant moved|0|||
23461841|NCT04971109|65434913|FG000|Overall Study|Adverse Event|4|||
23461842|NCT04971109|65434914|FG001|Overall Study|Adverse Event|3|||
23461843|NCT04971109|65434913|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
23461844|NCT04971109|65434914|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
23461845|NCT04971109|65434913|FG000|Overall Study|Lost to Follow-up|8|||
23461846|NCT04971109|65434914|FG001|Overall Study|Lost to Follow-up|2|||
23461847|NCT04971109|65434913|FG000|Overall Study|Physician Decision|5|||
23461848|NCT04971109|65434914|FG001|Overall Study|Physician Decision|0|||
23461849|NCT04971109|65434913|FG000|Overall Study|Protocol Violation|0|||
23461850|NCT04971109|65434914|FG001|Overall Study|Protocol Violation|1|||
23461851|NCT04971109|65434913|FG000|Overall Study|Withdrawal by Subject|18|||
23461852|NCT04971109|65434914|FG001|Overall Study|Withdrawal by Subject|3|||
23461853|NCT04971109|65434913|FG000|Overall Study|Subject was randomized in error|1|||
23461854|NCT04971109|65434914|FG001|Overall Study|Subject was randomized in error|0|||
23461855|NCT02115282|65434915|FG000|Overall Study|Disease progression during treatment|216|||
23461856|NCT02115282|65434916|FG001|Overall Study|Disease progression during treatment|229|||
23461857|NCT02115282|65434915|FG000|Overall Study|Adverse Event|49|||
23461858|NCT02115282|65434916|FG001|Overall Study|Adverse Event|23|||
23584715|NCT00404079|65869271|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
23789322|NCT04133311|66606351|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
23789323|NCT04133311|66606352|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
23789324|NCT04133311|66606349|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23789325|NCT04133311|66606350|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23789326|NCT04133311|66606351|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
23789327|NCT04133311|66606352|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
23789328|NCT04133311|66606349|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
23789329|NCT04133311|66606350|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
23789330|NCT04133311|66606351|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
23789331|NCT04133311|66606352|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
23789332|NCT04133311|66606349|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
23789333|NCT04133311|66606350|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
23789334|NCT04133311|66606351|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
23789335|NCT04133311|66606352|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
23789336|NCT00115063|66606355|FG000|Overall Study|Lost to Follow-up|98|||
23789337|NCT00115063|66606356|FG001|Overall Study|Lost to Follow-up|104|||
23789338|NCT00115063|66606355|FG000|Overall Study|Death|1|||
23461859|NCT02115282|65434915|FG000|Overall Study|Death|1|||
23461860|NCT02115282|65434916|FG001|Overall Study|Death|3|||
23789339|NCT00115063|66606356|FG001|Overall Study|Death|0|||
23789340|NCT00414726|66606357|FG000|Overall Study|Withdrawal by Subject|0|||
23789341|NCT00414726|66606358|FG001|Overall Study|Withdrawal by Subject|1|||
23789342|NCT01977456|66606359|FG000|Overall Study|Death|5|||
23789343|NCT00503867|66606370|FG000|Overall Study|Lost to Follow-up|1|||
23789344|NCT00503867|66606370|FG000|Overall Study|Adverse Event|1|||
23789345|NCT00654186|66606378|FG000|Overall Study|Withdrawal by Subject|5|||
23789346|NCT02488239|66606379|FG000|Overall Study|Death|3|||
23789347|NCT02488239|66606379|FG000|Overall Study|Withdrawal by Subject|3|||
23789348|NCT02488239|66606379|FG000|Overall Study|Physician Decision|2|||
23789349|NCT02488239|66606379|FG000|Overall Study|Consent ineligible|1|||
23789350|NCT02488239|66606379|FG000|Overall Study|Did not undergo implant procedure|1|||
23461861|NCT02115282|65434915|FG000|Overall Study|Alternative therapy|1|||
23461862|NCT02115282|65434916|FG001|Overall Study|Alternative therapy|1|||
23639556|NCT03377699|66064686|FG000|Overall Study|Lost to Follow-up|1|||
23639557|NCT03377699|66064687|FG001|Overall Study|Lost to Follow-up|1|||
23639558|NCT03377699|66064686|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
23639559|NCT03377699|66064687|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
23639560|NCT03377699|66064686|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
23789351|NCT02336074|66606380|FG000|Overall Study|Adverse Event|0|||
23789352|NCT02336074|66606381|FG001|Overall Study|Adverse Event|2|||
23461863|NCT02115282|65434915|FG000|Overall Study|Complicating disease|0|||
23461864|NCT02115282|65434916|FG001|Overall Study|Complicating disease|3|||
23461865|NCT02115282|65434915|FG000|Overall Study|Withdrawal by Subject|12|||
23461866|NCT02115282|65434916|FG001|Overall Study|Withdrawal by Subject|10|||
23461867|NCT02115282|65434915|FG000|Overall Study|Symptomatic progression/deterioration|7|||
23461868|NCT02115282|65434916|FG001|Overall Study|Symptomatic progression/deterioration|18|||
23461869|NCT02115282|65434915|FG000|Overall Study|Non-compliance|5|||
23461870|NCT02115282|65434916|FG001|Overall Study|Non-compliance|1|||
23461871|NCT02115282|65434915|FG000|Overall Study|Protocol Violation|2|||
23461872|NCT02115282|65434916|FG001|Overall Study|Protocol Violation|2|||
23461873|NCT02115282|65434915|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
23461874|NCT02115282|65434916|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
23461875|NCT02115282|65434915|FG000|Overall Study|Not start protocol therapy|9|||
23461876|NCT02115282|65434916|FG001|Overall Study|Not start protocol therapy|10|||
23461877|NCT00539591|65434917|FG000|Overall Study|Toxicity|3|||
23461878|NCT00539591|65434918|FG001|Overall Study|Toxicity|0|||
23461879|NCT00539591|65434919|FG002|Overall Study|Toxicity|0|||
23461880|NCT00539591|65434917|FG000|Overall Study|Disease progression|2|||
23461881|NCT00539591|65434918|FG001|Overall Study|Disease progression|2|||
23461882|NCT00539591|65434919|FG002|Overall Study|Disease progression|3|||
23461883|NCT00098475|65434920|FG000|Step 1|Progressive disease|33|||
23461884|NCT00098475|65434921|FG001|Step 1|Progressive disease|35|||
23461885|NCT00098475|65434922|FG002|Step 1|Progressive disease|2|||
23461886|NCT00098475|65434923|FG003|Step 1|Progressive disease|1|||
23461887|NCT00098475|65434920|FG000|Step 1|Adverse Event|56|||
23461888|NCT00098475|65434921|FG001|Step 1|Adverse Event|37|||
23461889|NCT00098475|65434922|FG002|Step 1|Adverse Event|0|||
23461890|NCT00098475|65434923|FG003|Step 1|Adverse Event|1|||
23461891|NCT00098475|65434920|FG000|Step 1|Death|8|||
23461892|NCT00098475|65434921|FG001|Step 1|Death|5|||
23461893|NCT00098475|65434922|FG002|Step 1|Death|0|||
23461894|NCT00098475|65434923|FG003|Step 1|Death|1|||
23461895|NCT00098475|65434920|FG000|Step 1|Withdrawal by Subject|14|||
23461896|NCT00098475|65434921|FG001|Step 1|Withdrawal by Subject|11|||
23789353|NCT03867760|66606382|FG000|Overall Study|Lost to Follow-up|2|||
23789354|NCT03867760|66606383|FG001|Overall Study|Lost to Follow-up|3|||
23461897|NCT00098475|65434922|FG002|Step 1|Withdrawal by Subject|0|||
23461898|NCT00098475|65434923|FG003|Step 1|Withdrawal by Subject|0|||
23461899|NCT00098475|65434920|FG000|Step 1|Physician Decision|5|||
23461900|NCT00098475|65434921|FG001|Step 1|Physician Decision|2|||
23461901|NCT00098475|65434922|FG002|Step 1|Physician Decision|0|||
23461902|NCT00098475|65434923|FG003|Step 1|Physician Decision|0|||
23789355|NCT03867760|66606382|FG000|Overall Study|Withdrawal by Subject|1|||
23789356|NCT03867760|66606383|FG001|Overall Study|Withdrawal by Subject|2|||
23789357|NCT03867760|66606382|FG000|Overall Study|subject could not meet study logistics|3|||
23789358|NCT03867760|66606383|FG001|Overall Study|subject could not meet study logistics|3|||
23789359|NCT01174186|66606384|FG000|Overall Study|Lost to Follow-up|0|||
23789360|NCT01174186|66606385|FG001|Overall Study|Lost to Follow-up|1|||
23789361|NCT01174186|66606384|FG000|Overall Study|Withdrawal by Subject|0|||
23789362|NCT01174186|66606385|FG001|Overall Study|Withdrawal by Subject|2|||
23789363|NCT01562613|66606386|FG000|Overall Study|Lost to Follow-up|2|||
23789364|NCT01562613|66606386|FG000|Overall Study|Withdrawal by Subject|2|||
23789365|NCT00421304|66606389|FG000|Overall Study|Lost to Follow-up|5|||
23789366|NCT00421304|66606390|FG001|Overall Study|Lost to Follow-up|2|||
23789367|NCT00421304|66606391|FG002|Overall Study|Lost to Follow-up|5|||
23789368|NCT00421304|66606389|FG000|Overall Study|Withdrawal by Subject|2|||
23789369|NCT00421304|66606390|FG001|Overall Study|Withdrawal by Subject|2|||
23789370|NCT00421304|66606391|FG002|Overall Study|Withdrawal by Subject|2|||
23789371|NCT00421304|66606389|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
23789372|NCT00421304|66606390|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
23789373|NCT00421304|66606391|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
23789374|NCT00421304|66606389|FG000|Overall Study|Did not attend Day 360 visit|0|||
23584716|NCT00404079|65869272|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
23584717|NCT04084769|65869273|FG000|Overall Study|Protocol Violation|1|||
23584718|NCT04084769|65869274|FG001|Overall Study|Protocol Violation|3|||
23584719|NCT04084769|65869275|FG002|Overall Study|Protocol Violation|0|||
23584720|NCT04084769|65869276|FG003|Overall Study|Protocol Violation|1|||
23584721|NCT04084769|65869273|FG000|Overall Study|Withdrawal by Subject|0|||
23584722|NCT04084769|65869274|FG001|Overall Study|Withdrawal by Subject|1|||
23584723|NCT04084769|65869275|FG002|Overall Study|Withdrawal by Subject|0|||
23584724|NCT04084769|65869276|FG003|Overall Study|Withdrawal by Subject|0|||
23584725|NCT04084769|65869273|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23584726|NCT04084769|65869274|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23584727|NCT04084769|65869275|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23584728|NCT04084769|65869276|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23584729|NCT04084769|65869273|FG000|Overall Study|Lost to Follow-up|2|||
23584730|NCT04084769|65869274|FG001|Overall Study|Lost to Follow-up|0|||
23584731|NCT04084769|65869275|FG002|Overall Study|Lost to Follow-up|0|||
23584732|NCT04084769|65869276|FG003|Overall Study|Lost to Follow-up|0|||
23584733|NCT01191086|65869277|FG000|Overall Study|Adverse Event|20|||
23584734|NCT01191086|65869277|FG000|Overall Study|Lack of Efficacy|10|||
23584735|NCT01191086|65869277|FG000|Overall Study|Lost to Follow-up|4|||
23584736|NCT01191086|65869277|FG000|Overall Study|Physician Decision|2|||
23584737|NCT01191086|65869277|FG000|Overall Study|Withdrawal by Subject|24|||
23584738|NCT01191086|65869277|FG000|Overall Study|Discontinuation criterion met|1|||
23584739|NCT01191086|65869277|FG000|Overall Study|Other|1|||
23639561|NCT03377699|66064687|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
23639562|NCT03377699|66064686|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
23639563|NCT03377699|66064687|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
23639564|NCT03377699|66064686|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
23639565|NCT03377699|66064687|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
23639566|NCT00400725|66064688|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
23639567|NCT00400725|66064689|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
23639568|NCT00400725|66064690|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
23639569|NCT00400725|66064688|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
23639570|NCT00400725|66064689|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
23639571|NCT00400725|66064690|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
23639572|NCT00400725|66064688|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
23639573|NCT00400725|66064689|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
23639574|NCT00400725|66064690|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
23639575|NCT00400725|66064688|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
23584740|NCT02140554|65869279|FG000|Overall Study|Withdrawal of consent|1|||
23639576|NCT00400725|66064689|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
23639577|NCT00400725|66064690|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
23639578|NCT00400725|66064688|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
23639579|NCT00400725|66064689|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
23639580|NCT00400725|66064690|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
23639581|NCT00400725|66064688|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
23639582|NCT00400725|66064689|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
23639583|NCT00400725|66064690|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
23639584|NCT00400725|66064688|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
23639585|NCT00400725|66064689|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
23584741|NCT02140554|65869280|FG001|Overall Study|Withdrawal of consent|0|||
23584742|NCT02140554|65869281|FG002|Overall Study|Withdrawal of consent|4|||
23584743|NCT02140554|65869279|FG000|Overall Study|Physician Decision|1|||
23789375|NCT00421304|66606390|FG001|Overall Study|Did not attend Day 360 visit|0|||
23639586|NCT00400725|66064690|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
23639587|NCT00400725|66064688|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
23639588|NCT00400725|66064689|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
23639589|NCT00400725|66064690|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
23639590|NCT00400725|66064688|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
23639591|NCT00400725|66064689|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
23639592|NCT00400725|66064690|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
23639593|NCT03223662|66064691|FG000|Overall Study|Physician Decision|1|||
23639594|NCT03223662|66064691|FG000|Overall Study|Study closure|1|||
23639595|NCT00890695|66064692|FG000|Overall Study|Protocol Violation|1|||
23639596|NCT00890695|66064693|FG001|Overall Study|Protocol Violation|0|||
23639597|NCT01373151|66064696|FG000|Period 1|Lack of Efficacy|3|||
23639598|NCT01373151|66064697|FG001|Period 1|Lack of Efficacy|0|||
23639599|NCT01373151|66064698|FG002|Period 1|Lack of Efficacy|0|||
23639600|NCT01373151|66064699|FG003|Period 1|Lack of Efficacy|0|||
23639601|NCT01373151|66064700|FG004|Period 1|Lack of Efficacy|1|||
23639602|NCT01373151|66064701|FG005|Period 1|Lack of Efficacy|0|||
23639603|NCT01373151|66064702|FG006|Period 1|Lack of Efficacy|0|||
23639604|NCT01373151|66064696|FG000|Period 1|Adverse Event|0|||
23639605|NCT01373151|66064697|FG001|Period 1|Adverse Event|0|||
23639606|NCT01373151|66064698|FG002|Period 1|Adverse Event|1|||
23639607|NCT01373151|66064699|FG003|Period 1|Adverse Event|0|||
23639608|NCT01373151|66064700|FG004|Period 1|Adverse Event|4|||
23639609|NCT01373151|66064701|FG005|Period 1|Adverse Event|3|||
23639610|NCT01373151|66064702|FG006|Period 1|Adverse Event|0|||
23639611|NCT01373151|66064696|FG000|Period 1|Withdrawal by Subject|2|||
23639612|NCT01373151|66064697|FG001|Period 1|Withdrawal by Subject|0|||
23639613|NCT01373151|66064698|FG002|Period 1|Withdrawal by Subject|3|||
23639614|NCT01373151|66064699|FG003|Period 1|Withdrawal by Subject|1|||
23639615|NCT01373151|66064700|FG004|Period 1|Withdrawal by Subject|0|||
23639616|NCT01373151|66064701|FG005|Period 1|Withdrawal by Subject|1|||
23639617|NCT01373151|66064702|FG006|Period 1|Withdrawal by Subject|0|||
23639618|NCT01373151|66064696|FG000|Period 2|Lack of Efficacy|9|||
23639619|NCT01373151|66064697|FG001|Period 2|Lack of Efficacy|0|||
23639620|NCT01373151|66064698|FG002|Period 2|Lack of Efficacy|0|||
23639621|NCT01373151|66064699|FG003|Period 2|Lack of Efficacy|1|||
23639622|NCT01373151|66064700|FG004|Period 2|Lack of Efficacy|2|||
23639623|NCT01373151|66064701|FG005|Period 2|Lack of Efficacy|0|||
23639624|NCT01373151|66064702|FG006|Period 2|Lack of Efficacy|3|||
23639625|NCT01373151|66064696|FG000|Period 2|Adverse Event|0|||
23639626|NCT01373151|66064697|FG001|Period 2|Adverse Event|0|||
23639627|NCT01373151|66064698|FG002|Period 2|Adverse Event|3|||
23639628|NCT01373151|66064699|FG003|Period 2|Adverse Event|3|||
23639629|NCT01373151|66064700|FG004|Period 2|Adverse Event|0|||
23639630|NCT01373151|66064701|FG005|Period 2|Adverse Event|0|||
23639631|NCT01373151|66064702|FG006|Period 2|Adverse Event|1|||
23639632|NCT01373151|66064696|FG000|Period 2|subject request to discontinue|0|||
23639633|NCT01373151|66064697|FG001|Period 2|subject request to discontinue|1|||
23639634|NCT01373151|66064698|FG002|Period 2|subject request to discontinue|0|||
23639635|NCT01373151|66064699|FG003|Period 2|subject request to discontinue|0|||
23639636|NCT01373151|66064700|FG004|Period 2|subject request to discontinue|0|||
23639637|NCT01373151|66064701|FG005|Period 2|subject request to discontinue|0|||
23584744|NCT02140554|65869280|FG001|Overall Study|Physician Decision|0|||
23584745|NCT02140554|65869281|FG002|Overall Study|Physician Decision|2|||
23584746|NCT02140554|65869279|FG000|Overall Study|Death|0|||
23584747|NCT02140554|65869280|FG001|Overall Study|Death|0|||
23584748|NCT02140554|65869281|FG002|Overall Study|Death|1|||
23584749|NCT02140554|65869279|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
23584750|NCT02140554|65869280|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
23584751|NCT02140554|65869281|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
23584752|NCT01605136|65869282|FG000|Study Period|Withdrawal by Subject|2|||
23584753|NCT01605136|65869283|FG001|Study Period|Withdrawal by Subject|0|||
23584754|NCT01605136|65869282|FG000|Study Period|Physician Decision|1|||
23584755|NCT01605136|65869283|FG001|Study Period|Physician Decision|1|||
23584756|NCT01605136|65869282|FG000|Study Period|Lost to Follow-up|0|||
23639638|NCT01373151|66064702|FG006|Period 2|subject request to discontinue|0|||
23639639|NCT01373151|66064696|FG000|Period 2|Withdrawal by Subject|0|||
23639640|NCT01373151|66064697|FG001|Period 2|Withdrawal by Subject|0|||
23584757|NCT01605136|65869283|FG001|Study Period|Lost to Follow-up|2|||
23639641|NCT01373151|66064698|FG002|Period 2|Withdrawal by Subject|0|||
23639642|NCT01373151|66064699|FG003|Period 2|Withdrawal by Subject|1|||
23584758|NCT01605136|65869282|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
23584759|NCT01605136|65869283|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
23639643|NCT01373151|66064700|FG004|Period 2|Withdrawal by Subject|0|||
23639644|NCT01373151|66064701|FG005|Period 2|Withdrawal by Subject|0|||
23639645|NCT01373151|66064702|FG006|Period 2|Withdrawal by Subject|0|||
23639646|NCT01373151|66064696|FG000|Period 2|Other|0|||
23639647|NCT01373151|66064697|FG001|Period 2|Other|0|||
23639648|NCT01373151|66064698|FG002|Period 2|Other|1|||
23639649|NCT01373151|66064699|FG003|Period 2|Other|0|||
23639650|NCT01373151|66064700|FG004|Period 2|Other|0|||
23639651|NCT01373151|66064701|FG005|Period 2|Other|0|||
23639652|NCT01373151|66064702|FG006|Period 2|Other|1|||
23639653|NCT02217475|66064703|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
23639654|NCT02217475|66064704|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
23639655|NCT02217475|66064705|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
23639656|NCT02217475|66064703|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
23639657|NCT02217475|66064704|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
23639658|NCT02217475|66064705|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
23639659|NCT02217475|66064703|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
23639660|NCT02217475|66064704|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
23639661|NCT02217475|66064705|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
23639662|NCT02217475|66064703|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
23639663|NCT02217475|66064704|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
23639664|NCT02217475|66064705|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
23639665|NCT02217475|66064703|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
23639666|NCT02217475|66064704|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
23639667|NCT02217475|66064705|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
23639668|NCT02217475|66064703|FG000|Discontinued After Period 1|Adverse Event|1|||
23639669|NCT02217475|66064704|FG001|Discontinued After Period 1|Adverse Event|2|||
23639670|NCT02217475|66064705|FG002|Discontinued After Period 1|Adverse Event|0|||
23349656|NCT01752634|65025253|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
23349657|NCT01752634|65025254|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
23349658|NCT01752634|65025255|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
23349659|NCT01752634|65025250|FG000|Week 24 to Week 260|Physician Decision|1|||
23349660|NCT01752634|65025251|FG001|Week 24 to Week 260|Physician Decision|2|||
23349661|NCT01752634|65025252|FG002|Week 24 to Week 260|Physician Decision|4|||
23349662|NCT01752634|65025253|FG003|Week 24 to Week 260|Physician Decision|2|||
23349663|NCT01752634|65025254|FG004|Week 24 to Week 260|Physician Decision|1|||
23349664|NCT01752634|65025255|FG005|Week 24 to Week 260|Physician Decision|0|||
23584760|NCT03593070|65869284|FG000|Overall Study|administrative withdrawal|1|||
23584761|NCT03593070|65869285|FG001|Overall Study|administrative withdrawal|1|||
23584762|NCT01178762|65869286|FG000|Overall Study|Lost to Follow-up|15|||
23584763|NCT04044664|65869287|FG000|Stage 1|Adverse Event|3|||
23584764|NCT04044664|65869288|FG001|Stage 1|Adverse Event|3|||
23584765|NCT04044664|65869289|FG002|Stage 1|Adverse Event|1|||
23584766|NCT04044664|65869287|FG000|Stage 1|Lost to Follow-up|3|||
23584767|NCT04044664|65869288|FG001|Stage 1|Lost to Follow-up|2|||
23584768|NCT04044664|65869289|FG002|Stage 1|Lost to Follow-up|2|||
23584769|NCT04044664|65869287|FG000|Stage 1|Withdrawal by Subject|9|||
23584770|NCT04044664|65869288|FG001|Stage 1|Withdrawal by Subject|1|||
23584771|NCT04044664|65869289|FG002|Stage 1|Withdrawal by Subject|0|||
23584772|NCT04044664|65869287|FG000|Stage 1|noncompliance, personal reason|2|||
23584773|NCT04044664|65869288|FG001|Stage 1|noncompliance, personal reason|0|||
23584774|NCT04044664|65869289|FG002|Stage 1|noncompliance, personal reason|0|||
23584775|NCT04044664|65869287|FG000|Stage 1|randomization error|0|||
23639671|NCT02217475|66064703|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
23639672|NCT02217475|66064704|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
23584776|NCT04044664|65869288|FG001|Stage 1|randomization error|1|||
23584777|NCT04044664|65869289|FG002|Stage 1|randomization error|0|||
23349665|NCT01752634|65025250|FG000|Week 24 to Week 260|Death|0|||
23584778|NCT04044664|65869287|FG000|Stage 2|Adverse Event|2|||
23349666|NCT01752634|65025251|FG001|Week 24 to Week 260|Death|1|||
23349667|NCT01752634|65025252|FG002|Week 24 to Week 260|Death|0|||
23349668|NCT01752634|65025253|FG003|Week 24 to Week 260|Death|0|||
23349669|NCT01752634|65025254|FG004|Week 24 to Week 260|Death|0|||
23349670|NCT01752634|65025255|FG005|Week 24 to Week 260|Death|0|||
23349671|NCT01752634|65025250|FG000|Week 24 to Week 260|Pregnancy|0|||
23349672|NCT01752634|65025251|FG001|Week 24 to Week 260|Pregnancy|0|||
23349673|NCT01752634|65025252|FG002|Week 24 to Week 260|Pregnancy|1|||
23349674|NCT01752634|65025253|FG003|Week 24 to Week 260|Pregnancy|0|||
23349675|NCT01752634|65025254|FG004|Week 24 to Week 260|Pregnancy|0|||
23349676|NCT01752634|65025255|FG005|Week 24 to Week 260|Pregnancy|0|||
23349677|NCT01752634|65025250|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349678|NCT01752634|65025251|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349679|NCT01752634|65025252|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
23349680|NCT01752634|65025253|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349681|NCT01752634|65025254|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349682|NCT01752634|65025255|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349683|NCT01752634|65025250|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
23349684|NCT01752634|65025251|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
23349685|NCT01752634|65025252|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
23349686|NCT01752634|65025253|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
23349687|NCT01752634|65025254|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
23349688|NCT01752634|65025255|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
23349689|NCT01752634|65025250|FG000|Week 24 to Week 260|Adverse Event|4|||
23349690|NCT01752634|65025251|FG001|Week 24 to Week 260|Adverse Event|8|||
23349691|NCT01752634|65025252|FG002|Week 24 to Week 260|Adverse Event|8|||
23349692|NCT01752634|65025253|FG003|Week 24 to Week 260|Adverse Event|4|||
23349693|NCT01752634|65025254|FG004|Week 24 to Week 260|Adverse Event|2|||
23349694|NCT01752634|65025255|FG005|Week 24 to Week 260|Adverse Event|0|||
23349695|NCT01078298|65025259|FG000|Overall Study|Lost to Follow-up|12|||
23349696|NCT01078298|65025260|FG001|Overall Study|Lost to Follow-up|13|||
23349697|NCT01078298|65025259|FG000|Overall Study|Withdrawal by Subject|31|||
23349698|NCT01078298|65025260|FG001|Overall Study|Withdrawal by Subject|33|||
23349699|NCT01078298|65025259|FG000|Overall Study|Protocol Violation|6|||
23349700|NCT01078298|65025260|FG001|Overall Study|Protocol Violation|6|||
23349701|NCT01078298|65025259|FG000|Overall Study|Adverse Event|6|||
23349702|NCT01078298|65025260|FG001|Overall Study|Adverse Event|5|||
23349703|NCT01078298|65025259|FG000|Overall Study|Death|2|||
23349704|NCT01078298|65025260|FG001|Overall Study|Death|0|||
23349705|NCT01078298|65025259|FG000|Overall Study|Did not meet entrance criteria|0|||
23349706|NCT01078298|65025260|FG001|Overall Study|Did not meet entrance criteria|1|||
23349707|NCT01078298|65025259|FG000|Overall Study|Other|24|||
23349708|NCT01078298|65025260|FG001|Overall Study|Other|32|||
23349709|NCT01651000|65025263|FG000|Overall Study|Adverse Event|2|||
23349710|NCT01651000|65025264|FG001|Overall Study|Adverse Event|8|||
23349711|NCT01651000|65025263|FG000|Overall Study|Lost to Follow-up|3|||
23349712|NCT01651000|65025264|FG001|Overall Study|Lost to Follow-up|2|||
23349713|NCT01651000|65025263|FG000|Overall Study|Protocol Violation|0|||
23349714|NCT01651000|65025264|FG001|Overall Study|Protocol Violation|3|||
23349715|NCT01651000|65025263|FG000|Overall Study|Withdrawal by Subject|2|||
23349716|NCT01651000|65025264|FG001|Overall Study|Withdrawal by Subject|10|||
23349717|NCT01651000|65025263|FG000|Overall Study|Subject noncompliance|0|||
23349718|NCT01651000|65025264|FG001|Overall Study|Subject noncompliance|3|||
23461903|NCT00098475|65434920|FG000|Step 1|Alternative therapy|31|||
23461904|NCT00098475|65434921|FG001|Step 1|Alternative therapy|43|||
23461905|NCT00098475|65434922|FG002|Step 1|Alternative therapy|1|||
23461906|NCT00098475|65434923|FG003|Step 1|Alternative therapy|0|||
23461907|NCT00098475|65434920|FG000|Step 1|Other disease|2|||
23461908|NCT00098475|65434921|FG001|Step 1|Other disease|1|||
23461909|NCT00098475|65434922|FG002|Step 1|Other disease|1|||
23461910|NCT00098475|65434923|FG003|Step 1|Other disease|0|||
23461911|NCT00098475|65434920|FG000|Step 1|Never started treatment|0|||
23461912|NCT00098475|65434921|FG001|Step 1|Never started treatment|2|||
23461913|NCT00098475|65434922|FG002|Step 1|Never started treatment|0|||
23461914|NCT00098475|65434923|FG003|Step 1|Never started treatment|0|||
23461915|NCT00098475|65434920|FG000|Step 1|Still on treatment as of this analysis|14|||
23461916|NCT00098475|65434921|FG001|Step 1|Still on treatment as of this analysis|27|||
23461917|NCT00098475|65434922|FG002|Step 1|Still on treatment as of this analysis|0|||
23461918|NCT00098475|65434923|FG003|Step 1|Still on treatment as of this analysis|0|||
23461919|NCT00098475|65434920|FG000|Step 1|Knee surgery|1|||
23461920|NCT00098475|65434921|FG001|Step 1|Knee surgery|0|||
23461921|NCT00098475|65434922|FG002|Step 1|Knee surgery|0|||
23461922|NCT00098475|65434923|FG003|Step 1|Knee surgery|0|||
23461923|NCT00098475|65434920|FG000|Step 1|Complications|1|||
23461924|NCT00098475|65434921|FG001|Step 1|Complications|0|||
23461925|NCT00098475|65434922|FG002|Step 1|Complications|0|||
23461926|NCT00098475|65434923|FG003|Step 1|Complications|0|||
23461927|NCT00098475|65434920|FG000|Step 1|Cannot comply due to other tx|0|||
23461928|NCT00098475|65434921|FG001|Step 1|Cannot comply due to other tx|1|||
23461929|NCT00098475|65434922|FG002|Step 1|Cannot comply due to other tx|0|||
23461930|NCT00098475|65434923|FG003|Step 1|Cannot comply due to other tx|0|||
23461931|NCT00098475|65434920|FG000|Step 1|Both patient and physician's decision|2|||
23461932|NCT00098475|65434921|FG001|Step 1|Both patient and physician's decision|1|||
23461933|NCT00098475|65434922|FG002|Step 1|Both patient and physician's decision|0|||
23461934|NCT00098475|65434923|FG003|Step 1|Both patient and physician's decision|0|||
23461935|NCT00098475|65434920|FG000|Step 1|Incorrect disease assessment|2|||
23461936|NCT00098475|65434921|FG001|Step 1|Incorrect disease assessment|0|||
23461937|NCT00098475|65434922|FG002|Step 1|Incorrect disease assessment|0|||
23461938|NCT00098475|65434923|FG003|Step 1|Incorrect disease assessment|0|||
23461939|NCT00098475|65434920|FG000|Step 1|Off treatment for > specified timeframe|1|||
23461940|NCT00098475|65434921|FG001|Step 1|Off treatment for > specified timeframe|1|||
23461941|NCT00098475|65434922|FG002|Step 1|Off treatment for > specified timeframe|0|||
23461942|NCT00098475|65434923|FG003|Step 1|Off treatment for > specified timeframe|0|||
23461943|NCT00098475|65434920|FG000|Step 1|Declining performance status|0|||
23461944|NCT00098475|65434921|FG001|Step 1|Declining performance status|1|||
23461945|NCT00098475|65434922|FG002|Step 1|Declining performance status|0|||
23461946|NCT00098475|65434923|FG003|Step 1|Declining performance status|0|||
23461947|NCT00098475|65434920|FG000|Step 1|Insurance issue|0|||
23584779|NCT04044664|65869288|FG001|Stage 2|Adverse Event|0|||
23584780|NCT04044664|65869289|FG002|Stage 2|Adverse Event|0|||
23584781|NCT04044664|65869287|FG000|Stage 2|Lost to Follow-up|3|||
23584782|NCT04044664|65869288|FG001|Stage 2|Lost to Follow-up|2|||
23584783|NCT04044664|65869289|FG002|Stage 2|Lost to Follow-up|1|||
23789376|NCT00421304|66606391|FG002|Overall Study|Did not attend Day 360 visit|1|||
23789377|NCT00835796|66606392|FG000|First Intervention|Withdrawal by Subject|0|||
23789378|NCT00835796|66606393|FG001|First Intervention|Withdrawal by Subject|1|||
23789379|NCT04299087|66606394|FG000|Overall Study|Lost to Follow-up|2|||
23789380|NCT04299087|66606395|FG001|Overall Study|Lost to Follow-up|1|||
23789381|NCT00918684|66606403|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
23789382|NCT00918684|66606403|FG000|Treatment Phase|Lack of Efficacy|6|||
23789383|NCT00918684|66606403|FG000|Treatment Phase|Lost to Follow-up|2|||
23789384|NCT00918684|66606403|FG000|Treatment Phase|Physician Decision|8|||
23789385|NCT00918684|66606403|FG000|Treatment Phase|Protocol Violation|1|||
23789386|NCT00918684|66606403|FG000|Treatment Phase|Withdrawal by Subject|8|||
23789387|NCT01624233|66606404|FG000|Period 2 - Induction|Adverse Event|1|||
23789388|NCT01624233|66606404|FG000|Period 3 - Maintenance|Adverse Event|2|||
23789389|NCT01624233|66606404|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
23789390|NCT01624233|66606404|FG000|Period 3 - Maintenance|Physician Decision|2|||
23789391|NCT01624233|66606404|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
23461948|NCT00098475|65434921|FG001|Step 1|Insurance issue|1|||
23461949|NCT00098475|65434922|FG002|Step 1|Insurance issue|0|||
23461950|NCT00098475|65434923|FG003|Step 1|Insurance issue|0|||
23461951|NCT00098475|65434920|FG000|Step 1|Rising paraprotein|0|||
23461952|NCT00098475|65434921|FG001|Step 1|Rising paraprotein|1|||
23461953|NCT00098475|65434922|FG002|Step 1|Rising paraprotein|0|||
23461954|NCT00098475|65434923|FG003|Step 1|Rising paraprotein|0|||
23461955|NCT00098475|65434920|FG000|Step 1|Referred to other physicians|0|||
23789392|NCT01624233|66606404|FG000|Period 4 - Drug Free Period|Relapsed|61|||
23789393|NCT01624233|66606404|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
23461956|NCT00098475|65434921|FG001|Step 1|Referred to other physicians|1|||
23584784|NCT04044664|65869287|FG000|Stage 2|Withdrawal by Subject|3|||
23461957|NCT00098475|65434922|FG002|Step 1|Referred to other physicians|0|||
23461958|NCT00098475|65434923|FG003|Step 1|Referred to other physicians|0|||
23461959|NCT00098475|65434920|FG000|Step 1|Criteria to continue treatment not met|0|||
23461960|NCT00098475|65434921|FG001|Step 1|Criteria to continue treatment not met|1|||
23461961|NCT00098475|65434922|FG002|Step 1|Criteria to continue treatment not met|0|||
23461962|NCT00098475|65434923|FG003|Step 1|Criteria to continue treatment not met|0|||
23461963|NCT00098475|65434920|FG000|Step 1|Misinterpretation of lab data|0|||
23461964|NCT00098475|65434921|FG001|Step 1|Misinterpretation of lab data|1|||
23461965|NCT00098475|65434922|FG002|Step 1|Misinterpretation of lab data|0|||
23461966|NCT00098475|65434923|FG003|Step 1|Misinterpretation of lab data|0|||
23461967|NCT00098475|65434920|FG000|Step 1|Patient fell with fracture|1|||
23461968|NCT00098475|65434921|FG001|Step 1|Patient fell with fracture|0|||
23461969|NCT00098475|65434922|FG002|Step 1|Patient fell with fracture|0|||
23461970|NCT00098475|65434923|FG003|Step 1|Patient fell with fracture|0|||
23461971|NCT00098475|65434920|FG000|Step 1|Not documented|0|||
23461972|NCT00098475|65434921|FG001|Step 1|Not documented|1|||
23461973|NCT00098475|65434922|FG002|Step 1|Not documented|0|||
23461974|NCT00098475|65434923|FG003|Step 1|Not documented|0|||
23461975|NCT00098475|65434920|FG000|Step 2|Disease progression|1|||
23461976|NCT00098475|65434921|FG001|Step 2|Disease progression|4|||
23461977|NCT00098475|65434922|FG002|Step 2|Disease progression|0|||
23461978|NCT00098475|65434923|FG003|Step 2|Disease progression|0|||
23461979|NCT00098475|65434920|FG000|Step 2|Adverse Event|2|||
23461980|NCT00098475|65434921|FG001|Step 2|Adverse Event|0|||
23461981|NCT00098475|65434922|FG002|Step 2|Adverse Event|0|||
23461982|NCT00098475|65434923|FG003|Step 2|Adverse Event|0|||
23461983|NCT00098475|65434920|FG000|Step 2|Withdrawal by Subject|0|||
23461984|NCT00098475|65434921|FG001|Step 2|Withdrawal by Subject|2|||
23461985|NCT00098475|65434922|FG002|Step 2|Withdrawal by Subject|0|||
23461986|NCT00098475|65434923|FG003|Step 2|Withdrawal by Subject|0|||
23461987|NCT00098475|65434920|FG000|Step 2|Physician Decision|0|||
23461988|NCT00098475|65434921|FG001|Step 2|Physician Decision|1|||
23461989|NCT00098475|65434922|FG002|Step 2|Physician Decision|0|||
23461990|NCT00098475|65434923|FG003|Step 2|Physician Decision|0|||
23461991|NCT00098475|65434920|FG000|Step 2|Alternative therapy|1|||
23461992|NCT00098475|65434921|FG001|Step 2|Alternative therapy|2|||
23461993|NCT00098475|65434922|FG002|Step 2|Alternative therapy|0|||
23461994|NCT00098475|65434923|FG003|Step 2|Alternative therapy|0|||
23461995|NCT00098475|65434920|FG000|Step 2|Never started treatment|1|||
23461996|NCT00098475|65434921|FG001|Step 2|Never started treatment|1|||
23461997|NCT00098475|65434922|FG002|Step 2|Never started treatment|0|||
23461998|NCT00098475|65434923|FG003|Step 2|Never started treatment|0|||
23461999|NCT05786651|65434929|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
23462000|NCT02516241|65434931|FG000|Overall Study|Death|255|||
23462001|NCT02516241|65434932|FG001|Overall Study|Death|262|||
23462002|NCT02516241|65434933|FG002|Overall Study|Death|270|||
23462003|NCT02516241|65434931|FG000|Overall Study|Lost to Follow-up|1|||
23584785|NCT04044664|65869288|FG001|Stage 2|Withdrawal by Subject|0|||
23584786|NCT04044664|65869289|FG002|Stage 2|Withdrawal by Subject|0|||
23584787|NCT04044664|65869287|FG000|Stage 2|protocol deviation|1|||
23584788|NCT04044664|65869288|FG001|Stage 2|protocol deviation|0|||
23584789|NCT04044664|65869289|FG002|Stage 2|protocol deviation|0|||
23584790|NCT00542386|65869290|FG000|Overall Study|Adverse Event|1|||
23584791|NCT00542386|65869291|FG001|Overall Study|Adverse Event|7|||
23584792|NCT00542386|65869292|FG002|Overall Study|Adverse Event|7|||
23462004|NCT02516241|65434932|FG001|Overall Study|Lost to Follow-up|1|||
23462005|NCT02516241|65434933|FG002|Overall Study|Lost to Follow-up|3|||
23462006|NCT02516241|65434931|FG000|Overall Study|Withdrawal by Subject|2|||
23462007|NCT02516241|65434932|FG001|Overall Study|Withdrawal by Subject|7|||
23584793|NCT00542386|65869293|FG003|Overall Study|Adverse Event|8|||
23584794|NCT00542386|65869294|FG004|Overall Study|Adverse Event|13|||
23584795|NCT00542386|65869295|FG005|Overall Study|Adverse Event|4|||
23584796|NCT00542386|65869290|FG000|Overall Study|Death|0|||
23462008|NCT02516241|65434933|FG002|Overall Study|Withdrawal by Subject|12|||
23584797|NCT00542386|65869291|FG001|Overall Study|Death|0|||
23462009|NCT02516241|65434931|FG000|Overall Study|participants ongoing at data cut-off|84|||
23462010|NCT02516241|65434932|FG001|Overall Study|participants ongoing at data cut-off|76|||
23462011|NCT02516241|65434933|FG002|Overall Study|participants ongoing at data cut-off|59|||
23462012|NCT04201262|65434934|FG000|Overall Study|Adverse Event|1|||
23462013|NCT04201262|65434935|FG001|Overall Study|Adverse Event|2|||
23462014|NCT04201262|65434934|FG000|Overall Study|Continuing in the study|57|||
23462015|NCT04201262|65434935|FG001|Overall Study|Continuing in the study|0|||
23462016|NCT04201262|65434934|FG000|Overall Study|Withdrawal by Subject|0|||
23462017|NCT04201262|65434935|FG001|Overall Study|Withdrawal by Subject|1|||
23462018|NCT03213691|65434936|FG000|Overall Study|Adverse Event|2|||
23462019|NCT03213691|65434936|FG000|Overall Study|Death|3|||
23462020|NCT03213691|65434936|FG000|Overall Study|Physician Decision|1|||
23462021|NCT03213691|65434936|FG000|Overall Study|Progressive Disease|14|||
23462022|NCT03213691|65434936|FG000|Overall Study|Ineligible|1|||
23462023|NCT03043872|65434937|FG000|Overall Study|Withdrawal by Subject|6|||
23462024|NCT03043872|65434938|FG001|Overall Study|Withdrawal by Subject|6|||
23462025|NCT03043872|65434939|FG002|Overall Study|Withdrawal by Subject|15|||
23462026|NCT03043872|65434937|FG000|Overall Study|Lost to Follow-up|2|||
23462027|NCT03043872|65434938|FG001|Overall Study|Lost to Follow-up|1|||
23462028|NCT03043872|65434939|FG002|Overall Study|Lost to Follow-up|1|||
23462029|NCT03043872|65434937|FG000|Overall Study|Death|270|||
23462030|NCT03043872|65434938|FG001|Overall Study|Death|269|||
23462031|NCT03043872|65434939|FG002|Overall Study|Death|296|||
23462032|NCT02939287|65434940|FG000|Overall Study|met exclusion criteria|1|||
23462033|NCT02939287|65434941|FG001|Overall Study|met exclusion criteria|1|||
23462034|NCT02939287|65434942|FG002|Overall Study|met exclusion criteria|1|||
23462035|NCT02939287|65434940|FG000|Overall Study|Did not complete survey|2|||
23462036|NCT02939287|65434941|FG001|Overall Study|Did not complete survey|2|||
23462037|NCT02939287|65434942|FG002|Overall Study|Did not complete survey|0|||
23462038|NCT02939287|65434940|FG000|Overall Study|Withdrawal by Subject|1|||
23462039|NCT02939287|65434941|FG001|Overall Study|Withdrawal by Subject|1|||
23462040|NCT02939287|65434942|FG002|Overall Study|Withdrawal by Subject|0|||
23462041|NCT04139798|65434943|FG000|Overall Study|Withdrawal by Subject|6|||
23462042|NCT04139798|65434944|FG001|Overall Study|Withdrawal by Subject|5|||
23462043|NCT04139798|65434943|FG000|Overall Study|Lost to Follow-up|2|||
23462044|NCT04139798|65434944|FG001|Overall Study|Lost to Follow-up|5|||
23462045|NCT04139798|65434943|FG000|Overall Study|Discontinued|4|||
23462046|NCT04139798|65434944|FG001|Overall Study|Discontinued|2|||
23462047|NCT04139798|65434943|FG000|Overall Study|Adverse Event|1|||
23462048|NCT04139798|65434944|FG001|Overall Study|Adverse Event|3|||
23462049|NCT04139798|65434943|FG000|Overall Study|Protocol Violation|1|||
23462050|NCT04139798|65434944|FG001|Overall Study|Protocol Violation|0|||
23462051|NCT01721044|65434945|FG000|Treatment Period|Adverse Event|7|||
23462052|NCT01721044|65434946|FG001|Treatment Period|Adverse Event|7|||
23462053|NCT01721044|65434947|FG002|Treatment Period|Adverse Event|10|||
23462054|NCT01721044|65434945|FG000|Treatment Period|Death|0|||
23462055|NCT01721044|65434946|FG001|Treatment Period|Death|0|||
23462056|NCT01721044|65434947|FG002|Treatment Period|Death|1|||
23462057|NCT01721044|65434945|FG000|Treatment Period|Lack of Efficacy|16|||
23462058|NCT01721044|65434946|FG001|Treatment Period|Lack of Efficacy|4|||
23462059|NCT01721044|65434947|FG002|Treatment Period|Lack of Efficacy|4|||
23462060|NCT01721044|65434945|FG000|Treatment Period|Lost to Follow-up|0|||
23462061|NCT01721044|65434946|FG001|Treatment Period|Lost to Follow-up|0|||
23462062|NCT01721044|65434947|FG002|Treatment Period|Lost to Follow-up|1|||
23462063|NCT01721044|65434945|FG000|Treatment Period|Physician Decision|1|||
23462064|NCT01721044|65434946|FG001|Treatment Period|Physician Decision|0|||
23462065|NCT01721044|65434947|FG002|Treatment Period|Physician Decision|2|||
23462066|NCT01721044|65434945|FG000|Treatment Period|Protocol Violation|1|||
23462067|NCT01721044|65434946|FG001|Treatment Period|Protocol Violation|0|||
23462068|NCT01721044|65434947|FG002|Treatment Period|Protocol Violation|0|||
23462069|NCT01721044|65434945|FG000|Treatment Period|Withdrawal by Subject|7|||
23462070|NCT01721044|65434946|FG001|Treatment Period|Withdrawal by Subject|6|||
23462071|NCT01721044|65434947|FG002|Treatment Period|Withdrawal by Subject|1|||
23462072|NCT04385277|65434948|FG000|Overall Study|Physician Decision|2|||
23462073|NCT04385277|65434948|FG000|Overall Study|Ineligible|1|||
23789394|NCT01624233|66606404|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
23462074|NCT04385277|65434948|FG000|Overall Study|Patient/Parent Refusal|2|||
23462075|NCT01002339|65434949|FG000|Overall Study|Withdrawal by Subject|0|||
23789395|NCT01624233|66606404|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
23789396|NCT01624233|66606404|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
23789397|NCT01624233|66606404|FG000|Period 6: Follow-up|Adverse Event|3|||
23789398|NCT01624233|66606404|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
23462076|NCT01002339|65434950|FG001|Overall Study|Withdrawal by Subject|1|||
23462077|NCT01002339|65434951|FG002|Overall Study|Withdrawal by Subject|0|||
23462078|NCT01002339|65434949|FG000|Overall Study|Incorrect treatment assignment|0|||
23462079|NCT01002339|65434950|FG001|Overall Study|Incorrect treatment assignment|0|||
23462080|NCT01002339|65434951|FG002|Overall Study|Incorrect treatment assignment|1|||
23462081|NCT01002339|65434949|FG000|Overall Study|Protocol Violation|0|||
23462082|NCT01002339|65434950|FG001|Overall Study|Protocol Violation|0|||
23462083|NCT01002339|65434951|FG002|Overall Study|Protocol Violation|2|||
23462084|NCT01002339|65434949|FG000|Overall Study|Lung cancer detected before transplant|0|||
23462085|NCT01002339|65434950|FG001|Overall Study|Lung cancer detected before transplant|0|||
23462086|NCT01002339|65434951|FG002|Overall Study|Lung cancer detected before transplant|1|||
23462087|NCT01002339|65434949|FG000|Overall Study|Randomized. Not transplanted|0|||
23462088|NCT01002339|65434950|FG001|Overall Study|Randomized. Not transplanted|0|||
23789399|NCT01624233|66606404|FG000|Period 6: Follow-up|Physician Decision|1|||
23789400|NCT01624233|66606404|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
23789401|NCT00406393|66606405|FG000|Overall Study|Did not undergo transplantation|2|||
23789402|NCT00406393|66606406|FG001|Overall Study|Did not undergo transplantation|1|||
23789403|NCT04561115|66609369|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
23789404|NCT04561115|66609370|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
23789405|NCT04561115|66609369|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
23789406|NCT04561115|66609370|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
23789407|NCT04561115|66609369|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
23789408|NCT04561115|66609370|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
23789409|NCT04968925|66609371|FG000|Phase I- Period 1|COVID-19 related|0|||
23789410|NCT04968925|66609372|FG001|Phase I- Period 1|COVID-19 related|1|||
23789411|NCT04968925|66609373|FG002|Phase I- Period 1|COVID-19 related|0|||
23789412|NCT04968925|66609374|FG003|Phase I- Period 1|COVID-19 related|0|||
23789413|NCT04968925|66609371|FG000|Phase I- Period 1|Subject enrolled in error|1|||
23789414|NCT04968925|66609372|FG001|Phase I- Period 1|Subject enrolled in error|1|||
23462089|NCT01002339|65434951|FG002|Overall Study|Randomized. Not transplanted|1|||
23462090|NCT00535496|65434956|FG000|Overall Study|Lost to Follow-up|0|||
23462091|NCT00535496|65434957|FG001|Overall Study|Lost to Follow-up|1|||
23462092|NCT00535496|65434958|FG002|Overall Study|Lost to Follow-up|0|||
23462093|NCT00535496|65434959|FG003|Overall Study|Lost to Follow-up|0|||
23462094|NCT00535496|65434956|FG000|Overall Study|Not treated with sugammadex|0|||
23462095|NCT00535496|65434957|FG001|Overall Study|Not treated with sugammadex|1|||
23462096|NCT00535496|65434958|FG002|Overall Study|Not treated with sugammadex|0|||
23462097|NCT00535496|65434959|FG003|Overall Study|Not treated with sugammadex|0|||
23462098|NCT03877510|65434960|FG000|Overall Study|Death|6|||
23462099|NCT03877510|65434960|FG000|Overall Study|Lost to Follow-up|2|||
23462100|NCT03877510|65434960|FG000|Overall Study|Non-compliance with study drug|2|||
23462101|NCT03877510|65434960|FG000|Overall Study|Lack of Efficacy|14|||
23462102|NCT03877510|65434960|FG000|Overall Study|Adverse Event|20|||
23462103|NCT03877510|65434960|FG000|Overall Study|Withdrawal by Subject|22|||
23462104|NCT03877510|65434960|FG000|Overall Study|Miscellaneous|1|||
23462105|NCT02628873|65434961|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
23462106|NCT02628873|65434962|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
23462107|NCT02628873|65434961|FG000|Second Test (1 Hour)|Physician Decision|1|||
23462108|NCT02628873|65434962|FG001|Second Test (1 Hour)|Physician Decision|0|||
23462109|NCT01550003|65434965|FG000|Overall Study|Adverse Event|0|||
23462110|NCT01550003|65434966|FG001|Overall Study|Adverse Event|9|||
23462111|NCT01550003|65434967|FG002|Overall Study|Adverse Event|15|||
23462112|NCT01550003|65434965|FG000|Overall Study|Lack of Efficacy|4|||
23462113|NCT01550003|65434966|FG001|Overall Study|Lack of Efficacy|11|||
23462114|NCT01550003|65434967|FG002|Overall Study|Lack of Efficacy|15|||
23462115|NCT01550003|65434965|FG000|Overall Study|Protocol Violation|0|||
23462116|NCT01550003|65434966|FG001|Overall Study|Protocol Violation|3|||
23462117|NCT01550003|65434967|FG002|Overall Study|Protocol Violation|2|||
23462118|NCT01550003|65434965|FG000|Overall Study|Lost to Follow-up|1|||
23462119|NCT01550003|65434966|FG001|Overall Study|Lost to Follow-up|4|||
23462120|NCT01550003|65434967|FG002|Overall Study|Lost to Follow-up|8|||
23462121|NCT01550003|65434965|FG000|Overall Study|Consent withdrawn|2|||
23462122|NCT01550003|65434966|FG001|Overall Study|Consent withdrawn|11|||
23462123|NCT01550003|65434967|FG002|Overall Study|Consent withdrawn|23|||
23462124|NCT01550003|65434965|FG000|Overall Study|Missing|1|||
23462125|NCT01550003|65434966|FG001|Overall Study|Missing|0|||
23462126|NCT01550003|65434967|FG002|Overall Study|Missing|2|||
23462127|NCT01550003|65434965|FG000|Overall Study|Study closure as announced by sponsor|7|||
23462128|NCT01550003|65434966|FG001|Overall Study|Study closure as announced by sponsor|6|||
23462129|NCT01550003|65434967|FG002|Overall Study|Study closure as announced by sponsor|24|||
23462130|NCT01550003|65434965|FG000|Overall Study|Protocol Noncompliance|1|||
23462131|NCT01550003|65434966|FG001|Overall Study|Protocol Noncompliance|0|||
23462132|NCT01550003|65434967|FG002|Overall Study|Protocol Noncompliance|0|||
23462133|NCT01550003|65434965|FG000|Overall Study|Study closure|0|||
23462134|NCT01550003|65434966|FG001|Overall Study|Study closure|1|||
23462135|NCT01550003|65434967|FG002|Overall Study|Study closure|1|||
23462136|NCT01550003|65434965|FG000|Overall Study|Patient reached adulthood|0|||
23462137|NCT01550003|65434966|FG001|Overall Study|Patient reached adulthood|1|||
23462138|NCT01550003|65434967|FG002|Overall Study|Patient reached adulthood|0|||
23462139|NCT01550003|65434965|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
23462140|NCT01550003|65434966|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
23462141|NCT01550003|65434967|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
23462142|NCT01550003|65434965|FG000|Overall Study|Sponsor's order|0|||
23462143|NCT01550003|65434966|FG001|Overall Study|Sponsor's order|3|||
23462144|NCT01550003|65434967|FG002|Overall Study|Sponsor's order|3|||
23462145|NCT01550003|65434965|FG000|Overall Study|Sponsor's decision|1|||
23462146|NCT01550003|65434966|FG001|Overall Study|Sponsor's decision|5|||
23462147|NCT01550003|65434967|FG002|Overall Study|Sponsor's decision|4|||
23462148|NCT01550003|65434965|FG000|Overall Study|Subject mother passed away|0|||
23462149|NCT01550003|65434966|FG001|Overall Study|Subject mother passed away|1|||
23462150|NCT01550003|65434967|FG002|Overall Study|Subject mother passed away|0|||
23462151|NCT01550003|65434965|FG000|Overall Study|Discontinuation|0|||
23462152|NCT01550003|65434966|FG001|Overall Study|Discontinuation|1|||
23462153|NCT01550003|65434967|FG002|Overall Study|Discontinuation|0|||
23462154|NCT01550003|65434965|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
23462155|NCT01550003|65434966|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
23462156|NCT01550003|65434967|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
23462157|NCT01550003|65434965|FG000|Overall Study|Site closure|0|||
23462158|NCT01550003|65434966|FG001|Overall Study|Site closure|2|||
23462159|NCT01550003|65434967|FG002|Overall Study|Site closure|0|||
23462160|NCT01550003|65434965|FG000|Overall Study|Pregnancy|0|||
23462161|NCT01550003|65434966|FG001|Overall Study|Pregnancy|1|||
23462162|NCT01550003|65434967|FG002|Overall Study|Pregnancy|0|||
23462163|NCT01550003|65434965|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
23462164|NCT01550003|65434966|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
23462165|NCT01550003|65434967|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
23462166|NCT01550003|65434965|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
23462167|NCT01550003|65434966|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
23462168|NCT01550003|65434967|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
23462169|NCT01550003|65434965|FG000|Overall Study|Switching to adult rheumatologist|0|||
23462170|NCT01550003|65434966|FG001|Overall Study|Switching to adult rheumatologist|0|||
23462171|NCT01550003|65434967|FG002|Overall Study|Switching to adult rheumatologist|1|||
23462172|NCT01550003|65434965|FG000|Overall Study|Patient transition to adult care|0|||
23462173|NCT01550003|65434966|FG001|Overall Study|Patient transition to adult care|0|||
23462174|NCT01550003|65434967|FG002|Overall Study|Patient transition to adult care|1|||
23462175|NCT01550003|65434965|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
23462176|NCT01550003|65434966|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
23462177|NCT01550003|65434967|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
23462178|NCT01550003|65434965|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
23462179|NCT01550003|65434966|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
23462180|NCT01550003|65434967|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
23462181|NCT01550003|65434965|FG000|Overall Study|Per Sponsor request|1|||
23462182|NCT01550003|65434966|FG001|Overall Study|Per Sponsor request|0|||
23462183|NCT01550003|65434967|FG002|Overall Study|Per Sponsor request|1|||
23462184|NCT01550003|65434965|FG000|Overall Study|Patient not compliance|0|||
23462185|NCT01550003|65434966|FG001|Overall Study|Patient not compliance|0|||
23462186|NCT01550003|65434967|FG002|Overall Study|Patient not compliance|1|||
23462187|NCT01550003|65434965|FG000|Overall Study|Non-compliance|0|||
23462188|NCT01550003|65434966|FG001|Overall Study|Non-compliance|0|||
23462189|NCT01550003|65434967|FG002|Overall Study|Non-compliance|1|||
23462190|NCT01550003|65434965|FG000|Overall Study|Study closed|0|||
23462191|NCT01550003|65434966|FG001|Overall Study|Study closed|1|||
23462192|NCT01550003|65434967|FG002|Overall Study|Study closed|0|||
23462193|NCT01550003|65434965|FG000|Overall Study|Transitioned to adult rheumatology|0|||
23462194|NCT01550003|65434966|FG001|Overall Study|Transitioned to adult rheumatology|0|||
23462195|NCT01550003|65434967|FG002|Overall Study|Transitioned to adult rheumatology|1|||
23462196|NCT01909453|65434968|FG000|Overall Study|Ongoing|118|||
23462197|NCT01909453|65434969|FG001|Overall Study|Ongoing|103|||
23462198|NCT01909453|65434970|FG002|Overall Study|Ongoing|83|||
23462199|NCT01909453|65434971|FG003|Overall Study|Ongoing|164|||
23462200|NCT01909453|65434972|FG004|Overall Study|Ongoing|50|||
23462201|NCT01909453|65434968|FG000|Overall Study|Death|69|||
23462202|NCT01909453|65434969|FG001|Overall Study|Death|74|||
23462203|NCT01909453|65434970|FG002|Overall Study|Death|88|||
23462204|NCT01909453|65434971|FG003|Overall Study|Death|86|||
23462205|NCT01909453|65434972|FG004|Overall Study|Death|29|||
23462206|NCT01909453|65434968|FG000|Overall Study|Lost to Follow-up|3|||
23462207|NCT01909453|65434969|FG001|Overall Study|Lost to Follow-up|4|||
23462208|NCT01909453|65434970|FG002|Overall Study|Lost to Follow-up|4|||
23462209|NCT01909453|65434971|FG003|Overall Study|Lost to Follow-up|3|||
23462210|NCT01909453|65434972|FG004|Overall Study|Lost to Follow-up|3|||
23462211|NCT01909453|65434968|FG000|Overall Study|Withdrawal by Subject|2|||
23462212|NCT01909453|65434969|FG001|Overall Study|Withdrawal by Subject|13|||
23462213|NCT01909453|65434970|FG002|Overall Study|Withdrawal by Subject|16|||
23462214|NCT01909453|65434971|FG003|Overall Study|Withdrawal by Subject|5|||
23584798|NCT00542386|65869292|FG002|Overall Study|Death|1|||
23462215|NCT01909453|65434972|FG004|Overall Study|Withdrawal by Subject|4|||
23462216|NCT04885998|65434973|FG000|Overall Study|Ongoing in study|3|||
23462217|NCT04885998|65434974|FG001|Overall Study|Ongoing in study|2|||
23462218|NCT04885998|65434975|FG002|Overall Study|Ongoing in study|2|||
23462219|NCT04885998|65434976|FG003|Overall Study|Ongoing in study|6|||
23462220|NCT04885998|65434973|FG000|Overall Study|Withdrawal by Subject|0|||
23462221|NCT04885998|65434974|FG001|Overall Study|Withdrawal by Subject|2|||
23462222|NCT04885998|65434975|FG002|Overall Study|Withdrawal by Subject|1|||
23462223|NCT04885998|65434976|FG003|Overall Study|Withdrawal by Subject|1|||
23462224|NCT04885998|65434973|FG000|Overall Study|Lost to Follow-up|1|||
23462225|NCT04885998|65434974|FG001|Overall Study|Lost to Follow-up|0|||
23462226|NCT04885998|65434975|FG002|Overall Study|Lost to Follow-up|0|||
23462227|NCT04885998|65434976|FG003|Overall Study|Lost to Follow-up|0|||
23462228|NCT04885998|65434973|FG000|Overall Study|Death|2|||
23462229|NCT04885998|65434974|FG001|Overall Study|Death|1|||
23462230|NCT04885998|65434975|FG002|Overall Study|Death|1|||
23462231|NCT04885998|65434976|FG003|Overall Study|Death|0|||
23462232|NCT01317472|65434978|FG000|Overall Study|Withdrawal by Subject|1|||
23462233|NCT01317472|65434979|FG001|Overall Study|Withdrawal by Subject|0|||
23462234|NCT01317472|65434978|FG000|Overall Study|Unrelated hospitalization|1|||
23462235|NCT01317472|65434979|FG001|Overall Study|Unrelated hospitalization|0|||
23462236|NCT03815929|65434980|FG000|Overall Study|Lost to Follow-up|2|||
23462237|NCT03815929|65434981|FG001|Overall Study|Lost to Follow-up|1|||
23462238|NCT03815929|65434982|FG002|Overall Study|Lost to Follow-up|0|||
23462239|NCT03815929|65434980|FG000|Overall Study|Physician Decision|2|||
23462240|NCT03815929|65434981|FG001|Overall Study|Physician Decision|2|||
23462241|NCT03815929|65434982|FG002|Overall Study|Physician Decision|0|||
23462242|NCT03815929|65434980|FG000|Overall Study|Withdrawal by Subject|0|||
23462243|NCT03815929|65434981|FG001|Overall Study|Withdrawal by Subject|0|||
23462244|NCT03815929|65434982|FG002|Overall Study|Withdrawal by Subject|1|||
23462245|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462246|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
23462247|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462248|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462249|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462250|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462251|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462252|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462253|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462254|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462255|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462256|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462257|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462258|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462259|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
23462260|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462261|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462262|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462263|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462264|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462265|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462266|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462267|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462268|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462269|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462270|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462271|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
23462272|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462273|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462274|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462275|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462276|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462277|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462278|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462279|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462280|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462281|NCT04225897|65434987|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462282|NCT04225897|65434988|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462283|NCT04225897|65434989|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462284|NCT04225897|65434990|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462285|NCT04225897|65434991|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462286|NCT04225897|65434992|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462287|NCT04225897|65434993|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462288|NCT04225897|65434994|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
23462289|NCT04225897|65434995|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462290|NCT04225897|65434996|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462291|NCT04225897|65434997|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462292|NCT04225897|65434998|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462293|NCT04798196|65434999|FG000|Overall Study|Lost to Follow-up|3|||
23462294|NCT04798196|65435000|FG001|Overall Study|Lost to Follow-up|1|||
23462295|NCT04798196|65435001|FG002|Overall Study|Lost to Follow-up|3|||
23462296|NCT00724698|65435003|FG000|Overall Study|Adverse Event|9|||
23462297|NCT00724698|65435003|FG000|Overall Study|Failure of Therapy|4|||
23462298|NCT00724698|65435003|FG000|Overall Study|Poor Compliance|16|||
23462299|NCT00724698|65435003|FG000|Overall Study|Lost to Follow-up|36|||
23462300|NCT00724698|65435003|FG000|Overall Study|No Info|25|||
23462301|NCT03780244|65435009|FG000|Overall Study|Lost to Follow-up|1|||
23462302|NCT03780244|65435010|FG001|Overall Study|Lost to Follow-up|0|||
23462303|NCT02458313|65435011|FG000|Overall Study|Withdrawal by Subject|6|||
23462304|NCT02458313|65435012|FG001|Overall Study|Withdrawal by Subject|8|||
23462305|NCT02458313|65435011|FG000|Overall Study|Excluded for motion during MRI|1|||
23462306|NCT02458313|65435012|FG001|Overall Study|Excluded for motion during MRI|2|||
23462307|NCT02892344|65435013|FG000|Overall Study|Protocol deviation|3|||
23462308|NCT02892344|65435014|FG001|Overall Study|Protocol deviation|4|||
23462309|NCT02892344|65435013|FG000|Overall Study|Adverse Event|1|||
23462310|NCT02892344|65435014|FG001|Overall Study|Adverse Event|8|||
23462311|NCT02892344|65435013|FG000|Overall Study|Lost to Follow-up|0|||
23462312|NCT02892344|65435014|FG001|Overall Study|Lost to Follow-up|1|||
23462313|NCT02892344|65435013|FG000|Overall Study|Non-compliance with study treatment|0|||
23462314|NCT02892344|65435014|FG001|Overall Study|Non-compliance with study treatment|1|||
23462315|NCT02892344|65435013|FG000|Overall Study|Physician Decision|0|||
23462316|NCT02892344|65435014|FG001|Overall Study|Physician Decision|2|||
23462317|NCT02892344|65435013|FG000|Overall Study|Subject/guardian decision|0|||
23462318|NCT02892344|65435014|FG001|Overall Study|Subject/guardian decision|4|||
23462319|NCT02892344|65435013|FG000|Overall Study|Technical problems|0|||
23462320|NCT02892344|65435014|FG001|Overall Study|Technical problems|1|||
23462321|NCT01598532|65435015|FG000|Overall Study|Lost to Follow-up|3|||
23462322|NCT01598532|65435015|FG000|Overall Study|Did not meet inclusion criteria|8|||
23462323|NCT01353898|65435016|FG000|Overall Study|Study site terminated|0|||
23462324|NCT01353898|65435017|FG001|Overall Study|Study site terminated|0|||
23462325|NCT01353898|65435018|FG002|Overall Study|Study site terminated|0|||
23462326|NCT01353898|65435019|FG003|Overall Study|Study site terminated|0|||
23462327|NCT01353898|65435020|FG004|Overall Study|Study site terminated|0|||
23462328|NCT01353898|65435021|FG005|Overall Study|Study site terminated|1|||
23462329|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
23462330|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
23462331|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
23462332|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
23462333|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
23462334|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
23462335|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
23462336|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
23462337|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
23462338|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
23462339|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
23462340|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
23462341|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
23462342|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
23462343|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
23462344|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
23462345|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
23462346|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
23462347|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23462348|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23584799|NCT00542386|65869293|FG003|Overall Study|Death|2|||
23462349|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23462350|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
23462351|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
23462352|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
23462353|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
23462354|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
23462355|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
23462356|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
23462357|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
23462358|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
23462359|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
23462360|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
23462361|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
23462362|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
23462363|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
23462364|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
23462365|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
23462366|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
23462367|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
23462368|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Not treated|0|||
23462369|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Not treated|0|||
23462370|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Not treated|1|||
23462371|NCT01910298|65435028|FG000|Overall Study|Adverse Event|1|||
23462372|NCT01910298|65435029|FG001|Overall Study|Adverse Event|0|||
23462373|NCT01910298|65435028|FG000|Overall Study|Withdrawal by Subject|2|||
23462374|NCT01910298|65435029|FG001|Overall Study|Withdrawal by Subject|7|||
23462375|NCT01910298|65435028|FG000|Overall Study|Protocol Deviation|0|||
23462376|NCT01910298|65435029|FG001|Overall Study|Protocol Deviation|5|||
23462377|NCT01910298|65435028|FG000|Overall Study|Lost to Follow-up|1|||
23462378|NCT01910298|65435029|FG001|Overall Study|Lost to Follow-up|1|||
23462379|NCT01910298|65435028|FG000|Overall Study|Study Terminated by Sponsor|1|||
23462380|NCT01910298|65435029|FG001|Overall Study|Study Terminated by Sponsor|17|||
23462381|NCT01910298|65435028|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23462382|NCT01910298|65435029|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23462383|NCT01213472|65435030|FG000|Overall Study|Recurrence/Progressive disease|25|||
23462384|NCT01213472|65435030|FG000|Overall Study|Withdrawal by Subject|1|||
23462385|NCT01213472|65435030|FG000|Overall Study|Physician Decision|1|||
23462386|NCT00632229|65435031|FG000|Overall Study|Adverse Event|6|||
23462387|NCT00632229|65435032|FG001|Overall Study|Adverse Event|0|||
23462388|NCT00632229|65435031|FG000|Overall Study|Lost to Follow-up|0|||
23462389|NCT00632229|65435032|FG001|Overall Study|Lost to Follow-up|3|||
23462390|NCT00632229|65435031|FG000|Overall Study|Lack of Efficacy|0|||
23462391|NCT00632229|65435032|FG001|Overall Study|Lack of Efficacy|2|||
23462392|NCT00632229|65435031|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
23462393|NCT00632229|65435032|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
23462394|NCT02807402|65435033|FG000|Overall Study|Failure to Return|1|||
23462395|NCT02807402|65435033|FG000|Overall Study|Death|3|||
23462396|NCT02807402|65435033|FG000|Overall Study|Other|2|||
23462397|NCT02202759|65435034|FG000|Overall Study|Study Terminated by Sponsor|3|||
23462398|NCT02202759|65435035|FG001|Overall Study|Study Terminated by Sponsor|3|||
23462399|NCT02202759|65435036|FG002|Overall Study|Study Terminated by Sponsor|3|||
23462400|NCT02202759|65435034|FG000|Overall Study|Withdrawal by Subject|2|||
23462401|NCT02202759|65435035|FG001|Overall Study|Withdrawal by Subject|1|||
23462402|NCT02202759|65435036|FG002|Overall Study|Withdrawal by Subject|1|||
23462403|NCT02202759|65435034|FG000|Overall Study|Reason not Specified|4|||
23462404|NCT02202759|65435035|FG001|Overall Study|Reason not Specified|11|||
23462405|NCT02202759|65435036|FG002|Overall Study|Reason not Specified|10|||
23462406|NCT04322526|65435037|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
23462407|NCT04322526|65435038|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23462408|NCT04322526|65435037|FG000|Washout (1 Week)|Lost to Follow-up|1|||
23462409|NCT04322526|65435038|FG001|Washout (1 Week)|Lost to Follow-up|2|||
23462410|NCT01352793|65435039|FG000|Overall Study|Lost to Follow-up|289|||
23462411|NCT01352793|65435040|FG001|Overall Study|Lost to Follow-up|125|||
23462412|NCT01352793|65435039|FG000|Overall Study|Withdrawal by Subject|120|||
23462413|NCT01352793|65435040|FG001|Overall Study|Withdrawal by Subject|55|||
23462414|NCT01352793|65435039|FG000|Overall Study|Protocol Violation|44|||
23462415|NCT01352793|65435040|FG001|Overall Study|Protocol Violation|23|||
23462416|NCT01352793|65435039|FG000|Overall Study|Adverse Event|44|||
23462417|NCT01352793|65435040|FG001|Overall Study|Adverse Event|10|||
23462418|NCT01352793|65435039|FG000|Overall Study|Physician Decision|1|||
23462419|NCT01352793|65435040|FG001|Overall Study|Physician Decision|0|||
23462420|NCT01352793|65435039|FG000|Overall Study|Pregnancy|26|||
23462421|NCT01352793|65435040|FG001|Overall Study|Pregnancy|8|||
23462422|NCT01352793|65435039|FG000|Overall Study|Other|25|||
23462423|NCT01352793|65435040|FG001|Overall Study|Other|7|||
23462424|NCT01352793|65435039|FG000|Overall Study|Medication error|2|||
23462425|NCT01352793|65435040|FG001|Overall Study|Medication error|2|||
23462426|NCT01352793|65435039|FG000|Overall Study|Death|1|||
23462427|NCT01352793|65435040|FG001|Overall Study|Death|0|||
23462428|NCT01352793|65435039|FG000|Overall Study|Randomized but not vaccinated|8|||
23462429|NCT01352793|65435040|FG001|Overall Study|Randomized but not vaccinated|0|||
23462430|NCT01352793|65435039|FG000|Overall Study|No longer meets eligibility criteria|25|||
23462431|NCT01352793|65435040|FG001|Overall Study|No longer meets eligibility criteria|15|||
23462432|NCT00656513|65435045|FG000|Overall Study|Protocol Violation|1|||
23462433|NCT00656513|65435046|FG001|Overall Study|Protocol Violation|0|||
23462434|NCT00656513|65435047|FG002|Overall Study|Protocol Violation|2|||
23462435|NCT00656513|65435045|FG000|Overall Study|Withdrawal by Subject|0|||
23462436|NCT00656513|65435046|FG001|Overall Study|Withdrawal by Subject|11|||
23462437|NCT00656513|65435047|FG002|Overall Study|Withdrawal by Subject|4|||
23462438|NCT00656513|65435045|FG000|Overall Study|Death|0|||
23462439|NCT00656513|65435046|FG001|Overall Study|Death|0|||
23462440|NCT00656513|65435047|FG002|Overall Study|Death|1|||
23462441|NCT00656513|65435045|FG000|Overall Study|Missing data|0|||
23462442|NCT00656513|65435046|FG001|Overall Study|Missing data|11|||
23462443|NCT00656513|65435047|FG002|Overall Study|Missing data|9|||
23462444|NCT00656513|65435045|FG000|Overall Study|Incomplete treatment|3|||
23462445|NCT00656513|65435046|FG001|Overall Study|Incomplete treatment|0|||
23462446|NCT00656513|65435047|FG002|Overall Study|Incomplete treatment|0|||
23462447|NCT00656513|65435045|FG000|Overall Study|Treatment completed outside of timeframe|0|||
23462448|NCT00656513|65435046|FG001|Overall Study|Treatment completed outside of timeframe|3|||
23462449|NCT00656513|65435047|FG002|Overall Study|Treatment completed outside of timeframe|1|||
23462450|NCT00656513|65435045|FG000|Overall Study|Missing baseline form|0|||
23462451|NCT00656513|65435046|FG001|Overall Study|Missing baseline form|5|||
23462452|NCT00656513|65435047|FG002|Overall Study|Missing baseline form|5|||
23462453|NCT00885170|65435051|FG000|Overall Study|Adverse Event|12|||
23462454|NCT00885170|65435052|FG001|Overall Study|Adverse Event|4|||
23462455|NCT00885170|65435051|FG000|Overall Study|Excessive bone loss|6|||
23462456|NCT00885170|65435052|FG001|Overall Study|Excessive bone loss|3|||
23462457|NCT00885170|65435051|FG000|Overall Study|Lost to Follow-up|2|||
23462458|NCT00885170|65435052|FG001|Overall Study|Lost to Follow-up|1|||
23462459|NCT00885170|65435051|FG000|Overall Study|Physician Decision|2|||
23462460|NCT00885170|65435052|FG001|Overall Study|Physician Decision|1|||
23462461|NCT00885170|65435051|FG000|Overall Study|Protocol Violation|3|||
23462462|NCT00885170|65435052|FG001|Overall Study|Protocol Violation|1|||
23462463|NCT00885170|65435051|FG000|Overall Study|Withdrawal by Subject|13|||
23462464|NCT00885170|65435052|FG001|Overall Study|Withdrawal by Subject|13|||
23462465|NCT01980017|65435053|FG000|Overall Study|Lost to Follow-up|30|||
23462466|NCT01980017|65435054|FG001|Overall Study|Lost to Follow-up|21|||
23462467|NCT01980017|65435053|FG000|Overall Study|Death|0|||
23462468|NCT01980017|65435054|FG001|Overall Study|Death|1|||
23462469|NCT00887809|65435055|FG000|Overall Study|Patient Not Treated|3|||
23462470|NCT00887809|65435056|FG001|Overall Study|Patient Not Treated|0|||
23462471|NCT00887809|65435055|FG000|Overall Study|Death|1|||
23462472|NCT00887809|65435056|FG001|Overall Study|Death|0|||
23462473|NCT02038933|65435057|FG000|Overall Study|Disease progression|104|||
23462474|NCT02038933|65435057|FG000|Overall Study|Study drug toxicity|6|||
23462475|NCT02038933|65435057|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23789415|NCT04968925|66609373|FG002|Phase I- Period 1|Subject enrolled in error|0|||
23789416|NCT04968925|66609374|FG003|Phase I- Period 1|Subject enrolled in error|0|||
23789417|NCT04968925|66609371|FG000|Phase II- Period 1|COVID-19 Related|0|||
23789418|NCT04968925|66609372|FG001|Phase II- Period 1|COVID-19 Related|0|||
23789419|NCT04968925|66609373|FG002|Phase II- Period 1|COVID-19 Related|6|||
23789420|NCT04968925|66609374|FG003|Phase II- Period 1|COVID-19 Related|6|||
23462476|NCT02038933|65435057|FG000|Overall Study|Participant request to discontinue treatment|2|||
23462477|NCT02038933|65435057|FG000|Overall Study|Lost to Follow-up|1|||
23462478|NCT02038933|65435057|FG000|Overall Study|Other reasons|2|||
23462479|NCT03472885|65435058|FG000|24-Week Treatment Period|Adverse Event|1|||
23462480|NCT01491607|65435059|FG000|Overall Study|Lost to Follow-up|7|||
23462481|NCT01491607|65435059|FG000|Overall Study|Withdrawal by Subject|3|||
23462482|NCT00446849|65437889|FG000|Acute Phase|Lack of Efficacy|64|||
23462483|NCT00446849|65437889|FG000|Acute Phase|Protocol Violation|10|||
23584800|NCT00542386|65869294|FG004|Overall Study|Death|1|||
23462484|NCT00446849|65437889|FG000|Acute Phase|Consent withdrawn|4|||
23462485|NCT00446849|65437889|FG000|Acute Phase|Lost to Follow-up|2|||
23462486|NCT00446849|65437889|FG000|Acute Phase|Physician Decision|1|||
23462487|NCT00446849|65437889|FG000|Acute Phase|noncompliance|1|||
23462488|NCT00446849|65437889|FG000|Maintenance Phase|Lack of Efficacy|40|||
23789421|NCT04968925|66609371|FG000|Phase II- Period 1|Subject enrolled in error|0|||
23789422|NCT04968925|66609372|FG001|Phase II- Period 1|Subject enrolled in error|0|||
23789423|NCT04968925|66609373|FG002|Phase II- Period 1|Subject enrolled in error|1|||
23462489|NCT00446849|65437889|FG000|Maintenance Phase|Protocol Violation|7|||
23462490|NCT00446849|65437889|FG000|Maintenance Phase|Adverse Event|6|||
23462491|NCT00446849|65437889|FG000|Maintenance Phase|Consent withdrawn|5|||
23462492|NCT00446849|65437889|FG000|Maintenance Phase|Lost to Follow-up|3|||
23462493|NCT00446849|65437889|FG000|Maintenance Phase|Pregnancy|1|||
23462494|NCT00446849|65437889|FG000|Maintenance Phase|noncompliance|2|||
23462495|NCT00446849|65437889|FG000|Maintenance Phase|prohibited medication use|2|||
23462496|NCT00446849|65437889|FG000|Maintenance Phase|antibiotic use|1|||
23462497|NCT00446849|65437889|FG000|Maintenance Phase|study closure|1|||
23639673|NCT02217475|66064705|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
23639674|NCT02217475|66064703|FG000|Discontinued After Period 1|Physician Decision|0|||
23639675|NCT02217475|66064704|FG001|Discontinued After Period 1|Physician Decision|0|||
23789424|NCT04968925|66609374|FG003|Phase II- Period 1|Subject enrolled in error|0|||
23789425|NCT04968925|66609371|FG000|Phase II -Period 2|COVID-19 related|0|||
23789426|NCT04968925|66609372|FG001|Phase II -Period 2|COVID-19 related|0|||
23789427|NCT04968925|66609373|FG002|Phase II -Period 2|COVID-19 related|4|||
23789428|NCT04968925|66609374|FG003|Phase II -Period 2|COVID-19 related|3|||
23789429|NCT04968925|66609371|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
23789430|NCT04968925|66609372|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
23789431|NCT04968925|66609373|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
23789432|NCT04968925|66609374|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
23789433|NCT00985751|66609375|FG000|Overall Study|Adverse Event|0|||
23789434|NCT00985751|66609376|FG001|Overall Study|Adverse Event|0|||
23789435|NCT00985751|66609377|FG002|Overall Study|Adverse Event|0|||
23789436|NCT00985751|66609378|FG003|Overall Study|Adverse Event|0|||
23789437|NCT00985751|66609379|FG004|Overall Study|Adverse Event|1|||
23789438|NCT00484679|66609388|FG000|Overall Study|Withdrawal by Subject|3|||
23639676|NCT02217475|66064705|FG002|Discontinued After Period 1|Physician Decision|1|||
23639677|NCT02217475|66064703|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
23639678|NCT02217475|66064704|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
23639679|NCT02217475|66064705|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
23639680|NCT02217475|66064703|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
23639681|NCT02217475|66064704|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
23639682|NCT02217475|66064705|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
23639683|NCT02217475|66064703|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
23639684|NCT02217475|66064704|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
23639685|NCT02217475|66064705|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
23639686|NCT02217475|66064703|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
23639687|NCT02217475|66064704|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
23639688|NCT02217475|66064705|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
23639689|NCT02217475|66064703|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
23639690|NCT02217475|66064704|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
23639691|NCT02217475|66064705|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
23639692|NCT03449901|66064706|FG000|Overall Study|Progression|57|||
23639693|NCT03449901|66064707|FG001|Overall Study|Progression|12|||
23639694|NCT03449901|66064706|FG000|Overall Study|Adverse Event|3|||
23639695|NCT03449901|66064707|FG001|Overall Study|Adverse Event|0|||
23639696|NCT03449901|66064706|FG000|Overall Study|Death|6|||
23639697|NCT03449901|66064707|FG001|Overall Study|Death|2|||
23639698|NCT03449901|66064706|FG000|Overall Study|Withdrawal by Subject|12|||
23639699|NCT03449901|66064707|FG001|Overall Study|Withdrawal by Subject|1|||
23789439|NCT01018862|66609389|FG000|Overall Study|Adverse Event|2|||
23789440|NCT01018862|66609390|FG001|Overall Study|Adverse Event|0|||
23789441|NCT01018862|66609391|FG002|Overall Study|Adverse Event|6|||
23789442|NCT01018862|66609389|FG000|Overall Study|Lack of Efficacy|1|||
23789443|NCT01018862|66609390|FG001|Overall Study|Lack of Efficacy|0|||
23639700|NCT03449901|66064706|FG000|Overall Study|Physician Decision|1|||
23789444|NCT01018862|66609391|FG002|Overall Study|Lack of Efficacy|2|||
23789445|NCT01018862|66609389|FG000|Overall Study|Lost to Follow-up|3|||
23789446|NCT01018862|66609390|FG001|Overall Study|Lost to Follow-up|1|||
23462498|NCT00446849|65437889|FG000|Maintenance Phase|hydrocodone use|1|||
23639701|NCT03449901|66064707|FG001|Overall Study|Physician Decision|0|||
23639702|NCT03449901|66064706|FG000|Overall Study|Patient elected for surgical intervention|1|||
23639703|NCT03449901|66064707|FG001|Overall Study|Patient elected for surgical intervention|0|||
23639704|NCT03449901|66064706|FG000|Overall Study|Patient off for other complicating disease|1|||
23706195|NCT01258348|66301085|FG004|Overall Study|Adverse Event|4|||
23789447|NCT01018862|66609391|FG002|Overall Study|Lost to Follow-up|0|||
23789448|NCT01018862|66609389|FG000|Overall Study|Protocol Violation|1|||
23789449|NCT01018862|66609390|FG001|Overall Study|Protocol Violation|3|||
23789450|NCT01018862|66609391|FG002|Overall Study|Protocol Violation|3|||
23462499|NCT00446849|65437889|FG000|Maintenance Phase|concomitant medication use|1|||
23462500|NCT01498068|65437890|FG000|Overall Study|Withdrawal by Subject|1|||
23349719|NCT01651000|65025263|FG000|Overall Study|Lack of Efficacy|1|||
23349720|NCT01651000|65025264|FG001|Overall Study|Lack of Efficacy|1|||
23349721|NCT01651000|65025263|FG000|Overall Study|Physician Decision|1|||
23349722|NCT01651000|65025264|FG001|Overall Study|Physician Decision|0|||
23639705|NCT03449901|66064707|FG001|Overall Study|Patient off for other complicating disease|0|||
23639706|NCT01327495|66064708|FG000|Overall Study|Adverse Event|2|||
23789451|NCT01018862|66609389|FG000|Overall Study|Withdrawal by Subject|1|||
23789452|NCT01018862|66609390|FG001|Overall Study|Withdrawal by Subject|2|||
23789453|NCT01018862|66609391|FG002|Overall Study|Withdrawal by Subject|1|||
23789454|NCT01018862|66609389|FG000|Overall Study|administrative problems|5|||
23789455|NCT01018862|66609390|FG001|Overall Study|administrative problems|4|||
23789456|NCT01018862|66609391|FG002|Overall Study|administrative problems|4|||
23789457|NCT03025087|66609394|FG000|Overall Study|Physician Decision|3|||
23789458|NCT03025087|66609395|FG001|Overall Study|Physician Decision|3|||
23789459|NCT03025087|66609396|FG002|Overall Study|Physician Decision|0|||
23789460|NCT03025087|66609397|FG003|Overall Study|Physician Decision|0|||
23789461|NCT03025087|66609398|FG004|Overall Study|Physician Decision|0|||
23789462|NCT03025087|66609394|FG000|Overall Study|Withdrawal by Subject|1|||
23789463|NCT03025087|66609395|FG001|Overall Study|Withdrawal by Subject|1|||
23789464|NCT03025087|66609396|FG002|Overall Study|Withdrawal by Subject|0|||
23789465|NCT03025087|66609397|FG003|Overall Study|Withdrawal by Subject|0|||
23789466|NCT03025087|66609398|FG004|Overall Study|Withdrawal by Subject|0|||
23789467|NCT03025087|66609394|FG000|Overall Study|Unable to complete MRI|2|||
23349723|NCT01651000|65025263|FG000|Overall Study|Administrative reason|1|||
23349724|NCT01651000|65025264|FG001|Overall Study|Administrative reason|0|||
23349725|NCT01651000|65025263|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
23349726|NCT01651000|65025264|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
23789468|NCT03025087|66609395|FG001|Overall Study|Unable to complete MRI|2|||
23789469|NCT03025087|66609396|FG002|Overall Study|Unable to complete MRI|0|||
23789470|NCT03025087|66609397|FG003|Overall Study|Unable to complete MRI|0|||
23789471|NCT03025087|66609398|FG004|Overall Study|Unable to complete MRI|0|||
23789472|NCT00113919|66609405|FG000|Overall Study|Physician Decision|8|||
23789473|NCT00113919|66609405|FG000|Overall Study|Death|6|||
23789474|NCT02179190|66609409|FG000|Enrollment|Exit Prior to Device Attempt|11|||
23789475|NCT02179190|66609409|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
23789476|NCT02179190|66609409|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
23789477|NCT02179190|66609409|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
23789478|NCT02179190|66609409|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
23789479|NCT02179190|66609409|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
23789480|NCT03541252|66609410|FG000|Overall Study|Withdrawal by Subject|1|||
23789481|NCT01519947|66609413|FG000|Overall Study|Death|0|||
23349727|NCT01199822|65025267|FG000|Overall Study|Investigator discontinued therapy|0|||
23349728|NCT01199822|65025268|FG001|Overall Study|Investigator discontinued therapy|1|||
23462501|NCT01498068|65437891|FG001|Overall Study|Withdrawal by Subject|1|||
23584801|NCT00542386|65869295|FG005|Overall Study|Death|2|||
23584802|NCT00542386|65869290|FG000|Overall Study|Lack of Efficacy|32|||
23584803|NCT00542386|65869291|FG001|Overall Study|Lack of Efficacy|12|||
23584804|NCT00542386|65869292|FG002|Overall Study|Lack of Efficacy|10|||
23584805|NCT00542386|65869293|FG003|Overall Study|Lack of Efficacy|13|||
23584806|NCT00542386|65869294|FG004|Overall Study|Lack of Efficacy|7|||
23584807|NCT00542386|65869295|FG005|Overall Study|Lack of Efficacy|31|||
23584808|NCT00542386|65869290|FG000|Overall Study|Physician Decision|1|||
23584809|NCT00542386|65869291|FG001|Overall Study|Physician Decision|0|||
23584810|NCT00542386|65869292|FG002|Overall Study|Physician Decision|0|||
23584811|NCT00542386|65869293|FG003|Overall Study|Physician Decision|1|||
23584812|NCT00542386|65869294|FG004|Overall Study|Physician Decision|0|||
23584813|NCT00542386|65869295|FG005|Overall Study|Physician Decision|0|||
23584814|NCT00542386|65869290|FG000|Overall Study|Protocol Violation|0|||
23789482|NCT01519947|66609414|FG001|Overall Study|Death|0|||
23789483|NCT01519947|66609415|FG002|Overall Study|Death|0|||
23789484|NCT01519947|66609416|FG003|Overall Study|Death|1|||
23789485|NCT01519947|66609413|FG000|Overall Study|Protocol Violation|0|||
23789486|NCT01519947|66609414|FG001|Overall Study|Protocol Violation|0|||
23789487|NCT01519947|66609415|FG002|Overall Study|Protocol Violation|2|||
23789488|NCT01519947|66609416|FG003|Overall Study|Protocol Violation|1|||
23789489|NCT01519947|66609413|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
23349729|NCT01199822|65025269|FG002|Overall Study|Investigator discontinued therapy|0|||
23639707|NCT01327495|66064709|FG001|Overall Study|Adverse Event|1|||
23639708|NCT01327495|66064710|FG002|Overall Study|Adverse Event|1|||
23639709|NCT01327495|66064711|FG003|Overall Study|Adverse Event|0|||
23789490|NCT01519947|66609414|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
23789491|NCT01519947|66609415|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
23789492|NCT01519947|66609416|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
23639710|NCT01327495|66064712|FG004|Overall Study|Adverse Event|0|||
23639711|NCT01327495|66064713|FG005|Overall Study|Adverse Event|2|||
23639712|NCT01327495|66064708|FG000|Overall Study|Withdrawal by Subject|0|||
23639713|NCT01327495|66064709|FG001|Overall Study|Withdrawal by Subject|1|||
23639714|NCT01327495|66064710|FG002|Overall Study|Withdrawal by Subject|1|||
23639715|NCT01327495|66064711|FG003|Overall Study|Withdrawal by Subject|0|||
23639716|NCT01327495|66064712|FG004|Overall Study|Withdrawal by Subject|1|||
23639717|NCT01327495|66064713|FG005|Overall Study|Withdrawal by Subject|0|||
23639718|NCT01327495|66064708|FG000|Overall Study|Physician Decision|0|||
23639719|NCT01327495|66064709|FG001|Overall Study|Physician Decision|0|||
23639720|NCT01327495|66064710|FG002|Overall Study|Physician Decision|0|||
23639721|NCT01327495|66064711|FG003|Overall Study|Physician Decision|0|||
23639722|NCT01327495|66064712|FG004|Overall Study|Physician Decision|2|||
23639723|NCT01327495|66064713|FG005|Overall Study|Physician Decision|0|||
23639724|NCT00414908|66067328|FG000|Overall Study|Protocol Violation|1|||
23639725|NCT00414908|66067329|FG001|Overall Study|Protocol Violation|1|||
23639726|NCT00488475|66067330|FG000|Overall Study|Other|1754|||
23639727|NCT01789567|66067331|FG000|Overall Study|Death|6|||
23639728|NCT02731690|66067333|FG000|Overall Study|Adverse Event|1|||
23639729|NCT02731690|66067333|FG000|Overall Study|Withdrawal by Subject|3|||
23639730|NCT02731690|66067333|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
23639731|NCT01994837|66067334|FG000|Overall Study|Progressive disease per protocol|23|||
23639732|NCT01994837|66067334|FG000|Overall Study|Adv event related to progressive disease|3|||
23639733|NCT01994837|66067334|FG000|Overall Study|Fatal progressive disease|2|||
23639734|NCT01994837|66067334|FG000|Overall Study|Adverse event not related to progression|1|||
23639735|NCT01994837|66067334|FG000|Overall Study|Chose palliative care|1|||
23639736|NCT01994837|66067334|FG000|Overall Study|Proceeded to transplant|1|||
23639737|NCT01994837|66067334|FG000|Overall Study|Removed from study due to no response|1|||
23639738|NCT01639560|66067335|FG000|Overall Study|Withdrawal by Subject|9|||
23639739|NCT01639560|66067336|FG001|Overall Study|Withdrawal by Subject|14|||
23639740|NCT01639560|66067335|FG000|Overall Study|Lack of Efficacy|1|||
23639741|NCT01639560|66067336|FG001|Overall Study|Lack of Efficacy|2|||
23639742|NCT01639560|66067335|FG000|Overall Study|Lost to Follow-up|9|||
23639743|NCT01639560|66067336|FG001|Overall Study|Lost to Follow-up|11|||
23639744|NCT01639560|66067335|FG000|Overall Study|Adverse Event|0|||
23789493|NCT01519947|66609413|FG000|Overall Study|Development of Anemia|0|||
23789494|NCT01519947|66609414|FG001|Overall Study|Development of Anemia|1|||
23789495|NCT01519947|66609415|FG002|Overall Study|Development of Anemia|0|||
23789496|NCT01519947|66609416|FG003|Overall Study|Development of Anemia|1|||
23789497|NCT01519947|66609413|FG000|Overall Study|Blood Transfusion|0|||
23789498|NCT01519947|66609414|FG001|Overall Study|Blood Transfusion|1|||
23789499|NCT01519947|66609415|FG002|Overall Study|Blood Transfusion|1|||
23789500|NCT01519947|66609416|FG003|Overall Study|Blood Transfusion|0|||
23789501|NCT01519947|66609413|FG000|Overall Study|Withdrawal by Subject|0|||
23789502|NCT01519947|66609414|FG001|Overall Study|Withdrawal by Subject|1|||
23789503|NCT01519947|66609415|FG002|Overall Study|Withdrawal by Subject|0|||
23789504|NCT01519947|66609416|FG003|Overall Study|Withdrawal by Subject|1|||
23789505|NCT01519947|66609413|FG000|Overall Study|Lost to Follow-up|0|||
23789506|NCT01519947|66609414|FG001|Overall Study|Lost to Follow-up|0|||
23349730|NCT03871829|65025270|FG000|Overall Study|Lost to Follow-up|0|||
23349731|NCT03871829|65025271|FG001|Overall Study|Lost to Follow-up|1|||
23349732|NCT03871829|65025270|FG000|Overall Study|Withdrawal by Subject|1|||
23349733|NCT03871829|65025271|FG001|Overall Study|Withdrawal by Subject|1|||
23349734|NCT03871829|65025270|FG000|Overall Study|Death|12|||
23349735|NCT03871829|65025271|FG001|Overall Study|Death|8|||
23349736|NCT03871829|65025270|FG000|Overall Study|Study terminated by sponsor|31|||
23349737|NCT03871829|65025271|FG001|Overall Study|Study terminated by sponsor|34|||
23349738|NCT04594941|65025273|FG000|Overall Study|Other|0|||
23639745|NCT01639560|66067336|FG001|Overall Study|Adverse Event|2|||
23639746|NCT01305200|66067339|FG000|Overall Study|Physician Decision|4|||
23789507|NCT01519947|66609415|FG002|Overall Study|Lost to Follow-up|3|||
23789508|NCT01519947|66609416|FG003|Overall Study|Lost to Follow-up|2|||
23349739|NCT04594941|65025274|FG001|Overall Study|Other|3|||
23639747|NCT01305200|66067340|FG001|Overall Study|Physician Decision|6|||
23639748|NCT01305200|66067341|FG002|Overall Study|Physician Decision|1|||
23639749|NCT01305200|66067339|FG000|Overall Study|Withdrawal by Subject|24|||
23639750|NCT01305200|66067340|FG001|Overall Study|Withdrawal by Subject|21|||
23639751|NCT01305200|66067341|FG002|Overall Study|Withdrawal by Subject|1|||
23789509|NCT01519947|66609413|FG000|Overall Study|Poor Response|1|||
23789510|NCT01519947|66609414|FG001|Overall Study|Poor Response|0|||
23349740|NCT04594941|65025275|FG002|Overall Study|Other|1|||
23639752|NCT01305200|66067339|FG000|Overall Study|Ineligible|1|||
23639753|NCT01305200|66067340|FG001|Overall Study|Ineligible|2|||
23639754|NCT01305200|66067341|FG002|Overall Study|Ineligible|1|||
23639755|NCT01305200|66067339|FG000|Overall Study|Death|0|||
23639756|NCT01305200|66067340|FG001|Overall Study|Death|2|||
23639757|NCT01305200|66067341|FG002|Overall Study|Death|0|||
23639758|NCT01151410|66067342|FG000|Overall Study|Withdrawal by Subject|3|||
23584815|NCT00542386|65869291|FG001|Overall Study|Protocol Violation|0|||
23584816|NCT00542386|65869292|FG002|Overall Study|Protocol Violation|1|||
23584817|NCT00542386|65869293|FG003|Overall Study|Protocol Violation|0|||
23584818|NCT00542386|65869294|FG004|Overall Study|Protocol Violation|0|||
23584819|NCT00542386|65869295|FG005|Overall Study|Protocol Violation|4|||
23584820|NCT00542386|65869290|FG000|Overall Study|Withdrawal by Subject|5|||
23584821|NCT00542386|65869291|FG001|Overall Study|Withdrawal by Subject|8|||
23584822|NCT00542386|65869292|FG002|Overall Study|Withdrawal by Subject|10|||
23584823|NCT00542386|65869293|FG003|Overall Study|Withdrawal by Subject|11|||
23584824|NCT00542386|65869294|FG004|Overall Study|Withdrawal by Subject|15|||
23639759|NCT01151410|66067343|FG001|Overall Study|Withdrawal by Subject|5|||
23639760|NCT01151410|66067342|FG000|Overall Study|Lost to Follow-up|3|||
23639761|NCT01151410|66067343|FG001|Overall Study|Lost to Follow-up|4|||
23639762|NCT01151410|66067342|FG000|Overall Study|Adverse Event|1|||
23639763|NCT01151410|66067343|FG001|Overall Study|Adverse Event|2|||
23639764|NCT01151410|66067342|FG000|Overall Study|Protocol deviation|2|||
23639765|NCT01151410|66067343|FG001|Overall Study|Protocol deviation|1|||
23639766|NCT01151410|66067342|FG000|Overall Study|Administrative problems|1|||
23639767|NCT01151410|66067343|FG001|Overall Study|Administrative problems|1|||
23639768|NCT01151410|66067342|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23639769|NCT01151410|66067343|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23639770|NCT01151410|66067342|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23639771|NCT01151410|66067343|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23639772|NCT00818168|66067344|FG000|Overall Study|Lack of Efficacy|18|||
23639773|NCT00818168|66067344|FG000|Overall Study|Pregnancy|2|||
23639774|NCT00818168|66067344|FG000|Overall Study|Withdrawal by Subject|16|||
23639775|NCT00818168|66067344|FG000|Overall Study|Lost to Follow-up|7|||
23639776|NCT00818168|66067344|FG000|Overall Study|Adverse Event|19|||
23639777|NCT00818168|66067344|FG000|Overall Study|Reason for Non-completion Not reported|6|||
23639778|NCT00818168|66067344|FG000|Overall Study|Participant Moved|2|||
23639779|NCT04032613|66067345|FG000|Overall Study|Did not complete post-program assessment|5|||
23639780|NCT04032613|66067346|FG001|Overall Study|Did not complete post-program assessment|2|||
23639781|NCT00379288|66067347|FG000|Overall Study|Adverse Event|5|||
23639782|NCT00379288|66067348|FG001|Overall Study|Adverse Event|6|||
23639783|NCT00379288|66067349|FG002|Overall Study|Adverse Event|2|||
23639784|NCT00379288|66067350|FG003|Overall Study|Adverse Event|0|||
23639785|NCT00379288|66067347|FG000|Overall Study|Treatment Failure|0|||
23639786|NCT00379288|66067348|FG001|Overall Study|Treatment Failure|1|||
23639787|NCT00379288|66067349|FG002|Overall Study|Treatment Failure|0|||
23639788|NCT00379288|66067350|FG003|Overall Study|Treatment Failure|1|||
23639789|NCT00379288|66067347|FG000|Overall Study|Lost to Follow-up|3|||
23639790|NCT00379288|66067348|FG001|Overall Study|Lost to Follow-up|3|||
23639791|NCT00379288|66067349|FG002|Overall Study|Lost to Follow-up|2|||
23639792|NCT00379288|66067350|FG003|Overall Study|Lost to Follow-up|0|||
23639793|NCT00379288|66067347|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
23639794|NCT00379288|66067348|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
23639795|NCT00379288|66067349|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
23639796|NCT00379288|66067350|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
23639797|NCT00379288|66067347|FG000|Overall Study|Subject withdrew-related to study drug|1|||
23639798|NCT00379288|66067348|FG001|Overall Study|Subject withdrew-related to study drug|0|||
23639799|NCT00379288|66067349|FG002|Overall Study|Subject withdrew-related to study drug|0|||
23639800|NCT00379288|66067350|FG003|Overall Study|Subject withdrew-related to study drug|1|||
23639801|NCT00379288|66067347|FG000|Overall Study|Noncompliance with protocol|8|||
23639802|NCT00379288|66067348|FG001|Overall Study|Noncompliance with protocol|6|||
23639803|NCT00379288|66067349|FG002|Overall Study|Noncompliance with protocol|2|||
23639804|NCT00379288|66067350|FG003|Overall Study|Noncompliance with protocol|1|||
23639805|NCT00379288|66067347|FG000|Overall Study|Did not meet protocol eligibility|0|||
23639806|NCT00379288|66067348|FG001|Overall Study|Did not meet protocol eligibility|1|||
23789511|NCT01519947|66609415|FG002|Overall Study|Poor Response|0|||
23789512|NCT01519947|66609416|FG003|Overall Study|Poor Response|1|||
23789513|NCT01519947|66609413|FG000|Overall Study|Adverse Event|1|||
23789514|NCT01519947|66609414|FG001|Overall Study|Adverse Event|0|||
23789515|NCT01519947|66609415|FG002|Overall Study|Adverse Event|1|||
23789516|NCT01519947|66609416|FG003|Overall Study|Adverse Event|1|||
23789517|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
23639807|NCT00379288|66067349|FG002|Overall Study|Did not meet protocol eligibility|0|||
23639808|NCT00379288|66067350|FG003|Overall Study|Did not meet protocol eligibility|2|||
23639809|NCT00379288|66067347|FG000|Overall Study|Administrative|2|||
23639810|NCT00379288|66067348|FG001|Overall Study|Administrative|2|||
23639811|NCT00379288|66067349|FG002|Overall Study|Administrative|0|||
23639812|NCT00379288|66067350|FG003|Overall Study|Administrative|1|||
23639813|NCT01655693|66067353|FG000|Overall Study|Progression of Disease|92|||
23462502|NCT04434937|65437892|FG000|Overall Study|Death|4|||
23462503|NCT04434937|65437892|FG000|Overall Study|Withdrawal by Subject|1|||
23462504|NCT04434937|65437892|FG000|Overall Study|Transitioned to Rollover Study|19|||
23462505|NCT04434937|65437892|FG000|Overall Study|Progressive Disease|18|||
23462506|NCT03220035|65437893|FG000|Overall Study|Adverse Event|1|||
23462507|NCT03220035|65437893|FG000|Overall Study|Protocol Violation|1|||
23584825|NCT00542386|65869295|FG005|Overall Study|Withdrawal by Subject|7|||
23584826|NCT00542386|65869290|FG000|Overall Study|Other Reasons|4|||
23584827|NCT00542386|65869291|FG001|Overall Study|Other Reasons|1|||
23584828|NCT00542386|65869292|FG002|Overall Study|Other Reasons|4|||
23584829|NCT00542386|65869293|FG003|Overall Study|Other Reasons|3|||
23584830|NCT00542386|65869294|FG004|Overall Study|Other Reasons|4|||
23584831|NCT00542386|65869295|FG005|Overall Study|Other Reasons|2|||
23584832|NCT00545844|65869296|FG000|Overall Study|Lost to Follow-up|9|||
23584833|NCT00545844|65869296|FG000|Overall Study|Protocol Violation|1|||
23584834|NCT00545844|65869296|FG000|Overall Study|Withdrawal by Subject|2|||
23584835|NCT03210402|65869297|FG000|Overall Study|Withdrawal by Subject|0|||
23584836|NCT03210402|65869298|FG001|Overall Study|Withdrawal by Subject|1|||
23584837|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
23584838|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
23584839|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
23584840|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
23584841|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
23584842|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
23584843|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
23584844|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
23584845|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Death|1|||
23584846|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Death|0|||
23349741|NCT04594941|65025276|FG003|Overall Study|Other|0|||
23349742|NCT01167634|65025277|FG000|Overall Study|Lost to Follow-up|1|||
23462508|NCT03220035|65437893|FG000|Overall Study|Progressive Disease|2|||
23584847|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
23584848|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
23584849|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
23584850|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
23639814|NCT01655693|66067354|FG001|Overall Study|Progression of Disease|76|||
23639815|NCT01655693|66067355|FG002|Overall Study|Progression of Disease|58|||
23639816|NCT01655693|66067353|FG000|Overall Study|Death|8|||
23349743|NCT01167634|65025278|FG001|Overall Study|Lost to Follow-up|3|||
23462509|NCT04986904|65437894|FG000|Overall Study|Lost to Follow-up|11|||
23639817|NCT01655693|66067354|FG001|Overall Study|Death|9|||
23639818|NCT01655693|66067355|FG002|Overall Study|Death|12|||
23639819|NCT01655693|66067353|FG000|Overall Study|Serious Adverse Event|3|||
23789518|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
23789519|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
23789520|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
23789521|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
23789522|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
23789523|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
23789524|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
23789525|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
23789526|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
23789527|NCT01438060|66609417|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
23789528|NCT01438060|66609418|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
23789529|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
23789530|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
23789531|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
23789532|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
23789533|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
23789534|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
23789535|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
23789536|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
23789537|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
23789538|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
23789539|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
23789540|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
23789541|NCT01438060|66609417|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
23789542|NCT01438060|66609418|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
23789543|NCT01438060|66609417|FG000|On Study Beyond Week 140|Adverse Event|0|||
23789544|NCT01438060|66609418|FG001|On Study Beyond Week 140|Adverse Event|2|||
23789545|NCT01438060|66609417|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
23789546|NCT01438060|66609418|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
23789547|NCT01438060|66609417|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
23789548|NCT01438060|66609418|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
23789549|NCT01438060|66609417|FG000|On Study Beyond Week 140|Death|0|||
23789550|NCT01438060|66609418|FG001|On Study Beyond Week 140|Death|1|||
23789551|NCT01438060|66609417|FG000|On Study Beyond Week 140|Other Reason|0|||
23789552|NCT01438060|66609418|FG001|On Study Beyond Week 140|Other Reason|3|||
23789553|NCT01675596|66609419|FG000|Overall Study|Death|6|||
23789554|NCT01675596|66609419|FG000|Overall Study|Exit with other reason|1|||
23789555|NCT01675596|66609419|FG000|Overall Study|Missed Visit|1|||
23789556|NCT02003391|66609420|FG000|Overall Study|Withdrawal by Subject|2|||
23789557|NCT02003391|66609421|FG001|Overall Study|Withdrawal by Subject|1|||
23639820|NCT01655693|66067354|FG001|Overall Study|Serious Adverse Event|15|||
23639821|NCT01655693|66067355|FG002|Overall Study|Serious Adverse Event|11|||
23639822|NCT01655693|66067353|FG000|Overall Study|Withdrawal by Subject|3|||
23639823|NCT01655693|66067354|FG001|Overall Study|Withdrawal by Subject|2|||
23639824|NCT01655693|66067355|FG002|Overall Study|Withdrawal by Subject|20|||
23639825|NCT01655693|66067353|FG000|Overall Study|Adverse Event|3|||
23639826|NCT01655693|66067354|FG001|Overall Study|Adverse Event|11|||
23789558|NCT02003391|66609420|FG000|Overall Study|Protocol Violation|0|||
23349744|NCT01167634|65025279|FG002|Overall Study|Lost to Follow-up|3|||
23349745|NCT01167634|65025280|FG003|Overall Study|Lost to Follow-up|4|||
23349746|NCT01167634|65025277|FG000|Overall Study|Withdrawal by Subject|1|||
23349747|NCT01167634|65025278|FG001|Overall Study|Withdrawal by Subject|1|||
23349748|NCT01167634|65025279|FG002|Overall Study|Withdrawal by Subject|0|||
23349749|NCT01167634|65025280|FG003|Overall Study|Withdrawal by Subject|0|||
23349750|NCT03338569|65025281|FG000|Overall Study|Physician Decision|8|||
23349751|NCT03338569|65025282|FG001|Overall Study|Physician Decision|3|||
23349752|NCT03338569|65025281|FG000|Overall Study|Withdrawal by Subject|0|||
23349753|NCT03338569|65025282|FG001|Overall Study|Withdrawal by Subject|1|||
23349754|NCT03338569|65025281|FG000|Overall Study|Lost to Follow-up|0|||
23349755|NCT03338569|65025282|FG001|Overall Study|Lost to Follow-up|1|||
23349756|NCT02854605|65025285|FG000|Overall Study|Adverse Event|1|||
23349757|NCT02854605|65025286|FG001|Overall Study|Adverse Event|5|||
23349758|NCT02854605|65025287|FG002|Overall Study|Adverse Event|2|||
23349759|NCT02854605|65025285|FG000|Overall Study|Lost to Follow-up|0|||
23349760|NCT02854605|65025286|FG001|Overall Study|Lost to Follow-up|2|||
23349761|NCT02854605|65025287|FG002|Overall Study|Lost to Follow-up|0|||
23349762|NCT02854605|65025285|FG000|Overall Study|Withdrew Consent|1|||
23349763|NCT02854605|65025286|FG001|Overall Study|Withdrew Consent|0|||
23349764|NCT02854605|65025287|FG002|Overall Study|Withdrew Consent|1|||
23349765|NCT02854605|65025285|FG000|Overall Study|Investigator's Discretion|1|||
23349766|NCT02854605|65025286|FG001|Overall Study|Investigator's Discretion|0|||
23349767|NCT02854605|65025287|FG002|Overall Study|Investigator's Discretion|0|||
23349768|NCT02854605|65025285|FG000|Overall Study|Protocol Violation|0|||
23349769|NCT02854605|65025286|FG001|Overall Study|Protocol Violation|0|||
23349770|NCT02854605|65025287|FG002|Overall Study|Protocol Violation|1|||
23349771|NCT04529850|65025288|FG000|Overall Study|Death|2|||
23349772|NCT04529850|65025288|FG000|Overall Study|Physician Decision|1|||
23349773|NCT04529850|65025288|FG000|Overall Study|Withdrawal by Subject|2|||
23349774|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349775|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349776|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23462510|NCT04986904|65437894|FG000|Overall Study|Withdrawal by Subject|1|||
23462511|NCT00807911|65437895|FG000|Overall Study|Withdrawal by Subject|12|||
23462512|NCT00807911|65437896|FG001|Overall Study|Withdrawal by Subject|10|||
23462513|NCT00807911|65437895|FG000|Overall Study|Ineligible|0|||
23462514|NCT00807911|65437896|FG001|Overall Study|Ineligible|4|||
23462515|NCT01704599|65437897|FG000|Overall Study|Adverse Event|1|||
23462516|NCT02636595|65437902|FG000|Overall Study|Lost to Follow-up|1|||
23462517|NCT02636595|65437902|FG000|Overall Study|Other|1|||
23462518|NCT02007096|65437903|FG000|Overall Study|medication not available|2|||
23462519|NCT02007096|65437904|FG001|Overall Study|medication not available|0|||
23462520|NCT02007096|65437903|FG000|Overall Study|did not inject saline|0|||
23462521|NCT02007096|65437904|FG001|Overall Study|did not inject saline|3|||
23462522|NCT02007096|65437903|FG000|Overall Study|did not follow postoperative protocol|8|||
23462523|NCT02007096|65437904|FG001|Overall Study|did not follow postoperative protocol|11|||
23639827|NCT01655693|66067355|FG002|Overall Study|Adverse Event|3|||
23349777|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349778|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349779|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349780|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349781|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349782|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349783|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349784|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349785|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23462524|NCT02007096|65437903|FG000|Overall Study|converted to open surgery|1|||
23462525|NCT02007096|65437904|FG001|Overall Study|converted to open surgery|1|||
23349786|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349787|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349788|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
23462526|NCT02007096|65437903|FG000|Overall Study|no mesh placed|0|||
23462527|NCT02007096|65437904|FG001|Overall Study|no mesh placed|1|||
23462528|NCT02703597|65437905|FG000|Assignment to Baseline|Lost to Follow-up|17|||
23462529|NCT02703597|65437906|FG001|Assignment to Baseline|Lost to Follow-up|16|||
23462530|NCT02703597|65437905|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
23462531|NCT02703597|65437906|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
23462532|NCT02703597|65437905|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
23462533|NCT02703597|65437906|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
23462534|NCT02703597|65437905|FG000|First Post-test to First Follow-up|Site drop out|0|||
23462535|NCT02703597|65437906|FG001|First Post-test to First Follow-up|Site drop out|58|||
23462536|NCT02703597|65437905|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
23462537|NCT02703597|65437906|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
23462538|NCT02703597|65437905|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
23462539|NCT02703597|65437906|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
23349789|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349790|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349791|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349792|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349793|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349794|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349795|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349796|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23462540|NCT02703597|65437905|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
23462541|NCT02703597|65437906|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
23584851|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
23584852|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
23584853|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
23584854|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
23584855|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
23584856|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
23462542|NCT03100149|65437907|FG000|Overall Study|Adverse Event|0|||
23462543|NCT03100149|65437908|FG001|Overall Study|Adverse Event|1|||
23462544|NCT03100149|65437909|FG002|Overall Study|Adverse Event|0|||
23584857|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
23584858|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
23584859|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
23584860|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
23462545|NCT03100149|65437907|FG000|Overall Study|Participant Moved out of Country|0|||
23462546|NCT03100149|65437908|FG001|Overall Study|Participant Moved out of Country|0|||
23462547|NCT03100149|65437909|FG002|Overall Study|Participant Moved out of Country|1|||
23462548|NCT03100149|65437907|FG000|Overall Study|Withdrawal by Subject|0|||
23462549|NCT03100149|65437908|FG001|Overall Study|Withdrawal by Subject|3|||
23462550|NCT03100149|65437909|FG002|Overall Study|Withdrawal by Subject|1|||
23462551|NCT03848728|65437910|FG000|Overall Study|Death|16|||
23462552|NCT03848728|65437911|FG001|Overall Study|Death|13|||
23462553|NCT03848728|65437910|FG000|Overall Study|Outmigrated to non-study community|98|||
23462554|NCT03848728|65437911|FG001|Overall Study|Outmigrated to non-study community|106|||
23462555|NCT03848728|65437910|FG000|Overall Study|Transfered to non-study clinic|32|||
23462556|NCT03848728|65437911|FG001|Overall Study|Transfered to non-study clinic|48|||
23462557|NCT03848728|65437910|FG000|Overall Study|Withdrawal by Subject|1|||
23462558|NCT03848728|65437911|FG001|Overall Study|Withdrawal by Subject|0|||
23462559|NCT03405792|65437916|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
23462560|NCT03405792|65437917|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
23462561|NCT03405792|65437916|FG000|Overall Study|o Did not receive pembrolizumab|1|||
23462562|NCT03405792|65437917|FG001|Overall Study|o Did not receive pembrolizumab|0|||
23462563|NCT03331315|65437918|FG000|Overall Study|Physician Decision|18|||
23584861|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
23584862|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
23639828|NCT01655693|66067353|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
23706196|NCT01258348|66301081|FG000|Overall Study|Progressive Disease|0|||
23462564|NCT03331315|65437919|FG001|Overall Study|Physician Decision|14|||
23462565|NCT03525678|65437923|FG000|Overall Study|Withdrawal by Subject|8|||
23462566|NCT03525678|65437924|FG001|Overall Study|Withdrawal by Subject|2|||
23462567|NCT03525678|65437925|FG002|Overall Study|Withdrawal by Subject|2|||
23462568|NCT03525678|65437923|FG000|Overall Study|Physician Decision|2|||
23462569|NCT03525678|65437924|FG001|Overall Study|Physician Decision|4|||
23462570|NCT03525678|65437925|FG002|Overall Study|Physician Decision|0|||
23462571|NCT03525678|65437923|FG000|Overall Study|Lost to Follow-up|2|||
23462572|NCT03525678|65437924|FG001|Overall Study|Lost to Follow-up|1|||
23462573|NCT03525678|65437925|FG002|Overall Study|Lost to Follow-up|2|||
23349797|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23462574|NCT03525678|65437923|FG000|Overall Study|Death|70|||
23462575|NCT03525678|65437924|FG001|Overall Study|Death|80|||
23462576|NCT03525678|65437925|FG002|Overall Study|Death|16|||
23462577|NCT03525678|65437923|FG000|Overall Study|other reasons|14|||
23462578|NCT03525678|65437924|FG001|Overall Study|other reasons|10|||
23462579|NCT03525678|65437925|FG002|Overall Study|other reasons|5|||
23462580|NCT03525678|65437923|FG000|Overall Study|ongoing at the time of analysis|1|||
23462581|NCT03525678|65437924|FG001|Overall Study|ongoing at the time of analysis|2|||
23462582|NCT03525678|65437925|FG002|Overall Study|ongoing at the time of analysis|0|||
23462583|NCT01435382|65437928|FG000|Overall Study|Lost to Follow-up|1|||
23462584|NCT01435382|65437929|FG001|Overall Study|Lost to Follow-up|0|||
23462585|NCT01435382|65437930|FG002|Overall Study|Lost to Follow-up|1|||
23462586|NCT01435382|65437931|FG003|Overall Study|Lost to Follow-up|0|||
23462587|NCT01435382|65437928|FG000|Overall Study|Withdrawal by Subject|0|||
23462588|NCT01435382|65437929|FG001|Overall Study|Withdrawal by Subject|2|||
23462589|NCT01435382|65437930|FG002|Overall Study|Withdrawal by Subject|0|||
23462590|NCT01435382|65437931|FG003|Overall Study|Withdrawal by Subject|1|||
23462591|NCT03910244|65437932|FG000|Overall Study|Adverse Event|14|||
23462592|NCT03910244|65437933|FG001|Overall Study|Adverse Event|0|||
23462593|NCT03910244|65437932|FG000|Overall Study|Death|1|||
23462594|NCT03910244|65437933|FG001|Overall Study|Death|0|||
23462595|NCT03910244|65437932|FG000|Overall Study|Lost to Follow-up|0|||
23462596|NCT03910244|65437933|FG001|Overall Study|Lost to Follow-up|2|||
23462597|NCT03910244|65437932|FG000|Overall Study|Joint withdrawal decision|1|||
23462598|NCT03910244|65437933|FG001|Overall Study|Joint withdrawal decision|0|||
23462599|NCT03910244|65437932|FG000|Overall Study|Study Terminated by Sponsor|7|||
23462600|NCT03910244|65437933|FG001|Overall Study|Study Terminated by Sponsor|4|||
23462601|NCT03910244|65437932|FG000|Overall Study|Physician Decision|1|||
23462602|NCT03910244|65437933|FG001|Overall Study|Physician Decision|0|||
23462603|NCT03910244|65437932|FG000|Overall Study|Protocol Violation|1|||
23462604|NCT03910244|65437933|FG001|Overall Study|Protocol Violation|0|||
23462605|NCT03910244|65437932|FG000|Overall Study|Withdrawal by Subject|7|||
23462606|NCT03910244|65437933|FG001|Overall Study|Withdrawal by Subject|2|||
23462607|NCT03126591|65437936|FG000|Overall Study|Death|6|||
23462608|NCT03126591|65437937|FG001|Overall Study|Death|3|||
23462609|NCT03126591|65437938|FG002|Overall Study|Death|17|||
23462610|NCT03126591|65437936|FG000|Overall Study|Progressive Disease|0|||
23462611|NCT03126591|65437937|FG001|Overall Study|Progressive Disease|1|||
23584863|NCT02759731|65869301|FG000|Overall Study|Did not complete treatment.|8|||
23462612|NCT03126591|65437938|FG002|Overall Study|Progressive Disease|2|||
23462613|NCT03126591|65437936|FG000|Overall Study|Terminated by Sponsor|0|||
23462614|NCT03126591|65437937|FG001|Overall Study|Terminated by Sponsor|1|||
23462615|NCT03126591|65437938|FG002|Overall Study|Terminated by Sponsor|4|||
23462616|NCT03126591|65437936|FG000|Overall Study|Withdrawal by Subject|1|||
23462617|NCT03126591|65437937|FG001|Overall Study|Withdrawal by Subject|1|||
23462618|NCT03126591|65437938|FG002|Overall Study|Withdrawal by Subject|4|||
23462619|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
23462620|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
23462621|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
23462622|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Death|9|||
23462623|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Death|0|||
23462624|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Death|0|||
23462625|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
23462626|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
23462627|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
23462628|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
23462629|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
23462630|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
23462631|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Other|135|||
23462632|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Other|0|||
23462633|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Other|0|||
23462634|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
23462635|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
23462636|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
23462637|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
23462638|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
23462639|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
23462640|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
23462641|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
23462642|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
23462643|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Other|3|||
23462644|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Other|0|||
23462645|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Other|0|||
23462646|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
23462647|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
23462648|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
23462649|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
23462650|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
23462651|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
23462652|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
23462653|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
23462654|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
23462655|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
23462656|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
23462657|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
23462658|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
23462659|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
23462660|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
23462661|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
23462662|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
23462663|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
23462664|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
23639829|NCT01655693|66067354|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
23789559|NCT02003391|66609421|FG001|Overall Study|Protocol Violation|1|||
23789560|NCT02003391|66609420|FG000|Overall Study|Adverse Event|1|||
23789561|NCT02003391|66609421|FG001|Overall Study|Adverse Event|0|||
23789562|NCT01923740|66609422|FG000|Overall Study|Lost to Follow-up|4|||
23789563|NCT01923740|66609423|FG001|Overall Study|Lost to Follow-up|9|||
23789564|NCT01923740|66609422|FG000|Overall Study|Withdrawal by Subject|2|||
23789565|NCT01923740|66609423|FG001|Overall Study|Withdrawal by Subject|0|||
23789566|NCT03669861|66609424|FG000|Overall Study|Disease Flare|5|||
23789567|NCT03669861|66609424|FG000|Overall Study|Lack of Efficacy|2|||
23789568|NCT01963260|66609430|FG000|Overall Study|Withdrawal by Subject|2|||
23789569|NCT01963260|66609431|FG001|Overall Study|Withdrawal by Subject|0|||
23789570|NCT01963260|66609432|FG002|Overall Study|Withdrawal by Subject|0|||
23789571|NCT01963260|66609433|FG003|Overall Study|Withdrawal by Subject|1|||
23789572|NCT01963260|66609434|FG004|Overall Study|Withdrawal by Subject|2|||
23789573|NCT01963260|66609435|FG005|Overall Study|Withdrawal by Subject|0|||
23789574|NCT01963260|66609436|FG006|Overall Study|Withdrawal by Subject|0|||
23789575|NCT01963260|66609437|FG007|Overall Study|Withdrawal by Subject|0|||
23462665|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
23462666|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
23462667|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
23462668|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
23789576|NCT01963260|66609438|FG008|Overall Study|Withdrawal by Subject|0|||
23789577|NCT01963260|66609439|FG009|Overall Study|Withdrawal by Subject|0|||
23789578|NCT02694536|66609440|FG000|Overall Study|Progressive Disease|40|||
23789579|NCT02694536|66609440|FG000|Overall Study|Lost to Follow-up|1|||
23789580|NCT02694536|66609440|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
23789581|NCT02694536|66609440|FG000|Overall Study|Withdrawal by Subject|8|||
23789582|NCT02694536|66609440|FG000|Overall Study|Death|8|||
23789583|NCT02694536|66609440|FG000|Overall Study|Other|22|||
23789584|NCT04473326|66609444|FG000|Overall Study|Death|0|||
23789585|NCT04473326|66609445|FG001|Overall Study|Death|1|||
23789586|NCT04473326|66609444|FG000|Overall Study|Withdrawal by Subject|1|||
23789587|NCT04473326|66609445|FG001|Overall Study|Withdrawal by Subject|2|||
23789588|NCT00529763|66609446|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23789589|NCT00529763|66609447|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
23789590|NCT00529763|66609448|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23789591|NCT00529763|66609446|FG000|Overall Study|Death|1|||
23789592|NCT00529763|66609447|FG001|Overall Study|Death|1|||
23789593|NCT00529763|66609448|FG002|Overall Study|Death|1|||
23789594|NCT00529763|66609446|FG000|Overall Study|Disease Progression|10|||
23789595|NCT00529763|66609447|FG001|Overall Study|Disease Progression|16|||
23789596|NCT00529763|66609448|FG002|Overall Study|Disease Progression|11|||
23789597|NCT00529763|66609446|FG000|Overall Study|Lost to Follow-up|1|||
23789598|NCT00529763|66609447|FG001|Overall Study|Lost to Follow-up|2|||
23789599|NCT00529763|66609448|FG002|Overall Study|Lost to Follow-up|3|||
23789600|NCT00529763|66609446|FG000|Overall Study|Stem Cell Transplant|0|||
23789601|NCT00529763|66609447|FG001|Overall Study|Stem Cell Transplant|3|||
23789602|NCT00529763|66609448|FG002|Overall Study|Stem Cell Transplant|1|||
23789603|NCT00529763|66609446|FG000|Overall Study|Study Drug Toxicity|3|||
23789604|NCT00529763|66609447|FG001|Overall Study|Study Drug Toxicity|6|||
23349798|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349799|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349800|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23789605|NCT00529763|66609448|FG002|Overall Study|Study Drug Toxicity|4|||
23789606|NCT00529763|66609446|FG000|Overall Study|Participant Withdrew Consent|2|||
23789607|NCT00529763|66609447|FG001|Overall Study|Participant Withdrew Consent|3|||
23349801|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349802|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23349803|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23349804|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349805|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23639830|NCT01655693|66067355|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
23639831|NCT01655693|66067353|FG000|Overall Study|Non-Compliance|0|||
23639832|NCT01655693|66067354|FG001|Overall Study|Non-Compliance|0|||
23639833|NCT01655693|66067355|FG002|Overall Study|Non-Compliance|7|||
23639834|NCT01655693|66067353|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
23639835|NCT01655693|66067354|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
23639836|NCT01655693|66067355|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
23639837|NCT01655693|66067353|FG000|Overall Study|Protocol Violation|1|||
23639838|NCT01655693|66067354|FG001|Overall Study|Protocol Violation|0|||
23639839|NCT01655693|66067355|FG002|Overall Study|Protocol Violation|3|||
23639840|NCT01655693|66067353|FG000|Overall Study|Lost to Follow-up|1|||
23639841|NCT01655693|66067354|FG001|Overall Study|Lost to Follow-up|0|||
23639842|NCT01655693|66067355|FG002|Overall Study|Lost to Follow-up|1|||
23639843|NCT01655693|66067353|FG000|Overall Study|Screening Failure|1|||
23639844|NCT01655693|66067354|FG001|Overall Study|Screening Failure|0|||
23639845|NCT01655693|66067355|FG002|Overall Study|Screening Failure|0|||
23349806|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349807|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349808|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349809|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349810|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349811|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23462669|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
23639846|NCT01655693|66067353|FG000|Overall Study|Other|8|||
23639847|NCT01655693|66067354|FG001|Overall Study|Other|6|||
23789608|NCT00529763|66609448|FG002|Overall Study|Participant Withdrew Consent|4|||
23349812|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23639848|NCT01655693|66067355|FG002|Overall Study|Other|15|||
23789609|NCT00529763|66609446|FG000|Overall Study|Other reasons|2|||
23789610|NCT00529763|66609447|FG001|Overall Study|Other reasons|0|||
23789611|NCT00529763|66609448|FG002|Overall Study|Other reasons|2|||
23789612|NCT00529763|66609446|FG000|Overall Study|Participant request to discontinue treatment|1|||
23462670|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
23462671|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
23789613|NCT00529763|66609447|FG001|Overall Study|Participant request to discontinue treatment|1|||
23789614|NCT00529763|66609448|FG002|Overall Study|Participant request to discontinue treatment|3|||
23789615|NCT03382041|66609449|FG000|Overall Study|Consent Form Lost|2|||
23789616|NCT03382041|66609450|FG001|Overall Study|Consent Form Lost|1|||
23789617|NCT03382041|66609449|FG000|Overall Study|Withdrawal by Subject|1|||
23789618|NCT03382041|66609450|FG001|Overall Study|Withdrawal by Subject|4|||
23789619|NCT03382041|66609449|FG000|Overall Study|Lost to Follow-up|1|||
23462672|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
23462673|NCT01169337|65437942|FG000|Overall Study|Lack of Efficacy|5|||
23462674|NCT01169337|65437943|FG001|Overall Study|Lack of Efficacy|7|||
23462675|NCT01169337|65437944|FG002|Overall Study|Lack of Efficacy|0|||
23789620|NCT03382041|66609450|FG001|Overall Study|Lost to Follow-up|4|||
23462676|NCT01169337|65437942|FG000|Overall Study|Adverse Event|12|||
23462677|NCT01169337|65437943|FG001|Overall Study|Adverse Event|18|||
23462678|NCT01169337|65437944|FG002|Overall Study|Adverse Event|0|||
23462679|NCT01169337|65437942|FG000|Overall Study|Death|2|||
23462680|NCT01169337|65437943|FG001|Overall Study|Death|0|||
23462681|NCT01169337|65437944|FG002|Overall Study|Death|0|||
23462682|NCT01169337|65437942|FG000|Overall Study|Withdrawal by Subject|11|||
23462683|NCT01169337|65437943|FG001|Overall Study|Withdrawal by Subject|11|||
23462684|NCT01169337|65437944|FG002|Overall Study|Withdrawal by Subject|6|||
23462685|NCT01169337|65437942|FG000|Overall Study|Noncompliance|2|||
23462686|NCT01169337|65437943|FG001|Overall Study|Noncompliance|0|||
23462687|NCT01169337|65437944|FG002|Overall Study|Noncompliance|0|||
23462688|NCT01169337|65437942|FG000|Overall Study|Other complicating disease|1|||
23462689|NCT01169337|65437943|FG001|Overall Study|Other complicating disease|1|||
23462690|NCT01169337|65437944|FG002|Overall Study|Other complicating disease|0|||
23462691|NCT01169337|65437942|FG000|Overall Study|Physician Decision|1|||
23462692|NCT01169337|65437943|FG001|Overall Study|Physician Decision|5|||
23584864|NCT03389477|65869303|FG000|Step 1|Withdrawal by Subject|1|||
23584865|NCT03389477|65869304|FG001|Step 1|Withdrawal by Subject|0|||
23584866|NCT03389477|65869303|FG000|Step 2|Withdrawal by Subject|1|||
23584867|NCT03389477|65869304|FG001|Step 2|Withdrawal by Subject|2|||
23584868|NCT03389477|65869303|FG000|Step 2|Disease progression|1|||
23584869|NCT03389477|65869304|FG001|Step 2|Disease progression|0|||
23584870|NCT03389477|65869303|FG000|Step 2|Death|0|||
23584871|NCT03389477|65869304|FG001|Step 2|Death|1|||
23584872|NCT03389477|65869303|FG000|Step 2|Poor performance status and nutrition|0|||
23584873|NCT03389477|65869304|FG001|Step 2|Poor performance status and nutrition|1|||
23584874|NCT03389477|65869303|FG000|Step 3|Withdrawal after 3 cycles|0|||
23584875|NCT03389477|65869304|FG001|Step 3|Withdrawal after 3 cycles|1|||
23584876|NCT03389477|65869303|FG000|Step 3|Still receiving active treatment|4|||
23584877|NCT03389477|65869304|FG001|Step 3|Still receiving active treatment|0|||
23584878|NCT03389477|65869303|FG000|Step 3|Progressive disease after 2 cycles|1|||
23584879|NCT03389477|65869304|FG001|Step 3|Progressive disease after 2 cycles|0|||
23584880|NCT01329328|65869305|FG000|Overall Study|Withdrawal by Subject|2|||
23584881|NCT01329328|65869306|FG001|Overall Study|Withdrawal by Subject|4|||
23584882|NCT01329328|65869307|FG002|Overall Study|Withdrawal by Subject|3|||
23584883|NCT04565249|65869310|FG000|Overall Study|Death|0|||
23584884|NCT04565249|65869311|FG001|Overall Study|Death|0|||
23584885|NCT04565249|65869312|FG002|Overall Study|Death|0|||
23584886|NCT04565249|65869313|FG003|Overall Study|Death|1|||
23584887|NCT02520154|65869314|FG000|Overall Study|Death|1|||
23584888|NCT02520154|65869314|FG000|Overall Study|Withdrawal by Subject|2|||
23584889|NCT02520154|65869314|FG000|Overall Study|Physician Decision|2|||
23584890|NCT04335591|65869315|FG000|Overall Study|Adverse Event|5|||
23584891|NCT04335591|65869316|FG001|Overall Study|Adverse Event|2|||
23584892|NCT04335591|65869317|FG002|Overall Study|Adverse Event|3|||
23584893|NCT04335591|65869318|FG003|Overall Study|Adverse Event|2|||
23584894|NCT04335591|65869315|FG000|Overall Study|Protocol Violation|1|||
23584895|NCT04335591|65869316|FG001|Overall Study|Protocol Violation|0|||
23584896|NCT04335591|65869317|FG002|Overall Study|Protocol Violation|0|||
23584897|NCT04335591|65869318|FG003|Overall Study|Protocol Violation|0|||
23584898|NCT04335591|65869315|FG000|Overall Study|Withdrawal by Subject|8|||
23789621|NCT01131260|66609451|FG000|Overall Study|Randomization error|5|||
23462693|NCT01169337|65437944|FG002|Overall Study|Physician Decision|0|||
23462694|NCT01169337|65437942|FG000|Overall Study|Alternative therapy|0|||
23462695|NCT01169337|65437943|FG001|Overall Study|Alternative therapy|2|||
23462696|NCT01169337|65437944|FG002|Overall Study|Alternative therapy|0|||
23584899|NCT04335591|65869316|FG001|Overall Study|Withdrawal by Subject|4|||
23584900|NCT04335591|65869317|FG002|Overall Study|Withdrawal by Subject|4|||
23584901|NCT04335591|65869318|FG003|Overall Study|Withdrawal by Subject|5|||
23584902|NCT04335591|65869315|FG000|Overall Study|Subject planning pregnancy|0|||
23789622|NCT01131260|66609452|FG001|Overall Study|Randomization error|1|||
23462697|NCT01169337|65437942|FG000|Overall Study|Changed hospital|0|||
23462698|NCT01169337|65437943|FG001|Overall Study|Changed hospital|1|||
23462699|NCT01169337|65437944|FG002|Overall Study|Changed hospital|0|||
23462700|NCT01169337|65437942|FG000|Overall Study|Never started treatment|0|||
23462701|NCT01169337|65437943|FG001|Overall Study|Never started treatment|2|||
23462702|NCT01169337|65437944|FG002|Overall Study|Never started treatment|0|||
23462703|NCT01169337|65437942|FG000|Overall Study|Reason not reported|1|||
23462704|NCT01169337|65437943|FG001|Overall Study|Reason not reported|0|||
23462705|NCT01169337|65437944|FG002|Overall Study|Reason not reported|0|||
23462706|NCT01169337|65437942|FG000|Overall Study|Continuing lenalidomide|9|||
23462707|NCT01169337|65437943|FG001|Overall Study|Continuing lenalidomide|43|||
23462708|NCT01169337|65437944|FG002|Overall Study|Continuing lenalidomide|0|||
23462709|NCT01207414|65437946|FG000|Overall Study|Adverse Event|25|||
23789623|NCT01131260|66609451|FG000|Overall Study|Declined to continue participation|8|||
23789624|NCT01131260|66609452|FG001|Overall Study|Declined to continue participation|13|||
23789625|NCT01131260|66609451|FG000|Overall Study|Physician Decision|22|||
23789626|NCT01131260|66609452|FG001|Overall Study|Physician Decision|24|||
23349813|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349814|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349815|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349816|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
23349817|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
23349818|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462710|NCT01207414|65437947|FG001|Overall Study|Adverse Event|39|||
23462711|NCT01207414|65437946|FG000|Overall Study|Abnormal test procedure results|0|||
23462712|NCT01207414|65437947|FG001|Overall Study|Abnormal test procedure results|1|||
23462713|NCT01207414|65437946|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23462714|NCT01207414|65437947|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23462715|NCT01207414|65437946|FG000|Overall Study|Patient withdrew consent|14|||
23462716|NCT01207414|65437947|FG001|Overall Study|Patient withdrew consent|11|||
23462717|NCT01207414|65437946|FG000|Overall Study|Lost to Follow-up|15|||
23462718|NCT01207414|65437947|FG001|Overall Study|Lost to Follow-up|17|||
23462719|NCT01207414|65437946|FG000|Overall Study|Administrative problems|1|||
23462720|NCT01207414|65437947|FG001|Overall Study|Administrative problems|1|||
23462721|NCT01207414|65437946|FG000|Overall Study|Protocol deviation|12|||
23462722|NCT01207414|65437947|FG001|Overall Study|Protocol deviation|9|||
23462723|NCT01207414|65437946|FG000|Overall Study|Randomized in error|1|||
23462724|NCT01207414|65437947|FG001|Overall Study|Randomized in error|0|||
23462725|NCT02594124|65437948|FG000|Overall Study|Adverse Event|0|||
23462726|NCT02594124|65437949|FG001|Overall Study|Adverse Event|5|||
23462727|NCT02594124|65437950|FG002|Overall Study|Adverse Event|8|||
23462728|NCT02594124|65437951|FG003|Overall Study|Adverse Event|1|||
23462729|NCT02594124|65437952|FG004|Overall Study|Adverse Event|0|||
23462730|NCT02594124|65437953|FG005|Overall Study|Adverse Event|0|||
23462731|NCT02594124|65437954|FG006|Overall Study|Adverse Event|2|||
23462732|NCT02594124|65437955|FG007|Overall Study|Adverse Event|2|||
23462733|NCT02594124|65437956|FG008|Overall Study|Adverse Event|0|||
23462734|NCT02594124|65437948|FG000|Overall Study|Withdrawal by Subject|2|||
23462735|NCT02594124|65437949|FG001|Overall Study|Withdrawal by Subject|3|||
23462736|NCT02594124|65437950|FG002|Overall Study|Withdrawal by Subject|5|||
23462737|NCT02594124|65437951|FG003|Overall Study|Withdrawal by Subject|1|||
23462738|NCT02594124|65437952|FG004|Overall Study|Withdrawal by Subject|8|||
23462739|NCT02594124|65437953|FG005|Overall Study|Withdrawal by Subject|4|||
23462740|NCT02594124|65437954|FG006|Overall Study|Withdrawal by Subject|13|||
23462741|NCT02594124|65437955|FG007|Overall Study|Withdrawal by Subject|19|||
23462742|NCT02594124|65437956|FG008|Overall Study|Withdrawal by Subject|0|||
23584903|NCT04335591|65869316|FG001|Overall Study|Subject planning pregnancy|1|||
23584904|NCT04335591|65869317|FG002|Overall Study|Subject planning pregnancy|0|||
23584905|NCT04335591|65869318|FG003|Overall Study|Subject planning pregnancy|0|||
23584906|NCT04335591|65869315|FG000|Overall Study|Ukrainian Russian war conflict|4|||
23584907|NCT04335591|65869316|FG001|Overall Study|Ukrainian Russian war conflict|5|||
23789627|NCT01131260|66609451|FG000|Overall Study|Technical problems|7|||
23349819|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349820|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349821|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349822|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462743|NCT02594124|65437948|FG000|Overall Study|Physician Decision|0|||
23462744|NCT02594124|65437949|FG001|Overall Study|Physician Decision|2|||
23462745|NCT02594124|65437950|FG002|Overall Study|Physician Decision|0|||
23462746|NCT02594124|65437951|FG003|Overall Study|Physician Decision|0|||
23462747|NCT02594124|65437952|FG004|Overall Study|Physician Decision|0|||
23462748|NCT02594124|65437953|FG005|Overall Study|Physician Decision|0|||
23584908|NCT04335591|65869317|FG002|Overall Study|Ukrainian Russian war conflict|2|||
23789628|NCT01131260|66609452|FG001|Overall Study|Technical problems|6|||
23462749|NCT02594124|65437954|FG006|Overall Study|Physician Decision|0|||
23462750|NCT02594124|65437955|FG007|Overall Study|Physician Decision|1|||
23462751|NCT02594124|65437956|FG008|Overall Study|Physician Decision|0|||
23462752|NCT02594124|65437948|FG000|Overall Study|Commercial drug|0|||
23349823|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462753|NCT02594124|65437949|FG001|Overall Study|Commercial drug|1|||
23462754|NCT02594124|65437950|FG002|Overall Study|Commercial drug|6|||
23462755|NCT02594124|65437951|FG003|Overall Study|Commercial drug|3|||
23462756|NCT02594124|65437952|FG004|Overall Study|Commercial drug|0|||
23462757|NCT02594124|65437953|FG005|Overall Study|Commercial drug|0|||
23462758|NCT02594124|65437954|FG006|Overall Study|Commercial drug|7|||
23462759|NCT02594124|65437955|FG007|Overall Study|Commercial drug|11|||
23462760|NCT02594124|65437956|FG008|Overall Study|Commercial drug|2|||
23462761|NCT02594124|65437948|FG000|Overall Study|Reason Not Specified|1|||
23462762|NCT02594124|65437949|FG001|Overall Study|Reason Not Specified|3|||
23462763|NCT02594124|65437950|FG002|Overall Study|Reason Not Specified|4|||
23462764|NCT02594124|65437951|FG003|Overall Study|Reason Not Specified|0|||
23462765|NCT02594124|65437952|FG004|Overall Study|Reason Not Specified|0|||
23462766|NCT02594124|65437953|FG005|Overall Study|Reason Not Specified|1|||
23462767|NCT02594124|65437954|FG006|Overall Study|Reason Not Specified|1|||
23462768|NCT02594124|65437955|FG007|Overall Study|Reason Not Specified|6|||
23462769|NCT02594124|65437956|FG008|Overall Study|Reason Not Specified|1|||
23462770|NCT02923726|65437962|FG000|Overall Study|Death|196|||
23462771|NCT02923726|65437963|FG001|Overall Study|Death|175|||
23462772|NCT02923726|65437962|FG000|Overall Study|Withdrawal by Subject|337|||
23462773|NCT02923726|65437963|FG001|Overall Study|Withdrawal by Subject|307|||
23462774|NCT04081103|65437964|FG000|Overall Study|Adverse Event|1|||
23639849|NCT01416389|66067360|FG000|Overall Study|Lost to Follow-up|1|||
23639850|NCT01416389|66067361|FG001|Overall Study|Lost to Follow-up|0|||
23639851|NCT01416389|66067360|FG000|Overall Study|Started New Therapy|2|||
23639852|NCT01416389|66067361|FG001|Overall Study|Started New Therapy|0|||
23639853|NCT00564889|66067372|FG000|Overall Study|Death|7|||
23639854|NCT00564889|66067372|FG000|Overall Study|Adverse Event|12|||
23789629|NCT01131260|66609451|FG000|Overall Study|Staff error|2|||
23789630|NCT01131260|66609452|FG001|Overall Study|Staff error|1|||
23789631|NCT01131260|66609451|FG000|Overall Study|Ineligible|0|||
23789632|NCT01131260|66609452|FG001|Overall Study|Ineligible|2|||
23349824|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23789633|NCT03366792|66609453|FG000|Overall Study|Withdrawal by Subject|7|||
23789634|NCT03366792|66609453|FG000|Overall Study|Lost to Follow-up|2|||
23789635|NCT03366792|66609453|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
23789636|NCT03366792|66609453|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
23789637|NCT00796562|66609454|FG000|Overall Study|Death|49|||
23789638|NCT01370863|66609457|FG000|Overall Study|Adverse Event|1|||
23789639|NCT01370863|66609458|FG001|Overall Study|Adverse Event|1|||
23349825|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349826|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349827|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349828|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349829|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349830|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349831|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349832|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
23462775|NCT04081103|65437965|FG001|Overall Study|Adverse Event|1|||
23462776|NCT04081103|65437966|FG002|Overall Study|Adverse Event|1|||
23462777|NCT04081103|65437964|FG000|Overall Study|Physician Decision|0|||
23462778|NCT04081103|65437965|FG001|Overall Study|Physician Decision|0|||
23462779|NCT04081103|65437966|FG002|Overall Study|Physician Decision|1|||
23639855|NCT00564889|66067372|FG000|Overall Study|Alternative treatment|3|||
23639856|NCT00564889|66067372|FG000|Overall Study|Disease progression|3|||
23789640|NCT01370863|66609457|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
23462780|NCT02419001|65437968|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
23462781|NCT02419001|65437969|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
23462782|NCT03944577|65437970|FG000|Overall Study|Adverse Event|3|||
23462783|NCT04139018|65437975|FG000|Overall Study|Screen fail|1|||
23639857|NCT00564889|66067372|FG000|Overall Study|Other, not specified|4|||
23789641|NCT01370863|66609458|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
23789642|NCT01370863|66609457|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23789643|NCT01370863|66609458|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23789644|NCT03247686|66609459|FG000|Overall Study|Withdrawal by Subject|1|||
23789645|NCT03247686|66609460|FG001|Overall Study|Withdrawal by Subject|2|||
23789646|NCT00660387|66609463|FG000|Overall Study|Adverse Event|1|||
23789647|NCT00660387|66609464|FG001|Overall Study|Adverse Event|2|||
23789648|NCT00660387|66609463|FG000|Overall Study|Lack of Efficacy|0|||
23789649|NCT00660387|66609464|FG001|Overall Study|Lack of Efficacy|1|||
23462784|NCT04139018|65437976|FG001|Overall Study|Screen fail|0|||
23789650|NCT00660387|66609463|FG000|Overall Study|Protocol Violation|1|||
23789651|NCT00660387|66609464|FG001|Overall Study|Protocol Violation|0|||
23789652|NCT03101358|66609467|FG000|Overall Study|Non-compliance with study schedule|1|||
23789653|NCT03101358|66609468|FG001|Overall Study|Non-compliance with study schedule|0|||
23789654|NCT03101358|66609469|FG002|Overall Study|Non-compliance with study schedule|0|||
23789655|NCT03101358|66609470|FG003|Overall Study|Non-compliance with study schedule|1|||
23789656|NCT03101358|66609467|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23789657|NCT03101358|66609468|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23789658|NCT03101358|66609469|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
23789659|NCT03101358|66609470|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23789660|NCT03101358|66609467|FG000|Overall Study|Physician Decision|1|||
23789661|NCT03101358|66609468|FG001|Overall Study|Physician Decision|0|||
23789662|NCT03101358|66609469|FG002|Overall Study|Physician Decision|0|||
23789663|NCT03101358|66609470|FG003|Overall Study|Physician Decision|3|||
23789664|NCT03101358|66609467|FG000|Overall Study|Adverse Event|0|||
23789665|NCT03101358|66609468|FG001|Overall Study|Adverse Event|0|||
23789666|NCT03101358|66609469|FG002|Overall Study|Adverse Event|1|||
23789667|NCT03101358|66609470|FG003|Overall Study|Adverse Event|0|||
23789668|NCT03101358|66609467|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23789669|NCT03101358|66609468|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23789670|NCT03101358|66609469|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23789671|NCT03101358|66609470|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
23789672|NCT03101358|66609467|FG000|Overall Study|Lost to Follow-up|1|||
23789673|NCT03101358|66609468|FG001|Overall Study|Lost to Follow-up|0|||
23789674|NCT03101358|66609469|FG002|Overall Study|Lost to Follow-up|0|||
23789675|NCT03101358|66609470|FG003|Overall Study|Lost to Follow-up|1|||
23789676|NCT00826241|66609471|FG000|Overall Study|Withdrawal from Follow-up|1|||
23789677|NCT00826241|66609471|FG000|Overall Study|Withdrew consent|2|||
23789678|NCT00826241|66609471|FG000|Overall Study|Death|4|||
23789679|NCT00826241|66609471|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
23789680|NCT00826241|66609471|FG000|Overall Study|Non-compliance|1|||
23789681|NCT00826241|66609471|FG000|Overall Study|Progression of disease|1|||
23789682|NCT00826241|66609471|FG000|Overall Study|Patient refused follow-up|3|||
23789683|NCT00826241|66609471|FG000|Overall Study|Lost to Follow-up|9|||
23789684|NCT00826241|66609471|FG000|Overall Study|Could not obtain records|1|||
23789685|NCT00826241|66609471|FG000|Overall Study|Screen failure|2|||
23789686|NCT00826241|66609471|FG000|Overall Study|Pt unable to proceed to registration|1|||
23789687|NCT00826241|66609471|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
23789688|NCT05065619|66609474|FG000|Up to Day 42|Lost to Follow-up|1|||
23789689|NCT05065619|66609475|FG001|Up to Day 42|Lost to Follow-up|0|||
23789690|NCT05065619|66609474|FG000|Up to Day 42|Withdrawal by Subject|1|||
23789691|NCT05065619|66609475|FG001|Up to Day 42|Withdrawal by Subject|0|||
23789692|NCT05065619|66609474|FG000|After Day 43|Lost to Follow-up|1|||
23789693|NCT05065619|66609475|FG001|After Day 43|Lost to Follow-up|0|||
23789694|NCT05065619|66609474|FG000|After Day 43|Physician Decision|3|||
23789695|NCT05065619|66609475|FG001|After Day 43|Physician Decision|0|||
23789696|NCT05065619|66609474|FG000|After Day 43|Withdrawal by Subject|1|||
23789697|NCT05065619|66609475|FG001|After Day 43|Withdrawal by Subject|2|||
23789698|NCT05065619|66609474|FG000|After Day 43|Public vaccination|6|||
23789699|NCT05065619|66609475|FG001|After Day 43|Public vaccination|8|||
23789700|NCT05065619|66609474|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
23789701|NCT05065619|66609475|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
23789702|NCT05065619|66609474|FG000|After Day 43|Study Terminated by Sponsor|88|||
23789703|NCT05065619|66609475|FG001|After Day 43|Study Terminated by Sponsor|16|||
23789704|NCT00515216|66609483|FG000|Overall Study|Withdrawal by Subject|1|||
23789705|NCT02420353|66609484|FG000|Overall Study|Withdrawal by Subject|0|||
23789706|NCT02420353|66609485|FG001|Overall Study|Withdrawal by Subject|1|||
23789707|NCT00420095|66609488|FG000|Overall Study|Adverse Event|1|||
23584909|NCT04335591|65869318|FG003|Overall Study|Ukrainian Russian war conflict|0|||
23584910|NCT03256344|65869319|FG000|Overall Study|Death|6|||
23789708|NCT00420095|66609489|FG001|Overall Study|Adverse Event|0|||
23789709|NCT00420095|66609488|FG000|Overall Study|Protocol Violation|1|||
23789710|NCT00420095|66609489|FG001|Overall Study|Protocol Violation|1|||
23789711|NCT00420095|66609488|FG000|Overall Study|Lost to Follow-up|1|||
23789712|NCT00420095|66609489|FG001|Overall Study|Lost to Follow-up|0|||
23789713|NCT02676973|66609490|FG000|Overall Study|Withdrawal by Subject|9|||
23789714|NCT02676973|66609491|FG001|Overall Study|Withdrawal by Subject|8|||
23789715|NCT02676973|66609492|FG002|Overall Study|Withdrawal by Subject|11|||
23789716|NCT02676973|66609490|FG000|Overall Study|Lost to Follow-up|8|||
23349833|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349834|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349835|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349836|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349837|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349838|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23789717|NCT02676973|66609491|FG001|Overall Study|Lost to Follow-up|12|||
23789718|NCT02676973|66609492|FG002|Overall Study|Lost to Follow-up|8|||
23789719|NCT02676973|66609490|FG000|Overall Study|Death|2|||
23789720|NCT02676973|66609491|FG001|Overall Study|Death|1|||
23349839|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349840|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349841|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349842|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23789721|NCT02676973|66609492|FG002|Overall Study|Death|5|||
23789722|NCT04364763|66609494|FG000|Overall Study|Death|1|||
23789723|NCT04364763|66609495|FG001|Overall Study|Death|2|||
23789724|NCT04364763|66609494|FG000|Overall Study|Lost to Follow-up|1|||
23789725|NCT04364763|66609495|FG001|Overall Study|Lost to Follow-up|0|||
23789726|NCT01051349|66609496|FG000|Overall Study|Adverse Event|88|||
23789727|NCT01051349|66609496|FG000|Overall Study|Consent Withdrawn|54|||
23349843|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349844|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349845|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23789728|NCT01051349|66609496|FG000|Overall Study|Investigator Decision|6|||
23789729|NCT01051349|66609496|FG000|Overall Study|Lost to Follow-up|6|||
23789730|NCT01051349|66609496|FG000|Overall Study|Subject non-compliance|7|||
23789731|NCT01051349|66609496|FG000|Overall Study|Reason not Specified|12|||
23789732|NCT02096705|66609497|FG000|Treatment|Adverse Event|6|||
23789733|NCT02096705|66609498|FG001|Treatment|Adverse Event|3|||
23789734|NCT02096705|66609497|FG000|Treatment|Subject request to discontinue treatment|1|||
23789735|NCT02096705|66609498|FG001|Treatment|Subject request to discontinue treatment|1|||
23789736|NCT02096705|66609497|FG000|Treatment|Withdrawal by Subject|1|||
23789737|NCT02096705|66609498|FG001|Treatment|Withdrawal by Subject|0|||
23789738|NCT02096705|66609497|FG000|Treatment|Other|1|||
23789739|NCT02096705|66609498|FG001|Treatment|Other|1|||
23789740|NCT02096705|66609497|FG000|Follow-up|Withdrawal by Subject|1|||
23789741|NCT02096705|66609498|FG001|Follow-up|Withdrawal by Subject|0|||
23789742|NCT02096705|66609497|FG000|Follow-up|Adverse Event|2|||
23789743|NCT02096705|66609498|FG001|Follow-up|Adverse Event|2|||
23789744|NCT02096705|66609497|FG000|Follow-up|Subjects not reporting status|1|||
23789745|NCT02096705|66609498|FG001|Follow-up|Subjects not reporting status|2|||
23789746|NCT03257254|66609499|FG000|Overall Study|Withdrawal by Subject|7|||
23789747|NCT03257254|66609499|FG000|Overall Study|Lost to Follow-up|9|||
23789748|NCT03257254|66609499|FG000|Overall Study|Study discontinued by sponsor|5|||
23789749|NCT02046122|66609507|FG000|Overall Study|Physician Decision|8|||
23789750|NCT02046122|66609507|FG000|Overall Study|Withdrawal by Subject|1|||
23789751|NCT02679729|66609510|FG000|Overall Study|Lost to Follow-up|0|||
23789752|NCT02679729|66609511|FG001|Overall Study|Lost to Follow-up|1|||
23789753|NCT02679729|66609512|FG002|Overall Study|Lost to Follow-up|0|||
23789754|NCT02679729|66609513|FG003|Overall Study|Lost to Follow-up|0|||
23789755|NCT02679729|66609514|FG004|Overall Study|Lost to Follow-up|1|||
23349846|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349847|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349848|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349849|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23402748|NCT01669902|65219993|FG000|Overall Study|Other|8|||
23789756|NCT02679729|66609515|FG005|Overall Study|Lost to Follow-up|0|||
23789757|NCT02679729|66609516|FG006|Overall Study|Lost to Follow-up|0|||
23789758|NCT02679729|66609517|FG007|Overall Study|Lost to Follow-up|0|||
23789759|NCT02679729|66609518|FG008|Overall Study|Lost to Follow-up|0|||
23789760|NCT02679729|66609510|FG000|Overall Study|Participant decision|0|||
23462785|NCT04139018|65437975|FG000|Overall Study|Withdrawal by Subject|2|||
23462786|NCT04139018|65437976|FG001|Overall Study|Withdrawal by Subject|0|||
23462787|NCT04139018|65437975|FG000|Overall Study|Lost to Follow-up|0|||
23462788|NCT04139018|65437976|FG001|Overall Study|Lost to Follow-up|1|||
23462789|NCT01597596|65437978|FG000|Overall Study|Study terminated by sponsor|1|||
23462790|NCT01597596|65437979|FG001|Overall Study|Study terminated by sponsor|0|||
23462791|NCT01597596|65437978|FG000|Overall Study|Physician Decision|0|||
23789761|NCT02679729|66609511|FG001|Overall Study|Participant decision|1|||
23789762|NCT02679729|66609512|FG002|Overall Study|Participant decision|0|||
23789763|NCT02679729|66609513|FG003|Overall Study|Participant decision|0|||
23789764|NCT02679729|66609514|FG004|Overall Study|Participant decision|0|||
23789765|NCT02679729|66609515|FG005|Overall Study|Participant decision|0|||
23789766|NCT02679729|66609516|FG006|Overall Study|Participant decision|1|||
23789767|NCT02679729|66609517|FG007|Overall Study|Participant decision|0|||
23789768|NCT02679729|66609518|FG008|Overall Study|Participant decision|0|||
23789769|NCT03218787|66609523|FG000|Overall Study|Lost to Follow-up|12|||
23789770|NCT03218787|66609523|FG000|Overall Study|Withdrawal by Subject|72|||
23789771|NCT03218787|66609523|FG000|Overall Study|Physician Decision|11|||
23789772|NCT03218787|66609523|FG000|Overall Study|Death|111|||
23789773|NCT01942135|66609526|FG000|Overall Study|Adverse Event|21|||
23789774|NCT01942135|66609527|FG001|Overall Study|Adverse Event|7|||
23789775|NCT01942135|66609526|FG000|Overall Study|Global Deterioration of Health Status|9|||
23789776|NCT01942135|66609527|FG001|Overall Study|Global Deterioration of Health Status|6|||
23789777|NCT01942135|66609526|FG000|Overall Study|Randomized Not Treated|2|||
23789778|NCT01942135|66609527|FG001|Overall Study|Randomized Not Treated|2|||
23789779|NCT01942135|66609526|FG000|Overall Study|Death|2|||
23789780|NCT01942135|66609527|FG001|Overall Study|Death|1|||
23789781|NCT01942135|66609526|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
23789782|NCT01942135|66609527|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
23789783|NCT01942135|66609526|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
23789784|NCT01942135|66609527|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
23789785|NCT01942135|66609526|FG000|Overall Study|Withdrawal by Subject|4|||
23789786|NCT01942135|66609527|FG001|Overall Study|Withdrawal by Subject|3|||
23789787|NCT01942135|66609526|FG000|Overall Study|Protocol Violation|1|||
23789788|NCT01942135|66609527|FG001|Overall Study|Protocol Violation|0|||
23789789|NCT01942135|66609526|FG000|Overall Study|Other|19|||
23789790|NCT01942135|66609527|FG001|Overall Study|Other|4|||
23789791|NCT03419403|66609528|FG000|Overall Study|Withdrawal by Subject|5|||
23462792|NCT01597596|65437979|FG001|Overall Study|Physician Decision|1|||
23462793|NCT00003475|65437980|FG000|Overall Study|Not evaluable|13|||
23462794|NCT00674817|65437983|FG000|Period 1|Withdrawal by Subject|2|||
23462795|NCT00674817|65437983|FG000|Period 1|Protocol Violation|1|||
23462796|NCT00674817|65437983|FG000|Period 3|Adverse Event|1|||
23462797|NCT00674817|65437983|FG000|Period 3|Protocol Violation|1|||
23462798|NCT00674817|65437983|FG000|Period 4|Adverse Event|1|||
23462799|NCT03879772|65437984|FG000|Overall Study|Adverse Event|2|||
23462800|NCT03879772|65437985|FG001|Overall Study|Adverse Event|2|||
23462801|NCT03879772|65437986|FG002|Overall Study|Adverse Event|3|||
23462802|NCT03879772|65437987|FG003|Overall Study|Adverse Event|4|||
23462803|NCT03879772|65437988|FG004|Overall Study|Adverse Event|3|||
23462804|NCT03879772|65437984|FG000|Overall Study|Treatment Failure|1|||
23462805|NCT03879772|65437985|FG001|Overall Study|Treatment Failure|0|||
23462806|NCT03879772|65437986|FG002|Overall Study|Treatment Failure|0|||
23462807|NCT03879772|65437987|FG003|Overall Study|Treatment Failure|2|||
23462808|NCT03879772|65437988|FG004|Overall Study|Treatment Failure|1|||
23462809|NCT03879772|65437984|FG000|Overall Study|Lost to Follow-up|0|||
23462810|NCT03879772|65437985|FG001|Overall Study|Lost to Follow-up|0|||
23462811|NCT03879772|65437986|FG002|Overall Study|Lost to Follow-up|0|||
23462812|NCT03879772|65437987|FG003|Overall Study|Lost to Follow-up|0|||
23462813|NCT03879772|65437988|FG004|Overall Study|Lost to Follow-up|1|||
23462814|NCT03879772|65437984|FG000|Overall Study|Withdrawal by Subject|0|||
23462815|NCT03879772|65437985|FG001|Overall Study|Withdrawal by Subject|1|||
23462816|NCT03879772|65437986|FG002|Overall Study|Withdrawal by Subject|3|||
23462817|NCT03879772|65437987|FG003|Overall Study|Withdrawal by Subject|1|||
23462818|NCT03879772|65437988|FG004|Overall Study|Withdrawal by Subject|1|||
23462819|NCT03879772|65437984|FG000|Overall Study|Protocol Violation|0|||
23462820|NCT03879772|65437985|FG001|Overall Study|Protocol Violation|0|||
23462821|NCT03879772|65437986|FG002|Overall Study|Protocol Violation|3|||
23789792|NCT03419403|66609529|FG001|Overall Study|Withdrawal by Subject|2|||
23789793|NCT03419403|66609530|FG002|Overall Study|Withdrawal by Subject|5|||
23789794|NCT03419403|66609531|FG003|Overall Study|Withdrawal by Subject|1|||
23789795|NCT03419403|66609528|FG000|Overall Study|Progressive disease (per protocol)|0|||
23789796|NCT03419403|66609529|FG001|Overall Study|Progressive disease (per protocol)|2|||
23462822|NCT03879772|65437987|FG003|Overall Study|Protocol Violation|1|||
23462823|NCT03879772|65437988|FG004|Overall Study|Protocol Violation|2|||
23462824|NCT03879772|65437984|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
23462825|NCT03879772|65437985|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
23462826|NCT03879772|65437986|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
23789797|NCT03419403|66609530|FG002|Overall Study|Progressive disease (per protocol)|2|||
23462827|NCT03879772|65437987|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
23462828|NCT03879772|65437988|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
23462829|NCT00665652|65437989|FG000|Overall Study|Adverse Event|4|||
23789798|NCT03419403|66609531|FG003|Overall Study|Progressive disease (per protocol)|0|||
23789799|NCT03419403|66609528|FG000|Overall Study|Other, not specified|6|||
23789800|NCT03419403|66609529|FG001|Overall Study|Other, not specified|4|||
23789801|NCT03419403|66609530|FG002|Overall Study|Other, not specified|5|||
23789802|NCT03419403|66609531|FG003|Overall Study|Other, not specified|1|||
23789803|NCT03419403|66609528|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
23789804|NCT03419403|66609529|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
23789805|NCT03419403|66609530|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
23789806|NCT03419403|66609531|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
23789807|NCT04590027|66609533|FG000|Overall Study|Lost to Follow-up|17|||
23789808|NCT04590027|66609534|FG001|Overall Study|Lost to Follow-up|14|||
23789809|NCT04590027|66609533|FG000|Overall Study|Protocol Violation|0|||
23789810|NCT04590027|66609534|FG001|Overall Study|Protocol Violation|3|||
23789811|NCT03684928|66609535|FG000|First Intervention|Lost to Follow-up|0|||
23789812|NCT03684928|66609536|FG001|First Intervention|Lost to Follow-up|1|||
23789813|NCT03684928|66609535|FG000|First Intervention|Withdrawal by Subject|0|||
23639858|NCT02182947|66067374|FG000|Overall Study|Withdrawal by Subject|7|||
23639859|NCT02182947|66067374|FG000|Overall Study|Lost to Follow-up|3|||
23639860|NCT02182947|66067374|FG000|Overall Study|Failed screening activities|8|||
23639861|NCT02153073|66067375|FG000|Overall Study|Case Report Forms Uncollected|230|||
23639862|NCT02153073|66067375|FG000|Overall Study|Protocol Deviation|68|||
23639863|NCT01242800|66067376|FG000|Overall Study|Patient refusal|0|||
23639864|NCT01242800|66067377|FG001|Overall Study|Patient refusal|10|||
23639865|NCT01242800|66067376|FG000|Overall Study|Physician Decision|0|||
23639866|NCT01242800|66067377|FG001|Overall Study|Physician Decision|1|||
23639867|NCT01242800|66067376|FG000|Overall Study|Disease progression|0|||
23639868|NCT01242800|66067377|FG001|Overall Study|Disease progression|3|||
23639869|NCT01242800|66067376|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
23639870|NCT01242800|66067377|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
23639871|NCT01242800|66067376|FG000|Overall Study|Reasons not reported|0|||
23706197|NCT01258348|66301082|FG001|Overall Study|Progressive Disease|3|||
23789814|NCT03684928|66609536|FG001|First Intervention|Withdrawal by Subject|2|||
23789815|NCT03684928|66609535|FG000|Second Intervention|Soft Tissue Injury|1|||
23789816|NCT03684928|66609536|FG001|Second Intervention|Soft Tissue Injury|0|||
23349850|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
23349851|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349852|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349853|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349854|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349855|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349856|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349857|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349858|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349859|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349860|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349861|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349862|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349863|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
23349864|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
23349865|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349866|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
23349867|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349868|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349869|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349870|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349871|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349872|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349873|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349874|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349875|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349876|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349877|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
23349878|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349879|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349880|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349881|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349882|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349883|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349884|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349885|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23584911|NCT03256344|65869320|FG001|Overall Study|Death|22|||
23584912|NCT03256344|65869319|FG000|Overall Study|Withdrawal by Subject|3|||
23349886|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349887|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349888|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349889|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349890|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23462830|NCT00665652|65437989|FG000|Overall Study|Death|1|||
23462831|NCT00665652|65437989|FG000|Overall Study|No longer met inclusion criteria.|1|||
23462832|NCT01074502|65437996|FG000|Overall Study|Withdrawal by Subject|1|||
23462833|NCT01347112|65438013|FG000|Overall Study|Withdrawal by Subject|1|||
23462834|NCT01347112|65438014|FG001|Overall Study|Withdrawal by Subject|7|||
23462835|NCT01347112|65438013|FG000|Overall Study|Lost to Follow-up|3|||
23462836|NCT01347112|65438014|FG001|Overall Study|Lost to Follow-up|5|||
23462837|NCT02201953|65438017|FG000|Overall Study|Randomized but Never Treated|1|||
23462838|NCT02201953|65438018|FG001|Overall Study|Randomized but Never Treated|5|||
23462839|NCT02201953|65438017|FG000|Overall Study|Lack of Efficacy|9|||
23462840|NCT02201953|65438018|FG001|Overall Study|Lack of Efficacy|30|||
23462841|NCT02201953|65438017|FG000|Overall Study|Lost to Follow-up|8|||
23462842|NCT02201953|65438018|FG001|Overall Study|Lost to Follow-up|8|||
23462843|NCT02201953|65438017|FG000|Overall Study|Withdrew Consent|2|||
23462844|NCT02201953|65438018|FG001|Overall Study|Withdrew Consent|5|||
23462845|NCT02201953|65438017|FG000|Overall Study|Adverse Event|0|||
23462846|NCT02201953|65438018|FG001|Overall Study|Adverse Event|5|||
23462847|NCT02201953|65438017|FG000|Overall Study|Death|0|||
23462848|NCT02201953|65438018|FG001|Overall Study|Death|3|||
23462849|NCT01614886|65438022|FG000|Overall Study|Adverse Event|15|||
23462850|NCT01614886|65438023|FG001|Overall Study|Adverse Event|20|||
23462851|NCT01614886|65438022|FG000|Overall Study|Withdrawal by Subject|4|||
23462852|NCT01614886|65438023|FG001|Overall Study|Withdrawal by Subject|4|||
23462853|NCT01614886|65438022|FG000|Overall Study|Death|1|||
23462854|NCT01614886|65438023|FG001|Overall Study|Death|0|||
23462855|NCT01614886|65438022|FG000|Overall Study|Protocol deviation|0|||
23462856|NCT01614886|65438023|FG001|Overall Study|Protocol deviation|2|||
23462857|NCT01772316|65438024|FG000|Overall Study|Serious adverse event|1|||
23462858|NCT01772316|65438024|FG000|Overall Study|Inform consent withdrawn|1|||
23462859|NCT01772316|65438024|FG000|Overall Study|Withdrawn by sponsor decision|5|||
23462860|NCT02392624|65438025|FG000|Overall Study|Withdrawal by Subject|15|||
23462861|NCT02392624|65438026|FG001|Overall Study|Withdrawal by Subject|12|||
23462862|NCT02392624|65438027|FG002|Overall Study|Withdrawal by Subject|9|||
23462863|NCT02392624|65438025|FG000|Overall Study|Adverse Event|4|||
23462864|NCT02392624|65438026|FG001|Overall Study|Adverse Event|1|||
23462865|NCT02392624|65438027|FG002|Overall Study|Adverse Event|2|||
23462866|NCT02392624|65438025|FG000|Overall Study|Pregnancy|1|||
23462867|NCT02392624|65438026|FG001|Overall Study|Pregnancy|0|||
23462868|NCT02392624|65438027|FG002|Overall Study|Pregnancy|0|||
23462869|NCT02392624|65438025|FG000|Overall Study|Protocol Violation|0|||
23462870|NCT02392624|65438026|FG001|Overall Study|Protocol Violation|0|||
23462871|NCT02392624|65438027|FG002|Overall Study|Protocol Violation|1|||
23462872|NCT02392624|65438025|FG000|Overall Study|Sponsor/Investigator Decision|2|||
23462873|NCT02392624|65438026|FG001|Overall Study|Sponsor/Investigator Decision|1|||
23462874|NCT02392624|65438027|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23462875|NCT02392624|65438025|FG000|Overall Study|Other|49|||
23462876|NCT02392624|65438026|FG001|Overall Study|Other|1|||
23462877|NCT02392624|65438027|FG002|Overall Study|Other|1|||
23462878|NCT02435992|65438028|FG000|Overall Study|non compliance with protocol|2|||
23462879|NCT02435992|65438029|FG001|Overall Study|non compliance with protocol|0|||
23462880|NCT02435992|65438030|FG002|Overall Study|non compliance with protocol|1|||
23462881|NCT02435992|65438031|FG003|Overall Study|non compliance with protocol|0|||
23462882|NCT02435992|65438032|FG004|Overall Study|non compliance with protocol|0|||
23462883|NCT02435992|65438028|FG000|Overall Study|Adverse Event|11|||
23462884|NCT02435992|65438029|FG001|Overall Study|Adverse Event|6|||
23349891|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23462885|NCT02435992|65438030|FG002|Overall Study|Adverse Event|12|||
23462886|NCT02435992|65438031|FG003|Overall Study|Adverse Event|0|||
23462887|NCT02435992|65438032|FG004|Overall Study|Adverse Event|0|||
23706198|NCT01258348|66301083|FG002|Overall Study|Progressive Disease|0|||
23349892|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
23402749|NCT01621178|65219994|FG000|Overall Study|Adverse Event|5|||
23462888|NCT02435992|65438028|FG000|Overall Study|Lack of Efficacy|4|||
23462889|NCT02435992|65438029|FG001|Overall Study|Lack of Efficacy|10|||
23462890|NCT02435992|65438030|FG002|Overall Study|Lack of Efficacy|9|||
23462891|NCT02435992|65438031|FG003|Overall Study|Lack of Efficacy|0|||
23462892|NCT02435992|65438032|FG004|Overall Study|Lack of Efficacy|0|||
23462893|NCT02435992|65438028|FG000|Overall Study|Withdrawal by Subject|10|||
23462894|NCT02435992|65438029|FG001|Overall Study|Withdrawal by Subject|8|||
23462895|NCT02435992|65438030|FG002|Overall Study|Withdrawal by Subject|20|||
23462896|NCT02435992|65438031|FG003|Overall Study|Withdrawal by Subject|0|||
23462897|NCT02435992|65438032|FG004|Overall Study|Withdrawal by Subject|0|||
23462898|NCT02435992|65438028|FG000|Overall Study|Other Reason|1|||
23462899|NCT02435992|65438029|FG001|Overall Study|Other Reason|0|||
23462900|NCT02435992|65438030|FG002|Overall Study|Other Reason|0|||
23462901|NCT02435992|65438031|FG003|Overall Study|Other Reason|0|||
23462902|NCT02435992|65438032|FG004|Overall Study|Other Reason|0|||
23462903|NCT02435992|65438028|FG000|Overall Study|Physician Decision|0|||
23462904|NCT02435992|65438029|FG001|Overall Study|Physician Decision|0|||
23462905|NCT02435992|65438030|FG002|Overall Study|Physician Decision|1|||
23462906|NCT02435992|65438031|FG003|Overall Study|Physician Decision|0|||
23462907|NCT02435992|65438032|FG004|Overall Study|Physician Decision|0|||
23462908|NCT02900378|65438033|FG000|Randomization (Visit 2)|Adverse Event|14|||
23462909|NCT02900378|65438034|FG001|Randomization (Visit 2)|Adverse Event|11|||
23462910|NCT02900378|65438033|FG000|Randomization (Visit 2)|Death|1|||
23462911|NCT02900378|65438034|FG001|Randomization (Visit 2)|Death|4|||
23462912|NCT02900378|65438033|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
23462913|NCT02900378|65438034|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
23462914|NCT02900378|65438033|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
23462915|NCT02900378|65438034|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
23462916|NCT02900378|65438033|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
23462917|NCT02900378|65438034|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
23462918|NCT02900378|65438033|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
23462919|NCT02900378|65438034|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
23462920|NCT02900378|65438033|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
23462921|NCT02900378|65438034|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
23462922|NCT01193244|65438040|FG000|Overall Study|Withdrawal by Subject|79|||
23462923|NCT01193244|65438041|FG001|Overall Study|Withdrawal by Subject|97|||
23462924|NCT01193244|65438040|FG000|Overall Study|Other|303|||
23462925|NCT01193244|65438041|FG001|Overall Study|Other|278|||
23462926|NCT01193244|65438040|FG000|Overall Study|Lost to Follow-up|6|||
23462927|NCT01193244|65438041|FG001|Overall Study|Lost to Follow-up|15|||
23462928|NCT00912197|65438045|FG000|Overall Study|Withdrawal by Subject|3|||
23462929|NCT00912197|65438046|FG001|Overall Study|Withdrawal by Subject|3|||
23462930|NCT00313014|65438047|FG000|Overall Study|Withdrawal by Subject|11|||
23462931|NCT00313014|65438048|FG001|Overall Study|Withdrawal by Subject|7|||
23462932|NCT00313014|65438049|FG002|Overall Study|Withdrawal by Subject|5|||
23462933|NCT00313014|65438047|FG000|Overall Study|Adverse Event|14|||
23462934|NCT00313014|65438048|FG001|Overall Study|Adverse Event|29|||
23462935|NCT00313014|65438049|FG002|Overall Study|Adverse Event|16|||
23462936|NCT00313014|65438047|FG000|Overall Study|Lost to Follow-up|7|||
23462937|NCT00313014|65438048|FG001|Overall Study|Lost to Follow-up|6|||
23462938|NCT00313014|65438049|FG002|Overall Study|Lost to Follow-up|10|||
23462939|NCT00313014|65438047|FG000|Overall Study|Administrative|9|||
23462940|NCT00313014|65438048|FG001|Overall Study|Administrative|6|||
23462941|NCT00313014|65438049|FG002|Overall Study|Administrative|14|||
23462942|NCT00313014|65438047|FG000|Overall Study|Lack of Efficacy|52|||
23462943|NCT00313014|65438048|FG001|Overall Study|Lack of Efficacy|25|||
23462944|NCT00313014|65438049|FG002|Overall Study|Lack of Efficacy|16|||
23462945|NCT02177032|65438053|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
23462946|NCT02177032|65438054|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
23462947|NCT02177032|65438055|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
23462948|NCT02177032|65438056|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
23462949|NCT02177032|65438053|FG000|Overall Study|Lost to Follow-up|0|||
23462950|NCT02177032|65438054|FG001|Overall Study|Lost to Follow-up|2|||
23462951|NCT02177032|65438055|FG002|Overall Study|Lost to Follow-up|0|||
23462952|NCT02177032|65438056|FG003|Overall Study|Lost to Follow-up|0|||
23462953|NCT02177032|65438053|FG000|Overall Study|OTHER|2|||
23462954|NCT02177032|65438054|FG001|Overall Study|OTHER|0|||
23462955|NCT02177032|65438055|FG002|Overall Study|OTHER|1|||
23462956|NCT02177032|65438056|FG003|Overall Study|OTHER|0|||
23462957|NCT02177032|65438053|FG000|Overall Study|Withdrawal by Subject|1|||
23462958|NCT02177032|65438054|FG001|Overall Study|Withdrawal by Subject|0|||
23462959|NCT02177032|65438055|FG002|Overall Study|Withdrawal by Subject|1|||
23462960|NCT02177032|65438056|FG003|Overall Study|Withdrawal by Subject|0|||
23462961|NCT02195518|65438057|FG000|Overall Study|Adverse Event|1|||
23584913|NCT03256344|65869320|FG001|Overall Study|Withdrawal by Subject|3|||
23584914|NCT03256344|65869319|FG000|Overall Study|Sponsor Decision|1|||
23462962|NCT02195518|65438057|FG000|Overall Study|Protocol Violation|4|||
23462963|NCT02195518|65438057|FG000|Overall Study|Pregnancy|2|||
23462964|NCT02195518|65438057|FG000|Overall Study|Withdrawal by Subject|1|||
23462965|NCT02195518|65438057|FG000|Overall Study|Lost to Follow-up|1|||
23462966|NCT01967940|65438060|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462967|NCT01967940|65438061|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462968|NCT01967940|65438062|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462969|NCT01967940|65438063|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
23462970|NCT01967940|65438060|FG000|Part 2|Adverse Event|0|||
23584915|NCT03256344|65869320|FG001|Overall Study|Sponsor Decision|0|||
23462971|NCT01967940|65438061|FG001|Part 2|Adverse Event|0|||
23462972|NCT01967940|65438062|FG002|Part 2|Adverse Event|0|||
23462973|NCT01967940|65438063|FG003|Part 2|Adverse Event|1|||
23349893|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349894|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349895|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349896|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349897|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349898|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349899|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349900|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349901|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349902|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349903|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349904|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349905|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349906|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349907|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
23349908|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349909|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349910|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349911|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349912|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349913|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349914|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349915|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349916|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349917|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349918|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349919|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349920|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
23349921|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23349922|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349923|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349924|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349925|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349926|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349927|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349928|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349929|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349930|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349931|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349932|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349933|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349934|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349935|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23349936|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349937|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349938|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349939|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349940|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349941|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349942|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349943|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349944|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349945|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349946|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349947|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
23349948|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349949|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349950|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349951|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23462974|NCT01967940|65438060|FG000|Part 2|Unknown Reason|0|||
23462975|NCT01967940|65438061|FG001|Part 2|Unknown Reason|0|||
23462976|NCT01967940|65438062|FG002|Part 2|Unknown Reason|0|||
23639872|NCT01242800|66067377|FG001|Overall Study|Reasons not reported|4|||
23462977|NCT01967940|65438063|FG003|Part 2|Unknown Reason|1|||
23462978|NCT04119414|65438064|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
23462979|NCT02141295|65438065|FG000|Overall Study|Adverse Event|1|||
23462980|NCT02141295|65438066|FG001|Overall Study|Adverse Event|18|||
23462981|NCT02141295|65438067|FG002|Overall Study|Adverse Event|11|||
23462982|NCT02141295|65438065|FG000|Overall Study|Physician Decision|2|||
23462983|NCT02141295|65438066|FG001|Overall Study|Physician Decision|19|||
23462984|NCT02141295|65438067|FG002|Overall Study|Physician Decision|14|||
23462985|NCT02141295|65438065|FG000|Overall Study|Study terminated by sponsor|0|||
23462986|NCT02141295|65438066|FG001|Overall Study|Study terminated by sponsor|6|||
23462987|NCT02141295|65438067|FG002|Overall Study|Study terminated by sponsor|6|||
23462988|NCT02141295|65438065|FG000|Overall Study|Non-compliance|0|||
23462989|NCT02141295|65438066|FG001|Overall Study|Non-compliance|1|||
23462990|NCT02141295|65438067|FG002|Overall Study|Non-compliance|0|||
23462991|NCT02141295|65438065|FG000|Overall Study|Progressive disease|3|||
23462992|NCT02141295|65438066|FG001|Overall Study|Progressive disease|32|||
23462993|NCT02141295|65438067|FG002|Overall Study|Progressive disease|50|||
23462994|NCT02141295|65438065|FG000|Overall Study|Reason not specified|0|||
23462995|NCT02141295|65438066|FG001|Overall Study|Reason not specified|9|||
23462996|NCT02141295|65438067|FG002|Overall Study|Reason not specified|10|||
23462997|NCT02141295|65438065|FG000|Overall Study|Withdrawal by Subject|0|||
23462998|NCT02141295|65438066|FG001|Overall Study|Withdrawal by Subject|9|||
23462999|NCT02141295|65438067|FG002|Overall Study|Withdrawal by Subject|4|||
23463000|NCT02383576|65438068|FG000|Overall Study|Death|53|||
23463001|NCT02383576|65438069|FG001|Overall Study|Death|33|||
23463002|NCT02383576|65438068|FG000|Overall Study|Lost to Follow-up|7|||
23463003|NCT02383576|65438069|FG001|Overall Study|Lost to Follow-up|1|||
23463004|NCT02383576|65438068|FG000|Overall Study|Withdrew Consent|1|||
23463005|NCT02383576|65438069|FG001|Overall Study|Withdrew Consent|6|||
23463006|NCT02383576|65438068|FG000|Overall Study|Investigator's Decision|0|||
23463007|NCT02383576|65438069|FG001|Overall Study|Investigator's Decision|1|||
23463008|NCT02383576|65438068|FG000|Overall Study|Administrative/Other|2|||
23463009|NCT02383576|65438069|FG001|Overall Study|Administrative/Other|4|||
23463010|NCT04393454|65438070|FG000|Overall Study|Death|1|||
23463011|NCT04393454|65438070|FG000|Overall Study|Lost to Follow-up|1|||
23463012|NCT02079246|65438071|FG000|OLEX|Withdrawal before treatment|1|||
23463013|NCT02079246|65438072|FG001|OLEX|Withdrawal before treatment|0|||
23463014|NCT02079246|65438071|FG000|OLEX|Death|11|||
23463015|NCT02079246|65438072|FG001|OLEX|Death|0|||
23463016|NCT02079246|65438071|FG000|OLEX|Adverse Event|66|||
23463017|NCT02079246|65438072|FG001|OLEX|Adverse Event|0|||
23463018|NCT02079246|65438071|FG000|OLEX|Withdrawal by Subject|60|||
23463019|NCT02079246|65438072|FG001|OLEX|Withdrawal by Subject|0|||
23463020|NCT02079246|65438071|FG000|OLEX|Lost to Follow-up|6|||
23463021|NCT02079246|65438072|FG001|OLEX|Lost to Follow-up|0|||
23463022|NCT02079246|65438071|FG000|OLEX|Protocol Violation|6|||
23463023|NCT02079246|65438072|FG001|OLEX|Protocol Violation|0|||
23463024|NCT02079246|65438071|FG000|OLEX|Lack of Efficacy|3|||
23463025|NCT02079246|65438072|FG001|OLEX|Lack of Efficacy|0|||
23463026|NCT02079246|65438071|FG000|OLEX|Results of the lead-in studies|58|||
23463027|NCT02079246|65438072|FG001|OLEX|Results of the lead-in studies|0|||
23463028|NCT02079246|65438071|FG000|OLEX|Other: Disallowed medication|8|||
23463029|NCT02079246|65438072|FG001|OLEX|Other: Disallowed medication|0|||
23584916|NCT03586544|65869323|FG000|First Intervention|Adverse Event|0|||
23584917|NCT03586544|65869324|FG001|First Intervention|Adverse Event|1|||
23584918|NCT03586544|65869323|FG000|Second Intervention|Withdrawal by Subject|0|||
23584919|NCT03586544|65869324|FG001|Second Intervention|Withdrawal by Subject|1|||
23584920|NCT00099437|65869325|FG000|Overall Study|Lost to Follow-up|30|||
23584921|NCT00099437|65869326|FG001|Overall Study|Lost to Follow-up|33|||
23584922|NCT00099437|65869325|FG000|Overall Study|Death|293|||
23584923|NCT00099437|65869326|FG001|Overall Study|Death|261|||
23584924|NCT00099437|65869325|FG000|Overall Study|Withdrawal by Subject|6|||
23584925|NCT00099437|65869326|FG001|Overall Study|Withdrawal by Subject|10|||
23463030|NCT02079246|65438071|FG000|OLEX|Other: Insufficient compliance|2|||
23463031|NCT02079246|65438072|FG001|OLEX|Other: Insufficient compliance|0|||
23463032|NCT02079246|65438071|FG000|OLEX|Other: Caregiver unavailable|3|||
23584926|NCT00099437|65869325|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
23463033|NCT02079246|65438072|FG001|OLEX|Other: Caregiver unavailable|0|||
23463034|NCT02079246|65438071|FG000|OLEX|Other: Coordinator decision|1|||
23463035|NCT02079246|65438072|FG001|OLEX|Other: Coordinator decision|0|||
23463036|NCT02079246|65438071|FG000|OLEX|Other: Worsening of condition|1|||
23463037|NCT02079246|65438072|FG001|OLEX|Other: Worsening of condition|0|||
23463038|NCT02079246|65438071|FG000|OLEX|Other: Moved to nursing home|1|||
23584927|NCT00099437|65869326|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
23584928|NCT02954055|65869327|FG000|Overall Study|Did not initiate therapy|6|||
23639873|NCT02187159|66067380|FG000|Overall Study|Protocol Violation|4|||
23463039|NCT02079246|65438072|FG001|OLEX|Other: Moved to nursing home|0|||
23463040|NCT02079246|65438071|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
23463041|NCT02079246|65438072|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
23463042|NCT02079246|65438071|FG000|OLEX-MEM|Adverse Event|0|||
23463043|NCT02079246|65438072|FG001|OLEX-MEM|Adverse Event|6|||
23463044|NCT02079246|65438071|FG000|OLEX-MEM|Withdrawal by Subject|0|||
23463045|NCT02079246|65438072|FG001|OLEX-MEM|Withdrawal by Subject|7|||
23463046|NCT02079246|65438071|FG000|OLEX-MEM|Protocol Violation|0|||
23463047|NCT02079246|65438072|FG001|OLEX-MEM|Protocol Violation|2|||
23463048|NCT02079246|65438071|FG000|OLEX-MEM|Lost to Follow-up|0|||
23463049|NCT02079246|65438072|FG001|OLEX-MEM|Lost to Follow-up|1|||
23463050|NCT02079246|65438071|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
23463051|NCT02079246|65438072|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
23463052|NCT00124943|65438073|FG000|Phase II|Adverse Event|0|||
23463053|NCT00124943|65438074|FG001|Phase II|Adverse Event|2|||
23463054|NCT00124943|65438075|FG002|Phase II|Adverse Event|0|||
23463055|NCT00124943|65438076|FG003|Phase II|Adverse Event|1|||
23463056|NCT00124943|65438073|FG000|Phase II|Protocol Violation|0|||
23463057|NCT00124943|65438074|FG001|Phase II|Protocol Violation|0|||
23463058|NCT00124943|65438075|FG002|Phase II|Protocol Violation|0|||
23463059|NCT00124943|65438076|FG003|Phase II|Protocol Violation|1|||
23463060|NCT00124943|65438073|FG000|Phase II|Lost to Follow-up|0|||
23463061|NCT00124943|65438074|FG001|Phase II|Lost to Follow-up|0|||
23463062|NCT00124943|65438075|FG002|Phase II|Lost to Follow-up|0|||
23463063|NCT00124943|65438076|FG003|Phase II|Lost to Follow-up|1|||
23463064|NCT00124943|65438073|FG000|Phase II|Withdrawal by Subject|0|||
23463065|NCT00124943|65438074|FG001|Phase II|Withdrawal by Subject|0|||
23789817|NCT01859598|66609537|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
23789818|NCT00909038|66609538|FG000|Overall Study|Protocol Violation|187|||
23789819|NCT00909038|66609538|FG000|Overall Study|Non-evaluable Subjects|230|||
23789820|NCT01460628|66609540|FG000|Overall Study|Adverse Event|3|||
23789821|NCT01460628|66609540|FG000|Overall Study|Withdrawal by Subject|2|||
23789822|NCT01944722|66609543|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
23789823|NCT01944722|66609543|FG000|Overall Study|Specimen Shipping Issues|34|||
23789824|NCT01944722|66609543|FG000|Overall Study|Improper Storage/Transport|5|||
23789825|NCT01944722|66609543|FG000|Overall Study|Insufficient Volume for Test|1|||
23789826|NCT01944722|66609543|FG000|Overall Study|Missing Specimens|3|||
23789827|NCT01944722|66609543|FG000|Overall Study|Specimens Mislabeled|2|||
23789828|NCT01944722|66609543|FG000|Overall Study|Withdrawal by Subject|8|||
23789829|NCT01944722|66609543|FG000|Overall Study|NILM Subjects <30 years old|8106|||
23789830|NCT01944722|66609543|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
23789831|NCT01944722|66609543|FG000|Overall Study|>ASCUS Cytology|1122|||
23789832|NCT02426918|66609544|FG000|Overall Study|Adverse Event|2|||
23789833|NCT02426918|66609545|FG001|Overall Study|Adverse Event|2|||
23789834|NCT02426918|66609546|FG002|Overall Study|Adverse Event|0|||
23789835|NCT02426918|66609544|FG000|Overall Study|Physician Decision|1|||
23789836|NCT02426918|66609545|FG001|Overall Study|Physician Decision|1|||
23789837|NCT02426918|66609546|FG002|Overall Study|Physician Decision|1|||
23789838|NCT02426918|66609544|FG000|Overall Study|Withdrawal by Subject|5|||
23789839|NCT02426918|66609545|FG001|Overall Study|Withdrawal by Subject|5|||
23789840|NCT02426918|66609546|FG002|Overall Study|Withdrawal by Subject|4|||
23789841|NCT02426918|66609544|FG000|Overall Study|Other|9|||
23789842|NCT02426918|66609545|FG001|Overall Study|Other|11|||
23789843|NCT02426918|66609546|FG002|Overall Study|Other|9|||
23789844|NCT04878211|66609547|FG000|Overall Study|Lost to Follow-up|0|||
23789845|NCT04878211|66609548|FG001|Overall Study|Lost to Follow-up|0|||
23789846|NCT04878211|66609549|FG002|Overall Study|Lost to Follow-up|0|||
23789847|NCT04878211|66609550|FG003|Overall Study|Lost to Follow-up|1|||
23789848|NCT04878211|66609551|FG004|Overall Study|Lost to Follow-up|0|||
23789849|NCT04878211|66609552|FG005|Overall Study|Lost to Follow-up|1|||
23789850|NCT04878211|66609547|FG000|Overall Study|Protocol deviation|1|||
23584929|NCT02954055|65869328|FG001|Overall Study|Did not initiate therapy|1|||
23584930|NCT00256243|65869329|FG000|Overall Study|Lost to Follow-up|2|||
23584931|NCT00256243|65869329|FG000|Overall Study|Death|7|||
23584932|NCT00256243|65869329|FG000|Overall Study|Not treated|1|||
23584933|NCT05025449|65869331|FG000|Overall Study|Withdrawal by Subject|1|||
23584934|NCT05025449|65869331|FG000|Overall Study|Patient emergently taken to operating room|1|||
23584935|NCT01175707|65869332|FG000|Overall Study|Adverse Event|4|||
23463066|NCT00124943|65438075|FG002|Phase II|Withdrawal by Subject|0|||
23463067|NCT00124943|65438076|FG003|Phase II|Withdrawal by Subject|2|||
23584936|NCT01175707|65869333|FG001|Overall Study|Adverse Event|6|||
23584937|NCT01124162|65869334|FG000|First Intervention|Adverse Event|2|||
23463068|NCT01295814|65438077|FG000|Overall Study|Lack of Efficacy|0|||
23463069|NCT01295814|65438078|FG001|Overall Study|Lack of Efficacy|2|||
23463070|NCT01295814|65438077|FG000|Overall Study|Withdrawal by Subject|2|||
23463071|NCT01295814|65438078|FG001|Overall Study|Withdrawal by Subject|0|||
23463072|NCT03096288|65438079|FG000|Overall Study|Withdrawal by Subject|0|||
23463073|NCT03096288|65438080|FG001|Overall Study|Withdrawal by Subject|1|||
23584938|NCT01124162|65869335|FG001|First Intervention|Adverse Event|0|||
23584939|NCT01124162|65869334|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23584940|NCT01124162|65869335|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23463074|NCT03096288|65438081|FG002|Overall Study|Withdrawal by Subject|0|||
23639874|NCT02187159|66067381|FG001|Overall Study|Protocol Violation|6|||
23584941|NCT00886613|65869336|FG000|Overall Study|Protocol deviation (Part B)|1|||
23584942|NCT00886613|65869337|FG001|Overall Study|Protocol deviation (Part B)|0|||
23584943|NCT00886613|65869338|FG002|Overall Study|Protocol deviation (Part B)|0|||
23584944|NCT00886613|65869336|FG000|Overall Study|Lost to follow-up (Part B)|1|||
23584945|NCT00886613|65869337|FG001|Overall Study|Lost to follow-up (Part B)|0|||
23584946|NCT00886613|65869338|FG002|Overall Study|Lost to follow-up (Part B)|1|||
23584947|NCT00886613|65869336|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
23584948|NCT00886613|65869337|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
23584949|NCT00886613|65869338|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
23584950|NCT01268891|65869339|FG000|Overall Study|Adverse Event|3|||
23584951|NCT01268891|65869340|FG001|Overall Study|Adverse Event|7|||
23584952|NCT01268891|65869339|FG000|Overall Study|Lack of Efficacy|1|||
23584953|NCT01268891|65869340|FG001|Overall Study|Lack of Efficacy|0|||
23584954|NCT01268891|65869339|FG000|Overall Study|Withdrawal of Consent|3|||
23584955|NCT01268891|65869340|FG001|Overall Study|Withdrawal of Consent|1|||
23584956|NCT01268891|65869339|FG000|Overall Study|Administrative or other reason(s)|1|||
23584957|NCT01268891|65869340|FG001|Overall Study|Administrative or other reason(s)|0|||
23584958|NCT03213678|65869352|FG000|Overall Study|Death|1|||
23349952|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23584959|NCT03213678|65869352|FG000|Overall Study|Physician Decision|1|||
23349953|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349954|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349955|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349956|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
23349957|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
23349958|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
23349959|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
23349960|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
23349961|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
23349962|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
23349963|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
23349964|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
23349965|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
23349966|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
23349967|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
23349968|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
23349969|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
23349970|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349971|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349972|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349973|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349974|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349975|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349976|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349977|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349978|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349979|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349980|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349981|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23349982|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23349983|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349984|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349985|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349986|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23584960|NCT03213678|65869352|FG000|Overall Study|Progressive disease|16|||
23584961|NCT02968004|65869356|FG000|Overall Study|Adverse Event|1|||
23584962|NCT02968004|65869357|FG001|Overall Study|Adverse Event|0|||
23584963|NCT02968004|65869356|FG000|Overall Study|Withdrawal by Subject|0|||
23463075|NCT03096288|65438082|FG003|Overall Study|Withdrawal by Subject|1|||
23463076|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
23463077|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
23463078|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
23463079|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23463080|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23463081|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23584964|NCT02968004|65869357|FG001|Overall Study|Withdrawal by Subject|1|||
23789851|NCT04878211|66609548|FG001|Overall Study|Protocol deviation|0|||
23789852|NCT04878211|66609549|FG002|Overall Study|Protocol deviation|0|||
23789853|NCT04878211|66609550|FG003|Overall Study|Protocol deviation|0|||
23789854|NCT04878211|66609551|FG004|Overall Study|Protocol deviation|0|||
23789855|NCT04878211|66609552|FG005|Overall Study|Protocol deviation|0|||
23789856|NCT04878211|66609547|FG000|Overall Study|Study terminated by sponsor|0|||
23789857|NCT04878211|66609548|FG001|Overall Study|Study terminated by sponsor|0|||
23789858|NCT04878211|66609549|FG002|Overall Study|Study terminated by sponsor|0|||
23789859|NCT04878211|66609550|FG003|Overall Study|Study terminated by sponsor|0|||
23789860|NCT04878211|66609551|FG004|Overall Study|Study terminated by sponsor|9|||
23789861|NCT04878211|66609552|FG005|Overall Study|Study terminated by sponsor|4|||
23789862|NCT04878211|66609547|FG000|Overall Study|Subject decision|0|||
23789863|NCT04878211|66609548|FG001|Overall Study|Subject decision|0|||
23789864|NCT04878211|66609549|FG002|Overall Study|Subject decision|0|||
23463082|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
23463083|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
23463084|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23463085|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
23463086|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
23463087|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
23463088|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
23463089|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
23463090|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
23463091|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23463092|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23463093|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23463094|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23463095|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23463096|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23463097|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
23463098|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23463099|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23463100|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Other|10|||
23463101|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Other|2|||
23463102|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Other|6|||
23463103|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23463104|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23463105|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23463106|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23463107|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23463108|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23463109|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23789865|NCT04878211|66609550|FG003|Overall Study|Subject decision|0|||
23789866|NCT04878211|66609551|FG004|Overall Study|Subject decision|1|||
23789867|NCT04878211|66609552|FG005|Overall Study|Subject decision|0|||
23789868|NCT00288704|66609553|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
23789869|NCT00288704|66609554|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
23789870|NCT00288704|66609555|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
23789871|NCT00288704|66609553|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
23789872|NCT00288704|66609554|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
23789873|NCT00288704|66609555|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
23789874|NCT00288704|66609553|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
23463110|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23463111|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23463112|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23789875|NCT00288704|66609554|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
23789876|NCT00288704|66609555|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
23789877|NCT00288704|66609553|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
23584965|NCT02403674|65869358|FG000|Base Study|Death|1|||
23402750|NCT01621178|65219995|FG001|Overall Study|Adverse Event|2|||
23789878|NCT00288704|66609554|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
23789879|NCT00288704|66609555|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
23789880|NCT00288704|66609553|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
23789881|NCT00288704|66609554|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
23463113|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23463114|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
23463115|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23463116|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23463117|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23463118|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Other|8|||
23463119|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Other|3|||
23463120|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23463121|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23463122|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23463123|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23463124|NCT04476797|65438088|FG000|Overall Study|Withdrawal by Subject|1|||
23463125|NCT04476797|65438089|FG001|Overall Study|Withdrawal by Subject|0|||
23463126|NCT04476797|65438090|FG002|Overall Study|Withdrawal by Subject|0|||
23463127|NCT04476797|65438088|FG000|Overall Study|Death|0|||
23463128|NCT04476797|65438089|FG001|Overall Study|Death|1|||
23789882|NCT00288704|66609555|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
23789883|NCT00288704|66609553|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
23789884|NCT00288704|66609554|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
23789885|NCT00288704|66609555|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
23789886|NCT00288704|66609553|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
23789887|NCT00288704|66609554|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
23789888|NCT00288704|66609555|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
23789889|NCT02637141|66609560|FG000|Overall Study|Adverse Event|1|||
23789890|NCT02637141|66609561|FG001|Overall Study|Adverse Event|1|||
23789891|NCT02637141|66609562|FG002|Overall Study|Adverse Event|0|||
23789892|NCT02637141|66609560|FG000|Overall Study|Withdrawal by Subject|1|||
23789893|NCT02637141|66609561|FG001|Overall Study|Withdrawal by Subject|1|||
23789894|NCT02637141|66609562|FG002|Overall Study|Withdrawal by Subject|1|||
23789895|NCT00292227|66609565|FG000|Patch Period|Adverse Event|1|||
23789896|NCT00292227|66609566|FG001|Patch Period|Adverse Event|0|||
23463129|NCT04476797|65438090|FG002|Overall Study|Death|2|||
23463130|NCT04476797|65438088|FG000|Overall Study|Sponsor Terminated Study|0|||
23463131|NCT04476797|65438089|FG001|Overall Study|Sponsor Terminated Study|18|||
23463132|NCT04476797|65438090|FG002|Overall Study|Sponsor Terminated Study|17|||
23463133|NCT03038100|65438091|FG000|Overall Study|Death|289|||
23789897|NCT00292227|66609567|FG002|Patch Period|Adverse Event|2|||
23789898|NCT00292227|66609565|FG000|Patch Period|Withdrawal by Subject|0|||
23789899|NCT00292227|66609566|FG001|Patch Period|Withdrawal by Subject|0|||
23789900|NCT00292227|66609567|FG002|Patch Period|Withdrawal by Subject|1|||
23789901|NCT00847535|66609568|FG000|Overall Study|Withdrawal by Subject|2|||
23789902|NCT00847535|66609569|FG001|Overall Study|Withdrawal by Subject|1|||
23789903|NCT00847535|66609570|FG002|Overall Study|Withdrawal by Subject|1|||
23789904|NCT00847535|66609568|FG000|Overall Study|Lost to Follow-up|0|||
23789905|NCT00847535|66609569|FG001|Overall Study|Lost to Follow-up|1|||
23789906|NCT00847535|66609570|FG002|Overall Study|Lost to Follow-up|0|||
23789907|NCT00642993|66609575|FG000|Overall Study|Adverse Event|85|||
23789908|NCT00642993|66609576|FG001|Overall Study|Adverse Event|4|||
23463134|NCT03038100|65438092|FG001|Overall Study|Death|272|||
23463135|NCT03038100|65438091|FG000|Overall Study|Lost to Follow-up|9|||
23463136|NCT03038100|65438092|FG001|Overall Study|Lost to Follow-up|10|||
23463137|NCT03038100|65438091|FG000|Overall Study|Protocol Deviation|1|||
23463138|NCT03038100|65438092|FG001|Overall Study|Protocol Deviation|4|||
23463139|NCT03038100|65438091|FG000|Overall Study|Withdrawal by Subject|45|||
23463140|NCT03038100|65438092|FG001|Overall Study|Withdrawal by Subject|51|||
23463141|NCT03038100|65438091|FG000|Overall Study|Study Terminated By Sponsor|305|||
23463142|NCT03038100|65438092|FG001|Overall Study|Study Terminated By Sponsor|311|||
23789909|NCT00642993|66609575|FG000|Overall Study|Lost to Follow-up|8|||
23463143|NCT03038100|65438091|FG000|Overall Study|Physician Decision|1|||
23463144|NCT03038100|65438092|FG001|Overall Study|Physician Decision|3|||
23463145|NCT02085161|65438094|FG000|Overall Study|Not Treated|1|||
23463146|NCT02085161|65438095|FG001|Overall Study|Not Treated|0|||
23789910|NCT00642993|66609576|FG001|Overall Study|Lost to Follow-up|4|||
23789911|NCT00642993|66609575|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
23463147|NCT02085161|65438096|FG002|Overall Study|Not Treated|0|||
23463148|NCT02085161|65438097|FG003|Overall Study|Not Treated|0|||
23463149|NCT02085161|65438094|FG000|Overall Study|Adverse Event|8|||
23463150|NCT02085161|65438095|FG001|Overall Study|Adverse Event|5|||
23463151|NCT02085161|65438096|FG002|Overall Study|Adverse Event|4|||
23463152|NCT02085161|65438097|FG003|Overall Study|Adverse Event|5|||
23463153|NCT02085161|65438094|FG000|Overall Study|Protocol Violation|0|||
23463154|NCT02085161|65438095|FG001|Overall Study|Protocol Violation|1|||
23463155|NCT02085161|65438096|FG002|Overall Study|Protocol Violation|0|||
23463156|NCT02085161|65438097|FG003|Overall Study|Protocol Violation|1|||
23463157|NCT02085161|65438094|FG000|Overall Study|Withdrawal by Subject|2|||
23463158|NCT02085161|65438095|FG001|Overall Study|Withdrawal by Subject|4|||
23463159|NCT02085161|65438096|FG002|Overall Study|Withdrawal by Subject|0|||
23463160|NCT02085161|65438097|FG003|Overall Study|Withdrawal by Subject|3|||
23463161|NCT02085161|65438094|FG000|Overall Study|Other Reason|1|||
23463162|NCT02085161|65438095|FG001|Overall Study|Other Reason|0|||
23463163|NCT02085161|65438096|FG002|Overall Study|Other Reason|1|||
23463164|NCT02085161|65438097|FG003|Overall Study|Other Reason|1|||
23463165|NCT03085095|65438098|FG000|Overall Study|Adverse Event|23|||
23463166|NCT03085095|65438099|FG001|Overall Study|Adverse Event|8|||
23463167|NCT03085095|65438098|FG000|Overall Study|Protocol Violation|0|||
23463168|NCT03085095|65438099|FG001|Overall Study|Protocol Violation|1|||
23463169|NCT03085095|65438098|FG000|Overall Study|Lost to Follow-up|2|||
23463170|NCT03085095|65438099|FG001|Overall Study|Lost to Follow-up|1|||
23463171|NCT03085095|65438098|FG000|Overall Study|Withdrawal by Subject|17|||
23463172|NCT03085095|65438099|FG001|Overall Study|Withdrawal by Subject|6|||
23463173|NCT03085095|65438098|FG000|Overall Study|Physician Decision|9|||
23463174|NCT03085095|65438099|FG001|Overall Study|Physician Decision|3|||
23463175|NCT03085095|65438098|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
23463176|NCT03085095|65438099|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
23463177|NCT03085095|65438098|FG000|Overall Study|Did not Receive Study Drug|2|||
23463178|NCT03085095|65438099|FG001|Overall Study|Did not Receive Study Drug|2|||
23463179|NCT03085095|65438098|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
23463180|NCT03085095|65438099|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
23463181|NCT01942837|65438102|FG000|Overall Study|Death|1|||
23463182|NCT01942837|65438102|FG000|Overall Study|Symptomatic or radiographic progression|49|||
23463183|NCT01942837|65438102|FG000|Overall Study|Adverse Event|6|||
23463184|NCT01942837|65438102|FG000|Overall Study|Physician Decision|3|||
23463185|NCT01942837|65438102|FG000|Overall Study|Withdrawal by Subject|2|||
23463186|NCT01942837|65438102|FG000|Overall Study|Intercurrent Illness|1|||
23463187|NCT01942837|65438102|FG000|Overall Study|On treatment|3|||
23463188|NCT01942837|65438102|FG000|Overall Study|Never initiate the treatment|2|||
23463189|NCT02153086|65438105|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
23463190|NCT02153086|65438105|FG000|Overall Study|Other|2|||
23463191|NCT04596267|65438106|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
23463192|NCT04596267|65438107|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
23789912|NCT00642993|66609576|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
23789913|NCT00642993|66609575|FG000|Overall Study|Protocol Violation|1|||
23789914|NCT00642993|66609576|FG001|Overall Study|Protocol Violation|4|||
23789915|NCT00642993|66609575|FG000|Overall Study|Did not meet protocol eligibility|0|||
23463193|NCT04596267|65438106|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
23463194|NCT04596267|65438107|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
23463195|NCT01108185|65438109|FG000|Overall Study|Non-compliance|15|||
23463196|NCT01108185|65438109|FG000|Overall Study|Lost to Follow-up|12|||
23463197|NCT01462370|65438110|FG000|Overall Study|Lack of Qualifying Event|1|||
23463198|NCT01462370|65438111|FG001|Overall Study|Lack of Qualifying Event|1|||
23463199|NCT01462370|65438110|FG000|Overall Study|Physician Decision|0|||
23463200|NCT01462370|65438111|FG001|Overall Study|Physician Decision|1|||
23463201|NCT01462370|65438110|FG000|Overall Study|Withdrawal by Subject|0|||
23463202|NCT01462370|65438111|FG001|Overall Study|Withdrawal by Subject|3|||
23463203|NCT00199381|65438112|FG000|Overall Study|Withdrawal by Subject|38|||
23463204|NCT00199381|65438112|FG000|Overall Study|Adverse Event|73|||
23463205|NCT00199381|65438112|FG000|Overall Study|Protocol Violation|6|||
23463206|NCT00199381|65438112|FG000|Overall Study|Lack of Efficacy|27|||
23463207|NCT00199381|65438112|FG000|Overall Study|Not including due to early termination|37|||
23463208|NCT00199381|65438112|FG000|Overall Study|Study termination by Sponsor|323|||
23463209|NCT01716234|65438113|FG000|Overall Study|Protocol Violation|0|||
23463210|NCT01716234|65438114|FG001|Overall Study|Protocol Violation|0|||
23463211|NCT01716234|65438115|FG002|Overall Study|Protocol Violation|0|||
23463212|NCT01716234|65438116|FG003|Overall Study|Protocol Violation|1|||
23463213|NCT01716234|65438117|FG004|Overall Study|Protocol Violation|1|||
23584966|NCT02403674|65869359|FG001|Base Study|Death|4|||
23789916|NCT00642993|66609576|FG001|Overall Study|Did not meet protocol eligibility|1|||
23789917|NCT00642993|66609575|FG000|Overall Study|Administrative|1|||
23463214|NCT01716234|65438118|FG005|Overall Study|Protocol Violation|1|||
23463215|NCT01716234|65438119|FG006|Overall Study|Protocol Violation|0|||
23463216|NCT01716234|65438113|FG000|Overall Study|Lack of Efficacy|0|||
23463217|NCT01716234|65438114|FG001|Overall Study|Lack of Efficacy|0|||
23463218|NCT01716234|65438115|FG002|Overall Study|Lack of Efficacy|0|||
23463219|NCT01716234|65438116|FG003|Overall Study|Lack of Efficacy|1|||
23463220|NCT01716234|65438117|FG004|Overall Study|Lack of Efficacy|0|||
23463221|NCT01716234|65438118|FG005|Overall Study|Lack of Efficacy|0|||
23463222|NCT01716234|65438119|FG006|Overall Study|Lack of Efficacy|0|||
23463223|NCT01716234|65438113|FG000|Overall Study|Did not meet protocol eligibility|0|||
23463224|NCT01716234|65438114|FG001|Overall Study|Did not meet protocol eligibility|0|||
23463225|NCT01716234|65438115|FG002|Overall Study|Did not meet protocol eligibility|1|||
23463226|NCT01716234|65438116|FG003|Overall Study|Did not meet protocol eligibility|0|||
23463227|NCT01716234|65438117|FG004|Overall Study|Did not meet protocol eligibility|0|||
23463228|NCT01716234|65438118|FG005|Overall Study|Did not meet protocol eligibility|4|||
23463229|NCT01716234|65438119|FG006|Overall Study|Did not meet protocol eligibility|0|||
23789918|NCT00642993|66609576|FG001|Overall Study|Administrative|0|||
23789919|NCT00874276|66609583|FG000|Overall Study|Withdrawal by Subject|1|||
23789920|NCT00874276|66609584|FG001|Overall Study|Withdrawal by Subject|1|||
23789921|NCT00556673|66609585|FG000|Overall Study|Protocol deviation|3|||
23789922|NCT00556673|66609586|FG001|Overall Study|Protocol deviation|2|||
23789923|NCT01547728|66609588|FG000|Overall Study|Change in procedure and equipment|1|||
23789924|NCT01547728|66609588|FG000|Overall Study|Drug not ready for subject|1|||
23789925|NCT01547728|66609588|FG000|Overall Study|Screen failure|39|||
23789926|NCT01297504|66609589|FG000|Overall Study|Invalid Consent|1|||
23789927|NCT01297504|66609589|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
23789928|NCT01297504|66609589|FG000|Overall Study|No Study Visits|4|||
23789929|NCT01297504|66609589|FG000|Overall Study|Death|3|||
23463230|NCT01716234|65438113|FG000|Overall Study|Adverse Event|7|||
23463231|NCT01716234|65438114|FG001|Overall Study|Adverse Event|10|||
23463232|NCT01716234|65438115|FG002|Overall Study|Adverse Event|2|||
23463233|NCT01716234|65438116|FG003|Overall Study|Adverse Event|8|||
23463234|NCT01716234|65438117|FG004|Overall Study|Adverse Event|3|||
23463235|NCT01716234|65438118|FG005|Overall Study|Adverse Event|6|||
23463236|NCT01716234|65438119|FG006|Overall Study|Adverse Event|0|||
23463237|NCT01716234|65438113|FG000|Overall Study|Withdrawal by Subject|3|||
23463238|NCT01716234|65438114|FG001|Overall Study|Withdrawal by Subject|0|||
23463239|NCT01716234|65438115|FG002|Overall Study|Withdrawal by Subject|2|||
23463240|NCT01716234|65438116|FG003|Overall Study|Withdrawal by Subject|2|||
23463241|NCT01716234|65438117|FG004|Overall Study|Withdrawal by Subject|1|||
23463242|NCT01716234|65438118|FG005|Overall Study|Withdrawal by Subject|3|||
23463243|NCT01716234|65438119|FG006|Overall Study|Withdrawal by Subject|0|||
23463244|NCT03841604|65438127|FG000|Overall Study|Withdrawal by Subject|3|||
23463245|NCT03841604|65438128|FG001|Overall Study|Withdrawal by Subject|1|||
23463246|NCT03841604|65438127|FG000|Overall Study|Adverse Event|4|||
23463247|NCT03841604|65438128|FG001|Overall Study|Adverse Event|2|||
23463248|NCT03841604|65438127|FG000|Overall Study|Physician Decision|1|||
23463249|NCT03841604|65438128|FG001|Overall Study|Physician Decision|0|||
23463250|NCT00760617|65438131|FG000|Overall Study|Adverse Event|5|||
23463251|NCT00760617|65438132|FG001|Overall Study|Adverse Event|2|||
23463252|NCT00760617|65438133|FG002|Overall Study|Adverse Event|0|||
23463253|NCT00760617|65438131|FG000|Overall Study|Lost to Follow-up|0|||
23463254|NCT00760617|65438132|FG001|Overall Study|Lost to Follow-up|0|||
23463255|NCT00760617|65438133|FG002|Overall Study|Lost to Follow-up|5|||
23463256|NCT00361296|65440790|FG000|Overall Study|Physician Decision|1|||
23463257|NCT00361296|65440790|FG000|Overall Study|Lack of Efficacy|2|||
23463258|NCT02851615|65440791|FG000|Overall Study|Cognitive Issue|1|||
23463259|NCT02851615|65440792|FG001|Overall Study|Cognitive Issue|0|||
23463260|NCT02851615|65440791|FG000|Overall Study|Lost to Follow-up|0|||
23463261|NCT02851615|65440792|FG001|Overall Study|Lost to Follow-up|4|||
23463262|NCT02004093|65440793|FG000|Overall Study|Death|2|||
23789930|NCT01297504|66609589|FG000|Overall Study|Lost to Follow-up|43|||
23463263|NCT02004093|65440794|FG001|Overall Study|Death|1|||
23463264|NCT02004093|65440793|FG000|Overall Study|Lack of Efficacy|66|||
23463265|NCT02004093|65440794|FG001|Overall Study|Lack of Efficacy|62|||
23463266|NCT02004093|65440793|FG000|Overall Study|Protocol Violation|0|||
23463267|NCT02004093|65440794|FG001|Overall Study|Protocol Violation|1|||
23463268|NCT02004093|65440793|FG000|Overall Study|Lost to Follow-up|0|||
23463269|NCT02004093|65440794|FG001|Overall Study|Lost to Follow-up|1|||
23789931|NCT01297504|66609589|FG000|Overall Study|Withdrawal by Subject|9|||
23789932|NCT01297504|66609589|FG000|Overall Study|Site Closure|3|||
23789933|NCT01297504|66609589|FG000|Overall Study|Protocol Violation|3|||
23463270|NCT02004093|65440793|FG000|Overall Study|Withdrawal by Subject|3|||
23463271|NCT02004093|65440794|FG001|Overall Study|Withdrawal by Subject|7|||
23463272|NCT02004093|65440793|FG000|Overall Study|Other|3|||
23463273|NCT02004093|65440794|FG001|Overall Study|Other|1|||
23463274|NCT01662102|65440796|FG000|Overall Study|Sponsor's decision|1|||
23463275|NCT01662102|65440797|FG001|Overall Study|Sponsor's decision|0|||
23789934|NCT00673660|66609594|FG000|Overall Study|Lost to Follow-up|107|||
23789935|NCT00087529|66609595|FG000|Overall Study|Death|1|||
23789936|NCT00087529|66609596|FG001|Overall Study|Death|0|||
23789937|NCT00087529|66609595|FG000|Overall Study|Adverse Event|0|||
23789938|NCT00087529|66609596|FG001|Overall Study|Adverse Event|8|||
23789939|NCT00087529|66609595|FG000|Overall Study|Pregnancy|0|||
23789940|NCT00087529|66609596|FG001|Overall Study|Pregnancy|1|||
23789941|NCT00087529|66609595|FG000|Overall Study|Lost to Follow-up|2|||
23463276|NCT03829228|65440798|FG000|Overall Study|Protocol Violation|1|||
23463277|NCT05101122|65440799|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
23463278|NCT05101122|65440799|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
23463279|NCT05101122|65440799|FG000|AD313 80/5|Withdrawal by Subject|1|||
23463280|NCT05101122|65440799|FG000|AD313 80/10|Physician Decision|1|||
23463281|NCT01188343|65440800|FG000|Overall Study|Not vaccinated|0|||
23463282|NCT01188343|65440801|FG001|Overall Study|Not vaccinated|2|||
23463283|NCT01188343|65440802|FG002|Overall Study|Not vaccinated|1|||
23463284|NCT01188343|65440800|FG000|Overall Study|Withdrawal by Subject|1|||
23463285|NCT01188343|65440801|FG001|Overall Study|Withdrawal by Subject|24|||
23463286|NCT01188343|65440802|FG002|Overall Study|Withdrawal by Subject|0|||
23463287|NCT03771664|65440803|FG000|Overall Study|Adverse Event|1|||
23463288|NCT03771664|65440804|FG001|Overall Study|Adverse Event|0|||
23463289|NCT03771664|65440803|FG000|Overall Study|Lost to Follow-up|1|||
23463290|NCT03771664|65440804|FG001|Overall Study|Lost to Follow-up|0|||
23463291|NCT03771664|65440803|FG000|Overall Study|Withdrawal by Participant|1|||
23463292|NCT03771664|65440804|FG001|Overall Study|Withdrawal by Participant|4|||
23463293|NCT03771664|65440803|FG000|Overall Study|Randomized but not Treated|0|||
23639875|NCT02187159|66067382|FG002|Overall Study|Protocol Violation|3|||
23463294|NCT03771664|65440804|FG001|Overall Study|Randomized but not Treated|1|||
23639876|NCT02187159|66067383|FG003|Overall Study|Protocol Violation|4|||
23349987|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349988|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23789942|NCT00087529|66609596|FG001|Overall Study|Lost to Follow-up|3|||
23463295|NCT03044106|65440805|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
23349989|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23789943|NCT00087529|66609595|FG000|Overall Study|Participant Decision|14|||
23789944|NCT00087529|66609596|FG001|Overall Study|Participant Decision|37|||
23349990|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23789945|NCT00087529|66609595|FG000|Overall Study|Physician Decision|4|||
23789946|NCT00087529|66609596|FG001|Overall Study|Physician Decision|8|||
23789947|NCT00087529|66609595|FG000|Overall Study|Initiation of Excluded Therapy|0|||
23789948|NCT00087529|66609596|FG001|Overall Study|Initiation of Excluded Therapy|1|||
23789949|NCT00087529|66609595|FG000|Overall Study|Participant Noncompliance|0|||
23789950|NCT00087529|66609596|FG001|Overall Study|Participant Noncompliance|1|||
23789951|NCT00087529|66609595|FG000|Overall Study|Disease Progression|5|||
23789952|NCT00087529|66609596|FG001|Overall Study|Disease Progression|4|||
23789953|NCT00087529|66609595|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
23789954|NCT00087529|66609596|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
23789955|NCT02858037|66609597|FG000|Overall Study|Death|1|||
23789956|NCT02858037|66609597|FG000|Overall Study|Withdrawal by Subject|18|||
23789957|NCT02858037|66609597|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
23789958|NCT02858037|66609597|FG000|Overall Study|Lost to Follow-up|3|||
23789959|NCT02858037|66609597|FG000|Overall Study|Other|4|||
23789960|NCT04435782|66609598|FG000|Overall Study|Study terminated by sponsor|4|||
23789961|NCT01320722|66609599|FG000|Overall Study|Did not Receive Intervention|3|||
23789962|NCT01320722|66609600|FG001|Overall Study|Did not Receive Intervention|2|||
23789963|NCT01320722|66609601|FG002|Overall Study|Did not Receive Intervention|1|||
23789964|NCT01320722|66609602|FG003|Overall Study|Did not Receive Intervention|1|||
23789965|NCT01320722|66609603|FG004|Overall Study|Did not Receive Intervention|2|||
23789966|NCT01320722|66609599|FG000|Overall Study|Lost to Follow-up|0|||
23789967|NCT01320722|66609600|FG001|Overall Study|Lost to Follow-up|1|||
23789968|NCT01320722|66609601|FG002|Overall Study|Lost to Follow-up|0|||
23789969|NCT01320722|66609602|FG003|Overall Study|Lost to Follow-up|1|||
23789970|NCT01320722|66609603|FG004|Overall Study|Lost to Follow-up|3|||
23789971|NCT01320722|66609599|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
23789972|NCT01320722|66609600|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
23349991|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349992|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349993|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349994|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349995|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23349996|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23349997|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349998|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23349999|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350000|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350001|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350002|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350003|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350004|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350005|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350006|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23463296|NCT03044106|65440806|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
23789973|NCT01320722|66609601|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
23789974|NCT01320722|66609602|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
23789975|NCT01320722|66609603|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
23789976|NCT01320722|66609599|FG000|Overall Study|Participant Developed a Rash|0|||
23789977|NCT01320722|66609600|FG001|Overall Study|Participant Developed a Rash|0|||
23789978|NCT01320722|66609601|FG002|Overall Study|Participant Developed a Rash|2|||
23789979|NCT01320722|66609602|FG003|Overall Study|Participant Developed a Rash|1|||
23789980|NCT01320722|66609603|FG004|Overall Study|Participant Developed a Rash|1|||
23789981|NCT01320722|66609599|FG000|Overall Study|Non-compliant with Medication|0|||
23789982|NCT01320722|66609600|FG001|Overall Study|Non-compliant with Medication|0|||
23789983|NCT01320722|66609601|FG002|Overall Study|Non-compliant with Medication|1|||
23350007|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23789984|NCT01320722|66609602|FG003|Overall Study|Non-compliant with Medication|0|||
23789985|NCT01320722|66609603|FG004|Overall Study|Non-compliant with Medication|0|||
23789986|NCT01320722|66609599|FG000|Overall Study|Adverse Event|0|||
23789987|NCT01320722|66609600|FG001|Overall Study|Adverse Event|0|||
23789988|NCT01320722|66609601|FG002|Overall Study|Adverse Event|3|||
23789989|NCT01320722|66609602|FG003|Overall Study|Adverse Event|6|||
23789990|NCT01320722|66609603|FG004|Overall Study|Adverse Event|0|||
23789991|NCT01320722|66609599|FG000|Overall Study|Not Compliant with Study Procedures|0|||
23789992|NCT01320722|66609600|FG001|Overall Study|Not Compliant with Study Procedures|0|||
23789993|NCT01320722|66609601|FG002|Overall Study|Not Compliant with Study Procedures|0|||
23789994|NCT01320722|66609602|FG003|Overall Study|Not Compliant with Study Procedures|4|||
23789995|NCT01320722|66609603|FG004|Overall Study|Not Compliant with Study Procedures|0|||
23789996|NCT01320722|66609599|FG000|Overall Study|Pregnancy|0|||
23789997|NCT01320722|66609600|FG001|Overall Study|Pregnancy|0|||
23789998|NCT01320722|66609601|FG002|Overall Study|Pregnancy|0|||
23789999|NCT01320722|66609602|FG003|Overall Study|Pregnancy|1|||
23790000|NCT01320722|66609603|FG004|Overall Study|Pregnancy|0|||
23790001|NCT01320722|66609599|FG000|Overall Study|Started an Exclusionary Medication|0|||
23790002|NCT01320722|66609600|FG001|Overall Study|Started an Exclusionary Medication|0|||
23790003|NCT01320722|66609601|FG002|Overall Study|Started an Exclusionary Medication|0|||
23790004|NCT01320722|66609602|FG003|Overall Study|Started an Exclusionary Medication|0|||
23790005|NCT01320722|66609603|FG004|Overall Study|Started an Exclusionary Medication|1|||
23790006|NCT01320722|66609599|FG000|Overall Study|Withdrew due to Health Condition|0|||
23790007|NCT01320722|66609600|FG001|Overall Study|Withdrew due to Health Condition|0|||
23790008|NCT01320722|66609601|FG002|Overall Study|Withdrew due to Health Condition|0|||
23790009|NCT01320722|66609602|FG003|Overall Study|Withdrew due to Health Condition|0|||
23790010|NCT01320722|66609603|FG004|Overall Study|Withdrew due to Health Condition|1|||
23790011|NCT01604941|66609610|FG000|Overall Study|Adverse Event|1|||
23790012|NCT01604941|66609611|FG001|Overall Study|Adverse Event|2|||
23790013|NCT01604941|66609612|FG002|Overall Study|Adverse Event|0|||
23790014|NCT01604941|66609613|FG003|Overall Study|Adverse Event|0|||
23790015|NCT01604941|66609614|FG004|Overall Study|Adverse Event|1|||
23790016|NCT01604941|66609615|FG005|Overall Study|Adverse Event|5|||
23790017|NCT01604941|66609610|FG000|Overall Study|Non-compliance|1|||
23790018|NCT01604941|66609611|FG001|Overall Study|Non-compliance|0|||
23790019|NCT01604941|66609612|FG002|Overall Study|Non-compliance|0|||
23790020|NCT01604941|66609613|FG003|Overall Study|Non-compliance|0|||
23790021|NCT01604941|66609614|FG004|Overall Study|Non-compliance|0|||
23790022|NCT01604941|66609615|FG005|Overall Study|Non-compliance|0|||
23790023|NCT01604941|66609610|FG000|Overall Study|Participant Decision|0|||
23790024|NCT01604941|66609611|FG001|Overall Study|Participant Decision|0|||
23790025|NCT01604941|66609612|FG002|Overall Study|Participant Decision|0|||
23790026|NCT01604941|66609613|FG003|Overall Study|Participant Decision|0|||
23790027|NCT01604941|66609614|FG004|Overall Study|Participant Decision|0|||
23790028|NCT01604941|66609615|FG005|Overall Study|Participant Decision|2|||
23790029|NCT01604941|66609610|FG000|Overall Study|Early Study Termination|9|||
23790030|NCT01604941|66609611|FG001|Overall Study|Early Study Termination|2|||
23790031|NCT01604941|66609612|FG002|Overall Study|Early Study Termination|3|||
23790032|NCT01604941|66609613|FG003|Overall Study|Early Study Termination|3|||
23790033|NCT01604941|66609614|FG004|Overall Study|Early Study Termination|0|||
23790034|NCT01604941|66609615|FG005|Overall Study|Early Study Termination|0|||
23790035|NCT03306277|66609623|FG000|Overall Study|Death|1|||
23790036|NCT03306277|66609623|FG000|Overall Study|Adverse Event|1|||
23790037|NCT03306277|66609623|FG000|Overall Study|Withdrawal by Subject|1|||
23790038|NCT01663896|66609624|FG000|Overall Study|Various reasons|43|||
23790039|NCT04553406|66609625|FG000|Overall Study|Study Discontinuation|0|||
23790040|NCT04553406|66609626|FG001|Overall Study|Study Discontinuation|1|||
23790041|NCT03255733|66609631|FG000|Overall Study|Lost to Follow-up|4|||
23790042|NCT00252564|66609635|FG000|Overall Study|Adverse Event|17|||
23790043|NCT00252564|66609636|FG001|Overall Study|Adverse Event|13|||
23790044|NCT00252564|66609635|FG000|Overall Study|Unrelated Complication|2|||
23790045|NCT00252564|66609636|FG001|Overall Study|Unrelated Complication|1|||
23790046|NCT00252564|66609635|FG000|Overall Study|Disease Progression|14|||
23790047|NCT00252564|66609636|FG001|Overall Study|Disease Progression|20|||
23790048|NCT00252564|66609635|FG000|Overall Study|Death|0|||
23790049|NCT00252564|66609636|FG001|Overall Study|Death|3|||
23790050|NCT00252564|66609635|FG000|Overall Study|Physician Decision|1|||
23790051|NCT00252564|66609636|FG001|Overall Study|Physician Decision|0|||
23790052|NCT00252564|66609635|FG000|Overall Study|Lost to Follow-up|1|||
23790053|NCT00252564|66609636|FG001|Overall Study|Lost to Follow-up|0|||
23790054|NCT00252564|66609635|FG000|Overall Study|Patient Request|4|||
23790055|NCT00252564|66609636|FG001|Overall Study|Patient Request|5|||
23790056|NCT00252564|66609635|FG000|Overall Study|Withdrawal by Subject|0|||
23790057|NCT00252564|66609636|FG001|Overall Study|Withdrawal by Subject|2|||
23790058|NCT00516295|66609644|FG000|Overall Study|Lack of Efficacy|2|||
23790059|NCT00516295|66609645|FG001|Overall Study|Lack of Efficacy|0|||
23790060|NCT00516295|66609646|FG002|Overall Study|Lack of Efficacy|0|||
23790061|NCT00516295|66609644|FG000|Overall Study|Ineligible|1|||
23790062|NCT00516295|66609645|FG001|Overall Study|Ineligible|0|||
23790063|NCT00516295|66609646|FG002|Overall Study|Ineligible|0|||
23790064|NCT04535986|66609647|FG000|Overall Study|Death|4|||
23790065|NCT04535986|66609648|FG001|Overall Study|Death|5|||
23790066|NCT04535986|66609647|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
23790067|NCT04535986|66609648|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
23790068|NCT04535986|66609647|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
23790069|NCT04535986|66609648|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
23790070|NCT04535986|66609647|FG000|Overall Study|Adverse Event|10|||
23402751|NCT01621178|65219996|FG002|Overall Study|Adverse Event|8|||
23790071|NCT04535986|66609648|FG001|Overall Study|Adverse Event|1|||
23790072|NCT04535986|66609647|FG000|Overall Study|Lack of Efficacy|3|||
23790073|NCT04535986|66609648|FG001|Overall Study|Lack of Efficacy|2|||
23790074|NCT04535986|66609647|FG000|Overall Study|Investigator discretion|3|||
23790075|NCT04535986|66609648|FG001|Overall Study|Investigator discretion|0|||
23790076|NCT04535986|66609647|FG000|Overall Study|Withdrawal by Subject|32|||
23790077|NCT04535986|66609648|FG001|Overall Study|Withdrawal by Subject|14|||
23790078|NCT04535986|66609647|FG000|Overall Study|Lost to Follow-up|5|||
23790079|NCT04535986|66609648|FG001|Overall Study|Lost to Follow-up|3|||
23790080|NCT04535986|66609647|FG000|Overall Study|Other|7|||
23790081|NCT04535986|66609648|FG001|Overall Study|Other|3|||
23790082|NCT02340780|66609649|FG000|Overall Study|Ineligible|1|||
23790083|NCT03141151|66609650|FG000|Overall Study|Lost to Follow-up|3|||
23790084|NCT03141151|66609651|FG001|Overall Study|Lost to Follow-up|2|||
23790085|NCT03141151|66609650|FG000|Overall Study|Withdrawal by Subject|3|||
23790086|NCT03141151|66609651|FG001|Overall Study|Withdrawal by Subject|2|||
23790087|NCT00633022|66609657|FG000|Overall Study|Adverse Event|1|||
23350008|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350009|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350010|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350011|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
23350012|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350013|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350014|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350015|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350016|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350017|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350018|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350019|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350020|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350021|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23790088|NCT00633022|66609658|FG001|Overall Study|Adverse Event|0|||
23790089|NCT00633022|66609659|FG002|Overall Study|Adverse Event|5|||
23790090|NCT00633022|66609657|FG000|Overall Study|Physician Decision|0|||
23790091|NCT00633022|66609658|FG001|Overall Study|Physician Decision|1|||
23790092|NCT00633022|66609659|FG002|Overall Study|Physician Decision|0|||
23790093|NCT00715676|66609660|FG000|Overall Study|Adverse Event|3|||
23350022|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350023|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
23350024|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
23350025|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23350026|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350027|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350028|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350029|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350030|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350031|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350032|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350033|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350034|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350035|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350036|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350037|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
23350038|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
23350039|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23350040|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350041|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350042|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350043|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350044|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350045|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350046|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350047|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350048|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350049|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350050|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350051|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
23350052|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
23790094|NCT00715676|66609661|FG001|Overall Study|Adverse Event|5|||
23790095|NCT00715676|66609662|FG002|Overall Study|Adverse Event|21|||
23790096|NCT00715676|66609660|FG000|Overall Study|Withdrawal by Subject|1|||
23790097|NCT00715676|66609661|FG001|Overall Study|Withdrawal by Subject|3|||
23350053|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23350054|NCT03015194|65025304|FG000|Overall Study|Death|10|||
23350055|NCT03015194|65025304|FG000|Overall Study|Withdrawal by Subject|2|||
23790098|NCT00715676|66609662|FG002|Overall Study|Withdrawal by Subject|8|||
23790099|NCT00715676|66609660|FG000|Overall Study|Lost to Follow-up|1|||
23790100|NCT00715676|66609661|FG001|Overall Study|Lost to Follow-up|2|||
23790101|NCT00715676|66609662|FG002|Overall Study|Lost to Follow-up|1|||
23790102|NCT00715676|66609660|FG000|Overall Study|Terminated by Sponsor|1|||
23790103|NCT00715676|66609661|FG001|Overall Study|Terminated by Sponsor|0|||
23790104|NCT00715676|66609662|FG002|Overall Study|Terminated by Sponsor|0|||
23790105|NCT00715676|66609660|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
23790106|NCT00715676|66609661|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
23790107|NCT00715676|66609662|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
23790108|NCT00715676|66609660|FG000|Overall Study|Use of Exclusionary Medication|0|||
23790109|NCT00715676|66609661|FG001|Overall Study|Use of Exclusionary Medication|0|||
23790110|NCT00715676|66609662|FG002|Overall Study|Use of Exclusionary Medication|1|||
23790111|NCT00715676|66609660|FG000|Overall Study|Elevated Blood Glucose|0|||
23790112|NCT00715676|66609661|FG001|Overall Study|Elevated Blood Glucose|1|||
23790113|NCT00715676|66609662|FG002|Overall Study|Elevated Blood Glucose|0|||
23790114|NCT04408924|66612706|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
23790115|NCT04408924|66612706|FG000|Overall Study|Lost to Follow-up|3|||
23790116|NCT04408924|66612706|FG000|Overall Study|Withdrawal by Subject|5|||
23790117|NCT04408924|66612706|FG000|Overall Study|Sponsor Decision|2|||
23790118|NCT01374451|66612709|FG000|Overall Study|Administrative problems|1|||
23790119|NCT01374451|66612710|FG001|Overall Study|Administrative problems|0|||
23790120|NCT02416180|66612711|FG000|Overall Study|Withdrawal by Subject|1|||
23790121|NCT00487435|66612712|FG000|Overall Study|Adverse Event|146|||
23790122|NCT00487435|66612712|FG000|Overall Study|Death|2|||
23790123|NCT00487435|66612712|FG000|Overall Study|Lack of Efficacy|33|||
23790124|NCT00487435|66612712|FG000|Overall Study|Lost to Follow-up|54|||
23790125|NCT00487435|66612712|FG000|Overall Study|Pregnancy|2|||
23790126|NCT00487435|66612712|FG000|Overall Study|Withdrawal by Subject|132|||
23790127|NCT00487435|66612712|FG000|Overall Study|Resolution Of Pain|1|||
23790128|NCT00487435|66612712|FG000|Overall Study|Study Medication Non-Compliant|32|||
23790129|NCT00487435|66612712|FG000|Overall Study|Other|83|||
23790130|NCT01841060|66612728|FG000|Overall Study|Protocol Violation|10|||
23790131|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
23790132|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
23350056|NCT00431067|65025305|FG000|Overall Study|Other Adverse Event|9|||
23350057|NCT00431067|65025305|FG000|Overall Study|Progressive disease|30|||
23350058|NCT00431067|65025305|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
23350059|NCT01068626|65025306|FG000|Overall Study|Adverse Event|3|||
23350060|NCT01068626|65025307|FG001|Overall Study|Adverse Event|0|||
23350061|NCT01068626|65025306|FG000|Overall Study|Withdrawal by Subject|0|||
23350062|NCT01068626|65025307|FG001|Overall Study|Withdrawal by Subject|2|||
23350063|NCT02717442|65025320|FG000|Overall Study|Study Terminated by Sponsor|31|||
23350064|NCT02717442|65025321|FG001|Overall Study|Study Terminated by Sponsor|29|||
23790133|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
23790134|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
23790135|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
23790136|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
23790137|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
23350065|NCT02717442|65025320|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
23350066|NCT02717442|65025321|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
23350067|NCT02717442|65025320|FG000|Overall Study|Other - Not Specified|2|||
23350068|NCT02717442|65025321|FG001|Overall Study|Other - Not Specified|0|||
23350069|NCT01907217|65025322|FG000|Overall Study|Withdrawal by Subject|0|||
23350070|NCT01907217|65025323|FG001|Overall Study|Withdrawal by Subject|2|||
23350071|NCT02117713|65025324|FG000|Week 48|Adverse Event|4|||
23350072|NCT02117713|65025324|FG000|Week 48|Withdrawal by caregiver|2|||
23350073|NCT02117713|65025324|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
23350074|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
23350075|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
23350076|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
23350077|NCT01398410|65025325|FG000|Overall Study|Adverse Event|12|||
23350078|NCT01398410|65025326|FG001|Overall Study|Adverse Event|16|||
23350079|NCT01398410|65025325|FG000|Overall Study|Participants Choice|8|||
23350080|NCT01398410|65025326|FG001|Overall Study|Participants Choice|11|||
23350081|NCT01398410|65025325|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
23350082|NCT01398410|65025326|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
23350083|NCT01398410|65025325|FG000|Overall Study|Other|36|||
23350084|NCT01398410|65025326|FG001|Overall Study|Other|29|||
23350085|NCT01714609|65025327|FG000|Overall Study|Protocol Violation|1|||
23350086|NCT01714609|65025328|FG001|Overall Study|Protocol Violation|0|||
23350087|NCT03570554|65025329|FG000|Overall Study|Non-compliance with study drug|0|||
23350088|NCT03570554|65025330|FG001|Overall Study|Non-compliance with study drug|0|||
23350089|NCT03570554|65025331|FG002|Overall Study|Non-compliance with study drug|1|||
23350090|NCT03570554|65025332|FG003|Overall Study|Non-compliance with study drug|0|||
23350091|NCT03570554|65025329|FG000|Overall Study|Adverse Event|0|||
23350092|NCT03570554|65025330|FG001|Overall Study|Adverse Event|0|||
23350093|NCT03570554|65025331|FG002|Overall Study|Adverse Event|0|||
23350094|NCT03570554|65025332|FG003|Overall Study|Adverse Event|1|||
23350095|NCT00524173|65025336|FG000|Overall Study|Lost to Follow-up|0|||
23350096|NCT00524173|65025337|FG001|Overall Study|Lost to Follow-up|1|||
23350097|NCT00524173|65025336|FG000|Overall Study|Death|1|||
23350098|NCT00524173|65025337|FG001|Overall Study|Death|0|||
23350099|NCT00524173|65025336|FG000|Overall Study|Had not reached endpoint at study close|4|||
23350100|NCT00524173|65025337|FG001|Overall Study|Had not reached endpoint at study close|1|||
23350101|NCT02083653|65025340|FG000|Overall Study|Randomized but not Treated|0|||
23350102|NCT02083653|65025341|FG001|Overall Study|Randomized but not Treated|2|||
23350103|NCT02083653|65025342|FG002|Overall Study|Randomized but not Treated|7|||
23350104|NCT02083653|65025340|FG000|Overall Study|Adverse Event|12|||
23350105|NCT02083653|65025341|FG001|Overall Study|Adverse Event|5|||
23350106|NCT02083653|65025342|FG002|Overall Study|Adverse Event|4|||
23350107|NCT02083653|65025340|FG000|Overall Study|Lost to Follow-up|1|||
23350108|NCT02083653|65025341|FG001|Overall Study|Lost to Follow-up|0|||
23350109|NCT02083653|65025342|FG002|Overall Study|Lost to Follow-up|0|||
23790138|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
23790139|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
23790140|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
23350110|NCT02083653|65025340|FG000|Overall Study|Death|2|||
23350111|NCT02083653|65025341|FG001|Overall Study|Death|2|||
23350112|NCT02083653|65025342|FG002|Overall Study|Death|2|||
23350113|NCT02083653|65025340|FG000|Overall Study|Progressive Disease|65|||
23350114|NCT02083653|65025341|FG001|Overall Study|Progressive Disease|73|||
23350115|NCT02083653|65025342|FG002|Overall Study|Progressive Disease|63|||
23350116|NCT02083653|65025340|FG000|Overall Study|Withdrawal by Subject|2|||
23350117|NCT02083653|65025341|FG001|Overall Study|Withdrawal by Subject|1|||
23350118|NCT02083653|65025342|FG002|Overall Study|Withdrawal by Subject|2|||
23350119|NCT02083653|65025340|FG000|Overall Study|Other Events|0|||
23350120|NCT02083653|65025341|FG001|Overall Study|Other Events|2|||
23350121|NCT02083653|65025342|FG002|Overall Study|Other Events|2|||
23790141|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
23790142|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
23790143|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
23790144|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
23790145|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
23790146|NCT00385736|66612729|FG000|Efficacy Analysis Set - Induction|Other|0|||
23790147|NCT00385736|66612730|FG001|Efficacy Analysis Set - Induction|Other|0|||
23790148|NCT00385736|66612731|FG002|Efficacy Analysis Set - Induction|Other|1|||
23790149|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
23790150|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
23350122|NCT02083653|65025340|FG000|Overall Study|Reason Missing|0|||
23350123|NCT02083653|65025341|FG001|Overall Study|Reason Missing|0|||
23350124|NCT02083653|65025342|FG002|Overall Study|Reason Missing|4|||
23350125|NCT02332239|65025343|FG000|Overall Study|Lost to Follow-up|4|||
23350126|NCT02332239|65025344|FG001|Overall Study|Lost to Follow-up|6|||
23350127|NCT01397786|65025347|FG000|Phase A|Lost to Follow-up|0|||
23350128|NCT01397786|65025348|FG001|Phase A|Lost to Follow-up|0|||
23350129|NCT01397786|65025349|FG002|Phase A|Lost to Follow-up|6|||
23463297|NCT00999804|65440807|FG000|Overall Study|Lack of Efficacy|9|||
23463298|NCT00999804|65440808|FG001|Overall Study|Lack of Efficacy|2|||
23463299|NCT00999804|65440807|FG000|Overall Study|Adverse Event|4|||
23463300|NCT00999804|65440808|FG001|Overall Study|Adverse Event|3|||
23463301|NCT00999804|65440807|FG000|Overall Study|Withdrawal by Subject|4|||
23463302|NCT00999804|65440808|FG001|Overall Study|Withdrawal by Subject|0|||
23463303|NCT00999804|65440807|FG000|Overall Study|Death|1|||
23463304|NCT00999804|65440808|FG001|Overall Study|Death|0|||
23463305|NCT00999804|65440807|FG000|Overall Study|Ineligible|3|||
23463306|NCT00999804|65440808|FG001|Overall Study|Ineligible|0|||
23463307|NCT01318915|65440815|FG000|Overall Study|Lost to Follow-up|1|||
23463308|NCT01520506|65440817|FG000|Overall Study|Missed Visit|4|||
23463309|NCT01520506|65440817|FG000|Overall Study|Lost to Follow-up|1|||
23463310|NCT01520506|65440817|FG000|Overall Study|Withdrawal by Subject|1|||
23463311|NCT02156076|65440818|FG000|Treatment Period|no longer meets study criteria|0|||
23463312|NCT02156076|65440819|FG001|Treatment Period|no longer meets study criteria|0|||
23463313|NCT02156076|65440820|FG002|Treatment Period|no longer meets study criteria|1|||
23463314|NCT02156076|65440821|FG003|Treatment Period|no longer meets study criteria|0|||
23463315|NCT02156076|65440818|FG000|Treatment Period|Poor/non-compliance|0|||
23463316|NCT02156076|65440819|FG001|Treatment Period|Poor/non-compliance|1|||
23463317|NCT02156076|65440820|FG002|Treatment Period|Poor/non-compliance|0|||
23463318|NCT02156076|65440821|FG003|Treatment Period|Poor/non-compliance|0|||
23463319|NCT02156076|65440818|FG000|Treatment Period|Lost to Follow-up|0|||
23463320|NCT02156076|65440819|FG001|Treatment Period|Lost to Follow-up|0|||
23463321|NCT02156076|65440820|FG002|Treatment Period|Lost to Follow-up|0|||
23463322|NCT02156076|65440821|FG003|Treatment Period|Lost to Follow-up|1|||
23463323|NCT02156076|65440818|FG000|Treatment Period|Withdrawal by Subject|0|||
23463324|NCT02156076|65440819|FG001|Treatment Period|Withdrawal by Subject|0|||
23463325|NCT02156076|65440820|FG002|Treatment Period|Withdrawal by Subject|1|||
23463326|NCT02156076|65440821|FG003|Treatment Period|Withdrawal by Subject|0|||
23463327|NCT02156076|65440818|FG000|Treatment Period|Subject request to discontinue treatment|0|||
23463328|NCT02156076|65440819|FG001|Treatment Period|Subject request to discontinue treatment|1|||
23463329|NCT02156076|65440820|FG002|Treatment Period|Subject request to discontinue treatment|0|||
23463330|NCT02156076|65440821|FG003|Treatment Period|Subject request to discontinue treatment|0|||
23584967|NCT02403674|65869358|FG000|Base Study|Adverse Event|11|||
23584968|NCT02403674|65869359|FG001|Base Study|Adverse Event|26|||
23350130|NCT01397786|65025347|FG000|Phase A|Adverse Event|0|||
23350131|NCT01397786|65025348|FG001|Phase A|Adverse Event|0|||
23350132|NCT01397786|65025349|FG002|Phase A|Adverse Event|8|||
23350133|NCT01397786|65025347|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
23350134|NCT01397786|65025348|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
23350135|NCT01397786|65025349|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
23350136|NCT01397786|65025347|FG000|Phase A|Physician Decision|0|||
23350137|NCT01397786|65025348|FG001|Phase A|Physician Decision|0|||
23350138|NCT01397786|65025349|FG002|Phase A|Physician Decision|1|||
23350139|NCT01397786|65025347|FG000|Phase A|Withdrawal by Subject|0|||
23350140|NCT01397786|65025348|FG001|Phase A|Withdrawal by Subject|0|||
23350141|NCT01397786|65025349|FG002|Phase A|Withdrawal by Subject|5|||
23350142|NCT01397786|65025347|FG000|Phase A|Lack of Efficacy|0|||
23350143|NCT01397786|65025348|FG001|Phase A|Lack of Efficacy|0|||
23350144|NCT01397786|65025349|FG002|Phase A|Lack of Efficacy|1|||
23350145|NCT01397786|65025347|FG000|Phase B|Lost to Follow-up|22|||
23350146|NCT01397786|65025348|FG001|Phase B|Lost to Follow-up|12|||
23350147|NCT01397786|65025349|FG002|Phase B|Lost to Follow-up|22|||
23350148|NCT01397786|65025347|FG000|Phase B|Adverse Event|109|||
23350149|NCT01397786|65025348|FG001|Phase B|Adverse Event|23|||
23350150|NCT01397786|65025349|FG002|Phase B|Adverse Event|27|||
23350151|NCT01397786|65025347|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
23350152|NCT01397786|65025348|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
23350153|NCT01397786|65025349|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
23350154|NCT01397786|65025347|FG000|Phase B|Physician Decision|9|||
23350155|NCT01397786|65025348|FG001|Phase B|Physician Decision|1|||
23350156|NCT01397786|65025349|FG002|Phase B|Physician Decision|3|||
23350157|NCT01397786|65025347|FG000|Phase B|Withdrawal by Subject|102|||
23350158|NCT01397786|65025348|FG001|Phase B|Withdrawal by Subject|45|||
23350159|NCT01397786|65025349|FG002|Phase B|Withdrawal by Subject|30|||
23350160|NCT01397786|65025347|FG000|Phase B|Protocol Deviation|1|||
23350161|NCT01397786|65025348|FG001|Phase B|Protocol Deviation|2|||
23350162|NCT01397786|65025349|FG002|Phase B|Protocol Deviation|4|||
23350163|NCT01397786|65025347|FG000|Phase B|Lack of Efficacy|22|||
23350164|NCT01397786|65025348|FG001|Phase B|Lack of Efficacy|7|||
23350165|NCT01397786|65025349|FG002|Phase B|Lack of Efficacy|14|||
23350166|NCT03235115|65025351|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350167|NCT03235115|65025352|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350168|NCT03235115|65025353|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350169|NCT03235115|65025354|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350170|NCT03235115|65025355|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350171|NCT03235115|65025356|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
23350172|NCT04907227|65025360|FG000|Overall Study|Death|12|||
23350173|NCT04907227|65025361|FG001|Overall Study|Death|8|||
23350174|NCT04907227|65025360|FG000|Overall Study|Withdrawal by Subject|2|||
23350175|NCT04907227|65025361|FG001|Overall Study|Withdrawal by Subject|2|||
23350176|NCT04907227|65025360|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
23350177|NCT04907227|65025361|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23350178|NCT04907227|65025360|FG000|Overall Study|Sponsor Decision|25|||
23350179|NCT04907227|65025361|FG001|Overall Study|Sponsor Decision|30|||
23350180|NCT04907227|65025360|FG000|Overall Study|Physician Decision|1|||
23350181|NCT04907227|65025361|FG001|Overall Study|Physician Decision|0|||
23350182|NCT02921750|65025363|FG000|Overall Study|Adverse Event|1|||
23350183|NCT02921750|65025364|FG001|Overall Study|Adverse Event|2|||
23350184|NCT02921750|65025363|FG000|Overall Study|Withdrawal by Subject|1|||
23350185|NCT02921750|65025364|FG001|Overall Study|Withdrawal by Subject|1|||
23350186|NCT02921750|65025363|FG000|Overall Study|Lost to Follow-up|3|||
23350187|NCT02921750|65025364|FG001|Overall Study|Lost to Follow-up|3|||
23350188|NCT02921750|65025363|FG000|Overall Study|Wound healed|3|||
23350189|NCT02921750|65025364|FG001|Overall Study|Wound healed|3|||
23350190|NCT02921750|65025363|FG000|Overall Study|Serious Adverse Event|1|||
23350191|NCT02921750|65025364|FG001|Overall Study|Serious Adverse Event|2|||
23350192|NCT01675154|65025365|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350193|NCT01675154|65025366|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
23350194|NCT01675154|65025367|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350195|NCT01675154|65025368|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350196|NCT04472026|65025373|FG000|Overall Study|Lost to Follow-up|5|||
23350197|NCT01627782|65025374|FG000|Overall Study|Adverse Event|1|||
23463331|NCT02156076|65440818|FG000|Treatment Period|Adverse Event|0|||
23463332|NCT02156076|65440819|FG001|Treatment Period|Adverse Event|0|||
23463333|NCT02156076|65440820|FG002|Treatment Period|Adverse Event|0|||
23463334|NCT02156076|65440821|FG003|Treatment Period|Adverse Event|1|||
23463335|NCT02156076|65440818|FG000|Follow-up Period|Withdrawal by Subject|1|||
23463336|NCT02156076|65440819|FG001|Follow-up Period|Withdrawal by Subject|0|||
23463337|NCT02156076|65440820|FG002|Follow-up Period|Withdrawal by Subject|0|||
23463338|NCT02156076|65440821|FG003|Follow-up Period|Withdrawal by Subject|0|||
23463339|NCT00853307|65440822|FG000|Overall Study|Adverse Event|1|||
23463340|NCT00853307|65440823|FG001|Overall Study|Adverse Event|2|||
23463341|NCT00853307|65440822|FG000|Overall Study|Withdrawal by Subject|1|||
23463342|NCT00853307|65440823|FG001|Overall Study|Withdrawal by Subject|2|||
23463343|NCT00853307|65440822|FG000|Overall Study|Reason Not Specified|0|||
23463344|NCT00853307|65440823|FG001|Overall Study|Reason Not Specified|1|||
23463345|NCT02057250|65440824|FG000|AID Assessment Phase|Adverse Event|3|||
23463346|NCT02057250|65440825|FG001|AID Assessment Phase|Adverse Event|2|||
23463347|NCT02057250|65440826|FG002|AID Assessment Phase|Adverse Event|6|||
23463348|NCT02057250|65440827|FG003|AID Assessment Phase|Adverse Event|1|||
23463349|NCT02057250|65440828|FG004|AID Assessment Phase|Adverse Event|0|||
23463350|NCT02057250|65440824|FG000|AID Assessment Phase|Other than specified above|1|||
23463351|NCT02057250|65440825|FG001|AID Assessment Phase|Other than specified above|1|||
23463352|NCT02057250|65440826|FG002|AID Assessment Phase|Other than specified above|1|||
23463353|NCT02057250|65440827|FG003|AID Assessment Phase|Other than specified above|1|||
23463354|NCT02057250|65440828|FG004|AID Assessment Phase|Other than specified above|0|||
23463355|NCT02057250|65440824|FG000|Extension Phase|Adverse Event|0|||
23463356|NCT02057250|65440825|FG001|Extension Phase|Adverse Event|0|||
23463357|NCT02057250|65440826|FG002|Extension Phase|Adverse Event|0|||
23463358|NCT02057250|65440827|FG003|Extension Phase|Adverse Event|0|||
23463359|NCT02057250|65440828|FG004|Extension Phase|Adverse Event|15|||
23463360|NCT02057250|65440824|FG000|Extension Phase|Lack of Efficacy|0|||
23463361|NCT02057250|65440825|FG001|Extension Phase|Lack of Efficacy|0|||
23463362|NCT02057250|65440826|FG002|Extension Phase|Lack of Efficacy|0|||
23463363|NCT02057250|65440827|FG003|Extension Phase|Lack of Efficacy|0|||
23463364|NCT02057250|65440828|FG004|Extension Phase|Lack of Efficacy|10|||
23463365|NCT02057250|65440824|FG000|Extension Phase|Entered in this period but not treated|0|||
23463366|NCT02057250|65440825|FG001|Extension Phase|Entered in this period but not treated|0|||
23463367|NCT02057250|65440826|FG002|Extension Phase|Entered in this period but not treated|0|||
23463368|NCT02057250|65440827|FG003|Extension Phase|Entered in this period but not treated|0|||
23463369|NCT02057250|65440828|FG004|Extension Phase|Entered in this period but not treated|4|||
23463370|NCT02057250|65440824|FG000|Extension Phase|Other than specified above|0|||
23463371|NCT02057250|65440825|FG001|Extension Phase|Other than specified above|0|||
23463372|NCT02057250|65440826|FG002|Extension Phase|Other than specified above|0|||
23463373|NCT02057250|65440827|FG003|Extension Phase|Other than specified above|0|||
23463374|NCT02057250|65440828|FG004|Extension Phase|Other than specified above|7|||
23463375|NCT02131259|65440829|FG000|Overall Study|Progressive disease|751|||
23463376|NCT02131259|65440829|FG000|Overall Study|Adverse Event|341|||
23463377|NCT02131259|65440829|FG000|Overall Study|Lost to Follow-up|7|||
23463378|NCT02131259|65440829|FG000|Overall Study|Relocation|32|||
23463379|NCT02131259|65440829|FG000|Overall Study|Other|63|||
23463380|NCT02131259|65440829|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
23463381|NCT02131259|65440829|FG000|Overall Study|Progressive disease/relocation|1|||
23463382|NCT02131259|65440829|FG000|Overall Study|Progressive disease/other|2|||
23463383|NCT02131259|65440829|FG000|Overall Study|AE/lost to follow-up|1|||
23463384|NCT02131259|65440829|FG000|Overall Study|AE/other|1|||
23463385|NCT02131259|65440829|FG000|Overall Study|Progressive disease/AE/other|1|||
23463386|NCT02131259|65440829|FG000|Overall Study|Missing|3|||
23463387|NCT01488890|65440836|FG000|Overall Study|Serious adverse event|2|||
23463388|NCT01488890|65440837|FG001|Overall Study|Serious adverse event|0|||
23463389|NCT01488890|65440838|FG002|Overall Study|Serious adverse event|0|||
23463390|NCT01488890|65440839|FG003|Overall Study|Serious adverse event|0|||
23463391|NCT01488890|65440836|FG000|Overall Study|Protocol Violation|3|||
23463392|NCT01488890|65440837|FG001|Overall Study|Protocol Violation|0|||
23463393|NCT01488890|65440838|FG002|Overall Study|Protocol Violation|4|||
23463394|NCT01488890|65440839|FG003|Overall Study|Protocol Violation|0|||
23463395|NCT01488890|65440836|FG000|Overall Study|Lost to Follow-up|13|||
23463396|NCT01488890|65440837|FG001|Overall Study|Lost to Follow-up|10|||
23463397|NCT01488890|65440838|FG002|Overall Study|Lost to Follow-up|20|||
23463398|NCT01488890|65440839|FG003|Overall Study|Lost to Follow-up|3|||
23463399|NCT01488890|65440836|FG000|Overall Study|Withdrawal by Subject|14|||
23463400|NCT01488890|65440837|FG001|Overall Study|Withdrawal by Subject|10|||
23463401|NCT01488890|65440838|FG002|Overall Study|Withdrawal by Subject|11|||
23463402|NCT01488890|65440839|FG003|Overall Study|Withdrawal by Subject|2|||
23463403|NCT01600716|65440840|FG000|Overall Study|Other Reasons|3|||
23463404|NCT01600716|65440841|FG001|Overall Study|Other Reasons|1|||
23463405|NCT01600716|65440840|FG000|Overall Study|Personal Reasons|0|||
23463406|NCT01600716|65440841|FG001|Overall Study|Personal Reasons|2|||
23463407|NCT01600716|65440840|FG000|Overall Study|Lost to Follow-up|0|||
23463408|NCT01600716|65440841|FG001|Overall Study|Lost to Follow-up|2|||
23463409|NCT01600716|65440840|FG000|Overall Study|Pregnancy|1|||
23463410|NCT01600716|65440841|FG001|Overall Study|Pregnancy|0|||
23463411|NCT01600716|65440840|FG000|Overall Study|Lack of Efficacy|2|||
23463412|NCT01600716|65440841|FG001|Overall Study|Lack of Efficacy|1|||
23463413|NCT01600716|65440840|FG000|Overall Study|Adverse Event|1|||
23463414|NCT01600716|65440841|FG001|Overall Study|Adverse Event|1|||
23463415|NCT01532986|65440847|FG000|Overall Study|Death|9|||
23463416|NCT01532986|65440848|FG001|Overall Study|Death|9|||
23463417|NCT01532986|65440847|FG000|Overall Study|Withdrawal by Subject|7|||
23463418|NCT01532986|65440848|FG001|Overall Study|Withdrawal by Subject|10|||
23463419|NCT01532986|65440847|FG000|Overall Study|Physician Decision|7|||
23463420|NCT01532986|65440848|FG001|Overall Study|Physician Decision|5|||
23463421|NCT02066181|65440849|FG000|Overall Study|Withdrawal by Subject|1|||
23463422|NCT02066181|65440850|FG001|Overall Study|Withdrawal by Subject|1|||
23463423|NCT03399552|65440853|FG000|Overall Study|No evidence of disease|1|||
23463424|NCT03399552|65440853|FG000|Overall Study|Unevaluable|1|||
23463425|NCT03367793|65440857|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463426|NCT03367793|65440858|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463427|NCT03367793|65440859|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
23463428|NCT03367793|65440860|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463429|NCT03367793|65440861|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463430|NCT03367793|65440862|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463431|NCT00918255|65440864|FG000|Overall Study|Adverse Event|1|||
23463432|NCT00918255|65440865|FG001|Overall Study|Adverse Event|0|||
23463433|NCT00918255|65440866|FG002|Overall Study|Adverse Event|0|||
23463434|NCT00918255|65440864|FG000|Overall Study|Withdrawal by Subject|1|||
23463435|NCT00918255|65440865|FG001|Overall Study|Withdrawal by Subject|0|||
23463436|NCT00918255|65440866|FG002|Overall Study|Withdrawal by Subject|2|||
23463437|NCT00918255|65440864|FG000|Overall Study|Lack of Efficacy|1|||
23463438|NCT00918255|65440865|FG001|Overall Study|Lack of Efficacy|0|||
23463439|NCT00918255|65440866|FG002|Overall Study|Lack of Efficacy|0|||
23463440|NCT00918255|65440864|FG000|Overall Study|Lost to Follow-up|1|||
23463441|NCT00918255|65440865|FG001|Overall Study|Lost to Follow-up|0|||
23463442|NCT00918255|65440866|FG002|Overall Study|Lost to Follow-up|2|||
23463443|NCT00918255|65440864|FG000|Overall Study|Exceeded allowed number of interventions|0|||
23463444|NCT00918255|65440865|FG001|Overall Study|Exceeded allowed number of interventions|0|||
23463445|NCT00918255|65440866|FG002|Overall Study|Exceeded allowed number of interventions|1|||
23463446|NCT00918255|65440864|FG000|Overall Study|Non-compliance|1|||
23463447|NCT00918255|65440865|FG001|Overall Study|Non-compliance|0|||
23463448|NCT00918255|65440866|FG002|Overall Study|Non-compliance|0|||
23463449|NCT00918255|65440864|FG000|Overall Study|Investigator discretion|1|||
23463450|NCT00918255|65440865|FG001|Overall Study|Investigator discretion|0|||
23463451|NCT00918255|65440866|FG002|Overall Study|Investigator discretion|0|||
23463452|NCT01454102|65440867|FG000|Overall Study|Continuing in the treatment period|0|||
23463453|NCT01454102|65440868|FG001|Overall Study|Continuing in the treatment period|0|||
23463454|NCT01454102|65440869|FG002|Overall Study|Continuing in the treatment period|0|||
23463455|NCT01454102|65440870|FG003|Overall Study|Continuing in the treatment period|0|||
23463456|NCT01454102|65440871|FG004|Overall Study|Continuing in the treatment period|3|||
23463457|NCT01454102|65440872|FG005|Overall Study|Continuing in the treatment period|3|||
23790151|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
23790152|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
23790153|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
23790154|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
23790155|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
23790156|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
23463458|NCT01454102|65440873|FG006|Overall Study|Continuing in the treatment period|2|||
23790157|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
23790158|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
23790159|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
23790160|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
23790161|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
23463459|NCT01454102|65440874|FG007|Overall Study|Continuing in the treatment period|0|||
23463460|NCT01454102|65440875|FG008|Overall Study|Continuing in the treatment period|1|||
23463461|NCT01454102|65440876|FG009|Overall Study|Continuing in the treatment period|0|||
23463462|NCT01454102|65440877|FG010|Overall Study|Continuing in the treatment period|0|||
23463463|NCT01454102|65440878|FG011|Overall Study|Continuing in the treatment period|4|||
23463464|NCT01454102|65440879|FG012|Overall Study|Continuing in the treatment period|7|||
23463465|NCT01454102|65440880|FG013|Overall Study|Continuing in the treatment period|4|||
23463466|NCT01454102|65440881|FG014|Overall Study|Continuing in the treatment period|3|||
23463467|NCT01454102|65440882|FG015|Overall Study|Continuing in the treatment period|1|||
23463468|NCT03895840|65440884|FG000|Overall Study|Withdrawal by Subject|21|||
23790162|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
23790163|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
23790164|NCT00385736|66612729|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
23790165|NCT00385736|66612730|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
23790166|NCT00385736|66612731|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
23790167|NCT00385736|66612729|FG000|Safety Analysis Set|Adverse Event|23|||
23790168|NCT00385736|66612730|FG001|Safety Analysis Set|Adverse Event|15|||
23790169|NCT00385736|66612731|FG002|Safety Analysis Set|Adverse Event|23|||
23790170|NCT00385736|66612729|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
23790171|NCT00385736|66612730|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
23790172|NCT00385736|66612731|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
23790173|NCT00385736|66612729|FG000|Safety Analysis Set|Lost to Follow-up|0|||
23790174|NCT00385736|66612730|FG001|Safety Analysis Set|Lost to Follow-up|2|||
23790175|NCT00385736|66612731|FG002|Safety Analysis Set|Lost to Follow-up|2|||
23790176|NCT00385736|66612729|FG000|Safety Analysis Set|Lack of Efficacy|38|||
23790177|NCT00385736|66612730|FG001|Safety Analysis Set|Lack of Efficacy|16|||
23350198|NCT01627782|65025375|FG001|Overall Study|Adverse Event|2|||
23350199|NCT01627782|65025376|FG002|Overall Study|Adverse Event|0|||
23350200|NCT01627782|65025377|FG003|Overall Study|Adverse Event|1|||
23350201|NCT01627782|65025374|FG000|Overall Study|Lack of Efficacy|11|||
23350202|NCT01627782|65025375|FG001|Overall Study|Lack of Efficacy|1|||
23350203|NCT01627782|65025376|FG002|Overall Study|Lack of Efficacy|15|||
23350204|NCT01627782|65025377|FG003|Overall Study|Lack of Efficacy|2|||
23350205|NCT01627782|65025374|FG000|Overall Study|Protocol Violation|1|||
23350206|NCT01627782|65025375|FG001|Overall Study|Protocol Violation|0|||
23350207|NCT01627782|65025376|FG002|Overall Study|Protocol Violation|0|||
23350208|NCT01627782|65025377|FG003|Overall Study|Protocol Violation|0|||
23350209|NCT01627782|65025374|FG000|Overall Study|Withdrawal by Subject|2|||
23350210|NCT01627782|65025375|FG001|Overall Study|Withdrawal by Subject|1|||
23350211|NCT01627782|65025376|FG002|Overall Study|Withdrawal by Subject|0|||
23350212|NCT01627782|65025377|FG003|Overall Study|Withdrawal by Subject|0|||
23350213|NCT01627782|65025374|FG000|Overall Study|Other|0|||
23350214|NCT01627782|65025375|FG001|Overall Study|Other|2|||
23350215|NCT01627782|65025376|FG002|Overall Study|Other|0|||
23350216|NCT01627782|65025377|FG003|Overall Study|Other|3|||
23350217|NCT01627782|65025374|FG000|Overall Study|Randomized But Not Treated|1|||
23350218|NCT01627782|65025375|FG001|Overall Study|Randomized But Not Treated|0|||
23350219|NCT01627782|65025376|FG002|Overall Study|Randomized But Not Treated|0|||
23350220|NCT01627782|65025377|FG003|Overall Study|Randomized But Not Treated|0|||
23350221|NCT00480493|65025387|FG000|Overall Study|moved|2|||
23463469|NCT02651675|65440885|FG000|Overall Study|Death|0|||
23350222|NCT00480493|65025388|FG001|Overall Study|moved|7|||
23350223|NCT03004924|65025391|FG000|Overall Study|Adverse Event|6|||
23350224|NCT03004924|65025392|FG001|Overall Study|Adverse Event|5|||
23350225|NCT03004924|65025393|FG002|Overall Study|Adverse Event|10|||
23350226|NCT03004924|65025391|FG000|Overall Study|Protocol Violation|4|||
23350227|NCT03004924|65025392|FG001|Overall Study|Protocol Violation|0|||
23350228|NCT03004924|65025393|FG002|Overall Study|Protocol Violation|1|||
23463470|NCT02651675|65440886|FG001|Overall Study|Death|0|||
23350229|NCT03004924|65025391|FG000|Overall Study|Withdrawal by Subject|5|||
23350230|NCT03004924|65025392|FG001|Overall Study|Withdrawal by Subject|3|||
23350231|NCT03004924|65025393|FG002|Overall Study|Withdrawal by Subject|5|||
23350232|NCT03004924|65025391|FG000|Overall Study|Lost to Follow-up|6|||
23790178|NCT00385736|66612731|FG002|Safety Analysis Set|Lack of Efficacy|31|||
23790179|NCT00385736|66612729|FG000|Safety Analysis Set|Protocol Violation|2|||
23463471|NCT02651675|65440887|FG002|Overall Study|Death|1|||
23463472|NCT01599637|65440888|FG000|Overall Study|administrative problems|0|||
23463473|NCT01599637|65440889|FG001|Overall Study|administrative problems|2|||
23463474|NCT01599637|65440890|FG002|Overall Study|administrative problems|0|||
23463475|NCT01599637|65440888|FG000|Overall Study|Adverse Event|1|||
23463476|NCT01599637|65440889|FG001|Overall Study|Adverse Event|0|||
23463477|NCT01599637|65440890|FG002|Overall Study|Adverse Event|0|||
23463478|NCT01001325|65440893|FG000|Overall Study|Lost to Follow-up|16|||
23463479|NCT01001325|65440894|FG001|Overall Study|Lost to Follow-up|10|||
23463480|NCT01001325|65440893|FG000|Overall Study|Protocol Violation|2|||
23463481|NCT01001325|65440894|FG001|Overall Study|Protocol Violation|0|||
23463482|NCT02667119|65440896|FG000|Overall Study|Lost to Follow-up|3|||
23463483|NCT02667119|65440897|FG001|Overall Study|Lost to Follow-up|0|||
23463484|NCT00325897|65440903|FG000|Overall Study|Lost to Follow-up|12|||
23463485|NCT00325897|65440904|FG001|Overall Study|Lost to Follow-up|13|||
23790180|NCT00385736|66612730|FG001|Safety Analysis Set|Protocol Violation|1|||
23463486|NCT02675634|65440905|FG000|Test Period 1|Adverse Event|0|||
23463487|NCT02675634|65440906|FG001|Test Period 1|Adverse Event|1|||
23463488|NCT02675634|65440907|FG002|Test Period 1|Adverse Event|0|||
23463489|NCT02675634|65440908|FG003|Test Period 1|Adverse Event|1|||
23584969|NCT02403674|65869358|FG000|Base Study|Lack of Efficacy|31|||
23584970|NCT02403674|65869359|FG001|Base Study|Lack of Efficacy|23|||
23790181|NCT00385736|66612731|FG002|Safety Analysis Set|Protocol Violation|6|||
23790182|NCT00385736|66612729|FG000|Safety Analysis Set|Other|1|||
23463490|NCT02675634|65440909|FG004|Test Period 1|Adverse Event|0|||
23463491|NCT02675634|65440910|FG005|Test Period 1|Adverse Event|0|||
23463492|NCT02675634|65440905|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
23463493|NCT02675634|65440906|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
23463494|NCT02675634|65440907|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
23463495|NCT02675634|65440908|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
23463496|NCT02675634|65440909|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
23463497|NCT02675634|65440910|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
23463498|NCT02675634|65440905|FG000|Test Period 2|Lack of Efficacy|1|||
23463499|NCT02675634|65440906|FG001|Test Period 2|Lack of Efficacy|0|||
23463500|NCT02675634|65440907|FG002|Test Period 2|Lack of Efficacy|0|||
23463501|NCT02675634|65440908|FG003|Test Period 2|Lack of Efficacy|0|||
23463502|NCT02675634|65440909|FG004|Test Period 2|Lack of Efficacy|0|||
23790183|NCT00385736|66612730|FG001|Safety Analysis Set|Other|4|||
23790184|NCT00385736|66612731|FG002|Safety Analysis Set|Other|4|||
23790185|NCT01590563|66612736|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
23790186|NCT01726803|66612739|FG000|Overall Study|Lost to Follow-up|6|||
23463503|NCT02675634|65440910|FG005|Test Period 2|Lack of Efficacy|0|||
23463504|NCT02675634|65440905|FG000|Test Period 2|Adverse Event|0|||
23463505|NCT02675634|65440906|FG001|Test Period 2|Adverse Event|0|||
23463506|NCT02675634|65440907|FG002|Test Period 2|Adverse Event|0|||
23463507|NCT02675634|65440908|FG003|Test Period 2|Adverse Event|0|||
23790187|NCT01726803|66612740|FG001|Overall Study|Lost to Follow-up|1|||
23790188|NCT01726803|66612739|FG000|Overall Study|Withdrawal by Subject|1|||
23463508|NCT02675634|65440909|FG004|Test Period 2|Adverse Event|0|||
23790189|NCT01726803|66612740|FG001|Overall Study|Withdrawal by Subject|0|||
23463509|NCT02675634|65440910|FG005|Test Period 2|Adverse Event|1|||
23463510|NCT03697252|65440911|FG000|Overall Study|Adverse Event|3|||
23463511|NCT03697252|65440912|FG001|Overall Study|Adverse Event|2|||
23463512|NCT03697252|65440911|FG000|Overall Study|Withdrawal by Subject|14|||
23463513|NCT03697252|65440912|FG001|Overall Study|Withdrawal by Subject|14|||
23463514|NCT03697252|65440911|FG000|Overall Study|Lost to Follow-up|0|||
23463515|NCT03697252|65440912|FG001|Overall Study|Lost to Follow-up|1|||
23463516|NCT03697252|65440911|FG000|Overall Study|Physician Decision|1|||
23463517|NCT03697252|65440912|FG001|Overall Study|Physician Decision|1|||
23463518|NCT03697252|65440911|FG000|Overall Study|Other|0|||
23463519|NCT03697252|65440912|FG001|Overall Study|Other|1|||
23584971|NCT02403674|65869358|FG000|Base Study|Lost to Follow-up|6|||
23584972|NCT02403674|65869359|FG001|Base Study|Lost to Follow-up|8|||
23584973|NCT02403674|65869358|FG000|Base Study|Withdrawal by Subject|10|||
23584974|NCT02403674|65869359|FG001|Base Study|Withdrawal by Subject|17|||
23584975|NCT02403674|65869358|FG000|Base Study|Physician Decision|2|||
23584976|NCT02403674|65869359|FG001|Base Study|Physician Decision|2|||
23584977|NCT02403674|65869358|FG000|Base Study|Pregnancy|2|||
23584978|NCT02403674|65869359|FG001|Base Study|Pregnancy|2|||
23584979|NCT02403674|65869358|FG000|Base Study|Protocol Violation|8|||
23584980|NCT02403674|65869359|FG001|Base Study|Protocol Violation|4|||
23584981|NCT02403674|65869358|FG000|Base Study|Non-Compliance with study drug|1|||
23584982|NCT02403674|65869359|FG001|Base Study|Non-Compliance with study drug|4|||
23584983|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
23584984|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
23584985|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
23584986|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
23584987|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
23584988|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
23584989|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
23584990|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
23584991|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
23584992|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
23584993|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
23584994|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
23584995|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Death|1|||
23584996|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Death|0|||
23584997|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
23584998|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
23584999|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
23790190|NCT02957331|66612742|FG000|Overall Study|Protocol Violation|1|||
23790191|NCT02957331|66612743|FG001|Overall Study|Protocol Violation|0|||
23790192|NCT02964039|66612746|FG000|Overall Study|Medical reason unrelated to study participation|1|||
23790193|NCT02964039|66612747|FG001|Overall Study|Medical reason unrelated to study participation|0|||
23585000|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
23585001|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
23585002|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
23790194|NCT02964039|66612748|FG002|Overall Study|Medical reason unrelated to study participation|3|||
23585003|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
23639877|NCT02187159|66067380|FG000|Overall Study|Lack of Efficacy|10|||
23790195|NCT02964039|66612746|FG000|Overall Study|Research shutdown due to pandemic|2|||
23790196|NCT02964039|66612747|FG001|Overall Study|Research shutdown due to pandemic|0|||
23790197|NCT02964039|66612748|FG002|Overall Study|Research shutdown due to pandemic|1|||
23790198|NCT02964039|66612746|FG000|Overall Study|Withdrawal by Subject|0|||
23463520|NCT02963506|65440913|FG000|Double-Blind Period|Adverse Event|0|||
23463521|NCT02963506|65440914|FG001|Double-Blind Period|Adverse Event|0|||
23463522|NCT02963506|65440915|FG002|Double-Blind Period|Adverse Event|1|||
23463523|NCT02963506|65440916|FG003|Double-Blind Period|Adverse Event|0|||
23463524|NCT02963506|65440917|FG004|Double-Blind Period|Adverse Event|0|||
23463525|NCT02963506|65440918|FG005|Double-Blind Period|Adverse Event|0|||
23463526|NCT02963506|65440919|FG006|Double-Blind Period|Adverse Event|0|||
23463527|NCT02963506|65440920|FG007|Double-Blind Period|Adverse Event|0|||
23463528|NCT02963506|65440921|FG008|Double-Blind Period|Adverse Event|0|||
23463529|NCT02963506|65440922|FG009|Double-Blind Period|Adverse Event|0|||
23463530|NCT02963506|65440923|FG010|Double-Blind Period|Adverse Event|0|||
23463531|NCT02963506|65440924|FG011|Double-Blind Period|Adverse Event|0|||
23463532|NCT02963506|65440925|FG012|Double-Blind Period|Adverse Event|0|||
23463533|NCT02963506|65440913|FG000|Double-Blind Period|Death|0|||
23463534|NCT02963506|65440914|FG001|Double-Blind Period|Death|0|||
23463535|NCT02963506|65440915|FG002|Double-Blind Period|Death|0|||
23463536|NCT02963506|65440916|FG003|Double-Blind Period|Death|1|||
23463537|NCT02963506|65440917|FG004|Double-Blind Period|Death|0|||
23463538|NCT02963506|65440918|FG005|Double-Blind Period|Death|0|||
23463539|NCT02963506|65440919|FG006|Double-Blind Period|Death|0|||
23463540|NCT02963506|65440920|FG007|Double-Blind Period|Death|0|||
23463541|NCT02963506|65440921|FG008|Double-Blind Period|Death|0|||
23463542|NCT02963506|65440922|FG009|Double-Blind Period|Death|0|||
23463543|NCT02963506|65440923|FG010|Double-Blind Period|Death|0|||
23463544|NCT02963506|65440924|FG011|Double-Blind Period|Death|0|||
23463545|NCT02963506|65440925|FG012|Double-Blind Period|Death|0|||
23463546|NCT02963506|65440913|FG000|Double-Blind Period|Lost to Follow-up|0|||
23463547|NCT02963506|65440914|FG001|Double-Blind Period|Lost to Follow-up|1|||
23463548|NCT02963506|65440915|FG002|Double-Blind Period|Lost to Follow-up|0|||
23463549|NCT02963506|65440916|FG003|Double-Blind Period|Lost to Follow-up|0|||
23463550|NCT02963506|65440917|FG004|Double-Blind Period|Lost to Follow-up|0|||
23463551|NCT02963506|65440918|FG005|Double-Blind Period|Lost to Follow-up|0|||
23463552|NCT02963506|65440919|FG006|Double-Blind Period|Lost to Follow-up|0|||
23463553|NCT02963506|65440920|FG007|Double-Blind Period|Lost to Follow-up|0|||
23463554|NCT02963506|65440921|FG008|Double-Blind Period|Lost to Follow-up|0|||
23463555|NCT02963506|65440922|FG009|Double-Blind Period|Lost to Follow-up|0|||
23463556|NCT02963506|65440923|FG010|Double-Blind Period|Lost to Follow-up|0|||
23463557|NCT02963506|65440924|FG011|Double-Blind Period|Lost to Follow-up|0|||
23463558|NCT02963506|65440925|FG012|Double-Blind Period|Lost to Follow-up|0|||
23463559|NCT02963506|65440913|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23463560|NCT02963506|65440914|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23463561|NCT02963506|65440915|FG002|Double-Blind Period|Withdrawal by Subject|1|||
23463562|NCT02963506|65440916|FG003|Double-Blind Period|Withdrawal by Subject|1|||
23463563|NCT02963506|65440917|FG004|Double-Blind Period|Withdrawal by Subject|0|||
23463564|NCT02963506|65440918|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23463565|NCT02963506|65440919|FG006|Double-Blind Period|Withdrawal by Subject|0|||
23463566|NCT02963506|65440920|FG007|Double-Blind Period|Withdrawal by Subject|0|||
23463567|NCT02963506|65440921|FG008|Double-Blind Period|Withdrawal by Subject|0|||
23463568|NCT02963506|65440922|FG009|Double-Blind Period|Withdrawal by Subject|0|||
23463569|NCT02963506|65440923|FG010|Double-Blind Period|Withdrawal by Subject|0|||
23463570|NCT02963506|65440924|FG011|Double-Blind Period|Withdrawal by Subject|0|||
23463571|NCT02963506|65440925|FG012|Double-Blind Period|Withdrawal by Subject|0|||
23463572|NCT02963506|65440913|FG000|Double-Blind Period|No compliance|0|||
23463573|NCT02963506|65440914|FG001|Double-Blind Period|No compliance|1|||
23463574|NCT02963506|65440915|FG002|Double-Blind Period|No compliance|0|||
23463575|NCT02963506|65440916|FG003|Double-Blind Period|No compliance|0|||
23463576|NCT02963506|65440917|FG004|Double-Blind Period|No compliance|0|||
23463577|NCT02963506|65440918|FG005|Double-Blind Period|No compliance|0|||
23463578|NCT02963506|65440919|FG006|Double-Blind Period|No compliance|0|||
23463579|NCT02963506|65440920|FG007|Double-Blind Period|No compliance|0|||
23463580|NCT02963506|65440921|FG008|Double-Blind Period|No compliance|0|||
23463581|NCT02963506|65440922|FG009|Double-Blind Period|No compliance|0|||
23463582|NCT02963506|65440923|FG010|Double-Blind Period|No compliance|0|||
23463583|NCT02963506|65440924|FG011|Double-Blind Period|No compliance|0|||
23463584|NCT02963506|65440925|FG012|Double-Blind Period|No compliance|0|||
23463585|NCT02963506|65440913|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23790199|NCT02964039|66612747|FG001|Overall Study|Withdrawal by Subject|1|||
23350233|NCT03004924|65025392|FG001|Overall Study|Lost to Follow-up|1|||
23350234|NCT03004924|65025393|FG002|Overall Study|Lost to Follow-up|4|||
23463586|NCT02963506|65440914|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
23463587|NCT02963506|65440915|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463588|NCT02963506|65440916|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463589|NCT02963506|65440917|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463590|NCT02963506|65440918|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463591|NCT02963506|65440919|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463592|NCT02963506|65440920|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463593|NCT02963506|65440921|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463594|NCT02963506|65440922|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463595|NCT02963506|65440923|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463596|NCT02963506|65440924|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463597|NCT02963506|65440925|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463598|NCT02963506|65440913|FG000|Dose-Blind Period|Adverse Event|0|||
23463599|NCT02963506|65440914|FG001|Dose-Blind Period|Adverse Event|0|||
23790200|NCT02964039|66612748|FG002|Overall Study|Withdrawal by Subject|0|||
23463600|NCT02963506|65440915|FG002|Dose-Blind Period|Adverse Event|0|||
23463601|NCT02963506|65440916|FG003|Dose-Blind Period|Adverse Event|0|||
23790201|NCT02964039|66612746|FG000|Overall Study|Lost to Follow-up|1|||
23790202|NCT02964039|66612747|FG001|Overall Study|Lost to Follow-up|0|||
23790203|NCT02964039|66612748|FG002|Overall Study|Lost to Follow-up|1|||
23463602|NCT02963506|65440917|FG004|Dose-Blind Period|Adverse Event|0|||
23463603|NCT02963506|65440918|FG005|Dose-Blind Period|Adverse Event|1|||
23463604|NCT02963506|65440919|FG006|Dose-Blind Period|Adverse Event|3|||
23463605|NCT02963506|65440920|FG007|Dose-Blind Period|Adverse Event|2|||
23463606|NCT02963506|65440921|FG008|Dose-Blind Period|Adverse Event|2|||
23463607|NCT02963506|65440922|FG009|Dose-Blind Period|Adverse Event|2|||
23463608|NCT02963506|65440923|FG010|Dose-Blind Period|Adverse Event|1|||
23463609|NCT02963506|65440924|FG011|Dose-Blind Period|Adverse Event|1|||
23463610|NCT02963506|65440925|FG012|Dose-Blind Period|Adverse Event|6|||
23463611|NCT02963506|65440913|FG000|Dose-Blind Period|Lack of Efficacy|0|||
23463612|NCT02963506|65440914|FG001|Dose-Blind Period|Lack of Efficacy|0|||
23463613|NCT02963506|65440915|FG002|Dose-Blind Period|Lack of Efficacy|0|||
23463614|NCT02963506|65440916|FG003|Dose-Blind Period|Lack of Efficacy|0|||
23463615|NCT02963506|65440917|FG004|Dose-Blind Period|Lack of Efficacy|0|||
23463616|NCT02963506|65440918|FG005|Dose-Blind Period|Lack of Efficacy|0|||
23463617|NCT02963506|65440919|FG006|Dose-Blind Period|Lack of Efficacy|0|||
23463618|NCT02963506|65440920|FG007|Dose-Blind Period|Lack of Efficacy|1|||
23463619|NCT02963506|65440921|FG008|Dose-Blind Period|Lack of Efficacy|0|||
23463620|NCT02963506|65440922|FG009|Dose-Blind Period|Lack of Efficacy|1|||
23463621|NCT02963506|65440923|FG010|Dose-Blind Period|Lack of Efficacy|0|||
23463622|NCT02963506|65440924|FG011|Dose-Blind Period|Lack of Efficacy|0|||
23463623|NCT02963506|65440925|FG012|Dose-Blind Period|Lack of Efficacy|0|||
23463624|NCT02963506|65440913|FG000|Dose-Blind Period|Lost to Follow-up|0|||
23463625|NCT02963506|65440914|FG001|Dose-Blind Period|Lost to Follow-up|0|||
23463626|NCT02963506|65440915|FG002|Dose-Blind Period|Lost to Follow-up|0|||
23463627|NCT02963506|65440916|FG003|Dose-Blind Period|Lost to Follow-up|0|||
23463628|NCT02963506|65440917|FG004|Dose-Blind Period|Lost to Follow-up|0|||
23463629|NCT02963506|65440918|FG005|Dose-Blind Period|Lost to Follow-up|1|||
23463630|NCT02963506|65440919|FG006|Dose-Blind Period|Lost to Follow-up|0|||
23463631|NCT02963506|65440920|FG007|Dose-Blind Period|Lost to Follow-up|0|||
23463632|NCT02963506|65440921|FG008|Dose-Blind Period|Lost to Follow-up|1|||
23463633|NCT02963506|65440922|FG009|Dose-Blind Period|Lost to Follow-up|0|||
23463634|NCT02963506|65440923|FG010|Dose-Blind Period|Lost to Follow-up|0|||
23463635|NCT02963506|65440924|FG011|Dose-Blind Period|Lost to Follow-up|1|||
23463636|NCT02963506|65440925|FG012|Dose-Blind Period|Lost to Follow-up|0|||
23463637|NCT02963506|65440913|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
23463638|NCT02963506|65440914|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
23463639|NCT02963506|65440915|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
23463640|NCT02963506|65440916|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
23463641|NCT02963506|65440917|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
23463642|NCT02963506|65440918|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
23463643|NCT02963506|65440919|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
23463644|NCT02963506|65440920|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
23463645|NCT02963506|65440921|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
23463646|NCT02963506|65440922|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
23463647|NCT02963506|65440923|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
23463648|NCT02963506|65440924|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
23463649|NCT02963506|65440925|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
23463650|NCT02963506|65440913|FG000|Dose-Blind Period|Sponsor decision|0|||
23463651|NCT02963506|65440914|FG001|Dose-Blind Period|Sponsor decision|0|||
23463652|NCT02963506|65440915|FG002|Dose-Blind Period|Sponsor decision|0|||
23463653|NCT02963506|65440916|FG003|Dose-Blind Period|Sponsor decision|0|||
23463654|NCT02963506|65440917|FG004|Dose-Blind Period|Sponsor decision|0|||
23463655|NCT02963506|65440918|FG005|Dose-Blind Period|Sponsor decision|1|||
23463656|NCT02963506|65440919|FG006|Dose-Blind Period|Sponsor decision|0|||
23463657|NCT02963506|65440920|FG007|Dose-Blind Period|Sponsor decision|0|||
23463658|NCT02963506|65440921|FG008|Dose-Blind Period|Sponsor decision|0|||
23463659|NCT02963506|65440922|FG009|Dose-Blind Period|Sponsor decision|0|||
23463660|NCT02963506|65440923|FG010|Dose-Blind Period|Sponsor decision|0|||
23463661|NCT02963506|65440924|FG011|Dose-Blind Period|Sponsor decision|0|||
23463662|NCT02963506|65440925|FG012|Dose-Blind Period|Sponsor decision|0|||
23463663|NCT02963506|65440913|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463664|NCT02963506|65440914|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463665|NCT02963506|65440915|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23790204|NCT00787605|66612755|FG000|Overall Study|Administrative Problems|3|||
23790205|NCT00787605|66612756|FG001|Overall Study|Administrative Problems|0|||
23463666|NCT02963506|65440916|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463667|NCT02963506|65440917|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463668|NCT02963506|65440918|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463669|NCT02963506|65440919|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463670|NCT02963506|65440920|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463671|NCT02963506|65440921|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463672|NCT02963506|65440922|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463673|NCT02963506|65440923|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463674|NCT02963506|65440924|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463675|NCT02963506|65440925|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
23463676|NCT00525161|65440928|FG000|Overall Study|Adverse Event|1|||
23463677|NCT04004988|65440933|FG000|Period 1|Physician Decision|2|||
23463678|NCT04004988|65440934|FG001|Period 1|Physician Decision|0|||
23463679|NCT04004988|65440933|FG000|Period 1|Withdrawal by Subject|0|||
23463680|NCT04004988|65440934|FG001|Period 1|Withdrawal by Subject|1|||
23463681|NCT04004988|65440933|FG000|Period 1|Adverse Event|1|||
23463682|NCT04004988|65440934|FG001|Period 1|Adverse Event|2|||
23463683|NCT00067002|65440937|FG000|Overall Study|Early Death|1|||
23463684|NCT00067002|65440938|FG001|Overall Study|Early Death|2|||
23463685|NCT00067002|65440937|FG000|Overall Study|Delayed|1|||
23463686|NCT00067002|65440938|FG001|Overall Study|Delayed|1|||
23463687|NCT00067002|65440937|FG000|Overall Study|Graft Failure|5|||
23463688|NCT00067002|65440938|FG001|Overall Study|Graft Failure|6|||
23463689|NCT00478023|65440941|FG000|Overall Study|Adverse Event|11|||
23463690|NCT00478023|65440942|FG001|Overall Study|Adverse Event|7|||
23463691|NCT00478023|65440943|FG002|Overall Study|Adverse Event|8|||
23463692|NCT00478023|65440944|FG003|Overall Study|Adverse Event|14|||
23463693|NCT00478023|65440945|FG004|Overall Study|Adverse Event|6|||
23463694|NCT00478023|65440941|FG000|Overall Study|Death|1|||
23463695|NCT00478023|65440942|FG001|Overall Study|Death|0|||
23463696|NCT00478023|65440943|FG002|Overall Study|Death|0|||
23463697|NCT00478023|65440944|FG003|Overall Study|Death|0|||
23463698|NCT00478023|65440945|FG004|Overall Study|Death|0|||
23463699|NCT00478023|65440941|FG000|Overall Study|Lack of Efficacy|11|||
23463700|NCT00478023|65440942|FG001|Overall Study|Lack of Efficacy|10|||
23463701|NCT00478023|65440943|FG002|Overall Study|Lack of Efficacy|4|||
23463702|NCT00478023|65440944|FG003|Overall Study|Lack of Efficacy|5|||
23463703|NCT00478023|65440945|FG004|Overall Study|Lack of Efficacy|41|||
23463704|NCT00478023|65440941|FG000|Overall Study|Lost to Follow-up|3|||
23463705|NCT00478023|65440942|FG001|Overall Study|Lost to Follow-up|1|||
23463706|NCT00478023|65440943|FG002|Overall Study|Lost to Follow-up|1|||
23463707|NCT00478023|65440944|FG003|Overall Study|Lost to Follow-up|1|||
23463708|NCT00478023|65440945|FG004|Overall Study|Lost to Follow-up|0|||
23463709|NCT00478023|65440941|FG000|Overall Study|Withdrawal by Subject|2|||
23463710|NCT00478023|65440942|FG001|Overall Study|Withdrawal by Subject|3|||
23463711|NCT00478023|65440943|FG002|Overall Study|Withdrawal by Subject|2|||
23463712|NCT00478023|65440944|FG003|Overall Study|Withdrawal by Subject|4|||
23463713|NCT00478023|65440945|FG004|Overall Study|Withdrawal by Subject|5|||
23463714|NCT00478023|65440941|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
23463715|NCT00478023|65440942|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
23463716|NCT00478023|65440943|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
23463717|NCT00478023|65440944|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
23463718|NCT00478023|65440945|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
23463719|NCT00912808|65440946|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
23463720|NCT00912808|65440947|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23463721|NCT00912808|65440946|FG000|Washout|Withdrawal by Subject|0|||
23463722|NCT00912808|65440947|FG001|Washout|Withdrawal by Subject|1|||
23463723|NCT00912808|65440946|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23463724|NCT00912808|65440947|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
23463725|NCT00912808|65440946|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
23463726|NCT00912808|65440947|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23463727|NCT00728689|65440948|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
23463728|NCT00728689|65440949|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
23463729|NCT00914316|65440951|FG000|Phase 1|Physician Decision|4|||
23463730|NCT00914316|65440952|FG001|Phase 1|Physician Decision|0|||
23463731|NCT00914316|65440953|FG002|Phase 1|Physician Decision|1|||
23463732|NCT00914316|65440954|FG003|Phase 1|Physician Decision|2|||
23463733|NCT00914316|65440951|FG000|Phase 1|Withdrawal by Subject|0|||
23463734|NCT00914316|65440952|FG001|Phase 1|Withdrawal by Subject|2|||
23463735|NCT00914316|65440953|FG002|Phase 1|Withdrawal by Subject|4|||
23463736|NCT00914316|65440954|FG003|Phase 1|Withdrawal by Subject|0|||
23463737|NCT00914316|65440951|FG000|Phase 1|Adverse Event|1|||
23463738|NCT00914316|65440952|FG001|Phase 1|Adverse Event|0|||
23463739|NCT00914316|65440953|FG002|Phase 1|Adverse Event|0|||
23463740|NCT00914316|65440954|FG003|Phase 1|Adverse Event|0|||
23463741|NCT00914316|65440951|FG000|Phase 2|Withdrawal by Subject|1|||
23463742|NCT00914316|65440952|FG001|Phase 2|Withdrawal by Subject|0|||
23463743|NCT00914316|65440953|FG002|Phase 2|Withdrawal by Subject|1|||
23463744|NCT00914316|65440954|FG003|Phase 2|Withdrawal by Subject|0|||
23463745|NCT00577889|65440957|FG000|Overall Study|Withdrawal by Subject|1|||
23463746|NCT00577889|65440958|FG001|Overall Study|Withdrawal by Subject|0|||
23463747|NCT00577889|65440959|FG002|Overall Study|Withdrawal by Subject|0|||
23463748|NCT01652534|65440960|FG000|Overall Study|Lack of Efficacy|1|||
23463749|NCT01652534|65440961|FG001|Overall Study|Lack of Efficacy|0|||
23350235|NCT03004924|65025391|FG000|Overall Study|Lack of Efficacy|2|||
23350236|NCT03004924|65025392|FG001|Overall Study|Lack of Efficacy|4|||
23350237|NCT03004924|65025393|FG002|Overall Study|Lack of Efficacy|2|||
23350238|NCT03004924|65025391|FG000|Overall Study|Physician Decision|1|||
23350239|NCT03004924|65025392|FG001|Overall Study|Physician Decision|0|||
23350240|NCT03004924|65025393|FG002|Overall Study|Physician Decision|1|||
23350241|NCT03004924|65025391|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23350242|NCT03004924|65025392|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23350243|NCT03004924|65025393|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23350244|NCT03004924|65025391|FG000|Overall Study|Screen Failure|1|||
23350245|NCT03004924|65025392|FG001|Overall Study|Screen Failure|0|||
23350246|NCT03004924|65025393|FG002|Overall Study|Screen Failure|0|||
23350247|NCT03004924|65025391|FG000|Overall Study|Pregnancy|0|||
23350248|NCT03004924|65025392|FG001|Overall Study|Pregnancy|1|||
23350249|NCT03004924|65025393|FG002|Overall Study|Pregnancy|0|||
23350250|NCT03004924|65025391|FG000|Overall Study|Terminated by Sponsor|0|||
23350251|NCT03004924|65025392|FG001|Overall Study|Terminated by Sponsor|0|||
23350252|NCT03004924|65025393|FG002|Overall Study|Terminated by Sponsor|1|||
23350253|NCT03004924|65025391|FG000|Overall Study|Missed Study Visit|0|||
23350254|NCT03004924|65025392|FG001|Overall Study|Missed Study Visit|0|||
23350255|NCT03004924|65025393|FG002|Overall Study|Missed Study Visit|2|||
23350256|NCT03004924|65025391|FG000|Overall Study|HSV1 Positive|1|||
23350257|NCT03004924|65025392|FG001|Overall Study|HSV1 Positive|0|||
23350258|NCT03004924|65025393|FG002|Overall Study|HSV1 Positive|0|||
23350259|NCT01273155|65025396|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
23350260|NCT01273155|65025397|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
23463750|NCT02083354|65440962|FG000|Overall Study|Withdrawal by Subject|9|||
23350261|NCT01273155|65025398|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
23350262|NCT01273155|65025399|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
23350263|NCT01273155|65025400|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
23350264|NCT01273155|65025401|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
23350265|NCT01273155|65025402|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
23350266|NCT01273155|65025396|FG000|Overall Study|Change in liver function/no longer eval.|0|||
23463751|NCT02083354|65440962|FG000|Overall Study|Lost to Follow-up|1|||
23463752|NCT02083354|65440962|FG000|Overall Study|Adverse Event|3|||
23463753|NCT02083354|65440962|FG000|Overall Study|Disease progression|46|||
23463754|NCT02083354|65440962|FG000|Overall Study|Study closed/terminated|5|||
23463755|NCT02015637|65440966|FG000|Overall Study|Lost to Follow-up|3|||
23463756|NCT02015637|65440967|FG001|Overall Study|Lost to Follow-up|5|||
23463757|NCT02015637|65440966|FG000|Overall Study|Adverse Event|3|||
23463758|NCT02015637|65440967|FG001|Overall Study|Adverse Event|0|||
23463759|NCT02015637|65440966|FG000|Overall Study|Did not take study drug|2|||
23463760|NCT02015637|65440967|FG001|Overall Study|Did not take study drug|0|||
23463761|NCT01782378|65440968|FG000|First Series|Lost to Follow-up|7|||
23463762|NCT01782378|65440969|FG001|First Series|Lost to Follow-up|8|||
23463763|NCT01782378|65440968|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
23463764|NCT01782378|65440969|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
23463765|NCT01782378|65440968|FG000|Second Series|Lost to Follow-up|8|||
23463766|NCT01782378|65440969|FG001|Second Series|Lost to Follow-up|7|||
23463767|NCT01782378|65440968|FG000|Second Series|Did not choose to complete S2 Optional|18|||
23463768|NCT01782378|65440969|FG001|Second Series|Did not choose to complete S2 Optional|0|||
23463769|NCT00321620|65440970|FG000|Overall Study|Death|269|||
23790206|NCT00787605|66612755|FG000|Overall Study|Adverse Event|14|||
23790207|NCT00787605|66612756|FG001|Overall Study|Adverse Event|25|||
23790208|NCT00787605|66612755|FG000|Overall Study|Lost to Follow-up|3|||
23790209|NCT00787605|66612756|FG001|Overall Study|Lost to Follow-up|6|||
23790210|NCT00787605|66612755|FG000|Overall Study|Protocol Violation|7|||
23790211|NCT00787605|66612756|FG001|Overall Study|Protocol Violation|3|||
23790212|NCT00787605|66612755|FG000|Overall Study|Withdrawal by Subject|6|||
23790213|NCT00787605|66612756|FG001|Overall Study|Withdrawal by Subject|13|||
23790214|NCT00787605|66612755|FG000|Overall Study|Lack of Efficacy|13|||
23790215|NCT00787605|66612756|FG001|Overall Study|Lack of Efficacy|9|||
23790216|NCT00868998|66612757|FG000|Overall Study|Screen Failure|1|||
23790217|NCT00868998|66612757|FG000|Overall Study|Withdrawal by Subject|1|||
23790218|NCT00868998|66612757|FG000|Overall Study|Progression of disease|2|||
23790219|NCT00868998|66612757|FG000|Overall Study|Death|1|||
23790220|NCT03555695|66612758|FG000|Overall Study|Withdrawal by Subject|1|||
23790221|NCT03555695|66612758|FG000|Overall Study|Lost to Follow-up|1|||
23350267|NCT01273155|65025397|FG001|Overall Study|Change in liver function/no longer eval.|1|||
23350268|NCT01273155|65025398|FG002|Overall Study|Change in liver function/no longer eval.|0|||
23463770|NCT00321620|65440971|FG001|Overall Study|Death|294|||
23463771|NCT00321620|65440970|FG000|Overall Study|Withdrawal by Subject|164|||
23463772|NCT00321620|65440971|FG001|Overall Study|Withdrawal by Subject|147|||
23463773|NCT00321620|65440970|FG000|Overall Study|Disease progression|113|||
23463774|NCT00321620|65440971|FG001|Overall Study|Disease progression|117|||
23463775|NCT00321620|65440970|FG000|Overall Study|Adverse Event|43|||
23463776|NCT00321620|65440971|FG001|Overall Study|Adverse Event|56|||
23463777|NCT00321620|65440970|FG000|Overall Study|Lost to Follow-up|13|||
23463778|NCT00321620|65440971|FG001|Overall Study|Lost to Follow-up|9|||
23463779|NCT00321620|65440970|FG000|Overall Study|Physician Decision|4|||
23463780|NCT00321620|65440971|FG001|Overall Study|Physician Decision|1|||
23463781|NCT00321620|65440970|FG000|Overall Study|Noncompliance|14|||
23463782|NCT00321620|65440971|FG001|Overall Study|Noncompliance|7|||
23463783|NCT00321620|65440970|FG000|Overall Study|Protocol deviation|4|||
23463784|NCT00321620|65440971|FG001|Overall Study|Protocol deviation|3|||
23463785|NCT00321620|65440970|FG000|Overall Study|Ineligibility determined|2|||
23463786|NCT00321620|65440971|FG001|Overall Study|Ineligibility determined|3|||
23463787|NCT00321620|65440970|FG000|Overall Study|Participant request|75|||
23463788|NCT00321620|65440971|FG001|Overall Study|Participant request|52|||
23463789|NCT00321620|65440970|FG000|Overall Study|Other|42|||
23463790|NCT00321620|65440971|FG001|Overall Study|Other|33|||
23463791|NCT00716417|65440972|FG000|Overall Study|Adverse Event|0|||
23463792|NCT00716417|65440973|FG001|Overall Study|Adverse Event|0|||
23463793|NCT00716417|65440974|FG002|Overall Study|Adverse Event|2|||
23463794|NCT00716417|65440975|FG003|Overall Study|Adverse Event|1|||
23463795|NCT00716417|65440976|FG004|Overall Study|Adverse Event|0|||
23463796|NCT00716417|65440977|FG005|Overall Study|Adverse Event|0|||
23463797|NCT00716417|65440978|FG006|Overall Study|Adverse Event|3|||
23463798|NCT00716417|65440979|FG007|Overall Study|Adverse Event|1|||
23463799|NCT00716417|65440980|FG008|Overall Study|Adverse Event|0|||
23463800|NCT00716417|65440981|FG009|Overall Study|Adverse Event|3|||
23463801|NCT00716417|65440972|FG000|Overall Study|Withdrawal by Subject|0|||
23463802|NCT00716417|65440973|FG001|Overall Study|Withdrawal by Subject|1|||
23463803|NCT00716417|65440974|FG002|Overall Study|Withdrawal by Subject|0|||
23463804|NCT00716417|65440975|FG003|Overall Study|Withdrawal by Subject|2|||
23463805|NCT00716417|65440976|FG004|Overall Study|Withdrawal by Subject|0|||
23463806|NCT00716417|65440977|FG005|Overall Study|Withdrawal by Subject|0|||
23463807|NCT00716417|65440978|FG006|Overall Study|Withdrawal by Subject|1|||
23463808|NCT00716417|65440979|FG007|Overall Study|Withdrawal by Subject|0|||
23463809|NCT00716417|65440980|FG008|Overall Study|Withdrawal by Subject|0|||
23463810|NCT00716417|65440981|FG009|Overall Study|Withdrawal by Subject|0|||
23463811|NCT00716417|65440972|FG000|Overall Study|Progressive disease|3|||
23790222|NCT03555695|66612758|FG000|Overall Study|appendicitis (unrelated)|1|||
23790223|NCT03555695|66612758|FG000|Overall Study|pre-existing sciatica|1|||
23790224|NCT01968031|66612759|FG000|Overall Study|Adverse Event|13|||
23790225|NCT01968031|66612760|FG001|Overall Study|Adverse Event|10|||
23790226|NCT01968031|66612761|FG002|Overall Study|Adverse Event|22|||
23463812|NCT00716417|65440973|FG001|Overall Study|Progressive disease|5|||
23463813|NCT00716417|65440974|FG002|Overall Study|Progressive disease|3|||
23463814|NCT00716417|65440975|FG003|Overall Study|Progressive disease|8|||
23463815|NCT00716417|65440976|FG004|Overall Study|Progressive disease|0|||
23463816|NCT00716417|65440977|FG005|Overall Study|Progressive disease|3|||
23463817|NCT00716417|65440978|FG006|Overall Study|Progressive disease|3|||
23463818|NCT00716417|65440979|FG007|Overall Study|Progressive disease|1|||
23463819|NCT00716417|65440980|FG008|Overall Study|Progressive disease|5|||
23463820|NCT00716417|65440981|FG009|Overall Study|Progressive disease|0|||
23463821|NCT00716417|65440972|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
23463822|NCT00716417|65440973|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
23463823|NCT00716417|65440974|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
23463824|NCT00716417|65440975|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
23463825|NCT00716417|65440976|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
23463826|NCT00716417|65440977|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
23463827|NCT00716417|65440978|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
23463828|NCT00716417|65440979|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
23463829|NCT00716417|65440980|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
23463830|NCT00716417|65440981|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
23463831|NCT00716417|65440972|FG000|Overall Study|On patient request due to toxicities|0|||
23463832|NCT00716417|65440973|FG001|Overall Study|On patient request due to toxicities|0|||
23463833|NCT00716417|65440974|FG002|Overall Study|On patient request due to toxicities|0|||
23463834|NCT00716417|65440975|FG003|Overall Study|On patient request due to toxicities|0|||
23463835|NCT00716417|65440976|FG004|Overall Study|On patient request due to toxicities|0|||
23463836|NCT00716417|65440977|FG005|Overall Study|On patient request due to toxicities|0|||
23463837|NCT00716417|65440978|FG006|Overall Study|On patient request due to toxicities|0|||
23463838|NCT00716417|65440979|FG007|Overall Study|On patient request due to toxicities|1|||
23463839|NCT00716417|65440980|FG008|Overall Study|On patient request due to toxicities|0|||
23463840|NCT00716417|65440981|FG009|Overall Study|On patient request due to toxicities|0|||
23463841|NCT00369265|65440986|FG000|Overall Study|Study terminated|4|||
23585004|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
23585005|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
23790227|NCT01968031|66612759|FG000|Overall Study|Withdrawal by Subject|3|||
23790228|NCT01968031|66612760|FG001|Overall Study|Withdrawal by Subject|7|||
23790229|NCT01968031|66612761|FG002|Overall Study|Withdrawal by Subject|3|||
23790230|NCT01968031|66612759|FG000|Overall Study|Did not meet entry criteria|1|||
23790231|NCT01968031|66612760|FG001|Overall Study|Did not meet entry criteria|1|||
23790232|NCT01968031|66612761|FG002|Overall Study|Did not meet entry criteria|1|||
23790233|NCT01968031|66612759|FG000|Overall Study|Noncompliance|0|||
23790234|NCT01968031|66612760|FG001|Overall Study|Noncompliance|0|||
23790235|NCT01968031|66612761|FG002|Overall Study|Noncompliance|2|||
23790236|NCT01968031|66612759|FG000|Overall Study|Failed inclusion criteria|0|||
23790237|NCT01968031|66612760|FG001|Overall Study|Failed inclusion criteria|2|||
23790238|NCT01968031|66612761|FG002|Overall Study|Failed inclusion criteria|0|||
23402752|NCT01621178|65219994|FG000|Overall Study|Death|6|||
23402753|NCT01621178|65219995|FG001|Overall Study|Death|7|||
23402754|NCT01621178|65219996|FG002|Overall Study|Death|2|||
23402755|NCT01621178|65219994|FG000|Overall Study|Lost to Follow-up|1|||
23402756|NCT01621178|65219995|FG001|Overall Study|Lost to Follow-up|2|||
23402757|NCT01621178|65219996|FG002|Overall Study|Lost to Follow-up|1|||
23402758|NCT01621178|65219994|FG000|Overall Study|Withdrawal by Subject|14|||
23402759|NCT01621178|65219995|FG001|Overall Study|Withdrawal by Subject|17|||
23402760|NCT01621178|65219996|FG002|Overall Study|Withdrawal by Subject|18|||
23402761|NCT01621178|65219994|FG000|Overall Study|Physician Decision|5|||
23402762|NCT01621178|65219995|FG001|Overall Study|Physician Decision|2|||
23402763|NCT01621178|65219996|FG002|Overall Study|Physician Decision|7|||
23402764|NCT01535287|65219999|FG000|Overall Study|drug not prepared in time|5|||
23402765|NCT01535287|65220000|FG001|Overall Study|drug not prepared in time|6|||
23402766|NCT03493958|65220002|FG000|Overall Study|Withdrawal by Subject|6|||
23402767|NCT03493958|65220002|FG000|Overall Study|Lost to Follow-up|7|||
23402768|NCT03493958|65220002|FG000|Overall Study|Did not complete all required study procedures|2|||
23402769|NCT01446874|65220003|FG000|Overall Study|Not eligible|1|||
23463842|NCT00369265|65440987|FG001|Overall Study|Study terminated|7|||
23463843|NCT01055197|65440990|FG000|Overall Study|Protocol Violation|7|||
23463844|NCT01055197|65440991|FG001|Overall Study|Protocol Violation|2|||
23585006|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
23463845|NCT01055197|65440990|FG000|Overall Study|Withdrawal by Subject|2|||
23463846|NCT01055197|65440991|FG001|Overall Study|Withdrawal by Subject|0|||
23463847|NCT03131219|65441000|FG000|Initial Evaluation Period|Adverse Event|2|||
23463848|NCT03131219|65441001|FG001|Initial Evaluation Period|Adverse Event|0|||
23463849|NCT03131219|65441000|FG000|Initial Evaluation Period|Protocol Violation|1|||
23463850|NCT03131219|65441001|FG001|Initial Evaluation Period|Protocol Violation|0|||
23463851|NCT03131219|65441000|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
23463852|NCT03131219|65441001|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
23463853|NCT03131219|65441000|FG000|Initial Evaluation Period|Physician Decision|1|||
23463854|NCT03131219|65441001|FG001|Initial Evaluation Period|Physician Decision|0|||
23463855|NCT03131219|65441000|FG000|Extension Period|Physician Decision|1|||
23463856|NCT03131219|65441001|FG001|Extension Period|Physician Decision|0|||
23463857|NCT00391586|65441007|FG000|Overall Study|Progressive disease|13|||
23463858|NCT00391586|65441007|FG000|Overall Study|Adverse Event|5|||
23463859|NCT00391586|65441007|FG000|Overall Study|Physician Decision|2|||
23463860|NCT00391586|65441007|FG000|Overall Study|Death|4|||
23463861|NCT02395081|65441008|FG000|Overall Study|Withdrawal by Subject|1|||
23463862|NCT02395081|65441009|FG001|Overall Study|Withdrawal by Subject|1|||
23463863|NCT02395081|65441010|FG002|Overall Study|Withdrawal by Subject|0|||
23463864|NCT02395081|65441008|FG000|Overall Study|Moved where blood couldn't be collected|4|||
23463865|NCT02395081|65441009|FG001|Overall Study|Moved where blood couldn't be collected|1|||
23463866|NCT02395081|65441010|FG002|Overall Study|Moved where blood couldn't be collected|3|||
23463867|NCT02395081|65441008|FG000|Overall Study|Fetal Loss|2|||
23463868|NCT02395081|65441009|FG001|Overall Study|Fetal Loss|3|||
23463869|NCT02395081|65441010|FG002|Overall Study|Fetal Loss|1|||
23463870|NCT03822117|65441011|FG000|Overall Study|Death|18|||
23463871|NCT03822117|65441012|FG001|Overall Study|Death|17|||
23463872|NCT03822117|65441013|FG002|Overall Study|Death|12|||
23463873|NCT03822117|65441014|FG003|Overall Study|Death|4|||
23463874|NCT03822117|65441011|FG000|Overall Study|Lost to Follow-up|1|||
23463875|NCT03822117|65441012|FG001|Overall Study|Lost to Follow-up|2|||
23463876|NCT03822117|65441013|FG002|Overall Study|Lost to Follow-up|3|||
23463877|NCT03822117|65441014|FG003|Overall Study|Lost to Follow-up|0|||
23463878|NCT03822117|65441011|FG000|Overall Study|Study Terminated by Sponsor|25|||
23790239|NCT01968031|66612759|FG000|Overall Study|Death|0|||
23790240|NCT01968031|66612760|FG001|Overall Study|Death|0|||
23790241|NCT01968031|66612761|FG002|Overall Study|Death|1|||
23790242|NCT01968031|66612759|FG000|Overall Study|Prohibited concomitant medication|1|||
23790243|NCT01968031|66612760|FG001|Overall Study|Prohibited concomitant medication|0|||
23790244|NCT01968031|66612761|FG002|Overall Study|Prohibited concomitant medication|0|||
23790245|NCT03428750|66612762|FG000|Overall Study|Withdrawal by Subject|11|||
23790246|NCT03428750|66612763|FG001|Overall Study|Withdrawal by Subject|10|||
23790247|NCT03428750|66612762|FG000|Overall Study|Lost to Follow-up|3|||
23790248|NCT03428750|66612763|FG001|Overall Study|Lost to Follow-up|9|||
23790249|NCT03428750|66612762|FG000|Overall Study|Adverse Event|9|||
23585007|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
23585008|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
23639878|NCT02187159|66067381|FG001|Overall Study|Lack of Efficacy|5|||
23463879|NCT03822117|65441012|FG001|Overall Study|Study Terminated by Sponsor|11|||
23639879|NCT02187159|66067382|FG002|Overall Study|Lack of Efficacy|4|||
23790250|NCT03428750|66612763|FG001|Overall Study|Adverse Event|1|||
23790251|NCT03428750|66612762|FG000|Overall Study|Protocol Violation|1|||
23790252|NCT03428750|66612763|FG001|Overall Study|Protocol Violation|0|||
23790253|NCT03428750|66612762|FG000|Overall Study|Administrative|0|||
23790254|NCT03428750|66612763|FG001|Overall Study|Administrative|1|||
23463880|NCT03822117|65441013|FG002|Overall Study|Study Terminated by Sponsor|6|||
23463881|NCT03822117|65441014|FG003|Overall Study|Study Terminated by Sponsor|0|||
23790255|NCT00450658|66612764|FG000|Overall Study|Adverse Event|24|||
23463882|NCT03822117|65441011|FG000|Overall Study|Withdrawal by Subject|4|||
23463883|NCT03822117|65441012|FG001|Overall Study|Withdrawal by Subject|0|||
23463884|NCT03822117|65441013|FG002|Overall Study|Withdrawal by Subject|3|||
23463885|NCT03822117|65441014|FG003|Overall Study|Withdrawal by Subject|0|||
23463886|NCT03822117|65441011|FG000|Overall Study|Disease Progression|1|||
23463887|NCT03822117|65441012|FG001|Overall Study|Disease Progression|2|||
23463888|NCT03822117|65441013|FG002|Overall Study|Disease Progression|1|||
23463889|NCT03822117|65441014|FG003|Overall Study|Disease Progression|0|||
23463890|NCT03822117|65441011|FG000|Overall Study|Never Returned to Hospital|0|||
23463891|NCT03822117|65441012|FG001|Overall Study|Never Returned to Hospital|0|||
23463892|NCT03822117|65441013|FG002|Overall Study|Never Returned to Hospital|1|||
23463893|NCT03822117|65441014|FG003|Overall Study|Never Returned to Hospital|0|||
23463894|NCT02668653|65441015|FG000|Overall Study|Refractory disease|41|||
23790256|NCT00450658|66612765|FG001|Overall Study|Adverse Event|15|||
23790257|NCT00450658|66612764|FG000|Overall Study|Withdrawal by Subject|43|||
23790258|NCT00450658|66612765|FG001|Overall Study|Withdrawal by Subject|26|||
23790259|NCT00450658|66612764|FG000|Overall Study|Lost to Follow-up|22|||
23790260|NCT00450658|66612765|FG001|Overall Study|Lost to Follow-up|5|||
23790261|NCT00450658|66612764|FG000|Overall Study|UGI ulcer|33|||
23790262|NCT00450658|66612765|FG001|Overall Study|UGI ulcer|34|||
23790263|NCT00450658|66612764|FG000|Overall Study|misc|21|||
23463895|NCT02668653|65441016|FG001|Overall Study|Refractory disease|70|||
23463896|NCT02668653|65441015|FG000|Overall Study|Relapse|44|||
23463897|NCT02668653|65441016|FG001|Overall Study|Relapse|65|||
23463898|NCT02668653|65441015|FG000|Overall Study|Adverse Event|58|||
23463899|NCT02668653|65441016|FG001|Overall Study|Adverse Event|23|||
23463900|NCT02668653|65441015|FG000|Overall Study|Subject decision to stop study drug|25|||
23463901|NCT02668653|65441016|FG001|Overall Study|Subject decision to stop study drug|23|||
23463902|NCT02668653|65441015|FG000|Overall Study|Other reasons not specified|16|||
23463903|NCT02668653|65441016|FG001|Overall Study|Other reasons not specified|11|||
23463904|NCT02668653|65441015|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
23463905|NCT02668653|65441016|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
23463906|NCT02668653|65441015|FG000|Overall Study|Investigator decision|10|||
23463907|NCT02668653|65441016|FG001|Overall Study|Investigator decision|7|||
23463908|NCT02668653|65441015|FG000|Overall Study|Failure to meet continuation criteria|5|||
23463909|NCT02668653|65441016|FG001|Overall Study|Failure to meet continuation criteria|12|||
23463910|NCT02668653|65441015|FG000|Overall Study|Lost to Follow-up|1|||
23463911|NCT02668653|65441016|FG001|Overall Study|Lost to Follow-up|0|||
23463912|NCT02668653|65441015|FG000|Overall Study|Pregnancy|0|||
23463913|NCT02668653|65441016|FG001|Overall Study|Pregnancy|1|||
23463914|NCT02668653|65441015|FG000|Overall Study|Death|0|||
23463915|NCT02668653|65441016|FG001|Overall Study|Death|1|||
23463916|NCT03863080|65441017|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463917|NCT03863080|65441018|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463918|NCT03863080|65441019|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
23463919|NCT03863080|65441020|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463920|NCT03863080|65441017|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463921|NCT03863080|65441018|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463922|NCT03863080|65441019|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463923|NCT03863080|65441020|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
23463924|NCT03863080|65441017|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463925|NCT03863080|65441018|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463926|NCT03863080|65441019|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463927|NCT03863080|65441020|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
23463928|NCT01868997|65441027|FG000|Overall Study|Adverse Event|2|||
23463929|NCT01868997|65441028|FG001|Overall Study|Adverse Event|5|||
23463930|NCT01868997|65441027|FG000|Overall Study|Lack of Efficacy|2|||
23790264|NCT00450658|66612765|FG001|Overall Study|misc|10|||
23790265|NCT01456949|66612766|FG000|Enrollment|PI death- incomplete data|6|||
23790266|NCT01456949|66612766|FG000|Enrollment|Death|1|||
23790267|NCT01456949|66612766|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
23463931|NCT01868997|65441028|FG001|Overall Study|Lack of Efficacy|0|||
23463932|NCT01868997|65441027|FG000|Overall Study|Other|3|||
23585009|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
23790268|NCT01456949|66612766|FG000|Enrollment|Physician Decision|10|||
23463933|NCT01868997|65441028|FG001|Overall Study|Other|1|||
23463934|NCT00106704|65441029|FG000|Overall Study|Adverse Event|10|||
23463935|NCT00106704|65441030|FG001|Overall Study|Adverse Event|7|||
23463936|NCT00106704|65441029|FG000|Overall Study|Death|2|||
23463937|NCT00106704|65441030|FG001|Overall Study|Death|1|||
23463938|NCT00106704|65441029|FG000|Overall Study|Lack of Efficacy|67|||
23463939|NCT00106704|65441030|FG001|Overall Study|Lack of Efficacy|69|||
23585010|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
23585011|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Death|2|||
23790269|NCT01456949|66612766|FG000|Enrollment|Withdrawal by Subject|7|||
23790270|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
23463940|NCT00106704|65441029|FG000|Overall Study|Lost to Follow-up|7|||
23463941|NCT00106704|65441030|FG001|Overall Study|Lost to Follow-up|3|||
23463942|NCT00106704|65441029|FG000|Overall Study|Pregnancy|1|||
23463943|NCT00106704|65441030|FG001|Overall Study|Pregnancy|0|||
23463944|NCT00106704|65441029|FG000|Overall Study|Protocol Violation|4|||
23463945|NCT00106704|65441030|FG001|Overall Study|Protocol Violation|7|||
23463946|NCT00106704|65441029|FG000|Overall Study|Withdrawal by Subject|14|||
23463947|NCT00106704|65441030|FG001|Overall Study|Withdrawal by Subject|21|||
23463948|NCT00106704|65441029|FG000|Overall Study|Patient moved|1|||
23463949|NCT00106704|65441030|FG001|Overall Study|Patient moved|0|||
23463950|NCT00106704|65441029|FG000|Overall Study|Site terminated|0|||
23463951|NCT00106704|65441030|FG001|Overall Study|Site terminated|1|||
23463952|NCT00106704|65441029|FG000|Overall Study|Planned major surgery|1|||
23463953|NCT00106704|65441030|FG001|Overall Study|Planned major surgery|0|||
23463954|NCT00106704|65441029|FG000|Overall Study|Patient Received Glycemic Medication|22|||
23463955|NCT00106704|65441030|FG001|Overall Study|Patient Received Glycemic Medication|41|||
23463956|NCT00106704|65441029|FG000|Overall Study|Unable to re-enter US|1|||
23463957|NCT00106704|65441030|FG001|Overall Study|Unable to re-enter US|0|||
23463958|NCT00106704|65441029|FG000|Overall Study|Laboratory test|1|||
23463959|NCT00106704|65441030|FG001|Overall Study|Laboratory test|1|||
23463960|NCT01120964|65441031|FG000|Overall Study|Did not receive full treatment|1|||
23463961|NCT01120964|65441032|FG001|Overall Study|Did not receive full treatment|0|||
23463962|NCT01987453|65441035|FG000|Overall Study|Death|0|||
23463963|NCT01987453|65441036|FG001|Overall Study|Death|0|||
23463964|NCT01987453|65441037|FG002|Overall Study|Death|1|||
23463965|NCT01987453|65441035|FG000|Overall Study|Lack of Efficacy|1|||
23463966|NCT01987453|65441036|FG001|Overall Study|Lack of Efficacy|12|||
23463967|NCT01987453|65441037|FG002|Overall Study|Lack of Efficacy|0|||
23463968|NCT00702221|65441038|FG000|Overall Study|Adverse Event|4|||
23463969|NCT00702221|65441039|FG001|Overall Study|Adverse Event|3|||
23463970|NCT01709084|65441046|FG000|Overall Study|Lost to Follow-up|4|||
23463971|NCT01709084|65441047|FG001|Overall Study|Lost to Follow-up|7|||
23463972|NCT01709084|65441046|FG000|Overall Study|Withdrawal by Subject|2|||
23463973|NCT01709084|65441047|FG001|Overall Study|Withdrawal by Subject|2|||
23463974|NCT01709084|65441046|FG000|Overall Study|Adverse Event|5|||
23463975|NCT01709084|65441047|FG001|Overall Study|Adverse Event|0|||
23463976|NCT01709084|65441046|FG000|Overall Study|Other|5|||
23463977|NCT01709084|65441047|FG001|Overall Study|Other|3|||
23463978|NCT01709084|65441046|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
23463979|NCT01709084|65441047|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
23463980|NCT01709084|65441046|FG000|Overall Study|Not Treated|0|||
23463981|NCT01709084|65441047|FG001|Overall Study|Not Treated|2|||
23463982|NCT02461134|65441048|FG000|Overall Study|Adverse Event|1|||
23463983|NCT02699749|65441050|FG000|Overall Study|Other|0|||
23463984|NCT02699749|65441051|FG001|Overall Study|Other|0|||
23463985|NCT02699749|65441052|FG002|Overall Study|Other|2|||
23463986|NCT02699749|65441053|FG003|Overall Study|Other|0|||
23463987|NCT02699749|65441054|FG004|Overall Study|Other|0|||
23463988|NCT02699749|65441055|FG005|Overall Study|Other|1|||
23463989|NCT02699749|65441056|FG006|Overall Study|Other|1|||
23463990|NCT02699749|65441057|FG007|Overall Study|Other|0|||
23463991|NCT02699749|65441058|FG008|Overall Study|Other|0|||
23463992|NCT02699749|65441059|FG009|Overall Study|Other|0|||
23463993|NCT02699749|65441060|FG010|Overall Study|Other|1|||
23463994|NCT02699749|65441061|FG011|Overall Study|Other|0|||
23463995|NCT02699749|65441062|FG012|Overall Study|Other|0|||
23463996|NCT02699749|65441063|FG013|Overall Study|Other|0|||
23463997|NCT02699749|65441050|FG000|Overall Study|Progressive Disease|3|||
23463998|NCT02699749|65441051|FG001|Overall Study|Progressive Disease|3|||
23463999|NCT02699749|65441052|FG002|Overall Study|Progressive Disease|14|||
23464000|NCT02699749|65441053|FG003|Overall Study|Progressive Disease|3|||
23464001|NCT02699749|65441054|FG004|Overall Study|Progressive Disease|3|||
23464002|NCT02699749|65441055|FG005|Overall Study|Progressive Disease|7|||
23639880|NCT02187159|66067383|FG003|Overall Study|Lack of Efficacy|7|||
23464003|NCT02699749|65441056|FG006|Overall Study|Progressive Disease|5|||
23464004|NCT02699749|65441057|FG007|Overall Study|Progressive Disease|5|||
23464005|NCT02699749|65441058|FG008|Overall Study|Progressive Disease|6|||
23464006|NCT02699749|65441059|FG009|Overall Study|Progressive Disease|6|||
23464007|NCT02699749|65441060|FG010|Overall Study|Progressive Disease|5|||
23464008|NCT02699749|65441061|FG011|Overall Study|Progressive Disease|4|||
23464009|NCT02699749|65441062|FG012|Overall Study|Progressive Disease|3|||
23464010|NCT02699749|65441063|FG013|Overall Study|Progressive Disease|5|||
23464011|NCT02699749|65441050|FG000|Overall Study|Death|0|||
23464012|NCT02699749|65441051|FG001|Overall Study|Death|0|||
23464013|NCT02699749|65441052|FG002|Overall Study|Death|0|||
23464014|NCT02699749|65441053|FG003|Overall Study|Death|0|||
23464015|NCT02699749|65441054|FG004|Overall Study|Death|0|||
23464016|NCT02699749|65441055|FG005|Overall Study|Death|0|||
23464017|NCT02699749|65441056|FG006|Overall Study|Death|0|||
23464018|NCT02699749|65441057|FG007|Overall Study|Death|0|||
23464019|NCT02699749|65441058|FG008|Overall Study|Death|0|||
23464020|NCT02699749|65441059|FG009|Overall Study|Death|0|||
23464021|NCT02699749|65441060|FG010|Overall Study|Death|0|||
23464022|NCT02699749|65441061|FG011|Overall Study|Death|0|||
23464023|NCT02699749|65441062|FG012|Overall Study|Death|0|||
23464024|NCT02699749|65441063|FG013|Overall Study|Death|1|||
23464025|NCT02699749|65441050|FG000|Overall Study|Lost to Follow-up|0|||
23464026|NCT02699749|65441051|FG001|Overall Study|Lost to Follow-up|0|||
23464027|NCT02699749|65441052|FG002|Overall Study|Lost to Follow-up|0|||
23464028|NCT02699749|65441053|FG003|Overall Study|Lost to Follow-up|0|||
23464029|NCT02699749|65441054|FG004|Overall Study|Lost to Follow-up|0|||
23464030|NCT02699749|65441055|FG005|Overall Study|Lost to Follow-up|1|||
23464031|NCT02699749|65441056|FG006|Overall Study|Lost to Follow-up|0|||
23464032|NCT02699749|65441057|FG007|Overall Study|Lost to Follow-up|1|||
23464033|NCT02699749|65441058|FG008|Overall Study|Lost to Follow-up|0|||
23464034|NCT02699749|65441059|FG009|Overall Study|Lost to Follow-up|0|||
23464035|NCT02699749|65441060|FG010|Overall Study|Lost to Follow-up|0|||
23464036|NCT02699749|65441061|FG011|Overall Study|Lost to Follow-up|0|||
23464037|NCT02699749|65441062|FG012|Overall Study|Lost to Follow-up|0|||
23464038|NCT02699749|65441063|FG013|Overall Study|Lost to Follow-up|0|||
23464039|NCT00976560|65441065|FG000|Overall Study|Adverse Event|5|||
23464040|NCT00976560|65441066|FG001|Overall Study|Adverse Event|5|||
23464041|NCT00976560|65441065|FG000|Overall Study|Lack of Efficacy|3|||
23464042|NCT00976560|65441066|FG001|Overall Study|Lack of Efficacy|5|||
23464043|NCT00976560|65441065|FG000|Overall Study|Protocol Violation|1|||
23464044|NCT00976560|65441066|FG001|Overall Study|Protocol Violation|0|||
23464045|NCT00976560|65441065|FG000|Overall Study|Lost to Follow-up|1|||
23464046|NCT00976560|65441066|FG001|Overall Study|Lost to Follow-up|0|||
23790271|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
23790272|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
23790273|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
23790274|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
23790275|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
23790276|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
23790277|NCT01456949|66612766|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
23790278|NCT01962298|66612767|FG000|Overall Study|Protocol Violation|1|||
23790279|NCT01962298|66612768|FG001|Overall Study|Protocol Violation|0|||
23790280|NCT01962298|66612769|FG002|Overall Study|Protocol Violation|1|||
23790281|NCT01962298|66612770|FG003|Overall Study|Protocol Violation|1|||
23790282|NCT01962298|66612771|FG004|Overall Study|Protocol Violation|0|||
23790283|NCT01962298|66612767|FG000|Overall Study|Data quality insufficient|2|||
23790284|NCT01962298|66612768|FG001|Overall Study|Data quality insufficient|0|||
23790285|NCT01962298|66612769|FG002|Overall Study|Data quality insufficient|3|||
23790286|NCT01962298|66612770|FG003|Overall Study|Data quality insufficient|1|||
23790287|NCT01962298|66612771|FG004|Overall Study|Data quality insufficient|4|||
23790288|NCT01962298|66612767|FG000|Overall Study|Insufficient data|0|||
23790289|NCT01962298|66612768|FG001|Overall Study|Insufficient data|2|||
23790290|NCT01962298|66612769|FG002|Overall Study|Insufficient data|1|||
23790291|NCT01962298|66612770|FG003|Overall Study|Insufficient data|0|||
23790292|NCT01962298|66612771|FG004|Overall Study|Insufficient data|1|||
23790293|NCT01962298|66612767|FG000|Overall Study|Incorrect data recorded|0|||
23790294|NCT01962298|66612768|FG001|Overall Study|Incorrect data recorded|1|||
23790295|NCT01962298|66612769|FG002|Overall Study|Incorrect data recorded|0|||
23790296|NCT01962298|66612770|FG003|Overall Study|Incorrect data recorded|0|||
23790297|NCT01962298|66612771|FG004|Overall Study|Incorrect data recorded|0|||
23790298|NCT01962298|66612767|FG000|Overall Study|Physician Decision|0|||
23790299|NCT01962298|66612768|FG001|Overall Study|Physician Decision|1|||
23790300|NCT01962298|66612769|FG002|Overall Study|Physician Decision|0|||
23790301|NCT01962298|66612770|FG003|Overall Study|Physician Decision|0|||
23790302|NCT01962298|66612771|FG004|Overall Study|Physician Decision|1|||
23790303|NCT01488448|66612774|FG000|Overall Study|Withdrawal by Subject|3|||
23790304|NCT01488448|66612775|FG001|Overall Study|Withdrawal by Subject|1|||
23790305|NCT01488448|66612774|FG000|Overall Study|Adverse Event|9|||
23790306|NCT01488448|66612775|FG001|Overall Study|Adverse Event|4|||
23790307|NCT01488448|66612774|FG000|Overall Study|Physician Decision|4|||
23790308|NCT01488448|66612775|FG001|Overall Study|Physician Decision|9|||
23790309|NCT01488448|66612774|FG000|Overall Study|Protocol Violation|4|||
23350269|NCT01273155|65025399|FG003|Overall Study|Change in liver function/no longer eval.|0|||
23464047|NCT00976560|65441065|FG000|Overall Study|Physician Decision|2|||
23464048|NCT00976560|65441066|FG001|Overall Study|Physician Decision|0|||
23464049|NCT00976560|65441065|FG000|Overall Study|Withdrawal by Subject|2|||
23464050|NCT00976560|65441066|FG001|Overall Study|Withdrawal by Subject|3|||
23464051|NCT03125395|65441067|FG000|Overall Study|Adverse Event|2|||
23790310|NCT01488448|66612775|FG001|Overall Study|Protocol Violation|3|||
23790311|NCT01717313|66612776|FG000|Phase A (Weeks 0 to 24)|Death|0|||
23790312|NCT01717313|66612777|FG001|Phase A (Weeks 0 to 24)|Death|1|||
23464052|NCT03125395|65441067|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23464053|NCT03125395|65441067|FG000|Overall Study|Physician Decision|2|||
23464054|NCT03125395|65441067|FG000|Overall Study|Commercial drug is available|5|||
23790313|NCT01717313|66612776|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
23790314|NCT01717313|66612777|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
23790315|NCT01717313|66612776|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
23790316|NCT01717313|66612777|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
23790317|NCT01717313|66612776|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
23790318|NCT01717313|66612777|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
23790319|NCT01717313|66612776|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
23790320|NCT01717313|66612777|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
23790321|NCT01717313|66612776|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
23790322|NCT01717313|66612777|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
23790323|NCT01717313|66612776|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
23790324|NCT01717313|66612777|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
23790325|NCT01717313|66612776|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
23790326|NCT01717313|66612777|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
23790327|NCT01717313|66612776|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
23790328|NCT01717313|66612777|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
23790329|NCT05776901|66612778|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
23790330|NCT03828539|66612783|FG000|Overall Study|Adverse Event|3|||
23790331|NCT03828539|66612784|FG001|Overall Study|Adverse Event|12|||
23790332|NCT03828539|66612783|FG000|Overall Study|Patient's/guardian's decision|3|||
23790333|NCT03828539|66612784|FG001|Overall Study|Patient's/guardian's decision|5|||
23790334|NCT03828539|66612783|FG000|Overall Study|Lost to Follow-up|4|||
23790335|NCT03828539|66612784|FG001|Overall Study|Lost to Follow-up|2|||
23790336|NCT03828539|66612783|FG000|Overall Study|Protocol Violation|3|||
23790337|NCT03828539|66612784|FG001|Overall Study|Protocol Violation|2|||
23790338|NCT03828539|66612783|FG000|Overall Study|Withdrawal of informed consent|2|||
23790339|NCT03828539|66612784|FG001|Overall Study|Withdrawal of informed consent|1|||
23350270|NCT01273155|65025400|FG004|Overall Study|Change in liver function/no longer eval.|1|||
23350271|NCT01273155|65025401|FG005|Overall Study|Change in liver function/no longer eval.|0|||
23350272|NCT01273155|65025402|FG006|Overall Study|Change in liver function/no longer eval.|0|||
23350273|NCT01273155|65025396|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
23350274|NCT01273155|65025397|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
23350275|NCT01273155|65025398|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
23350276|NCT01273155|65025399|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
23350277|NCT01273155|65025400|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
23350278|NCT01273155|65025401|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
23350279|NCT01273155|65025402|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
23350280|NCT01273155|65025396|FG000|Overall Study|Died during Cycle 1|0|||
23350281|NCT01273155|65025397|FG001|Overall Study|Died during Cycle 1|0|||
23350282|NCT01273155|65025398|FG002|Overall Study|Died during Cycle 1|1|||
23350283|NCT01273155|65025399|FG003|Overall Study|Died during Cycle 1|1|||
23350284|NCT01273155|65025400|FG004|Overall Study|Died during Cycle 1|0|||
23350285|NCT01273155|65025401|FG005|Overall Study|Died during Cycle 1|2|||
23350286|NCT01273155|65025402|FG006|Overall Study|Died during Cycle 1|2|||
23350287|NCT01273155|65025396|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
23350288|NCT01273155|65025397|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
23790340|NCT03828539|66612783|FG000|Overall Study|New therapy for study indication|1|||
23790341|NCT03828539|66612784|FG001|Overall Study|New therapy for study indication|0|||
23585012|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Death|2|||
23790342|NCT03498560|66612785|FG000|Overall Study|Found Ineligible|2|||
23790343|NCT03498560|66612785|FG000|Overall Study|Withdrawal by Subject|14|||
23790344|NCT03498560|66612785|FG000|Overall Study|Lost to Follow-up|4|||
23585013|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
23639881|NCT02187159|66067380|FG000|Overall Study|Adverse Event|28|||
23790345|NCT03498560|66612785|FG000|Overall Study|Death|1|||
23350289|NCT01273155|65025398|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
23350290|NCT01273155|65025399|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
23790346|NCT01896934|66612786|FG000|Overall Study|Adverse Event|1|||
23790347|NCT01896934|66612786|FG000|Overall Study|Withdrawal by Subject|1|||
23790348|NCT01151280|66612787|FG000|Overall Study|Adverse Event|1|||
23790349|NCT01151280|66612787|FG000|Overall Study|Lack of Efficacy|3|||
23790350|NCT00452348|66612790|FG000|Overall Study|Adverse Event|6|||
23790351|NCT00452348|66612791|FG001|Overall Study|Adverse Event|9|||
23790352|NCT00452348|66612790|FG000|Overall Study|Lack of Efficacy|10|||
23790353|NCT00452348|66612791|FG001|Overall Study|Lack of Efficacy|9|||
23790354|NCT00452348|66612790|FG000|Overall Study|Lost to Follow-up|14|||
23790355|NCT00452348|66612791|FG001|Overall Study|Lost to Follow-up|8|||
23790356|NCT00452348|66612790|FG000|Overall Study|Protocol Violation|22|||
23350291|NCT01273155|65025400|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
23350292|NCT01273155|65025401|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
23350293|NCT01273155|65025402|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
23350294|NCT00424021|65025405|FG000|NCT00046319 Study Period|Adverse Event|1|||
23464055|NCT02976038|65441068|FG000|Overall Study|Physician Decision|22|||
23464056|NCT02976038|65441068|FG000|Overall Study|Withdrawal by Subject|3|||
23464057|NCT02976038|65441068|FG000|Overall Study|Lost to Follow-up|2|||
23464058|NCT02976038|65441068|FG000|Overall Study|Adverse Event|1|||
23464059|NCT04085289|65441069|FG000|Overall Study|Withdrawal by Subject|0|||
23464060|NCT04085289|65441070|FG001|Overall Study|Withdrawal by Subject|0|||
23464061|NCT04085289|65441071|FG002|Overall Study|Withdrawal by Subject|1|||
23464062|NCT04411667|65441074|FG000|Overall Study|Physician Decision|1|||
23464063|NCT04411667|65441075|FG001|Overall Study|Physician Decision|0|||
23464064|NCT03304626|65441076|FG000|Overall Study|Adverse Event|1|||
23585014|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
23585015|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
23585016|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
23585017|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
23585018|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
23585019|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
23585020|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
23585021|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
23585022|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
23585023|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
23585024|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
23585025|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
23585026|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
23585027|NCT02750709|65869360|FG000|Treatment Period 1|Adverse Event|0|||
23585028|NCT02750709|65869361|FG001|Treatment Period 1|Adverse Event|0|||
23585029|NCT02750709|65869362|FG002|Treatment Period 1|Adverse Event|0|||
23585030|NCT02750709|65869363|FG003|Treatment Period 1|Adverse Event|0|||
23585031|NCT02750709|65869364|FG004|Treatment Period 1|Adverse Event|0|||
23585032|NCT02750709|65869365|FG005|Treatment Period 1|Adverse Event|1|||
23585033|NCT01710514|65869366|FG000|Overall Study|Adverse Event|6|||
23585034|NCT01710514|65869367|FG001|Overall Study|Adverse Event|7|||
23585035|NCT01710514|65869366|FG000|Overall Study|Withdrawal by Subject|1|||
23585036|NCT01710514|65869367|FG001|Overall Study|Withdrawal by Subject|0|||
23585037|NCT01362491|65869370|FG000|Overall Study|Ineligible|1|||
23585038|NCT01362491|65869371|FG001|Overall Study|Ineligible|0|||
23585039|NCT01362491|65869372|FG002|Overall Study|Ineligible|0|||
23585040|NCT01280591|65869376|FG000|Overall Study|Withdrawal by Subject|0|||
23585041|NCT01280591|65869377|FG001|Overall Study|Withdrawal by Subject|0|||
23585042|NCT01280591|65869378|FG002|Overall Study|Withdrawal by Subject|0|||
23350295|NCT00424021|65025406|FG001|NCT00046319 Study Period|Adverse Event|0|||
23350296|NCT00424021|65025407|FG002|NCT00046319 Study Period|Adverse Event|1|||
23585043|NCT01280591|65869379|FG003|Overall Study|Withdrawal by Subject|2|||
23585044|NCT01280591|65869376|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
23585045|NCT01280591|65869377|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
23790357|NCT00452348|66612791|FG001|Overall Study|Protocol Violation|28|||
23790358|NCT00452348|66612790|FG000|Overall Study|Withdrawal by Subject|18|||
23790359|NCT00452348|66612791|FG001|Overall Study|Withdrawal by Subject|21|||
23790360|NCT00452348|66612790|FG000|Overall Study|Other|9|||
23790361|NCT00452348|66612791|FG001|Overall Study|Other|9|||
23790362|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
23790363|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
23790364|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
23790365|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
23790366|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
23790367|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
23790368|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
23464065|NCT03304626|65441077|FG001|Overall Study|Adverse Event|0|||
23464066|NCT03304626|65441076|FG000|Overall Study|Lack of Efficacy|1|||
23790369|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
23464067|NCT03304626|65441077|FG001|Overall Study|Lack of Efficacy|1|||
23585046|NCT01280591|65869378|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
23585047|NCT01280591|65869379|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
23585048|NCT05512949|65869380|FG000|Overall Study|Lost to Follow-up|4|||
23790370|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
23790371|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
23790372|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
23790373|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
23790374|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
23790375|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
23350297|NCT00424021|65025408|FG003|NCT00046319 Study Period|Adverse Event|1|||
23350298|NCT00424021|65025405|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350299|NCT00424021|65025406|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
23350300|NCT00424021|65025407|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350301|NCT00424021|65025408|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350302|NCT00424021|65025405|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
23350303|NCT00424021|65025406|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
23350304|NCT00424021|65025407|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
23350305|NCT00424021|65025408|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
23350306|NCT00424021|65025405|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
23350307|NCT00424021|65025406|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
23350308|NCT00424021|65025407|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
23350309|NCT00424021|65025408|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
23350310|NCT00424021|65025405|FG000|AMB-220-E Study Period|Adverse Event|1|||
23464068|NCT03337477|65441078|FG000|Overall Study|not categorized into the listed ones|11|||
23464069|NCT03337477|65441079|FG001|Overall Study|not categorized into the listed ones|9|||
23464070|NCT03337477|65441078|FG000|Overall Study|Withdrawal by Subject|0|||
23464071|NCT03337477|65441079|FG001|Overall Study|Withdrawal by Subject|1|||
23464072|NCT03337477|65441078|FG000|Overall Study|Death|0|||
23464073|NCT03337477|65441079|FG001|Overall Study|Death|1|||
23585049|NCT05512949|65869381|FG001|Overall Study|Lost to Follow-up|6|||
23585050|NCT05512949|65869382|FG002|Overall Study|Lost to Follow-up|2|||
23790376|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
23790377|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23790378|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
23790379|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23790380|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
23790381|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
23790382|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
23790383|NCT02227238|66612792|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
23790384|NCT02227238|66612793|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
23790385|NCT02227238|66612794|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
23790386|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
23790387|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
23790388|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
23790389|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
23790390|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
23790391|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
23790392|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
23790393|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
23790394|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
23790395|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
23790396|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
23790397|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
23790398|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
23790399|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
23790400|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
23790401|NCT02227238|66612792|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
23790402|NCT02227238|66612793|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
23790403|NCT02227238|66612794|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
23790404|NCT01426854|66612795|FG000|Overall Study|Adverse Event|1|||
23350311|NCT00424021|65025406|FG001|AMB-220-E Study Period|Adverse Event|1|||
23585051|NCT05512949|65869380|FG000|Overall Study|Protocol Violation|0|||
23350312|NCT00424021|65025407|FG002|AMB-220-E Study Period|Adverse Event|3|||
23350313|NCT00424021|65025408|FG003|AMB-220-E Study Period|Adverse Event|7|||
23350314|NCT00424021|65025405|FG000|AMB-220-E Study Period|Death|0|||
23350315|NCT00424021|65025406|FG001|AMB-220-E Study Period|Death|0|||
23350316|NCT00424021|65025407|FG002|AMB-220-E Study Period|Death|1|||
23350317|NCT00424021|65025408|FG003|AMB-220-E Study Period|Death|1|||
23350318|NCT00424021|65025405|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
23350319|NCT00424021|65025406|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
23350320|NCT00424021|65025407|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
23350321|NCT00424021|65025408|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
23350322|NCT00424021|65025405|FG000|AMB-220-E Study Period|Physician Decision|0|||
23350323|NCT00424021|65025406|FG001|AMB-220-E Study Period|Physician Decision|0|||
23350324|NCT00424021|65025407|FG002|AMB-220-E Study Period|Physician Decision|0|||
23350325|NCT00424021|65025408|FG003|AMB-220-E Study Period|Physician Decision|1|||
23350326|NCT01237327|65025409|FG000|Overall Study|Protocol Violation: Core Study|1|||
23350327|NCT01237327|65025410|FG001|Overall Study|Protocol Violation: Core Study|0|||
23350328|NCT01237327|65025409|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
23350329|NCT01237327|65025410|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
23350330|NCT01237327|65025409|FG000|Overall Study|Progression of Disease: Core Study|18|||
23350331|NCT01237327|65025410|FG001|Overall Study|Progression of Disease: Core Study|22|||
23350332|NCT01237327|65025409|FG000|Overall Study|Progression of Disease: Extension Study|15|||
23350333|NCT01237327|65025410|FG001|Overall Study|Progression of Disease: Extension Study|13|||
23350334|NCT01237327|65025409|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
23350335|NCT01237327|65025410|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
23350336|NCT01237327|65025409|FG000|Overall Study|Withdrawal by Subject|1|||
23350337|NCT01237327|65025410|FG001|Overall Study|Withdrawal by Subject|3|||
23350338|NCT01237327|65025409|FG000|Overall Study|Lost to Follow-up|3|||
23350339|NCT01237327|65025410|FG001|Overall Study|Lost to Follow-up|0|||
23350340|NCT00630747|65025414|FG000|Overall Study|Death|1|||
23350341|NCT00630747|65025414|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
23350342|NCT00630747|65025414|FG000|Overall Study|Returned to country of origin|1|||
23464074|NCT03337477|65441078|FG000|Overall Study|Lost to Follow-up|0|||
23464075|NCT03337477|65441079|FG001|Overall Study|Lost to Follow-up|2|||
23464076|NCT02266888|65441084|FG000|Overall Study|Death|2|||
23464077|NCT02266888|65441085|FG001|Overall Study|Death|2|||
23464078|NCT02266888|65441086|FG002|Overall Study|Death|4|||
23464079|NCT02266888|65441087|FG003|Overall Study|Death|2|||
23464080|NCT02266888|65441084|FG000|Overall Study|Physician Decision|0|||
23464081|NCT02266888|65441085|FG001|Overall Study|Physician Decision|1|||
23464082|NCT02266888|65441086|FG002|Overall Study|Physician Decision|2|||
23464083|NCT02266888|65441087|FG003|Overall Study|Physician Decision|2|||
23464084|NCT02266888|65441084|FG000|Overall Study|Study Terminated|5|||
23639882|NCT02187159|66067381|FG001|Overall Study|Adverse Event|33|||
23790405|NCT01426854|66612796|FG001|Overall Study|Adverse Event|5|||
23790406|NCT01426854|66612795|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
23790407|NCT01426854|66612796|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
23790408|NCT01426854|66612795|FG000|Overall Study|Lost to Follow-up|3|||
23790409|NCT01426854|66612796|FG001|Overall Study|Lost to Follow-up|0|||
23790410|NCT01426854|66612795|FG000|Overall Study|Noncompliance|0|||
23790411|NCT01426854|66612796|FG001|Overall Study|Noncompliance|1|||
23790412|NCT01426854|66612795|FG000|Overall Study|Treatment Failure|0|||
23790413|NCT01426854|66612796|FG001|Overall Study|Treatment Failure|16|||
23790414|NCT01426854|66612795|FG000|Overall Study|Protocol Deviation|0|||
23790415|NCT01426854|66612796|FG001|Overall Study|Protocol Deviation|1|||
23790416|NCT01426854|66612795|FG000|Overall Study|Other|3|||
23464085|NCT02266888|65441085|FG001|Overall Study|Study Terminated|1|||
23464086|NCT02266888|65441086|FG002|Overall Study|Study Terminated|0|||
23464087|NCT02266888|65441087|FG003|Overall Study|Study Terminated|0|||
23464088|NCT02266888|65441084|FG000|Overall Study|No Longer Eligible|0|||
23464089|NCT02266888|65441085|FG001|Overall Study|No Longer Eligible|0|||
23464090|NCT02266888|65441086|FG002|Overall Study|No Longer Eligible|0|||
23464091|NCT02266888|65441087|FG003|Overall Study|No Longer Eligible|2|||
23464092|NCT02266888|65441084|FG000|Overall Study|Randomization Closed|0|||
23464093|NCT02266888|65441085|FG001|Overall Study|Randomization Closed|0|||
23464094|NCT02266888|65441086|FG002|Overall Study|Randomization Closed|4|||
23464095|NCT02266888|65441087|FG003|Overall Study|Randomization Closed|0|||
23639883|NCT02187159|66067382|FG002|Overall Study|Adverse Event|42|||
23790417|NCT01426854|66612796|FG001|Overall Study|Other|2|||
23790418|NCT01891357|66612799|FG000|Overall Study|Protocol Violation|3|||
23350343|NCT00078949|65025415|FG000|Overall Study|No treated|4|||
23350344|NCT00078949|65025416|FG001|Overall Study|No treated|5|||
23350345|NCT00078949|65025417|FG002|Overall Study|No treated|3|||
23350346|NCT00078949|65025418|FG003|Overall Study|No treated|3|||
23350347|NCT04526574|65025421|FG000|Overall Study|Protocol Violation|3|||
23464096|NCT02266888|65441084|FG000|Overall Study|Personnel unavailable at transplant|0|||
23790419|NCT02933060|66612800|FG000|Overall Study|Withdrawal by Subject|0|||
23790420|NCT02933060|66612801|FG001|Overall Study|Withdrawal by Subject|1|||
23585052|NCT05512949|65869381|FG001|Overall Study|Protocol Violation|0|||
23350348|NCT04526574|65025422|FG001|Overall Study|Protocol Violation|1|||
23790421|NCT01155531|66612802|FG000|Overall Study|Adverse Event|0|||
23790422|NCT01155531|66612803|FG001|Overall Study|Adverse Event|0|||
23350349|NCT04526574|65025421|FG000|Overall Study|Withdrawal by Subject|12|||
23350350|NCT04526574|65025422|FG001|Overall Study|Withdrawal by Subject|9|||
23350351|NCT04526574|65025421|FG000|Overall Study|Other|1|||
23350352|NCT04526574|65025422|FG001|Overall Study|Other|2|||
23350353|NCT04526574|65025421|FG000|Overall Study|Adverse Event|1|||
23350354|NCT04526574|65025422|FG001|Overall Study|Adverse Event|1|||
23350355|NCT04526574|65025421|FG000|Overall Study|Death|2|||
23350356|NCT04526574|65025422|FG001|Overall Study|Death|3|||
23350357|NCT04526574|65025421|FG000|Overall Study|Lost to Follow-up|9|||
23350358|NCT04526574|65025422|FG001|Overall Study|Lost to Follow-up|9|||
23350359|NCT04526574|65025421|FG000|Overall Study|No longer meets eligibility criteria|8|||
23350360|NCT04526574|65025422|FG001|Overall Study|No longer meets eligibility criteria|8|||
23350361|NCT00290693|65025423|FG000|Overall Study|Withdrawal by Subject|2|||
23350362|NCT00986986|65025424|FG000|Overall Study|Lost to Follow-up|0|||
23350363|NCT00986986|65025425|FG001|Overall Study|Lost to Follow-up|1|||
23350364|NCT00821015|65025432|FG000|Overall Study|Lost to Follow-up|12|||
23350365|NCT01043705|65025433|FG000|Overall Study|Death|28|||
23350366|NCT01043705|65025434|FG001|Overall Study|Death|60|||
23350367|NCT01043705|65025435|FG002|Overall Study|Death|26|||
23350368|NCT01043705|65025433|FG000|Overall Study|Lost to Follow-up|27|||
23350369|NCT01043705|65025434|FG001|Overall Study|Lost to Follow-up|12|||
23350370|NCT01043705|65025435|FG002|Overall Study|Lost to Follow-up|0|||
23350371|NCT01043705|65025433|FG000|Overall Study|Multiple Reasons|4|||
23350372|NCT01043705|65025434|FG001|Overall Study|Multiple Reasons|7|||
23350373|NCT01043705|65025435|FG002|Overall Study|Multiple Reasons|0|||
23464097|NCT02266888|65441085|FG001|Overall Study|Personnel unavailable at transplant|0|||
23350374|NCT01043705|65025433|FG000|Overall Study|Protocol Violation|2|||
23464098|NCT02266888|65441086|FG002|Overall Study|Personnel unavailable at transplant|0|||
23350375|NCT01043705|65025434|FG001|Overall Study|Protocol Violation|1|||
23350376|NCT01043705|65025435|FG002|Overall Study|Protocol Violation|0|||
23350377|NCT01043705|65025433|FG000|Overall Study|Withdrawal by Subject|8|||
23350378|NCT01043705|65025434|FG001|Overall Study|Withdrawal by Subject|6|||
23464099|NCT02266888|65441087|FG003|Overall Study|Personnel unavailable at transplant|1|||
23790423|NCT01155531|66612804|FG002|Overall Study|Adverse Event|1|||
23790424|NCT01155531|66612805|FG003|Overall Study|Adverse Event|0|||
23790425|NCT01155531|66612802|FG000|Overall Study|Lost to Follow-up|0|||
23790426|NCT01155531|66612803|FG001|Overall Study|Lost to Follow-up|0|||
23790427|NCT01155531|66612804|FG002|Overall Study|Lost to Follow-up|0|||
23790428|NCT01155531|66612805|FG003|Overall Study|Lost to Follow-up|1|||
23790429|NCT01155531|66612802|FG000|Overall Study|Withdrawal by Subject|1|||
23790430|NCT01155531|66612803|FG001|Overall Study|Withdrawal by Subject|0|||
23790431|NCT01155531|66612804|FG002|Overall Study|Withdrawal by Subject|1|||
23350379|NCT01043705|65025435|FG002|Overall Study|Withdrawal by Subject|0|||
23350380|NCT01043705|65025433|FG000|Overall Study|Site Closure|8|||
23464100|NCT02266888|65441084|FG000|Overall Study|Transfer of care|0|||
23790432|NCT01155531|66612805|FG003|Overall Study|Withdrawal by Subject|0|||
23790433|NCT03500094|66612806|FG000|Overall Study|Withdrawal by Subject|1|||
23790434|NCT03500094|66612806|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
23790435|NCT03500094|66612806|FG000|Overall Study|Lost to Follow-up|1|||
23350381|NCT01043705|65025434|FG001|Overall Study|Site Closure|0|||
23350382|NCT01043705|65025435|FG002|Overall Study|Site Closure|0|||
23350383|NCT01043705|65025433|FG000|Overall Study|Subsequent Procedure|9|||
23350384|NCT01043705|65025434|FG001|Overall Study|Subsequent Procedure|24|||
23350385|NCT01043705|65025435|FG002|Overall Study|Subsequent Procedure|29|||
23350386|NCT01043705|65025433|FG000|Overall Study|Adverse Event|0|||
23350387|NCT01043705|65025434|FG001|Overall Study|Adverse Event|2|||
23350388|NCT01043705|65025435|FG002|Overall Study|Adverse Event|0|||
23350389|NCT01043705|65025433|FG000|Overall Study|Screen Fail|21|||
23350390|NCT01043705|65025434|FG001|Overall Study|Screen Fail|0|||
23350391|NCT01043705|65025435|FG002|Overall Study|Screen Fail|0|||
23350392|NCT01043705|65025433|FG000|Overall Study|Other|0|||
23790436|NCT00021541|66612807|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
23790437|NCT00021541|66612808|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
23790438|NCT00021541|66612807|FG000|Period 1-First Treatment|Adverse Event|2|||
23790439|NCT00021541|66612808|FG001|Period 1-First Treatment|Adverse Event|1|||
23790440|NCT00021541|66612807|FG000|Period 1-First Treatment|non-adherence|3|||
23464101|NCT02266888|65441085|FG001|Overall Study|Transfer of care|0|||
23464102|NCT02266888|65441086|FG002|Overall Study|Transfer of care|1|||
23464103|NCT02266888|65441087|FG003|Overall Study|Transfer of care|0|||
23464104|NCT01147874|65441088|FG000|Overall Study|Adverse Event|5|||
23464105|NCT01147874|65441088|FG000|Overall Study|Investigator's Request|1|||
23464106|NCT01147874|65441088|FG000|Overall Study|Lost to Follow-up|25|||
23464107|NCT01147874|65441088|FG000|Overall Study|Other|5|||
23464108|NCT01147874|65441088|FG000|Overall Study|Protocol Violation|5|||
23464109|NCT01147874|65441088|FG000|Overall Study|Sponsor's Decision|2|||
23464110|NCT01147874|65441088|FG000|Overall Study|Withdrawal by Subject|24|||
23464111|NCT01708902|65441089|FG000|Overall Study|Adverse Event|3|||
23464112|NCT01708902|65441090|FG001|Overall Study|Adverse Event|4|||
23464113|NCT01708902|65441091|FG002|Overall Study|Adverse Event|9|||
23464114|NCT01708902|65441092|FG003|Overall Study|Adverse Event|2|||
23464115|NCT01708902|65441093|FG004|Overall Study|Adverse Event|7|||
23464116|NCT01708902|65441094|FG005|Overall Study|Adverse Event|3|||
23464117|NCT01708902|65441095|FG006|Overall Study|Adverse Event|5|||
23464118|NCT01708902|65441089|FG000|Overall Study|Lack of Efficacy|3|||
23464119|NCT01708902|65441090|FG001|Overall Study|Lack of Efficacy|1|||
23464120|NCT01708902|65441091|FG002|Overall Study|Lack of Efficacy|0|||
23464121|NCT01708902|65441092|FG003|Overall Study|Lack of Efficacy|0|||
23464122|NCT01708902|65441093|FG004|Overall Study|Lack of Efficacy|0|||
23464123|NCT01708902|65441094|FG005|Overall Study|Lack of Efficacy|1|||
23464124|NCT01708902|65441095|FG006|Overall Study|Lack of Efficacy|0|||
23790441|NCT00021541|66612808|FG001|Period 1-First Treatment|non-adherence|0|||
23790442|NCT00021541|66612807|FG000|Period 1-First Treatment|Death|1|||
23790443|NCT00021541|66612808|FG001|Period 1-First Treatment|Death|0|||
23790444|NCT00021541|66612807|FG000|Period 1-First Treatment|Pts that did not progress|2|||
23790445|NCT00021541|66612808|FG001|Period 1-First Treatment|Pts that did not progress|2|||
23790446|NCT00021541|66612807|FG000|Period 1-First Treatment|Ineligible|0|||
23464125|NCT01708902|65441089|FG000|Overall Study|Non compliance with protocol|0|||
23790447|NCT00021541|66612808|FG001|Period 1-First Treatment|Ineligible|2|||
23464126|NCT01708902|65441090|FG001|Overall Study|Non compliance with protocol|2|||
23464127|NCT01708902|65441091|FG002|Overall Study|Non compliance with protocol|1|||
23464128|NCT01708902|65441092|FG003|Overall Study|Non compliance with protocol|3|||
23790448|NCT00021541|66612807|FG000|Period 2-crossover|refused phase B|2|||
23790449|NCT00021541|66612808|FG001|Period 2-crossover|refused phase B|2|||
23790450|NCT00021541|66612807|FG000|Period 2-crossover|Withdrawal by Subject|3|||
23790451|NCT00021541|66612808|FG001|Period 2-crossover|Withdrawal by Subject|4|||
23790452|NCT00021541|66612807|FG000|Period 2-crossover|Adverse Event|2|||
23790453|NCT00021541|66612808|FG001|Period 2-crossover|Adverse Event|2|||
23790454|NCT00021541|66612807|FG000|Period 2-crossover|non-adherence|1|||
23790455|NCT00021541|66612808|FG001|Period 2-crossover|non-adherence|0|||
23790456|NCT00021541|66612807|FG000|Period 2-crossover|Pts that did not progress|2|||
23790457|NCT00021541|66612808|FG001|Period 2-crossover|Pts that did not progress|3|||
23790458|NCT02670551|66612809|FG000|Overall Study|Adverse Event|4|||
23790459|NCT02670551|66612810|FG001|Overall Study|Adverse Event|7|||
23790460|NCT02670551|66612811|FG002|Overall Study|Adverse Event|9|||
23464129|NCT01708902|65441093|FG004|Overall Study|Non compliance with protocol|0|||
23464130|NCT01708902|65441094|FG005|Overall Study|Non compliance with protocol|0|||
23464131|NCT01708902|65441095|FG006|Overall Study|Non compliance with protocol|0|||
23464132|NCT01708902|65441089|FG000|Overall Study|Lost to Follow-up|2|||
23790461|NCT02670551|66612809|FG000|Overall Study|Lack of Efficacy|2|||
23464133|NCT01708902|65441090|FG001|Overall Study|Lost to Follow-up|1|||
23464134|NCT01708902|65441091|FG002|Overall Study|Lost to Follow-up|2|||
23464135|NCT01708902|65441092|FG003|Overall Study|Lost to Follow-up|2|||
23790462|NCT02670551|66612810|FG001|Overall Study|Lack of Efficacy|0|||
23790463|NCT02670551|66612811|FG002|Overall Study|Lack of Efficacy|3|||
23790464|NCT02670551|66612809|FG000|Overall Study|Withdrawal of Consent|6|||
23790465|NCT02670551|66612810|FG001|Overall Study|Withdrawal of Consent|3|||
23790466|NCT02670551|66612811|FG002|Overall Study|Withdrawal of Consent|8|||
23790467|NCT02670551|66612809|FG000|Overall Study|Lost to Follow-up|5|||
23350393|NCT01043705|65025434|FG001|Overall Study|Other|19|||
23350394|NCT01043705|65025435|FG002|Overall Study|Other|25|||
23350395|NCT01785849|65025438|FG000|Overall Study|Death|7|||
23350396|NCT01785849|65025439|FG001|Overall Study|Death|9|||
23350397|NCT01785849|65025438|FG000|Overall Study|Protocol Specified Criteria|29|||
23350398|NCT01785849|65025439|FG001|Overall Study|Protocol Specified Criteria|1|||
23350399|NCT01785849|65025438|FG000|Overall Study|Withdrawal by Subject|15|||
23350400|NCT01785849|65025439|FG001|Overall Study|Withdrawal by Subject|12|||
23350401|NCT01785849|65025438|FG000|Overall Study|Sponsor Decision|0|||
23350402|NCT01785849|65025439|FG001|Overall Study|Sponsor Decision|1|||
23350403|NCT01785849|65025438|FG000|Overall Study|Lost to Follow-up|10|||
23350404|NCT01785849|65025439|FG001|Overall Study|Lost to Follow-up|11|||
23350405|NCT01826370|65025442|FG000|Overall Study|Protocol Violation|6|||
23350406|NCT01826370|65025442|FG000|Overall Study|Lost to Follow-up|12|||
23350407|NCT01826370|65025442|FG000|Overall Study|Other reason not defined above|2|||
23350408|NCT00525902|65025443|FG000|Overall Study|Lack of Efficacy|1|||
23350409|NCT00552032|65025447|FG000|Overall Study|Withdrawal by Subject|2|||
23350410|NCT00552032|65025448|FG001|Overall Study|Withdrawal by Subject|2|||
23350411|NCT00552032|65025447|FG000|Overall Study|Protocol Violation|7|||
23350412|NCT00552032|65025448|FG001|Overall Study|Protocol Violation|12|||
23350413|NCT00552032|65025447|FG000|Overall Study|Lost to Follow-up|8|||
23350414|NCT00552032|65025448|FG001|Overall Study|Lost to Follow-up|5|||
23350415|NCT00948506|65025452|FG000|Overall Study|Withdrawal by Subject|3|||
23350416|NCT00948506|65025453|FG001|Overall Study|Withdrawal by Subject|1|||
23350417|NCT00979420|65025454|FG000|Overall Study|Adverse Event|1|||
23350418|NCT00979420|65025455|FG001|Overall Study|Adverse Event|0|||
23350419|NCT00979420|65025456|FG002|Overall Study|Adverse Event|0|||
23350420|NCT00979420|65025457|FG003|Overall Study|Adverse Event|0|||
23350421|NCT00979420|65025454|FG000|Overall Study|Lack of Efficacy|3|||
23350422|NCT00979420|65025455|FG001|Overall Study|Lack of Efficacy|0|||
23350423|NCT00979420|65025456|FG002|Overall Study|Lack of Efficacy|1|||
23350424|NCT00979420|65025457|FG003|Overall Study|Lack of Efficacy|1|||
23350425|NCT00979420|65025454|FG000|Overall Study|Other reasons not related to Viramune|3|||
23350426|NCT00979420|65025455|FG001|Overall Study|Other reasons not related to Viramune|0|||
23350427|NCT00979420|65025456|FG002|Overall Study|Other reasons not related to Viramune|0|||
23350428|NCT00979420|65025457|FG003|Overall Study|Other reasons not related to Viramune|1|||
23350429|NCT00085098|65025464|FG000|Overall Study|Withdrawal by Subject|0|||
23350430|NCT00085098|65025465|FG001|Overall Study|Withdrawal by Subject|1|||
23350431|NCT00085098|65025464|FG000|Overall Study|Ineligible|1|||
23350432|NCT00085098|65025465|FG001|Overall Study|Ineligible|1|||
23350433|NCT01764659|65025466|FG000|Overall Study|Death|1|||
23350434|NCT01764659|65025466|FG000|Overall Study|Physician Decision|1|||
23350435|NCT02273908|65025476|FG000|Overall Study|Adverse Event|16|||
23350436|NCT02273908|65025477|FG001|Overall Study|Adverse Event|0|||
23350437|NCT02273908|65025476|FG000|Overall Study|Lost to Follow-up|10|||
23350438|NCT02273908|65025477|FG001|Overall Study|Lost to Follow-up|1|||
23350439|NCT02273908|65025476|FG000|Overall Study|Did not meet entrance criteria|3|||
23350440|NCT02273908|65025477|FG001|Overall Study|Did not meet entrance criteria|2|||
23350441|NCT02273908|65025476|FG000|Overall Study|Withdrawal by Subject|4|||
23350442|NCT02273908|65025477|FG001|Overall Study|Withdrawal by Subject|2|||
23350443|NCT01643798|65025478|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
23350444|NCT01643798|65025479|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
23350445|NCT04811664|65025481|FG000|Overall Study|Lost to Follow-up|78|||
23350446|NCT04811664|65025482|FG001|Overall Study|Lost to Follow-up|125|||
23350447|NCT04811664|65025483|FG002|Overall Study|Lost to Follow-up|46|||
23350448|NCT04811664|65025481|FG000|Overall Study|Withdrawal by Subject|39|||
23350449|NCT04811664|65025482|FG001|Overall Study|Withdrawal by Subject|76|||
23350450|NCT04811664|65025483|FG002|Overall Study|Withdrawal by Subject|12|||
23350451|NCT04811664|65025481|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
23790468|NCT02670551|66612810|FG001|Overall Study|Lost to Follow-up|7|||
23790469|NCT02670551|66612811|FG002|Overall Study|Lost to Follow-up|6|||
23790470|NCT02670551|66612809|FG000|Overall Study|Protocol Violation|1|||
23350452|NCT04811664|65025482|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
23350453|NCT04811664|65025483|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
23350454|NCT04811664|65025481|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
23350455|NCT04811664|65025482|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
23350456|NCT04811664|65025483|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
23350457|NCT04811664|65025481|FG000|Overall Study|Protocol Violation|0|||
23350458|NCT04811664|65025482|FG001|Overall Study|Protocol Violation|5|||
23350459|NCT04811664|65025483|FG002|Overall Study|Protocol Violation|11|||
23350460|NCT04811664|65025481|FG000|Overall Study|Study Terminated by Sponsor|4|||
23350461|NCT04811664|65025482|FG001|Overall Study|Study Terminated by Sponsor|3|||
23790471|NCT02670551|66612810|FG001|Overall Study|Protocol Violation|0|||
23790472|NCT02670551|66612811|FG002|Overall Study|Protocol Violation|0|||
23790473|NCT02670551|66612809|FG000|Overall Study|Noncompliance with study drug|3|||
23790474|NCT02670551|66612810|FG001|Overall Study|Noncompliance with study drug|3|||
23790475|NCT02670551|66612811|FG002|Overall Study|Noncompliance with study drug|2|||
23790476|NCT02670551|66612809|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23790477|NCT02670551|66612810|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23790478|NCT02670551|66612811|FG002|Overall Study|Other Miscellaneous Reasons|3|||
23790479|NCT02670551|66612809|FG000|Overall Study|Did Not Receive Treatment|5|||
23790480|NCT02670551|66612810|FG001|Overall Study|Did Not Receive Treatment|3|||
23790481|NCT02670551|66612811|FG002|Overall Study|Did Not Receive Treatment|0|||
23790482|NCT01277510|66612812|FG000|Double-blind Phase|Non-compliance|0|||
23790483|NCT01277510|66612813|FG001|Double-blind Phase|Non-compliance|1|||
23790484|NCT01277510|66612812|FG000|Double-blind Phase|Adverse Event|1|||
23790485|NCT01277510|66612813|FG001|Double-blind Phase|Adverse Event|0|||
23790486|NCT01277510|66612812|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23790487|NCT01277510|66612813|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23790488|NCT01277510|66612812|FG000|Double-blind Phase|Administrative decision|7|||
23790489|NCT01277510|66612813|FG001|Double-blind Phase|Administrative decision|9|||
23790490|NCT01277510|66612812|FG000|Double-blind Phase|Death|0|||
23790491|NCT01277510|66612813|FG001|Double-blind Phase|Death|1|||
23350462|NCT04811664|65025483|FG002|Overall Study|Study Terminated by Sponsor|34|||
23350463|NCT04811664|65025481|FG000|Overall Study|Early Study Closure|3|||
23350464|NCT04811664|65025482|FG001|Overall Study|Early Study Closure|7|||
23350465|NCT04811664|65025483|FG002|Overall Study|Early Study Closure|79|||
23350466|NCT04811664|65025481|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
23350467|NCT04811664|65025482|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
23350468|NCT04811664|65025483|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
23350469|NCT05007041|65025486|FG000|Overall Study|Missing Diary Entries|0|||
23350470|NCT05007041|65025487|FG001|Overall Study|Missing Diary Entries|1|||
23350471|NCT03436199|65025488|FG000|Overall Study|Adverse Event|15|||
23350472|NCT03436199|65025489|FG001|Overall Study|Adverse Event|40|||
23350473|NCT03436199|65025490|FG002|Overall Study|Adverse Event|7|||
23350474|NCT03436199|65025488|FG000|Overall Study|Withdrawal by Subject|4|||
23350475|NCT03436199|65025489|FG001|Overall Study|Withdrawal by Subject|10|||
23350476|NCT03436199|65025490|FG002|Overall Study|Withdrawal by Subject|3|||
23350477|NCT03436199|65025488|FG000|Overall Study|Lost to Follow-up|1|||
23350478|NCT03436199|65025489|FG001|Overall Study|Lost to Follow-up|0|||
23350479|NCT03436199|65025490|FG002|Overall Study|Lost to Follow-up|2|||
23350480|NCT03436199|65025488|FG000|Overall Study|Protocol Violation|1|||
23350481|NCT03436199|65025489|FG001|Overall Study|Protocol Violation|1|||
23350482|NCT03436199|65025490|FG002|Overall Study|Protocol Violation|0|||
23350483|NCT03436199|65025488|FG000|Overall Study|Physician Decision|0|||
23350484|NCT03436199|65025489|FG001|Overall Study|Physician Decision|1|||
23350485|NCT03436199|65025490|FG002|Overall Study|Physician Decision|0|||
23350486|NCT03436199|65025488|FG000|Overall Study|Could not return to clinic|1|||
23350487|NCT03436199|65025489|FG001|Overall Study|Could not return to clinic|0|||
23350488|NCT03436199|65025490|FG002|Overall Study|Could not return to clinic|0|||
23350489|NCT03436199|65025488|FG000|Overall Study|Withdrawn per physician|0|||
23350490|NCT03436199|65025489|FG001|Overall Study|Withdrawn per physician|1|||
23350491|NCT03436199|65025490|FG002|Overall Study|Withdrawn per physician|0|||
23350492|NCT01380691|65025491|FG000|Washout (7 Days)|Protocol Violation|0|||
23350493|NCT01380691|65025492|FG001|Washout (7 Days)|Protocol Violation|0|||
23350494|NCT01380691|65025493|FG002|Washout (7 Days)|Protocol Violation|0|||
23350495|NCT01380691|65025494|FG003|Washout (7 Days)|Protocol Violation|1|||
23350496|NCT01380691|65025491|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23350497|NCT01380691|65025492|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
23350498|NCT01380691|65025493|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
23350499|NCT01380691|65025494|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
23350500|NCT03077659|65025495|FG000|Overall Study|Withdrawal by Subject|0|||
23350501|NCT03077659|65025496|FG001|Overall Study|Withdrawal by Subject|0|||
23350502|NCT03077659|65025497|FG002|Overall Study|Withdrawal by Subject|1|||
23350503|NCT01546038|65025498|FG000|Overall Study|Death|15|||
23350504|NCT01546038|65025499|FG001|Overall Study|Death|6|||
23350505|NCT01546038|65025500|FG002|Overall Study|Death|4|||
23350506|NCT01546038|65025501|FG003|Overall Study|Death|2|||
23464136|NCT01708902|65441093|FG004|Overall Study|Lost to Follow-up|0|||
23585053|NCT05512949|65869382|FG002|Overall Study|Protocol Violation|1|||
23585054|NCT05512949|65869380|FG000|Overall Study|Withdrawal by Subject|1|||
23585055|NCT05512949|65869381|FG001|Overall Study|Withdrawal by Subject|1|||
23790492|NCT01277510|66612812|FG000|Double-blind Phase|Protocol-specified criteria|2|||
23790493|NCT01277510|66612813|FG001|Double-blind Phase|Protocol-specified criteria|6|||
23790494|NCT01277510|66612812|FG000|Double-blind Phase|Other|1|||
23790495|NCT01277510|66612813|FG001|Double-blind Phase|Other|1|||
23350507|NCT01546038|65025502|FG004|Overall Study|Death|9|||
23350508|NCT01546038|65025503|FG005|Overall Study|Death|3|||
23350509|NCT01546038|65025504|FG006|Overall Study|Death|46|||
23790496|NCT01277510|66612812|FG000|Open-label Phase|Administrative decision|4|||
23790497|NCT01277510|66612813|FG001|Open-label Phase|Administrative decision|3|||
23790498|NCT01277510|66612812|FG000|Open-label Phase|Protocol-specified criteria|1|||
23790499|NCT01277510|66612813|FG001|Open-label Phase|Protocol-specified criteria|0|||
23790500|NCT01277510|66612812|FG000|Open-label Phase|Never received investigational product|2|||
23790501|NCT01277510|66612813|FG001|Open-label Phase|Never received investigational product|0|||
23790502|NCT00396162|66612816|FG000|Overall Study|Withdrawal by Subject|2|||
23790503|NCT00396162|66612817|FG001|Overall Study|Withdrawal by Subject|3|||
23790504|NCT01993940|66612818|FG000|Overall Study|Adverse Event|16|||
23790505|NCT01993940|66612819|FG001|Overall Study|Adverse Event|11|||
23790506|NCT01993940|66612818|FG000|Overall Study|Withdrawal by Subject|15|||
23464137|NCT01708902|65441094|FG005|Overall Study|Lost to Follow-up|0|||
23464138|NCT01708902|65441095|FG006|Overall Study|Lost to Follow-up|1|||
23464139|NCT01708902|65441089|FG000|Overall Study|Refused to continue trial medication|8|||
23464140|NCT01708902|65441090|FG001|Overall Study|Refused to continue trial medication|0|||
23464141|NCT01708902|65441091|FG002|Overall Study|Refused to continue trial medication|4|||
23464142|NCT01708902|65441092|FG003|Overall Study|Refused to continue trial medication|2|||
23464143|NCT01708902|65441093|FG004|Overall Study|Refused to continue trial medication|8|||
23464144|NCT01708902|65441094|FG005|Overall Study|Refused to continue trial medication|1|||
23464145|NCT01708902|65441095|FG006|Overall Study|Refused to continue trial medication|1|||
23464146|NCT01708902|65441089|FG000|Overall Study|Other Reason|1|||
23464147|NCT01708902|65441090|FG001|Overall Study|Other Reason|0|||
23464148|NCT01708902|65441091|FG002|Overall Study|Other Reason|1|||
23464149|NCT01708902|65441092|FG003|Overall Study|Other Reason|1|||
23464150|NCT01708902|65441093|FG004|Overall Study|Other Reason|1|||
23464151|NCT01708902|65441094|FG005|Overall Study|Other Reason|2|||
23464152|NCT01708902|65441095|FG006|Overall Study|Other Reason|0|||
23464153|NCT00907335|65441096|FG000|Overall Study|Withdrawal by Subject|2|||
23464154|NCT00907335|65441097|FG001|Overall Study|Withdrawal by Subject|0|||
23464155|NCT00907335|65441096|FG000|Overall Study|Adverse Event|4|||
23464156|NCT00907335|65441097|FG001|Overall Study|Adverse Event|1|||
23464157|NCT00907335|65441096|FG000|Overall Study|Lost to Follow-up|2|||
23464158|NCT00907335|65441097|FG001|Overall Study|Lost to Follow-up|0|||
23464159|NCT03131570|65441098|FG000|Overall Study|Adverse Event|1|||
23464160|NCT03131570|65441099|FG001|Overall Study|Adverse Event|0|||
23464161|NCT03857867|65441100|FG000|Overall Study|Physician Decision|1|||
23464162|NCT01958164|65441101|FG000|Overall Study|Adverse Event|0|||
23464163|NCT01958164|65441102|FG001|Overall Study|Adverse Event|2|||
23464164|NCT01958164|65441101|FG000|Overall Study|Lost to Follow-up|2|||
23464165|NCT01958164|65441102|FG001|Overall Study|Lost to Follow-up|3|||
23464166|NCT03133793|65441104|FG000|Overall Study|Withdrawal by Subject|0|||
23464167|NCT03133793|65441105|FG001|Overall Study|Withdrawal by Subject|4|||
23464168|NCT03133793|65441106|FG002|Overall Study|Withdrawal by Subject|2|||
23464169|NCT03133793|65441107|FG003|Overall Study|Withdrawal by Subject|4|||
23464170|NCT03133793|65441104|FG000|Overall Study|Lost to Follow-up|1|||
23464171|NCT03133793|65441105|FG001|Overall Study|Lost to Follow-up|0|||
23464172|NCT03133793|65441106|FG002|Overall Study|Lost to Follow-up|2|||
23464173|NCT03133793|65441107|FG003|Overall Study|Lost to Follow-up|0|||
23464174|NCT03133793|65441104|FG000|Overall Study|Death|0|||
23464175|NCT03133793|65441105|FG001|Overall Study|Death|0|||
23464176|NCT03133793|65441106|FG002|Overall Study|Death|0|||
23790507|NCT01993940|66612819|FG001|Overall Study|Withdrawal by Subject|19|||
23790508|NCT01993940|66612818|FG000|Overall Study|Lost to Follow-up|2|||
23790509|NCT01993940|66612819|FG001|Overall Study|Lost to Follow-up|5|||
23790510|NCT01993940|66612818|FG000|Overall Study|Protocol Violation|5|||
23790511|NCT01993940|66612819|FG001|Overall Study|Protocol Violation|8|||
23790512|NCT01993940|66612818|FG000|Overall Study|Death|1|||
23790513|NCT01993940|66612819|FG001|Overall Study|Death|0|||
23790514|NCT01993940|66612818|FG000|Overall Study|Other - Miscellaneous|1|||
23790515|NCT01993940|66612819|FG001|Overall Study|Other - Miscellaneous|1|||
23790516|NCT01160640|66612821|FG000|Overall Study|Physician Decision|3|||
23790517|NCT01160640|66612822|FG001|Overall Study|Physician Decision|3|||
23790518|NCT01160640|66612821|FG000|Overall Study|Incarceration|1|||
23790519|NCT01160640|66612822|FG001|Overall Study|Incarceration|0|||
23790520|NCT01160640|66612821|FG000|Overall Study|Withdrawal by Subject|0|||
23464177|NCT03133793|65441107|FG003|Overall Study|Death|1|||
23790521|NCT01160640|66612822|FG001|Overall Study|Withdrawal by Subject|3|||
23464178|NCT01112917|65441108|FG000|Overall Study|Death|2|||
23464179|NCT01112917|65441109|FG001|Overall Study|Death|11|||
23464180|NCT01112917|65441108|FG000|Overall Study|Lost to Follow-up|1|||
23464181|NCT01112917|65441109|FG001|Overall Study|Lost to Follow-up|1|||
23790522|NCT01912807|66612823|FG000|Overall Study|Did not meet elegibility criteria|6|||
23790523|NCT01912807|66612824|FG001|Overall Study|Did not meet elegibility criteria|4|||
23790524|NCT01912807|66612823|FG000|Overall Study|Lost to Follow-up|36|||
23464182|NCT01112917|65441108|FG000|Overall Study|Withdrawal by Subject|1|||
23464183|NCT01112917|65441109|FG001|Overall Study|Withdrawal by Subject|3|||
23464184|NCT01112917|65441108|FG000|Overall Study|Unable to Convert Filter|3|||
23790525|NCT01912807|66612824|FG001|Overall Study|Lost to Follow-up|37|||
23464185|NCT01112917|65441109|FG001|Overall Study|Unable to Convert Filter|0|||
23464186|NCT01780506|65444535|FG000|Double-Blind Phase|Randomized but not Treated|3|||
23464187|NCT01780506|65444536|FG001|Double-Blind Phase|Randomized but not Treated|2|||
23464188|NCT01780506|65444535|FG000|Double-Blind Phase|Adverse Event|4|||
23464189|NCT01780506|65444536|FG001|Double-Blind Phase|Adverse Event|14|||
23464190|NCT01780506|65444535|FG000|Double-Blind Phase|Death|1|||
23464191|NCT01780506|65444536|FG001|Double-Blind Phase|Death|2|||
23464192|NCT01780506|65444535|FG000|Double-Blind Phase|Pregnancy|2|||
23464193|NCT01780506|65444536|FG001|Double-Blind Phase|Pregnancy|1|||
23464194|NCT01780506|65444535|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23464195|NCT01780506|65444536|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23464196|NCT01780506|65444535|FG000|Double-Blind Phase|Investigator's Discretion|5|||
23464197|NCT01780506|65444536|FG001|Double-Blind Phase|Investigator's Discretion|2|||
23464198|NCT01780506|65444535|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
23464199|NCT01780506|65444536|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23464200|NCT01780506|65444535|FG000|Double-Blind Phase|Protocol Violation|4|||
23464201|NCT01780506|65444536|FG001|Double-Blind Phase|Protocol Violation|3|||
23464202|NCT01780506|65444535|FG000|Double-Blind Phase|Withdrew Consent|23|||
23464203|NCT01780506|65444536|FG001|Double-Blind Phase|Withdrew Consent|24|||
23464204|NCT01780506|65444535|FG000|Double-Blind Phase|Lost to Follow-up|23|||
23464205|NCT01780506|65444536|FG001|Double-Blind Phase|Lost to Follow-up|26|||
23464206|NCT01780506|65444535|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
23464207|NCT01780506|65444536|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
23464208|NCT04161157|65444538|FG000|Overall Study|Lost to Follow-up|4|||
23464209|NCT04161157|65444538|FG000|Overall Study|Death|3|||
23464210|NCT04161157|65444538|FG000|Overall Study|Ineligible|2|||
23464211|NCT04161157|65444538|FG000|Overall Study|Withdrawal by Subject|4|||
23464212|NCT03682770|65444539|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464213|NCT03682770|65444540|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
23464214|NCT03682770|65444541|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464215|NCT03682770|65444542|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464216|NCT03682770|65444543|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464217|NCT03682770|65444544|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464218|NCT03682770|65444545|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464219|NCT03682770|65444539|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
23464220|NCT03682770|65444540|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
23464221|NCT03682770|65444541|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464222|NCT03682770|65444542|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464223|NCT03682770|65444543|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464224|NCT03682770|65444544|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464225|NCT03682770|65444545|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464226|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464227|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464228|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
23464229|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
23464230|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464231|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464232|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464233|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464234|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464235|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464236|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
23464237|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464238|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464239|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464240|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464241|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464242|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
23464243|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
23464244|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464245|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464246|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464247|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464248|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464249|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
23464250|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464251|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464252|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464253|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464254|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464255|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464256|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
23464257|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464258|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464259|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464260|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464261|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464262|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464263|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464264|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
23464265|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464266|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464267|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464268|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464269|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464270|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464271|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464272|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
23464273|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
23464274|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
23464275|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464276|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464277|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464278|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464279|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
23464280|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464281|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464282|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464283|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464284|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464285|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464286|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464287|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
23464288|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464289|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464290|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464291|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464292|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464293|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464294|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
23464295|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
23464296|NCT01812252|65444546|FG000|Overall Study|Persistent Disease|1|||
23464297|NCT01812252|65444547|FG001|Overall Study|Persistent Disease|0|||
23464298|NCT01812252|65444546|FG000|Overall Study|Not transplanted|11|||
23464299|NCT01812252|65444547|FG001|Overall Study|Not transplanted|11|||
23464300|NCT01812252|65444546|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
23464301|NCT01812252|65444547|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
23464302|NCT01812252|65444546|FG000|Overall Study|Withdrawal by Subject|1|||
23464303|NCT01812252|65444547|FG001|Overall Study|Withdrawal by Subject|1|||
23464304|NCT01812252|65444546|FG000|Overall Study|Screen Failure|1|||
23464305|NCT01812252|65444547|FG001|Overall Study|Screen Failure|0|||
23464306|NCT02919995|65444549|FG000|Overall Study|Adverse Event|0|||
23464307|NCT02919995|65444550|FG001|Overall Study|Adverse Event|0|||
23464308|NCT02919995|65444551|FG002|Overall Study|Adverse Event|0|||
23464309|NCT02919995|65444552|FG003|Overall Study|Adverse Event|0|||
23464310|NCT02919995|65444553|FG004|Overall Study|Adverse Event|0|||
23464311|NCT02919995|65444554|FG005|Overall Study|Adverse Event|1|||
23464312|NCT01780974|65444557|FG000|Overall Study|Death|1|||
23464313|NCT01780974|65444558|FG001|Overall Study|Death|0|||
23464314|NCT01780974|65444557|FG000|Overall Study|Adverse Event|1|||
23464315|NCT01780974|65444558|FG001|Overall Study|Adverse Event|3|||
23464316|NCT02565108|65444559|FG000|Overall Study|Adverse Event|1|||
23464317|NCT02565108|65444560|FG001|Overall Study|Adverse Event|0|||
23464318|NCT02565108|65444559|FG000|Overall Study|Withdrew Consent|1|||
23464319|NCT02565108|65444560|FG001|Overall Study|Withdrew Consent|0|||
23464320|NCT00753506|65444561|FG000|Overall Study|Withdrawal by Subject|4|||
23464321|NCT00753506|65444562|FG001|Overall Study|Withdrawal by Subject|1|||
23790526|NCT00860262|66612825|FG000|Overall Study|Adverse Event|9|||
23790527|NCT00860262|66612826|FG001|Overall Study|Adverse Event|6|||
23790528|NCT00860262|66612827|FG002|Overall Study|Adverse Event|7|||
23790529|NCT00860262|66612825|FG000|Overall Study|Protocol Violation|0|||
23790530|NCT00860262|66612826|FG001|Overall Study|Protocol Violation|1|||
23350510|NCT01546038|65025505|FG007|Overall Study|Death|76|||
23350511|NCT01546038|65025506|FG008|Overall Study|Death|39|||
23350512|NCT01546038|65025498|FG000|Overall Study|Lost to Follow-up|0|||
23350513|NCT01546038|65025499|FG001|Overall Study|Lost to Follow-up|0|||
23350514|NCT01546038|65025500|FG002|Overall Study|Lost to Follow-up|0|||
23350515|NCT01546038|65025501|FG003|Overall Study|Lost to Follow-up|0|||
23350516|NCT01546038|65025502|FG004|Overall Study|Lost to Follow-up|1|||
23350517|NCT01546038|65025503|FG005|Overall Study|Lost to Follow-up|0|||
23350518|NCT01546038|65025504|FG006|Overall Study|Lost to Follow-up|2|||
23350519|NCT01546038|65025505|FG007|Overall Study|Lost to Follow-up|1|||
23350520|NCT01546038|65025506|FG008|Overall Study|Lost to Follow-up|0|||
23350521|NCT01546038|65025498|FG000|Overall Study|Withdrawal by Subject|1|||
23350522|NCT01546038|65025499|FG001|Overall Study|Withdrawal by Subject|0|||
23350523|NCT01546038|65025500|FG002|Overall Study|Withdrawal by Subject|0|||
23350524|NCT01546038|65025501|FG003|Overall Study|Withdrawal by Subject|1|||
23350525|NCT01546038|65025502|FG004|Overall Study|Withdrawal by Subject|0|||
23350526|NCT01546038|65025503|FG005|Overall Study|Withdrawal by Subject|1|||
23350527|NCT01546038|65025504|FG006|Overall Study|Withdrawal by Subject|3|||
23350528|NCT01546038|65025505|FG007|Overall Study|Withdrawal by Subject|3|||
23350529|NCT01546038|65025506|FG008|Overall Study|Withdrawal by Subject|1|||
23350530|NCT01546038|65025498|FG000|Overall Study|: Randomized, not treated|0|||
23350531|NCT01546038|65025499|FG001|Overall Study|: Randomized, not treated|0|||
23350532|NCT01546038|65025500|FG002|Overall Study|: Randomized, not treated|0|||
23350533|NCT01546038|65025501|FG003|Overall Study|: Randomized, not treated|0|||
23350534|NCT01546038|65025502|FG004|Overall Study|: Randomized, not treated|0|||
23350535|NCT01546038|65025503|FG005|Overall Study|: Randomized, not treated|0|||
23350536|NCT01546038|65025504|FG006|Overall Study|: Randomized, not treated|2|||
23350537|NCT01546038|65025505|FG007|Overall Study|: Randomized, not treated|4|||
23350538|NCT01546038|65025506|FG008|Overall Study|: Randomized, not treated|3|||
23350539|NCT00087126|65025509|FG000|Overall Study|Ineligible - second primary|1|||
23350540|NCT00087126|65025509|FG000|Overall Study|Never treated|1|||
23350541|NCT01473394|65025510|FG000|Overall Study|Adverse Event|13|||
23350542|NCT01473394|65025511|FG001|Overall Study|Adverse Event|16|||
23350543|NCT01473394|65025510|FG000|Overall Study|Insufficient Therapeutic Response|4|||
23350544|NCT01473394|65025511|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23350545|NCT01473394|65025510|FG000|Overall Study|Protocol Violation|7|||
23350546|NCT01473394|65025511|FG001|Overall Study|Protocol Violation|5|||
23350547|NCT01473394|65025510|FG000|Overall Study|Withdrew Consent|12|||
23350548|NCT01473394|65025511|FG001|Overall Study|Withdrew Consent|10|||
23350549|NCT01473394|65025510|FG000|Overall Study|Lost to Follow-up|9|||
23350550|NCT01473394|65025511|FG001|Overall Study|Lost to Follow-up|11|||
23350551|NCT00586898|65025512|FG000|Overall Study|Adverse Event|1|||
23350552|NCT00586898|65025512|FG000|Overall Study|Patiemt Non-compliance|1|||
23350553|NCT00586898|65025512|FG000|Overall Study|Evaluable for Toxicity Only|5|||
23350554|NCT00574249|65025513|FG000|Overall Study|Adverse Event|6|||
23350555|NCT00574249|65025514|FG001|Overall Study|Adverse Event|18|||
23350556|NCT00574249|65025513|FG000|Overall Study|Lack of Efficacy|5|||
23350557|NCT00574249|65025514|FG001|Overall Study|Lack of Efficacy|3|||
23350558|NCT00574249|65025513|FG000|Overall Study|Lost to Follow-up|4|||
23350559|NCT00574249|65025514|FG001|Overall Study|Lost to Follow-up|3|||
23350560|NCT00574249|65025513|FG000|Overall Study|Protocol Violation|5|||
23350561|NCT00574249|65025514|FG001|Overall Study|Protocol Violation|2|||
23350562|NCT00574249|65025513|FG000|Overall Study|History of carcinoma|1|||
23350563|NCT00574249|65025514|FG001|Overall Study|History of carcinoma|0|||
23350564|NCT00574249|65025513|FG000|Overall Study|Withdrawal by Subject|3|||
23350565|NCT00574249|65025514|FG001|Overall Study|Withdrawal by Subject|0|||
23350566|NCT00574249|65025513|FG000|Overall Study|Physician Decision|1|||
23350567|NCT00574249|65025514|FG001|Overall Study|Physician Decision|0|||
23350568|NCT00574249|65025513|FG000|Overall Study|Pregnancy|1|||
23350569|NCT00574249|65025514|FG001|Overall Study|Pregnancy|0|||
23350570|NCT00574249|65025513|FG000|Overall Study|Excluded by company|0|||
23790531|NCT00860262|66612827|FG002|Overall Study|Protocol Violation|0|||
23350571|NCT00574249|65025514|FG001|Overall Study|Excluded by company|1|||
23350572|NCT00574249|65025513|FG000|Overall Study|PPD test taken twice|0|||
23790532|NCT00860262|66612825|FG000|Overall Study|Lost to Follow-up|2|||
23350573|NCT00574249|65025514|FG001|Overall Study|PPD test taken twice|1|||
23350574|NCT01702532|65025515|FG000|Overall Study|Adverse Event|0|||
23790533|NCT00860262|66612826|FG001|Overall Study|Lost to Follow-up|0|||
23350575|NCT01702532|65025516|FG001|Overall Study|Adverse Event|1|||
23350576|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
23350577|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
23350578|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
23350579|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
23464322|NCT00753506|65444561|FG000|Overall Study|Lost to Follow-up|2|||
23464323|NCT00753506|65444562|FG001|Overall Study|Lost to Follow-up|0|||
23464324|NCT00753506|65444561|FG000|Overall Study|Other reason|1|||
23464325|NCT00753506|65444562|FG001|Overall Study|Other reason|1|||
23464326|NCT04032093|65444563|FG000|Overall Study|Lost to Follow-up|7|||
23464327|NCT04032093|65444564|FG001|Overall Study|Lost to Follow-up|7|||
23464328|NCT04032093|65444565|FG002|Overall Study|Lost to Follow-up|6|||
23464329|NCT04032093|65444566|FG003|Overall Study|Lost to Follow-up|10|||
23464330|NCT04032093|65444567|FG004|Overall Study|Lost to Follow-up|13|||
23464331|NCT04032093|65444568|FG005|Overall Study|Lost to Follow-up|7|||
23464332|NCT04032093|65444569|FG006|Overall Study|Lost to Follow-up|7|||
23464333|NCT04032093|65444570|FG007|Overall Study|Lost to Follow-up|5|||
23464334|NCT04032093|65444571|FG008|Overall Study|Lost to Follow-up|9|||
23464335|NCT04032093|65444572|FG009|Overall Study|Lost to Follow-up|12|||
23464336|NCT04032093|65444563|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464337|NCT04032093|65444564|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464338|NCT04032093|65444565|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464339|NCT04032093|65444566|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
23464340|NCT04032093|65444567|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464341|NCT04032093|65444568|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464342|NCT04032093|65444569|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464343|NCT04032093|65444570|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464344|NCT04032093|65444571|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464345|NCT04032093|65444572|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464346|NCT04032093|65444563|FG000|Overall Study|Other|1|||
23464347|NCT04032093|65444564|FG001|Overall Study|Other|0|||
23464348|NCT04032093|65444565|FG002|Overall Study|Other|0|||
23464349|NCT04032093|65444566|FG003|Overall Study|Other|1|||
23464350|NCT04032093|65444567|FG004|Overall Study|Other|1|||
23464351|NCT04032093|65444568|FG005|Overall Study|Other|0|||
23464352|NCT04032093|65444569|FG006|Overall Study|Other|0|||
23464353|NCT04032093|65444570|FG007|Overall Study|Other|0|||
23464354|NCT04032093|65444571|FG008|Overall Study|Other|0|||
23464355|NCT04032093|65444572|FG009|Overall Study|Other|1|||
23464356|NCT04032093|65444563|FG000|Overall Study|Withdrawal by Subject|1|||
23464357|NCT04032093|65444564|FG001|Overall Study|Withdrawal by Subject|3|||
23464358|NCT04032093|65444565|FG002|Overall Study|Withdrawal by Subject|2|||
23464359|NCT04032093|65444566|FG003|Overall Study|Withdrawal by Subject|2|||
23464360|NCT04032093|65444567|FG004|Overall Study|Withdrawal by Subject|3|||
23464361|NCT04032093|65444568|FG005|Overall Study|Withdrawal by Subject|0|||
23464362|NCT04032093|65444569|FG006|Overall Study|Withdrawal by Subject|0|||
23464363|NCT04032093|65444570|FG007|Overall Study|Withdrawal by Subject|0|||
23464364|NCT04032093|65444571|FG008|Overall Study|Withdrawal by Subject|0|||
23464365|NCT04032093|65444572|FG009|Overall Study|Withdrawal by Subject|0|||
23464366|NCT04032093|65444563|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23464367|NCT04032093|65444564|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23464368|NCT04032093|65444565|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23464369|NCT04032093|65444566|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23464370|NCT04032093|65444567|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23464371|NCT04032093|65444568|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23464372|NCT04032093|65444569|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
23464373|NCT04032093|65444570|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
23464374|NCT04032093|65444571|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
23464375|NCT04032093|65444572|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
23464376|NCT04032093|65444563|FG000|Overall Study|Adverse Event|0|||
23464377|NCT04032093|65444564|FG001|Overall Study|Adverse Event|0|||
23464378|NCT04032093|65444565|FG002|Overall Study|Adverse Event|0|||
23464379|NCT04032093|65444566|FG003|Overall Study|Adverse Event|0|||
23585056|NCT05512949|65869382|FG002|Overall Study|Withdrawal by Subject|2|||
23639884|NCT02187159|66067383|FG003|Overall Study|Adverse Event|50|||
23464380|NCT04032093|65444567|FG004|Overall Study|Adverse Event|0|||
23464381|NCT04032093|65444568|FG005|Overall Study|Adverse Event|0|||
23464382|NCT04032093|65444569|FG006|Overall Study|Adverse Event|0|||
23464383|NCT04032093|65444570|FG007|Overall Study|Adverse Event|0|||
23464384|NCT04032093|65444571|FG008|Overall Study|Adverse Event|0|||
23464385|NCT04032093|65444572|FG009|Overall Study|Adverse Event|1|||
23464386|NCT04032093|65444563|FG000|Overall Study|Physician Decision|0|||
23464387|NCT04032093|65444564|FG001|Overall Study|Physician Decision|0|||
23464388|NCT04032093|65444565|FG002|Overall Study|Physician Decision|0|||
23464389|NCT04032093|65444566|FG003|Overall Study|Physician Decision|0|||
23464390|NCT04032093|65444567|FG004|Overall Study|Physician Decision|0|||
23464391|NCT04032093|65444568|FG005|Overall Study|Physician Decision|1|||
23790534|NCT00860262|66612827|FG002|Overall Study|Lost to Follow-up|1|||
23402770|NCT01446874|65220004|FG001|Overall Study|Not eligible|0|||
23464392|NCT04032093|65444569|FG006|Overall Study|Physician Decision|0|||
23464393|NCT04032093|65444570|FG007|Overall Study|Physician Decision|0|||
23464394|NCT04032093|65444571|FG008|Overall Study|Physician Decision|0|||
23464395|NCT04032093|65444572|FG009|Overall Study|Physician Decision|0|||
23464396|NCT00686712|65444573|FG000|Overall Study|Protocol Violation|8|||
23464397|NCT00686712|65444574|FG001|Overall Study|Protocol Violation|8|||
23464398|NCT00686712|65444575|FG002|Overall Study|Protocol Violation|10|||
23464399|NCT00686712|65444573|FG000|Overall Study|Lost to Follow-up|1|||
23464400|NCT00686712|65444574|FG001|Overall Study|Lost to Follow-up|2|||
23464401|NCT00686712|65444575|FG002|Overall Study|Lost to Follow-up|3|||
23464402|NCT00686712|65444573|FG000|Overall Study|Adverse Event|1|||
23464403|NCT00686712|65444574|FG001|Overall Study|Adverse Event|1|||
23464404|NCT00686712|65444575|FG002|Overall Study|Adverse Event|0|||
23464405|NCT00473564|65444578|FG000|Overall Study|robot surgery aborted in OR|23|||
23464406|NCT03557034|65444579|FG000|Overall Study|Withdrawal by Subject|1|||
23464407|NCT03557034|65444580|FG001|Overall Study|Withdrawal by Subject|0|||
23464408|NCT04226742|65444581|FG000|Overall Study|Lost to Follow-up|16|||
23464409|NCT04226742|65444582|FG001|Overall Study|Lost to Follow-up|13|||
23464410|NCT04226742|65444581|FG000|Overall Study|Withdrawal by Subject|5|||
23464411|NCT04226742|65444582|FG001|Overall Study|Withdrawal by Subject|3|||
23464412|NCT00408317|65444583|FG000|First Intervention Period|Adverse Event|0|||
23464413|NCT00408317|65444584|FG001|First Intervention Period|Adverse Event|1|||
23464414|NCT00408317|65444583|FG000|Second Intervention Period|Adverse Event|2|||
23464415|NCT00408317|65444584|FG001|Second Intervention Period|Adverse Event|0|||
23464416|NCT00408317|65444583|FG000|Second Intervention Period|Protocol Violation|0|||
23464417|NCT00408317|65444584|FG001|Second Intervention Period|Protocol Violation|1|||
23464418|NCT00408317|65444583|FG000|Second Intervention Period|Withdrawal of consent|0|||
23464419|NCT00408317|65444584|FG001|Second Intervention Period|Withdrawal of consent|1|||
23464420|NCT01760733|65444585|FG000|Waiting List|Death|18|||
23464421|NCT01760733|65444585|FG000|Waiting List|Removed from waiting list|41|||
23464422|NCT01760733|65444585|FG000|Waiting List|Not received a transplant yet|13|||
23464423|NCT01760733|65444585|FG000|Transplanted|Not reached 10 years post transplant|184|||
23464424|NCT01760733|65444585|FG000|Transplanted|Death|26|||
23464425|NCT01760733|65444585|FG000|Transplanted|Graft loss|7|||
23464426|NCT01654302|65444586|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
23464427|NCT01654302|65444587|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
23464428|NCT02766023|65444588|FG000|Overall Study|Lost to Follow-up|23|||
23464429|NCT02766023|65444589|FG001|Overall Study|Lost to Follow-up|11|||
23464430|NCT02766023|65444588|FG000|Overall Study|Pregnancy|1|||
23464431|NCT02766023|65444589|FG001|Overall Study|Pregnancy|0|||
23464432|NCT02766023|65444588|FG000|Overall Study|Adverse Event|1|||
23464433|NCT02766023|65444589|FG001|Overall Study|Adverse Event|0|||
23464434|NCT02766023|65444588|FG000|Overall Study|Withdrawal by Subject|4|||
23464435|NCT02766023|65444589|FG001|Overall Study|Withdrawal by Subject|5|||
23585057|NCT05512949|65869380|FG000|Overall Study|Completion status unknown|1|||
23585058|NCT05512949|65869381|FG001|Overall Study|Completion status unknown|3|||
23585059|NCT05512949|65869382|FG002|Overall Study|Completion status unknown|0|||
23585060|NCT00631917|65869383|FG000|Overall Study|Adverse Event|34|||
23585061|NCT00631917|65869384|FG001|Overall Study|Adverse Event|45|||
23585062|NCT00631917|65869383|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23585063|NCT00631917|65869384|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23585064|NCT00631917|65869383|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23585065|NCT00631917|65869384|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23585066|NCT00631917|65869383|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
23585067|NCT00631917|65869384|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
23585068|NCT00631917|65869383|FG000|Overall Study|No longer required study drug|0|||
23585069|NCT00631917|65869384|FG001|Overall Study|No longer required study drug|1|||
23585070|NCT00631917|65869383|FG000|Overall Study|Protocol deviation|6|||
23585071|NCT00631917|65869384|FG001|Overall Study|Protocol deviation|5|||
23585072|NCT00631917|65869383|FG000|Overall Study|Subject withdrew consent|25|||
23585073|NCT00631917|65869384|FG001|Overall Study|Subject withdrew consent|33|||
23585074|NCT00631917|65869383|FG000|Overall Study|Lost to Follow-up|7|||
23585075|NCT00631917|65869384|FG001|Overall Study|Lost to Follow-up|7|||
23585076|NCT00631917|65869383|FG000|Overall Study|Administrative problems|2|||
23585077|NCT00631917|65869384|FG001|Overall Study|Administrative problems|0|||
23790535|NCT00860262|66612825|FG000|Overall Study|Withdrawal by Subject|4|||
23464436|NCT02766023|65444588|FG000|Overall Study|Physician Decision|1|||
23464437|NCT02766023|65444589|FG001|Overall Study|Physician Decision|0|||
23464438|NCT02766023|65444588|FG000|Overall Study|Not Eligible at Enrollment|0|||
23464439|NCT02766023|65444589|FG001|Overall Study|Not Eligible at Enrollment|1|||
23585078|NCT00631917|65869383|FG000|Overall Study|Death|1|||
23585079|NCT00631917|65869384|FG001|Overall Study|Death|0|||
23585080|NCT03107611|65869385|FG000|Overall Study|Adverse Event|1|||
23585081|NCT03107611|65869386|FG001|Overall Study|Adverse Event|0|||
23639885|NCT02187159|66067380|FG000|Overall Study|Withdrawal by Subject|24|||
23464440|NCT01077076|65444591|FG000|First Intervention|Withdrawal by Subject|1|||
23464441|NCT01077076|65444592|FG001|First Intervention|Withdrawal by Subject|0|||
23585082|NCT03107611|65869387|FG002|Overall Study|Adverse Event|2|||
23464442|NCT01077076|65444593|FG002|First Intervention|Withdrawal by Subject|0|||
23464443|NCT01077076|65444594|FG003|First Intervention|Withdrawal by Subject|0|||
23585083|NCT03107611|65869385|FG000|Overall Study|Lost to Follow-up|3|||
23585084|NCT03107611|65869386|FG001|Overall Study|Lost to Follow-up|3|||
23585085|NCT03107611|65869387|FG002|Overall Study|Lost to Follow-up|3|||
23585086|NCT03107611|65869385|FG000|Overall Study|Protocol Violation|0|||
23585087|NCT03107611|65869386|FG001|Overall Study|Protocol Violation|0|||
23585088|NCT03107611|65869387|FG002|Overall Study|Protocol Violation|1|||
23585089|NCT03107611|65869385|FG000|Overall Study|Withdrawal by Subject|1|||
23585090|NCT03107611|65869386|FG001|Overall Study|Withdrawal by Subject|0|||
23585091|NCT03107611|65869387|FG002|Overall Study|Withdrawal by Subject|1|||
23585092|NCT03107611|65869385|FG000|Overall Study|Worsening signs/symptoms|2|||
23585093|NCT03107611|65869386|FG001|Overall Study|Worsening signs/symptoms|1|||
23585094|NCT03107611|65869387|FG002|Overall Study|Worsening signs/symptoms|2|||
23585095|NCT02689349|65869388|FG000|Overall Study|Not implanted|4|||
23585096|NCT02689349|65869389|FG001|Overall Study|Not implanted|0|||
23585097|NCT02689349|65869388|FG000|Overall Study|Withdrawal by Subject|9|||
23585098|NCT02689349|65869389|FG001|Overall Study|Withdrawal by Subject|0|||
23585099|NCT00995709|65869393|FG000|Overall Study|Adverse Event|4|||
23585100|NCT00995709|65869394|FG001|Overall Study|Adverse Event|2|||
23585101|NCT00995709|65869395|FG002|Overall Study|Adverse Event|0|||
23585102|NCT00995709|65869393|FG000|Overall Study|Lack of Efficacy|0|||
23790536|NCT00860262|66612826|FG001|Overall Study|Withdrawal by Subject|8|||
23790537|NCT00860262|66612827|FG002|Overall Study|Withdrawal by Subject|6|||
23790538|NCT00860262|66612825|FG000|Overall Study|Lack of Efficacy|0|||
23790539|NCT00860262|66612826|FG001|Overall Study|Lack of Efficacy|4|||
23790540|NCT00860262|66612827|FG002|Overall Study|Lack of Efficacy|3|||
23790541|NCT00860262|66612825|FG000|Overall Study|Other|5|||
23790542|NCT00860262|66612826|FG001|Overall Study|Other|3|||
23790543|NCT00860262|66612827|FG002|Overall Study|Other|1|||
23790544|NCT00045162|66612828|FG000|Overall Study|Ineligible|12|||
23790545|NCT00045162|66612829|FG001|Overall Study|Ineligible|8|||
23790546|NCT00045162|66612828|FG000|Overall Study|Not treated|7|||
23790547|NCT00045162|66612829|FG001|Overall Study|Not treated|2|||
23790548|NCT00045162|66612828|FG000|Overall Study|Adverse Event|55|||
23790549|NCT00045162|66612829|FG001|Overall Study|Adverse Event|50|||
23790550|NCT00045162|66612828|FG000|Overall Study|Lack of Efficacy|32|||
23585103|NCT00995709|65869394|FG001|Overall Study|Lack of Efficacy|1|||
23585104|NCT00995709|65869395|FG002|Overall Study|Lack of Efficacy|4|||
23585105|NCT00995709|65869393|FG000|Overall Study|Withdrawal by Subject|0|||
23585106|NCT00995709|65869394|FG001|Overall Study|Withdrawal by Subject|4|||
23585107|NCT00995709|65869395|FG002|Overall Study|Withdrawal by Subject|1|||
23585108|NCT00995709|65869393|FG000|Overall Study|Lost to Follow-up|1|||
23350580|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
23350581|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
23350582|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
23585109|NCT00995709|65869394|FG001|Overall Study|Lost to Follow-up|0|||
23585110|NCT00995709|65869395|FG002|Overall Study|Lost to Follow-up|0|||
23585111|NCT00995709|65869393|FG000|Overall Study|Death|0|||
23585112|NCT00995709|65869394|FG001|Overall Study|Death|1|||
23585113|NCT00995709|65869395|FG002|Overall Study|Death|0|||
23350583|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
23585114|NCT00995709|65869393|FG000|Overall Study|Protocol Violation|2|||
23585115|NCT00995709|65869394|FG001|Overall Study|Protocol Violation|1|||
23585116|NCT00995709|65869395|FG002|Overall Study|Protocol Violation|0|||
23585117|NCT01823341|65869398|FG000|Overall Study|Failed run-in|7|||
23585118|NCT01823341|65869398|FG000|Overall Study|Withdrawal by Subject|7|||
23585119|NCT01823341|65869398|FG000|Overall Study|Adverse Event|1|||
23585120|NCT01537133|65869399|FG000|Overall Study|Withdrawal by Subject|2|||
23585121|NCT01537133|65869400|FG001|Overall Study|Withdrawal by Subject|0|||
23585122|NCT01537133|65869401|FG002|Overall Study|Withdrawal by Subject|0|||
23585123|NCT01537133|65869402|FG003|Overall Study|Withdrawal by Subject|0|||
23585124|NCT01537133|65869399|FG000|Overall Study|Lost to Follow-up|1|||
23585125|NCT01537133|65869400|FG001|Overall Study|Lost to Follow-up|0|||
23585126|NCT01537133|65869401|FG002|Overall Study|Lost to Follow-up|0|||
23585127|NCT01537133|65869402|FG003|Overall Study|Lost to Follow-up|0|||
23585128|NCT00536380|65869403|FG000|Overall Study|Adverse Event|0|||
23585129|NCT00536380|65869404|FG001|Overall Study|Adverse Event|2|||
23585130|NCT00536380|65869405|FG002|Overall Study|Adverse Event|2|||
23585131|NCT00536380|65869403|FG000|Overall Study|Lost to Follow-up|0|||
23585132|NCT00536380|65869404|FG001|Overall Study|Lost to Follow-up|0|||
23585133|NCT00536380|65869405|FG002|Overall Study|Lost to Follow-up|1|||
23585134|NCT00536380|65869403|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
23585135|NCT00536380|65869404|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
23585136|NCT00536380|65869405|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
23585137|NCT00536380|65869403|FG000|Overall Study|Withdrawal related to study drug|7|||
23585138|NCT00536380|65869404|FG001|Overall Study|Withdrawal related to study drug|5|||
23585139|NCT00536380|65869405|FG002|Overall Study|Withdrawal related to study drug|2|||
23585140|NCT00536380|65869403|FG000|Overall Study|Noncompliance with protocol|3|||
23585141|NCT00536380|65869404|FG001|Overall Study|Noncompliance with protocol|2|||
23585142|NCT00536380|65869405|FG002|Overall Study|Noncompliance with protocol|2|||
23585143|NCT00536380|65869403|FG000|Overall Study|Did not meet protocol eligibility|0|||
23585144|NCT00536380|65869404|FG001|Overall Study|Did not meet protocol eligibility|0|||
23585145|NCT00536380|65869405|FG002|Overall Study|Did not meet protocol eligibility|1|||
23585146|NCT00536380|65869403|FG000|Overall Study|Administrative|0|||
23585147|NCT00536380|65869404|FG001|Overall Study|Administrative|0|||
23585148|NCT00536380|65869405|FG002|Overall Study|Administrative|1|||
23585149|NCT04163458|65869406|FG000|Overall Study|Protocol Deviation|7|||
23585150|NCT04163458|65869407|FG001|Overall Study|Protocol Deviation|13|||
23350584|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
23585151|NCT04163458|65869406|FG000|Overall Study|Adverse Event|5|||
23585152|NCT04163458|65869407|FG001|Overall Study|Adverse Event|8|||
23585153|NCT04163458|65869406|FG000|Overall Study|Due to COVID-19 pandemic|4|||
23585154|NCT04163458|65869407|FG001|Overall Study|Due to COVID-19 pandemic|2|||
23585155|NCT04163458|65869406|FG000|Overall Study|Participant withdrew consent|2|||
23585156|NCT04163458|65869407|FG001|Overall Study|Participant withdrew consent|3|||
23585157|NCT04163458|65869406|FG000|Overall Study|Randomization failure|2|||
23585158|NCT04163458|65869407|FG001|Overall Study|Randomization failure|2|||
23585159|NCT04163458|65869406|FG000|Overall Study|Other|4|||
23464444|NCT01077076|65444595|FG004|First Intervention|Withdrawal by Subject|0|||
23464445|NCT01077076|65444596|FG005|First Intervention|Withdrawal by Subject|0|||
23464446|NCT01077076|65444591|FG000|Third Intervention|Death in the participant's family|0|||
23464447|NCT01077076|65444592|FG001|Third Intervention|Death in the participant's family|0|||
23585160|NCT04163458|65869407|FG001|Overall Study|Other|2|||
23585161|NCT01090024|65869408|FG000|Period 1|Met exclusion criteria|0|||
23585162|NCT01090024|65869409|FG001|Period 1|Met exclusion criteria|0|||
23585163|NCT01090024|65869410|FG002|Period 1|Met exclusion criteria|0|||
23585164|NCT01090024|65869411|FG003|Period 1|Met exclusion criteria|0|||
23585165|NCT01090024|65869412|FG004|Period 1|Met exclusion criteria|0|||
23585166|NCT01090024|65869413|FG005|Period 1|Met exclusion criteria|0|||
23585167|NCT01090024|65869414|FG006|Period 1|Met exclusion criteria|0|||
23585168|NCT01090024|65869415|FG007|Period 1|Met exclusion criteria|0|||
23585169|NCT01090024|65869416|FG008|Period 1|Met exclusion criteria|0|||
23585170|NCT01090024|65869417|FG009|Period 1|Met exclusion criteria|0|||
23585171|NCT01090024|65869418|FG010|Period 1|Met exclusion criteria|0|||
23585172|NCT01090024|65869419|FG011|Period 1|Met exclusion criteria|0|||
23585173|NCT01090024|65869420|FG012|Period 1|Met exclusion criteria|0|||
23585174|NCT01090024|65869421|FG013|Period 1|Met exclusion criteria|0|||
23585175|NCT01090024|65869422|FG014|Period 1|Met exclusion criteria|1|||
23585176|NCT01090024|65869423|FG015|Period 1|Met exclusion criteria|0|||
23585177|NCT01090024|65869424|FG016|Period 1|Met exclusion criteria|0|||
23585178|NCT01090024|65869425|FG017|Period 1|Met exclusion criteria|0|||
23585179|NCT01090024|65869408|FG000|Period 1|Adverse Event|0|||
23585180|NCT01090024|65869409|FG001|Period 1|Adverse Event|0|||
23585181|NCT01090024|65869410|FG002|Period 1|Adverse Event|0|||
23585182|NCT01090024|65869411|FG003|Period 1|Adverse Event|0|||
23585183|NCT01090024|65869412|FG004|Period 1|Adverse Event|0|||
23585184|NCT01090024|65869413|FG005|Period 1|Adverse Event|0|||
23585185|NCT01090024|65869414|FG006|Period 1|Adverse Event|0|||
23585186|NCT01090024|65869415|FG007|Period 1|Adverse Event|0|||
23585187|NCT01090024|65869416|FG008|Period 1|Adverse Event|0|||
23585188|NCT01090024|65869417|FG009|Period 1|Adverse Event|1|||
23585189|NCT01090024|65869418|FG010|Period 1|Adverse Event|0|||
23585190|NCT01090024|65869419|FG011|Period 1|Adverse Event|1|||
23585191|NCT01090024|65869420|FG012|Period 1|Adverse Event|0|||
23585192|NCT01090024|65869421|FG013|Period 1|Adverse Event|0|||
23585193|NCT01090024|65869422|FG014|Period 1|Adverse Event|0|||
23585194|NCT01090024|65869423|FG015|Period 1|Adverse Event|0|||
23464448|NCT01077076|65444593|FG002|Third Intervention|Death in the participant's family|0|||
23585195|NCT01090024|65869424|FG016|Period 1|Adverse Event|0|||
23585196|NCT01090024|65869425|FG017|Period 1|Adverse Event|1|||
23585197|NCT01090024|65869408|FG000|Period 1|Withdrawal by Subject|0|||
23585198|NCT01090024|65869409|FG001|Period 1|Withdrawal by Subject|0|||
23585199|NCT01090024|65869410|FG002|Period 1|Withdrawal by Subject|0|||
23585200|NCT01090024|65869411|FG003|Period 1|Withdrawal by Subject|1|||
23585201|NCT01090024|65869412|FG004|Period 1|Withdrawal by Subject|0|||
23585202|NCT01090024|65869413|FG005|Period 1|Withdrawal by Subject|0|||
23585203|NCT01090024|65869414|FG006|Period 1|Withdrawal by Subject|0|||
23585204|NCT01090024|65869415|FG007|Period 1|Withdrawal by Subject|0|||
23790551|NCT00045162|66612829|FG001|Overall Study|Lack of Efficacy|29|||
23790552|NCT00045162|66612828|FG000|Overall Study|Death|10|||
23790553|NCT00045162|66612829|FG001|Overall Study|Death|10|||
23790554|NCT00045162|66612828|FG000|Overall Study|Withdrawal by Subject|5|||
23790555|NCT00045162|66612829|FG001|Overall Study|Withdrawal by Subject|3|||
23790556|NCT00045162|66612828|FG000|Overall Study|Other|21|||
23790557|NCT00045162|66612829|FG001|Overall Study|Other|16|||
23790558|NCT02252016|66612830|FG000|Overall Study|Lost to Follow-up|2|||
23790559|NCT02252016|66612831|FG001|Overall Study|Lost to Follow-up|1|||
23790560|NCT02252016|66612830|FG000|Overall Study|Physician Decision|1|||
23464449|NCT01077076|65444594|FG003|Third Intervention|Death in the participant's family|0|||
23464450|NCT01077076|65444595|FG004|Third Intervention|Death in the participant's family|0|||
23790561|NCT02252016|66612831|FG001|Overall Study|Physician Decision|0|||
23790562|NCT02252016|66612830|FG000|Overall Study|Withdrawal by Subject|0|||
23790563|NCT02252016|66612831|FG001|Overall Study|Withdrawal by Subject|2|||
23790564|NCT01929681|66612832|FG000|Overall Study|Withdrawal by Subject|1|||
23790565|NCT01929681|66612833|FG001|Overall Study|Withdrawal by Subject|0|||
23790566|NCT01929681|66612832|FG000|Overall Study|Physician Decision|1|||
23790567|NCT01929681|66612833|FG001|Overall Study|Physician Decision|1|||
23790568|NCT02623218|66612834|FG000|Overall Study|Lost to Follow-up|0|||
23790569|NCT02623218|66612835|FG001|Overall Study|Lost to Follow-up|1|||
23790570|NCT02623218|66612836|FG002|Overall Study|Lost to Follow-up|0|||
23790571|NCT02623218|66612837|FG003|Overall Study|Lost to Follow-up|0|||
23790572|NCT02623218|66612838|FG004|Overall Study|Lost to Follow-up|0|||
23790573|NCT04194008|66612839|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
23790574|NCT04194008|66612839|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
23350585|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
23350586|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
23790575|NCT04194008|66612839|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
23790576|NCT04194008|66612839|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
23790577|NCT04194008|66612839|FG000|Treatment Phase With Nerivio|Missing data|4|||
23790578|NCT04194008|66612839|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
23790579|NCT03666143|66612840|FG000|Overall Study|Death|158|||
23790580|NCT03666143|66612840|FG000|Overall Study|Sponsor Decision|31|||
23790581|NCT03666143|66612840|FG000|Overall Study|Withdrawal by Subject|11|||
23790582|NCT03666143|66612840|FG000|Overall Study|Lost to Follow-up|5|||
23790583|NCT03666143|66612840|FG000|Overall Study|Physician Decision|1|||
23350587|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
23350588|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
23464451|NCT01077076|65444596|FG005|Third Intervention|Death in the participant's family|1|||
23464452|NCT01526733|65444597|FG000|Phase 1|Protocol Violation|1|||
23464453|NCT01526733|65444598|FG001|Phase 1|Protocol Violation|0|||
23464454|NCT01526733|65444597|FG000|Phase 1|Withdrawal by Subject|1|||
23464455|NCT01526733|65444598|FG001|Phase 1|Withdrawal by Subject|1|||
23585205|NCT01090024|65869416|FG008|Period 1|Withdrawal by Subject|0|||
23585206|NCT01090024|65869417|FG009|Period 1|Withdrawal by Subject|0|||
23639886|NCT02187159|66067381|FG001|Overall Study|Withdrawal by Subject|28|||
23639887|NCT02187159|66067382|FG002|Overall Study|Withdrawal by Subject|25|||
23639888|NCT02187159|66067383|FG003|Overall Study|Withdrawal by Subject|26|||
23639889|NCT02187159|66067380|FG000|Overall Study|Other|3|||
23639890|NCT02187159|66067381|FG001|Overall Study|Other|7|||
23639891|NCT02187159|66067382|FG002|Overall Study|Other|3|||
23639892|NCT02187159|66067383|FG003|Overall Study|Other|9|||
23639893|NCT00316017|66067384|FG000|Overall Study|Protocol Violation|11|||
23639894|NCT00316017|66067385|FG001|Overall Study|Protocol Violation|13|||
23639895|NCT00316017|66067386|FG002|Overall Study|Protocol Violation|19|||
23639896|NCT02060370|66067387|FG000|Overall Study|Physician Decision|1|||
23639897|NCT00837694|66067388|FG000|Overall Study|Lost to Follow-up|2|||
23639898|NCT00837694|66067389|FG001|Overall Study|Lost to Follow-up|0|||
23639899|NCT00837694|66067390|FG002|Overall Study|Lost to Follow-up|2|||
23639900|NCT00837694|66067391|FG003|Overall Study|Lost to Follow-up|1|||
23639901|NCT00837694|66067392|FG004|Overall Study|Lost to Follow-up|1|||
23639902|NCT00837694|66067393|FG005|Overall Study|Lost to Follow-up|1|||
23639903|NCT04677179|66067394|FG000|Induction Treatment Period|Adverse Event|1|||
23639904|NCT04677179|66067395|FG001|Induction Treatment Period|Adverse Event|0|||
23639905|NCT04677179|66067396|FG002|Induction Treatment Period|Adverse Event|0|||
23639906|NCT04677179|66067397|FG003|Induction Treatment Period|Adverse Event|0|||
23639907|NCT04677179|66067398|FG004|Induction Treatment Period|Adverse Event|0|||
23639908|NCT04677179|66067399|FG005|Induction Treatment Period|Adverse Event|0|||
23639909|NCT04677179|66067400|FG006|Induction Treatment Period|Adverse Event|0|||
23639910|NCT04677179|66067401|FG007|Induction Treatment Period|Adverse Event|0|||
23639911|NCT04677179|66067402|FG008|Induction Treatment Period|Adverse Event|0|||
23639912|NCT04677179|66067403|FG009|Induction Treatment Period|Adverse Event|0|||
23639913|NCT04677179|66067394|FG000|Induction Treatment Period|Physician Decision|1|||
23639914|NCT04677179|66067395|FG001|Induction Treatment Period|Physician Decision|0|||
23639915|NCT04677179|66067396|FG002|Induction Treatment Period|Physician Decision|1|||
23585207|NCT01090024|65869418|FG010|Period 1|Withdrawal by Subject|0|||
23585208|NCT01090024|65869419|FG011|Period 1|Withdrawal by Subject|0|||
23585209|NCT01090024|65869420|FG012|Period 1|Withdrawal by Subject|0|||
23585210|NCT01090024|65869421|FG013|Period 1|Withdrawal by Subject|0|||
23585211|NCT01090024|65869422|FG014|Period 1|Withdrawal by Subject|0|||
23585212|NCT01090024|65869423|FG015|Period 1|Withdrawal by Subject|0|||
23585213|NCT01090024|65869424|FG016|Period 1|Withdrawal by Subject|0|||
23585214|NCT01090024|65869425|FG017|Period 1|Withdrawal by Subject|0|||
23585215|NCT01090024|65869408|FG000|Period 1|Lost to Follow-up|0|||
23585216|NCT01090024|65869409|FG001|Period 1|Lost to Follow-up|1|||
23585217|NCT01090024|65869410|FG002|Period 1|Lost to Follow-up|0|||
23585218|NCT01090024|65869411|FG003|Period 1|Lost to Follow-up|0|||
23585219|NCT01090024|65869412|FG004|Period 1|Lost to Follow-up|0|||
23585220|NCT01090024|65869413|FG005|Period 1|Lost to Follow-up|0|||
23585221|NCT01090024|65869414|FG006|Period 1|Lost to Follow-up|0|||
23585222|NCT01090024|65869415|FG007|Period 1|Lost to Follow-up|0|||
23585223|NCT01090024|65869416|FG008|Period 1|Lost to Follow-up|0|||
23585224|NCT01090024|65869417|FG009|Period 1|Lost to Follow-up|0|||
23585225|NCT01090024|65869418|FG010|Period 1|Lost to Follow-up|0|||
23585226|NCT01090024|65869419|FG011|Period 1|Lost to Follow-up|0|||
23585227|NCT01090024|65869420|FG012|Period 1|Lost to Follow-up|0|||
23585228|NCT01090024|65869421|FG013|Period 1|Lost to Follow-up|0|||
23585229|NCT01090024|65869422|FG014|Period 1|Lost to Follow-up|0|||
23585230|NCT01090024|65869423|FG015|Period 1|Lost to Follow-up|0|||
23585231|NCT01090024|65869424|FG016|Period 1|Lost to Follow-up|0|||
23585232|NCT01090024|65869425|FG017|Period 1|Lost to Follow-up|0|||
23585233|NCT01090024|65869408|FG000|Period 2|Lost to Follow-up|0|||
23585234|NCT01090024|65869409|FG001|Period 2|Lost to Follow-up|0|||
23585235|NCT01090024|65869410|FG002|Period 2|Lost to Follow-up|0|||
23585236|NCT01090024|65869411|FG003|Period 2|Lost to Follow-up|1|||
23585237|NCT01090024|65869412|FG004|Period 2|Lost to Follow-up|0|||
23585238|NCT01090024|65869413|FG005|Period 2|Lost to Follow-up|0|||
23585239|NCT01090024|65869414|FG006|Period 2|Lost to Follow-up|0|||
23585240|NCT01090024|65869415|FG007|Period 2|Lost to Follow-up|0|||
23585241|NCT01090024|65869416|FG008|Period 2|Lost to Follow-up|0|||
23585242|NCT01090024|65869417|FG009|Period 2|Lost to Follow-up|0|||
23585243|NCT01090024|65869418|FG010|Period 2|Lost to Follow-up|0|||
23585244|NCT01090024|65869419|FG011|Period 2|Lost to Follow-up|0|||
23585245|NCT01090024|65869420|FG012|Period 2|Lost to Follow-up|0|||
23585246|NCT01090024|65869421|FG013|Period 2|Lost to Follow-up|0|||
23585247|NCT01090024|65869422|FG014|Period 2|Lost to Follow-up|0|||
23585248|NCT01090024|65869423|FG015|Period 2|Lost to Follow-up|0|||
23585249|NCT01090024|65869424|FG016|Period 2|Lost to Follow-up|0|||
23585250|NCT01090024|65869425|FG017|Period 2|Lost to Follow-up|0|||
23585251|NCT01090024|65869408|FG000|Period 2|Adverse Event|1|||
23585252|NCT01090024|65869409|FG001|Period 2|Adverse Event|0|||
23585253|NCT01090024|65869410|FG002|Period 2|Adverse Event|0|||
23585254|NCT01090024|65869411|FG003|Period 2|Adverse Event|0|||
23585255|NCT01090024|65869412|FG004|Period 2|Adverse Event|0|||
23585256|NCT01090024|65869413|FG005|Period 2|Adverse Event|0|||
23585257|NCT01090024|65869414|FG006|Period 2|Adverse Event|0|||
23585258|NCT01090024|65869415|FG007|Period 2|Adverse Event|0|||
23585259|NCT01090024|65869416|FG008|Period 2|Adverse Event|0|||
23585260|NCT01090024|65869417|FG009|Period 2|Adverse Event|0|||
23585261|NCT01090024|65869418|FG010|Period 2|Adverse Event|0|||
23585262|NCT01090024|65869419|FG011|Period 2|Adverse Event|0|||
23585263|NCT01090024|65869420|FG012|Period 2|Adverse Event|0|||
23585264|NCT01090024|65869421|FG013|Period 2|Adverse Event|0|||
23585265|NCT01090024|65869422|FG014|Period 2|Adverse Event|0|||
23585266|NCT01090024|65869423|FG015|Period 2|Adverse Event|0|||
23585267|NCT01090024|65869424|FG016|Period 2|Adverse Event|0|||
23585268|NCT01090024|65869425|FG017|Period 2|Adverse Event|0|||
23585269|NCT01090024|65869408|FG000|Period 3|Withdrawal by Subject|0|||
23585270|NCT01090024|65869409|FG001|Period 3|Withdrawal by Subject|0|||
23585271|NCT01090024|65869410|FG002|Period 3|Withdrawal by Subject|0|||
23585272|NCT01090024|65869411|FG003|Period 3|Withdrawal by Subject|0|||
23585273|NCT01090024|65869412|FG004|Period 3|Withdrawal by Subject|0|||
23585274|NCT01090024|65869413|FG005|Period 3|Withdrawal by Subject|0|||
23585275|NCT01090024|65869414|FG006|Period 3|Withdrawal by Subject|0|||
23585276|NCT01090024|65869415|FG007|Period 3|Withdrawal by Subject|0|||
23585277|NCT01090024|65869416|FG008|Period 3|Withdrawal by Subject|0|||
23585278|NCT01090024|65869417|FG009|Period 3|Withdrawal by Subject|0|||
23585279|NCT01090024|65869418|FG010|Period 3|Withdrawal by Subject|0|||
23585280|NCT01090024|65869419|FG011|Period 3|Withdrawal by Subject|0|||
23585281|NCT01090024|65869420|FG012|Period 3|Withdrawal by Subject|0|||
23402771|NCT01446874|65220005|FG002|Overall Study|Not eligible|0|||
23585282|NCT01090024|65869421|FG013|Period 3|Withdrawal by Subject|0|||
23585283|NCT01090024|65869422|FG014|Period 3|Withdrawal by Subject|0|||
23639916|NCT04677179|66067397|FG003|Induction Treatment Period|Physician Decision|0|||
23639917|NCT04677179|66067398|FG004|Induction Treatment Period|Physician Decision|0|||
23585284|NCT01090024|65869423|FG015|Period 3|Withdrawal by Subject|1|||
23585285|NCT01090024|65869424|FG016|Period 3|Withdrawal by Subject|0|||
23585286|NCT01090024|65869425|FG017|Period 3|Withdrawal by Subject|0|||
23585287|NCT01090024|65869408|FG000|Period 3|Protocol Violation|0|||
23585288|NCT01090024|65869409|FG001|Period 3|Protocol Violation|0|||
23639918|NCT04677179|66067399|FG005|Induction Treatment Period|Physician Decision|0|||
23790584|NCT03666143|66612840|FG000|Overall Study|Rolled into extension study|9|||
23790585|NCT03666143|66612840|FG000|Overall Study|Progressive Disease|1|||
23790586|NCT02472639|66612841|FG000|Overall Study|Physician Decision|4|||
23790587|NCT02472639|66612842|FG001|Overall Study|Physician Decision|3|||
23790588|NCT02611362|66612845|FG000|Overall Study|Withdrawal by Subject|7|||
23790589|NCT02611362|66612846|FG001|Overall Study|Withdrawal by Subject|2|||
23790590|NCT02611362|66612845|FG000|Overall Study|Lost to Follow-up|2|||
23790591|NCT02611362|66612846|FG001|Overall Study|Lost to Follow-up|4|||
23790592|NCT01049581|66612847|FG000|Overall Study|Lost to Follow-up|2|||
23790593|NCT01049581|66612848|FG001|Overall Study|Lost to Follow-up|1|||
23790594|NCT03224624|66612849|FG000|Overall Study|Lost to Follow-up|9|||
23790595|NCT03224624|66612850|FG001|Overall Study|Lost to Follow-up|4|||
23790596|NCT03224624|66612849|FG000|Overall Study|Death|1|||
23790597|NCT03224624|66612850|FG001|Overall Study|Death|0|||
23790598|NCT02372006|66612851|FG000|Overall Study|Progressive disease|8|||
23790599|NCT02372006|66612852|FG001|Overall Study|Progressive disease|7|||
23790600|NCT02372006|66612853|FG002|Overall Study|Progressive disease|34|||
23790601|NCT02372006|66612851|FG000|Overall Study|Dose limiting toxicity|0|||
23790602|NCT02372006|66612852|FG001|Overall Study|Dose limiting toxicity|1|||
23790603|NCT02372006|66612853|FG002|Overall Study|Dose limiting toxicity|0|||
23790604|NCT02372006|66612851|FG000|Overall Study|Adverse Event|0|||
23790605|NCT02372006|66612852|FG001|Overall Study|Adverse Event|0|||
23790606|NCT02372006|66612853|FG002|Overall Study|Adverse Event|3|||
23790607|NCT02372006|66612851|FG000|Overall Study|Withdrawal by Subject|0|||
23790608|NCT02372006|66612852|FG001|Overall Study|Withdrawal by Subject|1|||
23790609|NCT02372006|66612853|FG002|Overall Study|Withdrawal by Subject|1|||
23790610|NCT02372006|66612851|FG000|Overall Study|Other reason for not completing|0|||
23790611|NCT02372006|66612852|FG001|Overall Study|Other reason for not completing|0|||
23790612|NCT02372006|66612853|FG002|Overall Study|Other reason for not completing|1|||
23790613|NCT04531527|66612856|FG000|Overall Study|Found to be Ineligible|3|||
23790614|NCT02387762|66612857|FG000|Overall Study|Withdrawal by Subject|1|||
23790615|NCT02387762|66612858|FG001|Overall Study|Withdrawal by Subject|0|||
23790616|NCT01971554|66612859|FG000|Overall Study|Lost to Follow-up|1|||
23790617|NCT01971554|66612860|FG001|Overall Study|Lost to Follow-up|0|||
23790618|NCT01971554|66612861|FG002|Overall Study|Lost to Follow-up|0|||
23790619|NCT01971554|66612862|FG003|Overall Study|Lost to Follow-up|0|||
23790620|NCT01685008|66612863|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
23790621|NCT01685008|66612864|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
23790622|NCT01685008|66612865|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
23790623|NCT01685008|66612866|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
23790624|NCT01685008|66612863|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23790625|NCT01685008|66612864|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
23790626|NCT01685008|66612865|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23790627|NCT01685008|66612866|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23790628|NCT01685008|66612863|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23790629|NCT01685008|66612864|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
23790630|NCT01685008|66612865|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23790631|NCT01685008|66612866|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23790632|NCT01685008|66612863|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
23790633|NCT01685008|66612864|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
23790634|NCT01685008|66612865|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
23790635|NCT01685008|66612866|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
23790636|NCT01685008|66612863|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
23350589|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
23350590|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
23350591|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
23790637|NCT01685008|66612864|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
23350592|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
23350593|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
23350594|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
23350595|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
23350596|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
23350597|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
23790638|NCT01685008|66612865|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
23790639|NCT01685008|66612866|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
23790640|NCT05665387|66612867|FG000|Overall Study|Withdrawal by Subject|1|||
23790641|NCT05665387|66612868|FG001|Overall Study|Withdrawal by Subject|0|||
23790642|NCT05665387|66612869|FG002|Overall Study|Withdrawal by Subject|1|||
23790643|NCT03950674|66612870|FG000|Overall Study|Death|16|||
23790644|NCT03950674|66612871|FG001|Overall Study|Death|15|||
23790645|NCT03950674|66612870|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
23790646|NCT03950674|66612871|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
23790647|NCT00160524|66612872|FG000|Overall Study|Adverse Event|119|||
23790648|NCT00160524|66612872|FG000|Overall Study|Adverse Event and Other|94|||
23790649|NCT00160524|66612872|FG000|Overall Study|Protocol Violation|16|||
23790650|NCT00160524|66612872|FG000|Overall Study|Protocol Violation and Other|2|||
23790651|NCT00160524|66612872|FG000|Overall Study|Withdrawal by Subject|141|||
23790652|NCT00160524|66612872|FG000|Overall Study|Withdrawal by Subject and Other|17|||
23790653|NCT00160524|66612872|FG000|Overall Study|Physician Decision|27|||
23790654|NCT00160524|66612872|FG000|Overall Study|Physician Decision and Other|6|||
23790655|NCT00160524|66612872|FG000|Overall Study|Lost to Follow-up|13|||
23790656|NCT00160524|66612872|FG000|Overall Study|Lost to Follow-up and Other|1|||
23790657|NCT00160524|66612872|FG000|Overall Study|Lack of Efficacy|21|||
23790658|NCT00160524|66612872|FG000|Overall Study|Lack of Efficacy and Other|1|||
23790659|NCT00160524|66612872|FG000|Overall Study|Other|20|||
23790660|NCT02699866|66612873|FG000|Overall Study|Withdrawal by Subject|3|||
23790661|NCT02699866|66612873|FG000|Overall Study|Physician Decision|2|||
23790662|NCT02699866|66612873|FG000|Overall Study|Adverse Event|3|||
23790663|NCT03614728|66612874|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
23790664|NCT03614728|66612875|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23790665|NCT03614728|66612876|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23350598|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
23350599|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
23350600|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
23350601|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
23350602|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
23350603|NCT02631070|65025522|FG000|Overall Study|Withdrawal by Subject|35|||
23350604|NCT02631070|65025523|FG001|Overall Study|Withdrawal by Subject|13|||
23350605|NCT02631070|65025522|FG000|Overall Study|Death|45|||
23350606|NCT02631070|65025523|FG001|Overall Study|Death|24|||
23350607|NCT02631070|65025522|FG000|Overall Study|Lost to Follow-up|5|||
23350608|NCT02631070|65025523|FG001|Overall Study|Lost to Follow-up|1|||
23350609|NCT02631070|65025522|FG000|Overall Study|Transition to rollover protocol|52|||
23350610|NCT02631070|65025523|FG001|Overall Study|Transition to rollover protocol|21|||
23350611|NCT02631070|65025522|FG000|Overall Study|Other reasons|12|||
23350612|NCT02631070|65025523|FG001|Overall Study|Other reasons|5|||
23350613|NCT02943785|65025543|FG000|Overall Study|Adverse Event|112|||
23350614|NCT02943785|65025544|FG001|Overall Study|Adverse Event|97|||
23350615|NCT02943785|65025543|FG000|Overall Study|Withdrawal by Subject|63|||
23350616|NCT02943785|65025544|FG001|Overall Study|Withdrawal by Subject|126|||
23350617|NCT02943785|65025543|FG000|Overall Study|Physician Decision|23|||
23350618|NCT02943785|65025544|FG001|Overall Study|Physician Decision|47|||
23350619|NCT02943785|65025543|FG000|Overall Study|Death|46|||
23350620|NCT02943785|65025544|FG001|Overall Study|Death|46|||
23350621|NCT02943785|65025543|FG000|Overall Study|Lost to Follow-up|1|||
23350622|NCT02943785|65025544|FG001|Overall Study|Lost to Follow-up|0|||
23350623|NCT02943785|65025543|FG000|Overall Study|Other|16|||
23350624|NCT02943785|65025544|FG001|Overall Study|Other|19|||
23350625|NCT02943785|65025543|FG000|Overall Study|Did not receive any study medication|21|||
23350626|NCT02943785|65025544|FG001|Overall Study|Did not receive any study medication|28|||
23790666|NCT03614728|66612877|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23790667|NCT03614728|66612874|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23790668|NCT03614728|66612875|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
23790669|NCT03614728|66612876|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23790670|NCT03614728|66612877|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23790671|NCT01583530|66612878|FG000|Overall Study|Adverse Event|0|||
23585289|NCT01090024|65869410|FG002|Period 3|Protocol Violation|0|||
23790672|NCT01583530|66612879|FG001|Overall Study|Adverse Event|0|||
23790673|NCT01583530|66612880|FG002|Overall Study|Adverse Event|0|||
23790674|NCT01583530|66612881|FG003|Overall Study|Adverse Event|0|||
23790675|NCT01583530|66612882|FG004|Overall Study|Adverse Event|0|||
23790676|NCT01583530|66612883|FG005|Overall Study|Adverse Event|1|||
23790677|NCT01583530|66612878|FG000|Overall Study|Withdrawal by Subject|0|||
23790678|NCT01583530|66612879|FG001|Overall Study|Withdrawal by Subject|3|||
23790679|NCT01583530|66612880|FG002|Overall Study|Withdrawal by Subject|0|||
23790680|NCT01583530|66612881|FG003|Overall Study|Withdrawal by Subject|1|||
23790681|NCT01583530|66612882|FG004|Overall Study|Withdrawal by Subject|1|||
23790682|NCT01583530|66612883|FG005|Overall Study|Withdrawal by Subject|2|||
23790683|NCT01583530|66612878|FG000|Overall Study|Lost to Follow-up|0|||
23790684|NCT01583530|66612879|FG001|Overall Study|Lost to Follow-up|0|||
23790685|NCT01583530|66612880|FG002|Overall Study|Lost to Follow-up|0|||
23790686|NCT01583530|66612881|FG003|Overall Study|Lost to Follow-up|0|||
23790687|NCT01583530|66612882|FG004|Overall Study|Lost to Follow-up|3|||
23790688|NCT01583530|66612883|FG005|Overall Study|Lost to Follow-up|0|||
23790689|NCT01583530|66612878|FG000|Overall Study|Lack of compliance|0|||
23790690|NCT01583530|66612879|FG001|Overall Study|Lack of compliance|0|||
23790691|NCT01583530|66612880|FG002|Overall Study|Lack of compliance|0|||
23790692|NCT01583530|66612881|FG003|Overall Study|Lack of compliance|0|||
23790693|NCT01583530|66612882|FG004|Overall Study|Lack of compliance|1|||
23790694|NCT01583530|66612883|FG005|Overall Study|Lack of compliance|0|||
23790695|NCT02030535|66612884|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
23790696|NCT03920280|66612886|FG000|Overall Study|Adverse Event|2|||
23790697|NCT03920280|66612887|FG001|Overall Study|Adverse Event|3|||
23790698|NCT03920280|66612886|FG000|Overall Study|Lost to Follow-up|0|||
23790699|NCT03920280|66612887|FG001|Overall Study|Lost to Follow-up|1|||
23790700|NCT03920280|66612886|FG000|Overall Study|Withdrawal by Subject|1|||
23790701|NCT03920280|66612887|FG001|Overall Study|Withdrawal by Subject|1|||
23790702|NCT03920280|66612886|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
23790703|NCT03920280|66612887|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
23790704|NCT00965731|66612888|FG000|Overall Study|Death|0|||
23790705|NCT00965731|66612889|FG001|Overall Study|Death|4|||
23790706|NCT00965731|66612888|FG000|Overall Study|Withdrawal by Subject|0|||
23790707|NCT00965731|66612889|FG001|Overall Study|Withdrawal by Subject|1|||
23790708|NCT00965731|66612888|FG000|Overall Study|Other|7|||
23790709|NCT00965731|66612889|FG001|Overall Study|Other|15|||
23790710|NCT04449341|66612892|FG000|Overall Study|Protocol Violation|1|||
23790711|NCT04449341|66612893|FG001|Overall Study|Protocol Violation|0|||
23790712|NCT01266902|66612894|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
23790713|NCT01266902|66612895|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
23585290|NCT01090024|65869411|FG003|Period 3|Protocol Violation|0|||
23790714|NCT01266902|66612896|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
23790715|NCT01266902|66612894|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
23790716|NCT01266902|66612895|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
23790717|NCT01266902|66612896|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
23790718|NCT01266902|66612894|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
23585291|NCT01090024|65869412|FG004|Period 3|Protocol Violation|0|||
23464456|NCT01759446|65444599|FG000|Overall Study|Protocol Violation|1|||
23464457|NCT01759446|65444600|FG001|Overall Study|Protocol Violation|0|||
23464458|NCT01759446|65444601|FG002|Overall Study|Protocol Violation|1|||
23464459|NCT01759446|65444602|FG003|Overall Study|Protocol Violation|0|||
23464460|NCT01759446|65444603|FG004|Overall Study|Protocol Violation|0|||
23464461|NCT01759446|65444599|FG000|Overall Study|Withdrawal by Subject|0|||
23464462|NCT01759446|65444600|FG001|Overall Study|Withdrawal by Subject|1|||
23464463|NCT01759446|65444601|FG002|Overall Study|Withdrawal by Subject|0|||
23464464|NCT01759446|65444602|FG003|Overall Study|Withdrawal by Subject|1|||
23464465|NCT01759446|65444603|FG004|Overall Study|Withdrawal by Subject|0|||
23464466|NCT01658436|65444639|FG000|Overall Study|Adverse Event|6|||
23464467|NCT01658436|65444640|FG001|Overall Study|Adverse Event|5|||
23790719|NCT01266902|66612895|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
23790720|NCT01266902|66612896|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
23790721|NCT01266902|66612894|FG000|Period 1 (Main Study)|Adverse Event|3|||
23790722|NCT01266902|66612895|FG001|Period 1 (Main Study)|Adverse Event|11|||
23790723|NCT01266902|66612896|FG002|Period 1 (Main Study)|Adverse Event|0|||
23790724|NCT01266902|66612894|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
23790725|NCT01266902|66612895|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
23790726|NCT01266902|66612896|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
23790727|NCT01266902|66612894|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
23790728|NCT01266902|66612895|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
23790729|NCT01266902|66612896|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
23790730|NCT01266902|66612894|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
23790731|NCT01266902|66612895|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
23790732|NCT01266902|66612896|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
23790733|NCT01266902|66612894|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
23790734|NCT01266902|66612895|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
23790735|NCT01266902|66612896|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
23790736|NCT01266902|66612894|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
23790737|NCT01266902|66612895|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
23790738|NCT01266902|66612896|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
23790739|NCT01266902|66612894|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
23790740|NCT01266902|66612895|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
23790741|NCT01266902|66612896|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
23790742|NCT02761915|66612901|FG000|Overall Study|Death|3|||
23790743|NCT02761915|66612902|FG001|Overall Study|Death|1|||
23639919|NCT04677179|66067400|FG006|Induction Treatment Period|Physician Decision|0|||
23464468|NCT01658436|65444639|FG000|Overall Study|Physician Decision|1|||
23464469|NCT01658436|65444640|FG001|Overall Study|Physician Decision|0|||
23464470|NCT01658436|65444639|FG000|Overall Study|Progressive disease|12|||
23706199|NCT01258348|66301084|FG003|Overall Study|Progressive Disease|2|||
23790744|NCT02761915|66612903|FG002|Overall Study|Death|1|||
23790745|NCT02761915|66612904|FG003|Overall Study|Death|1|||
23464471|NCT01658436|65444640|FG001|Overall Study|Progressive disease|4|||
23464472|NCT01658436|65444639|FG000|Overall Study|Study terminated by sponsor|0|||
23464473|NCT01658436|65444640|FG001|Overall Study|Study terminated by sponsor|1|||
23464474|NCT01658436|65444639|FG000|Overall Study|Subject/guardian decision|0|||
23464475|NCT01658436|65444640|FG001|Overall Study|Subject/guardian decision|1|||
23464476|NCT01658436|65444639|FG000|Overall Study|Death|1|||
23464477|NCT01658436|65444640|FG001|Overall Study|Death|0|||
23464478|NCT01092546|65444646|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
23464479|NCT01354314|65444656|FG000|Overall Study|Lost to Follow-up|1|||
23464480|NCT01354314|65444657|FG001|Overall Study|Lost to Follow-up|0|||
23464481|NCT01354314|65444658|FG002|Overall Study|Lost to Follow-up|1|||
23464482|NCT01354314|65444659|FG003|Overall Study|Lost to Follow-up|1|||
23464483|NCT01354314|65444656|FG000|Overall Study|Withdrawal by Subject|0|||
23464484|NCT01354314|65444657|FG001|Overall Study|Withdrawal by Subject|0|||
23464485|NCT01354314|65444658|FG002|Overall Study|Withdrawal by Subject|1|||
23464486|NCT01354314|65444659|FG003|Overall Study|Withdrawal by Subject|0|||
23464487|NCT01354314|65444656|FG000|Overall Study|Adverse Event|0|||
23464488|NCT01354314|65444657|FG001|Overall Study|Adverse Event|0|||
23464489|NCT01354314|65444658|FG002|Overall Study|Adverse Event|0|||
23464490|NCT01354314|65444659|FG003|Overall Study|Adverse Event|1|||
23464491|NCT01354314|65444656|FG000|Overall Study|Protocol Violation|1|||
23464492|NCT01354314|65444657|FG001|Overall Study|Protocol Violation|1|||
23464493|NCT01354314|65444658|FG002|Overall Study|Protocol Violation|0|||
23464494|NCT01354314|65444659|FG003|Overall Study|Protocol Violation|0|||
23350627|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23464495|NCT01354314|65444656|FG000|Overall Study|Less than 90% Adherence|4|||
23464496|NCT01354314|65444657|FG001|Overall Study|Less than 90% Adherence|2|||
23464497|NCT01354314|65444658|FG002|Overall Study|Less than 90% Adherence|6|||
23464498|NCT01354314|65444659|FG003|Overall Study|Less than 90% Adherence|4|||
23464499|NCT00198822|65444662|FG000|Overall Study|Lost to Follow-up|14|||
23464500|NCT00198822|65444663|FG001|Overall Study|Lost to Follow-up|20|||
23464501|NCT00198822|65444664|FG002|Overall Study|Lost to Follow-up|21|||
23464502|NCT04292899|65444665|FG000|Overall Study|Death|21|||
23464503|NCT04292899|65444666|FG001|Overall Study|Death|28|||
23464504|NCT04292899|65444667|FG002|Overall Study|Death|188|||
23464505|NCT04292899|65444668|FG003|Overall Study|Death|371|||
23464506|NCT04292899|65444665|FG000|Overall Study|Lost to Follow-up|8|||
23464507|NCT04292899|65444666|FG001|Overall Study|Lost to Follow-up|4|||
23464508|NCT04292899|65444667|FG002|Overall Study|Lost to Follow-up|22|||
23464509|NCT04292899|65444668|FG003|Overall Study|Lost to Follow-up|235|||
23464510|NCT04292899|65444665|FG000|Overall Study|Withdrew consent|1|||
23464511|NCT04292899|65444666|FG001|Overall Study|Withdrew consent|0|||
23464512|NCT04292899|65444667|FG002|Overall Study|Withdrew consent|11|||
23464513|NCT04292899|65444668|FG003|Overall Study|Withdrew consent|32|||
23464514|NCT04292899|65444665|FG000|Overall Study|Adverse Event|2|||
23464515|NCT04292899|65444666|FG001|Overall Study|Adverse Event|1|||
23790746|NCT02761915|66612905|FG004|Overall Study|Death|0|||
23790747|NCT02761915|66612906|FG005|Overall Study|Death|1|||
23790748|NCT02761915|66612901|FG000|Overall Study|Withdrawal by Subject|1|||
23790749|NCT02761915|66612902|FG001|Overall Study|Withdrawal by Subject|0|||
23790750|NCT02761915|66612903|FG002|Overall Study|Withdrawal by Subject|0|||
23790751|NCT02761915|66612904|FG003|Overall Study|Withdrawal by Subject|0|||
23790752|NCT02761915|66612905|FG004|Overall Study|Withdrawal by Subject|1|||
23790753|NCT02761915|66612906|FG005|Overall Study|Withdrawal by Subject|2|||
23790754|NCT02761915|66612901|FG000|Overall Study|Disease Progression|0|||
23790755|NCT02761915|66612902|FG001|Overall Study|Disease Progression|0|||
23790756|NCT02761915|66612903|FG002|Overall Study|Disease Progression|0|||
23790757|NCT02761915|66612904|FG003|Overall Study|Disease Progression|2|||
23790758|NCT02761915|66612905|FG004|Overall Study|Disease Progression|2|||
23790759|NCT02761915|66612906|FG005|Overall Study|Disease Progression|2|||
23790760|NCT01971645|66612907|FG000|Overall Study|Adverse Event|1|||
23790761|NCT01971645|66612908|FG001|Overall Study|Adverse Event|0|||
23790762|NCT01971645|66612909|FG002|Overall Study|Adverse Event|0|||
23585292|NCT01090024|65869413|FG005|Period 3|Protocol Violation|0|||
23790763|NCT01971645|66612907|FG000|Overall Study|Lost to Follow-up|1|||
23350628|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
23464516|NCT04292899|65444667|FG002|Overall Study|Adverse Event|2|||
23464517|NCT04292899|65444668|FG003|Overall Study|Adverse Event|2|||
23585293|NCT01090024|65869414|FG006|Period 3|Protocol Violation|0|||
23464518|NCT04292899|65444665|FG000|Overall Study|Investigator's Discretion|0|||
23464519|NCT04292899|65444666|FG001|Overall Study|Investigator's Discretion|0|||
23464520|NCT04292899|65444667|FG002|Overall Study|Investigator's Discretion|0|||
23464521|NCT04292899|65444668|FG003|Overall Study|Investigator's Discretion|3|||
23464522|NCT04292899|65444665|FG000|Overall Study|Non-compliance With Study Drug|0|||
23464523|NCT04292899|65444666|FG001|Overall Study|Non-compliance With Study Drug|0|||
23790764|NCT01971645|66612908|FG001|Overall Study|Lost to Follow-up|0|||
23790765|NCT01971645|66612909|FG002|Overall Study|Lost to Follow-up|1|||
23790766|NCT01971645|66612907|FG000|Overall Study|Protocol Violation|0|||
23790767|NCT01971645|66612908|FG001|Overall Study|Protocol Violation|0|||
23464524|NCT04292899|65444667|FG002|Overall Study|Non-compliance With Study Drug|0|||
23464525|NCT04292899|65444668|FG003|Overall Study|Non-compliance With Study Drug|1|||
23464526|NCT04292899|65444665|FG000|Overall Study|Protocol Violation|0|||
23464527|NCT04292899|65444666|FG001|Overall Study|Protocol Violation|0|||
23464528|NCT04292899|65444667|FG002|Overall Study|Protocol Violation|0|||
23464529|NCT04292899|65444668|FG003|Overall Study|Protocol Violation|1|||
23464530|NCT01668589|65444669|FG000|Overall Study|Lost to Follow-up|29|||
23464531|NCT01668589|65444670|FG001|Overall Study|Lost to Follow-up|37|||
23464532|NCT01668589|65444671|FG002|Overall Study|Lost to Follow-up|15|||
23464533|NCT01668589|65444672|FG003|Overall Study|Lost to Follow-up|5|||
23464534|NCT01668589|65444669|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
23464535|NCT01668589|65444670|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
23464536|NCT01668589|65444671|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
23464537|NCT01668589|65444672|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
23464538|NCT01668589|65444669|FG000|Overall Study|Death|12|||
23464539|NCT01668589|65444670|FG001|Overall Study|Death|3|||
23464540|NCT01668589|65444671|FG002|Overall Study|Death|2|||
23464541|NCT01668589|65444672|FG003|Overall Study|Death|11|||
23464542|NCT01668589|65444669|FG000|Overall Study|Other|44|||
23464543|NCT01668589|65444670|FG001|Overall Study|Other|10|||
23464544|NCT01668589|65444671|FG002|Overall Study|Other|7|||
23464545|NCT01668589|65444672|FG003|Overall Study|Other|15|||
23464546|NCT01021020|65444673|FG000|Period I|Protocol Violation|1|||
23464547|NCT01021020|65444673|FG000|Period I|Withdrawal by Subject|1|||
23464548|NCT01021020|65444673|FG000|14 Day Washout Period A|Physician Decision|1|||
23464549|NCT00815659|65444674|FG000|Overall Study|Adverse Event|9|||
23464550|NCT00815659|65444674|FG000|Overall Study|Withdrawal by Subject|9|||
23464551|NCT00815659|65444674|FG000|Overall Study|Lost to Follow-up|4|||
23464552|NCT00815659|65444674|FG000|Overall Study|Protocol Violation|1|||
23464553|NCT00891904|65444675|FG000|Overall Study|Death|1|||
23464554|NCT00891904|65444675|FG000|Overall Study|Adverse Event|1|||
23464555|NCT00831181|65444676|FG000|Overall Study|Adverse Event|12|||
23464556|NCT00071058|65444677|FG000|Overall Study|brain tumor-removed from study|1|||
23464557|NCT01472289|65444680|FG000|Overall Study|Death|2|||
23464558|NCT02055118|65444681|FG000|Overall Study|Withdrawal by Subject|0|||
23464559|NCT02055118|65444682|FG001|Overall Study|Withdrawal by Subject|2|||
23464560|NCT02055118|65444683|FG002|Overall Study|Withdrawal by Subject|0|||
23464561|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
23464562|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
23464563|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
23464564|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
23464565|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
23464566|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
23464567|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Recurrence|2|||
23464568|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Recurrence|0|||
23464569|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Adverse Event|2|||
23464570|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Adverse Event|6|||
23464571|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Participant wishes|12|||
23464572|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Participant wishes|7|||
23464573|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Physician Decision|2|||
23464574|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Physician Decision|1|||
23464575|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
23464576|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
23464577|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Death|0|||
23464578|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Death|1|||
23464579|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
23464580|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
23464581|NCT02035267|65444691|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
23464582|NCT02035267|65444692|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
23464583|NCT02035267|65444693|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
23464584|NCT02035267|65444694|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
23464585|NCT02035267|65444691|FG000|Overall Study|Adverse Event|0|||
23464586|NCT02035267|65444692|FG001|Overall Study|Adverse Event|0|||
23585294|NCT01090024|65869415|FG007|Period 3|Protocol Violation|0|||
23464587|NCT02035267|65444693|FG002|Overall Study|Adverse Event|1|||
23464588|NCT02035267|65444694|FG003|Overall Study|Adverse Event|0|||
23464589|NCT02035267|65444691|FG000|Overall Study|Lost to Follow-up|0|||
23464590|NCT02035267|65444692|FG001|Overall Study|Lost to Follow-up|0|||
23464591|NCT02035267|65444693|FG002|Overall Study|Lost to Follow-up|0|||
23464592|NCT02035267|65444694|FG003|Overall Study|Lost to Follow-up|1|||
23464593|NCT02035267|65444691|FG000|Overall Study|Other unspecified|0|||
23464594|NCT02035267|65444692|FG001|Overall Study|Other unspecified|1|||
23464595|NCT02035267|65444693|FG002|Overall Study|Other unspecified|0|||
23464596|NCT02035267|65444694|FG003|Overall Study|Other unspecified|0|||
23464597|NCT03774576|65444695|FG000|Period 2|Adverse Event|1|||
23464598|NCT01442103|65444696|FG000|Overall Study|Lost to Follow-up|2|||
23464599|NCT02454517|65444697|FG000|Overall Study|Withdrawal by Subject|3|||
23464600|NCT02454517|65444698|FG001|Overall Study|Withdrawal by Subject|0|||
23464601|NCT02454517|65444697|FG000|Overall Study|Lost to Follow-up|4|||
23464602|NCT02454517|65444698|FG001|Overall Study|Lost to Follow-up|7|||
23464603|NCT02454517|65444697|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
23464604|NCT02454517|65444698|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
23585295|NCT01090024|65869416|FG008|Period 3|Protocol Violation|1|||
23585296|NCT01090024|65869417|FG009|Period 3|Protocol Violation|0|||
23585297|NCT01090024|65869418|FG010|Period 3|Protocol Violation|0|||
23585298|NCT01090024|65869419|FG011|Period 3|Protocol Violation|0|||
23585299|NCT01090024|65869420|FG012|Period 3|Protocol Violation|0|||
23585300|NCT01090024|65869421|FG013|Period 3|Protocol Violation|0|||
23585301|NCT01090024|65869422|FG014|Period 3|Protocol Violation|0|||
23585302|NCT01090024|65869423|FG015|Period 3|Protocol Violation|0|||
23585303|NCT01090024|65869424|FG016|Period 3|Protocol Violation|0|||
23585304|NCT01090024|65869425|FG017|Period 3|Protocol Violation|0|||
23585305|NCT01090024|65869408|FG000|Period 3|Adverse Event|0|||
23585306|NCT01090024|65869409|FG001|Period 3|Adverse Event|0|||
23585307|NCT01090024|65869410|FG002|Period 3|Adverse Event|0|||
23585308|NCT01090024|65869411|FG003|Period 3|Adverse Event|0|||
23585309|NCT01090024|65869412|FG004|Period 3|Adverse Event|0|||
23585310|NCT01090024|65869413|FG005|Period 3|Adverse Event|1|||
23585311|NCT01090024|65869414|FG006|Period 3|Adverse Event|0|||
23585312|NCT01090024|65869415|FG007|Period 3|Adverse Event|0|||
23585313|NCT01090024|65869416|FG008|Period 3|Adverse Event|0|||
23585314|NCT01090024|65869417|FG009|Period 3|Adverse Event|0|||
23585315|NCT01090024|65869418|FG010|Period 3|Adverse Event|0|||
23585316|NCT01090024|65869419|FG011|Period 3|Adverse Event|0|||
23585317|NCT01090024|65869420|FG012|Period 3|Adverse Event|0|||
23585318|NCT01090024|65869421|FG013|Period 3|Adverse Event|0|||
23585319|NCT01090024|65869422|FG014|Period 3|Adverse Event|0|||
23585320|NCT01090024|65869423|FG015|Period 3|Adverse Event|0|||
23585321|NCT01090024|65869424|FG016|Period 3|Adverse Event|0|||
23585322|NCT01090024|65869425|FG017|Period 3|Adverse Event|0|||
23585323|NCT00290706|65869426|FG000|Overall Study|Withdrawal by Subject|2|||
23585324|NCT00290706|65869427|FG001|Overall Study|Withdrawal by Subject|0|||
23585325|NCT00290706|65869428|FG002|Overall Study|Withdrawal by Subject|0|||
23585326|NCT00290706|65869429|FG003|Overall Study|Withdrawal by Subject|0|||
23585327|NCT00290706|65869426|FG000|Overall Study|Progressive Disease|3|||
23585328|NCT00290706|65869427|FG001|Overall Study|Progressive Disease|5|||
23790768|NCT01971645|66612909|FG002|Overall Study|Protocol Violation|1|||
23790769|NCT00396630|66612910|FG000|Overall Study|Lost to Follow-up|1|||
23790770|NCT00396630|66612911|FG001|Overall Study|Lost to Follow-up|1|||
23790771|NCT00396630|66612910|FG000|Overall Study|Withdrawal by Subject|1|||
23790772|NCT00396630|66612911|FG001|Overall Study|Withdrawal by Subject|1|||
23790773|NCT00396630|66612910|FG000|Overall Study|Not vaccinated at Visit 3|3|||
23790774|NCT00396630|66612911|FG001|Overall Study|Not vaccinated at Visit 3|3|||
23585329|NCT00290706|65869428|FG002|Overall Study|Progressive Disease|4|||
23585330|NCT00290706|65869429|FG003|Overall Study|Progressive Disease|10|||
23585331|NCT00290706|65869426|FG000|Overall Study|Adverse Event|0|||
23585332|NCT00290706|65869427|FG001|Overall Study|Adverse Event|1|||
23585333|NCT00290706|65869428|FG002|Overall Study|Adverse Event|2|||
23706200|NCT01258348|66301085|FG004|Overall Study|Progressive Disease|2|||
23790775|NCT02436200|66612912|FG000|Overall Study|Significant outlier|1|||
23790776|NCT01598896|66612913|FG000|Overall Study|Withdrawal by Subject|0|||
23790777|NCT01598896|66612914|FG001|Overall Study|Withdrawal by Subject|1|||
23790778|NCT01598896|66612913|FG000|Overall Study|Lack of Efficacy|0|||
23790779|NCT01598896|66612914|FG001|Overall Study|Lack of Efficacy|1|||
23790780|NCT02218216|66612917|FG000|Overall Study|Study terminated before completed|6|||
23790781|NCT02218216|66612918|FG001|Overall Study|Study terminated before completed|0|||
23585334|NCT00290706|65869429|FG003|Overall Study|Adverse Event|0|||
23585335|NCT00290706|65869426|FG000|Overall Study|Receive auto transplant or radiation|0|||
23585336|NCT00290706|65869427|FG001|Overall Study|Receive auto transplant or radiation|0|||
23585337|NCT00290706|65869428|FG002|Overall Study|Receive auto transplant or radiation|0|||
23585338|NCT00290706|65869429|FG003|Overall Study|Receive auto transplant or radiation|1|||
23585339|NCT00290706|65869426|FG000|Overall Study|Physician Decision|0|||
23464605|NCT03818321|65444701|FG000|Overall Study|Withdrawal by Subject|1|||
23464606|NCT03818321|65444702|FG001|Overall Study|Withdrawal by Subject|2|||
23585340|NCT00290706|65869427|FG001|Overall Study|Physician Decision|0|||
23585341|NCT00290706|65869428|FG002|Overall Study|Physician Decision|0|||
23585342|NCT00290706|65869429|FG003|Overall Study|Physician Decision|1|||
23585343|NCT00771667|65869430|FG000|Induction Phase|Adverse Event|5|||
23585344|NCT00771667|65869431|FG001|Induction Phase|Adverse Event|2|||
23585345|NCT00771667|65869432|FG002|Induction Phase|Adverse Event|4|||
23585346|NCT00771667|65869433|FG003|Induction Phase|Adverse Event|1|||
23790782|NCT02218216|66612919|FG002|Overall Study|Study terminated before completed|0|||
23585347|NCT00771667|65869434|FG004|Induction Phase|Adverse Event|0|||
23585348|NCT00771667|65869435|FG005|Induction Phase|Adverse Event|0|||
23790783|NCT00685334|66612920|FG000|Overall Study|Withdrawal by Subject|5|||
23790784|NCT00685334|66612921|FG001|Overall Study|Withdrawal by Subject|6|||
23464607|NCT02453321|65444703|FG000|Overall Study|Weakness|1|||
23464608|NCT02453321|65444704|FG001|Overall Study|Weakness|1|||
23464609|NCT02453321|65444705|FG002|Overall Study|Weakness|2|||
23464610|NCT02453321|65444703|FG000|Overall Study|Deep Venous Thrombosis|0|||
23464611|NCT02453321|65444704|FG001|Overall Study|Deep Venous Thrombosis|1|||
23464612|NCT02453321|65444705|FG002|Overall Study|Deep Venous Thrombosis|0|||
23464613|NCT04639258|65444706|FG000|Overall Study|Screen failure|5|||
23464614|NCT04639258|65444706|FG000|Overall Study|Physician Decision|2|||
23464615|NCT04639258|65444706|FG000|Overall Study|Early study termination|3|||
23464616|NCT04639258|65444706|FG000|Overall Study|Withdrawal by Subject|1|||
23464617|NCT02531802|65444707|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
23464618|NCT02531802|65444708|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
23464619|NCT02531802|65444709|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
23464620|NCT02531802|65444710|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
23464621|NCT02531802|65444711|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
23464622|NCT02531802|65444712|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
23464623|NCT02531802|65444713|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
23464624|NCT02531802|65444714|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
23464625|NCT02531802|65444715|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
23464626|NCT02531802|65444716|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
23464627|NCT02531802|65444717|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
23464628|NCT02531802|65444718|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
23464629|NCT02531802|65444719|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
23464630|NCT02531802|65444720|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
23464631|NCT02531802|65444721|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
23464632|NCT02531802|65444722|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
23464633|NCT02531802|65444723|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
23464634|NCT02531802|65444724|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
23464635|NCT02531802|65444725|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
23464636|NCT02531802|65444726|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
23464637|NCT02531802|65444727|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
23464638|NCT02531802|65444707|FG000|Received Vaccination 2|Physician Decision|0|||
23464639|NCT02531802|65444708|FG001|Received Vaccination 2|Physician Decision|0|||
23464640|NCT02531802|65444709|FG002|Received Vaccination 2|Physician Decision|0|||
23464641|NCT02531802|65444710|FG003|Received Vaccination 2|Physician Decision|0|||
23464642|NCT02531802|65444711|FG004|Received Vaccination 2|Physician Decision|0|||
23464643|NCT02531802|65444712|FG005|Received Vaccination 2|Physician Decision|1|||
23464644|NCT02531802|65444713|FG006|Received Vaccination 2|Physician Decision|0|||
23790785|NCT00685334|66612920|FG000|Overall Study|Lost to Follow-up|4|||
23790786|NCT00685334|66612921|FG001|Overall Study|Lost to Follow-up|0|||
23790787|NCT00685334|66612920|FG000|Overall Study|Chose to enter hospital|1|||
23790788|NCT00685334|66612921|FG001|Overall Study|Chose to enter hospital|1|||
23790789|NCT00697827|66612922|FG000|Overall Study|enrolled but not treated|2|||
23790790|NCT00697827|66612923|FG001|Overall Study|enrolled but not treated|1|||
23790791|NCT01044433|66612924|FG000|Overall Study|Lost to Follow-up|3|||
23790792|NCT01044433|66612924|FG000|Overall Study|Withdrawal by Subject|3|||
23790793|NCT00757172|66612928|FG000|Overall Study|Withdrawal by Subject|4|||
23790794|NCT00757172|66612928|FG000|Overall Study|Physician Decision|3|||
23790795|NCT00757172|66612928|FG000|Overall Study|Progression|4|||
23790796|NCT02705716|66612930|FG000|Overall Study|Adverse Event|0|||
23790797|NCT02705716|66612931|FG001|Overall Study|Adverse Event|1|||
23790798|NCT02705716|66612930|FG000|Overall Study|Protocol Violation|3|||
23790799|NCT02705716|66612931|FG001|Overall Study|Protocol Violation|0|||
23790800|NCT02705716|66612930|FG000|Overall Study|Withdrawal of Consent|1|||
23790801|NCT02705716|66612931|FG001|Overall Study|Withdrawal of Consent|1|||
23790802|NCT01450800|66612932|FG000|Overall Study|Protocol Violation|1|||
23790803|NCT01450800|66612933|FG001|Overall Study|Protocol Violation|3|||
23790804|NCT01401062|66612934|FG000|Overall Study|Death|9|||
23464645|NCT02531802|65444714|FG007|Received Vaccination 2|Physician Decision|0|||
23464646|NCT02531802|65444715|FG008|Received Vaccination 2|Physician Decision|0|||
23464647|NCT02531802|65444716|FG009|Received Vaccination 2|Physician Decision|2|||
23464648|NCT02531802|65444717|FG010|Received Vaccination 2|Physician Decision|0|||
23790805|NCT01401062|66612935|FG001|Overall Study|Death|7|||
23790806|NCT01401062|66612934|FG000|Overall Study|Physician Decision|1|||
23464649|NCT02531802|65444718|FG011|Received Vaccination 2|Physician Decision|0|||
23790807|NCT01401062|66612935|FG001|Overall Study|Physician Decision|0|||
23790808|NCT01401062|66612934|FG000|Overall Study|Withdrawal by Subject|1|||
23790809|NCT01401062|66612935|FG001|Overall Study|Withdrawal by Subject|1|||
23464650|NCT02531802|65444719|FG012|Received Vaccination 2|Physician Decision|0|||
23464651|NCT02531802|65444720|FG013|Received Vaccination 2|Physician Decision|1|||
23464652|NCT02531802|65444721|FG014|Received Vaccination 2|Physician Decision|0|||
23464653|NCT02531802|65444722|FG015|Received Vaccination 2|Physician Decision|0|||
23790810|NCT00688844|66612936|FG000|Overall Study|Lost to Follow-up|10|||
23790811|NCT02986139|66612938|FG000|Overall Study|Sponsor Decision|1|||
23790812|NCT02986139|66612939|FG001|Overall Study|Sponsor Decision|2|||
23790813|NCT02986139|66612938|FG000|Overall Study|Withdrawal by Subject|0|||
23790814|NCT02986139|66612939|FG001|Overall Study|Withdrawal by Subject|1|||
23790815|NCT02986139|66612938|FG000|Overall Study|Lost to Follow-up|0|||
23790816|NCT02986139|66612939|FG001|Overall Study|Lost to Follow-up|1|||
23790817|NCT02121184|66612940|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
23790818|NCT02121184|66612941|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
23790819|NCT02121184|66612940|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
23790820|NCT02121184|66612941|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
23464654|NCT02531802|65444723|FG016|Received Vaccination 2|Physician Decision|0|||
23464655|NCT02531802|65444724|FG017|Received Vaccination 2|Physician Decision|1|||
23464656|NCT02531802|65444725|FG018|Received Vaccination 2|Physician Decision|0|||
23464657|NCT02531802|65444726|FG019|Received Vaccination 2|Physician Decision|0|||
23464658|NCT02531802|65444727|FG020|Received Vaccination 2|Physician Decision|0|||
23464659|NCT02531802|65444707|FG000|Received Vaccination 2|Adverse Event|0|||
23464660|NCT02531802|65444708|FG001|Received Vaccination 2|Adverse Event|0|||
23464661|NCT02531802|65444709|FG002|Received Vaccination 2|Adverse Event|0|||
23464662|NCT02531802|65444710|FG003|Received Vaccination 2|Adverse Event|0|||
23464663|NCT02531802|65444711|FG004|Received Vaccination 2|Adverse Event|0|||
23464664|NCT02531802|65444712|FG005|Received Vaccination 2|Adverse Event|2|||
23464665|NCT02531802|65444713|FG006|Received Vaccination 2|Adverse Event|0|||
23464666|NCT02531802|65444714|FG007|Received Vaccination 2|Adverse Event|0|||
23464667|NCT02531802|65444715|FG008|Received Vaccination 2|Adverse Event|0|||
23464668|NCT02531802|65444716|FG009|Received Vaccination 2|Adverse Event|0|||
23464669|NCT02531802|65444717|FG010|Received Vaccination 2|Adverse Event|0|||
23790821|NCT02121184|66612940|FG000|Overall Study|Emergency cesarean section required|0|||
23790822|NCT02121184|66612941|FG001|Overall Study|Emergency cesarean section required|2|||
23790823|NCT02121184|66612940|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
23790824|NCT02121184|66612941|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
23790825|NCT01344018|66612942|FG000|Overall Study|Death|22|||
23790826|NCT01344018|66612943|FG001|Overall Study|Death|25|||
23790827|NCT01344018|66612942|FG000|Overall Study|Lost to Follow-up|4|||
23790828|NCT01344018|66612943|FG001|Overall Study|Lost to Follow-up|7|||
23790829|NCT02050321|66612944|FG000|Overall Study|Withdrawal by Subject|1|||
23790830|NCT02050321|66612944|FG000|Overall Study|Adverse Event|1|||
23790831|NCT01559116|66612945|FG000|Overall Study|Adverse Event|10|||
23790832|NCT01559116|66612945|FG000|Overall Study|Lack of Efficacy|1|||
23790833|NCT01559116|66612945|FG000|Overall Study|Lost to Follow-up|1|||
23790834|NCT01559116|66612945|FG000|Overall Study|Protocol Violation|1|||
23790835|NCT01559116|66612945|FG000|Overall Study|Withdrawal by Subject|4|||
23790836|NCT01559116|66612945|FG000|Overall Study|other than stated above|9|||
23790837|NCT01253564|66612949|FG000|Overall Study|Disease Progression|22|||
23790838|NCT01253564|66612949|FG000|Overall Study|Withdrawal by Subject|1|||
23790839|NCT01253564|66612949|FG000|Overall Study|Serious Adverse Event|1|||
23790840|NCT01924364|66612956|FG000|Overall Study|Physician Decision|3|||
23790841|NCT02219009|66612957|FG000|Overall Study|Withdrawal by Subject|5|||
23790842|NCT02219009|66612958|FG001|Overall Study|Withdrawal by Subject|1|||
23790843|NCT02219009|66612957|FG000|Overall Study|Adverse Event|2|||
23790844|NCT02219009|66612958|FG001|Overall Study|Adverse Event|4|||
23790845|NCT02219009|66612957|FG000|Overall Study|Lost to Follow-up|2|||
23790846|NCT02219009|66612958|FG001|Overall Study|Lost to Follow-up|2|||
23790847|NCT02219009|66612957|FG000|Overall Study|Protocol deviation|1|||
23790848|NCT02219009|66612958|FG001|Overall Study|Protocol deviation|0|||
23790849|NCT02219009|66612957|FG000|Overall Study|Physician Decision|0|||
23790850|NCT02219009|66612958|FG001|Overall Study|Physician Decision|1|||
23790851|NCT00695110|66612959|FG000|Treatment Period 1|Adverse Event|1|||
23790852|NCT00695110|66612959|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23464670|NCT02531802|65444718|FG011|Received Vaccination 2|Adverse Event|0|||
23464671|NCT02531802|65444719|FG012|Received Vaccination 2|Adverse Event|0|||
23464672|NCT02531802|65444720|FG013|Received Vaccination 2|Adverse Event|0|||
23464673|NCT02531802|65444721|FG014|Received Vaccination 2|Adverse Event|0|||
23585349|NCT00771667|65869436|FG006|Induction Phase|Adverse Event|0|||
23790853|NCT00695110|66612959|FG000|Treatment Period 3|Withdrawal by Subject|1|||
23790854|NCT00695110|66612959|FG000|Treatment Period 4|Adverse Event|1|||
23790855|NCT01972841|66612960|FG000|Overall Study|Randomized but Never Received Treatment|2|||
23790856|NCT01972841|66612961|FG001|Overall Study|Randomized but Never Received Treatment|5|||
23790857|NCT01972841|66612962|FG002|Overall Study|Randomized but Never Received Treatment|4|||
23790858|NCT01972841|66612963|FG003|Overall Study|Randomized but Never Received Treatment|2|||
23790859|NCT01972841|66612964|FG004|Overall Study|Randomized but Never Received Treatment|6|||
23790860|NCT01972841|66612965|FG005|Overall Study|Randomized but Never Received Treatment|13|||
23790861|NCT01972841|66612960|FG000|Overall Study|Adverse Event|13|||
23790862|NCT01972841|66612961|FG001|Overall Study|Adverse Event|8|||
23790863|NCT01972841|66612962|FG002|Overall Study|Adverse Event|12|||
23790864|NCT01972841|66612963|FG003|Overall Study|Adverse Event|9|||
23790865|NCT01972841|66612964|FG004|Overall Study|Adverse Event|21|||
23790866|NCT01972841|66612965|FG005|Overall Study|Adverse Event|26|||
23790867|NCT01972841|66612960|FG000|Overall Study|Lack of Efficacy|1|||
23790868|NCT01972841|66612961|FG001|Overall Study|Lack of Efficacy|0|||
23790869|NCT01972841|66612962|FG002|Overall Study|Lack of Efficacy|0|||
23790870|NCT01972841|66612963|FG003|Overall Study|Lack of Efficacy|2|||
23790871|NCT01972841|66612964|FG004|Overall Study|Lack of Efficacy|4|||
23790872|NCT01972841|66612965|FG005|Overall Study|Lack of Efficacy|1|||
23790873|NCT01972841|66612960|FG000|Overall Study|Lost to Follow-up|4|||
23790874|NCT01972841|66612961|FG001|Overall Study|Lost to Follow-up|2|||
23790875|NCT01972841|66612962|FG002|Overall Study|Lost to Follow-up|4|||
23790876|NCT01972841|66612963|FG003|Overall Study|Lost to Follow-up|2|||
23790877|NCT01972841|66612964|FG004|Overall Study|Lost to Follow-up|9|||
23790878|NCT01972841|66612965|FG005|Overall Study|Lost to Follow-up|3|||
23790879|NCT01972841|66612960|FG000|Overall Study|Protocol Violation|2|||
23790880|NCT01972841|66612961|FG001|Overall Study|Protocol Violation|2|||
23790881|NCT01972841|66612962|FG002|Overall Study|Protocol Violation|3|||
23790882|NCT01972841|66612963|FG003|Overall Study|Protocol Violation|5|||
23790883|NCT01972841|66612964|FG004|Overall Study|Protocol Violation|9|||
23790884|NCT01972841|66612965|FG005|Overall Study|Protocol Violation|4|||
23790885|NCT01972841|66612960|FG000|Overall Study|Withdrawal by participants|21|||
23790886|NCT01972841|66612961|FG001|Overall Study|Withdrawal by participants|27|||
23790887|NCT01972841|66612962|FG002|Overall Study|Withdrawal by participants|23|||
23790888|NCT01972841|66612963|FG003|Overall Study|Withdrawal by participants|16|||
23790889|NCT01972841|66612964|FG004|Overall Study|Withdrawal by participants|33|||
23790890|NCT01972841|66612965|FG005|Overall Study|Withdrawal by participants|34|||
23790891|NCT01972841|66612960|FG000|Overall Study|Miscellaneous|0|||
23790892|NCT01972841|66612961|FG001|Overall Study|Miscellaneous|0|||
23790893|NCT01972841|66612962|FG002|Overall Study|Miscellaneous|4|||
23790894|NCT01972841|66612963|FG003|Overall Study|Miscellaneous|1|||
23790895|NCT01972841|66612964|FG004|Overall Study|Miscellaneous|0|||
23790896|NCT01972841|66612965|FG005|Overall Study|Miscellaneous|4|||
23790897|NCT01972841|66612960|FG000|Overall Study|Did not have end of treatment page|0|||
23790898|NCT01972841|66612961|FG001|Overall Study|Did not have end of treatment page|0|||
23464674|NCT02531802|65444722|FG015|Received Vaccination 2|Adverse Event|0|||
23464675|NCT02531802|65444723|FG016|Received Vaccination 2|Adverse Event|0|||
23464676|NCT02531802|65444724|FG017|Received Vaccination 2|Adverse Event|2|||
23464677|NCT02531802|65444725|FG018|Received Vaccination 2|Adverse Event|1|||
23464678|NCT02531802|65444726|FG019|Received Vaccination 2|Adverse Event|0|||
23464679|NCT02531802|65444727|FG020|Received Vaccination 2|Adverse Event|1|||
23464680|NCT02531802|65444707|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23464681|NCT02531802|65444708|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23790899|NCT01972841|66612962|FG002|Overall Study|Did not have end of treatment page|0|||
23790900|NCT01972841|66612963|FG003|Overall Study|Did not have end of treatment page|0|||
23790901|NCT01972841|66612964|FG004|Overall Study|Did not have end of treatment page|1|||
23790902|NCT01972841|66612965|FG005|Overall Study|Did not have end of treatment page|0|||
23790903|NCT00372996|66612966|FG000|Overall Study|Death|11|||
23790904|NCT00372996|66612967|FG001|Overall Study|Death|4|||
23790905|NCT00372996|66612968|FG002|Overall Study|Death|8|||
23790906|NCT00372996|66612969|FG003|Overall Study|Death|7|||
23585350|NCT00771667|65869437|FG007|Induction Phase|Adverse Event|0|||
23585351|NCT00771667|65869438|FG008|Induction Phase|Adverse Event|0|||
23585352|NCT00771667|65869439|FG009|Induction Phase|Adverse Event|0|||
23585353|NCT00771667|65869430|FG000|Induction Phase|Lack of Efficacy|9|||
23585354|NCT00771667|65869431|FG001|Induction Phase|Lack of Efficacy|2|||
23585355|NCT00771667|65869432|FG002|Induction Phase|Lack of Efficacy|4|||
23585356|NCT00771667|65869433|FG003|Induction Phase|Lack of Efficacy|3|||
23585357|NCT00771667|65869434|FG004|Induction Phase|Lack of Efficacy|0|||
23585358|NCT00771667|65869435|FG005|Induction Phase|Lack of Efficacy|0|||
23585359|NCT00771667|65869436|FG006|Induction Phase|Lack of Efficacy|0|||
23585360|NCT00771667|65869437|FG007|Induction Phase|Lack of Efficacy|0|||
23585361|NCT00771667|65869438|FG008|Induction Phase|Lack of Efficacy|0|||
23585362|NCT00771667|65869439|FG009|Induction Phase|Lack of Efficacy|0|||
23790907|NCT00372996|66612966|FG000|Overall Study|Lost to Follow-up|0|||
23790908|NCT00372996|66612967|FG001|Overall Study|Lost to Follow-up|2|||
23790909|NCT00372996|66612968|FG002|Overall Study|Lost to Follow-up|0|||
23790910|NCT00372996|66612969|FG003|Overall Study|Lost to Follow-up|1|||
23790911|NCT00372996|66612966|FG000|Overall Study|Withdrawal by Subject|12|||
23790912|NCT00372996|66612967|FG001|Overall Study|Withdrawal by Subject|6|||
23790913|NCT00372996|66612968|FG002|Overall Study|Withdrawal by Subject|9|||
23790914|NCT00372996|66612969|FG003|Overall Study|Withdrawal by Subject|5|||
23790915|NCT00372996|66612966|FG000|Overall Study|Study Terminated by Sponsor|4|||
23790916|NCT00372996|66612967|FG001|Overall Study|Study Terminated by Sponsor|0|||
23790917|NCT00372996|66612968|FG002|Overall Study|Study Terminated by Sponsor|4|||
23790918|NCT00372996|66612969|FG003|Overall Study|Study Terminated by Sponsor|0|||
23790919|NCT00372996|66612966|FG000|Overall Study|Other|10|||
23790920|NCT00372996|66612967|FG001|Overall Study|Other|2|||
23790921|NCT00372996|66612968|FG002|Overall Study|Other|7|||
23790922|NCT00372996|66612969|FG003|Overall Study|Other|7|||
23790923|NCT00301964|66612970|FG000|Overall Study|Second primary|2|||
23790924|NCT00301964|66612970|FG000|Overall Study|Wrong primary|1|||
23790925|NCT00301964|66612970|FG000|Overall Study|Inadequate pathology|1|||
23790926|NCT00884390|66612971|FG000|Overall Study|Adverse Event|0|||
23790927|NCT00884390|66612972|FG001|Overall Study|Adverse Event|1|||
23790928|NCT00884390|66612971|FG000|Overall Study|Lost to Follow-up|0|||
23790929|NCT00884390|66612972|FG001|Overall Study|Lost to Follow-up|1|||
23790930|NCT00884390|66612971|FG000|Overall Study|Physician Decision|2|||
23790931|NCT00884390|66612972|FG001|Overall Study|Physician Decision|1|||
23790932|NCT00884390|66612971|FG000|Overall Study|Protocol Violation|4|||
23790933|NCT00884390|66612972|FG001|Overall Study|Protocol Violation|1|||
23790934|NCT00884390|66612971|FG000|Overall Study|Withdrawal by Subject|4|||
23790935|NCT00884390|66612972|FG001|Overall Study|Withdrawal by Subject|1|||
23790936|NCT00884390|66612971|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
23790937|NCT00884390|66612972|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
23790938|NCT00884390|66612971|FG000|Overall Study|Other|11|||
23790939|NCT00884390|66612972|FG001|Overall Study|Other|1|||
23790940|NCT00090753|66616009|FG000|First Treatment Period|Adverse Event|20|||
23790941|NCT00090753|66616010|FG001|First Treatment Period|Adverse Event|8|||
23790942|NCT00090753|66616009|FG000|First Treatment Period|Death|88|||
23790943|NCT00090753|66616010|FG001|First Treatment Period|Death|62|||
23790944|NCT00090753|66616009|FG000|First Treatment Period|Lack of Efficacy|2|||
23790945|NCT00090753|66616010|FG001|First Treatment Period|Lack of Efficacy|1|||
23790946|NCT00090753|66616009|FG000|First Treatment Period|Refused Treatment|32|||
23790947|NCT00090753|66616010|FG001|First Treatment Period|Refused Treatment|25|||
23790948|NCT00090753|66616009|FG000|First Treatment Period|Lost to Follow-up|4|||
23790949|NCT00090753|66616010|FG001|First Treatment Period|Lost to Follow-up|4|||
23790950|NCT00090753|66616009|FG000|First Treatment Period|Renal Transplant|70|||
23790951|NCT00090753|66616010|FG001|First Treatment Period|Renal Transplant|50|||
23790952|NCT00090753|66616009|FG000|First Treatment Period|Mircera Commercialization|1|||
23790953|NCT00090753|66616010|FG001|First Treatment Period|Mircera Commercialization|0|||
23790954|NCT00090753|66616009|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
23790955|NCT00090753|66616010|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
23790956|NCT00090753|66616009|FG000|Extended Treatment Period|Adverse Event|11|||
23790957|NCT00090753|66616010|FG001|Extended Treatment Period|Adverse Event|0|||
23585363|NCT00771667|65869430|FG000|Induction Phase|Lost to Follow-up|1|||
23585364|NCT00771667|65869431|FG001|Induction Phase|Lost to Follow-up|0|||
23585365|NCT00771667|65869432|FG002|Induction Phase|Lost to Follow-up|1|||
23790958|NCT00090753|66616009|FG000|Extended Treatment Period|Death|58|||
23790959|NCT00090753|66616010|FG001|Extended Treatment Period|Death|30|||
23790960|NCT00090753|66616009|FG000|Extended Treatment Period|Lack of Efficacy|1|||
23790961|NCT00090753|66616010|FG001|Extended Treatment Period|Lack of Efficacy|0|||
23790962|NCT00090753|66616009|FG000|Extended Treatment Period|Refused Treatment|18|||
23790963|NCT00090753|66616010|FG001|Extended Treatment Period|Refused Treatment|12|||
23790964|NCT00090753|66616009|FG000|Extended Treatment Period|Lost to Follow-up|3|||
23790965|NCT00090753|66616010|FG001|Extended Treatment Period|Lost to Follow-up|1|||
23464682|NCT02531802|65444709|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
23464683|NCT02531802|65444710|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23464684|NCT02531802|65444711|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23464685|NCT02531802|65444712|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
23464686|NCT02531802|65444713|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
23464687|NCT02531802|65444714|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
23464688|NCT02531802|65444715|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
23464689|NCT02531802|65444716|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
23464690|NCT02531802|65444717|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
23790966|NCT00090753|66616009|FG000|Extended Treatment Period|Renal Transplant|15|||
23790967|NCT00090753|66616010|FG001|Extended Treatment Period|Renal Transplant|12|||
23790968|NCT00090753|66616009|FG000|Extended Treatment Period|Mircera Commercialization|188|||
23790969|NCT00090753|66616010|FG001|Extended Treatment Period|Mircera Commercialization|93|||
23790970|NCT00090753|66616009|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
23790971|NCT00090753|66616010|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
23790972|NCT04142658|66616011|FG000|Overall Study|Death|2|||
23790973|NCT04142658|66616012|FG001|Overall Study|Death|1|||
23790974|NCT04142658|66616011|FG000|Overall Study|Lost to Follow-up|4|||
23790975|NCT04142658|66616012|FG001|Overall Study|Lost to Follow-up|13|||
23790976|NCT04142658|66616011|FG000|Overall Study|Withdrawal by Subject|9|||
23790977|NCT04142658|66616012|FG001|Overall Study|Withdrawal by Subject|16|||
23790978|NCT02614898|66616019|FG000|Overall Study|Participated until study termination|10|||
23790979|NCT02614898|66616020|FG001|Overall Study|Participated until study termination|26|||
23790980|NCT02614898|66616019|FG000|Overall Study|Lost to Follow-up|0|||
23790981|NCT02614898|66616020|FG001|Overall Study|Lost to Follow-up|2|||
23790982|NCT02614898|66616019|FG000|Overall Study|Physician Decision|1|||
23790983|NCT02614898|66616020|FG001|Overall Study|Physician Decision|8|||
23790984|NCT02614898|66616019|FG000|Overall Study|Study Terminated by Sponsor|3|||
23790985|NCT02614898|66616020|FG001|Overall Study|Study Terminated by Sponsor|0|||
23790986|NCT02614898|66616019|FG000|Overall Study|Withdrawal by Subject|0|||
23790987|NCT02614898|66616020|FG001|Overall Study|Withdrawal by Subject|2|||
23790988|NCT02614898|66616019|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23790989|NCT02614898|66616020|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23790990|NCT02614898|66616019|FG000|Overall Study|Other-Additional Information Unavailable|0|||
23790991|NCT02614898|66616020|FG001|Overall Study|Other-Additional Information Unavailable|11|||
23790992|NCT02614898|66616019|FG000|Overall Study|Missing|0|||
23790993|NCT02614898|66616020|FG001|Overall Study|Missing|1|||
23790994|NCT01243151|66616021|FG000|Overall Study|Adverse Event|0|||
23790995|NCT01243151|66616022|FG001|Overall Study|Adverse Event|1|||
23790996|NCT01243151|66616023|FG002|Overall Study|Adverse Event|0|||
23790997|NCT01243151|66616024|FG003|Overall Study|Adverse Event|0|||
23790998|NCT01243151|66616025|FG004|Overall Study|Adverse Event|0|||
23790999|NCT01243151|66616021|FG000|Overall Study|Protocol Violation|0|||
23791000|NCT01243151|66616022|FG001|Overall Study|Protocol Violation|0|||
23791001|NCT01243151|66616023|FG002|Overall Study|Protocol Violation|1|||
23791002|NCT01243151|66616024|FG003|Overall Study|Protocol Violation|0|||
23791003|NCT01243151|66616025|FG004|Overall Study|Protocol Violation|0|||
23791004|NCT01243151|66616021|FG000|Overall Study|Other|0|||
23464691|NCT02531802|65444718|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
23464692|NCT02531802|65444719|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
23464693|NCT02531802|65444720|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
23464694|NCT02531802|65444721|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
23464695|NCT02531802|65444722|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
23464696|NCT02531802|65444723|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
23464697|NCT02531802|65444724|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
23464698|NCT02531802|65444725|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
23464699|NCT02531802|65444726|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
23464700|NCT02531802|65444727|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
23464701|NCT02633020|65444728|FG000|Overall Study|Adverse Event|1|||
23464702|NCT02633020|65444729|FG001|Overall Study|Adverse Event|0|||
23464703|NCT01298648|65444730|FG000|Overall Study|Withdrawal by Subject|2|||
23464704|NCT01298648|65444730|FG000|Overall Study|Lost to Follow-up|21|||
23464705|NCT03077412|65444731|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
23464706|NCT03077412|65444732|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
23791005|NCT01243151|66616022|FG001|Overall Study|Other|0|||
23464707|NCT03077412|65444733|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
23464708|NCT03077412|65444731|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
23791006|NCT01243151|66616023|FG002|Overall Study|Other|0|||
23791007|NCT01243151|66616024|FG003|Overall Study|Other|1|||
23791008|NCT01243151|66616025|FG004|Overall Study|Other|0|||
23791009|NCT01243151|66616021|FG000|Overall Study|Randomized but not treated|0|||
23791010|NCT01243151|66616022|FG001|Overall Study|Randomized but not treated|0|||
23791011|NCT01243151|66616023|FG002|Overall Study|Randomized but not treated|0|||
23791012|NCT01243151|66616024|FG003|Overall Study|Randomized but not treated|1|||
23464709|NCT03077412|65444732|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
23464710|NCT03077412|65444733|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
23464711|NCT03077412|65444731|FG000|Overall Study|Adverse Event|1|||
23791013|NCT01243151|66616025|FG004|Overall Study|Randomized but not treated|0|||
23791014|NCT00323258|66616028|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
23791015|NCT00323258|66616029|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
23791016|NCT00323258|66616028|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
23791017|NCT00323258|66616029|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
23791018|NCT00323258|66616028|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
23791019|NCT00323258|66616029|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
23791020|NCT00323258|66616028|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
23791021|NCT00323258|66616029|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
23585366|NCT00771667|65869433|FG003|Induction Phase|Lost to Follow-up|0|||
23791022|NCT00323258|66616028|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
23791023|NCT00323258|66616029|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
23585367|NCT00771667|65869434|FG004|Induction Phase|Lost to Follow-up|0|||
23585368|NCT00771667|65869435|FG005|Induction Phase|Lost to Follow-up|0|||
23585369|NCT00771667|65869436|FG006|Induction Phase|Lost to Follow-up|0|||
23585370|NCT00771667|65869437|FG007|Induction Phase|Lost to Follow-up|0|||
23585371|NCT00771667|65869438|FG008|Induction Phase|Lost to Follow-up|0|||
23585372|NCT00771667|65869439|FG009|Induction Phase|Lost to Follow-up|0|||
23585373|NCT00771667|65869430|FG000|Induction Phase|Other|4|||
23585374|NCT00771667|65869431|FG001|Induction Phase|Other|6|||
23585375|NCT00771667|65869432|FG002|Induction Phase|Other|3|||
23585376|NCT00771667|65869433|FG003|Induction Phase|Other|4|||
23585377|NCT00771667|65869434|FG004|Induction Phase|Other|0|||
23585378|NCT00771667|65869435|FG005|Induction Phase|Other|0|||
23585379|NCT00771667|65869436|FG006|Induction Phase|Other|0|||
23585380|NCT00771667|65869437|FG007|Induction Phase|Other|0|||
23585381|NCT00771667|65869438|FG008|Induction Phase|Other|0|||
23585382|NCT00771667|65869439|FG009|Induction Phase|Other|0|||
23585383|NCT00771667|65869430|FG000|Maintenance Phase|Adverse Event|0|||
23585384|NCT00771667|65869431|FG001|Maintenance Phase|Adverse Event|0|||
23585385|NCT00771667|65869432|FG002|Maintenance Phase|Adverse Event|0|||
23585386|NCT00771667|65869433|FG003|Maintenance Phase|Adverse Event|0|||
23585387|NCT00771667|65869434|FG004|Maintenance Phase|Adverse Event|1|||
23585388|NCT00771667|65869435|FG005|Maintenance Phase|Adverse Event|3|||
23791024|NCT00323258|66616028|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
23791025|NCT00323258|66616029|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
23791026|NCT00323258|66616028|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
23791027|NCT00323258|66616029|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
23791028|NCT00398073|66616030|FG000|Overall Study|Withdrawal by Subject|1|||
23791029|NCT00398073|66616031|FG001|Overall Study|Withdrawal by Subject|0|||
23791030|NCT03119662|66616034|FG000|Overall Study|Withdrawal by Subject|0|||
23791031|NCT03119662|66616035|FG001|Overall Study|Withdrawal by Subject|1|||
23791032|NCT00397254|66616036|FG000|Overall Study|Lost to Follow-up|2|||
23791033|NCT00397254|66616037|FG001|Overall Study|Lost to Follow-up|2|||
23791034|NCT01148225|66616038|FG000|Overall Study|Other|185|||
23791035|NCT00691704|66616041|FG000|Induction Therapy|Disease Progression|1|||
23791036|NCT00691704|66616041|FG000|Induction Therapy|Active Hepatitis|1|||
23791037|NCT00691704|66616041|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
23791038|NCT00691704|66616041|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
23791039|NCT00691704|66616041|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
23791040|NCT03105297|66616042|FG000|Baseline Phase (Day 1)|Other|21|||
23791041|NCT03105297|66616042|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
23791042|NCT03105297|66616042|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
23791043|NCT03419962|66616047|FG000|Overall Study|Change to other medication|1|||
23791044|NCT03419962|66616047|FG000|Overall Study|Refusal of continuing with trial drug|1|||
23791045|NCT03419962|66616047|FG000|Overall Study|Lost to Follow-up|3|||
23585389|NCT00771667|65869436|FG006|Maintenance Phase|Adverse Event|5|||
23585390|NCT00771667|65869437|FG007|Maintenance Phase|Adverse Event|1|||
23585391|NCT00771667|65869438|FG008|Maintenance Phase|Adverse Event|8|||
23585392|NCT00771667|65869439|FG009|Maintenance Phase|Adverse Event|7|||
23585393|NCT00771667|65869430|FG000|Maintenance Phase|Lack of Efficacy|0|||
23585394|NCT00771667|65869431|FG001|Maintenance Phase|Lack of Efficacy|0|||
23585395|NCT00771667|65869432|FG002|Maintenance Phase|Lack of Efficacy|0|||
23585396|NCT00771667|65869433|FG003|Maintenance Phase|Lack of Efficacy|0|||
23464712|NCT03077412|65444732|FG001|Overall Study|Adverse Event|2|||
23585397|NCT00771667|65869434|FG004|Maintenance Phase|Lack of Efficacy|1|||
23585398|NCT00771667|65869435|FG005|Maintenance Phase|Lack of Efficacy|3|||
23791046|NCT03419962|66616047|FG000|Overall Study|Difficulty in inhaling the doses|1|||
23791047|NCT03419962|66616047|FG000|Overall Study|Missing completion data|31|||
23791048|NCT01828112|66616048|FG000|Overall Study|Adverse Event|6|||
23791049|NCT01828112|66616049|FG001|Overall Study|Adverse Event|8|||
23350629|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23350630|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23350631|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23350632|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23464713|NCT03077412|65444733|FG002|Overall Study|Adverse Event|2|||
23791050|NCT01828112|66616048|FG000|Overall Study|Death|9|||
23464714|NCT03077412|65444731|FG000|Overall Study|Investigator's Discretion|0|||
23464715|NCT03077412|65444732|FG001|Overall Study|Investigator's Discretion|1|||
23464716|NCT03077412|65444733|FG002|Overall Study|Investigator's Discretion|1|||
23791051|NCT01828112|66616049|FG001|Overall Study|Death|5|||
23791052|NCT01828112|66616048|FG000|Overall Study|Physician Decision|5|||
23791053|NCT01828112|66616049|FG001|Overall Study|Physician Decision|5|||
23791054|NCT01828112|66616048|FG000|Overall Study|Progressive disease|56|||
23791055|NCT01828112|66616049|FG001|Overall Study|Progressive disease|82|||
23791056|NCT01828112|66616048|FG000|Overall Study|Subject/guardian decision|6|||
23791057|NCT01828112|66616049|FG001|Overall Study|Subject/guardian decision|8|||
23791058|NCT03183141|66616050|FG000|Overall Study|Withdrawal by Subject|2|||
23791059|NCT03183141|66616051|FG001|Overall Study|Withdrawal by Subject|4|||
23791060|NCT03183141|66616050|FG000|Overall Study|Death|0|||
23791061|NCT03183141|66616051|FG001|Overall Study|Death|8|||
23791062|NCT02817828|66616057|FG000|Overall Study|Lost to Follow-up|41|||
23791063|NCT02817828|66616057|FG000|Overall Study|Adverse event not related to bleeding|104|||
23791064|NCT02817828|66616057|FG000|Overall Study|Adverse event related to bleeding|53|||
23791065|NCT02817828|66616057|FG000|Overall Study|Protocol Violation|11|||
23791066|NCT02817828|66616057|FG000|Overall Study|Pregnancy|7|||
23791067|NCT02817828|66616057|FG000|Overall Study|Pregnancy wish|15|||
23791068|NCT02817828|66616057|FG000|Overall Study|Withdrawal by Subject|78|||
23791069|NCT02817828|66616057|FG000|Overall Study|Other|26|||
23791070|NCT03250117|66616058|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
23791071|NCT03250117|66616059|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23791072|NCT03250117|66616060|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23791073|NCT03250117|66616061|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23791074|NCT00651183|66616062|FG000|Overall Study|Lack of Efficacy|1|||
23791075|NCT00651183|66616063|FG001|Overall Study|Lack of Efficacy|0|||
23791076|NCT00651183|66616062|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
23791077|NCT00651183|66616063|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
23585399|NCT00771667|65869436|FG006|Maintenance Phase|Lack of Efficacy|3|||
23639920|NCT04677179|66067401|FG007|Induction Treatment Period|Physician Decision|0|||
23791078|NCT00651183|66616062|FG000|Overall Study|Tolerability insufficient|5|||
23791079|NCT00651183|66616063|FG001|Overall Study|Tolerability insufficient|2|||
23791080|NCT00651183|66616062|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
23791081|NCT00651183|66616063|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
23791082|NCT00651183|66616062|FG000|Overall Study|Withdrawal by Subject|6|||
23791083|NCT00651183|66616063|FG001|Overall Study|Withdrawal by Subject|3|||
23791084|NCT00651183|66616062|FG000|Overall Study|Lost to Follow-up|3|||
23791085|NCT00651183|66616063|FG001|Overall Study|Lost to Follow-up|1|||
23791086|NCT00651183|66616062|FG000|Overall Study|Other reasons|4|||
23791087|NCT00651183|66616063|FG001|Overall Study|Other reasons|2|||
23791088|NCT00651183|66616062|FG000|Overall Study|missing|1|||
23791089|NCT00651183|66616063|FG001|Overall Study|missing|0|||
23791090|NCT03277248|66616064|FG000|Overall Study|Adverse Event|3|||
23791091|NCT03277248|66616065|FG001|Overall Study|Adverse Event|1|||
23350633|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23350634|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
23350635|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
23350636|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350637|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350638|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350639|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
23350640|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
23350641|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
23350642|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
23350643|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350644|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350645|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350646|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
23350647|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
23350648|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
23350649|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
23350650|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
23350651|NCT00934856|65025550|FG000|Feasibility Part|Progressive disease|4|||
23350652|NCT00934856|65025551|FG001|Feasibility Part|Progressive disease|4|||
23350653|NCT00934856|65025552|FG002|Feasibility Part|Progressive disease|2|||
23350654|NCT00934856|65025553|FG003|Feasibility Part|Progressive disease|3|||
23350655|NCT00934856|65025554|FG004|Feasibility Part|Progressive disease|0|||
23350656|NCT00934856|65025555|FG005|Feasibility Part|Progressive disease|0|||
23350657|NCT00934856|65025550|FG000|Feasibility Part|Physician Decision|0|||
23350658|NCT00934856|65025551|FG001|Feasibility Part|Physician Decision|0|||
23350659|NCT00934856|65025552|FG002|Feasibility Part|Physician Decision|1|||
23350660|NCT00934856|65025553|FG003|Feasibility Part|Physician Decision|0|||
23350661|NCT00934856|65025554|FG004|Feasibility Part|Physician Decision|0|||
23350662|NCT00934856|65025555|FG005|Feasibility Part|Physician Decision|0|||
23350663|NCT00934856|65025550|FG000|Feasibility Part|Adverse Event|1|||
23350664|NCT00934856|65025551|FG001|Feasibility Part|Adverse Event|1|||
23350665|NCT00934856|65025552|FG002|Feasibility Part|Adverse Event|0|||
23350666|NCT00934856|65025553|FG003|Feasibility Part|Adverse Event|1|||
23639921|NCT04677179|66067402|FG008|Induction Treatment Period|Physician Decision|0|||
23639922|NCT04677179|66067403|FG009|Induction Treatment Period|Physician Decision|0|||
23639923|NCT04677179|66067394|FG000|Induction Treatment Period|Protocol Violation|0|||
23791092|NCT03277248|66616064|FG000|Overall Study|Subject Withdrawal of Consent|6|||
23791093|NCT03277248|66616065|FG001|Overall Study|Subject Withdrawal of Consent|23|||
23791094|NCT03277248|66616064|FG000|Overall Study|Investigator/Sponsor Decision|2|||
23791095|NCT03277248|66616065|FG001|Overall Study|Investigator/Sponsor Decision|2|||
23791096|NCT03277248|66616064|FG000|Overall Study|Pregnancy|4|||
23791097|NCT03277248|66616065|FG001|Overall Study|Pregnancy|1|||
23791098|NCT03277248|66616064|FG000|Overall Study|Lost to Follow-up|0|||
23791099|NCT03277248|66616065|FG001|Overall Study|Lost to Follow-up|2|||
23791100|NCT03277248|66616064|FG000|Overall Study|Lack of Efficacy|0|||
23791101|NCT03277248|66616065|FG001|Overall Study|Lack of Efficacy|2|||
23791102|NCT03277248|66616064|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
23791103|NCT03277248|66616065|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
23791104|NCT00577655|66616070|FG000|Overall Study|Patient Request|0|||
23791105|NCT00577655|66616071|FG001|Overall Study|Patient Request|2|||
23791106|NCT00577655|66616070|FG000|Overall Study|Protocol Violation|0|||
23791107|NCT00577655|66616071|FG001|Overall Study|Protocol Violation|1|||
23791108|NCT00577655|66616070|FG000|Overall Study|Lost to Follow-up|1|||
23791109|NCT00577655|66616071|FG001|Overall Study|Lost to Follow-up|1|||
23791110|NCT01507662|66616080|FG000|Overall Study|Death|26|||
23791111|NCT01507662|66616081|FG001|Overall Study|Death|18|||
23791112|NCT01507662|66616080|FG000|Overall Study|Withdrawal by Subject|290|||
23791113|NCT01507662|66616081|FG001|Overall Study|Withdrawal by Subject|287|||
23791114|NCT01507662|66616080|FG000|Overall Study|Lost to Follow-up|498|||
23791115|NCT01507662|66616081|FG001|Overall Study|Lost to Follow-up|523|||
23791116|NCT01507662|66616080|FG000|Overall Study|Proxy interview done|2|||
23791117|NCT01507662|66616081|FG001|Overall Study|Proxy interview done|3|||
23350667|NCT00934856|65025554|FG004|Feasibility Part|Adverse Event|0|||
23350668|NCT00934856|65025555|FG005|Feasibility Part|Adverse Event|2|||
23350669|NCT00934856|65025550|FG000|Feasibility Part|Withdrawal by Subject|0|||
23350670|NCT00934856|65025551|FG001|Feasibility Part|Withdrawal by Subject|0|||
23791118|NCT00724958|66616082|FG000|Overall Study|Adverse Event|28|||
23791119|NCT00724958|66616082|FG000|Overall Study|Loss of Response|40|||
23791120|NCT00724958|66616082|FG000|Overall Study|No Response|18|||
23350671|NCT00934856|65025552|FG002|Feasibility Part|Withdrawal by Subject|0|||
23350672|NCT00934856|65025553|FG003|Feasibility Part|Withdrawal by Subject|1|||
23350673|NCT00934856|65025554|FG004|Feasibility Part|Withdrawal by Subject|0|||
23350674|NCT00934856|65025555|FG005|Feasibility Part|Withdrawal by Subject|1|||
23350675|NCT00934856|65025550|FG000|Extension Part|Adverse Event|0|||
23350676|NCT00934856|65025551|FG001|Extension Part|Adverse Event|0|||
23350677|NCT00934856|65025552|FG002|Extension Part|Adverse Event|0|||
23350678|NCT00934856|65025553|FG003|Extension Part|Adverse Event|1|||
23350679|NCT00934856|65025554|FG004|Extension Part|Adverse Event|4|||
23350680|NCT00934856|65025555|FG005|Extension Part|Adverse Event|4|||
23350681|NCT00934856|65025550|FG000|Extension Part|Progressive disease|0|||
23350682|NCT00934856|65025551|FG001|Extension Part|Progressive disease|0|||
23350683|NCT00934856|65025552|FG002|Extension Part|Progressive disease|0|||
23350684|NCT00934856|65025553|FG003|Extension Part|Progressive disease|1|||
23350685|NCT00934856|65025554|FG004|Extension Part|Progressive disease|0|||
23350686|NCT00934856|65025555|FG005|Extension Part|Progressive disease|0|||
23350687|NCT00934856|65025550|FG000|Extension Part|Non-compliance with drug|0|||
23350688|NCT00934856|65025551|FG001|Extension Part|Non-compliance with drug|0|||
23464717|NCT03077412|65444731|FG000|Overall Study|Withdrew Consent|0|||
23464718|NCT03077412|65444732|FG001|Overall Study|Withdrew Consent|2|||
23791121|NCT00724958|66616082|FG000|Overall Study|Remission|7|||
23791122|NCT00724958|66616082|FG000|Overall Study|Other Reason|76|||
23791123|NCT00724958|66616082|FG000|Overall Study|No documentation for end of therapy|13|||
23791124|NCT01572662|66616090|FG000|Overall Study|Withdrawal by Subject|1|||
23791125|NCT01572662|66616091|FG001|Overall Study|Withdrawal by Subject|0|||
23791126|NCT01572662|66616090|FG000|Overall Study|Physician Decision|0|||
23791127|NCT01572662|66616091|FG001|Overall Study|Physician Decision|1|||
23791128|NCT00566722|66616092|FG000|Overall Study|Adverse Event|0|||
23791129|NCT00566722|66616093|FG001|Overall Study|Adverse Event|1|||
23791130|NCT00566722|66616094|FG002|Overall Study|Adverse Event|0|||
23791131|NCT00566722|66616092|FG000|Overall Study|Withdrawal by Subject|0|||
23791132|NCT00566722|66616093|FG001|Overall Study|Withdrawal by Subject|0|||
23791133|NCT00566722|66616094|FG002|Overall Study|Withdrawal by Subject|1|||
23791134|NCT00566722|66616092|FG000|Overall Study|Lost to Follow-up|1|||
23791135|NCT00566722|66616093|FG001|Overall Study|Lost to Follow-up|1|||
23791136|NCT00566722|66616094|FG002|Overall Study|Lost to Follow-up|1|||
23791137|NCT00566722|66616092|FG000|Overall Study|Lack of Efficacy|1|||
23791138|NCT00566722|66616093|FG001|Overall Study|Lack of Efficacy|2|||
23791139|NCT00566722|66616094|FG002|Overall Study|Lack of Efficacy|4|||
23791140|NCT00566722|66616092|FG000|Overall Study|Did not meet exclusion criteria|0|||
23791141|NCT00566722|66616093|FG001|Overall Study|Did not meet exclusion criteria|0|||
23791142|NCT00566722|66616094|FG002|Overall Study|Did not meet exclusion criteria|2|||
23791143|NCT00566722|66616092|FG000|Overall Study|Serious adverse event|0|||
23791144|NCT00566722|66616093|FG001|Overall Study|Serious adverse event|1|||
23791145|NCT00566722|66616094|FG002|Overall Study|Serious adverse event|0|||
23791146|NCT00566722|66616092|FG000|Overall Study|Noncompliant with drug administration|0|||
23791147|NCT00566722|66616093|FG001|Overall Study|Noncompliant with drug administration|0|||
23791148|NCT00566722|66616094|FG002|Overall Study|Noncompliant with drug administration|1|||
23791149|NCT02664415|66616097|FG000|Overall Study|Adverse Event|1|||
23791150|NCT02664415|66616098|FG001|Overall Study|Adverse Event|0|||
23791151|NCT00198133|66616099|FG000|Overall Study|Disease progression|2|||
23791152|NCT00198133|66616100|FG001|Overall Study|Disease progression|5|||
23464719|NCT03077412|65444733|FG002|Overall Study|Withdrew Consent|0|||
23791153|NCT00198133|66616099|FG000|Overall Study|Adverse Event|1|||
23791154|NCT00198133|66616100|FG001|Overall Study|Adverse Event|3|||
23791155|NCT00198133|66616099|FG000|Overall Study|Withdrawal by Subject|1|||
23791156|NCT00198133|66616100|FG001|Overall Study|Withdrawal by Subject|0|||
23791157|NCT00198133|66616099|FG000|Overall Study|Physician Decision|1|||
23791158|NCT00198133|66616100|FG001|Overall Study|Physician Decision|0|||
23791159|NCT02169336|66616101|FG000|Overall Study|Lack of Efficacy|1|||
23791160|NCT02169336|66616102|FG001|Overall Study|Lack of Efficacy|1|||
23791161|NCT02169336|66616103|FG002|Overall Study|Lack of Efficacy|0|||
23791162|NCT02169336|66616101|FG000|Overall Study|Adverse Event|2|||
23350689|NCT00934856|65025552|FG002|Extension Part|Non-compliance with drug|0|||
23350690|NCT00934856|65025553|FG003|Extension Part|Non-compliance with drug|0|||
23464720|NCT02578706|65444734|FG000|Overall Study|Withdrawal by Subject|1|||
23464721|NCT02578706|65444735|FG001|Overall Study|Withdrawal by Subject|0|||
23350691|NCT00934856|65025554|FG004|Extension Part|Non-compliance with drug|0|||
23350692|NCT00934856|65025555|FG005|Extension Part|Non-compliance with drug|1|||
23350693|NCT03099694|65025556|FG000|Overall Study|Withdrawal by Subject|11|||
23350694|NCT03099694|65025557|FG001|Overall Study|Withdrawal by Subject|13|||
23706201|NCT01258348|66301081|FG000|Overall Study|Physician Decision|0|||
23791163|NCT02169336|66616102|FG001|Overall Study|Adverse Event|3|||
23791164|NCT02169336|66616103|FG002|Overall Study|Adverse Event|1|||
23791165|NCT02169336|66616101|FG000|Overall Study|Withdrawal by Subject|1|||
23791166|NCT02169336|66616102|FG001|Overall Study|Withdrawal by Subject|0|||
23791167|NCT02169336|66616103|FG002|Overall Study|Withdrawal by Subject|0|||
23791168|NCT02169336|66616101|FG000|Overall Study|Physician Decision|0|||
23791169|NCT02169336|66616102|FG001|Overall Study|Physician Decision|0|||
23791170|NCT02169336|66616103|FG002|Overall Study|Physician Decision|1|||
23791171|NCT02169336|66616101|FG000|Overall Study|Subject declined to continue dosing|0|||
23791172|NCT02169336|66616102|FG001|Overall Study|Subject declined to continue dosing|0|||
23791173|NCT02169336|66616103|FG002|Overall Study|Subject declined to continue dosing|1|||
23791174|NCT01091363|66616106|FG000|Overall Study|Withdrawal by Subject|11|||
23791175|NCT01091363|66616107|FG001|Overall Study|Withdrawal by Subject|15|||
23791176|NCT01091363|66616106|FG000|Overall Study|Lost to Follow-up|2|||
23791177|NCT01091363|66616107|FG001|Overall Study|Lost to Follow-up|2|||
23791178|NCT00642811|66616108|FG000|Overall Study|Adverse Event|2|||
23791179|NCT00642811|66616109|FG001|Overall Study|Adverse Event|3|||
23791180|NCT00642811|66616110|FG002|Overall Study|Adverse Event|0|||
23791181|NCT00642811|66616111|FG003|Overall Study|Adverse Event|0|||
23791182|NCT00642811|66616112|FG004|Overall Study|Adverse Event|0|||
23791183|NCT00642811|66616113|FG005|Overall Study|Adverse Event|1|||
23791184|NCT00642811|66616108|FG000|Overall Study|Developement of discontinuation criteria|0|||
23791185|NCT00642811|66616109|FG001|Overall Study|Developement of discontinuation criteria|0|||
23791186|NCT00642811|66616110|FG002|Overall Study|Developement of discontinuation criteria|0|||
23791187|NCT00642811|66616111|FG003|Overall Study|Developement of discontinuation criteria|0|||
23791188|NCT00642811|66616112|FG004|Overall Study|Developement of discontinuation criteria|1|||
23791189|NCT00642811|66616113|FG005|Overall Study|Developement of discontinuation criteria|0|||
23791190|NCT00642811|66616108|FG000|Overall Study|Severe Non-compliance to protocol|1|||
23791191|NCT00642811|66616109|FG001|Overall Study|Severe Non-compliance to protocol|0|||
23791192|NCT00642811|66616110|FG002|Overall Study|Severe Non-compliance to protocol|0|||
23791193|NCT00642811|66616111|FG003|Overall Study|Severe Non-compliance to protocol|0|||
23791194|NCT00642811|66616112|FG004|Overall Study|Severe Non-compliance to protocol|0|||
23791195|NCT00642811|66616113|FG005|Overall Study|Severe Non-compliance to protocol|0|||
23791196|NCT00642811|66616108|FG000|Overall Study|Other|0|||
23791197|NCT00642811|66616109|FG001|Overall Study|Other|1|||
23791198|NCT00642811|66616110|FG002|Overall Study|Other|0|||
23791199|NCT00642811|66616111|FG003|Overall Study|Other|1|||
23791200|NCT00642811|66616112|FG004|Overall Study|Other|0|||
23791201|NCT00642811|66616113|FG005|Overall Study|Other|0|||
23791202|NCT00874822|66616116|FG000|Overall Study|excluded by criteria|8|||
23791203|NCT01824498|66616117|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
23791204|NCT01824498|66616118|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
23791205|NCT01824498|66616119|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
23791206|NCT01824498|66616120|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
23350695|NCT03099694|65025556|FG000|Overall Study|Lost to Follow-up|9|||
23350696|NCT03099694|65025557|FG001|Overall Study|Lost to Follow-up|5|||
23350697|NCT01428115|65025558|FG000|Overall Study|Lack of Efficacy|3|||
23464722|NCT02578706|65444736|FG002|Overall Study|Withdrawal by Subject|0|||
23464723|NCT02578706|65444734|FG000|Overall Study|Lost to Follow-up|0|||
23464724|NCT02578706|65444735|FG001|Overall Study|Lost to Follow-up|4|||
23464725|NCT02578706|65444736|FG002|Overall Study|Lost to Follow-up|0|||
23464726|NCT02578706|65444734|FG000|Overall Study|Physician Decision|0|||
23464727|NCT02578706|65444735|FG001|Overall Study|Physician Decision|1|||
23464728|NCT02578706|65444736|FG002|Overall Study|Physician Decision|0|||
23464729|NCT02839200|65444738|FG000|Overall Study|Withdrawal by Subject|2|||
23464730|NCT02839200|65444739|FG001|Overall Study|Withdrawal by Subject|0|||
23464731|NCT02839200|65444740|FG002|Overall Study|Withdrawal by Subject|1|||
23464732|NCT02839200|65444741|FG003|Overall Study|Withdrawal by Subject|0|||
23464733|NCT02839200|65444742|FG004|Overall Study|Withdrawal by Subject|0|||
23464734|NCT02839200|65444743|FG005|Overall Study|Withdrawal by Subject|1|||
23464735|NCT02839200|65444738|FG000|Overall Study|Lost to Follow-up|2|||
23464736|NCT02839200|65444739|FG001|Overall Study|Lost to Follow-up|0|||
23464737|NCT02839200|65444740|FG002|Overall Study|Lost to Follow-up|0|||
23464738|NCT02839200|65444741|FG003|Overall Study|Lost to Follow-up|0|||
23464739|NCT02839200|65444742|FG004|Overall Study|Lost to Follow-up|1|||
23464740|NCT02839200|65444743|FG005|Overall Study|Lost to Follow-up|0|||
23464741|NCT02839200|65444738|FG000|Overall Study|Adverse Event|0|||
23464742|NCT02839200|65444739|FG001|Overall Study|Adverse Event|0|||
23464743|NCT02839200|65444740|FG002|Overall Study|Adverse Event|0|||
23464744|NCT02839200|65444741|FG003|Overall Study|Adverse Event|0|||
23464745|NCT02839200|65444742|FG004|Overall Study|Adverse Event|1|||
23791207|NCT01824498|66616121|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
23791208|NCT01824498|66616122|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
23791209|NCT00735696|66616123|FG000|Overall Study|Withdrawal by Subject|1|||
23791210|NCT00735696|66616123|FG000|Overall Study|Enrolled but never Treated|1|||
23791211|NCT00105157|66616134|FG000|Double-Blind (DB)|Never Treated|1|||
23791212|NCT00105157|66616135|FG001|Double-Blind (DB)|Never Treated|0|||
23791213|NCT00105157|66616136|FG002|Double-Blind (DB)|Never Treated|0|||
23464746|NCT02839200|65444743|FG005|Overall Study|Adverse Event|0|||
23350698|NCT01428115|65025558|FG000|Overall Study|Lost to Follow-up|10|||
23464747|NCT02839200|65444738|FG000|Overall Study|Randomized in error|0|||
23350699|NCT01428115|65025558|FG000|Overall Study|Pregnancy|1|||
23350700|NCT01428115|65025558|FG000|Overall Study|Protocol Violation|3|||
23350701|NCT01428115|65025558|FG000|Overall Study|Withdrawal by Subject|4|||
23350702|NCT05940077|65025560|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
23350703|NCT02984267|65025561|FG000|Overall Study|Protocol Violation|1|||
23350704|NCT02984267|65025562|FG001|Overall Study|Protocol Violation|0|||
23350705|NCT02984267|65025561|FG000|Overall Study|Withdrawal by Subject|0|||
23464748|NCT02839200|65444739|FG001|Overall Study|Randomized in error|1|||
23464749|NCT02839200|65444740|FG002|Overall Study|Randomized in error|0|||
23464750|NCT02839200|65444741|FG003|Overall Study|Randomized in error|0|||
23464751|NCT02839200|65444742|FG004|Overall Study|Randomized in error|0|||
23464752|NCT02839200|65444743|FG005|Overall Study|Randomized in error|0|||
23464753|NCT04198714|65444745|FG000|Overall Study|Physician Decision|0|||
23464754|NCT04198714|65444746|FG001|Overall Study|Physician Decision|1|||
23464755|NCT02396199|65444748|FG000|Overall Study|Lost to Follow-up|1|||
23464756|NCT02396199|65444748|FG000|Overall Study|Death|4|||
23464757|NCT02506244|65444749|FG000|Overall Study|Did not undergo active monitoring|458|||
23464758|NCT02506244|65444750|FG001|Overall Study|Did not undergo active monitoring|459|||
23464759|NCT02506244|65444751|FG002|Overall Study|Did not undergo active monitoring|0|||
23464760|NCT03486834|65444753|FG000|Overall Study|Withdrawal by Subject|46|||
23464761|NCT03486834|65444754|FG001|Overall Study|Withdrawal by Subject|46|||
23464762|NCT03486834|65444755|FG002|Overall Study|Withdrawal by Subject|52|||
23464763|NCT03486834|65444753|FG000|Overall Study|Adverse Event|8|||
23464764|NCT03486834|65444754|FG001|Overall Study|Adverse Event|7|||
23464765|NCT03486834|65444755|FG002|Overall Study|Adverse Event|0|||
23464766|NCT03486834|65444753|FG000|Overall Study|Lost to Follow-up|41|||
23791214|NCT00105157|66616137|FG003|Double-Blind (DB)|Never Treated|0|||
23791215|NCT00105157|66616134|FG000|Double-Blind (DB)|Adverse Event|2|||
23791216|NCT00105157|66616135|FG001|Double-Blind (DB)|Adverse Event|0|||
23791217|NCT00105157|66616136|FG002|Double-Blind (DB)|Adverse Event|1|||
23791218|NCT00105157|66616137|FG003|Double-Blind (DB)|Adverse Event|1|||
23791219|NCT00105157|66616134|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
23791220|NCT00105157|66616135|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
23791221|NCT00105157|66616136|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
23791222|NCT00105157|66616137|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
23791223|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Adverse Event|3|||
23791224|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Adverse Event|1|||
23791225|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Adverse Event|0|||
23791226|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Adverse Event|0|||
23791227|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
23791228|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
23791229|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
23791230|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
23791231|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
23791232|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
23791233|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
23791234|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
23791235|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
23791236|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
23639924|NCT04677179|66067395|FG001|Induction Treatment Period|Protocol Violation|1|||
23639925|NCT04677179|66067396|FG002|Induction Treatment Period|Protocol Violation|0|||
23639926|NCT04677179|66067397|FG003|Induction Treatment Period|Protocol Violation|0|||
23639927|NCT04677179|66067398|FG004|Induction Treatment Period|Protocol Violation|0|||
23639928|NCT04677179|66067399|FG005|Induction Treatment Period|Protocol Violation|0|||
23639929|NCT04677179|66067400|FG006|Induction Treatment Period|Protocol Violation|0|||
23639930|NCT04677179|66067401|FG007|Induction Treatment Period|Protocol Violation|0|||
23639931|NCT04677179|66067402|FG008|Induction Treatment Period|Protocol Violation|0|||
23791237|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
23464767|NCT03486834|65444754|FG001|Overall Study|Lost to Follow-up|24|||
23464768|NCT03486834|65444755|FG002|Overall Study|Lost to Follow-up|39|||
23464769|NCT03486834|65444753|FG000|Overall Study|Non-compliance with Study Drug|2|||
23464770|NCT03486834|65444754|FG001|Overall Study|Non-compliance with Study Drug|2|||
23464771|NCT03486834|65444755|FG002|Overall Study|Non-compliance with Study Drug|0|||
23350706|NCT02984267|65025562|FG001|Overall Study|Withdrawal by Subject|1|||
23464772|NCT03486834|65444753|FG000|Overall Study|Physician Decision|5|||
23350707|NCT00743288|65025563|FG000|Overall Study|Adverse Event|1|||
23791238|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
23464773|NCT03486834|65444754|FG001|Overall Study|Physician Decision|2|||
23464774|NCT03486834|65444755|FG002|Overall Study|Physician Decision|3|||
23464775|NCT03486834|65444753|FG000|Overall Study|Pregnancy|10|||
23464776|NCT03486834|65444754|FG001|Overall Study|Pregnancy|12|||
23464777|NCT03486834|65444755|FG002|Overall Study|Pregnancy|12|||
23464778|NCT03486834|65444753|FG000|Overall Study|Protocol Deviation|2|||
23464779|NCT03486834|65444754|FG001|Overall Study|Protocol Deviation|3|||
23464780|NCT03486834|65444755|FG002|Overall Study|Protocol Deviation|3|||
23464781|NCT03486834|65444753|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23464782|NCT03486834|65444754|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23464783|NCT03486834|65444755|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23464784|NCT03486834|65444753|FG000|Overall Study|Randomized but not treated|4|||
23464785|NCT03486834|65444754|FG001|Overall Study|Randomized but not treated|4|||
23464786|NCT03486834|65444755|FG002|Overall Study|Randomized but not treated|1|||
23464787|NCT02761330|65444756|FG000|Treatment Week 1|Withdrawal by Subject|0|||
23464788|NCT02761330|65444757|FG001|Treatment Week 1|Withdrawal by Subject|0|||
23464789|NCT02761330|65444758|FG002|Treatment Week 1|Withdrawal by Subject|0|||
23464790|NCT02761330|65444759|FG003|Treatment Week 1|Withdrawal by Subject|1|||
23464791|NCT02761330|65444760|FG004|Treatment Week 1|Withdrawal by Subject|0|||
23464792|NCT02761330|65444761|FG005|Treatment Week 1|Withdrawal by Subject|1|||
23464793|NCT02577718|65444768|FG000|Overall Study|Death|6|||
23464794|NCT02577718|65444768|FG000|Overall Study|Withdrawal by Subject|2|||
23464795|NCT01337960|65444769|FG000|Overall Study|Lost to Follow-up|1|||
23464796|NCT01337960|65444770|FG001|Overall Study|Lost to Follow-up|0|||
23464797|NCT01337960|65444771|FG002|Overall Study|Lost to Follow-up|0|||
23464798|NCT01337960|65444769|FG000|Overall Study|Withdrawal by Subject|1|||
23464799|NCT01337960|65444770|FG001|Overall Study|Withdrawal by Subject|0|||
23464800|NCT01337960|65444771|FG002|Overall Study|Withdrawal by Subject|0|||
23464801|NCT04960202|65444777|FG000|Overall Study|Other|12|||
23464802|NCT04960202|65444778|FG001|Overall Study|Other|10|||
23464803|NCT04960202|65444777|FG000|Overall Study|Withdrawal by Subject|43|||
23464804|NCT04960202|65444778|FG001|Overall Study|Withdrawal by Subject|45|||
23464805|NCT04960202|65444777|FG000|Overall Study|Lost to Follow-up|20|||
23464806|NCT04960202|65444778|FG001|Overall Study|Lost to Follow-up|17|||
23464807|NCT04960202|65444777|FG000|Overall Study|Death|0|||
23464808|NCT04960202|65444778|FG001|Overall Study|Death|15|||
23464809|NCT01177397|65444779|FG000|Overall Study|Protocol Violation|0|||
23464810|NCT01177397|65444780|FG001|Overall Study|Protocol Violation|0|||
23464811|NCT01177397|65444781|FG002|Overall Study|Protocol Violation|0|||
23464812|NCT01177397|65444782|FG003|Overall Study|Protocol Violation|0|||
23464813|NCT01177397|65444783|FG004|Overall Study|Protocol Violation|0|||
23464814|NCT01177397|65444784|FG005|Overall Study|Protocol Violation|1|||
23464815|NCT01177397|65444785|FG006|Overall Study|Protocol Violation|0|||
23464816|NCT01177397|65444786|FG007|Overall Study|Protocol Violation|0|||
23464817|NCT01177397|65444787|FG008|Overall Study|Protocol Violation|0|||
23464818|NCT01177397|65444788|FG009|Overall Study|Protocol Violation|0|||
23464819|NCT01177397|65444789|FG010|Overall Study|Protocol Violation|0|||
23464820|NCT01177397|65444790|FG011|Overall Study|Protocol Violation|0|||
23464821|NCT01177397|65444779|FG000|Overall Study|Lost to Follow-up|0|||
23464822|NCT01177397|65444780|FG001|Overall Study|Lost to Follow-up|0|||
23464823|NCT01177397|65444781|FG002|Overall Study|Lost to Follow-up|0|||
23464824|NCT01177397|65444782|FG003|Overall Study|Lost to Follow-up|0|||
23464825|NCT01177397|65444783|FG004|Overall Study|Lost to Follow-up|1|||
23464826|NCT01177397|65444784|FG005|Overall Study|Lost to Follow-up|0|||
23464827|NCT01177397|65444785|FG006|Overall Study|Lost to Follow-up|0|||
23791239|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
23791240|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23791241|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23791242|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23791243|NCT00105157|66616134|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
23791244|NCT00105157|66616135|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
23350708|NCT00743288|65025564|FG001|Overall Study|Adverse Event|1|||
23464828|NCT01177397|65444786|FG007|Overall Study|Lost to Follow-up|2|||
23464829|NCT01177397|65444787|FG008|Overall Study|Lost to Follow-up|0|||
23464830|NCT01177397|65444788|FG009|Overall Study|Lost to Follow-up|0|||
23464831|NCT01177397|65444789|FG010|Overall Study|Lost to Follow-up|0|||
23464832|NCT01177397|65444790|FG011|Overall Study|Lost to Follow-up|0|||
23464833|NCT01177397|65444779|FG000|Overall Study|Death|0|||
23464834|NCT01177397|65444780|FG001|Overall Study|Death|0|||
23464835|NCT01177397|65444781|FG002|Overall Study|Death|1|||
23464836|NCT01177397|65444782|FG003|Overall Study|Death|1|||
23350709|NCT00743288|65025565|FG002|Overall Study|Adverse Event|2|||
23464837|NCT01177397|65444783|FG004|Overall Study|Death|0|||
23464838|NCT01177397|65444784|FG005|Overall Study|Death|0|||
23464839|NCT01177397|65444785|FG006|Overall Study|Death|0|||
23464840|NCT01177397|65444786|FG007|Overall Study|Death|5|||
23464841|NCT01177397|65444787|FG008|Overall Study|Death|2|||
23464842|NCT01177397|65444788|FG009|Overall Study|Death|1|||
23464843|NCT01177397|65444789|FG010|Overall Study|Death|0|||
23464844|NCT01177397|65444790|FG011|Overall Study|Death|0|||
23464845|NCT01177397|65444779|FG000|Overall Study|Withdrawal by Subject|0|||
23464846|NCT01177397|65444780|FG001|Overall Study|Withdrawal by Subject|0|||
23464847|NCT01177397|65444781|FG002|Overall Study|Withdrawal by Subject|1|||
23464848|NCT01177397|65444782|FG003|Overall Study|Withdrawal by Subject|1|||
23464849|NCT01177397|65444783|FG004|Overall Study|Withdrawal by Subject|1|||
23464850|NCT01177397|65444784|FG005|Overall Study|Withdrawal by Subject|2|||
23464851|NCT01177397|65444785|FG006|Overall Study|Withdrawal by Subject|0|||
23791245|NCT00105157|66616136|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
23791246|NCT00105157|66616137|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
23350710|NCT00743288|65025566|FG003|Overall Study|Adverse Event|2|||
23350711|NCT00743288|65025567|FG004|Overall Study|Adverse Event|1|||
23350712|NCT00743288|65025568|FG005|Overall Study|Adverse Event|1|||
23350713|NCT00743288|65025569|FG006|Overall Study|Adverse Event|2|||
23350714|NCT00743288|65025563|FG000|Overall Study|Withdrawal by Subject|0|||
23350715|NCT00743288|65025564|FG001|Overall Study|Withdrawal by Subject|0|||
23350716|NCT00743288|65025565|FG002|Overall Study|Withdrawal by Subject|1|||
23350717|NCT00743288|65025566|FG003|Overall Study|Withdrawal by Subject|0|||
23350718|NCT00743288|65025567|FG004|Overall Study|Withdrawal by Subject|0|||
23350719|NCT00743288|65025568|FG005|Overall Study|Withdrawal by Subject|1|||
23350720|NCT00743288|65025569|FG006|Overall Study|Withdrawal by Subject|1|||
23350721|NCT00743288|65025563|FG000|Overall Study|Progressive disease (PD)|2|||
23350722|NCT00743288|65025564|FG001|Overall Study|Progressive disease (PD)|0|||
23350723|NCT00743288|65025565|FG002|Overall Study|Progressive disease (PD)|1|||
23350724|NCT00743288|65025566|FG003|Overall Study|Progressive disease (PD)|4|||
23350725|NCT00743288|65025567|FG004|Overall Study|Progressive disease (PD)|5|||
23350726|NCT00743288|65025568|FG005|Overall Study|Progressive disease (PD)|3|||
23350727|NCT00743288|65025569|FG006|Overall Study|Progressive disease (PD)|6|||
23350728|NCT00743288|65025563|FG000|Overall Study|Worsening of condition (Not PD)|0|||
23350729|NCT00743288|65025564|FG001|Overall Study|Worsening of condition (Not PD)|2|||
23350730|NCT00743288|65025565|FG002|Overall Study|Worsening of condition (Not PD)|1|||
23350731|NCT00743288|65025566|FG003|Overall Study|Worsening of condition (Not PD)|1|||
23350732|NCT00743288|65025567|FG004|Overall Study|Worsening of condition (Not PD)|0|||
23350733|NCT00743288|65025568|FG005|Overall Study|Worsening of condition (Not PD)|0|||
23350734|NCT00743288|65025569|FG006|Overall Study|Worsening of condition (Not PD)|0|||
23350735|NCT00337779|65025570|FG000|Overall Study|Withdrawal by Subject|10|||
23350736|NCT00337779|65025571|FG001|Overall Study|Withdrawal by Subject|12|||
23350737|NCT00337779|65025570|FG000|Overall Study|Sponsor decision|1|||
23350738|NCT00337779|65025571|FG001|Overall Study|Sponsor decision|1|||
23350739|NCT00337779|65025570|FG000|Overall Study|Physician Decision|3|||
23350740|NCT00337779|65025571|FG001|Overall Study|Physician Decision|6|||
23350741|NCT00337779|65025570|FG000|Overall Study|Protocol Violation|1|||
23350742|NCT00337779|65025571|FG001|Overall Study|Protocol Violation|1|||
23350743|NCT00337779|65025570|FG000|Overall Study|Lost to Follow-up|6|||
23350744|NCT00337779|65025571|FG001|Overall Study|Lost to Follow-up|5|||
23350745|NCT00337779|65025570|FG000|Overall Study|Adverse Event|28|||
23350746|NCT00337779|65025571|FG001|Overall Study|Adverse Event|51|||
23350747|NCT00337779|65025570|FG000|Overall Study|Pregnancy|3|||
23350748|NCT00337779|65025571|FG001|Overall Study|Pregnancy|2|||
23350749|NCT00337779|65025570|FG000|Overall Study|Death|0|||
23464852|NCT01177397|65444786|FG007|Overall Study|Withdrawal by Subject|5|||
23464853|NCT01177397|65444787|FG008|Overall Study|Withdrawal by Subject|9|||
23464854|NCT01177397|65444788|FG009|Overall Study|Withdrawal by Subject|1|||
23464855|NCT01177397|65444789|FG010|Overall Study|Withdrawal by Subject|1|||
23464856|NCT01177397|65444790|FG011|Overall Study|Withdrawal by Subject|0|||
23791247|NCT00105157|66616134|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23791248|NCT00105157|66616135|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23791249|NCT00105157|66616136|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23791250|NCT00105157|66616137|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
23791251|NCT00105157|66616134|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
23791252|NCT00105157|66616135|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
23791253|NCT00105157|66616136|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
23791254|NCT00105157|66616137|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
23791255|NCT00105157|66616134|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
23791256|NCT00105157|66616135|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
23791257|NCT00105157|66616136|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
23791258|NCT00105157|66616137|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
23350750|NCT00337779|65025571|FG001|Overall Study|Death|1|||
23350751|NCT00114738|65025574|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
23350752|NCT00114738|65025575|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
23350753|NCT00114738|65025576|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
23350754|NCT00114738|65025574|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
23350755|NCT00114738|65025575|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
23464857|NCT01177397|65444779|FG000|Overall Study|Adverse Event|0|||
23464858|NCT01177397|65444780|FG001|Overall Study|Adverse Event|0|||
23464859|NCT01177397|65444781|FG002|Overall Study|Adverse Event|1|||
23464860|NCT01177397|65444782|FG003|Overall Study|Adverse Event|2|||
23464861|NCT01177397|65444783|FG004|Overall Study|Adverse Event|0|||
23464862|NCT01177397|65444784|FG005|Overall Study|Adverse Event|12|||
23464863|NCT01177397|65444785|FG006|Overall Study|Adverse Event|1|||
23464864|NCT01177397|65444786|FG007|Overall Study|Adverse Event|14|||
23464865|NCT01177397|65444787|FG008|Overall Study|Adverse Event|8|||
23464866|NCT01177397|65444788|FG009|Overall Study|Adverse Event|6|||
23464867|NCT01177397|65444789|FG010|Overall Study|Adverse Event|3|||
23464868|NCT01177397|65444790|FG011|Overall Study|Adverse Event|7|||
23464869|NCT01177397|65444779|FG000|Overall Study|Disease progression|1|||
23464870|NCT01177397|65444780|FG001|Overall Study|Disease progression|2|||
23464871|NCT01177397|65444781|FG002|Overall Study|Disease progression|5|||
23464872|NCT01177397|65444782|FG003|Overall Study|Disease progression|5|||
23464873|NCT01177397|65444783|FG004|Overall Study|Disease progression|4|||
23464874|NCT01177397|65444784|FG005|Overall Study|Disease progression|10|||
23464875|NCT01177397|65444785|FG006|Overall Study|Disease progression|10|||
23464876|NCT01177397|65444786|FG007|Overall Study|Disease progression|21|||
23464877|NCT01177397|65444787|FG008|Overall Study|Disease progression|18|||
23464878|NCT01177397|65444788|FG009|Overall Study|Disease progression|12|||
23464879|NCT01177397|65444789|FG010|Overall Study|Disease progression|10|||
23464880|NCT01177397|65444790|FG011|Overall Study|Disease progression|8|||
23464881|NCT01177397|65444779|FG000|Overall Study|Other reasons|0|||
23464882|NCT01177397|65444780|FG001|Overall Study|Other reasons|0|||
23464883|NCT01177397|65444781|FG002|Overall Study|Other reasons|1|||
23464884|NCT01177397|65444782|FG003|Overall Study|Other reasons|0|||
23791259|NCT00105157|66616134|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23464885|NCT01177397|65444783|FG004|Overall Study|Other reasons|1|||
23464886|NCT01177397|65444784|FG005|Overall Study|Other reasons|1|||
23464887|NCT01177397|65444785|FG006|Overall Study|Other reasons|2|||
23464888|NCT01177397|65444786|FG007|Overall Study|Other reasons|6|||
23464889|NCT01177397|65444787|FG008|Overall Study|Other reasons|10|||
23464890|NCT01177397|65444788|FG009|Overall Study|Other reasons|8|||
23464891|NCT01177397|65444789|FG010|Overall Study|Other reasons|0|||
23464892|NCT01177397|65444790|FG011|Overall Study|Other reasons|2|||
23464893|NCT00068692|65444791|FG000|Step 1: Registration|Disese progression/relapse|5|||
23464894|NCT00068692|65444792|FG001|Step 1: Registration|Disese progression/relapse|0|||
23464895|NCT00068692|65444793|FG002|Step 1: Registration|Disese progression/relapse|0|||
23464896|NCT00068692|65444794|FG003|Step 1: Registration|Disese progression/relapse|0|||
23464897|NCT00068692|65444795|FG004|Step 1: Registration|Disese progression/relapse|0|||
23639932|NCT04677179|66067403|FG009|Induction Treatment Period|Protocol Violation|0|||
23639933|NCT04677179|66067394|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
23791260|NCT00105157|66616135|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23791261|NCT00105157|66616136|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23791262|NCT00105157|66616137|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
23791263|NCT00105157|66616134|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23791264|NCT00105157|66616135|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
23791265|NCT00105157|66616136|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23791266|NCT00105157|66616137|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23791267|NCT02034513|66616141|FG000|Overall Study|Adverse Event|11|||
23791268|NCT02034513|66616142|FG001|Overall Study|Adverse Event|10|||
23791269|NCT02034513|66616141|FG000|Overall Study|Lack of Efficacy|0|||
23791270|NCT02034513|66616142|FG001|Overall Study|Lack of Efficacy|1|||
23791271|NCT02034513|66616141|FG000|Overall Study|Lost to Follow-up|6|||
23791272|NCT02034513|66616142|FG001|Overall Study|Lost to Follow-up|7|||
23791273|NCT02034513|66616141|FG000|Overall Study|Pregnancy|0|||
23791274|NCT02034513|66616142|FG001|Overall Study|Pregnancy|3|||
23791275|NCT02034513|66616141|FG000|Overall Study|Protocol Violation|7|||
23791276|NCT02034513|66616142|FG001|Overall Study|Protocol Violation|10|||
23791277|NCT02034513|66616141|FG000|Overall Study|Withdrawal by Subject|25|||
23791278|NCT02034513|66616142|FG001|Overall Study|Withdrawal by Subject|25|||
23464898|NCT00068692|65444796|FG005|Step 1: Registration|Disese progression/relapse|0|||
23464899|NCT00068692|65444797|FG006|Step 1: Registration|Disese progression/relapse|0|||
23464900|NCT00068692|65444798|FG007|Step 1: Registration|Disese progression/relapse|0|||
23464901|NCT00068692|65444791|FG000|Step 1: Registration|Adverse Event|7|||
23585400|NCT00771667|65869437|FG007|Maintenance Phase|Lack of Efficacy|2|||
23585401|NCT00771667|65869438|FG008|Maintenance Phase|Lack of Efficacy|11|||
23464902|NCT00068692|65444792|FG001|Step 1: Registration|Adverse Event|0|||
23464903|NCT00068692|65444793|FG002|Step 1: Registration|Adverse Event|0|||
23464904|NCT00068692|65444794|FG003|Step 1: Registration|Adverse Event|0|||
23464905|NCT00068692|65444795|FG004|Step 1: Registration|Adverse Event|0|||
23464906|NCT00068692|65444796|FG005|Step 1: Registration|Adverse Event|0|||
23464907|NCT00068692|65444797|FG006|Step 1: Registration|Adverse Event|0|||
23791279|NCT02034513|66616141|FG000|Overall Study|Unclassified|0|||
23791280|NCT02034513|66616142|FG001|Overall Study|Unclassified|1|||
23791281|NCT04608448|66616143|FG000|Overall Study|Withdrawal by Subject|1|||
23791282|NCT04608448|66616143|FG000|Overall Study|Adverse Event|1|||
23791283|NCT02028455|66616144|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23791284|NCT02028455|66616145|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23791285|NCT02028455|66616146|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23791286|NCT02028455|66616147|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23464908|NCT00068692|65444798|FG007|Step 1: Registration|Adverse Event|0|||
23464909|NCT00068692|65444791|FG000|Step 1: Registration|Death|1|||
23464910|NCT00068692|65444792|FG001|Step 1: Registration|Death|0|||
23464911|NCT00068692|65444793|FG002|Step 1: Registration|Death|0|||
23464912|NCT00068692|65444794|FG003|Step 1: Registration|Death|0|||
23464913|NCT00068692|65444795|FG004|Step 1: Registration|Death|0|||
23464914|NCT00068692|65444796|FG005|Step 1: Registration|Death|0|||
23464915|NCT00068692|65444797|FG006|Step 1: Registration|Death|0|||
23464916|NCT00068692|65444798|FG007|Step 1: Registration|Death|0|||
23464917|NCT00068692|65444791|FG000|Step 1: Registration|Withdrawal by Subject|11|||
23464918|NCT00068692|65444792|FG001|Step 1: Registration|Withdrawal by Subject|0|||
23464919|NCT00068692|65444793|FG002|Step 1: Registration|Withdrawal by Subject|0|||
23585402|NCT00771667|65869439|FG009|Maintenance Phase|Lack of Efficacy|7|||
23585403|NCT00771667|65869430|FG000|Maintenance Phase|Other|0|||
23350756|NCT00114738|65025576|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
23350757|NCT00114738|65025574|FG000|Screening for Randomization|Neuropathy|17|||
23585404|NCT00771667|65869431|FG001|Maintenance Phase|Other|0|||
23585405|NCT00771667|65869432|FG002|Maintenance Phase|Other|0|||
23585406|NCT00771667|65869433|FG003|Maintenance Phase|Other|0|||
23585407|NCT00771667|65869434|FG004|Maintenance Phase|Other|0|||
23585408|NCT00771667|65869435|FG005|Maintenance Phase|Other|1|||
23585409|NCT00771667|65869436|FG006|Maintenance Phase|Other|2|||
23585410|NCT00771667|65869437|FG007|Maintenance Phase|Other|2|||
23585411|NCT00771667|65869438|FG008|Maintenance Phase|Other|3|||
23585412|NCT00771667|65869439|FG009|Maintenance Phase|Other|3|||
23350758|NCT00114738|65025575|FG001|Screening for Randomization|Neuropathy|0|||
23464920|NCT00068692|65444794|FG003|Step 1: Registration|Withdrawal by Subject|0|||
23464921|NCT00068692|65444795|FG004|Step 1: Registration|Withdrawal by Subject|0|||
23464922|NCT00068692|65444796|FG005|Step 1: Registration|Withdrawal by Subject|0|||
23464923|NCT00068692|65444797|FG006|Step 1: Registration|Withdrawal by Subject|0|||
23585413|NCT00864682|65869441|FG000|Overall Study|Protocol Violation|2|||
23585414|NCT00864682|65869442|FG001|Overall Study|Protocol Violation|1|||
23464924|NCT00068692|65444798|FG007|Step 1: Registration|Withdrawal by Subject|0|||
23464925|NCT00068692|65444791|FG000|Step 1: Registration|Alternative therapy|2|||
23464926|NCT00068692|65444792|FG001|Step 1: Registration|Alternative therapy|0|||
23464927|NCT00068692|65444793|FG002|Step 1: Registration|Alternative therapy|0|||
23464928|NCT00068692|65444794|FG003|Step 1: Registration|Alternative therapy|0|||
23464929|NCT00068692|65444795|FG004|Step 1: Registration|Alternative therapy|0|||
23464930|NCT00068692|65444796|FG005|Step 1: Registration|Alternative therapy|0|||
23464931|NCT00068692|65444797|FG006|Step 1: Registration|Alternative therapy|0|||
23464932|NCT00068692|65444798|FG007|Step 1: Registration|Alternative therapy|0|||
23464933|NCT00068692|65444791|FG000|Step 1: Registration|Complicating disease|2|||
23464934|NCT00068692|65444792|FG001|Step 1: Registration|Complicating disease|0|||
23464935|NCT00068692|65444793|FG002|Step 1: Registration|Complicating disease|0|||
23464936|NCT00068692|65444794|FG003|Step 1: Registration|Complicating disease|0|||
23464937|NCT00068692|65444795|FG004|Step 1: Registration|Complicating disease|0|||
23464938|NCT00068692|65444796|FG005|Step 1: Registration|Complicating disease|0|||
23464939|NCT00068692|65444797|FG006|Step 1: Registration|Complicating disease|0|||
23464940|NCT00068692|65444798|FG007|Step 1: Registration|Complicating disease|0|||
23464941|NCT00068692|65444791|FG000|Step 1: Registration|Protocol Violation|1|||
23464942|NCT00068692|65444792|FG001|Step 1: Registration|Protocol Violation|0|||
23464943|NCT00068692|65444793|FG002|Step 1: Registration|Protocol Violation|0|||
23464944|NCT00068692|65444794|FG003|Step 1: Registration|Protocol Violation|0|||
23464945|NCT00068692|65444795|FG004|Step 1: Registration|Protocol Violation|0|||
23464946|NCT00068692|65444796|FG005|Step 1: Registration|Protocol Violation|0|||
23464947|NCT00068692|65444797|FG006|Step 1: Registration|Protocol Violation|0|||
23464948|NCT00068692|65444798|FG007|Step 1: Registration|Protocol Violation|0|||
23464949|NCT00068692|65444791|FG000|Step 1: Registration|Not eligible|6|||
23464950|NCT00068692|65444792|FG001|Step 1: Registration|Not eligible|0|||
23464951|NCT00068692|65444793|FG002|Step 1: Registration|Not eligible|0|||
23464952|NCT00068692|65444794|FG003|Step 1: Registration|Not eligible|0|||
23464953|NCT00068692|65444795|FG004|Step 1: Registration|Not eligible|0|||
23464954|NCT00068692|65444796|FG005|Step 1: Registration|Not eligible|0|||
23464955|NCT00068692|65444797|FG006|Step 1: Registration|Not eligible|0|||
23464956|NCT00068692|65444798|FG007|Step 1: Registration|Not eligible|0|||
23464957|NCT00068692|65444791|FG000|Step 1: Registration|Other|2|||
23791287|NCT02028455|66616148|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23791288|NCT02028455|66616149|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23791289|NCT02028455|66616150|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
23791290|NCT02028455|66616151|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
23791291|NCT02028455|66616144|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
23791292|NCT02028455|66616145|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
23791293|NCT02028455|66616146|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
23791294|NCT02028455|66616147|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
23350759|NCT00114738|65025576|FG002|Screening for Randomization|Neuropathy|0|||
23350760|NCT00114738|65025574|FG000|Screening for Randomization|Progressive disease|2|||
23350761|NCT00114738|65025575|FG001|Screening for Randomization|Progressive disease|0|||
23350762|NCT00114738|65025576|FG002|Screening for Randomization|Progressive disease|0|||
23350763|NCT00114738|65025574|FG000|Screening for Randomization|CNS Hemorrhage|1|||
23350764|NCT00114738|65025575|FG001|Screening for Randomization|CNS Hemorrhage|0|||
23350765|NCT00114738|65025576|FG002|Screening for Randomization|CNS Hemorrhage|0|||
23350766|NCT00114738|65025574|FG000|Screening for Randomization|Other|1|||
23350767|NCT00114738|65025575|FG001|Screening for Randomization|Other|0|||
23350768|NCT00114738|65025576|FG002|Screening for Randomization|Other|0|||
23350769|NCT00958412|65025577|FG000|Overall Study|Study prematurely terminated|18|||
23350770|NCT01868165|65025578|FG000|Overall Study|Withdrawal by Subject|36|||
23350771|NCT01868165|65025578|FG000|Overall Study|Physician Decision|2|||
23350772|NCT01868165|65025578|FG000|Overall Study|Lost to Follow-up|3|||
23350773|NCT01868165|65025578|FG000|Overall Study|Death|4|||
23350774|NCT00636961|65025579|FG000|Period 1|Administrative problems|1|||
23350775|NCT00636961|65025580|FG001|Period 1|Administrative problems|1|||
23350776|NCT00636961|65025579|FG000|Period 2|Adverse Event|1|||
23350777|NCT00636961|65025580|FG001|Period 2|Adverse Event|0|||
23350778|NCT01877551|65029398|FG000|Overall Study|Physician Decision|0|||
23350779|NCT01877551|65029399|FG001|Overall Study|Physician Decision|1|||
23350780|NCT03970200|65029402|FG000|Overall Study|Death|2|||
23350781|NCT03970200|65029403|FG001|Overall Study|Death|2|||
23350782|NCT03970200|65029404|FG002|Overall Study|Death|1|||
23350783|NCT03970200|65029402|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
23464958|NCT00068692|65444792|FG001|Step 1: Registration|Other|0|||
23464959|NCT00068692|65444793|FG002|Step 1: Registration|Other|0|||
23464960|NCT00068692|65444794|FG003|Step 1: Registration|Other|0|||
23464961|NCT00068692|65444795|FG004|Step 1: Registration|Other|0|||
23464962|NCT00068692|65444796|FG005|Step 1: Registration|Other|0|||
23464963|NCT00068692|65444797|FG006|Step 1: Registration|Other|0|||
23464964|NCT00068692|65444798|FG007|Step 1: Registration|Other|0|||
23464965|NCT00068692|65444791|FG000|Step 1: Registration|Not start protocol therapy|3|||
23464966|NCT00068692|65444792|FG001|Step 1: Registration|Not start protocol therapy|0|||
23464967|NCT00068692|65444793|FG002|Step 1: Registration|Not start protocol therapy|0|||
23464968|NCT00068692|65444794|FG003|Step 1: Registration|Not start protocol therapy|0|||
23464969|NCT00068692|65444795|FG004|Step 1: Registration|Not start protocol therapy|0|||
23350784|NCT03970200|65029403|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
23350785|NCT03970200|65029404|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
23350786|NCT00524680|65029405|FG000|Overall Study|progression|0|||
23350787|NCT00524680|65029406|FG001|Overall Study|progression|0|||
23464970|NCT00068692|65444796|FG005|Step 1: Registration|Not start protocol therapy|0|||
23464971|NCT00068692|65444797|FG006|Step 1: Registration|Not start protocol therapy|0|||
23464972|NCT00068692|65444798|FG007|Step 1: Registration|Not start protocol therapy|0|||
23585415|NCT00864682|65869443|FG002|Overall Study|Protocol Violation|2|||
23585416|NCT03721016|65869445|FG000|Overall Study|Adverse Event|0|||
23791295|NCT02028455|66616148|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
23791296|NCT02028455|66616149|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
23791297|NCT02028455|66616150|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
23791298|NCT02028455|66616151|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
23791299|NCT02028455|66616144|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791300|NCT02028455|66616145|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791301|NCT02028455|66616146|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791302|NCT02028455|66616147|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791303|NCT02028455|66616148|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791304|NCT02028455|66616149|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
23791305|NCT02028455|66616150|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23791306|NCT02028455|66616151|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
23791307|NCT02028455|66616144|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23791308|NCT02028455|66616145|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23791309|NCT02028455|66616146|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
23791310|NCT02028455|66616147|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
23791311|NCT02028455|66616148|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23791312|NCT02028455|66616149|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23791313|NCT02028455|66616150|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
23791314|NCT02028455|66616151|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
23791315|NCT04164758|66616152|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
23791316|NCT04164758|66616153|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
23791317|NCT04164758|66616154|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
23791318|NCT04164758|66616152|FG000|Overall Study|Adverse Event|0|||
23350788|NCT00524680|65029407|FG002|Overall Study|progression|0|||
23350789|NCT00524680|65029408|FG003|Overall Study|progression|1|||
23350790|NCT00524680|65029405|FG000|Overall Study|Adverse Event|2|||
23464973|NCT00068692|65444791|FG000|Step 1: Registration|Registered but not randomized|0|||
23464974|NCT00068692|65444792|FG001|Step 1: Registration|Registered but not randomized|1|||
23464975|NCT00068692|65444793|FG002|Step 1: Registration|Registered but not randomized|0|||
23585417|NCT03721016|65869446|FG001|Overall Study|Adverse Event|1|||
23464976|NCT00068692|65444794|FG003|Step 1: Registration|Registered but not randomized|0|||
23464977|NCT00068692|65444795|FG004|Step 1: Registration|Registered but not randomized|0|||
23585418|NCT03721016|65869447|FG002|Overall Study|Adverse Event|1|||
23585419|NCT03721016|65869445|FG000|Overall Study|Withdrawal by Subject|8|||
23350791|NCT00524680|65029406|FG001|Overall Study|Adverse Event|0|||
23585420|NCT03721016|65869446|FG001|Overall Study|Withdrawal by Subject|16|||
23585421|NCT03721016|65869447|FG002|Overall Study|Withdrawal by Subject|13|||
23350792|NCT00524680|65029407|FG002|Overall Study|Adverse Event|0|||
23350793|NCT00524680|65029408|FG003|Overall Study|Adverse Event|1|||
23350794|NCT00524680|65029405|FG000|Overall Study|Other|0|||
23350795|NCT00524680|65029406|FG001|Overall Study|Other|1|||
23350796|NCT00524680|65029407|FG002|Overall Study|Other|2|||
23350797|NCT00524680|65029408|FG003|Overall Study|Other|3|||
23350798|NCT00524680|65029405|FG000|Overall Study|Withdrawal by Subject|1|||
23350799|NCT00524680|65029406|FG001|Overall Study|Withdrawal by Subject|0|||
23350800|NCT00524680|65029407|FG002|Overall Study|Withdrawal by Subject|1|||
23585422|NCT03721016|65869445|FG000|Overall Study|Lost to Follow-up|4|||
23585423|NCT03721016|65869446|FG001|Overall Study|Lost to Follow-up|6|||
23585424|NCT03721016|65869447|FG002|Overall Study|Lost to Follow-up|5|||
23791319|NCT04164758|66616153|FG001|Overall Study|Adverse Event|1|||
23791320|NCT04164758|66616154|FG002|Overall Study|Adverse Event|0|||
23350801|NCT00524680|65029408|FG003|Overall Study|Withdrawal by Subject|1|||
23791321|NCT01143337|66616155|FG000|Overall Study|Adverse Event|3|||
23791322|NCT01143337|66616156|FG001|Overall Study|Adverse Event|9|||
23791323|NCT01143337|66616157|FG002|Overall Study|Adverse Event|5|||
23791324|NCT01143337|66616155|FG000|Overall Study|Lack of Efficacy|6|||
23791325|NCT01143337|66616156|FG001|Overall Study|Lack of Efficacy|2|||
23791326|NCT01143337|66616157|FG002|Overall Study|Lack of Efficacy|1|||
23791327|NCT01143337|66616155|FG000|Overall Study|Protocol Violation|1|||
23791328|NCT01143337|66616156|FG001|Overall Study|Protocol Violation|0|||
23791329|NCT01143337|66616157|FG002|Overall Study|Protocol Violation|0|||
23791330|NCT01143337|66616155|FG000|Overall Study|Withdrawal by Subject|0|||
23791331|NCT01143337|66616156|FG001|Overall Study|Withdrawal by Subject|0|||
23791332|NCT01143337|66616157|FG002|Overall Study|Withdrawal by Subject|1|||
23791333|NCT01143337|66616155|FG000|Overall Study|Other reason|0|||
23791334|NCT01143337|66616156|FG001|Overall Study|Other reason|0|||
23791335|NCT01143337|66616157|FG002|Overall Study|Other reason|5|||
23350802|NCT00628927|65029409|FG000|Overall Study|Problems performing blood draw|6|||
23350803|NCT00628927|65029410|FG001|Overall Study|Problems performing blood draw|0|||
23350804|NCT00628927|65029409|FG000|Overall Study|Lost to Follow-up|1|||
23350805|NCT00628927|65029410|FG001|Overall Study|Lost to Follow-up|0|||
23585425|NCT03721016|65869445|FG000|Overall Study|Physician Decision|0|||
23791336|NCT00486434|66616160|FG000|Overall Study|Withdrawal by Subject|34|||
23791337|NCT00486434|66616161|FG001|Overall Study|Withdrawal by Subject|39|||
23791338|NCT00486434|66616160|FG000|Overall Study|Adverse Event|118|||
23791339|NCT00486434|66616161|FG001|Overall Study|Adverse Event|44|||
23791340|NCT00486434|66616160|FG000|Overall Study|Protocol Violation|22|||
23791341|NCT00486434|66616161|FG001|Overall Study|Protocol Violation|21|||
23791342|NCT00486434|66616160|FG000|Overall Study|Lack of Efficacy|12|||
23585426|NCT03721016|65869446|FG001|Overall Study|Physician Decision|1|||
23585427|NCT03721016|65869447|FG002|Overall Study|Physician Decision|2|||
23585428|NCT03721016|65869445|FG000|Overall Study|Protocol Violation|0|||
23585429|NCT03721016|65869446|FG001|Overall Study|Protocol Violation|1|||
23585430|NCT03721016|65869447|FG002|Overall Study|Protocol Violation|0|||
23585431|NCT03721016|65869445|FG000|Overall Study|Site terminated by sponsor|3|||
23585432|NCT03721016|65869446|FG001|Overall Study|Site terminated by sponsor|7|||
23585433|NCT03721016|65869447|FG002|Overall Study|Site terminated by sponsor|6|||
23585434|NCT03721016|65869445|FG000|Overall Study|Subject exited early due to COVID-19|1|||
23585435|NCT03721016|65869446|FG001|Overall Study|Subject exited early due to COVID-19|0|||
23585436|NCT03721016|65869447|FG002|Overall Study|Subject exited early due to COVID-19|0|||
23585437|NCT00768066|65869449|FG000|Overall Study|Did not receive study product injection.|3|||
23585438|NCT00768066|65869450|FG001|Overall Study|Did not receive study product injection.|3|||
23585439|NCT00768066|65869451|FG002|Overall Study|Did not receive study product injection.|0|||
23585440|NCT02359435|65869454|FG000|Overall Study|Lost to Follow-up|4|||
23585441|NCT02359435|65869455|FG001|Overall Study|Lost to Follow-up|4|||
23585442|NCT00151996|65869456|FG000|Overall Study|Adverse Event|3|||
23464978|NCT00068692|65444796|FG005|Step 1: Registration|Registered but not randomized|0|||
23464979|NCT00068692|65444797|FG006|Step 1: Registration|Registered but not randomized|0|||
23464980|NCT00068692|65444798|FG007|Step 1: Registration|Registered but not randomized|0|||
23464981|NCT00068692|65444791|FG000|Step 2: Randomization|Disesae progression/replase|0|||
23464982|NCT00068692|65444792|FG001|Step 2: Randomization|Disesae progression/replase|0|||
23464983|NCT00068692|65444793|FG002|Step 2: Randomization|Disesae progression/replase|1|||
23464984|NCT00068692|65444794|FG003|Step 2: Randomization|Disesae progression/replase|1|||
23464985|NCT00068692|65444795|FG004|Step 2: Randomization|Disesae progression/replase|0|||
23464986|NCT00068692|65444796|FG005|Step 2: Randomization|Disesae progression/replase|0|||
23464987|NCT00068692|65444797|FG006|Step 2: Randomization|Disesae progression/replase|0|||
23464988|NCT00068692|65444798|FG007|Step 2: Randomization|Disesae progression/replase|0|||
23464989|NCT00068692|65444791|FG000|Step 2: Randomization|Adverse Event|0|||
23464990|NCT00068692|65444792|FG001|Step 2: Randomization|Adverse Event|0|||
23585443|NCT00151996|65869457|FG001|Overall Study|Adverse Event|2|||
23350806|NCT00628927|65029409|FG000|Overall Study|Equipment failure|1|||
23464991|NCT00068692|65444793|FG002|Step 2: Randomization|Adverse Event|4|||
23585444|NCT00151996|65869456|FG000|Overall Study|Withdrawal by Subject|1|||
23585445|NCT00151996|65869457|FG001|Overall Study|Withdrawal by Subject|1|||
23585446|NCT00151996|65869456|FG000|Overall Study|Protocol Violation|1|||
23585447|NCT00151996|65869457|FG001|Overall Study|Protocol Violation|2|||
23585448|NCT00151996|65869456|FG000|Overall Study|Sponsor's decision|0|||
23585449|NCT00151996|65869457|FG001|Overall Study|Sponsor's decision|2|||
23585450|NCT01345292|65869458|FG000|Overall Study|Withdrawal by Subject|2|||
23585451|NCT01345292|65869459|FG001|Overall Study|Withdrawal by Subject|0|||
23585452|NCT01345292|65869460|FG002|Overall Study|Withdrawal by Subject|1|||
23585453|NCT03635567|65869463|FG000|Overall Study|Lost to Follow-up|0|||
23585454|NCT03635567|65869464|FG001|Overall Study|Lost to Follow-up|2|||
23585455|NCT03635567|65869463|FG000|Overall Study|Withdrawal by Subject|9|||
23585456|NCT03635567|65869464|FG001|Overall Study|Withdrawal by Subject|10|||
23585457|NCT03635567|65869463|FG000|Overall Study|Ongoing in Study|125|||
23585458|NCT03635567|65869464|FG001|Overall Study|Ongoing in Study|76|||
23585459|NCT03635567|65869463|FG000|Overall Study|Death|174|||
23585460|NCT03635567|65869464|FG001|Overall Study|Death|221|||
23585461|NCT00817635|65869465|FG000|Overall Study|Adverse Event|1|||
23585462|NCT00817635|65869466|FG001|Overall Study|Adverse Event|0|||
23585463|NCT00817635|65869467|FG002|Overall Study|Adverse Event|0|||
23791343|NCT00486434|66616161|FG001|Overall Study|Lack of Efficacy|19|||
23791344|NCT00486434|66616160|FG000|Overall Study|Lost to Follow-up|2|||
23585464|NCT00817635|65869468|FG003|Overall Study|Adverse Event|1|||
23585465|NCT00817635|65869469|FG004|Overall Study|Adverse Event|1|||
23585466|NCT00817635|65869465|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23585467|NCT00817635|65869466|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23585468|NCT00817635|65869467|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23585469|NCT00817635|65869468|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23585470|NCT00817635|65869469|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
23585471|NCT00817635|65869465|FG000|Overall Study|Withdrawal by Subject|2|||
23585472|NCT00817635|65869466|FG001|Overall Study|Withdrawal by Subject|1|||
23585473|NCT00817635|65869467|FG002|Overall Study|Withdrawal by Subject|0|||
23791345|NCT00486434|66616161|FG001|Overall Study|Lost to Follow-up|3|||
23791346|NCT00486434|66616160|FG000|Overall Study|Death|1|||
23791347|NCT00486434|66616161|FG001|Overall Study|Death|2|||
23791348|NCT00486434|66616160|FG000|Overall Study|Personal reasons|5|||
23791349|NCT00486434|66616161|FG001|Overall Study|Personal reasons|6|||
23791350|NCT03922750|66616165|FG000|Overall Study|Unclassified|0|||
23791351|NCT03922750|66616166|FG001|Overall Study|Unclassified|0|||
23791352|NCT03922750|66616167|FG002|Overall Study|Unclassified|1|||
23350807|NCT00628927|65029410|FG001|Overall Study|Equipment failure|0|||
23350808|NCT00590538|65029411|FG000|Overall Study|Study terminated before completed|2|||
23464992|NCT00068692|65444794|FG003|Step 2: Randomization|Adverse Event|2|||
23464993|NCT00068692|65444795|FG004|Step 2: Randomization|Adverse Event|2|||
23464994|NCT00068692|65444796|FG005|Step 2: Randomization|Adverse Event|3|||
23464995|NCT00068692|65444797|FG006|Step 2: Randomization|Adverse Event|4|||
23464996|NCT00068692|65444798|FG007|Step 2: Randomization|Adverse Event|4|||
23464997|NCT00068692|65444791|FG000|Step 2: Randomization|Death|0|||
23464998|NCT00068692|65444792|FG001|Step 2: Randomization|Death|0|||
23464999|NCT00068692|65444793|FG002|Step 2: Randomization|Death|0|||
23465000|NCT00068692|65444794|FG003|Step 2: Randomization|Death|0|||
23465001|NCT00068692|65444795|FG004|Step 2: Randomization|Death|1|||
23465002|NCT00068692|65444796|FG005|Step 2: Randomization|Death|0|||
23465003|NCT00068692|65444797|FG006|Step 2: Randomization|Death|0|||
23465004|NCT00068692|65444798|FG007|Step 2: Randomization|Death|1|||
23465005|NCT00068692|65444791|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
23465006|NCT00068692|65444792|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
23465007|NCT00068692|65444793|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
23465008|NCT00068692|65444794|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
23465009|NCT00068692|65444795|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
23350809|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
23465010|NCT00068692|65444796|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
23585474|NCT00817635|65869468|FG003|Overall Study|Withdrawal by Subject|1|||
23585475|NCT00817635|65869469|FG004|Overall Study|Withdrawal by Subject|2|||
23585476|NCT00817635|65869465|FG000|Overall Study|Lost to Follow-up|0|||
23585477|NCT00817635|65869466|FG001|Overall Study|Lost to Follow-up|1|||
23585478|NCT00817635|65869467|FG002|Overall Study|Lost to Follow-up|0|||
23585479|NCT00817635|65869468|FG003|Overall Study|Lost to Follow-up|1|||
23585480|NCT00817635|65869469|FG004|Overall Study|Lost to Follow-up|0|||
23585481|NCT00817635|65869465|FG000|Overall Study|Administrative Problems|0|||
23585482|NCT00817635|65869466|FG001|Overall Study|Administrative Problems|0|||
23791353|NCT03922750|66616165|FG000|Overall Study|Adverse Event|0|||
23791354|NCT03922750|66616166|FG001|Overall Study|Adverse Event|1|||
23465011|NCT00068692|65444797|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
23465012|NCT00068692|65444798|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
23465013|NCT00068692|65444791|FG000|Step 2: Randomization|alternative therapy|0|||
23465014|NCT00068692|65444792|FG001|Step 2: Randomization|alternative therapy|0|||
23465015|NCT00068692|65444793|FG002|Step 2: Randomization|alternative therapy|0|||
23465016|NCT00068692|65444794|FG003|Step 2: Randomization|alternative therapy|1|||
23465017|NCT00068692|65444795|FG004|Step 2: Randomization|alternative therapy|1|||
23465018|NCT00068692|65444796|FG005|Step 2: Randomization|alternative therapy|0|||
23465019|NCT00068692|65444797|FG006|Step 2: Randomization|alternative therapy|0|||
23465020|NCT00068692|65444798|FG007|Step 2: Randomization|alternative therapy|0|||
23465021|NCT00068692|65444791|FG000|Step 2: Randomization|Physician Decision|0|||
23585483|NCT00817635|65869467|FG002|Overall Study|Administrative Problems|0|||
23639934|NCT04677179|66067395|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
23639935|NCT04677179|66067396|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
23639936|NCT04677179|66067397|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
23639937|NCT04677179|66067398|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
23585484|NCT00817635|65869468|FG003|Overall Study|Administrative Problems|0|||
23585485|NCT00817635|65869469|FG004|Overall Study|Administrative Problems|1|||
23585486|NCT00817635|65869465|FG000|Overall Study|Protocol Violation|5|||
23585487|NCT00817635|65869466|FG001|Overall Study|Protocol Violation|1|||
23585488|NCT00817635|65869467|FG002|Overall Study|Protocol Violation|3|||
23585489|NCT00817635|65869468|FG003|Overall Study|Protocol Violation|2|||
23585490|NCT00817635|65869469|FG004|Overall Study|Protocol Violation|3|||
23585491|NCT00586339|65869472|FG000|Overall Study|Withdrawal by Subject|1|||
23585492|NCT00586339|65869473|FG001|Overall Study|Withdrawal by Subject|3|||
23585493|NCT00586339|65869474|FG002|Overall Study|Withdrawal by Subject|1|||
23585494|NCT00586339|65869472|FG000|Overall Study|Migrated/moved from study area|3|||
23585495|NCT00586339|65869473|FG001|Overall Study|Migrated/moved from study area|2|||
23465022|NCT00068692|65444792|FG001|Step 2: Randomization|Physician Decision|0|||
23465023|NCT00068692|65444793|FG002|Step 2: Randomization|Physician Decision|0|||
23465024|NCT00068692|65444794|FG003|Step 2: Randomization|Physician Decision|1|||
23465025|NCT00068692|65444795|FG004|Step 2: Randomization|Physician Decision|1|||
23585496|NCT00586339|65869474|FG002|Overall Study|Migrated/moved from study area|4|||
23585497|NCT00586339|65869472|FG000|Overall Study|Lost to Follow-up|3|||
23585498|NCT00586339|65869473|FG001|Overall Study|Lost to Follow-up|2|||
23585499|NCT00586339|65869474|FG002|Overall Study|Lost to Follow-up|1|||
23791355|NCT03922750|66616167|FG002|Overall Study|Adverse Event|0|||
23791356|NCT00057941|66616172|FG000|Overall Study|Death|1|||
23791357|NCT00057941|66616173|FG001|Overall Study|Death|2|||
23791358|NCT00057941|66616172|FG000|Overall Study|Adverse Event|7|||
23791359|NCT00057941|66616173|FG001|Overall Study|Adverse Event|9|||
23791360|NCT00057941|66616172|FG000|Overall Study|Lack of Efficacy|54|||
23791361|NCT00057941|66616173|FG001|Overall Study|Lack of Efficacy|53|||
23791362|NCT00057941|66616172|FG000|Overall Study|Withdrawal by Subject|6|||
23791363|NCT00057941|66616173|FG001|Overall Study|Withdrawal by Subject|1|||
23791364|NCT00057941|66616172|FG000|Overall Study|still on treatment|3|||
23791365|NCT00057941|66616173|FG001|Overall Study|still on treatment|1|||
23791366|NCT00057941|66616172|FG000|Overall Study|insurance, symptomatic deterioration|1|||
23791367|NCT00057941|66616173|FG001|Overall Study|insurance, symptomatic deterioration|3|||
23791368|NCT00057941|66616172|FG000|Overall Study|Ineligible|2|||
23791369|NCT00057941|66616173|FG001|Overall Study|Ineligible|5|||
23791370|NCT00640926|66616174|FG000|Overall Study|Adverse Event|2|||
23791371|NCT00640926|66616175|FG001|Overall Study|Adverse Event|3|||
23791372|NCT00640926|66616176|FG002|Overall Study|Adverse Event|2|||
23791373|NCT00640926|66616174|FG000|Overall Study|Lack of Efficacy|0|||
23791374|NCT00640926|66616175|FG001|Overall Study|Lack of Efficacy|2|||
23791375|NCT00640926|66616176|FG002|Overall Study|Lack of Efficacy|1|||
23791376|NCT00640926|66616174|FG000|Overall Study|Protocol Violation|2|||
23585500|NCT02701361|65869480|FG000|Overall Study|Lost to Follow-up|5|||
23585501|NCT02701361|65869481|FG001|Overall Study|Lost to Follow-up|2|||
23585502|NCT02701361|65869482|FG002|Overall Study|Lost to Follow-up|1|||
23585503|NCT02701361|65869480|FG000|Overall Study|Withdrawal by Subject|4|||
23585504|NCT02701361|65869481|FG001|Overall Study|Withdrawal by Subject|0|||
23585505|NCT02701361|65869482|FG002|Overall Study|Withdrawal by Subject|0|||
23585506|NCT02701361|65869480|FG000|Overall Study|timed out in rehab center|0|||
23585507|NCT02701361|65869481|FG001|Overall Study|timed out in rehab center|1|||
23585508|NCT02701361|65869482|FG002|Overall Study|timed out in rehab center|0|||
23585509|NCT02701361|65869480|FG000|Overall Study|incarceration|0|||
23585510|NCT02701361|65869481|FG001|Overall Study|incarceration|0|||
23585511|NCT02701361|65869482|FG002|Overall Study|incarceration|1|||
23350810|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350811|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350812|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350813|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350814|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350815|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350816|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350817|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350818|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350819|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
23350820|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
23350821|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
23350822|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350823|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
23465026|NCT00068692|65444796|FG005|Step 2: Randomization|Physician Decision|0|||
23465027|NCT00068692|65444797|FG006|Step 2: Randomization|Physician Decision|0|||
23465028|NCT00068692|65444798|FG007|Step 2: Randomization|Physician Decision|0|||
23465029|NCT00068692|65444791|FG000|Step 2: Randomization|Other|0|||
23465030|NCT00068692|65444792|FG001|Step 2: Randomization|Other|0|||
23465031|NCT00068692|65444793|FG002|Step 2: Randomization|Other|0|||
23465032|NCT00068692|65444794|FG003|Step 2: Randomization|Other|1|||
23465033|NCT00068692|65444795|FG004|Step 2: Randomization|Other|0|||
23465034|NCT00068692|65444796|FG005|Step 2: Randomization|Other|1|||
23465035|NCT00068692|65444797|FG006|Step 2: Randomization|Other|0|||
23465036|NCT00068692|65444798|FG007|Step 2: Randomization|Other|0|||
23465037|NCT00068692|65444791|FG000|Step 2: Randomization|never start protocol therapy|0|||
23465038|NCT00068692|65444792|FG001|Step 2: Randomization|never start protocol therapy|0|||
23465039|NCT00068692|65444793|FG002|Step 2: Randomization|never start protocol therapy|1|||
23465040|NCT00068692|65444794|FG003|Step 2: Randomization|never start protocol therapy|0|||
23465041|NCT00068692|65444795|FG004|Step 2: Randomization|never start protocol therapy|1|||
23465042|NCT00068692|65444796|FG005|Step 2: Randomization|never start protocol therapy|0|||
23465043|NCT00068692|65444797|FG006|Step 2: Randomization|never start protocol therapy|0|||
23465044|NCT00068692|65444798|FG007|Step 2: Randomization|never start protocol therapy|0|||
23465045|NCT01931566|65444801|FG000|Overall Study|Randomized But Not Treated|6|||
23465046|NCT01931566|65444802|FG001|Overall Study|Randomized But Not Treated|9|||
23585514|NCT03586167|65869485|FG000|Overall Study|Other|1|||
23585515|NCT03586167|65869486|FG001|Overall Study|Other|0|||
23585516|NCT00554801|65869487|FG000|Overall Study|left area before completion|5|||
23585517|NCT00554801|65869488|FG001|Overall Study|left area before completion|0|||
23585518|NCT00554801|65869487|FG000|Overall Study|Withdrawal by Subject|14|||
23585519|NCT00554801|65869488|FG001|Overall Study|Withdrawal by Subject|0|||
23465047|NCT01931566|65444803|FG002|Overall Study|Randomized But Not Treated|14|||
23465048|NCT01931566|65444801|FG000|Overall Study|Adverse Event|37|||
23585520|NCT03545984|65869489|FG000|Overall Study|CSF cases not present during rotation|11|||
23585521|NCT03545984|65869490|FG001|Overall Study|CSF cases not present during rotation|9|||
23585522|NCT04567615|65869497|FG000|Randomization|Participant withdrew consent|1|||
23585523|NCT04567615|65869498|FG001|Randomization|Participant withdrew consent|0|||
23585524|NCT04567615|65869499|FG002|Randomization|Participant withdrew consent|0|||
23585525|NCT04567615|65869497|FG000|Randomization|Adverse event unrelated to study drug|0|||
23585526|NCT04567615|65869498|FG001|Randomization|Adverse event unrelated to study drug|1|||
23465049|NCT01931566|65444802|FG001|Overall Study|Adverse Event|167|||
23465050|NCT01931566|65444803|FG002|Overall Study|Adverse Event|132|||
23465051|NCT01931566|65444801|FG000|Overall Study|Major Protocol Deviation|5|||
23465052|NCT01931566|65444802|FG001|Overall Study|Major Protocol Deviation|14|||
23465053|NCT01931566|65444803|FG002|Overall Study|Major Protocol Deviation|21|||
23465054|NCT01931566|65444801|FG000|Overall Study|Lost to Follow-up|3|||
23465055|NCT01931566|65444802|FG001|Overall Study|Lost to Follow-up|26|||
23465056|NCT01931566|65444803|FG002|Overall Study|Lost to Follow-up|23|||
23465057|NCT01931566|65444801|FG000|Overall Study|Voluntary Withdrawal|78|||
23585527|NCT04567615|65869499|FG002|Randomization|Adverse event unrelated to study drug|0|||
23585528|NCT04567615|65869497|FG000|Treatment Period|Participant Withdrew Consent|2|||
23791377|NCT00640926|66616175|FG001|Overall Study|Protocol Violation|0|||
23791378|NCT00640926|66616176|FG002|Overall Study|Protocol Violation|2|||
23791379|NCT00640926|66616174|FG000|Overall Study|Lost to Follow-up|3|||
23791380|NCT00640926|66616175|FG001|Overall Study|Lost to Follow-up|1|||
23791381|NCT00640926|66616176|FG002|Overall Study|Lost to Follow-up|2|||
23791382|NCT00640926|66616174|FG000|Overall Study|Withdrawal by Subject|1|||
23791383|NCT00640926|66616175|FG001|Overall Study|Withdrawal by Subject|0|||
23791384|NCT00640926|66616176|FG002|Overall Study|Withdrawal by Subject|1|||
23791385|NCT02119936|66616179|FG000|Overall Study|Lost to Follow-up|10|||
23791386|NCT00613730|66616180|FG000|Overall Study|Disease progression|2|||
23791387|NCT00613730|66616180|FG000|Overall Study|Administrative decision|1|||
23791388|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Adverse Event|8|||
23791389|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Adverse Event|5|||
23791390|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Adverse Event|9|||
23791391|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Adverse Event|0|||
23791392|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Adverse Event|0|||
23791393|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Adverse Event|0|||
23791394|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
23791395|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
23791396|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
23791397|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
23465058|NCT01931566|65444802|FG001|Overall Study|Voluntary Withdrawal|245|||
23465059|NCT01931566|65444803|FG002|Overall Study|Voluntary Withdrawal|225|||
23465060|NCT01931566|65444801|FG000|Overall Study|Study Termination|289|||
23465061|NCT01931566|65444802|FG001|Overall Study|Study Termination|968|||
23465062|NCT01931566|65444803|FG002|Overall Study|Study Termination|1037|||
23791398|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
23791399|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
23791400|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
23791401|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
23791402|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
23791403|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
23791404|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
23791405|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
23791406|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Physician Decision|4|||
23791407|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Physician Decision|0|||
23791408|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Physician Decision|2|||
23791409|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Physician Decision|0|||
23791410|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Physician Decision|0|||
23791411|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Physician Decision|0|||
23791412|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Pregnancy|1|||
23791413|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Pregnancy|2|||
23791414|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Pregnancy|0|||
23465063|NCT01931566|65444801|FG000|Overall Study|Reason Not Specified|11|||
23465064|NCT01931566|65444802|FG001|Overall Study|Reason Not Specified|47|||
23465065|NCT01931566|65444803|FG002|Overall Study|Reason Not Specified|53|||
23465066|NCT01931566|65444801|FG000|Overall Study|Missing|0|||
23791415|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Pregnancy|0|||
23791416|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Pregnancy|0|||
23791417|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Pregnancy|0|||
23585529|NCT04567615|65869498|FG001|Treatment Period|Participant Withdrew Consent|5|||
23585530|NCT04567615|65869499|FG002|Treatment Period|Participant Withdrew Consent|1|||
23585531|NCT04567615|65869497|FG000|Treatment Period|Death|1|||
23585532|NCT04567615|65869498|FG001|Treatment Period|Death|2|||
23791418|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
23791419|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
23791420|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
23791421|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
23791422|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
23791423|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
23791424|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
23791425|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
23791426|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
23791427|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
23791428|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
23791429|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
23791430|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
23791431|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
23791432|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
23791433|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
23791434|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23791435|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23791436|NCT02614196|66616181|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
23791437|NCT02614196|66616182|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
23465067|NCT01931566|65444802|FG001|Overall Study|Missing|0|||
23465068|NCT01931566|65444803|FG002|Overall Study|Missing|1|||
23465069|NCT02556177|65444806|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
23465070|NCT02556177|65444807|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
23465071|NCT02840461|65444811|FG000|Overall Study|Adverse Event|1|||
23465072|NCT02840461|65444812|FG001|Overall Study|Adverse Event|5|||
23465073|NCT02840461|65444813|FG002|Overall Study|Adverse Event|3|||
23465074|NCT02840461|65444811|FG000|Overall Study|Lost to Follow-up|10|||
23465075|NCT02840461|65444812|FG001|Overall Study|Lost to Follow-up|7|||
23465076|NCT02840461|65444813|FG002|Overall Study|Lost to Follow-up|6|||
23465077|NCT02840461|65444811|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
23465078|NCT02840461|65444812|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
23465079|NCT02840461|65444813|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
23465080|NCT02840461|65444811|FG000|Overall Study|Protocol Violation|2|||
23465081|NCT02840461|65444812|FG001|Overall Study|Protocol Violation|3|||
23465082|NCT02840461|65444813|FG002|Overall Study|Protocol Violation|1|||
23465083|NCT02840461|65444811|FG000|Overall Study|Withdrawal by Subject|10|||
23465084|NCT02840461|65444812|FG001|Overall Study|Withdrawal by Subject|6|||
23465085|NCT02840461|65444813|FG002|Overall Study|Withdrawal by Subject|2|||
23465086|NCT02840461|65444811|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
23465087|NCT02840461|65444812|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
23465088|NCT02840461|65444813|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
23465089|NCT01774721|65444829|FG000|Overall Study|Death|133|||
23465090|NCT01774721|65444830|FG001|Overall Study|Death|152|||
23465091|NCT01774721|65444829|FG000|Overall Study|Withdrawal by Subject|20|||
23465092|NCT01774721|65444830|FG001|Overall Study|Withdrawal by Subject|14|||
23465093|NCT01774721|65444829|FG000|Overall Study|Lost to Follow-up|6|||
23465094|NCT01774721|65444830|FG001|Overall Study|Lost to Follow-up|7|||
23465095|NCT01774721|65444829|FG000|Overall Study|Did not meet eligibility criteria|0|||
23465096|NCT01774721|65444830|FG001|Overall Study|Did not meet eligibility criteria|3|||
23465097|NCT01774721|65444829|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
23465098|NCT01774721|65444830|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
23465099|NCT01774721|65444829|FG000|Overall Study|Study terminated by sponsor|5|||
23465100|NCT01774721|65444830|FG001|Overall Study|Study terminated by sponsor|0|||
23465101|NCT01774721|65444829|FG000|Overall Study|Disease progression|5|||
23465102|NCT01774721|65444830|FG001|Overall Study|Disease progression|0|||
23465103|NCT01094119|65444831|FG000|Overall Study|Lack of Efficacy|2|||
23465104|NCT01094119|65444832|FG001|Overall Study|Lack of Efficacy|4|||
23465105|NCT00929695|65444834|FG000|Overall Study|Death|2|||
23465106|NCT00929695|65444835|FG001|Overall Study|Death|1|||
23465107|NCT00929695|65444834|FG000|Overall Study|Withdrawal by Subject|0|||
23465108|NCT00929695|65444835|FG001|Overall Study|Withdrawal by Subject|2|||
23465109|NCT00929695|65444834|FG000|Overall Study|discharge home|4|||
23465110|NCT00929695|65444835|FG001|Overall Study|discharge home|3|||
23465111|NCT00929695|65444834|FG000|Overall Study|incorrect stratification|2|||
23465112|NCT00929695|65444835|FG001|Overall Study|incorrect stratification|0|||
23465113|NCT04396639|65444836|FG000|Overall Study|Withdrawal by Subject|1|||
23465114|NCT04396639|65444836|FG000|Overall Study|Other|1|||
23465115|NCT00705016|65444841|FG000|Overall Study|Adverse Event|6|||
23465116|NCT00705016|65444842|FG001|Overall Study|Adverse Event|11|||
23465117|NCT00705016|65444843|FG002|Overall Study|Adverse Event|10|||
23465118|NCT00705016|65444841|FG000|Overall Study|Death|5|||
23465119|NCT00705016|65444842|FG001|Overall Study|Death|7|||
23465120|NCT00705016|65444843|FG002|Overall Study|Death|5|||
23791438|NCT02614196|66616183|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
23791439|NCT02614196|66616184|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
23791440|NCT02614196|66616185|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
23791441|NCT02614196|66616186|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
23791442|NCT02614196|66616181|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
23791443|NCT02614196|66616182|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23791444|NCT02614196|66616183|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23350824|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
23350825|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350826|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23639938|NCT04677179|66067399|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
23639939|NCT04677179|66067400|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
23639940|NCT04677179|66067401|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
23639941|NCT04677179|66067402|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
23791445|NCT02614196|66616184|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23791446|NCT02614196|66616185|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
23791447|NCT02614196|66616186|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23791448|NCT02614196|66616181|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
23791449|NCT02614196|66616182|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
23791450|NCT02614196|66616183|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
23791451|NCT02614196|66616184|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
23791452|NCT02614196|66616185|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
23791453|NCT02614196|66616186|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
23791454|NCT02614196|66616181|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
23791455|NCT02614196|66616182|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
23791456|NCT02614196|66616183|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
23791457|NCT02614196|66616184|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
23791458|NCT02614196|66616185|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
23791459|NCT02614196|66616186|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
23791460|NCT02614196|66616181|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
23791461|NCT02614196|66616182|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23791462|NCT02614196|66616183|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
23791463|NCT02614196|66616184|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23791464|NCT02614196|66616185|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23791465|NCT02614196|66616186|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23791466|NCT01567527|66616192|FG000|Conversion Phase.|Protocol deviation|3|||
23791467|NCT01567527|66616193|FG001|Conversion Phase.|Protocol deviation|0|||
23791468|NCT01567527|66616194|FG002|Conversion Phase.|Protocol deviation|0|||
23791469|NCT01567527|66616195|FG003|Conversion Phase.|Protocol deviation|0|||
23791470|NCT01567527|66616196|FG004|Conversion Phase.|Protocol deviation|0|||
23791471|NCT01567527|66616192|FG000|Conversion Phase.|Met withdrawal criteria|10|||
23791472|NCT01567527|66616193|FG001|Conversion Phase.|Met withdrawal criteria|0|||
23791473|NCT01567527|66616194|FG002|Conversion Phase.|Met withdrawal criteria|0|||
23791474|NCT01567527|66616195|FG003|Conversion Phase.|Met withdrawal criteria|0|||
23791475|NCT01567527|66616196|FG004|Conversion Phase.|Met withdrawal criteria|0|||
23791476|NCT01567527|66616192|FG000|Conversion Phase.|Withdrawal by Subject|32|||
23791477|NCT01567527|66616193|FG001|Conversion Phase.|Withdrawal by Subject|0|||
23791478|NCT01567527|66616194|FG002|Conversion Phase.|Withdrawal by Subject|0|||
23791479|NCT01567527|66616195|FG003|Conversion Phase.|Withdrawal by Subject|0|||
23791480|NCT01567527|66616196|FG004|Conversion Phase.|Withdrawal by Subject|0|||
23791481|NCT01567527|66616192|FG000|Conversion Phase.|Lost to Follow-up|16|||
23791482|NCT01567527|66616193|FG001|Conversion Phase.|Lost to Follow-up|0|||
23791483|NCT01567527|66616194|FG002|Conversion Phase.|Lost to Follow-up|0|||
23791484|NCT01567527|66616195|FG003|Conversion Phase.|Lost to Follow-up|0|||
23791485|NCT01567527|66616196|FG004|Conversion Phase.|Lost to Follow-up|0|||
23791486|NCT01567527|66616192|FG000|Conversion Phase.|Lack of Efficacy|2|||
23791487|NCT01567527|66616193|FG001|Conversion Phase.|Lack of Efficacy|0|||
23791488|NCT01567527|66616194|FG002|Conversion Phase.|Lack of Efficacy|0|||
23791489|NCT01567527|66616195|FG003|Conversion Phase.|Lack of Efficacy|0|||
23791490|NCT01567527|66616196|FG004|Conversion Phase.|Lack of Efficacy|0|||
23791491|NCT01567527|66616192|FG000|Conversion Phase.|Adverse Event|33|||
23791492|NCT01567527|66616193|FG001|Conversion Phase.|Adverse Event|0|||
23791493|NCT01567527|66616194|FG002|Conversion Phase.|Adverse Event|0|||
23791494|NCT01567527|66616195|FG003|Conversion Phase.|Adverse Event|0|||
23791495|NCT01567527|66616196|FG004|Conversion Phase.|Adverse Event|0|||
23791496|NCT01567527|66616192|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
23791497|NCT01567527|66616193|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
23791498|NCT01567527|66616194|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
23791499|NCT01567527|66616195|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
23791500|NCT01567527|66616196|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
23791501|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23791502|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
23465121|NCT00705016|65444841|FG000|Overall Study|Protocol Violation|0|||
23465122|NCT00705016|65444842|FG001|Overall Study|Protocol Violation|1|||
23465123|NCT00705016|65444843|FG002|Overall Study|Protocol Violation|1|||
23465124|NCT00705016|65444841|FG000|Overall Study|Withdrawal by Subject|4|||
23465125|NCT00705016|65444842|FG001|Overall Study|Withdrawal by Subject|3|||
23465126|NCT00705016|65444843|FG002|Overall Study|Withdrawal by Subject|2|||
23465127|NCT00705016|65444841|FG000|Overall Study|Progressive Disease|33|||
23465128|NCT00705016|65444842|FG001|Overall Study|Progressive Disease|29|||
23465129|NCT00705016|65444843|FG002|Overall Study|Progressive Disease|33|||
23465130|NCT00705016|65444841|FG000|Overall Study|Symptomatic Deterioration|3|||
23465131|NCT00705016|65444842|FG001|Overall Study|Symptomatic Deterioration|1|||
23465132|NCT00705016|65444843|FG002|Overall Study|Symptomatic Deterioration|1|||
23465133|NCT00705016|65444841|FG000|Overall Study|Other|9|||
23465134|NCT00705016|65444842|FG001|Overall Study|Other|6|||
23465135|NCT00705016|65444843|FG002|Overall Study|Other|6|||
23465136|NCT01189032|65444845|FG000|Overall Study|Adverse Event|1|||
23465137|NCT01189032|65444846|FG001|Overall Study|Adverse Event|3|||
23465138|NCT01189032|65444847|FG002|Overall Study|Adverse Event|4|||
23465139|NCT01189032|65444845|FG000|Overall Study|Lack of Efficacy|2|||
23465140|NCT01189032|65444846|FG001|Overall Study|Lack of Efficacy|3|||
23465141|NCT01189032|65444847|FG002|Overall Study|Lack of Efficacy|0|||
23465142|NCT01189032|65444845|FG000|Overall Study|Withdrawal by Subject|1|||
23465143|NCT01189032|65444846|FG001|Overall Study|Withdrawal by Subject|0|||
23465144|NCT01189032|65444847|FG002|Overall Study|Withdrawal by Subject|1|||
23465145|NCT01189032|65444845|FG000|Overall Study|Protocol Violation|1|||
23465146|NCT01189032|65444846|FG001|Overall Study|Protocol Violation|1|||
23465147|NCT01189032|65444847|FG002|Overall Study|Protocol Violation|1|||
23465148|NCT05660577|65444850|FG000|Overall Study|Discontinued|9|||
23465149|NCT01456039|65444853|FG000|Phase 1 (First Step)|Disease Progression|1|||
23465150|NCT01456039|65444854|FG001|Phase 1 (First Step)|Disease Progression|1|||
23465151|NCT01456039|65444855|FG002|Phase 1 (First Step)|Disease Progression|0|||
23465152|NCT01456039|65444853|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
23465153|NCT01456039|65444854|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
23465154|NCT01456039|65444855|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
23465155|NCT01456039|65444853|FG000|Phase 1 (First Step)|Adverse Event|0|||
23465156|NCT01456039|65444854|FG001|Phase 1 (First Step)|Adverse Event|3|||
23465157|NCT01456039|65444855|FG002|Phase 1 (First Step)|Adverse Event|0|||
23465158|NCT01456039|65444853|FG000|Phase 1 (First Step)|Other|0|||
23465159|NCT01456039|65444854|FG001|Phase 1 (First Step)|Other|1|||
23465160|NCT01456039|65444855|FG002|Phase 1 (First Step)|Other|0|||
23465161|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Disease Progression|0|||
23465162|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Disease Progression|0|||
23465163|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Disease Progression|17|||
23465164|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Adverse Event|0|||
23465165|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Adverse Event|0|||
23465166|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Adverse Event|10|||
23465167|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
23465168|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
23465169|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
23465170|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
23465171|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
23465172|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
23465173|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Other|0|||
23465174|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Other|0|||
23465175|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Other|1|||
23465176|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
23465177|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
23465178|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
23465179|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
23465180|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
23465181|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
23465182|NCT01929317|65444856|FG000|Long-term Phase|Adverse Event|5|||
23465183|NCT01929317|65444857|FG001|Long-term Phase|Adverse Event|1|||
23465184|NCT01929317|65444856|FG000|Long-term Phase|Physician Decision|3|||
23639942|NCT04677179|66067403|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
23639943|NCT04677179|66067394|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
23465185|NCT01929317|65444857|FG001|Long-term Phase|Physician Decision|0|||
23465186|NCT01929317|65444856|FG000|Long-term Phase|Withdrawal by Subject|4|||
23465187|NCT01929317|65444857|FG001|Long-term Phase|Withdrawal by Subject|0|||
23465188|NCT01929317|65444856|FG000|Long-term Phase|Protocol Violation|1|||
23465189|NCT01929317|65444857|FG001|Long-term Phase|Protocol Violation|0|||
23465190|NCT01929317|65444856|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
23465191|NCT01929317|65444857|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
23465192|NCT01929317|65444856|FG000|Long-term Phase|Study Closed/Terminated|5|||
23639944|NCT04677179|66067395|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
23465193|NCT01929317|65444857|FG001|Long-term Phase|Study Closed/Terminated|3|||
23465194|NCT02377817|65444858|FG000|Overall Study|Transportation/childcare barriers.|2|||
23465195|NCT02377817|65444859|FG001|Overall Study|Transportation/childcare barriers.|0|||
23465196|NCT02377817|65444858|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
23465197|NCT02377817|65444859|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
23465198|NCT05021978|65444862|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
23465199|NCT05021978|65444863|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23465200|NCT05021978|65444864|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23465201|NCT05021978|65444865|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23585533|NCT04567615|65869499|FG002|Treatment Period|Death|0|||
23585534|NCT04567615|65869497|FG000|Treatment Period|Lost to Follow-up|0|||
23585535|NCT04567615|65869498|FG001|Treatment Period|Lost to Follow-up|1|||
23585536|NCT04567615|65869499|FG002|Treatment Period|Lost to Follow-up|0|||
23585537|NCT04567615|65869497|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
23585538|NCT04567615|65869498|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
23585539|NCT04567615|65869499|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
23585540|NCT04567615|65869497|FG000|Treatment Period|Disease Progression|85|||
23585541|NCT04567615|65869498|FG001|Treatment Period|Disease Progression|63|||
23585542|NCT04567615|65869499|FG002|Treatment Period|Disease Progression|16|||
23585543|NCT04567615|65869497|FG000|Treatment Period|Study Drug Toxicity|3|||
23585544|NCT04567615|65869498|FG001|Treatment Period|Study Drug Toxicity|10|||
23585545|NCT04567615|65869499|FG002|Treatment Period|Study Drug Toxicity|4|||
23585546|NCT04567615|65869497|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
23639945|NCT04677179|66067396|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
23639946|NCT04677179|66067397|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
23639947|NCT04677179|66067398|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
23639948|NCT04677179|66067399|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
23639949|NCT04677179|66067400|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
23639950|NCT04677179|66067401|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
23639951|NCT04677179|66067402|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
23639952|NCT04677179|66067403|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
23639953|NCT04677179|66067394|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
23639954|NCT04677179|66067395|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
23639955|NCT04677179|66067396|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
23465202|NCT05021978|65444862|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465203|NCT05021978|65444863|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
23585547|NCT04567615|65869498|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
23639956|NCT04677179|66067397|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
23639957|NCT04677179|66067398|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
23639958|NCT04677179|66067399|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
23639959|NCT04677179|66067400|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
23639960|NCT04677179|66067401|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
23639961|NCT04677179|66067402|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
23639962|NCT04677179|66067403|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
23639963|NCT04677179|66067394|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639964|NCT04677179|66067395|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639965|NCT04677179|66067396|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639966|NCT04677179|66067397|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
23585548|NCT04567615|65869499|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
23585549|NCT04567615|65869497|FG000|Treatment Period|Other Reasons|1|||
23585550|NCT04567615|65869498|FG001|Treatment Period|Other Reasons|2|||
23585551|NCT04567615|65869499|FG002|Treatment Period|Other Reasons|0|||
23585552|NCT04567615|65869497|FG000|Treatment Period|Still On-going Treatment|21|||
23585553|NCT04567615|65869498|FG001|Treatment Period|Still On-going Treatment|22|||
23585554|NCT04567615|65869499|FG002|Treatment Period|Still On-going Treatment|2|||
23585555|NCT00465985|65869501|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
23585556|NCT00465985|65869502|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
23585557|NCT00465985|65869501|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
23585558|NCT00465985|65869502|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
23585559|NCT00465985|65869501|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
23585560|NCT00465985|65869502|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
23585561|NCT00465985|65869501|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
23585562|NCT00465985|65869502|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
23585563|NCT03386929|65872785|FG000|Overall Study|Death|0|||
23585564|NCT03386929|65872786|FG001|Overall Study|Death|0|||
23585565|NCT03386929|65872787|FG002|Overall Study|Death|1|||
23585566|NCT03386929|65872785|FG000|Overall Study|Withdrawal by Subject|0|||
23585567|NCT03386929|65872786|FG001|Overall Study|Withdrawal by Subject|1|||
23585568|NCT03386929|65872787|FG002|Overall Study|Withdrawal by Subject|0|||
23585569|NCT03386929|65872785|FG000|Overall Study|Physician Decision|0|||
23585570|NCT03386929|65872786|FG001|Overall Study|Physician Decision|0|||
23585571|NCT03386929|65872787|FG002|Overall Study|Physician Decision|1|||
23585572|NCT03386929|65872785|FG000|Overall Study|Progression|4|||
23585573|NCT03386929|65872786|FG001|Overall Study|Progression|4|||
23585574|NCT03386929|65872787|FG002|Overall Study|Progression|0|||
23585575|NCT03386929|65872785|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585576|NCT03386929|65872786|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585577|NCT03386929|65872787|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585578|NCT03386929|65872785|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
23585579|NCT03386929|65872786|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
23585580|NCT03386929|65872787|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
23585581|NCT00290732|65872788|FG000|Overall Study|Inability to instill drug intraductally.|0|||
23585582|NCT00290732|65872789|FG001|Overall Study|Inability to instill drug intraductally.|1|||
23585583|NCT00290732|65872790|FG002|Overall Study|Inability to instill drug intraductally.|1|||
23585584|NCT00290732|65872791|FG003|Overall Study|Inability to instill drug intraductally.|0|||
23585585|NCT00290732|65872792|FG004|Overall Study|Inability to instill drug intraductally.|0|||
23585586|NCT02390557|65872793|FG000|Wave 2|Survey non-respondent|72|||
23585587|NCT02390557|65872794|FG001|Wave 2|Survey non-respondent|41|||
23585588|NCT02390557|65872795|FG002|Wave 2|Survey non-respondent|23|||
23585589|NCT02930343|65872798|FG000|Overall Study|Lost to Follow-up|9|||
23585590|NCT02930343|65872799|FG001|Overall Study|Lost to Follow-up|7|||
23585591|NCT03264456|65872801|FG000|Overall Study|Withdrawal by Subject|3|||
23639967|NCT04677179|66067398|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639968|NCT04677179|66067399|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639969|NCT04677179|66067400|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639970|NCT04677179|66067401|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639971|NCT04677179|66067402|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639972|NCT04677179|66067403|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
23639973|NCT04677179|66067394|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
23585592|NCT03264456|65872801|FG000|Overall Study|Lost to Follow-up|1|||
23585593|NCT02236559|65872802|FG000|Overall Study|Met Exclusion|3|||
23585594|NCT02236559|65872803|FG001|Overall Study|Met Exclusion|6|||
23585595|NCT02236559|65872802|FG000|Overall Study|Did not Meet Inclusion|3|||
23585596|NCT02236559|65872803|FG001|Overall Study|Did not Meet Inclusion|3|||
23585597|NCT02236559|65872802|FG000|Overall Study|Subject Did Not Consent|4|||
23585598|NCT02236559|65872803|FG001|Overall Study|Subject Did Not Consent|2|||
23585599|NCT02236559|65872802|FG000|Overall Study|Physician Decision|1|||
23585600|NCT02236559|65872803|FG001|Overall Study|Physician Decision|1|||
23585601|NCT02236559|65872802|FG000|Overall Study|Withdrawal by Subject|1|||
23585602|NCT02236559|65872803|FG001|Overall Study|Withdrawal by Subject|0|||
23585603|NCT01806714|65872805|FG000|Overall Study|No functioning phone number|200|||
23585604|NCT01806714|65872806|FG001|Overall Study|No functioning phone number|170|||
23585605|NCT01076335|65872807|FG000|Overall Study|Withdrawal by Subject|3|||
23585606|NCT01076335|65872807|FG000|Overall Study|Withdrawal without treatment|1|||
23585607|NCT03278028|65872808|FG000|Overall Study|Lost to Follow-up|1|||
23585608|NCT03278028|65872809|FG001|Overall Study|Lost to Follow-up|0|||
23585609|NCT03278028|65872808|FG000|Overall Study|Withdrawal by Subject|3|||
23585610|NCT03278028|65872809|FG001|Overall Study|Withdrawal by Subject|1|||
23585611|NCT03278028|65872808|FG000|Overall Study|Pregnancy|0|||
23585612|NCT03278028|65872809|FG001|Overall Study|Pregnancy|1|||
23585613|NCT03467724|65872811|FG000|Overall Study|Lost to Follow-up|5|||
23585614|NCT03467724|65872811|FG000|Overall Study|Withdrawal by Subject|1|||
23585615|NCT03467724|65872811|FG000|Overall Study|Protocol Violation|1|||
23585616|NCT03467724|65872811|FG000|Overall Study|Adverse Event|1|||
23585617|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
23585618|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
23465204|NCT05021978|65444864|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465205|NCT05021978|65444865|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465206|NCT01642589|65444866|FG000|Overall Study|Withdrawal by Subject|1|||
23465207|NCT01642589|65444867|FG001|Overall Study|Withdrawal by Subject|1|||
23465208|NCT00482053|65444868|FG000|Inter-treatment Period|Disease progression|1|||
23465209|NCT03388164|65444869|FG000|Overall Study|Withdrawal by Subject|3|||
23465210|NCT03388164|65444870|FG001|Overall Study|Withdrawal by Subject|1|||
23465211|NCT00888134|65444871|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
23465212|NCT00888134|65444871|FG000|Follow-up|being followed for long-term survival|1|||
23465213|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Adverse Event|9|||
23465214|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Adverse Event|3|||
23465215|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Death|7|||
23465216|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Death|7|||
23465217|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
23465218|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
23465219|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Physician Decision|1|||
23465220|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Physician Decision|0|||
23465221|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
23465222|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
23465223|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
23706202|NCT01258348|66301082|FG001|Overall Study|Physician Decision|0|||
23791503|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23791504|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23791505|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23791506|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23791507|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
23791508|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23791509|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23791510|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23791511|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23791512|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
23791513|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23791514|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23791515|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23791516|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23791517|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
23791518|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23791519|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23791520|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23791521|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23791522|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
23791523|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23791524|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23791525|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23791526|NCT01567527|66616192|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23791527|NCT01567527|66616193|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
23791528|NCT01567527|66616194|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23791529|NCT01567527|66616195|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23791530|NCT01567527|66616196|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23791531|NCT01567527|66616192|FG000|IM Depot Stabilization.|Protocol deviation|0|||
23791532|NCT01567527|66616193|FG001|IM Depot Stabilization.|Protocol deviation|0|||
23791533|NCT01567527|66616194|FG002|IM Depot Stabilization.|Protocol deviation|5|||
23791534|NCT01567527|66616195|FG003|IM Depot Stabilization.|Protocol deviation|0|||
23585619|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
23585620|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Other|1|||
23585621|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
23585622|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23585623|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
23585624|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Other|1|||
23585625|NCT03612804|65872818|FG000|Overall Study|Death|0|||
23585626|NCT03612804|65872819|FG001|Overall Study|Death|7|||
23585627|NCT03612804|65872820|FG002|Overall Study|Death|0|||
23585628|NCT03612804|65872821|FG003|Overall Study|Death|8|||
23585629|NCT03612804|65872818|FG000|Overall Study|Medication copay coverage issues|0|||
23585630|NCT03612804|65872819|FG001|Overall Study|Medication copay coverage issues|0|||
23585631|NCT03612804|65872820|FG002|Overall Study|Medication copay coverage issues|0|||
23585632|NCT03612804|65872821|FG003|Overall Study|Medication copay coverage issues|17|||
23585633|NCT03612804|65872818|FG000|Overall Study|Not current smoker at time of screening|0|||
23585634|NCT03612804|65872819|FG001|Overall Study|Not current smoker at time of screening|1|||
23585635|NCT03612804|65872820|FG002|Overall Study|Not current smoker at time of screening|0|||
23585636|NCT03612804|65872821|FG003|Overall Study|Not current smoker at time of screening|3|||
23585637|NCT03612804|65872818|FG000|Overall Study|Non-veteran status|0|||
23585638|NCT03612804|65872819|FG001|Overall Study|Non-veteran status|1|||
23585639|NCT03612804|65872820|FG002|Overall Study|Non-veteran status|0|||
23585640|NCT03612804|65872821|FG003|Overall Study|Non-veteran status|0|||
23585641|NCT03612804|65872818|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
23585642|NCT03612804|65872819|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
23585643|NCT03612804|65872820|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
23585644|NCT03612804|65872821|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
23585645|NCT03612804|65872818|FG000|Overall Study|Provider retired from VA|0|||
23585646|NCT03612804|65872819|FG001|Overall Study|Provider retired from VA|0|||
23585647|NCT03612804|65872820|FG002|Overall Study|Provider retired from VA|2|||
23585648|NCT03612804|65872821|FG003|Overall Study|Provider retired from VA|0|||
23585649|NCT03612804|65872818|FG000|Overall Study|Withdrawal by Subject|0|||
23585650|NCT03612804|65872819|FG001|Overall Study|Withdrawal by Subject|0|||
23585651|NCT03612804|65872820|FG002|Overall Study|Withdrawal by Subject|7|||
23585652|NCT03612804|65872821|FG003|Overall Study|Withdrawal by Subject|0|||
23585653|NCT03612804|65872818|FG000|Overall Study|Provider involved with study activities|1|||
23585654|NCT03612804|65872819|FG001|Overall Study|Provider involved with study activities|0|||
23585655|NCT03612804|65872820|FG002|Overall Study|Provider involved with study activities|0|||
23585656|NCT03612804|65872821|FG003|Overall Study|Provider involved with study activities|0|||
23791535|NCT01567527|66616196|FG004|IM Depot Stabilization.|Protocol deviation|0|||
23791536|NCT01567527|66616192|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
23791537|NCT01567527|66616193|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
23791538|NCT01567527|66616194|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
23791539|NCT01567527|66616195|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
23791540|NCT01567527|66616196|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
23791541|NCT01567527|66616192|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
23585657|NCT00920686|65872822|FG000|Overall Study|Lost to Follow-up|2|||
23791542|NCT01567527|66616193|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
23791543|NCT01567527|66616194|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
23791544|NCT01567527|66616195|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
23791545|NCT01567527|66616196|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
23791546|NCT01567527|66616192|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
23791547|NCT01567527|66616193|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
23791548|NCT01567527|66616194|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
23791549|NCT01567527|66616195|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
23791550|NCT01567527|66616196|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
23791551|NCT01567527|66616192|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
23791552|NCT01567527|66616193|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
23791553|NCT01567527|66616194|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
23585658|NCT00920686|65872823|FG001|Overall Study|Lost to Follow-up|3|||
23585659|NCT00920686|65872824|FG002|Overall Study|Lost to Follow-up|1|||
23585660|NCT00920686|65872822|FG000|Overall Study|Study drug dosing criteria not met|17|||
23585661|NCT00920686|65872823|FG001|Overall Study|Study drug dosing criteria not met|19|||
23585662|NCT00920686|65872824|FG002|Overall Study|Study drug dosing criteria not met|12|||
23585663|NCT02380742|65872825|FG000|Overall Study|Withdrawal by Subject|1|||
23585664|NCT02380742|65872826|FG001|Overall Study|Withdrawal by Subject|0|||
23585665|NCT03601507|65872827|FG000|Overall Study|Adverse Event|1|||
23585666|NCT00038103|65872828|FG000|Overall Study|Adverse Event|5|||
23585667|NCT00038103|65872829|FG001|Overall Study|Adverse Event|6|||
23585668|NCT00038103|65872828|FG000|Overall Study|Lack of Efficacy|48|||
23585669|NCT00038103|65872829|FG001|Overall Study|Lack of Efficacy|41|||
23585670|NCT00038103|65872828|FG000|Overall Study|Withdrawal by Subject|0|||
23585671|NCT00038103|65872829|FG001|Overall Study|Withdrawal by Subject|3|||
23585672|NCT00038103|65872828|FG000|Overall Study|Lost to Follow-up|0|||
23585673|NCT00038103|65872829|FG001|Overall Study|Lost to Follow-up|3|||
23585674|NCT00038103|65872828|FG000|Overall Study|Protocol Violation|0|||
23585675|NCT00038103|65872829|FG001|Overall Study|Protocol Violation|2|||
23585676|NCT00038103|65872828|FG000|Overall Study|Sponsor Decision|0|||
23639974|NCT04677179|66067395|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
23639975|NCT04677179|66067396|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
23791554|NCT01567527|66616195|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
23585677|NCT00038103|65872829|FG001|Overall Study|Sponsor Decision|1|||
23791555|NCT01567527|66616196|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
23585678|NCT00038103|65872828|FG000|Overall Study|Randomized/never treated|2|||
23791556|NCT01567527|66616192|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
23791557|NCT01567527|66616193|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
23791558|NCT01567527|66616194|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
23791559|NCT01567527|66616195|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
23791560|NCT01567527|66616196|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
23791561|NCT01567527|66616192|FG000|IM Depot Stabilization.|Adverse Event|0|||
23791562|NCT01567527|66616193|FG001|IM Depot Stabilization.|Adverse Event|0|||
23791563|NCT01567527|66616194|FG002|IM Depot Stabilization.|Adverse Event|37|||
23791564|NCT01567527|66616195|FG003|IM Depot Stabilization.|Adverse Event|0|||
23791565|NCT01567527|66616196|FG004|IM Depot Stabilization.|Adverse Event|0|||
23791566|NCT01567527|66616192|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23791567|NCT01567527|66616193|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23791568|NCT01567527|66616194|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
23791569|NCT01567527|66616195|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23791570|NCT01567527|66616196|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23791571|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23791572|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23791573|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23791574|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
23791575|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
23791576|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23791577|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23791578|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23791579|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
23791580|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
23791581|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23791582|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23791583|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23791584|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
23791585|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
23791586|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23791587|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23791588|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23791589|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
23791590|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
23791591|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23791592|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23791593|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23791594|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
23791595|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
23791596|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23791597|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23791598|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23791599|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
23791600|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
23791601|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23791602|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23791603|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23791604|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
23791605|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
23791606|NCT01567527|66616192|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23791607|NCT01567527|66616193|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23791608|NCT01567527|66616194|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23791609|NCT01567527|66616195|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
23350827|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
23350828|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
23350829|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
23350830|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
23350831|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
23350832|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
23350833|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
23350834|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
23350835|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
23791610|NCT01567527|66616196|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
23791611|NCT04974580|66616199|FG000|Overall Study|Lost to Follow-up|33|||
23791612|NCT04974580|66616200|FG001|Overall Study|Lost to Follow-up|39|||
23791613|NCT04974580|66616201|FG002|Overall Study|Lost to Follow-up|30|||
23350836|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
23350837|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
23350838|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23350839|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23350840|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23465224|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
23585679|NCT00038103|65872829|FG001|Overall Study|Randomized/never treated|0|||
23585680|NCT01191788|65872840|FG000|Overall Study|Lost to Follow-up|21|||
23639976|NCT04677179|66067397|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
23639977|NCT04677179|66067398|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
23639978|NCT04677179|66067399|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
23639979|NCT04677179|66067400|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
23639980|NCT04677179|66067401|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
23639981|NCT04677179|66067402|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
23639982|NCT04677179|66067403|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
23639983|NCT04677179|66067394|FG000|Extension Treatment Period|Lack of Efficacy|0|||
23639984|NCT04677179|66067395|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23639985|NCT04677179|66067396|FG002|Extension Treatment Period|Lack of Efficacy|0|||
23639986|NCT04677179|66067397|FG003|Extension Treatment Period|Lack of Efficacy|0|||
23639987|NCT04677179|66067398|FG004|Extension Treatment Period|Lack of Efficacy|0|||
23639988|NCT04677179|66067399|FG005|Extension Treatment Period|Lack of Efficacy|0|||
23791614|NCT04974580|66616202|FG003|Overall Study|Lost to Follow-up|29|||
23791615|NCT02218541|66616203|FG000|Overall Study|Lost to Follow-up|2|||
23791616|NCT02218541|66616204|FG001|Overall Study|Lost to Follow-up|1|||
23791617|NCT02218541|66616203|FG000|Overall Study|Implant Failure|4|||
23791618|NCT02218541|66616204|FG001|Overall Study|Implant Failure|1|||
23791619|NCT00210639|66616205|FG000|Overall Study|Lost to Follow-up|37|||
23791620|NCT00210639|66616206|FG001|Overall Study|Lost to Follow-up|29|||
23791621|NCT00210639|66616205|FG000|Overall Study|Withdrawal by Subject|8|||
23791622|NCT00210639|66616206|FG001|Overall Study|Withdrawal by Subject|1|||
23791623|NCT00210639|66616205|FG000|Overall Study|Other|18|||
23791624|NCT00210639|66616206|FG001|Overall Study|Other|12|||
23791625|NCT03185741|66616210|FG000|Baseline|Withdrawal by Subject|1|||
23791626|NCT03185741|66616211|FG001|Baseline|Withdrawal by Subject|3|||
23791627|NCT03185741|66616212|FG002|Baseline|Withdrawal by Subject|2|||
23791628|NCT03185741|66616210|FG000|Baseline|Lost to Follow-up|1|||
23791629|NCT03185741|66616211|FG001|Baseline|Lost to Follow-up|2|||
23791630|NCT03185741|66616212|FG002|Baseline|Lost to Follow-up|3|||
23791631|NCT03185741|66616210|FG000|3Month|Death|1|||
23791632|NCT03185741|66616211|FG001|3Month|Death|1|||
23791633|NCT03185741|66616212|FG002|3Month|Death|2|||
23791634|NCT03185741|66616210|FG000|3Month|Withdrawal by Subject|1|||
23791635|NCT03185741|66616211|FG001|3Month|Withdrawal by Subject|5|||
23791636|NCT03185741|66616212|FG002|3Month|Withdrawal by Subject|1|||
23791637|NCT03185741|66616210|FG000|3Month|Lost to Follow-up|7|||
23791638|NCT03185741|66616211|FG001|3Month|Lost to Follow-up|9|||
23791639|NCT03185741|66616212|FG002|3Month|Lost to Follow-up|8|||
23791640|NCT03185741|66616210|FG000|3Month|Unavailable for 3Month|11|||
23791641|NCT03185741|66616211|FG001|3Month|Unavailable for 3Month|10|||
23791642|NCT03185741|66616212|FG002|3Month|Unavailable for 3Month|11|||
23791643|NCT03185741|66616210|FG000|3Month|Protocol Violation|0|||
23791644|NCT03185741|66616211|FG001|3Month|Protocol Violation|0|||
23791645|NCT03185741|66616212|FG002|3Month|Protocol Violation|3|||
23791646|NCT03185741|66616210|FG000|6Month|Death|1|||
23791647|NCT03185741|66616211|FG001|6Month|Death|1|||
23791648|NCT03185741|66616212|FG002|6Month|Death|2|||
23791649|NCT03185741|66616210|FG000|6Month|Withdrawal by Subject|2|||
23639989|NCT04677179|66067400|FG006|Extension Treatment Period|Lack of Efficacy|6|||
23706203|NCT01258348|66301083|FG002|Overall Study|Physician Decision|0|||
23791650|NCT03185741|66616211|FG001|6Month|Withdrawal by Subject|3|||
23791651|NCT03185741|66616212|FG002|6Month|Withdrawal by Subject|1|||
23791652|NCT03185741|66616210|FG000|6Month|Lost to Follow-up|16|||
23465225|NCT02558296|65444872|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
23465226|NCT02558296|65444873|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
23465227|NCT02558296|65444872|FG000|Completed the Study|Adverse Event|14|||
23465228|NCT02558296|65444873|FG001|Completed the Study|Adverse Event|5|||
23465229|NCT02558296|65444872|FG000|Completed the Study|Death|39|||
23465230|NCT02558296|65444873|FG001|Completed the Study|Death|25|||
23465231|NCT02558296|65444872|FG000|Completed the Study|Lost to Follow-up|31|||
23465232|NCT02558296|65444873|FG001|Completed the Study|Lost to Follow-up|23|||
23465233|NCT02558296|65444872|FG000|Completed the Study|Physician Decision|6|||
23791653|NCT03185741|66616211|FG001|6Month|Lost to Follow-up|15|||
23791654|NCT03185741|66616212|FG002|6Month|Lost to Follow-up|16|||
23791655|NCT03008005|66616213|FG000|Overall Study|Physician Decision|1|||
23791656|NCT03008005|66616214|FG001|Overall Study|Physician Decision|0|||
23791657|NCT03008005|66616215|FG002|Overall Study|Physician Decision|0|||
23791658|NCT03008005|66616213|FG000|Overall Study|Withdrawal by Subject|1|||
23791659|NCT03008005|66616214|FG001|Overall Study|Withdrawal by Subject|0|||
23465234|NCT02558296|65444873|FG001|Completed the Study|Physician Decision|0|||
23465235|NCT02558296|65444872|FG000|Completed the Study|Protocol Violation|2|||
23465236|NCT02558296|65444873|FG001|Completed the Study|Protocol Violation|1|||
23465237|NCT02558296|65444872|FG000|Completed the Study|Withdrawal by Subject|53|||
23465238|NCT02558296|65444873|FG001|Completed the Study|Withdrawal by Subject|31|||
23465239|NCT02558296|65444872|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
23465240|NCT02558296|65444873|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
23465241|NCT01747876|65444875|FG000|Overall Study|Adverse Event|1|||
23465242|NCT01747876|65444876|FG001|Overall Study|Adverse Event|0|||
23465243|NCT01747876|65444877|FG002|Overall Study|Adverse Event|2|||
23465244|NCT01747876|65444875|FG000|Overall Study|Withdrawal by Subject|0|||
23465245|NCT01747876|65444876|FG001|Overall Study|Withdrawal by Subject|1|||
23465246|NCT01747876|65444877|FG002|Overall Study|Withdrawal by Subject|1|||
23465247|NCT01747876|65444875|FG000|Overall Study|Disease progression|4|||
23465248|NCT01747876|65444876|FG001|Overall Study|Disease progression|13|||
23465249|NCT01747876|65444877|FG002|Overall Study|Disease progression|8|||
23465250|NCT01747876|65444875|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
23465251|NCT01747876|65444876|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
23465252|NCT01747876|65444877|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
23465253|NCT02948634|65447974|FG000|Overall Study|Lack of efficacy and study suspended|10|||
23465254|NCT02948634|65447975|FG001|Overall Study|Lack of efficacy and study suspended|2|||
23465255|NCT01459497|65447976|FG000|Overall Study|Inability to meet trial constraints.|1|||
23465256|NCT01459497|65447977|FG001|Overall Study|Inability to meet trial constraints.|0|||
23465257|NCT01459497|65447976|FG000|Overall Study|Physician Decision|1|||
23465258|NCT01459497|65447977|FG001|Overall Study|Physician Decision|1|||
23465259|NCT01459497|65447976|FG000|Overall Study|Hospitalization.|0|||
23465260|NCT01459497|65447977|FG001|Overall Study|Hospitalization.|3|||
23465261|NCT01459497|65447976|FG000|Overall Study|Disease progression.|0|||
23465262|NCT01459497|65447977|FG001|Overall Study|Disease progression.|1|||
23465263|NCT00432172|65447979|FG000|Overall Study|Physician Decision|0|||
23465264|NCT00432172|65447980|FG001|Overall Study|Physician Decision|0|||
23465265|NCT00432172|65447981|FG002|Overall Study|Physician Decision|2|||
23465266|NCT00432172|65447982|FG003|Overall Study|Physician Decision|0|||
23465267|NCT00432172|65447979|FG000|Overall Study|Adverse Event|4|||
23465268|NCT00432172|65447980|FG001|Overall Study|Adverse Event|2|||
23465269|NCT00432172|65447981|FG002|Overall Study|Adverse Event|4|||
23585681|NCT01191788|65872841|FG001|Overall Study|Lost to Follow-up|22|||
23585682|NCT00946114|65872845|FG000|Overall Study|Death|5|||
23585683|NCT00946114|65872846|FG001|Overall Study|Death|2|||
23585684|NCT00946114|65872845|FG000|Overall Study|Other|1|||
23585685|NCT00946114|65872846|FG001|Overall Study|Other|0|||
23585686|NCT00946114|65872845|FG000|Overall Study|Withdrawal by Subject|2|||
23585687|NCT00946114|65872846|FG001|Overall Study|Withdrawal by Subject|0|||
23585688|NCT01585038|65872847|FG000|Overall Study|Adverse Event|2|||
23585689|NCT01585038|65872848|FG001|Overall Study|Adverse Event|2|||
23585690|NCT03034915|65872850|FG000|Overall Study|Adverse Event|29|||
23465270|NCT00432172|65447982|FG003|Overall Study|Adverse Event|3|||
23465271|NCT00432172|65447979|FG000|Overall Study|Disease progression|0|||
23465272|NCT00432172|65447980|FG001|Overall Study|Disease progression|2|||
23465273|NCT00432172|65447981|FG002|Overall Study|Disease progression|5|||
23465274|NCT00432172|65447982|FG003|Overall Study|Disease progression|1|||
23465275|NCT00432172|65447979|FG000|Overall Study|Withdrawal by Subject|0|||
23465276|NCT00432172|65447980|FG001|Overall Study|Withdrawal by Subject|1|||
23465277|NCT00432172|65447981|FG002|Overall Study|Withdrawal by Subject|0|||
23465278|NCT00432172|65447982|FG003|Overall Study|Withdrawal by Subject|2|||
23465279|NCT00432172|65447979|FG000|Overall Study|No treatment received|2|||
23585691|NCT03034915|65872851|FG001|Overall Study|Adverse Event|32|||
23585692|NCT03034915|65872852|FG002|Overall Study|Adverse Event|22|||
23791660|NCT03008005|66616215|FG002|Overall Study|Withdrawal by Subject|0|||
23791661|NCT03008005|66616213|FG000|Overall Study|Ineligible|0|||
23639990|NCT04677179|66067401|FG007|Extension Treatment Period|Lack of Efficacy|0|||
23639991|NCT04677179|66067402|FG008|Extension Treatment Period|Lack of Efficacy|0|||
23639992|NCT04677179|66067403|FG009|Extension Treatment Period|Lack of Efficacy|0|||
23639993|NCT04677179|66067394|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23639994|NCT04677179|66067395|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23639995|NCT04677179|66067396|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23639996|NCT04677179|66067397|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
23639997|NCT04677179|66067398|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
23639998|NCT04677179|66067399|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
23639999|NCT04677179|66067400|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
23640000|NCT04677179|66067401|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
23640001|NCT04677179|66067402|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
23640002|NCT04677179|66067403|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
23640003|NCT04677179|66067394|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
23640004|NCT04677179|66067395|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
23640005|NCT04677179|66067396|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
23640006|NCT04677179|66067397|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
23640007|NCT04677179|66067398|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
23640008|NCT04677179|66067399|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
23640009|NCT04677179|66067400|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
23640010|NCT04677179|66067401|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
23640011|NCT04677179|66067402|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
23640012|NCT04677179|66067403|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
23640013|NCT04677179|66067394|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
23640014|NCT04677179|66067395|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
23640015|NCT04677179|66067396|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
23640016|NCT04677179|66067397|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
23640017|NCT04677179|66067398|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
23640018|NCT04677179|66067399|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
23791662|NCT03008005|66616214|FG001|Overall Study|Ineligible|1|||
23791663|NCT03008005|66616215|FG002|Overall Study|Ineligible|0|||
23791664|NCT00413049|66616217|FG000|Overall Study|Adverse Event|10|||
23791665|NCT00413049|66616218|FG001|Overall Study|Adverse Event|8|||
23791666|NCT00413049|66616217|FG000|Overall Study|Withdrawal by Subject|7|||
23791667|NCT00413049|66616218|FG001|Overall Study|Withdrawal by Subject|5|||
23791668|NCT00413049|66616217|FG000|Overall Study|Lost to Follow-up|2|||
23791669|NCT00413049|66616218|FG001|Overall Study|Lost to Follow-up|3|||
23791670|NCT00413049|66616217|FG000|Overall Study|Protocol Violation|3|||
23791671|NCT00413049|66616218|FG001|Overall Study|Protocol Violation|1|||
23791672|NCT00413049|66616217|FG000|Overall Study|Subject no longer requires study drug|0|||
23791673|NCT00413049|66616218|FG001|Overall Study|Subject no longer requires study drug|1|||
23791674|NCT00413049|66616217|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23640019|NCT04677179|66067400|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
23640020|NCT04677179|66067401|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
23640021|NCT04677179|66067402|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
23640022|NCT04677179|66067403|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
23640023|NCT04677179|66067394|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640024|NCT04677179|66067395|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640025|NCT04677179|66067396|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640026|NCT04677179|66067397|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640027|NCT04677179|66067398|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640028|NCT04677179|66067399|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23791675|NCT00413049|66616218|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23791676|NCT00413049|66616217|FG000|Overall Study|Lack of Efficacy|1|||
23791677|NCT00413049|66616218|FG001|Overall Study|Lack of Efficacy|0|||
23791678|NCT05889039|66616219|FG000|Overall Study|error in completing survey|0|||
23791679|NCT05889039|66616220|FG001|Overall Study|error in completing survey|2|||
23791680|NCT05889039|66616221|FG002|Overall Study|error in completing survey|0|||
23791681|NCT05889039|66616222|FG003|Overall Study|error in completing survey|0|||
23791682|NCT05889039|66616219|FG000|Overall Study|Lost to Follow-up|4|||
23791683|NCT05889039|66616220|FG001|Overall Study|Lost to Follow-up|0|||
23791684|NCT05889039|66616221|FG002|Overall Study|Lost to Follow-up|0|||
23791685|NCT05889039|66616222|FG003|Overall Study|Lost to Follow-up|0|||
23640029|NCT04677179|66067400|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23791686|NCT04476277|66616223|FG000|Overall Study|Withdrawal by Subject|0|||
23791687|NCT04476277|66616224|FG001|Overall Study|Withdrawal by Subject|0|||
23791688|NCT04476277|66616225|FG002|Overall Study|Withdrawal by Subject|1|||
23791689|NCT04476277|66616226|FG003|Overall Study|Withdrawal by Subject|0|||
23791690|NCT01835548|66616227|FG000|Dose Optimization Period|Adverse Event|0|||
23791691|NCT01835548|66616228|FG001|Dose Optimization Period|Adverse Event|0|||
23791692|NCT01835548|66616229|FG002|Dose Optimization Period|Adverse Event|1|||
23791693|NCT01835548|66616227|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
23350841|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23350842|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23640030|NCT04677179|66067401|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
23640031|NCT04677179|66067402|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
23640032|NCT04677179|66067403|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23640033|NCT04677179|66067394|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640034|NCT04677179|66067395|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640035|NCT04677179|66067396|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640036|NCT04677179|66067397|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640037|NCT04677179|66067398|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640038|NCT04677179|66067399|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640039|NCT04677179|66067400|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640040|NCT04677179|66067401|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
23465280|NCT00432172|65447980|FG001|Overall Study|No treatment received|2|||
23465281|NCT00432172|65447981|FG002|Overall Study|No treatment received|0|||
23465282|NCT00432172|65447982|FG003|Overall Study|No treatment received|1|||
23465283|NCT01598506|65447987|FG000|Overall Study|Withdrawal by Subject|2|||
23465284|NCT01134055|65447989|FG000|Overall Study|Adverse Event|5|||
23465285|NCT01134055|65447990|FG001|Overall Study|Adverse Event|2|||
23465286|NCT01134055|65447991|FG002|Overall Study|Adverse Event|2|||
23465287|NCT01134055|65447992|FG003|Overall Study|Adverse Event|2|||
23465288|NCT01134055|65447993|FG004|Overall Study|Adverse Event|5|||
23465289|NCT01134055|65447994|FG005|Overall Study|Adverse Event|7|||
23465290|NCT01134055|65447995|FG006|Overall Study|Adverse Event|2|||
23465291|NCT01134055|65447989|FG000|Overall Study|Lost to Follow-up|0|||
23465292|NCT01134055|65447990|FG001|Overall Study|Lost to Follow-up|1|||
23465293|NCT01134055|65447991|FG002|Overall Study|Lost to Follow-up|0|||
23465294|NCT01134055|65447992|FG003|Overall Study|Lost to Follow-up|1|||
23465295|NCT01134055|65447993|FG004|Overall Study|Lost to Follow-up|0|||
23465296|NCT01134055|65447994|FG005|Overall Study|Lost to Follow-up|0|||
23465297|NCT01134055|65447995|FG006|Overall Study|Lost to Follow-up|0|||
23465298|NCT01134055|65447989|FG000|Overall Study|Withdrawal by Subject|3|||
23465299|NCT01134055|65447990|FG001|Overall Study|Withdrawal by Subject|3|||
23465300|NCT01134055|65447991|FG002|Overall Study|Withdrawal by Subject|1|||
23465301|NCT01134055|65447992|FG003|Overall Study|Withdrawal by Subject|2|||
23465302|NCT01134055|65447993|FG004|Overall Study|Withdrawal by Subject|0|||
23465303|NCT01134055|65447994|FG005|Overall Study|Withdrawal by Subject|0|||
23465304|NCT01134055|65447995|FG006|Overall Study|Withdrawal by Subject|8|||
23465305|NCT01134055|65447989|FG000|Overall Study|Protocol Violation|0|||
23465306|NCT01134055|65447990|FG001|Overall Study|Protocol Violation|0|||
23465307|NCT01134055|65447991|FG002|Overall Study|Protocol Violation|0|||
23465308|NCT01134055|65447992|FG003|Overall Study|Protocol Violation|1|||
23465309|NCT01134055|65447993|FG004|Overall Study|Protocol Violation|1|||
23465310|NCT01134055|65447994|FG005|Overall Study|Protocol Violation|0|||
23465311|NCT01134055|65447995|FG006|Overall Study|Protocol Violation|0|||
23465312|NCT01134055|65447989|FG000|Overall Study|Physician Decision|0|||
23465313|NCT01134055|65447990|FG001|Overall Study|Physician Decision|0|||
23465314|NCT01134055|65447991|FG002|Overall Study|Physician Decision|0|||
23465315|NCT01134055|65447992|FG003|Overall Study|Physician Decision|0|||
23465316|NCT01134055|65447993|FG004|Overall Study|Physician Decision|0|||
23465317|NCT01134055|65447994|FG005|Overall Study|Physician Decision|0|||
23585693|NCT03034915|65872850|FG000|Overall Study|Lost to Follow-up|5|||
23585694|NCT03034915|65872851|FG001|Overall Study|Lost to Follow-up|13|||
23585695|NCT03034915|65872852|FG002|Overall Study|Lost to Follow-up|3|||
23585696|NCT03034915|65872850|FG000|Overall Study|Withdrawal by Subject|29|||
23585697|NCT03034915|65872851|FG001|Overall Study|Withdrawal by Subject|46|||
23585698|NCT03034915|65872852|FG002|Overall Study|Withdrawal by Subject|41|||
23585699|NCT03034915|65872850|FG000|Overall Study|Protocol Deviation|2|||
23585700|NCT03034915|65872851|FG001|Overall Study|Protocol Deviation|14|||
23585701|NCT03034915|65872852|FG002|Overall Study|Protocol Deviation|7|||
23585702|NCT03034915|65872850|FG000|Overall Study|Lack of Efficacy|8|||
23585703|NCT03034915|65872851|FG001|Overall Study|Lack of Efficacy|16|||
23640041|NCT04677179|66067402|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640042|NCT04677179|66067403|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23640043|NCT04677179|66067394|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23465318|NCT01134055|65447995|FG006|Overall Study|Physician Decision|1|||
23465319|NCT02581410|65447996|FG000|Vaccination Phase|Adverse Event|2|||
23465320|NCT02581410|65447997|FG001|Vaccination Phase|Adverse Event|1|||
23465321|NCT02581410|65447996|FG000|Vaccination Phase|Withdrawal by Subject|0|||
23465322|NCT02581410|65447997|FG001|Vaccination Phase|Withdrawal by Subject|1|||
23465323|NCT02581410|65447996|FG000|Vaccination Phase|Migrated/moved from study area|0|||
23465324|NCT02581410|65447997|FG001|Vaccination Phase|Migrated/moved from study area|1|||
23465325|NCT02581410|65447996|FG000|End of Study Phase|Adverse Event|4|||
23585704|NCT03034915|65872852|FG002|Overall Study|Lack of Efficacy|18|||
23585705|NCT03034915|65872850|FG000|Overall Study|Site closed|2|||
23585706|NCT03034915|65872851|FG001|Overall Study|Site closed|2|||
23640044|NCT04677179|66067395|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640045|NCT04677179|66067396|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640046|NCT04677179|66067397|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640047|NCT04677179|66067398|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640048|NCT04677179|66067399|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640049|NCT04677179|66067400|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640050|NCT04677179|66067401|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
23640051|NCT04677179|66067402|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
23640052|NCT04677179|66067403|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23640053|NCT04677179|66067394|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23465326|NCT02581410|65447997|FG001|End of Study Phase|Adverse Event|3|||
23465327|NCT02581410|65447996|FG000|End of Study Phase|Withdrawal by Subject|1|||
23465328|NCT02581410|65447997|FG001|End of Study Phase|Withdrawal by Subject|2|||
23465329|NCT02581410|65447996|FG000|End of Study Phase|Migrated/moved from study area|0|||
23640054|NCT04677179|66067395|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23640055|NCT04677179|66067396|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23791694|NCT01835548|66616228|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
23791695|NCT01835548|66616229|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
23791696|NCT01835548|66616227|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23791697|NCT01835548|66616228|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23791698|NCT01835548|66616229|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23791699|NCT01835548|66616227|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23465330|NCT02581410|65447997|FG001|End of Study Phase|Migrated/moved from study area|3|||
23465331|NCT02581410|65447996|FG000|End of Study Phase|Lost to Follow-up|0|||
23465332|NCT02581410|65447997|FG001|End of Study Phase|Lost to Follow-up|2|||
23465333|NCT02581410|65447996|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
23465334|NCT02581410|65447997|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
23465335|NCT02492763|65447999|FG000|Overall Study|Withdrawal by Subject|0|||
23465336|NCT02492763|65448000|FG001|Overall Study|Withdrawal by Subject|2|||
23465337|NCT02492763|65448001|FG002|Overall Study|Withdrawal by Subject|1|||
23465338|NCT02492763|65448002|FG003|Overall Study|Withdrawal by Subject|0|||
23465339|NCT02492763|65447999|FG000|Overall Study|Adverse Event|3|||
23465340|NCT02492763|65448000|FG001|Overall Study|Adverse Event|1|||
23465341|NCT02492763|65448001|FG002|Overall Study|Adverse Event|1|||
23465342|NCT02492763|65448002|FG003|Overall Study|Adverse Event|2|||
23465343|NCT02492763|65447999|FG000|Overall Study|Death|0|||
23465344|NCT02492763|65448000|FG001|Overall Study|Death|0|||
23465345|NCT02492763|65448001|FG002|Overall Study|Death|1|||
23465346|NCT02492763|65448002|FG003|Overall Study|Death|0|||
23465347|NCT02492763|65447999|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465348|NCT02492763|65448000|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
23465349|NCT02492763|65448001|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465350|NCT02492763|65448002|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465351|NCT02492763|65447999|FG000|Overall Study|Lost to Follow-up|0|||
23465352|NCT02492763|65448000|FG001|Overall Study|Lost to Follow-up|0|||
23791700|NCT01835548|66616228|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23791701|NCT01835548|66616229|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23791702|NCT01949532|66616230|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
23791703|NCT01949532|66616231|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
23791704|NCT02888756|66616232|FG000|Analytical Treatment Interruption|Physician Decision|10|||
23350843|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23350844|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
23350845|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350846|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350847|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350848|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
23350849|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23791705|NCT02888756|66616233|FG001|Analytical Treatment Interruption|Physician Decision|6|||
23791706|NCT02888756|66616234|FG002|Analytical Treatment Interruption|Physician Decision|5|||
23791707|NCT03573544|66616237|FG000|Overall Study|Adverse Event|0|||
23791708|NCT03573544|66616238|FG001|Overall Study|Adverse Event|0|||
23791709|NCT03573544|66616239|FG002|Overall Study|Adverse Event|0|||
23350850|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
23465353|NCT02492763|65448001|FG002|Overall Study|Lost to Follow-up|1|||
23465354|NCT02492763|65448002|FG003|Overall Study|Lost to Follow-up|0|||
23640056|NCT04677179|66067397|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23791710|NCT03573544|66616240|FG003|Overall Study|Adverse Event|3|||
23791711|NCT03573544|66616241|FG004|Overall Study|Adverse Event|1|||
23350851|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23465355|NCT02492763|65447999|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23465356|NCT02492763|65448000|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23465357|NCT02492763|65448001|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23465358|NCT02492763|65448002|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23465359|NCT02492763|65447999|FG000|Overall Study|Screen Failure|0|||
23465360|NCT02492763|65448000|FG001|Overall Study|Screen Failure|0|||
23465361|NCT02492763|65448001|FG002|Overall Study|Screen Failure|0|||
23465362|NCT02492763|65448002|FG003|Overall Study|Screen Failure|1|||
23465363|NCT02492763|65447999|FG000|Overall Study|Study Terminated by Sponsor|13|||
23465364|NCT02492763|65448000|FG001|Overall Study|Study Terminated by Sponsor|10|||
23465365|NCT02492763|65448001|FG002|Overall Study|Study Terminated by Sponsor|6|||
23465366|NCT02492763|65448002|FG003|Overall Study|Study Terminated by Sponsor|10|||
23465367|NCT00060840|65448003|FG000|Overall Study|Change in surgical plan|2|||
23465368|NCT00060840|65448004|FG001|Overall Study|Change in surgical plan|6|||
23465369|NCT00060840|65448003|FG000|Overall Study|Death|0|||
23465370|NCT00060840|65448004|FG001|Overall Study|Death|1|||
23465371|NCT00060840|65448003|FG000|Overall Study|Withdrawal by Subject|0|||
23465372|NCT00060840|65448004|FG001|Overall Study|Withdrawal by Subject|1|||
23465373|NCT00060840|65448003|FG000|Overall Study|Subinvestigator unavailable|0|||
23465374|NCT00060840|65448004|FG001|Overall Study|Subinvestigator unavailable|1|||
23465375|NCT00060840|65448003|FG000|Overall Study|Physician Decision|1|||
23465376|NCT00060840|65448004|FG001|Overall Study|Physician Decision|0|||
23465377|NCT00060840|65448003|FG000|Overall Study|Other|1|||
23465378|NCT00060840|65448004|FG001|Overall Study|Other|0|||
23465379|NCT01077050|65448005|FG000|Overall Study|Subjects signed ICF could not be located|1|||
23465380|NCT01077050|65448005|FG000|Overall Study|Screen failure|8|||
23465381|NCT04287517|65448006|FG000|Overall Study|Withdrawal by Subject|1|||
23465382|NCT04287517|65448007|FG001|Overall Study|Withdrawal by Subject|1|||
23465383|NCT01287741|65448008|FG000|Overall Study|Withdrawal by Subject|35|||
23465384|NCT01287741|65448009|FG001|Overall Study|Withdrawal by Subject|38|||
23465385|NCT01287741|65448008|FG000|Overall Study|Protocol Violation|2|||
23465386|NCT01287741|65448009|FG001|Overall Study|Protocol Violation|0|||
23465387|NCT01287741|65448008|FG000|Overall Study|Physician Decision|15|||
23465388|NCT01287741|65448009|FG001|Overall Study|Physician Decision|23|||
23465389|NCT01287741|65448008|FG000|Overall Study|Non-compliance|8|||
23465390|NCT01287741|65448009|FG001|Overall Study|Non-compliance|6|||
23465391|NCT01287741|65448008|FG000|Overall Study|Lost to Follow-up|10|||
23465392|NCT01287741|65448009|FG001|Overall Study|Lost to Follow-up|8|||
23791712|NCT03573544|66616242|FG005|Overall Study|Adverse Event|0|||
23791713|NCT03573544|66616243|FG006|Overall Study|Adverse Event|2|||
23791714|NCT03573544|66616244|FG007|Overall Study|Adverse Event|0|||
23791715|NCT03573544|66616237|FG000|Overall Study|Physician Decision|0|||
23791716|NCT03573544|66616238|FG001|Overall Study|Physician Decision|0|||
23791717|NCT03573544|66616239|FG002|Overall Study|Physician Decision|0|||
23791718|NCT03573544|66616240|FG003|Overall Study|Physician Decision|0|||
23791719|NCT03573544|66616241|FG004|Overall Study|Physician Decision|0|||
23791720|NCT03573544|66616242|FG005|Overall Study|Physician Decision|0|||
23791721|NCT03573544|66616243|FG006|Overall Study|Physician Decision|1|||
23791722|NCT03573544|66616244|FG007|Overall Study|Physician Decision|0|||
23791723|NCT03573544|66616237|FG000|Overall Study|Withdrawal by Subject|2|||
23791724|NCT03573544|66616238|FG001|Overall Study|Withdrawal by Subject|0|||
23791725|NCT03573544|66616239|FG002|Overall Study|Withdrawal by Subject|0|||
23791726|NCT03573544|66616240|FG003|Overall Study|Withdrawal by Subject|1|||
23791727|NCT03573544|66616241|FG004|Overall Study|Withdrawal by Subject|1|||
23791728|NCT03573544|66616242|FG005|Overall Study|Withdrawal by Subject|1|||
23791729|NCT03573544|66616243|FG006|Overall Study|Withdrawal by Subject|0|||
23791730|NCT03573544|66616244|FG007|Overall Study|Withdrawal by Subject|1|||
23791731|NCT03573544|66616237|FG000|Overall Study|Disease progression|3|||
23791732|NCT03573544|66616238|FG001|Overall Study|Disease progression|3|||
23791733|NCT03573544|66616239|FG002|Overall Study|Disease progression|6|||
23791734|NCT03573544|66616240|FG003|Overall Study|Disease progression|4|||
23465393|NCT01287741|65448008|FG000|Overall Study|Death|32|||
23465394|NCT01287741|65448009|FG001|Overall Study|Death|44|||
23465395|NCT01287741|65448008|FG000|Overall Study|Adverse Event|4|||
23465396|NCT01287741|65448009|FG001|Overall Study|Adverse Event|6|||
23465397|NCT01287741|65448008|FG000|Overall Study|Study terminated by Sponsor|307|||
23791735|NCT03573544|66616241|FG004|Overall Study|Disease progression|5|||
23791736|NCT03573544|66616242|FG005|Overall Study|Disease progression|7|||
23791737|NCT03573544|66616243|FG006|Overall Study|Disease progression|6|||
23791738|NCT03573544|66616244|FG007|Overall Study|Disease progression|7|||
23465398|NCT01287741|65448009|FG001|Overall Study|Study terminated by Sponsor|315|||
23465399|NCT01287741|65448008|FG000|Overall Study|Progressive disease|190|||
23465400|NCT01287741|65448009|FG001|Overall Study|Progressive disease|166|||
23465401|NCT01287741|65448008|FG000|Overall Study|Reason not specified|23|||
23465402|NCT01287741|65448009|FG001|Overall Study|Reason not specified|9|||
23465403|NCT01342211|65448010|FG000|Overall Study|Lost to Follow-up|0|||
23465404|NCT01342211|65448011|FG001|Overall Study|Lost to Follow-up|0|||
23465405|NCT01342211|65448012|FG002|Overall Study|Lost to Follow-up|0|||
23465406|NCT01342211|65448013|FG003|Overall Study|Lost to Follow-up|1|||
23465407|NCT01342211|65448014|FG004|Overall Study|Lost to Follow-up|0|||
23465408|NCT01342211|65448010|FG000|Overall Study|Adverse Event|0|||
23465409|NCT01342211|65448011|FG001|Overall Study|Adverse Event|0|||
23465410|NCT01342211|65448012|FG002|Overall Study|Adverse Event|0|||
23791739|NCT01451541|66616249|FG000|Overall Study|Adverse Event|4|||
23791740|NCT01451541|66616250|FG001|Overall Study|Adverse Event|3|||
23791741|NCT01451541|66616251|FG002|Overall Study|Adverse Event|6|||
23791742|NCT01451541|66616249|FG000|Overall Study|Lack of Efficacy|2|||
23791743|NCT01451541|66616250|FG001|Overall Study|Lack of Efficacy|0|||
23465411|NCT01342211|65448013|FG003|Overall Study|Adverse Event|0|||
23465412|NCT01342211|65448014|FG004|Overall Study|Adverse Event|1|||
23465413|NCT01342211|65448010|FG000|Overall Study|Withdrawal by Subject|0|||
23465414|NCT01342211|65448011|FG001|Overall Study|Withdrawal by Subject|0|||
23465415|NCT01342211|65448012|FG002|Overall Study|Withdrawal by Subject|0|||
23465416|NCT01342211|65448013|FG003|Overall Study|Withdrawal by Subject|1|||
23465417|NCT01342211|65448014|FG004|Overall Study|Withdrawal by Subject|0|||
23465418|NCT01342211|65448010|FG000|Overall Study|Randomized, but not Treated|0|||
23465419|NCT01342211|65448011|FG001|Overall Study|Randomized, but not Treated|2|||
23465420|NCT01342211|65448012|FG002|Overall Study|Randomized, but not Treated|0|||
23465421|NCT01342211|65448013|FG003|Overall Study|Randomized, but not Treated|0|||
23465422|NCT01342211|65448014|FG004|Overall Study|Randomized, but not Treated|1|||
23465423|NCT01936870|65448015|FG000|Overall Study|No Visit After Treatment|176|||
23465424|NCT01936870|65448015|FG000|Overall Study|Protocol Violation|12|||
23465425|NCT01936870|65448015|FG000|Overall Study|No Drug Administration|1|||
23465426|NCT01208207|65448019|FG000|Part I|Adverse Event|19|||
23465427|NCT01208207|65448020|FG001|Part I|Adverse Event|2|||
23465428|NCT01208207|65448021|FG002|Part I|Adverse Event|6|||
23465429|NCT01208207|65448022|FG003|Part I|Adverse Event|0|||
23465430|NCT01208207|65448023|FG004|Part I|Adverse Event|0|||
23465431|NCT01208207|65448024|FG005|Part I|Adverse Event|0|||
23465432|NCT01208207|65448025|FG006|Part I|Adverse Event|0|||
23465433|NCT01208207|65448019|FG000|Part I|Lack of Efficacy|21|||
23465434|NCT01208207|65448020|FG001|Part I|Lack of Efficacy|3|||
23465435|NCT01208207|65448021|FG002|Part I|Lack of Efficacy|2|||
23465436|NCT01208207|65448022|FG003|Part I|Lack of Efficacy|0|||
23465437|NCT01208207|65448023|FG004|Part I|Lack of Efficacy|0|||
23465438|NCT01208207|65448024|FG005|Part I|Lack of Efficacy|0|||
23465439|NCT01208207|65448025|FG006|Part I|Lack of Efficacy|0|||
23465440|NCT01208207|65448019|FG000|Part I|Lost to Follow-up|6|||
23465441|NCT01208207|65448020|FG001|Part I|Lost to Follow-up|1|||
23465442|NCT01208207|65448021|FG002|Part I|Lost to Follow-up|0|||
23465443|NCT01208207|65448022|FG003|Part I|Lost to Follow-up|0|||
23465444|NCT01208207|65448023|FG004|Part I|Lost to Follow-up|0|||
23465445|NCT01208207|65448024|FG005|Part I|Lost to Follow-up|0|||
23465446|NCT01208207|65448025|FG006|Part I|Lost to Follow-up|0|||
23465447|NCT01208207|65448019|FG000|Part I|Non-Compliance With Study Drug|1|||
23791744|NCT01451541|66616251|FG002|Overall Study|Lack of Efficacy|0|||
23791745|NCT01451541|66616249|FG000|Overall Study|Lost to Follow-up|4|||
23791746|NCT01451541|66616250|FG001|Overall Study|Lost to Follow-up|4|||
23791747|NCT01451541|66616251|FG002|Overall Study|Lost to Follow-up|7|||
23791748|NCT01451541|66616249|FG000|Overall Study|Withdrawal by Subject|15|||
23465448|NCT01208207|65448020|FG001|Part I|Non-Compliance With Study Drug|0|||
23465449|NCT01208207|65448021|FG002|Part I|Non-Compliance With Study Drug|1|||
23465450|NCT01208207|65448022|FG003|Part I|Non-Compliance With Study Drug|0|||
23465451|NCT01208207|65448023|FG004|Part I|Non-Compliance With Study Drug|0|||
23465452|NCT01208207|65448024|FG005|Part I|Non-Compliance With Study Drug|0|||
23465453|NCT01208207|65448025|FG006|Part I|Non-Compliance With Study Drug|0|||
23465454|NCT01208207|65448019|FG000|Part I|Physician Decision|0|||
23791749|NCT01451541|66616250|FG001|Overall Study|Withdrawal by Subject|8|||
23465455|NCT01208207|65448020|FG001|Part I|Physician Decision|1|||
23465456|NCT01208207|65448021|FG002|Part I|Physician Decision|0|||
23465457|NCT01208207|65448022|FG003|Part I|Physician Decision|0|||
23465458|NCT01208207|65448023|FG004|Part I|Physician Decision|0|||
23465459|NCT01208207|65448024|FG005|Part I|Physician Decision|0|||
23465460|NCT01208207|65448025|FG006|Part I|Physician Decision|0|||
23465461|NCT01208207|65448019|FG000|Part I|Progressive Disease|1|||
23465462|NCT01208207|65448020|FG001|Part I|Progressive Disease|0|||
23465463|NCT01208207|65448021|FG002|Part I|Progressive Disease|0|||
23465464|NCT01208207|65448022|FG003|Part I|Progressive Disease|0|||
23791750|NCT01451541|66616251|FG002|Overall Study|Withdrawal by Subject|6|||
23791751|NCT01451541|66616249|FG000|Overall Study|randomization error, noncompliance|11|||
23791752|NCT01451541|66616250|FG001|Overall Study|randomization error, noncompliance|10|||
23791753|NCT01451541|66616251|FG002|Overall Study|randomization error, noncompliance|8|||
23791754|NCT02311894|66616252|FG000|Overall Study|Discontinued in error|1|||
23791755|NCT02311894|66616252|FG000|Overall Study|Lost to Follow-up|1|||
23791756|NCT02311894|66616252|FG000|Overall Study|Adverse Event|1|||
23791757|NCT02311894|66616252|FG000|Overall Study|Withdrawal by Subject|1|||
23791758|NCT00766493|66616255|FG000|30 Days Post-Procedure|Discontinued|7|||
23791759|NCT00766493|66616255|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
23791760|NCT00766493|66616255|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
23791761|NCT04203823|66616260|FG000|Overall Study|Withdrawal by Subject|2|||
23791762|NCT04203823|66616261|FG001|Overall Study|Withdrawal by Subject|2|||
23791763|NCT04203823|66616260|FG000|Overall Study|Adverse Event|1|||
23465465|NCT01208207|65448023|FG004|Part I|Progressive Disease|0|||
23465466|NCT01208207|65448024|FG005|Part I|Progressive Disease|0|||
23465467|NCT01208207|65448025|FG006|Part I|Progressive Disease|0|||
23465468|NCT01208207|65448019|FG000|Part I|Protocol Violation|8|||
23465469|NCT01208207|65448020|FG001|Part I|Protocol Violation|0|||
23465470|NCT01208207|65448021|FG002|Part I|Protocol Violation|2|||
23465471|NCT01208207|65448022|FG003|Part I|Protocol Violation|0|||
23465472|NCT01208207|65448023|FG004|Part I|Protocol Violation|0|||
23465473|NCT01208207|65448024|FG005|Part I|Protocol Violation|0|||
23465474|NCT01208207|65448025|FG006|Part I|Protocol Violation|0|||
23465475|NCT01208207|65448019|FG000|Part I|Withdrawal by Subject|14|||
23465476|NCT01208207|65448020|FG001|Part I|Withdrawal by Subject|4|||
23465477|NCT01208207|65448021|FG002|Part I|Withdrawal by Subject|4|||
23465478|NCT01208207|65448022|FG003|Part I|Withdrawal by Subject|0|||
23465479|NCT01208207|65448023|FG004|Part I|Withdrawal by Subject|0|||
23465480|NCT01208207|65448024|FG005|Part I|Withdrawal by Subject|0|||
23791764|NCT04203823|66616261|FG001|Overall Study|Adverse Event|1|||
23791765|NCT04203823|66616260|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23465481|NCT01208207|65448025|FG006|Part I|Withdrawal by Subject|0|||
23465482|NCT01208207|65448019|FG000|Part II|Withdrawal by Subject|0|||
23465483|NCT01208207|65448020|FG001|Part II|Withdrawal by Subject|0|||
23465484|NCT01208207|65448021|FG002|Part II|Withdrawal by Subject|0|||
23465485|NCT01208207|65448022|FG003|Part II|Withdrawal by Subject|10|||
23465486|NCT01208207|65448023|FG004|Part II|Withdrawal by Subject|9|||
23465487|NCT01208207|65448024|FG005|Part II|Withdrawal by Subject|3|||
23465488|NCT01208207|65448025|FG006|Part II|Withdrawal by Subject|5|||
23465489|NCT01208207|65448019|FG000|Part II|Adverse Event|0|||
23465490|NCT01208207|65448020|FG001|Part II|Adverse Event|0|||
23465491|NCT01208207|65448021|FG002|Part II|Adverse Event|0|||
23465492|NCT01208207|65448022|FG003|Part II|Adverse Event|5|||
23465493|NCT01208207|65448023|FG004|Part II|Adverse Event|9|||
23465494|NCT01208207|65448024|FG005|Part II|Adverse Event|4|||
23465495|NCT01208207|65448025|FG006|Part II|Adverse Event|2|||
23465496|NCT01208207|65448019|FG000|Part II|Lack of Efficacy|0|||
23465497|NCT01208207|65448020|FG001|Part II|Lack of Efficacy|0|||
23465498|NCT01208207|65448021|FG002|Part II|Lack of Efficacy|0|||
23465499|NCT01208207|65448022|FG003|Part II|Lack of Efficacy|6|||
23465500|NCT01208207|65448023|FG004|Part II|Lack of Efficacy|4|||
23465501|NCT01208207|65448024|FG005|Part II|Lack of Efficacy|3|||
23465502|NCT01208207|65448025|FG006|Part II|Lack of Efficacy|3|||
23465503|NCT01208207|65448019|FG000|Part II|Lost to Follow-up|0|||
23465504|NCT01208207|65448020|FG001|Part II|Lost to Follow-up|0|||
23465505|NCT01208207|65448021|FG002|Part II|Lost to Follow-up|0|||
23465506|NCT01208207|65448022|FG003|Part II|Lost to Follow-up|4|||
23465507|NCT01208207|65448023|FG004|Part II|Lost to Follow-up|0|||
23465508|NCT01208207|65448024|FG005|Part II|Lost to Follow-up|2|||
23465509|NCT01208207|65448025|FG006|Part II|Lost to Follow-up|1|||
23465510|NCT01208207|65448019|FG000|Part II|Non-Compliance With Study Drug|0|||
23465511|NCT01208207|65448020|FG001|Part II|Non-Compliance With Study Drug|0|||
23465512|NCT01208207|65448021|FG002|Part II|Non-Compliance With Study Drug|0|||
23465513|NCT01208207|65448022|FG003|Part II|Non-Compliance With Study Drug|4|||
23465514|NCT01208207|65448023|FG004|Part II|Non-Compliance With Study Drug|1|||
23465515|NCT01208207|65448024|FG005|Part II|Non-Compliance With Study Drug|1|||
23465516|NCT01208207|65448025|FG006|Part II|Non-Compliance With Study Drug|0|||
23465517|NCT01208207|65448019|FG000|Part II|Physician Decision|0|||
23465518|NCT01208207|65448020|FG001|Part II|Physician Decision|0|||
23465519|NCT01208207|65448021|FG002|Part II|Physician Decision|0|||
23465520|NCT01208207|65448022|FG003|Part II|Physician Decision|1|||
23465521|NCT01208207|65448023|FG004|Part II|Physician Decision|0|||
23465522|NCT01208207|65448024|FG005|Part II|Physician Decision|2|||
23465523|NCT01208207|65448025|FG006|Part II|Physician Decision|0|||
23465524|NCT01208207|65448019|FG000|Part II|Protocol Violation|0|||
23465525|NCT01208207|65448020|FG001|Part II|Protocol Violation|0|||
23465526|NCT01208207|65448021|FG002|Part II|Protocol Violation|0|||
23465527|NCT01208207|65448022|FG003|Part II|Protocol Violation|1|||
23791766|NCT04203823|66616261|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
23791767|NCT01142908|66616262|FG000|Overall Study|Lost to Follow-up|19|||
23465528|NCT01208207|65448023|FG004|Part II|Protocol Violation|0|||
23350852|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350853|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350854|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350855|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350856|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350857|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350858|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350859|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350860|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350861|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350862|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350863|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
23350864|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350865|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350866|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
23350867|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23465529|NCT01208207|65448024|FG005|Part II|Protocol Violation|0|||
23465530|NCT01208207|65448025|FG006|Part II|Protocol Violation|0|||
23465531|NCT01208207|65448019|FG000|Part II|Technical Problems|0|||
23465532|NCT01208207|65448020|FG001|Part II|Technical Problems|0|||
23465533|NCT01208207|65448021|FG002|Part II|Technical Problems|0|||
23465534|NCT01208207|65448022|FG003|Part II|Technical Problems|1|||
23465535|NCT01208207|65448023|FG004|Part II|Technical Problems|0|||
23465536|NCT01208207|65448024|FG005|Part II|Technical Problems|1|||
23465537|NCT01208207|65448025|FG006|Part II|Technical Problems|0|||
23465538|NCT01635153|65448027|FG000|Overall Study|Lost to Follow-up|40|||
23465539|NCT01635153|65448028|FG001|Overall Study|Lost to Follow-up|43|||
23465540|NCT01803607|65448031|FG000|Overall Study|Adverse Event|5|||
23465541|NCT01803607|65448032|FG001|Overall Study|Adverse Event|3|||
23465542|NCT01803607|65448031|FG000|Overall Study|Lack of Efficacy|0|||
23465543|NCT01803607|65448032|FG001|Overall Study|Lack of Efficacy|1|||
23465544|NCT01803607|65448031|FG000|Overall Study|Protocol Violation|3|||
23465545|NCT01803607|65448032|FG001|Overall Study|Protocol Violation|2|||
23465546|NCT01803607|65448031|FG000|Overall Study|Study terminated by sponsor|54|||
23706204|NCT01258348|66301084|FG003|Overall Study|Physician Decision|2|||
23791768|NCT01142908|66616263|FG001|Overall Study|Lost to Follow-up|13|||
23791769|NCT01142908|66616262|FG000|Overall Study|Death|1|||
23791770|NCT01142908|66616263|FG001|Overall Study|Death|4|||
23791771|NCT01142908|66616262|FG000|Overall Study|Excluded - did not meet criteria|9|||
23791772|NCT01142908|66616263|FG001|Overall Study|Excluded - did not meet criteria|5|||
23791773|NCT01142908|66616262|FG000|Overall Study|Withdrawal by Subject|3|||
23791774|NCT01142908|66616263|FG001|Overall Study|Withdrawal by Subject|0|||
23791775|NCT02483416|66616270|FG000|Overall Study|Other reason|0|||
23791776|NCT02483416|66616271|FG001|Overall Study|Other reason|1|||
23791777|NCT02483416|66616270|FG000|Overall Study|Treatment stop|3|||
23791778|NCT02483416|66616271|FG001|Overall Study|Treatment stop|0|||
23465547|NCT01803607|65448032|FG001|Overall Study|Study terminated by sponsor|56|||
23465548|NCT01803607|65448031|FG000|Overall Study|Withdrawal by Subject|6|||
23791779|NCT00127166|66616275|FG000|Period I|Protocol Violation|0|||
23465549|NCT01803607|65448032|FG001|Overall Study|Withdrawal by Subject|5|||
23791780|NCT00127166|66616276|FG001|Period I|Protocol Violation|2|||
23640057|NCT04677179|66067398|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23640058|NCT04677179|66067399|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23640059|NCT04677179|66067400|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23791781|NCT00127166|66616275|FG000|Period I|Withdrawal by Subject|2|||
23791782|NCT00127166|66616276|FG001|Period I|Withdrawal by Subject|0|||
23791783|NCT00127166|66616275|FG000|Period I|Patient did not meet inclusion criteria|1|||
23791784|NCT00127166|66616276|FG001|Period I|Patient did not meet inclusion criteria|0|||
23791785|NCT00127166|66616275|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
23791786|NCT00127166|66616276|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
23791787|NCT00127166|66616275|FG000|Period II|Withdrawal by Subject|2|||
23791788|NCT00127166|66616276|FG001|Period II|Withdrawal by Subject|0|||
23791789|NCT00127166|66616275|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
23791790|NCT00127166|66616276|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
23791791|NCT00960154|66616277|FG000|Overall Study|Study termination|25|||
23791792|NCT00960154|66616278|FG001|Overall Study|Study termination|25|||
23791793|NCT02663349|66616279|FG000|Overall Study|Withdrawal by Subject|6|||
23791794|NCT04230876|66616280|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
23791795|NCT04230876|66616281|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
23791796|NCT00674128|66616286|FG000|Overall Study|Withdrawal by Subject|25|||
23791797|NCT00674128|66616287|FG001|Overall Study|Withdrawal by Subject|23|||
23791798|NCT00508651|66616288|FG000|Overall Study|Lost to Follow-up|3|||
23791799|NCT00508651|66616289|FG001|Overall Study|Lost to Follow-up|1|||
23791800|NCT00508651|66616288|FG000|Overall Study|Withdrawal by Subject|1|||
23791801|NCT00508651|66616289|FG001|Overall Study|Withdrawal by Subject|1|||
23585707|NCT03034915|65872852|FG002|Overall Study|Site closed|4|||
23585708|NCT03034915|65872850|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
23465550|NCT01039376|65448033|FG000|Overall Study|Lost to Follow-up|5|||
23585709|NCT03034915|65872851|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
23585710|NCT03034915|65872852|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
23640060|NCT04677179|66067401|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
23640061|NCT04677179|66067402|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
23350868|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350869|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23585711|NCT03034915|65872850|FG000|Overall Study|Physician Decision|1|||
23585712|NCT03034915|65872851|FG001|Overall Study|Physician Decision|5|||
23585713|NCT03034915|65872852|FG002|Overall Study|Physician Decision|2|||
23585714|NCT01913340|65872853|FG000|Overall Study|Death|2|||
23585715|NCT01913340|65872854|FG001|Overall Study|Death|5|||
23585716|NCT01913340|65872853|FG000|Overall Study|Lost to Follow-up|1|||
23585717|NCT01913340|65872854|FG001|Overall Study|Lost to Follow-up|1|||
23585718|NCT01729819|65872855|FG000|Overall Study|Adverse Event|2|||
23585719|NCT01729819|65872856|FG001|Overall Study|Adverse Event|4|||
23585720|NCT01729819|65872855|FG000|Overall Study|Lack of Efficacy|1|||
23585721|NCT01729819|65872856|FG001|Overall Study|Lack of Efficacy|0|||
23585722|NCT01729819|65872855|FG000|Overall Study|Lost to Follow-up|2|||
23585723|NCT01729819|65872856|FG001|Overall Study|Lost to Follow-up|0|||
23585724|NCT01729819|65872855|FG000|Overall Study|Other reason|1|||
23585725|NCT01729819|65872856|FG001|Overall Study|Other reason|0|||
23585726|NCT01729819|65872855|FG000|Overall Study|Protocol Violation|0|||
23585727|NCT01729819|65872856|FG001|Overall Study|Protocol Violation|1|||
23585728|NCT01729819|65872855|FG000|Overall Study|Withdrawal by Subject|0|||
23585729|NCT01729819|65872856|FG001|Overall Study|Withdrawal by Subject|2|||
23585730|NCT01751724|65872858|FG000|Overall Study|extubated bef.start assigned treatment|1|||
23585731|NCT01751724|65872859|FG001|Overall Study|extubated bef.start assigned treatment|0|||
23585732|NCT01751724|65872858|FG000|Overall Study|withdrawn by parent|0|||
23585733|NCT01751724|65872859|FG001|Overall Study|withdrawn by parent|2|||
23585734|NCT03518112|65872861|FG000|Overall Study|Withdrawal by Subject|1|||
23585735|NCT00587288|65872864|FG000|Overall Study|Adverse Event|0|||
23350870|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
23350871|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350872|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
23350873|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
23350874|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
23350875|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23350876|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23350877|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23465551|NCT01039376|65448034|FG001|Overall Study|Lost to Follow-up|12|||
23465552|NCT01039376|65448033|FG000|Overall Study|Physician Decision|15|||
23465553|NCT01039376|65448034|FG001|Overall Study|Physician Decision|10|||
23465554|NCT01039376|65448033|FG000|Overall Study|Withdrawal by Subject|20|||
23465555|NCT01039376|65448034|FG001|Overall Study|Withdrawal by Subject|32|||
23465556|NCT01039376|65448033|FG000|Overall Study|Study terminated by Sponsor|90|||
23465557|NCT01039376|65448034|FG001|Overall Study|Study terminated by Sponsor|72|||
23465558|NCT01417377|65448037|FG000|Overall Study|Lost to Follow-up|12|||
23465559|NCT01417377|65448037|FG000|Overall Study|Enrolled, but not treated|1|||
23465560|NCT00975780|65448038|FG000|Follow Up|Death|88|||
23465561|NCT00975780|65448039|FG001|Follow Up|Death|122|||
23465562|NCT00975780|65448038|FG000|Follow Up|Facility Withdrawal|7|||
23640062|NCT04677179|66067403|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
23640063|NCT01518153|66067405|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
23640064|NCT01518153|66067406|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
23640065|NCT01518153|66067407|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
23640066|NCT01518153|66067405|FG000|Stem Cell Transplant|Death|2|||
23640067|NCT01518153|66067406|FG001|Stem Cell Transplant|Death|0|||
23465563|NCT00975780|65448039|FG001|Follow Up|Facility Withdrawal|23|||
23465564|NCT00975780|65448038|FG000|Follow Up|Discharged from Facility|7|||
23465565|NCT00975780|65448039|FG001|Follow Up|Discharged from Facility|12|||
23465566|NCT00714870|65448040|FG000|Overall Study|Lost to Follow-up|22|||
23465567|NCT00714870|65448041|FG001|Overall Study|Lost to Follow-up|5|||
23465568|NCT00714870|65448040|FG000|Overall Study|patient unable to come b/c back pain|1|||
23465569|NCT00714870|65448041|FG001|Overall Study|patient unable to come b/c back pain|0|||
23465570|NCT00714870|65448040|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
23640068|NCT01518153|66067407|FG002|Stem Cell Transplant|Death|0|||
23640069|NCT01518153|66067405|FG000|Stem Cell Transplant|Secondary graft failure|1|||
23640070|NCT01518153|66067406|FG001|Stem Cell Transplant|Secondary graft failure|0|||
23640071|NCT01518153|66067407|FG002|Stem Cell Transplant|Secondary graft failure|0|||
23640072|NCT01518153|66067405|FG000|Stem Cell Transplant|Adverse Event|1|||
23640073|NCT01518153|66067406|FG001|Stem Cell Transplant|Adverse Event|0|||
23640074|NCT01518153|66067407|FG002|Stem Cell Transplant|Adverse Event|0|||
23640075|NCT01518153|66067405|FG000|Donor Lymphocyte Infusion|Death|0|||
23640076|NCT01518153|66067406|FG001|Donor Lymphocyte Infusion|Death|2|||
23640077|NCT01518153|66067407|FG002|Donor Lymphocyte Infusion|Death|1|||
23640078|NCT03245151|66067413|FG000|Overall Study|Withdrawal by Subject|2|||
23640079|NCT03245151|66067414|FG001|Overall Study|Withdrawal by Subject|0|||
23640080|NCT03245151|66067415|FG002|Overall Study|Withdrawal by Subject|0|||
23640081|NCT03245151|66067416|FG003|Overall Study|Withdrawal by Subject|2|||
23640082|NCT03245151|66067417|FG004|Overall Study|Withdrawal by Subject|1|||
23640083|NCT03245151|66067413|FG000|Overall Study|Death|3|||
23640084|NCT03245151|66067414|FG001|Overall Study|Death|14|||
23640085|NCT03245151|66067415|FG002|Overall Study|Death|9|||
23640086|NCT03245151|66067416|FG003|Overall Study|Death|16|||
23640087|NCT03245151|66067417|FG004|Overall Study|Death|7|||
23640088|NCT03245151|66067413|FG000|Overall Study|Sponsor's decision|0|||
23791802|NCT01525628|66616290|FG000|Overall Study|Adverse Event|1|||
23791803|NCT01525628|66616291|FG001|Overall Study|Adverse Event|1|||
23791804|NCT01525628|66616292|FG002|Overall Study|Adverse Event|2|||
23791805|NCT01525628|66616293|FG003|Overall Study|Adverse Event|0|||
23791806|NCT01525628|66616294|FG004|Overall Study|Adverse Event|1|||
23791807|NCT01525628|66616290|FG000|Overall Study|Lack of Efficacy|0|||
23791808|NCT01525628|66616291|FG001|Overall Study|Lack of Efficacy|2|||
23791809|NCT01525628|66616292|FG002|Overall Study|Lack of Efficacy|2|||
23791810|NCT01525628|66616293|FG003|Overall Study|Lack of Efficacy|1|||
23791811|NCT01525628|66616294|FG004|Overall Study|Lack of Efficacy|2|||
23791812|NCT01525628|66616290|FG000|Overall Study|Protocol Violation|0|||
23791813|NCT01525628|66616291|FG001|Overall Study|Protocol Violation|0|||
23791814|NCT01525628|66616292|FG002|Overall Study|Protocol Violation|1|||
23465571|NCT00714870|65448041|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
23640089|NCT03245151|66067414|FG001|Overall Study|Sponsor's decision|1|||
23640090|NCT03245151|66067415|FG002|Overall Study|Sponsor's decision|0|||
23640091|NCT03245151|66067416|FG003|Overall Study|Sponsor's decision|0|||
23640092|NCT03245151|66067417|FG004|Overall Study|Sponsor's decision|0|||
23791815|NCT01525628|66616293|FG003|Overall Study|Protocol Violation|0|||
23791816|NCT01525628|66616294|FG004|Overall Study|Protocol Violation|0|||
23791817|NCT01525628|66616290|FG000|Overall Study|Lost to Follow-up|1|||
23640093|NCT00979576|66067418|FG000|Combination Treatment Phase|Progressive disease|3|||
23640094|NCT00979576|66067419|FG001|Combination Treatment Phase|Progressive disease|1|||
23640095|NCT00979576|66067420|FG002|Combination Treatment Phase|Progressive disease|5|||
23640096|NCT00979576|66067418|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
23640097|NCT00979576|66067419|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
23640098|NCT00979576|66067420|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
23640099|NCT00979576|66067418|FG000|Combination Treatment Phase|Adverse Event|0|||
23640100|NCT00979576|66067419|FG001|Combination Treatment Phase|Adverse Event|2|||
23640101|NCT00979576|66067420|FG002|Combination Treatment Phase|Adverse Event|2|||
23640102|NCT00979576|66067418|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
23640103|NCT00979576|66067419|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
23640104|NCT00979576|66067420|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
23640105|NCT01743989|66067421|FG000|Treatment Phase|Unstable MR4.0|0|||
23640106|NCT01743989|66067422|FG001|Treatment Phase|Unstable MR4.0|6|||
23640107|NCT01743989|66067423|FG002|Treatment Phase|Unstable MR4.0|263|||
23791818|NCT01525628|66616291|FG001|Overall Study|Lost to Follow-up|1|||
23791819|NCT01525628|66616292|FG002|Overall Study|Lost to Follow-up|0|||
23791820|NCT01525628|66616293|FG003|Overall Study|Lost to Follow-up|0|||
23791821|NCT01525628|66616294|FG004|Overall Study|Lost to Follow-up|0|||
23791822|NCT01525628|66616290|FG000|Overall Study|Withdrawal by Subject|0|||
23791823|NCT01525628|66616291|FG001|Overall Study|Withdrawal by Subject|1|||
23791824|NCT01525628|66616292|FG002|Overall Study|Withdrawal by Subject|0|||
23791825|NCT01525628|66616293|FG003|Overall Study|Withdrawal by Subject|0|||
23791826|NCT01525628|66616294|FG004|Overall Study|Withdrawal by Subject|0|||
23791827|NCT01525628|66616290|FG000|Overall Study|Other reason not defined above|0|||
23791828|NCT01525628|66616291|FG001|Overall Study|Other reason not defined above|0|||
23791829|NCT01525628|66616292|FG002|Overall Study|Other reason not defined above|0|||
23791830|NCT01525628|66616293|FG003|Overall Study|Other reason not defined above|3|||
23791831|NCT01525628|66616294|FG004|Overall Study|Other reason not defined above|0|||
23791832|NCT01229150|66616295|FG000|Overall Study|Toxicity|2|||
23791833|NCT01229150|66616296|FG001|Overall Study|Toxicity|2|||
23791834|NCT01229150|66616297|FG002|Overall Study|Toxicity|0|||
23791835|NCT01229150|66616298|FG003|Overall Study|Toxicity|0|||
23791836|NCT00434590|66616299|FG000|Overall Study|Administrative problems|5|||
23791837|NCT00434590|66616300|FG001|Overall Study|Administrative problems|5|||
23585736|NCT00587288|65872865|FG001|Overall Study|Adverse Event|1|||
23585737|NCT00587288|65872864|FG000|Overall Study|Lack of Efficacy|2|||
23585738|NCT00587288|65872865|FG001|Overall Study|Lack of Efficacy|8|||
23585739|NCT00587288|65872864|FG000|Overall Study|Protocol Violation|1|||
23585740|NCT00587288|65872865|FG001|Overall Study|Protocol Violation|0|||
23585741|NCT03357341|65872866|FG000|Overall Study|Withdrawal by Subject|3|||
23585742|NCT03357341|65872867|FG001|Overall Study|Withdrawal by Subject|6|||
23585743|NCT03357341|65872866|FG000|Overall Study|Lost to Follow-up|4|||
23585744|NCT03357341|65872867|FG001|Overall Study|Lost to Follow-up|5|||
23585745|NCT03357341|65872866|FG000|Overall Study|Death|0|||
23640108|NCT01743989|66067421|FG000|Treatment Phase|Adverse Event|0|||
23640109|NCT01743989|66067422|FG001|Treatment Phase|Adverse Event|4|||
23640110|NCT01743989|66067423|FG002|Treatment Phase|Adverse Event|67|||
23791838|NCT01670097|66616301|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
23791839|NCT01670097|66616302|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
23791840|NCT01670097|66616301|FG000|Overall Study|Study burden|1|||
23585746|NCT03357341|65872867|FG001|Overall Study|Death|1|||
23585747|NCT05298111|65872869|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
23640111|NCT01743989|66067421|FG000|Treatment Phase|Withdrawal by Subject|1|||
23640112|NCT01743989|66067422|FG001|Treatment Phase|Withdrawal by Subject|3|||
23640113|NCT01743989|66067423|FG002|Treatment Phase|Withdrawal by Subject|28|||
23350878|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
23350879|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
23350880|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
23350881|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
23350882|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
23350883|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
23350884|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350885|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
23640114|NCT01743989|66067421|FG000|Treatment Phase|Death|0|||
23640115|NCT01743989|66067422|FG001|Treatment Phase|Death|1|||
23640116|NCT01743989|66067423|FG002|Treatment Phase|Death|3|||
23640117|NCT01743989|66067421|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
23640118|NCT01743989|66067422|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
23640119|NCT01743989|66067423|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
23640120|NCT01743989|66067421|FG000|Treatment Phase|Protocol deviation|0|||
23640121|NCT01743989|66067422|FG001|Treatment Phase|Protocol deviation|0|||
23640122|NCT01743989|66067423|FG002|Treatment Phase|Protocol deviation|3|||
23640123|NCT01743989|66067421|FG000|Treatment Phase|Pregnancy|0|||
23640124|NCT01743989|66067422|FG001|Treatment Phase|Pregnancy|0|||
23640125|NCT01743989|66067423|FG002|Treatment Phase|Pregnancy|2|||
23640126|NCT01743989|66067421|FG000|Treatment Phase|Lost to Follow-up|0|||
23640127|NCT01743989|66067422|FG001|Treatment Phase|Lost to Follow-up|0|||
23640128|NCT01743989|66067423|FG002|Treatment Phase|Lost to Follow-up|2|||
23640129|NCT01743989|66067421|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
23640130|NCT01743989|66067422|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
23640131|NCT01743989|66067423|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
23640132|NCT01743989|66067421|FG000|Treatment Phase|Administrative problems|0|||
23640133|NCT01743989|66067422|FG001|Treatment Phase|Administrative problems|0|||
23640134|NCT01743989|66067423|FG002|Treatment Phase|Administrative problems|1|||
23640135|NCT01743989|66067421|FG000|Treatment Phase|New cancer (CML) therapy|0|||
23640136|NCT01743989|66067422|FG001|Treatment Phase|New cancer (CML) therapy|1|||
23640137|NCT01743989|66067423|FG002|Treatment Phase|New cancer (CML) therapy|0|||
23640138|NCT01743989|66067421|FG000|Treatment Phase|Physician Decision|0|||
23640139|NCT01743989|66067422|FG001|Treatment Phase|Physician Decision|0|||
23640140|NCT01743989|66067423|FG002|Treatment Phase|Physician Decision|3|||
23640141|NCT01743989|66067421|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
23640142|NCT01743989|66067422|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
23640143|NCT01743989|66067423|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
23640144|NCT01743989|66067421|FG000|Treatment Phase|Not randomized by mistake|0|||
23640145|NCT01743989|66067422|FG001|Treatment Phase|Not randomized by mistake|0|||
23350886|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
23640146|NCT01743989|66067423|FG002|Treatment Phase|Not randomized by mistake|1|||
23585748|NCT05298111|65872870|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
23640147|NCT01743989|66067421|FG000|Treatment Phase|Included by mistake|0|||
23640148|NCT01743989|66067422|FG001|Treatment Phase|Included by mistake|0|||
23585749|NCT00771849|65872873|FG000|Overall Study|Lost to Follow-up|1|||
23791841|NCT01670097|66616302|FG001|Overall Study|Study burden|0|||
23791842|NCT01670097|66616301|FG000|Overall Study|COPD exacerbation|0|||
23791843|NCT01670097|66616302|FG001|Overall Study|COPD exacerbation|1|||
23791844|NCT01670097|66616301|FG000|Overall Study|Neutropenia|0|||
23791845|NCT01670097|66616302|FG001|Overall Study|Neutropenia|1|||
23791846|NCT01670097|66616301|FG000|Overall Study|Clinical deterioration|0|||
23791847|NCT01670097|66616302|FG001|Overall Study|Clinical deterioration|1|||
23791848|NCT01670097|66616301|FG000|Overall Study|Disease progression|0|||
23791849|NCT01670097|66616302|FG001|Overall Study|Disease progression|1|||
23791850|NCT02834390|66616303|FG000|Induction Phase|Progressive disease|0|||
23791851|NCT02834390|66616304|FG001|Induction Phase|Progressive disease|1|||
23791852|NCT02834390|66616303|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
23791853|NCT02834390|66616304|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
23791854|NCT02834390|66616303|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
23791855|NCT02834390|66616304|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
23791856|NCT02834390|66616303|FG000|Consolidation Phase|Physician Decision|1|||
23791857|NCT02834390|66616304|FG001|Consolidation Phase|Physician Decision|1|||
23791858|NCT00928057|66616306|FG000|Overall Study|Adverse Event|1|||
23791859|NCT00928057|66616307|FG001|Overall Study|Adverse Event|2|||
23791860|NCT00928057|66616306|FG000|Overall Study|Withdrawal by Subject|1|||
23791861|NCT00928057|66616307|FG001|Overall Study|Withdrawal by Subject|0|||
23791862|NCT00928057|66616306|FG000|Overall Study|Lost to Follow-up|0|||
23791863|NCT00928057|66616307|FG001|Overall Study|Lost to Follow-up|1|||
23791864|NCT00928057|66616306|FG000|Overall Study|Protocol Violation|0|||
23791865|NCT00928057|66616307|FG001|Overall Study|Protocol Violation|1|||
23791866|NCT01483820|66616311|FG000|Overall Study|Lack of Efficacy|6|||
23791867|NCT01483820|66616311|FG000|Overall Study|Adverse Event|1|||
23791868|NCT01483820|66616311|FG000|Overall Study|Death|1|||
23791869|NCT03234608|66616313|FG000|Overall Study|Lost to Follow-up|23|||
23791870|NCT03234608|66616314|FG001|Overall Study|Lost to Follow-up|21|||
23791871|NCT03234907|66616317|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
23791872|NCT03234907|66616318|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
23791873|NCT03234907|66616319|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23791874|NCT03234907|66616320|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23791875|NCT03234907|66616321|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23791876|NCT03234907|66616322|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23791877|NCT03234907|66616317|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
23791878|NCT03234907|66616318|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
23791879|NCT03234907|66616319|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23791880|NCT03234907|66616320|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23791881|NCT03234907|66616321|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23791882|NCT03234907|66616322|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23791883|NCT03234907|66616317|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
23791884|NCT03234907|66616318|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23791885|NCT03234907|66616319|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23791886|NCT03234907|66616320|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23791887|NCT03234907|66616321|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23791888|NCT03234907|66616322|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23791889|NCT03234907|66616317|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
23791890|NCT03234907|66616318|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
23791891|NCT03234907|66616319|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23791892|NCT03234907|66616320|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23791893|NCT03234907|66616321|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23791894|NCT03234907|66616322|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23791895|NCT03234907|66616317|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23791896|NCT03234907|66616318|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23791897|NCT03234907|66616319|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23791898|NCT03234907|66616320|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
23791899|NCT03234907|66616321|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
23791900|NCT03234907|66616322|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
23791901|NCT03234907|66616317|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
23791902|NCT03234907|66616318|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
23791903|NCT03234907|66616319|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
23791904|NCT03234907|66616320|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
23791905|NCT03234907|66616321|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
23791906|NCT03234907|66616322|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
23791907|NCT03234907|66616317|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23585750|NCT00771849|65872874|FG001|Overall Study|Lost to Follow-up|2|||
23706205|NCT01258348|66301085|FG004|Overall Study|Physician Decision|0|||
23585751|NCT00771849|65872873|FG000|Overall Study|Withdrawal by Subject|1|||
23585752|NCT00771849|65872874|FG001|Overall Study|Withdrawal by Subject|1|||
23585753|NCT00771849|65872873|FG000|Overall Study|Not vaccinated|0|||
23585754|NCT00771849|65872874|FG001|Overall Study|Not vaccinated|1|||
23585755|NCT00470626|65872875|FG000|Overall Study|Lost to Follow-up|10|||
23585756|NCT00470626|65872875|FG000|Overall Study|Withdrawal by Subject|7|||
23585757|NCT02351180|65872879|FG000|Overall Study|Withdrawal by Subject|1|||
23585758|NCT02351180|65872880|FG001|Overall Study|Withdrawal by Subject|0|||
23585759|NCT02839330|65872881|FG000|Overall Study|Adverse Event|0|||
23585760|NCT02839330|65872882|FG001|Overall Study|Adverse Event|1|||
23585761|NCT02839330|65872883|FG002|Overall Study|Adverse Event|2|||
23585762|NCT02839330|65872884|FG003|Overall Study|Adverse Event|2|||
23350887|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
23640149|NCT01743989|66067423|FG002|Treatment Phase|Included by mistake|1|||
23640150|NCT01743989|66067421|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
23640151|NCT01743989|66067422|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
23640152|NCT01743989|66067423|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
23640153|NCT01743989|66067421|FG000|TFR Phase|Adverse Event|0|||
23640154|NCT01743989|66067422|FG001|TFR Phase|Adverse Event|1|||
23640155|NCT01743989|66067423|FG002|TFR Phase|Adverse Event|0|||
23640156|NCT01743989|66067421|FG000|TFR Phase|Lost to Follow-up|0|||
23640157|NCT01743989|66067422|FG001|TFR Phase|Lost to Follow-up|2|||
23640158|NCT01743989|66067423|FG002|TFR Phase|Lost to Follow-up|0|||
23350888|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350889|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350890|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
23350891|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
23350892|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
23350893|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
23350894|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
23350895|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
23350896|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
23350897|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
23350898|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
23350899|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
23350900|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
23350901|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350902|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350903|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
23350904|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
23350905|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
23350906|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
23350907|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350908|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350909|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350910|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350911|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350912|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350913|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350914|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350915|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350916|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350917|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350918|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350919|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350920|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350921|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
23350922|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
23350923|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350924|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350925|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23640159|NCT01743989|66067421|FG000|TFR Phase|Physician Decision|0|||
23585763|NCT02839330|65872881|FG000|Overall Study|Death|4|||
23585764|NCT02839330|65872882|FG001|Overall Study|Death|6|||
23585765|NCT02839330|65872883|FG002|Overall Study|Death|1|||
23585766|NCT02839330|65872884|FG003|Overall Study|Death|1|||
23585767|NCT02839330|65872881|FG000|Overall Study|Withdrawal by Subject|27|||
23585768|NCT02839330|65872882|FG001|Overall Study|Withdrawal by Subject|19|||
23585769|NCT02839330|65872883|FG002|Overall Study|Withdrawal by Subject|11|||
23585770|NCT02839330|65872884|FG003|Overall Study|Withdrawal by Subject|13|||
23585771|NCT02839330|65872881|FG000|Overall Study|Lost to Follow-up|22|||
23585772|NCT02839330|65872882|FG001|Overall Study|Lost to Follow-up|27|||
23585773|NCT02839330|65872883|FG002|Overall Study|Lost to Follow-up|29|||
23585774|NCT02839330|65872884|FG003|Overall Study|Lost to Follow-up|25|||
23585775|NCT02839330|65872881|FG000|Overall Study|Administrative Reason|0|||
23585776|NCT02839330|65872882|FG001|Overall Study|Administrative Reason|0|||
23585777|NCT02839330|65872883|FG002|Overall Study|Administrative Reason|0|||
23585778|NCT02839330|65872884|FG003|Overall Study|Administrative Reason|1|||
23585779|NCT02839330|65872881|FG000|Overall Study|Protocol Violation|1|||
23585780|NCT02839330|65872882|FG001|Overall Study|Protocol Violation|2|||
23585781|NCT02839330|65872883|FG002|Overall Study|Protocol Violation|2|||
23585782|NCT02839330|65872884|FG003|Overall Study|Protocol Violation|3|||
23585783|NCT02839330|65872881|FG000|Overall Study|Other reason, not specified|4|||
23585784|NCT02839330|65872882|FG001|Overall Study|Other reason, not specified|3|||
23585785|NCT02839330|65872883|FG002|Overall Study|Other reason, not specified|3|||
23585786|NCT02839330|65872884|FG003|Overall Study|Other reason, not specified|6|||
23350926|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350927|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350928|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350929|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350930|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350931|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23465572|NCT01411891|65448047|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
23585787|NCT03822351|65872887|FG000|Overall Study|Death|27|||
23585788|NCT03822351|65872888|FG001|Overall Study|Death|23|||
23585789|NCT03822351|65872889|FG002|Overall Study|Death|24|||
23585790|NCT03822351|65872887|FG000|Overall Study|Lost to Follow-up|6|||
23585791|NCT03822351|65872888|FG001|Overall Study|Lost to Follow-up|2|||
23585792|NCT03822351|65872889|FG002|Overall Study|Lost to Follow-up|1|||
23585793|NCT03822351|65872887|FG000|Overall Study|Withdrawal by Subject|10|||
23585794|NCT03822351|65872888|FG001|Overall Study|Withdrawal by Subject|4|||
23585795|NCT03822351|65872889|FG002|Overall Study|Withdrawal by Subject|6|||
23585796|NCT03822351|65872887|FG000|Overall Study|Progressive Disease|2|||
23585797|NCT03822351|65872888|FG001|Overall Study|Progressive Disease|1|||
23585798|NCT03822351|65872889|FG002|Overall Study|Progressive Disease|0|||
23585799|NCT03822351|65872887|FG000|Overall Study|Not Treated|1|||
23585800|NCT03822351|65872888|FG001|Overall Study|Not Treated|1|||
23585801|NCT03822351|65872889|FG002|Overall Study|Not Treated|1|||
23585802|NCT03613129|65872890|FG000|Pre-treatment Assessment|Protocol Violation|2|||
23640160|NCT01743989|66067422|FG001|TFR Phase|Physician Decision|1|||
23640161|NCT01743989|66067423|FG002|TFR Phase|Physician Decision|0|||
23640162|NCT01743989|66067421|FG000|TFR Phase|Logistical problems|0|||
23640163|NCT01743989|66067422|FG001|TFR Phase|Logistical problems|2|||
23640164|NCT01743989|66067423|FG002|TFR Phase|Logistical problems|0|||
23640165|NCT01743989|66067421|FG000|TFR Phase|Protocol deviation|0|||
23640166|NCT01743989|66067422|FG001|TFR Phase|Protocol deviation|1|||
23640167|NCT01743989|66067423|FG002|TFR Phase|Protocol deviation|0|||
23640168|NCT01743989|66067421|FG000|TFR Phase|Withdrawal by Subject|0|||
23640169|NCT01743989|66067422|FG001|TFR Phase|Withdrawal by Subject|2|||
23640170|NCT01743989|66067423|FG002|TFR Phase|Withdrawal by Subject|0|||
23640171|NCT01743989|66067421|FG000|Re-treatment Phase|Adverse Event|8|||
23640172|NCT01743989|66067422|FG001|Re-treatment Phase|Adverse Event|4|||
23640173|NCT01743989|66067423|FG002|Re-treatment Phase|Adverse Event|0|||
23640174|NCT01743989|66067421|FG000|Re-treatment Phase|Death|1|||
23640175|NCT01743989|66067422|FG001|Re-treatment Phase|Death|1|||
23640176|NCT01743989|66067423|FG002|Re-treatment Phase|Death|0|||
23791908|NCT03234907|66616318|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23791909|NCT03234907|66616319|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23350932|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350933|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350934|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350935|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350936|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350937|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
23350938|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350939|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
23350940|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
23585803|NCT03613129|65872891|FG001|Pre-treatment Assessment|Protocol Violation|0|||
23640177|NCT01743989|66067421|FG000|Re-treatment Phase|Administrative problems|1|||
23640178|NCT01743989|66067422|FG001|Re-treatment Phase|Administrative problems|1|||
23640179|NCT01743989|66067423|FG002|Re-treatment Phase|Administrative problems|0|||
23640180|NCT01743989|66067421|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
23640181|NCT01743989|66067422|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
23640182|NCT01743989|66067423|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
23640183|NCT01743989|66067421|FG000|Re-treatment Phase|Unstable MR|1|||
23640184|NCT01743989|66067422|FG001|Re-treatment Phase|Unstable MR|0|||
23640185|NCT01743989|66067423|FG002|Re-treatment Phase|Unstable MR|0|||
23640186|NCT01743989|66067421|FG000|Re-treatment Phase|Physician Decision|0|||
23640187|NCT01743989|66067422|FG001|Re-treatment Phase|Physician Decision|1|||
23640188|NCT01743989|66067423|FG002|Re-treatment Phase|Physician Decision|0|||
23640189|NCT01743989|66067421|FG000|Re-treatment Phase|Lost to Follow-up|0|||
23640190|NCT01743989|66067422|FG001|Re-treatment Phase|Lost to Follow-up|1|||
23640191|NCT01743989|66067423|FG002|Re-treatment Phase|Lost to Follow-up|0|||
23640192|NCT00589121|66067427|FG000|Overall Study|Protocol Violation|2|||
23640193|NCT00589121|66067428|FG001|Overall Study|Protocol Violation|6|||
23640194|NCT00589121|66067427|FG000|Overall Study|No protocol treatment received|0|||
23640195|NCT00589121|66067428|FG001|Overall Study|No protocol treatment received|1|||
23640196|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
23640197|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
23640198|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
23640199|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
23640200|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
23585804|NCT03613129|65872892|FG002|Pre-treatment Assessment|Protocol Violation|0|||
23585805|NCT03613129|65872893|FG003|Pre-treatment Assessment|Protocol Violation|0|||
23585806|NCT03613129|65872894|FG004|Pre-treatment Assessment|Protocol Violation|0|||
23585807|NCT03613129|65872890|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
23585808|NCT03613129|65872891|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585809|NCT03613129|65872892|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585810|NCT03613129|65872893|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585811|NCT03613129|65872894|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585812|NCT04511650|65872895|FG000|Overall Study|Lost to Follow-up|1|||
23585813|NCT04511650|65872896|FG001|Overall Study|Lost to Follow-up|0|||
23585814|NCT04511650|65872897|FG002|Overall Study|Lost to Follow-up|0|||
23585815|NCT04511650|65872895|FG000|Overall Study|Withdrawal by Subject|1|||
23585816|NCT04511650|65872896|FG001|Overall Study|Withdrawal by Subject|0|||
23585817|NCT04511650|65872897|FG002|Overall Study|Withdrawal by Subject|0|||
23585818|NCT04511650|65872895|FG000|Overall Study|reason not provided|0|||
23585819|NCT04511650|65872896|FG001|Overall Study|reason not provided|0|||
23640201|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
23350941|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
23585820|NCT04511650|65872897|FG002|Overall Study|reason not provided|1|||
23640202|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
23640203|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
23640204|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
23640205|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
23640206|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23465573|NCT01411891|65448048|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
23465574|NCT03962504|65448049|FG000|Overall Study|Other|11|||
23465575|NCT03962504|65448050|FG001|Overall Study|Other|32|||
23465576|NCT00414596|65448051|FG000|Overall Study|Protocol Violation|2|||
23465577|NCT00936715|65448054|FG000|Overall Study|Investigators Discretion|1|||
23465578|NCT00936715|65448054|FG000|Overall Study|Protocol Violation|1|||
23465579|NCT00936715|65448054|FG000|Overall Study|Safety or Tolerability Reasons|4|||
23465580|NCT00953056|65448055|FG000|Overall Study|Withdrew Consent|0|||
23465581|NCT00953056|65448056|FG001|Overall Study|Withdrew Consent|0|||
23465582|NCT00953056|65448057|FG002|Overall Study|Withdrew Consent|0|||
23465583|NCT00953056|65448058|FG003|Overall Study|Withdrew Consent|0|||
23465584|NCT00953056|65448059|FG004|Overall Study|Withdrew Consent|2|||
23465585|NCT00953056|65448060|FG005|Overall Study|Withdrew Consent|3|||
23465586|NCT00953056|65448055|FG000|Overall Study|Serious Adverse Event|0|||
23465587|NCT00953056|65448056|FG001|Overall Study|Serious Adverse Event|0|||
23465588|NCT00953056|65448057|FG002|Overall Study|Serious Adverse Event|0|||
23465589|NCT00953056|65448058|FG003|Overall Study|Serious Adverse Event|0|||
23465590|NCT00953056|65448059|FG004|Overall Study|Serious Adverse Event|0|||
23465591|NCT00953056|65448060|FG005|Overall Study|Serious Adverse Event|1|||
23465592|NCT02284243|65448061|FG000|Overall Study|Lack of Efficacy|3|||
23585821|NCT04511650|65872895|FG000|Overall Study|Death|1|||
23585822|NCT04511650|65872896|FG001|Overall Study|Death|1|||
23585823|NCT04511650|65872897|FG002|Overall Study|Death|1|||
23585824|NCT00197015|65872898|FG000|Overall Study|Adverse Event|3|||
23585825|NCT00197015|65872899|FG001|Overall Study|Adverse Event|0|||
23585826|NCT00197015|65872900|FG002|Overall Study|Adverse Event|1|||
23585827|NCT00197015|65872898|FG000|Overall Study|Protocol Violation|0|||
23585828|NCT00197015|65872899|FG001|Overall Study|Protocol Violation|3|||
23585829|NCT00197015|65872900|FG002|Overall Study|Protocol Violation|3|||
23585830|NCT00197015|65872898|FG000|Overall Study|Withdrawal by Subject|17|||
23640207|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Adverse Event|0|||
23640208|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Adverse Event|3|||
23640209|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Adverse Event|2|||
23640210|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Adverse Event|13|||
23640211|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23791910|NCT03234907|66616320|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
23791911|NCT03234907|66616321|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
23791912|NCT03234907|66616322|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
23791913|NCT03255980|66616323|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
23791914|NCT03255980|66616324|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
23791915|NCT03255980|66616325|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
23791916|NCT03255980|66616326|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
23791917|NCT03255980|66616323|FG000|Overall Study|Adverse Event|1|||
23791918|NCT03255980|66616324|FG001|Overall Study|Adverse Event|1|||
23791919|NCT03255980|66616325|FG002|Overall Study|Adverse Event|0|||
23791920|NCT03255980|66616326|FG003|Overall Study|Adverse Event|1|||
23791921|NCT03255980|66616323|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
23791922|NCT03255980|66616324|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
23791923|NCT03255980|66616325|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
23791924|NCT03255980|66616326|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
23791925|NCT03255980|66616323|FG000|Overall Study|Lost to Follow-up|1|||
23791926|NCT03255980|66616324|FG001|Overall Study|Lost to Follow-up|1|||
23791927|NCT03255980|66616325|FG002|Overall Study|Lost to Follow-up|0|||
23791928|NCT03255980|66616326|FG003|Overall Study|Lost to Follow-up|3|||
23791929|NCT03255980|66616323|FG000|Overall Study|Withdrawal by Subject|0|||
23791930|NCT03255980|66616324|FG001|Overall Study|Withdrawal by Subject|1|||
23465593|NCT02284243|65448062|FG001|Overall Study|Lack of Efficacy|3|||
23465594|NCT02284243|65448061|FG000|Overall Study|Adverse Event|1|||
23585831|NCT00197015|65872899|FG001|Overall Study|Withdrawal by Subject|37|||
23585832|NCT00197015|65872900|FG002|Overall Study|Withdrawal by Subject|34|||
23585833|NCT00197015|65872898|FG000|Overall Study|Lost to Follow-up|28|||
23465595|NCT02284243|65448062|FG001|Overall Study|Adverse Event|0|||
23465596|NCT01281124|65448063|FG000|Overall Study|Death|1|||
23465597|NCT05024032|65448064|FG000|Overall Study|Withdrawal by Subject|0|||
23465598|NCT05024032|65448065|FG001|Overall Study|Withdrawal by Subject|3|||
23465599|NCT05024032|65448066|FG002|Overall Study|Withdrawal by Subject|4|||
23465600|NCT05024032|65448064|FG000|Overall Study|Adverse Event|0|||
23465601|NCT05024032|65448065|FG001|Overall Study|Adverse Event|1|||
23465602|NCT05024032|65448066|FG002|Overall Study|Adverse Event|0|||
23465603|NCT05024032|65448064|FG000|Overall Study|Protocol Deviation|1|||
23465604|NCT05024032|65448065|FG001|Overall Study|Protocol Deviation|0|||
23465605|NCT05024032|65448066|FG002|Overall Study|Protocol Deviation|0|||
23465606|NCT01198977|65448069|FG000|Overall Study|Lost to Follow-up|1|||
23465607|NCT01198977|65448070|FG001|Overall Study|Lost to Follow-up|0|||
23465608|NCT04237116|65448071|FG000|Overall Study|Adverse Event|0|||
23465609|NCT04237116|65448072|FG001|Overall Study|Adverse Event|1|||
23465610|NCT04237116|65448071|FG000|Overall Study|Study terminated by Sponsor|4|||
23465611|NCT04237116|65448072|FG001|Overall Study|Study terminated by Sponsor|1|||
23465612|NCT01216189|65448077|FG000|Overall Study|Lost to Follow-up|21|||
23465613|NCT01216189|65448078|FG001|Overall Study|Lost to Follow-up|3|||
23465614|NCT01216189|65448077|FG000|Overall Study|Death|4|||
23465615|NCT01216189|65448078|FG001|Overall Study|Death|2|||
23465616|NCT04308291|65448079|FG000|Run-In Phase|Withdrawal by Subject|4|||
23465617|NCT04308291|65448079|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
23465618|NCT04308291|65448079|FG000|Study Phase 6-M|Physician Decision|2|||
23791931|NCT03255980|66616325|FG002|Overall Study|Withdrawal by Subject|0|||
23791932|NCT03255980|66616326|FG003|Overall Study|Withdrawal by Subject|3|||
23791933|NCT00874549|66616327|FG000|Overall Study|Adverse Event|0|||
23791934|NCT00874549|66616328|FG001|Overall Study|Adverse Event|0|||
23465619|NCT04308291|65448079|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
23465620|NCT04308291|65448079|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
23465621|NCT04308291|65448079|FG000|Study Phase 12-M|Physician Decision|2|||
23465622|NCT04308291|65448079|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
23465623|NCT02873377|65448080|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
23465624|NCT02873377|65448081|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
23465625|NCT02873377|65448080|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
23465626|NCT02873377|65448081|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
23465627|NCT02161016|65448082|FG000|Overall Study|withdrawn by IRB|1|||
23465628|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
23465629|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465630|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465631|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465632|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465633|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465634|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465635|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
23465636|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465637|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465638|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465639|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465640|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465641|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465642|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
23465643|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465644|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465645|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465646|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465647|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465648|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465649|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
23465650|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23791935|NCT00874549|66616329|FG002|Overall Study|Adverse Event|1|||
23465651|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465652|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23791936|NCT00874549|66616330|FG003|Overall Study|Adverse Event|0|||
23791937|NCT00874549|66616327|FG000|Overall Study|Protocol Violation|1|||
23791938|NCT00874549|66616328|FG001|Overall Study|Protocol Violation|0|||
23465653|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465654|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465655|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23791939|NCT00874549|66616329|FG002|Overall Study|Protocol Violation|2|||
23791940|NCT00874549|66616330|FG003|Overall Study|Protocol Violation|1|||
23465656|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
23465657|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465658|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465659|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465660|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465661|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
23585834|NCT00197015|65872899|FG001|Overall Study|Lost to Follow-up|46|||
23585835|NCT00197015|65872900|FG002|Overall Study|Lost to Follow-up|37|||
23585836|NCT00197015|65872898|FG000|Overall Study|Other|2|||
23465662|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465663|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
23465664|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465665|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465666|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465667|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23791941|NCT00874549|66616327|FG000|Overall Study|Lost to Follow-up|0|||
23791942|NCT00874549|66616328|FG001|Overall Study|Lost to Follow-up|0|||
23791943|NCT00874549|66616329|FG002|Overall Study|Lost to Follow-up|1|||
23791944|NCT00874549|66616330|FG003|Overall Study|Lost to Follow-up|0|||
23791945|NCT00874549|66616327|FG000|Overall Study|Withdrawal by Subject|0|||
23791946|NCT00874549|66616328|FG001|Overall Study|Withdrawal by Subject|1|||
23791947|NCT00874549|66616329|FG002|Overall Study|Withdrawal by Subject|0|||
23791948|NCT00874549|66616330|FG003|Overall Study|Withdrawal by Subject|1|||
23791949|NCT03488108|66616331|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23791950|NCT03488108|66616332|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23791951|NCT03488108|66616331|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
23791952|NCT03488108|66616332|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
23465668|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465669|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465670|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23465671|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
23465672|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
23465673|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
23465674|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
23465675|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
23465676|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
23465677|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465678|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465679|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23465680|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
23465681|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465682|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
23465683|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465684|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23465685|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
23585837|NCT00197015|65872899|FG001|Overall Study|Other|3|||
23585838|NCT00197015|65872900|FG002|Overall Study|Other|2|||
23585839|NCT01494662|65872902|FG000|Overall Study|Withdrawal by Subject|0|||
23585840|NCT01494662|65872903|FG001|Overall Study|Withdrawal by Subject|0|||
23585841|NCT01494662|65872904|FG002|Overall Study|Withdrawal by Subject|1|||
23791953|NCT00393705|66616333|FG000|Overall Study|Adverse Event|0|||
23791954|NCT00393705|66616334|FG001|Overall Study|Adverse Event|2|||
23791955|NCT00393705|66616333|FG000|Overall Study|Death|0|||
23791956|NCT00393705|66616334|FG001|Overall Study|Death|1|||
23791957|NCT00393705|66616333|FG000|Overall Study|Lost to Follow-up|2|||
23791958|NCT00393705|66616334|FG001|Overall Study|Lost to Follow-up|2|||
23791959|NCT00393705|66616333|FG000|Overall Study|Entry Criteria Not Met|10|||
23791960|NCT00393705|66616334|FG001|Overall Study|Entry Criteria Not Met|10|||
23791961|NCT00393705|66616333|FG000|Overall Study|Protocol Violation|4|||
23791962|NCT00393705|66616334|FG001|Overall Study|Protocol Violation|3|||
23791963|NCT00393705|66616333|FG000|Overall Study|Withdrawal by Subject|5|||
23791964|NCT00393705|66616334|FG001|Overall Study|Withdrawal by Subject|3|||
23791965|NCT00393705|66616333|FG000|Overall Study|Physician Decision|2|||
23791966|NCT00393705|66616334|FG001|Overall Study|Physician Decision|2|||
23585842|NCT01494662|65872905|FG003|Overall Study|Withdrawal by Subject|0|||
23791967|NCT04610580|66616339|FG000|Two-way Crossover Period|Adverse Event|1|||
23791968|NCT04610580|66616340|FG001|Two-way Crossover Period|Adverse Event|0|||
23791969|NCT04610580|66616341|FG002|Two-way Crossover Period|Adverse Event|0|||
23585843|NCT01494662|65872906|FG004|Overall Study|Withdrawal by Subject|0|||
23585844|NCT01494662|65872907|FG005|Overall Study|Withdrawal by Subject|0|||
23465686|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
23465687|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
23465688|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
23465689|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
23465690|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
23465691|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23465692|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
23465693|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
23465694|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23465695|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23465696|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
23465697|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23465698|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
23465699|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465700|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
23465701|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465702|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465703|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
23465704|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
23465705|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465706|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465707|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
23465708|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465709|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465710|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465711|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
23465712|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465713|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23465714|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23465715|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465716|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465717|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23465718|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23465719|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23465720|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
23465721|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465722|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
23465723|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
23465724|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465725|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465726|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23465727|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
23465728|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23465729|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23465730|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
23465731|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23465732|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
23465733|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
23465734|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
23465735|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
23465736|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
23465737|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Other|2|||
23465738|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
23465739|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
23465740|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
23465741|NCT02509026|65448092|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
23465742|NCT02509026|65448092|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
23465743|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
23465744|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
23465745|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
23465746|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
23465747|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
23465748|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
23465749|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
23465750|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
23465751|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
23465752|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
23465753|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
23465754|NCT02592798|65448097|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
23465755|NCT02592798|65448098|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
23465756|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
23465757|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
23465758|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
23465759|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
23465760|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
23465761|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
23465762|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
23465763|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
23465764|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
23465765|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
23465766|NCT02592798|65448097|FG000|Transition From DB2 to OLE|Other reasons|1|||
23465767|NCT02592798|65448098|FG001|Transition From DB2 to OLE|Other reasons|0|||
23465768|NCT02592798|65448097|FG000|Open Label Period (OLE)|Other reasons|0|||
23465769|NCT02592798|65448098|FG001|Open Label Period (OLE)|Other reasons|2|||
23465770|NCT02592798|65448097|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
23465771|NCT02592798|65448098|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
23465772|NCT02592798|65448097|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
23465773|NCT02592798|65448098|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
23465774|NCT02592798|65448097|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
23465775|NCT02592798|65448098|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
23465776|NCT02592798|65448097|FG000|Open Label Period (OLE)|Adverse Event|0|||
23465777|NCT02592798|65448098|FG001|Open Label Period (OLE)|Adverse Event|1|||
23465778|NCT02608684|65448102|FG000|Overall Study|Physician Decision|2|||
23465779|NCT02608684|65448102|FG000|Overall Study|Withdrawal by Subject|1|||
23465780|NCT01519921|65448121|FG000|Overall Study|Adverse Event|10|||
23465781|NCT01519921|65448122|FG001|Overall Study|Adverse Event|9|||
23465782|NCT01519921|65448121|FG000|Overall Study|Lack of Efficacy|4|||
23465783|NCT01519921|65448122|FG001|Overall Study|Lack of Efficacy|3|||
23465784|NCT01519921|65448121|FG000|Overall Study|Withdrawal by Subject|3|||
23465785|NCT01519921|65448122|FG001|Overall Study|Withdrawal by Subject|0|||
23465786|NCT01519921|65448121|FG000|Overall Study|Lost to Follow-up|2|||
23465787|NCT01519921|65448122|FG001|Overall Study|Lost to Follow-up|1|||
23465788|NCT01519921|65448121|FG000|Overall Study|Treatment refusal|2|||
23465789|NCT01519921|65448122|FG001|Overall Study|Treatment refusal|1|||
23465790|NCT01519921|65448121|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
23465791|NCT01519921|65448122|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
23465792|NCT02892448|65448123|FG000|Overall Study|Screening failure|2|||
23465793|NCT02892448|65448124|FG001|Overall Study|Screening failure|2|||
23465794|NCT02892448|65448125|FG002|Overall Study|Screening failure|1|||
23465795|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
23585845|NCT01494662|65872908|FG006|Overall Study|Withdrawal by Subject|0|||
23585846|NCT01494662|65872902|FG000|Overall Study|Physician Decision|0|||
23585847|NCT01494662|65872903|FG001|Overall Study|Physician Decision|0|||
23585848|NCT01494662|65872904|FG002|Overall Study|Physician Decision|1|||
23585849|NCT01494662|65872905|FG003|Overall Study|Physician Decision|0|||
23585850|NCT01494662|65872906|FG004|Overall Study|Physician Decision|0|||
23640212|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23640213|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
23640214|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23640215|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
23791970|NCT04610580|66616342|FG003|Two-way Crossover Period|Adverse Event|0|||
23791971|NCT04610580|66616343|FG004|Two-way Crossover Period|Adverse Event|0|||
23791972|NCT04610580|66616344|FG005|Two-way Crossover Period|Adverse Event|0|||
23791973|NCT04610580|66616339|FG000|Two-way Crossover Period|Physician Decision|1|||
23791974|NCT04610580|66616340|FG001|Two-way Crossover Period|Physician Decision|0|||
23791975|NCT04610580|66616341|FG002|Two-way Crossover Period|Physician Decision|0|||
23791976|NCT04610580|66616342|FG003|Two-way Crossover Period|Physician Decision|0|||
23791977|NCT04610580|66616343|FG004|Two-way Crossover Period|Physician Decision|0|||
23465796|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
23465797|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
23465798|NCT01263197|65448128|FG000|First Intervention (Period 1)|Adverse Event|0|||
23465799|NCT01263197|65448129|FG001|First Intervention (Period 1)|Adverse Event|0|||
23465800|NCT01263197|65448130|FG002|First Intervention (Period 1)|Adverse Event|0|||
23465801|NCT01263197|65448131|FG003|First Intervention (Period 1)|Adverse Event|0|||
23585851|NCT01494662|65872907|FG005|Overall Study|Physician Decision|0|||
23791978|NCT04610580|66616344|FG005|Two-way Crossover Period|Physician Decision|0|||
23791979|NCT04610580|66616339|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
23791980|NCT04610580|66616340|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
23791981|NCT04610580|66616341|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
23791982|NCT04610580|66616342|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
23791983|NCT04610580|66616343|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
23791984|NCT04610580|66616344|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
23791985|NCT04610580|66616339|FG000|Two-way Crossover Period|Other than specified|0|||
23791986|NCT04610580|66616340|FG001|Two-way Crossover Period|Other than specified|1|||
23791987|NCT04610580|66616341|FG002|Two-way Crossover Period|Other than specified|0|||
23791988|NCT04610580|66616342|FG003|Two-way Crossover Period|Other than specified|0|||
23791989|NCT04610580|66616343|FG004|Two-way Crossover Period|Other than specified|0|||
23791990|NCT04610580|66616344|FG005|Two-way Crossover Period|Other than specified|0|||
23791991|NCT04610580|66616339|FG000|Washout Before Extension Period|Other than specified|0|||
23791992|NCT04610580|66616340|FG001|Washout Before Extension Period|Other than specified|1|||
23791993|NCT04610580|66616341|FG002|Washout Before Extension Period|Other than specified|0|||
23465802|NCT01263197|65448132|FG004|First Intervention (Period 1)|Adverse Event|0|||
23465803|NCT01263197|65448133|FG005|First Intervention (Period 1)|Adverse Event|1|||
23465804|NCT01263197|65448128|FG000|Washout Period 1|Protocol Violation|0|||
23465805|NCT01263197|65448129|FG001|Washout Period 1|Protocol Violation|0|||
23465806|NCT01263197|65448130|FG002|Washout Period 1|Protocol Violation|0|||
23465807|NCT01263197|65448131|FG003|Washout Period 1|Protocol Violation|0|||
23465808|NCT01263197|65448132|FG004|Washout Period 1|Protocol Violation|1|||
23465809|NCT01263197|65448133|FG005|Washout Period 1|Protocol Violation|0|||
23465810|NCT01263197|65448128|FG000|Washout Period 2|Physician Decision|0|||
23465811|NCT01263197|65448129|FG001|Washout Period 2|Physician Decision|0|||
23465812|NCT01263197|65448130|FG002|Washout Period 2|Physician Decision|0|||
23465813|NCT01263197|65448131|FG003|Washout Period 2|Physician Decision|0|||
23465814|NCT01263197|65448132|FG004|Washout Period 2|Physician Decision|0|||
23465815|NCT01263197|65448133|FG005|Washout Period 2|Physician Decision|1|||
23465816|NCT01263197|65448128|FG000|Washout Period 2|Protocol Violation|0|||
23465817|NCT01263197|65448129|FG001|Washout Period 2|Protocol Violation|0|||
23465818|NCT01263197|65448130|FG002|Washout Period 2|Protocol Violation|0|||
23465819|NCT01263197|65448131|FG003|Washout Period 2|Protocol Violation|1|||
23465820|NCT01263197|65448132|FG004|Washout Period 2|Protocol Violation|0|||
23465821|NCT01263197|65448133|FG005|Washout Period 2|Protocol Violation|0|||
23465822|NCT01263197|65448128|FG000|Third Intervention (Period 3)|Adverse Event|0|||
23465823|NCT01263197|65448129|FG001|Third Intervention (Period 3)|Adverse Event|1|||
23465824|NCT01263197|65448130|FG002|Third Intervention (Period 3)|Adverse Event|0|||
23465825|NCT01263197|65448131|FG003|Third Intervention (Period 3)|Adverse Event|0|||
23465826|NCT01263197|65448132|FG004|Third Intervention (Period 3)|Adverse Event|0|||
23465827|NCT01263197|65448133|FG005|Third Intervention (Period 3)|Adverse Event|0|||
23465828|NCT03349034|65448151|FG000|Overall Study|catheters dislodged during transport|2|||
23465829|NCT03349034|65448152|FG001|Overall Study|catheters dislodged during transport|0|||
23465830|NCT03349034|65448151|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
23465831|NCT03349034|65448152|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
23465832|NCT03349034|65448151|FG000|Overall Study|soft tissue flap used|1|||
23350942|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
23350943|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
23350944|NCT00583102|65029421|FG000|Overall Study|Adverse Event|3|||
23350945|NCT00467558|65029422|FG000|Overall Study|Lost to Follow-up|2|||
23350946|NCT00467558|65029423|FG001|Overall Study|Lost to Follow-up|0|||
23350947|NCT05020366|65029424|FG000|Overall Study|Lost to Follow-up|2|||
23350948|NCT05020366|65029425|FG001|Overall Study|Lost to Follow-up|0|||
23350949|NCT05020366|65029424|FG000|Overall Study|Withdrawal by Subject|2|||
23465833|NCT03349034|65448152|FG001|Overall Study|soft tissue flap used|0|||
23465834|NCT03349034|65448151|FG000|Overall Study|Other|0|||
23465835|NCT03349034|65448152|FG001|Overall Study|Other|1|||
23465836|NCT01470326|65448163|FG000|Overall Study|Protocol Violation|32|||
23465837|NCT01470326|65448163|FG000|Overall Study|No Drug Administration Information|2|||
23350950|NCT05020366|65029425|FG001|Overall Study|Withdrawal by Subject|0|||
23350951|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
23465838|NCT01470326|65448163|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
23465839|NCT02304367|65448164|FG000|Overall Study|Lack of Response to Bruosumab|1|||
23465840|NCT02304367|65448164|FG000|Overall Study|Sponsor Decision|3|||
23465841|NCT02304367|65448164|FG000|Overall Study|Death|2|||
23465842|NCT02304367|65448164|FG000|Overall Study|Physician Decision|1|||
23465843|NCT02304367|65448164|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
23465844|NCT00960999|65448165|FG000|Overall Study|Withdrawal by Subject|1|||
23465845|NCT00960999|65448166|FG001|Overall Study|Withdrawal by Subject|0|||
23465846|NCT00960999|65448165|FG000|Overall Study|Protocol Violation|5|||
23465847|NCT00960999|65448166|FG001|Overall Study|Protocol Violation|2|||
23465848|NCT00960999|65448165|FG000|Overall Study|RT dose constraints not met|2|||
23465849|NCT00960999|65448166|FG001|Overall Study|RT dose constraints not met|0|||
23465850|NCT03860259|65448167|FG000|Overall Study|Lost to Follow-up|5|||
23465851|NCT03860259|65448168|FG001|Overall Study|Lost to Follow-up|5|||
23465852|NCT03860259|65448167|FG000|Overall Study|Protocol Violation|1|||
23465853|NCT03860259|65448168|FG001|Overall Study|Protocol Violation|0|||
23465854|NCT00711191|65448169|FG000|Overall Study|Adverse Event|1|||
23465855|NCT00711191|65448170|FG001|Overall Study|Adverse Event|1|||
23465856|NCT00711191|65448171|FG002|Overall Study|Adverse Event|2|||
23465857|NCT00711191|65448169|FG000|Overall Study|Objective progression or relapse|2|||
23640216|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Patient's wish|0|||
23640217|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Patient's wish|0|||
23640218|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Patient's wish|19|||
23640219|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Patient's wish|9|||
23465858|NCT00711191|65448170|FG001|Overall Study|Objective progression or relapse|3|||
23465859|NCT00711191|65448171|FG002|Overall Study|Objective progression or relapse|7|||
23465860|NCT00711191|65448169|FG000|Overall Study|Withdrawal by Subject|0|||
23465861|NCT00711191|65448170|FG001|Overall Study|Withdrawal by Subject|1|||
23465862|NCT00711191|65448171|FG002|Overall Study|Withdrawal by Subject|3|||
23465863|NCT00494676|65448176|FG000|Allocation|Withdrawal by Subject|2|||
23465864|NCT00494676|65448177|FG001|Allocation|Withdrawal by Subject|4|||
23465865|NCT00494676|65448176|FG000|First Intervention|Withdrawal by Subject|1|||
23465866|NCT00494676|65448177|FG001|First Intervention|Withdrawal by Subject|3|||
23465867|NCT00494676|65448176|FG000|Second Intervention|Withdrawal by Subject|1|||
23465868|NCT00494676|65448177|FG001|Second Intervention|Withdrawal by Subject|1|||
23465869|NCT02367833|65448178|FG000|Overall Study|Withdrawal by Subject|1|||
23465870|NCT02367833|65448179|FG001|Overall Study|Withdrawal by Subject|1|||
23585852|NCT01494662|65872908|FG006|Overall Study|Physician Decision|0|||
23465871|NCT02367833|65448180|FG002|Overall Study|Withdrawal by Subject|0|||
23465872|NCT01578486|65448181|FG000|Overall Study|Physician Decision|3|||
23465873|NCT01578486|65448181|FG000|Overall Study|Withdrawal by Subject|2|||
23465874|NCT01339052|65448182|FG000|Overall Study|Disease progression|13|||
23465875|NCT01339052|65448183|FG001|Overall Study|Disease progression|46|||
23585853|NCT00711646|65872909|FG000|Overall Study|Adverse Event|6|||
23585854|NCT00711646|65872910|FG001|Overall Study|Adverse Event|1|||
23585855|NCT00711646|65872909|FG000|Overall Study|Withdrawal by Subject|4|||
23585856|NCT00711646|65872910|FG001|Overall Study|Withdrawal by Subject|0|||
23585857|NCT00711646|65872909|FG000|Overall Study|Protocol Violation|0|||
23585858|NCT00711646|65872910|FG001|Overall Study|Protocol Violation|1|||
23585859|NCT00711646|65872909|FG000|Overall Study|Lost to Follow-up|1|||
23465876|NCT01339052|65448182|FG000|Overall Study|Adverse Event|1|||
23465877|NCT01339052|65448183|FG001|Overall Study|Adverse Event|1|||
23465878|NCT01339052|65448182|FG000|Overall Study|Withdrawal by Subject|0|||
23465879|NCT01339052|65448183|FG001|Overall Study|Withdrawal by Subject|3|||
23465880|NCT01339052|65448182|FG000|Overall Study|Physician Decision|1|||
23465881|NCT01339052|65448183|FG001|Overall Study|Physician Decision|0|||
23465882|NCT00439517|65448185|FG000|Overall Study|Subject on treatment|1|||
23465883|NCT00439517|65448186|FG001|Overall Study|Subject on treatment|0|||
23465884|NCT00439517|65448185|FG000|Overall Study|Subject in survival follow-up|1|||
23465885|NCT00439517|65448186|FG001|Overall Study|Subject in survival follow-up|0|||
23465886|NCT00560352|65448193|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23465887|NCT00560352|65448194|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23465888|NCT00560352|65448195|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23465889|NCT00560352|65448193|FG000|Overall Study|Study drug toxicity|3|||
23465890|NCT00560352|65448194|FG001|Overall Study|Study drug toxicity|0|||
23465891|NCT00560352|65448195|FG002|Overall Study|Study drug toxicity|1|||
23465892|NCT00560352|65448193|FG000|Overall Study|Disease progression|0|||
23465893|NCT00560352|65448194|FG001|Overall Study|Disease progression|1|||
23465894|NCT00560352|65448195|FG002|Overall Study|Disease progression|1|||
23465895|NCT00560352|65448193|FG000|Overall Study|Withdrawal by Subject|1|||
23465896|NCT00560352|65448194|FG001|Overall Study|Withdrawal by Subject|1|||
23465897|NCT00560352|65448195|FG002|Overall Study|Withdrawal by Subject|1|||
23465898|NCT00560352|65448193|FG000|Overall Study|Maximum clinical benefit|1|||
23465899|NCT00560352|65448194|FG001|Overall Study|Maximum clinical benefit|0|||
23465900|NCT00560352|65448195|FG002|Overall Study|Maximum clinical benefit|0|||
23465901|NCT02561832|65448215|FG000|Overall Study|Withdrawal by Subject|1|||
23465902|NCT02561832|65448216|FG001|Overall Study|Withdrawal by Subject|1|||
23465903|NCT02561832|65448215|FG000|Overall Study|Adverse Event|3|||
23465904|NCT02561832|65448216|FG001|Overall Study|Adverse Event|0|||
23465905|NCT02561832|65448215|FG000|Overall Study|Disease progression|3|||
23465906|NCT02561832|65448216|FG001|Overall Study|Disease progression|3|||
23465907|NCT00275509|65448217|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
23465908|NCT00275509|65448218|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
23465909|NCT03694353|65448219|FG000|Overall Study|Withdrawal by Subject|1|||
23465910|NCT03694353|65448219|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
23465911|NCT03041181|65448220|FG000|Overall Study|Disease Progression|1|||
23791994|NCT04610580|66616342|FG003|Washout Before Extension Period|Other than specified|0|||
23791995|NCT04610580|66616343|FG004|Washout Before Extension Period|Other than specified|0|||
23791996|NCT04610580|66616344|FG005|Washout Before Extension Period|Other than specified|0|||
23791997|NCT04610580|66616339|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
23791998|NCT04610580|66616340|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
23465912|NCT03041181|65448221|FG001|Overall Study|Disease Progression|2|||
23465913|NCT00759941|65448226|FG000|Overall Study|Use of medication|1|||
23465914|NCT00759941|65448227|FG001|Overall Study|Use of medication|0|||
23465915|NCT00759941|65448226|FG000|Overall Study|Adverse Event|1|||
23465916|NCT00759941|65448227|FG001|Overall Study|Adverse Event|0|||
23465917|NCT00759941|65448226|FG000|Overall Study|Exited in error by site|1|||
23465918|NCT00759941|65448227|FG001|Overall Study|Exited in error by site|1|||
23465919|NCT02000440|65448230|FG000|Overall Study|Adverse Event|3|||
23465920|NCT02000440|65448230|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
23465921|NCT01143246|65448231|FG000|Overall Study|Adverse Event|24|||
23465922|NCT01143246|65448232|FG001|Overall Study|Adverse Event|28|||
23465923|NCT01143246|65448231|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
23465924|NCT01143246|65448232|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
23465925|NCT01143246|65448231|FG000|Overall Study|Lost to Follow-up|0|||
23465926|NCT01143246|65448232|FG001|Overall Study|Lost to Follow-up|1|||
23465927|NCT01143246|65448231|FG000|Overall Study|Death|16|||
23465928|NCT01143246|65448232|FG001|Overall Study|Death|15|||
23465929|NCT01143246|65448231|FG000|Overall Study|Reason not Specified|3|||
23640220|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Patient's wish|20|||
23706283|NCT00431847|66301140|FG001|Overall Study|Protocol Violation|0|||
23791999|NCT04610580|66616341|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
23792000|NCT04610580|66616342|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
23792001|NCT04610580|66616343|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
23465930|NCT01143246|65448232|FG001|Overall Study|Reason not Specified|5|||
23465931|NCT00400946|65448233|FG000|Overall Study|Ineligible|0|||
23465932|NCT00400946|65448234|FG001|Overall Study|Ineligible|0|||
23465933|NCT00400946|65448235|FG002|Overall Study|Ineligible|0|||
23465934|NCT00400946|65448236|FG003|Overall Study|Ineligible|5|||
23465935|NCT00400946|65448237|FG004|Overall Study|Ineligible|1|||
23465936|NCT00400946|65448233|FG000|Overall Study|Induction Failure|0|||
23465937|NCT00400946|65448234|FG001|Overall Study|Induction Failure|0|||
23465938|NCT00400946|65448235|FG002|Overall Study|Induction Failure|0|||
23465939|NCT00400946|65448236|FG003|Overall Study|Induction Failure|11|||
23465940|NCT00400946|65448237|FG004|Overall Study|Induction Failure|8|||
23465941|NCT00400946|65448233|FG000|Overall Study|Induction Death|0|||
23465942|NCT00400946|65448234|FG001|Overall Study|Induction Death|0|||
23465943|NCT00400946|65448235|FG002|Overall Study|Induction Death|0|||
23465944|NCT00400946|65448236|FG003|Overall Study|Induction Death|13|||
23465945|NCT00400946|65448237|FG004|Overall Study|Induction Death|3|||
23465946|NCT00400946|65448233|FG000|Overall Study|Lost to Follow-up|1|||
23792002|NCT04610580|66616344|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
23792003|NCT04610580|66616339|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23465947|NCT00400946|65448234|FG001|Overall Study|Lost to Follow-up|1|||
23465948|NCT00400946|65448235|FG002|Overall Study|Lost to Follow-up|0|||
23465949|NCT00400946|65448236|FG003|Overall Study|Lost to Follow-up|0|||
23465950|NCT00400946|65448237|FG004|Overall Study|Lost to Follow-up|1|||
23465951|NCT00400946|65448233|FG000|Overall Study|Remission Death|1|||
23465952|NCT00400946|65448234|FG001|Overall Study|Remission Death|1|||
23465953|NCT00400946|65448235|FG002|Overall Study|Remission Death|0|||
23585860|NCT00711646|65872910|FG001|Overall Study|Lost to Follow-up|0|||
23585861|NCT00711646|65872909|FG000|Overall Study|administrative decision|0|||
23585862|NCT00711646|65872910|FG001|Overall Study|administrative decision|1|||
23585863|NCT00711646|65872909|FG000|Overall Study|patient non-compliance|1|||
23640221|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
23640222|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
23640223|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
23640224|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
23585864|NCT00711646|65872910|FG001|Overall Study|patient non-compliance|0|||
23585865|NCT01981356|65872914|FG000|Overall Study|Lost to Follow-up|4|||
23585866|NCT01981356|65872915|FG001|Overall Study|Lost to Follow-up|1|||
23640225|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
23640226|NCT00444275|66067429|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
23640227|NCT00444275|66067430|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
23640228|NCT00444275|66067431|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
23640229|NCT00444275|66067432|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
23640230|NCT00444275|66067433|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
23640231|NCT01323972|66067434|FG000|Overall Study|Withdrawal by Subject|1|||
23640232|NCT01323972|66067435|FG001|Overall Study|Withdrawal by Subject|0|||
23640233|NCT01323972|66067436|FG002|Overall Study|Withdrawal by Subject|1|||
23640234|NCT01323972|66067437|FG003|Overall Study|Withdrawal by Subject|0|||
23640235|NCT01323972|66067434|FG000|Overall Study|Migrated/moved from study area|1|||
23640236|NCT01323972|66067435|FG001|Overall Study|Migrated/moved from study area|2|||
23640237|NCT01323972|66067436|FG002|Overall Study|Migrated/moved from study area|0|||
23640238|NCT01323972|66067437|FG003|Overall Study|Migrated/moved from study area|0|||
23640239|NCT01323972|66067434|FG000|Overall Study|Lost to Follow-up|0|||
23640240|NCT01323972|66067435|FG001|Overall Study|Lost to Follow-up|1|||
23640241|NCT01323972|66067436|FG002|Overall Study|Lost to Follow-up|1|||
23792004|NCT04610580|66616340|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23792005|NCT04610580|66616341|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23465954|NCT00400946|65448236|FG003|Overall Study|Remission Death|0|||
23465955|NCT00400946|65448237|FG004|Overall Study|Remission Death|1|||
23585867|NCT01981356|65872914|FG000|Overall Study|Withdrawal by Subject|1|||
23585868|NCT01981356|65872915|FG001|Overall Study|Withdrawal by Subject|1|||
23640242|NCT01323972|66067437|FG003|Overall Study|Lost to Follow-up|1|||
23792006|NCT04610580|66616342|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23792007|NCT04610580|66616343|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
23792008|NCT04610580|66616344|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23792009|NCT00562718|66620268|FG000|Overall Study|Death|1|||
23792010|NCT00562718|66620268|FG000|Overall Study|Withdrawal by Subject|3|||
23792011|NCT00562718|66620268|FG000|Overall Study|Adverse Event|4|||
23792012|NCT00562718|66620268|FG000|Overall Study|Lack of Efficacy|2|||
23792013|NCT00562718|66620268|FG000|Overall Study|not stated|1|||
23792014|NCT01055886|66620269|FG000|Overall Study|Withdrawal by Subject|4|||
23792015|NCT01055886|66620270|FG001|Overall Study|Withdrawal by Subject|9|||
23792016|NCT01055886|66620269|FG000|Overall Study|Lost to Follow-up|1|||
23792017|NCT01055886|66620270|FG001|Overall Study|Lost to Follow-up|1|||
23792018|NCT01055886|66620269|FG000|Overall Study|Withdrawal by PI|0|||
23792019|NCT01055886|66620270|FG001|Overall Study|Withdrawal by PI|1|||
23792020|NCT03885934|66620271|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23792021|NCT03885934|66620272|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
23792022|NCT03885934|66620273|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23792023|NCT03885934|66620274|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
23465956|NCT00400946|65448233|FG000|Overall Study|Relapse|9|||
23465957|NCT00400946|65448234|FG001|Overall Study|Relapse|2|||
23465958|NCT00400946|65448235|FG002|Overall Study|Relapse|1|||
23465959|NCT00400946|65448236|FG003|Overall Study|Relapse|1|||
23465960|NCT00400946|65448237|FG004|Overall Study|Relapse|5|||
23465961|NCT00400946|65448233|FG000|Overall Study|Transplant in CR1|0|||
23465962|NCT00400946|65448234|FG001|Overall Study|Transplant in CR1|0|||
23640243|NCT00943111|66067440|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
23640244|NCT00943111|66067441|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
23706284|NCT00431847|66301141|FG002|Overall Study|Protocol Violation|0|||
23465963|NCT00400946|65448235|FG002|Overall Study|Transplant in CR1|0|||
23465964|NCT00400946|65448236|FG003|Overall Study|Transplant in CR1|10|||
23465965|NCT00400946|65448237|FG004|Overall Study|Transplant in CR1|1|||
23465966|NCT00400946|65448233|FG000|Overall Study|Withdrawal by Subject|2|||
23465967|NCT00400946|65448234|FG001|Overall Study|Withdrawal by Subject|5|||
23465968|NCT00400946|65448235|FG002|Overall Study|Withdrawal by Subject|1|||
23465969|NCT00400946|65448236|FG003|Overall Study|Withdrawal by Subject|5|||
23465970|NCT00400946|65448237|FG004|Overall Study|Withdrawal by Subject|8|||
23465971|NCT00400946|65448233|FG000|Overall Study|Clinical|1|||
23465972|NCT00400946|65448234|FG001|Overall Study|Clinical|2|||
23465973|NCT00400946|65448235|FG002|Overall Study|Clinical|0|||
23465974|NCT00400946|65448236|FG003|Overall Study|Clinical|2|||
23350952|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
23465975|NCT00400946|65448237|FG004|Overall Study|Clinical|9|||
23465976|NCT00400946|65448233|FG000|Overall Study|Other|0|||
23465977|NCT00400946|65448234|FG001|Overall Study|Other|0|||
23465978|NCT00400946|65448235|FG002|Overall Study|Other|0|||
23465979|NCT00400946|65448236|FG003|Overall Study|Other|0|||
23465980|NCT00400946|65448237|FG004|Overall Study|Other|1|||
23465981|NCT00658359|65448240|FG000|Overall Study|Death|3|||
23350953|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
23350954|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
23350955|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
23350956|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
23350957|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
23350958|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
23350959|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
23465982|NCT00658359|65448241|FG001|Overall Study|Death|1|||
23465983|NCT00658359|65448242|FG002|Overall Study|Death|2|||
23465984|NCT00658359|65448240|FG000|Overall Study|Adverse Event|13|||
23465985|NCT00658359|65448241|FG001|Overall Study|Adverse Event|6|||
23465986|NCT00658359|65448242|FG002|Overall Study|Adverse Event|9|||
23465987|NCT00658359|65448240|FG000|Overall Study|Protocol Violation|1|||
23350960|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
23640245|NCT00943111|66067442|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
23640246|NCT00943111|66067440|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
23640247|NCT00943111|66067441|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
23640248|NCT00943111|66067442|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
23640249|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
23640250|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
23640251|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
23640252|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
23640253|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
23640254|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
23640255|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
23640256|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
23640257|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
23640258|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
23640259|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
23640260|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
23640261|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
23640262|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
23640263|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
23640264|NCT00943111|66067440|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
23640265|NCT00943111|66067441|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
23640266|NCT00943111|66067442|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
23640267|NCT04811131|66067445|FG000|Overall Study|Adverse Event|0|||
23640268|NCT04811131|66067446|FG001|Overall Study|Adverse Event|0|||
23640269|NCT04811131|66067447|FG002|Overall Study|Adverse Event|1|||
23640270|NCT04811131|66067448|FG003|Overall Study|Adverse Event|0|||
23640271|NCT04811131|66067445|FG000|Overall Study|Lack of Efficacy|0|||
23640272|NCT04811131|66067446|FG001|Overall Study|Lack of Efficacy|0|||
23640273|NCT04811131|66067447|FG002|Overall Study|Lack of Efficacy|0|||
23792024|NCT03885934|66620275|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
23792025|NCT03885934|66620276|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
23792026|NCT02751424|66620277|FG000|Part 2|Adverse Event|0|||
23792027|NCT02751424|66620278|FG001|Part 2|Adverse Event|0|||
23792028|NCT02751424|66620279|FG002|Part 2|Adverse Event|0|||
23792029|NCT02751424|66620280|FG003|Part 2|Adverse Event|0|||
23792030|NCT02751424|66620281|FG004|Part 2|Adverse Event|0|||
23792031|NCT02751424|66620282|FG005|Part 2|Adverse Event|0|||
23792032|NCT02751424|66620283|FG006|Part 2|Adverse Event|0|||
23792033|NCT02751424|66620284|FG007|Part 2|Adverse Event|5|||
23792034|NCT02751424|66620285|FG008|Part 2|Adverse Event|0|||
23350961|NCT00862459|65029428|FG000|Overall Study|Lost to Follow-up|1|||
23350962|NCT00862459|65029429|FG001|Overall Study|Lost to Follow-up|2|||
23350963|NCT00862459|65029430|FG002|Overall Study|Lost to Follow-up|2|||
23350964|NCT00862459|65029428|FG000|Overall Study|Protocol Violation|1|||
23350965|NCT00862459|65029429|FG001|Overall Study|Protocol Violation|0|||
23350966|NCT00862459|65029430|FG002|Overall Study|Protocol Violation|0|||
23350967|NCT00862459|65029428|FG000|Overall Study|Withdrawal by Subject|1|||
23465988|NCT00658359|65448241|FG001|Overall Study|Protocol Violation|0|||
23640274|NCT04811131|66067448|FG003|Overall Study|Lack of Efficacy|1|||
23792035|NCT02760433|66620303|FG000|Overall Study|Lost to Follow-up|1|||
23792036|NCT02760433|66620304|FG001|Overall Study|Lost to Follow-up|0|||
23792037|NCT02760433|66620305|FG002|Overall Study|Lost to Follow-up|1|||
23792038|NCT02760433|66620306|FG003|Overall Study|Lost to Follow-up|0|||
23792039|NCT02760433|66620307|FG004|Overall Study|Lost to Follow-up|0|||
23792040|NCT02760433|66620303|FG000|Overall Study|Withdrawal by Subject|23|||
23792041|NCT02760433|66620304|FG001|Overall Study|Withdrawal by Subject|9|||
23792042|NCT02760433|66620305|FG002|Overall Study|Withdrawal by Subject|0|||
23640275|NCT04811131|66067445|FG000|Overall Study|Lost to Follow-up|0|||
23640276|NCT04811131|66067446|FG001|Overall Study|Lost to Follow-up|1|||
23792043|NCT02760433|66620306|FG003|Overall Study|Withdrawal by Subject|2|||
23792044|NCT02760433|66620307|FG004|Overall Study|Withdrawal by Subject|9|||
23350968|NCT00862459|65029429|FG001|Overall Study|Withdrawal by Subject|1|||
23465989|NCT00658359|65448242|FG002|Overall Study|Protocol Violation|0|||
23465990|NCT00658359|65448240|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
23465991|NCT00658359|65448241|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
23465992|NCT00658359|65448242|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
23465993|NCT00658359|65448240|FG000|Overall Study|Withdrawal by Subject|7|||
23585869|NCT01981356|65872914|FG000|Overall Study|Protocol Violation|2|||
23585870|NCT01981356|65872915|FG001|Overall Study|Protocol Violation|0|||
23350969|NCT00862459|65029430|FG002|Overall Study|Withdrawal by Subject|3|||
23350970|NCT00862459|65029428|FG000|Overall Study|Adverse Event|0|||
23350971|NCT00862459|65029429|FG001|Overall Study|Adverse Event|1|||
23350972|NCT00862459|65029430|FG002|Overall Study|Adverse Event|0|||
23350973|NCT00862459|65029428|FG000|Overall Study|Personal reasons|1|||
23350974|NCT00862459|65029429|FG001|Overall Study|Personal reasons|0|||
23350975|NCT00862459|65029430|FG002|Overall Study|Personal reasons|0|||
23350976|NCT00862459|65029428|FG000|Overall Study|Operation|1|||
23350977|NCT00862459|65029429|FG001|Overall Study|Operation|1|||
23350978|NCT00862459|65029430|FG002|Overall Study|Operation|0|||
23350979|NCT00862459|65029428|FG000|Overall Study|Intravenous (IV) site problems|1|||
23350980|NCT00862459|65029429|FG001|Overall Study|Intravenous (IV) site problems|0|||
23350981|NCT00862459|65029430|FG002|Overall Study|Intravenous (IV) site problems|1|||
23350982|NCT00862459|65029428|FG000|Overall Study|Unable to hold still for imaging|0|||
23350983|NCT00862459|65029429|FG001|Overall Study|Unable to hold still for imaging|1|||
23350984|NCT00862459|65029430|FG002|Overall Study|Unable to hold still for imaging|0|||
23350985|NCT00862459|65029428|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23350986|NCT00862459|65029429|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
23350987|NCT00862459|65029430|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
23350988|NCT00862459|65029428|FG000|Overall Study|Administrative problems|0|||
23585871|NCT01405924|65872916|FG000|Overall Study|Protocol Violation|8|||
23585872|NCT01405924|65872916|FG000|Overall Study|Missing/Incomplete Data|2|||
23585873|NCT00891618|65872917|FG000|Overall Study|Withdrawal by Subject|1|||
23585874|NCT04310579|65872918|FG000|Overall Study|Adverse Event|0|||
23585875|NCT04310579|65872919|FG001|Overall Study|Adverse Event|0|||
23585876|NCT04310579|65872920|FG002|Overall Study|Adverse Event|0|||
23585877|NCT04310579|65872921|FG003|Overall Study|Adverse Event|0|||
23585878|NCT04310579|65872922|FG004|Overall Study|Adverse Event|0|||
23585879|NCT04310579|65872923|FG005|Overall Study|Adverse Event|0|||
23585880|NCT04310579|65872924|FG006|Overall Study|Adverse Event|2|||
23585881|NCT04310579|65872925|FG007|Overall Study|Adverse Event|0|||
23585882|NCT04310579|65872926|FG008|Overall Study|Adverse Event|1|||
23585883|NCT04310579|65872927|FG009|Overall Study|Adverse Event|1|||
23585884|NCT04310579|65872928|FG010|Overall Study|Adverse Event|0|||
23585885|NCT04310579|65872918|FG000|Overall Study|Withdrawal by Subject|0|||
23585886|NCT04310579|65872919|FG001|Overall Study|Withdrawal by Subject|0|||
23585887|NCT04310579|65872920|FG002|Overall Study|Withdrawal by Subject|0|||
23585888|NCT04310579|65872921|FG003|Overall Study|Withdrawal by Subject|0|||
23350989|NCT00862459|65029429|FG001|Overall Study|Administrative problems|1|||
23350990|NCT00862459|65029430|FG002|Overall Study|Administrative problems|0|||
23350991|NCT02539134|65029441|FG000|Overall Study|Lost to Follow-up|1|||
23585889|NCT04310579|65872922|FG004|Overall Study|Withdrawal by Subject|0|||
23350992|NCT02539134|65029442|FG001|Overall Study|Lost to Follow-up|0|||
23350993|NCT02539134|65029443|FG002|Overall Study|Lost to Follow-up|0|||
23350994|NCT02539134|65029444|FG003|Overall Study|Lost to Follow-up|0|||
23585890|NCT04310579|65872923|FG005|Overall Study|Withdrawal by Subject|1|||
23585891|NCT04310579|65872924|FG006|Overall Study|Withdrawal by Subject|0|||
23585892|NCT04310579|65872925|FG007|Overall Study|Withdrawal by Subject|0|||
23585893|NCT04310579|65872926|FG008|Overall Study|Withdrawal by Subject|0|||
23585894|NCT04310579|65872927|FG009|Overall Study|Withdrawal by Subject|0|||
23585895|NCT04310579|65872928|FG010|Overall Study|Withdrawal by Subject|0|||
23585896|NCT04310579|65872918|FG000|Overall Study|Positive COVID-19 test|0|||
23585897|NCT04310579|65872919|FG001|Overall Study|Positive COVID-19 test|0|||
23585898|NCT04310579|65872920|FG002|Overall Study|Positive COVID-19 test|0|||
23585899|NCT04310579|65872921|FG003|Overall Study|Positive COVID-19 test|0|||
23585900|NCT04310579|65872922|FG004|Overall Study|Positive COVID-19 test|0|||
23585901|NCT04310579|65872923|FG005|Overall Study|Positive COVID-19 test|0|||
23585902|NCT04310579|65872924|FG006|Overall Study|Positive COVID-19 test|0|||
23585903|NCT04310579|65872925|FG007|Overall Study|Positive COVID-19 test|0|||
23585904|NCT04310579|65872926|FG008|Overall Study|Positive COVID-19 test|0|||
23585905|NCT04310579|65872927|FG009|Overall Study|Positive COVID-19 test|0|||
23585906|NCT04310579|65872928|FG010|Overall Study|Positive COVID-19 test|1|||
23350995|NCT02539134|65029445|FG004|Overall Study|Lost to Follow-up|0|||
23350996|NCT02539134|65029446|FG005|Overall Study|Lost to Follow-up|0|||
23350997|NCT01618916|65029447|FG000|Overall Study|Adverse Event|1|||
23350998|NCT01618916|65029448|FG001|Overall Study|Adverse Event|0|||
23350999|NCT01618916|65029449|FG002|Overall Study|Adverse Event|0|||
23351000|NCT01618916|65029450|FG003|Overall Study|Adverse Event|0|||
23351001|NCT01618916|65029451|FG004|Overall Study|Adverse Event|0|||
23351002|NCT01618916|65029452|FG005|Overall Study|Adverse Event|0|||
23585907|NCT03254394|65872929|FG000|Overall Study|Withdrawal by Subject|0|||
23585908|NCT03254394|65872930|FG001|Overall Study|Withdrawal by Subject|2|||
23585909|NCT00371566|65872933|FG000|Treatment Phase|Withdrawal by Subject|0|||
23585910|NCT00371566|65872934|FG001|Treatment Phase|Withdrawal by Subject|1|||
23585911|NCT00371566|65872933|FG000|Treatment Phase|Adverse Event|0|||
23585912|NCT00371566|65872934|FG001|Treatment Phase|Adverse Event|1|||
23585913|NCT00371566|65872933|FG000|Treatment Phase|Protocol Violation|0|||
23585914|NCT00371566|65872934|FG001|Treatment Phase|Protocol Violation|1|||
23585915|NCT00371566|65872933|FG000|Chemoradiation Phase|Physician Decision|2|||
23585916|NCT00371566|65872934|FG001|Chemoradiation Phase|Physician Decision|0|||
23585917|NCT00371566|65872933|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
23585918|NCT00371566|65872934|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
23585919|NCT00371566|65872933|FG000|Chemoradiation Phase|Non compliant|0|||
23585920|NCT00371566|65872934|FG001|Chemoradiation Phase|Non compliant|1|||
23585921|NCT00371566|65872933|FG000|Chemoradiation Phase|Progressive Disease|1|||
23585922|NCT00371566|65872934|FG001|Chemoradiation Phase|Progressive Disease|1|||
23585923|NCT00371566|65872933|FG000|Chemoradiation Phase|Death|2|||
23585924|NCT00371566|65872934|FG001|Chemoradiation Phase|Death|0|||
23351003|NCT01618916|65029447|FG000|Overall Study|Withdrawal by Subject|0|||
23351004|NCT01618916|65029448|FG001|Overall Study|Withdrawal by Subject|1|||
23585925|NCT00371566|65872933|FG000|Follow Up Phase|Death|0|||
23585926|NCT00371566|65872934|FG001|Follow Up Phase|Death|5|||
23585927|NCT00371566|65872933|FG000|Follow Up Phase|Disease progression|1|||
23585928|NCT00371566|65872934|FG001|Follow Up Phase|Disease progression|0|||
23585929|NCT00371566|65872933|FG000|Follow Up Phase|Withdrawal by Subject|0|||
23585930|NCT00371566|65872934|FG001|Follow Up Phase|Withdrawal by Subject|1|||
23585931|NCT00371566|65872933|FG000|Follow Up Phase|Physician Decision|1|||
23585932|NCT00371566|65872934|FG001|Follow Up Phase|Physician Decision|1|||
23585933|NCT00371566|65872933|FG000|Follow Up Phase|Lost to Follow-up|1|||
23351005|NCT01618916|65029449|FG002|Overall Study|Withdrawal by Subject|1|||
23351006|NCT01618916|65029450|FG003|Overall Study|Withdrawal by Subject|0|||
23351007|NCT01618916|65029451|FG004|Overall Study|Withdrawal by Subject|1|||
23351008|NCT01618916|65029452|FG005|Overall Study|Withdrawal by Subject|0|||
23585934|NCT00371566|65872934|FG001|Follow Up Phase|Lost to Follow-up|0|||
23585935|NCT00530335|65872936|FG000|Overall Study|Adverse Event|3|||
23585936|NCT00530335|65872936|FG000|Overall Study|Protocol Violation|1|||
23585937|NCT00530335|65872936|FG000|Overall Study|Withdrawal by Subject|1|||
23585938|NCT00530335|65872936|FG000|Overall Study|Physician Decision|1|||
23351009|NCT01618916|65029447|FG000|Overall Study|Lost to Follow-up|1|||
23351010|NCT01618916|65029448|FG001|Overall Study|Lost to Follow-up|0|||
23351011|NCT01618916|65029449|FG002|Overall Study|Lost to Follow-up|0|||
23585939|NCT01664104|65872945|FG000|Overall Study|Adverse Event|6|||
23585940|NCT01664104|65872945|FG000|Overall Study|Lack of Efficacy|2|||
23585941|NCT01664104|65872945|FG000|Overall Study|Withdrawal by Subject|1|||
23585942|NCT01664104|65872945|FG000|Overall Study|Lost to Follow-up|4|||
23585943|NCT01664104|65872945|FG000|Overall Study|Other|1|||
23585944|NCT01664104|65872945|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
23585945|NCT03140176|65872948|FG000|Overall Study|Reason missing|23|||
23585946|NCT03140176|65872948|FG000|Overall Study|Death|33|||
23585947|NCT03140176|65872948|FG000|Overall Study|Disease progression|1|||
23585948|NCT03140176|65872948|FG000|Overall Study|Physician Decision|1|||
23585949|NCT03140176|65872948|FG000|Overall Study|Withdrawal by Subject|1|||
23585950|NCT03140176|65872948|FG000|Overall Study|Lost to Follow-up|15|||
23585951|NCT03158948|65872949|FG000|Overall Study|Death|1|||
23585952|NCT03158948|65872950|FG001|Overall Study|Death|1|||
23585953|NCT03158948|65872951|FG002|Overall Study|Death|3|||
23585954|NCT03158948|65872952|FG003|Overall Study|Death|2|||
23585955|NCT03158948|65872949|FG000|Overall Study|Physician Decision|0|||
23585956|NCT03158948|65872950|FG001|Overall Study|Physician Decision|0|||
23585957|NCT03158948|65872951|FG002|Overall Study|Physician Decision|0|||
23585958|NCT03158948|65872952|FG003|Overall Study|Physician Decision|1|||
23585959|NCT01167426|65872953|FG000|Overall Study|Lost to Follow-up|6|||
23585960|NCT01167426|65872953|FG000|Overall Study|Protocol Violation|1|||
23585961|NCT01167426|65872953|FG000|Overall Study|Withdrawal by Subject|2|||
23585962|NCT01167426|65872953|FG000|Overall Study|Sponsor Decision|1|||
23585963|NCT02046616|65872954|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
23585964|NCT02046616|65872954|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
23585965|NCT02046616|65872954|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
23585966|NCT02046616|65872954|FG000|24-Week Treatment Period|Physician Decision|3|||
23585967|NCT02046616|65872954|FG000|24-Week Treatment Period|Other|1|||
23585968|NCT02046616|65872954|FG000|8-Week FU Period|Lost to Follow-up|1|||
23585969|NCT03098030|65872955|FG000|Overall Study|Death|10|||
23585970|NCT03098030|65872956|FG001|Overall Study|Death|156|||
23585971|NCT03098030|65872957|FG002|Overall Study|Death|156|||
23585972|NCT03098030|65872958|FG003|Overall Study|Death|82|||
23585973|NCT03098030|65872955|FG000|Overall Study|Withdrawal by Subject|0|||
23585974|NCT03098030|65872956|FG001|Overall Study|Withdrawal by Subject|7|||
23585975|NCT03098030|65872957|FG002|Overall Study|Withdrawal by Subject|8|||
23351012|NCT01618916|65029450|FG003|Overall Study|Lost to Follow-up|2|||
23351013|NCT01618916|65029451|FG004|Overall Study|Lost to Follow-up|0|||
23351014|NCT01618916|65029452|FG005|Overall Study|Lost to Follow-up|0|||
23351015|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
23351016|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
23351017|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
23351018|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
23640277|NCT04811131|66067447|FG002|Overall Study|Lost to Follow-up|0|||
23351019|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|No response|5|||
23351020|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|No response|5|||
23351021|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|No response|5|||
23351022|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|No response|2|||
23351023|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351024|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351025|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351026|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
23351027|NCT04093492|65029453|FG000|30 Weeks GA|Delivered before assessment|1|||
23351028|NCT04093492|65029454|FG001|30 Weeks GA|Delivered before assessment|2|||
23465994|NCT00658359|65448241|FG001|Overall Study|Withdrawal by Subject|4|||
23585976|NCT03098030|65872958|FG003|Overall Study|Withdrawal by Subject|2|||
23585977|NCT03098030|65872955|FG000|Overall Study|Lost to Follow-up|0|||
23640278|NCT04811131|66067448|FG003|Overall Study|Lost to Follow-up|0|||
23351029|NCT04093492|65029455|FG002|30 Weeks GA|Delivered before assessment|0|||
23585978|NCT03098030|65872956|FG001|Overall Study|Lost to Follow-up|0|||
23585979|NCT03098030|65872957|FG002|Overall Study|Lost to Follow-up|2|||
23585980|NCT03098030|65872958|FG003|Overall Study|Lost to Follow-up|1|||
23585981|NCT02784704|65872959|FG000|Overall Study|Adverse Event|4|||
23640279|NCT04811131|66067445|FG000|Overall Study|Sponsor request|31|||
23585982|NCT02784704|65872960|FG001|Overall Study|Adverse Event|2|||
23585983|NCT02784704|65872959|FG000|Overall Study|Lost to Follow-up|6|||
23585984|NCT02784704|65872960|FG001|Overall Study|Lost to Follow-up|4|||
23585985|NCT02784704|65872959|FG000|Overall Study|Withdrawal by Subject|1|||
23585986|NCT02784704|65872960|FG001|Overall Study|Withdrawal by Subject|3|||
23585987|NCT02784704|65872959|FG000|Overall Study|Subject Non Compliance|2|||
23585988|NCT02784704|65872960|FG001|Overall Study|Subject Non Compliance|0|||
23585989|NCT04716933|65872961|FG000|Overall Study|Ongoing|46|||
23351030|NCT04093492|65029456|FG003|30 Weeks GA|Delivered before assessment|0|||
23351031|NCT04093492|65029453|FG000|30 Weeks GA|No response|7|||
23585990|NCT04716933|65872962|FG001|Overall Study|Ongoing|37|||
23585991|NCT04716933|65872961|FG000|Overall Study|Sponsor Decision|55|||
23585992|NCT04716933|65872962|FG001|Overall Study|Sponsor Decision|63|||
23585993|NCT04088188|65872964|FG000|Overall Study|Withdrawal by Subject|2|||
23585994|NCT04088188|65872965|FG001|Overall Study|Withdrawal by Subject|0|||
23585995|NCT04088188|65872964|FG000|Overall Study|Adverse Event|2|||
23585996|NCT04088188|65872965|FG001|Overall Study|Adverse Event|0|||
23585997|NCT00837616|65872968|FG000|Overall Study|Withdrawal by Subject|0|||
23585998|NCT00837616|65872969|FG001|Overall Study|Withdrawal by Subject|1|||
23585999|NCT00938340|65872976|FG000|Overall Study|Withdrawal by Subject|3|||
23586000|NCT00938340|65872976|FG000|Overall Study|Protocol Violation|1|||
23586001|NCT00938340|65872976|FG000|Overall Study|Adverse Event|1|||
23586002|NCT00425503|65872977|FG000|Overall Study|Adverse Event|2|||
23586003|NCT00425503|65872977|FG000|Overall Study|Protocol Violation|1|||
23586004|NCT00506519|65872980|FG000|Overall Study|Death|4|||
23586005|NCT00506519|65872981|FG001|Overall Study|Death|6|||
23586006|NCT00506519|65872982|FG002|Overall Study|Death|0|||
23586007|NCT00506519|65872980|FG000|Overall Study|Adverse Event|1|||
23586008|NCT00506519|65872981|FG001|Overall Study|Adverse Event|0|||
23792045|NCT02760433|66620303|FG000|Overall Study|Lack of Response At Week 14|0|||
23792046|NCT02760433|66620304|FG001|Overall Study|Lack of Response At Week 14|0|||
23792047|NCT02760433|66620305|FG002|Overall Study|Lack of Response At Week 14|0|||
23792048|NCT02760433|66620306|FG003|Overall Study|Lack of Response At Week 14|0|||
23792049|NCT02760433|66620307|FG004|Overall Study|Lack of Response At Week 14|1|||
23792050|NCT02760433|66620303|FG000|Overall Study|Subject refused to continue the study|1|||
23792051|NCT02760433|66620304|FG001|Overall Study|Subject refused to continue the study|0|||
23792052|NCT02760433|66620305|FG002|Overall Study|Subject refused to continue the study|0|||
23792053|NCT02760433|66620306|FG003|Overall Study|Subject refused to continue the study|0|||
23792054|NCT02760433|66620307|FG004|Overall Study|Subject refused to continue the study|0|||
23586009|NCT00506519|65872982|FG002|Overall Study|Adverse Event|0|||
23586010|NCT02013037|65872983|FG000|Overall Study|Death|6|||
23465995|NCT00658359|65448242|FG002|Overall Study|Withdrawal by Subject|2|||
23465996|NCT00658359|65448240|FG000|Overall Study|Lost to Follow-up|2|||
23465997|NCT00658359|65448241|FG001|Overall Study|Lost to Follow-up|2|||
23465998|NCT00658359|65448242|FG002|Overall Study|Lost to Follow-up|4|||
23465999|NCT00658359|65448240|FG000|Overall Study|Lack of Efficacy|0|||
23466000|NCT00658359|65448241|FG001|Overall Study|Lack of Efficacy|1|||
23466001|NCT00658359|65448242|FG002|Overall Study|Lack of Efficacy|0|||
23466002|NCT02362282|65448243|FG000|Overall Study|Withdrawal by Subject|1|||
23466003|NCT02362282|65448244|FG001|Overall Study|Withdrawal by Subject|0|||
23792055|NCT02760433|66620303|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
23792056|NCT02760433|66620304|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23792057|NCT02760433|66620305|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23792058|NCT02760433|66620306|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23792059|NCT02760433|66620307|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23792060|NCT02760433|66620303|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23792061|NCT02760433|66620304|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
23792062|NCT02760433|66620305|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23466004|NCT00297258|65448245|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
23466005|NCT00297258|65448245|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
23466006|NCT00297258|65448245|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
23466007|NCT00297258|65448245|FG000|Overall Study|Intercurrent Illness|3|||
23466008|NCT00297258|65448245|FG000|Overall Study|Intercurrent Death|2|||
23466009|NCT00297258|65448245|FG000|Overall Study|Deteriorization of General Condition|1|||
23466010|NCT00297258|65448245|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
23466011|NCT00297258|65448245|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
23466012|NCT00297258|65448245|FG000|Overall Study|Switch to Commercial Treatment|1|||
23466013|NCT00297258|65448245|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
23466014|NCT01656408|65448249|FG000|Overall Study|Adverse Event|0|||
23466015|NCT01656408|65448250|FG001|Overall Study|Adverse Event|0|||
23466016|NCT01656408|65448251|FG002|Overall Study|Adverse Event|1|||
23466017|NCT01656408|65448252|FG003|Overall Study|Adverse Event|0|||
23466018|NCT01656408|65448253|FG004|Overall Study|Adverse Event|0|||
23466019|NCT01656408|65448254|FG005|Overall Study|Adverse Event|1|||
23466020|NCT01656408|65448255|FG006|Overall Study|Adverse Event|1|||
23466021|NCT01656408|65448256|FG007|Overall Study|Adverse Event|0|||
23466022|NCT01656408|65448257|FG008|Overall Study|Adverse Event|1|||
23466023|NCT01656408|65448258|FG009|Overall Study|Adverse Event|0|||
23466024|NCT01656408|65448249|FG000|Overall Study|Physician Decision|1|||
23466025|NCT01656408|65448250|FG001|Overall Study|Physician Decision|0|||
23466026|NCT01656408|65448251|FG002|Overall Study|Physician Decision|1|||
23466027|NCT01656408|65448252|FG003|Overall Study|Physician Decision|0|||
23466028|NCT01656408|65448253|FG004|Overall Study|Physician Decision|1|||
23466029|NCT01656408|65448254|FG005|Overall Study|Physician Decision|1|||
23466030|NCT01656408|65448255|FG006|Overall Study|Physician Decision|0|||
23466031|NCT01656408|65448256|FG007|Overall Study|Physician Decision|1|||
23466032|NCT01656408|65448257|FG008|Overall Study|Physician Decision|1|||
23792063|NCT02760433|66620306|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23792064|NCT02760433|66620307|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23792065|NCT02212457|66620308|FG000|Overall Study|Adverse Event|1|||
23792066|NCT02212457|66620309|FG001|Overall Study|Adverse Event|2|||
23792067|NCT02212457|66620310|FG002|Overall Study|Adverse Event|2|||
23792068|NCT02212457|66620311|FG003|Overall Study|Adverse Event|2|||
23792069|NCT02212457|66620312|FG004|Overall Study|Adverse Event|0|||
23792070|NCT02212457|66620313|FG005|Overall Study|Adverse Event|1|||
23792071|NCT02212457|66620308|FG000|Overall Study|Withdrawal by Subject|8|||
23792072|NCT02212457|66620309|FG001|Overall Study|Withdrawal by Subject|10|||
23792073|NCT02212457|66620310|FG002|Overall Study|Withdrawal by Subject|8|||
23792074|NCT02212457|66620311|FG003|Overall Study|Withdrawal by Subject|6|||
23792075|NCT02212457|66620312|FG004|Overall Study|Withdrawal by Subject|5|||
23792076|NCT02212457|66620313|FG005|Overall Study|Withdrawal by Subject|4|||
23351032|NCT04093492|65029454|FG001|30 Weeks GA|No response|5|||
23351033|NCT04093492|65029455|FG002|30 Weeks GA|No response|5|||
23351034|NCT04093492|65029456|FG003|30 Weeks GA|No response|2|||
23351035|NCT04093492|65029453|FG000|30 Weeks GA|Lost to Follow-up|0|||
23351036|NCT04093492|65029454|FG001|30 Weeks GA|Lost to Follow-up|1|||
23466033|NCT01656408|65448258|FG009|Overall Study|Physician Decision|3|||
23466034|NCT01083771|65448269|FG000|Overall Study|non-compliant|2|||
23466035|NCT01083771|65448269|FG000|Overall Study|Withdrawal by Subject|3|||
23466036|NCT03809104|65448271|FG000|Overall Study|Withdrawal by Subject|3|||
23466037|NCT00942604|65448272|FG000|Overall Study|Protocol Violation|1|||
23466038|NCT00942604|65448273|FG001|Overall Study|Protocol Violation|1|||
23466039|NCT00942604|65448272|FG000|Overall Study|Adverse Event|0|||
23466040|NCT00942604|65448273|FG001|Overall Study|Adverse Event|1|||
23466041|NCT00942604|65448272|FG000|Overall Study|Withdrawal by Subject|0|||
23466042|NCT00942604|65448273|FG001|Overall Study|Withdrawal by Subject|1|||
23466043|NCT00942604|65448272|FG000|Overall Study|Patient relocation|1|||
23466044|NCT00942604|65448273|FG001|Overall Study|Patient relocation|1|||
23466045|NCT03040336|65448281|FG000|Overall Study|Death|1|||
23351037|NCT04093492|65029455|FG002|30 Weeks GA|Lost to Follow-up|0|||
23351038|NCT04093492|65029456|FG003|30 Weeks GA|Lost to Follow-up|0|||
23351039|NCT04093492|65029453|FG000|34 Weeks GA|Delivered before assessment|6|||
23466046|NCT03040336|65448282|FG001|Overall Study|Death|0|||
23466047|NCT03040336|65448281|FG000|Overall Study|Withdrawal by Subject|2|||
23466048|NCT03040336|65448282|FG001|Overall Study|Withdrawal by Subject|3|||
23466049|NCT00807001|65448283|FG000|Overall Study|Non-compliance|0|||
23466050|NCT00807001|65448284|FG001|Overall Study|Non-compliance|1|||
23466051|NCT00807001|65448285|FG002|Overall Study|Non-compliance|0|||
23466052|NCT00807001|65448286|FG003|Overall Study|Non-compliance|0|||
23466053|NCT00807001|65448287|FG004|Overall Study|Non-compliance|0|||
23466054|NCT01702311|65448288|FG000|Overall Study|Withdrawal by Subject|3|||
23466055|NCT01702311|65448289|FG001|Overall Study|Withdrawal by Subject|2|||
23466056|NCT01702311|65448288|FG000|Overall Study|Discharge less than 24 hours|10|||
23466057|NCT01702311|65448289|FG001|Overall Study|Discharge less than 24 hours|7|||
23466058|NCT01702311|65448288|FG000|Overall Study|Physician Decision|3|||
23466059|NCT01702311|65448289|FG001|Overall Study|Physician Decision|4|||
23466060|NCT00472030|65448290|FG000|Overall Study|Physician Decision|1|||
23466061|NCT00472030|65448291|FG001|Overall Study|Physician Decision|0|||
23640280|NCT04811131|66067446|FG001|Overall Study|Sponsor request|35|||
23640281|NCT04811131|66067447|FG002|Overall Study|Sponsor request|27|||
23640282|NCT04811131|66067448|FG003|Overall Study|Sponsor request|10|||
23640283|NCT04811131|66067445|FG000|Overall Study|Withdrawal by Subject|3|||
23351040|NCT04093492|65029454|FG001|34 Weeks GA|Delivered before assessment|3|||
23466062|NCT01995838|65448293|FG000|Overall Study|Lost to Follow-up|0|||
23466063|NCT01995838|65448294|FG001|Overall Study|Lost to Follow-up|1|||
23466064|NCT01995838|65448295|FG002|Overall Study|Lost to Follow-up|0|||
23466065|NCT01995838|65448296|FG003|Overall Study|Lost to Follow-up|0|||
23466066|NCT01995838|65448297|FG004|Overall Study|Lost to Follow-up|0|||
23466067|NCT01995838|65448298|FG005|Overall Study|Lost to Follow-up|0|||
23466068|NCT01995838|65448299|FG006|Overall Study|Lost to Follow-up|1|||
23466069|NCT01995838|65448293|FG000|Overall Study|Participant choice|2|||
23466070|NCT01995838|65448294|FG001|Overall Study|Participant choice|0|||
23466071|NCT01995838|65448295|FG002|Overall Study|Participant choice|0|||
23466072|NCT01995838|65448296|FG003|Overall Study|Participant choice|0|||
23466073|NCT01995838|65448297|FG004|Overall Study|Participant choice|0|||
23466074|NCT01995838|65448298|FG005|Overall Study|Participant choice|1|||
23466075|NCT01995838|65448299|FG006|Overall Study|Participant choice|1|||
23466076|NCT01995838|65448293|FG000|Overall Study|Adverse Event|0|||
23466077|NCT01995838|65448294|FG001|Overall Study|Adverse Event|0|||
23466078|NCT01995838|65448295|FG002|Overall Study|Adverse Event|0|||
23466079|NCT01995838|65448296|FG003|Overall Study|Adverse Event|0|||
23466080|NCT01995838|65448297|FG004|Overall Study|Adverse Event|0|||
23466081|NCT01995838|65448298|FG005|Overall Study|Adverse Event|0|||
23466082|NCT01995838|65448299|FG006|Overall Study|Adverse Event|1|||
23466083|NCT01995838|65448293|FG000|Overall Study|Withdrawal by Subject|0|||
23466084|NCT01995838|65448294|FG001|Overall Study|Withdrawal by Subject|0|||
23466085|NCT01995838|65448295|FG002|Overall Study|Withdrawal by Subject|0|||
23466086|NCT01995838|65448296|FG003|Overall Study|Withdrawal by Subject|0|||
23466087|NCT01995838|65448297|FG004|Overall Study|Withdrawal by Subject|1|||
23466088|NCT01995838|65448298|FG005|Overall Study|Withdrawal by Subject|0|||
23466089|NCT01995838|65448299|FG006|Overall Study|Withdrawal by Subject|0|||
23466090|NCT01995838|65448293|FG000|Overall Study|Other|3|||
23466091|NCT01995838|65448294|FG001|Overall Study|Other|1|||
23466092|NCT01995838|65448295|FG002|Overall Study|Other|0|||
23466093|NCT01995838|65448296|FG003|Overall Study|Other|2|||
23466094|NCT01995838|65448297|FG004|Overall Study|Other|1|||
23466095|NCT01995838|65448298|FG005|Overall Study|Other|1|||
23466096|NCT01995838|65448299|FG006|Overall Study|Other|2|||
23466097|NCT04953728|65448302|FG000|Overall Study|Withdrawal by Subject|3|||
23466098|NCT04953728|65448302|FG000|Overall Study|Physician Decision|1|||
23466099|NCT02754440|65448303|FG000|Overall Study|Protocol Violation|3|||
23466100|NCT02754440|65448304|FG001|Overall Study|Protocol Violation|2|||
23466101|NCT02754440|65448305|FG002|Overall Study|Protocol Violation|2|||
23466102|NCT02754440|65448306|FG003|Overall Study|Protocol Violation|6|||
23466103|NCT02754440|65448303|FG000|Overall Study|Adverse Event|3|||
23466104|NCT02754440|65448304|FG001|Overall Study|Adverse Event|1|||
23466105|NCT02754440|65448305|FG002|Overall Study|Adverse Event|0|||
23466106|NCT02754440|65448306|FG003|Overall Study|Adverse Event|9|||
23466107|NCT02754440|65448303|FG000|Overall Study|Withdrawal by Subject|0|||
23466108|NCT02754440|65448304|FG001|Overall Study|Withdrawal by Subject|0|||
23466109|NCT02754440|65448305|FG002|Overall Study|Withdrawal by Subject|0|||
23466110|NCT02754440|65448306|FG003|Overall Study|Withdrawal by Subject|1|||
23466111|NCT02754440|65448303|FG000|Overall Study|Equipment failure|0|||
23466112|NCT02754440|65448304|FG001|Overall Study|Equipment failure|5|||
23466113|NCT02754440|65448305|FG002|Overall Study|Equipment failure|5|||
23466114|NCT02754440|65448306|FG003|Overall Study|Equipment failure|7|||
23466115|NCT02754440|65448303|FG000|Overall Study|Subject issues not resulting in AE|0|||
23466116|NCT02754440|65448304|FG001|Overall Study|Subject issues not resulting in AE|0|||
23466117|NCT02754440|65448305|FG002|Overall Study|Subject issues not resulting in AE|0|||
23466118|NCT02754440|65448306|FG003|Overall Study|Subject issues not resulting in AE|12|||
23466119|NCT02170077|65448307|FG000|Overall Study|Withdrawal by Subject|3|||
23466120|NCT02170077|65448308|FG001|Overall Study|Withdrawal by Subject|4|||
23586011|NCT02013037|65872983|FG000|Overall Study|Withdrawal by Subject|1|||
23792077|NCT02212457|66620308|FG000|Overall Study|Lost to Follow-up|6|||
23792078|NCT02212457|66620309|FG001|Overall Study|Lost to Follow-up|7|||
23792079|NCT02212457|66620310|FG002|Overall Study|Lost to Follow-up|4|||
23792080|NCT02212457|66620311|FG003|Overall Study|Lost to Follow-up|1|||
23792081|NCT02212457|66620312|FG004|Overall Study|Lost to Follow-up|8|||
23792082|NCT02212457|66620313|FG005|Overall Study|Lost to Follow-up|4|||
23792083|NCT02212457|66620308|FG000|Overall Study|Protocol Violation|2|||
23792084|NCT02212457|66620309|FG001|Overall Study|Protocol Violation|1|||
23792085|NCT02212457|66620310|FG002|Overall Study|Protocol Violation|0|||
23466121|NCT02170077|65448309|FG002|Overall Study|Withdrawal by Subject|2|||
23466122|NCT02170077|65448307|FG000|Overall Study|Adverse Event|4|||
23586012|NCT02013037|65872983|FG000|Overall Study|Awaiting Transplantation|7|||
23792086|NCT02212457|66620311|FG003|Overall Study|Protocol Violation|1|||
23792087|NCT02212457|66620312|FG004|Overall Study|Protocol Violation|2|||
23792088|NCT02212457|66620313|FG005|Overall Study|Protocol Violation|3|||
23792089|NCT02212457|66620308|FG000|Overall Study|Other|2|||
23466123|NCT02170077|65448308|FG001|Overall Study|Adverse Event|4|||
23466124|NCT02170077|65448309|FG002|Overall Study|Adverse Event|4|||
23466125|NCT02170077|65448307|FG000|Overall Study|Lost to Follow-up|0|||
23466126|NCT02170077|65448308|FG001|Overall Study|Lost to Follow-up|1|||
23466127|NCT02170077|65448309|FG002|Overall Study|Lost to Follow-up|0|||
23466128|NCT02170077|65448307|FG000|Overall Study|Exclusion criteria|2|||
23466129|NCT02170077|65448308|FG001|Overall Study|Exclusion criteria|2|||
23466130|NCT02170077|65448309|FG002|Overall Study|Exclusion criteria|5|||
23466131|NCT02170077|65448307|FG000|Overall Study|Exacerbation of seizures|0|||
23466132|NCT02170077|65448308|FG001|Overall Study|Exacerbation of seizures|2|||
23466133|NCT02170077|65448309|FG002|Overall Study|Exacerbation of seizures|1|||
23466134|NCT01523756|65448310|FG000|Baseline Period|Adverse Event|0|||
23792090|NCT02212457|66620309|FG001|Overall Study|Other|1|||
23466135|NCT01523756|65448311|FG001|Baseline Period|Adverse Event|1|||
23466136|NCT01523756|65448310|FG000|Test Period 1|Adverse Event|1|||
23466137|NCT01523756|65448311|FG001|Test Period 1|Adverse Event|0|||
23466138|NCT01523756|65448310|FG000|Test Period 2|Withdrawal by Subject|0|||
23466139|NCT01523756|65448311|FG001|Test Period 2|Withdrawal by Subject|1|||
23466140|NCT00774566|65451966|FG000|Overall Study|Protocol Violation|18|||
23466141|NCT00774566|65451967|FG001|Overall Study|Protocol Violation|15|||
23466142|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
23466143|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
23466144|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
23466145|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
23466146|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
23466147|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
23466148|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
23466149|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
23466150|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
23466151|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
23466152|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
23466153|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
23466154|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
23466155|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
23792091|NCT02212457|66620310|FG002|Overall Study|Other|2|||
23792092|NCT02212457|66620311|FG003|Overall Study|Other|1|||
23792093|NCT02212457|66620312|FG004|Overall Study|Other|0|||
23792094|NCT02212457|66620313|FG005|Overall Study|Other|1|||
23792095|NCT01073631|66620314|FG000|Overall Study|Death|82|||
23466156|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
23466157|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
23466158|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Reason missing|2|||
23466159|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Reason missing|0|||
23466160|NCT02640508|65451970|FG000|Overall Study|Death|19|||
23466161|NCT02640508|65451970|FG000|Overall Study|Withdrawal by Subject|8|||
23466162|NCT02640508|65451970|FG000|Overall Study|Physician Decision|1|||
23466163|NCT02640508|65451970|FG000|Overall Study|Lost to Follow-up|1|||
23466164|NCT00566696|65451971|FG000|Overall Study|Met Exclusion Criteria|2|||
23466165|NCT00566696|65451971|FG000|Overall Study|Muromonab not available|1|||
23466166|NCT00566696|65451971|FG000|Overall Study|Health Status Change|1|||
23466167|NCT00566696|65451971|FG000|Overall Study|Physician Decision|1|||
23466168|NCT00566696|65451971|FG000|Overall Study|Non-Patient Donors|37|||
23466169|NCT04421027|65451972|FG000|Treatment Period|Adverse Event|5|||
23466170|NCT04421027|65451973|FG001|Treatment Period|Adverse Event|3|||
23466171|NCT04421027|65451974|FG002|Treatment Period|Adverse Event|0|||
23466172|NCT04421027|65451975|FG003|Treatment Period|Adverse Event|0|||
23466173|NCT04421027|65451972|FG000|Treatment Period|Death|98|||
23466174|NCT04421027|65451973|FG001|Treatment Period|Death|61|||
23466175|NCT04421027|65451974|FG002|Treatment Period|Death|0|||
23466176|NCT04421027|65451975|FG003|Treatment Period|Death|0|||
23466177|NCT04421027|65451972|FG000|Treatment Period|Lost to Follow-up|22|||
23466178|NCT04421027|65451973|FG001|Treatment Period|Lost to Follow-up|20|||
23466179|NCT04421027|65451974|FG002|Treatment Period|Lost to Follow-up|0|||
23466180|NCT04421027|65451975|FG003|Treatment Period|Lost to Follow-up|0|||
23466181|NCT04421027|65451972|FG000|Treatment Period|Other-Unknown|15|||
23466182|NCT04421027|65451973|FG001|Treatment Period|Other-Unknown|9|||
23466183|NCT04421027|65451974|FG002|Treatment Period|Other-Unknown|0|||
23466184|NCT04421027|65451975|FG003|Treatment Period|Other-Unknown|0|||
23466185|NCT04421027|65451972|FG000|Treatment Period|Physician Decision|1|||
23466186|NCT04421027|65451973|FG001|Treatment Period|Physician Decision|1|||
23466187|NCT04421027|65451974|FG002|Treatment Period|Physician Decision|0|||
23466188|NCT04421027|65451975|FG003|Treatment Period|Physician Decision|0|||
23792096|NCT01073631|66620314|FG000|Overall Study|Adverse Event|24|||
23792097|NCT01073631|66620314|FG000|Overall Study|Other|63|||
23792098|NCT01899053|66620317|FG000|Overall Study|Progressive Disease|4|||
23792099|NCT01899053|66620318|FG001|Overall Study|Progressive Disease|0|||
23466189|NCT04421027|65451972|FG000|Treatment Period|Withdrawal by Subject|7|||
23466190|NCT04421027|65451973|FG001|Treatment Period|Withdrawal by Subject|12|||
23466191|NCT04421027|65451974|FG002|Treatment Period|Withdrawal by Subject|0|||
23466192|NCT04421027|65451975|FG003|Treatment Period|Withdrawal by Subject|0|||
23466193|NCT04421027|65451972|FG000|Treatment Period|Randomized Not Dosed|9|||
23466194|NCT04421027|65451973|FG001|Treatment Period|Randomized Not Dosed|14|||
23466195|NCT04421027|65451974|FG002|Treatment Period|Randomized Not Dosed|0|||
23466196|NCT04421027|65451975|FG003|Treatment Period|Randomized Not Dosed|0|||
23466197|NCT04421027|65451972|FG000|Follow-Up Period|Adverse Event|0|||
23466198|NCT04421027|65451973|FG001|Follow-Up Period|Adverse Event|0|||
23466199|NCT04421027|65451974|FG002|Follow-Up Period|Adverse Event|0|||
23466200|NCT04421027|65451975|FG003|Follow-Up Period|Adverse Event|3|||
23466201|NCT04421027|65451972|FG000|Follow-Up Period|Death|0|||
23466202|NCT04421027|65451973|FG001|Follow-Up Period|Death|0|||
23586013|NCT02013037|65872983|FG000|Overall Study|Transplanted without DSA|2|||
23586014|NCT00984282|65872984|FG000|Double Blind Treatment|Adverse Event|40|||
23586015|NCT00984282|65872985|FG001|Double Blind Treatment|Adverse Event|6|||
23586016|NCT00984282|65872984|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
23586017|NCT00984282|65872985|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
23466203|NCT04421027|65451974|FG002|Follow-Up Period|Death|16|||
23466204|NCT04421027|65451975|FG003|Follow-Up Period|Death|17|||
23466205|NCT04421027|65451972|FG000|Follow-Up Period|Lost to Follow-up|0|||
23466206|NCT04421027|65451973|FG001|Follow-Up Period|Lost to Follow-up|0|||
23466207|NCT04421027|65451974|FG002|Follow-Up Period|Lost to Follow-up|7|||
23466208|NCT04421027|65451975|FG003|Follow-Up Period|Lost to Follow-up|7|||
23466209|NCT04421027|65451972|FG000|Follow-Up Period|Protocol Deviation|0|||
23466210|NCT04421027|65451973|FG001|Follow-Up Period|Protocol Deviation|0|||
23466211|NCT04421027|65451974|FG002|Follow-Up Period|Protocol Deviation|1|||
23466212|NCT04421027|65451975|FG003|Follow-Up Period|Protocol Deviation|0|||
23466213|NCT04421027|65451972|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466214|NCT04421027|65451973|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466215|NCT04421027|65451974|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
23466216|NCT04421027|65451975|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466217|NCT04421027|65451972|FG000|Follow-Up Period|Left message, participant did not call back|0|||
23466218|NCT04421027|65451973|FG001|Follow-Up Period|Left message, participant did not call back|0|||
23466219|NCT04421027|65451974|FG002|Follow-Up Period|Left message, participant did not call back|0|||
23466220|NCT04421027|65451975|FG003|Follow-Up Period|Left message, participant did not call back|1|||
23466221|NCT04421027|65451972|FG000|Follow-Up Period|Participant died|0|||
23466222|NCT04421027|65451973|FG001|Follow-Up Period|Participant died|0|||
23466223|NCT04421027|65451974|FG002|Follow-Up Period|Participant died|0|||
23466224|NCT04421027|65451975|FG003|Follow-Up Period|Participant died|1|||
23466225|NCT04421027|65451972|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23792100|NCT01899053|66620319|FG002|Overall Study|Progressive Disease|3|||
23466226|NCT04421027|65451973|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23466227|NCT04421027|65451974|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23466228|NCT04421027|65451975|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
23466229|NCT01165216|65451976|FG000|Overall Study|Adverse Event|6|||
23466230|NCT01165216|65451977|FG001|Overall Study|Adverse Event|3|||
23466231|NCT01165216|65451976|FG000|Overall Study|Withdrawal by Subject|1|||
23466232|NCT01165216|65451977|FG001|Overall Study|Withdrawal by Subject|1|||
23466233|NCT01165216|65451976|FG000|Overall Study|Disease progression|1|||
23466234|NCT01165216|65451977|FG001|Overall Study|Disease progression|3|||
23466235|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
23466236|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
23466237|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Adverse Event|31|||
23466238|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Adverse Event|21|||
23466239|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
23466240|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
23466241|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
23466242|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
23466243|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
23466244|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
23466245|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
23466246|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
23466247|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Administrative problems|3|||
23466248|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Administrative problems|3|||
23466249|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Death|5|||
23466250|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Death|8|||
23466251|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Disease progression|139|||
23466252|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Disease progression|119|||
23466253|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
23466254|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
23466255|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
23466256|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
23466257|NCT00785785|65451978|FG000|Optional Extension Phase|Adverse Event|4|||
23466258|NCT00785785|65451979|FG001|Optional Extension Phase|Adverse Event|5|||
23586018|NCT00984282|65872984|FG000|Double Blind Treatment|Physician Decision|1|||
23586019|NCT00984282|65872985|FG001|Double Blind Treatment|Physician Decision|2|||
23586020|NCT00984282|65872984|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
23466259|NCT00785785|65451978|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
23466260|NCT00785785|65451979|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
23466261|NCT00785785|65451978|FG000|Optional Extension Phase|Lost to Follow-up|1|||
23466262|NCT00785785|65451979|FG001|Optional Extension Phase|Lost to Follow-up|0|||
23586021|NCT00984282|65872985|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
23466263|NCT00785785|65451978|FG000|Optional Extension Phase|Administrative problems|2|||
23466264|NCT00785785|65451979|FG001|Optional Extension Phase|Administrative problems|0|||
23466265|NCT00785785|65451978|FG000|Optional Extension Phase|Death|1|||
23466266|NCT00785785|65451979|FG001|Optional Extension Phase|Death|5|||
23466267|NCT00785785|65451978|FG000|Optional Extension Phase|Disease progression|22|||
23466268|NCT00785785|65451979|FG001|Optional Extension Phase|Disease progression|70|||
23466269|NCT00785785|65451978|FG000|Optional Extension Phase|Protocol deviation|0|||
23466270|NCT00785785|65451979|FG001|Optional Extension Phase|Protocol deviation|2|||
23466271|NCT00785785|65451978|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
23466272|NCT00785785|65451979|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
23466273|NCT02745119|65451980|FG000|Overall Study|Adverse Event|1|||
23466274|NCT02745119|65451981|FG001|Overall Study|Adverse Event|0|||
23466275|NCT02745119|65451982|FG002|Overall Study|Adverse Event|1|||
23466276|NCT02745119|65451983|FG003|Overall Study|Adverse Event|3|||
23466277|NCT02745119|65451980|FG000|Overall Study|Death|3|||
23466278|NCT02745119|65451981|FG001|Overall Study|Death|3|||
23466279|NCT02745119|65451982|FG002|Overall Study|Death|0|||
23586022|NCT00984282|65872984|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
23586023|NCT00984282|65872985|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
23586024|NCT00984282|65872984|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
23586025|NCT00984282|65872985|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
23466280|NCT02745119|65451983|FG003|Overall Study|Death|4|||
23466281|NCT02745119|65451980|FG000|Overall Study|Lost to Follow-up|0|||
23586026|NCT00984282|65872984|FG000|Double Blind Treatment|Lost to Follow-up|3|||
23586027|NCT00984282|65872985|FG001|Double Blind Treatment|Lost to Follow-up|0|||
23586028|NCT00984282|65872984|FG000|Double Blind Treatment|Death|8|||
23586029|NCT00984282|65872985|FG001|Double Blind Treatment|Death|4|||
23586030|NCT00984282|65872984|FG000|Double Blind Treatment|Not treated|0|||
23586031|NCT00984282|65872985|FG001|Double Blind Treatment|Not treated|1|||
23640284|NCT04811131|66067446|FG001|Overall Study|Withdrawal by Subject|1|||
23792101|NCT01899053|66620320|FG003|Overall Study|Progressive Disease|0|||
23792102|NCT01899053|66620321|FG004|Overall Study|Progressive Disease|3|||
23792103|NCT01899053|66620322|FG005|Overall Study|Progressive Disease|1|||
23792104|NCT01899053|66620323|FG006|Overall Study|Progressive Disease|1|||
23792105|NCT01899053|66620324|FG007|Overall Study|Progressive Disease|1|||
23792106|NCT01899053|66620325|FG008|Overall Study|Progressive Disease|4|||
23792107|NCT01899053|66620326|FG009|Overall Study|Progressive Disease|3|||
23792108|NCT01899053|66620327|FG010|Overall Study|Progressive Disease|12|||
23792109|NCT01899053|66620328|FG011|Overall Study|Progressive Disease|5|||
23792110|NCT01899053|66620329|FG012|Overall Study|Progressive Disease|8|||
23792111|NCT01899053|66620330|FG013|Overall Study|Progressive Disease|17|||
23792112|NCT01899053|66620317|FG000|Overall Study|Adverse Event|1|||
23792113|NCT01899053|66620318|FG001|Overall Study|Adverse Event|1|||
23792114|NCT01899053|66620319|FG002|Overall Study|Adverse Event|1|||
23792115|NCT01899053|66620320|FG003|Overall Study|Adverse Event|3|||
23792116|NCT01899053|66620321|FG004|Overall Study|Adverse Event|1|||
23792117|NCT01899053|66620322|FG005|Overall Study|Adverse Event|1|||
23792118|NCT01899053|66620323|FG006|Overall Study|Adverse Event|1|||
23792119|NCT01899053|66620324|FG007|Overall Study|Adverse Event|0|||
23792120|NCT01899053|66620325|FG008|Overall Study|Adverse Event|2|||
23792121|NCT01899053|66620326|FG009|Overall Study|Adverse Event|0|||
23466282|NCT02745119|65451981|FG001|Overall Study|Lost to Follow-up|0|||
23466283|NCT02745119|65451982|FG002|Overall Study|Lost to Follow-up|0|||
23466284|NCT02745119|65451983|FG003|Overall Study|Lost to Follow-up|1|||
23466285|NCT02745119|65451980|FG000|Overall Study|Protocol Deviation|0|||
23466286|NCT02745119|65451981|FG001|Overall Study|Protocol Deviation|0|||
23792122|NCT01899053|66620327|FG010|Overall Study|Adverse Event|3|||
23792123|NCT01899053|66620328|FG011|Overall Study|Adverse Event|1|||
23792124|NCT01899053|66620329|FG012|Overall Study|Adverse Event|2|||
23586032|NCT00984282|65872984|FG000|Double Blind Treatment|Switched to commercial drug|6|||
23586033|NCT00984282|65872985|FG001|Double Blind Treatment|Switched to commercial drug|1|||
23586034|NCT00984282|65872984|FG000|Double Blind Treatment|protocol driven decision point|1|||
23586035|NCT00984282|65872985|FG001|Double Blind Treatment|protocol driven decision point|1|||
23586036|NCT00984282|65872984|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
23586037|NCT00984282|65872985|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
23586038|NCT00984282|65872984|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
23586039|NCT00984282|65872985|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
23586040|NCT00984282|65872984|FG000|Open-label Treatment|Adverse Event|20|||
23586041|NCT00984282|65872985|FG001|Open-label Treatment|Adverse Event|30|||
23586042|NCT00984282|65872984|FG000|Open-label Treatment|Withdrawal by Subject|6|||
23586043|NCT00984282|65872985|FG001|Open-label Treatment|Withdrawal by Subject|21|||
23586044|NCT00984282|65872984|FG000|Open-label Treatment|Death|7|||
23586045|NCT00984282|65872985|FG001|Open-label Treatment|Death|15|||
23586046|NCT00984282|65872984|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
23586047|NCT00984282|65872985|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
23586048|NCT00984282|65872984|FG000|Open-label Treatment|Lost to Follow-up|1|||
23586049|NCT00984282|65872985|FG001|Open-label Treatment|Lost to Follow-up|1|||
23586050|NCT00984282|65872984|FG000|Open-label Treatment|Patient convenience|1|||
23586051|NCT00984282|65872985|FG001|Open-label Treatment|Patient convenience|0|||
23586052|NCT00984282|65872984|FG000|Open-label Treatment|Non-compliant with study medication|1|||
23586053|NCT00984282|65872985|FG001|Open-label Treatment|Non-compliant with study medication|0|||
23586054|NCT00984282|65872984|FG000|Open-label Treatment|Target lesion removed|0|||
23586055|NCT00984282|65872985|FG001|Open-label Treatment|Target lesion removed|1|||
23586056|NCT00984282|65872984|FG000|Open-label Treatment|Protocol driven decision point|1|||
23586057|NCT00984282|65872985|FG001|Open-label Treatment|Protocol driven decision point|1|||
23586058|NCT00984282|65872984|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
23586059|NCT00984282|65872985|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
23586060|NCT00984282|65872984|FG000|Open-label Treatment|Switched to commercial drug|6|||
23586061|NCT00984282|65872985|FG001|Open-label Treatment|Switched to commercial drug|7|||
23586062|NCT00984282|65872984|FG000|Open-label Treatment|Physician Decision|1|||
23586063|NCT00984282|65872985|FG001|Open-label Treatment|Physician Decision|0|||
23586064|NCT00984282|65872984|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
23586065|NCT00984282|65872985|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
23586066|NCT00984282|65872984|FG000|Long Term Follow-up|Death|27|||
23586067|NCT00984282|65872985|FG001|Long Term Follow-up|Death|68|||
23586068|NCT00984282|65872984|FG000|Long Term Follow-up|Lost to Follow-up|3|||
23586069|NCT00984282|65872985|FG001|Long Term Follow-up|Lost to Follow-up|6|||
23586070|NCT00984282|65872984|FG000|Long Term Follow-up|Protocol driven decision point|25|||
23586071|NCT00984282|65872985|FG001|Long Term Follow-up|Protocol driven decision point|26|||
23586072|NCT00984282|65872984|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
23586073|NCT00984282|65872985|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
23586074|NCT00984282|65872984|FG000|Long Term Follow-up|Switched to commercial drug|4|||
23586075|NCT00984282|65872985|FG001|Long Term Follow-up|Switched to commercial drug|2|||
23586076|NCT00984282|65872984|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
23640285|NCT04811131|66067447|FG002|Overall Study|Withdrawal by Subject|3|||
23640286|NCT04811131|66067448|FG003|Overall Study|Withdrawal by Subject|1|||
23792125|NCT01899053|66620330|FG013|Overall Study|Adverse Event|2|||
23792126|NCT01899053|66620317|FG000|Overall Study|Reason Not Specified|0|||
23792127|NCT01899053|66620318|FG001|Overall Study|Reason Not Specified|0|||
23792128|NCT01899053|66620319|FG002|Overall Study|Reason Not Specified|0|||
23792129|NCT01899053|66620320|FG003|Overall Study|Reason Not Specified|0|||
23792130|NCT01899053|66620321|FG004|Overall Study|Reason Not Specified|0|||
23792131|NCT01899053|66620322|FG005|Overall Study|Reason Not Specified|0|||
23792132|NCT01899053|66620323|FG006|Overall Study|Reason Not Specified|1|||
23640287|NCT05593445|66067449|FG000|12-Week DBVC Period|Adverse Event|1|||
23586077|NCT00984282|65872985|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
23586078|NCT00941031|65872986|FG000|Induction Period|Lack of Efficacy|2|||
23640288|NCT05593445|66067450|FG001|12-Week DBVC Period|Adverse Event|0|||
23792133|NCT01899053|66620324|FG007|Overall Study|Reason Not Specified|0|||
23792134|NCT01899053|66620325|FG008|Overall Study|Reason Not Specified|0|||
23351041|NCT04093492|65029455|FG002|34 Weeks GA|Delivered before assessment|0|||
23351042|NCT04093492|65029456|FG003|34 Weeks GA|Delivered before assessment|0|||
23351043|NCT04093492|65029453|FG000|34 Weeks GA|No response|0|||
23351044|NCT04093492|65029454|FG001|34 Weeks GA|No response|7|||
23351045|NCT04093492|65029455|FG002|34 Weeks GA|No response|5|||
23351046|NCT04093492|65029456|FG003|34 Weeks GA|No response|3|||
23351047|NCT04093492|65029453|FG000|34 Weeks GA|Lost to Follow-up|0|||
23351048|NCT04093492|65029454|FG001|34 Weeks GA|Lost to Follow-up|1|||
23351049|NCT04093492|65029455|FG002|34 Weeks GA|Lost to Follow-up|0|||
23351050|NCT04093492|65029456|FG003|34 Weeks GA|Lost to Follow-up|0|||
23351051|NCT02906033|65029457|FG000|Baseline|Protocol Violation|37|||
23351052|NCT02906033|65029458|FG001|Baseline|Protocol Violation|33|||
23351053|NCT02906033|65029457|FG000|Follow-up|Lost to Follow-up|46|||
23351054|NCT02906033|65029458|FG001|Follow-up|Lost to Follow-up|62|||
23351055|NCT04643964|65029461|FG000|Overall Study|Lost to Follow-up|55|||
23351056|NCT04643964|65029462|FG001|Overall Study|Lost to Follow-up|59|||
23351057|NCT04643964|65029463|FG002|Overall Study|Lost to Follow-up|54|||
23351058|NCT04643964|65029464|FG003|Overall Study|Lost to Follow-up|129|||
23351059|NCT04643964|65029465|FG004|Overall Study|Lost to Follow-up|48|||
23351060|NCT04643964|65029461|FG000|Overall Study|Failed attention check|1|||
23351061|NCT04643964|65029462|FG001|Overall Study|Failed attention check|8|||
23351062|NCT04643964|65029463|FG002|Overall Study|Failed attention check|2|||
23351063|NCT04643964|65029464|FG003|Overall Study|Failed attention check|14|||
23351064|NCT04643964|65029465|FG004|Overall Study|Failed attention check|11|||
23351065|NCT04401202|65029466|FG000|Overall Study|Lost to Follow-up|2|||
23351066|NCT04401202|65029467|FG001|Overall Study|Lost to Follow-up|2|||
23351067|NCT04401202|65029466|FG000|Overall Study|Adverse Event|0|||
23351068|NCT04401202|65029467|FG001|Overall Study|Adverse Event|1|||
23351069|NCT04401202|65029466|FG000|Overall Study|Hospitalized|4|||
23351070|NCT04401202|65029467|FG001|Overall Study|Hospitalized|1|||
23351071|NCT00308750|65029468|FG000|Overall Study|Adverse Event|9|||
23351072|NCT00308750|65029469|FG001|Overall Study|Adverse Event|9|||
23351073|NCT00308750|65029470|FG002|Overall Study|Adverse Event|13|||
23351074|NCT00308750|65029468|FG000|Overall Study|Withdrawal by Subject|6|||
23351075|NCT00308750|65029469|FG001|Overall Study|Withdrawal by Subject|2|||
23351076|NCT00308750|65029470|FG002|Overall Study|Withdrawal by Subject|3|||
23351077|NCT00308750|65029468|FG000|Overall Study|Physician Decision|3|||
23351078|NCT00308750|65029469|FG001|Overall Study|Physician Decision|4|||
23351079|NCT00308750|65029470|FG002|Overall Study|Physician Decision|3|||
23351080|NCT00308750|65029468|FG000|Overall Study|Sponsor Decision|1|||
23586079|NCT00941031|65872987|FG001|Induction Period|Lack of Efficacy|1|||
23586080|NCT00941031|65872988|FG002|Induction Period|Lack of Efficacy|0|||
23586081|NCT00941031|65872989|FG003|Induction Period|Lack of Efficacy|5|||
23586082|NCT00941031|65872990|FG004|Induction Period|Lack of Efficacy|0|||
23586083|NCT00941031|65872991|FG005|Induction Period|Lack of Efficacy|0|||
23586084|NCT00941031|65872992|FG006|Induction Period|Lack of Efficacy|0|||
23586085|NCT00941031|65872986|FG000|Induction Period|Withdrawal by Subject|1|||
23586086|NCT00941031|65872987|FG001|Induction Period|Withdrawal by Subject|2|||
23586087|NCT00941031|65872988|FG002|Induction Period|Withdrawal by Subject|2|||
23586088|NCT00941031|65872989|FG003|Induction Period|Withdrawal by Subject|2|||
23586089|NCT00941031|65872990|FG004|Induction Period|Withdrawal by Subject|0|||
23351081|NCT00308750|65029469|FG001|Overall Study|Sponsor Decision|0|||
23351082|NCT00308750|65029470|FG002|Overall Study|Sponsor Decision|0|||
23351083|NCT00308750|65029468|FG000|Overall Study|Disease Progression|47|||
23586090|NCT00941031|65872991|FG005|Induction Period|Withdrawal by Subject|0|||
23640289|NCT05593445|66067451|FG002|12-Week DBVC Period|Adverse Event|0|||
23351084|NCT00308750|65029469|FG001|Overall Study|Disease Progression|24|||
23351085|NCT00308750|65029470|FG002|Overall Study|Disease Progression|28|||
23351086|NCT00308750|65029468|FG000|Overall Study|Unrelated Complication|3|||
23351087|NCT00308750|65029469|FG001|Overall Study|Unrelated Complication|0|||
23351088|NCT00308750|65029470|FG002|Overall Study|Unrelated Complication|1|||
23351089|NCT00308750|65029468|FG000|Overall Study|Death|1|||
23586091|NCT00941031|65872992|FG006|Induction Period|Withdrawal by Subject|0|||
23586092|NCT00941031|65872986|FG000|Induction Period|Adminstative Problems|1|||
23586093|NCT00941031|65872987|FG001|Induction Period|Adminstative Problems|1|||
23586094|NCT00941031|65872988|FG002|Induction Period|Adminstative Problems|1|||
23586095|NCT00941031|65872989|FG003|Induction Period|Adminstative Problems|0|||
23586096|NCT00941031|65872990|FG004|Induction Period|Adminstative Problems|0|||
23586097|NCT00941031|65872991|FG005|Induction Period|Adminstative Problems|0|||
23586098|NCT00941031|65872992|FG006|Induction Period|Adminstative Problems|0|||
23586099|NCT00941031|65872986|FG000|Induction Period|Adverse Event|1|||
23586100|NCT00941031|65872987|FG001|Induction Period|Adverse Event|0|||
23586101|NCT00941031|65872988|FG002|Induction Period|Adverse Event|3|||
23586102|NCT00941031|65872989|FG003|Induction Period|Adverse Event|2|||
23586103|NCT00941031|65872990|FG004|Induction Period|Adverse Event|0|||
23586104|NCT00941031|65872991|FG005|Induction Period|Adverse Event|0|||
23586105|NCT00941031|65872992|FG006|Induction Period|Adverse Event|0|||
23586106|NCT00941031|65872986|FG000|Maintenance Period|Withdrawal by Subject|0|||
23586107|NCT00941031|65872987|FG001|Maintenance Period|Withdrawal by Subject|0|||
23586108|NCT00941031|65872988|FG002|Maintenance Period|Withdrawal by Subject|0|||
23586109|NCT00941031|65872989|FG003|Maintenance Period|Withdrawal by Subject|0|||
23640290|NCT05593445|66067452|FG003|12-Week DBVC Period|Adverse Event|0|||
23640291|NCT05593445|66067449|FG000|12-Week DBVC Period|Physician Decision|0|||
23640292|NCT05593445|66067450|FG001|12-Week DBVC Period|Physician Decision|1|||
23792135|NCT01899053|66620326|FG009|Overall Study|Reason Not Specified|0|||
23792136|NCT01899053|66620327|FG010|Overall Study|Reason Not Specified|0|||
23792137|NCT01899053|66620328|FG011|Overall Study|Reason Not Specified|0|||
23792138|NCT01899053|66620329|FG012|Overall Study|Reason Not Specified|1|||
23792139|NCT01899053|66620330|FG013|Overall Study|Reason Not Specified|0|||
23792140|NCT01899053|66620317|FG000|Overall Study|Withdrawal by Subject|1|||
23792141|NCT01899053|66620318|FG001|Overall Study|Withdrawal by Subject|1|||
23792142|NCT01899053|66620319|FG002|Overall Study|Withdrawal by Subject|2|||
23792143|NCT01899053|66620320|FG003|Overall Study|Withdrawal by Subject|0|||
23792144|NCT01899053|66620321|FG004|Overall Study|Withdrawal by Subject|2|||
23792145|NCT01899053|66620322|FG005|Overall Study|Withdrawal by Subject|0|||
23792146|NCT01899053|66620323|FG006|Overall Study|Withdrawal by Subject|0|||
23792147|NCT01899053|66620324|FG007|Overall Study|Withdrawal by Subject|1|||
23792148|NCT01899053|66620325|FG008|Overall Study|Withdrawal by Subject|0|||
23792149|NCT01899053|66620326|FG009|Overall Study|Withdrawal by Subject|0|||
23586110|NCT00941031|65872990|FG004|Maintenance Period|Withdrawal by Subject|6|||
23586111|NCT00941031|65872991|FG005|Maintenance Period|Withdrawal by Subject|2|||
23586112|NCT00941031|65872992|FG006|Maintenance Period|Withdrawal by Subject|13|||
23586113|NCT00941031|65872986|FG000|Maintenance Period|Administrative Problems|0|||
23640293|NCT05593445|66067451|FG002|12-Week DBVC Period|Physician Decision|0|||
23351090|NCT00308750|65029469|FG001|Overall Study|Death|0|||
23351091|NCT00308750|65029470|FG002|Overall Study|Death|1|||
23351092|NCT00308750|65029468|FG000|Overall Study|Protocol Violation|1|||
23351093|NCT00308750|65029469|FG001|Overall Study|Protocol Violation|0|||
23351094|NCT00308750|65029470|FG002|Overall Study|Protocol Violation|0|||
23351095|NCT00308750|65029468|FG000|Overall Study|New Primary Disease Identified|1|||
23351096|NCT00308750|65029469|FG001|Overall Study|New Primary Disease Identified|1|||
23351097|NCT00308750|65029470|FG002|Overall Study|New Primary Disease Identified|0|||
23351098|NCT00312572|65029471|FG000|Overall Study|Adverse Event|10|||
23351099|NCT00312572|65029472|FG001|Overall Study|Adverse Event|16|||
23351100|NCT00312572|65029471|FG000|Overall Study|Lost to Follow-up|1|||
23792150|NCT01899053|66620327|FG010|Overall Study|Withdrawal by Subject|0|||
23792151|NCT01899053|66620328|FG011|Overall Study|Withdrawal by Subject|0|||
23792152|NCT01899053|66620329|FG012|Overall Study|Withdrawal by Subject|1|||
23792153|NCT01899053|66620330|FG013|Overall Study|Withdrawal by Subject|1|||
23351101|NCT00312572|65029472|FG001|Overall Study|Lost to Follow-up|1|||
23351102|NCT00312572|65029471|FG000|Overall Study|Administrative|4|||
23351103|NCT00312572|65029472|FG001|Overall Study|Administrative|2|||
23351104|NCT00312572|65029471|FG000|Overall Study|Lack of Efficacy|1|||
23351105|NCT00312572|65029472|FG001|Overall Study|Lack of Efficacy|2|||
23351106|NCT00492232|65029475|FG000|Placebo Run-in|Adverse Event|0|||
23351107|NCT00492232|65029476|FG001|Placebo Run-in|Adverse Event|2|||
23351108|NCT00492232|65029475|FG000|Placebo Run-in|Protocol Violation|0|||
23351109|NCT00492232|65029476|FG001|Placebo Run-in|Protocol Violation|3|||
23351110|NCT00492232|65029475|FG000|Placebo Run-in|Lost to Follow-up|0|||
23351111|NCT00492232|65029476|FG001|Placebo Run-in|Lost to Follow-up|3|||
23351112|NCT00492232|65029475|FG000|Placebo Run-in|Withdrawal by Subject|0|||
23351113|NCT00492232|65029476|FG001|Placebo Run-in|Withdrawal by Subject|8|||
23351114|NCT00492232|65029475|FG000|Placebo Run-in|Pregnancy|0|||
23351115|NCT00492232|65029476|FG001|Placebo Run-in|Pregnancy|1|||
23351116|NCT00492232|65029475|FG000|Placebo Run-in|Entrance criteria not met|0|||
23351117|NCT00492232|65029476|FG001|Placebo Run-in|Entrance criteria not met|45|||
23351118|NCT00492232|65029475|FG000|Placebo Run-in|Other|0|||
23351119|NCT00492232|65029476|FG001|Placebo Run-in|Other|6|||
23351120|NCT00492232|65029475|FG000|Placebo Run-in|Missing|0|||
23351121|NCT00492232|65029476|FG001|Placebo Run-in|Missing|2|||
23351122|NCT00492232|65029475|FG000|Double-Blind Treatment|Adverse Event|1|||
23351123|NCT00492232|65029476|FG001|Double-Blind Treatment|Adverse Event|2|||
23351124|NCT00492232|65029475|FG000|Double-Blind Treatment|Protocol Violation|3|||
23351125|NCT00492232|65029476|FG001|Double-Blind Treatment|Protocol Violation|7|||
23351126|NCT00492232|65029475|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
23351127|NCT00492232|65029476|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
23351128|NCT00492232|65029475|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
23351129|NCT00492232|65029476|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
23351130|NCT00492232|65029475|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
23351131|NCT00492232|65029476|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
23351132|NCT00492232|65029475|FG000|Double-Blind Treatment|Other|6|||
23351133|NCT00492232|65029476|FG001|Double-Blind Treatment|Other|5|||
23351134|NCT00492232|65029475|FG000|Double-Blind Treatment|Randomized not treated|1|||
23351135|NCT00492232|65029476|FG001|Double-Blind Treatment|Randomized not treated|0|||
23351136|NCT00492232|65029475|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
23351137|NCT00492232|65029476|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23351138|NCT01267201|65029477|FG000|First Intervention Period|Withdrawal by Subject|1|||
23351139|NCT01267201|65029478|FG001|First Intervention Period|Withdrawal by Subject|0|||
23792154|NCT01899053|66620317|FG000|Overall Study|Protocol Violation|0|||
23792155|NCT01899053|66620318|FG001|Overall Study|Protocol Violation|0|||
23792156|NCT01899053|66620319|FG002|Overall Study|Protocol Violation|1|||
23792157|NCT01899053|66620320|FG003|Overall Study|Protocol Violation|0|||
23792158|NCT01899053|66620321|FG004|Overall Study|Protocol Violation|0|||
23792159|NCT01899053|66620322|FG005|Overall Study|Protocol Violation|0|||
23792160|NCT01899053|66620323|FG006|Overall Study|Protocol Violation|0|||
23792161|NCT01899053|66620324|FG007|Overall Study|Protocol Violation|0|||
23792162|NCT01899053|66620325|FG008|Overall Study|Protocol Violation|0|||
23792163|NCT01899053|66620326|FG009|Overall Study|Protocol Violation|0|||
23792164|NCT01899053|66620327|FG010|Overall Study|Protocol Violation|0|||
23351140|NCT01267201|65029479|FG002|First Intervention Period|Withdrawal by Subject|0|||
23351141|NCT01267201|65029480|FG003|First Intervention Period|Withdrawal by Subject|0|||
23351142|NCT01267201|65029481|FG004|First Intervention Period|Withdrawal by Subject|0|||
23351143|NCT01267201|65029482|FG005|First Intervention Period|Withdrawal by Subject|0|||
23351144|NCT01267201|65029477|FG000|Second Intervention Period|Withdrawal by Subject|0|||
23351145|NCT01267201|65029478|FG001|Second Intervention Period|Withdrawal by Subject|1|||
23351146|NCT01267201|65029479|FG002|Second Intervention Period|Withdrawal by Subject|0|||
23351147|NCT01267201|65029480|FG003|Second Intervention Period|Withdrawal by Subject|0|||
23792165|NCT01899053|66620328|FG011|Overall Study|Protocol Violation|0|||
23792166|NCT01899053|66620329|FG012|Overall Study|Protocol Violation|0|||
23792167|NCT01899053|66620330|FG013|Overall Study|Protocol Violation|0|||
23792168|NCT01899053|66620317|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23792169|NCT01899053|66620318|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
23792170|NCT01899053|66620319|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23586114|NCT00941031|65872987|FG001|Maintenance Period|Administrative Problems|0|||
23586115|NCT00941031|65872988|FG002|Maintenance Period|Administrative Problems|0|||
23586116|NCT00941031|65872989|FG003|Maintenance Period|Administrative Problems|0|||
23586117|NCT00941031|65872990|FG004|Maintenance Period|Administrative Problems|1|||
23586118|NCT00941031|65872991|FG005|Maintenance Period|Administrative Problems|0|||
23586119|NCT00941031|65872992|FG006|Maintenance Period|Administrative Problems|1|||
23586120|NCT00941031|65872986|FG000|Maintenance Period|Protocol Violation|0|||
23586121|NCT00941031|65872987|FG001|Maintenance Period|Protocol Violation|0|||
23640294|NCT05593445|66067452|FG003|12-Week DBVC Period|Physician Decision|0|||
23640295|NCT05593445|66067449|FG000|12-Week DBVC Period|Protocol Violation|0|||
23792171|NCT01899053|66620320|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792172|NCT01899053|66620321|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792173|NCT01899053|66620322|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792174|NCT01899053|66620323|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792175|NCT01899053|66620324|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792176|NCT01899053|66620325|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792177|NCT01899053|66620326|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792178|NCT01899053|66620327|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
23792179|NCT01899053|66620328|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792180|NCT01899053|66620329|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792181|NCT01899053|66620330|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
23792182|NCT01899053|66620317|FG000|Overall Study|Symptomatic Deterioration|0|||
23792183|NCT01899053|66620318|FG001|Overall Study|Symptomatic Deterioration|0|||
23792184|NCT01899053|66620319|FG002|Overall Study|Symptomatic Deterioration|0|||
23792185|NCT01899053|66620320|FG003|Overall Study|Symptomatic Deterioration|0|||
23792186|NCT01899053|66620321|FG004|Overall Study|Symptomatic Deterioration|0|||
23792187|NCT01899053|66620322|FG005|Overall Study|Symptomatic Deterioration|1|||
23792188|NCT01899053|66620323|FG006|Overall Study|Symptomatic Deterioration|0|||
23792189|NCT01899053|66620324|FG007|Overall Study|Symptomatic Deterioration|1|||
23792190|NCT01899053|66620325|FG008|Overall Study|Symptomatic Deterioration|0|||
23792191|NCT01899053|66620326|FG009|Overall Study|Symptomatic Deterioration|0|||
23792192|NCT01899053|66620327|FG010|Overall Study|Symptomatic Deterioration|0|||
23792193|NCT01899053|66620328|FG011|Overall Study|Symptomatic Deterioration|1|||
23792194|NCT01899053|66620329|FG012|Overall Study|Symptomatic Deterioration|2|||
23792195|NCT01899053|66620330|FG013|Overall Study|Symptomatic Deterioration|0|||
23792196|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
23792197|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
23792198|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
23792199|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
23792200|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23792201|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23792202|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
23792203|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
23792204|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
23792205|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
23792206|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
23792207|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
23792208|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
23586122|NCT00941031|65872988|FG002|Maintenance Period|Protocol Violation|0|||
23792209|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
23792210|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
23792211|NCT02250651|66620331|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
23351148|NCT01267201|65029481|FG004|Second Intervention Period|Withdrawal by Subject|0|||
23351149|NCT01267201|65029482|FG005|Second Intervention Period|Withdrawal by Subject|0|||
23351150|NCT02696434|65029483|FG000|Overall Study|Adverse Event|3|||
23351151|NCT02696434|65029484|FG001|Overall Study|Adverse Event|1|||
23351152|NCT02696434|65029483|FG000|Overall Study|Lost to Follow-up|5|||
23351153|NCT02696434|65029484|FG001|Overall Study|Lost to Follow-up|4|||
23351154|NCT02696434|65029483|FG000|Overall Study|Withdrawal by Subject|14|||
23351155|NCT02696434|65029484|FG001|Overall Study|Withdrawal by Subject|12|||
23351156|NCT02696434|65029483|FG000|Overall Study|Physician Decision|0|||
23351157|NCT02696434|65029484|FG001|Overall Study|Physician Decision|1|||
23351158|NCT03597022|65029487|FG000|Overall Study|Premature termination of the study|7|||
23351159|NCT03597022|65029488|FG001|Overall Study|Premature termination of the study|7|||
23351160|NCT03597022|65029489|FG002|Overall Study|Premature termination of the study|8|||
23351161|NCT03597022|65029487|FG000|Overall Study|Serious adverse event|1|||
23351162|NCT03597022|65029488|FG001|Overall Study|Serious adverse event|1|||
23351163|NCT03597022|65029489|FG002|Overall Study|Serious adverse event|0|||
23351164|NCT02494401|65029490|FG000|Overall Study|Lost to Follow-up|22|||
23351165|NCT02494401|65029491|FG001|Overall Study|Lost to Follow-up|25|||
23351166|NCT02494401|65029490|FG000|Overall Study|Withdrawal by Subject|3|||
23351167|NCT02494401|65029491|FG001|Overall Study|Withdrawal by Subject|2|||
23351168|NCT02093390|65029492|FG000|Overall Study|Withdrawal by Subject|0|||
23351169|NCT02093390|65029493|FG001|Overall Study|Withdrawal by Subject|1|||
23351170|NCT02045732|65029494|FG000|Overall Study|At the discretion of the investigator|1|||
23351171|NCT02045732|65029495|FG001|Overall Study|At the discretion of the investigator|1|||
23351172|NCT00636636|65029496|FG000|Overall Study|Other reason|4|||
23351173|NCT00636636|65029497|FG001|Overall Study|Other reason|6|||
23351174|NCT00636636|65029496|FG000|Overall Study|Adverse Event|19|||
23351175|NCT00636636|65029497|FG001|Overall Study|Adverse Event|8|||
23351176|NCT00636636|65029496|FG000|Overall Study|Lack of Efficacy|7|||
23351177|NCT00636636|65029497|FG001|Overall Study|Lack of Efficacy|12|||
23351178|NCT00636636|65029496|FG000|Overall Study|Protocol Violation|2|||
23351179|NCT00636636|65029497|FG001|Overall Study|Protocol Violation|2|||
23351180|NCT00636636|65029496|FG000|Overall Study|Lost to Follow-up|0|||
23351181|NCT00636636|65029497|FG001|Overall Study|Lost to Follow-up|1|||
23351182|NCT00636636|65029496|FG000|Overall Study|Death|0|||
23351183|NCT00636636|65029497|FG001|Overall Study|Death|1|||
23351184|NCT00636636|65029496|FG000|Overall Study|Withdrawal by Subject|4|||
23351185|NCT00636636|65029497|FG001|Overall Study|Withdrawal by Subject|9|||
23351186|NCT01801280|65029500|FG000|Period 1|Withdrawal by Subject|0|||
23351187|NCT01801280|65029501|FG001|Period 1|Withdrawal by Subject|1|||
23351188|NCT01801280|65029502|FG002|Period 1|Withdrawal by Subject|0|||
23351189|NCT01801280|65029503|FG003|Period 1|Withdrawal by Subject|0|||
23351190|NCT01801280|65029500|FG000|Period 2|Withdrawal by Subject|1|||
23351191|NCT01801280|65029501|FG001|Period 2|Withdrawal by Subject|0|||
23351192|NCT01801280|65029502|FG002|Period 2|Withdrawal by Subject|0|||
23351193|NCT01801280|65029503|FG003|Period 2|Withdrawal by Subject|0|||
23351194|NCT01801280|65029500|FG000|Period 4|Protocol Violation|0|||
23351195|NCT01801280|65029501|FG001|Period 4|Protocol Violation|0|||
23351196|NCT01801280|65029502|FG002|Period 4|Protocol Violation|1|||
23351197|NCT01801280|65029503|FG003|Period 4|Protocol Violation|0|||
23351198|NCT01124292|65029505|FG000|Overall Study|Lost to Follow-up|2|||
23351199|NCT01124292|65029506|FG001|Overall Study|Lost to Follow-up|4|||
23351200|NCT01124292|65029507|FG002|Overall Study|Lost to Follow-up|3|||
23351201|NCT01124292|65029505|FG000|Overall Study|Physician Decision|0|||
23351202|NCT01124292|65029506|FG001|Overall Study|Physician Decision|3|||
23351203|NCT01124292|65029507|FG002|Overall Study|Physician Decision|2|||
23351204|NCT01124292|65029505|FG000|Overall Study|Withdrawal by Subject|0|||
23351205|NCT01124292|65029506|FG001|Overall Study|Withdrawal by Subject|6|||
23351206|NCT01124292|65029507|FG002|Overall Study|Withdrawal by Subject|2|||
23351207|NCT01124292|65029505|FG000|Overall Study|medical issue unrelated to the study|0|||
23351208|NCT01124292|65029506|FG001|Overall Study|medical issue unrelated to the study|0|||
23351209|NCT01124292|65029507|FG002|Overall Study|medical issue unrelated to the study|2|||
23351210|NCT01124292|65029505|FG000|Overall Study|piercing track closed|0|||
23351211|NCT01124292|65029506|FG001|Overall Study|piercing track closed|2|||
23351212|NCT01124292|65029507|FG002|Overall Study|piercing track closed|1|||
23351213|NCT00568334|65029510|FG000|Overall Study|Withdrawal by Subject|0|||
23351214|NCT00568334|65029511|FG001|Overall Study|Withdrawal by Subject|1|||
23351215|NCT00568334|65029510|FG000|Overall Study|Lost to Follow-up|1|||
23351216|NCT00568334|65029511|FG001|Overall Study|Lost to Follow-up|0|||
23351217|NCT00422292|65029512|FG000|Overall Study|Serious adverse events|1|||
23351218|NCT00422292|65029513|FG001|Overall Study|Serious adverse events|4|||
23351219|NCT00422292|65029514|FG002|Overall Study|Serious adverse events|0|||
23351220|NCT00422292|65029515|FG003|Overall Study|Serious adverse events|0|||
23351221|NCT00422292|65029512|FG000|Overall Study|Adverse Event|1|||
23351222|NCT00422292|65029513|FG001|Overall Study|Adverse Event|0|||
23351223|NCT00422292|65029514|FG002|Overall Study|Adverse Event|1|||
23351224|NCT00422292|65029515|FG003|Overall Study|Adverse Event|0|||
23351225|NCT00422292|65029512|FG000|Overall Study|Protocol Violation|4|||
23351226|NCT00422292|65029513|FG001|Overall Study|Protocol Violation|25|||
23351227|NCT00422292|65029514|FG002|Overall Study|Protocol Violation|8|||
23351228|NCT00422292|65029515|FG003|Overall Study|Protocol Violation|5|||
23351229|NCT00422292|65029512|FG000|Overall Study|Lost to Follow-up|6|||
23351230|NCT00422292|65029513|FG001|Overall Study|Lost to Follow-up|12|||
23351231|NCT00422292|65029514|FG002|Overall Study|Lost to Follow-up|6|||
23351232|NCT00422292|65029515|FG003|Overall Study|Lost to Follow-up|6|||
23351233|NCT00422292|65029512|FG000|Overall Study|Withdrawal by Subject|6|||
23351234|NCT00422292|65029513|FG001|Overall Study|Withdrawal by Subject|25|||
23351235|NCT00422292|65029514|FG002|Overall Study|Withdrawal by Subject|7|||
23351236|NCT00422292|65029515|FG003|Overall Study|Withdrawal by Subject|13|||
23351237|NCT01969084|65029524|FG000|Overall Study|Adverse Event|0|||
23351238|NCT01969084|65029525|FG001|Overall Study|Adverse Event|1|||
23351239|NCT00783224|65029529|FG000|Overall Study|Adverse Event|0|||
23351240|NCT00783224|65029530|FG001|Overall Study|Adverse Event|0|||
23586123|NCT00941031|65872989|FG003|Maintenance Period|Protocol Violation|0|||
23586124|NCT00941031|65872990|FG004|Maintenance Period|Protocol Violation|0|||
23586125|NCT00941031|65872991|FG005|Maintenance Period|Protocol Violation|0|||
23586126|NCT00941031|65872992|FG006|Maintenance Period|Protocol Violation|1|||
23351241|NCT00783224|65029531|FG002|Overall Study|Adverse Event|1|||
23351242|NCT00783224|65029532|FG003|Overall Study|Adverse Event|0|||
23351243|NCT00783224|65029529|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
23351244|NCT00783224|65029530|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
23351245|NCT00783224|65029531|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
23351246|NCT00783224|65029532|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
23351247|NCT00783224|65029529|FG000|Overall Study|Inappropriate as a study subject|0|||
23351248|NCT00783224|65029530|FG001|Overall Study|Inappropriate as a study subject|0|||
23351249|NCT00783224|65029531|FG002|Overall Study|Inappropriate as a study subject|0|||
23351250|NCT00783224|65029532|FG003|Overall Study|Inappropriate as a study subject|1|||
23351251|NCT00427999|65029538|FG000|Overall Study|Adverse Event|6|||
23351252|NCT00427999|65029538|FG000|Overall Study|Abnormal laboratory values|1|||
23351253|NCT00427999|65029538|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
23351254|NCT00427999|65029538|FG000|Overall Study|Protocol Violation|2|||
23351255|NCT00427999|65029538|FG000|Overall Study|Withdrawal by Subject|9|||
23351256|NCT00427999|65029538|FG000|Overall Study|Death|1|||
23351257|NCT01632150|65029541|FG000|Overall Study|Disease progression|27|||
23351258|NCT01632150|65029541|FG000|Overall Study|Study drug toxicity|1|||
23351259|NCT01632150|65029541|FG000|Overall Study|Unrelated adverse event|7|||
23351260|NCT01632150|65029541|FG000|Overall Study|Withdrawal by Subject|2|||
23351261|NCT01632150|65029541|FG000|Overall Study|Patient underwent autologous transplant|1|||
23351262|NCT01632150|65029541|FG000|Overall Study|Moved to compassionate program|2|||
23586127|NCT00941031|65872986|FG000|Maintenance Period|Adverse Event|0|||
23586128|NCT00941031|65872987|FG001|Maintenance Period|Adverse Event|0|||
23586129|NCT00941031|65872988|FG002|Maintenance Period|Adverse Event|0|||
23586130|NCT00941031|65872989|FG003|Maintenance Period|Adverse Event|0|||
23586131|NCT00941031|65872990|FG004|Maintenance Period|Adverse Event|0|||
23586132|NCT00941031|65872991|FG005|Maintenance Period|Adverse Event|2|||
23586133|NCT00941031|65872992|FG006|Maintenance Period|Adverse Event|8|||
23586134|NCT00941031|65872986|FG000|Maintenance Period|Lost to Follow-up|0|||
23586135|NCT00941031|65872987|FG001|Maintenance Period|Lost to Follow-up|0|||
23586136|NCT00941031|65872988|FG002|Maintenance Period|Lost to Follow-up|0|||
23586137|NCT00941031|65872989|FG003|Maintenance Period|Lost to Follow-up|0|||
23586138|NCT00941031|65872990|FG004|Maintenance Period|Lost to Follow-up|2|||
23351263|NCT01389258|65029542|FG000|Overall Study|Lost to Follow-up|5|||
23351264|NCT00388297|65029543|FG000|Overall Study|Lost to Follow-up|16|||
23351265|NCT00388297|65029544|FG001|Overall Study|Lost to Follow-up|12|||
23351266|NCT00388297|65029545|FG002|Overall Study|Lost to Follow-up|11|||
23351267|NCT00388297|65029546|FG003|Overall Study|Lost to Follow-up|8|||
23466287|NCT02745119|65451982|FG002|Overall Study|Protocol Deviation|0|||
23586139|NCT00941031|65872991|FG005|Maintenance Period|Lost to Follow-up|2|||
23586140|NCT00941031|65872992|FG006|Maintenance Period|Lost to Follow-up|7|||
23586141|NCT00941031|65872986|FG000|Maintenance Period|Lack of Efficacy|0|||
23586142|NCT00941031|65872987|FG001|Maintenance Period|Lack of Efficacy|0|||
23586143|NCT00941031|65872988|FG002|Maintenance Period|Lack of Efficacy|0|||
23586144|NCT00941031|65872989|FG003|Maintenance Period|Lack of Efficacy|0|||
23586145|NCT00941031|65872990|FG004|Maintenance Period|Lack of Efficacy|0|||
23586146|NCT00941031|65872991|FG005|Maintenance Period|Lack of Efficacy|0|||
23586147|NCT00941031|65872992|FG006|Maintenance Period|Lack of Efficacy|13|||
23586148|NCT01670019|65872998|FG000|Overall Study|Adverse Event|3|||
23586149|NCT01670019|65872999|FG001|Overall Study|Adverse Event|0|||
23586150|NCT01670019|65872998|FG000|Overall Study|Withdrawal by Subject|6|||
23586151|NCT01670019|65872999|FG001|Overall Study|Withdrawal by Subject|0|||
23586152|NCT01720446|65873000|FG000|Overall Study|Lost to Follow-up|12|||
23586153|NCT01720446|65873001|FG001|Overall Study|Lost to Follow-up|6|||
23586154|NCT01720446|65873002|FG002|Overall Study|Lost to Follow-up|16|||
23586155|NCT01720446|65873003|FG003|Overall Study|Lost to Follow-up|16|||
23586156|NCT01720446|65873000|FG000|Overall Study|Withdrawal by Subject|2|||
23586157|NCT01720446|65873001|FG001|Overall Study|Withdrawal by Subject|5|||
23586158|NCT01720446|65873002|FG002|Overall Study|Withdrawal by Subject|4|||
23351268|NCT04679051|65029551|FG000|Overall Study|felt tired after restricted time in bed|3|||
23351269|NCT04679051|65029552|FG001|Overall Study|felt tired after restricted time in bed|0|||
23351270|NCT04679051|65029551|FG000|Overall Study|discomfort with blood pressure cuff|2|||
23351271|NCT04679051|65029552|FG001|Overall Study|discomfort with blood pressure cuff|0|||
23351272|NCT04679051|65029551|FG000|Overall Study|scheduling conflict|1|||
23351273|NCT04679051|65029552|FG001|Overall Study|scheduling conflict|1|||
23351274|NCT04679051|65029551|FG000|Overall Study|Protocol Violation|0|||
23351275|NCT04679051|65029552|FG001|Overall Study|Protocol Violation|4|||
23351276|NCT01987232|65029553|FG000|Overall Study|Ongoing in Study|0|||
23351277|NCT01987232|65029554|FG001|Overall Study|Ongoing in Study|0|||
23351278|NCT01987232|65029555|FG002|Overall Study|Ongoing in Study|0|||
23351279|NCT01987232|65029556|FG003|Overall Study|Ongoing in Study|1|||
23351280|NCT01987232|65029557|FG004|Overall Study|Ongoing in Study|0|||
23351281|NCT00553358|65029562|FG000|Overall Study|Randomized but did not receive treatment|3|||
23351282|NCT00553358|65029563|FG001|Overall Study|Randomized but did not receive treatment|3|||
23351283|NCT00553358|65029564|FG002|Overall Study|Randomized but did not receive treatment|1|||
23351284|NCT00553358|65029562|FG000|Overall Study|Lost to Follow-up|22|||
23351285|NCT00553358|65029563|FG001|Overall Study|Lost to Follow-up|26|||
23351286|NCT00553358|65029564|FG002|Overall Study|Lost to Follow-up|18|||
23351287|NCT00553358|65029562|FG000|Overall Study|Withdrew completely|23|||
23351288|NCT00553358|65029563|FG001|Overall Study|Withdrew completely|33|||
23351289|NCT00553358|65029564|FG002|Overall Study|Withdrew completely|34|||
23351290|NCT00553358|65029562|FG000|Overall Study|Died during clinical follow-up|25|||
23466288|NCT02745119|65451983|FG003|Overall Study|Protocol Deviation|1|||
23586159|NCT01720446|65873003|FG003|Overall Study|Withdrawal by Subject|4|||
23586160|NCT00502593|65873004|FG000|Overall Study|Withdrawn unspecified reason|1|||
23586161|NCT00502593|65873005|FG001|Overall Study|Withdrawn unspecified reason|1|||
23586162|NCT00502593|65873006|FG002|Overall Study|Withdrawn unspecified reason|3|||
23586163|NCT00502593|65873007|FG003|Overall Study|Withdrawn unspecified reason|1|||
23351291|NCT00553358|65029563|FG001|Overall Study|Died during clinical follow-up|29|||
23351292|NCT00553358|65029564|FG002|Overall Study|Died during clinical follow-up|32|||
23402772|NCT01446874|65220003|FG000|Overall Study|No surgery/No qualifying surgery|1|||
23586164|NCT00502593|65873008|FG004|Overall Study|Withdrawn unspecified reason|2|||
23586165|NCT00502593|65873009|FG005|Overall Study|Withdrawn unspecified reason|0|||
23586166|NCT00502593|65873010|FG006|Overall Study|Withdrawn unspecified reason|2|||
23586167|NCT00502593|65873011|FG007|Overall Study|Withdrawn unspecified reason|0|||
23586168|NCT00502593|65873012|FG008|Overall Study|Withdrawn unspecified reason|0|||
23586169|NCT00502593|65873013|FG009|Overall Study|Withdrawn unspecified reason|0|||
23586170|NCT00502593|65873014|FG010|Overall Study|Withdrawn unspecified reason|0|||
23586171|NCT00502593|65873015|FG011|Overall Study|Withdrawn unspecified reason|0|||
23586172|NCT00502593|65873004|FG000|Overall Study|Withdrawal by Subject|0|||
23466289|NCT02745119|65451980|FG000|Overall Study|Withdrawal by Subject|7|||
23466290|NCT02745119|65451981|FG001|Overall Study|Withdrawal by Subject|15|||
23466291|NCT02745119|65451982|FG002|Overall Study|Withdrawal by Subject|8|||
23466292|NCT02745119|65451983|FG003|Overall Study|Withdrawal by Subject|14|||
23466293|NCT02745119|65451980|FG000|Overall Study|Study Terminated by Sponsor|134|||
23586173|NCT00502593|65873005|FG001|Overall Study|Withdrawal by Subject|0|||
23586174|NCT00502593|65873006|FG002|Overall Study|Withdrawal by Subject|6|||
23586175|NCT00502593|65873007|FG003|Overall Study|Withdrawal by Subject|2|||
23586176|NCT00502593|65873008|FG004|Overall Study|Withdrawal by Subject|2|||
23586177|NCT00502593|65873009|FG005|Overall Study|Withdrawal by Subject|0|||
23586178|NCT00502593|65873010|FG006|Overall Study|Withdrawal by Subject|3|||
23586179|NCT00502593|65873011|FG007|Overall Study|Withdrawal by Subject|0|||
23586180|NCT00502593|65873012|FG008|Overall Study|Withdrawal by Subject|3|||
23586181|NCT00502593|65873013|FG009|Overall Study|Withdrawal by Subject|0|||
23586182|NCT00502593|65873014|FG010|Overall Study|Withdrawal by Subject|1|||
23586183|NCT00502593|65873015|FG011|Overall Study|Withdrawal by Subject|0|||
23586184|NCT00502593|65873004|FG000|Overall Study|Lost to Follow-up|2|||
23586185|NCT00502593|65873005|FG001|Overall Study|Lost to Follow-up|1|||
23586186|NCT00502593|65873006|FG002|Overall Study|Lost to Follow-up|1|||
23586187|NCT00502593|65873007|FG003|Overall Study|Lost to Follow-up|1|||
23586188|NCT00502593|65873008|FG004|Overall Study|Lost to Follow-up|0|||
23586189|NCT00502593|65873009|FG005|Overall Study|Lost to Follow-up|0|||
23586190|NCT00502593|65873010|FG006|Overall Study|Lost to Follow-up|0|||
23586191|NCT00502593|65873011|FG007|Overall Study|Lost to Follow-up|0|||
23586192|NCT00502593|65873012|FG008|Overall Study|Lost to Follow-up|3|||
23586193|NCT00502593|65873013|FG009|Overall Study|Lost to Follow-up|0|||
23586194|NCT00502593|65873014|FG010|Overall Study|Lost to Follow-up|1|||
23792212|NCT02250651|66620332|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
23792213|NCT02250651|66620333|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
23792214|NCT02250651|66620331|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
23586195|NCT00502593|65873015|FG011|Overall Study|Lost to Follow-up|0|||
23586196|NCT02993471|65873021|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
23586197|NCT02993471|65873021|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
23586198|NCT01123083|65873022|FG000|Overall Study|Investigator recommendation|1|||
23586199|NCT01123083|65873023|FG001|Overall Study|Investigator recommendation|1|||
23586200|NCT01123083|65873022|FG000|Overall Study|Administrative reasons|0|||
23586201|NCT01123083|65873023|FG001|Overall Study|Administrative reasons|4|||
23586202|NCT01123083|65873022|FG000|Overall Study|Lost to Follow-up|2|||
23586203|NCT01123083|65873023|FG001|Overall Study|Lost to Follow-up|6|||
23586204|NCT01123083|65873022|FG000|Overall Study|Adverse Event|1|||
23792215|NCT02250651|66620332|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
23792216|NCT02250651|66620333|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
23792217|NCT02250651|66620331|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
23792218|NCT02250651|66620332|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
23792219|NCT02250651|66620333|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
23792220|NCT02250651|66620331|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
23792221|NCT02250651|66620332|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
23792222|NCT02250651|66620333|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
23792223|NCT02250651|66620331|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
23792224|NCT02250651|66620332|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
23792225|NCT02250651|66620333|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
23792226|NCT02250651|66620331|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
23792227|NCT02250651|66620332|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
23792228|NCT02250651|66620333|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
23792229|NCT02250651|66620331|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
23792230|NCT02250651|66620332|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
23792231|NCT02250651|66620333|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
23792232|NCT02250651|66620331|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
23586205|NCT01123083|65873023|FG001|Overall Study|Adverse Event|0|||
23586206|NCT01123083|65873022|FG000|Overall Study|Withdrew for another reason not covered|0|||
23586207|NCT01123083|65873023|FG001|Overall Study|Withdrew for another reason not covered|1|||
23586208|NCT01123083|65873022|FG000|Overall Study|Participant/legal representative request|7|||
23586209|NCT01123083|65873023|FG001|Overall Study|Participant/legal representative request|3|||
23586210|NCT00424762|65873027|FG000|Overall Study|Withdrawal by Subject|18|||
23586211|NCT00424762|65873028|FG001|Overall Study|Withdrawal by Subject|19|||
23586212|NCT00424762|65873027|FG000|Overall Study|Lost to Follow-up|2|||
23586213|NCT00424762|65873028|FG001|Overall Study|Lost to Follow-up|3|||
23586214|NCT02430532|65873029|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
23586215|NCT02430532|65873030|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
23586216|NCT02430532|65873029|FG000|Overall Study|Consent Withdrawn|0|||
23586217|NCT02430532|65873030|FG001|Overall Study|Consent Withdrawn|2|||
23586218|NCT02430532|65873029|FG000|Overall Study|Adverse Event|0|||
23586219|NCT02430532|65873030|FG001|Overall Study|Adverse Event|1|||
23586220|NCT02943993|65873031|FG000|Overall Study|Withdrawal by Subject|52|||
23586221|NCT02943993|65873031|FG000|Overall Study|Transfer to another institution|6|||
23586222|NCT02943993|65873031|FG000|Overall Study|Lost to Follow-up|135|||
23586223|NCT02943993|65873031|FG000|Overall Study|Death|98|||
23586224|NCT02943993|65873031|FG000|Overall Study|Other reason for premature termination|32|||
23586225|NCT02943993|65873031|FG000|Overall Study|Missing reason for termination|7|||
23586226|NCT03532178|65873033|FG000|First Period|Withdrawal by Subject|1|||
23586227|NCT03532178|65873034|FG001|First Period|Withdrawal by Subject|3|||
23586228|NCT03532178|65873033|FG000|First Period|technical issues in data collection Technical issues|0|||
23586229|NCT03532178|65873034|FG001|First Period|technical issues in data collection Technical issues|1|||
23586230|NCT03532178|65873033|FG000|Second Period|Withdrawal by Subject|1|||
23586231|NCT03532178|65873034|FG001|Second Period|Withdrawal by Subject|1|||
23586232|NCT03532178|65873033|FG000|Second Period|Technical issues|0|||
23586233|NCT03532178|65873034|FG001|Second Period|Technical issues|1|||
23586234|NCT01235949|65873039|FG000|Primary Phase|Migrated/moved from study area|1|||
23586235|NCT01235949|65873040|FG001|Primary Phase|Migrated/moved from study area|1|||
23586236|NCT01235949|65873041|FG002|Primary Phase|Migrated/moved from study area|0|||
23586237|NCT01235949|65873042|FG003|Primary Phase|Migrated/moved from study area|0|||
23586238|NCT01235949|65873043|FG004|Primary Phase|Migrated/moved from study area|1|||
23586239|NCT01235949|65873044|FG005|Primary Phase|Migrated/moved from study area|2|||
23586240|NCT01235949|65873045|FG006|Primary Phase|Migrated/moved from study area|0|||
23586241|NCT01235949|65873046|FG007|Primary Phase|Migrated/moved from study area|0|||
23586242|NCT01235949|65873047|FG008|Primary Phase|Migrated/moved from study area|0|||
23586243|NCT01235949|65873048|FG009|Primary Phase|Migrated/moved from study area|0|||
23586244|NCT01235949|65873049|FG010|Primary Phase|Migrated/moved from study area|0|||
23586245|NCT01235949|65873050|FG011|Primary Phase|Migrated/moved from study area|0|||
23586246|NCT01235949|65873051|FG012|Primary Phase|Migrated/moved from study area|0|||
23586247|NCT01235949|65873052|FG013|Primary Phase|Migrated/moved from study area|0|||
23586248|NCT01235949|65873053|FG014|Primary Phase|Migrated/moved from study area|0|||
23586249|NCT01235949|65873054|FG015|Primary Phase|Migrated/moved from study area|0|||
23586250|NCT01235949|65873055|FG016|Primary Phase|Migrated/moved from study area|0|||
23586251|NCT01235949|65873056|FG017|Primary Phase|Migrated/moved from study area|0|||
23586252|NCT01235949|65873039|FG000|Primary Phase|Adverse Event|0|||
23586253|NCT01235949|65873040|FG001|Primary Phase|Adverse Event|0|||
23586254|NCT01235949|65873041|FG002|Primary Phase|Adverse Event|0|||
23586255|NCT01235949|65873042|FG003|Primary Phase|Adverse Event|1|||
23586256|NCT01235949|65873043|FG004|Primary Phase|Adverse Event|0|||
23586257|NCT01235949|65873044|FG005|Primary Phase|Adverse Event|0|||
23586258|NCT01235949|65873045|FG006|Primary Phase|Adverse Event|0|||
23586259|NCT01235949|65873046|FG007|Primary Phase|Adverse Event|0|||
23586260|NCT01235949|65873047|FG008|Primary Phase|Adverse Event|0|||
23586261|NCT01235949|65873048|FG009|Primary Phase|Adverse Event|0|||
23586262|NCT01235949|65873049|FG010|Primary Phase|Adverse Event|0|||
23586263|NCT01235949|65873050|FG011|Primary Phase|Adverse Event|0|||
23586264|NCT01235949|65873051|FG012|Primary Phase|Adverse Event|0|||
23586265|NCT01235949|65873052|FG013|Primary Phase|Adverse Event|0|||
23586266|NCT01235949|65873053|FG014|Primary Phase|Adverse Event|0|||
23586267|NCT01235949|65873054|FG015|Primary Phase|Adverse Event|0|||
23586268|NCT01235949|65873055|FG016|Primary Phase|Adverse Event|0|||
23586269|NCT01235949|65873056|FG017|Primary Phase|Adverse Event|0|||
23586270|NCT01235949|65873039|FG000|Primary Phase|Withdrawal by Subject|3|||
23586271|NCT01235949|65873040|FG001|Primary Phase|Withdrawal by Subject|2|||
23586272|NCT01235949|65873041|FG002|Primary Phase|Withdrawal by Subject|2|||
23586273|NCT01235949|65873042|FG003|Primary Phase|Withdrawal by Subject|0|||
23586274|NCT01235949|65873043|FG004|Primary Phase|Withdrawal by Subject|0|||
23586275|NCT01235949|65873044|FG005|Primary Phase|Withdrawal by Subject|3|||
23586276|NCT01235949|65873045|FG006|Primary Phase|Withdrawal by Subject|0|||
23640296|NCT05593445|66067450|FG001|12-Week DBVC Period|Protocol Violation|1|||
23351293|NCT00553358|65029562|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
23586277|NCT01235949|65873046|FG007|Primary Phase|Withdrawal by Subject|0|||
23586278|NCT01235949|65873047|FG008|Primary Phase|Withdrawal by Subject|0|||
23586279|NCT01235949|65873048|FG009|Primary Phase|Withdrawal by Subject|0|||
23586280|NCT01235949|65873049|FG010|Primary Phase|Withdrawal by Subject|0|||
23586281|NCT01235949|65873050|FG011|Primary Phase|Withdrawal by Subject|0|||
23586282|NCT01235949|65873051|FG012|Primary Phase|Withdrawal by Subject|0|||
23640297|NCT05593445|66067451|FG002|12-Week DBVC Period|Protocol Violation|0|||
23640298|NCT05593445|66067452|FG003|12-Week DBVC Period|Protocol Violation|0|||
23640299|NCT05593445|66067449|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
23640300|NCT05593445|66067450|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
23640301|NCT05593445|66067451|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
23640302|NCT05593445|66067452|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
23792233|NCT02250651|66620332|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
23792234|NCT02250651|66620333|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
23792235|NCT02250651|66620331|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
23792236|NCT02250651|66620332|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
23792237|NCT02250651|66620333|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
23792238|NCT02250651|66620331|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
23792239|NCT02250651|66620332|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
23792240|NCT02250651|66620333|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
23792241|NCT03750695|66620334|FG000|Overall Study|Lost to Follow-up|0|||
23792242|NCT03750695|66620335|FG001|Overall Study|Lost to Follow-up|1|||
23792243|NCT00283842|66620348|FG000|Overall Study|Adverse Event|8|||
23792244|NCT00283842|66620349|FG001|Overall Study|Adverse Event|7|||
23792245|NCT00283842|66620350|FG002|Overall Study|Adverse Event|21|||
23792246|NCT00283842|66620351|FG003|Overall Study|Adverse Event|21|||
23792247|NCT00283842|66620352|FG004|Overall Study|Adverse Event|5|||
23792248|NCT00283842|66620348|FG000|Overall Study|Protocol Violation|1|||
23792249|NCT00283842|66620349|FG001|Overall Study|Protocol Violation|5|||
23792250|NCT00283842|66620350|FG002|Overall Study|Protocol Violation|4|||
23792251|NCT00283842|66620351|FG003|Overall Study|Protocol Violation|0|||
23792252|NCT00283842|66620352|FG004|Overall Study|Protocol Violation|0|||
23792253|NCT00283842|66620348|FG000|Overall Study|Protocol deviation|0|||
23792254|NCT00283842|66620349|FG001|Overall Study|Protocol deviation|0|||
23792255|NCT00283842|66620350|FG002|Overall Study|Protocol deviation|0|||
23792256|NCT00283842|66620351|FG003|Overall Study|Protocol deviation|0|||
23792257|NCT00283842|66620352|FG004|Overall Study|Protocol deviation|2|||
23792258|NCT00283842|66620348|FG000|Overall Study|Withdrawal by Subject|2|||
23792259|NCT00283842|66620349|FG001|Overall Study|Withdrawal by Subject|1|||
23792260|NCT00283842|66620350|FG002|Overall Study|Withdrawal by Subject|1|||
23792261|NCT00283842|66620351|FG003|Overall Study|Withdrawal by Subject|5|||
23792262|NCT00283842|66620352|FG004|Overall Study|Withdrawal by Subject|4|||
23792263|NCT00283842|66620348|FG000|Overall Study|Lack of Efficacy|1|||
23792264|NCT00283842|66620349|FG001|Overall Study|Lack of Efficacy|3|||
23792265|NCT00283842|66620350|FG002|Overall Study|Lack of Efficacy|1|||
23792266|NCT00283842|66620351|FG003|Overall Study|Lack of Efficacy|0|||
23792267|NCT00283842|66620352|FG004|Overall Study|Lack of Efficacy|3|||
23792268|NCT00283842|66620348|FG000|Overall Study|Lost to Follow-up|0|||
23792269|NCT00283842|66620349|FG001|Overall Study|Lost to Follow-up|2|||
23792270|NCT00283842|66620350|FG002|Overall Study|Lost to Follow-up|4|||
23792271|NCT00283842|66620351|FG003|Overall Study|Lost to Follow-up|1|||
23792272|NCT00283842|66620352|FG004|Overall Study|Lost to Follow-up|1|||
23792273|NCT01596127|66620353|FG000|Overall Study|Patient Ineligible|1|||
23706285|NCT00431847|66301142|FG003|Overall Study|Protocol Violation|0|||
23792274|NCT04129554|66620358|FG000|Overall Study|Withdrawal by Subject|4|||
23792275|NCT04129554|66620359|FG001|Overall Study|Withdrawal by Subject|3|||
23792276|NCT04129554|66620358|FG000|Overall Study|Other|0|||
23792277|NCT04129554|66620359|FG001|Overall Study|Other|2|||
23792278|NCT01532908|66620363|FG000|Overall Study|Not Transplanted|1|||
23792279|NCT01532908|66620364|FG001|Overall Study|Not Transplanted|0|||
23792280|NCT01881737|66620370|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
23792281|NCT01881737|66620370|FG000|Overall Study|Withdrawal by Subject|1|||
23792282|NCT01881737|66620370|FG000|Overall Study|Worsening of baseline behavior|1|||
23792283|NCT04404725|66620371|FG000|First Intervention|Withdrawal by Subject|0|||
23792284|NCT04404725|66620372|FG001|First Intervention|Withdrawal by Subject|2|||
23792285|NCT04404725|66620371|FG000|Second Intervention|Adverse Event|1|||
23792286|NCT04404725|66620372|FG001|Second Intervention|Adverse Event|1|||
23792287|NCT04404725|66620371|FG000|Second Intervention|Withdrawal by Subject|0|||
23792288|NCT04404725|66620372|FG001|Second Intervention|Withdrawal by Subject|1|||
23792289|NCT01077258|66620374|FG000|Overall Study|Lost to Follow-up|1390|||
23792290|NCT01077258|66620374|FG000|Overall Study|Adverse drug reaction|218|||
23792291|NCT01077258|66620374|FG000|Overall Study|Lack of Efficacy|663|||
23792292|NCT01077258|66620374|FG000|Overall Study|Clinical remission|37|||
23792293|NCT01077258|66620374|FG000|Overall Study|Other reasons|260|||
23792294|NCT05412121|66620375|FG000|Overall Study|Withdrawal by Subject|4|||
23792295|NCT05412121|66620375|FG000|Overall Study|Physician Decision|1|||
23792296|NCT05412121|66620375|FG000|Overall Study|Lost to Follow-up|5|||
23351294|NCT00553358|65029563|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
23351295|NCT00553358|65029564|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
23351296|NCT00553358|65029562|FG000|Overall Study|Died after clinical follow-up ended|1|||
23351297|NCT00553358|65029563|FG001|Overall Study|Died after clinical follow-up ended|2|||
23351298|NCT00553358|65029564|FG002|Overall Study|Died after clinical follow-up ended|0|||
23351299|NCT00553358|65029562|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351300|NCT00553358|65029563|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351301|NCT00553358|65029564|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351302|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
23792297|NCT00721955|66620378|FG000|Overall Study|Adverse Event|0|||
23792298|NCT00721955|66620379|FG001|Overall Study|Adverse Event|0|||
23351303|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351304|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351305|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351306|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351307|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351308|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
23351309|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351310|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351311|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351312|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351313|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351314|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
23351315|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351316|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351317|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351318|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351319|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351320|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351321|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
23351322|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
23351323|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
23351324|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351325|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351326|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
23351327|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
23351328|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
23351329|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
23351330|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
23351331|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
23351332|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
23351333|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
23351334|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
23792299|NCT00721955|66620380|FG002|Overall Study|Adverse Event|2|||
23792300|NCT00725764|66620381|FG000|Overall Study|Withdrawal by Subject|2|||
23792301|NCT00725764|66620381|FG000|Overall Study|Physician Decision|1|||
23792302|NCT00725764|66620381|FG000|Overall Study|Progressive Disease|7|||
23586283|NCT01235949|65873052|FG013|Primary Phase|Withdrawal by Subject|0|||
23586284|NCT01235949|65873053|FG014|Primary Phase|Withdrawal by Subject|0|||
23586285|NCT01235949|65873054|FG015|Primary Phase|Withdrawal by Subject|0|||
23586286|NCT01235949|65873055|FG016|Primary Phase|Withdrawal by Subject|0|||
23586287|NCT01235949|65873056|FG017|Primary Phase|Withdrawal by Subject|0|||
23792303|NCT00725764|66620381|FG000|Overall Study|Lost to Follow-up|1|||
23792304|NCT00725764|66620381|FG000|Overall Study|Death|1|||
23792305|NCT00725764|66620381|FG000|Overall Study|Participant non compliant with protocol|1|||
23792306|NCT00725764|66620381|FG000|Overall Study|Decline in performance status|1|||
23792307|NCT02587143|66620382|FG000|Overall Study|Adverse Event|1|||
23792308|NCT02587143|66620383|FG001|Overall Study|Adverse Event|0|||
23792309|NCT00274625|66620384|FG000|Overall Study|Lost to Follow-up|46|||
23792310|NCT00274625|66620385|FG001|Overall Study|Lost to Follow-up|54|||
23792311|NCT00274625|66620384|FG000|Overall Study|Excluded from analysis|14|||
23792312|NCT00274625|66620385|FG001|Overall Study|Excluded from analysis|8|||
23792313|NCT04148287|66620386|FG000|Overall Study|Death|2|||
23792314|NCT02328040|66620387|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
23792315|NCT02328040|66620388|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
23792316|NCT01945580|66620389|FG000|Overall Study|Withdrawal by Subject|13|||
23792317|NCT01945580|66620390|FG001|Overall Study|Withdrawal by Subject|35|||
23792318|NCT01945580|66620389|FG000|Overall Study|Physician Decision|3|||
23792319|NCT01945580|66620390|FG001|Overall Study|Physician Decision|2|||
23792320|NCT01945580|66620389|FG000|Overall Study|Lost to Follow-up|26|||
23351335|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
23351336|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
23351337|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
23351338|NCT01573754|65029575|FG000|Overall Study|Noncompliance or remission not achieved|3|||
23351339|NCT01573754|65029576|FG001|Overall Study|Noncompliance or remission not achieved|15|||
23351340|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
23351341|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351342|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351343|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351344|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
23351345|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351346|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351347|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351348|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
23351349|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
23351350|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
23351351|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
23351352|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
23351353|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23351354|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23586288|NCT01235949|65873039|FG000|Primary Phase|Lost to Follow-up|0|||
23586289|NCT01235949|65873040|FG001|Primary Phase|Lost to Follow-up|0|||
23792321|NCT01945580|66620390|FG001|Overall Study|Lost to Follow-up|39|||
23792322|NCT01945580|66620389|FG000|Overall Study|Death|7|||
23792323|NCT01945580|66620390|FG001|Overall Study|Death|2|||
23466294|NCT02745119|65451981|FG001|Overall Study|Study Terminated by Sponsor|252|||
23466295|NCT02745119|65451982|FG002|Overall Study|Study Terminated by Sponsor|135|||
23466296|NCT02745119|65451983|FG003|Overall Study|Study Terminated by Sponsor|251|||
23466297|NCT02745119|65451980|FG000|Overall Study|Physician Decision|0|||
23466298|NCT02745119|65451981|FG001|Overall Study|Physician Decision|2|||
23466299|NCT02745119|65451982|FG002|Overall Study|Physician Decision|2|||
23466300|NCT02745119|65451983|FG003|Overall Study|Physician Decision|2|||
23466301|NCT02745119|65451980|FG000|Overall Study|Reason Not Specified|0|||
23792324|NCT01945580|66620389|FG000|Overall Study|Patient moved out of state|0|||
23792325|NCT01945580|66620390|FG001|Overall Study|Patient moved out of state|1|||
23792326|NCT01945580|66620389|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
23466302|NCT02745119|65451981|FG001|Overall Study|Reason Not Specified|2|||
23466303|NCT02745119|65451982|FG002|Overall Study|Reason Not Specified|0|||
23466304|NCT02745119|65451983|FG003|Overall Study|Reason Not Specified|1|||
23466305|NCT03023397|65451986|FG000|Run-In|Failed screening allergen challenge|1|||
23792327|NCT01945580|66620390|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
23792328|NCT01945580|66620389|FG000|Overall Study|Family illness - unable to return|0|||
23792329|NCT01945580|66620390|FG001|Overall Study|Family illness - unable to return|1|||
23792330|NCT01945580|66620389|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
23792331|NCT01945580|66620390|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
23792332|NCT01945580|66620389|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
23792333|NCT01945580|66620390|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
23466306|NCT03023397|65451987|FG001|Run-In|Failed screening allergen challenge|0|||
23466307|NCT03023397|65451988|FG002|Run-In|Failed screening allergen challenge|0|||
23466308|NCT03023397|65451986|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
23466309|NCT03023397|65451987|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
23466310|NCT03023397|65451988|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
23466311|NCT02224560|65451989|FG000|Overall Study|Protocol Deviation|1|||
23466312|NCT02224560|65451990|FG001|Overall Study|Protocol Deviation|0|||
23466313|NCT02224560|65451991|FG002|Overall Study|Protocol Deviation|0|||
23466314|NCT02224560|65451989|FG000|Overall Study|Withdrawal by Subject|2|||
23466315|NCT02224560|65451990|FG001|Overall Study|Withdrawal by Subject|0|||
23466316|NCT02224560|65451991|FG002|Overall Study|Withdrawal by Subject|1|||
23466317|NCT02224560|65451989|FG000|Overall Study|Met Withdrawal Criteria|1|||
23466318|NCT02224560|65451990|FG001|Overall Study|Met Withdrawal Criteria|0|||
23466319|NCT02224560|65451991|FG002|Overall Study|Met Withdrawal Criteria|0|||
23466320|NCT02224560|65451989|FG000|Overall Study|Adverse Event|4|||
23466321|NCT02224560|65451990|FG001|Overall Study|Adverse Event|1|||
23466322|NCT02224560|65451991|FG002|Overall Study|Adverse Event|1|||
23466323|NCT02224560|65451989|FG000|Overall Study|Withdrawn by Investigator|1|||
23466324|NCT02224560|65451990|FG001|Overall Study|Withdrawn by Investigator|1|||
23466325|NCT02224560|65451991|FG002|Overall Study|Withdrawn by Investigator|0|||
23466326|NCT01941186|65451996|FG000|Follow-up|Lost to Follow-up|1|||
23466327|NCT01941186|65451997|FG001|Follow-up|Lost to Follow-up|0|||
23466328|NCT02624986|65451998|FG000|Overall Study|Death|0|||
23466329|NCT02624986|65451999|FG001|Overall Study|Death|1|||
23466330|NCT02624986|65452000|FG002|Overall Study|Death|2|||
23466331|NCT02624986|65452001|FG003|Overall Study|Death|2|||
23466332|NCT02624986|65452002|FG004|Overall Study|Death|2|||
23466333|NCT02624986|65452003|FG005|Overall Study|Death|0|||
23466334|NCT02624986|65452004|FG006|Overall Study|Death|0|||
23466335|NCT02624986|65452005|FG007|Overall Study|Death|1|||
23466336|NCT02624986|65451998|FG000|Overall Study|Study Terminated by Sponsor|1|||
23466337|NCT02624986|65451999|FG001|Overall Study|Study Terminated by Sponsor|1|||
23466338|NCT02624986|65452000|FG002|Overall Study|Study Terminated by Sponsor|0|||
23351355|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23351356|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
23351357|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
23351358|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
23466339|NCT02624986|65452001|FG003|Overall Study|Study Terminated by Sponsor|1|||
23466340|NCT02624986|65452002|FG004|Overall Study|Study Terminated by Sponsor|2|||
23466341|NCT02624986|65452003|FG005|Overall Study|Study Terminated by Sponsor|2|||
23466342|NCT02624986|65452004|FG006|Overall Study|Study Terminated by Sponsor|4|||
23466343|NCT02624986|65452005|FG007|Overall Study|Study Terminated by Sponsor|3|||
23466344|NCT02624986|65451998|FG000|Overall Study|Progressive Disease|0|||
23466345|NCT02624986|65451999|FG001|Overall Study|Progressive Disease|1|||
23466346|NCT02624986|65452000|FG002|Overall Study|Progressive Disease|0|||
23466347|NCT02624986|65452001|FG003|Overall Study|Progressive Disease|0|||
23466348|NCT02624986|65452002|FG004|Overall Study|Progressive Disease|0|||
23466349|NCT02624986|65452003|FG005|Overall Study|Progressive Disease|0|||
23466350|NCT02624986|65452004|FG006|Overall Study|Progressive Disease|0|||
23466351|NCT02624986|65452005|FG007|Overall Study|Progressive Disease|0|||
23466352|NCT02624986|65451998|FG000|Overall Study|Protocol Violation|1|||
23466353|NCT02624986|65451999|FG001|Overall Study|Protocol Violation|0|||
23466354|NCT02624986|65452000|FG002|Overall Study|Protocol Violation|0|||
23466355|NCT02624986|65452001|FG003|Overall Study|Protocol Violation|0|||
23466356|NCT02624986|65452002|FG004|Overall Study|Protocol Violation|0|||
23466357|NCT02624986|65452003|FG005|Overall Study|Protocol Violation|0|||
23466358|NCT02624986|65452004|FG006|Overall Study|Protocol Violation|0|||
23586290|NCT01235949|65873041|FG002|Primary Phase|Lost to Follow-up|1|||
23586291|NCT01235949|65873042|FG003|Primary Phase|Lost to Follow-up|1|||
23586292|NCT01235949|65873043|FG004|Primary Phase|Lost to Follow-up|0|||
23351359|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
23351360|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351361|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351362|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351363|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
23351364|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351365|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351366|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351367|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
23351368|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351369|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351370|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
23351371|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351372|NCT00637806|65029593|FG000|Double-blind Phase|Study Discontinued|2|||
23351373|NCT00637806|65029594|FG001|Double-blind Phase|Study Discontinued|0|||
23351374|NCT00637806|65029595|FG002|Double-blind Phase|Study Discontinued|1|||
23351375|NCT00637806|65029596|FG003|Double-blind Phase|Study Discontinued|0|||
23351376|NCT00637806|65029593|FG000|Extension Phase|Study Discontinued|0|||
23351377|NCT00637806|65029594|FG001|Extension Phase|Study Discontinued|0|||
23351378|NCT00637806|65029595|FG002|Extension Phase|Study Discontinued|0|||
23351379|NCT00637806|65029596|FG003|Extension Phase|Study Discontinued|1|||
23351380|NCT02243046|65029604|FG000|Overall Study|Lost to Follow-up|1|||
23466359|NCT02624986|65452005|FG007|Overall Study|Protocol Violation|0|||
23466360|NCT02624986|65451998|FG000|Overall Study|Withdrawal by Subject|0|||
23466361|NCT02624986|65451999|FG001|Overall Study|Withdrawal by Subject|0|||
23586293|NCT01235949|65873044|FG005|Primary Phase|Lost to Follow-up|2|||
23586294|NCT01235949|65873045|FG006|Primary Phase|Lost to Follow-up|0|||
23706286|NCT00431847|66301143|FG004|Overall Study|Protocol Violation|1|||
23466362|NCT02624986|65452000|FG002|Overall Study|Withdrawal by Subject|0|||
23466363|NCT02624986|65452001|FG003|Overall Study|Withdrawal by Subject|0|||
23466364|NCT02624986|65452002|FG004|Overall Study|Withdrawal by Subject|0|||
23351381|NCT02243046|65029605|FG001|Overall Study|Lost to Follow-up|1|||
23351382|NCT02243046|65029606|FG002|Overall Study|Lost to Follow-up|4|||
23351383|NCT01451554|65029611|FG000|Overall Study|Withdrawal by Subject|14|||
23466365|NCT02624986|65452003|FG005|Overall Study|Withdrawal by Subject|0|||
23586295|NCT01235949|65873046|FG007|Primary Phase|Lost to Follow-up|0|||
23586296|NCT01235949|65873047|FG008|Primary Phase|Lost to Follow-up|0|||
23466366|NCT02624986|65452004|FG006|Overall Study|Withdrawal by Subject|0|||
23466367|NCT02624986|65452005|FG007|Overall Study|Withdrawal by Subject|1|||
23466368|NCT02215252|65452006|FG000|Overall Study|Adverse Event|1|||
23466369|NCT02215252|65452007|FG001|Overall Study|Adverse Event|5|||
23466370|NCT02215252|65452008|FG002|Overall Study|Adverse Event|2|||
23466371|NCT02215252|65452006|FG000|Overall Study|Lost to Follow-up|0|||
23466372|NCT02215252|65452007|FG001|Overall Study|Lost to Follow-up|0|||
23466373|NCT02215252|65452008|FG002|Overall Study|Lost to Follow-up|1|||
23466374|NCT02215252|65452006|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
23466375|NCT02215252|65452007|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
23466376|NCT02215252|65452008|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
23466377|NCT02215252|65452006|FG000|Overall Study|Protocol Violation|0|||
23466378|NCT02215252|65452007|FG001|Overall Study|Protocol Violation|1|||
23466379|NCT02215252|65452008|FG002|Overall Study|Protocol Violation|0|||
23466380|NCT02215252|65452006|FG000|Overall Study|Withdrawal by Subject|1|||
23466381|NCT02215252|65452007|FG001|Overall Study|Withdrawal by Subject|0|||
23466382|NCT02215252|65452008|FG002|Overall Study|Withdrawal by Subject|0|||
23466383|NCT02215252|65452006|FG000|Overall Study|Other|0|||
23466384|NCT02215252|65452007|FG001|Overall Study|Other|1|||
23466385|NCT02215252|65452008|FG002|Overall Study|Other|1|||
23466386|NCT01317277|65452009|FG000|Overall Study|Lost to Follow-up|3|||
23466387|NCT01317277|65452010|FG001|Overall Study|Lost to Follow-up|1|||
23466388|NCT01317277|65452009|FG000|Overall Study|Lost MEMS|1|||
23466389|NCT01317277|65452010|FG001|Overall Study|Lost MEMS|1|||
23466390|NCT01317277|65452009|FG000|Overall Study|Unable to comply with intervention|1|||
23466391|NCT01317277|65452010|FG001|Overall Study|Unable to comply with intervention|0|||
23466392|NCT01317277|65452009|FG000|Overall Study|Withdrawal by Subject|1|||
23792334|NCT01945580|66620389|FG000|Overall Study|Noncompliance with 36 month visit|1|||
23792335|NCT01945580|66620390|FG001|Overall Study|Noncompliance with 36 month visit|0|||
23792336|NCT01945580|66620389|FG000|Overall Study|The patient moved.|1|||
23792337|NCT01945580|66620390|FG001|Overall Study|The patient moved.|0|||
23792338|NCT01945580|66620389|FG000|Overall Study|No data available|0|||
23792339|NCT01945580|66620390|FG001|Overall Study|No data available|2|||
23792340|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
23792341|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
23792342|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
23792343|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
23792344|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
23351384|NCT01451554|65029612|FG001|Overall Study|Withdrawal by Subject|9|||
23351385|NCT02536781|65029613|FG000|Overall Study|Lost to Follow-up|2|||
23351386|NCT02536781|65029614|FG001|Overall Study|Lost to Follow-up|0|||
23466393|NCT01317277|65452010|FG001|Overall Study|Withdrawal by Subject|0|||
23466394|NCT01317277|65452009|FG000|Overall Study|Adverse Event|1|||
23466395|NCT01317277|65452010|FG001|Overall Study|Adverse Event|0|||
23586297|NCT01235949|65873048|FG009|Primary Phase|Lost to Follow-up|0|||
23351387|NCT01853696|65029615|FG000|Overall Study|Withdrawal by Subject|1|||
23351388|NCT01853696|65029616|FG001|Overall Study|Withdrawal by Subject|1|||
23351389|NCT01853696|65029615|FG000|Overall Study|Lost to Follow-up|5|||
23351390|NCT01853696|65029616|FG001|Overall Study|Lost to Follow-up|4|||
23351391|NCT02735096|65029617|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
23351392|NCT00396383|65029618|FG000|Overall Study|Death|2|||
23351393|NCT00396383|65029618|FG000|Overall Study|Lost to Follow-up|1|||
23351394|NCT01593254|65029619|FG000|Overall Study|Disease progression|2|||
23351395|NCT01593254|65029620|FG001|Overall Study|Disease progression|7|||
23466396|NCT00889720|65452011|FG000|Overall Study|Withdrawal by Subject|4|||
23586298|NCT01235949|65873049|FG010|Primary Phase|Lost to Follow-up|0|||
23586299|NCT01235949|65873050|FG011|Primary Phase|Lost to Follow-up|0|||
23586300|NCT01235949|65873051|FG012|Primary Phase|Lost to Follow-up|0|||
23586301|NCT01235949|65873052|FG013|Primary Phase|Lost to Follow-up|0|||
23586302|NCT01235949|65873053|FG014|Primary Phase|Lost to Follow-up|0|||
23586303|NCT01235949|65873054|FG015|Primary Phase|Lost to Follow-up|0|||
23586304|NCT01235949|65873055|FG016|Primary Phase|Lost to Follow-up|0|||
23586305|NCT01235949|65873056|FG017|Primary Phase|Lost to Follow-up|0|||
23586306|NCT01235949|65873039|FG000|Booster Phase|Migrated/moved from study area|0|||
23586307|NCT01235949|65873040|FG001|Booster Phase|Migrated/moved from study area|0|||
23586308|NCT01235949|65873041|FG002|Booster Phase|Migrated/moved from study area|0|||
23466397|NCT00889720|65452011|FG000|Overall Study|Other|4|||
23466398|NCT00048074|65452012|FG000|Overall Study|Adverse Event|46|||
23466399|NCT00048074|65452013|FG001|Overall Study|Adverse Event|41|||
23351396|NCT01593254|65029619|FG000|Overall Study|Study drug toxicity|6|||
23351397|NCT01593254|65029620|FG001|Overall Study|Study drug toxicity|20|||
23351398|NCT01593254|65029619|FG000|Overall Study|Death|3|||
23351399|NCT01593254|65029620|FG001|Overall Study|Death|3|||
23466400|NCT00048074|65452014|FG002|Overall Study|Adverse Event|53|||
23466401|NCT00048074|65452012|FG000|Overall Study|Death|3|||
23466402|NCT00048074|65452013|FG001|Overall Study|Death|3|||
23586309|NCT01235949|65873042|FG003|Booster Phase|Migrated/moved from study area|0|||
23706514|NCT03554005|66301238|FG005|Overall Study|Physician Decision|0|||
23466403|NCT00048074|65452014|FG002|Overall Study|Death|2|||
23466404|NCT00048074|65452012|FG000|Overall Study|Lost to Follow-up|2|||
23466405|NCT00048074|65452013|FG001|Overall Study|Lost to Follow-up|6|||
23466406|NCT00048074|65452014|FG002|Overall Study|Lost to Follow-up|6|||
23466407|NCT00048074|65452012|FG000|Overall Study|Withdrawal by Subject|28|||
23466408|NCT00048074|65452013|FG001|Overall Study|Withdrawal by Subject|30|||
23466409|NCT00048074|65452014|FG002|Overall Study|Withdrawal by Subject|35|||
23466410|NCT00048074|65452012|FG000|Overall Study|Protocol Violation|1|||
23466411|NCT00048074|65452013|FG001|Overall Study|Protocol Violation|3|||
23466412|NCT00048074|65452014|FG002|Overall Study|Protocol Violation|0|||
23466413|NCT00048074|65452012|FG000|Overall Study|Study participation was terminated|0|||
23466414|NCT00048074|65452013|FG001|Overall Study|Study participation was terminated|1|||
23466415|NCT00048074|65452014|FG002|Overall Study|Study participation was terminated|0|||
23466416|NCT00048074|65452012|FG000|Overall Study|Husband ill|0|||
23466417|NCT00048074|65452013|FG001|Overall Study|Husband ill|1|||
23466418|NCT00048074|65452014|FG002|Overall Study|Husband ill|0|||
23466419|NCT00048074|65452012|FG000|Overall Study|Poor compliance|0|||
23792345|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
23792346|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
23792347|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
23792348|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
23792349|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
23792350|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
23466420|NCT00048074|65452013|FG001|Overall Study|Poor compliance|1|||
23466421|NCT00048074|65452014|FG002|Overall Study|Poor compliance|0|||
23466422|NCT00048074|65452012|FG000|Overall Study|Out of station|0|||
23466423|NCT00048074|65452013|FG001|Overall Study|Out of station|1|||
23466424|NCT00048074|65452014|FG002|Overall Study|Out of station|1|||
23466425|NCT00048074|65452012|FG000|Overall Study|Social reasons|1|||
23466426|NCT00048074|65452013|FG001|Overall Study|Social reasons|0|||
23466427|NCT00048074|65452014|FG002|Overall Study|Social reasons|0|||
23466428|NCT02504151|65452015|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
23466429|NCT02504151|65452016|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
23466430|NCT02504151|65452015|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
23466431|NCT02504151|65452016|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
23466432|NCT02504151|65452015|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23466433|NCT02504151|65452016|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23466434|NCT02504151|65452015|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
23466435|NCT02504151|65452016|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
23466436|NCT00927953|65452017|FG000|Overall Study|Death|2|||
23466437|NCT00927953|65452018|FG001|Overall Study|Death|1|||
23466438|NCT00521404|65452019|FG000|Overall Study|Adverse Event|13|||
23466439|NCT00521404|65452019|FG000|Overall Study|Disease Progression|33|||
23466440|NCT00521404|65452019|FG000|Overall Study|Investigator decision|5|||
23466441|NCT00521404|65452019|FG000|Overall Study|Withdrawal of consent|3|||
23466442|NCT00521404|65452019|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
23466443|NCT00521404|65452019|FG000|Overall Study|Other|7|||
23466444|NCT01867671|65452021|FG000|Overall Study|Adverse Event|5|||
23466445|NCT01867671|65452022|FG001|Overall Study|Adverse Event|3|||
23586310|NCT01235949|65873043|FG004|Booster Phase|Migrated/moved from study area|0|||
23586311|NCT01235949|65873044|FG005|Booster Phase|Migrated/moved from study area|0|||
23586312|NCT01235949|65873045|FG006|Booster Phase|Migrated/moved from study area|0|||
23586313|NCT01235949|65873046|FG007|Booster Phase|Migrated/moved from study area|0|||
23586314|NCT01235949|65873047|FG008|Booster Phase|Migrated/moved from study area|0|||
23586315|NCT01235949|65873048|FG009|Booster Phase|Migrated/moved from study area|0|||
23586316|NCT01235949|65873049|FG010|Booster Phase|Migrated/moved from study area|0|||
23586317|NCT01235949|65873050|FG011|Booster Phase|Migrated/moved from study area|1|||
23586318|NCT01235949|65873051|FG012|Booster Phase|Migrated/moved from study area|1|||
23586319|NCT01235949|65873052|FG013|Booster Phase|Migrated/moved from study area|0|||
23586320|NCT01235949|65873053|FG014|Booster Phase|Migrated/moved from study area|0|||
23586321|NCT01235949|65873054|FG015|Booster Phase|Migrated/moved from study area|0|||
23586322|NCT01235949|65873055|FG016|Booster Phase|Migrated/moved from study area|0|||
23466446|NCT01867671|65452021|FG000|Overall Study|Anaphylaxis|0|||
23466447|NCT01867671|65452022|FG001|Overall Study|Anaphylaxis|1|||
23466448|NCT01867671|65452021|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
23466449|NCT01867671|65452022|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
23466450|NCT01867671|65452021|FG000|Overall Study|Lost to Follow-up|0|||
23466451|NCT01867671|65452022|FG001|Overall Study|Lost to Follow-up|1|||
23466452|NCT01867671|65452021|FG000|Overall Study|Non-compliance with Study Drug|1|||
23466453|NCT01867671|65452022|FG001|Overall Study|Non-compliance with Study Drug|2|||
23586323|NCT01235949|65873056|FG017|Booster Phase|Migrated/moved from study area|1|||
23792351|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
23792352|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
23792353|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
23792354|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
23792355|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
23792356|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
23792357|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
23792358|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
23792359|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
23792360|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
23586324|NCT01235949|65873039|FG000|Booster Phase|Adverse Event|0|||
23586325|NCT01235949|65873040|FG001|Booster Phase|Adverse Event|0|||
23586326|NCT01235949|65873041|FG002|Booster Phase|Adverse Event|0|||
23466454|NCT01867671|65452021|FG000|Overall Study|Withdrawal by Subject|21|||
23466455|NCT01867671|65452022|FG001|Overall Study|Withdrawal by Subject|21|||
23586327|NCT01235949|65873042|FG003|Booster Phase|Adverse Event|0|||
23586328|NCT01235949|65873043|FG004|Booster Phase|Adverse Event|0|||
23586329|NCT01235949|65873044|FG005|Booster Phase|Adverse Event|0|||
23466456|NCT00628108|65452023|FG000|Overall Study|Adverse Event|0|||
23466457|NCT00628108|65452024|FG001|Overall Study|Adverse Event|3|||
23466458|NCT00628108|65452023|FG000|Overall Study|Withdrawal by Subject|1|||
23466459|NCT00628108|65452024|FG001|Overall Study|Withdrawal by Subject|0|||
23466460|NCT01265537|65452025|FG000|Overall Study|Adverse Event|2|||
23466461|NCT01265537|65452026|FG001|Overall Study|Adverse Event|1|||
23466462|NCT01265537|65452025|FG000|Overall Study|Physician Decision|0|||
23466463|NCT01265537|65452026|FG001|Overall Study|Physician Decision|1|||
23466464|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
23466465|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
23466466|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
23351400|NCT01593254|65029619|FG000|Overall Study|AE unrelated to study drug|0|||
23466467|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23466468|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23466469|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23466470|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23466471|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23466472|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
23466473|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23466474|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23466475|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
23466476|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
23466477|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
23466478|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
23466479|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
23466480|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
23466481|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
23466482|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
23466483|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
23466484|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
23466485|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
23466486|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
23466487|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
23466488|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
23466489|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
23466490|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
23466491|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
23466492|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
23466493|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
23466494|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
23466495|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
23466496|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
23466497|NCT02560558|65452031|FG000|Overall Study|Adverse Event|1|||
23466498|NCT02560558|65452032|FG001|Overall Study|Adverse Event|0|||
23466499|NCT02560558|65452031|FG000|Overall Study|Death|0|||
23466500|NCT02560558|65452032|FG001|Overall Study|Death|2|||
23466501|NCT02560558|65452031|FG000|Overall Study|Lost to Follow-up|0|||
23792361|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
23792362|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
23466502|NCT02560558|65452032|FG001|Overall Study|Lost to Follow-up|4|||
23466503|NCT02560558|65452031|FG000|Overall Study|Protocol Violation|3|||
23466504|NCT02560558|65452032|FG001|Overall Study|Protocol Violation|0|||
23466505|NCT02560558|65452031|FG000|Overall Study|Withdrawal by Subject|3|||
23466506|NCT02560558|65452032|FG001|Overall Study|Withdrawal by Subject|0|||
23466507|NCT02351856|65452033|FG000|Overall Study|Adverse Event|2|||
23466508|NCT02351856|65452033|FG000|Overall Study|Physician Decision|5|||
23466509|NCT02351856|65452033|FG000|Overall Study|Study terminated by sponsor|1|||
23466510|NCT03819114|65452039|FG000|Overall Study|Protocol Violation|0|||
23466511|NCT03819114|65452040|FG001|Overall Study|Protocol Violation|1|||
23466512|NCT03819114|65452041|FG002|Overall Study|Protocol Violation|1|||
23466513|NCT03819114|65452042|FG003|Overall Study|Protocol Violation|0|||
23466514|NCT03819114|65452039|FG000|Overall Study|Lost to Follow-up|0|||
23466515|NCT03819114|65452040|FG001|Overall Study|Lost to Follow-up|0|||
23466516|NCT03819114|65452041|FG002|Overall Study|Lost to Follow-up|1|||
23466517|NCT03819114|65452042|FG003|Overall Study|Lost to Follow-up|0|||
23466518|NCT01166282|65452054|FG000|Open-label Period|Adverse Event|0|||
23466519|NCT01166282|65452055|FG001|Open-label Period|Adverse Event|0|||
23466520|NCT01166282|65452056|FG002|Open-label Period|Adverse Event|6|||
23466521|NCT01166282|65452054|FG000|Open-label Period|Withdrawal by Subject|0|||
23466522|NCT01166282|65452055|FG001|Open-label Period|Withdrawal by Subject|0|||
23466523|NCT01166282|65452056|FG002|Open-label Period|Withdrawal by Subject|4|||
23466524|NCT01166282|65452054|FG000|Open-label Period|Lack of Efficacy|0|||
23466525|NCT01166282|65452055|FG001|Open-label Period|Lack of Efficacy|0|||
23466526|NCT01166282|65452056|FG002|Open-label Period|Lack of Efficacy|2|||
23466527|NCT01166282|65452054|FG000|Open-label Period|Remission|0|||
23466528|NCT01166282|65452055|FG001|Open-label Period|Remission|0|||
23466529|NCT01166282|65452056|FG002|Open-label Period|Remission|4|||
23466530|NCT01166282|65452054|FG000|Open-label Period|Irregular Compliance|0|||
23466531|NCT01166282|65452055|FG001|Open-label Period|Irregular Compliance|0|||
23466532|NCT01166282|65452056|FG002|Open-label Period|Irregular Compliance|1|||
23466533|NCT00196313|65452057|FG000|Overall Study|Protocol Violation|2|||
23466534|NCT00196313|65452058|FG001|Overall Study|Protocol Violation|3|||
23466535|NCT00196313|65452057|FG000|Overall Study|Withdrawal by Subject|3|||
23466536|NCT00196313|65452058|FG001|Overall Study|Withdrawal by Subject|1|||
23466537|NCT00196313|65452057|FG000|Overall Study|Adverse Event|3|||
23586330|NCT01235949|65873045|FG006|Booster Phase|Adverse Event|0|||
23586331|NCT01235949|65873046|FG007|Booster Phase|Adverse Event|0|||
23586332|NCT01235949|65873047|FG008|Booster Phase|Adverse Event|0|||
23586333|NCT01235949|65873048|FG009|Booster Phase|Adverse Event|0|||
23586334|NCT01235949|65873049|FG010|Booster Phase|Adverse Event|0|||
23586335|NCT01235949|65873050|FG011|Booster Phase|Adverse Event|0|||
23586336|NCT01235949|65873051|FG012|Booster Phase|Adverse Event|0|||
23586337|NCT01235949|65873052|FG013|Booster Phase|Adverse Event|0|||
23586338|NCT01235949|65873053|FG014|Booster Phase|Adverse Event|0|||
23586339|NCT01235949|65873054|FG015|Booster Phase|Adverse Event|1|||
23586340|NCT01235949|65873055|FG016|Booster Phase|Adverse Event|0|||
23586341|NCT01235949|65873056|FG017|Booster Phase|Adverse Event|0|||
23586342|NCT01235949|65873039|FG000|Booster Phase|Withdrawal by Subject|0|||
23640303|NCT05593445|66067449|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
23640304|NCT05593445|66067450|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23640305|NCT05593445|66067451|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23640306|NCT05593445|66067452|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23466538|NCT00196313|65452058|FG001|Overall Study|Adverse Event|1|||
23586343|NCT01235949|65873040|FG001|Booster Phase|Withdrawal by Subject|0|||
23640307|NCT05593445|66067449|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
23640308|NCT05593445|66067450|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
23466539|NCT00196313|65452057|FG000|Overall Study|Subject Pregnant|1|||
23466540|NCT00196313|65452058|FG001|Overall Study|Subject Pregnant|1|||
23466541|NCT00196313|65452057|FG000|Overall Study|Lost to Follow-up|2|||
23466542|NCT00196313|65452058|FG001|Overall Study|Lost to Follow-up|2|||
23586344|NCT01235949|65873041|FG002|Booster Phase|Withdrawal by Subject|0|||
23586345|NCT01235949|65873042|FG003|Booster Phase|Withdrawal by Subject|0|||
23586346|NCT01235949|65873043|FG004|Booster Phase|Withdrawal by Subject|0|||
23586347|NCT01235949|65873044|FG005|Booster Phase|Withdrawal by Subject|0|||
23586348|NCT01235949|65873045|FG006|Booster Phase|Withdrawal by Subject|0|||
23586349|NCT01235949|65873046|FG007|Booster Phase|Withdrawal by Subject|1|||
23586350|NCT01235949|65873047|FG008|Booster Phase|Withdrawal by Subject|1|||
23586351|NCT01235949|65873048|FG009|Booster Phase|Withdrawal by Subject|0|||
23586352|NCT01235949|65873049|FG010|Booster Phase|Withdrawal by Subject|1|||
23586353|NCT01235949|65873050|FG011|Booster Phase|Withdrawal by Subject|1|||
23586354|NCT01235949|65873051|FG012|Booster Phase|Withdrawal by Subject|2|||
23586355|NCT01235949|65873052|FG013|Booster Phase|Withdrawal by Subject|0|||
23586356|NCT01235949|65873053|FG014|Booster Phase|Withdrawal by Subject|2|||
23586357|NCT01235949|65873054|FG015|Booster Phase|Withdrawal by Subject|0|||
23586358|NCT01235949|65873055|FG016|Booster Phase|Withdrawal by Subject|0|||
23586359|NCT01235949|65873056|FG017|Booster Phase|Withdrawal by Subject|0|||
23586360|NCT01235949|65873039|FG000|Booster Phase|Lost to Follow-up|0|||
23586361|NCT01235949|65873040|FG001|Booster Phase|Lost to Follow-up|0|||
23586362|NCT01235949|65873041|FG002|Booster Phase|Lost to Follow-up|0|||
23586363|NCT01235949|65873042|FG003|Booster Phase|Lost to Follow-up|0|||
23586364|NCT01235949|65873043|FG004|Booster Phase|Lost to Follow-up|0|||
23586365|NCT01235949|65873044|FG005|Booster Phase|Lost to Follow-up|0|||
23586366|NCT01235949|65873045|FG006|Booster Phase|Lost to Follow-up|0|||
23586367|NCT01235949|65873046|FG007|Booster Phase|Lost to Follow-up|0|||
23640309|NCT05593445|66067451|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
23640310|NCT05593445|66067452|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
23640311|NCT05593445|66067449|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
23640312|NCT05593445|66067450|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
23640313|NCT05593445|66067451|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
23640314|NCT05593445|66067452|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
23640315|NCT05593445|66067449|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23640316|NCT05593445|66067450|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23640317|NCT05593445|66067451|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
23640318|NCT05593445|66067452|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23640319|NCT03241927|66067459|FG000|Overall Study|study terminated|1|||
23640320|NCT03241927|66067460|FG001|Overall Study|study terminated|0|||
23586368|NCT01235949|65873047|FG008|Booster Phase|Lost to Follow-up|1|||
23640321|NCT02030002|66067461|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
23640322|NCT02030002|66067461|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
23586369|NCT01235949|65873048|FG009|Booster Phase|Lost to Follow-up|1|||
23586370|NCT01235949|65873049|FG010|Booster Phase|Lost to Follow-up|1|||
23586371|NCT01235949|65873050|FG011|Booster Phase|Lost to Follow-up|1|||
23586372|NCT01235949|65873051|FG012|Booster Phase|Lost to Follow-up|0|||
23640323|NCT02030002|66067461|FG000|Follow-up|Lost to Follow-up|2|||
23640324|NCT00588692|66067462|FG000|Overall Study|Withdrawal by Subject|4|||
23640325|NCT00588692|66067463|FG001|Overall Study|Withdrawal by Subject|2|||
23640326|NCT00588692|66067462|FG000|Overall Study|Hip Surgery|0|||
23640327|NCT00588692|66067463|FG001|Overall Study|Hip Surgery|1|||
23640328|NCT00588692|66067462|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
23640329|NCT00588692|66067463|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
23640330|NCT00588692|66067462|FG000|Overall Study|Cancer|1|||
23640331|NCT00588692|66067463|FG001|Overall Study|Cancer|0|||
23640332|NCT00588692|66067462|FG000|Overall Study|Death|1|||
23640333|NCT00588692|66067463|FG001|Overall Study|Death|0|||
23640334|NCT01879722|66067465|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23640335|NCT01879722|66067466|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23640336|NCT01879722|66067467|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23640337|NCT01879722|66067468|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23586373|NCT01235949|65873052|FG013|Booster Phase|Lost to Follow-up|0|||
23586374|NCT01235949|65873053|FG014|Booster Phase|Lost to Follow-up|0|||
23586375|NCT01235949|65873054|FG015|Booster Phase|Lost to Follow-up|0|||
23586376|NCT01235949|65873055|FG016|Booster Phase|Lost to Follow-up|0|||
23586377|NCT01235949|65873056|FG017|Booster Phase|Lost to Follow-up|1|||
23586378|NCT02107014|65873057|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
23586379|NCT00387465|65873058|FG000|Overall Study|Withdrawal by Subject|0|||
23586380|NCT00387465|65873059|FG001|Overall Study|Withdrawal by Subject|1|||
23586381|NCT00387465|65873060|FG002|Overall Study|Withdrawal by Subject|0|||
23640338|NCT01879722|66067469|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
23640339|NCT01879722|66067470|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23586382|NCT00763282|65873061|FG000|Overall Study|Withdrawal by Subject|6|||
23586383|NCT00763282|65873062|FG001|Overall Study|Withdrawal by Subject|5|||
23586384|NCT00763282|65873061|FG000|Overall Study|Death|4|||
23586385|NCT00763282|65873062|FG001|Overall Study|Death|3|||
23640340|NCT01879722|66067471|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
23640341|NCT01879722|66067472|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
23640342|NCT01879722|66067473|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
23466543|NCT00981058|65452061|FG000|Overall Study|Adverse Event|1|||
23466544|NCT00981058|65452062|FG001|Overall Study|Adverse Event|1|||
23466545|NCT00981058|65452061|FG000|Overall Study|Progressive Disease|61|||
23466546|NCT00981058|65452062|FG001|Overall Study|Progressive Disease|49|||
23586386|NCT00763282|65873061|FG000|Overall Study|Lost to Follow-up|22|||
23586387|NCT00763282|65873062|FG001|Overall Study|Lost to Follow-up|26|||
23586388|NCT00608907|65873063|FG000|Overall Study|Adverse Event|6|||
23586389|NCT00608907|65873064|FG001|Overall Study|Adverse Event|0|||
23586390|NCT00608907|65873065|FG002|Overall Study|Adverse Event|1|||
23586391|NCT00608907|65873063|FG000|Overall Study|Death|1|||
23586392|NCT00608907|65873064|FG001|Overall Study|Death|0|||
23586393|NCT00608907|65873065|FG002|Overall Study|Death|0|||
23586394|NCT00608907|65873063|FG000|Overall Study|Withdrawal by Subject|4|||
23586395|NCT00608907|65873064|FG001|Overall Study|Withdrawal by Subject|0|||
23586396|NCT00608907|65873065|FG002|Overall Study|Withdrawal by Subject|0|||
23586397|NCT00608907|65873063|FG000|Overall Study|Progressive Disease|1|||
23586398|NCT00608907|65873064|FG001|Overall Study|Progressive Disease|0|||
23586399|NCT00608907|65873065|FG002|Overall Study|Progressive Disease|0|||
23586400|NCT02282527|65873066|FG000|Overall Study|Lost to Follow-up|0|||
23792363|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
23792364|NCT01435928|66620397|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
23792365|NCT01435928|66620398|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
23792366|NCT01435928|66620399|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
23792367|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
23792368|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
23792369|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
23792370|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
23792371|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
23792372|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
23792373|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
23792374|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
23792375|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
23792376|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
23792377|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
23792378|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
23792379|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
23792380|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
23792381|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
23792382|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
23792383|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
23792384|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
23466547|NCT00981058|65452061|FG000|Overall Study|Lost to Follow-up|16|||
23466548|NCT00981058|65452062|FG001|Overall Study|Lost to Follow-up|15|||
23466549|NCT00981058|65452061|FG000|Overall Study|New Anticancer Therapy|6|||
23466550|NCT00981058|65452062|FG001|Overall Study|New Anticancer Therapy|6|||
23466551|NCT00981058|65452061|FG000|Overall Study|Noncompliance|1|||
23466552|NCT00981058|65452062|FG001|Overall Study|Noncompliance|0|||
23466553|NCT00981058|65452061|FG000|Overall Study|Radiologist Error|0|||
23466554|NCT00981058|65452062|FG001|Overall Study|Radiologist Error|1|||
23466555|NCT00981058|65452061|FG000|Overall Study|Randomization Error|1|||
23466556|NCT00981058|65452062|FG001|Overall Study|Randomization Error|2|||
23466557|NCT00981058|65452061|FG000|Overall Study|Withdrawal by Subject|25|||
23466558|NCT00981058|65452062|FG001|Overall Study|Withdrawal by Subject|23|||
23466559|NCT00981058|65452061|FG000|Overall Study|On study treatment at conclusion|9|||
23466560|NCT00981058|65452062|FG001|Overall Study|On study treatment at conclusion|0|||
23466561|NCT02350478|65452064|FG000|Overall Study|Lost to Follow-up|5|||
23466562|NCT02350478|65452065|FG001|Overall Study|Lost to Follow-up|1|||
23466563|NCT00035932|65452066|FG000|Overall Study|Adverse Event|10|||
23466564|NCT00035932|65452067|FG001|Overall Study|Adverse Event|9|||
23466565|NCT00035932|65452068|FG002|Overall Study|Adverse Event|9|||
23466566|NCT00035932|65452066|FG000|Overall Study|Death|0|||
23466567|NCT00035932|65452067|FG001|Overall Study|Death|0|||
23466568|NCT00035932|65452068|FG002|Overall Study|Death|1|||
23466569|NCT00035932|65452066|FG000|Overall Study|Disease Progression / Relapse|1|||
23466570|NCT00035932|65452067|FG001|Overall Study|Disease Progression / Relapse|1|||
23351401|NCT01593254|65029620|FG001|Overall Study|AE unrelated to study drug|1|||
23351402|NCT01593254|65029619|FG000|Overall Study|participant request to discontinue study treatment|1|||
23351403|NCT01593254|65029620|FG001|Overall Study|participant request to discontinue study treatment|3|||
23351404|NCT01593254|65029619|FG000|Overall Study|participant withdrew consent|0|||
23351405|NCT01593254|65029620|FG001|Overall Study|participant withdrew consent|9|||
23466571|NCT00035932|65452068|FG002|Overall Study|Disease Progression / Relapse|0|||
23466572|NCT00035932|65452066|FG000|Overall Study|Lost to Follow-up|4|||
23586401|NCT02282527|65873067|FG001|Overall Study|Lost to Follow-up|1|||
23640343|NCT01879722|66067474|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
23640344|NCT01879722|66067465|FG000|Overall Study|Voluntary Withdrawal|0|||
23640345|NCT01879722|66067466|FG001|Overall Study|Voluntary Withdrawal|0|||
23640346|NCT01879722|66067467|FG002|Overall Study|Voluntary Withdrawal|0|||
23586402|NCT02282527|65873066|FG000|Overall Study|Lack of home health aid|1|||
23586403|NCT02282527|65873067|FG001|Overall Study|Lack of home health aid|0|||
23586404|NCT01211665|65873068|FG000|Overall Study|Withdrawal by Subject|1|||
23586405|NCT01211665|65873069|FG001|Overall Study|Withdrawal by Subject|0|||
23586406|NCT01211665|65873068|FG000|Overall Study|Death|1|||
23586407|NCT01211665|65873069|FG001|Overall Study|Death|0|||
23586408|NCT01549652|65873070|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
23586409|NCT01549652|65873071|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
23586410|NCT01549652|65873072|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
23586411|NCT01549652|65873073|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
23586412|NCT01549652|65873070|FG000|Overall Study|Study Drug Titration Failure|5|||
23586413|NCT01549652|65873071|FG001|Overall Study|Study Drug Titration Failure|6|||
23586414|NCT01549652|65873072|FG002|Overall Study|Study Drug Titration Failure|0|||
23586415|NCT01549652|65873073|FG003|Overall Study|Study Drug Titration Failure|0|||
23586416|NCT01549652|65873070|FG000|Overall Study|Withdrawal Effect|0|||
23586417|NCT01549652|65873071|FG001|Overall Study|Withdrawal Effect|2|||
23586418|NCT01549652|65873072|FG002|Overall Study|Withdrawal Effect|0|||
23640347|NCT01879722|66067468|FG003|Overall Study|Voluntary Withdrawal|0|||
23640348|NCT01879722|66067469|FG004|Overall Study|Voluntary Withdrawal|0|||
23640349|NCT01879722|66067470|FG005|Overall Study|Voluntary Withdrawal|0|||
23640350|NCT01879722|66067471|FG006|Overall Study|Voluntary Withdrawal|0|||
23351406|NCT01593254|65029619|FG000|Overall Study|lost to follow up|1|||
23466573|NCT00035932|65452067|FG001|Overall Study|Lost to Follow-up|4|||
23640351|NCT01879722|66067472|FG007|Overall Study|Voluntary Withdrawal|0|||
23640352|NCT01879722|66067473|FG008|Overall Study|Voluntary Withdrawal|1|||
23640353|NCT01879722|66067474|FG009|Overall Study|Voluntary Withdrawal|0|||
23640354|NCT02781090|66067479|FG000|3-Month Follow-Up|Missed Visit|20|||
23640355|NCT02781090|66067480|FG001|3-Month Follow-Up|Missed Visit|20|||
23586419|NCT01549652|65873073|FG003|Overall Study|Withdrawal Effect|0|||
23640356|NCT02781090|66067479|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
23466574|NCT00035932|65452068|FG002|Overall Study|Lost to Follow-up|3|||
23466575|NCT00035932|65452066|FG000|Overall Study|Noncompliance|6|||
23466576|NCT00035932|65452067|FG001|Overall Study|Noncompliance|7|||
23466577|NCT00035932|65452068|FG002|Overall Study|Noncompliance|6|||
23466578|NCT00035932|65452066|FG000|Overall Study|Protocol Violation While on Study|0|||
23466579|NCT00035932|65452067|FG001|Overall Study|Protocol Violation While on Study|1|||
23466580|NCT00035932|65452068|FG002|Overall Study|Protocol Violation While on Study|2|||
23466581|NCT00035932|65452066|FG000|Overall Study|Withdrawal by Subject|1|||
23466582|NCT00035932|65452067|FG001|Overall Study|Withdrawal by Subject|5|||
23466583|NCT00035932|65452068|FG002|Overall Study|Withdrawal by Subject|0|||
23466584|NCT00035932|65452066|FG000|Overall Study|Study Termination by Sponsor|1|||
23466585|NCT00035932|65452067|FG001|Overall Study|Study Termination by Sponsor|0|||
23466586|NCT00035932|65452068|FG002|Overall Study|Study Termination by Sponsor|0|||
23466587|NCT00035932|65452066|FG000|Overall Study|Lack of Efficacy|33|||
23466588|NCT00035932|65452067|FG001|Overall Study|Lack of Efficacy|33|||
23586420|NCT01549652|65873070|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
23586421|NCT01549652|65873071|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
23586422|NCT01549652|65873072|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
23586423|NCT01549652|65873073|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
23586424|NCT01549652|65873070|FG000|Overall Study|Problem with Infusion|1|||
23586425|NCT01549652|65873071|FG001|Overall Study|Problem with Infusion|0|||
23792385|NCT01435928|66620397|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
23792386|NCT01435928|66620398|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
23792387|NCT01435928|66620399|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
23792388|NCT04428645|66620404|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
23792389|NCT04010227|66620417|FG000|Overall Study|Death|1|||
23792390|NCT04010227|66620418|FG001|Overall Study|Death|2|||
23792391|NCT04010227|66620417|FG000|Overall Study|Medical Reasons|4|||
23792392|NCT04010227|66620418|FG001|Overall Study|Medical Reasons|3|||
23792393|NCT04010227|66620417|FG000|Overall Study|Withdrawal by Subject|2|||
23792394|NCT04010227|66620418|FG001|Overall Study|Withdrawal by Subject|0|||
23792395|NCT04010227|66620417|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
23792396|NCT04010227|66620418|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
23792397|NCT02107196|66620425|FG000|12-week Treatment Period|Adverse Event|6|||
23792398|NCT02107196|66620426|FG001|12-week Treatment Period|Adverse Event|3|||
23792399|NCT02107196|66620425|FG000|12-week Treatment Period|Lack of Efficacy|2|||
23792400|NCT02107196|66620426|FG001|12-week Treatment Period|Lack of Efficacy|1|||
23792401|NCT02107196|66620425|FG000|12-week Treatment Period|Lost to Follow-up|3|||
23792402|NCT02107196|66620426|FG001|12-week Treatment Period|Lost to Follow-up|6|||
23792403|NCT02107196|66620425|FG000|12-week Treatment Period|Physician Decision|0|||
23792404|NCT02107196|66620426|FG001|12-week Treatment Period|Physician Decision|1|||
23792405|NCT02107196|66620425|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
23792406|NCT02107196|66620426|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
23792407|NCT02107196|66620425|FG000|12-week Treatment Period|Protocol Violation|7|||
23792408|NCT02107196|66620426|FG001|12-week Treatment Period|Protocol Violation|8|||
23792409|NCT02107196|66620425|FG000|12-week Treatment Period|Reason Missing|11|||
23792410|NCT02107196|66620426|FG001|12-week Treatment Period|Reason Missing|8|||
23792411|NCT02107196|66620425|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
23792412|NCT02107196|66620426|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
23792413|NCT02107196|66620425|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
23792414|NCT02107196|66620426|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23792415|NCT02107196|66620425|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
23792416|NCT02107196|66620426|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
23466589|NCT00035932|65452068|FG002|Overall Study|Lack of Efficacy|28|||
23792417|NCT02107196|66620425|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
23792418|NCT02107196|66620426|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
23792419|NCT00379353|66620427|FG000|Overall Study|Hospitalization|3|||
23792420|NCT00379353|66620428|FG001|Overall Study|Hospitalization|3|||
23466590|NCT01388335|65452071|FG000|Period 1|Progressive Disease|1|||
23706515|NCT03554005|66301233|FG000|Overall Study|Other|0|||
23792421|NCT00379353|66620427|FG000|Overall Study|Withdrawal by Subject|5|||
23792422|NCT00379353|66620428|FG001|Overall Study|Withdrawal by Subject|2|||
23792423|NCT00379353|66620427|FG000|Overall Study|Death|1|||
23792424|NCT00379353|66620428|FG001|Overall Study|Death|0|||
23792425|NCT00379353|66620427|FG000|Overall Study|Cardiac Tamponade|1|||
23792426|NCT00379353|66620428|FG001|Overall Study|Cardiac Tamponade|0|||
23792427|NCT00379353|66620427|FG000|Overall Study|Non-compliance|1|||
23792428|NCT00379353|66620428|FG001|Overall Study|Non-compliance|0|||
23792429|NCT00379353|66620427|FG000|Overall Study|Conflicting drug treatment|0|||
23792430|NCT00379353|66620428|FG001|Overall Study|Conflicting drug treatment|1|||
23792431|NCT00469898|66620429|FG000|Overall Study|Adverse Event|7|||
23792432|NCT00469898|66620429|FG000|Overall Study|Withdrawal by Subject|4|||
23792433|NCT00469898|66620429|FG000|Overall Study|Death|4|||
23792434|NCT00469898|66620429|FG000|Overall Study|Disease progression|9|||
23792435|NCT00469898|66620429|FG000|Overall Study|Decreased performance status|1|||
23792436|NCT02151149|66620430|FG000|Treatment Period|Death|2|||
23792437|NCT02151149|66620431|FG001|Treatment Period|Death|3|||
23792438|NCT02151149|66620430|FG000|Treatment Period|Adverse Event|17|||
23792439|NCT02151149|66620431|FG001|Treatment Period|Adverse Event|14|||
23792440|NCT02151149|66620430|FG000|Treatment Period|Progressive Disease|25|||
23792441|NCT02151149|66620431|FG001|Treatment Period|Progressive Disease|24|||
23792442|NCT02151149|66620430|FG000|Treatment Period|Symptomatic Deterioration|2|||
23792443|NCT02151149|66620431|FG001|Treatment Period|Symptomatic Deterioration|10|||
23792444|NCT02151149|66620430|FG000|Treatment Period|Withdrawal by Subject|13|||
23351407|NCT01593254|65029620|FG001|Overall Study|lost to follow up|6|||
23351408|NCT01593254|65029619|FG000|Overall Study|maximum clinical benefit|1|||
23351409|NCT01593254|65029620|FG001|Overall Study|maximum clinical benefit|2|||
23351410|NCT01593254|65029619|FG000|Overall Study|Poor/non compliance|1|||
23351411|NCT01593254|65029620|FG001|Overall Study|Poor/non compliance|1|||
23792445|NCT02151149|66620431|FG001|Treatment Period|Withdrawal by Subject|11|||
23792446|NCT02151149|66620430|FG000|Treatment Period|Miscellaneous|8|||
23792447|NCT02151149|66620431|FG001|Treatment Period|Miscellaneous|7|||
23792448|NCT02151149|66620430|FG000|Treatment Period|Participants randomized but not treated|3|||
23792449|NCT02151149|66620431|FG001|Treatment Period|Participants randomized but not treated|2|||
23792450|NCT02151149|66620430|FG000|Follow-Up Period|Lost to Follow-up|2|||
23792451|NCT02151149|66620431|FG001|Follow-Up Period|Lost to Follow-up|3|||
23792452|NCT02151149|66620430|FG000|Follow-Up Period|Death|37|||
23351412|NCT01593254|65029619|FG000|Overall Study|Pregnancy|0|||
23351413|NCT01593254|65029620|FG001|Overall Study|Pregnancy|3|||
23466591|NCT01388335|65452071|FG000|Period 2|Progressive Disease|2|||
23586426|NCT01549652|65873072|FG002|Overall Study|Problem with Infusion|0|||
23586427|NCT01549652|65873073|FG003|Overall Study|Problem with Infusion|0|||
23586428|NCT01549652|65873070|FG000|Overall Study|Titration Non-Compliance|1|||
23586429|NCT01549652|65873071|FG001|Overall Study|Titration Non-Compliance|3|||
23586430|NCT01549652|65873072|FG002|Overall Study|Titration Non-Compliance|4|||
23586431|NCT01549652|65873073|FG003|Overall Study|Titration Non-Compliance|5|||
23586432|NCT01549652|65873070|FG000|Overall Study|Titration Side Effects|0|||
23586433|NCT01549652|65873071|FG001|Overall Study|Titration Side Effects|0|||
23586434|NCT01549652|65873072|FG002|Overall Study|Titration Side Effects|6|||
23586435|NCT01549652|65873073|FG003|Overall Study|Titration Side Effects|3|||
23586436|NCT01549652|65873070|FG000|Overall Study|Withdrawal by Subject|0|||
23586437|NCT01549652|65873071|FG001|Overall Study|Withdrawal by Subject|0|||
23586438|NCT01549652|65873072|FG002|Overall Study|Withdrawal by Subject|5|||
23792453|NCT02151149|66620431|FG001|Follow-Up Period|Death|34|||
23792454|NCT02725515|66620432|FG000|Overall Study|Refused infusion (no study treatment)|1|||
23792455|NCT02725515|66620433|FG001|Overall Study|Refused infusion (no study treatment)|0|||
23792456|NCT02725515|66620432|FG000|Overall Study|Loss of Improvement per Protocol|14|||
23792457|NCT02725515|66620433|FG001|Overall Study|Loss of Improvement per Protocol|25|||
23792458|NCT02725515|66620432|FG000|Overall Study|Withdrawal by Subject|2|||
23792459|NCT02725515|66620433|FG001|Overall Study|Withdrawal by Subject|1|||
23792460|NCT02725515|66620432|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23792461|NCT02725515|66620433|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23792462|NCT02725515|66620432|FG000|Overall Study|Lost to Follow-up|1|||
23792463|NCT02725515|66620433|FG001|Overall Study|Lost to Follow-up|1|||
23792464|NCT02725515|66620432|FG000|Overall Study|Adverse Event|7|||
23792465|NCT02725515|66620433|FG001|Overall Study|Adverse Event|2|||
23792466|NCT02725515|66620432|FG000|Overall Study|No Documented Disease Improvement|0|||
23792467|NCT02725515|66620433|FG001|Overall Study|No Documented Disease Improvement|1|||
23792468|NCT02725515|66620432|FG000|Overall Study|Completed Study Under Original Protocol|0|||
23792469|NCT02725515|66620433|FG001|Overall Study|Completed Study Under Original Protocol|1|||
23792470|NCT02725515|66620432|FG000|Overall Study|Lack of Response|0|||
23792471|NCT02725515|66620433|FG001|Overall Study|Lack of Response|1|||
23792472|NCT03206749|66620436|FG000|Overall Study|Withdrawal of consent|5|||
23792473|NCT03206749|66620437|FG001|Overall Study|Withdrawal of consent|3|||
23792474|NCT03206749|66620438|FG002|Overall Study|Withdrawal of consent|6|||
23792475|NCT03206749|66620436|FG000|Overall Study|Lost to Follow-up|0|||
23792476|NCT03206749|66620437|FG001|Overall Study|Lost to Follow-up|0|||
23792477|NCT03206749|66620438|FG002|Overall Study|Lost to Follow-up|1|||
23792478|NCT01688882|66620445|FG000|Overall Study|Adverse Event|1|||
23792479|NCT01688882|66620446|FG001|Overall Study|Adverse Event|0|||
23792480|NCT01688882|66620445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23792481|NCT01688882|66620446|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23792482|NCT01688882|66620445|FG000|Overall Study|Administrative problems|1|||
23792483|NCT01688882|66620446|FG001|Overall Study|Administrative problems|0|||
23792484|NCT01098539|66620448|FG000|Overall Study|Adverse Event|26|||
23792485|NCT01098539|66620449|FG001|Overall Study|Adverse Event|26|||
23792486|NCT01098539|66620448|FG000|Overall Study|Protocol Violation|1|||
23792487|NCT01098539|66620449|FG001|Overall Study|Protocol Violation|4|||
23792488|NCT01098539|66620448|FG000|Overall Study|Noncompliance|3|||
23792489|NCT01098539|66620449|FG001|Overall Study|Noncompliance|5|||
23792490|NCT01098539|66620448|FG000|Overall Study|Lost to Follow-up|4|||
23792491|NCT01098539|66620449|FG001|Overall Study|Lost to Follow-up|4|||
23792492|NCT01098539|66620448|FG000|Overall Study|Withdrawal by Subject|12|||
23792493|NCT01098539|66620449|FG001|Overall Study|Withdrawal by Subject|26|||
23792494|NCT01098539|66620448|FG000|Overall Study|Physician Decision|5|||
23792495|NCT01098539|66620449|FG001|Overall Study|Physician Decision|3|||
23792496|NCT01086969|66620450|FG000|Overall Study|Withdrawal by Subject|1|||
23792497|NCT01086969|66620451|FG001|Overall Study|Withdrawal by Subject|2|||
23792498|NCT01086969|66620452|FG002|Overall Study|Withdrawal by Subject|0|||
23792499|NCT02340962|66620453|FG000|Overall Study|Lost to Follow-up|1|||
23792500|NCT02340962|66620454|FG001|Overall Study|Lost to Follow-up|0|||
23792501|NCT00258856|66620455|FG000|Overall Study|Lost to Follow-up|1|||
23792502|NCT00258856|66620456|FG001|Overall Study|Lost to Follow-up|0|||
23792503|NCT00258856|66620457|FG002|Overall Study|Lost to Follow-up|2|||
23792504|NCT00258856|66620458|FG003|Overall Study|Lost to Follow-up|0|||
23792505|NCT00258856|66620455|FG000|Overall Study|Non-compliance|2|||
23792506|NCT00258856|66620456|FG001|Overall Study|Non-compliance|0|||
23792507|NCT00258856|66620457|FG002|Overall Study|Non-compliance|0|||
23792508|NCT00258856|66620458|FG003|Overall Study|Non-compliance|1|||
23792509|NCT03428945|66620463|FG000|Overall Study|Lost to Follow-up|5|||
23466592|NCT01388335|65452071|FG000|Period 2|Sponsor Decision|1|||
23466593|NCT01388335|65452071|FG000|Safety Extension|Progressive Disease|7|||
23466594|NCT04154189|65452072|FG000|Overall Study|Withdrawal by Subject|4|||
23466595|NCT04154189|65452073|FG001|Overall Study|Withdrawal by Subject|6|||
23466596|NCT04154189|65452072|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
23466597|NCT04154189|65452073|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
23466598|NCT04154189|65452072|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
23466599|NCT04154189|65452073|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
23466600|NCT04154189|65452072|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
23466601|NCT04154189|65452073|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
23466602|NCT04154189|65452072|FG000|Overall Study|Death|25|||
23792510|NCT03428945|66620464|FG001|Overall Study|Lost to Follow-up|3|||
23792511|NCT03428945|66620463|FG000|Overall Study|Withdrawal by Subject|10|||
23792512|NCT03428945|66620464|FG001|Overall Study|Withdrawal by Subject|10|||
23792513|NCT02451696|66620465|FG000|Overall Study|Surgery postponed|1|||
23792514|NCT02451696|66620466|FG001|Overall Study|Surgery postponed|0|||
23792515|NCT04049097|66620467|FG000|Overall Study|Adverse Event|18|||
23792516|NCT04049097|66620467|FG000|Overall Study|Death|2|||
23792517|NCT04049097|66620467|FG000|Overall Study|Lost to Follow-up|1|||
23466603|NCT04154189|65452073|FG001|Overall Study|Death|25|||
23792518|NCT04049097|66620467|FG000|Overall Study|Physician Decision|2|||
23792519|NCT04049097|66620467|FG000|Overall Study|Withdrawal by Subject|9|||
23792520|NCT04049097|66620467|FG000|Overall Study|Protocol Violation|2|||
23792521|NCT04049097|66620467|FG000|Overall Study|Other|1|||
23792522|NCT04049097|66620467|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
23792523|NCT02161549|66620468|FG000|Overall Study|Physician Decision|6|||
23792524|NCT02161549|66620469|FG001|Overall Study|Physician Decision|2|||
23792525|NCT00474188|66620474|FG000|Overall Study|Withdrawal by Subject|1|||
23792526|NCT00474188|66620474|FG000|Overall Study|Study discontinued by sponsor|5|||
23792527|NCT04129944|66620475|FG000|Overall Study|Death|0|||
23792528|NCT04129944|66620476|FG001|Overall Study|Death|0|||
23792529|NCT04129944|66620477|FG002|Overall Study|Death|0|||
23466604|NCT02500797|65452078|FG000|Overall Study|Cancel (rapid disease progression)|0|||
23466605|NCT02500797|65452079|FG001|Overall Study|Cancel (rapid disease progression)|0|||
23466606|NCT02500797|65452080|FG002|Overall Study|Cancel (rapid disease progression)|0|||
23466607|NCT02500797|65452081|FG003|Overall Study|Cancel (rapid disease progression)|0|||
23466608|NCT02500797|65452082|FG004|Overall Study|Cancel (rapid disease progression)|1|||
23586439|NCT01549652|65873073|FG003|Overall Study|Withdrawal by Subject|3|||
23586440|NCT00357396|65873074|FG000|Overall Study|Adverse Event|1|||
23586441|NCT00357396|65873075|FG001|Overall Study|Adverse Event|0|||
23586442|NCT02994654|65876005|FG000|Overall Study|Lost to Follow-up|1|||
23586443|NCT00686517|65876014|FG000|Treatment|Serious Adverse Event|1|||
23586444|NCT00686517|65876015|FG001|Treatment|Serious Adverse Event|2|||
23586445|NCT00686517|65876016|FG002|Treatment|Serious Adverse Event|1|||
23586446|NCT00686517|65876014|FG000|Treatment|Adverse Event|2|||
23586447|NCT00686517|65876015|FG001|Treatment|Adverse Event|0|||
23586448|NCT00686517|65876016|FG002|Treatment|Adverse Event|0|||
23640357|NCT02781090|66067480|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
23792530|NCT04129944|66620478|FG003|Overall Study|Death|1|||
23640358|NCT02781090|66067479|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
23640359|NCT02781090|66067480|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
23640360|NCT02781090|66067479|FG000|3-Month Follow-Up|Death|1|||
23640361|NCT02781090|66067480|FG001|3-Month Follow-Up|Death|0|||
23640362|NCT02781090|66067479|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
23640363|NCT02781090|66067480|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
23640364|NCT02781090|66067479|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
23640365|NCT02781090|66067480|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
23640366|NCT02781090|66067479|FG000|6-Month Follow-Up|Death|0|||
23640367|NCT02781090|66067480|FG001|6-Month Follow-Up|Death|1|||
23640368|NCT02643472|66067481|FG000|Overall Study|Death|2|||
23640369|NCT02643472|66067482|FG001|Overall Study|Death|5|||
23640370|NCT02643472|66067481|FG000|Overall Study|Withdrawal by Subject|3|||
23640371|NCT02643472|66067482|FG001|Overall Study|Withdrawal by Subject|2|||
23640372|NCT02643472|66067481|FG000|Overall Study|Protocol Violation|0|||
23640373|NCT02643472|66067482|FG001|Overall Study|Protocol Violation|1|||
23640374|NCT02643472|66067481|FG000|Overall Study|Lost to Follow-up|22|||
23640375|NCT02643472|66067482|FG001|Overall Study|Lost to Follow-up|26|||
23640376|NCT03705832|66067483|FG000|Overall Study|Physician Decision|0|||
23640377|NCT03705832|66067484|FG001|Overall Study|Physician Decision|1|||
23640378|NCT03705832|66067483|FG000|Overall Study|Withdrawal by Subject|1|||
23792531|NCT04129944|66620475|FG000|Overall Study|Lost to Follow-up|1|||
23792532|NCT04129944|66620476|FG001|Overall Study|Lost to Follow-up|0|||
23792533|NCT04129944|66620477|FG002|Overall Study|Lost to Follow-up|0|||
23792534|NCT04129944|66620478|FG003|Overall Study|Lost to Follow-up|0|||
23792535|NCT04129944|66620475|FG000|Overall Study|Withdrawal by Subject|1|||
23792536|NCT04129944|66620476|FG001|Overall Study|Withdrawal by Subject|0|||
23351414|NCT01593254|65029619|FG000|Overall Study|participant no longer meets study criteria|1|||
23351415|NCT01593254|65029620|FG001|Overall Study|participant no longer meets study criteria|1|||
23351416|NCT01593254|65029619|FG000|Overall Study|Admin reason by sponsor|7|||
23351417|NCT01593254|65029620|FG001|Overall Study|Admin reason by sponsor|3|||
23351418|NCT01593254|65029619|FG000|Overall Study|Imatinib treatment failure|2|||
23351419|NCT01593254|65029620|FG001|Overall Study|Imatinib treatment failure|0|||
23351420|NCT01593254|65029619|FG000|Overall Study|Other Reasons|61|||
23351421|NCT01593254|65029620|FG001|Overall Study|Other Reasons|115|||
23351422|NCT04490018|65029621|FG000|Overall Study|Protocol Violation|0|||
23351423|NCT04490018|65029622|FG001|Overall Study|Protocol Violation|2|||
23351424|NCT04490018|65029623|FG002|Overall Study|Protocol Violation|1|||
23351425|NCT04490018|65029621|FG000|Overall Study|Lost to Follow-up|2|||
23351426|NCT04490018|65029622|FG001|Overall Study|Lost to Follow-up|2|||
23351427|NCT04490018|65029623|FG002|Overall Study|Lost to Follow-up|0|||
23640379|NCT03705832|66067484|FG001|Overall Study|Withdrawal by Subject|0|||
23640380|NCT00616902|66067487|FG000|Overall Study|Termination of study|6|||
23640381|NCT00616902|66067488|FG001|Overall Study|Termination of study|6|||
23640382|NCT04738292|66067489|FG000|Overall Study|Death|1|||
23640383|NCT02081417|66067494|FG000|Overall Study|Lost to Follow-up|26|||
23640384|NCT02081417|66067495|FG001|Overall Study|Lost to Follow-up|23|||
23792537|NCT04129944|66620477|FG002|Overall Study|Withdrawal by Subject|1|||
23792538|NCT04129944|66620478|FG003|Overall Study|Withdrawal by Subject|2|||
23792539|NCT02845336|66620482|FG000|Overall Study|Lost to Follow-up|3|||
23792540|NCT02845336|66620483|FG001|Overall Study|Lost to Follow-up|1|||
23792541|NCT02845336|66620482|FG000|Overall Study|Inability to get medication|2|||
23792542|NCT02845336|66620483|FG001|Overall Study|Inability to get medication|0|||
23792543|NCT02661022|66620488|FG000|Overall Study|Withdrawal by Subject|3|||
23466609|NCT02500797|65452083|FG005|Overall Study|Cancel (rapid disease progression)|1|||
23466610|NCT02500797|65452084|FG006|Overall Study|Cancel (rapid disease progression)|0|||
23466611|NCT02500797|65452085|FG007|Overall Study|Cancel (rapid disease progression)|0|||
23466612|NCT02500797|65452078|FG000|Overall Study|Withdrawal by Subject|1|||
23466613|NCT02500797|65452079|FG001|Overall Study|Withdrawal by Subject|0|||
23466614|NCT02500797|65452080|FG002|Overall Study|Withdrawal by Subject|0|||
23466615|NCT02500797|65452081|FG003|Overall Study|Withdrawal by Subject|0|||
23466616|NCT02500797|65452082|FG004|Overall Study|Withdrawal by Subject|0|||
23466617|NCT02500797|65452083|FG005|Overall Study|Withdrawal by Subject|0|||
23466618|NCT02500797|65452084|FG006|Overall Study|Withdrawal by Subject|0|||
23466619|NCT02500797|65452085|FG007|Overall Study|Withdrawal by Subject|0|||
23466620|NCT00853567|65452086|FG000|Overall Study|Study prematurely terminated|71|||
23466621|NCT00354432|65452087|FG000|Overall Study|Adverse Event|3|||
23466622|NCT00354432|65452088|FG001|Overall Study|Adverse Event|1|||
23466623|NCT00354432|65452089|FG002|Overall Study|Adverse Event|5|||
23466624|NCT00354432|65452090|FG003|Overall Study|Adverse Event|5|||
23466625|NCT00354432|65452087|FG000|Overall Study|Off/Toxicity|3|||
23466626|NCT00354432|65452088|FG001|Overall Study|Off/Toxicity|7|||
23466627|NCT00354432|65452089|FG002|Overall Study|Off/Toxicity|5|||
23466628|NCT00354432|65452090|FG003|Overall Study|Off/Toxicity|5|||
23466629|NCT00706238|65452091|FG000|Overall Study|Disease progression|4|||
23466630|NCT00706238|65452091|FG000|Overall Study|Other|1|||
23466631|NCT00670306|65452094|FG000|Overall Study|Adverse Event|8|||
23466632|NCT00670306|65452094|FG000|Overall Study|Lack of Efficacy|10|||
23466633|NCT00670306|65452094|FG000|Overall Study|Withdrawal by Subject|9|||
23466634|NCT00670306|65452094|FG000|Overall Study|Physician Decision|1|||
23466635|NCT00670306|65452094|FG000|Overall Study|Lost to Follow-up|8|||
23466636|NCT00670306|65452094|FG000|Overall Study|incl/excl criterias did not meet|19|||
23466637|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
23466638|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466639|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466640|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466641|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466642|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
23466643|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
23466644|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
23466645|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
23466646|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
23466647|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
23466648|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466649|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466650|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466651|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466652|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
23466653|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
23466654|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466655|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466656|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466657|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
23466658|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466659|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466660|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466661|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466662|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466663|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
23466664|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466665|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466666|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466667|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23792544|NCT02661022|66620489|FG001|Overall Study|Withdrawal by Subject|0|||
23792545|NCT02661022|66620488|FG000|Overall Study|Adverse Event|1|||
23792546|NCT02661022|66620489|FG001|Overall Study|Adverse Event|1|||
23466668|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23466669|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
23466670|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
23466671|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23792547|NCT02661022|66620488|FG000|Overall Study|Physician Decision|1|||
23466672|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
23466673|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
23466674|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
23466675|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
23466676|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
23466677|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466678|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466679|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
23466680|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466681|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466682|NCT00131248|65452102|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
23466683|NCT00131248|65452103|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
23466684|NCT01677377|65452104|FG000|Overall Study|Protocol Violation|1|||
23792548|NCT02661022|66620489|FG001|Overall Study|Physician Decision|0|||
23792549|NCT02661022|66620488|FG000|Overall Study|Progressive Disease|2|||
23466685|NCT01677377|65452105|FG001|Overall Study|Protocol Violation|0|||
23466686|NCT01677377|65452106|FG002|Overall Study|Protocol Violation|0|||
23466687|NCT01677377|65452104|FG000|Overall Study|Lost to Follow-up|0|||
23466688|NCT01677377|65452105|FG001|Overall Study|Lost to Follow-up|1|||
23466689|NCT01677377|65452106|FG002|Overall Study|Lost to Follow-up|1|||
23466690|NCT01677377|65452104|FG000|Overall Study|Withdrawal by Subject|0|||
23466691|NCT01677377|65452105|FG001|Overall Study|Withdrawal by Subject|0|||
23466692|NCT01677377|65452106|FG002|Overall Study|Withdrawal by Subject|3|||
23466693|NCT01677377|65452104|FG000|Overall Study|Lack of Efficacy|0|||
23466694|NCT01677377|65452105|FG001|Overall Study|Lack of Efficacy|0|||
23466695|NCT01677377|65452106|FG002|Overall Study|Lack of Efficacy|1|||
23466696|NCT01677377|65452104|FG000|Overall Study|Pregnancy|0|||
23466697|NCT01677377|65452105|FG001|Overall Study|Pregnancy|0|||
23466698|NCT01677377|65452106|FG002|Overall Study|Pregnancy|1|||
23466699|NCT01626872|65452107|FG000|Overall Study|Physician Decision|13|||
23466700|NCT01626872|65452108|FG001|Overall Study|Physician Decision|9|||
23466701|NCT01626872|65452109|FG002|Overall Study|Physician Decision|6|||
23466702|NCT01626872|65452107|FG000|Overall Study|Withdrawal by Subject|19|||
23466703|NCT01626872|65452108|FG001|Overall Study|Withdrawal by Subject|27|||
23466704|NCT01626872|65452109|FG002|Overall Study|Withdrawal by Subject|8|||
23466705|NCT01626872|65452107|FG000|Overall Study|Adverse Event (including Death)|20|||
23466706|NCT01626872|65452108|FG001|Overall Study|Adverse Event (including Death)|28|||
23466707|NCT01626872|65452109|FG002|Overall Study|Adverse Event (including Death)|8|||
23466708|NCT01626872|65452107|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
23466709|NCT01626872|65452108|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
23466710|NCT01626872|65452109|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
23466711|NCT01185080|65452111|FG000|Overall Study|Adverse Event|1|||
23466712|NCT01185080|65452112|FG001|Overall Study|Adverse Event|1|||
23466713|NCT01185080|65452113|FG002|Overall Study|Adverse Event|0|||
23466714|NCT01185080|65452111|FG000|Overall Study|Personal reasons|0|||
23466715|NCT01185080|65452112|FG001|Overall Study|Personal reasons|0|||
23466716|NCT01185080|65452113|FG002|Overall Study|Personal reasons|1|||
23466717|NCT01064947|65452115|FG000|Overall Study|negative culture|41|||
23466718|NCT02136069|65452116|FG000|Overall Study|UC flare-up|1|||
23466719|NCT02136069|65452117|FG001|Overall Study|UC flare-up|0|||
23466720|NCT02136069|65452116|FG000|Overall Study|Adverse Event|6|||
23466721|NCT02136069|65452117|FG001|Overall Study|Adverse Event|8|||
23466722|NCT02136069|65452116|FG000|Overall Study|Death|0|||
23466723|NCT02136069|65452117|FG001|Overall Study|Death|1|||
23466724|NCT02136069|65452116|FG000|Overall Study|Lack of Efficacy|10|||
23466725|NCT02136069|65452117|FG001|Overall Study|Lack of Efficacy|4|||
23466726|NCT02136069|65452116|FG000|Overall Study|Lost to Follow-up|1|||
23466727|NCT02136069|65452117|FG001|Overall Study|Lost to Follow-up|0|||
23466728|NCT02136069|65452116|FG000|Overall Study|Non-Compliance|1|||
23466729|NCT02136069|65452117|FG001|Overall Study|Non-Compliance|0|||
23466730|NCT02136069|65452116|FG000|Overall Study|Physician Decision|5|||
23466731|NCT02136069|65452117|FG001|Overall Study|Physician Decision|4|||
23466732|NCT02136069|65452116|FG000|Overall Study|Withdrawal by Subject|10|||
23466733|NCT02136069|65452117|FG001|Overall Study|Withdrawal by Subject|11|||
23466734|NCT00380367|65452118|FG000|Overall Study|Lost to Follow-up|1|||
23466735|NCT00380367|65452118|FG000|Overall Study|Withdrawal by Subject|1|||
23466736|NCT01544335|65452119|FG000|Overall Study|Lost to Follow-up|27|||
23466737|NCT01544335|65452119|FG000|Overall Study|Death|4|||
23466738|NCT01544335|65452119|FG000|Overall Study|Disease progression|3|||
23586449|NCT00686517|65876014|FG000|Treatment|Poor Protocol Compliance|1|||
23586450|NCT00686517|65876015|FG001|Treatment|Poor Protocol Compliance|0|||
23792550|NCT02661022|66620489|FG001|Overall Study|Progressive Disease|1|||
23466739|NCT01544335|65452119|FG000|Overall Study|Baseline Measurements not Available|19|||
23466740|NCT01821118|65452120|FG000|Overall Study|Death|0|||
23466741|NCT01821118|65452121|FG001|Overall Study|Death|1|||
23466742|NCT01076361|65452122|FG000|Overall Study|22 leads were excluded from analysis|21|||
23466743|NCT00686686|65452123|FG000|Overall Study|Non-compliance|1|||
23466744|NCT00686686|65452123|FG000|Overall Study|Adverse Event|2|||
23466745|NCT00686686|65452123|FG000|Overall Study|Lost to Follow-up|3|||
23466746|NCT01286480|65452125|FG000|Overall Study|Withdrawal by Subject|5|||
23466747|NCT01286480|65452126|FG001|Overall Study|Withdrawal by Subject|3|||
23466748|NCT00755183|65452133|FG000|Overall Study|Adverse Event|5|||
23466749|NCT00755183|65452134|FG001|Overall Study|Adverse Event|2|||
23466750|NCT00755183|65452133|FG000|Overall Study|Protocol Violation|0|||
23466751|NCT00755183|65452134|FG001|Overall Study|Protocol Violation|1|||
23466752|NCT00755183|65452133|FG000|Overall Study|Withdrawal by Subject|0|||
23466753|NCT00755183|65452134|FG001|Overall Study|Withdrawal by Subject|2|||
23466754|NCT00755183|65452133|FG000|Overall Study|Administrative|2|||
23466755|NCT00755183|65452134|FG001|Overall Study|Administrative|1|||
23466756|NCT00803569|65452135|FG000|Overall Study|Progressive Disease|3|||
23466757|NCT00803569|65452135|FG000|Overall Study|Noncompliance|1|||
23466758|NCT03312634|65452136|FG000|Overall Study|Adverse Event|11|||
23466759|NCT03312634|65452137|FG001|Overall Study|Adverse Event|0|||
23466760|NCT03312634|65452136|FG000|Overall Study|Sponsor request|2|||
23466761|NCT03312634|65452137|FG001|Overall Study|Sponsor request|0|||
23466762|NCT03312634|65452136|FG000|Overall Study|Withdrawal by Subject|31|||
23466763|NCT03312634|65452137|FG001|Overall Study|Withdrawal by Subject|9|||
23466764|NCT03312634|65452136|FG000|Overall Study|Enrolled in an interventional study|0|||
23466765|NCT03312634|65452137|FG001|Overall Study|Enrolled in an interventional study|52|||
23466766|NCT03312634|65452136|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
23792551|NCT01041495|66620490|FG000|Overall Study|Withdrawal by Subject|2|||
23792552|NCT01041495|66620491|FG001|Overall Study|Withdrawal by Subject|5|||
23792553|NCT01041495|66620490|FG000|Overall Study|Adverse Event|2|||
23792554|NCT01041495|66620491|FG001|Overall Study|Adverse Event|1|||
23792555|NCT01041495|66620490|FG000|Overall Study|Lost to Follow-up|0|||
23792556|NCT01041495|66620491|FG001|Overall Study|Lost to Follow-up|1|||
23792557|NCT00046839|66620492|FG000|Overall Study|Ineligible / No protocol treatment|0|||
23466767|NCT03312634|65452137|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
23466768|NCT03312634|65452136|FG000|Overall Study|Death|0|||
23466769|NCT03312634|65452137|FG001|Overall Study|Death|1|||
23466770|NCT03312634|65452136|FG000|Overall Study|Non-compliance|0|||
23466771|NCT03312634|65452137|FG001|Overall Study|Non-compliance|2|||
23466772|NCT03312634|65452136|FG000|Overall Study|Lost to Follow-up|0|||
23466773|NCT03312634|65452137|FG001|Overall Study|Lost to Follow-up|1|||
23466774|NCT03312634|65452136|FG000|Overall Study|Enrolled into non-interventional study|0|||
23466775|NCT03312634|65452137|FG001|Overall Study|Enrolled into non-interventional study|5|||
23466776|NCT03312634|65452136|FG000|Overall Study|Worsening clinical condition|0|||
23466777|NCT03312634|65452137|FG001|Overall Study|Worsening clinical condition|1|||
23466778|NCT03312634|65452136|FG000|Overall Study|Participant did not want to travel|0|||
23466779|NCT03312634|65452137|FG001|Overall Study|Participant did not want to travel|1|||
23466780|NCT03312634|65452136|FG000|Overall Study|Physician Decision|1|||
23466781|NCT03312634|65452137|FG001|Overall Study|Physician Decision|0|||
23466782|NCT03312634|65452136|FG000|Overall Study|Other|13|||
23466783|NCT03312634|65452137|FG001|Overall Study|Other|0|||
23466784|NCT00372593|65452138|FG000|Overall Study|Adverse Event|43|||
23466785|NCT00372593|65452139|FG001|Overall Study|Adverse Event|45|||
23466786|NCT00372593|65452140|FG002|Overall Study|Adverse Event|0|||
23466787|NCT00372593|65452138|FG000|Overall Study|Death|16|||
23466788|NCT00372593|65452139|FG001|Overall Study|Death|20|||
23466789|NCT00372593|65452140|FG002|Overall Study|Death|1|||
23466790|NCT00372593|65452138|FG000|Overall Study|Lack of Efficacy|82|||
23466791|NCT00372593|65452139|FG001|Overall Study|Lack of Efficacy|71|||
23466792|NCT00372593|65452140|FG002|Overall Study|Lack of Efficacy|2|||
23466793|NCT00372593|65452138|FG000|Overall Study|Lost to Follow-up|1|||
23466794|NCT00372593|65452139|FG001|Overall Study|Lost to Follow-up|0|||
23466795|NCT00372593|65452140|FG002|Overall Study|Lost to Follow-up|0|||
23466796|NCT00372593|65452138|FG000|Overall Study|Physician Decision|42|||
23466797|NCT00372593|65452139|FG001|Overall Study|Physician Decision|41|||
23466798|NCT00372593|65452140|FG002|Overall Study|Physician Decision|0|||
23466799|NCT00372593|65452138|FG000|Overall Study|Ineligible|20|||
23466800|NCT00372593|65452139|FG001|Overall Study|Ineligible|21|||
23466801|NCT00372593|65452140|FG002|Overall Study|Ineligible|1|||
23466802|NCT00080899|65452141|FG000|Overall Study|Adverse Event|1|||
23792558|NCT00046839|66620493|FG001|Overall Study|Ineligible / No protocol treatment|2|||
23466803|NCT01244893|65452142|FG000|Baseline|Protocol Violation|0|||
23466804|NCT01244893|65452143|FG001|Baseline|Protocol Violation|1|||
23466805|NCT01244893|65452142|FG000|1-Week Follow Up|Lost to Follow-up|1|||
23466806|NCT01244893|65452143|FG001|1-Week Follow Up|Lost to Follow-up|0|||
23466807|NCT00885534|65452144|FG000|Overall Study|Patient deemed ineligible|1|||
23792559|NCT00046839|66620492|FG000|Overall Study|Withdrawal of consent|1|||
23466808|NCT01192191|65452145|FG000|Overall Study|Adverse Event|7|||
23466809|NCT01192191|65452146|FG001|Overall Study|Adverse Event|12|||
23466810|NCT01192191|65452145|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
23466811|NCT01192191|65452146|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
23466812|NCT01192191|65452145|FG000|Overall Study|Lost to Follow-up|0|||
23466813|NCT01192191|65452146|FG001|Overall Study|Lost to Follow-up|1|||
23466814|NCT01192191|65452145|FG000|Overall Study|Withdrawal by Subject|1|||
23466815|NCT01192191|65452146|FG001|Overall Study|Withdrawal by Subject|6|||
23466816|NCT03083873|65452148|FG000|Overall Study|Death|6|||
23466817|NCT03083873|65452149|FG001|Overall Study|Death|15|||
23466818|NCT03083873|65452150|FG002|Overall Study|Death|13|||
23466819|NCT03083873|65452151|FG003|Overall Study|Death|9|||
23466820|NCT03083873|65452152|FG004|Overall Study|Death|0|||
23466821|NCT03083873|65452148|FG000|Overall Study|Sponsor Terminated Study|0|||
23466822|NCT03083873|65452149|FG001|Overall Study|Sponsor Terminated Study|1|||
23466823|NCT03083873|65452150|FG002|Overall Study|Sponsor Terminated Study|2|||
23466824|NCT03083873|65452151|FG003|Overall Study|Sponsor Terminated Study|3|||
23466825|NCT03083873|65452152|FG004|Overall Study|Sponsor Terminated Study|0|||
23466826|NCT03083873|65452148|FG000|Overall Study|Lost to Follow-up|0|||
23466827|NCT03083873|65452149|FG001|Overall Study|Lost to Follow-up|1|||
23466828|NCT03083873|65452150|FG002|Overall Study|Lost to Follow-up|1|||
23466829|NCT03083873|65452151|FG003|Overall Study|Lost to Follow-up|0|||
23466830|NCT03083873|65452152|FG004|Overall Study|Lost to Follow-up|0|||
23466831|NCT03083873|65452148|FG000|Overall Study|Withdrawal by Subject|2|||
23466832|NCT03083873|65452149|FG001|Overall Study|Withdrawal by Subject|0|||
23466833|NCT03083873|65452150|FG002|Overall Study|Withdrawal by Subject|0|||
23466834|NCT03083873|65452151|FG003|Overall Study|Withdrawal by Subject|0|||
23466835|NCT03083873|65452152|FG004|Overall Study|Withdrawal by Subject|0|||
23466836|NCT03083873|65452148|FG000|Overall Study|Did Not Receive TIL|2|||
23466837|NCT03083873|65452149|FG001|Overall Study|Did Not Receive TIL|5|||
23466838|NCT03083873|65452150|FG002|Overall Study|Did Not Receive TIL|3|||
23466839|NCT03083873|65452151|FG003|Overall Study|Did Not Receive TIL|1|||
23466840|NCT03083873|65452152|FG004|Overall Study|Did Not Receive TIL|0|||
23466841|NCT03614156|65452153|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
23466842|NCT03614156|65452154|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466843|NCT03614156|65452155|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466844|NCT03614156|65452156|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466845|NCT03614156|65452153|FG000|Open-Label Treatment Period|Adverse Event|7|||
23466846|NCT03614156|65452154|FG001|Open-Label Treatment Period|Adverse Event|0|||
23466847|NCT03614156|65452155|FG002|Open-Label Treatment Period|Adverse Event|0|||
23466848|NCT03614156|65452156|FG003|Open-Label Treatment Period|Adverse Event|0|||
23466849|NCT03614156|65452153|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
23466850|NCT03614156|65452154|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23466851|NCT03614156|65452155|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23466852|NCT03614156|65452156|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23466853|NCT03614156|65452153|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
23466854|NCT03614156|65452154|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466855|NCT03614156|65452155|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466856|NCT03614156|65452156|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466857|NCT03614156|65452153|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
23466858|NCT03614156|65452154|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23466859|NCT03614156|65452155|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23466860|NCT03614156|65452156|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23466861|NCT03614156|65452153|FG000|Open-Label Treatment Period|Protocol Violation|2|||
23466862|NCT03614156|65452154|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23466863|NCT03614156|65452155|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23586451|NCT00686517|65876016|FG002|Treatment|Poor Protocol Compliance|0|||
23586452|NCT00686517|65876014|FG000|Treatment|Protocol Violation|2|||
23466864|NCT03614156|65452156|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23466865|NCT03614156|65452153|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
23466866|NCT03614156|65452154|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466867|NCT03614156|65452155|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466868|NCT03614156|65452156|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466869|NCT03614156|65452153|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
23466870|NCT03614156|65452154|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466871|NCT03614156|65452155|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466872|NCT03614156|65452156|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466873|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
23466874|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
23466875|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
23466876|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
23466877|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23466878|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
23466879|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23586453|NCT00686517|65876015|FG001|Treatment|Protocol Violation|1|||
23792560|NCT00046839|66620493|FG001|Overall Study|Withdrawal of consent|0|||
23792561|NCT02418754|66620496|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23792562|NCT02418754|66620497|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
23792563|NCT02418754|66620498|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23351428|NCT04490018|65029621|FG000|Overall Study|Withdrawal by Subject|2|||
23351429|NCT04490018|65029622|FG001|Overall Study|Withdrawal by Subject|1|||
23351430|NCT04490018|65029623|FG002|Overall Study|Withdrawal by Subject|0|||
23351431|NCT04490018|65029621|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23351432|NCT04490018|65029622|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23351433|NCT04490018|65029623|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23351434|NCT02920177|65029624|FG000|Overall Study|Withdrawal by Subject|1|||
23792564|NCT02418754|66620499|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23792565|NCT02418754|66620500|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23792566|NCT02418754|66620496|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
23792567|NCT02418754|66620497|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
23792568|NCT02418754|66620498|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
23792569|NCT02418754|66620499|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
23792570|NCT02418754|66620500|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
23792571|NCT02418754|66620496|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
23792572|NCT02418754|66620497|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23792573|NCT02418754|66620498|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23792574|NCT02418754|66620499|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23792575|NCT02418754|66620500|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23792576|NCT02418754|66620496|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23792577|NCT02418754|66620497|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
23792578|NCT02418754|66620498|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
23792579|NCT02418754|66620499|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23792580|NCT02418754|66620500|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23792581|NCT02418754|66620496|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23792582|NCT02418754|66620497|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23792583|NCT02418754|66620498|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
23792584|NCT02418754|66620499|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23792585|NCT02418754|66620500|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23792586|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
23792587|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
23792588|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
23792589|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
23792590|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
23792591|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
23792592|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23792593|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23792594|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23792595|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23792596|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
23792597|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
23792598|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
23792599|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
23792600|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
23792601|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
23792602|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
23792603|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
23792604|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
23792605|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
23792606|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
23792607|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
23792608|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
23351435|NCT02920177|65029625|FG001|Overall Study|Withdrawal by Subject|1|||
23351436|NCT02920177|65029624|FG000|Overall Study|Physician Decision|1|||
23351437|NCT02920177|65029625|FG001|Overall Study|Physician Decision|0|||
23351438|NCT02920177|65029624|FG000|Overall Study|Lost to Follow-up|0|||
23351439|NCT02920177|65029625|FG001|Overall Study|Lost to Follow-up|1|||
23351440|NCT03564795|65029626|FG000|Overall Study|Withdrawal by Subject|3|||
23351441|NCT03564795|65029626|FG000|Overall Study|Lost to Follow-up|6|||
23351442|NCT03564795|65029626|FG000|Overall Study|Physician Decision|2|||
23351443|NCT02636439|65029627|FG000|Overall Study|Adverse Event|2|||
23351444|NCT02636439|65029628|FG001|Overall Study|Adverse Event|2|||
23351445|NCT02636439|65029627|FG000|Overall Study|Lost to Follow-up|1|||
23351446|NCT02636439|65029628|FG001|Overall Study|Lost to Follow-up|0|||
23351447|NCT02636439|65029627|FG000|Overall Study|Non-compliance|1|||
23351448|NCT02636439|65029628|FG001|Overall Study|Non-compliance|1|||
23466880|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23466881|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23466882|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23466883|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
23351449|NCT02636439|65029627|FG000|Overall Study|Personal reasons|2|||
23466884|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
23466885|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
23466886|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466887|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466888|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466889|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
23466890|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
23466891|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
23466892|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
23466893|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466894|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
23466895|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466896|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466897|NCT03614156|65452153|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
23466898|NCT03614156|65452154|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23466899|NCT03614156|65452155|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23466900|NCT03614156|65452156|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23586454|NCT00686517|65876016|FG002|Treatment|Protocol Violation|0|||
23586455|NCT02918071|65876017|FG000|Overall Study|Withdrawal by Subject|2|||
23586456|NCT02918071|65876017|FG000|Overall Study|Lost to Follow-up|1|||
23586457|NCT00364286|65876018|FG000|Overall Study|Withdrawal by Subject|1|||
23792609|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
23586458|NCT00364286|65876018|FG000|Overall Study|Adverse Event|2|||
23586459|NCT00927823|65876024|FG000|Continuous Dosing Period|Death|0|||
23586460|NCT00927823|65876025|FG001|Continuous Dosing Period|Death|0|||
23586461|NCT00927823|65876026|FG002|Continuous Dosing Period|Death|6|||
23586462|NCT00927823|65876027|FG003|Continuous Dosing Period|Death|0|||
23586463|NCT00927823|65876024|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
23586464|NCT00927823|65876025|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
23586465|NCT00927823|65876026|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
23586466|NCT00927823|65876027|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
23586467|NCT00927823|65876024|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
23586468|NCT00927823|65876025|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
23586469|NCT00927823|65876026|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
23586470|NCT00927823|65876027|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
23586471|NCT00927823|65876024|FG000|Continuous Dosing Period|Other|1|||
23586472|NCT00927823|65876025|FG001|Continuous Dosing Period|Other|2|||
23586473|NCT00927823|65876026|FG002|Continuous Dosing Period|Other|9|||
23586474|NCT00927823|65876027|FG003|Continuous Dosing Period|Other|3|||
23586475|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Other|4|||
23586476|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Other|0|||
23586477|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
23586478|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
23586479|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
23586480|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
23586481|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
23586482|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
23640385|NCT02081417|66067494|FG000|Overall Study|Moved Away|1|||
23351450|NCT02636439|65029628|FG001|Overall Study|Personal reasons|0|||
23351451|NCT01074255|65029633|FG000|Overall Study|Did not receive EMEND|2|||
23351452|NCT02787083|65029634|FG000|Overall Study|Adverse Event|1|||
23351453|NCT02787083|65029635|FG001|Overall Study|Adverse Event|0|||
23466901|NCT03614156|65452153|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
23466902|NCT03614156|65452154|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
23466903|NCT03614156|65452155|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
23640386|NCT02081417|66067495|FG001|Overall Study|Moved Away|2|||
23640387|NCT02081417|66067494|FG000|Overall Study|Incarcerated|2|||
23586483|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
23586484|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
23586485|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
23586486|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
23586487|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
23586488|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
23586489|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
23586490|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
23586491|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
23586492|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
23640388|NCT02081417|66067495|FG001|Overall Study|Incarcerated|2|||
23586493|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
23586494|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
23586495|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
23586496|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
23586497|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
23586498|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
23586499|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
23586500|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
23586501|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
23586502|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
23586503|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
23351454|NCT02787083|65029634|FG000|Overall Study|Withdrawal by Subject|2|||
23586504|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
23586505|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Death|1|||
23586506|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Death|6|||
23586507|NCT03710564|65876030|FG000|Overall Study|Study Terminated by Sponsor|104|||
23586508|NCT03710564|65876031|FG001|Overall Study|Study Terminated by Sponsor|55|||
23586509|NCT03710564|65876030|FG000|Overall Study|Withdrawal by Subject|57|||
23586510|NCT03710564|65876031|FG001|Overall Study|Withdrawal by Subject|25|||
23586511|NCT03710564|65876030|FG000|Overall Study|Death|10|||
23586512|NCT03710564|65876031|FG001|Overall Study|Death|4|||
23586513|NCT03710564|65876030|FG000|Overall Study|Lost to Follow-up|5|||
23586514|NCT03710564|65876031|FG001|Overall Study|Lost to Follow-up|4|||
23586515|NCT03710564|65876030|FG000|Overall Study|Protocol Violation|3|||
23586516|NCT03710564|65876031|FG001|Overall Study|Protocol Violation|2|||
23586517|NCT03710564|65876030|FG000|Overall Study|Adverse Event|3|||
23586518|NCT03710564|65876031|FG001|Overall Study|Adverse Event|0|||
23640389|NCT02081417|66067494|FG000|Overall Study|Death|4|||
23586519|NCT03710564|65876030|FG000|Overall Study|Physician Decision|2|||
23586520|NCT03710564|65876031|FG001|Overall Study|Physician Decision|3|||
23586521|NCT02987543|65876032|FG000|Overall Study|Ongoing study at data cut off|49|||
23586522|NCT02987543|65876033|FG001|Overall Study|Ongoing study at data cut off|21|||
23586523|NCT02987543|65876034|FG002|Overall Study|Ongoing study at data cut off|19|||
23586524|NCT02987543|65876035|FG003|Overall Study|Ongoing study at data cut off|12|||
23586525|NCT02987543|65876032|FG000|Overall Study|Death|88|||
23586526|NCT02987543|65876033|FG001|Overall Study|Death|54|||
23586527|NCT02987543|65876034|FG002|Overall Study|Death|67|||
23586528|NCT02987543|65876035|FG003|Overall Study|Death|28|||
23586529|NCT02987543|65876032|FG000|Overall Study|Lost to Follow-up|3|||
23586530|NCT02987543|65876033|FG001|Overall Study|Lost to Follow-up|0|||
23586531|NCT02987543|65876034|FG002|Overall Study|Lost to Follow-up|1|||
23586532|NCT02987543|65876035|FG003|Overall Study|Lost to Follow-up|0|||
23586533|NCT02987543|65876032|FG000|Overall Study|Screen failure|0|||
23586534|NCT02987543|65876033|FG001|Overall Study|Screen failure|0|||
23586535|NCT02987543|65876034|FG002|Overall Study|Screen failure|0|||
23586536|NCT02987543|65876035|FG003|Overall Study|Screen failure|1|||
23640390|NCT02081417|66067495|FG001|Overall Study|Death|3|||
23586537|NCT02987543|65876032|FG000|Overall Study|Withdrawal by Subject|21|||
23586538|NCT02987543|65876033|FG001|Overall Study|Withdrawal by Subject|7|||
23640391|NCT02081417|66067494|FG000|Overall Study|Withdrawal by Subject|4|||
23586539|NCT02987543|65876034|FG002|Overall Study|Withdrawal by Subject|7|||
23586540|NCT02987543|65876035|FG003|Overall Study|Withdrawal by Subject|6|||
23586541|NCT02987543|65876032|FG000|Overall Study|Study terminated by sponsor|1|||
23351455|NCT02787083|65029635|FG001|Overall Study|Withdrawal by Subject|2|||
23351456|NCT02588092|65029637|FG000|Overall Study|Death|4|||
23351457|NCT02588092|65029638|FG001|Overall Study|Death|3|||
23351458|NCT02588092|65029639|FG002|Overall Study|Death|3|||
23351459|NCT02588092|65029640|FG003|Overall Study|Death|3|||
23351460|NCT02588092|65029641|FG004|Overall Study|Death|2|||
23351461|NCT02588092|65029642|FG005|Overall Study|Death|2|||
23351462|NCT02588092|65029643|FG006|Overall Study|Death|2|||
23351463|NCT02588092|65029644|FG007|Overall Study|Death|1|||
23351464|NCT02588092|65029645|FG008|Overall Study|Death|5|||
23351465|NCT02588092|65029646|FG009|Overall Study|Death|2|||
23351466|NCT02588092|65029637|FG000|Overall Study|Withdrawal by Subject|0|||
23351467|NCT02588092|65029638|FG001|Overall Study|Withdrawal by Subject|0|||
23351468|NCT02588092|65029639|FG002|Overall Study|Withdrawal by Subject|0|||
23351469|NCT02588092|65029640|FG003|Overall Study|Withdrawal by Subject|0|||
23351470|NCT02588092|65029641|FG004|Overall Study|Withdrawal by Subject|0|||
23351471|NCT02588092|65029642|FG005|Overall Study|Withdrawal by Subject|1|||
23351472|NCT02588092|65029643|FG006|Overall Study|Withdrawal by Subject|1|||
23351473|NCT02588092|65029644|FG007|Overall Study|Withdrawal by Subject|2|||
23351474|NCT02588092|65029645|FG008|Overall Study|Withdrawal by Subject|0|||
23351475|NCT02588092|65029646|FG009|Overall Study|Withdrawal by Subject|0|||
23351476|NCT02588092|65029637|FG000|Overall Study|Started Another Treatment|0|||
23351477|NCT02588092|65029638|FG001|Overall Study|Started Another Treatment|0|||
23351478|NCT02588092|65029639|FG002|Overall Study|Started Another Treatment|0|||
23351479|NCT02588092|65029640|FG003|Overall Study|Started Another Treatment|0|||
23351480|NCT02588092|65029641|FG004|Overall Study|Started Another Treatment|1|||
23351481|NCT02588092|65029642|FG005|Overall Study|Started Another Treatment|0|||
23466904|NCT03614156|65452156|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
23351482|NCT02588092|65029643|FG006|Overall Study|Started Another Treatment|0|||
23351483|NCT02588092|65029644|FG007|Overall Study|Started Another Treatment|1|||
23351484|NCT02588092|65029645|FG008|Overall Study|Started Another Treatment|0|||
23351485|NCT02588092|65029646|FG009|Overall Study|Started Another Treatment|0|||
23351486|NCT02588092|65029637|FG000|Overall Study|Sponsor Decision|0|||
23466905|NCT03614156|65452153|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
23351487|NCT02588092|65029638|FG001|Overall Study|Sponsor Decision|0|||
23351488|NCT02588092|65029639|FG002|Overall Study|Sponsor Decision|0|||
23351489|NCT02588092|65029640|FG003|Overall Study|Sponsor Decision|0|||
23351490|NCT02588092|65029641|FG004|Overall Study|Sponsor Decision|0|||
23351491|NCT02588092|65029642|FG005|Overall Study|Sponsor Decision|0|||
23586542|NCT02987543|65876033|FG001|Overall Study|Study terminated by sponsor|0|||
23586543|NCT02987543|65876034|FG002|Overall Study|Study terminated by sponsor|0|||
23586544|NCT02987543|65876035|FG003|Overall Study|Study terminated by sponsor|0|||
23586545|NCT02987543|65876032|FG000|Overall Study|Investigator decision|0|||
23792610|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
23792611|NCT02418754|66620496|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23792612|NCT02418754|66620497|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
23792613|NCT02418754|66620498|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23792614|NCT02418754|66620499|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
23792615|NCT02418754|66620500|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23792616|NCT03540160|66620504|FG000|Overall Study|Protocol Violation|1|||
23792617|NCT03540160|66620504|FG000|Overall Study|Physician Decision|8|||
23792618|NCT03540160|66620504|FG000|Overall Study|Lack of Efficacy|60|||
23792619|NCT03540160|66620504|FG000|Overall Study|Pregnancy|1|||
23792620|NCT03540160|66620504|FG000|Overall Study|Adverse Event|20|||
23792621|NCT03540160|66620504|FG000|Overall Study|Withdrawal by Subject|68|||
23792622|NCT03540160|66620504|FG000|Overall Study|COVID-19|2|||
23792623|NCT03540160|66620504|FG000|Overall Study|Study Closure|10|||
23792624|NCT03540160|66620504|FG000|Overall Study|Lost to Follow-up|18|||
23792625|NCT03540160|66620504|FG000|Overall Study|Sponsor decision|191|||
23792626|NCT02490800|66620505|FG000|Overall Study|Adverse Event|0|||
23792627|NCT02490800|66620506|FG001|Overall Study|Adverse Event|0|||
23792628|NCT02490800|66620507|FG002|Overall Study|Adverse Event|0|||
23792629|NCT02490800|66620508|FG003|Overall Study|Adverse Event|2|||
23466906|NCT03614156|65452154|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
23586546|NCT02987543|65876033|FG001|Overall Study|Investigator decision|1|||
23586547|NCT02987543|65876034|FG002|Overall Study|Investigator decision|0|||
23586548|NCT02987543|65876035|FG003|Overall Study|Investigator decision|0|||
23586549|NCT02987543|65876032|FG000|Overall Study|Disease progression|0|||
23586550|NCT02987543|65876033|FG001|Overall Study|Disease progression|0|||
23586551|NCT02987543|65876034|FG002|Overall Study|Disease progression|0|||
23586552|NCT02987543|65876035|FG003|Overall Study|Disease progression|1|||
23586553|NCT00315055|65876036|FG000|Overall Study|Protocol Violation|2|||
23586554|NCT00315055|65876037|FG001|Overall Study|Protocol Violation|4|||
23586555|NCT00315055|65876036|FG000|Overall Study|Lost to Follow-up|1|||
23586556|NCT00315055|65876037|FG001|Overall Study|Lost to Follow-up|1|||
23586557|NCT01786564|65876043|FG000|Overall Study|Lost to Follow-up|47|||
23586558|NCT01786564|65876043|FG000|Overall Study|Ineligible|17|||
23586559|NCT01651949|65876049|FG000|Overall Study|Unknown status|4|||
23586560|NCT01651949|65876050|FG001|Overall Study|Unknown status|4|||
23586561|NCT01651949|65876051|FG002|Overall Study|Unknown status|0|||
23586562|NCT01651949|65876049|FG000|Overall Study|Lost to Follow-up|30|||
23586563|NCT01651949|65876050|FG001|Overall Study|Lost to Follow-up|56|||
23586564|NCT01651949|65876051|FG002|Overall Study|Lost to Follow-up|20|||
23586565|NCT01651949|65876049|FG000|Overall Study|Protocol Violation|0|||
23586566|NCT01651949|65876050|FG001|Overall Study|Protocol Violation|2|||
23586567|NCT01651949|65876051|FG002|Overall Study|Protocol Violation|1|||
23586568|NCT01651949|65876049|FG000|Overall Study|Physician Decision|0|||
23586569|NCT01651949|65876050|FG001|Overall Study|Physician Decision|2|||
23586570|NCT01651949|65876051|FG002|Overall Study|Physician Decision|0|||
23586571|NCT01651949|65876049|FG000|Overall Study|Adverse Event|0|||
23586572|NCT01651949|65876050|FG001|Overall Study|Adverse Event|2|||
23586573|NCT01651949|65876051|FG002|Overall Study|Adverse Event|1|||
23586574|NCT01651949|65876049|FG000|Overall Study|Screen failure|2|||
23586575|NCT01651949|65876050|FG001|Overall Study|Screen failure|2|||
23586576|NCT01651949|65876051|FG002|Overall Study|Screen failure|0|||
23586577|NCT01651949|65876049|FG000|Overall Study|Withdrawal by Subject|17|||
23586578|NCT01651949|65876050|FG001|Overall Study|Withdrawal by Subject|18|||
23586579|NCT01651949|65876051|FG002|Overall Study|Withdrawal by Subject|9|||
23586580|NCT01196988|65876054|FG000|Overall Study|Adverse Event|1|||
23586581|NCT01196988|65876055|FG001|Overall Study|Adverse Event|2|||
23586582|NCT01196988|65876056|FG002|Overall Study|Adverse Event|0|||
23586583|NCT01196988|65876057|FG003|Overall Study|Adverse Event|0|||
23586584|NCT01196988|65876054|FG000|Overall Study|Withdrawal by Subject|5|||
23586585|NCT01196988|65876055|FG001|Overall Study|Withdrawal by Subject|1|||
23586586|NCT01196988|65876056|FG002|Overall Study|Withdrawal by Subject|4|||
23586587|NCT01196988|65876057|FG003|Overall Study|Withdrawal by Subject|0|||
23466907|NCT03614156|65452155|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
23586588|NCT01196988|65876054|FG000|Overall Study|Lost to Follow-up|16|||
23586589|NCT01196988|65876055|FG001|Overall Study|Lost to Follow-up|29|||
23586590|NCT01196988|65876056|FG002|Overall Study|Lost to Follow-up|21|||
23586591|NCT01196988|65876057|FG003|Overall Study|Lost to Follow-up|1|||
23586592|NCT01196988|65876054|FG000|Overall Study|Other|2|||
23586593|NCT01196988|65876055|FG001|Overall Study|Other|0|||
23586594|NCT01196988|65876056|FG002|Overall Study|Other|0|||
23586595|NCT01196988|65876057|FG003|Overall Study|Other|0|||
23792630|NCT02490800|66620509|FG004|Overall Study|Adverse Event|3|||
23351492|NCT02588092|65029643|FG006|Overall Study|Sponsor Decision|0|||
23351493|NCT02588092|65029644|FG007|Overall Study|Sponsor Decision|0|||
23351494|NCT02588092|65029645|FG008|Overall Study|Sponsor Decision|1|||
23351495|NCT02588092|65029646|FG009|Overall Study|Sponsor Decision|1|||
23351496|NCT02440854|65029647|FG000|Overall Study|Relocation of patient|1|||
23351497|NCT02440854|65029647|FG000|Overall Study|Death|6|||
23351498|NCT02440854|65029647|FG000|Overall Study|Lost to Follow-up|10|||
23351499|NCT02440854|65029647|FG000|Overall Study|Afatinib discontinuation|46|||
23640392|NCT02081417|66067495|FG001|Overall Study|Withdrawal by Subject|0|||
23640393|NCT02081417|66067494|FG000|Overall Study|Admitted to Residential Treatment|2|||
23640394|NCT02081417|66067495|FG001|Overall Study|Admitted to Residential Treatment|0|||
23640395|NCT02081417|66067494|FG000|Overall Study|Did not start treatment|17|||
23640396|NCT02081417|66067495|FG001|Overall Study|Did not start treatment|21|||
23640397|NCT02964325|66067496|FG000|Overall Study|Lost to Follow-up|3|||
23640398|NCT02964325|66067497|FG001|Overall Study|Lost to Follow-up|3|||
23640399|NCT02964325|66067496|FG000|Overall Study|Physician Decision|5|||
23640400|NCT02964325|66067497|FG001|Overall Study|Physician Decision|4|||
23640401|NCT02964325|66067496|FG000|Overall Study|Death|1|||
23640402|NCT02964325|66067497|FG001|Overall Study|Death|3|||
23640403|NCT02964325|66067496|FG000|Overall Study|Withdrawal by Subject|2|||
23640404|NCT02964325|66067497|FG001|Overall Study|Withdrawal by Subject|1|||
23640405|NCT02964325|66067496|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
23640406|NCT02964325|66067497|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
23640407|NCT00439231|66067498|FG000|Overall Study|Lack of Efficacy|28|||
23640408|NCT01631227|66067499|FG000|Overall Study|withdrawn consent|27|||
23640409|NCT01631227|66067500|FG001|Overall Study|withdrawn consent|21|||
23640410|NCT01631227|66067499|FG000|Overall Study|Adverse Event|1|||
23792631|NCT02490800|66620510|FG005|Overall Study|Adverse Event|2|||
23792632|NCT02490800|66620511|FG006|Overall Study|Adverse Event|0|||
23792633|NCT02490800|66620512|FG007|Overall Study|Adverse Event|0|||
23792634|NCT02490800|66620513|FG008|Overall Study|Adverse Event|0|||
23792635|NCT02490800|66620514|FG009|Overall Study|Adverse Event|0|||
23351500|NCT02440854|65029647|FG000|Overall Study|stopped study at earlier timepoint|14|||
23351501|NCT02440854|65029647|FG000|Overall Study|Study medication not received|1|||
23792636|NCT02490800|66620515|FG010|Overall Study|Adverse Event|0|||
23792637|NCT02490800|66620516|FG011|Overall Study|Adverse Event|2|||
23792638|NCT02490800|66620517|FG012|Overall Study|Adverse Event|2|||
23792639|NCT02490800|66620505|FG000|Overall Study|Withdrawal by Subject|0|||
23792640|NCT02490800|66620506|FG001|Overall Study|Withdrawal by Subject|0|||
23351502|NCT02440854|65029647|FG000|Overall Study|Violation of inclusion criteria|2|||
23351503|NCT03677934|65029651|FG000|Overall Study|Adverse Event|1|||
23351504|NCT03677934|65029652|FG001|Overall Study|Adverse Event|1|||
23351505|NCT03677934|65029651|FG000|Overall Study|Death|8|||
23351506|NCT03677934|65029652|FG001|Overall Study|Death|4|||
23351507|NCT03677934|65029651|FG000|Overall Study|Lost to Follow-up|3|||
23351508|NCT03677934|65029652|FG001|Overall Study|Lost to Follow-up|0|||
23466908|NCT03614156|65452156|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
23466909|NCT00790842|65452157|FG000|Dose Level 1|Adverse Event|1|||
23466910|NCT00790842|65452158|FG001|Dose Level 1|Adverse Event|0|||
23466911|NCT00790842|65452159|FG002|Dose Level 1|Adverse Event|0|||
23466912|NCT00790842|65452160|FG003|Dose Level 1|Adverse Event|2|||
23466913|NCT00790842|65452161|FG004|Dose Level 1|Adverse Event|0|||
23792641|NCT02490800|66620507|FG002|Overall Study|Withdrawal by Subject|0|||
23792642|NCT02490800|66620508|FG003|Overall Study|Withdrawal by Subject|1|||
23792643|NCT02490800|66620509|FG004|Overall Study|Withdrawal by Subject|0|||
23792644|NCT02490800|66620510|FG005|Overall Study|Withdrawal by Subject|0|||
23792645|NCT02490800|66620511|FG006|Overall Study|Withdrawal by Subject|0|||
23792646|NCT02490800|66620512|FG007|Overall Study|Withdrawal by Subject|0|||
23792647|NCT02490800|66620513|FG008|Overall Study|Withdrawal by Subject|1|||
23351509|NCT03677934|65029651|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23466914|NCT00790842|65452162|FG005|Dose Level 1|Adverse Event|0|||
23466915|NCT00790842|65452163|FG006|Dose Level 1|Adverse Event|0|||
23466916|NCT00790842|65452164|FG007|Dose Level 1|Adverse Event|1|||
23466917|NCT00790842|65452165|FG008|Dose Level 1|Adverse Event|0|||
23466918|NCT00790842|65452166|FG009|Dose Level 1|Adverse Event|0|||
23640411|NCT01631227|66067500|FG001|Overall Study|Adverse Event|0|||
23640412|NCT01631227|66067499|FG000|Overall Study|administrative|2|||
23640413|NCT01631227|66067500|FG001|Overall Study|administrative|1|||
23792648|NCT02490800|66620514|FG009|Overall Study|Withdrawal by Subject|0|||
23792649|NCT02490800|66620515|FG010|Overall Study|Withdrawal by Subject|0|||
23792650|NCT02490800|66620516|FG011|Overall Study|Withdrawal by Subject|0|||
23466919|NCT00790842|65452167|FG010|Dose Level 1|Adverse Event|0|||
23466920|NCT00790842|65452157|FG000|Dose Level 1|Physician Decision|1|||
23466921|NCT00790842|65452158|FG001|Dose Level 1|Physician Decision|0|||
23466922|NCT00790842|65452159|FG002|Dose Level 1|Physician Decision|0|||
23466923|NCT00790842|65452160|FG003|Dose Level 1|Physician Decision|0|||
23466924|NCT00790842|65452161|FG004|Dose Level 1|Physician Decision|0|||
23466925|NCT00790842|65452162|FG005|Dose Level 1|Physician Decision|0|||
23466926|NCT00790842|65452163|FG006|Dose Level 1|Physician Decision|0|||
23466927|NCT00790842|65452164|FG007|Dose Level 1|Physician Decision|1|||
23466928|NCT00790842|65452165|FG008|Dose Level 1|Physician Decision|0|||
23466929|NCT00790842|65452166|FG009|Dose Level 1|Physician Decision|0|||
23466930|NCT00790842|65452167|FG010|Dose Level 1|Physician Decision|0|||
23466931|NCT00790842|65452157|FG000|Dose Level 1|Withdrawal by Subject|1|||
23466932|NCT00790842|65452158|FG001|Dose Level 1|Withdrawal by Subject|0|||
23466933|NCT00790842|65452159|FG002|Dose Level 1|Withdrawal by Subject|0|||
23466934|NCT00790842|65452160|FG003|Dose Level 1|Withdrawal by Subject|0|||
23466935|NCT00790842|65452161|FG004|Dose Level 1|Withdrawal by Subject|0|||
23466936|NCT00790842|65452162|FG005|Dose Level 1|Withdrawal by Subject|0|||
23466937|NCT00790842|65452163|FG006|Dose Level 1|Withdrawal by Subject|0|||
23466938|NCT00790842|65452164|FG007|Dose Level 1|Withdrawal by Subject|0|||
23466939|NCT00790842|65452165|FG008|Dose Level 1|Withdrawal by Subject|0|||
23466940|NCT00790842|65452166|FG009|Dose Level 1|Withdrawal by Subject|0|||
23466941|NCT00790842|65452167|FG010|Dose Level 1|Withdrawal by Subject|0|||
23466942|NCT00790842|65452157|FG000|Dose Level 2|Death|0|||
23466943|NCT00790842|65452158|FG001|Dose Level 2|Death|1|||
23466944|NCT00790842|65452159|FG002|Dose Level 2|Death|0|||
23466945|NCT00790842|65452160|FG003|Dose Level 2|Death|0|||
23466946|NCT00790842|65452161|FG004|Dose Level 2|Death|1|||
23466947|NCT00790842|65452162|FG005|Dose Level 2|Death|0|||
23466948|NCT00790842|65452163|FG006|Dose Level 2|Death|0|||
23466949|NCT00790842|65452164|FG007|Dose Level 2|Death|0|||
23466950|NCT00790842|65452165|FG008|Dose Level 2|Death|0|||
23466951|NCT00790842|65452166|FG009|Dose Level 2|Death|0|||
23466952|NCT00790842|65452167|FG010|Dose Level 2|Death|0|||
23466953|NCT00790842|65452157|FG000|Dose Level 2|Physician Decision|0|||
23466954|NCT00790842|65452158|FG001|Dose Level 2|Physician Decision|1|||
23466955|NCT00790842|65452159|FG002|Dose Level 2|Physician Decision|0|||
23466956|NCT00790842|65452160|FG003|Dose Level 2|Physician Decision|0|||
23466957|NCT00790842|65452161|FG004|Dose Level 2|Physician Decision|0|||
23466958|NCT00790842|65452162|FG005|Dose Level 2|Physician Decision|0|||
23466959|NCT00790842|65452163|FG006|Dose Level 2|Physician Decision|0|||
23466960|NCT00790842|65452164|FG007|Dose Level 2|Physician Decision|0|||
23466961|NCT00790842|65452165|FG008|Dose Level 2|Physician Decision|0|||
23466962|NCT00790842|65452166|FG009|Dose Level 2|Physician Decision|0|||
23466963|NCT00790842|65452167|FG010|Dose Level 2|Physician Decision|0|||
23466964|NCT00790842|65452157|FG000|Dose Level 2|Withdrawal by Subject|0|||
23466965|NCT00790842|65452158|FG001|Dose Level 2|Withdrawal by Subject|1|||
23466966|NCT00790842|65452159|FG002|Dose Level 2|Withdrawal by Subject|0|||
23466967|NCT00790842|65452160|FG003|Dose Level 2|Withdrawal by Subject|0|||
23466968|NCT00790842|65452161|FG004|Dose Level 2|Withdrawal by Subject|0|||
23466969|NCT00790842|65452162|FG005|Dose Level 2|Withdrawal by Subject|0|||
23466970|NCT00790842|65452163|FG006|Dose Level 2|Withdrawal by Subject|0|||
23466971|NCT00790842|65452164|FG007|Dose Level 2|Withdrawal by Subject|0|||
23466972|NCT00790842|65452165|FG008|Dose Level 2|Withdrawal by Subject|0|||
23466973|NCT00790842|65452166|FG009|Dose Level 2|Withdrawal by Subject|0|||
23466974|NCT00790842|65452167|FG010|Dose Level 2|Withdrawal by Subject|0|||
23466975|NCT00790842|65452157|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466976|NCT00790842|65452158|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466977|NCT00790842|65452159|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466978|NCT00790842|65452160|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466979|NCT00790842|65452161|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23792651|NCT02490800|66620517|FG012|Overall Study|Withdrawal by Subject|0|||
23792652|NCT02490800|66620505|FG000|Overall Study|Progressive disease|3|||
23792653|NCT02490800|66620506|FG001|Overall Study|Progressive disease|3|||
23466980|NCT00790842|65452162|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23792654|NCT02490800|66620507|FG002|Overall Study|Progressive disease|3|||
23792655|NCT02490800|66620508|FG003|Overall Study|Progressive disease|4|||
23792656|NCT02490800|66620509|FG004|Overall Study|Progressive disease|4|||
23466981|NCT00790842|65452163|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466982|NCT00790842|65452164|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466983|NCT00790842|65452165|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
23466984|NCT00790842|65452166|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466985|NCT00790842|65452167|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466986|NCT00790842|65452157|FG000|Dose Level 3|Adverse Event|0|||
23466987|NCT00790842|65452158|FG001|Dose Level 3|Adverse Event|0|||
23466988|NCT00790842|65452159|FG002|Dose Level 3|Adverse Event|1|||
23792657|NCT02490800|66620510|FG005|Overall Study|Progressive disease|1|||
23466989|NCT00790842|65452160|FG003|Dose Level 3|Adverse Event|0|||
23792658|NCT02490800|66620511|FG006|Overall Study|Progressive disease|4|||
23792659|NCT02490800|66620512|FG007|Overall Study|Progressive disease|3|||
23792660|NCT02490800|66620513|FG008|Overall Study|Progressive disease|6|||
23792661|NCT02490800|66620514|FG009|Overall Study|Progressive disease|2|||
23792662|NCT02490800|66620515|FG010|Overall Study|Progressive disease|7|||
23792663|NCT02490800|66620516|FG011|Overall Study|Progressive disease|1|||
23792664|NCT02490800|66620517|FG012|Overall Study|Progressive disease|10|||
23792665|NCT02490800|66620505|FG000|Overall Study|Patient enrolled in post-trial access|0|||
23792666|NCT02490800|66620506|FG001|Overall Study|Patient enrolled in post-trial access|0|||
23466990|NCT00790842|65452161|FG004|Dose Level 3|Adverse Event|0|||
23466991|NCT00790842|65452162|FG005|Dose Level 3|Adverse Event|0|||
23466992|NCT00790842|65452163|FG006|Dose Level 3|Adverse Event|0|||
23466993|NCT00790842|65452164|FG007|Dose Level 3|Adverse Event|0|||
23466994|NCT00790842|65452165|FG008|Dose Level 3|Adverse Event|0|||
23466995|NCT00790842|65452166|FG009|Dose Level 3|Adverse Event|0|||
23466996|NCT00790842|65452167|FG010|Dose Level 3|Adverse Event|0|||
23466997|NCT00790842|65452157|FG000|Dose Level 3|Withdrawal by Subject|0|||
23466998|NCT00790842|65452158|FG001|Dose Level 3|Withdrawal by Subject|0|||
23466999|NCT00790842|65452159|FG002|Dose Level 3|Withdrawal by Subject|3|||
23467000|NCT00790842|65452160|FG003|Dose Level 3|Withdrawal by Subject|0|||
23467001|NCT00790842|65452161|FG004|Dose Level 3|Withdrawal by Subject|0|||
23467002|NCT00790842|65452162|FG005|Dose Level 3|Withdrawal by Subject|0|||
23467003|NCT00790842|65452163|FG006|Dose Level 3|Withdrawal by Subject|0|||
23467004|NCT00790842|65452164|FG007|Dose Level 3|Withdrawal by Subject|0|||
23467005|NCT00790842|65452165|FG008|Dose Level 3|Withdrawal by Subject|0|||
23467006|NCT00790842|65452166|FG009|Dose Level 3|Withdrawal by Subject|2|||
23467007|NCT00790842|65452167|FG010|Dose Level 3|Withdrawal by Subject|0|||
23467008|NCT00790842|65452157|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467009|NCT00790842|65452158|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467010|NCT00790842|65452159|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467011|NCT00790842|65452160|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467012|NCT00790842|65452161|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467013|NCT00790842|65452162|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
23467014|NCT00790842|65452163|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467015|NCT00790842|65452164|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467016|NCT00790842|65452165|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467017|NCT00790842|65452166|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467018|NCT00790842|65452167|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467019|NCT00790842|65452157|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467020|NCT00790842|65452158|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467021|NCT00790842|65452159|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
23467022|NCT00790842|65452160|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467023|NCT00790842|65452161|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467024|NCT00790842|65452162|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467025|NCT00790842|65452163|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467026|NCT00790842|65452164|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467027|NCT00790842|65452165|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467028|NCT00790842|65452166|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467029|NCT00790842|65452167|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467030|NCT00790842|65452157|FG000|Dose Level 4|Adverse Event|0|||
23467031|NCT00790842|65452158|FG001|Dose Level 4|Adverse Event|0|||
23467032|NCT00790842|65452159|FG002|Dose Level 4|Adverse Event|0|||
23467033|NCT00790842|65452160|FG003|Dose Level 4|Adverse Event|0|||
23467034|NCT00790842|65452161|FG004|Dose Level 4|Adverse Event|0|||
23467035|NCT00790842|65452162|FG005|Dose Level 4|Adverse Event|0|||
23467036|NCT00790842|65452163|FG006|Dose Level 4|Adverse Event|1|||
23640414|NCT02766777|66067504|FG000|Overall Study|Adverse Event|12|||
23792667|NCT02490800|66620507|FG002|Overall Study|Patient enrolled in post-trial access|0|||
23792668|NCT02490800|66620508|FG003|Overall Study|Patient enrolled in post-trial access|0|||
23792669|NCT02490800|66620509|FG004|Overall Study|Patient enrolled in post-trial access|0|||
23792670|NCT02490800|66620510|FG005|Overall Study|Patient enrolled in post-trial access|0|||
23792671|NCT02490800|66620511|FG006|Overall Study|Patient enrolled in post-trial access|0|||
23467037|NCT00790842|65452164|FG007|Dose Level 4|Adverse Event|0|||
23467038|NCT00790842|65452165|FG008|Dose Level 4|Adverse Event|0|||
23467039|NCT00790842|65452166|FG009|Dose Level 4|Adverse Event|0|||
23467040|NCT00790842|65452167|FG010|Dose Level 4|Adverse Event|0|||
23467041|NCT00790842|65452157|FG000|Dose Level 4|Physician Decision|0|||
23467042|NCT00790842|65452158|FG001|Dose Level 4|Physician Decision|0|||
23467043|NCT00790842|65452159|FG002|Dose Level 4|Physician Decision|0|||
23792672|NCT02490800|66620512|FG007|Overall Study|Patient enrolled in post-trial access|0|||
23792673|NCT02490800|66620513|FG008|Overall Study|Patient enrolled in post-trial access|0|||
23467044|NCT00790842|65452160|FG003|Dose Level 4|Physician Decision|0|||
23467045|NCT00790842|65452161|FG004|Dose Level 4|Physician Decision|0|||
23467046|NCT00790842|65452162|FG005|Dose Level 4|Physician Decision|0|||
23467047|NCT00790842|65452163|FG006|Dose Level 4|Physician Decision|1|||
23467048|NCT00790842|65452164|FG007|Dose Level 4|Physician Decision|0|||
23467049|NCT00790842|65452165|FG008|Dose Level 4|Physician Decision|0|||
23467050|NCT00790842|65452166|FG009|Dose Level 4|Physician Decision|0|||
23467051|NCT00790842|65452167|FG010|Dose Level 4|Physician Decision|1|||
23467052|NCT00790842|65452157|FG000|Dose Level 4|Withdrawal by Subject|0|||
23467053|NCT00790842|65452158|FG001|Dose Level 4|Withdrawal by Subject|0|||
23467054|NCT00790842|65452159|FG002|Dose Level 4|Withdrawal by Subject|0|||
23467055|NCT00790842|65452160|FG003|Dose Level 4|Withdrawal by Subject|0|||
23467056|NCT00790842|65452161|FG004|Dose Level 4|Withdrawal by Subject|0|||
23467057|NCT00790842|65452162|FG005|Dose Level 4|Withdrawal by Subject|0|||
23467058|NCT00790842|65452163|FG006|Dose Level 4|Withdrawal by Subject|0|||
23467059|NCT00790842|65452164|FG007|Dose Level 4|Withdrawal by Subject|0|||
23467060|NCT00790842|65452165|FG008|Dose Level 4|Withdrawal by Subject|0|||
23467061|NCT00790842|65452166|FG009|Dose Level 4|Withdrawal by Subject|0|||
23467062|NCT00790842|65452167|FG010|Dose Level 4|Withdrawal by Subject|1|||
23467063|NCT00790842|65452157|FG000|Expansion Cohort|Adverse Event|0|||
23467064|NCT00790842|65452158|FG001|Expansion Cohort|Adverse Event|0|||
23467065|NCT00790842|65452159|FG002|Expansion Cohort|Adverse Event|0|||
23467066|NCT00790842|65452160|FG003|Expansion Cohort|Adverse Event|0|||
23467067|NCT00790842|65452161|FG004|Expansion Cohort|Adverse Event|0|||
23467068|NCT00790842|65452162|FG005|Expansion Cohort|Adverse Event|0|||
23467069|NCT00790842|65452163|FG006|Expansion Cohort|Adverse Event|1|||
23467070|NCT00790842|65452164|FG007|Expansion Cohort|Adverse Event|0|||
23467071|NCT00790842|65452165|FG008|Expansion Cohort|Adverse Event|0|||
23467072|NCT00790842|65452166|FG009|Expansion Cohort|Adverse Event|0|||
23467073|NCT00790842|65452167|FG010|Expansion Cohort|Adverse Event|0|||
23467074|NCT00790842|65452157|FG000|Expansion Cohort|Death|0|||
23351510|NCT03677934|65029652|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23467075|NCT00790842|65452158|FG001|Expansion Cohort|Death|0|||
23467076|NCT00790842|65452159|FG002|Expansion Cohort|Death|2|||
23792674|NCT02490800|66620514|FG009|Overall Study|Patient enrolled in post-trial access|1|||
23467077|NCT00790842|65452160|FG003|Expansion Cohort|Death|0|||
23467078|NCT00790842|65452161|FG004|Expansion Cohort|Death|0|||
23467079|NCT00790842|65452162|FG005|Expansion Cohort|Death|0|||
23467080|NCT00790842|65452163|FG006|Expansion Cohort|Death|0|||
23467081|NCT00790842|65452164|FG007|Expansion Cohort|Death|0|||
23467082|NCT00790842|65452165|FG008|Expansion Cohort|Death|0|||
23467083|NCT00790842|65452166|FG009|Expansion Cohort|Death|0|||
23467084|NCT00790842|65452167|FG010|Expansion Cohort|Death|0|||
23467085|NCT00790842|65452157|FG000|Expansion Cohort|Physician Decision|0|||
23467086|NCT00790842|65452158|FG001|Expansion Cohort|Physician Decision|0|||
23467087|NCT00790842|65452159|FG002|Expansion Cohort|Physician Decision|1|||
23467088|NCT00790842|65452160|FG003|Expansion Cohort|Physician Decision|0|||
23467089|NCT00790842|65452161|FG004|Expansion Cohort|Physician Decision|0|||
23467090|NCT00790842|65452162|FG005|Expansion Cohort|Physician Decision|0|||
23467091|NCT00790842|65452163|FG006|Expansion Cohort|Physician Decision|0|||
23467092|NCT00790842|65452164|FG007|Expansion Cohort|Physician Decision|0|||
23467093|NCT00790842|65452165|FG008|Expansion Cohort|Physician Decision|0|||
23467094|NCT00790842|65452166|FG009|Expansion Cohort|Physician Decision|0|||
23467095|NCT00790842|65452167|FG010|Expansion Cohort|Physician Decision|0|||
23467096|NCT00790842|65452157|FG000|Expansion Cohort|Withdrawal by Subject|0|||
23467097|NCT00790842|65452158|FG001|Expansion Cohort|Withdrawal by Subject|0|||
23467098|NCT00790842|65452159|FG002|Expansion Cohort|Withdrawal by Subject|3|||
23467099|NCT00790842|65452160|FG003|Expansion Cohort|Withdrawal by Subject|0|||
23467100|NCT00790842|65452161|FG004|Expansion Cohort|Withdrawal by Subject|0|||
23467101|NCT00790842|65452162|FG005|Expansion Cohort|Withdrawal by Subject|0|||
23467102|NCT00790842|65452163|FG006|Expansion Cohort|Withdrawal by Subject|0|||
23467103|NCT00790842|65452164|FG007|Expansion Cohort|Withdrawal by Subject|0|||
23640415|NCT02766777|66067504|FG000|Overall Study|Lost to Follow-up|16|||
23467104|NCT00790842|65452165|FG008|Expansion Cohort|Withdrawal by Subject|0|||
23467105|NCT00790842|65452166|FG009|Expansion Cohort|Withdrawal by Subject|0|||
23467106|NCT00790842|65452167|FG010|Expansion Cohort|Withdrawal by Subject|0|||
23467107|NCT00790842|65452157|FG000|Expansion Cohort|Study Closure|0|||
23467108|NCT00790842|65452158|FG001|Expansion Cohort|Study Closure|0|||
23792675|NCT02490800|66620515|FG010|Overall Study|Patient enrolled in post-trial access|1|||
23792676|NCT02490800|66620516|FG011|Overall Study|Patient enrolled in post-trial access|0|||
23792677|NCT02490800|66620517|FG012|Overall Study|Patient enrolled in post-trial access|6|||
23792678|NCT01541215|66620520|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
23792679|NCT01541215|66620521|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
23792680|NCT01541215|66620520|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
23792681|NCT01541215|66620521|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
23792682|NCT01541215|66620520|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
23467109|NCT00790842|65452159|FG002|Expansion Cohort|Study Closure|1|||
23467110|NCT00790842|65452160|FG003|Expansion Cohort|Study Closure|0|||
23351511|NCT03677934|65029651|FG000|Overall Study|Physician Decision|0|||
23351512|NCT03677934|65029652|FG001|Overall Study|Physician Decision|1|||
23351513|NCT03677934|65029651|FG000|Overall Study|Withdrawal by Subject|1|||
23351514|NCT03677934|65029652|FG001|Overall Study|Withdrawal by Subject|7|||
23351515|NCT00184093|65029653|FG000|Overall Study|Adverse Event|3|||
23351516|NCT00184093|65029653|FG000|Overall Study|Lost to Follow-up|3|||
23351517|NCT00184093|65029653|FG000|Overall Study|Physician Decision|1|||
23351518|NCT00184093|65029653|FG000|Overall Study|Withdrawal by Subject|2|||
23792683|NCT01541215|66620521|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
23792684|NCT01541215|66620520|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
23792685|NCT01541215|66620521|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
23792686|NCT01541215|66620520|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
23792687|NCT01541215|66620521|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
23792688|NCT01541215|66620520|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
23792689|NCT01541215|66620521|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
23792690|NCT02616380|66620526|FG000|Overall Study|Lost to Follow-up|1|||
23792691|NCT02616380|66620526|FG000|Overall Study|Other|2|||
23792692|NCT00659815|66620527|FG000|Overall Study|Study related symptoms and complaints|2|||
23351519|NCT01618019|65029654|FG000|Overall Study|Withdrawal by Subject|14|||
23351520|NCT01618019|65029655|FG001|Overall Study|Withdrawal by Subject|14|||
23351521|NCT02427802|65029656|FG000|Overall Study|Adverse Event|11|||
23351522|NCT02427802|65029657|FG001|Overall Study|Adverse Event|3|||
23351523|NCT02427802|65029658|FG002|Overall Study|Adverse Event|7|||
23351524|NCT02427802|65029656|FG000|Overall Study|Death|0|||
23351525|NCT02427802|65029657|FG001|Overall Study|Death|4|||
23351526|NCT02427802|65029658|FG002|Overall Study|Death|1|||
23792693|NCT00659815|66620528|FG001|Overall Study|Study related symptoms and complaints|1|||
23792694|NCT00659815|66620527|FG000|Overall Study|Inability to maintain wearing schedule|1|||
23792695|NCT00659815|66620528|FG001|Overall Study|Inability to maintain wearing schedule|2|||
23467111|NCT00790842|65452161|FG004|Expansion Cohort|Study Closure|0|||
23467112|NCT00790842|65452162|FG005|Expansion Cohort|Study Closure|0|||
23467113|NCT00790842|65452163|FG006|Expansion Cohort|Study Closure|0|||
23351527|NCT02427802|65029656|FG000|Overall Study|Lost to Follow-up|13|||
23467114|NCT00790842|65452164|FG007|Expansion Cohort|Study Closure|0|||
23467115|NCT00790842|65452165|FG008|Expansion Cohort|Study Closure|0|||
23467116|NCT00790842|65452166|FG009|Expansion Cohort|Study Closure|0|||
23467117|NCT00790842|65452167|FG010|Expansion Cohort|Study Closure|0|||
23467118|NCT00753649|65452168|FG000|Overall Study|Migrated/moved from study area|1|||
23467119|NCT00753649|65452169|FG001|Overall Study|Migrated/moved from study area|0|||
23467120|NCT00753649|65452168|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
23467121|NCT00753649|65452169|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
23467122|NCT00753649|65452168|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
23467123|NCT00753649|65452169|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
23467124|NCT00753649|65452168|FG000|Overall Study|Protocol Violation|2|||
23467125|NCT00753649|65452169|FG001|Overall Study|Protocol Violation|0|||
23467126|NCT02447003|65452170|FG000|Overall Study|Other|0|||
23467127|NCT02447003|65452171|FG001|Overall Study|Other|4|||
23467128|NCT02447003|65452170|FG000|Overall Study|Site discontinued|0|||
23467129|NCT02447003|65452171|FG001|Overall Study|Site discontinued|2|||
23467130|NCT02447003|65452170|FG000|Overall Study|Physician Decision|0|||
23467131|NCT02447003|65452171|FG001|Overall Study|Physician Decision|1|||
23467132|NCT02447003|65452170|FG000|Overall Study|Withdrawal by Subject|4|||
23467133|NCT02447003|65452171|FG001|Overall Study|Withdrawal by Subject|3|||
23467134|NCT02447003|65452170|FG000|Overall Study|Sponsor Decision|6|||
23467135|NCT02447003|65452171|FG001|Overall Study|Sponsor Decision|11|||
23467136|NCT02447003|65452170|FG000|Overall Study|Progressive Disease|1|||
23467137|NCT02447003|65452171|FG001|Overall Study|Progressive Disease|0|||
23467138|NCT02447003|65452170|FG000|Overall Study|Lost to Follow-up|5|||
23467139|NCT02447003|65452171|FG001|Overall Study|Lost to Follow-up|0|||
23467140|NCT02447003|65452170|FG000|Overall Study|Death|154|||
23467141|NCT02447003|65452171|FG001|Overall Study|Death|63|||
23467142|NCT00346697|65452172|FG000|Overall Study|Lost to Follow-up|0|||
23467143|NCT00346697|65452173|FG001|Overall Study|Lost to Follow-up|1|||
23467144|NCT00357006|65452174|FG000|Overall Study|Lost to Follow-up|1|||
23467145|NCT00357006|65452175|FG001|Overall Study|Lost to Follow-up|2|||
23467146|NCT00357006|65452176|FG002|Overall Study|Lost to Follow-up|1|||
23467147|NCT00357006|65452174|FG000|Overall Study|Withdrawal by Subject|1|||
23467148|NCT00357006|65452175|FG001|Overall Study|Withdrawal by Subject|3|||
23467149|NCT00357006|65452176|FG002|Overall Study|Withdrawal by Subject|2|||
23467150|NCT00396253|65452177|FG000|Overall Study|Protocol Violation|1|||
23467151|NCT00396253|65452177|FG000|Overall Study|Withdrawal by Subject|7|||
23467152|NCT00396253|65452177|FG000|Overall Study|Death|3|||
23467153|NCT00396253|65452177|FG000|Overall Study|Physician Decision|1|||
23467154|NCT00396253|65452177|FG000|Overall Study|Change in eligibility status|1|||
23467155|NCT03212144|65452182|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
23467156|NCT03212144|65452183|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
23467157|NCT03212144|65452182|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
23467158|NCT03212144|65452183|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
23467159|NCT02625909|65452184|FG000|Overall Study|Death|2|||
23467160|NCT02625909|65452185|FG001|Overall Study|Death|0|||
23467161|NCT02625909|65452184|FG000|Overall Study|Lost to Follow-up|3|||
23467162|NCT02625909|65452185|FG001|Overall Study|Lost to Follow-up|5|||
23586596|NCT02962674|65876059|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
23586597|NCT03784963|65876073|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
23586598|NCT03784963|65876074|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
23586599|NCT03784963|65876075|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
23586600|NCT03784963|65876076|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
23586601|NCT02486588|65876077|FG000|Overall Study|Randomized in error- ineligible|738|||
23640416|NCT02766777|66067504|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23640417|NCT02766777|66067504|FG000|Overall Study|Protocol Violation|1|||
23640418|NCT02766777|66067504|FG000|Overall Study|Withdrawal by Subject|4|||
23640419|NCT01394978|66067505|FG000|Overall Study|Withdrawal by Subject|2|||
23640420|NCT01394978|66067506|FG001|Overall Study|Withdrawal by Subject|4|||
23586602|NCT02486588|65876078|FG001|Overall Study|Randomized in error- ineligible|750|||
23586603|NCT02486588|65876079|FG002|Overall Study|Randomized in error- ineligible|755|||
23640421|NCT01394978|66067505|FG000|Overall Study|Lost to Follow-up|13|||
23640422|NCT01394978|66067506|FG001|Overall Study|Lost to Follow-up|20|||
23467163|NCT02625909|65452184|FG000|Overall Study|Lack of Efficacy|9|||
23467164|NCT02625909|65452185|FG001|Overall Study|Lack of Efficacy|2|||
23467165|NCT02625909|65452184|FG000|Overall Study|Reinfection|3|||
23467166|NCT02625909|65452185|FG001|Overall Study|Reinfection|2|||
23640423|NCT01394978|66067505|FG000|Overall Study|Death|6|||
23640424|NCT01394978|66067506|FG001|Overall Study|Death|7|||
23640425|NCT00653523|66067507|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
23640426|NCT00653523|66067507|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
23467167|NCT03530124|65452189|FG000|Overall Study|Withdrawal by Subject|0|||
23467168|NCT03530124|65452190|FG001|Overall Study|Withdrawal by Subject|1|||
23467169|NCT03530124|65452189|FG000|Overall Study|Protocol Violation|1|||
23467170|NCT03530124|65452190|FG001|Overall Study|Protocol Violation|0|||
23467171|NCT03530124|65452189|FG000|Overall Study|Discharged prior to study completion|1|||
23467172|NCT03530124|65452190|FG001|Overall Study|Discharged prior to study completion|0|||
23467173|NCT02999672|65452196|FG000|Overall Study|Death|0|||
23467174|NCT02999672|65452197|FG001|Overall Study|Death|1|||
23467175|NCT02999672|65452196|FG000|Overall Study|Study Terminated by Sponsor|0|||
23467176|NCT02999672|65452197|FG001|Overall Study|Study Terminated by Sponsor|1|||
23467177|NCT02999672|65452196|FG000|Overall Study|Progressive Disease|9|||
23467178|NCT02999672|65452197|FG001|Overall Study|Progressive Disease|5|||
23467179|NCT02999672|65452196|FG000|Overall Study|Adverse Event|4|||
23467180|NCT02999672|65452197|FG001|Overall Study|Adverse Event|0|||
23467181|NCT01657019|65452202|FG000|Overall Study|Withdrawal by Subject|65|||
23467182|NCT01657019|65452202|FG000|Overall Study|Adverse Event|55|||
23467183|NCT01657019|65452202|FG000|Overall Study|Lost to Follow-up|48|||
23467184|NCT01657019|65452202|FG000|Overall Study|Protocol Violation|6|||
23467185|NCT01657019|65452202|FG000|Overall Study|Lack of Efficacy|3|||
23467186|NCT01657019|65452202|FG000|Overall Study|Other|58|||
23467187|NCT00043979|65452208|FG000|Period 1|recipient with progressive disease|7|||
23467188|NCT00043979|65452209|FG001|Period 1|recipient with progressive disease|4|||
23467189|NCT00043979|65452210|FG002|Period 1|recipient with progressive disease|3|||
23467190|NCT01413204|65452211|FG000|Overall Study|Adverse Event|1|||
23467191|NCT01413204|65452212|FG001|Overall Study|Adverse Event|2|||
23467192|NCT01413204|65452213|FG002|Overall Study|Adverse Event|2|||
23467193|NCT01413204|65452211|FG000|Overall Study|Physician Decision|3|||
23467194|NCT01413204|65452212|FG001|Overall Study|Physician Decision|0|||
23467195|NCT01413204|65452213|FG002|Overall Study|Physician Decision|2|||
23467196|NCT01413204|65452211|FG000|Overall Study|Withdrawal by Subject|1|||
23467197|NCT01413204|65452212|FG001|Overall Study|Withdrawal by Subject|4|||
23467198|NCT01413204|65452213|FG002|Overall Study|Withdrawal by Subject|4|||
23467199|NCT01413204|65452211|FG000|Overall Study|Clearly not eligible for the study|0|||
23467200|NCT01413204|65452212|FG001|Overall Study|Clearly not eligible for the study|0|||
23467201|NCT01413204|65452213|FG002|Overall Study|Clearly not eligible for the study|1|||
23467202|NCT01413204|65452211|FG000|Overall Study|Fasting plasma glucose level increased|1|||
23467203|NCT01413204|65452212|FG001|Overall Study|Fasting plasma glucose level increased|0|||
23467204|NCT01413204|65452213|FG002|Overall Study|Fasting plasma glucose level increased|10|||
23467205|NCT01012440|65452218|FG000|Overall Study|Withdrawal by Subject|2|||
23467206|NCT03714672|65452219|FG000|Overall Study|Adverse Event|0|||
23467207|NCT03714672|65452220|FG001|Overall Study|Adverse Event|0|||
23467208|NCT03714672|65452221|FG002|Overall Study|Adverse Event|3|||
23467209|NCT03714672|65452222|FG003|Overall Study|Adverse Event|0|||
23467210|NCT03714672|65452219|FG000|Overall Study|Physician Decision|0|||
23467211|NCT03714672|65452220|FG001|Overall Study|Physician Decision|1|||
23467212|NCT03714672|65452221|FG002|Overall Study|Physician Decision|0|||
23467213|NCT03714672|65452222|FG003|Overall Study|Physician Decision|0|||
23467214|NCT03714672|65452219|FG000|Overall Study|Other Reason|1|||
23467215|NCT03714672|65452220|FG001|Overall Study|Other Reason|2|||
23467216|NCT03714672|65452221|FG002|Overall Study|Other Reason|1|||
23467217|NCT03714672|65452222|FG003|Overall Study|Other Reason|1|||
23467218|NCT03714672|65452219|FG000|Overall Study|Lost to Follow-up|1|||
23640427|NCT00653523|66067507|FG000|Overall Study|Adverse Event|7|||
23351528|NCT02427802|65029657|FG001|Overall Study|Lost to Follow-up|8|||
23467219|NCT03714672|65452220|FG001|Overall Study|Lost to Follow-up|1|||
23467220|NCT03714672|65452221|FG002|Overall Study|Lost to Follow-up|0|||
23467221|NCT03714672|65452222|FG003|Overall Study|Lost to Follow-up|0|||
23467222|NCT01976741|65452228|FG000|Overall Study|Withdrawal by Subject|1|||
23467223|NCT01976741|65452229|FG001|Overall Study|Withdrawal by Subject|0|||
23467224|NCT01976741|65452230|FG002|Overall Study|Withdrawal by Subject|1|||
23467225|NCT01976741|65452231|FG003|Overall Study|Withdrawal by Subject|1|||
23467226|NCT01976741|65452232|FG004|Overall Study|Withdrawal by Subject|0|||
23467227|NCT01976741|65452233|FG005|Overall Study|Withdrawal by Subject|0|||
23467228|NCT01976741|65452234|FG006|Overall Study|Withdrawal by Subject|1|||
23467229|NCT01976741|65452235|FG007|Overall Study|Withdrawal by Subject|4|||
23640428|NCT00653523|66067507|FG000|Overall Study|Withdrawal by Subject|6|||
23467230|NCT01976741|65452236|FG008|Overall Study|Withdrawal by Subject|0|||
23467231|NCT01976741|65452237|FG009|Overall Study|Withdrawal by Subject|0|||
23467232|NCT01976741|65452228|FG000|Overall Study|Adverse Event|0|||
23467233|NCT01976741|65452229|FG001|Overall Study|Adverse Event|0|||
23467234|NCT01976741|65452230|FG002|Overall Study|Adverse Event|2|||
23467235|NCT01976741|65452231|FG003|Overall Study|Adverse Event|0|||
23467236|NCT01976741|65452232|FG004|Overall Study|Adverse Event|0|||
23467237|NCT01976741|65452233|FG005|Overall Study|Adverse Event|0|||
23467238|NCT01976741|65452234|FG006|Overall Study|Adverse Event|3|||
23467239|NCT01976741|65452235|FG007|Overall Study|Adverse Event|8|||
23467240|NCT01976741|65452236|FG008|Overall Study|Adverse Event|1|||
23467241|NCT01976741|65452237|FG009|Overall Study|Adverse Event|4|||
23467242|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
23467243|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
23467244|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
23467245|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
23467246|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
23467247|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
23467248|NCT00828204|65452238|FG000|Main Study: After Study Restart|Adverse Event|0|||
23351529|NCT02427802|65029658|FG002|Overall Study|Lost to Follow-up|8|||
23351530|NCT02427802|65029656|FG000|Overall Study|Physician Decision|4|||
23351531|NCT02427802|65029657|FG001|Overall Study|Physician Decision|2|||
23351532|NCT02427802|65029658|FG002|Overall Study|Physician Decision|4|||
23467249|NCT00828204|65452239|FG001|Main Study: After Study Restart|Adverse Event|2|||
23467250|NCT00828204|65452238|FG000|Main Study: After Study Restart|Noncompliance|0|||
23467251|NCT00828204|65452239|FG001|Main Study: After Study Restart|Noncompliance|1|||
23467252|NCT00828204|65452238|FG000|Extension Study|Lost to Follow-up|0|||
23467253|NCT00828204|65452239|FG001|Extension Study|Lost to Follow-up|1|||
23467254|NCT00828204|65452238|FG000|Extension Study|Physician Decision|0|||
23467255|NCT00828204|65452239|FG001|Extension Study|Physician Decision|2|||
23467256|NCT02736578|65452240|FG000|Overall Study|Adverse Event|1|||
23467257|NCT02736578|65452241|FG001|Overall Study|Adverse Event|0|||
23467258|NCT00477386|65452246|FG000|Overall Study|Adverse Event|4|||
23467259|NCT00477386|65452247|FG001|Overall Study|Adverse Event|8|||
23467260|NCT00477386|65452246|FG000|Overall Study|Disease progression, relapse|3|||
23467261|NCT00477386|65452247|FG001|Overall Study|Disease progression, relapse|4|||
23467262|NCT00477386|65452246|FG000|Overall Study|Disease progression, refractory|1|||
23467263|NCT00477386|65452247|FG001|Overall Study|Disease progression, refractory|3|||
23467264|NCT00477386|65452246|FG000|Overall Study|Other|1|||
23467265|NCT00477386|65452247|FG001|Overall Study|Other|2|||
23467266|NCT00477386|65452246|FG000|Overall Study|Physician Decision|1|||
23467267|NCT00477386|65452247|FG001|Overall Study|Physician Decision|0|||
23467268|NCT00477386|65452246|FG000|Overall Study|Withdrawal by Subject|1|||
23467269|NCT00477386|65452247|FG001|Overall Study|Withdrawal by Subject|0|||
23467270|NCT02281383|65452248|FG000|Overall Study|Progressive Disease|1|||
23467271|NCT02281383|65452248|FG000|Overall Study|Withdrawal by Subject|6|||
23467272|NCT02281383|65452248|FG000|Overall Study|Protocol Violation|2|||
23467273|NCT02281383|65452248|FG000|Overall Study|Death|1|||
23467274|NCT02281383|65452248|FG000|Overall Study|Adverse Event|2|||
23467275|NCT00750438|65452249|FG000|Overall Study|Protocol Violation|4|||
23467276|NCT00750438|65452250|FG001|Overall Study|Protocol Violation|1|||
23467277|NCT00750438|65452249|FG000|Overall Study|Physician Decision|2|||
23467278|NCT00750438|65452250|FG001|Overall Study|Physician Decision|2|||
23467279|NCT00750438|65452249|FG000|Overall Study|Withdrawal by Subject|1|||
23351533|NCT02427802|65029656|FG000|Overall Study|Withdrawal by Subject|10|||
23351534|NCT02427802|65029657|FG001|Overall Study|Withdrawal by Subject|5|||
23467280|NCT00750438|65452250|FG001|Overall Study|Withdrawal by Subject|1|||
23467281|NCT01587924|65452251|FG000|Overall Study|Adverse Event|0|||
23467282|NCT01587924|65452252|FG001|Overall Study|Adverse Event|2|||
23467283|NCT01587924|65452253|FG002|Overall Study|Adverse Event|0|||
23467284|NCT01587924|65452254|FG003|Overall Study|Adverse Event|0|||
23467285|NCT01587924|65452251|FG000|Overall Study|Protocol Violation|2|||
23467286|NCT01587924|65452252|FG001|Overall Study|Protocol Violation|1|||
23467287|NCT01587924|65452253|FG002|Overall Study|Protocol Violation|2|||
23467288|NCT01587924|65452254|FG003|Overall Study|Protocol Violation|1|||
23467289|NCT01587924|65452251|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
23467290|NCT01587924|65452252|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
23467291|NCT01587924|65452253|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
23467292|NCT01587924|65452254|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
23467293|NCT01587924|65452251|FG000|Overall Study|Withdrawal by Subject|0|||
23467294|NCT01587924|65452252|FG001|Overall Study|Withdrawal by Subject|1|||
23467295|NCT01587924|65452253|FG002|Overall Study|Withdrawal by Subject|1|||
23467296|NCT01587924|65452254|FG003|Overall Study|Withdrawal by Subject|0|||
23467297|NCT00892099|65452257|FG000|Overall Study|Death|1|||
23467298|NCT00892099|65452258|FG001|Overall Study|Death|0|||
23467299|NCT00892099|65452259|FG002|Overall Study|Death|1|||
23467300|NCT00892099|65452257|FG000|Overall Study|Adverse Event|1|||
23467301|NCT00892099|65452258|FG001|Overall Study|Adverse Event|0|||
23467302|NCT00892099|65452259|FG002|Overall Study|Adverse Event|0|||
23467303|NCT00892099|65452257|FG000|Overall Study|replocated|1|||
23467304|NCT00892099|65452258|FG001|Overall Study|replocated|0|||
23467305|NCT00892099|65452259|FG002|Overall Study|replocated|2|||
23467306|NCT00892099|65452257|FG000|Overall Study|Prolonged hospitalization|1|||
23467307|NCT00892099|65452258|FG001|Overall Study|Prolonged hospitalization|0|||
23467308|NCT00892099|65452259|FG002|Overall Study|Prolonged hospitalization|1|||
23792696|NCT00659815|66620527|FG000|Overall Study|Withdrawal by Subject|1|||
23792697|NCT00659815|66620528|FG001|Overall Study|Withdrawal by Subject|1|||
23792698|NCT02896296|66620529|FG000|Overall Study|Adverse Event|1|||
23792699|NCT02896296|66620529|FG000|Overall Study|Lost to Follow-up|19|||
23792700|NCT02896296|66620529|FG000|Overall Study|Pregnancy|1|||
23792701|NCT02896296|66620529|FG000|Overall Study|Physician Decision|2|||
23792702|NCT02896296|66620529|FG000|Overall Study|Withdrawal by Subject|10|||
23792703|NCT02896296|66620529|FG000|Overall Study|Site closing|7|||
23792704|NCT02896296|66620529|FG000|Overall Study|Incarceration|1|||
23792705|NCT02896296|66620529|FG000|Overall Study|Relocation|1|||
23792706|NCT01911429|66620530|FG000|Overall Study|Adverse Event|5|||
23792707|NCT01911429|66620531|FG001|Overall Study|Adverse Event|3|||
23792708|NCT01911429|66620532|FG002|Overall Study|Adverse Event|9|||
23792709|NCT01911429|66620530|FG000|Overall Study|Lack of Efficacy|1|||
23792710|NCT01911429|66620531|FG001|Overall Study|Lack of Efficacy|2|||
23792711|NCT01911429|66620532|FG002|Overall Study|Lack of Efficacy|4|||
23792712|NCT01911429|66620530|FG000|Overall Study|Lost to Follow-up|0|||
23792713|NCT01911429|66620531|FG001|Overall Study|Lost to Follow-up|0|||
23792714|NCT01911429|66620532|FG002|Overall Study|Lost to Follow-up|1|||
23792715|NCT01911429|66620530|FG000|Overall Study|Protocol Violation|0|||
23792716|NCT01911429|66620531|FG001|Overall Study|Protocol Violation|0|||
23792717|NCT01911429|66620532|FG002|Overall Study|Protocol Violation|1|||
23792718|NCT01911429|66620530|FG000|Overall Study|Withdrawal by Subject|5|||
23792719|NCT01911429|66620531|FG001|Overall Study|Withdrawal by Subject|5|||
23792720|NCT01911429|66620532|FG002|Overall Study|Withdrawal by Subject|4|||
23792721|NCT01911429|66620530|FG000|Overall Study|Accidental randomization|0|||
23792722|NCT01911429|66620531|FG001|Overall Study|Accidental randomization|0|||
23792723|NCT01911429|66620532|FG002|Overall Study|Accidental randomization|1|||
23792724|NCT01911429|66620530|FG000|Overall Study|subject left study|1|||
23792725|NCT01911429|66620531|FG001|Overall Study|subject left study|0|||
23792726|NCT01911429|66620532|FG002|Overall Study|subject left study|0|||
23792727|NCT02359864|66620535|FG000|Overall Study|Withdrawal by Subject|1|||
23792728|NCT02359864|66620536|FG001|Overall Study|Withdrawal by Subject|0|||
23792729|NCT02597049|66620537|FG000|Overall Study|Lost to Follow-up|0|||
23792730|NCT02597049|66620538|FG001|Overall Study|Lost to Follow-up|3|||
23792731|NCT02597049|66620539|FG002|Overall Study|Lost to Follow-up|2|||
23792732|NCT02597049|66620537|FG000|Overall Study|Withdrawal by Subject|2|||
23792733|NCT02597049|66620538|FG001|Overall Study|Withdrawal by Subject|2|||
23792734|NCT02597049|66620539|FG002|Overall Study|Withdrawal by Subject|1|||
23792735|NCT02597049|66620537|FG000|Overall Study|Adverse Event|2|||
23792736|NCT02597049|66620538|FG001|Overall Study|Adverse Event|0|||
23792737|NCT02597049|66620539|FG002|Overall Study|Adverse Event|0|||
23792738|NCT02597049|66620537|FG000|Overall Study|Death|2|||
23792739|NCT02597049|66620538|FG001|Overall Study|Death|0|||
23792740|NCT02597049|66620539|FG002|Overall Study|Death|0|||
23792741|NCT02597049|66620537|FG000|Overall Study|Noncompliant with Study Visits|1|||
23792742|NCT02597049|66620538|FG001|Overall Study|Noncompliant with Study Visits|0|||
23467309|NCT00892099|65452257|FG000|Overall Study|no further details|1|||
23467310|NCT00892099|65452258|FG001|Overall Study|no further details|0|||
23467311|NCT00892099|65452259|FG002|Overall Study|no further details|1|||
23467312|NCT00892099|65452257|FG000|Overall Study|kidney function recovered|0|||
23792743|NCT02597049|66620539|FG002|Overall Study|Noncompliant with Study Visits|0|||
23640429|NCT00653523|66067507|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
23792744|NCT01211262|66620540|FG000|Overall Study|Progressive Disease|18|||
23351535|NCT02427802|65029658|FG002|Overall Study|Withdrawal by Subject|11|||
23351536|NCT02427802|65029656|FG000|Overall Study|Protocol Violation|3|||
23792745|NCT01211262|66620541|FG001|Overall Study|Progressive Disease|9|||
23792746|NCT01211262|66620540|FG000|Overall Study|Adverse Event|4|||
23792747|NCT01211262|66620541|FG001|Overall Study|Adverse Event|0|||
23792748|NCT01211262|66620540|FG000|Overall Study|Withdrawal of Consent|1|||
23792749|NCT01211262|66620541|FG001|Overall Study|Withdrawal of Consent|0|||
23467313|NCT00892099|65452258|FG001|Overall Study|kidney function recovered|1|||
23467314|NCT00892099|65452259|FG002|Overall Study|kidney function recovered|0|||
23467315|NCT00892099|65452257|FG000|Overall Study|investigator decision|0|||
23467316|NCT00892099|65452258|FG001|Overall Study|investigator decision|0|||
23467317|NCT00892099|65452259|FG002|Overall Study|investigator decision|1|||
23467318|NCT00892099|65452257|FG000|Overall Study|Lost to Follow-up|0|||
23467319|NCT00892099|65452258|FG001|Overall Study|Lost to Follow-up|0|||
23467320|NCT00892099|65452259|FG002|Overall Study|Lost to Follow-up|1|||
23467321|NCT00622440|65452260|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
23467322|NCT00622440|65452261|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
23467323|NCT00622440|65452260|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
23467324|NCT00622440|65452261|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
23467325|NCT00622440|65452260|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
23467326|NCT00622440|65452261|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
23467327|NCT00622440|65452260|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
23467328|NCT00622440|65452261|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
23467329|NCT00871975|65452263|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
23467330|NCT00871975|65452263|FG000|Overall Study|Catheters could not be inserted|1|||
23467331|NCT00871975|65452263|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
23467332|NCT00871975|65452263|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
23467333|NCT00888940|65452264|FG000|Overall Study|Adverse Event|12|||
23467334|NCT00888940|65452265|FG001|Overall Study|Adverse Event|3|||
23467335|NCT00888940|65452264|FG000|Overall Study|Lost to Follow-up|5|||
23467336|NCT00888940|65452265|FG001|Overall Study|Lost to Follow-up|5|||
23467337|NCT00888940|65452264|FG000|Overall Study|Randomized Not Treated|11|||
23467338|NCT00888940|65452265|FG001|Overall Study|Randomized Not Treated|13|||
23467339|NCT02858362|65452266|FG000|Overall Study|Protocol Violation|0|||
23467340|NCT02858362|65452267|FG001|Overall Study|Protocol Violation|1|||
23467341|NCT02858362|65452268|FG002|Overall Study|Protocol Violation|0|||
23467342|NCT02858362|65452266|FG000|Overall Study|Withdrawal by Subject|1|||
23467343|NCT02858362|65452267|FG001|Overall Study|Withdrawal by Subject|0|||
23467344|NCT02858362|65452268|FG002|Overall Study|Withdrawal by Subject|0|||
23467345|NCT02858362|65452266|FG000|Overall Study|Early Study Termination|0|||
23467346|NCT02858362|65452267|FG001|Overall Study|Early Study Termination|0|||
23467347|NCT02858362|65452268|FG002|Overall Study|Early Study Termination|3|||
23467348|NCT02858362|65452266|FG000|Overall Study|Lost to Follow-up|1|||
23467349|NCT02858362|65452267|FG001|Overall Study|Lost to Follow-up|0|||
23467350|NCT02858362|65452268|FG002|Overall Study|Lost to Follow-up|0|||
23467351|NCT00345358|65452274|FG000|Primary Vaccination Phase|Other|0|||
23467352|NCT00345358|65452275|FG001|Primary Vaccination Phase|Other|1|||
23467353|NCT00345358|65452276|FG002|Primary Vaccination Phase|Other|1|||
23467354|NCT00345358|65452277|FG003|Primary Vaccination Phase|Other|0|||
23467355|NCT00345358|65452274|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
23467356|NCT00345358|65452275|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
23467357|NCT00345358|65452276|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
23467358|NCT00345358|65452277|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
23467359|NCT00345358|65452274|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
23467360|NCT00345358|65452275|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
23467361|NCT00345358|65452276|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
23467362|NCT00345358|65452277|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
23467363|NCT00345358|65452274|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
23467364|NCT00345358|65452275|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
23467365|NCT00345358|65452276|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
23467366|NCT00345358|65452277|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
23467367|NCT00345358|65452274|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
23467368|NCT00345358|65452275|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467369|NCT00345358|65452276|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467370|NCT00345358|65452277|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467371|NCT00345358|65452274|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
23467372|NCT00345358|65452275|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
23467373|NCT00345358|65452276|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
23467374|NCT00345358|65452277|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
23467375|NCT01605799|65452278|FG000|Overall Study|Withdrawal by Subject|2|||
23467376|NCT01605799|65452279|FG001|Overall Study|Withdrawal by Subject|1|||
23467377|NCT00334113|65452282|FG000|Overall Study|Lost to Follow-up|2|||
23467378|NCT00334113|65452283|FG001|Overall Study|Lost to Follow-up|2|||
23467379|NCT00334113|65452282|FG000|Overall Study|Withdrawal by Subject|0|||
23467380|NCT00334113|65452283|FG001|Overall Study|Withdrawal by Subject|1|||
23467381|NCT01421719|65452284|FG000|Overall Study|Withdrawal by Subject|4|||
23467382|NCT01583296|65452286|FG000|Overall Study|Withdrawal by Subject|11|||
23467383|NCT01583296|65452287|FG001|Overall Study|Withdrawal by Subject|10|||
23467384|NCT02873702|65452288|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
23706516|NCT03554005|66301234|FG001|Overall Study|Other|0|||
23467385|NCT02873702|65452289|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
23467386|NCT02873702|65452290|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
23467387|NCT02873702|65452291|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
23467388|NCT02873702|65452288|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467389|NCT02873702|65452289|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
23467390|NCT02873702|65452290|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467391|NCT02873702|65452291|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467392|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467393|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467394|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
23467395|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467396|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
23467397|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
23467398|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
23467399|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
23467400|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
23467401|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
23467402|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
23467403|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
23467404|NCT00499083|65452292|FG000|Overall Study|Not evaluable|3|||
23586604|NCT02486588|65876080|FG003|Overall Study|Randomized in error- ineligible|738|||
23467405|NCT02668393|65452293|FG000|Overall Study|Progressive disease|6|||
23792750|NCT01211262|66620540|FG000|Overall Study|Other|0|||
23792751|NCT01211262|66620541|FG001|Overall Study|Other|1|||
23792752|NCT00926367|66620544|FG000|Overall Study|Withdrawal by Subject|0|||
23792753|NCT00926367|66620545|FG001|Overall Study|Withdrawal by Subject|1|||
23792754|NCT00926367|66620544|FG000|Overall Study|Lost to Follow-up|1|||
23792755|NCT00926367|66620545|FG001|Overall Study|Lost to Follow-up|0|||
23792756|NCT00926367|66620544|FG000|Overall Study|Skin Irritation|1|||
23792757|NCT00926367|66620545|FG001|Overall Study|Skin Irritation|2|||
23792758|NCT05562011|66620546|FG000|Overall Study|Withdrawal by Subject|3|||
23792759|NCT05562011|66620546|FG000|Overall Study|Lost to Follow-up|1|||
23792760|NCT05562011|66620546|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
23792761|NCT05562011|66620546|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
23792762|NCT05562011|66620546|FG000|Overall Study|Device malfunction|13|||
23792763|NCT01617096|66620547|FG000|Overall Study|Withdrawal by Subject|96|||
23792764|NCT01617096|66620548|FG001|Overall Study|Withdrawal by Subject|81|||
23792765|NCT01617096|66620547|FG000|Overall Study|Lost to Follow-up|37|||
23792766|NCT01617096|66620548|FG001|Overall Study|Lost to Follow-up|32|||
23792767|NCT01617096|66620547|FG000|Overall Study|Physician Decision|10|||
23792768|NCT01617096|66620548|FG001|Overall Study|Physician Decision|18|||
23792769|NCT01617096|66620547|FG000|Overall Study|Death|4|||
23792770|NCT01617096|66620548|FG001|Overall Study|Death|3|||
23792771|NCT01617096|66620547|FG000|Overall Study|Other|1|||
23792772|NCT01617096|66620548|FG001|Overall Study|Other|3|||
23792773|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
23792774|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
23351537|NCT02427802|65029657|FG001|Overall Study|Protocol Violation|1|||
23351538|NCT02427802|65029658|FG002|Overall Study|Protocol Violation|1|||
23351539|NCT02427802|65029656|FG000|Overall Study|protocol specific treatment unrelated|18|||
23351540|NCT02427802|65029657|FG001|Overall Study|protocol specific treatment unrelated|11|||
23351541|NCT02427802|65029658|FG002|Overall Study|protocol specific treatment unrelated|11|||
23351542|NCT03448939|65029659|FG000|Overall Study|Adverse Event|5|||
23640430|NCT00653523|66067507|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
23640431|NCT01342341|66067510|FG000|Overall Study|Lost to Follow-up|4|||
23640432|NCT01342341|66067511|FG001|Overall Study|Lost to Follow-up|4|||
23640433|NCT04510090|66067512|FG000|FE-HS|Withdrawal by Subject|0|||
23467406|NCT02668393|65452294|FG001|Overall Study|Progressive disease|3|||
23467407|NCT02668393|65452293|FG000|Overall Study|Adverse Event|0|||
23351543|NCT03448939|65029660|FG001|Overall Study|Adverse Event|1|||
23351544|NCT03448939|65029659|FG000|Overall Study|Lost to Follow-up|6|||
23467408|NCT02668393|65452294|FG001|Overall Study|Adverse Event|2|||
23467409|NCT02668393|65452293|FG000|Overall Study|Withdrawal from the trial|0|||
23467410|NCT02668393|65452294|FG001|Overall Study|Withdrawal from the trial|1|||
23467411|NCT02668393|65452293|FG000|Overall Study|Lack of benefit and side effects|1|||
23467412|NCT02668393|65452294|FG001|Overall Study|Lack of benefit and side effects|0|||
23467413|NCT00934362|65452295|FG000|Overall Study|Adverse Event|1|||
23467414|NCT00934362|65452296|FG001|Overall Study|Adverse Event|0|||
23467415|NCT02157883|65457032|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
23467416|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
23467417|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
23467418|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
23467419|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
23467420|NCT05097963|65457037|FG000|Overall Study|Protocol Violation|13|||
23467421|NCT05097963|65457037|FG000|Overall Study|Withdrawal by Subject|21|||
23467422|NCT00943618|65457038|FG000|Overall Study|Lost to Follow-up|38|||
23467423|NCT00943618|65457039|FG001|Overall Study|Lost to Follow-up|48|||
23467424|NCT00943618|65457040|FG002|Overall Study|Lost to Follow-up|20|||
23467425|NCT00943618|65457038|FG000|Overall Study|Discontinued Medication|17|||
23586605|NCT02486588|65876081|FG004|Overall Study|Randomized in error- ineligible|746|||
23586606|NCT02486588|65876082|FG005|Overall Study|Randomized in error- ineligible|746|||
23586607|NCT01419717|65876083|FG000|Overall Study|Protocol-specified Criteria|62|||
23586608|NCT01419717|65876083|FG000|Overall Study|Adverse Event|19|||
23586609|NCT01419717|65876083|FG000|Overall Study|Death|17|||
23586610|NCT01419717|65876083|FG000|Overall Study|Withdrawal by Subject|10|||
23586611|NCT01419717|65876083|FG000|Overall Study|Disease Progression|9|||
23586612|NCT01419717|65876083|FG000|Overall Study|Other|4|||
23586613|NCT01419717|65876083|FG000|Overall Study|Lost to Follow-up|2|||
23586614|NCT01419717|65876083|FG000|Overall Study|Administrative Decision|1|||
23586615|NCT01419717|65876083|FG000|Overall Study|Noncompliance|1|||
23586616|NCT00094809|65876085|FG000|Overall Study|Protocol deviation|2|||
23586617|NCT00094809|65876086|FG001|Overall Study|Protocol deviation|2|||
23586618|NCT00094809|65876085|FG000|Overall Study|Noncompliance|1|||
23586619|NCT00094809|65876086|FG001|Overall Study|Noncompliance|0|||
23586620|NCT00094809|65876085|FG000|Overall Study|Adverse Event|3|||
23586621|NCT00094809|65876086|FG001|Overall Study|Adverse Event|1|||
23586622|NCT00094809|65876085|FG000|Overall Study|Withdrawal by Subject|8|||
23586623|NCT00094809|65876086|FG001|Overall Study|Withdrawal by Subject|9|||
23586624|NCT00094809|65876085|FG000|Overall Study|Disease progression|3|||
23586625|NCT00094809|65876086|FG001|Overall Study|Disease progression|3|||
23586626|NCT00094809|65876085|FG000|Overall Study|Physician Decision|3|||
23586627|NCT00094809|65876086|FG001|Overall Study|Physician Decision|5|||
23586628|NCT00094809|65876085|FG000|Overall Study|Lost to Follow-up|6|||
23586629|NCT00094809|65876086|FG001|Overall Study|Lost to Follow-up|6|||
23586630|NCT00094809|65876085|FG000|Overall Study|Death|19|||
23586631|NCT00094809|65876086|FG001|Overall Study|Death|25|||
23586632|NCT00094809|65876085|FG000|Overall Study|Protocol-specified criteria|1|||
23586633|NCT00094809|65876086|FG001|Overall Study|Protocol-specified criteria|1|||
23586634|NCT00094809|65876085|FG000|Overall Study|Other|2|||
23586635|NCT00094809|65876086|FG001|Overall Study|Other|4|||
23586636|NCT00094809|65876085|FG000|Overall Study|Informed consent signed after treatment|1|||
23792775|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
23351545|NCT03448939|65029660|FG001|Overall Study|Lost to Follow-up|6|||
23792776|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
23792777|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
23792778|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792779|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792780|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792781|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792782|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792783|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
23640434|NCT04510090|66067513|FG001|FE-HS|Withdrawal by Subject|0|||
23640435|NCT04510090|66067514|FG002|FE-HS|Withdrawal by Subject|0|||
23640436|NCT04510090|66067515|FG003|FE-HS|Withdrawal by Subject|0|||
23640437|NCT04510090|66067516|FG004|FE-HS|Withdrawal by Subject|1|||
23640438|NCT04510090|66067517|FG005|FE-HS|Withdrawal by Subject|0|||
23640439|NCT04510090|66067518|FG006|FE-HS|Withdrawal by Subject|0|||
23640440|NCT04510090|66067519|FG007|FE-HS|Withdrawal by Subject|0|||
23640441|NCT01144052|66067520|FG000|Overall Study|Withdrawal by Subject|1|||
23640442|NCT01144052|66067521|FG001|Overall Study|Withdrawal by Subject|1|||
23640443|NCT01605916|66067524|FG000|Overall Study|Adverse Event|1|||
23640444|NCT01605916|66067525|FG001|Overall Study|Adverse Event|0|||
23640445|NCT01605916|66067526|FG002|Overall Study|Adverse Event|0|||
23640446|NCT01605916|66067527|FG003|Overall Study|Adverse Event|1|||
23640447|NCT01605916|66067528|FG004|Overall Study|Adverse Event|0|||
23640448|NCT01605916|66067524|FG000|Overall Study|Lack of Efficacy|2|||
23640449|NCT01605916|66067525|FG001|Overall Study|Lack of Efficacy|3|||
23640450|NCT01605916|66067526|FG002|Overall Study|Lack of Efficacy|3|||
23640451|NCT01605916|66067527|FG003|Overall Study|Lack of Efficacy|5|||
23640452|NCT01605916|66067528|FG004|Overall Study|Lack of Efficacy|4|||
23640453|NCT01605916|66067524|FG000|Overall Study|Withdrawal by Subject|1|||
23640454|NCT01605916|66067525|FG001|Overall Study|Withdrawal by Subject|1|||
23640455|NCT01605916|66067526|FG002|Overall Study|Withdrawal by Subject|0|||
23640456|NCT01605916|66067527|FG003|Overall Study|Withdrawal by Subject|0|||
23640457|NCT01605916|66067528|FG004|Overall Study|Withdrawal by Subject|2|||
23640458|NCT00935818|66067529|FG000|Overall Study|Withdrawal by Subject|45|||
23640459|NCT00935818|66067530|FG001|Overall Study|Withdrawal by Subject|50|||
23640460|NCT00935818|66067529|FG000|Overall Study|Lost to Follow-up|40|||
23640461|NCT00935818|66067530|FG001|Overall Study|Lost to Follow-up|42|||
23640462|NCT00935818|66067529|FG000|Overall Study|Adverse Event|6|||
23640463|NCT00935818|66067530|FG001|Overall Study|Adverse Event|7|||
23640464|NCT00935818|66067529|FG000|Overall Study|Physician Decision|0|||
23640465|NCT00935818|66067530|FG001|Overall Study|Physician Decision|1|||
23640466|NCT03056300|66067531|FG000|Overall Study|Surgical reason per study protocol|3|||
23640467|NCT00608868|66067536|FG000|Overall Study|Withdrawal by Subject|7|||
23640468|NCT00608868|66067536|FG000|Overall Study|Protocol Violation|3|||
23640469|NCT00608868|66067536|FG000|Overall Study|Lost to Follow-up|2|||
23640470|NCT00608868|66067536|FG000|Overall Study|Adverse Event|1|||
23640471|NCT00608868|66067536|FG000|Overall Study|Physician Decision|2|||
23640472|NCT04540887|66067537|FG000|Overall Study|Withdrawal by Subject|2|||
23640473|NCT02008877|66067539|FG000|Overall Study|Inevaluable|0|||
23640474|NCT02008877|66067540|FG001|Overall Study|Inevaluable|1|||
23640475|NCT02008877|66067541|FG002|Overall Study|Inevaluable|0|||
23640476|NCT03291288|66067543|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
23640477|NCT03291288|66067544|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
23640478|NCT03291288|66067543|FG000|Drug-drug Interaction Phase|Disease progression|1|||
23640479|NCT03291288|66067544|FG001|Drug-drug Interaction Phase|Disease progression|0|||
23640480|NCT03291288|66067543|FG000|Drug-drug Interaction Phase|Other|3|||
23640481|NCT03291288|66067544|FG001|Drug-drug Interaction Phase|Other|0|||
23640482|NCT03291288|66067543|FG000|Pexidartinib Only|Ongoing|0|||
23640483|NCT03291288|66067544|FG001|Pexidartinib Only|Ongoing|2|||
23640484|NCT00704405|66067545|FG000|Overall Study (NC Population)|Adverse Event|1|||
23640485|NCT00704405|66067546|FG001|Overall Study (NC Population)|Adverse Event|0|||
23640486|NCT00704405|66067547|FG002|Overall Study (NC Population)|Adverse Event|0|||
23351546|NCT03448939|65029659|FG000|Overall Study|Pregnancy|1|||
23351547|NCT03448939|65029660|FG001|Overall Study|Pregnancy|1|||
23351548|NCT03448939|65029659|FG000|Overall Study|Withdrawal by Subject|9|||
23351549|NCT03448939|65029660|FG001|Overall Study|Withdrawal by Subject|3|||
23351550|NCT00438256|65029661|FG000|Overall Study|Ineligible for Resection|2|||
23351551|NCT00438256|65029662|FG001|Overall Study|Ineligible for Resection|1|||
23351552|NCT00438256|65029663|FG002|Overall Study|Ineligible for Resection|1|||
23351553|NCT00438256|65029664|FG003|Overall Study|Ineligible for Resection|7|||
23351554|NCT00438256|65029661|FG000|Overall Study|Excluded final Diagnosis|0|||
23351555|NCT00438256|65029662|FG001|Overall Study|Excluded final Diagnosis|0|||
23586637|NCT00094809|65876086|FG001|Overall Study|Informed consent signed after treatment|0|||
23586638|NCT00094809|65876085|FG000|Overall Study|Study drug not received|2|||
23586639|NCT00094809|65876086|FG001|Overall Study|Study drug not received|8|||
23586640|NCT00094809|65876085|FG000|Overall Study|Other|1|||
23586641|NCT00094809|65876086|FG001|Overall Study|Other|1|||
23586642|NCT00208767|65876092|FG000|Overall Study|Adverse Event|9|||
23586643|NCT00208767|65876093|FG001|Overall Study|Adverse Event|1|||
23586644|NCT00208767|65876092|FG000|Overall Study|Withdrawal by Subject|14|||
23586645|NCT00208767|65876093|FG001|Overall Study|Withdrawal by Subject|3|||
23586646|NCT00208767|65876092|FG000|Overall Study|Death|1|||
23586647|NCT00208767|65876093|FG001|Overall Study|Death|0|||
23586648|NCT00208767|65876092|FG000|Overall Study|Lost to Follow-up|3|||
23586649|NCT00208767|65876093|FG001|Overall Study|Lost to Follow-up|3|||
23586650|NCT00367055|65876097|FG000|Overall Study|Adverse Event|6|||
23586651|NCT00367055|65876098|FG001|Overall Study|Adverse Event|3|||
23586652|NCT00367055|65876097|FG000|Overall Study|Patient's Willing|3|||
23586653|NCT00367055|65876098|FG001|Overall Study|Patient's Willing|2|||
23586654|NCT00367055|65876097|FG000|Overall Study|Lack of Efficacy|1|||
23792784|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792785|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
23586655|NCT00367055|65876098|FG001|Overall Study|Lack of Efficacy|2|||
23586656|NCT00367055|65876097|FG000|Overall Study|Lost to Follow-up|1|||
23586657|NCT00367055|65876098|FG001|Overall Study|Lost to Follow-up|1|||
23586658|NCT00367055|65876097|FG000|Overall Study|Protocol Violation|0|||
23792786|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792787|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792788|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792789|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792790|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792791|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792792|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792793|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792794|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792795|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792796|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792797|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792798|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
23792799|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792800|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
23792801|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792802|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792803|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792804|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792805|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792806|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792807|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792808|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792809|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792810|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792811|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792812|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792813|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792814|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792815|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792816|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792817|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23586659|NCT00367055|65876098|FG001|Overall Study|Protocol Violation|1|||
23586660|NCT00367055|65876097|FG000|Overall Study|Stopping Criterion Met|0|||
23351556|NCT00438256|65029663|FG002|Overall Study|Excluded final Diagnosis|0|||
23351557|NCT00438256|65029664|FG003|Overall Study|Excluded final Diagnosis|2|||
23792818|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792819|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23351558|NCT00236899|65029665|FG000|Overall Study|Adverse Event (Study Related)|1|||
23586661|NCT00367055|65876098|FG001|Overall Study|Stopping Criterion Met|1|||
23586662|NCT00367055|65876097|FG000|Overall Study|Participant Living too Far from Hospital|0|||
23586663|NCT00367055|65876098|FG001|Overall Study|Participant Living too Far from Hospital|1|||
23586664|NCT01803646|65876099|FG000|Overall Study|Protocol Violation|1|||
23586665|NCT01803646|65876100|FG001|Overall Study|Protocol Violation|0|||
23586666|NCT01803646|65876099|FG000|Overall Study|Adverse Event|1|||
23586667|NCT01803646|65876100|FG001|Overall Study|Adverse Event|1|||
23586668|NCT01803646|65876099|FG000|Overall Study|Withdrawal by Subject|9|||
23586669|NCT01803646|65876100|FG001|Overall Study|Withdrawal by Subject|6|||
23586670|NCT01803646|65876099|FG000|Overall Study|Randomization error|1|||
23586671|NCT01803646|65876100|FG001|Overall Study|Randomization error|2|||
23586672|NCT01803646|65876099|FG000|Overall Study|Lost to Follow-up|5|||
23586673|NCT01803646|65876100|FG001|Overall Study|Lost to Follow-up|1|||
23586674|NCT03861767|65876101|FG000|Overall Study|Withdrawal by Subject|2|||
23586675|NCT03861767|65876102|FG001|Overall Study|Withdrawal by Subject|1|||
23351559|NCT00236899|65029666|FG001|Overall Study|Adverse Event (Study Related)|1|||
23351560|NCT00236899|65029667|FG002|Overall Study|Adverse Event (Study Related)|2|||
23351561|NCT00236899|65029668|FG003|Overall Study|Adverse Event (Study Related)|1|||
23351562|NCT00236899|65029665|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
23351563|NCT00236899|65029666|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
23351564|NCT00236899|65029667|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
23351565|NCT00236899|65029668|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
23351566|NCT00236899|65029665|FG000|Overall Study|Death (Study Disease)|1|||
23351567|NCT00236899|65029666|FG001|Overall Study|Death (Study Disease)|4|||
23586676|NCT03861767|65876103|FG002|Overall Study|Withdrawal by Subject|0|||
23586677|NCT03861767|65876104|FG003|Overall Study|Withdrawal by Subject|5|||
23586678|NCT03861767|65876105|FG004|Overall Study|Withdrawal by Subject|2|||
23586679|NCT03861767|65876106|FG005|Overall Study|Withdrawal by Subject|1|||
23586680|NCT03861767|65876107|FG006|Overall Study|Withdrawal by Subject|3|||
23586681|NCT03861767|65876108|FG007|Overall Study|Withdrawal by Subject|1|||
23586682|NCT03861767|65876109|FG008|Overall Study|Withdrawal by Subject|0|||
23586683|NCT03861767|65876110|FG009|Overall Study|Withdrawal by Subject|5|||
23586684|NCT00957658|65876111|FG000|Overall Study|Death|1|||
23586685|NCT00957658|65876111|FG000|Overall Study|Lost to Follow-up|4|||
23351568|NCT00236899|65029667|FG002|Overall Study|Death (Study Disease)|0|||
23351569|NCT00236899|65029668|FG003|Overall Study|Death (Study Disease)|0|||
23351570|NCT00236899|65029665|FG000|Overall Study|Death (Not Study Related)|2|||
23586686|NCT00957658|65876111|FG000|Overall Study|Withdrawal by Subject|12|||
23586687|NCT00957658|65876111|FG000|Overall Study|Revision|1|||
23586688|NCT00957658|65876111|FG000|Overall Study|Incomplete 2 yr data|28|||
23586689|NCT00957658|65876111|FG000|Overall Study|Site termination|10|||
23586690|NCT00957658|65876111|FG000|Overall Study|unwilling/unable to return|2|||
23586691|NCT00957658|65876111|FG000|Overall Study|surgery cancelled|2|||
23586692|NCT00957658|65876111|FG000|Overall Study|Protocol Violation|5|||
23586693|NCT03055767|65876112|FG000|Open-Label Period|Lost to Follow-up|0|||
23586694|NCT03055767|65876113|FG001|Open-Label Period|Lost to Follow-up|0|||
23640487|NCT00704405|66067548|FG003|Overall Study (NC Population)|Adverse Event|0|||
23706517|NCT03554005|66301235|FG002|Overall Study|Other|0|||
23351571|NCT00236899|65029666|FG001|Overall Study|Death (Not Study Related)|0|||
23351572|NCT00236899|65029667|FG002|Overall Study|Death (Not Study Related)|0|||
23351573|NCT00236899|65029668|FG003|Overall Study|Death (Not Study Related)|0|||
23351574|NCT00236899|65029665|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
23351575|NCT00236899|65029666|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
23351576|NCT00236899|65029667|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
23351577|NCT00236899|65029668|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
23351578|NCT00236899|65029665|FG000|Overall Study|Lost to Follow-up|0|||
23351579|NCT00236899|65029666|FG001|Overall Study|Lost to Follow-up|1|||
23351580|NCT00236899|65029667|FG002|Overall Study|Lost to Follow-up|0|||
23351581|NCT00236899|65029668|FG003|Overall Study|Lost to Follow-up|0|||
23351582|NCT00236899|65029665|FG000|Overall Study|Entry Criteria Exclusion|0|||
23351583|NCT00236899|65029666|FG001|Overall Study|Entry Criteria Exclusion|1|||
23351584|NCT00236899|65029667|FG002|Overall Study|Entry Criteria Exclusion|1|||
23351585|NCT00236899|65029668|FG003|Overall Study|Entry Criteria Exclusion|0|||
23351586|NCT00236899|65029665|FG000|Overall Study|Protocol Violation|1|||
23351587|NCT00236899|65029666|FG001|Overall Study|Protocol Violation|0|||
23351588|NCT00236899|65029667|FG002|Overall Study|Protocol Violation|0|||
23351589|NCT00236899|65029668|FG003|Overall Study|Protocol Violation|0|||
23351590|NCT00236899|65029665|FG000|Overall Study|Withdrawal by Subject|6|||
23792820|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792821|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792822|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792823|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792824|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23792825|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792826|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
23792827|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792828|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792829|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792830|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792831|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792832|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792833|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792834|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792835|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792836|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792837|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792838|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23351591|NCT00236899|65029666|FG001|Overall Study|Withdrawal by Subject|4|||
23351592|NCT00236899|65029667|FG002|Overall Study|Withdrawal by Subject|5|||
23351593|NCT00236899|65029668|FG003|Overall Study|Withdrawal by Subject|2|||
23351594|NCT00236899|65029665|FG000|Overall Study|Physician Decision|7|||
23792839|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792840|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792841|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23586695|NCT03055767|65876114|FG002|Open-Label Period|Lost to Follow-up|2|||
23586696|NCT03055767|65876115|FG003|Open-Label Period|Lost to Follow-up|0|||
23586697|NCT03055767|65876112|FG000|Open-Label Period|Withdrawal by Subject|0|||
23351595|NCT00236899|65029666|FG001|Overall Study|Physician Decision|8|||
23586698|NCT03055767|65876113|FG001|Open-Label Period|Withdrawal by Subject|0|||
23351596|NCT00236899|65029667|FG002|Overall Study|Physician Decision|7|||
23351597|NCT00236899|65029668|FG003|Overall Study|Physician Decision|6|||
23351598|NCT00236899|65029665|FG000|Overall Study|Satisfactory Response|2|||
23351599|NCT00236899|65029666|FG001|Overall Study|Satisfactory Response|0|||
23351600|NCT00236899|65029667|FG002|Overall Study|Satisfactory Response|0|||
23351601|NCT00236899|65029668|FG003|Overall Study|Satisfactory Response|1|||
23351602|NCT00236899|65029665|FG000|Overall Study|Lack of Efficacy|18|||
23351603|NCT00236899|65029666|FG001|Overall Study|Lack of Efficacy|18|||
23792842|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792843|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792844|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792845|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792846|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792847|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792848|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792849|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792850|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23792851|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23792852|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792853|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
23792854|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23792855|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23792856|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792857|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792858|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792859|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792860|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792861|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792862|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792863|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792864|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792865|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792866|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792867|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792868|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792869|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792870|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792871|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792872|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792873|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792874|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792875|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792876|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23792877|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
23792878|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
23792879|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
23792880|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
23792881|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
23792882|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792883|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792884|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792885|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792886|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792887|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792888|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792889|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792890|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792891|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792892|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792893|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792894|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792895|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792896|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23586699|NCT03055767|65876114|FG002|Open-Label Period|Withdrawal by Subject|0|||
23586700|NCT03055767|65876115|FG003|Open-Label Period|Withdrawal by Subject|1|||
23586701|NCT01156116|65876117|FG000|Overall Study|Withdrawal by Subject|3|||
23586702|NCT01156116|65876118|FG001|Overall Study|Withdrawal by Subject|1|||
23586703|NCT01156116|65876117|FG000|Overall Study|CPAP intolerance|2|||
23586704|NCT01156116|65876118|FG001|Overall Study|CPAP intolerance|0|||
23351604|NCT00236899|65029667|FG002|Overall Study|Lack of Efficacy|25|||
23351605|NCT00236899|65029668|FG003|Overall Study|Lack of Efficacy|23|||
23586705|NCT01833832|65876120|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
23586706|NCT01499134|65876123|FG000|Overall Study|Withdrawal by Subject|0|||
23586707|NCT01499134|65876124|FG001|Overall Study|Withdrawal by Subject|1|||
23586708|NCT03761784|65876125|FG000|Overall Study|Adverse Event|4|||
23586709|NCT03761784|65876126|FG001|Overall Study|Adverse Event|0|||
23586710|NCT03761784|65876125|FG000|Overall Study|Lost to Follow-up|10|||
23640488|NCT00704405|66067549|FG004|Overall Study (NC Population)|Adverse Event|0|||
23640489|NCT00704405|66067545|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
23640490|NCT00704405|66067546|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
23640491|NCT00704405|66067547|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
23640492|NCT00704405|66067548|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
23640493|NCT00704405|66067549|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
23640494|NCT00704405|66067545|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
23640495|NCT00704405|66067546|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
23640496|NCT00704405|66067547|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
23640497|NCT00704405|66067548|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
23640498|NCT00704405|66067549|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
23640499|NCT00704405|66067545|FG000|Overall Study (NC Population)|Other|0|||
23640500|NCT00704405|66067546|FG001|Overall Study (NC Population)|Other|0|||
23640501|NCT00704405|66067547|FG002|Overall Study (NC Population)|Other|0|||
23640502|NCT00704405|66067548|FG003|Overall Study (NC Population)|Other|0|||
23640503|NCT00704405|66067549|FG004|Overall Study (NC Population)|Other|1|||
23640504|NCT00704405|66067545|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
23640505|NCT00704405|66067546|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
23640506|NCT00704405|66067547|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
23640507|NCT00704405|66067548|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
23640508|NCT00704405|66067549|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
23640509|NCT00704405|66067545|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
23640510|NCT00704405|66067546|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
23640511|NCT00704405|66067547|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
23640512|NCT00704405|66067548|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
23640513|NCT00704405|66067549|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
23640514|NCT02236988|66067550|FG000|Overall Study|Lost to Follow-up|0|||
23640515|NCT02236988|66067551|FG001|Overall Study|Lost to Follow-up|0|||
23640516|NCT02236988|66067552|FG002|Overall Study|Lost to Follow-up|0|||
23640517|NCT02236988|66067553|FG003|Overall Study|Lost to Follow-up|1|||
23640518|NCT02236988|66067550|FG000|Overall Study|Unable to Comply with Study Visits|0|||
23640519|NCT02236988|66067551|FG001|Overall Study|Unable to Comply with Study Visits|0|||
23640520|NCT02236988|66067552|FG002|Overall Study|Unable to Comply with Study Visits|0|||
23640521|NCT02236988|66067553|FG003|Overall Study|Unable to Comply with Study Visits|2|||
23640522|NCT03466073|66067554|FG000|Overall Study|Death|1|||
23640523|NCT03466073|66067555|FG001|Overall Study|Death|0|||
23586711|NCT03761784|65876126|FG001|Overall Study|Lost to Follow-up|7|||
23640524|NCT03466073|66067556|FG002|Overall Study|Death|0|||
23640525|NCT03466073|66067557|FG003|Overall Study|Death|0|||
23351606|NCT04015518|65029669|FG000|Overall Study|Adverse Event|6|||
23792897|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792898|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792899|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792900|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792901|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23792902|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23351607|NCT04015518|65029670|FG001|Overall Study|Adverse Event|1|||
23351608|NCT04015518|65029671|FG002|Overall Study|Adverse Event|1|||
23792903|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|moved|0|||
23792904|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|moved|1|||
23792905|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|moved|1|||
23792906|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|moved|0|||
23792907|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|moved|0|||
23792908|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|moved|0|||
23792909|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|moved|0|||
23792910|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|moved|0|||
23792911|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|moved|0|||
23792912|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|moved|0|||
23792913|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|moved|0|||
23792914|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|moved|0|||
23792915|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|moved|0|||
23792916|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|moved|0|||
23792917|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|moved|0|||
23792918|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|moved|0|||
23792919|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|moved|0|||
23792920|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|moved|0|||
23792921|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|moved|0|||
23792922|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|moved|0|||
23792923|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|moved|0|||
23792924|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|moved|0|||
23792925|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|moved|0|||
23792926|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|moved|0|||
23792927|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|moved|0|||
23792928|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|moved|0|||
23792929|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792930|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792931|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792932|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
23792933|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792934|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792935|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792936|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792937|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792938|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792939|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23351609|NCT04015518|65029672|FG003|Overall Study|Adverse Event|3|||
23351610|NCT04015518|65029673|FG004|Overall Study|Adverse Event|3|||
23351611|NCT04015518|65029669|FG000|Overall Study|Lack of Efficacy|1|||
23351612|NCT04015518|65029670|FG001|Overall Study|Lack of Efficacy|0|||
23351613|NCT04015518|65029671|FG002|Overall Study|Lack of Efficacy|1|||
23351614|NCT04015518|65029672|FG003|Overall Study|Lack of Efficacy|0|||
23467426|NCT00943618|65457039|FG001|Overall Study|Discontinued Medication|29|||
23467427|NCT00943618|65457040|FG002|Overall Study|Discontinued Medication|11|||
23467428|NCT01254422|65457041|FG000|Overall Study|Protocol Violation|1|||
23792940|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792941|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792942|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792943|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792944|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792945|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792946|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792947|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792948|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792949|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792950|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792951|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792952|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792953|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792954|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23792955|NCT00112437|66620549|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792956|NCT00112437|66620550|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792957|NCT00112437|66620551|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792958|NCT00112437|66620552|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792959|NCT00112437|66620553|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
23792960|NCT00112437|66620554|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792961|NCT00112437|66620555|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792962|NCT00112437|66620556|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792963|NCT00112437|66620557|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792964|NCT00112437|66620558|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792965|NCT00112437|66620559|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792966|NCT00112437|66620560|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792967|NCT00112437|66620561|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792968|NCT00112437|66620562|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792969|NCT00112437|66620563|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792970|NCT00112437|66620564|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792971|NCT00112437|66620565|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792972|NCT00112437|66620566|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792973|NCT00112437|66620567|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792974|NCT00112437|66620568|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792975|NCT00112437|66620569|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792976|NCT00112437|66620570|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792977|NCT00112437|66620571|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23351615|NCT04015518|65029673|FG004|Overall Study|Lack of Efficacy|4|||
23467429|NCT01254422|65457042|FG001|Overall Study|Protocol Violation|0|||
23467430|NCT01254422|65457041|FG000|Overall Study|Adverse Event|1|||
23467431|NCT01254422|65457042|FG001|Overall Study|Adverse Event|0|||
23467432|NCT01254422|65457041|FG000|Overall Study|Serious adverse event|0|||
23351616|NCT04015518|65029669|FG000|Overall Study|Lost to Follow-up|0|||
23467433|NCT01254422|65457042|FG001|Overall Study|Serious adverse event|1|||
23467434|NCT01254422|65457041|FG000|Overall Study|Lost to Follow-up|1|||
23467435|NCT01254422|65457042|FG001|Overall Study|Lost to Follow-up|0|||
23467436|NCT01273519|65457043|FG000|Overall Study|Adverse Event|3|||
23467437|NCT01273519|65457044|FG001|Overall Study|Adverse Event|0|||
23467438|NCT01273519|65457045|FG002|Overall Study|Adverse Event|0|||
23467439|NCT01273519|65457043|FG000|Overall Study|Lost to Follow-up|2|||
23467440|NCT01273519|65457044|FG001|Overall Study|Lost to Follow-up|1|||
23467441|NCT01273519|65457045|FG002|Overall Study|Lost to Follow-up|3|||
23467442|NCT01273519|65457043|FG000|Overall Study|Lack of Efficacy|8|||
23467443|NCT01273519|65457044|FG001|Overall Study|Lack of Efficacy|3|||
23467444|NCT01273519|65457045|FG002|Overall Study|Lack of Efficacy|4|||
23467445|NCT01273519|65457043|FG000|Overall Study|Other|6|||
23467446|NCT01273519|65457044|FG001|Overall Study|Other|1|||
23467447|NCT01273519|65457045|FG002|Overall Study|Other|1|||
23467448|NCT00433004|65457046|FG000|Overall Study|Lost to Follow-up|5|||
23467449|NCT00433004|65457047|FG001|Overall Study|Lost to Follow-up|7|||
23467450|NCT00865566|65457048|FG000|Overall Study|Death|1|||
23467451|NCT00865566|65457049|FG001|Overall Study|Death|11|||
23467452|NCT00865566|65457048|FG000|Overall Study|Lost to Follow-up|314|||
23467453|NCT00865566|65457049|FG001|Overall Study|Lost to Follow-up|315|||
23467454|NCT00865566|65457048|FG000|Overall Study|Withdrawal by Subject|45|||
23467455|NCT00865566|65457049|FG001|Overall Study|Withdrawal by Subject|65|||
23467456|NCT00865566|65457048|FG000|Overall Study|Physician Decision|0|||
23467457|NCT00865566|65457049|FG001|Overall Study|Physician Decision|1|||
23467458|NCT00865566|65457048|FG000|Overall Study|Participant relocated|78|||
23467459|NCT00865566|65457049|FG001|Overall Study|Participant relocated|107|||
23467460|NCT00865566|65457048|FG000|Overall Study|Participant unable to adhere|27|||
23467461|NCT00865566|65457049|FG001|Overall Study|Participant unable to adhere|42|||
23467462|NCT00865566|65457048|FG000|Overall Study|Other; N=245 due to early study closure|154|||
23467463|NCT00865566|65457049|FG001|Overall Study|Other; N=245 due to early study closure|139|||
23467464|NCT00865566|65457048|FG000|Overall Study|HIV infection|5|||
23467465|NCT00865566|65457049|FG001|Overall Study|HIV infection|7|||
23467466|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467467|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
23467468|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467469|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
23467470|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467471|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
23467472|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
23467473|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467474|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
23792978|NCT00112437|66620572|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792979|NCT00112437|66620573|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792980|NCT00112437|66620574|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23792981|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
23792982|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
23792983|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
23792984|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
23792985|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
23792986|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
23792987|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
23792988|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
23792989|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
23792990|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
23792991|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
23792992|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
23792993|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
23792994|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
23792995|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
23792996|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
23792997|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
23792998|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
23792999|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
23793000|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
23793001|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
23793002|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
23467475|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
23467476|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467477|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
23467478|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23793003|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
23793004|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
23793005|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
23467479|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467480|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467481|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467482|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467483|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467484|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467485|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
23467486|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467487|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467488|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467489|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
23467490|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467491|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
23467492|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
23467493|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Other|0|||
23467494|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Other|0|||
23467495|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Other|1|||
23467496|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Other|1|||
23467497|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Other|0|||
23467498|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Other|0|||
23467499|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Other|0|||
23467500|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Other|1|||
23467501|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Other|0|||
23467502|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Death|0|||
23467503|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Death|0|||
23467504|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Death|0|||
23467505|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Death|0|||
23467506|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Death|0|||
23467507|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Death|1|||
23467508|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Death|0|||
23467509|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Death|0|||
23467510|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Death|0|||
23467511|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467512|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467513|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467514|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467515|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467516|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
23467517|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
23467518|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467519|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467520|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
23467521|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467522|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467523|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467524|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467525|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467526|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467527|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467528|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467529|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467530|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467531|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467532|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467533|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467534|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467535|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467536|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
23586712|NCT03761784|65876125|FG000|Overall Study|Pregnancy|1|||
23793006|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
23793007|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793008|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793009|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793010|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793011|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23467537|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
23467538|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467539|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467540|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467541|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467542|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467543|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467544|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467545|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467546|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
23467547|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
23467548|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
23467549|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
23467550|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
23467551|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
23467552|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
23467553|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
23467554|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
23467555|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
23467556|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Other|0|||
23467557|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Other|0|||
23467558|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Other|0|||
23467559|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Other|0|||
23467560|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Other|0|||
23467561|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Other|0|||
23467562|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Other|0|||
23467563|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Other|0|||
23467564|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Other|1|||
23467565|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Death|0|||
23467566|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Death|0|||
23467567|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Death|0|||
23467568|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Death|0|||
23467569|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Death|0|||
23467570|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Death|0|||
23467571|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Death|0|||
23467572|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Death|0|||
23467573|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Death|2|||
23467574|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467575|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467576|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467577|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467578|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467579|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
23793012|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
23793013|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
23793014|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793015|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793016|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
23793017|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793018|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23586713|NCT03761784|65876126|FG001|Overall Study|Pregnancy|0|||
23586714|NCT03761784|65876125|FG000|Overall Study|Protocol Violation|2|||
23586715|NCT03761784|65876126|FG001|Overall Study|Protocol Violation|0|||
23586716|NCT03761784|65876125|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
23586717|NCT03761784|65876126|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
23586718|NCT03761784|65876125|FG000|Overall Study|Withdrawal by Subject|9|||
23467580|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467581|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467582|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
23467583|NCT01750229|65457062|FG000|Randomized Crossover Phase|Adverse Event|1|||
23467584|NCT01750229|65457062|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
23467585|NCT01750229|65457062|FG000|Long-term Follow-up Phase|Adverse Event|2|||
23467586|NCT01750229|65457062|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
23467587|NCT02357368|65457063|FG000|Overall Study|Lost to Follow-up|0|||
23467588|NCT02357368|65457064|FG001|Overall Study|Lost to Follow-up|0|||
23793019|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793020|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793021|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793022|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793023|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793024|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793025|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793026|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793027|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793028|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23467589|NCT02357368|65457065|FG002|Overall Study|Lost to Follow-up|0|||
23467590|NCT02357368|65457066|FG003|Overall Study|Lost to Follow-up|1|||
23467591|NCT02357368|65457063|FG000|Overall Study|Pregnancy|3|||
23467592|NCT02357368|65457064|FG001|Overall Study|Pregnancy|2|||
23467593|NCT02357368|65457065|FG002|Overall Study|Pregnancy|0|||
23467594|NCT02357368|65457066|FG003|Overall Study|Pregnancy|0|||
23467595|NCT02357368|65457063|FG000|Overall Study|Withdrawal by Subject|3|||
23467596|NCT02357368|65457064|FG001|Overall Study|Withdrawal by Subject|1|||
23467597|NCT02357368|65457065|FG002|Overall Study|Withdrawal by Subject|1|||
23467598|NCT02357368|65457066|FG003|Overall Study|Withdrawal by Subject|2|||
23467599|NCT04041414|65457067|FG000|Overall Study|Lost to Follow-up|1|||
23793029|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793030|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793031|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793032|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23793033|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793034|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793035|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793036|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793037|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793038|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793039|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793040|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793041|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
23793042|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23467600|NCT04041414|65457068|FG001|Overall Study|Lost to Follow-up|2|||
23467601|NCT01903811|65457069|FG000|Overall Study|No measurable disease|1|||
23467602|NCT01903811|65457070|FG001|Overall Study|No measurable disease|1|||
23586719|NCT03761784|65876126|FG001|Overall Study|Withdrawal by Subject|4|||
23586720|NCT03761784|65876125|FG000|Overall Study|Physician Decision|1|||
23586721|NCT03761784|65876126|FG001|Overall Study|Physician Decision|0|||
23467603|NCT01903811|65457069|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
23793043|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23586722|NCT03761784|65876125|FG000|Overall Study|Other Than Specified|1|||
23351617|NCT04015518|65029670|FG001|Overall Study|Lost to Follow-up|0|||
23467604|NCT01903811|65457070|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
23793044|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793045|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793046|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793047|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793048|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793049|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23467605|NCT01903811|65457069|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
23467606|NCT01903811|65457070|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
23793050|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793051|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793052|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23467607|NCT01903811|65457069|FG000|Overall Study|Withdrawal by Subject|0|||
23467608|NCT01903811|65457070|FG001|Overall Study|Withdrawal by Subject|1|||
23467609|NCT00834093|65457071|FG000|Overall Study|Progressive Disease|3|||
23467610|NCT00834093|65457071|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
23467611|NCT02721966|65457072|FG000|Overall Study|Protocol Violation|1|||
23467612|NCT02721966|65457073|FG001|Overall Study|Protocol Violation|0|||
23793053|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793054|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793055|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793056|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793057|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793058|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23793059|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793060|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793061|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793062|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793063|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793064|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793065|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793066|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793067|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
23467613|NCT02721966|65457074|FG002|Overall Study|Protocol Violation|0|||
23467614|NCT02721966|65457075|FG003|Overall Study|Protocol Violation|0|||
23467615|NCT02721966|65457076|FG004|Overall Study|Protocol Violation|0|||
23793068|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
23467616|NCT02721966|65457072|FG000|Overall Study|Withdrawal by Subject|9|||
23467617|NCT02721966|65457073|FG001|Overall Study|Withdrawal by Subject|2|||
23467618|NCT02721966|65457074|FG002|Overall Study|Withdrawal by Subject|3|||
23467619|NCT02721966|65457075|FG003|Overall Study|Withdrawal by Subject|7|||
23467620|NCT02721966|65457076|FG004|Overall Study|Withdrawal by Subject|0|||
23467621|NCT02721966|65457072|FG000|Overall Study|Adverse Event|4|||
23793069|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793070|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793071|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793072|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793073|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793074|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
23586723|NCT03761784|65876126|FG001|Overall Study|Other Than Specified|0|||
23586724|NCT02163915|65876127|FG000|Overall Study|Withdrawal by Subject|2|||
23586725|NCT02163915|65876128|FG001|Overall Study|Withdrawal by Subject|0|||
23586726|NCT02163915|65876129|FG002|Overall Study|Withdrawal by Subject|2|||
23586727|NCT02163915|65876130|FG003|Overall Study|Withdrawal by Subject|2|||
23586728|NCT02163915|65876131|FG004|Overall Study|Withdrawal by Subject|2|||
23467622|NCT02721966|65457073|FG001|Overall Study|Adverse Event|4|||
23467623|NCT02721966|65457074|FG002|Overall Study|Adverse Event|3|||
23467624|NCT02721966|65457075|FG003|Overall Study|Adverse Event|0|||
23467625|NCT02721966|65457076|FG004|Overall Study|Adverse Event|0|||
23793075|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
23586729|NCT02163915|65876127|FG000|Overall Study|Study termination|1|||
23586730|NCT02163915|65876128|FG001|Overall Study|Study termination|0|||
23586731|NCT02163915|65876129|FG002|Overall Study|Study termination|0|||
23586732|NCT02163915|65876130|FG003|Overall Study|Study termination|0|||
23467626|NCT02721966|65457072|FG000|Overall Study|Death|1|||
23640526|NCT03466073|66067558|FG004|Overall Study|Death|0|||
23586733|NCT02163915|65876131|FG004|Overall Study|Study termination|2|||
23586734|NCT02163915|65876127|FG000|Overall Study|Physician Decision|0|||
23586735|NCT02163915|65876128|FG001|Overall Study|Physician Decision|0|||
23640527|NCT03466073|66067559|FG005|Overall Study|Death|1|||
23467627|NCT02721966|65457073|FG001|Overall Study|Death|0|||
23467628|NCT02721966|65457074|FG002|Overall Study|Death|0|||
23467629|NCT02721966|65457075|FG003|Overall Study|Death|0|||
23640528|NCT01276379|66067560|FG000|Overall Study|Screening failure|40|||
23793076|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793077|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
23586736|NCT02163915|65876129|FG002|Overall Study|Physician Decision|0|||
23586737|NCT02163915|65876130|FG003|Overall Study|Physician Decision|1|||
23586738|NCT02163915|65876131|FG004|Overall Study|Physician Decision|0|||
23586739|NCT03942042|65876134|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
23586740|NCT03942042|65876135|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
23586741|NCT03942042|65876134|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
23586742|NCT03942042|65876135|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
23586743|NCT01152190|65876136|FG000|Overall Study|Adverse Event|2|||
23586744|NCT01152190|65876137|FG001|Overall Study|Adverse Event|4|||
23586745|NCT01152190|65876136|FG000|Overall Study|Death|1|||
23586746|NCT01152190|65876137|FG001|Overall Study|Death|0|||
23586747|NCT01152190|65876136|FG000|Overall Study|Protocol Violation|1|||
23586748|NCT01152190|65876137|FG001|Overall Study|Protocol Violation|1|||
23586749|NCT01152190|65876136|FG000|Overall Study|Withdrawal by Subject|1|||
23586750|NCT01152190|65876137|FG001|Overall Study|Withdrawal by Subject|3|||
23586751|NCT03635112|65876138|FG000|Overall Study|Adverse Event|5|||
23586752|NCT03635112|65876139|FG001|Overall Study|Adverse Event|9|||
23586753|NCT03635112|65876140|FG002|Overall Study|Adverse Event|14|||
23586754|NCT03635112|65876138|FG000|Overall Study|Lost to Follow-up|1|||
23586755|NCT03635112|65876139|FG001|Overall Study|Lost to Follow-up|0|||
23586756|NCT03635112|65876140|FG002|Overall Study|Lost to Follow-up|1|||
23586757|NCT03635112|65876138|FG000|Overall Study|Physician Decision|5|||
23586758|NCT03635112|65876139|FG001|Overall Study|Physician Decision|7|||
23586759|NCT03635112|65876140|FG002|Overall Study|Physician Decision|5|||
23586760|NCT03635112|65876138|FG000|Overall Study|Protocol Violation|0|||
23351618|NCT04015518|65029671|FG002|Overall Study|Lost to Follow-up|0|||
23351619|NCT04015518|65029672|FG003|Overall Study|Lost to Follow-up|0|||
23351620|NCT04015518|65029673|FG004|Overall Study|Lost to Follow-up|1|||
23351621|NCT04015518|65029669|FG000|Overall Study|Withdrawal by Subject|0|||
23351622|NCT04015518|65029670|FG001|Overall Study|Withdrawal by Subject|1|||
23351623|NCT04015518|65029671|FG002|Overall Study|Withdrawal by Subject|0|||
23351624|NCT04015518|65029672|FG003|Overall Study|Withdrawal by Subject|1|||
23351625|NCT04015518|65029673|FG004|Overall Study|Withdrawal by Subject|1|||
23351626|NCT04015518|65029669|FG000|Overall Study|Patient did not come for consecutive visits|0|||
23351627|NCT04015518|65029670|FG001|Overall Study|Patient did not come for consecutive visits|1|||
23351628|NCT04015518|65029671|FG002|Overall Study|Patient did not come for consecutive visits|0|||
23351629|NCT04015518|65029672|FG003|Overall Study|Patient did not come for consecutive visits|0|||
23351630|NCT04015518|65029673|FG004|Overall Study|Patient did not come for consecutive visits|0|||
23351631|NCT04015518|65029669|FG000|Overall Study|not willing to travel due to Covid-19|0|||
23351632|NCT04015518|65029670|FG001|Overall Study|not willing to travel due to Covid-19|0|||
23351633|NCT04015518|65029671|FG002|Overall Study|not willing to travel due to Covid-19|1|||
23351634|NCT04015518|65029672|FG003|Overall Study|not willing to travel due to Covid-19|0|||
23351635|NCT04015518|65029673|FG004|Overall Study|not willing to travel due to Covid-19|0|||
23351636|NCT04015518|65029669|FG000|Overall Study|Patient wants to discontinue treatment|0|||
23351637|NCT04015518|65029670|FG001|Overall Study|Patient wants to discontinue treatment|0|||
23351638|NCT04015518|65029671|FG002|Overall Study|Patient wants to discontinue treatment|0|||
23351639|NCT04015518|65029672|FG003|Overall Study|Patient wants to discontinue treatment|1|||
23467630|NCT02721966|65457076|FG004|Overall Study|Death|0|||
23467631|NCT02721966|65457072|FG000|Overall Study|Lack of Efficacy|7|||
23467632|NCT02721966|65457073|FG001|Overall Study|Lack of Efficacy|4|||
23467633|NCT02721966|65457074|FG002|Overall Study|Lack of Efficacy|0|||
23467634|NCT02721966|65457075|FG003|Overall Study|Lack of Efficacy|0|||
23467635|NCT02721966|65457076|FG004|Overall Study|Lack of Efficacy|0|||
23467636|NCT02721966|65457072|FG000|Overall Study|Lost to Follow-up|0|||
23467637|NCT02721966|65457073|FG001|Overall Study|Lost to Follow-up|0|||
23586761|NCT03635112|65876139|FG001|Overall Study|Protocol Violation|0|||
23586762|NCT03635112|65876140|FG002|Overall Study|Protocol Violation|1|||
23586763|NCT03635112|65876138|FG000|Overall Study|Study Terminated by Sponsor|11|||
23793078|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793079|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793080|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793081|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793082|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793083|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793084|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
23793085|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793086|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793087|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23586764|NCT03635112|65876139|FG001|Overall Study|Study Terminated by Sponsor|17|||
23586765|NCT03635112|65876140|FG002|Overall Study|Study Terminated by Sponsor|21|||
23586766|NCT03635112|65876138|FG000|Overall Study|Withdrawal by Subject|4|||
23586767|NCT03635112|65876139|FG001|Overall Study|Withdrawal by Subject|9|||
23793088|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793089|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23467638|NCT02721966|65457074|FG002|Overall Study|Lost to Follow-up|3|||
23351640|NCT04015518|65029673|FG004|Overall Study|Patient wants to discontinue treatment|0|||
23351641|NCT04015518|65029669|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
23351642|NCT04015518|65029670|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
23467639|NCT02721966|65457075|FG003|Overall Study|Lost to Follow-up|0|||
23467640|NCT02721966|65457076|FG004|Overall Study|Lost to Follow-up|0|||
23467641|NCT02721966|65457072|FG000|Overall Study|Physician Decision|1|||
23467642|NCT02721966|65457073|FG001|Overall Study|Physician Decision|1|||
23467643|NCT02721966|65457074|FG002|Overall Study|Physician Decision|0|||
23467644|NCT02721966|65457075|FG003|Overall Study|Physician Decision|0|||
23467645|NCT02721966|65457076|FG004|Overall Study|Physician Decision|0|||
23467646|NCT02721966|65457072|FG000|Overall Study|Pregnancy|1|||
23467647|NCT02721966|65457073|FG001|Overall Study|Pregnancy|0|||
23467648|NCT02721966|65457074|FG002|Overall Study|Pregnancy|0|||
23467649|NCT02721966|65457075|FG003|Overall Study|Pregnancy|0|||
23467650|NCT02721966|65457076|FG004|Overall Study|Pregnancy|0|||
23467651|NCT02721966|65457072|FG000|Overall Study|Did not continue to period 2|5|||
23467652|NCT02721966|65457073|FG001|Overall Study|Did not continue to period 2|12|||
23467653|NCT02721966|65457074|FG002|Overall Study|Did not continue to period 2|0|||
23467654|NCT02721966|65457075|FG003|Overall Study|Did not continue to period 2|0|||
23467655|NCT02721966|65457076|FG004|Overall Study|Did not continue to period 2|5|||
23467656|NCT04540913|65457077|FG000|Overall Study|Withdrawal by Subject|14|||
23467657|NCT04540913|65457078|FG001|Overall Study|Withdrawal by Subject|3|||
23467658|NCT03216226|65457079|FG000|Overall Study|Adverse Event|3|||
23467659|NCT03216226|65457080|FG001|Overall Study|Adverse Event|0|||
23467660|NCT03216226|65457079|FG000|Overall Study|Protocol Violation|1|||
23467661|NCT03216226|65457080|FG001|Overall Study|Protocol Violation|3|||
23467662|NCT03216226|65457079|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
23467663|NCT03216226|65457080|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
23467664|NCT03216226|65457079|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
23467665|NCT03216226|65457080|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
23467666|NCT03216226|65457079|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
23467667|NCT03216226|65457080|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
23467668|NCT00998296|65457081|FG000|Overall Study|Progressive disease|0|||
23467669|NCT00998296|65457082|FG001|Overall Study|Progressive disease|1|||
23467670|NCT00998296|65457083|FG002|Overall Study|Progressive disease|0|||
23467671|NCT00998296|65457084|FG003|Overall Study|Progressive disease|0|||
23467672|NCT00998296|65457085|FG004|Overall Study|Progressive disease|0|||
23467673|NCT00998296|65457086|FG005|Overall Study|Progressive disease|0|||
23467674|NCT00998296|65457087|FG006|Overall Study|Progressive disease|1|||
23467675|NCT00998296|65457088|FG007|Overall Study|Progressive disease|0|||
23467676|NCT00998296|65457089|FG008|Overall Study|Progressive disease|0|||
23467677|NCT00998296|65457090|FG009|Overall Study|Progressive disease|14|||
23467678|NCT00998296|65457091|FG010|Overall Study|Progressive disease|5|||
23467679|NCT00998296|65457081|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467680|NCT00998296|65457082|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467681|NCT00998296|65457083|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467682|NCT00998296|65457084|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467683|NCT00998296|65457085|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
23467684|NCT00998296|65457086|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467685|NCT00998296|65457087|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467686|NCT00998296|65457088|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
23467687|NCT00998296|65457089|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
23467688|NCT00998296|65457090|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467689|NCT00998296|65457091|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467690|NCT00998296|65457081|FG000|Overall Study|Other adverse event|0|||
23467691|NCT00998296|65457082|FG001|Overall Study|Other adverse event|0|||
23467692|NCT00998296|65457083|FG002|Overall Study|Other adverse event|0|||
23467693|NCT00998296|65457084|FG003|Overall Study|Other adverse event|0|||
23467694|NCT00998296|65457085|FG004|Overall Study|Other adverse event|1|||
23467695|NCT00998296|65457086|FG005|Overall Study|Other adverse event|0|||
23467696|NCT00998296|65457087|FG006|Overall Study|Other adverse event|0|||
23467697|NCT00998296|65457088|FG007|Overall Study|Other adverse event|0|||
23467698|NCT00998296|65457089|FG008|Overall Study|Other adverse event|0|||
23467699|NCT00998296|65457090|FG009|Overall Study|Other adverse event|1|||
23467700|NCT00998296|65457091|FG010|Overall Study|Other adverse event|2|||
23467701|NCT00998296|65457081|FG000|Overall Study|Refused to continue taking trial med.|0|||
23467702|NCT00998296|65457082|FG001|Overall Study|Refused to continue taking trial med.|0|||
23467703|NCT00998296|65457083|FG002|Overall Study|Refused to continue taking trial med.|0|||
23467704|NCT00998296|65457084|FG003|Overall Study|Refused to continue taking trial med.|0|||
23467705|NCT00998296|65457085|FG004|Overall Study|Refused to continue taking trial med.|0|||
23467706|NCT00998296|65457086|FG005|Overall Study|Refused to continue taking trial med.|0|||
23467707|NCT00998296|65457087|FG006|Overall Study|Refused to continue taking trial med.|0|||
23467708|NCT00998296|65457088|FG007|Overall Study|Refused to continue taking trial med.|0|||
23467709|NCT00998296|65457089|FG008|Overall Study|Refused to continue taking trial med.|0|||
23467710|NCT00998296|65457090|FG009|Overall Study|Refused to continue taking trial med.|2|||
23467711|NCT00998296|65457091|FG010|Overall Study|Refused to continue taking trial med.|0|||
23467712|NCT00998296|65457081|FG000|Overall Study|Reason other than those specified above|0|||
23467713|NCT00998296|65457082|FG001|Overall Study|Reason other than those specified above|0|||
23467714|NCT00998296|65457083|FG002|Overall Study|Reason other than those specified above|0|||
23467715|NCT00998296|65457084|FG003|Overall Study|Reason other than those specified above|0|||
23467716|NCT00998296|65457085|FG004|Overall Study|Reason other than those specified above|0|||
23467717|NCT00998296|65457086|FG005|Overall Study|Reason other than those specified above|0|||
23467718|NCT00998296|65457087|FG006|Overall Study|Reason other than those specified above|0|||
23467719|NCT00998296|65457088|FG007|Overall Study|Reason other than those specified above|0|||
23467720|NCT00998296|65457089|FG008|Overall Study|Reason other than those specified above|0|||
23467721|NCT00998296|65457090|FG009|Overall Study|Reason other than those specified above|1|||
23467722|NCT00998296|65457091|FG010|Overall Study|Reason other than those specified above|0|||
23467723|NCT02637037|65457098|FG000|Overall Study|Positive drug screen at admission|1|||
23467724|NCT02637037|65457099|FG001|Overall Study|Positive drug screen at admission|0|||
23467725|NCT02637037|65457098|FG000|Overall Study|Withdrawal by Subject|2|||
23467726|NCT02637037|65457099|FG001|Overall Study|Withdrawal by Subject|1|||
23467727|NCT02637037|65457098|FG000|Overall Study|Adverse Event|1|||
23467728|NCT02637037|65457099|FG001|Overall Study|Adverse Event|0|||
23467729|NCT02633306|65457104|FG000|Overall Study|Withdrawal by Subject|3|||
23467730|NCT00737672|65457107|FG000|Overall Study|Graft Abandonment|48|||
23467731|NCT00737672|65457108|FG001|Overall Study|Graft Abandonment|56|||
23467732|NCT00737672|65457107|FG000|Overall Study|Death|23|||
23467733|NCT00737672|65457108|FG001|Overall Study|Death|22|||
23467734|NCT00737672|65457107|FG000|Overall Study|Withdrawal by Subject|1|||
23351643|NCT04015518|65029671|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
23351644|NCT04015518|65029672|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
23351645|NCT04015518|65029673|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
23351646|NCT04015518|65029669|FG000|Overall Study|Pregnancy|0|||
23351647|NCT04015518|65029670|FG001|Overall Study|Pregnancy|0|||
23351648|NCT04015518|65029671|FG002|Overall Study|Pregnancy|0|||
23351649|NCT04015518|65029672|FG003|Overall Study|Pregnancy|0|||
23351650|NCT04015518|65029673|FG004|Overall Study|Pregnancy|1|||
23351651|NCT04015518|65029669|FG000|Overall Study|Personal reasons|1|||
23351652|NCT04015518|65029670|FG001|Overall Study|Personal reasons|0|||
23351653|NCT04015518|65029671|FG002|Overall Study|Personal reasons|0|||
23351654|NCT04015518|65029672|FG003|Overall Study|Personal reasons|0|||
23351655|NCT04015518|65029673|FG004|Overall Study|Personal reasons|1|||
23351656|NCT04015518|65029669|FG000|Overall Study|Withdrew consent|1|||
23351657|NCT04015518|65029670|FG001|Overall Study|Withdrew consent|0|||
23351658|NCT04015518|65029671|FG002|Overall Study|Withdrew consent|0|||
23351659|NCT04015518|65029672|FG003|Overall Study|Withdrew consent|0|||
23351660|NCT04015518|65029673|FG004|Overall Study|Withdrew consent|0|||
23351661|NCT04015518|65029669|FG000|Overall Study|Prostate carcinoma|1|||
23351662|NCT04015518|65029670|FG001|Overall Study|Prostate carcinoma|0|||
23351663|NCT04015518|65029671|FG002|Overall Study|Prostate carcinoma|0|||
23351664|NCT04015518|65029672|FG003|Overall Study|Prostate carcinoma|0|||
23351665|NCT04015518|65029673|FG004|Overall Study|Prostate carcinoma|0|||
23351666|NCT04015518|65029669|FG000|Overall Study|Could not keep appointments due to work|1|||
23351667|NCT04015518|65029670|FG001|Overall Study|Could not keep appointments due to work|0|||
23351668|NCT04015518|65029671|FG002|Overall Study|Could not keep appointments due to work|0|||
23351669|NCT04015518|65029672|FG003|Overall Study|Could not keep appointments due to work|0|||
23351670|NCT04015518|65029673|FG004|Overall Study|Could not keep appointments due to work|0|||
23351671|NCT01941537|65029680|FG000|Overall Study|Lack of Efficacy|1|||
23351672|NCT01941537|65029681|FG001|Overall Study|Lack of Efficacy|2|||
23351673|NCT01941537|65029680|FG000|Overall Study|Lost to Follow-up|1|||
23351674|NCT01941537|65029681|FG001|Overall Study|Lost to Follow-up|0|||
23351675|NCT01941537|65029680|FG000|Overall Study|Pregnancy|1|||
23351676|NCT01941537|65029681|FG001|Overall Study|Pregnancy|0|||
23467735|NCT00737672|65457108|FG001|Overall Study|Withdrawal by Subject|2|||
23467736|NCT00737672|65457107|FG000|Overall Study|Lost to Follow-up|1|||
23706518|NCT03554005|66301236|FG003|Overall Study|Other|0|||
23351677|NCT01941537|65029680|FG000|Overall Study|Adverse Event|1|||
23351678|NCT01941537|65029681|FG001|Overall Study|Adverse Event|0|||
23467737|NCT00737672|65457108|FG001|Overall Study|Lost to Follow-up|0|||
23467738|NCT00737672|65457107|FG000|Overall Study|Miscellaneous|7|||
23351679|NCT01941537|65029680|FG000|Overall Study|Withdrawal by Subject|0|||
23351680|NCT01941537|65029681|FG001|Overall Study|Withdrawal by Subject|1|||
23351681|NCT02457832|65029686|FG000|Training|Lost to Follow-up|10|||
23351682|NCT02457832|65029687|FG001|Training|Lost to Follow-up|6|||
23351683|NCT02457832|65029688|FG002|Training|Lost to Follow-up|3|||
23351684|NCT02457832|65029686|FG000|One Month Washout|Lost to Follow-up|0|||
23351685|NCT02457832|65029687|FG001|One Month Washout|Lost to Follow-up|1|||
23351686|NCT02457832|65029688|FG002|One Month Washout|Lost to Follow-up|1|||
23351687|NCT02073656|65029689|FG000|Primary Study|Lost to Follow-up|6|||
23351688|NCT02073656|65029689|FG000|Primary Study|Death|1|||
23351689|NCT02073656|65029689|FG000|Primary Study|Withdrew Consent|1|||
23351690|NCT00379808|65029690|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
23351691|NCT00379808|65029691|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
23351692|NCT00772005|65029692|FG000|Overall Study|Adverse Event|9|||
23351693|NCT00772005|65029693|FG001|Overall Study|Adverse Event|14|||
23351694|NCT00772005|65029694|FG002|Overall Study|Adverse Event|10|||
23351695|NCT00772005|65029695|FG003|Overall Study|Adverse Event|13|||
23351696|NCT00772005|65029692|FG000|Overall Study|Lack of Efficacy|0|||
23351697|NCT00772005|65029693|FG001|Overall Study|Lack of Efficacy|1|||
23351698|NCT00772005|65029694|FG002|Overall Study|Lack of Efficacy|0|||
23586768|NCT03635112|65876140|FG002|Overall Study|Withdrawal by Subject|7|||
23586769|NCT03635112|65876138|FG000|Overall Study|Miscellaneous|0|||
23586770|NCT03635112|65876139|FG001|Overall Study|Miscellaneous|0|||
23586771|NCT03635112|65876140|FG002|Overall Study|Miscellaneous|1|||
23586772|NCT00299702|65876141|FG000|Overall Study|Death|1|||
23351699|NCT00772005|65029695|FG003|Overall Study|Lack of Efficacy|0|||
23351700|NCT00772005|65029692|FG000|Overall Study|Withdrawal by Subject|3|||
23351701|NCT00772005|65029693|FG001|Overall Study|Withdrawal by Subject|7|||
23351702|NCT00772005|65029694|FG002|Overall Study|Withdrawal by Subject|10|||
23351703|NCT00772005|65029695|FG003|Overall Study|Withdrawal by Subject|2|||
23351704|NCT00772005|65029692|FG000|Overall Study|Protocol Violation|2|||
23351705|NCT00772005|65029693|FG001|Overall Study|Protocol Violation|4|||
23351706|NCT00772005|65029694|FG002|Overall Study|Protocol Violation|1|||
23351707|NCT00772005|65029695|FG003|Overall Study|Protocol Violation|6|||
23351708|NCT00772005|65029692|FG000|Overall Study|Lost to Follow-up|7|||
23351709|NCT00772005|65029693|FG001|Overall Study|Lost to Follow-up|3|||
23351710|NCT00772005|65029694|FG002|Overall Study|Lost to Follow-up|6|||
23351711|NCT00772005|65029695|FG003|Overall Study|Lost to Follow-up|3|||
23351712|NCT00772005|65029692|FG000|Overall Study|Non-compliance with study procedures|1|||
23351713|NCT00772005|65029693|FG001|Overall Study|Non-compliance with study procedures|1|||
23351714|NCT00772005|65029694|FG002|Overall Study|Non-compliance with study procedures|0|||
23351715|NCT00772005|65029695|FG003|Overall Study|Non-compliance with study procedures|1|||
23351716|NCT00772005|65029692|FG000|Overall Study|Non-compliance with drug administration|3|||
23351717|NCT00772005|65029693|FG001|Overall Study|Non-compliance with drug administration|0|||
23351718|NCT00772005|65029694|FG002|Overall Study|Non-compliance with drug administration|1|||
23351719|NCT00772005|65029695|FG003|Overall Study|Non-compliance with drug administration|1|||
23351720|NCT00099632|65029698|FG000|Overall Study|Lost to Follow-up|1|||
23351721|NCT00099632|65029699|FG001|Overall Study|Lost to Follow-up|0|||
23351722|NCT00099632|65029700|FG002|Overall Study|Lost to Follow-up|3|||
23351723|NCT00099632|65029701|FG003|Overall Study|Lost to Follow-up|1|||
23351724|NCT00099632|65029702|FG004|Overall Study|Lost to Follow-up|1|||
23351725|NCT00099632|65029703|FG005|Overall Study|Lost to Follow-up|0|||
23351726|NCT00099632|65029698|FG000|Overall Study|Withdrawal by Subject|0|||
23351727|NCT00099632|65029699|FG001|Overall Study|Withdrawal by Subject|1|||
23351728|NCT00099632|65029700|FG002|Overall Study|Withdrawal by Subject|0|||
23351729|NCT00099632|65029701|FG003|Overall Study|Withdrawal by Subject|0|||
23351730|NCT00099632|65029702|FG004|Overall Study|Withdrawal by Subject|0|||
23351731|NCT00099632|65029703|FG005|Overall Study|Withdrawal by Subject|1|||
23351732|NCT00099632|65029698|FG000|Overall Study|Protocol Violation|0|||
23351733|NCT00099632|65029699|FG001|Overall Study|Protocol Violation|0|||
23351734|NCT00099632|65029700|FG002|Overall Study|Protocol Violation|0|||
23351735|NCT00099632|65029701|FG003|Overall Study|Protocol Violation|0|||
23351736|NCT00099632|65029702|FG004|Overall Study|Protocol Violation|0|||
23351737|NCT00099632|65029703|FG005|Overall Study|Protocol Violation|1|||
23351738|NCT03114657|65029705|FG000|Overall Study|Adverse Event|9|||
23351739|NCT03114657|65029706|FG001|Overall Study|Adverse Event|6|||
23351740|NCT03114657|65029705|FG000|Overall Study|Death|4|||
23351741|NCT03114657|65029706|FG001|Overall Study|Death|0|||
23351742|NCT03114657|65029705|FG000|Overall Study|Multiple Reasons|1|||
23351743|NCT03114657|65029706|FG001|Overall Study|Multiple Reasons|2|||
23351744|NCT03114657|65029705|FG000|Overall Study|Physician Decision|2|||
23586773|NCT00299702|65876142|FG001|Overall Study|Death|0|||
23586774|NCT00299702|65876141|FG000|Overall Study|Adverse Event|0|||
23586775|NCT00299702|65876142|FG001|Overall Study|Adverse Event|4|||
23586776|NCT00299702|65876141|FG000|Overall Study|Lost to Follow-up|18|||
23586777|NCT00299702|65876142|FG001|Overall Study|Lost to Follow-up|10|||
23586778|NCT00299702|65876141|FG000|Overall Study|Withdrawal by Subject|25|||
23586779|NCT00299702|65876142|FG001|Overall Study|Withdrawal by Subject|23|||
23586780|NCT00299702|65876141|FG000|Overall Study|Pregnancy|0|||
23586781|NCT00299702|65876142|FG001|Overall Study|Pregnancy|1|||
23586782|NCT00299702|65876141|FG000|Overall Study|Insufficient Response|4|||
23586783|NCT00299702|65876142|FG001|Overall Study|Insufficient Response|3|||
23586784|NCT00299702|65876141|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
23586785|NCT00299702|65876142|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
23586786|NCT02512042|65876144|FG000|Overall Study|Adverse Event|0|||
23586787|NCT02512042|65876145|FG001|Overall Study|Adverse Event|4|||
23586788|NCT02512042|65876144|FG000|Overall Study|Withdrawal by Subject|6|||
23467739|NCT00737672|65457108|FG001|Overall Study|Miscellaneous|1|||
23706519|NCT03554005|66301237|FG004|Overall Study|Other|0|||
23467740|NCT00737672|65457107|FG000|Overall Study|Physician Decision|0|||
23467741|NCT00737672|65457108|FG001|Overall Study|Physician Decision|2|||
23467742|NCT00950859|65457109|FG000|Overall Study|Adverse Event|3|||
23793090|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23793091|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23793092|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
23793093|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
23793094|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23793095|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793096|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23351745|NCT03114657|65029706|FG001|Overall Study|Physician Decision|2|||
23351746|NCT03114657|65029705|FG000|Overall Study|Study Terminated By Sponsor|355|||
23351747|NCT03114657|65029706|FG001|Overall Study|Study Terminated By Sponsor|374|||
23351748|NCT03114657|65029705|FG000|Overall Study|Symptomatic Deterioration|0|||
23351749|NCT03114657|65029706|FG001|Overall Study|Symptomatic Deterioration|1|||
23351750|NCT03114657|65029705|FG000|Overall Study|Withdrawal by Subject|28|||
23351751|NCT03114657|65029706|FG001|Overall Study|Withdrawal by Subject|22|||
23351752|NCT03877224|65029715|FG000|Overall Study|Death|3|||
23351753|NCT03877224|65029716|FG001|Overall Study|Death|2|||
23351754|NCT03877224|65029715|FG000|Overall Study|Withdrawal by Subject|1|||
23351755|NCT03877224|65029716|FG001|Overall Study|Withdrawal by Subject|6|||
23351756|NCT03877224|65029715|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
23793097|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793098|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23402773|NCT01446874|65220004|FG001|Overall Study|No surgery/No qualifying surgery|0|||
23793099|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23640529|NCT01395888|66067561|FG000|2-week Run-in Period|Adverse Event|2|||
23640530|NCT01395888|66067562|FG001|2-week Run-in Period|Adverse Event|0|||
23640531|NCT01395888|66067563|FG002|2-week Run-in Period|Adverse Event|0|||
23640532|NCT01395888|66067561|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
23640533|NCT01395888|66067562|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23640534|NCT01395888|66067563|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23640535|NCT01395888|66067561|FG000|2-week Run-in Period|Lost to Follow-up|1|||
23640536|NCT01395888|66067562|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23640537|NCT01395888|66067563|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23640538|NCT01395888|66067561|FG000|2-week Run-in Period|Protocol Violation|2|||
23640539|NCT01395888|66067562|FG001|2-week Run-in Period|Protocol Violation|0|||
23640540|NCT01395888|66067563|FG002|2-week Run-in Period|Protocol Violation|0|||
23640541|NCT01395888|66067561|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
23640542|NCT01395888|66067562|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23640543|NCT01395888|66067563|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23640544|NCT01395888|66067561|FG000|Treatment Period (TP)|Adverse Event|0|||
23640545|NCT01395888|66067562|FG001|Treatment Period (TP)|Adverse Event|7|||
23640546|NCT01395888|66067563|FG002|Treatment Period (TP)|Adverse Event|6|||
23640547|NCT01395888|66067561|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
23640548|NCT01395888|66067562|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
23640549|NCT01395888|66067563|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
23640550|NCT01395888|66067561|FG000|Treatment Period (TP)|Protocol Violation|0|||
23640551|NCT01395888|66067562|FG001|Treatment Period (TP)|Protocol Violation|1|||
23640552|NCT01395888|66067563|FG002|Treatment Period (TP)|Protocol Violation|5|||
23640553|NCT01395888|66067561|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
23640554|NCT01395888|66067562|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
23640555|NCT01395888|66067563|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
23640556|NCT01395888|66067561|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
23640557|NCT01395888|66067562|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
23640558|NCT01395888|66067563|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
23640559|NCT03592745|66067569|FG000|Overall Study|Adverse Event|0|||
23640560|NCT03592745|66067570|FG001|Overall Study|Adverse Event|2|||
23640561|NCT03592745|66067569|FG000|Overall Study|Lost to Follow-up|2|||
23640562|NCT03592745|66067570|FG001|Overall Study|Lost to Follow-up|0|||
23640563|NCT03592745|66067569|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
23640564|NCT03592745|66067570|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
23640565|NCT03500159|66067573|FG000|Overall Study|Study Terminated|2|||
23793100|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793101|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793102|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793103|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793104|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793105|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793106|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793107|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793108|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23467743|NCT00950859|65457110|FG001|Overall Study|Adverse Event|3|||
23640566|NCT03500159|66067574|FG001|Overall Study|Study Terminated|1|||
23640567|NCT01888900|66067581|FG000|Overall Study|failed treatment|0|||
23793109|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793110|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23793111|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793112|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793113|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793114|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793115|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793116|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793117|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793118|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793119|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793120|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
23793121|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793122|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793123|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793124|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793125|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793126|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793127|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793128|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793129|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23467744|NCT00950859|65457109|FG000|Overall Study|Insufficient Viral Load Response|12|||
23467745|NCT00950859|65457110|FG001|Overall Study|Insufficient Viral Load Response|3|||
23467746|NCT00950859|65457109|FG000|Overall Study|Protocol Violation|1|||
23793130|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793131|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23640568|NCT01888900|66067582|FG001|Overall Study|failed treatment|2|||
23640569|NCT03001076|66067583|FG000|Overall Study|Withdrawal by patient|2|||
23640570|NCT03001076|66067584|FG001|Overall Study|Withdrawal by patient|0|||
23793132|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793133|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793134|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793135|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23640571|NCT03001076|66067583|FG000|Overall Study|Other|1|||
23793136|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23793137|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793138|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793139|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793140|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793141|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793142|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
23351757|NCT03877224|65029716|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
23351758|NCT01554176|65029717|FG000|Treatment Phase|Protocol Violation|1|||
23467747|NCT00950859|65457110|FG001|Overall Study|Protocol Violation|1|||
23467748|NCT00950859|65457109|FG000|Overall Study|Lost to Follow-up|0|||
23467749|NCT00950859|65457110|FG001|Overall Study|Lost to Follow-up|3|||
23467750|NCT02105961|65457121|FG000|Overall Study|Adverse Event|18|||
23467751|NCT02105961|65457122|FG001|Overall Study|Adverse Event|7|||
23467752|NCT02105961|65457123|FG002|Overall Study|Adverse Event|13|||
23467753|NCT02105961|65457121|FG000|Overall Study|Lack of Efficacy|3|||
23467754|NCT02105961|65457122|FG001|Overall Study|Lack of Efficacy|0|||
23467755|NCT02105961|65457123|FG002|Overall Study|Lack of Efficacy|3|||
23351759|NCT01554176|65029718|FG001|Treatment Phase|Protocol Violation|2|||
23351760|NCT01554176|65029719|FG002|Treatment Phase|Protocol Violation|0|||
23467756|NCT02105961|65457121|FG000|Overall Study|Lost to Follow-up|2|||
23467757|NCT02105961|65457122|FG001|Overall Study|Lost to Follow-up|0|||
23467758|NCT02105961|65457123|FG002|Overall Study|Lost to Follow-up|1|||
23467759|NCT02105961|65457121|FG000|Overall Study|Physician Decision|3|||
23467760|NCT02105961|65457122|FG001|Overall Study|Physician Decision|3|||
23467761|NCT02105961|65457123|FG002|Overall Study|Physician Decision|2|||
23467762|NCT02105961|65457121|FG000|Overall Study|Withdrawal by Subject|15|||
23467763|NCT02105961|65457122|FG001|Overall Study|Withdrawal by Subject|7|||
23467764|NCT02105961|65457123|FG002|Overall Study|Withdrawal by Subject|11|||
23467765|NCT04646044|65457125|FG000|Overall Study|Lost to Follow-up|0|||
23467766|NCT04646044|65457126|FG001|Overall Study|Lost to Follow-up|0|||
23467767|NCT04646044|65457127|FG002|Overall Study|Lost to Follow-up|1|||
23467768|NCT04646044|65457128|FG003|Overall Study|Lost to Follow-up|0|||
23467769|NCT04646044|65457125|FG000|Overall Study|Withdrawal by Subject|0|||
23467770|NCT04646044|65457126|FG001|Overall Study|Withdrawal by Subject|1|||
23467771|NCT04646044|65457127|FG002|Overall Study|Withdrawal by Subject|0|||
23467772|NCT04646044|65457128|FG003|Overall Study|Withdrawal by Subject|0|||
23467773|NCT03038880|65457132|FG000|Overall Study|Death|1|||
23467774|NCT03038880|65457133|FG001|Overall Study|Death|2|||
23467775|NCT03038880|65457134|FG002|Overall Study|Death|0|||
23467776|NCT03038880|65457132|FG000|Overall Study|Physician Decision|2|||
23467777|NCT03038880|65457133|FG001|Overall Study|Physician Decision|1|||
23467778|NCT03038880|65457134|FG002|Overall Study|Physician Decision|0|||
23467779|NCT04555616|65457135|FG000|Overall Study|Death|1|||
23467780|NCT04555616|65457136|FG001|Overall Study|Death|0|||
23467781|NCT04555616|65457137|FG002|Overall Study|Death|1|||
23467782|NCT04555616|65457135|FG000|Overall Study|Withdrawal by Subject|2|||
23467783|NCT04555616|65457136|FG001|Overall Study|Withdrawal by Subject|1|||
23467784|NCT04555616|65457137|FG002|Overall Study|Withdrawal by Subject|0|||
23467785|NCT03345784|65457138|FG000|Overall Study|Withdrawal by Subject|2|||
23467786|NCT03345784|65457139|FG001|Overall Study|Withdrawal by Subject|1|||
23351761|NCT01554176|65029720|FG003|Treatment Phase|Protocol Violation|0|||
23351762|NCT01554176|65029721|FG004|Treatment Phase|Protocol Violation|0|||
23351763|NCT01554176|65029717|FG000|Treatment Phase|Physician Decision|1|||
23351764|NCT01554176|65029718|FG001|Treatment Phase|Physician Decision|1|||
23351765|NCT01554176|65029719|FG002|Treatment Phase|Physician Decision|0|||
23351766|NCT01554176|65029720|FG003|Treatment Phase|Physician Decision|0|||
23351767|NCT01554176|65029721|FG004|Treatment Phase|Physician Decision|0|||
23351768|NCT01554176|65029717|FG000|Treatment Phase|Lack of Efficacy|0|||
23351769|NCT01554176|65029718|FG001|Treatment Phase|Lack of Efficacy|1|||
23351770|NCT01554176|65029719|FG002|Treatment Phase|Lack of Efficacy|0|||
23793143|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793144|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793145|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793146|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
23351771|NCT01554176|65029720|FG003|Treatment Phase|Lack of Efficacy|0|||
23351772|NCT01554176|65029721|FG004|Treatment Phase|Lack of Efficacy|0|||
23351773|NCT01554176|65029717|FG000|Treatment Phase|Adverse event, non-fatal|1|||
23351774|NCT01554176|65029718|FG001|Treatment Phase|Adverse event, non-fatal|1|||
23351775|NCT01554176|65029719|FG002|Treatment Phase|Adverse event, non-fatal|0|||
23351776|NCT01554176|65029720|FG003|Treatment Phase|Adverse event, non-fatal|0|||
23351777|NCT01554176|65029721|FG004|Treatment Phase|Adverse event, non-fatal|0|||
23351778|NCT01554176|65029717|FG000|Treatment Phase|Non-compliance with study drug|1|||
23351779|NCT01554176|65029718|FG001|Treatment Phase|Non-compliance with study drug|0|||
23351780|NCT01554176|65029719|FG002|Treatment Phase|Non-compliance with study drug|0|||
23351781|NCT01554176|65029720|FG003|Treatment Phase|Non-compliance with study drug|0|||
23351782|NCT01554176|65029721|FG004|Treatment Phase|Non-compliance with study drug|0|||
23351783|NCT01554176|65029717|FG000|Treatment Phase|Withdrawal by Subject|1|||
23351784|NCT01554176|65029718|FG001|Treatment Phase|Withdrawal by Subject|0|||
23351785|NCT01554176|65029719|FG002|Treatment Phase|Withdrawal by Subject|0|||
23351786|NCT01554176|65029720|FG003|Treatment Phase|Withdrawal by Subject|0|||
23351787|NCT01554176|65029721|FG004|Treatment Phase|Withdrawal by Subject|0|||
23351788|NCT01554176|65029717|FG000|Treatment Phase|Lost to Follow-up|3|||
23351789|NCT01554176|65029718|FG001|Treatment Phase|Lost to Follow-up|0|||
23351790|NCT01554176|65029719|FG002|Treatment Phase|Lost to Follow-up|0|||
23351791|NCT01554176|65029720|FG003|Treatment Phase|Lost to Follow-up|0|||
23793147|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793148|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793149|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793150|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793151|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793152|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793153|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793154|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793155|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
23351792|NCT01554176|65029721|FG004|Treatment Phase|Lost to Follow-up|0|||
23351793|NCT01554176|65029717|FG000|Run-out Phase|Protocol Violation|0|||
23351794|NCT01554176|65029718|FG001|Run-out Phase|Protocol Violation|0|||
23351795|NCT01554176|65029719|FG002|Run-out Phase|Protocol Violation|0|||
23351796|NCT01554176|65029720|FG003|Run-out Phase|Protocol Violation|1|||
23351797|NCT01554176|65029721|FG004|Run-out Phase|Protocol Violation|0|||
23351798|NCT00586508|65029724|FG000|Overall Study|Progressive disease|52|||
23351799|NCT00586508|65029725|FG001|Overall Study|Progressive disease|8|||
23351800|NCT00586508|65029724|FG000|Overall Study|Death|0|||
23351801|NCT00586508|65029725|FG001|Overall Study|Death|1|||
23351802|NCT00586508|65029724|FG000|Overall Study|Adverse Event|12|||
23351803|NCT00586508|65029725|FG001|Overall Study|Adverse Event|4|||
23351804|NCT00586508|65029724|FG000|Overall Study|Withdrawal by Subject|4|||
23351805|NCT00586508|65029725|FG001|Overall Study|Withdrawal by Subject|0|||
23402774|NCT01446874|65220005|FG002|Overall Study|No surgery/No qualifying surgery|12|||
23402775|NCT01446874|65220003|FG000|Overall Study|Non-compliance|0|||
23402776|NCT01446874|65220004|FG001|Overall Study|Non-compliance|4|||
23402777|NCT01446874|65220005|FG002|Overall Study|Non-compliance|0|||
23402778|NCT01446874|65220003|FG000|Overall Study|Antibiotics for pre-op infection|0|||
23402779|NCT01446874|65220004|FG001|Overall Study|Antibiotics for pre-op infection|0|||
23402780|NCT01446874|65220005|FG002|Overall Study|Antibiotics for pre-op infection|2|||
23402781|NCT01446874|65220003|FG000|Overall Study|Withdrawal by Subject|0|||
23402782|NCT01446874|65220004|FG001|Overall Study|Withdrawal by Subject|0|||
23402783|NCT01446874|65220005|FG002|Overall Study|Withdrawal by Subject|4|||
23402784|NCT03848416|65220006|FG000|Overall Study|Withdrawal by Subject|1|||
23402785|NCT03848416|65220007|FG001|Overall Study|Withdrawal by Subject|0|||
23402786|NCT03848416|65220008|FG002|Overall Study|Withdrawal by Subject|0|||
23402787|NCT03848416|65220006|FG000|Overall Study|Death|0|||
23402788|NCT03848416|65220007|FG001|Overall Study|Death|0|||
23402789|NCT03848416|65220008|FG002|Overall Study|Death|1|||
23402790|NCT03824392|65220009|FG000|Overall Study|Adverse Event|1|||
23402791|NCT03824392|65220010|FG001|Overall Study|Adverse Event|0|||
23402792|NCT03824392|65220011|FG002|Overall Study|Adverse Event|0|||
23402793|NCT03824392|65220012|FG003|Overall Study|Adverse Event|0|||
23402794|NCT03824392|65220009|FG000|Overall Study|Investigator Decision|0|||
23402795|NCT03824392|65220010|FG001|Overall Study|Investigator Decision|1|||
23402796|NCT03824392|65220011|FG002|Overall Study|Investigator Decision|0|||
23402797|NCT03824392|65220012|FG003|Overall Study|Investigator Decision|0|||
23402798|NCT03824392|65220009|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
23793156|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793157|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793158|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793159|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793160|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793161|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
23793162|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
23402799|NCT03824392|65220010|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
23402800|NCT03824392|65220011|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
23467787|NCT01327482|65457140|FG000|Overall Study|Adverse Event|1|||
23467788|NCT01701674|65457142|FG000|Overall Study|Unable to safely complete treatment|1|||
23402801|NCT03824392|65220012|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
23402802|NCT00560508|65220013|FG000|12 Week Double-blind Period|Adverse Event|3|||
23402803|NCT00560508|65220014|FG001|12 Week Double-blind Period|Adverse Event|2|||
23402804|NCT00560508|65220013|FG000|12 Week Double-blind Period|Protocol Violation|1|||
23402805|NCT00560508|65220014|FG001|12 Week Double-blind Period|Protocol Violation|0|||
23467789|NCT00616759|65457143|FG000|Overall Study|Physician Decision|2|||
23467790|NCT00616759|65457144|FG001|Overall Study|Physician Decision|0|||
23467791|NCT00616759|65457143|FG000|Overall Study|Withdrawal by Subject|1|||
23467792|NCT00616759|65457144|FG001|Overall Study|Withdrawal by Subject|2|||
23467793|NCT02792829|65457145|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467794|NCT02792829|65457146|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
23467795|NCT02792829|65457147|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467796|NCT02792829|65457148|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467797|NCT02792829|65457149|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467798|NCT02792829|65457150|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467799|NCT02792829|65457151|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23793163|NCT00112437|66620549|FG000|Year 2 (12-Month Extension)|Moved|0|||
23793164|NCT00112437|66620550|FG001|Year 2 (12-Month Extension)|Moved|0|||
23793165|NCT00112437|66620551|FG002|Year 2 (12-Month Extension)|Moved|0|||
23793166|NCT00112437|66620552|FG003|Year 2 (12-Month Extension)|Moved|0|||
23793167|NCT00112437|66620553|FG004|Year 2 (12-Month Extension)|Moved|0|||
23793168|NCT00112437|66620554|FG005|Year 2 (12-Month Extension)|Moved|0|||
23793169|NCT00112437|66620555|FG006|Year 2 (12-Month Extension)|Moved|0|||
23793170|NCT00112437|66620556|FG007|Year 2 (12-Month Extension)|Moved|0|||
23793171|NCT00112437|66620557|FG008|Year 2 (12-Month Extension)|Moved|0|||
23402806|NCT00560508|65220013|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
23402807|NCT00560508|65220014|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
23402808|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
23640572|NCT03001076|66067584|FG001|Overall Study|Other|0|||
23793172|NCT00112437|66620558|FG009|Year 2 (12-Month Extension)|Moved|1|||
23793173|NCT00112437|66620559|FG010|Year 2 (12-Month Extension)|Moved|0|||
23351806|NCT05052697|65032856|FG000|Substudy A|Lost to Follow-up|0|||
23351807|NCT05052697|65032857|FG001|Substudy A|Lost to Follow-up|0|||
23793174|NCT00112437|66620560|FG011|Year 2 (12-Month Extension)|Moved|0|||
23793175|NCT00112437|66620561|FG012|Year 2 (12-Month Extension)|Moved|0|||
23351808|NCT05052697|65032858|FG002|Substudy A|Lost to Follow-up|0|||
23351809|NCT05052697|65032859|FG003|Substudy A|Lost to Follow-up|0|||
23351810|NCT05052697|65032860|FG004|Substudy A|Lost to Follow-up|0|||
23351811|NCT05052697|65032861|FG005|Substudy A|Lost to Follow-up|1|||
23351812|NCT05052697|65032862|FG006|Substudy A|Lost to Follow-up|0|||
23351813|NCT05052697|65032863|FG007|Substudy A|Lost to Follow-up|0|||
23351814|NCT05052697|65032864|FG008|Substudy A|Lost to Follow-up|0|||
23351815|NCT05052697|65032865|FG009|Substudy A|Lost to Follow-up|0|||
23351816|NCT05052697|65032866|FG010|Substudy A|Lost to Follow-up|0|||
23351817|NCT05052697|65032867|FG011|Substudy A|Lost to Follow-up|0|||
23351818|NCT05052697|65032868|FG012|Substudy A|Lost to Follow-up|0|||
23351819|NCT05052697|65032869|FG013|Substudy A|Lost to Follow-up|0|||
23351820|NCT05052697|65032870|FG014|Substudy A|Lost to Follow-up|0|||
23351821|NCT05052697|65032871|FG015|Substudy A|Lost to Follow-up|2|||
23351822|NCT05052697|65032872|FG016|Substudy A|Lost to Follow-up|0|||
23351823|NCT05052697|65032873|FG017|Substudy A|Lost to Follow-up|0|||
23351824|NCT05052697|65032874|FG018|Substudy A|Lost to Follow-up|0|||
23351825|NCT05052697|65032875|FG019|Substudy A|Lost to Follow-up|0|||
23351826|NCT05052697|65032876|FG020|Substudy A|Lost to Follow-up|0|||
23351827|NCT05052697|65032877|FG021|Substudy A|Lost to Follow-up|0|||
23351828|NCT05052697|65032878|FG022|Substudy A|Lost to Follow-up|0|||
23351829|NCT05052697|65032879|FG023|Substudy A|Lost to Follow-up|0|||
23351830|NCT05052697|65032880|FG024|Substudy A|Lost to Follow-up|0|||
23793176|NCT00112437|66620562|FG013|Year 2 (12-Month Extension)|Moved|0|||
23793177|NCT00112437|66620563|FG014|Year 2 (12-Month Extension)|Moved|0|||
23793178|NCT00112437|66620564|FG015|Year 2 (12-Month Extension)|Moved|0|||
23793179|NCT00112437|66620565|FG016|Year 2 (12-Month Extension)|Moved|0|||
23793180|NCT00112437|66620566|FG017|Year 2 (12-Month Extension)|Moved|0|||
23793181|NCT00112437|66620567|FG018|Year 2 (12-Month Extension)|Moved|0|||
23793182|NCT00112437|66620568|FG019|Year 2 (12-Month Extension)|Moved|0|||
23793183|NCT00112437|66620569|FG020|Year 2 (12-Month Extension)|Moved|0|||
23351831|NCT05052697|65032881|FG025|Substudy A|Lost to Follow-up|0|||
23351832|NCT05052697|65032882|FG026|Substudy A|Lost to Follow-up|0|||
23351833|NCT05052697|65032883|FG027|Substudy A|Lost to Follow-up|0|||
23793184|NCT00112437|66620570|FG021|Year 2 (12-Month Extension)|Moved|0|||
23351834|NCT05052697|65032884|FG028|Substudy A|Lost to Follow-up|0|||
23351835|NCT05052697|65032885|FG029|Substudy A|Lost to Follow-up|0|||
23351836|NCT05052697|65032886|FG030|Substudy A|Lost to Follow-up|0|||
23351837|NCT05052697|65032887|FG031|Substudy A|Lost to Follow-up|0|||
23351838|NCT05052697|65032888|FG032|Substudy A|Lost to Follow-up|0|||
23793185|NCT00112437|66620571|FG022|Year 2 (12-Month Extension)|Moved|0|||
23793186|NCT00112437|66620572|FG023|Year 2 (12-Month Extension)|Moved|0|||
23793187|NCT00112437|66620573|FG024|Year 2 (12-Month Extension)|Moved|0|||
23793188|NCT00112437|66620574|FG025|Year 2 (12-Month Extension)|Moved|0|||
23793189|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
23793190|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
23793191|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
23793192|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
23793193|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
23793194|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
23793195|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
23793196|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
23793197|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
23793198|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
23793199|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
23793200|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
23793201|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
23793202|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
23793203|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
23793204|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
23793205|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
23793206|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
23793207|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
23793208|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
23793209|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
23793210|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
23793211|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
23793212|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
23793213|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
23793214|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
23793215|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793216|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793217|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793218|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793219|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793220|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793221|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793222|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793223|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793224|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793225|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793226|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23793227|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793228|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23793229|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793230|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23793231|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793232|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793233|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
23793234|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793235|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793236|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793237|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793238|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793239|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793240|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23793241|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793242|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793243|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793244|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793245|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793246|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793247|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793248|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793249|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793250|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793251|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793252|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793253|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793254|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793255|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793256|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
23640573|NCT03001076|66067583|FG000|Overall Study|Adverse Event|3|||
23793257|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793258|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793259|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793260|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793261|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23351839|NCT05052697|65032889|FG033|Substudy A|Lost to Follow-up|0|||
23351840|NCT05052697|65032856|FG000|Substudy A|No longer met eligibility criteria|0|||
23793262|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793263|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793264|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793265|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793266|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23793267|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793268|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793269|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793270|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793271|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793272|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793273|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793274|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793275|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793276|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793277|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793278|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793279|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793280|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793281|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793282|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
23351841|NCT05052697|65032857|FG001|Substudy A|No longer met eligibility criteria|0|||
23351842|NCT05052697|65032858|FG002|Substudy A|No longer met eligibility criteria|0|||
23351843|NCT05052697|65032859|FG003|Substudy A|No longer met eligibility criteria|0|||
23351844|NCT05052697|65032860|FG004|Substudy A|No longer met eligibility criteria|0|||
23351845|NCT05052697|65032861|FG005|Substudy A|No longer met eligibility criteria|0|||
23351846|NCT05052697|65032862|FG006|Substudy A|No longer met eligibility criteria|0|||
23351847|NCT05052697|65032863|FG007|Substudy A|No longer met eligibility criteria|0|||
23351848|NCT05052697|65032864|FG008|Substudy A|No longer met eligibility criteria|0|||
23640574|NCT03001076|66067584|FG001|Overall Study|Adverse Event|3|||
23640575|NCT03001076|66067583|FG000|Overall Study|Sponsor decision|1|||
23640576|NCT03001076|66067584|FG001|Overall Study|Sponsor decision|0|||
23640577|NCT03001076|66067583|FG000|Overall Study|Lost to Follow-up|0|||
23640578|NCT03001076|66067584|FG001|Overall Study|Lost to Follow-up|2|||
23640579|NCT02124811|66067585|FG000|Overall Study|Early termination|2|||
23640580|NCT02124811|66067586|FG001|Overall Study|Early termination|2|||
23640581|NCT02124811|66067585|FG000|Overall Study|Withdrawal by Subject|1|||
23640582|NCT02124811|66067586|FG001|Overall Study|Withdrawal by Subject|0|||
23351849|NCT05052697|65032865|FG009|Substudy A|No longer met eligibility criteria|0|||
23351850|NCT05052697|65032866|FG010|Substudy A|No longer met eligibility criteria|0|||
23351851|NCT05052697|65032867|FG011|Substudy A|No longer met eligibility criteria|0|||
23351852|NCT05052697|65032868|FG012|Substudy A|No longer met eligibility criteria|0|||
23640583|NCT01127763|66067587|FG000|Overall Study|Adverse Event|2|||
23640584|NCT01127763|66067587|FG000|Overall Study|Withdrawal by Subject|1|||
23793283|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793284|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793285|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793286|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
23640585|NCT01127763|66067587|FG000|Overall Study|Physician Decision|2|||
23793287|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793288|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793289|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793290|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793291|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793292|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
23793293|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793294|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793295|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793296|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793297|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793298|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793299|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793300|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793301|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793302|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793303|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793304|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
23793305|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793306|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793307|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
23793308|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793309|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793310|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793311|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793312|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793313|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793314|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793315|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793316|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793317|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23640586|NCT00998790|66067588|FG000|Overall Study|Withdrawal by Subject|21|||
23640587|NCT02314780|66067589|FG000|Overall Study|organizational reasons|0|||
23640588|NCT02314780|66067590|FG001|Overall Study|organizational reasons|2|||
23640589|NCT02314780|66067591|FG002|Overall Study|organizational reasons|0|||
23640590|NCT02314780|66067589|FG000|Overall Study|Adverse Event|0|||
23640591|NCT02314780|66067590|FG001|Overall Study|Adverse Event|1|||
23640592|NCT02314780|66067591|FG002|Overall Study|Adverse Event|0|||
23640593|NCT03140280|66071389|FG000|Overall Study|Physician Decision|5|||
23640594|NCT05398237|66071395|FG000|Overall Study|Withdrawal by Subject|1|||
23640595|NCT02514239|66071398|FG000|Overall Study|Refused to continue trial medication|0|||
23640596|NCT02514239|66071399|FG001|Overall Study|Refused to continue trial medication|0|||
23640597|NCT02514239|66071400|FG002|Overall Study|Refused to continue trial medication|0|||
23640598|NCT02514239|66071401|FG003|Overall Study|Refused to continue trial medication|0|||
23640599|NCT02514239|66071402|FG004|Overall Study|Refused to continue trial medication|0|||
23640600|NCT02514239|66071403|FG005|Overall Study|Refused to continue trial medication|0|||
23640601|NCT02514239|66071404|FG006|Overall Study|Refused to continue trial medication|0|||
23640602|NCT02514239|66071405|FG007|Overall Study|Refused to continue trial medication|0|||
23640603|NCT02514239|66071406|FG008|Overall Study|Refused to continue trial medication|0|||
23640604|NCT02514239|66071407|FG009|Overall Study|Refused to continue trial medication|1|||
23640605|NCT02514239|66071398|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
23793318|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23793319|NCT00112437|66620549|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793320|NCT00112437|66620550|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23467800|NCT02792829|65457152|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467801|NCT02792829|65457145|FG000|Treatment Period 2|Adverse Event|0|||
23467802|NCT02792829|65457146|FG001|Treatment Period 2|Adverse Event|0|||
23586789|NCT02512042|65876145|FG001|Overall Study|Withdrawal by Subject|6|||
23467803|NCT02792829|65457147|FG002|Treatment Period 2|Adverse Event|0|||
23467804|NCT02792829|65457148|FG003|Treatment Period 2|Adverse Event|0|||
23586790|NCT02512042|65876144|FG000|Overall Study|Non-compliance with study drug|1|||
23793321|NCT00112437|66620551|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793322|NCT00112437|66620552|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793323|NCT00112437|66620553|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793324|NCT00112437|66620554|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793325|NCT00112437|66620555|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793326|NCT00112437|66620556|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793327|NCT00112437|66620557|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793328|NCT00112437|66620558|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793329|NCT00112437|66620559|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
23793330|NCT00112437|66620560|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
23793331|NCT00112437|66620561|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793332|NCT00112437|66620562|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793333|NCT00112437|66620563|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793334|NCT00112437|66620564|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793335|NCT00112437|66620565|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793336|NCT00112437|66620566|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793337|NCT00112437|66620567|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793338|NCT00112437|66620568|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793339|NCT00112437|66620569|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793340|NCT00112437|66620570|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793341|NCT00112437|66620571|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793342|NCT00112437|66620572|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793343|NCT00112437|66620573|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23793344|NCT00112437|66620574|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23586791|NCT02512042|65876145|FG001|Overall Study|Non-compliance with study drug|2|||
23586792|NCT02512042|65876144|FG000|Overall Study|Lost to Follow-up|5|||
23467805|NCT02792829|65457149|FG004|Treatment Period 2|Adverse Event|1|||
23467806|NCT02792829|65457150|FG005|Treatment Period 2|Adverse Event|0|||
23467807|NCT02792829|65457151|FG006|Treatment Period 2|Adverse Event|1|||
23467808|NCT02792829|65457152|FG007|Treatment Period 2|Adverse Event|1|||
23467809|NCT02792829|65457145|FG000|Treatment Period 2|Use of proscribed medications|0|||
23467810|NCT02792829|65457146|FG001|Treatment Period 2|Use of proscribed medications|0|||
23467811|NCT02792829|65457147|FG002|Treatment Period 2|Use of proscribed medications|0|||
23793345|NCT00112437|66620549|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793346|NCT00112437|66620550|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793347|NCT00112437|66620551|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793348|NCT00112437|66620552|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793349|NCT00112437|66620553|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793350|NCT00112437|66620554|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793351|NCT00112437|66620555|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793352|NCT00112437|66620556|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793353|NCT00112437|66620557|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793354|NCT00112437|66620558|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793355|NCT00112437|66620559|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793356|NCT00112437|66620560|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793357|NCT00112437|66620561|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793358|NCT00112437|66620562|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793359|NCT00112437|66620563|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793360|NCT00112437|66620564|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793361|NCT00112437|66620565|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793362|NCT00112437|66620566|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793363|NCT00112437|66620567|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793364|NCT00112437|66620568|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793365|NCT00112437|66620569|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
23793366|NCT00112437|66620570|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
23793367|NCT00112437|66620571|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793368|NCT00112437|66620572|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793369|NCT00112437|66620573|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793370|NCT00112437|66620574|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23793371|NCT00112437|66620549|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793372|NCT00112437|66620550|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793373|NCT00112437|66620551|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793374|NCT00112437|66620552|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793375|NCT00112437|66620553|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793376|NCT00112437|66620554|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23586793|NCT02512042|65876145|FG001|Overall Study|Lost to Follow-up|2|||
23586794|NCT02512042|65876144|FG000|Overall Study|Other|11|||
23586795|NCT02512042|65876145|FG001|Overall Study|Other|11|||
23586796|NCT02595398|65876150|FG000|Overall Study|Non-compliance|1|||
23586797|NCT02595398|65876151|FG001|Overall Study|Non-compliance|0|||
23467812|NCT02792829|65457148|FG003|Treatment Period 2|Use of proscribed medications|0|||
23467813|NCT02792829|65457149|FG004|Treatment Period 2|Use of proscribed medications|0|||
23467814|NCT02792829|65457150|FG005|Treatment Period 2|Use of proscribed medications|0|||
23467815|NCT02792829|65457151|FG006|Treatment Period 2|Use of proscribed medications|0|||
23467816|NCT02792829|65457152|FG007|Treatment Period 2|Use of proscribed medications|1|||
23467817|NCT00719472|65457159|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
23467818|NCT00719472|65457159|FG000|Enrolled in Study|Subject decision to withdraw|8|||
23467819|NCT00719472|65457159|FG000|Enrolled in Study|Various Reasons|17|||
23467820|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
23467821|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Death|5|||
23467822|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
23467823|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
23467824|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
23467825|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
23467826|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
23467827|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Death|6|||
23467828|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Disease progression|3|||
23467829|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
23467830|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
23467831|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
23467832|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
23467833|NCT00286468|65457160|FG000|Overall Study|Hyperglycemic Rescue|28|||
23467834|NCT00286468|65457161|FG001|Overall Study|Hyperglycemic Rescue|30|||
23640606|NCT02514239|66071399|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
23640607|NCT02514239|66071400|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
23586798|NCT02595398|65876150|FG000|Overall Study|Withdrawal by Subject|2|||
23586799|NCT02595398|65876151|FG001|Overall Study|Withdrawal by Subject|1|||
23351853|NCT05052697|65032869|FG013|Substudy A|No longer met eligibility criteria|1|||
23351854|NCT05052697|65032870|FG014|Substudy A|No longer met eligibility criteria|0|||
23467835|NCT00286468|65457162|FG002|Overall Study|Hyperglycemic Rescue|31|||
23467836|NCT00286468|65457160|FG000|Overall Study|Adverse Event|2|||
23467837|NCT00286468|65457161|FG001|Overall Study|Adverse Event|6|||
23586800|NCT02595398|65876150|FG000|Overall Study|Lost to Follow-up|1|||
23467838|NCT00286468|65457162|FG002|Overall Study|Adverse Event|4|||
23467839|NCT00286468|65457160|FG000|Overall Study|Protocol Violation|0|||
23467840|NCT00286468|65457161|FG001|Overall Study|Protocol Violation|3|||
23467841|NCT00286468|65457162|FG002|Overall Study|Protocol Violation|1|||
23467842|NCT00286468|65457160|FG000|Overall Study|Lost to Follow-up|1|||
23467843|NCT00286468|65457161|FG001|Overall Study|Lost to Follow-up|1|||
23467844|NCT00286468|65457162|FG002|Overall Study|Lost to Follow-up|2|||
23467845|NCT00286468|65457160|FG000|Overall Study|Withdrawal by Subject|3|||
23467846|NCT00286468|65457161|FG001|Overall Study|Withdrawal by Subject|8|||
23467847|NCT00286468|65457162|FG002|Overall Study|Withdrawal by Subject|11|||
23467848|NCT00286468|65457160|FG000|Overall Study|Physician Decision|3|||
23467849|NCT00286468|65457161|FG001|Overall Study|Physician Decision|2|||
23467850|NCT00286468|65457162|FG002|Overall Study|Physician Decision|1|||
23467851|NCT03339219|65457163|FG000|Overall Study|Death|12|||
23467852|NCT03339219|65457163|FG000|Overall Study|Site Terminated by Sponsor|22|||
23467853|NCT03339219|65457163|FG000|Overall Study|Withdrawal by Subject|1|||
23467854|NCT01249261|65457164|FG000|Overall Study|Withdrawal by Subject|1|||
23467855|NCT01249261|65457165|FG001|Overall Study|Withdrawal by Subject|0|||
23467856|NCT03763877|65457166|FG000|Overall Study|Withdrawal by Subject|3|||
23467857|NCT03763877|65457167|FG001|Overall Study|Withdrawal by Subject|1|||
23467858|NCT03763877|65457168|FG002|Overall Study|Withdrawal by Subject|3|||
23467859|NCT03763877|65457169|FG003|Overall Study|Withdrawal by Subject|4|||
23467860|NCT03763877|65457166|FG000|Overall Study|Adverse Event|1|||
23467861|NCT03763877|65457167|FG001|Overall Study|Adverse Event|1|||
23467862|NCT03763877|65457168|FG002|Overall Study|Adverse Event|3|||
23467863|NCT03763877|65457169|FG003|Overall Study|Adverse Event|1|||
23467864|NCT03763877|65457166|FG000|Overall Study|Protocol Violation|1|||
23467865|NCT03763877|65457167|FG001|Overall Study|Protocol Violation|1|||
23467866|NCT03763877|65457168|FG002|Overall Study|Protocol Violation|0|||
23467867|NCT03763877|65457169|FG003|Overall Study|Protocol Violation|0|||
23467868|NCT03763877|65457166|FG000|Overall Study|Lost to Follow-up|0|||
23467869|NCT03763877|65457167|FG001|Overall Study|Lost to Follow-up|1|||
23467870|NCT03763877|65457168|FG002|Overall Study|Lost to Follow-up|1|||
23467871|NCT03763877|65457169|FG003|Overall Study|Lost to Follow-up|0|||
23467872|NCT00357552|65457170|FG000|Screening|Did not meet eligibility criteria|84|||
23467873|NCT00357552|65457170|FG000|Weeks 0 to 24|Death|1|||
23467874|NCT00357552|65457170|FG000|Weeks 24 to 104|Death|3|||
23467875|NCT00357552|65457170|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
23467876|NCT01088048|65457171|FG000|Overall Study|Adverse Event|7|||
23467877|NCT01088048|65457172|FG001|Overall Study|Adverse Event|9|||
23467878|NCT01088048|65457173|FG002|Overall Study|Adverse Event|7|||
23467879|NCT01088048|65457174|FG003|Overall Study|Adverse Event|5|||
23467880|NCT01088048|65457175|FG004|Overall Study|Adverse Event|6|||
23467881|NCT01088048|65457176|FG005|Overall Study|Adverse Event|3|||
23467882|NCT01088048|65457177|FG006|Overall Study|Adverse Event|3|||
23467883|NCT01088048|65457178|FG007|Overall Study|Adverse Event|0|||
23793377|NCT00112437|66620555|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793378|NCT00112437|66620556|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793379|NCT00112437|66620557|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793380|NCT00112437|66620558|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793381|NCT00112437|66620559|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793382|NCT00112437|66620560|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793383|NCT00112437|66620561|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793384|NCT00112437|66620562|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793385|NCT00112437|66620563|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23586801|NCT02595398|65876151|FG001|Overall Study|Lost to Follow-up|0|||
23586802|NCT02680756|65876153|FG000|Overall Study|Adverse Event|10|||
23793386|NCT00112437|66620564|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793387|NCT00112437|66620565|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793388|NCT00112437|66620566|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793389|NCT00112437|66620567|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23467884|NCT01088048|65457179|FG008|Overall Study|Adverse Event|2|||
23467885|NCT01088048|65457180|FG009|Overall Study|Adverse Event|2|||
23467886|NCT01088048|65457171|FG000|Overall Study|Withdrew Consent|1|||
23467887|NCT01088048|65457172|FG001|Overall Study|Withdrew Consent|1|||
23467888|NCT01088048|65457173|FG002|Overall Study|Withdrew Consent|1|||
23467889|NCT01088048|65457174|FG003|Overall Study|Withdrew Consent|1|||
23467890|NCT01088048|65457175|FG004|Overall Study|Withdrew Consent|2|||
23467891|NCT01088048|65457176|FG005|Overall Study|Withdrew Consent|1|||
23467892|NCT01088048|65457177|FG006|Overall Study|Withdrew Consent|0|||
23467893|NCT01088048|65457178|FG007|Overall Study|Withdrew Consent|2|||
23467894|NCT01088048|65457179|FG008|Overall Study|Withdrew Consent|2|||
23467895|NCT01088048|65457180|FG009|Overall Study|Withdrew Consent|1|||
23467896|NCT01088048|65457171|FG000|Overall Study|Concomitant Medication Prohibited|1|||
23467897|NCT01088048|65457172|FG001|Overall Study|Concomitant Medication Prohibited|0|||
23467898|NCT01088048|65457173|FG002|Overall Study|Concomitant Medication Prohibited|0|||
23467899|NCT01088048|65457174|FG003|Overall Study|Concomitant Medication Prohibited|0|||
23467900|NCT01088048|65457175|FG004|Overall Study|Concomitant Medication Prohibited|0|||
23640608|NCT02514239|66071401|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23640609|NCT02514239|66071402|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
23640610|NCT02514239|66071403|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
23467901|NCT01088048|65457176|FG005|Overall Study|Concomitant Medication Prohibited|0|||
23467902|NCT01088048|65457177|FG006|Overall Study|Concomitant Medication Prohibited|0|||
23467903|NCT01088048|65457178|FG007|Overall Study|Concomitant Medication Prohibited|0|||
23467904|NCT01088048|65457179|FG008|Overall Study|Concomitant Medication Prohibited|0|||
23467905|NCT01088048|65457180|FG009|Overall Study|Concomitant Medication Prohibited|0|||
23467906|NCT01088048|65457171|FG000|Overall Study|Investigator Request|2|||
23467907|NCT01088048|65457172|FG001|Overall Study|Investigator Request|2|||
23467908|NCT01088048|65457173|FG002|Overall Study|Investigator Request|0|||
23467909|NCT01088048|65457174|FG003|Overall Study|Investigator Request|0|||
23467910|NCT01088048|65457175|FG004|Overall Study|Investigator Request|3|||
23467911|NCT01088048|65457176|FG005|Overall Study|Investigator Request|1|||
23467912|NCT01088048|65457177|FG006|Overall Study|Investigator Request|1|||
23467913|NCT01088048|65457178|FG007|Overall Study|Investigator Request|0|||
23467914|NCT01088048|65457179|FG008|Overall Study|Investigator Request|0|||
23467915|NCT01088048|65457180|FG009|Overall Study|Investigator Request|0|||
23467916|NCT01088048|65457171|FG000|Overall Study|Patient Non-compliance|0|||
23467917|NCT01088048|65457172|FG001|Overall Study|Patient Non-compliance|1|||
23467918|NCT01088048|65457173|FG002|Overall Study|Patient Non-compliance|0|||
23467919|NCT01088048|65457174|FG003|Overall Study|Patient Non-compliance|0|||
23467920|NCT01088048|65457175|FG004|Overall Study|Patient Non-compliance|0|||
23467921|NCT01088048|65457176|FG005|Overall Study|Patient Non-compliance|0|||
23467922|NCT01088048|65457177|FG006|Overall Study|Patient Non-compliance|0|||
23467923|NCT01088048|65457178|FG007|Overall Study|Patient Non-compliance|0|||
23467924|NCT01088048|65457179|FG008|Overall Study|Patient Non-compliance|0|||
23467925|NCT01088048|65457180|FG009|Overall Study|Patient Non-compliance|0|||
23467926|NCT01088048|65457171|FG000|Overall Study|Disease Progression|7|||
23467927|NCT01088048|65457172|FG001|Overall Study|Disease Progression|4|||
23467928|NCT01088048|65457173|FG002|Overall Study|Disease Progression|3|||
23467929|NCT01088048|65457174|FG003|Overall Study|Disease Progression|5|||
23467930|NCT01088048|65457175|FG004|Overall Study|Disease Progression|3|||
23467931|NCT01088048|65457176|FG005|Overall Study|Disease Progression|3|||
23467932|NCT01088048|65457177|FG006|Overall Study|Disease Progression|2|||
23467933|NCT01088048|65457178|FG007|Overall Study|Disease Progression|1|||
23467934|NCT01088048|65457179|FG008|Overall Study|Disease Progression|0|||
23640611|NCT02514239|66071404|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
23640612|NCT02514239|66071405|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
23640613|NCT02514239|66071406|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
23640614|NCT02514239|66071407|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
23640615|NCT02514239|66071398|FG000|Overall Study|Not treated|0|||
23640616|NCT02514239|66071399|FG001|Overall Study|Not treated|1|||
23640617|NCT02514239|66071400|FG002|Overall Study|Not treated|0|||
23640618|NCT02514239|66071401|FG003|Overall Study|Not treated|0|||
23640619|NCT02514239|66071402|FG004|Overall Study|Not treated|0|||
23793390|NCT00112437|66620568|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793391|NCT00112437|66620569|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
23793392|NCT00112437|66620570|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793393|NCT00112437|66620571|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793394|NCT00112437|66620572|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23467935|NCT01088048|65457180|FG009|Overall Study|Disease Progression|0|||
23467936|NCT01088048|65457171|FG000|Overall Study|Death|1|||
23467937|NCT01088048|65457172|FG001|Overall Study|Death|5|||
23640620|NCT02514239|66071403|FG005|Overall Study|Not treated|0|||
23640621|NCT02514239|66071404|FG006|Overall Study|Not treated|0|||
23640622|NCT02514239|66071405|FG007|Overall Study|Not treated|0|||
23640623|NCT02514239|66071406|FG008|Overall Study|Not treated|0|||
23640624|NCT02514239|66071407|FG009|Overall Study|Not treated|0|||
23640625|NCT02514239|66071398|FG000|Overall Study|Other Adverse Events|2|||
23640626|NCT02514239|66071399|FG001|Overall Study|Other Adverse Events|0|||
23467938|NCT01088048|65457173|FG002|Overall Study|Death|3|||
23467939|NCT01088048|65457174|FG003|Overall Study|Death|3|||
23467940|NCT01088048|65457175|FG004|Overall Study|Death|1|||
23467941|NCT01088048|65457176|FG005|Overall Study|Death|3|||
23467942|NCT01088048|65457177|FG006|Overall Study|Death|0|||
23640627|NCT02514239|66071400|FG002|Overall Study|Other Adverse Events|0|||
23640628|NCT02514239|66071401|FG003|Overall Study|Other Adverse Events|1|||
23467943|NCT01088048|65457178|FG007|Overall Study|Death|0|||
23467944|NCT01088048|65457179|FG008|Overall Study|Death|3|||
23467945|NCT01088048|65457180|FG009|Overall Study|Death|1|||
23467946|NCT01088048|65457171|FG000|Overall Study|Other|3|||
23640629|NCT02514239|66071402|FG004|Overall Study|Other Adverse Events|0|||
23793395|NCT00112437|66620573|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23351855|NCT05052697|65032871|FG015|Substudy A|No longer met eligibility criteria|0|||
23351856|NCT05052697|65032872|FG016|Substudy A|No longer met eligibility criteria|0|||
23351857|NCT05052697|65032873|FG017|Substudy A|No longer met eligibility criteria|0|||
23351858|NCT05052697|65032874|FG018|Substudy A|No longer met eligibility criteria|0|||
23351859|NCT05052697|65032875|FG019|Substudy A|No longer met eligibility criteria|0|||
23351860|NCT05052697|65032876|FG020|Substudy A|No longer met eligibility criteria|0|||
23351861|NCT05052697|65032877|FG021|Substudy A|No longer met eligibility criteria|0|||
23351862|NCT05052697|65032878|FG022|Substudy A|No longer met eligibility criteria|0|||
23351863|NCT05052697|65032879|FG023|Substudy A|No longer met eligibility criteria|0|||
23351864|NCT05052697|65032880|FG024|Substudy A|No longer met eligibility criteria|0|||
23351865|NCT05052697|65032881|FG025|Substudy A|No longer met eligibility criteria|0|||
23351866|NCT05052697|65032882|FG026|Substudy A|No longer met eligibility criteria|0|||
23351867|NCT05052697|65032883|FG027|Substudy A|No longer met eligibility criteria|0|||
23351868|NCT05052697|65032884|FG028|Substudy A|No longer met eligibility criteria|0|||
23351869|NCT05052697|65032885|FG029|Substudy A|No longer met eligibility criteria|0|||
23351870|NCT05052697|65032886|FG030|Substudy A|No longer met eligibility criteria|0|||
23467947|NCT01088048|65457172|FG001|Overall Study|Other|5|||
23467948|NCT01088048|65457173|FG002|Overall Study|Other|0|||
23467949|NCT01088048|65457174|FG003|Overall Study|Other|0|||
23467950|NCT01088048|65457175|FG004|Overall Study|Other|2|||
23467951|NCT01088048|65457176|FG005|Overall Study|Other|0|||
23467952|NCT01088048|65457177|FG006|Overall Study|Other|0|||
23467953|NCT01088048|65457178|FG007|Overall Study|Other|2|||
23467954|NCT01088048|65457179|FG008|Overall Study|Other|0|||
23467955|NCT01088048|65457180|FG009|Overall Study|Other|0|||
23467956|NCT03847896|65457181|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467957|NCT03847896|65457182|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467958|NCT03847896|65457183|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
23586803|NCT02680756|65876154|FG001|Overall Study|Adverse Event|2|||
23586804|NCT02680756|65876153|FG000|Overall Study|Lost to Follow-up|7|||
23586805|NCT02680756|65876154|FG001|Overall Study|Lost to Follow-up|6|||
23586806|NCT02680756|65876153|FG000|Overall Study|Withdrawal by Subject|5|||
23467959|NCT03847896|65457184|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467960|NCT03847896|65457185|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467961|NCT03847896|65457181|FG000|Overall Study|Withdrawal by Subject|2|||
23467962|NCT03847896|65457182|FG001|Overall Study|Withdrawal by Subject|10|||
23467963|NCT03847896|65457183|FG002|Overall Study|Withdrawal by Subject|5|||
23586807|NCT02680756|65876154|FG001|Overall Study|Withdrawal by Subject|5|||
23586808|NCT02680756|65876153|FG000|Overall Study|Physician Decision|4|||
23586809|NCT02680756|65876154|FG001|Overall Study|Physician Decision|1|||
23586810|NCT02680756|65876153|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
23586811|NCT02680756|65876154|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
23586812|NCT02680756|65876153|FG000|Overall Study|Blood transfusion for any reason|0|||
23586813|NCT02680756|65876154|FG001|Overall Study|Blood transfusion for any reason|1|||
23586814|NCT02680756|65876153|FG000|Overall Study|Death|1|||
23586815|NCT02680756|65876154|FG001|Overall Study|Death|0|||
23586816|NCT02680756|65876153|FG000|Overall Study|Protocol Violation|1|||
23586817|NCT02680756|65876154|FG001|Overall Study|Protocol Violation|0|||
23586818|NCT02680756|65876153|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
23586819|NCT02680756|65876154|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
23586820|NCT02680756|65876153|FG000|Overall Study|None of above or not recorded|3|||
23586821|NCT02680756|65876154|FG001|Overall Study|None of above or not recorded|2|||
23586822|NCT04860258|65876155|FG000|Overall Study|Withdrawal by Subject|0|||
23586823|NCT04860258|65876156|FG001|Overall Study|Withdrawal by Subject|0|||
23586824|NCT04860258|65876157|FG002|Overall Study|Withdrawal by Subject|4|||
23793396|NCT00112437|66620574|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23793397|NCT00112437|66620549|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793398|NCT00112437|66620550|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23351871|NCT05052697|65032887|FG031|Substudy A|No longer met eligibility criteria|0|||
23351872|NCT05052697|65032888|FG032|Substudy A|No longer met eligibility criteria|0|||
23351873|NCT05052697|65032889|FG033|Substudy A|No longer met eligibility criteria|0|||
23351874|NCT05052697|65032856|FG000|Substudy A|Not vaccinated|0|||
23467964|NCT03847896|65457184|FG003|Overall Study|Withdrawal by Subject|9|||
23467965|NCT03847896|65457185|FG004|Overall Study|Withdrawal by Subject|8|||
23467966|NCT03847896|65457181|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23586825|NCT04860258|65876158|FG003|Overall Study|Withdrawal by Subject|1|||
23586826|NCT04860258|65876159|FG004|Overall Study|Withdrawal by Subject|4|||
23586827|NCT04860258|65876160|FG005|Overall Study|Withdrawal by Subject|1|||
23586828|NCT04860258|65876161|FG006|Overall Study|Withdrawal by Subject|0|||
23586829|NCT01466881|65876167|FG000|Overall Study|Ineligible|5|||
23586830|NCT01466881|65876167|FG000|Overall Study|Adverse Event|6|||
23586831|NCT01466881|65876167|FG000|Overall Study|Progression/relapse|20|||
23586832|NCT01466881|65876167|FG000|Overall Study|Death|4|||
23706520|NCT03554005|66301238|FG005|Overall Study|Other|1|||
23351875|NCT05052697|65032857|FG001|Substudy A|Not vaccinated|0|||
23351876|NCT05052697|65032858|FG002|Substudy A|Not vaccinated|0|||
23586833|NCT01466881|65876167|FG000|Overall Study|Other reason not protocol specified|5|||
23586834|NCT01137292|65876168|FG000|Overall Study|Death|30|||
23586835|NCT01137292|65876168|FG000|Overall Study|Adverse Event|3|||
23586836|NCT01137292|65876168|FG000|Overall Study|Lack of Efficacy|13|||
23586837|NCT01137292|65876168|FG000|Overall Study|Lost to Follow-up|1|||
23586838|NCT01137292|65876168|FG000|Overall Study|Other|7|||
23467967|NCT03847896|65457182|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23467968|NCT03847896|65457183|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23467969|NCT03847896|65457184|FG003|Overall Study|Withdrawal by parent/guardian|0|||
23467970|NCT03847896|65457185|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23467971|NCT03847896|65457181|FG000|Overall Study|Adverse Event|2|||
23467972|NCT03847896|65457182|FG001|Overall Study|Adverse Event|1|||
23467973|NCT03847896|65457183|FG002|Overall Study|Adverse Event|3|||
23467974|NCT03847896|65457184|FG003|Overall Study|Adverse Event|2|||
23467975|NCT03847896|65457185|FG004|Overall Study|Adverse Event|4|||
23467976|NCT03847896|65457181|FG000|Overall Study|A severe exacerbation event|0|||
23586839|NCT01144182|65876171|FG000|Overall Study|Death|5|||
23586840|NCT01144182|65876172|FG001|Overall Study|Death|6|||
23586841|NCT01144182|65876171|FG000|Overall Study|Withdrawal by Subject|3|||
23467977|NCT03847896|65457182|FG001|Overall Study|A severe exacerbation event|0|||
23467978|NCT03847896|65457183|FG002|Overall Study|A severe exacerbation event|0|||
23467979|NCT03847896|65457184|FG003|Overall Study|A severe exacerbation event|0|||
23467980|NCT03847896|65457185|FG004|Overall Study|A severe exacerbation event|3|||
23467981|NCT03847896|65457181|FG000|Overall Study|Protocol Violation|0|||
23467982|NCT03847896|65457182|FG001|Overall Study|Protocol Violation|2|||
23467983|NCT03847896|65457183|FG002|Overall Study|Protocol Violation|1|||
23467984|NCT03847896|65457184|FG003|Overall Study|Protocol Violation|0|||
23467985|NCT03847896|65457185|FG004|Overall Study|Protocol Violation|2|||
23467986|NCT03847896|65457181|FG000|Overall Study|Lost to Follow-up|0|||
23467987|NCT03847896|65457182|FG001|Overall Study|Lost to Follow-up|0|||
23467988|NCT03847896|65457183|FG002|Overall Study|Lost to Follow-up|0|||
23467989|NCT03847896|65457184|FG003|Overall Study|Lost to Follow-up|1|||
23467990|NCT03847896|65457185|FG004|Overall Study|Lost to Follow-up|0|||
23467991|NCT03847896|65457181|FG000|Overall Study|Condition under investigation worsened|0|||
23467992|NCT03847896|65457182|FG001|Overall Study|Condition under investigation worsened|0|||
23467993|NCT03847896|65457183|FG002|Overall Study|Condition under investigation worsened|0|||
23467994|NCT03847896|65457184|FG003|Overall Study|Condition under investigation worsened|1|||
23467995|NCT03847896|65457185|FG004|Overall Study|Condition under investigation worsened|1|||
23467996|NCT03847896|65457181|FG000|Overall Study|Lack of Efficacy|0|||
23467997|NCT03847896|65457182|FG001|Overall Study|Lack of Efficacy|0|||
23467998|NCT03847896|65457183|FG002|Overall Study|Lack of Efficacy|0|||
23467999|NCT03847896|65457184|FG003|Overall Study|Lack of Efficacy|2|||
23468000|NCT03847896|65457185|FG004|Overall Study|Lack of Efficacy|2|||
23468001|NCT03847896|65457181|FG000|Overall Study|Other reasons|3|||
23468002|NCT03847896|65457182|FG001|Overall Study|Other reasons|3|||
23468003|NCT03847896|65457183|FG002|Overall Study|Other reasons|1|||
23468004|NCT03847896|65457184|FG003|Overall Study|Other reasons|2|||
23468005|NCT03847896|65457185|FG004|Overall Study|Other reasons|1|||
23468006|NCT02541604|65457186|FG000|Overall Study|Death|6|||
23468007|NCT02541604|65457187|FG001|Overall Study|Death|5|||
23586842|NCT01144182|65876172|FG001|Overall Study|Withdrawal by Subject|6|||
23586843|NCT01144182|65876171|FG000|Overall Study|Lost to Follow-up|9|||
23586844|NCT01144182|65876172|FG001|Overall Study|Lost to Follow-up|9|||
23586845|NCT04304534|65876175|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
23586846|NCT04304534|65876176|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
23468008|NCT02541604|65457188|FG002|Overall Study|Death|7|||
23468009|NCT02541604|65457189|FG003|Overall Study|Death|2|||
23468010|NCT02541604|65457190|FG004|Overall Study|Death|9|||
23468011|NCT02541604|65457191|FG005|Overall Study|Death|8|||
23586847|NCT04304534|65876177|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
23640630|NCT02514239|66071403|FG005|Overall Study|Other Adverse Events|1|||
23640631|NCT02514239|66071404|FG006|Overall Study|Other Adverse Events|0|||
23640632|NCT02514239|66071405|FG007|Overall Study|Other Adverse Events|1|||
23640633|NCT02514239|66071406|FG008|Overall Study|Other Adverse Events|2|||
23640634|NCT02514239|66071407|FG009|Overall Study|Other Adverse Events|0|||
23640635|NCT02514239|66071398|FG000|Overall Study|Progressive disease|3|||
23640636|NCT02514239|66071399|FG001|Overall Study|Progressive disease|3|||
23640637|NCT02514239|66071400|FG002|Overall Study|Progressive disease|2|||
23351877|NCT05052697|65032859|FG003|Substudy A|Not vaccinated|1|||
23468012|NCT02541604|65457192|FG006|Overall Study|Death|9|||
23468013|NCT02541604|65457193|FG007|Overall Study|Death|9|||
23468014|NCT02541604|65457194|FG008|Overall Study|Death|3|||
23468015|NCT02541604|65457195|FG009|Overall Study|Death|4|||
23468016|NCT02541604|65457196|FG010|Overall Study|Death|2|||
23468017|NCT02541604|65457197|FG011|Overall Study|Death|3|||
23468018|NCT02541604|65457186|FG000|Overall Study|Lost to Follow-up|2|||
23586848|NCT04304534|65876178|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
23586849|NCT04304534|65876175|FG000|Overall Study|Non-Compliance with study drug|0|||
23586850|NCT04304534|65876176|FG001|Overall Study|Non-Compliance with study drug|1|||
23586851|NCT04304534|65876177|FG002|Overall Study|Non-Compliance with study drug|1|||
23586852|NCT04304534|65876178|FG003|Overall Study|Non-Compliance with study drug|1|||
23586853|NCT04304534|65876175|FG000|Overall Study|Lost to Follow-up|0|||
23586854|NCT04304534|65876176|FG001|Overall Study|Lost to Follow-up|1|||
23586855|NCT04304534|65876177|FG002|Overall Study|Lost to Follow-up|2|||
23586856|NCT04304534|65876178|FG003|Overall Study|Lost to Follow-up|3|||
23586857|NCT04304534|65876175|FG000|Overall Study|Unspecific|4|||
23586858|NCT04304534|65876176|FG001|Overall Study|Unspecific|2|||
23586859|NCT04304534|65876177|FG002|Overall Study|Unspecific|2|||
23586860|NCT04304534|65876178|FG003|Overall Study|Unspecific|2|||
23586861|NCT04304534|65876175|FG000|Overall Study|Technical Problems|2|||
23586862|NCT04304534|65876176|FG001|Overall Study|Technical Problems|2|||
23586863|NCT04304534|65876177|FG002|Overall Study|Technical Problems|3|||
23586864|NCT04304534|65876178|FG003|Overall Study|Technical Problems|4|||
23586865|NCT04304534|65876175|FG000|Overall Study|Death|7|||
23586866|NCT04304534|65876176|FG001|Overall Study|Death|2|||
23586867|NCT04304534|65876177|FG002|Overall Study|Death|4|||
23586868|NCT04304534|65876178|FG003|Overall Study|Death|3|||
23586869|NCT04304534|65876175|FG000|Overall Study|Withdrawal by Subject|7|||
23586870|NCT04304534|65876176|FG001|Overall Study|Withdrawal by Subject|2|||
23586871|NCT04304534|65876177|FG002|Overall Study|Withdrawal by Subject|7|||
23586872|NCT04304534|65876178|FG003|Overall Study|Withdrawal by Subject|4|||
23586873|NCT04304534|65876175|FG000|Overall Study|Physician Decision|4|||
23586874|NCT04304534|65876176|FG001|Overall Study|Physician Decision|9|||
23586875|NCT04304534|65876177|FG002|Overall Study|Physician Decision|9|||
23586876|NCT04304534|65876178|FG003|Overall Study|Physician Decision|5|||
23586877|NCT04304534|65876175|FG000|Overall Study|Subject Decision|34|||
23793399|NCT00112437|66620551|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23351878|NCT05052697|65032860|FG004|Substudy A|Not vaccinated|0|||
23351879|NCT05052697|65032861|FG005|Substudy A|Not vaccinated|0|||
23351880|NCT05052697|65032862|FG006|Substudy A|Not vaccinated|0|||
23351881|NCT05052697|65032863|FG007|Substudy A|Not vaccinated|0|||
23351882|NCT05052697|65032864|FG008|Substudy A|Not vaccinated|1|||
23351883|NCT05052697|65032865|FG009|Substudy A|Not vaccinated|0|||
23351884|NCT05052697|65032866|FG010|Substudy A|Not vaccinated|0|||
23351885|NCT05052697|65032867|FG011|Substudy A|Not vaccinated|0|||
23351886|NCT05052697|65032868|FG012|Substudy A|Not vaccinated|0|||
23351887|NCT05052697|65032869|FG013|Substudy A|Not vaccinated|0|||
23351888|NCT05052697|65032870|FG014|Substudy A|Not vaccinated|0|||
23351889|NCT05052697|65032871|FG015|Substudy A|Not vaccinated|0|||
23351890|NCT05052697|65032872|FG016|Substudy A|Not vaccinated|0|||
23351891|NCT05052697|65032873|FG017|Substudy A|Not vaccinated|0|||
23351892|NCT05052697|65032874|FG018|Substudy A|Not vaccinated|0|||
23351893|NCT05052697|65032875|FG019|Substudy A|Not vaccinated|0|||
23351894|NCT05052697|65032876|FG020|Substudy A|Not vaccinated|0|||
23351895|NCT05052697|65032877|FG021|Substudy A|Not vaccinated|0|||
23351896|NCT05052697|65032878|FG022|Substudy A|Not vaccinated|0|||
23351897|NCT05052697|65032879|FG023|Substudy A|Not vaccinated|0|||
23351898|NCT05052697|65032880|FG024|Substudy A|Not vaccinated|0|||
23351899|NCT05052697|65032881|FG025|Substudy A|Not vaccinated|0|||
23586878|NCT04304534|65876176|FG001|Overall Study|Subject Decision|25|||
23586879|NCT04304534|65876177|FG002|Overall Study|Subject Decision|25|||
23793400|NCT00112437|66620552|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793401|NCT00112437|66620553|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793402|NCT00112437|66620554|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793403|NCT00112437|66620555|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793404|NCT00112437|66620556|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793405|NCT00112437|66620557|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793406|NCT00112437|66620558|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793407|NCT00112437|66620559|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793408|NCT00112437|66620560|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793409|NCT00112437|66620561|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793410|NCT00112437|66620562|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793411|NCT00112437|66620563|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793412|NCT00112437|66620564|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793413|NCT00112437|66620565|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793414|NCT00112437|66620566|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793415|NCT00112437|66620567|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23586880|NCT04304534|65876178|FG003|Overall Study|Subject Decision|26|||
23351900|NCT05052697|65032882|FG026|Substudy A|Not vaccinated|0|||
23351901|NCT05052697|65032883|FG027|Substudy A|Not vaccinated|0|||
23351902|NCT05052697|65032884|FG028|Substudy A|Not vaccinated|0|||
23586881|NCT04304534|65876175|FG000|Overall Study|Adverse Event|35|||
23351903|NCT05052697|65032885|FG029|Substudy A|Not vaccinated|0|||
23351904|NCT05052697|65032886|FG030|Substudy A|Not vaccinated|0|||
23586882|NCT04304534|65876176|FG001|Overall Study|Adverse Event|40|||
23793416|NCT00112437|66620568|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793417|NCT00112437|66620569|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23586883|NCT04304534|65876177|FG002|Overall Study|Adverse Event|39|||
23586884|NCT04304534|65876178|FG003|Overall Study|Adverse Event|44|||
23586885|NCT03396835|65876184|FG000|Overall Study|Withdrawn prior to completion|1|||
23586886|NCT03396835|65876184|FG000|Overall Study|Did not meet criteria for data analysis|1|||
23586887|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
23586888|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
23586889|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
23586890|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
23586891|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
23586892|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
23586893|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
23586894|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
23586895|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
23586896|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
23586897|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
23586898|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
23586899|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
23586900|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
23586901|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
23586902|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
23586903|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
23586904|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
23586905|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
23586906|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
23586907|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
23640638|NCT02514239|66071401|FG003|Overall Study|Progressive disease|2|||
23640639|NCT02514239|66071402|FG004|Overall Study|Progressive disease|3|||
23640640|NCT02514239|66071403|FG005|Overall Study|Progressive disease|3|||
23640641|NCT02514239|66071404|FG006|Overall Study|Progressive disease|4|||
23640642|NCT02514239|66071405|FG007|Overall Study|Progressive disease|2|||
23640643|NCT02514239|66071406|FG008|Overall Study|Progressive disease|5|||
23793418|NCT00112437|66620570|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
23793419|NCT00112437|66620571|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793420|NCT00112437|66620572|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793421|NCT00112437|66620573|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793422|NCT00112437|66620574|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23793423|NCT00112437|66620549|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793424|NCT00112437|66620550|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793425|NCT00112437|66620551|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793426|NCT00112437|66620552|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793427|NCT00112437|66620553|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793428|NCT00112437|66620554|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793429|NCT00112437|66620555|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793430|NCT00112437|66620556|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793431|NCT00112437|66620557|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793432|NCT00112437|66620558|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793433|NCT00112437|66620559|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793434|NCT00112437|66620560|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793435|NCT00112437|66620561|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793436|NCT00112437|66620562|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793437|NCT00112437|66620563|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793438|NCT00112437|66620564|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793439|NCT00112437|66620565|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793440|NCT00112437|66620566|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793441|NCT00112437|66620567|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793442|NCT00112437|66620568|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793443|NCT00112437|66620569|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
23351905|NCT05052697|65032887|FG031|Substudy A|Not vaccinated|0|||
23351906|NCT05052697|65032888|FG032|Substudy A|Not vaccinated|0|||
23586908|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
23586909|NCT00741988|65876187|FG000|Overall Study|Adverse Event|2|||
23586910|NCT00741988|65876188|FG001|Overall Study|Adverse Event|4|||
23586911|NCT00741988|65876187|FG000|Overall Study|Lack of Efficacy|2|||
23586912|NCT00741988|65876188|FG001|Overall Study|Lack of Efficacy|0|||
23351907|NCT05052697|65032889|FG033|Substudy A|Not vaccinated|0|||
23351908|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23586913|NCT01616654|65876189|FG000|Overall Study|Lack of Efficacy|1|||
23586914|NCT01616654|65876190|FG001|Overall Study|Lack of Efficacy|0|||
23586915|NCT01616654|65876191|FG002|Overall Study|Lack of Efficacy|0|||
23586916|NCT01616654|65876192|FG003|Overall Study|Lack of Efficacy|0|||
23586917|NCT01616654|65876193|FG004|Overall Study|Lack of Efficacy|1|||
23586918|NCT01616654|65876189|FG000|Overall Study|Adverse Event|0|||
23586919|NCT01616654|65876190|FG001|Overall Study|Adverse Event|1|||
23586920|NCT01616654|65876191|FG002|Overall Study|Adverse Event|2|||
23586921|NCT01616654|65876192|FG003|Overall Study|Adverse Event|1|||
23586922|NCT01616654|65876193|FG004|Overall Study|Adverse Event|0|||
23586923|NCT01616654|65876189|FG000|Overall Study|Withdrawal by Subject|2|||
23586924|NCT01616654|65876190|FG001|Overall Study|Withdrawal by Subject|2|||
23586925|NCT01616654|65876191|FG002|Overall Study|Withdrawal by Subject|3|||
23586926|NCT01616654|65876192|FG003|Overall Study|Withdrawal by Subject|1|||
23586927|NCT01616654|65876193|FG004|Overall Study|Withdrawal by Subject|5|||
23586928|NCT01616654|65876189|FG000|Overall Study|Protocol Violation|0|||
23586929|NCT01616654|65876190|FG001|Overall Study|Protocol Violation|5|||
23586930|NCT01616654|65876191|FG002|Overall Study|Protocol Violation|2|||
23586931|NCT01616654|65876192|FG003|Overall Study|Protocol Violation|4|||
23586932|NCT01616654|65876193|FG004|Overall Study|Protocol Violation|4|||
23586933|NCT01616654|65876189|FG000|Overall Study|Lost to Follow-up|1|||
23586934|NCT01616654|65876190|FG001|Overall Study|Lost to Follow-up|0|||
23586935|NCT01616654|65876191|FG002|Overall Study|Lost to Follow-up|3|||
23586936|NCT01616654|65876192|FG003|Overall Study|Lost to Follow-up|2|||
23586937|NCT01616654|65876193|FG004|Overall Study|Lost to Follow-up|1|||
23586938|NCT01616654|65876189|FG000|Overall Study|Pregnancy|1|||
23586939|NCT01616654|65876190|FG001|Overall Study|Pregnancy|0|||
23586940|NCT01616654|65876191|FG002|Overall Study|Pregnancy|0|||
23586941|NCT01616654|65876192|FG003|Overall Study|Pregnancy|0|||
23586942|NCT01616654|65876193|FG004|Overall Study|Pregnancy|1|||
23586943|NCT00139737|65876198|FG000|Overall Study|Withdrawal by Subject|190|||
23586944|NCT00139737|65876198|FG000|Overall Study|Adverse Event|58|||
23586945|NCT00139737|65876198|FG000|Overall Study|Lack of Efficacy|40|||
23586946|NCT00139737|65876198|FG000|Overall Study|Lost to Follow-up|8|||
23586947|NCT00139737|65876198|FG000|Overall Study|Death|3|||
23586948|NCT00139737|65876198|FG000|Overall Study|Laboratory Abnormality|2|||
23586949|NCT00139737|65876198|FG000|Overall Study|Protocol Violation|18|||
23586950|NCT00139737|65876198|FG000|Overall Study|Withdrew During Screening Phase|8|||
23586951|NCT00139737|65876198|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23586952|NCT00139737|65876198|FG000|Overall Study|Screened, Not Treated|13|||
23586953|NCT00591838|65876202|FG000|Overall Study|Withdrawal by Subject|0|||
23586954|NCT00591838|65876203|FG001|Overall Study|Withdrawal by Subject|0|||
23586955|NCT00591838|65876204|FG002|Overall Study|Withdrawal by Subject|0|||
23586956|NCT00591838|65876205|FG003|Overall Study|Withdrawal by Subject|1|||
23586957|NCT00591838|65876206|FG004|Overall Study|Withdrawal by Subject|0|||
23586958|NCT00619645|65876207|FG000|Overall Study|Adverse Event|1|||
23586959|NCT02106442|65876208|FG000|Overall Study|Case Report Forms Uncollected|7|||
23586960|NCT02106442|65876208|FG000|Overall Study|Protocol Deviation|30|||
23586961|NCT03255018|65876209|FG000|Overall Study|Death on study|0|||
23586962|NCT03255018|65876210|FG001|Overall Study|Death on study|5|||
23586963|NCT03255018|65876209|FG000|Overall Study|Withdrawal by Subject|0|||
23586964|NCT03255018|65876210|FG001|Overall Study|Withdrawal by Subject|2|||
23586965|NCT01648140|65876213|FG000|Overall Study|Physician Decision|1|||
23586966|NCT01648140|65876214|FG001|Overall Study|Physician Decision|0|||
23586967|NCT01648140|65876215|FG002|Overall Study|Physician Decision|0|||
23586968|NCT01648140|65876216|FG003|Overall Study|Physician Decision|0|||
23586969|NCT01648140|65876213|FG000|Overall Study|Lack of Efficacy|4|||
23586970|NCT01648140|65876214|FG001|Overall Study|Lack of Efficacy|7|||
23586971|NCT01648140|65876215|FG002|Overall Study|Lack of Efficacy|1|||
23586972|NCT01648140|65876216|FG003|Overall Study|Lack of Efficacy|0|||
23640644|NCT02514239|66071407|FG009|Overall Study|Progressive disease|0|||
23586973|NCT01648140|65876213|FG000|Overall Study|Adverse Event|3|||
23586974|NCT01648140|65876214|FG001|Overall Study|Adverse Event|1|||
23586975|NCT01648140|65876215|FG002|Overall Study|Adverse Event|2|||
23586976|NCT01648140|65876216|FG003|Overall Study|Adverse Event|0|||
23586977|NCT01648140|65876213|FG000|Overall Study|Withdrawal by Subject|2|||
23586978|NCT01648140|65876214|FG001|Overall Study|Withdrawal by Subject|3|||
23586979|NCT01648140|65876215|FG002|Overall Study|Withdrawal by Subject|3|||
23586980|NCT01648140|65876216|FG003|Overall Study|Withdrawal by Subject|2|||
23586981|NCT01648140|65876213|FG000|Overall Study|Lost to Follow-up|2|||
23586982|NCT01648140|65876214|FG001|Overall Study|Lost to Follow-up|1|||
23586983|NCT01648140|65876215|FG002|Overall Study|Lost to Follow-up|2|||
23586984|NCT01648140|65876216|FG003|Overall Study|Lost to Follow-up|0|||
23586985|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
23586986|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
23586987|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
23586988|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
23586989|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
23586990|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
23586991|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
23586992|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
23586993|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
23586994|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
23586995|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
23586996|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
23586997|NCT00762463|65876217|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
23586998|NCT00762463|65876218|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
23586999|NCT00762463|65876219|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
23587000|NCT00762463|65876220|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
23587001|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
23351909|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351910|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351911|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23793444|NCT00112437|66620570|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
23793445|NCT00112437|66620571|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793446|NCT00112437|66620572|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793447|NCT00112437|66620573|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793448|NCT00112437|66620574|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
23793449|NCT00112437|66620549|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793450|NCT00112437|66620550|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793451|NCT00112437|66620551|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793452|NCT00112437|66620552|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793453|NCT00112437|66620553|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793454|NCT00112437|66620554|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793455|NCT00112437|66620555|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793456|NCT00112437|66620556|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793457|NCT00112437|66620557|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793458|NCT00112437|66620558|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793459|NCT00112437|66620559|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793460|NCT00112437|66620560|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793461|NCT00112437|66620561|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793462|NCT00112437|66620562|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793463|NCT00112437|66620563|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793464|NCT00112437|66620564|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793465|NCT00112437|66620565|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793466|NCT00112437|66620566|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793467|NCT00112437|66620567|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793468|NCT00112437|66620568|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793469|NCT00112437|66620569|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
23793470|NCT00112437|66620570|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
23793471|NCT00112437|66620571|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793472|NCT00112437|66620572|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793473|NCT00112437|66620573|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793474|NCT00112437|66620574|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23793475|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793476|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793477|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793478|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793479|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793480|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793481|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793482|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793483|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793484|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793485|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793486|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793487|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793488|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793489|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793490|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793491|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793492|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793493|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793494|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793495|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793496|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793497|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
23793498|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
23793499|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23793500|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
23793501|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Death|0|||
23793502|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Death|0|||
23793503|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Death|0|||
23793504|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Death|0|||
23793505|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Death|0|||
23793506|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Death|0|||
23351912|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351913|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351914|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351915|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351916|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351917|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351918|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351919|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351920|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351921|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351922|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351923|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351924|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351925|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351926|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351927|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351928|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351929|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351930|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
23351931|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351932|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351933|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351934|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351935|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351936|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351937|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351938|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351939|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351940|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351941|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351942|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351943|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351944|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351945|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351946|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351947|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351948|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351949|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351950|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351951|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351952|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351953|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351954|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351955|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351956|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351957|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351958|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351959|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
23351960|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351961|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351962|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351963|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351964|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351965|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351966|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351967|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351968|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351969|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351970|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351971|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351972|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351973|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351974|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351975|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351976|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351977|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351978|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351979|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351980|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351981|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351982|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351983|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351984|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351985|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351986|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351987|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351988|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351989|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351990|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351991|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351992|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351993|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351994|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351995|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
23351996|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351997|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351998|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351999|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352000|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352001|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352002|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352003|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352004|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352005|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352006|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352007|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352008|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352009|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352010|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352011|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352012|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352013|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352014|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352015|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352016|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352017|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352018|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352019|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352020|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352021|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352022|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352023|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352024|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352025|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352026|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352027|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352028|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352029|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352030|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352031|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352032|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352033|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352034|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352035|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352036|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352037|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352038|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352039|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352040|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352041|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352042|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352043|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352044|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352045|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352046|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352047|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352048|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352049|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352050|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352051|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352052|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352053|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352054|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352055|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352056|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352057|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352058|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352059|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352060|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352061|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352062|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352063|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352064|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352065|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352066|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352067|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352068|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352069|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352070|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352071|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352072|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
23352073|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352074|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352075|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352076|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352077|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352078|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352079|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352080|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352081|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352082|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352083|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352084|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352085|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352086|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352087|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23640645|NCT00266227|66071408|FG000|Initial Treatment|Adverse Event|0|||
23793507|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Death|0|||
23793508|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Death|0|||
23793509|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Death|0|||
23793510|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Death|0|||
23793511|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Death|0|||
23793512|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Death|0|||
23793513|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Death|0|||
23793514|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Death|0|||
23352088|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352089|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352090|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352091|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352092|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352093|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352094|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352095|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352096|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352097|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352098|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352099|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352100|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352101|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352102|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352103|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352104|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352105|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352106|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
23352107|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
23352108|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
23352109|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
23352110|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
23352111|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352112|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352113|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352114|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352115|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352116|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352117|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352118|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352119|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352120|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352121|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352122|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352123|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352124|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352125|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352126|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352127|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352128|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352129|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352130|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352131|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352132|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352133|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352134|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352135|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352136|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23587002|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
23587003|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
23587004|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
23587005|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587006|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587007|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
23587008|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587009|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
23587010|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
23587011|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
23587012|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
23587013|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
23640646|NCT00266227|66071409|FG001|Initial Treatment|Adverse Event|0|||
23640647|NCT00266227|66071410|FG002|Initial Treatment|Adverse Event|13|||
23640648|NCT00266227|66071408|FG000|Initial Treatment|Lost to Follow-up|0|||
23352137|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352138|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352139|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352140|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352141|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352142|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352143|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352144|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
23352145|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352146|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352147|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352148|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352149|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352150|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352151|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352152|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352153|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352154|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352155|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352156|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352157|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352158|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352159|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352160|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352161|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352162|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352163|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352164|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352165|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352166|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352167|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352168|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352169|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23793515|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Death|0|||
23793516|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Death|0|||
23793517|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Death|0|||
23793518|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Death|0|||
23793519|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Death|0|||
23793520|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Death|0|||
23793521|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Death|0|||
23352170|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352171|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352172|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352173|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352174|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
23352175|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
23352176|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
23352177|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352178|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352179|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352180|NCT00096993|65032896|FG000|Overall Study|Death|1|||
23352181|NCT00096993|65032897|FG001|Overall Study|Death|0|||
23352182|NCT00096993|65032896|FG000|Overall Study|Disease progression|56|||
23352183|NCT00096993|65032897|FG001|Overall Study|Disease progression|53|||
23352184|NCT00096993|65032896|FG000|Overall Study|Adverse Event|2|||
23352185|NCT00096993|65032897|FG001|Overall Study|Adverse Event|8|||
23352186|NCT00096993|65032896|FG000|Overall Study|Subject's decision|3|||
23352187|NCT00096993|65032897|FG001|Overall Study|Subject's decision|1|||
23352188|NCT00096993|65032896|FG000|Overall Study|Physician Decision|2|||
23352189|NCT00096993|65032897|FG001|Overall Study|Physician Decision|1|||
23352190|NCT00096993|65032896|FG000|Overall Study|Non-compliance|0|||
23352191|NCT00096993|65032897|FG001|Overall Study|Non-compliance|1|||
23352192|NCT00096993|65032896|FG000|Overall Study|Other unspecified|1|||
23352193|NCT00096993|65032897|FG001|Overall Study|Other unspecified|1|||
23352194|NCT02913105|65032909|FG000|Overall Study|Adverse Event|11|||
23352195|NCT02913105|65032910|FG001|Overall Study|Adverse Event|0|||
23352196|NCT02913105|65032911|FG002|Overall Study|Adverse Event|4|||
23352197|NCT02913105|65032909|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23793522|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Death|0|||
23352198|NCT02913105|65032910|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23352199|NCT02913105|65032911|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23352200|NCT02913105|65032909|FG000|Overall Study|Reason Not Specified|3|||
23352201|NCT02913105|65032910|FG001|Overall Study|Reason Not Specified|1|||
23352202|NCT02913105|65032911|FG002|Overall Study|Reason Not Specified|1|||
23793523|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Death|0|||
23793524|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Death|2|||
23793525|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Death|0|||
23793526|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Death|0|||
23587014|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
23587015|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
23587016|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
23587017|NCT01726023|65876221|FG000|Overall Study|Death|1|||
23587018|NCT01726023|65876222|FG001|Overall Study|Death|1|||
23587019|NCT01726023|65876221|FG000|Overall Study|Lost to Follow-up|5|||
23587020|NCT01726023|65876222|FG001|Overall Study|Lost to Follow-up|10|||
23587021|NCT01726023|65876221|FG000|Overall Study|Other Eligibility criteria|7|||
23587022|NCT01726023|65876222|FG001|Overall Study|Other Eligibility criteria|7|||
23587023|NCT01726023|65876221|FG000|Overall Study|Withdrawal by Subject|16|||
23793527|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793528|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793529|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793530|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793531|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793532|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793533|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793534|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793535|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793536|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793537|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793538|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793539|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793540|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793541|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793542|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793543|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793544|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793545|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793546|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793547|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793548|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793549|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793550|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793551|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23793552|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
23793553|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Other|0|||
23793554|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Other|0|||
23793555|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Other|0|||
23793556|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Other|0|||
23793557|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Other|0|||
23793558|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Other|0|||
23793559|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Other|0|||
23793560|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Other|0|||
23793561|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Other|0|||
23793562|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Other|0|||
23793563|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Other|0|||
23793564|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Other|0|||
23793565|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Other|0|||
23793566|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Other|0|||
23793567|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Other|0|||
23793568|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Other|0|||
23793569|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Other|0|||
23793570|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Other|0|||
23793571|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Other|0|||
23793572|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Other|0|||
23793573|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Other|0|||
23793574|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Other|0|||
23793575|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Other|0|||
23468019|NCT02541604|65457187|FG001|Overall Study|Lost to Follow-up|0|||
23468020|NCT02541604|65457188|FG002|Overall Study|Lost to Follow-up|1|||
23468021|NCT02541604|65457189|FG003|Overall Study|Lost to Follow-up|0|||
23468022|NCT02541604|65457190|FG004|Overall Study|Lost to Follow-up|0|||
23468023|NCT02541604|65457191|FG005|Overall Study|Lost to Follow-up|1|||
23468024|NCT02541604|65457192|FG006|Overall Study|Lost to Follow-up|1|||
23468025|NCT02541604|65457193|FG007|Overall Study|Lost to Follow-up|0|||
23468026|NCT02541604|65457194|FG008|Overall Study|Lost to Follow-up|0|||
23468027|NCT02541604|65457195|FG009|Overall Study|Lost to Follow-up|0|||
23468028|NCT02541604|65457196|FG010|Overall Study|Lost to Follow-up|0|||
23468029|NCT02541604|65457197|FG011|Overall Study|Lost to Follow-up|0|||
23468030|NCT02541604|65457186|FG000|Overall Study|Withdrawal by Subject|2|||
23468031|NCT02541604|65457187|FG001|Overall Study|Withdrawal by Subject|0|||
23468032|NCT02541604|65457188|FG002|Overall Study|Withdrawal by Subject|1|||
23587024|NCT01726023|65876222|FG001|Overall Study|Withdrawal by Subject|8|||
23587025|NCT01145885|65876223|FG000|Overall Study|Progressive Disease|7|||
23587026|NCT02072226|65876225|FG000|Overall Study|Lost to Follow-up|11|||
23587027|NCT02072226|65876226|FG001|Overall Study|Lost to Follow-up|7|||
23587028|NCT02072226|65876225|FG000|Overall Study|Patient Non-compliance|2|||
23587029|NCT02072226|65876226|FG001|Overall Study|Patient Non-compliance|3|||
23587030|NCT02072226|65876225|FG000|Overall Study|Death|1|||
23587031|NCT02072226|65876226|FG001|Overall Study|Death|0|||
23587032|NCT02072226|65876225|FG000|Overall Study|Patient Withdrawal of Consent|1|||
23587033|NCT02072226|65876226|FG001|Overall Study|Patient Withdrawal of Consent|0|||
23587034|NCT03061474|65876227|FG000|Overall Study|Adverse Event|2|||
23587035|NCT03061474|65876228|FG001|Overall Study|Adverse Event|0|||
23587036|NCT03061474|65876227|FG000|Overall Study|Safety Risk|0|||
23587037|NCT03061474|65876228|FG001|Overall Study|Safety Risk|1|||
23587038|NCT03061474|65876227|FG000|Overall Study|Participant unwilling or unable to participate|0|||
23587039|NCT03061474|65876228|FG001|Overall Study|Participant unwilling or unable to participate|2|||
23587040|NCT03061474|65876227|FG000|Overall Study|Lost to Follow-up|0|||
23587041|NCT03061474|65876228|FG001|Overall Study|Lost to Follow-up|1|||
23587042|NCT01908634|65876232|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
23587043|NCT01908634|65876232|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
23587044|NCT01801930|65876233|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
23587045|NCT01801930|65876234|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
23587046|NCT01801930|65876235|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
23587047|NCT01801930|65876236|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
23587048|NCT01801930|65876233|FG000|Overall Study|DLT occurs|0|||
23587049|NCT01801930|65876234|FG001|Overall Study|DLT occurs|1|||
23587050|NCT01801930|65876235|FG002|Overall Study|DLT occurs|0|||
23793576|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Other|0|||
23793577|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Other|1|||
23793578|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Other|0|||
23793579|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793580|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793581|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793582|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793583|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793584|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793585|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793586|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793587|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793588|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793589|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793590|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793591|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793592|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793593|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793594|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793595|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793596|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793597|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793598|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793599|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793600|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793601|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23352203|NCT02913105|65032909|FG000|Overall Study|Physician Decision|1|||
23587051|NCT01801930|65876236|FG003|Overall Study|DLT occurs|0|||
23587052|NCT00612586|65876237|FG000|Overall Study|Adverse Event|6|||
23468033|NCT02541604|65457189|FG003|Overall Study|Withdrawal by Subject|0|||
23468034|NCT02541604|65457190|FG004|Overall Study|Withdrawal by Subject|1|||
23352204|NCT02913105|65032910|FG001|Overall Study|Physician Decision|1|||
23352205|NCT02913105|65032911|FG002|Overall Study|Physician Decision|0|||
23352206|NCT02913105|65032909|FG000|Overall Study|Withdrawal by Subject|0|||
23352207|NCT02913105|65032910|FG001|Overall Study|Withdrawal by Subject|3|||
23352208|NCT02913105|65032911|FG002|Overall Study|Withdrawal by Subject|1|||
23352209|NCT02603107|65032912|FG000|Randomized Phase|Withdrew consent|8|||
23352210|NCT02603107|65032913|FG001|Randomized Phase|Withdrew consent|15|||
23352211|NCT02603107|65032912|FG000|Randomized Phase|Lost to Follow-up|1|||
23352212|NCT02603107|65032913|FG001|Randomized Phase|Lost to Follow-up|3|||
23352213|NCT02603107|65032912|FG000|Randomized Phase|Adverse Event|2|||
23352214|NCT02603107|65032913|FG001|Randomized Phase|Adverse Event|0|||
23352215|NCT02603107|65032912|FG000|Randomized Phase|Death|1|||
23352216|NCT02603107|65032913|FG001|Randomized Phase|Death|1|||
23352217|NCT02603107|65032912|FG000|Randomized Phase|Non-compliance with study drug|1|||
23352218|NCT02603107|65032913|FG001|Randomized Phase|Non-compliance with study drug|1|||
23352219|NCT02603107|65032912|FG000|Randomized Phase|Investigator's discretion|0|||
23352220|NCT02603107|65032913|FG001|Randomized Phase|Investigator's discretion|1|||
23352221|NCT02603107|65032912|FG000|Randomized Phase|Lack of Efficacy|1|||
23352222|NCT02603107|65032913|FG001|Randomized Phase|Lack of Efficacy|0|||
23352223|NCT02603107|65032912|FG000|Randomized Phase|Protocol Violation|1|||
23352224|NCT02603107|65032913|FG001|Randomized Phase|Protocol Violation|0|||
23352225|NCT02603107|65032912|FG000|Optional Extension Phase|Lost to Follow-up|3|||
23352226|NCT02603107|65032913|FG001|Optional Extension Phase|Lost to Follow-up|3|||
23352227|NCT02603107|65032912|FG000|Optional Extension Phase|Withdrew consent|3|||
23352228|NCT02603107|65032913|FG001|Optional Extension Phase|Withdrew consent|2|||
23352229|NCT02603107|65032912|FG000|Optional Extension Phase|Investigator's discretion|2|||
23352230|NCT02603107|65032913|FG001|Optional Extension Phase|Investigator's discretion|2|||
23352231|NCT02603107|65032912|FG000|Optional Extension Phase|Pregnancy|0|||
23352232|NCT02603107|65032913|FG001|Optional Extension Phase|Pregnancy|3|||
23352233|NCT02603107|65032912|FG000|Optional Extension Phase|Adverse Event|0|||
23352234|NCT02603107|65032913|FG001|Optional Extension Phase|Adverse Event|2|||
23352235|NCT02603107|65032912|FG000|Optional Extension Phase|Not treated in extension phase|0|||
23352236|NCT02603107|65032913|FG001|Optional Extension Phase|Not treated in extension phase|1|||
23352237|NCT02603107|65032912|FG000|Optional Extension Phase|Protocol Violation|1|||
23352238|NCT02603107|65032913|FG001|Optional Extension Phase|Protocol Violation|0|||
23352239|NCT03796676|65032914|FG000|Overall Study|Adverse Event|2|||
23352240|NCT03796676|65032915|FG001|Overall Study|Adverse Event|1|||
23352241|NCT03796676|65032916|FG002|Overall Study|Adverse Event|2|||
23352242|NCT03796676|65032914|FG000|Overall Study|Lost to Follow-up|2|||
23352243|NCT03796676|65032915|FG001|Overall Study|Lost to Follow-up|1|||
23352244|NCT03796676|65032916|FG002|Overall Study|Lost to Follow-up|0|||
23352245|NCT03796676|65032914|FG000|Overall Study|Protocol Violation|0|||
23352246|NCT03796676|65032915|FG001|Overall Study|Protocol Violation|0|||
23352247|NCT03796676|65032916|FG002|Overall Study|Protocol Violation|1|||
23352248|NCT03796676|65032914|FG000|Overall Study|Withdrawal by Subject|1|||
23352249|NCT03796676|65032915|FG001|Overall Study|Withdrawal by Subject|1|||
23352250|NCT03796676|65032916|FG002|Overall Study|Withdrawal by Subject|0|||
23352251|NCT03796676|65032914|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
23352252|NCT03796676|65032915|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
23352253|NCT03796676|65032916|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
23352254|NCT00539032|65032917|FG000|Overall Study|Withdrawal by Subject|2|||
23352255|NCT00539032|65032918|FG001|Overall Study|Withdrawal by Subject|1|||
23352256|NCT02003963|65032920|FG000|Overall Study|Lost to Follow-up|2|||
23352257|NCT02003963|65032921|FG001|Overall Study|Lost to Follow-up|1|||
23352258|NCT04933617|65032924|FG000|Dose Escalation|Early closure of study|0|||
23352259|NCT04933617|65032925|FG001|Dose Escalation|Early closure of study|3|||
23352260|NCT04933617|65032926|FG002|Dose Escalation|Early closure of study|0|||
23352261|NCT04933617|65032927|FG003|Dose Escalation|Early closure of study|0|||
23793602|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
23793603|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793604|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23793605|NCT00112437|66620549|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793606|NCT00112437|66620550|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793607|NCT00112437|66620551|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793608|NCT00112437|66620552|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793609|NCT00112437|66620553|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793610|NCT00112437|66620554|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793611|NCT00112437|66620555|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23352262|NCT04933617|65032928|FG004|Dose Escalation|Early closure of study|0|||
23352263|NCT03309696|65032933|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
23587053|NCT00612586|65876238|FG001|Overall Study|Adverse Event|2|||
23587054|NCT00612586|65876237|FG000|Overall Study|Death|1|||
23587055|NCT00612586|65876238|FG001|Overall Study|Death|0|||
23793612|NCT00112437|66620556|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793613|NCT00112437|66620557|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793614|NCT00112437|66620558|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793615|NCT00112437|66620559|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793616|NCT00112437|66620560|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793617|NCT00112437|66620561|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793618|NCT00112437|66620562|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23468035|NCT02541604|65457191|FG005|Overall Study|Withdrawal by Subject|1|||
23468036|NCT02541604|65457192|FG006|Overall Study|Withdrawal by Subject|0|||
23468037|NCT02541604|65457193|FG007|Overall Study|Withdrawal by Subject|0|||
23468038|NCT02541604|65457194|FG008|Overall Study|Withdrawal by Subject|1|||
23468039|NCT02541604|65457195|FG009|Overall Study|Withdrawal by Subject|0|||
23468040|NCT02541604|65457196|FG010|Overall Study|Withdrawal by Subject|0|||
23468041|NCT02541604|65457197|FG011|Overall Study|Withdrawal by Subject|0|||
23468042|NCT02541604|65457186|FG000|Overall Study|Study Terminated by Sponsor|1|||
23468043|NCT02541604|65457187|FG001|Overall Study|Study Terminated by Sponsor|4|||
23468044|NCT02541604|65457188|FG002|Overall Study|Study Terminated by Sponsor|2|||
23468045|NCT02541604|65457189|FG003|Overall Study|Study Terminated by Sponsor|1|||
23468046|NCT02541604|65457190|FG004|Overall Study|Study Terminated by Sponsor|0|||
23468047|NCT02541604|65457191|FG005|Overall Study|Study Terminated by Sponsor|0|||
23468048|NCT02541604|65457192|FG006|Overall Study|Study Terminated by Sponsor|0|||
23468049|NCT02541604|65457193|FG007|Overall Study|Study Terminated by Sponsor|0|||
23468050|NCT02541604|65457194|FG008|Overall Study|Study Terminated by Sponsor|0|||
23468051|NCT02541604|65457195|FG009|Overall Study|Study Terminated by Sponsor|0|||
23468052|NCT02541604|65457196|FG010|Overall Study|Study Terminated by Sponsor|0|||
23468053|NCT02541604|65457197|FG011|Overall Study|Study Terminated by Sponsor|0|||
23468054|NCT02541604|65457186|FG000|Overall Study|Medical condition may jeopardize safety|0|||
23468055|NCT02541604|65457187|FG001|Overall Study|Medical condition may jeopardize safety|0|||
23468056|NCT02541604|65457188|FG002|Overall Study|Medical condition may jeopardize safety|0|||
23468057|NCT02541604|65457189|FG003|Overall Study|Medical condition may jeopardize safety|0|||
23468058|NCT02541604|65457190|FG004|Overall Study|Medical condition may jeopardize safety|0|||
23468059|NCT02541604|65457191|FG005|Overall Study|Medical condition may jeopardize safety|0|||
23468060|NCT02541604|65457192|FG006|Overall Study|Medical condition may jeopardize safety|0|||
23468061|NCT02541604|65457193|FG007|Overall Study|Medical condition may jeopardize safety|1|||
23468062|NCT02541604|65457194|FG008|Overall Study|Medical condition may jeopardize safety|0|||
23468063|NCT02541604|65457195|FG009|Overall Study|Medical condition may jeopardize safety|0|||
23468064|NCT02541604|65457196|FG010|Overall Study|Medical condition may jeopardize safety|0|||
23468065|NCT02541604|65457197|FG011|Overall Study|Medical condition may jeopardize safety|0|||
23468066|NCT03196349|65457198|FG000|Overall Study|Did not receive study drug|0|||
23468067|NCT03196349|65457199|FG001|Overall Study|Did not receive study drug|1|||
23468068|NCT03196349|65457200|FG002|Overall Study|Did not receive study drug|2|||
23468069|NCT03196349|65457198|FG000|Overall Study|No data entered|2|||
23468070|NCT03196349|65457199|FG001|Overall Study|No data entered|4|||
23468071|NCT03196349|65457200|FG002|Overall Study|No data entered|0|||
23468072|NCT03196349|65457198|FG000|Overall Study|Study Terminated early|15|||
23468073|NCT03196349|65457199|FG001|Overall Study|Study Terminated early|9|||
23587056|NCT00612586|65876237|FG000|Overall Study|Entry Criteria Not Met|0|||
23587057|NCT00612586|65876238|FG001|Overall Study|Entry Criteria Not Met|2|||
23587058|NCT00612586|65876237|FG000|Overall Study|Withdrawal by Subject|7|||
23587059|NCT00612586|65876238|FG001|Overall Study|Withdrawal by Subject|9|||
23793619|NCT00112437|66620563|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23352264|NCT03309696|65032934|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
23468074|NCT03196349|65457200|FG002|Overall Study|Study Terminated early|11|||
23587060|NCT00612586|65876237|FG000|Overall Study|Physician Decision|1|||
23793620|NCT00112437|66620564|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793621|NCT00112437|66620565|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793622|NCT00112437|66620566|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23468075|NCT01039519|65457201|FG000|Treatment|Progressive disease|20|||
23587061|NCT00612586|65876238|FG001|Overall Study|Physician Decision|2|||
23468076|NCT01039519|65457201|FG000|Treatment|Treatment failure|2|||
23468077|NCT01039519|65457201|FG000|Treatment|Adverse Event|3|||
23468078|NCT01039519|65457201|FG000|Treatment|Physician Decision|2|||
23468079|NCT01039519|65457201|FG000|Survival Follow-up|Death|23|||
23468080|NCT01039519|65457201|FG000|Survival Follow-up|Sponsor decision|4|||
23468081|NCT01623050|65457202|FG000|Overall Study|Lost to Follow-up|9|||
23468082|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
23468083|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
23468084|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
23468085|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23468086|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
23468087|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
23468088|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23468089|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23468090|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
23468091|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23468092|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
23468093|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23468094|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
23468095|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
23468096|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
23468097|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
23468098|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
23468099|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
23468100|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
23468101|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
23468102|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
23468103|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
23468104|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
23468105|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
23468106|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
23468107|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
23468108|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
23468109|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
23468110|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
23468111|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
23468112|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
23468113|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
23468114|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
23468115|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
23468116|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
23468117|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
23468118|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
23468119|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
23468120|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
23468121|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
23468122|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
23468123|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
23468124|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Death|1|||
23468125|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Death|0|||
23468126|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Death|0|||
23468127|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Other|4|||
23468128|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Other|1|||
23468129|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Other|0|||
23468130|NCT00295880|65457209|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
23468131|NCT00295880|65457209|FG000|Overall Study|Unit randomization did not occur|1|||
23468132|NCT01104311|65457210|FG000|Overall Study|Withdrawal by Subject|6|||
23468133|NCT01104311|65457211|FG001|Overall Study|Withdrawal by Subject|6|||
23468134|NCT01104311|65457210|FG000|Overall Study|Protocol Violation|0|||
23468135|NCT01104311|65457211|FG001|Overall Study|Protocol Violation|1|||
23468136|NCT01104311|65457210|FG000|Overall Study|Physician Decision|2|||
23468137|NCT01104311|65457211|FG001|Overall Study|Physician Decision|2|||
23468138|NCT01104311|65457210|FG000|Overall Study|low compliance|1|||
23468139|NCT01104311|65457211|FG001|Overall Study|low compliance|1|||
23468140|NCT01104311|65457210|FG000|Overall Study|Adverse Event|1|||
23468141|NCT01104311|65457211|FG001|Overall Study|Adverse Event|2|||
23468142|NCT02803580|65457217|FG000|Overall Study|Death|13|||
23468143|NCT02803580|65457217|FG000|Overall Study|Lost to Follow-up|19|||
23468144|NCT02803580|65457217|FG000|Overall Study|Withdrawal by Subject|3|||
23468145|NCT02803580|65457217|FG000|Overall Study|Inclusion in clinical trial|1|||
23468146|NCT02379637|65457218|FG000|Overall Study|Protocol Violation|0|||
23468147|NCT02379637|65457219|FG001|Overall Study|Protocol Violation|1|||
23468148|NCT02379637|65457218|FG000|Overall Study|Adverse Event|1|||
23468149|NCT02379637|65457219|FG001|Overall Study|Adverse Event|0|||
23468150|NCT02379637|65457218|FG000|Overall Study|Withdrawal by Subject|1|||
23468151|NCT02379637|65457219|FG001|Overall Study|Withdrawal by Subject|0|||
23468152|NCT02536963|65457220|FG000|Overall Study|Withdrawal by Subject|18|||
23468153|NCT04816669|65457221|FG000|Part 1|Adverse Event|1|||
23468154|NCT04816669|65457222|FG001|Part 1|Adverse Event|1|||
23468155|NCT04816669|65457223|FG002|Part 1|Adverse Event|0|||
23468156|NCT04816669|65457224|FG003|Part 1|Adverse Event|0|||
23468157|NCT04816669|65457221|FG000|Part 1|Lost to Follow-up|2|||
23468158|NCT04816669|65457222|FG001|Part 1|Lost to Follow-up|2|||
23468159|NCT04816669|65457223|FG002|Part 1|Lost to Follow-up|0|||
23468160|NCT04816669|65457224|FG003|Part 1|Lost to Follow-up|0|||
23468161|NCT04816669|65457221|FG000|Part 1|Protocol Violation|0|||
23468162|NCT04816669|65457222|FG001|Part 1|Protocol Violation|1|||
23468163|NCT04816669|65457223|FG002|Part 1|Protocol Violation|0|||
23468164|NCT04816669|65457224|FG003|Part 1|Protocol Violation|0|||
23468165|NCT04816669|65457221|FG000|Part 1|Withdrawal by Subject|1|||
23468166|NCT04816669|65457222|FG001|Part 1|Withdrawal by Subject|2|||
23468167|NCT04816669|65457223|FG002|Part 1|Withdrawal by Subject|0|||
23468168|NCT04816669|65457224|FG003|Part 1|Withdrawal by Subject|0|||
23468169|NCT04816669|65457221|FG000|Part 2|Other|0|||
23468170|NCT04816669|65457222|FG001|Part 2|Other|0|||
23468171|NCT04816669|65457223|FG002|Part 2|Other|1|||
23468172|NCT04816669|65457224|FG003|Part 2|Other|0|||
23468173|NCT04816669|65457221|FG000|Part 2|Withdrawal by Subject|0|||
23468174|NCT04816669|65457222|FG001|Part 2|Withdrawal by Subject|0|||
23793623|NCT00112437|66620567|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793624|NCT00112437|66620568|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793625|NCT00112437|66620569|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793626|NCT00112437|66620570|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793627|NCT00112437|66620571|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
23793628|NCT00112437|66620572|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
23793629|NCT00112437|66620573|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23793630|NCT00112437|66620574|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
23793631|NCT05263505|66620575|FG000|Overall Study|Adverse Event|0|||
23793632|NCT05263505|66620576|FG001|Overall Study|Adverse Event|1|||
23793633|NCT03201003|66620582|FG000|Overall Study|Adverse Event|14|||
23793634|NCT03201003|66620583|FG001|Overall Study|Adverse Event|1|||
23793635|NCT03201003|66620582|FG000|Overall Study|Other reasons|5|||
23793636|NCT03201003|66620583|FG001|Overall Study|Other reasons|1|||
23793637|NCT03201003|66620582|FG000|Overall Study|Withdrawal by Subject|4|||
23793638|NCT03201003|66620583|FG001|Overall Study|Withdrawal by Subject|1|||
23793639|NCT03201003|66620582|FG000|Overall Study|Lost to Follow-up|2|||
23793640|NCT03201003|66620583|FG001|Overall Study|Lost to Follow-up|0|||
23793641|NCT03201003|66620582|FG000|Overall Study|Protocol Violation|1|||
23793642|NCT03201003|66620583|FG001|Overall Study|Protocol Violation|0|||
23793643|NCT00858403|66620587|FG000|Overall Study|Withdrawal by Subject|1|||
23793644|NCT00858403|66620587|FG000|Overall Study|Death|3|||
23793645|NCT00858403|66620587|FG000|Overall Study|Disease Progression|1|||
23793646|NCT02888743|66620589|FG000|Overall Study|Withdrawal by Subject|1|||
23793647|NCT02888743|66620590|FG001|Overall Study|Withdrawal by Subject|2|||
23793648|NCT02888743|66620591|FG002|Overall Study|Withdrawal by Subject|2|||
23793649|NCT02888743|66620592|FG003|Overall Study|Withdrawal by Subject|0|||
23793650|NCT02888743|66620593|FG004|Overall Study|Withdrawal by Subject|1|||
23468175|NCT04816669|65457223|FG002|Part 2|Withdrawal by Subject|0|||
23468176|NCT04816669|65457224|FG003|Part 2|Withdrawal by Subject|1|||
23468177|NCT04816669|65457221|FG000|Part 2|Lost to Follow-up|0|||
23468178|NCT04816669|65457222|FG001|Part 2|Lost to Follow-up|0|||
23468179|NCT04816669|65457223|FG002|Part 2|Lost to Follow-up|1|||
23468180|NCT04816669|65457224|FG003|Part 2|Lost to Follow-up|0|||
23793651|NCT02888743|66620589|FG000|Overall Study|Disease progression before treatment|2|||
23468181|NCT02318706|65457226|FG000|Double-blind Phase|Adverse Event|7|||
23468182|NCT02318706|65457227|FG001|Double-blind Phase|Adverse Event|4|||
23468183|NCT02318706|65457228|FG002|Double-blind Phase|Adverse Event|3|||
23468184|NCT02318706|65457229|FG003|Double-blind Phase|Adverse Event|10|||
23468185|NCT02318706|65457230|FG004|Double-blind Phase|Adverse Event|0|||
23468186|NCT02318706|65457226|FG000|Double-blind Phase|Lost to Follow-up|1|||
23793652|NCT02888743|66620590|FG001|Overall Study|Disease progression before treatment|0|||
23468187|NCT02318706|65457227|FG001|Double-blind Phase|Lost to Follow-up|0|||
23793653|NCT02888743|66620591|FG002|Overall Study|Disease progression before treatment|2|||
23793654|NCT02888743|66620592|FG003|Overall Study|Disease progression before treatment|0|||
23793655|NCT02888743|66620593|FG004|Overall Study|Disease progression before treatment|0|||
23793656|NCT02888743|66620589|FG000|Overall Study|Patient ineligible|1|||
23793657|NCT02888743|66620590|FG001|Overall Study|Patient ineligible|2|||
23793658|NCT02888743|66620591|FG002|Overall Study|Patient ineligible|0|||
23793659|NCT02888743|66620592|FG003|Overall Study|Patient ineligible|0|||
23793660|NCT02888743|66620593|FG004|Overall Study|Patient ineligible|0|||
23793661|NCT04573309|66620594|FG000|Overall Study|Protocol Violation|1|||
23793662|NCT04573309|66620595|FG001|Overall Study|Protocol Violation|0|||
23793663|NCT02906917|66620596|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
23793664|NCT02906917|66620597|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
23793665|NCT02906917|66620596|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
23793666|NCT02906917|66620597|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
23793667|NCT02906917|66620596|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
23793668|NCT02906917|66620597|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
23793669|NCT02906917|66620596|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
23793670|NCT02906917|66620597|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
23793671|NCT02906917|66620596|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
23793672|NCT02906917|66620597|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
23793673|NCT02906917|66620596|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
23793674|NCT02906917|66620597|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
23793675|NCT02906917|66620596|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
23793676|NCT02906917|66620597|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
23793677|NCT02906917|66620596|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
23793678|NCT02906917|66620597|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
23793679|NCT00569777|66620600|FG000|Overall Study|Withdrawal by Subject|4|||
23793680|NCT00569777|66620601|FG001|Overall Study|Withdrawal by Subject|0|||
23793681|NCT00569777|66620600|FG000|Overall Study|Adverse Event|3|||
23793682|NCT00569777|66620601|FG001|Overall Study|Adverse Event|0|||
23468188|NCT02318706|65457228|FG002|Double-blind Phase|Lost to Follow-up|0|||
23468189|NCT02318706|65457229|FG003|Double-blind Phase|Lost to Follow-up|0|||
23468190|NCT02318706|65457230|FG004|Double-blind Phase|Lost to Follow-up|0|||
23793683|NCT00569777|66620600|FG000|Overall Study|Lost to Follow-up|1|||
23793684|NCT00569777|66620601|FG001|Overall Study|Lost to Follow-up|0|||
23793685|NCT00569777|66620600|FG000|Overall Study|scheduled eye surgery|0|||
23793686|NCT00569777|66620601|FG001|Overall Study|scheduled eye surgery|1|||
23793687|NCT00569777|66620600|FG000|Overall Study|did not meet exclusion criteria|1|||
23793688|NCT00569777|66620601|FG001|Overall Study|did not meet exclusion criteria|2|||
23793689|NCT00569777|66620600|FG000|Overall Study|pregnant|1|||
23793690|NCT00569777|66620601|FG001|Overall Study|pregnant|0|||
23793691|NCT02058160|66620603|FG000|Overall Study|Randomized but not treated|2|||
23793692|NCT02058160|66620604|FG001|Overall Study|Randomized but not treated|4|||
23793693|NCT02058160|66620603|FG000|Overall Study|Poor compliance to protocol|4|||
23793694|NCT02058160|66620604|FG001|Overall Study|Poor compliance to protocol|1|||
23468191|NCT02318706|65457226|FG000|Double-blind Phase|Protocol Violation|4|||
23793695|NCT02058160|66620603|FG000|Overall Study|Adverse Event|12|||
23793696|NCT02058160|66620604|FG001|Overall Study|Adverse Event|3|||
23793697|NCT02058160|66620603|FG000|Overall Study|Lost to Follow-up|1|||
23793698|NCT02058160|66620604|FG001|Overall Study|Lost to Follow-up|0|||
23793699|NCT02058160|66620603|FG000|Overall Study|Other than specified above|12|||
23793700|NCT02058160|66620604|FG001|Overall Study|Other than specified above|6|||
23793701|NCT00757705|66620605|FG000|Overall Study|Adverse Event|19|||
23793702|NCT00757705|66620605|FG000|Overall Study|Lost to Follow-up|16|||
23793703|NCT00757705|66620605|FG000|Overall Study|Withdrawal by Subject|25|||
23793704|NCT00757705|66620605|FG000|Overall Study|Insufficient Response|26|||
23468192|NCT02318706|65457227|FG001|Double-blind Phase|Protocol Violation|2|||
23468193|NCT02318706|65457228|FG002|Double-blind Phase|Protocol Violation|4|||
23468194|NCT02318706|65457229|FG003|Double-blind Phase|Protocol Violation|3|||
23468195|NCT02318706|65457230|FG004|Double-blind Phase|Protocol Violation|0|||
23468196|NCT02318706|65457226|FG000|Double-blind Phase|Withdrawal by Subject|9|||
23468197|NCT02318706|65457227|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23468198|NCT02318706|65457228|FG002|Double-blind Phase|Withdrawal by Subject|7|||
23468199|NCT02318706|65457229|FG003|Double-blind Phase|Withdrawal by Subject|10|||
23468200|NCT02318706|65457230|FG004|Double-blind Phase|Withdrawal by Subject|0|||
23468201|NCT02318706|65457226|FG000|Double-blind Phase|Other|4|||
23468202|NCT02318706|65457227|FG001|Double-blind Phase|Other|1|||
23468203|NCT02318706|65457228|FG002|Double-blind Phase|Other|2|||
23468204|NCT02318706|65457229|FG003|Double-blind Phase|Other|1|||
23468205|NCT02318706|65457230|FG004|Double-blind Phase|Other|0|||
23468206|NCT02318706|65457226|FG000|Double-blind Phase|Death|0|||
23468207|NCT02318706|65457227|FG001|Double-blind Phase|Death|0|||
23468208|NCT02318706|65457228|FG002|Double-blind Phase|Death|2|||
23468209|NCT02318706|65457229|FG003|Double-blind Phase|Death|0|||
23468210|NCT02318706|65457230|FG004|Double-blind Phase|Death|0|||
23468211|NCT02318706|65457226|FG000|Open-label Extension Phase|Adverse Event|0|||
23468212|NCT02318706|65457227|FG001|Open-label Extension Phase|Adverse Event|0|||
23468213|NCT02318706|65457228|FG002|Open-label Extension Phase|Adverse Event|0|||
23468214|NCT02318706|65457229|FG003|Open-label Extension Phase|Adverse Event|0|||
23468215|NCT02318706|65457230|FG004|Open-label Extension Phase|Adverse Event|21|||
23468216|NCT02318706|65457226|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
23468217|NCT02318706|65457227|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23468218|NCT02318706|65457228|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
23468219|NCT02318706|65457229|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
23468220|NCT02318706|65457230|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
23468221|NCT02318706|65457226|FG000|Open-label Extension Phase|Death|0|||
23468222|NCT02318706|65457227|FG001|Open-label Extension Phase|Death|0|||
23468223|NCT02318706|65457228|FG002|Open-label Extension Phase|Death|0|||
23468224|NCT02318706|65457229|FG003|Open-label Extension Phase|Death|0|||
23468225|NCT02318706|65457230|FG004|Open-label Extension Phase|Death|1|||
23468226|NCT02318706|65457226|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
23468227|NCT02318706|65457227|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23468228|NCT02318706|65457228|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
23468229|NCT02318706|65457229|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
23468230|NCT02318706|65457230|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
23468231|NCT01528969|65457231|FG000|Overall Study|absent from the school at baseline|2|||
23468232|NCT01528969|65457232|FG001|Overall Study|absent from the school at baseline|0|||
23468233|NCT01523366|65457237|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23468234|NCT01523366|65457238|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23468235|NCT01523366|65457237|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
23468236|NCT01523366|65457238|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
23468237|NCT00470275|65457239|FG000|Overall Study|Death|1|||
23468238|NCT00470275|65457239|FG000|Overall Study|Lack of Efficacy|7|||
23468239|NCT00470275|65457239|FG000|Overall Study|Withdrawal by Subject|2|||
23468240|NCT00602472|65457240|FG000|Overall Study|Adverse Event|5|||
23793705|NCT00757705|66620605|FG000|Overall Study|Ineligible to continue|8|||
23793706|NCT00757705|66620605|FG000|Overall Study|Non-compliant|9|||
23793707|NCT00757705|66620605|FG000|Overall Study|Other|18|||
23793708|NCT01653704|66620606|FG000|Overall Study|Technical failure during recording|1|||
23793709|NCT01653704|66620607|FG001|Overall Study|Technical failure during recording|1|||
23793710|NCT01653704|66620606|FG000|Overall Study|Performance not reflective of training|1|||
23793711|NCT01653704|66620607|FG001|Overall Study|Performance not reflective of training|0|||
23793712|NCT01206439|66620608|FG000|Overall Study|subject did not meet inclusion criteria|1|||
23468241|NCT00602472|65457241|FG001|Overall Study|Adverse Event|23|||
23468242|NCT00602472|65457240|FG000|Overall Study|Protocol Violation|4|||
23468243|NCT00602472|65457241|FG001|Overall Study|Protocol Violation|19|||
23468244|NCT00602472|65457240|FG000|Overall Study|Withdrawal by Subject|8|||
23640649|NCT00266227|66071409|FG001|Initial Treatment|Lost to Follow-up|0|||
23793713|NCT00640341|66620610|FG000|Overall Study|Adverse Event|0|||
23640650|NCT00266227|66071410|FG002|Initial Treatment|Lost to Follow-up|6|||
23468245|NCT00602472|65457241|FG001|Overall Study|Withdrawal by Subject|14|||
23468246|NCT00602472|65457240|FG000|Overall Study|Other incl. lack of efficacy|4|||
23468247|NCT00602472|65457241|FG001|Overall Study|Other incl. lack of efficacy|2|||
23468248|NCT00220636|65457242|FG000|Overall Study|Withdrawal by Subject|4|||
23468249|NCT03252925|65457243|FG000|Overall Study|Withdrawal by Subject|1|||
23468250|NCT03252925|65457244|FG001|Overall Study|Withdrawal by Subject|0|||
23793714|NCT00640341|66620611|FG001|Overall Study|Adverse Event|0|||
23468251|NCT03252925|65457243|FG000|Overall Study|Protocol Violation|6|||
23468252|NCT03252925|65457244|FG001|Overall Study|Protocol Violation|0|||
23468253|NCT03252925|65457243|FG000|Overall Study|Adverse Event|1|||
23468254|NCT03252925|65457244|FG001|Overall Study|Adverse Event|0|||
23468255|NCT03252925|65457243|FG000|Overall Study|Lost to Follow-up|6|||
23468256|NCT03252925|65457244|FG001|Overall Study|Lost to Follow-up|6|||
23468257|NCT03584789|65457246|FG000|Overall Study|refused EHR permission|19|||
23468258|NCT03584789|65457247|FG001|Overall Study|refused EHR permission|28|||
23468259|NCT03584789|65457248|FG002|Overall Study|refused EHR permission|23|||
23793715|NCT00640341|66620612|FG002|Overall Study|Adverse Event|1|||
23793716|NCT00640341|66620610|FG000|Overall Study|Positive Slit Lamp Findings|0|||
23793717|NCT00640341|66620611|FG001|Overall Study|Positive Slit Lamp Findings|0|||
23793718|NCT00640341|66620612|FG002|Overall Study|Positive Slit Lamp Findings|1|||
23793719|NCT00640341|66620610|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
23793720|NCT00640341|66620611|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
23793721|NCT00640341|66620612|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
23793722|NCT00640341|66620610|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
23793723|NCT00640341|66620611|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
23793724|NCT00640341|66620612|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
23793725|NCT00640341|66620610|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
23793726|NCT00640341|66620611|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
23793727|NCT00640341|66620612|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
23793728|NCT00640341|66620610|FG000|Overall Study|Lost to Follow-up|2|||
23793729|NCT00640341|66620611|FG001|Overall Study|Lost to Follow-up|0|||
23793730|NCT00640341|66620612|FG002|Overall Study|Lost to Follow-up|0|||
23793731|NCT00640341|66620610|FG000|Overall Study|Withdrawal by Subject|4|||
23793732|NCT00640341|66620611|FG001|Overall Study|Withdrawal by Subject|0|||
23793733|NCT00640341|66620612|FG002|Overall Study|Withdrawal by Subject|1|||
23793734|NCT00640341|66620610|FG000|Overall Study|Unacceptable Lens Movement|1|||
23793735|NCT00640341|66620611|FG001|Overall Study|Unacceptable Lens Movement|0|||
23793736|NCT00640341|66620612|FG002|Overall Study|Unacceptable Lens Movement|0|||
23793737|NCT00640341|66620610|FG000|Overall Study|Poor fit/Uncomfortable|4|||
23793738|NCT00640341|66620611|FG001|Overall Study|Poor fit/Uncomfortable|0|||
23793739|NCT00640341|66620612|FG002|Overall Study|Poor fit/Uncomfortable|0|||
23793740|NCT00640341|66620610|FG000|Overall Study|Ineligable at Baseline|5|||
23793741|NCT00640341|66620611|FG001|Overall Study|Ineligable at Baseline|3|||
23793742|NCT00640341|66620612|FG002|Overall Study|Ineligable at Baseline|2|||
23793743|NCT00640341|66620610|FG000|Overall Study|Adverse event and positive slit lamp|1|||
23793744|NCT00640341|66620611|FG001|Overall Study|Adverse event and positive slit lamp|0|||
23793745|NCT00640341|66620612|FG002|Overall Study|Adverse event and positive slit lamp|0|||
23793746|NCT00796328|66620613|FG000|Overall Study|experienced hypotension requiring tx|6|||
23793747|NCT03387462|66620614|FG000|Overall Study|Lost to Follow-up|1|||
23793748|NCT00494013|66620615|FG000|Overall Study|Adverse Event|0|||
23793749|NCT00494013|66620616|FG001|Overall Study|Adverse Event|1|||
23793750|NCT00494013|66620615|FG000|Overall Study|Entry Criteria Not Met|1|||
23793751|NCT00494013|66620616|FG001|Overall Study|Entry Criteria Not Met|4|||
23468260|NCT03584789|65457246|FG000|Overall Study|patients tied to a provider who retired|0|||
23468261|NCT03584789|65457247|FG001|Overall Study|patients tied to a provider who retired|0|||
23587062|NCT00612586|65876237|FG000|Overall Study|Sponsor Decision|1|||
23352265|NCT03309696|65032935|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
23352266|NCT03309696|65032936|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
23352267|NCT02432144|65032937|FG000|Overall Study|Participant Non-Compliance|1|||
23352268|NCT03885999|65032938|FG000|Overall Study|Adverse Event|1|||
23352269|NCT03391232|65032939|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
23352270|NCT03391232|65032940|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
23352271|NCT03391232|65032939|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
23352272|NCT03391232|65032940|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
23352273|NCT01926197|65032943|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
23352274|NCT01926197|65032944|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
23352275|NCT01926197|65032943|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
23352276|NCT01926197|65032944|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
23352277|NCT00938587|65032945|FG000|Overall Study|Adverse Event|2|||
23352278|NCT00938587|65032946|FG001|Overall Study|Adverse Event|0|||
23352279|NCT00938587|65032947|FG002|Overall Study|Adverse Event|0|||
23352280|NCT00938587|65032948|FG003|Overall Study|Adverse Event|2|||
23352281|NCT00938587|65032945|FG000|Overall Study|Did not meet entrance criteria|0|||
23352282|NCT00938587|65032946|FG001|Overall Study|Did not meet entrance criteria|0|||
23352283|NCT00938587|65032947|FG002|Overall Study|Did not meet entrance criteria|1|||
23352284|NCT00938587|65032948|FG003|Overall Study|Did not meet entrance criteria|0|||
23352285|NCT00938587|65032945|FG000|Overall Study|Withdrawal by Subject|1|||
23352286|NCT00938587|65032946|FG001|Overall Study|Withdrawal by Subject|1|||
23352287|NCT00938587|65032947|FG002|Overall Study|Withdrawal by Subject|0|||
23352288|NCT00938587|65032948|FG003|Overall Study|Withdrawal by Subject|0|||
23352289|NCT00089635|65032953|FG000|Overall Study|Adverse Event|2|||
23352290|NCT00089635|65032953|FG000|Overall Study|Death|17|||
23352291|NCT00089635|65032953|FG000|Overall Study|Disease Progression|12|||
23352292|NCT00089635|65032953|FG000|Overall Study|Lost to Follow-up|3|||
23352293|NCT00089635|65032953|FG000|Overall Study|Withdrawal by Subject|6|||
23352294|NCT00089635|65032953|FG000|Overall Study|Ineligibility determined|1|||
23352295|NCT00089635|65032953|FG000|Overall Study|Other|2|||
23352296|NCT02971800|65032954|FG000|Overall Study|Protocol Violation|1|||
23352297|NCT02971800|65032954|FG000|Overall Study|Withdrawal by Subject|1|||
23352298|NCT02971800|65032954|FG000|Overall Study|Exclusion criteria prior intervention|1|||
23352299|NCT02971800|65032954|FG000|Overall Study|Number evaluable participant already reached|4|||
23352300|NCT01092637|65032955|FG000|Overall Study|Death|47|||
23352301|NCT01092637|65032956|FG001|Overall Study|Death|49|||
23352302|NCT01672294|65032957|FG000|Overall Study|Withdrawal by Subject|4|||
23352303|NCT01672294|65032958|FG001|Overall Study|Withdrawal by Subject|4|||
23352304|NCT01672294|65032959|FG002|Overall Study|Withdrawal by Subject|4|||
23468262|NCT03584789|65457248|FG002|Overall Study|patients tied to a provider who retired|3|||
23587063|NCT00612586|65876238|FG001|Overall Study|Sponsor Decision|1|||
23587064|NCT00612586|65876237|FG000|Overall Study|Progressive Disease|26|||
23587065|NCT00612586|65876238|FG001|Overall Study|Progressive Disease|24|||
23587066|NCT00612586|65876237|FG000|Overall Study|Randomized and Not Treated|1|||
23587067|NCT00612586|65876238|FG001|Overall Study|Randomized and Not Treated|1|||
23587068|NCT03603717|65876239|FG000|Overall Study|Lost to Follow-up|20|||
23587069|NCT03603717|65876240|FG001|Overall Study|Lost to Follow-up|20|||
23587070|NCT03603717|65876239|FG000|Overall Study|Withdrawal by Subject|16|||
23468263|NCT01383356|65457252|FG000|Period 1|Adverse Event|5|||
23587071|NCT03603717|65876240|FG001|Overall Study|Withdrawal by Subject|10|||
23587072|NCT02357784|65876241|FG000|Overall Study|Withdrawal by Subject|1|||
23587073|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Death|1|||
23587074|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Death|1|||
23352305|NCT01672294|65032960|FG003|Overall Study|Withdrawal by Subject|4|||
23352306|NCT01672294|65032957|FG000|Overall Study|Excluded by study|1|||
23352307|NCT01672294|65032958|FG001|Overall Study|Excluded by study|1|||
23352308|NCT01672294|65032959|FG002|Overall Study|Excluded by study|0|||
23352309|NCT01672294|65032960|FG003|Overall Study|Excluded by study|0|||
23352310|NCT01672294|65032957|FG000|Overall Study|Lost to Follow-up|1|||
23352311|NCT01672294|65032958|FG001|Overall Study|Lost to Follow-up|16|||
23352312|NCT01672294|65032959|FG002|Overall Study|Lost to Follow-up|7|||
23587075|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Death|0|||
23587076|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Death|0|||
23587077|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Death|0|||
23587078|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
23587079|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
23587080|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
23587081|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
23587082|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
23587083|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Physician Decision|0|||
23587084|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Physician Decision|0|||
23587085|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Physician Decision|0|||
23587086|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Physician Decision|0|||
23587087|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Physician Decision|1|||
23587088|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
23587089|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
23587090|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
23587091|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
23793752|NCT00494013|66620615|FG000|Overall Study|Lost to Follow-up|5|||
23793753|NCT00494013|66620616|FG001|Overall Study|Lost to Follow-up|6|||
23793754|NCT00494013|66620615|FG000|Overall Study|Physician Decision|3|||
23352313|NCT01672294|65032960|FG003|Overall Study|Lost to Follow-up|9|||
23352314|NCT03383692|65032961|FG000|Overall Study|Progressive disease as per RECIST|3|||
23587092|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
23793755|NCT00494013|66620616|FG001|Overall Study|Physician Decision|5|||
23793756|NCT00494013|66620615|FG000|Overall Study|Protocol Violation|8|||
23793757|NCT00494013|66620616|FG001|Overall Study|Protocol Violation|5|||
23793758|NCT00494013|66620615|FG000|Overall Study|Withdrawal by Subject|13|||
23793759|NCT00494013|66620616|FG001|Overall Study|Withdrawal by Subject|14|||
23793760|NCT00494013|66620615|FG000|Overall Study|Sponsor Decision|0|||
23793761|NCT00494013|66620616|FG001|Overall Study|Sponsor Decision|1|||
23793762|NCT01868243|66620617|FG000|Overall Study|Death|0|||
23793763|NCT01868243|66620618|FG001|Overall Study|Death|1|||
23793764|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
23793765|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
23793766|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
23793767|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
23793768|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
23793769|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
23793770|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
23793771|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
23793772|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
23793773|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
23793774|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
23793775|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
23793776|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
23793777|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
23793778|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
23793779|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
23793780|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
23793781|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
23793782|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
23587093|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23352315|NCT03383692|65032962|FG001|Overall Study|Progressive disease as per RECIST|3|||
23468264|NCT01383356|65457253|FG001|Period 1|Adverse Event|3|||
23468265|NCT01383356|65457252|FG000|Period 1|Non-compliance|3|||
23468266|NCT01383356|65457253|FG001|Period 1|Non-compliance|0|||
23468267|NCT01383356|65457252|FG000|Period 1|Out of Range Mid-study-Test|0|||
23468268|NCT01383356|65457253|FG001|Period 1|Out of Range Mid-study-Test|1|||
23468269|NCT01383356|65457252|FG000|Period 1|Personal|0|||
23468270|NCT01383356|65457253|FG001|Period 1|Personal|2|||
23468271|NCT03436082|65457256|FG000|Overall Study|Did not undergo procedure|1|||
23468272|NCT03436082|65457257|FG001|Overall Study|Did not undergo procedure|0|||
23468273|NCT00214201|65457262|FG000|Overall Study|Withdrawal by Subject|2|||
23468274|NCT00214201|65457263|FG001|Overall Study|Withdrawal by Subject|0|||
23468275|NCT00214201|65457262|FG000|Overall Study|Death|0|||
23468276|NCT00214201|65457263|FG001|Overall Study|Death|2|||
23468277|NCT02533453|65457264|FG000|Overall Study|Adverse Event|6|||
23468278|NCT02533453|65457264|FG000|Overall Study|Protocol Violation|1|||
23468279|NCT02533453|65457264|FG000|Overall Study|Withdrawal by Subject|2|||
23468280|NCT00594815|65457265|FG000|Overall Study|Never Treated|3|||
23468281|NCT00594815|65457265|FG000|Overall Study|Withdrawal by Subject|2|||
23468282|NCT00594815|65457265|FG000|Overall Study|Toxicity|4|||
23468283|NCT02819804|65457266|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
23468284|NCT03848832|65457267|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
23468285|NCT03848832|65457268|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
23468286|NCT03848832|65457269|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
23468287|NCT03848832|65457267|FG000|Overall Study|Withdrawal by Subject|0|||
23468288|NCT03848832|65457268|FG001|Overall Study|Withdrawal by Subject|0|||
23468289|NCT03848832|65457269|FG002|Overall Study|Withdrawal by Subject|1|||
23468290|NCT03848832|65457267|FG000|Overall Study|Withdrawal (Covid-19)|0|||
23468291|NCT03848832|65457268|FG001|Overall Study|Withdrawal (Covid-19)|2|||
23468292|NCT03848832|65457269|FG002|Overall Study|Withdrawal (Covid-19)|0|||
23468293|NCT03848832|65457267|FG000|Overall Study|Physician Decision|2|||
23468294|NCT03848832|65457268|FG001|Overall Study|Physician Decision|1|||
23468295|NCT03848832|65457269|FG002|Overall Study|Physician Decision|3|||
23468296|NCT03848832|65457267|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
23468297|NCT03848832|65457268|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
23468298|NCT03848832|65457269|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
23468299|NCT03848832|65457267|FG000|Overall Study|Adverse Event|1|||
23468300|NCT03848832|65457268|FG001|Overall Study|Adverse Event|0|||
23468301|NCT03848832|65457269|FG002|Overall Study|Adverse Event|0|||
23468302|NCT00423917|65457274|FG000|Overall Study|Cancel|2|||
23468303|NCT00423917|65457274|FG000|Overall Study|Ineligible|1|||
23468304|NCT02461758|65457275|FG000|Overall Study|Lost to Follow-up|0|||
23468305|NCT02461758|65457276|FG001|Overall Study|Lost to Follow-up|1|||
23468306|NCT02461758|65457277|FG002|Overall Study|Lost to Follow-up|1|||
23468307|NCT02461758|65457278|FG003|Overall Study|Lost to Follow-up|0|||
23468308|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
23468309|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
23468310|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
23468311|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
23706744|NCT00968253|66301322|FG001|Overall Study|Adverse Event|0|||
23468312|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
23468313|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
23468314|NCT00118417|65457280|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
23468315|NCT00118417|65457281|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
23468316|NCT00118417|65457280|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
23468317|NCT00118417|65457281|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
23468318|NCT02175030|65457282|FG000|Overall Study|Failed screen after consent|7|||
23468319|NCT02175030|65457283|FG001|Overall Study|Failed screen after consent|6|||
23468320|NCT02175030|65457282|FG000|Overall Study|Failed IUD Insertion|20|||
23468321|NCT02175030|65457283|FG001|Overall Study|Failed IUD Insertion|21|||
23468322|NCT02175030|65457282|FG000|Overall Study|Physician Decision|1|||
23468323|NCT02175030|65457283|FG001|Overall Study|Physician Decision|1|||
23468324|NCT02175030|65457282|FG000|Overall Study|Lost to Follow-up|6|||
23352316|NCT03383692|65032961|FG000|Overall Study|Clinical progression|0|||
23352317|NCT03383692|65032962|FG001|Overall Study|Clinical progression|1|||
23352318|NCT03383692|65032961|FG000|Overall Study|Adverse Event|3|||
23352319|NCT03383692|65032962|FG001|Overall Study|Adverse Event|0|||
23468325|NCT02175030|65457283|FG001|Overall Study|Lost to Follow-up|6|||
23468326|NCT02175030|65457282|FG000|Overall Study|Withdrawal by Subject|1|||
23468327|NCT02175030|65457283|FG001|Overall Study|Withdrawal by Subject|4|||
23468328|NCT00996333|65457284|FG000|Overall Study|Screen failure|1|||
23468329|NCT00996333|65457284|FG000|Overall Study|Withdrawal by Subject|1|||
23468330|NCT00996333|65457284|FG000|Overall Study|Death|4|||
23468331|NCT00996333|65457284|FG000|Overall Study|Adverse Event|1|||
23468332|NCT00996333|65457284|FG000|Overall Study|Physician Decision|1|||
23468333|NCT00996333|65457284|FG000|Overall Study|Other|5|||
23468334|NCT04413617|65457285|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468335|NCT04413617|65457286|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468336|NCT04413617|65457287|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468337|NCT04413617|65457288|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
23468338|NCT04413617|65457289|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468339|NCT04413617|65457285|FG000|Overall Study|Protocol Violation|0|||
23793783|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
23793784|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
23352320|NCT02223364|65032963|FG000|Overall Study|Protocol Violation|3|||
23352321|NCT02223364|65032964|FG001|Overall Study|Protocol Violation|0|||
23352322|NCT02223364|65032965|FG002|Overall Study|Protocol Violation|3|||
23352323|NCT02223364|65032963|FG000|Overall Study|subject expired before surgery|1|||
23352324|NCT02223364|65032964|FG001|Overall Study|subject expired before surgery|0|||
23352325|NCT02223364|65032965|FG002|Overall Study|subject expired before surgery|0|||
23352326|NCT02223364|65032963|FG000|Overall Study|Physician Decision|1|||
23352327|NCT02223364|65032964|FG001|Overall Study|Physician Decision|0|||
23352328|NCT02223364|65032965|FG002|Overall Study|Physician Decision|0|||
23352329|NCT00577005|65032968|FG000|Overall Study|Lost to Follow-up|3|||
23352330|NCT00577005|65032969|FG001|Overall Study|Lost to Follow-up|2|||
23352331|NCT00577005|65032968|FG000|Overall Study|Withdrawal by Subject|2|||
23352332|NCT00577005|65032969|FG001|Overall Study|Withdrawal by Subject|1|||
23468340|NCT04413617|65457286|FG001|Overall Study|Protocol Violation|1|||
23468341|NCT04413617|65457287|FG002|Overall Study|Protocol Violation|0|||
23468342|NCT04413617|65457288|FG003|Overall Study|Protocol Violation|0|||
23468343|NCT04413617|65457289|FG004|Overall Study|Protocol Violation|1|||
23793785|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
23793786|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
23793787|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
23793788|NCT01710358|66620619|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
23793789|NCT01710358|66620620|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
23793790|NCT01710358|66620621|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
23793791|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
23793792|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
23793793|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
23793794|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
23793795|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
23793796|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
23793797|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
23793798|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
23793799|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
23352333|NCT00441363|65032971|FG000|Overall Study|Adverse Event|4|||
23352334|NCT00441363|65032972|FG001|Overall Study|Adverse Event|2|||
23352335|NCT00441363|65032971|FG000|Overall Study|Withdrawal by Subject|3|||
23352336|NCT00441363|65032972|FG001|Overall Study|Withdrawal by Subject|4|||
23352337|NCT00441363|65032971|FG000|Overall Study|Physician Decision|6|||
23352338|NCT00441363|65032972|FG001|Overall Study|Physician Decision|7|||
23352339|NCT00441363|65032971|FG000|Overall Study|Lost to Follow-up|2|||
23352340|NCT00441363|65032972|FG001|Overall Study|Lost to Follow-up|2|||
23352341|NCT00441363|65032971|FG000|Overall Study|Other|2|||
23352342|NCT00441363|65032972|FG001|Overall Study|Other|0|||
23352343|NCT02651688|65032973|FG000|Overall Study|Non-compliance|0|||
23352344|NCT02651688|65032974|FG001|Overall Study|Non-compliance|0|||
23352345|NCT02651688|65032975|FG002|Overall Study|Non-compliance|1|||
23352346|NCT02651688|65032973|FG000|Overall Study|Principal Investigator (PI) decision|0|||
23352347|NCT02651688|65032974|FG001|Overall Study|Principal Investigator (PI) decision|2|||
23468344|NCT04413617|65457285|FG000|Overall Study|Lack of Efficacy|2|||
23468345|NCT04413617|65457286|FG001|Overall Study|Lack of Efficacy|0|||
23352348|NCT02651688|65032975|FG002|Overall Study|Principal Investigator (PI) decision|0|||
23352349|NCT02651688|65032973|FG000|Overall Study|Lost to Follow-up|1|||
23468346|NCT04413617|65457287|FG002|Overall Study|Lack of Efficacy|2|||
23352350|NCT02651688|65032974|FG001|Overall Study|Lost to Follow-up|3|||
23352351|NCT02651688|65032975|FG002|Overall Study|Lost to Follow-up|0|||
23352352|NCT02651688|65032973|FG000|Overall Study|Withdrawal by Subject|1|||
23352353|NCT02651688|65032974|FG001|Overall Study|Withdrawal by Subject|0|||
23352354|NCT02651688|65032975|FG002|Overall Study|Withdrawal by Subject|2|||
23352355|NCT02554318|65032976|FG000|Overall Study|Withdrawal by Subject|10|||
23352356|NCT02554318|65032977|FG001|Overall Study|Withdrawal by Subject|8|||
23352357|NCT03816007|65032978|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
23352358|NCT03816007|65032979|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
23352359|NCT03816007|65032978|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
23352360|NCT03816007|65032979|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
23352361|NCT03816007|65032978|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
23352362|NCT03816007|65032979|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
23352363|NCT00520767|65032980|FG000|Overall Study|Death|2|||
23793800|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
23793801|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
23793802|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
23793803|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
23793804|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
23793805|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
23793806|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
23793807|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
23793808|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
23793809|NCT01710358|66620619|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
23793810|NCT01710358|66620620|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
23793811|NCT01710358|66620621|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
23793812|NCT01710358|66620619|FG000|Rescue Period|Adverse Event|0|||
23793813|NCT01710358|66620620|FG001|Rescue Period|Adverse Event|15|||
23793814|NCT01710358|66620621|FG002|Rescue Period|Adverse Event|0|||
23793815|NCT01710358|66620619|FG000|Rescue Period|Death|0|||
23793816|NCT01710358|66620620|FG001|Rescue Period|Death|1|||
23793817|NCT01710358|66620621|FG002|Rescue Period|Death|0|||
23793818|NCT01710358|66620619|FG000|Rescue Period|Lack of Efficacy|0|||
23793819|NCT01710358|66620620|FG001|Rescue Period|Lack of Efficacy|7|||
23793820|NCT01710358|66620621|FG002|Rescue Period|Lack of Efficacy|0|||
23793821|NCT01710358|66620619|FG000|Rescue Period|Withdrawal by Subject|0|||
23793822|NCT01710358|66620620|FG001|Rescue Period|Withdrawal by Subject|8|||
23793823|NCT01710358|66620621|FG002|Rescue Period|Withdrawal by Subject|0|||
23793824|NCT01496118|66623515|FG000|Overall Study|Disease progression|3|||
23793825|NCT01496118|66623516|FG001|Overall Study|Disease progression|2|||
23793826|NCT01496118|66623517|FG002|Overall Study|Disease progression|3|||
23793827|NCT01496118|66623518|FG003|Overall Study|Disease progression|1|||
23793828|NCT01496118|66623519|FG004|Overall Study|Disease progression|2|||
23793829|NCT01496118|66623520|FG005|Overall Study|Disease progression|2|||
23793830|NCT01496118|66623521|FG006|Overall Study|Disease progression|14|||
23793831|NCT01496118|66623522|FG007|Overall Study|Disease progression|10|||
23793832|NCT01496118|66623515|FG000|Overall Study|Physician Decision|0|||
23793833|NCT01496118|66623516|FG001|Overall Study|Physician Decision|0|||
23793834|NCT01496118|66623517|FG002|Overall Study|Physician Decision|0|||
23793835|NCT01496118|66623518|FG003|Overall Study|Physician Decision|0|||
23793836|NCT01496118|66623519|FG004|Overall Study|Physician Decision|1|||
23793837|NCT01496118|66623520|FG005|Overall Study|Physician Decision|0|||
23793838|NCT01496118|66623521|FG006|Overall Study|Physician Decision|3|||
23793839|NCT01496118|66623522|FG007|Overall Study|Physician Decision|6|||
23793840|NCT01496118|66623515|FG000|Overall Study|Adverse Event|1|||
23793841|NCT01496118|66623516|FG001|Overall Study|Adverse Event|1|||
23793842|NCT01496118|66623517|FG002|Overall Study|Adverse Event|0|||
23793843|NCT01496118|66623518|FG003|Overall Study|Adverse Event|0|||
23793844|NCT01496118|66623519|FG004|Overall Study|Adverse Event|0|||
23793845|NCT01496118|66623520|FG005|Overall Study|Adverse Event|0|||
23793846|NCT01496118|66623521|FG006|Overall Study|Adverse Event|6|||
23793847|NCT01496118|66623522|FG007|Overall Study|Adverse Event|10|||
23793848|NCT01496118|66623515|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23352364|NCT01259375|65032986|FG000|Overall Study|Adverse Event|1|||
23793849|NCT01496118|66623516|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23587094|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23587095|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
23352365|NCT03403621|65032987|FG000|Overall Study|Withdrawal by Subject|2|||
23352366|NCT03403621|65032988|FG001|Overall Study|Withdrawal by Subject|2|||
23352367|NCT00723697|65032989|FG000|Overall Study|Physician questionnaires not received|2|||
23352368|NCT00723697|65032989|FG000|Overall Study|Missing Informed Consent Form|10|||
23352369|NCT00723697|65032989|FG000|Overall Study|Other exclusion criteria applied|6|||
23352370|NCT03853291|65032991|FG000|Overall Study|Lost to Follow-up|1|||
23352371|NCT03853291|65032992|FG001|Overall Study|Lost to Follow-up|2|||
23352372|NCT03853291|65032993|FG002|Overall Study|Lost to Follow-up|0|||
23352373|NCT03853291|65032994|FG003|Overall Study|Lost to Follow-up|0|||
23352374|NCT03853291|65032995|FG004|Overall Study|Lost to Follow-up|0|||
23352375|NCT03853291|65032996|FG005|Overall Study|Lost to Follow-up|0|||
23352376|NCT03853291|65032991|FG000|Overall Study|Determined to be ineligible|1|||
23352377|NCT03853291|65032992|FG001|Overall Study|Determined to be ineligible|1|||
23352378|NCT03853291|65032993|FG002|Overall Study|Determined to be ineligible|0|||
23352379|NCT03853291|65032994|FG003|Overall Study|Determined to be ineligible|0|||
23352380|NCT03853291|65032995|FG004|Overall Study|Determined to be ineligible|0|||
23352381|NCT03853291|65032996|FG005|Overall Study|Determined to be ineligible|0|||
23352382|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
23352383|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
23352384|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
23352385|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
23352386|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
23352387|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
23352388|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
23352389|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
23352390|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
23352391|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
23352392|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|All other|33|||
23352393|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|All other|0|||
23352394|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
23352395|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
23352396|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
23352397|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
23352398|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
23352399|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
23352400|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
23352401|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
23352402|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
23352403|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
23352404|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
23352405|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
23468347|NCT04413617|65457288|FG003|Overall Study|Lack of Efficacy|1|||
23468348|NCT04413617|65457289|FG004|Overall Study|Lack of Efficacy|0|||
23793850|NCT01496118|66623517|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23793851|NCT01496118|66623518|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23793852|NCT01496118|66623519|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23793853|NCT01496118|66623520|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23793854|NCT01496118|66623521|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
23793855|NCT01496118|66623522|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23793856|NCT01496118|66623515|FG000|Overall Study|Death|0|||
23793857|NCT01496118|66623516|FG001|Overall Study|Death|0|||
23793858|NCT01496118|66623517|FG002|Overall Study|Death|0|||
23793859|NCT01496118|66623518|FG003|Overall Study|Death|0|||
23352406|NCT00006305|65033007|FG000|Overall Study|Withdrawal by Subject|17|||
23352407|NCT00006305|65033008|FG001|Overall Study|Withdrawal by Subject|10|||
23352408|NCT00006305|65033009|FG002|Overall Study|Withdrawal by Subject|15|||
23468349|NCT04413617|65457285|FG000|Overall Study|Withdrawal by Subject|3|||
23468350|NCT04413617|65457286|FG001|Overall Study|Withdrawal by Subject|4|||
23793860|NCT01496118|66623519|FG004|Overall Study|Death|0|||
23793861|NCT01496118|66623520|FG005|Overall Study|Death|0|||
23793862|NCT01496118|66623521|FG006|Overall Study|Death|1|||
23793863|NCT01496118|66623522|FG007|Overall Study|Death|1|||
23640651|NCT00266227|66071408|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
23640652|NCT00266227|66071409|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
23640653|NCT00266227|66071410|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
23640654|NCT00266227|66071408|FG000|Initial Treatment|Physician decision to withdraw|0|||
23640655|NCT00266227|66071409|FG001|Initial Treatment|Physician decision to withdraw|0|||
23640656|NCT00266227|66071410|FG002|Initial Treatment|Physician decision to withdraw|12|||
23640657|NCT00266227|66071408|FG000|Initial Treatment|Pregnancy|0|||
23640658|NCT00266227|66071409|FG001|Initial Treatment|Pregnancy|0|||
23640659|NCT00266227|66071410|FG002|Initial Treatment|Pregnancy|1|||
23640660|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Death|1|||
23640661|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Death|0|||
23640662|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Death|0|||
23640663|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
23587096|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
23587097|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23587098|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
23587099|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
23587100|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
23587101|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
23587102|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
23587103|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Death|1|||
23587104|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Death|0|||
23587105|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Death|0|||
23587106|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Death|0|||
23587107|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Death|0|||
23587108|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
23587109|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
23587110|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
23587111|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
23587112|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
23587113|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Physician Decision|1|||
23587114|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Physician Decision|0|||
23587115|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Physician Decision|1|||
23587116|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Physician Decision|3|||
23587117|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Physician Decision|0|||
23587118|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
23587119|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
23587120|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
23352409|NCT00006305|65033010|FG003|Overall Study|Withdrawal by Subject|14|||
23352410|NCT00473824|65033011|FG000|Overall Study|Virologic Breakthrough|1|||
23352411|NCT00473824|65033012|FG001|Overall Study|Virologic Breakthrough|0|||
23352412|NCT00473824|65033011|FG000|Overall Study|Adverse Event|1|||
23352413|NCT00473824|65033012|FG001|Overall Study|Adverse Event|0|||
23352414|NCT00473824|65033011|FG000|Overall Study|Death|1|||
23352415|NCT00473824|65033012|FG001|Overall Study|Death|0|||
23352416|NCT00473824|65033011|FG000|Overall Study|Lost to Follow-up|1|||
23352417|NCT00473824|65033012|FG001|Overall Study|Lost to Follow-up|0|||
23352418|NCT00473824|65033011|FG000|Overall Study|Withdrawal by physician|1|||
23352419|NCT00473824|65033012|FG001|Overall Study|Withdrawal by physician|0|||
23352420|NCT00382109|65033016|FG000|Overall Study|Adverse Event|3|||
23352421|NCT00382109|65033017|FG001|Overall Study|Adverse Event|0|||
23352422|NCT00382109|65033016|FG000|Overall Study|Physician Decision|6|||
23352423|NCT00382109|65033017|FG001|Overall Study|Physician Decision|1|||
23352424|NCT00382109|65033016|FG000|Overall Study|Withdrawal by Subject|1|||
23352425|NCT00382109|65033017|FG001|Overall Study|Withdrawal by Subject|0|||
23352426|NCT00382109|65033016|FG000|Overall Study|ineligible|2|||
23352427|NCT00382109|65033017|FG001|Overall Study|ineligible|0|||
23352428|NCT00382109|65033016|FG000|Overall Study|Other|0|||
23352429|NCT00382109|65033017|FG001|Overall Study|Other|2|||
23352430|NCT00382109|65033016|FG000|Overall Study|consent withdrawal|0|||
23352431|NCT00382109|65033017|FG001|Overall Study|consent withdrawal|1|||
23352432|NCT05095311|65033018|FG000|Overall Study|Lost to Follow-up|7|||
23352433|NCT05095311|65033019|FG001|Overall Study|Lost to Follow-up|0|||
23352434|NCT05095311|65033020|FG002|Overall Study|Lost to Follow-up|0|||
23352435|NCT01903993|65033023|FG000|Overall Study|Death|118|||
23352436|NCT01903993|65033024|FG001|Overall Study|Death|121|||
23352437|NCT01903993|65033023|FG000|Overall Study|Withdrawal by Subject|15|||
23352438|NCT01903993|65033024|FG001|Overall Study|Withdrawal by Subject|4|||
23352439|NCT01903993|65033023|FG000|Overall Study|Lost to Follow-up|2|||
23352440|NCT01903993|65033024|FG001|Overall Study|Lost to Follow-up|3|||
23352441|NCT01903993|65033023|FG000|Overall Study|Study Terminated by Sponsor|8|||
23352442|NCT01903993|65033024|FG001|Overall Study|Study Terminated by Sponsor|14|||
23587121|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
23587122|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
23587123|NCT02049866|65876251|FG000|Overall Study|Withdrawal by Subject|1|||
23587124|NCT00961636|65876252|FG000|Overall Study|Adverse Event|35|||
23587125|NCT00961636|65876253|FG001|Overall Study|Adverse Event|54|||
23587126|NCT00961636|65876254|FG002|Overall Study|Adverse Event|13|||
23352443|NCT01903993|65033023|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
23352444|NCT01903993|65033024|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
23352445|NCT02907619|65033026|FG000|Overall Study|Study terminated by sponsor|18|||
23352446|NCT02907619|65033027|FG001|Overall Study|Study terminated by sponsor|18|||
23352447|NCT02907619|65033028|FG002|Overall Study|Study terminated by sponsor|19|||
23352448|NCT02907619|65033026|FG000|Overall Study|Death|0|||
23352449|NCT02907619|65033027|FG001|Overall Study|Death|0|||
23352450|NCT02907619|65033028|FG002|Overall Study|Death|1|||
23352451|NCT02907619|65033026|FG000|Overall Study|Withdrawal by Subject|1|||
23352452|NCT02907619|65033027|FG001|Overall Study|Withdrawal by Subject|1|||
23352453|NCT02907619|65033028|FG002|Overall Study|Withdrawal by Subject|0|||
23352454|NCT02907619|65033026|FG000|Overall Study|Other|0|||
23352455|NCT02907619|65033027|FG001|Overall Study|Other|1|||
23793864|NCT01496118|66623515|FG000|Overall Study|Withdrawal by Subject|0|||
23793865|NCT01496118|66623516|FG001|Overall Study|Withdrawal by Subject|0|||
23793866|NCT01496118|66623517|FG002|Overall Study|Withdrawal by Subject|0|||
23793867|NCT01496118|66623518|FG003|Overall Study|Withdrawal by Subject|2|||
23793868|NCT01496118|66623519|FG004|Overall Study|Withdrawal by Subject|0|||
23793869|NCT01496118|66623520|FG005|Overall Study|Withdrawal by Subject|1|||
23793870|NCT01496118|66623521|FG006|Overall Study|Withdrawal by Subject|6|||
23793871|NCT01496118|66623522|FG007|Overall Study|Withdrawal by Subject|3|||
23352456|NCT02907619|65033028|FG002|Overall Study|Other|0|||
23352457|NCT00269477|65033033|FG000|Overall Study|Protocol Violation|5|||
23468351|NCT04413617|65457287|FG002|Overall Study|Withdrawal by Subject|2|||
23468352|NCT04413617|65457288|FG003|Overall Study|Withdrawal by Subject|5|||
23468353|NCT04413617|65457289|FG004|Overall Study|Withdrawal by Subject|3|||
23793872|NCT01120899|66623528|FG000|Overall Study|Withdrawal by Subject|3|||
23793873|NCT04019054|66623529|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
23793874|NCT04019054|66623530|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
23793875|NCT04019054|66623529|FG000|Overall Study|Withdrawal by Subject|3|||
23793876|NCT04019054|66623530|FG001|Overall Study|Withdrawal by Subject|1|||
23793877|NCT00683592|66623534|FG000|Overall Study|Adverse Event|12|||
23793878|NCT00683592|66623535|FG001|Overall Study|Adverse Event|4|||
23793879|NCT00683592|66623534|FG000|Overall Study|Withdrawal by Subject|11|||
23793880|NCT00683592|66623535|FG001|Overall Study|Withdrawal by Subject|11|||
23793881|NCT00683592|66623534|FG000|Overall Study|Lost to Follow-up|17|||
23793882|NCT00683592|66623535|FG001|Overall Study|Lost to Follow-up|17|||
23793883|NCT00683592|66623534|FG000|Overall Study|Lack of Efficacy|3|||
23793884|NCT00683592|66623535|FG001|Overall Study|Lack of Efficacy|7|||
23793885|NCT00683592|66623534|FG000|Overall Study|Physician Decision|0|||
23793886|NCT00683592|66623535|FG001|Overall Study|Physician Decision|1|||
23793887|NCT00683592|66623534|FG000|Overall Study|Non-compliance|3|||
23793888|NCT00683592|66623535|FG001|Overall Study|Non-compliance|5|||
23793889|NCT00683592|66623534|FG000|Overall Study|Other|1|||
23793890|NCT00683592|66623535|FG001|Overall Study|Other|1|||
23793891|NCT01923311|66623538|FG000|Overall Study|Pregnancy|1|||
23793892|NCT01923311|66623539|FG001|Overall Study|Pregnancy|0|||
23793893|NCT01923311|66623538|FG000|Overall Study|Investigator's Discretion|1|||
23793894|NCT01923311|66623539|FG001|Overall Study|Investigator's Discretion|0|||
23793895|NCT01923311|66623538|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23793896|NCT01923311|66623539|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23793897|NCT01923311|66623538|FG000|Overall Study|Withdrew Consent|1|||
23793898|NCT01923311|66623539|FG001|Overall Study|Withdrew Consent|0|||
23793899|NCT01923311|66623538|FG000|Overall Study|Study Terminated by Sponsor|12|||
23793900|NCT01923311|66623539|FG001|Overall Study|Study Terminated by Sponsor|0|||
23793901|NCT01169038|66623540|FG000|Overall Study|Death|1|||
23793902|NCT01169038|66623540|FG000|Overall Study|Adverse Event|5|||
23793903|NCT01169038|66623540|FG000|Overall Study|Required antibiotic administration|1|||
23793904|NCT00377156|66623541|FG000|Overall Study|Death|23|||
23793905|NCT00377156|66623542|FG001|Overall Study|Death|19|||
23793906|NCT00377156|66623541|FG000|Overall Study|Withdrawal by Subject|16|||
23793907|NCT00377156|66623542|FG001|Overall Study|Withdrawal by Subject|24|||
23793908|NCT00377156|66623541|FG000|Overall Study|Had follow-up <90 d|3|||
23793909|NCT00377156|66623542|FG001|Overall Study|Had follow-up <90 d|6|||
23793910|NCT00377156|66623541|FG000|Overall Study|Cancellation|1|||
23793911|NCT00377156|66623542|FG001|Overall Study|Cancellation|0|||
23793912|NCT00377156|66623541|FG000|Overall Study|Refused testing|0|||
23793913|NCT00377156|66623542|FG001|Overall Study|Refused testing|1|||
23352458|NCT00269477|65033034|FG001|Overall Study|Protocol Violation|5|||
23352459|NCT00269477|65033035|FG002|Overall Study|Protocol Violation|1|||
23352460|NCT00269477|65033036|FG003|Overall Study|Protocol Violation|0|||
23352461|NCT00269477|65033033|FG000|Overall Study|Missed post-vaccination blood draw|0|||
23468354|NCT04413617|65457285|FG000|Overall Study|Death|1|||
23468355|NCT04413617|65457286|FG001|Overall Study|Death|0|||
23468356|NCT04413617|65457287|FG002|Overall Study|Death|0|||
23468357|NCT04413617|65457288|FG003|Overall Study|Death|0|||
23468358|NCT04413617|65457289|FG004|Overall Study|Death|0|||
23468359|NCT04413617|65457285|FG000|Overall Study|Adverse Event|1|||
23468360|NCT04413617|65457286|FG001|Overall Study|Adverse Event|0|||
23468361|NCT04413617|65457287|FG002|Overall Study|Adverse Event|0|||
23468362|NCT04413617|65457288|FG003|Overall Study|Adverse Event|1|||
23468363|NCT04413617|65457289|FG004|Overall Study|Adverse Event|1|||
23468364|NCT04413617|65457285|FG000|Overall Study|COVID-19|0|||
23587127|NCT00961636|65876252|FG000|Overall Study|Flushing Symptoms|29|||
23587128|NCT00961636|65876253|FG001|Overall Study|Flushing Symptoms|46|||
23587129|NCT00961636|65876254|FG002|Overall Study|Flushing Symptoms|3|||
23587130|NCT00961636|65876252|FG000|Overall Study|Lost to Follow-up|2|||
23587131|NCT00961636|65876253|FG001|Overall Study|Lost to Follow-up|3|||
23587132|NCT00961636|65876254|FG002|Overall Study|Lost to Follow-up|1|||
23587133|NCT00961636|65876252|FG000|Overall Study|Physician Decision|3|||
23587134|NCT00961636|65876253|FG001|Overall Study|Physician Decision|1|||
23587135|NCT00961636|65876254|FG002|Overall Study|Physician Decision|1|||
23587136|NCT00961636|65876252|FG000|Overall Study|Protocol Violation|9|||
23587137|NCT00961636|65876253|FG001|Overall Study|Protocol Violation|5|||
23587138|NCT00961636|65876254|FG002|Overall Study|Protocol Violation|1|||
23587139|NCT00961636|65876252|FG000|Overall Study|Withdrawal by Subject|29|||
23587140|NCT00961636|65876253|FG001|Overall Study|Withdrawal by Subject|22|||
23587141|NCT00961636|65876254|FG002|Overall Study|Withdrawal by Subject|13|||
23587142|NCT00646451|65876258|FG000|Overall Study|Adverse Event|3|||
23587143|NCT00646451|65876259|FG001|Overall Study|Adverse Event|0|||
23587144|NCT00646451|65876258|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
23793914|NCT00377156|66623541|FG000|Overall Study|Ineligible|0|||
23793915|NCT00377156|66623542|FG001|Overall Study|Ineligible|1|||
23793916|NCT00377156|66623541|FG000|Overall Study|Disability or language problem|0|||
23793917|NCT00377156|66623542|FG001|Overall Study|Disability or language problem|1|||
23793918|NCT00377156|66623541|FG000|Overall Study|Other|5|||
23793919|NCT00377156|66623542|FG001|Overall Study|Other|2|||
23793920|NCT01256060|66623546|FG000|Overall Study|Lost to Follow-up|0|||
23793921|NCT01256060|66623547|FG001|Overall Study|Lost to Follow-up|1|||
23793922|NCT01256060|66623548|FG002|Overall Study|Lost to Follow-up|0|||
23793923|NCT01256060|66623549|FG003|Overall Study|Lost to Follow-up|0|||
23793924|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
23793925|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
23793926|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23793927|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23793928|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23793929|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
23793930|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23793931|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23793932|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
23793933|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23793934|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23793935|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23793936|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
23793937|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
23793938|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23793939|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23793940|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Death|2|||
23352462|NCT00269477|65033034|FG001|Overall Study|Missed post-vaccination blood draw|1|||
23352463|NCT00269477|65033035|FG002|Overall Study|Missed post-vaccination blood draw|0|||
23352464|NCT00269477|65033036|FG003|Overall Study|Missed post-vaccination blood draw|0|||
23352465|NCT00423813|65033039|FG000|Overall Study|Adverse Event|11|||
23352466|NCT00423813|65033040|FG001|Overall Study|Adverse Event|30|||
23352467|NCT00423813|65033041|FG002|Overall Study|Adverse Event|40|||
23352468|NCT00423813|65033039|FG000|Overall Study|Withdrawal by Subject|6|||
23352469|NCT00423813|65033040|FG001|Overall Study|Withdrawal by Subject|8|||
23352470|NCT00423813|65033041|FG002|Overall Study|Withdrawal by Subject|5|||
23352471|NCT00423813|65033039|FG000|Overall Study|Lost to Follow-up|5|||
23352472|NCT00423813|65033040|FG001|Overall Study|Lost to Follow-up|4|||
23352473|NCT00423813|65033041|FG002|Overall Study|Lost to Follow-up|4|||
23352474|NCT00423813|65033039|FG000|Overall Study|Lack of Efficacy|23|||
23352475|NCT00423813|65033040|FG001|Overall Study|Lack of Efficacy|18|||
23352476|NCT00423813|65033041|FG002|Overall Study|Lack of Efficacy|19|||
23352477|NCT00423813|65033039|FG000|Overall Study|Physician Decision|2|||
23352478|NCT00423813|65033040|FG001|Overall Study|Physician Decision|0|||
23352479|NCT00423813|65033041|FG002|Overall Study|Physician Decision|0|||
23352480|NCT00423813|65033039|FG000|Overall Study|Sponsor Decision|0|||
23352481|NCT00423813|65033040|FG001|Overall Study|Sponsor Decision|1|||
23352482|NCT00423813|65033041|FG002|Overall Study|Sponsor Decision|0|||
23352483|NCT00423813|65033039|FG000|Overall Study|Protocol Violation|9|||
23352484|NCT00423813|65033040|FG001|Overall Study|Protocol Violation|4|||
23352485|NCT00423813|65033041|FG002|Overall Study|Protocol Violation|4|||
23352486|NCT00423813|65033039|FG000|Overall Study|Pregnancy|0|||
23352487|NCT00423813|65033040|FG001|Overall Study|Pregnancy|0|||
23352488|NCT00423813|65033041|FG002|Overall Study|Pregnancy|1|||
23352489|NCT00423813|65033039|FG000|Overall Study|Subject started night shift work|1|||
23352490|NCT00423813|65033040|FG001|Overall Study|Subject started night shift work|0|||
23352491|NCT00423813|65033041|FG002|Overall Study|Subject started night shift work|0|||
23352492|NCT00423813|65033039|FG000|Overall Study|Will start exclusionary medications|0|||
23352493|NCT00423813|65033040|FG001|Overall Study|Will start exclusionary medications|1|||
23352494|NCT00423813|65033041|FG002|Overall Study|Will start exclusionary medications|0|||
23352495|NCT00423813|65033039|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
23352496|NCT00423813|65033040|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
23352497|NCT00423813|65033041|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
23352498|NCT01254721|65033043|FG000|Overall Study|Lost to Follow-up|0|||
23352499|NCT01254721|65033044|FG001|Overall Study|Lost to Follow-up|4|||
23352500|NCT01254721|65033043|FG000|Overall Study|Lack of Efficacy|4|||
23352501|NCT01254721|65033044|FG001|Overall Study|Lack of Efficacy|2|||
23352502|NCT01254721|65033043|FG000|Overall Study|Death|0|||
23352503|NCT01254721|65033044|FG001|Overall Study|Death|1|||
23352504|NCT01254721|65033043|FG000|Overall Study|technical problum|1|||
23352505|NCT01254721|65033044|FG001|Overall Study|technical problum|0|||
23352506|NCT01254721|65033043|FG000|Overall Study|Adverse Event|2|||
23352507|NCT01254721|65033044|FG001|Overall Study|Adverse Event|3|||
23352508|NCT01254721|65033043|FG000|Overall Study|Withdrawal by Subject|8|||
23352509|NCT01254721|65033044|FG001|Overall Study|Withdrawal by Subject|11|||
23352510|NCT01254721|65033043|FG000|Overall Study|Wrongly randomization|0|||
23352511|NCT01254721|65033044|FG001|Overall Study|Wrongly randomization|1|||
23352512|NCT03209518|65033046|FG000|Overall Study|Case Report Forms Uncollected|1|||
23352513|NCT03209518|65033046|FG000|Overall Study|Protocol Deviation|1|||
23352514|NCT03769194|65033048|FG000|Overall Study|Withdrawal by Subject|0|||
23352515|NCT03769194|65033049|FG001|Overall Study|Withdrawal by Subject|7|||
23352516|NCT03769194|65033050|FG002|Overall Study|Withdrawal by Subject|4|||
23352517|NCT03769194|65033051|FG003|Overall Study|Withdrawal by Subject|1|||
23352518|NCT03769194|65033048|FG000|Overall Study|moved from study area|0|||
23352519|NCT03769194|65033049|FG001|Overall Study|moved from study area|2|||
23352520|NCT03769194|65033050|FG002|Overall Study|moved from study area|1|||
23352521|NCT03769194|65033051|FG003|Overall Study|moved from study area|1|||
23352522|NCT03769194|65033048|FG000|Overall Study|Lost to Follow-up|3|||
23352523|NCT03769194|65033049|FG001|Overall Study|Lost to Follow-up|6|||
23352524|NCT03769194|65033050|FG002|Overall Study|Lost to Follow-up|3|||
23352525|NCT03769194|65033051|FG003|Overall Study|Lost to Follow-up|6|||
23352526|NCT03769194|65033048|FG000|Overall Study|other|1|||
23352527|NCT03769194|65033049|FG001|Overall Study|other|3|||
23352528|NCT03769194|65033050|FG002|Overall Study|other|0|||
23352529|NCT03769194|65033051|FG003|Overall Study|other|1|||
23352530|NCT00869557|65033057|FG000|Randomized Phase|Lost to Follow-up|2|||
23352531|NCT00869557|65033058|FG001|Randomized Phase|Lost to Follow-up|1|||
23352532|NCT00869557|65033057|FG000|Randomized Phase|Investigator's Discretion|1|||
23352533|NCT00869557|65033058|FG001|Randomized Phase|Investigator's Discretion|0|||
23352534|NCT00869557|65033057|FG000|Randomized Phase|Withdrew Consent|0|||
23352535|NCT00869557|65033058|FG001|Randomized Phase|Withdrew Consent|1|||
23352536|NCT00869557|65033057|FG000|Extension Phase|Adverse Event|2|||
23352537|NCT00869557|65033058|FG001|Extension Phase|Adverse Event|2|||
23352538|NCT00869557|65033057|FG000|Extension Phase|Lack of Efficacy|1|||
23352539|NCT00869557|65033058|FG001|Extension Phase|Lack of Efficacy|0|||
23352540|NCT00869557|65033057|FG000|Extension Phase|Lost to Follow-up|3|||
23352541|NCT00869557|65033058|FG001|Extension Phase|Lost to Follow-up|1|||
23352542|NCT00869557|65033057|FG000|Extension Phase|Investigator's Discretion|2|||
23352543|NCT00869557|65033058|FG001|Extension Phase|Investigator's Discretion|0|||
23352544|NCT00869557|65033057|FG000|Extension Phase|Withdrew Consent|2|||
23352545|NCT00869557|65033058|FG001|Extension Phase|Withdrew Consent|0|||
23352546|NCT02578940|65033061|FG000|Overall Study|Screening failure|5|||
23352547|NCT02578940|65033061|FG000|Overall Study|Lost to Follow-up|1|||
23352548|NCT02431806|65033063|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352549|NCT02431806|65033064|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
23352550|NCT02431806|65033065|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352551|NCT02431806|65033066|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352552|NCT02431806|65033063|FG000|Double-blind Treatment Period|Adverse Event|4|||
23352553|NCT02431806|65033064|FG001|Double-blind Treatment Period|Adverse Event|7|||
23352554|NCT02431806|65033065|FG002|Double-blind Treatment Period|Adverse Event|11|||
23352555|NCT02431806|65033066|FG003|Double-blind Treatment Period|Adverse Event|7|||
23352556|NCT02431806|65033063|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
23352557|NCT02431806|65033064|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23352558|NCT02431806|65033065|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
23352559|NCT02431806|65033066|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
23352560|NCT02431806|65033063|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
23352561|NCT02431806|65033064|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
23352562|NCT02431806|65033065|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
23352563|NCT02431806|65033066|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
23352564|NCT02431806|65033063|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
23352565|NCT02431806|65033064|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
23793941|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Death|1|||
23793942|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Death|0|||
23793943|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Death|0|||
23793944|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
23793945|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
23793946|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
23793947|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
23793948|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23352566|NCT02431806|65033065|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23352567|NCT02431806|65033066|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
23352568|NCT02431806|65033063|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
23352569|NCT02431806|65033064|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
23352570|NCT02431806|65033065|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
23352571|NCT02431806|65033066|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
23352572|NCT02431806|65033063|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
23352573|NCT02431806|65033064|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
23352574|NCT02431806|65033065|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
23352575|NCT02431806|65033066|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
23352576|NCT02561455|65033067|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352577|NCT02561455|65033068|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352578|NCT02561455|65033069|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
23352579|NCT02561455|65033070|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352580|NCT02561455|65033067|FG000|Overall Study|Withdrawal by Subject|1|||
23352581|NCT02561455|65033068|FG001|Overall Study|Withdrawal by Subject|0|||
23352582|NCT02561455|65033069|FG002|Overall Study|Withdrawal by Subject|1|||
23352583|NCT02561455|65033070|FG003|Overall Study|Withdrawal by Subject|0|||
23352584|NCT02561455|65033067|FG000|Overall Study|Disease Progression|0|||
23352585|NCT02561455|65033068|FG001|Overall Study|Disease Progression|1|||
23352586|NCT02561455|65033069|FG002|Overall Study|Disease Progression|0|||
23352587|NCT02561455|65033070|FG003|Overall Study|Disease Progression|0|||
23352588|NCT01810783|65033071|FG000|Overall Study|Adverse Event|32|||
23793949|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23793950|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23793951|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23793952|NCT03110380|66623552|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23793953|NCT03110380|66623553|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
23793954|NCT03110380|66623554|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23352589|NCT01810783|65033071|FG000|Overall Study|Withdrawal by Subject|22|||
23352590|NCT01810783|65033071|FG000|Overall Study|Lack of Efficacy|12|||
23468365|NCT04413617|65457286|FG001|Overall Study|COVID-19|1|||
23468366|NCT04413617|65457287|FG002|Overall Study|COVID-19|0|||
23793955|NCT03110380|66623555|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23793956|NCT03110380|66623552|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23793957|NCT03110380|66623553|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23793958|NCT03110380|66623554|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
23793959|NCT03110380|66623555|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
23793960|NCT03110380|66623552|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
23793961|NCT03110380|66623553|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
23793962|NCT03110380|66623554|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
23793963|NCT03110380|66623555|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
23793964|NCT03110380|66623552|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23793965|NCT03110380|66623553|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23793966|NCT03110380|66623554|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23793967|NCT03110380|66623555|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
23468367|NCT04413617|65457288|FG003|Overall Study|COVID-19|0|||
23468368|NCT04413617|65457289|FG004|Overall Study|COVID-19|0|||
23468369|NCT01671319|65457291|FG000|Overall Study|Withdrawal by Subject|1|||
23468370|NCT00930046|65457295|FG000|Overall Study|Wound catheter malfunctioned|1|||
23468371|NCT00930046|65457296|FG001|Overall Study|Wound catheter malfunctioned|2|||
23468372|NCT00248040|65457301|FG000|Overall Study|transplantectomy|2|||
23468373|NCT00248040|65457302|FG001|Overall Study|transplantectomy|1|||
23468374|NCT00248040|65457303|FG002|Overall Study|transplantectomy|3|||
23468375|NCT00248040|65457301|FG000|Overall Study|transplant cancelled post treat start|1|||
23468376|NCT00248040|65457302|FG001|Overall Study|transplant cancelled post treat start|0|||
23468377|NCT00248040|65457303|FG002|Overall Study|transplant cancelled post treat start|0|||
23468378|NCT00248040|65457301|FG000|Overall Study|Death|0|||
23468379|NCT00248040|65457302|FG001|Overall Study|Death|0|||
23468380|NCT00248040|65457303|FG002|Overall Study|Death|1|||
23468381|NCT04233216|65457304|FG000|Overall Study|Lost to Follow-up|0|||
23468382|NCT04233216|65457305|FG001|Overall Study|Lost to Follow-up|0|||
23468383|NCT04233216|65457306|FG002|Overall Study|Lost to Follow-up|2|||
23468384|NCT04233216|65457307|FG003|Overall Study|Lost to Follow-up|0|||
23468385|NCT04233216|65457304|FG000|Overall Study|Physician Decision|0|||
23468386|NCT04233216|65457305|FG001|Overall Study|Physician Decision|1|||
23468387|NCT04233216|65457306|FG002|Overall Study|Physician Decision|0|||
23468388|NCT04233216|65457307|FG003|Overall Study|Physician Decision|0|||
23468389|NCT04233216|65457304|FG000|Overall Study|Withdrawal by Subject|0|||
23468390|NCT04233216|65457305|FG001|Overall Study|Withdrawal by Subject|1|||
23468391|NCT04233216|65457306|FG002|Overall Study|Withdrawal by Subject|1|||
23468392|NCT04233216|65457307|FG003|Overall Study|Withdrawal by Subject|0|||
23468393|NCT04233216|65457304|FG000|Overall Study|Ongoing participation in study|7|||
23468394|NCT04233216|65457305|FG001|Overall Study|Ongoing participation in study|12|||
23468395|NCT04233216|65457306|FG002|Overall Study|Ongoing participation in study|4|||
23468396|NCT04233216|65457307|FG003|Overall Study|Ongoing participation in study|7|||
23468397|NCT02872935|65457312|FG000|Overall Study|Other|0|||
23468398|NCT02872935|65457313|FG001|Overall Study|Other|1|||
23468399|NCT02817464|65457314|FG000|Overall Study|Lost to Follow-up|1|||
23468400|NCT02817464|65457315|FG001|Overall Study|Lost to Follow-up|0|||
23468401|NCT02817464|65457314|FG000|Overall Study|Discontinued early due to personal decision|1|||
23793968|NCT01928615|66623556|FG000|Overall Study|Study Terminated by Sponsor|2|||
23793969|NCT00645944|66623557|FG000|Randomized|Withdrawal by Subject|1|||
23468402|NCT02817464|65457315|FG001|Overall Study|Discontinued early due to personal decision|1|||
23468403|NCT01524796|65457316|FG000|Overall Study|Adverse Event|13|||
23468404|NCT01524796|65457316|FG000|Overall Study|Lack of Efficacy|3|||
23468405|NCT01524796|65457316|FG000|Overall Study|Lost to Follow-up|1|||
23468406|NCT01524796|65457316|FG000|Overall Study|The price|1|||
23468407|NCT01524796|65457316|FG000|Overall Study|Withdrawal by Subject|4|||
23468408|NCT01524796|65457316|FG000|Overall Study|Move|1|||
23468409|NCT01524796|65457316|FG000|Overall Study|Deterioration of pains|1|||
23468410|NCT01524796|65457316|FG000|Overall Study|Gall stone surgery|1|||
23793970|NCT00645944|66623558|FG001|Randomized|Withdrawal by Subject|2|||
23468411|NCT01524796|65457316|FG000|Overall Study|Nervous about confidentiality|1|||
23468412|NCT01524796|65457316|FG000|Overall Study|Switch to carbamazapine|1|||
23468413|NCT01524796|65457316|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
23468414|NCT02876601|65457319|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468415|NCT02876601|65457320|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468416|NCT02876601|65457321|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
23468417|NCT02876601|65457322|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468418|NCT02427464|65457323|FG000|Overall Study|Adverse Event|6|||
23468419|NCT02427464|65457324|FG001|Overall Study|Adverse Event|1|||
23468420|NCT02427464|65457323|FG000|Overall Study|Lost to Follow-up|16|||
23468421|NCT02427464|65457324|FG001|Overall Study|Lost to Follow-up|5|||
23468422|NCT02427464|65457323|FG000|Overall Study|Physician Decision|2|||
23468423|NCT02427464|65457324|FG001|Overall Study|Physician Decision|0|||
23468424|NCT02427464|65457323|FG000|Overall Study|Withdrawal by Subject|10|||
23468425|NCT02427464|65457324|FG001|Overall Study|Withdrawal by Subject|8|||
23468426|NCT02427464|65457323|FG000|Overall Study|Noncompliance|16|||
23468427|NCT02427464|65457324|FG001|Overall Study|Noncompliance|10|||
23468428|NCT02453711|65457325|FG000|Overall Study|Withdrawal by Subject|5|||
23468429|NCT02453711|65457326|FG001|Overall Study|Withdrawal by Subject|4|||
23468430|NCT02453711|65457327|FG002|Overall Study|Withdrawal by Subject|6|||
23468431|NCT02453711|65457328|FG003|Overall Study|Withdrawal by Subject|4|||
23468432|NCT02453711|65457329|FG004|Overall Study|Withdrawal by Subject|1|||
23352591|NCT01810783|65033071|FG000|Overall Study|Lost to Follow-up|10|||
23352592|NCT01810783|65033071|FG000|Overall Study|Protocol Violation|5|||
23352593|NCT01810783|65033071|FG000|Overall Study|Non-compliance with IMP|4|||
23468433|NCT02453711|65457330|FG005|Overall Study|Withdrawal by Subject|1|||
23468434|NCT02453711|65457331|FG006|Overall Study|Withdrawal by Subject|0|||
23468435|NCT02453711|65457332|FG007|Overall Study|Withdrawal by Subject|1|||
23468436|NCT02453711|65457333|FG008|Overall Study|Withdrawal by Subject|7|||
23468437|NCT02453711|65457325|FG000|Overall Study|Lost to Follow-up|5|||
23468438|NCT02453711|65457326|FG001|Overall Study|Lost to Follow-up|3|||
23468439|NCT02453711|65457327|FG002|Overall Study|Lost to Follow-up|2|||
23793971|NCT00645944|66623557|FG000|Received Medication|Adverse Event|2|||
23793972|NCT00645944|66623558|FG001|Received Medication|Adverse Event|1|||
23468440|NCT02453711|65457328|FG003|Overall Study|Lost to Follow-up|3|||
23468441|NCT02453711|65457329|FG004|Overall Study|Lost to Follow-up|1|||
23468442|NCT02453711|65457330|FG005|Overall Study|Lost to Follow-up|5|||
23468443|NCT02453711|65457331|FG006|Overall Study|Lost to Follow-up|2|||
23468444|NCT02453711|65457332|FG007|Overall Study|Lost to Follow-up|6|||
23468445|NCT02453711|65457333|FG008|Overall Study|Lost to Follow-up|6|||
23468446|NCT02453711|65457325|FG000|Overall Study|Death|0|||
23468447|NCT02453711|65457326|FG001|Overall Study|Death|0|||
23468448|NCT02453711|65457327|FG002|Overall Study|Death|0|||
23468449|NCT02453711|65457328|FG003|Overall Study|Death|0|||
23468450|NCT02453711|65457329|FG004|Overall Study|Death|0|||
23468451|NCT02453711|65457330|FG005|Overall Study|Death|0|||
23468452|NCT02453711|65457331|FG006|Overall Study|Death|1|||
23468453|NCT02453711|65457332|FG007|Overall Study|Death|0|||
23468454|NCT02453711|65457333|FG008|Overall Study|Death|0|||
23468455|NCT02453711|65457325|FG000|Overall Study|Unclassified|1|||
23468456|NCT02453711|65457326|FG001|Overall Study|Unclassified|0|||
23468457|NCT02453711|65457327|FG002|Overall Study|Unclassified|1|||
23468458|NCT02453711|65457328|FG003|Overall Study|Unclassified|0|||
23468459|NCT02453711|65457329|FG004|Overall Study|Unclassified|0|||
23468460|NCT02453711|65457330|FG005|Overall Study|Unclassified|0|||
23468461|NCT02453711|65457331|FG006|Overall Study|Unclassified|0|||
23468462|NCT02453711|65457332|FG007|Overall Study|Unclassified|0|||
23587145|NCT00646451|65876259|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
23793973|NCT00645944|66623557|FG000|Received Medication|Withdrawal by Subject|1|||
23793974|NCT00645944|66623558|FG001|Received Medication|Withdrawal by Subject|1|||
23793975|NCT00645944|66623557|FG000|Received Medication|Lost to Follow-up|1|||
23793976|NCT00645944|66623558|FG001|Received Medication|Lost to Follow-up|0|||
23793977|NCT00645944|66623557|FG000|Received Medication|Protocol Violation|2|||
23352594|NCT01810783|65033071|FG000|Overall Study|Adminstrative or other reason(s)|23|||
23468463|NCT02453711|65457333|FG008|Overall Study|Unclassified|0|||
23468464|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
23468465|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
23468466|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
23468467|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
23468468|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
23468469|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468470|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468471|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468472|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
23793978|NCT00645944|66623558|FG001|Received Medication|Protocol Violation|1|||
23793979|NCT00530348|66623559|FG000|Overall Study|Adverse Event|5|||
23793980|NCT00530348|66623560|FG001|Overall Study|Adverse Event|1|||
23468473|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468474|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468475|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468476|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468477|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
23468478|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468479|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468480|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468481|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
23468482|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468483|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468484|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468485|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468486|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
23468487|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468488|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468489|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468490|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
23468491|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468492|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468493|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468494|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
23468495|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468496|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468497|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468498|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
23468499|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468500|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
23468501|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
23468502|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
23468503|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
23468504|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468505|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468506|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468507|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
23468508|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23587146|NCT00919763|65876260|FG000|Overall Study|Adverse Event|7|||
23587147|NCT00919763|65876261|FG001|Overall Study|Adverse Event|1|||
23587148|NCT00919763|65876260|FG000|Overall Study|Lost to Follow-up|1|||
23468509|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23587149|NCT00919763|65876261|FG001|Overall Study|Lost to Follow-up|0|||
23587150|NCT00919763|65876260|FG000|Overall Study|Protocol Violation|1|||
23468510|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23468511|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
23468512|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468513|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468514|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468515|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
23468516|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
23468517|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
23468518|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
23468519|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
23468520|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468521|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468522|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468523|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
23352595|NCT01810783|65033071|FG000|Overall Study|Enrolled, not treated|1|||
23352596|NCT00494221|65033072|FG000|Overall Study|Death|15|||
23352597|NCT00494221|65033073|FG001|Overall Study|Death|9|||
23468524|NCT00555061|65457338|FG000|Overall Study|Adverse Event|3|||
23468525|NCT00555061|65457338|FG000|Overall Study|Protocol Violation|1|||
23468526|NCT00555061|65457338|FG000|Overall Study|Lost to Follow-up|2|||
23468527|NCT00555061|65457338|FG000|Overall Study|Withdrawal by Subject|2|||
23468528|NCT00555061|65457338|FG000|Overall Study|Participant enrolled, but never treated|1|||
23468529|NCT01379508|65457339|FG000|Treatment to Week 104|Adverse Event|2|||
23468530|NCT01379508|65457340|FG001|Treatment to Week 104|Adverse Event|0|||
23468531|NCT01379508|65457341|FG002|Treatment to Week 104|Adverse Event|5|||
23468532|NCT01379508|65457342|FG003|Treatment to Week 104|Adverse Event|0|||
23468533|NCT01379508|65457339|FG000|Treatment to Week 104|Abnormal lab value|1|||
23468534|NCT01379508|65457340|FG001|Treatment to Week 104|Abnormal lab value|0|||
23468535|NCT01379508|65457341|FG002|Treatment to Week 104|Abnormal lab value|0|||
23468536|NCT01379508|65457342|FG003|Treatment to Week 104|Abnormal lab value|0|||
23468537|NCT01379508|65457339|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
23468538|NCT01379508|65457340|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468539|NCT01379508|65457341|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468540|NCT01379508|65457342|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468541|NCT01379508|65457339|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
23468542|NCT01379508|65457340|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
23468543|NCT01379508|65457341|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
23468544|NCT01379508|65457342|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
23468545|NCT01379508|65457339|FG000|Treatment to Week 104|Lost to Follow-up|5|||
23468546|NCT01379508|65457340|FG001|Treatment to Week 104|Lost to Follow-up|0|||
23468547|NCT01379508|65457341|FG002|Treatment to Week 104|Lost to Follow-up|3|||
23468548|NCT01379508|65457342|FG003|Treatment to Week 104|Lost to Follow-up|0|||
23468549|NCT01379508|65457339|FG000|Treatment to Week 104|Administrative problems|3|||
23468550|NCT01379508|65457340|FG001|Treatment to Week 104|Administrative problems|1|||
23468551|NCT01379508|65457341|FG002|Treatment to Week 104|Administrative problems|0|||
23468552|NCT01379508|65457342|FG003|Treatment to Week 104|Administrative problems|0|||
23352598|NCT00494221|65033074|FG002|Overall Study|Death|14|||
23352599|NCT00494221|65033072|FG000|Overall Study|Withdrawal by Subject|1|||
23352600|NCT00494221|65033073|FG001|Overall Study|Withdrawal by Subject|2|||
23468553|NCT01379508|65457339|FG000|Treatment to Week 104|Protocol Violation|1|||
23468554|NCT01379508|65457340|FG001|Treatment to Week 104|Protocol Violation|1|||
23468555|NCT01379508|65457341|FG002|Treatment to Week 104|Protocol Violation|1|||
23468556|NCT01379508|65457342|FG003|Treatment to Week 104|Protocol Violation|0|||
23468557|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
23468558|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
23468559|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
23468560|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
23468561|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
23468562|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
23468563|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
23468564|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
23468565|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
23468566|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
23468567|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
23468568|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
23468569|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
23468570|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
23352601|NCT00494221|65033074|FG002|Overall Study|Withdrawal by Subject|0|||
23468571|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
23468572|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
23468573|NCT01616693|65457343|FG000|Evaluated for Safety|Physician Decision|1|||
23468574|NCT01616693|65457344|FG001|Evaluated for Safety|Physician Decision|0|||
23468575|NCT01616693|65457345|FG002|Evaluated for Safety|Physician Decision|1|||
23468576|NCT01616693|65457346|FG003|Evaluated for Safety|Physician Decision|0|||
23468577|NCT01616693|65457343|FG000|Received Both Vaccines|Adverse Event|2|||
23468578|NCT01616693|65457344|FG001|Received Both Vaccines|Adverse Event|0|||
23468579|NCT01616693|65457345|FG002|Received Both Vaccines|Adverse Event|0|||
23468580|NCT01616693|65457346|FG003|Received Both Vaccines|Adverse Event|0|||
23468581|NCT01616693|65457343|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
23468582|NCT01616693|65457344|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
23468583|NCT01616693|65457345|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
23468584|NCT01616693|65457346|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
23468585|NCT01616693|65457343|FG000|Received Both Vaccines|Lost to Follow-up|4|||
23468586|NCT01616693|65457344|FG001|Received Both Vaccines|Lost to Follow-up|3|||
23468587|NCT01616693|65457345|FG002|Received Both Vaccines|Lost to Follow-up|4|||
23793981|NCT00530348|66623559|FG000|Overall Study|Death|0|||
23793982|NCT00530348|66623560|FG001|Overall Study|Death|1|||
23793983|NCT00530348|66623559|FG000|Overall Study|Lack of Efficacy|2|||
23793984|NCT00530348|66623560|FG001|Overall Study|Lack of Efficacy|0|||
23793985|NCT00530348|66623559|FG000|Overall Study|Lost to Follow-up|0|||
23793986|NCT00530348|66623560|FG001|Overall Study|Lost to Follow-up|2|||
23793987|NCT00530348|66623559|FG000|Overall Study|Physician Decision|1|||
23793988|NCT00530348|66623560|FG001|Overall Study|Physician Decision|2|||
23793989|NCT00530348|66623559|FG000|Overall Study|Pregnancy|1|||
23793990|NCT00530348|66623560|FG001|Overall Study|Pregnancy|0|||
23793991|NCT00530348|66623559|FG000|Overall Study|Withdrawal by Subject|12|||
23793992|NCT00530348|66623560|FG001|Overall Study|Withdrawal by Subject|12|||
23793993|NCT00530348|66623559|FG000|Overall Study|Randomised in error|1|||
23793994|NCT00530348|66623560|FG001|Overall Study|Randomised in error|0|||
23352602|NCT01522235|65033075|FG000|Overall Study|Physician Decision|1|||
23468588|NCT01616693|65457346|FG003|Received Both Vaccines|Lost to Follow-up|4|||
23468589|NCT01616693|65457343|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
23468590|NCT01616693|65457344|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
23468591|NCT01616693|65457345|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
23468592|NCT01616693|65457346|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
23468593|NCT02167139|65457347|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
23468594|NCT02167139|65457348|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
23468595|NCT02167139|65457349|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
23468596|NCT02167139|65457350|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
23468597|NCT02167139|65457347|FG000|Randomised, Double-blind|Adverse Event|2|||
23468598|NCT02167139|65457348|FG001|Randomised, Double-blind|Adverse Event|9|||
23468599|NCT02167139|65457349|FG002|Randomised, Double-blind|Adverse Event|0|||
23468600|NCT02167139|65457350|FG003|Randomised, Double-blind|Adverse Event|0|||
23468601|NCT02167139|65457347|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
23468602|NCT02167139|65457348|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
23468603|NCT02167139|65457349|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
23468604|NCT02167139|65457350|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
23468605|NCT02167139|65457347|FG000|Randomised, Double-blind|Other|3|||
23468606|NCT02167139|65457348|FG001|Randomised, Double-blind|Other|0|||
23468607|NCT02167139|65457349|FG002|Randomised, Double-blind|Other|0|||
23468608|NCT02167139|65457350|FG003|Randomised, Double-blind|Other|0|||
23468609|NCT02167139|65457347|FG000|Transition-extension|Adverse Event|2|||
23468610|NCT02167139|65457348|FG001|Transition-extension|Adverse Event|0|||
23468611|NCT02167139|65457349|FG002|Transition-extension|Adverse Event|2|||
23640664|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
23640665|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
23640666|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
23640667|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
23793995|NCT00530348|66623559|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
23352603|NCT01522235|65033076|FG001|Overall Study|Physician Decision|1|||
23468612|NCT02167139|65457350|FG003|Transition-extension|Adverse Event|3|||
23468613|NCT02167139|65457347|FG000|Transition-extension|Withdrawal by Subject|2|||
23587151|NCT00919763|65876261|FG001|Overall Study|Protocol Violation|1|||
23587152|NCT00919763|65876260|FG000|Overall Study|Withdrawal by Subject|3|||
23587153|NCT00919763|65876261|FG001|Overall Study|Withdrawal by Subject|1|||
23587154|NCT00919763|65876260|FG000|Overall Study|Non-compliance|0|||
23587155|NCT00919763|65876261|FG001|Overall Study|Non-compliance|1|||
23587156|NCT03121950|65876262|FG000|Overall Study|Withdrawal by Subject|11|||
23640668|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
23793996|NCT00530348|66623560|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
23468614|NCT02167139|65457348|FG001|Transition-extension|Withdrawal by Subject|0|||
23468615|NCT02167139|65457349|FG002|Transition-extension|Withdrawal by Subject|4|||
23468616|NCT02167139|65457350|FG003|Transition-extension|Withdrawal by Subject|1|||
23468617|NCT02167139|65457347|FG000|Transition-extension|Lack of Efficacy|0|||
23468618|NCT02167139|65457348|FG001|Transition-extension|Lack of Efficacy|0|||
23468619|NCT02167139|65457349|FG002|Transition-extension|Lack of Efficacy|1|||
23468620|NCT02167139|65457350|FG003|Transition-extension|Lack of Efficacy|1|||
23468621|NCT02167139|65457347|FG000|Transition-extension|Other|1|||
23468622|NCT02167139|65457348|FG001|Transition-extension|Other|0|||
23468623|NCT02167139|65457349|FG002|Transition-extension|Other|1|||
23468624|NCT02167139|65457350|FG003|Transition-extension|Other|0|||
23468625|NCT02167139|65457347|FG000|Transition-extension|Lost to Follow-up|1|||
23468626|NCT02167139|65457348|FG001|Transition-extension|Lost to Follow-up|0|||
23468627|NCT02167139|65457349|FG002|Transition-extension|Lost to Follow-up|0|||
23468628|NCT02167139|65457350|FG003|Transition-extension|Lost to Follow-up|0|||
23468629|NCT01967576|65457353|FG000|Overall Study|Withdrawal by Subject|3|||
23468630|NCT01967576|65457353|FG000|Overall Study|Progressed/Removed from treatment|1|||
23468631|NCT01967576|65457353|FG000|Overall Study|Study closing at site|1|||
23468632|NCT01967576|65457353|FG000|Overall Study|Adverse Event|1|||
23468633|NCT01967576|65457353|FG000|Overall Study|Refused further treatment|1|||
23468634|NCT01157234|65457358|FG000|Overall Study|Withdrawal by Subject|1|||
23468635|NCT01157234|65457359|FG001|Overall Study|Withdrawal by Subject|0|||
23468636|NCT03599089|65457360|FG000|Overall Study|Lost to Follow-up|1|||
23468637|NCT03599089|65457361|FG001|Overall Study|Lost to Follow-up|0|||
23468638|NCT03599089|65457362|FG002|Overall Study|Lost to Follow-up|0|||
23468639|NCT03599089|65457363|FG003|Overall Study|Lost to Follow-up|0|||
23468640|NCT03599089|65457360|FG000|Overall Study|Withdrawal by Subject|2|||
23468641|NCT03599089|65457361|FG001|Overall Study|Withdrawal by Subject|1|||
23468642|NCT03599089|65457362|FG002|Overall Study|Withdrawal by Subject|0|||
23468643|NCT03599089|65457363|FG003|Overall Study|Withdrawal by Subject|0|||
23468644|NCT03599089|65457360|FG000|Overall Study|Lack of Efficacy|0|||
23468645|NCT03599089|65457361|FG001|Overall Study|Lack of Efficacy|0|||
23468646|NCT03599089|65457362|FG002|Overall Study|Lack of Efficacy|1|||
23468647|NCT03599089|65457363|FG003|Overall Study|Lack of Efficacy|2|||
23468648|NCT01621802|65457364|FG000|Overall Study|Protocol Violation|0|||
23468649|NCT01621802|65457365|FG001|Overall Study|Protocol Violation|0|||
23468650|NCT01621802|65457366|FG002|Overall Study|Protocol Violation|0|||
23468651|NCT01621802|65457367|FG003|Overall Study|Protocol Violation|0|||
23468652|NCT01621802|65457368|FG004|Overall Study|Protocol Violation|0|||
23468653|NCT01621802|65457369|FG005|Overall Study|Protocol Violation|1|||
23468654|NCT01621802|65457364|FG000|Overall Study|Withdrawal by Subject|8|||
23468655|NCT01621802|65457365|FG001|Overall Study|Withdrawal by Subject|4|||
23468656|NCT01621802|65457366|FG002|Overall Study|Withdrawal by Subject|4|||
23468657|NCT01621802|65457367|FG003|Overall Study|Withdrawal by Subject|2|||
23468658|NCT01621802|65457368|FG004|Overall Study|Withdrawal by Subject|2|||
23468659|NCT01621802|65457369|FG005|Overall Study|Withdrawal by Subject|0|||
23468660|NCT01621802|65457364|FG000|Overall Study|Migrated/moved from study area|0|||
23468661|NCT01621802|65457365|FG001|Overall Study|Migrated/moved from study area|0|||
23468662|NCT01621802|65457366|FG002|Overall Study|Migrated/moved from study area|2|||
23468663|NCT01621802|65457367|FG003|Overall Study|Migrated/moved from study area|0|||
23706745|NCT00968253|66301323|FG002|Overall Study|Adverse Event|1|||
23793997|NCT01970592|66623561|FG000|Overall Study|Withdrawal by Subject|4|||
23793998|NCT01970592|66623561|FG000|Overall Study|Physician Decision|1|||
23793999|NCT01970592|66623561|FG000|Overall Study|Adverse Event|1|||
23794000|NCT01120691|66623564|FG000|Overall Study|Adverse Event|59|||
23794001|NCT01120691|66623565|FG001|Overall Study|Adverse Event|67|||
23794002|NCT01120691|66623566|FG002|Overall Study|Adverse Event|47|||
23794003|NCT01120691|66623564|FG000|Overall Study|Subject withdrew consent|33|||
23794004|NCT01120691|66623565|FG001|Overall Study|Subject withdrew consent|50|||
23794005|NCT01120691|66623566|FG002|Overall Study|Subject withdrew consent|44|||
23794006|NCT01120691|66623564|FG000|Overall Study|Death|21|||
23794007|NCT01120691|66623565|FG001|Overall Study|Death|22|||
23794008|NCT01120691|66623566|FG002|Overall Study|Death|24|||
23794009|NCT01120691|66623564|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23794010|NCT01120691|66623565|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
23794011|NCT01120691|66623566|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
23794012|NCT01120691|66623564|FG000|Overall Study|Administrative problems|15|||
23794013|NCT01120691|66623565|FG001|Overall Study|Administrative problems|8|||
23794014|NCT01120691|66623566|FG002|Overall Study|Administrative problems|9|||
23794015|NCT01120691|66623564|FG000|Overall Study|Protocol deviation|13|||
23794016|NCT01120691|66623565|FG001|Overall Study|Protocol deviation|12|||
23794017|NCT01120691|66623566|FG002|Overall Study|Protocol deviation|12|||
23794018|NCT01120691|66623564|FG000|Overall Study|Lost to Follow-up|5|||
23468664|NCT01621802|65457368|FG004|Overall Study|Migrated/moved from study area|1|||
23468665|NCT01621802|65457369|FG005|Overall Study|Migrated/moved from study area|0|||
23468666|NCT01621802|65457364|FG000|Overall Study|Others|3|||
23468667|NCT01621802|65457365|FG001|Overall Study|Others|3|||
23468668|NCT01621802|65457366|FG002|Overall Study|Others|3|||
23468669|NCT01621802|65457367|FG003|Overall Study|Others|2|||
23468670|NCT01621802|65457368|FG004|Overall Study|Others|1|||
23468671|NCT01621802|65457369|FG005|Overall Study|Others|0|||
23352604|NCT02305446|65033078|FG000|Overall Study|Adverse Event|1|||
23352605|NCT02368210|65033079|FG000|Overall Study|Withdrawal by Subject|1|||
23587157|NCT03121950|65876263|FG001|Overall Study|Withdrawal by Subject|2|||
23587158|NCT01227707|65876266|FG000|Overall Study|Adverse Event|10|||
23587159|NCT01227707|65876266|FG000|Overall Study|Progression of disease|3|||
23794019|NCT01120691|66623565|FG001|Overall Study|Lost to Follow-up|6|||
23794020|NCT01120691|66623566|FG002|Overall Study|Lost to Follow-up|4|||
23587160|NCT01227707|65876266|FG000|Overall Study|Withdrawal by Subject|1|||
23587161|NCT01227707|65876266|FG000|Overall Study|Patient non-compliance|3|||
23794021|NCT01120691|66623564|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23794022|NCT01120691|66623565|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23587162|NCT01227707|65876266|FG000|Overall Study|Medical decision|6|||
23587163|NCT01227707|65876266|FG000|Overall Study|Death|1|||
23794023|NCT01120691|66623566|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23794024|NCT01120691|66623564|FG000|Overall Study|Patient's inability to use the device|3|||
23794025|NCT01120691|66623565|FG001|Overall Study|Patient's inability to use the device|1|||
23794026|NCT01120691|66623566|FG002|Overall Study|Patient's inability to use the device|0|||
23794027|NCT01120691|66623564|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23794028|NCT01120691|66623565|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23794029|NCT01120691|66623566|FG002|Overall Study|Abnormal laboratory value(s)|4|||
23794030|NCT01023061|66623567|FG000|Overall Study|Withdrawal prior to treatment|2|||
23794031|NCT01292837|66623573|FG000|Overall Study|Adverse Event|1|||
23794032|NCT01292837|66623573|FG000|Overall Study|Further treatment determined|1|||
23794033|NCT03366194|66623575|FG000|Overall Study|Lost to Follow-up|2|||
23794034|NCT02369458|66623578|FG000|Overall Study|Determined to be not eligible|1|||
23794035|NCT02369458|66623579|FG001|Overall Study|Determined to be not eligible|0|||
23794036|NCT00751023|66623580|FG000|Overall Study|Lost to Follow-up|11|||
23794037|NCT00751023|66623581|FG001|Overall Study|Lost to Follow-up|7|||
23794038|NCT01691612|66623582|FG000|Overall Study|deemed ineligible after 1st visit|6|||
23352606|NCT02368210|65033080|FG001|Overall Study|Withdrawal by Subject|0|||
23794039|NCT01691612|66623582|FG000|Overall Study|Adverse Event|1|||
23352607|NCT02368210|65033079|FG000|Overall Study|Adverse Event|0|||
23352608|NCT02368210|65033080|FG001|Overall Study|Adverse Event|1|||
23352609|NCT00369161|65033096|FG000|Overall Study|Adverse Event|15|||
23352610|NCT00369161|65033097|FG001|Overall Study|Adverse Event|13|||
23352611|NCT00369161|65033096|FG000|Overall Study|Abnormal laboratory value|0|||
23352612|NCT00369161|65033097|FG001|Overall Study|Abnormal laboratory value|1|||
23352613|NCT00369161|65033096|FG000|Overall Study|Lack of Efficacy|3|||
23352614|NCT00369161|65033097|FG001|Overall Study|Lack of Efficacy|1|||
23794040|NCT00654641|66623585|FG000|Overall Study|Lost to Follow-up|2|||
23794041|NCT00654641|66623586|FG001|Overall Study|Lost to Follow-up|3|||
23794042|NCT00570128|66623587|FG000|Overall Study|Adverse Event|1|||
23794043|NCT00570128|66623588|FG001|Overall Study|Adverse Event|0|||
23794044|NCT00570128|66623587|FG000|Overall Study|Lost to Follow-up|1|||
23794045|NCT00570128|66623588|FG001|Overall Study|Lost to Follow-up|0|||
23794046|NCT00570128|66623587|FG000|Overall Study|Withdrawal by Subject|2|||
23794047|NCT00570128|66623588|FG001|Overall Study|Withdrawal by Subject|0|||
23794048|NCT01898598|66623589|FG000|Overall Study|Adverse Event|1|||
23794049|NCT01898598|66623590|FG001|Overall Study|Adverse Event|0|||
23794050|NCT01898598|66623589|FG000|Overall Study|Withdrawal by Subject|3|||
23794051|NCT01898598|66623590|FG001|Overall Study|Withdrawal by Subject|0|||
23794052|NCT01898598|66623589|FG000|Overall Study|Lost to Follow-up|0|||
23794053|NCT01898598|66623590|FG001|Overall Study|Lost to Follow-up|1|||
23794054|NCT01898598|66623589|FG000|Overall Study|Other|0|||
23794055|NCT01898598|66623590|FG001|Overall Study|Other|1|||
23794056|NCT01630616|66623591|FG000|Overall Study|Adverse Event|0|||
23794057|NCT01630616|66623592|FG001|Overall Study|Adverse Event|0|||
23794058|NCT01630616|66623593|FG002|Overall Study|Adverse Event|0|||
23794059|NCT01630616|66623594|FG003|Overall Study|Adverse Event|1|||
23794060|NCT01630616|66623595|FG004|Overall Study|Adverse Event|0|||
23794061|NCT01630616|66623596|FG005|Overall Study|Adverse Event|0|||
23794062|NCT01630616|66623591|FG000|Overall Study|Withdrawal by Subject|0|||
23794063|NCT01630616|66623592|FG001|Overall Study|Withdrawal by Subject|0|||
23794064|NCT01630616|66623593|FG002|Overall Study|Withdrawal by Subject|0|||
23794065|NCT01630616|66623594|FG003|Overall Study|Withdrawal by Subject|2|||
23794066|NCT01630616|66623595|FG004|Overall Study|Withdrawal by Subject|0|||
23794067|NCT01630616|66623596|FG005|Overall Study|Withdrawal by Subject|0|||
23794068|NCT01781234|66623597|FG000|Overall Study|Adverse Event|2|||
23794069|NCT01781234|66623598|FG001|Overall Study|Adverse Event|0|||
23794070|NCT01781234|66623597|FG000|Overall Study|Protocol Violation|3|||
23794071|NCT01781234|66623598|FG001|Overall Study|Protocol Violation|0|||
23794072|NCT01781234|66623597|FG000|Overall Study|Withdrawal by Subject|4|||
23794073|NCT01781234|66623598|FG001|Overall Study|Withdrawal by Subject|3|||
23794074|NCT04660032|66623599|FG000|Overall Study|Protocol Violation|1|||
23794075|NCT04660032|66623600|FG001|Overall Study|Protocol Violation|1|||
23794076|NCT00748566|66623603|FG000|Overall Study|Adverse Event|49|||
23794077|NCT00748566|66623603|FG000|Overall Study|Death|1|||
23794078|NCT00748566|66623603|FG000|Overall Study|Lack of Efficacy|12|||
23794079|NCT00748566|66623603|FG000|Overall Study|Lost to Follow-up|1|||
23794080|NCT00748566|66623603|FG000|Overall Study|Protocol Violation|13|||
23794081|NCT00748566|66623603|FG000|Overall Study|Withdrawal by Subject|22|||
23794082|NCT00748566|66623603|FG000|Overall Study|Study terminated by sponsor|5|||
23794083|NCT00748566|66623603|FG000|Overall Study|Other|9|||
23794084|NCT00958724|66623604|FG000|Overall Study|Disease Progression|6|||
23794085|NCT00919711|66623605|FG000|Overall Study|Withdrawal by Subject|15|||
23794086|NCT00919711|66623606|FG001|Overall Study|Withdrawal by Subject|7|||
23794087|NCT00919711|66623605|FG000|Overall Study|Adverse Event|13|||
23794088|NCT00919711|66623606|FG001|Overall Study|Adverse Event|3|||
23794089|NCT00919711|66623605|FG000|Overall Study|Other|1|||
23794090|NCT00919711|66623606|FG001|Overall Study|Other|2|||
23794091|NCT00919711|66623605|FG000|Overall Study|Administrative Decision|0|||
23794092|NCT00919711|66623606|FG001|Overall Study|Administrative Decision|1|||
23794093|NCT00919711|66623605|FG000|Overall Study|Lost to Follow-up|2|||
23352615|NCT00369161|65033096|FG000|Overall Study|Protocol Violation|0|||
23468672|NCT01621802|65457364|FG000|Overall Study|Lost to Follow-up|36|||
23794094|NCT00919711|66623606|FG001|Overall Study|Lost to Follow-up|0|||
23794095|NCT00919711|66623605|FG000|Overall Study|Death|1|||
23352616|NCT00369161|65033097|FG001|Overall Study|Protocol Violation|2|||
23352617|NCT00369161|65033096|FG000|Overall Study|Withdrawal by Subject|2|||
23468673|NCT01621802|65457365|FG001|Overall Study|Lost to Follow-up|16|||
23352618|NCT00369161|65033097|FG001|Overall Study|Withdrawal by Subject|3|||
23468674|NCT01621802|65457366|FG002|Overall Study|Lost to Follow-up|24|||
23794096|NCT00919711|66623606|FG001|Overall Study|Death|0|||
23794097|NCT00919711|66623605|FG000|Overall Study|Noncompliance|1|||
23794098|NCT00919711|66623606|FG001|Overall Study|Noncompliance|0|||
23794099|NCT05061992|66623609|FG000|Overall Study|Excess bowel movements|1|||
23794100|NCT05061992|66623610|FG001|Overall Study|Excess bowel movements|0|||
23794101|NCT05061992|66623609|FG000|Overall Study|Complications of Medical Care|1|||
23794102|NCT05061992|66623610|FG001|Overall Study|Complications of Medical Care|0|||
23352619|NCT00369161|65033096|FG000|Overall Study|Death|1|||
23468675|NCT01621802|65457367|FG003|Overall Study|Lost to Follow-up|7|||
23468676|NCT01621802|65457368|FG004|Overall Study|Lost to Follow-up|31|||
23468677|NCT01621802|65457369|FG005|Overall Study|Lost to Follow-up|11|||
23468678|NCT00670748|65460577|FG000|Overall Study|Death during treatment|1|||
23468679|NCT00670748|65460578|FG001|Overall Study|Death during treatment|1|||
23468680|NCT00670748|65460579|FG002|Overall Study|Death during treatment|1|||
23468681|NCT00670748|65460580|FG003|Overall Study|Death during treatment|0|||
23794103|NCT05061992|66623609|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
23794104|NCT05061992|66623610|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
23794105|NCT05061992|66623609|FG000|Overall Study|Withdrawal by Subject|0|||
23794106|NCT05061992|66623610|FG001|Overall Study|Withdrawal by Subject|1|||
23794107|NCT00152516|66623611|FG000|Overall Study|Adverse Event|18|||
23794108|NCT00152516|66623611|FG000|Overall Study|Lack and Loss of Efficacy|30|||
23794109|NCT00152516|66623611|FG000|Overall Study|Lost to Follow-up|5|||
23794110|NCT00152516|66623611|FG000|Overall Study|Withdrawal by Subject|8|||
23794111|NCT00152516|66623611|FG000|Overall Study|Protocol Violation|3|||
23794112|NCT00152516|66623611|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
23794113|NCT00152516|66623611|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
23794114|NCT00152516|66623611|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
23794115|NCT00152516|66623611|FG000|Overall Study|Other: Non-Compliance|2|||
23794116|NCT00152516|66623611|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
23794117|NCT00152516|66623611|FG000|Overall Study|Other: Moved Out Of State|1|||
23794118|NCT00152516|66623611|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
23794119|NCT00152516|66623611|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
23794120|NCT03493919|66623612|FG000|Overall Study|Other|2|||
23794121|NCT03493919|66623613|FG001|Overall Study|Other|0|||
23794122|NCT03493919|66623614|FG002|Overall Study|Other|1|||
23794123|NCT03493919|66623615|FG003|Overall Study|Other|0|||
23794124|NCT03493919|66623612|FG000|Overall Study|Withdrawal by Subject|9|||
23794125|NCT03493919|66623613|FG001|Overall Study|Withdrawal by Subject|3|||
23794126|NCT03493919|66623614|FG002|Overall Study|Withdrawal by Subject|1|||
23794127|NCT03493919|66623615|FG003|Overall Study|Withdrawal by Subject|1|||
23794128|NCT03493919|66623612|FG000|Overall Study|Lost to Follow-up|5|||
23794129|NCT03493919|66623613|FG001|Overall Study|Lost to Follow-up|0|||
23794130|NCT03493919|66623614|FG002|Overall Study|Lost to Follow-up|0|||
23794131|NCT03493919|66623615|FG003|Overall Study|Lost to Follow-up|3|||
23794132|NCT03493919|66623612|FG000|Overall Study|Adverse Event|0|||
23794133|NCT03493919|66623613|FG001|Overall Study|Adverse Event|1|||
23794134|NCT03493919|66623614|FG002|Overall Study|Adverse Event|0|||
23794135|NCT03493919|66623615|FG003|Overall Study|Adverse Event|0|||
23794136|NCT02941523|66623617|FG000|Monotherapy|Withdrawal by Subject|0|||
23794137|NCT02941523|66623618|FG001|Monotherapy|Withdrawal by Subject|1|||
23352620|NCT00369161|65033097|FG001|Overall Study|Death|2|||
23352621|NCT00369161|65033096|FG000|Overall Study|Graft loss|4|||
23794138|NCT02941523|66623617|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
23794139|NCT02941523|66623618|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
23794140|NCT02941523|66623617|FG000|Carboplatin Combination Therapy|Death|1|||
23794141|NCT02941523|66623618|FG001|Carboplatin Combination Therapy|Death|2|||
23794142|NCT02941523|66623617|FG000|Carboplatin Combination Therapy|Disease progression|2|||
23352622|NCT00369161|65033097|FG001|Overall Study|Graft loss|0|||
23352623|NCT00369161|65033096|FG000|Overall Study|Administrative Problem|2|||
23794143|NCT02941523|66623618|FG001|Carboplatin Combination Therapy|Disease progression|0|||
23794144|NCT02941523|66623617|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
23794145|NCT02941523|66623618|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
23794146|NCT01475487|66623621|FG000|Overall Study|had to leave early for personal reasons|2|||
23794147|NCT01475487|66623622|FG001|Overall Study|had to leave early for personal reasons|1|||
23794148|NCT04254809|66623623|FG000|Overall Study|Lost to Follow-up|5|||
23794149|NCT04254809|66623624|FG001|Overall Study|Lost to Follow-up|10|||
23794150|NCT04194151|66623625|FG000|Overall Study|Physician Decision|1|||
23794151|NCT04194151|66623626|FG001|Overall Study|Physician Decision|1|||
23794152|NCT04194151|66623627|FG002|Overall Study|Physician Decision|1|||
23794153|NCT04194151|66623628|FG003|Overall Study|Physician Decision|1|||
23794154|NCT04194151|66623629|FG004|Overall Study|Physician Decision|0|||
23468682|NCT00670748|65460577|FG000|Overall Study|Not off study|2|||
23352624|NCT00369161|65033097|FG001|Overall Study|Administrative Problem|2|||
23794155|NCT04194151|66623630|FG005|Overall Study|Physician Decision|1|||
23352625|NCT01556932|65033100|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
23352626|NCT01556932|65033101|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
23794156|NCT04194151|66623625|FG000|Overall Study|Monitorization problem|0|||
23794157|NCT04194151|66623626|FG001|Overall Study|Monitorization problem|1|||
23352627|NCT01797094|65033102|FG000|Overall Study|Adverse Event|1|||
23352628|NCT01797094|65033103|FG001|Overall Study|Adverse Event|1|||
23352629|NCT01797094|65033102|FG000|Overall Study|Personal Reasons|4|||
23352630|NCT01797094|65033103|FG001|Overall Study|Personal Reasons|0|||
23352631|NCT01797094|65033102|FG000|Overall Study|Protocol Violation|0|||
23352632|NCT01797094|65033103|FG001|Overall Study|Protocol Violation|1|||
23352633|NCT01797094|65033102|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23352634|NCT01797094|65033103|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23352635|NCT00345878|65033107|FG000|Overall Study|Adverse Event|1|||
23352636|NCT00345878|65033108|FG001|Overall Study|Adverse Event|0|||
23352637|NCT00345878|65033107|FG000|Overall Study|Lost to Follow-up|2|||
23352638|NCT00345878|65033108|FG001|Overall Study|Lost to Follow-up|1|||
23352639|NCT00345878|65033107|FG000|Overall Study|Other|1|||
23352640|NCT00345878|65033108|FG001|Overall Study|Other|0|||
23352641|NCT04527978|65033109|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23352642|NCT04527978|65033110|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23352643|NCT00662558|65033111|FG000|Overall Study|Adverse Event|21|||
23352644|NCT00662558|65033112|FG001|Overall Study|Adverse Event|59|||
23352645|NCT00662558|65033111|FG000|Overall Study|Lack of Efficacy|4|||
23352646|NCT00662558|65033112|FG001|Overall Study|Lack of Efficacy|7|||
23352647|NCT00662558|65033111|FG000|Overall Study|Lost to Follow-up|13|||
23352648|NCT00662558|65033112|FG001|Overall Study|Lost to Follow-up|10|||
23352649|NCT00662558|65033111|FG000|Overall Study|Other|9|||
23352650|NCT00662558|65033112|FG001|Overall Study|Other|14|||
23352651|NCT00662558|65033111|FG000|Overall Study|Withdrawal by Subject|7|||
23352652|NCT00662558|65033112|FG001|Overall Study|Withdrawal by Subject|12|||
23352653|NCT00662558|65033111|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
23352654|NCT00662558|65033112|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
23352655|NCT02669667|65033114|FG000|Overall Study|Lost to Follow-up|0|||
23352656|NCT02669667|65033115|FG001|Overall Study|Lost to Follow-up|0|||
23352657|NCT02669667|65033116|FG002|Overall Study|Lost to Follow-up|0|||
23352658|NCT02669667|65033117|FG003|Overall Study|Lost to Follow-up|0|||
23352659|NCT02669667|65033118|FG004|Overall Study|Lost to Follow-up|0|||
23352660|NCT02669667|65033119|FG005|Overall Study|Lost to Follow-up|1|||
23352661|NCT02669667|65033120|FG006|Overall Study|Lost to Follow-up|0|||
23352662|NCT02469168|65033126|FG000|Overall Study|Trial closed|1|||
23352663|NCT02469168|65033127|FG001|Overall Study|Trial closed|0|||
23352664|NCT00448812|65033128|FG000|Year 2|Missed visit but remained in study|4|||
23352665|NCT00448812|65033129|FG001|Year 2|Missed visit but remained in study|1|||
23352666|NCT00448812|65033128|FG000|Year 3|Withdrawal by Subject|1|||
23352667|NCT00448812|65033129|FG001|Year 3|Withdrawal by Subject|3|||
23352668|NCT00448812|65033128|FG000|Year 3|Lost to Follow-up|1|||
23352669|NCT00448812|65033129|FG001|Year 3|Lost to Follow-up|0|||
23352670|NCT00448812|65033128|FG000|Year 3|Missed visit but remained in study|2|||
23352671|NCT00448812|65033129|FG001|Year 3|Missed visit but remained in study|0|||
23352672|NCT00448812|65033128|FG000|Year 5|Missed visit but remained in study|1|||
23352673|NCT00448812|65033129|FG001|Year 5|Missed visit but remained in study|0|||
23352674|NCT04318132|65033130|FG000|Overall Study|Protocol Violation|0|||
23352675|NCT04318132|65033131|FG001|Overall Study|Protocol Violation|0|||
23352676|NCT04318132|65033132|FG002|Overall Study|Protocol Violation|3|||
23352677|NCT04318132|65033133|FG003|Overall Study|Protocol Violation|0|||
23352678|NCT00575510|65033134|FG000|Overall Study|Lost to Follow-up|4|||
23352679|NCT00575510|65033135|FG001|Overall Study|Lost to Follow-up|6|||
23352680|NCT00575510|65033136|FG002|Overall Study|Lost to Follow-up|9|||
23352681|NCT00575510|65033134|FG000|Overall Study|Withdrawal by Subject|1|||
23352682|NCT00575510|65033135|FG001|Overall Study|Withdrawal by Subject|0|||
23352683|NCT00575510|65033136|FG002|Overall Study|Withdrawal by Subject|0|||
23352684|NCT00575510|65033134|FG000|Overall Study|Clinic Called Patient|7|||
23587164|NCT01352507|65876269|FG000|Treatment Period 1|Adverse Event|3|||
23468683|NCT00670748|65460578|FG001|Overall Study|Not off study|1|||
23468684|NCT00670748|65460579|FG002|Overall Study|Not off study|1|||
23468685|NCT00670748|65460580|FG003|Overall Study|Not off study|1|||
23468686|NCT02991040|65460581|FG000|Overall Study|Withdrawal by Subject|2|||
23468687|NCT02991040|65460581|FG000|Overall Study|Lost to Follow-up|2|||
23352685|NCT00575510|65033135|FG001|Overall Study|Clinic Called Patient|7|||
23352686|NCT00575510|65033136|FG002|Overall Study|Clinic Called Patient|7|||
23352687|NCT00575510|65033134|FG000|Overall Study|Pregnancy|0|||
23352688|NCT00575510|65033135|FG001|Overall Study|Pregnancy|0|||
23352689|NCT00575510|65033136|FG002|Overall Study|Pregnancy|1|||
23587165|NCT01352507|65876270|FG001|Treatment Period 1|Adverse Event|0|||
23468688|NCT00775593|65460582|FG000|Overall Study|Unmet eligibility criteria|6|||
23468689|NCT00775593|65460582|FG000|Overall Study|Death|1|||
23468690|NCT02249832|65460583|FG000|Overall Study|Withdrawal by Subject|3|||
23587166|NCT01352507|65876269|FG000|Treatment Period 1|Lost to Follow-up|3|||
23587167|NCT01352507|65876270|FG001|Treatment Period 1|Lost to Follow-up|4|||
23587168|NCT01352507|65876269|FG000|Treatment Period 1|Withdrawal by Subject|7|||
23587169|NCT01352507|65876270|FG001|Treatment Period 1|Withdrawal by Subject|5|||
23587170|NCT01352507|65876269|FG000|Treatment Period 1|Physician Decision|1|||
23587171|NCT01352507|65876270|FG001|Treatment Period 1|Physician Decision|0|||
23587172|NCT01352507|65876269|FG000|Washout Period|Withdrawal by Subject|0|||
23587173|NCT01352507|65876270|FG001|Washout Period|Withdrawal by Subject|1|||
23587174|NCT01352507|65876269|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
23587175|NCT01352507|65876270|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
23587176|NCT01352507|65876269|FG000|Treatment Period 2|Withdrawal by Subject|4|||
23587177|NCT01352507|65876270|FG001|Treatment Period 2|Withdrawal by Subject|3|||
23587178|NCT01352507|65876269|FG000|Treatment Period 2|Lack of Efficacy|1|||
23587179|NCT01352507|65876270|FG001|Treatment Period 2|Lack of Efficacy|0|||
23587180|NCT04176458|65876271|FG000|Overall Study|Covid 19|4|||
23587181|NCT01193153|65876272|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
23587182|NCT01193153|65876273|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
23587183|NCT01193153|65876272|FG000|Open-label Lead in Period|Pregnancy|1|||
23587184|NCT01193153|65876273|FG001|Open-label Lead in Period|Pregnancy|0|||
23587185|NCT01193153|65876272|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
23587186|NCT01193153|65876273|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
23587187|NCT01193153|65876272|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
23587188|NCT01193153|65876273|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
23587189|NCT01193153|65876272|FG000|Open-label Lead in Period|Other|14|||
23587190|NCT01193153|65876273|FG001|Open-label Lead in Period|Other|0|||
23587191|NCT01193153|65876272|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
23587192|NCT01193153|65876273|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
23587193|NCT01193153|65876272|FG000|Open-label Lead in Period|Adverse Event|41|||
23587194|NCT01193153|65876273|FG001|Open-label Lead in Period|Adverse Event|0|||
23587195|NCT01193153|65876272|FG000|Open-label Lead in Period|Death|1|||
23352690|NCT02772809|65033140|FG000|Overall Study|not completed some tasks|6|||
23468691|NCT02249832|65460583|FG000|Overall Study|Lost to Follow-up|10|||
23468692|NCT00223080|65460585|FG000|Overall Study|Withdrawal by Subject|253|||
23468693|NCT00223080|65460586|FG001|Overall Study|Withdrawal by Subject|232|||
23468694|NCT00223080|65460585|FG000|Overall Study|Required contraindicated med|0|||
23468695|NCT00223080|65460586|FG001|Overall Study|Required contraindicated med|1|||
23468696|NCT00223080|65460585|FG000|Overall Study|Non-compliant|7|||
23468697|NCT00223080|65460586|FG001|Overall Study|Non-compliant|7|||
23468698|NCT00223080|65460585|FG000|Overall Study|Moved from study area|37|||
23468699|NCT00223080|65460586|FG001|Overall Study|Moved from study area|47|||
23587196|NCT01193153|65876273|FG001|Open-label Lead in Period|Death|0|||
23587197|NCT01193153|65876272|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
23352691|NCT02649426|65033143|FG000|Overall Study|Follow-up on going|1|||
23352692|NCT02649426|65033144|FG001|Overall Study|Follow-up on going|26|||
23352693|NCT02649426|65033145|FG002|Overall Study|Follow-up on going|28|||
23352694|NCT02649426|65033146|FG003|Overall Study|Follow-up on going|31|||
23352695|NCT00481767|65033147|FG000|Overall Study|Withdrawal by Subject|16|||
23352696|NCT00481767|65033148|FG001|Overall Study|Withdrawal by Subject|11|||
23352697|NCT00481767|65033147|FG000|Overall Study|Lost to Follow-up|16|||
23352698|NCT00481767|65033148|FG001|Overall Study|Lost to Follow-up|10|||
23352699|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
23352700|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
23352701|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Adverse Event|1|||
23352702|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Adverse Event|2|||
23352703|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Physician Decision|1|||
23352704|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Physician Decision|0|||
23352705|NCT02697734|65037326|FG000|Optional Extension Phase|Adverse Event|5|||
23352706|NCT02697734|65037327|FG001|Optional Extension Phase|Adverse Event|1|||
23352707|NCT02697734|65037326|FG000|Optional Extension Phase|Physician Decision|0|||
23352708|NCT02697734|65037327|FG001|Optional Extension Phase|Physician Decision|1|||
23352709|NCT02028169|65037328|FG000|Overall Study|Lost to Follow-up|21|||
23352710|NCT02028169|65037328|FG000|Overall Study|Lack of Efficacy|2|||
23352711|NCT02028169|65037328|FG000|Overall Study|Withdrawal by Subject|2|||
23352712|NCT02028169|65037328|FG000|Overall Study|Adverse Event|1|||
23352713|NCT02028169|65037328|FG000|Overall Study|Cessation of Drug|1|||
23352714|NCT02028169|65037328|FG000|Overall Study|Concomitant Medication Usage|1|||
23352715|NCT00792116|65037331|FG000|Overall Study|Lost to Follow-up|0|||
23352716|NCT00792116|65037332|FG001|Overall Study|Lost to Follow-up|1|||
23352717|NCT00792116|65037331|FG000|Overall Study|Discontnued intervention|1|||
23352718|NCT00792116|65037332|FG001|Overall Study|Discontnued intervention|0|||
23352719|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
23352720|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
23352721|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
23352722|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352723|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352724|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352725|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
23352726|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352727|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352728|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352729|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352730|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352731|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
23352732|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
23352733|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352734|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352735|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352736|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352737|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
23352738|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
23352739|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
23352740|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352741|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352742|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352743|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352744|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352745|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352746|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
23352747|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
23352748|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
23352749|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352750|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352751|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352752|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
23352753|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
23352754|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
23587198|NCT01193153|65876273|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
23587199|NCT01193153|65876272|FG000|Open-label Stabilization Period|Adverse Event|9|||
23587200|NCT01193153|65876273|FG001|Open-label Stabilization Period|Adverse Event|0|||
23352755|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352756|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352757|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352758|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352759|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
23352760|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
23352761|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352762|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352763|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352764|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
23352765|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
23352766|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
23352767|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352768|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352769|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352770|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
23352771|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
23352772|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
23352773|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352774|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352775|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352776|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352777|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352778|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
23352779|NCT01285492|65037347|FG000|Overall Study|Adverse Event|11|||
23352780|NCT01285492|65037348|FG001|Overall Study|Adverse Event|0|||
23352781|NCT01285492|65037347|FG000|Overall Study|Protocol Violation|3|||
23352782|NCT01285492|65037348|FG001|Overall Study|Protocol Violation|0|||
23352783|NCT01285492|65037347|FG000|Overall Study|Withdrawal by Subject|2|||
23352784|NCT01285492|65037348|FG001|Overall Study|Withdrawal by Subject|1|||
23352785|NCT01285492|65037347|FG000|Overall Study|Death|1|||
23352786|NCT01285492|65037348|FG001|Overall Study|Death|0|||
23352787|NCT01857102|65037349|FG000|Period 1|No longer meets Eligibility Criteria|0|||
23352788|NCT01857102|65037350|FG001|Period 1|No longer meets Eligibility Criteria|2|||
23468700|NCT00223080|65460585|FG000|Overall Study|Lost to Follow-up|259|||
23468701|NCT00223080|65460586|FG001|Overall Study|Lost to Follow-up|284|||
23468702|NCT00223080|65460585|FG000|Overall Study|Death|85|||
23468703|NCT00223080|65460586|FG001|Overall Study|Death|74|||
23468704|NCT00223080|65460585|FG000|Overall Study|Other|14|||
23468705|NCT00223080|65460586|FG001|Overall Study|Other|11|||
23468706|NCT00223080|65460585|FG000|Overall Study|Reason not provided|141|||
23468707|NCT00223080|65460586|FG001|Overall Study|Reason not provided|140|||
23468708|NCT00223080|65460585|FG000|Overall Study|Adverse Event|0|||
23587201|NCT01193153|65876272|FG000|Open-label Stabilization Period|Death|2|||
23794158|NCT04194151|66623627|FG002|Overall Study|Monitorization problem|0|||
23794159|NCT04194151|66623628|FG003|Overall Study|Monitorization problem|0|||
23794160|NCT04194151|66623629|FG004|Overall Study|Monitorization problem|0|||
23794161|NCT04194151|66623630|FG005|Overall Study|Monitorization problem|0|||
23794162|NCT02416934|66623631|FG000|Overall Study|given steroids|1|||
23794163|NCT02416934|66623632|FG001|Overall Study|given steroids|2|||
23794164|NCT02416934|66623631|FG000|Overall Study|Lost to Follow-up|0|||
23794165|NCT02416934|66623632|FG001|Overall Study|Lost to Follow-up|2|||
23794166|NCT02416934|66623631|FG000|Overall Study|Withdrawal by Subject|1|||
23794167|NCT02416934|66623632|FG001|Overall Study|Withdrawal by Subject|0|||
23794168|NCT02416934|66623631|FG000|Overall Study|recruited during continuing renewal proc|0|||
23794169|NCT02416934|66623632|FG001|Overall Study|recruited during continuing renewal proc|1|||
23794170|NCT02416934|66623631|FG000|Overall Study|Protocol Violation|0|||
23468709|NCT00223080|65460586|FG001|Overall Study|Adverse Event|1|||
23794171|NCT02416934|66623632|FG001|Overall Study|Protocol Violation|1|||
23794172|NCT02416934|66623631|FG000|Overall Study|surgery started late|0|||
23794173|NCT02416934|66623632|FG001|Overall Study|surgery started late|1|||
23794174|NCT02416934|66623631|FG000|Overall Study|re-operation|1|||
23794175|NCT02416934|66623632|FG001|Overall Study|re-operation|0|||
23640669|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
23640670|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
23640671|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
23640672|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
23640673|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
23640674|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
23640675|NCT00266227|66071408|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
23640676|NCT00266227|66071409|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
23640677|NCT00266227|66071410|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
23794176|NCT01223027|66623642|FG000|Overall Study|Adverse Event|20|||
23794177|NCT01223027|66623643|FG001|Overall Study|Adverse Event|10|||
23352789|NCT01857102|65037349|FG000|Period 1|Lost to Follow-up|0|||
23794178|NCT01223027|66623642|FG000|Overall Study|Death|42|||
23352790|NCT01857102|65037350|FG001|Period 1|Lost to Follow-up|3|||
23352791|NCT01857102|65037349|FG000|Period 1|Unsatisfactory Lens Fit|1|||
23794179|NCT01223027|66623643|FG001|Overall Study|Death|42|||
23794180|NCT01223027|66623642|FG000|Overall Study|Lost to Follow-up|2|||
23794181|NCT01223027|66623643|FG001|Overall Study|Lost to Follow-up|1|||
23794182|NCT01223027|66623642|FG000|Overall Study|Physician Decision|4|||
23794183|NCT01223027|66623643|FG001|Overall Study|Physician Decision|8|||
23352792|NCT01857102|65037350|FG001|Period 1|Unsatisfactory Lens Fit|0|||
23352793|NCT01857102|65037349|FG000|Period 1|Unsatisfactory Visual Response|1|||
23794184|NCT01223027|66623642|FG000|Overall Study|Progressive Disease|167|||
23794185|NCT01223027|66623643|FG001|Overall Study|Progressive Disease|183|||
23352794|NCT01857102|65037350|FG001|Period 1|Unsatisfactory Visual Response|0|||
23352795|NCT01857102|65037349|FG000|Period 1|Physician Decision|1|||
23352796|NCT01857102|65037350|FG001|Period 1|Physician Decision|0|||
23352797|NCT01857102|65037349|FG000|Period 2|Lens Discomfort|1|||
23352798|NCT01857102|65037350|FG001|Period 2|Lens Discomfort|0|||
23352799|NCT01857102|65037349|FG000|Period 2|Unsatisfactory Lens Fit|1|||
23352800|NCT01857102|65037350|FG001|Period 2|Unsatisfactory Lens Fit|0|||
23352801|NCT01900899|65037353|FG000|Overall Study|Withdrawal by Subject|7|||
23352802|NCT01900899|65037354|FG001|Overall Study|Withdrawal by Subject|1|||
23352803|NCT01900899|65037353|FG000|Overall Study|Migrated from study area|2|||
23352804|NCT01900899|65037354|FG001|Overall Study|Migrated from study area|0|||
23352805|NCT00957905|65037356|FG000|Part B|Not Treated|0|||
23640678|NCT00266227|66071408|FG000|Retreatment: Week 48 to Week 72|Death|1|||
23640679|NCT00266227|66071409|FG001|Retreatment: Week 48 to Week 72|Death|1|||
23794186|NCT01223027|66623642|FG000|Overall Study|Protocol Violation|2|||
23794187|NCT01223027|66623643|FG001|Overall Study|Protocol Violation|1|||
23794188|NCT01223027|66623642|FG000|Overall Study|Subject/guardian decicion|18|||
23352806|NCT00957905|65037357|FG001|Part B|Not Treated|1|||
23352807|NCT00957905|65037356|FG000|Part B|Physician Decision|0|||
23352808|NCT00957905|65037357|FG001|Part B|Physician Decision|1|||
23352809|NCT00957905|65037356|FG000|Part B|Death|0|||
23640680|NCT00266227|66071410|FG002|Retreatment: Week 48 to Week 72|Death|0|||
23468710|NCT01474239|65460587|FG000|Overall Study|Disease Progression|37|||
23468711|NCT01474239|65460588|FG001|Overall Study|Disease Progression|25|||
23468712|NCT01474239|65460587|FG000|Overall Study|Adverse Event|12|||
23468713|NCT01474239|65460588|FG001|Overall Study|Adverse Event|3|||
23468714|NCT01474239|65460587|FG000|Overall Study|Withdrawal by Subject|1|||
23468715|NCT01474239|65460588|FG001|Overall Study|Withdrawal by Subject|2|||
23468716|NCT01474239|65460587|FG000|Overall Study|Death|1|||
23468717|NCT01474239|65460588|FG001|Overall Study|Death|1|||
23468718|NCT01474239|65460587|FG000|Overall Study|Clinical Disease Progression|7|||
23468719|NCT01474239|65460588|FG001|Overall Study|Clinical Disease Progression|1|||
23468720|NCT01474239|65460587|FG000|Overall Study|Withdrawal for Economic Reason|1|||
23468721|NCT01474239|65460588|FG001|Overall Study|Withdrawal for Economic Reason|0|||
23468722|NCT02106390|65460595|FG000|Overall Study|Withdrawal by Subject|15|||
23468723|NCT02106390|65460596|FG001|Overall Study|Withdrawal by Subject|16|||
23468724|NCT02106390|65460597|FG002|Overall Study|Withdrawal by Subject|15|||
23468725|NCT02106390|65460595|FG000|Overall Study|Lost to Follow-up|25|||
23468726|NCT02106390|65460596|FG001|Overall Study|Lost to Follow-up|20|||
23468727|NCT02106390|65460597|FG002|Overall Study|Lost to Follow-up|13|||
23468728|NCT02106390|65460595|FG000|Overall Study|Other: Administrative Reason|8|||
23794189|NCT01223027|66623643|FG001|Overall Study|Subject/guardian decicion|16|||
23794190|NCT01223027|66623642|FG000|Overall Study|New therapy for study indication|17|||
23468729|NCT02106390|65460596|FG001|Overall Study|Other: Administrative Reason|5|||
23468730|NCT02106390|65460597|FG002|Overall Study|Other: Administrative Reason|12|||
23468731|NCT02106390|65460595|FG000|Overall Study|Other: Unspecified|1|||
23468732|NCT02106390|65460596|FG001|Overall Study|Other: Unspecified|4|||
23468733|NCT02106390|65460597|FG002|Overall Study|Other: Unspecified|2|||
23468734|NCT02106390|65460595|FG000|Overall Study|Adverse Event|0|||
23468735|NCT02106390|65460596|FG001|Overall Study|Adverse Event|2|||
23468736|NCT02106390|65460597|FG002|Overall Study|Adverse Event|1|||
23468737|NCT02106390|65460595|FG000|Overall Study|Protocol Violation|0|||
23468738|NCT02106390|65460596|FG001|Overall Study|Protocol Violation|1|||
23468739|NCT02106390|65460597|FG002|Overall Study|Protocol Violation|0|||
23468740|NCT00611026|65460598|FG000|Randomized to Double-blind Treatment|Not treated|2|||
23468741|NCT00611026|65460599|FG001|Randomized to Double-blind Treatment|Not treated|1|||
23468742|NCT00611026|65460600|FG002|Randomized to Double-blind Treatment|Not treated|3|||
23468743|NCT00611026|65460598|FG000|Double-blind Treatment Period|Death|1|||
23468744|NCT00611026|65460599|FG001|Double-blind Treatment Period|Death|0|||
23468745|NCT00611026|65460600|FG002|Double-blind Treatment Period|Death|0|||
23468746|NCT00611026|65460598|FG000|Double-blind Treatment Period|Adverse Event|9|||
23468747|NCT00611026|65460599|FG001|Double-blind Treatment Period|Adverse Event|28|||
23468748|NCT00611026|65460600|FG002|Double-blind Treatment Period|Adverse Event|46|||
23468749|NCT00611026|65460598|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
23468750|NCT00611026|65460599|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
23468751|NCT00611026|65460600|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
23468752|NCT00611026|65460598|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
23468753|NCT00611026|65460599|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
23468754|NCT00611026|65460600|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
23468755|NCT00611026|65460598|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
23468756|NCT00611026|65460599|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
23468757|NCT00611026|65460600|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
23468758|NCT00611026|65460598|FG000|Double-blind Treatment Period|Other|13|||
23468759|NCT00611026|65460599|FG001|Double-blind Treatment Period|Other|20|||
23468760|NCT00611026|65460600|FG002|Double-blind Treatment Period|Other|18|||
23468761|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
23468762|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
23468763|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
23468764|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
23468765|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
23794191|NCT01223027|66623643|FG001|Overall Study|New therapy for study indication|8|||
23794192|NCT01223027|66623642|FG000|Overall Study|Study terminated by sponsor|2|||
23794193|NCT01223027|66623643|FG001|Overall Study|Study terminated by sponsor|8|||
23794194|NCT01499160|66623644|FG000|Overall Study|Adverse Event|1|||
23794195|NCT01499160|66623644|FG000|Overall Study|Withdrawal by Subject|1|||
23468766|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
23468767|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
23468768|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
23468769|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
23468770|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
23468771|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
23468772|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
23468773|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
23468774|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
23468775|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
23468776|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
23468777|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
23468778|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
23468779|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
23468780|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
23468781|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
23468782|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
23468783|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
23468784|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
23468785|NCT05343624|65460604|FG000|Overall Study|Chart review not completed|1|||
23468786|NCT01376804|65460611|FG000|Treatment Period|Withdrawal by Subject|1|||
23468787|NCT01376804|65460611|FG000|Treatment Period|Adverse Event|6|||
23468788|NCT01376804|65460611|FG000|Treatment Period|Patient did not receive study drug|1|||
23468789|NCT00882557|65460612|FG000|Overall Study|Withdrawal by Subject|1|||
23468790|NCT00882557|65460613|FG001|Overall Study|Withdrawal by Subject|0|||
23468791|NCT00882557|65460612|FG000|Overall Study|Trouble with Vein Access|1|||
23468792|NCT00882557|65460613|FG001|Overall Study|Trouble with Vein Access|0|||
23468793|NCT00882557|65460612|FG000|Overall Study|Randomized Not Treated|0|||
23468794|NCT00882557|65460613|FG001|Overall Study|Randomized Not Treated|1|||
23794196|NCT02952924|66623645|FG000|Overall Study|Protocol Violation|0|||
23794197|NCT02952924|66623646|FG001|Overall Study|Protocol Violation|0|||
23794198|NCT02952924|66623647|FG002|Overall Study|Protocol Violation|0|||
23794199|NCT02952924|66623648|FG003|Overall Study|Protocol Violation|0|||
23468795|NCT02399163|65460617|FG000|Overall Study|Adverse Event|2|||
23468796|NCT02399163|65460617|FG000|Overall Study|Protocol Deviation|2|||
23468797|NCT02399163|65460617|FG000|Overall Study|Withdrawal by Participant|5|||
23468798|NCT04195893|65460618|FG000|Second Intervention|Withdrawal by Subject|1|||
23468799|NCT04195893|65460619|FG001|Second Intervention|Withdrawal by Subject|0|||
23468800|NCT01063283|65460623|FG000|Cycle 1|Adverse Event|2|||
23468801|NCT01063283|65460624|FG001|Cycle 1|Adverse Event|0|||
23468802|NCT01063283|65460625|FG002|Cycle 1|Adverse Event|0|||
23468803|NCT01063283|65460623|FG000|Cycle 1|Technical failure in data collection|1|||
23468804|NCT01063283|65460624|FG001|Cycle 1|Technical failure in data collection|0|||
23468805|NCT01063283|65460625|FG002|Cycle 1|Technical failure in data collection|0|||
23468806|NCT03436290|65460626|FG000|Overall Study|Post-randomization Exclusion|1|||
23468807|NCT03436290|65460627|FG001|Overall Study|Post-randomization Exclusion|0|||
23468808|NCT03436290|65460626|FG000|Overall Study|Death|6|||
23468809|NCT03436290|65460627|FG001|Overall Study|Death|0|||
23468810|NCT03436290|65460626|FG000|Overall Study|Withdrawal by Subject|4|||
23468811|NCT03436290|65460627|FG001|Overall Study|Withdrawal by Subject|0|||
23468812|NCT03436290|65460626|FG000|Overall Study|Protocol Violation|30|||
23468813|NCT03436290|65460627|FG001|Overall Study|Protocol Violation|0|||
23468814|NCT04294680|65460628|FG000|Overall Study|Withdrawal by Subject|2|||
23468815|NCT04294680|65460629|FG001|Overall Study|Withdrawal by Subject|1|||
23468816|NCT04294680|65460628|FG000|Overall Study|Follow-up visits completed outside of window|1|||
23468817|NCT04294680|65460629|FG001|Overall Study|Follow-up visits completed outside of window|0|||
23468818|NCT01209689|65460630|FG000|Overall Study|Insufficient Therapeutic Response|7|||
23468819|NCT01209689|65460631|FG001|Overall Study|Insufficient Therapeutic Response|2|||
23468820|NCT01209689|65460630|FG000|Overall Study|Refused Treatment|8|||
23468821|NCT01209689|65460631|FG001|Overall Study|Refused Treatment|3|||
23468822|NCT01209689|65460630|FG000|Overall Study|Adverse Event|4|||
23468823|NCT01209689|65460631|FG001|Overall Study|Adverse Event|0|||
23468824|NCT01209689|65460630|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23468825|NCT01209689|65460631|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23468826|NCT01209689|65460630|FG000|Overall Study|Failure to Return|3|||
23468827|NCT01209689|65460631|FG001|Overall Study|Failure to Return|0|||
23468828|NCT01209689|65460630|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
23468829|NCT01209689|65460631|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
23468830|NCT01663103|65460632|FG000|Overall Study|Withdrawal by Subject|1|||
23468831|NCT01663103|65460633|FG001|Overall Study|Withdrawal by Subject|2|||
23468832|NCT01663103|65460632|FG000|Overall Study|Adverse Event|1|||
23468833|NCT01663103|65460633|FG001|Overall Study|Adverse Event|0|||
23468834|NCT01663103|65460632|FG000|Overall Study|dog bite|1|||
23468835|NCT01663103|65460633|FG001|Overall Study|dog bite|0|||
23468836|NCT02346721|65460644|FG000|Overall Study|Withdrew Consent|3|||
23468837|NCT02346721|65460644|FG000|Overall Study|Lack of Efficacy|1|||
23794200|NCT02952924|66623649|FG004|Overall Study|Protocol Violation|0|||
23468838|NCT02722304|65460645|FG000|Overall Study|Study Terminated by Sponsor|1|||
23794201|NCT02952924|66623650|FG005|Overall Study|Protocol Violation|0|||
23794202|NCT02952924|66623651|FG006|Overall Study|Protocol Violation|0|||
23468839|NCT02722304|65460646|FG001|Overall Study|Study Terminated by Sponsor|0|||
23468840|NCT02722304|65460647|FG002|Overall Study|Study Terminated by Sponsor|2|||
23468841|NCT02722304|65460648|FG003|Overall Study|Study Terminated by Sponsor|1|||
23468842|NCT02722304|65460649|FG004|Overall Study|Study Terminated by Sponsor|1|||
23468843|NCT02722304|65460645|FG000|Overall Study|Other|0|||
23468844|NCT02722304|65460646|FG001|Overall Study|Other|0|||
23468845|NCT02722304|65460647|FG002|Overall Study|Other|0|||
23468846|NCT02722304|65460648|FG003|Overall Study|Other|1|||
23468847|NCT02722304|65460649|FG004|Overall Study|Other|1|||
23468848|NCT00473382|65460650|FG000|Core Study|Adverse Event|3|||
23468849|NCT00473382|65460651|FG001|Core Study|Adverse Event|1|||
23468850|NCT00473382|65460652|FG002|Core Study|Adverse Event|1|||
23468851|NCT00473382|65460650|FG000|Core Study|Death|3|||
23468852|NCT00473382|65460651|FG001|Core Study|Death|5|||
23468853|NCT00473382|65460652|FG002|Core Study|Death|10|||
23468854|NCT00473382|65460650|FG000|Core Study|Lost to Follow-up|3|||
23468855|NCT00473382|65460651|FG001|Core Study|Lost to Follow-up|3|||
23468856|NCT00473382|65460652|FG002|Core Study|Lost to Follow-up|3|||
23468857|NCT00473382|65460650|FG000|Core Study|Physician Decision|1|||
23468858|NCT00473382|65460651|FG001|Core Study|Physician Decision|2|||
23468859|NCT00473382|65460652|FG002|Core Study|Physician Decision|2|||
23468860|NCT00473382|65460650|FG000|Core Study|Subject non-compliance|5|||
23468861|NCT00473382|65460651|FG001|Core Study|Subject non-compliance|2|||
23468862|NCT00473382|65460652|FG002|Core Study|Subject non-compliance|1|||
23468863|NCT00473382|65460650|FG000|Core Study|Subject needed other treatment|1|||
23468864|NCT00473382|65460651|FG001|Core Study|Subject needed other treatment|3|||
23468865|NCT00473382|65460652|FG002|Core Study|Subject needed other treatment|2|||
23468866|NCT00473382|65460650|FG000|Core Study|Subject's decision|12|||
23468867|NCT00473382|65460651|FG001|Core Study|Subject's decision|11|||
23468868|NCT00473382|65460652|FG002|Core Study|Subject's decision|10|||
23468869|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
23468870|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
23468871|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
23468872|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Death|1|||
23468873|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Death|3|||
23468874|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Death|3|||
23468875|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23468876|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
23468877|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23468878|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
23468879|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
23468880|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
23468881|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
23468882|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
23468883|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
23468884|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
23468885|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
23468886|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
23468887|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
23468888|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
23468889|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
23468890|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Death|1|||
23587202|NCT01193153|65876273|FG001|Open-label Stabilization Period|Death|0|||
23587203|NCT01193153|65876272|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
23587204|NCT01193153|65876273|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
23587205|NCT01193153|65876272|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
23587206|NCT01193153|65876273|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
23587207|NCT01193153|65876272|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
23468891|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Death|7|||
23468892|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Death|4|||
23468893|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
23468894|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
23468895|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
23587208|NCT01193153|65876273|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
23352810|NCT00957905|65037357|FG001|Part B|Death|1|||
23352811|NCT00957905|65037356|FG000|Part B|Protocol Violation|0|||
23352812|NCT00957905|65037357|FG001|Part B|Protocol Violation|1|||
23587209|NCT01193153|65876272|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
23587210|NCT01193153|65876273|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
23587211|NCT01193153|65876272|FG000|Open-label Stabilization Period|Other|8|||
23587212|NCT01193153|65876273|FG001|Open-label Stabilization Period|Other|0|||
23587213|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Other|2|||
23587214|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Other|3|||
23587215|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
23352813|NCT00534105|65037358|FG000|Overall Study|Lost to Follow-up|23|||
23352814|NCT00534105|65037359|FG001|Overall Study|Lost to Follow-up|39|||
23352815|NCT00195494|65037361|FG000|Year 1|Adverse Event|0|||
23352816|NCT00195494|65037362|FG001|Year 1|Adverse Event|0|||
23352817|NCT00195494|65037363|FG002|Year 1|Adverse Event|0|||
23352818|NCT00195494|65037364|FG003|Year 1|Adverse Event|0|||
23352819|NCT00195494|65037365|FG004|Year 1|Adverse Event|34|||
23352820|NCT00195494|65037366|FG005|Year 1|Adverse Event|27|||
23352821|NCT00195494|65037361|FG000|Year 1|System Toxicity|0|||
23352822|NCT00195494|65037362|FG001|Year 1|System Toxicity|0|||
23352823|NCT00195494|65037363|FG002|Year 1|System Toxicity|0|||
23352824|NCT00195494|65037364|FG003|Year 1|System Toxicity|0|||
23352825|NCT00195494|65037365|FG004|Year 1|System Toxicity|0|||
23352826|NCT00195494|65037366|FG005|Year 1|System Toxicity|1|||
23352827|NCT00195494|65037361|FG000|Year 1|Lack of Efficacy|0|||
23352828|NCT00195494|65037362|FG001|Year 1|Lack of Efficacy|0|||
23352829|NCT00195494|65037363|FG002|Year 1|Lack of Efficacy|0|||
23352830|NCT00195494|65037364|FG003|Year 1|Lack of Efficacy|0|||
23352831|NCT00195494|65037365|FG004|Year 1|Lack of Efficacy|24|||
23352832|NCT00195494|65037366|FG005|Year 1|Lack of Efficacy|9|||
23352833|NCT00195494|65037361|FG000|Year 1|Compliance|0|||
23352834|NCT00195494|65037362|FG001|Year 1|Compliance|0|||
23352835|NCT00195494|65037363|FG002|Year 1|Compliance|0|||
23352836|NCT00195494|65037364|FG003|Year 1|Compliance|0|||
23352837|NCT00195494|65037365|FG004|Year 1|Compliance|5|||
23352838|NCT00195494|65037366|FG005|Year 1|Compliance|1|||
23352839|NCT00195494|65037361|FG000|Year 1|Lost to Follow-up|0|||
23352840|NCT00195494|65037362|FG001|Year 1|Lost to Follow-up|0|||
23352841|NCT00195494|65037363|FG002|Year 1|Lost to Follow-up|0|||
23352842|NCT00195494|65037364|FG003|Year 1|Lost to Follow-up|0|||
23352843|NCT00195494|65037365|FG004|Year 1|Lost to Follow-up|1|||
23352844|NCT00195494|65037366|FG005|Year 1|Lost to Follow-up|0|||
23352845|NCT00195494|65037361|FG000|Year 1|Missed >4 consecutive doses|0|||
23352846|NCT00195494|65037362|FG001|Year 1|Missed >4 consecutive doses|0|||
23352847|NCT00195494|65037363|FG002|Year 1|Missed >4 consecutive doses|0|||
23352848|NCT00195494|65037364|FG003|Year 1|Missed >4 consecutive doses|0|||
23352849|NCT00195494|65037365|FG004|Year 1|Missed >4 consecutive doses|3|||
23352850|NCT00195494|65037366|FG005|Year 1|Missed >4 consecutive doses|2|||
23352851|NCT00195494|65037361|FG000|Year 1|Protocol deviation|0|||
23352852|NCT00195494|65037362|FG001|Year 1|Protocol deviation|0|||
23352853|NCT00195494|65037363|FG002|Year 1|Protocol deviation|0|||
23352854|NCT00195494|65037364|FG003|Year 1|Protocol deviation|0|||
23352855|NCT00195494|65037365|FG004|Year 1|Protocol deviation|2|||
23706819|NCT00002663|66301345|FG006|Overall Study|Death|0|||
23794203|NCT02952924|66623652|FG007|Overall Study|Protocol Violation|0|||
23794204|NCT02952924|66623653|FG008|Overall Study|Protocol Violation|0|||
23794205|NCT02952924|66623654|FG009|Overall Study|Protocol Violation|0|||
23794206|NCT02952924|66623655|FG010|Overall Study|Protocol Violation|0|||
23794207|NCT02952924|66623656|FG011|Overall Study|Protocol Violation|0|||
23794208|NCT02952924|66623657|FG012|Overall Study|Protocol Violation|0|||
23794209|NCT02952924|66623658|FG013|Overall Study|Protocol Violation|0|||
23794210|NCT02952924|66623659|FG014|Overall Study|Protocol Violation|0|||
23794211|NCT02952924|66623660|FG015|Overall Study|Protocol Violation|0|||
23352856|NCT00195494|65037366|FG005|Year 1|Protocol deviation|3|||
23352857|NCT00195494|65037361|FG000|Year 1|Physician Decision|0|||
23352858|NCT00195494|65037362|FG001|Year 1|Physician Decision|0|||
23352859|NCT00195494|65037363|FG002|Year 1|Physician Decision|0|||
23352860|NCT00195494|65037364|FG003|Year 1|Physician Decision|0|||
23352861|NCT00195494|65037365|FG004|Year 1|Physician Decision|1|||
23352862|NCT00195494|65037366|FG005|Year 1|Physician Decision|0|||
23352863|NCT00195494|65037361|FG000|Year 1|Withdrawal by Subject|0|||
23352864|NCT00195494|65037362|FG001|Year 1|Withdrawal by Subject|0|||
23352865|NCT00195494|65037363|FG002|Year 1|Withdrawal by Subject|0|||
23352866|NCT00195494|65037364|FG003|Year 1|Withdrawal by Subject|0|||
23352867|NCT00195494|65037365|FG004|Year 1|Withdrawal by Subject|8|||
23352868|NCT00195494|65037366|FG005|Year 1|Withdrawal by Subject|9|||
23468896|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
23794212|NCT02952924|66623661|FG016|Overall Study|Protocol Violation|0|||
23794213|NCT02952924|66623662|FG017|Overall Study|Protocol Violation|0|||
23794214|NCT02952924|66623663|FG018|Overall Study|Protocol Violation|0|||
23794215|NCT02952924|66623664|FG019|Overall Study|Protocol Violation|1|||
23794216|NCT02952924|66623665|FG020|Overall Study|Protocol Violation|0|||
23794217|NCT02952924|66623666|FG021|Overall Study|Protocol Violation|0|||
23794218|NCT02952924|66623645|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
23794219|NCT02952924|66623646|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
23794220|NCT02952924|66623647|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
23794221|NCT02952924|66623648|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
23794222|NCT02952924|66623649|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
23794223|NCT02952924|66623650|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
23794224|NCT02952924|66623651|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
23794225|NCT02952924|66623652|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
23468897|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
23468898|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
23468899|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
23468900|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
23468901|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
23468902|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
23468903|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
23468904|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
23468905|NCT01746901|65460653|FG000|Naloxone Challenge Phase|Adverse Event|2|||
23468906|NCT01746901|65460654|FG001|Naloxone Challenge Phase|Adverse Event|0|||
23468907|NCT01746901|65460655|FG002|Naloxone Challenge Phase|Adverse Event|0|||
23468908|NCT01746901|65460656|FG003|Naloxone Challenge Phase|Adverse Event|0|||
23468909|NCT01746901|65460657|FG004|Naloxone Challenge Phase|Adverse Event|0|||
23468910|NCT01746901|65460658|FG005|Naloxone Challenge Phase|Adverse Event|0|||
23468911|NCT01746901|65460659|FG006|Naloxone Challenge Phase|Adverse Event|0|||
23468912|NCT01746901|65460660|FG007|Naloxone Challenge Phase|Adverse Event|0|||
23468913|NCT01746901|65460661|FG008|Naloxone Challenge Phase|Adverse Event|0|||
23468914|NCT01746901|65460653|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
23468915|NCT01746901|65460654|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468916|NCT01746901|65460655|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468917|NCT01746901|65460656|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468918|NCT01746901|65460657|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23794226|NCT02952924|66623653|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
23794227|NCT02952924|66623654|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
23352869|NCT00195494|65037361|FG000|Year 1|Protocol Violation|0|||
23352870|NCT00195494|65037362|FG001|Year 1|Protocol Violation|0|||
23352871|NCT00195494|65037363|FG002|Year 1|Protocol Violation|0|||
23352872|NCT00195494|65037364|FG003|Year 1|Protocol Violation|0|||
23352873|NCT00195494|65037365|FG004|Year 1|Protocol Violation|1|||
23352874|NCT00195494|65037366|FG005|Year 1|Protocol Violation|1|||
23352875|NCT00195494|65037361|FG000|Year 2|Adverse Event|3|||
23352876|NCT00195494|65037362|FG001|Year 2|Adverse Event|7|||
23352877|NCT00195494|65037363|FG002|Year 2|Adverse Event|5|||
23352878|NCT00195494|65037364|FG003|Year 2|Adverse Event|9|||
23352879|NCT00195494|65037365|FG004|Year 2|Adverse Event|0|||
23352880|NCT00195494|65037366|FG005|Year 2|Adverse Event|0|||
23352881|NCT00195494|65037361|FG000|Year 2|Lack of Efficacy|0|||
23352882|NCT00195494|65037362|FG001|Year 2|Lack of Efficacy|1|||
23352883|NCT00195494|65037363|FG002|Year 2|Lack of Efficacy|7|||
23468919|NCT01746901|65460658|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468920|NCT01746901|65460659|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468921|NCT01746901|65460660|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468922|NCT01746901|65460661|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468923|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23794228|NCT02952924|66623655|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
23794229|NCT02952924|66623656|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
23794230|NCT02952924|66623657|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
23794231|NCT02952924|66623658|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
23794232|NCT02952924|66623659|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
23794233|NCT02952924|66623660|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
23794234|NCT02952924|66623661|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
23794235|NCT02952924|66623662|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
23794236|NCT02952924|66623663|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
23352884|NCT00195494|65037364|FG003|Year 2|Lack of Efficacy|7|||
23352885|NCT00195494|65037365|FG004|Year 2|Lack of Efficacy|0|||
23640681|NCT00266227|66071408|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
23640682|NCT00266227|66071409|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
23640683|NCT00266227|66071410|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
23352886|NCT00195494|65037366|FG005|Year 2|Lack of Efficacy|0|||
23352887|NCT00195494|65037361|FG000|Year 2|Compliance|1|||
23352888|NCT00195494|65037362|FG001|Year 2|Compliance|0|||
23640684|NCT00266227|66071408|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
23352889|NCT00195494|65037363|FG002|Year 2|Compliance|0|||
23352890|NCT00195494|65037364|FG003|Year 2|Compliance|2|||
23352891|NCT00195494|65037365|FG004|Year 2|Compliance|0|||
23352892|NCT00195494|65037366|FG005|Year 2|Compliance|0|||
23352893|NCT00195494|65037361|FG000|Year 2|Lost to Follow-up|0|||
23352894|NCT00195494|65037362|FG001|Year 2|Lost to Follow-up|0|||
23352895|NCT00195494|65037363|FG002|Year 2|Lost to Follow-up|1|||
23352896|NCT00195494|65037364|FG003|Year 2|Lost to Follow-up|1|||
23352897|NCT00195494|65037365|FG004|Year 2|Lost to Follow-up|0|||
23352898|NCT00195494|65037366|FG005|Year 2|Lost to Follow-up|0|||
23352899|NCT00195494|65037361|FG000|Year 2|Missed >4 consecutive doses|1|||
23352900|NCT00195494|65037362|FG001|Year 2|Missed >4 consecutive doses|1|||
23352901|NCT00195494|65037363|FG002|Year 2|Missed >4 consecutive doses|1|||
23352902|NCT00195494|65037364|FG003|Year 2|Missed >4 consecutive doses|0|||
23352903|NCT00195494|65037365|FG004|Year 2|Missed >4 consecutive doses|0|||
23352904|NCT00195494|65037366|FG005|Year 2|Missed >4 consecutive doses|0|||
23352905|NCT00195494|65037361|FG000|Year 2|Protocol deviation|0|||
23352906|NCT00195494|65037362|FG001|Year 2|Protocol deviation|1|||
23352907|NCT00195494|65037363|FG002|Year 2|Protocol deviation|0|||
23352908|NCT00195494|65037364|FG003|Year 2|Protocol deviation|0|||
23352909|NCT00195494|65037365|FG004|Year 2|Protocol deviation|0|||
23352910|NCT00195494|65037366|FG005|Year 2|Protocol deviation|0|||
23352911|NCT00195494|65037361|FG000|Year 2|Physician Decision|1|||
23352912|NCT00195494|65037362|FG001|Year 2|Physician Decision|1|||
23352913|NCT00195494|65037363|FG002|Year 2|Physician Decision|0|||
23352914|NCT00195494|65037364|FG003|Year 2|Physician Decision|0|||
23794237|NCT02952924|66623664|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
23794238|NCT02952924|66623665|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
23794239|NCT02952924|66623666|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
23352915|NCT00195494|65037365|FG004|Year 2|Physician Decision|0|||
23352916|NCT00195494|65037366|FG005|Year 2|Physician Decision|0|||
23468924|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
23468925|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468926|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468927|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468928|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468929|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468930|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468931|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468932|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468933|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
23468934|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
23468935|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468936|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23706820|NCT00002663|66301346|FG007|Overall Study|Death|1|||
23352917|NCT00195494|65037361|FG000|Year 2|Withdrawal by Subject|1|||
23352918|NCT00195494|65037362|FG001|Year 2|Withdrawal by Subject|5|||
23352919|NCT00195494|65037363|FG002|Year 2|Withdrawal by Subject|4|||
23352920|NCT00195494|65037364|FG003|Year 2|Withdrawal by Subject|3|||
23352921|NCT00195494|65037365|FG004|Year 2|Withdrawal by Subject|0|||
23352922|NCT00195494|65037366|FG005|Year 2|Withdrawal by Subject|0|||
23352923|NCT00195494|65037361|FG000|Year 2|System toxicity|0|||
23352924|NCT00195494|65037362|FG001|Year 2|System toxicity|0|||
23794240|NCT02952924|66623645|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794241|NCT02952924|66623646|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794242|NCT02952924|66623647|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794243|NCT02952924|66623648|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794244|NCT02952924|66623649|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794245|NCT02952924|66623650|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794246|NCT02952924|66623651|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794247|NCT02952924|66623652|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794248|NCT02952924|66623653|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794249|NCT02952924|66623654|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794250|NCT02952924|66623655|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794251|NCT02952924|66623656|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794252|NCT02952924|66623657|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794253|NCT02952924|66623658|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
23352925|NCT00195494|65037363|FG002|Year 2|System toxicity|0|||
23352926|NCT00195494|65037364|FG003|Year 2|System toxicity|1|||
23352927|NCT00195494|65037365|FG004|Year 2|System toxicity|0|||
23352928|NCT00195494|65037366|FG005|Year 2|System toxicity|0|||
23352929|NCT00750919|65037367|FG000|Overall Study|Adverse Event|9|||
23352930|NCT00750919|65037367|FG000|Overall Study|Withdrawal by Subject|1|||
23468937|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468938|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468939|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468940|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468941|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468942|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
23468943|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
23468944|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468945|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468946|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468947|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468948|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468949|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468950|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468951|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
23468952|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
23468953|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468954|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468955|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468956|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468957|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468958|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468959|NCT01746901|65460653|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
23352931|NCT00750919|65037367|FG000|Overall Study|Lack of Efficacy|8|||
23468960|NCT01746901|65460654|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
23468961|NCT01746901|65460655|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
23468962|NCT01746901|65460656|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
23468963|NCT01746901|65460657|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
23468964|NCT01746901|65460658|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
23468965|NCT01746901|65460659|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
23468966|NCT01746901|65460660|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
23468967|NCT01746901|65460661|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
23468968|NCT01746901|65460653|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468969|NCT01746901|65460654|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468970|NCT01746901|65460655|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468971|NCT01746901|65460656|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468972|NCT01746901|65460657|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468973|NCT01746901|65460658|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468974|NCT01746901|65460659|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468975|NCT01746901|65460660|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
23468976|NCT01746901|65460661|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468977|NCT01746901|65460653|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468978|NCT01746901|65460654|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468979|NCT01746901|65460655|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468980|NCT01746901|65460656|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468981|NCT01746901|65460657|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468982|NCT01746901|65460658|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
23468983|NCT01746901|65460659|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
23468984|NCT01746901|65460660|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468985|NCT01746901|65460661|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468986|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468987|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468988|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468989|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
23468990|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468991|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468992|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468993|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468994|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468995|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468996|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468997|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468998|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468999|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469000|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
23469001|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469002|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469003|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
23469004|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469005|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469006|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469007|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469008|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469009|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469010|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
23469011|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23706821|NCT00002663|66301347|FG008|Overall Study|Death|1|||
23469012|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
23469013|NCT01047553|65460667|FG000|Overall Study|Adverse Event|10|||
23469014|NCT01047553|65460668|FG001|Overall Study|Adverse Event|5|||
23469015|NCT01047553|65460667|FG000|Overall Study|Withdrawal by Subject|4|||
23469016|NCT01047553|65460668|FG001|Overall Study|Withdrawal by Subject|2|||
23469017|NCT01047553|65460667|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
23469018|NCT01047553|65460668|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
23469019|NCT01047553|65460667|FG000|Overall Study|Lost to Follow-up|1|||
23469020|NCT01047553|65460668|FG001|Overall Study|Lost to Follow-up|0|||
23469021|NCT01047553|65460667|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
23469022|NCT01047553|65460668|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
23469023|NCT01047553|65460667|FG000|Overall Study|PI's decision|0|||
23469024|NCT01047553|65460668|FG001|Overall Study|PI's decision|1|||
23469025|NCT00993967|65460669|FG000|Overall Study|Adverse Event|8|||
23469026|NCT00993967|65460669|FG000|Overall Study|Death|1|||
23469027|NCT00993967|65460669|FG000|Overall Study|Lost to Follow-up|14|||
23469028|NCT00993967|65460669|FG000|Overall Study|Withdrawal by Subject|36|||
23469029|NCT00993967|65460669|FG000|Overall Study|Protocol Violation|2|||
23469030|NCT03710161|65460670|FG000|Overall Study|Study halted due to COVID pandemic|3|||
23469031|NCT03710161|65460671|FG001|Overall Study|Study halted due to COVID pandemic|2|||
23469032|NCT04200352|65460672|FG000|Overall Study|Death|1|||
23469033|NCT04200352|65460672|FG000|Overall Study|Adverse Event|6|||
23469034|NCT04200352|65460672|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23469035|NCT04200352|65460672|FG000|Overall Study|Lack of Efficacy|1|||
23469036|NCT04200352|65460672|FG000|Overall Study|Other than specified|6|||
23469037|NCT01075685|65460674|FG000|Overall Study|Protocol Violation|9|||
23469038|NCT01075685|65460675|FG001|Overall Study|Protocol Violation|1|||
23469039|NCT01075685|65460674|FG000|Overall Study|Withdrawal by Subject|20|||
23469040|NCT01075685|65460675|FG001|Overall Study|Withdrawal by Subject|5|||
23469041|NCT01075685|65460674|FG000|Overall Study|Lost to Follow-up|563|||
23469042|NCT01075685|65460675|FG001|Overall Study|Lost to Follow-up|220|||
23469043|NCT03179319|65460676|FG000|Overall Study|Lost to Follow-up|6|||
23469044|NCT03179319|65460677|FG001|Overall Study|Lost to Follow-up|0|||
23469045|NCT01763996|65460678|FG000|Treatment Period 2|Adverse Event|0|||
23469046|NCT01763996|65460679|FG001|Treatment Period 2|Adverse Event|1|||
23469047|NCT02395471|65460694|FG000|Overall Study|Lost to Follow-up|2|||
23469048|NCT02395471|65460695|FG001|Overall Study|Lost to Follow-up|0|||
23469049|NCT02395471|65460694|FG000|Overall Study|Withdrawal by Subject|2|||
23469050|NCT02395471|65460695|FG001|Overall Study|Withdrawal by Subject|1|||
23469051|NCT02395471|65460694|FG000|Overall Study|Physician Decision|1|||
23794254|NCT02952924|66623659|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
23469052|NCT02395471|65460695|FG001|Overall Study|Physician Decision|0|||
23469053|NCT02395471|65460694|FG000|Overall Study|Protocol Violation|0|||
23469054|NCT02395471|65460695|FG001|Overall Study|Protocol Violation|1|||
23469055|NCT02395471|65460694|FG000|Overall Study|Failure to swollow sponge twice|1|||
23469056|NCT02395471|65460695|FG001|Overall Study|Failure to swollow sponge twice|0|||
23794255|NCT02952924|66623660|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794256|NCT02952924|66623661|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794257|NCT02952924|66623662|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794258|NCT02952924|66623663|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794259|NCT02952924|66623664|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794260|NCT02952924|66623665|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
23794261|NCT02952924|66623666|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
23794262|NCT02952924|66623645|FG000|Overall Study|Noncompliance with study drug|0|||
23794263|NCT02952924|66623646|FG001|Overall Study|Noncompliance with study drug|0|||
23794264|NCT02952924|66623647|FG002|Overall Study|Noncompliance with study drug|0|||
23794265|NCT02952924|66623648|FG003|Overall Study|Noncompliance with study drug|0|||
23794266|NCT02952924|66623649|FG004|Overall Study|Noncompliance with study drug|0|||
23794267|NCT02952924|66623650|FG005|Overall Study|Noncompliance with study drug|0|||
23794268|NCT02952924|66623651|FG006|Overall Study|Noncompliance with study drug|0|||
23794269|NCT02952924|66623652|FG007|Overall Study|Noncompliance with study drug|0|||
23469057|NCT02395471|65460694|FG000|Overall Study|Patient did not return for procedure|0|||
23469058|NCT02395471|65460695|FG001|Overall Study|Patient did not return for procedure|1|||
23794270|NCT02952924|66623653|FG008|Overall Study|Noncompliance with study drug|0|||
23794271|NCT02952924|66623654|FG009|Overall Study|Noncompliance with study drug|0|||
23794272|NCT02952924|66623655|FG010|Overall Study|Noncompliance with study drug|0|||
23469059|NCT02395471|65460694|FG000|Overall Study|Subject not eligible|1|||
23469060|NCT02395471|65460695|FG001|Overall Study|Subject not eligible|0|||
23469061|NCT00811018|65460701|FG000|Overall Study|Additional Chronic Treatment|31|||
23469062|NCT00811018|65460701|FG000|Overall Study|Adverse Event|79|||
23469063|NCT00811018|65460701|FG000|Overall Study|Death|147|||
23469064|NCT00811018|65460701|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
23469065|NCT00811018|65460701|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
23469066|NCT00811018|65460701|FG000|Overall Study|Investigator Decision|57|||
23469067|NCT00811018|65460701|FG000|Overall Study|Lost to Follow-up|19|||
23469068|NCT00811018|65460701|FG000|Overall Study|Pregnancy|6|||
23469069|NCT00811018|65460701|FG000|Overall Study|Sponsor Decision|450|||
23469070|NCT00811018|65460701|FG000|Overall Study|Withdrawal by Subject|70|||
23469071|NCT00811018|65460701|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
23469072|NCT00811018|65460701|FG000|Overall Study|Other|26|||
23469073|NCT00363480|65460702|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
23469074|NCT00363480|65460702|FG000|Overall Study|Adverse Event|4|||
23469075|NCT00363480|65460702|FG000|Overall Study|Lost to Follow-up|5|||
23469076|NCT00363480|65460702|FG000|Overall Study|Withdrawal by Subject|5|||
23469077|NCT00363480|65460702|FG000|Overall Study|Non-compliance of subject|1|||
23469078|NCT00363480|65460702|FG000|Overall Study|Participant discontinued on its own|1|||
23469079|NCT02598583|65460703|FG000|Extension Period|Withdrawal by Subject|1|||
23469080|NCT02598583|65460704|FG001|Extension Period|Withdrawal by Subject|0|||
23469081|NCT01310075|65460705|FG000|Overall Study|Lost to Follow-up|1|||
23469082|NCT01310075|65460706|FG001|Overall Study|Lost to Follow-up|0|||
23469083|NCT01310075|65460705|FG000|Overall Study|Physician Decision|10|||
23469084|NCT01310075|65460706|FG001|Overall Study|Physician Decision|7|||
23469085|NCT01310075|65460705|FG000|Overall Study|Protocol Violation|2|||
23469086|NCT01310075|65460706|FG001|Overall Study|Protocol Violation|2|||
23469087|NCT01310075|65460705|FG000|Overall Study|Withdrawal by Subject|1|||
23469088|NCT01310075|65460706|FG001|Overall Study|Withdrawal by Subject|1|||
23469089|NCT03636893|65460707|FG000|Overall Study|Death|0|||
23469090|NCT03636893|65460708|FG001|Overall Study|Death|1|||
23469091|NCT03636893|65460707|FG000|Overall Study|Protocol Violation|0|||
23469092|NCT03636893|65460708|FG001|Overall Study|Protocol Violation|3|||
23469093|NCT03636893|65460707|FG000|Overall Study|Withdrawal by Subject|1|||
23469094|NCT03636893|65460708|FG001|Overall Study|Withdrawal by Subject|2|||
23469095|NCT03636893|65460707|FG000|Overall Study|Refusal to surgery|4|||
23469096|NCT03636893|65460708|FG001|Overall Study|Refusal to surgery|3|||
23794273|NCT02952924|66623656|FG011|Overall Study|Noncompliance with study drug|0|||
23794274|NCT02952924|66623657|FG012|Overall Study|Noncompliance with study drug|0|||
23794275|NCT02952924|66623658|FG013|Overall Study|Noncompliance with study drug|0|||
23794276|NCT02952924|66623659|FG014|Overall Study|Noncompliance with study drug|0|||
23794277|NCT02952924|66623660|FG015|Overall Study|Noncompliance with study drug|0|||
23794278|NCT02952924|66623661|FG016|Overall Study|Noncompliance with study drug|0|||
23794279|NCT02952924|66623662|FG017|Overall Study|Noncompliance with study drug|0|||
23469097|NCT03636893|65460707|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
23469098|NCT03636893|65460708|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
23469099|NCT03636893|65460707|FG000|Overall Study|Adverse Event|1|||
23352932|NCT00750919|65037367|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
23352933|NCT00750919|65037367|FG000|Overall Study|Other|36|||
23352934|NCT01085084|65037376|FG000|Overall Study|Withdrawal by Subject|1|||
23352935|NCT01085084|65037377|FG001|Overall Study|Withdrawal by Subject|0|||
23352936|NCT01085084|65037378|FG002|Overall Study|Withdrawal by Subject|0|||
23352937|NCT01085084|65037376|FG000|Overall Study|Lost to Follow-up|2|||
23352938|NCT01085084|65037377|FG001|Overall Study|Lost to Follow-up|1|||
23352939|NCT01085084|65037378|FG002|Overall Study|Lost to Follow-up|1|||
23352940|NCT01085084|65037376|FG000|Overall Study|Adverse Event|4|||
23352941|NCT01085084|65037377|FG001|Overall Study|Adverse Event|3|||
23352942|NCT01085084|65037378|FG002|Overall Study|Adverse Event|6|||
23469100|NCT03636893|65460708|FG001|Overall Study|Adverse Event|1|||
23469101|NCT02597478|65460719|FG000|Overall Study|Withdrawal by Subject|2|||
23469102|NCT02597478|65460720|FG001|Overall Study|Withdrawal by Subject|0|||
23469103|NCT02597478|65460719|FG000|Overall Study|Change of opioid dose|1|||
23469104|NCT02597478|65460720|FG001|Overall Study|Change of opioid dose|0|||
23469105|NCT02597478|65460719|FG000|Overall Study|Insufficient exertional dyspnea|0|||
23469106|NCT02597478|65460720|FG001|Overall Study|Insufficient exertional dyspnea|1|||
23352943|NCT01085084|65037376|FG000|Overall Study|Treatment Failure|0|||
23352944|NCT01085084|65037377|FG001|Overall Study|Treatment Failure|1|||
23352945|NCT01085084|65037378|FG002|Overall Study|Treatment Failure|2|||
23352946|NCT00926536|65037406|FG000|Overall Study|Physician Decision|1|||
23352947|NCT00926536|65037407|FG001|Overall Study|Physician Decision|2|||
23352948|NCT03420222|65037408|FG000|Overall Study|Withdrawal by Subject|5|||
23352949|NCT03420222|65037409|FG001|Overall Study|Withdrawal by Subject|0|||
23352950|NCT03420222|65037408|FG000|Overall Study|Physician Decision|0|||
23352951|NCT03420222|65037409|FG001|Overall Study|Physician Decision|1|||
23352952|NCT03092791|65037411|FG000|Overall Study|Lost to Follow-up|0|||
23352953|NCT03092791|65037412|FG001|Overall Study|Lost to Follow-up|0|||
23352954|NCT03092791|65037413|FG002|Overall Study|Lost to Follow-up|0|||
23469107|NCT01396057|65460722|FG000|Overall Study|Adverse Event|2|||
23469108|NCT01396057|65460723|FG001|Overall Study|Adverse Event|6|||
23469109|NCT01396057|65460722|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23469110|NCT01396057|65460723|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23469111|NCT01396057|65460722|FG000|Overall Study|Protocol deviation|4|||
23469112|NCT01396057|65460723|FG001|Overall Study|Protocol deviation|4|||
23469113|NCT01396057|65460722|FG000|Overall Study|Consent withdrawn|3|||
23469114|NCT01396057|65460723|FG001|Overall Study|Consent withdrawn|2|||
23469115|NCT03967444|65460731|FG000|Overall Study|Lost to Follow-up|1|||
23469116|NCT03967444|65460732|FG001|Overall Study|Lost to Follow-up|2|||
23469117|NCT01938716|65460736|FG000|Overall Study|Physician Decision|2|||
23469118|NCT01938716|65460736|FG000|Overall Study|Withdrawal by Subject|2|||
23469119|NCT01519869|65460737|FG000|Overall Study|Lost to Follow-up|1|||
23469120|NCT03894813|65460745|FG000|Overall Study|Adverse Event|1|||
23469121|NCT03894813|65460746|FG001|Overall Study|Adverse Event|1|||
23469122|NCT03894813|65460745|FG000|Overall Study|Lack of Efficacy|3|||
23469123|NCT03894813|65460746|FG001|Overall Study|Lack of Efficacy|3|||
23587216|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
23587217|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Death|2|||
23587218|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Death|0|||
23587219|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
23587220|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
23587221|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
23587222|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
23587223|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
23587224|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
23587225|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
23587226|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
23587227|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
23469124|NCT03894813|65460745|FG000|Overall Study|Lost to Follow-up|1|||
23469125|NCT03894813|65460746|FG001|Overall Study|Lost to Follow-up|0|||
23469126|NCT03894813|65460745|FG000|Overall Study|Pregnancy|2|||
23469127|NCT03894813|65460746|FG001|Overall Study|Pregnancy|1|||
23469128|NCT03894813|65460745|FG000|Overall Study|Protocol Violation|3|||
23469129|NCT03894813|65460746|FG001|Overall Study|Protocol Violation|7|||
23469130|NCT03894813|65460745|FG000|Overall Study|Withdrawal by Subject|1|||
23469131|NCT03894813|65460746|FG001|Overall Study|Withdrawal by Subject|3|||
23469132|NCT03894813|65460745|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
23469133|NCT03894813|65460746|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
23469134|NCT02888119|65460752|FG000|Overall Study|Lost to Follow-up|5|||
23469135|NCT02888119|65460753|FG001|Overall Study|Lost to Follow-up|4|||
23469136|NCT02888119|65460754|FG002|Overall Study|Lost to Follow-up|0|||
23469137|NCT03527732|65460755|FG000|Overall Study|Lost to Follow-up|21|||
23469138|NCT03527732|65460756|FG001|Overall Study|Lost to Follow-up|23|||
23469139|NCT03527732|65460757|FG002|Overall Study|Lost to Follow-up|80|||
23469140|NCT03527732|65460758|FG003|Overall Study|Lost to Follow-up|62|||
23469141|NCT03527732|65460759|FG004|Overall Study|Lost to Follow-up|12|||
23469142|NCT03527732|65460760|FG005|Overall Study|Lost to Follow-up|20|||
23469143|NCT03116152|65460763|FG000|Overall Study|Disease Progression|49|||
23469144|NCT03116152|65460764|FG001|Overall Study|Disease Progression|47|||
23469145|NCT03116152|65460763|FG000|Overall Study|Death|5|||
23469146|NCT03116152|65460764|FG001|Overall Study|Death|2|||
23469147|NCT03116152|65460763|FG000|Overall Study|Adverse Event|21|||
23469148|NCT03116152|65460764|FG001|Overall Study|Adverse Event|7|||
23469149|NCT03116152|65460763|FG000|Overall Study|Protocol Violation|2|||
23469150|NCT03116152|65460764|FG001|Overall Study|Protocol Violation|2|||
23469151|NCT03116152|65460763|FG000|Overall Study|Withdrawal by Subject|0|||
23469152|NCT03116152|65460764|FG001|Overall Study|Withdrawal by Subject|1|||
23469153|NCT03116152|65460763|FG000|Overall Study|Physician Decision|3|||
23469154|NCT03116152|65460764|FG001|Overall Study|Physician Decision|2|||
23469155|NCT03116152|65460763|FG000|Overall Study|other|11|||
23469156|NCT03116152|65460764|FG001|Overall Study|other|34|||
23640685|NCT00266227|66071409|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
23640686|NCT00266227|66071410|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
23469157|NCT00948441|65460767|FG000|Overall Study|no longer meet inclusion criteria|1|||
23469158|NCT00948441|65460768|FG001|Overall Study|no longer meet inclusion criteria|4|||
23469159|NCT00750152|65460771|FG000|Overall Study|Adverse Event|2|||
23469160|NCT00750152|65460772|FG001|Overall Study|Adverse Event|1|||
23469161|NCT00750152|65460771|FG000|Overall Study|Lost to Follow-up|8|||
23469162|NCT00750152|65460772|FG001|Overall Study|Lost to Follow-up|13|||
23469163|NCT00750152|65460771|FG000|Overall Study|Withdrawal by Subject|3|||
23469164|NCT00750152|65460772|FG001|Overall Study|Withdrawal by Subject|3|||
23469165|NCT00750152|65460771|FG000|Overall Study|Physician Decision|1|||
23706822|NCT00002663|66301348|FG009|Overall Study|Death|1|||
23469166|NCT00750152|65460772|FG001|Overall Study|Physician Decision|1|||
23469167|NCT00750152|65460771|FG000|Overall Study|Non-compliance|0|||
23469168|NCT00750152|65460772|FG001|Overall Study|Non-compliance|1|||
23469169|NCT00750152|65460771|FG000|Overall Study|Termination by sponsor|1|||
23469170|NCT00750152|65460772|FG001|Overall Study|Termination by sponsor|0|||
23469171|NCT00750152|65460771|FG000|Overall Study|Other|7|||
23469172|NCT00750152|65460772|FG001|Overall Study|Other|8|||
23469173|NCT00843284|65460773|FG000|Overall Study|Adverse Event|39|||
23469174|NCT00843284|65460773|FG000|Overall Study|Lack of Efficacy|5|||
23469175|NCT00843284|65460773|FG000|Overall Study|Lost to Follow-up|11|||
23469176|NCT00843284|65460773|FG000|Overall Study|Other|10|||
23469177|NCT00843284|65460773|FG000|Overall Study|Withdrawal by Subject|4|||
23469178|NCT00843284|65460773|FG000|Overall Study|Death|3|||
23469179|NCT00526071|65460774|FG000|Overall Study|Adverse Event|1|||
23469180|NCT00526071|65460774|FG000|Overall Study|Withdrawal by Subject|1|||
23469181|NCT00526071|65460774|FG000|Overall Study|Lack of Response to Study Drug|4|||
23469182|NCT01696188|65460775|FG000|Overall Study|Protocol Violation|1|||
23469183|NCT01696188|65460776|FG001|Overall Study|Protocol Violation|1|||
23469184|NCT01229267|65460779|FG000|Overall Study|Adverse Event|4|||
23469185|NCT01229267|65460780|FG001|Overall Study|Adverse Event|6|||
23469186|NCT01229267|65460781|FG002|Overall Study|Adverse Event|3|||
23469187|NCT01229267|65460782|FG003|Overall Study|Adverse Event|2|||
23469188|NCT01229267|65460783|FG004|Overall Study|Adverse Event|10|||
23469189|NCT01229267|65460779|FG000|Overall Study|Death|40|||
23469190|NCT01229267|65460780|FG001|Overall Study|Death|37|||
23469191|NCT01229267|65460781|FG002|Overall Study|Death|35|||
23469192|NCT01229267|65460782|FG003|Overall Study|Death|13|||
23469193|NCT01229267|65460783|FG004|Overall Study|Death|103|||
23469194|NCT01229267|65460779|FG000|Overall Study|Withdrawal by Subject|23|||
23469195|NCT01229267|65460780|FG001|Overall Study|Withdrawal by Subject|22|||
23469196|NCT01229267|65460781|FG002|Overall Study|Withdrawal by Subject|32|||
23469197|NCT01229267|65460782|FG003|Overall Study|Withdrawal by Subject|14|||
23469198|NCT01229267|65460783|FG004|Overall Study|Withdrawal by Subject|59|||
23469199|NCT01229267|65460779|FG000|Overall Study|Protocol Violation|0|||
23469200|NCT01229267|65460780|FG001|Overall Study|Protocol Violation|1|||
23469201|NCT01229267|65460781|FG002|Overall Study|Protocol Violation|0|||
23469202|NCT01229267|65460782|FG003|Overall Study|Protocol Violation|0|||
23469203|NCT01229267|65460783|FG004|Overall Study|Protocol Violation|0|||
23469204|NCT01229267|65460779|FG000|Overall Study|Progressive disease|0|||
23469205|NCT01229267|65460780|FG001|Overall Study|Progressive disease|0|||
23469206|NCT01229267|65460781|FG002|Overall Study|Progressive disease|0|||
23469207|NCT01229267|65460782|FG003|Overall Study|Progressive disease|0|||
23469208|NCT01229267|65460783|FG004|Overall Study|Progressive disease|1|||
23469209|NCT01229267|65460779|FG000|Overall Study|Physician Decision|8|||
23469210|NCT01229267|65460780|FG001|Overall Study|Physician Decision|11|||
23469211|NCT01229267|65460781|FG002|Overall Study|Physician Decision|8|||
23469212|NCT01229267|65460782|FG003|Overall Study|Physician Decision|3|||
23469213|NCT01229267|65460783|FG004|Overall Study|Physician Decision|25|||
23469214|NCT01229267|65460779|FG000|Overall Study|Lost to Follow-up|6|||
23469215|NCT01229267|65460780|FG001|Overall Study|Lost to Follow-up|5|||
23469216|NCT01229267|65460781|FG002|Overall Study|Lost to Follow-up|8|||
23352955|NCT03092791|65037414|FG003|Overall Study|Lost to Follow-up|0|||
23469217|NCT01229267|65460782|FG003|Overall Study|Lost to Follow-up|3|||
23469218|NCT01229267|65460783|FG004|Overall Study|Lost to Follow-up|22|||
23469219|NCT00329797|65460784|FG000|Overall Study|Protocol Violation|1|||
23469220|NCT00329797|65460785|FG001|Overall Study|Protocol Violation|0|||
23469221|NCT00329797|65460784|FG000|Overall Study|Withdrawal by Subject|6|||
23469222|NCT00329797|65460785|FG001|Overall Study|Withdrawal by Subject|6|||
23469223|NCT01869764|65460786|FG000|Overall Study|Withdrawal by Subject|0|||
23469224|NCT01869764|65460787|FG001|Overall Study|Withdrawal by Subject|2|||
23469225|NCT00845897|65460792|FG000|Overall Study|Lost to Follow-up|1|||
23469226|NCT00845897|65460793|FG001|Overall Study|Lost to Follow-up|1|||
23469227|NCT00845897|65460794|FG002|Overall Study|Lost to Follow-up|0|||
23352956|NCT03092791|65037415|FG004|Overall Study|Lost to Follow-up|0|||
23352957|NCT03092791|65037416|FG005|Overall Study|Lost to Follow-up|0|||
23352958|NCT03092791|65037417|FG006|Overall Study|Lost to Follow-up|1|||
23469228|NCT00845897|65460792|FG000|Overall Study|Withdrawal by Subject|0|||
23469229|NCT00845897|65460793|FG001|Overall Study|Withdrawal by Subject|3|||
23469230|NCT00845897|65460794|FG002|Overall Study|Withdrawal by Subject|2|||
23469231|NCT00845897|65460792|FG000|Overall Study|Ulcer did not heal|1|||
23469232|NCT00845897|65460793|FG001|Overall Study|Ulcer did not heal|0|||
23469233|NCT00845897|65460794|FG002|Overall Study|Ulcer did not heal|1|||
23469234|NCT00845897|65460792|FG000|Overall Study|Too ill to participate|0|||
23469235|NCT00845897|65460793|FG001|Overall Study|Too ill to participate|1|||
23469236|NCT00845897|65460794|FG002|Overall Study|Too ill to participate|0|||
23469237|NCT04270370|65460795|FG000|Overall Study|Lost to Follow-up|1|||
23469238|NCT04270370|65460796|FG001|Overall Study|Lost to Follow-up|0|||
23469239|NCT04270370|65460797|FG002|Overall Study|Lost to Follow-up|0|||
23469240|NCT04270370|65460798|FG003|Overall Study|Lost to Follow-up|0|||
23469241|NCT04270370|65460799|FG004|Overall Study|Lost to Follow-up|0|||
23352959|NCT03092791|65037418|FG007|Overall Study|Lost to Follow-up|0|||
23352960|NCT03092791|65037411|FG000|Overall Study|Withdrawal of Consent|0|||
23352961|NCT03092791|65037412|FG001|Overall Study|Withdrawal of Consent|0|||
23352962|NCT03092791|65037413|FG002|Overall Study|Withdrawal of Consent|0|||
23352963|NCT03092791|65037414|FG003|Overall Study|Withdrawal of Consent|0|||
23352964|NCT03092791|65037415|FG004|Overall Study|Withdrawal of Consent|4|||
23352965|NCT03092791|65037416|FG005|Overall Study|Withdrawal of Consent|12|||
23352966|NCT03092791|65037417|FG006|Overall Study|Withdrawal of Consent|6|||
23352967|NCT03092791|65037418|FG007|Overall Study|Withdrawal of Consent|4|||
23352968|NCT03092791|65037411|FG000|Overall Study|Study Termination|0|||
23352969|NCT03092791|65037412|FG001|Overall Study|Study Termination|0|||
23352970|NCT03092791|65037413|FG002|Overall Study|Study Termination|0|||
23352971|NCT03092791|65037414|FG003|Overall Study|Study Termination|0|||
23352972|NCT03092791|65037415|FG004|Overall Study|Study Termination|55|||
23352973|NCT03092791|65037416|FG005|Overall Study|Study Termination|46|||
23352974|NCT03092791|65037417|FG006|Overall Study|Study Termination|53|||
23352975|NCT03092791|65037418|FG007|Overall Study|Study Termination|55|||
23352976|NCT03092791|65037411|FG000|Overall Study|Death|0|||
23352977|NCT03092791|65037412|FG001|Overall Study|Death|0|||
23352978|NCT03092791|65037413|FG002|Overall Study|Death|0|||
23352979|NCT03092791|65037414|FG003|Overall Study|Death|0|||
23352980|NCT03092791|65037415|FG004|Overall Study|Death|0|||
23352981|NCT03092791|65037416|FG005|Overall Study|Death|1|||
23352982|NCT03092791|65037417|FG006|Overall Study|Death|0|||
23352983|NCT03092791|65037418|FG007|Overall Study|Death|1|||
23352984|NCT03092791|65037411|FG000|Overall Study|Reason Not Specified|0|||
23352985|NCT03092791|65037412|FG001|Overall Study|Reason Not Specified|0|||
23352986|NCT03092791|65037413|FG002|Overall Study|Reason Not Specified|0|||
23352987|NCT03092791|65037414|FG003|Overall Study|Reason Not Specified|0|||
23352988|NCT03092791|65037415|FG004|Overall Study|Reason Not Specified|1|||
23352989|NCT03092791|65037416|FG005|Overall Study|Reason Not Specified|1|||
23352990|NCT03092791|65037417|FG006|Overall Study|Reason Not Specified|0|||
23352991|NCT03092791|65037418|FG007|Overall Study|Reason Not Specified|0|||
23352992|NCT04521114|65037419|FG000|Overall Study|Lost to Follow-up|1|||
23352993|NCT04521114|65037420|FG001|Overall Study|Lost to Follow-up|2|||
23352994|NCT04521114|65037421|FG002|Overall Study|Lost to Follow-up|0|||
23352995|NCT04521114|65037419|FG000|Overall Study|Withdrawal by Subject|1|||
23352996|NCT04521114|65037420|FG001|Overall Study|Withdrawal by Subject|2|||
23352997|NCT04521114|65037421|FG002|Overall Study|Withdrawal by Subject|2|||
23352998|NCT04521114|65037419|FG000|Overall Study|Adverse Event|1|||
23352999|NCT04521114|65037420|FG001|Overall Study|Adverse Event|0|||
23353000|NCT04521114|65037421|FG002|Overall Study|Adverse Event|0|||
23353001|NCT04521114|65037419|FG000|Overall Study|Sponsor Wish|1|||
23353002|NCT04521114|65037420|FG001|Overall Study|Sponsor Wish|0|||
23353003|NCT04521114|65037421|FG002|Overall Study|Sponsor Wish|0|||
23353004|NCT04521114|65037419|FG000|Overall Study|Withdrawal of Consent|2|||
23353005|NCT04521114|65037420|FG001|Overall Study|Withdrawal of Consent|2|||
23353006|NCT04521114|65037421|FG002|Overall Study|Withdrawal of Consent|0|||
23353007|NCT03326518|65037423|FG000|Overall Study|Protocol Violation|1|||
23353008|NCT03326518|65037424|FG001|Overall Study|Protocol Violation|0|||
23353009|NCT03326518|65037425|FG002|Overall Study|Protocol Violation|0|||
23353010|NCT03326518|65037423|FG000|Overall Study|Withdrawal by Subject|1|||
23353011|NCT03326518|65037424|FG001|Overall Study|Withdrawal by Subject|0|||
23353012|NCT03326518|65037425|FG002|Overall Study|Withdrawal by Subject|0|||
23353013|NCT03326518|65037423|FG000|Overall Study|Lost to Follow-up|1|||
23353014|NCT03326518|65037424|FG001|Overall Study|Lost to Follow-up|0|||
23353015|NCT03326518|65037425|FG002|Overall Study|Lost to Follow-up|1|||
23353016|NCT01094782|65037435|FG000|Overall Study|Withdrawal by Subject|5|||
23353017|NCT01094782|65037436|FG001|Overall Study|Withdrawal by Subject|5|||
23353018|NCT01094782|65037437|FG002|Overall Study|Withdrawal by Subject|1|||
23353019|NCT01094782|65037438|FG003|Overall Study|Withdrawal by Subject|5|||
23353020|NCT01094782|65037439|FG004|Overall Study|Withdrawal by Subject|5|||
23353021|NCT01094782|65037440|FG005|Overall Study|Withdrawal by Subject|0|||
23353022|NCT01094782|65037435|FG000|Overall Study|Lost to Follow-up|1|||
23353023|NCT01094782|65037436|FG001|Overall Study|Lost to Follow-up|0|||
23469242|NCT04270370|65460800|FG005|Overall Study|Lost to Follow-up|0|||
23469243|NCT04270370|65460801|FG006|Overall Study|Lost to Follow-up|0|||
23469244|NCT04270370|65460802|FG007|Overall Study|Lost to Follow-up|0|||
23469245|NCT04270370|65460803|FG008|Overall Study|Lost to Follow-up|1|||
23469246|NCT04270370|65460804|FG009|Overall Study|Lost to Follow-up|0|||
23469247|NCT04270370|65460805|FG010|Overall Study|Lost to Follow-up|0|||
23469248|NCT04270370|65460806|FG011|Overall Study|Lost to Follow-up|0|||
23469249|NCT04343235|65460808|FG000|Overall Study|Lost to Follow-up|3|||
23469250|NCT04343235|65460809|FG001|Overall Study|Lost to Follow-up|2|||
23469251|NCT00796419|65460810|FG000|Overall Study|Death|0|||
23469252|NCT00796419|65460811|FG001|Overall Study|Death|1|||
23469253|NCT03224819|65460813|FG000|Overall Study|Withdrawal by Subject|0|||
23469254|NCT03224819|65460814|FG001|Overall Study|Withdrawal by Subject|0|||
23469255|NCT03224819|65460815|FG002|Overall Study|Withdrawal by Subject|0|||
23469256|NCT03224819|65460816|FG003|Overall Study|Withdrawal by Subject|0|||
23469257|NCT03224819|65460817|FG004|Overall Study|Withdrawal by Subject|0|||
23469258|NCT03224819|65460818|FG005|Overall Study|Withdrawal by Subject|0|||
23469259|NCT03224819|65460819|FG006|Overall Study|Withdrawal by Subject|0|||
23469260|NCT03224819|65460820|FG007|Overall Study|Withdrawal by Subject|0|||
23469261|NCT03224819|65460821|FG008|Overall Study|Withdrawal by Subject|0|||
23469262|NCT03224819|65460822|FG009|Overall Study|Withdrawal by Subject|0|||
23469263|NCT03224819|65460823|FG010|Overall Study|Withdrawal by Subject|0|||
23469264|NCT03224819|65460824|FG011|Overall Study|Withdrawal by Subject|0|||
23469265|NCT03224819|65460825|FG012|Overall Study|Withdrawal by Subject|1|||
23469266|NCT03224819|65460826|FG013|Overall Study|Withdrawal by Subject|0|||
23469267|NCT03224819|65460813|FG000|Overall Study|Sponsor Decision|0|||
23469268|NCT03224819|65460814|FG001|Overall Study|Sponsor Decision|0|||
23469269|NCT03224819|65460815|FG002|Overall Study|Sponsor Decision|0|||
23469270|NCT03224819|65460816|FG003|Overall Study|Sponsor Decision|1|||
23469271|NCT03224819|65460817|FG004|Overall Study|Sponsor Decision|1|||
23469272|NCT03224819|65460818|FG005|Overall Study|Sponsor Decision|2|||
23469273|NCT03224819|65460819|FG006|Overall Study|Sponsor Decision|1|||
23469274|NCT03224819|65460820|FG007|Overall Study|Sponsor Decision|1|||
23469275|NCT03224819|65460821|FG008|Overall Study|Sponsor Decision|1|||
23469276|NCT03224819|65460822|FG009|Overall Study|Sponsor Decision|2|||
23469277|NCT03224819|65460823|FG010|Overall Study|Sponsor Decision|1|||
23469278|NCT03224819|65460824|FG011|Overall Study|Sponsor Decision|1|||
23469279|NCT03224819|65460825|FG012|Overall Study|Sponsor Decision|1|||
23469280|NCT03224819|65460826|FG013|Overall Study|Sponsor Decision|0|||
23469281|NCT03224819|65460813|FG000|Overall Study|Lost to Follow-up|0|||
23469282|NCT03224819|65460814|FG001|Overall Study|Lost to Follow-up|0|||
23469283|NCT03224819|65460815|FG002|Overall Study|Lost to Follow-up|0|||
23469284|NCT03224819|65460816|FG003|Overall Study|Lost to Follow-up|0|||
23469285|NCT03224819|65460817|FG004|Overall Study|Lost to Follow-up|0|||
23469286|NCT03224819|65460818|FG005|Overall Study|Lost to Follow-up|0|||
23469287|NCT03224819|65460819|FG006|Overall Study|Lost to Follow-up|0|||
23469288|NCT03224819|65460820|FG007|Overall Study|Lost to Follow-up|0|||
23469289|NCT03224819|65460821|FG008|Overall Study|Lost to Follow-up|1|||
23469290|NCT03224819|65460822|FG009|Overall Study|Lost to Follow-up|0|||
23469291|NCT03224819|65460823|FG010|Overall Study|Lost to Follow-up|0|||
23469292|NCT03224819|65460824|FG011|Overall Study|Lost to Follow-up|0|||
23469293|NCT03224819|65460825|FG012|Overall Study|Lost to Follow-up|0|||
23469294|NCT03224819|65460826|FG013|Overall Study|Lost to Follow-up|0|||
23469295|NCT03224819|65460813|FG000|Overall Study|Death|0|||
23469296|NCT03224819|65460814|FG001|Overall Study|Death|1|||
23469297|NCT03224819|65460815|FG002|Overall Study|Death|0|||
23469298|NCT03224819|65460816|FG003|Overall Study|Death|0|||
23469299|NCT03224819|65460817|FG004|Overall Study|Death|0|||
23469300|NCT03224819|65460818|FG005|Overall Study|Death|0|||
23469301|NCT03224819|65460819|FG006|Overall Study|Death|0|||
23469302|NCT03224819|65460820|FG007|Overall Study|Death|1|||
23469303|NCT03224819|65460821|FG008|Overall Study|Death|0|||
23469304|NCT03224819|65460822|FG009|Overall Study|Death|0|||
23469305|NCT03224819|65460823|FG010|Overall Study|Death|0|||
23469306|NCT03224819|65460824|FG011|Overall Study|Death|1|||
23469307|NCT03224819|65460825|FG012|Overall Study|Death|0|||
23469308|NCT03224819|65460826|FG013|Overall Study|Death|0|||
23469309|NCT01467960|65460835|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23469310|NCT01467960|65460836|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23706823|NCT00002663|66301339|FG000|Overall Study|Lost to Follow-up|3|||
23353024|NCT01094782|65037437|FG002|Overall Study|Lost to Follow-up|0|||
23353025|NCT01094782|65037438|FG003|Overall Study|Lost to Follow-up|2|||
23353026|NCT01094782|65037439|FG004|Overall Study|Lost to Follow-up|1|||
23353027|NCT01094782|65037440|FG005|Overall Study|Lost to Follow-up|4|||
23353028|NCT01094782|65037435|FG000|Overall Study|Positive Drug Screen|2|||
23353029|NCT01094782|65037436|FG001|Overall Study|Positive Drug Screen|2|||
23353030|NCT01094782|65037437|FG002|Overall Study|Positive Drug Screen|1|||
23353031|NCT01094782|65037438|FG003|Overall Study|Positive Drug Screen|1|||
23353032|NCT01094782|65037439|FG004|Overall Study|Positive Drug Screen|3|||
23353033|NCT01094782|65037440|FG005|Overall Study|Positive Drug Screen|2|||
23353034|NCT01094782|65037435|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
23353035|NCT01094782|65037436|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
23353036|NCT01094782|65037437|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
23353037|NCT01094782|65037438|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
23353038|NCT01094782|65037439|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
23353039|NCT01094782|65037440|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
23353040|NCT01094782|65037435|FG000|Overall Study|Unable to Complete Questionnaires|0|||
23353041|NCT01094782|65037436|FG001|Overall Study|Unable to Complete Questionnaires|1|||
23353042|NCT01094782|65037437|FG002|Overall Study|Unable to Complete Questionnaires|0|||
23353043|NCT01094782|65037438|FG003|Overall Study|Unable to Complete Questionnaires|0|||
23353044|NCT01094782|65037439|FG004|Overall Study|Unable to Complete Questionnaires|0|||
23353045|NCT01094782|65037440|FG005|Overall Study|Unable to Complete Questionnaires|0|||
23353046|NCT01094782|65037435|FG000|Overall Study|Healthy Subject Had Pain|0|||
23353047|NCT01094782|65037436|FG001|Overall Study|Healthy Subject Had Pain|1|||
23353048|NCT01094782|65037437|FG002|Overall Study|Healthy Subject Had Pain|0|||
23353049|NCT01094782|65037438|FG003|Overall Study|Healthy Subject Had Pain|0|||
23353050|NCT01094782|65037439|FG004|Overall Study|Healthy Subject Had Pain|0|||
23353051|NCT01094782|65037440|FG005|Overall Study|Healthy Subject Had Pain|0|||
23353052|NCT01094782|65037435|FG000|Overall Study|Hypertension|0|||
23353053|NCT01094782|65037436|FG001|Overall Study|Hypertension|0|||
23353054|NCT01094782|65037437|FG002|Overall Study|Hypertension|1|||
23353055|NCT01094782|65037438|FG003|Overall Study|Hypertension|0|||
23353056|NCT01094782|65037439|FG004|Overall Study|Hypertension|0|||
23353057|NCT01094782|65037440|FG005|Overall Study|Hypertension|0|||
23353058|NCT01094782|65037435|FG000|Overall Study|Wrong Pain Condition|0|||
23353059|NCT01094782|65037436|FG001|Overall Study|Wrong Pain Condition|0|||
23353060|NCT01094782|65037437|FG002|Overall Study|Wrong Pain Condition|0|||
23353061|NCT01094782|65037438|FG003|Overall Study|Wrong Pain Condition|2|||
23353062|NCT01094782|65037439|FG004|Overall Study|Wrong Pain Condition|1|||
23353063|NCT01094782|65037440|FG005|Overall Study|Wrong Pain Condition|1|||
23353064|NCT01094782|65037435|FG000|Overall Study|Recent Interventional Injection|0|||
23353065|NCT01094782|65037436|FG001|Overall Study|Recent Interventional Injection|0|||
23353066|NCT01094782|65037437|FG002|Overall Study|Recent Interventional Injection|0|||
23353067|NCT01094782|65037438|FG003|Overall Study|Recent Interventional Injection|0|||
23353068|NCT01094782|65037439|FG004|Overall Study|Recent Interventional Injection|0|||
23353069|NCT01094782|65037440|FG005|Overall Study|Recent Interventional Injection|1|||
23353070|NCT01094782|65037435|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353071|NCT01094782|65037436|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353072|NCT01094782|65037437|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353073|NCT01094782|65037438|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353074|NCT01094782|65037439|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
23353075|NCT01094782|65037440|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353076|NCT01094782|65037435|FG000|Overall Study|Noncompliance With Study Schedule|0|||
23353077|NCT01094782|65037436|FG001|Overall Study|Noncompliance With Study Schedule|0|||
23353078|NCT01094782|65037437|FG002|Overall Study|Noncompliance With Study Schedule|0|||
23353079|NCT01094782|65037438|FG003|Overall Study|Noncompliance With Study Schedule|1|||
23353080|NCT01094782|65037439|FG004|Overall Study|Noncompliance With Study Schedule|0|||
23353081|NCT01094782|65037440|FG005|Overall Study|Noncompliance With Study Schedule|0|||
23587228|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
23587229|NCT00930813|65876274|FG000|Overall Study|Death|4|||
23706824|NCT00002663|66301340|FG001|Overall Study|Lost to Follow-up|0|||
23353082|NCT03913104|65037441|FG000|Overall Study|Lost to Follow-up|20|||
23353083|NCT03913104|65037441|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
23587230|NCT00930813|65876275|FG001|Overall Study|Death|5|||
23587231|NCT00930813|65876274|FG000|Overall Study|Withdrawal by Subject|2|||
23353084|NCT03913104|65037441|FG000|Overall Study|Withdrawal by Subject|2|||
23353085|NCT00513357|65037442|FG000|Overall Study|did not receive allocated placebo|2|||
23353086|NCT00513357|65037443|FG001|Overall Study|did not receive allocated placebo|3|||
23353087|NCT00513357|65037442|FG000|Overall Study|Adverse Event|4|||
23353088|NCT00513357|65037443|FG001|Overall Study|Adverse Event|2|||
23469311|NCT01467960|65460837|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23469312|NCT01467960|65460838|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23353089|NCT00513357|65037442|FG000|Overall Study|Death|2|||
23353090|NCT00513357|65037443|FG001|Overall Study|Death|0|||
23353091|NCT00513357|65037442|FG000|Overall Study|Withdrawal by Subject|5|||
23353092|NCT00513357|65037443|FG001|Overall Study|Withdrawal by Subject|4|||
23353093|NCT00513357|65037442|FG000|Overall Study|Disease Progression|2|||
23353094|NCT00513357|65037443|FG001|Overall Study|Disease Progression|1|||
23469313|NCT01467960|65460839|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23640687|NCT00266227|66071408|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
23353095|NCT02864316|65037444|FG000|Overall Study|Progressive Disease|2|||
23353096|NCT02864316|65037445|FG001|Overall Study|Progressive Disease|1|||
23353097|NCT02864316|65037444|FG000|Overall Study|Adverse Event|0|||
23353098|NCT02864316|65037445|FG001|Overall Study|Adverse Event|1|||
23353099|NCT03810235|65037462|FG000|Overall Study|Withdrawal by Subject|2|||
23353100|NCT03810235|65037463|FG001|Overall Study|Withdrawal by Subject|0|||
23353101|NCT02510820|65037464|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23353102|NCT02510820|65037465|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23353103|NCT02510820|65037464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23353104|NCT02510820|65037465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23353105|NCT01832818|65037467|FG000|Overall Study|Lost to Follow-up|6|||
23353106|NCT02417961|65037468|FG000|Overall Study|Adverse Event|1|||
23353107|NCT02417961|65037468|FG000|Overall Study|Lost to Follow-up|1|||
23706825|NCT00002663|66301341|FG002|Overall Study|Lost to Follow-up|0|||
23353108|NCT02417961|65037468|FG000|Overall Study|Withdrawal by Subject|2|||
23353109|NCT01108237|65037469|FG000|Overall Study|No alignment data|2|||
23353110|NCT01108237|65037470|FG001|Overall Study|No alignment data|15|||
23640688|NCT00266227|66071409|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
23353111|NCT01108237|65037469|FG000|Overall Study|Did not meet criteria for analysis|7|||
23353112|NCT01108237|65037470|FG001|Overall Study|Did not meet criteria for analysis|0|||
23353113|NCT02509078|65037473|FG000|Overall Study|Protocol Violation|1|||
23353114|NCT02509078|65037474|FG001|Overall Study|Protocol Violation|1|||
23353115|NCT01451164|65037477|FG000|Overall Study|Adverse Event|19|||
23353116|NCT01451164|65037478|FG001|Overall Study|Adverse Event|12|||
23353117|NCT01451164|65037479|FG002|Overall Study|Adverse Event|18|||
23353118|NCT01451164|65037480|FG003|Overall Study|Adverse Event|21|||
23353119|NCT01451164|65037477|FG000|Overall Study|Withdrawal Criteria|1|||
23353120|NCT01451164|65037478|FG001|Overall Study|Withdrawal Criteria|1|||
23353121|NCT01451164|65037479|FG002|Overall Study|Withdrawal Criteria|1|||
23353122|NCT01451164|65037480|FG003|Overall Study|Withdrawal Criteria|1|||
23587232|NCT00930813|65876275|FG001|Overall Study|Withdrawal by Subject|5|||
23587233|NCT00930813|65876274|FG000|Overall Study|Lost to Follow-up|2|||
23587234|NCT00930813|65876275|FG001|Overall Study|Lost to Follow-up|4|||
23587235|NCT00906035|65876276|FG000|Overall Study|Withdrawal by Subject|2|||
23587236|NCT00906035|65876277|FG001|Overall Study|Withdrawal by Subject|3|||
23587237|NCT00906035|65876278|FG002|Overall Study|Withdrawal by Subject|0|||
23587238|NCT01185522|65876279|FG000|Overall Study|Lack of Efficacy|28|||
23587239|NCT01185522|65876279|FG000|Overall Study|Lost to Follow-up|19|||
23587240|NCT01185522|65876279|FG000|Overall Study|Withdrawal by Subject|10|||
23587241|NCT01185522|65876279|FG000|Overall Study|Poor tolerance|39|||
23587242|NCT01185522|65876279|FG000|Overall Study|Other reasons|12|||
23587243|NCT00909363|65876280|FG000|Overall Study|Withdrawal by Subject|1|||
23587244|NCT00909363|65876281|FG001|Overall Study|Withdrawal by Subject|0|||
23587245|NCT00909363|65876282|FG002|Overall Study|Withdrawal by Subject|0|||
23587246|NCT00909363|65876280|FG000|Overall Study|Lack of Efficacy|1|||
23587247|NCT00909363|65876281|FG001|Overall Study|Lack of Efficacy|0|||
23587248|NCT00909363|65876282|FG002|Overall Study|Lack of Efficacy|0|||
23587249|NCT01792830|65876285|FG000|Overall Study|Withdrawal by Subject|22|||
23587250|NCT01792830|65876286|FG001|Overall Study|Withdrawal by Subject|0|||
23353123|NCT01451164|65037477|FG000|Overall Study|Physician Decision|2|||
23353124|NCT01451164|65037478|FG001|Overall Study|Physician Decision|0|||
23587251|NCT01792830|65876287|FG002|Overall Study|Withdrawal by Subject|0|||
23794280|NCT02952924|66623663|FG018|Overall Study|Noncompliance with study drug|0|||
23794281|NCT02952924|66623664|FG019|Overall Study|Noncompliance with study drug|0|||
23794282|NCT02952924|66623665|FG020|Overall Study|Noncompliance with study drug|0|||
23794283|NCT02952924|66623666|FG021|Overall Study|Noncompliance with study drug|1|||
23794284|NCT01151618|66623667|FG000|Overall Study|Adverse Event|2|||
23794285|NCT01151618|66623667|FG000|Overall Study|Withdrawal by Subject|7|||
23794286|NCT02754492|66623668|FG000|Overall Study|Protocol Violation|2|||
23794287|NCT02754492|66623669|FG001|Overall Study|Protocol Violation|2|||
23794288|NCT02754492|66623670|FG002|Overall Study|Protocol Violation|0|||
23794289|NCT02754492|66623671|FG003|Overall Study|Protocol Violation|1|||
23794290|NCT02754492|66623668|FG000|Overall Study|Withdrawal by Subject|2|||
23794291|NCT02754492|66623669|FG001|Overall Study|Withdrawal by Subject|0|||
23794292|NCT02754492|66623670|FG002|Overall Study|Withdrawal by Subject|0|||
23794293|NCT02754492|66623671|FG003|Overall Study|Withdrawal by Subject|0|||
23794294|NCT02754492|66623668|FG000|Overall Study|Equipment malfuntion|0|||
23794295|NCT02754492|66623669|FG001|Overall Study|Equipment malfuntion|0|||
23794296|NCT02754492|66623670|FG002|Overall Study|Equipment malfuntion|2|||
23794297|NCT02754492|66623671|FG003|Overall Study|Equipment malfuntion|5|||
23794298|NCT02754492|66623668|FG000|Overall Study|Adverse Event|0|||
23794299|NCT02754492|66623669|FG001|Overall Study|Adverse Event|0|||
23794300|NCT02754492|66623670|FG002|Overall Study|Adverse Event|0|||
23794301|NCT02754492|66623671|FG003|Overall Study|Adverse Event|13|||
23794302|NCT02754492|66623668|FG000|Overall Study|Venous access issues not resulting in AE|0|||
23794303|NCT02754492|66623669|FG001|Overall Study|Venous access issues not resulting in AE|0|||
23794304|NCT02754492|66623670|FG002|Overall Study|Venous access issues not resulting in AE|0|||
23794305|NCT02754492|66623671|FG003|Overall Study|Venous access issues not resulting in AE|4|||
23794306|NCT02377349|66623677|FG000|Overall Study|Serious Adverse Event|1|||
23794307|NCT02377349|66623678|FG001|Overall Study|Serious Adverse Event|0|||
23794308|NCT02377349|66623677|FG000|Overall Study|Protocol Violation|3|||
23794309|NCT02377349|66623678|FG001|Overall Study|Protocol Violation|2|||
23794310|NCT02377349|66623677|FG000|Overall Study|Withdrawal by Subject|5|||
23794311|NCT02377349|66623678|FG001|Overall Study|Withdrawal by Subject|3|||
23794312|NCT02377349|66623677|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
23794313|NCT02377349|66623678|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
23794314|NCT02377349|66623677|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
23794315|NCT02377349|66623678|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
23794316|NCT02377349|66623677|FG000|Overall Study|Other|0|||
23794317|NCT02377349|66623678|FG001|Overall Study|Other|1|||
23794318|NCT01721772|66623679|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
23794319|NCT01721772|66623680|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
23794320|NCT01721772|66623679|FG000|Pre-Treatment|Poor/non-compliance|0|||
23794321|NCT01721772|66623680|FG001|Pre-Treatment|Poor/non-compliance|1|||
23706826|NCT00002663|66301342|FG003|Overall Study|Lost to Follow-up|1|||
23353125|NCT01451164|65037479|FG002|Overall Study|Physician Decision|1|||
23353126|NCT01451164|65037480|FG003|Overall Study|Physician Decision|0|||
23353127|NCT01451164|65037477|FG000|Overall Study|Withdrawal by Subject|14|||
23353128|NCT01451164|65037478|FG001|Overall Study|Withdrawal by Subject|11|||
23353129|NCT01451164|65037479|FG002|Overall Study|Withdrawal by Subject|16|||
23353130|NCT01451164|65037480|FG003|Overall Study|Withdrawal by Subject|17|||
23353131|NCT01451164|65037477|FG000|Overall Study|Protocol Violation|0|||
23353132|NCT01451164|65037478|FG001|Overall Study|Protocol Violation|1|||
23353133|NCT01451164|65037479|FG002|Overall Study|Protocol Violation|0|||
23794322|NCT01721772|66623679|FG000|Pre-Treatment|Participant withdrew consent|0|||
23794323|NCT01721772|66623680|FG001|Pre-Treatment|Participant withdrew consent|1|||
23794324|NCT01721772|66623679|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23794325|NCT01721772|66623680|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
23794326|NCT01721772|66623679|FG000|Treatment|Disease progression|119|||
23794327|NCT01721772|66623680|FG001|Treatment|Disease progression|168|||
23794328|NCT01721772|66623679|FG000|Treatment|Study drug toxicity|19|||
23794329|NCT01721772|66623680|FG001|Treatment|Study drug toxicity|10|||
23794330|NCT01721772|66623679|FG000|Treatment|Adverse event unrelated to study drug|7|||
23794331|NCT01721772|66623680|FG001|Treatment|Adverse event unrelated to study drug|7|||
23794332|NCT01721772|66623679|FG000|Treatment|Maximum clinical benefit|16|||
23794333|NCT01721772|66623680|FG001|Treatment|Maximum clinical benefit|4|||
23794334|NCT01721772|66623679|FG000|Treatment|Other|19|||
23794335|NCT01721772|66623680|FG001|Treatment|Other|2|||
23353134|NCT01451164|65037480|FG003|Overall Study|Protocol Violation|0|||
23353135|NCT01451164|65037477|FG000|Overall Study|Lack of Efficacy|7|||
23353136|NCT01451164|65037478|FG001|Overall Study|Lack of Efficacy|9|||
23353137|NCT01451164|65037479|FG002|Overall Study|Lack of Efficacy|9|||
23353138|NCT01451164|65037480|FG003|Overall Study|Lack of Efficacy|7|||
23353139|NCT00350779|65037483|FG000|Overall Study|Adverse Event|4|||
23353140|NCT00350779|65037484|FG001|Overall Study|Adverse Event|2|||
23353141|NCT00350779|65037483|FG000|Overall Study|Lack of Efficacy|0|||
23353142|NCT00350779|65037484|FG001|Overall Study|Lack of Efficacy|4|||
23353143|NCT00350779|65037483|FG000|Overall Study|Lost to Follow-up|2|||
23353144|NCT00350779|65037484|FG001|Overall Study|Lost to Follow-up|0|||
23353145|NCT00350779|65037483|FG000|Overall Study|Physician Decision|2|||
23353146|NCT00350779|65037484|FG001|Overall Study|Physician Decision|4|||
23353147|NCT00350779|65037483|FG000|Overall Study|Protocol Violation|3|||
23353148|NCT00350779|65037484|FG001|Overall Study|Protocol Violation|1|||
23353149|NCT00350779|65037483|FG000|Overall Study|Withdrawal by Subject|9|||
23353150|NCT00350779|65037484|FG001|Overall Study|Withdrawal by Subject|8|||
23353151|NCT00350779|65037483|FG000|Overall Study|Patient Moved|2|||
23353152|NCT00350779|65037484|FG001|Overall Study|Patient Moved|1|||
23353153|NCT00350779|65037483|FG000|Overall Study|Non-compliance with study procedures|0|||
23353154|NCT00350779|65037484|FG001|Overall Study|Non-compliance with study procedures|1|||
23794336|NCT01721772|66623679|FG000|Treatment|Participant withdrew consent|2|||
23794337|NCT01721772|66623680|FG001|Treatment|Participant withdrew consent|5|||
23794338|NCT01721772|66623679|FG000|Treatment|Participant request to discontinue study treatment|21|||
23794339|NCT01721772|66623680|FG001|Treatment|Participant request to discontinue study treatment|8|||
23794340|NCT01721772|66623679|FG000|Treatment|Death|1|||
23794341|NCT01721772|66623680|FG001|Treatment|Death|0|||
23353155|NCT02208050|65037492|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
23353156|NCT02208050|65037493|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
23353157|NCT01937715|65037497|FG000|Overall Study|Death|0|||
23353158|NCT01937715|65037498|FG001|Overall Study|Death|0|||
23353159|NCT01937715|65037499|FG002|Overall Study|Death|0|||
23353160|NCT01937715|65037500|FG003|Overall Study|Death|1|||
23353161|NCT01937715|65037501|FG004|Overall Study|Death|0|||
23353162|NCT01937715|65037497|FG000|Overall Study|Withdrawal by Subject|0|||
23353163|NCT01937715|65037498|FG001|Overall Study|Withdrawal by Subject|1|||
23353164|NCT01937715|65037499|FG002|Overall Study|Withdrawal by Subject|0|||
23353165|NCT01937715|65037500|FG003|Overall Study|Withdrawal by Subject|0|||
23353166|NCT01937715|65037501|FG004|Overall Study|Withdrawal by Subject|2|||
23794342|NCT01721772|66623679|FG000|Treatment|Not reported|1|||
23794343|NCT01721772|66623680|FG001|Treatment|Not reported|0|||
23794344|NCT01721772|66623679|FG000|Treatment|Poor/non-compliance|1|||
23794345|NCT01721772|66623680|FG001|Treatment|Poor/non-compliance|0|||
23794346|NCT01721772|66623679|FG000|Treatment|Lost to Follow-up|0|||
23794347|NCT01721772|66623680|FG001|Treatment|Lost to Follow-up|1|||
23794348|NCT03023137|66623681|FG000|Overall Study|Multiple pregnancy|2|||
23353167|NCT01937715|65037497|FG000|Overall Study|Other|0|||
23353168|NCT01937715|65037498|FG001|Overall Study|Other|0|||
23353169|NCT01937715|65037499|FG002|Overall Study|Other|0|||
23353170|NCT01937715|65037500|FG003|Overall Study|Other|3|||
23353171|NCT01937715|65037501|FG004|Overall Study|Other|0|||
23353172|NCT00594386|65037502|FG000|Overall Study|Major protocol violation|2|||
23353173|NCT00594386|65037502|FG000|Overall Study|Lack of Efficacy|12|||
23353174|NCT00594386|65037502|FG000|Overall Study|Adverse Event|68|||
23353175|NCT00594386|65037502|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
23794349|NCT03023137|66623682|FG001|Overall Study|Multiple pregnancy|4|||
23469314|NCT01467960|65460840|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23469315|NCT03524118|65460845|FG000|Overall Study|Lost to Follow-up|0|||
23469316|NCT03524118|65460846|FG001|Overall Study|Lost to Follow-up|0|||
23469317|NCT03524118|65460847|FG002|Overall Study|Lost to Follow-up|0|||
23469318|NCT03524118|65460848|FG003|Overall Study|Lost to Follow-up|0|||
23469319|NCT03524118|65460849|FG004|Overall Study|Lost to Follow-up|1|||
23469320|NCT03524118|65460850|FG005|Overall Study|Lost to Follow-up|0|||
23469321|NCT03524118|65460845|FG000|Overall Study|Other|0|||
23469322|NCT03524118|65460846|FG001|Overall Study|Other|1|||
23469323|NCT03524118|65460847|FG002|Overall Study|Other|0|||
23469324|NCT03524118|65460848|FG003|Overall Study|Other|0|||
23469325|NCT03524118|65460849|FG004|Overall Study|Other|1|||
23469326|NCT03524118|65460850|FG005|Overall Study|Other|1|||
23469327|NCT03524118|65460845|FG000|Overall Study|Physician Decision|0|||
23469328|NCT03524118|65460846|FG001|Overall Study|Physician Decision|0|||
23469329|NCT03524118|65460847|FG002|Overall Study|Physician Decision|0|||
23469330|NCT03524118|65460848|FG003|Overall Study|Physician Decision|0|||
23469331|NCT03524118|65460849|FG004|Overall Study|Physician Decision|1|||
23469332|NCT03524118|65460850|FG005|Overall Study|Physician Decision|0|||
23469333|NCT03524118|65460845|FG000|Overall Study|Protocol Violation|0|||
23469334|NCT03524118|65460846|FG001|Overall Study|Protocol Violation|0|||
23794350|NCT03023137|66623681|FG000|Overall Study|Lost to Follow-up|1|||
23794351|NCT03023137|66623682|FG001|Overall Study|Lost to Follow-up|1|||
23794352|NCT03023137|66623681|FG000|Overall Study|Protocol Violation|0|||
23794353|NCT03023137|66623682|FG001|Overall Study|Protocol Violation|4|||
23794354|NCT03023137|66623681|FG000|Overall Study|Lost the baby in a car accident|1|||
23794355|NCT03023137|66623682|FG001|Overall Study|Lost the baby in a car accident|0|||
23794356|NCT03450629|66623683|FG000|Overall Study|Adverse Event|15|||
23794357|NCT03450629|66623684|FG001|Overall Study|Adverse Event|14|||
23794358|NCT03450629|66623683|FG000|Overall Study|Physician Decision|2|||
23794359|NCT03450629|66623684|FG001|Overall Study|Physician Decision|2|||
23794360|NCT03450629|66623683|FG000|Overall Study|Lack of Efficacy|2|||
23794361|NCT03450629|66623684|FG001|Overall Study|Lack of Efficacy|0|||
23794362|NCT03450629|66623683|FG000|Overall Study|Lost to Follow-up|4|||
23469335|NCT03524118|65460847|FG002|Overall Study|Protocol Violation|1|||
23469336|NCT03524118|65460848|FG003|Overall Study|Protocol Violation|0|||
23469337|NCT03524118|65460849|FG004|Overall Study|Protocol Violation|1|||
23469338|NCT03524118|65460850|FG005|Overall Study|Protocol Violation|0|||
23469339|NCT03524118|65460845|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23469340|NCT03524118|65460846|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23469341|NCT03524118|65460847|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23469342|NCT03524118|65460848|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
23469343|NCT03524118|65460849|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
23469344|NCT03524118|65460850|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23469345|NCT02447302|65460857|FG000|Overall Study|Physician Decision|1|||
23469346|NCT02447302|65460858|FG001|Overall Study|Physician Decision|0|||
23469347|NCT02447302|65460859|FG002|Overall Study|Physician Decision|0|||
23469348|NCT02447302|65460857|FG000|Overall Study|Adverse Event|4|||
23469349|NCT02447302|65460858|FG001|Overall Study|Adverse Event|3|||
23469350|NCT02447302|65460859|FG002|Overall Study|Adverse Event|0|||
23469351|NCT02447302|65460857|FG000|Overall Study|Withdrawal by Subject|0|||
23469352|NCT02447302|65460858|FG001|Overall Study|Withdrawal by Subject|1|||
23469353|NCT02447302|65460859|FG002|Overall Study|Withdrawal by Subject|5|||
23469354|NCT02447302|65460857|FG000|Overall Study|Sponsor Decision|0|||
23469355|NCT02447302|65460858|FG001|Overall Study|Sponsor Decision|0|||
23469356|NCT02447302|65460859|FG002|Overall Study|Sponsor Decision|1|||
23587252|NCT01792830|65876288|FG003|Overall Study|Withdrawal by Subject|2|||
23640689|NCT00266227|66071410|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
23469357|NCT01391546|65460862|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
23469358|NCT01391546|65460863|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
23469359|NCT00804908|65460864|FG000|Overall Study|Other|115|||
23469360|NCT00804908|65460865|FG001|Overall Study|Other|116|||
23469361|NCT00804908|65460866|FG002|Overall Study|Other|114|||
23640690|NCT00266227|66071408|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
23794363|NCT03450629|66623684|FG001|Overall Study|Lost to Follow-up|2|||
23469362|NCT01590888|65460867|FG000|Overall Study|Adverse Event|3|||
23469363|NCT01590888|65460868|FG001|Overall Study|Adverse Event|0|||
23469364|NCT01590888|65460869|FG002|Overall Study|Adverse Event|1|||
23469365|NCT01590888|65460867|FG000|Overall Study|Lost to Follow-up|1|||
23794364|NCT03450629|66623683|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23794365|NCT03450629|66623684|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23794366|NCT03450629|66623683|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23794367|NCT03450629|66623684|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23469366|NCT01590888|65460868|FG001|Overall Study|Lost to Follow-up|0|||
23469367|NCT01590888|65460869|FG002|Overall Study|Lost to Follow-up|0|||
23353176|NCT00594386|65037502|FG000|Overall Study|Subject withdrew consent|35|||
23353177|NCT00594386|65037502|FG000|Overall Study|Study ended per sponsor|115|||
23640691|NCT00266227|66071409|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
23640692|NCT00266227|66071410|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
23794368|NCT03450629|66623683|FG000|Overall Study|Protocol Violation|11|||
23794369|NCT03450629|66623684|FG001|Overall Study|Protocol Violation|8|||
23794370|NCT03450629|66623683|FG000|Overall Study|Withdrawal by Subject|12|||
23794371|NCT03450629|66623684|FG001|Overall Study|Withdrawal by Subject|6|||
23794372|NCT03712124|66623686|FG000|Overall Study|Protocol Violation|1|||
23794373|NCT03712124|66623687|FG001|Overall Study|Protocol Violation|0|||
23794374|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
23353178|NCT00594386|65037502|FG000|Overall Study|Lost to Follow-up|6|||
23353179|NCT00594386|65037502|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
23353180|NCT00594386|65037502|FG000|Overall Study|Other: Subject moved to Seattle|1|||
23353181|NCT00594386|65037502|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
23794375|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
23794376|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
23794377|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
23794378|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
23794379|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
23794380|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
23794381|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
23794382|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
23794383|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
23794384|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
23794385|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
23794386|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
23794387|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
23794388|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
23794389|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
23794390|NCT01067521|66623690|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
23794391|NCT01067521|66623691|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
23794392|NCT01067521|66623690|FG000|Open-Label Period|Death|3|||
23794393|NCT01067521|66623691|FG001|Open-Label Period|Death|1|||
23794394|NCT01067521|66623690|FG000|Open-Label Period|Adverse Event|30|||
23794395|NCT01067521|66623691|FG001|Open-Label Period|Adverse Event|28|||
23794396|NCT01067521|66623690|FG000|Open-Label Period|Withdrawal by Subject|160|||
23794397|NCT01067521|66623691|FG001|Open-Label Period|Withdrawal by Subject|88|||
23794398|NCT01067521|66623690|FG000|Open-Label Period|Physician Decision|13|||
23794399|NCT01067521|66623691|FG001|Open-Label Period|Physician Decision|11|||
23794400|NCT01067521|66623690|FG000|Open-Label Period|Non-compliance with study drug|5|||
23794401|NCT01067521|66623691|FG001|Open-Label Period|Non-compliance with study drug|0|||
23794402|NCT01067521|66623690|FG000|Open-Label Period|Protocol Violation|3|||
23469368|NCT03534180|65460871|FG000|Overall Study|Withdrawal by Subject|1|||
23469369|NCT00802945|65460872|FG000|Overall Study|Death|27|||
23469370|NCT00802945|65460873|FG001|Overall Study|Death|23|||
23469371|NCT00802945|65460872|FG000|Overall Study|Terminated by sponsor|8|||
23469372|NCT00802945|65460873|FG001|Overall Study|Terminated by sponsor|12|||
23469373|NCT01330108|65460874|FG000|Overall Study|Withdrawal by Subject|4|||
23469374|NCT01255436|65460875|FG000|Overall Study|Lost to Follow-up|178|||
23469375|NCT01255436|65460876|FG001|Overall Study|Lost to Follow-up|191|||
23469376|NCT01255436|65460875|FG000|Overall Study|Death, stroke, or MI|4|||
23469377|NCT01255436|65460876|FG001|Overall Study|Death, stroke, or MI|3|||
23469378|NCT00865280|65460880|FG000|Overall Study|Withdrawal by Subject|4|||
23469379|NCT00865280|65460881|FG001|Overall Study|Withdrawal by Subject|1|||
23469380|NCT00865280|65460880|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
23469381|NCT00865280|65460881|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
23469382|NCT00865280|65460880|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
23469383|NCT00865280|65460881|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
23469384|NCT00865280|65460880|FG000|Overall Study|Exclusion Condition|1|||
23469385|NCT00865280|65460881|FG001|Overall Study|Exclusion Condition|0|||
23469386|NCT00865280|65460880|FG000|Overall Study|Adverse Event|0|||
23469387|NCT00865280|65460881|FG001|Overall Study|Adverse Event|1|||
23469388|NCT02280408|65460882|FG000|Overall Study|Lost to Follow-up|0|||
23794403|NCT01067521|66623691|FG001|Open-Label Period|Protocol Violation|0|||
23794404|NCT01067521|66623690|FG000|Open-Label Period|Pregnancy|14|||
23794405|NCT01067521|66623691|FG001|Open-Label Period|Pregnancy|8|||
23353182|NCT00594386|65037502|FG000|Overall Study|Other: Study terminated per investigator|2|||
23353183|NCT00594386|65037502|FG000|Overall Study|Other: Sponsor closure of study|1|||
23469389|NCT02280408|65460883|FG001|Overall Study|Lost to Follow-up|2|||
23469390|NCT02280408|65460884|FG002|Overall Study|Lost to Follow-up|0|||
23469391|NCT02280408|65460885|FG003|Overall Study|Lost to Follow-up|0|||
23353184|NCT00594386|65037502|FG000|Overall Study|Other: Site terminated participation|1|||
23353185|NCT00594386|65037502|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
23353186|NCT00594386|65037502|FG000|Overall Study|Other: Loss of drivers license|1|||
23353187|NCT02155322|65037504|FG000|Overall Study|Adverse Event|1|||
23353188|NCT02155322|65037504|FG000|Overall Study|Physician Decision|1|||
23353189|NCT02155322|65037504|FG000|Overall Study|Relapse/Recurrence|8|||
23353190|NCT02155322|65037504|FG000|Overall Study|Withdrawal by Subject|4|||
23353191|NCT01375374|65037505|FG000|Overall Study|Adverse Event|1|||
23353192|NCT01964716|65037506|FG000|Overall Study|Withdrawal by Subject|2|||
23353193|NCT01964716|65037507|FG001|Overall Study|Withdrawal by Subject|3|||
23353194|NCT01964716|65037506|FG000|Overall Study|Lost to Follow-up|1|||
23353195|NCT01964716|65037507|FG001|Overall Study|Lost to Follow-up|2|||
23353196|NCT01964716|65037506|FG000|Overall Study|No longer met eligibility criteria|1|||
23353197|NCT01964716|65037507|FG001|Overall Study|No longer met eligibility criteria|1|||
23353198|NCT01964716|65037506|FG000|Overall Study|Death|1|||
23353199|NCT01964716|65037507|FG001|Overall Study|Death|0|||
23353200|NCT01754766|65037508|FG000|Overall Study|Personal reasons|1|||
23353201|NCT01754766|65037509|FG001|Overall Study|Personal reasons|1|||
23353202|NCT01754766|65037510|FG002|Overall Study|Personal reasons|0|||
23353203|NCT01080391|65037515|FG000|Overall Study|Randomized but not treated|7|||
23353204|NCT01080391|65037516|FG001|Overall Study|Randomized but not treated|4|||
23794406|NCT01067521|66623690|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
23794407|NCT01067521|66623691|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
23794408|NCT01067521|66623690|FG000|Open-Label Period|Lost to Follow-up|21|||
23794409|NCT01067521|66623691|FG001|Open-Label Period|Lost to Follow-up|20|||
23353205|NCT03301831|65037520|FG000|Overall Study|Lost to Follow-up|5|||
23353206|NCT03301831|65037521|FG001|Overall Study|Lost to Follow-up|3|||
23353207|NCT03301831|65037520|FG000|Overall Study|Protocol Violation|4|||
23353208|NCT03301831|65037521|FG001|Overall Study|Protocol Violation|0|||
23353209|NCT03301831|65037520|FG000|Overall Study|Withdrawal by Subject|11|||
23353210|NCT03301831|65037521|FG001|Overall Study|Withdrawal by Subject|0|||
23353211|NCT00508157|65037524|FG000|Overall Study|Adverse Event|0|||
23353212|NCT00508157|65037525|FG001|Overall Study|Adverse Event|1|||
23469392|NCT00541385|65460886|FG000|Overall Study|Adverse Event|6|||
23469393|NCT00541385|65460887|FG001|Overall Study|Adverse Event|3|||
23469394|NCT00541385|65460886|FG000|Overall Study|Withdrawal by Subject|2|||
23469395|NCT00541385|65460887|FG001|Overall Study|Withdrawal by Subject|2|||
23469396|NCT00541385|65460886|FG000|Overall Study|Lost to Follow-up|6|||
23469397|NCT00541385|65460887|FG001|Overall Study|Lost to Follow-up|1|||
23469398|NCT00541385|65460886|FG000|Overall Study|Parasite reappearance/malaria|67|||
23469399|NCT00541385|65460887|FG001|Overall Study|Parasite reappearance/malaria|32|||
23469400|NCT04455815|65460890|FG000|Randomisation Phase|Adverse Event|1|||
23469401|NCT04455815|65460891|FG001|Randomisation Phase|Adverse Event|0|||
23469402|NCT04455815|65460890|FG000|Treatment Phase|Adverse Event|0|||
23469403|NCT04455815|65460891|FG001|Treatment Phase|Adverse Event|1|||
23469404|NCT04455815|65460890|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
23469405|NCT04455815|65460891|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
23469406|NCT04455815|65460890|FG000|Treatment Phase|Withdrawal by Subject|1|||
23469407|NCT04455815|65460891|FG001|Treatment Phase|Withdrawal by Subject|1|||
23794410|NCT02308241|66623692|FG000|Overall Study|Withdrawal by Subject|3|||
23794411|NCT00084864|66623696|FG000|Overall Study|Adverse Event|1|||
23794412|NCT00084864|66623697|FG001|Overall Study|Adverse Event|0|||
23794413|NCT00084864|66623698|FG002|Overall Study|Adverse Event|0|||
23794414|NCT00084864|66623699|FG003|Overall Study|Adverse Event|0|||
23353213|NCT00508157|65037524|FG000|Overall Study|Subject Withdrew Consent|1|||
23353214|NCT00508157|65037525|FG001|Overall Study|Subject Withdrew Consent|0|||
23353215|NCT00508157|65037524|FG000|Overall Study|Lost to Follow-up|1|||
23353216|NCT00508157|65037525|FG001|Overall Study|Lost to Follow-up|0|||
23353217|NCT00508157|65037524|FG000|Overall Study|Subject no longer met study criteria|0|||
23469408|NCT01033448|65460893|FG000|Overall Study|Withdrawal by Subject|4|||
23469409|NCT01033448|65460893|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
23469410|NCT01033448|65460893|FG000|Overall Study|Lost to Follow-up|3|||
23640693|NCT04165031|66071413|FG000|Overall Study|Adverse Event|1|||
23469411|NCT01033448|65460893|FG000|Overall Study|Withdrew due to other reasons|3|||
23469412|NCT01033448|65460893|FG000|Overall Study|Unknown disposition|1|||
23469413|NCT03048578|65460894|FG000|Overall Study|Withdrawal by Subject|5|||
23469414|NCT03048578|65460895|FG001|Overall Study|Withdrawal by Subject|6|||
23469415|NCT03048578|65460894|FG000|Overall Study|Lost to Follow-up|22|||
23469416|NCT03048578|65460895|FG001|Overall Study|Lost to Follow-up|10|||
23469417|NCT03048578|65460894|FG000|Overall Study|Adverse Event|1|||
23469418|NCT03048578|65460895|FG001|Overall Study|Adverse Event|2|||
23469419|NCT03048578|65460894|FG000|Overall Study|Terminated|3|||
23469420|NCT03048578|65460895|FG001|Overall Study|Terminated|2|||
23469421|NCT00599339|65460896|FG000|Overall Study|Adverse Event|79|||
23469422|NCT00599339|65460896|FG000|Overall Study|Withdrawal by Subject|137|||
23469423|NCT00599339|65460896|FG000|Overall Study|Other Reason|179|||
23469424|NCT00599339|65460896|FG000|Overall Study|Lost to Follow-up|221|||
23469425|NCT00599339|65460896|FG000|Overall Study|No valid data consent|36|||
23469426|NCT00599339|65460896|FG000|Overall Study|Study Termination Status Unknown|12|||
23469427|NCT03070964|65460897|FG000|Overall Study|Progressive disease|8|||
23469428|NCT03070964|65460897|FG000|Overall Study|Treatment-unrelated adverse event|2|||
23469429|NCT03070964|65460897|FG000|Overall Study|Never treated|1|||
23469430|NCT03070964|65460897|FG000|Overall Study|Physician Decision|1|||
23469431|NCT03070964|65460897|FG000|Overall Study|Withdrawal by Subject|1|||
23469432|NCT03070964|65460897|FG000|Overall Study|Adverse Event|1|||
23469433|NCT00829504|65460898|FG000|First Intervention|Adverse Event|1|||
23469434|NCT00829504|65460899|FG001|First Intervention|Adverse Event|0|||
23469435|NCT00829504|65460898|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23469436|NCT00829504|65460899|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23469437|NCT00829504|65460898|FG000|Second Intervention|Physician Decision|1|||
23469438|NCT00829504|65460899|FG001|Second Intervention|Physician Decision|0|||
23469439|NCT00387790|65464228|FG000|Overall Study|Adverse Event|5|||
23469440|NCT00387790|65464228|FG000|Overall Study|Lack of Efficacy|2|||
23469441|NCT00387790|65464228|FG000|Overall Study|Physician Decision|2|||
23469442|NCT00387790|65464228|FG000|Overall Study|Withdrawal by Subject|3|||
23469443|NCT00387790|65464228|FG000|Overall Study|Ineligible for study|2|||
23469444|NCT02970942|65464229|FG000|Overall Study|Death|0|||
23469445|NCT02970942|65464230|FG001|Overall Study|Death|1|||
23469446|NCT02970942|65464231|FG002|Overall Study|Death|0|||
23469447|NCT02970942|65464232|FG003|Overall Study|Death|0|||
23469448|NCT02970942|65464229|FG000|Overall Study|Lost to Follow-up|1|||
23469449|NCT02970942|65464230|FG001|Overall Study|Lost to Follow-up|0|||
23469450|NCT02970942|65464231|FG002|Overall Study|Lost to Follow-up|2|||
23469451|NCT02970942|65464232|FG003|Overall Study|Lost to Follow-up|1|||
23469452|NCT02970942|65464229|FG000|Overall Study|Withdrawal by Subject|3|||
23469453|NCT02970942|65464230|FG001|Overall Study|Withdrawal by Subject|5|||
23469454|NCT02970942|65464231|FG002|Overall Study|Withdrawal by Subject|3|||
23469455|NCT02970942|65464232|FG003|Overall Study|Withdrawal by Subject|2|||
23587253|NCT01792830|65876289|FG004|Overall Study|Withdrawal by Subject|1|||
23587254|NCT01792830|65876290|FG005|Overall Study|Withdrawal by Subject|1|||
23469456|NCT05300763|65464233|FG000|Overall Study|Adverse Event|0|||
23469457|NCT05300763|65464234|FG001|Overall Study|Adverse Event|1|||
23469458|NCT05300763|65464233|FG000|Overall Study|Major Protocol Deviation|1|||
23469459|NCT05300763|65464234|FG001|Overall Study|Major Protocol Deviation|0|||
23587255|NCT01792830|65876291|FG006|Overall Study|Withdrawal by Subject|1|||
23469460|NCT05300763|65464233|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
23469461|NCT05300763|65464234|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23469462|NCT02259088|65464235|FG000|Overall Study|Adverse Event|6|||
23469463|NCT02259088|65464236|FG001|Overall Study|Adverse Event|4|||
23469464|NCT02259088|65464235|FG000|Overall Study|Lost to Follow-up|2|||
23469465|NCT02259088|65464236|FG001|Overall Study|Lost to Follow-up|0|||
23469466|NCT02259088|65464235|FG000|Overall Study|Death|2|||
23469467|NCT02259088|65464236|FG001|Overall Study|Death|0|||
23469468|NCT02259088|65464235|FG000|Overall Study|Physician Decision|5|||
23469469|NCT02259088|65464236|FG001|Overall Study|Physician Decision|2|||
23469470|NCT02259088|65464235|FG000|Overall Study|Protocol deviation|5|||
23469471|NCT02259088|65464236|FG001|Overall Study|Protocol deviation|0|||
23469472|NCT02259088|65464235|FG000|Overall Study|Subject/guardian decision|8|||
23469473|NCT02259088|65464236|FG001|Overall Study|Subject/guardian decision|8|||
23469474|NCT00643162|65464239|FG000|Overall Study|Withdrawal by Subject|1|||
23794415|NCT05278858|66623706|FG000|Overall Study|Withdrawal by Subject|1|||
23469475|NCT00643162|65464240|FG001|Overall Study|Withdrawal by Subject|1|||
23469476|NCT00467753|65464241|FG000|Overall Study|Lost to Follow-up|1|||
23469477|NCT00467753|65464242|FG001|Overall Study|Lost to Follow-up|2|||
23469478|NCT00467753|65464241|FG000|Overall Study|Adverse Event|2|||
23469479|NCT00467753|65464242|FG001|Overall Study|Adverse Event|0|||
23469480|NCT01276054|65464244|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
23469481|NCT01276054|65464245|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
23469482|NCT02141204|65464246|FG000|Overall Study|Lost to Follow-up|2|||
23469483|NCT02141204|65464247|FG001|Overall Study|Lost to Follow-up|1|||
23469484|NCT02141204|65464246|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
23469485|NCT02141204|65464247|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
23469486|NCT02141204|65464246|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23469487|NCT02141204|65464247|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
23469488|NCT02141204|65464246|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
23469489|NCT02141204|65464247|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
23469490|NCT01215097|65464248|FG000|Overall Study|Adverse Event|1|||
23469491|NCT01215097|65464249|FG001|Overall Study|Adverse Event|3|||
23469492|NCT01215097|65464248|FG000|Overall Study|Protocol Violation|0|||
23469493|NCT01215097|65464249|FG001|Overall Study|Protocol Violation|2|||
23469494|NCT01215097|65464248|FG000|Overall Study|Lost to Follow-up|2|||
23469495|NCT01215097|65464249|FG001|Overall Study|Lost to Follow-up|0|||
23469496|NCT01215097|65464248|FG000|Overall Study|Withdrawal by Subject|6|||
23469497|NCT01215097|65464249|FG001|Overall Study|Withdrawal by Subject|3|||
23469498|NCT01215097|65464248|FG000|Overall Study|Lack of Efficacy|0|||
23469499|NCT01215097|65464249|FG001|Overall Study|Lack of Efficacy|3|||
23794416|NCT03343639|66623707|FG000|Overall Study|Withdrawal by Subject|10|||
23794417|NCT03343639|66623708|FG001|Overall Study|Withdrawal by Subject|6|||
23794418|NCT03343639|66623707|FG000|Overall Study|Lost to Follow-up|4|||
23794419|NCT03343639|66623708|FG001|Overall Study|Lost to Follow-up|5|||
23794420|NCT03343639|66623707|FG000|Overall Study|Protocol Violation|0|||
23794421|NCT03343639|66623708|FG001|Overall Study|Protocol Violation|1|||
23794422|NCT00089973|66623709|FG000|Overall Study|Adverse Event|3|||
23794423|NCT00089973|66623709|FG000|Overall Study|Withdrawal by Subject|1|||
23794424|NCT00089973|66623709|FG000|Overall Study|Disease progression|45|||
23794425|NCT00089973|66623709|FG000|Overall Study|Death|1|||
23794426|NCT02611323|66623715|FG000|Overall Study|Death|3|||
23794427|NCT02611323|66623716|FG001|Overall Study|Death|1|||
23794428|NCT02611323|66623717|FG002|Overall Study|Death|0|||
23794429|NCT02611323|66623718|FG003|Overall Study|Death|0|||
23794430|NCT02611323|66623719|FG004|Overall Study|Death|1|||
23794431|NCT02611323|66623720|FG005|Overall Study|Death|1|||
23794432|NCT02611323|66623721|FG006|Overall Study|Death|8|||
23469500|NCT01215097|65464248|FG000|Overall Study|patient's refusal to come|2|||
23469501|NCT01215097|65464249|FG001|Overall Study|patient's refusal to come|2|||
23469502|NCT01215097|65464248|FG000|Overall Study|patient's private reason|1|||
23469503|NCT01215097|65464249|FG001|Overall Study|patient's private reason|1|||
23469504|NCT02656693|65464251|FG000|Overall Study|Pregnancy|1|||
23469505|NCT02656693|65464252|FG001|Overall Study|Pregnancy|1|||
23469506|NCT02656693|65464253|FG002|Overall Study|Pregnancy|1|||
23469507|NCT02656693|65464251|FG000|Overall Study|Bariatric surgery|0|||
23587256|NCT01792830|65876292|FG007|Overall Study|Withdrawal by Subject|1|||
23640694|NCT04165031|66071414|FG001|Overall Study|Adverse Event|1|||
23794433|NCT02611323|66623722|FG007|Overall Study|Death|0|||
23794434|NCT02611323|66623723|FG008|Overall Study|Death|4|||
23794435|NCT02611323|66623724|FG009|Overall Study|Death|6|||
23469508|NCT02656693|65464252|FG001|Overall Study|Bariatric surgery|1|||
23469509|NCT02656693|65464253|FG002|Overall Study|Bariatric surgery|2|||
23469510|NCT00114517|65464254|FG000|Overall Study|Adverse Event|6|||
23469511|NCT00114517|65464255|FG001|Overall Study|Adverse Event|1|||
23469512|NCT00114517|65464256|FG002|Overall Study|Adverse Event|6|||
23794436|NCT02611323|66623725|FG010|Overall Study|Death|26|||
23794437|NCT02611323|66623715|FG000|Overall Study|Lost to Follow-up|1|||
23794438|NCT02611323|66623716|FG001|Overall Study|Lost to Follow-up|0|||
23469513|NCT00114517|65464257|FG003|Overall Study|Adverse Event|3|||
23469514|NCT00114517|65464254|FG000|Overall Study|Lost to Follow-up|2|||
23469515|NCT00114517|65464255|FG001|Overall Study|Lost to Follow-up|2|||
23469516|NCT00114517|65464256|FG002|Overall Study|Lost to Follow-up|2|||
23469517|NCT00114517|65464257|FG003|Overall Study|Lost to Follow-up|1|||
23469518|NCT00114517|65464254|FG000|Overall Study|Too busy|3|||
23469519|NCT00114517|65464255|FG001|Overall Study|Too busy|1|||
23469520|NCT00114517|65464256|FG002|Overall Study|Too busy|1|||
23469521|NCT00114517|65464257|FG003|Overall Study|Too busy|2|||
23469522|NCT00114517|65464254|FG000|Overall Study|Moved from area|0|||
23469523|NCT00114517|65464255|FG001|Overall Study|Moved from area|3|||
23469524|NCT00114517|65464256|FG002|Overall Study|Moved from area|2|||
23469525|NCT00114517|65464257|FG003|Overall Study|Moved from area|1|||
23469526|NCT00114517|65464254|FG000|Overall Study|Did not want estradiol|1|||
23469527|NCT00114517|65464255|FG001|Overall Study|Did not want estradiol|1|||
23469528|NCT00114517|65464256|FG002|Overall Study|Did not want estradiol|0|||
23469529|NCT00114517|65464257|FG003|Overall Study|Did not want estradiol|0|||
23469530|NCT00114517|65464254|FG000|Overall Study|Armed-services duty|0|||
23469531|NCT00114517|65464255|FG001|Overall Study|Armed-services duty|1|||
23469532|NCT00114517|65464256|FG002|Overall Study|Armed-services duty|0|||
23469533|NCT00114517|65464257|FG003|Overall Study|Armed-services duty|1|||
23469534|NCT00114517|65464254|FG000|Overall Study|Competing family issue|0|||
23469535|NCT00114517|65464255|FG001|Overall Study|Competing family issue|1|||
23469536|NCT00114517|65464256|FG002|Overall Study|Competing family issue|0|||
23469537|NCT00114517|65464257|FG003|Overall Study|Competing family issue|1|||
23469538|NCT00114517|65464254|FG000|Overall Study|Physician Decision|0|||
23469539|NCT00114517|65464255|FG001|Overall Study|Physician Decision|1|||
23469540|NCT00114517|65464256|FG002|Overall Study|Physician Decision|0|||
23469541|NCT00114517|65464257|FG003|Overall Study|Physician Decision|0|||
23469542|NCT00114517|65464254|FG000|Overall Study|Lost interest|0|||
23469543|NCT00114517|65464255|FG001|Overall Study|Lost interest|0|||
23469544|NCT00114517|65464256|FG002|Overall Study|Lost interest|1|||
23469545|NCT00114517|65464257|FG003|Overall Study|Lost interest|0|||
23469546|NCT00114517|65464254|FG000|Overall Study|Weight increase|0|||
23469547|NCT00114517|65464255|FG001|Overall Study|Weight increase|0|||
23469548|NCT00114517|65464256|FG002|Overall Study|Weight increase|1|||
23469549|NCT00114517|65464257|FG003|Overall Study|Weight increase|0|||
23469550|NCT00114517|65464254|FG000|Overall Study|Concern about blood clots|0|||
23469551|NCT00114517|65464255|FG001|Overall Study|Concern about blood clots|0|||
23469552|NCT00114517|65464256|FG002|Overall Study|Concern about blood clots|1|||
23469553|NCT00114517|65464257|FG003|Overall Study|Concern about blood clots|0|||
23469554|NCT00114517|65464254|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469555|NCT00114517|65464255|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469556|NCT00114517|65464256|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469557|NCT00114517|65464257|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
23469558|NCT03052426|65464258|FG000|Overall Study|Withdrawal by Subject|0|||
23469559|NCT03052426|65464259|FG001|Overall Study|Withdrawal by Subject|1|||
23469560|NCT03052426|65464260|FG002|Overall Study|Withdrawal by Subject|0|||
23587257|NCT01792830|65876293|FG008|Overall Study|Withdrawal by Subject|7|||
23587258|NCT01792830|65876294|FG009|Overall Study|Withdrawal by Subject|0|||
23587259|NCT01792830|65876295|FG010|Overall Study|Withdrawal by Subject|2|||
23587260|NCT01792830|65876285|FG000|Overall Study|Death|3|||
23587261|NCT01792830|65876286|FG001|Overall Study|Death|0|||
23587262|NCT01792830|65876287|FG002|Overall Study|Death|0|||
23587263|NCT01792830|65876288|FG003|Overall Study|Death|1|||
23587264|NCT01792830|65876289|FG004|Overall Study|Death|0|||
23587265|NCT01792830|65876290|FG005|Overall Study|Death|0|||
23587266|NCT01792830|65876291|FG006|Overall Study|Death|1|||
23587267|NCT01792830|65876292|FG007|Overall Study|Death|0|||
23587268|NCT01792830|65876293|FG008|Overall Study|Death|1|||
23587269|NCT01792830|65876294|FG009|Overall Study|Death|0|||
23587270|NCT01792830|65876295|FG010|Overall Study|Death|1|||
23587271|NCT01792830|65876285|FG000|Overall Study|Adverse Event|0|||
23587272|NCT01792830|65876286|FG001|Overall Study|Adverse Event|0|||
23587273|NCT01792830|65876287|FG002|Overall Study|Adverse Event|0|||
23587274|NCT01792830|65876288|FG003|Overall Study|Adverse Event|0|||
23469561|NCT03052426|65464258|FG000|Overall Study|Lost to Follow-up|2|||
23469562|NCT03052426|65464259|FG001|Overall Study|Lost to Follow-up|0|||
23469563|NCT03052426|65464260|FG002|Overall Study|Lost to Follow-up|1|||
23587275|NCT01792830|65876289|FG004|Overall Study|Adverse Event|0|||
23587276|NCT01792830|65876290|FG005|Overall Study|Adverse Event|0|||
23587277|NCT01792830|65876291|FG006|Overall Study|Adverse Event|0|||
23469564|NCT03710083|65464262|FG000|Overall Study|Withdrawal by Subject|2|||
23469565|NCT03710083|65464262|FG000|Overall Study|Unsuccessful Procedure|1|||
23469566|NCT02269267|65464263|FG000|Overall Study|Death|5|||
23587278|NCT01792830|65876292|FG007|Overall Study|Adverse Event|0|||
23587279|NCT01792830|65876293|FG008|Overall Study|Adverse Event|1|||
23587280|NCT01792830|65876294|FG009|Overall Study|Adverse Event|0|||
23587281|NCT01792830|65876295|FG010|Overall Study|Adverse Event|0|||
23587282|NCT01649791|65876296|FG000|Overall Study|Disease Progression|2|||
23469567|NCT00993148|65464266|FG000|Overall Study|Lost to Follow-up|2|||
23469568|NCT00993148|65464266|FG000|Overall Study|never initiated treatment|1|||
23469569|NCT04080167|65464267|FG000|Overall Study|Lost to Follow-up-Patients|7|||
23469570|NCT04080167|65464268|FG001|Overall Study|Lost to Follow-up-Patients|14|||
23469571|NCT04080167|65464269|FG002|Overall Study|Lost to Follow-up-Patients|0|||
23469572|NCT04080167|65464267|FG000|Overall Study|Lost to Follow-up-Providers|2|||
23469573|NCT04080167|65464268|FG001|Overall Study|Lost to Follow-up-Providers|2|||
23469574|NCT04080167|65464269|FG002|Overall Study|Lost to Follow-up-Providers|0|||
23469575|NCT04080167|65464267|FG000|Overall Study|Withdrawal by Subject|1|||
23469576|NCT04080167|65464268|FG001|Overall Study|Withdrawal by Subject|2|||
23469577|NCT04080167|65464269|FG002|Overall Study|Withdrawal by Subject|0|||
23469578|NCT04080167|65464267|FG000|Overall Study|Withdrawal by Provider|0|||
23469579|NCT04080167|65464268|FG001|Overall Study|Withdrawal by Provider|0|||
23469580|NCT04080167|65464269|FG002|Overall Study|Withdrawal by Provider|4|||
23469581|NCT04080167|65464267|FG000|Overall Study|Death-Patient|2|||
23469582|NCT04080167|65464268|FG001|Overall Study|Death-Patient|1|||
23469583|NCT04080167|65464269|FG002|Overall Study|Death-Patient|0|||
23469584|NCT04080167|65464267|FG000|Overall Study|Hydroxyurea New Starts|0|||
23469585|NCT04080167|65464268|FG001|Overall Study|Hydroxyurea New Starts|0|||
23469586|NCT04080167|65464269|FG002|Overall Study|Hydroxyurea New Starts|1|||
23469587|NCT04080167|65464267|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
23469588|NCT04080167|65464268|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
23469589|NCT04080167|65464269|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
23469590|NCT03583385|65464270|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23469591|NCT03583385|65464271|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23469592|NCT03583385|65464270|FG000|Treatment Period 2|Adverse Event|1|||
23469593|NCT03583385|65464271|FG001|Treatment Period 2|Adverse Event|0|||
23469594|NCT00441116|65464277|FG000|Overall Study|Adverse Event|1|||
23469595|NCT00441116|65464278|FG001|Overall Study|Adverse Event|1|||
23469596|NCT00441116|65464277|FG000|Overall Study|Withdrawal by Subject|1|||
23469597|NCT00441116|65464278|FG001|Overall Study|Withdrawal by Subject|0|||
23469598|NCT00441116|65464277|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
23469599|NCT00441116|65464278|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
23469600|NCT03554486|65464284|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
23469601|NCT03554486|65464285|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
23469602|NCT03554486|65464286|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
23469603|NCT03554486|65464284|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
23469604|NCT03554486|65464285|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
23469605|NCT03554486|65464286|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
23469606|NCT03554486|65464284|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23469607|NCT03554486|65464285|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23469608|NCT03554486|65464286|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23469609|NCT02282605|65464295|FG000|Overall Study|negative SA result on Day -1|3|||
23469610|NCT02282605|65464296|FG001|Overall Study|negative SA result on Day -1|0|||
23469611|NCT02282605|65464297|FG002|Overall Study|negative SA result on Day -1|0|||
23469612|NCT00241839|65464298|FG000|Overall Study|Withdrawal by Subject|18|||
23469613|NCT00241839|65464299|FG001|Overall Study|Withdrawal by Subject|17|||
23469614|NCT00241839|65464298|FG000|Overall Study|Adverse Event|1|||
23469615|NCT00241839|65464299|FG001|Overall Study|Adverse Event|1|||
23469616|NCT01296672|65464300|FG000|Overall Study|Lost to Follow-up|73|||
23469617|NCT01296672|65464301|FG001|Overall Study|Lost to Follow-up|18|||
23469618|NCT00775190|65464304|FG000|Overall Study|Lost to Follow-up|2|||
23469619|NCT00775190|65464305|FG001|Overall Study|Lost to Follow-up|3|||
23469620|NCT00775190|65464304|FG000|Overall Study|Withdrawal by Subject|1|||
23469621|NCT00775190|65464305|FG001|Overall Study|Withdrawal by Subject|2|||
23469622|NCT00775190|65464304|FG000|Overall Study|Protocol Violation|1|||
23469623|NCT00775190|65464305|FG001|Overall Study|Protocol Violation|0|||
23469624|NCT04629066|65464311|FG000|Overall Study|Lost to Follow-up|3|||
23469625|NCT04629066|65464312|FG001|Overall Study|Lost to Follow-up|2|||
23469626|NCT03565497|65464313|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
23469627|NCT03565497|65464314|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
23469628|NCT03565497|65464315|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
23469629|NCT03565497|65464313|FG000|Overall Study|Lost to Follow-up|1|||
23469630|NCT03565497|65464314|FG001|Overall Study|Lost to Follow-up|1|||
23469631|NCT03565497|65464315|FG002|Overall Study|Lost to Follow-up|2|||
23469632|NCT03565497|65464313|FG000|Overall Study|Withdrawal by Subject|1|||
23469633|NCT03565497|65464314|FG001|Overall Study|Withdrawal by Subject|1|||
23469634|NCT03565497|65464315|FG002|Overall Study|Withdrawal by Subject|1|||
23469635|NCT00939393|65464316|FG000|Overall Study|Withdrawal by Subject|1|||
23794439|NCT02611323|66623717|FG002|Overall Study|Lost to Follow-up|0|||
23469636|NCT00939393|65464317|FG001|Overall Study|Withdrawal by Subject|0|||
23469637|NCT00939393|65464316|FG000|Overall Study|Lost to Follow-up|3|||
23640695|NCT04165031|66071415|FG002|Overall Study|Adverse Event|0|||
23469638|NCT00939393|65464317|FG001|Overall Study|Lost to Follow-up|0|||
23587283|NCT01649791|65876296|FG000|Overall Study|Adverse Event|1|||
23469639|NCT01146795|65464324|FG000|Overall Study|Withdrawal by Subject|4|||
23469640|NCT01146795|65464324|FG000|Overall Study|Adverse Event|6|||
23640696|NCT04165031|66071416|FG003|Overall Study|Adverse Event|0|||
23640697|NCT04165031|66071417|FG004|Overall Study|Adverse Event|0|||
23640698|NCT04165031|66071418|FG005|Overall Study|Adverse Event|0|||
23640699|NCT04165031|66071413|FG000|Overall Study|Withdrawal by Subject|0|||
23640700|NCT04165031|66071414|FG001|Overall Study|Withdrawal by Subject|0|||
23640701|NCT04165031|66071415|FG002|Overall Study|Withdrawal by Subject|1|||
23640702|NCT04165031|66071416|FG003|Overall Study|Withdrawal by Subject|0|||
23640703|NCT04165031|66071417|FG004|Overall Study|Withdrawal by Subject|0|||
23640704|NCT04165031|66071418|FG005|Overall Study|Withdrawal by Subject|0|||
23640705|NCT00910039|66071422|FG000|Overall Study|Physician Decision|1|||
23640706|NCT00760474|66071425|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
23640707|NCT00760474|66071426|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
23640708|NCT00760474|66071425|FG000|Placebo Washout Period|Other|0|||
23640709|NCT00760474|66071426|FG001|Placebo Washout Period|Other|1|||
23640710|NCT00760474|66071425|FG000|Period 2 (P2)|Lost to Follow-up|1|||
23640711|NCT00760474|66071426|FG001|Period 2 (P2)|Lost to Follow-up|0|||
23640712|NCT00760474|66071425|FG000|Period 2 (P2)|Adverse Event|0|||
23640713|NCT00760474|66071426|FG001|Period 2 (P2)|Adverse Event|1|||
23794440|NCT02611323|66623718|FG003|Overall Study|Lost to Follow-up|0|||
23469641|NCT01146795|65464324|FG000|Overall Study|Still in treatment at study closure|10|||
23469642|NCT00441064|65464325|FG000|Overall Study|Adverse Event|1|||
23469643|NCT00441064|65464326|FG001|Overall Study|Adverse Event|0|||
23469644|NCT00441064|65464325|FG000|Overall Study|Abnormal laboratory values|0|||
23469645|NCT00441064|65464326|FG001|Overall Study|Abnormal laboratory values|2|||
23469646|NCT00441064|65464325|FG000|Overall Study|Abnormal test procedure results|0|||
23469647|NCT00441064|65464326|FG001|Overall Study|Abnormal test procedure results|1|||
23469648|NCT00441064|65464325|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23469649|NCT00441064|65464326|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23469650|NCT00441064|65464325|FG000|Overall Study|Protocol Deviation|3|||
23469651|NCT00441064|65464326|FG001|Overall Study|Protocol Deviation|2|||
23469652|NCT00441064|65464325|FG000|Overall Study|Patient withdrew consent|5|||
23469653|NCT00441064|65464326|FG001|Overall Study|Patient withdrew consent|2|||
23469654|NCT00606593|65464327|FG000|Overall Study|Adverse Event|0|||
23469655|NCT00606593|65464328|FG001|Overall Study|Adverse Event|0|||
23469656|NCT00606593|65464329|FG002|Overall Study|Adverse Event|0|||
23469657|NCT00606593|65464330|FG003|Overall Study|Adverse Event|1|||
23469658|NCT00606593|65464331|FG004|Overall Study|Adverse Event|1|||
23469659|NCT00606593|65464332|FG005|Overall Study|Adverse Event|0|||
23469660|NCT00606593|65464333|FG006|Overall Study|Adverse Event|1|||
23469661|NCT00606593|65464334|FG007|Overall Study|Adverse Event|2|||
23469662|NCT00606593|65464335|FG008|Overall Study|Adverse Event|1|||
23469663|NCT00606593|65464336|FG009|Overall Study|Adverse Event|0|||
23469664|NCT00606593|65464327|FG000|Overall Study|Withdrawal of consent|1|||
23469665|NCT00606593|65464328|FG001|Overall Study|Withdrawal of consent|0|||
23469666|NCT00606593|65464329|FG002|Overall Study|Withdrawal of consent|1|||
23469667|NCT00606593|65464330|FG003|Overall Study|Withdrawal of consent|0|||
23469668|NCT00606593|65464331|FG004|Overall Study|Withdrawal of consent|0|||
23469669|NCT00606593|65464332|FG005|Overall Study|Withdrawal of consent|0|||
23469670|NCT00606593|65464333|FG006|Overall Study|Withdrawal of consent|0|||
23469671|NCT00606593|65464334|FG007|Overall Study|Withdrawal of consent|0|||
23469672|NCT00606593|65464335|FG008|Overall Study|Withdrawal of consent|0|||
23469673|NCT00606593|65464336|FG009|Overall Study|Withdrawal of consent|0|||
23469674|NCT00606593|65464327|FG000|Overall Study|Administrative/Other|0|||
23469675|NCT00606593|65464328|FG001|Overall Study|Administrative/Other|0|||
23469676|NCT00606593|65464329|FG002|Overall Study|Administrative/Other|1|||
23469677|NCT00606593|65464330|FG003|Overall Study|Administrative/Other|0|||
23469678|NCT00606593|65464331|FG004|Overall Study|Administrative/Other|0|||
23794441|NCT02611323|66623719|FG004|Overall Study|Lost to Follow-up|0|||
23794442|NCT02611323|66623720|FG005|Overall Study|Lost to Follow-up|0|||
23794443|NCT02611323|66623721|FG006|Overall Study|Lost to Follow-up|3|||
23794444|NCT02611323|66623722|FG007|Overall Study|Lost to Follow-up|0|||
23794445|NCT02611323|66623723|FG008|Overall Study|Lost to Follow-up|0|||
23469679|NCT00606593|65464332|FG005|Overall Study|Administrative/Other|0|||
23640714|NCT01353859|66071427|FG000|Overall Study|Adverse Event|3|||
23640715|NCT01353859|66071427|FG000|Overall Study|Lack of Efficacy|1|||
23640716|NCT03261700|66071428|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
23706827|NCT00002663|66301343|FG004|Overall Study|Lost to Follow-up|0|||
23794446|NCT02611323|66623724|FG009|Overall Study|Lost to Follow-up|0|||
23469680|NCT00606593|65464333|FG006|Overall Study|Administrative/Other|0|||
23469681|NCT00606593|65464334|FG007|Overall Study|Administrative/Other|0|||
23469682|NCT00606593|65464335|FG008|Overall Study|Administrative/Other|0|||
23469683|NCT00606593|65464336|FG009|Overall Study|Administrative/Other|0|||
23469684|NCT04040933|65464338|FG000|Overall Study|Protocol Violation|1|||
23469685|NCT04040933|65464338|FG000|Overall Study|Withdrawal by Subject|2|||
23469686|NCT02379091|65464340|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23469687|NCT02379091|65464341|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23469688|NCT02379091|65464342|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23469689|NCT02379091|65464343|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23469690|NCT02379091|65464340|FG000|Overall Study|Principal Investigator Discretion|0|||
23469691|NCT02379091|65464341|FG001|Overall Study|Principal Investigator Discretion|1|||
23469692|NCT02379091|65464342|FG002|Overall Study|Principal Investigator Discretion|0|||
23469693|NCT02379091|65464343|FG003|Overall Study|Principal Investigator Discretion|0|||
23469694|NCT02379091|65464340|FG000|Overall Study|Lost to Follow-up|0|||
23469695|NCT02379091|65464341|FG001|Overall Study|Lost to Follow-up|0|||
23469696|NCT02379091|65464342|FG002|Overall Study|Lost to Follow-up|0|||
23469697|NCT02379091|65464343|FG003|Overall Study|Lost to Follow-up|1|||
23469698|NCT02379091|65464340|FG000|Overall Study|Voluntary Withdrawal|2|||
23469699|NCT02379091|65464341|FG001|Overall Study|Voluntary Withdrawal|5|||
23469700|NCT02379091|65464342|FG002|Overall Study|Voluntary Withdrawal|2|||
23469701|NCT02379091|65464343|FG003|Overall Study|Voluntary Withdrawal|4|||
23469702|NCT02379091|65464340|FG000|Overall Study|Study Termination|7|||
23469703|NCT02379091|65464341|FG001|Overall Study|Study Termination|2|||
23469704|NCT02379091|65464342|FG002|Overall Study|Study Termination|5|||
23469705|NCT02379091|65464343|FG003|Overall Study|Study Termination|8|||
23469706|NCT02379091|65464340|FG000|Overall Study|Lack of Efficacy|3|||
23469707|NCT02379091|65464341|FG001|Overall Study|Lack of Efficacy|0|||
23469708|NCT02379091|65464342|FG002|Overall Study|Lack of Efficacy|0|||
23469709|NCT02379091|65464343|FG003|Overall Study|Lack of Efficacy|0|||
23469710|NCT00122980|65464344|FG000|Overall Study|Death|0|||
23469711|NCT00122980|65464345|FG001|Overall Study|Death|1|||
23469712|NCT00122980|65464344|FG000|Overall Study|Physician Decision|2|||
23469713|NCT00122980|65464345|FG001|Overall Study|Physician Decision|0|||
23469714|NCT00122980|65464344|FG000|Overall Study|Protocol Violation|5|||
23469715|NCT00122980|65464345|FG001|Overall Study|Protocol Violation|1|||
23469716|NCT00122980|65464344|FG000|Overall Study|Withdrawal by Subject|2|||
23469717|NCT00122980|65464345|FG001|Overall Study|Withdrawal by Subject|3|||
23469718|NCT00122980|65464344|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
23469719|NCT00122980|65464345|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
23469720|NCT00122980|65464344|FG000|Overall Study|Study termination|27|||
23469721|NCT00122980|65464345|FG001|Overall Study|Study termination|35|||
23469722|NCT02709538|65464346|FG000|Overall Study|Adverse Event|13|||
23469723|NCT02709538|65464347|FG001|Overall Study|Adverse Event|2|||
23469724|NCT02709538|65464348|FG002|Overall Study|Adverse Event|3|||
23469725|NCT02709538|65464346|FG000|Overall Study|Lack of Efficacy|1|||
23469726|NCT02709538|65464347|FG001|Overall Study|Lack of Efficacy|0|||
23469727|NCT02709538|65464348|FG002|Overall Study|Lack of Efficacy|0|||
23469728|NCT02709538|65464346|FG000|Overall Study|Lost to Follow-up|24|||
23469729|NCT02709538|65464347|FG001|Overall Study|Lost to Follow-up|8|||
23469730|NCT02709538|65464348|FG002|Overall Study|Lost to Follow-up|4|||
23469731|NCT02709538|65464346|FG000|Overall Study|Physician Decision|1|||
23469732|NCT02709538|65464347|FG001|Overall Study|Physician Decision|0|||
23469733|NCT02709538|65464348|FG002|Overall Study|Physician Decision|0|||
23469734|NCT02709538|65464346|FG000|Overall Study|Withdrawal by Subject|40|||
23469735|NCT02709538|65464347|FG001|Overall Study|Withdrawal by Subject|7|||
23469736|NCT02709538|65464348|FG002|Overall Study|Withdrawal by Subject|4|||
23469737|NCT02709538|65464346|FG000|Overall Study|Non-compliance with study procedures|5|||
23469738|NCT02709538|65464347|FG001|Overall Study|Non-compliance with study procedures|0|||
23469739|NCT02709538|65464348|FG002|Overall Study|Non-compliance with study procedures|0|||
23469740|NCT02709538|65464346|FG000|Overall Study|Non-compliance with study drug|2|||
23469741|NCT02709538|65464347|FG001|Overall Study|Non-compliance with study drug|0|||
23469742|NCT02709538|65464348|FG002|Overall Study|Non-compliance with study drug|0|||
23469743|NCT02709538|65464346|FG000|Overall Study|Protocol deviation|10|||
23469744|NCT02709538|65464347|FG001|Overall Study|Protocol deviation|4|||
23469745|NCT02709538|65464348|FG002|Overall Study|Protocol deviation|4|||
23469746|NCT02709538|65464346|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
23469747|NCT02709538|65464347|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
23469748|NCT02709538|65464348|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
23469749|NCT02709538|65464346|FG000|Overall Study|Other|16|||
23469750|NCT02709538|65464347|FG001|Overall Study|Other|7|||
23469751|NCT02709538|65464348|FG002|Overall Study|Other|5|||
23469752|NCT01399372|65464350|FG000|Overall Study|Protocol Violation|3|||
23469753|NCT01399372|65464351|FG001|Overall Study|Protocol Violation|1|||
23587284|NCT03939819|65878977|FG000|Overall Study|Death|2|||
23587285|NCT03939819|65878978|FG001|Overall Study|Death|0|||
23469754|NCT00485134|65464352|FG000|Overall Study|Lost to Follow-up|1|||
23469755|NCT00485134|65464353|FG001|Overall Study|Lost to Follow-up|0|||
23469756|NCT00485134|65464354|FG002|Overall Study|Lost to Follow-up|0|||
23469757|NCT00485134|65464355|FG003|Overall Study|Lost to Follow-up|0|||
23469758|NCT00485134|65464356|FG004|Overall Study|Lost to Follow-up|0|||
23469759|NCT00485134|65464357|FG005|Overall Study|Lost to Follow-up|0|||
23469760|NCT00485134|65464358|FG006|Overall Study|Lost to Follow-up|0|||
23469761|NCT00485134|65464359|FG007|Overall Study|Lost to Follow-up|0|||
23587286|NCT01134562|65878979|FG000|Overall Study|Adverse Event|0|||
23469762|NCT00485134|65464352|FG000|Overall Study|Withdrawal by Subject|0|||
23469763|NCT00485134|65464353|FG001|Overall Study|Withdrawal by Subject|1|||
23469764|NCT00485134|65464354|FG002|Overall Study|Withdrawal by Subject|0|||
23469765|NCT00485134|65464355|FG003|Overall Study|Withdrawal by Subject|0|||
23469766|NCT00485134|65464356|FG004|Overall Study|Withdrawal by Subject|0|||
23469767|NCT00485134|65464357|FG005|Overall Study|Withdrawal by Subject|0|||
23469768|NCT00485134|65464358|FG006|Overall Study|Withdrawal by Subject|0|||
23469769|NCT00485134|65464359|FG007|Overall Study|Withdrawal by Subject|0|||
23469770|NCT00485134|65464352|FG000|Overall Study|Change in health status|0|||
23469771|NCT00485134|65464353|FG001|Overall Study|Change in health status|1|||
23469772|NCT00485134|65464354|FG002|Overall Study|Change in health status|2|||
23469773|NCT00485134|65464355|FG003|Overall Study|Change in health status|1|||
23469774|NCT00485134|65464356|FG004|Overall Study|Change in health status|0|||
23469775|NCT00485134|65464357|FG005|Overall Study|Change in health status|1|||
23469776|NCT00485134|65464358|FG006|Overall Study|Change in health status|0|||
23469777|NCT00485134|65464359|FG007|Overall Study|Change in health status|0|||
23469778|NCT00485134|65464352|FG000|Overall Study|Withdrew for adverse event|0|||
23469779|NCT00485134|65464353|FG001|Overall Study|Withdrew for adverse event|0|||
23469780|NCT00485134|65464354|FG002|Overall Study|Withdrew for adverse event|1|||
23469781|NCT00485134|65464355|FG003|Overall Study|Withdrew for adverse event|0|||
23469782|NCT00485134|65464356|FG004|Overall Study|Withdrew for adverse event|0|||
23469783|NCT00485134|65464357|FG005|Overall Study|Withdrew for adverse event|0|||
23469784|NCT00485134|65464358|FG006|Overall Study|Withdrew for adverse event|0|||
23469785|NCT00485134|65464359|FG007|Overall Study|Withdrew for adverse event|0|||
23469786|NCT00485134|65464352|FG000|Overall Study|Positive drug test|0|||
23469787|NCT00485134|65464353|FG001|Overall Study|Positive drug test|0|||
23469788|NCT00485134|65464354|FG002|Overall Study|Positive drug test|0|||
23469789|NCT00485134|65464355|FG003|Overall Study|Positive drug test|0|||
23469790|NCT00485134|65464356|FG004|Overall Study|Positive drug test|2|||
23469791|NCT00485134|65464357|FG005|Overall Study|Positive drug test|1|||
23469792|NCT00485134|65464358|FG006|Overall Study|Positive drug test|0|||
23469793|NCT00485134|65464359|FG007|Overall Study|Positive drug test|0|||
23469794|NCT00485134|65464352|FG000|Overall Study|Non-compliance|0|||
23469795|NCT00485134|65464353|FG001|Overall Study|Non-compliance|0|||
23469796|NCT00485134|65464354|FG002|Overall Study|Non-compliance|0|||
23469797|NCT00485134|65464355|FG003|Overall Study|Non-compliance|0|||
23469798|NCT00485134|65464356|FG004|Overall Study|Non-compliance|1|||
23469799|NCT00485134|65464357|FG005|Overall Study|Non-compliance|2|||
23469800|NCT00485134|65464358|FG006|Overall Study|Non-compliance|2|||
23469801|NCT00485134|65464359|FG007|Overall Study|Non-compliance|0|||
23469802|NCT00485134|65464352|FG000|Overall Study|Unable to comply with study schedule|0|||
23469803|NCT00485134|65464353|FG001|Overall Study|Unable to comply with study schedule|0|||
23469804|NCT00485134|65464354|FG002|Overall Study|Unable to comply with study schedule|0|||
23469805|NCT00485134|65464355|FG003|Overall Study|Unable to comply with study schedule|0|||
23469806|NCT00485134|65464356|FG004|Overall Study|Unable to comply with study schedule|0|||
23469807|NCT00485134|65464357|FG005|Overall Study|Unable to comply with study schedule|0|||
23469808|NCT00485134|65464358|FG006|Overall Study|Unable to comply with study schedule|0|||
23469809|NCT00485134|65464359|FG007|Overall Study|Unable to comply with study schedule|1|||
23794447|NCT02611323|66623725|FG010|Overall Study|Lost to Follow-up|2|||
23794448|NCT02611323|66623715|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794449|NCT02611323|66623716|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794450|NCT02611323|66623717|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794451|NCT02611323|66623718|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794452|NCT02611323|66623719|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794453|NCT02611323|66623720|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794454|NCT02611323|66623721|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794455|NCT02611323|66623722|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794456|NCT02611323|66623723|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794457|NCT02611323|66623724|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
23794458|NCT02611323|66623725|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
23794459|NCT02611323|66623715|FG000|Overall Study|Progressive Disease|0|||
23794460|NCT02611323|66623716|FG001|Overall Study|Progressive Disease|0|||
23469810|NCT00485134|65464352|FG000|Overall Study|Pregnancy|0|||
23469811|NCT00485134|65464353|FG001|Overall Study|Pregnancy|0|||
23469812|NCT00485134|65464354|FG002|Overall Study|Pregnancy|0|||
23469813|NCT00485134|65464355|FG003|Overall Study|Pregnancy|0|||
23469814|NCT00485134|65464356|FG004|Overall Study|Pregnancy|0|||
23469815|NCT00485134|65464357|FG005|Overall Study|Pregnancy|0|||
23469816|NCT00485134|65464358|FG006|Overall Study|Pregnancy|1|||
23469817|NCT00485134|65464359|FG007|Overall Study|Pregnancy|0|||
23469818|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
23469819|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
23469820|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
23469821|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
23469822|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
23469823|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
23469824|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
23469825|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
23469826|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
23469827|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
23469828|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
23469829|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
23469830|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
23469831|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
23469832|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
23469833|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
23469834|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
23469835|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
23469836|NCT01235741|65464360|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
23469837|NCT01235741|65464361|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
23469838|NCT01235741|65464362|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
23469839|NCT01235741|65464360|FG000|Randomized to Treatment|Adverse Event|0|||
23469840|NCT01235741|65464361|FG001|Randomized to Treatment|Adverse Event|1|||
23469841|NCT01235741|65464362|FG002|Randomized to Treatment|Adverse Event|1|||
23469842|NCT01235741|65464360|FG000|Randomized to Treatment|Sponsor terminated study|0|||
23469843|NCT01235741|65464361|FG001|Randomized to Treatment|Sponsor terminated study|35|||
23469844|NCT01235741|65464362|FG002|Randomized to Treatment|Sponsor terminated study|34|||
23469845|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
23469846|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
23469847|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
23469848|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
23469849|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
23794461|NCT02611323|66623717|FG002|Overall Study|Progressive Disease|0|||
23469850|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
23469851|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
23469852|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
23469853|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
23469854|NCT01716052|65464363|FG000|Overall Study|Withdrawal of funding|1|||
23469855|NCT01716052|65464364|FG001|Overall Study|Withdrawal of funding|1|||
23469856|NCT01120717|65464367|FG000|Overall Study|Withdrawal by Subject|11|||
23469857|NCT01120717|65464368|FG001|Overall Study|Withdrawal by Subject|6|||
23469858|NCT01120717|65464367|FG000|Overall Study|Adverse Event|10|||
23469859|NCT01120717|65464368|FG001|Overall Study|Adverse Event|6|||
23469860|NCT01120717|65464367|FG000|Overall Study|Protocol Deviation|2|||
23469861|NCT01120717|65464368|FG001|Overall Study|Protocol Deviation|5|||
23469862|NCT01120717|65464367|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23469863|NCT01120717|65464368|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23469864|NCT01120717|65464367|FG000|Overall Study|Lost to Follow-up|2|||
23469865|NCT01120717|65464368|FG001|Overall Study|Lost to Follow-up|3|||
23469866|NCT01120717|65464367|FG000|Overall Study|Death|3|||
23469867|NCT01120717|65464368|FG001|Overall Study|Death|1|||
23469868|NCT01120717|65464367|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23469869|NCT01120717|65464368|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23469870|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
23469871|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
23469872|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
23469873|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
23469874|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
23469875|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
23469876|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
23469877|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
23469878|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
23469879|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
23469880|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
23794462|NCT02611323|66623718|FG003|Overall Study|Progressive Disease|0|||
23469881|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
23469882|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
23469883|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
23469884|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
23469885|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
23640717|NCT03261700|66071429|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
23469886|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
23469887|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
23469888|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
23469889|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
23469890|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
23469891|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
23469892|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
23469893|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
23469894|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
23469895|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
23469896|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
23469897|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
23469898|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
23469899|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
23469900|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
23469901|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
23469902|NCT02474069|65464376|FG000|Selection Phase (SP)|Adverse Event|8|||
23469903|NCT02474069|65464377|FG001|Selection Phase (SP)|Adverse Event|0|||
23469904|NCT02474069|65464378|FG002|Selection Phase (SP)|Adverse Event|0|||
23469905|NCT02474069|65464376|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
23469906|NCT02474069|65464377|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
23469907|NCT02474069|65464378|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
23469908|NCT02474069|65464376|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
23469909|NCT02474069|65464377|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
23469910|NCT02474069|65464378|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
23469911|NCT02474069|65464376|FG000|Selection Phase (SP)|Physician Decision|1|||
23469912|NCT02474069|65464377|FG001|Selection Phase (SP)|Physician Decision|0|||
23469913|NCT02474069|65464378|FG002|Selection Phase (SP)|Physician Decision|0|||
23469914|NCT02474069|65464376|FG000|Selection Phase (SP)|Protocol Violation|1|||
23469915|NCT02474069|65464377|FG001|Selection Phase (SP)|Protocol Violation|0|||
23587287|NCT01134562|65878980|FG001|Overall Study|Adverse Event|1|||
23587288|NCT01134562|65878981|FG002|Overall Study|Adverse Event|0|||
23469916|NCT02474069|65464378|FG002|Selection Phase (SP)|Protocol Violation|0|||
23469917|NCT02474069|65464376|FG000|Selection Phase (SP)|No longer requires treatment|1|||
23469918|NCT02474069|65464377|FG001|Selection Phase (SP)|No longer requires treatment|0|||
23469919|NCT02474069|65464378|FG002|Selection Phase (SP)|No longer requires treatment|0|||
23469920|NCT02474069|65464376|FG000|Selection Phase (SP)|Technical Problem|1|||
23469921|NCT02474069|65464377|FG001|Selection Phase (SP)|Technical Problem|0|||
23469922|NCT02474069|65464378|FG002|Selection Phase (SP)|Technical Problem|0|||
23469923|NCT02474069|65464376|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
23469924|NCT02474069|65464377|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
23469925|NCT02474069|65464378|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
23469926|NCT02474069|65464376|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
23469927|NCT02474069|65464377|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
23469928|NCT02474069|65464378|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
23469929|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
23469930|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
23469931|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
23469932|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
23469933|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
23469934|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
23469935|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
23469936|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
23469937|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
23469938|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
23469939|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
23469940|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
23469941|NCT01509053|65464379|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
23469942|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
23469943|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
23469944|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
23469945|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
23469946|NCT01509053|65464379|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
23469947|NCT00123422|65464380|FG000|Overall Study|Physician Decision|2|||
23794463|NCT02611323|66623719|FG004|Overall Study|Progressive Disease|0|||
23794464|NCT02611323|66623720|FG005|Overall Study|Progressive Disease|0|||
23794465|NCT02611323|66623721|FG006|Overall Study|Progressive Disease|0|||
23794466|NCT02611323|66623722|FG007|Overall Study|Progressive Disease|0|||
23794467|NCT02611323|66623723|FG008|Overall Study|Progressive Disease|0|||
23794468|NCT02611323|66623724|FG009|Overall Study|Progressive Disease|0|||
23794469|NCT02611323|66623725|FG010|Overall Study|Progressive Disease|1|||
23794470|NCT02611323|66623715|FG000|Overall Study|Withdrawal by Subject|1|||
23794471|NCT02611323|66623716|FG001|Overall Study|Withdrawal by Subject|0|||
23794472|NCT02611323|66623717|FG002|Overall Study|Withdrawal by Subject|0|||
23794473|NCT02611323|66623718|FG003|Overall Study|Withdrawal by Subject|0|||
23794474|NCT02611323|66623719|FG004|Overall Study|Withdrawal by Subject|0|||
23794475|NCT02611323|66623720|FG005|Overall Study|Withdrawal by Subject|0|||
23794476|NCT02611323|66623721|FG006|Overall Study|Withdrawal by Subject|0|||
23794477|NCT02611323|66623722|FG007|Overall Study|Withdrawal by Subject|1|||
23794478|NCT02611323|66623723|FG008|Overall Study|Withdrawal by Subject|0|||
23794479|NCT02611323|66623724|FG009|Overall Study|Withdrawal by Subject|1|||
23794480|NCT02611323|66623725|FG010|Overall Study|Withdrawal by Subject|0|||
23794481|NCT00772148|66623727|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
23794482|NCT00772148|66623728|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
23794483|NCT00772148|66623727|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
23794484|NCT00772148|66623728|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
23794485|NCT00772148|66623727|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
23794486|NCT00772148|66623728|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
23794487|NCT00772148|66623727|FG000|Maintenance Phase (Week 52)|Death|2|||
23794488|NCT00772148|66623728|FG001|Maintenance Phase (Week 52)|Death|2|||
23794489|NCT00772148|66623727|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
23794490|NCT00772148|66623728|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
23794491|NCT00772148|66623727|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
23794492|NCT00772148|66623728|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
23794493|NCT00772148|66623727|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
23794494|NCT00772148|66623728|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
23794495|NCT00550147|66623731|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
23794496|NCT00550147|66623731|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
23794497|NCT00550147|66623731|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
23794498|NCT00550147|66623731|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
23794499|NCT00550147|66623731|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
23794500|NCT02105701|66623732|FG000|Overall Study|Lost to Follow-up|1|||
23794501|NCT02105701|66623733|FG001|Overall Study|Lost to Follow-up|0|||
23794502|NCT02105701|66623734|FG002|Overall Study|Lost to Follow-up|2|||
23794503|NCT02105701|66623735|FG003|Overall Study|Lost to Follow-up|1|||
23794504|NCT02105701|66623732|FG000|Overall Study|Protocol Violation|0|||
23794505|NCT02105701|66623733|FG001|Overall Study|Protocol Violation|0|||
23794506|NCT02105701|66623734|FG002|Overall Study|Protocol Violation|1|||
23794507|NCT02105701|66623735|FG003|Overall Study|Protocol Violation|0|||
23794508|NCT02105701|66623732|FG000|Overall Study|Withdrawal by Subject|2|||
23794509|NCT02105701|66623733|FG001|Overall Study|Withdrawal by Subject|1|||
23794510|NCT02105701|66623734|FG002|Overall Study|Withdrawal by Subject|0|||
23794511|NCT02105701|66623735|FG003|Overall Study|Withdrawal by Subject|1|||
23794512|NCT02105701|66623732|FG000|Overall Study|Death|1|||
23794513|NCT02105701|66623733|FG001|Overall Study|Death|0|||
23794514|NCT02105701|66623734|FG002|Overall Study|Death|0|||
23794515|NCT02105701|66623735|FG003|Overall Study|Death|0|||
23794516|NCT00743145|66623736|FG000|Overall Study|Withdrawal by Subject|1|||
23794517|NCT00743145|66623736|FG000|Overall Study|Adverse Event|2|||
23794518|NCT00743145|66623736|FG000|Overall Study|Pregnancy|1|||
23794519|NCT01119625|66623737|FG000|Overall Study|Lost to Follow-up|1|||
23794520|NCT01119625|66623738|FG001|Overall Study|Lost to Follow-up|2|||
23794521|NCT01119625|66623737|FG000|Overall Study|Withdrawal by Subject|2|||
23794522|NCT01119625|66623738|FG001|Overall Study|Withdrawal by Subject|1|||
23794523|NCT01119625|66623737|FG000|Overall Study|Other|0|||
23794524|NCT01119625|66623738|FG001|Overall Study|Other|1|||
23469948|NCT00123422|65464381|FG001|Overall Study|Physician Decision|2|||
23469949|NCT00123422|65464382|FG002|Overall Study|Physician Decision|6|||
23469950|NCT00123422|65464380|FG000|Overall Study|Withdrawal by Subject|1|||
23469951|NCT00123422|65464381|FG001|Overall Study|Withdrawal by Subject|2|||
23469952|NCT00123422|65464382|FG002|Overall Study|Withdrawal by Subject|2|||
23469953|NCT00123422|65464380|FG000|Overall Study|Lost to Follow-up|1|||
23469954|NCT00123422|65464381|FG001|Overall Study|Lost to Follow-up|2|||
23469955|NCT00123422|65464382|FG002|Overall Study|Lost to Follow-up|2|||
23469956|NCT01950013|65464383|FG000|Overall Study|Withdrawal by Subject|0|||
23469957|NCT01950013|65464384|FG001|Overall Study|Withdrawal by Subject|2|||
23469958|NCT01950013|65464385|FG002|Overall Study|Withdrawal by Subject|0|||
23469959|NCT03926611|65464388|FG000|Overall Study|Adverse Event|0|||
23469960|NCT03926611|65464389|FG001|Overall Study|Adverse Event|0|||
23469961|NCT03926611|65464390|FG002|Overall Study|Adverse Event|0|||
23469962|NCT03926611|65464391|FG003|Overall Study|Adverse Event|3|||
23469963|NCT03926611|65464392|FG004|Overall Study|Adverse Event|1|||
23469964|NCT03926611|65464393|FG005|Overall Study|Adverse Event|3|||
23469965|NCT03926611|65464394|FG006|Overall Study|Adverse Event|0|||
23469966|NCT03926611|65464388|FG000|Overall Study|Lack of Efficacy|1|||
23469967|NCT03926611|65464389|FG001|Overall Study|Lack of Efficacy|2|||
23469968|NCT03926611|65464390|FG002|Overall Study|Lack of Efficacy|0|||
23469969|NCT03926611|65464391|FG003|Overall Study|Lack of Efficacy|0|||
23469970|NCT03926611|65464392|FG004|Overall Study|Lack of Efficacy|1|||
23469971|NCT03926611|65464393|FG005|Overall Study|Lack of Efficacy|0|||
23469972|NCT03926611|65464394|FG006|Overall Study|Lack of Efficacy|1|||
23469973|NCT03926611|65464388|FG000|Overall Study|Physician Decision|0|||
23469974|NCT03926611|65464389|FG001|Overall Study|Physician Decision|0|||
23469975|NCT03926611|65464390|FG002|Overall Study|Physician Decision|0|||
23469976|NCT03926611|65464391|FG003|Overall Study|Physician Decision|0|||
23469977|NCT03926611|65464392|FG004|Overall Study|Physician Decision|0|||
23469978|NCT03926611|65464393|FG005|Overall Study|Physician Decision|1|||
23469979|NCT03926611|65464394|FG006|Overall Study|Physician Decision|0|||
23469980|NCT03926611|65464388|FG000|Overall Study|Protocol Violation|1|||
23469981|NCT03926611|65464389|FG001|Overall Study|Protocol Violation|0|||
23469982|NCT03926611|65464390|FG002|Overall Study|Protocol Violation|0|||
23469983|NCT03926611|65464391|FG003|Overall Study|Protocol Violation|1|||
23469984|NCT03926611|65464392|FG004|Overall Study|Protocol Violation|1|||
23469985|NCT03926611|65464393|FG005|Overall Study|Protocol Violation|1|||
23469986|NCT03926611|65464394|FG006|Overall Study|Protocol Violation|1|||
23469987|NCT03926611|65464388|FG000|Overall Study|Technical problems|0|||
23469988|NCT03926611|65464389|FG001|Overall Study|Technical problems|0|||
23469989|NCT03926611|65464390|FG002|Overall Study|Technical problems|0|||
23353218|NCT00508157|65037525|FG001|Overall Study|Subject no longer met study criteria|1|||
23353219|NCT00508157|65037524|FG000|Overall Study|Other known cause|0|||
23353220|NCT00508157|65037525|FG001|Overall Study|Other known cause|1|||
23353221|NCT01658904|65037528|FG000|Overall Study|Principal Investigator discretion|2|||
23353222|NCT01658904|65037529|FG001|Overall Study|Principal Investigator discretion|0|||
23353223|NCT01658904|65037530|FG002|Overall Study|Principal Investigator discretion|0|||
23353224|NCT00530790|65037531|FG000|Overall Study|Adverse Event|2|||
23353225|NCT00530790|65037531|FG000|Overall Study|Withdrawal by Subject|2|||
23353226|NCT00530790|65037531|FG000|Overall Study|Physician Decision|1|||
23353227|NCT01348100|65037532|FG000|Overall Study|Subject Withdrew Consent|0|||
23353228|NCT01348100|65037533|FG001|Overall Study|Subject Withdrew Consent|0|||
23353229|NCT01348100|65037534|FG002|Overall Study|Subject Withdrew Consent|2|||
23353230|NCT01348100|65037535|FG003|Overall Study|Subject Withdrew Consent|0|||
23353231|NCT01348100|65037536|FG004|Overall Study|Subject Withdrew Consent|1|||
23353232|NCT01348100|65037537|FG005|Overall Study|Subject Withdrew Consent|0|||
23353233|NCT01348100|65037538|FG006|Overall Study|Subject Withdrew Consent|1|||
23353234|NCT01348100|65037532|FG000|Overall Study|Protocol Deviation|0|||
23353235|NCT01348100|65037533|FG001|Overall Study|Protocol Deviation|0|||
23353236|NCT01348100|65037534|FG002|Overall Study|Protocol Deviation|0|||
23353237|NCT01348100|65037535|FG003|Overall Study|Protocol Deviation|1|||
23353238|NCT01348100|65037536|FG004|Overall Study|Protocol Deviation|0|||
23353239|NCT01348100|65037537|FG005|Overall Study|Protocol Deviation|0|||
23353240|NCT01348100|65037538|FG006|Overall Study|Protocol Deviation|0|||
23353241|NCT01348100|65037532|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353242|NCT01348100|65037533|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23469990|NCT03926611|65464391|FG003|Overall Study|Technical problems|0|||
23353243|NCT01348100|65037534|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353244|NCT01348100|65037535|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353245|NCT01348100|65037536|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353246|NCT01348100|65037537|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23353247|NCT01348100|65037538|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23469991|NCT03926611|65464392|FG004|Overall Study|Technical problems|0|||
23469992|NCT03926611|65464393|FG005|Overall Study|Technical problems|1|||
23469993|NCT03926611|65464394|FG006|Overall Study|Technical problems|0|||
23469994|NCT03926611|65464388|FG000|Overall Study|Withdrawal by Subject|1|||
23353248|NCT01348100|65037532|FG000|Overall Study|Lost to Follow-up|0|||
23353249|NCT01348100|65037533|FG001|Overall Study|Lost to Follow-up|0|||
23353250|NCT01348100|65037534|FG002|Overall Study|Lost to Follow-up|0|||
23353251|NCT01348100|65037535|FG003|Overall Study|Lost to Follow-up|0|||
23469995|NCT03926611|65464389|FG001|Overall Study|Withdrawal by Subject|1|||
23469996|NCT03926611|65464390|FG002|Overall Study|Withdrawal by Subject|1|||
23353252|NCT01348100|65037536|FG004|Overall Study|Lost to Follow-up|0|||
23353253|NCT01348100|65037537|FG005|Overall Study|Lost to Follow-up|0|||
23353254|NCT01348100|65037538|FG006|Overall Study|Lost to Follow-up|1|||
23353255|NCT01348100|65037532|FG000|Overall Study|Administrative Problems|0|||
23353256|NCT01348100|65037533|FG001|Overall Study|Administrative Problems|0|||
23353257|NCT01348100|65037534|FG002|Overall Study|Administrative Problems|0|||
23353258|NCT01348100|65037535|FG003|Overall Study|Administrative Problems|0|||
23353259|NCT01348100|65037536|FG004|Overall Study|Administrative Problems|0|||
23353260|NCT01348100|65037537|FG005|Overall Study|Administrative Problems|1|||
23353261|NCT01348100|65037538|FG006|Overall Study|Administrative Problems|1|||
23353262|NCT02453256|65037539|FG000|Double Blind Period|Death|1|||
23353263|NCT02453256|65037540|FG001|Double Blind Period|Death|1|||
23469997|NCT03926611|65464391|FG003|Overall Study|Withdrawal by Subject|0|||
23469998|NCT03926611|65464392|FG004|Overall Study|Withdrawal by Subject|0|||
23469999|NCT03926611|65464393|FG005|Overall Study|Withdrawal by Subject|1|||
23470000|NCT03926611|65464394|FG006|Overall Study|Withdrawal by Subject|3|||
23470001|NCT03926611|65464388|FG000|Overall Study|Covid-19 pandemic|0|||
23587289|NCT01134562|65878982|FG003|Overall Study|Adverse Event|0|||
23353264|NCT02453256|65037539|FG000|Double Blind Period|Adverse Event|3|||
23353265|NCT02453256|65037540|FG001|Double Blind Period|Adverse Event|2|||
23470002|NCT03926611|65464389|FG001|Overall Study|Covid-19 pandemic|0|||
23587290|NCT01134562|65878983|FG004|Overall Study|Adverse Event|0|||
23353266|NCT02453256|65037539|FG000|Double Blind Period|Withdrawal by Subject|9|||
23470003|NCT03926611|65464390|FG002|Overall Study|Covid-19 pandemic|1|||
23470004|NCT03926611|65464391|FG003|Overall Study|Covid-19 pandemic|0|||
23470005|NCT03926611|65464392|FG004|Overall Study|Covid-19 pandemic|1|||
23353267|NCT02453256|65037540|FG001|Double Blind Period|Withdrawal by Subject|5|||
23353268|NCT02453256|65037539|FG000|Double Blind Period|Other|0|||
23353269|NCT02453256|65037540|FG001|Double Blind Period|Other|1|||
23353270|NCT02453256|65037539|FG000|Open Label Period|Adverse Event|1|||
23353271|NCT02453256|65037540|FG001|Open Label Period|Adverse Event|3|||
23353272|NCT02453256|65037539|FG000|Open Label Period|Death|0|||
23353273|NCT02453256|65037540|FG001|Open Label Period|Death|1|||
23353274|NCT02453256|65037539|FG000|Open Label Period|Lost to Follow-up|1|||
23353275|NCT02453256|65037540|FG001|Open Label Period|Lost to Follow-up|0|||
23353276|NCT02453256|65037539|FG000|Open Label Period|Other|0|||
23353277|NCT02453256|65037540|FG001|Open Label Period|Other|2|||
23353278|NCT02453256|65037539|FG000|Open Label Period|Withdrawal by Subject|5|||
23353279|NCT02453256|65037540|FG001|Open Label Period|Withdrawal by Subject|1|||
23353280|NCT02086448|65037543|FG000|Overall Study|Withdrawal by Subject|1|||
23353281|NCT02086448|65037544|FG001|Overall Study|Withdrawal by Subject|0|||
23353282|NCT02086448|65037545|FG002|Overall Study|Withdrawal by Subject|0|||
23353283|NCT02086448|65037546|FG003|Overall Study|Withdrawal by Subject|2|||
23353284|NCT01492101|65037547|FG000|Overall Study|Death|323|||
23353285|NCT01492101|65037548|FG001|Overall Study|Death|322|||
23353286|NCT01492101|65037547|FG000|Overall Study|Withdrawal by Subject|14|||
23353287|NCT01492101|65037548|FG001|Overall Study|Withdrawal by Subject|18|||
23353288|NCT01492101|65037547|FG000|Overall Study|Lost to Follow-up|0|||
23353289|NCT01492101|65037548|FG001|Overall Study|Lost to Follow-up|2|||
23353290|NCT03275389|65037549|FG000|Overall Study|Lost to Follow-up|10|||
23353291|NCT03275389|65037550|FG001|Overall Study|Lost to Follow-up|10|||
23353292|NCT03275389|65037551|FG002|Overall Study|Lost to Follow-up|19|||
23353293|NCT03275389|65037552|FG003|Overall Study|Lost to Follow-up|12|||
23353294|NCT03275389|65037553|FG004|Overall Study|Lost to Follow-up|11|||
23353295|NCT03275389|65037554|FG005|Overall Study|Lost to Follow-up|12|||
23353296|NCT03275389|65037555|FG006|Overall Study|Lost to Follow-up|21|||
23353297|NCT03275389|65037556|FG007|Overall Study|Lost to Follow-up|15|||
23353298|NCT03275389|65037557|FG008|Overall Study|Lost to Follow-up|12|||
23353299|NCT03275389|65037558|FG009|Overall Study|Lost to Follow-up|14|||
23353300|NCT03275389|65037549|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353301|NCT03275389|65037550|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353302|NCT03275389|65037551|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353303|NCT03275389|65037552|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353304|NCT03275389|65037553|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353305|NCT03275389|65037554|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
23353306|NCT03275389|65037555|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353307|NCT03275389|65037556|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353308|NCT03275389|65037557|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353309|NCT03275389|65037558|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
23353310|NCT03275389|65037549|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23353311|NCT03275389|65037550|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23353312|NCT03275389|65037551|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23353313|NCT03275389|65037552|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
23353314|NCT03275389|65037553|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353315|NCT03275389|65037554|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353316|NCT03275389|65037555|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353317|NCT03275389|65037556|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353318|NCT03275389|65037557|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23353319|NCT03275389|65037558|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23353320|NCT03275389|65037549|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353321|NCT03275389|65037550|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23353322|NCT03275389|65037551|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353323|NCT03275389|65037552|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23353324|NCT03275389|65037553|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353325|NCT03275389|65037554|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353326|NCT03275389|65037555|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23353327|NCT03275389|65037556|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353328|NCT03275389|65037557|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353329|NCT03275389|65037558|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353330|NCT03275389|65037549|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353331|NCT03275389|65037550|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353332|NCT03275389|65037551|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23353333|NCT03275389|65037552|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353334|NCT03275389|65037553|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353335|NCT03275389|65037554|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353336|NCT03275389|65037555|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353337|NCT03275389|65037556|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353338|NCT03275389|65037557|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353339|NCT03275389|65037558|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23353340|NCT03275389|65037549|FG000|Overall Study|Other|0|||
23353341|NCT03275389|65037550|FG001|Overall Study|Other|4|||
23353342|NCT03275389|65037551|FG002|Overall Study|Other|3|||
23353343|NCT03275389|65037552|FG003|Overall Study|Other|2|||
23353344|NCT03275389|65037553|FG004|Overall Study|Other|2|||
23353345|NCT03275389|65037554|FG005|Overall Study|Other|2|||
23353346|NCT03275389|65037555|FG006|Overall Study|Other|0|||
23353347|NCT03275389|65037556|FG007|Overall Study|Other|0|||
23353348|NCT03275389|65037557|FG008|Overall Study|Other|1|||
23353349|NCT03275389|65037558|FG009|Overall Study|Other|0|||
23353350|NCT02661061|65037560|FG000|Overall Study|Lack of Efficacy|1|||
23353351|NCT02661061|65037561|FG001|Overall Study|Lack of Efficacy|1|||
23353352|NCT02661061|65037560|FG000|Overall Study|Withdrawal by Subject|1|||
23353353|NCT02661061|65037561|FG001|Overall Study|Withdrawal by Subject|1|||
23353354|NCT01366638|65037562|FG000|Overall Study|Withdrawal by Subject|0|||
23353355|NCT01366638|65037563|FG001|Overall Study|Withdrawal by Subject|0|||
23353356|NCT01366638|65037564|FG002|Overall Study|Withdrawal by Subject|6|||
23353357|NCT01366638|65037562|FG000|Overall Study|Other|1|||
23353358|NCT01366638|65037563|FG001|Overall Study|Other|0|||
23353359|NCT01366638|65037564|FG002|Overall Study|Other|0|||
23353360|NCT02172040|65037565|FG000|Overall Study|Adverse Event|0|||
23353361|NCT02172040|65037566|FG001|Overall Study|Adverse Event|2|||
23353362|NCT02172040|65037567|FG002|Overall Study|Adverse Event|0|||
23353363|NCT02172040|65037568|FG003|Overall Study|Adverse Event|0|||
23353364|NCT02172040|65037565|FG000|Overall Study|Protocol Violation|0|||
23353365|NCT02172040|65037566|FG001|Overall Study|Protocol Violation|1|||
23353366|NCT02172040|65037567|FG002|Overall Study|Protocol Violation|0|||
23353367|NCT02172040|65037568|FG003|Overall Study|Protocol Violation|0|||
23353368|NCT02172040|65037565|FG000|Overall Study|Withdrawal by Subject|0|||
23353369|NCT02172040|65037566|FG001|Overall Study|Withdrawal by Subject|0|||
23353370|NCT02172040|65037567|FG002|Overall Study|Withdrawal by Subject|1|||
23353371|NCT02172040|65037568|FG003|Overall Study|Withdrawal by Subject|0|||
23353372|NCT02172040|65037565|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
23353373|NCT02172040|65037566|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
23353374|NCT02172040|65037567|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
23353375|NCT02172040|65037568|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
23353376|NCT02172040|65037565|FG000|Overall Study|Family emergency abroad|0|||
23353377|NCT02172040|65037566|FG001|Overall Study|Family emergency abroad|0|||
23353378|NCT02172040|65037567|FG002|Overall Study|Family emergency abroad|0|||
23353379|NCT02172040|65037568|FG003|Overall Study|Family emergency abroad|1|||
23353380|NCT00359294|65037569|FG000|Overall Study|Progressive disease|1|||
23353381|NCT00359294|65037570|FG001|Overall Study|Progressive disease|1|||
23353382|NCT00359294|65037571|FG002|Overall Study|Progressive disease|2|||
23353383|NCT00359294|65037572|FG003|Overall Study|Progressive disease|3|||
23353384|NCT00359294|65037573|FG004|Overall Study|Progressive disease|2|||
23353385|NCT00359294|65037569|FG000|Overall Study|Withdrawal by Subject|0|||
23353386|NCT00359294|65037570|FG001|Overall Study|Withdrawal by Subject|0|||
23353387|NCT00359294|65037571|FG002|Overall Study|Withdrawal by Subject|0|||
23353388|NCT00359294|65037572|FG003|Overall Study|Withdrawal by Subject|0|||
23353389|NCT00359294|65037573|FG004|Overall Study|Withdrawal by Subject|1|||
23353390|NCT00359294|65037569|FG000|Overall Study|Not treated|0|||
23353391|NCT00359294|65037570|FG001|Overall Study|Not treated|0|||
23353392|NCT00359294|65037571|FG002|Overall Study|Not treated|0|||
23353393|NCT00359294|65037572|FG003|Overall Study|Not treated|1|||
23353394|NCT00359294|65037573|FG004|Overall Study|Not treated|0|||
23353395|NCT00359294|65037569|FG000|Overall Study|Physician Decision|0|||
23353396|NCT00359294|65037570|FG001|Overall Study|Physician Decision|0|||
23353397|NCT00359294|65037571|FG002|Overall Study|Physician Decision|1|||
23353398|NCT00359294|65037572|FG003|Overall Study|Physician Decision|0|||
23353399|NCT00359294|65037573|FG004|Overall Study|Physician Decision|0|||
23353400|NCT00830518|65037574|FG000|Overall Study|Progressive Disease|18|||
23353401|NCT00830518|65037575|FG001|Overall Study|Progressive Disease|8|||
23353402|NCT00830518|65037574|FG000|Overall Study|Symptomatic Deterioration|4|||
23353403|NCT00830518|65037575|FG001|Overall Study|Symptomatic Deterioration|1|||
23353404|NCT00830518|65037574|FG000|Overall Study|Adverse Event|14|||
23353405|NCT00830518|65037575|FG001|Overall Study|Adverse Event|1|||
23353406|NCT00830518|65037574|FG000|Overall Study|Withdrawal by Patient|2|||
23353407|NCT00830518|65037575|FG001|Overall Study|Withdrawal by Patient|0|||
23353408|NCT00830518|65037574|FG000|Overall Study|Reason not Specified|8|||
23353409|NCT00830518|65037575|FG001|Overall Study|Reason not Specified|1|||
23353410|NCT01210352|65037582|FG000|Overall Study|Adverse Event|0|||
23353411|NCT01210352|65037583|FG001|Overall Study|Adverse Event|0|||
23353412|NCT01210352|65037584|FG002|Overall Study|Adverse Event|0|||
23353413|NCT01210352|65037585|FG003|Overall Study|Adverse Event|0|||
23353414|NCT01210352|65037586|FG004|Overall Study|Adverse Event|0|||
23353415|NCT01210352|65037587|FG005|Overall Study|Adverse Event|0|||
23353416|NCT01210352|65037588|FG006|Overall Study|Adverse Event|0|||
23353417|NCT01210352|65037589|FG007|Overall Study|Adverse Event|2|||
23353418|NCT01210352|65037590|FG008|Overall Study|Adverse Event|1|||
23353419|NCT01210352|65037582|FG000|Overall Study|Lack of Efficacy|0|||
23353420|NCT01210352|65037583|FG001|Overall Study|Lack of Efficacy|0|||
23353421|NCT01210352|65037584|FG002|Overall Study|Lack of Efficacy|0|||
23353422|NCT01210352|65037585|FG003|Overall Study|Lack of Efficacy|0|||
23353423|NCT01210352|65037586|FG004|Overall Study|Lack of Efficacy|0|||
23353424|NCT01210352|65037587|FG005|Overall Study|Lack of Efficacy|0|||
23353425|NCT01210352|65037588|FG006|Overall Study|Lack of Efficacy|1|||
23353426|NCT01210352|65037589|FG007|Overall Study|Lack of Efficacy|0|||
23353427|NCT01210352|65037590|FG008|Overall Study|Lack of Efficacy|0|||
23353428|NCT01210352|65037582|FG000|Overall Study|Physician Decision|0|||
23353429|NCT01210352|65037583|FG001|Overall Study|Physician Decision|0|||
23353430|NCT01210352|65037584|FG002|Overall Study|Physician Decision|0|||
23353431|NCT01210352|65037585|FG003|Overall Study|Physician Decision|0|||
23353432|NCT01210352|65037586|FG004|Overall Study|Physician Decision|0|||
23353433|NCT01210352|65037587|FG005|Overall Study|Physician Decision|0|||
23353434|NCT01210352|65037588|FG006|Overall Study|Physician Decision|0|||
23353435|NCT01210352|65037589|FG007|Overall Study|Physician Decision|1|||
23353436|NCT01210352|65037590|FG008|Overall Study|Physician Decision|2|||
23353437|NCT01210352|65037582|FG000|Overall Study|Withdrawal by Subject|0|||
23353438|NCT01210352|65037583|FG001|Overall Study|Withdrawal by Subject|0|||
23353439|NCT01210352|65037584|FG002|Overall Study|Withdrawal by Subject|1|||
23353440|NCT01210352|65037585|FG003|Overall Study|Withdrawal by Subject|0|||
23353441|NCT01210352|65037586|FG004|Overall Study|Withdrawal by Subject|0|||
23353442|NCT01210352|65037587|FG005|Overall Study|Withdrawal by Subject|0|||
23353443|NCT01210352|65037588|FG006|Overall Study|Withdrawal by Subject|1|||
23353444|NCT01210352|65037589|FG007|Overall Study|Withdrawal by Subject|0|||
23353445|NCT01210352|65037590|FG008|Overall Study|Withdrawal by Subject|1|||
23353446|NCT01210352|65037582|FG000|Overall Study|Patient Discharged Early|0|||
23353447|NCT01210352|65037583|FG001|Overall Study|Patient Discharged Early|0|||
23353448|NCT01210352|65037584|FG002|Overall Study|Patient Discharged Early|1|||
23353449|NCT01210352|65037585|FG003|Overall Study|Patient Discharged Early|0|||
23353450|NCT01210352|65037586|FG004|Overall Study|Patient Discharged Early|0|||
23353451|NCT01210352|65037587|FG005|Overall Study|Patient Discharged Early|0|||
23353452|NCT01210352|65037588|FG006|Overall Study|Patient Discharged Early|0|||
23353453|NCT01210352|65037589|FG007|Overall Study|Patient Discharged Early|0|||
23353454|NCT01210352|65037590|FG008|Overall Study|Patient Discharged Early|0|||
23353455|NCT04686266|65037591|FG000|Overall Study|Withdrawal by Subject|0|||
23353456|NCT04686266|65037592|FG001|Overall Study|Withdrawal by Subject|1|||
23353457|NCT03430856|65037593|FG000|Overall Study|Adverse Event|0|||
23353458|NCT03430856|65037594|FG001|Overall Study|Adverse Event|1|||
23353459|NCT03430856|65037595|FG002|Overall Study|Adverse Event|0|||
23353460|NCT03430856|65037593|FG000|Overall Study|Rescue criteria|1|||
23353461|NCT03430856|65037594|FG001|Overall Study|Rescue criteria|1|||
23353462|NCT03430856|65037595|FG002|Overall Study|Rescue criteria|0|||
23353463|NCT03430856|65037593|FG000|Overall Study|Voluntary withdrawal of consent|1|||
23353464|NCT03430856|65037594|FG001|Overall Study|Voluntary withdrawal of consent|1|||
23353465|NCT03430856|65037595|FG002|Overall Study|Voluntary withdrawal of consent|1|||
23353466|NCT00731731|65037596|FG000|Overall Study|Protocol Violation|0|||
23794525|NCT00562120|66623739|FG000|First Intervention Period|Adverse Event|1|||
23353467|NCT00731731|65037597|FG001|Overall Study|Protocol Violation|0|||
23353468|NCT00731731|65037598|FG002|Overall Study|Protocol Violation|1|||
23353469|NCT00731731|65037596|FG000|Overall Study|Cancel prior to treatment|0|||
23353470|NCT00731731|65037597|FG001|Overall Study|Cancel prior to treatment|0|||
23353471|NCT00731731|65037598|FG002|Overall Study|Cancel prior to treatment|2|||
23353472|NCT03681184|65037599|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
23353473|NCT03681184|65037600|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
23353474|NCT02688764|65037603|FG000|Overall Study|Adverse Event|3|||
23353475|NCT02688764|65037604|FG001|Overall Study|Adverse Event|3|||
23353476|NCT02688764|65037603|FG000|Overall Study|AE/Kidney transplant|1|||
23353477|NCT02688764|65037604|FG001|Overall Study|AE/Kidney transplant|0|||
23353478|NCT02688764|65037603|FG000|Overall Study|AE/Lack of efficacy|1|||
23794526|NCT00562120|66623740|FG001|First Intervention Period|Adverse Event|0|||
23794527|NCT00562120|66623741|FG002|First Intervention Period|Adverse Event|0|||
23794528|NCT00562120|66623742|FG003|First Intervention Period|Adverse Event|0|||
23353479|NCT02688764|65037604|FG001|Overall Study|AE/Lack of efficacy|0|||
23353480|NCT02688764|65037603|FG000|Overall Study|AE/Non-compl.|1|||
23353481|NCT02688764|65037604|FG001|Overall Study|AE/Non-compl.|0|||
23353482|NCT02688764|65037603|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
23353483|NCT02688764|65037604|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
23353484|NCT02688764|65037603|FG000|Overall Study|AE/Other|0|||
23353485|NCT02688764|65037604|FG001|Overall Study|AE/Other|1|||
23353486|NCT02688764|65037603|FG000|Overall Study|AE/Physician decision|1|||
23353487|NCT02688764|65037604|FG001|Overall Study|AE/Physician decision|0|||
23353488|NCT02688764|65037603|FG000|Overall Study|AE/Withd. parent|3|||
23353489|NCT02688764|65037604|FG001|Overall Study|AE/Withd. parent|0|||
23353490|NCT02688764|65037603|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
23353491|NCT02688764|65037604|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
23353492|NCT02688764|65037603|FG000|Overall Study|AE/Withd. subject|1|||
23353493|NCT02688764|65037604|FG001|Overall Study|AE/Withd. subject|0|||
23353494|NCT02688764|65037603|FG000|Overall Study|Kidney transplant|10|||
23353495|NCT02688764|65037604|FG001|Overall Study|Kidney transplant|4|||
23353496|NCT02688764|65037603|FG000|Overall Study|Lack of Efficacy|3|||
23353497|NCT02688764|65037604|FG001|Overall Study|Lack of Efficacy|2|||
23353498|NCT02688764|65037603|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
23353499|NCT02688764|65037604|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
23353500|NCT02688764|65037603|FG000|Overall Study|Non-compliance with study drug|4|||
23353501|NCT02688764|65037604|FG001|Overall Study|Non-compliance with study drug|0|||
23353502|NCT02688764|65037603|FG000|Overall Study|Non-compl./Physician decision|2|||
23353503|NCT02688764|65037604|FG001|Overall Study|Non-compl./Physician decision|0|||
23353504|NCT02688764|65037603|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
23353505|NCT02688764|65037604|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
23353506|NCT02688764|65037603|FG000|Overall Study|Non-compl./Withd. subject|0|||
23353507|NCT02688764|65037604|FG001|Overall Study|Non-compl./Withd. subject|2|||
23353508|NCT02688764|65037603|FG000|Overall Study|Phosphorus level outside safe range|0|||
23353509|NCT02688764|65037604|FG001|Overall Study|Phosphorus level outside safe range|1|||
23353510|NCT02688764|65037603|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
23353511|NCT02688764|65037604|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
23353512|NCT02688764|65037603|FG000|Overall Study|Study drug taste/Withd. parent|1|||
23353513|NCT02688764|65037604|FG001|Overall Study|Study drug taste/Withd. parent|0|||
23640718|NCT03889704|66071433|FG000|Overall Study|Study terminated due to pandemic|1|||
23640719|NCT00735475|66071434|FG000|Overall Study|Adverse Event|0|||
23640720|NCT00735475|66071435|FG001|Overall Study|Adverse Event|1|||
23640721|NCT00735475|66071434|FG000|Overall Study|Death|1|||
23640722|NCT00735475|66071435|FG001|Overall Study|Death|1|||
23640723|NCT00735475|66071434|FG000|Overall Study|Lost to Follow-up|3|||
23640724|NCT00735475|66071435|FG001|Overall Study|Lost to Follow-up|3|||
23640725|NCT00735475|66071434|FG000|Overall Study|Physician Decision|0|||
23353514|NCT02688764|65037603|FG000|Overall Study|Subject moving out|2|||
23353515|NCT02688764|65037604|FG001|Overall Study|Subject moving out|0|||
23353516|NCT02688764|65037603|FG000|Overall Study|Subject taken off dialysis|1|||
23640726|NCT00735475|66071435|FG001|Overall Study|Physician Decision|1|||
23353517|NCT02688764|65037604|FG001|Overall Study|Subject taken off dialysis|0|||
23353518|NCT02688764|65037603|FG000|Overall Study|Withdrawal by parent|3|||
23353519|NCT02688764|65037604|FG001|Overall Study|Withdrawal by parent|0|||
23794529|NCT00562120|66623739|FG000|First Intervention Period|Randomized but not Treated|1|||
23353520|NCT00483704|65037605|FG000|Randomization|Withdrawal by Subject|19|||
23353521|NCT00483704|65037606|FG001|Randomization|Withdrawal by Subject|28|||
23640727|NCT00735475|66071434|FG000|Overall Study|Withdrawal by Subject|4|||
23353522|NCT00483704|65037607|FG002|Randomization|Withdrawal by Subject|18|||
23353523|NCT00483704|65037605|FG000|Randomization|Protocol Violation|14|||
23353524|NCT00483704|65037606|FG001|Randomization|Protocol Violation|25|||
23353525|NCT00483704|65037607|FG002|Randomization|Protocol Violation|22|||
23353526|NCT00483704|65037605|FG000|Randomization|Lost to Follow-up|14|||
23353527|NCT00483704|65037606|FG001|Randomization|Lost to Follow-up|14|||
23353528|NCT00483704|65037607|FG002|Randomization|Lost to Follow-up|19|||
23353529|NCT00483704|65037605|FG000|Randomization|Pregnancy|1|||
23353530|NCT00483704|65037606|FG001|Randomization|Pregnancy|0|||
23353531|NCT00483704|65037607|FG002|Randomization|Pregnancy|0|||
23353532|NCT00483704|65037605|FG000|Randomization|Physician Decision|2|||
23353533|NCT00483704|65037606|FG001|Randomization|Physician Decision|4|||
23353534|NCT00483704|65037607|FG002|Randomization|Physician Decision|0|||
23353535|NCT00483704|65037605|FG000|Randomization|Progressive disease|0|||
23353536|NCT00483704|65037606|FG001|Randomization|Progressive disease|0|||
23353537|NCT00483704|65037607|FG002|Randomization|Progressive disease|1|||
23353538|NCT00483704|65037605|FG000|Randomization|Lack of qualifying migraines|21|||
23353539|NCT00483704|65037606|FG001|Randomization|Lack of qualifying migraines|25|||
23353540|NCT00483704|65037607|FG002|Randomization|Lack of qualifying migraines|31|||
23353541|NCT00483704|65037605|FG000|Treatment|Lack of qualifying migraines|101|||
23353542|NCT00483704|65037606|FG001|Treatment|Lack of qualifying migraines|99|||
23353543|NCT00483704|65037607|FG002|Treatment|Lack of qualifying migraines|116|||
23353544|NCT00483704|65037605|FG000|Treatment|Adverse Event|3|||
23353545|NCT00483704|65037606|FG001|Treatment|Adverse Event|5|||
23353546|NCT00483704|65037607|FG002|Treatment|Adverse Event|4|||
23353547|NCT00483704|65037605|FG000|Treatment|Withdrawal by Subject|16|||
23353548|NCT00483704|65037606|FG001|Treatment|Withdrawal by Subject|12|||
23353549|NCT00483704|65037607|FG002|Treatment|Withdrawal by Subject|21|||
23353550|NCT00483704|65037605|FG000|Treatment|Protocol Violation|6|||
23353551|NCT00483704|65037606|FG001|Treatment|Protocol Violation|3|||
23353552|NCT00483704|65037607|FG002|Treatment|Protocol Violation|5|||
23353553|NCT00483704|65037605|FG000|Treatment|Lost to Follow-up|2|||
23353554|NCT00483704|65037606|FG001|Treatment|Lost to Follow-up|7|||
23353555|NCT00483704|65037607|FG002|Treatment|Lost to Follow-up|5|||
23353556|NCT00483704|65037605|FG000|Treatment|Lack of Efficacy|1|||
23353557|NCT00483704|65037606|FG001|Treatment|Lack of Efficacy|1|||
23353558|NCT00483704|65037607|FG002|Treatment|Lack of Efficacy|1|||
23353559|NCT00483704|65037605|FG000|Treatment|Pregnancy|0|||
23353560|NCT00483704|65037606|FG001|Treatment|Pregnancy|1|||
23353561|NCT00483704|65037607|FG002|Treatment|Pregnancy|0|||
23353562|NCT00483704|65037605|FG000|Treatment|Physician Decision|0|||
23353563|NCT00483704|65037606|FG001|Treatment|Physician Decision|1|||
23353564|NCT00483704|65037607|FG002|Treatment|Physician Decision|4|||
23353565|NCT01027897|65037610|FG000|Overall Study|Protocol Violation|1|||
23353566|NCT01027897|65037610|FG000|Overall Study|Withdrawal by Subject|1|||
23353567|NCT00985426|65037616|FG000|Overall Study|Adverse Event|0|||
23353568|NCT00985426|65037617|FG001|Overall Study|Adverse Event|1|||
23587291|NCT03621761|65878984|FG000|Overall Study|Lost to Follow-up|1|||
23587292|NCT03621761|65878985|FG001|Overall Study|Lost to Follow-up|1|||
23587293|NCT03621761|65878986|FG002|Overall Study|Lost to Follow-up|2|||
23587294|NCT03621761|65878984|FG000|Overall Study|Withdrawal by Subject|2|||
23353569|NCT00985426|65037616|FG000|Overall Study|Subject Non-Compliance|3|||
23353570|NCT00985426|65037617|FG001|Overall Study|Subject Non-Compliance|3|||
23353571|NCT00985426|65037616|FG000|Overall Study|Withdrawal by Subject|12|||
23353572|NCT00985426|65037617|FG001|Overall Study|Withdrawal by Subject|16|||
23353573|NCT00985426|65037616|FG000|Overall Study|Lost to Follow-up|8|||
23353574|NCT00985426|65037617|FG001|Overall Study|Lost to Follow-up|10|||
23353575|NCT00985426|65037616|FG000|Overall Study|Death|7|||
23353576|NCT00985426|65037617|FG001|Overall Study|Death|3|||
23353577|NCT00985426|65037616|FG000|Overall Study|Protocol Violation|2|||
23353578|NCT00985426|65037617|FG001|Overall Study|Protocol Violation|0|||
23353579|NCT00985426|65037616|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
23353580|NCT00985426|65037617|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
23353581|NCT02565706|65037618|FG000|Overall Study|Withdrawal by Subject|5|||
23353582|NCT02565706|65037619|FG001|Overall Study|Withdrawal by Subject|7|||
23353583|NCT02565706|65037620|FG002|Overall Study|Withdrawal by Subject|7|||
23353584|NCT02565706|65037621|FG003|Overall Study|Withdrawal by Subject|11|||
23353585|NCT02565706|65037618|FG000|Overall Study|Lost to Follow-up|72|||
23353586|NCT02565706|65037619|FG001|Overall Study|Lost to Follow-up|75|||
23353587|NCT02565706|65037620|FG002|Overall Study|Lost to Follow-up|82|||
23353588|NCT02565706|65037621|FG003|Overall Study|Lost to Follow-up|74|||
23353589|NCT01243177|65037622|FG000|Overall Study|Lack of Efficacy|47|||
23353590|NCT01243177|65037623|FG001|Overall Study|Lack of Efficacy|31|||
23353591|NCT01243177|65037622|FG000|Overall Study|Protocol Violation|11|||
23353592|NCT01243177|65037623|FG001|Overall Study|Protocol Violation|10|||
23353593|NCT01243177|65037622|FG000|Overall Study|Lost to Follow-up|15|||
23353594|NCT01243177|65037623|FG001|Overall Study|Lost to Follow-up|18|||
23353595|NCT01243177|65037622|FG000|Overall Study|Withdrawal by Subject|46|||
23353596|NCT01243177|65037623|FG001|Overall Study|Withdrawal by Subject|38|||
23353597|NCT01243177|65037622|FG000|Overall Study|AE, serious fatal|0|||
23353598|NCT01243177|65037623|FG001|Overall Study|AE, serious fatal|1|||
23353599|NCT01243177|65037622|FG000|Overall Study|SAE, non-fatal|7|||
23353600|NCT01243177|65037623|FG001|Overall Study|SAE, non-fatal|9|||
23353601|NCT01243177|65037622|FG000|Overall Study|AE, non-serious non-fatal|40|||
23353602|NCT01243177|65037623|FG001|Overall Study|AE, non-serious non-fatal|58|||
23353603|NCT01243177|65037622|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
23353604|NCT01243177|65037623|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
23353605|NCT01243177|65037622|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23353606|NCT01243177|65037623|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23353607|NCT01243177|65037622|FG000|Overall Study|Other Reason|11|||
23353608|NCT01243177|65037623|FG001|Overall Study|Other Reason|12|||
23353609|NCT03170609|65037627|FG000|Overall Study|Death|0|||
23470006|NCT03926611|65464393|FG005|Overall Study|Covid-19 pandemic|2|||
23470007|NCT03926611|65464394|FG006|Overall Study|Covid-19 pandemic|0|||
23640728|NCT00735475|66071435|FG001|Overall Study|Withdrawal by Subject|5|||
23640729|NCT03122223|66071443|FG000|Overall Study|Withdrawal by Subject|2|||
23353610|NCT03170609|65037628|FG001|Overall Study|Death|0|||
23587295|NCT03621761|65878985|FG001|Overall Study|Withdrawal by Subject|1|||
23353611|NCT03170609|65037629|FG002|Overall Study|Death|1|||
23353612|NCT03170609|65037630|FG003|Overall Study|Death|0|||
23353613|NCT03170609|65037631|FG004|Overall Study|Death|0|||
23353614|NCT03170609|65037632|FG005|Overall Study|Death|0|||
23353615|NCT03170609|65037633|FG006|Overall Study|Death|0|||
23353616|NCT03170609|65037627|FG000|Overall Study|Withdrawal by Subject|1|||
23353617|NCT03170609|65037628|FG001|Overall Study|Withdrawal by Subject|2|||
23353618|NCT03170609|65037629|FG002|Overall Study|Withdrawal by Subject|0|||
23353619|NCT03170609|65037630|FG003|Overall Study|Withdrawal by Subject|0|||
23353620|NCT03170609|65037631|FG004|Overall Study|Withdrawal by Subject|0|||
23470008|NCT03237286|65464395|FG000|Overall Study|Withdrawal by Subject|1|||
23470009|NCT03237286|65464396|FG001|Overall Study|Withdrawal by Subject|0|||
23470010|NCT03237286|65464397|FG002|Overall Study|Withdrawal by Subject|2|||
23470011|NCT03237286|65464395|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
23470012|NCT03237286|65464396|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
23470013|NCT03237286|65464397|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
23470014|NCT00436345|65464404|FG000|Overall Study|ICU resident beyond follow-up period|3|||
23470015|NCT00436345|65464405|FG001|Overall Study|ICU resident beyond follow-up period|0|||
23470016|NCT02722499|65464406|FG000|Overall Study|Lost to Follow-up|2|||
23470017|NCT02722499|65464407|FG001|Overall Study|Lost to Follow-up|0|||
23470018|NCT02722499|65464408|FG002|Overall Study|Lost to Follow-up|1|||
23470019|NCT02779556|65464411|FG000|Baseline|Partial baseline interview completed|1|||
23470020|NCT02779556|65464412|FG001|Baseline|Partial baseline interview completed|0|||
23470021|NCT02779556|65464411|FG000|3 Months|Lost to Follow-up|40|||
23470022|NCT02779556|65464412|FG001|3 Months|Lost to Follow-up|29|||
23470023|NCT02779556|65464411|FG000|3 Months|Missed 3 month clinic visit|27|||
23470024|NCT02779556|65464412|FG001|3 Months|Missed 3 month clinic visit|19|||
23470025|NCT02779556|65464411|FG000|6 Month|Lost to Follow-up|33|||
23794530|NCT00562120|66623740|FG001|First Intervention Period|Randomized but not Treated|0|||
23794531|NCT00562120|66623741|FG002|First Intervention Period|Randomized but not Treated|0|||
23794532|NCT00562120|66623742|FG003|First Intervention Period|Randomized but not Treated|0|||
23794533|NCT04668274|66623743|FG000|Part 1 Study Period 1|Adverse Event|3|||
23640730|NCT03122223|66071444|FG001|Overall Study|Withdrawal by Subject|2|||
23640731|NCT03122223|66071445|FG002|Overall Study|Withdrawal by Subject|1|||
23640732|NCT03122223|66071446|FG003|Overall Study|Withdrawal by Subject|0|||
23794534|NCT04668274|66623744|FG001|Part 1 Study Period 1|Adverse Event|0|||
23794535|NCT04668274|66623745|FG002|Part 1 Study Period 1|Adverse Event|0|||
23794536|NCT04668274|66623746|FG003|Part 1 Study Period 1|Adverse Event|0|||
23794537|NCT04668274|66623743|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
23794538|NCT04668274|66623744|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
23794539|NCT04668274|66623745|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
23794540|NCT04668274|66623746|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
23794541|NCT04668274|66623743|FG000|Part 1 Study Period 2|Other|0|||
23794542|NCT04668274|66623744|FG001|Part 1 Study Period 2|Other|1|||
23794543|NCT04668274|66623745|FG002|Part 1 Study Period 2|Other|0|||
23794544|NCT04668274|66623746|FG003|Part 1 Study Period 2|Other|0|||
23794545|NCT04668274|66623743|FG000|Part 1 Study Period 3|Adverse Event|0|||
23794546|NCT04668274|66623744|FG001|Part 1 Study Period 3|Adverse Event|0|||
23794547|NCT04668274|66623745|FG002|Part 1 Study Period 3|Adverse Event|1|||
23794548|NCT04668274|66623746|FG003|Part 1 Study Period 3|Adverse Event|0|||
23794549|NCT04668274|66623743|FG000|Part 1 Study Period 3|Other|0|||
23794550|NCT04668274|66623744|FG001|Part 1 Study Period 3|Other|0|||
23794551|NCT04668274|66623745|FG002|Part 1 Study Period 3|Other|2|||
23794552|NCT04668274|66623746|FG003|Part 1 Study Period 3|Other|0|||
23794553|NCT04668274|66623743|FG000|Part 2 Study Period 4|Other|0|||
23794554|NCT04668274|66623744|FG001|Part 2 Study Period 4|Other|0|||
23794555|NCT04668274|66623745|FG002|Part 2 Study Period 4|Other|0|||
23794556|NCT04668274|66623746|FG003|Part 2 Study Period 4|Other|1|||
23794557|NCT02260258|66623747|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
23794558|NCT02260258|66623748|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
23794559|NCT05070754|66623749|FG000|Overall Study|Withdrawal by Subject|0|||
23794560|NCT05070754|66623750|FG001|Overall Study|Withdrawal by Subject|0|||
23794561|NCT05070754|66623751|FG002|Overall Study|Withdrawal by Subject|0|||
23794562|NCT05070754|66623752|FG003|Overall Study|Withdrawal by Subject|1|||
23794563|NCT05070754|66623749|FG000|Overall Study|Protocol Violation|0|||
23794564|NCT05070754|66623750|FG001|Overall Study|Protocol Violation|0|||
23794565|NCT05070754|66623751|FG002|Overall Study|Protocol Violation|0|||
23794566|NCT05070754|66623752|FG003|Overall Study|Protocol Violation|1|||
23794567|NCT00697619|66623753|FG000|Overall Study|Lack of Efficacy|2|||
23794568|NCT00697619|66623754|FG001|Overall Study|Lack of Efficacy|2|||
23794569|NCT00697619|66623753|FG000|Overall Study|Adverse Event|4|||
23794570|NCT00697619|66623754|FG001|Overall Study|Adverse Event|6|||
23794571|NCT05497557|66623757|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
23794572|NCT05497557|66623758|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
23794573|NCT05497557|66623759|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
23794574|NCT02448563|66623761|FG000|Overall Study|Lost to Follow-up|16|||
23794575|NCT02448563|66623762|FG001|Overall Study|Lost to Follow-up|10|||
23794576|NCT02448563|66623761|FG000|Overall Study|Withdrawal by Subject|0|||
23794577|NCT02448563|66623762|FG001|Overall Study|Withdrawal by Subject|1|||
23794578|NCT01050764|66623764|FG000|Overall Study|Death, before HSCT|1|||
23470026|NCT02779556|65464412|FG001|6 Month|Lost to Follow-up|39|||
23470027|NCT02779556|65464411|FG000|6 Month HbA1c|No value collected during window|69|||
23470028|NCT02779556|65464412|FG001|6 Month HbA1c|No value collected during window|50|||
23640733|NCT03122223|66071443|FG000|Overall Study|Lost to Follow-up|0|||
23353621|NCT03170609|65037632|FG005|Overall Study|Withdrawal by Subject|0|||
23353622|NCT03170609|65037633|FG006|Overall Study|Withdrawal by Subject|1|||
23353623|NCT03170609|65037627|FG000|Overall Study|Lost to Follow-up|1|||
23353624|NCT03170609|65037628|FG001|Overall Study|Lost to Follow-up|0|||
23353625|NCT03170609|65037629|FG002|Overall Study|Lost to Follow-up|5|||
23353626|NCT03170609|65037630|FG003|Overall Study|Lost to Follow-up|2|||
23353627|NCT03170609|65037631|FG004|Overall Study|Lost to Follow-up|1|||
23587296|NCT03621761|65878986|FG002|Overall Study|Withdrawal by Subject|1|||
23587297|NCT03621761|65878984|FG000|Overall Study|Became Ineligible|0|||
23640734|NCT03122223|66071444|FG001|Overall Study|Lost to Follow-up|2|||
23640735|NCT03122223|66071445|FG002|Overall Study|Lost to Follow-up|2|||
23640736|NCT03122223|66071446|FG003|Overall Study|Lost to Follow-up|0|||
23640737|NCT03122223|66071443|FG000|Overall Study|Participant unable to adhere|1|||
23640738|NCT03122223|66071444|FG001|Overall Study|Participant unable to adhere|1|||
23640739|NCT03122223|66071445|FG002|Overall Study|Participant unable to adhere|1|||
23640740|NCT03122223|66071446|FG003|Overall Study|Participant unable to adhere|0|||
23640741|NCT00446043|66071453|FG000|Overall Study|Adverse Event|9|||
23640742|NCT00446043|66071453|FG000|Overall Study|Withdrawal by Subject|70|||
23640743|NCT00446043|66071453|FG000|Overall Study|Protocol Violation|2|||
23640744|NCT00446043|66071453|FG000|Overall Study|Lost to Follow-up|42|||
23640745|NCT00446043|66071453|FG000|Overall Study|Pregnancy|2|||
23640746|NCT00307684|66071454|FG000|Open Label Phase|Lack of Efficacy|0|||
23640747|NCT00307684|66071455|FG001|Open Label Phase|Lack of Efficacy|0|||
23640748|NCT00307684|66071456|FG002|Open Label Phase|Lack of Efficacy|3|||
23640749|NCT00307684|66071454|FG000|Open Label Phase|Adverse Event|0|||
23640750|NCT00307684|66071455|FG001|Open Label Phase|Adverse Event|0|||
23640751|NCT00307684|66071456|FG002|Open Label Phase|Adverse Event|16|||
23640752|NCT00307684|66071454|FG000|Open Label Phase|Withdrawal by Subject|0|||
23640753|NCT00307684|66071455|FG001|Open Label Phase|Withdrawal by Subject|0|||
23640754|NCT00307684|66071456|FG002|Open Label Phase|Withdrawal by Subject|15|||
23640755|NCT00307684|66071454|FG000|Open Label Phase|Lost to Follow-up|0|||
23640756|NCT00307684|66071455|FG001|Open Label Phase|Lost to Follow-up|0|||
23640757|NCT00307684|66071456|FG002|Open Label Phase|Lost to Follow-up|11|||
23640758|NCT00307684|66071454|FG000|Open Label Phase|non compliance|0|||
23640759|NCT00307684|66071455|FG001|Open Label Phase|non compliance|0|||
23640760|NCT00307684|66071456|FG002|Open Label Phase|non compliance|5|||
23640761|NCT00307684|66071454|FG000|Open Label Phase|other|0|||
23640762|NCT00307684|66071455|FG001|Open Label Phase|other|0|||
23640763|NCT00307684|66071456|FG002|Open Label Phase|other|6|||
23587298|NCT03621761|65878985|FG001|Overall Study|Became Ineligible|2|||
23587299|NCT03621761|65878986|FG002|Overall Study|Became Ineligible|0|||
23587300|NCT00762606|65878987|FG000|Overall Study|Lost to Follow-up|18|||
23587301|NCT00762606|65878988|FG001|Overall Study|Lost to Follow-up|13|||
23640764|NCT00307684|66071454|FG000|Double Blind Phase|Lack of Efficacy|2|||
23640765|NCT00307684|66071455|FG001|Double Blind Phase|Lack of Efficacy|5|||
23587302|NCT00309452|65878989|FG000|Overall Study|Withdrawal by Subject|3|||
23587303|NCT00309452|65878990|FG001|Overall Study|Withdrawal by Subject|0|||
23587304|NCT01768676|65879000|FG000|Overall Study|Adverse Event|3|||
23587305|NCT01768676|65879001|FG001|Overall Study|Adverse Event|3|||
23640766|NCT00307684|66071456|FG002|Double Blind Phase|Lack of Efficacy|0|||
23640767|NCT01877239|66071461|FG000|Overall Study|Adverse Event|4|||
23640768|NCT01877239|66071461|FG000|Overall Study|Disease Remission|1|||
23640769|NCT01877239|66071461|FG000|Overall Study|Withdrawal by Subject|4|||
23353628|NCT03170609|65037632|FG005|Overall Study|Lost to Follow-up|1|||
23353629|NCT03170609|65037633|FG006|Overall Study|Lost to Follow-up|0|||
23353630|NCT03170609|65037627|FG000|Overall Study|Other|1|||
23353631|NCT03170609|65037628|FG001|Overall Study|Other|0|||
23353632|NCT03170609|65037629|FG002|Overall Study|Other|0|||
23353633|NCT03170609|65037630|FG003|Overall Study|Other|0|||
23353634|NCT03170609|65037631|FG004|Overall Study|Other|0|||
23353635|NCT03170609|65037632|FG005|Overall Study|Other|1|||
23353636|NCT03170609|65037633|FG006|Overall Study|Other|0|||
23353637|NCT01038752|65037638|FG000|Overall Study|Tumor Progression|2|||
23353638|NCT01038752|65037639|FG001|Overall Study|Tumor Progression|2|||
23353639|NCT01038752|65037638|FG000|Overall Study|Lost to Follow-up|3|||
23353640|NCT01038752|65037639|FG001|Overall Study|Lost to Follow-up|3|||
23353641|NCT03251482|65037642|FG000|Overall Study|Withdrawal by Subject|0|||
23353642|NCT03251482|65037643|FG001|Overall Study|Withdrawal by Subject|1|||
23353643|NCT03251482|65037644|FG002|Overall Study|Withdrawal by Subject|0|||
23353644|NCT03251482|65037645|FG003|Overall Study|Withdrawal by Subject|0|||
23353645|NCT03251482|65037646|FG004|Overall Study|Withdrawal by Subject|0|||
23353646|NCT01709409|65037647|FG000|Overall Study|Protocol Violation|1|||
23353647|NCT01709409|65037648|FG001|Overall Study|Protocol Violation|0|||
23353648|NCT02131636|65037655|FG000|Overall Study|Personal Reasons|4|||
23353649|NCT02131636|65037656|FG001|Overall Study|Personal Reasons|4|||
23353650|NCT02131636|65037655|FG000|Overall Study|Lost to Follow-up|4|||
23353651|NCT02131636|65037656|FG001|Overall Study|Lost to Follow-up|0|||
23353652|NCT02131636|65037655|FG000|Overall Study|Adverse Event|4|||
23353653|NCT02131636|65037656|FG001|Overall Study|Adverse Event|1|||
23353654|NCT01533688|65037657|FG000|Overall Study|Withdrawal by Subject|5|||
23353655|NCT01533688|65037658|FG001|Overall Study|Withdrawal by Subject|4|||
23353656|NCT01533688|65037659|FG002|Overall Study|Withdrawal by Subject|3|||
23353657|NCT01533688|65037657|FG000|Overall Study|Medically unstable|1|||
23353658|NCT01533688|65037658|FG001|Overall Study|Medically unstable|3|||
23353659|NCT01533688|65037659|FG002|Overall Study|Medically unstable|3|||
23353660|NCT01533688|65037657|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
23353661|NCT01533688|65037658|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
23353662|NCT01533688|65037659|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
23353663|NCT03749109|65037660|FG000|Overall Study|Adverse Event|2|||
23353664|NCT03749109|65037661|FG001|Overall Study|Adverse Event|0|||
23353665|NCT02187861|65037666|FG000|Overall Study|Adverse Event|2|||
23353666|NCT02187861|65037667|FG001|Overall Study|Adverse Event|1|||
23353667|NCT02187861|65037668|FG002|Overall Study|Adverse Event|2|||
23353668|NCT02187861|65037669|FG003|Overall Study|Adverse Event|1|||
23353669|NCT02187861|65037666|FG000|Overall Study|Death|0|||
23353670|NCT02187861|65037667|FG001|Overall Study|Death|3|||
23353671|NCT02187861|65037668|FG002|Overall Study|Death|1|||
23353672|NCT02187861|65037669|FG003|Overall Study|Death|2|||
23353673|NCT02187861|65037666|FG000|Overall Study|Physician Decision|0|||
23353674|NCT02187861|65037667|FG001|Overall Study|Physician Decision|1|||
23353675|NCT02187861|65037668|FG002|Overall Study|Physician Decision|0|||
23353676|NCT02187861|65037669|FG003|Overall Study|Physician Decision|3|||
23353677|NCT02187861|65037666|FG000|Overall Study|Progressive Disease|4|||
23353678|NCT02187861|65037667|FG001|Overall Study|Progressive Disease|42|||
23353679|NCT02187861|65037668|FG002|Overall Study|Progressive Disease|19|||
23353680|NCT02187861|65037669|FG003|Overall Study|Progressive Disease|22|||
23353681|NCT02187861|65037666|FG000|Overall Study|Withdrawal by Subject|0|||
23353682|NCT02187861|65037667|FG001|Overall Study|Withdrawal by Subject|0|||
23353683|NCT02187861|65037668|FG002|Overall Study|Withdrawal by Subject|3|||
23353684|NCT02187861|65037669|FG003|Overall Study|Withdrawal by Subject|3|||
23353685|NCT02187861|65037666|FG000|Overall Study|Other|0|||
23353686|NCT02187861|65037667|FG001|Overall Study|Other|1|||
23353687|NCT02187861|65037668|FG002|Overall Study|Other|7|||
23353688|NCT02187861|65037669|FG003|Overall Study|Other|1|||
23353689|NCT01994902|65037670|FG000|Test Period 1|Withdrawal by Subject|3|||
23353690|NCT01994902|65037671|FG001|Test Period 1|Withdrawal by Subject|0|||
23353691|NCT01994902|65037670|FG000|Test Period 1|device deficiency with adverse event|0|||
23353692|NCT01994902|65037671|FG001|Test Period 1|device deficiency with adverse event|1|||
23353693|NCT01994902|65037670|FG000|Test Period 1|Adverse Event|2|||
23353694|NCT01994902|65037671|FG001|Test Period 1|Adverse Event|1|||
23353695|NCT01994902|65037670|FG000|Test Period 1|Lack of Efficacy|0|||
23587306|NCT01768676|65879000|FG000|Overall Study|Lost to Follow-up|13|||
23587307|NCT01768676|65879001|FG001|Overall Study|Lost to Follow-up|16|||
23353696|NCT01994902|65037671|FG001|Test Period 1|Lack of Efficacy|1|||
23353697|NCT01994902|65037670|FG000|Test Period 1|bag too small|1|||
23353698|NCT01994902|65037671|FG001|Test Period 1|bag too small|0|||
23353699|NCT01994902|65037670|FG000|Test Period 2|Withdrawal by Subject|0|||
23353700|NCT01994902|65037671|FG001|Test Period 2|Withdrawal by Subject|2|||
23353701|NCT01994902|65037670|FG000|Test Period 2|Lack of Efficacy|0|||
23353702|NCT01994902|65037671|FG001|Test Period 2|Lack of Efficacy|1|||
23353703|NCT01994902|65037670|FG000|Test Period 2|Other|0|||
23353704|NCT01994902|65037671|FG001|Test Period 2|Other|3|||
23353705|NCT01119846|65037672|FG000|Overall Study|Adverse Event|1|||
23470029|NCT02779556|65464411|FG000|12 Month HbA1c|No value collected during window|138|||
23640770|NCT01877239|66071461|FG000|Overall Study|Other|2|||
23353706|NCT01119846|65037673|FG001|Overall Study|Adverse Event|0|||
23353707|NCT01119846|65037674|FG002|Overall Study|Adverse Event|6|||
23353708|NCT01119846|65037672|FG000|Overall Study|Physician Decision|1|||
23353709|NCT01119846|65037673|FG001|Overall Study|Physician Decision|0|||
23353710|NCT01119846|65037674|FG002|Overall Study|Physician Decision|0|||
23353711|NCT01119846|65037672|FG000|Overall Study|Protocol Violation|0|||
23353712|NCT01119846|65037673|FG001|Overall Study|Protocol Violation|0|||
23353713|NCT01119846|65037674|FG002|Overall Study|Protocol Violation|1|||
23353714|NCT01119846|65037672|FG000|Overall Study|Withdrawal by Subject|0|||
23794579|NCT01050764|66623764|FG000|Overall Study|Donor mobilization failure, death|1|||
23794580|NCT01050764|66623764|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
23794581|NCT03573336|66623766|FG000|Overall Study|Study terminated|2|||
23794582|NCT03573336|66623767|FG001|Overall Study|Study terminated|4|||
23794583|NCT03573336|66623768|FG002|Overall Study|Study terminated|2|||
23794584|NCT01833169|66623769|FG000|Overall Study|Disease Progression|99|||
23794585|NCT01833169|66623769|FG000|Overall Study|Adverse Event|33|||
23794586|NCT01833169|66623769|FG000|Overall Study|Withdrawal by Subject|9|||
23353715|NCT01119846|65037673|FG001|Overall Study|Withdrawal by Subject|0|||
23353716|NCT01119846|65037674|FG002|Overall Study|Withdrawal by Subject|4|||
23353717|NCT04750278|65037679|FG000|Overall Study|Death|9|||
23353718|NCT04750278|65037680|FG001|Overall Study|Death|10|||
23353719|NCT04750278|65037681|FG002|Overall Study|Death|10|||
23353720|NCT04750278|65037679|FG000|Overall Study|Withdrawal by Subject|4|||
23353721|NCT04750278|65037680|FG001|Overall Study|Withdrawal by Subject|1|||
23353722|NCT04750278|65037681|FG002|Overall Study|Withdrawal by Subject|2|||
23353723|NCT04750278|65037679|FG000|Overall Study|Lost to Follow-up|1|||
23470030|NCT02779556|65464412|FG001|12 Month HbA1c|No value collected during window|102|||
23640771|NCT01877239|66071461|FG000|Overall Study|Lack of Efficacy|4|||
23640772|NCT01877239|66071461|FG000|Overall Study|Data not available|35|||
23640773|NCT01859988|66071467|FG000|Overall Study|Withdrawal by Subject|6|||
23640774|NCT01859988|66071468|FG001|Overall Study|Withdrawal by Subject|3|||
23794587|NCT01833169|66623769|FG000|Overall Study|Death|3|||
23794588|NCT01833169|66623769|FG000|Overall Study|Physician Decision|2|||
23640775|NCT01859988|66071469|FG002|Overall Study|Withdrawal by Subject|4|||
23640776|NCT01859988|66071470|FG003|Overall Study|Withdrawal by Subject|3|||
23640777|NCT01859988|66071471|FG004|Overall Study|Withdrawal by Subject|2|||
23640778|NCT01859988|66071472|FG005|Overall Study|Withdrawal by Subject|2|||
23640779|NCT01859988|66071467|FG000|Overall Study|Lack of Efficacy|1|||
23640780|NCT01859988|66071468|FG001|Overall Study|Lack of Efficacy|1|||
23640781|NCT01859988|66071469|FG002|Overall Study|Lack of Efficacy|5|||
23640782|NCT01859988|66071470|FG003|Overall Study|Lack of Efficacy|0|||
23640783|NCT01859988|66071471|FG004|Overall Study|Lack of Efficacy|7|||
23640784|NCT01859988|66071472|FG005|Overall Study|Lack of Efficacy|9|||
23640785|NCT01859988|66071467|FG000|Overall Study|Physician Decision|1|||
23640786|NCT01859988|66071468|FG001|Overall Study|Physician Decision|3|||
23640787|NCT01859988|66071469|FG002|Overall Study|Physician Decision|1|||
23640788|NCT01859988|66071470|FG003|Overall Study|Physician Decision|3|||
23640789|NCT01859988|66071471|FG004|Overall Study|Physician Decision|4|||
23640790|NCT01859988|66071472|FG005|Overall Study|Physician Decision|1|||
23640791|NCT01859988|66071467|FG000|Overall Study|Adverse Event|2|||
23640792|NCT01859988|66071468|FG001|Overall Study|Adverse Event|1|||
23640793|NCT01859988|66071469|FG002|Overall Study|Adverse Event|3|||
23640794|NCT01859988|66071470|FG003|Overall Study|Adverse Event|1|||
23640795|NCT01859988|66071471|FG004|Overall Study|Adverse Event|2|||
23640796|NCT01859988|66071472|FG005|Overall Study|Adverse Event|2|||
23640797|NCT01859988|66071467|FG000|Overall Study|Lost to Follow-up|1|||
23640798|NCT01859988|66071468|FG001|Overall Study|Lost to Follow-up|2|||
23640799|NCT01859988|66071469|FG002|Overall Study|Lost to Follow-up|3|||
23640800|NCT01859988|66071470|FG003|Overall Study|Lost to Follow-up|0|||
23640801|NCT01859988|66071471|FG004|Overall Study|Lost to Follow-up|3|||
23640802|NCT01859988|66071472|FG005|Overall Study|Lost to Follow-up|2|||
23640803|NCT01859988|66071467|FG000|Overall Study|Protocol Violation|0|||
23640804|NCT01859988|66071468|FG001|Overall Study|Protocol Violation|0|||
23640805|NCT01859988|66071469|FG002|Overall Study|Protocol Violation|1|||
23470031|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
23353724|NCT04750278|65037680|FG001|Overall Study|Lost to Follow-up|1|||
23353725|NCT04750278|65037681|FG002|Overall Study|Lost to Follow-up|1|||
23353726|NCT04750278|65037679|FG000|Overall Study|Pregnancy|1|||
23353727|NCT04750278|65037680|FG001|Overall Study|Pregnancy|0|||
23640806|NCT01859988|66071470|FG003|Overall Study|Protocol Violation|0|||
23640807|NCT01859988|66071471|FG004|Overall Study|Protocol Violation|0|||
23640808|NCT01859988|66071472|FG005|Overall Study|Protocol Violation|0|||
23640809|NCT01859988|66071467|FG000|Overall Study|Other than specified above|0|||
23640810|NCT01859988|66071468|FG001|Overall Study|Other than specified above|2|||
23794589|NCT03868631|66623773|FG000|Baseline to Week 6|Adverse Event|0|||
23470032|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
23640811|NCT01859988|66071469|FG002|Overall Study|Other than specified above|11|||
23353728|NCT04750278|65037681|FG002|Overall Study|Pregnancy|0|||
23353729|NCT04750278|65037679|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
23353730|NCT04750278|65037680|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
23353731|NCT04750278|65037681|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
23353732|NCT04750278|65037679|FG000|Overall Study|Non-compliance|0|||
23353733|NCT04750278|65037680|FG001|Overall Study|Non-compliance|0|||
23353734|NCT04750278|65037681|FG002|Overall Study|Non-compliance|1|||
23353735|NCT04750278|65037679|FG000|Overall Study|Transfer to Outside Facility|0|||
23353736|NCT04750278|65037680|FG001|Overall Study|Transfer to Outside Facility|2|||
23353737|NCT04750278|65037681|FG002|Overall Study|Transfer to Outside Facility|1|||
23353738|NCT04750278|65037679|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
23353739|NCT04750278|65037680|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
23353740|NCT04750278|65037681|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
23353741|NCT04750278|65037679|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
23353742|NCT04750278|65037680|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
23353743|NCT04750278|65037681|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
23353744|NCT01653327|65037682|FG000|Overall Study|Withdrawal by Subject|1|||
23353745|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
23353746|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
23353747|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
23353748|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
23353749|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
23353750|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
23353751|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Death|0|||
23353752|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Death|1|||
23353753|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Death|0|||
23353754|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
23353755|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
23353756|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
23794590|NCT03868631|66623774|FG001|Baseline to Week 6|Adverse Event|3|||
23794591|NCT03868631|66623773|FG000|Baseline to Week 6|Protocol Violation|1|||
23794592|NCT03868631|66623774|FG001|Baseline to Week 6|Protocol Violation|1|||
23794593|NCT03868631|66623773|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
23794594|NCT03868631|66623774|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
23794595|NCT03868631|66623773|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
23794596|NCT03868631|66623774|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
23794597|NCT03868631|66623773|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
23794598|NCT03868631|66623774|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
23794599|NCT03868631|66623773|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
23794600|NCT03868631|66623774|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
23794601|NCT02412722|66623781|FG000|Overall Study|Adverse Event|0|||
23794602|NCT02412722|66623782|FG001|Overall Study|Adverse Event|2|||
23794603|NCT02412722|66623783|FG002|Overall Study|Adverse Event|0|||
23794604|NCT02412722|66623784|FG003|Overall Study|Adverse Event|3|||
23794605|NCT02412722|66623785|FG004|Overall Study|Adverse Event|0|||
23794606|NCT02412722|66623786|FG005|Overall Study|Adverse Event|3|||
23794607|NCT02412722|66623781|FG000|Overall Study|Progressive Disease|6|||
23794608|NCT02412722|66623782|FG001|Overall Study|Progressive Disease|4|||
23794609|NCT02412722|66623783|FG002|Overall Study|Progressive Disease|4|||
23794610|NCT02412722|66623784|FG003|Overall Study|Progressive Disease|9|||
23794611|NCT02412722|66623785|FG004|Overall Study|Progressive Disease|3|||
23794612|NCT02412722|66623786|FG005|Overall Study|Progressive Disease|3|||
23794613|NCT02412722|66623781|FG000|Overall Study|Withdrawal by Subject|2|||
23794614|NCT02412722|66623782|FG001|Overall Study|Withdrawal by Subject|0|||
23794615|NCT02412722|66623783|FG002|Overall Study|Withdrawal by Subject|1|||
23794616|NCT02412722|66623784|FG003|Overall Study|Withdrawal by Subject|2|||
23794617|NCT02412722|66623785|FG004|Overall Study|Withdrawal by Subject|1|||
23794618|NCT02412722|66623786|FG005|Overall Study|Withdrawal by Subject|1|||
23794619|NCT02412722|66623781|FG000|Overall Study|Lost to Follow-up|0|||
23794620|NCT02412722|66623782|FG001|Overall Study|Lost to Follow-up|0|||
23794621|NCT02412722|66623783|FG002|Overall Study|Lost to Follow-up|0|||
23794622|NCT02412722|66623784|FG003|Overall Study|Lost to Follow-up|0|||
23794623|NCT02412722|66623785|FG004|Overall Study|Lost to Follow-up|1|||
23794624|NCT02412722|66623786|FG005|Overall Study|Lost to Follow-up|0|||
23353757|NCT01030718|65037683|FG000|Study CA180-036 Only|insufficient effect|1|||
23353758|NCT01030718|65037684|FG001|Study CA180-036 Only|insufficient effect|1|||
23353759|NCT01030718|65037685|FG002|Study CA180-036 Only|insufficient effect|5|||
23353760|NCT01030718|65037683|FG000|Study CA180-036 Only|Adverse Event|2|||
23353761|NCT01030718|65037684|FG001|Study CA180-036 Only|Adverse Event|3|||
23794625|NCT02412722|66623781|FG000|Overall Study|Received drug in run-in and discontinued|0|||
23794626|NCT02412722|66623782|FG001|Overall Study|Received drug in run-in and discontinued|2|||
23794627|NCT02412722|66623783|FG002|Overall Study|Received drug in run-in and discontinued|0|||
23794628|NCT02412722|66623784|FG003|Overall Study|Received drug in run-in and discontinued|0|||
23794629|NCT02412722|66623785|FG004|Overall Study|Received drug in run-in and discontinued|0|||
23794630|NCT02412722|66623786|FG005|Overall Study|Received drug in run-in and discontinued|0|||
23794631|NCT02412722|66623781|FG000|Overall Study|Reason not Specified|3|||
23794632|NCT02412722|66623782|FG001|Overall Study|Reason not Specified|0|||
23794633|NCT02412722|66623783|FG002|Overall Study|Reason not Specified|2|||
23587308|NCT01768676|65879000|FG000|Overall Study|Protocol Violation|1|||
23587309|NCT01768676|65879001|FG001|Overall Study|Protocol Violation|1|||
23587310|NCT01768676|65879000|FG000|Overall Study|Physician Decision|4|||
23587311|NCT01768676|65879001|FG001|Overall Study|Physician Decision|1|||
23587312|NCT01768676|65879000|FG000|Overall Study|Withdrawal by Subject|3|||
23587313|NCT01768676|65879001|FG001|Overall Study|Withdrawal by Subject|10|||
23587314|NCT00269399|65879004|FG000|Overall Study|Lack of Efficacy|27|||
23587315|NCT00269399|65879005|FG001|Overall Study|Lack of Efficacy|10|||
23587316|NCT00269399|65879004|FG000|Overall Study|Adverse Event|10|||
23587317|NCT00269399|65879005|FG001|Overall Study|Adverse Event|4|||
23587318|NCT00269399|65879004|FG000|Overall Study|Withdrawal by Subject|2|||
23794634|NCT02412722|66623784|FG003|Overall Study|Reason not Specified|1|||
23794635|NCT02412722|66623785|FG004|Overall Study|Reason not Specified|2|||
23794636|NCT02412722|66623786|FG005|Overall Study|Reason not Specified|6|||
23470033|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Patient requirement|20|||
23470034|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Death|5|||
23470035|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Change of therapy|6|||
23470036|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
23470037|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
23470038|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
23470039|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
23470040|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
23470041|NCT01711216|65464421|FG000|Overall Study|Adverse Event|4|||
23470042|NCT01711216|65464421|FG000|Overall Study|Pregnancy|56|||
23470043|NCT01711216|65464421|FG000|Overall Study|Withdrawal by Subject|6|||
23470044|NCT01711216|65464421|FG000|Overall Study|Lost to Follow-up|46|||
23470045|NCT01711216|65464421|FG000|Overall Study|variety of other minor reasons|83|||
23470046|NCT01711216|65464421|FG000|Overall Study|no reason specified|22|||
23470047|NCT02228980|65464422|FG000|Overall Study|Adverse Event|14|||
23470048|NCT02228980|65464423|FG001|Overall Study|Adverse Event|0|||
23470049|NCT02228980|65464424|FG002|Overall Study|Adverse Event|0|||
23470050|NCT02228980|65464425|FG003|Overall Study|Adverse Event|0|||
23470051|NCT02228980|65464422|FG000|Overall Study|Protocol Violation|7|||
23470052|NCT02228980|65464423|FG001|Overall Study|Protocol Violation|0|||
23470053|NCT02228980|65464424|FG002|Overall Study|Protocol Violation|0|||
23470054|NCT02228980|65464425|FG003|Overall Study|Protocol Violation|0|||
23470055|NCT02228980|65464422|FG000|Overall Study|Withdrawal by Subject|3|||
23470056|NCT02228980|65464423|FG001|Overall Study|Withdrawal by Subject|3|||
23470057|NCT02228980|65464424|FG002|Overall Study|Withdrawal by Subject|2|||
23470058|NCT02228980|65464425|FG003|Overall Study|Withdrawal by Subject|3|||
23470059|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
23470060|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
23470061|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
23470062|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
23470063|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
23470064|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
23470065|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
23470066|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
23587319|NCT00269399|65879005|FG001|Overall Study|Withdrawal by Subject|5|||
23587320|NCT00269399|65879004|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
23587321|NCT00269399|65879005|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
23587322|NCT00269399|65879004|FG000|Overall Study|Other|0|||
23794637|NCT02943096|66623787|FG000|Overall Study|Lack of Efficacy|0|||
23794638|NCT02943096|66623788|FG001|Overall Study|Lack of Efficacy|1|||
23794639|NCT03303417|66623789|FG000|Overall Study|Withdrawal by Subject|1|||
23794640|NCT03303417|66623790|FG001|Overall Study|Withdrawal by Subject|1|||
23470067|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
23470068|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
23470069|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
23470070|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
23470071|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
23470072|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
23470073|NCT00634101|65464437|FG000|Overall Study|Study Terminated|3|||
23470074|NCT00634101|65464438|FG001|Overall Study|Study Terminated|3|||
23470075|NCT00634101|65464437|FG000|Overall Study|Lost to Follow-up|2|||
23470076|NCT00634101|65464438|FG001|Overall Study|Lost to Follow-up|0|||
23470077|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
23470078|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
23470079|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
23470080|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
23470081|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
23470082|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
23470083|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
23470084|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
23470085|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
23470086|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
23470087|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
23470088|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
23470089|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
23470090|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
23470091|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
23470092|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
23470093|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
23470094|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
23470095|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
23470096|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
23470097|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
23470098|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
23470099|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
23470100|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
23470101|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
23470102|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
23470103|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
23470104|NCT00808080|65464446|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
23470105|NCT00867815|65464454|FG000|Overall Study|Lost to Follow-up|1|||
23470106|NCT02223858|65464455|FG000|Overall Study|Death|1|||
23470107|NCT02223858|65464456|FG001|Overall Study|Death|1|||
23470108|NCT02223858|65464455|FG000|Overall Study|Lost to Follow-up|6|||
23470109|NCT02223858|65464456|FG001|Overall Study|Lost to Follow-up|11|||
23470110|NCT02223858|65464455|FG000|Overall Study|Withdrawal by Subject|8|||
23470111|NCT02223858|65464456|FG001|Overall Study|Withdrawal by Subject|5|||
23470112|NCT02223858|65464455|FG000|Overall Study|Refused|9|||
23470113|NCT02223858|65464456|FG001|Overall Study|Refused|9|||
23470114|NCT01469377|65464457|FG000|Overall Study|Protocol Deviation|7|||
23470115|NCT01469377|65464458|FG001|Overall Study|Protocol Deviation|10|||
23470116|NCT01469377|65464459|FG002|Overall Study|Protocol Deviation|10|||
23470117|NCT01469377|65464457|FG000|Overall Study|Lost to Follow-up|3|||
23470118|NCT01469377|65464458|FG001|Overall Study|Lost to Follow-up|2|||
23470119|NCT01469377|65464459|FG002|Overall Study|Lost to Follow-up|5|||
23587323|NCT00269399|65879005|FG001|Overall Study|Other|4|||
23587324|NCT00269399|65879004|FG000|Overall Study|Development of exclusion criteria|0|||
23587325|NCT00269399|65879005|FG001|Overall Study|Development of exclusion criteria|1|||
23587326|NCT00197236|65879010|FG000|Overall Study|Adverse Event|1|||
23587327|NCT00197236|65879011|FG001|Overall Study|Adverse Event|0|||
23587328|NCT00197236|65879012|FG002|Overall Study|Adverse Event|1|||
23587329|NCT00197236|65879010|FG000|Overall Study|Lost to Follow-up|5|||
23587330|NCT00197236|65879011|FG001|Overall Study|Lost to Follow-up|14|||
23587331|NCT00197236|65879012|FG002|Overall Study|Lost to Follow-up|6|||
23587332|NCT00197236|65879010|FG000|Overall Study|Protocol Violation|0|||
23470120|NCT01469377|65464457|FG000|Overall Study|Withdrawal of Consent|12|||
23470121|NCT01469377|65464458|FG001|Overall Study|Withdrawal of Consent|14|||
23587333|NCT00197236|65879011|FG001|Overall Study|Protocol Violation|0|||
23587334|NCT00197236|65879012|FG002|Overall Study|Protocol Violation|1|||
23587335|NCT00197236|65879010|FG000|Overall Study|Withdrawal by Subject|7|||
23587336|NCT00197236|65879011|FG001|Overall Study|Withdrawal by Subject|3|||
23587337|NCT00197236|65879012|FG002|Overall Study|Withdrawal by Subject|11|||
23470122|NCT01469377|65464459|FG002|Overall Study|Withdrawal of Consent|15|||
23470123|NCT01469377|65464457|FG000|Overall Study|Adverse Event|8|||
23470124|NCT01469377|65464458|FG001|Overall Study|Adverse Event|18|||
23470125|NCT01469377|65464459|FG002|Overall Study|Adverse Event|36|||
23470126|NCT01469377|65464457|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23470127|NCT01469377|65464458|FG001|Overall Study|Insufficient Therapeutic Response|4|||
23470128|NCT01469377|65464459|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23470129|NCT01469377|65464457|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23470130|NCT01469377|65464458|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23470131|NCT01469377|65464459|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23470132|NCT01006291|65464460|FG000|Overall Study|Adverse Event|2|||
23470133|NCT01006291|65464461|FG001|Overall Study|Adverse Event|1|||
23470134|NCT01006291|65464462|FG002|Overall Study|Adverse Event|2|||
23470135|NCT01006291|65464460|FG000|Overall Study|Lack of Efficacy|2|||
23470136|NCT01006291|65464461|FG001|Overall Study|Lack of Efficacy|2|||
23470137|NCT01006291|65464462|FG002|Overall Study|Lack of Efficacy|1|||
23470138|NCT01006291|65464460|FG000|Overall Study|Protocol Violation|3|||
23470139|NCT01006291|65464461|FG001|Overall Study|Protocol Violation|3|||
23470140|NCT01006291|65464462|FG002|Overall Study|Protocol Violation|3|||
23470141|NCT01006291|65464460|FG000|Overall Study|Withdrawal criteria|5|||
23470142|NCT01006291|65464461|FG001|Overall Study|Withdrawal criteria|4|||
23470143|NCT01006291|65464462|FG002|Overall Study|Withdrawal criteria|4|||
23470144|NCT01006291|65464460|FG000|Overall Study|Other|14|||
23470145|NCT01006291|65464461|FG001|Overall Study|Other|14|||
23470146|NCT01006291|65464462|FG002|Overall Study|Other|17|||
23470147|NCT00098813|65464463|FG000|Overall Study|Death|8|||
23470148|NCT00098813|65464463|FG000|Overall Study|Protocol Violation|1|||
23470149|NCT00098813|65464463|FG000|Overall Study|Withdrawal by Subject|7|||
23470150|NCT00098813|65464463|FG000|Overall Study|Progression of Disease|1|||
23470151|NCT00098813|65464463|FG000|Overall Study|Other complicating disease|1|||
23470152|NCT00098813|65464463|FG000|Overall Study|Reversal of RAI resistance|1|||
23470153|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
23470154|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
23470155|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
23470156|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
23470157|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
23470158|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
23470159|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
23470160|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
23470161|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
23470162|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
23470163|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
23470164|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
23470165|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470166|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
23470167|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470168|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470169|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
23470170|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
23470171|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
23470172|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
23470173|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
23470174|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
23470175|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
23470176|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
23470177|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
23470178|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
23470179|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
23587338|NCT00197236|65879010|FG000|Overall Study|Study drug/medication expiration|1|||
23353762|NCT01030718|65037685|FG002|Study CA180-036 Only|Adverse Event|0|||
23470180|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
23470181|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
23470182|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
23470183|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
23470184|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
23470185|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470186|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
23470187|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470188|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470189|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470190|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
23470191|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470192|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470193|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470194|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
23470195|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470196|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470197|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470198|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
23470199|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470200|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470201|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470202|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
23640812|NCT01859988|66071470|FG003|Overall Study|Other than specified above|3|||
23640813|NCT01859988|66071471|FG004|Overall Study|Other than specified above|5|||
23640814|NCT01859988|66071472|FG005|Overall Study|Other than specified above|3|||
23640815|NCT01757197|66071473|FG000|Overall Study|Death|2|||
23640816|NCT02544451|66071474|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
23640817|NCT02544451|66071475|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
23640818|NCT02544451|66071476|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
23640819|NCT02544451|66071477|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
23640820|NCT02544451|66071474|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
23640821|NCT02544451|66071475|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
23640822|NCT02544451|66071476|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
23640823|NCT02544451|66071477|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
23640824|NCT02544451|66071474|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
23794641|NCT02914457|66623792|FG000|Overall Study|Withdrawal by Subject|1|||
23353763|NCT01030718|65037683|FG000|Study CA180-036 Only|Death|0|||
23470203|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470204|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470205|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
23470206|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23470207|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23587339|NCT00197236|65879011|FG001|Overall Study|Study drug/medication expiration|0|||
23587340|NCT00197236|65879012|FG002|Overall Study|Study drug/medication expiration|3|||
23587341|NCT00197236|65879010|FG000|Overall Study|Returned out of specified time window|0|||
23587342|NCT00197236|65879011|FG001|Overall Study|Returned out of specified time window|0|||
23587343|NCT00197236|65879012|FG002|Overall Study|Returned out of specified time window|1|||
23587344|NCT03006341|65879013|FG000|Overall Study|Not linked in the EMR|25069|||
23587345|NCT03006341|65879014|FG001|Overall Study|Not linked in the EMR|67505|||
23587346|NCT03006341|65879015|FG002|Overall Study|Not linked in the EMR|30993|||
23587347|NCT03006341|65879016|FG003|Overall Study|Not linked in the EMR|10685|||
23587348|NCT01876511|65879017|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
23587349|NCT01876511|65879018|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
23587350|NCT01876511|65879019|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
23587351|NCT01876511|65879017|FG000|Overall Study|Death (unrelated)|3|||
23587352|NCT01876511|65879018|FG001|Overall Study|Death (unrelated)|0|||
23587353|NCT01876511|65879019|FG002|Overall Study|Death (unrelated)|2|||
23587354|NCT01876511|65879017|FG000|Overall Study|Drug-related Toxicity|5|||
23587355|NCT01876511|65879018|FG001|Overall Study|Drug-related Toxicity|1|||
23587356|NCT01876511|65879019|FG002|Overall Study|Drug-related Toxicity|6|||
23587357|NCT01876511|65879017|FG000|Overall Study|Patient Decision|3|||
23587358|NCT01876511|65879018|FG001|Overall Study|Patient Decision|0|||
23587359|NCT01876511|65879019|FG002|Overall Study|Patient Decision|6|||
23794642|NCT02914457|66623792|FG000|Overall Study|Physician Decision|1|||
23794643|NCT02914457|66623792|FG000|Overall Study|No veins available for lead placement|1|||
23794644|NCT02914457|66623792|FG000|Overall Study|Electrical instability of patient|1|||
23794645|NCT02914457|66623792|FG000|Overall Study|ECG acquisition error due to sweating|1|||
23794646|NCT02914457|66623792|FG000|Overall Study|Protocol Violation|1|||
23794647|NCT00522041|66623798|FG000|Overall Study|Adverse Event|9|||
23794648|NCT00522041|66623799|FG001|Overall Study|Adverse Event|3|||
23794649|NCT00522041|66623798|FG000|Overall Study|Protocol Violation|2|||
23353764|NCT01030718|65037684|FG001|Study CA180-036 Only|Death|1|||
23353765|NCT01030718|65037685|FG002|Study CA180-036 Only|Death|0|||
23353766|NCT01030718|65037683|FG000|Study CA180-036 Only|Other Reasons|0|||
23794650|NCT00522041|66623799|FG001|Overall Study|Protocol Violation|0|||
23794651|NCT00522041|66623798|FG000|Overall Study|Lost to Follow-up|1|||
23794652|NCT00522041|66623799|FG001|Overall Study|Lost to Follow-up|4|||
23470208|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23470209|NCT01160822|65464472|FG000|Overall Study|Adverse Event|0|||
23470210|NCT01160822|65464473|FG001|Overall Study|Adverse Event|0|||
23470211|NCT01160822|65464474|FG002|Overall Study|Adverse Event|0|||
23470212|NCT01160822|65464475|FG003|Overall Study|Adverse Event|0|||
23470213|NCT01160822|65464476|FG004|Overall Study|Adverse Event|1|||
23470214|NCT01160822|65464477|FG005|Overall Study|Adverse Event|2|||
23470215|NCT01160822|65464478|FG006|Overall Study|Adverse Event|5|||
23470216|NCT01160822|65464472|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23470217|NCT01160822|65464473|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23470218|NCT01160822|65464474|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23470219|NCT01160822|65464475|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23470220|NCT01160822|65464476|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
23470221|NCT01160822|65464477|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
23470222|NCT01160822|65464478|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
23470223|NCT01160822|65464472|FG000|Overall Study|Withdrawal by Subject|0|||
23470224|NCT01160822|65464473|FG001|Overall Study|Withdrawal by Subject|0|||
23470225|NCT01160822|65464474|FG002|Overall Study|Withdrawal by Subject|0|||
23470226|NCT01160822|65464475|FG003|Overall Study|Withdrawal by Subject|0|||
23470227|NCT01160822|65464476|FG004|Overall Study|Withdrawal by Subject|0|||
23470228|NCT01160822|65464477|FG005|Overall Study|Withdrawal by Subject|0|||
23470229|NCT01160822|65464478|FG006|Overall Study|Withdrawal by Subject|1|||
23470230|NCT01160822|65464472|FG000|Overall Study|Lost to Follow-up|0|||
23470231|NCT01160822|65464473|FG001|Overall Study|Lost to Follow-up|0|||
23470232|NCT01160822|65464474|FG002|Overall Study|Lost to Follow-up|0|||
23470233|NCT01160822|65464475|FG003|Overall Study|Lost to Follow-up|0|||
23470234|NCT01160822|65464476|FG004|Overall Study|Lost to Follow-up|1|||
23470235|NCT01160822|65464477|FG005|Overall Study|Lost to Follow-up|0|||
23470236|NCT01160822|65464478|FG006|Overall Study|Lost to Follow-up|0|||
23794653|NCT00522041|66623798|FG000|Overall Study|Voluntary withdrawal|5|||
23353767|NCT01030718|65037684|FG001|Study CA180-036 Only|Other Reasons|2|||
23587360|NCT01876511|65879017|FG000|Overall Study|Physician Decision|1|||
23587361|NCT01876511|65879018|FG001|Overall Study|Physician Decision|0|||
23587362|NCT01876511|65879019|FG002|Overall Study|Physician Decision|1|||
23587363|NCT00244855|65879023|FG000|Overall Study|Withdrawal by Subject|0|||
23587364|NCT00244855|65879024|FG001|Overall Study|Withdrawal by Subject|1|||
23587365|NCT00464672|65879025|FG000|Overall Study|withdrawal of consent|0|||
23640825|NCT02544451|66071475|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23353768|NCT01030718|65037685|FG002|Study CA180-036 Only|Other Reasons|0|||
23353769|NCT01578499|65037686|FG000|Overall Study|Reason not Specified|0|||
23470237|NCT01160822|65464472|FG000|Overall Study|Administrative problems|0|||
23470238|NCT01160822|65464473|FG001|Overall Study|Administrative problems|0|||
23470239|NCT01160822|65464474|FG002|Overall Study|Administrative problems|0|||
23587366|NCT00464672|65879026|FG001|Overall Study|withdrawal of consent|0|||
23587367|NCT00464672|65879027|FG002|Overall Study|withdrawal of consent|0|||
23353770|NCT01578499|65037687|FG001|Overall Study|Reason not Specified|1|||
23353771|NCT01578499|65037686|FG000|Overall Study|Lost to Follow-up|2|||
23587368|NCT00464672|65879028|FG003|Overall Study|withdrawal of consent|1|||
23470240|NCT01160822|65464475|FG003|Overall Study|Administrative problems|0|||
23470241|NCT01160822|65464476|FG004|Overall Study|Administrative problems|1|||
23587369|NCT00464672|65879029|FG004|Overall Study|withdrawal of consent|9|||
23706828|NCT00002663|66301344|FG005|Overall Study|Lost to Follow-up|1|||
23470242|NCT01160822|65464477|FG005|Overall Study|Administrative problems|0|||
23706829|NCT00002663|66301345|FG006|Overall Study|Lost to Follow-up|0|||
23706830|NCT00002663|66301346|FG007|Overall Study|Lost to Follow-up|0|||
23706831|NCT00002663|66301347|FG008|Overall Study|Lost to Follow-up|0|||
23706832|NCT00002663|66301348|FG009|Overall Study|Lost to Follow-up|0|||
23706833|NCT00002663|66301339|FG000|Overall Study|Other|0|||
23706834|NCT00002663|66301340|FG001|Overall Study|Other|1|||
23706835|NCT00002663|66301341|FG002|Overall Study|Other|0|||
23706836|NCT00002663|66301342|FG003|Overall Study|Other|0|||
23706837|NCT00002663|66301343|FG004|Overall Study|Other|0|||
23353772|NCT01578499|65037687|FG001|Overall Study|Lost to Follow-up|1|||
23640826|NCT02544451|66071476|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23640827|NCT02544451|66071477|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23640828|NCT02544451|66071474|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
23640829|NCT02544451|66071475|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23640830|NCT02544451|66071476|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23640831|NCT02544451|66071477|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23640832|NCT02544451|66071474|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
23640833|NCT02544451|66071475|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
23353773|NCT01578499|65037686|FG000|Overall Study|Withdrawal by Subject|10|||
23353774|NCT01578499|65037687|FG001|Overall Study|Withdrawal by Subject|16|||
23353775|NCT01578499|65037686|FG000|Overall Study|Death|20|||
23353776|NCT01578499|65037687|FG001|Overall Study|Death|25|||
23794654|NCT00522041|66623799|FG001|Overall Study|Voluntary withdrawal|4|||
23353777|NCT01578499|65037686|FG000|Overall Study|Died and End of Study Page not Completed|2|||
23353778|NCT01578499|65037687|FG001|Overall Study|Died and End of Study Page not Completed|0|||
23353779|NCT01739764|65037689|FG000|Overall Study|Adverse Event|0|||
23353780|NCT01739764|65037690|FG001|Overall Study|Adverse Event|3|||
23353781|NCT01739764|65037691|FG002|Overall Study|Adverse Event|4|||
23353782|NCT01739764|65037689|FG000|Overall Study|Death|4|||
23353783|NCT01739764|65037690|FG001|Overall Study|Death|6|||
23353784|NCT01739764|65037691|FG002|Overall Study|Death|38|||
23353785|NCT01739764|65037689|FG000|Overall Study|Lost to Follow-up|0|||
23353786|NCT01739764|65037690|FG001|Overall Study|Lost to Follow-up|0|||
23353787|NCT01739764|65037691|FG002|Overall Study|Lost to Follow-up|5|||
23470243|NCT01160822|65464478|FG006|Overall Study|Administrative problems|0|||
23470244|NCT01160822|65464472|FG000|Overall Study|Protocol deviation|0|||
23470245|NCT01160822|65464473|FG001|Overall Study|Protocol deviation|0|||
23470246|NCT01160822|65464474|FG002|Overall Study|Protocol deviation|0|||
23470247|NCT01160822|65464475|FG003|Overall Study|Protocol deviation|0|||
23470248|NCT01160822|65464476|FG004|Overall Study|Protocol deviation|2|||
23470249|NCT01160822|65464477|FG005|Overall Study|Protocol deviation|0|||
23470250|NCT01160822|65464478|FG006|Overall Study|Protocol deviation|0|||
23470251|NCT01908803|65464479|FG000|Overall Study|Adverse Event|1|||
23470252|NCT01908803|65464480|FG001|Overall Study|Adverse Event|0|||
23470253|NCT01908803|65464479|FG000|Overall Study|Physician Decision|0|||
23470254|NCT01908803|65464480|FG001|Overall Study|Physician Decision|1|||
23470255|NCT01908803|65464479|FG000|Overall Study|Withdrawal by Subject|1|||
23470256|NCT01908803|65464480|FG001|Overall Study|Withdrawal by Subject|0|||
23470257|NCT01908803|65464479|FG000|Overall Study|Randomization Error|1|||
23794655|NCT00522041|66623798|FG000|Overall Study|Did not receive treatment|0|||
23794656|NCT00522041|66623799|FG001|Overall Study|Did not receive treatment|1|||
23794657|NCT01958476|66623800|FG000|Overall Study|Parent requested exclusion from analysis|1|||
23794658|NCT01958476|66623801|FG001|Overall Study|Parent requested exclusion from analysis|0|||
23794659|NCT01557920|66623805|FG000|Overall Study|Withdrawal by Subject|2|||
23794660|NCT01557920|66623806|FG001|Overall Study|Withdrawal by Subject|3|||
23794661|NCT01557920|66623805|FG000|Overall Study|Lack of Efficacy|1|||
23794662|NCT01557920|66623806|FG001|Overall Study|Lack of Efficacy|0|||
23794663|NCT01808248|66623811|FG000|Overall Study|Lack of Efficacy|3|||
23794664|NCT01808248|66623811|FG000|Overall Study|Withdrawal by Subject|1|||
23794665|NCT01808248|66623811|FG000|Overall Study|Lost to Follow-up|1|||
23794666|NCT01097694|66623812|FG000|Overall Study|Adverse Event|5|||
23794667|NCT01097694|66623813|FG001|Overall Study|Adverse Event|0|||
23794668|NCT01097694|66623812|FG000|Overall Study|Lost to Follow-up|0|||
23794669|NCT01097694|66623813|FG001|Overall Study|Lost to Follow-up|3|||
23794670|NCT01097694|66623812|FG000|Overall Study|Withdrawal by Subject|3|||
23794671|NCT01097694|66623813|FG001|Overall Study|Withdrawal by Subject|1|||
23794672|NCT01824576|66623814|FG000|Overall Study|Device deficiency|2|||
23794673|NCT03433703|66623817|FG000|Overall Study|Study terminated by Sponsor|2|||
23794674|NCT01992094|66623818|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
23794675|NCT01992094|66623819|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
23794676|NCT01992094|66623820|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
23794677|NCT01992094|66623818|FG000|Overall Study|Adverse Event|1|||
23470258|NCT01908803|65464480|FG001|Overall Study|Randomization Error|0|||
23794678|NCT01992094|66623819|FG001|Overall Study|Adverse Event|0|||
23353788|NCT01739764|65037689|FG000|Overall Study|Non-Compliance|0|||
23353789|NCT01739764|65037690|FG001|Overall Study|Non-Compliance|0|||
23640834|NCT02544451|66071476|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
23640835|NCT02544451|66071477|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
23353790|NCT01739764|65037691|FG002|Overall Study|Non-Compliance|1|||
23470259|NCT01908803|65464479|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
23353791|NCT01739764|65037689|FG000|Overall Study|Multiple Reasons|3|||
23353792|NCT01739764|65037690|FG001|Overall Study|Multiple Reasons|2|||
23353793|NCT01739764|65037691|FG002|Overall Study|Multiple Reasons|3|||
23353794|NCT01739764|65037689|FG000|Overall Study|Physician Decision|2|||
23353795|NCT01739764|65037690|FG001|Overall Study|Physician Decision|2|||
23353796|NCT01739764|65037691|FG002|Overall Study|Physician Decision|4|||
23640836|NCT02544451|66071474|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23353797|NCT01739764|65037689|FG000|Overall Study|Progressive Disease|3|||
23640837|NCT02544451|66071475|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23640838|NCT02544451|66071476|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23640839|NCT02544451|66071477|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
23794679|NCT01992094|66623820|FG002|Overall Study|Adverse Event|0|||
23794680|NCT01992094|66623818|FG000|Overall Study|Death|5|||
23794681|NCT01992094|66623819|FG001|Overall Study|Death|5|||
23794682|NCT01992094|66623820|FG002|Overall Study|Death|2|||
23794683|NCT01992094|66623818|FG000|Overall Study|Lost to Follow-up|26|||
23794684|NCT01992094|66623819|FG001|Overall Study|Lost to Follow-up|9|||
23794685|NCT01992094|66623820|FG002|Overall Study|Lost to Follow-up|13|||
23794686|NCT01992094|66623818|FG000|Overall Study|OTHER|4|||
23794687|NCT01992094|66623819|FG001|Overall Study|OTHER|0|||
23794688|NCT01992094|66623820|FG002|Overall Study|OTHER|0|||
23794689|NCT01992094|66623818|FG000|Overall Study|Protocol Violation|1|||
23794690|NCT01992094|66623819|FG001|Overall Study|Protocol Violation|0|||
23794691|NCT01992094|66623820|FG002|Overall Study|Protocol Violation|1|||
23794692|NCT01992094|66623818|FG000|Overall Study|Withdrawal by Subject|7|||
23794693|NCT01992094|66623819|FG001|Overall Study|Withdrawal by Subject|3|||
23794694|NCT01992094|66623820|FG002|Overall Study|Withdrawal by Subject|4|||
23794695|NCT02174276|66623821|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
23794696|NCT02174276|66623822|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23794697|NCT02174276|66623823|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23794698|NCT02174276|66623824|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23794699|NCT02174276|66623821|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23794700|NCT02174276|66623822|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23794701|NCT02174276|66623823|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
23794702|NCT02174276|66623824|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23794703|NCT02174276|66623821|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
23794704|NCT02174276|66623822|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
23794705|NCT02174276|66623823|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
23794706|NCT02174276|66623824|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
23794707|NCT02174276|66623821|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23794708|NCT02174276|66623822|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23794709|NCT02174276|66623823|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
23353798|NCT01739764|65037690|FG001|Overall Study|Progressive Disease|5|||
23794710|NCT02174276|66623824|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23794711|NCT02174276|66623821|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23353799|NCT01739764|65037691|FG002|Overall Study|Progressive Disease|16|||
23353800|NCT01739764|65037689|FG000|Overall Study|Protocol Violation|0|||
23353801|NCT01739764|65037690|FG001|Overall Study|Protocol Violation|0|||
23353802|NCT01739764|65037691|FG002|Overall Study|Protocol Violation|2|||
23353803|NCT01739764|65037689|FG000|Overall Study|Study Terminated by Sponsor|8|||
23353804|NCT01739764|65037690|FG001|Overall Study|Study Terminated by Sponsor|13|||
23353805|NCT01739764|65037691|FG002|Overall Study|Study Terminated by Sponsor|26|||
23353806|NCT01739764|65037689|FG000|Overall Study|Withdrawal by Subject|6|||
23353807|NCT01739764|65037690|FG001|Overall Study|Withdrawal by Subject|5|||
23353808|NCT01739764|65037691|FG002|Overall Study|Withdrawal by Subject|27|||
23353809|NCT03617861|65037692|FG000|Second Intervention (1 Day)|Adverse Event|0|||
23353810|NCT03617861|65037693|FG001|Second Intervention (1 Day)|Adverse Event|0|||
23353811|NCT03617861|65037694|FG002|Second Intervention (1 Day)|Adverse Event|1|||
23353812|NCT03617861|65037695|FG003|Second Intervention (1 Day)|Adverse Event|0|||
23353813|NCT02000882|65037696|FG000|Overall Study|Adverse Event|3|||
23353814|NCT02000882|65037696|FG000|Overall Study|Physician Decision|2|||
23353815|NCT02000882|65037696|FG000|Overall Study|Withdrawal by Subject|1|||
23353816|NCT03747302|65037697|FG000|Overall Study|Withdrawal by Subject|1|||
23353817|NCT03747302|65037698|FG001|Overall Study|Withdrawal by Subject|2|||
23353818|NCT00463840|65041262|FG000|Overall Study|Disease progression|7|||
23353819|NCT00463840|65041262|FG000|Overall Study|Withdrawal by Subject|2|||
23794712|NCT02174276|66623822|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23794713|NCT02174276|66623823|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
23794714|NCT02174276|66623824|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23794715|NCT02174276|66623821|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
23794716|NCT02174276|66623822|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
23794717|NCT02174276|66623823|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
23794718|NCT02174276|66623824|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
23794719|NCT01691430|66623825|FG000|Overall Study|Death|17|||
23794720|NCT01691430|66623826|FG001|Overall Study|Death|16|||
23794721|NCT01691430|66623825|FG000|Overall Study|Withdrawal by Subject|5|||
23794722|NCT01691430|66623826|FG001|Overall Study|Withdrawal by Subject|1|||
23794723|NCT01691430|66623825|FG000|Overall Study|Lost to Follow-up|0|||
23794724|NCT01691430|66623826|FG001|Overall Study|Lost to Follow-up|3|||
23794725|NCT01728116|66623827|FG000|Overall Study|Sponsor Terminated Study|106|||
23794726|NCT01728116|66623828|FG001|Overall Study|Sponsor Terminated Study|35|||
23794727|NCT01728116|66623827|FG000|Overall Study|Withdrawal by Subject|16|||
23794728|NCT01728116|66623828|FG001|Overall Study|Withdrawal by Subject|9|||
23794729|NCT01728116|66623827|FG000|Overall Study|Adverse Event|13|||
23794730|NCT01728116|66623828|FG001|Overall Study|Adverse Event|0|||
23794731|NCT01728116|66623827|FG000|Overall Study|Procedure/device failure|7|||
23794732|NCT01728116|66623828|FG001|Overall Study|Procedure/device failure|0|||
23794733|NCT01728116|66623827|FG000|Overall Study|Lost to Follow-up|9|||
23794734|NCT01728116|66623828|FG001|Overall Study|Lost to Follow-up|2|||
23794735|NCT01728116|66623827|FG000|Overall Study|Physician Decision|2|||
23794736|NCT01728116|66623828|FG001|Overall Study|Physician Decision|0|||
23794737|NCT01728116|66623827|FG000|Overall Study|Subject Non-Compliance|2|||
23794738|NCT01728116|66623828|FG001|Overall Study|Subject Non-Compliance|0|||
23794739|NCT01728116|66623827|FG000|Overall Study|Inter-current finding at procedure|1|||
23794740|NCT01728116|66623828|FG001|Overall Study|Inter-current finding at procedure|0|||
23794741|NCT01728116|66623827|FG000|Overall Study|Incorrectly enrolled in Study|0|||
23794742|NCT01728116|66623828|FG001|Overall Study|Incorrectly enrolled in Study|1|||
23794743|NCT01728116|66623827|FG000|Overall Study|various not noted previously|5|||
23794744|NCT01728116|66623828|FG001|Overall Study|various not noted previously|0|||
23794745|NCT01198873|66623829|FG000|Overall Study|Adverse Event|4|||
23794746|NCT01198873|66623830|FG001|Overall Study|Adverse Event|7|||
23794747|NCT01198873|66623829|FG000|Overall Study|Study closure|29|||
23794748|NCT01198873|66623830|FG001|Overall Study|Study closure|23|||
23794749|NCT01198873|66623829|FG000|Overall Study|Other than above|4|||
23794750|NCT01198873|66623830|FG001|Overall Study|Other than above|2|||
23794751|NCT03727139|66626479|FG000|Overall Study|Protocol Violation|60|||
23794752|NCT00250705|66626482|FG000|Overall Study|Lack of Efficacy|2|||
23794753|NCT04158687|66626483|FG000|Overall Study|Adverse Event|2|||
23794754|NCT04158687|66626484|FG001|Overall Study|Adverse Event|3|||
23794755|NCT04158687|66626485|FG002|Overall Study|Adverse Event|0|||
23794756|NCT04158687|66626486|FG003|Overall Study|Adverse Event|3|||
23353820|NCT00463840|65041262|FG000|Overall Study|Adverse Event|3|||
23353821|NCT03484403|65041263|FG000|Overall Study|Withdrawal by Subject|6|||
23353822|NCT03484403|65041264|FG001|Overall Study|Withdrawal by Subject|4|||
23353823|NCT04126317|65041265|FG000|Overall Study|Adverse Event|0|||
23353824|NCT04126317|65041266|FG001|Overall Study|Adverse Event|1|||
23353825|NCT04126317|65041265|FG000|Overall Study|Withdrawal by Subject|4|||
23353826|NCT04126317|65041266|FG001|Overall Study|Withdrawal by Subject|1|||
23353827|NCT02700698|65041267|FG000|Overall Study|Withdrawal by Subject|1|||
23353828|NCT02700698|65041268|FG001|Overall Study|Withdrawal by Subject|0|||
23353829|NCT01410240|65041269|FG000|Overall Study|Physician Decision|0|||
23353830|NCT01410240|65041270|FG001|Overall Study|Physician Decision|0|||
23353831|NCT01410240|65041271|FG002|Overall Study|Physician Decision|1|||
23353832|NCT01410240|65041269|FG000|Overall Study|Missed week 6 assessments|1|||
23353833|NCT01410240|65041270|FG001|Overall Study|Missed week 6 assessments|1|||
23353834|NCT01410240|65041271|FG002|Overall Study|Missed week 6 assessments|1|||
23353835|NCT01588405|65041273|FG000|Overall Study|Adverse Event|1|||
23353836|NCT01588405|65041273|FG000|Overall Study|Clinical Worsening|1|||
23353837|NCT01260584|65041276|FG000|Period 1|Protocol Violation|0|||
23470260|NCT01908803|65464480|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
23470261|NCT00990704|65464481|FG000|Overall Study|Adverse Event|1|||
23470262|NCT00990704|65464482|FG001|Overall Study|Adverse Event|1|||
23353838|NCT01260584|65041277|FG001|Period 1|Protocol Violation|0|||
23353839|NCT01260584|65041278|FG002|Period 1|Protocol Violation|1|||
23353840|NCT01260584|65041279|FG003|Period 1|Protocol Violation|1|||
23353841|NCT01260584|65041276|FG000|Period 1|Adverse Event|0|||
23353842|NCT01260584|65041277|FG001|Period 1|Adverse Event|0|||
23353843|NCT01260584|65041278|FG002|Period 1|Adverse Event|1|||
23353844|NCT01260584|65041279|FG003|Period 1|Adverse Event|0|||
23353845|NCT01260584|65041276|FG000|Period 2|Protocol Violation|0|||
23353846|NCT01260584|65041277|FG001|Period 2|Protocol Violation|2|||
23353847|NCT01260584|65041278|FG002|Period 2|Protocol Violation|3|||
23353848|NCT01260584|65041279|FG003|Period 2|Protocol Violation|1|||
23353849|NCT01260584|65041276|FG000|Period 2|Adverse Event|1|||
23353850|NCT01260584|65041277|FG001|Period 2|Adverse Event|0|||
23353851|NCT01260584|65041278|FG002|Period 2|Adverse Event|2|||
23353852|NCT01260584|65041279|FG003|Period 2|Adverse Event|0|||
23353853|NCT01260584|65041276|FG000|Period 2|Withdrawal by Subject|0|||
23353854|NCT01260584|65041277|FG001|Period 2|Withdrawal by Subject|1|||
23353855|NCT01260584|65041278|FG002|Period 2|Withdrawal by Subject|0|||
23353856|NCT01260584|65041279|FG003|Period 2|Withdrawal by Subject|0|||
23353857|NCT01737879|65041280|FG000|Overall Study|Death|1|||
23353858|NCT01737879|65041280|FG000|Overall Study|Sponsor decision|40|||
23353859|NCT00642954|65041282|FG000|Overall Study|Progressive Disease|3|||
23353860|NCT00642954|65041283|FG001|Overall Study|Progressive Disease|3|||
23353861|NCT00642954|65041284|FG002|Overall Study|Progressive Disease|3|||
23353862|NCT00642954|65041285|FG003|Overall Study|Progressive Disease|3|||
23353863|NCT00642954|65041286|FG004|Overall Study|Progressive Disease|9|||
23353864|NCT00642954|65041282|FG000|Overall Study|Withdrawal by Subject|0|||
23353865|NCT00642954|65041283|FG001|Overall Study|Withdrawal by Subject|0|||
23353866|NCT00642954|65041284|FG002|Overall Study|Withdrawal by Subject|0|||
23353867|NCT00642954|65041285|FG003|Overall Study|Withdrawal by Subject|0|||
23353868|NCT00642954|65041286|FG004|Overall Study|Withdrawal by Subject|1|||
23794757|NCT04158687|66626483|FG000|Overall Study|Lost to Follow-up|5|||
23794758|NCT04158687|66626484|FG001|Overall Study|Lost to Follow-up|12|||
23794759|NCT04158687|66626485|FG002|Overall Study|Lost to Follow-up|4|||
23794760|NCT04158687|66626486|FG003|Overall Study|Lost to Follow-up|5|||
23794761|NCT04158687|66626483|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
23794762|NCT04158687|66626484|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
23794763|NCT04158687|66626485|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
23794764|NCT04158687|66626486|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
23794765|NCT04158687|66626483|FG000|Overall Study|Non-Compliance with Study Medication|2|||
23794766|NCT04158687|66626484|FG001|Overall Study|Non-Compliance with Study Medication|2|||
23794767|NCT04158687|66626485|FG002|Overall Study|Non-Compliance with Study Medication|3|||
23794768|NCT04158687|66626486|FG003|Overall Study|Non-Compliance with Study Medication|0|||
23794769|NCT04158687|66626483|FG000|Overall Study|Investigator Decision|0|||
23470263|NCT00990704|65464481|FG000|Overall Study|Physician Decision|0|||
23353869|NCT00642954|65041282|FG000|Overall Study|Adverse Event|1|||
23353870|NCT00642954|65041283|FG001|Overall Study|Adverse Event|1|||
23470264|NCT00990704|65464482|FG001|Overall Study|Physician Decision|1|||
23470265|NCT00899431|65464483|FG000|Overall Study|Physician Decision|1|||
23353871|NCT00642954|65041284|FG002|Overall Study|Adverse Event|0|||
23353872|NCT00642954|65041285|FG003|Overall Study|Adverse Event|0|||
23353873|NCT00642954|65041286|FG004|Overall Study|Adverse Event|6|||
23470266|NCT00899431|65464484|FG001|Overall Study|Physician Decision|0|||
23353874|NCT01017601|65041287|FG000|Overall Study|Disease Progression|12|||
23353875|NCT01017601|65041288|FG001|Overall Study|Disease Progression|12|||
23353876|NCT01017601|65041287|FG000|Overall Study|Withdrawal by Subject|0|||
23353877|NCT01017601|65041288|FG001|Overall Study|Withdrawal by Subject|1|||
23353878|NCT02065518|65041289|FG000|Overall Study|Lost to Follow-up|3|||
23353879|NCT02065518|65041290|FG001|Overall Study|Lost to Follow-up|4|||
23353880|NCT02065518|65041291|FG002|Overall Study|Lost to Follow-up|0|||
23353881|NCT02065518|65041292|FG003|Overall Study|Lost to Follow-up|3|||
23353882|NCT02065518|65041289|FG000|Overall Study|Withdrawal by Subject|3|||
23353883|NCT02065518|65041290|FG001|Overall Study|Withdrawal by Subject|4|||
23353884|NCT02065518|65041291|FG002|Overall Study|Withdrawal by Subject|9|||
23353885|NCT02065518|65041292|FG003|Overall Study|Withdrawal by Subject|2|||
23353886|NCT01438814|65041293|FG000|Overall Study|Adverse Event|3|||
23353887|NCT01438814|65041294|FG001|Overall Study|Adverse Event|3|||
23353888|NCT01438814|65041293|FG000|Overall Study|Protocol Violation|1|||
23353889|NCT01438814|65041294|FG001|Overall Study|Protocol Violation|2|||
23353890|NCT01438814|65041293|FG000|Overall Study|Lost to Follow-up|4|||
23353891|NCT01438814|65041294|FG001|Overall Study|Lost to Follow-up|3|||
23353892|NCT01438814|65041293|FG000|Overall Study|Withdrawal by Subject|4|||
23353893|NCT01438814|65041294|FG001|Overall Study|Withdrawal by Subject|2|||
23353894|NCT01438814|65041293|FG000|Overall Study|Other|2|||
23353895|NCT01438814|65041294|FG001|Overall Study|Other|4|||
23353896|NCT00135356|65041295|FG000|Overall Study|Adverse Event|6|||
23353897|NCT00135356|65041296|FG001|Overall Study|Adverse Event|2|||
23353898|NCT00135356|65041295|FG000|Overall Study|Lack of Efficacy|2|||
23353899|NCT00135356|65041296|FG001|Overall Study|Lack of Efficacy|0|||
23353900|NCT00135356|65041295|FG000|Overall Study|Lost to Follow-up|3|||
23353901|NCT00135356|65041296|FG001|Overall Study|Lost to Follow-up|1|||
23353902|NCT00135356|65041295|FG000|Overall Study|Surgery for abdominal fat|1|||
23353903|NCT00135356|65041296|FG001|Overall Study|Surgery for abdominal fat|0|||
23353904|NCT00135356|65041295|FG000|Overall Study|Change in antiviral regimen|0|||
23353905|NCT00135356|65041296|FG001|Overall Study|Change in antiviral regimen|1|||
23353906|NCT00135356|65041295|FG000|Overall Study|Poor/noncompliance|1|||
23353907|NCT00135356|65041296|FG001|Overall Study|Poor/noncompliance|1|||
23353908|NCT00135356|65041295|FG000|Overall Study|No longer meets study criteria|2|||
23353909|NCT00135356|65041296|FG001|Overall Study|No longer meets study criteria|0|||
23353910|NCT00135356|65041295|FG000|Overall Study|Withdrawal by Subject|2|||
23353911|NCT00135356|65041296|FG001|Overall Study|Withdrawal by Subject|4|||
23353912|NCT02014558|65041297|FG000|Overall Study|Never Received Study Drug|0|||
23353913|NCT02014558|65041298|FG001|Overall Study|Never Received Study Drug|0|||
23353914|NCT02014558|65041299|FG002|Overall Study|Never Received Study Drug|0|||
23353915|NCT02014558|65041300|FG003|Overall Study|Never Received Study Drug|0|||
23794770|NCT04158687|66626484|FG001|Overall Study|Investigator Decision|0|||
23794771|NCT04158687|66626485|FG002|Overall Study|Investigator Decision|2|||
23353916|NCT02014558|65041301|FG004|Overall Study|Never Received Study Drug|1|||
23353917|NCT02014558|65041302|FG005|Overall Study|Never Received Study Drug|0|||
23353918|NCT02014558|65041303|FG006|Overall Study|Never Received Study Drug|1|||
23353919|NCT02014558|65041304|FG007|Overall Study|Never Received Study Drug|0|||
23353920|NCT02014558|65041305|FG008|Overall Study|Never Received Study Drug|2|||
23353921|NCT02014558|65041306|FG009|Overall Study|Never Received Study Drug|0|||
23353922|NCT02014558|65041307|FG010|Overall Study|Never Received Study Drug|2|||
23353923|NCT02014558|65041308|FG011|Overall Study|Never Received Study Drug|2|||
23353924|NCT02014558|65041309|FG012|Overall Study|Never Received Study Drug|0|||
23353925|NCT02014558|65041297|FG000|Overall Study|Adverse Event|0|||
23353926|NCT02014558|65041298|FG001|Overall Study|Adverse Event|0|||
23353927|NCT02014558|65041299|FG002|Overall Study|Adverse Event|0|||
23353928|NCT02014558|65041300|FG003|Overall Study|Adverse Event|0|||
23353929|NCT02014558|65041301|FG004|Overall Study|Adverse Event|1|||
23353930|NCT02014558|65041302|FG005|Overall Study|Adverse Event|0|||
23353931|NCT02014558|65041303|FG006|Overall Study|Adverse Event|0|||
23353932|NCT02014558|65041304|FG007|Overall Study|Adverse Event|0|||
23470267|NCT00899431|65464485|FG002|Overall Study|Physician Decision|0|||
23794772|NCT04158687|66626486|FG003|Overall Study|Investigator Decision|0|||
23794773|NCT04158687|66626483|FG000|Overall Study|Protocol Violation|0|||
23353933|NCT02014558|65041305|FG008|Overall Study|Adverse Event|2|||
23353934|NCT02014558|65041306|FG009|Overall Study|Adverse Event|2|||
23353935|NCT02014558|65041307|FG010|Overall Study|Adverse Event|5|||
23353936|NCT02014558|65041308|FG011|Overall Study|Adverse Event|21|||
23353937|NCT02014558|65041309|FG012|Overall Study|Adverse Event|3|||
23470268|NCT02998268|65464486|FG000|Overall Study|Adverse Event|0|||
23794774|NCT04158687|66626484|FG001|Overall Study|Protocol Violation|2|||
23353938|NCT02014558|65041297|FG000|Overall Study|Death|1|||
23470269|NCT02998268|65464487|FG001|Overall Study|Adverse Event|2|||
23794775|NCT04158687|66626485|FG002|Overall Study|Protocol Violation|1|||
23353939|NCT02014558|65041298|FG001|Overall Study|Death|0|||
23353940|NCT02014558|65041299|FG002|Overall Study|Death|0|||
23353941|NCT02014558|65041300|FG003|Overall Study|Death|0|||
23353942|NCT02014558|65041301|FG004|Overall Study|Death|0|||
23470270|NCT02998268|65464486|FG000|Overall Study|Withdrawal by Subject|0|||
23353943|NCT02014558|65041302|FG005|Overall Study|Death|0|||
23470271|NCT02998268|65464487|FG001|Overall Study|Withdrawal by Subject|1|||
23353944|NCT02014558|65041303|FG006|Overall Study|Death|1|||
23353945|NCT02014558|65041304|FG007|Overall Study|Death|1|||
23353946|NCT02014558|65041305|FG008|Overall Study|Death|2|||
23353947|NCT02014558|65041306|FG009|Overall Study|Death|5|||
23353948|NCT02014558|65041307|FG010|Overall Study|Death|5|||
23353949|NCT02014558|65041308|FG011|Overall Study|Death|19|||
23353950|NCT02014558|65041309|FG012|Overall Study|Death|2|||
23353951|NCT02014558|65041297|FG000|Overall Study|Lack of Efficacy|1|||
23587370|NCT00464672|65879030|FG005|Overall Study|withdrawal of consent|4|||
23794776|NCT04158687|66626486|FG003|Overall Study|Protocol Violation|0|||
23794777|NCT04158687|66626483|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
23794778|NCT04158687|66626484|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
23794779|NCT04158687|66626485|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
23794780|NCT04158687|66626486|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
23794781|NCT04158687|66626483|FG000|Overall Study|Reason not Specified|3|||
23794782|NCT04158687|66626484|FG001|Overall Study|Reason not Specified|2|||
23794783|NCT04158687|66626485|FG002|Overall Study|Reason not Specified|4|||
23794784|NCT04158687|66626486|FG003|Overall Study|Reason not Specified|4|||
23794785|NCT01964950|66626487|FG000|Overall Study|Protocol Violation|25|||
23794786|NCT02583048|66626488|FG000|Overall Study|Withdrawal by Subject|0|||
23794787|NCT02583048|66626489|FG001|Overall Study|Withdrawal by Subject|1|||
23794788|NCT02583048|66626490|FG002|Overall Study|Withdrawal by Subject|0|||
23794789|NCT02583048|66626488|FG000|Overall Study|Failed to meet eligibility criterion|0|||
23794790|NCT02583048|66626489|FG001|Overall Study|Failed to meet eligibility criterion|0|||
23794791|NCT02583048|66626490|FG002|Overall Study|Failed to meet eligibility criterion|1|||
23794792|NCT03942211|66626491|FG000|Overall Study|Death|1|||
23794793|NCT03942211|66626492|FG001|Overall Study|Death|0|||
23794794|NCT03942211|66626491|FG000|Overall Study|Study terminated by sponsor|5|||
23794795|NCT03942211|66626492|FG001|Overall Study|Study terminated by sponsor|3|||
23794796|NCT03942211|66626491|FG000|Overall Study|Adverse Event|0|||
23794797|NCT03942211|66626492|FG001|Overall Study|Adverse Event|1|||
23794798|NCT02795676|66626493|FG000|Overall Study|Adverse Event|2|||
23794799|NCT02795676|66626494|FG001|Overall Study|Adverse Event|0|||
23794800|NCT02795676|66626493|FG000|Overall Study|Withdrawal by Subject|3|||
23794801|NCT02795676|66626494|FG001|Overall Study|Withdrawal by Subject|1|||
23794802|NCT00640393|66626501|FG000|Part 1|Lost to Follow-up|2|||
23794803|NCT00640393|66626502|FG001|Part 1|Lost to Follow-up|0|||
23794804|NCT00640393|66626503|FG002|Part 1|Lost to Follow-up|0|||
23794805|NCT00640393|66626501|FG000|Part 1|Withdrawal by Subject|3|||
23794806|NCT00640393|66626502|FG001|Part 1|Withdrawal by Subject|0|||
23794807|NCT00640393|66626503|FG002|Part 1|Withdrawal by Subject|0|||
23794808|NCT00640393|66626501|FG000|Randomization|Withdrawn per protocol|17|||
23794809|NCT00640393|66626502|FG001|Randomization|Withdrawn per protocol|0|||
23794810|NCT00640393|66626503|FG002|Randomization|Withdrawn per protocol|0|||
23794811|NCT00640393|66626501|FG000|Randomization|Never randomized by site|2|||
23794812|NCT00640393|66626502|FG001|Randomization|Never randomized by site|0|||
23794813|NCT00640393|66626503|FG002|Randomization|Never randomized by site|0|||
23794814|NCT00640393|66626501|FG000|Part 2|Lost to Follow-up|0|||
23794815|NCT00640393|66626502|FG001|Part 2|Lost to Follow-up|2|||
23794816|NCT00640393|66626503|FG002|Part 2|Lost to Follow-up|2|||
23794817|NCT00640393|66626501|FG000|Part 2|Withdrawal by Subject|0|||
23794818|NCT00640393|66626502|FG001|Part 2|Withdrawal by Subject|6|||
23794819|NCT00640393|66626503|FG002|Part 2|Withdrawal by Subject|1|||
23794820|NCT00640393|66626501|FG000|Part 2|Non-adherence|0|||
23794821|NCT00640393|66626502|FG001|Part 2|Non-adherence|1|||
23794822|NCT00640393|66626503|FG002|Part 2|Non-adherence|0|||
23794823|NCT00640393|66626501|FG000|Part 2|Adverse Event|0|||
23794824|NCT00640393|66626502|FG001|Part 2|Adverse Event|1|||
23794825|NCT00640393|66626503|FG002|Part 2|Adverse Event|0|||
23794826|NCT03496298|66626509|FG000|Overall Study|Adverse Event|49|||
23794827|NCT03496298|66626510|FG001|Overall Study|Adverse Event|68|||
23794828|NCT03496298|66626511|FG002|Overall Study|Adverse Event|79|||
23587371|NCT00464672|65879025|FG000|Overall Study|Lost to Follow-up|25|||
23794829|NCT03496298|66626509|FG000|Overall Study|Study terminated by Sponsor|1050|||
23794830|NCT03496298|66626510|FG001|Overall Study|Study terminated by Sponsor|1063|||
23794831|NCT03496298|66626511|FG002|Overall Study|Study terminated by Sponsor|1071|||
23794832|NCT03496298|66626509|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
23353952|NCT02014558|65041298|FG001|Overall Study|Lack of Efficacy|2|||
23353953|NCT02014558|65041299|FG002|Overall Study|Lack of Efficacy|1|||
23353954|NCT02014558|65041300|FG003|Overall Study|Lack of Efficacy|1|||
23587372|NCT00464672|65879026|FG001|Overall Study|Lost to Follow-up|10|||
23587373|NCT00464672|65879027|FG002|Overall Study|Lost to Follow-up|0|||
23587374|NCT00464672|65879028|FG003|Overall Study|Lost to Follow-up|0|||
23587375|NCT00464672|65879029|FG004|Overall Study|Lost to Follow-up|1|||
23587376|NCT00464672|65879030|FG005|Overall Study|Lost to Follow-up|0|||
23587377|NCT04148937|65879051|FG000|Overall Study|Withdrawal by Subject|0|||
23587378|NCT04148937|65879052|FG001|Overall Study|Withdrawal by Subject|0|||
23587379|NCT04148937|65879053|FG002|Overall Study|Withdrawal by Subject|0|||
23587380|NCT04148937|65879054|FG003|Overall Study|Withdrawal by Subject|1|||
23587381|NCT04148937|65879055|FG004|Overall Study|Withdrawal by Subject|0|||
23587382|NCT04148937|65879056|FG005|Overall Study|Withdrawal by Subject|1|||
23353955|NCT02014558|65041301|FG004|Overall Study|Lack of Efficacy|0|||
23353956|NCT02014558|65041302|FG005|Overall Study|Lack of Efficacy|0|||
23353957|NCT02014558|65041303|FG006|Overall Study|Lack of Efficacy|1|||
23353958|NCT02014558|65041304|FG007|Overall Study|Lack of Efficacy|3|||
23353959|NCT02014558|65041305|FG008|Overall Study|Lack of Efficacy|3|||
23353960|NCT02014558|65041306|FG009|Overall Study|Lack of Efficacy|3|||
23353961|NCT02014558|65041307|FG010|Overall Study|Lack of Efficacy|16|||
23353962|NCT02014558|65041308|FG011|Overall Study|Lack of Efficacy|8|||
23353963|NCT02014558|65041309|FG012|Overall Study|Lack of Efficacy|5|||
23353964|NCT02014558|65041297|FG000|Overall Study|Lost to Follow-up|0|||
23353965|NCT02014558|65041298|FG001|Overall Study|Lost to Follow-up|0|||
23353966|NCT02014558|65041299|FG002|Overall Study|Lost to Follow-up|0|||
23353967|NCT02014558|65041300|FG003|Overall Study|Lost to Follow-up|0|||
23353968|NCT02014558|65041301|FG004|Overall Study|Lost to Follow-up|0|||
23353969|NCT02014558|65041302|FG005|Overall Study|Lost to Follow-up|0|||
23353970|NCT02014558|65041303|FG006|Overall Study|Lost to Follow-up|0|||
23353971|NCT02014558|65041304|FG007|Overall Study|Lost to Follow-up|0|||
23353972|NCT02014558|65041305|FG008|Overall Study|Lost to Follow-up|0|||
23353973|NCT02014558|65041306|FG009|Overall Study|Lost to Follow-up|0|||
23353974|NCT02014558|65041307|FG010|Overall Study|Lost to Follow-up|1|||
23353975|NCT02014558|65041308|FG011|Overall Study|Lost to Follow-up|0|||
23353976|NCT02014558|65041309|FG012|Overall Study|Lost to Follow-up|0|||
23353977|NCT02014558|65041297|FG000|Overall Study|Progressive Disease|1|||
23353978|NCT02014558|65041298|FG001|Overall Study|Progressive Disease|0|||
23353979|NCT02014558|65041299|FG002|Overall Study|Progressive Disease|1|||
23353980|NCT02014558|65041300|FG003|Overall Study|Progressive Disease|1|||
23353981|NCT02014558|65041301|FG004|Overall Study|Progressive Disease|1|||
23353982|NCT02014558|65041302|FG005|Overall Study|Progressive Disease|2|||
23353983|NCT02014558|65041303|FG006|Overall Study|Progressive Disease|1|||
23353984|NCT02014558|65041304|FG007|Overall Study|Progressive Disease|6|||
23587383|NCT04148937|65879057|FG006|Overall Study|Withdrawal by Subject|1|||
23587384|NCT04148937|65879058|FG007|Overall Study|Withdrawal by Subject|0|||
23587385|NCT04148937|65879051|FG000|Overall Study|Lost to Follow-up|0|||
23587386|NCT04148937|65879052|FG001|Overall Study|Lost to Follow-up|0|||
23587387|NCT04148937|65879053|FG002|Overall Study|Lost to Follow-up|1|||
23587388|NCT04148937|65879054|FG003|Overall Study|Lost to Follow-up|0|||
23587389|NCT04148937|65879055|FG004|Overall Study|Lost to Follow-up|0|||
23587390|NCT04148937|65879056|FG005|Overall Study|Lost to Follow-up|2|||
23587391|NCT04148937|65879057|FG006|Overall Study|Lost to Follow-up|0|||
23587392|NCT04148937|65879058|FG007|Overall Study|Lost to Follow-up|0|||
23587393|NCT03987451|65879061|FG000|Overall Study|Lost to Follow-up|1|||
23587394|NCT03987451|65879062|FG001|Overall Study|Lost to Follow-up|0|||
23587395|NCT03987451|65879061|FG000|Overall Study|Withdrawal by Subject|1|||
23587396|NCT03987451|65879062|FG001|Overall Study|Withdrawal by Subject|1|||
23587397|NCT01977612|65879065|FG000|Overall Study|Lost to Follow-up|1|||
23587398|NCT01977612|65879066|FG001|Overall Study|Lost to Follow-up|1|||
23587399|NCT01149681|65879067|FG000|Overall Study|Withdrawal by Subject|7|||
23587400|NCT01149681|65879067|FG000|Overall Study|Progressive disease|1|||
23587401|NCT01149681|65879067|FG000|Overall Study|Physician Decision|2|||
23587402|NCT01149681|65879067|FG000|Overall Study|adverse events nonrelated study drug|2|||
23587403|NCT02317016|65879068|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
23353985|NCT02014558|65041305|FG008|Overall Study|Progressive Disease|5|||
23353986|NCT02014558|65041306|FG009|Overall Study|Progressive Disease|6|||
23353987|NCT02014558|65041307|FG010|Overall Study|Progressive Disease|22|||
23353988|NCT02014558|65041308|FG011|Overall Study|Progressive Disease|31|||
23353989|NCT02014558|65041309|FG012|Overall Study|Progressive Disease|6|||
23353990|NCT02014558|65041297|FG000|Overall Study|Withdrawal by Subject|0|||
23353991|NCT02014558|65041298|FG001|Overall Study|Withdrawal by Subject|0|||
23587404|NCT02317016|65879068|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
23587405|NCT02317016|65879068|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
23587406|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
23587407|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
23587408|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
23587409|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
23587410|NCT01190150|65879071|FG000|First Treatment|Withdrawal by Subject|1|||
23587411|NCT01190150|65879072|FG001|First Treatment|Withdrawal by Subject|0|||
23353992|NCT02014558|65041299|FG002|Overall Study|Withdrawal by Subject|0|||
23353993|NCT02014558|65041300|FG003|Overall Study|Withdrawal by Subject|0|||
23353994|NCT02014558|65041301|FG004|Overall Study|Withdrawal by Subject|1|||
23353995|NCT02014558|65041302|FG005|Overall Study|Withdrawal by Subject|0|||
23353996|NCT02014558|65041303|FG006|Overall Study|Withdrawal by Subject|0|||
23353997|NCT02014558|65041304|FG007|Overall Study|Withdrawal by Subject|0|||
23353998|NCT02014558|65041305|FG008|Overall Study|Withdrawal by Subject|0|||
23353999|NCT02014558|65041306|FG009|Overall Study|Withdrawal by Subject|2|||
23354000|NCT02014558|65041307|FG010|Overall Study|Withdrawal by Subject|6|||
23354001|NCT02014558|65041308|FG011|Overall Study|Withdrawal by Subject|10|||
23354002|NCT02014558|65041309|FG012|Overall Study|Withdrawal by Subject|0|||
23354003|NCT02014558|65041297|FG000|Overall Study|Miscellaneous|2|||
23640840|NCT04552899|66071479|FG000|Overall Study|Adverse Event|4|||
23354004|NCT02014558|65041298|FG001|Overall Study|Miscellaneous|1|||
23640841|NCT04552899|66071480|FG001|Overall Study|Adverse Event|3|||
23640842|NCT04552899|66071479|FG000|Overall Study|Death|4|||
23354005|NCT02014558|65041299|FG002|Overall Study|Miscellaneous|1|||
23354006|NCT02014558|65041300|FG003|Overall Study|Miscellaneous|1|||
23640843|NCT04552899|66071480|FG001|Overall Study|Death|4|||
23640844|NCT04552899|66071479|FG000|Overall Study|Lost to Follow-up|8|||
23354007|NCT02014558|65041301|FG004|Overall Study|Miscellaneous|0|||
23354008|NCT02014558|65041302|FG005|Overall Study|Miscellaneous|1|||
23354009|NCT02014558|65041303|FG006|Overall Study|Miscellaneous|0|||
23354010|NCT02014558|65041304|FG007|Overall Study|Miscellaneous|1|||
23354011|NCT02014558|65041305|FG008|Overall Study|Miscellaneous|1|||
23354012|NCT02014558|65041306|FG009|Overall Study|Miscellaneous|3|||
23354013|NCT02014558|65041307|FG010|Overall Study|Miscellaneous|12|||
23354014|NCT02014558|65041308|FG011|Overall Study|Miscellaneous|11|||
23354015|NCT02014558|65041309|FG012|Overall Study|Miscellaneous|1|||
23354016|NCT01324570|65041310|FG000|Overall Study|Adverse Event|4|||
23354017|NCT01324570|65041311|FG001|Overall Study|Adverse Event|7|||
23354018|NCT01324570|65041310|FG000|Overall Study|Withdrawal by Subject|0|||
23354019|NCT01324570|65041311|FG001|Overall Study|Withdrawal by Subject|3|||
23354020|NCT01324570|65041310|FG000|Overall Study|Lack of Efficacy|0|||
23354021|NCT01324570|65041311|FG001|Overall Study|Lack of Efficacy|1|||
23354022|NCT01324570|65041310|FG000|Overall Study|Confirmed or suspected diversion|0|||
23354023|NCT01324570|65041311|FG001|Overall Study|Confirmed or suspected diversion|1|||
23354024|NCT01324570|65041310|FG000|Overall Study|Administrative|0|||
23354025|NCT01324570|65041311|FG001|Overall Study|Administrative|2|||
23354026|NCT00282152|65041312|FG000|Overall Study|Withdrawal by Subject|1|||
23354027|NCT00282152|65041313|FG001|Overall Study|Withdrawal by Subject|0|||
23354028|NCT00253370|65041314|FG000|Overall Study|Adverse Event|18|||
23354029|NCT00253370|65041314|FG000|Overall Study|Disease progression|13|||
23354030|NCT00253370|65041314|FG000|Overall Study|Death|2|||
23354031|NCT00253370|65041314|FG000|Overall Study|Withdrawal by Subject|6|||
23354032|NCT00253370|65041314|FG000|Overall Study|Non-protocol therapy|1|||
23354033|NCT00253370|65041314|FG000|Overall Study|Physician Decision|1|||
23354034|NCT00253370|65041314|FG000|Overall Study|Protocol Violation|1|||
23354035|NCT00253370|65041314|FG000|Overall Study|Abdominal pain due to disease|1|||
23354036|NCT00791492|65041317|FG000|Overall Study|Withdrawal by Subject|1|||
23354037|NCT00791492|65041318|FG001|Overall Study|Withdrawal by Subject|2|||
23354038|NCT00791492|65041317|FG000|Overall Study|Liver transplantation|5|||
23354039|NCT00791492|65041318|FG001|Overall Study|Liver transplantation|1|||
23354040|NCT00422422|65041321|FG000|Overall Study|Lack of Efficacy|1|||
23354041|NCT00422422|65041321|FG000|Overall Study|Protocol Violation|1|||
23354042|NCT00422422|65041321|FG000|Overall Study|Withdrawal by Subject|2|||
23354043|NCT00422422|65041321|FG000|Overall Study|SAE, non-fatal|1|||
23354044|NCT00422422|65041321|FG000|Overall Study|AE, non-serious non-fatal|5|||
23354045|NCT01313221|65041322|FG000|Overall Study|Protocol Violation|0|||
23354046|NCT01313221|65041323|FG001|Overall Study|Protocol Violation|1|||
23354047|NCT01313221|65041324|FG002|Overall Study|Protocol Violation|1|||
23354048|NCT01313221|65041322|FG000|Overall Study|Non-compliance|3|||
23354049|NCT01313221|65041323|FG001|Overall Study|Non-compliance|0|||
23354050|NCT01313221|65041324|FG002|Overall Study|Non-compliance|2|||
23470272|NCT00357903|65464488|FG000|Overall Study|Adverse Event|87|||
23470273|NCT00357903|65464489|FG001|Overall Study|Adverse Event|4|||
23470274|NCT00357903|65464488|FG000|Overall Study|Death|33|||
23470275|NCT00357903|65464489|FG001|Overall Study|Death|0|||
23470276|NCT00357903|65464488|FG000|Overall Study|Lost to Follow-up|23|||
23470277|NCT00357903|65464489|FG001|Overall Study|Lost to Follow-up|4|||
23470278|NCT00357903|65464488|FG000|Overall Study|Physician Decision|39|||
23470279|NCT00357903|65464489|FG001|Overall Study|Physician Decision|5|||
23470280|NCT00357903|65464488|FG000|Overall Study|Withdrawal by Subject|57|||
23470281|NCT00357903|65464489|FG001|Overall Study|Withdrawal by Subject|7|||
23470282|NCT00357903|65464488|FG000|Overall Study|Completed month 12 only|0|||
23470283|NCT00357903|65464489|FG001|Overall Study|Completed month 12 only|1|||
23470284|NCT00357903|65464488|FG000|Overall Study|Protocol issues|14|||
23470285|NCT00357903|65464489|FG001|Overall Study|Protocol issues|3|||
23470286|NCT00357903|65464488|FG000|Overall Study|Response status|61|||
23470287|NCT00357903|65464489|FG001|Overall Study|Response status|9|||
23470288|NCT00357903|65464488|FG000|Overall Study|Other|49|||
23470289|NCT00357903|65464489|FG001|Overall Study|Other|10|||
23470290|NCT00706342|65464490|FG000|Overall Study|Adverse Event|3|||
23470291|NCT00706342|65464490|FG000|Overall Study|Not responding to treatment|2|||
23354051|NCT01313221|65041322|FG000|Overall Study|Withdrawal by Subject|2|||
23354052|NCT01313221|65041323|FG001|Overall Study|Withdrawal by Subject|3|||
23354053|NCT01313221|65041324|FG002|Overall Study|Withdrawal by Subject|5|||
23354054|NCT01313221|65041322|FG000|Overall Study|Requirement for alternative therapy|0|||
23354055|NCT01313221|65041323|FG001|Overall Study|Requirement for alternative therapy|1|||
23354056|NCT01313221|65041324|FG002|Overall Study|Requirement for alternative therapy|1|||
23354057|NCT01313221|65041322|FG000|Overall Study|Lost to Follow-up|6|||
23354058|NCT01313221|65041323|FG001|Overall Study|Lost to Follow-up|3|||
23354059|NCT01313221|65041324|FG002|Overall Study|Lost to Follow-up|1|||
23470292|NCT00706342|65464490|FG000|Overall Study|Withdrawn due to failure to respond|1|||
23470293|NCT00706342|65464490|FG000|Overall Study|Death|1|||
23354060|NCT01313221|65041322|FG000|Overall Study|Other|1|||
23354061|NCT01313221|65041323|FG001|Overall Study|Other|0|||
23470294|NCT00706342|65464490|FG000|Overall Study|Withdrew from the study on his own.|1|||
23470295|NCT00706342|65464490|FG000|Overall Study|Investigator discretion|2|||
23470296|NCT00706342|65464490|FG000|Overall Study|Non-responder Week 12|1|||
23470297|NCT00706342|65464490|FG000|Overall Study|Ongoing|6|||
23470298|NCT00706342|65464490|FG000|Overall Study|WIthdrawal of consent|1|||
23470299|NCT03091348|65464491|FG000|Overall Study|Lost to Follow-up|2|||
23470300|NCT03091348|65464492|FG001|Overall Study|Lost to Follow-up|1|||
23470301|NCT02425943|65464494|FG000|Overall Study|Adverse Event|3|||
23470302|NCT02425943|65464495|FG001|Overall Study|Adverse Event|1|||
23470303|NCT02425943|65464494|FG000|Overall Study|Lost to Follow-up|59|||
23470304|NCT02425943|65464495|FG001|Overall Study|Lost to Follow-up|37|||
23470305|NCT02425943|65464494|FG000|Overall Study|Protocol Violation|4|||
23470306|NCT02425943|65464495|FG001|Overall Study|Protocol Violation|1|||
23470307|NCT02425943|65464494|FG000|Overall Study|Withdrawal by Subject|64|||
23470308|NCT02425943|65464495|FG001|Overall Study|Withdrawal by Subject|31|||
23470309|NCT02425943|65464494|FG000|Overall Study|Other|6|||
23470310|NCT02425943|65464495|FG001|Overall Study|Other|0|||
23470311|NCT02978781|65464499|FG000|Part A|Adverse Event|1|||
23470312|NCT02978781|65464500|FG001|Part A|Adverse Event|1|||
23470313|NCT02978781|65464501|FG002|Part A|Adverse Event|0|||
23470314|NCT02978781|65464502|FG003|Part A|Adverse Event|0|||
23470315|NCT02978781|65464503|FG004|Part A|Adverse Event|0|||
23470316|NCT02978781|65464499|FG000|Part A|Withdrawal by Subject|0|||
23470317|NCT02978781|65464500|FG001|Part A|Withdrawal by Subject|1|||
23470318|NCT02978781|65464501|FG002|Part A|Withdrawal by Subject|0|||
23470319|NCT02978781|65464502|FG003|Part A|Withdrawal by Subject|0|||
23470320|NCT02978781|65464503|FG004|Part A|Withdrawal by Subject|0|||
23470321|NCT02978781|65464499|FG000|Part B|Withdrawal by Subject|0|||
23470322|NCT02978781|65464500|FG001|Part B|Withdrawal by Subject|0|||
23470323|NCT02978781|65464501|FG002|Part B|Withdrawal by Subject|0|||
23470324|NCT02978781|65464502|FG003|Part B|Withdrawal by Subject|1|||
23470325|NCT02978781|65464503|FG004|Part B|Withdrawal by Subject|0|||
23470326|NCT02978781|65464499|FG000|Part C|Adverse Event|0|||
23470327|NCT02978781|65464500|FG001|Part C|Adverse Event|0|||
23470328|NCT02978781|65464501|FG002|Part C|Adverse Event|0|||
23470329|NCT02978781|65464502|FG003|Part C|Adverse Event|0|||
23587412|NCT01190150|65879071|FG000|Washout|Withdrawal by Subject|0|||
23587413|NCT01190150|65879072|FG001|Washout|Withdrawal by Subject|1|||
23587414|NCT01190150|65879071|FG000|Washout|Difficulty in adherence|0|||
23587415|NCT01190150|65879072|FG001|Washout|Difficulty in adherence|1|||
23587416|NCT04173572|65879075|FG000|Overall Study|Withdrawal by Subject|1|||
23587417|NCT04173572|65879076|FG001|Overall Study|Withdrawal by Subject|5|||
23587418|NCT04173572|65879075|FG000|Overall Study|Lost to Follow-up|3|||
23587419|NCT04173572|65879076|FG001|Overall Study|Lost to Follow-up|1|||
23587420|NCT01695317|65879077|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
23587421|NCT01695317|65879078|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
23587422|NCT01695317|65879077|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
23587423|NCT01695317|65879078|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
23587424|NCT01838200|65879079|FG000|Overall Study|Adverse Event|0|||
23587425|NCT01838200|65879080|FG001|Overall Study|Adverse Event|2|||
23587426|NCT01838200|65879079|FG000|Overall Study|Progressive disease|3|||
23354062|NCT01313221|65041324|FG002|Overall Study|Other|0|||
23470330|NCT02978781|65464503|FG004|Part C|Adverse Event|2|||
23470331|NCT02978781|65464499|FG000|Part C|Withdrawal by Subject|0|||
23470332|NCT02978781|65464500|FG001|Part C|Withdrawal by Subject|0|||
23470333|NCT02978781|65464501|FG002|Part C|Withdrawal by Subject|0|||
23470334|NCT02978781|65464502|FG003|Part C|Withdrawal by Subject|0|||
23470335|NCT02978781|65464503|FG004|Part C|Withdrawal by Subject|1|||
23470336|NCT02978781|65464499|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470337|NCT02978781|65464500|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470338|NCT02978781|65464501|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470339|NCT02978781|65464502|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
23587427|NCT01838200|65879080|FG001|Overall Study|Progressive disease|0|||
23587428|NCT00109967|65879082|FG000|Overall Study|Cancel Prior to Treatment|2|||
23794833|NCT03496298|66626510|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
23794834|NCT03496298|66626511|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
23794835|NCT03496298|66626509|FG000|Overall Study|Withdrawal by Subject|176|||
23794836|NCT03496298|66626510|FG001|Overall Study|Withdrawal by Subject|154|||
23794837|NCT03496298|66626511|FG002|Overall Study|Withdrawal by Subject|151|||
23794838|NCT03496298|66626509|FG000|Overall Study|Other|29|||
23794839|NCT03496298|66626510|FG001|Overall Study|Other|20|||
23794840|NCT03496298|66626511|FG002|Overall Study|Other|23|||
23794841|NCT03496298|66626509|FG000|Overall Study|Randomized and not treated|1|||
23794842|NCT03496298|66626510|FG001|Overall Study|Randomized and not treated|1|||
23794843|NCT03496298|66626511|FG002|Overall Study|Randomized and not treated|1|||
23354063|NCT01313221|65041322|FG000|Overall Study|Adverse Event|0|||
23354064|NCT01313221|65041323|FG001|Overall Study|Adverse Event|0|||
23354065|NCT01313221|65041324|FG002|Overall Study|Adverse Event|7|||
23354066|NCT01313221|65041322|FG000|Overall Study|Disease progression|0|||
23354067|NCT01313221|65041323|FG001|Overall Study|Disease progression|0|||
23354068|NCT01313221|65041324|FG002|Overall Study|Disease progression|2|||
23354069|NCT01313221|65041322|FG000|Overall Study|Physician Decision|0|||
23354070|NCT01313221|65041323|FG001|Overall Study|Physician Decision|0|||
23354071|NCT01313221|65041324|FG002|Overall Study|Physician Decision|2|||
23354072|NCT01313221|65041322|FG000|Overall Study|Pregnancy|0|||
23354073|NCT01313221|65041323|FG001|Overall Study|Pregnancy|0|||
23354074|NCT01313221|65041324|FG002|Overall Study|Pregnancy|2|||
23354075|NCT01402986|65041325|FG000|Overall Study|Withdrawal by Subject|7|||
23354076|NCT01402986|65041326|FG001|Overall Study|Withdrawal by Subject|10|||
23354077|NCT01402986|65041327|FG002|Overall Study|Withdrawal by Subject|7|||
23354078|NCT01402986|65041328|FG003|Overall Study|Withdrawal by Subject|13|||
23354079|NCT01402986|65041325|FG000|Overall Study|Death|0|||
23354080|NCT01402986|65041326|FG001|Overall Study|Death|0|||
23354081|NCT01402986|65041327|FG002|Overall Study|Death|0|||
23354082|NCT01402986|65041328|FG003|Overall Study|Death|2|||
23354083|NCT01402986|65041325|FG000|Overall Study|Lost to Follow-up|0|||
23354084|NCT01402986|65041326|FG001|Overall Study|Lost to Follow-up|0|||
23354085|NCT01402986|65041327|FG002|Overall Study|Lost to Follow-up|0|||
23354086|NCT01402986|65041328|FG003|Overall Study|Lost to Follow-up|1|||
23354087|NCT01402986|65041325|FG000|Overall Study|Other|2|||
23354088|NCT01402986|65041326|FG001|Overall Study|Other|5|||
23354089|NCT01402986|65041327|FG002|Overall Study|Other|1|||
23354090|NCT01402986|65041328|FG003|Overall Study|Other|6|||
23354091|NCT02069093|65041329|FG000|Overall Study|Disease progression|14|||
23354092|NCT02069093|65041329|FG000|Overall Study|New cancer therapy|1|||
23354093|NCT02069093|65041329|FG000|Overall Study|Death|1|||
23354094|NCT02069093|65041329|FG000|Overall Study|Administrative problems|1|||
23354095|NCT02069093|65041329|FG000|Overall Study|Withdrawal by Subject|2|||
23354096|NCT02069093|65041329|FG000|Overall Study|Abnormal laboratory values|1|||
23354097|NCT02069093|65041329|FG000|Overall Study|Adverse Event|10|||
23354098|NCT02380859|65041332|FG000|Overall Study|Withdrawal by Subject|2|||
23354099|NCT02380859|65041333|FG001|Overall Study|Withdrawal by Subject|0|||
23354100|NCT02109445|65041334|FG000|Overall Study|Symptomatic deterioration|2|||
23354101|NCT02109445|65041334|FG000|Overall Study|Adverse Event|1|||
23354102|NCT01603394|65041336|FG000|Overall Study|Adverse Event|1|||
23354103|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
23794844|NCT04320745|66626512|FG000|Overall Study|Adverse Event|26|||
23794845|NCT04320745|66626512|FG000|Overall Study|Withdrawal by Subject|4|||
23794846|NCT04320745|66626512|FG000|Overall Study|Lost to Follow-up|12|||
23794847|NCT04320745|66626512|FG000|Overall Study|Protocol Deviation|2|||
23794848|NCT04320745|66626512|FG000|Overall Study|Non-compliance With Study Drug|2|||
23794849|NCT04320745|66626512|FG000|Overall Study|Reason Not Specified|1|||
23354104|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23354105|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23794850|NCT00544167|66626514|FG000|Overall Study|Adverse Event|21|||
23794851|NCT00544167|66626514|FG000|Overall Study|Physician Decision|8|||
23794852|NCT02727192|66626515|FG000|Overall Study|Lost to Follow-up|1|||
23794853|NCT02727192|66626516|FG001|Overall Study|Lost to Follow-up|0|||
23354106|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23354107|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
23354108|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23354109|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23354110|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23794854|NCT02727192|66626517|FG002|Overall Study|Lost to Follow-up|0|||
23794855|NCT00762411|66626518|FG000|Initial Treatment|Death|7|||
23794856|NCT00762411|66626519|FG001|Initial Treatment|Death|6|||
23354111|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
23354112|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354113|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354114|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354115|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
23354116|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23354117|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23354118|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23794857|NCT00762411|66626518|FG000|Initial Treatment|Adverse Event|132|||
23354119|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
23354120|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23794858|NCT00762411|66626519|FG001|Initial Treatment|Adverse Event|40|||
23794859|NCT00762411|66626518|FG000|Initial Treatment|Protocol Violation|4|||
23794860|NCT00762411|66626519|FG001|Initial Treatment|Protocol Violation|1|||
23794861|NCT00762411|66626518|FG000|Initial Treatment|Withdrawal by Subject|65|||
23794862|NCT00762411|66626519|FG001|Initial Treatment|Withdrawal by Subject|52|||
23794863|NCT00762411|66626518|FG000|Initial Treatment|Physician Decision|1|||
23794864|NCT00762411|66626519|FG001|Initial Treatment|Physician Decision|0|||
23794865|NCT00762411|66626518|FG000|Initial Treatment|Sponsor Decision|293|||
23794866|NCT00762411|66626519|FG001|Initial Treatment|Sponsor Decision|401|||
23794867|NCT00762411|66626518|FG000|Initial Treatment|Lost to Follow-up|5|||
23794868|NCT00762411|66626519|FG001|Initial Treatment|Lost to Follow-up|0|||
23794869|NCT00762411|66626518|FG000|Initial Treatment|Caregiver Decision|21|||
23354121|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23354122|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23354123|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
23354124|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354125|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354126|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354127|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
23354128|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354129|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354130|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354131|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
23354132|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23354133|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23354134|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23354135|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
23354136|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23354137|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23640845|NCT04552899|66071480|FG001|Overall Study|Lost to Follow-up|13|||
23640846|NCT04552899|66071479|FG000|Overall Study|Lung Transplant|4|||
23640847|NCT04552899|66071480|FG001|Overall Study|Lung Transplant|3|||
23640848|NCT04552899|66071479|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
23640849|NCT04552899|66071480|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
23640850|NCT04552899|66071479|FG000|Overall Study|Physician Decision|3|||
23794870|NCT00762411|66626519|FG001|Initial Treatment|Caregiver Decision|16|||
23794871|NCT00762411|66626518|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
23794872|NCT00762411|66626519|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
23794873|NCT00762411|66626518|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
23794874|NCT00762411|66626519|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
23794875|NCT00762411|66626518|FG000|Delayed Start|Adverse Event|0|||
23794876|NCT00762411|66626519|FG001|Delayed Start|Adverse Event|4|||
23794877|NCT00762411|66626518|FG000|Delayed Start|Protocol Violation|0|||
23794878|NCT00762411|66626519|FG001|Delayed Start|Protocol Violation|1|||
23794879|NCT00762411|66626518|FG000|Delayed Start|Sponsor Decision|16|||
23794880|NCT00762411|66626519|FG001|Delayed Start|Sponsor Decision|20|||
23794881|NCT00762411|66626518|FG000|Delayed Start|Caregiver Decision|1|||
23794882|NCT00762411|66626519|FG001|Delayed Start|Caregiver Decision|1|||
23794883|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
23794884|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
23794885|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23794886|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
23794887|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
23794888|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
23794889|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
23794890|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
23354138|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23470340|NCT02978781|65464503|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
23470341|NCT01262820|65464504|FG000|Overall Study|Adverse Event|5|||
23470342|NCT01262820|65464504|FG000|Overall Study|Lack of Efficacy|9|||
23470343|NCT01262820|65464504|FG000|Overall Study|Drug held for 21+ days|1|||
23470344|NCT00960570|65464505|FG000|21 Day Washout Period|Adverse Event|1|||
23470345|NCT00960570|65464505|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
23470346|NCT00960570|65464505|FG000|1 Day Period Between Dosing|Adverse Event|2|||
23470347|NCT00960570|65464505|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
23470348|NCT01011309|65464506|FG000|Overall Study|Adverse Event|2|||
23470349|NCT01011309|65464507|FG001|Overall Study|Adverse Event|1|||
23470350|NCT01011309|65464508|FG002|Overall Study|Adverse Event|2|||
23470351|NCT01011309|65464506|FG000|Overall Study|Lack of Efficacy|0|||
23470352|NCT01011309|65464507|FG001|Overall Study|Lack of Efficacy|1|||
23470353|NCT01011309|65464508|FG002|Overall Study|Lack of Efficacy|0|||
23470354|NCT01011309|65464506|FG000|Overall Study|Protocol Violation|0|||
23470355|NCT01011309|65464507|FG001|Overall Study|Protocol Violation|1|||
23470356|NCT01011309|65464508|FG002|Overall Study|Protocol Violation|3|||
23470357|NCT00515619|65464511|FG000|Overall Study|Adverse Event|34|||
23470358|NCT00515619|65464511|FG000|Overall Study|Lack of Efficacy|92|||
23470359|NCT00515619|65464511|FG000|Overall Study|Withdrawal by Subject|66|||
23470360|NCT00515619|65464511|FG000|Overall Study|Protocol Violation|3|||
23470361|NCT00515619|65464511|FG000|Overall Study|Lost to Follow-up|4|||
23470362|NCT00515619|65464511|FG000|Overall Study|Unsatisfactory compliance|6|||
23470363|NCT00515619|65464511|FG000|Overall Study|Other: Site discontinuing trials|2|||
23470364|NCT00515619|65464511|FG000|Overall Study|Other: Subject cannot attend visits|2|||
23794891|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
23794892|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
23794893|NCT00762411|66626518|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
23794894|NCT00762411|66626519|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
23794895|NCT00856349|66626522|FG000|Overall Study|Death|418|||
23794896|NCT00856349|66626522|FG000|Overall Study|Withdrawal by Subject|116|||
23794897|NCT00856349|66626522|FG000|Overall Study|Lost to Follow-up|91|||
23794898|NCT00856349|66626522|FG000|Overall Study|Protocol Violation|38|||
23794899|NCT00856349|66626522|FG000|Overall Study|Physician Decision|13|||
23794900|NCT00856349|66626522|FG000|Overall Study|Subject relocation|104|||
23794901|NCT00856349|66626522|FG000|Overall Study|Device explant|33|||
23794902|NCT00856349|66626522|FG000|Overall Study|Site closure|78|||
23794903|NCT00856349|66626522|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
23794904|NCT03693950|66626523|FG000|Overall Study|Withdrawal by Subject|1|||
23794905|NCT03693950|66626524|FG001|Overall Study|Withdrawal by Subject|0|||
23794906|NCT02435433|66626526|FG000|Overall Study|Withdrawal by Subject|2|||
23794907|NCT02435433|66626527|FG001|Overall Study|Withdrawal by Subject|3|||
23794908|NCT02435433|66626528|FG002|Overall Study|Withdrawal by Subject|1|||
23794909|NCT02435433|66626529|FG003|Overall Study|Withdrawal by Subject|0|||
23794910|NCT02435433|66626530|FG004|Overall Study|Withdrawal by Subject|0|||
23794911|NCT02435433|66626526|FG000|Overall Study|Lost to Follow-up|2|||
23794912|NCT02435433|66626527|FG001|Overall Study|Lost to Follow-up|2|||
23794913|NCT02435433|66626528|FG002|Overall Study|Lost to Follow-up|4|||
23794914|NCT02435433|66626529|FG003|Overall Study|Lost to Follow-up|1|||
23470365|NCT00515619|65464511|FG000|Overall Study|Other: Subject required surgery|1|||
23470366|NCT00515619|65464511|FG000|Overall Study|Other: Subject moved to another country|1|||
23470367|NCT00515619|65464511|FG000|Overall Study|Other: Investigator decision|1|||
23470368|NCT00515619|65464511|FG000|Overall Study|Other: Subject became pregnant|1|||
23470369|NCT00515619|65464511|FG000|Overall Study|Other: Request from sponsor|1|||
23640851|NCT04552899|66071480|FG001|Overall Study|Physician Decision|4|||
23794915|NCT02435433|66626530|FG004|Overall Study|Lost to Follow-up|0|||
23794916|NCT00842309|66626533|FG000|Overall Study|Withdrawal by Subject|3|||
23794917|NCT00842309|66626534|FG001|Overall Study|Withdrawal by Subject|1|||
23794918|NCT00609154|66626539|FG000|Overall Study|Protocol Violation|1|||
23794919|NCT00609154|66626540|FG001|Overall Study|Protocol Violation|2|||
23470370|NCT00515619|65464511|FG000|Overall Study|Other: Drug available on license|1|||
23470371|NCT00515619|65464511|FG000|Overall Study|Other: Subject interested in other AED|1|||
23470372|NCT01262989|65464513|FG000|Period 1|Lost to Follow-up|1|||
23470373|NCT01262989|65464514|FG001|Period 1|Lost to Follow-up|1|||
23470374|NCT01262989|65464513|FG000|Period 1|Intercurrent disease|0|||
23470375|NCT01262989|65464514|FG001|Period 1|Intercurrent disease|1|||
23470376|NCT01262989|65464513|FG000|Period 1|Positive answer for exclusion criteria|0|||
23470377|NCT01262989|65464514|FG001|Period 1|Positive answer for exclusion criteria|1|||
23470378|NCT01262989|65464513|FG000|Period 2|Intercurrent disease|0|||
23470379|NCT01262989|65464514|FG001|Period 2|Intercurrent disease|1|||
23470380|NCT00806819|65464517|FG000|Overall Study|progressive disease (modified RECIST )|217|||
23470381|NCT00806819|65464518|FG001|Overall Study|progressive disease (modified RECIST )|216|||
23470382|NCT00806819|65464517|FG000|Overall Study|Worsening or AE of underlying disease|18|||
23470383|NCT00806819|65464518|FG001|Overall Study|Worsening or AE of underlying disease|25|||
23470384|NCT00806819|65464517|FG000|Overall Study|Other AE|38|||
23470385|NCT00806819|65464518|FG001|Overall Study|Other AE|40|||
23470386|NCT00806819|65464517|FG000|Overall Study|Protocol Violation|9|||
23470387|NCT00806819|65464518|FG001|Overall Study|Protocol Violation|4|||
23470388|NCT00806819|65464517|FG000|Overall Study|Lost to Follow-up|1|||
23470389|NCT00806819|65464518|FG001|Overall Study|Lost to Follow-up|0|||
23470390|NCT00806819|65464517|FG000|Overall Study|Withdrawal by Subject|32|||
23470391|NCT00806819|65464518|FG001|Overall Study|Withdrawal by Subject|29|||
23470392|NCT00806819|65464517|FG000|Overall Study|Not treated|6|||
23470393|NCT00806819|65464518|FG001|Overall Study|Not treated|3|||
23470394|NCT00806819|65464517|FG000|Overall Study|Reasons other than stated above|25|||
23470395|NCT00806819|65464518|FG001|Overall Study|Reasons other than stated above|41|||
23470396|NCT00661427|65464519|FG000|Overall Study|Adverse Event|5|||
23470397|NCT00661427|65464520|FG001|Overall Study|Adverse Event|5|||
23470398|NCT00661427|65464519|FG000|Overall Study|Patient not treated|0|||
23470399|NCT00661427|65464520|FG001|Overall Study|Patient not treated|2|||
23470400|NCT04075734|65464521|FG000|Overall Study|Lost to Follow-up|1|||
23470401|NCT04075734|65464522|FG001|Overall Study|Lost to Follow-up|1|||
23470402|NCT04075734|65464523|FG002|Overall Study|Lost to Follow-up|0|||
23470403|NCT04075734|65464521|FG000|Overall Study|Withdrawal by Subject|3|||
23470404|NCT04075734|65464522|FG001|Overall Study|Withdrawal by Subject|0|||
23470405|NCT04075734|65464523|FG002|Overall Study|Withdrawal by Subject|0|||
23470406|NCT00787267|65464544|FG000|Overall Study|Screen failure/Ineligible|10|||
23470407|NCT00787267|65464544|FG000|Overall Study|No Reason Provided|1|||
23470408|NCT00787267|65464544|FG000|Overall Study|Withdrawal by Subject|1|||
23587429|NCT00109967|65879083|FG001|Overall Study|Cancel Prior to Treatment|0|||
23587430|NCT00109967|65879082|FG000|Overall Study|Adverse Event|12|||
23587431|NCT00109967|65879083|FG001|Overall Study|Adverse Event|1|||
23587432|NCT00109967|65879082|FG000|Overall Study|Withdrawal by Subject|5|||
23587433|NCT00109967|65879083|FG001|Overall Study|Withdrawal by Subject|0|||
23587434|NCT00109967|65879082|FG000|Overall Study|Physician Decision|1|||
23587435|NCT00109967|65879083|FG001|Overall Study|Physician Decision|3|||
23587436|NCT00109967|65879082|FG000|Overall Study|Death|0|||
23587437|NCT00109967|65879083|FG001|Overall Study|Death|2|||
23587438|NCT01451814|65879085|FG000|Overall Study|Withdrawal by Subject|1|||
23587439|NCT01451814|65879086|FG001|Overall Study|Withdrawal by Subject|1|||
23587440|NCT01451814|65879085|FG000|Overall Study|Lost to Follow-up|5|||
23587441|NCT01451814|65879086|FG001|Overall Study|Lost to Follow-up|4|||
23587442|NCT01020838|65879095|FG000|Overall Study|Death|90|||
23587443|NCT01020838|65879095|FG000|Overall Study|Adverse Event|1|||
23587444|NCT01020838|65879095|FG000|Overall Study|Withdrawal by Subject|9|||
23587445|NCT01020838|65879095|FG000|Overall Study|Lost to Follow-up|6|||
23587446|NCT01020838|65879095|FG000|Overall Study|Most common: Study ended by sponsor|77|||
23587447|NCT01831791|65879097|FG000|Overall Study|Withdrawal by Subject|10|||
23587448|NCT00954707|65879104|FG000|Overall Study|Death|34|||
23587449|NCT00954707|65879104|FG000|Overall Study|Withdrawal by Subject|100|||
23587450|NCT00954707|65879104|FG000|Overall Study|Lost to Follow-up|33|||
23706838|NCT00002663|66301344|FG005|Overall Study|Other|1|||
23470409|NCT02704143|65466499|FG000|Overall Study|disease progression|10|||
23470410|NCT03671148|65466503|FG000|Overall Study|Adverse Event|3|||
23470411|NCT03671148|65466504|FG001|Overall Study|Adverse Event|2|||
23470412|NCT03671148|65466503|FG000|Overall Study|Withdrawal by Subject|8|||
23470413|NCT03671148|65466504|FG001|Overall Study|Withdrawal by Subject|2|||
23470414|NCT03671148|65466503|FG000|Overall Study|Lost to Follow-up|1|||
23470415|NCT03671148|65466504|FG001|Overall Study|Lost to Follow-up|2|||
23470416|NCT03671148|65466503|FG000|Overall Study|Lack of Efficacy|7|||
23470417|NCT03671148|65466504|FG001|Overall Study|Lack of Efficacy|2|||
23470418|NCT03671148|65466503|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
23587451|NCT01570751|65879105|FG000|Period A (16 Weeks)|Protocol Violation|1|||
23587452|NCT01570751|65879106|FG001|Period A (16 Weeks)|Protocol Violation|1|||
23587453|NCT01570751|65879105|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
23587454|NCT01570751|65879106|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
23587455|NCT01570751|65879105|FG000|Period A (16 Weeks)|Unclassified|2|||
23587456|NCT01570751|65879106|FG001|Period A (16 Weeks)|Unclassified|3|||
23470419|NCT03671148|65466504|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23470420|NCT03671148|65466503|FG000|Overall Study|Other|1|||
23470421|NCT03671148|65466504|FG001|Overall Study|Other|0|||
23470422|NCT03671148|65466503|FG000|Overall Study|Incomplete Randomization Visit|1|||
23470423|NCT03671148|65466504|FG001|Overall Study|Incomplete Randomization Visit|0|||
23470424|NCT01419197|65466505|FG000|Overall Study|Death|247|||
23470425|NCT01419197|65466506|FG001|Overall Study|Death|122|||
23470426|NCT01419197|65466505|FG000|Overall Study|Physician Decision|4|||
23470427|NCT01419197|65466506|FG001|Overall Study|Physician Decision|4|||
23470428|NCT01419197|65466505|FG000|Overall Study|Non-compliance|3|||
23470429|NCT01419197|65466506|FG001|Overall Study|Non-compliance|1|||
23470430|NCT01419197|65466505|FG000|Overall Study|Withdrawal by Subject|33|||
23470431|NCT01419197|65466506|FG001|Overall Study|Withdrawal by Subject|32|||
23470432|NCT01419197|65466505|FG000|Overall Study|Study Completed by Sponsor|103|||
23470433|NCT01419197|65466506|FG001|Overall Study|Study Completed by Sponsor|34|||
23470434|NCT01419197|65466505|FG000|Overall Study|Reason Not Specified|0|||
23470435|NCT01419197|65466506|FG001|Overall Study|Reason Not Specified|1|||
23470436|NCT01419197|65466505|FG000|Overall Study|Lost to Follow-up|14|||
23470437|NCT01419197|65466506|FG001|Overall Study|Lost to Follow-up|4|||
23470438|NCT01106248|65466508|FG000|Overall Study|Adverse Event|1|||
23470439|NCT01106248|65466508|FG000|Overall Study|Administrative|2|||
23470440|NCT00312195|65466511|FG000|Overall Study|Adverse Event|4|||
23470441|NCT00312195|65466512|FG001|Overall Study|Adverse Event|6|||
23470442|NCT00312195|65466511|FG000|Overall Study|Lost to Follow-up|1|||
23470443|NCT00312195|65466512|FG001|Overall Study|Lost to Follow-up|0|||
23470444|NCT00312195|65466511|FG000|Overall Study|Protocol Violation|1|||
23470445|NCT00312195|65466512|FG001|Overall Study|Protocol Violation|0|||
23470446|NCT00392769|65466513|FG000|Overall Study|Clinical Deterioration|9|||
23470447|NCT00392769|65466513|FG000|Overall Study|Adverse Event|1|||
23470448|NCT02930018|65466514|FG000|Overall Study|Lost to Follow-up|1|||
23470449|NCT02930018|65466515|FG001|Overall Study|Lost to Follow-up|1|||
23470450|NCT02930018|65466514|FG000|Overall Study|Withdrawal by Subject|5|||
23470451|NCT02930018|65466515|FG001|Overall Study|Withdrawal by Subject|2|||
23470452|NCT02252939|65466516|FG000|Overall Study|Lost to Follow-up|3|||
23470453|NCT00393861|65466517|FG000|Overall Study|Adverse Event|2|||
23470454|NCT00393861|65466517|FG000|Overall Study|Disease Progression|24|||
23470455|NCT01301027|65466518|FG000|Overall Study|Physician Decision|2|||
23470456|NCT01301027|65466519|FG001|Overall Study|Physician Decision|0|||
23470457|NCT01301027|65466518|FG000|Overall Study|Withdrawal by Subject|2|||
23470458|NCT01301027|65466519|FG001|Overall Study|Withdrawal by Subject|3|||
23470459|NCT01301027|65466518|FG000|Overall Study|Adverse Event|0|||
23470460|NCT01301027|65466519|FG001|Overall Study|Adverse Event|2|||
23470461|NCT01301027|65466518|FG000|Overall Study|Fracture|1|||
23470462|NCT01301027|65466519|FG001|Overall Study|Fracture|3|||
23470463|NCT01301027|65466518|FG000|Overall Study|Transplant|0|||
23470464|NCT01301027|65466519|FG001|Overall Study|Transplant|2|||
23470465|NCT01301027|65466518|FG000|Overall Study|Volume Overload|3|||
23470466|NCT01301027|65466519|FG001|Overall Study|Volume Overload|0|||
23470467|NCT03783078|65466522|FG000|Overall Study|Participants Ongoing|29|||
23470468|NCT03783078|65466522|FG000|Overall Study|Death|26|||
23470469|NCT03085797|65466523|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
23470470|NCT03085797|65466524|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
23470471|NCT03085797|65466523|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
23470472|NCT03085797|65466524|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
23470473|NCT03085797|65466523|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
23470474|NCT03085797|65466524|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
23470475|NCT04328077|65466525|FG000|Overall Study|Lost to Follow-up|0|||
23470476|NCT04328077|65466526|FG001|Overall Study|Lost to Follow-up|1|||
23470477|NCT04328077|65466527|FG002|Overall Study|Lost to Follow-up|0|||
23470478|NCT04328077|65466528|FG003|Overall Study|Lost to Follow-up|0|||
23470479|NCT04328077|65466525|FG000|Overall Study|Withdrawal by Subject|0|||
23470480|NCT04328077|65466526|FG001|Overall Study|Withdrawal by Subject|1|||
23470481|NCT04328077|65466527|FG002|Overall Study|Withdrawal by Subject|1|||
23470482|NCT04328077|65466528|FG003|Overall Study|Withdrawal by Subject|3|||
23470483|NCT03704636|65466529|FG000|Overall Study|Inadequate Venous Flow|3|||
23470484|NCT00452361|65466530|FG000|Overall Study|Adverse Event|8|||
23470485|NCT00452361|65466531|FG001|Overall Study|Adverse Event|0|||
23470486|NCT00452361|65466530|FG000|Overall Study|Withdrawal by Subject|0|||
23470487|NCT00452361|65466531|FG001|Overall Study|Withdrawal by Subject|1|||
23470488|NCT00452361|65466530|FG000|Overall Study|Premature termination|13|||
23470489|NCT00452361|65466531|FG001|Overall Study|Premature termination|9|||
23470490|NCT00641667|65466532|FG000|Overall Study|Withdrawal by Subject|1|||
23470491|NCT00641667|65466532|FG000|Overall Study|Adverse Event|1|||
23470492|NCT00641667|65466532|FG000|Overall Study|Physician Decision|1|||
23470493|NCT00641667|65466532|FG000|Overall Study|Worsening of underlying disease|3|||
23470494|NCT05366738|65466533|FG000|Overall Study|Adverse Event|0|||
23470495|NCT05366738|65466534|FG001|Overall Study|Adverse Event|1|||
23470496|NCT05366738|65466535|FG002|Overall Study|Adverse Event|0|||
23470497|NCT04463069|65466539|FG000|Overall Study|Withdrawal by Subject|2|||
23470498|NCT04463069|65466540|FG001|Overall Study|Withdrawal by Subject|10|||
23470499|NCT04463069|65466539|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
23470500|NCT04463069|65466540|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
23470501|NCT02067676|65466543|FG000|Overall Study|Withdrawal by Subject|1|||
23470502|NCT02067676|65466544|FG001|Overall Study|Withdrawal by Subject|0|||
23470503|NCT02067676|65466545|FG002|Overall Study|Withdrawal by Subject|0|||
23470504|NCT02067676|65466546|FG003|Overall Study|Withdrawal by Subject|0|||
23470505|NCT02067676|65466547|FG004|Overall Study|Withdrawal by Subject|0|||
23470506|NCT02067676|65466548|FG005|Overall Study|Withdrawal by Subject|0|||
23470507|NCT01358721|65466551|FG000|Overall Study|Withdrawal by Subject|0|||
23470508|NCT01358721|65466552|FG001|Overall Study|Withdrawal by Subject|0|||
23470509|NCT01358721|65466553|FG002|Overall Study|Withdrawal by Subject|0|||
23470510|NCT01358721|65466554|FG003|Overall Study|Withdrawal by Subject|1|||
23470511|NCT01358721|65466551|FG000|Overall Study|Death|0|||
23470512|NCT01358721|65466552|FG001|Overall Study|Death|2|||
23470513|NCT01358721|65466553|FG002|Overall Study|Death|0|||
23470514|NCT01358721|65466554|FG003|Overall Study|Death|0|||
23470515|NCT01358721|65466551|FG000|Overall Study|Study Drug Toxicity|1|||
23470516|NCT01358721|65466552|FG001|Overall Study|Study Drug Toxicity|3|||
23470517|NCT01358721|65466553|FG002|Overall Study|Study Drug Toxicity|4|||
23470518|NCT01358721|65466554|FG003|Overall Study|Study Drug Toxicity|5|||
23470519|NCT01358721|65466551|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
23470520|NCT01358721|65466552|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
23470521|NCT01358721|65466553|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
23470522|NCT01358721|65466554|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
23470523|NCT01358721|65466551|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23470524|NCT01358721|65466552|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23470525|NCT01358721|65466553|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23470526|NCT01358721|65466554|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
23470527|NCT01358721|65466551|FG000|Overall Study|Adverse Event related to study drug|1|||
23706839|NCT00002663|66301345|FG006|Overall Study|Other|1|||
23794920|NCT00609154|66626539|FG000|Overall Study|Unable to establish IV access|0|||
23794921|NCT00609154|66626540|FG001|Overall Study|Unable to establish IV access|4|||
23794922|NCT00609154|66626539|FG000|Overall Study|Adverse Event|0|||
23794923|NCT00609154|66626540|FG001|Overall Study|Adverse Event|2|||
23794924|NCT00329160|66626554|FG000|Overall Study|Adverse Event|27|||
23794925|NCT00329160|66626554|FG000|Overall Study|Withdrawal by Subject|13|||
23794926|NCT00329160|66626554|FG000|Overall Study|Protocol Violation|2|||
23794927|NCT00329160|66626554|FG000|Overall Study|Did not Receive Study Drug|1|||
23794928|NCT00329160|66626554|FG000|Overall Study|Incomplete IVUS|45|||
23794929|NCT01109849|66626556|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
23794930|NCT01109849|66626557|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
23794931|NCT01109849|66626558|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23794932|NCT01109849|66626559|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23470528|NCT01358721|65466552|FG001|Overall Study|Adverse Event related to study drug|0|||
23794933|NCT01109849|66626560|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23470529|NCT01358721|65466553|FG002|Overall Study|Adverse Event related to study drug|0|||
23470530|NCT01358721|65466554|FG003|Overall Study|Adverse Event related to study drug|1|||
23794934|NCT01109849|66626556|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
23794935|NCT01109849|66626557|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23794936|NCT01109849|66626558|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23794937|NCT01109849|66626559|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23794938|NCT01109849|66626560|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23794939|NCT01109849|66626556|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
23794940|NCT01109849|66626557|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
23794941|NCT01109849|66626558|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23794942|NCT01109849|66626559|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23794943|NCT01109849|66626560|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23794944|NCT01109849|66626556|FG000|Initial Randomization: ADHD Treatment|move away|2|||
23794945|NCT01109849|66626557|FG001|Initial Randomization: ADHD Treatment|move away|7|||
23794946|NCT01109849|66626558|FG002|Initial Randomization: ADHD Treatment|move away|0|||
23794947|NCT01109849|66626559|FG003|Initial Randomization: ADHD Treatment|move away|0|||
23794948|NCT01109849|66626560|FG004|Initial Randomization: ADHD Treatment|move away|0|||
23794949|NCT01109849|66626556|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
23794950|NCT01109849|66626557|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
23794951|NCT01109849|66626558|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23794952|NCT01109849|66626559|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23794953|NCT01109849|66626560|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23794954|NCT01109849|66626556|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
23794955|NCT01109849|66626557|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
23794956|NCT01109849|66626558|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
23794957|NCT01109849|66626559|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
23794958|NCT01109849|66626560|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
23794959|NCT00880334|66626563|FG000|Randomized Phase|Physician Decision|1|||
23794960|NCT00880334|66626564|FG001|Randomized Phase|Physician Decision|0|||
23794961|NCT00880334|66626563|FG000|Randomized Phase|Withdrawal by Subject|2|||
23794962|NCT00880334|66626564|FG001|Randomized Phase|Withdrawal by Subject|1|||
23794963|NCT00880334|66626563|FG000|Randomized Phase|Inadequate Labs|1|||
23794964|NCT00880334|66626564|FG001|Randomized Phase|Inadequate Labs|1|||
23794965|NCT00880334|66626563|FG000|Randomized Phase|Brain Metastasis|0|||
23794966|NCT00880334|66626564|FG001|Randomized Phase|Brain Metastasis|1|||
23794967|NCT00880334|66626563|FG000|Randomized Phase|Crossover Participants|0|||
23794968|NCT00880334|66626564|FG001|Randomized Phase|Crossover Participants|37|||
23794969|NCT01685216|66626568|FG000|Overall Study|Did not receive study drug|1|||
23794970|NCT04801420|66626574|FG000|Overall Study|Other|1|||
23794971|NCT04801420|66626575|FG001|Overall Study|Other|2|||
23794972|NCT04801420|66626576|FG002|Overall Study|Other|1|||
23794973|NCT04801420|66626574|FG000|Overall Study|Lost to Follow-up|7|||
23794974|NCT04801420|66626575|FG001|Overall Study|Lost to Follow-up|9|||
23794975|NCT04801420|66626576|FG002|Overall Study|Lost to Follow-up|10|||
23794976|NCT04801420|66626574|FG000|Overall Study|Moved from study area|0|||
23794977|NCT04801420|66626575|FG001|Overall Study|Moved from study area|1|||
23794978|NCT04801420|66626576|FG002|Overall Study|Moved from study area|1|||
23794979|NCT04801420|66626574|FG000|Overall Study|Withdrawal by Subject|5|||
23794980|NCT04801420|66626575|FG001|Overall Study|Withdrawal by Subject|1|||
23794981|NCT04801420|66626576|FG002|Overall Study|Withdrawal by Subject|4|||
23794982|NCT04801420|66626574|FG000|Overall Study|Individual stopping criteria reached|0|||
23794983|NCT04801420|66626575|FG001|Overall Study|Individual stopping criteria reached|1|||
23354139|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23470531|NCT01358721|65466551|FG000|Overall Study|Disease Progression|19|||
23587457|NCT01570751|65879105|FG000|Period B (16 Weeks)|Adverse Event|1|||
23587458|NCT01570751|65879106|FG001|Period B (16 Weeks)|Adverse Event|0|||
23587459|NCT01570751|65879105|FG000|Period B (16 Weeks)|Protocol Violation|0|||
23794984|NCT04801420|66626576|FG002|Overall Study|Individual stopping criteria reached|0|||
23794985|NCT04801420|66626574|FG000|Overall Study|Ongoing in the study|195|||
23794986|NCT04801420|66626575|FG001|Overall Study|Ongoing in the study|195|||
23794987|NCT04801420|66626576|FG002|Overall Study|Ongoing in the study|192|||
23794988|NCT04599166|66626580|FG000|Overall Study|Technological failure connecting to study app|80|||
23794989|NCT01557751|66626581|FG000|Overall Study|Physician Decision|3|||
23794990|NCT01055834|66626585|FG000|Treatment Period I|Adverse Event|1|||
23587460|NCT01570751|65879106|FG001|Period B (16 Weeks)|Protocol Violation|1|||
23354140|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
23587461|NCT00487578|65879107|FG000|Overall Study|Adverse Event|1|||
23587462|NCT00487578|65879108|FG001|Overall Study|Adverse Event|2|||
23587463|NCT00487578|65879107|FG000|Overall Study|Lack of Efficacy|0|||
23587464|NCT00487578|65879108|FG001|Overall Study|Lack of Efficacy|1|||
23587465|NCT00487578|65879107|FG000|Overall Study|Lost to Follow-up|0|||
23587466|NCT00487578|65879108|FG001|Overall Study|Lost to Follow-up|1|||
23354141|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23587467|NCT03395353|65879110|FG000|Overall Study|Adverse Event|20|||
23354142|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23354143|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23587468|NCT03395353|65879110|FG000|Overall Study|Protocol Violation|1|||
23587469|NCT03395353|65879110|FG000|Overall Study|Lack of Efficacy|3|||
23470532|NCT01358721|65466552|FG001|Overall Study|Disease Progression|15|||
23470533|NCT01358721|65466553|FG002|Overall Study|Disease Progression|17|||
23470534|NCT01358721|65466554|FG003|Overall Study|Disease Progression|15|||
23470535|NCT01358721|65466551|FG000|Overall Study|Out of State/Unmet Criteria|0|||
23470536|NCT01358721|65466552|FG001|Overall Study|Out of State/Unmet Criteria|0|||
23470537|NCT01358721|65466553|FG002|Overall Study|Out of State/Unmet Criteria|1|||
23640852|NCT04552899|66071479|FG000|Overall Study|Study Terminated By Sponsor|237|||
23640853|NCT04552899|66071480|FG001|Overall Study|Study Terminated By Sponsor|239|||
23640854|NCT04552899|66071479|FG000|Overall Study|Withdrawal by Subject|15|||
23640855|NCT04552899|66071480|FG001|Overall Study|Withdrawal by Subject|17|||
23640856|NCT03292432|66071481|FG000|Overall Study|Lost to Follow-up|11|||
23640857|NCT03292432|66071482|FG001|Overall Study|Lost to Follow-up|8|||
23640858|NCT03292432|66071481|FG000|Overall Study|Death|2|||
23640859|NCT03292432|66071482|FG001|Overall Study|Death|1|||
23640860|NCT03292432|66071481|FG000|Overall Study|Withdrawal by Subject|1|||
23640861|NCT03292432|66071482|FG001|Overall Study|Withdrawal by Subject|2|||
23640862|NCT03292432|66071481|FG000|Overall Study|Site closed before any data collected|1|||
23640863|NCT03292432|66071482|FG001|Overall Study|Site closed before any data collected|0|||
23640864|NCT01081665|66071483|FG000|Overall Study|Death|41|||
23640865|NCT01081665|66071483|FG000|Overall Study|Lost to Follow-up|18|||
23640866|NCT01081665|66071483|FG000|Overall Study|Withdrawal by Subject|17|||
23640867|NCT01081665|66071483|FG000|Overall Study|Change of dialysis unit|10|||
23640868|NCT01081665|66071483|FG000|Overall Study|Regulation of iPTH|5|||
23640869|NCT01081665|66071483|FG000|Overall Study|Change in renal replacement therapy|2|||
23640870|NCT01081665|66071483|FG000|Overall Study|Adverse Event|1|||
23640871|NCT01081665|66071483|FG000|Overall Study|Lack of Efficacy|1|||
23640872|NCT01712659|66071484|FG000|Dose Escalation|Physician Decision|0|||
23640873|NCT01712659|66071485|FG001|Dose Escalation|Physician Decision|1|||
23640874|NCT01712659|66071486|FG002|Dose Escalation|Physician Decision|0|||
23640875|NCT01712659|66071487|FG003|Dose Escalation|Physician Decision|0|||
23640876|NCT01712659|66071488|FG004|Dose Escalation|Physician Decision|0|||
23640877|NCT01712659|66071484|FG000|Dose Escalation|Unable to take study drug|0|||
23640878|NCT01712659|66071485|FG001|Dose Escalation|Unable to take study drug|1|||
23640879|NCT01712659|66071486|FG002|Dose Escalation|Unable to take study drug|0|||
23640880|NCT01712659|66071487|FG003|Dose Escalation|Unable to take study drug|0|||
23640881|NCT01712659|66071488|FG004|Dose Escalation|Unable to take study drug|0|||
23640882|NCT01712659|66071484|FG000|Dose Expansion|Early disease progression|1|||
23640883|NCT01712659|66071485|FG001|Dose Expansion|Early disease progression|0|||
23470538|NCT01358721|65466554|FG003|Overall Study|Out of State/Unmet Criteria|0|||
23470539|NCT00068419|65466555|FG000|Overall Study|Adverse Event|3|||
23470540|NCT00068419|65466555|FG000|Overall Study|Lack of Efficacy|24|||
23470541|NCT00068419|65466555|FG000|Overall Study|Lost to Follow-up|1|||
23470542|NCT00068419|65466555|FG000|Overall Study|Physician Decision|7|||
23640884|NCT01712659|66071486|FG002|Dose Expansion|Early disease progression|0|||
23640885|NCT01712659|66071487|FG003|Dose Expansion|Early disease progression|0|||
23640886|NCT01712659|66071488|FG004|Dose Expansion|Early disease progression|0|||
23640887|NCT01712659|66071484|FG000|Dose Expansion|Physician Decision|1|||
23640888|NCT01712659|66071485|FG001|Dose Expansion|Physician Decision|0|||
23640889|NCT01712659|66071486|FG002|Dose Expansion|Physician Decision|0|||
23640890|NCT01712659|66071487|FG003|Dose Expansion|Physician Decision|0|||
23640891|NCT01712659|66071488|FG004|Dose Expansion|Physician Decision|0|||
23587470|NCT03395353|65879110|FG000|Overall Study|Withdrawal by Subject|24|||
23354144|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
23354145|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23587471|NCT03395353|65879110|FG000|Overall Study|Discontinued visit|1|||
23587472|NCT03395353|65879110|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
23587473|NCT03395353|65879110|FG000|Overall Study|Physician Decision|4|||
23587474|NCT03395353|65879110|FG000|Overall Study|Early termination of overall study|33|||
23587475|NCT04842604|65879114|FG000|Overall Study|Death|1|||
23587476|NCT04842604|65879115|FG001|Overall Study|Death|0|||
23640892|NCT05007080|66071489|FG000|Overall Study|Lost to Follow-up|0|||
23640893|NCT05007080|66071490|FG001|Overall Study|Lost to Follow-up|1|||
23354146|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23640894|NCT05007080|66071491|FG002|Overall Study|Lost to Follow-up|0|||
23587477|NCT04842604|65879114|FG000|Overall Study|Other|4|||
23587478|NCT04842604|65879115|FG001|Overall Study|Other|4|||
23354147|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354148|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
23354149|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354150|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354151|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23587479|NCT04842604|65879114|FG000|Overall Study|Randomized but not treated|1|||
23794991|NCT01055834|66626586|FG001|Treatment Period I|Adverse Event|0|||
23794992|NCT02832167|66626587|FG000|Treatment Period 1|Disease progression|90|||
23794993|NCT02832167|66626587|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
23794994|NCT02832167|66626587|FG000|Treatment Period 1|Death|2|||
23794995|NCT02832167|66626587|FG000|Treatment Period 1|Study Drug Toxicity|6|||
23794996|NCT02832167|66626587|FG000|Treatment Period 1|Participant request to discontinue|9|||
23794997|NCT02832167|66626587|FG000|Treatment Period 1|No longer meet study criteria|1|||
23794998|NCT02832167|66626587|FG000|Treatment Period 1|Participant withdrew consent|3|||
23794999|NCT02832167|66626587|FG000|Treatment Period 1|Other reasons|6|||
23795000|NCT02832167|66626587|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
23795001|NCT02832167|66626587|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
23795002|NCT02832167|66626587|FG000|Transition From Period 1 to Period 2|Death|2|||
23795003|NCT02832167|66626587|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
23795004|NCT02832167|66626587|FG000|Treatment Period 2|Disease progression|69|||
23795005|NCT02832167|66626587|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
23795006|NCT02832167|66626587|FG000|Treatment Period 2|Maximum clinical benefit|1|||
23795007|NCT02832167|66626587|FG000|Treatment Period 2|Study Drug Toxicity|5|||
23795008|NCT02832167|66626587|FG000|Treatment Period 2|Participant request to discontinue|2|||
23795009|NCT02832167|66626587|FG000|Treatment Period 2|Participant withdrew consent|3|||
23795010|NCT02832167|66626587|FG000|Treatment Period 2|Other reasons|3|||
23795011|NCT01853176|66626588|FG000|Overall Study|Study terminated|4|||
23795012|NCT01853176|66626589|FG001|Overall Study|Study terminated|0|||
23795013|NCT02654015|66626590|FG000|Overall Study|Death|12|||
23587480|NCT04842604|65879115|FG001|Overall Study|Randomized but not treated|0|||
23587481|NCT00408928|65879122|FG000|Overall Study|Withdrawal by Subject|1|||
23587482|NCT00408928|65879122|FG000|Overall Study|Death|1|||
23795014|NCT02654015|66626590|FG000|Overall Study|Lost to Follow-up|3|||
23795015|NCT00939523|66626600|FG000|Overall Study|Lack of Efficacy|1|||
23795016|NCT00939523|66626600|FG000|Overall Study|Physician Decision|2|||
23795017|NCT00381849|66626601|FG000|Wash Out|Withdrawal by Subject|0|||
23795018|NCT00381849|66626602|FG001|Wash Out|Withdrawal by Subject|1|||
23795019|NCT01958060|66626603|FG000|Overall Study|Not treated|2|||
23795020|NCT01958060|66626604|FG001|Overall Study|Not treated|0|||
23795021|NCT01958060|66626605|FG002|Overall Study|Not treated|0|||
23795022|NCT01958060|66626606|FG003|Overall Study|Not treated|0|||
23795023|NCT01958060|66626607|FG004|Overall Study|Not treated|1|||
23795024|NCT01958060|66626608|FG005|Overall Study|Not treated|0|||
23795025|NCT04232540|66626610|FG000|Overall Study|Lost to Follow-up|1|||
23795026|NCT04232540|66626611|FG001|Overall Study|Lost to Follow-up|0|||
23795027|NCT00676650|66626612|FG000|Overall Study|Death|45|||
23587483|NCT00408928|65879122|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
23587484|NCT03125382|65879133|FG000|Randomization|screening failure|1|||
23587485|NCT03125382|65879134|FG001|Randomization|screening failure|4|||
23587486|NCT03125382|65879135|FG002|Randomization|screening failure|2|||
23587487|NCT03125382|65879136|FG003|Randomization|screening failure|0|||
23587488|NCT03125382|65879133|FG000|Follow-up|Death|1|||
23587489|NCT03125382|65879134|FG001|Follow-up|Death|2|||
23587490|NCT03125382|65879135|FG002|Follow-up|Death|1|||
23587491|NCT03125382|65879136|FG003|Follow-up|Death|2|||
23587492|NCT03125382|65879133|FG000|Follow-up|Lost to Follow-up|1|||
23587493|NCT03125382|65879134|FG001|Follow-up|Lost to Follow-up|4|||
23587494|NCT03125382|65879135|FG002|Follow-up|Lost to Follow-up|3|||
23587495|NCT03125382|65879136|FG003|Follow-up|Lost to Follow-up|1|||
23587496|NCT02674750|65879145|FG000|Overall Study|Death|4|||
23587497|NCT02674750|65879146|FG001|Overall Study|Death|5|||
23587498|NCT02674750|65879147|FG002|Overall Study|Death|8|||
23640895|NCT05007080|66071492|FG003|Overall Study|Lost to Follow-up|1|||
23640896|NCT05007080|66071493|FG004|Overall Study|Lost to Follow-up|1|||
23640897|NCT05007080|66071494|FG005|Overall Study|Lost to Follow-up|1|||
23795028|NCT00676650|66626613|FG001|Overall Study|Death|14|||
23795029|NCT00676650|66626612|FG000|Overall Study|Adverse Event|159|||
23795030|NCT00676650|66626613|FG001|Overall Study|Adverse Event|21|||
23795031|NCT00676650|66626612|FG000|Overall Study|Global deterioration of health status|66|||
23795032|NCT00676650|66626613|FG001|Overall Study|Global deterioration of health status|31|||
23795033|NCT00676650|66626612|FG000|Overall Study|Lost to Follow-up|0|||
23795034|NCT00676650|66626613|FG001|Overall Study|Lost to Follow-up|1|||
23795035|NCT00676650|66626612|FG000|Overall Study|Objective progression or relapse|189|||
23795036|NCT00676650|66626613|FG001|Overall Study|Objective progression or relapse|140|||
23587499|NCT02674750|65879145|FG000|Overall Study|Lost to Follow-up|0|||
23587500|NCT02674750|65879146|FG001|Overall Study|Lost to Follow-up|8|||
23640898|NCT05007080|66071489|FG000|Overall Study|Death|0|||
23587501|NCT02674750|65879147|FG002|Overall Study|Lost to Follow-up|0|||
23587502|NCT02674750|65879145|FG000|Overall Study|Lack of Efficacy|1|||
23587503|NCT02674750|65879146|FG001|Overall Study|Lack of Efficacy|17|||
23587504|NCT02674750|65879147|FG002|Overall Study|Lack of Efficacy|3|||
23587505|NCT02674750|65879145|FG000|Overall Study|Withdrawal by Subject|0|||
23587506|NCT02674750|65879146|FG001|Overall Study|Withdrawal by Subject|7|||
23587507|NCT02674750|65879147|FG002|Overall Study|Withdrawal by Subject|1|||
23587508|NCT02674750|65879145|FG000|Overall Study|Other|0|||
23587509|NCT02674750|65879146|FG001|Overall Study|Other|8|||
23587510|NCT02674750|65879147|FG002|Overall Study|Other|0|||
23587511|NCT00878722|65879152|FG000|Overall Study|Progressive disease|3|||
23587512|NCT00878722|65879153|FG001|Overall Study|Progressive disease|3|||
23587513|NCT00878722|65879154|FG002|Overall Study|Progressive disease|3|||
23587514|NCT00878722|65879155|FG003|Overall Study|Progressive disease|7|||
23587515|NCT00878722|65879156|FG004|Overall Study|Progressive disease|7|||
23587516|NCT00878722|65879157|FG005|Overall Study|Progressive disease|1|||
23587517|NCT00878722|65879158|FG006|Overall Study|Progressive disease|4|||
23587518|NCT00878722|65879159|FG007|Overall Study|Progressive disease|3|||
23587519|NCT00878722|65879152|FG000|Overall Study|Death|0|||
23587520|NCT00878722|65879153|FG001|Overall Study|Death|0|||
23587521|NCT00878722|65879154|FG002|Overall Study|Death|0|||
23587522|NCT00878722|65879155|FG003|Overall Study|Death|1|||
23640899|NCT05007080|66071490|FG001|Overall Study|Death|1|||
23640900|NCT05007080|66071491|FG002|Overall Study|Death|0|||
23640901|NCT05007080|66071492|FG003|Overall Study|Death|0|||
23640902|NCT05007080|66071493|FG004|Overall Study|Death|0|||
23640903|NCT05007080|66071494|FG005|Overall Study|Death|0|||
23640904|NCT05007080|66071489|FG000|Overall Study|Withdrawal by Subject|1|||
23640905|NCT05007080|66071490|FG001|Overall Study|Withdrawal by Subject|2|||
23640906|NCT05007080|66071491|FG002|Overall Study|Withdrawal by Subject|0|||
23640907|NCT05007080|66071492|FG003|Overall Study|Withdrawal by Subject|2|||
23640908|NCT05007080|66071493|FG004|Overall Study|Withdrawal by Subject|1|||
23640909|NCT05007080|66071494|FG005|Overall Study|Withdrawal by Subject|1|||
23640910|NCT05007080|66071489|FG000|Overall Study|Other|1|||
23640911|NCT05007080|66071490|FG001|Overall Study|Other|0|||
23640912|NCT05007080|66071491|FG002|Overall Study|Other|1|||
23640913|NCT05007080|66071492|FG003|Overall Study|Other|1|||
23640914|NCT05007080|66071493|FG004|Overall Study|Other|0|||
23640915|NCT05007080|66071494|FG005|Overall Study|Other|2|||
23640916|NCT05007080|66071489|FG000|Overall Study|Randomized not vaccinated|0|||
23640917|NCT05007080|66071490|FG001|Overall Study|Randomized not vaccinated|0|||
23640918|NCT05007080|66071491|FG002|Overall Study|Randomized not vaccinated|0|||
23354152|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
23354153|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23354154|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23354155|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354156|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
23354157|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354158|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354159|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354160|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
23354161|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354162|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354163|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354164|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
23354165|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354166|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354167|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354168|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
23354169|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354170|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354171|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354172|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
23640919|NCT05007080|66071492|FG003|Overall Study|Randomized not vaccinated|0|||
23354173|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354174|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354175|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23587523|NCT00878722|65879156|FG004|Overall Study|Death|0|||
23587524|NCT00878722|65879157|FG005|Overall Study|Death|1|||
23640920|NCT05007080|66071493|FG004|Overall Study|Randomized not vaccinated|0|||
23587525|NCT00878722|65879158|FG006|Overall Study|Death|0|||
23587526|NCT00878722|65879159|FG007|Overall Study|Death|2|||
23587527|NCT00878722|65879152|FG000|Overall Study|Adverse Event|0|||
23587528|NCT00878722|65879153|FG001|Overall Study|Adverse Event|0|||
23640921|NCT05007080|66071494|FG005|Overall Study|Randomized not vaccinated|1|||
23795037|NCT00676650|66626612|FG000|Overall Study|Other|14|||
23795038|NCT00676650|66626613|FG001|Overall Study|Other|10|||
23795039|NCT00676650|66626612|FG000|Overall Study|Protocol Violation|3|||
23795040|NCT00676650|66626613|FG001|Overall Study|Protocol Violation|1|||
23795041|NCT00676650|66626612|FG000|Overall Study|Study terminated by sponsor|57|||
23795042|NCT00676650|66626613|FG001|Overall Study|Study terminated by sponsor|43|||
23795043|NCT00676650|66626612|FG000|Overall Study|Withdrawal by Subject|48|||
23795044|NCT00676650|66626613|FG001|Overall Study|Withdrawal by Subject|24|||
23795045|NCT00676650|66626612|FG000|Overall Study|Randomized but not treated|3|||
23795046|NCT00676650|66626613|FG001|Overall Study|Randomized but not treated|4|||
23795047|NCT00942734|66626618|FG000|Overall Study|Adverse Event|2|||
23795048|NCT00942734|66626618|FG000|Overall Study|Protocol Violation|3|||
23795049|NCT00942734|66626618|FG000|Overall Study|Disease Progression|2|||
23795050|NCT00942734|66626618|FG000|Overall Study|Physician Decision|1|||
23354176|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
23354177|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354178|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354179|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
23354180|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
23354181|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
23354182|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
23354183|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
23354184|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
23587529|NCT00878722|65879154|FG002|Overall Study|Adverse Event|0|||
23795051|NCT01015287|66626619|FG000|Overall Study|Death|21|||
23795052|NCT01015287|66626620|FG001|Overall Study|Death|16|||
23795053|NCT01015287|66626619|FG000|Overall Study|Adverse Event|1|||
23795054|NCT01015287|66626620|FG001|Overall Study|Adverse Event|0|||
23795055|NCT01015287|66626619|FG000|Overall Study|Sponsor Decision|3|||
23795056|NCT01015287|66626620|FG001|Overall Study|Sponsor Decision|7|||
23795057|NCT01015287|66626619|FG000|Overall Study|Physician Decision|19|||
23795058|NCT01015287|66626620|FG001|Overall Study|Physician Decision|21|||
23795059|NCT01015287|66626619|FG000|Overall Study|Withdrawal by Subject|14|||
23795060|NCT01015287|66626620|FG001|Overall Study|Withdrawal by Subject|19|||
23795061|NCT01015287|66626619|FG000|Overall Study|Entry Criteria not Met|11|||
23795062|NCT01015287|66626620|FG001|Overall Study|Entry Criteria not Met|14|||
23795063|NCT01015287|66626619|FG000|Overall Study|Lost to Follow-up|2|||
23795064|NCT01015287|66626620|FG001|Overall Study|Lost to Follow-up|1|||
23795065|NCT01015287|66626619|FG000|Overall Study|Protocol Violation|1|||
23795066|NCT01015287|66626620|FG001|Overall Study|Protocol Violation|1|||
23795067|NCT00559637|66626621|FG000|Overall Study|Adverse Event|22|||
23795068|NCT00559637|66626621|FG000|Overall Study|Withdrawal by Subject|4|||
23354185|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
23354186|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
23354187|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
23587530|NCT00878722|65879155|FG003|Overall Study|Adverse Event|0|||
23587531|NCT00878722|65879156|FG004|Overall Study|Adverse Event|0|||
23587532|NCT00878722|65879157|FG005|Overall Study|Adverse Event|0|||
23587533|NCT00878722|65879158|FG006|Overall Study|Adverse Event|2|||
23587534|NCT00878722|65879159|FG007|Overall Study|Adverse Event|0|||
23587535|NCT00878722|65879152|FG000|Overall Study|Withdrawal by Subject|0|||
23587536|NCT00878722|65879153|FG001|Overall Study|Withdrawal by Subject|0|||
23795069|NCT00559637|66626621|FG000|Overall Study|Protocol Violation|6|||
23795070|NCT00559637|66626621|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
23795071|NCT00559637|66626621|FG000|Overall Study|Failure to return|6|||
23795072|NCT00559637|66626621|FG000|Overall Study|Insufficient response|3|||
23795073|NCT00559637|66626621|FG000|Overall Study|Started requiring dialysis after month 7|2|||
23795074|NCT00559637|66626621|FG000|Overall Study|Suspected lung cancer|1|||
23795075|NCT00559637|66626621|FG000|Overall Study|Participation in another study|1|||
23795076|NCT00559637|66626621|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
23795077|NCT00559637|66626621|FG000|Overall Study|Change of center|1|||
23354188|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
23640922|NCT00620282|66071497|FG000|Overall Study|Adverse Event|0|||
23640923|NCT00620282|66071498|FG001|Overall Study|Adverse Event|1|||
23640924|NCT00620282|66071499|FG002|Overall Study|Adverse Event|0|||
23640925|NCT00620282|66071497|FG000|Overall Study|Arterial line unable to be placed|0|||
23640926|NCT00620282|66071498|FG001|Overall Study|Arterial line unable to be placed|0|||
23640927|NCT00620282|66071499|FG002|Overall Study|Arterial line unable to be placed|1|||
23640928|NCT00620282|66071497|FG000|Overall Study|Withdrawal by Subject|0|||
23640929|NCT00620282|66071498|FG001|Overall Study|Withdrawal by Subject|1|||
23640930|NCT00620282|66071499|FG002|Overall Study|Withdrawal by Subject|0|||
23354189|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
23354190|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
23795078|NCT00559637|66626621|FG000|Overall Study|Change of home|1|||
23795079|NCT00559637|66626621|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
23795080|NCT03732833|66626630|FG000|Overall Study|Adverse Event|0|||
23354191|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
23354192|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
23354193|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
23354194|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
23795081|NCT03732833|66626631|FG001|Overall Study|Adverse Event|3|||
23795082|NCT03732833|66626632|FG002|Overall Study|Adverse Event|1|||
23354195|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
23640931|NCT04189952|66071500|FG000|Follow-up Period|Death|1|||
23640932|NCT04189952|66071500|FG000|Follow-up Period|Withdrawal by Subject|1|||
23640933|NCT01215188|66071503|FG000|Overall Study|Lost to Follow-up|22|||
23640934|NCT01215188|66071504|FG001|Overall Study|Lost to Follow-up|22|||
23640935|NCT01215188|66071505|FG002|Overall Study|Lost to Follow-up|16|||
23640936|NCT01215188|66071503|FG000|Overall Study|Adverse Event|1|||
23640937|NCT01215188|66071504|FG001|Overall Study|Adverse Event|1|||
23640938|NCT01215188|66071505|FG002|Overall Study|Adverse Event|3|||
23640939|NCT01215188|66071503|FG000|Overall Study|Physician Decision|2|||
23640940|NCT01215188|66071504|FG001|Overall Study|Physician Decision|1|||
23640941|NCT01215188|66071505|FG002|Overall Study|Physician Decision|0|||
23640942|NCT01215188|66071503|FG000|Overall Study|Lack of Efficacy|0|||
23640943|NCT01215188|66071504|FG001|Overall Study|Lack of Efficacy|0|||
23354196|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
23354197|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
23354198|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
23354199|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354200|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354201|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
23354202|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354203|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
23470543|NCT00068419|65466555|FG000|Overall Study|Withdrawal by Subject|14|||
23470544|NCT00068419|65466555|FG000|Overall Study|Ineligible|11|||
23470545|NCT02194985|65466556|FG000|Overall Study|Adverse Event|1|||
23470546|NCT02194985|65466556|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
23470547|NCT02194985|65466556|FG000|Overall Study|Physician Decision|4|||
23470548|NCT02194985|65466556|FG000|Overall Study|Lost to Follow-up|1|||
23470549|NCT02194985|65466556|FG000|Overall Study|Withdrawal by Subject|2|||
23470550|NCT03120351|65466557|FG000|Overall Study|Physician Decision|1|||
23470551|NCT03120351|65466558|FG001|Overall Study|Physician Decision|1|||
23470552|NCT01818752|65466562|FG000|Overall Study|Adverse Event|64|||
23470553|NCT01818752|65466563|FG001|Overall Study|Adverse Event|74|||
23470554|NCT01818752|65466562|FG000|Overall Study|Death|14|||
23470555|NCT01818752|65466563|FG001|Overall Study|Death|18|||
23640944|NCT01215188|66071505|FG002|Overall Study|Lack of Efficacy|1|||
23640945|NCT01215188|66071503|FG000|Overall Study|Protocol Violation|1|||
23640946|NCT01215188|66071504|FG001|Overall Study|Protocol Violation|1|||
23795083|NCT03732833|66626630|FG000|Overall Study|Withdrawal by Subject|11|||
23470556|NCT01818752|65466562|FG000|Overall Study|Non-compliance|16|||
23640947|NCT01215188|66071505|FG002|Overall Study|Protocol Violation|1|||
23640948|NCT01215188|66071503|FG000|Overall Study|Withdrawal by Subject|32|||
23795084|NCT03732833|66626631|FG001|Overall Study|Withdrawal by Subject|13|||
23470557|NCT01818752|65466563|FG001|Overall Study|Non-compliance|20|||
23470558|NCT01818752|65466562|FG000|Overall Study|Withdrawal by Subject|15|||
23470559|NCT01818752|65466563|FG001|Overall Study|Withdrawal by Subject|14|||
23470560|NCT01818752|65466562|FG000|Overall Study|Physician Decision|9|||
23470561|NCT01818752|65466563|FG001|Overall Study|Physician Decision|8|||
23470562|NCT01818752|65466562|FG000|Overall Study|Disease Progression|54|||
23470563|NCT01818752|65466563|FG001|Overall Study|Disease Progression|48|||
23470564|NCT01818752|65466562|FG000|Overall Study|Other|7|||
23470565|NCT01818752|65466563|FG001|Overall Study|Other|8|||
23470566|NCT01818752|65466562|FG000|Overall Study|Continuing Treatment|1|||
23470567|NCT01818752|65466563|FG001|Overall Study|Continuing Treatment|4|||
23470568|NCT01818752|65466562|FG000|Overall Study|Randomized but not Dosed|7|||
23470569|NCT01818752|65466563|FG001|Overall Study|Randomized but not Dosed|4|||
23470570|NCT02504216|65466564|FG000|Overall Study|Lost to Follow-up|3|||
23470571|NCT02504216|65466565|FG001|Overall Study|Lost to Follow-up|3|||
23470572|NCT02504216|65466564|FG000|Overall Study|Withdrawal by Subject|8|||
23470573|NCT02504216|65466565|FG001|Overall Study|Withdrawal by Subject|12|||
23470574|NCT00476229|65466566|FG000|Overall Study|Progressive shortness of breath|1|||
23470575|NCT02657408|65466567|FG000|Overall Study|Adverse Event|3|||
23470576|NCT02657408|65466568|FG001|Overall Study|Adverse Event|7|||
23470577|NCT01733680|65466569|FG000|Overall Study|Withdrawal by Subject|0|||
23470578|NCT01733680|65466570|FG001|Overall Study|Withdrawal by Subject|1|||
23470579|NCT01297491|65466572|FG000|Overall Study|Adverse Event|11|||
23470580|NCT01297491|65466573|FG001|Overall Study|Adverse Event|6|||
23470581|NCT01297491|65466572|FG000|Overall Study|Physician Decision|3|||
23470582|NCT01297491|65466573|FG001|Overall Study|Physician Decision|2|||
23470583|NCT01297491|65466572|FG000|Overall Study|Progressive disease|11|||
23470584|NCT01297491|65466573|FG001|Overall Study|Progressive disease|20|||
23470585|NCT01297491|65466572|FG000|Overall Study|Patient/Guardian decision|3|||
23470586|NCT01297491|65466573|FG001|Overall Study|Patient/Guardian decision|4|||
23470587|NCT01297491|65466572|FG000|Overall Study|Death|2|||
23470588|NCT01297491|65466573|FG001|Overall Study|Death|1|||
23470589|NCT03313037|65466574|FG000|Overall Study|Protocol Violation|4|||
23470590|NCT03313037|65466575|FG001|Overall Study|Protocol Violation|1|||
23470591|NCT03313037|65466574|FG000|Overall Study|Other|1|||
23470592|NCT03313037|65466575|FG001|Overall Study|Other|1|||
23470593|NCT03313037|65466574|FG000|Overall Study|Withdrawal by Subject|4|||
23470594|NCT03313037|65466575|FG001|Overall Study|Withdrawal by Subject|3|||
23470595|NCT03313037|65466574|FG000|Overall Study|No longer meets eligibility criteria|1|||
23470596|NCT03313037|65466575|FG001|Overall Study|No longer meets eligibility criteria|7|||
23470597|NCT03313037|65466574|FG000|Overall Study|Lost to Follow-up|9|||
23470598|NCT03313037|65466575|FG001|Overall Study|Lost to Follow-up|8|||
23470599|NCT03313037|65466574|FG000|Overall Study|Randomized but not treated|1|||
23470600|NCT03313037|65466575|FG001|Overall Study|Randomized but not treated|0|||
23470601|NCT02054104|65466578|FG000|Overall Study|Did not want to continue due to college classes|1|||
23470602|NCT02054104|65466579|FG001|Overall Study|Did not want to continue due to college classes|0|||
23470603|NCT02054104|65466578|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
23470604|NCT02054104|65466579|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
23470605|NCT02054104|65466578|FG000|Overall Study|No evidence of immunologic response|2|||
23470606|NCT02054104|65466579|FG001|Overall Study|No evidence of immunologic response|2|||
23470607|NCT02054104|65466578|FG000|Overall Study|Disease Progression On Study|4|||
23470608|NCT02054104|65466579|FG001|Overall Study|Disease Progression On Study|5|||
23470609|NCT02054104|65466578|FG000|Overall Study|Diagnosis of lymphoma|0|||
23470610|NCT02054104|65466579|FG001|Overall Study|Diagnosis of lymphoma|1|||
23470611|NCT02054104|65466578|FG000|Overall Study|Inconclusive response|0|||
23470612|NCT02054104|65466579|FG001|Overall Study|Inconclusive response|1|||
23470613|NCT00419952|65466580|FG000|Overall Study|Adverse Event|8|||
23470614|NCT00419952|65466581|FG001|Overall Study|Adverse Event|10|||
23470615|NCT00419952|65466580|FG000|Overall Study|Withdrawal by Subject|44|||
23470616|NCT00419952|65466581|FG001|Overall Study|Withdrawal by Subject|43|||
23470617|NCT00419952|65466580|FG000|Overall Study|Lost to Follow-up|43|||
23470618|NCT00419952|65466581|FG001|Overall Study|Lost to Follow-up|34|||
23470619|NCT00419952|65466580|FG000|Overall Study|Protocol Violation|32|||
23470620|NCT00419952|65466581|FG001|Overall Study|Protocol Violation|24|||
23470621|NCT00419952|65466580|FG000|Overall Study|Pregnancy|4|||
23470622|NCT00419952|65466581|FG001|Overall Study|Pregnancy|2|||
23470623|NCT00419952|65466580|FG000|Overall Study|Physician Decision|1|||
23470624|NCT00419952|65466581|FG001|Overall Study|Physician Decision|3|||
23470625|NCT00419952|65466580|FG000|Overall Study|Incorrectly enrolled|10|||
23470626|NCT00419952|65466581|FG001|Overall Study|Incorrectly enrolled|3|||
23470627|NCT00419952|65466580|FG000|Overall Study|Intake of prohibited medication|2|||
23470628|NCT00419952|65466581|FG001|Overall Study|Intake of prohibited medication|2|||
23470629|NCT00419952|65466580|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
23470630|NCT00419952|65466581|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
23470631|NCT00419952|65466580|FG000|Overall Study|Diary or medication non-compliance|2|||
23470632|NCT00419952|65466581|FG001|Overall Study|Diary or medication non-compliance|4|||
23587537|NCT00878722|65879154|FG002|Overall Study|Withdrawal by Subject|0|||
23587538|NCT00878722|65879155|FG003|Overall Study|Withdrawal by Subject|0|||
23587539|NCT00878722|65879156|FG004|Overall Study|Withdrawal by Subject|0|||
23587540|NCT00878722|65879157|FG005|Overall Study|Withdrawal by Subject|0|||
23587541|NCT00878722|65879158|FG006|Overall Study|Withdrawal by Subject|0|||
23354204|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
23354205|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
23354206|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
23354207|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354208|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354209|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354210|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
23354211|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354212|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354213|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
23354214|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
23354215|NCT00703326|65041348|FG000|Overall Study|Lost to Follow-up|47|||
23354216|NCT00703326|65041349|FG001|Overall Study|Lost to Follow-up|18|||
23354217|NCT00703326|65041348|FG000|Overall Study|Withdrawal by Subject|54|||
23354218|NCT00703326|65041349|FG001|Overall Study|Withdrawal by Subject|20|||
23354219|NCT00703326|65041348|FG000|Overall Study|Adverse Event|1|||
23354220|NCT00703326|65041349|FG001|Overall Study|Adverse Event|0|||
23354221|NCT02412878|65041350|FG000|Overall Study|Withdrawal by Subject|19|||
23354222|NCT02412878|65041351|FG001|Overall Study|Withdrawal by Subject|10|||
23354223|NCT02412878|65041350|FG000|Overall Study|Lost to Follow-up|2|||
23354224|NCT02412878|65041351|FG001|Overall Study|Lost to Follow-up|3|||
23354225|NCT03013985|65041352|FG000|Overall Study|Protocol Violation|2|||
23354226|NCT03013985|65041353|FG001|Overall Study|Protocol Violation|2|||
23354227|NCT03013985|65041352|FG000|Overall Study|Withdrawal by Subject|14|||
23354228|NCT03013985|65041353|FG001|Overall Study|Withdrawal by Subject|17|||
23354229|NCT04424914|65041354|FG000|Overall Study|Other|0|||
23354230|NCT04424914|65041355|FG001|Overall Study|Other|0|||
23354231|NCT04424914|65041356|FG002|Overall Study|Other|28|||
23354232|NCT04424914|65041354|FG000|Overall Study|Withdrawal by Subject|3|||
23354233|NCT04424914|65041355|FG001|Overall Study|Withdrawal by Subject|0|||
23354234|NCT04424914|65041356|FG002|Overall Study|Withdrawal by Subject|0|||
23354235|NCT04424914|65041354|FG000|Overall Study|Study terminated by sponsor|23|||
23354236|NCT04424914|65041355|FG001|Overall Study|Study terminated by sponsor|7|||
23354237|NCT04424914|65041356|FG002|Overall Study|Study terminated by sponsor|0|||
23354238|NCT04424914|65041354|FG000|Overall Study|Lost to Follow-up|0|||
23354239|NCT04424914|65041355|FG001|Overall Study|Lost to Follow-up|0|||
23354240|NCT04424914|65041356|FG002|Overall Study|Lost to Follow-up|1|||
23354241|NCT04424914|65041354|FG000|Overall Study|Death|3|||
23354242|NCT04424914|65041355|FG001|Overall Study|Death|1|||
23354243|NCT04424914|65041356|FG002|Overall Study|Death|0|||
23354244|NCT04122625|65041357|FG000|Part A (up to 2.92 Years)|Death|2|||
23354245|NCT04122625|65041358|FG001|Part A (up to 2.92 Years)|Death|4|||
23354246|NCT04122625|65041359|FG002|Part A (up to 2.92 Years)|Death|0|||
23354247|NCT04122625|65041360|FG003|Part A (up to 2.92 Years)|Death|0|||
23354248|NCT04122625|65041361|FG004|Part A (up to 2.92 Years)|Death|0|||
23354249|NCT04122625|65041362|FG005|Part A (up to 2.92 Years)|Death|0|||
23354250|NCT04122625|65041357|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354251|NCT04122625|65041358|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354252|NCT04122625|65041359|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
23354253|NCT04122625|65041360|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
23354254|NCT04122625|65041361|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
23354255|NCT04122625|65041362|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354256|NCT04122625|65041357|FG000|Part B (up to 2.33 Years)|Death|0|||
23354257|NCT04122625|65041358|FG001|Part B (up to 2.33 Years)|Death|0|||
23354258|NCT04122625|65041359|FG002|Part B (up to 2.33 Years)|Death|5|||
23354259|NCT04122625|65041360|FG003|Part B (up to 2.33 Years)|Death|7|||
23354260|NCT04122625|65041361|FG004|Part B (up to 2.33 Years)|Death|6|||
23354261|NCT04122625|65041362|FG005|Part B (up to 2.33 Years)|Death|7|||
23354262|NCT02347072|65041366|FG000|Overall Study|Adverse Event|2|||
23354263|NCT02347072|65041366|FG000|Overall Study|Withdrawal by Subject|6|||
23354264|NCT02347072|65041366|FG000|Overall Study|Physician Decision|1|||
23354265|NCT02347072|65041366|FG000|Overall Study|Lost to Follow-up|2|||
23354266|NCT02347072|65041366|FG000|Overall Study|Protocol Violation|1|||
23354267|NCT02347072|65041366|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
23354268|NCT02756819|65041368|FG000|Overall Study|Lost for observation|23|||
23354269|NCT02756819|65041368|FG000|Overall Study|Patient's unwillingness|16|||
23354270|NCT02756819|65041368|FG000|Overall Study|Insufficient efficacy|2|||
23587542|NCT00878722|65879159|FG007|Overall Study|Withdrawal by Subject|2|||
23470633|NCT00419952|65466580|FG000|Overall Study|Abnormal ECG|1|||
23470634|NCT00419952|65466581|FG001|Overall Study|Abnormal ECG|0|||
23470635|NCT00074490|65466582|FG000|Overall Study|Progressive malignancy|0|||
23470636|NCT00074490|65466583|FG001|Overall Study|Progressive malignancy|7|||
23470637|NCT00074490|65466584|FG002|Overall Study|Progressive malignancy|0|||
23470638|NCT00074490|65466585|FG003|Overall Study|Progressive malignancy|0|||
23470639|NCT00074490|65466586|FG004|Overall Study|Progressive malignancy|3|||
23470640|NCT00074490|65466587|FG005|Overall Study|Progressive malignancy|0|||
23470641|NCT00947882|65466588|FG000|Overall Study|Adverse Event|0|||
23470642|NCT00947882|65466589|FG001|Overall Study|Adverse Event|1|||
23587543|NCT00878722|65879152|FG000|Overall Study|Relapse|0|||
23587544|NCT00878722|65879153|FG001|Overall Study|Relapse|0|||
23587545|NCT00878722|65879154|FG002|Overall Study|Relapse|0|||
23587546|NCT00878722|65879155|FG003|Overall Study|Relapse|1|||
23587547|NCT00878722|65879156|FG004|Overall Study|Relapse|0|||
23587548|NCT00878722|65879157|FG005|Overall Study|Relapse|0|||
23587549|NCT00878722|65879158|FG006|Overall Study|Relapse|0|||
23587550|NCT00878722|65879159|FG007|Overall Study|Relapse|0|||
23587551|NCT01689519|65879160|FG000|Intent to Treat|Death|157|||
23587552|NCT01689519|65879161|FG001|Intent to Treat|Death|167|||
23470643|NCT00947882|65466590|FG002|Overall Study|Adverse Event|4|||
23470644|NCT00947882|65466591|FG003|Overall Study|Adverse Event|4|||
23470645|NCT00947882|65466588|FG000|Overall Study|Withdrawal by Subject|2|||
23470646|NCT00947882|65466589|FG001|Overall Study|Withdrawal by Subject|0|||
23470647|NCT00947882|65466590|FG002|Overall Study|Withdrawal by Subject|8|||
23470648|NCT00947882|65466591|FG003|Overall Study|Withdrawal by Subject|2|||
23470649|NCT00947882|65466588|FG000|Overall Study|Protocol Violation|0|||
23470650|NCT00947882|65466589|FG001|Overall Study|Protocol Violation|0|||
23470651|NCT00947882|65466590|FG002|Overall Study|Protocol Violation|1|||
23470652|NCT00947882|65466591|FG003|Overall Study|Protocol Violation|0|||
23470653|NCT00947882|65466588|FG000|Overall Study|Lost to Follow-up|0|||
23470654|NCT00947882|65466589|FG001|Overall Study|Lost to Follow-up|2|||
23470655|NCT00947882|65466590|FG002|Overall Study|Lost to Follow-up|1|||
23470656|NCT00947882|65466591|FG003|Overall Study|Lost to Follow-up|0|||
23470657|NCT00947882|65466588|FG000|Overall Study|Other/Unknown|10|||
23470658|NCT00947882|65466589|FG001|Overall Study|Other/Unknown|13|||
23587553|NCT01689519|65879160|FG000|Intent to Treat|Lost to Follow-up|4|||
23587554|NCT01689519|65879161|FG001|Intent to Treat|Lost to Follow-up|8|||
23640949|NCT01215188|66071504|FG001|Overall Study|Withdrawal by Subject|34|||
23640950|NCT01215188|66071505|FG002|Overall Study|Withdrawal by Subject|31|||
23640951|NCT00928018|66071509|FG000|Overall Study|Withdrawal by Subject|1|||
23795085|NCT03732833|66626632|FG002|Overall Study|Withdrawal by Subject|8|||
23795086|NCT03732833|66626630|FG000|Overall Study|Lost to Follow-up|3|||
23795087|NCT03732833|66626631|FG001|Overall Study|Lost to Follow-up|5|||
23795088|NCT03732833|66626632|FG002|Overall Study|Lost to Follow-up|4|||
23795089|NCT03732833|66626630|FG000|Overall Study|Pregnancy|0|||
23795090|NCT03732833|66626631|FG001|Overall Study|Pregnancy|2|||
23795091|NCT03732833|66626632|FG002|Overall Study|Pregnancy|0|||
23795092|NCT03732833|66626630|FG000|Overall Study|Physician Decision|2|||
23795093|NCT03732833|66626631|FG001|Overall Study|Physician Decision|3|||
23795094|NCT03732833|66626632|FG002|Overall Study|Physician Decision|1|||
23795095|NCT03732833|66626630|FG000|Overall Study|Covid-19 related and other reasons|2|||
23795096|NCT03732833|66626631|FG001|Overall Study|Covid-19 related and other reasons|7|||
23795097|NCT03732833|66626632|FG002|Overall Study|Covid-19 related and other reasons|3|||
23795098|NCT00265785|66626633|FG000|Overall Study|Adverse Event|4|||
23795099|NCT00265785|66626633|FG000|Overall Study|Withdrawal by Subject|3|||
23795100|NCT00265785|66626633|FG000|Overall Study|Progression/Relapse|15|||
23795101|NCT00265785|66626633|FG000|Overall Study|Not protocol specified|2|||
23795102|NCT00265785|66626633|FG000|Overall Study|Ineligible|1|||
23795103|NCT00265785|66626633|FG000|Overall Study|Did not receive protocol treatment|2|||
23795104|NCT02129062|66626635|FG000|Overall Study|Death|1|||
23470659|NCT00947882|65466590|FG002|Overall Study|Other/Unknown|3|||
23470660|NCT00947882|65466591|FG003|Overall Study|Other/Unknown|6|||
23470661|NCT00947882|65466588|FG000|Overall Study|Trial Terminated by Sponsor|62|||
23470662|NCT00947882|65466589|FG001|Overall Study|Trial Terminated by Sponsor|61|||
23470663|NCT00947882|65466590|FG002|Overall Study|Trial Terminated by Sponsor|62|||
23470664|NCT00947882|65466591|FG003|Overall Study|Trial Terminated by Sponsor|70|||
23470665|NCT01646125|65466598|FG000|Overall Study|Untreated|2|||
23470666|NCT01646125|65466599|FG001|Overall Study|Untreated|5|||
23587555|NCT01689519|65879160|FG000|Intent to Treat|Other|2|||
23587556|NCT01689519|65879161|FG001|Intent to Treat|Other|4|||
23587557|NCT01689519|65879160|FG000|Intent to Treat|Physician Decision|4|||
23587558|NCT01689519|65879161|FG001|Intent to Treat|Physician Decision|1|||
23795105|NCT02129062|66626635|FG000|Overall Study|Disease Progression|2|||
23795106|NCT01207492|66626636|FG000|Overall Study|Still on study|1|||
23795107|NCT01207492|66626636|FG000|Overall Study|Withdrawal by Subject|9|||
23470667|NCT01646125|65466598|FG000|Overall Study|Adverse Event|2|||
23587559|NCT01689519|65879160|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
23587560|NCT01689519|65879161|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
23795108|NCT01207492|66626636|FG000|Overall Study|Physician Decision|1|||
23795109|NCT01207492|66626636|FG000|Overall Study|Progressive disease|3|||
23795110|NCT01207492|66626636|FG000|Overall Study|Toxicity|1|||
23795111|NCT02166606|66626637|FG000|Overall Study|Adverse Event|3|||
23795112|NCT02166606|66626637|FG000|Overall Study|Death|31|||
23795113|NCT02166606|66626637|FG000|Overall Study|Protocol Violation|7|||
23795114|NCT02166606|66626637|FG000|Overall Study|Lost to Follow-up|30|||
23795115|NCT02166606|66626637|FG000|Overall Study|Withdrawal by Subject|1|||
23795116|NCT02166606|66626637|FG000|Overall Study|Physician Decision|1|||
23795117|NCT02166606|66626637|FG000|Overall Study|Device upgrade|1|||
23795118|NCT02166606|66626637|FG000|Overall Study|Enrolled after End of Enrollment|4|||
23795119|NCT03843125|66626638|FG000|Overall Study|Adverse Event|17|||
23795120|NCT03843125|66626639|FG001|Overall Study|Adverse Event|13|||
23795121|NCT03843125|66626640|FG002|Overall Study|Adverse Event|5|||
23795122|NCT03843125|66626641|FG003|Overall Study|Adverse Event|9|||
23795123|NCT03843125|66626638|FG000|Overall Study|Death|0|||
23795124|NCT03843125|66626639|FG001|Overall Study|Death|6|||
23795125|NCT03843125|66626640|FG002|Overall Study|Death|2|||
23795126|NCT03843125|66626641|FG003|Overall Study|Death|0|||
23795127|NCT03843125|66626638|FG000|Overall Study|Lack of Efficacy|14|||
23795128|NCT03843125|66626639|FG001|Overall Study|Lack of Efficacy|11|||
23795129|NCT03843125|66626640|FG002|Overall Study|Lack of Efficacy|9|||
23470668|NCT01646125|65466599|FG001|Overall Study|Adverse Event|1|||
23470669|NCT01646125|65466598|FG000|Overall Study|Death|1|||
23470670|NCT01646125|65466599|FG001|Overall Study|Death|1|||
23795130|NCT03843125|66626641|FG003|Overall Study|Lack of Efficacy|4|||
23470671|NCT01646125|65466598|FG000|Overall Study|Physician Decision|1|||
23470672|NCT01646125|65466599|FG001|Overall Study|Physician Decision|3|||
23470673|NCT01646125|65466598|FG000|Overall Study|Progressive disease|22|||
23470674|NCT01646125|65466599|FG001|Overall Study|Progressive disease|16|||
23470675|NCT01646125|65466598|FG000|Overall Study|Study terminated by sponsor|2|||
23470676|NCT01646125|65466599|FG001|Overall Study|Study terminated by sponsor|1|||
23470677|NCT01646125|65466598|FG000|Overall Study|Subject/Guardian decision|1|||
23470678|NCT01646125|65466599|FG001|Overall Study|Subject/Guardian decision|1|||
23470679|NCT01554241|65466601|FG000|Overall Study|Death|3|||
23470680|NCT01554241|65466602|FG001|Overall Study|Death|1|||
23470681|NCT01554241|65466603|FG002|Overall Study|Death|1|||
23470682|NCT01554241|65466604|FG003|Overall Study|Death|0|||
23470683|NCT01554241|65466601|FG000|Overall Study|protocol specified renal stone|0|||
23470684|NCT01554241|65466602|FG001|Overall Study|protocol specified renal stone|0|||
23470685|NCT01554241|65466603|FG002|Overall Study|protocol specified renal stone|0|||
23470686|NCT01554241|65466604|FG003|Overall Study|protocol specified renal stone|1|||
23470687|NCT01554241|65466601|FG000|Overall Study|protocol specified change in eGFR|0|||
23470688|NCT01554241|65466602|FG001|Overall Study|protocol specified change in eGFR|0|||
23470689|NCT01554241|65466603|FG002|Overall Study|protocol specified change in eGFR|1|||
23470690|NCT01554241|65466604|FG003|Overall Study|protocol specified change in eGFR|0|||
23470691|NCT01554241|65466601|FG000|Overall Study|Withdrawal by Subject|0|||
23470692|NCT01554241|65466602|FG001|Overall Study|Withdrawal by Subject|0|||
23470693|NCT01554241|65466603|FG002|Overall Study|Withdrawal by Subject|2|||
23470694|NCT01554241|65466604|FG003|Overall Study|Withdrawal by Subject|0|||
23470695|NCT03695367|65466605|FG000|Overall Study|Missed the Day 28 visit.|1|||
23470696|NCT03695367|65466606|FG001|Overall Study|Missed the Day 28 visit.|0|||
23470697|NCT03695367|65466605|FG000|Overall Study|Lost to Follow-up|0|||
23470698|NCT03695367|65466606|FG001|Overall Study|Lost to Follow-up|1|||
23470699|NCT03695367|65466605|FG000|Overall Study|Withdrawal by Subject|0|||
23470700|NCT03695367|65466606|FG001|Overall Study|Withdrawal by Subject|1|||
23470701|NCT03695367|65466605|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
23470702|NCT03695367|65466606|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
23470703|NCT02636361|65466609|FG000|Period 4|Physician Decision|0|||
23470704|NCT02636361|65466610|FG001|Period 4|Physician Decision|0|||
23470705|NCT02636361|65466611|FG002|Period 4|Physician Decision|0|||
23470706|NCT02636361|65466612|FG003|Period 4|Physician Decision|1|||
23354271|NCT02756819|65041368|FG000|Overall Study|Adverse Event|2|||
23470707|NCT02636361|65466613|FG004|Period 4|Physician Decision|0|||
23470708|NCT00233064|65466617|FG000|Overall Study|Lost to Follow-up|7|||
23470709|NCT00233064|65466618|FG001|Overall Study|Lost to Follow-up|7|||
23795131|NCT03843125|66626638|FG000|Overall Study|Lost to Follow-up|3|||
23795132|NCT03843125|66626639|FG001|Overall Study|Lost to Follow-up|4|||
23795133|NCT03843125|66626640|FG002|Overall Study|Lost to Follow-up|0|||
23795134|NCT03843125|66626641|FG003|Overall Study|Lost to Follow-up|2|||
23795135|NCT03843125|66626638|FG000|Overall Study|Other|12|||
23795136|NCT03843125|66626639|FG001|Overall Study|Other|14|||
23470710|NCT00233064|65466617|FG000|Overall Study|Withdrawal by Subject|5|||
23470711|NCT00233064|65466618|FG001|Overall Study|Withdrawal by Subject|3|||
23470712|NCT00233064|65466617|FG000|Overall Study|Death|0|||
23470713|NCT00233064|65466618|FG001|Overall Study|Death|1|||
23470714|NCT00233064|65466617|FG000|Overall Study|Relocation|0|||
23470715|NCT00233064|65466618|FG001|Overall Study|Relocation|1|||
23470716|NCT00233064|65466617|FG000|Overall Study|Protocol Violation|1|||
23470717|NCT00233064|65466618|FG001|Overall Study|Protocol Violation|0|||
23470718|NCT00233064|65466617|FG000|Overall Study|Moved to Dom. Republic|1|||
23470719|NCT00233064|65466618|FG001|Overall Study|Moved to Dom. Republic|0|||
23470720|NCT00721968|65466619|FG000|Overall Study|Lost to Follow-up|2|||
23470721|NCT00721968|65466620|FG001|Overall Study|Lost to Follow-up|0|||
23470722|NCT00862082|65466621|FG000|Overall Study|Sponsor decision to terminate the study|5|||
23470723|NCT00862082|65466622|FG001|Overall Study|Sponsor decision to terminate the study|0|||
23470724|NCT00862082|65466621|FG000|Overall Study|Withdrawal by Subject|0|||
23470725|NCT00862082|65466622|FG001|Overall Study|Withdrawal by Subject|1|||
23470726|NCT01092117|65466625|FG000|Index Procedure to 1 Month|Death|1|||
23470727|NCT01092117|65466625|FG000|1 Month|Death|1|||
23470728|NCT01092117|65466625|FG000|1 Month|Withdrawal by Subject|1|||
23470729|NCT01092117|65466625|FG000|1 Month|Lost to Follow-up|1|||
23470730|NCT01092117|65466625|FG000|6 Months|Death|2|||
23470731|NCT01092117|65466625|FG000|6 Months|Withdrawal by Subject|3|||
23470732|NCT01092117|65466625|FG000|12 Month|Death|11|||
23470733|NCT01092117|65466625|FG000|12 Month|Withdrawal by Subject|2|||
23470734|NCT01092117|65466625|FG000|12 Month|Lost to Follow-up|1|||
23470735|NCT01092117|65466625|FG000|Year 2|Death|5|||
23470736|NCT01092117|65466625|FG000|Year 2|Withdrawal by Subject|4|||
23470737|NCT01092117|65466625|FG000|Year 2|Lost to Follow-up|1|||
23470738|NCT01092117|65466625|FG000|Year 3|Death|7|||
23470739|NCT01092117|65466625|FG000|Year 3|Withdrawal by Subject|9|||
23470740|NCT01092117|65466625|FG000|Year 3|Lost to Follow-up|3|||
23470741|NCT01092117|65466625|FG000|Year 4|Death|8|||
23470742|NCT01092117|65466625|FG000|Year 4|Withdrawal by Subject|4|||
23470743|NCT01092117|65466625|FG000|Year 4|Lost to Follow-up|4|||
23470744|NCT00859456|65466626|FG000|Overall Study|Adverse Event|3|||
23470745|NCT00859456|65466626|FG000|Overall Study|Progressive disease|2|||
23470746|NCT00859456|65466626|FG000|Overall Study|Non-compliance|3|||
23470747|NCT02537015|65466631|FG000|Overall Study|Adverse Event|3|||
23470748|NCT02537015|65466631|FG000|Overall Study|Withdrawal by Subject|2|||
23795137|NCT03843125|66626640|FG002|Overall Study|Other|3|||
23795138|NCT03843125|66626641|FG003|Overall Study|Other|4|||
23795139|NCT03843125|66626638|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
23795140|NCT03843125|66626639|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
23795141|NCT03843125|66626640|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
23795142|NCT03843125|66626641|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
23795143|NCT03843125|66626638|FG000|Overall Study|Study Terminated by Sponsor|318|||
23795144|NCT03843125|66626639|FG001|Overall Study|Study Terminated by Sponsor|318|||
23470749|NCT02537015|65466631|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23470750|NCT01738477|65466634|FG000|Overall Study|Lost to Follow-up|1|||
23470751|NCT01738477|65466635|FG001|Overall Study|Lost to Follow-up|4|||
23470752|NCT00831493|65466636|FG000|Overall Study|Intractable nausea and vomiting|1|||
23470753|NCT03181529|65466637|FG000|Overall Study|Withdrawal by Subject|1|||
23470754|NCT03181529|65466638|FG001|Overall Study|Withdrawal by Subject|1|||
23470755|NCT03181529|65466637|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
23470756|NCT03181529|65466638|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
23470757|NCT03023813|65466639|FG000|Overall Study|Lost to Follow-up|1|||
23470758|NCT03023813|65466640|FG001|Overall Study|Lost to Follow-up|2|||
23470759|NCT03023813|65466641|FG002|Overall Study|Lost to Follow-up|0|||
23640952|NCT00928018|66071510|FG001|Overall Study|Withdrawal by Subject|0|||
23795145|NCT03843125|66626640|FG002|Overall Study|Study Terminated by Sponsor|163|||
23795146|NCT03843125|66626641|FG003|Overall Study|Study Terminated by Sponsor|163|||
23795147|NCT03843125|66626638|FG000|Overall Study|Withdrawal by Subject|23|||
23795148|NCT03843125|66626639|FG001|Overall Study|Withdrawal by Subject|12|||
23795149|NCT03843125|66626640|FG002|Overall Study|Withdrawal by Subject|6|||
23795150|NCT03843125|66626641|FG003|Overall Study|Withdrawal by Subject|9|||
23795151|NCT03843125|66626638|FG000|Overall Study|Missing data|0|||
23795152|NCT03843125|66626639|FG001|Overall Study|Missing data|1|||
23795153|NCT03843125|66626640|FG002|Overall Study|Missing data|1|||
23795154|NCT03843125|66626641|FG003|Overall Study|Missing data|0|||
23795155|NCT03370510|66626642|FG000|Overall Study|COVID-19|2|||
23795156|NCT03370510|66626643|FG001|Overall Study|COVID-19|0|||
23795157|NCT02005562|66626644|FG000|Overall Study|Death|2|||
23354272|NCT02756819|65041368|FG000|Overall Study|Reason not Specified|9|||
23795158|NCT02005562|66626645|FG001|Overall Study|Death|2|||
23795159|NCT02005562|66626644|FG000|Overall Study|Graft loss|7|||
23470760|NCT03544333|65466642|FG000|Overall Study|Withdrawal by Subject|1|||
23470761|NCT03544333|65466643|FG001|Overall Study|Withdrawal by Subject|0|||
23470762|NCT03773796|65466646|FG000|Overall Study|Adverse Event|1|||
23470763|NCT03773796|65466646|FG000|Overall Study|Withdrawal by Subject|1|||
23470764|NCT03773796|65466646|FG000|Overall Study|Lack of Efficacy|1|||
23795160|NCT02005562|66626645|FG001|Overall Study|Graft loss|6|||
23470765|NCT01918306|65466647|FG000|Overall Study|progresive disease|4|||
23470766|NCT01918306|65466648|FG001|Overall Study|progresive disease|0|||
23470767|NCT01918306|65466649|FG002|Overall Study|progresive disease|1|||
23470768|NCT01918306|65466650|FG003|Overall Study|progresive disease|1|||
23470769|NCT01918306|65466647|FG000|Overall Study|Withdrawal by Subject|0|||
23470770|NCT01918306|65466648|FG001|Overall Study|Withdrawal by Subject|0|||
23470771|NCT01918306|65466649|FG002|Overall Study|Withdrawal by Subject|0|||
23470772|NCT01918306|65466650|FG003|Overall Study|Withdrawal by Subject|2|||
23470773|NCT01918306|65466647|FG000|Overall Study|neutropenia|1|||
23470774|NCT01918306|65466648|FG001|Overall Study|neutropenia|0|||
23470775|NCT01918306|65466649|FG002|Overall Study|neutropenia|0|||
23470776|NCT01918306|65466650|FG003|Overall Study|neutropenia|0|||
23470777|NCT01918306|65466647|FG000|Overall Study|Lack of Efficacy|1|||
23470778|NCT01918306|65466648|FG001|Overall Study|Lack of Efficacy|0|||
23470779|NCT01918306|65466649|FG002|Overall Study|Lack of Efficacy|0|||
23470780|NCT01918306|65466650|FG003|Overall Study|Lack of Efficacy|0|||
23470781|NCT01918306|65466647|FG000|Overall Study|progress disease, crossover|0|||
23470782|NCT01918306|65466648|FG001|Overall Study|progress disease, crossover|0|||
23470783|NCT01918306|65466649|FG002|Overall Study|progress disease, crossover|1|||
23470784|NCT01918306|65466650|FG003|Overall Study|progress disease, crossover|0|||
23470785|NCT02023697|65466653|FG000|Treatment Period|Radiological progression|13|||
23470786|NCT02023697|65466654|FG001|Treatment Period|Radiological progression|17|||
23470787|NCT02023697|65466655|FG002|Treatment Period|Radiological progression|26|||
23470788|NCT02023697|65466653|FG000|Treatment Period|Never Treated|5|||
23470789|NCT02023697|65466654|FG001|Treatment Period|Never Treated|6|||
23470790|NCT02023697|65466655|FG002|Treatment Period|Never Treated|10|||
23470791|NCT02023697|65466653|FG000|Treatment Period|Adverse Event|13|||
23470792|NCT02023697|65466654|FG001|Treatment Period|Adverse Event|25|||
23470793|NCT02023697|65466655|FG002|Treatment Period|Adverse Event|23|||
23470794|NCT02023697|65466653|FG000|Treatment Period|Logistical difficulties|1|||
23470795|NCT02023697|65466654|FG001|Treatment Period|Logistical difficulties|1|||
23470796|NCT02023697|65466655|FG002|Treatment Period|Logistical difficulties|1|||
23470797|NCT02023697|65466653|FG000|Treatment Period|Clinical progression|10|||
23470798|NCT02023697|65466654|FG001|Treatment Period|Clinical progression|8|||
23470799|NCT02023697|65466655|FG002|Treatment Period|Clinical progression|28|||
23470800|NCT02023697|65466653|FG000|Treatment Period|Withdrawal by Subject|4|||
23470801|NCT02023697|65466654|FG001|Treatment Period|Withdrawal by Subject|5|||
23470802|NCT02023697|65466655|FG002|Treatment Period|Withdrawal by Subject|13|||
23470803|NCT02023697|65466653|FG000|Treatment Period|Safety outcome reached|0|||
23470804|NCT02023697|65466654|FG001|Treatment Period|Safety outcome reached|1|||
23470805|NCT02023697|65466655|FG002|Treatment Period|Safety outcome reached|0|||
23470806|NCT02023697|65466653|FG000|Treatment Period|Physician Decision|0|||
23470807|NCT02023697|65466654|FG001|Treatment Period|Physician Decision|0|||
23470808|NCT02023697|65466655|FG002|Treatment Period|Physician Decision|1|||
23470809|NCT02023697|65466653|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
23470810|NCT02023697|65466654|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
23470811|NCT02023697|65466655|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
23470812|NCT02023697|65466653|FG000|Active Follow-up Period|Lost to Follow-up|1|||
23470813|NCT02023697|65466654|FG001|Active Follow-up Period|Lost to Follow-up|1|||
23470814|NCT02023697|65466655|FG002|Active Follow-up Period|Lost to Follow-up|1|||
23470815|NCT02023697|65466653|FG000|Active Follow-up Period|Deterioration of general condition|1|||
23640953|NCT02787044|66071526|FG000|Overall Study|Lost to Follow-up|15|||
23640954|NCT02787044|66071527|FG001|Overall Study|Lost to Follow-up|19|||
23640955|NCT00528931|66071528|FG000|Overall Study|Lost to Follow-up|1|||
23640956|NCT03333876|66071529|FG000|Screening Period|Screen Failure|4|||
23470816|NCT02023697|65466654|FG001|Active Follow-up Period|Deterioration of general condition|1|||
23470817|NCT02023697|65466655|FG002|Active Follow-up Period|Deterioration of general condition|1|||
23470818|NCT02023697|65466653|FG000|Active Follow-up Period|Other unspecified|2|||
23470819|NCT02023697|65466654|FG001|Active Follow-up Period|Other unspecified|0|||
23640957|NCT03333876|66071529|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
23640958|NCT03333876|66071529|FG000|Mandibular Advancement|Adverse Event|2|||
23640959|NCT03333876|66071529|FG000|Mandibular Advancement|Product Damage|2|||
23640960|NCT01691768|66071530|FG000|Overall Study|Death|0|||
23640961|NCT01691768|66071531|FG001|Overall Study|Death|2|||
23640962|NCT01691768|66071530|FG000|Overall Study|Lost to Follow-up|4|||
23640963|NCT01691768|66071531|FG001|Overall Study|Lost to Follow-up|3|||
23640964|NCT01691768|66071530|FG000|Overall Study|Withdrawal by Subject|10|||
23640965|NCT01691768|66071531|FG001|Overall Study|Withdrawal by Subject|9|||
23640966|NCT01691768|66071530|FG000|Overall Study|Relocated|0|||
23795161|NCT02005562|66626644|FG000|Overall Study|Withdrawal by Subject|2|||
23470820|NCT02023697|65466655|FG002|Active Follow-up Period|Other unspecified|1|||
23470821|NCT02023697|65466653|FG000|Active Follow-up Period|Clinical progression|0|||
23470822|NCT02023697|65466654|FG001|Active Follow-up Period|Clinical progression|2|||
23470823|NCT02023697|65466655|FG002|Active Follow-up Period|Clinical progression|1|||
23470824|NCT02023697|65466653|FG000|Active Follow-up Period|Radiological progression|0|||
23470825|NCT02023697|65466654|FG001|Active Follow-up Period|Radiological progression|0|||
23470826|NCT02023697|65466655|FG002|Active Follow-up Period|Radiological progression|1|||
23470827|NCT02023697|65466653|FG000|Active Follow-up Period|Death|83|||
23470828|NCT02023697|65466654|FG001|Active Follow-up Period|Death|82|||
23470829|NCT02023697|65466655|FG002|Active Follow-up Period|Death|87|||
23470830|NCT02023697|65466653|FG000|Long-term Follow-up Period|Death|9|||
23470831|NCT02023697|65466654|FG001|Long-term Follow-up Period|Death|6|||
23470832|NCT02023697|65466655|FG002|Long-term Follow-up Period|Death|4|||
23470833|NCT02023697|65466653|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
23470834|NCT02023697|65466654|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
23470835|NCT02023697|65466655|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
23470836|NCT02023697|65466653|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
23470837|NCT02023697|65466654|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
23470838|NCT02023697|65466655|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
23470839|NCT02023697|65466653|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
23470840|NCT02023697|65466654|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
23470841|NCT02023697|65466655|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
23470842|NCT02023697|65466653|FG000|Long-term Follow-up Period|Technical problems|0|||
23470843|NCT02023697|65466654|FG001|Long-term Follow-up Period|Technical problems|0|||
23470844|NCT02023697|65466655|FG002|Long-term Follow-up Period|Technical problems|1|||
23470845|NCT02023697|65466653|FG000|Long-term Follow-up Period|Other unspecified|6|||
23470846|NCT02023697|65466654|FG001|Long-term Follow-up Period|Other unspecified|3|||
23470847|NCT02023697|65466655|FG002|Long-term Follow-up Period|Other unspecified|5|||
23470848|NCT00092443|65466656|FG000|Overall Study|Adverse Event|9|||
23470849|NCT00092443|65466657|FG001|Overall Study|Adverse Event|13|||
23470850|NCT00092443|65466656|FG000|Overall Study|Lost to Follow-up|7|||
23470851|NCT00092443|65466657|FG001|Overall Study|Lost to Follow-up|3|||
23470852|NCT00092443|65466656|FG000|Overall Study|Protocol Violation|11|||
23470853|NCT00092443|65466657|FG001|Overall Study|Protocol Violation|9|||
23470854|NCT00092443|65466656|FG000|Overall Study|Withdrawal by Subject|9|||
23470855|NCT00092443|65466657|FG001|Overall Study|Withdrawal by Subject|11|||
23470856|NCT00092443|65466656|FG000|Overall Study|Moved|5|||
23470857|NCT00092443|65466657|FG001|Overall Study|Moved|5|||
23470858|NCT00092443|65466656|FG000|Overall Study|Other|17|||
23470859|NCT00092443|65466657|FG001|Overall Study|Other|13|||
23470860|NCT01253577|65466658|FG000|Overall Study|Lost to Follow-up|3|||
23470861|NCT05334212|65466659|FG000|Overall Study|Study terminated prematurely|7|||
23470862|NCT01781299|65466660|FG000|Overall Study|Withdrawal by Subject|0|||
23470863|NCT01781299|65466661|FG001|Overall Study|Withdrawal by Subject|1|||
23470864|NCT02954172|65466663|FG000|Overall Study|Protocol Violation|3|||
23470865|NCT02954172|65466664|FG001|Overall Study|Protocol Violation|0|||
23470866|NCT02954172|65466663|FG000|Overall Study|allergic reaction|2|||
23470867|NCT02954172|65466664|FG001|Overall Study|allergic reaction|1|||
23470868|NCT02954172|65466663|FG000|Overall Study|non-measurable lesions at baseline|1|||
23470869|NCT02954172|65466664|FG001|Overall Study|non-measurable lesions at baseline|2|||
23470870|NCT02527421|65466665|FG000|Overall Study|Withdrawal by Subject|1|||
23470871|NCT02527421|65466666|FG001|Overall Study|Withdrawal by Subject|0|||
23470872|NCT01499277|65466667|FG000|Overall Study|Adverse Event|3|||
23470873|NCT01499277|65466668|FG001|Overall Study|Adverse Event|6|||
23470874|NCT01499277|65466667|FG000|Overall Study|Death|3|||
23470875|NCT01499277|65466668|FG001|Overall Study|Death|2|||
23470876|NCT01499277|65466667|FG000|Overall Study|Lost to Follow-up|15|||
23470877|NCT01499277|65466668|FG001|Overall Study|Lost to Follow-up|8|||
23470878|NCT01499277|65466667|FG000|Overall Study|Protocol Violation|2|||
23470879|NCT01499277|65466668|FG001|Overall Study|Protocol Violation|3|||
23470880|NCT01499277|65466667|FG000|Overall Study|Withdrawal by Subject|16|||
23470881|NCT01499277|65466668|FG001|Overall Study|Withdrawal by Subject|6|||
23470882|NCT01499277|65466667|FG000|Overall Study|Lack of therapeutic response and other|8|||
23470883|NCT01499277|65466668|FG001|Overall Study|Lack of therapeutic response and other|7|||
23470884|NCT03198507|65466669|FG000|Overall Study|Withdrawal by Subject|1|||
23470885|NCT03198507|65466670|FG001|Overall Study|Withdrawal by Subject|0|||
23470886|NCT01026324|65466671|FG000|Follow up/Survival|Withdrawal by Subject|1|||
23470887|NCT01026324|65466672|FG001|Follow up/Survival|Withdrawal by Subject|0|||
23354273|NCT01607346|65041372|FG000|Overall Study|Adverse Event|3|||
23354274|NCT01738191|65041375|FG000|Overall Study|Withdrawal by Subject|4|||
23354275|NCT01738191|65041376|FG001|Overall Study|Withdrawal by Subject|1|||
23354276|NCT02557516|65041377|FG000|Overall Study|Adverse Event|1|||
23470888|NCT01026324|65466673|FG002|Follow up/Survival|Withdrawal by Subject|0|||
23470889|NCT02974543|65466674|FG000|Overall Study|Withdrawal by Subject|1|||
23470890|NCT02974543|65466675|FG001|Overall Study|Withdrawal by Subject|0|||
23470891|NCT01456897|65466676|FG000|Overall Study|Adverse Event|19|||
23470892|NCT01456897|65466677|FG001|Overall Study|Adverse Event|22|||
23470893|NCT01456897|65466676|FG000|Overall Study|Protocol Violation|3|||
23470894|NCT01456897|65466677|FG001|Overall Study|Protocol Violation|4|||
23470895|NCT01456897|65466676|FG000|Overall Study|Physician Decision|5|||
23470896|NCT01456897|65466677|FG001|Overall Study|Physician Decision|3|||
23470897|NCT01456897|65466676|FG000|Overall Study|Withdrawal by Subject|44|||
23470898|NCT01456897|65466677|FG001|Overall Study|Withdrawal by Subject|17|||
23470899|NCT01456897|65466676|FG000|Overall Study|Lack of Efficacy|4|||
23470900|NCT01456897|65466677|FG001|Overall Study|Lack of Efficacy|11|||
23470901|NCT01243242|65466678|FG000|Overall Study|Adverse Event|1|||
23470902|NCT01243242|65466679|FG001|Overall Study|Adverse Event|1|||
23470903|NCT01243242|65466678|FG000|Overall Study|Withdrawal by Subject|1|||
23470904|NCT01243242|65466679|FG001|Overall Study|Withdrawal by Subject|1|||
23470905|NCT01243242|65466678|FG000|Overall Study|Physician Decision|0|||
23470906|NCT01243242|65466679|FG001|Overall Study|Physician Decision|1|||
23470907|NCT01243242|65466678|FG000|Overall Study|sponsor decision|0|||
23470908|NCT01243242|65466679|FG001|Overall Study|sponsor decision|1|||
23470909|NCT01243242|65466678|FG000|Overall Study|non compliance|1|||
23470910|NCT01243242|65466679|FG001|Overall Study|non compliance|0|||
23470911|NCT01474018|65466683|FG000|Overall Study|Lost to Follow-up|0|||
23470912|NCT01474018|65466684|FG001|Overall Study|Lost to Follow-up|1|||
23470913|NCT01474018|65466683|FG000|Overall Study|Withdrawal by Subject|0|||
23795162|NCT02005562|66626645|FG001|Overall Study|Withdrawal by Subject|2|||
23795163|NCT02005562|66626644|FG000|Overall Study|No transplant|1|||
23795164|NCT02005562|66626645|FG001|Overall Study|No transplant|4|||
23795165|NCT02005562|66626644|FG000|Overall Study|Physician Decision|0|||
23795166|NCT02005562|66626645|FG001|Overall Study|Physician Decision|1|||
23795167|NCT04499482|66626646|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
23795168|NCT03168906|66626647|FG000|Overall Study|Lack of Efficacy|6|||
23795169|NCT03168906|66626648|FG001|Overall Study|Lack of Efficacy|6|||
23795170|NCT01872715|66626656|FG000|Overall Study|Adverse Event|1|||
23470914|NCT01474018|65466684|FG001|Overall Study|Withdrawal by Subject|2|||
23470915|NCT00711477|65466687|FG000|Overall Study|Adverse Event|3|||
23470916|NCT00711477|65466688|FG001|Overall Study|Adverse Event|1|||
23470917|NCT00711477|65466687|FG000|Overall Study|Lost to Follow-up|0|||
23470918|NCT00711477|65466688|FG001|Overall Study|Lost to Follow-up|1|||
23470919|NCT00711477|65466687|FG000|Overall Study|Noncompliance|0|||
23470920|NCT00711477|65466688|FG001|Overall Study|Noncompliance|1|||
23470921|NCT05083585|65466694|FG000|Overall Study|Death|1|||
23470922|NCT05083585|65466695|FG001|Overall Study|Death|1|||
23470923|NCT05083585|65466694|FG000|Overall Study|Lost to Follow-up|1|||
23470924|NCT05083585|65466695|FG001|Overall Study|Lost to Follow-up|1|||
23470925|NCT05083585|65466694|FG000|Overall Study|Withdrawal by Subject|2|||
23470926|NCT05083585|65466695|FG001|Overall Study|Withdrawal by Subject|0|||
23470927|NCT05083585|65466694|FG000|Overall Study|Randomized but not vaccinated|2|||
23470928|NCT05083585|65466695|FG001|Overall Study|Randomized but not vaccinated|0|||
23470929|NCT04254913|65466696|FG000|Overall Study|Adverse Event|1|||
23470930|NCT00256997|65466698|FG000|Overall Study|Protocol Violation|1|||
23470931|NCT00256997|65466699|FG001|Overall Study|Protocol Violation|4|||
23470932|NCT00256997|65466698|FG000|Overall Study|Lack of Efficacy|1|||
23470933|NCT00256997|65466699|FG001|Overall Study|Lack of Efficacy|4|||
23470934|NCT00256997|65466698|FG000|Overall Study|Death|2|||
23470935|NCT00256997|65466699|FG001|Overall Study|Death|0|||
23470936|NCT00256997|65466698|FG000|Overall Study|Adverse Event|4|||
23470937|NCT00256997|65466699|FG001|Overall Study|Adverse Event|0|||
23470938|NCT00256997|65466698|FG000|Overall Study|Lost to Follow-up|3|||
23470939|NCT00256997|65466699|FG001|Overall Study|Lost to Follow-up|5|||
23470940|NCT00256997|65466698|FG000|Overall Study|Withdrawal by Subject|13|||
23470941|NCT00256997|65466699|FG001|Overall Study|Withdrawal by Subject|3|||
23470942|NCT00256997|65466698|FG000|Overall Study|Started but not treated|2|||
23470943|NCT00256997|65466699|FG001|Overall Study|Started but not treated|0|||
23470944|NCT00256997|65466698|FG000|Overall Study|Other|5|||
23470945|NCT00256997|65466699|FG001|Overall Study|Other|8|||
23470946|NCT00256997|65466698|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
23470947|NCT00256997|65466699|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
23470948|NCT00256997|65466698|FG000|Overall Study|Participant Non-compliant|3|||
23470949|NCT00256997|65466699|FG001|Overall Study|Participant Non-compliant|6|||
23470950|NCT00256997|65466698|FG000|Overall Study|Investigator Withdrew Participant|2|||
23470951|NCT00256997|65466699|FG001|Overall Study|Investigator Withdrew Participant|1|||
23470952|NCT00006289|65466700|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
23470953|NCT00006289|65466701|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
23470954|NCT00006289|65466700|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
23470955|NCT00006289|65466701|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
23470956|NCT00554216|65466704|FG000|Overall Study|Lost to Follow-up|92|||
23470957|NCT00554216|65466705|FG001|Overall Study|Lost to Follow-up|31|||
23470958|NCT00554216|65466706|FG002|Overall Study|Lost to Follow-up|63|||
23470959|NCT00554216|65466704|FG000|Overall Study|Adverse Event|16|||
23470960|NCT00554216|65466705|FG001|Overall Study|Adverse Event|16|||
23470961|NCT00554216|65466706|FG002|Overall Study|Adverse Event|36|||
23470962|NCT00554216|65466704|FG000|Overall Study|Withdrawal by Subject|92|||
23470963|NCT00554216|65466705|FG001|Overall Study|Withdrawal by Subject|31|||
23470964|NCT00554216|65466706|FG002|Overall Study|Withdrawal by Subject|43|||
23470965|NCT00554216|65466704|FG000|Overall Study|Non compliance|10|||
23470966|NCT00554216|65466705|FG001|Overall Study|Non compliance|4|||
23470967|NCT00554216|65466706|FG002|Overall Study|Non compliance|5|||
23470968|NCT00554216|65466704|FG000|Overall Study|Pregnancy|2|||
23470969|NCT00554216|65466705|FG001|Overall Study|Pregnancy|1|||
23470970|NCT00554216|65466706|FG002|Overall Study|Pregnancy|14|||
23470971|NCT00554216|65466704|FG000|Overall Study|Restricted med|3|||
23470972|NCT00554216|65466705|FG001|Overall Study|Restricted med|1|||
23470973|NCT00554216|65466706|FG002|Overall Study|Restricted med|1|||
23470974|NCT00554216|65466704|FG000|Overall Study|Other|12|||
23470975|NCT00554216|65466705|FG001|Overall Study|Other|7|||
23470976|NCT00554216|65466706|FG002|Overall Study|Other|10|||
23470977|NCT00554216|65466704|FG000|Overall Study|Lack of Efficacy|15|||
23470978|NCT00554216|65466705|FG001|Overall Study|Lack of Efficacy|3|||
23470979|NCT00554216|65466706|FG002|Overall Study|Lack of Efficacy|0|||
23470980|NCT00636363|65470547|FG000|Overall Study|Conjunctivitis|0|||
23470981|NCT00636363|65470548|FG001|Overall Study|Conjunctivitis|0|||
23470982|NCT00636363|65470549|FG002|Overall Study|Conjunctivitis|1|||
23470983|NCT00636363|65470547|FG000|Overall Study|Adverse Event|0|||
23470984|NCT00636363|65470548|FG001|Overall Study|Adverse Event|0|||
23470985|NCT00636363|65470549|FG002|Overall Study|Adverse Event|1|||
23470986|NCT00636363|65470547|FG000|Overall Study|Positive slit lamp finding|0|||
23470987|NCT00636363|65470548|FG001|Overall Study|Positive slit lamp finding|2|||
23470988|NCT00636363|65470549|FG002|Overall Study|Positive slit lamp finding|1|||
23470989|NCT00636363|65470547|FG000|Overall Study|Study related symptoms/complaints|8|||
23470990|NCT00636363|65470548|FG001|Overall Study|Study related symptoms/complaints|7|||
23470991|NCT00636363|65470549|FG002|Overall Study|Study related symptoms/complaints|4|||
23470992|NCT00636363|65470547|FG000|Overall Study|Met ineligibility criteria|0|||
23470993|NCT00636363|65470548|FG001|Overall Study|Met ineligibility criteria|0|||
23470994|NCT00636363|65470549|FG002|Overall Study|Met ineligibility criteria|3|||
23470995|NCT00636363|65470547|FG000|Overall Study|Missed > 1 visit|0|||
23470996|NCT00636363|65470548|FG001|Overall Study|Missed > 1 visit|1|||
23470997|NCT00636363|65470549|FG002|Overall Study|Missed > 1 visit|3|||
23470998|NCT00636363|65470547|FG000|Overall Study|Lack of motivation|1|||
23470999|NCT00636363|65470548|FG001|Overall Study|Lack of motivation|0|||
23471000|NCT00636363|65470549|FG002|Overall Study|Lack of motivation|1|||
23471001|NCT00636363|65470547|FG000|Overall Study|Protocol Violation|0|||
23471002|NCT00636363|65470548|FG001|Overall Study|Protocol Violation|3|||
23471003|NCT00636363|65470549|FG002|Overall Study|Protocol Violation|0|||
23471004|NCT00636363|65470547|FG000|Overall Study|Lost to Follow-up|3|||
23471005|NCT00636363|65470548|FG001|Overall Study|Lost to Follow-up|4|||
23471006|NCT00636363|65470549|FG002|Overall Study|Lost to Follow-up|2|||
23471007|NCT00636363|65470547|FG000|Overall Study|Withdrawal by Subject|1|||
23471008|NCT00636363|65470548|FG001|Overall Study|Withdrawal by Subject|3|||
23471009|NCT00636363|65470549|FG002|Overall Study|Withdrawal by Subject|2|||
23471010|NCT00724867|65470550|FG000|Overall Study|Adverse Event|25|||
23471011|NCT00724867|65470550|FG000|Overall Study|Lack of Efficacy|14|||
23471012|NCT00724867|65470550|FG000|Overall Study|Lost to Follow-up|12|||
23471013|NCT00724867|65470550|FG000|Overall Study|Non-compliance with study drug|6|||
23471014|NCT00724867|65470550|FG000|Overall Study|Physician Decision|17|||
23471015|NCT00724867|65470550|FG000|Overall Study|Protocol Violation|1|||
23471016|NCT00724867|65470550|FG000|Overall Study|Withdrawal by Subject|31|||
23471017|NCT00724867|65470550|FG000|Overall Study|Sponsor decision to end study|14|||
23471018|NCT00724867|65470550|FG000|Overall Study|Subject incarcerated|1|||
23471019|NCT00724867|65470550|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
23471020|NCT00724867|65470550|FG000|Overall Study|Subject moved out of state|1|||
23471021|NCT00724867|65470550|FG000|Overall Study|Elected to exit due to site closure|2|||
23471022|NCT00834080|65470551|FG000|Overall Study|Adverse Event|7|||
23471023|NCT00834080|65470551|FG000|Overall Study|Lost to Follow-up|7|||
23471024|NCT00834080|65470551|FG000|Overall Study|Withdrawal by Subject|5|||
23471025|NCT00834080|65470551|FG000|Overall Study|Other - Pregnancy|1|||
23587561|NCT01689519|65879160|FG000|Intent to Treat|Withdrawal by Subject|21|||
23587562|NCT01689519|65879161|FG001|Intent to Treat|Withdrawal by Subject|20|||
23587563|NCT01689519|65879160|FG000|Safety Population|Death|158|||
23587564|NCT01689519|65879161|FG001|Safety Population|Death|165|||
23587565|NCT01689519|65879160|FG000|Safety Population|Lost to Follow-up|4|||
23471026|NCT00834080|65470551|FG000|Overall Study|Other - False positive tests of the UDS|1|||
23471027|NCT00834080|65470551|FG000|Overall Study|Physician Decision|1|||
23471028|NCT00834080|65470551|FG000|Overall Study|Subject Relocated|1|||
23471029|NCT02118961|65470553|FG000|Overall Study|Withdrawal by Subject|1|||
23471030|NCT02118961|65470554|FG001|Overall Study|Withdrawal by Subject|0|||
23471031|NCT03698591|65470555|FG000|Overall Study|Withdrawal by Subject|2|||
23471032|NCT03698591|65470556|FG001|Overall Study|Withdrawal by Subject|2|||
23471033|NCT03698591|65470555|FG000|Overall Study|Failed drug screen|1|||
23471034|NCT03698591|65470556|FG001|Overall Study|Failed drug screen|1|||
23471035|NCT03698591|65470555|FG000|Overall Study|Failed health screen|0|||
23471036|NCT03698591|65470556|FG001|Overall Study|Failed health screen|1|||
23471037|NCT03698591|65470555|FG000|Overall Study|Ineligible for financial compensation|1|||
23795171|NCT01872715|66626656|FG000|Overall Study|Protocol Violation|1|||
23795172|NCT01872715|66626656|FG000|Overall Study|Withdrawal by Subject|2|||
23795173|NCT03407729|66626657|FG000|Overall Study|Lost to Follow-up|2|||
23354277|NCT02557516|65041378|FG001|Overall Study|Adverse Event|0|||
23354278|NCT02557516|65041379|FG002|Overall Study|Adverse Event|2|||
23354279|NCT02557516|65041380|FG003|Overall Study|Adverse Event|1|||
23354280|NCT02557516|65041377|FG000|Overall Study|Disease progression|0|||
23354281|NCT02557516|65041378|FG001|Overall Study|Disease progression|2|||
23354282|NCT02557516|65041379|FG002|Overall Study|Disease progression|0|||
23587566|NCT01689519|65879161|FG001|Safety Population|Lost to Follow-up|8|||
23587567|NCT01689519|65879160|FG000|Safety Population|Other|2|||
23587568|NCT01689519|65879161|FG001|Safety Population|Other|4|||
23587569|NCT01689519|65879160|FG000|Safety Population|Physician Decision|4|||
23587570|NCT01689519|65879161|FG001|Safety Population|Physician Decision|1|||
23587571|NCT01689519|65879160|FG000|Safety Population|Study Terminated By Sponsor|60|||
23587572|NCT01689519|65879161|FG001|Safety Population|Study Terminated By Sponsor|47|||
23587573|NCT01689519|65879160|FG000|Safety Population|Withdrawal by Subject|20|||
23587574|NCT01689519|65879161|FG001|Safety Population|Withdrawal by Subject|20|||
23587575|NCT00831415|65879162|FG000|Overall Study|Adverse Event|14|||
23587576|NCT00831415|65879162|FG000|Overall Study|Failed to return|3|||
23587577|NCT00831415|65879162|FG000|Overall Study|Physician Decision|6|||
23587578|NCT00831415|65879162|FG000|Overall Study|Lost to Follow-up|9|||
23587579|NCT00831415|65879162|FG000|Overall Study|Protocol Violation|3|||
23587580|NCT00831415|65879162|FG000|Overall Study|Withdrawal by Subject|35|||
23587581|NCT00831415|65879162|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
23587582|NCT00831415|65879162|FG000|Overall Study|Death|1|||
23587583|NCT05179837|65879163|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
23587584|NCT05179837|65879163|FG000|Overall Study|Device malfunctioned|1|||
23587585|NCT05179837|65879163|FG000|Overall Study|Image quality too low|2|||
23587586|NCT01048788|65879164|FG000|Overall Study|Adverse Event|5|||
23587587|NCT01048788|65879165|FG001|Overall Study|Adverse Event|1|||
23587588|NCT01048788|65879166|FG002|Overall Study|Adverse Event|1|||
23587589|NCT01048788|65879164|FG000|Overall Study|Lack of Efficacy|0|||
23587590|NCT01048788|65879165|FG001|Overall Study|Lack of Efficacy|0|||
23587591|NCT01048788|65879166|FG002|Overall Study|Lack of Efficacy|1|||
23587592|NCT01048788|65879164|FG000|Overall Study|Withdrawal by Subject|0|||
23587593|NCT01048788|65879165|FG001|Overall Study|Withdrawal by Subject|1|||
23587594|NCT01048788|65879166|FG002|Overall Study|Withdrawal by Subject|0|||
23587595|NCT01460342|65879169|FG000|Overall Study|Adverse Event|5|||
23587596|NCT01460342|65879170|FG001|Overall Study|Adverse Event|4|||
23587597|NCT01460342|65879169|FG000|Overall Study|Lost to Follow-up|1|||
23587598|NCT01460342|65879170|FG001|Overall Study|Lost to Follow-up|2|||
23587599|NCT01460342|65879169|FG000|Overall Study|Protocol Violation|0|||
23587600|NCT01460342|65879170|FG001|Overall Study|Protocol Violation|1|||
23587601|NCT01460342|65879169|FG000|Overall Study|Withdrawal by Subject|3|||
23587602|NCT01460342|65879170|FG001|Overall Study|Withdrawal by Subject|4|||
23587603|NCT01460342|65879169|FG000|Overall Study|Physician Decision|1|||
23587604|NCT01460342|65879170|FG001|Overall Study|Physician Decision|3|||
23587605|NCT01460342|65879169|FG000|Overall Study|Lack of Efficacy|1|||
23587606|NCT01460342|65879170|FG001|Overall Study|Lack of Efficacy|0|||
23587607|NCT00157014|65879171|FG000|Overall Study|Death|4|||
23587608|NCT00157014|65879172|FG001|Overall Study|Death|2|||
23587609|NCT00157014|65879173|FG002|Overall Study|Death|1|||
23587610|NCT00157014|65879174|FG003|Overall Study|Death|1|||
23587611|NCT00157014|65879171|FG000|Overall Study|Physician Decision|0|||
23587612|NCT00157014|65879172|FG001|Overall Study|Physician Decision|1|||
23587613|NCT00157014|65879173|FG002|Overall Study|Physician Decision|0|||
23587614|NCT00157014|65879174|FG003|Overall Study|Physician Decision|0|||
23587615|NCT00157014|65879171|FG000|Overall Study|Medications withdrawn on family request|0|||
23587616|NCT00157014|65879172|FG001|Overall Study|Medications withdrawn on family request|1|||
23587617|NCT00157014|65879173|FG002|Overall Study|Medications withdrawn on family request|0|||
23587618|NCT00157014|65879174|FG003|Overall Study|Medications withdrawn on family request|0|||
23587619|NCT00157014|65879171|FG000|Overall Study|Patient withdrawn by investigator|1|||
23587620|NCT00157014|65879172|FG001|Overall Study|Patient withdrawn by investigator|0|||
23587621|NCT00157014|65879173|FG002|Overall Study|Patient withdrawn by investigator|0|||
23587622|NCT00157014|65879174|FG003|Overall Study|Patient withdrawn by investigator|0|||
23587623|NCT00157014|65879171|FG000|Overall Study|Patient unable to return in nursing home|1|||
23587624|NCT00157014|65879172|FG001|Overall Study|Patient unable to return in nursing home|0|||
23587625|NCT00157014|65879173|FG002|Overall Study|Patient unable to return in nursing home|0|||
23587626|NCT00157014|65879174|FG003|Overall Study|Patient unable to return in nursing home|0|||
23795174|NCT03407729|66626658|FG001|Overall Study|Lost to Follow-up|0|||
23795175|NCT03407729|66626657|FG000|Overall Study|Unable to schedule|0|||
23795176|NCT03407729|66626658|FG001|Overall Study|Unable to schedule|3|||
23795177|NCT00879684|66626663|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
23354283|NCT02557516|65041380|FG003|Overall Study|Disease progression|0|||
23354284|NCT02557516|65041377|FG000|Overall Study|Physician Decision|0|||
23640967|NCT01691768|66071531|FG001|Overall Study|Relocated|1|||
23471038|NCT03698591|65470556|FG001|Overall Study|Ineligible for financial compensation|0|||
23471039|NCT03698591|65470555|FG000|Overall Study|Equipment Error|1|||
23471040|NCT03698591|65470556|FG001|Overall Study|Equipment Error|0|||
23795178|NCT00879684|66626664|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
23795179|NCT00879684|66626665|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
23795180|NCT00879684|66626666|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
23795181|NCT00879684|66626667|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
23795182|NCT00879684|66626668|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
23795183|NCT00879684|66626669|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
23795184|NCT00879684|66626663|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
23795185|NCT00879684|66626664|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
23795186|NCT00879684|66626665|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
23795187|NCT00879684|66626666|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
23795188|NCT00879684|66626667|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
23795189|NCT00879684|66626668|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
23795190|NCT00879684|66626669|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
23795191|NCT00879684|66626663|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
23640968|NCT01691768|66071530|FG000|Overall Study|Investigator decision|1|||
23640969|NCT01691768|66071531|FG001|Overall Study|Investigator decision|1|||
23471041|NCT03698591|65470555|FG000|Overall Study|Could not establish TMS dosage|0|||
23471042|NCT03698591|65470556|FG001|Overall Study|Could not establish TMS dosage|1|||
23471043|NCT03083990|65470557|FG000|Overall Study|Adverse Event|1|||
23471044|NCT03083990|65470558|FG001|Overall Study|Adverse Event|0|||
23471045|NCT00640224|65470561|FG000|Overall Study|Lost to Follow-up|5|||
23471046|NCT00640224|65470562|FG001|Overall Study|Lost to Follow-up|2|||
23471047|NCT00640224|65470563|FG002|Overall Study|Lost to Follow-up|0|||
23471048|NCT00640224|65470564|FG003|Overall Study|Lost to Follow-up|0|||
23471049|NCT00640224|65470561|FG000|Overall Study|Withdrawal by Subject|1|||
23471050|NCT00640224|65470562|FG001|Overall Study|Withdrawal by Subject|0|||
23471051|NCT00640224|65470563|FG002|Overall Study|Withdrawal by Subject|0|||
23640970|NCT02576587|66071532|FG000|Baseline|Equipment failure|0|||
23795192|NCT00879684|66626664|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
23795193|NCT00879684|66626665|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
23795194|NCT00879684|66626666|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
23795195|NCT00879684|66626667|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
23795196|NCT00879684|66626668|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
23795197|NCT00879684|66626669|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
23795198|NCT00879684|66626663|FG000|Stage 1: Dose Escalation|Death|0|||
23795199|NCT00879684|66626664|FG001|Stage 1: Dose Escalation|Death|0|||
23795200|NCT00879684|66626665|FG002|Stage 1: Dose Escalation|Death|1|||
23795201|NCT00879684|66626666|FG003|Stage 1: Dose Escalation|Death|0|||
23795202|NCT00879684|66626667|FG004|Stage 1: Dose Escalation|Death|0|||
23795203|NCT00879684|66626668|FG005|Stage 1: Dose Escalation|Death|0|||
23795204|NCT00879684|66626669|FG006|Stage 1: Dose Escalation|Death|0|||
23795205|NCT00879684|66626663|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795206|NCT00879684|66626664|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795207|NCT00879684|66626665|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795208|NCT00879684|66626666|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795209|NCT00879684|66626667|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795210|NCT00879684|66626668|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23795211|NCT00879684|66626669|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
23795212|NCT00879684|66626663|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795213|NCT00879684|66626664|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795214|NCT00879684|66626665|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795215|NCT00879684|66626666|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795216|NCT00879684|66626667|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795217|NCT00879684|66626668|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
23795218|NCT00879684|66626669|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
23471052|NCT00640224|65470564|FG003|Overall Study|Withdrawal by Subject|0|||
23587627|NCT00157014|65879171|FG000|Overall Study|Patient would not receive transplant|0|||
23587628|NCT00157014|65879172|FG001|Overall Study|Patient would not receive transplant|1|||
23471053|NCT00640224|65470561|FG000|Overall Study|Headaches|0|||
23587629|NCT00157014|65879173|FG002|Overall Study|Patient would not receive transplant|0|||
23587630|NCT00157014|65879174|FG003|Overall Study|Patient would not receive transplant|0|||
23587631|NCT00157014|65879171|FG000|Overall Study|Withdrawal by Subject|1|||
23587632|NCT00157014|65879172|FG001|Overall Study|Withdrawal by Subject|0|||
23640971|NCT02576587|66071533|FG001|Baseline|Equipment failure|1|||
23706840|NCT00002663|66301346|FG007|Overall Study|Other|0|||
23471054|NCT00640224|65470562|FG001|Overall Study|Headaches|1|||
23471055|NCT00640224|65470563|FG002|Overall Study|Headaches|0|||
23471056|NCT00640224|65470564|FG003|Overall Study|Headaches|0|||
23471057|NCT04556383|65470565|FG000|PCP|Lack of Efficacy|28|||
23471058|NCT04556383|65470566|FG001|PCP|Lack of Efficacy|23|||
23471059|NCT04556383|65470567|FG002|PCP|Lack of Efficacy|23|||
23471060|NCT04556383|65470568|FG003|PCP|Lack of Efficacy|0|||
23471061|NCT04556383|65470565|FG000|PCP|Study terminated by sponsor|15|||
23471062|NCT04556383|65470566|FG001|PCP|Study terminated by sponsor|13|||
23471063|NCT04556383|65470567|FG002|PCP|Study terminated by sponsor|16|||
23471064|NCT04556383|65470568|FG003|PCP|Study terminated by sponsor|0|||
23795219|NCT00879684|66626663|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795220|NCT00879684|66626664|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795221|NCT00879684|66626665|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795222|NCT00879684|66626666|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795223|NCT00879684|66626667|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795224|NCT00879684|66626668|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23795225|NCT00879684|66626669|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
23795226|NCT02786927|66626670|FG000|Overall Study|Adverse Event|1|||
23795227|NCT02786927|66626670|FG000|Overall Study|Protocol Violation|4|||
23795228|NCT01341405|66626671|FG000|Overall Study|Adverse Event|0|||
23795229|NCT01341405|66626672|FG001|Overall Study|Adverse Event|1|||
23795230|NCT01341405|66626673|FG002|Overall Study|Adverse Event|1|||
23795231|NCT01341405|66626671|FG000|Overall Study|Withdrawal by Subject|3|||
23795232|NCT01341405|66626672|FG001|Overall Study|Withdrawal by Subject|2|||
23795233|NCT01341405|66626673|FG002|Overall Study|Withdrawal by Subject|1|||
23795234|NCT03448692|66626676|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
23795235|NCT03448692|66626677|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
23795236|NCT03448692|66626676|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
23795237|NCT03448692|66626677|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
23795238|NCT03448692|66626676|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
23795239|NCT03448692|66626677|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
23795240|NCT03448692|66626676|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
23795241|NCT03448692|66626677|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
23795242|NCT03448692|66626676|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
23471065|NCT04556383|65470565|FG000|PCP|Withdrawal by Subject|8|||
23471066|NCT04556383|65470566|FG001|PCP|Withdrawal by Subject|6|||
23471067|NCT04556383|65470567|FG002|PCP|Withdrawal by Subject|6|||
23471068|NCT04556383|65470568|FG003|PCP|Withdrawal by Subject|0|||
23471069|NCT04556383|65470565|FG000|PCP|Adverse Event|1|||
23471070|NCT04556383|65470566|FG001|PCP|Adverse Event|7|||
23471071|NCT04556383|65470567|FG002|PCP|Adverse Event|7|||
23471072|NCT04556383|65470568|FG003|PCP|Adverse Event|0|||
23471073|NCT04556383|65470565|FG000|PCP|Other, Not Specified|1|||
23471074|NCT04556383|65470566|FG001|PCP|Other, Not Specified|2|||
23471075|NCT04556383|65470567|FG002|PCP|Other, Not Specified|1|||
23471076|NCT04556383|65470568|FG003|PCP|Other, Not Specified|0|||
23471077|NCT04556383|65470565|FG000|PCP|Protocol Violation|1|||
23471078|NCT04556383|65470566|FG001|PCP|Protocol Violation|0|||
23471079|NCT04556383|65470567|FG002|PCP|Protocol Violation|1|||
23471080|NCT04556383|65470568|FG003|PCP|Protocol Violation|0|||
23471081|NCT04556383|65470565|FG000|PCP|Lost to Follow-up|1|||
23471082|NCT04556383|65470566|FG001|PCP|Lost to Follow-up|0|||
23471083|NCT04556383|65470567|FG002|PCP|Lost to Follow-up|0|||
23471084|NCT04556383|65470568|FG003|PCP|Lost to Follow-up|0|||
23471085|NCT04556383|65470565|FG000|PCP|Physician Decision|0|||
23587633|NCT00157014|65879173|FG002|Overall Study|Withdrawal by Subject|0|||
23587634|NCT00157014|65879174|FG003|Overall Study|Withdrawal by Subject|0|||
23587635|NCT01713530|65879176|FG000|Overall Study|Adverse Event|0|||
23587636|NCT01713530|65879177|FG001|Overall Study|Adverse Event|5|||
23587637|NCT01713530|65879176|FG000|Overall Study|Withdrawal criteria|21|||
23587638|NCT01713530|65879177|FG001|Overall Study|Withdrawal criteria|12|||
23587639|NCT01713530|65879176|FG000|Overall Study|Unclassified|4|||
23587640|NCT01713530|65879177|FG001|Overall Study|Unclassified|2|||
23354285|NCT02557516|65041378|FG001|Overall Study|Physician Decision|2|||
23471086|NCT04556383|65470566|FG001|PCP|Physician Decision|1|||
23471087|NCT04556383|65470567|FG002|PCP|Physician Decision|0|||
23471088|NCT04556383|65470568|FG003|PCP|Physician Decision|0|||
23471089|NCT04556383|65470565|FG000|PCP|Site terminated by sponsor|0|||
23471090|NCT04556383|65470566|FG001|PCP|Site terminated by sponsor|1|||
23471091|NCT04556383|65470567|FG002|PCP|Site terminated by sponsor|0|||
23471092|NCT04556383|65470568|FG003|PCP|Site terminated by sponsor|0|||
23471093|NCT04556383|65470565|FG000|OLE|Study terminated by sponsor|0|||
23471094|NCT04556383|65470566|FG001|OLE|Study terminated by sponsor|0|||
23471095|NCT04556383|65470567|FG002|OLE|Study terminated by sponsor|0|||
23587641|NCT00217672|65879183|FG000|Allocation|Ineligible|2|||
23471096|NCT04556383|65470568|FG003|OLE|Study terminated by sponsor|68|||
23471097|NCT04556383|65470565|FG000|OLE|Withdrawal by Subject|0|||
23640972|NCT02576587|66071532|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
23640973|NCT02576587|66071533|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
23640974|NCT02576587|66071532|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
23640975|NCT02576587|66071533|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
23471098|NCT04556383|65470566|FG001|OLE|Withdrawal by Subject|0|||
23471099|NCT04556383|65470567|FG002|OLE|Withdrawal by Subject|0|||
23471100|NCT04556383|65470568|FG003|OLE|Withdrawal by Subject|10|||
23471101|NCT04556383|65470565|FG000|OLE|Lack of Efficacy|0|||
23471102|NCT04556383|65470566|FG001|OLE|Lack of Efficacy|0|||
23471103|NCT04556383|65470567|FG002|OLE|Lack of Efficacy|0|||
23471104|NCT04556383|65470568|FG003|OLE|Lack of Efficacy|7|||
23471105|NCT04556383|65470565|FG000|OLE|Adverse Event|0|||
23471106|NCT04556383|65470566|FG001|OLE|Adverse Event|0|||
23471107|NCT04556383|65470567|FG002|OLE|Adverse Event|0|||
23471108|NCT04556383|65470568|FG003|OLE|Adverse Event|2|||
23471109|NCT04556383|65470565|FG000|OLE|Other, Not Specified|0|||
23471110|NCT04556383|65470566|FG001|OLE|Other, Not Specified|0|||
23471111|NCT04556383|65470567|FG002|OLE|Other, Not Specified|0|||
23471112|NCT04556383|65470568|FG003|OLE|Other, Not Specified|2|||
23471113|NCT04556383|65470565|FG000|OLE|Death|0|||
23471114|NCT04556383|65470566|FG001|OLE|Death|0|||
23471115|NCT04556383|65470567|FG002|OLE|Death|0|||
23471116|NCT04556383|65470568|FG003|OLE|Death|1|||
23471117|NCT04556383|65470565|FG000|OLE|Lost to Follow-up|0|||
23471118|NCT04556383|65470566|FG001|OLE|Lost to Follow-up|0|||
23471119|NCT04556383|65470567|FG002|OLE|Lost to Follow-up|0|||
23471120|NCT04556383|65470568|FG003|OLE|Lost to Follow-up|1|||
23471121|NCT01587898|65470569|FG000|Overall Study|Adverse Event|1|||
23471122|NCT01587898|65470570|FG001|Overall Study|Adverse Event|1|||
23471123|NCT01587898|65470571|FG002|Overall Study|Adverse Event|0|||
23471124|NCT01587898|65470572|FG003|Overall Study|Adverse Event|0|||
23471125|NCT01587898|65470569|FG000|Overall Study|Protocol Violation|0|||
23471126|NCT01587898|65470570|FG001|Overall Study|Protocol Violation|2|||
23471127|NCT01587898|65470571|FG002|Overall Study|Protocol Violation|1|||
23471128|NCT01587898|65470572|FG003|Overall Study|Protocol Violation|1|||
23471129|NCT01587898|65470569|FG000|Overall Study|Lost to Follow-up|0|||
23471130|NCT01587898|65470570|FG001|Overall Study|Lost to Follow-up|0|||
23471131|NCT01587898|65470571|FG002|Overall Study|Lost to Follow-up|0|||
23471132|NCT01587898|65470572|FG003|Overall Study|Lost to Follow-up|1|||
23471133|NCT01587898|65470569|FG000|Overall Study|Withdrawal by Subject|2|||
23471134|NCT01587898|65470570|FG001|Overall Study|Withdrawal by Subject|1|||
23471135|NCT01587898|65470571|FG002|Overall Study|Withdrawal by Subject|0|||
23471136|NCT01587898|65470572|FG003|Overall Study|Withdrawal by Subject|0|||
23471137|NCT01587898|65470569|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
23471138|NCT01587898|65470570|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
23471139|NCT01587898|65470571|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
23471140|NCT01587898|65470572|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
23471141|NCT04027608|65470576|FG000|Overall Study|Withdrawal by Subject|13|||
23471142|NCT04027608|65470577|FG001|Overall Study|Withdrawal by Subject|2|||
23471143|NCT04027608|65470576|FG000|Overall Study|Protocol Violation|2|||
23471144|NCT04027608|65470577|FG001|Overall Study|Protocol Violation|1|||
23471145|NCT04027608|65470576|FG000|Overall Study|Physician Decision|1|||
23471146|NCT04027608|65470577|FG001|Overall Study|Physician Decision|0|||
23640976|NCT02576587|66071532|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
23640977|NCT02576587|66071533|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
23471147|NCT04027608|65470576|FG000|Overall Study|Lost to Follow-up|20|||
23471148|NCT04027608|65470577|FG001|Overall Study|Lost to Follow-up|4|||
23471149|NCT01994889|65470591|FG000|Overall Study|Adverse Event|5|||
23471150|NCT01994889|65470592|FG001|Overall Study|Adverse Event|12|||
23471151|NCT01994889|65470593|FG002|Overall Study|Adverse Event|11|||
23471152|NCT01994889|65470591|FG000|Overall Study|Cardiac Device Implantation|0|||
23471153|NCT01994889|65470592|FG001|Overall Study|Cardiac Device Implantation|2|||
23471154|NCT01994889|65470593|FG002|Overall Study|Cardiac Device Implantation|0|||
23471155|NCT01994889|65470591|FG000|Overall Study|Organ Transplantation|1|||
23354286|NCT02557516|65041379|FG002|Overall Study|Physician Decision|0|||
23471156|NCT01994889|65470592|FG001|Overall Study|Organ Transplantation|5|||
23471157|NCT01994889|65470593|FG002|Overall Study|Organ Transplantation|5|||
23471158|NCT01994889|65470591|FG000|Overall Study|No longer willing to participate|8|||
23471159|NCT01994889|65470592|FG001|Overall Study|No longer willing to participate|17|||
23471160|NCT01994889|65470593|FG002|Overall Study|No longer willing to participate|37|||
23471161|NCT01994889|65470591|FG000|Overall Study|Lost to Follow-up|0|||
23471162|NCT01994889|65470592|FG001|Overall Study|Lost to Follow-up|1|||
23471163|NCT01994889|65470593|FG002|Overall Study|Lost to Follow-up|0|||
23471164|NCT01994889|65470591|FG000|Overall Study|Protocol Violation|0|||
23471165|NCT01994889|65470592|FG001|Overall Study|Protocol Violation|1|||
23471166|NCT01994889|65470593|FG002|Overall Study|Protocol Violation|1|||
23471167|NCT01994889|65470591|FG000|Overall Study|Death|14|||
23471168|NCT01994889|65470592|FG001|Overall Study|Death|25|||
23640978|NCT04101318|66071534|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
23640979|NCT04101318|66071535|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
23640980|NCT04101318|66071534|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
23640981|NCT04101318|66071535|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
23640982|NCT04101318|66071534|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
23640983|NCT04101318|66071535|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
23640984|NCT02040259|66071538|FG000|Overall Study|Death|280|||
23640985|NCT02040259|66071538|FG000|Overall Study|Lost to Follow-up|76|||
23640986|NCT02040259|66071538|FG000|Overall Study|Assessment not completed|3|||
23640987|NCT02040259|66071538|FG000|Overall Study|Withdrawal by Subject|4|||
23640988|NCT03435692|66071539|FG000|Overall Study|Lack of Efficacy|2|||
23640989|NCT03435692|66071540|FG001|Overall Study|Lack of Efficacy|2|||
23640990|NCT03435692|66071541|FG002|Overall Study|Lack of Efficacy|0|||
23640991|NCT04958642|66071542|FG000|Overall Study|Transferred to OLEX program|3|||
23640992|NCT04958642|66071543|FG001|Overall Study|Transferred to OLEX program|0|||
23640993|NCT04958642|66071544|FG002|Overall Study|Transferred to OLEX program|5|||
23640994|NCT04958642|66071542|FG000|Overall Study|Death|0|||
23640995|NCT04958642|66071543|FG001|Overall Study|Death|0|||
23640996|NCT04958642|66071544|FG002|Overall Study|Death|1|||
23640997|NCT04958642|66071542|FG000|Overall Study|Withdrawal by Subject|4|||
23587642|NCT00217672|65879184|FG001|Allocation|Ineligible|0|||
23354287|NCT02557516|65041380|FG003|Overall Study|Physician Decision|0|||
23354288|NCT02557516|65041377|FG000|Overall Study|Sponsor decision|0|||
23587643|NCT00217672|65879183|FG000|Treatment|disease progression|33|||
23587644|NCT00217672|65879184|FG001|Treatment|disease progression|4|||
23587645|NCT00217672|65879183|FG000|Treatment|Adverse Event|18|||
23587646|NCT00217672|65879184|FG001|Treatment|Adverse Event|2|||
23587647|NCT00217672|65879183|FG000|Treatment|reqd treatment not permitted by protocol|6|||
23587648|NCT00217672|65879184|FG001|Treatment|reqd treatment not permitted by protocol|0|||
23587649|NCT00217672|65879183|FG000|Treatment|Physician Decision|6|||
23587650|NCT00217672|65879184|FG001|Treatment|Physician Decision|0|||
23587651|NCT00217672|65879183|FG000|Treatment|insurance issues|1|||
23587652|NCT00217672|65879184|FG001|Treatment|insurance issues|1|||
23587653|NCT00217672|65879183|FG000|Treatment|Death|2|||
23587654|NCT00217672|65879184|FG001|Treatment|Death|0|||
23587655|NCT00217672|65879183|FG000|Treatment|secondary malignancy|1|||
23587656|NCT00217672|65879184|FG001|Treatment|secondary malignancy|0|||
23640998|NCT04958642|66071543|FG001|Overall Study|Withdrawal by Subject|9|||
23640999|NCT04958642|66071544|FG002|Overall Study|Withdrawal by Subject|13|||
23641000|NCT04958642|66071542|FG000|Overall Study|Investigator's Decision|0|||
23641001|NCT04958642|66071543|FG001|Overall Study|Investigator's Decision|0|||
23795243|NCT03448692|66626677|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
23795244|NCT01214239|66626678|FG000|Overall Study|Adverse Event|3|||
23795245|NCT01214239|66626679|FG001|Overall Study|Adverse Event|4|||
23795246|NCT01214239|66626678|FG000|Overall Study|Protocol Violation|2|||
23795247|NCT01214239|66626679|FG001|Overall Study|Protocol Violation|1|||
23795248|NCT01214239|66626678|FG000|Overall Study|Lost to Follow-up|1|||
23795249|NCT01214239|66626679|FG001|Overall Study|Lost to Follow-up|1|||
23795250|NCT01214239|66626678|FG000|Overall Study|Withdrawal by Subject|4|||
23795251|NCT01214239|66626679|FG001|Overall Study|Withdrawal by Subject|9|||
23795252|NCT01214239|66626678|FG000|Overall Study|Lack of Efficacy|1|||
23587657|NCT00217672|65879183|FG000|Follow-up|Withdrawal by Subject|4|||
23587658|NCT00217672|65879184|FG001|Follow-up|Withdrawal by Subject|0|||
23354289|NCT02557516|65041378|FG001|Overall Study|Sponsor decision|1|||
23354290|NCT02557516|65041379|FG002|Overall Study|Sponsor decision|2|||
23354291|NCT02557516|65041380|FG003|Overall Study|Sponsor decision|8|||
23354292|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
23354293|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354294|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354295|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
23354296|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
23354297|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
23354298|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
23354299|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354300|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354301|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354302|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354303|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354304|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354305|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354306|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354307|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354308|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354309|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354310|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354311|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354312|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354313|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354314|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354315|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354316|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354317|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354318|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354319|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23471169|NCT01994889|65470593|FG002|Overall Study|Death|38|||
23471170|NCT00001213|65470594|FG000|Overall Study|Death|18|||
23471171|NCT01657461|65470598|FG000|Overall Study|Death|9|||
23471172|NCT01657461|65470599|FG001|Overall Study|Death|12|||
23471173|NCT01657461|65470598|FG000|Overall Study|Lost to Follow-up|0|||
23471174|NCT01657461|65470599|FG001|Overall Study|Lost to Follow-up|3|||
23471175|NCT01657461|65470598|FG000|Overall Study|Physician Decision|0|||
23471176|NCT01657461|65470599|FG001|Overall Study|Physician Decision|2|||
23471177|NCT01657461|65470598|FG000|Overall Study|Withdrawal by Subject|1|||
23471178|NCT01657461|65470599|FG001|Overall Study|Withdrawal by Subject|3|||
23354320|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
23471179|NCT04543279|65470602|FG000|Overall Study|Withdrawal by Subject|1|||
23471180|NCT04543279|65470603|FG001|Overall Study|Withdrawal by Subject|0|||
23471181|NCT04543279|65470602|FG000|Overall Study|Adverse Event|1|||
23471182|NCT04543279|65470603|FG001|Overall Study|Adverse Event|0|||
23471183|NCT04543279|65470602|FG000|Overall Study|Physician Decision|1|||
23587659|NCT00217672|65879183|FG000|Follow-up|Lost to Follow-up|1|||
23587660|NCT00217672|65879184|FG001|Follow-up|Lost to Follow-up|0|||
23587661|NCT03999554|65879187|FG000|Overall Study|Lost to Follow-up|4|||
23471184|NCT04543279|65470603|FG001|Overall Study|Physician Decision|0|||
23471185|NCT00530504|65470606|FG000|Overall Study|Death|54|||
23471186|NCT00530504|65470606|FG000|Overall Study|Lost to Follow-up|26|||
23471187|NCT00530504|65470606|FG000|Overall Study|Withdrawal by Subject|39|||
23587662|NCT03999554|65879188|FG001|Overall Study|Lost to Follow-up|5|||
23587663|NCT03999554|65879189|FG002|Overall Study|Lost to Follow-up|4|||
23587664|NCT03999554|65879190|FG003|Overall Study|Lost to Follow-up|5|||
23354321|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354322|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23641002|NCT04958642|66071544|FG002|Overall Study|Investigator's Decision|1|||
23641003|NCT04958642|66071542|FG000|Overall Study|Adverse Event|1|||
23641004|NCT04958642|66071543|FG001|Overall Study|Adverse Event|0|||
23641005|NCT04958642|66071544|FG002|Overall Study|Adverse Event|1|||
23641006|NCT04958642|66071542|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
23641007|NCT04958642|66071543|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
23641008|NCT04958642|66071544|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
23641009|NCT04958642|66071542|FG000|Overall Study|Lost to Follow-up|1|||
23641010|NCT04958642|66071543|FG001|Overall Study|Lost to Follow-up|0|||
23641011|NCT04958642|66071544|FG002|Overall Study|Lost to Follow-up|0|||
23641012|NCT04958642|66071542|FG000|Overall Study|Transferred to EAP following study termination|0|||
23641013|NCT04958642|66071543|FG001|Overall Study|Transferred to EAP following study termination|0|||
23641014|NCT04958642|66071544|FG002|Overall Study|Transferred to EAP following study termination|1|||
23641015|NCT04958642|66071542|FG000|Overall Study|Transferred to Expanded Access Program|1|||
23641016|NCT04958642|66071543|FG001|Overall Study|Transferred to Expanded Access Program|0|||
23641017|NCT04958642|66071544|FG002|Overall Study|Transferred to Expanded Access Program|0|||
23641018|NCT00743431|66071546|FG000|Overall Study|Toxicity|6|||
23641019|NCT00743431|66071546|FG000|Overall Study|Tumor progression|56|||
23641020|NCT00743431|66071546|FG000|Overall Study|Withdrawal by Subject|13|||
23641021|NCT00743431|66071546|FG000|Overall Study|Death|9|||
23641022|NCT00743431|66071546|FG000|Overall Study|Reason for discontinuation not specified|29|||
23641023|NCT00743431|66071546|FG000|Overall Study|No documentation available|13|||
23641024|NCT00831129|66071551|FG000|Overall Study|Adverse Event|0|||
23641025|NCT00831129|66071552|FG001|Overall Study|Adverse Event|1|||
23641026|NCT00831129|66071551|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
23641027|NCT00831129|66071552|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
23641028|NCT01867333|66071553|FG000|Overall Study|Withdrawal by Subject|1|||
23641029|NCT01867333|66071554|FG001|Overall Study|Withdrawal by Subject|0|||
23641030|NCT01867333|66071553|FG000|Overall Study|Adverse Event|1|||
23641031|NCT01867333|66071554|FG001|Overall Study|Adverse Event|0|||
23641032|NCT01867333|66071553|FG000|Overall Study|Participant choice|1|||
23641033|NCT01867333|66071554|FG001|Overall Study|Participant choice|2|||
23641034|NCT01867333|66071553|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
23641035|NCT01867333|66071554|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
23641036|NCT01867333|66071553|FG000|Overall Study|Death|0|||
23641037|NCT01867333|66071554|FG001|Overall Study|Death|1|||
23641038|NCT01867333|66071553|FG000|Overall Study|Physician Decision|3|||
23641039|NCT01867333|66071554|FG001|Overall Study|Physician Decision|2|||
23641040|NCT01867333|66071553|FG000|Overall Study|Switched to alternative treatment|1|||
23641041|NCT01867333|66071554|FG001|Overall Study|Switched to alternative treatment|0|||
23641042|NCT00532493|66071556|FG000|Overall Study|Death|1|||
23641043|NCT00532493|66071557|FG001|Overall Study|Death|1|||
23641044|NCT00532493|66071556|FG000|Overall Study|Lost to Follow-up|10|||
23641045|NCT00532493|66071557|FG001|Overall Study|Lost to Follow-up|7|||
23641046|NCT00532493|66071556|FG000|Overall Study|Withdrawal by Subject|7|||
23641047|NCT00532493|66071557|FG001|Overall Study|Withdrawal by Subject|9|||
23641048|NCT00532493|66071556|FG000|Overall Study|Physician Decision|1|||
23641049|NCT00532493|66071557|FG001|Overall Study|Physician Decision|6|||
23641050|NCT00532493|66071556|FG000|Overall Study|Adverse Event|6|||
23641051|NCT00532493|66071557|FG001|Overall Study|Adverse Event|5|||
23641052|NCT00532493|66071556|FG000|Overall Study|Protocol Deviation|1|||
23641053|NCT00532493|66071557|FG001|Overall Study|Protocol Deviation|0|||
23641054|NCT00532493|66071556|FG000|Overall Study|Subject Moved Away|3|||
23641055|NCT00532493|66071557|FG001|Overall Study|Subject Moved Away|1|||
23641056|NCT00532493|66071556|FG000|Overall Study|Contraindicative Medication|1|||
23641057|NCT00532493|66071557|FG001|Overall Study|Contraindicative Medication|0|||
23641058|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
23641059|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23641060|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23641061|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23641062|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23641063|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23641064|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
23641065|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23641066|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23641067|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23641068|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23641069|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23641070|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
23641071|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23641072|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23641073|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23641074|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23641075|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23587665|NCT03999554|65879191|FG004|Overall Study|Lost to Follow-up|8|||
23587666|NCT03999554|65879187|FG000|Overall Study|Protocol Violation|0|||
23641076|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
23641077|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23641078|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23641079|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23641080|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23641081|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23641082|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
23641083|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23641084|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23641085|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23641086|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23641087|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23641088|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
23641089|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23641090|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23641091|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23587667|NCT03999554|65879188|FG001|Overall Study|Protocol Violation|0|||
23587668|NCT03999554|65879189|FG002|Overall Study|Protocol Violation|5|||
23587669|NCT03999554|65879190|FG003|Overall Study|Protocol Violation|0|||
23587670|NCT03999554|65879191|FG004|Overall Study|Protocol Violation|0|||
23587671|NCT03999554|65879187|FG000|Overall Study|Pregnancy|0|||
23587672|NCT03999554|65879188|FG001|Overall Study|Pregnancy|0|||
23587673|NCT03999554|65879189|FG002|Overall Study|Pregnancy|1|||
23587674|NCT03999554|65879190|FG003|Overall Study|Pregnancy|0|||
23587675|NCT03999554|65879191|FG004|Overall Study|Pregnancy|0|||
23587676|NCT03999554|65879187|FG000|Overall Study|Withdrawal by Subject|2|||
23587677|NCT03999554|65879188|FG001|Overall Study|Withdrawal by Subject|2|||
23587678|NCT03999554|65879189|FG002|Overall Study|Withdrawal by Subject|2|||
23587679|NCT03999554|65879190|FG003|Overall Study|Withdrawal by Subject|1|||
23587680|NCT03999554|65879191|FG004|Overall Study|Withdrawal by Subject|1|||
23587681|NCT03999554|65879187|FG000|Overall Study|failure to comply with protocol requirements|0|||
23587682|NCT03999554|65879188|FG001|Overall Study|failure to comply with protocol requirements|0|||
23587683|NCT03999554|65879189|FG002|Overall Study|failure to comply with protocol requirements|0|||
23587684|NCT03999554|65879190|FG003|Overall Study|failure to comply with protocol requirements|1|||
23587685|NCT03999554|65879191|FG004|Overall Study|failure to comply with protocol requirements|0|||
23587686|NCT03184558|65879192|FG000|Overall Study|Withdrawal by Subject|2|||
23587687|NCT03184558|65879192|FG000|Overall Study|Death|16|||
23587688|NCT03184558|65879192|FG000|Overall Study|Lost to Follow-up|2|||
23587689|NCT03184558|65879192|FG000|Overall Study|Other|9|||
23587690|NCT02030028|65879197|FG000|Overall Study|Withdrawal by Subject|4|||
23641092|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23641093|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23641094|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
23641095|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23641096|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23641097|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23641098|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23641099|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23706841|NCT00002663|66301347|FG008|Overall Study|Other|0|||
23795253|NCT01214239|66626679|FG001|Overall Study|Lack of Efficacy|2|||
23795254|NCT01214239|66626678|FG000|Overall Study|patient's private reason|1|||
23471188|NCT00530504|65470606|FG000|Overall Study|Exited study due to other reasons|33|||
23587691|NCT02030028|65879197|FG000|Overall Study|lack of transportation|1|||
23587692|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
23587693|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
23354323|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354324|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471189|NCT00275340|65470607|FG000|Overall Study|Lost to Follow-up|2|||
23471190|NCT00275340|65470608|FG001|Overall Study|Lost to Follow-up|4|||
23471191|NCT00548184|65470609|FG000|Overall Study|Adverse Event|3|||
23471192|NCT00548184|65470609|FG000|Overall Study|took other drug|1|||
23471193|NCT00548184|65470609|FG000|Overall Study|Found Her2 negative|1|||
23471194|NCT01788215|65470610|FG000|Overall Study|Withdrawal by Subject|0|||
23471195|NCT01788215|65470611|FG001|Overall Study|Withdrawal by Subject|1|||
23471196|NCT01788215|65470610|FG000|Overall Study|Lost to Follow-up|2|||
23471197|NCT01788215|65470611|FG001|Overall Study|Lost to Follow-up|0|||
23471198|NCT00502203|65470612|FG000|Overall Study|Inevaluable|1|||
23471199|NCT02563067|65470613|FG000|Overall Study|Subject/guardian decision|14|||
23471200|NCT02563067|65470614|FG001|Overall Study|Subject/guardian decision|20|||
23471201|NCT02563067|65470615|FG002|Overall Study|Subject/guardian decision|16|||
23471202|NCT02563067|65470613|FG000|Overall Study|Physician Decision|0|||
23471203|NCT02563067|65470614|FG001|Overall Study|Physician Decision|1|||
23471204|NCT02563067|65470615|FG002|Overall Study|Physician Decision|3|||
23471205|NCT02563067|65470613|FG000|Overall Study|Lost to Follow-up|1|||
23471206|NCT02563067|65470614|FG001|Overall Study|Lost to Follow-up|2|||
23471207|NCT02563067|65470615|FG002|Overall Study|Lost to Follow-up|0|||
23471208|NCT02563067|65470613|FG000|Overall Study|Technical problems|0|||
23471209|NCT02563067|65470614|FG001|Overall Study|Technical problems|1|||
23471210|NCT02563067|65470615|FG002|Overall Study|Technical problems|0|||
23354325|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354326|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471211|NCT02563067|65470613|FG000|Overall Study|Lack of Efficacy|1|||
23471212|NCT02563067|65470614|FG001|Overall Study|Lack of Efficacy|0|||
23354327|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471213|NCT02563067|65470615|FG002|Overall Study|Lack of Efficacy|0|||
23587694|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
23587695|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
23587696|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
23587697|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
23587698|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
23587699|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
23587700|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
23587701|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
23587702|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
23587703|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
23587704|NCT04880733|65879198|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
23641100|NCT01160289|66071558|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
23641101|NCT01160289|66071559|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23641102|NCT01160289|66071560|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23641103|NCT01160289|66071561|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23641104|NCT01160289|66071562|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23795255|NCT01214239|66626679|FG001|Overall Study|patient's private reason|1|||
23795256|NCT03358147|66626692|FG000|Overall Study|Withdrawal by Subject|13|||
23795257|NCT03358147|66626693|FG001|Overall Study|Withdrawal by Subject|19|||
23795258|NCT03358147|66626694|FG002|Overall Study|Withdrawal by Subject|16|||
23795259|NCT03358147|66626695|FG003|Overall Study|Withdrawal by Subject|10|||
23795260|NCT03358147|66626696|FG004|Overall Study|Withdrawal by Subject|5|||
23795261|NCT03358147|66626692|FG000|Overall Study|Adverse Event|3|||
23795262|NCT03358147|66626693|FG001|Overall Study|Adverse Event|9|||
23795263|NCT03358147|66626694|FG002|Overall Study|Adverse Event|7|||
23795264|NCT03358147|66626695|FG003|Overall Study|Adverse Event|5|||
23354328|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23795265|NCT03358147|66626696|FG004|Overall Study|Adverse Event|2|||
23795266|NCT03358147|66626692|FG000|Overall Study|Lost to Follow-up|4|||
23795267|NCT03358147|66626693|FG001|Overall Study|Lost to Follow-up|3|||
23471214|NCT02563067|65470613|FG000|Overall Study|Death|0|||
23795268|NCT03358147|66626694|FG002|Overall Study|Lost to Follow-up|7|||
23795269|NCT03358147|66626695|FG003|Overall Study|Lost to Follow-up|6|||
23795270|NCT03358147|66626696|FG004|Overall Study|Lost to Follow-up|4|||
23795271|NCT03358147|66626692|FG000|Overall Study|Major Protocol Deviation|11|||
23795272|NCT03358147|66626693|FG001|Overall Study|Major Protocol Deviation|3|||
23471215|NCT02563067|65470614|FG001|Overall Study|Death|1|||
23471216|NCT02563067|65470615|FG002|Overall Study|Death|1|||
23471217|NCT02563067|65470613|FG000|Overall Study|Adverse Event|2|||
23471218|NCT02563067|65470614|FG001|Overall Study|Adverse Event|1|||
23471219|NCT02563067|65470615|FG002|Overall Study|Adverse Event|0|||
23471220|NCT02563067|65470613|FG000|Overall Study|Death post Treatment/safety period|1|||
23471221|NCT02563067|65470614|FG001|Overall Study|Death post Treatment/safety period|0|||
23471222|NCT02563067|65470615|FG002|Overall Study|Death post Treatment/safety period|0|||
23471223|NCT01915303|65470616|FG000|Core Phase|Adverse Event|7|||
23471224|NCT01915303|65470616|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
23471225|NCT01915303|65470616|FG000|Core Phase|Death|2|||
23471226|NCT01915303|65470616|FG000|Core Phase|Protocol Violation|2|||
23471227|NCT01915303|65470616|FG000|Core Phase|Abnormal lab value|1|||
23587705|NCT04880733|65879199|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
23587706|NCT04880733|65879200|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
23587707|NCT04072822|65879201|FG000|Treatment|Adverse Event|9|||
23641105|NCT01160289|66071563|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23641106|NCT01160289|66071558|FG000|Post-Randomization Period|Adverse Event|0|||
23795273|NCT03358147|66626694|FG002|Overall Study|Major Protocol Deviation|2|||
23795274|NCT03358147|66626695|FG003|Overall Study|Major Protocol Deviation|3|||
23795275|NCT03358147|66626696|FG004|Overall Study|Major Protocol Deviation|1|||
23795276|NCT03358147|66626692|FG000|Overall Study|Protocol specified criteria|2|||
23795277|NCT03358147|66626693|FG001|Overall Study|Protocol specified criteria|3|||
23471228|NCT01915303|65470616|FG000|Core Phase|Withdrawal by Subject|1|||
23354329|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354330|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354331|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354332|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354333|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354334|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
23354335|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
23354336|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
23354337|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
23354338|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
23354339|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
23354340|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
23354341|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
23354342|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
23354343|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
23354344|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
23354345|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
23354346|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
23354347|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
23354348|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
23354349|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
23354350|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
23354351|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
23354352|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
23354353|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
23354354|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
23354355|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
23354356|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
23354357|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
23354358|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
23354359|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
23354360|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
23354361|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
23354362|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354363|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354364|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354365|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354366|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354367|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354368|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354369|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354370|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354371|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354372|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354373|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354374|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354375|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354376|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354377|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354378|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354379|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354380|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354381|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354382|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23471229|NCT01915303|65470616|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
23471230|NCT01915303|65470616|FG000|Extension Phase|Withdrawal by Subject|4|||
23471231|NCT01915303|65470616|FG000|Extension Phase|Adverse Event|3|||
23471232|NCT01915303|65470616|FG000|Extension Phase|Death|1|||
23795278|NCT03358147|66626694|FG002|Overall Study|Protocol specified criteria|0|||
23795279|NCT03358147|66626695|FG003|Overall Study|Protocol specified criteria|3|||
23795280|NCT03358147|66626696|FG004|Overall Study|Protocol specified criteria|1|||
23795281|NCT03358147|66626692|FG000|Overall Study|Physician Decision|1|||
23795282|NCT03358147|66626693|FG001|Overall Study|Physician Decision|0|||
23795283|NCT03358147|66626694|FG002|Overall Study|Physician Decision|1|||
23795284|NCT03358147|66626695|FG003|Overall Study|Physician Decision|6|||
23795285|NCT03358147|66626696|FG004|Overall Study|Physician Decision|1|||
23795286|NCT03358147|66626692|FG000|Overall Study|Administrative reasons|0|||
23795287|NCT03358147|66626693|FG001|Overall Study|Administrative reasons|1|||
23795288|NCT03358147|66626694|FG002|Overall Study|Administrative reasons|0|||
23795289|NCT03358147|66626695|FG003|Overall Study|Administrative reasons|3|||
23795290|NCT03358147|66626696|FG004|Overall Study|Administrative reasons|0|||
23795291|NCT03358147|66626692|FG000|Overall Study|Lack of Efficacy|0|||
23795292|NCT03358147|66626693|FG001|Overall Study|Lack of Efficacy|1|||
23795293|NCT03358147|66626694|FG002|Overall Study|Lack of Efficacy|1|||
23795294|NCT03358147|66626695|FG003|Overall Study|Lack of Efficacy|0|||
23795295|NCT03358147|66626696|FG004|Overall Study|Lack of Efficacy|0|||
23795296|NCT02197416|66626700|FG000|Overall Study|Other reasons|0|||
23795297|NCT02197416|66626701|FG001|Overall Study|Other reasons|2|||
23795298|NCT02197416|66626702|FG002|Overall Study|Other reasons|5|||
23795299|NCT02197416|66626700|FG000|Overall Study|Withdrawal by Subject|0|||
23795300|NCT02197416|66626701|FG001|Overall Study|Withdrawal by Subject|2|||
23795301|NCT02197416|66626702|FG002|Overall Study|Withdrawal by Subject|1|||
23795302|NCT02197416|66626700|FG000|Overall Study|Protocol Violation|1|||
23795303|NCT02197416|66626701|FG001|Overall Study|Protocol Violation|0|||
23795304|NCT02197416|66626702|FG002|Overall Study|Protocol Violation|1|||
23795305|NCT02197416|66626700|FG000|Overall Study|Adverse Event|0|||
23795306|NCT02197416|66626701|FG001|Overall Study|Adverse Event|0|||
23795307|NCT02197416|66626702|FG002|Overall Study|Adverse Event|1|||
23795308|NCT01175473|66626705|FG000|Overall Study|Adverse Event|2|||
23795309|NCT01175473|66626706|FG001|Overall Study|Adverse Event|2|||
23795310|NCT03294317|66626709|FG000|Overall Study|Physician Decision|1|||
23795311|NCT03294317|66626709|FG000|Overall Study|Withdrawal by Subject|6|||
23795312|NCT03294317|66626709|FG000|Overall Study|Lost to Follow-up|1|||
23795313|NCT03294317|66626709|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
23795314|NCT03294317|66626709|FG000|Overall Study|Failed HB lead implant|8|||
23795315|NCT03294317|66626709|FG000|Overall Study|Received CRT instead|1|||
23795316|NCT03294317|66626709|FG000|Overall Study|Exited after lead revision|2|||
23795317|NCT01634854|66626710|FG000|Overall Study|Cesarean delivery|2|||
23795318|NCT01634854|66626711|FG001|Overall Study|Cesarean delivery|7|||
23795319|NCT01475786|66626714|FG000|Overall Study|Adverse Event|0|||
23795320|NCT01475786|66626715|FG001|Overall Study|Adverse Event|1|||
23795321|NCT01475786|66626716|FG002|Overall Study|Adverse Event|0|||
23795322|NCT01475786|66626714|FG000|Overall Study|Lost to Follow-up|1|||
23795323|NCT01475786|66626715|FG001|Overall Study|Lost to Follow-up|2|||
23795324|NCT01475786|66626716|FG002|Overall Study|Lost to Follow-up|1|||
23795325|NCT01475786|66626714|FG000|Overall Study|Withdrawal by Subject|0|||
23795326|NCT01475786|66626715|FG001|Overall Study|Withdrawal by Subject|1|||
23795327|NCT01475786|66626716|FG002|Overall Study|Withdrawal by Subject|1|||
23795328|NCT01475786|66626714|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
23795329|NCT01475786|66626715|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
23795330|NCT01475786|66626716|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
23795331|NCT00440115|66626718|FG000|Overall Study|Death|7|||
23795332|NCT00440115|66626719|FG001|Overall Study|Death|9|||
23471233|NCT01915303|65470616|FG000|Extension Phase|Protocol Violation|1|||
23641107|NCT01160289|66071559|FG001|Post-Randomization Period|Adverse Event|4|||
23641108|NCT01160289|66071560|FG002|Post-Randomization Period|Adverse Event|4|||
23795333|NCT00440115|66626720|FG002|Overall Study|Death|5|||
23795334|NCT00440115|66626718|FG000|Overall Study|Incarceration|0|||
23795335|NCT00440115|66626719|FG001|Overall Study|Incarceration|2|||
23795336|NCT00440115|66626720|FG002|Overall Study|Incarceration|1|||
23471234|NCT02175199|65470617|FG000|Overall Study|Withdrawal by Subject|1|||
23641109|NCT01160289|66071561|FG003|Post-Randomization Period|Adverse Event|2|||
23641110|NCT01160289|66071562|FG004|Post-Randomization Period|Adverse Event|0|||
23795337|NCT00526162|66626721|FG000|Overall Study|Device not implanted|3|||
23795338|NCT01802216|66626722|FG000|4 Month Visit|Participant did not show to visit|3|||
23354383|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354384|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23354385|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354386|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354387|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23354388|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354389|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23641111|NCT01160289|66071563|FG005|Post-Randomization Period|Adverse Event|0|||
23641112|NCT01160289|66071558|FG000|Post-Randomization Period|Death|0|||
23641113|NCT01160289|66071559|FG001|Post-Randomization Period|Death|0|||
23641114|NCT01160289|66071560|FG002|Post-Randomization Period|Death|0|||
23641115|NCT01160289|66071561|FG003|Post-Randomization Period|Death|1|||
23641116|NCT01160289|66071562|FG004|Post-Randomization Period|Death|0|||
23641117|NCT01160289|66071563|FG005|Post-Randomization Period|Death|0|||
23795339|NCT01802216|66626723|FG001|4 Month Visit|Participant did not show to visit|4|||
23795340|NCT01802216|66626722|FG000|8 Month Visit|Participant did not show to visit|3|||
23795341|NCT01802216|66626723|FG001|8 Month Visit|Participant did not show to visit|5|||
23354390|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354391|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354392|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354393|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354394|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354395|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354396|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354397|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354398|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
23354399|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354400|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
23354401|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354402|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354403|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
23354404|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354405|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354406|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23587708|NCT04072822|65879202|FG001|Treatment|Adverse Event|5|||
23587709|NCT04072822|65879201|FG000|Treatment|Met Stopping Criteria|13|||
23587710|NCT04072822|65879202|FG001|Treatment|Met Stopping Criteria|24|||
23587711|NCT04072822|65879201|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
23587712|NCT04072822|65879202|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
23587713|NCT04072822|65879201|FG000|Treatment|Withdrawal by Subject|0|||
23587714|NCT04072822|65879202|FG001|Treatment|Withdrawal by Subject|2|||
23587715|NCT04072822|65879201|FG000|Treatment|Death|0|||
23587716|NCT04072822|65879202|FG001|Treatment|Death|2|||
23587717|NCT04072822|65879201|FG000|Treatment|Lost to Follow-up|11|||
23587718|NCT04072822|65879202|FG001|Treatment|Lost to Follow-up|3|||
23587719|NCT04072822|65879201|FG000|Treatment|Physician Decision|1|||
23587720|NCT04072822|65879202|FG001|Treatment|Physician Decision|0|||
23587721|NCT04072822|65879201|FG000|Treatment|Other|7|||
23587722|NCT04072822|65879202|FG001|Treatment|Other|9|||
23641118|NCT01160289|66071558|FG000|Post-Randomization Period|Lack of Efficacy|0|||
23641119|NCT01160289|66071559|FG001|Post-Randomization Period|Lack of Efficacy|1|||
23795342|NCT01802216|66626722|FG000|12 Month Visit|Participant did not show to visit|3|||
23641120|NCT01160289|66071560|FG002|Post-Randomization Period|Lack of Efficacy|0|||
23795343|NCT01802216|66626723|FG001|12 Month Visit|Participant did not show to visit|4|||
23795344|NCT02697617|66626728|FG000|Overall Study|Withdrawal by Subject|0|||
23795345|NCT02697617|66626729|FG001|Overall Study|Withdrawal by Subject|2|||
23795346|NCT02697617|66626728|FG000|Overall Study|Pregnancy|1|||
23795347|NCT02697617|66626729|FG001|Overall Study|Pregnancy|0|||
23795348|NCT04661202|66626732|FG000|Overall Study|Withdrawal by Subject|1|||
23795349|NCT04661202|66626733|FG001|Overall Study|Withdrawal by Subject|1|||
23795350|NCT04661202|66626732|FG000|Overall Study|Lack of Efficacy|2|||
23795351|NCT04661202|66626733|FG001|Overall Study|Lack of Efficacy|0|||
23795352|NCT01386125|66626734|FG000|Overall Study|Lost to Follow-up|3|||
23795353|NCT01386125|66626735|FG001|Overall Study|Lost to Follow-up|9|||
23587723|NCT04072822|65879201|FG000|Follow-up|Withdrawal by Subject|1|||
23587724|NCT04072822|65879202|FG001|Follow-up|Withdrawal by Subject|0|||
23641121|NCT01160289|66071561|FG003|Post-Randomization Period|Lack of Efficacy|3|||
23641122|NCT01160289|66071562|FG004|Post-Randomization Period|Lack of Efficacy|0|||
23795354|NCT01386125|66626734|FG000|Overall Study|Physician Decision|0|||
23795355|NCT01386125|66626735|FG001|Overall Study|Physician Decision|1|||
23795356|NCT01386125|66626734|FG000|Overall Study|Protocol Violation|5|||
23795357|NCT01386125|66626735|FG001|Overall Study|Protocol Violation|7|||
23795358|NCT01386125|66626734|FG000|Overall Study|Disease Progress|1|||
23795359|NCT01386125|66626735|FG001|Overall Study|Disease Progress|2|||
23795360|NCT01386125|66626734|FG000|Overall Study|Withdrawal by Subject|13|||
23795361|NCT01386125|66626735|FG001|Overall Study|Withdrawal by Subject|12|||
23795362|NCT01386125|66626734|FG000|Overall Study|Adverse Event|2|||
23795363|NCT01386125|66626735|FG001|Overall Study|Adverse Event|5|||
23795364|NCT01386125|66626734|FG000|Overall Study|Lack of Efficacy|0|||
23795365|NCT01386125|66626735|FG001|Overall Study|Lack of Efficacy|1|||
23795366|NCT01386125|66626734|FG000|Overall Study|Participant Leaving Country|1|||
23795367|NCT01386125|66626735|FG001|Overall Study|Participant Leaving Country|0|||
23795368|NCT03365791|66626736|FG000|Overall Study|Adverse Event|5|||
23795369|NCT03365791|66626736|FG000|Overall Study|Death|1|||
23795370|NCT03365791|66626736|FG000|Overall Study|Lost to Follow-up|1|||
23795371|NCT03365791|66626736|FG000|Overall Study|Physician Decision|9|||
23795372|NCT03365791|66626736|FG000|Overall Study|Progressive disease|51|||
23795373|NCT03365791|66626736|FG000|Overall Study|Subject/guardian decision|5|||
23795374|NCT01952691|66626749|FG000|Overall Study|Lost to Follow-up|2|||
23795375|NCT02308696|66626751|FG000|Overall Study|Lost to Follow-up|28|||
23354407|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354408|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354409|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354410|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354411|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354412|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
23354413|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354414|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354415|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354416|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
23354417|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
23354418|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
23354419|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
23354420|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
23354421|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
23354422|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
23354423|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
23354424|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
23354425|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
23354426|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
23354427|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
23354428|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
23354429|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
23354430|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
23354431|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
23354432|NCT03268005|65041399|FG000|Overall Study|Death|2|||
23354433|NCT03268005|65041400|FG001|Overall Study|Death|1|||
23354434|NCT03268005|65041399|FG000|Overall Study|Lost to Follow-up|2|||
23354435|NCT03268005|65041400|FG001|Overall Study|Lost to Follow-up|2|||
23354436|NCT03268005|65041399|FG000|Overall Study|Withdrawal by Subject|11|||
23471235|NCT02175199|65470618|FG001|Overall Study|Withdrawal by Subject|5|||
23795376|NCT02308696|66626752|FG001|Overall Study|Lost to Follow-up|21|||
23795377|NCT02308696|66626751|FG000|Overall Study|Death|8|||
23795378|NCT02308696|66626752|FG001|Overall Study|Death|4|||
23795379|NCT02308696|66626751|FG000|Overall Study|Moved to a Higher Level of Care|17|||
23354437|NCT03268005|65041400|FG001|Overall Study|Withdrawal by Subject|11|||
23354438|NCT01935128|65041401|FG000|Overall Study|Death|1|||
23795380|NCT02308696|66626752|FG001|Overall Study|Moved to a Higher Level of Care|6|||
23471236|NCT02175199|65470617|FG000|Overall Study|Randomized in Error|1|||
23471237|NCT02175199|65470618|FG001|Overall Study|Randomized in Error|0|||
23471238|NCT02175199|65470617|FG000|Overall Study|Sponsor Decision|1|||
23471239|NCT02175199|65470618|FG001|Overall Study|Sponsor Decision|0|||
23471240|NCT03214666|65470627|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471241|NCT03214666|65470628|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471242|NCT03214666|65470629|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471243|NCT03214666|65470630|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471244|NCT03214666|65470631|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
23471245|NCT03214666|65470632|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471246|NCT00314795|65470633|FG000|Overall Study|Adverse Event|8|||
23471247|NCT00314795|65470633|FG000|Overall Study|Death|4|||
23471248|NCT00314795|65470633|FG000|Overall Study|Reason not Specified|3|||
23471249|NCT00314795|65470633|FG000|Overall Study|Renal Transplant|3|||
23471250|NCT00314795|65470633|FG000|Overall Study|Participants Withdrew Consent|2|||
23471251|NCT02100696|65470634|FG000|Induction Phase|Adverse Event|0|||
23471252|NCT02100696|65470635|FG001|Induction Phase|Adverse Event|0|||
23471253|NCT02100696|65470636|FG002|Induction Phase|Adverse Event|1|||
23471254|NCT02100696|65470637|FG003|Induction Phase|Adverse Event|0|||
23471255|NCT02100696|65470638|FG004|Induction Phase|Adverse Event|0|||
23471256|NCT02100696|65470639|FG005|Induction Phase|Adverse Event|0|||
23471257|NCT02100696|65470634|FG000|Induction Phase|Lost to Follow-up|1|||
23471258|NCT02100696|65470635|FG001|Induction Phase|Lost to Follow-up|0|||
23471259|NCT02100696|65470636|FG002|Induction Phase|Lost to Follow-up|1|||
23471260|NCT02100696|65470637|FG003|Induction Phase|Lost to Follow-up|0|||
23471261|NCT02100696|65470638|FG004|Induction Phase|Lost to Follow-up|0|||
23471262|NCT02100696|65470639|FG005|Induction Phase|Lost to Follow-up|0|||
23471263|NCT02100696|65470634|FG000|Induction Phase|Protocol Violation|0|||
23471264|NCT02100696|65470635|FG001|Induction Phase|Protocol Violation|1|||
23471265|NCT02100696|65470636|FG002|Induction Phase|Protocol Violation|1|||
23471266|NCT02100696|65470637|FG003|Induction Phase|Protocol Violation|0|||
23471267|NCT02100696|65470638|FG004|Induction Phase|Protocol Violation|0|||
23471268|NCT02100696|65470639|FG005|Induction Phase|Protocol Violation|0|||
23471269|NCT02100696|65470634|FG000|Induction Phase|Withdrawal by Subject|8|||
23471270|NCT02100696|65470635|FG001|Induction Phase|Withdrawal by Subject|2|||
23471271|NCT02100696|65470636|FG002|Induction Phase|Withdrawal by Subject|13|||
23471272|NCT02100696|65470637|FG003|Induction Phase|Withdrawal by Subject|0|||
23471273|NCT02100696|65470638|FG004|Induction Phase|Withdrawal by Subject|0|||
23471274|NCT02100696|65470639|FG005|Induction Phase|Withdrawal by Subject|0|||
23471275|NCT02100696|65470634|FG000|Induction Phase|Physician Decision|1|||
23471276|NCT02100696|65470635|FG001|Induction Phase|Physician Decision|0|||
23471277|NCT02100696|65470636|FG002|Induction Phase|Physician Decision|2|||
23471278|NCT02100696|65470637|FG003|Induction Phase|Physician Decision|0|||
23471279|NCT02100696|65470638|FG004|Induction Phase|Physician Decision|0|||
23471280|NCT02100696|65470639|FG005|Induction Phase|Physician Decision|0|||
23471281|NCT02100696|65470634|FG000|Induction Phase|Multiple Reasons|5|||
23471282|NCT02100696|65470635|FG001|Induction Phase|Multiple Reasons|2|||
23471283|NCT02100696|65470636|FG002|Induction Phase|Multiple Reasons|8|||
23471284|NCT02100696|65470637|FG003|Induction Phase|Multiple Reasons|0|||
23471285|NCT02100696|65470638|FG004|Induction Phase|Multiple Reasons|0|||
23471286|NCT02100696|65470639|FG005|Induction Phase|Multiple Reasons|0|||
23471287|NCT02100696|65470634|FG000|Maintenance Phase|Adverse Event|0|||
23471288|NCT02100696|65470635|FG001|Maintenance Phase|Adverse Event|0|||
23471289|NCT02100696|65470636|FG002|Maintenance Phase|Adverse Event|0|||
23471290|NCT02100696|65470637|FG003|Maintenance Phase|Adverse Event|0|||
23471291|NCT02100696|65470638|FG004|Maintenance Phase|Adverse Event|0|||
23471292|NCT02100696|65470639|FG005|Maintenance Phase|Adverse Event|2|||
23471293|NCT02100696|65470634|FG000|Maintenance Phase|Lost to Follow-up|0|||
23587725|NCT04072822|65879201|FG000|Follow-up|Lost to Follow-up|5|||
23587726|NCT04072822|65879202|FG001|Follow-up|Lost to Follow-up|4|||
23587727|NCT01909336|65879208|FG000|Overall Study|Lost to Follow-up|4|||
23587728|NCT01909336|65879209|FG001|Overall Study|Lost to Follow-up|2|||
23587729|NCT01909336|65879210|FG002|Overall Study|Lost to Follow-up|2|||
23587730|NCT01909336|65879208|FG000|Overall Study|Physician Decision|0|||
23587731|NCT01909336|65879209|FG001|Overall Study|Physician Decision|1|||
23641123|NCT01160289|66071563|FG005|Post-Randomization Period|Lack of Efficacy|0|||
23471294|NCT02100696|65470635|FG001|Maintenance Phase|Lost to Follow-up|0|||
23471295|NCT02100696|65470636|FG002|Maintenance Phase|Lost to Follow-up|0|||
23587732|NCT01909336|65879210|FG002|Overall Study|Physician Decision|1|||
23587733|NCT03179787|65879211|FG000|Overall Study|Lost to Follow-up|15|||
23587734|NCT03179787|65879211|FG000|Overall Study|Case report failures|2|||
23587735|NCT03179787|65879211|FG000|Overall Study|Treatment not administered|1|||
23587736|NCT02918968|65879219|FG000|1st Line AAT|Progressive disease|9|||
23471296|NCT02100696|65470637|FG003|Maintenance Phase|Lost to Follow-up|0|||
23471297|NCT02100696|65470638|FG004|Maintenance Phase|Lost to Follow-up|1|||
23471298|NCT02100696|65470639|FG005|Maintenance Phase|Lost to Follow-up|0|||
23471299|NCT02100696|65470634|FG000|Maintenance Phase|Protocol Violation|0|||
23354439|NCT01935128|65041401|FG000|Overall Study|Adverse Event|6|||
23354440|NCT04702997|65041402|FG000|Overall Study|Withdrawal by Subject|1|||
23354441|NCT04702997|65041403|FG001|Overall Study|Withdrawal by Subject|1|||
23354442|NCT01870297|65041406|FG000|Overall Study|Adverse Event|0|||
23354443|NCT01870297|65041407|FG001|Overall Study|Adverse Event|0|||
23354444|NCT01870297|65041408|FG002|Overall Study|Adverse Event|0|||
23354445|NCT01870297|65041409|FG003|Overall Study|Adverse Event|0|||
23354446|NCT01870297|65041410|FG004|Overall Study|Adverse Event|2|||
23354447|NCT01870297|65041411|FG005|Overall Study|Adverse Event|0|||
23354448|NCT01870297|65041412|FG006|Overall Study|Adverse Event|0|||
23354449|NCT01870297|65041406|FG000|Overall Study|Lost to Follow-up|0|||
23471300|NCT02100696|65470635|FG001|Maintenance Phase|Protocol Violation|0|||
23471301|NCT02100696|65470636|FG002|Maintenance Phase|Protocol Violation|0|||
23471302|NCT02100696|65470637|FG003|Maintenance Phase|Protocol Violation|0|||
23471303|NCT02100696|65470638|FG004|Maintenance Phase|Protocol Violation|1|||
23471304|NCT02100696|65470639|FG005|Maintenance Phase|Protocol Violation|0|||
23471305|NCT02100696|65470634|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23471306|NCT02100696|65470635|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23471307|NCT02100696|65470636|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23471308|NCT02100696|65470637|FG003|Maintenance Phase|Withdrawal by Subject|1|||
23471309|NCT02100696|65470638|FG004|Maintenance Phase|Withdrawal by Subject|4|||
23471310|NCT02100696|65470639|FG005|Maintenance Phase|Withdrawal by Subject|2|||
23471311|NCT02100696|65470634|FG000|Maintenance Phase|Physician Decision|0|||
23471312|NCT02100696|65470635|FG001|Maintenance Phase|Physician Decision|0|||
23471313|NCT02100696|65470636|FG002|Maintenance Phase|Physician Decision|0|||
23471314|NCT02100696|65470637|FG003|Maintenance Phase|Physician Decision|0|||
23471315|NCT02100696|65470638|FG004|Maintenance Phase|Physician Decision|1|||
23471316|NCT02100696|65470639|FG005|Maintenance Phase|Physician Decision|0|||
23587737|NCT02918968|65879220|FG001|1st Line AAT|Progressive disease|4|||
23587738|NCT02918968|65879219|FG000|1st Line AAT|Adverse Event|12|||
23587739|NCT02918968|65879220|FG001|1st Line AAT|Adverse Event|3|||
23354450|NCT01870297|65041407|FG001|Overall Study|Lost to Follow-up|1|||
23471317|NCT02100696|65470634|FG000|Maintenance Phase|Multiple Reasons|0|||
23471318|NCT02100696|65470635|FG001|Maintenance Phase|Multiple Reasons|0|||
23641124|NCT01160289|66071558|FG000|Post-Randomization Period|Lost to Follow-up|0|||
23641125|NCT01160289|66071559|FG001|Post-Randomization Period|Lost to Follow-up|3|||
23641126|NCT01160289|66071560|FG002|Post-Randomization Period|Lost to Follow-up|2|||
23641127|NCT01160289|66071561|FG003|Post-Randomization Period|Lost to Follow-up|5|||
23641128|NCT01160289|66071562|FG004|Post-Randomization Period|Lost to Follow-up|3|||
23641129|NCT01160289|66071563|FG005|Post-Randomization Period|Lost to Follow-up|4|||
23641130|NCT01160289|66071558|FG000|Post-Randomization Period|Physician Decision|0|||
23641131|NCT01160289|66071559|FG001|Post-Randomization Period|Physician Decision|0|||
23641132|NCT01160289|66071560|FG002|Post-Randomization Period|Physician Decision|1|||
23641133|NCT01160289|66071561|FG003|Post-Randomization Period|Physician Decision|0|||
23641134|NCT01160289|66071562|FG004|Post-Randomization Period|Physician Decision|0|||
23471319|NCT02100696|65470636|FG002|Maintenance Phase|Multiple Reasons|0|||
23587740|NCT02918968|65879219|FG000|1st Line AAT|Physician Decision|4|||
23587741|NCT02918968|65879220|FG001|1st Line AAT|Physician Decision|2|||
23587742|NCT02918968|65879219|FG000|1st Line AAT|Withdrawal by Subject|2|||
23587743|NCT02918968|65879220|FG001|1st Line AAT|Withdrawal by Subject|1|||
23587744|NCT02918968|65879219|FG000|1st Line AAT|Lost to Follow-up|0|||
23587745|NCT02918968|65879220|FG001|1st Line AAT|Lost to Follow-up|1|||
23587746|NCT02918968|65879219|FG000|1st Line AAT|Death|1|||
23587747|NCT02918968|65879220|FG001|1st Line AAT|Death|0|||
23354451|NCT01870297|65041408|FG002|Overall Study|Lost to Follow-up|1|||
23354452|NCT01870297|65041409|FG003|Overall Study|Lost to Follow-up|0|||
23641135|NCT01160289|66071563|FG005|Post-Randomization Period|Physician Decision|0|||
23587748|NCT02918968|65879219|FG000|1st Line AAT|Miscellaneous|1|||
23587749|NCT02918968|65879220|FG001|1st Line AAT|Miscellaneous|0|||
23354453|NCT01870297|65041410|FG004|Overall Study|Lost to Follow-up|0|||
23471320|NCT02100696|65470637|FG003|Maintenance Phase|Multiple Reasons|0|||
23471321|NCT02100696|65470638|FG004|Maintenance Phase|Multiple Reasons|2|||
23471322|NCT02100696|65470639|FG005|Maintenance Phase|Multiple Reasons|1|||
23471323|NCT02238080|65470642|FG000|Overall Study|Death|13|||
23471324|NCT02238080|65470642|FG000|Overall Study|Treatment interrupted|6|||
23471325|NCT02238080|65470642|FG000|Overall Study|Withdrawal by Subject|2|||
23471326|NCT02238080|65470642|FG000|Overall Study|Other|4|||
23471327|NCT02302339|65470643|FG000|Overall Study|Lost to Follow-up|1|||
23471328|NCT02302339|65470644|FG001|Overall Study|Lost to Follow-up|0|||
23471329|NCT02302339|65470645|FG002|Overall Study|Lost to Follow-up|0|||
23471330|NCT02302339|65470646|FG003|Overall Study|Lost to Follow-up|0|||
23471331|NCT02302339|65470643|FG000|Overall Study|Withdrawal by Subject|0|||
23471332|NCT02302339|65470644|FG001|Overall Study|Withdrawal by Subject|2|||
23471333|NCT02302339|65470645|FG002|Overall Study|Withdrawal by Subject|1|||
23471334|NCT02302339|65470646|FG003|Overall Study|Withdrawal by Subject|0|||
23471335|NCT00373113|65470650|FG000|Overall Study|Death|1|||
23471336|NCT00373113|65470651|FG001|Overall Study|Death|7|||
23471337|NCT00373113|65470650|FG000|Overall Study|Adverse Event|38|||
23471338|NCT00373113|65470651|FG001|Overall Study|Adverse Event|24|||
23471339|NCT00373113|65470650|FG000|Overall Study|Study terminated by sponsor|9|||
23471340|NCT00373113|65470651|FG001|Overall Study|Study terminated by sponsor|1|||
23471341|NCT00373113|65470650|FG000|Overall Study|Global deterioration of health status|10|||
23471342|NCT00373113|65470651|FG001|Overall Study|Global deterioration of health status|7|||
23471343|NCT00373113|65470650|FG000|Overall Study|Lost to Follow-up|1|||
23471344|NCT00373113|65470651|FG001|Overall Study|Lost to Follow-up|3|||
23471345|NCT00373113|65470650|FG000|Overall Study|Objective progression or relapse|150|||
23471346|NCT00373113|65470651|FG001|Overall Study|Objective progression or relapse|169|||
23471347|NCT00373113|65470650|FG000|Overall Study|Other|14|||
23471348|NCT00373113|65470651|FG001|Overall Study|Other|17|||
23471349|NCT00373113|65470650|FG000|Overall Study|Protocol Violation|5|||
23471350|NCT00373113|65470651|FG001|Overall Study|Protocol Violation|1|||
23471351|NCT00373113|65470650|FG000|Overall Study|Withdrawal by Subject|10|||
23471352|NCT00373113|65470651|FG001|Overall Study|Withdrawal by Subject|15|||
23354454|NCT01870297|65041411|FG005|Overall Study|Lost to Follow-up|0|||
23354455|NCT01870297|65041412|FG006|Overall Study|Lost to Follow-up|0|||
23471353|NCT01432730|65470652|FG000|Period 1|Adverse Event|2|||
23471354|NCT01432730|65470653|FG001|Period 1|Adverse Event|0|||
23471355|NCT01432730|65470652|FG000|Period 2|Adverse Event|0|||
23471356|NCT01432730|65470653|FG001|Period 2|Adverse Event|4|||
23471357|NCT01516034|65470654|FG000|Overall Study|Physician Decision|1|||
23471358|NCT01516034|65470654|FG000|Overall Study|Lack of Efficacy|7|||
23471359|NCT00567398|65470657|FG000|Overall Study|Adverse Event|6|||
23471360|NCT00567398|65470658|FG001|Overall Study|Adverse Event|14|||
23641136|NCT01160289|66071558|FG000|Post-Randomization Period|Protocol Violation|0|||
23641137|NCT01160289|66071559|FG001|Post-Randomization Period|Protocol Violation|4|||
23641138|NCT01160289|66071560|FG002|Post-Randomization Period|Protocol Violation|2|||
23641139|NCT01160289|66071561|FG003|Post-Randomization Period|Protocol Violation|0|||
23641140|NCT01160289|66071562|FG004|Post-Randomization Period|Protocol Violation|1|||
23641141|NCT01160289|66071563|FG005|Post-Randomization Period|Protocol Violation|3|||
23641142|NCT01160289|66071558|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
23641143|NCT01160289|66071559|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
23641144|NCT01160289|66071560|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
23641145|NCT01160289|66071561|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
23641146|NCT01160289|66071562|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
23641147|NCT01160289|66071563|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
23641148|NCT01160289|66071558|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
23641149|NCT01160289|66071559|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
23641150|NCT01160289|66071560|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
23641151|NCT01160289|66071561|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
23641152|NCT01160289|66071562|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
23641153|NCT01160289|66071563|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
23641154|NCT01160289|66071558|FG000|Post-Randomization Period|Sponsor Decision|0|||
23641155|NCT01160289|66071559|FG001|Post-Randomization Period|Sponsor Decision|1|||
23641156|NCT01160289|66071560|FG002|Post-Randomization Period|Sponsor Decision|0|||
23641157|NCT01160289|66071561|FG003|Post-Randomization Period|Sponsor Decision|0|||
23641158|NCT01160289|66071562|FG004|Post-Randomization Period|Sponsor Decision|0|||
23641159|NCT01160289|66071563|FG005|Post-Randomization Period|Sponsor Decision|0|||
23641160|NCT02412371|66071564|FG000|Overall Study|Withdrawal by Subject|0|||
23641161|NCT02412371|66071565|FG001|Overall Study|Withdrawal by Subject|2|||
23641162|NCT02412371|66071566|FG002|Overall Study|Withdrawal by Subject|0|||
23641163|NCT02412371|66071567|FG003|Overall Study|Withdrawal by Subject|1|||
23641164|NCT02412371|66071568|FG004|Overall Study|Withdrawal by Subject|1|||
23641165|NCT02412371|66071569|FG005|Overall Study|Withdrawal by Subject|0|||
23641166|NCT02412371|66071564|FG000|Overall Study|Sponsor Discontinued Study|1|||
23641167|NCT02412371|66071565|FG001|Overall Study|Sponsor Discontinued Study|4|||
23641168|NCT02412371|66071566|FG002|Overall Study|Sponsor Discontinued Study|6|||
23641169|NCT02412371|66071567|FG003|Overall Study|Sponsor Discontinued Study|4|||
23641170|NCT02412371|66071568|FG004|Overall Study|Sponsor Discontinued Study|5|||
23641171|NCT02412371|66071569|FG005|Overall Study|Sponsor Discontinued Study|0|||
23641172|NCT02412371|66071564|FG000|Overall Study|Death|4|||
23641173|NCT02412371|66071565|FG001|Overall Study|Death|2|||
23641174|NCT02412371|66071566|FG002|Overall Study|Death|1|||
23641175|NCT02412371|66071567|FG003|Overall Study|Death|3|||
23641176|NCT02412371|66071568|FG004|Overall Study|Death|5|||
23641177|NCT02412371|66071569|FG005|Overall Study|Death|2|||
23641178|NCT02412371|66071564|FG000|Overall Study|Other|2|||
23641179|NCT02412371|66071565|FG001|Overall Study|Other|1|||
23641180|NCT02412371|66071566|FG002|Overall Study|Other|0|||
23641181|NCT02412371|66071567|FG003|Overall Study|Other|0|||
23641182|NCT02412371|66071568|FG004|Overall Study|Other|1|||
23641183|NCT02412371|66071569|FG005|Overall Study|Other|3|||
23795381|NCT00716625|66626753|FG000|Overall Study|Safety was not Assessable|1|||
23354456|NCT01870297|65041406|FG000|Overall Study|Withdrawal by Subject|0|||
23354457|NCT01870297|65041407|FG001|Overall Study|Withdrawal by Subject|0|||
23354458|NCT01870297|65041408|FG002|Overall Study|Withdrawal by Subject|0|||
23354459|NCT01870297|65041409|FG003|Overall Study|Withdrawal by Subject|0|||
23354460|NCT01870297|65041410|FG004|Overall Study|Withdrawal by Subject|1|||
23471361|NCT00567398|65470657|FG000|Overall Study|Physician Decision|0|||
23471362|NCT00567398|65470658|FG001|Overall Study|Physician Decision|4|||
23354461|NCT01870297|65041411|FG005|Overall Study|Withdrawal by Subject|1|||
23354462|NCT01870297|65041412|FG006|Overall Study|Withdrawal by Subject|1|||
23354463|NCT01870297|65041406|FG000|Overall Study|Sponsor Decision|0|||
23354464|NCT01870297|65041407|FG001|Overall Study|Sponsor Decision|6|||
23354465|NCT01870297|65041408|FG002|Overall Study|Sponsor Decision|0|||
23354466|NCT01870297|65041409|FG003|Overall Study|Sponsor Decision|0|||
23354467|NCT01870297|65041410|FG004|Overall Study|Sponsor Decision|0|||
23354468|NCT01870297|65041411|FG005|Overall Study|Sponsor Decision|0|||
23354469|NCT01870297|65041412|FG006|Overall Study|Sponsor Decision|1|||
23354470|NCT00840034|65041417|FG000|Acute Treatment Phase|Adverse Event|6|||
23354471|NCT00840034|65041418|FG001|Acute Treatment Phase|Adverse Event|8|||
23354472|NCT00840034|65041417|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
23471363|NCT00567398|65470657|FG000|Overall Study|Withdrawal by Subject|0|||
23471364|NCT00567398|65470658|FG001|Overall Study|Withdrawal by Subject|2|||
23354473|NCT00840034|65041418|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
23354474|NCT00840034|65041417|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
23354475|NCT00840034|65041418|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
23471365|NCT00567398|65470657|FG000|Overall Study|Renal Transplantation|0|||
23641184|NCT03727438|66071572|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
23795382|NCT01664039|66626754|FG000|Overall Study|Adverse Event|3|||
23354476|NCT00840034|65041417|FG000|Acute Treatment Phase|Physician Decision|0|||
23354477|NCT00840034|65041418|FG001|Acute Treatment Phase|Physician Decision|1|||
23354478|NCT00840034|65041417|FG000|Acute Treatment Phase|Protocol Violation|2|||
23354479|NCT00840034|65041418|FG001|Acute Treatment Phase|Protocol Violation|4|||
23354480|NCT00840034|65041417|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
23354481|NCT00840034|65041418|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
23354482|NCT00840034|65041417|FG000|Taper Phase|Adverse Event|1|||
23354483|NCT00840034|65041418|FG001|Taper Phase|Adverse Event|0|||
23354484|NCT00840034|65041417|FG000|Taper Phase|Lost to Follow-up|1|||
23354485|NCT00840034|65041418|FG001|Taper Phase|Lost to Follow-up|1|||
23354486|NCT00840034|65041417|FG000|Taper Phase|Withdrawal by Subject|1|||
23354487|NCT00840034|65041418|FG001|Taper Phase|Withdrawal by Subject|1|||
23354488|NCT04631107|65041420|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
23354489|NCT04631107|65041420|FG000|Second Intervention (1 Night)|Adverse Event|1|||
23354490|NCT04631107|65041420|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
23795383|NCT01664039|66626755|FG001|Overall Study|Adverse Event|4|||
23795384|NCT01664039|66626754|FG000|Overall Study|Lost to Follow-up|1|||
23795385|NCT01664039|66626755|FG001|Overall Study|Lost to Follow-up|1|||
23795386|NCT01664039|66626754|FG000|Overall Study|Withdrawal by Subject|1|||
23795387|NCT01664039|66626755|FG001|Overall Study|Withdrawal by Subject|3|||
23795388|NCT01664039|66626754|FG000|Overall Study|Noncompliance|1|||
23795389|NCT01664039|66626755|FG001|Overall Study|Noncompliance|1|||
23795390|NCT01390948|66626757|FG000|Overall Study|End of Study|1|||
23795391|NCT01390948|66626758|FG001|Overall Study|End of Study|0|||
23795392|NCT01390948|66626759|FG002|Overall Study|End of Study|0|||
23795393|NCT01390948|66626757|FG000|Overall Study|Withdrew consent|2|||
23354491|NCT04631107|65041420|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
23354492|NCT02107313|65041421|FG000|Overall Study|One participant did not do the FED cohor|0|||
23354493|NCT02107313|65041422|FG001|Overall Study|One participant did not do the FED cohor|1|||
23354494|NCT00957424|65041430|FG000|Overall Study|Lost to Follow-up|19|||
23354495|NCT00957424|65041430|FG000|Overall Study|Protocol Violation|3|||
23471366|NCT00567398|65470658|FG001|Overall Study|Renal Transplantation|3|||
23471367|NCT00567398|65470657|FG000|Overall Study|Other|1|||
23471368|NCT00567398|65470658|FG001|Overall Study|Other|0|||
23471369|NCT01776307|65470659|FG000|Overall Study|Not dosed|0|||
23471370|NCT01776307|65470660|FG001|Overall Study|Not dosed|0|||
23354496|NCT00957424|65041430|FG000|Overall Study|Withdrawal by Subject|1|||
23354497|NCT02634983|65041431|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
23354498|NCT02634983|65041432|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
23471371|NCT01776307|65470661|FG002|Overall Study|Not dosed|1|||
23795394|NCT01390948|66626758|FG001|Overall Study|Withdrew consent|2|||
23471372|NCT00228553|65470662|FG000|Overall Study|Adverse Event|112|||
23354499|NCT01616758|65041445|FG000|Overall Study|Adverse Event|1|||
23354500|NCT01616758|65041445|FG000|Overall Study|Withdrawal by Subject|2|||
23795395|NCT01390948|66626759|FG002|Overall Study|Withdrew consent|0|||
23795396|NCT01390948|66626757|FG000|Overall Study|Progressive Disease|2|||
23795397|NCT01390948|66626758|FG001|Overall Study|Progressive Disease|5|||
23471373|NCT00228553|65470662|FG000|Overall Study|Lack of Efficacy|34|||
23471374|NCT00228553|65470662|FG000|Overall Study|Lost to Follow-up|67|||
23471375|NCT00228553|65470662|FG000|Overall Study|Physician Decision|48|||
23471376|NCT00228553|65470662|FG000|Overall Study|Protocol Violation|6|||
23471377|NCT00228553|65470662|FG000|Overall Study|Withdrawal by Subject|115|||
23471378|NCT00228553|65470662|FG000|Overall Study|Pregnancy|2|||
23354501|NCT01616758|65041445|FG000|Overall Study|Disease progression|18|||
23354502|NCT01616758|65041445|FG000|Overall Study|Study termination by Sponsor|1|||
23354503|NCT00908596|65041453|FG000|Overall Study|Other reasons|46|||
23354504|NCT00908596|65041454|FG001|Overall Study|Other reasons|6|||
23354505|NCT00908596|65041455|FG002|Overall Study|Other reasons|2|||
23354506|NCT00908596|65041456|FG003|Overall Study|Other reasons|0|||
23354507|NCT00908596|65041453|FG000|Overall Study|Lost to Follow-up|0|||
23354508|NCT00908596|65041454|FG001|Overall Study|Lost to Follow-up|1|||
23354509|NCT00908596|65041455|FG002|Overall Study|Lost to Follow-up|12|||
23354510|NCT00908596|65041456|FG003|Overall Study|Lost to Follow-up|4|||
23354511|NCT00908596|65041453|FG000|Overall Study|Death|0|||
23354512|NCT00908596|65041454|FG001|Overall Study|Death|5|||
23354513|NCT00908596|65041455|FG002|Overall Study|Death|57|||
23354514|NCT00908596|65041456|FG003|Overall Study|Death|32|||
23354515|NCT00908596|65041453|FG000|Overall Study|Protocol Violation|1|||
23354516|NCT00908596|65041454|FG001|Overall Study|Protocol Violation|0|||
23354517|NCT00908596|65041455|FG002|Overall Study|Protocol Violation|0|||
23354518|NCT00908596|65041456|FG003|Overall Study|Protocol Violation|0|||
23354519|NCT00908596|65041453|FG000|Overall Study|Withdrawal by Subject|0|||
23354520|NCT00908596|65041454|FG001|Overall Study|Withdrawal by Subject|1|||
23354521|NCT00908596|65041455|FG002|Overall Study|Withdrawal by Subject|3|||
23471379|NCT00228553|65470662|FG000|Overall Study|Miscellaneous|46|||
23471380|NCT04380519|65470663|FG000|Overall Study|Withdrawal by Subject|4|||
23471381|NCT04380519|65470664|FG001|Overall Study|Withdrawal by Subject|0|||
23471382|NCT04380519|65470665|FG002|Overall Study|Withdrawal by Subject|1|||
23471383|NCT04380519|65470663|FG000|Overall Study|Death|14|||
23471384|NCT04380519|65470664|FG001|Overall Study|Death|9|||
23471385|NCT04380519|65470665|FG002|Overall Study|Death|6|||
23471386|NCT04380519|65470663|FG000|Overall Study|Adverse Event|0|||
23471387|NCT04380519|65470664|FG001|Overall Study|Adverse Event|1|||
23471388|NCT04380519|65470665|FG002|Overall Study|Adverse Event|0|||
23471389|NCT04380519|65470663|FG000|Overall Study|relatives' decision|0|||
23471390|NCT04380519|65470664|FG001|Overall Study|relatives' decision|1|||
23471391|NCT04380519|65470665|FG002|Overall Study|relatives' decision|0|||
23471392|NCT02164461|65470666|FG000|Overall Study|Adverse Event|0|||
23471393|NCT02164461|65470667|FG001|Overall Study|Adverse Event|0|||
23471394|NCT02164461|65470668|FG002|Overall Study|Adverse Event|1|||
23471395|NCT02164461|65470666|FG000|Overall Study|Disease Progression|1|||
23471396|NCT02164461|65470667|FG001|Overall Study|Disease Progression|3|||
23471397|NCT02164461|65470668|FG002|Overall Study|Disease Progression|4|||
23471398|NCT02164461|65470666|FG000|Overall Study|Withdrawal by Subject|0|||
23471399|NCT02164461|65470667|FG001|Overall Study|Withdrawal by Subject|3|||
23471400|NCT02164461|65470668|FG002|Overall Study|Withdrawal by Subject|0|||
23471401|NCT00101452|65470669|FG000|Overall Study|Adverse Event|2|||
23471402|NCT00101452|65470670|FG001|Overall Study|Adverse Event|0|||
23471403|NCT00101452|65470671|FG002|Overall Study|Adverse Event|1|||
23471404|NCT00101452|65470669|FG000|Overall Study|Lost to Follow-up|13|||
23471405|NCT00101452|65470670|FG001|Overall Study|Lost to Follow-up|8|||
23471406|NCT00101452|65470671|FG002|Overall Study|Lost to Follow-up|14|||
23471407|NCT00101452|65470669|FG000|Overall Study|Withdrawal by Subject|10|||
23471408|NCT00101452|65470670|FG001|Overall Study|Withdrawal by Subject|14|||
23471409|NCT00101452|65470671|FG002|Overall Study|Withdrawal by Subject|9|||
23471410|NCT00101452|65470669|FG000|Overall Study|Baseline Fail|2|||
23471411|NCT00101452|65470670|FG001|Overall Study|Baseline Fail|1|||
23471412|NCT00101452|65470671|FG002|Overall Study|Baseline Fail|2|||
23471413|NCT00101452|65470669|FG000|Overall Study|Physician Decision|0|||
23471414|NCT00101452|65470670|FG001|Overall Study|Physician Decision|3|||
23471415|NCT00101452|65470671|FG002|Overall Study|Physician Decision|2|||
23471416|NCT00101452|65470669|FG000|Overall Study|Protocol Violation|2|||
23471417|NCT00101452|65470670|FG001|Overall Study|Protocol Violation|1|||
23471418|NCT00101452|65470671|FG002|Overall Study|Protocol Violation|3|||
23471419|NCT00101452|65470669|FG000|Overall Study|Other|15|||
23471420|NCT00101452|65470670|FG001|Overall Study|Other|16|||
23354522|NCT00908596|65041456|FG003|Overall Study|Withdrawal by Subject|1|||
23354523|NCT01915771|65041457|FG000|Day 1|Withdrawal by Subject|1|||
23354524|NCT01915771|65041457|FG000|Day 15|Withdrawal by Subject|1|||
23354525|NCT00153816|65041460|FG000|Overall Study|Death|6|||
23354526|NCT00153816|65041461|FG001|Overall Study|Death|5|||
23354527|NCT00153816|65041462|FG002|Overall Study|Death|4|||
23354528|NCT00153816|65041463|FG003|Overall Study|Death|6|||
23471421|NCT00101452|65470671|FG002|Overall Study|Other|12|||
23354529|NCT00153816|65041464|FG004|Overall Study|Death|0|||
23354530|NCT00153816|65041465|FG005|Overall Study|Death|2|||
23471422|NCT00635219|65470672|FG000|Overall Study|Adverse Event|12|||
23471423|NCT00635219|65470673|FG001|Overall Study|Adverse Event|10|||
23354531|NCT00153816|65041460|FG000|Overall Study|Lost to Follow-up|7|||
23354532|NCT00153816|65041461|FG001|Overall Study|Lost to Follow-up|8|||
23354533|NCT00153816|65041462|FG002|Overall Study|Lost to Follow-up|5|||
23354534|NCT00153816|65041463|FG003|Overall Study|Lost to Follow-up|8|||
23354535|NCT00153816|65041464|FG004|Overall Study|Lost to Follow-up|7|||
23354536|NCT00153816|65041465|FG005|Overall Study|Lost to Follow-up|9|||
23354537|NCT00153816|65041460|FG000|Overall Study|Withdrawal by Subject|9|||
23354538|NCT00153816|65041461|FG001|Overall Study|Withdrawal by Subject|9|||
23354539|NCT00153816|65041462|FG002|Overall Study|Withdrawal by Subject|9|||
23354540|NCT00153816|65041463|FG003|Overall Study|Withdrawal by Subject|4|||
23354541|NCT00153816|65041464|FG004|Overall Study|Withdrawal by Subject|1|||
23354542|NCT00153816|65041465|FG005|Overall Study|Withdrawal by Subject|5|||
23354543|NCT00153816|65041460|FG000|Overall Study|Follow-up exam not done|8|||
23354544|NCT00153816|65041461|FG001|Overall Study|Follow-up exam not done|7|||
23354545|NCT00153816|65041462|FG002|Overall Study|Follow-up exam not done|11|||
23354546|NCT00153816|65041463|FG003|Overall Study|Follow-up exam not done|10|||
23354547|NCT00153816|65041464|FG004|Overall Study|Follow-up exam not done|8|||
23354548|NCT00153816|65041465|FG005|Overall Study|Follow-up exam not done|9|||
23354549|NCT00153816|65041460|FG000|Overall Study|Follow-up exam done, histology missing|2|||
23354550|NCT00153816|65041461|FG001|Overall Study|Follow-up exam done, histology missing|3|||
23354551|NCT00153816|65041462|FG002|Overall Study|Follow-up exam done, histology missing|3|||
23354552|NCT00153816|65041463|FG003|Overall Study|Follow-up exam done, histology missing|3|||
23354553|NCT00153816|65041464|FG004|Overall Study|Follow-up exam done, histology missing|1|||
23354554|NCT00153816|65041465|FG005|Overall Study|Follow-up exam done, histology missing|2|||
23354555|NCT02191046|65041466|FG000|Overall Study|low compliance|5|||
23354556|NCT02191046|65041467|FG001|Overall Study|low compliance|1|||
23354557|NCT00435188|65041468|FG000|Overall Study|Death|1|||
23354558|NCT00435188|65041469|FG001|Overall Study|Death|6|||
23354559|NCT00435188|65041468|FG000|Overall Study|Withdrawal by Subject|16|||
23354560|NCT00435188|65041469|FG001|Overall Study|Withdrawal by Subject|11|||
23354561|NCT00435188|65041468|FG000|Overall Study|Lost to Follow-up|5|||
23354562|NCT00435188|65041469|FG001|Overall Study|Lost to Follow-up|6|||
23354563|NCT02007278|65041472|FG000|Overall Study|Failure to comply with an eligibility|0|||
23354564|NCT02007278|65041473|FG001|Overall Study|Failure to comply with an eligibility|1|||
23354565|NCT02007278|65041472|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
23587750|NCT02918968|65879219|FG000|2nd Line AAT|Progressive disease|21|||
23587751|NCT02918968|65879220|FG001|2nd Line AAT|Progressive disease|3|||
23587752|NCT02918968|65879219|FG000|2nd Line AAT|Adverse Event|2|||
23587753|NCT02918968|65879220|FG001|2nd Line AAT|Adverse Event|5|||
23587754|NCT02918968|65879219|FG000|2nd Line AAT|Physician Decision|0|||
23587755|NCT02918968|65879220|FG001|2nd Line AAT|Physician Decision|1|||
23587756|NCT02918968|65879219|FG000|2nd Line AAT|Withdrawal by Subject|2|||
23587757|NCT02918968|65879220|FG001|2nd Line AAT|Withdrawal by Subject|2|||
23587758|NCT02918968|65879219|FG000|2nd Line AAT|Death|0|||
23587759|NCT02918968|65879220|FG001|2nd Line AAT|Death|1|||
23587760|NCT02174562|65879223|FG000|Overall Study|Withdrawal by Subject|7|||
23587761|NCT02174562|65879224|FG001|Overall Study|Withdrawal by Subject|2|||
23354566|NCT02007278|65041473|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
23354567|NCT02007278|65041472|FG000|Overall Study|Incorrect medication administration|1|||
23354568|NCT02007278|65041473|FG001|Overall Study|Incorrect medication administration|0|||
23354569|NCT02007278|65041472|FG000|Overall Study|Mis-randomization|1|||
23354570|NCT02007278|65041473|FG001|Overall Study|Mis-randomization|1|||
23354571|NCT01554163|65041474|FG000|Overall Study|Adverse Event|3|||
23354572|NCT01554163|65041475|FG001|Overall Study|Adverse Event|0|||
23354573|NCT01554163|65041474|FG000|Overall Study|Lack of Efficacy|1|||
23587762|NCT02174562|65879223|FG000|Overall Study|Death|2|||
23795398|NCT01390948|66626759|FG002|Overall Study|Progressive Disease|0|||
23795399|NCT01390948|66626757|FG000|Overall Study|Death during follow-up|10|||
23354574|NCT01554163|65041475|FG001|Overall Study|Lack of Efficacy|0|||
23354575|NCT01554163|65041474|FG000|Overall Study|Lost to Follow-up|1|||
23354576|NCT01554163|65041475|FG001|Overall Study|Lost to Follow-up|0|||
23354577|NCT01554163|65041474|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23354578|NCT01554163|65041475|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23354579|NCT01554163|65041474|FG000|Overall Study|Protocol Violation|0|||
23354580|NCT01554163|65041475|FG001|Overall Study|Protocol Violation|4|||
23354581|NCT01554163|65041474|FG000|Overall Study|Withdrawal by Subject|1|||
23354582|NCT01554163|65041475|FG001|Overall Study|Withdrawal by Subject|5|||
23354583|NCT01554163|65041474|FG000|Overall Study|Not Treated|1|||
23354584|NCT01554163|65041475|FG001|Overall Study|Not Treated|0|||
23354585|NCT01250171|65041479|FG000|Overall Study|Administrative reasons|1|||
23354586|NCT01250171|65041480|FG001|Overall Study|Administrative reasons|0|||
23354587|NCT01250171|65041481|FG002|Overall Study|Administrative reasons|0|||
23354588|NCT01289574|65041482|FG000|Overall Study|Lack of Efficacy|4|||
23354589|NCT01289574|65041483|FG001|Overall Study|Lack of Efficacy|0|||
23471424|NCT00635219|65470674|FG002|Overall Study|Adverse Event|18|||
23471425|NCT00635219|65470675|FG003|Overall Study|Adverse Event|15|||
23471426|NCT00635219|65470676|FG004|Overall Study|Adverse Event|19|||
23471427|NCT00635219|65470672|FG000|Overall Study|Lack of Efficacy|5|||
23471428|NCT00635219|65470673|FG001|Overall Study|Lack of Efficacy|6|||
23471429|NCT00635219|65470674|FG002|Overall Study|Lack of Efficacy|3|||
23471430|NCT00635219|65470675|FG003|Overall Study|Lack of Efficacy|4|||
23471431|NCT00635219|65470676|FG004|Overall Study|Lack of Efficacy|6|||
23471432|NCT00635219|65470672|FG000|Overall Study|Non-compliance With Study Product|0|||
23471433|NCT00635219|65470673|FG001|Overall Study|Non-compliance With Study Product|0|||
23471434|NCT00635219|65470674|FG002|Overall Study|Non-compliance With Study Product|0|||
23471435|NCT00635219|65470675|FG003|Overall Study|Non-compliance With Study Product|2|||
23471436|NCT00635219|65470676|FG004|Overall Study|Non-compliance With Study Product|1|||
23471437|NCT00635219|65470672|FG000|Overall Study|Protocol Violation|0|||
23471438|NCT00635219|65470673|FG001|Overall Study|Protocol Violation|2|||
23471439|NCT00635219|65470674|FG002|Overall Study|Protocol Violation|3|||
23471440|NCT00635219|65470675|FG003|Overall Study|Protocol Violation|2|||
23471441|NCT00635219|65470676|FG004|Overall Study|Protocol Violation|4|||
23471442|NCT00635219|65470672|FG000|Overall Study|Withdrawal of Consent|8|||
23471443|NCT00635219|65470673|FG001|Overall Study|Withdrawal of Consent|6|||
23471444|NCT00635219|65470674|FG002|Overall Study|Withdrawal of Consent|8|||
23471445|NCT00635219|65470675|FG003|Overall Study|Withdrawal of Consent|11|||
23471446|NCT00635219|65470676|FG004|Overall Study|Withdrawal of Consent|8|||
23471447|NCT00635219|65470672|FG000|Overall Study|Lost to Follow-up|0|||
23471448|NCT00635219|65470673|FG001|Overall Study|Lost to Follow-up|0|||
23471449|NCT00635219|65470674|FG002|Overall Study|Lost to Follow-up|2|||
23471450|NCT00635219|65470675|FG003|Overall Study|Lost to Follow-up|0|||
23587763|NCT02174562|65879224|FG001|Overall Study|Death|0|||
23587764|NCT02174562|65879223|FG000|Overall Study|Lost to Follow-up|0|||
23587765|NCT02174562|65879224|FG001|Overall Study|Lost to Follow-up|3|||
23587766|NCT05019729|65879231|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587767|NCT05019729|65879232|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587768|NCT05019729|65879233|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587769|NCT05019729|65879234|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587770|NCT05019729|65879235|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
23587771|NCT05019729|65879236|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587772|NCT02736799|65879238|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587773|NCT02736799|65879239|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587774|NCT02736799|65879240|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587775|NCT02736799|65879241|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
23587776|NCT00395018|65879244|FG000|On-Treatment|Death|4|||
23587777|NCT00395018|65879244|FG000|On-Treatment|Other Reason|2|||
23587778|NCT00395018|65879244|FG000|On-Treatment|Poor/non-compliance|2|||
23587779|NCT00395018|65879244|FG000|On-Treatment|Subject no longer meets study criteria|2|||
23587780|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
23354590|NCT01289574|65041484|FG002|Overall Study|Lack of Efficacy|1|||
23354591|NCT01289574|65041482|FG000|Overall Study|Lost to Follow-up|2|||
23471451|NCT00635219|65470676|FG004|Overall Study|Lost to Follow-up|3|||
23471452|NCT00635219|65470672|FG000|Overall Study|Administrative or Other Reasons|0|||
23471453|NCT00635219|65470673|FG001|Overall Study|Administrative or Other Reasons|1|||
23471454|NCT00635219|65470674|FG002|Overall Study|Administrative or Other Reasons|1|||
23354592|NCT01289574|65041483|FG001|Overall Study|Lost to Follow-up|0|||
23354593|NCT01289574|65041484|FG002|Overall Study|Lost to Follow-up|1|||
23354594|NCT01289574|65041482|FG000|Overall Study|Withdrawal by Subject|1|||
23471455|NCT00635219|65470675|FG003|Overall Study|Administrative or Other Reasons|0|||
23471456|NCT00635219|65470676|FG004|Overall Study|Administrative or Other Reasons|1|||
23471457|NCT00539864|65470678|FG000|Overall Study|Lost to Follow-up|0|||
23471458|NCT00539864|65470679|FG001|Overall Study|Lost to Follow-up|1|||
23471459|NCT00539864|65470678|FG000|Overall Study|Withdrawal by Subject|1|||
23471460|NCT00539864|65470679|FG001|Overall Study|Withdrawal by Subject|1|||
23471461|NCT01864603|65470685|FG000|Stage 2|DSMB design modification|86056|||
23471462|NCT01864603|65470686|FG001|Stage 2|DSMB design modification|92558|||
23471463|NCT03500224|65470691|FG000|Overall Study|Withdrawal by Subject|2|||
23471464|NCT01124006|65470692|FG000|Overall Study|Withdrawal by Subject|2|||
23471465|NCT01124006|65470693|FG001|Overall Study|Withdrawal by Subject|2|||
23471466|NCT01124006|65470694|FG002|Overall Study|Withdrawal by Subject|0|||
23471467|NCT01124006|65470692|FG000|Overall Study|Lost to Follow-up|1|||
23471468|NCT01124006|65470693|FG001|Overall Study|Lost to Follow-up|0|||
23471469|NCT01124006|65470694|FG002|Overall Study|Lost to Follow-up|1|||
23471470|NCT01124006|65470692|FG000|Overall Study|Other|0|||
23471471|NCT01124006|65470693|FG001|Overall Study|Other|0|||
23471472|NCT01124006|65470694|FG002|Overall Study|Other|1|||
23471473|NCT00499590|65470697|FG000|Overall Study|Study Terminated|112|||
23471474|NCT00499590|65470698|FG001|Overall Study|Study Terminated|112|||
23471475|NCT00499590|65470699|FG002|Overall Study|Study Terminated|112|||
23471476|NCT00499590|65470697|FG000|Overall Study|Not treated|1|||
23471477|NCT00499590|65470698|FG001|Overall Study|Not treated|0|||
23471478|NCT00499590|65470699|FG002|Overall Study|Not treated|1|||
23471479|NCT02920242|65470700|FG000|Overall Study|Withdrawal by Subject|1|||
23471480|NCT02920242|65470701|FG001|Overall Study|Withdrawal by Subject|0|||
23471481|NCT02920242|65470702|FG002|Overall Study|Withdrawal by Subject|1|||
23471482|NCT02920242|65470700|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
23471483|NCT02920242|65470701|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
23471484|NCT02920242|65470702|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
23471485|NCT03110770|65470703|FG000|Overall Study|Death|1|||
23471486|NCT03110770|65470704|FG001|Overall Study|Death|0|||
23471487|NCT03110770|65470705|FG002|Overall Study|Death|0|||
23471488|NCT03110770|65470706|FG003|Overall Study|Death|1|||
23471489|NCT03110770|65470707|FG004|Overall Study|Death|0|||
23471490|NCT03110770|65470703|FG000|Overall Study|Enrolled but did not receive product|0|||
23471491|NCT03110770|65470704|FG001|Overall Study|Enrolled but did not receive product|0|||
23471492|NCT03110770|65470705|FG002|Overall Study|Enrolled but did not receive product|0|||
23471493|NCT03110770|65470706|FG003|Overall Study|Enrolled but did not receive product|8|||
23471494|NCT03110770|65470707|FG004|Overall Study|Enrolled but did not receive product|7|||
23471495|NCT03110770|65470703|FG000|Overall Study|Lost to Follow-up|0|||
23471496|NCT03110770|65470704|FG001|Overall Study|Lost to Follow-up|0|||
23471497|NCT03110770|65470705|FG002|Overall Study|Lost to Follow-up|0|||
23471498|NCT03110770|65470706|FG003|Overall Study|Lost to Follow-up|53|||
23471499|NCT03110770|65470707|FG004|Overall Study|Lost to Follow-up|45|||
23471500|NCT03110770|65470703|FG000|Overall Study|Investigator Decision|0|||
23471501|NCT03110770|65470704|FG001|Overall Study|Investigator Decision|0|||
23471502|NCT03110770|65470705|FG002|Overall Study|Investigator Decision|0|||
23471503|NCT03110770|65470706|FG003|Overall Study|Investigator Decision|5|||
23471504|NCT03110770|65470707|FG004|Overall Study|Investigator Decision|3|||
23471505|NCT03110770|65470703|FG000|Overall Study|Withdrawal by Subject|0|||
23471506|NCT03110770|65470704|FG001|Overall Study|Withdrawal by Subject|0|||
23471507|NCT03110770|65470705|FG002|Overall Study|Withdrawal by Subject|0|||
23471508|NCT03110770|65470706|FG003|Overall Study|Withdrawal by Subject|24|||
23471509|NCT03110770|65470707|FG004|Overall Study|Withdrawal by Subject|24|||
23471510|NCT03110770|65470703|FG000|Overall Study|Moved from area|5|||
23471511|NCT03110770|65470704|FG001|Overall Study|Moved from area|0|||
23471512|NCT03110770|65470705|FG002|Overall Study|Moved from area|2|||
23471513|NCT03110770|65470706|FG003|Overall Study|Moved from area|42|||
23471514|NCT03110770|65470707|FG004|Overall Study|Moved from area|43|||
23471515|NCT03110770|65470703|FG000|Overall Study|Illness/Injury unrelated to product|0|||
23471516|NCT03110770|65470704|FG001|Overall Study|Illness/Injury unrelated to product|0|||
23471517|NCT03110770|65470705|FG002|Overall Study|Illness/Injury unrelated to product|0|||
23471518|NCT03110770|65470706|FG003|Overall Study|Illness/Injury unrelated to product|0|||
23471519|NCT03110770|65470707|FG004|Overall Study|Illness/Injury unrelated to product|1|||
23471520|NCT02644109|65470711|FG000|Overall Study|Adverse Event|0|||
23471521|NCT02644109|65470712|FG001|Overall Study|Adverse Event|4|||
23471522|NCT01191762|65470713|FG000|Overall Study|Adverse Event|1|||
23471523|NCT01191762|65470714|FG001|Overall Study|Adverse Event|0|||
23471524|NCT02703337|65470715|FG000|Period One (Part A)|Withdrawal by Subject|0|||
23471525|NCT02703337|65470716|FG001|Period One (Part A)|Withdrawal by Subject|0|||
23471526|NCT02703337|65470717|FG002|Period One (Part A)|Withdrawal by Subject|0|||
23471527|NCT02703337|65470718|FG003|Period One (Part A)|Withdrawal by Subject|0|||
23471528|NCT02703337|65470719|FG004|Period One (Part A)|Withdrawal by Subject|1|||
23471529|NCT02703337|65470720|FG005|Period One (Part A)|Withdrawal by Subject|0|||
23471530|NCT02703337|65470721|FG006|Period One (Part A)|Withdrawal by Subject|0|||
23471531|NCT02703337|65470722|FG007|Period One (Part A)|Withdrawal by Subject|0|||
23471532|NCT02446899|65470726|FG000|Overall Study|Adverse Event|4|||
23795400|NCT01390948|66626758|FG001|Overall Study|Death during follow-up|11|||
23795401|NCT01390948|66626759|FG002|Overall Study|Death during follow-up|1|||
23795402|NCT00820599|66626760|FG000|Overall Study|Death|129|||
23795403|NCT00820599|66626760|FG000|Overall Study|Withdrawal by Subject|2|||
23795404|NCT01876368|66626761|FG000|Overall Study|Adverse Event|2|||
23795405|NCT01876368|66626762|FG001|Overall Study|Adverse Event|5|||
23795406|NCT01876368|66626761|FG000|Overall Study|Lack of Efficacy|1|||
23795407|NCT01876368|66626762|FG001|Overall Study|Lack of Efficacy|0|||
23795408|NCT01876368|66626761|FG000|Overall Study|Lost to Follow-up|0|||
23795409|NCT01876368|66626762|FG001|Overall Study|Lost to Follow-up|1|||
23795410|NCT01876368|66626761|FG000|Overall Study|Non-compliance with study treatment|0|||
23354595|NCT01289574|65041483|FG001|Overall Study|Withdrawal by Subject|1|||
23354596|NCT01289574|65041484|FG002|Overall Study|Withdrawal by Subject|1|||
23354597|NCT01289574|65041482|FG000|Overall Study|Adverse Event|0|||
23354598|NCT01289574|65041483|FG001|Overall Study|Adverse Event|1|||
23354599|NCT01289574|65041484|FG002|Overall Study|Adverse Event|0|||
23354600|NCT01289574|65041482|FG000|Overall Study|Subject wanted alternate treatment|0|||
23471533|NCT02446899|65470727|FG001|Overall Study|Adverse Event|7|||
23471534|NCT02446899|65470726|FG000|Overall Study|Condition Under Investigation Worsened|1|||
23471535|NCT02446899|65470727|FG001|Overall Study|Condition Under Investigation Worsened|4|||
23471536|NCT02446899|65470726|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
23471537|NCT02446899|65470727|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
23587781|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
23587782|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
23795411|NCT01876368|66626762|FG001|Overall Study|Non-compliance with study treatment|1|||
23795412|NCT01876368|66626761|FG000|Overall Study|Physician Decision|0|||
23795413|NCT01876368|66626762|FG001|Overall Study|Physician Decision|2|||
23795414|NCT01876368|66626761|FG000|Overall Study|Protocol deviation|3|||
23354601|NCT01289574|65041483|FG001|Overall Study|Subject wanted alternate treatment|1|||
23795415|NCT01876368|66626762|FG001|Overall Study|Protocol deviation|3|||
23354602|NCT01289574|65041484|FG002|Overall Study|Subject wanted alternate treatment|0|||
23354603|NCT04710368|65041485|FG000|Overall Study|Withdrawal by Subject|9|||
23471538|NCT02446899|65470726|FG000|Overall Study|Lack of Efficacy|2|||
23471539|NCT02446899|65470727|FG001|Overall Study|Lack of Efficacy|8|||
23471540|NCT02446899|65470726|FG000|Overall Study|Lost to Follow-up|1|||
23471541|NCT02446899|65470727|FG001|Overall Study|Lost to Follow-up|3|||
23471542|NCT02446899|65470726|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23471543|NCT02446899|65470727|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
23471544|NCT02446899|65470726|FG000|Overall Study|Withdrawal by Subject|11|||
23471545|NCT02446899|65470727|FG001|Overall Study|Withdrawal by Subject|19|||
23471546|NCT02446899|65470726|FG000|Overall Study|Miscellaneous|5|||
23471547|NCT02446899|65470727|FG001|Overall Study|Miscellaneous|4|||
23471548|NCT02446899|65470726|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23471549|NCT02446899|65470727|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
23471550|NCT00509145|65470729|FG000|Overall Study|Death|0|||
23471551|NCT00509145|65470730|FG001|Overall Study|Death|2|||
23471552|NCT00509145|65470729|FG000|Overall Study|Adverse Event|42|||
23471553|NCT00509145|65470730|FG001|Overall Study|Adverse Event|28|||
23471554|NCT00509145|65470729|FG000|Overall Study|Withdrawal by Subject|32|||
23471555|NCT00509145|65470730|FG001|Overall Study|Withdrawal by Subject|38|||
23471556|NCT00509145|65470729|FG000|Overall Study|Physician Decision|11|||
23471557|NCT00509145|65470730|FG001|Overall Study|Physician Decision|14|||
23471558|NCT00509145|65470729|FG000|Overall Study|Protocol Violation|1|||
23471559|NCT00509145|65470730|FG001|Overall Study|Protocol Violation|6|||
23471560|NCT00509145|65470729|FG000|Overall Study|Pregnancy|3|||
23471561|NCT00509145|65470730|FG001|Overall Study|Pregnancy|8|||
23471562|NCT00509145|65470729|FG000|Overall Study|Lost to Follow-up|6|||
23471563|NCT00509145|65470730|FG001|Overall Study|Lost to Follow-up|5|||
23471564|NCT00509145|65470729|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
23471565|NCT00509145|65470730|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
23471566|NCT00509145|65470729|FG000|Overall Study|Other|6|||
23471567|NCT00509145|65470730|FG001|Overall Study|Other|6|||
23471568|NCT02762370|65470732|FG000|Overall Study|Protocol Violation|1|||
23471569|NCT02762370|65470733|FG001|Overall Study|Protocol Violation|0|||
23471570|NCT02934503|65470734|FG000|Overall Study|progression of disease|3|||
23471571|NCT02934503|65470734|FG000|Overall Study|Withdrawal by Subject|1|||
23471572|NCT00916929|65470735|FG000|Overall Study|Lost to Follow-up|1|||
23471573|NCT00916929|65470736|FG001|Overall Study|Lost to Follow-up|3|||
23471574|NCT00916929|65470735|FG000|Overall Study|Death|5|||
23471575|NCT00916929|65470736|FG001|Overall Study|Death|10|||
23471576|NCT00916929|65470735|FG000|Overall Study|Withdrawal by Subject|1|||
23471577|NCT00916929|65470736|FG001|Overall Study|Withdrawal by Subject|5|||
23471578|NCT00916929|65470735|FG000|Overall Study|Left ventricular epicardial lead|1|||
23471579|NCT00916929|65470736|FG001|Overall Study|Left ventricular epicardial lead|2|||
23471580|NCT00916929|65470735|FG000|Overall Study|Transferred to hospice care|1|||
23471581|NCT00916929|65470736|FG001|Overall Study|Transferred to hospice care|1|||
23471582|NCT00916929|65470735|FG000|Overall Study|System explant|1|||
23587783|NCT03192046|65879245|FG000|Overall Study|Withdrawal by Subject|1|||
23587784|NCT03192046|65879246|FG001|Overall Study|Withdrawal by Subject|1|||
23471583|NCT00916929|65470736|FG001|Overall Study|System explant|0|||
23471584|NCT00916929|65470735|FG000|Overall Study|Moved to another state|0|||
23471585|NCT00916929|65470736|FG001|Overall Study|Moved to another state|1|||
23471586|NCT00916929|65470735|FG000|Overall Study|Device unable to process impedance data|0|||
23471587|NCT00916929|65470736|FG001|Overall Study|Device unable to process impedance data|7|||
23471588|NCT00486291|65470740|FG000|Overall Study|Adverse Event|3|||
23471589|NCT00486291|65470741|FG001|Overall Study|Adverse Event|4|||
23587785|NCT01186848|65879247|FG000|Overall Study|Lost to Follow-up|4|||
23587786|NCT01186848|65879247|FG000|Overall Study|Withdrawal by Subject|2|||
23587787|NCT01186848|65879247|FG000|Overall Study|Adverse Event|2|||
23587788|NCT01988233|65879250|FG000|Overall Study|Lost to Follow-up|64|||
23587789|NCT01988233|65879251|FG001|Overall Study|Lost to Follow-up|51|||
23587790|NCT00751036|65879252|FG000|Overall Study|Disease Progression|28|||
23587791|NCT00751036|65879253|FG001|Overall Study|Disease Progression|29|||
23587792|NCT00751036|65879252|FG000|Overall Study|Adverse Event|6|||
23587793|NCT00751036|65879253|FG001|Overall Study|Adverse Event|4|||
23471590|NCT00486291|65470740|FG000|Overall Study|Lost to Follow-up|3|||
23471591|NCT00486291|65470741|FG001|Overall Study|Lost to Follow-up|7|||
23471592|NCT00486291|65470740|FG000|Overall Study|protocol non-compliance|10|||
23471593|NCT00486291|65470741|FG001|Overall Study|protocol non-compliance|15|||
23587794|NCT00751036|65879252|FG000|Overall Study|Administrative Problems|3|||
23471594|NCT00486291|65470740|FG000|Overall Study|requirement for restricted medication|0|||
23471595|NCT00486291|65470741|FG001|Overall Study|requirement for restricted medication|3|||
23471596|NCT02207088|65470742|FG000|Overall Study|Adverse Event|2|||
23471597|NCT00607373|65470745|FG000|Treatment Period|Adverse Event|0|||
23471598|NCT00607373|65470746|FG001|Treatment Period|Adverse Event|4|||
23471599|NCT00607373|65470745|FG000|Treatment Period|Physician Decision|0|||
23471600|NCT00607373|65470746|FG001|Treatment Period|Physician Decision|1|||
23587795|NCT00751036|65879253|FG001|Overall Study|Administrative Problems|4|||
23587796|NCT00751036|65879252|FG000|Overall Study|Withdrawal by Subject|5|||
23641185|NCT03727438|66071573|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
23641186|NCT03727438|66071572|FG000|Intervention Period|Excluded (health)|1|||
23471601|NCT00607373|65470745|FG000|Treatment Period|Withdrawal by Subject|0|||
23471602|NCT00607373|65470746|FG001|Treatment Period|Withdrawal by Subject|1|||
23471603|NCT00607373|65470745|FG000|Follow-up Period|Other|0|||
23471604|NCT00607373|65470746|FG001|Follow-up Period|Other|1|||
23471605|NCT00607373|65470745|FG000|Follow-up Period|Protocol Violation|0|||
23471606|NCT00607373|65470746|FG001|Follow-up Period|Protocol Violation|1|||
23471607|NCT00607373|65470745|FG000|Follow-up Period|Withdrawal by Subject|1|||
23471608|NCT00607373|65470746|FG001|Follow-up Period|Withdrawal by Subject|3|||
23471609|NCT03052400|65470750|FG000|Overall Study|Lost to Follow-up|1|||
23471610|NCT03052400|65470751|FG001|Overall Study|Lost to Follow-up|0|||
23471611|NCT03052400|65470750|FG000|Overall Study|Withdrawal by Subject|0|||
23471612|NCT03052400|65470751|FG001|Overall Study|Withdrawal by Subject|1|||
23471613|NCT00947193|65470755|FG000|Overall Study|Lost to Follow-up|1|||
23471614|NCT00947193|65470756|FG001|Overall Study|Lost to Follow-up|0|||
23471615|NCT00947193|65470755|FG000|Overall Study|Withdrawal by Subject|1|||
23471616|NCT00947193|65470756|FG001|Overall Study|Withdrawal by Subject|0|||
23471617|NCT00947193|65470755|FG000|Overall Study|Factor VIII >1%|1|||
23471618|NCT00947193|65470756|FG001|Overall Study|Factor VIII >1%|0|||
23471619|NCT00488683|65470757|FG000|Overall Study|Withdrawal by Subject|1|||
23471620|NCT00488683|65470758|FG001|Overall Study|Withdrawal by Subject|2|||
23471621|NCT00488683|65470759|FG002|Overall Study|Withdrawal by Subject|2|||
23471622|NCT00488683|65470757|FG000|Overall Study|Lost to Follow-up|5|||
23471623|NCT00488683|65470758|FG001|Overall Study|Lost to Follow-up|3|||
23471624|NCT00488683|65470759|FG002|Overall Study|Lost to Follow-up|0|||
23471625|NCT00488683|65470757|FG000|Overall Study|Protocol Violation|5|||
23471626|NCT00488683|65470758|FG001|Overall Study|Protocol Violation|1|||
23471627|NCT00488683|65470759|FG002|Overall Study|Protocol Violation|0|||
23471628|NCT00488683|65470757|FG000|Overall Study|Unable to Classify|1|||
23471629|NCT00488683|65470758|FG001|Overall Study|Unable to Classify|0|||
23471630|NCT00488683|65470759|FG002|Overall Study|Unable to Classify|0|||
23471631|NCT01712399|65470761|FG000|Overall Study|Lost to Follow-up|1|||
23471632|NCT01712399|65470761|FG000|Overall Study|Withdrawal by Subject|39|||
23471633|NCT01712399|65470761|FG000|Overall Study|Death|1|||
23471634|NCT01712399|65470761|FG000|Overall Study|Adverse Event|11|||
23471635|NCT01712399|65470761|FG000|Overall Study|Study closure|345|||
23471636|NCT03073733|65470763|FG000|Overall Study|Lost to Follow-up|1|||
23471637|NCT03073733|65470764|FG001|Overall Study|Lost to Follow-up|0|||
23471638|NCT03073733|65470765|FG002|Overall Study|Lost to Follow-up|0|||
23471639|NCT03073733|65470763|FG000|Overall Study|Physician Decision|0|||
23471640|NCT03073733|65470764|FG001|Overall Study|Physician Decision|1|||
23471641|NCT03073733|65470765|FG002|Overall Study|Physician Decision|0|||
23471642|NCT03073733|65470763|FG000|Overall Study|Withdrawal by Subject|0|||
23471643|NCT03073733|65470764|FG001|Overall Study|Withdrawal by Subject|0|||
23471644|NCT03073733|65470765|FG002|Overall Study|Withdrawal by Subject|1|||
23471645|NCT02840799|65470766|FG000|Phase 1|Physician Decision|1|||
23471646|NCT02840799|65470767|FG001|Phase 1|Physician Decision|3|||
23471647|NCT02840799|65470766|FG000|Phase 1|Withdrawal by Subject|4|||
23471648|NCT02840799|65470767|FG001|Phase 1|Withdrawal by Subject|0|||
23471649|NCT02840799|65470766|FG000|Phase 2 (Crossover)|Adverse Event|0|||
23471650|NCT02840799|65470767|FG001|Phase 2 (Crossover)|Adverse Event|1|||
23471651|NCT02840799|65470766|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
23471652|NCT02840799|65470767|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
23471653|NCT00740857|65470768|FG000|Overall Study|Withdrawal by Subject|1|||
23471654|NCT00740857|65470769|FG001|Overall Study|Withdrawal by Subject|0|||
23471655|NCT00740857|65470770|FG002|Overall Study|Withdrawal by Subject|0|||
23471656|NCT02433080|65470771|FG000|Overall Study|Lost to Follow-up|1|||
23471657|NCT02433080|65470772|FG001|Overall Study|Lost to Follow-up|2|||
23471658|NCT02433080|65470771|FG000|Overall Study|Withdrawal by Subject|0|||
23471659|NCT02433080|65470772|FG001|Overall Study|Withdrawal by Subject|2|||
23471660|NCT01525225|65470773|FG000|Enrollment|No longer met study criteria|1|||
23471661|NCT01525225|65470773|FG000|Enrollment|Other|1|||
23471662|NCT00459186|65470774|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
23471663|NCT00459186|65470774|FG000|PET Imaging and Assessment|Adverse Event|3|||
23471664|NCT00744042|65470775|FG000|Overall Study|Withdrawal by Subject|1|||
23706842|NCT00002663|66301348|FG009|Overall Study|Other|0|||
23471665|NCT00823615|65470780|FG000|Period 2|Lost to Follow-up|2|||
23471666|NCT00823615|65470781|FG001|Period 2|Lost to Follow-up|0|||
23471667|NCT00823615|65470780|FG000|Period 2|Time/Job Conflict|1|||
23471668|NCT00823615|65470781|FG001|Period 2|Time/Job Conflict|2|||
23471669|NCT01798849|65470782|FG000|Overall Study|Physician Decision|0|||
23471670|NCT01798849|65470783|FG001|Overall Study|Physician Decision|0|||
23471671|NCT01798849|65470784|FG002|Overall Study|Physician Decision|1|||
23471672|NCT01068600|65470786|FG000|Overall Study|Withdrawal by Subject|5|||
23471673|NCT01068600|65470787|FG001|Overall Study|Withdrawal by Subject|6|||
23471674|NCT01068600|65470786|FG000|Overall Study|Adverse Event|3|||
23471675|NCT01068600|65470787|FG001|Overall Study|Adverse Event|3|||
23471676|NCT01068600|65470786|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23471677|NCT01068600|65470787|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23471678|NCT01068600|65470786|FG000|Overall Study|Lost to Follow-up|1|||
23471679|NCT01068600|65470787|FG001|Overall Study|Lost to Follow-up|2|||
23471680|NCT01068600|65470786|FG000|Overall Study|Protocol deviation|1|||
23471681|NCT01068600|65470787|FG001|Overall Study|Protocol deviation|1|||
23471682|NCT01068600|65470786|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23471683|NCT01068600|65470787|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23471684|NCT01068600|65470786|FG000|Overall Study|Administrative problems|0|||
23471685|NCT01068600|65470787|FG001|Overall Study|Administrative problems|1|||
23471686|NCT01409811|65470788|FG000|Overall Study|Insurance denial|1|||
23471687|NCT01598129|65470792|FG000|Overall Study|Disease progression|6|||
23471688|NCT01598129|65470792|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
23471689|NCT01598129|65470792|FG000|Overall Study|Withdrawal by Subject|1|||
23471690|NCT01015638|65470793|FG000|Overall Study|Withdrawal by Subject|1|||
23471691|NCT01015638|65470794|FG001|Overall Study|Withdrawal by Subject|0|||
23471692|NCT00481091|65470796|FG000|Overall Study|Withdrawal by Subject|0|||
23471693|NCT00481091|65470797|FG001|Overall Study|Withdrawal by Subject|1|||
23471694|NCT00481091|65470798|FG002|Overall Study|Withdrawal by Subject|1|||
23471695|NCT00481091|65470799|FG003|Overall Study|Withdrawal by Subject|0|||
23471696|NCT00481091|65470800|FG004|Overall Study|Withdrawal by Subject|0|||
23471697|NCT00481091|65470801|FG005|Overall Study|Withdrawal by Subject|0|||
23471698|NCT00481091|65470802|FG006|Overall Study|Withdrawal by Subject|0|||
23471699|NCT00481091|65470803|FG007|Overall Study|Withdrawal by Subject|0|||
23471700|NCT00481091|65470804|FG008|Overall Study|Withdrawal by Subject|1|||
23471701|NCT00481091|65470805|FG009|Overall Study|Withdrawal by Subject|6|||
23471702|NCT00481091|65470796|FG000|Overall Study|Other, Not Specified|0|||
23471703|NCT00481091|65470797|FG001|Overall Study|Other, Not Specified|1|||
23471704|NCT00481091|65470798|FG002|Overall Study|Other, Not Specified|1|||
23471705|NCT00481091|65470799|FG003|Overall Study|Other, Not Specified|0|||
23471706|NCT00481091|65470800|FG004|Overall Study|Other, Not Specified|0|||
23471707|NCT00481091|65470801|FG005|Overall Study|Other, Not Specified|1|||
23471708|NCT00481091|65470802|FG006|Overall Study|Other, Not Specified|0|||
23471709|NCT00481091|65470803|FG007|Overall Study|Other, Not Specified|0|||
23471710|NCT00481091|65470804|FG008|Overall Study|Other, Not Specified|0|||
23587797|NCT00751036|65879253|FG001|Overall Study|Withdrawal by Subject|2|||
23587798|NCT00751036|65879252|FG000|Overall Study|Death|3|||
23795416|NCT01876368|66626761|FG000|Overall Study|Subject/guardian decision|3|||
23471711|NCT00481091|65470805|FG009|Overall Study|Other, Not Specified|4|||
23471712|NCT00481091|65470796|FG000|Overall Study|Adverse Event|1|||
23471713|NCT00481091|65470797|FG001|Overall Study|Adverse Event|2|||
23471714|NCT00481091|65470798|FG002|Overall Study|Adverse Event|0|||
23471715|NCT00481091|65470799|FG003|Overall Study|Adverse Event|1|||
23471716|NCT00481091|65470800|FG004|Overall Study|Adverse Event|1|||
23471717|NCT00481091|65470801|FG005|Overall Study|Adverse Event|1|||
23795417|NCT01876368|66626762|FG001|Overall Study|Subject/guardian decision|1|||
23795418|NCT00668395|66626763|FG000|Overall Study|Withdrawal by Subject|4|||
23795419|NCT00668395|66626764|FG001|Overall Study|Withdrawal by Subject|4|||
23795420|NCT00668395|66626765|FG002|Overall Study|Withdrawal by Subject|1|||
23795421|NCT00668395|66626763|FG000|Overall Study|Adverse Event|1|||
23795422|NCT00668395|66626764|FG001|Overall Study|Adverse Event|1|||
23795423|NCT00668395|66626765|FG002|Overall Study|Adverse Event|0|||
23795424|NCT00668395|66626763|FG000|Overall Study|Physician Decision|1|||
23795425|NCT00668395|66626764|FG001|Overall Study|Physician Decision|1|||
23795426|NCT00668395|66626765|FG002|Overall Study|Physician Decision|0|||
23795427|NCT04729101|66626767|FG000|Overall Study|Adverse Event|1|||
23354604|NCT04710368|65041485|FG000|Overall Study|Lost to Follow-up|4|||
23471718|NCT00481091|65470802|FG006|Overall Study|Adverse Event|2|||
23471719|NCT00481091|65470803|FG007|Overall Study|Adverse Event|1|||
23354605|NCT04710368|65041485|FG000|Overall Study|Death|2|||
23354606|NCT04710368|65041485|FG000|Overall Study|Patient preference|11|||
23354607|NCT04710368|65041485|FG000|Overall Study|Treatment discontinuation|1|||
23354608|NCT01342445|65041486|FG000|Overall Study|Experienced side effects|0|||
23354609|NCT01342445|65041487|FG001|Overall Study|Experienced side effects|2|||
23354610|NCT03882957|65041488|FG000|Overall Study|Did not complete all three arms|1|||
23354611|NCT02452554|65041489|FG000|Overall Study|Death|2|||
23354612|NCT02452554|65041490|FG001|Overall Study|Death|1|||
23354613|NCT02452554|65041491|FG002|Overall Study|Death|0|||
23354614|NCT02452554|65041492|FG003|Overall Study|Death|0|||
23354615|NCT02452554|65041493|FG004|Overall Study|Death|0|||
23354616|NCT02452554|65041494|FG005|Overall Study|Death|0|||
23471720|NCT00481091|65470804|FG008|Overall Study|Adverse Event|1|||
23471721|NCT00481091|65470805|FG009|Overall Study|Adverse Event|6|||
23641187|NCT03727438|66071573|FG001|Intervention Period|Excluded (health)|0|||
23354617|NCT02452554|65041489|FG000|Overall Study|Lack of Efficacy|13|||
23354618|NCT02452554|65041490|FG001|Overall Study|Lack of Efficacy|14|||
23471722|NCT00481091|65470796|FG000|Overall Study|Progressive disease clinical|0|||
23471723|NCT00481091|65470797|FG001|Overall Study|Progressive disease clinical|0|||
23471724|NCT00481091|65470798|FG002|Overall Study|Progressive disease clinical|0|||
23471725|NCT00481091|65470799|FG003|Overall Study|Progressive disease clinical|0|||
23471726|NCT00481091|65470800|FG004|Overall Study|Progressive disease clinical|0|||
23354619|NCT02452554|65041491|FG002|Overall Study|Lack of Efficacy|9|||
23354620|NCT02452554|65041492|FG003|Overall Study|Lack of Efficacy|1|||
23354621|NCT02452554|65041493|FG004|Overall Study|Lack of Efficacy|5|||
23354622|NCT02452554|65041494|FG005|Overall Study|Lack of Efficacy|8|||
23354623|NCT02452554|65041489|FG000|Overall Study|Physician Decision|0|||
23354624|NCT02452554|65041490|FG001|Overall Study|Physician Decision|1|||
23354625|NCT02452554|65041491|FG002|Overall Study|Physician Decision|0|||
23354626|NCT02452554|65041492|FG003|Overall Study|Physician Decision|0|||
23354627|NCT02452554|65041493|FG004|Overall Study|Physician Decision|0|||
23354628|NCT02452554|65041494|FG005|Overall Study|Physician Decision|0|||
23354629|NCT02452554|65041489|FG000|Overall Study|Withdrawal by Subject|1|||
23354630|NCT02452554|65041490|FG001|Overall Study|Withdrawal by Subject|0|||
23354631|NCT02452554|65041491|FG002|Overall Study|Withdrawal by Subject|2|||
23354632|NCT02452554|65041492|FG003|Overall Study|Withdrawal by Subject|0|||
23354633|NCT02452554|65041493|FG004|Overall Study|Withdrawal by Subject|0|||
23354634|NCT02452554|65041494|FG005|Overall Study|Withdrawal by Subject|1|||
23471727|NCT00481091|65470801|FG005|Overall Study|Progressive disease clinical|0|||
23587799|NCT00751036|65879253|FG001|Overall Study|Death|3|||
23587800|NCT00751036|65879252|FG000|Overall Study|Lost to Follow-up|0|||
23587801|NCT00751036|65879253|FG001|Overall Study|Lost to Follow-up|1|||
23587802|NCT00751036|65879252|FG000|Overall Study|Protocol Violation|1|||
23587803|NCT00751036|65879253|FG001|Overall Study|Protocol Violation|0|||
23587804|NCT00751036|65879252|FG000|Overall Study|Missing end of Treatment Page|2|||
23587805|NCT00751036|65879253|FG001|Overall Study|Missing end of Treatment Page|3|||
23587806|NCT00603538|65879254|FG000|Overall Study|Adverse Event|0|||
23587807|NCT00603538|65879255|FG001|Overall Study|Adverse Event|4|||
23587808|NCT00603538|65879256|FG002|Overall Study|Adverse Event|2|||
23587809|NCT00603538|65879254|FG000|Overall Study|Objective progression or relapse|3|||
23587810|NCT00603538|65879255|FG001|Overall Study|Objective progression or relapse|0|||
23587811|NCT00603538|65879256|FG002|Overall Study|Objective progression or relapse|0|||
23587812|NCT00324038|65879257|FG000|Overall Study|Adverse Event|38|||
23587813|NCT00324038|65879258|FG001|Overall Study|Adverse Event|23|||
23587814|NCT00324038|65879257|FG000|Overall Study|Lack of Efficacy|5|||
23587815|NCT00324038|65879258|FG001|Overall Study|Lack of Efficacy|13|||
23587816|NCT00324038|65879257|FG000|Overall Study|Lost to Follow-up|0|||
23587817|NCT00324038|65879258|FG001|Overall Study|Lost to Follow-up|2|||
23587818|NCT00324038|65879257|FG000|Overall Study|Other|6|||
23587819|NCT00324038|65879258|FG001|Overall Study|Other|13|||
23587820|NCT00770965|65882022|FG000|Safety Set|Withdrawal by Subject|0|||
23587821|NCT00770965|65882023|FG001|Safety Set|Withdrawal by Subject|0|||
23587822|NCT00770965|65882024|FG002|Safety Set|Withdrawal by Subject|0|||
23641188|NCT03727438|66071572|FG000|Intervention Period|Withdrawal by Subject|3|||
23795428|NCT04729101|66626768|FG001|Overall Study|Adverse Event|0|||
23795429|NCT04729101|66626767|FG000|Overall Study|Physician Decision|1|||
23795430|NCT04729101|66626768|FG001|Overall Study|Physician Decision|0|||
23795431|NCT04729101|66626767|FG000|Overall Study|Withdrawal by Subject|1|||
23795432|NCT04729101|66626768|FG001|Overall Study|Withdrawal by Subject|0|||
23795433|NCT01520987|66629869|FG000|Overall Study|Withdrawal by Subject|1|||
23795434|NCT01520987|66629870|FG001|Overall Study|Withdrawal by Subject|0|||
23795435|NCT01520987|66629871|FG002|Overall Study|Withdrawal by Subject|0|||
23795436|NCT01520987|66629872|FG003|Overall Study|Withdrawal by Subject|0|||
23795437|NCT01520987|66629873|FG004|Overall Study|Withdrawal by Subject|0|||
23795438|NCT01520987|66629874|FG005|Overall Study|Withdrawal by Subject|1|||
23795439|NCT01520987|66629875|FG006|Overall Study|Withdrawal by Subject|0|||
23795440|NCT01520987|66629876|FG007|Overall Study|Withdrawal by Subject|0|||
23471728|NCT00481091|65470802|FG006|Overall Study|Progressive disease clinical|0|||
23471729|NCT00481091|65470803|FG007|Overall Study|Progressive disease clinical|0|||
23471730|NCT00481091|65470804|FG008|Overall Study|Progressive disease clinical|1|||
23471731|NCT00481091|65470805|FG009|Overall Study|Progressive disease clinical|7|||
23471732|NCT00481091|65470796|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471733|NCT00481091|65470797|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471734|NCT00481091|65470798|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471735|NCT00481091|65470799|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471736|NCT00481091|65470800|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471737|NCT00481091|65470801|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471738|NCT00481091|65470802|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471739|NCT00481091|65470803|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471740|NCT00481091|65470804|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471741|NCT00481091|65470805|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23795441|NCT01609582|66629877|FG000|Overall Study|Adverse Event|20|||
23795442|NCT01609582|66629878|FG001|Overall Study|Adverse Event|18|||
23795443|NCT01609582|66629877|FG000|Overall Study|Lost to Follow-up|10|||
23795444|NCT01609582|66629878|FG001|Overall Study|Lost to Follow-up|10|||
23795445|NCT01609582|66629877|FG000|Overall Study|Withdrawal by Subject|21|||
23795446|NCT01609582|66629878|FG001|Overall Study|Withdrawal by Subject|15|||
23795447|NCT01609582|66629877|FG000|Overall Study|Study Terminated by Sponsor|1543|||
23795448|NCT01609582|66629878|FG001|Overall Study|Study Terminated by Sponsor|1548|||
23795449|NCT01609582|66629877|FG000|Overall Study|Other|9|||
23795450|NCT01609582|66629878|FG001|Overall Study|Other|10|||
23795451|NCT01609582|66629877|FG000|Overall Study|Randomized, but not treated|0|||
23471742|NCT00481091|65470796|FG000|Overall Study|Progressive disease other|1|||
23587823|NCT00770965|65882025|FG003|Safety Set|Withdrawal by Subject|1|||
23587824|NCT00770965|65882022|FG000|Safety Set|Protocol deviation|0|||
23354635|NCT02452554|65041489|FG000|Overall Study|Ineligible|0|||
23354636|NCT02452554|65041490|FG001|Overall Study|Ineligible|1|||
23354637|NCT02452554|65041491|FG002|Overall Study|Ineligible|0|||
23354638|NCT02452554|65041492|FG003|Overall Study|Ineligible|0|||
23354639|NCT02452554|65041493|FG004|Overall Study|Ineligible|0|||
23354640|NCT02452554|65041494|FG005|Overall Study|Ineligible|0|||
23587825|NCT00770965|65882023|FG001|Safety Set|Protocol deviation|0|||
23587826|NCT00770965|65882024|FG002|Safety Set|Protocol deviation|1|||
23587827|NCT00770965|65882025|FG003|Safety Set|Protocol deviation|0|||
23587828|NCT00770965|65882022|FG000|Excluded Set|Administrative problems|14|||
23587829|NCT00770965|65882023|FG001|Excluded Set|Administrative problems|12|||
23587830|NCT00770965|65882024|FG002|Excluded Set|Administrative problems|12|||
23795452|NCT01609582|66629878|FG001|Overall Study|Randomized, but not treated|3|||
23795453|NCT00024258|66629879|FG000|Overall Study|Withdrawal by Subject|1|||
23795454|NCT00024258|66629879|FG000|Overall Study|Disease Progression|8|||
23795455|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
23795456|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
23795457|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
23795458|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
23795459|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
23795460|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
23795461|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
23587831|NCT00770965|65882025|FG003|Excluded Set|Administrative problems|10|||
23587832|NCT00770965|65882022|FG000|Excluded Set|Withdrawal by Subject|1|||
23587833|NCT00770965|65882023|FG001|Excluded Set|Withdrawal by Subject|1|||
23587834|NCT00770965|65882024|FG002|Excluded Set|Withdrawal by Subject|2|||
23587835|NCT00770965|65882025|FG003|Excluded Set|Withdrawal by Subject|3|||
23587836|NCT04012853|65882026|FG000|Overall Study|Withdrawal by Subject|1|||
23587837|NCT04012853|65882027|FG001|Overall Study|Withdrawal by Subject|1|||
23587838|NCT04012853|65882026|FG000|Overall Study|Protocol Violation|1|||
23587839|NCT04012853|65882027|FG001|Overall Study|Protocol Violation|0|||
23795462|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
23795463|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
23795464|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Other|1|||
23795465|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Other|4|||
23795466|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Other|5|||
23354641|NCT02452554|65041489|FG000|Overall Study|Never Received Treatment|1|||
23354642|NCT02452554|65041490|FG001|Overall Study|Never Received Treatment|0|||
23641189|NCT03727438|66071573|FG001|Intervention Period|Withdrawal by Subject|1|||
23641190|NCT03727438|66071572|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
23641191|NCT03727438|66071573|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
23641192|NCT03727438|66071572|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
23641193|NCT03727438|66071573|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
23641194|NCT03727438|66071572|FG000|8 Week Assessment|Withdrawal by Subject|6|||
23641195|NCT03727438|66071573|FG001|8 Week Assessment|Withdrawal by Subject|1|||
23641196|NCT03727438|66071572|FG000|6 mo Assessment|did not complete assessment|10|||
23641197|NCT03727438|66071573|FG001|6 mo Assessment|did not complete assessment|11|||
23641198|NCT03534284|66071576|FG000|Overall Study|Death|2|||
23641199|NCT03534284|66071577|FG001|Overall Study|Death|3|||
23641200|NCT03534284|66071578|FG002|Overall Study|Death|3|||
23641201|NCT03534284|66071576|FG000|Overall Study|Withdrawal by Subject|5|||
23641202|NCT03534284|66071577|FG001|Overall Study|Withdrawal by Subject|0|||
23471743|NCT00481091|65470797|FG001|Overall Study|Progressive disease other|1|||
23471744|NCT00481091|65470798|FG002|Overall Study|Progressive disease other|0|||
23471745|NCT00481091|65470799|FG003|Overall Study|Progressive disease other|1|||
23471746|NCT00481091|65470800|FG004|Overall Study|Progressive disease other|1|||
23471747|NCT00481091|65470801|FG005|Overall Study|Progressive disease other|1|||
23795467|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
23795468|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
23795469|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
23795470|NCT02725411|66629887|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
23795471|NCT02725411|66629888|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
23795472|NCT02725411|66629889|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
23795473|NCT02725411|66629887|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
23795474|NCT02725411|66629888|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
23795475|NCT02725411|66629889|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
23795476|NCT02725411|66629887|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
23795477|NCT02725411|66629888|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
23795478|NCT02725411|66629889|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
23795479|NCT02725411|66629887|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
23795480|NCT02725411|66629888|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
23795481|NCT02725411|66629889|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
23795482|NCT02725411|66629887|FG000|Follow-up Period (24 Weeks)|Other|1|||
23471748|NCT00481091|65470802|FG006|Overall Study|Progressive disease other|0|||
23795483|NCT02725411|66629888|FG001|Follow-up Period (24 Weeks)|Other|4|||
23795484|NCT02725411|66629889|FG002|Follow-up Period (24 Weeks)|Other|2|||
23795485|NCT02725411|66629887|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23471749|NCT00481091|65470803|FG007|Overall Study|Progressive disease other|2|||
23471750|NCT00481091|65470804|FG008|Overall Study|Progressive disease other|0|||
23795486|NCT02725411|66629888|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
23795487|NCT02725411|66629889|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
23471751|NCT00481091|65470805|FG009|Overall Study|Progressive disease other|0|||
23471752|NCT00481091|65470796|FG000|Overall Study|No reason given|0|||
23471753|NCT00481091|65470797|FG001|Overall Study|No reason given|0|||
23471754|NCT00481091|65470798|FG002|Overall Study|No reason given|1|||
23471755|NCT00481091|65470799|FG003|Overall Study|No reason given|1|||
23471756|NCT00481091|65470800|FG004|Overall Study|No reason given|1|||
23471757|NCT00481091|65470801|FG005|Overall Study|No reason given|0|||
23471758|NCT00481091|65470802|FG006|Overall Study|No reason given|1|||
23471759|NCT00481091|65470803|FG007|Overall Study|No reason given|1|||
23471760|NCT00481091|65470804|FG008|Overall Study|No reason given|1|||
23471761|NCT00481091|65470805|FG009|Overall Study|No reason given|4|||
23471762|NCT01874340|65470807|FG000|Overall Study|Study terminated by Sponsor|6|||
23471763|NCT01874340|65470808|FG001|Overall Study|Study terminated by Sponsor|8|||
23471764|NCT01874340|65470809|FG002|Overall Study|Study terminated by Sponsor|8|||
23471765|NCT01874340|65470810|FG003|Overall Study|Study terminated by Sponsor|4|||
23471766|NCT01874340|65470807|FG000|Overall Study|Withdrawal by Subject|0|||
23471767|NCT01874340|65470808|FG001|Overall Study|Withdrawal by Subject|0|||
23471768|NCT01874340|65470809|FG002|Overall Study|Withdrawal by Subject|0|||
23471769|NCT01874340|65470810|FG003|Overall Study|Withdrawal by Subject|1|||
23471770|NCT00330967|65470811|FG000|Overall Study|Withdrawal by Subject|0|||
23471771|NCT00330967|65470812|FG001|Overall Study|Withdrawal by Subject|5|||
23471772|NCT00330967|65470811|FG000|Overall Study|Physician Decision|0|||
23471773|NCT00330967|65470812|FG001|Overall Study|Physician Decision|9|||
23471774|NCT02036853|65470813|FG000|Overall Study|Adverse Event|0|||
23471775|NCT02036853|65470814|FG001|Overall Study|Adverse Event|2|||
23471776|NCT02036853|65470813|FG000|Overall Study|Lack of Efficacy|0|||
23471777|NCT02036853|65470814|FG001|Overall Study|Lack of Efficacy|2|||
23471778|NCT02036853|65470813|FG000|Overall Study|Physician Decision|0|||
23471779|NCT02036853|65470814|FG001|Overall Study|Physician Decision|1|||
23471780|NCT02036853|65470813|FG000|Overall Study|Withdrawal by Subject|0|||
23471781|NCT02036853|65470814|FG001|Overall Study|Withdrawal by Subject|1|||
23471782|NCT00126490|65470815|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
23471783|NCT01500720|65470826|FG000|Overall Study|Randomized But Not Treated|1|||
23471784|NCT01500720|65470827|FG001|Overall Study|Randomized But Not Treated|1|||
23471785|NCT01500720|65470826|FG000|Overall Study|Other|4|||
23471786|NCT01500720|65470827|FG001|Overall Study|Other|8|||
23471787|NCT00578292|65470828|FG000|Overall Study|Death|1|||
23471788|NCT00578292|65470828|FG000|Overall Study|Graft failure|2|||
23471789|NCT03304249|65470829|FG000|Overall Study|Lost to Follow-up|8|||
23471790|NCT03304249|65470830|FG001|Overall Study|Lost to Follow-up|10|||
23471791|NCT03304249|65470829|FG000|Overall Study|Withdrawal by Subject|12|||
23471792|NCT03304249|65470830|FG001|Overall Study|Withdrawal by Subject|2|||
23471793|NCT03304249|65470829|FG000|Overall Study|Moved Out of District|4|||
23471794|NCT03304249|65470830|FG001|Overall Study|Moved Out of District|2|||
23471795|NCT00531427|65470831|FG000|Overall Study|Withdrawal by Subject|7|||
23471796|NCT00531427|65470832|FG001|Overall Study|Withdrawal by Subject|13|||
23471797|NCT00531427|65470831|FG000|Overall Study|Adverse Event|44|||
23795488|NCT00749411|66629890|FG000|Overall Study|Adverse Event|0|||
23795489|NCT00749411|66629891|FG001|Overall Study|Adverse Event|2|||
23795490|NCT00749411|66629890|FG000|Overall Study|Lack of Efficacy|0|||
23795491|NCT00749411|66629891|FG001|Overall Study|Lack of Efficacy|1|||
23795492|NCT00749411|66629890|FG000|Overall Study|Protocol Violation|1|||
23471798|NCT00531427|65470832|FG001|Overall Study|Adverse Event|30|||
23587840|NCT04012853|65882026|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
23587841|NCT04012853|65882027|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
23795493|NCT00749411|66629891|FG001|Overall Study|Protocol Violation|1|||
23795494|NCT00749411|66629890|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23795495|NCT00749411|66629891|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23795496|NCT03480022|66629896|FG000|Overall Study|Pregnancy|2|||
23795497|NCT03480022|66629897|FG001|Overall Study|Pregnancy|0|||
23795498|NCT03480022|66629896|FG000|Overall Study|Adverse Event|6|||
23795499|NCT03480022|66629897|FG001|Overall Study|Adverse Event|0|||
23471799|NCT00531427|65470831|FG000|Overall Study|Lost to Follow-up|4|||
23471800|NCT00531427|65470832|FG001|Overall Study|Lost to Follow-up|3|||
23471801|NCT00531427|65470831|FG000|Overall Study|Lack of Efficacy|14|||
23471802|NCT00531427|65470832|FG001|Overall Study|Lack of Efficacy|39|||
23471803|NCT00531427|65470831|FG000|Overall Study|Administrative|4|||
23471804|NCT00531427|65470832|FG001|Overall Study|Administrative|9|||
23471805|NCT01396070|65470833|FG000|Overall Study|Withdrawal by Subject|2|||
23471806|NCT01396070|65470833|FG000|Overall Study|Death|2|||
23471807|NCT01396070|65470833|FG000|Overall Study|Adverse Event|8|||
23471808|NCT01396070|65470833|FG000|Overall Study|Physician Decision|3|||
23471809|NCT01396070|65470833|FG000|Overall Study|Lack of Efficacy|4|||
23795500|NCT03480022|66629896|FG000|Overall Study|Lack of Efficacy|0|||
23354643|NCT02452554|65041491|FG002|Overall Study|Never Received Treatment|0|||
23471810|NCT03037580|65470834|FG000|Overall Study|Withdrawal by Subject|3|||
23471811|NCT03037580|65470835|FG001|Overall Study|Withdrawal by Subject|0|||
23471812|NCT03037580|65470834|FG000|Overall Study|Adverse Event|1|||
23471813|NCT03037580|65470835|FG001|Overall Study|Adverse Event|0|||
23471814|NCT03037580|65470834|FG000|Overall Study|Study Terminated by Sponsor|12|||
23471815|NCT03037580|65470835|FG001|Overall Study|Study Terminated by Sponsor|15|||
23471816|NCT03037580|65470834|FG000|Overall Study|Death|0|||
23471817|NCT03037580|65470835|FG001|Overall Study|Death|1|||
23471818|NCT02687191|65470836|FG000|Overall Study|Death|0|||
23471819|NCT02687191|65470837|FG001|Overall Study|Death|1|||
23471820|NCT02687191|65470838|FG002|Overall Study|Death|1|||
23471821|NCT02687191|65470839|FG003|Overall Study|Death|0|||
23471822|NCT02687191|65470840|FG004|Overall Study|Death|1|||
23471823|NCT02687191|65470841|FG005|Overall Study|Death|1|||
23471824|NCT02687191|65470836|FG000|Overall Study|Withdrawal by Subject|0|||
23471825|NCT02687191|65470837|FG001|Overall Study|Withdrawal by Subject|0|||
23471826|NCT02687191|65470838|FG002|Overall Study|Withdrawal by Subject|0|||
23471827|NCT02687191|65470839|FG003|Overall Study|Withdrawal by Subject|1|||
23471828|NCT02687191|65470840|FG004|Overall Study|Withdrawal by Subject|0|||
23471829|NCT02687191|65470841|FG005|Overall Study|Withdrawal by Subject|0|||
23471830|NCT01354899|65470842|FG000|Overall Study|discharge from the hospital|2|||
23471831|NCT01354899|65470842|FG000|Overall Study|Protocol Violation|1|||
23471832|NCT03566485|65470843|FG000|Overall Study|Disease progression|5|||
23471833|NCT03566485|65470844|FG001|Overall Study|Disease progression|4|||
23471834|NCT03566485|65470843|FG000|Overall Study|Clinical progression|0|||
23471835|NCT03566485|65470844|FG001|Overall Study|Clinical progression|1|||
23471836|NCT03566485|65470843|FG000|Overall Study|Toxicity|0|||
23471837|NCT03566485|65470844|FG001|Overall Study|Toxicity|2|||
23471838|NCT01387542|65470854|FG000|Overall Study|Adverse Event|3|||
23471839|NCT01387542|65470854|FG000|Overall Study|Withdrawal by Subject|1|||
23471840|NCT01387542|65470854|FG000|Overall Study|Changed diagnosis|1|||
23471841|NCT01387542|65470854|FG000|Overall Study|Insufficient response|1|||
23471842|NCT01387542|65470854|FG000|Overall Study|Non-compliant|1|||
23471843|NCT01387542|65470854|FG000|Overall Study|Lost to Follow-up|1|||
23471844|NCT01761240|65470855|FG000|Overall Study|Progressive disease:radiology assessment|3|||
23471845|NCT01761240|65470856|FG001|Overall Study|Progressive disease:radiology assessment|3|||
23471846|NCT01761240|65470857|FG002|Overall Study|Progressive disease:radiology assessment|0|||
23471847|NCT01761240|65470858|FG003|Overall Study|Progressive disease:radiology assessment|0|||
23471848|NCT01761240|65470859|FG004|Overall Study|Progressive disease:radiology assessment|0|||
23471849|NCT01761240|65470855|FG000|Overall Study|Progressive disease:clinical assessment|0|||
23471850|NCT01761240|65470856|FG001|Overall Study|Progressive disease:clinical assessment|0|||
23471851|NCT01761240|65470857|FG002|Overall Study|Progressive disease:clinical assessment|3|||
23471852|NCT01761240|65470858|FG003|Overall Study|Progressive disease:clinical assessment|1|||
23587842|NCT02314117|65882030|FG000|Overall Study|Lost to Follow-up|9|||
23587843|NCT02314117|65882031|FG001|Overall Study|Lost to Follow-up|14|||
23587844|NCT02314117|65882030|FG000|Overall Study|Withdrawal by Subject|3|||
23587845|NCT02314117|65882031|FG001|Overall Study|Withdrawal by Subject|2|||
23587846|NCT02488980|65882039|FG000|Overall Study|Protocol Violation|2|||
23587847|NCT02488980|65882040|FG001|Overall Study|Protocol Violation|2|||
23587848|NCT02488980|65882041|FG002|Overall Study|Protocol Violation|2|||
23587849|NCT00708032|65882045|FG000|Overall Study|Adverse Event|0|||
23587850|NCT00708032|65882046|FG001|Overall Study|Adverse Event|2|||
23587851|NCT00708032|65882045|FG000|Overall Study|Lost to Follow-up|1|||
23587852|NCT00708032|65882046|FG001|Overall Study|Lost to Follow-up|2|||
23587853|NCT00708032|65882045|FG000|Overall Study|Pregnancy|0|||
23795501|NCT03480022|66629897|FG001|Overall Study|Lack of Efficacy|2|||
23471853|NCT01761240|65470859|FG004|Overall Study|Progressive disease:clinical assessment|0|||
23471854|NCT01761240|65470855|FG000|Overall Study|Withdrawal by Subject|0|||
23471855|NCT01761240|65470856|FG001|Overall Study|Withdrawal by Subject|0|||
23471856|NCT01761240|65470857|FG002|Overall Study|Withdrawal by Subject|0|||
23471857|NCT01761240|65470858|FG003|Overall Study|Withdrawal by Subject|3|||
23471858|NCT01761240|65470859|FG004|Overall Study|Withdrawal by Subject|1|||
23471859|NCT01761240|65470855|FG000|Overall Study|Adverse Event|0|||
23471860|NCT01761240|65470856|FG001|Overall Study|Adverse Event|0|||
23587854|NCT00708032|65882046|FG001|Overall Study|Pregnancy|1|||
23471861|NCT01761240|65470857|FG002|Overall Study|Adverse Event|0|||
23471862|NCT01761240|65470858|FG003|Overall Study|Adverse Event|1|||
23471863|NCT01761240|65470859|FG004|Overall Study|Adverse Event|6|||
23471864|NCT01761240|65470855|FG000|Overall Study|Death|0|||
23471865|NCT01761240|65470856|FG001|Overall Study|Death|1|||
23471866|NCT01761240|65470857|FG002|Overall Study|Death|1|||
23471867|NCT01761240|65470858|FG003|Overall Study|Death|2|||
23471868|NCT01761240|65470859|FG004|Overall Study|Death|1|||
23471869|NCT01761240|65470855|FG000|Overall Study|Non-compliance|0|||
23471870|NCT01761240|65470856|FG001|Overall Study|Non-compliance|0|||
23471871|NCT01761240|65470857|FG002|Overall Study|Non-compliance|1|||
23587855|NCT00708032|65882045|FG000|Overall Study|Poor vision|0|||
23471872|NCT01761240|65470858|FG003|Overall Study|Non-compliance|0|||
23471873|NCT01761240|65470859|FG004|Overall Study|Non-compliance|0|||
23471874|NCT02442804|65470860|FG000|Overall Study|Withdrawal by Subject|0|||
23471875|NCT02442804|65470861|FG001|Overall Study|Withdrawal by Subject|1|||
23471876|NCT02442804|65470860|FG000|Overall Study|Adverse Event|1|||
23471877|NCT02442804|65470861|FG001|Overall Study|Adverse Event|0|||
23471878|NCT02969655|65470862|FG000|Overall Study|Withdrawal by Subject|3|||
23471879|NCT02969655|65470863|FG001|Overall Study|Withdrawal by Subject|2|||
23471880|NCT02969655|65470862|FG000|Overall Study|Physician Decision|4|||
23471881|NCT02969655|65470863|FG001|Overall Study|Physician Decision|3|||
23471882|NCT02969655|65470862|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
23471883|NCT02969655|65470863|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
23471884|NCT02969655|65470862|FG000|Overall Study|Adverse Event|10|||
23471885|NCT02969655|65470863|FG001|Overall Study|Adverse Event|8|||
23471886|NCT00790088|65470864|FG000|Overall Study|Protocol Violation|11|||
23471887|NCT00790088|65470864|FG000|Overall Study|Withdrawal by Subject|17|||
23795502|NCT03480022|66629896|FG000|Overall Study|Physician Decision|0|||
23795503|NCT03480022|66629897|FG001|Overall Study|Physician Decision|1|||
23795504|NCT03480022|66629896|FG000|Overall Study|Withdrawal by Subject|2|||
23795505|NCT03480022|66629897|FG001|Overall Study|Withdrawal by Subject|0|||
23471888|NCT00790088|65470864|FG000|Overall Study|Lost to Follow-up|7|||
23471889|NCT00790088|65470864|FG000|Overall Study|Physician Decision|4|||
23471890|NCT02152956|65470865|FG000|Overall Study|Adverse Event|0|||
23471891|NCT02152956|65470866|FG001|Overall Study|Adverse Event|0|||
23471892|NCT02152956|65470867|FG002|Overall Study|Adverse Event|0|||
23471893|NCT02152956|65470868|FG003|Overall Study|Adverse Event|0|||
23471894|NCT02152956|65470869|FG004|Overall Study|Adverse Event|0|||
23471895|NCT02152956|65470870|FG005|Overall Study|Adverse Event|0|||
23471896|NCT02152956|65470871|FG006|Overall Study|Adverse Event|0|||
23471897|NCT02152956|65470872|FG007|Overall Study|Adverse Event|0|||
23471898|NCT02152956|65470873|FG008|Overall Study|Adverse Event|0|||
23471899|NCT02152956|65470874|FG009|Overall Study|Adverse Event|0|||
23471900|NCT02152956|65470875|FG010|Overall Study|Adverse Event|0|||
23471901|NCT02152956|65470876|FG011|Overall Study|Adverse Event|4|||
23471902|NCT02152956|65470877|FG012|Overall Study|Adverse Event|0|||
23471903|NCT02152956|65470865|FG000|Overall Study|Death|0|||
23471904|NCT02152956|65470866|FG001|Overall Study|Death|3|||
23471905|NCT02152956|65470867|FG002|Overall Study|Death|3|||
23471906|NCT02152956|65470868|FG003|Overall Study|Death|4|||
23587856|NCT00708032|65882046|FG001|Overall Study|Poor vision|6|||
23587857|NCT00708032|65882045|FG000|Overall Study|Visit out of range at month 12|4|||
23587858|NCT00708032|65882046|FG001|Overall Study|Visit out of range at month 12|1|||
23587859|NCT00708032|65882045|FG000|Overall Study|Did not meet protocol criteria|1|||
23587860|NCT00708032|65882046|FG001|Overall Study|Did not meet protocol criteria|2|||
23587861|NCT00708032|65882045|FG000|Overall Study|Protocol Violation|4|||
23795506|NCT03480022|66629896|FG000|Overall Study|Medication concerns|1|||
23354644|NCT02452554|65041492|FG003|Overall Study|Never Received Treatment|0|||
23795507|NCT03480022|66629897|FG001|Overall Study|Medication concerns|0|||
23795508|NCT03480022|66629896|FG000|Overall Study|Family member COVID exposure|0|||
23795509|NCT03480022|66629897|FG001|Overall Study|Family member COVID exposure|1|||
23354645|NCT02452554|65041493|FG004|Overall Study|Never Received Treatment|0|||
23354646|NCT02452554|65041494|FG005|Overall Study|Never Received Treatment|0|||
23354647|NCT02327013|65041495|FG000|Overall Study|Adverse Event|4|||
23354648|NCT02327013|65041496|FG001|Overall Study|Adverse Event|4|||
23354649|NCT02327013|65041497|FG002|Overall Study|Adverse Event|3|||
23354650|NCT02327013|65041498|FG003|Overall Study|Adverse Event|0|||
23354651|NCT02327013|65041499|FG004|Overall Study|Adverse Event|1|||
23354652|NCT02327013|65041495|FG000|Overall Study|Lack of Efficacy|2|||
23354653|NCT02327013|65041496|FG001|Overall Study|Lack of Efficacy|0|||
23354654|NCT02327013|65041497|FG002|Overall Study|Lack of Efficacy|5|||
23354655|NCT02327013|65041498|FG003|Overall Study|Lack of Efficacy|0|||
23354656|NCT02327013|65041499|FG004|Overall Study|Lack of Efficacy|1|||
23354657|NCT02327013|65041495|FG000|Overall Study|Non-compliance with IMP|1|||
23471907|NCT02152956|65470869|FG004|Overall Study|Death|1|||
23471908|NCT02152956|65470870|FG005|Overall Study|Death|2|||
23354658|NCT02327013|65041496|FG001|Overall Study|Non-compliance with IMP|2|||
23354659|NCT02327013|65041497|FG002|Overall Study|Non-compliance with IMP|7|||
23354660|NCT02327013|65041498|FG003|Overall Study|Non-compliance with IMP|0|||
23471909|NCT02152956|65470871|FG006|Overall Study|Death|6|||
23471910|NCT02152956|65470872|FG007|Overall Study|Death|6|||
23471911|NCT02152956|65470873|FG008|Overall Study|Death|4|||
23471912|NCT02152956|65470874|FG009|Overall Study|Death|5|||
23587862|NCT00708032|65882046|FG001|Overall Study|Protocol Violation|1|||
23795510|NCT01115933|66629899|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
23587863|NCT00708032|65882045|FG000|Overall Study|Withdrawal by Subject|0|||
23587864|NCT00708032|65882046|FG001|Overall Study|Withdrawal by Subject|1|||
23471913|NCT02152956|65470875|FG010|Overall Study|Death|3|||
23471914|NCT02152956|65470876|FG011|Overall Study|Death|143|||
23471915|NCT02152956|65470877|FG012|Overall Study|Death|12|||
23795511|NCT01398787|66629901|FG000|Overall Study|Adverse Event|1|||
23795512|NCT03108820|66629905|FG000|Overall Study|Lost to Follow-up|30|||
23795513|NCT03108820|66629906|FG001|Overall Study|Lost to Follow-up|28|||
23795514|NCT03108820|66629905|FG000|Overall Study|Withdrawal by Subject|32|||
23795515|NCT03108820|66629906|FG001|Overall Study|Withdrawal by Subject|24|||
23795516|NCT03108820|66629905|FG000|Overall Study|Death|6|||
23795517|NCT03108820|66629906|FG001|Overall Study|Death|11|||
23795518|NCT01863433|66629907|FG000|Overall Study|Protocol Violation|1|||
23795519|NCT01501110|66629908|FG000|Overall Study|Death|0|||
23795520|NCT01501110|66629909|FG001|Overall Study|Death|1|||
23795521|NCT01719562|66629910|FG000|Overall Study|Lost to Follow-up|1|||
23795522|NCT01719562|66629911|FG001|Overall Study|Lost to Follow-up|0|||
23795523|NCT01719562|66629910|FG000|Overall Study|Death|1|||
23795524|NCT01719562|66629911|FG001|Overall Study|Death|0|||
23795525|NCT01719562|66629910|FG000|Overall Study|New cancer diagnosis|1|||
23795526|NCT01719562|66629911|FG001|Overall Study|New cancer diagnosis|0|||
23795527|NCT01622660|66629912|FG000|Overall Study|Adverse Event|1|||
23795528|NCT01579006|66629918|FG000|Overall Study|Lack of Efficacy|10|||
23795529|NCT01579006|66629918|FG000|Overall Study|Adverse Event|13|||
23795530|NCT01579006|66629918|FG000|Overall Study|Withdrawal by Subject|5|||
23795531|NCT01579006|66629918|FG000|Overall Study|Non-compliance|3|||
23795532|NCT01579006|66629918|FG000|Overall Study|Due to participant's health fund|1|||
23795533|NCT01579006|66629918|FG000|Overall Study|Scheduled surgery|1|||
23795534|NCT02169791|66629919|FG000|Overall Study|Death|6|||
23795535|NCT02169791|66629919|FG000|Overall Study|patient withdrew consent|1|||
23795536|NCT02940522|66629920|FG000|Overall Study|Lost to Follow-up|1|||
23354661|NCT02327013|65041499|FG004|Overall Study|Non-compliance with IMP|0|||
23354662|NCT02327013|65041495|FG000|Overall Study|Withdrawal of Consent|1|||
23354663|NCT02327013|65041496|FG001|Overall Study|Withdrawal of Consent|0|||
23354664|NCT02327013|65041497|FG002|Overall Study|Withdrawal of Consent|3|||
23354665|NCT02327013|65041498|FG003|Overall Study|Withdrawal of Consent|0|||
23587865|NCT03441360|65882047|FG000|Overall Study|Radiological disease progression|5|||
23587866|NCT03441360|65882048|FG001|Overall Study|Radiological disease progression|6|||
23587867|NCT03441360|65882049|FG002|Overall Study|Radiological disease progression|4|||
23587868|NCT03441360|65882047|FG000|Overall Study|Clinical disease progression|2|||
23587869|NCT03441360|65882048|FG001|Overall Study|Clinical disease progression|2|||
23795537|NCT02940522|66629921|FG001|Overall Study|Lost to Follow-up|2|||
23795538|NCT02940522|66629920|FG000|Overall Study|Withdrawal by Subject|1|||
23795539|NCT02940522|66629921|FG001|Overall Study|Withdrawal by Subject|0|||
23641203|NCT03534284|66071578|FG002|Overall Study|Withdrawal by Subject|0|||
23641204|NCT01732822|66071579|FG000|Overall Study|Withdrawal by Subject|123|||
23641205|NCT01732822|66071580|FG001|Overall Study|Withdrawal by Subject|113|||
23641206|NCT00618618|66071581|FG000|Overall Study|Patient Request|0|||
23641207|NCT00618618|66071582|FG001|Overall Study|Patient Request|0|||
23641208|NCT00618618|66071583|FG002|Overall Study|Patient Request|2|||
23641209|NCT00618618|66071584|FG003|Overall Study|Patient Request|0|||
23641210|NCT00618618|66071581|FG000|Overall Study|Inability to Complete Study Procedures|0|||
23641211|NCT00618618|66071582|FG001|Overall Study|Inability to Complete Study Procedures|1|||
23641212|NCT00618618|66071583|FG002|Overall Study|Inability to Complete Study Procedures|0|||
23641213|NCT00618618|66071584|FG003|Overall Study|Inability to Complete Study Procedures|0|||
23641214|NCT00618618|66071581|FG000|Overall Study|Lost to Follow-up|3|||
23641215|NCT00618618|66071582|FG001|Overall Study|Lost to Follow-up|0|||
23641216|NCT00618618|66071583|FG002|Overall Study|Lost to Follow-up|0|||
23641217|NCT00618618|66071584|FG003|Overall Study|Lost to Follow-up|1|||
23641218|NCT00618618|66071581|FG000|Overall Study|Non-compliance|1|||
23641219|NCT00618618|66071582|FG001|Overall Study|Non-compliance|1|||
23641220|NCT00618618|66071583|FG002|Overall Study|Non-compliance|0|||
23641221|NCT00618618|66071584|FG003|Overall Study|Non-compliance|0|||
23641222|NCT00618618|66071581|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
23641223|NCT00618618|66071582|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
23641224|NCT00618618|66071583|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
23641225|NCT00618618|66071584|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
23641226|NCT00618618|66071581|FG000|Overall Study|Death|0|||
23641227|NCT00618618|66071582|FG001|Overall Study|Death|1|||
23641228|NCT00618618|66071583|FG002|Overall Study|Death|0|||
23641229|NCT00618618|66071584|FG003|Overall Study|Death|0|||
23641230|NCT01204398|66071585|FG000|Overall Study|Adverse Event|1|||
23641231|NCT01204710|66071586|FG000|Randomization Treatment|Lost to Follow-up|1|||
23641232|NCT01204710|66071587|FG001|Randomization Treatment|Lost to Follow-up|0|||
23641233|NCT01204710|66071586|FG000|Randomization Treatment|Withdrawal by Subject|6|||
23641234|NCT01204710|66071587|FG001|Randomization Treatment|Withdrawal by Subject|5|||
23641235|NCT01204710|66071586|FG000|Randomization Treatment|Physician Decision|3|||
23641236|NCT01204710|66071587|FG001|Randomization Treatment|Physician Decision|2|||
23641237|NCT01204710|66071586|FG000|Randomization Treatment|Entry criteria not met|0|||
23641238|NCT01204710|66071587|FG001|Randomization Treatment|Entry criteria not met|1|||
23587870|NCT03441360|65882049|FG002|Overall Study|Clinical disease progression|0|||
23587871|NCT03441360|65882047|FG000|Overall Study|Adverse Event|1|||
23587872|NCT03441360|65882048|FG001|Overall Study|Adverse Event|0|||
23587873|NCT03441360|65882049|FG002|Overall Study|Adverse Event|1|||
23587874|NCT03885596|65882051|FG000|Overall Study|Withdrawal by Subject|2|||
23587875|NCT03885596|65882052|FG001|Overall Study|Withdrawal by Subject|1|||
23587876|NCT03885596|65882053|FG002|Overall Study|Withdrawal by Subject|0|||
23587877|NCT03885596|65882054|FG003|Overall Study|Withdrawal by Subject|0|||
23587878|NCT00957229|65882055|FG000|Study Start|Adverse Event|0|||
23587879|NCT00957229|65882056|FG001|Study Start|Adverse Event|3|||
23587880|NCT00957229|65882055|FG000|Study Start|Disease Progression|1|||
23587881|NCT00957229|65882056|FG001|Study Start|Disease Progression|0|||
23587882|NCT00957229|65882055|FG000|Reallocated to or Continued Vismodegib|Death|1|||
23587883|NCT00957229|65882056|FG001|Reallocated to or Continued Vismodegib|Death|1|||
23587884|NCT00957229|65882055|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
23587885|NCT00957229|65882056|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
23587886|NCT01050569|65882057|FG000|Overall Study|Lost to Follow-up|20|||
23587887|NCT01050569|65882058|FG001|Overall Study|Lost to Follow-up|14|||
23587888|NCT01050569|65882059|FG002|Overall Study|Lost to Follow-up|16|||
23587889|NCT01050569|65882057|FG000|Overall Study|Withdrawal by Subject|9|||
23587890|NCT01050569|65882058|FG001|Overall Study|Withdrawal by Subject|3|||
23641239|NCT01204710|66071586|FG000|Randomization Treatment|Adverse Event|4|||
23641240|NCT01204710|66071587|FG001|Randomization Treatment|Adverse Event|2|||
23641241|NCT01204710|66071586|FG000|Randomization Treatment|Sponsor Decision|0|||
23641242|NCT01204710|66071587|FG001|Randomization Treatment|Sponsor Decision|1|||
23641243|NCT01204710|66071586|FG000|Randomization Treatment|Worsening of General condition|0|||
23641244|NCT01204710|66071587|FG001|Randomization Treatment|Worsening of General condition|1|||
23641245|NCT01204710|66071586|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
23587891|NCT01050569|65882059|FG002|Overall Study|Withdrawal by Subject|11|||
23641246|NCT01204710|66071587|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
23795540|NCT02063217|66629925|FG000|Overall Study|Withdrawal by Subject|1|||
23587892|NCT01050569|65882057|FG000|Overall Study|Lack of Efficacy|5|||
23587893|NCT01050569|65882058|FG001|Overall Study|Lack of Efficacy|4|||
23587894|NCT01050569|65882059|FG002|Overall Study|Lack of Efficacy|3|||
23587895|NCT01050569|65882057|FG000|Overall Study|Adverse Event|1|||
23641247|NCT01204710|66071586|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
23641248|NCT01204710|66071587|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
23641249|NCT01204710|66071586|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
23641250|NCT01204710|66071587|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
23641251|NCT01204710|66071586|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
23641252|NCT01204710|66071587|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
23641253|NCT03432260|66071591|FG000|Overall Study|Lost to Follow-up|1|||
23641254|NCT03432260|66071592|FG001|Overall Study|Lost to Follow-up|1|||
23641255|NCT03432260|66071593|FG002|Overall Study|Lost to Follow-up|0|||
23641256|NCT03432260|66071594|FG003|Overall Study|Lost to Follow-up|0|||
23641257|NCT03432260|66071595|FG004|Overall Study|Lost to Follow-up|1|||
23641258|NCT00888927|66071596|FG000|Overall Study|Adverse Event|0|||
23641259|NCT00888927|66071597|FG001|Overall Study|Adverse Event|0|||
23641260|NCT00888927|66071598|FG002|Overall Study|Adverse Event|0|||
23641261|NCT00888927|66071599|FG003|Overall Study|Adverse Event|1|||
23641262|NCT00888927|66071596|FG000|Overall Study|Withdrawal of consent|0|||
23641263|NCT00888927|66071597|FG001|Overall Study|Withdrawal of consent|0|||
23641264|NCT00888927|66071598|FG002|Overall Study|Withdrawal of consent|0|||
23641265|NCT00888927|66071599|FG003|Overall Study|Withdrawal of consent|1|||
23641266|NCT02053792|66071602|FG000|Overall Study|Physician Decision|0|||
23641267|NCT02053792|66071603|FG001|Overall Study|Physician Decision|1|||
23641268|NCT02053792|66071602|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
23641269|NCT02053792|66071603|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
23641270|NCT02053792|66071602|FG000|Overall Study|Lack of Efficacy|1|||
23641271|NCT02053792|66071603|FG001|Overall Study|Lack of Efficacy|0|||
23641272|NCT02053792|66071602|FG000|Overall Study|Adverse Event|1|||
23641273|NCT02053792|66071603|FG001|Overall Study|Adverse Event|0|||
23641274|NCT02053792|66071602|FG000|Overall Study|Withdrawal by Subject|2|||
23641275|NCT02053792|66071603|FG001|Overall Study|Withdrawal by Subject|2|||
23641276|NCT02053792|66071602|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
23641277|NCT02053792|66071603|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
23641278|NCT02053792|66071602|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
23354666|NCT02327013|65041499|FG004|Overall Study|Withdrawal of Consent|0|||
23354667|NCT02327013|65041495|FG000|Overall Study|Lost to Follow-up|2|||
23354668|NCT02327013|65041496|FG001|Overall Study|Lost to Follow-up|4|||
23354669|NCT02327013|65041497|FG002|Overall Study|Lost to Follow-up|5|||
23354670|NCT02327013|65041498|FG003|Overall Study|Lost to Follow-up|0|||
23354671|NCT02327013|65041499|FG004|Overall Study|Lost to Follow-up|0|||
23354672|NCT02327013|65041495|FG000|Overall Study|Administrative or other reason(s)|1|||
23354673|NCT02327013|65041496|FG001|Overall Study|Administrative or other reason(s)|5|||
23354674|NCT02327013|65041497|FG002|Overall Study|Administrative or other reason(s)|11|||
23354675|NCT02327013|65041498|FG003|Overall Study|Administrative or other reason(s)|1|||
23471916|NCT02152956|65470865|FG000|Overall Study|Lost to Follow-up|0|||
23471917|NCT02152956|65470866|FG001|Overall Study|Lost to Follow-up|1|||
23471918|NCT02152956|65470867|FG002|Overall Study|Lost to Follow-up|0|||
23471919|NCT02152956|65470868|FG003|Overall Study|Lost to Follow-up|0|||
23471920|NCT02152956|65470869|FG004|Overall Study|Lost to Follow-up|0|||
23471921|NCT02152956|65470870|FG005|Overall Study|Lost to Follow-up|0|||
23471922|NCT02152956|65470871|FG006|Overall Study|Lost to Follow-up|0|||
23471923|NCT02152956|65470872|FG007|Overall Study|Lost to Follow-up|0|||
23471924|NCT02152956|65470873|FG008|Overall Study|Lost to Follow-up|0|||
23471925|NCT02152956|65470874|FG009|Overall Study|Lost to Follow-up|0|||
23471926|NCT02152956|65470875|FG010|Overall Study|Lost to Follow-up|0|||
23641279|NCT02053792|66071603|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
23641280|NCT04476251|66071611|FG000|Overall Study|Not treated|1|||
23641281|NCT03900416|66071612|FG000|Six Week Follow-up|Lost to Follow-up|1|||
23354676|NCT02327013|65041499|FG004|Overall Study|Administrative or other reason(s)|1|||
23354677|NCT02327013|65041495|FG000|Overall Study|Protocol Violation|0|||
23471927|NCT02152956|65470876|FG011|Overall Study|Lost to Follow-up|3|||
23354678|NCT02327013|65041496|FG001|Overall Study|Protocol Violation|0|||
23471928|NCT02152956|65470877|FG012|Overall Study|Lost to Follow-up|0|||
23795541|NCT02063217|66629926|FG001|Overall Study|Withdrawal by Subject|0|||
23795542|NCT02063217|66629927|FG002|Overall Study|Withdrawal by Subject|0|||
23795543|NCT00360490|66629928|FG000|Overall Study|Adverse Event|4|||
23795544|NCT00360490|66629929|FG001|Overall Study|Adverse Event|2|||
23795545|NCT00360490|66629928|FG000|Overall Study|Lost to Follow-up|2|||
23795546|NCT00360490|66629929|FG001|Overall Study|Lost to Follow-up|1|||
23795547|NCT00360490|66629928|FG000|Overall Study|Physician Decision|2|||
23795548|NCT00360490|66629929|FG001|Overall Study|Physician Decision|1|||
23795549|NCT00360490|66629928|FG000|Overall Study|Protocol Violation|0|||
23795550|NCT00360490|66629929|FG001|Overall Study|Protocol Violation|4|||
23795551|NCT00360490|66629928|FG000|Overall Study|Withdrawal by Subject|1|||
23795552|NCT00360490|66629929|FG001|Overall Study|Withdrawal by Subject|3|||
23471929|NCT02152956|65470865|FG000|Overall Study|Withdrawal by Subject|1|||
23471930|NCT02152956|65470866|FG001|Overall Study|Withdrawal by Subject|0|||
23471931|NCT02152956|65470867|FG002|Overall Study|Withdrawal by Subject|1|||
23471932|NCT02152956|65470868|FG003|Overall Study|Withdrawal by Subject|0|||
23795553|NCT00605176|66629932|FG000|Overall Study|Adverse Event|2|||
23471933|NCT02152956|65470869|FG004|Overall Study|Withdrawal by Subject|2|||
23471934|NCT02152956|65470870|FG005|Overall Study|Withdrawal by Subject|2|||
23471935|NCT02152956|65470871|FG006|Overall Study|Withdrawal by Subject|0|||
23471936|NCT02152956|65470872|FG007|Overall Study|Withdrawal by Subject|0|||
23471937|NCT02152956|65470873|FG008|Overall Study|Withdrawal by Subject|1|||
23354679|NCT02327013|65041497|FG002|Overall Study|Protocol Violation|3|||
23354680|NCT02327013|65041498|FG003|Overall Study|Protocol Violation|0|||
23354681|NCT02327013|65041499|FG004|Overall Study|Protocol Violation|1|||
23354682|NCT02327013|65041495|FG000|Overall Study|Withdrawal before treatment|2|||
23354683|NCT02327013|65041496|FG001|Overall Study|Withdrawal before treatment|1|||
23354684|NCT02327013|65041497|FG002|Overall Study|Withdrawal before treatment|5|||
23354685|NCT02327013|65041498|FG003|Overall Study|Withdrawal before treatment|0|||
23354686|NCT02327013|65041499|FG004|Overall Study|Withdrawal before treatment|0|||
23471938|NCT02152956|65470874|FG009|Overall Study|Withdrawal by Subject|0|||
23795554|NCT00605176|66629933|FG001|Overall Study|Adverse Event|1|||
23471939|NCT02152956|65470875|FG010|Overall Study|Withdrawal by Subject|0|||
23795555|NCT00605176|66629934|FG002|Overall Study|Adverse Event|3|||
23795556|NCT00605176|66629932|FG000|Overall Study|Withdrawal by Subject|4|||
23354687|NCT02584959|65041500|FG000|Period 1|Withdrawn from study|3|||
23354688|NCT02584959|65041501|FG001|Period 1|Withdrawn from study|4|||
23471940|NCT02152956|65470876|FG011|Overall Study|Withdrawal by Subject|4|||
23795557|NCT00605176|66629933|FG001|Overall Study|Withdrawal by Subject|2|||
23795558|NCT00605176|66629934|FG002|Overall Study|Withdrawal by Subject|4|||
23354689|NCT02584959|65041502|FG002|Period 1|Withdrawn from study|0|||
23354690|NCT02584959|65041500|FG000|Period 2|Withdrawn from study|6|||
23354691|NCT02584959|65041501|FG001|Period 2|Withdrawn from study|1|||
23354692|NCT02584959|65041502|FG002|Period 2|Withdrawn from study|2|||
23354693|NCT03230838|65041503|FG000|Overall Study|Withdrawal by Subject|3|||
23471941|NCT02152956|65470877|FG012|Overall Study|Withdrawal by Subject|0|||
23795559|NCT00605176|66629932|FG000|Overall Study|Lost to Follow-up|2|||
23354694|NCT03230838|65041504|FG001|Overall Study|Withdrawal by Subject|0|||
23354695|NCT03230838|65041503|FG000|Overall Study|Temperature excursion|1|||
23354696|NCT03230838|65041504|FG001|Overall Study|Temperature excursion|0|||
23354697|NCT00845676|65041505|FG000|Overall Study|Virologic breakthrough at week 20|1|||
23354698|NCT00845676|65041505|FG000|Overall Study|Adverse Event|1|||
23354699|NCT00715520|65041506|FG000|Overall Study|Screen failure|8|||
23354700|NCT00715520|65041507|FG001|Overall Study|Screen failure|1|||
23354701|NCT00715520|65041508|FG002|Overall Study|Screen failure|1|||
23354702|NCT00715520|65041506|FG000|Overall Study|Withdrawal by Subject|2|||
23354703|NCT00715520|65041507|FG001|Overall Study|Withdrawal by Subject|0|||
23354704|NCT00715520|65041508|FG002|Overall Study|Withdrawal by Subject|1|||
23354705|NCT02005627|65041512|FG000|Overall Study|Lost to Follow-up|1|||
23354706|NCT02005627|65041513|FG001|Overall Study|Lost to Follow-up|2|||
23587896|NCT01050569|65882058|FG001|Overall Study|Adverse Event|0|||
23354707|NCT02005627|65041512|FG000|Overall Study|Withdrawal by Subject|1|||
23354708|NCT02005627|65041513|FG001|Overall Study|Withdrawal by Subject|2|||
23354709|NCT01390428|65041514|FG000|Overall Study|Elective Surgery|0|||
23354710|NCT01390428|65041515|FG001|Overall Study|Elective Surgery|0|||
23354711|NCT01390428|65041516|FG002|Overall Study|Elective Surgery|0|||
23354712|NCT01390428|65041517|FG003|Overall Study|Elective Surgery|0|||
23354713|NCT01390428|65041518|FG004|Overall Study|Elective Surgery|1|||
23587897|NCT01050569|65882059|FG002|Overall Study|Adverse Event|0|||
23587898|NCT01050569|65882057|FG000|Overall Study|Physician Decision|3|||
23587899|NCT01050569|65882058|FG001|Overall Study|Physician Decision|3|||
23587900|NCT01050569|65882059|FG002|Overall Study|Physician Decision|3|||
23587901|NCT00337818|65882060|FG000|Overall Study|Lost to Follow-up|289|||
23587902|NCT00337818|65882061|FG001|Overall Study|Lost to Follow-up|91|||
23587903|NCT00337818|65882062|FG002|Overall Study|Lost to Follow-up|107|||
23587904|NCT01810263|65882063|FG000|Overall Study|Lost to Follow-up|8|||
23587905|NCT01810263|65882064|FG001|Overall Study|Lost to Follow-up|7|||
23587906|NCT03478696|65882065|FG000|Overall Study|Adverse Event|1|||
23587907|NCT03478696|65882066|FG001|Overall Study|Adverse Event|5|||
23587908|NCT03478696|65882065|FG000|Overall Study|Lost to Follow-up|1|||
23587909|NCT03478696|65882066|FG001|Overall Study|Lost to Follow-up|0|||
23587910|NCT03478696|65882065|FG000|Overall Study|Physician Decision|6|||
23587911|NCT03478696|65882066|FG001|Overall Study|Physician Decision|3|||
23587912|NCT03478696|65882065|FG000|Overall Study|Withdrawal by Subject|9|||
23587913|NCT03478696|65882066|FG001|Overall Study|Withdrawal by Subject|4|||
23641282|NCT03900416|66071613|FG001|Six Week Follow-up|Lost to Follow-up|0|||
23471942|NCT02152956|65470865|FG000|Overall Study|Physician Decision|0|||
23587914|NCT04107805|65882067|FG000|Overall Study|Adverse Event|0|||
23587915|NCT04107805|65882068|FG001|Overall Study|Adverse Event|0|||
23354714|NCT01390428|65041519|FG005|Overall Study|Elective Surgery|0|||
23354715|NCT01390428|65041514|FG000|Overall Study|Withdrawal by Subject|0|||
23354716|NCT01390428|65041515|FG001|Overall Study|Withdrawal by Subject|0|||
23354717|NCT01390428|65041516|FG002|Overall Study|Withdrawal by Subject|1|||
23354718|NCT01390428|65041517|FG003|Overall Study|Withdrawal by Subject|0|||
23354719|NCT01390428|65041518|FG004|Overall Study|Withdrawal by Subject|0|||
23354720|NCT01390428|65041519|FG005|Overall Study|Withdrawal by Subject|0|||
23354721|NCT01897571|65041520|FG000|Overall Study|Lost to Follow-up|3|||
23354722|NCT01897571|65041521|FG001|Overall Study|Lost to Follow-up|0|||
23354723|NCT01897571|65041522|FG002|Overall Study|Lost to Follow-up|0|||
23354724|NCT01897571|65041523|FG003|Overall Study|Lost to Follow-up|0|||
23354725|NCT01897571|65041524|FG004|Overall Study|Lost to Follow-up|2|||
23354726|NCT01897571|65041525|FG005|Overall Study|Lost to Follow-up|0|||
23354727|NCT01897571|65041526|FG006|Overall Study|Lost to Follow-up|0|||
23354728|NCT01897571|65041527|FG007|Overall Study|Lost to Follow-up|0|||
23354729|NCT01897571|65041528|FG008|Overall Study|Lost to Follow-up|1|||
23354730|NCT01897571|65041529|FG009|Overall Study|Lost to Follow-up|2|||
23354731|NCT01897571|65041530|FG010|Overall Study|Lost to Follow-up|4|||
23354732|NCT01897571|65041520|FG000|Overall Study|Withdrawal by Subject|0|||
23354733|NCT01897571|65041521|FG001|Overall Study|Withdrawal by Subject|0|||
23354734|NCT01897571|65041522|FG002|Overall Study|Withdrawal by Subject|0|||
23354735|NCT01897571|65041523|FG003|Overall Study|Withdrawal by Subject|0|||
23354736|NCT01897571|65041524|FG004|Overall Study|Withdrawal by Subject|0|||
23354737|NCT01897571|65041525|FG005|Overall Study|Withdrawal by Subject|0|||
23354738|NCT01897571|65041526|FG006|Overall Study|Withdrawal by Subject|0|||
23354739|NCT01897571|65041527|FG007|Overall Study|Withdrawal by Subject|1|||
23354740|NCT01897571|65041528|FG008|Overall Study|Withdrawal by Subject|4|||
23641283|NCT03900416|66071612|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
23641284|NCT03900416|66071613|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
23641285|NCT03900416|66071612|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
23641286|NCT03900416|66071613|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
23641287|NCT03900416|66071612|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
23641288|NCT03900416|66071613|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
23641289|NCT03900416|66071612|FG000|Twelve Week Follow-up|Adverse Event|1|||
23641290|NCT03900416|66071613|FG001|Twelve Week Follow-up|Adverse Event|1|||
23641291|NCT03900416|66071612|FG000|Six Month Follow-up|Lost to Follow-up|4|||
23795560|NCT00605176|66629933|FG001|Overall Study|Lost to Follow-up|2|||
23795561|NCT00605176|66629934|FG002|Overall Study|Lost to Follow-up|1|||
23795562|NCT00605176|66629932|FG000|Overall Study|Non-complicance with study procedures|1|||
23795563|NCT00605176|66629933|FG001|Overall Study|Non-complicance with study procedures|0|||
23795564|NCT00605176|66629934|FG002|Overall Study|Non-complicance with study procedures|0|||
23795565|NCT00605176|66629932|FG000|Overall Study|Use of concomitant therapy|1|||
23795566|NCT00605176|66629933|FG001|Overall Study|Use of concomitant therapy|0|||
23795567|NCT00605176|66629934|FG002|Overall Study|Use of concomitant therapy|1|||
23795568|NCT00605176|66629932|FG000|Overall Study|Other (not due to AE)|1|||
23795569|NCT00605176|66629933|FG001|Overall Study|Other (not due to AE)|1|||
23795570|NCT00605176|66629934|FG002|Overall Study|Other (not due to AE)|0|||
23795571|NCT02488824|66629937|FG000|Overall Study|Adverse Event|1|||
23795572|NCT02488824|66629938|FG001|Overall Study|Adverse Event|1|||
23795573|NCT01263561|66629941|FG000|Overall Study|Death|1|||
23795574|NCT01263561|66629942|FG001|Overall Study|Death|2|||
23795575|NCT00124462|66629944|FG000|Overall Study|Lost to Follow-up|3|||
23795576|NCT00124462|66629945|FG001|Overall Study|Lost to Follow-up|3|||
23795577|NCT00124462|66629944|FG000|Overall Study|Physician Decision|3|||
23795578|NCT00124462|66629945|FG001|Overall Study|Physician Decision|4|||
23795579|NCT00124462|66629944|FG000|Overall Study|Withdrawal by Subject|4|||
23641292|NCT03900416|66071613|FG001|Six Month Follow-up|Lost to Follow-up|3|||
23641293|NCT03900416|66071612|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
23641294|NCT03900416|66071613|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
23641295|NCT02019667|66071616|FG000|First Intervention (6 Months)|Adverse Event|0|||
23354741|NCT01897571|65041529|FG009|Overall Study|Withdrawal by Subject|3|||
23354742|NCT01897571|65041530|FG010|Overall Study|Withdrawal by Subject|1|||
23354743|NCT01897571|65041520|FG000|Overall Study|Other|1|||
23641296|NCT02019667|66071617|FG001|First Intervention (6 Months)|Adverse Event|1|||
23354744|NCT01897571|65041521|FG001|Overall Study|Other|0|||
23354745|NCT01897571|65041522|FG002|Overall Study|Other|0|||
23354746|NCT01897571|65041523|FG003|Overall Study|Other|3|||
23354747|NCT01897571|65041524|FG004|Overall Study|Other|3|||
23354748|NCT01897571|65041525|FG005|Overall Study|Other|4|||
23354749|NCT01897571|65041526|FG006|Overall Study|Other|7|||
23641297|NCT02019667|66071616|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
23706843|NCT00002663|66301339|FG000|Overall Study|Physician Decision|0|||
23706844|NCT00002663|66301340|FG001|Overall Study|Physician Decision|0|||
23354750|NCT01897571|65041527|FG007|Overall Study|Other|0|||
23706845|NCT00002663|66301341|FG002|Overall Study|Physician Decision|0|||
23706846|NCT00002663|66301342|FG003|Overall Study|Physician Decision|0|||
23706847|NCT00002663|66301343|FG004|Overall Study|Physician Decision|1|||
23706848|NCT00002663|66301344|FG005|Overall Study|Physician Decision|0|||
23641298|NCT02019667|66071617|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
23641299|NCT02019667|66071616|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
23641300|NCT02019667|66071617|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
23641301|NCT03932812|66071618|FG000|Overall Study|Lost to Follow-up|12|||
23641302|NCT03932812|66071619|FG001|Overall Study|Lost to Follow-up|14|||
23641303|NCT03932812|66071618|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
23641304|NCT03932812|66071619|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
23641305|NCT01081132|66071620|FG000|Overall Study|Lack of Efficacy|25|||
23641306|NCT01081132|66071621|FG001|Overall Study|Lack of Efficacy|9|||
23641307|NCT01081132|66071620|FG000|Overall Study|Withdrawal by Subject|13|||
23641308|NCT01081132|66071621|FG001|Overall Study|Withdrawal by Subject|16|||
23641309|NCT01081132|66071620|FG000|Overall Study|Lost to Follow-up|4|||
23641310|NCT01081132|66071621|FG001|Overall Study|Lost to Follow-up|11|||
23641311|NCT01081132|66071620|FG000|Overall Study|Adverse Event|3|||
23641312|NCT01081132|66071621|FG001|Overall Study|Adverse Event|9|||
23641313|NCT01081132|66071620|FG000|Overall Study|Non Compliance|4|||
23641314|NCT01081132|66071621|FG001|Overall Study|Non Compliance|2|||
23354751|NCT01897571|65041528|FG008|Overall Study|Other|0|||
23354752|NCT01897571|65041529|FG009|Overall Study|Other|0|||
23354753|NCT01897571|65041530|FG010|Overall Study|Other|0|||
23354754|NCT01897571|65041520|FG000|Overall Study|Enrolled in rollover study|0|||
23354755|NCT01897571|65041521|FG001|Overall Study|Enrolled in rollover study|0|||
23354756|NCT01897571|65041522|FG002|Overall Study|Enrolled in rollover study|0|||
23354757|NCT01897571|65041523|FG003|Overall Study|Enrolled in rollover study|0|||
23354758|NCT01897571|65041524|FG004|Overall Study|Enrolled in rollover study|0|||
23354759|NCT01897571|65041525|FG005|Overall Study|Enrolled in rollover study|0|||
23587916|NCT04107805|65882069|FG002|Overall Study|Adverse Event|0|||
23587917|NCT04107805|65882070|FG003|Overall Study|Adverse Event|1|||
23587918|NCT04107805|65882071|FG004|Overall Study|Adverse Event|0|||
23587919|NCT04107805|65882072|FG005|Overall Study|Adverse Event|1|||
23587920|NCT04107805|65882073|FG006|Overall Study|Adverse Event|0|||
23587921|NCT04107805|65882074|FG007|Overall Study|Adverse Event|0|||
23587922|NCT04107805|65882075|FG008|Overall Study|Adverse Event|1|||
23587923|NCT04364269|65882079|FG000|Overall Study|Adverse Event|1|||
23795580|NCT00124462|66629945|FG001|Overall Study|Withdrawal by Subject|5|||
23795581|NCT00124462|66629944|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
23795582|NCT00124462|66629945|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
23795583|NCT01264835|66629950|FG000|Overall Study|Lost to Follow-up|1|||
23795584|NCT03619876|66629951|FG000|Overall Study|Withdrawal by Subject|1|||
23795585|NCT03619876|66629952|FG001|Overall Study|Withdrawal by Subject|2|||
23795586|NCT03619876|66629951|FG000|Overall Study|Withdrawal due to incidental finding|0|||
23795587|NCT03619876|66629952|FG001|Overall Study|Withdrawal due to incidental finding|2|||
23795588|NCT01560819|66629955|FG000|Overall Study|Physician Decision|1|||
23795589|NCT01560819|66629956|FG001|Overall Study|Physician Decision|0|||
23795590|NCT01896505|66629957|FG000|Overall Study|Adverse Event|1|||
23795591|NCT01896505|66629958|FG001|Overall Study|Adverse Event|0|||
23795592|NCT01896505|66629959|FG002|Overall Study|Adverse Event|2|||
23795593|NCT01896505|66629960|FG003|Overall Study|Adverse Event|1|||
23795594|NCT01896505|66629961|FG004|Overall Study|Adverse Event|1|||
23795595|NCT01896505|66629962|FG005|Overall Study|Adverse Event|0|||
23795596|NCT01896505|66629957|FG000|Overall Study|Physician Decision|1|||
23795597|NCT01896505|66629958|FG001|Overall Study|Physician Decision|3|||
23795598|NCT01896505|66629959|FG002|Overall Study|Physician Decision|2|||
23795599|NCT01896505|66629960|FG003|Overall Study|Physician Decision|0|||
23795600|NCT01896505|66629961|FG004|Overall Study|Physician Decision|0|||
23795601|NCT01896505|66629962|FG005|Overall Study|Physician Decision|1|||
23795602|NCT01896505|66629957|FG000|Overall Study|Withdrawal by Subject|1|||
23795603|NCT01896505|66629958|FG001|Overall Study|Withdrawal by Subject|0|||
23354760|NCT01897571|65041526|FG006|Overall Study|Enrolled in rollover study|0|||
23354761|NCT01897571|65041527|FG007|Overall Study|Enrolled in rollover study|9|||
23354762|NCT01897571|65041528|FG008|Overall Study|Enrolled in rollover study|7|||
23354763|NCT01897571|65041529|FG009|Overall Study|Enrolled in rollover study|9|||
23795604|NCT01896505|66629959|FG002|Overall Study|Withdrawal by Subject|3|||
23354764|NCT01897571|65041530|FG010|Overall Study|Enrolled in rollover study|1|||
23795605|NCT01896505|66629960|FG003|Overall Study|Withdrawal by Subject|1|||
23354765|NCT01897571|65041520|FG000|Overall Study|Death|2|||
23354766|NCT01897571|65041521|FG001|Overall Study|Death|2|||
23587924|NCT04364269|65882080|FG001|Overall Study|Adverse Event|0|||
23354767|NCT01897571|65041522|FG002|Overall Study|Death|3|||
23354768|NCT01897571|65041523|FG003|Overall Study|Death|6|||
23354769|NCT01897571|65041524|FG004|Overall Study|Death|7|||
23354770|NCT01897571|65041525|FG005|Overall Study|Death|9|||
23354771|NCT01897571|65041526|FG006|Overall Study|Death|5|||
23354772|NCT01897571|65041527|FG007|Overall Study|Death|22|||
23354773|NCT01897571|65041528|FG008|Overall Study|Death|23|||
23354774|NCT01897571|65041529|FG009|Overall Study|Death|129|||
23354775|NCT01897571|65041530|FG010|Overall Study|Death|59|||
23354776|NCT02588664|65041531|FG000|Overall Study|Death|56|||
23354777|NCT02588664|65041532|FG001|Overall Study|Death|55|||
23354778|NCT02588664|65041531|FG000|Overall Study|Lost to Follow-up|1305|||
23354779|NCT02588664|65041532|FG001|Overall Study|Lost to Follow-up|990|||
23354780|NCT00966355|65041533|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
23354781|NCT00966355|65041534|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
23354782|NCT00966355|65041535|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
23354783|NCT00966355|65041533|FG000|Overall Study|newly diagnosed advanced HCC|11|||
23354784|NCT00966355|65041534|FG001|Overall Study|newly diagnosed advanced HCC|12|||
23354785|NCT00966355|65041535|FG002|Overall Study|newly diagnosed advanced HCC|10|||
23354786|NCT00966355|65041533|FG000|Overall Study|Lost to Follow-up|5|||
23354787|NCT00966355|65041534|FG001|Overall Study|Lost to Follow-up|4|||
23354788|NCT00966355|65041535|FG002|Overall Study|Lost to Follow-up|3|||
23354789|NCT00621517|65041536|FG000|Overall Study|Lost to Follow-up|3|||
23354790|NCT00621517|65041537|FG001|Overall Study|Lost to Follow-up|3|||
23354791|NCT00621517|65041536|FG000|Overall Study|Withdrawal by Subject|3|||
23354792|NCT00621517|65041537|FG001|Overall Study|Withdrawal by Subject|4|||
23471943|NCT02152956|65470866|FG001|Overall Study|Physician Decision|0|||
23471944|NCT02152956|65470867|FG002|Overall Study|Physician Decision|0|||
23354793|NCT00621517|65041536|FG000|Overall Study|Adverse Event|1|||
23795606|NCT01896505|66629961|FG004|Overall Study|Withdrawal by Subject|0|||
23795607|NCT01896505|66629962|FG005|Overall Study|Withdrawal by Subject|0|||
23354794|NCT00621517|65041537|FG001|Overall Study|Adverse Event|0|||
23354795|NCT00303472|65041538|FG000|Treatment Period|Adverse Event|0|||
23354796|NCT00303472|65041539|FG001|Treatment Period|Adverse Event|0|||
23354797|NCT00303472|65041540|FG002|Treatment Period|Adverse Event|0|||
23354798|NCT00303472|65041541|FG003|Treatment Period|Adverse Event|0|||
23471945|NCT02152956|65470868|FG003|Overall Study|Physician Decision|0|||
23471946|NCT02152956|65470869|FG004|Overall Study|Physician Decision|0|||
23471947|NCT02152956|65470870|FG005|Overall Study|Physician Decision|0|||
23471948|NCT02152956|65470871|FG006|Overall Study|Physician Decision|0|||
23471949|NCT02152956|65470872|FG007|Overall Study|Physician Decision|0|||
23471950|NCT02152956|65470873|FG008|Overall Study|Physician Decision|0|||
23471951|NCT02152956|65470874|FG009|Overall Study|Physician Decision|0|||
23471952|NCT02152956|65470875|FG010|Overall Study|Physician Decision|0|||
23471953|NCT02152956|65470876|FG011|Overall Study|Physician Decision|1|||
23795608|NCT01896505|66629957|FG000|Overall Study|Disease Progression|7|||
23795609|NCT01896505|66629958|FG001|Overall Study|Disease Progression|5|||
23795610|NCT01896505|66629959|FG002|Overall Study|Disease Progression|8|||
23795611|NCT01896505|66629960|FG003|Overall Study|Disease Progression|4|||
23795612|NCT01896505|66629961|FG004|Overall Study|Disease Progression|4|||
23795613|NCT01896505|66629962|FG005|Overall Study|Disease Progression|4|||
23354799|NCT00303472|65041542|FG004|Treatment Period|Adverse Event|1|||
23354800|NCT00303472|65041543|FG005|Treatment Period|Adverse Event|0|||
23354801|NCT00303472|65041544|FG006|Treatment Period|Adverse Event|0|||
23354802|NCT00303472|65041538|FG000|Treatment Period|Death|0|||
23354803|NCT00303472|65041539|FG001|Treatment Period|Death|0|||
23354804|NCT00303472|65041540|FG002|Treatment Period|Death|0|||
23354805|NCT00303472|65041541|FG003|Treatment Period|Death|1|||
23354806|NCT00303472|65041542|FG004|Treatment Period|Death|0|||
23795614|NCT01896505|66629957|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
23795615|NCT01896505|66629958|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
23795616|NCT01896505|66629959|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
23795617|NCT01896505|66629960|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
23795618|NCT01896505|66629961|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
23795619|NCT01896505|66629962|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
23795620|NCT01896505|66629957|FG000|Overall Study|Intercurrent illness|0|||
23795621|NCT01896505|66629958|FG001|Overall Study|Intercurrent illness|1|||
23795622|NCT01896505|66629959|FG002|Overall Study|Intercurrent illness|0|||
23354807|NCT00303472|65041543|FG005|Treatment Period|Death|0|||
23354808|NCT00303472|65041544|FG006|Treatment Period|Death|1|||
23354809|NCT00303472|65041538|FG000|Treatment Period|Withdrawal by Subject|0|||
23354810|NCT00303472|65041539|FG001|Treatment Period|Withdrawal by Subject|0|||
23354811|NCT00303472|65041540|FG002|Treatment Period|Withdrawal by Subject|0|||
23471954|NCT02152956|65470877|FG012|Overall Study|Physician Decision|0|||
23471955|NCT02152956|65470865|FG000|Overall Study|Study terminated by sponsor|0|||
23471956|NCT02152956|65470866|FG001|Overall Study|Study terminated by sponsor|0|||
23354812|NCT00303472|65041541|FG003|Treatment Period|Withdrawal by Subject|1|||
23354813|NCT00303472|65041542|FG004|Treatment Period|Withdrawal by Subject|0|||
23354814|NCT00303472|65041543|FG005|Treatment Period|Withdrawal by Subject|1|||
23471957|NCT02152956|65470867|FG002|Overall Study|Study terminated by sponsor|0|||
23471958|NCT02152956|65470868|FG003|Overall Study|Study terminated by sponsor|0|||
23471959|NCT02152956|65470869|FG004|Overall Study|Study terminated by sponsor|0|||
23471960|NCT02152956|65470870|FG005|Overall Study|Study terminated by sponsor|0|||
23471961|NCT02152956|65470871|FG006|Overall Study|Study terminated by sponsor|0|||
23471962|NCT02152956|65470872|FG007|Overall Study|Study terminated by sponsor|0|||
23471963|NCT02152956|65470873|FG008|Overall Study|Study terminated by sponsor|0|||
23471964|NCT02152956|65470874|FG009|Overall Study|Study terminated by sponsor|0|||
23471965|NCT02152956|65470875|FG010|Overall Study|Study terminated by sponsor|0|||
23471966|NCT02152956|65470876|FG011|Overall Study|Study terminated by sponsor|29|||
23471967|NCT02152956|65470877|FG012|Overall Study|Study terminated by sponsor|0|||
23471968|NCT02152956|65470865|FG000|Overall Study|progressive disease|0|||
23471969|NCT02152956|65470866|FG001|Overall Study|progressive disease|0|||
23471970|NCT02152956|65470867|FG002|Overall Study|progressive disease|0|||
23471971|NCT02152956|65470868|FG003|Overall Study|progressive disease|0|||
23471972|NCT02152956|65470869|FG004|Overall Study|progressive disease|0|||
23471973|NCT02152956|65470870|FG005|Overall Study|progressive disease|0|||
23471974|NCT02152956|65470871|FG006|Overall Study|progressive disease|0|||
23471975|NCT02152956|65470872|FG007|Overall Study|progressive disease|0|||
23471976|NCT02152956|65470873|FG008|Overall Study|progressive disease|1|||
23795623|NCT01896505|66629960|FG003|Overall Study|Intercurrent illness|0|||
23795624|NCT01896505|66629961|FG004|Overall Study|Intercurrent illness|0|||
23795625|NCT01896505|66629962|FG005|Overall Study|Intercurrent illness|0|||
23795626|NCT01896505|66629957|FG000|Overall Study|Death|0|||
23795627|NCT01896505|66629958|FG001|Overall Study|Death|0|||
23795628|NCT01896505|66629959|FG002|Overall Study|Death|1|||
23471977|NCT02152956|65470874|FG009|Overall Study|progressive disease|0|||
23471978|NCT02152956|65470875|FG010|Overall Study|progressive disease|0|||
23471979|NCT02152956|65470876|FG011|Overall Study|progressive disease|1|||
23471980|NCT02152956|65470877|FG012|Overall Study|progressive disease|0|||
23471981|NCT01069900|65470878|FG000|Overall Study|Technical problems|0|||
23795629|NCT01896505|66629960|FG003|Overall Study|Death|1|||
23795630|NCT01896505|66629961|FG004|Overall Study|Death|0|||
23795631|NCT01896505|66629962|FG005|Overall Study|Death|1|||
23795632|NCT03139240|66629965|FG000|Overall Study|Lost to Follow-up|0|||
23795633|NCT03139240|66629966|FG001|Overall Study|Lost to Follow-up|1|||
23795634|NCT03139240|66629967|FG002|Overall Study|Lost to Follow-up|1|||
23795635|NCT03139240|66629968|FG003|Overall Study|Lost to Follow-up|0|||
23795636|NCT00927251|66629969|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
23795637|NCT00593827|66629970|FG000|Overall Study|On Active Treatment/Pending|0|||
23795638|NCT00593827|66629971|FG001|Overall Study|On Active Treatment/Pending|2|||
23795639|NCT03969641|66629972|FG000|Overall Study|Lost to Follow-up|5|||
23795640|NCT03969641|66629973|FG001|Overall Study|Lost to Follow-up|3|||
23471982|NCT01069900|65470879|FG001|Overall Study|Technical problems|1|||
23471983|NCT01069900|65470878|FG000|Overall Study|Lost to Follow-up|7|||
23641315|NCT01081132|66071620|FG000|Overall Study|Lack Of Compliance|0|||
23795641|NCT03969641|66629972|FG000|Overall Study|Withdrawal by Subject|1|||
23795642|NCT03969641|66629973|FG001|Overall Study|Withdrawal by Subject|2|||
23795643|NCT03969641|66629972|FG000|Overall Study|Found to be ineligible|1|||
23471984|NCT01069900|65470879|FG001|Overall Study|Lost to Follow-up|1|||
23587925|NCT04364269|65882081|FG002|Overall Study|Adverse Event|0|||
23587926|NCT04364269|65882079|FG000|Overall Study|Withdrawal by Subject|0|||
23587927|NCT04364269|65882080|FG001|Overall Study|Withdrawal by Subject|1|||
23587928|NCT04364269|65882081|FG002|Overall Study|Withdrawal by Subject|0|||
23587929|NCT00606580|65882084|FG000|Overall Study|Lost to Follow-up|1|||
23587930|NCT00606580|65882085|FG001|Overall Study|Lost to Follow-up|1|||
23587931|NCT00606580|65882086|FG002|Overall Study|Lost to Follow-up|4|||
23587932|NCT00606580|65882084|FG000|Overall Study|Clinical failures|1|||
23587933|NCT00606580|65882085|FG001|Overall Study|Clinical failures|0|||
23471985|NCT01069900|65470878|FG000|Overall Study|Withdrawal by Subject|6|||
23471986|NCT01069900|65470879|FG001|Overall Study|Withdrawal by Subject|1|||
23471987|NCT01069900|65470878|FG000|Overall Study|Protocol Violation|4|||
23471988|NCT01069900|65470879|FG001|Overall Study|Protocol Violation|1|||
23471989|NCT01069900|65470878|FG000|Overall Study|Insufficient Therapeutic effect|1|||
23471990|NCT01069900|65470879|FG001|Overall Study|Insufficient Therapeutic effect|0|||
23471991|NCT01942733|65470884|FG000|Overall Study|Lost to Follow-up|1|||
23471992|NCT01942733|65470884|FG000|Overall Study|Non-compliance with IMP|1|||
23471993|NCT01942733|65470884|FG000|Overall Study|Administrative|1|||
23471994|NCT04050202|65470885|FG000|Overall Study|Lost to Follow-up|2|||
23471995|NCT00918736|65470887|FG000|Overall Study|Withdrawal by Subject|4|||
23471996|NCT02654717|65470899|FG000|Overall Study|Adverse Event|2|||
23471997|NCT02654717|65470900|FG001|Overall Study|Adverse Event|2|||
23641316|NCT01081132|66071621|FG001|Overall Study|Lack Of Compliance|1|||
23641317|NCT01081132|66071620|FG000|Overall Study|Missed Visits|1|||
23471998|NCT02654717|65470899|FG000|Overall Study|Protocol Violation|1|||
23471999|NCT02654717|65470900|FG001|Overall Study|Protocol Violation|2|||
23472000|NCT02654717|65470899|FG000|Overall Study|Withdrawal by Subject|0|||
23472001|NCT02654717|65470900|FG001|Overall Study|Withdrawal by Subject|1|||
23472002|NCT02654717|65470899|FG000|Overall Study|Non-permitted medication|3|||
23472003|NCT02654717|65470900|FG001|Overall Study|Non-permitted medication|0|||
23472004|NCT03983317|65470902|FG000|Overall Study|Physician Decision|5|||
23472005|NCT00856518|65470903|FG000|Overall Study|Lost to Follow-up|4|||
23472006|NCT00856518|65470904|FG001|Overall Study|Lost to Follow-up|2|||
23472007|NCT00615901|65470906|FG000|Overall Study|Withdrawal by Subject|2|||
23472008|NCT00615901|65470906|FG000|Overall Study|Adverse Event|7|||
23472009|NCT01765218|65470907|FG000|Overall Study|Protocol Violation|1|||
23472010|NCT01765218|65470908|FG001|Overall Study|Protocol Violation|2|||
23472011|NCT02267317|65473804|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
23472012|NCT02267317|65473805|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472013|NCT02267317|65473806|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472014|NCT02267317|65473807|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472015|NCT02267317|65473808|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472016|NCT02267317|65473809|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472017|NCT02267317|65473804|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
23472018|NCT02267317|65473805|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472019|NCT02267317|65473806|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23641318|NCT01081132|66071621|FG001|Overall Study|Missed Visits|1|||
23641319|NCT01081132|66071620|FG000|Overall Study|Stopped Taking Meds|2|||
23641320|NCT01081132|66071621|FG001|Overall Study|Stopped Taking Meds|0|||
23641321|NCT01081132|66071620|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
23641322|NCT01081132|66071621|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
23641323|NCT01081132|66071620|FG000|Overall Study|Declined Taper Phase|0|||
23641324|NCT01081132|66071621|FG001|Overall Study|Declined Taper Phase|1|||
23641325|NCT01081132|66071620|FG000|Overall Study|Protocol Violation|3|||
23641326|NCT01081132|66071621|FG001|Overall Study|Protocol Violation|1|||
23641327|NCT03218397|66071622|FG000|Overall Study|Prior positive blood culture|8|||
23641328|NCT03218397|66071623|FG001|Overall Study|Prior positive blood culture|13|||
23641329|NCT03218397|66071622|FG000|Overall Study|Comfort care|8|||
23641330|NCT03218397|66071623|FG001|Overall Study|Comfort care|5|||
23641331|NCT03218397|66071622|FG000|Overall Study|Comfort care and positive blood culture|1|||
23641332|NCT03218397|66071623|FG001|Overall Study|Comfort care and positive blood culture|0|||
23641333|NCT03218397|66071622|FG000|Overall Study|Comfort care and mixed culture|0|||
23641334|NCT03218397|66071623|FG001|Overall Study|Comfort care and mixed culture|1|||
23641335|NCT03218397|66071622|FG000|Overall Study|Mixed culture|2|||
23472020|NCT02267317|65473807|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472021|NCT02267317|65473808|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472022|NCT02267317|65473809|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472023|NCT02864862|65473816|FG000|Overall Study|Lost to Follow-up|1|||
23472024|NCT02864862|65473817|FG001|Overall Study|Lost to Follow-up|0|||
23472025|NCT02864862|65473818|FG002|Overall Study|Lost to Follow-up|1|||
23472026|NCT02864862|65473816|FG000|Overall Study|Protocol Violation|0|||
23472027|NCT02864862|65473817|FG001|Overall Study|Protocol Violation|0|||
23472028|NCT02864862|65473818|FG002|Overall Study|Protocol Violation|1|||
23472029|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
23641336|NCT03218397|66071623|FG001|Overall Study|Mixed culture|2|||
23641337|NCT03218397|66071622|FG000|Overall Study|Inaccessible hospital records|2|||
23641338|NCT03218397|66071623|FG001|Overall Study|Inaccessible hospital records|5|||
23472030|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
23472031|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
23472032|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
23472033|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
23472034|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
23472035|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
23472036|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
23472037|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
23472038|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
23472039|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
23472040|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
23472041|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
23472042|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
23472043|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
23472044|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
23472045|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
23472046|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
23472047|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
23472048|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
23472049|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
23472050|NCT00402740|65473836|FG000|Overall Study|Withdrawal by Subject|18|||
23472051|NCT00402740|65473836|FG000|Overall Study|Death|50|||
23472052|NCT00402740|65473836|FG000|Overall Study|Lost to Follow-up|6|||
23472053|NCT00402740|65473836|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
23472054|NCT00402740|65473836|FG000|Overall Study|Subject disposition unknown.|1|||
23472055|NCT00742235|65473841|FG000|Overall Study|Lost to Follow-up|0|||
23472056|NCT00742235|65473842|FG001|Overall Study|Lost to Follow-up|31|||
23472057|NCT00125164|65473843|FG000|Overall Study|Adverse Event|0|||
23472058|NCT00125164|65473844|FG001|Overall Study|Adverse Event|0|||
23472059|NCT00125164|65473845|FG002|Overall Study|Adverse Event|2|||
23472060|NCT00125164|65473846|FG003|Overall Study|Adverse Event|4|||
23472061|NCT00125164|65473843|FG000|Overall Study|Lost to Follow-up|0|||
23472062|NCT00125164|65473844|FG001|Overall Study|Lost to Follow-up|0|||
23472063|NCT00125164|65473845|FG002|Overall Study|Lost to Follow-up|1|||
23472064|NCT00125164|65473846|FG003|Overall Study|Lost to Follow-up|1|||
23472065|NCT00125164|65473843|FG000|Overall Study|Withdrawal by Subject|2|||
23472066|NCT00125164|65473844|FG001|Overall Study|Withdrawal by Subject|0|||
23472067|NCT00125164|65473845|FG002|Overall Study|Withdrawal by Subject|1|||
23472068|NCT00125164|65473846|FG003|Overall Study|Withdrawal by Subject|1|||
23472069|NCT04450381|65473851|FG000|Overall Study|Protocol Violation|4|||
23472070|NCT04450381|65473851|FG000|Overall Study|Wrong device setting|2|||
23472071|NCT00771953|65473856|FG000|Overall Study|Adverse Event|5|||
23472072|NCT00771953|65473857|FG001|Overall Study|Adverse Event|3|||
23472073|NCT00771953|65473856|FG000|Overall Study|Death|2|||
23472074|NCT00771953|65473857|FG001|Overall Study|Death|2|||
23472075|NCT00771953|65473856|FG000|Overall Study|Progression before active Tx|1|||
23472076|NCT00771953|65473857|FG001|Overall Study|Progression before active Tx|2|||
23472077|NCT00771953|65473856|FG000|Overall Study|Sponsor decision|1|||
23795644|NCT03969641|66629973|FG001|Overall Study|Found to be ineligible|1|||
23795645|NCT03969641|66629972|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
23795646|NCT03969641|66629973|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
23795647|NCT03969641|66629972|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
23795648|NCT03969641|66629973|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
23795649|NCT03969641|66629972|FG000|Overall Study|Elective termination|0|||
23795650|NCT03969641|66629973|FG001|Overall Study|Elective termination|1|||
23795651|NCT02000115|66629974|FG000|Overall Study|Death|56|||
23795652|NCT02000115|66629975|FG001|Overall Study|Death|45|||
23795653|NCT02000115|66629976|FG002|Overall Study|Death|0|||
23795654|NCT02000115|66629977|FG003|Overall Study|Death|0|||
23795655|NCT02000115|66629974|FG000|Overall Study|Missed Visit|6|||
23795656|NCT02000115|66629975|FG001|Overall Study|Missed Visit|8|||
23795657|NCT02000115|66629976|FG002|Overall Study|Missed Visit|1|||
23795658|NCT02000115|66629977|FG003|Overall Study|Missed Visit|0|||
23795659|NCT02000115|66629974|FG000|Overall Study|Protocol Violation|2|||
23795660|NCT02000115|66629975|FG001|Overall Study|Protocol Violation|1|||
23472078|NCT00771953|65473857|FG001|Overall Study|Sponsor decision|0|||
23472079|NCT00771953|65473856|FG000|Overall Study|Other complicating disease|1|||
23472080|NCT00771953|65473857|FG001|Overall Study|Other complicating disease|0|||
23472081|NCT00771953|65473856|FG000|Overall Study|Withdrawal by Subject|0|||
23472082|NCT00771953|65473857|FG001|Overall Study|Withdrawal by Subject|3|||
23472083|NCT00777153|65473858|FG000|Overall Study|Lost to Follow-up|1|||
23472084|NCT00777153|65473859|FG001|Overall Study|Lost to Follow-up|1|||
23472085|NCT00777153|65473860|FG002|Overall Study|Lost to Follow-up|0|||
23472086|NCT00777153|65473858|FG000|Overall Study|Death|85|||
23795661|NCT02000115|66629976|FG002|Overall Study|Protocol Violation|0|||
23795662|NCT02000115|66629977|FG003|Overall Study|Protocol Violation|0|||
23795663|NCT02000115|66629974|FG000|Overall Study|Physician Decision|2|||
23795664|NCT02000115|66629975|FG001|Overall Study|Physician Decision|0|||
23795665|NCT02000115|66629976|FG002|Overall Study|Physician Decision|0|||
23795666|NCT02000115|66629977|FG003|Overall Study|Physician Decision|0|||
23795667|NCT02000115|66629974|FG000|Overall Study|Withdrawal by Subject|11|||
23795668|NCT02000115|66629975|FG001|Overall Study|Withdrawal by Subject|11|||
23795669|NCT02000115|66629976|FG002|Overall Study|Withdrawal by Subject|0|||
23795670|NCT02000115|66629977|FG003|Overall Study|Withdrawal by Subject|0|||
23795671|NCT02000115|66629974|FG000|Overall Study|Lost to Follow-up|0|||
23795672|NCT02000115|66629975|FG001|Overall Study|Lost to Follow-up|1|||
23795673|NCT02000115|66629976|FG002|Overall Study|Lost to Follow-up|0|||
23795674|NCT02000115|66629977|FG003|Overall Study|Lost to Follow-up|0|||
23795675|NCT02000115|66629974|FG000|Overall Study|Non-compliance|2|||
23795676|NCT02000115|66629975|FG001|Overall Study|Non-compliance|1|||
23795677|NCT02000115|66629976|FG002|Overall Study|Non-compliance|0|||
23795678|NCT02000115|66629977|FG003|Overall Study|Non-compliance|0|||
23795679|NCT02000115|66629974|FG000|Overall Study|Withdrawn on day of randomization|0|||
23795680|NCT02000115|66629975|FG001|Overall Study|Withdrawn on day of randomization|1|||
23795681|NCT02000115|66629976|FG002|Overall Study|Withdrawn on day of randomization|0|||
23795682|NCT02000115|66629977|FG003|Overall Study|Withdrawn on day of randomization|0|||
23795683|NCT02000115|66629974|FG000|Overall Study|Still on Study|0|||
23795684|NCT02000115|66629975|FG001|Overall Study|Still on Study|0|||
23795685|NCT02000115|66629976|FG002|Overall Study|Still on Study|0|||
23795686|NCT02000115|66629977|FG003|Overall Study|Still on Study|53|||
23795687|NCT02329431|66629982|FG000|Overall Study|Lost to Follow-up|20|||
23795688|NCT02329431|66629983|FG001|Overall Study|Lost to Follow-up|13|||
23795689|NCT03507686|66629984|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
23795690|NCT03507686|66629985|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
23795691|NCT03507686|66629984|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
23472087|NCT00777153|65473859|FG001|Overall Study|Death|73|||
23472088|NCT00777153|65473860|FG002|Overall Study|Death|33|||
23472089|NCT00777153|65473858|FG000|Overall Study|Withdrawal by Subject|3|||
23472090|NCT00777153|65473859|FG001|Overall Study|Withdrawal by Subject|4|||
23472091|NCT00777153|65473860|FG002|Overall Study|Withdrawal by Subject|3|||
23472092|NCT00777153|65473858|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
23472093|NCT00777153|65473859|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
23472094|NCT00777153|65473860|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
23472095|NCT02139592|65473864|FG000|Overall Study|Case Report Forms Uncollected|8|||
23472096|NCT01497366|65473866|FG000|Overall Study|Virologic failure|2|||
23472097|NCT01497366|65473867|FG001|Overall Study|Virologic failure|50|||
23472098|NCT01497366|65473866|FG000|Overall Study|Lost to Follow-up|11|||
23587934|NCT00606580|65882086|FG002|Overall Study|Clinical failures|12|||
23587935|NCT00606580|65882084|FG000|Overall Study|Withdrawal by investigator|0|||
23587936|NCT00606580|65882085|FG001|Overall Study|Withdrawal by investigator|1|||
23587937|NCT00606580|65882086|FG002|Overall Study|Withdrawal by investigator|6|||
23587938|NCT00606580|65882084|FG000|Overall Study|Withdrawal by Subject|0|||
23587939|NCT00606580|65882085|FG001|Overall Study|Withdrawal by Subject|1|||
23587940|NCT00606580|65882086|FG002|Overall Study|Withdrawal by Subject|0|||
23587941|NCT03478956|65882087|FG000|Overall Study|Adverse Event|1|||
23587942|NCT03478956|65882088|FG001|Overall Study|Adverse Event|0|||
23587943|NCT03478956|65882087|FG000|Overall Study|Withdrawal by Subject|0|||
23587944|NCT03478956|65882088|FG001|Overall Study|Withdrawal by Subject|1|||
23587945|NCT03478956|65882087|FG000|Overall Study|Ongoing in the Study|11|||
23587946|NCT03478956|65882088|FG001|Overall Study|Ongoing in the Study|11|||
23587947|NCT00305695|65882089|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
23587948|NCT00305695|65882090|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
23587949|NCT00305695|65882089|FG000|Overall Study|Did not have baseline scan|1|||
23587950|NCT00305695|65882090|FG001|Overall Study|Did not have baseline scan|1|||
23587951|NCT00377455|65882094|FG000|Overall Study|Withdrawal by Subject|1|||
23587952|NCT04439799|65882101|FG000|Overall Study|Lost to Follow-up|6|||
23587953|NCT04439799|65882102|FG001|Overall Study|Lost to Follow-up|6|||
23587954|NCT04439799|65882101|FG000|Overall Study|Withdrawal by Subject|2|||
23587955|NCT04439799|65882102|FG001|Overall Study|Withdrawal by Subject|6|||
23587956|NCT04439799|65882101|FG000|Overall Study|Adverse Event|2|||
23795692|NCT03507686|66629985|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
23795693|NCT03507686|66629984|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
23795694|NCT03507686|66629985|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
23587957|NCT04439799|65882102|FG001|Overall Study|Adverse Event|5|||
23795695|NCT03507686|66629984|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
23472099|NCT01497366|65473867|FG001|Overall Study|Lost to Follow-up|10|||
23472100|NCT01497366|65473866|FG000|Overall Study|Withdrawal by Subject|6|||
23472101|NCT01497366|65473867|FG001|Overall Study|Withdrawal by Subject|6|||
23587958|NCT02982213|65882105|FG000|Overall Study|Did not complete follow up questionnaire|5|||
23587959|NCT02982213|65882106|FG001|Overall Study|Did not complete follow up questionnaire|1|||
23587960|NCT01289119|65882107|FG000|Overall Study|Adverse Event|2|||
23587961|NCT01289119|65882108|FG001|Overall Study|Adverse Event|1|||
23587962|NCT01289119|65882109|FG002|Overall Study|Adverse Event|0|||
23587963|NCT01289119|65882110|FG003|Overall Study|Adverse Event|2|||
23472102|NCT01497366|65473866|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
23472103|NCT01497366|65473867|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
23472104|NCT01497366|65473866|FG000|Overall Study|Other|5|||
23472105|NCT01497366|65473867|FG001|Overall Study|Other|0|||
23472106|NCT01497366|65473866|FG000|Overall Study|Death|1|||
23472107|NCT01497366|65473867|FG001|Overall Study|Death|1|||
23472108|NCT01497366|65473866|FG000|Overall Study|Randomized but not treated|7|||
23472109|NCT01497366|65473867|FG001|Overall Study|Randomized but not treated|21|||
23472110|NCT02260180|65473870|FG000|Overall Study|Adverse Event|2|||
23472111|NCT02260180|65473871|FG001|Overall Study|Adverse Event|0|||
23472112|NCT02260180|65473872|FG002|Overall Study|Adverse Event|1|||
23472113|NCT00243269|65473873|FG000|Overall Study|Protocol Violation|2|||
23472114|NCT00243269|65473874|FG001|Overall Study|Protocol Violation|1|||
23472115|NCT00243269|65473875|FG002|Overall Study|Protocol Violation|0|||
23472116|NCT00243269|65473876|FG003|Overall Study|Protocol Violation|1|||
23472117|NCT00243269|65473873|FG000|Overall Study|Lost to Follow-up|1|||
23472118|NCT00243269|65473874|FG001|Overall Study|Lost to Follow-up|0|||
23472119|NCT00243269|65473875|FG002|Overall Study|Lost to Follow-up|1|||
23472120|NCT00243269|65473876|FG003|Overall Study|Lost to Follow-up|3|||
23472121|NCT00280748|65473877|FG000|Overall Study|Decline in performance|3|||
23472122|NCT00280748|65473877|FG000|Overall Study|Extra-cranial disease progression|1|||
23472123|NCT04530136|65473878|FG000|Overall Study|Lost to Follow-up|2|||
23472124|NCT04530136|65473879|FG001|Overall Study|Lost to Follow-up|3|||
23472125|NCT04530136|65473878|FG000|Overall Study|Withdrawal by Subject|1|||
23472126|NCT04530136|65473879|FG001|Overall Study|Withdrawal by Subject|0|||
23472127|NCT04530136|65473878|FG000|Overall Study|Death|0|||
23472128|NCT04530136|65473879|FG001|Overall Study|Death|1|||
23472129|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472130|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472131|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
23472132|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
23472133|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472134|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472135|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472136|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472137|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
23472138|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472139|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Death|0|||
23472140|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Death|0|||
23472141|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Death|0|||
23472142|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Death|0|||
23472143|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Death|0|||
23472144|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Death|0|||
23472145|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Death|0|||
23587964|NCT01289119|65882111|FG004|Overall Study|Adverse Event|1|||
23587965|NCT01289119|65882112|FG005|Overall Study|Adverse Event|0|||
23587966|NCT01289119|65882107|FG000|Overall Study|Major Protocol Deviation|2|||
23587967|NCT01289119|65882108|FG001|Overall Study|Major Protocol Deviation|1|||
23587968|NCT01289119|65882109|FG002|Overall Study|Major Protocol Deviation|3|||
23587969|NCT01289119|65882110|FG003|Overall Study|Major Protocol Deviation|0|||
23587970|NCT01289119|65882111|FG004|Overall Study|Major Protocol Deviation|2|||
23354815|NCT00303472|65041544|FG006|Treatment Period|Withdrawal by Subject|0|||
23472146|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Death|0|||
23472147|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Death|1|||
23472148|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Death|0|||
23354816|NCT00303472|65041538|FG000|Treatment Period|Other|0|||
23354817|NCT00303472|65041539|FG001|Treatment Period|Other|0|||
23587971|NCT01289119|65882112|FG005|Overall Study|Major Protocol Deviation|1|||
23587972|NCT01289119|65882107|FG000|Overall Study|Lost to Follow-up|0|||
23472149|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
23472150|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472151|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
23587973|NCT01289119|65882108|FG001|Overall Study|Lost to Follow-up|3|||
23587974|NCT01289119|65882109|FG002|Overall Study|Lost to Follow-up|0|||
23354818|NCT00303472|65041540|FG002|Treatment Period|Other|0|||
23472152|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472153|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472154|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472155|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472156|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472157|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
23472158|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472159|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472160|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472161|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472162|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472163|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
23472164|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472165|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472166|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472167|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
23472168|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
23472169|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472170|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472171|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472172|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
23472173|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472174|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472175|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472176|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472177|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472178|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23354819|NCT00303472|65041541|FG003|Treatment Period|Other|0|||
23472179|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
23472180|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
23472181|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
23472182|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
23472183|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
23472184|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
23472185|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
23587975|NCT01289119|65882110|FG003|Overall Study|Lost to Follow-up|0|||
23587976|NCT01289119|65882111|FG004|Overall Study|Lost to Follow-up|0|||
23354820|NCT00303472|65041542|FG004|Treatment Period|Other|1|||
23472186|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
23472187|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
23472188|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
23472189|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472190|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472191|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472192|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472193|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472194|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472195|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472196|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
23587977|NCT01289119|65882112|FG005|Overall Study|Lost to Follow-up|1|||
23795696|NCT03507686|66629985|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
23795697|NCT03507686|66629984|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
23587978|NCT01289119|65882107|FG000|Overall Study|Withdrawal by Subject|4|||
23587979|NCT01289119|65882108|FG001|Overall Study|Withdrawal by Subject|2|||
23587980|NCT01289119|65882109|FG002|Overall Study|Withdrawal by Subject|4|||
23587981|NCT01289119|65882110|FG003|Overall Study|Withdrawal by Subject|3|||
23587982|NCT01289119|65882111|FG004|Overall Study|Withdrawal by Subject|1|||
23587983|NCT01289119|65882112|FG005|Overall Study|Withdrawal by Subject|1|||
23587984|NCT01289119|65882107|FG000|Overall Study|Pregnancy|0|||
23587985|NCT01289119|65882108|FG001|Overall Study|Pregnancy|1|||
23587986|NCT01289119|65882109|FG002|Overall Study|Pregnancy|0|||
23587987|NCT01289119|65882110|FG003|Overall Study|Pregnancy|0|||
23587988|NCT01289119|65882111|FG004|Overall Study|Pregnancy|0|||
23587989|NCT01289119|65882112|FG005|Overall Study|Pregnancy|0|||
23587990|NCT01289119|65882107|FG000|Overall Study|Lack of Efficacy|0|||
23587991|NCT01289119|65882108|FG001|Overall Study|Lack of Efficacy|1|||
23587992|NCT01289119|65882109|FG002|Overall Study|Lack of Efficacy|1|||
23587993|NCT01289119|65882110|FG003|Overall Study|Lack of Efficacy|1|||
23587994|NCT01289119|65882111|FG004|Overall Study|Lack of Efficacy|1|||
23587995|NCT01289119|65882112|FG005|Overall Study|Lack of Efficacy|1|||
23587996|NCT01289119|65882107|FG000|Overall Study|Other|1|||
23587997|NCT01289119|65882108|FG001|Overall Study|Other|0|||
23587998|NCT01289119|65882109|FG002|Overall Study|Other|1|||
23587999|NCT01289119|65882110|FG003|Overall Study|Other|0|||
23588000|NCT01289119|65882111|FG004|Overall Study|Other|0|||
23588001|NCT01289119|65882112|FG005|Overall Study|Other|0|||
23588002|NCT01685606|65882117|FG000|Overall Study|Withdrawal by Subject|1|||
23588003|NCT00964366|65882118|FG000|Overall Study|Did not qualify at Day 1|1|||
23588004|NCT00964366|65882119|FG001|Overall Study|Did not qualify at Day 1|0|||
23588005|NCT00964366|65882118|FG000|Overall Study|Withdrawal by Subject|0|||
23588006|NCT00964366|65882119|FG001|Overall Study|Withdrawal by Subject|1|||
23588007|NCT00943605|65882120|FG000|Overall Study|Study termination|30|||
23588008|NCT00943605|65882121|FG001|Overall Study|Study termination|30|||
23588009|NCT00530842|65882122|FG000|Overall Study|Adverse Event|10|||
23588010|NCT00530842|65882123|FG001|Overall Study|Adverse Event|6|||
23588011|NCT00530842|65882122|FG000|Overall Study|Lack of Efficacy|2|||
23588012|NCT00530842|65882123|FG001|Overall Study|Lack of Efficacy|1|||
23588013|NCT00530842|65882122|FG000|Overall Study|Lost to Follow-up|0|||
23588014|NCT00530842|65882123|FG001|Overall Study|Lost to Follow-up|4|||
23588015|NCT00530842|65882122|FG000|Overall Study|Protocol Violation|3|||
23588016|NCT00530842|65882123|FG001|Overall Study|Protocol Violation|2|||
23588017|NCT00530842|65882122|FG000|Overall Study|Withdrawal by Subject|4|||
23588018|NCT00530842|65882123|FG001|Overall Study|Withdrawal by Subject|5|||
23588019|NCT00530842|65882122|FG000|Overall Study|Individual different reasons|4|||
23588020|NCT00530842|65882123|FG001|Overall Study|Individual different reasons|3|||
23588021|NCT00530842|65882122|FG000|Period 1|Adverse Event|7|||
23641339|NCT03218397|66071622|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
23641340|NCT03218397|66071623|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
23641341|NCT03218397|66071622|FG000|Overall Study|Randomized during laboratory off hours|2|||
23641342|NCT03218397|66071623|FG001|Overall Study|Randomized during laboratory off hours|1|||
23641343|NCT01153321|66071625|FG000|Overall Study|Development of study withdrawal criteria|0|||
23641344|NCT01153321|66071626|FG001|Overall Study|Development of study withdrawal criteria|1|||
23641345|NCT01153321|66071625|FG000|Overall Study|Withdrawal by Subject|0|||
23354821|NCT00303472|65041543|FG005|Treatment Period|Other|0|||
23588022|NCT00530842|65882123|FG001|Period 1|Adverse Event|3|||
23588023|NCT00530842|65882122|FG000|Period 1|Lack of Efficacy|1|||
23588024|NCT00530842|65882123|FG001|Period 1|Lack of Efficacy|1|||
23588025|NCT00530842|65882122|FG000|Period 1|Protocol Violation|2|||
23795698|NCT03507686|66629985|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
23472197|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
23588026|NCT00530842|65882123|FG001|Period 1|Protocol Violation|1|||
23588027|NCT00530842|65882122|FG000|Period 1|Withdrawal by Subject|2|||
23588028|NCT00530842|65882123|FG001|Period 1|Withdrawal by Subject|3|||
23588029|NCT00530842|65882122|FG000|Period 1|Individual different reasons|2|||
23588030|NCT00530842|65882123|FG001|Period 1|Individual different reasons|3|||
23588031|NCT00530842|65882122|FG000|Period 2|Adverse Event|3|||
23588032|NCT00530842|65882123|FG001|Period 2|Adverse Event|3|||
23588033|NCT00530842|65882122|FG000|Period 2|Lack of Efficacy|1|||
23588034|NCT00530842|65882123|FG001|Period 2|Lack of Efficacy|0|||
23588035|NCT00530842|65882122|FG000|Period 2|Lost to Follow-up|0|||
23588036|NCT00530842|65882123|FG001|Period 2|Lost to Follow-up|4|||
23588037|NCT00530842|65882122|FG000|Period 2|Protocol Violation|1|||
23588038|NCT00530842|65882123|FG001|Period 2|Protocol Violation|0|||
23588039|NCT00530842|65882122|FG000|Period 2|Withdrawal by Subject|1|||
23588040|NCT00530842|65882123|FG001|Period 2|Withdrawal by Subject|2|||
23588041|NCT00530842|65882122|FG000|Period 2|Individual different reasons|2|||
23588042|NCT00530842|65882123|FG001|Period 2|Individual different reasons|0|||
23588043|NCT04588480|65882126|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
23588044|NCT04588480|65882127|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
23588045|NCT04588480|65882128|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
23588046|NCT04588480|65882126|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
23588047|NCT04588480|65882127|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
23588048|NCT04588480|65882128|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
23588049|NCT00597519|65882129|FG000|Overall Study|Death|1|||
23588050|NCT00678795|65882130|FG000|Overall Study|Adverse Event|7|||
23588051|NCT00678795|65882131|FG001|Overall Study|Adverse Event|3|||
23588052|NCT00678795|65882130|FG000|Overall Study|Withdrawal by Subject|3|||
23588053|NCT00678795|65882131|FG001|Overall Study|Withdrawal by Subject|0|||
23588054|NCT00678795|65882130|FG000|Overall Study|Protocol Violation|0|||
23588055|NCT00678795|65882131|FG001|Overall Study|Protocol Violation|1|||
23588056|NCT00678795|65882130|FG000|Overall Study|Lost to Follow-up|0|||
23588057|NCT00678795|65882131|FG001|Overall Study|Lost to Follow-up|1|||
23588058|NCT00678795|65882130|FG000|Overall Study|Lack of Efficacy|1|||
23588059|NCT00678795|65882131|FG001|Overall Study|Lack of Efficacy|1|||
23588060|NCT03823911|65882133|FG000|Overall Study|Lost to Follow-up|1|||
23588061|NCT03823911|65882134|FG001|Overall Study|Lost to Follow-up|5|||
23588062|NCT03823911|65882135|FG002|Overall Study|Lost to Follow-up|2|||
23588063|NCT03823911|65882133|FG000|Overall Study|Did not meet eligibility criteria|13|||
23588064|NCT03823911|65882134|FG001|Overall Study|Did not meet eligibility criteria|7|||
23588065|NCT03823911|65882135|FG002|Overall Study|Did not meet eligibility criteria|4|||
23588066|NCT03823911|65882133|FG000|Overall Study|Death|0|||
23588067|NCT03823911|65882134|FG001|Overall Study|Death|1|||
23588068|NCT03823911|65882135|FG002|Overall Study|Death|0|||
23588069|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588070|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588071|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588072|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
23588073|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
23588074|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
23588075|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
23588076|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
23588077|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
23588078|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588079|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588080|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588081|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
23588082|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
23588083|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
23588084|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
23588085|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588086|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588087|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588088|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
23588089|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
23588090|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
23588091|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
23588092|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
23588093|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
23588094|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
23588095|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
23588096|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
23588097|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588098|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
23588099|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588100|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588101|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
23588102|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23641346|NCT01153321|66071626|FG001|Overall Study|Withdrawal by Subject|1|||
23588103|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23588104|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23641347|NCT01153321|66071625|FG000|Overall Study|Adverse Event|1|||
23641348|NCT01153321|66071626|FG001|Overall Study|Adverse Event|1|||
23354822|NCT00303472|65041544|FG006|Treatment Period|Other|1|||
23354823|NCT00303472|65041538|FG000|Treatment Period|Disease Progression (to AML)|0|||
23354824|NCT00303472|65041539|FG001|Treatment Period|Disease Progression (to AML)|0|||
23588105|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
23588106|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
23588107|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
23588108|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
23588109|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
23588110|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
23588111|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
23588112|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
23588113|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
23588114|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
23641349|NCT02665338|66071627|FG000|Overall Study|Withdrawal by Subject|0|||
23641350|NCT02665338|66071628|FG001|Overall Study|Withdrawal by Subject|1|||
23641351|NCT01050790|66071629|FG000|Overall Study|Adverse Event|1|||
23641352|NCT03053518|66071632|FG000|Overall Study|Withdrawal by Subject|3|||
23641353|NCT03053518|66071632|FG000|Overall Study|Lost to Follow-up|2|||
23641354|NCT03053518|66071632|FG000|Overall Study|Ineligible|5|||
23641355|NCT01699503|66071633|FG000|Overall Study|Death|31|||
23354825|NCT00303472|65041540|FG002|Treatment Period|Disease Progression (to AML)|0|||
23354826|NCT00303472|65041541|FG003|Treatment Period|Disease Progression (to AML)|0|||
23354827|NCT00303472|65041542|FG004|Treatment Period|Disease Progression (to AML)|1|||
23354828|NCT00303472|65041543|FG005|Treatment Period|Disease Progression (to AML)|0|||
23354829|NCT00303472|65041544|FG006|Treatment Period|Disease Progression (to AML)|0|||
23354830|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Adverse Event|1|||
23354831|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Adverse Event|0|||
23354832|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Adverse Event|1|||
23354833|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Adverse Event|0|||
23354834|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Adverse Event|0|||
23354835|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Adverse Event|0|||
23354836|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Adverse Event|0|||
23354837|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Death|2|||
23354838|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Death|0|||
23354839|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Death|1|||
23354840|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Death|0|||
23354841|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Death|0|||
23354842|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Death|0|||
23354843|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Death|0|||
23354844|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354845|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354846|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354847|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
23354848|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354849|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
23641356|NCT01699503|66071634|FG001|Overall Study|Death|40|||
23641357|NCT01699503|66071633|FG000|Overall Study|Withdrawal by Subject|65|||
23641358|NCT01699503|66071634|FG001|Overall Study|Withdrawal by Subject|57|||
23641359|NCT01699503|66071633|FG000|Overall Study|Lost to Follow-up|121|||
23795699|NCT03507686|66629984|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
23795700|NCT03507686|66629985|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
23795701|NCT02259348|66629989|FG000|Overall Study|Donors|6|||
23795702|NCT02259348|66629989|FG000|Overall Study|Death|4|||
23795703|NCT00183196|66629993|FG000|Overall Study|Withdrawal by Subject|18|||
23795704|NCT00183196|66629994|FG001|Overall Study|Withdrawal by Subject|11|||
23795705|NCT00183196|66629995|FG002|Overall Study|Withdrawal by Subject|13|||
23795706|NCT00183196|66629993|FG000|Overall Study|Adverse Event|1|||
23795707|NCT00183196|66629994|FG001|Overall Study|Adverse Event|2|||
23795708|NCT00183196|66629995|FG002|Overall Study|Adverse Event|2|||
23354850|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354851|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Physician Decision|0|||
23641360|NCT01699503|66071634|FG001|Overall Study|Lost to Follow-up|117|||
23795709|NCT00183196|66629993|FG000|Overall Study|Legal event|1|||
23795710|NCT00183196|66629994|FG001|Overall Study|Legal event|1|||
23795711|NCT00183196|66629995|FG002|Overall Study|Legal event|1|||
23354852|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Physician Decision|4|||
23354853|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Physician Decision|2|||
23354854|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Physician Decision|3|||
23354855|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Physician Decision|2|||
23354856|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Physician Decision|0|||
23354857|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Physician Decision|0|||
23354858|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354859|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354860|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354861|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
23354862|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354863|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354864|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354865|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Other|0|||
23354866|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Other|2|||
23354867|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Other|4|||
23354868|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Other|2|||
23354869|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Other|1|||
23354870|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Other|0|||
23354871|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Other|0|||
23472198|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472199|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472200|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
23472201|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
23472202|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472203|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472204|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472205|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472206|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472207|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
23472208|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472209|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472210|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
23472211|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
23472212|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
23472213|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472214|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472215|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
23588115|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
23588116|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
23588117|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
23588118|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23795712|NCT00183196|66629993|FG000|Overall Study|Required more intensive care|0|||
23795713|NCT00183196|66629994|FG001|Overall Study|Required more intensive care|1|||
23472216|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472217|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
23354872|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
23354873|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354874|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354875|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354876|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354877|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
23795714|NCT00183196|66629995|FG002|Overall Study|Required more intensive care|2|||
23795715|NCT04640194|66629996|FG000|Overall Study|Adverse Event|3|||
23795716|NCT04640194|66629997|FG001|Overall Study|Adverse Event|7|||
23795717|NCT04640194|66629998|FG002|Overall Study|Adverse Event|0|||
23795718|NCT04640194|66629999|FG003|Overall Study|Adverse Event|5|||
23795719|NCT04640194|66630000|FG004|Overall Study|Adverse Event|0|||
23795720|NCT04640194|66630001|FG005|Overall Study|Adverse Event|4|||
23795721|NCT04640194|66630002|FG006|Overall Study|Adverse Event|0|||
23795722|NCT04640194|66629996|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
23795723|NCT04640194|66629997|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
23795724|NCT04640194|66629998|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
23472218|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
23472219|NCT00854113|65473890|FG000|Overall Study|Adverse Event|0|||
23472220|NCT00854113|65473891|FG001|Overall Study|Adverse Event|0|||
23472221|NCT00854113|65473892|FG002|Overall Study|Adverse Event|0|||
23472222|NCT00854113|65473893|FG003|Overall Study|Adverse Event|0|||
23472223|NCT00854113|65473894|FG004|Overall Study|Adverse Event|0|||
23472224|NCT00854113|65473895|FG005|Overall Study|Adverse Event|0|||
23472225|NCT00854113|65473896|FG006|Overall Study|Adverse Event|0|||
23472226|NCT00854113|65473897|FG007|Overall Study|Adverse Event|2|||
23472227|NCT00854113|65473898|FG008|Overall Study|Adverse Event|0|||
23472228|NCT00854113|65473899|FG009|Overall Study|Adverse Event|0|||
23472229|NCT00854113|65473900|FG010|Overall Study|Adverse Event|0|||
23588119|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23588120|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23588121|NCT03265210|65882140|FG000|Overall Study|Withdrawal by Subject|7|||
23588122|NCT03265210|65882141|FG001|Overall Study|Withdrawal by Subject|9|||
23588123|NCT03265210|65882140|FG000|Overall Study|Lost to Follow-up|2|||
23588124|NCT03265210|65882141|FG001|Overall Study|Lost to Follow-up|0|||
23588125|NCT03265210|65882140|FG000|Overall Study|Physician Decision|2|||
23588126|NCT03265210|65882141|FG001|Overall Study|Physician Decision|0|||
23588127|NCT03265210|65882140|FG000|Overall Study|Adverse Event|1|||
23588128|NCT03265210|65882141|FG001|Overall Study|Adverse Event|0|||
23588129|NCT03068468|65882142|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
23588130|NCT03068468|65882143|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
23588131|NCT03068468|65882144|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
23588132|NCT03068468|65882145|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
23588133|NCT03068468|65882142|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
23588134|NCT03068468|65882143|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
23795725|NCT04640194|66629999|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
23795726|NCT04640194|66630000|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
23472230|NCT00854113|65473890|FG000|Overall Study|Withdrawal by Subject|0|||
23588135|NCT03068468|65882144|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
23588136|NCT03068468|65882145|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
23795727|NCT04640194|66630001|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
23795728|NCT04640194|66630002|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
23795729|NCT04640194|66629996|FG000|Overall Study|fibrinogen level too low|0|||
23795730|NCT04640194|66629997|FG001|Overall Study|fibrinogen level too low|0|||
23795731|NCT04640194|66629998|FG002|Overall Study|fibrinogen level too low|0|||
23795732|NCT04640194|66629999|FG003|Overall Study|fibrinogen level too low|1|||
23795733|NCT04640194|66630000|FG004|Overall Study|fibrinogen level too low|0|||
23795734|NCT04640194|66630001|FG005|Overall Study|fibrinogen level too low|0|||
23795735|NCT04640194|66630002|FG006|Overall Study|fibrinogen level too low|0|||
23795736|NCT04640194|66629996|FG000|Overall Study|mild bleeding|0|||
23795737|NCT04640194|66629997|FG001|Overall Study|mild bleeding|0|||
23795738|NCT04640194|66629998|FG002|Overall Study|mild bleeding|0|||
23795739|NCT04640194|66629999|FG003|Overall Study|mild bleeding|1|||
23795740|NCT04640194|66630000|FG004|Overall Study|mild bleeding|0|||
23795741|NCT04640194|66630001|FG005|Overall Study|mild bleeding|0|||
23795742|NCT04640194|66630002|FG006|Overall Study|mild bleeding|0|||
23795743|NCT04640194|66629996|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23795744|NCT04640194|66629997|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
23795745|NCT04640194|66629998|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23795746|NCT04640194|66629999|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23641361|NCT01699503|66071633|FG000|Overall Study|Excluded due to quality|783|||
23641362|NCT01699503|66071634|FG001|Overall Study|Excluded due to quality|791|||
23354878|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354879|NCT00551525|65041545|FG000|Overall Study|Protocol Violation|5|||
23354880|NCT01162122|65041547|FG000|Overall Study|Withdrawal by Subject|52|||
23354881|NCT01162122|65041548|FG001|Overall Study|Withdrawal by Subject|43|||
23354882|NCT01162122|65041547|FG000|Overall Study|Lost to Follow-up|73|||
23354883|NCT01162122|65041548|FG001|Overall Study|Lost to Follow-up|91|||
23354884|NCT01162122|65041547|FG000|Overall Study|Adverse Event|3|||
23354885|NCT01162122|65041548|FG001|Overall Study|Adverse Event|2|||
23354886|NCT01162122|65041547|FG000|Overall Study|Death|51|||
23354887|NCT01162122|65041548|FG001|Overall Study|Death|46|||
23354888|NCT01162122|65041547|FG000|Overall Study|Protocol Violation|2|||
23354889|NCT01162122|65041548|FG001|Overall Study|Protocol Violation|2|||
23354890|NCT01162122|65041547|FG000|Overall Study|Inappropriate enrollment|5|||
23354891|NCT01162122|65041548|FG001|Overall Study|Inappropriate enrollment|4|||
23354892|NCT01162122|65041547|FG000|Overall Study|Administrative reason|1|||
23641363|NCT01470001|66071638|FG000|Overall Study|Lost to Follow-up|1|||
23641364|NCT01470001|66071639|FG001|Overall Study|Lost to Follow-up|1|||
23354893|NCT01162122|65041548|FG001|Overall Study|Administrative reason|1|||
23354894|NCT01162122|65041547|FG000|Overall Study|Unable to classify|3|||
23354895|NCT01162122|65041548|FG001|Overall Study|Unable to classify|7|||
23354896|NCT01162122|65041547|FG000|Overall Study|Missing primary reason|1|||
23354897|NCT01162122|65041548|FG001|Overall Study|Missing primary reason|0|||
23354898|NCT03000530|65041549|FG000|Overall Study|Adverse Event|0|||
23354899|NCT03000530|65041550|FG001|Overall Study|Adverse Event|0|||
23354900|NCT03000530|65041551|FG002|Overall Study|Adverse Event|2|||
23354901|NCT03000530|65041549|FG000|Overall Study|Lost to Follow-up|0|||
23354902|NCT03000530|65041550|FG001|Overall Study|Lost to Follow-up|3|||
23354903|NCT03000530|65041551|FG002|Overall Study|Lost to Follow-up|1|||
23354904|NCT03000530|65041549|FG000|Overall Study|Withdrawal by Subject|0|||
23354905|NCT03000530|65041550|FG001|Overall Study|Withdrawal by Subject|2|||
23354906|NCT03000530|65041551|FG002|Overall Study|Withdrawal by Subject|1|||
23354907|NCT03084315|65041552|FG000|Overall Study|Lost to Follow-up|8|||
23354908|NCT03084315|65041553|FG001|Overall Study|Lost to Follow-up|7|||
23588137|NCT03068468|65882142|FG000|Placebo-Controlled Period|Adverse Event|16|||
23588138|NCT03068468|65882143|FG001|Placebo-Controlled Period|Adverse Event|21|||
23354909|NCT03084315|65041552|FG000|Overall Study|Withdrawal by Subject|2|||
23354910|NCT03084315|65041553|FG001|Overall Study|Withdrawal by Subject|2|||
23354911|NCT01026818|65041554|FG000|Screening Period|Entry Criteria Not Met|105|||
23354912|NCT01026818|65041555|FG001|Screening Period|Entry Criteria Not Met|0|||
23795747|NCT04640194|66630000|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23795748|NCT04640194|66630001|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23354913|NCT01026818|65041556|FG002|Screening Period|Entry Criteria Not Met|0|||
23354914|NCT01026818|65041557|FG003|Screening Period|Entry Criteria Not Met|0|||
23354915|NCT01026818|65041554|FG000|Screening Period|Withdrawal by Subject|49|||
23641365|NCT01470001|66071638|FG000|Overall Study|Physician Decision|2|||
23354916|NCT01026818|65041555|FG001|Screening Period|Withdrawal by Subject|0|||
23354917|NCT01026818|65041556|FG002|Screening Period|Withdrawal by Subject|0|||
23354918|NCT01026818|65041557|FG003|Screening Period|Withdrawal by Subject|0|||
23354919|NCT01026818|65041554|FG000|Screening Period|Protocol Deviation|3|||
23354920|NCT01026818|65041555|FG001|Screening Period|Protocol Deviation|0|||
23354921|NCT01026818|65041556|FG002|Screening Period|Protocol Deviation|0|||
23354922|NCT01026818|65041557|FG003|Screening Period|Protocol Deviation|0|||
23354923|NCT01026818|65041554|FG000|Screening Period|Adverse Event|2|||
23354924|NCT01026818|65041555|FG001|Screening Period|Adverse Event|0|||
23354925|NCT01026818|65041556|FG002|Screening Period|Adverse Event|0|||
23354926|NCT01026818|65041557|FG003|Screening Period|Adverse Event|0|||
23354927|NCT01026818|65041554|FG000|Screening Period|Physician Decision|1|||
23354928|NCT01026818|65041555|FG001|Screening Period|Physician Decision|0|||
23354929|NCT01026818|65041556|FG002|Screening Period|Physician Decision|0|||
23354930|NCT01026818|65041557|FG003|Screening Period|Physician Decision|0|||
23354931|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
23354932|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
23354933|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
23354934|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
23354935|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
23354936|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
23354937|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
23354938|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
23354939|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
23354940|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
23354941|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
23354942|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
23354943|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
23354944|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
23354945|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
23354946|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
23354947|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
23354948|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
23354949|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
23354950|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
23354951|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
23354952|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
23354953|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
23354954|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
23354955|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
23354956|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
23354957|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
23354958|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
23354959|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
23354960|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
23354961|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
23354962|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
23354963|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354964|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
23354965|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354966|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354967|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
23354968|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
23641366|NCT01470001|66071639|FG001|Overall Study|Physician Decision|0|||
23641367|NCT01470001|66071638|FG000|Overall Study|Withdrawal by Subject|2|||
23354969|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
23354970|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
23354971|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
23641368|NCT01470001|66071639|FG001|Overall Study|Withdrawal by Subject|1|||
23641369|NCT04797650|66071640|FG000|Overall Study|Reason Not Specified|5|||
23472231|NCT00854113|65473891|FG001|Overall Study|Withdrawal by Subject|0|||
23472232|NCT00854113|65473892|FG002|Overall Study|Withdrawal by Subject|0|||
23472233|NCT00854113|65473893|FG003|Overall Study|Withdrawal by Subject|0|||
23472234|NCT00854113|65473894|FG004|Overall Study|Withdrawal by Subject|0|||
23472235|NCT00854113|65473895|FG005|Overall Study|Withdrawal by Subject|0|||
23795749|NCT04640194|66630002|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23795750|NCT04501094|66630014|FG000|Overall Study|Death (unrelated to research)|1|||
23472236|NCT00854113|65473896|FG006|Overall Study|Withdrawal by Subject|0|||
23472237|NCT00854113|65473897|FG007|Overall Study|Withdrawal by Subject|1|||
23795751|NCT04501094|66630015|FG001|Overall Study|Death (unrelated to research)|0|||
23795752|NCT04590781|66630016|FG000|Overall Study|Death|0|||
23795753|NCT04590781|66630017|FG001|Overall Study|Death|2|||
23795754|NCT04590781|66630016|FG000|Overall Study|Withdrawal by Subject|2|||
23795755|NCT04590781|66630017|FG001|Overall Study|Withdrawal by Subject|0|||
23795756|NCT05135273|66630018|FG000|Overall Study|Recruited into the army|0|||
23795757|NCT05135273|66630019|FG001|Overall Study|Recruited into the army|0|||
23795758|NCT05135273|66630020|FG002|Overall Study|Recruited into the army|0|||
23795759|NCT05135273|66630021|FG003|Overall Study|Recruited into the army|0|||
23795760|NCT05135273|66630022|FG004|Overall Study|Recruited into the army|1|||
23795761|NCT05135273|66630023|FG005|Overall Study|Recruited into the army|0|||
23472238|NCT00854113|65473898|FG008|Overall Study|Withdrawal by Subject|1|||
23472239|NCT00854113|65473899|FG009|Overall Study|Withdrawal by Subject|0|||
23472240|NCT00854113|65473900|FG010|Overall Study|Withdrawal by Subject|0|||
23472241|NCT01209325|65473901|FG000|Overall Study|Lost to Follow-up|24|||
23472242|NCT01209325|65473901|FG000|Overall Study|Adverse Event|1|||
23472243|NCT01209325|65473901|FG000|Overall Study|Relocated|3|||
23472244|NCT01209325|65473901|FG000|Overall Study|Refusal after starting therapy|8|||
23472245|NCT01209325|65473901|FG000|Overall Study|Protocol Violation|4|||
23472246|NCT01209325|65473901|FG000|Overall Study|Refusal prior to therapy|1|||
23472247|NCT01209325|65473901|FG000|Overall Study|Incarceration|2|||
23472248|NCT00029146|65473902|FG000|Overall Study|Lost to Follow-up|2|||
23472249|NCT00029146|65473903|FG001|Overall Study|Lost to Follow-up|1|||
23472250|NCT04335136|65473911|FG000|Overall Study|Death|8|||
23472251|NCT04335136|65473912|FG001|Overall Study|Death|4|||
23472252|NCT04335136|65473911|FG000|Overall Study|Lost to Follow-up|2|||
23472253|NCT04335136|65473912|FG001|Overall Study|Lost to Follow-up|0|||
23472254|NCT04335136|65473911|FG000|Overall Study|Protocol Violation|1|||
23472255|NCT04335136|65473912|FG001|Overall Study|Protocol Violation|0|||
23472256|NCT04335136|65473911|FG000|Overall Study|Withdrawal by Subject|1|||
23472257|NCT04335136|65473912|FG001|Overall Study|Withdrawal by Subject|1|||
23472258|NCT04335136|65473911|FG000|Overall Study|Health-threatening condition|0|||
23472259|NCT04335136|65473912|FG001|Overall Study|Health-threatening condition|1|||
23472260|NCT04335136|65473911|FG000|Overall Study|Adverse Event|0|||
23472261|NCT04335136|65473912|FG001|Overall Study|Adverse Event|1|||
23472262|NCT04335136|65473911|FG000|Overall Study|Erroneously randomized|2|||
23472263|NCT04335136|65473912|FG001|Overall Study|Erroneously randomized|0|||
23472264|NCT00942994|65473914|FG000|Overall Study|Adverse Event|7|||
23472265|NCT00942994|65473915|FG001|Overall Study|Adverse Event|4|||
23472266|NCT00942994|65473914|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23472267|NCT00942994|65473915|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23472268|NCT00942994|65473914|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23472269|NCT00942994|65473915|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23472270|NCT00942994|65473914|FG000|Overall Study|Patient withdrew consent|5|||
23472271|NCT00942994|65473915|FG001|Overall Study|Patient withdrew consent|8|||
23472272|NCT00942994|65473914|FG000|Overall Study|Lost to Follow-up|1|||
23472273|NCT00942994|65473915|FG001|Overall Study|Lost to Follow-up|4|||
23795762|NCT05135273|66630024|FG006|Overall Study|Recruited into the army|0|||
23795763|NCT05135273|66630025|FG007|Overall Study|Recruited into the army|0|||
23472274|NCT00942994|65473914|FG000|Overall Study|Protocol deviation|1|||
23795764|NCT05135273|66630018|FG000|Overall Study|Moved away from study site|0|||
23795765|NCT05135273|66630019|FG001|Overall Study|Moved away from study site|0|||
23354972|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
23354973|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
23354974|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
23354975|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354976|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
23354977|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354978|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354979|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
23354980|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
23354981|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
23354982|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
23354983|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354984|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354985|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354986|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
23354987|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354988|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
23354989|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354990|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354991|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354992|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
23354993|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354994|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354995|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
23354996|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
23354997|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
23354998|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
23354999|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
23355000|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
23355001|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
23355002|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
23355003|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
23355004|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
23355005|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
23355006|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
23355007|NCT00496587|65041558|FG000|Overall Study|Adverse Event|2|||
23355008|NCT00496587|65041558|FG000|Overall Study|Progressive Disease|24|||
23355009|NCT00496587|65041558|FG000|Overall Study|Withdrawal by Subject|2|||
23355010|NCT00496587|65041558|FG000|Overall Study|Death|1|||
23355011|NCT00496587|65041558|FG000|Overall Study|Complications unrelated|2|||
23355012|NCT03055494|65041559|FG000|Overall Study|Lost to Follow-up|6|||
23355013|NCT03055494|65041560|FG001|Overall Study|Lost to Follow-up|0|||
23355014|NCT03055494|65041559|FG000|Overall Study|Physician Decision|2|||
23355015|NCT03055494|65041560|FG001|Overall Study|Physician Decision|0|||
23355016|NCT03055494|65041559|FG000|Overall Study|Withdrawal by Subject|1|||
23355017|NCT03055494|65041560|FG001|Overall Study|Withdrawal by Subject|0|||
23355018|NCT03055494|65041559|FG000|Overall Study|Adverse Event|0|||
23355019|NCT03055494|65041560|FG001|Overall Study|Adverse Event|1|||
23355020|NCT03055494|65041559|FG000|Overall Study|Non-compliance with study treatment|1|||
23355021|NCT03055494|65041560|FG001|Overall Study|Non-compliance with study treatment|0|||
23355022|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
23355023|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
23355024|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
23355025|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
23355026|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
23355027|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
23355028|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
23355029|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
23355030|NCT04114656|65041561|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
23355031|NCT04114656|65041562|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
23355032|NCT01270321|65044810|FG000|Overall Study|Death|3|||
23355033|NCT01270321|65044811|FG001|Overall Study|Death|1|||
23355034|NCT01270321|65044812|FG002|Overall Study|Death|4|||
23355035|NCT01270321|65044810|FG000|Overall Study|Adverse Event|7|||
23355036|NCT01270321|65044811|FG001|Overall Study|Adverse Event|9|||
23355037|NCT01270321|65044812|FG002|Overall Study|Adverse Event|5|||
23355038|NCT04336475|65044814|FG000|Overall Study|pain|1|||
23355039|NCT04336475|65044815|FG001|Overall Study|pain|0|||
23355040|NCT04336475|65044814|FG000|Overall Study|upper respiratory infection|1|||
23641370|NCT04797650|66071641|FG001|Overall Study|Reason Not Specified|12|||
23355041|NCT04336475|65044815|FG001|Overall Study|upper respiratory infection|0|||
23355042|NCT04336475|65044814|FG000|Overall Study|Lost to Follow-up|0|||
23355043|NCT04336475|65044815|FG001|Overall Study|Lost to Follow-up|2|||
23355044|NCT01066793|65044818|FG000|Overall Study|Death|4|||
23355045|NCT01066793|65044819|FG001|Overall Study|Death|1|||
23355046|NCT01066793|65044820|FG002|Overall Study|Death|1|||
23355047|NCT01066793|65044821|FG003|Overall Study|Death|0|||
23355048|NCT01066793|65044822|FG004|Overall Study|Death|0|||
23355049|NCT01066793|65044823|FG005|Overall Study|Death|0|||
23355050|NCT01066793|65044818|FG000|Overall Study|Lack of Efficacy|2|||
23355051|NCT01066793|65044819|FG001|Overall Study|Lack of Efficacy|1|||
23355052|NCT01066793|65044820|FG002|Overall Study|Lack of Efficacy|0|||
23355053|NCT01066793|65044821|FG003|Overall Study|Lack of Efficacy|0|||
23355054|NCT01066793|65044822|FG004|Overall Study|Lack of Efficacy|0|||
23355055|NCT01066793|65044823|FG005|Overall Study|Lack of Efficacy|0|||
23355056|NCT01066793|65044818|FG000|Overall Study|Lost to Follow-up|180|||
23355057|NCT01066793|65044819|FG001|Overall Study|Lost to Follow-up|39|||
23355058|NCT01066793|65044820|FG002|Overall Study|Lost to Follow-up|82|||
23355059|NCT01066793|65044821|FG003|Overall Study|Lost to Follow-up|16|||
23355060|NCT01066793|65044822|FG004|Overall Study|Lost to Follow-up|0|||
23355061|NCT01066793|65044823|FG005|Overall Study|Lost to Follow-up|1|||
23355062|NCT01066793|65044818|FG000|Overall Study|Physician Decision|3|||
23355063|NCT01066793|65044819|FG001|Overall Study|Physician Decision|0|||
23355064|NCT01066793|65044820|FG002|Overall Study|Physician Decision|0|||
23355065|NCT01066793|65044821|FG003|Overall Study|Physician Decision|0|||
23355066|NCT01066793|65044822|FG004|Overall Study|Physician Decision|0|||
23355067|NCT01066793|65044823|FG005|Overall Study|Physician Decision|0|||
23355068|NCT01066793|65044818|FG000|Overall Study|Protocol Violation|3|||
23355069|NCT01066793|65044819|FG001|Overall Study|Protocol Violation|2|||
23355070|NCT01066793|65044820|FG002|Overall Study|Protocol Violation|2|||
23355071|NCT01066793|65044821|FG003|Overall Study|Protocol Violation|0|||
23355072|NCT01066793|65044822|FG004|Overall Study|Protocol Violation|0|||
23355073|NCT01066793|65044823|FG005|Overall Study|Protocol Violation|0|||
23355074|NCT01066793|65044818|FG000|Overall Study|Withdrawal by Subject|7|||
23355075|NCT01066793|65044819|FG001|Overall Study|Withdrawal by Subject|4|||
23355076|NCT01066793|65044820|FG002|Overall Study|Withdrawal by Subject|1|||
23355077|NCT01066793|65044821|FG003|Overall Study|Withdrawal by Subject|0|||
23355078|NCT01066793|65044822|FG004|Overall Study|Withdrawal by Subject|0|||
23355079|NCT01066793|65044823|FG005|Overall Study|Withdrawal by Subject|0|||
23355080|NCT01066793|65044818|FG000|Overall Study|Early Termination|3|||
23355081|NCT01066793|65044819|FG001|Overall Study|Early Termination|0|||
23355082|NCT01066793|65044820|FG002|Overall Study|Early Termination|0|||
23355083|NCT01066793|65044821|FG003|Overall Study|Early Termination|0|||
23355084|NCT01066793|65044822|FG004|Overall Study|Early Termination|0|||
23355085|NCT01066793|65044823|FG005|Overall Study|Early Termination|0|||
23355086|NCT01066793|65044818|FG000|Overall Study|Lab test not done|7|||
23355087|NCT01066793|65044819|FG001|Overall Study|Lab test not done|0|||
23355088|NCT01066793|65044820|FG002|Overall Study|Lab test not done|0|||
23355089|NCT01066793|65044821|FG003|Overall Study|Lab test not done|1|||
23355090|NCT01066793|65044822|FG004|Overall Study|Lab test not done|0|||
23355091|NCT01066793|65044823|FG005|Overall Study|Lab test not done|0|||
23355092|NCT01066793|65044818|FG000|Overall Study|Miscellaneous|4|||
23355093|NCT01066793|65044819|FG001|Overall Study|Miscellaneous|5|||
23355094|NCT01066793|65044820|FG002|Overall Study|Miscellaneous|6|||
23355095|NCT01066793|65044821|FG003|Overall Study|Miscellaneous|0|||
23355096|NCT01066793|65044822|FG004|Overall Study|Miscellaneous|0|||
23355097|NCT01066793|65044823|FG005|Overall Study|Miscellaneous|0|||
23355098|NCT01066793|65044818|FG000|Overall Study|Non-responders|104|||
23355099|NCT01066793|65044819|FG001|Overall Study|Non-responders|5|||
23641371|NCT04797650|66071642|FG002|Overall Study|Reason Not Specified|5|||
23641372|NCT04797650|66071640|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
23795766|NCT05135273|66630020|FG002|Overall Study|Moved away from study site|0|||
23355100|NCT01066793|65044820|FG002|Overall Study|Non-responders|11|||
23355101|NCT01066793|65044821|FG003|Overall Study|Non-responders|25|||
23355102|NCT01066793|65044822|FG004|Overall Study|Non-responders|0|||
23355103|NCT01066793|65044823|FG005|Overall Study|Non-responders|0|||
23355104|NCT01066793|65044818|FG000|Overall Study|Other|15|||
23355105|NCT01066793|65044819|FG001|Overall Study|Other|5|||
23355106|NCT01066793|65044820|FG002|Overall Study|Other|6|||
23355107|NCT01066793|65044821|FG003|Overall Study|Other|2|||
23355108|NCT01066793|65044822|FG004|Overall Study|Other|0|||
23355109|NCT01066793|65044823|FG005|Overall Study|Other|0|||
23355110|NCT01066793|65044818|FG000|Overall Study|Relapse|20|||
23355111|NCT01066793|65044819|FG001|Overall Study|Relapse|8|||
23355112|NCT01066793|65044820|FG002|Overall Study|Relapse|2|||
23355113|NCT01066793|65044821|FG003|Overall Study|Relapse|3|||
23355114|NCT01066793|65044822|FG004|Overall Study|Relapse|0|||
23355115|NCT01066793|65044823|FG005|Overall Study|Relapse|0|||
23355116|NCT01066793|65044818|FG000|Overall Study|Result Not Available|1|||
23355117|NCT01066793|65044819|FG001|Overall Study|Result Not Available|0|||
23588139|NCT03068468|65882144|FG002|Placebo-Controlled Period|Adverse Event|0|||
23588140|NCT03068468|65882145|FG003|Placebo-Controlled Period|Adverse Event|0|||
23355118|NCT01066793|65044820|FG002|Overall Study|Result Not Available|0|||
23355119|NCT01066793|65044821|FG003|Overall Study|Result Not Available|0|||
23355120|NCT01066793|65044822|FG004|Overall Study|Result Not Available|0|||
23355121|NCT01066793|65044823|FG005|Overall Study|Result Not Available|0|||
23355122|NCT01066793|65044818|FG000|Overall Study|Treatment Interrupted|1|||
23355123|NCT01066793|65044819|FG001|Overall Study|Treatment Interrupted|1|||
23355124|NCT01066793|65044820|FG002|Overall Study|Treatment Interrupted|0|||
23355125|NCT01066793|65044821|FG003|Overall Study|Treatment Interrupted|0|||
23355126|NCT01066793|65044822|FG004|Overall Study|Treatment Interrupted|0|||
23355127|NCT01066793|65044823|FG005|Overall Study|Treatment Interrupted|0|||
23355128|NCT01066793|65044818|FG000|Overall Study|Treatment Never Started|18|||
23355129|NCT01066793|65044819|FG001|Overall Study|Treatment Never Started|5|||
23355130|NCT01066793|65044820|FG002|Overall Study|Treatment Never Started|4|||
23355131|NCT01066793|65044821|FG003|Overall Study|Treatment Never Started|1|||
23355132|NCT01066793|65044822|FG004|Overall Study|Treatment Never Started|0|||
23355133|NCT01066793|65044823|FG005|Overall Study|Treatment Never Started|0|||
23355134|NCT01066793|65044818|FG000|Overall Study|Treatment Stopped|2|||
23355135|NCT01066793|65044819|FG001|Overall Study|Treatment Stopped|1|||
23355136|NCT01066793|65044820|FG002|Overall Study|Treatment Stopped|0|||
23355137|NCT01066793|65044821|FG003|Overall Study|Treatment Stopped|1|||
23355138|NCT01066793|65044822|FG004|Overall Study|Treatment Stopped|0|||
23355139|NCT01066793|65044823|FG005|Overall Study|Treatment Stopped|0|||
23355140|NCT03762681|65044824|FG000|Part 1|Withdrawal by Subject|0|||
23355141|NCT03762681|65044825|FG001|Part 1|Withdrawal by Subject|0|||
23355142|NCT03762681|65044826|FG002|Part 1|Withdrawal by Subject|0|||
23355143|NCT03762681|65044827|FG003|Part 1|Withdrawal by Subject|1|||
23355144|NCT03762681|65044828|FG004|Part 1|Withdrawal by Subject|0|||
23355145|NCT03762681|65044829|FG005|Part 1|Withdrawal by Subject|0|||
23355146|NCT03762681|65044830|FG006|Part 1|Withdrawal by Subject|0|||
23355147|NCT03762681|65044831|FG007|Part 1|Withdrawal by Subject|0|||
23355148|NCT03762681|65044824|FG000|Part 2a|Pandemic Travel Restrictions|0|||
23355149|NCT03762681|65044825|FG001|Part 2a|Pandemic Travel Restrictions|0|||
23355150|NCT03762681|65044826|FG002|Part 2a|Pandemic Travel Restrictions|0|||
23355151|NCT03762681|65044827|FG003|Part 2a|Pandemic Travel Restrictions|0|||
23355152|NCT03762681|65044828|FG004|Part 2a|Pandemic Travel Restrictions|0|||
23355153|NCT03762681|65044829|FG005|Part 2a|Pandemic Travel Restrictions|0|||
23355154|NCT03762681|65044830|FG006|Part 2a|Pandemic Travel Restrictions|0|||
23355155|NCT03762681|65044831|FG007|Part 2a|Pandemic Travel Restrictions|1|||
23355156|NCT01908582|65044833|FG000|Period 2|Physician Decision|1|||
23355157|NCT01908582|65044833|FG000|Period 2|Withdrawal by Subject|1|||
23355158|NCT02769312|65044834|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
23355159|NCT02769312|65044835|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
23355160|NCT02769312|65044834|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
23355161|NCT02769312|65044835|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
23355162|NCT02769312|65044834|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
23355163|NCT02769312|65044835|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
23355164|NCT02769312|65044834|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
23355165|NCT02769312|65044835|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
23355166|NCT02769312|65044834|FG000|Follow-up|Lost to Follow-up|1|||
23355167|NCT02769312|65044835|FG001|Follow-up|Lost to Follow-up|1|||
23355168|NCT01905592|65044836|FG000|Overall Study|Disease Progression|51|||
23355169|NCT01905592|65044837|FG001|Overall Study|Disease Progression|110|||
23355170|NCT01905592|65044836|FG000|Overall Study|Toxicity|1|||
23355171|NCT01905592|65044837|FG001|Overall Study|Toxicity|16|||
23355172|NCT01905592|65044836|FG000|Overall Study|Physician Decision|0|||
23588141|NCT03068468|65882142|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
23795767|NCT05135273|66630021|FG003|Overall Study|Moved away from study site|0|||
23795768|NCT05135273|66630022|FG004|Overall Study|Moved away from study site|0|||
23795769|NCT05135273|66630023|FG005|Overall Study|Moved away from study site|1|||
23795770|NCT05135273|66630024|FG006|Overall Study|Moved away from study site|1|||
23355173|NCT01905592|65044837|FG001|Overall Study|Physician Decision|2|||
23355174|NCT01905592|65044836|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
23355175|NCT01905592|65044837|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
23355176|NCT01905592|65044836|FG000|Overall Study|Protocol Violation|0|||
23355177|NCT01905592|65044837|FG001|Overall Study|Protocol Violation|1|||
23795771|NCT05135273|66630025|FG007|Overall Study|Moved away from study site|0|||
23795772|NCT05135273|66630018|FG000|Overall Study|Travel|0|||
23795773|NCT05135273|66630019|FG001|Overall Study|Travel|0|||
23795774|NCT05135273|66630020|FG002|Overall Study|Travel|0|||
23355178|NCT01905592|65044836|FG000|Overall Study|Sponsor's decision|1|||
23355179|NCT01905592|65044837|FG001|Overall Study|Sponsor's decision|1|||
23355180|NCT01905592|65044836|FG000|Overall Study|Not treated|7|||
23355181|NCT01905592|65044837|FG001|Overall Study|Not treated|3|||
23588142|NCT03068468|65882143|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
23588143|NCT03068468|65882144|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
23588144|NCT03068468|65882145|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
23588145|NCT03068468|65882142|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23588146|NCT03068468|65882143|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
23588147|NCT03068468|65882144|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23588148|NCT03068468|65882145|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23588149|NCT03068468|65882142|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
23641373|NCT04797650|66071641|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
23641374|NCT04797650|66071642|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
23641375|NCT04797650|66071640|FG000|Overall Study|Lack of Efficacy|1|||
23641376|NCT04797650|66071641|FG001|Overall Study|Lack of Efficacy|0|||
23641377|NCT04797650|66071642|FG002|Overall Study|Lack of Efficacy|1|||
23641378|NCT04797650|66071640|FG000|Overall Study|Non-compliance with Study Drug|0|||
23641379|NCT04797650|66071641|FG001|Overall Study|Non-compliance with Study Drug|0|||
23641380|NCT04797650|66071642|FG002|Overall Study|Non-compliance with Study Drug|2|||
23641381|NCT04797650|66071640|FG000|Overall Study|Lost to Follow-up|4|||
23641382|NCT04797650|66071641|FG001|Overall Study|Lost to Follow-up|6|||
23641383|NCT04797650|66071642|FG002|Overall Study|Lost to Follow-up|1|||
23641384|NCT03167359|66071643|FG000|Overall Study|Physician Decision|1|||
23641385|NCT03167359|66071643|FG000|Overall Study|Lost to Follow-up|1|||
23355182|NCT01905592|65044836|FG000|Overall Study|Withdrawal by Subject|10|||
23355183|NCT01905592|65044837|FG001|Overall Study|Withdrawal by Subject|2|||
23355184|NCT00549601|65044838|FG000|Randomized|Protocol Violation|0|||
23355185|NCT00549601|65044839|FG001|Randomized|Protocol Violation|0|||
23355186|NCT00549601|65044840|FG002|Randomized|Protocol Violation|1|||
23355187|NCT00549601|65044838|FG000|Randomized|Withdrawal by Subject|0|||
23355188|NCT00549601|65044839|FG001|Randomized|Withdrawal by Subject|1|||
23355189|NCT00549601|65044840|FG002|Randomized|Withdrawal by Subject|1|||
23355190|NCT00549601|65044838|FG000|Received Study Drug|Adverse Event|2|||
23355191|NCT00549601|65044839|FG001|Received Study Drug|Adverse Event|5|||
23355192|NCT00549601|65044840|FG002|Received Study Drug|Adverse Event|1|||
23355193|NCT00549601|65044838|FG000|Received Study Drug|Death|0|||
23355194|NCT00549601|65044839|FG001|Received Study Drug|Death|1|||
23355195|NCT00549601|65044840|FG002|Received Study Drug|Death|0|||
23355196|NCT00549601|65044838|FG000|Received Study Drug|Lost to Follow-up|0|||
23355197|NCT00549601|65044839|FG001|Received Study Drug|Lost to Follow-up|1|||
23355198|NCT00549601|65044840|FG002|Received Study Drug|Lost to Follow-up|1|||
23355199|NCT00549601|65044838|FG000|Received Study Drug|Protocol Violation|3|||
23355200|NCT00549601|65044839|FG001|Received Study Drug|Protocol Violation|4|||
23355201|NCT00549601|65044840|FG002|Received Study Drug|Protocol Violation|1|||
23355202|NCT00549601|65044838|FG000|Received Study Drug|Withdrawal by Subject|2|||
23355203|NCT00549601|65044839|FG001|Received Study Drug|Withdrawal by Subject|0|||
23355204|NCT00549601|65044840|FG002|Received Study Drug|Withdrawal by Subject|1|||
23355205|NCT00419159|65044843|FG000|Overall Study|Adverse Event|7|||
23355206|NCT00419159|65044844|FG001|Overall Study|Adverse Event|15|||
23355207|NCT00419159|65044843|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23355208|NCT00419159|65044844|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23588150|NCT03068468|65882143|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
23588151|NCT03068468|65882144|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
23641386|NCT03020576|66071644|FG000|Overall Study|Withdrawal by Subject|1|||
23641387|NCT03020576|66071645|FG001|Overall Study|Withdrawal by Subject|2|||
23355209|NCT00419159|65044843|FG000|Overall Study|Subject's no longer requires study drug|0|||
23355210|NCT00419159|65044844|FG001|Overall Study|Subject's no longer requires study drug|1|||
23641388|NCT00836745|66071651|FG000|Overall Study|Death|2|||
23355211|NCT00419159|65044843|FG000|Overall Study|Protocol Violation|1|||
23641389|NCT00836745|66071651|FG000|Overall Study|Lost to Follow-up|10|||
23355212|NCT00419159|65044844|FG001|Overall Study|Protocol Violation|0|||
23641390|NCT00836745|66071651|FG000|Overall Study|Adverse Event|3|||
23472275|NCT00942994|65473915|FG001|Overall Study|Protocol deviation|2|||
23472276|NCT00422513|65473916|FG000|Overall Study|Lack of Efficacy|4|||
23472277|NCT00422513|65473917|FG001|Overall Study|Lack of Efficacy|5|||
23472278|NCT00422513|65473916|FG000|Overall Study|Protocol Violation|23|||
23472279|NCT00422513|65473917|FG001|Overall Study|Protocol Violation|7|||
23472280|NCT00422513|65473916|FG000|Overall Study|Refused Treatment|4|||
23472281|NCT00422513|65473917|FG001|Overall Study|Refused Treatment|2|||
23472282|NCT00422513|65473916|FG000|Overall Study|Withdrawal by Subject|2|||
23472283|NCT00422513|65473917|FG001|Overall Study|Withdrawal by Subject|1|||
23472284|NCT00422513|65473916|FG000|Overall Study|early termination of the study|67|||
23472285|NCT00422513|65473917|FG001|Overall Study|early termination of the study|80|||
23472286|NCT00422513|65473916|FG000|Overall Study|Adverse Event|4|||
23472287|NCT00422513|65473917|FG001|Overall Study|Adverse Event|4|||
23472288|NCT00422513|65473916|FG000|Overall Study|Death|3|||
23588152|NCT03068468|65882145|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
23588153|NCT03068468|65882142|FG000|Placebo-Controlled Period|Death|0|||
23588154|NCT03068468|65882143|FG001|Placebo-Controlled Period|Death|1|||
23588155|NCT03068468|65882144|FG002|Placebo-Controlled Period|Death|0|||
23588156|NCT03068468|65882145|FG003|Placebo-Controlled Period|Death|0|||
23588157|NCT03068468|65882142|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
23588158|NCT03068468|65882143|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23588159|NCT03068468|65882144|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
23588160|NCT03068468|65882145|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
23588161|NCT03068468|65882142|FG000|Open-Label Extension Period|Adverse Event|0|||
23588162|NCT03068468|65882143|FG001|Open-Label Extension Period|Adverse Event|0|||
23588163|NCT03068468|65882144|FG002|Open-Label Extension Period|Adverse Event|13|||
23588164|NCT03068468|65882145|FG003|Open-Label Extension Period|Adverse Event|17|||
23588165|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
23588166|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
23588167|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
23588168|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
23588169|NCT03068468|65882142|FG000|Open-Label Extension Period|Death|0|||
23588170|NCT03068468|65882143|FG001|Open-Label Extension Period|Death|0|||
23588171|NCT03068468|65882144|FG002|Open-Label Extension Period|Death|0|||
23588172|NCT03068468|65882145|FG003|Open-Label Extension Period|Death|1|||
23588173|NCT03068468|65882142|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
23588174|NCT03068468|65882143|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
23588175|NCT03068468|65882144|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
23641391|NCT00836745|66071651|FG000|Overall Study|Objective progression or relapse|4|||
23641392|NCT00836745|66071651|FG000|Overall Study|Other|2|||
23641393|NCT02495792|66071652|FG000|Overall Study|Lost to Follow-up|5|||
23641394|NCT02495792|66071653|FG001|Overall Study|Lost to Follow-up|9|||
23641395|NCT02495792|66071652|FG000|Overall Study|Protocol Violation|32|||
23641396|NCT02495792|66071653|FG001|Overall Study|Protocol Violation|31|||
23641397|NCT00297427|66071655|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
23641398|NCT00297427|66071656|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
23641399|NCT00297427|66071655|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
23641400|NCT00297427|66071656|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
23641401|NCT00297427|66071655|FG000|Phase 1: Initial Intervention|Death|0|||
23641402|NCT00297427|66071656|FG001|Phase 1: Initial Intervention|Death|1|||
23641403|NCT00297427|66071655|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
23641404|NCT00297427|66071656|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
23641405|NCT00297427|66071655|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
23641406|NCT00297427|66071656|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
23641407|NCT00297427|66071655|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
23641408|NCT00297427|66071656|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
23641409|NCT00297427|66071655|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
23472289|NCT00422513|65473917|FG001|Overall Study|Death|7|||
23472290|NCT03179605|65473927|FG000|Overall Study|Withdrawal by Subject|1|||
23588176|NCT03068468|65882145|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
23588177|NCT03068468|65882142|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23588178|NCT03068468|65882143|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23641410|NCT00297427|66071656|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
23705486|NCT03382899|66297516|FG000|Overall Study|Withdrawal by Subject|0|||
23795775|NCT05135273|66630021|FG003|Overall Study|Travel|0|||
23472291|NCT00104520|65473928|FG000|Overall Study|Unrelated adverse event|34|||
23472292|NCT00104520|65473929|FG001|Overall Study|Unrelated adverse event|47|||
23472293|NCT00104520|65473928|FG000|Overall Study|Study drug intolerance|0|||
23355213|NCT00419159|65044843|FG000|Overall Study|Withdrawal by Subject|10|||
23355214|NCT00419159|65044844|FG001|Overall Study|Withdrawal by Subject|3|||
23355215|NCT00419159|65044843|FG000|Overall Study|Lost to Follow-up|0|||
23355216|NCT00419159|65044844|FG001|Overall Study|Lost to Follow-up|1|||
23355217|NCT00419159|65044843|FG000|Overall Study|Death|2|||
23355218|NCT00419159|65044844|FG001|Overall Study|Death|2|||
23355219|NCT00419159|65044843|FG000|Overall Study|Disease progression|79|||
23641411|NCT00297427|66071655|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
23641412|NCT00297427|66071656|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
23641413|NCT00872989|66071657|FG000|Overall Study|Adverse Event|7|||
23641414|NCT00872989|66071658|FG001|Overall Study|Adverse Event|15|||
23641415|NCT00872989|66071657|FG000|Overall Study|Withdrawal by Subject|8|||
23641416|NCT00872989|66071658|FG001|Overall Study|Withdrawal by Subject|5|||
23355220|NCT00419159|65044844|FG001|Overall Study|Disease progression|76|||
23355221|NCT01709864|65044847|FG000|Overall Study|Physician Decision|0|||
23355222|NCT01709864|65044848|FG001|Overall Study|Physician Decision|1|||
23355223|NCT01709864|65044847|FG000|Overall Study|subject/guardian decision|5|||
23355224|NCT01709864|65044848|FG001|Overall Study|subject/guardian decision|6|||
23355225|NCT01709864|65044847|FG000|Overall Study|Lost to Follow-up|1|||
23355226|NCT01709864|65044848|FG001|Overall Study|Lost to Follow-up|0|||
23355227|NCT01709864|65044847|FG000|Overall Study|non-compliance with study treatment|1|||
23641417|NCT00872989|66071657|FG000|Overall Study|Progression/relapse|47|||
23641418|NCT00872989|66071658|FG001|Overall Study|Progression/relapse|35|||
23641419|NCT00872989|66071657|FG000|Overall Study|Not protocol specified|3|||
23641420|NCT00872989|66071658|FG001|Overall Study|Not protocol specified|8|||
23641421|NCT00688103|66071660|FG000|Overall Study|Adverse Event|4|||
23641422|NCT00688103|66071661|FG001|Overall Study|Adverse Event|1|||
23641423|NCT00688103|66071660|FG000|Overall Study|Lack of Efficacy|11|||
23641424|NCT00688103|66071661|FG001|Overall Study|Lack of Efficacy|1|||
23641425|NCT00688103|66071660|FG000|Overall Study|Withdrawal by Subject|4|||
23641426|NCT00688103|66071661|FG001|Overall Study|Withdrawal by Subject|2|||
23355228|NCT01709864|65044848|FG001|Overall Study|non-compliance with study treatment|1|||
23355229|NCT01709864|65044847|FG000|Overall Study|Adverse Event|0|||
23355230|NCT01709864|65044848|FG001|Overall Study|Adverse Event|2|||
23355231|NCT01709864|65044847|FG000|Overall Study|Death|0|||
23355232|NCT01709864|65044848|FG001|Overall Study|Death|1|||
23355233|NCT04575584|65044849|FG000|Overall Study|Death|6|||
23355234|NCT04575584|65044850|FG001|Overall Study|Death|4|||
23355235|NCT04575584|65044851|FG002|Overall Study|Death|6|||
23355236|NCT04575584|65044852|FG003|Overall Study|Death|2|||
23355237|NCT04575584|65044853|FG004|Overall Study|Death|0|||
23641427|NCT00688103|66071660|FG000|Overall Study|complex reasons|11|||
23641428|NCT00688103|66071661|FG001|Overall Study|complex reasons|9|||
23641429|NCT03330405|66071671|FG000|Overall Study|Other|1|||
23641430|NCT03330405|66071672|FG001|Overall Study|Other|3|||
23355238|NCT04575584|65044854|FG005|Overall Study|Death|0|||
23355239|NCT04575584|65044849|FG000|Overall Study|Lost to Follow-up|1|||
23641431|NCT03330405|66071673|FG002|Overall Study|Other|1|||
23641432|NCT03330405|66071674|FG003|Overall Study|Other|0|||
23355240|NCT04575584|65044850|FG001|Overall Study|Lost to Follow-up|1|||
23355241|NCT04575584|65044851|FG002|Overall Study|Lost to Follow-up|1|||
23355242|NCT04575584|65044852|FG003|Overall Study|Lost to Follow-up|1|||
23641433|NCT03330405|66071675|FG004|Overall Study|Other|2|||
23355243|NCT04575584|65044853|FG004|Overall Study|Lost to Follow-up|0|||
23355244|NCT04575584|65044854|FG005|Overall Study|Lost to Follow-up|0|||
23355245|NCT04575584|65044849|FG000|Overall Study|Physician Decision|0|||
23355246|NCT04575584|65044850|FG001|Overall Study|Physician Decision|1|||
23355247|NCT04575584|65044851|FG002|Overall Study|Physician Decision|1|||
23355248|NCT04575584|65044852|FG003|Overall Study|Physician Decision|1|||
23355249|NCT04575584|65044853|FG004|Overall Study|Physician Decision|0|||
23355250|NCT04575584|65044854|FG005|Overall Study|Physician Decision|0|||
23355251|NCT04575584|65044849|FG000|Overall Study|Withdrawal by Subject|7|||
23355252|NCT04575584|65044850|FG001|Overall Study|Withdrawal by Subject|9|||
23355253|NCT04575584|65044851|FG002|Overall Study|Withdrawal by Subject|5|||
23355254|NCT04575584|65044852|FG003|Overall Study|Withdrawal by Subject|3|||
23355255|NCT04575584|65044853|FG004|Overall Study|Withdrawal by Subject|0|||
23355256|NCT04575584|65044854|FG005|Overall Study|Withdrawal by Subject|0|||
23355257|NCT04575584|65044849|FG000|Overall Study|Not recorded|0|||
23355258|NCT04575584|65044850|FG001|Overall Study|Not recorded|0|||
23355259|NCT04575584|65044851|FG002|Overall Study|Not recorded|0|||
23355260|NCT04575584|65044852|FG003|Overall Study|Not recorded|1|||
23355261|NCT04575584|65044853|FG004|Overall Study|Not recorded|0|||
23355262|NCT04575584|65044854|FG005|Overall Study|Not recorded|0|||
23355263|NCT02886884|65044855|FG000|Follow-up|Withdrawal by Subject|0|||
23355264|NCT02886884|65044856|FG001|Follow-up|Withdrawal by Subject|0|||
23355265|NCT02886884|65044857|FG002|Follow-up|Withdrawal by Subject|0|||
23355266|NCT02886884|65044858|FG003|Follow-up|Withdrawal by Subject|1|||
23355267|NCT01118663|65044865|FG000|Overall Study|Adverse Event|2|||
23355268|NCT01118663|65044866|FG001|Overall Study|Adverse Event|1|||
23355269|NCT01118663|65044865|FG000|Overall Study|Withdrawal by Subject|0|||
23355270|NCT01118663|65044866|FG001|Overall Study|Withdrawal by Subject|1|||
23355271|NCT00585325|65044867|FG000|Overall Study|Withdrawal by Subject|1|||
23355272|NCT00585325|65044868|FG001|Overall Study|Withdrawal by Subject|1|||
23472294|NCT00104520|65473929|FG001|Overall Study|Study drug intolerance|1|||
23472295|NCT00104520|65473928|FG000|Overall Study|Related adverse event|13|||
23472296|NCT00104520|65473929|FG001|Overall Study|Related adverse event|15|||
23355273|NCT01146561|65044869|FG000|Overall Study|Withdrawal by Subject|1|||
23355274|NCT01146561|65044869|FG000|Overall Study|Lost to Follow-up|1|||
23355275|NCT02324699|65044872|FG000|Overall Study|study terminated|1|||
23795776|NCT05135273|66630022|FG004|Overall Study|Travel|0|||
23355276|NCT00893971|65044875|FG000|Overall Study|Physician Decision|3|||
23355277|NCT01796301|65044876|FG000|Overall Study|Withdrawal by Subject|15|||
23472297|NCT00104520|65473928|FG000|Overall Study|Lost to Follow-up|1|||
23472298|NCT00104520|65473929|FG001|Overall Study|Lost to Follow-up|0|||
23355278|NCT01796301|65044877|FG001|Overall Study|Withdrawal by Subject|15|||
23355279|NCT01796301|65044876|FG000|Overall Study|Lost to Follow-up|3|||
23355280|NCT01796301|65044877|FG001|Overall Study|Lost to Follow-up|3|||
23795777|NCT05135273|66630023|FG005|Overall Study|Travel|0|||
23795778|NCT05135273|66630024|FG006|Overall Study|Travel|0|||
23795779|NCT05135273|66630025|FG007|Overall Study|Travel|1|||
23795780|NCT01801917|66630028|FG000|Period 1 - Randomized|Adverse Event|1|||
23795781|NCT01801917|66630029|FG001|Period 1 - Randomized|Adverse Event|0|||
23355281|NCT01796301|65044876|FG000|Overall Study|Death|0|||
23355282|NCT01796301|65044877|FG001|Overall Study|Death|1|||
23355283|NCT01796301|65044876|FG000|Overall Study|Decision by Sponsor|0|||
23355284|NCT01796301|65044877|FG001|Overall Study|Decision by Sponsor|1|||
23355285|NCT02869893|65044882|FG000|Overall Study|participant aversion to IV|5|||
23355286|NCT02869893|65044882|FG000|Overall Study|participant fear of MRI scanner|2|||
23355287|NCT03774394|65044883|FG000|Overall Study|Withdrawal by Subject|2|||
23355288|NCT03774394|65044884|FG001|Overall Study|Withdrawal by Subject|0|||
23355289|NCT03297021|65044885|FG000|Overall Study|Incomplete/illegible data sheet|4|||
23355290|NCT03297021|65044886|FG001|Overall Study|Incomplete/illegible data sheet|2|||
23355291|NCT03297021|65044887|FG002|Overall Study|Incomplete/illegible data sheet|3|||
23355292|NCT03297021|65044885|FG000|Overall Study|Missing Post-Op Data|1|||
23355293|NCT03297021|65044886|FG001|Overall Study|Missing Post-Op Data|2|||
23355294|NCT03297021|65044887|FG002|Overall Study|Missing Post-Op Data|1|||
23355295|NCT01180049|65044888|FG000|Overall Study|Other|9|||
23355296|NCT01180049|65044889|FG001|Overall Study|Other|7|||
23355297|NCT01180049|65044888|FG000|Overall Study|Lost to Follow-up|8|||
23355298|NCT01180049|65044889|FG001|Overall Study|Lost to Follow-up|6|||
23355299|NCT01180049|65044888|FG000|Overall Study|Death|36|||
23355300|NCT01180049|65044889|FG001|Overall Study|Death|35|||
23355301|NCT02263729|65044890|FG000|Overall Study|Lost to Follow-up|1|||
23355302|NCT02263729|65044891|FG001|Overall Study|Lost to Follow-up|1|||
23355303|NCT04186221|65044892|FG000|Overall Study|Death|1|||
23355304|NCT03396822|65044894|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
23355305|NCT03396822|65044894|FG000|Overall Study|Physician Decision|1|||
23355306|NCT01636947|65044896|FG000|Overall Study|Not Treated|2|||
23355307|NCT01636947|65044897|FG001|Overall Study|Not Treated|2|||
23472299|NCT00104520|65473928|FG000|Overall Study|Noncompliance|0|||
23472300|NCT00104520|65473929|FG001|Overall Study|Noncompliance|2|||
23472301|NCT00104520|65473928|FG000|Overall Study|Personal/administrative|1|||
23588179|NCT03068468|65882144|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
23588180|NCT03068468|65882145|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23588181|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
23588182|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
23588183|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
23588184|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
23588185|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588186|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588187|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588188|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
23588189|NCT03068468|65882142|FG000|Open-Label Extension Period|Reason not Specified|0|||
23588190|NCT03068468|65882143|FG001|Open-Label Extension Period|Reason not Specified|0|||
23588191|NCT03068468|65882144|FG002|Open-Label Extension Period|Reason not Specified|1|||
23588192|NCT03068468|65882145|FG003|Open-Label Extension Period|Reason not Specified|4|||
23588193|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23588194|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
23588195|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
23588196|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588197|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588198|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588199|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588200|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23355308|NCT01636947|65044896|FG000|Overall Study|Lost to Follow-up|4|||
23355309|NCT01636947|65044897|FG001|Overall Study|Lost to Follow-up|0|||
23355310|NCT01636947|65044896|FG000|Overall Study|Protocol Violation|1|||
23588201|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23355311|NCT01636947|65044897|FG001|Overall Study|Protocol Violation|1|||
23355312|NCT01636947|65044896|FG000|Overall Study|Withdrawal by Subject|3|||
23355313|NCT01636947|65044897|FG001|Overall Study|Withdrawal by Subject|3|||
23355314|NCT01636947|65044896|FG000|Overall Study|Adverse Event|1|||
23588202|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23355315|NCT01636947|65044897|FG001|Overall Study|Adverse Event|1|||
23588203|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23588204|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23588205|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23355316|NCT01636947|65044896|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23355317|NCT01636947|65044897|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
23355318|NCT01464619|65044898|FG000|Overall Study|Lost to Follow-up|3|||
23355319|NCT01464619|65044899|FG001|Overall Study|Lost to Follow-up|4|||
23355320|NCT02385110|65044900|FG000|Overall Study|Early Death|1|||
23355321|NCT02385110|65044901|FG001|Overall Study|Early Death|0|||
23355322|NCT01308463|65044902|FG000|Overall Study|Study Discontinued|23|||
23355323|NCT01308463|65044902|FG000|Overall Study|Death|4|||
23355324|NCT01308463|65044902|FG000|Overall Study|Revision|2|||
23355325|NCT00076999|65044903|FG000|Overall Study|Adverse Event|2|||
23355326|NCT00076999|65044904|FG001|Overall Study|Adverse Event|8|||
23355327|NCT00076999|65044905|FG002|Overall Study|Adverse Event|6|||
23355328|NCT00076999|65044906|FG003|Overall Study|Adverse Event|0|||
23355329|NCT00076999|65044907|FG004|Overall Study|Adverse Event|2|||
23355330|NCT00076999|65044903|FG000|Overall Study|Protocol Violation|0|||
23355331|NCT00076999|65044904|FG001|Overall Study|Protocol Violation|3|||
23355332|NCT00076999|65044905|FG002|Overall Study|Protocol Violation|4|||
23355333|NCT00076999|65044906|FG003|Overall Study|Protocol Violation|0|||
23355334|NCT00076999|65044907|FG004|Overall Study|Protocol Violation|9|||
23355335|NCT00076999|65044903|FG000|Overall Study|Lost to Follow-up|2|||
23355336|NCT00076999|65044904|FG001|Overall Study|Lost to Follow-up|1|||
23355337|NCT00076999|65044905|FG002|Overall Study|Lost to Follow-up|0|||
23355338|NCT00076999|65044906|FG003|Overall Study|Lost to Follow-up|0|||
23355339|NCT00076999|65044907|FG004|Overall Study|Lost to Follow-up|0|||
23355340|NCT00076999|65044903|FG000|Overall Study|Withdrawal by Subject|0|||
23355341|NCT00076999|65044904|FG001|Overall Study|Withdrawal by Subject|4|||
23355342|NCT00076999|65044905|FG002|Overall Study|Withdrawal by Subject|3|||
23355343|NCT00076999|65044906|FG003|Overall Study|Withdrawal by Subject|0|||
23355344|NCT00076999|65044907|FG004|Overall Study|Withdrawal by Subject|1|||
23355345|NCT00076999|65044903|FG000|Overall Study|Other reason (not specified)|8|||
23355346|NCT00076999|65044904|FG001|Overall Study|Other reason (not specified)|8|||
23355347|NCT00076999|65044905|FG002|Overall Study|Other reason (not specified)|4|||
23355348|NCT00076999|65044906|FG003|Overall Study|Other reason (not specified)|1|||
23355349|NCT00076999|65044907|FG004|Overall Study|Other reason (not specified)|13|||
23355350|NCT02626000|65044912|FG000|Overall Study|Decision by Sponsor|1|||
23355351|NCT02626000|65044912|FG000|Overall Study|Death|29|||
23355352|NCT01424241|65044913|FG000|Overall Study|Withdrawal by Subject|1|||
23355353|NCT01424241|65044913|FG000|Overall Study|Time constraints|2|||
23355354|NCT01863732|65044914|FG000|Overall Study|Adverse Event|2|||
23355355|NCT01863732|65044915|FG001|Overall Study|Adverse Event|0|||
23355356|NCT01863732|65044916|FG002|Overall Study|Adverse Event|3|||
23355357|NCT01863732|65044917|FG003|Overall Study|Adverse Event|3|||
23355358|NCT01863732|65044914|FG000|Overall Study|Lack of Efficacy|1|||
23355359|NCT01863732|65044915|FG001|Overall Study|Lack of Efficacy|0|||
23355360|NCT01863732|65044916|FG002|Overall Study|Lack of Efficacy|2|||
23355361|NCT01863732|65044917|FG003|Overall Study|Lack of Efficacy|1|||
23355362|NCT01863732|65044914|FG000|Overall Study|Lost to Follow-up|2|||
23355363|NCT01863732|65044915|FG001|Overall Study|Lost to Follow-up|2|||
23355364|NCT01863732|65044916|FG002|Overall Study|Lost to Follow-up|1|||
23355365|NCT01863732|65044917|FG003|Overall Study|Lost to Follow-up|1|||
23355366|NCT01863732|65044914|FG000|Overall Study|Physician Decision|1|||
23355367|NCT01863732|65044915|FG001|Overall Study|Physician Decision|0|||
23355368|NCT01863732|65044916|FG002|Overall Study|Physician Decision|1|||
23355369|NCT01863732|65044917|FG003|Overall Study|Physician Decision|0|||
23355370|NCT01863732|65044914|FG000|Overall Study|Pregnancy|0|||
23588206|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588207|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588208|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588209|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588210|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588211|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
23588212|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
23795782|NCT01801917|66630030|FG002|Period 1 - Randomized|Adverse Event|1|||
23355371|NCT01863732|65044915|FG001|Overall Study|Pregnancy|0|||
23355372|NCT01863732|65044916|FG002|Overall Study|Pregnancy|0|||
23355373|NCT01863732|65044917|FG003|Overall Study|Pregnancy|1|||
23355374|NCT01863732|65044914|FG000|Overall Study|Technical problems|0|||
23355375|NCT01863732|65044915|FG001|Overall Study|Technical problems|1|||
23355376|NCT01863732|65044916|FG002|Overall Study|Technical problems|1|||
23355377|NCT01863732|65044917|FG003|Overall Study|Technical problems|0|||
23355378|NCT01863732|65044914|FG000|Overall Study|Subject/guardian decision|6|||
23355379|NCT01863732|65044915|FG001|Overall Study|Subject/guardian decision|9|||
23355380|NCT01863732|65044916|FG002|Overall Study|Subject/guardian decision|3|||
23355381|NCT01863732|65044917|FG003|Overall Study|Subject/guardian decision|1|||
23355382|NCT01863732|65044914|FG000|Overall Study|Death|1|||
23355383|NCT01863732|65044915|FG001|Overall Study|Death|0|||
23355384|NCT01863732|65044916|FG002|Overall Study|Death|0|||
23355385|NCT01863732|65044917|FG003|Overall Study|Death|1|||
23355386|NCT05268016|65044918|FG000|Overall Study|Unacceptable toxicity or AE|2|||
23355387|NCT05268016|65044919|FG001|Overall Study|Unacceptable toxicity or AE|2|||
23355388|NCT05268016|65044920|FG002|Overall Study|Unacceptable toxicity or AE|4|||
23355389|NCT05268016|65044921|FG003|Overall Study|Unacceptable toxicity or AE|3|||
23355390|NCT05268016|65044922|FG004|Overall Study|Unacceptable toxicity or AE|1|||
23355391|NCT05268016|65044918|FG000|Overall Study|Withdrawal by Subject|1|||
23355392|NCT05268016|65044919|FG001|Overall Study|Withdrawal by Subject|3|||
23355393|NCT05268016|65044920|FG002|Overall Study|Withdrawal by Subject|2|||
23355394|NCT05268016|65044921|FG003|Overall Study|Withdrawal by Subject|2|||
23355395|NCT05268016|65044922|FG004|Overall Study|Withdrawal by Subject|1|||
23355396|NCT05268016|65044918|FG000|Overall Study|Lost to Follow-up|4|||
23355397|NCT05268016|65044919|FG001|Overall Study|Lost to Follow-up|7|||
23355398|NCT05268016|65044920|FG002|Overall Study|Lost to Follow-up|1|||
23355399|NCT05268016|65044921|FG003|Overall Study|Lost to Follow-up|3|||
23355400|NCT05268016|65044922|FG004|Overall Study|Lost to Follow-up|5|||
23355401|NCT05268016|65044918|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
23355402|NCT05268016|65044919|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355403|NCT05268016|65044920|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355404|NCT05268016|65044921|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
23355405|NCT05268016|65044922|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355406|NCT05268016|65044918|FG000|Overall Study|Lack of Efficacy|0|||
23355407|NCT05268016|65044919|FG001|Overall Study|Lack of Efficacy|0|||
23355408|NCT05268016|65044920|FG002|Overall Study|Lack of Efficacy|0|||
23355409|NCT05268016|65044921|FG003|Overall Study|Lack of Efficacy|0|||
23355410|NCT05268016|65044922|FG004|Overall Study|Lack of Efficacy|4|||
23355411|NCT05268016|65044918|FG000|Overall Study|Physician Decision|0|||
23355412|NCT05268016|65044919|FG001|Overall Study|Physician Decision|0|||
23355413|NCT05268016|65044920|FG002|Overall Study|Physician Decision|0|||
23355414|NCT05268016|65044921|FG003|Overall Study|Physician Decision|1|||
23355415|NCT05268016|65044922|FG004|Overall Study|Physician Decision|0|||
23588213|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
23588214|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588215|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588216|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588217|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23355416|NCT05268016|65044918|FG000|Overall Study|Other|1|||
23355417|NCT05268016|65044919|FG001|Overall Study|Other|0|||
23355418|NCT05268016|65044920|FG002|Overall Study|Other|1|||
23355419|NCT05268016|65044921|FG003|Overall Study|Other|2|||
23355420|NCT05268016|65044922|FG004|Overall Study|Other|0|||
23355421|NCT03594955|65044923|FG000|Overall Study|Adverse Event|1|||
23355422|NCT03594955|65044923|FG000|Overall Study|Progressive disease|5|||
23355423|NCT03594955|65044923|FG000|Overall Study|Sponsor's decision|1|||
23355424|NCT03373461|65044924|FG000|Part 2|Adverse Event|0|||
23355425|NCT03373461|65044925|FG001|Part 2|Adverse Event|1|||
23355426|NCT03373461|65044926|FG002|Part 2|Adverse Event|0|||
23355427|NCT03373461|65044927|FG003|Part 2|Adverse Event|0|||
23355428|NCT03373461|65044928|FG004|Part 2|Adverse Event|1|||
23355429|NCT00404924|65044932|FG000|Overall Study|Adverse Event|75|||
23355430|NCT00404924|65044933|FG001|Overall Study|Adverse Event|16|||
23355431|NCT00404924|65044932|FG000|Overall Study|Condition under investigation worsened|475|||
23355432|NCT00404924|65044933|FG001|Overall Study|Condition under investigation worsened|264|||
23355433|NCT00404924|65044932|FG000|Overall Study|Lost to Follow-up|1|||
23355434|NCT00404924|65044933|FG001|Overall Study|Lost to Follow-up|1|||
23355435|NCT00404924|65044932|FG000|Overall Study|Withdrawal by Subject|26|||
23355436|NCT00404924|65044933|FG001|Overall Study|Withdrawal by Subject|13|||
23355437|NCT00404924|65044932|FG000|Overall Study|Other|25|||
23355438|NCT00404924|65044933|FG001|Overall Study|Other|11|||
23355439|NCT00404924|65044932|FG000|Overall Study|Randomised but not received treatment|1|||
23355440|NCT00404924|65044933|FG001|Overall Study|Randomised but not received treatment|1|||
23355441|NCT03887117|65044934|FG000|Overall Study|Discontinued prematurely|0|||
23355442|NCT03887117|65044935|FG001|Overall Study|Discontinued prematurely|1|||
23588218|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23355443|NCT03887117|65044936|FG002|Overall Study|Discontinued prematurely|1|||
23355444|NCT03887117|65044937|FG003|Overall Study|Discontinued prematurely|2|||
23588219|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588220|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
23355445|NCT01133288|65044938|FG000|Eligibility Assessment|met exclusion criteria|5|||
23355446|NCT01133288|65044938|FG000|Intervention Allocation|study terminated|2|||
23355447|NCT02824562|65044945|FG000|Overall Study|Lost to Follow-up|3|||
23355448|NCT02824562|65044946|FG001|Overall Study|Lost to Follow-up|4|||
23355449|NCT02824562|65044945|FG000|Overall Study|Death|0|||
23355450|NCT02824562|65044946|FG001|Overall Study|Death|1|||
23355451|NCT00433017|65044951|FG000|Overall Study|Adverse Event|5|||
23355452|NCT00433017|65044952|FG001|Overall Study|Adverse Event|3|||
23355453|NCT00433017|65044951|FG000|Overall Study|Withdrawal by Subject|4|||
23355454|NCT00433017|65044952|FG001|Overall Study|Withdrawal by Subject|5|||
23355455|NCT00433017|65044951|FG000|Overall Study|Lost to Follow-up|3|||
23355456|NCT00433017|65044952|FG001|Overall Study|Lost to Follow-up|4|||
23355457|NCT00433017|65044951|FG000|Overall Study|Administrative problems|80|||
23355458|NCT00433017|65044952|FG001|Overall Study|Administrative problems|86|||
23355459|NCT00433017|65044951|FG000|Overall Study|Protocol Violation|1|||
23355460|NCT00433017|65044952|FG001|Overall Study|Protocol Violation|0|||
23355461|NCT00433017|65044951|FG000|Overall Study|Death|2|||
23355462|NCT00433017|65044952|FG001|Overall Study|Death|2|||
23355463|NCT00433017|65044951|FG000|Overall Study|Subject no longer requires study drug|1|||
23355464|NCT00433017|65044952|FG001|Overall Study|Subject no longer requires study drug|1|||
23355465|NCT02442206|65044953|FG000|Period 1|Adverse Event|1|||
23355466|NCT02442206|65044954|FG001|Period 1|Adverse Event|1|||
23355467|NCT02442206|65044953|FG000|Period 1|withdrew consent|0|||
23355468|NCT02442206|65044954|FG001|Period 1|withdrew consent|1|||
23355469|NCT02442206|65044953|FG000|Period 1|COPD exacerbation|0|||
23355470|NCT02442206|65044954|FG001|Period 1|COPD exacerbation|1|||
23355471|NCT02442206|65044953|FG000|Period 2|Adverse Event|1|||
23355472|NCT02442206|65044954|FG001|Period 2|Adverse Event|0|||
23355473|NCT02849171|65044961|FG000|Overall Study|Withdrawal by Subject|1|||
23355474|NCT02849171|65044961|FG000|Overall Study|Not treated|1|||
23355475|NCT00396877|65044964|FG000|Overall Study|Lost to Follow-up|2|||
23355476|NCT00396877|65044965|FG001|Overall Study|Lost to Follow-up|1|||
23355477|NCT00396877|65044964|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
23355478|NCT00396877|65044965|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
23355479|NCT04165135|65044966|FG000|Overall Study|Protocol Violation|10|||
23355480|NCT04165135|65044966|FG000|Overall Study|Participants withdrawal of consent|5|||
23355481|NCT01470144|65044969|FG000|Overall Study|Adverse Event|2|||
23355482|NCT01470144|65044969|FG000|Overall Study|Death|1|||
23355483|NCT01470144|65044969|FG000|Overall Study|Lung transplant|6|||
23641434|NCT03330405|66071676|FG005|Overall Study|Other|0|||
23641435|NCT03330405|66071677|FG006|Overall Study|Other|1|||
23641436|NCT03330405|66071678|FG007|Overall Study|Other|0|||
23641437|NCT03330405|66071679|FG008|Overall Study|Other|0|||
23641438|NCT03330405|66071680|FG009|Overall Study|Other|0|||
23641439|NCT03330405|66071681|FG010|Overall Study|Other|0|||
23641440|NCT03330405|66071671|FG000|Overall Study|Progressive disease|8|||
23641441|NCT03330405|66071672|FG001|Overall Study|Progressive disease|27|||
23355484|NCT01470144|65044969|FG000|Overall Study|Patient's and investigator's decision|1|||
23355485|NCT03035916|65044970|FG000|Overall Study|Puncture failed|0|||
23355486|NCT03035916|65044971|FG001|Overall Study|Puncture failed|2|||
23355487|NCT03035916|65044972|FG002|Overall Study|Puncture failed|0|||
23355488|NCT03034135|65044973|FG000|Overall Study|Withdrawal by Subject|2|||
23355489|NCT01884545|65044975|FG000|Overall Study|Lost to Follow-up|6|||
23355490|NCT01884545|65044976|FG001|Overall Study|Lost to Follow-up|4|||
23355491|NCT01884545|65044977|FG002|Overall Study|Lost to Follow-up|9|||
23355492|NCT01884545|65044978|FG003|Overall Study|Lost to Follow-up|4|||
23355493|NCT01884545|65044975|FG000|Overall Study|Patient withdrawn|7|||
23355494|NCT01884545|65044976|FG001|Overall Study|Patient withdrawn|12|||
23355495|NCT01884545|65044977|FG002|Overall Study|Patient withdrawn|5|||
23355496|NCT01884545|65044978|FG003|Overall Study|Patient withdrawn|5|||
23355497|NCT01884545|65044975|FG000|Overall Study|Non-adherence|0|||
23355498|NCT01884545|65044976|FG001|Overall Study|Non-adherence|2|||
23355499|NCT01884545|65044977|FG002|Overall Study|Non-adherence|0|||
23355500|NCT01884545|65044978|FG003|Overall Study|Non-adherence|0|||
23355501|NCT02304380|65044982|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355502|NCT02304380|65044983|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355503|NCT02304380|65044984|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355504|NCT02304380|65044985|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
23355505|NCT02304380|65044986|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23472302|NCT00104520|65473929|FG001|Overall Study|Personal/administrative|1|||
23355506|NCT02304380|65044987|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355507|NCT00048165|65044988|FG000|Completed 6 Months Study|Administration/Other|8|||
23472303|NCT00104520|65473928|FG000|Overall Study|Other|1|||
23472304|NCT00104520|65473929|FG001|Overall Study|Other|5|||
23641442|NCT03330405|66071673|FG002|Overall Study|Progressive disease|4|||
23795783|NCT01801917|66630031|FG003|Period 1 - Randomized|Adverse Event|0|||
23355508|NCT00048165|65044989|FG001|Completed 6 Months Study|Administration/Other|8|||
23355509|NCT00048165|65044988|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
23355510|NCT00048165|65044989|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
23355511|NCT00048165|65044988|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
23355512|NCT00048165|65044989|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
23355513|NCT00048165|65044988|FG000|Completed 6 Months Study|Death|12|||
23355514|NCT00048165|65044989|FG001|Completed 6 Months Study|Death|6|||
23355515|NCT00048165|65044988|FG000|Completed 6 Months Study|Insufficient therapy|1|||
23355516|NCT00048165|65044989|FG001|Completed 6 Months Study|Insufficient therapy|4|||
23641443|NCT03330405|66071674|FG003|Overall Study|Progressive disease|18|||
23641444|NCT03330405|66071675|FG004|Overall Study|Progressive disease|16|||
23641445|NCT03330405|66071676|FG005|Overall Study|Progressive disease|14|||
23641446|NCT03330405|66071677|FG006|Overall Study|Progressive disease|7|||
23641447|NCT03330405|66071678|FG007|Overall Study|Progressive disease|29|||
23641448|NCT03330405|66071679|FG008|Overall Study|Progressive disease|9|||
23641449|NCT03330405|66071680|FG009|Overall Study|Progressive disease|11|||
23641450|NCT03330405|66071681|FG010|Overall Study|Progressive disease|5|||
23355517|NCT00048165|65044988|FG000|Completed 6 Months Study|Other violation|4|||
23355518|NCT00048165|65044989|FG001|Completed 6 Months Study|Other violation|6|||
23355519|NCT00048165|65044988|FG000|Completed 6 Months Study|Refused treatment|5|||
23355520|NCT00048165|65044989|FG001|Completed 6 Months Study|Refused treatment|5|||
23355521|NCT00048165|65044988|FG000|Completed 6 Months Study|Violation criteria|0|||
23355522|NCT00048165|65044989|FG001|Completed 6 Months Study|Violation criteria|2|||
23355523|NCT00048165|65044988|FG000|Completed 6 Months Study|Did not receive study drug|6|||
23355524|NCT00048165|65044989|FG001|Completed 6 Months Study|Did not receive study drug|6|||
23355525|NCT00048165|65044988|FG000|Completed 12 Months Study|Administration/Other|0|||
23355526|NCT00048165|65044989|FG001|Completed 12 Months Study|Administration/Other|2|||
23355527|NCT00048165|65044988|FG000|Completed 12 Months Study|Death|2|||
23355528|NCT00048165|65044989|FG001|Completed 12 Months Study|Death|1|||
23355529|NCT00048165|65044988|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
23355530|NCT00048165|65044989|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
23355531|NCT04202965|65044992|FG000|Overall Study|Adverse Event|3|||
23355532|NCT04202965|65044992|FG000|Overall Study|Did not meet inclusion criteria|1|||
23355533|NCT02937636|65044994|FG000|Overall Study|Other (Not specified)|3|||
23355534|NCT02937636|65044995|FG001|Overall Study|Other (Not specified)|2|||
23355535|NCT00272844|65044998|FG000|Overall Study|Withdrawal by Subject|5|||
23355536|NCT04348500|65045000|FG000|Overall Study|Death|2|||
23355537|NCT04348500|65045001|FG001|Overall Study|Death|2|||
23355538|NCT04348500|65045000|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
23355539|NCT04348500|65045001|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
23355540|NCT01125813|65045009|FG000|Overall Study|Death|1|||
23355541|NCT01125813|65045009|FG000|Overall Study|Withdrawal by Subject|1|||
23355542|NCT01125813|65045009|FG000|Overall Study|Screen Failures|4|||
23355543|NCT00073008|65045011|FG000|Overall Study|Missing|6|||
23355544|NCT00073008|65045012|FG001|Overall Study|Missing|6|||
23355545|NCT00073008|65045011|FG000|Overall Study|Withdrawal by Subject|2|||
23795784|NCT01261624|66630032|FG000|Week 0 to Week 12|Disease Progression|1|||
23795785|NCT01261624|66630033|FG001|Week 0 to Week 12|Disease Progression|1|||
23795786|NCT01261624|66630032|FG000|Week 0 to Week 12|Insufficient Response|0|||
23795787|NCT01261624|66630033|FG001|Week 0 to Week 12|Insufficient Response|2|||
23795788|NCT01261624|66630032|FG000|Week 13 to Week 24|Insufficient Response|0|||
23795789|NCT01261624|66630033|FG001|Week 13 to Week 24|Insufficient Response|1|||
23795790|NCT02293460|66630034|FG000|Overall Study|Protocol Violation|1|||
23795791|NCT02293460|66630034|FG000|Overall Study|Lack of Efficacy|2|||
23795792|NCT02293460|66630034|FG000|Overall Study|Adverse Event|2|||
23795793|NCT02293460|66630034|FG000|Overall Study|Withdrawal by Subject|1|||
23795794|NCT02412137|66630035|FG000|Overall Study|Withdrawal by Subject|2|||
23795795|NCT02412137|66630036|FG001|Overall Study|Withdrawal by Subject|0|||
23795796|NCT02412137|66630035|FG000|Overall Study|Lost to Follow-up|21|||
23795797|NCT02412137|66630036|FG001|Overall Study|Lost to Follow-up|14|||
23795798|NCT02412137|66630035|FG000|Overall Study|Physician Decision|28|||
23795799|NCT02412137|66630036|FG001|Overall Study|Physician Decision|9|||
23795800|NCT00224484|66630037|FG000|Overall Study|Serious Adverse Event|1|||
23795801|NCT00224484|66630038|FG001|Overall Study|Serious Adverse Event|1|||
23795802|NCT00224484|66630039|FG002|Overall Study|Serious Adverse Event|0|||
23795803|NCT00224484|66630037|FG000|Overall Study|Non-Serious Adverse Event|5|||
23795804|NCT00224484|66630038|FG001|Overall Study|Non-Serious Adverse Event|7|||
23795805|NCT00224484|66630039|FG002|Overall Study|Non-Serious Adverse Event|3|||
23795806|NCT00224484|66630037|FG000|Overall Study|Protocol Violation|2|||
23795807|NCT00224484|66630038|FG001|Overall Study|Protocol Violation|2|||
23795808|NCT00224484|66630039|FG002|Overall Study|Protocol Violation|0|||
23795809|NCT00224484|66630037|FG000|Overall Study|Withdrawal by Subject|49|||
23795810|NCT00224484|66630038|FG001|Overall Study|Withdrawal by Subject|18|||
23795811|NCT00224484|66630039|FG002|Overall Study|Withdrawal by Subject|16|||
23795812|NCT00224484|66630037|FG000|Overall Study|Migrated/moved from study area|18|||
23795813|NCT00224484|66630038|FG001|Overall Study|Migrated/moved from study area|5|||
23795814|NCT00224484|66630039|FG002|Overall Study|Migrated/moved from study area|5|||
23355546|NCT00073008|65045012|FG001|Overall Study|Withdrawal by Subject|2|||
23472305|NCT01727024|65473933|FG000|Period 1|Lost to Follow-up|1|||
23588221|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588222|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
23641451|NCT03330405|66071671|FG000|Overall Study|Withdrawal by Subject|1|||
23641452|NCT03330405|66071672|FG001|Overall Study|Withdrawal by Subject|4|||
23641453|NCT03330405|66071673|FG002|Overall Study|Withdrawal by Subject|0|||
23641454|NCT03330405|66071674|FG003|Overall Study|Withdrawal by Subject|1|||
23641455|NCT03330405|66071675|FG004|Overall Study|Withdrawal by Subject|1|||
23641456|NCT03330405|66071676|FG005|Overall Study|Withdrawal by Subject|1|||
23641457|NCT03330405|66071677|FG006|Overall Study|Withdrawal by Subject|0|||
23641458|NCT03330405|66071678|FG007|Overall Study|Withdrawal by Subject|2|||
23641459|NCT03330405|66071679|FG008|Overall Study|Withdrawal by Subject|2|||
23641460|NCT03330405|66071680|FG009|Overall Study|Withdrawal by Subject|1|||
23588223|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588224|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588225|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588226|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588227|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588228|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588229|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23588230|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23588231|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
23588232|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588233|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588234|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23641461|NCT03330405|66071681|FG010|Overall Study|Withdrawal by Subject|1|||
23641462|NCT03330405|66071671|FG000|Overall Study|Global deterioration of health status|2|||
23641463|NCT03330405|66071672|FG001|Overall Study|Global deterioration of health status|3|||
23641464|NCT03330405|66071673|FG002|Overall Study|Global deterioration of health status|0|||
23641465|NCT03330405|66071674|FG003|Overall Study|Global deterioration of health status|2|||
23641466|NCT03330405|66071675|FG004|Overall Study|Global deterioration of health status|3|||
23641467|NCT03330405|66071676|FG005|Overall Study|Global deterioration of health status|3|||
23641468|NCT03330405|66071677|FG006|Overall Study|Global deterioration of health status|0|||
23641469|NCT03330405|66071678|FG007|Overall Study|Global deterioration of health status|2|||
23641470|NCT03330405|66071679|FG008|Overall Study|Global deterioration of health status|8|||
23641471|NCT03330405|66071680|FG009|Overall Study|Global deterioration of health status|4|||
23641472|NCT03330405|66071681|FG010|Overall Study|Global deterioration of health status|1|||
23641473|NCT03330405|66071671|FG000|Overall Study|Adverse Event|0|||
23588235|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588236|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588237|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588238|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588239|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23588240|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23588241|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588242|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588243|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588244|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588245|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588246|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588247|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
23588248|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
23588249|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23641474|NCT03330405|66071672|FG001|Overall Study|Adverse Event|1|||
23641475|NCT03330405|66071673|FG002|Overall Study|Adverse Event|0|||
23641476|NCT03330405|66071674|FG003|Overall Study|Adverse Event|1|||
23355547|NCT00073008|65045011|FG000|Overall Study|Lost to Follow-up|1|||
23641477|NCT03330405|66071675|FG004|Overall Study|Adverse Event|1|||
23472306|NCT01727024|65473934|FG001|Period 1|Lost to Follow-up|1|||
23472307|NCT01727024|65473933|FG000|Period 1|Withdrawal by Subject|2|||
23472308|NCT01727024|65473934|FG001|Period 1|Withdrawal by Subject|3|||
23472309|NCT02855541|65473935|FG000|Overall Study|Change in health status|2|||
23472310|NCT02855541|65473935|FG000|Overall Study|Withdrawal by Subject|2|||
23472311|NCT02404025|65473938|FG000|Overall Study|Adverse Event|1|||
23472312|NCT02404025|65473938|FG000|Overall Study|Lack of Efficacy|3|||
23472313|NCT00202878|65473939|FG000|Overall Study|Death|964|||
23472314|NCT00202878|65473940|FG001|Overall Study|Death|968|||
23472315|NCT00202878|65473939|FG000|Overall Study|Only Vital Status Known|357|||
23472316|NCT00202878|65473940|FG001|Overall Study|Only Vital Status Known|356|||
23472317|NCT00202878|65473939|FG000|Overall Study|Lost to Follow-up|44|||
23472318|NCT00202878|65473940|FG001|Overall Study|Lost to Follow-up|49|||
23472319|NCT00202878|65473939|FG000|Overall Study|Site Closure|39|||
23472320|NCT00202878|65473940|FG001|Overall Study|Site Closure|36|||
23472321|NCT00202878|65473939|FG000|Overall Study|Withdrawal by Subject|795|||
23472322|NCT00202878|65473940|FG001|Overall Study|Withdrawal by Subject|808|||
23472323|NCT03805659|65473941|FG000|Overall Study|Withdrawal by Subject|0|||
23472324|NCT03805659|65473942|FG001|Overall Study|Withdrawal by Subject|1|||
23472325|NCT01105767|65473945|FG000|Overall Study|Lost to Follow-up|1160|||
23472326|NCT01105767|65473946|FG001|Overall Study|Lost to Follow-up|1614|||
23472327|NCT01105767|65473947|FG002|Overall Study|Lost to Follow-up|1184|||
23472328|NCT01454778|65473950|FG000|Overall Study|Lost to Follow-up|2|||
23472329|NCT01454778|65473950|FG000|Overall Study|Death|1|||
23472330|NCT03672097|65473951|FG000|Period 1|Withdrawal by Subject|2|||
23472331|NCT03672097|65473951|FG000|Period 1|Adverse Event|1|||
23472332|NCT03672097|65473951|FG000|Period 1|Did not receive treatment|1|||
23472333|NCT03672097|65473951|FG000|Period 2|Withdrawal by Subject|3|||
23472334|NCT03672097|65473951|FG000|Period 2|Other|1|||
23472335|NCT01057589|65473952|FG000|Overall Study|Disease Progression|35|||
23472336|NCT01057589|65473952|FG000|Overall Study|Adverse Event|10|||
23472337|NCT01057589|65473952|FG000|Overall Study|Physician Decision|8|||
23472338|NCT01057589|65473952|FG000|Overall Study|Withdrawal by Subject|3|||
23472339|NCT01057589|65473952|FG000|Overall Study|Sponsor Decision|1|||
23472340|NCT01057589|65473952|FG000|Overall Study|Death|8|||
23472341|NCT01057589|65473952|FG000|Overall Study|Lost to Follow-up|1|||
23472342|NCT00635999|65473955|FG000|Overall Study|Withdrawal by Subject|4|||
23472343|NCT00635999|65473956|FG001|Overall Study|Withdrawal by Subject|2|||
23472344|NCT00635999|65473957|FG002|Overall Study|Withdrawal by Subject|1|||
23472345|NCT02929407|65473958|FG000|Overall Study|Adverse Event|1|||
23472346|NCT01802073|65473961|FG000|Overall Study|Lost to Follow-up|0|||
23472347|NCT01802073|65473962|FG001|Overall Study|Lost to Follow-up|1|||
23472348|NCT01802073|65473961|FG000|Overall Study|Non-compliant|4|||
23472349|NCT01802073|65473962|FG001|Overall Study|Non-compliant|2|||
23472350|NCT01802073|65473961|FG000|Overall Study|Withdrawal by Subject|1|||
23472351|NCT01802073|65473962|FG001|Overall Study|Withdrawal by Subject|1|||
23472352|NCT01802073|65473961|FG000|Overall Study|Physician Decision|0|||
23472353|NCT01802073|65473962|FG001|Overall Study|Physician Decision|7|||
23472354|NCT01159431|65473969|FG000|Overall Study|Adverse Event|1|||
23472355|NCT01159431|65473970|FG001|Overall Study|Adverse Event|2|||
23472356|NCT01159431|65473969|FG000|Overall Study|non-compliance|1|||
23472357|NCT01159431|65473970|FG001|Overall Study|non-compliance|1|||
23472358|NCT01159431|65473969|FG000|Overall Study|Lack of Efficacy|0|||
23472359|NCT01159431|65473970|FG001|Overall Study|Lack of Efficacy|3|||
23472360|NCT02791763|65473971|FG000|Overall Study|Protocol Violation|0|||
23472361|NCT02791763|65473972|FG001|Overall Study|Protocol Violation|0|||
23472362|NCT02791763|65473973|FG002|Overall Study|Protocol Violation|1|||
23472363|NCT02791763|65473971|FG000|Overall Study|Withdrawal by Subject|5|||
23472364|NCT02791763|65473972|FG001|Overall Study|Withdrawal by Subject|1|||
23472365|NCT02791763|65473973|FG002|Overall Study|Withdrawal by Subject|0|||
23472366|NCT02791763|65473971|FG000|Overall Study|Physician Decision|0|||
23472367|NCT02791763|65473972|FG001|Overall Study|Physician Decision|1|||
23472368|NCT02791763|65473973|FG002|Overall Study|Physician Decision|0|||
23472369|NCT02791763|65473971|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
23472370|NCT02791763|65473972|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
23472371|NCT02791763|65473973|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
23472372|NCT02791763|65473971|FG000|Overall Study|Cancer event|1|||
23472373|NCT02791763|65473972|FG001|Overall Study|Cancer event|3|||
23472374|NCT02791763|65473973|FG002|Overall Study|Cancer event|0|||
23472375|NCT02791763|65473971|FG000|Overall Study|Participant had renal transplant|3|||
23588250|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23472376|NCT02791763|65473972|FG001|Overall Study|Participant had renal transplant|0|||
23472377|NCT02791763|65473973|FG002|Overall Study|Participant had renal transplant|0|||
23472378|NCT02791763|65473971|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
23472379|NCT02791763|65473972|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
23472380|NCT02791763|65473973|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
23472381|NCT02791763|65473971|FG000|Overall Study|Adverse Event|12|||
23472382|NCT02791763|65473972|FG001|Overall Study|Adverse Event|13|||
23472383|NCT02791763|65473973|FG002|Overall Study|Adverse Event|7|||
23472384|NCT01148979|65473974|FG000|Overall Study|Lost to Follow-up|0|||
23472385|NCT01148979|65473975|FG001|Overall Study|Lost to Follow-up|1|||
23472386|NCT01640314|65473976|FG000|Overall Study|Protocol Violation|0|||
23472387|NCT01640314|65473977|FG001|Overall Study|Protocol Violation|1|||
23472388|NCT01689532|65473978|FG000|Overall Study|Adverse Event|9|||
23472389|NCT01689532|65473979|FG001|Overall Study|Adverse Event|5|||
23472390|NCT01689532|65473978|FG000|Overall Study|Lack of Efficacy|2|||
23472391|NCT01689532|65473979|FG001|Overall Study|Lack of Efficacy|2|||
23472392|NCT01689532|65473978|FG000|Overall Study|Withdrawal by Subject|1|||
23472393|NCT01689532|65473979|FG001|Overall Study|Withdrawal by Subject|2|||
23472394|NCT01689532|65473978|FG000|Overall Study|Physician Decision|2|||
23472395|NCT01689532|65473979|FG001|Overall Study|Physician Decision|0|||
23472396|NCT00782834|65473987|FG000|Treatment Phase|fibrous tumor not GIST|1|||
23472397|NCT02744040|65473992|FG000|Overall Study|Withdrawal by Subject|3|||
23472398|NCT02744040|65473993|FG001|Overall Study|Withdrawal by Subject|2|||
23472399|NCT02744040|65473994|FG002|Overall Study|Withdrawal by Subject|2|||
23472400|NCT02744040|65473992|FG000|Overall Study|Physician Decision|0|||
23472401|NCT02744040|65473993|FG001|Overall Study|Physician Decision|8|||
23472402|NCT02744040|65473994|FG002|Overall Study|Physician Decision|13|||
23472403|NCT02744040|65473992|FG000|Overall Study|Lost to Follow-up|3|||
23472404|NCT02744040|65473993|FG001|Overall Study|Lost to Follow-up|1|||
23472405|NCT02744040|65473994|FG002|Overall Study|Lost to Follow-up|7|||
23472406|NCT01510769|65473995|FG000|Overall Study|Adverse Event|7|||
23472407|NCT01510769|65473996|FG001|Overall Study|Adverse Event|6|||
23472408|NCT01510769|65473997|FG002|Overall Study|Adverse Event|4|||
23472409|NCT01510769|65473995|FG000|Overall Study|Gout Flare|0|||
23472410|NCT01510769|65473996|FG001|Overall Study|Gout Flare|3|||
23472411|NCT01510769|65473997|FG002|Overall Study|Gout Flare|1|||
23472412|NCT01510769|65473995|FG000|Overall Study|Protocol Violation|11|||
23472413|NCT01510769|65473996|FG001|Overall Study|Protocol Violation|10|||
23472414|NCT01510769|65473997|FG002|Overall Study|Protocol Violation|9|||
23472415|NCT01510769|65473995|FG000|Overall Study|Lost to Follow-up|5|||
23472416|NCT01510769|65473996|FG001|Overall Study|Lost to Follow-up|1|||
23472417|NCT01510769|65473997|FG002|Overall Study|Lost to Follow-up|5|||
23472418|NCT01510769|65473995|FG000|Overall Study|Withdrawal by Subject|3|||
23472419|NCT01510769|65473996|FG001|Overall Study|Withdrawal by Subject|4|||
23472420|NCT01510769|65473997|FG002|Overall Study|Withdrawal by Subject|3|||
23472421|NCT01510769|65473995|FG000|Overall Study|Death|1|||
23472422|NCT01510769|65473996|FG001|Overall Study|Death|1|||
23472423|NCT01510769|65473997|FG002|Overall Study|Death|0|||
23472424|NCT01338298|65473998|FG000|Overall Study|Withdrawal by Subject|1|||
23472425|NCT01338298|65473999|FG001|Overall Study|Withdrawal by Subject|1|||
23472426|NCT01338298|65473998|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
23472427|NCT01338298|65473999|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
23472428|NCT01338298|65473998|FG000|Overall Study|Administrative error|0|||
23472429|NCT01338298|65473999|FG001|Overall Study|Administrative error|1|||
23472430|NCT01338298|65473998|FG000|Overall Study|Positive symptom worsening|1|||
23472431|NCT01338298|65473999|FG001|Overall Study|Positive symptom worsening|0|||
23472432|NCT01338298|65473998|FG000|Overall Study|Depressive symptoms and nausea|1|||
23472433|NCT01338298|65473999|FG001|Overall Study|Depressive symptoms and nausea|0|||
23472434|NCT01338298|65473998|FG000|Overall Study|Non-adherence|1|||
23472435|NCT01338298|65473999|FG001|Overall Study|Non-adherence|0|||
23641478|NCT03330405|66071676|FG005|Overall Study|Adverse Event|1|||
23472436|NCT01587014|65474000|FG000|Overall Study|Death|2|||
23472437|NCT00475982|65474001|FG000|Overall Study|surgery rescheduled|7|||
23641479|NCT03330405|66071677|FG006|Overall Study|Adverse Event|3|||
23472438|NCT00475982|65474002|FG001|Overall Study|surgery rescheduled|3|||
23472439|NCT02123472|65474004|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
23472440|NCT02123472|65474005|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
23472441|NCT01864005|65474008|FG000|Overall Study|Protocol Violation|0|||
23472442|NCT01864005|65474009|FG001|Overall Study|Protocol Violation|1|||
23472443|NCT01864005|65474008|FG000|Overall Study|Withdrawal by Subject|0|||
23472444|NCT01864005|65474009|FG001|Overall Study|Withdrawal by Subject|1|||
23472445|NCT01864005|65474008|FG000|Overall Study|Incorrect enrolment|1|||
23472446|NCT01864005|65474009|FG001|Overall Study|Incorrect enrolment|0|||
23472447|NCT01864005|65474008|FG000|Overall Study|Disease need|1|||
23472448|NCT01864005|65474009|FG001|Overall Study|Disease need|1|||
23472449|NCT01864005|65474008|FG000|Overall Study|Need GP IIb/IIIa|1|||
23472450|NCT01864005|65474009|FG001|Overall Study|Need GP IIb/IIIa|3|||
23472451|NCT01837823|65474012|FG000|Overall Study|Lost to Follow-up|6|||
23472452|NCT01324401|65474013|FG000|Overall Study|Withdrawn before any treatment|0|||
23472453|NCT01324401|65474014|FG001|Overall Study|Withdrawn before any treatment|3|||
23472454|NCT01324401|65474013|FG000|Overall Study|Adverse Event|1|||
23472455|NCT01324401|65474014|FG001|Overall Study|Adverse Event|3|||
23472456|NCT02032238|65474015|FG000|Overall Study|Lost to Follow-up|2|||
23472457|NCT02032238|65474016|FG001|Overall Study|Lost to Follow-up|0|||
23472458|NCT00970684|65474020|FG000|Overall Study|Lack of Efficacy|5|||
23472459|NCT00970684|65474020|FG000|Overall Study|Adverse Event|4|||
23472460|NCT00970684|65474020|FG000|Overall Study|Withdrawal by Subject|1|||
23472461|NCT02695420|65474021|FG000|Overall Study|Death|0|||
23472462|NCT02695420|65474022|FG001|Overall Study|Death|1|||
23472463|NCT02695420|65474023|FG002|Overall Study|Death|0|||
23588251|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588252|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588253|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588254|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588255|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588256|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588257|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
23588258|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
23588259|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
23588260|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588261|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
23588262|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588263|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588264|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588265|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588266|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
23588267|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
23588268|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
23588269|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588270|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
23588271|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23641480|NCT03330405|66071678|FG007|Overall Study|Adverse Event|4|||
23795815|NCT00224484|66630037|FG000|Overall Study|Lost to Follow-up|66|||
23795816|NCT00224484|66630038|FG001|Overall Study|Lost to Follow-up|28|||
23795817|NCT00224484|66630039|FG002|Overall Study|Lost to Follow-up|36|||
23795818|NCT00224484|66630037|FG000|Overall Study|Reason not specified|5|||
23795819|NCT00224484|66630038|FG001|Overall Study|Reason not specified|4|||
23795820|NCT00224484|66630039|FG002|Overall Study|Reason not specified|2|||
23795821|NCT01266603|66630053|FG000|Overall Study|Adverse Event|1|||
23795822|NCT01266603|66630053|FG000|Overall Study|Lack of Efficacy|14|||
23795823|NCT01266603|66630053|FG000|Overall Study|Withdrawal by Subject|1|||
23795824|NCT01266603|66630053|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
23795825|NCT01040793|66630054|FG000|Overall Study|Adverse Event|5|||
23795826|NCT01040793|66630055|FG001|Overall Study|Adverse Event|3|||
23795827|NCT01040793|66630056|FG002|Overall Study|Adverse Event|0|||
23795828|NCT01040793|66630057|FG003|Overall Study|Adverse Event|2|||
23795829|NCT01040793|66630058|FG004|Overall Study|Adverse Event|2|||
23795830|NCT01040793|66630059|FG005|Overall Study|Adverse Event|1|||
23795831|NCT01040793|66630054|FG000|Overall Study|Protocol Violation|1|||
23795832|NCT01040793|66630055|FG001|Overall Study|Protocol Violation|1|||
23795833|NCT01040793|66630056|FG002|Overall Study|Protocol Violation|1|||
23795834|NCT01040793|66630057|FG003|Overall Study|Protocol Violation|0|||
23795835|NCT01040793|66630058|FG004|Overall Study|Protocol Violation|1|||
23795836|NCT01040793|66630059|FG005|Overall Study|Protocol Violation|0|||
23795837|NCT01040793|66630054|FG000|Overall Study|Lost to Follow-up|0|||
23472464|NCT02695420|65474024|FG003|Overall Study|Death|0|||
23641481|NCT03330405|66071679|FG008|Overall Study|Adverse Event|2|||
23641482|NCT03330405|66071680|FG009|Overall Study|Adverse Event|2|||
23641483|NCT03330405|66071681|FG010|Overall Study|Adverse Event|2|||
23641484|NCT03330405|66071671|FG000|Overall Study|Death|0|||
23641485|NCT03330405|66071672|FG001|Overall Study|Death|4|||
23641486|NCT03330405|66071673|FG002|Overall Study|Death|0|||
23641487|NCT03330405|66071674|FG003|Overall Study|Death|0|||
23641488|NCT03330405|66071675|FG004|Overall Study|Death|0|||
23641489|NCT03330405|66071676|FG005|Overall Study|Death|1|||
23641490|NCT03330405|66071677|FG006|Overall Study|Death|0|||
23641491|NCT03330405|66071678|FG007|Overall Study|Death|2|||
23641492|NCT03330405|66071679|FG008|Overall Study|Death|0|||
23641493|NCT03330405|66071680|FG009|Overall Study|Death|0|||
23641494|NCT03330405|66071681|FG010|Overall Study|Death|0|||
23641495|NCT03330405|66071671|FG000|Overall Study|Physician Decision|0|||
23641496|NCT03330405|66071672|FG001|Overall Study|Physician Decision|0|||
23641497|NCT03330405|66071673|FG002|Overall Study|Physician Decision|0|||
23641498|NCT03330405|66071674|FG003|Overall Study|Physician Decision|0|||
23795838|NCT01040793|66630055|FG001|Overall Study|Lost to Follow-up|1|||
23472465|NCT02605122|65474025|FG000|Overall Study|Withdrawal by Subject|4|||
23472466|NCT02605122|65474026|FG001|Overall Study|Withdrawal by Subject|1|||
23472467|NCT02605122|65474025|FG000|Overall Study|Lost to Follow-up|1|||
23472468|NCT02605122|65474026|FG001|Overall Study|Lost to Follow-up|1|||
23472469|NCT00145158|65474035|FG000|Overall Study|premature withdrawal|2|||
23472470|NCT00145158|65474036|FG001|Overall Study|premature withdrawal|3|||
23472471|NCT02314637|65474037|FG000|Overall Study|Adverse Event|4|||
23472472|NCT02314637|65474038|FG001|Overall Study|Adverse Event|8|||
23472473|NCT02314637|65474037|FG000|Overall Study|Lack of Efficacy|1|||
23472474|NCT02314637|65474038|FG001|Overall Study|Lack of Efficacy|0|||
23472475|NCT02314637|65474037|FG000|Overall Study|Physician Decision|5|||
23472476|NCT02314637|65474038|FG001|Overall Study|Physician Decision|2|||
23472477|NCT02314637|65474037|FG000|Overall Study|Withdrawal by Subject|5|||
23472478|NCT02314637|65474038|FG001|Overall Study|Withdrawal by Subject|4|||
23472479|NCT02314637|65474037|FG000|Overall Study|Other Reason|1|||
23472480|NCT02314637|65474038|FG001|Overall Study|Other Reason|0|||
23472481|NCT01821560|65474039|FG000|Overall Study|Lost to Follow-up|5|||
23641499|NCT03330405|66071675|FG004|Overall Study|Physician Decision|0|||
23641500|NCT03330405|66071676|FG005|Overall Study|Physician Decision|0|||
23641501|NCT03330405|66071677|FG006|Overall Study|Physician Decision|0|||
23641502|NCT03330405|66071678|FG007|Overall Study|Physician Decision|1|||
23641503|NCT03330405|66071679|FG008|Overall Study|Physician Decision|0|||
23641504|NCT03330405|66071680|FG009|Overall Study|Physician Decision|0|||
23641505|NCT03330405|66071681|FG010|Overall Study|Physician Decision|0|||
23641506|NCT02349425|66071682|FG000|Period 1|Adverse Event|1|||
23641507|NCT02349425|66071683|FG001|Period 1|Adverse Event|1|||
23641508|NCT02349425|66071684|FG002|Period 1|Adverse Event|0|||
23641509|NCT02349425|66071685|FG003|Period 1|Adverse Event|0|||
23641510|NCT02349425|66071682|FG000|Period 2|Adverse Event|0|||
23641511|NCT02349425|66071683|FG001|Period 2|Adverse Event|1|||
23641512|NCT02349425|66071684|FG002|Period 2|Adverse Event|1|||
23641513|NCT02349425|66071685|FG003|Period 2|Adverse Event|0|||
23641514|NCT01679405|66071686|FG000|Overall Study|Death|2|||
23641515|NCT01679405|66071687|FG001|Overall Study|Death|5|||
23641516|NCT02399254|66071688|FG000|Overall Study|Physician Decision|2|||
23641517|NCT00688870|66071689|FG000|Infant Series|Parent or legal guardian request|4|||
23795839|NCT01040793|66630056|FG002|Overall Study|Lost to Follow-up|1|||
23795840|NCT01040793|66630057|FG003|Overall Study|Lost to Follow-up|0|||
23795841|NCT01040793|66630058|FG004|Overall Study|Lost to Follow-up|0|||
23795842|NCT01040793|66630059|FG005|Overall Study|Lost to Follow-up|0|||
23795843|NCT01040793|66630054|FG000|Overall Study|Withdrawal by Subject|0|||
23795844|NCT01040793|66630055|FG001|Overall Study|Withdrawal by Subject|0|||
23795845|NCT01040793|66630056|FG002|Overall Study|Withdrawal by Subject|0|||
23795846|NCT01040793|66630057|FG003|Overall Study|Withdrawal by Subject|2|||
23795847|NCT01040793|66630058|FG004|Overall Study|Withdrawal by Subject|0|||
23795848|NCT01040793|66630059|FG005|Overall Study|Withdrawal by Subject|0|||
23795849|NCT01040793|66630054|FG000|Overall Study|Other reasons not listed above|0|||
23472482|NCT01821560|65474040|FG001|Overall Study|Lost to Follow-up|5|||
23472483|NCT01821560|65474039|FG000|Overall Study|Withdrawal by Subject|1|||
23795850|NCT01040793|66630055|FG001|Overall Study|Other reasons not listed above|0|||
23795851|NCT01040793|66630056|FG002|Overall Study|Other reasons not listed above|1|||
23472484|NCT01821560|65474040|FG001|Overall Study|Withdrawal by Subject|1|||
23795852|NCT01040793|66630057|FG003|Overall Study|Other reasons not listed above|0|||
23795853|NCT01040793|66630058|FG004|Overall Study|Other reasons not listed above|1|||
23795854|NCT01040793|66630059|FG005|Overall Study|Other reasons not listed above|0|||
23472485|NCT01821560|65474039|FG000|Overall Study|Protocol Violation|0|||
23472486|NCT01821560|65474040|FG001|Overall Study|Protocol Violation|1|||
23641518|NCT00688870|66071690|FG001|Infant Series|Parent or legal guardian request|0|||
23641519|NCT01131182|66071691|FG000|Overall Study|Withdrawal by Subject|1|||
23641520|NCT01131182|66071692|FG001|Overall Study|Withdrawal by Subject|1|||
23641521|NCT01131182|66071691|FG000|Overall Study|Lost to Follow-up|14|||
23795855|NCT01632306|66630060|FG000|Overall Study|Protocol Violation|1|||
23795856|NCT01632306|66630061|FG001|Overall Study|Protocol Violation|0|||
23795857|NCT01632306|66630062|FG002|Overall Study|Protocol Violation|0|||
23795858|NCT02539368|66630063|FG000|Overall Study|Death|4|||
23795859|NCT02539368|66630064|FG001|Overall Study|Death|2|||
23795860|NCT02539368|66630065|FG002|Overall Study|Death|1|||
23795861|NCT02539368|66630066|FG003|Overall Study|Death|0|||
23795862|NCT02539368|66630067|FG004|Overall Study|Death|0|||
23795863|NCT02539368|66630063|FG000|Overall Study|Withdrawal by Subject|44|||
23795864|NCT02539368|66630064|FG001|Overall Study|Withdrawal by Subject|35|||
23472487|NCT01012219|65474041|FG000|Period 1|Withdrawal by Subject|1|||
23472488|NCT01012219|65474041|FG000|Period 2|Withdrawal by Subject|1|||
23472489|NCT01305577|65474049|FG000|Overall Study|Adverse Event|2|||
23472490|NCT01305577|65474050|FG001|Overall Study|Adverse Event|2|||
23472491|NCT01305577|65474051|FG002|Overall Study|Adverse Event|1|||
23472492|NCT01305577|65474049|FG000|Overall Study|Withdrawal by Subject|7|||
23472493|NCT01305577|65474050|FG001|Overall Study|Withdrawal by Subject|5|||
23472494|NCT01305577|65474051|FG002|Overall Study|Withdrawal by Subject|6|||
23472495|NCT01305577|65474049|FG000|Overall Study|Lost to Follow-up|4|||
23472496|NCT01305577|65474050|FG001|Overall Study|Lost to Follow-up|3|||
23472497|NCT01305577|65474051|FG002|Overall Study|Lost to Follow-up|2|||
23472498|NCT01305577|65474049|FG000|Overall Study|Protocol Deviation|0|||
23472499|NCT01305577|65474050|FG001|Overall Study|Protocol Deviation|1|||
23472500|NCT01305577|65474051|FG002|Overall Study|Protocol Deviation|1|||
23472501|NCT00776919|65474052|FG000|Overall Study|Withdrawal by Subject|16|||
23472502|NCT00776919|65474053|FG001|Overall Study|Withdrawal by Subject|14|||
23472503|NCT00776919|65474054|FG002|Overall Study|Withdrawal by Subject|15|||
23472504|NCT00776919|65474055|FG003|Overall Study|Withdrawal by Subject|26|||
23472505|NCT00776919|65474052|FG000|Overall Study|Lost to Follow-up|8|||
23472506|NCT00776919|65474053|FG001|Overall Study|Lost to Follow-up|12|||
23472507|NCT00776919|65474054|FG002|Overall Study|Lost to Follow-up|11|||
23472508|NCT00776919|65474055|FG003|Overall Study|Lost to Follow-up|8|||
23472509|NCT00776919|65474052|FG000|Overall Study|Adverse Event|1|||
23472510|NCT00776919|65474053|FG001|Overall Study|Adverse Event|0|||
23472511|NCT00776919|65474054|FG002|Overall Study|Adverse Event|2|||
23472512|NCT00776919|65474055|FG003|Overall Study|Adverse Event|2|||
23472513|NCT00776919|65474052|FG000|Overall Study|Protocol Violation|1|||
23472514|NCT00776919|65474053|FG001|Overall Study|Protocol Violation|2|||
23472515|NCT00776919|65474054|FG002|Overall Study|Protocol Violation|0|||
23472516|NCT00776919|65474055|FG003|Overall Study|Protocol Violation|1|||
23472517|NCT00776919|65474052|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
23472518|NCT00776919|65474053|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
23472519|NCT00776919|65474054|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
23472520|NCT00776919|65474055|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
23472521|NCT00271505|65474056|FG000|Overall Study|Screen Failure|3|||
23472522|NCT00271505|65474056|FG000|Overall Study|Adverse Event|1|||
23472523|NCT00271505|65474056|FG000|Overall Study|Death|1|||
23472524|NCT00534599|65474057|FG000|Overall Study|Adverse Event|25|||
23472525|NCT00534599|65474058|FG001|Overall Study|Adverse Event|4|||
23472526|NCT00534599|65474057|FG000|Overall Study|Incorrect enrollment|2|||
23472527|NCT00534599|65474058|FG001|Overall Study|Incorrect enrollment|1|||
23472528|NCT00534599|65474057|FG000|Overall Study|Mis-randomization|2|||
23472529|NCT00534599|65474058|FG001|Overall Study|Mis-randomization|2|||
23472530|NCT00534599|65474057|FG000|Overall Study|Developed study-specific d/c criteria|5|||
23472531|NCT00534599|65474058|FG001|Overall Study|Developed study-specific d/c criteria|0|||
23472532|NCT00534599|65474057|FG000|Overall Study|Lack of Efficacy|0|||
23472533|NCT00534599|65474058|FG001|Overall Study|Lack of Efficacy|1|||
23472534|NCT00534599|65474057|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
23472535|NCT00534599|65474058|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
23472536|NCT00534599|65474057|FG000|Overall Study|Protocol Violation|1|||
23472537|NCT00534599|65474058|FG001|Overall Study|Protocol Violation|3|||
23472538|NCT00534599|65474057|FG000|Overall Study|Lost to Follow-up|11|||
23472539|NCT00534599|65474058|FG001|Overall Study|Lost to Follow-up|14|||
23472540|NCT00534599|65474057|FG000|Overall Study|Withdrawal by Subject|4|||
23472541|NCT00534599|65474058|FG001|Overall Study|Withdrawal by Subject|6|||
23472542|NCT00534599|65474057|FG000|Overall Study|Other|7|||
23472543|NCT00534599|65474058|FG001|Overall Study|Other|0|||
23641522|NCT01131182|66071692|FG001|Overall Study|Lost to Follow-up|15|||
23641523|NCT01131182|66071691|FG000|Overall Study|Other Reason|1|||
23795865|NCT02539368|66630065|FG002|Overall Study|Withdrawal by Subject|9|||
23472544|NCT04248491|65474064|FG000|Overall Study|Lost to Follow-up|1|||
23472545|NCT04248491|65474065|FG001|Overall Study|Lost to Follow-up|0|||
23472546|NCT00929643|65474068|FG000|Overall Study|Protocol Violation|2|||
23472547|NCT00336856|65474069|FG000|Overall Study|Withdrawal by Subject|3|||
23472548|NCT00336856|65474069|FG000|Overall Study|Found ineligible at time of analysis|1|||
23472549|NCT00545272|65474072|FG000|Overall Study|Protocol deviation|0|||
23795866|NCT02539368|66630066|FG003|Overall Study|Withdrawal by Subject|1|||
23641524|NCT01131182|66071692|FG001|Overall Study|Other Reason|0|||
23355548|NCT00073008|65045012|FG001|Overall Study|Lost to Follow-up|3|||
23355549|NCT00073008|65045011|FG000|Overall Study|Death|46|||
23355550|NCT00073008|65045012|FG001|Overall Study|Death|47|||
23355551|NCT00073008|65045011|FG000|Overall Study|"Other selected on Case Report Form"|7|||
23355552|NCT00073008|65045012|FG001|Overall Study|"Other selected on Case Report Form"|5|||
23355553|NCT03272347|65045015|FG000|Overall Study|Death|0|||
23355554|NCT03272347|65045016|FG001|Overall Study|Death|0|||
23355555|NCT03272347|65045017|FG002|Overall Study|Death|0|||
23355556|NCT03272347|65045018|FG003|Overall Study|Death|1|||
23355557|NCT03272347|65045015|FG000|Overall Study|Lost to Follow-up|1|||
23355558|NCT03272347|65045016|FG001|Overall Study|Lost to Follow-up|3|||
23355559|NCT03272347|65045017|FG002|Overall Study|Lost to Follow-up|5|||
23355560|NCT03272347|65045018|FG003|Overall Study|Lost to Follow-up|1|||
23355561|NCT03272347|65045015|FG000|Overall Study|Physician Decision|4|||
23355562|NCT03272347|65045016|FG001|Overall Study|Physician Decision|2|||
23355563|NCT03272347|65045017|FG002|Overall Study|Physician Decision|5|||
23355564|NCT03272347|65045018|FG003|Overall Study|Physician Decision|4|||
23355565|NCT03272347|65045015|FG000|Overall Study|Screen Failure|1|||
23355566|NCT03272347|65045016|FG001|Overall Study|Screen Failure|0|||
23355567|NCT03272347|65045017|FG002|Overall Study|Screen Failure|0|||
23355568|NCT03272347|65045018|FG003|Overall Study|Screen Failure|0|||
23355569|NCT03272347|65045015|FG000|Overall Study|Withdrawal by Subject|5|||
23355570|NCT03272347|65045016|FG001|Overall Study|Withdrawal by Subject|1|||
23795867|NCT02539368|66630067|FG004|Overall Study|Withdrawal by Subject|3|||
23795868|NCT02539368|66630063|FG000|Overall Study|Physician Decision|49|||
23795869|NCT02539368|66630064|FG001|Overall Study|Physician Decision|15|||
23795870|NCT02539368|66630065|FG002|Overall Study|Physician Decision|7|||
23795871|NCT02539368|66630066|FG003|Overall Study|Physician Decision|0|||
23795872|NCT02539368|66630067|FG004|Overall Study|Physician Decision|2|||
23795873|NCT02539368|66630063|FG000|Overall Study|Lost to Follow-up|96|||
23795874|NCT02539368|66630064|FG001|Overall Study|Lost to Follow-up|21|||
23795875|NCT02539368|66630065|FG002|Overall Study|Lost to Follow-up|16|||
23795876|NCT02539368|66630066|FG003|Overall Study|Lost to Follow-up|4|||
23355571|NCT03272347|65045017|FG002|Overall Study|Withdrawal by Subject|2|||
23355572|NCT03272347|65045018|FG003|Overall Study|Withdrawal by Subject|1|||
23355573|NCT01216332|65045023|FG000|Overall Study|Withdrawal by Subject|4|||
23795877|NCT02539368|66630067|FG004|Overall Study|Lost to Follow-up|3|||
23795878|NCT02539368|66630063|FG000|Overall Study|Adverse Event|44|||
23355574|NCT01216332|65045024|FG001|Overall Study|Withdrawal by Subject|0|||
23355575|NCT04769739|65045025|FG000|Overall Study|Colorectal cancer obstruction|2|||
23355576|NCT04769739|65045026|FG001|Overall Study|Colorectal cancer obstruction|0|||
23355577|NCT04769739|65045027|FG002|Overall Study|Colorectal cancer obstruction|0|||
23355578|NCT04769739|65045028|FG003|Overall Study|Colorectal cancer obstruction|0|||
23472550|NCT00545272|65474073|FG001|Overall Study|Protocol deviation|1|||
23472551|NCT00545272|65474074|FG002|Overall Study|Protocol deviation|0|||
23472552|NCT00545272|65474075|FG003|Overall Study|Protocol deviation|1|||
23472553|NCT00545272|65474076|FG004|Overall Study|Protocol deviation|0|||
23472554|NCT00545272|65474077|FG005|Overall Study|Protocol deviation|1|||
23472555|NCT00545272|65474072|FG000|Overall Study|Adverse Event|0|||
23472556|NCT00545272|65474073|FG001|Overall Study|Adverse Event|0|||
23795879|NCT02539368|66630064|FG001|Overall Study|Adverse Event|5|||
23795880|NCT02539368|66630065|FG002|Overall Study|Adverse Event|9|||
23795881|NCT02539368|66630066|FG003|Overall Study|Adverse Event|0|||
23795882|NCT02539368|66630067|FG004|Overall Study|Adverse Event|3|||
23795883|NCT02539368|66630063|FG000|Overall Study|Participant Non-compliant|13|||
23795884|NCT02539368|66630064|FG001|Overall Study|Participant Non-compliant|2|||
23795885|NCT02539368|66630065|FG002|Overall Study|Participant Non-compliant|1|||
23795886|NCT02539368|66630066|FG003|Overall Study|Participant Non-compliant|1|||
23472557|NCT00545272|65474074|FG002|Overall Study|Adverse Event|1|||
23472558|NCT00545272|65474075|FG003|Overall Study|Adverse Event|0|||
23472559|NCT00545272|65474076|FG004|Overall Study|Adverse Event|0|||
23472560|NCT00545272|65474077|FG005|Overall Study|Adverse Event|1|||
23472561|NCT00545272|65474072|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23472562|NCT00545272|65474073|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23472563|NCT00545272|65474074|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23472564|NCT00545272|65474075|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23588272|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588273|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23795887|NCT02539368|66630067|FG004|Overall Study|Participant Non-compliant|0|||
23795888|NCT02539368|66630063|FG000|Overall Study|Other|145|||
23795889|NCT02539368|66630064|FG001|Overall Study|Other|18|||
23795890|NCT02539368|66630065|FG002|Overall Study|Other|24|||
23795891|NCT02539368|66630066|FG003|Overall Study|Other|1|||
23795892|NCT02539368|66630067|FG004|Overall Study|Other|3|||
23795893|NCT02539368|66630063|FG000|Overall Study|Missing|10|||
23795894|NCT02539368|66630064|FG001|Overall Study|Missing|3|||
23795895|NCT02539368|66630065|FG002|Overall Study|Missing|0|||
23588274|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588275|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588276|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
23641525|NCT03339583|66071694|FG000|First Intervention (14 Days)|Adverse Event|1|||
23641526|NCT03339583|66071695|FG001|First Intervention (14 Days)|Adverse Event|0|||
23795896|NCT02539368|66630066|FG003|Overall Study|Missing|0|||
23795897|NCT02539368|66630067|FG004|Overall Study|Missing|0|||
23355579|NCT04769739|65045025|FG000|Overall Study|Failed cecal intubation|1|||
23472565|NCT00545272|65474076|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23795898|NCT01408888|66630078|FG000|First Intervention|Adverse Event|0|||
23795899|NCT01408888|66630079|FG001|First Intervention|Adverse Event|1|||
23795900|NCT01408888|66630078|FG000|First Intervention|Withdrawal by Subject|0|||
23472566|NCT00545272|65474077|FG005|Overall Study|Abnormal laboratory value(s)|1|||
23472567|NCT00545272|65474072|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23472568|NCT00545272|65474073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23588277|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588278|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588279|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588280|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588281|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588282|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23795901|NCT01408888|66630079|FG001|First Intervention|Withdrawal by Subject|2|||
23795902|NCT01408888|66630078|FG000|Second Intervention|Withdrawal by Subject|1|||
23795903|NCT01408888|66630079|FG001|Second Intervention|Withdrawal by Subject|0|||
23795904|NCT01408888|66630078|FG000|Second Intervention|Adverse Event|1|||
23795905|NCT01408888|66630079|FG001|Second Intervention|Adverse Event|0|||
23795906|NCT01181531|66630080|FG000|Overall Study|Other|17|||
23795907|NCT01181531|66630081|FG001|Overall Study|Other|12|||
23795908|NCT01181531|66630080|FG000|Overall Study|Partial consent by subject withdrawn|0|||
23795909|NCT01181531|66630081|FG001|Overall Study|Partial consent by subject withdrawn|1|||
23355580|NCT04769739|65045026|FG001|Overall Study|Failed cecal intubation|0|||
23588283|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588284|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588285|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
23588286|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588287|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
23588288|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588289|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588290|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588291|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588292|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588293|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23588294|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588295|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588296|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23588297|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588298|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588299|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588300|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588301|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588302|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
23588303|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
23588304|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588305|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588306|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588307|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588308|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588309|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588310|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588311|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588312|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588313|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588314|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588315|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588316|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588317|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588318|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
23588319|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588320|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
23588321|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
23588322|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588323|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588324|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588325|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588326|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
23588327|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
23588328|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588329|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
23588330|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
23588331|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588332|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588333|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23795910|NCT01181531|66630080|FG000|Overall Study|Physician Decision|3|||
23588334|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588335|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
23588336|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588337|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588338|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
23588339|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
23588340|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588341|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588342|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588343|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588344|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23588345|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
23588346|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588347|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588348|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
23588349|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588350|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588351|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588352|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588353|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588354|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588355|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588356|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
23588357|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
23588358|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588359|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588360|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588361|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588362|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
23588363|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588364|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588365|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
23588366|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
23588367|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588368|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588369|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588370|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588371|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
23588372|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
23588373|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588374|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588375|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
23588376|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588377|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23641527|NCT03339583|66071694|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
23588378|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588379|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23641528|NCT03339583|66071695|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
23641529|NCT03339583|66071694|FG000|Second Intervention (14 Days)|Adverse Event|0|||
23641530|NCT03339583|66071695|FG001|Second Intervention (14 Days)|Adverse Event|1|||
23641531|NCT03339583|66071694|FG000|Follow-up (14 Days)|Physician Decision|6|||
23641532|NCT03339583|66071695|FG001|Follow-up (14 Days)|Physician Decision|3|||
23641533|NCT01656200|66071699|FG000|Overall Study|Withdrawal by Subject|1|||
23641534|NCT01895101|66071700|FG000|Overall Study|OPCAB procedure|1|||
23641535|NCT01895101|66071701|FG001|Overall Study|OPCAB procedure|1|||
23641536|NCT01895101|66071702|FG002|Overall Study|OPCAB procedure|3|||
23641537|NCT01895101|66071700|FG000|Overall Study|Withdrawal by Subject|0|||
23641538|NCT01895101|66071701|FG001|Overall Study|Withdrawal by Subject|1|||
23641539|NCT01895101|66071702|FG002|Overall Study|Withdrawal by Subject|2|||
23641540|NCT01895101|66071700|FG000|Overall Study|another study, enrolled in other study|0|||
23641541|NCT01895101|66071701|FG001|Overall Study|another study, enrolled in other study|1|||
23641542|NCT01895101|66071702|FG002|Overall Study|another study, enrolled in other study|0|||
23641543|NCT01895101|66071700|FG000|Overall Study|Death|0|||
23641544|NCT01895101|66071701|FG001|Overall Study|Death|1|||
23588380|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23355581|NCT04769739|65045027|FG002|Overall Study|Failed cecal intubation|0|||
23355582|NCT04769739|65045028|FG003|Overall Study|Failed cecal intubation|1|||
23355583|NCT04769739|65045025|FG000|Overall Study|Poor bowel preparation|0|||
23355584|NCT04769739|65045026|FG001|Overall Study|Poor bowel preparation|0|||
23355585|NCT04769739|65045027|FG002|Overall Study|Poor bowel preparation|0|||
23355586|NCT04769739|65045028|FG003|Overall Study|Poor bowel preparation|1|||
23355587|NCT02334384|65045029|FG000|Overall Study|Lost to Follow-up|1|||
23355588|NCT02334384|65045030|FG001|Overall Study|Lost to Follow-up|1|||
23355589|NCT04003623|65045036|FG000|Overall Study|Withdrawal by Subject|1|||
23355590|NCT04003623|65045037|FG001|Overall Study|Withdrawal by Subject|0|||
23355591|NCT02075008|65045038|FG000|Overall Study|Technical problems|1|||
23355592|NCT02075008|65045038|FG000|Overall Study|Pregnancy|1|||
23355593|NCT02075008|65045038|FG000|Overall Study|Physician Decision|1|||
23355594|NCT02075008|65045038|FG000|Overall Study|Lost to Follow-up|1|||
23355595|NCT02075008|65045038|FG000|Overall Study|Lack of Efficacy|1|||
23355596|NCT02075008|65045038|FG000|Overall Study|Death|1|||
23355597|NCT02075008|65045038|FG000|Overall Study|Adverse Event|5|||
23355598|NCT02075008|65045038|FG000|Overall Study|Withdrawal by Subject|6|||
23355599|NCT02075008|65045038|FG000|Overall Study|Study terminated by Sponsor|159|||
23355600|NCT03824366|65045041|FG000|Overall Study|Death|1|||
23355601|NCT03824366|65045041|FG000|Overall Study|Previously unidentified metal artifact|1|||
23355602|NCT03824366|65045041|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
23355603|NCT03824366|65045041|FG000|Overall Study|Withdrawal by Subject|1|||
23355604|NCT02732327|65045042|FG000|Overall Study|Protocol Violation|0|||
23355605|NCT02732327|65045043|FG001|Overall Study|Protocol Violation|1|||
23355606|NCT00204477|65045046|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
23355607|NCT00204477|65045047|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
23355608|NCT00204477|65045046|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
23355609|NCT00204477|65045047|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
23355610|NCT01256385|65045050|FG000|Overall Study|Physician Decision|1|||
23355611|NCT01256385|65045051|FG001|Overall Study|Physician Decision|1|||
23355612|NCT01256385|65045050|FG000|Overall Study|Withdrawal by Subject|2|||
23355613|NCT01256385|65045051|FG001|Overall Study|Withdrawal by Subject|2|||
23355614|NCT00913770|65045053|FG000|Overall Study|Unable to contact|24|||
23355615|NCT00913770|65045054|FG001|Overall Study|Unable to contact|19|||
23355616|NCT00913770|65045055|FG002|Overall Study|Unable to contact|13|||
23355617|NCT00913770|65045053|FG000|Overall Study|Refused|11|||
23355618|NCT00913770|65045054|FG001|Overall Study|Refused|10|||
23355619|NCT00913770|65045055|FG002|Overall Study|Refused|8|||
23355620|NCT00734656|65045056|FG000|Lab Session 1|Withdrawal by Subject|2|||
23355621|NCT00734656|65045057|FG001|Lab Session 1|Withdrawal by Subject|0|||
23355622|NCT00734656|65045058|FG002|Lab Session 1|Withdrawal by Subject|0|||
23355623|NCT00734656|65045059|FG003|Lab Session 1|Withdrawal by Subject|0|||
23355624|NCT00734656|65045056|FG000|Washout 1|Withdrawal by Subject|1|||
23355625|NCT00734656|65045057|FG001|Washout 1|Withdrawal by Subject|5|||
23355626|NCT00734656|65045058|FG002|Washout 1|Withdrawal by Subject|2|||
23355627|NCT00734656|65045059|FG003|Washout 1|Withdrawal by Subject|3|||
23355628|NCT00734656|65045056|FG000|Lab Session 2|Withdrawal by Subject|1|||
23355629|NCT00734656|65045057|FG001|Lab Session 2|Withdrawal by Subject|0|||
23355630|NCT00734656|65045058|FG002|Lab Session 2|Withdrawal by Subject|0|||
23355631|NCT00734656|65045059|FG003|Lab Session 2|Withdrawal by Subject|1|||
23355632|NCT00734656|65045056|FG000|Washout 2|Withdrawal by Subject|1|||
23355633|NCT00734656|65045057|FG001|Washout 2|Withdrawal by Subject|1|||
23355634|NCT00734656|65045058|FG002|Washout 2|Withdrawal by Subject|1|||
23355635|NCT00734656|65045059|FG003|Washout 2|Withdrawal by Subject|0|||
23588381|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23355636|NCT00734656|65045056|FG000|Washout 3|Withdrawal by Subject|1|||
23588382|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23355637|NCT00734656|65045057|FG001|Washout 3|Withdrawal by Subject|0|||
23355638|NCT00734656|65045058|FG002|Washout 3|Withdrawal by Subject|0|||
23355639|NCT00734656|65045059|FG003|Washout 3|Withdrawal by Subject|1|||
23355640|NCT00734656|65045056|FG000|Lab Session 4|Withdrawal by Subject|0|||
23355641|NCT00734656|65045057|FG001|Lab Session 4|Withdrawal by Subject|0|||
23355642|NCT00734656|65045058|FG002|Lab Session 4|Withdrawal by Subject|0|||
23355643|NCT00734656|65045059|FG003|Lab Session 4|Withdrawal by Subject|1|||
23355644|NCT03173456|65045068|FG000|Baseline|Medication dispensing system malfunction'|0|||
23355645|NCT03173456|65045069|FG001|Baseline|Medication dispensing system malfunction'|1|||
23355646|NCT03173456|65045070|FG002|Baseline|Medication dispensing system malfunction'|0|||
23355647|NCT03173456|65045071|FG003|Baseline|Medication dispensing system malfunction'|0|||
23355648|NCT03173456|65045072|FG004|Baseline|Medication dispensing system malfunction'|2|||
23355649|NCT03173456|65045068|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
23355650|NCT03173456|65045069|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
23355651|NCT03173456|65045070|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
23355652|NCT03173456|65045071|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
23355653|NCT03173456|65045072|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
23355654|NCT02282163|65048620|FG000|Overall Study|Protocol Violation|1|||
23355655|NCT03597139|65048623|FG000|Overall Study|Adverse Event|3|||
23355656|NCT03597139|65048624|FG001|Overall Study|Adverse Event|0|||
23355657|NCT03597139|65048623|FG000|Overall Study|Protocol Non-compliance|1|||
23355658|NCT03597139|65048624|FG001|Overall Study|Protocol Non-compliance|0|||
23355659|NCT01031004|65048625|FG000|Overall Study|Protocol Violation|0|||
23355660|NCT01031004|65048626|FG001|Overall Study|Protocol Violation|1|||
23355661|NCT01031004|65048625|FG000|Overall Study|Lost to Follow-up|1|||
23355662|NCT01031004|65048626|FG001|Overall Study|Lost to Follow-up|0|||
23355663|NCT01210222|65048627|FG000|Overall Study|Ineligible|2|||
23355664|NCT01210222|65048627|FG000|Overall Study|Never treated|1|||
23355665|NCT03465709|65048628|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
23795911|NCT01181531|66630081|FG001|Overall Study|Physician Decision|1|||
23795912|NCT01181531|66630080|FG000|Overall Study|Noncompliance|2|||
23795913|NCT01181531|66630081|FG001|Overall Study|Noncompliance|2|||
23795914|NCT01181531|66630080|FG000|Overall Study|Ineligibility determined|1|||
23795915|NCT01181531|66630081|FG001|Overall Study|Ineligibility determined|2|||
23795916|NCT01181531|66630080|FG000|Overall Study|Protocol Specified Criteria|15|||
23795917|NCT01181531|66630081|FG001|Overall Study|Protocol Specified Criteria|8|||
23795918|NCT01181531|66630080|FG000|Overall Study|Pregnancy|0|||
23795919|NCT01181531|66630081|FG001|Overall Study|Pregnancy|1|||
23795920|NCT01181531|66630080|FG000|Overall Study|Withdrawal by Subject|8|||
23795921|NCT01181531|66630081|FG001|Overall Study|Withdrawal by Subject|7|||
23795922|NCT01181531|66630080|FG000|Overall Study|Protocol Violation|6|||
23795923|NCT01181531|66630081|FG001|Overall Study|Protocol Violation|6|||
23795924|NCT01181531|66630080|FG000|Overall Study|Death|9|||
23795925|NCT01181531|66630081|FG001|Overall Study|Death|12|||
23795926|NCT01181531|66630080|FG000|Overall Study|Adverse Event|0|||
23795927|NCT01181531|66630081|FG001|Overall Study|Adverse Event|1|||
23795928|NCT01466036|66630084|FG000|Overall Study|Death|1|||
23795929|NCT01466036|66630085|FG001|Overall Study|Death|1|||
23795930|NCT01466036|66630084|FG000|Overall Study|Physician Decision|0|||
23795931|NCT01466036|66630085|FG001|Overall Study|Physician Decision|4|||
23795932|NCT01466036|66630084|FG000|Overall Study|Adverse Event|2|||
23355666|NCT03465709|65048628|FG000|Overall Study|Withdrawal by Subject|3|||
23355667|NCT02697591|65048631|FG000|Overall Study|Lost to Follow-up|0|||
23472569|NCT00545272|65474074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23588383|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
23795933|NCT01466036|66630085|FG001|Overall Study|Adverse Event|6|||
23795934|NCT01466036|66630084|FG000|Overall Study|Withdrawal by Subject|2|||
23795935|NCT01466036|66630085|FG001|Overall Study|Withdrawal by Subject|8|||
23355668|NCT02697591|65048632|FG001|Overall Study|Lost to Follow-up|0|||
23355669|NCT02697591|65048633|FG002|Overall Study|Lost to Follow-up|0|||
23355670|NCT02697591|65048634|FG003|Overall Study|Lost to Follow-up|0|||
23355671|NCT02697591|65048635|FG004|Overall Study|Lost to Follow-up|0|||
23355672|NCT02697591|65048636|FG005|Overall Study|Lost to Follow-up|1|||
23355673|NCT02697591|65048637|FG006|Overall Study|Lost to Follow-up|1|||
23355674|NCT02697591|65048638|FG007|Overall Study|Lost to Follow-up|0|||
23355675|NCT02697591|65048639|FG008|Overall Study|Lost to Follow-up|0|||
23355676|NCT02697591|65048640|FG009|Overall Study|Lost to Follow-up|1|||
23355677|NCT02697591|65048631|FG000|Overall Study|Withdrawal by Subject|1|||
23355678|NCT02697591|65048632|FG001|Overall Study|Withdrawal by Subject|1|||
23355679|NCT02697591|65048633|FG002|Overall Study|Withdrawal by Subject|2|||
23355680|NCT02697591|65048634|FG003|Overall Study|Withdrawal by Subject|1|||
23355681|NCT02697591|65048635|FG004|Overall Study|Withdrawal by Subject|7|||
23355682|NCT02697591|65048636|FG005|Overall Study|Withdrawal by Subject|6|||
23355683|NCT02697591|65048637|FG006|Overall Study|Withdrawal by Subject|9|||
23355684|NCT02697591|65048638|FG007|Overall Study|Withdrawal by Subject|1|||
23355685|NCT02697591|65048639|FG008|Overall Study|Withdrawal by Subject|6|||
23355686|NCT02697591|65048640|FG009|Overall Study|Withdrawal by Subject|10|||
23355687|NCT02697591|65048631|FG000|Overall Study|Physician Decision|1|||
23355688|NCT02697591|65048632|FG001|Overall Study|Physician Decision|0|||
23355689|NCT02697591|65048633|FG002|Overall Study|Physician Decision|0|||
23355690|NCT02697591|65048634|FG003|Overall Study|Physician Decision|0|||
23355691|NCT02697591|65048635|FG004|Overall Study|Physician Decision|1|||
23355692|NCT02697591|65048636|FG005|Overall Study|Physician Decision|2|||
23355693|NCT02697591|65048637|FG006|Overall Study|Physician Decision|0|||
23355694|NCT02697591|65048638|FG007|Overall Study|Physician Decision|0|||
23355695|NCT02697591|65048639|FG008|Overall Study|Physician Decision|1|||
23355696|NCT02697591|65048640|FG009|Overall Study|Physician Decision|1|||
23355697|NCT02697591|65048631|FG000|Overall Study|Death|2|||
23355698|NCT02697591|65048632|FG001|Overall Study|Death|3|||
23355699|NCT02697591|65048633|FG002|Overall Study|Death|1|||
23355700|NCT02697591|65048634|FG003|Overall Study|Death|1|||
23355701|NCT02697591|65048635|FG004|Overall Study|Death|4|||
23355702|NCT02697591|65048636|FG005|Overall Study|Death|5|||
23355703|NCT02697591|65048637|FG006|Overall Study|Death|3|||
23355704|NCT02697591|65048638|FG007|Overall Study|Death|1|||
23355705|NCT02697591|65048639|FG008|Overall Study|Death|1|||
23355706|NCT02697591|65048640|FG009|Overall Study|Death|5|||
23355707|NCT02697591|65048631|FG000|Overall Study|Reason not Specified|0|||
23355708|NCT02697591|65048632|FG001|Overall Study|Reason not Specified|0|||
23355709|NCT02697591|65048633|FG002|Overall Study|Reason not Specified|0|||
23355710|NCT02697591|65048634|FG003|Overall Study|Reason not Specified|1|||
23355711|NCT02697591|65048635|FG004|Overall Study|Reason not Specified|1|||
23355712|NCT02697591|65048636|FG005|Overall Study|Reason not Specified|2|||
23355713|NCT02697591|65048637|FG006|Overall Study|Reason not Specified|3|||
23355714|NCT02697591|65048638|FG007|Overall Study|Reason not Specified|1|||
23355715|NCT02697591|65048639|FG008|Overall Study|Reason not Specified|1|||
23355716|NCT02697591|65048640|FG009|Overall Study|Reason not Specified|3|||
23355717|NCT04571385|65048647|FG000|Overall Study|Participant non-compliance|1|||
23355718|NCT04571385|65048648|FG001|Overall Study|Participant non-compliance|0|||
23355719|NCT04571385|65048649|FG002|Overall Study|Participant non-compliance|0|||
23355720|NCT04571385|65048647|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
23355721|NCT04571385|65048648|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
23588384|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588385|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588386|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23641545|NCT01895101|66071702|FG002|Overall Study|Death|0|||
23355722|NCT04571385|65048649|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
23355723|NCT04571385|65048647|FG000|Overall Study|Screen failure|0|||
23355724|NCT04571385|65048648|FG001|Overall Study|Screen failure|0|||
23355725|NCT04571385|65048649|FG002|Overall Study|Screen failure|1|||
23355726|NCT01048099|65048650|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
23355727|NCT01048099|65048650|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
23355728|NCT02985021|65048652|FG000|Overall Study|Inability to comply with study procedures|1|||
23355729|NCT00298363|65048653|FG000|Overall Study|Lost to Follow-up|0|||
23355730|NCT00298363|65048654|FG001|Overall Study|Lost to Follow-up|0|||
23355731|NCT00298363|65048655|FG002|Overall Study|Lost to Follow-up|1|||
23355732|NCT00298363|65048653|FG000|Overall Study|Physician Decision|4|||
23355733|NCT00298363|65048654|FG001|Overall Study|Physician Decision|1|||
23355734|NCT00298363|65048655|FG002|Overall Study|Physician Decision|0|||
23355735|NCT00298363|65048653|FG000|Overall Study|Protocol Violation|1|||
23355736|NCT00298363|65048654|FG001|Overall Study|Protocol Violation|1|||
23588387|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588388|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588389|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588390|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588391|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588392|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588393|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588394|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588395|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588396|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588397|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23641546|NCT01895101|66071700|FG000|Overall Study|coagulation disorder|0|||
23641547|NCT01895101|66071701|FG001|Overall Study|coagulation disorder|1|||
23641548|NCT01895101|66071702|FG002|Overall Study|coagulation disorder|0|||
23641549|NCT01302067|66071703|FG000|Overall Study|Death|0|||
23641550|NCT01302067|66071704|FG001|Overall Study|Death|0|||
23641551|NCT01302067|66071705|FG002|Overall Study|Death|1|||
23641552|NCT01302067|66071703|FG000|Overall Study|Physician Decision|9|||
23641553|NCT01302067|66071704|FG001|Overall Study|Physician Decision|5|||
23641554|NCT01302067|66071705|FG002|Overall Study|Physician Decision|14|||
23641555|NCT01302067|66071703|FG000|Overall Study|Lack of Efficacy|8|||
23641556|NCT01302067|66071704|FG001|Overall Study|Lack of Efficacy|4|||
23641557|NCT01302067|66071705|FG002|Overall Study|Lack of Efficacy|2|||
23641558|NCT01302067|66071703|FG000|Overall Study|Lost to Follow-up|9|||
23641559|NCT01302067|66071704|FG001|Overall Study|Lost to Follow-up|4|||
23641560|NCT01302067|66071705|FG002|Overall Study|Lost to Follow-up|15|||
23641561|NCT01302067|66071703|FG000|Overall Study|Withdrawal by Subject|13|||
23355737|NCT00298363|65048655|FG002|Overall Study|Protocol Violation|0|||
23355738|NCT00298363|65048653|FG000|Overall Study|Withdrawal by Subject|5|||
23355739|NCT00298363|65048654|FG001|Overall Study|Withdrawal by Subject|1|||
23355740|NCT00298363|65048655|FG002|Overall Study|Withdrawal by Subject|3|||
23355741|NCT00298363|65048653|FG000|Overall Study|Adverse Event|5|||
23355742|NCT00298363|65048654|FG001|Overall Study|Adverse Event|2|||
23355743|NCT00298363|65048655|FG002|Overall Study|Adverse Event|2|||
23641562|NCT01302067|66071704|FG001|Overall Study|Withdrawal by Subject|6|||
23641563|NCT01302067|66071705|FG002|Overall Study|Withdrawal by Subject|10|||
23641564|NCT01302067|66071703|FG000|Overall Study|Other|1|||
23641565|NCT01302067|66071704|FG001|Overall Study|Other|1|||
23641566|NCT01302067|66071705|FG002|Overall Study|Other|3|||
23641567|NCT01302067|66071703|FG000|Overall Study|Protocol Violation|11|||
23641568|NCT01302067|66071704|FG001|Overall Study|Protocol Violation|0|||
23641569|NCT01302067|66071705|FG002|Overall Study|Protocol Violation|8|||
23641570|NCT01302067|66071703|FG000|Overall Study|Adverse Event|27|||
23641571|NCT01302067|66071704|FG001|Overall Study|Adverse Event|14|||
23641572|NCT01302067|66071705|FG002|Overall Study|Adverse Event|45|||
23641573|NCT02207569|66071706|FG000|1-Month|Death|6|||
23641574|NCT02207569|66071706|FG000|1-Month|Withdrawal by Subject|2|||
23355744|NCT00298363|65048653|FG000|Overall Study|Lack of Efficacy|2|||
23355745|NCT00298363|65048654|FG001|Overall Study|Lack of Efficacy|3|||
23355746|NCT00298363|65048655|FG002|Overall Study|Lack of Efficacy|0|||
23355747|NCT03951753|65048656|FG000|Overall Study|Adverse Event|1|||
23355748|NCT03951753|65048657|FG001|Overall Study|Adverse Event|0|||
23355749|NCT03951753|65048658|FG002|Overall Study|Adverse Event|3|||
23355750|NCT03951753|65048656|FG000|Overall Study|Withdrawal by Subject|3|||
23355751|NCT03951753|65048657|FG001|Overall Study|Withdrawal by Subject|1|||
23355752|NCT03951753|65048658|FG002|Overall Study|Withdrawal by Subject|0|||
23355753|NCT03951753|65048656|FG000|Overall Study|Lost to Follow-up|0|||
23355754|NCT03951753|65048657|FG001|Overall Study|Lost to Follow-up|0|||
23355755|NCT03951753|65048658|FG002|Overall Study|Lost to Follow-up|1|||
23355756|NCT01190189|65048661|FG000|Overall Study|Lost to Follow-up|4|||
23355757|NCT01190189|65048661|FG000|Overall Study|Withdrawal by Subject|1|||
23355758|NCT01190189|65048661|FG000|Overall Study|Migrated/moved from study area|1|||
23355759|NCT03046056|65048662|FG000|Overall Study|Non-responder at Week 10|6|||
23355760|NCT03046056|65048663|FG001|Overall Study|Non-responder at Week 10|6|||
23355761|NCT03046056|65048664|FG002|Overall Study|Non-responder at Week 10|4|||
23355762|NCT03046056|65048662|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
23355763|NCT03046056|65048663|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
23355764|NCT03046056|65048664|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
23355765|NCT03046056|65048662|FG000|Overall Study|Adverse Event|1|||
23355766|NCT03046056|65048663|FG001|Overall Study|Adverse Event|5|||
23355767|NCT03046056|65048664|FG002|Overall Study|Adverse Event|0|||
23355768|NCT03046056|65048662|FG000|Overall Study|Non-compliance With Study Drug|0|||
23355769|NCT03046056|65048663|FG001|Overall Study|Non-compliance With Study Drug|0|||
23355770|NCT03046056|65048664|FG002|Overall Study|Non-compliance With Study Drug|2|||
23355771|NCT03046056|65048662|FG000|Overall Study|Protocol Violation|1|||
23355772|NCT03046056|65048663|FG001|Overall Study|Protocol Violation|1|||
23355773|NCT03046056|65048664|FG002|Overall Study|Protocol Violation|0|||
23355774|NCT03046056|65048662|FG000|Overall Study|Investigator's Discretion|0|||
23355775|NCT03046056|65048663|FG001|Overall Study|Investigator's Discretion|1|||
23355776|NCT03046056|65048664|FG002|Overall Study|Investigator's Discretion|0|||
23355777|NCT03046056|65048662|FG000|Overall Study|Withdrew Consent|1|||
23355778|NCT03046056|65048663|FG001|Overall Study|Withdrew Consent|0|||
23355779|NCT03046056|65048664|FG002|Overall Study|Withdrew Consent|0|||
23355780|NCT00741598|65048665|FG000|Overall Study|Lost to Follow-up|3|||
23355781|NCT00741598|65048666|FG001|Overall Study|Lost to Follow-up|4|||
23355782|NCT00741598|65048665|FG000|Overall Study|Lack of Efficacy|1|||
23355783|NCT00741598|65048666|FG001|Overall Study|Lack of Efficacy|2|||
23355784|NCT00741598|65048665|FG000|Overall Study|Physician Decision|1|||
23355785|NCT00741598|65048666|FG001|Overall Study|Physician Decision|1|||
23355786|NCT00741598|65048665|FG000|Overall Study|Pregnancy|1|||
23355787|NCT00741598|65048666|FG001|Overall Study|Pregnancy|0|||
23355788|NCT00741598|65048665|FG000|Overall Study|Withdrawal by Subject|3|||
23355789|NCT00741598|65048666|FG001|Overall Study|Withdrawal by Subject|2|||
23355790|NCT01084538|65048670|FG000|Overall Study|Drug not available|30|||
23355791|NCT01084538|65048670|FG000|Overall Study|Adverse Event|9|||
23355792|NCT01084538|65048670|FG000|Overall Study|Kidney transplant|6|||
23355793|NCT01084538|65048670|FG000|Overall Study|Serious Adverse Event|3|||
23355794|NCT01084538|65048670|FG000|Overall Study|Lack of effectiveness|2|||
23355795|NCT01084538|65048670|FG000|Overall Study|Patient noncompliance|2|||
23355796|NCT01084538|65048670|FG000|Overall Study|Hyperphosphatemia|2|||
23355797|NCT01084538|65048670|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
23355798|NCT01084538|65048670|FG000|Overall Study|Change of residence|2|||
23355799|NCT01084538|65048670|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
23472570|NCT00545272|65474075|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23641575|NCT02207569|66071706|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
23641576|NCT02207569|66071706|FG000|6-Month|Death|8|||
23641577|NCT02207569|66071706|FG000|6-Month|Withdrawal by Subject|2|||
23641578|NCT02207569|66071706|FG000|12-Month|Death|14|||
23795936|NCT01466036|66630084|FG000|Overall Study|progression/relapse|14|||
23355800|NCT01084538|65048670|FG000|Overall Study|Reason unknown|8|||
23355801|NCT03883477|65048677|FG000|Overall Study|Death|1|||
23355802|NCT03883477|65048678|FG001|Overall Study|Death|0|||
23355803|NCT03883477|65048677|FG000|Overall Study|Protocol Violation|0|||
23355804|NCT03883477|65048678|FG001|Overall Study|Protocol Violation|1|||
23355805|NCT02187029|65048687|FG000|Overall Study|Adverse Event|0|||
23355806|NCT02187029|65048688|FG001|Overall Study|Adverse Event|1|||
23355807|NCT02187029|65048689|FG002|Overall Study|Adverse Event|1|||
23641579|NCT02207569|66071706|FG000|12-Month|Withdrawal by Subject|2|||
23641580|NCT02207569|66071706|FG000|24-Month|Death|23|||
23641581|NCT02207569|66071706|FG000|24-Month|Withdrawal by Subject|3|||
23641582|NCT02207569|66071706|FG000|36-Month|Death|23|||
23355808|NCT02187029|65048690|FG003|Overall Study|Adverse Event|0|||
23355809|NCT02187029|65048687|FG000|Overall Study|Study Terminated by Sponsor|0|||
23355810|NCT02187029|65048688|FG001|Overall Study|Study Terminated by Sponsor|0|||
23355811|NCT02187029|65048689|FG002|Overall Study|Study Terminated by Sponsor|10|||
23355812|NCT02187029|65048690|FG003|Overall Study|Study Terminated by Sponsor|3|||
23355813|NCT02187029|65048687|FG000|Overall Study|Withdrawal by Subject|1|||
23355814|NCT02187029|65048688|FG001|Overall Study|Withdrawal by Subject|0|||
23355815|NCT02187029|65048689|FG002|Overall Study|Withdrawal by Subject|0|||
23355816|NCT02187029|65048690|FG003|Overall Study|Withdrawal by Subject|0|||
23355817|NCT00548249|65048691|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
23355818|NCT00548249|65048692|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23355819|NCT00548249|65048693|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23588398|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588399|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
23588400|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588401|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
23588402|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23355820|NCT00548249|65048694|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
23588403|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23355821|NCT00548249|65048695|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23355822|NCT00548249|65048691|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
23355823|NCT00548249|65048692|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
23355824|NCT00548249|65048693|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
23355825|NCT00548249|65048694|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
23355826|NCT00548249|65048695|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
23355827|NCT00548249|65048691|FG000|Overall Study|Protocol Violation|1|||
23355828|NCT00548249|65048692|FG001|Overall Study|Protocol Violation|1|||
23355829|NCT00548249|65048693|FG002|Overall Study|Protocol Violation|4|||
23355830|NCT00548249|65048694|FG003|Overall Study|Protocol Violation|0|||
23355831|NCT00548249|65048695|FG004|Overall Study|Protocol Violation|3|||
23355832|NCT00548249|65048691|FG000|Overall Study|Miscellaneous|2|||
23355833|NCT00548249|65048692|FG001|Overall Study|Miscellaneous|3|||
23355834|NCT00548249|65048693|FG002|Overall Study|Miscellaneous|2|||
23355835|NCT00548249|65048694|FG003|Overall Study|Miscellaneous|0|||
23355836|NCT00548249|65048695|FG004|Overall Study|Miscellaneous|2|||
23355837|NCT00548249|65048691|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
23355838|NCT00548249|65048692|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
23355839|NCT00548249|65048693|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
23355840|NCT00548249|65048694|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
23355841|NCT00548249|65048695|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
23355842|NCT00548249|65048691|FG000|Overall Study|Adverse Event|2|||
23355843|NCT00548249|65048692|FG001|Overall Study|Adverse Event|2|||
23355844|NCT00548249|65048693|FG002|Overall Study|Adverse Event|0|||
23355845|NCT00548249|65048694|FG003|Overall Study|Adverse Event|1|||
23355846|NCT00548249|65048695|FG004|Overall Study|Adverse Event|1|||
23355847|NCT00548249|65048691|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
23355848|NCT00548249|65048692|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
23355849|NCT00548249|65048693|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
23355850|NCT00548249|65048694|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
23355851|NCT00548249|65048695|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
23355852|NCT00548249|65048691|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
23355853|NCT00548249|65048692|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
23355854|NCT00548249|65048693|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
23355855|NCT00548249|65048694|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
23355856|NCT00548249|65048695|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
23355857|NCT00548249|65048691|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355858|NCT00548249|65048692|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355859|NCT00548249|65048693|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355860|NCT00548249|65048694|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355861|NCT00548249|65048695|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
23355862|NCT00548249|65048691|FG000|Overall Study|Prolonged hospitalization|0|||
23355863|NCT00548249|65048692|FG001|Overall Study|Prolonged hospitalization|0|||
23355864|NCT00548249|65048693|FG002|Overall Study|Prolonged hospitalization|2|||
23355865|NCT00548249|65048694|FG003|Overall Study|Prolonged hospitalization|1|||
23355866|NCT00548249|65048695|FG004|Overall Study|Prolonged hospitalization|0|||
23355867|NCT00548249|65048691|FG000|Overall Study|Withdrawal by Subject|2|||
23355868|NCT00548249|65048692|FG001|Overall Study|Withdrawal by Subject|0|||
23355869|NCT00548249|65048693|FG002|Overall Study|Withdrawal by Subject|0|||
23355870|NCT00548249|65048694|FG003|Overall Study|Withdrawal by Subject|0|||
23355871|NCT00548249|65048695|FG004|Overall Study|Withdrawal by Subject|0|||
23355872|NCT00548249|65048691|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355873|NCT00548249|65048692|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
23355874|NCT00548249|65048693|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355875|NCT00548249|65048694|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355876|NCT00548249|65048695|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
23355877|NCT00548249|65048691|FG000|Overall Study|Sponsor's request|0|||
23355878|NCT00548249|65048692|FG001|Overall Study|Sponsor's request|0|||
23355879|NCT00548249|65048693|FG002|Overall Study|Sponsor's request|0|||
23355880|NCT00548249|65048694|FG003|Overall Study|Sponsor's request|1|||
23355881|NCT00548249|65048695|FG004|Overall Study|Sponsor's request|0|||
23355882|NCT01281956|65048696|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
23355883|NCT01281956|65048697|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
23355884|NCT01882803|65048698|FG000|Overall Study|Disease Progression|1|||
23355885|NCT01882803|65048698|FG000|Overall Study|Withdrawal by Subject|9|||
23588404|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588405|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23355886|NCT01882803|65048698|FG000|Overall Study|Death|68|||
23355887|NCT01882803|65048698|FG000|Overall Study|Physician Decision|3|||
23355888|NCT01882803|65048698|FG000|Overall Study|Lost to Follow-up|3|||
23355889|NCT01882803|65048698|FG000|Overall Study|Follow-up Completed|39|||
23355890|NCT01882803|65048698|FG000|Overall Study|Study Terminated by the Sponsor|6|||
23355891|NCT02190721|65048699|FG000|Overall Study|Patient was out of the city|0|||
23588406|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23472571|NCT00545272|65474076|FG004|Overall Study|Abnormal test procedure result(s)|1|||
23641583|NCT02207569|66071706|FG000|36-Month|Withdrawal by Subject|4|||
23641584|NCT02207569|66071706|FG000|48-Month|Death|25|||
23641585|NCT02207569|66071706|FG000|48-Month|Withdrawal by Subject|2|||
23641586|NCT02207569|66071706|FG000|48-Month|Lost to Follow-up|4|||
23641587|NCT02207569|66071706|FG000|60-Month|Death|1|||
23641588|NCT02207569|66071706|FG000|60-Month|Lost to Follow-up|1|||
23641589|NCT02207569|66071706|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
23641590|NCT02207569|66071706|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
23472572|NCT00545272|65474077|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23641591|NCT00287690|66071709|FG000|Overall Study|Protocol Violation|20|||
23641592|NCT00287690|66071710|FG001|Overall Study|Protocol Violation|26|||
23641593|NCT04772898|66075174|FG000|Overall Study|Withdrawal by Subject|0|||
23641594|NCT04772898|66075175|FG001|Overall Study|Withdrawal by Subject|1|||
23641595|NCT01536015|66075179|FG000|Overall Study|Adverse Event|1|||
23641596|NCT01536015|66075180|FG001|Overall Study|Adverse Event|4|||
23641597|NCT01536015|66075179|FG000|Overall Study|Lost to Follow-up|0|||
23641598|NCT01536015|66075180|FG001|Overall Study|Lost to Follow-up|1|||
23641599|NCT01536015|66075179|FG000|Overall Study|Inclusion Criterion not met|2|||
23355892|NCT02190721|65048700|FG001|Overall Study|Patient was out of the city|1|||
23355893|NCT02190721|65048701|FG002|Overall Study|Patient was out of the city|0|||
23355894|NCT02227368|65048702|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
23355895|NCT02227368|65048703|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
23355896|NCT02227368|65048702|FG000|Overall Study|Lost to Follow-up|1|||
23355897|NCT02227368|65048703|FG001|Overall Study|Lost to Follow-up|0|||
23355898|NCT02227368|65048702|FG000|Overall Study|Adverse Event|1|||
23355899|NCT02227368|65048703|FG001|Overall Study|Adverse Event|0|||
23355900|NCT00632125|65048704|FG000|Overall Study|Death|82|||
23355901|NCT00632125|65048704|FG000|Overall Study|Withdrawal by Subject|44|||
23355902|NCT00632125|65048704|FG000|Overall Study|Adverse Event|36|||
23355903|NCT00632125|65048704|FG000|Overall Study|Renal transplantation|17|||
23641600|NCT01536015|66075180|FG001|Overall Study|Inclusion Criterion not met|0|||
23641601|NCT01536015|66075179|FG000|Overall Study|Study closure|5|||
23641602|NCT01536015|66075180|FG001|Overall Study|Study closure|5|||
23355904|NCT00632125|65048704|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
23641603|NCT00201643|66075183|FG000|Overall Study|Withdrawal by Subject|5|||
23641604|NCT00201643|66075184|FG001|Overall Study|Withdrawal by Subject|4|||
23641605|NCT01307579|66075185|FG000|Overall Study|Death|3|||
23641606|NCT01307579|66075186|FG001|Overall Study|Death|6|||
23641607|NCT01307579|66075185|FG000|Overall Study|Physician Decision|26|||
23641608|NCT01307579|66075186|FG001|Overall Study|Physician Decision|29|||
23641609|NCT01307579|66075185|FG000|Overall Study|Withdrawal by Subject|7|||
23641610|NCT01307579|66075186|FG001|Overall Study|Withdrawal by Subject|3|||
23795937|NCT01466036|66630085|FG001|Overall Study|progression/relapse|21|||
23795938|NCT01466036|66630084|FG000|Overall Study|prolonged treatment delay|1|||
23795939|NCT01466036|66630085|FG001|Overall Study|prolonged treatment delay|1|||
23795940|NCT00603512|66630088|FG000|Overall Study|Adverse Event|0|||
23795941|NCT00603512|66630089|FG001|Overall Study|Adverse Event|2|||
23795942|NCT00603512|66630090|FG002|Overall Study|Adverse Event|4|||
23795943|NCT00603512|66630091|FG003|Overall Study|Adverse Event|4|||
23795944|NCT00603512|66630092|FG004|Overall Study|Adverse Event|2|||
23795945|NCT00603512|66630088|FG000|Overall Study|Lack of Efficacy|0|||
23795946|NCT00603512|66630089|FG001|Overall Study|Lack of Efficacy|1|||
23355905|NCT00632125|65048704|FG000|Overall Study|Non-compliance|8|||
23355906|NCT00632125|65048704|FG000|Overall Study|Development of uncontrolled hypertension|5|||
23355907|NCT00632125|65048704|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
23795947|NCT00603512|66630090|FG002|Overall Study|Lack of Efficacy|0|||
23355908|NCT01931397|65048709|FG000|Overall Study|Physician Decision|2|||
23355909|NCT01931397|65048709|FG000|Overall Study|Withdrawal by Subject|8|||
23795948|NCT00603512|66630091|FG003|Overall Study|Lack of Efficacy|0|||
23795949|NCT00603512|66630092|FG004|Overall Study|Lack of Efficacy|1|||
23795950|NCT00603512|66630088|FG000|Overall Study|Other|2|||
23795951|NCT00603512|66630089|FG001|Overall Study|Other|1|||
23795952|NCT00603512|66630090|FG002|Overall Study|Other|0|||
23795953|NCT00603512|66630091|FG003|Overall Study|Other|1|||
23795954|NCT00603512|66630092|FG004|Overall Study|Other|1|||
23795955|NCT00603512|66630088|FG000|Overall Study|Withdrawal by Subject|0|||
23795956|NCT00603512|66630089|FG001|Overall Study|Withdrawal by Subject|0|||
23795957|NCT00603512|66630090|FG002|Overall Study|Withdrawal by Subject|0|||
23795958|NCT00603512|66630091|FG003|Overall Study|Withdrawal by Subject|0|||
23795959|NCT00603512|66630092|FG004|Overall Study|Withdrawal by Subject|1|||
23795960|NCT00603512|66630088|FG000|Overall Study|Randomized but not treated|0|||
23795961|NCT00603512|66630089|FG001|Overall Study|Randomized but not treated|1|||
23795962|NCT00603512|66630090|FG002|Overall Study|Randomized but not treated|1|||
23355910|NCT01931397|65048709|FG000|Overall Study|moved out of state|1|||
23355911|NCT03699540|65048712|FG000|Overall Study|Lost to Follow-up|1|||
23355912|NCT01317004|65048713|FG000|Overall Study|Withdrawal by Subject|1|||
23355913|NCT01317004|65048714|FG001|Overall Study|Withdrawal by Subject|4|||
23355914|NCT01317004|65048713|FG000|Overall Study|Protocol Violation|0|||
23641611|NCT01307579|66075185|FG000|Overall Study|Institutional diagnosis of IFD|21|||
23641612|NCT01307579|66075186|FG001|Overall Study|Institutional diagnosis of IFD|36|||
23641613|NCT01307579|66075185|FG000|Overall Study|Begin conditioning for HSCT|42|||
23641614|NCT01307579|66075186|FG001|Overall Study|Begin conditioning for HSCT|44|||
23641615|NCT01307579|66075185|FG000|Overall Study|Refractory or relapsed AML|38|||
23641616|NCT01307579|66075186|FG001|Overall Study|Refractory or relapsed AML|23|||
23641617|NCT01307579|66075185|FG000|Overall Study|Ineligible|3|||
23641618|NCT01307579|66075186|FG001|Overall Study|Ineligible|4|||
23641619|NCT02432196|66075187|FG000|Overall Study|Exit - did not receive study device|1|||
23641620|NCT02432196|66075187|FG000|Overall Study|Death|2|||
23641621|NCT02432196|66075187|FG000|Overall Study|Reoperation|3|||
23641622|NCT00864253|66075189|FG000|Overall Study|Adverse Event|56|||
23355915|NCT01317004|65048714|FG001|Overall Study|Protocol Violation|2|||
23355916|NCT01317004|65048713|FG000|Overall Study|Adverse Event|3|||
23355917|NCT01317004|65048714|FG001|Overall Study|Adverse Event|3|||
23355918|NCT01306214|65048715|FG000|Overall Study|Death|0|||
23355919|NCT01306214|65048716|FG001|Overall Study|Death|0|||
23355920|NCT01306214|65048717|FG002|Overall Study|Death|1|||
23355921|NCT01306214|65048715|FG000|Overall Study|Lost to Follow-up|3|||
23355922|NCT01306214|65048716|FG001|Overall Study|Lost to Follow-up|5|||
23355923|NCT01306214|65048717|FG002|Overall Study|Lost to Follow-up|4|||
23355924|NCT01306214|65048715|FG000|Overall Study|Withdrawal by Subject|24|||
23355925|NCT01306214|65048716|FG001|Overall Study|Withdrawal by Subject|22|||
23355926|NCT01306214|65048717|FG002|Overall Study|Withdrawal by Subject|16|||
23355927|NCT01306214|65048715|FG000|Overall Study|Not treated|1|||
23355928|NCT01306214|65048716|FG001|Overall Study|Not treated|1|||
23355929|NCT01306214|65048717|FG002|Overall Study|Not treated|1|||
23355930|NCT00593918|65048718|FG000|Overall Study|Withdrawal by Subject|5|||
23355931|NCT00593918|65048719|FG001|Overall Study|Withdrawal by Subject|24|||
23355932|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
23355933|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
23355934|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
23355935|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
23355936|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
23355937|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
23355938|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
23355939|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
23355940|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
23355941|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
23355942|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
23355943|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
23355944|NCT01777139|65048720|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
23355945|NCT01777139|65048721|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
23355946|NCT01777139|65048720|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
23355947|NCT01777139|65048721|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
23355948|NCT00262002|65048725|FG000|Overall Study|Adverse Event|2|||
23355949|NCT00262002|65048726|FG001|Overall Study|Adverse Event|1|||
23355950|NCT00262002|65048727|FG002|Overall Study|Adverse Event|0|||
23355951|NCT00262002|65048728|FG003|Overall Study|Adverse Event|0|||
23355952|NCT00262002|65048729|FG004|Overall Study|Adverse Event|0|||
23355953|NCT00262002|65048730|FG005|Overall Study|Adverse Event|1|||
23355954|NCT00262002|65048731|FG006|Overall Study|Adverse Event|0|||
23355955|NCT00262002|65048725|FG000|Overall Study|Withdrawal by Subject|4|||
23355956|NCT00262002|65048726|FG001|Overall Study|Withdrawal by Subject|2|||
23355957|NCT00262002|65048727|FG002|Overall Study|Withdrawal by Subject|0|||
23355958|NCT00262002|65048728|FG003|Overall Study|Withdrawal by Subject|1|||
23355959|NCT00262002|65048729|FG004|Overall Study|Withdrawal by Subject|2|||
23355960|NCT00262002|65048730|FG005|Overall Study|Withdrawal by Subject|2|||
23355961|NCT00262002|65048731|FG006|Overall Study|Withdrawal by Subject|2|||
23355962|NCT00262002|65048725|FG000|Overall Study|Lost to Follow-up|2|||
23355963|NCT00262002|65048726|FG001|Overall Study|Lost to Follow-up|0|||
23355964|NCT00262002|65048727|FG002|Overall Study|Lost to Follow-up|0|||
23355965|NCT00262002|65048728|FG003|Overall Study|Lost to Follow-up|2|||
23355966|NCT00262002|65048729|FG004|Overall Study|Lost to Follow-up|0|||
23355967|NCT00262002|65048730|FG005|Overall Study|Lost to Follow-up|1|||
23355968|NCT00262002|65048731|FG006|Overall Study|Lost to Follow-up|0|||
23641623|NCT00864253|66075190|FG001|Overall Study|Adverse Event|11|||
23641624|NCT00864253|66075189|FG000|Overall Study|Unrelated Adverse Event|3|||
23641625|NCT00864253|66075190|FG001|Overall Study|Unrelated Adverse Event|1|||
23641626|NCT00864253|66075189|FG000|Overall Study|Physician Decision|11|||
23641627|NCT00864253|66075190|FG001|Overall Study|Physician Decision|15|||
23641628|NCT00864253|66075189|FG000|Overall Study|Protocol Violation|0|||
23641629|NCT00864253|66075190|FG001|Overall Study|Protocol Violation|2|||
23641630|NCT00864253|66075189|FG000|Overall Study|Lost to Follow-up|1|||
23355969|NCT00262002|65048725|FG000|Overall Study|Inapropriate enrollment|0|||
23355970|NCT00262002|65048726|FG001|Overall Study|Inapropriate enrollment|1|||
23355971|NCT00262002|65048727|FG002|Overall Study|Inapropriate enrollment|0|||
23355972|NCT00262002|65048728|FG003|Overall Study|Inapropriate enrollment|0|||
23355973|NCT00262002|65048729|FG004|Overall Study|Inapropriate enrollment|0|||
23355974|NCT00262002|65048730|FG005|Overall Study|Inapropriate enrollment|0|||
23472573|NCT00545272|65474072|FG000|Overall Study|Lost to Follow-up|0|||
23641631|NCT00864253|66075190|FG001|Overall Study|Lost to Follow-up|1|||
23641632|NCT00864253|66075189|FG000|Overall Study|Withdrawal by Subject|18|||
23641633|NCT00864253|66075190|FG001|Overall Study|Withdrawal by Subject|18|||
23641634|NCT00864253|66075189|FG000|Overall Study|Death|1|||
23641635|NCT00864253|66075190|FG001|Overall Study|Death|0|||
23641636|NCT00864253|66075189|FG000|Overall Study|Ongoing|2|||
23355975|NCT00262002|65048731|FG006|Overall Study|Inapropriate enrollment|0|||
23355976|NCT00262002|65048725|FG000|Overall Study|Protocol Violation|3|||
23355977|NCT00262002|65048726|FG001|Overall Study|Protocol Violation|2|||
23355978|NCT00262002|65048727|FG002|Overall Study|Protocol Violation|0|||
23355979|NCT00262002|65048728|FG003|Overall Study|Protocol Violation|2|||
23355980|NCT00262002|65048729|FG004|Overall Study|Protocol Violation|5|||
23355981|NCT00262002|65048730|FG005|Overall Study|Protocol Violation|3|||
23355982|NCT00262002|65048731|FG006|Overall Study|Protocol Violation|2|||
23355983|NCT00262002|65048725|FG000|Overall Study|Unable to classify|0|||
23355984|NCT00262002|65048726|FG001|Overall Study|Unable to classify|0|||
23355985|NCT00262002|65048727|FG002|Overall Study|Unable to classify|0|||
23355986|NCT00262002|65048728|FG003|Overall Study|Unable to classify|0|||
23355987|NCT00262002|65048729|FG004|Overall Study|Unable to classify|0|||
23355988|NCT00262002|65048730|FG005|Overall Study|Unable to classify|0|||
23355989|NCT00262002|65048731|FG006|Overall Study|Unable to classify|2|||
23355990|NCT01204918|65048732|FG000|Overall Study|Withdrawal by Subject|4|||
23355991|NCT01204918|65048733|FG001|Overall Study|Withdrawal by Subject|10|||
23355992|NCT01204918|65048734|FG002|Overall Study|Withdrawal by Subject|5|||
23355993|NCT02437188|65048739|FG000|Overall Study|Randomized but did not receive surgery|4|||
23355994|NCT02437188|65048740|FG001|Overall Study|Randomized but did not receive surgery|8|||
23355995|NCT02437188|65048739|FG000|Overall Study|Adverse Event|0|||
23355996|NCT02437188|65048740|FG001|Overall Study|Adverse Event|1|||
23355997|NCT03488563|65048741|FG000|Overall Study|Lost to Follow-up|7|||
23355998|NCT03488563|65048742|FG001|Overall Study|Lost to Follow-up|6|||
23355999|NCT03488563|65048743|FG002|Overall Study|Lost to Follow-up|7|||
23356000|NCT03488563|65048741|FG000|Overall Study|Withdrawal by Subject|8|||
23356001|NCT03488563|65048742|FG001|Overall Study|Withdrawal by Subject|7|||
23588407|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23356002|NCT03488563|65048743|FG002|Overall Study|Withdrawal by Subject|7|||
23356003|NCT03488563|65048741|FG000|Overall Study|Physician Decision|0|||
23356004|NCT03488563|65048742|FG001|Overall Study|Physician Decision|0|||
23588408|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588409|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588410|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588411|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
23588412|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588413|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588414|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588415|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588416|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588417|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
23588418|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588419|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
23356005|NCT03488563|65048743|FG002|Overall Study|Physician Decision|1|||
23588420|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23641637|NCT00864253|66075190|FG001|Overall Study|Ongoing|3|||
23641638|NCT00864253|66075189|FG000|Overall Study|Untreated|7|||
23641639|NCT00864253|66075190|FG001|Overall Study|Untreated|7|||
23641640|NCT01034163|66075191|FG000|Overall Study|Treatment completed as per protocol|8|||
23641641|NCT01034163|66075192|FG001|Overall Study|Treatment completed as per protocol|7|||
23641642|NCT01034163|66075191|FG000|Overall Study|Withdrawal by Subject|8|||
23641643|NCT01034163|66075192|FG001|Overall Study|Withdrawal by Subject|2|||
23641644|NCT01034163|66075191|FG000|Overall Study|Protocol deviation|1|||
23641645|NCT01034163|66075192|FG001|Overall Study|Protocol deviation|0|||
23795963|NCT00603512|66630091|FG003|Overall Study|Randomized but not treated|2|||
23795964|NCT00603512|66630092|FG004|Overall Study|Randomized but not treated|0|||
23795965|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
23795966|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
23795967|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
23795968|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
23795969|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
23795970|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
23588421|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588422|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588423|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588424|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588425|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588426|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
23588427|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588428|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588429|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
23588430|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588431|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588432|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588433|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588434|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588435|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588436|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23795971|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
23795972|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
23588437|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
23588438|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
23588439|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23795973|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
23795974|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
23356006|NCT03488563|65048741|FG000|Overall Study|Protocol Violation|3|||
23356007|NCT03488563|65048742|FG001|Overall Study|Protocol Violation|2|||
23356008|NCT03488563|65048743|FG002|Overall Study|Protocol Violation|6|||
23356009|NCT03488563|65048741|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
23356010|NCT03488563|65048742|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
23356011|NCT03488563|65048743|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
23356012|NCT03488563|65048741|FG000|Overall Study|Use of prohibited medication|2|||
23356013|NCT03488563|65048742|FG001|Overall Study|Use of prohibited medication|0|||
23588440|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588441|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588442|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588443|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
23588444|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
23588445|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23641646|NCT01034163|66075191|FG000|Overall Study|Disease progression|3|||
23356014|NCT03488563|65048743|FG002|Overall Study|Use of prohibited medication|0|||
23356015|NCT03488563|65048741|FG000|Overall Study|Adverse Event|1|||
23356016|NCT03488563|65048742|FG001|Overall Study|Adverse Event|0|||
23356017|NCT03488563|65048743|FG002|Overall Study|Adverse Event|1|||
23356018|NCT03488563|65048741|FG000|Overall Study|Subject returned for ET visit|0|||
23356019|NCT03488563|65048742|FG001|Overall Study|Subject returned for ET visit|1|||
23641647|NCT01034163|66075192|FG001|Overall Study|Disease progression|4|||
23641648|NCT01034163|66075191|FG000|Overall Study|Adverse Event|6|||
23641649|NCT01034163|66075192|FG001|Overall Study|Adverse Event|0|||
23641650|NCT01034163|66075191|FG000|Overall Study|Administrative problems|0|||
23641651|NCT01034163|66075192|FG001|Overall Study|Administrative problems|1|||
23356020|NCT03488563|65048743|FG002|Overall Study|Subject returned for ET visit|0|||
23641652|NCT01034163|66075191|FG000|Overall Study|Abnormal laboratory value|1|||
23641653|NCT01034163|66075192|FG001|Overall Study|Abnormal laboratory value|0|||
23588446|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23588447|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
23356021|NCT03488563|65048741|FG000|Overall Study|Sponsor's decision|0|||
23356022|NCT03488563|65048742|FG001|Overall Study|Sponsor's decision|0|||
23356023|NCT03488563|65048743|FG002|Overall Study|Sponsor's decision|1|||
23356024|NCT02070978|65048744|FG000|Overall Study|Adverse Event|6|||
23356025|NCT02070978|65048745|FG001|Overall Study|Adverse Event|2|||
23356026|NCT02070978|65048746|FG002|Overall Study|Adverse Event|0|||
23356027|NCT02070978|65048744|FG000|Overall Study|Lost to Follow-up|1|||
23356028|NCT02070978|65048745|FG001|Overall Study|Lost to Follow-up|3|||
23356029|NCT02070978|65048746|FG002|Overall Study|Lost to Follow-up|4|||
23356030|NCT02070978|65048744|FG000|Overall Study|Withdrawal by Subject|3|||
23356031|NCT02070978|65048745|FG001|Overall Study|Withdrawal by Subject|5|||
23356032|NCT02070978|65048746|FG002|Overall Study|Withdrawal by Subject|3|||
23472574|NCT00545272|65474073|FG001|Overall Study|Lost to Follow-up|0|||
23472575|NCT00545272|65474074|FG002|Overall Study|Lost to Follow-up|0|||
23472576|NCT00545272|65474075|FG003|Overall Study|Lost to Follow-up|0|||
23472577|NCT00545272|65474076|FG004|Overall Study|Lost to Follow-up|1|||
23795975|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
23795976|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
23795977|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
23795978|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
23795979|NCT04592419|66630093|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
23795980|NCT04592419|66630094|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
23795981|NCT04592419|66630093|FG000|Open-Label Extension Period|Adverse Event|1|||
23795982|NCT04592419|66630094|FG001|Open-Label Extension Period|Adverse Event|2|||
23795983|NCT04592419|66630093|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
23472578|NCT00545272|65474077|FG005|Overall Study|Lost to Follow-up|0|||
23472579|NCT00539188|65474083|FG000|Overall Study|Withdrawal by Subject|1|||
23472580|NCT00539188|65474084|FG001|Overall Study|Withdrawal by Subject|0|||
23472581|NCT00539188|65474083|FG000|Overall Study|Lost to Follow-up|2|||
23472582|NCT00539188|65474084|FG001|Overall Study|Lost to Follow-up|1|||
23472583|NCT01010867|65474087|FG000|Overall Study|< 50% adherence to probiotic|1|||
23472584|NCT03275350|65474091|FG000|Overall Study|Lost to Follow-up|4|||
23472585|NCT03275350|65474092|FG001|Overall Study|Lost to Follow-up|6|||
23472586|NCT03275350|65474091|FG000|Overall Study|Death|2|||
23472587|NCT03275350|65474092|FG001|Overall Study|Death|1|||
23795984|NCT04592419|66630094|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
23795985|NCT04592419|66630093|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
23795986|NCT04592419|66630094|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
23795987|NCT04592419|66630093|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23795988|NCT04592419|66630094|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
23795989|NCT04592419|66630093|FG000|Open-Label Extension Period|Sponsor Request|73|||
23795990|NCT04592419|66630094|FG001|Open-Label Extension Period|Sponsor Request|84|||
23795991|NCT03180528|66630097|FG000|Overall Study|Adverse Event|1|||
23795992|NCT03180528|66630097|FG000|Overall Study|Withdrawal by Subject|1|||
23795993|NCT03180528|66630097|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
23795994|NCT01332968|66630100|FG000|Induction Period|Adverse Event|23|||
23795995|NCT01332968|66630101|FG001|Induction Period|Adverse Event|26|||
23795996|NCT01332968|66630102|FG002|Induction Period|Adverse Event|0|||
23795997|NCT01332968|66630103|FG003|Induction Period|Adverse Event|0|||
23795998|NCT01332968|66630104|FG004|Induction Period|Adverse Event|0|||
23795999|NCT01332968|66630105|FG005|Induction Period|Adverse Event|0|||
23796000|NCT01332968|66630106|FG006|Induction Period|Adverse Event|0|||
23796001|NCT01332968|66630107|FG007|Induction Period|Adverse Event|0|||
23796002|NCT01332968|66630100|FG000|Induction Period|Death|1|||
23796003|NCT01332968|66630101|FG001|Induction Period|Death|4|||
23796004|NCT01332968|66630102|FG002|Induction Period|Death|0|||
23796005|NCT01332968|66630103|FG003|Induction Period|Death|0|||
23796006|NCT01332968|66630104|FG004|Induction Period|Death|0|||
23796007|NCT01332968|66630105|FG005|Induction Period|Death|0|||
23796008|NCT01332968|66630106|FG006|Induction Period|Death|0|||
23796009|NCT01332968|66630107|FG007|Induction Period|Death|0|||
23796010|NCT01332968|66630100|FG000|Induction Period|Non-compliance|1|||
23796011|NCT01332968|66630101|FG001|Induction Period|Non-compliance|0|||
23796012|NCT01332968|66630102|FG002|Induction Period|Non-compliance|0|||
23796013|NCT01332968|66630103|FG003|Induction Period|Non-compliance|0|||
23796014|NCT01332968|66630104|FG004|Induction Period|Non-compliance|0|||
23796015|NCT01332968|66630105|FG005|Induction Period|Non-compliance|0|||
23796016|NCT01332968|66630106|FG006|Induction Period|Non-compliance|0|||
23356033|NCT02070978|65048744|FG000|Overall Study|Protocol Violation|1|||
23356034|NCT02070978|65048745|FG001|Overall Study|Protocol Violation|0|||
23356035|NCT02070978|65048746|FG002|Overall Study|Protocol Violation|3|||
23356036|NCT02070978|65048744|FG000|Overall Study|Lack of Efficacy|0|||
23472588|NCT03275350|65474091|FG000|Overall Study|Physician Decision|1|||
23796017|NCT01332968|66630107|FG007|Induction Period|Non-compliance|0|||
23796018|NCT01332968|66630100|FG000|Induction Period|Other|2|||
23796019|NCT01332968|66630101|FG001|Induction Period|Other|2|||
23796020|NCT01332968|66630102|FG002|Induction Period|Other|0|||
23356037|NCT02070978|65048745|FG001|Overall Study|Lack of Efficacy|1|||
23356038|NCT02070978|65048746|FG002|Overall Study|Lack of Efficacy|0|||
23356039|NCT02070978|65048744|FG000|Overall Study|Death|0|||
23356040|NCT02070978|65048745|FG001|Overall Study|Death|0|||
23356041|NCT02070978|65048746|FG002|Overall Study|Death|2|||
23356042|NCT02070978|65048744|FG000|Overall Study|Un-specified|3|||
23356043|NCT02070978|65048745|FG001|Overall Study|Un-specified|2|||
23356044|NCT02070978|65048746|FG002|Overall Study|Un-specified|2|||
23356045|NCT02070978|65048744|FG000|Overall Study|Terminated by Sponsor|33|||
23356046|NCT02070978|65048745|FG001|Overall Study|Terminated by Sponsor|40|||
23356047|NCT02070978|65048746|FG002|Overall Study|Terminated by Sponsor|39|||
23356048|NCT00313586|65048747|FG000|Overall Study|Disease progression|14|||
23356049|NCT00313586|65048748|FG001|Overall Study|Disease progression|19|||
23356050|NCT00313586|65048749|FG002|Overall Study|Disease progression|10|||
23356051|NCT00313586|65048750|FG003|Overall Study|Disease progression|3|||
23356052|NCT00313586|65048747|FG000|Overall Study|Adverse Event|12|||
23356053|NCT00313586|65048748|FG001|Overall Study|Adverse Event|18|||
23356054|NCT00313586|65048749|FG002|Overall Study|Adverse Event|3|||
23356055|NCT00313586|65048750|FG003|Overall Study|Adverse Event|10|||
23356056|NCT00313586|65048747|FG000|Overall Study|Death|11|||
23356057|NCT00313586|65048748|FG001|Overall Study|Death|8|||
23356058|NCT00313586|65048749|FG002|Overall Study|Death|1|||
23356059|NCT00313586|65048750|FG003|Overall Study|Death|7|||
23356060|NCT00313586|65048747|FG000|Overall Study|Withdrawal by Subject|13|||
23356061|NCT00313586|65048748|FG001|Overall Study|Withdrawal by Subject|6|||
23356062|NCT00313586|65048749|FG002|Overall Study|Withdrawal by Subject|6|||
23356063|NCT00313586|65048750|FG003|Overall Study|Withdrawal by Subject|2|||
23356064|NCT00313586|65048747|FG000|Overall Study|Alternative therapy|3|||
23356065|NCT00313586|65048748|FG001|Overall Study|Alternative therapy|6|||
23356066|NCT00313586|65048749|FG002|Overall Study|Alternative therapy|2|||
23356067|NCT00313586|65048750|FG003|Overall Study|Alternative therapy|0|||
23356068|NCT00313586|65048747|FG000|Overall Study|Other complicating disease|2|||
23356069|NCT00313586|65048748|FG001|Overall Study|Other complicating disease|2|||
23356070|NCT00313586|65048749|FG002|Overall Study|Other complicating disease|0|||
23356071|NCT00313586|65048750|FG003|Overall Study|Other complicating disease|0|||
23356072|NCT00313586|65048747|FG000|Overall Study|Did not achieve HI-major/better response|10|||
23356073|NCT00313586|65048748|FG001|Overall Study|Did not achieve HI-major/better response|7|||
23356074|NCT00313586|65048749|FG002|Overall Study|Did not achieve HI-major/better response|2|||
23356075|NCT00313586|65048750|FG003|Overall Study|Did not achieve HI-major/better response|1|||
23356076|NCT00313586|65048747|FG000|Overall Study|Physician Decision|2|||
23356077|NCT00313586|65048748|FG001|Overall Study|Physician Decision|1|||
23356078|NCT00313586|65048749|FG002|Overall Study|Physician Decision|0|||
23356079|NCT00313586|65048750|FG003|Overall Study|Physician Decision|0|||
23356080|NCT00313586|65048747|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
23356081|NCT00313586|65048748|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
23356082|NCT00313586|65048749|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
23472589|NCT03275350|65474092|FG001|Overall Study|Physician Decision|0|||
23472590|NCT03275350|65474091|FG000|Overall Study|Incarcerated|1|||
23472591|NCT03275350|65474092|FG001|Overall Study|Incarcerated|1|||
23356083|NCT00313586|65048750|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
23356084|NCT00313586|65048747|FG000|Overall Study|Lost insurance|0|||
23356085|NCT00313586|65048748|FG001|Overall Study|Lost insurance|1|||
23356086|NCT00313586|65048749|FG002|Overall Study|Lost insurance|0|||
23356087|NCT00313586|65048750|FG003|Overall Study|Lost insurance|0|||
23356088|NCT00313586|65048747|FG000|Overall Study|Moved|0|||
23356089|NCT00313586|65048748|FG001|Overall Study|Moved|1|||
23356090|NCT00313586|65048749|FG002|Overall Study|Moved|0|||
23472592|NCT01309282|65474097|FG000|Overall Study|Lost to Follow-up|1|||
23356091|NCT00313586|65048750|FG003|Overall Study|Moved|0|||
23356092|NCT00313586|65048747|FG000|Overall Study|Death before starting treatment|1|||
23356093|NCT00313586|65048748|FG001|Overall Study|Death before starting treatment|0|||
23356094|NCT00313586|65048749|FG002|Overall Study|Death before starting treatment|0|||
23356095|NCT00313586|65048750|FG003|Overall Study|Death before starting treatment|0|||
23356096|NCT03134911|65048756|FG000|Overall Study|Screen failure|31|||
23356097|NCT03134911|65048756|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
23356098|NCT01502033|65048757|FG000|Overall Study|1 participant had scalp discomfort|1|||
23356099|NCT01502033|65048757|FG000|Overall Study|1 participant had worsening depression|1|||
23356100|NCT01502033|65048757|FG000|Overall Study|1 participant went back to school|1|||
23356101|NCT01048944|65048759|FG000|Overall Study|Protocol Violation|8|||
23356102|NCT01048944|65048760|FG001|Overall Study|Protocol Violation|10|||
23356103|NCT01048944|65048761|FG002|Overall Study|Protocol Violation|10|||
23356104|NCT01048944|65048762|FG003|Overall Study|Protocol Violation|2|||
23356105|NCT00802672|65048765|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
23356106|NCT00802672|65048766|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
23356107|NCT00802672|65048767|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
23356108|NCT00802672|65048765|FG000|Overall Study|Adverse Event|1|||
23356109|NCT00802672|65048766|FG001|Overall Study|Adverse Event|1|||
23356110|NCT00802672|65048767|FG002|Overall Study|Adverse Event|1|||
23356111|NCT00802672|65048765|FG000|Overall Study|Protocol Violation|2|||
23356112|NCT00802672|65048766|FG001|Overall Study|Protocol Violation|1|||
23356113|NCT00802672|65048767|FG002|Overall Study|Protocol Violation|1|||
23356114|NCT00802672|65048765|FG000|Overall Study|Lost to Follow-up|5|||
23356115|NCT00802672|65048766|FG001|Overall Study|Lost to Follow-up|5|||
23356116|NCT00802672|65048767|FG002|Overall Study|Lost to Follow-up|3|||
23356117|NCT00802672|65048765|FG000|Overall Study|Withdrawal by Subject|1|||
23356118|NCT00802672|65048766|FG001|Overall Study|Withdrawal by Subject|1|||
23356119|NCT00802672|65048767|FG002|Overall Study|Withdrawal by Subject|2|||
23356120|NCT00802672|65048765|FG000|Overall Study|other|3|||
23356121|NCT00802672|65048766|FG001|Overall Study|other|1|||
23356122|NCT00802672|65048767|FG002|Overall Study|other|2|||
23356123|NCT00055497|65048784|FG000|Overall Study|Adverse Event|1|||
23356124|NCT00055497|65048785|FG001|Overall Study|Adverse Event|1|||
23356125|NCT00055497|65048786|FG002|Overall Study|Adverse Event|1|||
23356126|NCT00055497|65048787|FG003|Overall Study|Adverse Event|28|||
23356127|NCT00055497|65048784|FG000|Overall Study|Withdrawal by Subject|3|||
23356128|NCT00055497|65048785|FG001|Overall Study|Withdrawal by Subject|1|||
23356129|NCT00055497|65048786|FG002|Overall Study|Withdrawal by Subject|1|||
23356130|NCT00055497|65048787|FG003|Overall Study|Withdrawal by Subject|15|||
23356131|NCT00055497|65048784|FG000|Overall Study|Lost to Follow-up|0|||
23356132|NCT00055497|65048785|FG001|Overall Study|Lost to Follow-up|1|||
23356133|NCT00055497|65048786|FG002|Overall Study|Lost to Follow-up|0|||
23356134|NCT00055497|65048787|FG003|Overall Study|Lost to Follow-up|5|||
23796021|NCT01332968|66630103|FG003|Induction Period|Other|0|||
23796022|NCT01332968|66630104|FG004|Induction Period|Other|0|||
23796023|NCT01332968|66630105|FG005|Induction Period|Other|0|||
23796024|NCT01332968|66630106|FG006|Induction Period|Other|0|||
23796025|NCT01332968|66630107|FG007|Induction Period|Other|0|||
23796026|NCT01332968|66630100|FG000|Induction Period|Physician Decision|6|||
23796027|NCT01332968|66630101|FG001|Induction Period|Physician Decision|1|||
23796028|NCT01332968|66630102|FG002|Induction Period|Physician Decision|0|||
23796029|NCT01332968|66630103|FG003|Induction Period|Physician Decision|0|||
23796030|NCT01332968|66630104|FG004|Induction Period|Physician Decision|0|||
23796031|NCT01332968|66630105|FG005|Induction Period|Physician Decision|0|||
23796032|NCT01332968|66630106|FG006|Induction Period|Physician Decision|0|||
23796033|NCT01332968|66630107|FG007|Induction Period|Physician Decision|0|||
23796034|NCT01332968|66630100|FG000|Induction Period|Progressive Disease|15|||
23796035|NCT01332968|66630101|FG001|Induction Period|Progressive Disease|7|||
23796036|NCT01332968|66630102|FG002|Induction Period|Progressive Disease|0|||
23796037|NCT01332968|66630103|FG003|Induction Period|Progressive Disease|0|||
23796038|NCT01332968|66630104|FG004|Induction Period|Progressive Disease|0|||
23796039|NCT01332968|66630105|FG005|Induction Period|Progressive Disease|0|||
23796040|NCT01332968|66630106|FG006|Induction Period|Progressive Disease|0|||
23796041|NCT01332968|66630107|FG007|Induction Period|Progressive Disease|0|||
23796042|NCT01332968|66630100|FG000|Induction Period|Protocol Violation|3|||
23796043|NCT01332968|66630101|FG001|Induction Period|Protocol Violation|4|||
23796044|NCT01332968|66630102|FG002|Induction Period|Protocol Violation|0|||
23796045|NCT01332968|66630103|FG003|Induction Period|Protocol Violation|0|||
23796046|NCT01332968|66630104|FG004|Induction Period|Protocol Violation|0|||
23796047|NCT01332968|66630105|FG005|Induction Period|Protocol Violation|0|||
23796048|NCT01332968|66630106|FG006|Induction Period|Protocol Violation|0|||
23796049|NCT01332968|66630107|FG007|Induction Period|Protocol Violation|0|||
23796050|NCT01332968|66630100|FG000|Induction Period|Withdrawal by Subject|3|||
23796051|NCT01332968|66630101|FG001|Induction Period|Withdrawal by Subject|5|||
23796052|NCT01332968|66630102|FG002|Induction Period|Withdrawal by Subject|0|||
23796053|NCT01332968|66630103|FG003|Induction Period|Withdrawal by Subject|0|||
23796054|NCT01332968|66630104|FG004|Induction Period|Withdrawal by Subject|0|||
23796055|NCT01332968|66630105|FG005|Induction Period|Withdrawal by Subject|0|||
23796056|NCT01332968|66630106|FG006|Induction Period|Withdrawal by Subject|0|||
23796057|NCT01332968|66630107|FG007|Induction Period|Withdrawal by Subject|0|||
23796058|NCT01332968|66630100|FG000|Induction Period|Randomised but not treated|4|||
23796059|NCT01332968|66630101|FG001|Induction Period|Randomised but not treated|7|||
23796060|NCT01332968|66630102|FG002|Induction Period|Randomised but not treated|0|||
23796061|NCT01332968|66630103|FG003|Induction Period|Randomised but not treated|0|||
23356135|NCT00055497|65048784|FG000|Overall Study|Protocol Violation|0|||
23356136|NCT00055497|65048785|FG001|Overall Study|Protocol Violation|0|||
23356137|NCT00055497|65048786|FG002|Overall Study|Protocol Violation|0|||
23356138|NCT00055497|65048787|FG003|Overall Study|Protocol Violation|3|||
23356139|NCT00055497|65048784|FG000|Overall Study|Lack of Efficacy|1|||
23356140|NCT00055497|65048785|FG001|Overall Study|Lack of Efficacy|0|||
23356141|NCT00055497|65048786|FG002|Overall Study|Lack of Efficacy|0|||
23356142|NCT00055497|65048787|FG003|Overall Study|Lack of Efficacy|27|||
23356143|NCT00055497|65048784|FG000|Overall Study|Administrative Reasons|0|||
23356144|NCT00055497|65048785|FG001|Overall Study|Administrative Reasons|0|||
23356145|NCT00055497|65048786|FG002|Overall Study|Administrative Reasons|0|||
23356146|NCT00055497|65048787|FG003|Overall Study|Administrative Reasons|1|||
23356147|NCT00055497|65048784|FG000|Overall Study|Other|0|||
23356148|NCT00055497|65048785|FG001|Overall Study|Other|0|||
23356149|NCT00055497|65048786|FG002|Overall Study|Other|0|||
23356150|NCT00055497|65048787|FG003|Overall Study|Other|11|||
23356151|NCT00742027|65048789|FG000|Overall Study|Disease Progression|76|||
23356152|NCT00742027|65048789|FG000|Overall Study|New Cancer Therapy|19|||
23356153|NCT00742027|65048789|FG000|Overall Study|Withdrawal by Subject|18|||
23356154|NCT00742027|65048789|FG000|Overall Study|Death|7|||
23356155|NCT00742027|65048789|FG000|Overall Study|Lost to Follow-up|4|||
23356156|NCT00742027|65048789|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
23356157|NCT00742027|65048789|FG000|Overall Study|Missing|2|||
23356158|NCT00742027|65048789|FG000|Overall Study|Administrative Problems|1|||
23356159|NCT01698268|65048790|FG000|Overall Study|Physician Decision|2|||
23356160|NCT01698268|65048791|FG001|Overall Study|Physician Decision|1|||
23356161|NCT00849290|65048792|FG000|Overall Study|Adverse Event|3|||
23356162|NCT00849290|65048792|FG000|Overall Study|Death|14|||
23356163|NCT00849290|65048792|FG000|Overall Study|Withdrawal by Subject|11|||
23356164|NCT00849290|65048792|FG000|Overall Study|Lost to Follow-up|2|||
23356165|NCT00849290|65048792|FG000|Overall Study|Protocol Violation|5|||
23588448|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23588449|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23796062|NCT01332968|66630104|FG004|Induction Period|Randomised but not treated|0|||
23796063|NCT01332968|66630105|FG005|Induction Period|Randomised but not treated|0|||
23796064|NCT01332968|66630106|FG006|Induction Period|Randomised but not treated|0|||
23796065|NCT01332968|66630107|FG007|Induction Period|Randomised but not treated|0|||
23796066|NCT01332968|66630100|FG000|Maintenance/Observation Period|Adverse Event|0|||
23796067|NCT01332968|66630101|FG001|Maintenance/Observation Period|Adverse Event|0|||
23796068|NCT01332968|66630102|FG002|Maintenance/Observation Period|Adverse Event|53|||
23796069|NCT01332968|66630103|FG003|Maintenance/Observation Period|Adverse Event|66|||
23796070|NCT01332968|66630104|FG004|Maintenance/Observation Period|Adverse Event|0|||
23796071|NCT01332968|66630105|FG005|Maintenance/Observation Period|Adverse Event|0|||
23796072|NCT01332968|66630106|FG006|Maintenance/Observation Period|Adverse Event|0|||
23796073|NCT01332968|66630107|FG007|Maintenance/Observation Period|Adverse Event|0|||
23796074|NCT01332968|66630100|FG000|Maintenance/Observation Period|Death|0|||
23796075|NCT01332968|66630101|FG001|Maintenance/Observation Period|Death|0|||
23796076|NCT01332968|66630102|FG002|Maintenance/Observation Period|Death|5|||
23796077|NCT01332968|66630103|FG003|Maintenance/Observation Period|Death|6|||
23796078|NCT01332968|66630104|FG004|Maintenance/Observation Period|Death|0|||
23796079|NCT01332968|66630105|FG005|Maintenance/Observation Period|Death|0|||
23796080|NCT01332968|66630106|FG006|Maintenance/Observation Period|Death|0|||
23796081|NCT01332968|66630107|FG007|Maintenance/Observation Period|Death|0|||
23796082|NCT01332968|66630100|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
23796083|NCT01332968|66630101|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
23796084|NCT01332968|66630102|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
23356166|NCT00849290|65048792|FG000|Overall Study|Disease Progression|20|||
23356167|NCT00940888|65048793|FG000|Overall Study|Unsuccessful Implant|4|||
23356168|NCT00940888|65048793|FG000|Overall Study|Death|461|||
23356169|NCT00940888|65048793|FG000|Overall Study|Withdrawn - Non-Death|364|||
23356170|NCT00940888|65048793|FG000|Overall Study|Lost to Follow-up|6|||
23356171|NCT01386944|65048794|FG000|Overall Study|Adverse Event|26|||
23588450|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23588451|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23796085|NCT01332968|66630103|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
23356172|NCT01386944|65048794|FG000|Overall Study|Lack of Efficacy|14|||
23356173|NCT01386944|65048794|FG000|Overall Study|Lost to Follow-up|8|||
23356174|NCT01386944|65048794|FG000|Overall Study|Unspecified reason|8|||
23706849|NCT00002663|66301345|FG006|Overall Study|Physician Decision|0|||
23588452|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
23588453|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
23588454|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
23356175|NCT03544281|65048795|FG000|Overall Study|Death|3|||
23356176|NCT03544281|65048796|FG001|Overall Study|Death|2|||
23356177|NCT03544281|65048797|FG002|Overall Study|Death|6|||
23356178|NCT03544281|65048798|FG003|Overall Study|Death|8|||
23356179|NCT03544281|65048799|FG004|Overall Study|Death|4|||
23356180|NCT03544281|65048800|FG005|Overall Study|Death|2|||
23356181|NCT03544281|65048801|FG006|Overall Study|Death|4|||
23356182|NCT03544281|65048802|FG007|Overall Study|Death|5|||
23356183|NCT03544281|65048803|FG008|Overall Study|Death|5|||
23356184|NCT03544281|65048804|FG009|Overall Study|Death|8|||
23356185|NCT03544281|65048805|FG010|Overall Study|Death|6|||
23356186|NCT03544281|65048806|FG011|Overall Study|Death|4|||
23356187|NCT03544281|65048795|FG000|Overall Study|Lost to Follow-up|0|||
23356188|NCT03544281|65048796|FG001|Overall Study|Lost to Follow-up|0|||
23588455|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
23588456|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
23588457|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
23356189|NCT03544281|65048797|FG002|Overall Study|Lost to Follow-up|0|||
23356190|NCT03544281|65048798|FG003|Overall Study|Lost to Follow-up|0|||
23588458|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
23588459|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
23588460|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
23588461|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
23588462|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
23588463|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588464|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588465|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588466|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588467|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588468|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588469|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588470|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
23588471|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588472|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588473|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
23588474|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
23588475|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588476|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588477|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588478|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588479|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23588480|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23588481|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588482|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23641654|NCT01012817|66075193|FG000|Overall Study|Withdrawal by Subject|0|||
23356191|NCT03544281|65048799|FG004|Overall Study|Lost to Follow-up|0|||
23356192|NCT03544281|65048800|FG005|Overall Study|Lost to Follow-up|0|||
23588483|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23588484|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23356193|NCT03544281|65048801|FG006|Overall Study|Lost to Follow-up|0|||
23588485|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588486|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588487|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23641655|NCT01012817|66075194|FG001|Overall Study|Withdrawal by Subject|0|||
23641656|NCT01012817|66075195|FG002|Overall Study|Withdrawal by Subject|0|||
23356194|NCT03544281|65048802|FG007|Overall Study|Lost to Follow-up|0|||
23356195|NCT03544281|65048803|FG008|Overall Study|Lost to Follow-up|0|||
23356196|NCT03544281|65048804|FG009|Overall Study|Lost to Follow-up|0|||
23356197|NCT03544281|65048805|FG010|Overall Study|Lost to Follow-up|1|||
23356198|NCT03544281|65048806|FG011|Overall Study|Lost to Follow-up|0|||
23356199|NCT03544281|65048795|FG000|Overall Study|Physician Decision|0|||
23356200|NCT03544281|65048796|FG001|Overall Study|Physician Decision|0|||
23356201|NCT03544281|65048797|FG002|Overall Study|Physician Decision|0|||
23356202|NCT03544281|65048798|FG003|Overall Study|Physician Decision|0|||
23356203|NCT03544281|65048799|FG004|Overall Study|Physician Decision|0|||
23796086|NCT01332968|66630104|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
23796087|NCT01332968|66630105|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
23796088|NCT01332968|66630106|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
23796089|NCT01332968|66630107|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
23356204|NCT03544281|65048800|FG005|Overall Study|Physician Decision|0|||
23356205|NCT03544281|65048801|FG006|Overall Study|Physician Decision|0|||
23356206|NCT03544281|65048802|FG007|Overall Study|Physician Decision|1|||
23356207|NCT03544281|65048803|FG008|Overall Study|Physician Decision|0|||
23796090|NCT01332968|66630100|FG000|Maintenance/Observation Period|Non-compliance|0|||
23796091|NCT01332968|66630101|FG001|Maintenance/Observation Period|Non-compliance|0|||
23796092|NCT01332968|66630102|FG002|Maintenance/Observation Period|Non-compliance|4|||
23796093|NCT01332968|66630103|FG003|Maintenance/Observation Period|Non-compliance|3|||
23796094|NCT01332968|66630104|FG004|Maintenance/Observation Period|Non-compliance|0|||
23796095|NCT01332968|66630105|FG005|Maintenance/Observation Period|Non-compliance|0|||
23796096|NCT01332968|66630106|FG006|Maintenance/Observation Period|Non-compliance|0|||
23796097|NCT01332968|66630107|FG007|Maintenance/Observation Period|Non-compliance|0|||
23796098|NCT01332968|66630100|FG000|Maintenance/Observation Period|Other|0|||
23796099|NCT01332968|66630101|FG001|Maintenance/Observation Period|Other|0|||
23796100|NCT01332968|66630102|FG002|Maintenance/Observation Period|Other|4|||
23796101|NCT01332968|66630103|FG003|Maintenance/Observation Period|Other|7|||
23796102|NCT01332968|66630104|FG004|Maintenance/Observation Period|Other|0|||
23796103|NCT01332968|66630105|FG005|Maintenance/Observation Period|Other|0|||
23796104|NCT01332968|66630106|FG006|Maintenance/Observation Period|Other|0|||
23356208|NCT03544281|65048804|FG009|Overall Study|Physician Decision|0|||
23356209|NCT03544281|65048805|FG010|Overall Study|Physician Decision|0|||
23356210|NCT03544281|65048806|FG011|Overall Study|Physician Decision|0|||
23796105|NCT01332968|66630107|FG007|Maintenance/Observation Period|Other|0|||
23796106|NCT01332968|66630100|FG000|Maintenance/Observation Period|Physician Decision|0|||
23796107|NCT01332968|66630101|FG001|Maintenance/Observation Period|Physician Decision|0|||
23796108|NCT01332968|66630102|FG002|Maintenance/Observation Period|Physician Decision|14|||
23796109|NCT01332968|66630103|FG003|Maintenance/Observation Period|Physician Decision|19|||
23796110|NCT01332968|66630104|FG004|Maintenance/Observation Period|Physician Decision|0|||
23796111|NCT01332968|66630105|FG005|Maintenance/Observation Period|Physician Decision|1|||
23796112|NCT01332968|66630106|FG006|Maintenance/Observation Period|Physician Decision|0|||
23796113|NCT01332968|66630107|FG007|Maintenance/Observation Period|Physician Decision|0|||
23796114|NCT01332968|66630100|FG000|Maintenance/Observation Period|Progressive Disease|0|||
23796115|NCT01332968|66630101|FG001|Maintenance/Observation Period|Progressive Disease|0|||
23796116|NCT01332968|66630102|FG002|Maintenance/Observation Period|Progressive Disease|72|||
23796117|NCT01332968|66630103|FG003|Maintenance/Observation Period|Progressive Disease|40|||
23796118|NCT01332968|66630104|FG004|Maintenance/Observation Period|Progressive Disease|0|||
23796119|NCT01332968|66630105|FG005|Maintenance/Observation Period|Progressive Disease|0|||
23796120|NCT01332968|66630106|FG006|Maintenance/Observation Period|Progressive Disease|0|||
23796121|NCT01332968|66630107|FG007|Maintenance/Observation Period|Progressive Disease|0|||
23796122|NCT01332968|66630100|FG000|Maintenance/Observation Period|Protocol Violation|0|||
23796123|NCT01332968|66630101|FG001|Maintenance/Observation Period|Protocol Violation|0|||
23796124|NCT01332968|66630102|FG002|Maintenance/Observation Period|Protocol Violation|1|||
23796125|NCT01332968|66630103|FG003|Maintenance/Observation Period|Protocol Violation|1|||
23796126|NCT01332968|66630104|FG004|Maintenance/Observation Period|Protocol Violation|0|||
23796127|NCT01332968|66630105|FG005|Maintenance/Observation Period|Protocol Violation|0|||
23796128|NCT01332968|66630106|FG006|Maintenance/Observation Period|Protocol Violation|0|||
23796129|NCT01332968|66630107|FG007|Maintenance/Observation Period|Protocol Violation|0|||
23796130|NCT01332968|66630100|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796131|NCT01332968|66630101|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796132|NCT01332968|66630102|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
23796133|NCT01332968|66630103|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
23796134|NCT01332968|66630104|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796135|NCT01332968|66630105|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796136|NCT01332968|66630106|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796137|NCT01332968|66630107|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
23796138|NCT01332968|66630100|FG000|Follow-Up Period|Adverse Event|0|||
23356211|NCT03544281|65048795|FG000|Overall Study|Withdrawal by Subject|2|||
23356212|NCT03544281|65048796|FG001|Overall Study|Withdrawal by Subject|0|||
23356213|NCT03544281|65048797|FG002|Overall Study|Withdrawal by Subject|1|||
23356214|NCT03544281|65048798|FG003|Overall Study|Withdrawal by Subject|2|||
23356215|NCT03544281|65048799|FG004|Overall Study|Withdrawal by Subject|0|||
23356216|NCT03544281|65048800|FG005|Overall Study|Withdrawal by Subject|0|||
23356217|NCT03544281|65048801|FG006|Overall Study|Withdrawal by Subject|0|||
23356218|NCT03544281|65048802|FG007|Overall Study|Withdrawal by Subject|0|||
23356219|NCT03544281|65048803|FG008|Overall Study|Withdrawal by Subject|2|||
23356220|NCT03544281|65048804|FG009|Overall Study|Withdrawal by Subject|3|||
23356221|NCT03544281|65048805|FG010|Overall Study|Withdrawal by Subject|0|||
23356222|NCT03544281|65048806|FG011|Overall Study|Withdrawal by Subject|4|||
23356223|NCT03544281|65048795|FG000|Overall Study|Ongoing at the time of analysis|7|||
23356224|NCT03544281|65048796|FG001|Overall Study|Ongoing at the time of analysis|2|||
23356225|NCT03544281|65048797|FG002|Overall Study|Ongoing at the time of analysis|6|||
23356226|NCT03544281|65048798|FG003|Overall Study|Ongoing at the time of analysis|6|||
23472593|NCT00734539|65474100|FG000|Main Study|Death|33|||
23796139|NCT01332968|66630101|FG001|Follow-Up Period|Adverse Event|0|||
23356227|NCT03544281|65048799|FG004|Overall Study|Ongoing at the time of analysis|8|||
23356228|NCT03544281|65048800|FG005|Overall Study|Ongoing at the time of analysis|10|||
23356229|NCT03544281|65048801|FG006|Overall Study|Ongoing at the time of analysis|8|||
23356230|NCT03544281|65048802|FG007|Overall Study|Ongoing at the time of analysis|6|||
23356231|NCT03544281|65048803|FG008|Overall Study|Ongoing at the time of analysis|6|||
23356232|NCT03544281|65048804|FG009|Overall Study|Ongoing at the time of analysis|6|||
23472594|NCT00734539|65474101|FG001|Main Study|Death|32|||
23472595|NCT00734539|65474100|FG000|Main Study|Physician Decision|2|||
23472596|NCT00734539|65474101|FG001|Main Study|Physician Decision|0|||
23472597|NCT00734539|65474100|FG000|Main Study|Withdrawal by Subject|1|||
23472598|NCT00734539|65474101|FG001|Main Study|Withdrawal by Subject|3|||
23472599|NCT00734539|65474100|FG000|Main Study|Enrolled in error; ineligible|1|||
23472600|NCT00734539|65474101|FG001|Main Study|Enrolled in error; ineligible|0|||
23472601|NCT00899392|65474102|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
23472602|NCT00899392|65474103|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
23472603|NCT01738646|65474104|FG000|Overall Study|Still Receiving Treatment|2|||
23472604|NCT02331277|65474105|FG000|Overall Study|Withdrawal by Subject|1|||
23472605|NCT02331277|65474106|FG001|Overall Study|Withdrawal by Subject|0|||
23472606|NCT00003590|65474109|FG000|Overall Study|Ineligible Patient|1|||
23472607|NCT00003590|65474109|FG000|Overall Study|Adverse Event|7|||
23472608|NCT00003590|65474109|FG000|Overall Study|Withdrawal by Subject|1|||
23472609|NCT00003590|65474109|FG000|Overall Study|Lack of Efficacy|11|||
23472610|NCT00003590|65474109|FG000|Overall Study|Death|1|||
23472611|NCT00003590|65474109|FG000|Overall Study|Physician Decision|1|||
23472612|NCT02745080|65474110|FG000|Overall Study|Adverse Event|13|||
23472613|NCT02745080|65474111|FG001|Overall Study|Adverse Event|21|||
23472614|NCT02745080|65474110|FG000|Overall Study|Lack of Efficacy|11|||
23472615|NCT02745080|65474111|FG001|Overall Study|Lack of Efficacy|23|||
23472616|NCT02745080|65474110|FG000|Overall Study|Lost to Follow-up|3|||
23472617|NCT02745080|65474111|FG001|Overall Study|Lost to Follow-up|3|||
23472618|NCT02745080|65474110|FG000|Overall Study|Physician Decision|3|||
23472619|NCT02745080|65474111|FG001|Overall Study|Physician Decision|0|||
23472620|NCT02745080|65474110|FG000|Overall Study|Protocol Violation|3|||
23472621|NCT02745080|65474111|FG001|Overall Study|Protocol Violation|1|||
23472622|NCT02745080|65474110|FG000|Overall Study|Withdrawal by Subject|22|||
23472623|NCT02745080|65474111|FG001|Overall Study|Withdrawal by Subject|41|||
23472624|NCT04849559|65474114|FG000|Overall Study|Withdrawal by Subject|2|||
23472625|NCT04849559|65474115|FG001|Overall Study|Withdrawal by Subject|1|||
23472626|NCT01396447|65474116|FG000|Overall Study|Did Not Receive Treatment|3|||
23472627|NCT01396447|65474117|FG001|Overall Study|Did Not Receive Treatment|2|||
23472628|NCT01396447|65474118|FG002|Overall Study|Did Not Receive Treatment|1|||
23472629|NCT01396447|65474119|FG003|Overall Study|Did Not Receive Treatment|0|||
23472630|NCT01396447|65474116|FG000|Overall Study|Adverse Event|15|||
23472631|NCT01396447|65474117|FG001|Overall Study|Adverse Event|12|||
23641657|NCT01012817|66075196|FG003|Overall Study|Withdrawal by Subject|1|||
23356233|NCT03544281|65048805|FG010|Overall Study|Ongoing at the time of analysis|5|||
23472632|NCT01396447|65474118|FG002|Overall Study|Adverse Event|12|||
23472633|NCT01396447|65474119|FG003|Overall Study|Adverse Event|17|||
23472634|NCT01396447|65474116|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23472635|NCT01396447|65474117|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23472636|NCT01396447|65474118|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23588488|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23588489|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588490|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588491|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
23588492|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
23588493|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588494|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588495|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588496|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588497|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
23588498|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
23588499|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23641658|NCT01012817|66075197|FG004|Overall Study|Withdrawal by Subject|0|||
23472637|NCT01396447|65474119|FG003|Overall Study|Insufficient Therapeutic Response|4|||
23472638|NCT01396447|65474116|FG000|Overall Study|Protocol Violation|5|||
23472639|NCT01396447|65474117|FG001|Overall Study|Protocol Violation|2|||
23472640|NCT01396447|65474118|FG002|Overall Study|Protocol Violation|3|||
23472641|NCT01396447|65474119|FG003|Overall Study|Protocol Violation|7|||
23472642|NCT01396447|65474116|FG000|Overall Study|Withdrawal of Consent|11|||
23472643|NCT01396447|65474117|FG001|Overall Study|Withdrawal of Consent|9|||
23472644|NCT01396447|65474118|FG002|Overall Study|Withdrawal of Consent|4|||
23472645|NCT01396447|65474119|FG003|Overall Study|Withdrawal of Consent|15|||
23472646|NCT01396447|65474116|FG000|Overall Study|Lost to Follow-up|4|||
23472647|NCT01396447|65474117|FG001|Overall Study|Lost to Follow-up|8|||
23472648|NCT01396447|65474118|FG002|Overall Study|Lost to Follow-up|7|||
23472649|NCT01396447|65474119|FG003|Overall Study|Lost to Follow-up|9|||
23472650|NCT01396447|65474116|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23472651|NCT01396447|65474117|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23472652|NCT01396447|65474118|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23472653|NCT01396447|65474119|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23472654|NCT03241368|65474120|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
23472655|NCT03241368|65474120|FG000|Overall Study|Lost to Follow-up|1|||
23472656|NCT03241368|65474120|FG000|Overall Study|Physician Decision|6|||
23472657|NCT03241368|65474120|FG000|Overall Study|Withdrawal by Subject|6|||
23472658|NCT03241368|65474120|FG000|Overall Study|Protocol Violation|1|||
23472659|NCT02424578|65474124|FG000|Overall Study|Withdrawal by Subject|0|||
23472660|NCT02424578|65474125|FG001|Overall Study|Withdrawal by Subject|1|||
23472661|NCT02034409|65474126|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
23472662|NCT02034409|65474127|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
23472663|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
23472664|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
23472665|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
23472666|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
23472667|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
23472668|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
23472669|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
23472670|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
23472671|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
23472672|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
23472673|NCT01311024|65474128|FG000|Overall Study|Protocol Violation|35|||
23472674|NCT01311024|65474129|FG001|Overall Study|Protocol Violation|22|||
23472675|NCT01112306|65474130|FG000|Overall Study|Death|175|||
23472676|NCT01112306|65474130|FG000|Overall Study|Lost to Follow-up|9|||
23472677|NCT01112306|65474130|FG000|Overall Study|Withdrawal by Subject|31|||
23472678|NCT01112306|65474130|FG000|Overall Study|Other|70|||
23472679|NCT04681352|65474131|FG000|Overall Study|Lost to Follow-up|2|||
23472680|NCT04681352|65474131|FG000|Overall Study|Withdrawal by Subject|22|||
23472681|NCT02116205|65474132|FG000|Overall Study|Withdrawal by Subject|2|||
23472682|NCT02116205|65474133|FG001|Overall Study|Withdrawal by Subject|4|||
23472683|NCT02116205|65474134|FG002|Overall Study|Withdrawal by Subject|1|||
23472684|NCT02116205|65474135|FG003|Overall Study|Withdrawal by Subject|3|||
23472685|NCT02116205|65474132|FG000|Overall Study|Lost to Follow-up|0|||
23472686|NCT02116205|65474133|FG001|Overall Study|Lost to Follow-up|2|||
23472687|NCT02116205|65474134|FG002|Overall Study|Lost to Follow-up|1|||
23588500|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
23588501|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588502|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588503|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588504|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588505|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588506|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588507|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588508|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588509|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
23588510|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
23588511|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588512|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23641659|NCT01012817|66075198|FG005|Overall Study|Withdrawal by Subject|0|||
23472688|NCT02116205|65474135|FG003|Overall Study|Lost to Follow-up|2|||
23588513|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23472689|NCT02116205|65474132|FG000|Overall Study|Physician Decision|0|||
23472690|NCT02116205|65474133|FG001|Overall Study|Physician Decision|1|||
23472691|NCT02116205|65474134|FG002|Overall Study|Physician Decision|1|||
23472692|NCT02116205|65474135|FG003|Overall Study|Physician Decision|1|||
23472693|NCT02116205|65474132|FG000|Overall Study|Exclusion criteria|0|||
23472694|NCT02116205|65474133|FG001|Overall Study|Exclusion criteria|0|||
23472695|NCT02116205|65474134|FG002|Overall Study|Exclusion criteria|1|||
23472696|NCT02116205|65474135|FG003|Overall Study|Exclusion criteria|0|||
23641660|NCT01012817|66075199|FG006|Overall Study|Withdrawal by Subject|0|||
23641661|NCT01012817|66075200|FG007|Overall Study|Withdrawal by Subject|1|||
23641662|NCT01012817|66075201|FG008|Overall Study|Withdrawal by Subject|0|||
23641663|NCT01012817|66075202|FG009|Overall Study|Withdrawal by Subject|0|||
23641664|NCT01012817|66075203|FG010|Overall Study|Withdrawal by Subject|1|||
23641665|NCT01012817|66075204|FG011|Overall Study|Withdrawal by Subject|1|||
23641666|NCT01012817|66075205|FG012|Overall Study|Withdrawal by Subject|0|||
23641667|NCT01012817|66075206|FG013|Overall Study|Withdrawal by Subject|1|||
23641668|NCT01012817|66075193|FG000|Overall Study|Adverse Event|0|||
23641669|NCT01012817|66075194|FG001|Overall Study|Adverse Event|0|||
23641670|NCT01012817|66075195|FG002|Overall Study|Adverse Event|0|||
23641671|NCT01012817|66075196|FG003|Overall Study|Adverse Event|0|||
23641672|NCT01012817|66075197|FG004|Overall Study|Adverse Event|0|||
23641673|NCT01012817|66075198|FG005|Overall Study|Adverse Event|1|||
23641674|NCT01012817|66075199|FG006|Overall Study|Adverse Event|0|||
23641675|NCT01012817|66075200|FG007|Overall Study|Adverse Event|0|||
23641676|NCT01012817|66075201|FG008|Overall Study|Adverse Event|0|||
23641677|NCT01012817|66075202|FG009|Overall Study|Adverse Event|0|||
23641678|NCT01012817|66075203|FG010|Overall Study|Adverse Event|1|||
23641679|NCT01012817|66075204|FG011|Overall Study|Adverse Event|0|||
23641680|NCT01012817|66075205|FG012|Overall Study|Adverse Event|0|||
23641681|NCT01012817|66075206|FG013|Overall Study|Adverse Event|1|||
23641682|NCT01769326|66075207|FG000|Overall Study|Lost to Follow-up|1|||
23641683|NCT01769326|66075208|FG001|Overall Study|Lost to Follow-up|2|||
23641684|NCT01769326|66075209|FG002|Overall Study|Lost to Follow-up|0|||
23641685|NCT01769326|66075210|FG003|Overall Study|Lost to Follow-up|0|||
23641686|NCT01769326|66075207|FG000|Overall Study|unrelated injry|1|||
23641687|NCT01769326|66075208|FG001|Overall Study|unrelated injry|1|||
23641688|NCT01769326|66075209|FG002|Overall Study|unrelated injry|0|||
23641689|NCT01769326|66075210|FG003|Overall Study|unrelated injry|0|||
23641690|NCT01769326|66075207|FG000|Overall Study|got a job|0|||
23641691|NCT01769326|66075208|FG001|Overall Study|got a job|1|||
23641692|NCT01769326|66075209|FG002|Overall Study|got a job|0|||
23641693|NCT01769326|66075210|FG003|Overall Study|got a job|0|||
23641694|NCT01769326|66075207|FG000|Overall Study|Got sick and could not complete study|0|||
23641695|NCT01769326|66075208|FG001|Overall Study|Got sick and could not complete study|0|||
23641696|NCT01769326|66075209|FG002|Overall Study|Got sick and could not complete study|1|||
23641697|NCT01769326|66075210|FG003|Overall Study|Got sick and could not complete study|0|||
23641698|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|Death|1|||
23641699|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|Death|1|||
23641700|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
23641701|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
23641702|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
23641703|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
23641704|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
23641705|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
23641706|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
23641707|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
23641708|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
23641709|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
23641710|NCT00371683|66075219|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
23641711|NCT00371683|66075220|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
23641712|NCT00371683|66075219|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
23641713|NCT00371683|66075220|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
23641714|NCT00371683|66075219|FG000|Follow-Up Period - Randomized Patients|Death|0|||
23641715|NCT00371683|66075220|FG001|Follow-Up Period - Randomized Patients|Death|2|||
23641716|NCT00371683|66075219|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
23641717|NCT00371683|66075220|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
23641718|NCT00371683|66075219|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
23641719|NCT00371683|66075220|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
23641720|NCT01621568|66075224|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
23641721|NCT01621568|66075225|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
23641722|NCT01621568|66075224|FG000|Week 5-6 No Treatment|Death|1|||
23641723|NCT01621568|66075225|FG001|Week 5-6 No Treatment|Death|0|||
23641724|NCT05062759|66075226|FG000|Overall Study|Death|0|||
23641725|NCT05062759|66075227|FG001|Overall Study|Death|1|||
23641726|NCT05062759|66075226|FG000|Overall Study|Lost to Follow-up|1|||
23641727|NCT05062759|66075227|FG001|Overall Study|Lost to Follow-up|0|||
23472697|NCT01561313|65474139|FG000|Overall Study|Withdrawal by Subject|1|||
23641728|NCT00766363|66075230|FG000|Overall Study|Withdrawal by Subject|1|||
23641729|NCT00766363|66075231|FG001|Overall Study|Withdrawal by Subject|0|||
23641730|NCT00766363|66075232|FG002|Overall Study|Withdrawal by Subject|0|||
23641731|NCT00766363|66075233|FG003|Overall Study|Withdrawal by Subject|0|||
23641732|NCT00766363|66075230|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
23641733|NCT00766363|66075231|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
23641734|NCT00766363|66075232|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
23641735|NCT00766363|66075233|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
23641736|NCT00998335|66075234|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
23641737|NCT00998335|66075235|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
23641738|NCT03538301|66075237|FG000|Overall Study|Adverse Event|1|||
23641739|NCT03538301|66075238|FG001|Overall Study|Adverse Event|4|||
23641740|NCT03538301|66075239|FG002|Overall Study|Adverse Event|4|||
23641741|NCT03538301|66075237|FG000|Overall Study|Death|1|||
23641742|NCT03538301|66075238|FG001|Overall Study|Death|1|||
23641743|NCT03538301|66075239|FG002|Overall Study|Death|0|||
23641744|NCT03538301|66075237|FG000|Overall Study|Physician Decision|0|||
23641745|NCT03538301|66075238|FG001|Overall Study|Physician Decision|1|||
23641746|NCT03538301|66075239|FG002|Overall Study|Physician Decision|0|||
23641747|NCT03538301|66075237|FG000|Overall Study|Protocol Violation|0|||
23641748|NCT03538301|66075238|FG001|Overall Study|Protocol Violation|0|||
23641749|NCT03538301|66075239|FG002|Overall Study|Protocol Violation|1|||
23641750|NCT03538301|66075237|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
23641751|NCT03538301|66075238|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
23641752|NCT03538301|66075239|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
23641753|NCT04737187|66075240|FG000|Overall Study|Switched to marketed drug|32|||
23641754|NCT04737187|66075241|FG001|Overall Study|Switched to marketed drug|4|||
23641755|NCT04737187|66075240|FG000|Overall Study|Radiological Progressive Disease|145|||
23641756|NCT04737187|66075241|FG001|Overall Study|Radiological Progressive Disease|146|||
23641757|NCT04737187|66075240|FG000|Overall Study|Clinical Progressive Disease|20|||
23641758|NCT04737187|66075241|FG001|Overall Study|Clinical Progressive Disease|20|||
23641759|NCT04737187|66075240|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
23641760|NCT04737187|66075241|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
23641761|NCT04737187|66075240|FG000|Overall Study|Adverse Event|16|||
23641762|NCT04737187|66075241|FG001|Overall Study|Adverse Event|16|||
23641763|NCT04737187|66075240|FG000|Overall Study|Physician Decision|2|||
23641764|NCT04737187|66075241|FG001|Overall Study|Physician Decision|0|||
23641765|NCT04737187|66075240|FG000|Overall Study|Withdrawal by Subject|5|||
23641766|NCT04737187|66075241|FG001|Overall Study|Withdrawal by Subject|8|||
23641767|NCT03075410|66075242|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
23641768|NCT03075410|66075243|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641769|NCT03075410|66075244|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
23641770|NCT03075410|66075245|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641771|NCT03075410|66075246|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641772|NCT03075410|66075247|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641773|NCT03075410|66075248|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641774|NCT03075410|66075249|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641775|NCT03075410|66075250|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
23641776|NCT03075410|66075242|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
23641777|NCT03075410|66075243|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23472698|NCT01561313|65474140|FG001|Overall Study|Withdrawal by Subject|0|||
23472699|NCT01561313|65474139|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
23472700|NCT01561313|65474140|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
23472701|NCT00832624|65477440|FG000|Overall Study|Study Terminated|10|||
23472702|NCT01325337|65477448|FG000|Overall Study|Adverse Event|0|||
23641778|NCT03075410|66075244|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23472703|NCT01325337|65477449|FG001|Overall Study|Adverse Event|2|||
23641779|NCT03075410|66075245|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641780|NCT03075410|66075246|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641781|NCT03075410|66075247|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641782|NCT03075410|66075248|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641783|NCT03075410|66075249|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641784|NCT03075410|66075250|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23641785|NCT00738894|66075251|FG000|Overall Study|Lost to Follow-up|23|||
23641786|NCT00738894|66075252|FG001|Overall Study|Lost to Follow-up|13|||
23641787|NCT00738894|66075251|FG000|Overall Study|Withdrawal by Subject|10|||
23641788|NCT00738894|66075252|FG001|Overall Study|Withdrawal by Subject|15|||
23472704|NCT01325337|65477450|FG002|Overall Study|Adverse Event|2|||
23472705|NCT01325337|65477451|FG003|Overall Study|Adverse Event|1|||
23472706|NCT01325337|65477452|FG004|Overall Study|Adverse Event|2|||
23472707|NCT01325337|65477448|FG000|Overall Study|Lost to Follow-up|2|||
23472708|NCT01325337|65477449|FG001|Overall Study|Lost to Follow-up|2|||
23472709|NCT01325337|65477450|FG002|Overall Study|Lost to Follow-up|2|||
23472710|NCT01325337|65477451|FG003|Overall Study|Lost to Follow-up|1|||
23641789|NCT00738894|66075251|FG000|Overall Study|Physician Decision|4|||
23472711|NCT01325337|65477452|FG004|Overall Study|Lost to Follow-up|2|||
23641790|NCT00738894|66075252|FG001|Overall Study|Physician Decision|5|||
23356234|NCT03544281|65048806|FG011|Overall Study|Ongoing at the time of analysis|8|||
23356235|NCT03544281|65048795|FG000|Overall Study|Investigator Site Closed|0|||
23356236|NCT03544281|65048796|FG001|Overall Study|Investigator Site Closed|0|||
23356237|NCT03544281|65048797|FG002|Overall Study|Investigator Site Closed|0|||
23356238|NCT03544281|65048798|FG003|Overall Study|Investigator Site Closed|0|||
23356239|NCT03544281|65048799|FG004|Overall Study|Investigator Site Closed|0|||
23356240|NCT03544281|65048800|FG005|Overall Study|Investigator Site Closed|0|||
23356241|NCT03544281|65048801|FG006|Overall Study|Investigator Site Closed|0|||
23356242|NCT03544281|65048802|FG007|Overall Study|Investigator Site Closed|0|||
23356243|NCT03544281|65048803|FG008|Overall Study|Investigator Site Closed|0|||
23356244|NCT03544281|65048804|FG009|Overall Study|Investigator Site Closed|1|||
23356245|NCT03544281|65048805|FG010|Overall Study|Investigator Site Closed|0|||
23356246|NCT03544281|65048806|FG011|Overall Study|Investigator Site Closed|0|||
23356247|NCT03544281|65048795|FG000|Overall Study|Did not receive study treatment|0|||
23356248|NCT03544281|65048796|FG001|Overall Study|Did not receive study treatment|0|||
23356249|NCT03544281|65048797|FG002|Overall Study|Did not receive study treatment|0|||
23356250|NCT03544281|65048798|FG003|Overall Study|Did not receive study treatment|0|||
23356251|NCT03544281|65048799|FG004|Overall Study|Did not receive study treatment|0|||
23356252|NCT03544281|65048800|FG005|Overall Study|Did not receive study treatment|0|||
23356253|NCT03544281|65048801|FG006|Overall Study|Did not receive study treatment|1|||
23356254|NCT03544281|65048802|FG007|Overall Study|Did not receive study treatment|0|||
23356255|NCT03544281|65048803|FG008|Overall Study|Did not receive study treatment|0|||
23356256|NCT03544281|65048804|FG009|Overall Study|Did not receive study treatment|0|||
23356257|NCT03544281|65048805|FG010|Overall Study|Did not receive study treatment|0|||
23356258|NCT03544281|65048806|FG011|Overall Study|Did not receive study treatment|0|||
23356259|NCT00534638|65048807|FG000|Overall Study|Withdrawal by Subject|3|||
23356260|NCT00534638|65048808|FG001|Overall Study|Withdrawal by Subject|4|||
23356261|NCT00534638|65048807|FG000|Overall Study|Migrated/moved from study area|13|||
23356262|NCT00534638|65048808|FG001|Overall Study|Migrated/moved from study area|11|||
23356263|NCT00534638|65048807|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
23356264|NCT00534638|65048808|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
23356265|NCT00534638|65048807|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
23356266|NCT00534638|65048808|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
23356267|NCT00534638|65048807|FG000|Overall Study|Other|1685|||
23356268|NCT00534638|65048808|FG001|Overall Study|Other|902|||
23356269|NCT01172808|65048809|FG000|Overall Study|Adverse Event|8|||
23356270|NCT01172808|65048810|FG001|Overall Study|Adverse Event|4|||
23472712|NCT01325337|65477448|FG000|Overall Study|Personal Reasons|2|||
23472713|NCT01325337|65477449|FG001|Overall Study|Personal Reasons|5|||
23356271|NCT01172808|65048811|FG002|Overall Study|Adverse Event|8|||
23356272|NCT01172808|65048812|FG003|Overall Study|Adverse Event|3|||
23356273|NCT01172808|65048809|FG000|Overall Study|Lack of Efficacy|1|||
23356274|NCT01172808|65048810|FG001|Overall Study|Lack of Efficacy|0|||
23356275|NCT01172808|65048811|FG002|Overall Study|Lack of Efficacy|0|||
23356276|NCT01172808|65048812|FG003|Overall Study|Lack of Efficacy|0|||
23356277|NCT01172808|65048809|FG000|Overall Study|Protocol Violation|2|||
23356278|NCT01172808|65048810|FG001|Overall Study|Protocol Violation|2|||
23356279|NCT01172808|65048811|FG002|Overall Study|Protocol Violation|2|||
23356280|NCT01172808|65048812|FG003|Overall Study|Protocol Violation|0|||
23356281|NCT01172808|65048809|FG000|Overall Study|Lost to Follow-up|0|||
23356282|NCT01172808|65048810|FG001|Overall Study|Lost to Follow-up|1|||
23356283|NCT01172808|65048811|FG002|Overall Study|Lost to Follow-up|1|||
23356284|NCT01172808|65048812|FG003|Overall Study|Lost to Follow-up|3|||
23356285|NCT01172808|65048809|FG000|Overall Study|Withdrawal by Subject|4|||
23356286|NCT01172808|65048810|FG001|Overall Study|Withdrawal by Subject|1|||
23356287|NCT01172808|65048811|FG002|Overall Study|Withdrawal by Subject|3|||
23356288|NCT01172808|65048812|FG003|Overall Study|Withdrawal by Subject|2|||
23356289|NCT01172808|65048809|FG000|Overall Study|Other|6|||
23356290|NCT01172808|65048810|FG001|Overall Study|Other|5|||
23356291|NCT01172808|65048811|FG002|Overall Study|Other|9|||
23356292|NCT01172808|65048812|FG003|Overall Study|Other|7|||
23356293|NCT03959488|65048813|FG000|Season 1|Other|6|||
23356294|NCT03959488|65048814|FG001|Season 1|Other|7|||
23356295|NCT03959488|65048815|FG002|Season 1|Other|0|||
23356296|NCT03959488|65048816|FG003|Season 1|Other|0|||
23356297|NCT03959488|65048817|FG004|Season 1|Other|0|||
23356298|NCT03959488|65048813|FG000|Season 1|Withdrawal by parent/guardian|43|||
23356299|NCT03959488|65048814|FG001|Season 1|Withdrawal by parent/guardian|28|||
23356300|NCT03959488|65048815|FG002|Season 1|Withdrawal by parent/guardian|0|||
23356301|NCT03959488|65048816|FG003|Season 1|Withdrawal by parent/guardian|0|||
23356302|NCT03959488|65048817|FG004|Season 1|Withdrawal by parent/guardian|0|||
23356303|NCT03959488|65048813|FG000|Season 1|Due to COVID-19 pandemic|2|||
23356304|NCT03959488|65048814|FG001|Season 1|Due to COVID-19 pandemic|3|||
23356305|NCT03959488|65048815|FG002|Season 1|Due to COVID-19 pandemic|0|||
23356306|NCT03959488|65048816|FG003|Season 1|Due to COVID-19 pandemic|0|||
23356307|NCT03959488|65048817|FG004|Season 1|Due to COVID-19 pandemic|0|||
23356308|NCT03959488|65048813|FG000|Season 1|Lost to Follow-up|17|||
23356309|NCT03959488|65048814|FG001|Season 1|Lost to Follow-up|7|||
23356310|NCT03959488|65048815|FG002|Season 1|Lost to Follow-up|0|||
23356311|NCT03959488|65048816|FG003|Season 1|Lost to Follow-up|0|||
23356312|NCT03959488|65048817|FG004|Season 1|Lost to Follow-up|0|||
23356313|NCT03959488|65048813|FG000|Season 1|Death|5|||
23356314|NCT03959488|65048814|FG001|Season 1|Death|1|||
23356315|NCT03959488|65048815|FG002|Season 1|Death|0|||
23356316|NCT03959488|65048816|FG003|Season 1|Death|0|||
23356317|NCT03959488|65048817|FG004|Season 1|Death|0|||
23356318|NCT03959488|65048813|FG000|Season 2|Other|0|||
23356319|NCT03959488|65048814|FG001|Season 2|Other|0|||
23796140|NCT01332968|66630102|FG002|Follow-Up Period|Adverse Event|0|||
23796141|NCT01332968|66630103|FG003|Follow-Up Period|Adverse Event|0|||
23796142|NCT01332968|66630104|FG004|Follow-Up Period|Adverse Event|0|||
23356320|NCT03959488|65048815|FG002|Season 2|Other|2|||
23356321|NCT03959488|65048816|FG003|Season 2|Other|0|||
23356322|NCT03959488|65048817|FG004|Season 2|Other|0|||
23356323|NCT03959488|65048813|FG000|Season 2|Withdrawal by parent/guardian|0|||
23796143|NCT01332968|66630105|FG005|Follow-Up Period|Adverse Event|0|||
23356324|NCT03959488|65048814|FG001|Season 2|Withdrawal by parent/guardian|0|||
23356325|NCT03959488|65048815|FG002|Season 2|Withdrawal by parent/guardian|3|||
23641791|NCT00738894|66075251|FG000|Overall Study|Death|2|||
23641792|NCT00738894|66075252|FG001|Overall Study|Death|0|||
23641793|NCT02549196|66075253|FG000|Overall Study|Protocol Violation|0|||
23641794|NCT02549196|66075254|FG001|Overall Study|Protocol Violation|0|||
23641795|NCT02549196|66075255|FG002|Overall Study|Protocol Violation|0|||
23641796|NCT02549196|66075256|FG003|Overall Study|Protocol Violation|1|||
23641797|NCT02549196|66075253|FG000|Overall Study|Withdrawal by Subject|1|||
23796144|NCT01332968|66630106|FG006|Follow-Up Period|Adverse Event|0|||
23796145|NCT01332968|66630107|FG007|Follow-Up Period|Adverse Event|4|||
23796146|NCT01332968|66630100|FG000|Follow-Up Period|Death|0|||
23796147|NCT01332968|66630101|FG001|Follow-Up Period|Death|0|||
23796148|NCT01332968|66630102|FG002|Follow-Up Period|Death|0|||
23796149|NCT01332968|66630103|FG003|Follow-Up Period|Death|0|||
23796150|NCT01332968|66630104|FG004|Follow-Up Period|Death|0|||
23796151|NCT01332968|66630105|FG005|Follow-Up Period|Death|0|||
23796152|NCT01332968|66630106|FG006|Follow-Up Period|Death|27|||
23796153|NCT01332968|66630107|FG007|Follow-Up Period|Death|30|||
23796154|NCT01332968|66630100|FG000|Follow-Up Period|Lost to Follow-up|0|||
23796155|NCT01332968|66630101|FG001|Follow-Up Period|Lost to Follow-up|0|||
23796156|NCT01332968|66630102|FG002|Follow-Up Period|Lost to Follow-up|0|||
23796157|NCT01332968|66630103|FG003|Follow-Up Period|Lost to Follow-up|0|||
23796158|NCT01332968|66630104|FG004|Follow-Up Period|Lost to Follow-up|0|||
23796159|NCT01332968|66630105|FG005|Follow-Up Period|Lost to Follow-up|0|||
23796160|NCT01332968|66630106|FG006|Follow-Up Period|Lost to Follow-up|11|||
23796161|NCT01332968|66630107|FG007|Follow-Up Period|Lost to Follow-up|15|||
23796162|NCT01332968|66630100|FG000|Follow-Up Period|Non-compliance|0|||
23796163|NCT01332968|66630101|FG001|Follow-Up Period|Non-compliance|0|||
23796164|NCT01332968|66630102|FG002|Follow-Up Period|Non-compliance|0|||
23796165|NCT01332968|66630103|FG003|Follow-Up Period|Non-compliance|0|||
23796166|NCT01332968|66630104|FG004|Follow-Up Period|Non-compliance|0|||
23796167|NCT01332968|66630105|FG005|Follow-Up Period|Non-compliance|0|||
23796168|NCT01332968|66630106|FG006|Follow-Up Period|Non-compliance|4|||
23356326|NCT03959488|65048816|FG003|Season 2|Withdrawal by parent/guardian|1|||
23356327|NCT03959488|65048817|FG004|Season 2|Withdrawal by parent/guardian|1|||
23641798|NCT02549196|66075254|FG001|Overall Study|Withdrawal by Subject|0|||
23356328|NCT03959488|65048813|FG000|Season 2|Lost to Follow-up|0|||
23641799|NCT02549196|66075255|FG002|Overall Study|Withdrawal by Subject|1|||
23641800|NCT02549196|66075256|FG003|Overall Study|Withdrawal by Subject|0|||
23796169|NCT01332968|66630107|FG007|Follow-Up Period|Non-compliance|9|||
23796170|NCT01332968|66630100|FG000|Follow-Up Period|Other|0|||
23796171|NCT01332968|66630101|FG001|Follow-Up Period|Other|0|||
23796172|NCT01332968|66630102|FG002|Follow-Up Period|Other|0|||
23796173|NCT01332968|66630103|FG003|Follow-Up Period|Other|0|||
23796174|NCT01332968|66630104|FG004|Follow-Up Period|Other|0|||
23641801|NCT00540046|66075257|FG000|Overall Study|Lost to Follow-up|33|||
23641802|NCT00540046|66075258|FG001|Overall Study|Lost to Follow-up|23|||
23641803|NCT02766465|66075259|FG000|Overall Study|Withdrawal by Subject|0|||
23641804|NCT02766465|66075260|FG001|Overall Study|Withdrawal by Subject|10|||
23641805|NCT01427751|66075261|FG000|Overall Study|Adverse Event|18|||
23641806|NCT01427751|66075262|FG001|Overall Study|Adverse Event|2|||
23641807|NCT01427751|66075261|FG000|Overall Study|No further treatment benefit expected|5|||
23641808|NCT01427751|66075262|FG001|Overall Study|No further treatment benefit expected|1|||
23641809|NCT01427751|66075261|FG000|Overall Study|Lost to Follow-up|3|||
23641810|NCT01427751|66075262|FG001|Overall Study|Lost to Follow-up|1|||
23641811|NCT01427751|66075261|FG000|Overall Study|Withdrawal of consent|2|||
23641812|NCT01427751|66075262|FG001|Overall Study|Withdrawal of consent|2|||
23641813|NCT01427751|66075261|FG000|Overall Study|Protocol Violation|6|||
23641814|NCT01427751|66075262|FG001|Overall Study|Protocol Violation|4|||
23641815|NCT01427751|66075261|FG000|Overall Study|Death|2|||
23641816|NCT01427751|66075262|FG001|Overall Study|Death|0|||
23641817|NCT01427751|66075261|FG000|Overall Study|Other miscellaneous reasons|6|||
23641818|NCT01427751|66075262|FG001|Overall Study|Other miscellaneous reasons|4|||
23356329|NCT03959488|65048814|FG001|Season 2|Lost to Follow-up|0|||
23641819|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
23641820|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23641821|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23641822|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23641823|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23472714|NCT01325337|65477450|FG002|Overall Study|Personal Reasons|4|||
23472715|NCT01325337|65477451|FG003|Overall Study|Personal Reasons|8|||
23796175|NCT01332968|66630105|FG005|Follow-Up Period|Other|0|||
23796176|NCT01332968|66630106|FG006|Follow-Up Period|Other|18|||
23796177|NCT01332968|66630107|FG007|Follow-Up Period|Other|21|||
23796178|NCT01332968|66630100|FG000|Follow-Up Period|Physician Decision|0|||
23796179|NCT01332968|66630101|FG001|Follow-Up Period|Physician Decision|0|||
23796180|NCT01332968|66630102|FG002|Follow-Up Period|Physician Decision|0|||
23796181|NCT01332968|66630103|FG003|Follow-Up Period|Physician Decision|0|||
23796182|NCT01332968|66630104|FG004|Follow-Up Period|Physician Decision|0|||
23796183|NCT01332968|66630105|FG005|Follow-Up Period|Physician Decision|0|||
23796184|NCT01332968|66630106|FG006|Follow-Up Period|Physician Decision|12|||
23796185|NCT01332968|66630107|FG007|Follow-Up Period|Physician Decision|15|||
23796186|NCT01332968|66630100|FG000|Follow-Up Period|Progressive Disease|0|||
23796187|NCT01332968|66630101|FG001|Follow-Up Period|Progressive Disease|0|||
23796188|NCT01332968|66630102|FG002|Follow-Up Period|Progressive Disease|0|||
23796189|NCT01332968|66630103|FG003|Follow-Up Period|Progressive Disease|0|||
23796190|NCT01332968|66630104|FG004|Follow-Up Period|Progressive Disease|0|||
23796191|NCT01332968|66630105|FG005|Follow-Up Period|Progressive Disease|0|||
23796192|NCT01332968|66630106|FG006|Follow-Up Period|Progressive Disease|126|||
23796193|NCT01332968|66630107|FG007|Follow-Up Period|Progressive Disease|106|||
23641824|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
23641825|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23641826|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23641827|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23641828|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23641829|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
23641830|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23641831|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23641832|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23641833|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23641834|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
23641835|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23641836|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23641837|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23588514|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588515|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588516|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588517|NCT00811057|65882165|FG000|Overall Study|Protocol Violation|5|||
23588518|NCT00811057|65882166|FG001|Overall Study|Protocol Violation|10|||
23588519|NCT00811057|65882167|FG002|Overall Study|Protocol Violation|10|||
23588520|NCT03525119|65882171|FG000|Overall Study|Adverse Event|0|||
23588521|NCT03525119|65882172|FG001|Overall Study|Adverse Event|1|||
23588522|NCT03525119|65882173|FG002|Overall Study|Adverse Event|0|||
23588523|NCT03525119|65882171|FG000|Overall Study|Lost to Follow-up|32|||
23588524|NCT03525119|65882172|FG001|Overall Study|Lost to Follow-up|33|||
23588525|NCT03525119|65882173|FG002|Overall Study|Lost to Follow-up|37|||
23588526|NCT03525119|65882171|FG000|Overall Study|Withdrawal by Subject|5|||
23588527|NCT03525119|65882172|FG001|Overall Study|Withdrawal by Subject|4|||
23588528|NCT03525119|65882173|FG002|Overall Study|Withdrawal by Subject|2|||
23588529|NCT03525119|65882171|FG000|Overall Study|Reason not Specified|2|||
23588530|NCT03525119|65882172|FG001|Overall Study|Reason not Specified|1|||
23588531|NCT03525119|65882173|FG002|Overall Study|Reason not Specified|2|||
23588532|NCT03525119|65882171|FG000|Overall Study|Randomized but not Vaccinated|1|||
23588533|NCT03525119|65882172|FG001|Overall Study|Randomized but not Vaccinated|0|||
23588534|NCT03525119|65882173|FG002|Overall Study|Randomized but not Vaccinated|2|||
23588535|NCT03691428|65882176|FG000|Overall Study|Withdrawal by Subject|6|||
23588536|NCT03691428|65882177|FG001|Overall Study|Withdrawal by Subject|8|||
23588537|NCT00486759|65882178|FG000|Treatment|Adverse event/intercurrent illness|86|||
23588538|NCT00486759|65882179|FG001|Treatment|Adverse event/intercurrent illness|39|||
23588539|NCT00486759|65882178|FG000|Treatment|Insufficient therapeutic response|37|||
23588540|NCT00486759|65882179|FG001|Treatment|Insufficient therapeutic response|39|||
23588541|NCT00486759|65882178|FG000|Treatment|Death|17|||
23588542|NCT00486759|65882179|FG001|Treatment|Death|10|||
23588543|NCT00486759|65882178|FG000|Treatment|Withdrew consent|15|||
23588544|NCT00486759|65882179|FG001|Treatment|Withdrew consent|12|||
23588545|NCT00486759|65882178|FG000|Treatment|Administrative/reason not specified|17|||
23588546|NCT00486759|65882179|FG001|Treatment|Administrative/reason not specified|21|||
23588547|NCT00486759|65882178|FG000|Treatment|Refused treatment|10|||
23588548|NCT00486759|65882179|FG001|Treatment|Refused treatment|7|||
23588549|NCT00486759|65882178|FG000|Treatment|Violation of selection criteria at entry|3|||
23588550|NCT00486759|65882179|FG001|Treatment|Violation of selection criteria at entry|3|||
23588551|NCT00486759|65882178|FG000|Treatment|Other protocol violation|1|||
23588552|NCT00486759|65882179|FG001|Treatment|Other protocol violation|5|||
23588553|NCT00486759|65882178|FG000|Treatment|Failure to return|1|||
23588554|NCT00486759|65882179|FG001|Treatment|Failure to return|1|||
23588555|NCT00486759|65882178|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
23588556|NCT00486759|65882179|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
23588557|NCT00486759|65882178|FG000|Safety Follow-up|Death|40|||
23641838|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23641839|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
23641840|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23641841|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23641842|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23641843|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23641844|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
23641845|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23641846|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23641847|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23641848|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23641849|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
23641850|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23641851|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23641852|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23641853|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23641854|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
23641855|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23641856|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23641857|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23641858|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23641859|NCT00700427|66075266|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
23641860|NCT00700427|66075267|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23641861|NCT00700427|66075268|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23641862|NCT00700427|66075269|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23641863|NCT00700427|66075270|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23641864|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23641865|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
23588558|NCT00486759|65882179|FG001|Safety Follow-up|Death|29|||
23588559|NCT00486759|65882178|FG000|Safety Follow-up|Withdrew consent|32|||
23588560|NCT00486759|65882179|FG001|Safety Follow-up|Withdrew consent|23|||
23588561|NCT00486759|65882178|FG000|Safety Follow-up|Failure to return|9|||
23641866|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23641867|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23588562|NCT00486759|65882179|FG001|Safety Follow-up|Failure to return|6|||
23588563|NCT00486759|65882178|FG000|Safety Follow-up|Administrative/not specified|8|||
23588564|NCT00486759|65882179|FG001|Safety Follow-up|Administrative/not specified|6|||
23588565|NCT00486759|65882178|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
23641868|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23641869|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23641870|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
23641871|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23641872|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23588566|NCT00486759|65882179|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
23588567|NCT00486759|65882178|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
23588568|NCT00486759|65882179|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
23588569|NCT01368406|65882180|FG000|Overall Study|Lost to Follow-up|8|||
23588570|NCT01368406|65882181|FG001|Overall Study|Lost to Follow-up|4|||
23588571|NCT01368406|65882180|FG000|Overall Study|Withdrawal by Subject|8|||
23588572|NCT01368406|65882181|FG001|Overall Study|Withdrawal by Subject|4|||
23588573|NCT01368406|65882180|FG000|Overall Study|relapse of the disease|3|||
23588574|NCT01368406|65882181|FG001|Overall Study|relapse of the disease|2|||
23588575|NCT01368406|65882180|FG000|Overall Study|started working|2|||
23588576|NCT01368406|65882181|FG001|Overall Study|started working|3|||
23588577|NCT05046132|65882186|FG000|Overall Study|Adverse Event|4|||
23588578|NCT05046132|65882187|FG001|Overall Study|Adverse Event|0|||
23588579|NCT05046132|65882188|FG002|Overall Study|Adverse Event|0|||
23588580|NCT05046132|65882186|FG000|Overall Study|Withdrawal by Subject|3|||
23588581|NCT05046132|65882187|FG001|Overall Study|Withdrawal by Subject|0|||
23588582|NCT05046132|65882188|FG002|Overall Study|Withdrawal by Subject|0|||
23588583|NCT05046132|65882186|FG000|Overall Study|Positive Covid19 Result.|0|||
23588584|NCT05046132|65882187|FG001|Overall Study|Positive Covid19 Result.|1|||
23588585|NCT05046132|65882188|FG002|Overall Study|Positive Covid19 Result.|0|||
23588586|NCT01595321|65882189|FG000|Overall Study|Adverse Event|1|||
23588587|NCT01595321|65882190|FG001|Overall Study|Adverse Event|1|||
23588588|NCT01595321|65882191|FG002|Overall Study|Adverse Event|1|||
23588589|NCT01595321|65882189|FG000|Overall Study|Lack of Efficacy|0|||
23588590|NCT01595321|65882190|FG001|Overall Study|Lack of Efficacy|0|||
23588591|NCT01595321|65882191|FG002|Overall Study|Lack of Efficacy|4|||
23588592|NCT00798096|65882192|FG000|Overall Study|Ongoing|2|||
23588593|NCT00117988|65882193|FG000|Overall Study|Death|3|||
23588594|NCT00117988|65882193|FG000|Overall Study|Adverse Event|1|||
23588595|NCT00509769|65882194|FG000|Overall Study|Progressive disease|77|||
23588596|NCT00509769|65882194|FG000|Overall Study|Adverse Event|4|||
23588597|NCT00509769|65882194|FG000|Overall Study|Patient's decision|1|||
23588598|NCT00509769|65882194|FG000|Overall Study|Physician Decision|8|||
23588599|NCT00509769|65882194|FG000|Overall Study|Use of prohibited therapies during study|1|||
23588600|NCT00758602|65882196|FG000|Overall Study|Adverse Event|11|||
23588601|NCT00758602|65882197|FG001|Overall Study|Adverse Event|10|||
23588602|NCT00758602|65882196|FG000|Overall Study|Lost to Follow-up|4|||
23588603|NCT00758602|65882197|FG001|Overall Study|Lost to Follow-up|3|||
23588604|NCT00758602|65882196|FG000|Overall Study|Withdrawal by Subject|1|||
23588605|NCT00758602|65882197|FG001|Overall Study|Withdrawal by Subject|3|||
23588606|NCT00758602|65882196|FG000|Overall Study|Protocol Violation|0|||
23588607|NCT00758602|65882197|FG001|Overall Study|Protocol Violation|2|||
23588608|NCT00758602|65882196|FG000|Overall Study|Death|0|||
23588609|NCT00758602|65882197|FG001|Overall Study|Death|1|||
23588610|NCT00758602|65882196|FG000|Overall Study|Reason not specified|3|||
23588611|NCT00758602|65882197|FG001|Overall Study|Reason not specified|3|||
23588612|NCT03418324|65882198|FG000|Overall Study|Death|0|||
23588613|NCT03418324|65882199|FG001|Overall Study|Death|1|||
23588614|NCT03418324|65882198|FG000|Overall Study|Physician Decision|1|||
23588615|NCT03418324|65882199|FG001|Overall Study|Physician Decision|1|||
23588616|NCT02459899|65882200|FG000|Overall Study|Adverse Event|1|||
23588617|NCT02459899|65882201|FG001|Overall Study|Adverse Event|1|||
23588618|NCT02459899|65882202|FG002|Overall Study|Adverse Event|0|||
23588619|NCT02459899|65882203|FG003|Overall Study|Adverse Event|0|||
23588620|NCT02459899|65882200|FG000|Overall Study|Lost to Follow-up|1|||
23588621|NCT02459899|65882201|FG001|Overall Study|Lost to Follow-up|2|||
23588622|NCT02459899|65882202|FG002|Overall Study|Lost to Follow-up|0|||
23588623|NCT02459899|65882203|FG003|Overall Study|Lost to Follow-up|1|||
23588624|NCT02459899|65882200|FG000|Overall Study|Non-compliance with the treatment|0|||
23588625|NCT02459899|65882201|FG001|Overall Study|Non-compliance with the treatment|0|||
23588626|NCT02459899|65882202|FG002|Overall Study|Non-compliance with the treatment|0|||
23588627|NCT02459899|65882203|FG003|Overall Study|Non-compliance with the treatment|1|||
23588628|NCT02459899|65882200|FG000|Overall Study|Withdrawal by Subject|1|||
23588629|NCT02459899|65882201|FG001|Overall Study|Withdrawal by Subject|3|||
23588630|NCT02459899|65882202|FG002|Overall Study|Withdrawal by Subject|0|||
23588631|NCT02459899|65882203|FG003|Overall Study|Withdrawal by Subject|0|||
23588632|NCT02148133|65882204|FG000|Overall Study|Investigator discretion|1|||
23588633|NCT02148133|65882204|FG000|Overall Study|Lack of Efficacy|1|||
23588634|NCT02148133|65882204|FG000|Overall Study|Protocol deviation|1|||
23588635|NCT02148133|65882204|FG000|Overall Study|Protocol-defined stopping criteria|2|||
23588636|NCT00001575|65882208|FG000|Overall Study|Screening failures-Ph I portion|22|||
23641873|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23641874|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23641875|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
23641876|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23641877|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23641878|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23641879|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23641880|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
23641881|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23641882|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23641883|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23641884|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23641885|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
23641886|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23641887|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23641888|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23641889|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23641890|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
23641891|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23641892|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23641893|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23641894|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23641895|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
23641896|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23641897|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23641898|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23641899|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23641900|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
23641901|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23641902|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23641903|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23641904|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23641905|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
23641906|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23641907|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23641908|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23641909|NCT00700427|66075266|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23641910|NCT00700427|66075267|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
23706850|NCT00002663|66301346|FG007|Overall Study|Physician Decision|0|||
23356330|NCT03959488|65048815|FG002|Season 2|Lost to Follow-up|1|||
23356331|NCT03959488|65048816|FG003|Season 2|Lost to Follow-up|0|||
23356332|NCT03959488|65048817|FG004|Season 2|Lost to Follow-up|1|||
23472716|NCT01325337|65477452|FG004|Overall Study|Personal Reasons|3|||
23472717|NCT01325337|65477448|FG000|Overall Study|Withdrawal by Subject|1|||
23472718|NCT01325337|65477449|FG001|Overall Study|Withdrawal by Subject|0|||
23472719|NCT01325337|65477450|FG002|Overall Study|Withdrawal by Subject|1|||
23472720|NCT01325337|65477451|FG003|Overall Study|Withdrawal by Subject|0|||
23472721|NCT01325337|65477452|FG004|Overall Study|Withdrawal by Subject|1|||
23472722|NCT02948088|65477453|FG000|Overall Study|Lost to Follow-up|8|||
23472723|NCT02948088|65477453|FG000|Overall Study|Death|1|||
23472724|NCT02948088|65477453|FG000|Overall Study|Withdrawal by Subject|4|||
23472725|NCT02948088|65477453|FG000|Overall Study|Other|2|||
23472726|NCT00773838|65477454|FG000|Overall Study|Adverse Event|29|||
23472727|NCT00773838|65477454|FG000|Overall Study|Lost to Follow-up|1|||
23472728|NCT00773838|65477454|FG000|Overall Study|Physician Decision|8|||
23472729|NCT00773838|65477454|FG000|Overall Study|Progressive Disease|82|||
23472730|NCT00773838|65477454|FG000|Overall Study|Protocol Violation|2|||
23472731|NCT00773838|65477454|FG000|Overall Study|Withdrawal by Subject|21|||
23472732|NCT01290796|65477455|FG000|Overall Study|Lost to Follow-up|21|||
23472733|NCT01290796|65477455|FG000|Overall Study|Withdrawal by Subject|4|||
23472734|NCT01290796|65477455|FG000|Overall Study|Physician Decision|2|||
23472735|NCT01290796|65477455|FG000|Overall Study|Secondary Surgical Intervention|2|||
23472736|NCT01290796|65477455|FG000|Overall Study|Withdrawal by Sponsor|1|||
23472737|NCT01478048|65477457|FG000|Overall Study|Disease Progression|52|||
23472738|NCT01478048|65477458|FG001|Overall Study|Disease Progression|35|||
23472739|NCT01478048|65477457|FG000|Overall Study|study drug toxicity|11|||
23472740|NCT01478048|65477458|FG001|Overall Study|study drug toxicity|14|||
23472741|NCT01478048|65477457|FG000|Overall Study|Adverse Event|2|||
23472742|NCT01478048|65477458|FG001|Overall Study|Adverse Event|11|||
23472743|NCT01478048|65477457|FG000|Overall Study|subject request to discontinue treatment|3|||
23641911|NCT00700427|66075268|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23641912|NCT00700427|66075269|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23641913|NCT00700427|66075270|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23641914|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23641915|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23641916|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
23641917|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
23796194|NCT01332968|66630100|FG000|Follow-Up Period|Protocol Violation|0|||
23588637|NCT00001575|65882208|FG000|Overall Study|Withdrawn/deaths|23|||
23588638|NCT02299336|65882209|FG000|Overall Study|Withdrawal by Subject|11|||
23588639|NCT02299336|65882209|FG000|Overall Study|Adverse Event|1|||
23641918|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23356333|NCT01563913|65048818|FG000|Overall Study|Physician Decision|1|||
23356334|NCT01563913|65048819|FG001|Overall Study|Physician Decision|0|||
23356335|NCT01563913|65048818|FG000|Overall Study|Spouse Passed Away|1|||
23356336|NCT01563913|65048819|FG001|Overall Study|Spouse Passed Away|0|||
23356337|NCT00162097|65048820|FG000|Overall Study|Participant no longer met study criteria|0|||
23356338|NCT00162097|65048821|FG001|Overall Study|Participant no longer met study criteria|0|||
23356339|NCT00162097|65048822|FG002|Overall Study|Participant no longer met study criteria|0|||
23356340|NCT00162097|65048823|FG003|Overall Study|Participant no longer met study criteria|1|||
23356341|NCT00703677|65048824|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
23356342|NCT02496039|65048826|FG000|Overall Study|Adverse Event|3|||
23356343|NCT02496039|65048826|FG000|Overall Study|Protocol Violation|1|||
23356344|NCT02178358|65048827|FG000|Overall Study|Withdrawal by Subject|0|||
23356345|NCT02178358|65048828|FG001|Overall Study|Withdrawal by Subject|2|||
23356346|NCT02178358|65048829|FG002|Overall Study|Withdrawal by Subject|2|||
23356347|NCT02178358|65048827|FG000|Overall Study|Lost to Follow-up|1|||
23356348|NCT02178358|65048828|FG001|Overall Study|Lost to Follow-up|0|||
23356349|NCT02178358|65048829|FG002|Overall Study|Lost to Follow-up|0|||
23356350|NCT03333486|65048835|FG000|Overall Study|Withdrawal by Subject|1|||
23356351|NCT03333486|65048835|FG000|Overall Study|Lost to Follow-up|1|||
23356352|NCT00002525|65048838|FG000|Overall Study|Adverse Event|36|||
23356353|NCT00002525|65048839|FG001|Overall Study|Adverse Event|0|||
23356354|NCT00002525|65048838|FG000|Overall Study|Death|5|||
23356355|NCT00002525|65048839|FG001|Overall Study|Death|0|||
23356356|NCT00002525|65048838|FG000|Overall Study|Withdrawal by Subject|11|||
23356357|NCT00002525|65048839|FG001|Overall Study|Withdrawal by Subject|0|||
23356358|NCT00002525|65048838|FG000|Overall Study|Start non-protocol therapy|1|||
23356359|NCT00002525|65048839|FG001|Overall Study|Start non-protocol therapy|0|||
23356360|NCT00002525|65048838|FG000|Overall Study|Other complicating disease|1|||
23356361|NCT00002525|65048839|FG001|Overall Study|Other complicating disease|0|||
23356362|NCT00002525|65048838|FG000|Overall Study|Duke's A, B1, D disease|92|||
23356363|NCT00002525|65048839|FG001|Overall Study|Duke's A, B1, D disease|0|||
23356364|NCT00002525|65048838|FG000|Overall Study|Error|6|||
23356365|NCT00002525|65048839|FG001|Overall Study|Error|0|||
23356366|NCT00002525|65048838|FG000|Overall Study|Other|26|||
23356367|NCT00002525|65048839|FG001|Overall Study|Other|0|||
23356368|NCT00002525|65048838|FG000|Overall Study|Never start protocol therapy|8|||
23356369|NCT00002525|65048839|FG001|Overall Study|Never start protocol therapy|0|||
23356370|NCT01090050|65048848|FG000|Overall Study|Lost to Follow-up|0|||
23356371|NCT01090050|65048849|FG001|Overall Study|Lost to Follow-up|1|||
23356372|NCT01090050|65048848|FG000|Overall Study|Lack of Efficacy|1|||
23356373|NCT01090050|65048849|FG001|Overall Study|Lack of Efficacy|5|||
23356374|NCT01090050|65048848|FG000|Overall Study|Physician Decision|0|||
23356375|NCT01090050|65048849|FG001|Overall Study|Physician Decision|1|||
23356376|NCT03332095|65048850|FG000|Overall Study|Lost to Follow-up|1|||
23356377|NCT03332095|65048851|FG001|Overall Study|Lost to Follow-up|0|||
23356378|NCT03332095|65048850|FG000|Overall Study|Pregnancy|0|||
23356379|NCT03332095|65048851|FG001|Overall Study|Pregnancy|1|||
23356380|NCT01641471|65048855|FG000|Overall Study|Withdrawal by Subject|19|||
23356381|NCT01641471|65048856|FG001|Overall Study|Withdrawal by Subject|19|||
23356382|NCT01641471|65048855|FG000|Overall Study|Lost to Follow-up|2|||
23356383|NCT01641471|65048856|FG001|Overall Study|Lost to Follow-up|4|||
23356384|NCT01641471|65048855|FG000|Overall Study|Protocol Violation|2|||
23356385|NCT01641471|65048856|FG001|Overall Study|Protocol Violation|4|||
23796195|NCT01332968|66630101|FG001|Follow-Up Period|Protocol Violation|0|||
23796196|NCT01332968|66630102|FG002|Follow-Up Period|Protocol Violation|0|||
23796197|NCT01332968|66630103|FG003|Follow-Up Period|Protocol Violation|0|||
23796198|NCT01332968|66630104|FG004|Follow-Up Period|Protocol Violation|0|||
23796199|NCT01332968|66630105|FG005|Follow-Up Period|Protocol Violation|0|||
23356386|NCT00395642|65048857|FG000|Overall Study|Death|4|||
23356387|NCT00395642|65048857|FG000|Overall Study|Lost to Follow-up|1|||
23356388|NCT00395642|65048857|FG000|Overall Study|Physician Decision|7|||
23356389|NCT00395642|65048857|FG000|Overall Study|Withdrawal by Subject|1|||
23356390|NCT01775787|65048858|FG000|First 7-10 Days|Adverse Event|0|||
23588640|NCT02299336|65882209|FG000|Overall Study|Death|1|||
23356391|NCT01775787|65048859|FG001|First 7-10 Days|Adverse Event|1|||
23356392|NCT01775787|65048858|FG000|First 7-10 Days|family emergency|0|||
23356393|NCT01775787|65048859|FG001|First 7-10 Days|family emergency|1|||
23356394|NCT01775787|65048858|FG000|First 7-10 Days|time commitment|0|||
23356395|NCT01775787|65048859|FG001|First 7-10 Days|time commitment|2|||
23356396|NCT01775787|65048858|FG000|First 7-10 Days|concerns with using IV|1|||
23356397|NCT01775787|65048859|FG001|First 7-10 Days|concerns with using IV|2|||
23356398|NCT01775787|65048858|FG000|Second 7-10 Days|time commitment|0|||
23356399|NCT01775787|65048859|FG001|Second 7-10 Days|time commitment|1|||
23356400|NCT01775787|65048858|FG000|Second 7-10 Days|concerns with using IV|0|||
23356401|NCT01775787|65048859|FG001|Second 7-10 Days|concerns with using IV|1|||
23356402|NCT03246061|65048860|FG000|Overall Study|Still in follow-up|15|||
23356403|NCT03246061|65048861|FG001|Overall Study|Still in follow-up|21|||
23472744|NCT01478048|65477458|FG001|Overall Study|subject request to discontinue treatment|5|||
23472745|NCT01478048|65477457|FG000|Overall Study|Withdrawal by Subject|2|||
23472746|NCT01478048|65477458|FG001|Overall Study|Withdrawal by Subject|5|||
23472747|NCT01478048|65477457|FG000|Overall Study|non-specified|6|||
23472748|NCT01478048|65477458|FG001|Overall Study|non-specified|4|||
23472749|NCT01478048|65477457|FG000|Overall Study|poor/non-compliance|0|||
23472750|NCT01478048|65477458|FG001|Overall Study|poor/non-compliance|1|||
23641919|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23641920|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23641921|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
23641922|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
23641923|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23641924|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23641925|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23641926|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
23641927|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
23641928|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23641929|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23641930|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23641931|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
23796200|NCT01332968|66630106|FG006|Follow-Up Period|Protocol Violation|1|||
23796201|NCT01332968|66630107|FG007|Follow-Up Period|Protocol Violation|0|||
23796202|NCT01332968|66630100|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23472751|NCT01478048|65477457|FG000|Overall Study|no longer meets study criteria|1|||
23472752|NCT01478048|65477458|FG001|Overall Study|no longer meets study criteria|0|||
23472753|NCT00701662|65477459|FG000|Overall Study|Lack of Efficacy|1|||
23472754|NCT03425253|65477464|FG000|Overall Study|Adverse Event|2|||
23472755|NCT03425253|65477464|FG000|Overall Study|Lost to Follow-up|3|||
23472756|NCT03425253|65477464|FG000|Overall Study|Withdrew Consent|6|||
23796203|NCT01332968|66630101|FG001|Follow-Up Period|Withdrawal by Subject|0|||
23796204|NCT01332968|66630102|FG002|Follow-Up Period|Withdrawal by Subject|0|||
23796205|NCT01332968|66630103|FG003|Follow-Up Period|Withdrawal by Subject|0|||
23796206|NCT01332968|66630104|FG004|Follow-Up Period|Withdrawal by Subject|0|||
23796207|NCT01332968|66630105|FG005|Follow-Up Period|Withdrawal by Subject|0|||
23796208|NCT01332968|66630106|FG006|Follow-Up Period|Withdrawal by Subject|29|||
23796209|NCT01332968|66630107|FG007|Follow-Up Period|Withdrawal by Subject|32|||
23796210|NCT01332968|66630100|FG000|Follow-Up Period|No reason provided|0|||
23796211|NCT01332968|66630101|FG001|Follow-Up Period|No reason provided|0|||
23796212|NCT01332968|66630102|FG002|Follow-Up Period|No reason provided|0|||
23796213|NCT01332968|66630103|FG003|Follow-Up Period|No reason provided|0|||
23796214|NCT01332968|66630104|FG004|Follow-Up Period|No reason provided|0|||
23796215|NCT01332968|66630105|FG005|Follow-Up Period|No reason provided|0|||
23796216|NCT01332968|66630106|FG006|Follow-Up Period|No reason provided|2|||
23796217|NCT01332968|66630107|FG007|Follow-Up Period|No reason provided|3|||
23796218|NCT02578641|66630114|FG000|Overall Study|Adverse Event|5|||
23796219|NCT02578641|66630115|FG001|Overall Study|Adverse Event|15|||
23796220|NCT02578641|66630114|FG000|Overall Study|Death|16|||
23796221|NCT02578641|66630115|FG001|Overall Study|Death|8|||
23796222|NCT02578641|66630114|FG000|Overall Study|Lost to Follow-up|0|||
23796223|NCT02578641|66630115|FG001|Overall Study|Lost to Follow-up|1|||
23356404|NCT03504189|65048862|FG000|Overall Study|Withdrawal by Subject|1|||
23356405|NCT03504189|65048862|FG000|Overall Study|Screening Failure|1|||
23356406|NCT03504189|65048862|FG000|Overall Study|Device Failure|2|||
23472757|NCT03425253|65477464|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
23472758|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
23356407|NCT02749799|65048864|FG000|Overall Study|Adverse Event|2|||
23356408|NCT02749799|65048864|FG000|Overall Study|Lost to Follow-up|4|||
23796224|NCT02578641|66630114|FG000|Overall Study|Withdrawal by Subject|14|||
23796225|NCT02578641|66630115|FG001|Overall Study|Withdrawal by Subject|7|||
23796226|NCT02578641|66630114|FG000|Overall Study|Progressive Disease|69|||
23472759|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23588641|NCT02299336|65882209|FG000|Overall Study|Lost to Follow-up|1|||
23588642|NCT00420316|65882210|FG000|Overall Study|Withdrawal by Subject|0|||
23588643|NCT00420316|65882211|FG001|Overall Study|Withdrawal by Subject|1|||
23588644|NCT00420316|65882210|FG000|Overall Study|Lost to Follow-up|12|||
23588645|NCT00420316|65882211|FG001|Overall Study|Lost to Follow-up|8|||
23588646|NCT00723450|65882212|FG000|Open-Label Phase|Adverse Event|26|||
23588647|NCT00723450|65882213|FG001|Open-Label Phase|Adverse Event|0|||
23588648|NCT00723450|65882214|FG002|Open-Label Phase|Adverse Event|0|||
23588649|NCT00723450|65882212|FG000|Open-Label Phase|Lack of Efficacy|18|||
23588650|NCT00723450|65882213|FG001|Open-Label Phase|Lack of Efficacy|0|||
23472760|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23472761|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23472762|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Death|3|||
23472763|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Death|0|||
23472764|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Death|0|||
23472765|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Death|0|||
23472766|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
23472767|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472768|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472769|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472770|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
23588651|NCT00723450|65882214|FG002|Open-Label Phase|Lack of Efficacy|0|||
23588652|NCT00723450|65882212|FG000|Open-Label Phase|Protocol Violation|35|||
23641932|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
23641933|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23641934|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23796227|NCT02578641|66630115|FG001|Overall Study|Progressive Disease|21|||
23796228|NCT02578641|66630114|FG000|Overall Study|No Study Drug|2|||
23796229|NCT02578641|66630115|FG001|Overall Study|No Study Drug|0|||
23796230|NCT02578641|66630114|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
23796231|NCT02578641|66630115|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
23796232|NCT02578641|66630114|FG000|Overall Study|Non-compliance with Study Schedule|1|||
23796233|NCT02578641|66630115|FG001|Overall Study|Non-compliance with Study Schedule|0|||
23796234|NCT02578641|66630114|FG000|Overall Study|Other|1|||
23796235|NCT02578641|66630115|FG001|Overall Study|Other|10|||
23796236|NCT02578641|66630114|FG000|Overall Study|Not treated|1|||
23796237|NCT02578641|66630115|FG001|Overall Study|Not treated|4|||
23796238|NCT01186016|66630116|FG000|Overall Study|Withdrawal by Subject|46|||
23796239|NCT01186016|66630117|FG001|Overall Study|Withdrawal by Subject|29|||
23796240|NCT00685750|66630120|FG000|Overall Study|Tumor sampling failure|0|||
23796241|NCT00685750|66630121|FG001|Overall Study|Tumor sampling failure|0|||
23796242|NCT00685750|66630122|FG002|Overall Study|Tumor sampling failure|1|||
23796243|NCT00685750|66630123|FG003|Overall Study|Tumor sampling failure|0|||
23796244|NCT00685750|66630124|FG004|Overall Study|Tumor sampling failure|0|||
23796245|NCT00685750|66630125|FG005|Overall Study|Tumor sampling failure|0|||
23796246|NCT00685750|66630126|FG006|Overall Study|Tumor sampling failure|0|||
23796247|NCT00685750|66630120|FG000|Overall Study|Patient didn't receive the treatment|0|||
23796248|NCT00685750|66630121|FG001|Overall Study|Patient didn't receive the treatment|0|||
23796249|NCT00685750|66630122|FG002|Overall Study|Patient didn't receive the treatment|0|||
23796250|NCT00685750|66630123|FG003|Overall Study|Patient didn't receive the treatment|0|||
23796251|NCT00685750|66630124|FG004|Overall Study|Patient didn't receive the treatment|0|||
23796252|NCT00685750|66630125|FG005|Overall Study|Patient didn't receive the treatment|0|||
23796253|NCT00685750|66630126|FG006|Overall Study|Patient didn't receive the treatment|1|||
23796254|NCT00685750|66630120|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23796255|NCT00685750|66630121|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23796256|NCT00685750|66630122|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23796257|NCT00685750|66630123|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
23796258|NCT00685750|66630124|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23796259|NCT00685750|66630125|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
23796260|NCT00685750|66630126|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
23796261|NCT05692154|66630127|FG000|Overall Study|Adverse Event|0|||
23796262|NCT05692154|66630128|FG001|Overall Study|Adverse Event|1|||
23796263|NCT04556734|66630129|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
23588653|NCT00723450|65882213|FG001|Open-Label Phase|Protocol Violation|0|||
23796264|NCT04556734|66630130|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23796265|NCT04556734|66630131|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23796266|NCT04556734|66630132|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23796267|NCT04556734|66630133|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23472771|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23472772|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23588654|NCT00723450|65882214|FG002|Open-Label Phase|Protocol Violation|0|||
23588655|NCT00723450|65882212|FG000|Open-Label Phase|Lost to Follow-up|7|||
23641935|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23641936|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
23641937|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
23641938|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23641939|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23796268|NCT04556734|66630134|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23796269|NCT04556734|66630135|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23796270|NCT04556734|66630136|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23472773|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23472774|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
23472775|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472776|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472777|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472778|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
23472779|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472780|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472781|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472782|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472783|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
23472784|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472785|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472786|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
23472787|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
23472788|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
23472789|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
23472790|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472791|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
23472792|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472793|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472794|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472795|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
23472796|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472797|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472798|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23472799|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
23472800|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23796271|NCT04556734|66630129|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23796272|NCT04556734|66630130|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23796273|NCT04556734|66630131|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23796274|NCT04556734|66630132|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23588656|NCT00723450|65882213|FG001|Open-Label Phase|Lost to Follow-up|0|||
23588657|NCT00723450|65882214|FG002|Open-Label Phase|Lost to Follow-up|0|||
23588658|NCT00723450|65882212|FG000|Open-Label Phase|Physician Decision|2|||
23588659|NCT00723450|65882213|FG001|Open-Label Phase|Physician Decision|0|||
23472801|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23472802|NCT00884741|65477465|FG000|Randomization|Protocol Violation|0|||
23588660|NCT00723450|65882214|FG002|Open-Label Phase|Physician Decision|0|||
23356409|NCT02749799|65048864|FG000|Overall Study|Protocol Violation|1|||
23356410|NCT02749799|65048864|FG000|Overall Study|Withdrawal by Subject|1|||
23356411|NCT01491841|65048865|FG000|Overall Study|Screen Failure|10|||
23472803|NCT00884741|65477466|FG001|Randomization|Protocol Violation|0|||
23472804|NCT00884741|65477467|FG002|Randomization|Protocol Violation|8|||
23472805|NCT00884741|65477468|FG003|Randomization|Protocol Violation|8|||
23472806|NCT01767142|65477470|FG000|Overall Study|Lost to Follow-up|3|||
23472807|NCT00084136|65477471|FG000|PI Comparison|Death|10|||
23472808|NCT00084136|65477472|FG001|PI Comparison|Death|9|||
23472809|NCT00084136|65477473|FG002|PI Comparison|Death|0|||
23472810|NCT00084136|65477471|FG000|PI Comparison|Lost to Follow-up|11|||
23472811|NCT00084136|65477472|FG001|PI Comparison|Lost to Follow-up|8|||
23472812|NCT00084136|65477473|FG002|PI Comparison|Lost to Follow-up|0|||
23472813|NCT00084136|65477471|FG000|PI Comparison|Withdrawal by Subject|33|||
23472814|NCT00084136|65477472|FG001|PI Comparison|Withdrawal by Subject|30|||
23472815|NCT00084136|65477473|FG002|PI Comparison|Withdrawal by Subject|0|||
23641940|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23641941|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23641942|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
23796275|NCT04556734|66630133|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23796276|NCT04556734|66630134|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23796277|NCT04556734|66630135|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23796278|NCT04556734|66630136|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23472816|NCT00084136|65477471|FG000|PI Comparison|Clinic site closed|1|||
23472817|NCT00084136|65477472|FG001|PI Comparison|Clinic site closed|0|||
23472818|NCT00084136|65477473|FG002|PI Comparison|Clinic site closed|0|||
23472819|NCT00084136|65477471|FG000|NRTI Comparison|Death|20|||
23472820|NCT00084136|65477472|FG001|NRTI Comparison|Death|0|||
23472821|NCT00084136|65477473|FG002|NRTI Comparison|Death|18|||
23472822|NCT00084136|65477471|FG000|NRTI Comparison|Lost to Follow-up|14|||
23472823|NCT00084136|65477472|FG001|NRTI Comparison|Lost to Follow-up|0|||
23472824|NCT00084136|65477473|FG002|NRTI Comparison|Lost to Follow-up|12|||
23472825|NCT00084136|65477471|FG000|NRTI Comparison|Withdrawal by Subject|54|||
23472826|NCT00084136|65477472|FG001|NRTI Comparison|Withdrawal by Subject|0|||
23472827|NCT00084136|65477473|FG002|NRTI Comparison|Withdrawal by Subject|38|||
23472828|NCT00084136|65477471|FG000|NRTI Comparison|Clinic site closed|12|||
23472829|NCT00084136|65477472|FG001|NRTI Comparison|Clinic site closed|0|||
23472830|NCT00084136|65477473|FG002|NRTI Comparison|Clinic site closed|14|||
23472831|NCT00084136|65477471|FG000|NRTI Comparison|Not reason above|1|||
23472832|NCT00084136|65477472|FG001|NRTI Comparison|Not reason above|0|||
23472833|NCT00084136|65477473|FG002|NRTI Comparison|Not reason above|0|||
23472834|NCT00835211|65477476|FG000|First Intervention|Withdrawal by Subject|0|||
23472835|NCT00835211|65477477|FG001|First Intervention|Withdrawal by Subject|1|||
23472836|NCT00835211|65477476|FG000|Washout: 7 Days|Adverse Event|2|||
23472837|NCT00835211|65477477|FG001|Washout: 7 Days|Adverse Event|1|||
23472838|NCT00835211|65477476|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23472839|NCT00835211|65477477|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23472840|NCT00838513|65477478|FG000|Screening Period|Screen Failure|3|||
23472841|NCT00838513|65477478|FG000|Extension Treatment Period|Death|1|||
23472842|NCT00838513|65477478|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
23472843|NCT00145119|65477479|FG000|Overall Study|Death|45|||
23588661|NCT00723450|65882212|FG000|Open-Label Phase|Withdrawal by Subject|37|||
23796279|NCT04556734|66630129|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23796280|NCT04556734|66630130|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796281|NCT04556734|66630131|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23796282|NCT04556734|66630132|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796283|NCT04556734|66630133|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796284|NCT04556734|66630134|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796285|NCT04556734|66630135|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796286|NCT04556734|66630136|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23796287|NCT04556734|66630129|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
23796288|NCT04556734|66630130|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23796289|NCT04556734|66630131|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23796290|NCT04556734|66630132|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23588662|NCT00723450|65882213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23588663|NCT00723450|65882214|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23588664|NCT00723450|65882212|FG000|Randomized Phase|Adverse Event|0|||
23588665|NCT00723450|65882213|FG001|Randomized Phase|Adverse Event|26|||
23588666|NCT00723450|65882214|FG002|Randomized Phase|Adverse Event|17|||
23796291|NCT04556734|66630133|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23588667|NCT00723450|65882212|FG000|Randomized Phase|Lack of Efficacy|0|||
23588668|NCT00723450|65882213|FG001|Randomized Phase|Lack of Efficacy|11|||
23588669|NCT00723450|65882214|FG002|Randomized Phase|Lack of Efficacy|11|||
23796292|NCT04556734|66630134|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23588670|NCT00723450|65882212|FG000|Randomized Phase|Protocol Violation|0|||
23588671|NCT00723450|65882213|FG001|Randomized Phase|Protocol Violation|9|||
23588672|NCT00723450|65882214|FG002|Randomized Phase|Protocol Violation|13|||
23588673|NCT00723450|65882212|FG000|Randomized Phase|Lost to Follow-up|0|||
23588674|NCT00723450|65882213|FG001|Randomized Phase|Lost to Follow-up|2|||
23588675|NCT00723450|65882214|FG002|Randomized Phase|Lost to Follow-up|3|||
23588676|NCT00723450|65882212|FG000|Randomized Phase|Physician Decision|0|||
23588677|NCT00723450|65882213|FG001|Randomized Phase|Physician Decision|3|||
23588678|NCT00723450|65882214|FG002|Randomized Phase|Physician Decision|1|||
23588679|NCT00723450|65882212|FG000|Randomized Phase|Withdrawal by Subject|0|||
23356412|NCT01491841|65048865|FG000|Overall Study|Withdrawal by Subject|1|||
23472844|NCT02238067|65477480|FG000|Overall Study|Not completed survey at Month 6|45|||
23472845|NCT00943072|65477485|FG000|Overall Study|Adverse Event|0|||
23472846|NCT00943072|65477486|FG001|Overall Study|Adverse Event|3|||
23472847|NCT00943072|65477485|FG000|Overall Study|Death|0|||
23588680|NCT00723450|65882213|FG001|Randomized Phase|Withdrawal by Subject|14|||
23588681|NCT00723450|65882214|FG002|Randomized Phase|Withdrawal by Subject|22|||
23588682|NCT01131494|65882215|FG000|Overall Study|Withdrawal by Subject|2|||
23796293|NCT04556734|66630135|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23588683|NCT01981850|65882216|FG000|Main Phase Stage 1|Death|2|||
23796294|NCT04556734|66630136|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23356413|NCT03337048|65048866|FG000|Overall Study|Withdrawal by Subject|2|||
23472848|NCT00943072|65477486|FG001|Overall Study|Death|2|||
23472849|NCT00943072|65477485|FG000|Overall Study|Withdrawal by Subject|3|||
23472850|NCT00943072|65477486|FG001|Overall Study|Withdrawal by Subject|1|||
23588684|NCT01981850|65882217|FG001|Main Phase Stage 1|Death|0|||
23472851|NCT00943072|65477485|FG000|Overall Study|Protocol Violation|0|||
23472852|NCT00943072|65477486|FG001|Overall Study|Protocol Violation|1|||
23472853|NCT00943072|65477485|FG000|Overall Study|Lost to Follow-up|1|||
23472854|NCT00943072|65477486|FG001|Overall Study|Lost to Follow-up|2|||
23472855|NCT00943072|65477485|FG000|Overall Study|Lack of Efficacy|0|||
23472856|NCT00943072|65477486|FG001|Overall Study|Lack of Efficacy|4|||
23472857|NCT00943072|65477485|FG000|Overall Study|Other|1|||
23472858|NCT00943072|65477486|FG001|Overall Study|Other|1|||
23472859|NCT00505076|65477487|FG000|Overall Study|Adverse Event|1|||
23472860|NCT00505076|65477488|FG001|Overall Study|Adverse Event|0|||
23472861|NCT00505076|65477489|FG002|Overall Study|Adverse Event|1|||
23472862|NCT00505076|65477487|FG000|Overall Study|Protocol Violation|2|||
23472863|NCT00505076|65477488|FG001|Overall Study|Protocol Violation|1|||
23472864|NCT00505076|65477489|FG002|Overall Study|Protocol Violation|2|||
23472865|NCT00505076|65477487|FG000|Overall Study|Withdrawal by Subject|0|||
23472866|NCT00505076|65477488|FG001|Overall Study|Withdrawal by Subject|1|||
23472867|NCT00505076|65477489|FG002|Overall Study|Withdrawal by Subject|2|||
23472868|NCT02273596|65477490|FG000|24-Week Treatment Period|Adverse Event|3|||
23472869|NCT02273596|65477490|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
23472870|NCT02273596|65477490|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
23472871|NCT02273596|65477490|FG000|24-Week Treatment Period|Physician Decision|1|||
23472872|NCT02273596|65477490|FG000|24-Week Treatment Period|Protocol Deviation|1|||
23472873|NCT02273596|65477490|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
23472874|NCT02273596|65477490|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
23472875|NCT02273596|65477490|FG000|Extension Period|Lost to Follow-up|1|||
23472876|NCT02273596|65477490|FG000|Extension Period|Protocol Deviation|1|||
23472877|NCT04093024|65477491|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
23472878|NCT04093024|65477492|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
23472879|NCT04093024|65477491|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
23472880|NCT04093024|65477492|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
23472881|NCT04093024|65477491|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
23472882|NCT04093024|65477492|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
23472883|NCT04093024|65477491|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
23472884|NCT04093024|65477492|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
23472885|NCT02395172|65477493|FG000|Overall Study|Participants randomized but not treated|3|||
23472886|NCT02395172|65477494|FG001|Overall Study|Participants randomized but not treated|31|||
23472887|NCT00119678|65477495|FG000|Double-blind Treatment Period|Death|1|||
23472888|NCT00119678|65477496|FG001|Double-blind Treatment Period|Death|0|||
23472889|NCT00119678|65477495|FG000|Double-blind Treatment Period|Adverse Event|7|||
23472890|NCT00119678|65477496|FG001|Double-blind Treatment Period|Adverse Event|1|||
23472891|NCT00119678|65477495|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
23472892|NCT00119678|65477496|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
23472893|NCT00119678|65477495|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23472894|NCT00119678|65477496|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
23472895|NCT00119678|65477495|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
23472896|NCT00119678|65477496|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
23472897|NCT00119678|65477495|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
23472898|NCT00119678|65477496|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
23472899|NCT00119678|65477495|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
23472900|NCT00119678|65477496|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
23472901|NCT00119678|65477495|FG000|Double-blind Treatment Period|Pregnancy|0|||
23472902|NCT00119678|65477496|FG001|Double-blind Treatment Period|Pregnancy|2|||
23472903|NCT00119678|65477495|FG000|Double-blind Treatment Period|Not treated|1|||
23472904|NCT00119678|65477496|FG001|Double-blind Treatment Period|Not treated|2|||
23472905|NCT00119678|65477495|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
23472906|NCT00119678|65477496|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
23472907|NCT00119678|65477495|FG000|Open-label Treatment Period|Death|1|||
23472908|NCT00119678|65477496|FG001|Open-label Treatment Period|Death|0|||
23472909|NCT00119678|65477495|FG000|Open-label Treatment Period|Adverse Event|3|||
23472910|NCT00119678|65477496|FG001|Open-label Treatment Period|Adverse Event|0|||
23472911|NCT00119678|65477495|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
23472912|NCT00119678|65477496|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
23472913|NCT00119678|65477495|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
23472914|NCT00119678|65477496|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23472915|NCT00119678|65477495|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
23472916|NCT00119678|65477496|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
23472917|NCT00119678|65477495|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
23472918|NCT00119678|65477496|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
23472919|NCT00119678|65477495|FG000|Open-label Treatment Period|Pregnancy|1|||
23472920|NCT00119678|65477496|FG001|Open-label Treatment Period|Pregnancy|0|||
23472921|NCT00119678|65477495|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
23472922|NCT00119678|65477496|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
23472923|NCT02560025|65477501|FG000|Overall Study|Ineligible after consent/ registration|3|||
23472924|NCT00796978|65477502|FG000|Overall Study|Cardiac adverse event|5|||
23472925|NCT00796978|65477502|FG000|Overall Study|Adverse Event|4|||
23472926|NCT00796978|65477502|FG000|Overall Study|Withdrawal by Subject|3|||
23472927|NCT01181986|65477503|FG000|Phase 1|Lost to Follow-up|0|||
23472928|NCT01181986|65477504|FG001|Phase 1|Lost to Follow-up|1|||
23472929|NCT01181986|65477505|FG002|Phase 1|Lost to Follow-up|1|||
23472930|NCT01181986|65477503|FG000|Phase 1|Adverse Event|0|||
23472931|NCT01181986|65477504|FG001|Phase 1|Adverse Event|0|||
23472932|NCT01181986|65477505|FG002|Phase 1|Adverse Event|1|||
23472933|NCT01181986|65477503|FG000|Phase 1|Protocol Violation|1|||
23472934|NCT01181986|65477504|FG001|Phase 1|Protocol Violation|0|||
23472935|NCT01181986|65477505|FG002|Phase 1|Protocol Violation|0|||
23472936|NCT01181986|65477503|FG000|Phase 2|Adverse Event|0|||
23472937|NCT01181986|65477504|FG001|Phase 2|Adverse Event|3|||
23472938|NCT01181986|65477505|FG002|Phase 2|Adverse Event|0|||
23472939|NCT01181986|65477503|FG000|Phase 2|Medical condition|0|||
23472940|NCT01181986|65477504|FG001|Phase 2|Medical condition|1|||
23472941|NCT01181986|65477505|FG002|Phase 2|Medical condition|0|||
23472942|NCT00463567|65477506|FG000|Overall Study|Adverse Event|29|||
23472943|NCT00463567|65477507|FG001|Overall Study|Adverse Event|26|||
23472944|NCT00463567|65477508|FG002|Overall Study|Adverse Event|17|||
23472945|NCT00463567|65477509|FG003|Overall Study|Adverse Event|46|||
23472946|NCT00463567|65477510|FG004|Overall Study|Adverse Event|10|||
23472947|NCT00463567|65477511|FG005|Overall Study|Adverse Event|10|||
23472948|NCT00463567|65477512|FG006|Overall Study|Adverse Event|4|||
23472949|NCT00463567|65477506|FG000|Overall Study|Withdrawal by Subject|29|||
23472950|NCT00463567|65477507|FG001|Overall Study|Withdrawal by Subject|22|||
23472951|NCT00463567|65477508|FG002|Overall Study|Withdrawal by Subject|20|||
23472952|NCT00463567|65477509|FG003|Overall Study|Withdrawal by Subject|37|||
23472953|NCT00463567|65477510|FG004|Overall Study|Withdrawal by Subject|6|||
23472954|NCT00463567|65477511|FG005|Overall Study|Withdrawal by Subject|5|||
23472955|NCT00463567|65477512|FG006|Overall Study|Withdrawal by Subject|1|||
23472956|NCT00463567|65477506|FG000|Overall Study|Protocol Deviation|13|||
23472957|NCT00463567|65477507|FG001|Overall Study|Protocol Deviation|9|||
23472958|NCT00463567|65477508|FG002|Overall Study|Protocol Deviation|14|||
23472959|NCT00463567|65477509|FG003|Overall Study|Protocol Deviation|11|||
23472960|NCT00463567|65477510|FG004|Overall Study|Protocol Deviation|1|||
23472961|NCT00463567|65477511|FG005|Overall Study|Protocol Deviation|1|||
23472962|NCT00463567|65477512|FG006|Overall Study|Protocol Deviation|2|||
23472963|NCT00463567|65477506|FG000|Overall Study|Lost to Follow-up|12|||
23472964|NCT00463567|65477507|FG001|Overall Study|Lost to Follow-up|6|||
23472965|NCT00463567|65477508|FG002|Overall Study|Lost to Follow-up|13|||
23472966|NCT00463567|65477509|FG003|Overall Study|Lost to Follow-up|8|||
23472967|NCT00463567|65477510|FG004|Overall Study|Lost to Follow-up|1|||
23472968|NCT00463567|65477511|FG005|Overall Study|Lost to Follow-up|1|||
23472969|NCT00463567|65477512|FG006|Overall Study|Lost to Follow-up|1|||
23472970|NCT00463567|65477506|FG000|Overall Study|Administrative problems|5|||
23472971|NCT00463567|65477507|FG001|Overall Study|Administrative problems|3|||
23472972|NCT00463567|65477508|FG002|Overall Study|Administrative problems|6|||
23472973|NCT00463567|65477509|FG003|Overall Study|Administrative problems|9|||
23472974|NCT00463567|65477510|FG004|Overall Study|Administrative problems|3|||
23472975|NCT00463567|65477511|FG005|Overall Study|Administrative problems|2|||
23472976|NCT00463567|65477512|FG006|Overall Study|Administrative problems|2|||
23472977|NCT00463567|65477506|FG000|Overall Study|Lack of Efficacy|4|||
23472978|NCT00463567|65477507|FG001|Overall Study|Lack of Efficacy|9|||
23472979|NCT00463567|65477508|FG002|Overall Study|Lack of Efficacy|9|||
23472980|NCT00463567|65477509|FG003|Overall Study|Lack of Efficacy|17|||
23472981|NCT00463567|65477510|FG004|Overall Study|Lack of Efficacy|1|||
23472982|NCT00463567|65477511|FG005|Overall Study|Lack of Efficacy|0|||
23472983|NCT00463567|65477512|FG006|Overall Study|Lack of Efficacy|1|||
23472984|NCT00463567|65477506|FG000|Overall Study|Abnormal lab value(s)|1|||
23472985|NCT00463567|65477507|FG001|Overall Study|Abnormal lab value(s)|1|||
23472986|NCT00463567|65477508|FG002|Overall Study|Abnormal lab value(s)|2|||
23472987|NCT00463567|65477509|FG003|Overall Study|Abnormal lab value(s)|1|||
23472988|NCT00463567|65477510|FG004|Overall Study|Abnormal lab value(s)|1|||
23472989|NCT00463567|65477511|FG005|Overall Study|Abnormal lab value(s)|0|||
23472990|NCT00463567|65477512|FG006|Overall Study|Abnormal lab value(s)|0|||
23472991|NCT00463567|65477506|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23472992|NCT00463567|65477507|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23472993|NCT00463567|65477508|FG002|Overall Study|Abnormal test procedure result(s)|6|||
23472994|NCT00463567|65477509|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23472995|NCT00463567|65477510|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23472996|NCT00463567|65477511|FG005|Overall Study|Abnormal test procedure result(s)|2|||
23472997|NCT00463567|65477512|FG006|Overall Study|Abnormal test procedure result(s)|0|||
23472998|NCT00463567|65477506|FG000|Overall Study|Death|1|||
23472999|NCT00463567|65477507|FG001|Overall Study|Death|0|||
23473000|NCT00463567|65477508|FG002|Overall Study|Death|2|||
23473001|NCT00463567|65477509|FG003|Overall Study|Death|0|||
23473002|NCT00463567|65477510|FG004|Overall Study|Death|0|||
23473003|NCT00463567|65477511|FG005|Overall Study|Death|0|||
23473004|NCT00463567|65477512|FG006|Overall Study|Death|0|||
23473005|NCT02147561|65477513|FG000|Overall Study|Lost to Follow-up|3|||
23473006|NCT02147561|65477513|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
23473007|NCT01742286|65477514|FG000|Escalation Phase|Administrative problems|1|||
23473008|NCT01742286|65477515|FG001|Escalation Phase|Administrative problems|1|||
23473009|NCT01742286|65477516|FG002|Escalation Phase|Administrative problems|0|||
23473010|NCT01742286|65477517|FG003|Escalation Phase|Administrative problems|0|||
23473011|NCT01742286|65477518|FG004|Escalation Phase|Administrative problems|0|||
23473012|NCT01742286|65477519|FG005|Escalation Phase|Administrative problems|0|||
23473013|NCT01742286|65477520|FG006|Escalation Phase|Administrative problems|2|||
23473014|NCT01742286|65477514|FG000|Escalation Phase|Adverse Event|0|||
23473015|NCT01742286|65477515|FG001|Escalation Phase|Adverse Event|1|||
23473016|NCT01742286|65477516|FG002|Escalation Phase|Adverse Event|2|||
23473017|NCT01742286|65477517|FG003|Escalation Phase|Adverse Event|0|||
23473018|NCT01742286|65477518|FG004|Escalation Phase|Adverse Event|0|||
23473019|NCT01742286|65477519|FG005|Escalation Phase|Adverse Event|1|||
23473020|NCT01742286|65477520|FG006|Escalation Phase|Adverse Event|0|||
23473021|NCT01742286|65477514|FG000|Escalation Phase|Disease progression|3|||
23473022|NCT01742286|65477515|FG001|Escalation Phase|Disease progression|7|||
23473023|NCT01742286|65477516|FG002|Escalation Phase|Disease progression|4|||
23473024|NCT01742286|65477517|FG003|Escalation Phase|Disease progression|1|||
23473025|NCT01742286|65477518|FG004|Escalation Phase|Disease progression|4|||
23473026|NCT01742286|65477519|FG005|Escalation Phase|Disease progression|3|||
23473027|NCT01742286|65477520|FG006|Escalation Phase|Disease progression|2|||
23473028|NCT01742286|65477514|FG000|Escalation Phase|Death|0|||
23356414|NCT03337048|65048867|FG001|Overall Study|Withdrawal by Subject|0|||
23356415|NCT03337048|65048868|FG002|Overall Study|Withdrawal by Subject|0|||
23356416|NCT00791700|65048869|FG000|Overall Study|Insufficient clinical response|1|||
23356417|NCT00791700|65048870|FG001|Overall Study|Insufficient clinical response|4|||
23356418|NCT00791700|65048871|FG002|Overall Study|Insufficient clinical response|1|||
23356419|NCT00791700|65048872|FG003|Overall Study|Insufficient clinical response|8|||
23356420|NCT00791700|65048869|FG000|Overall Study|No longer willing to participate|1|||
23356421|NCT00791700|65048870|FG001|Overall Study|No longer willing to participate|1|||
23356422|NCT00791700|65048871|FG002|Overall Study|No longer willing to participate|0|||
23356423|NCT00791700|65048872|FG003|Overall Study|No longer willing to participate|8|||
23356424|NCT00791700|65048869|FG000|Overall Study|Non-compliance with study treatment|0|||
23356425|NCT00791700|65048870|FG001|Overall Study|Non-compliance with study treatment|2|||
23356426|NCT00791700|65048871|FG002|Overall Study|Non-compliance with study treatment|0|||
23356427|NCT00791700|65048872|FG003|Overall Study|Non-compliance with study treatment|4|||
23356428|NCT00791700|65048869|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23356429|NCT00791700|65048870|FG001|Overall Study|Withdrawn due to pregnancy|0|||
23356430|NCT00791700|65048871|FG002|Overall Study|Withdrawn due to pregnancy|0|||
23356431|NCT00791700|65048872|FG003|Overall Study|Withdrawn due to pregnancy|1|||
23356432|NCT00791700|65048869|FG000|Overall Study|Other|0|||
23356433|NCT00791700|65048870|FG001|Overall Study|Other|1|||
23356434|NCT00791700|65048871|FG002|Overall Study|Other|0|||
23356435|NCT00791700|65048872|FG003|Overall Study|Other|1|||
23356436|NCT00791700|65048869|FG000|Overall Study|Death|0|||
23356437|NCT00791700|65048870|FG001|Overall Study|Death|0|||
23356438|NCT00791700|65048871|FG002|Overall Study|Death|0|||
23356439|NCT00791700|65048872|FG003|Overall Study|Death|1|||
23356440|NCT00791700|65048869|FG000|Overall Study|Lost to Follow-up|4|||
23356441|NCT00791700|65048870|FG001|Overall Study|Lost to Follow-up|3|||
23473029|NCT01742286|65477515|FG001|Escalation Phase|Death|0|||
23796295|NCT04556734|66630129|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796296|NCT04556734|66630130|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796297|NCT04556734|66630131|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
23796298|NCT04556734|66630132|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796299|NCT04556734|66630133|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796300|NCT04556734|66630134|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796301|NCT04556734|66630135|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796302|NCT04556734|66630136|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23796303|NCT04556734|66630129|FG000|OLE Period (28 Weeks)|Not reported|0|||
23796304|NCT04556734|66630130|FG001|OLE Period (28 Weeks)|Not reported|0|||
23796305|NCT04556734|66630131|FG002|OLE Period (28 Weeks)|Not reported|0|||
23796306|NCT04556734|66630132|FG003|OLE Period (28 Weeks)|Not reported|0|||
23356442|NCT00791700|65048871|FG002|Overall Study|Lost to Follow-up|4|||
23356443|NCT00791700|65048872|FG003|Overall Study|Lost to Follow-up|6|||
23356444|NCT00791700|65048869|FG000|Overall Study|Adverse Event|0|||
23356445|NCT00791700|65048870|FG001|Overall Study|Adverse Event|0|||
23356446|NCT00791700|65048871|FG002|Overall Study|Adverse Event|1|||
23356447|NCT00791700|65048872|FG003|Overall Study|Adverse Event|1|||
23356448|NCT00316914|65048873|FG000|Overall Study|Withdrawal by Subject|5|||
23356449|NCT00316914|65048874|FG001|Overall Study|Withdrawal by Subject|3|||
23356450|NCT00316914|65048873|FG000|Overall Study|Adverse Event|8|||
23356451|NCT00316914|65048874|FG001|Overall Study|Adverse Event|7|||
23356452|NCT00316914|65048873|FG000|Overall Study|Other Problems|6|||
23356453|NCT00316914|65048874|FG001|Overall Study|Other Problems|11|||
23356454|NCT00316914|65048873|FG000|Overall Study|Missing end of treatment documentation|14|||
23356455|NCT00316914|65048874|FG001|Overall Study|Missing end of treatment documentation|15|||
23356456|NCT01711619|65048875|FG000|Overall Study|Early study termination|10|||
23356457|NCT01711619|65048876|FG001|Overall Study|Early study termination|14|||
23356458|NCT01711619|65048875|FG000|Overall Study|Withdrawal by Subject|3|||
23356459|NCT01711619|65048876|FG001|Overall Study|Withdrawal by Subject|7|||
23356460|NCT01711619|65048875|FG000|Overall Study|Protocol Violation|2|||
23356461|NCT01711619|65048876|FG001|Overall Study|Protocol Violation|3|||
23356462|NCT01711619|65048875|FG000|Overall Study|Adverse Event|2|||
23356463|NCT01711619|65048876|FG001|Overall Study|Adverse Event|0|||
23356464|NCT01711619|65048875|FG000|Overall Study|Lost to Follow-up|1|||
23356465|NCT01711619|65048876|FG001|Overall Study|Lost to Follow-up|0|||
23356466|NCT01121536|65048879|FG000|Overall Study|Adverse Event|63|||
23356467|NCT01121536|65048879|FG000|Overall Study|Lack of Efficacy|35|||
23356468|NCT01121536|65048879|FG000|Overall Study|Withdrawal by Subject|65|||
23356469|NCT01121536|65048879|FG000|Overall Study|Protocol Violation|20|||
23356470|NCT01121536|65048879|FG000|Overall Study|Noncompliance with study medication|12|||
23356471|NCT01121536|65048879|FG000|Overall Study|Noncompliance with study procedures|9|||
23356472|NCT01121536|65048879|FG000|Overall Study|Lost to Follow-up|39|||
23356473|NCT01121536|65048879|FG000|Overall Study|Other|118|||
23356474|NCT01605825|65048880|FG000|Overall Study|Adverse Event|4|||
23356475|NCT01605825|65048881|FG001|Overall Study|Adverse Event|2|||
23473030|NCT01742286|65477516|FG002|Escalation Phase|Death|0|||
23356476|NCT01605825|65048880|FG000|Overall Study|Withdrawal by Subject|0|||
23473031|NCT01742286|65477517|FG003|Escalation Phase|Death|0|||
23356477|NCT01605825|65048881|FG001|Overall Study|Withdrawal by Subject|1|||
23473032|NCT01742286|65477518|FG004|Escalation Phase|Death|0|||
23356478|NCT01605825|65048880|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
23356479|NCT01605825|65048881|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
23356480|NCT01605825|65048880|FG000|Overall Study|Non-Compliance with Protocol|3|||
23356481|NCT01605825|65048881|FG001|Overall Study|Non-Compliance with Protocol|0|||
23356482|NCT01677182|65048882|FG000|Overall Study|Adverse Event|2|||
23356483|NCT01677182|65048883|FG001|Overall Study|Adverse Event|1|||
23356484|NCT01677182|65048884|FG002|Overall Study|Adverse Event|8|||
23356485|NCT01677182|65048882|FG000|Overall Study|Protocol Violation|5|||
23356486|NCT01677182|65048883|FG001|Overall Study|Protocol Violation|1|||
23356487|NCT01677182|65048884|FG002|Overall Study|Protocol Violation|4|||
23356488|NCT01677182|65048882|FG000|Overall Study|Lost to Follow-up|4|||
23356489|NCT01677182|65048883|FG001|Overall Study|Lost to Follow-up|0|||
23356490|NCT01677182|65048884|FG002|Overall Study|Lost to Follow-up|3|||
23356491|NCT01677182|65048882|FG000|Overall Study|Withdrawal by Subject|7|||
23641943|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23641944|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23641945|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23641946|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23641947|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
23641948|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23641949|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23641950|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23641951|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
23641952|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
23641953|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23641954|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23641955|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23356492|NCT01677182|65048883|FG001|Overall Study|Withdrawal by Subject|12|||
23356493|NCT01677182|65048884|FG002|Overall Study|Withdrawal by Subject|10|||
23356494|NCT01677182|65048882|FG000|Overall Study|Study termination|12|||
23356495|NCT01677182|65048883|FG001|Overall Study|Study termination|9|||
23356496|NCT01677182|65048884|FG002|Overall Study|Study termination|11|||
23356497|NCT01677182|65048882|FG000|Overall Study|Lack of Efficacy|3|||
23473033|NCT01742286|65477519|FG005|Escalation Phase|Death|1|||
23473034|NCT01742286|65477520|FG006|Escalation Phase|Death|0|||
23473035|NCT01742286|65477514|FG000|Escalation Phase|Physician Decision|0|||
23473036|NCT01742286|65477515|FG001|Escalation Phase|Physician Decision|3|||
23473037|NCT01742286|65477516|FG002|Escalation Phase|Physician Decision|0|||
23473038|NCT01742286|65477517|FG003|Escalation Phase|Physician Decision|1|||
23473039|NCT01742286|65477518|FG004|Escalation Phase|Physician Decision|0|||
23473040|NCT01742286|65477519|FG005|Escalation Phase|Physician Decision|0|||
23473041|NCT01742286|65477520|FG006|Escalation Phase|Physician Decision|2|||
23473042|NCT01742286|65477514|FG000|Escalation Phase|Subject/guardian decision|1|||
23473043|NCT01742286|65477515|FG001|Escalation Phase|Subject/guardian decision|0|||
23473044|NCT01742286|65477516|FG002|Escalation Phase|Subject/guardian decision|0|||
23473045|NCT01742286|65477517|FG003|Escalation Phase|Subject/guardian decision|0|||
23473046|NCT01742286|65477518|FG004|Escalation Phase|Subject/guardian decision|0|||
23473047|NCT01742286|65477519|FG005|Escalation Phase|Subject/guardian decision|0|||
23473048|NCT01742286|65477520|FG006|Escalation Phase|Subject/guardian decision|0|||
23588685|NCT01981850|65882218|FG002|Main Phase Stage 1|Death|0|||
23473049|NCT01742286|65477514|FG000|Expansion Phase|Administrative problems|0|||
23473050|NCT01742286|65477515|FG001|Expansion Phase|Administrative problems|0|||
23473051|NCT01742286|65477516|FG002|Expansion Phase|Administrative problems|0|||
23473052|NCT01742286|65477517|FG003|Expansion Phase|Administrative problems|0|||
23473053|NCT01742286|65477518|FG004|Expansion Phase|Administrative problems|0|||
23473054|NCT01742286|65477519|FG005|Expansion Phase|Administrative problems|0|||
23473055|NCT01742286|65477520|FG006|Expansion Phase|Administrative problems|5|||
23473056|NCT01742286|65477514|FG000|Expansion Phase|Physician Decision|0|||
23473057|NCT01742286|65477515|FG001|Expansion Phase|Physician Decision|0|||
23473058|NCT01742286|65477516|FG002|Expansion Phase|Physician Decision|4|||
23588686|NCT01981850|65882219|FG003|Main Phase Stage 1|Death|0|||
23588687|NCT01981850|65882220|FG004|Main Phase Stage 1|Death|0|||
23588688|NCT01981850|65882221|FG005|Main Phase Stage 1|Death|0|||
23588689|NCT01981850|65882222|FG006|Main Phase Stage 1|Death|0|||
23588690|NCT01981850|65882223|FG007|Main Phase Stage 1|Death|0|||
23588691|NCT01981850|65882224|FG008|Main Phase Stage 1|Death|0|||
23588692|NCT01981850|65882225|FG009|Main Phase Stage 1|Death|0|||
23588693|NCT01981850|65882216|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
23588694|NCT01981850|65882217|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588695|NCT01981850|65882218|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23473059|NCT01742286|65477517|FG003|Expansion Phase|Physician Decision|0|||
23473060|NCT01742286|65477518|FG004|Expansion Phase|Physician Decision|0|||
23473061|NCT01742286|65477519|FG005|Expansion Phase|Physician Decision|0|||
23588696|NCT01981850|65882219|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23706851|NCT00002663|66301347|FG008|Overall Study|Physician Decision|1|||
23356498|NCT01677182|65048883|FG001|Overall Study|Lack of Efficacy|0|||
23356499|NCT01677182|65048884|FG002|Overall Study|Lack of Efficacy|1|||
23356500|NCT01677182|65048882|FG000|Overall Study|Other reasons|1|||
23356501|NCT01677182|65048883|FG001|Overall Study|Other reasons|5|||
23356502|NCT01677182|65048884|FG002|Overall Study|Other reasons|2|||
23356503|NCT02328937|65048887|FG000|Period 1|Lost to Follow-up|0|||
23356504|NCT02328937|65048888|FG001|Period 1|Lost to Follow-up|0|||
23356505|NCT02328937|65048889|FG002|Period 1|Lost to Follow-up|0|||
23356506|NCT02328937|65048890|FG003|Period 1|Lost to Follow-up|1|||
23356507|NCT02328937|65048891|FG004|Period 1|Lost to Follow-up|0|||
23356508|NCT02328937|65048892|FG005|Period 1|Lost to Follow-up|0|||
23356509|NCT02328937|65048887|FG000|Period 2|Adverse Event|0|||
23356510|NCT02328937|65048888|FG001|Period 2|Adverse Event|0|||
23356511|NCT02328937|65048889|FG002|Period 2|Adverse Event|1|||
23356512|NCT02328937|65048890|FG003|Period 2|Adverse Event|0|||
23356513|NCT02328937|65048891|FG004|Period 2|Adverse Event|0|||
23356514|NCT02328937|65048892|FG005|Period 2|Adverse Event|0|||
23356515|NCT01778751|65048893|FG000|Overall Study|Lost to Follow-up|1|||
23356516|NCT01778751|65048894|FG001|Overall Study|Lost to Follow-up|0|||
23356517|NCT01778751|65048893|FG000|Overall Study|Withdrawal by Subject|0|||
23356518|NCT01778751|65048894|FG001|Overall Study|Withdrawal by Subject|2|||
23356519|NCT01778751|65048893|FG000|Overall Study|Transfered care|1|||
23641956|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
23641957|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23641958|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23641959|NCT00700427|66075266|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
23641960|NCT00700427|66075267|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
23356520|NCT01778751|65048894|FG001|Overall Study|Transfered care|0|||
23356521|NCT03089853|65048895|FG000|Overall Study|Lost to Follow-up|2|||
23356522|NCT03089853|65048896|FG001|Overall Study|Lost to Follow-up|1|||
23641961|NCT00700427|66075268|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
23641962|NCT00700427|66075269|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
23641963|NCT00700427|66075270|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
23641964|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23641965|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23641966|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23641967|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23641968|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
23641969|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
23641970|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
23641971|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
23641972|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
23356523|NCT02290925|65048898|FG000|First Period of Three Months|Lost to Follow-up|2|||
23356524|NCT02290925|65048899|FG001|First Period of Three Months|Lost to Follow-up|1|||
23356525|NCT02290925|65048898|FG000|First Period of Three Months|Death|1|||
23356526|NCT02290925|65048899|FG001|First Period of Three Months|Death|0|||
23356527|NCT02290925|65048898|FG000|First Period of Three Months|Insulin Started|1|||
23356528|NCT02290925|65048899|FG001|First Period of Three Months|Insulin Started|1|||
23356529|NCT02290925|65048898|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
23356530|NCT02290925|65048899|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
23356531|NCT02290925|65048898|FG000|Second Period of 3 Months|insulin started|0|||
23356532|NCT02290925|65048899|FG001|Second Period of 3 Months|insulin started|1|||
23356533|NCT00321906|65048900|FG000|Overall Study|Adverse Event|36|||
23356534|NCT00321906|65048901|FG001|Overall Study|Adverse Event|44|||
23356535|NCT00321906|65048900|FG000|Overall Study|Death|9|||
23356536|NCT00321906|65048901|FG001|Overall Study|Death|6|||
23356537|NCT00321906|65048900|FG000|Overall Study|Lost to Follow-up|1|||
23356538|NCT00321906|65048901|FG001|Overall Study|Lost to Follow-up|2|||
23356539|NCT00321906|65048900|FG000|Overall Study|Withdrawal by Subject|0|||
23356540|NCT00321906|65048901|FG001|Overall Study|Withdrawal by Subject|4|||
23356541|NCT00572455|65048904|FG000|Stage I (14 Days)|Adverse Event|0|||
23356542|NCT00572455|65048905|FG001|Stage I (14 Days)|Adverse Event|0|||
23356543|NCT00572455|65048906|FG002|Stage I (14 Days)|Adverse Event|0|||
23356544|NCT00572455|65048907|FG003|Stage I (14 Days)|Adverse Event|0|||
23356545|NCT00572455|65048908|FG004|Stage I (14 Days)|Adverse Event|0|||
23356546|NCT00572455|65048909|FG005|Stage I (14 Days)|Adverse Event|3|||
23356547|NCT00572455|65048910|FG006|Stage I (14 Days)|Adverse Event|0|||
23356548|NCT00572455|65048911|FG007|Stage I (14 Days)|Adverse Event|0|||
23356549|NCT00572455|65048912|FG008|Stage I (14 Days)|Adverse Event|0|||
23356550|NCT00572455|65048913|FG009|Stage I (14 Days)|Adverse Event|0|||
23356551|NCT00572455|65048914|FG010|Stage I (14 Days)|Adverse Event|0|||
23356552|NCT00572455|65048915|FG011|Stage I (14 Days)|Adverse Event|0|||
23588697|NCT01981850|65882220|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23356553|NCT00572455|65048916|FG012|Stage I (14 Days)|Adverse Event|0|||
23356554|NCT00572455|65048917|FG013|Stage I (14 Days)|Adverse Event|0|||
23356555|NCT00572455|65048904|FG000|Stage I (14 Days)|Other|0|||
23356556|NCT00572455|65048905|FG001|Stage I (14 Days)|Other|0|||
23356557|NCT00572455|65048906|FG002|Stage I (14 Days)|Other|0|||
23356558|NCT00572455|65048907|FG003|Stage I (14 Days)|Other|0|||
23356559|NCT00572455|65048908|FG004|Stage I (14 Days)|Other|1|||
23356560|NCT00572455|65048909|FG005|Stage I (14 Days)|Other|0|||
23356561|NCT00572455|65048910|FG006|Stage I (14 Days)|Other|0|||
23356562|NCT00572455|65048911|FG007|Stage I (14 Days)|Other|0|||
23356563|NCT00572455|65048912|FG008|Stage I (14 Days)|Other|0|||
23356564|NCT00572455|65048913|FG009|Stage I (14 Days)|Other|0|||
23356565|NCT00572455|65048914|FG010|Stage I (14 Days)|Other|0|||
23356566|NCT00572455|65048915|FG011|Stage I (14 Days)|Other|0|||
23356567|NCT00572455|65048916|FG012|Stage I (14 Days)|Other|0|||
23356568|NCT00572455|65048917|FG013|Stage I (14 Days)|Other|0|||
23356569|NCT00572455|65048904|FG000|Stage II (28 Days)|Adverse Event|0|||
23356570|NCT00572455|65048905|FG001|Stage II (28 Days)|Adverse Event|0|||
23356571|NCT00572455|65048906|FG002|Stage II (28 Days)|Adverse Event|0|||
23356572|NCT00572455|65048907|FG003|Stage II (28 Days)|Adverse Event|0|||
23356573|NCT00572455|65048908|FG004|Stage II (28 Days)|Adverse Event|0|||
23356574|NCT00572455|65048909|FG005|Stage II (28 Days)|Adverse Event|0|||
23356575|NCT00572455|65048910|FG006|Stage II (28 Days)|Adverse Event|0|||
23356576|NCT00572455|65048911|FG007|Stage II (28 Days)|Adverse Event|0|||
23356577|NCT00572455|65048912|FG008|Stage II (28 Days)|Adverse Event|1|||
23356578|NCT00572455|65048913|FG009|Stage II (28 Days)|Adverse Event|3|||
23356579|NCT00572455|65048914|FG010|Stage II (28 Days)|Adverse Event|3|||
23356580|NCT00572455|65048915|FG011|Stage II (28 Days)|Adverse Event|4|||
23356581|NCT00572455|65048916|FG012|Stage II (28 Days)|Adverse Event|5|||
23356582|NCT00572455|65048917|FG013|Stage II (28 Days)|Adverse Event|1|||
23356583|NCT00572455|65048904|FG000|Stage II (28 Days)|Death|0|||
23356584|NCT00572455|65048905|FG001|Stage II (28 Days)|Death|0|||
23356585|NCT00572455|65048906|FG002|Stage II (28 Days)|Death|0|||
23356586|NCT00572455|65048907|FG003|Stage II (28 Days)|Death|0|||
23356587|NCT00572455|65048908|FG004|Stage II (28 Days)|Death|0|||
23356588|NCT00572455|65048909|FG005|Stage II (28 Days)|Death|0|||
23356589|NCT00572455|65048910|FG006|Stage II (28 Days)|Death|0|||
23356590|NCT00572455|65048911|FG007|Stage II (28 Days)|Death|0|||
23356591|NCT00572455|65048912|FG008|Stage II (28 Days)|Death|1|||
23356592|NCT00572455|65048913|FG009|Stage II (28 Days)|Death|0|||
23356593|NCT00572455|65048914|FG010|Stage II (28 Days)|Death|0|||
23356594|NCT00572455|65048915|FG011|Stage II (28 Days)|Death|0|||
23356595|NCT00572455|65048916|FG012|Stage II (28 Days)|Death|0|||
23356596|NCT00572455|65048917|FG013|Stage II (28 Days)|Death|0|||
23356597|NCT00572455|65048904|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
23356598|NCT00572455|65048905|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
23356599|NCT00572455|65048906|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
23356600|NCT00572455|65048907|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
23356601|NCT00572455|65048908|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
23356602|NCT00572455|65048909|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
23356603|NCT00572455|65048910|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
23356604|NCT00572455|65048911|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
23356605|NCT00572455|65048912|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
23356606|NCT00572455|65048913|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
23356607|NCT00572455|65048914|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
23356608|NCT00572455|65048915|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
23356609|NCT00572455|65048916|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
23356610|NCT00572455|65048917|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
23356611|NCT00572455|65048904|FG000|Stage II (28 Days)|Other|0|||
23356612|NCT00572455|65048905|FG001|Stage II (28 Days)|Other|0|||
23356613|NCT00572455|65048906|FG002|Stage II (28 Days)|Other|0|||
23356614|NCT00572455|65048907|FG003|Stage II (28 Days)|Other|0|||
23356615|NCT00572455|65048908|FG004|Stage II (28 Days)|Other|0|||
23356616|NCT00572455|65048909|FG005|Stage II (28 Days)|Other|0|||
23356617|NCT00572455|65048910|FG006|Stage II (28 Days)|Other|0|||
23356618|NCT00572455|65048911|FG007|Stage II (28 Days)|Other|0|||
23356619|NCT00572455|65048912|FG008|Stage II (28 Days)|Other|1|||
23356620|NCT00572455|65048913|FG009|Stage II (28 Days)|Other|0|||
23356621|NCT00572455|65048914|FG010|Stage II (28 Days)|Other|0|||
23356622|NCT00572455|65048915|FG011|Stage II (28 Days)|Other|0|||
23356623|NCT00572455|65048916|FG012|Stage II (28 Days)|Other|0|||
23356624|NCT00572455|65048917|FG013|Stage II (28 Days)|Other|0|||
23356625|NCT00572455|65048904|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
23356626|NCT00572455|65048905|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
23356627|NCT00572455|65048906|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
23796307|NCT04556734|66630133|FG004|OLE Period (28 Weeks)|Not reported|0|||
23796308|NCT04556734|66630134|FG005|OLE Period (28 Weeks)|Not reported|1|||
23796309|NCT04556734|66630135|FG006|OLE Period (28 Weeks)|Not reported|0|||
23796310|NCT04556734|66630136|FG007|OLE Period (28 Weeks)|Not reported|0|||
23796311|NCT04556734|66630129|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796312|NCT04556734|66630130|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796313|NCT04556734|66630131|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796314|NCT04556734|66630132|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23356628|NCT00572455|65048907|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
23356629|NCT00572455|65048908|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
23356630|NCT00572455|65048909|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
23356631|NCT00572455|65048910|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
23356632|NCT00572455|65048911|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
23356633|NCT00572455|65048912|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
23356634|NCT00572455|65048913|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
23356635|NCT00572455|65048914|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
23356636|NCT00572455|65048915|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
23356637|NCT00572455|65048916|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
23356638|NCT00572455|65048917|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
23356639|NCT03026283|65048918|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
23356640|NCT03026283|65048919|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
23356641|NCT03026283|65048920|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
23356642|NCT03026283|65048921|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
23356643|NCT03026283|65048922|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
23356644|NCT03026283|65048923|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
23356645|NCT03026283|65048924|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
23356646|NCT03026283|65048925|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
23356647|NCT03026283|65048918|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
23356648|NCT03026283|65048919|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
23356649|NCT03026283|65048920|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
23356650|NCT03026283|65048921|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
23356651|NCT03026283|65048922|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
23356652|NCT03026283|65048923|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
23356653|NCT03026283|65048924|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
23356654|NCT03026283|65048925|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
23356655|NCT03026283|65048918|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356656|NCT03026283|65048919|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
23356657|NCT03026283|65048920|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356658|NCT03026283|65048921|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356659|NCT03026283|65048922|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356660|NCT03026283|65048923|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356661|NCT03026283|65048924|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356662|NCT03026283|65048925|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356663|NCT03026283|65048918|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356664|NCT03026283|65048919|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356665|NCT03026283|65048920|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
23356666|NCT03026283|65048921|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356667|NCT03026283|65048922|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356668|NCT03026283|65048923|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356669|NCT03026283|65048924|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23473062|NCT01742286|65477520|FG006|Expansion Phase|Physician Decision|9|||
23473063|NCT01742286|65477514|FG000|Expansion Phase|Adverse Event|0|||
23588698|NCT01981850|65882221|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23356670|NCT03026283|65048925|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356671|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356672|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356673|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356674|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
23356675|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
23356676|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356677|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356678|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356679|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356680|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356681|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356682|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
23356683|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
23356684|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
23356685|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356686|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356687|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356688|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356689|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23641973|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
23641974|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23641975|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23641976|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23641977|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23641978|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
23641979|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23641980|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23641981|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23641982|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23641983|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
23641984|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23641985|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23641986|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23641987|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23641988|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
23641989|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23641990|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23356690|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
23356691|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356692|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
23356693|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356694|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356695|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356696|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356697|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23473064|NCT01742286|65477515|FG001|Expansion Phase|Adverse Event|0|||
23473065|NCT01742286|65477516|FG002|Expansion Phase|Adverse Event|0|||
23473066|NCT01742286|65477517|FG003|Expansion Phase|Adverse Event|0|||
23356698|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
23356699|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356700|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356701|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356702|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356703|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356704|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356705|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356706|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356707|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
23356708|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
23356709|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356710|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356711|NCT03313310|65048926|FG000|Phase 2|Lost to Follow-up|4|||
23356712|NCT03313310|65048927|FG001|Phase 2|Lost to Follow-up|0|||
23473067|NCT01742286|65477518|FG004|Expansion Phase|Adverse Event|0|||
23473068|NCT01742286|65477519|FG005|Expansion Phase|Adverse Event|0|||
23473069|NCT01742286|65477520|FG006|Expansion Phase|Adverse Event|6|||
23473070|NCT01742286|65477514|FG000|Expansion Phase|Disease progression|0|||
23473071|NCT01742286|65477515|FG001|Expansion Phase|Disease progression|0|||
23796315|NCT04556734|66630133|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796316|NCT04556734|66630134|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796317|NCT04556734|66630135|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23796318|NCT04556734|66630136|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
23796319|NCT04556734|66630129|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
23796320|NCT04556734|66630130|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
23796321|NCT04556734|66630131|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
23796322|NCT04556734|66630132|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
23796323|NCT04556734|66630133|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
23796324|NCT04556734|66630134|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
23796325|NCT04556734|66630135|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
23796326|NCT04556734|66630136|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
23796327|NCT04556734|66630129|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23796328|NCT04556734|66630130|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23796329|NCT04556734|66630131|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23796330|NCT04556734|66630132|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23796331|NCT04556734|66630133|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
23796332|NCT04556734|66630134|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
23356713|NCT03313310|65048926|FG000|Phase 3|Lost to Follow-up|0|||
23356714|NCT03313310|65048927|FG001|Phase 3|Lost to Follow-up|1|||
23356715|NCT00660595|65048928|FG000|Overall Study|Lost to Follow-up|0|||
23356716|NCT00660595|65048929|FG001|Overall Study|Lost to Follow-up|1|||
23356717|NCT00660595|65048928|FG000|Overall Study|Did not consent to participate in study|12|||
23473072|NCT01742286|65477516|FG002|Expansion Phase|Disease progression|3|||
23473073|NCT01742286|65477517|FG003|Expansion Phase|Disease progression|0|||
23473074|NCT01742286|65477518|FG004|Expansion Phase|Disease progression|0|||
23473075|NCT01742286|65477519|FG005|Expansion Phase|Disease progression|0|||
23473076|NCT01742286|65477520|FG006|Expansion Phase|Disease progression|15|||
23473077|NCT01742286|65477514|FG000|Expansion Phase|Withdrawal by Subject|0|||
23641991|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23796333|NCT04556734|66630135|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23796334|NCT04556734|66630136|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23796335|NCT02460835|66630139|FG000|Overall Study|Disease progression prior to treatment|3|||
23796336|NCT02460835|66630139|FG000|Overall Study|Unable to complete planning scans|2|||
23796337|NCT02460835|66630139|FG000|Overall Study|Decrease in performance status|1|||
23796338|NCT02460835|66630139|FG000|Overall Study|Withdrawal by Subject|3|||
23796339|NCT02460835|66630139|FG000|Overall Study|Underwent fractionated RT|10|||
23796340|NCT02460835|66630139|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
23796341|NCT04330157|66630144|FG000|Overall Study|Protocol Violation|4|||
23796342|NCT04330157|66630144|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
23796343|NCT01937117|66630145|FG000|Overall Study|Disease Progression|7|||
23356718|NCT00660595|65048929|FG001|Overall Study|Did not consent to participate in study|8|||
23356719|NCT00660595|65048928|FG000|Overall Study|Participant left hospital|1|||
23356720|NCT00660595|65048929|FG001|Overall Study|Participant left hospital|0|||
23356721|NCT00660595|65048928|FG000|Overall Study|Non Specified reasons|5|||
23796344|NCT01937117|66630145|FG000|Overall Study|Physician Decision|4|||
23796345|NCT01937117|66630145|FG000|Overall Study|Adverse Event|2|||
23796346|NCT02875028|66630146|FG000|Washout Period|Withdrawal by Subject|0|||
23796347|NCT02875028|66630147|FG001|Washout Period|Withdrawal by Subject|1|||
23796348|NCT03578809|66630148|FG000|Overall Study|Death|0|||
23796349|NCT03578809|66630149|FG001|Overall Study|Death|2|||
23796350|NCT03578809|66630150|FG002|Overall Study|Death|0|||
23796351|NCT03578809|66630151|FG003|Overall Study|Death|1|||
23796352|NCT03578809|66630148|FG000|Overall Study|Lost to Follow-up|0|||
23641992|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23588699|NCT01981850|65882222|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588700|NCT01981850|65882223|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588701|NCT01981850|65882224|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588702|NCT01981850|65882225|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588703|NCT01981850|65882216|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
23588704|NCT01981850|65882217|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
23641993|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
23641994|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23641995|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23641996|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23641997|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23641998|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
23641999|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23642000|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23642001|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23642002|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23642003|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
23642004|NCT00700427|66075266|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23642005|NCT00700427|66075267|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23796353|NCT03578809|66630149|FG001|Overall Study|Lost to Follow-up|1|||
23796354|NCT03578809|66630150|FG002|Overall Study|Lost to Follow-up|0|||
23796355|NCT03578809|66630151|FG003|Overall Study|Lost to Follow-up|0|||
23796356|NCT03578809|66630148|FG000|Overall Study|Withdrawal by Subject|3|||
23796357|NCT03578809|66630149|FG001|Overall Study|Withdrawal by Subject|5|||
23796358|NCT03578809|66630150|FG002|Overall Study|Withdrawal by Subject|2|||
23796359|NCT03578809|66630151|FG003|Overall Study|Withdrawal by Subject|0|||
23796360|NCT03578809|66630148|FG000|Overall Study|Other|3|||
23796361|NCT03578809|66630149|FG001|Overall Study|Other|6|||
23796362|NCT03578809|66630150|FG002|Overall Study|Other|2|||
23796363|NCT03578809|66630151|FG003|Overall Study|Other|8|||
23356722|NCT00660595|65048929|FG001|Overall Study|Non Specified reasons|0|||
23356723|NCT01911793|65048930|FG000|Overall Study|Physician Decision|1|||
23356724|NCT01911793|65048931|FG001|Overall Study|Physician Decision|5|||
23356725|NCT01299896|65048933|FG000|Overall Study|Withdrawal by Subject|1|||
23356726|NCT01299896|65048934|FG001|Overall Study|Withdrawal by Subject|7|||
23356727|NCT01299896|65048933|FG000|Overall Study|Lost to Follow-up|0|||
23588705|NCT01981850|65882218|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
23588706|NCT01981850|65882219|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
23588707|NCT01981850|65882220|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
23588708|NCT01981850|65882221|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
23642006|NCT00700427|66075268|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23796364|NCT04866017|66630154|FG000|Overall Study|Study Terminated by Sponsor|13|||
23796365|NCT04866017|66630155|FG001|Overall Study|Study Terminated by Sponsor|14|||
23796366|NCT04866017|66630156|FG002|Overall Study|Study Terminated by Sponsor|13|||
23796367|NCT04866017|66630154|FG000|Overall Study|Death|8|||
23796368|NCT04866017|66630155|FG001|Overall Study|Death|4|||
23796369|NCT04866017|66630156|FG002|Overall Study|Death|8|||
23796370|NCT04866017|66630154|FG000|Overall Study|Withdrawal by Subject|1|||
23796371|NCT04866017|66630155|FG001|Overall Study|Withdrawal by Subject|0|||
23796372|NCT04866017|66630156|FG002|Overall Study|Withdrawal by Subject|1|||
23796373|NCT04866017|66630154|FG000|Overall Study|Physician Decision|0|||
23356728|NCT01299896|65048934|FG001|Overall Study|Lost to Follow-up|11|||
23588709|NCT01981850|65882222|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
23796374|NCT04866017|66630155|FG001|Overall Study|Physician Decision|1|||
23796375|NCT04866017|66630156|FG002|Overall Study|Physician Decision|0|||
23796376|NCT05766787|66630157|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
23796377|NCT05766787|66630158|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
23796378|NCT05766787|66630157|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
23796379|NCT05766787|66630158|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
23796380|NCT05766787|66630157|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
23796381|NCT05766787|66630158|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
23796382|NCT01745094|66630159|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
23796383|NCT01745094|66630160|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
23356729|NCT02776670|65048935|FG000|Overall Study|Adverse Event|0|||
23356730|NCT02776670|65048936|FG001|Overall Study|Adverse Event|2|||
23356731|NCT02776670|65048935|FG000|Overall Study|Protocol Violation|0|||
23588710|NCT01981850|65882223|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
23588711|NCT01981850|65882224|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
23642007|NCT00700427|66075269|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23642008|NCT00700427|66075270|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
23642009|NCT00903006|66075271|FG000|Overall Study|Withdrawal by Subject|2|||
23642010|NCT00903006|66075272|FG001|Overall Study|Withdrawal by Subject|0|||
23642011|NCT00903006|66075273|FG002|Overall Study|Withdrawal by Subject|0|||
23642012|NCT00903006|66075274|FG003|Overall Study|Withdrawal by Subject|0|||
23588712|NCT01981850|65882225|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
23588713|NCT01981850|65882216|FG000|Main Phase Stage 1|Various reasons|0|||
23588714|NCT01981850|65882217|FG001|Main Phase Stage 1|Various reasons|0|||
23588715|NCT01981850|65882218|FG002|Main Phase Stage 1|Various reasons|2|||
23588716|NCT01981850|65882219|FG003|Main Phase Stage 1|Various reasons|0|||
23588717|NCT01981850|65882220|FG004|Main Phase Stage 1|Various reasons|0|||
23588718|NCT01981850|65882221|FG005|Main Phase Stage 1|Various reasons|0|||
23588719|NCT01981850|65882222|FG006|Main Phase Stage 1|Various reasons|0|||
23588720|NCT01981850|65882223|FG007|Main Phase Stage 1|Various reasons|0|||
23588721|NCT01981850|65882224|FG008|Main Phase Stage 1|Various reasons|0|||
23588722|NCT01981850|65882225|FG009|Main Phase Stage 1|Various reasons|0|||
23588723|NCT01981850|65882216|FG000|Main Phase Stage 2|Adverse Event|0|||
23588724|NCT01981850|65882217|FG001|Main Phase Stage 2|Adverse Event|0|||
23588725|NCT01981850|65882218|FG002|Main Phase Stage 2|Adverse Event|0|||
23588726|NCT01981850|65882219|FG003|Main Phase Stage 2|Adverse Event|0|||
23588727|NCT01981850|65882220|FG004|Main Phase Stage 2|Adverse Event|6|||
23588728|NCT01981850|65882221|FG005|Main Phase Stage 2|Adverse Event|5|||
23588729|NCT01981850|65882222|FG006|Main Phase Stage 2|Adverse Event|7|||
23588730|NCT01981850|65882223|FG007|Main Phase Stage 2|Adverse Event|0|||
23588731|NCT01981850|65882224|FG008|Main Phase Stage 2|Adverse Event|0|||
23588732|NCT01981850|65882225|FG009|Main Phase Stage 2|Adverse Event|0|||
23588733|NCT01981850|65882216|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23642013|NCT00903006|66075271|FG000|Overall Study|Progressive Disease|0|||
23642014|NCT00903006|66075272|FG001|Overall Study|Progressive Disease|3|||
23642015|NCT00903006|66075273|FG002|Overall Study|Progressive Disease|1|||
23642016|NCT00903006|66075274|FG003|Overall Study|Progressive Disease|0|||
23642017|NCT00730275|66075277|FG000|Overall Study|Withdrawal by Subject|0|||
23642018|NCT00730275|66075278|FG001|Overall Study|Withdrawal by Subject|0|||
23642019|NCT00730275|66075279|FG002|Overall Study|Withdrawal by Subject|0|||
23642020|NCT00730275|66075280|FG003|Overall Study|Withdrawal by Subject|1|||
23642021|NCT00621777|66075281|FG000|Open Phase|Adverse Event|20|||
23642022|NCT00621777|66075282|FG001|Open Phase|Adverse Event|0|||
23642023|NCT00621777|66075281|FG000|Open Phase|Did not abstain during open phase|56|||
23642024|NCT00621777|66075282|FG001|Open Phase|Did not abstain during open phase|0|||
23642025|NCT00621777|66075281|FG000|Open Phase|Withdrawal by Subject|17|||
23642026|NCT00621777|66075282|FG001|Open Phase|Withdrawal by Subject|0|||
23642027|NCT00621777|66075281|FG000|Open Phase|administrative|13|||
23642028|NCT00621777|66075282|FG001|Open Phase|administrative|0|||
23588734|NCT01981850|65882217|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588735|NCT01981850|65882218|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588736|NCT01981850|65882219|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588737|NCT01981850|65882220|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
23588738|NCT01981850|65882221|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
23588739|NCT01981850|65882222|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
23588740|NCT01981850|65882223|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588741|NCT01981850|65882224|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588742|NCT01981850|65882225|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588743|NCT01981850|65882216|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
23642029|NCT00621777|66075281|FG000|Open Phase|Lost to Follow-up|10|||
23642030|NCT00621777|66075282|FG001|Open Phase|Lost to Follow-up|0|||
23642031|NCT00621777|66075281|FG000|Randomized Phase|Adverse Event|3|||
23588744|NCT01981850|65882217|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
23588745|NCT01981850|65882218|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
23642032|NCT00621777|66075282|FG001|Randomized Phase|Adverse Event|3|||
23642033|NCT00621777|66075281|FG000|Randomized Phase|Lost to Follow-up|3|||
23796384|NCT01745094|66630161|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
23796385|NCT01745094|66630162|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
23796386|NCT01745094|66630159|FG000|Overall Study|Adverse Event|0|||
23796387|NCT01745094|66630160|FG001|Overall Study|Adverse Event|0|||
23796388|NCT01745094|66630161|FG002|Overall Study|Adverse Event|3|||
23796389|NCT01745094|66630162|FG003|Overall Study|Adverse Event|0|||
23796390|NCT01745094|66630159|FG000|Overall Study|Withdrawal by Subject|2|||
23796391|NCT01745094|66630160|FG001|Overall Study|Withdrawal by Subject|0|||
23796392|NCT01745094|66630161|FG002|Overall Study|Withdrawal by Subject|1|||
23796393|NCT01745094|66630162|FG003|Overall Study|Withdrawal by Subject|2|||
23796394|NCT01745094|66630159|FG000|Overall Study|Protocol Violation|1|||
23796395|NCT01745094|66630160|FG001|Overall Study|Protocol Violation|0|||
23796396|NCT01745094|66630161|FG002|Overall Study|Protocol Violation|3|||
23796397|NCT01745094|66630162|FG003|Overall Study|Protocol Violation|1|||
23796398|NCT01745094|66630159|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
23796399|NCT01745094|66630160|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
23796400|NCT01745094|66630161|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
23796401|NCT01745094|66630162|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
23796402|NCT01745094|66630159|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
23473078|NCT01742286|65477515|FG001|Expansion Phase|Withdrawal by Subject|0|||
23473079|NCT01742286|65477516|FG002|Expansion Phase|Withdrawal by Subject|0|||
23473080|NCT01742286|65477517|FG003|Expansion Phase|Withdrawal by Subject|0|||
23473081|NCT01742286|65477518|FG004|Expansion Phase|Withdrawal by Subject|0|||
23473082|NCT01742286|65477519|FG005|Expansion Phase|Withdrawal by Subject|0|||
23473083|NCT01742286|65477520|FG006|Expansion Phase|Withdrawal by Subject|1|||
23473084|NCT01964755|65477524|FG000|Overall Study|Death|2|||
23473085|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473086|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473087|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
23473088|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
23473089|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
23473090|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
23473091|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
23473092|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473093|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
23473094|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473095|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473096|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473097|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473098|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473099|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473100|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473101|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23588746|NCT01981850|65882219|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
23588747|NCT01981850|65882220|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
23588748|NCT01981850|65882221|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
23588749|NCT01981850|65882222|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
23588750|NCT01981850|65882223|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
23588751|NCT01981850|65882224|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
23588752|NCT01981850|65882225|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
23588753|NCT01981850|65882216|FG000|Main Phase Stage 2|Various reasons|0|||
23588754|NCT01981850|65882217|FG001|Main Phase Stage 2|Various reasons|0|||
23588755|NCT01981850|65882218|FG002|Main Phase Stage 2|Various reasons|0|||
23588756|NCT01981850|65882219|FG003|Main Phase Stage 2|Various reasons|0|||
23588757|NCT01981850|65882220|FG004|Main Phase Stage 2|Various reasons|2|||
23588758|NCT01981850|65882221|FG005|Main Phase Stage 2|Various reasons|0|||
23588759|NCT01981850|65882222|FG006|Main Phase Stage 2|Various reasons|1|||
23588760|NCT01981850|65882223|FG007|Main Phase Stage 2|Various reasons|0|||
23588761|NCT01981850|65882224|FG008|Main Phase Stage 2|Various reasons|0|||
23588762|NCT01981850|65882225|FG009|Main Phase Stage 2|Various reasons|0|||
23588763|NCT01981850|65882216|FG000|Main Phase Stage 2|Progressive Disease|0|||
23588764|NCT01981850|65882217|FG001|Main Phase Stage 2|Progressive Disease|0|||
23588765|NCT01981850|65882218|FG002|Main Phase Stage 2|Progressive Disease|0|||
23588766|NCT01981850|65882219|FG003|Main Phase Stage 2|Progressive Disease|0|||
23588767|NCT01981850|65882220|FG004|Main Phase Stage 2|Progressive Disease|0|||
23588768|NCT01981850|65882221|FG005|Main Phase Stage 2|Progressive Disease|6|||
23588769|NCT01981850|65882222|FG006|Main Phase Stage 2|Progressive Disease|6|||
23796403|NCT01745094|66630160|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
23796404|NCT01745094|66630161|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
23796405|NCT01745094|66630162|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
23796406|NCT01745094|66630159|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
23796407|NCT01745094|66630160|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23642034|NCT00621777|66075282|FG001|Randomized Phase|Lost to Follow-up|3|||
23642035|NCT00621777|66075281|FG000|Randomized Phase|Withdrawal by Subject|1|||
23642036|NCT00621777|66075282|FG001|Randomized Phase|Withdrawal by Subject|9|||
23642037|NCT00621777|66075281|FG000|Randomized Phase|administrative|0|||
23642038|NCT00621777|66075282|FG001|Randomized Phase|administrative|3|||
23642039|NCT00621777|66075281|FG000|Randomized Phase|Death|0|||
23642040|NCT00621777|66075282|FG001|Randomized Phase|Death|1|||
23642041|NCT03482466|66075283|FG000|Overall Study|Protocol Violation|2|||
23642042|NCT03282240|66075284|FG000|Overall Study|Adverse Event|2|||
23642043|NCT03282240|66075285|FG001|Overall Study|Adverse Event|2|||
23642044|NCT03282240|66075286|FG002|Overall Study|Adverse Event|0|||
23642045|NCT03282240|66075284|FG000|Overall Study|Lost to Follow-up|3|||
23642046|NCT03282240|66075285|FG001|Overall Study|Lost to Follow-up|0|||
23642047|NCT03282240|66075286|FG002|Overall Study|Lost to Follow-up|0|||
23642048|NCT03282240|66075284|FG000|Overall Study|Protocol Deviation|4|||
23642049|NCT03282240|66075285|FG001|Overall Study|Protocol Deviation|1|||
23642050|NCT03282240|66075286|FG002|Overall Study|Protocol Deviation|2|||
23642051|NCT03282240|66075284|FG000|Overall Study|Withdrawal by Subject|1|||
23642052|NCT03282240|66075285|FG001|Overall Study|Withdrawal by Subject|0|||
23642053|NCT03282240|66075286|FG002|Overall Study|Withdrawal by Subject|1|||
23642054|NCT00151281|66075287|FG000|Overall Study|Not evaluable|3|||
23642055|NCT00215137|66075288|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
23642056|NCT00215137|66075289|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
23642057|NCT00215137|66075290|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
23642058|NCT00215137|66075288|FG000|Randomization Period|Lost to Follow-up|0|||
23642059|NCT00215137|66075289|FG001|Randomization Period|Lost to Follow-up|1|||
23642060|NCT00215137|66075290|FG002|Randomization Period|Lost to Follow-up|0|||
23642061|NCT00215137|66075288|FG000|Randomization Period|Withdrawal by Subject|0|||
23642062|NCT00215137|66075289|FG001|Randomization Period|Withdrawal by Subject|1|||
23642063|NCT00215137|66075290|FG002|Randomization Period|Withdrawal by Subject|0|||
23642064|NCT01775475|66075291|FG000|Overall Study|Death|3|||
23642065|NCT01775475|66075292|FG001|Overall Study|Death|3|||
23642066|NCT00345293|66075293|FG000|Overall Study|Unable to access line for sample|1|||
23588770|NCT01981850|65882223|FG007|Main Phase Stage 2|Progressive Disease|0|||
23588771|NCT01981850|65882224|FG008|Main Phase Stage 2|Progressive Disease|0|||
23588772|NCT01981850|65882225|FG009|Main Phase Stage 2|Progressive Disease|0|||
23356732|NCT02776670|65048936|FG001|Overall Study|Protocol Violation|2|||
23588773|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Adverse Event|0|||
23588774|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Adverse Event|0|||
23588775|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Adverse Event|0|||
23588776|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Adverse Event|0|||
23588777|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Adverse Event|0|||
23588778|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Adverse Event|0|||
23588779|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Adverse Event|0|||
23588780|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Adverse Event|2|||
23588781|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Adverse Event|1|||
23642067|NCT00345293|66075294|FG001|Overall Study|Unable to access line for sample|0|||
23473102|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23588782|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Adverse Event|8|||
23588783|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588784|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588785|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
23642068|NCT00345293|66075293|FG000|Overall Study|Withdrawal by Subject|1|||
23642069|NCT00345293|66075294|FG001|Overall Study|Withdrawal by Subject|0|||
23642070|NCT00994682|66075295|FG000|Double Bilnd|Withdrawal by Subject|5|||
23642071|NCT00994682|66075296|FG001|Double Bilnd|Withdrawal by Subject|6|||
23642072|NCT00994682|66075295|FG000|Double Bilnd|Lost to Follow-up|3|||
23642073|NCT00994682|66075296|FG001|Double Bilnd|Lost to Follow-up|3|||
23642074|NCT00994682|66075295|FG000|Double Bilnd|Adverse Event|1|||
23642075|NCT00994682|66075296|FG001|Double Bilnd|Adverse Event|0|||
23642076|NCT00994682|66075295|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
23642077|NCT00994682|66075296|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
23642078|NCT00994682|66075295|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
23588786|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588787|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
23796408|NCT01745094|66630161|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23796409|NCT01745094|66630162|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23796410|NCT02462486|66630163|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23796411|NCT02462486|66630164|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23796412|NCT02462486|66630165|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
23796413|NCT02462486|66630163|FG000|Overall Study|Adverse Event|53|||
23796414|NCT02462486|66630164|FG001|Overall Study|Adverse Event|48|||
23356733|NCT02776670|65048935|FG000|Overall Study|Withdrawal by Subject|0|||
23356734|NCT02776670|65048936|FG001|Overall Study|Withdrawal by Subject|1|||
23356735|NCT02776670|65048935|FG000|Overall Study|Other - Reason not given|0|||
23356736|NCT02776670|65048936|FG001|Overall Study|Other - Reason not given|1|||
23356737|NCT05459558|65052546|FG000|Overall Study|Adverse Event|1|||
23356738|NCT05459558|65052547|FG001|Overall Study|Adverse Event|0|||
23356739|NCT05459558|65052548|FG002|Overall Study|Adverse Event|0|||
23356740|NCT05459558|65052546|FG000|Overall Study|Scheduling issue|0|||
23356741|NCT05459558|65052547|FG001|Overall Study|Scheduling issue|1|||
23356742|NCT05459558|65052548|FG002|Overall Study|Scheduling issue|3|||
23356743|NCT05459558|65052546|FG000|Overall Study|Withdrawal by Subject|0|||
23356744|NCT05459558|65052547|FG001|Overall Study|Withdrawal by Subject|0|||
23356745|NCT05459558|65052548|FG002|Overall Study|Withdrawal by Subject|2|||
23356746|NCT01887678|65052551|FG000|Overall Study|Adverse Event|4|||
23356747|NCT01887678|65052552|FG001|Overall Study|Adverse Event|6|||
23473103|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473104|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
23588788|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588789|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588790|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
23588791|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
23588792|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
23588793|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Various reasons|0|||
23588794|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Various reasons|0|||
23588795|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Various reasons|0|||
23642079|NCT00994682|66075296|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
23642080|NCT00994682|66075295|FG000|Pioglitazone Open Label|Physician Decision|6|||
23642081|NCT00994682|66075296|FG001|Pioglitazone Open Label|Physician Decision|1|||
23642082|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Adverse Event|6|||
23356748|NCT01887678|65052551|FG000|Overall Study|Exceeded rescue medication dosage|4|||
23356749|NCT01887678|65052552|FG001|Overall Study|Exceeded rescue medication dosage|5|||
23642083|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Adverse Event|6|||
23356750|NCT01887678|65052551|FG000|Overall Study|Withdrawal of consent|3|||
23356751|NCT01887678|65052552|FG001|Overall Study|Withdrawal of consent|4|||
23356752|NCT01887678|65052551|FG000|Overall Study|Lost to Follow-up|4|||
23356753|NCT01887678|65052552|FG001|Overall Study|Lost to Follow-up|2|||
23356754|NCT01887678|65052551|FG000|Overall Study|Deterioration of clinical condition|0|||
23473105|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473106|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473107|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473108|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473109|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473110|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
23473111|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473112|NCT01175083|65477540|FG000|Primary Epoch|Withdrawal by Subject|0|||
23473113|NCT01175083|65477541|FG001|Primary Epoch|Withdrawal by Subject|0|||
23588796|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Various reasons|0|||
23588797|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Various reasons|0|||
23588798|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Various reasons|0|||
23796415|NCT02462486|66630165|FG002|Overall Study|Adverse Event|21|||
23588799|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Various reasons|0|||
23796416|NCT02462486|66630163|FG000|Overall Study|Lack of Efficacy|6|||
23796417|NCT02462486|66630164|FG001|Overall Study|Lack of Efficacy|12|||
23796418|NCT02462486|66630165|FG002|Overall Study|Lack of Efficacy|3|||
23796419|NCT02462486|66630163|FG000|Overall Study|Lost to Follow-up|3|||
23796420|NCT02462486|66630164|FG001|Overall Study|Lost to Follow-up|4|||
23796421|NCT02462486|66630165|FG002|Overall Study|Lost to Follow-up|2|||
23796422|NCT02462486|66630163|FG000|Overall Study|Withdrawal by Subject|25|||
23796423|NCT02462486|66630164|FG001|Overall Study|Withdrawal by Subject|22|||
23796424|NCT02462486|66630165|FG002|Overall Study|Withdrawal by Subject|19|||
23796425|NCT02462486|66630163|FG000|Overall Study|Protocol Violation|3|||
23588800|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Various reasons|3|||
23588801|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Various reasons|1|||
23588802|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Various reasons|3|||
23588803|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
23588804|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
23796426|NCT02462486|66630164|FG001|Overall Study|Protocol Violation|1|||
23796427|NCT02462486|66630165|FG002|Overall Study|Protocol Violation|1|||
23796428|NCT02462486|66630163|FG000|Overall Study|Reason not Specified|3|||
23796429|NCT02462486|66630164|FG001|Overall Study|Reason not Specified|4|||
23796430|NCT02462486|66630165|FG002|Overall Study|Reason not Specified|3|||
23796431|NCT00799708|66630166|FG000|Overall Study|non-compliance|1|||
23796432|NCT00799708|66630167|FG001|Overall Study|non-compliance|0|||
23796433|NCT00799708|66630168|FG002|Overall Study|non-compliance|0|||
23796434|NCT03431337|66630169|FG000|Overall Study|Lost to Follow-up|21|||
23796435|NCT03431337|66630170|FG001|Overall Study|Lost to Follow-up|19|||
23796436|NCT03431337|66630169|FG000|Overall Study|Withdrawal by Subject|8|||
23796437|NCT03431337|66630170|FG001|Overall Study|Withdrawal by Subject|3|||
23796438|NCT01341587|66630171|FG000|Overall Study|Lost to Follow-up|2|||
23356755|NCT01887678|65052552|FG001|Overall Study|Deterioration of clinical condition|4|||
23356756|NCT01887678|65052551|FG000|Overall Study|Lack of Efficacy|1|||
23356757|NCT01887678|65052552|FG001|Overall Study|Lack of Efficacy|2|||
23356758|NCT01887678|65052551|FG000|Overall Study|Non-compliance|0|||
23356759|NCT01887678|65052552|FG001|Overall Study|Non-compliance|3|||
23356760|NCT01887678|65052551|FG000|Overall Study|Specified|1|||
23356761|NCT01887678|65052552|FG001|Overall Study|Specified|2|||
23356762|NCT01693185|65052554|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
23356763|NCT01693185|65052555|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
23356764|NCT03131687|65052557|FG000|Overall Study|Adverse Event|0|||
23356765|NCT03131687|65052558|FG001|Overall Study|Adverse Event|1|||
23356766|NCT03131687|65052559|FG002|Overall Study|Adverse Event|0|||
23356767|NCT03131687|65052560|FG003|Overall Study|Adverse Event|1|||
23356768|NCT03131687|65052561|FG004|Overall Study|Adverse Event|2|||
23356769|NCT03131687|65052562|FG005|Overall Study|Adverse Event|2|||
23356770|NCT03131687|65052557|FG000|Overall Study|Death|1|||
23356771|NCT03131687|65052558|FG001|Overall Study|Death|0|||
23356772|NCT03131687|65052559|FG002|Overall Study|Death|0|||
23473114|NCT01175083|65477542|FG002|Primary Epoch|Withdrawal by Subject|0|||
23588805|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
23588806|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
23588807|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
23796439|NCT01341587|66630172|FG001|Overall Study|Lost to Follow-up|0|||
23796440|NCT01341587|66630171|FG000|Overall Study|stopped using the meters|2|||
23796441|NCT01341587|66630172|FG001|Overall Study|stopped using the meters|10|||
23356773|NCT03131687|65052560|FG003|Overall Study|Death|0|||
23796442|NCT01203917|66630173|FG000|Overall Study|Death|29|||
23796443|NCT01203917|66630173|FG000|Overall Study|Lost to Follow-up|2|||
23356774|NCT03131687|65052561|FG004|Overall Study|Death|0|||
23356775|NCT03131687|65052562|FG005|Overall Study|Death|0|||
23356776|NCT03131687|65052557|FG000|Overall Study|Withdrawal by Subject|3|||
23796444|NCT01203917|66630173|FG000|Overall Study|Withdrawal by Subject|3|||
23796445|NCT01203917|66630173|FG000|Overall Study|Due to objective disease progression|1|||
23796446|NCT01203917|66630173|FG000|Overall Study|Due to EGFR M+I patient|1|||
23796447|NCT02427399|66630174|FG000|Overall Study|Protocol Violation|14|||
23796448|NCT02427399|66630175|FG001|Overall Study|Protocol Violation|16|||
23473115|NCT01175083|65477543|FG003|Primary Epoch|Withdrawal by Subject|0|||
23473116|NCT01175083|65477544|FG004|Primary Epoch|Withdrawal by Subject|0|||
23473117|NCT01175083|65477545|FG005|Primary Epoch|Withdrawal by Subject|2|||
23473118|NCT01175083|65477540|FG000|Primary Epoch|Lost to Follow-up|0|||
23473119|NCT01175083|65477541|FG001|Primary Epoch|Lost to Follow-up|0|||
23473120|NCT01175083|65477542|FG002|Primary Epoch|Lost to Follow-up|0|||
23473121|NCT01175083|65477543|FG003|Primary Epoch|Lost to Follow-up|0|||
23473122|NCT01175083|65477544|FG004|Primary Epoch|Lost to Follow-up|0|||
23473123|NCT01175083|65477545|FG005|Primary Epoch|Lost to Follow-up|1|||
23473124|NCT01175083|65477540|FG000|Booster Epoch|Death|0|||
23473125|NCT01175083|65477541|FG001|Booster Epoch|Death|0|||
23473126|NCT01175083|65477542|FG002|Booster Epoch|Death|1|||
23473127|NCT01175083|65477543|FG003|Booster Epoch|Death|0|||
23473128|NCT01175083|65477544|FG004|Booster Epoch|Death|0|||
23473129|NCT01175083|65477545|FG005|Booster Epoch|Death|0|||
23473130|NCT01175083|65477540|FG000|Booster Epoch|Withdrawal by Subject|0|||
23473131|NCT01175083|65477541|FG001|Booster Epoch|Withdrawal by Subject|0|||
23473132|NCT01175083|65477542|FG002|Booster Epoch|Withdrawal by Subject|0|||
23473133|NCT01175083|65477543|FG003|Booster Epoch|Withdrawal by Subject|1|||
23473134|NCT01175083|65477544|FG004|Booster Epoch|Withdrawal by Subject|0|||
23473135|NCT01175083|65477545|FG005|Booster Epoch|Withdrawal by Subject|0|||
23473136|NCT01536067|65477546|FG000|Overall Study|Disease Progression|1|||
23473137|NCT00324961|65477548|FG000|Overall Study|Adverse Event|5|||
23473138|NCT00324961|65477548|FG000|Overall Study|Consent Withdrawn|11|||
23473139|NCT00324961|65477548|FG000|Overall Study|Lost to Follow-up|22|||
23473140|NCT00324961|65477548|FG000|Overall Study|Protocol Violation|3|||
23473141|NCT00324961|65477548|FG000|Overall Study|Other|2|||
23473142|NCT01523275|65477549|FG000|Overall Study|Lost to Follow-up|1|||
23473143|NCT01523275|65477550|FG001|Overall Study|Lost to Follow-up|2|||
23473144|NCT01523275|65477549|FG000|Overall Study|Withdrawal by Subject|1|||
23473145|NCT01523275|65477550|FG001|Overall Study|Withdrawal by Subject|0|||
23473146|NCT01761162|65477556|FG000|Overall Study|Withdrawal by Subject|3|||
23796449|NCT02427399|66630176|FG002|Overall Study|Protocol Violation|12|||
23796450|NCT02427399|66630177|FG003|Overall Study|Protocol Violation|18|||
23796451|NCT02427399|66630178|FG004|Overall Study|Protocol Violation|15|||
23796452|NCT02075840|66630179|FG000|Overall Study|Withdrawal by Subject|13|||
23796453|NCT02075840|66630180|FG001|Overall Study|Withdrawal by Subject|22|||
23796454|NCT02075840|66630179|FG000|Overall Study|Reason not specified|1|||
23796455|NCT02075840|66630180|FG001|Overall Study|Reason not specified|0|||
23473147|NCT01124864|65477557|FG000|Overall Study|Follow up phase competed as per protocol|18|||
23473148|NCT01124864|65477558|FG001|Overall Study|Follow up phase competed as per protocol|22|||
23473149|NCT01124864|65477559|FG002|Overall Study|Follow up phase competed as per protocol|24|||
23473150|NCT01124864|65477560|FG003|Overall Study|Follow up phase competed as per protocol|18|||
23473151|NCT01124864|65477561|FG004|Overall Study|Follow up phase competed as per protocol|26|||
23473152|NCT01124864|65477562|FG005|Overall Study|Follow up phase competed as per protocol|2|||
23473153|NCT01124864|65477557|FG000|Overall Study|Death|6|||
23473154|NCT01124864|65477558|FG001|Overall Study|Death|9|||
23473155|NCT01124864|65477559|FG002|Overall Study|Death|6|||
23473156|NCT01124864|65477560|FG003|Overall Study|Death|2|||
23473157|NCT01124864|65477561|FG004|Overall Study|Death|1|||
23473158|NCT01124864|65477562|FG005|Overall Study|Death|0|||
23473159|NCT01124864|65477557|FG000|Overall Study|Withdrawal by Subject|2|||
23473160|NCT01124864|65477558|FG001|Overall Study|Withdrawal by Subject|3|||
23473161|NCT01124864|65477559|FG002|Overall Study|Withdrawal by Subject|4|||
23473162|NCT01124864|65477560|FG003|Overall Study|Withdrawal by Subject|0|||
23473163|NCT01124864|65477561|FG004|Overall Study|Withdrawal by Subject|2|||
23473164|NCT01124864|65477562|FG005|Overall Study|Withdrawal by Subject|1|||
23473165|NCT01124864|65477557|FG000|Overall Study|Lost to Follow-up|1|||
23473166|NCT01124864|65477558|FG001|Overall Study|Lost to Follow-up|1|||
23473167|NCT01124864|65477559|FG002|Overall Study|Lost to Follow-up|0|||
23473168|NCT01124864|65477560|FG003|Overall Study|Lost to Follow-up|1|||
23473169|NCT01124864|65477561|FG004|Overall Study|Lost to Follow-up|0|||
23473170|NCT01124864|65477562|FG005|Overall Study|Lost to Follow-up|0|||
23473171|NCT01124864|65477557|FG000|Overall Study|Protocol Violation|1|||
23473172|NCT01124864|65477558|FG001|Overall Study|Protocol Violation|0|||
23473173|NCT01124864|65477559|FG002|Overall Study|Protocol Violation|0|||
23473174|NCT01124864|65477560|FG003|Overall Study|Protocol Violation|0|||
23473175|NCT01124864|65477561|FG004|Overall Study|Protocol Violation|1|||
23473176|NCT01124864|65477562|FG005|Overall Study|Protocol Violation|0|||
23473177|NCT02059291|65477563|FG000|Epoch 2|Lack of Efficacy|0|||
23796456|NCT02075840|66630179|FG000|Overall Study|Adverse Event|0|||
23796457|NCT02075840|66630180|FG001|Overall Study|Adverse Event|2|||
23473178|NCT02059291|65477564|FG001|Epoch 2|Lack of Efficacy|0|||
23473179|NCT02059291|65477565|FG002|Epoch 2|Lack of Efficacy|0|||
23796458|NCT02075840|66630179|FG000|Overall Study|Death|35|||
23473180|NCT02059291|65477566|FG003|Epoch 2|Lack of Efficacy|1|||
23473181|NCT02059291|65477567|FG004|Epoch 2|Lack of Efficacy|0|||
23473182|NCT02059291|65477568|FG005|Epoch 2|Lack of Efficacy|1|||
23473183|NCT02059291|65477569|FG006|Epoch 2|Lack of Efficacy|0|||
23473184|NCT02059291|65477570|FG007|Epoch 2|Lack of Efficacy|0|||
23473185|NCT02059291|65477571|FG008|Epoch 2|Lack of Efficacy|0|||
23473186|NCT02059291|65477572|FG009|Epoch 2|Lack of Efficacy|0|||
23473187|NCT02059291|65477573|FG010|Epoch 2|Lack of Efficacy|0|||
23473188|NCT02059291|65477574|FG011|Epoch 2|Lack of Efficacy|0|||
23473189|NCT02059291|65477575|FG012|Epoch 2|Lack of Efficacy|0|||
23473190|NCT02059291|65477576|FG013|Epoch 2|Lack of Efficacy|0|||
23473191|NCT02059291|65477577|FG014|Epoch 2|Lack of Efficacy|0|||
23473192|NCT02059291|65477578|FG015|Epoch 2|Lack of Efficacy|0|||
23473193|NCT02059291|65477579|FG016|Epoch 2|Lack of Efficacy|0|||
23473194|NCT02059291|65477580|FG017|Epoch 2|Lack of Efficacy|0|||
23473195|NCT02059291|65477581|FG018|Epoch 2|Lack of Efficacy|0|||
23473196|NCT02059291|65477582|FG019|Epoch 2|Lack of Efficacy|0|||
23473197|NCT02059291|65477583|FG020|Epoch 2|Lack of Efficacy|0|||
23473198|NCT02059291|65477584|FG021|Epoch 2|Lack of Efficacy|0|||
23473199|NCT02059291|65477585|FG022|Epoch 2|Lack of Efficacy|0|||
23473200|NCT02059291|65477586|FG023|Epoch 2|Lack of Efficacy|0|||
23473201|NCT02059291|65477587|FG024|Epoch 2|Lack of Efficacy|0|||
23473202|NCT02059291|65477563|FG000|Epoch 2|Adverse Event|0|||
23473203|NCT02059291|65477564|FG001|Epoch 2|Adverse Event|0|||
23473204|NCT02059291|65477565|FG002|Epoch 2|Adverse Event|1|||
23473205|NCT02059291|65477566|FG003|Epoch 2|Adverse Event|1|||
23473206|NCT02059291|65477567|FG004|Epoch 2|Adverse Event|0|||
23473207|NCT02059291|65477568|FG005|Epoch 2|Adverse Event|0|||
23473208|NCT02059291|65477569|FG006|Epoch 2|Adverse Event|0|||
23473209|NCT02059291|65477570|FG007|Epoch 2|Adverse Event|1|||
23473210|NCT02059291|65477571|FG008|Epoch 2|Adverse Event|1|||
23473211|NCT02059291|65477572|FG009|Epoch 2|Adverse Event|0|||
23473212|NCT02059291|65477573|FG010|Epoch 2|Adverse Event|0|||
23473213|NCT02059291|65477574|FG011|Epoch 2|Adverse Event|0|||
23473214|NCT02059291|65477575|FG012|Epoch 2|Adverse Event|0|||
23473215|NCT02059291|65477576|FG013|Epoch 2|Adverse Event|0|||
23473216|NCT02059291|65477577|FG014|Epoch 2|Adverse Event|0|||
23473217|NCT02059291|65477578|FG015|Epoch 2|Adverse Event|0|||
23473218|NCT02059291|65477579|FG016|Epoch 2|Adverse Event|0|||
23473219|NCT02059291|65477580|FG017|Epoch 2|Adverse Event|0|||
23473220|NCT02059291|65477581|FG018|Epoch 2|Adverse Event|0|||
23473221|NCT02059291|65477582|FG019|Epoch 2|Adverse Event|0|||
23473222|NCT02059291|65477583|FG020|Epoch 2|Adverse Event|0|||
23473223|NCT02059291|65477584|FG021|Epoch 2|Adverse Event|0|||
23473224|NCT02059291|65477585|FG022|Epoch 2|Adverse Event|0|||
23473225|NCT02059291|65477586|FG023|Epoch 2|Adverse Event|0|||
23473226|NCT02059291|65477587|FG024|Epoch 2|Adverse Event|0|||
23473227|NCT02059291|65477563|FG000|Epoch 2|Withdrawal by Subject|0|||
23473228|NCT02059291|65477564|FG001|Epoch 2|Withdrawal by Subject|1|||
23473229|NCT02059291|65477565|FG002|Epoch 2|Withdrawal by Subject|0|||
23473230|NCT02059291|65477566|FG003|Epoch 2|Withdrawal by Subject|0|||
23473231|NCT02059291|65477567|FG004|Epoch 2|Withdrawal by Subject|0|||
23473232|NCT02059291|65477568|FG005|Epoch 2|Withdrawal by Subject|1|||
23473233|NCT02059291|65477569|FG006|Epoch 2|Withdrawal by Subject|0|||
23473234|NCT02059291|65477570|FG007|Epoch 2|Withdrawal by Subject|0|||
23473235|NCT02059291|65477571|FG008|Epoch 2|Withdrawal by Subject|1|||
23473236|NCT02059291|65477572|FG009|Epoch 2|Withdrawal by Subject|0|||
23473237|NCT02059291|65477573|FG010|Epoch 2|Withdrawal by Subject|0|||
23473238|NCT02059291|65477574|FG011|Epoch 2|Withdrawal by Subject|0|||
23473239|NCT02059291|65477575|FG012|Epoch 2|Withdrawal by Subject|0|||
23473240|NCT02059291|65477576|FG013|Epoch 2|Withdrawal by Subject|0|||
23588808|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
23588809|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
23588810|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
23588811|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
23473241|NCT02059291|65477577|FG014|Epoch 2|Withdrawal by Subject|0|||
23473242|NCT02059291|65477578|FG015|Epoch 2|Withdrawal by Subject|0|||
23473243|NCT02059291|65477579|FG016|Epoch 2|Withdrawal by Subject|0|||
23473244|NCT02059291|65477580|FG017|Epoch 2|Withdrawal by Subject|0|||
23473245|NCT02059291|65477581|FG018|Epoch 2|Withdrawal by Subject|0|||
23473246|NCT02059291|65477582|FG019|Epoch 2|Withdrawal by Subject|0|||
23473247|NCT02059291|65477583|FG020|Epoch 2|Withdrawal by Subject|0|||
23473248|NCT02059291|65477584|FG021|Epoch 2|Withdrawal by Subject|0|||
23473249|NCT02059291|65477585|FG022|Epoch 2|Withdrawal by Subject|0|||
23473250|NCT02059291|65477586|FG023|Epoch 2|Withdrawal by Subject|0|||
23473251|NCT02059291|65477587|FG024|Epoch 2|Withdrawal by Subject|0|||
23473252|NCT02059291|65477563|FG000|Epoch 3|Physician Decision|0|||
23473253|NCT02059291|65477564|FG001|Epoch 3|Physician Decision|0|||
23473254|NCT02059291|65477565|FG002|Epoch 3|Physician Decision|0|||
23473255|NCT02059291|65477566|FG003|Epoch 3|Physician Decision|0|||
23473256|NCT02059291|65477567|FG004|Epoch 3|Physician Decision|0|||
23473257|NCT02059291|65477568|FG005|Epoch 3|Physician Decision|0|||
23473258|NCT02059291|65477569|FG006|Epoch 3|Physician Decision|0|||
23473259|NCT02059291|65477570|FG007|Epoch 3|Physician Decision|0|||
23473260|NCT02059291|65477571|FG008|Epoch 3|Physician Decision|0|||
23473261|NCT02059291|65477572|FG009|Epoch 3|Physician Decision|0|||
23473262|NCT02059291|65477573|FG010|Epoch 3|Physician Decision|0|||
23473263|NCT02059291|65477574|FG011|Epoch 3|Physician Decision|0|||
23473264|NCT02059291|65477575|FG012|Epoch 3|Physician Decision|0|||
23473265|NCT02059291|65477576|FG013|Epoch 3|Physician Decision|1|||
23473266|NCT02059291|65477577|FG014|Epoch 3|Physician Decision|0|||
23473267|NCT02059291|65477578|FG015|Epoch 3|Physician Decision|1|||
23473268|NCT02059291|65477579|FG016|Epoch 3|Physician Decision|0|||
23473269|NCT02059291|65477580|FG017|Epoch 3|Physician Decision|0|||
23473270|NCT02059291|65477581|FG018|Epoch 3|Physician Decision|0|||
23473271|NCT02059291|65477582|FG019|Epoch 3|Physician Decision|0|||
23473272|NCT02059291|65477583|FG020|Epoch 3|Physician Decision|0|||
23473273|NCT02059291|65477584|FG021|Epoch 3|Physician Decision|0|||
23473274|NCT02059291|65477585|FG022|Epoch 3|Physician Decision|0|||
23473275|NCT02059291|65477586|FG023|Epoch 3|Physician Decision|0|||
23473276|NCT02059291|65477587|FG024|Epoch 3|Physician Decision|0|||
23473277|NCT02059291|65477563|FG000|Epoch 3|Adverse Event|0|||
23473278|NCT02059291|65477564|FG001|Epoch 3|Adverse Event|0|||
23473279|NCT02059291|65477565|FG002|Epoch 3|Adverse Event|0|||
23473280|NCT02059291|65477566|FG003|Epoch 3|Adverse Event|0|||
23473281|NCT02059291|65477567|FG004|Epoch 3|Adverse Event|0|||
23473282|NCT02059291|65477568|FG005|Epoch 3|Adverse Event|0|||
23473283|NCT02059291|65477569|FG006|Epoch 3|Adverse Event|0|||
23473284|NCT02059291|65477570|FG007|Epoch 3|Adverse Event|0|||
23473285|NCT02059291|65477571|FG008|Epoch 3|Adverse Event|0|||
23473286|NCT02059291|65477572|FG009|Epoch 3|Adverse Event|0|||
23473287|NCT02059291|65477573|FG010|Epoch 3|Adverse Event|0|||
23473288|NCT02059291|65477574|FG011|Epoch 3|Adverse Event|0|||
23588812|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
23588813|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588814|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588815|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588816|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588817|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588818|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588819|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588820|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588821|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588822|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
23588823|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
23796459|NCT02075840|66630180|FG001|Overall Study|Death|40|||
23473289|NCT02059291|65477575|FG012|Epoch 3|Adverse Event|0|||
23473290|NCT02059291|65477576|FG013|Epoch 3|Adverse Event|0|||
23473291|NCT02059291|65477577|FG014|Epoch 3|Adverse Event|0|||
23473292|NCT02059291|65477578|FG015|Epoch 3|Adverse Event|1|||
23473293|NCT02059291|65477579|FG016|Epoch 3|Adverse Event|0|||
23473294|NCT02059291|65477580|FG017|Epoch 3|Adverse Event|0|||
23473295|NCT02059291|65477581|FG018|Epoch 3|Adverse Event|0|||
23473296|NCT02059291|65477582|FG019|Epoch 3|Adverse Event|0|||
23473297|NCT02059291|65477583|FG020|Epoch 3|Adverse Event|0|||
23796460|NCT02075840|66630179|FG000|Overall Study|Lost to Follow-up|3|||
23796461|NCT02075840|66630180|FG001|Overall Study|Lost to Follow-up|2|||
23796462|NCT02075840|66630179|FG000|Overall Study|Physician Decision|1|||
23796463|NCT02075840|66630180|FG001|Overall Study|Physician Decision|3|||
23796464|NCT02075840|66630179|FG000|Overall Study|Ongoing at CCOD|99|||
23796465|NCT02075840|66630180|FG001|Overall Study|Ongoing at CCOD|82|||
23473298|NCT02059291|65477584|FG021|Epoch 3|Adverse Event|0|||
23473299|NCT02059291|65477585|FG022|Epoch 3|Adverse Event|0|||
23473300|NCT02059291|65477586|FG023|Epoch 3|Adverse Event|0|||
23473301|NCT02059291|65477587|FG024|Epoch 3|Adverse Event|0|||
23473302|NCT02059291|65477563|FG000|Epoch 3|Lack of Efficacy|0|||
23473303|NCT02059291|65477564|FG001|Epoch 3|Lack of Efficacy|0|||
23588824|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588825|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
23473304|NCT02059291|65477565|FG002|Epoch 3|Lack of Efficacy|0|||
23796466|NCT03761056|66630181|FG000|Overall Study|Still on Study|34|||
23796467|NCT03761056|66630181|FG000|Overall Study|Death|6|||
23473305|NCT02059291|65477566|FG003|Epoch 3|Lack of Efficacy|0|||
23473306|NCT02059291|65477567|FG004|Epoch 3|Lack of Efficacy|0|||
23473307|NCT02059291|65477568|FG005|Epoch 3|Lack of Efficacy|0|||
23473308|NCT02059291|65477569|FG006|Epoch 3|Lack of Efficacy|0|||
23473309|NCT02059291|65477570|FG007|Epoch 3|Lack of Efficacy|0|||
23473310|NCT02059291|65477571|FG008|Epoch 3|Lack of Efficacy|0|||
23473311|NCT02059291|65477572|FG009|Epoch 3|Lack of Efficacy|0|||
23796468|NCT03761056|66630181|FG000|Overall Study|Investigator Decision|1|||
23796469|NCT03761056|66630181|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
23796470|NCT02805309|66630182|FG000|Overall Study|Lost to Follow-up|2|||
23796471|NCT02805309|66630183|FG001|Overall Study|Lost to Follow-up|2|||
23796472|NCT02805309|66630184|FG002|Overall Study|Lost to Follow-up|2|||
23796473|NCT02805309|66630182|FG000|Overall Study|Post-Randomization Exclusion|0|||
23796474|NCT02805309|66630183|FG001|Overall Study|Post-Randomization Exclusion|2|||
23796475|NCT02805309|66630184|FG002|Overall Study|Post-Randomization Exclusion|1|||
23796476|NCT02726386|66630185|FG000|Overall Study|Adverse Event|17|||
23796477|NCT02726386|66630186|FG001|Overall Study|Adverse Event|20|||
23796478|NCT02726386|66630185|FG000|Overall Study|Withdrawal by Subject|14|||
23796479|NCT02726386|66630186|FG001|Overall Study|Withdrawal by Subject|28|||
23796480|NCT02726386|66630185|FG000|Overall Study|Other reasons|7|||
23796481|NCT02726386|66630186|FG001|Overall Study|Other reasons|8|||
23588826|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
23356777|NCT03131687|65052558|FG001|Overall Study|Withdrawal by Subject|3|||
23356778|NCT03131687|65052559|FG002|Overall Study|Withdrawal by Subject|3|||
23356779|NCT03131687|65052560|FG003|Overall Study|Withdrawal by Subject|1|||
23588827|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
23356780|NCT03131687|65052561|FG004|Overall Study|Withdrawal by Subject|2|||
23356781|NCT03131687|65052562|FG005|Overall Study|Withdrawal by Subject|1|||
23356782|NCT03131687|65052557|FG000|Overall Study|Lost to Follow-up|1|||
23356783|NCT03131687|65052558|FG001|Overall Study|Lost to Follow-up|4|||
23356784|NCT03131687|65052559|FG002|Overall Study|Lost to Follow-up|0|||
23356785|NCT03131687|65052560|FG003|Overall Study|Lost to Follow-up|1|||
23356786|NCT03131687|65052561|FG004|Overall Study|Lost to Follow-up|4|||
23356787|NCT03131687|65052562|FG005|Overall Study|Lost to Follow-up|2|||
23356788|NCT03131687|65052557|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
23356789|NCT03131687|65052558|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
23356790|NCT03131687|65052559|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
23356791|NCT03131687|65052560|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
23588828|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588829|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588830|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588831|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588832|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
23356792|NCT03131687|65052561|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
23356793|NCT03131687|65052562|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
23588833|NCT03781336|65882226|FG000|Overall Study|Withdrawal by Subject|2|||
23588834|NCT03781336|65882227|FG001|Overall Study|Withdrawal by Subject|2|||
23588835|NCT01393119|65882228|FG000|Overall Study|Adverse Event|1|||
23588836|NCT01393119|65882229|FG001|Overall Study|Adverse Event|1|||
23588837|NCT01393119|65882230|FG002|Overall Study|Adverse Event|0|||
23588838|NCT01393119|65882231|FG003|Overall Study|Adverse Event|1|||
23588839|NCT01393119|65882228|FG000|Overall Study|Withdrawal by Subject|0|||
23588840|NCT01393119|65882229|FG001|Overall Study|Withdrawal by Subject|1|||
23588841|NCT01393119|65882230|FG002|Overall Study|Withdrawal by Subject|1|||
23588842|NCT01393119|65882231|FG003|Overall Study|Withdrawal by Subject|0|||
23588843|NCT01393119|65882228|FG000|Overall Study|Lack of Efficacy|1|||
23796482|NCT01337596|66630191|FG000|Overall Study|Withdrawal by Subject|0|||
23796483|NCT01337596|66630192|FG001|Overall Study|Withdrawal by Subject|0|||
23796484|NCT01337596|66630193|FG002|Overall Study|Withdrawal by Subject|0|||
23796485|NCT01337596|66630194|FG003|Overall Study|Withdrawal by Subject|0|||
23356794|NCT03131687|65052557|FG000|Overall Study|Principle Investigator Decision|0|||
23473312|NCT02059291|65477573|FG010|Epoch 3|Lack of Efficacy|0|||
23356795|NCT03131687|65052558|FG001|Overall Study|Principle Investigator Decision|1|||
23356796|NCT03131687|65052559|FG002|Overall Study|Principle Investigator Decision|0|||
23356797|NCT03131687|65052560|FG003|Overall Study|Principle Investigator Decision|0|||
23356798|NCT03131687|65052561|FG004|Overall Study|Principle Investigator Decision|0|||
23356799|NCT03131687|65052562|FG005|Overall Study|Principle Investigator Decision|0|||
23356800|NCT03131687|65052557|FG000|Overall Study|Inadvertent Enrollment|0|||
23356801|NCT03131687|65052558|FG001|Overall Study|Inadvertent Enrollment|0|||
23356802|NCT03131687|65052559|FG002|Overall Study|Inadvertent Enrollment|0|||
23356803|NCT03131687|65052560|FG003|Overall Study|Inadvertent Enrollment|1|||
23356804|NCT03131687|65052561|FG004|Overall Study|Inadvertent Enrollment|0|||
23356805|NCT03131687|65052562|FG005|Overall Study|Inadvertent Enrollment|0|||
23356806|NCT01300247|65052563|FG000|Overall Study|Death|1|||
23356807|NCT01300247|65052564|FG001|Overall Study|Death|1|||
23356808|NCT01300247|65052563|FG000|Overall Study|Lost to Follow-up|2|||
23356809|NCT01300247|65052564|FG001|Overall Study|Lost to Follow-up|0|||
23356810|NCT01300247|65052563|FG000|Overall Study|Withdrawal by Subject|1|||
23356811|NCT01300247|65052564|FG001|Overall Study|Withdrawal by Subject|0|||
23356812|NCT01300247|65052563|FG000|Overall Study|Non-Compliance|0|||
23356813|NCT01300247|65052564|FG001|Overall Study|Non-Compliance|1|||
23356814|NCT02683239|65052565|FG000|Overall Study|Protocol Violation|35|||
23356815|NCT02683239|65052566|FG001|Overall Study|Protocol Violation|23|||
23796486|NCT01337596|66630195|FG004|Overall Study|Withdrawal by Subject|2|||
23796487|NCT01337596|66630196|FG005|Overall Study|Withdrawal by Subject|0|||
23796488|NCT01337596|66630197|FG006|Overall Study|Withdrawal by Subject|0|||
23796489|NCT01337596|66630198|FG007|Overall Study|Withdrawal by Subject|0|||
23796490|NCT01337596|66630199|FG008|Overall Study|Withdrawal by Subject|0|||
23796491|NCT01004510|66630202|FG000|Overall Study|Adverse Event|1|||
23796492|NCT00982228|66630203|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
23796493|NCT00982228|66630204|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
23796494|NCT00982228|66630203|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
23796495|NCT00982228|66630204|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
23796496|NCT00982228|66630203|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
23796497|NCT00982228|66630204|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
23796498|NCT00982228|66630203|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
23796499|NCT00982228|66630204|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
23796500|NCT00982228|66630203|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
23796501|NCT00982228|66630204|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
23796502|NCT00982228|66630203|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
23796503|NCT00982228|66630204|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
23796504|NCT00982228|66630203|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
23796505|NCT00982228|66630204|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
23796506|NCT00982228|66630203|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
23796507|NCT00982228|66630204|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
23796508|NCT00982228|66630203|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
23796509|NCT00982228|66630204|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
23796510|NCT00982228|66630203|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
23796511|NCT00982228|66630204|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
23796512|NCT03686215|66632998|FG000|Overall Study|Adverse Event|0|||
23796513|NCT03686215|66632999|FG001|Overall Study|Adverse Event|0|||
23796514|NCT03686215|66633000|FG002|Overall Study|Adverse Event|7|||
23796515|NCT03686215|66632998|FG000|Overall Study|Physician Decision|0|||
23796516|NCT03686215|66632999|FG001|Overall Study|Physician Decision|0|||
23796517|NCT03686215|66633000|FG002|Overall Study|Physician Decision|1|||
23796518|NCT03686215|66632998|FG000|Overall Study|Protocol Violation|0|||
23796519|NCT03686215|66632999|FG001|Overall Study|Protocol Violation|0|||
23796520|NCT03686215|66633000|FG002|Overall Study|Protocol Violation|4|||
23796521|NCT03686215|66632998|FG000|Overall Study|Device issue|1|||
23796522|NCT03686215|66632999|FG001|Overall Study|Device issue|0|||
23796523|NCT03686215|66633000|FG002|Overall Study|Device issue|2|||
23796524|NCT01192399|66633005|FG000|Overall Study|Lack of Efficacy|2|||
23796525|NCT00585312|66633006|FG000|Overall Study|Adverse Event|3|||
23796526|NCT00585312|66633007|FG001|Overall Study|Adverse Event|0|||
23796527|NCT00585312|66633006|FG000|Overall Study|Lack of Efficacy|6|||
23796528|NCT00585312|66633007|FG001|Overall Study|Lack of Efficacy|11|||
23796529|NCT00585312|66633006|FG000|Overall Study|Lost to Follow-up|1|||
23796530|NCT00585312|66633007|FG001|Overall Study|Lost to Follow-up|1|||
23796531|NCT00585312|66633006|FG000|Overall Study|Reason not specified|2|||
23796532|NCT00585312|66633007|FG001|Overall Study|Reason not specified|0|||
23796533|NCT00585312|66633006|FG000|Overall Study|Withdrawal by Subject|5|||
23796534|NCT00585312|66633007|FG001|Overall Study|Withdrawal by Subject|1|||
23796535|NCT00585312|66633006|FG000|Overall Study|Study terminated by the sponsor|34|||
23796536|NCT00585312|66633007|FG001|Overall Study|Study terminated by the sponsor|31|||
23356816|NCT02683239|65052567|FG002|Overall Study|Protocol Violation|26|||
23356817|NCT02683239|65052568|FG003|Overall Study|Protocol Violation|4|||
23356818|NCT02683239|65052569|FG004|Overall Study|Protocol Violation|35|||
23356819|NCT02683239|65052570|FG005|Overall Study|Protocol Violation|4|||
23356820|NCT02683239|65052571|FG006|Overall Study|Protocol Violation|5|||
23356821|NCT02683239|65052565|FG000|Overall Study|Adverse Event|64|||
23356822|NCT02683239|65052566|FG001|Overall Study|Adverse Event|39|||
23356823|NCT02683239|65052567|FG002|Overall Study|Adverse Event|42|||
23356824|NCT02683239|65052568|FG003|Overall Study|Adverse Event|16|||
23356825|NCT02683239|65052569|FG004|Overall Study|Adverse Event|189|||
23356826|NCT02683239|65052570|FG005|Overall Study|Adverse Event|9|||
23356827|NCT02683239|65052571|FG006|Overall Study|Adverse Event|9|||
23356828|NCT02683239|65052565|FG000|Overall Study|Physician Decision|38|||
23356829|NCT02683239|65052566|FG001|Overall Study|Physician Decision|19|||
23356830|NCT02683239|65052567|FG002|Overall Study|Physician Decision|14|||
23356831|NCT02683239|65052568|FG003|Overall Study|Physician Decision|73|||
23356832|NCT02683239|65052569|FG004|Overall Study|Physician Decision|143|||
23356833|NCT02683239|65052570|FG005|Overall Study|Physician Decision|14|||
23356834|NCT02683239|65052571|FG006|Overall Study|Physician Decision|15|||
23356835|NCT02683239|65052565|FG000|Overall Study|Withdrawal by Subject|187|||
23356836|NCT02683239|65052566|FG001|Overall Study|Withdrawal by Subject|99|||
23356837|NCT02683239|65052567|FG002|Overall Study|Withdrawal by Subject|91|||
23356838|NCT02683239|65052568|FG003|Overall Study|Withdrawal by Subject|18|||
23356839|NCT02683239|65052569|FG004|Overall Study|Withdrawal by Subject|248|||
23356840|NCT02683239|65052570|FG005|Overall Study|Withdrawal by Subject|22|||
23356841|NCT02683239|65052571|FG006|Overall Study|Withdrawal by Subject|28|||
23356842|NCT02683239|65052565|FG000|Overall Study|Lost to Follow-up|77|||
23356843|NCT02683239|65052566|FG001|Overall Study|Lost to Follow-up|24|||
23356844|NCT02683239|65052567|FG002|Overall Study|Lost to Follow-up|25|||
23356845|NCT02683239|65052568|FG003|Overall Study|Lost to Follow-up|7|||
23356846|NCT02683239|65052569|FG004|Overall Study|Lost to Follow-up|88|||
23356847|NCT02683239|65052570|FG005|Overall Study|Lost to Follow-up|8|||
23356848|NCT02683239|65052571|FG006|Overall Study|Lost to Follow-up|11|||
23356849|NCT02683239|65052565|FG000|Overall Study|Death|9|||
23356850|NCT02683239|65052566|FG001|Overall Study|Death|5|||
23356851|NCT02683239|65052567|FG002|Overall Study|Death|8|||
23356852|NCT02683239|65052568|FG003|Overall Study|Death|0|||
23356853|NCT02683239|65052569|FG004|Overall Study|Death|12|||
23642084|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Death|1|||
23642085|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Death|1|||
23642086|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23642087|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23356854|NCT02683239|65052570|FG005|Overall Study|Death|1|||
23588844|NCT01393119|65882229|FG001|Overall Study|Lack of Efficacy|0|||
23642088|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
23642089|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
23356855|NCT02683239|65052571|FG006|Overall Study|Death|0|||
23356856|NCT02683239|65052565|FG000|Overall Study|Lack of Efficacy|50|||
23356857|NCT02683239|65052566|FG001|Overall Study|Lack of Efficacy|23|||
23356858|NCT02683239|65052567|FG002|Overall Study|Lack of Efficacy|12|||
23356859|NCT02683239|65052568|FG003|Overall Study|Lack of Efficacy|2|||
23356860|NCT02683239|65052569|FG004|Overall Study|Lack of Efficacy|29|||
23356861|NCT02683239|65052570|FG005|Overall Study|Lack of Efficacy|2|||
23356862|NCT02683239|65052571|FG006|Overall Study|Lack of Efficacy|3|||
23356863|NCT02683239|65052565|FG000|Overall Study|Missing data|0|||
23356864|NCT02683239|65052566|FG001|Overall Study|Missing data|1|||
23356865|NCT02683239|65052567|FG002|Overall Study|Missing data|1|||
23356866|NCT02683239|65052568|FG003|Overall Study|Missing data|0|||
23356867|NCT02683239|65052569|FG004|Overall Study|Missing data|1|||
23356868|NCT02683239|65052570|FG005|Overall Study|Missing data|0|||
23356869|NCT02683239|65052571|FG006|Overall Study|Missing data|0|||
23356870|NCT01429441|65052573|FG000|Overall Study|Adverse Event|5|||
23356871|NCT01429441|65052574|FG001|Overall Study|Adverse Event|1|||
23356872|NCT01429441|65052573|FG000|Overall Study|Death|0|||
23356873|NCT01429441|65052574|FG001|Overall Study|Death|2|||
23356874|NCT01429441|65052573|FG000|Overall Study|Lost to Follow-up|5|||
23356875|NCT01429441|65052574|FG001|Overall Study|Lost to Follow-up|2|||
23356876|NCT01429441|65052573|FG000|Overall Study|Physician Decision|1|||
23356877|NCT01429441|65052574|FG001|Overall Study|Physician Decision|0|||
23356878|NCT01429441|65052573|FG000|Overall Study|Withdrawal by Subject|27|||
23356879|NCT01429441|65052574|FG001|Overall Study|Withdrawal by Subject|18|||
23356880|NCT01808222|65052575|FG000|Overall Study|mpMR scan was not performed|1|||
23356881|NCT02797678|65052576|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
23356882|NCT02797678|65052577|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356883|NCT02797678|65052578|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356884|NCT02797678|65052579|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356885|NCT02797678|65052576|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356886|NCT02797678|65052577|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
23356887|NCT02797678|65052578|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356888|NCT02797678|65052579|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356889|NCT02797678|65052576|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356890|NCT02797678|65052577|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356891|NCT02797678|65052578|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
23356892|NCT02797678|65052579|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356893|NCT00460746|65052582|FG000|Overall Study|Adverse Event|1|||
23356894|NCT00460746|65052582|FG000|Overall Study|Lost to Follow-up|1|||
23356895|NCT02840474|65052583|FG000|Overall Study|Lost to Follow-up|1|||
23356896|NCT02840474|65052584|FG001|Overall Study|Lost to Follow-up|0|||
23356897|NCT01398358|65052585|FG000|Overall Study|Lost to Follow-up|11|||
23356898|NCT01398358|65052586|FG001|Overall Study|Lost to Follow-up|21|||
23356899|NCT01398358|65052587|FG002|Overall Study|Lost to Follow-up|18|||
23356900|NCT01398358|65052585|FG000|Overall Study|Withdrawal by Subject|3|||
23356901|NCT01398358|65052586|FG001|Overall Study|Withdrawal by Subject|2|||
23356902|NCT01398358|65052587|FG002|Overall Study|Withdrawal by Subject|2|||
23356903|NCT01398358|65052585|FG000|Overall Study|no longer eligible|1|||
23356904|NCT01398358|65052586|FG001|Overall Study|no longer eligible|0|||
23356905|NCT01398358|65052587|FG002|Overall Study|no longer eligible|1|||
23356906|NCT00564278|65052590|FG000|Overall Study|Lost to Follow-up|35|||
23356907|NCT00564278|65052591|FG001|Overall Study|Lost to Follow-up|33|||
23356908|NCT00564278|65052590|FG000|Overall Study|Physician Decision|1|||
23356909|NCT00564278|65052591|FG001|Overall Study|Physician Decision|2|||
23356910|NCT00564278|65052590|FG000|Overall Study|Withdrawal by Subject|11|||
23356911|NCT00564278|65052591|FG001|Overall Study|Withdrawal by Subject|7|||
23588845|NCT01393119|65882230|FG002|Overall Study|Lack of Efficacy|2|||
23642090|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Physician Decision|1|||
23796537|NCT02310763|66633010|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23796538|NCT02310763|66633011|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23796539|NCT02310763|66633012|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23796540|NCT02310763|66633010|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
23796541|NCT02310763|66633011|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
23796542|NCT02310763|66633012|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
23796543|NCT02310763|66633010|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
23796544|NCT02310763|66633011|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23796545|NCT02310763|66633012|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23796546|NCT02310763|66633010|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
23796547|NCT02310763|66633011|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
23356912|NCT02226120|65052592|FG000|Overall Study|Adverse Event|60|||
23356913|NCT02226120|65052592|FG000|Overall Study|Death|172|||
23356914|NCT02226120|65052592|FG000|Overall Study|Study terminated by sponsor|1|||
23356915|NCT02226120|65052592|FG000|Overall Study|Technical problems|4|||
23356916|NCT02226120|65052592|FG000|Overall Study|Lost to Follow-up|13|||
23356917|NCT02226120|65052592|FG000|Overall Study|Physician Decision|21|||
23356918|NCT02226120|65052592|FG000|Overall Study|Withdrawal by parent/guardian|36|||
23356919|NCT02226120|65052592|FG000|Overall Study|Non-compliance with study drug|10|||
23356920|NCT02226120|65052592|FG000|Overall Study|Protocol deviation|1|||
23356921|NCT02226120|65052592|FG000|Overall Study|missing treatment disposition pages|2|||
23642091|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Physician Decision|4|||
23356922|NCT03859648|65052593|FG000|Overall Study|Lost to Follow-up|1|||
23356923|NCT03859648|65052593|FG000|Overall Study|Adverse Event|1|||
23356924|NCT02716779|65052597|FG000|Monotherapy|Adverse Event|0|||
23356925|NCT02716779|65052598|FG001|Monotherapy|Adverse Event|1|||
23356926|NCT02716779|65052599|FG002|Monotherapy|Adverse Event|1|||
23356927|NCT02716779|65052597|FG000|Combination Therapy|Adverse Event|0|||
23356928|NCT02716779|65052598|FG001|Combination Therapy|Adverse Event|2|||
23356929|NCT02716779|65052599|FG002|Combination Therapy|Adverse Event|1|||
23356930|NCT02579382|65052606|FG000|Main Study Phase|Lost to Follow-up|0|||
23356931|NCT02579382|65052607|FG001|Main Study Phase|Lost to Follow-up|0|||
23356932|NCT02579382|65052608|FG002|Main Study Phase|Lost to Follow-up|2|||
23356933|NCT02579382|65052609|FG003|Main Study Phase|Lost to Follow-up|0|||
23356934|NCT02579382|65052606|FG000|Main Study Phase|Withdrew Consent|0|||
23356935|NCT02579382|65052607|FG001|Main Study Phase|Withdrew Consent|0|||
23356936|NCT02579382|65052608|FG002|Main Study Phase|Withdrew Consent|0|||
23356937|NCT02579382|65052609|FG003|Main Study Phase|Withdrew Consent|2|||
23356938|NCT02579382|65052606|FG000|Main Study Phase|Lack of Efficacy|0|||
23356939|NCT02579382|65052607|FG001|Main Study Phase|Lack of Efficacy|0|||
23356940|NCT02579382|65052608|FG002|Main Study Phase|Lack of Efficacy|0|||
23356941|NCT02579382|65052609|FG003|Main Study Phase|Lack of Efficacy|1|||
23356942|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
23356943|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
23356944|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
23356945|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
23356946|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
23356947|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
23356948|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
23356949|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
23356950|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
23356951|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356952|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356953|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356954|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356955|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
23356956|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356957|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356958|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356959|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
23356960|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356961|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356962|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356963|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
23356964|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356965|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356966|NCT04152083|65052610|FG000|Overall Study|Lost to Follow-up|2|||
23356967|NCT04152083|65052611|FG001|Overall Study|Lost to Follow-up|1|||
23356968|NCT04152083|65052610|FG000|Overall Study|Adverse Event|1|||
23356969|NCT04152083|65052611|FG001|Overall Study|Adverse Event|0|||
23356970|NCT04152083|65052610|FG000|Overall Study|Randomized but not treated|3|||
23356971|NCT04152083|65052611|FG001|Overall Study|Randomized but not treated|2|||
23356972|NCT00885378|65052612|FG000|Overall Study|Lack of Efficacy|2|||
23356973|NCT00885378|65052613|FG001|Overall Study|Lack of Efficacy|2|||
23356974|NCT00885378|65052612|FG000|Overall Study|Withdrawal by Subject|1|||
23356975|NCT00885378|65052613|FG001|Overall Study|Withdrawal by Subject|2|||
23356976|NCT00885378|65052612|FG000|Overall Study|Lost to Follow-up|1|||
23356977|NCT00885378|65052613|FG001|Overall Study|Lost to Follow-up|2|||
23356978|NCT00885378|65052612|FG000|Overall Study|Poor/Noncompliance|2|||
23356979|NCT00885378|65052613|FG001|Overall Study|Poor/Noncompliance|2|||
23356980|NCT00885378|65052612|FG000|Overall Study|Protocol Violation|2|||
23356981|NCT00885378|65052613|FG001|Overall Study|Protocol Violation|0|||
23356982|NCT04727528|65052628|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
23356983|NCT04727528|65052629|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
23356984|NCT04727528|65052628|FG000|Open-label Period|Randomized who did not receive treatment|1|||
23642092|NCT03828747|66075297|FG000|Double-Blind Treatment Period|Various reasons|5|||
23356985|NCT04727528|65052629|FG001|Open-label Period|Randomized who did not receive treatment|0|||
23356986|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23356987|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Adverse Event|1|||
23356988|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Death|0|||
23356989|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Death|1|||
23356990|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
23473313|NCT02059291|65477574|FG011|Epoch 3|Lack of Efficacy|0|||
23642093|NCT03828747|66075298|FG001|Double-Blind Treatment Period|Various reasons|3|||
23642094|NCT03828747|66075297|FG000|Open-Label Extension|Adverse Event|9|||
23642095|NCT03828747|66075298|FG001|Open-Label Extension|Adverse Event|7|||
23642096|NCT03828747|66075297|FG000|Open-Label Extension|Death|0|||
23642097|NCT03828747|66075298|FG001|Open-Label Extension|Death|2|||
23642098|NCT03828747|66075297|FG000|Open-Label Extension|Lost to Follow-up|4|||
23642099|NCT03828747|66075298|FG001|Open-Label Extension|Lost to Follow-up|0|||
23642100|NCT03828747|66075297|FG000|Open-Label Extension|Withdrawal by Subject|31|||
23642101|NCT03828747|66075298|FG001|Open-Label Extension|Withdrawal by Subject|30|||
23642102|NCT03828747|66075297|FG000|Open-Label Extension|Various reasons|4|||
23642103|NCT03828747|66075298|FG001|Open-Label Extension|Various reasons|4|||
23642104|NCT03828747|66075297|FG000|Open-Label Extension|Physician Decision|6|||
23642105|NCT03828747|66075298|FG001|Open-Label Extension|Physician Decision|2|||
23642106|NCT00721149|66075299|FG000|Overall Study|Physician Decision|1|||
23642107|NCT04606771|66075300|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
23642108|NCT04606771|66075301|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
23642109|NCT04606771|66075300|FG000|Overall Study|Death|5|||
23642110|NCT04606771|66075301|FG001|Overall Study|Death|6|||
23642111|NCT04606771|66075300|FG000|Overall Study|Wrong randomisation|0|||
23642112|NCT04606771|66075301|FG001|Overall Study|Wrong randomisation|1|||
23642113|NCT01239043|66075302|FG000|Overall Study|Protocol Violation|2|||
23642114|NCT01239043|66075303|FG001|Overall Study|Protocol Violation|1|||
23642115|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
23642116|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
23642117|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
23642118|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
23642119|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
23642120|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
23642121|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
23642122|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
23642123|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
23642124|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
23642125|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
23473314|NCT02059291|65477575|FG012|Epoch 3|Lack of Efficacy|0|||
23473315|NCT02059291|65477576|FG013|Epoch 3|Lack of Efficacy|0|||
23473316|NCT02059291|65477577|FG014|Epoch 3|Lack of Efficacy|0|||
23473317|NCT02059291|65477578|FG015|Epoch 3|Lack of Efficacy|3|||
23473318|NCT02059291|65477579|FG016|Epoch 3|Lack of Efficacy|0|||
23473319|NCT02059291|65477580|FG017|Epoch 3|Lack of Efficacy|0|||
23473320|NCT02059291|65477581|FG018|Epoch 3|Lack of Efficacy|0|||
23473321|NCT02059291|65477582|FG019|Epoch 3|Lack of Efficacy|0|||
23473322|NCT02059291|65477583|FG020|Epoch 3|Lack of Efficacy|0|||
23473323|NCT02059291|65477584|FG021|Epoch 3|Lack of Efficacy|0|||
23473324|NCT02059291|65477585|FG022|Epoch 3|Lack of Efficacy|0|||
23473325|NCT02059291|65477586|FG023|Epoch 3|Lack of Efficacy|0|||
23473326|NCT02059291|65477587|FG024|Epoch 3|Lack of Efficacy|0|||
23473327|NCT02059291|65477563|FG000|Epoch 3|Withdrawal by Subject|0|||
23473328|NCT02059291|65477564|FG001|Epoch 3|Withdrawal by Subject|0|||
23473329|NCT02059291|65477565|FG002|Epoch 3|Withdrawal by Subject|0|||
23473330|NCT02059291|65477566|FG003|Epoch 3|Withdrawal by Subject|0|||
23473331|NCT02059291|65477567|FG004|Epoch 3|Withdrawal by Subject|0|||
23473332|NCT02059291|65477568|FG005|Epoch 3|Withdrawal by Subject|0|||
23473333|NCT02059291|65477569|FG006|Epoch 3|Withdrawal by Subject|0|||
23473334|NCT02059291|65477570|FG007|Epoch 3|Withdrawal by Subject|0|||
23588846|NCT01393119|65882231|FG003|Overall Study|Lack of Efficacy|1|||
23588847|NCT01393119|65882228|FG000|Overall Study|Protocol Violation|0|||
23588848|NCT01393119|65882229|FG001|Overall Study|Protocol Violation|0|||
23588849|NCT01393119|65882230|FG002|Overall Study|Protocol Violation|1|||
23588850|NCT01393119|65882231|FG003|Overall Study|Protocol Violation|0|||
23588851|NCT01393119|65882228|FG000|Overall Study|Death|0|||
23588852|NCT01393119|65882229|FG001|Overall Study|Death|0|||
23588853|NCT01393119|65882230|FG002|Overall Study|Death|0|||
23642126|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
23473335|NCT02059291|65477571|FG008|Epoch 3|Withdrawal by Subject|0|||
23473336|NCT02059291|65477572|FG009|Epoch 3|Withdrawal by Subject|0|||
23473337|NCT02059291|65477573|FG010|Epoch 3|Withdrawal by Subject|0|||
23588854|NCT01393119|65882231|FG003|Overall Study|Death|1|||
23642127|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
23642128|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
23642129|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
23642130|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
23642131|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
23473338|NCT02059291|65477574|FG011|Epoch 3|Withdrawal by Subject|0|||
23473339|NCT02059291|65477575|FG012|Epoch 3|Withdrawal by Subject|0|||
23473340|NCT02059291|65477576|FG013|Epoch 3|Withdrawal by Subject|0|||
23473341|NCT02059291|65477577|FG014|Epoch 3|Withdrawal by Subject|0|||
23588855|NCT01393119|65882228|FG000|Overall Study|Randomized but Not treated|1|||
23356991|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
23356992|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
23356993|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
23356994|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Physician Decision|0|||
23356995|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Physician Decision|1|||
23356996|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
23356997|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23356998|NCT00705341|65052630|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
23356999|NCT00705341|65052631|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
23357000|NCT00705341|65052632|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
23357001|NCT00705341|65052633|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
23357002|NCT00705341|65052630|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357003|NCT00705341|65052631|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357004|NCT00705341|65052632|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
23357005|NCT00705341|65052633|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357006|NCT00593606|65052634|FG000|Overall Study|Adverse Event|13|||
23357007|NCT00593606|65052634|FG000|Overall Study|Withdrawal by Subject|1|||
23357008|NCT00593606|65052634|FG000|Overall Study|Protocol Violation|3|||
23357009|NCT00593606|65052634|FG000|Overall Study|Lost to Follow-up|2|||
23357010|NCT00593606|65052634|FG000|Overall Study|Run-In Failure|5|||
23357011|NCT00593606|65052634|FG000|Overall Study|Screen Failure|3|||
23473342|NCT02059291|65477578|FG015|Epoch 3|Withdrawal by Subject|1|||
23357012|NCT01212159|65052640|FG000|Overall Study|Withdrawal by Subject|12|||
23357013|NCT01212159|65052641|FG001|Overall Study|Withdrawal by Subject|12|||
23642132|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
23357014|NCT00869128|65052644|FG000|Overall Study|lack of Compliance|6|||
23357015|NCT00869128|65052645|FG001|Overall Study|lack of Compliance|6|||
23357016|NCT00264290|65052646|FG000|Intervention (8 Weeks)|Adverse Event|1|||
23357017|NCT00264290|65052647|FG001|Intervention (8 Weeks)|Adverse Event|0|||
23357018|NCT03124537|65052648|FG000|Overall Study|Lost to Follow-up|3|||
23357019|NCT03124537|65052649|FG001|Overall Study|Lost to Follow-up|5|||
23357020|NCT03124537|65052648|FG000|Overall Study|App Crash, Incomplete Data|7|||
23357021|NCT03124537|65052649|FG001|Overall Study|App Crash, Incomplete Data|8|||
23357022|NCT03162328|65052652|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
23357023|NCT03162328|65052653|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
23357024|NCT03162328|65052654|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
23357025|NCT03162328|65052652|FG000|Screening Period|Withdrawal by Subject|1|||
23357026|NCT03162328|65052653|FG001|Screening Period|Withdrawal by Subject|0|||
23357027|NCT03162328|65052654|FG002|Screening Period|Withdrawal by Subject|0|||
23357028|NCT03162328|65052652|FG000|Study Period|Withdrawal by Subject|0|||
23357029|NCT03162328|65052653|FG001|Study Period|Withdrawal by Subject|0|||
23357030|NCT03162328|65052654|FG002|Study Period|Withdrawal by Subject|1|||
23357031|NCT02784288|65052655|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
23357032|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
23357033|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
23357034|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
23357035|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
23357036|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
23357037|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
23357038|NCT01972464|65052656|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
23357039|NCT01972464|65052657|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
23357040|NCT03307837|65052663|FG000|Overall Study|Withdrawal by Subject|0|||
23357041|NCT03307837|65052664|FG001|Overall Study|Withdrawal by Subject|0|||
23357042|NCT03307837|65052665|FG002|Overall Study|Withdrawal by Subject|1|||
23357043|NCT03307837|65052666|FG003|Overall Study|Withdrawal by Subject|0|||
23642133|NCT03412747|66075304|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
23357044|NCT03307837|65052667|FG004|Overall Study|Withdrawal by Subject|0|||
23357045|NCT03307837|65052668|FG005|Overall Study|Withdrawal by Subject|1|||
23357046|NCT03307837|65052663|FG000|Overall Study|Lost to Follow-up|1|||
23357047|NCT03307837|65052664|FG001|Overall Study|Lost to Follow-up|1|||
23357048|NCT03307837|65052665|FG002|Overall Study|Lost to Follow-up|0|||
23357049|NCT03307837|65052666|FG003|Overall Study|Lost to Follow-up|0|||
23357050|NCT03307837|65052667|FG004|Overall Study|Lost to Follow-up|0|||
23357051|NCT03307837|65052668|FG005|Overall Study|Lost to Follow-up|1|||
23357052|NCT04105842|65052669|FG000|Overall Study|Withdrawal by Subject|2|||
23357053|NCT00985686|65052670|FG000|Overall Study|Lost to Follow-up|1|||
23357054|NCT00985686|65052671|FG001|Overall Study|Lost to Follow-up|1|||
23357055|NCT00985686|65052672|FG002|Overall Study|Lost to Follow-up|0|||
23357056|NCT00985686|65052673|FG003|Overall Study|Lost to Follow-up|2|||
23357057|NCT04227405|65052674|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
23357058|NCT04227405|65052675|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
23357059|NCT04227405|65052674|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
23357060|NCT04227405|65052675|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
23357061|NCT04227405|65052674|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
23357062|NCT04227405|65052675|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
23357063|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
23357064|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
23357065|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
23357066|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
23357067|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
23357068|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
23357069|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
23357070|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
23357071|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
23357072|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
23357073|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
23357074|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
23357075|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
23357076|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
23357077|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
23357078|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
23642134|NCT03412747|66075305|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
23642135|NCT03412747|66075306|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
23796548|NCT02310763|66633012|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
23357079|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
23357080|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
23357081|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
23357082|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
23357083|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
23357084|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357085|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357086|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357087|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
23357088|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
23357089|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
23357090|NCT02634801|65052677|FG000|Follow-up Period|Lost to Follow-up|3|||
23357091|NCT02634801|65052678|FG001|Follow-up Period|Lost to Follow-up|1|||
23357092|NCT02634801|65052679|FG002|Follow-up Period|Lost to Follow-up|2|||
23357093|NCT02634801|65052677|FG000|Follow-up Period|Physician Decision|0|||
23357094|NCT02634801|65052678|FG001|Follow-up Period|Physician Decision|0|||
23357095|NCT02634801|65052679|FG002|Follow-up Period|Physician Decision|1|||
23357096|NCT02634801|65052677|FG000|Follow-up Period|Withdrawal by Subject|1|||
23357097|NCT02634801|65052678|FG001|Follow-up Period|Withdrawal by Subject|2|||
23357098|NCT02634801|65052679|FG002|Follow-up Period|Withdrawal by Subject|5|||
23357099|NCT02634801|65052677|FG000|Follow-up Period|Adverse Event|1|||
23357100|NCT02634801|65052678|FG001|Follow-up Period|Adverse Event|5|||
23357101|NCT02634801|65052679|FG002|Follow-up Period|Adverse Event|0|||
23357102|NCT01928199|65052683|FG000|Overall Study|Lost to Follow-up|2|||
23357103|NCT01928199|65052684|FG001|Overall Study|Lost to Follow-up|1|||
23357104|NCT01928199|65052683|FG000|Overall Study|Withdrawal by Subject|3|||
23357105|NCT01928199|65052684|FG001|Overall Study|Withdrawal by Subject|5|||
23357106|NCT03041467|65052685|FG000|Overall Study|Death|46|||
23357107|NCT03041467|65052686|FG001|Overall Study|Death|39|||
23357108|NCT03041467|65052685|FG000|Overall Study|Withdrawal by Subject|36|||
23357109|NCT03041467|65052686|FG001|Overall Study|Withdrawal by Subject|37|||
23357110|NCT03041467|65052685|FG000|Overall Study|Lost to Follow-up|6|||
23357111|NCT03041467|65052686|FG001|Overall Study|Lost to Follow-up|8|||
23357112|NCT03041467|65052685|FG000|Overall Study|Declined consent for study extension|21|||
23357113|NCT03041467|65052686|FG001|Overall Study|Declined consent for study extension|33|||
23357114|NCT03041467|65052685|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
23357115|NCT03041467|65052686|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
23357116|NCT03469999|65052687|FG000|Overall Study|Lost to Follow-up|2|||
23357117|NCT00154375|65052688|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
23357118|NCT00154375|65052689|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
23357119|NCT00154375|65052688|FG000|Overall Study|Adverse Event|18|||
23357120|NCT00154375|65052689|FG001|Overall Study|Adverse Event|20|||
23357121|NCT00154375|65052688|FG000|Overall Study|Withdrawal by Subject|14|||
23357122|NCT00154375|65052689|FG001|Overall Study|Withdrawal by Subject|10|||
23357123|NCT00154375|65052688|FG000|Overall Study|Death|5|||
23796549|NCT02310763|66633010|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23796550|NCT02310763|66633011|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23796551|NCT02310763|66633012|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23796552|NCT03203642|66633013|FG000|Overall Study|Adverse Event|3|||
23796553|NCT03203642|66633014|FG001|Overall Study|Adverse Event|1|||
23357124|NCT00154375|65052689|FG001|Overall Study|Death|13|||
23357125|NCT00154375|65052688|FG000|Overall Study|Study drug no longer required|5|||
23473343|NCT02059291|65477579|FG016|Epoch 3|Withdrawal by Subject|0|||
23588856|NCT01393119|65882229|FG001|Overall Study|Randomized but Not treated|0|||
23588857|NCT01393119|65882230|FG002|Overall Study|Randomized but Not treated|1|||
23588858|NCT01393119|65882231|FG003|Overall Study|Randomized but Not treated|1|||
23588859|NCT01393119|65882228|FG000|Overall Study|Sponsor Termination of Study|11|||
23796554|NCT03203642|66633013|FG000|Overall Study|Withdrawal by Subject|6|||
23796555|NCT03203642|66633014|FG001|Overall Study|Withdrawal by Subject|6|||
23796556|NCT03203642|66633013|FG000|Overall Study|Lost to Follow-up|2|||
23796557|NCT03203642|66633014|FG001|Overall Study|Lost to Follow-up|1|||
23796558|NCT03203642|66633013|FG000|Overall Study|Termination of the study by sponsor|1|||
23357126|NCT00154375|65052689|FG001|Overall Study|Study drug no longer required|3|||
23357127|NCT00154375|65052688|FG000|Overall Study|Lost to Follow-up|2|||
23357128|NCT00154375|65052689|FG001|Overall Study|Lost to Follow-up|1|||
23357129|NCT00154375|65052688|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23357130|NCT00154375|65052689|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23357131|NCT00154375|65052688|FG000|Overall Study|Protocol Violation|0|||
23357132|NCT00154375|65052689|FG001|Overall Study|Protocol Violation|1|||
23357133|NCT00154375|65052688|FG000|Overall Study|Suspected progression of disease|44|||
23357134|NCT00154375|65052689|FG001|Overall Study|Suspected progression of disease|30|||
23357135|NCT01687283|65052690|FG000|Overall Study|Adverse Event|11|||
23642136|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
23706852|NCT00002663|66301348|FG009|Overall Study|Physician Decision|1|||
23473344|NCT02059291|65477580|FG017|Epoch 3|Withdrawal by Subject|0|||
23473345|NCT02059291|65477581|FG018|Epoch 3|Withdrawal by Subject|0|||
23473346|NCT02059291|65477582|FG019|Epoch 3|Withdrawal by Subject|0|||
23473347|NCT02059291|65477583|FG020|Epoch 3|Withdrawal by Subject|0|||
23473348|NCT02059291|65477584|FG021|Epoch 3|Withdrawal by Subject|0|||
23473349|NCT02059291|65477585|FG022|Epoch 3|Withdrawal by Subject|0|||
23473350|NCT02059291|65477586|FG023|Epoch 3|Withdrawal by Subject|0|||
23473351|NCT02059291|65477587|FG024|Epoch 3|Withdrawal by Subject|0|||
23473352|NCT02059291|65477563|FG000|Epoch 4|Adverse Event|0|||
23473353|NCT02059291|65477564|FG001|Epoch 4|Adverse Event|0|||
23473354|NCT02059291|65477565|FG002|Epoch 4|Adverse Event|0|||
23473355|NCT02059291|65477566|FG003|Epoch 4|Adverse Event|0|||
23473356|NCT02059291|65477567|FG004|Epoch 4|Adverse Event|0|||
23473357|NCT02059291|65477568|FG005|Epoch 4|Adverse Event|0|||
23473358|NCT02059291|65477569|FG006|Epoch 4|Adverse Event|0|||
23473359|NCT02059291|65477570|FG007|Epoch 4|Adverse Event|0|||
23796559|NCT03203642|66633014|FG001|Overall Study|Termination of the study by sponsor|1|||
23796560|NCT03203642|66633013|FG000|Overall Study|Participant moved|0|||
23796561|NCT03203642|66633014|FG001|Overall Study|Participant moved|1|||
23796562|NCT03203642|66633013|FG000|Overall Study|Investigator's decision|3|||
23796563|NCT03203642|66633014|FG001|Overall Study|Investigator's decision|0|||
23796564|NCT03203642|66633013|FG000|Overall Study|Other than above specified|0|||
23796565|NCT03203642|66633014|FG001|Overall Study|Other than above specified|1|||
23796566|NCT00220727|66633017|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
23796567|NCT00220727|66633018|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
23796568|NCT01142661|66633021|FG000|Overall Study|Adverse Event|2|||
23796569|NCT01142661|66633021|FG000|Overall Study|Withdrawal by Subject|1|||
23796570|NCT01142661|66633021|FG000|Overall Study|Physician Decision|1|||
23473360|NCT02059291|65477571|FG008|Epoch 4|Adverse Event|0|||
23473361|NCT02059291|65477572|FG009|Epoch 4|Adverse Event|0|||
23473362|NCT02059291|65477573|FG010|Epoch 4|Adverse Event|0|||
23473363|NCT02059291|65477574|FG011|Epoch 4|Adverse Event|0|||
23473364|NCT02059291|65477575|FG012|Epoch 4|Adverse Event|0|||
23473365|NCT02059291|65477576|FG013|Epoch 4|Adverse Event|0|||
23473366|NCT02059291|65477577|FG014|Epoch 4|Adverse Event|0|||
23473367|NCT02059291|65477578|FG015|Epoch 4|Adverse Event|0|||
23473368|NCT02059291|65477579|FG016|Epoch 4|Adverse Event|1|||
23473369|NCT02059291|65477580|FG017|Epoch 4|Adverse Event|0|||
23473370|NCT02059291|65477581|FG018|Epoch 4|Adverse Event|0|||
23473371|NCT02059291|65477582|FG019|Epoch 4|Adverse Event|0|||
23473372|NCT02059291|65477583|FG020|Epoch 4|Adverse Event|0|||
23473373|NCT02059291|65477584|FG021|Epoch 4|Adverse Event|0|||
23473374|NCT02059291|65477585|FG022|Epoch 4|Adverse Event|1|||
23473375|NCT02059291|65477586|FG023|Epoch 4|Adverse Event|0|||
23473376|NCT02059291|65477587|FG024|Epoch 4|Adverse Event|0|||
23796571|NCT00756717|66633022|FG000|Overall Study|Withdrawal by Subject|2|||
23473377|NCT02059291|65477563|FG000|Epoch 4|Pregnancy|0|||
23473378|NCT02059291|65477564|FG001|Epoch 4|Pregnancy|0|||
23473379|NCT02059291|65477565|FG002|Epoch 4|Pregnancy|0|||
23473380|NCT02059291|65477566|FG003|Epoch 4|Pregnancy|0|||
23473381|NCT02059291|65477567|FG004|Epoch 4|Pregnancy|0|||
23473382|NCT02059291|65477568|FG005|Epoch 4|Pregnancy|0|||
23473383|NCT02059291|65477569|FG006|Epoch 4|Pregnancy|0|||
23473384|NCT02059291|65477570|FG007|Epoch 4|Pregnancy|0|||
23473385|NCT02059291|65477571|FG008|Epoch 4|Pregnancy|0|||
23473386|NCT02059291|65477572|FG009|Epoch 4|Pregnancy|0|||
23473387|NCT02059291|65477573|FG010|Epoch 4|Pregnancy|0|||
23588860|NCT01393119|65882229|FG001|Overall Study|Sponsor Termination of Study|12|||
23706853|NCT00002663|66301339|FG000|Overall Study|Adverse Event|0|||
23796572|NCT02289820|66633025|FG000|Overall Study|Withdrawal by Subject|2|||
23473388|NCT02059291|65477574|FG011|Epoch 4|Pregnancy|0|||
23473389|NCT02059291|65477575|FG012|Epoch 4|Pregnancy|0|||
23473390|NCT02059291|65477576|FG013|Epoch 4|Pregnancy|0|||
23473391|NCT02059291|65477577|FG014|Epoch 4|Pregnancy|0|||
23473392|NCT02059291|65477578|FG015|Epoch 4|Pregnancy|0|||
23473393|NCT02059291|65477579|FG016|Epoch 4|Pregnancy|1|||
23473394|NCT02059291|65477580|FG017|Epoch 4|Pregnancy|0|||
23473395|NCT02059291|65477581|FG018|Epoch 4|Pregnancy|0|||
23473396|NCT02059291|65477582|FG019|Epoch 4|Pregnancy|0|||
23473397|NCT02059291|65477583|FG020|Epoch 4|Pregnancy|0|||
23473398|NCT02059291|65477584|FG021|Epoch 4|Pregnancy|0|||
23473399|NCT02059291|65477585|FG022|Epoch 4|Pregnancy|0|||
23473400|NCT02059291|65477586|FG023|Epoch 4|Pregnancy|0|||
23473401|NCT02059291|65477587|FG024|Epoch 4|Pregnancy|0|||
23473402|NCT02059291|65477563|FG000|Epoch 4|Withdrawal by Subject|0|||
23473403|NCT02059291|65477564|FG001|Epoch 4|Withdrawal by Subject|0|||
23473404|NCT02059291|65477565|FG002|Epoch 4|Withdrawal by Subject|0|||
23473405|NCT02059291|65477566|FG003|Epoch 4|Withdrawal by Subject|0|||
23473406|NCT02059291|65477567|FG004|Epoch 4|Withdrawal by Subject|0|||
23473407|NCT02059291|65477568|FG005|Epoch 4|Withdrawal by Subject|0|||
23473408|NCT02059291|65477569|FG006|Epoch 4|Withdrawal by Subject|0|||
23473409|NCT02059291|65477570|FG007|Epoch 4|Withdrawal by Subject|0|||
23473410|NCT02059291|65477571|FG008|Epoch 4|Withdrawal by Subject|0|||
23473411|NCT02059291|65477572|FG009|Epoch 4|Withdrawal by Subject|0|||
23473412|NCT02059291|65477573|FG010|Epoch 4|Withdrawal by Subject|0|||
23473413|NCT02059291|65477574|FG011|Epoch 4|Withdrawal by Subject|0|||
23473414|NCT02059291|65477575|FG012|Epoch 4|Withdrawal by Subject|0|||
23473415|NCT02059291|65477576|FG013|Epoch 4|Withdrawal by Subject|0|||
23473416|NCT02059291|65477577|FG014|Epoch 4|Withdrawal by Subject|0|||
23473417|NCT02059291|65477578|FG015|Epoch 4|Withdrawal by Subject|0|||
23473418|NCT02059291|65477579|FG016|Epoch 4|Withdrawal by Subject|0|||
23473419|NCT02059291|65477580|FG017|Epoch 4|Withdrawal by Subject|0|||
23473420|NCT02059291|65477581|FG018|Epoch 4|Withdrawal by Subject|0|||
23473421|NCT02059291|65477582|FG019|Epoch 4|Withdrawal by Subject|0|||
23473422|NCT02059291|65477583|FG020|Epoch 4|Withdrawal by Subject|1|||
23473423|NCT02059291|65477584|FG021|Epoch 4|Withdrawal by Subject|0|||
23473424|NCT02059291|65477585|FG022|Epoch 4|Withdrawal by Subject|0|||
23473425|NCT02059291|65477586|FG023|Epoch 4|Withdrawal by Subject|0|||
23473426|NCT02059291|65477587|FG024|Epoch 4|Withdrawal by Subject|0|||
23473427|NCT02059291|65477563|FG000|Epoch 4|Lack of Efficacy|0|||
23473428|NCT02059291|65477564|FG001|Epoch 4|Lack of Efficacy|0|||
23473429|NCT02059291|65477565|FG002|Epoch 4|Lack of Efficacy|0|||
23473430|NCT02059291|65477566|FG003|Epoch 4|Lack of Efficacy|0|||
23473431|NCT02059291|65477567|FG004|Epoch 4|Lack of Efficacy|0|||
23473432|NCT02059291|65477568|FG005|Epoch 4|Lack of Efficacy|0|||
23473433|NCT02059291|65477569|FG006|Epoch 4|Lack of Efficacy|0|||
23473434|NCT02059291|65477570|FG007|Epoch 4|Lack of Efficacy|0|||
23473435|NCT02059291|65477571|FG008|Epoch 4|Lack of Efficacy|0|||
23473436|NCT02059291|65477572|FG009|Epoch 4|Lack of Efficacy|0|||
23473437|NCT02059291|65477573|FG010|Epoch 4|Lack of Efficacy|0|||
23473438|NCT02059291|65477574|FG011|Epoch 4|Lack of Efficacy|0|||
23473439|NCT02059291|65477575|FG012|Epoch 4|Lack of Efficacy|0|||
23473440|NCT02059291|65477576|FG013|Epoch 4|Lack of Efficacy|0|||
23473441|NCT02059291|65477577|FG014|Epoch 4|Lack of Efficacy|0|||
23473442|NCT02059291|65477578|FG015|Epoch 4|Lack of Efficacy|0|||
23473443|NCT02059291|65477579|FG016|Epoch 4|Lack of Efficacy|0|||
23473444|NCT02059291|65477580|FG017|Epoch 4|Lack of Efficacy|0|||
23473445|NCT02059291|65477581|FG018|Epoch 4|Lack of Efficacy|0|||
23473446|NCT02059291|65477582|FG019|Epoch 4|Lack of Efficacy|0|||
23473447|NCT02059291|65477583|FG020|Epoch 4|Lack of Efficacy|0|||
23473448|NCT02059291|65477584|FG021|Epoch 4|Lack of Efficacy|0|||
23642137|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
23642138|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
23642139|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
23642140|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
23796573|NCT02289820|66633026|FG001|Overall Study|Withdrawal by Subject|1|||
23473449|NCT02059291|65477585|FG022|Epoch 4|Lack of Efficacy|0|||
23473450|NCT02059291|65477586|FG023|Epoch 4|Lack of Efficacy|1|||
23473451|NCT02059291|65477587|FG024|Epoch 4|Lack of Efficacy|0|||
23473452|NCT03865381|65477593|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
23473453|NCT03865381|65477593|FG000|Overall Study|Withdrawal by Subject|2|||
23473454|NCT01097005|65477596|FG000|Overall Study|Case Report Form not collected|18|||
23473455|NCT01097005|65477596|FG000|Overall Study|Subjects cannot visit the hospital|1|||
23473456|NCT01097005|65477596|FG000|Overall Study|Poor medication compliance|1|||
23473457|NCT01097005|65477596|FG000|Overall Study|No examination data available|244|||
23473458|NCT01097005|65477596|FG000|Overall Study|Deviation from exclusion criteria|37|||
23473459|NCT01097005|65477596|FG000|Overall Study|Adverse Event|14|||
23473460|NCT01097005|65477596|FG000|Overall Study|Discontinuance by complication|50|||
23473461|NCT03844945|65477597|FG000|Overall Study|Adverse Event|1|||
23473462|NCT03844945|65477598|FG001|Overall Study|Adverse Event|1|||
23473463|NCT03844945|65477599|FG002|Overall Study|Adverse Event|4|||
23473464|NCT03844945|65477600|FG003|Overall Study|Adverse Event|0|||
23473465|NCT03844945|65477597|FG000|Overall Study|Withdrawal by Subject|0|||
23473466|NCT03844945|65477598|FG001|Overall Study|Withdrawal by Subject|0|||
23473467|NCT03844945|65477599|FG002|Overall Study|Withdrawal by Subject|1|||
23473468|NCT03844945|65477600|FG003|Overall Study|Withdrawal by Subject|0|||
23473469|NCT03844945|65477597|FG000|Overall Study|Lack of Efficacy|0|||
23473470|NCT03844945|65477598|FG001|Overall Study|Lack of Efficacy|0|||
23473471|NCT03844945|65477599|FG002|Overall Study|Lack of Efficacy|0|||
23473472|NCT03844945|65477600|FG003|Overall Study|Lack of Efficacy|1|||
23473473|NCT00612807|65477601|FG000|Overall Study|Withdrawal by Subject|2|||
23473474|NCT00612807|65477602|FG001|Overall Study|Withdrawal by Subject|0|||
23473475|NCT00689117|65477603|FG000|Overall Study|Adverse Event|6|||
23473476|NCT00689117|65477604|FG001|Overall Study|Adverse Event|0|||
23473477|NCT00689117|65477605|FG002|Overall Study|Adverse Event|5|||
23473478|NCT00689117|65477606|FG003|Overall Study|Adverse Event|0|||
23473479|NCT00689117|65477603|FG000|Overall Study|Lost to Follow-up|26|||
23473480|NCT00689117|65477604|FG001|Overall Study|Lost to Follow-up|19|||
23473481|NCT00689117|65477605|FG002|Overall Study|Lost to Follow-up|17|||
23473482|NCT00689117|65477606|FG003|Overall Study|Lost to Follow-up|11|||
23473483|NCT00689117|65477603|FG000|Overall Study|Lack of Efficacy|1|||
23473484|NCT00689117|65477604|FG001|Overall Study|Lack of Efficacy|2|||
23473485|NCT00689117|65477605|FG002|Overall Study|Lack of Efficacy|2|||
23473486|NCT00689117|65477606|FG003|Overall Study|Lack of Efficacy|2|||
23473487|NCT00689117|65477603|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
23473488|NCT00689117|65477604|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
23473489|NCT00689117|65477605|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
23473490|NCT00689117|65477606|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
23473491|NCT00689117|65477603|FG000|Overall Study|Withdrawal by Subject|19|||
23473492|NCT00689117|65477604|FG001|Overall Study|Withdrawal by Subject|18|||
23473493|NCT00689117|65477605|FG002|Overall Study|Withdrawal by Subject|26|||
23473494|NCT00689117|65477606|FG003|Overall Study|Withdrawal by Subject|13|||
23473495|NCT00689117|65477603|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
23473496|NCT00689117|65477604|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
23473497|NCT00689117|65477605|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
23473498|NCT00689117|65477606|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
23473499|NCT00689117|65477603|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23473500|NCT00689117|65477604|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23473501|NCT00689117|65477605|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23473502|NCT00689117|65477606|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23473503|NCT00689117|65477603|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
23473504|NCT00689117|65477604|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
23473505|NCT00689117|65477605|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
23473506|NCT00689117|65477606|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
23473507|NCT00689117|65477603|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
23473508|NCT00689117|65477604|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
23473509|NCT00689117|65477605|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
23473510|NCT00689117|65477606|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
23473511|NCT00689117|65477603|FG000|Overall Study|Use of Prohibitive Medication|2|||
23473512|NCT00689117|65477604|FG001|Overall Study|Use of Prohibitive Medication|1|||
23473513|NCT00689117|65477605|FG002|Overall Study|Use of Prohibitive Medication|3|||
23473514|NCT00689117|65477606|FG003|Overall Study|Use of Prohibitive Medication|0|||
23473515|NCT00689117|65477603|FG000|Overall Study|Pregnancy|0|||
23588861|NCT01393119|65882230|FG002|Overall Study|Sponsor Termination of Study|9|||
23796574|NCT02289820|66633027|FG002|Overall Study|Withdrawal by Subject|2|||
23796575|NCT02289820|66633028|FG003|Overall Study|Withdrawal by Subject|1|||
23796576|NCT02289820|66633029|FG004|Overall Study|Withdrawal by Subject|0|||
23796577|NCT02289820|66633030|FG005|Overall Study|Withdrawal by Subject|0|||
23796578|NCT02289820|66633031|FG006|Overall Study|Withdrawal by Subject|1|||
23796579|NCT02289820|66633025|FG000|Overall Study|Death|0|||
23796580|NCT02289820|66633026|FG001|Overall Study|Death|0|||
23796581|NCT02289820|66633027|FG002|Overall Study|Death|1|||
23796582|NCT02289820|66633028|FG003|Overall Study|Death|0|||
23796583|NCT02289820|66633029|FG004|Overall Study|Death|0|||
23796584|NCT02289820|66633030|FG005|Overall Study|Death|0|||
23796585|NCT02289820|66633031|FG006|Overall Study|Death|0|||
23796586|NCT02289820|66633025|FG000|Overall Study|Lost to Follow-up|0|||
23796587|NCT02289820|66633026|FG001|Overall Study|Lost to Follow-up|0|||
23473516|NCT00689117|65477604|FG001|Overall Study|Pregnancy|2|||
23473517|NCT00689117|65477605|FG002|Overall Study|Pregnancy|0|||
23473518|NCT00689117|65477606|FG003|Overall Study|Pregnancy|2|||
23473519|NCT00689117|65477603|FG000|Overall Study|Incarceration|2|||
23473520|NCT00689117|65477604|FG001|Overall Study|Incarceration|0|||
23473521|NCT00689117|65477605|FG002|Overall Study|Incarceration|0|||
23473522|NCT00689117|65477606|FG003|Overall Study|Incarceration|0|||
23473523|NCT00689117|65477603|FG000|Overall Study|Fear of Birth Defects|0|||
23473524|NCT00689117|65477604|FG001|Overall Study|Fear of Birth Defects|0|||
23796588|NCT02289820|66633027|FG002|Overall Study|Lost to Follow-up|3|||
23796589|NCT02289820|66633028|FG003|Overall Study|Lost to Follow-up|1|||
23796590|NCT02289820|66633029|FG004|Overall Study|Lost to Follow-up|0|||
23796591|NCT02289820|66633030|FG005|Overall Study|Lost to Follow-up|1|||
23796592|NCT02289820|66633031|FG006|Overall Study|Lost to Follow-up|1|||
23796593|NCT02289820|66633025|FG000|Overall Study|withdrawal of consent|0|||
23473525|NCT00689117|65477605|FG002|Overall Study|Fear of Birth Defects|1|||
23473526|NCT00689117|65477606|FG003|Overall Study|Fear of Birth Defects|0|||
23473527|NCT00689117|65477603|FG000|Overall Study|Transportation|1|||
23473528|NCT00689117|65477604|FG001|Overall Study|Transportation|0|||
23473529|NCT00689117|65477605|FG002|Overall Study|Transportation|0|||
23473530|NCT00689117|65477606|FG003|Overall Study|Transportation|0|||
23473531|NCT00689117|65477603|FG000|Overall Study|Patient Withdrew from Study|0|||
23473532|NCT00689117|65477604|FG001|Overall Study|Patient Withdrew from Study|0|||
23473533|NCT00689117|65477605|FG002|Overall Study|Patient Withdrew from Study|0|||
23473534|NCT00689117|65477606|FG003|Overall Study|Patient Withdrew from Study|1|||
23473535|NCT00689117|65477603|FG000|Overall Study|Personal Reason|0|||
23473536|NCT00689117|65477604|FG001|Overall Study|Personal Reason|1|||
23473537|NCT00689117|65477605|FG002|Overall Study|Personal Reason|0|||
23473538|NCT00689117|65477606|FG003|Overall Study|Personal Reason|0|||
23473539|NCT00689117|65477603|FG000|Overall Study|Dispensing Error|0|||
23473540|NCT00689117|65477604|FG001|Overall Study|Dispensing Error|1|||
23473541|NCT00689117|65477605|FG002|Overall Study|Dispensing Error|0|||
23473542|NCT00689117|65477606|FG003|Overall Study|Dispensing Error|0|||
23473543|NCT04605991|65477607|FG000|Overall Study|Adverse Event|5|||
23473544|NCT04605991|65477607|FG000|Overall Study|Lack of Efficacy|1|||
23473545|NCT04605991|65477607|FG000|Overall Study|Lost to Follow-up|8|||
23473546|NCT04605991|65477607|FG000|Overall Study|Physician Decision|4|||
23473547|NCT04605991|65477607|FG000|Overall Study|Withdrawal by Subject|14|||
23473548|NCT04605991|65477607|FG000|Overall Study|Non-compliance with study|1|||
23473549|NCT02873429|65477608|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
23473550|NCT02873429|65477609|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
23473551|NCT02873429|65477608|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
23473552|NCT02873429|65477609|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
23473553|NCT02873429|65477608|FG000|16 Weeks|Lost to Follow-up|3|||
23473554|NCT02873429|65477609|FG001|16 Weeks|Lost to Follow-up|0|||
23473555|NCT01932437|65477611|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473556|NCT01932437|65477612|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473557|NCT01932437|65477613|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473558|NCT01932437|65477614|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473559|NCT01932437|65477615|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473560|NCT01932437|65477616|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
23473561|NCT00096356|65477620|FG000|Overall Study|Adverse Event|11|||
23473562|NCT00096356|65477621|FG001|Overall Study|Adverse Event|9|||
23473563|NCT00096356|65477620|FG000|Overall Study|Physician Decision|5|||
23473564|NCT00096356|65477621|FG001|Overall Study|Physician Decision|3|||
23473565|NCT00096356|65477620|FG000|Overall Study|Withdrawal by Subject|17|||
23473566|NCT00096356|65477621|FG001|Overall Study|Withdrawal by Subject|23|||
23473567|NCT00096356|65477620|FG000|Overall Study|Lack of Efficacy|1|||
23473568|NCT00096356|65477621|FG001|Overall Study|Lack of Efficacy|0|||
23473569|NCT00096356|65477620|FG000|Overall Study|multiple reasons|10|||
23473570|NCT00096356|65477621|FG001|Overall Study|multiple reasons|18|||
23473571|NCT00715910|65477623|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
23473572|NCT00715910|65477624|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
23473573|NCT00715910|65477625|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
23473574|NCT00715910|65477626|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
23473575|NCT00715910|65477627|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
23473576|NCT00715910|65477628|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
23473577|NCT00715910|65477623|FG000|Booster and ESFU Phase|Other|0|||
23642141|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
23642142|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
23642143|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
23642144|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
23473578|NCT00715910|65477624|FG001|Booster and ESFU Phase|Other|0|||
23473579|NCT00715910|65477625|FG002|Booster and ESFU Phase|Other|0|||
23473580|NCT00715910|65477626|FG003|Booster and ESFU Phase|Other|5|||
23473581|NCT00715910|65477627|FG004|Booster and ESFU Phase|Other|1|||
23473582|NCT00715910|65477628|FG005|Booster and ESFU Phase|Other|0|||
23473583|NCT01596062|65477632|FG000|Overall Study|Adverse Event|1|||
23473584|NCT01596062|65477633|FG001|Overall Study|Adverse Event|0|||
23473585|NCT01596062|65477634|FG002|Overall Study|Adverse Event|2|||
23473586|NCT01596062|65477632|FG000|Overall Study|Lack of Efficacy|0|||
23473587|NCT01596062|65477633|FG001|Overall Study|Lack of Efficacy|0|||
23473588|NCT01596062|65477634|FG002|Overall Study|Lack of Efficacy|1|||
23473589|NCT00486811|65477635|FG000|Overall Study|Adverse Event|28|||
23473590|NCT00486811|65477636|FG001|Overall Study|Adverse Event|60|||
23642145|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
23642146|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
23642147|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
23642148|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
23642149|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
23473591|NCT00486811|65477637|FG002|Overall Study|Adverse Event|135|||
23473592|NCT00486811|65477635|FG000|Overall Study|Lack of Efficacy|34|||
23473593|NCT00486811|65477636|FG001|Overall Study|Lack of Efficacy|14|||
23642150|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
23796594|NCT02289820|66633026|FG001|Overall Study|withdrawal of consent|1|||
23796595|NCT02289820|66633027|FG002|Overall Study|withdrawal of consent|0|||
23796596|NCT02289820|66633028|FG003|Overall Study|withdrawal of consent|0|||
23796597|NCT02289820|66633029|FG004|Overall Study|withdrawal of consent|0|||
23796598|NCT02289820|66633030|FG005|Overall Study|withdrawal of consent|0|||
23796599|NCT02289820|66633031|FG006|Overall Study|withdrawal of consent|0|||
23796600|NCT02224053|66633032|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
23796601|NCT02224053|66633032|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
23796602|NCT02224053|66633032|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
23473594|NCT00486811|65477637|FG002|Overall Study|Lack of Efficacy|7|||
23473595|NCT00486811|65477635|FG000|Overall Study|Lost to Follow-up|4|||
23473596|NCT00486811|65477636|FG001|Overall Study|Lost to Follow-up|6|||
23473597|NCT00486811|65477637|FG002|Overall Study|Lost to Follow-up|4|||
23473598|NCT00486811|65477635|FG000|Overall Study|Withdrawal by Subject|33|||
23796603|NCT02224053|66633032|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
23796604|NCT02224053|66633032|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
23796605|NCT01849458|66633033|FG000|Overall Study|Lost to Follow-up|4|||
23796606|NCT01098851|66633037|FG000|Overall Study|Equipment failure|1|||
23473599|NCT00486811|65477636|FG001|Overall Study|Withdrawal by Subject|44|||
23473600|NCT00486811|65477637|FG002|Overall Study|Withdrawal by Subject|58|||
23473601|NCT00486811|65477635|FG000|Overall Study|Study drug non-compliant|5|||
23473602|NCT00486811|65477636|FG001|Overall Study|Study drug non-compliant|6|||
23473603|NCT00486811|65477637|FG002|Overall Study|Study drug non-compliant|3|||
23473604|NCT00486811|65477635|FG000|Overall Study|All other|18|||
23473605|NCT00486811|65477636|FG001|Overall Study|All other|11|||
23473606|NCT00486811|65477637|FG002|Overall Study|All other|7|||
23473607|NCT01808092|65477642|FG000|Overall Study|Death|39|||
23473608|NCT01808092|65477643|FG001|Overall Study|Death|29|||
23473609|NCT01808092|65477642|FG000|Overall Study|Lost to Follow-up|3|||
23473610|NCT01808092|65477643|FG001|Overall Study|Lost to Follow-up|7|||
23473611|NCT01808092|65477642|FG000|Overall Study|Withdrawal by Subject|9|||
23473612|NCT01808092|65477643|FG001|Overall Study|Withdrawal by Subject|4|||
23473613|NCT01808092|65477642|FG000|Overall Study|Other Eligibility criteria|3|||
23473614|NCT01808092|65477643|FG001|Overall Study|Other Eligibility criteria|5|||
23473615|NCT02102204|65477644|FG000|Overall Study|Withdrawal by Subject|137|||
23473616|NCT02102204|65477644|FG000|Overall Study|Death|92|||
23473617|NCT02102204|65477644|FG000|Overall Study|Lost to Follow-up|65|||
23473618|NCT02102204|65477644|FG000|Overall Study|Sponsor Decision|5|||
23473619|NCT02102204|65477644|FG000|Overall Study|Ongoing|5|||
23473620|NCT00955305|65477646|FG000|Overall Study|Disease progression|39|||
23473621|NCT00955305|65477647|FG001|Overall Study|Disease progression|41|||
23473622|NCT00955305|65477646|FG000|Overall Study|Adverse Event|22|||
23473623|NCT00955305|65477647|FG001|Overall Study|Adverse Event|22|||
23473624|NCT00955305|65477646|FG000|Overall Study|Death|2|||
23588862|NCT01393119|65882231|FG003|Overall Study|Sponsor Termination of Study|12|||
23588863|NCT05136443|65882236|FG000|Overall Study|Lost to Follow-up|2|||
23588864|NCT05136443|65882236|FG000|Overall Study|Adverse Event|2|||
23588865|NCT02248480|65882240|FG000|Overall Study|Lack of Efficacy|4|||
23588866|NCT02248480|65882241|FG001|Overall Study|Lack of Efficacy|6|||
23588867|NCT02248480|65882240|FG000|Overall Study|Adverse Event|11|||
23588868|NCT02248480|65882241|FG001|Overall Study|Adverse Event|2|||
23588869|NCT02248480|65882240|FG000|Overall Study|Withdrawal by Subject|2|||
23588870|NCT02248480|65882241|FG001|Overall Study|Withdrawal by Subject|4|||
23588871|NCT02248480|65882240|FG000|Overall Study|Entry Criteria Not Met|0|||
23588872|NCT02248480|65882241|FG001|Overall Study|Entry Criteria Not Met|1|||
23588873|NCT02248480|65882240|FG000|Overall Study|Other:Physician Decision|0|||
23473625|NCT00955305|65477647|FG001|Overall Study|Death|1|||
23473626|NCT00955305|65477646|FG000|Overall Study|Withdrawal by Subject|5|||
23473627|NCT00955305|65477647|FG001|Overall Study|Withdrawal by Subject|4|||
23473628|NCT00955305|65477646|FG000|Overall Study|Alternative therapy|4|||
23473629|NCT00955305|65477647|FG001|Overall Study|Alternative therapy|0|||
23473630|NCT00955305|65477646|FG000|Overall Study|Other complicating disease|2|||
23473631|NCT00955305|65477647|FG001|Overall Study|Other complicating disease|4|||
23588874|NCT02248480|65882241|FG001|Overall Study|Other:Physician Decision|1|||
23588875|NCT02770248|65882242|FG000|Overall Study|Adverse Event|0|||
23473632|NCT00955305|65477646|FG000|Overall Study|Physician Decision|1|||
23473633|NCT00955305|65477647|FG001|Overall Study|Physician Decision|0|||
23473634|NCT00955305|65477646|FG000|Overall Study|Continued presence of residual disease|0|||
23796607|NCT01098851|66633038|FG001|Overall Study|Equipment failure|0|||
23796608|NCT01908205|66633039|FG000|Overall Study|Lost to Follow-up|2|||
23796609|NCT01908205|66633040|FG001|Overall Study|Lost to Follow-up|0|||
23796610|NCT01908205|66633039|FG000|Overall Study|Withdrawal by Subject|3|||
23796611|NCT01908205|66633040|FG001|Overall Study|Withdrawal by Subject|1|||
23796612|NCT00380588|66633041|FG000|Overall Study|Unequivocal Disease Progression|25|||
23642151|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
23642152|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
23642153|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
23642154|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
23642155|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
23642156|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
23642157|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
23642158|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
23642159|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
23642160|NCT03412747|66075304|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
23642161|NCT03412747|66075305|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
23642162|NCT03412747|66075306|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
23642163|NCT00006011|66075312|FG000|Overall Study|Disease progression|13|||
23642164|NCT00006011|66075313|FG001|Overall Study|Disease progression|6|||
23642165|NCT00006011|66075314|FG002|Overall Study|Disease progression|26|||
23642166|NCT00006011|66075312|FG000|Overall Study|Refused further treatment|15|||
23642167|NCT00006011|66075313|FG001|Overall Study|Refused further treatment|13|||
23642168|NCT00006011|66075314|FG002|Overall Study|Refused further treatment|26|||
23642169|NCT00006011|66075312|FG000|Overall Study|Adverse Event|15|||
23642170|NCT00006011|66075313|FG001|Overall Study|Adverse Event|39|||
23473635|NCT00955305|65477647|FG001|Overall Study|Continued presence of residual disease|1|||
23473636|NCT00955305|65477646|FG000|Overall Study|Functional decline|2|||
23473637|NCT00955305|65477647|FG001|Overall Study|Functional decline|0|||
23473638|NCT00955305|65477646|FG000|Overall Study|Maximum response achieved|0|||
23473639|NCT00955305|65477647|FG001|Overall Study|Maximum response achieved|1|||
23473640|NCT00955305|65477646|FG000|Overall Study|Lost to Follow-up|0|||
23473641|NCT00955305|65477647|FG001|Overall Study|Lost to Follow-up|1|||
23473642|NCT00955305|65477646|FG000|Overall Study|No off-treatment reason submitted|1|||
23642171|NCT00006011|66075314|FG002|Overall Study|Adverse Event|5|||
23642172|NCT00006011|66075312|FG000|Overall Study|Death|0|||
23796613|NCT00380588|66633042|FG001|Overall Study|Unequivocal Disease Progression|34|||
23796614|NCT00380588|66633041|FG000|Overall Study|Next Cycle Not Started|4|||
23796615|NCT00380588|66633042|FG001|Overall Study|Next Cycle Not Started|0|||
23796616|NCT00380588|66633041|FG000|Overall Study|Adverse Event|7|||
23796617|NCT00380588|66633042|FG001|Overall Study|Adverse Event|3|||
23796618|NCT00380588|66633041|FG000|Overall Study|Withdrawal by Subject|1|||
23796619|NCT00380588|66633042|FG001|Overall Study|Withdrawal by Subject|3|||
23796620|NCT00380588|66633041|FG000|Overall Study|Physician Decision|2|||
23796621|NCT00380588|66633042|FG001|Overall Study|Physician Decision|0|||
23796622|NCT01483625|66633043|FG000|Overall Study|Adverse Event|1|||
23796623|NCT01483625|66633044|FG001|Overall Study|Adverse Event|1|||
23796624|NCT01483625|66633043|FG000|Overall Study|Refused to continue medication|2|||
23796625|NCT01483625|66633044|FG001|Overall Study|Refused to continue medication|1|||
23473643|NCT00955305|65477647|FG001|Overall Study|No off-treatment reason submitted|0|||
23473644|NCT00955305|65477646|FG000|Overall Study|Never started protocol treatment|5|||
23473645|NCT00955305|65477647|FG001|Overall Study|Never started protocol treatment|5|||
23473646|NCT00955305|65477646|FG000|Overall Study|Ineligible|5|||
23473647|NCT00955305|65477647|FG001|Overall Study|Ineligible|7|||
23473648|NCT00702715|65477648|FG000|Overall Study|Lost to Follow-up|1|||
23473649|NCT00702715|65477649|FG001|Overall Study|Lost to Follow-up|0|||
23473650|NCT01546623|65477650|FG000|Overall Study|Adverse Event|2|||
23473651|NCT01546623|65477651|FG001|Overall Study|Adverse Event|3|||
23473652|NCT01546623|65477650|FG000|Overall Study|Major Protocol Deviation|1|||
23473653|NCT01546623|65477651|FG001|Overall Study|Major Protocol Deviation|1|||
23473654|NCT01546623|65477650|FG000|Overall Study|High Prostate specific antigen|2|||
23642173|NCT00006011|66075313|FG001|Overall Study|Death|1|||
23473655|NCT01546623|65477651|FG001|Overall Study|High Prostate specific antigen|1|||
23473656|NCT01546623|65477650|FG000|Overall Study|Did Not Receive Study Drug|1|||
23796626|NCT01483625|66633043|FG000|Overall Study|Due to other reason|1|||
23796627|NCT01483625|66633044|FG001|Overall Study|Due to other reason|0|||
23796628|NCT01463982|66633050|FG000|Overall Study|Withdrawal by Subject|0|||
23473657|NCT01546623|65477651|FG001|Overall Study|Did Not Receive Study Drug|1|||
23642174|NCT00006011|66075314|FG002|Overall Study|Death|2|||
23642175|NCT00006011|66075312|FG000|Overall Study|Other|4|||
23796629|NCT01463982|66633051|FG001|Overall Study|Withdrawal by Subject|1|||
23796630|NCT01463982|66633052|FG002|Overall Study|Withdrawal by Subject|1|||
23642176|NCT00006011|66075313|FG001|Overall Study|Other|2|||
23642177|NCT00006011|66075314|FG002|Overall Study|Other|5|||
23642178|NCT00006011|66075312|FG000|Overall Study|Ineligible|18|||
23642179|NCT00006011|66075313|FG001|Overall Study|Ineligible|16|||
23642180|NCT00006011|66075314|FG002|Overall Study|Ineligible|9|||
23642181|NCT01171807|66075317|FG000|Overall Study|Treatment failure|2|||
23642182|NCT01171807|66075318|FG001|Overall Study|Treatment failure|4|||
23642183|NCT01171807|66075317|FG000|Overall Study|Non compliance|1|||
23642184|NCT01171807|66075318|FG001|Overall Study|Non compliance|0|||
23642185|NCT01171807|66075317|FG000|Overall Study|Lost to Follow-up|3|||
23642186|NCT01171807|66075318|FG001|Overall Study|Lost to Follow-up|0|||
23642187|NCT01076153|66075321|FG000|Overall Study|Symptoms improved/resolved|10|||
23642188|NCT01076153|66075321|FG000|Overall Study|Adverse Event|1|||
23642189|NCT05180500|66075322|FG000|Overall Study|Adverse Event|1|||
23642190|NCT05180500|66075323|FG001|Overall Study|Adverse Event|0|||
23642191|NCT05180500|66075322|FG000|Overall Study|Withdrawal by Subject|2|||
23642192|NCT05180500|66075323|FG001|Overall Study|Withdrawal by Subject|0|||
23642193|NCT01200589|66075327|FG000|Overall Study|Withdrawal by Subject|13|||
23642194|NCT01200589|66075328|FG001|Overall Study|Withdrawal by Subject|11|||
23642195|NCT01200589|66075327|FG000|Overall Study|Physician Decision|2|||
23642196|NCT01200589|66075328|FG001|Overall Study|Physician Decision|2|||
23642197|NCT01200589|66075327|FG000|Overall Study|Lost to Follow-up|5|||
23642198|NCT01200589|66075328|FG001|Overall Study|Lost to Follow-up|4|||
23642199|NCT01200589|66075327|FG000|Overall Study|Study terminated|170|||
23473658|NCT00862641|65477654|FG000|Overall Study|Randomized, but drug not received|1|||
23473659|NCT00862641|65477655|FG001|Overall Study|Randomized, but drug not received|4|||
23473660|NCT00862641|65477656|FG002|Overall Study|Randomized, but drug not received|1|||
23473661|NCT00862641|65477657|FG003|Overall Study|Randomized, but drug not received|4|||
23473662|NCT00246740|65477660|FG000|Initial Enrollment|Death|1|||
23473663|NCT00246740|65477661|FG001|Initial Enrollment|Death|0|||
23473664|NCT00246740|65477660|FG000|Initial Enrollment|Additional surgery scheduled|0|||
23473665|NCT00246740|65477661|FG001|Initial Enrollment|Additional surgery scheduled|2|||
23473666|NCT00246740|65477660|FG000|Initial Enrollment|Surgery schedule change|4|||
23473667|NCT00246740|65477661|FG001|Initial Enrollment|Surgery schedule change|4|||
23473668|NCT00246740|65477660|FG000|Initial Enrollment|Other|1|||
23473669|NCT00246740|65477661|FG001|Initial Enrollment|Other|2|||
23473670|NCT02365480|65477662|FG000|Overall Study|Withdrawal by Subject|2|||
23473671|NCT02365480|65477663|FG001|Overall Study|Withdrawal by Subject|0|||
23473672|NCT01137604|65477666|FG000|Overall Study|Adverse Event|3|||
23473673|NCT01137604|65477667|FG001|Overall Study|Adverse Event|6|||
23473674|NCT01137604|65477668|FG002|Overall Study|Adverse Event|9|||
23473675|NCT01137604|65477669|FG003|Overall Study|Adverse Event|9|||
23473676|NCT01137604|65477666|FG000|Overall Study|Participant Choice|0|||
23473677|NCT01137604|65477667|FG001|Overall Study|Participant Choice|2|||
23473678|NCT01137604|65477668|FG002|Overall Study|Participant Choice|2|||
23473679|NCT01137604|65477669|FG003|Overall Study|Participant Choice|0|||
23473680|NCT01137604|65477666|FG000|Overall Study|Withdrawal of consent|0|||
23473681|NCT01137604|65477667|FG001|Overall Study|Withdrawal of consent|0|||
23473682|NCT01137604|65477668|FG002|Overall Study|Withdrawal of consent|0|||
23473683|NCT01137604|65477669|FG003|Overall Study|Withdrawal of consent|2|||
23473684|NCT01137604|65477666|FG000|Overall Study|Clinical progression/deterioration|1|||
23473685|NCT01137604|65477667|FG001|Overall Study|Clinical progression/deterioration|2|||
23473686|NCT01137604|65477668|FG002|Overall Study|Clinical progression/deterioration|2|||
23473687|NCT01137604|65477669|FG003|Overall Study|Clinical progression/deterioration|0|||
23473688|NCT01388985|65477672|FG000|Overall Study|Death|0|||
23473689|NCT01388985|65477673|FG001|Overall Study|Death|1|||
23473690|NCT01388985|65477672|FG000|Overall Study|Lost to Follow-up|30|||
23473691|NCT01388985|65477673|FG001|Overall Study|Lost to Follow-up|30|||
23642200|NCT01200589|66075328|FG001|Overall Study|Study terminated|172|||
23642201|NCT04371198|66075329|FG000|Overall Study|inadequate sample|4|||
23473692|NCT01388985|65477672|FG000|Overall Study|Withdrawal by Subject|13|||
23473693|NCT01388985|65477673|FG001|Overall Study|Withdrawal by Subject|4|||
23473694|NCT01388985|65477672|FG000|Overall Study|Subject unavailable|1|||
23473695|NCT01388985|65477673|FG001|Overall Study|Subject unavailable|1|||
23473696|NCT01388985|65477672|FG000|Overall Study|Other (no reason)|0|||
23473697|NCT01388985|65477673|FG001|Overall Study|Other (no reason)|1|||
23473698|NCT01388985|65477672|FG000|Overall Study|Error of nurse|5|||
23642202|NCT05132127|66075330|FG000|Overall Study|Adverse Event|1|||
23642203|NCT01850446|66075332|FG000|Overall Study|Lack of Efficacy|1|||
23642204|NCT01850446|66075333|FG001|Overall Study|Lack of Efficacy|0|||
23642205|NCT01850446|66075332|FG000|Overall Study|Withdrawal by Subject|4|||
23642206|NCT01850446|66075333|FG001|Overall Study|Withdrawal by Subject|0|||
23357136|NCT01687283|65052691|FG001|Overall Study|Adverse Event|4|||
23357137|NCT01687283|65052690|FG000|Overall Study|Lack of Efficacy|3|||
23357138|NCT01687283|65052691|FG001|Overall Study|Lack of Efficacy|1|||
23357139|NCT01687283|65052690|FG000|Overall Study|Protocol Violation|1|||
23357140|NCT01687283|65052691|FG001|Overall Study|Protocol Violation|3|||
23357141|NCT01687283|65052690|FG000|Overall Study|protocol defined stopping criteria|8|||
23357142|NCT01687283|65052691|FG001|Overall Study|protocol defined stopping criteria|10|||
23357143|NCT01687283|65052690|FG000|Overall Study|Lost to Follow-up|1|||
23357144|NCT01687283|65052691|FG001|Overall Study|Lost to Follow-up|1|||
23357145|NCT01687283|65052690|FG000|Overall Study|Investigator discretion|2|||
23357146|NCT01687283|65052691|FG001|Overall Study|Investigator discretion|0|||
23357147|NCT01687283|65052690|FG000|Overall Study|Withdrawal by Subject|9|||
23357148|NCT01687283|65052691|FG001|Overall Study|Withdrawal by Subject|8|||
23357149|NCT01148459|65052692|FG000|Overall Study|Serious Adverse Event|5|||
23357150|NCT01148459|65052693|FG001|Overall Study|Serious Adverse Event|4|||
23357151|NCT01148459|65052692|FG000|Overall Study|Withdrawal by Subject|1|||
23357152|NCT01148459|65052693|FG001|Overall Study|Withdrawal by Subject|0|||
23357153|NCT01148459|65052692|FG000|Overall Study|Migrated/moved from study area|3|||
23357154|NCT01148459|65052693|FG001|Overall Study|Migrated/moved from study area|6|||
23357155|NCT01148459|65052692|FG000|Overall Study|Lost to Follow-up|2|||
23357156|NCT01148459|65052693|FG001|Overall Study|Lost to Follow-up|0|||
23357157|NCT01148459|65052692|FG000|Overall Study|Refusal|1|||
23357158|NCT01148459|65052693|FG001|Overall Study|Refusal|0|||
23357159|NCT01148459|65052692|FG000|Overall Study|Failure to comply with study procedures|0|||
23357160|NCT01148459|65052693|FG001|Overall Study|Failure to comply with study procedures|1|||
23357161|NCT00493311|65052702|FG000|Overall Study|Need for rescue medication|2|||
23357162|NCT00493311|65052703|FG001|Overall Study|Need for rescue medication|2|||
23357163|NCT04854057|65052704|FG000|Overall Study|Adverse Event|0|||
23357164|NCT04854057|65052705|FG001|Overall Study|Adverse Event|1|||
23357165|NCT03423147|65052706|FG000|Overall Study|Lost to Follow-up|5|||
23357166|NCT03423147|65052707|FG001|Overall Study|Lost to Follow-up|8|||
23357167|NCT03423147|65052706|FG000|Overall Study|Withdrawal by Subject|1|||
23357168|NCT03423147|65052707|FG001|Overall Study|Withdrawal by Subject|0|||
23357169|NCT03423147|65052706|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
23357170|NCT03423147|65052707|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
23357171|NCT03423147|65052706|FG000|Overall Study|Age < 18|1|||
23357172|NCT03423147|65052707|FG001|Overall Study|Age < 18|0|||
23357173|NCT03423147|65052706|FG000|Overall Study|No Trial of Labor|0|||
23357174|NCT03423147|65052707|FG001|Overall Study|No Trial of Labor|1|||
23473699|NCT01388985|65477673|FG001|Overall Study|Error of nurse|1|||
23473700|NCT01134705|65477674|FG000|Overall Study|Adverse Event|1|||
23796631|NCT01463982|66633053|FG003|Overall Study|Withdrawal by Subject|0|||
23796632|NCT01463982|66633050|FG000|Overall Study|Treatment delay over 5 week|0|||
23796633|NCT01463982|66633051|FG001|Overall Study|Treatment delay over 5 week|0|||
23796634|NCT01463982|66633052|FG002|Overall Study|Treatment delay over 5 week|1|||
23796635|NCT01463982|66633053|FG003|Overall Study|Treatment delay over 5 week|0|||
23796636|NCT00263887|66633056|FG000|Overall Study|Withdrawal by Subject|1|||
23796637|NCT00263887|66633057|FG001|Overall Study|Withdrawal by Subject|1|||
23796638|NCT00263887|66633056|FG000|Overall Study|Lung transplantation|1|||
23796639|NCT00263887|66633057|FG001|Overall Study|Lung transplantation|2|||
23796640|NCT00263887|66633056|FG000|Overall Study|Too ill to attend visit|1|||
23796641|NCT00263887|66633057|FG001|Overall Study|Too ill to attend visit|0|||
23796642|NCT00263887|66633056|FG000|Overall Study|Adverse Event|0|||
23796643|NCT00263887|66633057|FG001|Overall Study|Adverse Event|2|||
23796644|NCT00263887|66633056|FG000|Overall Study|Disease progression|0|||
23796645|NCT00263887|66633057|FG001|Overall Study|Disease progression|1|||
23796646|NCT00263887|66633056|FG000|Overall Study|Lack of Efficacy|0|||
23796647|NCT00263887|66633057|FG001|Overall Study|Lack of Efficacy|1|||
23796648|NCT03941834|66633058|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
23796649|NCT03941834|66633059|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
23796650|NCT03941834|66633060|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
23796651|NCT03941834|66633058|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
23796652|NCT03941834|66633059|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
23796653|NCT03941834|66633060|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
23796654|NCT03941834|66633058|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
23473701|NCT01134705|65477675|FG001|Overall Study|Adverse Event|7|||
23796655|NCT03941834|66633059|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
23796656|NCT03941834|66633060|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
23796657|NCT03941834|66633058|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
23796658|NCT03941834|66633059|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
23796659|NCT03941834|66633060|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
23357175|NCT00069823|65052712|FG000|Overall Study|Did not have follow-up diary cards|6|||
23357176|NCT00069823|65052713|FG001|Overall Study|Did not have follow-up diary cards|3|||
23357177|NCT01370616|65052714|FG000|Overall Study|Adverse Event|11|||
23357178|NCT01370616|65052715|FG001|Overall Study|Adverse Event|16|||
23642207|NCT01850446|66075332|FG000|Overall Study|Protocol Violation|0|||
23588876|NCT02770248|65882243|FG001|Overall Study|Adverse Event|1|||
23357179|NCT01370616|65052714|FG000|Overall Study|Death|1|||
23357180|NCT01370616|65052715|FG001|Overall Study|Death|0|||
23357181|NCT01370616|65052714|FG000|Overall Study|Lack of Efficacy|6|||
23357182|NCT01370616|65052715|FG001|Overall Study|Lack of Efficacy|2|||
23357183|NCT01370616|65052714|FG000|Overall Study|Lost to Follow-up|0|||
23357184|NCT01370616|65052715|FG001|Overall Study|Lost to Follow-up|3|||
23357185|NCT01370616|65052714|FG000|Overall Study|Physician Decision|6|||
23357186|NCT01370616|65052715|FG001|Overall Study|Physician Decision|6|||
23357187|NCT01370616|65052714|FG000|Overall Study|Progressive Disease|0|||
23357188|NCT01370616|65052715|FG001|Overall Study|Progressive Disease|1|||
23357189|NCT01370616|65052714|FG000|Overall Study|Recovery|1|||
23357190|NCT01370616|65052715|FG001|Overall Study|Recovery|0|||
23357191|NCT01370616|65052714|FG000|Overall Study|Technical Problems|3|||
23357192|NCT01370616|65052715|FG001|Overall Study|Technical Problems|5|||
23357193|NCT01370616|65052714|FG000|Overall Study|Withdrawal by Subject|34|||
23357194|NCT01370616|65052715|FG001|Overall Study|Withdrawal by Subject|34|||
23357195|NCT02020512|65052717|FG000|Overall Study|Adverse Event|1|||
23357196|NCT02020512|65052717|FG000|Overall Study|Lost to Follow-up|3|||
23357197|NCT02020512|65052717|FG000|Overall Study|Protocol Violation|4|||
23357198|NCT02933528|65052718|FG000|Overall Study|Lost to Follow-up|2|||
23357199|NCT03628716|65052719|FG000|Overall Study|Adverse Event|1|||
23357200|NCT03628716|65052720|FG001|Overall Study|Adverse Event|1|||
23357201|NCT03628716|65052719|FG000|Overall Study|Death|1|||
23357202|NCT03628716|65052720|FG001|Overall Study|Death|0|||
23357203|NCT03628716|65052719|FG000|Overall Study|Lack of Efficacy|15|||
23357204|NCT03628716|65052720|FG001|Overall Study|Lack of Efficacy|20|||
23357205|NCT03628716|65052719|FG000|Overall Study|Withdrawal by Subject|1|||
23357206|NCT03628716|65052720|FG001|Overall Study|Withdrawal by Subject|2|||
23588877|NCT02770248|65882242|FG000|Overall Study|Randomized in error, prior to treatment|0|||
23588878|NCT02770248|65882243|FG001|Overall Study|Randomized in error, prior to treatment|1|||
23588879|NCT03993392|65882249|FG000|Overall Study|Withdrawal by Subject|3|||
23588880|NCT03993392|65882249|FG000|Overall Study|Lost to Follow-up|2|||
23588881|NCT03993392|65882249|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
23588882|NCT01183780|65882253|FG000|Overall Study|Withdrawal by Subject|25|||
23588883|NCT01183780|65882254|FG001|Overall Study|Withdrawal by Subject|14|||
23588884|NCT01183780|65882253|FG000|Overall Study|Lost to Follow-up|6|||
23588885|NCT01183780|65882254|FG001|Overall Study|Lost to Follow-up|11|||
23588886|NCT01196429|65882255|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23588887|NCT01196429|65882256|FG001|Overall Study|Ineligible - inadequate pathology|0|||
23588888|NCT01196429|65882255|FG000|Overall Study|Ineligible - wrong cell type|1|||
23796660|NCT03941834|66633058|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
23796661|NCT03941834|66633059|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
23588889|NCT01196429|65882256|FG001|Overall Study|Ineligible - wrong cell type|0|||
23642208|NCT01850446|66075333|FG001|Overall Study|Protocol Violation|2|||
23796662|NCT03941834|66633060|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
23796663|NCT03941834|66633058|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
23796664|NCT03941834|66633059|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
23796665|NCT03941834|66633060|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
23796666|NCT01917084|66633061|FG000|Overall Study|Withdrawal by Subject|1|||
23796667|NCT01029392|66633066|FG000|Overall Study|Withdrawal by Subject|18|||
23796668|NCT01029392|66633067|FG001|Overall Study|Withdrawal by Subject|11|||
23796669|NCT01029392|66633066|FG000|Overall Study|Physician Decision|2|||
23796670|NCT01029392|66633067|FG001|Overall Study|Physician Decision|0|||
23796671|NCT01588548|66633068|FG000|Overall Study|Withdrawal by Subject|0|||
23796672|NCT01588548|66633069|FG001|Overall Study|Withdrawal by Subject|1|||
23796673|NCT01588548|66633070|FG002|Overall Study|Withdrawal by Subject|1|||
23796674|NCT01588548|66633071|FG003|Overall Study|Withdrawal by Subject|1|||
23796675|NCT01588548|66633072|FG004|Overall Study|Withdrawal by Subject|2|||
23796676|NCT01588548|66633073|FG005|Overall Study|Withdrawal by Subject|3|||
23357207|NCT03628716|65052719|FG000|Overall Study|Study Terminated by Sponsor|1|||
23357208|NCT03628716|65052720|FG001|Overall Study|Study Terminated by Sponsor|0|||
23796677|NCT01588548|66633068|FG000|Overall Study|Adverse Event|0|||
23796678|NCT01588548|66633069|FG001|Overall Study|Adverse Event|0|||
23796679|NCT01588548|66633070|FG002|Overall Study|Adverse Event|1|||
23796680|NCT01588548|66633071|FG003|Overall Study|Adverse Event|2|||
23357209|NCT01502956|65052722|FG000|Overall Study|Death|0|||
23357210|NCT01502956|65052723|FG001|Overall Study|Death|2|||
23357211|NCT01502956|65052722|FG000|Overall Study|Lost to Follow-up|14|||
23357212|NCT01502956|65052723|FG001|Overall Study|Lost to Follow-up|11|||
23357213|NCT01502956|65052722|FG000|Overall Study|Physician Decision|2|||
23642209|NCT03527550|66075334|FG000|Overall Study|Lost to Follow-up|4|||
23642210|NCT03527550|66075335|FG001|Overall Study|Lost to Follow-up|2|||
23642211|NCT03527550|66075334|FG000|Overall Study|Withdrawal by Subject|4|||
23642212|NCT03527550|66075335|FG001|Overall Study|Withdrawal by Subject|1|||
23642213|NCT03527550|66075334|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
23642214|NCT03527550|66075335|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
23642215|NCT01737827|66075337|FG000|Overall Study|Adverse Event|3|||
23642216|NCT01737827|66075338|FG001|Overall Study|Adverse Event|6|||
23642217|NCT01737827|66075339|FG002|Overall Study|Adverse Event|0|||
23642218|NCT01737827|66075337|FG000|Overall Study|Lost to Follow-up|0|||
23642219|NCT01737827|66075338|FG001|Overall Study|Lost to Follow-up|1|||
23642220|NCT01737827|66075339|FG002|Overall Study|Lost to Follow-up|0|||
23642221|NCT01737827|66075337|FG000|Overall Study|Physician Decision|0|||
23642222|NCT01737827|66075338|FG001|Overall Study|Physician Decision|2|||
23796681|NCT01588548|66633072|FG004|Overall Study|Adverse Event|1|||
23796682|NCT01588548|66633073|FG005|Overall Study|Adverse Event|0|||
23796683|NCT01588548|66633068|FG000|Overall Study|Condition Under Investigation Worsened|3|||
23796684|NCT01588548|66633069|FG001|Overall Study|Condition Under Investigation Worsened|6|||
23357214|NCT01502956|65052723|FG001|Overall Study|Physician Decision|3|||
23357215|NCT01502956|65052722|FG000|Overall Study|Withdrawal by Subject|8|||
23357216|NCT01502956|65052723|FG001|Overall Study|Withdrawal by Subject|10|||
23796685|NCT01588548|66633070|FG002|Overall Study|Condition Under Investigation Worsened|4|||
23796686|NCT01588548|66633071|FG003|Overall Study|Condition Under Investigation Worsened|4|||
23796687|NCT01588548|66633072|FG004|Overall Study|Condition Under Investigation Worsened|3|||
23357217|NCT05114564|65052724|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
23357218|NCT05114564|65052725|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
23357219|NCT05114564|65052724|FG000|First Intervention|Adverse Event|0|||
23588890|NCT01196429|65882255|FG000|Overall Study|Refused - Never Treated|1|||
23588891|NCT01196429|65882256|FG001|Overall Study|Refused - Never Treated|0|||
23642223|NCT01737827|66075339|FG002|Overall Study|Physician Decision|0|||
23642224|NCT01737827|66075337|FG000|Overall Study|Progressive Disease|5|||
23642225|NCT01737827|66075338|FG001|Overall Study|Progressive Disease|16|||
23642226|NCT01737827|66075339|FG002|Overall Study|Progressive Disease|2|||
23642227|NCT01737827|66075337|FG000|Overall Study|Study Terminated by Sponsor|0|||
23642228|NCT01737827|66075338|FG001|Overall Study|Study Terminated by Sponsor|1|||
23642229|NCT01737827|66075339|FG002|Overall Study|Study Terminated by Sponsor|0|||
23642230|NCT01737827|66075337|FG000|Overall Study|Subject/Guardian Decision|0|||
23642231|NCT01737827|66075338|FG001|Overall Study|Subject/Guardian Decision|2|||
23642232|NCT01737827|66075339|FG002|Overall Study|Subject/Guardian Decision|0|||
23642233|NCT00189488|66075343|FG000|Overall Study|Ineligibility determined|1|||
23642234|NCT00189488|66075344|FG001|Overall Study|Ineligibility determined|0|||
23642235|NCT00189488|66075343|FG000|Overall Study|Protocol deviation|2|||
23642236|NCT00189488|66075344|FG001|Overall Study|Protocol deviation|1|||
23642237|NCT00189488|66075343|FG000|Overall Study|Adverse Event|2|||
23642238|NCT00189488|66075344|FG001|Overall Study|Adverse Event|1|||
23642239|NCT00189488|66075343|FG000|Overall Study|Withdrawal by Subject|2|||
23642240|NCT00189488|66075344|FG001|Overall Study|Withdrawal by Subject|6|||
23642241|NCT00189488|66075343|FG000|Overall Study|Disease progression|2|||
23588892|NCT01697319|65882257|FG000|Primary Phase|Withdrawal by Subject|1|||
23588893|NCT01697319|65882257|FG000|Extension Phase|Terminated by Sponsor|15|||
23588894|NCT01560949|65882258|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
23588895|NCT01560949|65882258|FG000|Surgery Phase|Physician Decision|3|||
23588896|NCT00880906|65882259|FG000|Overall Study|Lost to Follow-up|0|||
23588897|NCT00880906|65882260|FG001|Overall Study|Lost to Follow-up|1|||
23588898|NCT00880906|65882259|FG000|Overall Study|Did not meet criteria following patholog|12|||
23588899|NCT00880906|65882260|FG001|Overall Study|Did not meet criteria following patholog|6|||
23588900|NCT03181958|65882264|FG000|Overall Study|Lost to Follow-up|17|||
23588901|NCT03181958|65882265|FG001|Overall Study|Lost to Follow-up|21|||
23588902|NCT03181958|65882266|FG002|Overall Study|Lost to Follow-up|15|||
23588903|NCT03394027|65882267|FG000|Overall Study|Ineligible|3|||
23642242|NCT00189488|66075344|FG001|Overall Study|Disease progression|4|||
23642243|NCT00189488|66075343|FG000|Overall Study|Administrative Decision|0|||
23796688|NCT01588548|66633073|FG005|Overall Study|Condition Under Investigation Worsened|3|||
23796689|NCT02820740|66633076|FG000|Overall Study|Did not have procedure|2|||
23796690|NCT00726895|66633077|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23588904|NCT03394027|65882268|FG001|Overall Study|Ineligible|1|||
23642244|NCT00189488|66075344|FG001|Overall Study|Administrative Decision|2|||
23642245|NCT00189488|66075343|FG000|Overall Study|Death|5|||
23642246|NCT00189488|66075344|FG001|Overall Study|Death|8|||
23642247|NCT00189488|66075343|FG000|Overall Study|Other|1|||
23642248|NCT00189488|66075344|FG001|Overall Study|Other|0|||
23642249|NCT02233543|66075345|FG000|Period 1|Withdrawal by Subject|1|||
23357220|NCT05114564|65052725|FG001|First Intervention|Adverse Event|1|||
23357221|NCT01134393|65052727|FG000|Overall Study|Adverse Event|18|||
23357222|NCT01134393|65052727|FG000|Overall Study|Lack of Efficacy|2|||
23357223|NCT01134393|65052727|FG000|Overall Study|Protocol Violation|12|||
23357224|NCT01134393|65052727|FG000|Overall Study|Lost to Follow-up|3|||
23357225|NCT01134393|65052727|FG000|Overall Study|Withdrawal by Subject|11|||
23357226|NCT01134393|65052727|FG000|Overall Study|Other|6|||
23357227|NCT00703118|65052728|FG000|Overall Study|Adverse Event|1|||
23357228|NCT00703118|65052729|FG001|Overall Study|Adverse Event|2|||
23357229|NCT00703118|65052730|FG002|Overall Study|Adverse Event|2|||
23357230|NCT00703118|65052728|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
23357231|NCT00703118|65052729|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
23357232|NCT00703118|65052730|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
23357233|NCT00703118|65052728|FG000|Overall Study|Lost to Follow-up|6|||
23357234|NCT00703118|65052729|FG001|Overall Study|Lost to Follow-up|4|||
23357235|NCT00703118|65052730|FG002|Overall Study|Lost to Follow-up|4|||
23357236|NCT00703118|65052728|FG000|Overall Study|Withdrawal by Subject|8|||
23357237|NCT00703118|65052729|FG001|Overall Study|Withdrawal by Subject|7|||
23357238|NCT00703118|65052730|FG002|Overall Study|Withdrawal by Subject|13|||
23357239|NCT00703118|65052728|FG000|Overall Study|Other|0|||
23357240|NCT00703118|65052729|FG001|Overall Study|Other|0|||
23357241|NCT00703118|65052730|FG002|Overall Study|Other|1|||
23357242|NCT02401035|65052733|FG000|Overall Study|Withdrawal by Subject|1|||
23357243|NCT02401035|65052734|FG001|Overall Study|Withdrawal by Subject|0|||
23357244|NCT03754972|65052735|FG000|Overall Study|Protocol Violation|25|||
23357245|NCT03539484|65052736|FG000|Overall Study|Death|1|||
23357246|NCT03539484|65052737|FG001|Overall Study|Death|0|||
23357247|NCT03539484|65052738|FG002|Overall Study|Death|0|||
23357248|NCT03539484|65052739|FG003|Overall Study|Death|2|||
23588905|NCT03394027|65882269|FG002|Overall Study|Ineligible|3|||
23357249|NCT03539484|65052740|FG004|Overall Study|Death|8|||
23357250|NCT03539484|65052741|FG005|Overall Study|Death|3|||
23357251|NCT03539484|65052742|FG006|Overall Study|Death|0|||
23357252|NCT03539484|65052736|FG000|Overall Study|Lost to Follow-up|0|||
23357253|NCT03539484|65052737|FG001|Overall Study|Lost to Follow-up|1|||
23357254|NCT03539484|65052738|FG002|Overall Study|Lost to Follow-up|0|||
23642250|NCT02233543|66075346|FG001|Period 1|Withdrawal by Subject|0|||
23642251|NCT02233543|66075345|FG000|Period 1|Participants required other treatment.|2|||
23642252|NCT02233543|66075346|FG001|Period 1|Participants required other treatment.|3|||
23642253|NCT02233543|66075345|FG000|Period 2|Adverse Event|1|||
23642254|NCT02233543|66075346|FG001|Period 2|Adverse Event|0|||
23642255|NCT02233543|66075345|FG000|Period 2|Participant required other treatment.|0|||
23642256|NCT02233543|66075346|FG001|Period 2|Participant required other treatment.|1|||
23642257|NCT02233543|66075345|FG000|Period 2|COPD exacerbation|1|||
23642258|NCT02233543|66075346|FG001|Period 2|COPD exacerbation|0|||
23642259|NCT01493427|66075347|FG000|Overall Study|Adverse Event|10|||
23642260|NCT01493427|66075347|FG000|Overall Study|Personal Reasons|4|||
23642261|NCT01493427|66075347|FG000|Overall Study|Lost to Follow-up|2|||
23642262|NCT01493427|66075347|FG000|Overall Study|Inability to Follow Instructions|2|||
23642263|NCT01493427|66075347|FG000|Overall Study|Other|2|||
23642264|NCT01983254|66075350|FG000|Overall Study|Death|6|||
23642265|NCT01983254|66075351|FG001|Overall Study|Death|6|||
23642266|NCT01983254|66075350|FG000|Overall Study|Lost to Follow-up|17|||
23642267|NCT01983254|66075351|FG001|Overall Study|Lost to Follow-up|16|||
23357255|NCT03539484|65052739|FG003|Overall Study|Lost to Follow-up|0|||
23642268|NCT01983254|66075350|FG000|Overall Study|too ill|11|||
23642269|NCT01983254|66075351|FG001|Overall Study|too ill|8|||
23642270|NCT03582943|66075356|FG000|Allocated to Groups|Withdrawal by Subject|1|||
23642271|NCT03582943|66075357|FG001|Allocated to Groups|Withdrawal by Subject|1|||
23642272|NCT03582943|66075356|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
23642273|NCT03582943|66075357|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
23642274|NCT03582943|66075356|FG000|Analyzed|Protocol Violation|4|||
23642275|NCT03582943|66075357|FG001|Analyzed|Protocol Violation|1|||
23642276|NCT00953745|66075358|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
23642277|NCT00953745|66075359|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
23642278|NCT00953745|66075358|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
23642279|NCT00953745|66075359|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
23642280|NCT00953745|66075358|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
23642281|NCT00953745|66075359|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
23642282|NCT00953745|66075358|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
23642283|NCT00953745|66075359|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
23642284|NCT00953745|66075358|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
23642285|NCT00953745|66075359|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
23642286|NCT00953745|66075358|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
23642287|NCT00953745|66075359|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
23642288|NCT01910181|66075360|FG000|Overall Study|Death|37|||
23642289|NCT01910181|66075360|FG000|Overall Study|Lost to Follow-up|3|||
23642290|NCT01910181|66075360|FG000|Overall Study|Study Terminated by Sponsor|6|||
23642291|NCT01993927|66075361|FG000|Overall Study|Case Report Forms Uncollected|18|||
23642292|NCT01993927|66075361|FG000|Overall Study|Protocol Violation|11|||
23642293|NCT00291642|66075362|FG000|Overall Study|Adverse Event|1|||
23642294|NCT00291642|66075363|FG001|Overall Study|Adverse Event|0|||
23642295|NCT00291642|66075364|FG002|Overall Study|Adverse Event|1|||
23796691|NCT00726895|66633078|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23796692|NCT01857973|66633079|FG000|Overall Study|Subject did not meet required BG range|3|||
23796693|NCT01857973|66633079|FG000|Overall Study|drop out after 3 failed attempts|1|||
23796694|NCT01857973|66633079|FG000|Overall Study|Physician Decision|1|||
23796695|NCT01644149|66633080|FG000|Overall Study|Withdrawal by Subject|1|||
23796696|NCT01644149|66633081|FG001|Overall Study|Withdrawal by Subject|0|||
23796697|NCT01644149|66633080|FG000|Overall Study|Lost to Follow-up|3|||
23796698|NCT01644149|66633081|FG001|Overall Study|Lost to Follow-up|1|||
23796699|NCT04703855|66633097|FG000|Overall Study|Heart Transplant|1|||
23796700|NCT02093923|66633101|FG000|Overall Study|Lost to Follow-up|0|||
23796701|NCT02093923|66633102|FG001|Overall Study|Lost to Follow-up|0|||
23796702|NCT02093923|66633103|FG002|Overall Study|Lost to Follow-up|0|||
23796703|NCT02093923|66633104|FG003|Overall Study|Lost to Follow-up|1|||
23796704|NCT02093923|66633105|FG004|Overall Study|Lost to Follow-up|0|||
23796705|NCT02093923|66633101|FG000|Overall Study|Screen failure after randomization|0|||
23473702|NCT01134705|65477674|FG000|Overall Study|Withdrawal by Subject|6|||
23642296|NCT00291642|66075365|FG003|Overall Study|Adverse Event|0|||
23642297|NCT00291642|66075366|FG004|Overall Study|Adverse Event|1|||
23642298|NCT00291642|66075362|FG000|Overall Study|Patient missed visit|0|||
23642299|NCT00291642|66075363|FG001|Overall Study|Patient missed visit|0|||
23642300|NCT00291642|66075364|FG002|Overall Study|Patient missed visit|1|||
23642301|NCT00291642|66075365|FG003|Overall Study|Patient missed visit|0|||
23796706|NCT02093923|66633102|FG001|Overall Study|Screen failure after randomization|0|||
23796707|NCT02093923|66633103|FG002|Overall Study|Screen failure after randomization|0|||
23796708|NCT02093923|66633104|FG003|Overall Study|Screen failure after randomization|1|||
23796709|NCT02093923|66633105|FG004|Overall Study|Screen failure after randomization|0|||
23796710|NCT01989676|66633111|FG000|Overall Study|Death|52|||
23796711|NCT01989676|66633112|FG001|Overall Study|Death|60|||
23796712|NCT01989676|66633111|FG000|Overall Study|Protocol Violation|2|||
23796713|NCT01989676|66633112|FG001|Overall Study|Protocol Violation|1|||
23796714|NCT01989676|66633111|FG000|Overall Study|Lost to Follow-up|8|||
23796715|NCT01989676|66633112|FG001|Overall Study|Lost to Follow-up|18|||
23796716|NCT01989676|66633111|FG000|Overall Study|No longer willing to participate in study|26|||
23796717|NCT01989676|66633112|FG001|Overall Study|No longer willing to participate in study|26|||
23473703|NCT01134705|65477675|FG001|Overall Study|Withdrawal by Subject|6|||
23473704|NCT01134705|65477674|FG000|Overall Study|Pregnancy|1|||
23473705|NCT01134705|65477675|FG001|Overall Study|Pregnancy|0|||
23473706|NCT01134705|65477674|FG000|Overall Study|Lost to Follow-up|5|||
23473707|NCT01134705|65477675|FG001|Overall Study|Lost to Follow-up|2|||
23473708|NCT01134705|65477674|FG000|Overall Study|Protocol Violation|1|||
23473709|NCT01134705|65477675|FG001|Overall Study|Protocol Violation|1|||
23473710|NCT01134705|65477674|FG000|Overall Study|Other|1|||
23642302|NCT00291642|66075366|FG004|Overall Study|Patient missed visit|0|||
23642303|NCT00291642|66075362|FG000|Overall Study|Intake of prohibited medication|1|||
23642304|NCT00291642|66075363|FG001|Overall Study|Intake of prohibited medication|0|||
23642305|NCT00291642|66075364|FG002|Overall Study|Intake of prohibited medication|0|||
23642306|NCT00291642|66075365|FG003|Overall Study|Intake of prohibited medication|0|||
23642307|NCT00291642|66075366|FG004|Overall Study|Intake of prohibited medication|0|||
23642308|NCT02738203|66075367|FG000|Overall Study|Failed IUD Insertion|2|||
23642309|NCT02738203|66075368|FG001|Overall Study|Failed IUD Insertion|2|||
23642310|NCT02738203|66075367|FG000|Overall Study|Protocol Violation|0|||
23642311|NCT02738203|66075368|FG001|Overall Study|Protocol Violation|1|||
23796718|NCT01989676|66633111|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
23796719|NCT01989676|66633112|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
23796720|NCT01989676|66633111|FG000|Overall Study|Other|4|||
23796721|NCT01989676|66633112|FG001|Overall Study|Other|3|||
23796722|NCT00676494|66633113|FG000|Overall Study|Missed Visit|8|||
23796723|NCT00676494|66633113|FG000|Overall Study|Withdrawal by Subject|6|||
23473711|NCT01134705|65477675|FG001|Overall Study|Other|6|||
23473712|NCT00344487|65477677|FG000|Overall Study|immunologic failure|1|||
23796724|NCT04100096|66633114|FG000|Overall Study|Adverse Event|19|||
23796725|NCT04100096|66633115|FG001|Overall Study|Adverse Event|7|||
23796726|NCT04100096|66633114|FG000|Overall Study|Lack of Efficacy|0|||
23796727|NCT04100096|66633115|FG001|Overall Study|Lack of Efficacy|1|||
23796728|NCT04100096|66633114|FG000|Overall Study|Lost to Follow-up|13|||
23796729|NCT04100096|66633115|FG001|Overall Study|Lost to Follow-up|11|||
23796730|NCT04100096|66633114|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23796731|NCT04100096|66633115|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23796732|NCT04100096|66633114|FG000|Overall Study|Protocol Deviation|1|||
23796733|NCT04100096|66633115|FG001|Overall Study|Protocol Deviation|1|||
23796734|NCT04100096|66633114|FG000|Overall Study|Withdrawal by Participant|13|||
23796735|NCT04100096|66633115|FG001|Overall Study|Withdrawal by Participant|15|||
23796736|NCT00480324|66633118|FG000|Overall Study|Adverse Event|1|||
23796737|NCT00480324|66633119|FG001|Overall Study|Adverse Event|1|||
23796738|NCT00480324|66633118|FG000|Overall Study|Protocol Violation|0|||
23796739|NCT00480324|66633119|FG001|Overall Study|Protocol Violation|1|||
23796740|NCT00480324|66633118|FG000|Overall Study|Withdrawal by Subject|14|||
23796741|NCT00480324|66633119|FG001|Overall Study|Withdrawal by Subject|5|||
23796742|NCT00480324|66633118|FG000|Overall Study|Lost to Follow-up|17|||
23796743|NCT00480324|66633119|FG001|Overall Study|Lost to Follow-up|8|||
23796744|NCT00480324|66633118|FG000|Overall Study|Subject's mother pregnant|0|||
23796745|NCT00480324|66633119|FG001|Overall Study|Subject's mother pregnant|1|||
23796746|NCT02927834|66633120|FG000|Overall Study|Lost to Follow-up|1|||
23796747|NCT02927834|66633121|FG001|Overall Study|Lost to Follow-up|2|||
23473713|NCT00335764|65477678|FG000|Overall Study|wrong histology|1|||
23473714|NCT00335764|65477679|FG001|Overall Study|wrong histology|0|||
23473715|NCT00335764|65477680|FG002|Overall Study|wrong histology|0|||
23473716|NCT00335764|65477681|FG003|Overall Study|wrong histology|0|||
23473717|NCT00335764|65477682|FG004|Overall Study|wrong histology|1|||
23473718|NCT00934440|65477683|FG000|Overall Study|Lost to Follow-up|1|||
23473719|NCT01363349|65477693|FG000|Overall Study|Adverse Event|6|||
23642312|NCT03330847|66075369|FG000|Overall Study|Patients ongoing study|62|||
23796748|NCT02927834|66633122|FG002|Overall Study|Lost to Follow-up|2|||
23473720|NCT01363349|65477694|FG001|Overall Study|Adverse Event|7|||
23473721|NCT01363349|65477693|FG000|Overall Study|Lack of Efficacy|3|||
23473722|NCT01363349|65477694|FG001|Overall Study|Lack of Efficacy|10|||
23796749|NCT03847974|66633123|FG000|Overall Study|relocated out of region|3|||
23796750|NCT03847974|66633123|FG000|Overall Study|Withdrawal by Subject|2|||
23796751|NCT03847974|66633123|FG000|Overall Study|Adverse Event|1|||
23473723|NCT01363349|65477693|FG000|Overall Study|Non compliance/Protocol deviations|2|||
23473724|NCT01363349|65477694|FG001|Overall Study|Non compliance/Protocol deviations|2|||
23796752|NCT02722616|66633126|FG000|Overall Study|Sponsor closed study after one month|2|||
23473725|NCT01363349|65477693|FG000|Overall Study|Withdrawal by Subject|14|||
23473726|NCT01363349|65477694|FG001|Overall Study|Withdrawal by Subject|6|||
23473727|NCT01363349|65477693|FG000|Overall Study|Lost to Follow-up|5|||
23796753|NCT02722616|66633127|FG001|Overall Study|Sponsor closed study after one month|0|||
23796754|NCT02722616|66633128|FG002|Overall Study|Sponsor closed study after one month|0|||
23796755|NCT01628549|66633129|FG000|Overall Study|Adverse Event|1|||
23796756|NCT01628549|66633130|FG001|Overall Study|Adverse Event|1|||
23796757|NCT01628549|66633131|FG002|Overall Study|Adverse Event|0|||
23796758|NCT01628549|66633132|FG003|Overall Study|Adverse Event|4|||
23796759|NCT01628549|66633129|FG000|Overall Study|Lost to Follow-up|3|||
23796760|NCT01628549|66633130|FG001|Overall Study|Lost to Follow-up|4|||
23796761|NCT01628549|66633131|FG002|Overall Study|Lost to Follow-up|3|||
23473728|NCT01363349|65477694|FG001|Overall Study|Lost to Follow-up|6|||
23473729|NCT01363349|65477693|FG000|Overall Study|Not reported|36|||
23473730|NCT01363349|65477694|FG001|Overall Study|Not reported|37|||
23473731|NCT01363349|65477693|FG000|Overall Study|missing|1|||
23473732|NCT01363349|65477694|FG001|Overall Study|missing|2|||
23473733|NCT00552188|65477695|FG000|Overall Study|Adverse Event|0|||
23473734|NCT00552188|65477696|FG001|Overall Study|Adverse Event|2|||
23473735|NCT00552188|65477695|FG000|Overall Study|Lost to Follow-up|2|||
23473736|NCT00552188|65477696|FG001|Overall Study|Lost to Follow-up|1|||
23473737|NCT00552188|65477695|FG000|Overall Study|Withdrawal of consent|0|||
23473738|NCT00552188|65477696|FG001|Overall Study|Withdrawal of consent|1|||
23473739|NCT00552188|65477695|FG000|Overall Study|Subject returned to home country|0|||
23473740|NCT00552188|65477696|FG001|Overall Study|Subject returned to home country|1|||
23473741|NCT01868542|65477697|FG000|Overall Study|Protocol Violation|0|||
23473742|NCT01868542|65477698|FG001|Overall Study|Protocol Violation|1|||
23473743|NCT01868542|65477697|FG000|Overall Study|Unclassified|0|||
23473744|NCT01868542|65477698|FG001|Overall Study|Unclassified|1|||
23473745|NCT03180840|65477702|FG000|Overall Study|Withdrawal by Subject|1|||
23473746|NCT00475306|65477703|FG000|Overall Study|Protocol Violation|1|||
23473747|NCT00475306|65477704|FG001|Overall Study|Protocol Violation|1|||
23473748|NCT00475306|65477705|FG002|Overall Study|Protocol Violation|0|||
23473749|NCT00475306|65477706|FG003|Overall Study|Protocol Violation|1|||
23473750|NCT00743106|65477707|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
23473751|NCT00743106|65477708|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
23473752|NCT04491604|65477709|FG000|Overall Study|Withdrawal by Subject|3|||
23473753|NCT02105662|65477710|FG000|Overall Study|Lost to Follow-up|5|||
23473754|NCT02105662|65477710|FG000|Overall Study|Withdrawal by Subject|1|||
23473755|NCT03087617|65477711|FG000|Overall Study|Lost to Follow-up|32|||
23473756|NCT03087617|65477712|FG001|Overall Study|Lost to Follow-up|30|||
23473757|NCT03087617|65477713|FG002|Overall Study|Lost to Follow-up|30|||
23473758|NCT03087617|65477714|FG003|Overall Study|Lost to Follow-up|39|||
23473759|NCT02565784|65477715|FG000|First Treatment|Adverse Event|1|||
23473760|NCT02565784|65477715|FG000|First Treatment|Withdrawal by Subject|1|||
23473761|NCT02565784|65477715|FG000|Second Treatment|Withdrawal by Subject|2|||
23473762|NCT02160899|65477716|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23473763|NCT02160899|65477717|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23473764|NCT02160899|65477718|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
23473765|NCT02160899|65477719|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
23473766|NCT02160899|65477720|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
23473767|NCT02160899|65477721|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
23642313|NCT03330847|66075370|FG001|Overall Study|Patients ongoing study|65|||
23642314|NCT03330847|66075371|FG002|Overall Study|Patients ongoing study|15|||
23642315|NCT00948766|66075372|FG000|Core Study|Adverse Event|73|||
23642316|NCT00948766|66075373|FG001|Core Study|Adverse Event|51|||
23642317|NCT00948766|66075372|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
23642318|NCT00948766|66075373|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
23642319|NCT00948766|66075372|FG000|Core Study|Patient Withdrew Consent|27|||
23642320|NCT00948766|66075373|FG001|Core Study|Patient Withdrew Consent|46|||
23642321|NCT00948766|66075372|FG000|Core Study|Lost to Follow-up|3|||
23642322|NCT00948766|66075373|FG001|Core Study|Lost to Follow-up|2|||
23642323|NCT00948766|66075372|FG000|Core Study|Administrative Problems|2|||
23642324|NCT00948766|66075373|FG001|Core Study|Administrative Problems|2|||
23796762|NCT01628549|66633132|FG003|Overall Study|Lost to Follow-up|3|||
23796763|NCT01628549|66633129|FG000|Overall Study|Withdrawal by Subject|3|||
23796764|NCT01628549|66633130|FG001|Overall Study|Withdrawal by Subject|4|||
23796765|NCT01628549|66633131|FG002|Overall Study|Withdrawal by Subject|4|||
23473768|NCT02720042|65477722|FG000|Overall Study|Death|3|||
23473769|NCT02720042|65477722|FG000|Overall Study|Lost to Follow-up|4|||
23473770|NCT02720042|65477722|FG000|Overall Study|Withdrawal by Subject|1|||
23473771|NCT02720042|65477722|FG000|Overall Study|Physician Decision|3|||
23473772|NCT02720042|65477722|FG000|Overall Study|Phasix Mesh explanted|1|||
23473773|NCT02720042|65477722|FG000|Overall Study|unable due to non-study-related illness|3|||
23642325|NCT00948766|66075372|FG000|Core Study|Death|1|||
23642326|NCT00948766|66075373|FG001|Core Study|Death|1|||
23642327|NCT00948766|66075372|FG000|Core Study|Protocol Deviation|8|||
23642328|NCT00948766|66075373|FG001|Core Study|Protocol Deviation|10|||
23642329|NCT00948766|66075372|FG000|Extension Study|Adverse Event|43|||
23796766|NCT01628549|66633132|FG003|Overall Study|Withdrawal by Subject|1|||
23796767|NCT01628549|66633129|FG000|Overall Study|Protocol Violation|2|||
23796768|NCT01628549|66633130|FG001|Overall Study|Protocol Violation|1|||
23796769|NCT01628549|66633131|FG002|Overall Study|Protocol Violation|1|||
23642330|NCT00948766|66075373|FG001|Extension Study|Adverse Event|0|||
23642331|NCT00948766|66075372|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
23642332|NCT00948766|66075373|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
23642333|NCT00948766|66075372|FG000|Extension Study|Study Drug No Longer Required|1|||
23642334|NCT00948766|66075373|FG001|Extension Study|Study Drug No Longer Required|0|||
23642335|NCT00948766|66075372|FG000|Extension Study|Patient Withdrew Consent|32|||
23642336|NCT00948766|66075373|FG001|Extension Study|Patient Withdrew Consent|0|||
23642337|NCT00948766|66075372|FG000|Extension Study|Lost to Follow-up|8|||
23357256|NCT03539484|65052740|FG004|Overall Study|Lost to Follow-up|1|||
23357257|NCT03539484|65052741|FG005|Overall Study|Lost to Follow-up|0|||
23357258|NCT03539484|65052742|FG006|Overall Study|Lost to Follow-up|0|||
23642338|NCT00948766|66075373|FG001|Extension Study|Lost to Follow-up|0|||
23642339|NCT00948766|66075372|FG000|Extension Study|Administrative Problems|1|||
23642340|NCT00948766|66075373|FG001|Extension Study|Administrative Problems|0|||
23642341|NCT00948766|66075372|FG000|Extension Study|Death|4|||
23642342|NCT00948766|66075373|FG001|Extension Study|Death|0|||
23642343|NCT02150343|66075374|FG000|Overall Study|Adverse Event|2|||
23642344|NCT02150343|66075375|FG001|Overall Study|Adverse Event|0|||
23642345|NCT02150343|66075376|FG002|Overall Study|Adverse Event|1|||
23642346|NCT02150343|66075377|FG003|Overall Study|Adverse Event|1|||
23642347|NCT02150343|66075374|FG000|Overall Study|Withdrawal by Subject|13|||
23642348|NCT02150343|66075375|FG001|Overall Study|Withdrawal by Subject|10|||
23642349|NCT02150343|66075376|FG002|Overall Study|Withdrawal by Subject|9|||
23642350|NCT02150343|66075377|FG003|Overall Study|Withdrawal by Subject|4|||
23642351|NCT02150343|66075374|FG000|Overall Study|Lost to Follow-up|4|||
23642352|NCT02150343|66075375|FG001|Overall Study|Lost to Follow-up|4|||
23642353|NCT02150343|66075376|FG002|Overall Study|Lost to Follow-up|2|||
23642354|NCT02150343|66075377|FG003|Overall Study|Lost to Follow-up|3|||
23796770|NCT01628549|66633132|FG003|Overall Study|Protocol Violation|0|||
23796771|NCT01628549|66633129|FG000|Overall Study|withdrawn for noncompliance|0|||
23796772|NCT01628549|66633130|FG001|Overall Study|withdrawn for noncompliance|2|||
23796773|NCT01628549|66633131|FG002|Overall Study|withdrawn for noncompliance|1|||
23796774|NCT01628549|66633132|FG003|Overall Study|withdrawn for noncompliance|0|||
23796775|NCT01628549|66633129|FG000|Overall Study|abnormal laboratory test results|0|||
23796776|NCT01628549|66633130|FG001|Overall Study|abnormal laboratory test results|0|||
23796777|NCT01628549|66633131|FG002|Overall Study|abnormal laboratory test results|1|||
23796778|NCT01628549|66633132|FG003|Overall Study|abnormal laboratory test results|0|||
23796779|NCT01628549|66633129|FG000|Overall Study|positive pregnancy test|0|||
23796780|NCT01628549|66633130|FG001|Overall Study|positive pregnancy test|0|||
23796781|NCT01628549|66633131|FG002|Overall Study|positive pregnancy test|0|||
23796782|NCT01628549|66633132|FG003|Overall Study|positive pregnancy test|1|||
23796783|NCT02363439|66633133|FG000|Overall Study|Lack of Efficacy|4|||
23357259|NCT03539484|65052736|FG000|Overall Study|Withdrawal by Subject|0|||
23357260|NCT03539484|65052737|FG001|Overall Study|Withdrawal by Subject|0|||
23642355|NCT02150343|66075374|FG000|Overall Study|Other|2|||
23796784|NCT02246764|66633135|FG000|Overall Study|Adverse Event|15|||
23642356|NCT02150343|66075375|FG001|Overall Study|Other|6|||
23642357|NCT02150343|66075376|FG002|Overall Study|Other|0|||
23642358|NCT02150343|66075377|FG003|Overall Study|Other|2|||
23642359|NCT01346475|66075378|FG000|First Intervention|Lost to Follow-up|4|||
23642360|NCT01346475|66075379|FG001|First Intervention|Lost to Follow-up|3|||
23642361|NCT00577577|66075380|FG000|Overall Study|Adverse Event|3|||
23357261|NCT03539484|65052738|FG002|Overall Study|Withdrawal by Subject|0|||
23796785|NCT02246764|66633136|FG001|Overall Study|Adverse Event|29|||
23796786|NCT02246764|66633137|FG002|Overall Study|Adverse Event|1|||
23796787|NCT02246764|66633135|FG000|Overall Study|Withdrawal by Subject|0|||
23796788|NCT02246764|66633136|FG001|Overall Study|Withdrawal by Subject|0|||
23473774|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
23473775|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
23473776|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
23473777|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
23473778|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
23473779|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
23796789|NCT02246764|66633137|FG002|Overall Study|Withdrawal by Subject|1|||
23796790|NCT02246764|66633135|FG000|Overall Study|Disallowed Concomitant Medication|1|||
23796791|NCT02246764|66633136|FG001|Overall Study|Disallowed Concomitant Medication|0|||
23796792|NCT02246764|66633137|FG002|Overall Study|Disallowed Concomitant Medication|0|||
23796793|NCT02246764|66633135|FG000|Overall Study|Physician Decision|0|||
23796794|NCT02246764|66633136|FG001|Overall Study|Physician Decision|2|||
23796795|NCT02246764|66633137|FG002|Overall Study|Physician Decision|1|||
23796796|NCT02246764|66633135|FG000|Overall Study|Protocol Violation|2|||
23796797|NCT02246764|66633136|FG001|Overall Study|Protocol Violation|1|||
23473780|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
23473781|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
23473782|NCT00946985|65477723|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
23473783|NCT02078960|65477729|FG000|Treatment Period|Other|0|||
23473784|NCT02078960|65477730|FG001|Treatment Period|Other|0|||
23473785|NCT02078960|65477731|FG002|Treatment Period|Other|1|||
23473786|NCT02078960|65477729|FG000|Treatment Period|Lack of Efficacy|0|||
23473787|NCT02078960|65477730|FG001|Treatment Period|Lack of Efficacy|1|||
23473788|NCT02078960|65477731|FG002|Treatment Period|Lack of Efficacy|0|||
23473789|NCT02078960|65477729|FG000|Treatment Period|Disease progression - accelerated phase|0|||
23473790|NCT02078960|65477730|FG001|Treatment Period|Disease progression - accelerated phase|1|||
23473791|NCT02078960|65477731|FG002|Treatment Period|Disease progression - accelerated phase|0|||
23473792|NCT02078960|65477729|FG000|Treatment Period|Disease progression - blast phase|1|||
23473793|NCT02078960|65477730|FG001|Treatment Period|Disease progression - blast phase|0|||
23473794|NCT02078960|65477731|FG002|Treatment Period|Disease progression - blast phase|0|||
23473795|NCT02078960|65477729|FG000|Treatment Period|Withdrawal by Subject|0|||
23473796|NCT02078960|65477730|FG001|Treatment Period|Withdrawal by Subject|1|||
23473797|NCT02078960|65477731|FG002|Treatment Period|Withdrawal by Subject|1|||
23473798|NCT02078960|65477729|FG000|Treatment Period|Adverse Event|1|||
23473799|NCT02078960|65477730|FG001|Treatment Period|Adverse Event|0|||
23473800|NCT02078960|65477731|FG002|Treatment Period|Adverse Event|0|||
23473801|NCT02078960|65477729|FG000|Treatment Period|Death|0|||
23473802|NCT02078960|65477730|FG001|Treatment Period|Death|0|||
23473803|NCT02078960|65477731|FG002|Treatment Period|Death|1|||
23473804|NCT02078960|65477729|FG000|Follow-up Period|Death|2|||
23473805|NCT02078960|65477730|FG001|Follow-up Period|Death|0|||
23473806|NCT02078960|65477731|FG002|Follow-up Period|Death|0|||
23473807|NCT02078960|65477729|FG000|Follow-up Period|Lost to Follow-up|0|||
23473808|NCT02078960|65477730|FG001|Follow-up Period|Lost to Follow-up|1|||
23473809|NCT02078960|65477731|FG002|Follow-up Period|Lost to Follow-up|0|||
23473810|NCT01705509|65477734|FG000|Inclusion CPET|Screen Failure|5|||
23473811|NCT01705509|65477734|FG000|Inclusion CPET|Withdrawal by Subject|2|||
23473812|NCT01705509|65477734|FG000|CPET w/ Ranexa|Screen Failure|2|||
23473813|NCT04889118|65477735|FG000|Overall Study|Death|33|||
23473814|NCT04889118|65477736|FG001|Overall Study|Death|37|||
23588906|NCT03394027|65882267|FG000|Overall Study|Participant declined to participate before treatment started|0|||
23588907|NCT03394027|65882268|FG001|Overall Study|Participant declined to participate before treatment started|0|||
23473815|NCT04889118|65477735|FG000|Overall Study|Ongoing in Study|31|||
23473816|NCT04889118|65477736|FG001|Overall Study|Ongoing in Study|30|||
23473817|NCT01601652|65477737|FG000|Overall Study|Death|1|||
23473818|NCT02925338|65477738|FG000|Overall Study|Death|0|||
23473819|NCT02925338|65477739|FG001|Overall Study|Death|2|||
23796798|NCT02246764|66633137|FG002|Overall Study|Protocol Violation|1|||
23473820|NCT02925338|65477740|FG002|Overall Study|Death|1|||
23473821|NCT02925338|65477741|FG003|Overall Study|Death|0|||
23473822|NCT02925338|65477742|FG004|Overall Study|Death|0|||
23473823|NCT02925338|65477738|FG000|Overall Study|Lost to Follow-up|30|||
23473824|NCT02925338|65477739|FG001|Overall Study|Lost to Follow-up|10|||
23473825|NCT02925338|65477740|FG002|Overall Study|Lost to Follow-up|1|||
23473826|NCT02925338|65477741|FG003|Overall Study|Lost to Follow-up|16|||
23473827|NCT02925338|65477742|FG004|Overall Study|Lost to Follow-up|3|||
23473828|NCT02925338|65477738|FG000|Overall Study|Withdrawal by Subject|3|||
23473829|NCT02925338|65477739|FG001|Overall Study|Withdrawal by Subject|0|||
23473830|NCT02925338|65477740|FG002|Overall Study|Withdrawal by Subject|3|||
23473831|NCT02925338|65477741|FG003|Overall Study|Withdrawal by Subject|2|||
23473832|NCT02925338|65477742|FG004|Overall Study|Withdrawal by Subject|2|||
23473833|NCT02925338|65477738|FG000|Overall Study|Missing|38|||
23473834|NCT02925338|65477739|FG001|Overall Study|Missing|27|||
23473835|NCT02925338|65477740|FG002|Overall Study|Missing|0|||
23473836|NCT02925338|65477741|FG003|Overall Study|Missing|3|||
23473837|NCT02925338|65477742|FG004|Overall Study|Missing|2|||
23473838|NCT02925338|65477738|FG000|Overall Study|Participant's Decision|11|||
23473839|NCT02925338|65477739|FG001|Overall Study|Participant's Decision|7|||
23473840|NCT02925338|65477740|FG002|Overall Study|Participant's Decision|3|||
23473841|NCT02925338|65477741|FG003|Overall Study|Participant's Decision|8|||
23473842|NCT02925338|65477742|FG004|Overall Study|Participant's Decision|1|||
23473843|NCT02925338|65477738|FG000|Overall Study|Treatment Discontinuation|144|||
23473844|NCT02925338|65477739|FG001|Overall Study|Treatment Discontinuation|65|||
23473845|NCT02925338|65477740|FG002|Overall Study|Treatment Discontinuation|56|||
23473846|NCT02925338|65477741|FG003|Overall Study|Treatment Discontinuation|131|||
23473847|NCT02925338|65477742|FG004|Overall Study|Treatment Discontinuation|22|||
23473848|NCT02039843|65477743|FG000|Randomization and Observation Period|Adverse Event|2|||
23473849|NCT02039843|65477744|FG001|Randomization and Observation Period|Adverse Event|0|||
23473850|NCT02039843|65477743|FG000|Randomization and Observation Period|Death|1|||
23473851|NCT02039843|65477744|FG001|Randomization and Observation Period|Death|0|||
23473852|NCT02039843|65477743|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
23473853|NCT02039843|65477744|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
23473854|NCT02039843|65477743|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
23473855|NCT02039843|65477744|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
23473856|NCT02039843|65477743|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
23473857|NCT02039843|65477744|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
23588908|NCT03394027|65882269|FG002|Overall Study|Participant declined to participate before treatment started|1|||
23796799|NCT02966340|66633138|FG000|Overall Study|Adverse Event|0|||
23796800|NCT02966340|66633139|FG001|Overall Study|Adverse Event|1|||
23796801|NCT02966340|66633138|FG000|Overall Study|Lost to Follow-up|0|||
23796802|NCT02966340|66633139|FG001|Overall Study|Lost to Follow-up|1|||
23796803|NCT02966340|66633138|FG000|Overall Study|Withdrawal by Subject|1|||
23796804|NCT02966340|66633139|FG001|Overall Study|Withdrawal by Subject|0|||
23796805|NCT02966340|66633138|FG000|Overall Study|data acquisition error|1|||
23796806|NCT02966340|66633139|FG001|Overall Study|data acquisition error|0|||
23796807|NCT02966340|66633138|FG000|Overall Study|startle non-responder|1|||
23796808|NCT02966340|66633139|FG001|Overall Study|startle non-responder|1|||
23796809|NCT04542694|66633140|FG000|Overall Study|The need for prohibited therapy|2|||
23796810|NCT04542694|66633141|FG001|Overall Study|The need for prohibited therapy|0|||
23796811|NCT04542694|66633140|FG000|Overall Study|Adverse Event|1|||
23796812|NCT04542694|66633141|FG001|Overall Study|Adverse Event|0|||
23796813|NCT04542694|66633140|FG000|Overall Study|Protocol Violation|1|||
23796814|NCT04542694|66633141|FG001|Overall Study|Protocol Violation|0|||
23796815|NCT00575380|66633142|FG000|Overall Study|Withdrawal by Subject|1|||
23796816|NCT00575380|66633143|FG001|Overall Study|Withdrawal by Subject|0|||
23796817|NCT00575380|66633142|FG000|Overall Study|Adverse Event|0|||
23796818|NCT00575380|66633143|FG001|Overall Study|Adverse Event|1|||
23796819|NCT00575380|66633142|FG000|Overall Study|Various|0|||
23473858|NCT02039843|65477743|FG000|Pairing With a Study Dog|Death|1|||
23473859|NCT02039843|65477744|FG001|Pairing With a Study Dog|Death|0|||
23473860|NCT02039843|65477743|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
23473861|NCT02039843|65477744|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
23473862|NCT02039843|65477743|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
23473863|NCT02039843|65477744|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
23473864|NCT02039843|65477743|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
23588909|NCT01360840|65882270|FG000|Overall Study|Ongoing at data cut-off|10|||
23588910|NCT01360840|65882271|FG001|Overall Study|Ongoing at data cut-off|10|||
23588911|NCT01360840|65882272|FG002|Overall Study|Ongoing at data cut-off|9|||
23588912|NCT01069341|65882273|FG000|Overall Study|Lost to Follow-up|1|||
23588913|NCT02385669|65882274|FG000|Overall Study|Adverse Event|2|||
23588914|NCT00559949|65882275|FG000|Overall Study|Progressive Disease during cycle 1|1|||
23796820|NCT00575380|66633143|FG001|Overall Study|Various|2|||
23796821|NCT01362296|66633149|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
23796822|NCT01362296|66633150|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
23588915|NCT00559949|65882275|FG000|Overall Study|Adverse Event|1|||
23588916|NCT00559949|65882275|FG000|Overall Study|Withdrawal by Subject|4|||
23588917|NCT00559949|65882275|FG000|Overall Study|No disease evaluation per protocol|1|||
23588918|NCT01467700|65882276|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23588919|NCT01467700|65882277|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23588920|NCT01467700|65882278|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
23588921|NCT01467700|65882279|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
23588922|NCT01467700|65882276|FG000|Overall Study|Major Protocol Deviation|3|||
23588923|NCT01467700|65882277|FG001|Overall Study|Major Protocol Deviation|3|||
23588924|NCT01467700|65882278|FG002|Overall Study|Major Protocol Deviation|2|||
23588925|NCT01467700|65882279|FG003|Overall Study|Major Protocol Deviation|3|||
23642362|NCT00577577|66075381|FG001|Overall Study|Adverse Event|2|||
23642363|NCT00577577|66075380|FG000|Overall Study|Lost to Follow-up|1|||
23642364|NCT00577577|66075381|FG001|Overall Study|Lost to Follow-up|0|||
23642365|NCT00577577|66075380|FG000|Overall Study|Protocol Violation|0|||
23642366|NCT00577577|66075381|FG001|Overall Study|Protocol Violation|3|||
23642367|NCT00577577|66075380|FG000|Overall Study|Transportation|1|||
23642368|NCT00577577|66075381|FG001|Overall Study|Transportation|0|||
23642369|NCT03756129|66075382|FG000|Overall Study|Adverse Event|1|||
23642370|NCT03756129|66075383|FG001|Overall Study|Adverse Event|1|||
23642371|NCT03756129|66075384|FG002|Overall Study|Adverse Event|0|||
23642372|NCT03756129|66075385|FG003|Overall Study|Adverse Event|2|||
23642373|NCT03756129|66075386|FG004|Overall Study|Adverse Event|0|||
23588926|NCT01467700|65882276|FG000|Overall Study|Lost to Follow-up|6|||
23588927|NCT01467700|65882277|FG001|Overall Study|Lost to Follow-up|5|||
23642374|NCT03756129|66075387|FG005|Overall Study|Adverse Event|0|||
23642375|NCT03756129|66075382|FG000|Overall Study|Withdrawal by Subject|2|||
23796823|NCT01362296|66633151|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
23588928|NCT01467700|65882278|FG002|Overall Study|Lost to Follow-up|2|||
23588929|NCT01467700|65882279|FG003|Overall Study|Lost to Follow-up|3|||
23642376|NCT03756129|66075383|FG001|Overall Study|Withdrawal by Subject|1|||
23642377|NCT03756129|66075384|FG002|Overall Study|Withdrawal by Subject|3|||
23796824|NCT01362296|66633152|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
23796825|NCT01362296|66633149|FG000|Randomized Phase (RP)|Physician Decision|1|||
23796826|NCT01362296|66633150|FG001|Randomized Phase (RP)|Physician Decision|9|||
23796827|NCT01362296|66633151|FG002|Randomized Phase (RP)|Physician Decision|0|||
23796828|NCT01362296|66633152|FG003|Randomized Phase (RP)|Physician Decision|0|||
23796829|NCT01362296|66633149|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
23796830|NCT01362296|66633150|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
23796831|NCT01362296|66633151|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
23796832|NCT01362296|66633152|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
23796833|NCT01362296|66633149|FG000|Randomized Phase (RP)|Adverse Event|20|||
23796834|NCT01362296|66633150|FG001|Randomized Phase (RP)|Adverse Event|4|||
23796835|NCT01362296|66633151|FG002|Randomized Phase (RP)|Adverse Event|0|||
23796836|NCT01362296|66633152|FG003|Randomized Phase (RP)|Adverse Event|0|||
23796837|NCT01362296|66633149|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
23796838|NCT01362296|66633150|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
23796839|NCT01362296|66633151|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
23796840|NCT01362296|66633152|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
23796841|NCT01362296|66633149|FG000|Crossover Phase|PD including Death due to PD|0|||
23796842|NCT01362296|66633150|FG001|Crossover Phase|PD including Death due to PD|0|||
23796843|NCT01362296|66633151|FG002|Crossover Phase|PD including Death due to PD|16|||
23796844|NCT01362296|66633152|FG003|Crossover Phase|PD including Death due to PD|1|||
23796845|NCT01362296|66633149|FG000|Crossover Phase|Withdrawal by Subject|0|||
23796846|NCT01362296|66633150|FG001|Crossover Phase|Withdrawal by Subject|0|||
23796847|NCT01362296|66633151|FG002|Crossover Phase|Withdrawal by Subject|2|||
23796848|NCT01362296|66633152|FG003|Crossover Phase|Withdrawal by Subject|1|||
23796849|NCT01362296|66633149|FG000|Crossover Phase|Adverse Event|0|||
23796850|NCT01362296|66633150|FG001|Crossover Phase|Adverse Event|0|||
23796851|NCT01362296|66633151|FG002|Crossover Phase|Adverse Event|4|||
23796852|NCT01362296|66633152|FG003|Crossover Phase|Adverse Event|0|||
23796853|NCT01362296|66633149|FG000|Crossover Phase|Study Closed/Terminated|0|||
23796854|NCT01362296|66633150|FG001|Crossover Phase|Study Closed/Terminated|0|||
23796855|NCT01362296|66633151|FG002|Crossover Phase|Study Closed/Terminated|1|||
23796856|NCT01362296|66633152|FG003|Crossover Phase|Study Closed/Terminated|0|||
23796857|NCT03566238|66633154|FG000|Overall Study|Adverse Event|0|||
23796858|NCT03566238|66633155|FG001|Overall Study|Adverse Event|1|||
23796859|NCT03566238|66633156|FG002|Overall Study|Adverse Event|0|||
23796860|NCT03566238|66633154|FG000|Overall Study|Lack of Efficacy|4|||
23796861|NCT03566238|66633155|FG001|Overall Study|Lack of Efficacy|2|||
23796862|NCT03566238|66633156|FG002|Overall Study|Lack of Efficacy|5|||
23796863|NCT03566238|66633154|FG000|Overall Study|Other|1|||
23642378|NCT03756129|66075385|FG003|Overall Study|Withdrawal by Subject|1|||
23642379|NCT03756129|66075386|FG004|Overall Study|Withdrawal by Subject|1|||
23642380|NCT03756129|66075387|FG005|Overall Study|Withdrawal by Subject|3|||
23642381|NCT03756129|66075382|FG000|Overall Study|Lost to Follow-up|0|||
23642382|NCT03756129|66075383|FG001|Overall Study|Lost to Follow-up|0|||
23642383|NCT03756129|66075384|FG002|Overall Study|Lost to Follow-up|0|||
23642384|NCT03756129|66075385|FG003|Overall Study|Lost to Follow-up|0|||
23642385|NCT03756129|66075386|FG004|Overall Study|Lost to Follow-up|0|||
23642386|NCT03756129|66075387|FG005|Overall Study|Lost to Follow-up|1|||
23642387|NCT03756129|66075382|FG000|Overall Study|Physician Decision|0|||
23642388|NCT03756129|66075383|FG001|Overall Study|Physician Decision|0|||
23642389|NCT03756129|66075384|FG002|Overall Study|Physician Decision|0|||
23642390|NCT03756129|66075385|FG003|Overall Study|Physician Decision|0|||
23642391|NCT03756129|66075386|FG004|Overall Study|Physician Decision|0|||
23642392|NCT03756129|66075387|FG005|Overall Study|Physician Decision|1|||
23642393|NCT03248492|66075388|FG000|Overall Study|Ongoing|23|||
23642394|NCT03248492|66075389|FG001|Overall Study|Ongoing|26|||
23642395|NCT03248492|66075390|FG002|Overall Study|Ongoing|3|||
23642396|NCT03248492|66075391|FG003|Overall Study|Ongoing|85|||
23642397|NCT03248492|66075392|FG004|Overall Study|Ongoing|2|||
23642398|NCT03248492|66075388|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
23642399|NCT03248492|66075389|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
23642400|NCT03248492|66075390|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
23642401|NCT03248492|66075391|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
23642402|NCT03248492|66075392|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
23642403|NCT03248492|66075388|FG000|Overall Study|Adverse Event|6|||
23642404|NCT03248492|66075389|FG001|Overall Study|Adverse Event|6|||
23642405|NCT03248492|66075390|FG002|Overall Study|Adverse Event|8|||
23642406|NCT03248492|66075391|FG003|Overall Study|Adverse Event|8|||
23642407|NCT03248492|66075392|FG004|Overall Study|Adverse Event|1|||
23642408|NCT03248492|66075388|FG000|Overall Study|Withdrawal by Subject|3|||
23642409|NCT03248492|66075389|FG001|Overall Study|Withdrawal by Subject|3|||
23642410|NCT03248492|66075390|FG002|Overall Study|Withdrawal by Subject|0|||
23642411|NCT03248492|66075391|FG003|Overall Study|Withdrawal by Subject|3|||
23642412|NCT03248492|66075392|FG004|Overall Study|Withdrawal by Subject|1|||
23357262|NCT03539484|65052739|FG003|Overall Study|Withdrawal by Subject|0|||
23357263|NCT03539484|65052740|FG004|Overall Study|Withdrawal by Subject|2|||
23357264|NCT03539484|65052741|FG005|Overall Study|Withdrawal by Subject|0|||
23357265|NCT03539484|65052742|FG006|Overall Study|Withdrawal by Subject|1|||
23357266|NCT03539484|65052736|FG000|Overall Study|Study Terminated by Sponsor|0|||
23357267|NCT03539484|65052737|FG001|Overall Study|Study Terminated by Sponsor|0|||
23357268|NCT03539484|65052738|FG002|Overall Study|Study Terminated by Sponsor|1|||
23357269|NCT03539484|65052739|FG003|Overall Study|Study Terminated by Sponsor|1|||
23357270|NCT03539484|65052740|FG004|Overall Study|Study Terminated by Sponsor|2|||
23357271|NCT03539484|65052741|FG005|Overall Study|Study Terminated by Sponsor|2|||
23357272|NCT03539484|65052742|FG006|Overall Study|Study Terminated by Sponsor|1|||
23357273|NCT03076515|65052743|FG000|Overall Study|DMC decision based on interim analysis|25|||
23357274|NCT03076515|65052744|FG001|Overall Study|DMC decision based on interim analysis|29|||
23357275|NCT02686814|65052745|FG000|Overall Study|Physician Decision|14|||
23357276|NCT02686814|65052745|FG000|Overall Study|Withdrawal by Subject|4|||
23357277|NCT02686814|65052745|FG000|Overall Study|Death|1|||
23357278|NCT02560623|65052746|FG000|Overall Study|Unable to swallow sponge|0|||
23357279|NCT02560623|65052747|FG001|Overall Study|Unable to swallow sponge|1|||
23357280|NCT02560623|65052748|FG002|Overall Study|Unable to swallow sponge|0|||
23357281|NCT02560623|65052749|FG003|Overall Study|Unable to swallow sponge|0|||
23357282|NCT02560623|65052746|FG000|Overall Study|Intervention prior to sponge administration|0|||
23357283|NCT02560623|65052747|FG001|Overall Study|Intervention prior to sponge administration|1|||
23357284|NCT02560623|65052748|FG002|Overall Study|Intervention prior to sponge administration|0|||
23357285|NCT02560623|65052749|FG003|Overall Study|Intervention prior to sponge administration|0|||
23357286|NCT01133704|65052750|FG000|Overall Study|Death|44|||
23357287|NCT01133704|65052751|FG001|Overall Study|Death|26|||
23357288|NCT01133704|65052750|FG000|Overall Study|Patient refused to continue|4|||
23357289|NCT01133704|65052751|FG001|Overall Study|Patient refused to continue|0|||
23588930|NCT01467700|65882276|FG000|Overall Study|Voluntary Withdrawal|5|||
23588931|NCT01467700|65882277|FG001|Overall Study|Voluntary Withdrawal|7|||
23588932|NCT01467700|65882278|FG002|Overall Study|Voluntary Withdrawal|6|||
23588933|NCT01467700|65882279|FG003|Overall Study|Voluntary Withdrawal|2|||
23588934|NCT01467700|65882276|FG000|Overall Study|Study Termination|6|||
23588935|NCT01467700|65882277|FG001|Overall Study|Study Termination|5|||
23588936|NCT01467700|65882278|FG002|Overall Study|Study Termination|10|||
23588937|NCT01467700|65882279|FG003|Overall Study|Study Termination|7|||
23588938|NCT01467700|65882276|FG000|Overall Study|Pregnancy|0|||
23588939|NCT01467700|65882277|FG001|Overall Study|Pregnancy|1|||
23588940|NCT01467700|65882278|FG002|Overall Study|Pregnancy|1|||
23588941|NCT01467700|65882279|FG003|Overall Study|Pregnancy|0|||
23357290|NCT01133704|65052750|FG000|Overall Study|Study Closure|1|||
23357291|NCT01133704|65052751|FG001|Overall Study|Study Closure|0|||
23357292|NCT01760447|65052752|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
23357293|NCT01760447|65052753|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
23357294|NCT01760447|65052754|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
23357295|NCT01760447|65052755|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
23357296|NCT01760447|65052752|FG000|Weeks 0-20|Withdrawal by Subject|2|||
23357297|NCT01760447|65052753|FG001|Weeks 0-20|Withdrawal by Subject|0|||
23357298|NCT01760447|65052754|FG002|Weeks 0-20|Withdrawal by Subject|1|||
23357299|NCT01760447|65052755|FG003|Weeks 0-20|Withdrawal by Subject|0|||
23357300|NCT01760447|65052752|FG000|Weeks 0-20|Lost to Follow-up|1|||
23357301|NCT01760447|65052753|FG001|Weeks 0-20|Lost to Follow-up|0|||
23357302|NCT01760447|65052754|FG002|Weeks 0-20|Lost to Follow-up|1|||
23357303|NCT01760447|65052755|FG003|Weeks 0-20|Lost to Follow-up|1|||
23357304|NCT01760447|65052752|FG000|Weeks 0-20|Randomized but not treated|0|||
23357305|NCT01760447|65052753|FG001|Weeks 0-20|Randomized but not treated|0|||
23357306|NCT01760447|65052754|FG002|Weeks 0-20|Randomized but not treated|2|||
23357307|NCT01760447|65052755|FG003|Weeks 0-20|Randomized but not treated|0|||
23357308|NCT01760447|65052752|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357309|NCT01760447|65052753|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357310|NCT01760447|65052754|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357311|NCT01760447|65052755|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
23357312|NCT01760447|65052752|FG000|Weeks 20-54|Withdrawal by Subject|2|||
23357313|NCT01760447|65052753|FG001|Weeks 20-54|Withdrawal by Subject|1|||
23796864|NCT03566238|66633155|FG001|Overall Study|Other|0|||
23796865|NCT03566238|66633156|FG002|Overall Study|Other|0|||
23796866|NCT04099641|66633157|FG000|Overall Study|Death|46|||
23796867|NCT04099641|66633158|FG001|Overall Study|Death|12|||
23796868|NCT04099641|66633157|FG000|Overall Study|Lost to Follow-up|1|||
23357314|NCT01760447|65052754|FG002|Weeks 20-54|Withdrawal by Subject|1|||
23357315|NCT01760447|65052755|FG003|Weeks 20-54|Withdrawal by Subject|2|||
23357316|NCT01760447|65052752|FG000|Weeks 20-54|Lost to Follow-up|0|||
23357317|NCT01760447|65052753|FG001|Weeks 20-54|Lost to Follow-up|0|||
23357318|NCT01760447|65052754|FG002|Weeks 20-54|Lost to Follow-up|1|||
23357319|NCT01760447|65052755|FG003|Weeks 20-54|Lost to Follow-up|2|||
23357320|NCT03334188|65052758|FG000|Overall Study|Withdrawal by Subject|0|||
23357321|NCT03334188|65052759|FG001|Overall Study|Withdrawal by Subject|1|||
23357322|NCT03334188|65052758|FG000|Overall Study|Death|1|||
23357323|NCT03334188|65052759|FG001|Overall Study|Death|0|||
23357324|NCT03334188|65052758|FG000|Overall Study|Never had qualifying clinic visit|7|||
23357325|NCT03334188|65052759|FG001|Overall Study|Never had qualifying clinic visit|7|||
23357326|NCT00376532|65052760|FG000|Overall Study|Lack sufficient blood sample|6|||
23357327|NCT00376532|65052761|FG001|Overall Study|Lack sufficient blood sample|6|||
23357328|NCT01301079|65052762|FG000|Overall Study|Lost to Follow-up|2|||
23357329|NCT01301079|65052763|FG001|Overall Study|Lost to Follow-up|2|||
23357330|NCT04391842|65052764|FG000|Overall Study|Withdrawal by Subject|2|||
23357331|NCT01937884|65052765|FG000|Overall Study|Withdrawal by Subject|1|||
23357332|NCT01937884|65052766|FG001|Overall Study|Withdrawal by Subject|0|||
23357333|NCT02315664|65052767|FG000|Overall Study|Lost to Follow-up|1|||
23357334|NCT02315664|65052768|FG001|Overall Study|Lost to Follow-up|1|||
23357335|NCT02315664|65052767|FG000|Overall Study|Withdrawal by Subject|0|||
23357336|NCT02315664|65052768|FG001|Overall Study|Withdrawal by Subject|3|||
23357337|NCT01808261|65052769|FG000|Overall Study|Physician Decision|0|||
23642413|NCT03248492|66075388|FG000|Overall Study|Physician Decision|1|||
23642414|NCT03248492|66075389|FG001|Overall Study|Physician Decision|0|||
23642415|NCT03248492|66075390|FG002|Overall Study|Physician Decision|1|||
23642416|NCT03248492|66075391|FG003|Overall Study|Physician Decision|2|||
23796869|NCT04099641|66633158|FG001|Overall Study|Lost to Follow-up|0|||
23796870|NCT04099641|66633157|FG000|Overall Study|Withdrawal by Subject|2|||
23796871|NCT04099641|66633158|FG001|Overall Study|Withdrawal by Subject|0|||
23796872|NCT01011556|66633162|FG000|Overall Study|Adverse Event|1|||
23796873|NCT01011556|66633163|FG001|Overall Study|Adverse Event|3|||
23642417|NCT03248492|66075392|FG004|Overall Study|Physician Decision|0|||
23642418|NCT03248492|66075388|FG000|Overall Study|Death|1|||
23642419|NCT03248492|66075389|FG001|Overall Study|Death|0|||
23642420|NCT03248492|66075390|FG002|Overall Study|Death|0|||
23642421|NCT03248492|66075391|FG003|Overall Study|Death|6|||
23796874|NCT01011556|66633164|FG002|Overall Study|Adverse Event|2|||
23357338|NCT01808261|65052770|FG001|Overall Study|Physician Decision|2|||
23357339|NCT01808261|65052769|FG000|Overall Study|Study Closed/Terminated|25|||
23357340|NCT01808261|65052770|FG001|Overall Study|Study Closed/Terminated|23|||
23357341|NCT01808261|65052769|FG000|Overall Study|Adverse event, non-fatal|2|||
23357342|NCT01808261|65052770|FG001|Overall Study|Adverse event, non-fatal|0|||
23357343|NCT01808261|65052769|FG000|Overall Study|Consent withdrawn by subject|6|||
23642422|NCT03248492|66075392|FG004|Overall Study|Death|0|||
23796875|NCT01011556|66633165|FG003|Overall Study|Adverse Event|1|||
23357344|NCT01808261|65052770|FG001|Overall Study|Consent withdrawn by subject|7|||
23642423|NCT03248492|66075388|FG000|Overall Study|Other|0|||
23642424|NCT03248492|66075389|FG001|Overall Study|Other|1|||
23796876|NCT01011556|66633162|FG000|Overall Study|Lost to Follow-up|1|||
23796877|NCT01011556|66633163|FG001|Overall Study|Lost to Follow-up|0|||
23588942|NCT01467700|65882276|FG000|Overall Study|Lack of Efficacy|2|||
23588943|NCT01467700|65882277|FG001|Overall Study|Lack of Efficacy|0|||
23588944|NCT01467700|65882278|FG002|Overall Study|Lack of Efficacy|2|||
23588945|NCT01467700|65882279|FG003|Overall Study|Lack of Efficacy|1|||
23588946|NCT01467700|65882276|FG000|Overall Study|Reason not Specified|1|||
23588947|NCT01467700|65882277|FG001|Overall Study|Reason not Specified|3|||
23588948|NCT01467700|65882278|FG002|Overall Study|Reason not Specified|2|||
23588949|NCT01467700|65882279|FG003|Overall Study|Reason not Specified|8|||
23588950|NCT04849416|65882280|FG000|Overall Study|Ongoing Treatment|12|||
23588951|NCT04849416|65882281|FG001|Overall Study|Ongoing Treatment|5|||
23588952|NCT04849416|65882282|FG002|Overall Study|Ongoing Treatment|3|||
23588953|NCT04849416|65882280|FG000|Overall Study|On Post-Treatment Follow-up|8|||
23588954|NCT04849416|65882281|FG001|Overall Study|On Post-Treatment Follow-up|9|||
23588955|NCT04849416|65882282|FG002|Overall Study|On Post-Treatment Follow-up|10|||
23588956|NCT04849416|65882280|FG000|Overall Study|Withdrawal by Subject|0|||
23588957|NCT04849416|65882281|FG001|Overall Study|Withdrawal by Subject|0|||
23588958|NCT04849416|65882282|FG002|Overall Study|Withdrawal by Subject|1|||
23588959|NCT04849416|65882280|FG000|Overall Study|Lost to Follow-up|1|||
23588960|NCT04849416|65882281|FG001|Overall Study|Lost to Follow-up|0|||
23588961|NCT04849416|65882282|FG002|Overall Study|Lost to Follow-up|0|||
23796878|NCT01011556|66633164|FG002|Overall Study|Lost to Follow-up|0|||
23796879|NCT01011556|66633165|FG003|Overall Study|Lost to Follow-up|0|||
23796880|NCT01011556|66633162|FG000|Overall Study|Physician Decision|1|||
23796881|NCT01011556|66633163|FG001|Overall Study|Physician Decision|0|||
23796882|NCT01011556|66633164|FG002|Overall Study|Physician Decision|0|||
23796883|NCT01011556|66633165|FG003|Overall Study|Physician Decision|1|||
23796884|NCT01011556|66633162|FG000|Overall Study|Protocol Violation|0|||
23796885|NCT01011556|66633163|FG001|Overall Study|Protocol Violation|1|||
23796886|NCT01011556|66633164|FG002|Overall Study|Protocol Violation|0|||
23796887|NCT01011556|66633165|FG003|Overall Study|Protocol Violation|0|||
23796888|NCT01011556|66633162|FG000|Overall Study|Withdrawal by Subject|1|||
23796889|NCT01011556|66633163|FG001|Overall Study|Withdrawal by Subject|2|||
23796890|NCT01011556|66633164|FG002|Overall Study|Withdrawal by Subject|4|||
23796891|NCT01011556|66633165|FG003|Overall Study|Withdrawal by Subject|4|||
23796892|NCT01011556|66633162|FG000|Overall Study|Sponsor decision|0|||
23796893|NCT01011556|66633163|FG001|Overall Study|Sponsor decision|1|||
23796894|NCT01011556|66633164|FG002|Overall Study|Sponsor decision|1|||
23796895|NCT01011556|66633165|FG003|Overall Study|Sponsor decision|2|||
23796896|NCT01011556|66633162|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
23796897|NCT01011556|66633163|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
23796898|NCT01011556|66633164|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
23796899|NCT01011556|66633165|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
23796900|NCT00537017|66633166|FG000|Treatment Phase|Adverse Event|19|||
23796901|NCT00537017|66633166|FG000|Treatment Phase|Withdrawal by Subject|13|||
23796902|NCT00537017|66633166|FG000|Treatment Phase|Protocol Violation|2|||
23588962|NCT01140048|65882286|FG000|Overall Study|Physician Decision|1|||
23357345|NCT01808261|65052769|FG000|Overall Study|Lost to Follow-up|3|||
23357346|NCT01808261|65052770|FG001|Overall Study|Lost to Follow-up|1|||
23357347|NCT00080483|65052771|FG000|Overall Study|Lost to Follow-up|1|||
23357348|NCT00080483|65052772|FG001|Overall Study|Lost to Follow-up|1|||
23357349|NCT00080483|65052771|FG000|Overall Study|Physician Decision|1|||
23357350|NCT00080483|65052772|FG001|Overall Study|Physician Decision|1|||
23357351|NCT01887288|65052774|FG000|Overall Study|The study was terminated and the PI has|16|||
23588963|NCT01140048|65882286|FG000|Overall Study|Withdrawal by Subject|13|||
23357352|NCT03585712|65052775|FG000|Treatment Period 1|Protocol Violation|1|||
23357353|NCT03585712|65052776|FG001|Treatment Period 1|Protocol Violation|0|||
23357354|NCT03585712|65052777|FG002|Treatment Period 1|Protocol Violation|0|||
23357355|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
23357356|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
23357357|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
23357358|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
23357359|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
23588964|NCT01140048|65882286|FG000|Overall Study|Lost to Follow-up|31|||
23642425|NCT03248492|66075390|FG002|Overall Study|Other|0|||
23357360|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
23357361|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
23357362|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
23357363|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
23357364|NCT01597492|65052778|FG000|Overall Study|Withdrawal by Subject|1|||
23357365|NCT01597492|65052779|FG001|Overall Study|Withdrawal by Subject|2|||
23357366|NCT01597492|65052778|FG000|Overall Study|Adverse Event|3|||
23357367|NCT01597492|65052779|FG001|Overall Study|Adverse Event|0|||
23357368|NCT01597492|65052778|FG000|Overall Study|Lost to Follow-up|0|||
23357369|NCT01597492|65052779|FG001|Overall Study|Lost to Follow-up|2|||
23357370|NCT01597492|65052778|FG000|Overall Study|Other Reason|2|||
23357371|NCT01597492|65052779|FG001|Overall Study|Other Reason|0|||
23357372|NCT02131233|65052784|FG000|Overall Study|Not Treated|2|||
23357373|NCT02131233|65052785|FG001|Overall Study|Not Treated|3|||
23357374|NCT02131233|65052784|FG000|Overall Study|Adverse Event|7|||
23357375|NCT02131233|65052785|FG001|Overall Study|Adverse Event|6|||
23357376|NCT02131233|65052784|FG000|Overall Study|Death|0|||
23357377|NCT02131233|65052785|FG001|Overall Study|Death|1|||
23357378|NCT02131233|65052784|FG000|Overall Study|Lack of Efficacy|6|||
23357379|NCT02131233|65052785|FG001|Overall Study|Lack of Efficacy|3|||
23357380|NCT02131233|65052784|FG000|Overall Study|Lost to Follow-up|14|||
23357381|NCT02131233|65052785|FG001|Overall Study|Lost to Follow-up|13|||
23357382|NCT02131233|65052784|FG000|Overall Study|Non-Compliance With Study Drug|8|||
23357383|NCT02131233|65052785|FG001|Overall Study|Non-Compliance With Study Drug|5|||
23357384|NCT02131233|65052784|FG000|Overall Study|Physician Decision|7|||
23357385|NCT02131233|65052785|FG001|Overall Study|Physician Decision|0|||
23357386|NCT02131233|65052784|FG000|Overall Study|Pregnancy|4|||
23357387|NCT02131233|65052785|FG001|Overall Study|Pregnancy|0|||
23357388|NCT02131233|65052784|FG000|Overall Study|Withdrawal by Subject|18|||
23357389|NCT02131233|65052785|FG001|Overall Study|Withdrawal by Subject|11|||
23357390|NCT02756364|65052786|FG000|Overall Study|Site Terminated by Sponsor|24|||
23357391|NCT02756364|65052787|FG001|Overall Study|Site Terminated by Sponsor|30|||
23357392|NCT02756364|65052788|FG002|Overall Study|Site Terminated by Sponsor|21|||
23357393|NCT02756364|65052786|FG000|Overall Study|Death|20|||
23357394|NCT02756364|65052787|FG001|Overall Study|Death|15|||
23357395|NCT02756364|65052788|FG002|Overall Study|Death|18|||
23357396|NCT02756364|65052786|FG000|Overall Study|Withdrawal by Patient|2|||
23357397|NCT02756364|65052787|FG001|Overall Study|Withdrawal by Patient|1|||
23357398|NCT02756364|65052788|FG002|Overall Study|Withdrawal by Patient|8|||
23357399|NCT02756364|65052786|FG000|Overall Study|Lost to Follow-up|0|||
23357400|NCT02756364|65052787|FG001|Overall Study|Lost to Follow-up|1|||
23357401|NCT02756364|65052788|FG002|Overall Study|Lost to Follow-up|1|||
23357402|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
23357403|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
23357404|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
23357405|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
23357406|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
23357407|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
23357408|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
23357409|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
23357410|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
23357411|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
23357412|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
23357413|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
23357414|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
23357415|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
23357416|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
23357417|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
23357418|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357419|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
23357420|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357421|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357422|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357423|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
23357424|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357425|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357426|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357427|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
23588965|NCT00845832|65882287|FG000|Treatment Period|Adverse Event|0|||
23357428|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
23357429|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
23357430|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
23642426|NCT03248492|66075391|FG003|Overall Study|Other|4|||
23642427|NCT03248492|66075392|FG004|Overall Study|Other|0|||
23642428|NCT00844532|66075393|FG000|Overall Study|Death|16|||
23642429|NCT00844532|66075393|FG000|Overall Study|Withdrawal by Subject|16|||
23642430|NCT00844532|66075393|FG000|Overall Study|Lost to Follow-up|7|||
23642431|NCT00774930|66075395|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
23642432|NCT00774930|66075396|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
23642433|NCT00774930|66075395|FG000|DB Phase|Adverse Event|1|||
23642434|NCT00774930|66075396|FG001|DB Phase|Adverse Event|2|||
23642435|NCT00774930|66075395|FG000|DB Phase|Subject Decision|1|||
23642436|NCT00774930|66075396|FG001|DB Phase|Subject Decision|5|||
23642437|NCT00774930|66075395|FG000|DB Phase|Sponsor Decision|0|||
23642438|NCT00774930|66075396|FG001|DB Phase|Sponsor Decision|1|||
23642439|NCT00774930|66075395|FG000|DB Phase|Disease Progression|1|||
23642440|NCT00774930|66075396|FG001|DB Phase|Disease Progression|1|||
23642441|NCT00774930|66075395|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
23642442|NCT00774930|66075396|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
23642443|NCT00774930|66075395|FG000|IOL Phase|Adverse Event|1|||
23642444|NCT00774930|66075396|FG001|IOL Phase|Adverse Event|1|||
23642445|NCT00774930|66075395|FG000|IOL Phase|Subject Decision|4|||
23642446|NCT00774930|66075396|FG001|IOL Phase|Subject Decision|3|||
23642447|NCT00774930|66075395|FG000|IOL Phase|Physician Decision|3|||
23642448|NCT00774930|66075396|FG001|IOL Phase|Physician Decision|2|||
23796903|NCT00537017|66633166|FG000|Follow-up Phase|Withdrawal by Subject|9|||
23796904|NCT01235715|66633168|FG000|Overall Study|Physician Decision|0|||
23357431|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
23357432|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
23357433|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
23357434|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
23357435|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
23796905|NCT01235715|66633169|FG001|Overall Study|Physician Decision|2|||
23796906|NCT00089076|66633170|FG000|Overall Study|Alternate Therapy|1|||
23796907|NCT00089076|66633170|FG000|Overall Study|Withdrawal by Subject|2|||
23796908|NCT00089076|66633170|FG000|Overall Study|Progression|7|||
23796909|NCT04149535|66633171|FG000|Overall Study|Death|11|||
23796910|NCT04149535|66633172|FG001|Overall Study|Death|7|||
23796911|NCT04149535|66633171|FG000|Overall Study|Physician Decision|10|||
23796912|NCT04149535|66633172|FG001|Overall Study|Physician Decision|4|||
23796913|NCT04149535|66633171|FG000|Overall Study|Withdrawal by Subject|6|||
23796914|NCT04149535|66633172|FG001|Overall Study|Withdrawal by Subject|7|||
23796915|NCT04149535|66633171|FG000|Overall Study|Not described|2|||
23796916|NCT04149535|66633172|FG001|Overall Study|Not described|0|||
23796917|NCT03847194|66633178|FG000|Overall Study|Lost to Follow-up|2|||
23796918|NCT03847194|66633179|FG001|Overall Study|Lost to Follow-up|5|||
23357436|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
23357437|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357438|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357439|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
23357440|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357441|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357442|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23796919|NCT03847194|66633178|FG000|Overall Study|Withdrawal by Subject|1|||
23357443|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23357444|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23642449|NCT00774930|66075395|FG000|IOL Phase|Sponsor Decision|1|||
23642450|NCT00774930|66075396|FG001|IOL Phase|Sponsor Decision|0|||
23642451|NCT00774930|66075395|FG000|IOL Phase|Disease Progression|2|||
23642452|NCT00774930|66075396|FG001|IOL Phase|Disease Progression|1|||
23796920|NCT03847194|66633179|FG001|Overall Study|Withdrawal by Subject|2|||
23796921|NCT03847194|66633178|FG000|Overall Study|Death|0|||
23796922|NCT03847194|66633179|FG001|Overall Study|Death|1|||
23796923|NCT00109850|66633183|FG000|Overall Study|Adverse Event|1|||
23796924|NCT00109850|66633183|FG000|Overall Study|Death|2|||
23796925|NCT00109850|66633183|FG000|Overall Study|Ineligible|1|||
23796926|NCT00179673|66633184|FG000|Overall Study|Adverse Event|7|||
23473865|NCT02039843|65477744|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
23473866|NCT01214395|65477745|FG000|Overall Study|All patients had infection|5|||
23473867|NCT00684060|65477747|FG000|Overall Study|Lost to Follow-up|1|||
23473868|NCT00684060|65477748|FG001|Overall Study|Lost to Follow-up|0|||
23796927|NCT00179673|66633184|FG000|Overall Study|Lack of Efficacy|15|||
23796928|NCT00179673|66633184|FG000|Overall Study|Withdrawal by Subject|3|||
23796929|NCT00179673|66633184|FG000|Overall Study|Death|4|||
23473869|NCT00684060|65477747|FG000|Overall Study|New stenosis identified|1|||
23473870|NCT00684060|65477748|FG001|Overall Study|New stenosis identified|0|||
23473871|NCT00684060|65477747|FG000|Overall Study|Unable to collect MRI|1|||
23473872|NCT00684060|65477748|FG001|Overall Study|Unable to collect MRI|2|||
23473873|NCT00684060|65477747|FG000|Overall Study|Death|0|||
23473874|NCT00684060|65477748|FG001|Overall Study|Death|1|||
23473875|NCT02604160|65477749|FG000|Overall Study|Protocol Violation|0|||
23473876|NCT02604160|65477750|FG001|Overall Study|Protocol Violation|1|||
23473877|NCT02604160|65477749|FG000|Overall Study|Physician Decision|0|||
23473878|NCT02604160|65477750|FG001|Overall Study|Physician Decision|1|||
23473879|NCT02878798|65477751|FG000|Overall Study|Withdrawal by Subject|5|||
23473880|NCT02878798|65477752|FG001|Overall Study|Withdrawal by Subject|4|||
23796930|NCT00179673|66633184|FG000|Overall Study|Other Observations and options|14|||
23796931|NCT00979212|66633185|FG000|Overall Study|Protocol Violation|1|||
23473881|NCT02878798|65477751|FG000|Overall Study|Lost to Follow-up|2|||
23473882|NCT02878798|65477752|FG001|Overall Study|Lost to Follow-up|2|||
23473883|NCT02878798|65477751|FG000|Overall Study|Protocol Violation|0|||
23473884|NCT02878798|65477752|FG001|Overall Study|Protocol Violation|1|||
23473885|NCT01410357|65477753|FG000|Overall Study|Death|2|||
23473886|NCT01410357|65477754|FG001|Overall Study|Death|1|||
23473887|NCT01410357|65477753|FG000|Overall Study|Withdrawal by Subject|1|||
23473888|NCT01410357|65477754|FG001|Overall Study|Withdrawal by Subject|2|||
23473889|NCT01410357|65477753|FG000|Overall Study|Lost to Follow-up|23|||
23473890|NCT01410357|65477754|FG001|Overall Study|Lost to Follow-up|21|||
23473891|NCT00146848|65477755|FG000|Pre-randomization|Death|19|||
23473892|NCT00146848|65477756|FG001|Pre-randomization|Death|0|||
23473893|NCT00146848|65477757|FG002|Pre-randomization|Death|0|||
23473894|NCT00146848|65477755|FG000|Pre-randomization|Lost to Follow-up|70|||
23473895|NCT00146848|65477756|FG001|Pre-randomization|Lost to Follow-up|0|||
23473896|NCT00146848|65477757|FG002|Pre-randomization|Lost to Follow-up|0|||
23473897|NCT00146848|65477755|FG000|Pre-randomization|Physician Decision|8|||
23473898|NCT00146848|65477756|FG001|Pre-randomization|Physician Decision|0|||
23473899|NCT00146848|65477757|FG002|Pre-randomization|Physician Decision|0|||
23473900|NCT00146848|65477755|FG000|Pre-randomization|Protocol Violation|172|||
23473901|NCT00146848|65477756|FG001|Pre-randomization|Protocol Violation|0|||
23473902|NCT00146848|65477757|FG002|Pre-randomization|Protocol Violation|0|||
23473903|NCT00146848|65477755|FG000|Pre-randomization|Withdrawal by Subject|40|||
23473904|NCT00146848|65477756|FG001|Pre-randomization|Withdrawal by Subject|0|||
23473905|NCT00146848|65477757|FG002|Pre-randomization|Withdrawal by Subject|0|||
23473906|NCT00146848|65477755|FG000|Post-randomization|Lost to Follow-up|12|||
23473907|NCT00146848|65477756|FG001|Post-randomization|Lost to Follow-up|15|||
23473908|NCT00146848|65477757|FG002|Post-randomization|Lost to Follow-up|12|||
23473909|NCT00146848|65477755|FG000|Post-randomization|Withdrawn|26|||
23588966|NCT00845832|65882288|FG001|Treatment Period|Adverse Event|2|||
23473910|NCT00146848|65477756|FG001|Post-randomization|Withdrawn|32|||
23473911|NCT00146848|65477757|FG002|Post-randomization|Withdrawn|27|||
23473912|NCT03207763|65481601|FG000|Overall Study|Lost to Follow-up|1|||
23588967|NCT00845832|65882289|FG002|Treatment Period|Adverse Event|0|||
23473913|NCT03207763|65481602|FG001|Overall Study|Lost to Follow-up|0|||
23796932|NCT00979212|66633186|FG001|Overall Study|Protocol Violation|8|||
23473914|NCT04145219|65481603|FG000|Overall Study|Adverse Event|18|||
23473915|NCT04145219|65481604|FG001|Overall Study|Adverse Event|6|||
23473916|NCT04145219|65481603|FG000|Overall Study|Lost to Follow-up|2|||
23473917|NCT04145219|65481604|FG001|Overall Study|Lost to Follow-up|3|||
23473918|NCT04145219|65481603|FG000|Overall Study|Physician Decision|0|||
23473919|NCT04145219|65481604|FG001|Overall Study|Physician Decision|2|||
23473920|NCT04145219|65481603|FG000|Overall Study|Withdrawal by Subject|12|||
23473921|NCT04145219|65481604|FG001|Overall Study|Withdrawal by Subject|8|||
23473922|NCT04145219|65481603|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
23473923|NCT04145219|65481604|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
23473924|NCT01206322|65481607|FG000|Overall Study|Adverse Event|0|||
23473925|NCT01206322|65481608|FG001|Overall Study|Adverse Event|0|||
23473926|NCT01206322|65481609|FG002|Overall Study|Adverse Event|0|||
23473927|NCT01206322|65481610|FG003|Overall Study|Adverse Event|1|||
23473928|NCT00763698|65481614|FG000|Overall Study|Unsuccessful Implant|5|||
23473929|NCT00763698|65481614|FG000|Overall Study|Death|4|||
23473930|NCT00763698|65481614|FG000|Overall Study|Withdrawal by Subject|1|||
23473931|NCT01675544|65481618|FG000|Overall Study|Withdrawal by Subject|2|||
23473932|NCT01182844|65481619|FG000|Overall Study|Withdrawal by Subject|0|||
23473933|NCT01182844|65481620|FG001|Overall Study|Withdrawal by Subject|2|||
23473934|NCT01136785|65481621|FG000|Overall Study|Protocol Violation|2|||
23473935|NCT01136785|65481622|FG001|Overall Study|Protocol Violation|1|||
23473936|NCT03288142|65481623|FG000|Overall Study|Lost to Follow-up|22|||
23473937|NCT03288142|65481624|FG001|Overall Study|Lost to Follow-up|15|||
23473938|NCT00530816|65481625|FG000|Overall Study|Progressive Disease|16|||
23473939|NCT00530816|65481626|FG001|Overall Study|Progressive Disease|24|||
23473940|NCT00530816|65481627|FG002|Overall Study|Progressive Disease|24|||
23796933|NCT00979212|66633185|FG000|Overall Study|No protocol therapy received|1|||
23796934|NCT00979212|66633186|FG001|Overall Study|No protocol therapy received|0|||
23357445|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23473941|NCT00530816|65481625|FG000|Overall Study|Adverse Event|6|||
23473942|NCT00530816|65481626|FG001|Overall Study|Adverse Event|13|||
23473943|NCT00530816|65481627|FG002|Overall Study|Adverse Event|7|||
23473944|NCT00530816|65481625|FG000|Overall Study|Other|3|||
23473945|NCT00530816|65481626|FG001|Overall Study|Other|3|||
23473946|NCT00530816|65481627|FG002|Overall Study|Other|4|||
23473947|NCT00530816|65481625|FG000|Overall Study|Withdrawal by Subject|1|||
23473948|NCT00530816|65481626|FG001|Overall Study|Withdrawal by Subject|2|||
23473949|NCT00530816|65481627|FG002|Overall Study|Withdrawal by Subject|6|||
23473950|NCT00783198|65481628|FG000|Overall Study|Adverse Event|15|||
23473951|NCT00783198|65481629|FG001|Overall Study|Adverse Event|19|||
23473952|NCT00783198|65481630|FG002|Overall Study|Adverse Event|3|||
23473953|NCT00783198|65481628|FG000|Overall Study|Lost to Follow-up|11|||
23473954|NCT00783198|65481629|FG001|Overall Study|Lost to Follow-up|1|||
23473955|NCT00783198|65481630|FG002|Overall Study|Lost to Follow-up|7|||
23473956|NCT00783198|65481628|FG000|Overall Study|Withdrawal by Subject|22|||
23473957|NCT00783198|65481629|FG001|Overall Study|Withdrawal by Subject|14|||
23473958|NCT00783198|65481630|FG002|Overall Study|Withdrawal by Subject|20|||
23473959|NCT00783198|65481628|FG000|Overall Study|Noncompliance with protocol|7|||
23473960|NCT00783198|65481629|FG001|Overall Study|Noncompliance with protocol|7|||
23473961|NCT00783198|65481630|FG002|Overall Study|Noncompliance with protocol|10|||
23473962|NCT00783198|65481628|FG000|Overall Study|Did not meet protocol eligibility|0|||
23473963|NCT00783198|65481629|FG001|Overall Study|Did not meet protocol eligibility|1|||
23473964|NCT00783198|65481630|FG002|Overall Study|Did not meet protocol eligibility|0|||
23473965|NCT00783198|65481628|FG000|Overall Study|Administrative|2|||
23473966|NCT00783198|65481629|FG001|Overall Study|Administrative|1|||
23473967|NCT00783198|65481630|FG002|Overall Study|Administrative|2|||
23357446|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
23357447|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357448|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357449|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
23357450|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
23357451|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357452|NCT00385827|65052794|FG000|Part 1|Adverse Event|1|||
23357453|NCT00385827|65052795|FG001|Part 1|Adverse Event|0|||
23357454|NCT00385827|65052796|FG002|Part 1|Adverse Event|0|||
23796935|NCT01999894|66633187|FG000|Overall Study|Adverse Event|9|||
23796936|NCT01999894|66633187|FG000|Overall Study|Lack of Efficacy|5|||
23796937|NCT01999894|66633187|FG000|Overall Study|Protocol Violation|1|||
23796938|NCT01999894|66633187|FG000|Overall Study|Withdrawal by Subject|7|||
23796939|NCT01999894|66633187|FG000|Overall Study|Lost to Follow-up|10|||
23796940|NCT01999894|66633187|FG000|Overall Study|Other Reason|3|||
23473968|NCT00160667|65481631|FG000|Overall Study|Adverse Event|3|||
23473969|NCT00160667|65481632|FG001|Overall Study|Adverse Event|1|||
23796941|NCT01999894|66633187|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
23473970|NCT00160667|65481633|FG002|Overall Study|Adverse Event|4|||
23473971|NCT00160667|65481631|FG000|Overall Study|Withdrawal by Subject|2|||
23796942|NCT01636934|66633188|FG000|Overall Study|Withdrawal by Subject|3|||
23796943|NCT01636934|66633189|FG001|Overall Study|Withdrawal by Subject|2|||
23473972|NCT00160667|65481632|FG001|Overall Study|Withdrawal by Subject|0|||
23473973|NCT00160667|65481633|FG002|Overall Study|Withdrawal by Subject|1|||
23473974|NCT00160667|65481631|FG000|Overall Study|Lack of Efficacy|0|||
23473975|NCT00160667|65481632|FG001|Overall Study|Lack of Efficacy|1|||
23473976|NCT00160667|65481633|FG002|Overall Study|Lack of Efficacy|0|||
23473977|NCT00160667|65481631|FG000|Overall Study|Protocol Violation|0|||
23473978|NCT00160667|65481632|FG001|Overall Study|Protocol Violation|1|||
23473979|NCT00160667|65481633|FG002|Overall Study|Protocol Violation|0|||
23473980|NCT00160667|65481631|FG000|Overall Study|Patient decision|0|||
23473981|NCT00160667|65481632|FG001|Overall Study|Patient decision|0|||
23473982|NCT00160667|65481633|FG002|Overall Study|Patient decision|1|||
23473983|NCT00796991|65481634|FG000|Overall Study|Adverse Event|0|||
23473984|NCT00796991|65481635|FG001|Overall Study|Adverse Event|0|||
23473985|NCT00796991|65481636|FG002|Overall Study|Adverse Event|1|||
23473986|NCT00796991|65481634|FG000|Overall Study|Death|2|||
23473987|NCT00796991|65481635|FG001|Overall Study|Death|0|||
23473988|NCT00796991|65481636|FG002|Overall Study|Death|0|||
23473989|NCT00796991|65481634|FG000|Overall Study|Disease Progression|10|||
23473990|NCT00796991|65481635|FG001|Overall Study|Disease Progression|9|||
23473991|NCT00796991|65481636|FG002|Overall Study|Disease Progression|7|||
23473992|NCT00796991|65481634|FG000|Overall Study|Study Drug Toxicity|3|||
23473993|NCT00796991|65481635|FG001|Overall Study|Study Drug Toxicity|3|||
23473994|NCT00796991|65481636|FG002|Overall Study|Study Drug Toxicity|5|||
23473995|NCT00796991|65481634|FG000|Overall Study|Withdrawal by Subject|0|||
23473996|NCT00796991|65481635|FG001|Overall Study|Withdrawal by Subject|0|||
23473997|NCT00796991|65481636|FG002|Overall Study|Withdrawal by Subject|1|||
23473998|NCT04784442|65481639|FG000|Overall Study|Adverse Event|1|||
23473999|NCT04784442|65481640|FG001|Overall Study|Adverse Event|0|||
23474000|NCT04784442|65481641|FG002|Overall Study|Adverse Event|2|||
23474001|NCT04784442|65481642|FG003|Overall Study|Adverse Event|1|||
23474002|NCT04784442|65481639|FG000|Overall Study|Protocol Violation|1|||
23474003|NCT04784442|65481640|FG001|Overall Study|Protocol Violation|0|||
23474004|NCT04784442|65481641|FG002|Overall Study|Protocol Violation|0|||
23474005|NCT04784442|65481642|FG003|Overall Study|Protocol Violation|0|||
23474006|NCT04784442|65481639|FG000|Overall Study|Non-compliance with study drug|1|||
23474007|NCT04784442|65481640|FG001|Overall Study|Non-compliance with study drug|0|||
23474008|NCT04784442|65481641|FG002|Overall Study|Non-compliance with study drug|0|||
23474009|NCT04784442|65481642|FG003|Overall Study|Non-compliance with study drug|0|||
23474010|NCT04525885|65481643|FG000|Overall Study|Screen Failure|1|||
23474011|NCT04525885|65481644|FG001|Overall Study|Screen Failure|0|||
23474012|NCT04525885|65481645|FG002|Overall Study|Screen Failure|0|||
23474013|NCT04525885|65481643|FG000|Overall Study|Withdrawal by Subject|14|||
23474014|NCT04525885|65481644|FG001|Overall Study|Withdrawal by Subject|6|||
23474015|NCT04525885|65481645|FG002|Overall Study|Withdrawal by Subject|20|||
23474016|NCT04525885|65481643|FG000|Overall Study|Physician Decision|1|||
23474017|NCT04525885|65481644|FG001|Overall Study|Physician Decision|0|||
23474018|NCT04525885|65481645|FG002|Overall Study|Physician Decision|1|||
23474019|NCT03085914|65481646|FG000|Overall Study|Death|6|||
23474020|NCT03085914|65481647|FG001|Overall Study|Death|6|||
23474021|NCT03085914|65481648|FG002|Overall Study|Death|4|||
23474022|NCT03085914|65481649|FG003|Overall Study|Death|1|||
23474023|NCT03085914|65481650|FG004|Overall Study|Death|5|||
23796944|NCT01636934|66633188|FG000|Overall Study|Chemo cancel|1|||
23474024|NCT03085914|65481651|FG005|Overall Study|Death|2|||
23474025|NCT03085914|65481652|FG006|Overall Study|Death|2|||
23474026|NCT03085914|65481646|FG000|Overall Study|Withdrawal by Subject|1|||
23474027|NCT03085914|65481647|FG001|Overall Study|Withdrawal by Subject|1|||
23474028|NCT03085914|65481648|FG002|Overall Study|Withdrawal by Subject|2|||
23474029|NCT03085914|65481649|FG003|Overall Study|Withdrawal by Subject|2|||
23796945|NCT01636934|66633189|FG001|Overall Study|Chemo cancel|0|||
23796946|NCT01636934|66633188|FG000|Overall Study|Too ill to continue|1|||
23796947|NCT01636934|66633189|FG001|Overall Study|Too ill to continue|0|||
23796948|NCT01636934|66633188|FG000|Overall Study|Never started study medication|1|||
23796949|NCT01636934|66633189|FG001|Overall Study|Never started study medication|1|||
23796950|NCT02302716|66633190|FG000|Overall Study|Adverse Event|1|||
23796951|NCT02302716|66633191|FG001|Overall Study|Adverse Event|1|||
23796952|NCT02302716|66633190|FG000|Overall Study|Death|0|||
23796953|NCT02302716|66633191|FG001|Overall Study|Death|1|||
23796954|NCT02302716|66633190|FG000|Overall Study|Lack of Efficacy|0|||
23796955|NCT02302716|66633191|FG001|Overall Study|Lack of Efficacy|1|||
23796956|NCT02302716|66633190|FG000|Overall Study|Lost to Follow-up|2|||
23796957|NCT02302716|66633191|FG001|Overall Study|Lost to Follow-up|4|||
23796958|NCT02302716|66633190|FG000|Overall Study|Physician Decision|3|||
23796959|NCT02302716|66633191|FG001|Overall Study|Physician Decision|4|||
23474030|NCT03085914|65481650|FG004|Overall Study|Withdrawal by Subject|2|||
23474031|NCT03085914|65481651|FG005|Overall Study|Withdrawal by Subject|0|||
23474032|NCT03085914|65481652|FG006|Overall Study|Withdrawal by Subject|1|||
23474033|NCT03085914|65481646|FG000|Overall Study|Lost to Follow-up|0|||
23474034|NCT03085914|65481647|FG001|Overall Study|Lost to Follow-up|0|||
23474035|NCT03085914|65481648|FG002|Overall Study|Lost to Follow-up|1|||
23474036|NCT03085914|65481649|FG003|Overall Study|Lost to Follow-up|0|||
23474037|NCT03085914|65481650|FG004|Overall Study|Lost to Follow-up|0|||
23474038|NCT03085914|65481651|FG005|Overall Study|Lost to Follow-up|1|||
23474039|NCT03085914|65481652|FG006|Overall Study|Lost to Follow-up|1|||
23474040|NCT03085914|65481646|FG000|Overall Study|Reason was not specified,|2|||
23474041|NCT03085914|65481647|FG001|Overall Study|Reason was not specified,|2|||
23474042|NCT03085914|65481648|FG002|Overall Study|Reason was not specified,|2|||
23474043|NCT03085914|65481649|FG003|Overall Study|Reason was not specified,|3|||
23474044|NCT03085914|65481650|FG004|Overall Study|Reason was not specified,|3|||
23474045|NCT03085914|65481651|FG005|Overall Study|Reason was not specified,|3|||
23474046|NCT03085914|65481652|FG006|Overall Study|Reason was not specified,|6|||
23474047|NCT03085914|65481646|FG000|Overall Study|Progressive Disease|0|||
23474048|NCT03085914|65481647|FG001|Overall Study|Progressive Disease|0|||
23474049|NCT03085914|65481648|FG002|Overall Study|Progressive Disease|2|||
23474050|NCT03085914|65481649|FG003|Overall Study|Progressive Disease|2|||
23474051|NCT03085914|65481650|FG004|Overall Study|Progressive Disease|1|||
23474052|NCT03085914|65481651|FG005|Overall Study|Progressive Disease|1|||
23474053|NCT03085914|65481652|FG006|Overall Study|Progressive Disease|1|||
23474054|NCT03085914|65481646|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23474055|NCT03085914|65481647|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23474056|NCT03085914|65481648|FG002|Overall Study|Study Terminated by the Sponsor|0|||
23474057|NCT03085914|65481649|FG003|Overall Study|Study Terminated by the Sponsor|1|||
23474058|NCT03085914|65481650|FG004|Overall Study|Study Terminated by the Sponsor|2|||
23474059|NCT03085914|65481651|FG005|Overall Study|Study Terminated by the Sponsor|1|||
23474060|NCT03085914|65481652|FG006|Overall Study|Study Terminated by the Sponsor|0|||
23474061|NCT01008423|65481653|FG000|Overall Study|Adverse Event|13|||
23474062|NCT01008423|65481654|FG001|Overall Study|Adverse Event|6|||
23474063|NCT01008423|65481653|FG000|Overall Study|Withdrawal by Subject|4|||
23474064|NCT01008423|65481654|FG001|Overall Study|Withdrawal by Subject|7|||
23474065|NCT01008423|65481653|FG000|Overall Study|Lost to Follow-up|0|||
23474066|NCT01008423|65481654|FG001|Overall Study|Lost to Follow-up|2|||
23588968|NCT00845832|65882287|FG000|Treatment Period|Protocol Violation|1|||
23588969|NCT00845832|65882288|FG001|Treatment Period|Protocol Violation|1|||
23588970|NCT00845832|65882289|FG002|Treatment Period|Protocol Violation|0|||
23588971|NCT00845832|65882287|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
23588972|NCT00845832|65882288|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
23588973|NCT00845832|65882289|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
23588974|NCT00845832|65882287|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
23588975|NCT00845832|65882288|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
23588976|NCT00845832|65882289|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
23588977|NCT00605033|65882290|FG000|Overall Study|Adverse Event|2|||
23588978|NCT00605033|65882291|FG001|Overall Study|Adverse Event|2|||
23588979|NCT00605033|65882290|FG000|Overall Study|Lost to Follow-up|1|||
23588980|NCT00605033|65882291|FG001|Overall Study|Lost to Follow-up|1|||
23588981|NCT00605033|65882290|FG000|Overall Study|Withdrawal by Subject|3|||
23588982|NCT00605033|65882291|FG001|Overall Study|Withdrawal by Subject|4|||
23588983|NCT00605033|65882290|FG000|Overall Study|Protocol Violation|1|||
23588984|NCT00605033|65882291|FG001|Overall Study|Protocol Violation|1|||
23588985|NCT02131324|65882292|FG000|Overall Study|Withdrawal by Subject|1|||
23588986|NCT02131324|65882293|FG001|Overall Study|Withdrawal by Subject|2|||
23588987|NCT02131324|65882292|FG000|Overall Study|Lost to Follow-up|1|||
23588988|NCT02131324|65882293|FG001|Overall Study|Lost to Follow-up|1|||
23588989|NCT01194258|65882297|FG000|Titration Period|Withdrawal by Subject|6|||
23588990|NCT01194258|65882298|FG001|Titration Period|Withdrawal by Subject|0|||
23588991|NCT01194258|65882299|FG002|Titration Period|Withdrawal by Subject|0|||
23588992|NCT01194258|65882300|FG003|Titration Period|Withdrawal by Subject|0|||
23588993|NCT01194258|65882301|FG004|Titration Period|Withdrawal by Subject|0|||
23588994|NCT01194258|65882297|FG000|Titration Period|Lost to Follow-up|2|||
23588995|NCT01194258|65882298|FG001|Titration Period|Lost to Follow-up|0|||
23588996|NCT01194258|65882299|FG002|Titration Period|Lost to Follow-up|0|||
23588997|NCT01194258|65882300|FG003|Titration Period|Lost to Follow-up|0|||
23588998|NCT01194258|65882301|FG004|Titration Period|Lost to Follow-up|0|||
23474067|NCT01008423|65481653|FG000|Overall Study|Low Cortisol|0|||
23474068|NCT01008423|65481654|FG001|Overall Study|Low Cortisol|1|||
23474069|NCT01008423|65481653|FG000|Overall Study|Lack of Efficacy|0|||
23474070|NCT01008423|65481654|FG001|Overall Study|Lack of Efficacy|5|||
23474071|NCT01008423|65481653|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
23474072|NCT01008423|65481654|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
23588999|NCT01194258|65882297|FG000|Titration Period|Titration failure|3|||
23589000|NCT01194258|65882298|FG001|Titration Period|Titration failure|0|||
23706854|NCT00002663|66301340|FG001|Overall Study|Adverse Event|0|||
23589001|NCT01194258|65882299|FG002|Titration Period|Titration failure|0|||
23589002|NCT01194258|65882300|FG003|Titration Period|Titration failure|0|||
23474073|NCT01008423|65481653|FG000|Overall Study|Personal Conflict|1|||
23474074|NCT01008423|65481654|FG001|Overall Study|Personal Conflict|0|||
23474075|NCT01008423|65481653|FG000|Overall Study|Other|0|||
23474076|NCT01008423|65481654|FG001|Overall Study|Other|1|||
23474077|NCT01667419|65481655|FG000|Overall Study|Reason Not Specified|1|||
23474078|NCT01667419|65481656|FG001|Overall Study|Reason Not Specified|0|||
23474079|NCT01667419|65481657|FG002|Overall Study|Reason Not Specified|0|||
23474080|NCT01667419|65481658|FG003|Overall Study|Reason Not Specified|0|||
23474081|NCT01667419|65481655|FG000|Overall Study|Withdrawal by Subject|16|||
23474082|NCT01667419|65481656|FG001|Overall Study|Withdrawal by Subject|8|||
23474083|NCT01667419|65481657|FG002|Overall Study|Withdrawal by Subject|9|||
23474084|NCT01667419|65481658|FG003|Overall Study|Withdrawal by Subject|8|||
23474085|NCT01667419|65481655|FG000|Overall Study|Non-compliance|0|||
23474086|NCT01667419|65481656|FG001|Overall Study|Non-compliance|0|||
23474087|NCT01667419|65481657|FG002|Overall Study|Non-compliance|0|||
23474088|NCT01667419|65481658|FG003|Overall Study|Non-compliance|1|||
23474089|NCT01667419|65481655|FG000|Overall Study|Protocol Violation|1|||
23474090|NCT01667419|65481656|FG001|Overall Study|Protocol Violation|0|||
23474091|NCT01667419|65481657|FG002|Overall Study|Protocol Violation|0|||
23474092|NCT01667419|65481658|FG003|Overall Study|Protocol Violation|0|||
23474093|NCT01667419|65481655|FG000|Overall Study|Lost to Follow-up|7|||
23474094|NCT01667419|65481656|FG001|Overall Study|Lost to Follow-up|6|||
23474095|NCT01667419|65481657|FG002|Overall Study|Lost to Follow-up|2|||
23474096|NCT01667419|65481658|FG003|Overall Study|Lost to Follow-up|4|||
23474097|NCT01667419|65481655|FG000|Overall Study|Death|18|||
23474098|NCT01667419|65481656|FG001|Overall Study|Death|33|||
23474099|NCT01667419|65481657|FG002|Overall Study|Death|25|||
23474100|NCT01667419|65481658|FG003|Overall Study|Death|26|||
23474101|NCT03976648|65481659|FG000|Overall Study|Adverse Event|0|||
23474102|NCT03976648|65481660|FG001|Overall Study|Adverse Event|2|||
23474103|NCT03976648|65481659|FG000|Overall Study|Study terminated by sponsor|21|||
23474104|NCT03976648|65481660|FG001|Overall Study|Study terminated by sponsor|8|||
23474105|NCT02043899|65481661|FG000|Overall Study|Adverse Event|3|||
23474106|NCT02043899|65481661|FG000|Overall Study|Physician Decision|1|||
23474107|NCT02043899|65481661|FG000|Overall Study|Withdrawal by Subject|2|||
23474108|NCT02043899|65481661|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
23474109|NCT02043899|65481661|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
23474110|NCT02043899|65481661|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
23357455|NCT00385827|65052794|FG000|Part 1|Death|2|||
23357456|NCT00385827|65052795|FG001|Part 1|Death|0|||
23357457|NCT00385827|65052796|FG002|Part 1|Death|0|||
23357458|NCT00385827|65052794|FG000|Part 1|Lack of Efficacy|5|||
23357459|NCT00385827|65052795|FG001|Part 1|Lack of Efficacy|0|||
23357460|NCT00385827|65052796|FG002|Part 1|Lack of Efficacy|0|||
23357461|NCT00385827|65052794|FG000|Part 1|Other|1|||
23357462|NCT00385827|65052795|FG001|Part 1|Other|0|||
23357463|NCT00385827|65052796|FG002|Part 1|Other|0|||
23474111|NCT02043899|65481661|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
23474112|NCT02043899|65481661|FG000|Overall Study|Treatment delayed|1|||
23474113|NCT00243841|65481662|FG000|Overall Study|Physician Decision|0|||
23589003|NCT01194258|65882301|FG004|Titration Period|Titration failure|0|||
23589004|NCT01194258|65882297|FG000|Period 1 (12 Weeks)|Death|0|||
23589005|NCT01194258|65882298|FG001|Period 1 (12 Weeks)|Death|0|||
23589006|NCT01194258|65882299|FG002|Period 1 (12 Weeks)|Death|0|||
23589007|NCT01194258|65882300|FG003|Period 1 (12 Weeks)|Death|0|||
23589008|NCT01194258|65882301|FG004|Period 1 (12 Weeks)|Death|1|||
23357464|NCT00385827|65052794|FG000|Part 2|Adverse Event|0|||
23357465|NCT00385827|65052795|FG001|Part 2|Adverse Event|6|||
23474114|NCT00243841|65481663|FG001|Overall Study|Physician Decision|0|||
23474115|NCT00243841|65481664|FG002|Overall Study|Physician Decision|1|||
23474116|NCT00243841|65481665|FG003|Overall Study|Physician Decision|0|||
23474117|NCT00243841|65481666|FG004|Overall Study|Physician Decision|0|||
23474118|NCT00243841|65481667|FG005|Overall Study|Physician Decision|2|||
23589009|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23642453|NCT00774930|66075395|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
23642454|NCT00774930|66075396|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
23474119|NCT01018810|65481668|FG000|Overall Study|Withdrawal by Subject|0|||
23474120|NCT01018810|65481669|FG001|Overall Study|Withdrawal by Subject|1|||
23474121|NCT01018810|65481670|FG002|Overall Study|Withdrawal by Subject|0|||
23474122|NCT01018810|65481671|FG003|Overall Study|Withdrawal by Subject|0|||
23474123|NCT01018810|65481672|FG004|Overall Study|Withdrawal by Subject|0|||
23474124|NCT01018810|65481668|FG000|Overall Study|Sponsor Decision|2|||
23474125|NCT01018810|65481669|FG001|Overall Study|Sponsor Decision|0|||
23474126|NCT01018810|65481670|FG002|Overall Study|Sponsor Decision|1|||
23589010|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23642455|NCT00774930|66075395|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
23357466|NCT00385827|65052796|FG002|Part 2|Adverse Event|10|||
23357467|NCT00385827|65052794|FG000|Part 2|Death|0|||
23589011|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23589012|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23589013|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
23589014|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
23589015|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
23589016|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
23589017|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
23589018|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
23589019|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23589020|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23589021|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23589022|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23642456|NCT00774930|66075396|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
23642457|NCT00774930|66075395|FG000|IOL Phase|Other|1|||
23642458|NCT00774930|66075396|FG001|IOL Phase|Other|0|||
23589023|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23589024|NCT00854906|65882302|FG000|Overall Study|One person had no ocular history|1|||
23589025|NCT00344019|65882304|FG000|Overall Study|did not meet final inclusion criteria|0|||
23589026|NCT00344019|65882305|FG001|Overall Study|did not meet final inclusion criteria|0|||
23589027|NCT00344019|65882306|FG002|Overall Study|did not meet final inclusion criteria|74|||
23589028|NCT01390402|65882307|FG000|Overall Study|Death|1|||
23589029|NCT01390402|65882307|FG000|Overall Study|Disease Progression|4|||
23589030|NCT01460290|65882308|FG000|Overall Study|Adverse Event|3|||
23589031|NCT01460290|65882308|FG000|Overall Study|Elevated liver function|1|||
23589032|NCT00547118|65882311|FG000|Overall Study|Did not qualify prior to starting drug|1|||
23589033|NCT00547118|65882312|FG001|Overall Study|Did not qualify prior to starting drug|1|||
23589034|NCT00547118|65882311|FG000|Overall Study|Study suspended|7|||
23589035|NCT00547118|65882312|FG001|Overall Study|Study suspended|8|||
23589036|NCT02261467|65882313|FG000|Overall Study|Enrolled in Error|1|||
23589037|NCT02261467|65882314|FG001|Overall Study|Enrolled in Error|0|||
23589038|NCT02261467|65882313|FG000|Overall Study|Protocol Violation|0|||
23589039|NCT02261467|65882314|FG001|Overall Study|Protocol Violation|1|||
23589040|NCT02261467|65882313|FG000|Overall Study|Personal Reasons|17|||
23589041|NCT02261467|65882314|FG001|Overall Study|Personal Reasons|22|||
23589042|NCT02261467|65882313|FG000|Overall Study|Lost to Follow-up|2|||
23589043|NCT02261467|65882314|FG001|Overall Study|Lost to Follow-up|13|||
23589044|NCT02261467|65882313|FG000|Overall Study|Adverse Event|1|||
23589045|NCT02261467|65882314|FG001|Overall Study|Adverse Event|1|||
23589046|NCT02482233|65882320|FG000|Overall Study|Lost to Follow-up|1|||
23589047|NCT02482233|65882321|FG001|Overall Study|Lost to Follow-up|1|||
23589048|NCT00130637|65882322|FG000|Overall Study|Adverse Event|2|||
23589049|NCT00130637|65882322|FG000|Overall Study|Withdrawal by Subject|1|||
23589050|NCT02281318|65882323|FG000|Overall Study|Adverse Event|2|||
23589051|NCT02281318|65882324|FG001|Overall Study|Adverse Event|2|||
23589052|NCT02281318|65882323|FG000|Overall Study|Lack of Efficacy|2|||
23589053|NCT02281318|65882324|FG001|Overall Study|Lack of Efficacy|0|||
23589054|NCT02281318|65882323|FG000|Overall Study|Lost to Follow-up|2|||
23589055|NCT02281318|65882324|FG001|Overall Study|Lost to Follow-up|1|||
23589056|NCT02281318|65882323|FG000|Overall Study|Physician Decision|2|||
23589057|NCT02281318|65882324|FG001|Overall Study|Physician Decision|0|||
23589058|NCT02281318|65882323|FG000|Overall Study|Withdrawal by Subject|6|||
23589059|NCT02281318|65882324|FG001|Overall Study|Withdrawal by Subject|2|||
23589060|NCT00922207|65885948|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
23589061|NCT00922207|65885949|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
23589062|NCT00922207|65885950|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
23589063|NCT00922207|65885948|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23589064|NCT00922207|65885949|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23589065|NCT00922207|65885950|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23589066|NCT00922207|65885948|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23589067|NCT00922207|65885949|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23589068|NCT00922207|65885950|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23589069|NCT00922207|65885948|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
23589070|NCT00922207|65885949|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23589071|NCT00922207|65885950|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23642459|NCT00774930|66075395|FG000|IOL Phase|Brain radiation|0|||
23589072|NCT00922207|65885948|FG000|Overall Study|Withdrew Consent|2|||
23589073|NCT00922207|65885949|FG001|Overall Study|Withdrew Consent|5|||
23589074|NCT00922207|65885950|FG002|Overall Study|Withdrew Consent|2|||
23589075|NCT00922207|65885948|FG000|Overall Study|Abnormality of Laboratory Test|0|||
23589076|NCT00922207|65885949|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23589077|NCT00922207|65885950|FG002|Overall Study|Abnormality of Laboratory Test|1|||
23589078|NCT02537522|65885957|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
23589079|NCT02537522|65885958|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
23589080|NCT02537522|65885959|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
23589081|NCT02537522|65885960|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
23642460|NCT00774930|66075396|FG001|IOL Phase|Brain radiation|1|||
23589082|NCT02537522|65885957|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
23589083|NCT02537522|65885958|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
23589084|NCT02537522|65885959|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
23589085|NCT02537522|65885960|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
23589086|NCT02537522|65885957|FG000|Phase I - Contralateral|incorrect randomization|0|||
23589087|NCT02537522|65885958|FG001|Phase I - Contralateral|incorrect randomization|1|||
23589088|NCT02537522|65885959|FG002|Phase I - Contralateral|incorrect randomization|0|||
23589089|NCT02537522|65885960|FG003|Phase I - Contralateral|incorrect randomization|0|||
23589090|NCT02537522|65885957|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589091|NCT02537522|65885958|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
23589092|NCT02537522|65885959|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589093|NCT02537522|65885960|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589094|NCT02537522|65885957|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589095|NCT02537522|65885958|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589096|NCT02537522|65885959|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589097|NCT02537522|65885960|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
23589098|NCT00544440|65885961|FG000|Overall Study|Other|1|||
23589099|NCT00544440|65885961|FG000|Overall Study|Adverse Event|1|||
23589100|NCT00544440|65885961|FG000|Overall Study|Withdrawal by Subject|2|||
23589101|NCT00544440|65885961|FG000|Overall Study|Subject Non-compliance|1|||
23589102|NCT00544440|65885961|FG000|Overall Study|Progressive Disease|47|||
23589103|NCT00544440|65885961|FG000|Overall Study|Other|5|||
23589104|NCT00732381|65885964|FG000|Overall Study|Adverse Event|1|||
23589105|NCT00732381|65885965|FG001|Overall Study|Adverse Event|0|||
23589106|NCT00732381|65885964|FG000|Overall Study|Treatment Failure|1|||
23589107|NCT00732381|65885965|FG001|Overall Study|Treatment Failure|1|||
23589108|NCT00003656|65885966|FG000|Overall Study|Adverse Event|0|||
23589109|NCT00003656|65885967|FG001|Overall Study|Adverse Event|1|||
23589110|NCT03439124|65885968|FG000|Overall Study|Adverse Event|2|||
23589111|NCT03439124|65885969|FG001|Overall Study|Adverse Event|0|||
23589112|NCT03439124|65885968|FG000|Overall Study|Lost to Follow-up|1|||
23589113|NCT03439124|65885969|FG001|Overall Study|Lost to Follow-up|0|||
23589114|NCT03439124|65885968|FG000|Overall Study|Other reasons|1|||
23589115|NCT03439124|65885969|FG001|Overall Study|Other reasons|0|||
23589116|NCT01591616|65885970|FG000|Overall Study|Withdrawal by Subject|1|||
23589117|NCT02045836|65885971|FG000|Overall Study|Adverse Event|4|||
23589118|NCT02045836|65885972|FG001|Overall Study|Adverse Event|4|||
23589119|NCT02045836|65885971|FG000|Overall Study|Withdrawal by Subject|1|||
23589120|NCT02045836|65885972|FG001|Overall Study|Withdrawal by Subject|1|||
23589121|NCT02045836|65885971|FG000|Overall Study|Lost to Follow-up|4|||
23589122|NCT02045836|65885972|FG001|Overall Study|Lost to Follow-up|7|||
23589123|NCT02045836|65885971|FG000|Overall Study|Migrated from study area|0|||
23589124|NCT02045836|65885972|FG001|Overall Study|Migrated from study area|2|||
23589125|NCT02000817|65885973|FG000|Overall Study|Withdrawal by Subject|2|||
23589126|NCT02000817|65885974|FG001|Overall Study|Withdrawal by Subject|0|||
23589127|NCT02000817|65885975|FG002|Overall Study|Withdrawal by Subject|0|||
23642461|NCT00774930|66075395|FG000|LTOLE Phase|Adverse Event|7|||
23642462|NCT00774930|66075396|FG001|LTOLE Phase|Adverse Event|3|||
23642463|NCT00774930|66075395|FG000|LTOLE Phase|Subject decision|0|||
23642464|NCT00774930|66075396|FG001|LTOLE Phase|Subject decision|5|||
23642465|NCT00774930|66075395|FG000|LTOLE Phase|Physician Decision|4|||
23642466|NCT00774930|66075396|FG001|LTOLE Phase|Physician Decision|1|||
23642467|NCT00774930|66075395|FG000|LTOLE Phase|Sponsor decision|2|||
23642468|NCT00774930|66075396|FG001|LTOLE Phase|Sponsor decision|1|||
23642469|NCT00774930|66075395|FG000|LTOLE Phase|Disease Progression|2|||
23642470|NCT00774930|66075396|FG001|LTOLE Phase|Disease Progression|5|||
23642471|NCT00774930|66075395|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
23642472|NCT00774930|66075396|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
23642473|NCT00774930|66075395|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
23642474|NCT00774930|66075396|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
23642475|NCT04833127|66075397|FG000|Overall Study|Lost to Follow-up|1|||
23642476|NCT04833127|66075398|FG001|Overall Study|Lost to Follow-up|1|||
23642477|NCT01293487|66075399|FG000|Overall Study|Lost to Follow-up|0|||
23589128|NCT02000817|65885976|FG003|Overall Study|Withdrawal by Subject|0|||
23589129|NCT02000817|65885973|FG000|Overall Study|Adverse Event|0|||
23589130|NCT02000817|65885974|FG001|Overall Study|Adverse Event|1|||
23589131|NCT02000817|65885975|FG002|Overall Study|Adverse Event|0|||
23589132|NCT02000817|65885976|FG003|Overall Study|Adverse Event|0|||
23589133|NCT02000817|65885973|FG000|Overall Study|Lost to Follow-up|0|||
23589134|NCT02000817|65885974|FG001|Overall Study|Lost to Follow-up|0|||
23642478|NCT01293487|66075400|FG001|Overall Study|Lost to Follow-up|0|||
23642479|NCT01293487|66075401|FG002|Overall Study|Lost to Follow-up|0|||
23642480|NCT01293487|66075402|FG003|Overall Study|Lost to Follow-up|1|||
23642481|NCT01293487|66075403|FG004|Overall Study|Lost to Follow-up|0|||
23642482|NCT01293487|66075404|FG005|Overall Study|Lost to Follow-up|0|||
23589135|NCT02000817|65885975|FG002|Overall Study|Lost to Follow-up|1|||
23589136|NCT02000817|65885976|FG003|Overall Study|Lost to Follow-up|0|||
23357468|NCT00385827|65052795|FG001|Part 2|Death|0|||
23357469|NCT00385827|65052796|FG002|Part 2|Death|2|||
23357470|NCT00385827|65052794|FG000|Part 2|Lack of Efficacy|0|||
23357471|NCT00385827|65052795|FG001|Part 2|Lack of Efficacy|14|||
23357472|NCT00385827|65052796|FG002|Part 2|Lack of Efficacy|13|||
23357473|NCT00385827|65052794|FG000|Part 2|Randomized but not treated|0|||
23357474|NCT00385827|65052795|FG001|Part 2|Randomized but not treated|2|||
23357475|NCT00385827|65052796|FG002|Part 2|Randomized but not treated|2|||
23357476|NCT00385827|65052794|FG000|Part 2|Other|0|||
23357477|NCT00385827|65052795|FG001|Part 2|Other|11|||
23357478|NCT00385827|65052796|FG002|Part 2|Other|21|||
23357479|NCT02559570|65052798|FG000|Overall Study|Adverse Event|0|||
23357480|NCT02559570|65052799|FG001|Overall Study|Adverse Event|2|||
23357481|NCT02559570|65052800|FG002|Overall Study|Adverse Event|0|||
23357482|NCT02559570|65052801|FG003|Overall Study|Adverse Event|1|||
23357483|NCT02559570|65052802|FG004|Overall Study|Adverse Event|0|||
23357484|NCT02559570|65052798|FG000|Overall Study|Withdrawal of Consent|0|||
23357485|NCT02559570|65052799|FG001|Overall Study|Withdrawal of Consent|0|||
23357486|NCT02559570|65052800|FG002|Overall Study|Withdrawal of Consent|1|||
23357487|NCT02559570|65052801|FG003|Overall Study|Withdrawal of Consent|2|||
23357488|NCT02559570|65052802|FG004|Overall Study|Withdrawal of Consent|1|||
23357489|NCT02559570|65052798|FG000|Overall Study|Lost to Follow-up|1|||
23589137|NCT05257798|65885977|FG000|Follow-up Phase|Lost to Follow-up|1|||
23589138|NCT05257798|65885978|FG001|Follow-up Phase|Lost to Follow-up|0|||
23796960|NCT02302716|66633190|FG000|Overall Study|Withdrawal by Subject|13|||
23796961|NCT02302716|66633191|FG001|Overall Study|Withdrawal by Subject|7|||
23796962|NCT02302716|66633190|FG000|Overall Study|Protocol Violation|0|||
23796963|NCT02302716|66633191|FG001|Overall Study|Protocol Violation|1|||
23796964|NCT02658019|66633192|FG000|Overall Study|Adverse Event|1|||
23796965|NCT05467982|66633193|FG000|Overall Study|Death|0|||
23796966|NCT05467982|66633194|FG001|Overall Study|Death|1|||
23796967|NCT05467982|66633193|FG000|Overall Study|Lost to Follow-up|3|||
23796968|NCT05467982|66633194|FG001|Overall Study|Lost to Follow-up|1|||
23796969|NCT01785615|66633197|FG000|Dietary Phase|Lost to Follow-up|0|||
23357490|NCT02559570|65052799|FG001|Overall Study|Lost to Follow-up|0|||
23357491|NCT02559570|65052800|FG002|Overall Study|Lost to Follow-up|0|||
23589139|NCT01835899|65885994|FG000|Overall Study|Adverse Event|0|||
23589140|NCT01835899|65885995|FG001|Overall Study|Adverse Event|0|||
23589141|NCT01835899|65885996|FG002|Overall Study|Adverse Event|1|||
23589142|NCT01835899|65885994|FG000|Overall Study|Other than stated above|0|||
23357492|NCT02559570|65052801|FG003|Overall Study|Lost to Follow-up|0|||
23357493|NCT02559570|65052802|FG004|Overall Study|Lost to Follow-up|0|||
23357494|NCT02559570|65052798|FG000|Overall Study|Protocol Violation|1|||
23589143|NCT01835899|65885995|FG001|Overall Study|Other than stated above|1|||
23796970|NCT01785615|66633198|FG001|Dietary Phase|Lost to Follow-up|0|||
23796971|NCT01785615|66633199|FG002|Dietary Phase|Lost to Follow-up|0|||
23796972|NCT01785615|66633200|FG003|Dietary Phase|Lost to Follow-up|24|||
23796973|NCT02004691|66633201|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
23357495|NCT02559570|65052799|FG001|Overall Study|Protocol Violation|0|||
23357496|NCT02559570|65052800|FG002|Overall Study|Protocol Violation|0|||
23357497|NCT02559570|65052801|FG003|Overall Study|Protocol Violation|0|||
23357498|NCT02559570|65052802|FG004|Overall Study|Protocol Violation|1|||
23357499|NCT02559570|65052798|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23642483|NCT01293487|66075405|FG006|Overall Study|Lost to Follow-up|0|||
23642484|NCT01293487|66075406|FG007|Overall Study|Lost to Follow-up|0|||
23642485|NCT01293487|66075399|FG000|Overall Study|Withdrawal by Subject|0|||
23642486|NCT01293487|66075400|FG001|Overall Study|Withdrawal by Subject|0|||
23642487|NCT01293487|66075401|FG002|Overall Study|Withdrawal by Subject|0|||
23642488|NCT01293487|66075402|FG003|Overall Study|Withdrawal by Subject|0|||
23642489|NCT01293487|66075403|FG004|Overall Study|Withdrawal by Subject|0|||
23796974|NCT02004691|66633202|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
23796975|NCT02004691|66633201|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
23796976|NCT02004691|66633202|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
23796977|NCT02004691|66633201|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
23796978|NCT02004691|66633202|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
23796979|NCT02004691|66633201|FG000|ETP: Ongoing From Week 52|Other|0|||
23796980|NCT02004691|66633202|FG001|ETP: Ongoing From Week 52|Other|1|||
23796981|NCT02004691|66633201|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
23796982|NCT02004691|66633202|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
23796983|NCT01011335|66633203|FG000|Overall Study|Lost to Follow-up|0|||
23796984|NCT01011335|66633204|FG001|Overall Study|Lost to Follow-up|0|||
23357500|NCT02559570|65052799|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23357501|NCT02559570|65052800|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23357502|NCT02559570|65052801|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23357503|NCT02559570|65052802|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23357504|NCT00624832|65052803|FG000|Overall Study|Adverse Event|0|||
23357505|NCT00624832|65052804|FG001|Overall Study|Adverse Event|1|||
23589144|NCT01835899|65885996|FG002|Overall Study|Other than stated above|0|||
23589145|NCT01596504|65885998|FG000|Overall Study|Participant's Private Reason|0|||
23796985|NCT01011335|66633205|FG002|Overall Study|Lost to Follow-up|1|||
23796986|NCT01011335|66633206|FG003|Overall Study|Lost to Follow-up|1|||
23796987|NCT01011335|66633207|FG004|Overall Study|Lost to Follow-up|1|||
23796988|NCT01011335|66633208|FG005|Overall Study|Lost to Follow-up|1|||
23796989|NCT01011335|66633209|FG006|Overall Study|Lost to Follow-up|2|||
23796990|NCT01011335|66633210|FG007|Overall Study|Lost to Follow-up|2|||
23589146|NCT01596504|65885999|FG001|Overall Study|Participant's Private Reason|1|||
23589147|NCT01596504|65886000|FG002|Overall Study|Participant's Private Reason|0|||
23589148|NCT01596504|65885998|FG000|Overall Study|Adverse Event|1|||
23589149|NCT01596504|65885999|FG001|Overall Study|Adverse Event|2|||
23589150|NCT01596504|65886000|FG002|Overall Study|Adverse Event|1|||
23357506|NCT00624832|65052805|FG002|Overall Study|Adverse Event|0|||
23357507|NCT00624832|65052806|FG003|Overall Study|Adverse Event|1|||
23589151|NCT01596504|65885998|FG000|Overall Study|Withdrawal by Subject|1|||
23589152|NCT01596504|65885999|FG001|Overall Study|Withdrawal by Subject|0|||
23642490|NCT01293487|66075404|FG005|Overall Study|Withdrawal by Subject|0|||
23642491|NCT01293487|66075405|FG006|Overall Study|Withdrawal by Subject|0|||
23642492|NCT01293487|66075406|FG007|Overall Study|Withdrawal by Subject|2|||
23642493|NCT02045875|66075408|FG000|Overall Study|Lost to Follow-up|3|||
23642494|NCT02045875|66075409|FG001|Overall Study|Lost to Follow-up|0|||
23642495|NCT02045875|66075408|FG000|Overall Study|Withdrawal by Subject|4|||
23796991|NCT01011335|66633211|FG008|Overall Study|Lost to Follow-up|1|||
23796992|NCT01011335|66633212|FG009|Overall Study|Lost to Follow-up|0|||
23796993|NCT01011335|66633213|FG010|Overall Study|Lost to Follow-up|0|||
23796994|NCT01011335|66633214|FG011|Overall Study|Lost to Follow-up|1|||
23642496|NCT02045875|66075409|FG001|Overall Study|Withdrawal by Subject|3|||
23642497|NCT01942590|66075412|FG000|Overall Study|Withdrawal by Subject|0|||
23642498|NCT01942590|66075413|FG001|Overall Study|Withdrawal by Subject|1|||
23642499|NCT01942590|66075412|FG000|Overall Study|Adverse Event|1|||
23642500|NCT01942590|66075413|FG001|Overall Study|Adverse Event|0|||
23642501|NCT00166712|66075414|FG000|Overall Study|Death|0|||
23357508|NCT00624832|65052803|FG000|Overall Study|Abnormal Laboratory Value|2|||
23357509|NCT00624832|65052804|FG001|Overall Study|Abnormal Laboratory Value|0|||
23357510|NCT00624832|65052805|FG002|Overall Study|Abnormal Laboratory Value|0|||
23357511|NCT00624832|65052806|FG003|Overall Study|Abnormal Laboratory Value|0|||
23357512|NCT00625183|65052808|FG000|Overall Study|Disease Progression|1|||
23357513|NCT02469961|65052813|FG000|Overall Study|Physician Decision|4|||
23357514|NCT02469961|65052814|FG001|Overall Study|Physician Decision|1|||
23357515|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
23357516|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
23357517|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
23357518|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
23357519|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
23357520|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
23357521|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
23357522|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
23357523|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
23357524|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
23357525|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357526|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357527|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357528|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
23357529|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357530|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357531|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
23357532|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357533|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357534|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357535|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357536|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357537|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
23357538|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357539|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357540|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357541|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357542|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357543|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357544|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357545|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357546|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357547|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357548|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357549|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357550|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
23357551|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357552|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
23357553|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357554|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357555|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357556|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23642502|NCT00166712|66075415|FG001|Overall Study|Death|1|||
23642503|NCT00166712|66075414|FG000|Overall Study|Adverse Event|1|||
23796995|NCT01011335|66633215|FG012|Overall Study|Lost to Follow-up|2|||
23642504|NCT00166712|66075415|FG001|Overall Study|Adverse Event|0|||
23642505|NCT00166712|66075414|FG000|Overall Study|Withdrawal by Subject|1|||
23642506|NCT00166712|66075415|FG001|Overall Study|Withdrawal by Subject|2|||
23357557|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357558|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357559|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
23357560|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357561|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23589153|NCT01596504|65886000|FG002|Overall Study|Withdrawal by Subject|0|||
23589154|NCT00246012|65886001|FG000|Overall Study|Adverse Event|0|||
23642507|NCT00166712|66075414|FG000|Overall Study|Physician Decision|0|||
23642508|NCT00166712|66075415|FG001|Overall Study|Physician Decision|2|||
23642509|NCT05020327|66075419|FG000|Overall Study|Physician Decision|3|||
23642510|NCT05020327|66075420|FG001|Overall Study|Physician Decision|0|||
23642511|NCT05020327|66075421|FG002|Overall Study|Physician Decision|0|||
23642512|NCT05020327|66075419|FG000|Overall Study|Withdrawal by Subject|1|||
23642513|NCT05020327|66075420|FG001|Overall Study|Withdrawal by Subject|1|||
23642514|NCT05020327|66075421|FG002|Overall Study|Withdrawal by Subject|0|||
23642515|NCT05020327|66075419|FG000|Overall Study|personal/cultural, ineligible|12|||
23642516|NCT05020327|66075420|FG001|Overall Study|personal/cultural, ineligible|0|||
23796996|NCT01011335|66633203|FG000|Overall Study|Protocol Violation|0|||
23796997|NCT01011335|66633204|FG001|Overall Study|Protocol Violation|1|||
23796998|NCT01011335|66633205|FG002|Overall Study|Protocol Violation|0|||
23796999|NCT01011335|66633206|FG003|Overall Study|Protocol Violation|0|||
23797000|NCT01011335|66633207|FG004|Overall Study|Protocol Violation|0|||
23797001|NCT01011335|66633208|FG005|Overall Study|Protocol Violation|0|||
23797002|NCT01011335|66633209|FG006|Overall Study|Protocol Violation|0|||
23797003|NCT01011335|66633210|FG007|Overall Study|Protocol Violation|0|||
23797004|NCT01011335|66633211|FG008|Overall Study|Protocol Violation|0|||
23589155|NCT00246012|65886002|FG001|Overall Study|Adverse Event|0|||
23589156|NCT00246012|65886003|FG002|Overall Study|Adverse Event|0|||
23589157|NCT00246012|65886004|FG003|Overall Study|Adverse Event|0|||
23589158|NCT00246012|65886005|FG004|Overall Study|Adverse Event|0|||
23589159|NCT00246012|65886006|FG005|Overall Study|Adverse Event|1|||
23589160|NCT00246012|65886007|FG006|Overall Study|Adverse Event|0|||
23589161|NCT00246012|65886008|FG007|Overall Study|Adverse Event|0|||
23589162|NCT00246012|65886009|FG008|Overall Study|Adverse Event|2|||
23589163|NCT00246012|65886001|FG000|Overall Study|Withdrawal by Subject|0|||
23589164|NCT00246012|65886002|FG001|Overall Study|Withdrawal by Subject|0|||
23589165|NCT00246012|65886003|FG002|Overall Study|Withdrawal by Subject|0|||
23589166|NCT00246012|65886004|FG003|Overall Study|Withdrawal by Subject|0|||
23589167|NCT00246012|65886005|FG004|Overall Study|Withdrawal by Subject|0|||
23589168|NCT00246012|65886006|FG005|Overall Study|Withdrawal by Subject|1|||
23589169|NCT00246012|65886007|FG006|Overall Study|Withdrawal by Subject|0|||
23589170|NCT00246012|65886008|FG007|Overall Study|Withdrawal by Subject|0|||
23797005|NCT01011335|66633212|FG009|Overall Study|Protocol Violation|0|||
23357562|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357563|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357564|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357565|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357566|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357567|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357568|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357569|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357570|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357571|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357572|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357573|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357574|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357575|NCT04074330|65052815|FG000|Dose Expansion (up to 42 Months)|Death|0|||
23357576|NCT04074330|65052816|FG001|Dose Expansion (up to 42 Months)|Death|0|||
23357577|NCT04074330|65052817|FG002|Dose Expansion (up to 42 Months)|Death|0|||
23357578|NCT04074330|65052818|FG003|Dose Expansion (up to 42 Months)|Death|0|||
23357579|NCT04074330|65052819|FG004|Dose Expansion (up to 42 Months)|Death|0|||
23357580|NCT04074330|65052820|FG005|Dose Expansion (up to 42 Months)|Death|0|||
23357581|NCT04074330|65052821|FG006|Dose Expansion (up to 42 Months)|Death|0|||
23357582|NCT04074330|65052822|FG007|Dose Expansion (up to 42 Months)|Death|0|||
23357583|NCT04074330|65052823|FG008|Dose Expansion (up to 42 Months)|Death|1|||
23357584|NCT04074330|65052824|FG009|Dose Expansion (up to 42 Months)|Death|0|||
23357585|NCT04074330|65052815|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357586|NCT04074330|65052816|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357587|NCT04074330|65052817|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357588|NCT04074330|65052818|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357589|NCT04074330|65052819|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357590|NCT04074330|65052820|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357591|NCT04074330|65052821|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357592|NCT04074330|65052822|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357593|NCT04074330|65052823|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
23357594|NCT04074330|65052824|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
23357595|NCT01909973|65052825|FG000|Overall Study|Lost to Follow-up|1|||
23357596|NCT01909973|65052826|FG001|Overall Study|Lost to Follow-up|0|||
23357597|NCT02383355|65052827|FG000|Overall Study|Adverse Event|2|||
23357598|NCT02383355|65052828|FG001|Overall Study|Adverse Event|0|||
23357599|NCT04625413|65052829|FG000|Overall Study|Hospice|2|||
23357600|NCT04625413|65052829|FG000|Overall Study|Distress|1|||
23589171|NCT00246012|65886009|FG008|Overall Study|Withdrawal by Subject|0|||
23589172|NCT00246012|65886001|FG000|Overall Study|Disease progression|3|||
23797006|NCT01011335|66633213|FG010|Overall Study|Protocol Violation|0|||
23797007|NCT01011335|66633214|FG011|Overall Study|Protocol Violation|0|||
23797008|NCT01011335|66633215|FG012|Overall Study|Protocol Violation|0|||
23797009|NCT01011335|66633203|FG000|Overall Study|Moved/deployed or no booster|1|||
23797010|NCT01011335|66633204|FG001|Overall Study|Moved/deployed or no booster|0|||
23797011|NCT01011335|66633205|FG002|Overall Study|Moved/deployed or no booster|0|||
23797012|NCT01011335|66633206|FG003|Overall Study|Moved/deployed or no booster|1|||
23797013|NCT01011335|66633207|FG004|Overall Study|Moved/deployed or no booster|0|||
23797014|NCT01011335|66633208|FG005|Overall Study|Moved/deployed or no booster|0|||
23797015|NCT01011335|66633209|FG006|Overall Study|Moved/deployed or no booster|1|||
23797016|NCT01011335|66633210|FG007|Overall Study|Moved/deployed or no booster|0|||
23797017|NCT01011335|66633211|FG008|Overall Study|Moved/deployed or no booster|1|||
23797018|NCT01011335|66633212|FG009|Overall Study|Moved/deployed or no booster|0|||
23797019|NCT01011335|66633213|FG010|Overall Study|Moved/deployed or no booster|2|||
23797020|NCT01011335|66633214|FG011|Overall Study|Moved/deployed or no booster|0|||
23797021|NCT01011335|66633215|FG012|Overall Study|Moved/deployed or no booster|0|||
23797022|NCT01011335|66633203|FG000|Overall Study|Adverse Event|0|||
23797023|NCT01011335|66633204|FG001|Overall Study|Adverse Event|0|||
23797024|NCT01011335|66633205|FG002|Overall Study|Adverse Event|0|||
23797025|NCT01011335|66633206|FG003|Overall Study|Adverse Event|0|||
23589173|NCT00246012|65886002|FG001|Overall Study|Disease progression|1|||
23797026|NCT01011335|66633207|FG004|Overall Study|Adverse Event|0|||
23797027|NCT01011335|66633208|FG005|Overall Study|Adverse Event|0|||
23357601|NCT04625413|65052829|FG000|Overall Study|Not feeling well|1|||
23357602|NCT00560703|65052834|FG000|Overall Study|Adverse Event|0|||
23357603|NCT00560703|65052835|FG001|Overall Study|Adverse Event|2|||
23357604|NCT00560703|65052834|FG000|Overall Study|Protocol Violation|0|||
23797028|NCT01011335|66633209|FG006|Overall Study|Adverse Event|0|||
23797029|NCT01011335|66633210|FG007|Overall Study|Adverse Event|0|||
23797030|NCT01011335|66633211|FG008|Overall Study|Adverse Event|0|||
23797031|NCT01011335|66633212|FG009|Overall Study|Adverse Event|0|||
23357605|NCT00560703|65052835|FG001|Overall Study|Protocol Violation|2|||
23357606|NCT00560703|65052834|FG000|Overall Study|Withdrawal by Subject|0|||
23357607|NCT00560703|65052835|FG001|Overall Study|Withdrawal by Subject|1|||
23357608|NCT00560703|65052834|FG000|Overall Study|non-compliance|0|||
23357609|NCT00560703|65052835|FG001|Overall Study|non-compliance|1|||
23357610|NCT01763203|65052836|FG000|Overall Study|Death|4|||
23357611|NCT01763203|65052837|FG001|Overall Study|Death|7|||
23357612|NCT01763203|65052836|FG000|Overall Study|Lost to Follow-up|12|||
23357613|NCT01763203|65052837|FG001|Overall Study|Lost to Follow-up|12|||
23357614|NCT01763203|65052836|FG000|Overall Study|Withdrawal by Subject|8|||
23357615|NCT01763203|65052837|FG001|Overall Study|Withdrawal by Subject|12|||
23357616|NCT01763203|65052836|FG000|Overall Study|Moved out of study region|7|||
23357617|NCT01763203|65052837|FG001|Overall Study|Moved out of study region|10|||
23357618|NCT01763203|65052836|FG000|Overall Study|Physician Decision|2|||
23642517|NCT05020327|66075421|FG002|Overall Study|personal/cultural, ineligible|0|||
23642518|NCT03316300|66075423|FG000|Overall Study|Withdrawal by Subject|3|||
23642519|NCT03316300|66075424|FG001|Overall Study|Withdrawal by Subject|2|||
23642520|NCT03316300|66075423|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
23642521|NCT03316300|66075424|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
23642522|NCT03316300|66075423|FG000|Overall Study|Adverse Event|1|||
23642523|NCT03316300|66075424|FG001|Overall Study|Adverse Event|0|||
23642524|NCT03316300|66075423|FG000|Overall Study|COVID-19|0|||
23642525|NCT03316300|66075424|FG001|Overall Study|COVID-19|1|||
23642526|NCT03446781|66075425|FG000|Overall Study|Lost to Follow-up|11|||
23642527|NCT03446781|66075426|FG001|Overall Study|Lost to Follow-up|5|||
23642528|NCT03446781|66075425|FG000|Overall Study|Withdrawal by Subject|9|||
23642529|NCT03446781|66075426|FG001|Overall Study|Withdrawal by Subject|7|||
23642530|NCT03446781|66075425|FG000|Overall Study|Adverse Event|8|||
23642531|NCT03446781|66075426|FG001|Overall Study|Adverse Event|2|||
23642532|NCT03446781|66075425|FG000|Overall Study|Protocol Violation|0|||
23642533|NCT03446781|66075426|FG001|Overall Study|Protocol Violation|3|||
23642534|NCT02112708|66075427|FG000|Baseline|Physician Decision|16|||
23357619|NCT01763203|65052837|FG001|Overall Study|Physician Decision|1|||
23357620|NCT01904032|65052838|FG000|Overall Study|Adverse Event|3|||
23642535|NCT02112708|66075428|FG001|Baseline|Physician Decision|11|||
23642536|NCT02112708|66075427|FG000|Baseline|Lost to Follow-up|12|||
23357621|NCT01904032|65052839|FG001|Overall Study|Adverse Event|1|||
23642537|NCT02112708|66075428|FG001|Baseline|Lost to Follow-up|0|||
23642538|NCT02112708|66075427|FG000|4 Month|Death|0|||
23642539|NCT02112708|66075428|FG001|4 Month|Death|1|||
23642540|NCT02112708|66075427|FG000|4 Month|Withdrawal by Subject|12|||
23642541|NCT02112708|66075428|FG001|4 Month|Withdrawal by Subject|0|||
23642542|NCT01153958|66075429|FG000|Overall Study|Study Terminated|36|||
23642543|NCT01153958|66075430|FG001|Overall Study|Study Terminated|32|||
23642544|NCT04289051|66075431|FG000|Overall Study|Lost to Follow-up|0|||
23642545|NCT04289051|66075432|FG001|Overall Study|Lost to Follow-up|0|||
23642546|NCT04289051|66075433|FG002|Overall Study|Lost to Follow-up|2|||
23642547|NCT00470366|66075436|FG000|Overall Study|Adverse Event|3|||
23642548|NCT00470366|66075436|FG000|Overall Study|Poor compliance|1|||
23642549|NCT03694275|66075437|FG000|Overall Study|Adverse Event|0|||
23642550|NCT03694275|66075438|FG001|Overall Study|Adverse Event|1|||
23642551|NCT03694275|66075437|FG000|Overall Study|Reason not Specified|0|||
23642552|NCT03694275|66075438|FG001|Overall Study|Reason not Specified|1|||
23642553|NCT00116753|66075440|FG000|Overall Study|Adverse Event|16|||
23642554|NCT00116753|66075441|FG001|Overall Study|Adverse Event|10|||
23642555|NCT00116753|66075442|FG002|Overall Study|Adverse Event|7|||
23642556|NCT00116753|66075440|FG000|Overall Study|Withdrawal by Subject|11|||
23642557|NCT00116753|66075441|FG001|Overall Study|Withdrawal by Subject|12|||
23642558|NCT00116753|66075442|FG002|Overall Study|Withdrawal by Subject|8|||
23642559|NCT00116753|66075440|FG000|Overall Study|Lost to Follow-up|0|||
23642560|NCT00116753|66075441|FG001|Overall Study|Lost to Follow-up|2|||
23642561|NCT00116753|66075442|FG002|Overall Study|Lost to Follow-up|1|||
23642562|NCT00116753|66075440|FG000|Overall Study|Protocol Violation|0|||
23642563|NCT00116753|66075441|FG001|Overall Study|Protocol Violation|0|||
23642564|NCT00116753|66075442|FG002|Overall Study|Protocol Violation|1|||
23642565|NCT00116753|66075440|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
23642566|NCT00116753|66075441|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
23642567|NCT00116753|66075442|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
23642568|NCT00116753|66075440|FG000|Overall Study|Disease Progression|3|||
23642569|NCT00116753|66075441|FG001|Overall Study|Disease Progression|4|||
23642570|NCT00116753|66075442|FG002|Overall Study|Disease Progression|3|||
23642571|NCT00116753|66075440|FG000|Overall Study|Abnormal Echocardiogram|0|||
23642572|NCT00116753|66075441|FG001|Overall Study|Abnormal Echocardiogram|0|||
23642573|NCT00116753|66075442|FG002|Overall Study|Abnormal Echocardiogram|1|||
23642574|NCT00116753|66075440|FG000|Overall Study|Progressive Parkinson's Disease|1|||
23642575|NCT00116753|66075441|FG001|Overall Study|Progressive Parkinson's Disease|0|||
23642576|NCT00116753|66075442|FG002|Overall Study|Progressive Parkinson's Disease|0|||
23642577|NCT00116753|66075440|FG000|Overall Study|Dosing Error|0|||
23642578|NCT00116753|66075441|FG001|Overall Study|Dosing Error|1|||
23642579|NCT00116753|66075442|FG002|Overall Study|Dosing Error|0|||
23642580|NCT04488770|66075443|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23797032|NCT01011335|66633213|FG010|Overall Study|Adverse Event|4|||
23797033|NCT01011335|66633214|FG011|Overall Study|Adverse Event|0|||
23797034|NCT01011335|66633215|FG012|Overall Study|Adverse Event|1|||
23797035|NCT03877926|66633218|FG000|Overall Study|Adverse Event|1|||
23797036|NCT03877926|66633219|FG001|Overall Study|Adverse Event|0|||
23797037|NCT03877926|66633220|FG002|Overall Study|Adverse Event|0|||
23797038|NCT03877926|66633221|FG003|Overall Study|Adverse Event|0|||
23797039|NCT03877926|66633218|FG000|Overall Study|Death|2|||
23797040|NCT03877926|66633219|FG001|Overall Study|Death|2|||
23797041|NCT03877926|66633220|FG002|Overall Study|Death|2|||
23797042|NCT03877926|66633221|FG003|Overall Study|Death|0|||
23642581|NCT04488770|66075444|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642582|NCT04488770|66075445|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642583|NCT04488770|66075446|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
23642584|NCT04488770|66075447|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642585|NCT04488770|66075448|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23357622|NCT01904032|65052838|FG000|Overall Study|Lost to Follow-up|4|||
23642586|NCT04488770|66075449|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23797043|NCT03877926|66633218|FG000|Overall Study|Lost to Follow-up|41|||
23797044|NCT03877926|66633219|FG001|Overall Study|Lost to Follow-up|52|||
23642587|NCT04488770|66075450|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642588|NCT04488770|66075451|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642589|NCT04488770|66075452|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642590|NCT04488770|66075453|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642591|NCT04488770|66075454|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23706855|NCT00002663|66301341|FG002|Overall Study|Adverse Event|0|||
23706856|NCT00002663|66301342|FG003|Overall Study|Adverse Event|1|||
23706857|NCT00002663|66301343|FG004|Overall Study|Adverse Event|0|||
23797045|NCT03877926|66633220|FG002|Overall Study|Lost to Follow-up|45|||
23474127|NCT01018810|65481671|FG003|Overall Study|Sponsor Decision|1|||
23474128|NCT01018810|65481672|FG004|Overall Study|Sponsor Decision|1|||
23474129|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474130|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
23474131|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474132|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474133|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474134|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474135|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474136|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474137|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23357623|NCT01904032|65052839|FG001|Overall Study|Lost to Follow-up|2|||
23357624|NCT01006590|65052840|FG000|Overall Study|Adverse Event|2|||
23474138|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474139|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474140|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474141|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474142|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474143|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474144|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474145|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474146|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474147|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474148|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
23474149|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474150|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474151|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474152|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474153|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474154|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474155|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474156|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474157|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474158|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
23474159|NCT01227018|65481684|FG000|Overall Study|Disease progression|9|||
23474160|NCT01227018|65481684|FG000|Overall Study|Toxicity|2|||
23474161|NCT01227018|65481684|FG000|Overall Study|Withdrew after beginning treatment|4|||
23474162|NCT01541397|65481689|FG000|Overall Study|Study ended prior to data collection|4|||
23474163|NCT01541397|65481690|FG001|Overall Study|Study ended prior to data collection|2|||
23474164|NCT00881868|65481692|FG000|Overall Study|Adverse Event|0|||
23474165|NCT00881868|65481693|FG001|Overall Study|Adverse Event|1|||
23474166|NCT00881868|65481692|FG000|Overall Study|Lost to Follow-up|2|||
23474167|NCT00881868|65481693|FG001|Overall Study|Lost to Follow-up|1|||
23474168|NCT00881868|65481692|FG000|Overall Study|Physician Decision|4|||
23474169|NCT00881868|65481693|FG001|Overall Study|Physician Decision|0|||
23474170|NCT00881868|65481692|FG000|Overall Study|Protocol Violation|2|||
23474171|NCT00881868|65481693|FG001|Overall Study|Protocol Violation|0|||
23474172|NCT01086358|65481694|FG000|First Intervention|Lost to Follow-up|9|||
23474173|NCT01086358|65481695|FG001|First Intervention|Lost to Follow-up|4|||
23474174|NCT01086358|65481694|FG000|First Intervention|Withdrawal by Subject|0|||
23474175|NCT01086358|65481695|FG001|First Intervention|Withdrawal by Subject|1|||
23474176|NCT01086358|65481694|FG000|Second Intervention|Lost to Follow-up|4|||
23474177|NCT01086358|65481695|FG001|Second Intervention|Lost to Follow-up|4|||
23474178|NCT03753789|65481696|FG000|Overall Study|Withdrawal by Subject|2|||
23474179|NCT04881942|65481697|FG000|Overall Study|Adverse Event|0|||
23474180|NCT04881942|65481698|FG001|Overall Study|Adverse Event|0|||
23474181|NCT04881942|65481699|FG002|Overall Study|Adverse Event|0|||
23474182|NCT04881942|65481700|FG003|Overall Study|Adverse Event|0|||
23474183|NCT04881942|65481701|FG004|Overall Study|Adverse Event|1|||
23474184|NCT04881942|65481697|FG000|Overall Study|Alternates|0|||
23474185|NCT04881942|65481698|FG001|Overall Study|Alternates|0|||
23474186|NCT04881942|65481699|FG002|Overall Study|Alternates|0|||
23474187|NCT04881942|65481700|FG003|Overall Study|Alternates|0|||
23474188|NCT04881942|65481701|FG004|Overall Study|Alternates|2|||
23474189|NCT03255083|65481703|FG000|Overall Study|Clinical progression|1|||
23474190|NCT03255083|65481704|FG001|Overall Study|Clinical progression|0|||
23474191|NCT03255083|65481705|FG002|Overall Study|Clinical progression|0|||
23474192|NCT03255083|65481706|FG003|Overall Study|Clinical progression|0|||
23474193|NCT03255083|65481703|FG000|Overall Study|Adverse Event|0|||
23474194|NCT03255083|65481704|FG001|Overall Study|Adverse Event|1|||
23474195|NCT03255083|65481705|FG002|Overall Study|Adverse Event|0|||
23474196|NCT03255083|65481706|FG003|Overall Study|Adverse Event|0|||
23474197|NCT03255083|65481703|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
23474198|NCT03255083|65481704|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
23474199|NCT03255083|65481705|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
23589174|NCT00246012|65886003|FG002|Overall Study|Disease progression|2|||
23589175|NCT00246012|65886004|FG003|Overall Study|Disease progression|3|||
23589176|NCT00246012|65886005|FG004|Overall Study|Disease progression|3|||
23589177|NCT00246012|65886006|FG005|Overall Study|Disease progression|25|||
23589178|NCT00246012|65886007|FG006|Overall Study|Disease progression|30|||
23589179|NCT00246012|65886008|FG007|Overall Study|Disease progression|27|||
23589180|NCT00246012|65886009|FG008|Overall Study|Disease progression|26|||
23589181|NCT00246012|65886001|FG000|Overall Study|Other|0|||
23589182|NCT00246012|65886002|FG001|Overall Study|Other|0|||
23589183|NCT00246012|65886003|FG002|Overall Study|Other|0|||
23589184|NCT00246012|65886004|FG003|Overall Study|Other|0|||
23589185|NCT00246012|65886005|FG004|Overall Study|Other|0|||
23589186|NCT00246012|65886006|FG005|Overall Study|Other|0|||
23589187|NCT00246012|65886007|FG006|Overall Study|Other|0|||
23589188|NCT00246012|65886008|FG007|Overall Study|Other|1|||
23589189|NCT00246012|65886009|FG008|Overall Study|Other|0|||
23589190|NCT00246012|65886001|FG000|Overall Study|Randomly assigned but not treated|0|||
23589191|NCT00246012|65886002|FG001|Overall Study|Randomly assigned but not treated|0|||
23589192|NCT00246012|65886003|FG002|Overall Study|Randomly assigned but not treated|0|||
23589193|NCT00246012|65886004|FG003|Overall Study|Randomly assigned but not treated|0|||
23589194|NCT00246012|65886005|FG004|Overall Study|Randomly assigned but not treated|0|||
23589195|NCT00246012|65886006|FG005|Overall Study|Randomly assigned but not treated|1|||
23589196|NCT00246012|65886007|FG006|Overall Study|Randomly assigned but not treated|1|||
23589197|NCT00246012|65886008|FG007|Overall Study|Randomly assigned but not treated|0|||
23589198|NCT00246012|65886009|FG008|Overall Study|Randomly assigned but not treated|0|||
23589199|NCT01490580|65886010|FG000|Overall Study|Parents withdrew consent|0|||
23589200|NCT01490580|65886011|FG001|Overall Study|Parents withdrew consent|2|||
23589201|NCT02026258|65886012|FG000|Randomized|Did not start treatment|2|||
23589202|NCT02026258|65886013|FG001|Randomized|Did not start treatment|1|||
23589203|NCT02026258|65886012|FG000|Randomized|Change in treatment plan|1|||
23589204|NCT02026258|65886013|FG001|Randomized|Change in treatment plan|0|||
23589205|NCT02026258|65886012|FG000|Randomized|Presence of periodontal disease|1|||
23589206|NCT02026258|65886013|FG001|Randomized|Presence of periodontal disease|1|||
23589207|NCT02026258|65886012|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
23589208|NCT02026258|65886013|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
23589209|NCT02026258|65886012|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
23589210|NCT02026258|65886013|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
23589211|NCT03743246|65886018|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589212|NCT03743246|65886019|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589213|NCT03743246|65886020|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
23589214|NCT03743246|65886021|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589215|NCT03743246|65886018|FG000|Pre-Treatment Period|Death|0|||
23589216|NCT03743246|65886019|FG001|Pre-Treatment Period|Death|1|||
23589217|NCT03743246|65886020|FG002|Pre-Treatment Period|Death|0|||
23589218|NCT03743246|65886021|FG003|Pre-Treatment Period|Death|1|||
23642592|NCT04488770|66075455|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23642593|NCT04488770|66075443|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
23642594|NCT04488770|66075444|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642595|NCT04488770|66075445|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642596|NCT04488770|66075446|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642597|NCT04488770|66075447|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642598|NCT04488770|66075448|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642599|NCT04488770|66075449|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23797046|NCT03877926|66633221|FG003|Overall Study|Lost to Follow-up|17|||
23589219|NCT03743246|65886018|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
23589220|NCT03743246|65886019|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23706858|NCT00002663|66301344|FG005|Overall Study|Adverse Event|0|||
23797047|NCT03877926|66633218|FG000|Overall Study|Physician Decision|2|||
23589221|NCT03743246|65886020|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23589222|NCT03743246|65886021|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23589223|NCT03743246|65886018|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
23589224|NCT03743246|65886019|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23589225|NCT03743246|65886020|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23474200|NCT03255083|65481706|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
23474201|NCT03255083|65481703|FG000|Overall Study|Withdrawal by Subject|1|||
23474202|NCT03255083|65481704|FG001|Overall Study|Withdrawal by Subject|1|||
23474203|NCT03255083|65481705|FG002|Overall Study|Withdrawal by Subject|1|||
23474204|NCT03255083|65481706|FG003|Overall Study|Withdrawal by Subject|0|||
23474205|NCT01754402|65481707|FG000|Overall Study|Death|0|||
23474206|NCT01754402|65481708|FG001|Overall Study|Death|0|||
23474207|NCT01754402|65481709|FG002|Overall Study|Death|1|||
23474208|NCT01754402|65481707|FG000|Overall Study|Adverse Event|2|||
23474209|NCT01754402|65481708|FG001|Overall Study|Adverse Event|2|||
23474210|NCT01754402|65481709|FG002|Overall Study|Adverse Event|1|||
23474211|NCT01754402|65481707|FG000|Overall Study|Withdrawal by Subject|0|||
23474212|NCT01754402|65481708|FG001|Overall Study|Withdrawal by Subject|0|||
23474213|NCT01754402|65481709|FG002|Overall Study|Withdrawal by Subject|1|||
23474214|NCT01754402|65481707|FG000|Overall Study|Lack of Efficacy|0|||
23474215|NCT01754402|65481708|FG001|Overall Study|Lack of Efficacy|0|||
23474216|NCT01754402|65481709|FG002|Overall Study|Lack of Efficacy|1|||
23474217|NCT01451437|65481710|FG000|Overall Study|Adverse Event|0|||
23474218|NCT01451437|65481711|FG001|Overall Study|Adverse Event|0|||
23474219|NCT01451437|65481712|FG002|Overall Study|Adverse Event|0|||
23474220|NCT01451437|65481713|FG003|Overall Study|Adverse Event|0|||
23474221|NCT01451437|65481714|FG004|Overall Study|Adverse Event|0|||
23474222|NCT01451437|65481715|FG005|Overall Study|Adverse Event|1|||
23797048|NCT03877926|66633219|FG001|Overall Study|Physician Decision|0|||
23797049|NCT03877926|66633220|FG002|Overall Study|Physician Decision|2|||
23797050|NCT03877926|66633221|FG003|Overall Study|Physician Decision|0|||
23797051|NCT03877926|66633218|FG000|Overall Study|Withdrawal by Subject|18|||
23797052|NCT03877926|66633219|FG001|Overall Study|Withdrawal by Subject|21|||
23797053|NCT03877926|66633220|FG002|Overall Study|Withdrawal by Subject|12|||
23797054|NCT03877926|66633221|FG003|Overall Study|Withdrawal by Subject|4|||
23797055|NCT03877926|66633218|FG000|Overall Study|Other - Various|4|||
23797056|NCT03877926|66633219|FG001|Overall Study|Other - Various|1|||
23474223|NCT01451437|65481716|FG006|Overall Study|Adverse Event|1|||
23474224|NCT01451437|65481717|FG007|Overall Study|Adverse Event|2|||
23797057|NCT03877926|66633220|FG002|Overall Study|Other - Various|1|||
23797058|NCT03877926|66633221|FG003|Overall Study|Other - Various|0|||
23797059|NCT03877926|66633218|FG000|Overall Study|Not Treated|3|||
23797060|NCT03877926|66633219|FG001|Overall Study|Not Treated|1|||
23797061|NCT03877926|66633220|FG002|Overall Study|Not Treated|1|||
23797062|NCT03877926|66633221|FG003|Overall Study|Not Treated|0|||
23797063|NCT00460109|66633222|FG000|Overall Study|Death|1|||
23797064|NCT00557245|66633223|FG000|Overall Study|Lost to Follow-up|7|||
23797065|NCT00557245|66633224|FG001|Overall Study|Lost to Follow-up|8|||
23474225|NCT01451437|65481718|FG008|Overall Study|Adverse Event|1|||
23474226|NCT01451437|65481710|FG000|Overall Study|Physician Decision|1|||
23474227|NCT01451437|65481711|FG001|Overall Study|Physician Decision|1|||
23589226|NCT03743246|65886021|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23357625|NCT01006590|65052841|FG001|Overall Study|Adverse Event|3|||
23357626|NCT01006590|65052840|FG000|Overall Study|Death|1|||
23589227|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
23589228|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23589229|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23589230|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23642600|NCT04488770|66075450|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23797066|NCT00557245|66633225|FG002|Overall Study|Lost to Follow-up|10|||
23797067|NCT00557245|66633223|FG000|Overall Study|Ineligible|5|||
23797068|NCT00557245|66633224|FG001|Overall Study|Ineligible|4|||
23797069|NCT00557245|66633225|FG002|Overall Study|Ineligible|2|||
23797070|NCT02688387|66633226|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23474228|NCT01451437|65481712|FG002|Overall Study|Physician Decision|2|||
23474229|NCT01451437|65481713|FG003|Overall Study|Physician Decision|0|||
23474230|NCT01451437|65481714|FG004|Overall Study|Physician Decision|0|||
23474231|NCT01451437|65481715|FG005|Overall Study|Physician Decision|0|||
23474232|NCT01451437|65481716|FG006|Overall Study|Physician Decision|0|||
23797071|NCT02688387|66633227|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23642601|NCT04488770|66075451|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642602|NCT04488770|66075452|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23797072|NCT02688387|66633228|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
23797073|NCT02688387|66633229|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797074|NCT02688387|66633230|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23357627|NCT01006590|65052841|FG001|Overall Study|Death|1|||
23474233|NCT01451437|65481717|FG007|Overall Study|Physician Decision|0|||
23474234|NCT01451437|65481718|FG008|Overall Study|Physician Decision|0|||
23474235|NCT01451437|65481710|FG000|Overall Study|Disease Progression|0|||
23474236|NCT01451437|65481711|FG001|Overall Study|Disease Progression|0|||
23474237|NCT01451437|65481712|FG002|Overall Study|Disease Progression|1|||
23474238|NCT01451437|65481713|FG003|Overall Study|Disease Progression|1|||
23474239|NCT01451437|65481714|FG004|Overall Study|Disease Progression|3|||
23474240|NCT01451437|65481715|FG005|Overall Study|Disease Progression|2|||
23474241|NCT01451437|65481716|FG006|Overall Study|Disease Progression|3|||
23474242|NCT01451437|65481717|FG007|Overall Study|Disease Progression|1|||
23474243|NCT01451437|65481718|FG008|Overall Study|Disease Progression|3|||
23474244|NCT01451437|65481710|FG000|Overall Study|Protocol Violation|0|||
23474245|NCT01451437|65481711|FG001|Overall Study|Protocol Violation|0|||
23474246|NCT01451437|65481712|FG002|Overall Study|Protocol Violation|0|||
23474247|NCT01451437|65481713|FG003|Overall Study|Protocol Violation|0|||
23474248|NCT01451437|65481714|FG004|Overall Study|Protocol Violation|0|||
23474249|NCT01451437|65481715|FG005|Overall Study|Protocol Violation|0|||
23474250|NCT01451437|65481716|FG006|Overall Study|Protocol Violation|1|||
23474251|NCT01451437|65481717|FG007|Overall Study|Protocol Violation|0|||
23474252|NCT01451437|65481718|FG008|Overall Study|Protocol Violation|0|||
23474253|NCT01451437|65481710|FG000|Overall Study|Withdrawal by Subject|0|||
23474254|NCT01451437|65481711|FG001|Overall Study|Withdrawal by Subject|0|||
23474255|NCT01451437|65481712|FG002|Overall Study|Withdrawal by Subject|0|||
23474256|NCT01451437|65481713|FG003|Overall Study|Withdrawal by Subject|0|||
23474257|NCT01451437|65481714|FG004|Overall Study|Withdrawal by Subject|1|||
23474258|NCT01451437|65481715|FG005|Overall Study|Withdrawal by Subject|0|||
23474259|NCT01451437|65481716|FG006|Overall Study|Withdrawal by Subject|1|||
23474260|NCT01451437|65481717|FG007|Overall Study|Withdrawal by Subject|0|||
23474261|NCT01451437|65481718|FG008|Overall Study|Withdrawal by Subject|0|||
23474262|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
23474263|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
23474264|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
23474265|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
23474266|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
23474267|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
23474268|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
23474269|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
23474270|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
23474271|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
23474272|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
23474273|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
23474274|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
23474275|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
23474276|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
23474277|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
23474278|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
23474279|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
23474280|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
23474281|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
23474282|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
23474283|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
23474284|NCT00612105|65481721|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
23474285|NCT00612105|65481722|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
23474286|NCT02870933|65481725|FG000|Overall Study|Death|2|||
23474287|NCT02870933|65481726|FG001|Overall Study|Death|1|||
23589231|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23589232|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
23589233|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23589234|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23474288|NCT02870933|65481725|FG000|Overall Study|Withdrawal by Subject|0|||
23589235|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
23642603|NCT04488770|66075453|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23474289|NCT02870933|65481726|FG001|Overall Study|Withdrawal by Subject|1|||
23474290|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23474291|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23474292|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
23474293|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
23474294|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23474295|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23474296|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
23474297|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
23474298|NCT02547363|65481727|FG000|12-month Follow-up|Withdrawal by Subject|4|||
23474299|NCT02547363|65481728|FG001|12-month Follow-up|Withdrawal by Subject|3|||
23474300|NCT02547363|65481727|FG000|12-month Follow-up|Lost to Follow-up|4|||
23474301|NCT02547363|65481728|FG001|12-month Follow-up|Lost to Follow-up|1|||
23474302|NCT02547363|65481727|FG000|12-month Follow-up|Lack of Efficacy|1|||
23474303|NCT02547363|65481728|FG001|12-month Follow-up|Lack of Efficacy|1|||
23474304|NCT02547363|65481727|FG000|12-month Follow-up|Other|1|||
23474305|NCT02547363|65481728|FG001|12-month Follow-up|Other|0|||
23474306|NCT01090323|65481729|FG000|Overall Study|Adverse Event|12|||
23474307|NCT01090323|65481730|FG001|Overall Study|Adverse Event|2|||
23474308|NCT01090323|65481729|FG000|Overall Study|Abnormal Lab Values|3|||
23474309|NCT01090323|65481730|FG001|Overall Study|Abnormal Lab Values|1|||
23474310|NCT01090323|65481729|FG000|Overall Study|Abnormal Test Procedure Results|2|||
23474311|NCT01090323|65481730|FG001|Overall Study|Abnormal Test Procedure Results|0|||
23474312|NCT01090323|65481729|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23474313|NCT01090323|65481730|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23474314|NCT01090323|65481729|FG000|Overall Study|Condition no longer requires drug|5|||
23474315|NCT01090323|65481730|FG001|Overall Study|Condition no longer requires drug|4|||
23474316|NCT01090323|65481729|FG000|Overall Study|Protocol Violation|2|||
23474317|NCT01090323|65481730|FG001|Overall Study|Protocol Violation|1|||
23474318|NCT01090323|65481729|FG000|Overall Study|Withdrew consent|33|||
23474319|NCT01090323|65481730|FG001|Overall Study|Withdrew consent|11|||
23474320|NCT01090323|65481729|FG000|Overall Study|Lost to Follow-up|11|||
23474321|NCT01090323|65481730|FG001|Overall Study|Lost to Follow-up|6|||
23474322|NCT01090323|65481729|FG000|Overall Study|Administrative problems|6|||
23474323|NCT01090323|65481730|FG001|Overall Study|Administrative problems|4|||
23474324|NCT01090323|65481729|FG000|Overall Study|Death|1|||
23642604|NCT04488770|66075454|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642605|NCT04488770|66075455|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23642606|NCT04488770|66075443|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642607|NCT04488770|66075444|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642608|NCT04488770|66075445|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642609|NCT04488770|66075446|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642610|NCT04488770|66075447|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642611|NCT04488770|66075448|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23642612|NCT04488770|66075449|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23642613|NCT04488770|66075450|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642614|NCT04488770|66075451|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642615|NCT04488770|66075452|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642616|NCT04488770|66075453|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642617|NCT04488770|66075454|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642618|NCT04488770|66075455|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23642619|NCT04488770|66075443|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642620|NCT04488770|66075444|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642621|NCT04488770|66075445|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642622|NCT04488770|66075446|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642623|NCT04488770|66075447|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
23642624|NCT04488770|66075448|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23474325|NCT01090323|65481730|FG001|Overall Study|Death|2|||
23474326|NCT01090323|65481729|FG000|Overall Study|Stopped end of core|7|||
23474327|NCT01090323|65481730|FG001|Overall Study|Stopped end of core|0|||
23474328|NCT01090323|65481729|FG000|Overall Study|Stopped end of extension 1#|3|||
23474329|NCT01090323|65481730|FG001|Overall Study|Stopped end of extension 1#|1|||
23474330|NCT05194579|65481731|FG000|Overall Study|Lost to Follow-up|2|||
23474331|NCT05194579|65481732|FG001|Overall Study|Lost to Follow-up|3|||
23474332|NCT05194579|65481731|FG000|Overall Study|Withdrawal by Subject|3|||
23474333|NCT05194579|65481732|FG001|Overall Study|Withdrawal by Subject|4|||
23474334|NCT05194579|65481731|FG000|Overall Study|Refused further study procedures|0|||
23474335|NCT05194579|65481732|FG001|Overall Study|Refused further study procedures|1|||
23474336|NCT05194579|65481731|FG000|Overall Study|Protocol deviation|1|||
23474337|NCT05194579|65481732|FG001|Overall Study|Protocol deviation|0|||
23474338|NCT00006409|65481735|FG000|Baseline|Protocol Violation|48|||
23474339|NCT00006409|65481736|FG001|Baseline|Protocol Violation|70|||
23474340|NCT00006409|65481737|FG002|Baseline|Protocol Violation|0|||
23474341|NCT00006409|65481738|FG003|Baseline|Protocol Violation|0|||
23474342|NCT00006409|65481739|FG004|Baseline|Protocol Violation|0|||
23474343|NCT00006409|65481740|FG005|Baseline|Protocol Violation|0|||
23474344|NCT00006409|65481735|FG000|Post-2 Year Intervention|Protocol Violation|0|||
23474345|NCT00006409|65481736|FG001|Post-2 Year Intervention|Protocol Violation|0|||
23474346|NCT00006409|65481737|FG002|Post-2 Year Intervention|Protocol Violation|251|||
23474347|NCT00006409|65481738|FG003|Post-2 Year Intervention|Protocol Violation|168|||
23474348|NCT00006409|65481739|FG004|Post-2 Year Intervention|Protocol Violation|0|||
23797075|NCT02688387|66633231|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797076|NCT02688387|66633232|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23474349|NCT00006409|65481740|FG005|Post-2 Year Intervention|Protocol Violation|0|||
23474350|NCT00006409|65481735|FG000|Post-3 Year Intervention|Protocol Violation|0|||
23474351|NCT00006409|65481736|FG001|Post-3 Year Intervention|Protocol Violation|0|||
23797077|NCT02688387|66633233|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797078|NCT02688387|66633234|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797079|NCT02688387|66633235|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797080|NCT02688387|66633236|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797081|NCT02688387|66633237|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797082|NCT02688387|66633238|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797083|NCT02688387|66633239|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797084|NCT02688387|66633240|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797085|NCT02688387|66633241|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23474352|NCT00006409|65481737|FG002|Post-3 Year Intervention|Protocol Violation|0|||
23474353|NCT00006409|65481738|FG003|Post-3 Year Intervention|Protocol Violation|0|||
23474354|NCT00006409|65481739|FG004|Post-3 Year Intervention|Protocol Violation|62|||
23474355|NCT00006409|65481740|FG005|Post-3 Year Intervention|Protocol Violation|62|||
23474356|NCT01501955|65481744|FG000|Overall Study|Withdrawal by Subject|1|||
23474357|NCT01501955|65481745|FG001|Overall Study|Withdrawal by Subject|0|||
23474358|NCT01501955|65481744|FG000|Overall Study|Adverse Event|1|||
23474359|NCT01501955|65481745|FG001|Overall Study|Adverse Event|3|||
23474360|NCT01590758|65481751|FG000|Overall Study|Withdrawal by Subject|0|||
23474361|NCT01590758|65481752|FG001|Overall Study|Withdrawal by Subject|3|||
23797086|NCT02688387|66633242|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797087|NCT02688387|66633243|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797088|NCT02688387|66633244|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797089|NCT02688387|66633245|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797090|NCT02688387|66633246|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797091|NCT02688387|66633247|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23797092|NCT02688387|66633226|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797093|NCT02688387|66633227|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797094|NCT02688387|66633228|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797095|NCT02688387|66633229|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
23797096|NCT02688387|66633230|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797097|NCT02688387|66633231|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23474362|NCT01590758|65481751|FG000|Overall Study|Physician Decision|1|||
23474363|NCT01590758|65481752|FG001|Overall Study|Physician Decision|2|||
23474364|NCT01590758|65481751|FG000|Overall Study|Lost to Follow-up|4|||
23474365|NCT01590758|65481752|FG001|Overall Study|Lost to Follow-up|2|||
23474366|NCT02813577|65481753|FG000|Overall Study|Study terminated|4|||
23474367|NCT02160041|65481755|FG000|Overall Study|Adverse Event|11|||
23474368|NCT02160041|65481755|FG000|Overall Study|Death|2|||
23474369|NCT02160041|65481755|FG000|Overall Study|disease progression|57|||
23474370|NCT02160041|65481755|FG000|Overall Study|Protocol Violation|1|||
23642625|NCT04488770|66075449|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23797098|NCT02688387|66633232|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797099|NCT02688387|66633233|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797100|NCT02688387|66633234|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797101|NCT02688387|66633235|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797102|NCT02688387|66633236|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797103|NCT02688387|66633237|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797104|NCT02688387|66633238|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797105|NCT02688387|66633239|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797106|NCT02688387|66633240|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23357628|NCT01006590|65052840|FG000|Overall Study|Lost to Follow-up|1|||
23357629|NCT01006590|65052841|FG001|Overall Study|Lost to Follow-up|1|||
23474371|NCT02160041|65481755|FG000|Overall Study|non-compliance with study|1|||
23474372|NCT02160041|65481755|FG000|Overall Study|Physician Decision|3|||
23474373|NCT02160041|65481755|FG000|Overall Study|Withdrawal by Subject|8|||
23474374|NCT02160041|65481755|FG000|Overall Study|study terminated by by sponsor|1|||
23474375|NCT01519167|65481756|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
23357630|NCT01006590|65052840|FG000|Overall Study|Protocol Violation|1|||
23357631|NCT01006590|65052841|FG001|Overall Study|Protocol Violation|0|||
23797107|NCT02688387|66633241|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797108|NCT02688387|66633242|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23642626|NCT04488770|66075450|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642627|NCT04488770|66075451|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642628|NCT04488770|66075452|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642629|NCT04488770|66075453|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642630|NCT04488770|66075454|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642631|NCT04488770|66075455|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23642632|NCT01445301|66075458|FG000|Overall Study|Adverse Event|15|||
23642633|NCT01445301|66075459|FG001|Overall Study|Adverse Event|25|||
23642634|NCT01445301|66075460|FG002|Overall Study|Adverse Event|4|||
23642635|NCT01445301|66075458|FG000|Overall Study|Lack of Efficacy|0|||
23642636|NCT01445301|66075459|FG001|Overall Study|Lack of Efficacy|1|||
23642637|NCT01445301|66075460|FG002|Overall Study|Lack of Efficacy|0|||
23642638|NCT01445301|66075458|FG000|Overall Study|Protocol Violation|1|||
23642639|NCT01445301|66075459|FG001|Overall Study|Protocol Violation|0|||
23642640|NCT01445301|66075460|FG002|Overall Study|Protocol Violation|0|||
23642641|NCT01445301|66075458|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
23642642|NCT01445301|66075459|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
23642643|NCT01445301|66075460|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
23642644|NCT01445301|66075458|FG000|Overall Study|Physician Decision|0|||
23642645|NCT01445301|66075459|FG001|Overall Study|Physician Decision|2|||
23642646|NCT01445301|66075460|FG002|Overall Study|Physician Decision|0|||
23642647|NCT01445301|66075458|FG000|Overall Study|Withdrawal by Subject|5|||
23642648|NCT01445301|66075459|FG001|Overall Study|Withdrawal by Subject|6|||
23642649|NCT01445301|66075460|FG002|Overall Study|Withdrawal by Subject|4|||
23642650|NCT01238900|66075462|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
23797109|NCT02688387|66633243|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797110|NCT02688387|66633244|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797111|NCT02688387|66633245|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797112|NCT02688387|66633246|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797113|NCT02688387|66633247|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797114|NCT02688387|66633226|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797115|NCT02688387|66633227|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
23797116|NCT02688387|66633228|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797117|NCT02688387|66633229|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797118|NCT02688387|66633230|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797119|NCT02688387|66633231|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797120|NCT02688387|66633232|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797121|NCT02688387|66633233|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797122|NCT02688387|66633234|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797123|NCT02688387|66633235|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797124|NCT02688387|66633236|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797125|NCT02688387|66633237|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797126|NCT02688387|66633238|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797127|NCT02688387|66633239|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797128|NCT02688387|66633240|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797129|NCT02688387|66633241|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797130|NCT02688387|66633242|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797131|NCT02688387|66633243|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797132|NCT02688387|66633244|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797133|NCT02688387|66633245|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23642651|NCT01238900|66075462|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
23797134|NCT02688387|66633246|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797135|NCT02688387|66633247|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23797136|NCT02688387|66633226|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797137|NCT02688387|66633227|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797138|NCT02688387|66633228|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
23797139|NCT02688387|66633229|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797140|NCT02688387|66633230|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
23797141|NCT02688387|66633231|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23642652|NCT01177800|66075463|FG000|Overall Study|Adverse Event|9|||
23642653|NCT01177800|66075464|FG001|Overall Study|Adverse Event|3|||
23642654|NCT01177800|66075463|FG000|Overall Study|Protocol Violation|0|||
23642655|NCT01177800|66075464|FG001|Overall Study|Protocol Violation|1|||
23797142|NCT02688387|66633232|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797143|NCT02688387|66633233|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797144|NCT02688387|66633234|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797145|NCT02688387|66633235|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797146|NCT02688387|66633236|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797147|NCT02688387|66633237|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797148|NCT02688387|66633238|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797149|NCT02688387|66633239|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797150|NCT02688387|66633240|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797151|NCT02688387|66633241|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797152|NCT02688387|66633242|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797153|NCT02688387|66633243|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23357632|NCT01006590|65052840|FG000|Overall Study|Withdrawal by Subject|4|||
23642656|NCT01177800|66075463|FG000|Overall Study|Physician Decision|1|||
23642657|NCT01177800|66075464|FG001|Overall Study|Physician Decision|0|||
23642658|NCT01177800|66075463|FG000|Overall Study|Withdrawal of informed consent|0|||
23642659|NCT01177800|66075464|FG001|Overall Study|Withdrawal of informed consent|1|||
23642660|NCT00658788|66075465|FG000|Overall Study|Adverse Event|11|||
23642661|NCT00658788|66075465|FG000|Overall Study|Withdrawal by Subject|13|||
23642662|NCT00658788|66075465|FG000|Overall Study|Lost to Follow-up|18|||
23642663|NCT00658788|66075465|FG000|Overall Study|Treatment Discontinuation|32|||
23642664|NCT02914275|66078964|FG000|Overall Study|Lost to Follow-up|84|||
23642665|NCT02914275|66078965|FG001|Overall Study|Lost to Follow-up|29|||
23357633|NCT01006590|65052841|FG001|Overall Study|Withdrawal by Subject|2|||
23357634|NCT01006590|65052840|FG000|Overall Study|Study specific discontinuation criteria|16|||
23357635|NCT01006590|65052841|FG001|Overall Study|Study specific discontinuation criteria|23|||
23357636|NCT01006590|65052840|FG000|Overall Study|Other|3|||
23357637|NCT01006590|65052841|FG001|Overall Study|Other|2|||
23357638|NCT01990768|65052842|FG000|Intervention Started|Found to be ineligible|14|||
23357639|NCT01990768|65052843|FG001|Intervention Started|Found to be ineligible|13|||
23357640|NCT01990768|65052844|FG002|Intervention Started|Found to be ineligible|11|||
23357641|NCT01990768|65052842|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
23357642|NCT01990768|65052843|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
23357643|NCT01990768|65052844|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
23357644|NCT01990768|65052842|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
23357645|NCT01990768|65052843|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
23357646|NCT01990768|65052844|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
23357647|NCT01990768|65052842|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
23357648|NCT01990768|65052843|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
23357649|NCT01990768|65052844|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
23357650|NCT01990768|65052842|FG000|Intervention Started|Patient care priority|1|||
23357651|NCT01990768|65052843|FG001|Intervention Started|Patient care priority|2|||
23357652|NCT01990768|65052844|FG002|Intervention Started|Patient care priority|3|||
23357653|NCT01990768|65052842|FG000|Intervention Started|IV lost|2|||
23357654|NCT01990768|65052843|FG001|Intervention Started|IV lost|2|||
23357655|NCT01990768|65052844|FG002|Intervention Started|IV lost|2|||
23357656|NCT01990768|65052842|FG000|Intervention Started|Required CPR|1|||
23357657|NCT01990768|65052843|FG001|Intervention Started|Required CPR|1|||
23357658|NCT01990768|65052844|FG002|Intervention Started|Required CPR|0|||
23357659|NCT01990768|65052842|FG000|Intervention Started|Seizure or hx of seizure|0|||
23357660|NCT01990768|65052843|FG001|Intervention Started|Seizure or hx of seizure|0|||
23357661|NCT01990768|65052844|FG002|Intervention Started|Seizure or hx of seizure|2|||
23357662|NCT01990768|65052842|FG000|Intervention Started|Discovered to be pregnant|0|||
23357663|NCT01990768|65052843|FG001|Intervention Started|Discovered to be pregnant|1|||
23357664|NCT01990768|65052844|FG002|Intervention Started|Discovered to be pregnant|0|||
23357665|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
23357666|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
23357667|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
23357668|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
23357669|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
23357670|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
23357671|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
23357672|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
23357673|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
23357674|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
23357675|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
23474376|NCT01519167|65481757|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
23642666|NCT02914275|66078964|FG000|Overall Study|Withdrawal by Subject|26|||
23642667|NCT02914275|66078965|FG001|Overall Study|Withdrawal by Subject|10|||
23642668|NCT02914275|66078964|FG000|Overall Study|Protocol Violation|1|||
23642669|NCT02914275|66078965|FG001|Overall Study|Protocol Violation|1|||
23642670|NCT02914275|66078964|FG000|Overall Study|Physician Decision|3|||
23642671|NCT02914275|66078965|FG001|Overall Study|Physician Decision|1|||
23642672|NCT02914275|66078964|FG000|Overall Study|Other|4|||
23642673|NCT02914275|66078965|FG001|Overall Study|Other|1|||
23642674|NCT02914275|66078964|FG000|Overall Study|Excluded due to invalid informed consent|3|||
23642675|NCT02914275|66078965|FG001|Overall Study|Excluded due to invalid informed consent|0|||
23642676|NCT03965689|66078966|FG000|Overall Study|Too sick to get study intervention|2|||
23642677|NCT02366468|66078967|FG000|Overall Study|Adverse Event|2|||
23642678|NCT02366468|66078968|FG001|Overall Study|Adverse Event|0|||
23642679|NCT02366468|66078967|FG000|Overall Study|Withdrawal by Subject|1|||
23642680|NCT02366468|66078968|FG001|Overall Study|Withdrawal by Subject|5|||
23642681|NCT02366468|66078967|FG000|Overall Study|Lost to Follow-up|2|||
23642682|NCT02366468|66078968|FG001|Overall Study|Lost to Follow-up|0|||
23642683|NCT02366468|66078967|FG000|Overall Study|Death|1|||
23642684|NCT02366468|66078968|FG001|Overall Study|Death|2|||
23642685|NCT02366468|66078967|FG000|Overall Study|Other|0|||
23642686|NCT02366468|66078968|FG001|Overall Study|Other|2|||
23642687|NCT02641496|66078971|FG000|Overall Study|Lost to Follow-up|13|||
23642688|NCT02641496|66078972|FG001|Overall Study|Lost to Follow-up|12|||
23642689|NCT02641496|66078971|FG000|Overall Study|Withdrawal by Subject|1|||
23642690|NCT02641496|66078972|FG001|Overall Study|Withdrawal by Subject|0|||
23642691|NCT00581555|66078973|FG000|Overall Study|Adverse Event|4|||
23642692|NCT00581555|66078974|FG001|Overall Study|Adverse Event|3|||
23642693|NCT00581555|66078973|FG000|Overall Study|Physician Decision|3|||
23642694|NCT00581555|66078974|FG001|Overall Study|Physician Decision|2|||
23642695|NCT00581555|66078973|FG000|Overall Study|Withdrawal by Subject|18|||
23642696|NCT00581555|66078974|FG001|Overall Study|Withdrawal by Subject|9|||
23642697|NCT00581555|66078973|FG000|Overall Study|Lost to Follow-up|2|||
23642698|NCT00581555|66078974|FG001|Overall Study|Lost to Follow-up|2|||
23642699|NCT00581555|66078973|FG000|Overall Study|Other reasons|16|||
23642700|NCT00581555|66078974|FG001|Overall Study|Other reasons|4|||
23642701|NCT02217501|66078975|FG000|Overall Study|Death|3|||
23642702|NCT02217501|66078976|FG001|Overall Study|Death|4|||
23642703|NCT00572039|66078977|FG000|Overall Study|Withdrawal by Subject|9|||
23642704|NCT00572039|66078978|FG001|Overall Study|Withdrawal by Subject|6|||
23642705|NCT00572039|66078977|FG000|Overall Study|Death|2|||
23642706|NCT00572039|66078978|FG001|Overall Study|Death|3|||
23642707|NCT00572039|66078977|FG000|Overall Study|Ill|5|||
23642708|NCT00572039|66078978|FG001|Overall Study|Ill|1|||
23642709|NCT00306670|66078979|FG000|Overall Study|patients recruited; Genentech, the st|0|||
23642710|NCT00306670|66078980|FG001|Overall Study|patients recruited; Genentech, the st|2|||
23642711|NCT01004848|66078981|FG000|Overall Study|Lost to Follow-up|55|||
23642712|NCT01004848|66078982|FG001|Overall Study|Lost to Follow-up|45|||
23642713|NCT01077271|66078983|FG000|Overall Study|Parental desire|8|||
23642714|NCT01077271|66078983|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
23642715|NCT01077271|66078983|FG000|Overall Study|Noncompliance|2|||
23642716|NCT01077271|66078983|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
23642717|NCT01077271|66078983|FG000|Overall Study|Changed doctors|2|||
23642718|NCT01077271|66078983|FG000|Overall Study|Parents thought too many injections|2|||
23642719|NCT01077271|66078983|FG000|Overall Study|End of RSV season nearly reached|1|||
23642720|NCT01077271|66078983|FG000|Overall Study|Mother unconvinced of the necessity|1|||
23642721|NCT02859324|66078984|FG000|Overall Study|Death|4|||
23642722|NCT02859324|66078985|FG001|Overall Study|Death|6|||
23642723|NCT02859324|66078986|FG002|Overall Study|Death|5|||
23642724|NCT02859324|66078984|FG000|Overall Study|Other reasons|3|||
23642725|NCT02859324|66078985|FG001|Overall Study|Other reasons|3|||
23642726|NCT02859324|66078986|FG002|Overall Study|Other reasons|0|||
23642727|NCT00700258|66078987|FG000|Overall Study|Premature discontinuation of documentation|136|||
23642728|NCT00700258|66078987|FG000|Overall Study|Type of study end not documented|1|||
23642729|NCT00700258|66078987|FG000|Overall Study|Lost to Follow-up|81|||
23642730|NCT00700258|66078987|FG000|Overall Study|Premature discontinuation of therapy|1013|||
23642731|NCT04725240|66078988|FG000|Overall Study|Adverse Event|2|||
23642732|NCT00440999|66078989|FG000|Overall Study|Adverse Event|0|||
23797154|NCT02688387|66633244|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23642733|NCT00440999|66078990|FG001|Overall Study|Adverse Event|2|||
23642734|NCT00440999|66078989|FG000|Overall Study|Lack of Efficacy|6|||
23642735|NCT00440999|66078990|FG001|Overall Study|Lack of Efficacy|7|||
23642736|NCT00440999|66078989|FG000|Overall Study|Lost to Follow-up|19|||
23642737|NCT00440999|66078990|FG001|Overall Study|Lost to Follow-up|12|||
23474377|NCT01519167|65481756|FG000|Overall Study|Adverse Event|0|||
23642738|NCT00440999|66078989|FG000|Overall Study|Protocol Violation|1|||
23642739|NCT00440999|66078990|FG001|Overall Study|Protocol Violation|0|||
23642740|NCT00440999|66078989|FG000|Overall Study|Withdrawal by Subject|2|||
23642741|NCT00440999|66078990|FG001|Overall Study|Withdrawal by Subject|5|||
23642742|NCT00440999|66078989|FG000|Overall Study|Subjets missed the visit|1|||
23642743|NCT00440999|66078990|FG001|Overall Study|Subjets missed the visit|0|||
23642744|NCT00440999|66078989|FG000|Overall Study|Mixed infection at entry|1|||
23642745|NCT00440999|66078990|FG001|Overall Study|Mixed infection at entry|0|||
23642746|NCT00440999|66078989|FG000|Overall Study|P. falciparum malaria|5|||
23642747|NCT00440999|66078990|FG001|Overall Study|P. falciparum malaria|14|||
23642748|NCT00440999|66078989|FG000|Overall Study|Subj left hosp without inform staff|0|||
23642749|NCT00440999|66078990|FG001|Overall Study|Subj left hosp without inform staff|1|||
23642750|NCT02663518|66078991|FG000|Part 1: Phase 1a Escalation|Death|0|||
23642751|NCT02663518|66078992|FG001|Part 1: Phase 1a Escalation|Death|0|||
23642752|NCT02663518|66078993|FG002|Part 1: Phase 1a Escalation|Death|1|||
23642753|NCT02663518|66078994|FG003|Part 1: Phase 1a Escalation|Death|0|||
23642754|NCT02663518|66078995|FG004|Part 1: Phase 1a Escalation|Death|0|||
23642755|NCT02663518|66078996|FG005|Part 1: Phase 1a Escalation|Death|0|||
23642756|NCT02663518|66078997|FG006|Part 1: Phase 1a Escalation|Death|0|||
23642757|NCT02663518|66078998|FG007|Part 1: Phase 1a Escalation|Death|0|||
23642758|NCT02663518|66078999|FG008|Part 1: Phase 1a Escalation|Death|0|||
23642759|NCT02663518|66079000|FG009|Part 1: Phase 1a Escalation|Death|0|||
23642760|NCT02663518|66079001|FG010|Part 1: Phase 1a Escalation|Death|0|||
23642761|NCT02663518|66079002|FG011|Part 1: Phase 1a Escalation|Death|0|||
23642762|NCT02663518|66079003|FG012|Part 1: Phase 1a Escalation|Death|0|||
23642763|NCT02663518|66079004|FG013|Part 1: Phase 1a Escalation|Death|0|||
23642764|NCT02663518|66078991|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642765|NCT02663518|66078992|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642766|NCT02663518|66078993|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
23642767|NCT02663518|66078994|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642768|NCT02663518|66078995|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642769|NCT02663518|66078996|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642770|NCT02663518|66078997|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642771|NCT02663518|66078998|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642772|NCT02663518|66078999|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642773|NCT02663518|66079000|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642774|NCT02663518|66079001|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642775|NCT02663518|66079002|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642776|NCT02663518|66079003|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642777|NCT02663518|66079004|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23642778|NCT02663518|66078991|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
23642779|NCT02663518|66078992|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
23642780|NCT02663518|66078993|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
23642781|NCT02663518|66078994|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
23642782|NCT02663518|66078995|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642783|NCT02663518|66078996|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642784|NCT02663518|66078997|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642785|NCT02663518|66078998|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642786|NCT02663518|66078999|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642787|NCT02663518|66079000|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642788|NCT02663518|66079001|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642789|NCT02663518|66079002|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642790|NCT02663518|66079003|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642791|NCT02663518|66079004|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23642792|NCT02663518|66078991|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23797155|NCT02688387|66633245|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797156|NCT02688387|66633246|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797157|NCT02688387|66633247|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23797158|NCT02688387|66633226|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
23474378|NCT01519167|65481757|FG001|Overall Study|Adverse Event|1|||
23474379|NCT01519167|65481756|FG000|Overall Study|Lack of Efficacy|0|||
23474380|NCT01519167|65481757|FG001|Overall Study|Lack of Efficacy|1|||
23474381|NCT01519167|65481756|FG000|Overall Study|Medical condition changes&deep sedation|0|||
23474382|NCT01519167|65481757|FG001|Overall Study|Medical condition changes&deep sedation|2|||
23474383|NCT01519167|65481756|FG000|Overall Study|Physician Decision|0|||
23474384|NCT01519167|65481757|FG001|Overall Study|Physician Decision|1|||
23474385|NCT02500056|65481761|FG000|Overall Study|Lost to Follow-up|3|||
23642793|NCT02663518|66078992|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23797159|NCT02688387|66633227|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797160|NCT02688387|66633228|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797161|NCT02688387|66633229|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797162|NCT02688387|66633230|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23474386|NCT02500056|65481762|FG001|Overall Study|Lost to Follow-up|7|||
23474387|NCT02500056|65481761|FG000|Overall Study|Recurrence|1|||
23474388|NCT02500056|65481762|FG001|Overall Study|Recurrence|0|||
23474389|NCT02500056|65481761|FG000|Overall Study|Death|3|||
23474390|NCT02500056|65481762|FG001|Overall Study|Death|1|||
23797163|NCT02688387|66633231|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797164|NCT02688387|66633232|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797165|NCT02688387|66633233|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797166|NCT02688387|66633234|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797167|NCT02688387|66633235|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797168|NCT02688387|66633236|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797169|NCT02688387|66633237|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797170|NCT02688387|66633238|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797171|NCT02688387|66633239|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797172|NCT02688387|66633240|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797173|NCT02688387|66633241|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797174|NCT02688387|66633242|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797175|NCT02688387|66633243|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797176|NCT02688387|66633244|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797177|NCT02688387|66633245|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797178|NCT02688387|66633246|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797179|NCT02688387|66633247|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23797180|NCT02688387|66633226|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797181|NCT02688387|66633227|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797182|NCT02688387|66633228|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797183|NCT02688387|66633229|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23642794|NCT02663518|66078993|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23642795|NCT02663518|66078994|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23642796|NCT02663518|66078995|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642797|NCT02663518|66078996|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642798|NCT02663518|66078997|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642799|NCT02663518|66078998|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642800|NCT02663518|66078999|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642801|NCT02663518|66079000|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642802|NCT02663518|66079001|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642803|NCT02663518|66079002|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642804|NCT02663518|66079003|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642805|NCT02663518|66079004|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23642806|NCT02663518|66078991|FG000|Part 1: Phase 1a Escalation|Other|0|||
23357676|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
23357677|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Death|3|||
23357678|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Death|1|||
23357679|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Death|1|||
23474391|NCT01343693|65481763|FG000|Overall Study|Lost to Follow-up|9|||
23474392|NCT03615040|65481764|FG000|Overall Study|Withdrawal by Subject|2|||
23474393|NCT03615040|65481765|FG001|Overall Study|Withdrawal by Subject|1|||
23474394|NCT03615040|65481764|FG000|Overall Study|Physician Decision|2|||
23642807|NCT02663518|66078992|FG001|Part 1: Phase 1a Escalation|Other|0|||
23642808|NCT02663518|66078993|FG002|Part 1: Phase 1a Escalation|Other|2|||
23642809|NCT02663518|66078994|FG003|Part 1: Phase 1a Escalation|Other|0|||
23642810|NCT02663518|66078995|FG004|Part 1: Phase 1a Escalation|Other|0|||
23642811|NCT02663518|66078996|FG005|Part 1: Phase 1a Escalation|Other|0|||
23642812|NCT02663518|66078997|FG006|Part 1: Phase 1a Escalation|Other|0|||
23642813|NCT02663518|66078998|FG007|Part 1: Phase 1a Escalation|Other|0|||
23642814|NCT02663518|66078999|FG008|Part 1: Phase 1a Escalation|Other|0|||
23642815|NCT02663518|66079000|FG009|Part 1: Phase 1a Escalation|Other|0|||
23642816|NCT02663518|66079001|FG010|Part 1: Phase 1a Escalation|Other|0|||
23642817|NCT02663518|66079002|FG011|Part 1: Phase 1a Escalation|Other|0|||
23642818|NCT02663518|66079003|FG012|Part 1: Phase 1a Escalation|Other|0|||
23642819|NCT02663518|66079004|FG013|Part 1: Phase 1a Escalation|Other|0|||
23642820|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642821|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642822|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642823|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642824|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
23589236|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589237|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589238|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589239|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
23589240|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
23589241|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
23589242|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
23589243|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
23474395|NCT03615040|65481765|FG001|Overall Study|Physician Decision|2|||
23474396|NCT03615040|65481764|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
23474397|NCT03615040|65481765|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
23474398|NCT03615040|65481764|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
23474399|NCT03615040|65481765|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
23474400|NCT03615040|65481764|FG000|Overall Study|Death|0|||
23474401|NCT03615040|65481765|FG001|Overall Study|Death|2|||
23474402|NCT01332799|65481772|FG000|Overall Study|Insufficient funding|10|||
23474403|NCT01332799|65481773|FG001|Overall Study|Insufficient funding|10|||
23474404|NCT00499616|65481774|FG000|Overall Study|Death|1|||
23474405|NCT00499616|65481775|FG001|Overall Study|Death|5|||
23474406|NCT00499616|65481776|FG002|Overall Study|Death|3|||
23474407|NCT00499616|65481777|FG003|Overall Study|Death|1|||
23474408|NCT00499616|65481774|FG000|Overall Study|Lack of Efficacy|5|||
23474409|NCT00499616|65481775|FG001|Overall Study|Lack of Efficacy|0|||
23474410|NCT00499616|65481776|FG002|Overall Study|Lack of Efficacy|19|||
23474411|NCT00499616|65481777|FG003|Overall Study|Lack of Efficacy|0|||
23474412|NCT00499616|65481774|FG000|Overall Study|Lost to Follow-up|0|||
23474413|NCT00499616|65481775|FG001|Overall Study|Lost to Follow-up|0|||
23474414|NCT00499616|65481776|FG002|Overall Study|Lost to Follow-up|1|||
23474415|NCT00499616|65481777|FG003|Overall Study|Lost to Follow-up|0|||
23642825|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
23474416|NCT00499616|65481774|FG000|Overall Study|Physician Decision|6|||
23589244|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23642826|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
23642827|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
23642828|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642829|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642830|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642831|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642832|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642833|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
23642834|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642835|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642836|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642837|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642838|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
23642839|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642840|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
23642841|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
23642842|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642843|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642844|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642845|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642846|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642847|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23642848|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23474417|NCT00499616|65481775|FG001|Overall Study|Physician Decision|16|||
23642849|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642850|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642851|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23706859|NCT00002663|66301345|FG006|Overall Study|Adverse Event|0|||
23357680|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Discharged|2|||
23357681|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Discharged|1|||
23357682|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Discharged|0|||
23357683|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
23357684|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
23357685|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
23357686|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
23357687|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
23357688|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
23357689|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
23357690|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
23357691|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
23357692|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
23357693|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
23357694|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
23357695|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
23357696|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
23357697|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
23357698|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
23357699|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
23357700|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
23357701|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
23357702|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
23357703|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
23357704|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
23357705|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
23357706|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
23357707|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
23357708|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
23357709|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
23357710|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
23357711|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
23357712|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
23357713|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
23357714|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
23357715|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
23357716|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
23589245|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23589246|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23357717|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
23357718|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
23357719|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
23357720|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
23357721|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
23357722|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23357723|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23357724|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23474418|NCT00499616|65481776|FG002|Overall Study|Physician Decision|9|||
23474419|NCT00499616|65481777|FG003|Overall Study|Physician Decision|0|||
23474420|NCT00499616|65481774|FG000|Overall Study|Withdrawal by Subject|1|||
23474421|NCT00499616|65481775|FG001|Overall Study|Withdrawal by Subject|0|||
23474422|NCT00499616|65481776|FG002|Overall Study|Withdrawal by Subject|1|||
23474423|NCT00499616|65481777|FG003|Overall Study|Withdrawal by Subject|0|||
23474424|NCT00499616|65481774|FG000|Overall Study|Ineligible|1|||
23474425|NCT00499616|65481775|FG001|Overall Study|Ineligible|2|||
23474426|NCT00499616|65481776|FG002|Overall Study|Ineligible|0|||
23474427|NCT00499616|65481777|FG003|Overall Study|Ineligible|15|||
23589247|NCT02596035|65886026|FG000|Overall Study|Disease Progression|64|||
23589248|NCT02596035|65886027|FG001|Overall Study|Disease Progression|32|||
23589249|NCT02596035|65886028|FG002|Overall Study|Disease Progression|1|||
23474428|NCT00499616|65481774|FG000|Overall Study|Not evaluable|0|||
23589250|NCT02596035|65886026|FG000|Overall Study|study drug toxicity|12|||
23589251|NCT02596035|65886027|FG001|Overall Study|study drug toxicity|3|||
23589252|NCT02596035|65886028|FG002|Overall Study|study drug toxicity|0|||
23589253|NCT02596035|65886026|FG000|Overall Study|AE unrelated to study drug|5|||
23589254|NCT02596035|65886027|FG001|Overall Study|AE unrelated to study drug|2|||
23589255|NCT02596035|65886028|FG002|Overall Study|AE unrelated to study drug|0|||
23797184|NCT02688387|66633230|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797185|NCT02688387|66633231|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797186|NCT02688387|66633232|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797187|NCT02688387|66633233|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797188|NCT02688387|66633234|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797189|NCT02688387|66633235|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797190|NCT02688387|66633236|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
23797191|NCT02688387|66633237|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797192|NCT02688387|66633238|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797193|NCT02688387|66633239|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797194|NCT02688387|66633240|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797195|NCT02688387|66633241|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797196|NCT02688387|66633242|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797197|NCT02688387|66633243|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23474429|NCT00499616|65481775|FG001|Overall Study|Not evaluable|0|||
23474430|NCT00499616|65481776|FG002|Overall Study|Not evaluable|0|||
23474431|NCT00499616|65481777|FG003|Overall Study|Not evaluable|41|||
23474432|NCT00499616|65481774|FG000|Overall Study|Patient/Parent Refusal|1|||
23474433|NCT00499616|65481775|FG001|Overall Study|Patient/Parent Refusal|5|||
23474434|NCT00499616|65481776|FG002|Overall Study|Patient/Parent Refusal|3|||
23589256|NCT02596035|65886026|FG000|Overall Study|participant request to discontinue study treatment|2|||
23589257|NCT02596035|65886027|FG001|Overall Study|participant request to discontinue study treatment|0|||
23589258|NCT02596035|65886028|FG002|Overall Study|participant request to discontinue study treatment|0|||
23589259|NCT02596035|65886026|FG000|Overall Study|participant withdrew consent|2|||
23589260|NCT02596035|65886027|FG001|Overall Study|participant withdrew consent|2|||
23589261|NCT02596035|65886028|FG002|Overall Study|participant withdrew consent|0|||
23589262|NCT02596035|65886026|FG000|Overall Study|Poor/Non Comlpiance|0|||
23589263|NCT02596035|65886027|FG001|Overall Study|Poor/Non Comlpiance|1|||
23589264|NCT02596035|65886028|FG002|Overall Study|Poor/Non Comlpiance|0|||
23589265|NCT02596035|65886026|FG000|Overall Study|participant no longer meets study criteria|1|||
23589266|NCT02596035|65886027|FG001|Overall Study|participant no longer meets study criteria|0|||
23589267|NCT02596035|65886028|FG002|Overall Study|participant no longer meets study criteria|0|||
23474435|NCT00499616|65481777|FG003|Overall Study|Patient/Parent Refusal|0|||
23474436|NCT00171834|65481778|FG000|Overall Study|Adverse Event|2|||
23589268|NCT02596035|65886026|FG000|Overall Study|other reasons|11|||
23589269|NCT02596035|65886027|FG001|Overall Study|other reasons|4|||
23797198|NCT02688387|66633244|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797199|NCT02688387|66633245|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23474437|NCT00171834|65481779|FG001|Overall Study|Adverse Event|1|||
23797200|NCT02688387|66633246|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23797201|NCT02688387|66633247|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23474438|NCT00171834|65481780|FG002|Overall Study|Adverse Event|3|||
23474439|NCT00171834|65481781|FG003|Overall Study|Adverse Event|2|||
23797202|NCT02688387|66633226|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797203|NCT02688387|66633227|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23589270|NCT02596035|65886028|FG002|Overall Study|other reasons|0|||
23357725|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
23357726|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
23797204|NCT02688387|66633228|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797205|NCT02688387|66633229|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797206|NCT02688387|66633230|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797207|NCT02688387|66633231|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23357727|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
23357728|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
23357729|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
23357730|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
23357731|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
23357732|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
23357733|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
23357734|NCT01990768|65052842|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
23357735|NCT01990768|65052843|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
23357736|NCT01990768|65052844|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
23357737|NCT01990768|65052842|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
23357738|NCT01990768|65052843|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
23357739|NCT01990768|65052844|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
23474440|NCT00171834|65481782|FG004|Overall Study|Adverse Event|2|||
23797208|NCT02688387|66633232|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797209|NCT02688387|66633233|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797210|NCT02688387|66633234|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797211|NCT02688387|66633235|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797212|NCT02688387|66633236|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797213|NCT02688387|66633237|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797214|NCT02688387|66633238|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797215|NCT02688387|66633239|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797216|NCT02688387|66633240|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
23797217|NCT02688387|66633241|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797218|NCT02688387|66633242|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797219|NCT02688387|66633243|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797220|NCT02688387|66633244|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797221|NCT02688387|66633245|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797222|NCT02688387|66633246|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797223|NCT02688387|66633247|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23797224|NCT02688387|66633226|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797225|NCT02688387|66633227|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797226|NCT02688387|66633228|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797227|NCT02688387|66633229|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23357740|NCT01990768|65052842|FG000|6-Month Follow-up|No contact information|5|||
23357741|NCT01990768|65052843|FG001|6-Month Follow-up|No contact information|6|||
23797228|NCT02688387|66633230|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797229|NCT02688387|66633231|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797230|NCT02688387|66633232|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797231|NCT02688387|66633233|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797232|NCT02688387|66633234|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797233|NCT02688387|66633235|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797234|NCT02688387|66633236|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797235|NCT02688387|66633237|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797236|NCT02688387|66633238|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23642852|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
23642853|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642854|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642855|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23797237|NCT02688387|66633239|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797238|NCT02688387|66633240|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797239|NCT02688387|66633241|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797240|NCT02688387|66633242|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797241|NCT02688387|66633243|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797242|NCT02688387|66633244|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797243|NCT02688387|66633245|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23797244|NCT02688387|66633246|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
23797245|NCT02688387|66633247|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23357742|NCT01990768|65052844|FG002|6-Month Follow-up|No contact information|5|||
23474441|NCT00171834|65481783|FG005|Overall Study|Adverse Event|15|||
23797246|NCT02688387|66633226|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797247|NCT02688387|66633227|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797248|NCT02688387|66633228|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797249|NCT02688387|66633229|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797250|NCT02688387|66633230|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23357743|NCT01990768|65052842|FG000|6-Month Follow-up|Homeless|4|||
23357744|NCT01990768|65052843|FG001|6-Month Follow-up|Homeless|3|||
23357745|NCT01990768|65052844|FG002|6-Month Follow-up|Homeless|6|||
23357746|NCT01990768|65052842|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
23357747|NCT01990768|65052843|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
23357748|NCT01990768|65052844|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
23357749|NCT01990768|65052842|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
23357750|NCT01990768|65052843|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
23357751|NCT01990768|65052844|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
23357752|NCT01990768|65052842|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
23357753|NCT01990768|65052843|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
23357754|NCT01990768|65052844|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
23357755|NCT01393106|65052849|FG000|Overall Study|Adverse Event|3|||
23357756|NCT01393106|65052849|FG000|Overall Study|Withdrawal by Subject|1|||
23357757|NCT01393106|65052849|FG000|Overall Study|Lack of Efficacy|1|||
23642856|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642857|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642858|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642859|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642860|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642861|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23642862|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642863|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23357758|NCT03472521|65052850|FG000|Overall Study|Lost to Follow-up|3|||
23357759|NCT03472521|65052851|FG001|Overall Study|Lost to Follow-up|2|||
23474442|NCT00171834|65481784|FG006|Overall Study|Adverse Event|1|||
23474443|NCT00171834|65481778|FG000|Overall Study|Withdrawal by Subject|0|||
23474444|NCT00171834|65481779|FG001|Overall Study|Withdrawal by Subject|2|||
23474445|NCT00171834|65481780|FG002|Overall Study|Withdrawal by Subject|0|||
23474446|NCT00171834|65481781|FG003|Overall Study|Withdrawal by Subject|1|||
23474447|NCT00171834|65481782|FG004|Overall Study|Withdrawal by Subject|1|||
23474448|NCT00171834|65481783|FG005|Overall Study|Withdrawal by Subject|1|||
23474449|NCT00171834|65481784|FG006|Overall Study|Withdrawal by Subject|0|||
23474450|NCT00171834|65481778|FG000|Overall Study|Death from study indication|0|||
23474451|NCT00171834|65481779|FG001|Overall Study|Death from study indication|1|||
23642864|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642865|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642866|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
23642867|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
23642868|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
23642869|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
23642870|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642871|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642872|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642873|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642874|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642875|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23642876|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
23797251|NCT02688387|66633231|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797252|NCT02688387|66633232|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797253|NCT02688387|66633233|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797254|NCT02688387|66633234|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797255|NCT02688387|66633235|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797256|NCT02688387|66633236|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797257|NCT02688387|66633237|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797258|NCT02688387|66633238|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797259|NCT02688387|66633239|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797260|NCT02688387|66633240|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797261|NCT02688387|66633241|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23357760|NCT03472521|65052850|FG000|Overall Study|Discontinued intervention|3|||
23357761|NCT03472521|65052851|FG001|Overall Study|Discontinued intervention|1|||
23357762|NCT01066871|65052852|FG000|Overall Study|Lost to Follow-up|0|||
23357763|NCT01066871|65052853|FG001|Overall Study|Lost to Follow-up|2|||
23474452|NCT00171834|65481780|FG002|Overall Study|Death from study indication|0|||
23474453|NCT00171834|65481781|FG003|Overall Study|Death from study indication|0|||
23357764|NCT01066871|65052854|FG002|Overall Study|Lost to Follow-up|2|||
23357765|NCT01066871|65052855|FG003|Overall Study|Lost to Follow-up|0|||
23797262|NCT02688387|66633242|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797263|NCT02688387|66633243|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797264|NCT02688387|66633244|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
23797265|NCT02688387|66633245|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797266|NCT02688387|66633246|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
23797267|NCT02688387|66633247|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23797268|NCT02688387|66633226|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23474454|NCT00171834|65481782|FG004|Overall Study|Death from study indication|1|||
23474455|NCT00171834|65481783|FG005|Overall Study|Death from study indication|0|||
23474456|NCT00171834|65481784|FG006|Overall Study|Death from study indication|0|||
23474457|NCT00171834|65481778|FG000|Overall Study|Disease Progression|4|||
23474458|NCT00171834|65481779|FG001|Overall Study|Disease Progression|8|||
23474459|NCT00171834|65481780|FG002|Overall Study|Disease Progression|8|||
23474460|NCT00171834|65481781|FG003|Overall Study|Disease Progression|9|||
23474461|NCT00171834|65481782|FG004|Overall Study|Disease Progression|2|||
23474462|NCT00171834|65481783|FG005|Overall Study|Disease Progression|18|||
23474463|NCT00171834|65481784|FG006|Overall Study|Disease Progression|3|||
23474464|NCT00171834|65481778|FG000|Overall Study|Treatment Duration Completed|0|||
23474465|NCT00171834|65481779|FG001|Overall Study|Treatment Duration Completed|0|||
23474466|NCT00171834|65481780|FG002|Overall Study|Treatment Duration Completed|1|||
23474467|NCT00171834|65481781|FG003|Overall Study|Treatment Duration Completed|0|||
23474468|NCT00171834|65481782|FG004|Overall Study|Treatment Duration Completed|2|||
23474469|NCT00171834|65481783|FG005|Overall Study|Treatment Duration Completed|1|||
23474470|NCT00171834|65481784|FG006|Overall Study|Treatment Duration Completed|0|||
23474471|NCT00781885|65481785|FG000|Overall Study|Physician Decision|1|||
23474472|NCT02741518|65481786|FG000|Overall Study|Withdrawal by Subject|1|||
23474473|NCT02741518|65481787|FG001|Overall Study|Withdrawal by Subject|1|||
23474474|NCT00904033|65481788|FG000|Overall Study|Withdrawal by Subject|1|||
23474475|NCT00904033|65481789|FG001|Overall Study|Withdrawal by Subject|1|||
23474476|NCT00904033|65481790|FG002|Overall Study|Withdrawal by Subject|0|||
23474477|NCT00904033|65481791|FG003|Overall Study|Withdrawal by Subject|0|||
23474478|NCT00904033|65481788|FG000|Overall Study|Physician Decision|0|||
23474479|NCT00904033|65481789|FG001|Overall Study|Physician Decision|0|||
23474480|NCT00904033|65481790|FG002|Overall Study|Physician Decision|1|||
23474481|NCT00904033|65481791|FG003|Overall Study|Physician Decision|0|||
23357766|NCT01066871|65052852|FG000|Overall Study|Protocol Violation|1|||
23474482|NCT00904033|65481788|FG000|Overall Study|Unable to obtain final blood draw|0|||
23474483|NCT00904033|65481789|FG001|Overall Study|Unable to obtain final blood draw|0|||
23474484|NCT00904033|65481790|FG002|Overall Study|Unable to obtain final blood draw|0|||
23474485|NCT00904033|65481791|FG003|Overall Study|Unable to obtain final blood draw|2|||
23474486|NCT00439738|65481796|FG000|Overall Study|Withdrawal by Subject|16|||
23474487|NCT00439738|65481797|FG001|Overall Study|Withdrawal by Subject|13|||
23474488|NCT00439738|65481796|FG000|Overall Study|Adverse Event|6|||
23642877|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
23474489|NCT00439738|65481797|FG001|Overall Study|Adverse Event|4|||
23474490|NCT00439738|65481796|FG000|Overall Study|Lost to Follow-up|5|||
23474491|NCT00439738|65481797|FG001|Overall Study|Lost to Follow-up|6|||
23642878|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
23474492|NCT00439738|65481796|FG000|Overall Study|Protocol Violation|6|||
23642879|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
23474493|NCT00439738|65481797|FG001|Overall Study|Protocol Violation|3|||
23474494|NCT00439738|65481796|FG000|Overall Study|Lack of Efficacy|2|||
23474495|NCT00439738|65481797|FG001|Overall Study|Lack of Efficacy|2|||
23474496|NCT00439738|65481796|FG000|Overall Study|Abnormal Lab Values|1|||
23474497|NCT00439738|65481797|FG001|Overall Study|Abnormal Lab Values|0|||
23474498|NCT02082340|65481800|FG000|Overall Study|Lost to Follow-up|1|||
23474499|NCT02082340|65481801|FG001|Overall Study|Lost to Follow-up|1|||
23474500|NCT00573144|65481802|FG000|Overall Study|Withdrawal by Subject|2|||
23474501|NCT00573144|65481803|FG001|Overall Study|Withdrawal by Subject|3|||
23474502|NCT00759564|65481804|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474503|NCT00759564|65481805|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474504|NCT00759564|65481806|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474505|NCT00759564|65481807|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474506|NCT00759564|65481808|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
23474507|NCT00375609|65481811|FG000|Overall Study|Did not receive treatment|1|||
23589271|NCT00457691|65886029|FG000|Overall Study|Adverse Event|4|||
23589272|NCT00457691|65886030|FG001|Overall Study|Adverse Event|1|||
23589273|NCT00457691|65886029|FG000|Overall Study|Death|163|||
23589274|NCT00457691|65886030|FG001|Overall Study|Death|148|||
23589275|NCT00457691|65886029|FG000|Overall Study|Protocol Violation|1|||
23589276|NCT00457691|65886030|FG001|Overall Study|Protocol Violation|3|||
23589277|NCT00457691|65886029|FG000|Overall Study|Lost to Follow-up|23|||
23589278|NCT00457691|65886030|FG001|Overall Study|Lost to Follow-up|14|||
23642880|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
23642881|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
23474508|NCT00375609|65481812|FG001|Overall Study|Did not receive treatment|0|||
23589279|NCT00457691|65886029|FG000|Overall Study|Study terminated by Sponsor|1|||
23474509|NCT00375609|65481813|FG002|Overall Study|Did not receive treatment|0|||
23474510|NCT00375609|65481811|FG000|Overall Study|Adverse Event|0|||
23474511|NCT00375609|65481812|FG001|Overall Study|Adverse Event|3|||
23474512|NCT00375609|65481813|FG002|Overall Study|Adverse Event|0|||
23474513|NCT00375609|65481811|FG000|Overall Study|Lost to Follow-up|1|||
23474514|NCT00375609|65481812|FG001|Overall Study|Lost to Follow-up|0|||
23474515|NCT00375609|65481813|FG002|Overall Study|Lost to Follow-up|0|||
23474516|NCT00375609|65481811|FG000|Overall Study|Physician Decision|0|||
23474517|NCT00375609|65481812|FG001|Overall Study|Physician Decision|0|||
23474518|NCT00375609|65481813|FG002|Overall Study|Physician Decision|1|||
23474519|NCT00375609|65481811|FG000|Overall Study|Withdrawal by Subject|1|||
23474520|NCT00375609|65481812|FG001|Overall Study|Withdrawal by Subject|4|||
23474521|NCT00375609|65481813|FG002|Overall Study|Withdrawal by Subject|0|||
23474522|NCT00375609|65481811|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
23474523|NCT00375609|65481812|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
23474524|NCT00375609|65481813|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
23474525|NCT00975689|65481814|FG000|Overall Study|Adverse Event|0|||
23797269|NCT02688387|66633227|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797270|NCT02688387|66633228|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23357767|NCT01066871|65052853|FG001|Overall Study|Protocol Violation|0|||
23357768|NCT01066871|65052854|FG002|Overall Study|Protocol Violation|3|||
23357769|NCT01066871|65052855|FG003|Overall Study|Protocol Violation|2|||
23357770|NCT01066871|65052852|FG000|Overall Study|Lack of Efficacy|0|||
23357771|NCT01066871|65052853|FG001|Overall Study|Lack of Efficacy|0|||
23357772|NCT01066871|65052854|FG002|Overall Study|Lack of Efficacy|0|||
23357773|NCT01066871|65052855|FG003|Overall Study|Lack of Efficacy|1|||
23357774|NCT01066871|65052852|FG000|Overall Study|Withdrawal by Subject|3|||
23357775|NCT01066871|65052853|FG001|Overall Study|Withdrawal by Subject|1|||
23357776|NCT01066871|65052854|FG002|Overall Study|Withdrawal by Subject|0|||
23474526|NCT00975689|65481815|FG001|Overall Study|Adverse Event|3|||
23474527|NCT00975689|65481814|FG000|Overall Study|Withdrawal by Subject|1|||
23797271|NCT02688387|66633229|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23474528|NCT00975689|65481815|FG001|Overall Study|Withdrawal by Subject|0|||
23474529|NCT00975689|65481814|FG000|Overall Study|Physician Decision|1|||
23474530|NCT00975689|65481815|FG001|Overall Study|Physician Decision|0|||
23474531|NCT04129151|65481817|FG000|Overall Study|Adverse Event|1|||
23474532|NCT04129151|65481817|FG000|Overall Study|Disease Progression|7|||
23474533|NCT04129151|65481817|FG000|Overall Study|Study closure|1|||
23474534|NCT01978938|65481818|FG000|Overall Study|Lost to Follow-up|12|||
23474535|NCT01978938|65481819|FG001|Overall Study|Lost to Follow-up|6|||
23474536|NCT01978938|65481818|FG000|Overall Study|Withdrawal by Subject|8|||
23474537|NCT01978938|65481819|FG001|Overall Study|Withdrawal by Subject|4|||
23474538|NCT01978938|65481818|FG000|Overall Study|Adverse Event, non-fatal|2|||
23474539|NCT01978938|65481819|FG001|Overall Study|Adverse Event, non-fatal|1|||
23474540|NCT01978938|65481818|FG000|Overall Study|Participant noncompliance|1|||
23474541|NCT01978938|65481819|FG001|Overall Study|Participant noncompliance|1|||
23474542|NCT01978938|65481818|FG000|Overall Study|Did not meet inclusion criteria|0|||
23474543|NCT01978938|65481819|FG001|Overall Study|Did not meet inclusion criteria|1|||
23474544|NCT01978938|65481818|FG000|Overall Study|Previously scheduled procedure|0|||
23474545|NCT01978938|65481819|FG001|Overall Study|Previously scheduled procedure|1|||
23474546|NCT02343549|65481820|FG000|Overall Study|Death|11|||
23474547|NCT02343549|65481820|FG000|Overall Study|Withdrawal by Subject|2|||
23474548|NCT00653939|65481821|FG000|Overall Study|Adverse Event|1|||
23474549|NCT00653939|65481822|FG001|Overall Study|Adverse Event|3|||
23474550|NCT00653939|65481821|FG000|Overall Study|Withdrawal by Subject|3|||
23797272|NCT02688387|66633230|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797273|NCT02688387|66633231|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797274|NCT02688387|66633232|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797275|NCT02688387|66633233|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797276|NCT02688387|66633234|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797277|NCT02688387|66633235|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797278|NCT02688387|66633236|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23357777|NCT01066871|65052855|FG003|Overall Study|Withdrawal by Subject|0|||
23474551|NCT00653939|65481822|FG001|Overall Study|Withdrawal by Subject|3|||
23474552|NCT00653939|65481821|FG000|Overall Study|Physician Decision|4|||
23474553|NCT00653939|65481822|FG001|Overall Study|Physician Decision|0|||
23474554|NCT00653939|65481821|FG000|Overall Study|Disease Progression|2|||
23474555|NCT00653939|65481822|FG001|Overall Study|Disease Progression|3|||
23474556|NCT00653939|65481821|FG000|Overall Study|Other|2|||
23474557|NCT00653939|65481822|FG001|Overall Study|Other|6|||
23474558|NCT03645434|65481823|FG000|Period 1|Adverse Event|0|||
23474559|NCT03645434|65481824|FG001|Period 1|Adverse Event|0|||
23357778|NCT01066871|65052852|FG000|Overall Study|Other|0|||
23474560|NCT03645434|65481825|FG002|Period 1|Adverse Event|0|||
23474561|NCT03645434|65481826|FG003|Period 1|Adverse Event|1|||
23474562|NCT03645434|65481827|FG004|Period 1|Adverse Event|0|||
23474563|NCT03645434|65481828|FG005|Period 1|Adverse Event|0|||
23474564|NCT03645434|65481823|FG000|Period 1|COPD exacerbation|0|||
23474565|NCT03645434|65481824|FG001|Period 1|COPD exacerbation|0|||
23474566|NCT03645434|65481825|FG002|Period 1|COPD exacerbation|0|||
23474567|NCT03645434|65481826|FG003|Period 1|COPD exacerbation|0|||
23474568|NCT03645434|65481827|FG004|Period 1|COPD exacerbation|1|||
23474569|NCT03645434|65481828|FG005|Period 1|COPD exacerbation|0|||
23474570|NCT01731938|65481829|FG000|Preliminary Part I|Withdrawal by Subject|2|||
23474571|NCT01731938|65481830|FG001|Preliminary Part I|Withdrawal by Subject|2|||
23474572|NCT01731938|65481829|FG000|Preliminary Part I|Physician Decision|1|||
23474573|NCT01731938|65481830|FG001|Preliminary Part I|Physician Decision|0|||
23474574|NCT01731938|65481829|FG000|Preliminary Part I|Lost to Follow-up|0|||
23474575|NCT01731938|65481830|FG001|Preliminary Part I|Lost to Follow-up|3|||
23474576|NCT01731938|65481829|FG000|Preliminary Part I|Missed Week 6 visit|0|||
23474577|NCT01731938|65481830|FG001|Preliminary Part I|Missed Week 6 visit|3|||
23474578|NCT01731938|65481829|FG000|Primary Part II|Withdrawal by Subject|5|||
23474579|NCT01731938|65481830|FG001|Primary Part II|Withdrawal by Subject|4|||
23474580|NCT01731938|65481829|FG000|Primary Part II|Lost to Follow-up|4|||
23474581|NCT01731938|65481830|FG001|Primary Part II|Lost to Follow-up|5|||
23474582|NCT01731938|65481829|FG000|Primary Part II|Death|2|||
23474583|NCT01731938|65481830|FG001|Primary Part II|Death|1|||
23474584|NCT01731938|65481829|FG000|Primary Part II|Missed Week 6 visit|2|||
23474585|NCT01731938|65481830|FG001|Primary Part II|Missed Week 6 visit|3|||
23474586|NCT02674204|65481831|FG000|Overall Study|Adverse Event|1|||
23474587|NCT02674204|65481832|FG001|Overall Study|Adverse Event|0|||
23474588|NCT04074161|65481833|FG000|Overall Study|Withdrawal by Subject|2|||
23474589|NCT04074161|65481834|FG001|Overall Study|Withdrawal by Subject|4|||
23474590|NCT04074161|65481835|FG002|Overall Study|Withdrawal by Subject|1|||
23474591|NCT04074161|65481833|FG000|Overall Study|Lost to Follow-up|4|||
23474592|NCT04074161|65481834|FG001|Overall Study|Lost to Follow-up|5|||
23474593|NCT04074161|65481835|FG002|Overall Study|Lost to Follow-up|3|||
23474594|NCT01282463|65481836|FG000|Overall Study|Lost to Follow-up|1|||
23474595|NCT01282463|65481837|FG001|Overall Study|Lost to Follow-up|0|||
23474596|NCT01282463|65481838|FG002|Overall Study|Lost to Follow-up|0|||
23474597|NCT01282463|65481836|FG000|Overall Study|Withdrawal by Subject|6|||
23474598|NCT01282463|65481837|FG001|Overall Study|Withdrawal by Subject|2|||
23474599|NCT01282463|65481838|FG002|Overall Study|Withdrawal by Subject|3|||
23474600|NCT01282463|65481836|FG000|Overall Study|"Never Treated Death"|0|||
23474601|NCT01282463|65481837|FG001|Overall Study|"Never Treated Death"|1|||
23474602|NCT01282463|65481838|FG002|Overall Study|"Never Treated Death"|0|||
23474603|NCT01282463|65481836|FG000|Overall Study|"Never Treated PD"|0|||
23474604|NCT01282463|65481837|FG001|Overall Study|"Never Treated PD"|1|||
23474605|NCT01282463|65481838|FG002|Overall Study|"Never Treated PD"|0|||
23474606|NCT01282463|65481836|FG000|Overall Study|Protocol Violation|0|||
23474607|NCT01282463|65481837|FG001|Overall Study|Protocol Violation|0|||
23474608|NCT01282463|65481838|FG002|Overall Study|Protocol Violation|1|||
23474609|NCT01282463|65481836|FG000|Overall Study|Physician Decision|1|||
23474610|NCT01282463|65481837|FG001|Overall Study|Physician Decision|0|||
23474611|NCT01282463|65481838|FG002|Overall Study|Physician Decision|0|||
23474612|NCT04493892|65481839|FG000|Overall Study|Withdrawal by Subject|15|||
23589280|NCT00457691|65886030|FG001|Overall Study|Study terminated by Sponsor|1|||
23357779|NCT01066871|65052853|FG001|Overall Study|Other|2|||
23357780|NCT01066871|65052854|FG002|Overall Study|Other|1|||
23357781|NCT01066871|65052855|FG003|Overall Study|Other|2|||
23474613|NCT01433289|65481841|FG000|Overall Study|Pregnancy|0|||
23474614|NCT01433289|65481842|FG001|Overall Study|Pregnancy|1|||
23474615|NCT01433289|65481843|FG002|Overall Study|Pregnancy|0|||
23474616|NCT01433289|65481844|FG003|Overall Study|Pregnancy|0|||
23474617|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
23474618|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
23474619|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
23474620|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
23357782|NCT02182830|65052856|FG000|Overall Study|Not Treated|1|||
23589281|NCT00457691|65886029|FG000|Overall Study|Subject refused (reason other than AE)|14|||
23589282|NCT00457691|65886030|FG001|Overall Study|Subject refused (reason other than AE)|19|||
23589283|NCT00457691|65886029|FG000|Overall Study|Disease progression, study terminated|180|||
23589284|NCT00457691|65886030|FG001|Overall Study|Disease progression, study terminated|196|||
23589285|NCT03235349|65886033|FG000|Overall Study|Adverse Event|1|||
23589286|NCT03235349|65886033|FG000|Overall Study|Other|1|||
23589287|NCT02954848|65886034|FG000|Overall Study|Randomized but Not Treated|0|||
23589288|NCT02954848|65886035|FG001|Overall Study|Randomized but Not Treated|1|||
23589289|NCT02954848|65886034|FG000|Overall Study|Adverse Event|2|||
23589290|NCT02954848|65886035|FG001|Overall Study|Adverse Event|3|||
23589291|NCT02954848|65886034|FG000|Overall Study|Withdrawal by Participant|0|||
23357783|NCT02182830|65052857|FG001|Overall Study|Not Treated|1|||
23474621|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
23474622|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
23474623|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
23474624|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
23474625|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
23474626|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
23474627|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
23474628|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
23474629|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
23474630|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
23474631|NCT03189524|65481852|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
23474632|NCT03189524|65481853|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
23474633|NCT03189524|65481854|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
23474634|NCT03189524|65481852|FG000|Overall Study|Death|2|||
23474635|NCT03189524|65481853|FG001|Overall Study|Death|2|||
23589292|NCT02954848|65886035|FG001|Overall Study|Withdrawal by Participant|1|||
23589293|NCT02001623|65886040|FG000|Overall Study|Disease Progression|2|||
23589294|NCT02001623|65886041|FG001|Overall Study|Disease Progression|2|||
23357784|NCT02182830|65052856|FG000|Overall Study|Trial stopped, reason missing|3|||
23474636|NCT03189524|65481854|FG002|Overall Study|Death|1|||
23474637|NCT03189524|65481852|FG000|Overall Study|Lost to Follow-up|1|||
23474638|NCT03189524|65481853|FG001|Overall Study|Lost to Follow-up|0|||
23474639|NCT03189524|65481854|FG002|Overall Study|Lost to Follow-up|8|||
23797279|NCT02688387|66633237|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797280|NCT02688387|66633238|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797281|NCT02688387|66633239|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797282|NCT02688387|66633240|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797283|NCT02688387|66633241|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797284|NCT02688387|66633242|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797285|NCT02688387|66633243|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797286|NCT02688387|66633244|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797287|NCT02688387|66633245|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
23797288|NCT02688387|66633246|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23797289|NCT02688387|66633247|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23474640|NCT03189524|65481852|FG000|Overall Study|Withdrawal by Subject|1|||
23474641|NCT03189524|65481853|FG001|Overall Study|Withdrawal by Subject|1|||
23474642|NCT03189524|65481854|FG002|Overall Study|Withdrawal by Subject|3|||
23474643|NCT03189524|65481852|FG000|Overall Study|Progressive Disease|0|||
23474644|NCT03189524|65481853|FG001|Overall Study|Progressive Disease|2|||
23474645|NCT03189524|65481854|FG002|Overall Study|Progressive Disease|0|||
23474646|NCT02445794|65481860|FG000|Overall Study|Adverse Event|0|||
23474647|NCT02445794|65481861|FG001|Overall Study|Adverse Event|0|||
23474648|NCT02445794|65481862|FG002|Overall Study|Adverse Event|2|||
23589295|NCT02001623|65886042|FG002|Overall Study|Disease Progression|3|||
23589296|NCT02001623|65886043|FG003|Overall Study|Disease Progression|2|||
23589297|NCT02001623|65886044|FG004|Overall Study|Disease Progression|3|||
23589298|NCT02001623|65886045|FG005|Overall Study|Disease Progression|2|||
23589299|NCT02001623|65886046|FG006|Overall Study|Disease Progression|3|||
23589300|NCT02001623|65886047|FG007|Overall Study|Disease Progression|3|||
23589301|NCT02001623|65886048|FG008|Overall Study|Disease Progression|7|||
23589302|NCT02001623|65886049|FG009|Overall Study|Disease Progression|40|||
23589303|NCT02001623|65886050|FG010|Overall Study|Disease Progression|5|||
23589304|NCT02001623|65886051|FG011|Overall Study|Disease Progression|9|||
23589305|NCT02001623|65886052|FG012|Overall Study|Disease Progression|9|||
23589306|NCT02001623|65886053|FG013|Overall Study|Disease Progression|20|||
23589307|NCT02001623|65886054|FG014|Overall Study|Disease Progression|9|||
23589308|NCT02001623|65886040|FG000|Overall Study|Physician Decision|0|||
23589309|NCT02001623|65886041|FG001|Overall Study|Physician Decision|0|||
23589310|NCT02001623|65886042|FG002|Overall Study|Physician Decision|0|||
23589311|NCT02001623|65886043|FG003|Overall Study|Physician Decision|0|||
23589312|NCT02001623|65886044|FG004|Overall Study|Physician Decision|0|||
23589313|NCT02001623|65886045|FG005|Overall Study|Physician Decision|0|||
23589314|NCT02001623|65886046|FG006|Overall Study|Physician Decision|0|||
23589315|NCT02001623|65886047|FG007|Overall Study|Physician Decision|0|||
23589316|NCT02001623|65886048|FG008|Overall Study|Physician Decision|3|||
23589317|NCT02001623|65886049|FG009|Overall Study|Physician Decision|2|||
23589318|NCT02001623|65886050|FG010|Overall Study|Physician Decision|3|||
23589319|NCT02001623|65886051|FG011|Overall Study|Physician Decision|3|||
23589320|NCT02001623|65886052|FG012|Overall Study|Physician Decision|1|||
23589321|NCT02001623|65886053|FG013|Overall Study|Physician Decision|2|||
23589322|NCT02001623|65886054|FG014|Overall Study|Physician Decision|1|||
23589323|NCT02001623|65886040|FG000|Overall Study|Death|0|||
23589324|NCT02001623|65886041|FG001|Overall Study|Death|1|||
23589325|NCT02001623|65886042|FG002|Overall Study|Death|0|||
23589326|NCT02001623|65886043|FG003|Overall Study|Death|0|||
23589327|NCT02001623|65886044|FG004|Overall Study|Death|0|||
23589328|NCT02001623|65886045|FG005|Overall Study|Death|0|||
23589329|NCT02001623|65886046|FG006|Overall Study|Death|0|||
23589330|NCT02001623|65886047|FG007|Overall Study|Death|0|||
23589331|NCT02001623|65886048|FG008|Overall Study|Death|0|||
23589332|NCT02001623|65886049|FG009|Overall Study|Death|0|||
23589333|NCT02001623|65886050|FG010|Overall Study|Death|0|||
23589334|NCT02001623|65886051|FG011|Overall Study|Death|0|||
23589335|NCT02001623|65886052|FG012|Overall Study|Death|0|||
23589336|NCT02001623|65886053|FG013|Overall Study|Death|0|||
23797290|NCT00683787|66633248|FG000|Overall Study|Progression|3|||
23474649|NCT02445794|65481863|FG003|Overall Study|Adverse Event|0|||
23474650|NCT03567343|65481866|FG000|Overall Study|Lost to Follow-up|2|||
23474651|NCT03567343|65481867|FG001|Overall Study|Lost to Follow-up|1|||
23474652|NCT03567343|65481866|FG000|Overall Study|No longer eligible|2|||
23589337|NCT02001623|65886054|FG014|Overall Study|Death|0|||
23589338|NCT02001623|65886040|FG000|Overall Study|Adverse Event|0|||
23589339|NCT02001623|65886041|FG001|Overall Study|Adverse Event|0|||
23589340|NCT02001623|65886042|FG002|Overall Study|Adverse Event|0|||
23589341|NCT02001623|65886043|FG003|Overall Study|Adverse Event|0|||
23589342|NCT02001623|65886044|FG004|Overall Study|Adverse Event|0|||
23589343|NCT02001623|65886045|FG005|Overall Study|Adverse Event|1|||
23589344|NCT02001623|65886046|FG006|Overall Study|Adverse Event|0|||
23797291|NCT00683787|66633249|FG001|Overall Study|Progression|3|||
23474653|NCT03567343|65481867|FG001|Overall Study|No longer eligible|1|||
23474654|NCT03567343|65481866|FG000|Overall Study|Adverse Event|1|||
23474655|NCT03567343|65481867|FG001|Overall Study|Adverse Event|0|||
23474656|NCT03567343|65481866|FG000|Overall Study|Protocol Violation|1|||
23474657|NCT03567343|65481867|FG001|Overall Study|Protocol Violation|1|||
23474658|NCT04535453|65481868|FG000|Overall Study|Death|0|||
23474659|NCT04535453|65481869|FG001|Overall Study|Death|1|||
23474660|NCT04535453|65481870|FG002|Overall Study|Death|0|||
23474661|NCT04535453|65481871|FG003|Overall Study|Death|0|||
23474662|NCT04535453|65481872|FG004|Overall Study|Death|0|||
23474663|NCT04535453|65481873|FG005|Overall Study|Death|0|||
23474664|NCT04535453|65481874|FG006|Overall Study|Death|0|||
23474665|NCT04535453|65481875|FG007|Overall Study|Death|0|||
23474666|NCT04535453|65481876|FG008|Overall Study|Death|0|||
23474667|NCT04535453|65481877|FG009|Overall Study|Death|0|||
23474668|NCT04535453|65481878|FG010|Overall Study|Death|0|||
23474669|NCT04535453|65481879|FG011|Overall Study|Death|0|||
23474670|NCT04535453|65481868|FG000|Overall Study|Lost to Follow-up|1|||
23474671|NCT04535453|65481869|FG001|Overall Study|Lost to Follow-up|1|||
23474672|NCT04535453|65481870|FG002|Overall Study|Lost to Follow-up|1|||
23474673|NCT04535453|65481871|FG003|Overall Study|Lost to Follow-up|0|||
23474674|NCT04535453|65481872|FG004|Overall Study|Lost to Follow-up|3|||
23474675|NCT04535453|65481873|FG005|Overall Study|Lost to Follow-up|1|||
23474676|NCT04535453|65481874|FG006|Overall Study|Lost to Follow-up|0|||
23474677|NCT04535453|65481875|FG007|Overall Study|Lost to Follow-up|0|||
23474678|NCT04535453|65481876|FG008|Overall Study|Lost to Follow-up|1|||
23474679|NCT04535453|65481877|FG009|Overall Study|Lost to Follow-up|1|||
23474680|NCT04535453|65481878|FG010|Overall Study|Lost to Follow-up|0|||
23474681|NCT04535453|65481879|FG011|Overall Study|Lost to Follow-up|0|||
23474682|NCT04535453|65481868|FG000|Overall Study|Physician Decision|0|||
23474683|NCT04535453|65481869|FG001|Overall Study|Physician Decision|0|||
23474684|NCT04535453|65481870|FG002|Overall Study|Physician Decision|0|||
23797292|NCT00683787|66633250|FG002|Overall Study|Progression|0|||
23797293|NCT00683787|66633248|FG000|Overall Study|Adverse Event|0|||
23797294|NCT00683787|66633249|FG001|Overall Study|Adverse Event|0|||
23797295|NCT00683787|66633250|FG002|Overall Study|Adverse Event|2|||
23474685|NCT04535453|65481871|FG003|Overall Study|Physician Decision|1|||
23474686|NCT04535453|65481872|FG004|Overall Study|Physician Decision|0|||
23474687|NCT04535453|65481873|FG005|Overall Study|Physician Decision|0|||
23474688|NCT04535453|65481874|FG006|Overall Study|Physician Decision|0|||
23474689|NCT04535453|65481875|FG007|Overall Study|Physician Decision|0|||
23474690|NCT04535453|65481876|FG008|Overall Study|Physician Decision|0|||
23474691|NCT04535453|65481877|FG009|Overall Study|Physician Decision|0|||
23474692|NCT04535453|65481878|FG010|Overall Study|Physician Decision|0|||
23474693|NCT04535453|65481879|FG011|Overall Study|Physician Decision|0|||
23474694|NCT04535453|65481868|FG000|Overall Study|Withdrawal by Subject|3|||
23474695|NCT04535453|65481869|FG001|Overall Study|Withdrawal by Subject|6|||
23474696|NCT04535453|65481870|FG002|Overall Study|Withdrawal by Subject|3|||
23474697|NCT04535453|65481871|FG003|Overall Study|Withdrawal by Subject|3|||
23474698|NCT04535453|65481872|FG004|Overall Study|Withdrawal by Subject|2|||
23474699|NCT04535453|65481873|FG005|Overall Study|Withdrawal by Subject|1|||
23474700|NCT04535453|65481874|FG006|Overall Study|Withdrawal by Subject|1|||
23474701|NCT04535453|65481875|FG007|Overall Study|Withdrawal by Subject|1|||
23474702|NCT04535453|65481876|FG008|Overall Study|Withdrawal by Subject|1|||
23474703|NCT04535453|65481877|FG009|Overall Study|Withdrawal by Subject|1|||
23474704|NCT04535453|65481878|FG010|Overall Study|Withdrawal by Subject|0|||
23474705|NCT04535453|65481879|FG011|Overall Study|Withdrawal by Subject|1|||
23474706|NCT04535453|65481868|FG000|Overall Study|Other|0|||
23474707|NCT04535453|65481869|FG001|Overall Study|Other|0|||
23474708|NCT04535453|65481870|FG002|Overall Study|Other|1|||
23474709|NCT04535453|65481871|FG003|Overall Study|Other|0|||
23474710|NCT04535453|65481872|FG004|Overall Study|Other|1|||
23589345|NCT02001623|65886047|FG007|Overall Study|Adverse Event|3|||
23589346|NCT02001623|65886048|FG008|Overall Study|Adverse Event|4|||
23589347|NCT02001623|65886049|FG009|Overall Study|Adverse Event|6|||
23706860|NCT00002663|66301346|FG007|Overall Study|Adverse Event|1|||
23474711|NCT04535453|65481873|FG005|Overall Study|Other|0|||
23474712|NCT04535453|65481874|FG006|Overall Study|Other|1|||
23474713|NCT04535453|65481875|FG007|Overall Study|Other|1|||
23474714|NCT04535453|65481876|FG008|Overall Study|Other|1|||
23474715|NCT04535453|65481877|FG009|Overall Study|Other|0|||
23474716|NCT04535453|65481878|FG010|Overall Study|Other|0|||
23474717|NCT04535453|65481879|FG011|Overall Study|Other|0|||
23474718|NCT00992589|65481880|FG000|Open-Label Phase|Adverse Event|4|||
23474719|NCT00992589|65481881|FG001|Open-Label Phase|Adverse Event|0|||
23474720|NCT00992589|65481882|FG002|Open-Label Phase|Adverse Event|0|||
23589348|NCT02001623|65886050|FG010|Overall Study|Adverse Event|4|||
23797296|NCT01470417|66633253|FG000|Overall Study|Disease progression|0|||
23474721|NCT00992589|65481883|FG003|Open-Label Phase|Adverse Event|0|||
23474722|NCT00992589|65481880|FG000|Open-Label Phase|Withdrawal by Subject|20|||
23474723|NCT00992589|65481881|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23589349|NCT02001623|65886051|FG011|Overall Study|Adverse Event|0|||
23474724|NCT00992589|65481882|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23474725|NCT00992589|65481883|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23474726|NCT00992589|65481880|FG000|Open-Label Phase|Lost to Follow-up|1|||
23474727|NCT00992589|65481881|FG001|Open-Label Phase|Lost to Follow-up|0|||
23474728|NCT00992589|65481882|FG002|Open-Label Phase|Lost to Follow-up|0|||
23474729|NCT00992589|65481883|FG003|Open-Label Phase|Lost to Follow-up|0|||
23474730|NCT00992589|65481880|FG000|Open-Label Phase|Protocol Violation|3|||
23474731|NCT00992589|65481881|FG001|Open-Label Phase|Protocol Violation|0|||
23474732|NCT00992589|65481882|FG002|Open-Label Phase|Protocol Violation|0|||
23474733|NCT00992589|65481883|FG003|Open-Label Phase|Protocol Violation|0|||
23474734|NCT00992589|65481880|FG000|Open-Label Phase|Physician Decision|4|||
23474735|NCT00992589|65481881|FG001|Open-Label Phase|Physician Decision|0|||
23474736|NCT00992589|65481882|FG002|Open-Label Phase|Physician Decision|0|||
23474737|NCT00992589|65481883|FG003|Open-Label Phase|Physician Decision|0|||
23474738|NCT00992589|65481880|FG000|Open-Label Phase|Other|45|||
23797297|NCT01470417|66633254|FG001|Overall Study|Disease progression|2|||
23797298|NCT01606228|66633255|FG000|Overall Study|Lost to Follow-up|20|||
23797299|NCT01606228|66633255|FG000|Overall Study|Withdrawal by Subject|3|||
23797300|NCT01606228|66633255|FG000|Overall Study|Non-compliant|3|||
23797301|NCT01606228|66633255|FG000|Overall Study|Lack of Efficacy|2|||
23797302|NCT01606228|66633255|FG000|Overall Study|Adverse Event|1|||
23797303|NCT02426541|66633256|FG000|Overall Study|Protocol Violation|1|||
23797304|NCT02426541|66633257|FG001|Overall Study|Protocol Violation|0|||
23474739|NCT00992589|65481881|FG001|Open-Label Phase|Other|0|||
23474740|NCT00992589|65481882|FG002|Open-Label Phase|Other|0|||
23474741|NCT00992589|65481883|FG003|Open-Label Phase|Other|0|||
23474742|NCT00992589|65481880|FG000|Double-Blind Phase|Adverse Event|0|||
23474743|NCT00992589|65481881|FG001|Double-Blind Phase|Adverse Event|6|||
23589350|NCT02001623|65886052|FG012|Overall Study|Adverse Event|3|||
23589351|NCT02001623|65886053|FG013|Overall Study|Adverse Event|5|||
23589352|NCT02001623|65886054|FG014|Overall Study|Adverse Event|6|||
23589353|NCT02001623|65886040|FG000|Overall Study|Other - Miscellaneous|0|||
23589354|NCT02001623|65886041|FG001|Overall Study|Other - Miscellaneous|0|||
23589355|NCT02001623|65886042|FG002|Overall Study|Other - Miscellaneous|0|||
23589356|NCT02001623|65886043|FG003|Overall Study|Other - Miscellaneous|0|||
23589357|NCT02001623|65886044|FG004|Overall Study|Other - Miscellaneous|0|||
23589358|NCT02001623|65886045|FG005|Overall Study|Other - Miscellaneous|0|||
23589359|NCT02001623|65886046|FG006|Overall Study|Other - Miscellaneous|0|||
23589360|NCT02001623|65886047|FG007|Overall Study|Other - Miscellaneous|0|||
23589361|NCT02001623|65886048|FG008|Overall Study|Other - Miscellaneous|0|||
23589362|NCT02001623|65886049|FG009|Overall Study|Other - Miscellaneous|1|||
23589363|NCT02001623|65886050|FG010|Overall Study|Other - Miscellaneous|0|||
23589364|NCT02001623|65886051|FG011|Overall Study|Other - Miscellaneous|0|||
23589365|NCT02001623|65886052|FG012|Overall Study|Other - Miscellaneous|0|||
23589366|NCT02001623|65886053|FG013|Overall Study|Other - Miscellaneous|1|||
23589367|NCT02001623|65886054|FG014|Overall Study|Other - Miscellaneous|0|||
23589368|NCT02001623|65886040|FG000|Overall Study|Withdrawal by Subject|1|||
23589369|NCT02001623|65886041|FG001|Overall Study|Withdrawal by Subject|0|||
23589370|NCT02001623|65886042|FG002|Overall Study|Withdrawal by Subject|0|||
23589371|NCT02001623|65886043|FG003|Overall Study|Withdrawal by Subject|0|||
23589372|NCT02001623|65886044|FG004|Overall Study|Withdrawal by Subject|0|||
23589373|NCT02001623|65886045|FG005|Overall Study|Withdrawal by Subject|0|||
23589374|NCT02001623|65886046|FG006|Overall Study|Withdrawal by Subject|0|||
23589375|NCT02001623|65886047|FG007|Overall Study|Withdrawal by Subject|0|||
23589376|NCT02001623|65886048|FG008|Overall Study|Withdrawal by Subject|1|||
23589377|NCT02001623|65886049|FG009|Overall Study|Withdrawal by Subject|3|||
23589378|NCT02001623|65886050|FG010|Overall Study|Withdrawal by Subject|2|||
23797305|NCT04167618|66633260|FG000|Overall Study|Trial terminated by sponsor|1|||
23797306|NCT04167618|66633261|FG001|Overall Study|Trial terminated by sponsor|1|||
23474744|NCT00992589|65481882|FG002|Double-Blind Phase|Adverse Event|2|||
23797307|NCT04205162|66633262|FG000|Overall Study|Lost to Follow-up|1|||
23357785|NCT02182830|65052857|FG001|Overall Study|Trial stopped, reason missing|3|||
23474745|NCT00992589|65481883|FG003|Double-Blind Phase|Adverse Event|3|||
23474746|NCT00992589|65481880|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23474747|NCT00992589|65481881|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23474748|NCT00992589|65481882|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
23589379|NCT02001623|65886051|FG011|Overall Study|Withdrawal by Subject|2|||
23589380|NCT02001623|65886052|FG012|Overall Study|Withdrawal by Subject|1|||
23589381|NCT02001623|65886053|FG013|Overall Study|Withdrawal by Subject|5|||
23589382|NCT02001623|65886054|FG014|Overall Study|Withdrawal by Subject|2|||
23589383|NCT02001623|65886040|FG000|Overall Study|Lost to Follow-up|0|||
23797308|NCT04205162|66633263|FG001|Overall Study|Lost to Follow-up|0|||
23357786|NCT02182830|65052856|FG000|Overall Study|Consent withdrawn|8|||
23357787|NCT02182830|65052857|FG001|Overall Study|Consent withdrawn|8|||
23357788|NCT02182830|65052856|FG000|Overall Study|Lost to Follow-up|3|||
23357789|NCT02182830|65052857|FG001|Overall Study|Lost to Follow-up|3|||
23357790|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
23357791|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357792|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357793|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357794|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357795|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
23357796|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23357797|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23642882|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
23642883|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
23642884|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
23642885|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
23642886|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
23357798|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23642887|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
23357799|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23357800|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
23357801|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357802|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357803|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357804|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357805|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
23357806|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357807|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357808|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357809|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357810|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
23357811|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357812|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357813|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357814|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357815|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
23357816|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
23357817|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
23357818|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
23357819|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
23357820|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
23357821|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
23357822|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
23357823|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
23357824|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
23357825|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
23357826|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
23357827|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
23357828|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
23357829|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
23589384|NCT02001623|65886041|FG001|Overall Study|Lost to Follow-up|0|||
23589385|NCT02001623|65886042|FG002|Overall Study|Lost to Follow-up|0|||
23589386|NCT02001623|65886043|FG003|Overall Study|Lost to Follow-up|0|||
23589387|NCT02001623|65886044|FG004|Overall Study|Lost to Follow-up|0|||
23589388|NCT02001623|65886045|FG005|Overall Study|Lost to Follow-up|0|||
23589389|NCT02001623|65886046|FG006|Overall Study|Lost to Follow-up|0|||
23357830|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357831|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357832|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357833|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
23357834|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357835|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
23357836|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
23357837|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
23357838|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
23357839|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
23357840|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
23357841|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
23357842|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
23357843|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
23357844|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
23357845|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357846|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357847|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357848|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357849|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
23357850|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357851|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357852|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357853|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357854|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
23357855|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357856|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357857|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357858|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357859|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
23357860|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357861|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357862|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357863|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357864|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
23357865|NCT03066778|65052875|FG000|Overall Study|Death|195|||
23357866|NCT03066778|65052876|FG001|Overall Study|Death|205|||
23357867|NCT03066778|65052875|FG000|Overall Study|Withdrawal by Subject|5|||
23357868|NCT03066778|65052876|FG001|Overall Study|Withdrawal by Subject|7|||
23357869|NCT02983045|65056130|FG000|Overall Study|Withdrawal by Subject|0|||
23357870|NCT02983045|65056131|FG001|Overall Study|Withdrawal by Subject|1|||
23357871|NCT02983045|65056132|FG002|Overall Study|Withdrawal by Subject|0|||
23357872|NCT02983045|65056133|FG003|Overall Study|Withdrawal by Subject|5|||
23357873|NCT02983045|65056134|FG004|Overall Study|Withdrawal by Subject|0|||
23642888|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
23642889|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
23642890|NCT02663518|66078991|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642891|NCT02663518|66078992|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642892|NCT02663518|66078993|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642893|NCT02663518|66078994|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642894|NCT02663518|66078995|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23797309|NCT04205162|66633262|FG000|Overall Study|Withdrawal by Subject|2|||
23797310|NCT04205162|66633263|FG001|Overall Study|Withdrawal by Subject|0|||
23357874|NCT02983045|65056135|FG005|Overall Study|Withdrawal by Subject|72|||
23642895|NCT02663518|66078996|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642896|NCT02663518|66078997|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
23642897|NCT02663518|66078998|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642898|NCT02663518|66078999|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642899|NCT02663518|66079000|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642900|NCT02663518|66079001|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642901|NCT02663518|66079002|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642902|NCT02663518|66079003|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642903|NCT02663518|66079004|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23642904|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
23642905|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
23797311|NCT04205162|66633262|FG000|Overall Study|University closure due to COVID-19|1|||
23357875|NCT02983045|65056136|FG006|Overall Study|Withdrawal by Subject|0|||
23357876|NCT02983045|65056137|FG007|Overall Study|Withdrawal by Subject|0|||
23642906|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
23642907|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
23642908|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
23642909|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
23642910|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
23642911|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
23642912|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
23642913|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
23642914|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
23642915|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
23642916|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
23642917|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
23642918|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642919|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642920|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642921|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642922|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642923|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642924|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642925|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642926|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23474749|NCT00992589|65481883|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
23474750|NCT00992589|65481880|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23474751|NCT00992589|65481881|FG001|Double-Blind Phase|Lost to Follow-up|0|||
23474752|NCT00992589|65481882|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23642927|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642928|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23357877|NCT02983045|65056138|FG008|Overall Study|Withdrawal by Subject|0|||
23474753|NCT00992589|65481883|FG003|Double-Blind Phase|Lost to Follow-up|2|||
23642929|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23642930|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
23797312|NCT04205162|66633263|FG001|Overall Study|University closure due to COVID-19|0|||
23797313|NCT02911935|66633264|FG000|Overall Study|Lost to Follow-up|5|||
23797314|NCT02911935|66633265|FG001|Overall Study|Lost to Follow-up|7|||
23797315|NCT00860743|66633266|FG000|Overall Study|Withdrawal by Subject|3|||
23797316|NCT00860743|66633267|FG001|Overall Study|Withdrawal by Subject|0|||
23797317|NCT01680016|66633268|FG000|Overall Study|Adverse Event|0|||
23797318|NCT01680016|66633269|FG001|Overall Study|Adverse Event|0|||
23589390|NCT02001623|65886047|FG007|Overall Study|Lost to Follow-up|0|||
23589391|NCT02001623|65886048|FG008|Overall Study|Lost to Follow-up|0|||
23589392|NCT02001623|65886049|FG009|Overall Study|Lost to Follow-up|1|||
23589393|NCT02001623|65886050|FG010|Overall Study|Lost to Follow-up|0|||
23357878|NCT02983045|65056139|FG009|Overall Study|Withdrawal by Subject|2|||
23357879|NCT02983045|65056130|FG000|Overall Study|Lost to Follow-up|0|||
23474754|NCT00992589|65481880|FG000|Double-Blind Phase|Other|0|||
23474755|NCT00992589|65481881|FG001|Double-Blind Phase|Other|1|||
23474756|NCT00992589|65481882|FG002|Double-Blind Phase|Other|6|||
23474757|NCT00992589|65481883|FG003|Double-Blind Phase|Other|3|||
23474758|NCT04345367|65481884|FG000|Overall Study|Other|3|||
23474759|NCT04345367|65481885|FG001|Overall Study|Other|4|||
23474760|NCT04345367|65481884|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
23474761|NCT04345367|65481885|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
23474762|NCT04345367|65481884|FG000|Overall Study|Withdrawal by Subject|11|||
23474763|NCT04345367|65481885|FG001|Overall Study|Withdrawal by Subject|11|||
23474764|NCT04345367|65481884|FG000|Overall Study|Protocol Violation|4|||
23474765|NCT04345367|65481885|FG001|Overall Study|Protocol Violation|3|||
23474766|NCT04345367|65481884|FG000|Overall Study|Lost to Follow-up|2|||
23589394|NCT02001623|65886051|FG011|Overall Study|Lost to Follow-up|0|||
23357880|NCT02983045|65056131|FG001|Overall Study|Lost to Follow-up|0|||
23357881|NCT02983045|65056132|FG002|Overall Study|Lost to Follow-up|0|||
23589395|NCT02001623|65886052|FG012|Overall Study|Lost to Follow-up|0|||
23589396|NCT02001623|65886053|FG013|Overall Study|Lost to Follow-up|0|||
23589397|NCT02001623|65886054|FG014|Overall Study|Lost to Follow-up|0|||
23589398|NCT02001623|65886040|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
23589399|NCT02001623|65886041|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
23589400|NCT02001623|65886042|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
23642931|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23706861|NCT00002663|66301347|FG008|Overall Study|Adverse Event|0|||
23474767|NCT04345367|65481885|FG001|Overall Study|Lost to Follow-up|4|||
23474768|NCT04345367|65481884|FG000|Overall Study|Lack of Efficacy|2|||
23589401|NCT02001623|65886043|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
23589402|NCT02001623|65886044|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
23589403|NCT02001623|65886045|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
23357882|NCT02983045|65056133|FG003|Overall Study|Lost to Follow-up|0|||
23357883|NCT02983045|65056134|FG004|Overall Study|Lost to Follow-up|0|||
23357884|NCT02983045|65056135|FG005|Overall Study|Lost to Follow-up|10|||
23357885|NCT02983045|65056136|FG006|Overall Study|Lost to Follow-up|0|||
23357886|NCT02983045|65056137|FG007|Overall Study|Lost to Follow-up|0|||
23357887|NCT02983045|65056138|FG008|Overall Study|Lost to Follow-up|0|||
23357888|NCT02983045|65056139|FG009|Overall Study|Lost to Follow-up|0|||
23357889|NCT02447328|65056143|FG000|Overall Study|Withdrawal by Subject|1|||
23357890|NCT01962948|65056144|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
23357891|NCT01962948|65056145|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
23357892|NCT01962948|65056146|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
23357893|NCT01962948|65056147|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
23357894|NCT00564395|65056148|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
23357895|NCT00564395|65056149|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
23357896|NCT00564395|65056148|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
23357897|NCT00564395|65056149|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
23357898|NCT01358578|65056150|FG000|Induction Period|Adverse Event|2|||
23357899|NCT01358578|65056151|FG001|Induction Period|Adverse Event|4|||
23357900|NCT01358578|65056152|FG002|Induction Period|Adverse Event|2|||
23357901|NCT01358578|65056153|FG003|Induction Period|Adverse Event|6|||
23357902|NCT01358578|65056154|FG004|Induction Period|Adverse Event|0|||
23357903|NCT01358578|65056155|FG005|Induction Period|Adverse Event|0|||
23357904|NCT01358578|65056150|FG000|Induction Period|Lack of Efficacy|0|||
23357905|NCT01358578|65056151|FG001|Induction Period|Lack of Efficacy|0|||
23357906|NCT01358578|65056152|FG002|Induction Period|Lack of Efficacy|9|||
23357907|NCT01358578|65056153|FG003|Induction Period|Lack of Efficacy|1|||
23357908|NCT01358578|65056154|FG004|Induction Period|Lack of Efficacy|0|||
23357909|NCT01358578|65056155|FG005|Induction Period|Lack of Efficacy|0|||
23357910|NCT01358578|65056150|FG000|Induction Period|Lost to Follow-up|0|||
23357911|NCT01358578|65056151|FG001|Induction Period|Lost to Follow-up|0|||
23357912|NCT01358578|65056152|FG002|Induction Period|Lost to Follow-up|1|||
23357913|NCT01358578|65056153|FG003|Induction Period|Lost to Follow-up|4|||
23357914|NCT01358578|65056154|FG004|Induction Period|Lost to Follow-up|0|||
23357915|NCT01358578|65056155|FG005|Induction Period|Lost to Follow-up|0|||
23357916|NCT01358578|65056150|FG000|Induction Period|Physician Decision|2|||
23357917|NCT01358578|65056151|FG001|Induction Period|Physician Decision|1|||
23357918|NCT01358578|65056152|FG002|Induction Period|Physician Decision|2|||
23797319|NCT01680016|66633270|FG002|Overall Study|Adverse Event|1|||
23797320|NCT01680016|66633271|FG003|Overall Study|Adverse Event|4|||
23797321|NCT01680016|66633268|FG000|Overall Study|The Subject went out of The Trial|1|||
23797322|NCT01680016|66633269|FG001|Overall Study|The Subject went out of The Trial|0|||
23357919|NCT01358578|65056153|FG003|Induction Period|Physician Decision|0|||
23797323|NCT01680016|66633270|FG002|Overall Study|The Subject went out of The Trial|3|||
23797324|NCT01680016|66633271|FG003|Overall Study|The Subject went out of The Trial|0|||
23797325|NCT01680016|66633268|FG000|Overall Study|Protocol Violation|0|||
23797326|NCT01680016|66633269|FG001|Overall Study|Protocol Violation|1|||
23797327|NCT01680016|66633270|FG002|Overall Study|Protocol Violation|0|||
23797328|NCT01680016|66633271|FG003|Overall Study|Protocol Violation|0|||
23797329|NCT01680016|66633268|FG000|Overall Study|Withdrawal by Subject|5|||
23797330|NCT01680016|66633269|FG001|Overall Study|Withdrawal by Subject|7|||
23797331|NCT01680016|66633270|FG002|Overall Study|Withdrawal by Subject|1|||
23797332|NCT01680016|66633271|FG003|Overall Study|Withdrawal by Subject|1|||
23797333|NCT04979858|66633275|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
23797334|NCT04979858|66633276|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
23797335|NCT02998541|66633277|FG000|Overall Study|Adverse Event|4|||
23797336|NCT02998541|66633278|FG001|Overall Study|Adverse Event|5|||
23797337|NCT02998541|66633279|FG002|Overall Study|Adverse Event|1|||
23797338|NCT02998541|66633277|FG000|Overall Study|Protocol Violation|1|||
23797339|NCT02998541|66633278|FG001|Overall Study|Protocol Violation|0|||
23797340|NCT02998541|66633279|FG002|Overall Study|Protocol Violation|0|||
23797341|NCT02998541|66633277|FG000|Overall Study|Withdrawal by Subject|3|||
23797342|NCT02998541|66633278|FG001|Overall Study|Withdrawal by Subject|1|||
23797343|NCT02998541|66633279|FG002|Overall Study|Withdrawal by Subject|0|||
23797344|NCT02998541|66633277|FG000|Overall Study|Lost to Follow-up|0|||
23797345|NCT02998541|66633278|FG001|Overall Study|Lost to Follow-up|3|||
23357920|NCT01358578|65056154|FG004|Induction Period|Physician Decision|0|||
23357921|NCT01358578|65056155|FG005|Induction Period|Physician Decision|0|||
23474769|NCT04345367|65481885|FG001|Overall Study|Lack of Efficacy|0|||
23797346|NCT02998541|66633279|FG002|Overall Study|Lost to Follow-up|1|||
23797347|NCT02998541|66633277|FG000|Overall Study|Physician Decision|0|||
23797348|NCT02998541|66633278|FG001|Overall Study|Physician Decision|0|||
23797349|NCT02998541|66633279|FG002|Overall Study|Physician Decision|3|||
23797350|NCT02998541|66633277|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23357922|NCT01358578|65056150|FG000|Induction Period|Protocol Deviation|3|||
23357923|NCT01358578|65056151|FG001|Induction Period|Protocol Deviation|5|||
23357924|NCT01358578|65056152|FG002|Induction Period|Protocol Deviation|0|||
23357925|NCT01358578|65056153|FG003|Induction Period|Protocol Deviation|3|||
23357926|NCT01358578|65056154|FG004|Induction Period|Protocol Deviation|0|||
23357927|NCT01358578|65056155|FG005|Induction Period|Protocol Deviation|0|||
23357928|NCT01358578|65056150|FG000|Induction Period|technical problems|0|||
23357929|NCT01358578|65056151|FG001|Induction Period|technical problems|0|||
23357930|NCT01358578|65056152|FG002|Induction Period|technical problems|1|||
23357931|NCT01358578|65056153|FG003|Induction Period|technical problems|1|||
23357932|NCT01358578|65056154|FG004|Induction Period|technical problems|0|||
23357933|NCT01358578|65056155|FG005|Induction Period|technical problems|0|||
23357934|NCT01358578|65056150|FG000|Induction Period|Withdrawal by Subject|5|||
23357935|NCT01358578|65056151|FG001|Induction Period|Withdrawal by Subject|5|||
23357936|NCT01358578|65056152|FG002|Induction Period|Withdrawal by Subject|10|||
23357937|NCT01358578|65056153|FG003|Induction Period|Withdrawal by Subject|6|||
23357938|NCT01358578|65056154|FG004|Induction Period|Withdrawal by Subject|0|||
23357939|NCT01358578|65056155|FG005|Induction Period|Withdrawal by Subject|0|||
23357940|NCT01358578|65056150|FG000|Maintenance Period|Adverse Event|2|||
23357941|NCT01358578|65056151|FG001|Maintenance Period|Adverse Event|7|||
23357942|NCT01358578|65056152|FG002|Maintenance Period|Adverse Event|0|||
23357943|NCT01358578|65056153|FG003|Maintenance Period|Adverse Event|6|||
23357944|NCT01358578|65056154|FG004|Maintenance Period|Adverse Event|4|||
23357945|NCT01358578|65056155|FG005|Maintenance Period|Adverse Event|3|||
23357946|NCT01358578|65056150|FG000|Maintenance Period|Lack of Efficacy|10|||
23357947|NCT01358578|65056151|FG001|Maintenance Period|Lack of Efficacy|2|||
23357948|NCT01358578|65056152|FG002|Maintenance Period|Lack of Efficacy|0|||
23357949|NCT01358578|65056153|FG003|Maintenance Period|Lack of Efficacy|11|||
23357950|NCT01358578|65056154|FG004|Maintenance Period|Lack of Efficacy|3|||
23357951|NCT01358578|65056155|FG005|Maintenance Period|Lack of Efficacy|0|||
23357952|NCT01358578|65056150|FG000|Maintenance Period|Lost to Follow-up|4|||
23357953|NCT01358578|65056151|FG001|Maintenance Period|Lost to Follow-up|0|||
23357954|NCT01358578|65056152|FG002|Maintenance Period|Lost to Follow-up|0|||
23357955|NCT01358578|65056153|FG003|Maintenance Period|Lost to Follow-up|5|||
23357956|NCT01358578|65056154|FG004|Maintenance Period|Lost to Follow-up|1|||
23357957|NCT01358578|65056155|FG005|Maintenance Period|Lost to Follow-up|1|||
23357958|NCT01358578|65056150|FG000|Maintenance Period|Non-compliance with study treatment|3|||
23357959|NCT01358578|65056151|FG001|Maintenance Period|Non-compliance with study treatment|1|||
23357960|NCT01358578|65056152|FG002|Maintenance Period|Non-compliance with study treatment|0|||
23357961|NCT01358578|65056153|FG003|Maintenance Period|Non-compliance with study treatment|2|||
23589404|NCT02001623|65886046|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
23589405|NCT02001623|65886047|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
23357962|NCT01358578|65056154|FG004|Maintenance Period|Non-compliance with study treatment|1|||
23357963|NCT01358578|65056155|FG005|Maintenance Period|Non-compliance with study treatment|2|||
23589406|NCT02001623|65886048|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
23474770|NCT04345367|65481884|FG000|Overall Study|Death|2|||
23474771|NCT04345367|65481885|FG001|Overall Study|Death|0|||
23474772|NCT04345367|65481884|FG000|Overall Study|Adverse Event|10|||
23474773|NCT04345367|65481885|FG001|Overall Study|Adverse Event|9|||
23474774|NCT01032889|65481886|FG000|Overall Study|Adverse Event|2|||
23474775|NCT01032889|65481887|FG001|Overall Study|Adverse Event|2|||
23474776|NCT01032889|65481888|FG002|Overall Study|Adverse Event|0|||
23474777|NCT01032889|65481886|FG000|Overall Study|Withdrawal of Consent|1|||
23474778|NCT01032889|65481887|FG001|Overall Study|Withdrawal of Consent|2|||
23474779|NCT01032889|65481888|FG002|Overall Study|Withdrawal of Consent|1|||
23474780|NCT01032889|65481886|FG000|Overall Study|Patient Request|0|||
23474781|NCT01032889|65481887|FG001|Overall Study|Patient Request|1|||
23474782|NCT01032889|65481888|FG002|Overall Study|Patient Request|0|||
23474783|NCT01032889|65481886|FG000|Overall Study|Lost to Follow-up|1|||
23474784|NCT01032889|65481887|FG001|Overall Study|Lost to Follow-up|1|||
23474785|NCT01032889|65481888|FG002|Overall Study|Lost to Follow-up|0|||
23474786|NCT01032889|65481886|FG000|Overall Study|Lack of Submental Fat|2|||
23474787|NCT01032889|65481887|FG001|Overall Study|Lack of Submental Fat|8|||
23474788|NCT01032889|65481888|FG002|Overall Study|Lack of Submental Fat|1|||
23589407|NCT02001623|65886049|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
23589408|NCT02001623|65886050|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
23589409|NCT02001623|65886051|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
23642932|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642933|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23474789|NCT01032889|65481886|FG000|Overall Study|Miscellaneous Reasons|2|||
23474790|NCT01032889|65481887|FG001|Overall Study|Miscellaneous Reasons|1|||
23474791|NCT01032889|65481888|FG002|Overall Study|Miscellaneous Reasons|1|||
23474792|NCT00282308|65481892|FG000|Treatment Period|Lost to Follow-up|1|||
23474793|NCT00282308|65481893|FG001|Treatment Period|Lost to Follow-up|0|||
23589410|NCT02001623|65886052|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
23589411|NCT02001623|65886053|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
23589412|NCT02001623|65886054|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
23589413|NCT02001623|65886040|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
23589414|NCT02001623|65886041|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
23589415|NCT02001623|65886042|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
23589416|NCT02001623|65886043|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
23589417|NCT02001623|65886044|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
23589418|NCT02001623|65886045|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
23589419|NCT02001623|65886046|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
23474794|NCT00282308|65481894|FG002|Treatment Period|Lost to Follow-up|0|||
23474795|NCT00282308|65481892|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
23357964|NCT01358578|65056150|FG000|Maintenance Period|Physician Decision|0|||
23357965|NCT01358578|65056151|FG001|Maintenance Period|Physician Decision|1|||
23357966|NCT01358578|65056152|FG002|Maintenance Period|Physician Decision|0|||
23357967|NCT01358578|65056153|FG003|Maintenance Period|Physician Decision|1|||
23357968|NCT01358578|65056154|FG004|Maintenance Period|Physician Decision|0|||
23357969|NCT01358578|65056155|FG005|Maintenance Period|Physician Decision|0|||
23357970|NCT01358578|65056150|FG000|Maintenance Period|Pregnancy|1|||
23357971|NCT01358578|65056151|FG001|Maintenance Period|Pregnancy|0|||
23357972|NCT01358578|65056152|FG002|Maintenance Period|Pregnancy|0|||
23357973|NCT01358578|65056153|FG003|Maintenance Period|Pregnancy|0|||
23357974|NCT01358578|65056154|FG004|Maintenance Period|Pregnancy|0|||
23357975|NCT01358578|65056155|FG005|Maintenance Period|Pregnancy|0|||
23357976|NCT01358578|65056150|FG000|Maintenance Period|Protocol deviation|7|||
23357977|NCT01358578|65056151|FG001|Maintenance Period|Protocol deviation|4|||
23357978|NCT01358578|65056152|FG002|Maintenance Period|Protocol deviation|0|||
23357979|NCT01358578|65056153|FG003|Maintenance Period|Protocol deviation|2|||
23357980|NCT01358578|65056154|FG004|Maintenance Period|Protocol deviation|2|||
23357981|NCT01358578|65056155|FG005|Maintenance Period|Protocol deviation|2|||
23357982|NCT01358578|65056150|FG000|Maintenance Period|Withdrawal by Subject|12|||
23357983|NCT01358578|65056151|FG001|Maintenance Period|Withdrawal by Subject|7|||
23357984|NCT01358578|65056152|FG002|Maintenance Period|Withdrawal by Subject|2|||
23357985|NCT01358578|65056153|FG003|Maintenance Period|Withdrawal by Subject|15|||
23357986|NCT01358578|65056154|FG004|Maintenance Period|Withdrawal by Subject|6|||
23357987|NCT01358578|65056155|FG005|Maintenance Period|Withdrawal by Subject|3|||
23357988|NCT01358578|65056150|FG000|Follow-up Period|Adverse Event|1|||
23357989|NCT01358578|65056151|FG001|Follow-up Period|Adverse Event|1|||
23357990|NCT01358578|65056152|FG002|Follow-up Period|Adverse Event|0|||
23357991|NCT01358578|65056153|FG003|Follow-up Period|Adverse Event|0|||
23642934|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642935|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642936|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642937|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642938|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642939|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642940|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642941|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642942|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642943|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
23642944|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642945|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23642946|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642947|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642948|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642949|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642950|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642951|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23357992|NCT01358578|65056154|FG004|Follow-up Period|Adverse Event|0|||
23357993|NCT01358578|65056155|FG005|Follow-up Period|Adverse Event|0|||
23357994|NCT01358578|65056150|FG000|Follow-up Period|Lack of Efficacy|3|||
23357995|NCT01358578|65056151|FG001|Follow-up Period|Lack of Efficacy|0|||
23357996|NCT01358578|65056152|FG002|Follow-up Period|Lack of Efficacy|4|||
23357997|NCT01358578|65056153|FG003|Follow-up Period|Lack of Efficacy|1|||
23357998|NCT01358578|65056154|FG004|Follow-up Period|Lack of Efficacy|0|||
23474796|NCT00282308|65481893|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
23474797|NCT00282308|65481894|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474798|NCT00282308|65481892|FG000|Treatment Period|Adverse Event|0|||
23474799|NCT00282308|65481893|FG001|Treatment Period|Adverse Event|2|||
23474800|NCT00282308|65481894|FG002|Treatment Period|Adverse Event|0|||
23474801|NCT00282308|65481892|FG000|Treatment Period|Not Treated with Study Drug|1|||
23474802|NCT00282308|65481893|FG001|Treatment Period|Not Treated with Study Drug|0|||
23474803|NCT00282308|65481894|FG002|Treatment Period|Not Treated with Study Drug|0|||
23474804|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
23474805|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
23474806|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
23474807|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
23474808|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
23474809|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
23474810|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474811|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474812|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
23474813|NCT00282308|65481892|FG000|Safety Follow-up Period|Adverse Event|0|||
23474814|NCT00282308|65481893|FG001|Safety Follow-up Period|Adverse Event|0|||
23474815|NCT00282308|65481894|FG002|Safety Follow-up Period|Adverse Event|1|||
23474816|NCT00282308|65481892|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
23474817|NCT00282308|65481893|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23474818|NCT00282308|65481894|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
23474819|NCT00282308|65481892|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
23474820|NCT00282308|65481893|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
23474821|NCT00282308|65481894|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
23474822|NCT00282308|65481892|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
23474823|NCT00282308|65481893|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
23474824|NCT00282308|65481894|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
23474825|NCT03079102|65481895|FG000|Overall Study|Physician Decision|0|||
23474826|NCT03079102|65481896|FG001|Overall Study|Physician Decision|1|||
23474827|NCT02872285|65481897|FG000|Overall Study|Withdrawal by Subject|2|||
23474828|NCT02872285|65481898|FG001|Overall Study|Withdrawal by Subject|0|||
23474829|NCT02872285|65481897|FG000|Overall Study|Lost to Follow-up|2|||
23474830|NCT02872285|65481898|FG001|Overall Study|Lost to Follow-up|2|||
23474831|NCT02872285|65481897|FG000|Overall Study|Discontinued due to back surgery|1|||
23474832|NCT02872285|65481898|FG001|Overall Study|Discontinued due to back surgery|0|||
23474833|NCT03887702|65481899|FG000|Overall Study|Study terminated|0|||
23474834|NCT03887702|65481900|FG001|Overall Study|Study terminated|0|||
23474835|NCT03887702|65481901|FG002|Overall Study|Study terminated|2|||
23474836|NCT03887702|65481902|FG003|Overall Study|Study terminated|2|||
23474837|NCT03830892|65481903|FG000|Overall Study|Physician Decision|2|||
23474838|NCT03830892|65481904|FG001|Overall Study|Physician Decision|3|||
23474839|NCT03830892|65481903|FG000|Overall Study|Study terminated due to COVID|4|||
23474840|NCT03830892|65481904|FG001|Overall Study|Study terminated due to COVID|0|||
23474841|NCT03830892|65481903|FG000|Overall Study|Protocol Violation|0|||
23474842|NCT03830892|65481904|FG001|Overall Study|Protocol Violation|1|||
23474843|NCT03830892|65481903|FG000|Overall Study|Withdrawal by Subject|0|||
23474844|NCT03830892|65481904|FG001|Overall Study|Withdrawal by Subject|2|||
23474845|NCT02466659|65481907|FG000|Overall Study|Lost to Follow-up|5|||
23474846|NCT02466659|65481908|FG001|Overall Study|Lost to Follow-up|2|||
23474847|NCT00966875|65481910|FG000|Part A|Adverse Event|2|||
23474848|NCT00966875|65481911|FG001|Part A|Adverse Event|1|||
23474849|NCT00966875|65481912|FG002|Part A|Adverse Event|0|||
23474850|NCT00966875|65481913|FG003|Part A|Adverse Event|1|||
23474851|NCT00966875|65481914|FG004|Part A|Adverse Event|0|||
23474852|NCT00966875|65481915|FG005|Part A|Adverse Event|1|||
23474853|NCT00966875|65481916|FG006|Part A|Adverse Event|0|||
23474854|NCT00966875|65481917|FG007|Part A|Adverse Event|3|||
23474855|NCT00966875|65481918|FG008|Part A|Adverse Event|3|||
23474856|NCT00966875|65481910|FG000|Part A|Entry Criteria|0|||
23474857|NCT00966875|65481911|FG001|Part A|Entry Criteria|0|||
23474858|NCT00966875|65481912|FG002|Part A|Entry Criteria|0|||
23474859|NCT00966875|65481913|FG003|Part A|Entry Criteria|0|||
23474860|NCT00966875|65481914|FG004|Part A|Entry Criteria|0|||
23589420|NCT02001623|65886047|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
23474861|NCT00966875|65481915|FG005|Part A|Entry Criteria|2|||
23357999|NCT01358578|65056155|FG005|Follow-up Period|Lack of Efficacy|0|||
23474862|NCT00966875|65481916|FG006|Part A|Entry Criteria|0|||
23474863|NCT00966875|65481917|FG007|Part A|Entry Criteria|0|||
23474864|NCT00966875|65481918|FG008|Part A|Entry Criteria|0|||
23474865|NCT00966875|65481910|FG000|Part A|Lack of Efficacy|0|||
23474866|NCT00966875|65481911|FG001|Part A|Lack of Efficacy|1|||
23474867|NCT00966875|65481912|FG002|Part A|Lack of Efficacy|0|||
23474868|NCT00966875|65481913|FG003|Part A|Lack of Efficacy|0|||
23474869|NCT00966875|65481914|FG004|Part A|Lack of Efficacy|0|||
23474870|NCT00966875|65481915|FG005|Part A|Lack of Efficacy|0|||
23474871|NCT00966875|65481916|FG006|Part A|Lack of Efficacy|4|||
23474872|NCT00966875|65481917|FG007|Part A|Lack of Efficacy|0|||
23474873|NCT00966875|65481918|FG008|Part A|Lack of Efficacy|0|||
23474874|NCT00966875|65481910|FG000|Part A|Lost to Follow-up|2|||
23474875|NCT00966875|65481911|FG001|Part A|Lost to Follow-up|0|||
23474876|NCT00966875|65481912|FG002|Part A|Lost to Follow-up|0|||
23474877|NCT00966875|65481913|FG003|Part A|Lost to Follow-up|0|||
23474878|NCT00966875|65481914|FG004|Part A|Lost to Follow-up|0|||
23474879|NCT00966875|65481915|FG005|Part A|Lost to Follow-up|1|||
23474880|NCT00966875|65481916|FG006|Part A|Lost to Follow-up|0|||
23474881|NCT00966875|65481917|FG007|Part A|Lost to Follow-up|0|||
23474882|NCT00966875|65481918|FG008|Part A|Lost to Follow-up|0|||
23474883|NCT00966875|65481910|FG000|Part A|Parent/Caregiver Decision|0|||
23474884|NCT00966875|65481911|FG001|Part A|Parent/Caregiver Decision|0|||
23474885|NCT00966875|65481912|FG002|Part A|Parent/Caregiver Decision|0|||
23474886|NCT00966875|65481913|FG003|Part A|Parent/Caregiver Decision|1|||
23474887|NCT00966875|65481914|FG004|Part A|Parent/Caregiver Decision|0|||
23474888|NCT00966875|65481915|FG005|Part A|Parent/Caregiver Decision|0|||
23474889|NCT00966875|65481916|FG006|Part A|Parent/Caregiver Decision|0|||
23474890|NCT00966875|65481917|FG007|Part A|Parent/Caregiver Decision|0|||
23474891|NCT00966875|65481918|FG008|Part A|Parent/Caregiver Decision|0|||
23474892|NCT00966875|65481910|FG000|Part A|Physician Decision|0|||
23474893|NCT00966875|65481911|FG001|Part A|Physician Decision|0|||
23474894|NCT00966875|65481912|FG002|Part A|Physician Decision|0|||
23474895|NCT00966875|65481913|FG003|Part A|Physician Decision|0|||
23474896|NCT00966875|65481914|FG004|Part A|Physician Decision|1|||
23474897|NCT00966875|65481915|FG005|Part A|Physician Decision|0|||
23474898|NCT00966875|65481916|FG006|Part A|Physician Decision|1|||
23474899|NCT00966875|65481917|FG007|Part A|Physician Decision|0|||
23474900|NCT00966875|65481918|FG008|Part A|Physician Decision|2|||
23474901|NCT00966875|65481910|FG000|Part A|Sponsor Decision|0|||
23474902|NCT00966875|65481911|FG001|Part A|Sponsor Decision|0|||
23474903|NCT00966875|65481912|FG002|Part A|Sponsor Decision|1|||
23474904|NCT00966875|65481913|FG003|Part A|Sponsor Decision|0|||
23474905|NCT00966875|65481914|FG004|Part A|Sponsor Decision|1|||
23474906|NCT00966875|65481915|FG005|Part A|Sponsor Decision|0|||
23474907|NCT00966875|65481916|FG006|Part A|Sponsor Decision|0|||
23474908|NCT00966875|65481917|FG007|Part A|Sponsor Decision|2|||
23474909|NCT00966875|65481918|FG008|Part A|Sponsor Decision|1|||
23474910|NCT00966875|65481910|FG000|Part A|Withdrawal by Subject|2|||
23474911|NCT00966875|65481911|FG001|Part A|Withdrawal by Subject|2|||
23474912|NCT00966875|65481912|FG002|Part A|Withdrawal by Subject|1|||
23474913|NCT00966875|65481913|FG003|Part A|Withdrawal by Subject|1|||
23474914|NCT00966875|65481914|FG004|Part A|Withdrawal by Subject|3|||
23474915|NCT00966875|65481915|FG005|Part A|Withdrawal by Subject|0|||
23474916|NCT00966875|65481916|FG006|Part A|Withdrawal by Subject|5|||
23474917|NCT00966875|65481917|FG007|Part A|Withdrawal by Subject|1|||
23474918|NCT00966875|65481918|FG008|Part A|Withdrawal by Subject|1|||
23474919|NCT00966875|65481910|FG000|Part A|Protocol Violation|0|||
23474920|NCT00966875|65481911|FG001|Part A|Protocol Violation|0|||
23474921|NCT00966875|65481912|FG002|Part A|Protocol Violation|0|||
23474922|NCT00966875|65481913|FG003|Part A|Protocol Violation|0|||
23474923|NCT00966875|65481914|FG004|Part A|Protocol Violation|0|||
23474924|NCT00966875|65481915|FG005|Part A|Protocol Violation|0|||
23474925|NCT00966875|65481916|FG006|Part A|Protocol Violation|2|||
23474926|NCT00966875|65481917|FG007|Part A|Protocol Violation|1|||
23474927|NCT00966875|65481918|FG008|Part A|Protocol Violation|1|||
23474928|NCT00966875|65481910|FG000|Part B|Adverse Event|0|||
23474929|NCT00966875|65481911|FG001|Part B|Adverse Event|1|||
23474930|NCT00966875|65481912|FG002|Part B|Adverse Event|1|||
23642952|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642953|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23474931|NCT00966875|65481913|FG003|Part B|Adverse Event|0|||
23474932|NCT00966875|65481914|FG004|Part B|Adverse Event|1|||
23474933|NCT00966875|65481915|FG005|Part B|Adverse Event|0|||
23474934|NCT00966875|65481916|FG006|Part B|Adverse Event|5|||
23474935|NCT00966875|65481917|FG007|Part B|Adverse Event|2|||
23474936|NCT00966875|65481918|FG008|Part B|Adverse Event|2|||
23474937|NCT00966875|65481910|FG000|Part B|Death|0|||
23474938|NCT00966875|65481911|FG001|Part B|Death|0|||
23474939|NCT00966875|65481912|FG002|Part B|Death|1|||
23474940|NCT00966875|65481913|FG003|Part B|Death|0|||
23474941|NCT00966875|65481914|FG004|Part B|Death|0|||
23474942|NCT00966875|65481915|FG005|Part B|Death|0|||
23474943|NCT00966875|65481916|FG006|Part B|Death|0|||
23474944|NCT00966875|65481917|FG007|Part B|Death|1|||
23474945|NCT00966875|65481918|FG008|Part B|Death|0|||
23474946|NCT00966875|65481910|FG000|Part B|Lack of Efficacy|2|||
23474947|NCT00966875|65481911|FG001|Part B|Lack of Efficacy|1|||
23474948|NCT00966875|65481912|FG002|Part B|Lack of Efficacy|1|||
23474949|NCT00966875|65481913|FG003|Part B|Lack of Efficacy|1|||
23474950|NCT00966875|65481914|FG004|Part B|Lack of Efficacy|2|||
23474951|NCT00966875|65481915|FG005|Part B|Lack of Efficacy|3|||
23474952|NCT00966875|65481916|FG006|Part B|Lack of Efficacy|12|||
23474953|NCT00966875|65481917|FG007|Part B|Lack of Efficacy|9|||
23474954|NCT00966875|65481918|FG008|Part B|Lack of Efficacy|6|||
23474955|NCT00966875|65481910|FG000|Part B|Lost to Follow-up|0|||
23474956|NCT00966875|65481911|FG001|Part B|Lost to Follow-up|0|||
23474957|NCT00966875|65481912|FG002|Part B|Lost to Follow-up|0|||
23474958|NCT00966875|65481913|FG003|Part B|Lost to Follow-up|1|||
23474959|NCT00966875|65481914|FG004|Part B|Lost to Follow-up|0|||
23474960|NCT00966875|65481915|FG005|Part B|Lost to Follow-up|0|||
23474961|NCT00966875|65481916|FG006|Part B|Lost to Follow-up|0|||
23474962|NCT00966875|65481917|FG007|Part B|Lost to Follow-up|0|||
23474963|NCT00966875|65481918|FG008|Part B|Lost to Follow-up|1|||
23474964|NCT00966875|65481910|FG000|Part B|Physician Decision|0|||
23474965|NCT00966875|65481911|FG001|Part B|Physician Decision|0|||
23474966|NCT00966875|65481912|FG002|Part B|Physician Decision|1|||
23474967|NCT00966875|65481913|FG003|Part B|Physician Decision|0|||
23474968|NCT00966875|65481914|FG004|Part B|Physician Decision|2|||
23474969|NCT00966875|65481915|FG005|Part B|Physician Decision|1|||
23474970|NCT00966875|65481916|FG006|Part B|Physician Decision|0|||
23474971|NCT00966875|65481917|FG007|Part B|Physician Decision|0|||
23474972|NCT00966875|65481918|FG008|Part B|Physician Decision|2|||
23474973|NCT00966875|65481910|FG000|Part B|Sponsor Decision|1|||
23474974|NCT00966875|65481911|FG001|Part B|Sponsor Decision|0|||
23474975|NCT00966875|65481912|FG002|Part B|Sponsor Decision|0|||
23474976|NCT00966875|65481913|FG003|Part B|Sponsor Decision|0|||
23474977|NCT00966875|65481914|FG004|Part B|Sponsor Decision|0|||
23474978|NCT00966875|65481915|FG005|Part B|Sponsor Decision|1|||
23474979|NCT00966875|65481916|FG006|Part B|Sponsor Decision|0|||
23474980|NCT00966875|65481917|FG007|Part B|Sponsor Decision|2|||
23474981|NCT00966875|65481918|FG008|Part B|Sponsor Decision|1|||
23474982|NCT00966875|65481910|FG000|Part B|Withdrawal by Subject|2|||
23474983|NCT00966875|65481911|FG001|Part B|Withdrawal by Subject|1|||
23474984|NCT00966875|65481912|FG002|Part B|Withdrawal by Subject|2|||
23474985|NCT00966875|65481913|FG003|Part B|Withdrawal by Subject|1|||
23474986|NCT00966875|65481914|FG004|Part B|Withdrawal by Subject|2|||
23474987|NCT00966875|65481915|FG005|Part B|Withdrawal by Subject|1|||
23642954|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642955|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
23474988|NCT00966875|65481916|FG006|Part B|Withdrawal by Subject|4|||
23474989|NCT00966875|65481917|FG007|Part B|Withdrawal by Subject|5|||
23474990|NCT00966875|65481918|FG008|Part B|Withdrawal by Subject|5|||
23474991|NCT00966875|65481910|FG000|Part B|Entry Criteria|0|||
23474992|NCT00966875|65481911|FG001|Part B|Entry Criteria|0|||
23474993|NCT00966875|65481912|FG002|Part B|Entry Criteria|0|||
23474994|NCT00966875|65481913|FG003|Part B|Entry Criteria|0|||
23474995|NCT00966875|65481914|FG004|Part B|Entry Criteria|0|||
23474996|NCT00966875|65481915|FG005|Part B|Entry Criteria|0|||
23474997|NCT00966875|65481916|FG006|Part B|Entry Criteria|1|||
23474998|NCT00966875|65481917|FG007|Part B|Entry Criteria|0|||
23797351|NCT02998541|66633278|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23797352|NCT02998541|66633279|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
23797353|NCT02327325|66633280|FG000|Overall Study|Withdrawal by Subject|1|||
23797354|NCT02327325|66633281|FG001|Overall Study|Withdrawal by Subject|4|||
23797355|NCT02327325|66633282|FG002|Overall Study|Withdrawal by Subject|4|||
23797356|NCT02327325|66633280|FG000|Overall Study|Excluded by Study Team|0|||
23797357|NCT02327325|66633281|FG001|Overall Study|Excluded by Study Team|0|||
23797358|NCT02327325|66633282|FG002|Overall Study|Excluded by Study Team|1|||
23797359|NCT02618382|66633287|FG000|Overall Study|Physician Decision|1|||
23797360|NCT02618382|66633287|FG000|Overall Study|Withdrawal by Subject|1|||
23797361|NCT02618382|66633287|FG000|Overall Study|Protocol Violation|1|||
23797362|NCT01144403|66633288|FG000|Overall Study|Lost to Follow-up|3|||
23797363|NCT01144403|66633288|FG000|Overall Study|Death|1|||
23797364|NCT01144403|66633288|FG000|Overall Study|Adverse Event|1|||
23797365|NCT03442569|66633289|FG000|Overall Study|Subject was ineligible after enrollment|1|||
23474999|NCT00966875|65481918|FG008|Part B|Entry Criteria|1|||
23797366|NCT04523480|66633290|FG000|Overall Study|Lost to Follow-up|30|||
23475000|NCT00348881|65481919|FG000|Overall Study|Lost to Follow-up|12|||
23475001|NCT00348881|65481920|FG001|Overall Study|Lost to Follow-up|6|||
23475002|NCT00348881|65481919|FG000|Overall Study|Withdrawal by Subject|3|||
23475003|NCT00348881|65481920|FG001|Overall Study|Withdrawal by Subject|4|||
23475004|NCT00348881|65481919|FG000|Overall Study|Adverse Event|2|||
23475005|NCT00348881|65481920|FG001|Overall Study|Adverse Event|0|||
23475006|NCT00348881|65481919|FG000|Overall Study|Serious Adverse Event|0|||
23475007|NCT00348881|65481920|FG001|Overall Study|Serious Adverse Event|2|||
23475008|NCT01675167|65481925|FG000|Open-label Titration Phase|Adverse Event|81|||
23475009|NCT01675167|65481926|FG001|Open-label Titration Phase|Adverse Event|0|||
23475010|NCT01675167|65481927|FG002|Open-label Titration Phase|Adverse Event|0|||
23475011|NCT01675167|65481925|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
23475012|NCT01675167|65481926|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
23475013|NCT01675167|65481927|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
23475014|NCT01675167|65481925|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
23475015|NCT01675167|65481926|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
23475016|NCT01675167|65481927|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
23475017|NCT01675167|65481925|FG000|Open-label Titration Phase|Protocol Violation|43|||
23475018|NCT01675167|65481926|FG001|Open-label Titration Phase|Protocol Violation|0|||
23475019|NCT01675167|65481927|FG002|Open-label Titration Phase|Protocol Violation|0|||
23475020|NCT01675167|65481925|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
23475021|NCT01675167|65481926|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
23475022|NCT01675167|65481927|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
23475023|NCT01675167|65481925|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
23475024|NCT01675167|65481926|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
23475025|NCT01675167|65481927|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
23475026|NCT01675167|65481925|FG000|Open-label Titration Phase|Other|55|||
23475027|NCT01675167|65481926|FG001|Open-label Titration Phase|Other|0|||
23475028|NCT01675167|65481927|FG002|Open-label Titration Phase|Other|0|||
23475029|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23475030|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
23475031|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
23475032|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23475033|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23475034|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23475035|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23475036|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Adverse Event|5|||
23475037|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Adverse Event|13|||
23475038|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23475039|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
23475040|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
23475041|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23475042|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23475043|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
23475044|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
23475045|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
23475046|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
23475047|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Other|0|||
23475048|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Other|7|||
23475049|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Other|5|||
23475050|NCT03531632|65481928|FG000|Overall Study|Adverse Event|0|||
23475051|NCT03531632|65481929|FG001|Overall Study|Adverse Event|0|||
23475052|NCT03531632|65481930|FG002|Overall Study|Adverse Event|1|||
23475053|NCT03531632|65481928|FG000|Overall Study|Death|4|||
23475054|NCT03531632|65481929|FG001|Overall Study|Death|0|||
23475055|NCT03531632|65481930|FG002|Overall Study|Death|14|||
23475056|NCT03531632|65481928|FG000|Overall Study|Study Terminated|1|||
23475057|NCT03531632|65481929|FG001|Overall Study|Study Terminated|3|||
23475058|NCT03531632|65481930|FG002|Overall Study|Study Terminated|11|||
23475059|NCT02894502|65481933|FG000|Baseline|Withdrawal by Subject|24|||
23475060|NCT02894502|65481934|FG001|Baseline|Withdrawal by Subject|31|||
23475061|NCT02894502|65481935|FG002|Baseline|Withdrawal by Subject|36|||
23475062|NCT02894502|65481933|FG000|Baseline|Death|3|||
23475063|NCT02894502|65481934|FG001|Baseline|Death|1|||
23475064|NCT02894502|65481935|FG002|Baseline|Death|9|||
23475065|NCT02894502|65481933|FG000|First Follow up|Withdrawal by Subject|32|||
23475066|NCT02894502|65481934|FG001|First Follow up|Withdrawal by Subject|29|||
23475067|NCT02894502|65481935|FG002|First Follow up|Withdrawal by Subject|37|||
23475068|NCT02894502|65481933|FG000|First Follow up|Death|2|||
23475069|NCT02894502|65481934|FG001|First Follow up|Death|2|||
23475070|NCT02894502|65481935|FG002|First Follow up|Death|3|||
23475071|NCT02894502|65481933|FG000|Second Follow up|Withdrawal by Subject|13|||
23475072|NCT02894502|65481934|FG001|Second Follow up|Withdrawal by Subject|15|||
23475073|NCT02894502|65481935|FG002|Second Follow up|Withdrawal by Subject|13|||
23475074|NCT02894502|65481933|FG000|Second Follow up|Death|2|||
23475075|NCT02894502|65481934|FG001|Second Follow up|Death|3|||
23475076|NCT02894502|65481935|FG002|Second Follow up|Death|1|||
23475077|NCT02894502|65481933|FG000|Third Follow up|Withdrawal by Subject|5|||
23475078|NCT02894502|65481934|FG001|Third Follow up|Withdrawal by Subject|6|||
23475079|NCT02894502|65481935|FG002|Third Follow up|Withdrawal by Subject|3|||
23475080|NCT02894502|65481933|FG000|Third Follow up|Death|1|||
23475081|NCT02894502|65481934|FG001|Third Follow up|Death|1|||
23475082|NCT02894502|65481935|FG002|Third Follow up|Death|0|||
23475083|NCT03137069|65485308|FG000|Overall Study|Withdrawal by Subject|1|||
23475084|NCT03137069|65485309|FG001|Overall Study|Withdrawal by Subject|2|||
23475085|NCT03137069|65485310|FG002|Overall Study|Withdrawal by Subject|2|||
23475086|NCT03137069|65485311|FG003|Overall Study|Withdrawal by Subject|2|||
23475087|NCT03137069|65485312|FG004|Overall Study|Withdrawal by Subject|0|||
23475088|NCT03137069|65485313|FG005|Overall Study|Withdrawal by Subject|0|||
23475089|NCT03137069|65485308|FG000|Overall Study|Adverse Event|0|||
23475090|NCT03137069|65485309|FG001|Overall Study|Adverse Event|3|||
23475091|NCT03137069|65485310|FG002|Overall Study|Adverse Event|1|||
23797367|NCT04523480|66633291|FG001|Overall Study|Lost to Follow-up|35|||
23797368|NCT04523480|66633292|FG002|Overall Study|Lost to Follow-up|0|||
23475092|NCT03137069|65485311|FG003|Overall Study|Adverse Event|1|||
23475093|NCT03137069|65485312|FG004|Overall Study|Adverse Event|0|||
23475094|NCT03137069|65485313|FG005|Overall Study|Adverse Event|1|||
23475095|NCT03137069|65485308|FG000|Overall Study|Protocol Violation|0|||
23475096|NCT03137069|65485309|FG001|Overall Study|Protocol Violation|1|||
23475097|NCT03137069|65485310|FG002|Overall Study|Protocol Violation|0|||
23475098|NCT03137069|65485311|FG003|Overall Study|Protocol Violation|1|||
23475099|NCT03137069|65485312|FG004|Overall Study|Protocol Violation|1|||
23475100|NCT03137069|65485313|FG005|Overall Study|Protocol Violation|1|||
23475101|NCT03137069|65485308|FG000|Overall Study|Physician Decision|0|||
23475102|NCT03137069|65485309|FG001|Overall Study|Physician Decision|0|||
23642956|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23642957|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23797369|NCT02300987|66633293|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
23797370|NCT02300987|66633294|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
23797371|NCT02300987|66633293|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
23797372|NCT02300987|66633294|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
23475103|NCT03137069|65485310|FG002|Overall Study|Physician Decision|0|||
23475104|NCT03137069|65485311|FG003|Overall Study|Physician Decision|1|||
23475105|NCT03137069|65485312|FG004|Overall Study|Physician Decision|0|||
23475106|NCT03137069|65485313|FG005|Overall Study|Physician Decision|0|||
23475107|NCT03137069|65485308|FG000|Overall Study|Study Terminated by Sponsor|0|||
23475108|NCT03137069|65485309|FG001|Overall Study|Study Terminated by Sponsor|0|||
23475109|NCT03137069|65485310|FG002|Overall Study|Study Terminated by Sponsor|0|||
23475110|NCT03137069|65485311|FG003|Overall Study|Study Terminated by Sponsor|0|||
23475111|NCT03137069|65485312|FG004|Overall Study|Study Terminated by Sponsor|1|||
23475112|NCT03137069|65485313|FG005|Overall Study|Study Terminated by Sponsor|0|||
23475113|NCT03137069|65485308|FG000|Overall Study|Data Entry Error|0|||
23475114|NCT03137069|65485309|FG001|Overall Study|Data Entry Error|0|||
23475115|NCT03137069|65485310|FG002|Overall Study|Data Entry Error|0|||
23475116|NCT03137069|65485311|FG003|Overall Study|Data Entry Error|1|||
23475117|NCT03137069|65485312|FG004|Overall Study|Data Entry Error|0|||
23475118|NCT03137069|65485313|FG005|Overall Study|Data Entry Error|0|||
23475119|NCT02255435|65485314|FG000|Overall Study|Patient's Limited Time Availability|0|||
23475120|NCT02255435|65485315|FG001|Overall Study|Patient's Limited Time Availability|0|||
23642958|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23797373|NCT02300987|66633293|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
23475121|NCT02255435|65485316|FG002|Overall Study|Patient's Limited Time Availability|0|||
23475122|NCT02255435|65485317|FG003|Overall Study|Patient's Limited Time Availability|0|||
23475123|NCT02255435|65485318|FG004|Overall Study|Patient's Limited Time Availability|0|||
23475124|NCT02255435|65485319|FG005|Overall Study|Patient's Limited Time Availability|0|||
23475125|NCT02255435|65485320|FG006|Overall Study|Patient's Limited Time Availability|0|||
23475126|NCT02255435|65485321|FG007|Overall Study|Patient's Limited Time Availability|1|||
23475127|NCT02255435|65485322|FG008|Overall Study|Patient's Limited Time Availability|0|||
23475128|NCT02255435|65485323|FG009|Overall Study|Patient's Limited Time Availability|0|||
23475129|NCT02255435|65485314|FG000|Overall Study|Withdrawal by Subject|0|||
23475130|NCT02255435|65485315|FG001|Overall Study|Withdrawal by Subject|0|||
23475131|NCT02255435|65485316|FG002|Overall Study|Withdrawal by Subject|0|||
23475132|NCT02255435|65485317|FG003|Overall Study|Withdrawal by Subject|0|||
23475133|NCT02255435|65485318|FG004|Overall Study|Withdrawal by Subject|0|||
23475134|NCT02255435|65485319|FG005|Overall Study|Withdrawal by Subject|0|||
23475135|NCT02255435|65485320|FG006|Overall Study|Withdrawal by Subject|0|||
23475136|NCT02255435|65485321|FG007|Overall Study|Withdrawal by Subject|0|||
23475137|NCT02255435|65485322|FG008|Overall Study|Withdrawal by Subject|1|||
23475138|NCT02255435|65485323|FG009|Overall Study|Withdrawal by Subject|4|||
23475139|NCT02255435|65485314|FG000|Overall Study|Administrative reasons|0|||
23475140|NCT02255435|65485315|FG001|Overall Study|Administrative reasons|0|||
23475141|NCT02255435|65485316|FG002|Overall Study|Administrative reasons|0|||
23475142|NCT02255435|65485317|FG003|Overall Study|Administrative reasons|0|||
23475143|NCT02255435|65485318|FG004|Overall Study|Administrative reasons|0|||
23475144|NCT02255435|65485319|FG005|Overall Study|Administrative reasons|0|||
23475145|NCT02255435|65485320|FG006|Overall Study|Administrative reasons|0|||
23475146|NCT02255435|65485321|FG007|Overall Study|Administrative reasons|0|||
23475147|NCT02255435|65485322|FG008|Overall Study|Administrative reasons|0|||
23475148|NCT02255435|65485323|FG009|Overall Study|Administrative reasons|2|||
23475149|NCT01242813|65485324|FG000|Overall Study|Lost to Follow-up|2|||
23475150|NCT03539549|65485329|FG000|Overall Study|Adverse Event|12|||
23475151|NCT03539549|65485329|FG000|Overall Study|Lost to Follow-up|1|||
23475152|NCT03539549|65485329|FG000|Overall Study|Death|2|||
23475153|NCT03539549|65485329|FG000|Overall Study|Progressive Disease|1|||
23475154|NCT03539549|65485329|FG000|Overall Study|Reason not Specified|1|||
23475155|NCT03135119|65485330|FG000|Overall Study|Lost to Follow-up|2|||
23475156|NCT03135119|65485331|FG001|Overall Study|Lost to Follow-up|0|||
23475157|NCT03135119|65485330|FG000|Overall Study|Physician Decision|1|||
23475158|NCT03135119|65485331|FG001|Overall Study|Physician Decision|1|||
23475159|NCT03135119|65485330|FG000|Overall Study|COVID-19 Shutdown|2|||
23475160|NCT03135119|65485331|FG001|Overall Study|COVID-19 Shutdown|2|||
23475161|NCT02230670|65485332|FG000|Overall Study|Adverse Event|1|||
23475162|NCT02230670|65485333|FG001|Overall Study|Adverse Event|2|||
23475163|NCT02230670|65485332|FG000|Overall Study|Withdrawal by Subject|2|||
23475164|NCT02230670|65485333|FG001|Overall Study|Withdrawal by Subject|2|||
23475165|NCT02230670|65485332|FG000|Overall Study|Physician Decision|0|||
23475166|NCT02230670|65485333|FG001|Overall Study|Physician Decision|1|||
23475167|NCT02230670|65485332|FG000|Overall Study|Protocol Violation|0|||
23475168|NCT02230670|65485333|FG001|Overall Study|Protocol Violation|1|||
23589421|NCT02001623|65886048|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
23589422|NCT02001623|65886049|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
23589423|NCT02001623|65886050|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
23589424|NCT02001623|65886051|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
23797374|NCT02300987|66633294|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
23797375|NCT02300987|66633293|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
23797376|NCT02300987|66633294|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
23797377|NCT02300987|66633293|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
23797378|NCT02300987|66633294|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
23797379|NCT00983528|66633295|FG000|Overall Study|Death|4|||
23797380|NCT00983528|66633295|FG000|Overall Study|Lost to Follow-up|1|||
23797381|NCT00983528|66633295|FG000|Overall Study|Study Terminated|1|||
23797382|NCT02488109|66633298|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
23797383|NCT02488109|66633299|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
23797384|NCT02488109|66633298|FG000|12-month Follow-Up|Lost to Follow-up|4|||
23797385|NCT02488109|66633299|FG001|12-month Follow-Up|Lost to Follow-up|7|||
23797386|NCT01592721|66633306|FG000|Long-term Follow-up|Death|1|||
23797387|NCT01731886|66633313|FG000|Overall Study|Death|1|||
23797388|NCT01731886|66633314|FG001|Overall Study|Death|0|||
23797389|NCT01731886|66633313|FG000|Overall Study|Never started treatment|0|||
23797390|NCT01731886|66633314|FG001|Overall Study|Never started treatment|1|||
23797391|NCT01731886|66633313|FG000|Overall Study|Non-compliant|1|||
23797392|NCT01731886|66633314|FG001|Overall Study|Non-compliant|0|||
23797393|NCT00194792|66636719|FG000|Overall Study|Withdrawal by Subject|1|||
23797394|NCT03086135|66636720|FG000|Overall Study|Adverse Event|1|||
23475169|NCT02230670|65485332|FG000|Overall Study|Progression to Child-Pugh C|1|||
23475170|NCT02230670|65485333|FG001|Overall Study|Progression to Child-Pugh C|2|||
23475171|NCT00363545|65485334|FG000|Overall Study|Serious Adverse Event|0|||
23475172|NCT00363545|65485335|FG001|Overall Study|Serious Adverse Event|1|||
23475173|NCT00363545|65485334|FG000|Overall Study|Withdrawal by Subject|12|||
23589425|NCT02001623|65886052|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
23589426|NCT02001623|65886053|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
23589427|NCT02001623|65886054|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
23589428|NCT02517307|65886055|FG000|Overall Study|Withdrawal by Subject|1|||
23589429|NCT02517307|65886056|FG001|Overall Study|Withdrawal by Subject|0|||
23589430|NCT02517307|65886057|FG002|Overall Study|Withdrawal by Subject|1|||
23589431|NCT02517307|65886058|FG003|Overall Study|Withdrawal by Subject|0|||
23589432|NCT02517307|65886055|FG000|Overall Study|Protocol Violation|0|||
23589433|NCT02517307|65886056|FG001|Overall Study|Protocol Violation|0|||
23589434|NCT02517307|65886057|FG002|Overall Study|Protocol Violation|1|||
23589435|NCT02517307|65886058|FG003|Overall Study|Protocol Violation|1|||
23589436|NCT01693614|65886059|FG000|Overall Study|Adverse Event|7|||
23589437|NCT01693614|65886060|FG001|Overall Study|Adverse Event|11|||
23589438|NCT01693614|65886061|FG002|Overall Study|Adverse Event|5|||
23589439|NCT01693614|65886059|FG000|Overall Study|Disease progression|11|||
23797395|NCT03086135|66636720|FG000|Overall Study|Lost to Follow-up|2|||
23797396|NCT00271024|66636721|FG000|Overall Study|Lost Interest|3|||
23797397|NCT00271024|66636722|FG001|Overall Study|Lost Interest|4|||
23797398|NCT00271024|66636723|FG002|Overall Study|Lost Interest|2|||
23797399|NCT00271024|66636724|FG003|Overall Study|Lost Interest|3|||
23797400|NCT00271024|66636721|FG000|Overall Study|Unknown/Unspecified|11|||
23797401|NCT00271024|66636722|FG001|Overall Study|Unknown/Unspecified|11|||
23797402|NCT00271024|66636723|FG002|Overall Study|Unknown/Unspecified|8|||
23797403|NCT00271024|66636724|FG003|Overall Study|Unknown/Unspecified|4|||
23797404|NCT00271024|66636721|FG000|Overall Study|Protocol Violation|1|||
23797405|NCT00271024|66636722|FG001|Overall Study|Protocol Violation|6|||
23797406|NCT00271024|66636723|FG002|Overall Study|Protocol Violation|5|||
23797407|NCT00271024|66636724|FG003|Overall Study|Protocol Violation|11|||
23797408|NCT00271024|66636721|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
23589440|NCT01693614|65886060|FG001|Overall Study|Disease progression|8|||
23589441|NCT01693614|65886061|FG002|Overall Study|Disease progression|7|||
23589442|NCT01693614|65886059|FG000|Overall Study|Protocol Violation|5|||
23589443|NCT01693614|65886060|FG001|Overall Study|Protocol Violation|2|||
23589444|NCT01693614|65886061|FG002|Overall Study|Protocol Violation|1|||
23589445|NCT01693614|65886059|FG000|Overall Study|Death|1|||
23589446|NCT01693614|65886060|FG001|Overall Study|Death|0|||
23589447|NCT01693614|65886061|FG002|Overall Study|Death|0|||
23589448|NCT01693614|65886059|FG000|Overall Study|Physician Decision|1|||
23589449|NCT01693614|65886060|FG001|Overall Study|Physician Decision|1|||
23589450|NCT01693614|65886061|FG002|Overall Study|Physician Decision|4|||
23589451|NCT01693614|65886059|FG000|Overall Study|Withdrawal by subject/guardian|0|||
23589452|NCT01693614|65886060|FG001|Overall Study|Withdrawal by subject/guardian|0|||
23589453|NCT01693614|65886061|FG002|Overall Study|Withdrawal by subject/guardian|2|||
23589454|NCT01693614|65886059|FG000|Overall Study|Withdrawal by Subject|1|||
23589455|NCT01693614|65886060|FG001|Overall Study|Withdrawal by Subject|0|||
23589456|NCT01693614|65886061|FG002|Overall Study|Withdrawal by Subject|5|||
23589457|NCT01254019|65886062|FG000|Overall Study|Adverse Event|0|||
23589458|NCT01254019|65886063|FG001|Overall Study|Adverse Event|2|||
23589459|NCT01254019|65886062|FG000|Overall Study|Protocol Violation|1|||
23589460|NCT01254019|65886063|FG001|Overall Study|Protocol Violation|0|||
23589461|NCT01254019|65886062|FG000|Overall Study|Withdrawal by Subject|0|||
23589462|NCT01254019|65886063|FG001|Overall Study|Withdrawal by Subject|2|||
23642959|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23797409|NCT00271024|66636722|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
23589463|NCT00814346|65886064|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
23589464|NCT00814346|65886065|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
23589465|NCT00814346|65886064|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
23589466|NCT00814346|65886065|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
23797410|NCT00271024|66636723|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
23589467|NCT00814346|65886064|FG000|Open Phase (17 Months)|Adverse Event|5|||
23797411|NCT00271024|66636724|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
23797412|NCT00271024|66636721|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
23589468|NCT00814346|65886065|FG001|Open Phase (17 Months)|Adverse Event|0|||
23589469|NCT00814346|65886064|FG000|Open Phase (17 Months)|Consent|2|||
23589470|NCT00814346|65886065|FG001|Open Phase (17 Months)|Consent|0|||
23589471|NCT00814346|65886064|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
23589472|NCT00814346|65886065|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
23589473|NCT00814346|65886064|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
23589474|NCT00814346|65886065|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
23589475|NCT00517933|65886066|FG000|Period 1|Death|2|||
23589476|NCT00517933|65886067|FG001|Period 1|Death|1|||
23589477|NCT00517933|65886066|FG000|Period 1|Adverse Event|4|||
23589478|NCT00517933|65886067|FG001|Period 1|Adverse Event|4|||
23589479|NCT00517933|65886066|FG000|Period 1|Lost to Follow-up|2|||
23589480|NCT00517933|65886067|FG001|Period 1|Lost to Follow-up|0|||
23589481|NCT00517933|65886066|FG000|Period 1|Underwent lung transplant|0|||
23589482|NCT00517933|65886067|FG001|Period 1|Underwent lung transplant|1|||
23589483|NCT00517933|65886066|FG000|Period 2|Death|2|||
23589484|NCT00517933|65886067|FG001|Period 2|Death|4|||
23589485|NCT00517933|65886066|FG000|Period 2|Adverse Event|2|||
23589486|NCT00517933|65886067|FG001|Period 2|Adverse Event|4|||
23642960|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
23642961|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
23642962|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
23642963|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
23642964|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
23642965|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
23642966|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
23642967|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
23642968|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
23642969|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
23642970|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
23642971|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
23642972|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
23642973|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
23642974|NCT02663518|66078991|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642975|NCT02663518|66078992|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642976|NCT02663518|66078993|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642977|NCT02663518|66078994|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642978|NCT02663518|66078995|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642979|NCT02663518|66078996|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642980|NCT02663518|66078997|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642981|NCT02663518|66078998|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642982|NCT02663518|66078999|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642983|NCT02663518|66079000|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642984|NCT02663518|66079001|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23706862|NCT00002663|66301348|FG009|Overall Study|Adverse Event|0|||
23589487|NCT00517933|65886066|FG000|Period 2|Physician Decision|1|||
23589488|NCT00517933|65886067|FG001|Period 2|Physician Decision|0|||
23589489|NCT00517933|65886066|FG000|Period 2|Withdrawal by Subject|1|||
23589490|NCT00517933|65886067|FG001|Period 2|Withdrawal by Subject|3|||
23589491|NCT00517933|65886066|FG000|Period 2|Underwent lung transplant|0|||
23589492|NCT00517933|65886067|FG001|Period 2|Underwent lung transplant|2|||
23589493|NCT00801983|65886068|FG000|Period 1|Lost to Follow-up|2|||
23642985|NCT02663518|66079002|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642986|NCT02663518|66079003|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
23642987|NCT02663518|66079004|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23642988|NCT01901432|66079005|FG000|Overall Study|Adverse Event|0|||
23642989|NCT01901432|66079006|FG001|Overall Study|Adverse Event|1|||
23642990|NCT01901432|66079007|FG002|Overall Study|Adverse Event|1|||
23642991|NCT01901432|66079008|FG003|Overall Study|Adverse Event|0|||
23642992|NCT01901432|66079009|FG004|Overall Study|Adverse Event|1|||
23642993|NCT01901432|66079005|FG000|Overall Study|Withdrawal by Subject|0|||
23642994|NCT01901432|66079006|FG001|Overall Study|Withdrawal by Subject|0|||
23642995|NCT01901432|66079007|FG002|Overall Study|Withdrawal by Subject|1|||
23642996|NCT01901432|66079008|FG003|Overall Study|Withdrawal by Subject|0|||
23642997|NCT01901432|66079009|FG004|Overall Study|Withdrawal by Subject|5|||
23642998|NCT01901432|66079005|FG000|Overall Study|Physician Decision|0|||
23642999|NCT01901432|66079006|FG001|Overall Study|Physician Decision|0|||
23643000|NCT01901432|66079007|FG002|Overall Study|Physician Decision|0|||
23643001|NCT01901432|66079008|FG003|Overall Study|Physician Decision|0|||
23643002|NCT01901432|66079009|FG004|Overall Study|Physician Decision|2|||
23643003|NCT01901432|66079005|FG000|Overall Study|Patient decision to stop study drug|0|||
23643004|NCT01901432|66079006|FG001|Overall Study|Patient decision to stop study drug|0|||
23643005|NCT01901432|66079007|FG002|Overall Study|Patient decision to stop study drug|0|||
23643006|NCT01901432|66079008|FG003|Overall Study|Patient decision to stop study drug|0|||
23643007|NCT01901432|66079009|FG004|Overall Study|Patient decision to stop study drug|1|||
23643008|NCT04138576|66079010|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
23643009|NCT03940703|66079018|FG000|Overall Study|Still under treatment|31|||
23643010|NCT03940703|66079019|FG001|Overall Study|Still under treatment|0|||
23643011|NCT01021215|66079020|FG000|Overall Study|Lost to Follow-up|3|||
23643012|NCT01021215|66079021|FG001|Overall Study|Lost to Follow-up|0|||
23643013|NCT02003573|66079022|FG000|Overall Study|Progressive disease|2|||
23643014|NCT02003573|66079023|FG001|Overall Study|Progressive disease|0|||
23643015|NCT02003573|66079024|FG002|Overall Study|Progressive disease|1|||
23643016|NCT02003573|66079022|FG000|Overall Study|Other Adverse event|0|||
23643017|NCT02003573|66079023|FG001|Overall Study|Other Adverse event|1|||
23643018|NCT02003573|66079024|FG002|Overall Study|Other Adverse event|1|||
23643019|NCT02003573|66079022|FG000|Overall Study|Refuse to take trial medication|0|||
23643020|NCT02003573|66079023|FG001|Overall Study|Refuse to take trial medication|1|||
23643021|NCT02003573|66079024|FG002|Overall Study|Refuse to take trial medication|1|||
23643022|NCT02003573|66079022|FG000|Overall Study|Other than specified|1|||
23643023|NCT02003573|66079023|FG001|Overall Study|Other than specified|2|||
23643024|NCT02003573|66079024|FG002|Overall Study|Other than specified|3|||
23643025|NCT02442336|66079025|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
23643026|NCT02442336|66079025|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
23643027|NCT02442336|66079025|FG000|Overall Study|Lost to Follow-up|11|||
23643028|NCT01278173|66079026|FG000|Overall Study|Lack of Efficacy|13|||
23643029|NCT01278173|66079026|FG000|Overall Study|Adverse Event|8|||
23643030|NCT01278173|66079026|FG000|Overall Study|Administrative or other reason|4|||
23643031|NCT01278173|66079026|FG000|Overall Study|Protocol Violation|1|||
23643032|NCT01278173|66079026|FG000|Overall Study|Withdrawal by Subject|1|||
23643033|NCT00744757|66079027|FG000|Overall Study|Objective disease progression|7|||
23643034|NCT00744757|66079027|FG000|Overall Study|Physician Decision|5|||
23358000|NCT01358578|65056150|FG000|Follow-up Period|Lost to Follow-up|0|||
23358001|NCT01358578|65056151|FG001|Follow-up Period|Lost to Follow-up|1|||
23358002|NCT01358578|65056152|FG002|Follow-up Period|Lost to Follow-up|0|||
23358003|NCT01358578|65056153|FG003|Follow-up Period|Lost to Follow-up|4|||
23358004|NCT01358578|65056154|FG004|Follow-up Period|Lost to Follow-up|0|||
23358005|NCT01358578|65056155|FG005|Follow-up Period|Lost to Follow-up|0|||
23358006|NCT01358578|65056150|FG000|Follow-up Period|non- compliance with study treatment|1|||
23358007|NCT01358578|65056151|FG001|Follow-up Period|non- compliance with study treatment|0|||
23358008|NCT01358578|65056152|FG002|Follow-up Period|non- compliance with study treatment|0|||
23358009|NCT01358578|65056153|FG003|Follow-up Period|non- compliance with study treatment|0|||
23358010|NCT01358578|65056154|FG004|Follow-up Period|non- compliance with study treatment|0|||
23358011|NCT01358578|65056155|FG005|Follow-up Period|non- compliance with study treatment|0|||
23358012|NCT01358578|65056150|FG000|Follow-up Period|Pregnancy|1|||
23358013|NCT01358578|65056151|FG001|Follow-up Period|Pregnancy|0|||
23358014|NCT01358578|65056152|FG002|Follow-up Period|Pregnancy|0|||
23358015|NCT01358578|65056153|FG003|Follow-up Period|Pregnancy|0|||
23643035|NCT00744757|66079027|FG000|Overall Study|Withdrawal by Subject|1|||
23643036|NCT00744757|66079027|FG000|Overall Study|Death|6|||
23643037|NCT00744757|66079027|FG000|Overall Study|Adverse Event|2|||
23643038|NCT02245737|66079028|FG000|Overall Study|Adverse Event|23|||
23643039|NCT02245737|66079029|FG001|Overall Study|Adverse Event|26|||
23643040|NCT02245737|66079030|FG002|Overall Study|Adverse Event|33|||
23643041|NCT02245737|66079028|FG000|Overall Study|Condition Worsened|9|||
23643042|NCT02245737|66079029|FG001|Overall Study|Condition Worsened|10|||
23358016|NCT01358578|65056154|FG004|Follow-up Period|Pregnancy|0|||
23358017|NCT01358578|65056155|FG005|Follow-up Period|Pregnancy|0|||
23358018|NCT01358578|65056150|FG000|Follow-up Period|Withdrawal by Subject|3|||
23589494|NCT00801983|65886069|FG001|Period 1|Lost to Follow-up|0|||
23589495|NCT00801983|65886068|FG000|Period 1|Withdrawal by Subject|2|||
23589496|NCT00801983|65886069|FG001|Period 1|Withdrawal by Subject|8|||
23589497|NCT00801983|65886068|FG000|Period 2|Withdrawal by Subject|2|||
23589498|NCT00801983|65886069|FG001|Period 2|Withdrawal by Subject|1|||
23589499|NCT00430300|65886074|FG000|Overall Study|Adverse Event|0|||
23589500|NCT00430300|65886075|FG001|Overall Study|Adverse Event|2|||
23589501|NCT00430300|65886076|FG002|Overall Study|Adverse Event|1|||
23589502|NCT00430300|65886077|FG003|Overall Study|Adverse Event|1|||
23589503|NCT00430300|65886074|FG000|Overall Study|Withdrawal by Subject|1|||
23589504|NCT00430300|65886075|FG001|Overall Study|Withdrawal by Subject|0|||
23589505|NCT00430300|65886076|FG002|Overall Study|Withdrawal by Subject|5|||
23358019|NCT01358578|65056151|FG001|Follow-up Period|Withdrawal by Subject|3|||
23358020|NCT01358578|65056152|FG002|Follow-up Period|Withdrawal by Subject|1|||
23358021|NCT01358578|65056153|FG003|Follow-up Period|Withdrawal by Subject|12|||
23358022|NCT01358578|65056154|FG004|Follow-up Period|Withdrawal by Subject|0|||
23358023|NCT01358578|65056155|FG005|Follow-up Period|Withdrawal by Subject|0|||
23358024|NCT01358578|65056150|FG000|Follow-up Period|Physician Decision|1|||
23589506|NCT00430300|65886077|FG003|Overall Study|Withdrawal by Subject|0|||
23358025|NCT01358578|65056151|FG001|Follow-up Period|Physician Decision|1|||
23358026|NCT01358578|65056152|FG002|Follow-up Period|Physician Decision|0|||
23358027|NCT01358578|65056153|FG003|Follow-up Period|Physician Decision|2|||
23358028|NCT01358578|65056154|FG004|Follow-up Period|Physician Decision|0|||
23358029|NCT01358578|65056155|FG005|Follow-up Period|Physician Decision|0|||
23358030|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
23358031|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
23358032|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
23358033|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
23358034|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
23358035|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
23358036|NCT00809094|65056164|FG000|Overall Study|Lost to Follow-up|0|||
23797413|NCT00271024|66636722|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
23797414|NCT00271024|66636723|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
23797415|NCT00271024|66636724|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
23797416|NCT00587431|66636725|FG000|Overall Study|Adverse Event|1|||
23358037|NCT00809094|65056165|FG001|Overall Study|Lost to Follow-up|1|||
23358038|NCT03411902|65056166|FG000|Overall Study|Lost to Follow-up|3|||
23358039|NCT03411902|65056167|FG001|Overall Study|Lost to Follow-up|0|||
23358040|NCT04676724|65056168|FG000|Overall Study|Adverse Event|2|||
23797417|NCT00587431|66636726|FG001|Overall Study|Adverse Event|0|||
23797418|NCT00587431|66636725|FG000|Overall Study|Withdrawal by Subject|0|||
23797419|NCT00587431|66636726|FG001|Overall Study|Withdrawal by Subject|1|||
23797420|NCT03170869|66636727|FG000|Overall Study|Protocol Violation|5|||
23797421|NCT03170869|66636727|FG000|Overall Study|Early study termination|3|||
23797422|NCT01955044|66636729|FG000|Overall Study|Death|1|||
23797423|NCT01955044|66636730|FG001|Overall Study|Death|1|||
23797424|NCT01955044|66636731|FG002|Overall Study|Death|0|||
23797425|NCT00708682|66636734|FG000|Infant Series|Adverse Event|1|||
23797426|NCT00708682|66636734|FG000|Infant Series|Lost to Follow-up|4|||
23797427|NCT00708682|66636734|FG000|Infant Series|Protocol Violation|1|||
23797428|NCT00708682|66636734|FG000|Infant Series|Parent/legal guardian request|6|||
23797429|NCT00708682|66636734|FG000|Infant Series|Failed to return|2|||
23797430|NCT00708682|66636734|FG000|Infant Series|Other|19|||
23797431|NCT00708682|66636734|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
23797432|NCT00708682|66636734|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
23797433|NCT00708682|66636734|FG000|Toddler Dose|Lost to Follow-up|3|||
23797434|NCT00708682|66636734|FG000|Toddler Dose|Failed to Return|4|||
23797435|NCT02510261|66636737|FG000|Overall Study|Adverse Event|5|||
23797436|NCT02510261|66636738|FG001|Overall Study|Adverse Event|8|||
23797437|NCT02510261|66636739|FG002|Overall Study|Adverse Event|0|||
23797438|NCT02510261|66636737|FG000|Overall Study|Physician Decision|1|||
23797439|NCT02510261|66636738|FG001|Overall Study|Physician Decision|5|||
23797440|NCT02510261|66636739|FG002|Overall Study|Physician Decision|0|||
23797441|NCT02510261|66636737|FG000|Overall Study|Death|19|||
23797442|NCT02510261|66636738|FG001|Overall Study|Death|19|||
23797443|NCT02510261|66636739|FG002|Overall Study|Death|0|||
23358041|NCT04676724|65056169|FG001|Overall Study|Adverse Event|0|||
23358042|NCT04676724|65056168|FG000|Overall Study|Lost to Follow-up|1|||
23358043|NCT04676724|65056169|FG001|Overall Study|Lost to Follow-up|0|||
23358044|NCT04676724|65056168|FG000|Overall Study|Physician Decision|0|||
23358045|NCT04676724|65056169|FG001|Overall Study|Physician Decision|1|||
23358046|NCT04676724|65056168|FG000|Overall Study|Withdrawal by Subject|3|||
23358047|NCT04676724|65056169|FG001|Overall Study|Withdrawal by Subject|2|||
23358048|NCT04153565|65056170|FG000|Overall Study|Death|13|||
23358049|NCT03130959|65056174|FG000|Overall Study|Disease progression|19|||
23358050|NCT03130959|65056175|FG001|Overall Study|Disease progression|7|||
23358051|NCT03130959|65056176|FG002|Overall Study|Disease progression|12|||
23358052|NCT03130959|65056177|FG003|Overall Study|Disease progression|7|||
23358053|NCT03130959|65056178|FG004|Overall Study|Disease progression|12|||
23358054|NCT03130959|65056179|FG005|Overall Study|Disease progression|3|||
23358055|NCT03130959|65056180|FG006|Overall Study|Disease progression|6|||
23358056|NCT03130959|65056181|FG007|Overall Study|Disease progression|3|||
23358057|NCT03130959|65056182|FG008|Overall Study|Disease progression|15|||
23358058|NCT03130959|65056183|FG009|Overall Study|Disease progression|8|||
23358059|NCT03130959|65056174|FG000|Overall Study|Study drug toxicity|2|||
23797444|NCT02510261|66636737|FG000|Overall Study|Withdrawal by Subject|3|||
23797445|NCT02510261|66636738|FG001|Overall Study|Withdrawal by Subject|10|||
23797446|NCT02510261|66636739|FG002|Overall Study|Withdrawal by Subject|3|||
23797447|NCT03430011|66636740|FG000|Pre-Treatment|Death|1|||
23797448|NCT03430011|66636741|FG001|Pre-Treatment|Death|0|||
23797449|NCT03430011|66636742|FG002|Pre-Treatment|Death|0|||
23797450|NCT03430011|66636743|FG003|Pre-Treatment|Death|0|||
23797451|NCT03430011|66636744|FG004|Pre-Treatment|Death|1|||
23797452|NCT03430011|66636745|FG005|Pre-Treatment|Death|0|||
23797453|NCT03430011|66636746|FG006|Pre-Treatment|Death|1|||
23797454|NCT03430011|66636747|FG007|Pre-Treatment|Death|0|||
23797455|NCT03430011|66636740|FG000|Pre-Treatment|Screen Fail|0|||
23797456|NCT03430011|66636741|FG001|Pre-Treatment|Screen Fail|0|||
23797457|NCT03430011|66636742|FG002|Pre-Treatment|Screen Fail|0|||
23797458|NCT03430011|66636743|FG003|Pre-Treatment|Screen Fail|0|||
23797459|NCT03430011|66636744|FG004|Pre-Treatment|Screen Fail|1|||
23797460|NCT03430011|66636745|FG005|Pre-Treatment|Screen Fail|0|||
23797461|NCT03430011|66636746|FG006|Pre-Treatment|Screen Fail|0|||
23797462|NCT03430011|66636747|FG007|Pre-Treatment|Screen Fail|0|||
23797463|NCT03430011|66636740|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797464|NCT03430011|66636741|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797465|NCT03430011|66636742|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
23797466|NCT03430011|66636743|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797467|NCT03430011|66636744|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797468|NCT03430011|66636745|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797469|NCT03430011|66636746|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797470|NCT03430011|66636747|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
23797471|NCT03430011|66636740|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
23797472|NCT03430011|66636741|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
23797473|NCT03430011|66636742|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
23797474|NCT03430011|66636743|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
23797475|NCT03430011|66636744|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
23797476|NCT03430011|66636745|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
23797477|NCT03430011|66636746|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
23797478|NCT03430011|66636747|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
23797479|NCT03430011|66636740|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
23797480|NCT03430011|66636741|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
23797481|NCT03430011|66636742|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
23797482|NCT03430011|66636743|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
23797483|NCT03430011|66636744|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
23797484|NCT03430011|66636745|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
23797485|NCT03430011|66636746|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
23797486|NCT03430011|66636747|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
23797487|NCT03430011|66636740|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
23797488|NCT03430011|66636741|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
23797489|NCT03430011|66636742|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
23797490|NCT03430011|66636743|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
23797491|NCT03430011|66636744|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
23797492|NCT03430011|66636745|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
23797493|NCT03430011|66636746|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
23797494|NCT03430011|66636747|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
23797495|NCT03430011|66636740|FG000|JCARH125 Treatment|Death|4|||
23797496|NCT03430011|66636741|FG001|JCARH125 Treatment|Death|19|||
23797497|NCT03430011|66636742|FG002|JCARH125 Treatment|Death|10|||
23797498|NCT03430011|66636743|FG003|JCARH125 Treatment|Death|8|||
23797499|NCT03430011|66636744|FG004|JCARH125 Treatment|Death|5|||
23797500|NCT03430011|66636745|FG005|JCARH125 Treatment|Death|3|||
23797501|NCT03430011|66636746|FG006|JCARH125 Treatment|Death|4|||
23797502|NCT03430011|66636747|FG007|JCARH125 Treatment|Death|2|||
23797503|NCT03430011|66636740|FG000|JCARH125 Treatment|Other reasons|1|||
23797504|NCT03430011|66636741|FG001|JCARH125 Treatment|Other reasons|0|||
23797505|NCT03430011|66636742|FG002|JCARH125 Treatment|Other reasons|4|||
23797506|NCT03430011|66636743|FG003|JCARH125 Treatment|Other reasons|2|||
23797507|NCT03430011|66636744|FG004|JCARH125 Treatment|Other reasons|2|||
23797508|NCT03430011|66636745|FG005|JCARH125 Treatment|Other reasons|1|||
23797509|NCT03430011|66636746|FG006|JCARH125 Treatment|Other reasons|3|||
23797510|NCT03430011|66636747|FG007|JCARH125 Treatment|Other reasons|2|||
23797511|NCT02662582|66636748|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
23797512|NCT02662582|66636749|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
23797513|NCT02662582|66636748|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
23797514|NCT02662582|66636749|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
23797515|NCT02662582|66636748|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
23797516|NCT02662582|66636749|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
23797517|NCT02662582|66636748|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23358060|NCT03130959|65056175|FG001|Overall Study|Study drug toxicity|2|||
23358061|NCT03130959|65056176|FG002|Overall Study|Study drug toxicity|1|||
23358062|NCT03130959|65056177|FG003|Overall Study|Study drug toxicity|2|||
23358063|NCT03130959|65056178|FG004|Overall Study|Study drug toxicity|1|||
23358064|NCT03130959|65056179|FG005|Overall Study|Study drug toxicity|1|||
23358065|NCT03130959|65056180|FG006|Overall Study|Study drug toxicity|3|||
23358066|NCT03130959|65056181|FG007|Overall Study|Study drug toxicity|0|||
23358067|NCT03130959|65056182|FG008|Overall Study|Study drug toxicity|3|||
23358068|NCT03130959|65056183|FG009|Overall Study|Study drug toxicity|3|||
23358069|NCT03130959|65056174|FG000|Overall Study|Other reasons|0|||
23358070|NCT03130959|65056175|FG001|Overall Study|Other reasons|0|||
23358071|NCT03130959|65056176|FG002|Overall Study|Other reasons|0|||
23358072|NCT03130959|65056177|FG003|Overall Study|Other reasons|0|||
23358073|NCT03130959|65056178|FG004|Overall Study|Other reasons|0|||
23358074|NCT03130959|65056179|FG005|Overall Study|Other reasons|1|||
23358075|NCT03130959|65056180|FG006|Overall Study|Other reasons|1|||
23358076|NCT03130959|65056181|FG007|Overall Study|Other reasons|0|||
23358077|NCT03130959|65056182|FG008|Overall Study|Other reasons|0|||
23358078|NCT03130959|65056183|FG009|Overall Study|Other reasons|0|||
23358079|NCT03130959|65056174|FG000|Overall Study|Subject request to discontinue therapy|0|||
23358080|NCT03130959|65056175|FG001|Overall Study|Subject request to discontinue therapy|0|||
23358081|NCT03130959|65056176|FG002|Overall Study|Subject request to discontinue therapy|1|||
23358082|NCT03130959|65056177|FG003|Overall Study|Subject request to discontinue therapy|1|||
23358083|NCT03130959|65056178|FG004|Overall Study|Subject request to discontinue therapy|0|||
23358084|NCT03130959|65056179|FG005|Overall Study|Subject request to discontinue therapy|0|||
23358085|NCT03130959|65056180|FG006|Overall Study|Subject request to discontinue therapy|1|||
23358086|NCT03130959|65056181|FG007|Overall Study|Subject request to discontinue therapy|1|||
23358087|NCT03130959|65056182|FG008|Overall Study|Subject request to discontinue therapy|0|||
23358088|NCT03130959|65056183|FG009|Overall Study|Subject request to discontinue therapy|0|||
23358089|NCT03130959|65056174|FG000|Overall Study|Not reported|0|||
23358090|NCT03130959|65056175|FG001|Overall Study|Not reported|0|||
23358091|NCT03130959|65056176|FG002|Overall Study|Not reported|0|||
23358092|NCT03130959|65056177|FG003|Overall Study|Not reported|1|||
23358093|NCT03130959|65056178|FG004|Overall Study|Not reported|0|||
23358094|NCT03130959|65056179|FG005|Overall Study|Not reported|1|||
23358095|NCT03130959|65056180|FG006|Overall Study|Not reported|0|||
23358096|NCT03130959|65056181|FG007|Overall Study|Not reported|0|||
23358097|NCT03130959|65056182|FG008|Overall Study|Not reported|0|||
23358098|NCT03130959|65056183|FG009|Overall Study|Not reported|1|||
23358099|NCT03130959|65056174|FG000|Overall Study|Adverse Event unrelated to drug|0|||
23358100|NCT03130959|65056175|FG001|Overall Study|Adverse Event unrelated to drug|0|||
23358101|NCT03130959|65056176|FG002|Overall Study|Adverse Event unrelated to drug|1|||
23358102|NCT03130959|65056177|FG003|Overall Study|Adverse Event unrelated to drug|1|||
23358103|NCT03130959|65056178|FG004|Overall Study|Adverse Event unrelated to drug|1|||
23358104|NCT03130959|65056179|FG005|Overall Study|Adverse Event unrelated to drug|0|||
23475174|NCT00363545|65485335|FG001|Overall Study|Withdrawal by Subject|15|||
23797518|NCT02662582|66636749|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23797519|NCT01436643|66636750|FG000|2-week Pre-treatment|Abnormal test result|0|||
23797520|NCT01436643|66636751|FG001|2-week Pre-treatment|Abnormal test result|0|||
23797521|NCT01436643|66636752|FG002|2-week Pre-treatment|Abnormal test result|0|||
23797522|NCT01436643|66636753|FG003|2-week Pre-treatment|Abnormal test result|1|||
23797523|NCT01436643|66636750|FG000|2-week Pre-treatment|Adverse Event|0|||
23797524|NCT01436643|66636751|FG001|2-week Pre-treatment|Adverse Event|0|||
23797525|NCT01436643|66636752|FG002|2-week Pre-treatment|Adverse Event|0|||
23797526|NCT01436643|66636753|FG003|2-week Pre-treatment|Adverse Event|5|||
23797527|NCT01436643|66636750|FG000|2-week Pre-treatment|Protocol Violation|0|||
23797528|NCT01436643|66636751|FG001|2-week Pre-treatment|Protocol Violation|0|||
23797529|NCT01436643|66636752|FG002|2-week Pre-treatment|Protocol Violation|0|||
23797530|NCT01436643|66636753|FG003|2-week Pre-treatment|Protocol Violation|4|||
23797531|NCT01436643|66636750|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
23797532|NCT01436643|66636751|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
23797533|NCT01436643|66636752|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
23358105|NCT03130959|65056180|FG006|Overall Study|Adverse Event unrelated to drug|1|||
23358106|NCT03130959|65056181|FG007|Overall Study|Adverse Event unrelated to drug|0|||
23358107|NCT03130959|65056182|FG008|Overall Study|Adverse Event unrelated to drug|1|||
23358108|NCT03130959|65056183|FG009|Overall Study|Adverse Event unrelated to drug|1|||
23358109|NCT03130959|65056174|FG000|Overall Study|Participant withdrew consent|0|||
23358110|NCT03130959|65056175|FG001|Overall Study|Participant withdrew consent|1|||
23358111|NCT03130959|65056176|FG002|Overall Study|Participant withdrew consent|0|||
23358112|NCT03130959|65056177|FG003|Overall Study|Participant withdrew consent|2|||
23358113|NCT03130959|65056178|FG004|Overall Study|Participant withdrew consent|1|||
23358114|NCT03130959|65056179|FG005|Overall Study|Participant withdrew consent|0|||
23358115|NCT03130959|65056180|FG006|Overall Study|Participant withdrew consent|0|||
23358116|NCT03130959|65056181|FG007|Overall Study|Participant withdrew consent|0|||
23358117|NCT03130959|65056182|FG008|Overall Study|Participant withdrew consent|0|||
23358118|NCT03130959|65056183|FG009|Overall Study|Participant withdrew consent|2|||
23358119|NCT03130959|65056174|FG000|Overall Study|Administrative reason by sponsor|1|||
23643043|NCT02245737|66079030|FG002|Overall Study|Condition Worsened|9|||
23643044|NCT02245737|66079028|FG000|Overall Study|Death|2|||
23643045|NCT02245737|66079029|FG001|Overall Study|Death|4|||
23643046|NCT02245737|66079030|FG002|Overall Study|Death|4|||
23643047|NCT02245737|66079028|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
23643048|NCT02245737|66079029|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
23643049|NCT02245737|66079030|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
23643050|NCT02245737|66079028|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
23643051|NCT02245737|66079029|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
23643052|NCT02245737|66079030|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
23643053|NCT02245737|66079028|FG000|Overall Study|Lost to Follow-up|2|||
23643054|NCT02245737|66079029|FG001|Overall Study|Lost to Follow-up|5|||
23643055|NCT02245737|66079030|FG002|Overall Study|Lost to Follow-up|4|||
23643056|NCT02245737|66079028|FG000|Overall Study|Other-determined by Investigator|9|||
23643057|NCT02245737|66079029|FG001|Overall Study|Other-determined by Investigator|10|||
23643058|NCT02245737|66079030|FG002|Overall Study|Other-determined by Investigator|10|||
23643059|NCT02245737|66079028|FG000|Overall Study|Physician Decision|6|||
23643060|NCT02245737|66079029|FG001|Overall Study|Physician Decision|3|||
23643061|NCT02245737|66079030|FG002|Overall Study|Physician Decision|6|||
23643062|NCT02245737|66079028|FG000|Overall Study|Protocol Violation|3|||
23643063|NCT02245737|66079029|FG001|Overall Study|Protocol Violation|2|||
23643064|NCT02245737|66079030|FG002|Overall Study|Protocol Violation|3|||
23643065|NCT02245737|66079028|FG000|Overall Study|Withdrawal by Subject|40|||
23643066|NCT02245737|66079029|FG001|Overall Study|Withdrawal by Subject|41|||
23643067|NCT02245737|66079030|FG002|Overall Study|Withdrawal by Subject|44|||
23643068|NCT02245737|66079028|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
23643069|NCT02245737|66079029|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
23643070|NCT02245737|66079030|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
23643071|NCT02245737|66079028|FG000|Overall Study|Sponsor Decision|445|||
23797534|NCT01436643|66636753|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
23797535|NCT01436643|66636750|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
23797536|NCT01436643|66636751|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
23797537|NCT01436643|66636752|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
23797538|NCT01436643|66636753|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
23797539|NCT01436643|66636750|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
23797540|NCT01436643|66636751|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
23797541|NCT01436643|66636752|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
23797542|NCT01436643|66636753|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
23797543|NCT02762994|66636754|FG000|Overall Study|Withdrawal by Subject|0|||
23797544|NCT02762994|66636755|FG001|Overall Study|Withdrawal by Subject|1|||
23797545|NCT02762994|66636756|FG002|Overall Study|Withdrawal by Subject|2|||
23797546|NCT02762994|66636757|FG003|Overall Study|Withdrawal by Subject|0|||
23797547|NCT02762994|66636754|FG000|Overall Study|Protocol Violation|1|||
23358120|NCT03130959|65056175|FG001|Overall Study|Administrative reason by sponsor|0|||
23358121|NCT03130959|65056176|FG002|Overall Study|Administrative reason by sponsor|1|||
23358122|NCT03130959|65056177|FG003|Overall Study|Administrative reason by sponsor|0|||
23358123|NCT03130959|65056178|FG004|Overall Study|Administrative reason by sponsor|0|||
23589507|NCT00430300|65886074|FG000|Overall Study|Laboratory abnormality|1|||
23643072|NCT02245737|66079029|FG001|Overall Study|Sponsor Decision|430|||
23643073|NCT02245737|66079030|FG002|Overall Study|Sponsor Decision|432|||
23643074|NCT00993668|66079031|FG000|Single-Blind Period|Adverse Event|1|||
23797548|NCT02762994|66636755|FG001|Overall Study|Protocol Violation|0|||
23589508|NCT00430300|65886075|FG001|Overall Study|Laboratory abnormality|0|||
23589509|NCT00430300|65886076|FG002|Overall Study|Laboratory abnormality|0|||
23589510|NCT00430300|65886077|FG003|Overall Study|Laboratory abnormality|0|||
23589511|NCT00430300|65886074|FG000|Overall Study|Other|0|||
23589512|NCT00430300|65886075|FG001|Overall Study|Other|0|||
23589513|NCT00430300|65886076|FG002|Overall Study|Other|0|||
23589514|NCT00430300|65886077|FG003|Overall Study|Other|1|||
23589515|NCT01546155|65886078|FG000|Overall Study|could not tolerate long scan duration|3|||
23589516|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Adverse Event|1|||
23589517|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
23589518|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
23589519|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
23589520|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Pregnancy|1|||
23589521|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
23589522|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
23589523|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
23589524|NCT01924767|65886080|FG000|Overall Study|Adverse Event|1|||
23589525|NCT01924767|65886081|FG001|Overall Study|Adverse Event|0|||
23589526|NCT01924767|65886082|FG002|Overall Study|Adverse Event|1|||
23589527|NCT01924767|65886083|FG003|Overall Study|Adverse Event|0|||
23589528|NCT01924767|65886084|FG004|Overall Study|Adverse Event|0|||
23589529|NCT04347954|65886085|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
23589530|NCT04347954|65886086|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
23589531|NCT04347954|65886087|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
23589532|NCT04347954|65886085|FG000|Overall Study|Lost to Follow-up|0|||
23589533|NCT04347954|65886086|FG001|Overall Study|Lost to Follow-up|1|||
23589534|NCT04347954|65886087|FG002|Overall Study|Lost to Follow-up|0|||
23589535|NCT05193318|65886091|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
23589536|NCT05193318|65886091|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
23797549|NCT02762994|66636756|FG002|Overall Study|Protocol Violation|0|||
23797550|NCT02762994|66636757|FG003|Overall Study|Protocol Violation|2|||
23797551|NCT01321697|66636765|FG000|Overall Study|Study Terminated|7|||
23797552|NCT02654587|66636769|FG000|Overall Study|patient alive at end of study|22|||
23358124|NCT03130959|65056179|FG005|Overall Study|Administrative reason by sponsor|0|||
23358125|NCT03130959|65056180|FG006|Overall Study|Administrative reason by sponsor|0|||
23358126|NCT03130959|65056181|FG007|Overall Study|Administrative reason by sponsor|0|||
23589537|NCT01070888|65886093|FG000|First Intervention (14 Days)|Adverse Event|0|||
23797553|NCT02654587|66636770|FG001|Overall Study|patient alive at end of study|8|||
23797554|NCT02654587|66636769|FG000|Overall Study|Withdrawal by Subject|1|||
23797555|NCT02654587|66636770|FG001|Overall Study|Withdrawal by Subject|7|||
23797556|NCT01235442|66636779|FG000|Overall Study|Lost to Follow-up|12|||
23797557|NCT01235442|66636780|FG001|Overall Study|Lost to Follow-up|10|||
23797558|NCT01235442|66636779|FG000|Overall Study|Death|0|||
23797559|NCT01235442|66636780|FG001|Overall Study|Death|2|||
23797560|NCT01235442|66636779|FG000|Overall Study|Pregnancy|1|||
23797561|NCT01235442|66636780|FG001|Overall Study|Pregnancy|1|||
23797562|NCT01235442|66636779|FG000|Overall Study|Ineligibility determined|5|||
23797563|NCT01235442|66636780|FG001|Overall Study|Ineligibility determined|4|||
23797564|NCT01235442|66636779|FG000|Overall Study|Protocol Violation|3|||
23797565|NCT01235442|66636780|FG001|Overall Study|Protocol Violation|3|||
23797566|NCT01235442|66636779|FG000|Overall Study|Adverse Event|4|||
23797567|NCT01235442|66636780|FG001|Overall Study|Adverse Event|6|||
23797568|NCT01235442|66636779|FG000|Overall Study|Withdrawal by Subject|15|||
23797569|NCT01235442|66636780|FG001|Overall Study|Withdrawal by Subject|9|||
23797570|NCT01235442|66636779|FG000|Overall Study|Lack of Efficacy|1|||
23797571|NCT01235442|66636780|FG001|Overall Study|Lack of Efficacy|3|||
23797572|NCT01235442|66636779|FG000|Overall Study|Noncompliance|1|||
23797573|NCT01235442|66636780|FG001|Overall Study|Noncompliance|2|||
23797574|NCT01235442|66636779|FG000|Overall Study|Administrative decision|1|||
23797575|NCT01235442|66636780|FG001|Overall Study|Administrative decision|2|||
23797576|NCT01235442|66636779|FG000|Overall Study|Other unspecified|1|||
23797577|NCT01235442|66636780|FG001|Overall Study|Other unspecified|2|||
23797578|NCT04252287|66636781|FG000|Overall Study|Death|5|||
23797579|NCT04252287|66636782|FG001|Overall Study|Death|3|||
23797580|NCT04252287|66636781|FG000|Overall Study|Lost to Follow-up|4|||
23797581|NCT04252287|66636782|FG001|Overall Study|Lost to Follow-up|6|||
23358127|NCT03130959|65056182|FG008|Overall Study|Administrative reason by sponsor|0|||
23358128|NCT03130959|65056183|FG009|Overall Study|Administrative reason by sponsor|0|||
23358129|NCT03130959|65056174|FG000|Overall Study|Lost to Follow-up|1|||
23797582|NCT04252287|66636781|FG000|Overall Study|Withdrawal by Subject|19|||
23797583|NCT04252287|66636782|FG001|Overall Study|Withdrawal by Subject|16|||
23797584|NCT04252287|66636781|FG000|Overall Study|Protocol Violation|3|||
23797585|NCT04252287|66636782|FG001|Overall Study|Protocol Violation|4|||
23797586|NCT03823287|66636783|FG000|Overall Study|Withdrawal by Subject|25|||
23797587|NCT03823287|66636784|FG001|Overall Study|Withdrawal by Subject|17|||
23797588|NCT03823287|66636783|FG000|Overall Study|Death|13|||
23797589|NCT03823287|66636784|FG001|Overall Study|Death|7|||
23358130|NCT03130959|65056175|FG001|Overall Study|Lost to Follow-up|0|||
23358131|NCT03130959|65056176|FG002|Overall Study|Lost to Follow-up|0|||
23358132|NCT03130959|65056177|FG003|Overall Study|Lost to Follow-up|0|||
23358133|NCT03130959|65056178|FG004|Overall Study|Lost to Follow-up|0|||
23358134|NCT03130959|65056179|FG005|Overall Study|Lost to Follow-up|0|||
23358135|NCT03130959|65056180|FG006|Overall Study|Lost to Follow-up|0|||
23358136|NCT03130959|65056181|FG007|Overall Study|Lost to Follow-up|0|||
23358137|NCT03130959|65056182|FG008|Overall Study|Lost to Follow-up|0|||
23358138|NCT03130959|65056183|FG009|Overall Study|Lost to Follow-up|0|||
23358139|NCT00824655|65056186|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
23358140|NCT00824655|65056187|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
23358141|NCT00824655|65056186|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
23358142|NCT00824655|65056187|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
23358143|NCT03665077|65056188|FG000|Overall Study|Lost to Follow-up|2|||
23358144|NCT03665077|65056188|FG000|Overall Study|Physician Decision|2|||
23358145|NCT01215435|65056191|FG000|Overall Study|Adverse Event|1|||
23358146|NCT01215435|65056192|FG001|Overall Study|Adverse Event|0|||
23358147|NCT01215435|65056191|FG000|Overall Study|Protocol Violation|2|||
23358148|NCT01215435|65056192|FG001|Overall Study|Protocol Violation|0|||
23358149|NCT01215435|65056191|FG000|Overall Study|Withdrawal Criteria|8|||
23358150|NCT01215435|65056192|FG001|Overall Study|Withdrawal Criteria|11|||
23358151|NCT01215435|65056191|FG000|Overall Study|Lost to Follow-up|3|||
23358152|NCT01215435|65056192|FG001|Overall Study|Lost to Follow-up|0|||
23358153|NCT01215435|65056191|FG000|Overall Study|Unclassified|5|||
23358154|NCT01215435|65056192|FG001|Overall Study|Unclassified|5|||
23358155|NCT02499263|65056193|FG000|Overall Study|Lost to Follow-up|9|||
23358156|NCT02499263|65056193|FG000|Overall Study|Participant's withdrawal of consent|4|||
23358157|NCT02499263|65056193|FG000|Overall Study|Lack of Efficacy|22|||
23475175|NCT00363545|65485334|FG000|Overall Study|Migrated/moved from study area|3|||
23475176|NCT00363545|65485335|FG001|Overall Study|Migrated/moved from study area|6|||
23475177|NCT00363545|65485334|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
23475178|NCT00363545|65485335|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
23475179|NCT00363545|65485334|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
23475180|NCT00363545|65485335|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
23475181|NCT00363545|65485334|FG000|Overall Study|Others|1|||
23475182|NCT00363545|65485335|FG001|Overall Study|Others|0|||
23475183|NCT00109590|65485336|FG000|Overall Study|Lost to Follow-up|1|||
23475184|NCT00109590|65485337|FG001|Overall Study|Lost to Follow-up|0|||
23475185|NCT00109590|65485338|FG002|Overall Study|Lost to Follow-up|1|||
23475186|NCT00109590|65485336|FG000|Overall Study|Never Started Treatment|1|||
23475187|NCT00109590|65485337|FG001|Overall Study|Never Started Treatment|2|||
23475188|NCT00109590|65485338|FG002|Overall Study|Never Started Treatment|3|||
23475189|NCT01485172|65485339|FG000|Overall Study|Adverse Event|2|||
23475190|NCT01485172|65485340|FG001|Overall Study|Adverse Event|1|||
23475191|NCT01485172|65485341|FG002|Overall Study|Adverse Event|2|||
23475192|NCT01485172|65485342|FG003|Overall Study|Adverse Event|2|||
23475193|NCT01485172|65485343|FG004|Overall Study|Adverse Event|1|||
23475194|NCT01485172|65485344|FG005|Overall Study|Adverse Event|2|||
23475195|NCT01485172|65485339|FG000|Overall Study|Lack of Efficacy|2|||
23475196|NCT01485172|65485340|FG001|Overall Study|Lack of Efficacy|0|||
23475197|NCT01485172|65485341|FG002|Overall Study|Lack of Efficacy|0|||
23475198|NCT01485172|65485342|FG003|Overall Study|Lack of Efficacy|0|||
23475199|NCT01485172|65485343|FG004|Overall Study|Lack of Efficacy|0|||
23475200|NCT01485172|65485344|FG005|Overall Study|Lack of Efficacy|0|||
23475201|NCT01485172|65485339|FG000|Overall Study|Protocol Violation|0|||
23589538|NCT01070888|65886094|FG001|First Intervention (14 Days)|Adverse Event|1|||
23589539|NCT01070888|65886093|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
23589540|NCT01070888|65886094|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
23589541|NCT01070888|65886093|FG000|Washout (14 Days)|Physician Decision|1|||
23589542|NCT01070888|65886094|FG001|Washout (14 Days)|Physician Decision|0|||
23589543|NCT01373346|65886095|FG000|Overall Study|Death|1|||
23589544|NCT00189202|65886096|FG000|Overall Study|Physician Decision|5|||
23589545|NCT02145182|65886097|FG000|Overall Study|Adverse Event|4|||
23589546|NCT02145182|65886098|FG001|Overall Study|Adverse Event|1|||
23589547|NCT02145182|65886097|FG000|Overall Study|Death|7|||
23589548|NCT02145182|65886098|FG001|Overall Study|Death|7|||
23589549|NCT02145182|65886097|FG000|Overall Study|Lost to Follow-up|2|||
23589550|NCT02145182|65886098|FG001|Overall Study|Lost to Follow-up|2|||
23358158|NCT02499263|65056193|FG000|Overall Study|investigator's judgment|12|||
23358159|NCT02499263|65056193|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
23358160|NCT02499263|65056193|FG000|Overall Study|Participant's decision|3|||
23358161|NCT02499263|65056193|FG000|Overall Study|Pregnancy|1|||
23358162|NCT02299388|65056196|FG000|Overall Study|Withdrawal by Subject|0|||
23358163|NCT02299388|65056197|FG001|Overall Study|Withdrawal by Subject|1|||
23475202|NCT01485172|65485340|FG001|Overall Study|Protocol Violation|0|||
23589551|NCT02145182|65886097|FG000|Overall Study|Pre-transplant Withdrawal|0|||
23358164|NCT02173379|65056198|FG000|Overall Study|Lost to Follow-up|89|||
23358165|NCT02173379|65056199|FG001|Overall Study|Lost to Follow-up|81|||
23475203|NCT01485172|65485341|FG002|Overall Study|Protocol Violation|4|||
23475204|NCT01485172|65485342|FG003|Overall Study|Protocol Violation|5|||
23475205|NCT01485172|65485343|FG004|Overall Study|Protocol Violation|1|||
23475206|NCT01485172|65485344|FG005|Overall Study|Protocol Violation|0|||
23475207|NCT01485172|65485339|FG000|Overall Study|Protocol defined stopping criteria|1|||
23475208|NCT01485172|65485340|FG001|Overall Study|Protocol defined stopping criteria|0|||
23475209|NCT01485172|65485341|FG002|Overall Study|Protocol defined stopping criteria|0|||
23475210|NCT01485172|65485342|FG003|Overall Study|Protocol defined stopping criteria|0|||
23475211|NCT01485172|65485343|FG004|Overall Study|Protocol defined stopping criteria|1|||
23475212|NCT01485172|65485344|FG005|Overall Study|Protocol defined stopping criteria|0|||
23475213|NCT01485172|65485339|FG000|Overall Study|Lost to Follow-up|0|||
23475214|NCT01485172|65485340|FG001|Overall Study|Lost to Follow-up|0|||
23475215|NCT01485172|65485341|FG002|Overall Study|Lost to Follow-up|1|||
23475216|NCT01485172|65485342|FG003|Overall Study|Lost to Follow-up|0|||
23475217|NCT01485172|65485343|FG004|Overall Study|Lost to Follow-up|0|||
23475218|NCT01485172|65485344|FG005|Overall Study|Lost to Follow-up|1|||
23475219|NCT01485172|65485339|FG000|Overall Study|Physician Decision|0|||
23475220|NCT01485172|65485340|FG001|Overall Study|Physician Decision|0|||
23475221|NCT01485172|65485341|FG002|Overall Study|Physician Decision|0|||
23475222|NCT01485172|65485342|FG003|Overall Study|Physician Decision|0|||
23475223|NCT01485172|65485343|FG004|Overall Study|Physician Decision|1|||
23475224|NCT01485172|65485344|FG005|Overall Study|Physician Decision|0|||
23475225|NCT01485172|65485339|FG000|Overall Study|Withdrawal by Subject|2|||
23475226|NCT01485172|65485340|FG001|Overall Study|Withdrawal by Subject|0|||
23475227|NCT01485172|65485341|FG002|Overall Study|Withdrawal by Subject|0|||
23475228|NCT01485172|65485342|FG003|Overall Study|Withdrawal by Subject|1|||
23475229|NCT01485172|65485343|FG004|Overall Study|Withdrawal by Subject|1|||
23475230|NCT01485172|65485344|FG005|Overall Study|Withdrawal by Subject|1|||
23475231|NCT01349049|65485353|FG000|Overall Study|Disease progression|3|||
23475232|NCT01349049|65485354|FG001|Overall Study|Disease progression|5|||
23475233|NCT01349049|65485355|FG002|Overall Study|Disease progression|3|||
23475234|NCT01349049|65485356|FG003|Overall Study|Disease progression|2|||
23475235|NCT01349049|65485357|FG004|Overall Study|Disease progression|2|||
23475236|NCT01349049|65485358|FG005|Overall Study|Disease progression|2|||
23475237|NCT01349049|65485359|FG006|Overall Study|Disease progression|3|||
23475238|NCT01349049|65485360|FG007|Overall Study|Disease progression|2|||
23475239|NCT01349049|65485361|FG008|Overall Study|Disease progression|33|||
23475240|NCT01349049|65485353|FG000|Overall Study|Adverse Event|0|||
23475241|NCT01349049|65485354|FG001|Overall Study|Adverse Event|1|||
23475242|NCT01349049|65485355|FG002|Overall Study|Adverse Event|0|||
23475243|NCT01349049|65485356|FG003|Overall Study|Adverse Event|0|||
23475244|NCT01349049|65485357|FG004|Overall Study|Adverse Event|0|||
23475245|NCT01349049|65485358|FG005|Overall Study|Adverse Event|3|||
23475246|NCT01349049|65485359|FG006|Overall Study|Adverse Event|1|||
23475247|NCT01349049|65485360|FG007|Overall Study|Adverse Event|0|||
23475248|NCT01349049|65485361|FG008|Overall Study|Adverse Event|4|||
23475249|NCT01349049|65485353|FG000|Overall Study|Physician Decision|0|||
23475250|NCT01349049|65485354|FG001|Overall Study|Physician Decision|1|||
23475251|NCT01349049|65485355|FG002|Overall Study|Physician Decision|0|||
23475252|NCT01349049|65485356|FG003|Overall Study|Physician Decision|0|||
23475253|NCT01349049|65485357|FG004|Overall Study|Physician Decision|0|||
23475254|NCT01349049|65485358|FG005|Overall Study|Physician Decision|0|||
23475255|NCT01349049|65485359|FG006|Overall Study|Physician Decision|0|||
23475256|NCT01349049|65485360|FG007|Overall Study|Physician Decision|0|||
23475257|NCT01349049|65485361|FG008|Overall Study|Physician Decision|2|||
23475258|NCT01349049|65485353|FG000|Overall Study|Protocol Violation|0|||
23475259|NCT01349049|65485354|FG001|Overall Study|Protocol Violation|0|||
23475260|NCT01349049|65485355|FG002|Overall Study|Protocol Violation|0|||
23475261|NCT01349049|65485356|FG003|Overall Study|Protocol Violation|0|||
23475262|NCT01349049|65485357|FG004|Overall Study|Protocol Violation|0|||
23475263|NCT01349049|65485358|FG005|Overall Study|Protocol Violation|0|||
23475264|NCT01349049|65485359|FG006|Overall Study|Protocol Violation|0|||
23475265|NCT01349049|65485360|FG007|Overall Study|Protocol Violation|0|||
23643075|NCT00993668|66079032|FG001|Single-Blind Period|Adverse Event|1|||
23643076|NCT00993668|66079031|FG000|Single-Blind Period|Lack of Efficacy|0|||
23475266|NCT01349049|65485361|FG008|Overall Study|Protocol Violation|1|||
23475267|NCT01349049|65485353|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
23475268|NCT01349049|65485354|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
23475269|NCT01349049|65485355|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
23475270|NCT01349049|65485356|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
23475271|NCT01349049|65485357|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
23475272|NCT01349049|65485358|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
23475273|NCT01349049|65485359|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
23475274|NCT01349049|65485360|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
23475275|NCT01349049|65485361|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
23475276|NCT01349049|65485353|FG000|Overall Study|Other|0|||
23797590|NCT03823287|66636783|FG000|Overall Study|Lost to Follow-up|7|||
23475277|NCT01349049|65485354|FG001|Overall Study|Other|0|||
23475278|NCT01349049|65485355|FG002|Overall Study|Other|0|||
23475279|NCT01349049|65485356|FG003|Overall Study|Other|0|||
23475280|NCT01349049|65485357|FG004|Overall Study|Other|0|||
23475281|NCT01349049|65485358|FG005|Overall Study|Other|1|||
23475282|NCT01349049|65485359|FG006|Overall Study|Other|0|||
23475283|NCT01349049|65485360|FG007|Overall Study|Other|0|||
23475284|NCT01349049|65485361|FG008|Overall Study|Other|4|||
23475285|NCT01349049|65485353|FG000|Overall Study|Death|0|||
23475286|NCT01349049|65485354|FG001|Overall Study|Death|0|||
23475287|NCT01349049|65485355|FG002|Overall Study|Death|0|||
23475288|NCT01349049|65485356|FG003|Overall Study|Death|0|||
23475289|NCT01349049|65485357|FG004|Overall Study|Death|0|||
23475290|NCT01349049|65485358|FG005|Overall Study|Death|0|||
23475291|NCT01349049|65485359|FG006|Overall Study|Death|0|||
23475292|NCT01349049|65485360|FG007|Overall Study|Death|1|||
23475293|NCT01349049|65485361|FG008|Overall Study|Death|5|||
23475294|NCT01349049|65485353|FG000|Overall Study|Non-compliance|0|||
23475295|NCT01349049|65485354|FG001|Overall Study|Non-compliance|0|||
23475296|NCT01349049|65485355|FG002|Overall Study|Non-compliance|0|||
23475297|NCT01349049|65485356|FG003|Overall Study|Non-compliance|1|||
23475298|NCT01349049|65485357|FG004|Overall Study|Non-compliance|0|||
23475299|NCT01349049|65485358|FG005|Overall Study|Non-compliance|0|||
23475300|NCT01349049|65485359|FG006|Overall Study|Non-compliance|0|||
23475301|NCT01349049|65485360|FG007|Overall Study|Non-compliance|0|||
23475302|NCT01349049|65485361|FG008|Overall Study|Non-compliance|0|||
23475303|NCT01349049|65485353|FG000|Overall Study|Withdrawal by Subject|0|||
23475304|NCT01349049|65485354|FG001|Overall Study|Withdrawal by Subject|0|||
23475305|NCT01349049|65485355|FG002|Overall Study|Withdrawal by Subject|0|||
23475306|NCT01349049|65485356|FG003|Overall Study|Withdrawal by Subject|0|||
23475307|NCT01349049|65485357|FG004|Overall Study|Withdrawal by Subject|0|||
23475308|NCT01349049|65485358|FG005|Overall Study|Withdrawal by Subject|0|||
23475309|NCT01349049|65485359|FG006|Overall Study|Withdrawal by Subject|0|||
23475310|NCT01349049|65485360|FG007|Overall Study|Withdrawal by Subject|0|||
23475311|NCT01349049|65485361|FG008|Overall Study|Withdrawal by Subject|6|||
23475312|NCT00313781|65485362|FG000|Before Crossover|Death|22|||
23475313|NCT00313781|65485363|FG001|Before Crossover|Death|8|||
23475314|NCT00313781|65485364|FG002|Before Crossover|Death|0|||
23475315|NCT00313781|65485362|FG000|Before Crossover|Lost to Follow-up|0|||
23475316|NCT00313781|65485363|FG001|Before Crossover|Lost to Follow-up|3|||
23475317|NCT00313781|65485364|FG002|Before Crossover|Lost to Follow-up|0|||
23475318|NCT00313781|65485362|FG000|Before Crossover|Withdrawal by Subject|3|||
23475319|NCT00313781|65485363|FG001|Before Crossover|Withdrawal by Subject|1|||
23475320|NCT00313781|65485364|FG002|Before Crossover|Withdrawal by Subject|0|||
23475321|NCT00313781|65485362|FG000|Before Crossover|Other|45|||
23475322|NCT00313781|65485363|FG001|Before Crossover|Other|30|||
23475323|NCT00313781|65485364|FG002|Before Crossover|Other|0|||
23475324|NCT00313781|65485362|FG000|Before Crossover|Crossover|0|||
23475325|NCT00313781|65485363|FG001|Before Crossover|Crossover|37|||
23475326|NCT00313781|65485364|FG002|Before Crossover|Crossover|0|||
23475327|NCT00313781|65485362|FG000|Before Crossover|Randomized, not treated|5|||
23475328|NCT00313781|65485363|FG001|Before Crossover|Randomized, not treated|0|||
23475329|NCT00313781|65485364|FG002|Before Crossover|Randomized, not treated|0|||
23475330|NCT00313781|65485362|FG000|After Crossover|Death|0|||
23475331|NCT00313781|65485363|FG001|After Crossover|Death|0|||
23475332|NCT00313781|65485364|FG002|After Crossover|Death|6|||
23475333|NCT00313781|65485362|FG000|After Crossover|Withdrawal by Subject|0|||
23475334|NCT00313781|65485363|FG001|After Crossover|Withdrawal by Subject|0|||
23475335|NCT00313781|65485364|FG002|After Crossover|Withdrawal by Subject|3|||
23475336|NCT00313781|65485362|FG000|After Crossover|Other|0|||
23475337|NCT00313781|65485363|FG001|After Crossover|Other|0|||
23475338|NCT00313781|65485364|FG002|After Crossover|Other|18|||
23475339|NCT01087736|65485365|FG000|Overall Study|Lost to Follow-up|1|||
23475340|NCT01087736|65485366|FG001|Overall Study|Lost to Follow-up|0|||
23589552|NCT02145182|65886098|FG001|Overall Study|Pre-transplant Withdrawal|2|||
23589553|NCT02145182|65886097|FG000|Overall Study|Withdrawal by Subject|5|||
23475341|NCT01087736|65485365|FG000|Overall Study|Death|0|||
23475342|NCT01087736|65485366|FG001|Overall Study|Death|1|||
23475343|NCT01087736|65485365|FG000|Overall Study|Withdrawal by Subject|0|||
23475344|NCT01087736|65485366|FG001|Overall Study|Withdrawal by Subject|1|||
23475345|NCT03836001|65485367|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
23475346|NCT03836001|65485368|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
23475347|NCT03836001|65485369|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
23475348|NCT03836001|65485367|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
23475349|NCT03836001|65485368|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
23475350|NCT03836001|65485369|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
23797591|NCT03823287|66636784|FG001|Overall Study|Lost to Follow-up|8|||
23475351|NCT03836001|65485367|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
23475352|NCT03836001|65485368|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
23475353|NCT03836001|65485369|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
23475354|NCT03836001|65485367|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
23475355|NCT03836001|65485368|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
23475356|NCT03836001|65485369|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
23589554|NCT02145182|65886098|FG001|Overall Study|Withdrawal by Subject|4|||
23589555|NCT00573833|65886099|FG000|Overall Study|Not Treated|2|||
23589556|NCT00768651|65886100|FG000|Overall Study|Withdrawal by Subject|1|||
23589557|NCT04581824|65886104|FG000|Overall Study|Ongoing|75|||
23589558|NCT04581824|65886105|FG001|Overall Study|Ongoing|69|||
23589559|NCT04581824|65886104|FG000|Overall Study|Withdrawal by Subject|3|||
23589560|NCT04581824|65886105|FG001|Overall Study|Withdrawal by Subject|5|||
23589561|NCT04581824|65886104|FG000|Overall Study|Lost to Follow-up|1|||
23589562|NCT04581824|65886105|FG001|Overall Study|Lost to Follow-up|0|||
23589563|NCT02751580|65886109|FG000|Overall Study|Lost to Follow-up|4|||
23589564|NCT02751580|65886109|FG000|Overall Study|Death|2|||
23589565|NCT03058991|65886110|FG000|Overall Study|Lost to Follow-up|17|||
23589566|NCT03058991|65886111|FG001|Overall Study|Lost to Follow-up|12|||
23589567|NCT03058991|65886112|FG002|Overall Study|Lost to Follow-up|12|||
23589568|NCT03058991|65886110|FG000|Overall Study|Withdrawal by Subject|1|||
23589569|NCT03058991|65886111|FG001|Overall Study|Withdrawal by Subject|0|||
23589570|NCT03058991|65886112|FG002|Overall Study|Withdrawal by Subject|0|||
23589571|NCT01897233|65886113|FG000|Part B (24 Weeks)|Adverse Event|1|||
23589572|NCT01897233|65886113|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
23797592|NCT03823287|66636783|FG000|Overall Study|Adverse Event|6|||
23475357|NCT01237899|65485373|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
23475358|NCT01237899|65485374|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
23475359|NCT01237899|65485375|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
23475360|NCT01237899|65485376|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
23475361|NCT01237899|65485377|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
23475362|NCT01237899|65485378|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
23475363|NCT01237899|65485379|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
23475364|NCT01237899|65485380|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
23475365|NCT01237899|65485381|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
23475366|NCT01237899|65485382|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
23475367|NCT01237899|65485383|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
23475368|NCT03337490|65485385|FG000|Overall Study|Withdrawal by Subject|1|||
23475369|NCT03337490|65485386|FG001|Overall Study|Withdrawal by Subject|0|||
23475370|NCT03337490|65485387|FG002|Overall Study|Withdrawal by Subject|0|||
23475371|NCT03337490|65485385|FG000|Overall Study|Lack of Efficacy|10|||
23475372|NCT03337490|65485386|FG001|Overall Study|Lack of Efficacy|12|||
23475373|NCT03337490|65485387|FG002|Overall Study|Lack of Efficacy|35|||
23475374|NCT03337490|65485385|FG000|Overall Study|Physician Decision|0|||
23475375|NCT03337490|65485386|FG001|Overall Study|Physician Decision|1|||
23475376|NCT03337490|65485387|FG002|Overall Study|Physician Decision|0|||
23475377|NCT03337490|65485385|FG000|Overall Study|Lost to Follow-up|0|||
23475378|NCT03337490|65485386|FG001|Overall Study|Lost to Follow-up|1|||
23475379|NCT03337490|65485387|FG002|Overall Study|Lost to Follow-up|0|||
23475380|NCT01536392|65485393|FG000|Overall Study|Adverse Event|2|||
23475381|NCT01536392|65485394|FG001|Overall Study|Adverse Event|2|||
23475382|NCT01536392|65485393|FG000|Overall Study|Physician Decision|2|||
23475383|NCT01536392|65485394|FG001|Overall Study|Physician Decision|3|||
23475384|NCT01536392|65485393|FG000|Overall Study|Withdrawal by Subject|3|||
23475385|NCT01536392|65485394|FG001|Overall Study|Withdrawal by Subject|6|||
23475386|NCT01536392|65485393|FG000|Overall Study|Non Compliance|3|||
23475387|NCT01536392|65485394|FG001|Overall Study|Non Compliance|4|||
23475388|NCT01536392|65485393|FG000|Overall Study|Completed therapy early|3|||
23475389|NCT01536392|65485394|FG001|Overall Study|Completed therapy early|0|||
23475390|NCT01433250|65485395|FG000|Overall Study|Protocol Violation|0|||
23475391|NCT01433250|65485396|FG001|Overall Study|Protocol Violation|1|||
23475392|NCT01433250|65485395|FG000|Overall Study|Withdrawal by Subject|3|||
23475393|NCT01433250|65485396|FG001|Overall Study|Withdrawal by Subject|2|||
23643077|NCT00993668|66079032|FG001|Single-Blind Period|Lack of Efficacy|1|||
23797593|NCT03823287|66636784|FG001|Overall Study|Adverse Event|8|||
23797594|NCT03823287|66636783|FG000|Overall Study|Physician Decision|5|||
23475394|NCT00003472|65485405|FG000|Overall Study|Not evaluable|3|||
23475395|NCT04359901|65485406|FG000|Overall Study|Withdrawal by Subject|0|||
23475396|NCT04359901|65485407|FG001|Overall Study|Withdrawal by Subject|1|||
23797595|NCT03823287|66636784|FG001|Overall Study|Physician Decision|2|||
23475397|NCT04359901|65485406|FG000|Overall Study|Death|6|||
23475398|NCT04359901|65485407|FG001|Overall Study|Death|2|||
23475399|NCT02577887|65485408|FG000|Overall Study|Death|93|||
23475400|NCT02577887|65485408|FG000|Overall Study|Protocol Violation|125|||
23589573|NCT01897233|65886113|FG000|Part B (24 Weeks)|Physician Decision|1|||
23589574|NCT02685033|65886114|FG000|Overall Study|Withdrawal of Consent|0|||
23589575|NCT02685033|65886115|FG001|Overall Study|Withdrawal of Consent|1|||
23589576|NCT02685033|65886114|FG000|Overall Study|Lost to Follow-up|2|||
23706863|NCT00372190|66301349|FG000|Overall Study|Lost to Follow-up|3|||
23589577|NCT02685033|65886115|FG001|Overall Study|Lost to Follow-up|1|||
23589578|NCT02685033|65886114|FG000|Overall Study|Adverse Event|1|||
23589579|NCT02685033|65886115|FG001|Overall Study|Adverse Event|0|||
23589580|NCT01241292|65886116|FG000|Overall Study|Administrative Reason by Sponsor|1|||
23589581|NCT01241292|65886117|FG001|Overall Study|Administrative Reason by Sponsor|0|||
23589582|NCT01241292|65886116|FG000|Overall Study|Disease Progression|2|||
23589583|NCT01241292|65886117|FG001|Overall Study|Disease Progression|0|||
23589584|NCT01241292|65886116|FG000|Overall Study|Study Drug Toxicity|0|||
23589585|NCT01241292|65886117|FG001|Overall Study|Study Drug Toxicity|1|||
23589586|NCT01241292|65886116|FG000|Overall Study|Participant Discontinued Treatment|0|||
23589587|NCT01241292|65886117|FG001|Overall Study|Participant Discontinued Treatment|2|||
23589588|NCT05274217|65886122|FG000|Overall Study|Study terminated.|11|||
23589589|NCT05274217|65886123|FG001|Overall Study|Study terminated.|0|||
23589590|NCT04033432|65886124|FG000|Overall Study|Progressive Disease|8|||
23589591|NCT04033432|65886124|FG000|Overall Study|Adverse Event|4|||
23589592|NCT04033432|65886124|FG000|Overall Study|Death|1|||
23589593|NCT02104765|65886127|FG000|Overall Study|Lost to Follow-up|0|||
23589594|NCT02104765|65886128|FG001|Overall Study|Lost to Follow-up|0|||
23589595|NCT02104765|65886129|FG002|Overall Study|Lost to Follow-up|1|||
23589596|NCT02104765|65886130|FG003|Overall Study|Lost to Follow-up|0|||
23589597|NCT02104765|65886131|FG004|Overall Study|Lost to Follow-up|0|||
23589598|NCT02104765|65886132|FG005|Overall Study|Lost to Follow-up|0|||
23797596|NCT03823287|66636783|FG000|Overall Study|Lack of Efficacy|2|||
23797597|NCT03823287|66636784|FG001|Overall Study|Lack of Efficacy|0|||
23797598|NCT03823287|66636783|FG000|Overall Study|Other|2|||
23797599|NCT03823287|66636784|FG001|Overall Study|Other|4|||
23358166|NCT02173379|65056198|FG000|Overall Study|Withdrawal by Subject|24|||
23358167|NCT02173379|65056199|FG001|Overall Study|Withdrawal by Subject|29|||
23358168|NCT02173379|65056198|FG000|Overall Study|Physician Decision|8|||
23358169|NCT02173379|65056199|FG001|Overall Study|Physician Decision|8|||
23358170|NCT02173379|65056198|FG000|Overall Study|Death|75|||
23358171|NCT02173379|65056199|FG001|Overall Study|Death|72|||
23358172|NCT02173379|65056198|FG000|Overall Study|Other Reason|1|||
23358173|NCT02173379|65056199|FG001|Overall Study|Other Reason|0|||
23358174|NCT00531947|65056202|FG000|Overall Study|Adverse Event|5|||
23358175|NCT00531947|65056203|FG001|Overall Study|Adverse Event|10|||
23358176|NCT00531947|65056202|FG000|Overall Study|Lost to Follow-up|12|||
23358177|NCT00531947|65056203|FG001|Overall Study|Lost to Follow-up|9|||
23358178|NCT00531947|65056202|FG000|Overall Study|Withdrawal by Subject|14|||
23358179|NCT00531947|65056203|FG001|Overall Study|Withdrawal by Subject|19|||
23358180|NCT00531947|65056202|FG000|Overall Study|Protocol Violation|2|||
23358181|NCT00531947|65056203|FG001|Overall Study|Protocol Violation|1|||
23358182|NCT00531947|65056202|FG000|Overall Study|Non-Compliance|4|||
23358183|NCT00531947|65056203|FG001|Overall Study|Non-Compliance|7|||
23358184|NCT00531947|65056202|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
23358185|NCT00531947|65056203|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
23358186|NCT02942277|65056207|FG000|Year 1|Withdrawal by Subject|0|||
23358187|NCT02942277|65056208|FG001|Year 1|Withdrawal by Subject|0|||
23358188|NCT02942277|65056209|FG002|Year 1|Withdrawal by Subject|0|||
23358189|NCT02942277|65056210|FG003|Year 1|Withdrawal by Subject|0|||
23358190|NCT02942277|65056211|FG004|Year 1|Withdrawal by Subject|1|||
23358191|NCT02942277|65056212|FG005|Year 1|Withdrawal by Subject|3|||
23358192|NCT02942277|65056213|FG006|Year 1|Withdrawal by Subject|0|||
23358193|NCT02942277|65056214|FG007|Year 1|Withdrawal by Subject|1|||
23358194|NCT02942277|65056215|FG008|Year 1|Withdrawal by Subject|0|||
23358195|NCT02942277|65056216|FG009|Year 1|Withdrawal by Subject|0|||
23358196|NCT02942277|65056217|FG010|Year 1|Withdrawal by Subject|3|||
23358197|NCT02942277|65056207|FG000|Year 1|Travel|0|||
23358198|NCT02942277|65056208|FG001|Year 1|Travel|1|||
23358199|NCT02942277|65056209|FG002|Year 1|Travel|0|||
23358200|NCT02942277|65056210|FG003|Year 1|Travel|0|||
23358201|NCT02942277|65056211|FG004|Year 1|Travel|4|||
23358202|NCT02942277|65056212|FG005|Year 1|Travel|5|||
23358203|NCT02942277|65056213|FG006|Year 1|Travel|0|||
23358204|NCT02942277|65056214|FG007|Year 1|Travel|0|||
23358205|NCT02942277|65056215|FG008|Year 1|Travel|0|||
23358206|NCT02942277|65056216|FG009|Year 1|Travel|0|||
23358207|NCT02942277|65056217|FG010|Year 1|Travel|8|||
23358208|NCT02942277|65056207|FG000|Year 1|Joined Army|0|||
23589599|NCT02104765|65886133|FG006|Overall Study|Lost to Follow-up|0|||
23589600|NCT02104765|65886127|FG000|Overall Study|Withdrawal by Subject|0|||
23589601|NCT02104765|65886128|FG001|Overall Study|Withdrawal by Subject|0|||
23589602|NCT02104765|65886129|FG002|Overall Study|Withdrawal by Subject|0|||
23589603|NCT02104765|65886130|FG003|Overall Study|Withdrawal by Subject|1|||
23589604|NCT02104765|65886131|FG004|Overall Study|Withdrawal by Subject|1|||
23589605|NCT02104765|65886132|FG005|Overall Study|Withdrawal by Subject|0|||
23589606|NCT02104765|65886133|FG006|Overall Study|Withdrawal by Subject|1|||
23589607|NCT00082810|65886134|FG000|Overall Study|Adverse Event|3|||
23589608|NCT00082810|65886134|FG000|Overall Study|Progressive disease|24|||
23589609|NCT00082810|65886134|FG000|Overall Study|Withdrawal by Subject|4|||
23589610|NCT02232178|65886135|FG000|Overall Study|Lost to Follow-up|0|||
23589611|NCT02232178|65886136|FG001|Overall Study|Lost to Follow-up|1|||
23589612|NCT02232178|65886137|FG002|Overall Study|Lost to Follow-up|0|||
23589613|NCT02232178|65886135|FG000|Overall Study|ineligibility|0|||
23589614|NCT02232178|65886136|FG001|Overall Study|ineligibility|0|||
23589615|NCT02232178|65886137|FG002|Overall Study|ineligibility|1|||
23797600|NCT02001051|66636790|FG000|Overall Study|Deemed not eligible following enrollment|0|||
23797601|NCT02001051|66636791|FG001|Overall Study|Deemed not eligible following enrollment|1|||
23797602|NCT01841073|66636793|FG000|Overall Study|Adverse Event|1|||
23475401|NCT02577887|65485408|FG000|Overall Study|Withdrawal by Subject|80|||
23475402|NCT00796523|65485409|FG000|Overall Study|Lost to Follow-up|9|||
23475403|NCT00796523|65485410|FG001|Overall Study|Lost to Follow-up|7|||
23475404|NCT04268823|65485413|FG000|Overall Study|Adverse Event|1|||
23475405|NCT04268823|65485414|FG001|Overall Study|Adverse Event|0|||
23475406|NCT04268823|65485413|FG000|Overall Study|Participant Decision|1|||
23475407|NCT04268823|65485414|FG001|Overall Study|Participant Decision|0|||
23475408|NCT01865552|65485415|FG000|Period 1|Adverse Event|1|||
23475409|NCT01865552|65485416|FG001|Period 1|Adverse Event|0|||
23475410|NCT01865552|65485417|FG002|Period 1|Adverse Event|0|||
23475411|NCT01865552|65485418|FG003|Period 1|Adverse Event|1|||
23475412|NCT01865552|65485419|FG004|Period 1|Adverse Event|1|||
23475413|NCT01865552|65485420|FG005|Period 1|Adverse Event|1|||
23475414|NCT01865552|65485415|FG000|Period 1|Pathological lab|0|||
23475415|NCT01865552|65485416|FG001|Period 1|Pathological lab|0|||
23475416|NCT01865552|65485417|FG002|Period 1|Pathological lab|0|||
23475417|NCT01865552|65485418|FG003|Period 1|Pathological lab|0|||
23475418|NCT01865552|65485419|FG004|Period 1|Pathological lab|1|||
23475419|NCT01865552|65485420|FG005|Period 1|Pathological lab|0|||
23475420|NCT01865552|65485415|FG000|Period 1|Other|0|||
23475421|NCT01865552|65485416|FG001|Period 1|Other|0|||
23475422|NCT01865552|65485417|FG002|Period 1|Other|0|||
23475423|NCT01865552|65485418|FG003|Period 1|Other|0|||
23475424|NCT01865552|65485419|FG004|Period 1|Other|1|||
23475425|NCT01865552|65485420|FG005|Period 1|Other|0|||
23475426|NCT01284491|65485421|FG000|Overall Study|Study termination|13|||
23475427|NCT00717236|65485422|FG000|Double-Blind Period|Adverse Event|33|||
23475428|NCT00717236|65485423|FG001|Double-Blind Period|Adverse Event|6|||
23475429|NCT00717236|65485422|FG000|Double-Blind Period|Lack of Efficacy|6|||
23475430|NCT00717236|65485423|FG001|Double-Blind Period|Lack of Efficacy|6|||
23475431|NCT00717236|65485422|FG000|Double-Blind Period|Lost to Follow-up|3|||
23475432|NCT00717236|65485423|FG001|Double-Blind Period|Lost to Follow-up|5|||
23475433|NCT00717236|65485422|FG000|Double-Blind Period|Withdrawal by Subject|10|||
23475434|NCT00717236|65485423|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23475435|NCT00717236|65485422|FG000|Double-Blind Period|Loss of efficacy|3|||
23475436|NCT00717236|65485423|FG001|Double-Blind Period|Loss of efficacy|0|||
23475437|NCT00717236|65485422|FG000|Double-Blind Period|Other: Death|1|||
23475438|NCT00717236|65485423|FG001|Double-Blind Period|Other: Death|0|||
23475439|NCT00717236|65485422|FG000|Double-Blind Period|Other: Pregnancy|1|||
23475440|NCT00717236|65485423|FG001|Double-Blind Period|Other: Pregnancy|0|||
23475441|NCT00717236|65485422|FG000|Double-Blind Period|Other: Protocol Violation|2|||
23475442|NCT00717236|65485423|FG001|Double-Blind Period|Other: Protocol Violation|0|||
23475443|NCT00717236|65485422|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
23475444|NCT00717236|65485423|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
23475445|NCT00717236|65485422|FG000|Double-Blind Period|Other: Site withdrew|2|||
23475446|NCT00717236|65485423|FG001|Double-Blind Period|Other: Site withdrew|0|||
23589616|NCT02232178|65886135|FG000|Overall Study|surgical complication|1|||
23589617|NCT02232178|65886136|FG001|Overall Study|surgical complication|0|||
23589618|NCT02232178|65886137|FG002|Overall Study|surgical complication|0|||
23797603|NCT01841073|66636794|FG001|Overall Study|Adverse Event|1|||
23797604|NCT01841073|66636793|FG000|Overall Study|Physician Decision|1|||
23797605|NCT01841073|66636794|FG001|Overall Study|Physician Decision|0|||
23797606|NCT01841073|66636793|FG000|Overall Study|Lost to Follow-up|0|||
23797607|NCT01841073|66636794|FG001|Overall Study|Lost to Follow-up|2|||
23797608|NCT02297841|66636795|FG000|Overall Study|Withdrawal by Subject|1|||
23797609|NCT02297841|66636795|FG000|Overall Study|Protocol Violation|7|||
23797610|NCT02260635|66636798|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
23797611|NCT02260635|66636799|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
23797612|NCT02260635|66636798|FG000|Open-Label Extension|Study Termination|25|||
23797613|NCT02260635|66636799|FG001|Open-Label Extension|Study Termination|25|||
23797614|NCT02260635|66636798|FG000|Open-Label Extension|Withdrawal by Subject|1|||
23797615|NCT02260635|66636799|FG001|Open-Label Extension|Withdrawal by Subject|0|||
23797616|NCT01894230|66636808|FG000|Overall Study|Lost to Follow-up|2|||
23797617|NCT01894230|66636809|FG001|Overall Study|Lost to Follow-up|2|||
23797618|NCT01894230|66636808|FG000|Overall Study|Withdrawal by Subject|4|||
23797619|NCT01894230|66636809|FG001|Overall Study|Withdrawal by Subject|4|||
23797620|NCT01894230|66636808|FG000|Overall Study|Non-adherent|0|||
23589619|NCT02551055|65886138|FG000|Overall Study|Death|2|||
23589620|NCT02551055|65886139|FG001|Overall Study|Death|4|||
23589621|NCT02551055|65886140|FG002|Overall Study|Death|2|||
23589622|NCT02551055|65886141|FG003|Overall Study|Death|2|||
23589623|NCT02551055|65886142|FG004|Overall Study|Death|2|||
23589624|NCT02551055|65886143|FG005|Overall Study|Death|1|||
23589625|NCT02551055|65886144|FG006|Overall Study|Death|2|||
23589626|NCT02551055|65886145|FG007|Overall Study|Death|0|||
23358209|NCT02942277|65056208|FG001|Year 1|Joined Army|1|||
23358210|NCT02942277|65056209|FG002|Year 1|Joined Army|0|||
23358211|NCT02942277|65056210|FG003|Year 1|Joined Army|0|||
23358212|NCT02942277|65056211|FG004|Year 1|Joined Army|0|||
23358213|NCT02942277|65056212|FG005|Year 1|Joined Army|0|||
23358214|NCT02942277|65056213|FG006|Year 1|Joined Army|0|||
23358215|NCT02942277|65056214|FG007|Year 1|Joined Army|0|||
23358216|NCT02942277|65056215|FG008|Year 1|Joined Army|0|||
23358217|NCT02942277|65056216|FG009|Year 1|Joined Army|0|||
23358218|NCT02942277|65056217|FG010|Year 1|Joined Army|0|||
23358219|NCT02942277|65056207|FG000|Year 1|Subject met withdrawal criteria|0|||
23358220|NCT02942277|65056208|FG001|Year 1|Subject met withdrawal criteria|0|||
23358221|NCT02942277|65056209|FG002|Year 1|Subject met withdrawal criteria|0|||
23358222|NCT02942277|65056210|FG003|Year 1|Subject met withdrawal criteria|1|||
23358223|NCT02942277|65056211|FG004|Year 1|Subject met withdrawal criteria|0|||
23358224|NCT02942277|65056212|FG005|Year 1|Subject met withdrawal criteria|0|||
23358225|NCT02942277|65056213|FG006|Year 1|Subject met withdrawal criteria|0|||
23475447|NCT00717236|65485422|FG000|Double-Blind Period|Other: Screening failure|1|||
23475448|NCT00717236|65485423|FG001|Double-Blind Period|Other: Screening failure|0|||
23475449|NCT00717236|65485422|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
23475450|NCT00717236|65485423|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
23475451|NCT00717236|65485422|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
23475452|NCT00717236|65485423|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
23475453|NCT00717236|65485422|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
23475454|NCT00717236|65485423|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
23475455|NCT00717236|65485422|FG000|Double-Blind Period|Other: History of cancer|1|||
23475456|NCT00717236|65485423|FG001|Double-Blind Period|Other: History of cancer|0|||
23475457|NCT00717236|65485422|FG000|Double-Blind Period|Other: Sponsor request|1|||
23475458|NCT00717236|65485423|FG001|Double-Blind Period|Other: Sponsor request|0|||
23475459|NCT00717236|65485422|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
23475460|NCT00717236|65485423|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
23475461|NCT00717236|65485422|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
23475462|NCT00717236|65485423|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
23475463|NCT00717236|65485422|FG000|Double-Blind Period|Other: Subject moved|1|||
23475464|NCT00717236|65485423|FG001|Double-Blind Period|Other: Subject moved|1|||
23475465|NCT00717236|65485422|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
23475466|NCT00717236|65485423|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
23475467|NCT00717236|65485422|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
23475468|NCT00717236|65485423|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
23475469|NCT00717236|65485422|FG000|Double-Blind Period|Other: Transportation problems|0|||
23475470|NCT00717236|65485423|FG001|Double-Blind Period|Other: Transportation problems|1|||
23475471|NCT00717236|65485422|FG000|Double-Blind Period|Other: Investigator Decision|0|||
23358226|NCT02942277|65056214|FG007|Year 1|Subject met withdrawal criteria|0|||
23475472|NCT00717236|65485423|FG001|Double-Blind Period|Other: Investigator Decision|1|||
23475473|NCT00717236|65485422|FG000|Open-Label Period|Adverse Event|29|||
23475474|NCT00717236|65485423|FG001|Open-Label Period|Adverse Event|4|||
23358227|NCT02942277|65056215|FG008|Year 1|Subject met withdrawal criteria|0|||
23358228|NCT02942277|65056216|FG009|Year 1|Subject met withdrawal criteria|0|||
23475475|NCT00717236|65485422|FG000|Open-Label Period|Lack of Efficacy|30|||
23358229|NCT02942277|65056217|FG010|Year 1|Subject met withdrawal criteria|0|||
23358230|NCT02942277|65056207|FG000|Year 1|Lost to Follow-up|0|||
23358231|NCT02942277|65056208|FG001|Year 1|Lost to Follow-up|0|||
23358232|NCT02942277|65056209|FG002|Year 1|Lost to Follow-up|0|||
23358233|NCT02942277|65056210|FG003|Year 1|Lost to Follow-up|0|||
23358234|NCT02942277|65056211|FG004|Year 1|Lost to Follow-up|1|||
23358235|NCT02942277|65056212|FG005|Year 1|Lost to Follow-up|0|||
23358236|NCT02942277|65056213|FG006|Year 1|Lost to Follow-up|0|||
23358237|NCT02942277|65056214|FG007|Year 1|Lost to Follow-up|0|||
23358238|NCT02942277|65056215|FG008|Year 1|Lost to Follow-up|0|||
23358239|NCT02942277|65056216|FG009|Year 1|Lost to Follow-up|0|||
23358240|NCT02942277|65056217|FG010|Year 1|Lost to Follow-up|2|||
23358241|NCT02942277|65056207|FG000|Year 1|Protocol Violation|0|||
23358242|NCT02942277|65056208|FG001|Year 1|Protocol Violation|0|||
23358243|NCT02942277|65056209|FG002|Year 1|Protocol Violation|0|||
23358244|NCT02942277|65056210|FG003|Year 1|Protocol Violation|0|||
23358245|NCT02942277|65056211|FG004|Year 1|Protocol Violation|1|||
23358246|NCT02942277|65056212|FG005|Year 1|Protocol Violation|1|||
23358247|NCT02942277|65056213|FG006|Year 1|Protocol Violation|0|||
23358248|NCT02942277|65056214|FG007|Year 1|Protocol Violation|0|||
23358249|NCT02942277|65056215|FG008|Year 1|Protocol Violation|0|||
23358250|NCT02942277|65056216|FG009|Year 1|Protocol Violation|0|||
23358251|NCT02942277|65056217|FG010|Year 1|Protocol Violation|2|||
23358252|NCT02942277|65056207|FG000|Year 1|Pregnancy|0|||
23358253|NCT02942277|65056208|FG001|Year 1|Pregnancy|0|||
23358254|NCT02942277|65056209|FG002|Year 1|Pregnancy|0|||
23589627|NCT02551055|65886138|FG000|Overall Study|Study Terminated by Sponsor|1|||
23358255|NCT02942277|65056210|FG003|Year 1|Pregnancy|0|||
23358256|NCT02942277|65056211|FG004|Year 1|Pregnancy|0|||
23358257|NCT02942277|65056212|FG005|Year 1|Pregnancy|1|||
23358258|NCT02942277|65056213|FG006|Year 1|Pregnancy|0|||
23358259|NCT02942277|65056214|FG007|Year 1|Pregnancy|0|||
23358260|NCT02942277|65056215|FG008|Year 1|Pregnancy|0|||
23358261|NCT02942277|65056216|FG009|Year 1|Pregnancy|0|||
23358262|NCT02942277|65056217|FG010|Year 1|Pregnancy|0|||
23358263|NCT02942277|65056207|FG000|Year 2|Lost to Follow-up|0|||
23358264|NCT02942277|65056208|FG001|Year 2|Lost to Follow-up|0|||
23358265|NCT02942277|65056209|FG002|Year 2|Lost to Follow-up|0|||
23358266|NCT02942277|65056210|FG003|Year 2|Lost to Follow-up|0|||
23358267|NCT02942277|65056211|FG004|Year 2|Lost to Follow-up|2|||
23358268|NCT02942277|65056212|FG005|Year 2|Lost to Follow-up|1|||
23358269|NCT02942277|65056213|FG006|Year 2|Lost to Follow-up|0|||
23358270|NCT02942277|65056214|FG007|Year 2|Lost to Follow-up|0|||
23358271|NCT02942277|65056215|FG008|Year 2|Lost to Follow-up|0|||
23358272|NCT02942277|65056216|FG009|Year 2|Lost to Follow-up|0|||
23358273|NCT02942277|65056217|FG010|Year 2|Lost to Follow-up|0|||
23358274|NCT02942277|65056207|FG000|Year 2|Did not rescreen|0|||
23358275|NCT02942277|65056208|FG001|Year 2|Did not rescreen|0|||
23358276|NCT02942277|65056209|FG002|Year 2|Did not rescreen|1|||
23358277|NCT02942277|65056210|FG003|Year 2|Did not rescreen|1|||
23358278|NCT02942277|65056211|FG004|Year 2|Did not rescreen|9|||
23358279|NCT02942277|65056212|FG005|Year 2|Did not rescreen|6|||
23358280|NCT02942277|65056213|FG006|Year 2|Did not rescreen|0|||
23358281|NCT02942277|65056214|FG007|Year 2|Did not rescreen|1|||
23358282|NCT02942277|65056215|FG008|Year 2|Did not rescreen|0|||
23358283|NCT02942277|65056216|FG009|Year 2|Did not rescreen|0|||
23358284|NCT02942277|65056217|FG010|Year 2|Did not rescreen|21|||
23358285|NCT02942277|65056207|FG000|Year 2|Met withdrawal criteria|0|||
23358286|NCT02942277|65056208|FG001|Year 2|Met withdrawal criteria|0|||
23358287|NCT02942277|65056209|FG002|Year 2|Met withdrawal criteria|0|||
23358288|NCT02942277|65056210|FG003|Year 2|Met withdrawal criteria|0|||
23358289|NCT02942277|65056211|FG004|Year 2|Met withdrawal criteria|1|||
23358290|NCT02942277|65056212|FG005|Year 2|Met withdrawal criteria|2|||
23358291|NCT02942277|65056213|FG006|Year 2|Met withdrawal criteria|0|||
23589628|NCT02551055|65886139|FG001|Overall Study|Study Terminated by Sponsor|1|||
23589629|NCT02551055|65886140|FG002|Overall Study|Study Terminated by Sponsor|0|||
23589630|NCT02551055|65886141|FG003|Overall Study|Study Terminated by Sponsor|2|||
23589631|NCT02551055|65886142|FG004|Overall Study|Study Terminated by Sponsor|2|||
23358292|NCT02942277|65056214|FG007|Year 2|Met withdrawal criteria|0|||
23358293|NCT02942277|65056215|FG008|Year 2|Met withdrawal criteria|0|||
23358294|NCT02942277|65056216|FG009|Year 2|Met withdrawal criteria|0|||
23358295|NCT02942277|65056217|FG010|Year 2|Met withdrawal criteria|1|||
23589632|NCT02551055|65886143|FG005|Overall Study|Study Terminated by Sponsor|0|||
23589633|NCT02551055|65886144|FG006|Overall Study|Study Terminated by Sponsor|0|||
23589634|NCT02551055|65886145|FG007|Overall Study|Study Terminated by Sponsor|0|||
23589635|NCT02551055|65886138|FG000|Overall Study|Withdrawal by Subject|1|||
23589636|NCT02551055|65886139|FG001|Overall Study|Withdrawal by Subject|1|||
23797621|NCT01894230|66636809|FG001|Overall Study|Non-adherent|1|||
23358296|NCT02942277|65056207|FG000|Year 2|Travel|0|||
23358297|NCT02942277|65056208|FG001|Year 2|Travel|1|||
23358298|NCT02942277|65056209|FG002|Year 2|Travel|0|||
23358299|NCT02942277|65056210|FG003|Year 2|Travel|0|||
23358300|NCT02942277|65056211|FG004|Year 2|Travel|0|||
23358301|NCT02942277|65056212|FG005|Year 2|Travel|1|||
23358302|NCT02942277|65056213|FG006|Year 2|Travel|0|||
23358303|NCT02942277|65056214|FG007|Year 2|Travel|0|||
23358304|NCT02942277|65056215|FG008|Year 2|Travel|0|||
23358305|NCT02942277|65056216|FG009|Year 2|Travel|1|||
23358306|NCT02942277|65056217|FG010|Year 2|Travel|3|||
23475476|NCT00717236|65485423|FG001|Open-Label Period|Lack of Efficacy|8|||
23475477|NCT00717236|65485422|FG000|Open-Label Period|Lost to Follow-up|28|||
23475478|NCT00717236|65485423|FG001|Open-Label Period|Lost to Follow-up|4|||
23475479|NCT00717236|65485422|FG000|Open-Label Period|Withdrawal by Subject|20|||
23475480|NCT00717236|65485423|FG001|Open-Label Period|Withdrawal by Subject|2|||
23589637|NCT02551055|65886140|FG002|Overall Study|Withdrawal by Subject|0|||
23589638|NCT02551055|65886141|FG003|Overall Study|Withdrawal by Subject|1|||
23589639|NCT02551055|65886142|FG004|Overall Study|Withdrawal by Subject|2|||
23797622|NCT01894230|66636808|FG000|Overall Study|Death|1|||
23358307|NCT02942277|65056207|FG000|Year 2|Non-compliant|0|||
23358308|NCT02942277|65056208|FG001|Year 2|Non-compliant|0|||
23358309|NCT02942277|65056209|FG002|Year 2|Non-compliant|0|||
23358310|NCT02942277|65056210|FG003|Year 2|Non-compliant|0|||
23358311|NCT02942277|65056211|FG004|Year 2|Non-compliant|1|||
23358312|NCT02942277|65056212|FG005|Year 2|Non-compliant|1|||
23358313|NCT02942277|65056213|FG006|Year 2|Non-compliant|0|||
23358314|NCT02942277|65056214|FG007|Year 2|Non-compliant|0|||
23358315|NCT02942277|65056215|FG008|Year 2|Non-compliant|0|||
23358316|NCT02942277|65056216|FG009|Year 2|Non-compliant|0|||
23358317|NCT02942277|65056217|FG010|Year 2|Non-compliant|0|||
23358318|NCT02942277|65056207|FG000|Year 2|Withdrawal by Subject|0|||
23589640|NCT02551055|65886143|FG005|Overall Study|Withdrawal by Subject|0|||
23797623|NCT01894230|66636809|FG001|Overall Study|Death|0|||
23797624|NCT00529217|66636810|FG000|Overall Study|Lack of Efficacy|2|||
23797625|NCT00529217|66636810|FG000|Overall Study|Unable to adhere to study schedule|2|||
23797626|NCT04980456|66636812|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
23797627|NCT04980456|66636813|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
23797628|NCT04980456|66636812|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
23797629|NCT04980456|66636813|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
23358319|NCT02942277|65056208|FG001|Year 2|Withdrawal by Subject|0|||
23358320|NCT02942277|65056209|FG002|Year 2|Withdrawal by Subject|0|||
23358321|NCT02942277|65056210|FG003|Year 2|Withdrawal by Subject|0|||
23358322|NCT02942277|65056211|FG004|Year 2|Withdrawal by Subject|0|||
23358323|NCT02942277|65056212|FG005|Year 2|Withdrawal by Subject|0|||
23358324|NCT02942277|65056213|FG006|Year 2|Withdrawal by Subject|1|||
23589641|NCT02551055|65886144|FG006|Overall Study|Withdrawal by Subject|0|||
23589642|NCT02551055|65886145|FG007|Overall Study|Withdrawal by Subject|0|||
23589643|NCT02551055|65886138|FG000|Overall Study|Reason not specified|0|||
23589644|NCT02551055|65886139|FG001|Overall Study|Reason not specified|0|||
23589645|NCT02551055|65886140|FG002|Overall Study|Reason not specified|0|||
23589646|NCT02551055|65886141|FG003|Overall Study|Reason not specified|0|||
23589647|NCT02551055|65886142|FG004|Overall Study|Reason not specified|1|||
23358325|NCT02942277|65056214|FG007|Year 2|Withdrawal by Subject|0|||
23358326|NCT02942277|65056215|FG008|Year 2|Withdrawal by Subject|0|||
23358327|NCT02942277|65056216|FG009|Year 2|Withdrawal by Subject|0|||
23358328|NCT02942277|65056217|FG010|Year 2|Withdrawal by Subject|0|||
23358329|NCT02782377|65056220|FG000|Overall Study|Physician Decision|5|||
23358330|NCT04399538|65056221|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
23358331|NCT04399538|65056222|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
23358332|NCT04399538|65056223|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
23358333|NCT04399538|65056224|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
23358334|NCT04399538|65056225|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
23358335|NCT04399538|65056221|FG000|Double-Blind Treatment|Adverse Event|0|||
23358336|NCT04399538|65056222|FG001|Double-Blind Treatment|Adverse Event|0|||
23358337|NCT04399538|65056223|FG002|Double-Blind Treatment|Adverse Event|0|||
23358338|NCT04399538|65056224|FG003|Double-Blind Treatment|Adverse Event|0|||
23358339|NCT04399538|65056225|FG004|Double-Blind Treatment|Adverse Event|1|||
23358340|NCT04399538|65056221|FG000|Follow-Up|Adverse Event|0|||
23358341|NCT04399538|65056222|FG001|Follow-Up|Adverse Event|0|||
23358342|NCT04399538|65056223|FG002|Follow-Up|Adverse Event|0|||
23358343|NCT04399538|65056224|FG003|Follow-Up|Adverse Event|0|||
23358344|NCT04399538|65056225|FG004|Follow-Up|Adverse Event|1|||
23358345|NCT04399538|65056221|FG000|Follow-Up|Withdrawal by Subject|0|||
23358346|NCT04399538|65056222|FG001|Follow-Up|Withdrawal by Subject|0|||
23358347|NCT04399538|65056223|FG002|Follow-Up|Withdrawal by Subject|0|||
23358348|NCT04399538|65056224|FG003|Follow-Up|Withdrawal by Subject|2|||
23358349|NCT04399538|65056225|FG004|Follow-Up|Withdrawal by Subject|0|||
23358350|NCT02669043|65056233|FG000|Overall Study|Didn't meet I/E criteria|4|||
23358351|NCT00948922|65056236|FG000|Overall Study|Did not start study treatment|2|||
23358352|NCT00948922|65056237|FG001|Overall Study|Did not start study treatment|5|||
23358353|NCT00948922|65056238|FG002|Overall Study|Did not start study treatment|0|||
23358354|NCT00948922|65056236|FG000|Overall Study|Withdrawal by Subject|0|||
23358355|NCT00948922|65056237|FG001|Overall Study|Withdrawal by Subject|2|||
23358356|NCT00948922|65056238|FG002|Overall Study|Withdrawal by Subject|1|||
23358357|NCT00948922|65056236|FG000|Overall Study|Death|3|||
23358358|NCT00948922|65056237|FG001|Overall Study|Death|0|||
23358359|NCT00948922|65056238|FG002|Overall Study|Death|0|||
23358360|NCT00948922|65056236|FG000|Overall Study|Disease progression|0|||
23358361|NCT00948922|65056237|FG001|Overall Study|Disease progression|1|||
23358362|NCT00948922|65056238|FG002|Overall Study|Disease progression|0|||
23358363|NCT00948922|65056236|FG000|Overall Study|Insurance issues|1|||
23358364|NCT00948922|65056237|FG001|Overall Study|Insurance issues|0|||
23358365|NCT00948922|65056238|FG002|Overall Study|Insurance issues|0|||
23358366|NCT00948922|65056236|FG000|Overall Study|Transplant eligibility issues|2|||
23358367|NCT00948922|65056237|FG001|Overall Study|Transplant eligibility issues|3|||
23358368|NCT00948922|65056238|FG002|Overall Study|Transplant eligibility issues|0|||
23358369|NCT00948922|65056236|FG000|Overall Study|Not evaluable at time of analysis|0|||
23358370|NCT00948922|65056237|FG001|Overall Study|Not evaluable at time of analysis|3|||
23358371|NCT00948922|65056238|FG002|Overall Study|Not evaluable at time of analysis|0|||
23358372|NCT00255164|65056239|FG000|Overall Study|Adverse Event|10|||
23358373|NCT00255164|65056240|FG001|Overall Study|Adverse Event|6|||
23589648|NCT02551055|65886143|FG005|Overall Study|Reason not specified|0|||
23589649|NCT02551055|65886144|FG006|Overall Study|Reason not specified|1|||
23589650|NCT02551055|65886145|FG007|Overall Study|Reason not specified|0|||
23589651|NCT01233050|65886147|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
23358374|NCT00255164|65056241|FG002|Overall Study|Adverse Event|9|||
23358375|NCT00255164|65056239|FG000|Overall Study|Lost to Follow-up|4|||
23358376|NCT00255164|65056240|FG001|Overall Study|Lost to Follow-up|3|||
23358377|NCT00255164|65056241|FG002|Overall Study|Lost to Follow-up|4|||
23589652|NCT01233050|65886148|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
23589653|NCT02698891|65886151|FG000|Overall Study|Withdrawal by Subject|2|||
23358378|NCT00255164|65056239|FG000|Overall Study|Withdrawal by Subject|18|||
23358379|NCT00255164|65056240|FG001|Overall Study|Withdrawal by Subject|17|||
23358380|NCT00255164|65056241|FG002|Overall Study|Withdrawal by Subject|8|||
23358381|NCT00255164|65056239|FG000|Overall Study|Noncompliance|0|||
23358382|NCT00255164|65056240|FG001|Overall Study|Noncompliance|1|||
23358383|NCT00255164|65056241|FG002|Overall Study|Noncompliance|2|||
23358384|NCT00255164|65056239|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
23358385|NCT00255164|65056240|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
23358386|NCT00255164|65056241|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
23358387|NCT00255164|65056239|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
23358388|NCT00255164|65056240|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
23358389|NCT00255164|65056241|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
23358390|NCT00255164|65056239|FG000|Overall Study|Possible Barrett's Esophagus|1|||
23358391|NCT00255164|65056240|FG001|Overall Study|Possible Barrett's Esophagus|3|||
23358392|NCT00255164|65056241|FG002|Overall Study|Possible Barrett's Esophagus|8|||
23358393|NCT00255164|65056239|FG000|Overall Study|Esophageal Stricture|0|||
23358394|NCT00255164|65056240|FG001|Overall Study|Esophageal Stricture|0|||
23358395|NCT00255164|65056241|FG002|Overall Study|Esophageal Stricture|1|||
23358396|NCT00255164|65056239|FG000|Overall Study|Therapeutic Failure|11|||
23358397|NCT00255164|65056240|FG001|Overall Study|Therapeutic Failure|2|||
23358398|NCT00255164|65056241|FG002|Overall Study|Therapeutic Failure|3|||
23358399|NCT01670045|65056242|FG000|Overall Study|Withdrawal by Subject|3|||
23358400|NCT01670045|65056242|FG000|Overall Study|Adverse Event|1|||
23358401|NCT01670045|65056242|FG000|Overall Study|Death|1|||
23358402|NCT01670045|65056242|FG000|Overall Study|Lost to Follow-up|11|||
23358403|NCT02113007|65056245|FG000|Overall Study|Progressive disease|2|||
23358404|NCT00645671|65056246|FG000|Overall Study|Protocol Violation|1|||
23358405|NCT00645671|65056247|FG001|Overall Study|Protocol Violation|0|||
23358406|NCT00645671|65056246|FG000|Overall Study|Withdrawal by Subject|0|||
23358407|NCT00645671|65056247|FG001|Overall Study|Withdrawal by Subject|4|||
23358408|NCT00645671|65056246|FG000|Overall Study|Adverse Event|0|||
23475481|NCT00717236|65485422|FG000|Open-Label Period|Loss of Efficacy|6|||
23475482|NCT00717236|65485423|FG001|Open-Label Period|Loss of Efficacy|1|||
23475483|NCT00717236|65485422|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
23475484|NCT00717236|65485423|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
23475485|NCT00717236|65485422|FG000|Open-Label Period|Other: Lack of Compliance|1|||
23475486|NCT00717236|65485423|FG001|Open-Label Period|Other: Lack of Compliance|1|||
23475487|NCT00717236|65485422|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
23475488|NCT00717236|65485423|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
23643078|NCT00993668|66079031|FG000|Single-Blind Period|Lost to Follow-up|3|||
23643079|NCT00993668|66079032|FG001|Single-Blind Period|Lost to Follow-up|1|||
23643080|NCT00993668|66079031|FG000|Open-Label Period|Adverse Event|9|||
23475489|NCT00717236|65485422|FG000|Open-Label Period|Other: Moved|1|||
23589654|NCT02698891|65886151|FG000|Overall Study|deemed ineligible|1|||
23589655|NCT02698891|65886151|FG000|Overall Study|Adverse Event|9|||
23589656|NCT00768664|65886153|FG000|Overall Study|Death|57|||
23589657|NCT00768664|65886153|FG000|Overall Study|Lost to Follow-up|2|||
23589658|NCT00768664|65886153|FG000|Overall Study|Other|9|||
23589659|NCT00768664|65886153|FG000|Overall Study|Participant refused|1|||
23589660|NCT02057692|65886157|FG000|Overall Study|Adverse Event|1|||
23589661|NCT02057692|65886158|FG001|Overall Study|Adverse Event|0|||
23589662|NCT02057692|65886159|FG002|Overall Study|Adverse Event|0|||
23589663|NCT02057692|65886160|FG003|Overall Study|Adverse Event|0|||
23589664|NCT02057692|65886157|FG000|Overall Study|Lost to Follow-up|0|||
23589665|NCT02057692|65886158|FG001|Overall Study|Lost to Follow-up|0|||
23589666|NCT02057692|65886159|FG002|Overall Study|Lost to Follow-up|0|||
23589667|NCT02057692|65886160|FG003|Overall Study|Lost to Follow-up|1|||
23589668|NCT00172185|65886161|FG000|Overall Study|Adverse Event|0|||
23589669|NCT00172185|65886162|FG001|Overall Study|Adverse Event|1|||
23589670|NCT00172185|65886163|FG002|Overall Study|Adverse Event|3|||
23589671|NCT00172185|65886164|FG003|Overall Study|Adverse Event|4|||
23589672|NCT00172185|65886161|FG000|Overall Study|Physician Decision|0|||
23589673|NCT00172185|65886162|FG001|Overall Study|Physician Decision|0|||
23589674|NCT00172185|65886163|FG002|Overall Study|Physician Decision|1|||
23589675|NCT00172185|65886164|FG003|Overall Study|Physician Decision|0|||
23589676|NCT00172185|65886161|FG000|Overall Study|SPONSOR Decision|0|||
23589677|NCT00172185|65886162|FG001|Overall Study|SPONSOR Decision|1|||
23589678|NCT00172185|65886163|FG002|Overall Study|SPONSOR Decision|0|||
23589679|NCT00172185|65886164|FG003|Overall Study|SPONSOR Decision|0|||
23589680|NCT00172185|65886161|FG000|Overall Study|Withdrawal by Subject|0|||
23589681|NCT00172185|65886162|FG001|Overall Study|Withdrawal by Subject|0|||
23589682|NCT00172185|65886163|FG002|Overall Study|Withdrawal by Subject|1|||
23589683|NCT00172185|65886164|FG003|Overall Study|Withdrawal by Subject|0|||
23589684|NCT00842257|65886165|FG000|Overall Study|Adverse Event|1|||
23589685|NCT00383188|65886166|FG000|Overall Study|Adverse Event|4|||
23589686|NCT00383188|65886167|FG001|Overall Study|Adverse Event|7|||
23589687|NCT00383188|65886168|FG002|Overall Study|Adverse Event|9|||
23589688|NCT00383188|65886169|FG003|Overall Study|Adverse Event|8|||
23589689|NCT00383188|65886170|FG004|Overall Study|Adverse Event|8|||
23589690|NCT00383188|65886166|FG000|Overall Study|Lack of Efficacy|9|||
23589691|NCT00383188|65886167|FG001|Overall Study|Lack of Efficacy|3|||
23589692|NCT00383188|65886168|FG002|Overall Study|Lack of Efficacy|3|||
23589693|NCT00383188|65886169|FG003|Overall Study|Lack of Efficacy|2|||
23589694|NCT00383188|65886170|FG004|Overall Study|Lack of Efficacy|6|||
23589695|NCT00383188|65886166|FG000|Overall Study|Other|3|||
23589696|NCT00383188|65886167|FG001|Overall Study|Other|1|||
23589697|NCT00383188|65886168|FG002|Overall Study|Other|0|||
23589698|NCT00383188|65886169|FG003|Overall Study|Other|2|||
23589699|NCT00383188|65886170|FG004|Overall Study|Other|6|||
23589700|NCT00383188|65886166|FG000|Overall Study|No longer willing to participate|1|||
23589701|NCT00383188|65886167|FG001|Overall Study|No longer willing to participate|0|||
23589702|NCT00383188|65886168|FG002|Overall Study|No longer willing to participate|1|||
23589703|NCT00383188|65886169|FG003|Overall Study|No longer willing to participate|0|||
23589704|NCT00383188|65886170|FG004|Overall Study|No longer willing to participate|2|||
23589705|NCT00383188|65886166|FG000|Overall Study|Lost to Follow-up|0|||
23589706|NCT00383188|65886167|FG001|Overall Study|Lost to Follow-up|0|||
23589707|NCT00383188|65886168|FG002|Overall Study|Lost to Follow-up|0|||
23589708|NCT00383188|65886169|FG003|Overall Study|Lost to Follow-up|0|||
23589709|NCT00383188|65886170|FG004|Overall Study|Lost to Follow-up|1|||
23589710|NCT02957539|65886175|FG000|Baseline to Week 16|Lost to Follow-up|8|||
23589711|NCT02957539|65886176|FG001|Baseline to Week 16|Lost to Follow-up|10|||
23643081|NCT00993668|66079032|FG001|Open-Label Period|Adverse Event|8|||
23358409|NCT00645671|65056247|FG001|Overall Study|Adverse Event|1|||
23358410|NCT00645671|65056246|FG000|Overall Study|Physician Decision|0|||
23358411|NCT00645671|65056247|FG001|Overall Study|Physician Decision|1|||
23358412|NCT01134263|65056248|FG000|Overall Study|Serious adverse event|2|||
23358413|NCT01134263|65056249|FG001|Overall Study|Serious adverse event|1|||
23358414|NCT01134263|65056250|FG002|Overall Study|Serious adverse event|1|||
23358415|NCT01134263|65056251|FG003|Overall Study|Serious adverse event|1|||
23358416|NCT01134263|65056252|FG004|Overall Study|Serious adverse event|1|||
23358417|NCT01134263|65056248|FG000|Overall Study|Other adverse event|1|||
23358418|NCT01134263|65056249|FG001|Overall Study|Other adverse event|2|||
23358419|NCT01134263|65056250|FG002|Overall Study|Other adverse event|5|||
23358420|NCT01134263|65056251|FG003|Overall Study|Other adverse event|3|||
23358421|NCT01134263|65056252|FG004|Overall Study|Other adverse event|0|||
23358422|NCT01134263|65056248|FG000|Overall Study|Protocol Violation|8|||
23358423|NCT01134263|65056249|FG001|Overall Study|Protocol Violation|7|||
23358424|NCT01134263|65056250|FG002|Overall Study|Protocol Violation|2|||
23358425|NCT01134263|65056251|FG003|Overall Study|Protocol Violation|4|||
23358426|NCT01134263|65056252|FG004|Overall Study|Protocol Violation|2|||
23358427|NCT01134263|65056248|FG000|Overall Study|Lost to Follow-up|4|||
23358428|NCT01134263|65056249|FG001|Overall Study|Lost to Follow-up|3|||
23358429|NCT01134263|65056250|FG002|Overall Study|Lost to Follow-up|5|||
23358430|NCT01134263|65056251|FG003|Overall Study|Lost to Follow-up|3|||
23358431|NCT01134263|65056252|FG004|Overall Study|Lost to Follow-up|1|||
23358432|NCT01134263|65056248|FG000|Overall Study|Withdrawal by Subject|8|||
23358433|NCT01134263|65056249|FG001|Overall Study|Withdrawal by Subject|6|||
23358434|NCT01134263|65056250|FG002|Overall Study|Withdrawal by Subject|16|||
23358435|NCT01134263|65056251|FG003|Overall Study|Withdrawal by Subject|7|||
23358436|NCT01134263|65056252|FG004|Overall Study|Withdrawal by Subject|5|||
23358437|NCT01134263|65056248|FG000|Overall Study|Enrolled, but not treated|1|||
23358438|NCT01134263|65056249|FG001|Overall Study|Enrolled, but not treated|1|||
23358439|NCT01134263|65056250|FG002|Overall Study|Enrolled, but not treated|0|||
23358440|NCT01134263|65056251|FG003|Overall Study|Enrolled, but not treated|1|||
23358441|NCT01134263|65056252|FG004|Overall Study|Enrolled, but not treated|0|||
23358442|NCT01471444|65056253|FG000|Overall Study|Physician Decision|3|||
23358443|NCT01471444|65056254|FG001|Overall Study|Physician Decision|2|||
23358444|NCT01471444|65056253|FG000|Overall Study|Withdrawal by Subject|0|||
23358445|NCT01471444|65056254|FG001|Overall Study|Withdrawal by Subject|1|||
23358446|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
23358447|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
23358448|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
23358449|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
23358450|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
23358451|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
23358452|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
23358453|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
23358454|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
23358455|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
23358456|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Personal reason|1|||
23358457|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Personal reason|1|||
23358458|NCT01765569|65056258|FG000|Period B|Withdrawal by Subject|1|||
23358459|NCT01765569|65056258|FG000|Period C|Death|1|||
23358460|NCT00314808|65056263|FG000|Overall Study|Disease Progression without AE|4|||
23358461|NCT00314808|65056263|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
23358462|NCT01859949|65056265|FG000|Overall Study|Family Matters|0|||
23358463|NCT01859949|65056266|FG001|Overall Study|Family Matters|1|||
23358464|NCT01859949|65056265|FG000|Overall Study|Physician Decision|2|||
23358465|NCT01859949|65056266|FG001|Overall Study|Physician Decision|4|||
23358466|NCT01859949|65056265|FG000|Overall Study|Withdrawal by Subject|11|||
23358467|NCT01859949|65056266|FG001|Overall Study|Withdrawal by Subject|10|||
23358468|NCT01859949|65056265|FG000|Overall Study|Protocol Violation|1|||
23358469|NCT01859949|65056266|FG001|Overall Study|Protocol Violation|1|||
23358470|NCT01859949|65056265|FG000|Overall Study|Adverse Event|0|||
23358471|NCT01859949|65056266|FG001|Overall Study|Adverse Event|1|||
23358472|NCT03060291|65056267|FG000|3-month Follow-up|Declined to respond|8|||
23358473|NCT03060291|65056268|FG001|3-month Follow-up|Declined to respond|10|||
23358474|NCT03060291|65056269|FG002|3-month Follow-up|Declined to respond|2|||
23358475|NCT03060291|65056267|FG000|6-month Follow-up|Declined to respond|7|||
23358476|NCT03060291|65056268|FG001|6-month Follow-up|Declined to respond|13|||
23358477|NCT03060291|65056269|FG002|6-month Follow-up|Declined to respond|4|||
23358478|NCT03060291|65056267|FG000|12-month Follow-up|Declined to respond|7|||
23358479|NCT03060291|65056268|FG001|12-month Follow-up|Declined to respond|16|||
23358480|NCT03060291|65056269|FG002|12-month Follow-up|Declined to respond|6|||
23358481|NCT00978341|65056270|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
23358482|NCT00978341|65056271|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
23358483|NCT00187278|65056280|FG000|Overall Study|Protocol Violation|10|||
23358484|NCT00187278|65056281|FG001|Overall Study|Protocol Violation|13|||
23358485|NCT02906579|65056282|FG000|Overall Study|Adverse Event|1|||
23358486|NCT02906579|65056282|FG000|Overall Study|Physician Decision|1|||
23358487|NCT02168777|65056283|FG000|Overall Study|Withdrawal by Subject|1|||
23358488|NCT02168777|65056284|FG001|Overall Study|Withdrawal by Subject|0|||
23358489|NCT02168777|65056285|FG002|Overall Study|Withdrawal by Subject|2|||
23358490|NCT02168777|65056283|FG000|Overall Study|Adverse Event|1|||
23358491|NCT02168777|65056284|FG001|Overall Study|Adverse Event|0|||
23358492|NCT02168777|65056285|FG002|Overall Study|Adverse Event|1|||
23358493|NCT02168777|65056283|FG000|Overall Study|Disease recurrence|0|||
23358494|NCT02168777|65056284|FG001|Overall Study|Disease recurrence|0|||
23358495|NCT02168777|65056285|FG002|Overall Study|Disease recurrence|1|||
23358496|NCT02168777|65056283|FG000|Overall Study|Radiological disease progression|0|||
23358497|NCT02168777|65056284|FG001|Overall Study|Radiological disease progression|5|||
23358498|NCT02168777|65056285|FG002|Overall Study|Radiological disease progression|5|||
23358499|NCT02168777|65056283|FG000|Overall Study|Clinical disease progression|0|||
23358500|NCT02168777|65056284|FG001|Overall Study|Clinical disease progression|1|||
23358501|NCT02168777|65056285|FG002|Overall Study|Clinical disease progression|2|||
23358502|NCT02168777|65056283|FG000|Overall Study|Other reason|0|||
23358503|NCT02168777|65056284|FG001|Overall Study|Other reason|1|||
23358504|NCT02168777|65056285|FG002|Overall Study|Other reason|0|||
23358505|NCT01548768|65056286|FG000|Overall Study|Withdrawal by Subject|0|||
23358506|NCT01548768|65056287|FG001|Overall Study|Withdrawal by Subject|2|||
23358507|NCT01548768|65056288|FG002|Overall Study|Withdrawal by Subject|1|||
23358508|NCT01548768|65056289|FG003|Overall Study|Withdrawal by Subject|0|||
23358509|NCT01548768|65056286|FG000|Overall Study|Physician Decision|1|||
23358510|NCT01548768|65056287|FG001|Overall Study|Physician Decision|0|||
23358511|NCT01548768|65056288|FG002|Overall Study|Physician Decision|0|||
23358512|NCT01548768|65056289|FG003|Overall Study|Physician Decision|0|||
23358513|NCT01548768|65056286|FG000|Overall Study|Adverse Event|0|||
23358514|NCT01548768|65056287|FG001|Overall Study|Adverse Event|0|||
23358515|NCT01548768|65056288|FG002|Overall Study|Adverse Event|0|||
23358516|NCT01548768|65056289|FG003|Overall Study|Adverse Event|1|||
23358517|NCT01548768|65056286|FG000|Overall Study|Non-Compliance|0|||
23358518|NCT01548768|65056287|FG001|Overall Study|Non-Compliance|0|||
23358519|NCT01548768|65056288|FG002|Overall Study|Non-Compliance|0|||
23358520|NCT01548768|65056289|FG003|Overall Study|Non-Compliance|3|||
23358521|NCT00694356|65056297|FG000|Overall Study|Adverse Event|1|||
23358522|NCT00694356|65056298|FG001|Overall Study|Adverse Event|0|||
23358523|NCT00694356|65056299|FG002|Overall Study|Adverse Event|0|||
23358524|NCT00694356|65056297|FG000|Overall Study|Progressive Disease|2|||
23358525|NCT00694356|65056298|FG001|Overall Study|Progressive Disease|6|||
23358526|NCT00694356|65056299|FG002|Overall Study|Progressive Disease|6|||
23358527|NCT03743025|65056300|FG000|Overall Study|Surgery was cancelled|2|||
23358528|NCT03743025|65056301|FG001|Overall Study|Surgery was cancelled|1|||
23358529|NCT03148067|65056308|FG000|Overall Study|Lost to Follow-up|3|||
23358530|NCT03148067|65056308|FG000|Overall Study|Death|1|||
23358531|NCT00759655|65056316|FG000|Overall Study|Termination of the study by sponsor|1|||
23358532|NCT00003896|65056319|FG000|Overall Study|Adverse Event|16|||
23358533|NCT00003896|65056319|FG000|Overall Study|Withdrawal by Subject|1|||
23358534|NCT00003896|65056319|FG000|Overall Study|Lack of Efficacy|1|||
23358535|NCT00003896|65056319|FG000|Overall Study|Death|3|||
23358536|NCT00003896|65056319|FG000|Overall Study|not protocol specified|3|||
23358537|NCT00003896|65056319|FG000|Overall Study|ineligible|5|||
23358538|NCT01066663|65056320|FG000|Overall Study|Adverse Event|0|||
23358539|NCT01066663|65056321|FG001|Overall Study|Adverse Event|0|||
23358540|NCT01066663|65056322|FG002|Overall Study|Adverse Event|1|||
23358541|NCT00662311|65056323|FG000|Overall Study|Respiratory Infection|1|||
23358542|NCT00662311|65056324|FG001|Overall Study|Respiratory Infection|0|||
23358543|NCT00662311|65056325|FG002|Overall Study|Respiratory Infection|0|||
23358544|NCT03373760|65056328|FG000|Overall Study|Adverse Event|8|||
23358545|NCT03373760|65056328|FG000|Overall Study|Disease Progression|46|||
23358546|NCT03373760|65056328|FG000|Overall Study|Death|4|||
23358547|NCT01189461|65056329|FG000|Overall Study|Lack of Efficacy|13|||
23589712|NCT02957539|65886177|FG002|Baseline to Week 16|Lost to Follow-up|16|||
23589713|NCT02957539|65886175|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
23589714|NCT02957539|65886176|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
23589715|NCT02957539|65886177|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
23589716|NCT02957539|65886175|FG000|Week 16 to 32|Withdrawal by Subject|3|||
23589717|NCT02957539|65886176|FG001|Week 16 to 32|Withdrawal by Subject|3|||
23589718|NCT02957539|65886177|FG002|Week 16 to 32|Withdrawal by Subject|1|||
23589719|NCT02957539|65886175|FG000|Week 16 to 32|Lost to Follow-up|8|||
23589720|NCT02957539|65886176|FG001|Week 16 to 32|Lost to Follow-up|7|||
23358548|NCT01189461|65056329|FG000|Overall Study|Lost to Follow-up|1|||
23589721|NCT02957539|65886177|FG002|Week 16 to 32|Lost to Follow-up|5|||
23358549|NCT01189461|65056329|FG000|Overall Study|Withdrawal by Subject|6|||
23358550|NCT01189461|65056329|FG000|Overall Study|Protocol Violation|1|||
23358551|NCT01189461|65056329|FG000|Overall Study|Adverse Event|2|||
23358552|NCT01189461|65056329|FG000|Overall Study|Did not meet entrance criteria|3|||
23358553|NCT01189461|65056329|FG000|Overall Study|Other|8|||
23358554|NCT00199849|65056330|FG000|Overall Study|Unrelated illness or complication|0|||
23358555|NCT00199849|65056331|FG001|Overall Study|Unrelated illness or complication|1|||
23358556|NCT00199849|65056332|FG002|Overall Study|Unrelated illness or complication|0|||
23643082|NCT00993668|66079031|FG000|Open-Label Period|Lack of Efficacy|4|||
23643083|NCT00993668|66079032|FG001|Open-Label Period|Lack of Efficacy|3|||
23643084|NCT00993668|66079031|FG000|Open-Label Period|Withdrawal by Subject|4|||
23358557|NCT00199849|65056330|FG000|Overall Study|Progressive disease requiring intervention|0|||
23358558|NCT00199849|65056331|FG001|Overall Study|Progressive disease requiring intervention|0|||
23358559|NCT00199849|65056332|FG002|Overall Study|Progressive disease requiring intervention|1|||
23358560|NCT00199849|65056330|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
23358561|NCT00199849|65056331|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
23358562|NCT00199849|65056332|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
23358563|NCT00329745|65056333|FG000|Overall Study|Protocol Violation|1|||
23358564|NCT00329745|65056334|FG001|Overall Study|Protocol Violation|0|||
23358565|NCT00329745|65056333|FG000|Overall Study|Withdrawal by Subject|0|||
23358566|NCT00329745|65056334|FG001|Overall Study|Withdrawal by Subject|1|||
23358567|NCT00329745|65056333|FG000|Overall Study|Lost to Follow-up|86|||
23358568|NCT00329745|65056334|FG001|Overall Study|Lost to Follow-up|101|||
23358569|NCT03253744|65056335|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
23358570|NCT03253744|65056336|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
23358571|NCT03253744|65056337|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
23358572|NCT03253744|65056338|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
23358573|NCT00582426|65056340|FG000|Overall Study|Lost to Follow-up|0|||
23475490|NCT00717236|65485423|FG001|Open-Label Period|Other: Moved|0|||
23358574|NCT00582426|65056341|FG001|Overall Study|Lost to Follow-up|2|||
23358575|NCT00582426|65056340|FG000|Overall Study|Adverse Event|4|||
23358576|NCT00582426|65056341|FG001|Overall Study|Adverse Event|2|||
23358577|NCT00582426|65056340|FG000|Overall Study|Protocol Violation|6|||
23358578|NCT00582426|65056341|FG001|Overall Study|Protocol Violation|2|||
23358579|NCT00582426|65056340|FG000|Overall Study|Death|4|||
23358580|NCT00582426|65056341|FG001|Overall Study|Death|3|||
23358581|NCT00582426|65056340|FG000|Overall Study|Withdrawal by Subject|3|||
23358582|NCT00582426|65056341|FG001|Overall Study|Withdrawal by Subject|2|||
23358583|NCT00582426|65056340|FG000|Overall Study|Disease Progression|2|||
23358584|NCT00582426|65056341|FG001|Overall Study|Disease Progression|2|||
23358585|NCT00582426|65056340|FG000|Overall Study|Use of illicit drugs|1|||
23358586|NCT00582426|65056341|FG001|Overall Study|Use of illicit drugs|0|||
23358587|NCT03042910|65056343|FG000|Overall Study|Adverse Event|1|||
23358588|NCT03042910|65056343|FG000|Overall Study|Disease Progression|2|||
23358589|NCT03042910|65056343|FG000|Overall Study|Withdrawal by Subject|3|||
23797630|NCT04980456|66636812|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
23797631|NCT04980456|66636813|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
23797632|NCT04980456|66636812|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
23797633|NCT04980456|66636813|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
23797634|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23797635|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
23797636|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23797637|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23797638|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23797639|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23797640|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
23358590|NCT03042910|65056343|FG000|Overall Study|Enrolled but not treated|1|||
23358591|NCT04304508|65056344|FG000|Overall Study|Subject Decision|29|||
23358592|NCT04304508|65056345|FG001|Overall Study|Subject Decision|39|||
23358593|NCT04304508|65056346|FG002|Overall Study|Subject Decision|37|||
23475491|NCT00717236|65485422|FG000|Open-Label Period|Other: Investigator Decision|1|||
23589722|NCT02957539|65886175|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
23589723|NCT02957539|65886176|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
23589724|NCT02957539|65886177|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
23589725|NCT02957539|65886175|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
23589726|NCT02957539|65886176|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
23589727|NCT02957539|65886177|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
23589728|NCT00972504|65886182|FG000|Overall Study|Adverse Event|2|||
23589729|NCT00972504|65886182|FG000|Overall Study|Investigator discretion|1|||
23589730|NCT02299635|65886183|FG000|Overall Study|Adverse Event|2|||
23797641|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23797642|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
23358594|NCT04304508|65056347|FG003|Overall Study|Subject Decision|48|||
23589731|NCT02299635|65886183|FG000|Overall Study|Death|1|||
23797643|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23797644|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23358595|NCT04304508|65056344|FG000|Overall Study|Death|6|||
23358596|NCT04304508|65056345|FG001|Overall Study|Death|1|||
23797645|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23358597|NCT04304508|65056346|FG002|Overall Study|Death|8|||
23358598|NCT04304508|65056347|FG003|Overall Study|Death|5|||
23358599|NCT04304508|65056344|FG000|Overall Study|Non-compliance With Study Drug|3|||
23358600|NCT04304508|65056345|FG001|Overall Study|Non-compliance With Study Drug|1|||
23358601|NCT04304508|65056346|FG002|Overall Study|Non-compliance With Study Drug|2|||
23358602|NCT04304508|65056347|FG003|Overall Study|Non-compliance With Study Drug|0|||
23358603|NCT04304508|65056344|FG000|Overall Study|Switching To Other Therapy|1|||
23358604|NCT04304508|65056345|FG001|Overall Study|Switching To Other Therapy|1|||
23358605|NCT04304508|65056346|FG002|Overall Study|Switching To Other Therapy|1|||
23358606|NCT04304508|65056347|FG003|Overall Study|Switching To Other Therapy|2|||
23358607|NCT04304508|65056344|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
23358608|NCT04304508|65056345|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
23358609|NCT04304508|65056346|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
23358610|NCT04304508|65056347|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
23358611|NCT04304508|65056344|FG000|Overall Study|Withdrawal by Subject|7|||
23358612|NCT04304508|65056345|FG001|Overall Study|Withdrawal by Subject|5|||
23358613|NCT04304508|65056346|FG002|Overall Study|Withdrawal by Subject|11|||
23358614|NCT04304508|65056347|FG003|Overall Study|Withdrawal by Subject|6|||
23358615|NCT04304508|65056344|FG000|Overall Study|Logistical Difficulties|2|||
23643085|NCT00993668|66079032|FG001|Open-Label Period|Withdrawal by Subject|3|||
23643086|NCT00993668|66079031|FG000|Open-Label Period|Lost to Follow-up|6|||
23643087|NCT00993668|66079032|FG001|Open-Label Period|Lost to Follow-up|1|||
23643088|NCT03702231|66079033|FG000|Overall Study|Withdrawal by Subject|1|||
23643089|NCT03702231|66079034|FG001|Overall Study|Withdrawal by Subject|0|||
23643090|NCT03702231|66079035|FG002|Overall Study|Withdrawal by Subject|0|||
23643091|NCT03702231|66079033|FG000|Overall Study|Protocol Violation|0|||
23643092|NCT03702231|66079034|FG001|Overall Study|Protocol Violation|0|||
23358616|NCT04304508|65056345|FG001|Overall Study|Logistical Difficulties|2|||
23358617|NCT04304508|65056346|FG002|Overall Study|Logistical Difficulties|3|||
23358618|NCT04304508|65056347|FG003|Overall Study|Logistical Difficulties|2|||
23358619|NCT04304508|65056344|FG000|Overall Study|Missing Information|1|||
23358620|NCT04304508|65056345|FG001|Overall Study|Missing Information|2|||
23358621|NCT04304508|65056346|FG002|Overall Study|Missing Information|1|||
23358622|NCT04304508|65056347|FG003|Overall Study|Missing Information|3|||
23358623|NCT04304508|65056344|FG000|Overall Study|Other|7|||
23358624|NCT04304508|65056345|FG001|Overall Study|Other|6|||
23358625|NCT04304508|65056346|FG002|Overall Study|Other|5|||
23358626|NCT04304508|65056347|FG003|Overall Study|Other|4|||
23358627|NCT04304508|65056344|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
23643093|NCT03702231|66079035|FG002|Overall Study|Protocol Violation|1|||
23643094|NCT03702231|66079033|FG000|Overall Study|Change in CLL Treatment|0|||
23643095|NCT03702231|66079034|FG001|Overall Study|Change in CLL Treatment|0|||
23643096|NCT03702231|66079035|FG002|Overall Study|Change in CLL Treatment|1|||
23643097|NCT03702231|66079033|FG000|Overall Study|COVID Pandemic|1|||
23643098|NCT03702231|66079034|FG001|Overall Study|COVID Pandemic|4|||
23643099|NCT03702231|66079035|FG002|Overall Study|COVID Pandemic|1|||
23643100|NCT03702231|66079033|FG000|Overall Study|Non-compliance|0|||
23643101|NCT03702231|66079034|FG001|Overall Study|Non-compliance|0|||
23643102|NCT03702231|66079035|FG002|Overall Study|Non-compliance|1|||
23643103|NCT04971681|66079036|FG000|Followup|Lost to Follow-up|1|||
23797646|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Death|0|||
23358628|NCT04304508|65056345|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358629|NCT04304508|65056346|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358630|NCT04304508|65056347|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358631|NCT04304508|65056344|FG000|Overall Study|Physician Decision|3|||
23358632|NCT04304508|65056345|FG001|Overall Study|Physician Decision|4|||
23358633|NCT04304508|65056346|FG002|Overall Study|Physician Decision|9|||
23358634|NCT04304508|65056347|FG003|Overall Study|Physician Decision|7|||
23358635|NCT04304508|65056344|FG000|Overall Study|Study drug never administered|10|||
23358636|NCT04304508|65056345|FG001|Overall Study|Study drug never administered|4|||
23358637|NCT04304508|65056346|FG002|Overall Study|Study drug never administered|4|||
23358638|NCT04304508|65056347|FG003|Overall Study|Study drug never administered|4|||
23358639|NCT04304508|65056344|FG000|Overall Study|Adverse Event|49|||
23643104|NCT04971681|66079037|FG001|Followup|Lost to Follow-up|0|||
23643105|NCT02075073|66079038|FG000|Overall Study|Withdrawal by Subject|0|||
23643106|NCT02075073|66079039|FG001|Overall Study|Withdrawal by Subject|1|||
23797647|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Death|1|||
23797648|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Death|0|||
23797649|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Death|0|||
23475492|NCT00717236|65485423|FG001|Open-Label Period|Other: Investigator Decision|0|||
23475493|NCT00717236|65485422|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
23475494|NCT00717236|65485423|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
23475495|NCT00717236|65485422|FG000|Open-Label Period|Other: Sponsor Request|3|||
23475496|NCT00717236|65485423|FG001|Open-Label Period|Other: Sponsor Request|0|||
23475497|NCT00717236|65485422|FG000|Open-Label Period|Other: Cataract Surgery|1|||
23475498|NCT00717236|65485423|FG001|Open-Label Period|Other: Cataract Surgery|0|||
23475499|NCT00717236|65485422|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
23475500|NCT00717236|65485423|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
23475501|NCT00717236|65485422|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
23475502|NCT00717236|65485423|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
23475503|NCT00717236|65485422|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
23475504|NCT00717236|65485423|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
23475505|NCT03642132|65485424|FG000|Chemotherapy Period|Adverse Event|1|||
23475506|NCT03642132|65485425|FG001|Chemotherapy Period|Adverse Event|1|||
23475507|NCT03642132|65485426|FG002|Chemotherapy Period|Adverse Event|0|||
23475508|NCT03642132|65485424|FG000|Chemotherapy Period|Physician's decision|4|||
23475509|NCT03642132|65485425|FG001|Chemotherapy Period|Physician's decision|1|||
23475510|NCT03642132|65485426|FG002|Chemotherapy Period|Physician's decision|0|||
23475511|NCT03642132|65485424|FG000|Chemotherapy Period|Progressive disease|0|||
23475512|NCT03642132|65485425|FG001|Chemotherapy Period|Progressive disease|0|||
23475513|NCT03642132|65485426|FG002|Chemotherapy Period|Progressive disease|1|||
23475514|NCT03642132|65485424|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
23643107|NCT02075073|66079040|FG002|Overall Study|Withdrawal by Subject|0|||
23643108|NCT03309813|66079041|FG000|Main Randomized Study|Withdrawal by Subject|1|||
23643109|NCT03309813|66079042|FG001|Main Randomized Study|Withdrawal by Subject|0|||
23643110|NCT02317432|66079043|FG000|Overall Study|Death|4|||
23643111|NCT02317432|66079044|FG001|Overall Study|Death|1|||
23643112|NCT02317432|66079043|FG000|Overall Study|Lost to Follow-up|0|||
23643113|NCT02317432|66079044|FG001|Overall Study|Lost to Follow-up|5|||
23643114|NCT02317432|66079043|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
23643115|NCT02317432|66079044|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
23643116|NCT01656733|66079045|FG000|Overall Study|No permission to collect birth outcomes|0|||
23643117|NCT01656733|66079046|FG001|Overall Study|No permission to collect birth outcomes|1|||
23643118|NCT01656733|66079045|FG000|Overall Study|Delivery at another hospital|0|||
23643119|NCT01656733|66079046|FG001|Overall Study|Delivery at another hospital|2|||
23643120|NCT01656733|66079045|FG000|Overall Study|Spontaneous abortion|0|||
23643121|NCT01656733|66079046|FG001|Overall Study|Spontaneous abortion|1|||
23643122|NCT00185965|66079047|FG000|Overall Study|Adverse Event|0|||
23643123|NCT00185965|66079048|FG001|Overall Study|Adverse Event|1|||
23643124|NCT04410523|66079049|FG000|Overall Study|Study terminated by sponsor|1|||
23643125|NCT04410523|66079050|FG001|Overall Study|Study terminated by sponsor|3|||
23643126|NCT04410523|66079051|FG002|Overall Study|Study terminated by sponsor|2|||
23643127|NCT04410523|66079052|FG003|Overall Study|Study terminated by sponsor|6|||
23643128|NCT04410523|66079053|FG004|Overall Study|Study terminated by sponsor|3|||
23643129|NCT04410523|66079054|FG005|Overall Study|Study terminated by sponsor|4|||
23643130|NCT04410523|66079049|FG000|Overall Study|Adverse Event|1|||
23643131|NCT04410523|66079050|FG001|Overall Study|Adverse Event|0|||
23643132|NCT04410523|66079051|FG002|Overall Study|Adverse Event|0|||
23643133|NCT04410523|66079052|FG003|Overall Study|Adverse Event|0|||
23643134|NCT04410523|66079053|FG004|Overall Study|Adverse Event|0|||
23643135|NCT04410523|66079054|FG005|Overall Study|Adverse Event|2|||
23643136|NCT04410523|66079049|FG000|Overall Study|Lost to Follow-up|0|||
23643137|NCT04410523|66079050|FG001|Overall Study|Lost to Follow-up|1|||
23643138|NCT04410523|66079051|FG002|Overall Study|Lost to Follow-up|0|||
23643139|NCT04410523|66079052|FG003|Overall Study|Lost to Follow-up|0|||
23643140|NCT04410523|66079053|FG004|Overall Study|Lost to Follow-up|0|||
23643141|NCT04410523|66079054|FG005|Overall Study|Lost to Follow-up|0|||
23643142|NCT04410523|66079049|FG000|Overall Study|Physician Decision|0|||
23475515|NCT03642132|65485425|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
23475516|NCT03642132|65485426|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
23475517|NCT03642132|65485424|FG000|Chemotherapy Period|Other|1|||
23475518|NCT03642132|65485425|FG001|Chemotherapy Period|Other|0|||
23475519|NCT03642132|65485426|FG002|Chemotherapy Period|Other|2|||
23643143|NCT04410523|66079050|FG001|Overall Study|Physician Decision|1|||
23643144|NCT04410523|66079051|FG002|Overall Study|Physician Decision|0|||
23643145|NCT04410523|66079052|FG003|Overall Study|Physician Decision|0|||
23643146|NCT04410523|66079053|FG004|Overall Study|Physician Decision|0|||
23643147|NCT04410523|66079054|FG005|Overall Study|Physician Decision|0|||
23643148|NCT04410523|66079049|FG000|Overall Study|Pregnancy|0|||
23643149|NCT04410523|66079050|FG001|Overall Study|Pregnancy|0|||
23643150|NCT04410523|66079051|FG002|Overall Study|Pregnancy|0|||
23643151|NCT04410523|66079052|FG003|Overall Study|Pregnancy|0|||
23475520|NCT03642132|65485424|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
23475521|NCT03642132|65485425|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
23475522|NCT03642132|65485426|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
23475523|NCT03642132|65485424|FG000|Maintenance Period|Adverse Event|1|||
23475524|NCT03642132|65485425|FG001|Maintenance Period|Adverse Event|2|||
23475525|NCT03642132|65485426|FG002|Maintenance Period|Adverse Event|0|||
23475526|NCT03642132|65485424|FG000|Maintenance Period|Non-compliance with study drug|0|||
23475527|NCT03642132|65485425|FG001|Maintenance Period|Non-compliance with study drug|0|||
23475528|NCT03642132|65485426|FG002|Maintenance Period|Non-compliance with study drug|1|||
23475529|NCT03642132|65485424|FG000|Maintenance Period|Physician's decision|2|||
23475530|NCT03642132|65485425|FG001|Maintenance Period|Physician's decision|2|||
23475531|NCT03642132|65485426|FG002|Maintenance Period|Physician's decision|2|||
23475532|NCT03642132|65485424|FG000|Maintenance Period|Progressive disease|9|||
23475533|NCT03642132|65485425|FG001|Maintenance Period|Progressive disease|3|||
23475534|NCT03642132|65485426|FG002|Maintenance Period|Progressive disease|6|||
23475535|NCT03642132|65485424|FG000|Maintenance Period|Other|0|||
23475536|NCT03642132|65485425|FG001|Maintenance Period|Other|0|||
23475537|NCT03642132|65485426|FG002|Maintenance Period|Other|3|||
23475538|NCT03642132|65485424|FG000|Maintenance Period|Withdrawal by Subject|1|||
23475539|NCT03642132|65485425|FG001|Maintenance Period|Withdrawal by Subject|1|||
23475540|NCT03642132|65485426|FG002|Maintenance Period|Withdrawal by Subject|2|||
23475541|NCT03642132|65485424|FG000|Follow-up Period|Other|0|||
23475542|NCT03642132|65485425|FG001|Follow-up Period|Other|0|||
23475543|NCT03642132|65485426|FG002|Follow-up Period|Other|1|||
23475544|NCT03642132|65485424|FG000|Follow-up Period|Withdrawal by Subject|1|||
23475545|NCT03642132|65485425|FG001|Follow-up Period|Withdrawal by Subject|2|||
23475546|NCT03642132|65485426|FG002|Follow-up Period|Withdrawal by Subject|0|||
23475547|NCT03642132|65485424|FG000|Follow-up Period|Study terminated by sponsor|1|||
23475548|NCT03642132|65485425|FG001|Follow-up Period|Study terminated by sponsor|0|||
23475549|NCT03642132|65485426|FG002|Follow-up Period|Study terminated by sponsor|1|||
23475550|NCT03642132|65485424|FG000|Follow-up Period|Lack of Efficacy|1|||
23475551|NCT03642132|65485425|FG001|Follow-up Period|Lack of Efficacy|0|||
23475552|NCT03642132|65485426|FG002|Follow-up Period|Lack of Efficacy|0|||
23475553|NCT03642132|65485424|FG000|Follow-up Period|Death|1|||
23475554|NCT03642132|65485425|FG001|Follow-up Period|Death|0|||
23475555|NCT03642132|65485426|FG002|Follow-up Period|Death|2|||
23475556|NCT03642132|65485424|FG000|Follow-up Period|Adverse Event|1|||
23475557|NCT03642132|65485425|FG001|Follow-up Period|Adverse Event|0|||
23475558|NCT03642132|65485426|FG002|Follow-up Period|Adverse Event|0|||
23475559|NCT02410343|65485427|FG000|Core Period (24 Weeks)|Adverse Event|1|||
23475560|NCT02410343|65485428|FG001|Core Period (24 Weeks)|Adverse Event|0|||
23475561|NCT02410343|65485427|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
23475562|NCT02410343|65485428|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
23475563|NCT02410343|65485427|FG000|Extension Period (12 Months)|Adverse Event|1|||
23475564|NCT02410343|65485428|FG001|Extension Period (12 Months)|Adverse Event|0|||
23475565|NCT02410343|65485427|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
23475566|NCT02410343|65485428|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
23475567|NCT02576145|65485429|FG000|Overall Study|Adverse Event|1|||
23475568|NCT02576145|65485430|FG001|Overall Study|Adverse Event|0|||
23475569|NCT02576145|65485429|FG000|Overall Study|Withdrawal by Subject|1|||
23475570|NCT02576145|65485430|FG001|Overall Study|Withdrawal by Subject|0|||
23475571|NCT02576145|65485429|FG000|Overall Study|Acute rejection|1|||
23475572|NCT02576145|65485430|FG001|Overall Study|Acute rejection|0|||
23475573|NCT02576145|65485429|FG000|Overall Study|Tetanus Titers Decreased|0|||
23475574|NCT02576145|65485430|FG001|Overall Study|Tetanus Titers Decreased|1|||
23475575|NCT03148691|65485431|FG000|Overall Study|Protocol Violation|1|||
23475576|NCT03148691|65485432|FG001|Overall Study|Protocol Violation|2|||
23475577|NCT03148691|65485433|FG002|Overall Study|Protocol Violation|7|||
23475578|NCT03148691|65485431|FG000|Overall Study|Lost to Follow-up|0|||
23475579|NCT03148691|65485432|FG001|Overall Study|Lost to Follow-up|0|||
23475580|NCT03148691|65485433|FG002|Overall Study|Lost to Follow-up|1|||
23475581|NCT03148691|65485431|FG000|Overall Study|Other|1|||
23475582|NCT03148691|65485432|FG001|Overall Study|Other|0|||
23475583|NCT03148691|65485433|FG002|Overall Study|Other|0|||
23643152|NCT04410523|66079053|FG004|Overall Study|Pregnancy|0|||
23643153|NCT04410523|66079054|FG005|Overall Study|Pregnancy|1|||
23643154|NCT04410523|66079049|FG000|Overall Study|Protocol deviation|0|||
23643155|NCT04410523|66079050|FG001|Overall Study|Protocol deviation|0|||
23643156|NCT04410523|66079051|FG002|Overall Study|Protocol deviation|0|||
23475584|NCT03148691|65485431|FG000|Overall Study|Withdrawal by Subject|1|||
23475585|NCT03148691|65485432|FG001|Overall Study|Withdrawal by Subject|0|||
23475586|NCT03148691|65485433|FG002|Overall Study|Withdrawal by Subject|0|||
23475587|NCT00294762|65485443|FG000|Overall Study|Did not receive study treatment|3|||
23475588|NCT00294762|65485444|FG001|Overall Study|Did not receive study treatment|3|||
23475589|NCT00668733|65485448|FG000|Overall Study|Lost to Follow-up|2|||
23475590|NCT00668733|65485449|FG001|Overall Study|Lost to Follow-up|3|||
23643157|NCT04410523|66079052|FG003|Overall Study|Protocol deviation|0|||
23475591|NCT00668733|65485448|FG000|Overall Study|Withdrawal by Subject|0|||
23475592|NCT00668733|65485449|FG001|Overall Study|Withdrawal by Subject|4|||
23475593|NCT01256294|65485453|FG000|Overall Study|Adverse Event|1|||
23475594|NCT01256294|65485454|FG001|Overall Study|Adverse Event|0|||
23475595|NCT01256294|65485453|FG000|Overall Study|Withdrawal by Subject|1|||
23643158|NCT04410523|66079053|FG004|Overall Study|Protocol deviation|0|||
23643159|NCT04410523|66079054|FG005|Overall Study|Protocol deviation|2|||
23643160|NCT04410523|66079049|FG000|Overall Study|Subject decision|2|||
23797650|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
23797651|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
23797652|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
23643161|NCT04410523|66079050|FG001|Overall Study|Subject decision|0|||
23643162|NCT04410523|66079051|FG002|Overall Study|Subject decision|0|||
23643163|NCT04410523|66079052|FG003|Overall Study|Subject decision|1|||
23643164|NCT04410523|66079053|FG004|Overall Study|Subject decision|0|||
23643165|NCT04410523|66079054|FG005|Overall Study|Subject decision|1|||
23643166|NCT03459443|66079055|FG000|Overall Study|Lack of Efficacy|3|||
23643167|NCT03459443|66079055|FG000|Overall Study|Adverse Event|1|||
23643168|NCT03459443|66079055|FG000|Overall Study|Sponsor's decision to close the study|18|||
23643169|NCT03207451|66079056|FG000|Overall Study|scheduling conflict|1|||
23643170|NCT03207451|66079057|FG001|Overall Study|scheduling conflict|0|||
23643171|NCT03207451|66079058|FG002|Overall Study|scheduling conflict|2|||
23643172|NCT03207451|66079059|FG003|Overall Study|scheduling conflict|2|||
23643173|NCT03207451|66079056|FG000|Overall Study|Adverse Event|0|||
23643174|NCT03207451|66079057|FG001|Overall Study|Adverse Event|0|||
23643175|NCT03207451|66079058|FG002|Overall Study|Adverse Event|0|||
23643176|NCT03207451|66079059|FG003|Overall Study|Adverse Event|1|||
23643177|NCT00412061|66079066|FG000|Double Blind Phase|Disease Progression|101|||
23643178|NCT00412061|66079067|FG001|Double Blind Phase|Disease Progression|154|||
23643179|NCT00412061|66079066|FG000|Double Blind Phase|Adverse Event|61|||
23643180|NCT00412061|66079067|FG001|Double Blind Phase|Adverse Event|16|||
23643181|NCT00412061|66079066|FG000|Double Blind Phase|Final Primary Analysis|26|||
23643182|NCT00412061|66079067|FG001|Double Blind Phase|Final Primary Analysis|14|||
23643183|NCT00412061|66079066|FG000|Double Blind Phase|Withdrawal by Subject|18|||
23643184|NCT00412061|66079067|FG001|Double Blind Phase|Withdrawal by Subject|20|||
23643185|NCT00412061|66079066|FG000|Double Blind Phase|Death|6|||
23643186|NCT00412061|66079067|FG001|Double Blind Phase|Death|3|||
23643187|NCT00412061|66079066|FG000|Double Blind Phase|Protocol Violation|3|||
23643188|NCT00412061|66079067|FG001|Double Blind Phase|Protocol Violation|4|||
23643189|NCT00412061|66079066|FG000|Double Blind Phase|New Cander Therapy|1|||
23643190|NCT00412061|66079067|FG001|Double Blind Phase|New Cander Therapy|1|||
23643191|NCT00412061|66079066|FG000|Double Blind Phase|Lost to Follow-up|0|||
23643192|NCT00412061|66079067|FG001|Double Blind Phase|Lost to Follow-up|1|||
23643193|NCT00412061|66079066|FG000|Open Label Phase|Disease Progression|0|||
23643194|NCT00412061|66079067|FG001|Open Label Phase|Disease Progression|86|||
23643195|NCT00412061|66079066|FG000|Open Label Phase|Adverse Event|0|||
23643196|NCT00412061|66079067|FG001|Open Label Phase|Adverse Event|46|||
23643197|NCT00412061|66079066|FG000|Open Label Phase|Withdrawal by Subject|0|||
23643198|NCT00412061|66079067|FG001|Open Label Phase|Withdrawal by Subject|15|||
23643199|NCT00412061|66079066|FG000|Open Label Phase|Administrative Problems|0|||
23643200|NCT00412061|66079067|FG001|Open Label Phase|Administrative Problems|13|||
23643201|NCT00412061|66079066|FG000|Open Label Phase|Death|0|||
23643202|NCT00412061|66079067|FG001|Open Label Phase|Death|7|||
23643203|NCT00412061|66079066|FG000|Open Label Phase|Lost to Follow-up|0|||
23643204|NCT00412061|66079067|FG001|Open Label Phase|Lost to Follow-up|2|||
23643205|NCT00412061|66079066|FG000|Open Label Phase|New Cancer Therapy|0|||
23643206|NCT00412061|66079067|FG001|Open Label Phase|New Cancer Therapy|1|||
23643207|NCT02004353|66079076|FG000|Overall Study|Voluntary participation|1334|||
23643208|NCT05559476|66079082|FG000|Overall Study|Adverse Event|2|||
23643209|NCT05559476|66079083|FG001|Overall Study|Adverse Event|0|||
23643210|NCT05559476|66079082|FG000|Overall Study|Lost to Follow-up|13|||
23643211|NCT05559476|66079083|FG001|Overall Study|Lost to Follow-up|12|||
23643212|NCT05559476|66079082|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
23643213|NCT05559476|66079083|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
23797653|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
23475596|NCT01256294|65485454|FG001|Overall Study|Withdrawal by Subject|1|||
23643214|NCT05559476|66079082|FG000|Overall Study|Other|0|||
23643215|NCT05559476|66079083|FG001|Overall Study|Other|2|||
23643216|NCT01142232|66079084|FG000|Overall Study|Adverse Event|1|||
23643217|NCT01142232|66079085|FG001|Overall Study|Adverse Event|2|||
23643218|NCT01142232|66079086|FG002|Overall Study|Adverse Event|1|||
23643219|NCT01142232|66079087|FG003|Overall Study|Adverse Event|0|||
23643220|NCT01142232|66079088|FG004|Overall Study|Adverse Event|4|||
23643221|NCT01142232|66079084|FG000|Overall Study|Death|0|||
23643222|NCT01142232|66079085|FG001|Overall Study|Death|0|||
23643223|NCT01142232|66079086|FG002|Overall Study|Death|0|||
23589732|NCT02299635|65886183|FG000|Overall Study|Global deterioration of health status|1|||
23589733|NCT02299635|65886183|FG000|Overall Study|Objective progression or relapse|10|||
23589734|NCT02299635|65886183|FG000|Overall Study|Withdrawal by Subject|2|||
23589735|NCT02299635|65886183|FG000|Overall Study|Other|3|||
23589736|NCT01391130|65886189|FG000|Overall Study|Withdrawal by Subject|3|||
23589737|NCT01391130|65886190|FG001|Overall Study|Withdrawal by Subject|2|||
23589738|NCT01391130|65886189|FG000|Overall Study|Physician Decision|2|||
23589739|NCT01391130|65886190|FG001|Overall Study|Physician Decision|3|||
23589740|NCT01391130|65886189|FG000|Overall Study|Did not Receive Drug|1|||
23589741|NCT01391130|65886190|FG001|Overall Study|Did not Receive Drug|1|||
23589742|NCT01253226|65886193|FG000|Overall Study|Adverse Event|0|||
23589743|NCT01253226|65886194|FG001|Overall Study|Adverse Event|0|||
23589744|NCT01253226|65886195|FG002|Overall Study|Adverse Event|1|||
23589745|NCT01253226|65886196|FG003|Overall Study|Adverse Event|0|||
23589746|NCT01253226|65886197|FG004|Overall Study|Adverse Event|0|||
23589747|NCT01253226|65886193|FG000|Overall Study|Death|0|||
23589748|NCT01253226|65886194|FG001|Overall Study|Death|1|||
23589749|NCT01253226|65886195|FG002|Overall Study|Death|0|||
23589750|NCT01253226|65886196|FG003|Overall Study|Death|0|||
23589751|NCT01253226|65886197|FG004|Overall Study|Death|0|||
23589752|NCT01253226|65886193|FG000|Overall Study|Physician Decision|0|||
23589753|NCT01253226|65886194|FG001|Overall Study|Physician Decision|0|||
23589754|NCT01253226|65886195|FG002|Overall Study|Physician Decision|0|||
23589755|NCT01253226|65886196|FG003|Overall Study|Physician Decision|0|||
23589756|NCT01253226|65886197|FG004|Overall Study|Physician Decision|2|||
23589757|NCT01253226|65886193|FG000|Overall Study|Withdrawal by Subject|0|||
23589758|NCT01253226|65886194|FG001|Overall Study|Withdrawal by Subject|0|||
23589759|NCT01253226|65886195|FG002|Overall Study|Withdrawal by Subject|0|||
23643224|NCT01142232|66079087|FG003|Overall Study|Death|0|||
23643225|NCT01142232|66079088|FG004|Overall Study|Death|1|||
23643226|NCT01142232|66079084|FG000|Overall Study|Disease Progression|2|||
23643227|NCT01142232|66079085|FG001|Overall Study|Disease Progression|0|||
23643228|NCT01142232|66079086|FG002|Overall Study|Disease Progression|1|||
23358640|NCT04304508|65056345|FG001|Overall Study|Adverse Event|50|||
23358641|NCT04304508|65056346|FG002|Overall Study|Adverse Event|51|||
23358642|NCT04304508|65056347|FG003|Overall Study|Adverse Event|56|||
23358643|NCT04304508|65056344|FG000|Overall Study|Lost to Follow-up|1|||
23358644|NCT04304508|65056345|FG001|Overall Study|Lost to Follow-up|5|||
23358645|NCT04304508|65056346|FG002|Overall Study|Lost to Follow-up|2|||
23358646|NCT04304508|65056347|FG003|Overall Study|Lost to Follow-up|3|||
23358647|NCT03442088|65056348|FG000|Overall Study|Adverse Event|1|||
23358648|NCT03442088|65056348|FG000|Overall Study|Lack of Efficacy|2|||
23358649|NCT03442088|65056348|FG000|Overall Study|Lost to Follow-up|2|||
23358650|NCT01844817|65056349|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
23358651|NCT01844817|65056350|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
23358652|NCT01844817|65056349|FG000|Treatment|Progressive Disease|27|||
23358653|NCT01844817|65056350|FG001|Treatment|Progressive Disease|36|||
23358654|NCT01844817|65056349|FG000|Treatment|Adverse Event|17|||
23358655|NCT01844817|65056350|FG001|Treatment|Adverse Event|9|||
23358656|NCT01844817|65056349|FG000|Treatment|Withdrawal by Subject|10|||
23358657|NCT01844817|65056350|FG001|Treatment|Withdrawal by Subject|6|||
23358658|NCT01844817|65056349|FG000|Treatment|Death|10|||
23358659|NCT01844817|65056350|FG001|Treatment|Death|8|||
23358660|NCT01844817|65056349|FG000|Treatment|Lost to Follow-up|0|||
23358661|NCT01844817|65056350|FG001|Treatment|Lost to Follow-up|1|||
23358662|NCT01844817|65056349|FG000|Treatment|Other|0|||
23358663|NCT01844817|65056350|FG001|Treatment|Other|3|||
23358664|NCT04446429|65056351|FG000|Overall Study|Lost to Follow-up|6|||
23358665|NCT04446429|65056352|FG001|Overall Study|Lost to Follow-up|0|||
23358666|NCT00805129|65056353|FG000|Overall Study|Not treated|1|||
23358667|NCT00255840|65056366|FG000|Overall Study|Lost to Follow-up|10|||
23358668|NCT00255840|65056367|FG001|Overall Study|Lost to Follow-up|14|||
23358669|NCT00255840|65056366|FG000|Overall Study|Discontinued intervention|53|||
23358670|NCT00255840|65056367|FG001|Overall Study|Discontinued intervention|56|||
23589760|NCT01253226|65886196|FG003|Overall Study|Withdrawal by Subject|1|||
23643229|NCT01142232|66079087|FG003|Overall Study|Disease Progression|2|||
23358671|NCT00627926|65056370|FG000|Overall Study|Adverse Event|26|||
23358672|NCT00627926|65056371|FG001|Overall Study|Adverse Event|37|||
23358673|NCT00627926|65056372|FG002|Overall Study|Adverse Event|36|||
23358674|NCT00627926|65056370|FG000|Overall Study|Death|1|||
23358675|NCT00627926|65056371|FG001|Overall Study|Death|0|||
23589761|NCT01253226|65886197|FG004|Overall Study|Withdrawal by Subject|0|||
23589762|NCT00442117|65886198|FG000|Overall Study|Adverse Event|3|||
23589763|NCT00442117|65886199|FG001|Overall Study|Adverse Event|2|||
23589764|NCT00442117|65886198|FG000|Overall Study|Lack of Efficacy|2|||
23643230|NCT01142232|66079088|FG004|Overall Study|Disease Progression|12|||
23358676|NCT00627926|65056372|FG002|Overall Study|Death|0|||
23589765|NCT00442117|65886199|FG001|Overall Study|Lack of Efficacy|6|||
23589766|NCT00442117|65886198|FG000|Overall Study|Lost to Follow-up|1|||
23589767|NCT00442117|65886199|FG001|Overall Study|Lost to Follow-up|2|||
23589768|NCT00442117|65886198|FG000|Overall Study|Withdrawal by Subject|2|||
23589769|NCT00442117|65886199|FG001|Overall Study|Withdrawal by Subject|2|||
23589770|NCT00442117|65886198|FG000|Overall Study|Major Deviation|25|||
23589771|NCT00442117|65886199|FG001|Overall Study|Major Deviation|20|||
23589772|NCT00442117|65886198|FG000|Overall Study|Non compliance with protocol|3|||
23589773|NCT00442117|65886199|FG001|Overall Study|Non compliance with protocol|5|||
23589774|NCT00442117|65886198|FG000|Overall Study|Met Withdrawal Criteria|2|||
23589775|NCT00442117|65886199|FG001|Overall Study|Met Withdrawal Criteria|1|||
23589776|NCT01353963|65886202|FG000|Overall Study|Adverse Event|2|||
23589777|NCT04246762|65886203|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
23589778|NCT02873754|65886209|FG000|Overall Study|Lost to Follow-up|5|||
23589779|NCT02873754|65886209|FG000|Overall Study|Couldn't complete study procedures|1|||
23589780|NCT03008915|65886210|FG000|Treatment 1|Withdrawal by Subject|0|||
23589781|NCT03008915|65886211|FG001|Treatment 1|Withdrawal by Subject|1|||
23589782|NCT01909778|65886212|FG000|Overall Study|failed screening|1|||
23589783|NCT01456936|65886213|FG000|Overall Study|Other reason|41|||
23589784|NCT01456936|65886214|FG001|Overall Study|Other reason|30|||
23589785|NCT01456936|65886215|FG002|Overall Study|Other reason|36|||
23589786|NCT01456936|65886216|FG003|Overall Study|Other reason|33|||
23589787|NCT01456936|65886213|FG000|Overall Study|No longer meets eligibility criteria|4|||
23589788|NCT01456936|65886214|FG001|Overall Study|No longer meets eligibility criteria|8|||
23589789|NCT01456936|65886215|FG002|Overall Study|No longer meets eligibility criteria|6|||
23589790|NCT01456936|65886216|FG003|Overall Study|No longer meets eligibility criteria|5|||
23589791|NCT01456936|65886213|FG000|Overall Study|Protocol Violation|4|||
23589792|NCT01456936|65886214|FG001|Overall Study|Protocol Violation|2|||
23589793|NCT01456936|65886215|FG002|Overall Study|Protocol Violation|5|||
23589794|NCT01456936|65886216|FG003|Overall Study|Protocol Violation|5|||
23589795|NCT01456936|65886213|FG000|Overall Study|Pregnancy|1|||
23589796|NCT01456936|65886214|FG001|Overall Study|Pregnancy|0|||
23589797|NCT01456936|65886215|FG002|Overall Study|Pregnancy|0|||
23589798|NCT01456936|65886216|FG003|Overall Study|Pregnancy|1|||
23589799|NCT01456936|65886213|FG000|Overall Study|Insufficient clinical response|4|||
23589800|NCT01456936|65886214|FG001|Overall Study|Insufficient clinical response|4|||
23589801|NCT01456936|65886215|FG002|Overall Study|Insufficient clinical response|14|||
23589802|NCT01456936|65886216|FG003|Overall Study|Insufficient clinical response|13|||
23589803|NCT01456936|65886213|FG000|Overall Study|No longer willing to participate|195|||
23589804|NCT01456936|65886214|FG001|Overall Study|No longer willing to participate|218|||
23589805|NCT01456936|65886215|FG002|Overall Study|No longer willing to participate|224|||
23797654|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
23797655|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23797656|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23797657|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23797658|NCT00545688|66636815|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
23797659|NCT00545688|66636816|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
23797660|NCT00545688|66636817|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
23797661|NCT00545688|66636818|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
23797662|NCT00545688|66636815|FG000|Adjuvant Treatment Period|Disease Progression|3|||
23797663|NCT00545688|66636816|FG001|Adjuvant Treatment Period|Disease Progression|3|||
23797664|NCT00545688|66636817|FG002|Adjuvant Treatment Period|Disease Progression|0|||
23797665|NCT00545688|66636818|FG003|Adjuvant Treatment Period|Disease Progression|7|||
23797666|NCT00545688|66636815|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
23797667|NCT00545688|66636816|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
23797668|NCT00545688|66636817|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
23797669|NCT00545688|66636818|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
23797670|NCT00545688|66636815|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
23797671|NCT00545688|66636816|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
23797672|NCT00545688|66636817|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
23797673|NCT00545688|66636818|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
23797674|NCT00545688|66636815|FG000|Adjuvant Treatment Period|Adverse Event|0|||
23797675|NCT00545688|66636816|FG001|Adjuvant Treatment Period|Adverse Event|3|||
23797676|NCT00545688|66636817|FG002|Adjuvant Treatment Period|Adverse Event|2|||
23797677|NCT00545688|66636818|FG003|Adjuvant Treatment Period|Adverse Event|2|||
23797678|NCT00545688|66636815|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
23475597|NCT01256294|65485453|FG000|Overall Study|Protocol deviation|2|||
23589806|NCT01456936|65886216|FG003|Overall Study|No longer willing to participate|248|||
23589807|NCT01456936|65886213|FG000|Overall Study|Lost to Follow-up|135|||
23589808|NCT01456936|65886214|FG001|Overall Study|Lost to Follow-up|126|||
23589809|NCT01456936|65886215|FG002|Overall Study|Lost to Follow-up|144|||
23589810|NCT01456936|65886216|FG003|Overall Study|Lost to Follow-up|127|||
23589811|NCT01456936|65886213|FG000|Overall Study|Medication error|0|||
23589812|NCT01456936|65886214|FG001|Overall Study|Medication error|1|||
23797679|NCT00545688|66636816|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
23797680|NCT00545688|66636817|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
23475598|NCT01256294|65485454|FG001|Overall Study|Protocol deviation|1|||
23589813|NCT01456936|65886215|FG002|Overall Study|Medication error|0|||
23643231|NCT01142232|66079084|FG000|Overall Study|Withdrawal by Subject|0|||
23643232|NCT01142232|66079085|FG001|Overall Study|Withdrawal by Subject|0|||
23643233|NCT01142232|66079086|FG002|Overall Study|Withdrawal by Subject|0|||
23643234|NCT01142232|66079087|FG003|Overall Study|Withdrawal by Subject|1|||
23643235|NCT01142232|66079088|FG004|Overall Study|Withdrawal by Subject|3|||
23643236|NCT01142232|66079084|FG000|Overall Study|Physician Decision|0|||
23643237|NCT01142232|66079085|FG001|Overall Study|Physician Decision|1|||
23358677|NCT00627926|65056370|FG000|Overall Study|Lost to Follow-up|4|||
23358678|NCT00627926|65056371|FG001|Overall Study|Lost to Follow-up|3|||
23358679|NCT00627926|65056372|FG002|Overall Study|Lost to Follow-up|4|||
23358680|NCT00627926|65056370|FG000|Overall Study|Withdrawal by Subject|2|||
23358681|NCT00627926|65056371|FG001|Overall Study|Withdrawal by Subject|1|||
23358682|NCT00627926|65056372|FG002|Overall Study|Withdrawal by Subject|0|||
23358683|NCT00627926|65056370|FG000|Overall Study|Lack of Efficacy|118|||
23358684|NCT00627926|65056371|FG001|Overall Study|Lack of Efficacy|40|||
23358685|NCT00627926|65056372|FG002|Overall Study|Lack of Efficacy|38|||
23358686|NCT00627926|65056370|FG000|Overall Study|Noncompliance/unspecified|8|||
23358687|NCT00627926|65056371|FG001|Overall Study|Noncompliance/unspecified|23|||
23358688|NCT00627926|65056372|FG002|Overall Study|Noncompliance/unspecified|17|||
23358689|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
23358690|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
23589814|NCT01456936|65886216|FG003|Overall Study|Medication error|1|||
23589815|NCT01456936|65886213|FG000|Overall Study|Adverse event (study drug)|25|||
23589816|NCT01456936|65886214|FG001|Overall Study|Adverse event (study drug)|21|||
23589817|NCT01456936|65886215|FG002|Overall Study|Adverse event (study drug)|26|||
23589818|NCT01456936|65886216|FG003|Overall Study|Adverse event (study drug)|17|||
23589819|NCT01456936|65886213|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
23589820|NCT01456936|65886214|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
23589821|NCT01456936|65886215|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
23589822|NCT01456936|65886216|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
23589823|NCT01456936|65886213|FG000|Overall Study|Death|0|||
23589824|NCT01456936|65886214|FG001|Overall Study|Death|3|||
23589825|NCT01456936|65886215|FG002|Overall Study|Death|1|||
23589826|NCT01456936|65886216|FG003|Overall Study|Death|3|||
23589827|NCT01456936|65886213|FG000|Overall Study|Randomized but not treated|21|||
23589828|NCT01456936|65886214|FG001|Overall Study|Randomized but not treated|28|||
23589829|NCT01456936|65886215|FG002|Overall Study|Randomized but not treated|16|||
23589830|NCT01456936|65886216|FG003|Overall Study|Randomized but not treated|21|||
23589831|NCT01190007|65886223|FG000|Overall Study|Withdrawal by Subject|4|||
23589832|NCT01190007|65886223|FG000|Overall Study|Adverse Event|8|||
23589833|NCT01190007|65886223|FG000|Overall Study|Difficulty of visit for complications|1|||
23589834|NCT01190007|65886223|FG000|Overall Study|Participant was arrested|1|||
23589835|NCT04381494|65886224|FG000|Overall Study|Early termination of trial|19|||
23589836|NCT04381494|65886224|FG000|Overall Study|Investigator's discretion|1|||
23589837|NCT04381494|65886224|FG000|Overall Study|Withdrawal by Subject|9|||
23589838|NCT04381494|65886224|FG000|Overall Study|NSCLC disease progression|4|||
23589839|NCT04381494|65886224|FG000|Overall Study|Device-Related Adverse Event|2|||
23589840|NCT04567888|65886227|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
23589841|NCT04567888|65886228|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
23589842|NCT04567888|65886227|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
23589843|NCT04567888|65886228|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
23589844|NCT04567888|65886227|FG000|Overall Study|Reported Unusual Birth Year|2|||
23589845|NCT04567888|65886228|FG001|Overall Study|Reported Unusual Birth Year|3|||
23589846|NCT04567888|65886227|FG000|Overall Study|Duplicate Responses|0|||
23589847|NCT04567888|65886228|FG001|Overall Study|Duplicate Responses|1|||
23589848|NCT03920215|65886229|FG000|Overall Study|Lost to Follow-up|1|||
23589849|NCT03920215|65886230|FG001|Overall Study|Lost to Follow-up|2|||
23589850|NCT03920215|65886231|FG002|Overall Study|Lost to Follow-up|0|||
23589851|NCT03920215|65886232|FG003|Overall Study|Lost to Follow-up|0|||
23589852|NCT03920215|65886229|FG000|Overall Study|Death|0|||
23589853|NCT03920215|65886230|FG001|Overall Study|Death|0|||
23589854|NCT03920215|65886231|FG002|Overall Study|Death|0|||
23589855|NCT03920215|65886232|FG003|Overall Study|Death|1|||
23589856|NCT01597258|65886233|FG000|Overall Study|No Drug Administration|1|||
23589857|NCT02614560|65886236|FG000|Overall Study|Death|6|||
23643238|NCT01142232|66079086|FG002|Overall Study|Physician Decision|0|||
23643239|NCT01142232|66079087|FG003|Overall Study|Physician Decision|2|||
23358691|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
23358692|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
23643240|NCT01142232|66079088|FG004|Overall Study|Physician Decision|10|||
23643241|NCT01142232|66079084|FG000|Overall Study|Alternative Therapy|0|||
23643242|NCT01142232|66079085|FG001|Overall Study|Alternative Therapy|1|||
23589858|NCT02614560|65886237|FG001|Overall Study|Death|2|||
23589859|NCT02975934|65886238|FG000|Treatment Phase|Ongoing at data-analysis|33|||
23589860|NCT02975934|65886239|FG001|Treatment Phase|Ongoing at data-analysis|5|||
23589861|NCT02975934|65886238|FG000|Treatment Phase|Discontinued prior to study drug|0|||
23643243|NCT01142232|66079086|FG002|Overall Study|Alternative Therapy|1|||
23643244|NCT01142232|66079087|FG003|Overall Study|Alternative Therapy|0|||
23643245|NCT01142232|66079088|FG004|Overall Study|Alternative Therapy|1|||
23643246|NCT01142232|66079084|FG000|Overall Study|Off Trt for other complicating disease|0|||
23643247|NCT01142232|66079085|FG001|Overall Study|Off Trt for other complicating disease|0|||
23643248|NCT01142232|66079086|FG002|Overall Study|Off Trt for other complicating disease|0|||
23643249|NCT01142232|66079087|FG003|Overall Study|Off Trt for other complicating disease|0|||
23643250|NCT01142232|66079088|FG004|Overall Study|Off Trt for other complicating disease|1|||
23643251|NCT01142232|66079084|FG000|Overall Study|Noncompliance|0|||
23643252|NCT01142232|66079085|FG001|Overall Study|Noncompliance|0|||
23643253|NCT01142232|66079086|FG002|Overall Study|Noncompliance|0|||
23643254|NCT01142232|66079087|FG003|Overall Study|Noncompliance|0|||
23643255|NCT01142232|66079088|FG004|Overall Study|Noncompliance|2|||
23643256|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23643257|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23643258|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
23643259|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
23643260|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23643261|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23643262|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
23643263|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
23643264|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
23643265|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
23643266|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
23643267|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
23797681|NCT00545688|66636818|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
23358693|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
23358694|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
23358695|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
23358696|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358697|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358698|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358699|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
23358700|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
23358701|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
23358702|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
23358703|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
23358704|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
23358705|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
23358706|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358707|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358708|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358709|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
23358710|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358711|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358712|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358713|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358714|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
23358715|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
23358716|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
23358717|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
23358718|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
23358719|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
23358720|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
23358721|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
23358722|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
23358723|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
23358724|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
23358725|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
23358726|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
23358727|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
23358728|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
23358729|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
23358730|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
23358731|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
23358732|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
23643268|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
23706864|NCT00372190|66301350|FG001|Overall Study|Lost to Follow-up|1|||
23797682|NCT00545688|66636815|FG000|Follow-Up Period|Death|4|||
23358733|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
23358734|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358735|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358736|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
23358737|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358738|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358739|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358740|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358741|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
23358742|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358743|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358744|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
23358745|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
23358746|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
23358747|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
23358748|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
23358749|NCT00631163|65056378|FG000|Number of Participants in Year 1|Adverse Event|12|||
23358750|NCT00631163|65056378|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
23358751|NCT00631163|65056378|FG000|Number of Participants in Year 1|Death|6|||
23358752|NCT00631163|65056378|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
23358753|NCT00631163|65056378|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
23358754|NCT00631163|65056378|FG000|Number of Participants in Year 1|Administrative problems|6|||
23358755|NCT00631163|65056378|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
23358756|NCT00631163|65056378|FG000|Number of Participants in Year 2|Adverse Event|1|||
23358757|NCT00631163|65056378|FG000|Number of Participants in Year 2|Protocol Violation|1|||
23358758|NCT00631163|65056378|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
23589862|NCT02975934|65886239|FG001|Treatment Phase|Discontinued prior to study drug|5|||
23589863|NCT02975934|65886238|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
23589864|NCT02975934|65886239|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
23589865|NCT02263508|65889461|FG000|Overall Study|Withdrawal by Subject|1|||
23589866|NCT02263508|65889462|FG001|Overall Study|Withdrawal by Subject|23|||
23589867|NCT02263508|65889463|FG002|Overall Study|Withdrawal by Subject|17|||
23589868|NCT02263508|65889461|FG000|Overall Study|Sponsor Decision|12|||
23589869|NCT02263508|65889462|FG001|Overall Study|Sponsor Decision|165|||
23589870|NCT02263508|65889463|FG002|Overall Study|Sponsor Decision|182|||
23589871|NCT02263508|65889461|FG000|Overall Study|Lost to Follow-up|2|||
23589872|NCT02263508|65889462|FG001|Overall Study|Lost to Follow-up|7|||
23589873|NCT02263508|65889463|FG002|Overall Study|Lost to Follow-up|7|||
23589874|NCT02263508|65889461|FG000|Overall Study|Death|6|||
23589875|NCT02263508|65889462|FG001|Overall Study|Death|151|||
23589876|NCT02263508|65889463|FG002|Overall Study|Death|140|||
23589877|NCT04379713|65889465|FG000|Overall Study|Adverse Event|2|||
23589878|NCT04379713|65889466|FG001|Overall Study|Adverse Event|0|||
23589879|NCT04379713|65889465|FG000|Overall Study|Physician Decision|2|||
23589880|NCT04379713|65889466|FG001|Overall Study|Physician Decision|1|||
23589881|NCT04379713|65889465|FG000|Overall Study|Protocol Violation|11|||
23589882|NCT04379713|65889466|FG001|Overall Study|Protocol Violation|6|||
23589883|NCT04379713|65889465|FG000|Overall Study|No longer met eligibility criteria|14|||
23589884|NCT04379713|65889466|FG001|Overall Study|No longer met eligibility criteria|11|||
23589885|NCT04379713|65889465|FG000|Overall Study|Withdrawal by parent/guardian|36|||
23589886|NCT04379713|65889466|FG001|Overall Study|Withdrawal by parent/guardian|15|||
23589887|NCT04379713|65889465|FG000|Overall Study|Lost to Follow-up|31|||
23589888|NCT04379713|65889466|FG001|Overall Study|Lost to Follow-up|21|||
23589889|NCT00868192|65889467|FG000|Overall Study|Ineligible|4|||
23589890|NCT00258895|65889475|FG000|Overall Study|Lost to Follow-up|3|||
23589891|NCT00258895|65889476|FG001|Overall Study|Lost to Follow-up|1|||
23589892|NCT00258895|65889475|FG000|Overall Study|Protocol Violation|6|||
23589893|NCT00258895|65889476|FG001|Overall Study|Protocol Violation|2|||
23589894|NCT00258895|65889475|FG000|Overall Study|Withdrawal by Subject|1|||
23589895|NCT00258895|65889476|FG001|Overall Study|Withdrawal by Subject|0|||
23589896|NCT03808883|65889477|FG000|Overall Study|Withdrawal by Subject|2|||
23589897|NCT03808883|65889478|FG001|Overall Study|Withdrawal by Subject|0|||
23589898|NCT03808883|65889477|FG000|Overall Study|Did not complete pre test or post test survey|4|||
23589899|NCT03808883|65889478|FG001|Overall Study|Did not complete pre test or post test survey|3|||
23589900|NCT02950558|65889479|FG000|Overall Study|Lost to Follow-up|2|||
23589901|NCT02950558|65889480|FG001|Overall Study|Lost to Follow-up|0|||
23589902|NCT00158054|65889483|FG000|Overall Study|Refused to continue|3|||
23589903|NCT00158054|65889484|FG001|Overall Study|Refused to continue|0|||
23589904|NCT00158054|65889483|FG000|Overall Study|Unavailable for follow up|7|||
23589905|NCT00158054|65889484|FG001|Overall Study|Unavailable for follow up|3|||
23589906|NCT03615924|65889488|FG000|Overall Study|Withdrawal by Subject|2|||
23589907|NCT03615924|65889489|FG001|Overall Study|Withdrawal by Subject|5|||
23358759|NCT02779075|65056381|FG000|Overall Study|Withdrawal by Subject|1|||
23358760|NCT02779075|65056382|FG001|Overall Study|Withdrawal by Subject|3|||
23358761|NCT02779075|65056381|FG000|Overall Study|IV lost during 2nd study|1|||
23358762|NCT02779075|65056382|FG001|Overall Study|IV lost during 2nd study|0|||
23358763|NCT00045734|65056397|FG000|Overall Study|Protocol Violation|1|||
23358764|NCT01663857|65056398|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
23358765|NCT01663857|65056399|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
23358766|NCT01663857|65056400|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
23358767|NCT01663857|65056401|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
23358768|NCT01663857|65056398|FG000|Overall Study|Lost to Follow-up|0|||
23358769|NCT01663857|65056399|FG001|Overall Study|Lost to Follow-up|0|||
23358770|NCT01663857|65056400|FG002|Overall Study|Lost to Follow-up|3|||
23358771|NCT01663857|65056401|FG003|Overall Study|Lost to Follow-up|1|||
23589908|NCT03615924|65889488|FG000|Overall Study|Death|3|||
23589909|NCT03615924|65889489|FG001|Overall Study|Death|1|||
23797683|NCT00545688|66636816|FG001|Follow-Up Period|Death|2|||
23797684|NCT00545688|66636817|FG002|Follow-Up Period|Death|2|||
23797685|NCT00545688|66636818|FG003|Follow-Up Period|Death|6|||
23797686|NCT00545688|66636815|FG000|Follow-Up Period|Disease Progression|6|||
23797687|NCT00545688|66636816|FG001|Follow-Up Period|Disease Progression|5|||
23797688|NCT00545688|66636817|FG002|Follow-Up Period|Disease Progression|9|||
23797689|NCT00545688|66636818|FG003|Follow-Up Period|Disease Progression|9|||
23797690|NCT00545688|66636815|FG000|Follow-Up Period|Refused Treatment|6|||
23797691|NCT00545688|66636816|FG001|Follow-Up Period|Refused Treatment|2|||
23797692|NCT00545688|66636817|FG002|Follow-Up Period|Refused Treatment|0|||
23797693|NCT00545688|66636818|FG003|Follow-Up Period|Refused Treatment|2|||
23797694|NCT00545688|66636815|FG000|Follow-Up Period|Lost to Follow-up|3|||
23797695|NCT00545688|66636816|FG001|Follow-Up Period|Lost to Follow-up|3|||
23797696|NCT00545688|66636817|FG002|Follow-Up Period|Lost to Follow-up|3|||
23797697|NCT00545688|66636818|FG003|Follow-Up Period|Lost to Follow-up|1|||
23797698|NCT00545688|66636815|FG000|Follow-Up Period|Unspecified Reason|2|||
23797699|NCT00545688|66636816|FG001|Follow-Up Period|Unspecified Reason|5|||
23797700|NCT00545688|66636817|FG002|Follow-Up Period|Unspecified Reason|6|||
23797701|NCT00545688|66636818|FG003|Follow-Up Period|Unspecified Reason|8|||
23797702|NCT00545688|66636815|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
23797703|NCT00545688|66636816|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
23797704|NCT00545688|66636817|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
23797705|NCT00545688|66636818|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
23797706|NCT02408120|66636823|FG000|Overall Study|Withdrawal by Subject|0|||
23797707|NCT02408120|66636824|FG001|Overall Study|Withdrawal by Subject|1|||
23797708|NCT02408120|66636823|FG000|Overall Study|Treatment Refusal|1|||
23797709|NCT02408120|66636824|FG001|Overall Study|Treatment Refusal|0|||
23797710|NCT02408120|66636823|FG000|Overall Study|Received Steroids|1|||
23797711|NCT02408120|66636824|FG001|Overall Study|Received Steroids|1|||
23797712|NCT02408120|66636823|FG000|Overall Study|Discharged same day|1|||
23797713|NCT02408120|66636824|FG001|Overall Study|Discharged same day|1|||
23797714|NCT02408120|66636823|FG000|Overall Study|Did not receive insulin|1|||
23797715|NCT02408120|66636824|FG001|Overall Study|Did not receive insulin|2|||
23797716|NCT01315028|66636827|FG000|Overall Study|Lost to Follow-up|1|||
23797717|NCT01315028|66636828|FG001|Overall Study|Lost to Follow-up|0|||
23797718|NCT01315028|66636827|FG000|Overall Study|Death|0|||
23797719|NCT01315028|66636828|FG001|Overall Study|Death|1|||
23797720|NCT00819767|66636831|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23797721|NCT00819767|66636832|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23797722|NCT00831233|66636833|FG000|Overall Study|Adverse Event|0|||
23797723|NCT00831233|66636834|FG001|Overall Study|Adverse Event|1|||
23797724|NCT00831233|66636833|FG000|Overall Study|Protocol Violation|1|||
23797725|NCT00831233|66636834|FG001|Overall Study|Protocol Violation|0|||
23358772|NCT02757625|65056402|FG000|Overall Study|Investigator's discretion|0|||
23358773|NCT02757625|65056403|FG001|Overall Study|Investigator's discretion|0|||
23589910|NCT03615924|65889488|FG000|Overall Study|Lost to Follow-up|1|||
23797726|NCT00831233|66636833|FG000|Overall Study|Selection Criteria Not Met|2|||
23797727|NCT00831233|66636834|FG001|Overall Study|Selection Criteria Not Met|0|||
23358774|NCT02757625|65056404|FG002|Overall Study|Investigator's discretion|1|||
23797728|NCT01662024|66636835|FG000|Overall Study|Pregnancy|2|||
23797729|NCT01662024|66636835|FG000|Overall Study|Withdrawal by Subject|3|||
23797730|NCT00784979|66636836|FG000|Overall Study|incomplete data|6|||
23797731|NCT00401245|66636837|FG000|Double Blind Titration Phase|Adverse Event|3|||
23797732|NCT00401245|66636838|FG001|Double Blind Titration Phase|Adverse Event|2|||
23358775|NCT02757625|65056405|FG003|Overall Study|Investigator's discretion|0|||
23797733|NCT00401245|66636839|FG002|Double Blind Titration Phase|Adverse Event|5|||
23797734|NCT00401245|66636840|FG003|Double Blind Titration Phase|Adverse Event|12|||
23797735|NCT00401245|66636841|FG004|Double Blind Titration Phase|Adverse Event|0|||
23797736|NCT00401245|66636842|FG005|Double Blind Titration Phase|Adverse Event|0|||
23797737|NCT00401245|66636843|FG006|Double Blind Titration Phase|Adverse Event|0|||
23797738|NCT00401245|66636844|FG007|Double Blind Titration Phase|Adverse Event|0|||
23797739|NCT00401245|66636837|FG000|Double Blind Titration Phase|Other|0|||
23797740|NCT00401245|66636838|FG001|Double Blind Titration Phase|Other|0|||
23797741|NCT00401245|66636839|FG002|Double Blind Titration Phase|Other|1|||
23797742|NCT00401245|66636840|FG003|Double Blind Titration Phase|Other|0|||
23797743|NCT00401245|66636841|FG004|Double Blind Titration Phase|Other|0|||
23797744|NCT00401245|66636842|FG005|Double Blind Titration Phase|Other|0|||
23797745|NCT00401245|66636843|FG006|Double Blind Titration Phase|Other|0|||
23797746|NCT00401245|66636844|FG007|Double Blind Titration Phase|Other|0|||
23797747|NCT00401245|66636837|FG000|Double Blind Titration Phase|Protocol Violation|0|||
23797748|NCT00401245|66636838|FG001|Double Blind Titration Phase|Protocol Violation|0|||
23797749|NCT00401245|66636839|FG002|Double Blind Titration Phase|Protocol Violation|0|||
23797750|NCT00401245|66636840|FG003|Double Blind Titration Phase|Protocol Violation|1|||
23797751|NCT00401245|66636841|FG004|Double Blind Titration Phase|Protocol Violation|0|||
23797752|NCT00401245|66636842|FG005|Double Blind Titration Phase|Protocol Violation|0|||
23797753|NCT00401245|66636843|FG006|Double Blind Titration Phase|Protocol Violation|0|||
23797754|NCT00401245|66636844|FG007|Double Blind Titration Phase|Protocol Violation|0|||
23797755|NCT00401245|66636837|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
23797756|NCT00401245|66636838|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
23797757|NCT00401245|66636839|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
23797758|NCT00401245|66636840|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
23797759|NCT00401245|66636841|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
23797760|NCT00401245|66636842|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
23797761|NCT00401245|66636843|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
23797762|NCT00401245|66636844|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
23797763|NCT00401245|66636837|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797764|NCT00401245|66636838|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
23797765|NCT00401245|66636839|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797766|NCT00401245|66636840|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
23797767|NCT00401245|66636841|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797768|NCT00401245|66636842|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797769|NCT00401245|66636843|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797770|NCT00401245|66636844|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23797771|NCT00401245|66636837|FG000|Open Label Phase|Adverse Event|5|||
23797772|NCT00401245|66636838|FG001|Open Label Phase|Adverse Event|14|||
23797773|NCT00401245|66636839|FG002|Open Label Phase|Adverse Event|6|||
23797774|NCT00401245|66636840|FG003|Open Label Phase|Adverse Event|7|||
23797775|NCT00401245|66636841|FG004|Open Label Phase|Adverse Event|0|||
23797776|NCT00401245|66636842|FG005|Open Label Phase|Adverse Event|0|||
23797777|NCT00401245|66636843|FG006|Open Label Phase|Adverse Event|0|||
23797778|NCT00401245|66636844|FG007|Open Label Phase|Adverse Event|0|||
23797779|NCT00401245|66636837|FG000|Open Label Phase|Lost to Follow-up|5|||
23797780|NCT00401245|66636838|FG001|Open Label Phase|Lost to Follow-up|7|||
23797781|NCT00401245|66636839|FG002|Open Label Phase|Lost to Follow-up|5|||
23797782|NCT00401245|66636840|FG003|Open Label Phase|Lost to Follow-up|4|||
23797783|NCT00401245|66636841|FG004|Open Label Phase|Lost to Follow-up|0|||
23643269|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23643270|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
23643271|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
23643272|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23643273|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23643274|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
23643275|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
23643276|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
23643277|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
23797784|NCT00401245|66636842|FG005|Open Label Phase|Lost to Follow-up|0|||
23797785|NCT00401245|66636843|FG006|Open Label Phase|Lost to Follow-up|0|||
23797786|NCT00401245|66636844|FG007|Open Label Phase|Lost to Follow-up|0|||
23475599|NCT03232333|65485455|FG000|Overall Study|Infection or Osteomyelitis|9|||
23797787|NCT00401245|66636837|FG000|Open Label Phase|Other|4|||
23797788|NCT00401245|66636838|FG001|Open Label Phase|Other|8|||
23797789|NCT00401245|66636839|FG002|Open Label Phase|Other|7|||
23643278|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
23643279|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
23797790|NCT00401245|66636840|FG003|Open Label Phase|Other|8|||
23797791|NCT00401245|66636841|FG004|Open Label Phase|Other|0|||
23797792|NCT00401245|66636842|FG005|Open Label Phase|Other|0|||
23475600|NCT03232333|65485455|FG000|Overall Study|Lost to Follow-up|4|||
23475601|NCT03232333|65485455|FG000|Overall Study|Withdrawal by Subject|2|||
23475602|NCT00732940|65485458|FG000|Overall Study|Withdrawal by Subject|1|||
23475603|NCT00732940|65485459|FG001|Overall Study|Withdrawal by Subject|2|||
23797793|NCT00401245|66636843|FG006|Open Label Phase|Other|0|||
23797794|NCT00401245|66636844|FG007|Open Label Phase|Other|0|||
23797795|NCT00401245|66636837|FG000|Open Label Phase|Protocol Violation|0|||
23797796|NCT00401245|66636838|FG001|Open Label Phase|Protocol Violation|1|||
23797797|NCT00401245|66636839|FG002|Open Label Phase|Protocol Violation|0|||
23797798|NCT00401245|66636840|FG003|Open Label Phase|Protocol Violation|1|||
23797799|NCT00401245|66636841|FG004|Open Label Phase|Protocol Violation|0|||
23797800|NCT00401245|66636842|FG005|Open Label Phase|Protocol Violation|0|||
23475604|NCT00732940|65485458|FG000|Overall Study|Adverse Event|0|||
23475605|NCT00732940|65485459|FG001|Overall Study|Adverse Event|1|||
23475606|NCT00732940|65485458|FG000|Overall Study|Lost to Follow-up|1|||
23589911|NCT03615924|65889489|FG001|Overall Study|Lost to Follow-up|0|||
23589912|NCT03615924|65889488|FG000|Overall Study|Randomized in error|1|||
23797801|NCT00401245|66636843|FG006|Open Label Phase|Protocol Violation|0|||
23797802|NCT00401245|66636844|FG007|Open Label Phase|Protocol Violation|0|||
23797803|NCT00401245|66636837|FG000|Open Label Phase|Withdrawal by Subject|3|||
23797804|NCT00401245|66636838|FG001|Open Label Phase|Withdrawal by Subject|3|||
23797805|NCT00401245|66636839|FG002|Open Label Phase|Withdrawal by Subject|2|||
23797806|NCT00401245|66636840|FG003|Open Label Phase|Withdrawal by Subject|1|||
23797807|NCT00401245|66636841|FG004|Open Label Phase|Withdrawal by Subject|0|||
23797808|NCT00401245|66636842|FG005|Open Label Phase|Withdrawal by Subject|0|||
23797809|NCT00401245|66636843|FG006|Open Label Phase|Withdrawal by Subject|0|||
23797810|NCT00401245|66636844|FG007|Open Label Phase|Withdrawal by Subject|0|||
23797811|NCT00401245|66636837|FG000|Open Label Phase|Lack of Efficacy|4|||
23797812|NCT00401245|66636838|FG001|Open Label Phase|Lack of Efficacy|2|||
23797813|NCT00401245|66636839|FG002|Open Label Phase|Lack of Efficacy|3|||
23797814|NCT00401245|66636840|FG003|Open Label Phase|Lack of Efficacy|0|||
23797815|NCT00401245|66636841|FG004|Open Label Phase|Lack of Efficacy|0|||
23797816|NCT00401245|66636842|FG005|Open Label Phase|Lack of Efficacy|0|||
23797817|NCT00401245|66636843|FG006|Open Label Phase|Lack of Efficacy|0|||
23797818|NCT00401245|66636844|FG007|Open Label Phase|Lack of Efficacy|0|||
23797819|NCT00401245|66636837|FG000|Double Blind Tapering Phase|Adverse Event|0|||
23475607|NCT00732940|65485459|FG001|Overall Study|Lost to Follow-up|0|||
23475608|NCT01217307|65485460|FG000|Overall Study|Withdrawal by Subject|0|||
23475609|NCT01217307|65485461|FG001|Overall Study|Withdrawal by Subject|1|||
23475610|NCT00311584|65485462|FG000|Overall Study|Death|1|||
23475611|NCT00311584|65485463|FG001|Overall Study|Death|0|||
23589913|NCT03615924|65889489|FG001|Overall Study|Randomized in error|0|||
23589914|NCT03615924|65889488|FG000|Overall Study|Study termination by Sponsor|94|||
23475612|NCT00311584|65485462|FG000|Overall Study|Lack of Efficacy|12|||
23589915|NCT03615924|65889489|FG001|Overall Study|Study termination by Sponsor|86|||
23589916|NCT00494442|65889490|FG000|Overall Study|Death|1|||
23797820|NCT00401245|66636838|FG001|Double Blind Tapering Phase|Adverse Event|0|||
23797821|NCT00401245|66636839|FG002|Double Blind Tapering Phase|Adverse Event|0|||
23797822|NCT00401245|66636840|FG003|Double Blind Tapering Phase|Adverse Event|0|||
23475613|NCT00311584|65485463|FG001|Overall Study|Lack of Efficacy|15|||
23589917|NCT00494442|65889491|FG001|Overall Study|Death|1|||
23475614|NCT00311584|65485462|FG000|Overall Study|Physician Decision|4|||
23643280|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
23643281|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643282|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
23643283|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23797823|NCT00401245|66636841|FG004|Double Blind Tapering Phase|Adverse Event|1|||
23797824|NCT00401245|66636842|FG005|Double Blind Tapering Phase|Adverse Event|1|||
23797825|NCT00401245|66636843|FG006|Double Blind Tapering Phase|Adverse Event|2|||
23797826|NCT00401245|66636844|FG007|Double Blind Tapering Phase|Adverse Event|4|||
23797827|NCT00401245|66636837|FG000|Double Blind Tapering Phase|Investigator request|0|||
23797828|NCT00401245|66636838|FG001|Double Blind Tapering Phase|Investigator request|0|||
23797829|NCT00401245|66636839|FG002|Double Blind Tapering Phase|Investigator request|0|||
23797830|NCT00401245|66636840|FG003|Double Blind Tapering Phase|Investigator request|0|||
23797831|NCT00401245|66636841|FG004|Double Blind Tapering Phase|Investigator request|0|||
23797832|NCT00401245|66636842|FG005|Double Blind Tapering Phase|Investigator request|0|||
23797833|NCT00401245|66636843|FG006|Double Blind Tapering Phase|Investigator request|0|||
23797834|NCT00401245|66636844|FG007|Double Blind Tapering Phase|Investigator request|1|||
23797835|NCT00401245|66636837|FG000|Double Blind Tapering Phase|Other|0|||
23797836|NCT00401245|66636838|FG001|Double Blind Tapering Phase|Other|0|||
23797837|NCT00401245|66636839|FG002|Double Blind Tapering Phase|Other|0|||
23797838|NCT00401245|66636840|FG003|Double Blind Tapering Phase|Other|0|||
23797839|NCT00401245|66636841|FG004|Double Blind Tapering Phase|Other|1|||
23797840|NCT00401245|66636842|FG005|Double Blind Tapering Phase|Other|0|||
23797841|NCT00401245|66636843|FG006|Double Blind Tapering Phase|Other|2|||
23797842|NCT00401245|66636844|FG007|Double Blind Tapering Phase|Other|2|||
23797843|NCT00401245|66636837|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23797844|NCT00401245|66636838|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23797845|NCT00401245|66636839|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23797846|NCT00401245|66636840|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23797847|NCT00401245|66636841|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
23797848|NCT00401245|66636842|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
23797849|NCT00401245|66636843|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
23797850|NCT00401245|66636844|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23797851|NCT00401245|66636837|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797852|NCT00401245|66636838|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797853|NCT00401245|66636839|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797854|NCT00401245|66636840|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797855|NCT00401245|66636841|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797856|NCT00401245|66636842|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
23797857|NCT00401245|66636843|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797858|NCT00401245|66636844|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
23797859|NCT04253236|66636845|FG000|Overall Study|Adverse Event|1|||
23797860|NCT04253236|66636846|FG001|Overall Study|Adverse Event|0|||
23797861|NCT04253236|66636845|FG000|Overall Study|Safety Concerns|1|||
23797862|NCT04253236|66636846|FG001|Overall Study|Safety Concerns|0|||
23797863|NCT04253236|66636845|FG000|Overall Study|Study Terminated by Sponsor|1|||
23797864|NCT04253236|66636846|FG001|Overall Study|Study Terminated by Sponsor|0|||
23797865|NCT02447887|66636847|FG000|Overall Study|Study was terminated|3|||
23797866|NCT01517867|66636848|FG000|Overall Study|never started treatment|29|||
23797867|NCT01517867|66636849|FG001|Overall Study|never started treatment|32|||
23797868|NCT01517867|66636848|FG000|Overall Study|Withdrawal by Subject|34|||
23797869|NCT01517867|66636849|FG001|Overall Study|Withdrawal by Subject|30|||
23797870|NCT01517867|66636848|FG000|Overall Study|Still in treatment at study end|0|||
23797871|NCT01517867|66636849|FG001|Overall Study|Still in treatment at study end|3|||
23643284|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23797872|NCT00108628|66636850|FG000|Overall Study|Withdrawal by Subject|17|||
23797873|NCT00108628|66636851|FG001|Overall Study|Withdrawal by Subject|9|||
23358776|NCT02757625|65056402|FG000|Overall Study|Adverse Event|0|||
23797874|NCT00108628|66636850|FG000|Overall Study|Lack of Efficacy|2|||
23797875|NCT00108628|66636851|FG001|Overall Study|Lack of Efficacy|1|||
23797876|NCT00108628|66636850|FG000|Overall Study|Death|1|||
23797877|NCT00108628|66636851|FG001|Overall Study|Death|0|||
23797878|NCT03635983|66636865|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
23797879|NCT03635983|66636866|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
23797880|NCT03635983|66636865|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23797881|NCT03635983|66636866|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
23797882|NCT03635983|66636865|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23797883|NCT03635983|66636866|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23797884|NCT03635983|66636865|FG000|Pre-Treatment Period|Other reasons|1|||
23797885|NCT03635983|66636866|FG001|Pre-Treatment Period|Other reasons|2|||
23797886|NCT03635983|66636865|FG000|Pre-Treatment Period|Disease Progression|0|||
23797887|NCT03635983|66636866|FG001|Pre-Treatment Period|Disease Progression|1|||
23797888|NCT03635983|66636865|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
23797889|NCT03635983|66636866|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
23797890|NCT03635983|66636865|FG000|Treatment Period|Completed treatment period|13|||
23797891|NCT03635983|66636866|FG001|Treatment Period|Completed treatment period|20|||
23797892|NCT03635983|66636865|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
23797893|NCT03635983|66636866|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
23797894|NCT03635983|66636865|FG000|Treatment Period|Withdrawal by Subject|2|||
23797895|NCT03635983|66636866|FG001|Treatment Period|Withdrawal by Subject|4|||
23797896|NCT03635983|66636865|FG000|Treatment Period|Death|3|||
23797897|NCT03635983|66636866|FG001|Treatment Period|Death|4|||
23797898|NCT03635983|66636865|FG000|Treatment Period|Poor/Non-compliance|1|||
23797899|NCT03635983|66636866|FG001|Treatment Period|Poor/Non-compliance|0|||
23797900|NCT03635983|66636865|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
23797901|NCT03635983|66636866|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
23797902|NCT03635983|66636865|FG000|Treatment Period|Other reasons|5|||
23797903|NCT03635983|66636866|FG001|Treatment Period|Other reasons|2|||
23797904|NCT03635983|66636865|FG000|Treatment Period|Disease progression|184|||
23797905|NCT03635983|66636866|FG001|Treatment Period|Disease progression|168|||
23797906|NCT03635983|66636865|FG000|Treatment Period|Study drug toxicity|26|||
23797907|NCT03635983|66636866|FG001|Treatment Period|Study drug toxicity|29|||
23797908|NCT03635983|66636865|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
23797909|NCT03635983|66636866|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
23797910|NCT03635983|66636865|FG000|Treatment Period|Maximum clinical benefit|3|||
23797911|NCT03635983|66636866|FG001|Treatment Period|Maximum clinical benefit|2|||
23797912|NCT01717040|66636867|FG000|Overall Study|Lost to Follow-up|2|||
23797913|NCT01717040|66636868|FG001|Overall Study|Lost to Follow-up|3|||
23797914|NCT01717040|66636867|FG000|Overall Study|Lack of Efficacy|1|||
23797915|NCT01717040|66636868|FG001|Overall Study|Lack of Efficacy|1|||
23797916|NCT01717040|66636867|FG000|Overall Study|Adverse Event|1|||
23797917|NCT01717040|66636868|FG001|Overall Study|Adverse Event|0|||
23797918|NCT01717040|66636867|FG000|Overall Study|Required Medication Change|0|||
23797919|NCT01717040|66636868|FG001|Overall Study|Required Medication Change|1|||
23797920|NCT01717040|66636867|FG000|Overall Study|New Substance Use Disorder|1|||
23797921|NCT01717040|66636868|FG001|Overall Study|New Substance Use Disorder|0|||
23797922|NCT02522780|66636869|FG000|Overall Study|Consent withdrawn by subject|5|||
23797923|NCT02522780|66636870|FG001|Overall Study|Consent withdrawn by subject|7|||
23797924|NCT02522780|66636869|FG000|Overall Study|Protocol deviation|1|||
23797925|NCT02522780|66636870|FG001|Overall Study|Protocol deviation|3|||
23797926|NCT02522780|66636869|FG000|Overall Study|Subject refused endoscopic procedure|0|||
23797927|NCT02522780|66636870|FG001|Overall Study|Subject refused endoscopic procedure|1|||
23797928|NCT02522780|66636869|FG000|Overall Study|Adverse event, non-fatal|11|||
23797929|NCT02522780|66636870|FG001|Overall Study|Adverse event, non-fatal|16|||
23797930|NCT02274558|66636871|FG000|Overall Study|Adverse Event|2|||
23797931|NCT02274558|66636872|FG001|Overall Study|Adverse Event|4|||
23797932|NCT02274558|66636873|FG002|Overall Study|Adverse Event|2|||
23797933|NCT02274558|66636871|FG000|Overall Study|Non-compliance|2|||
23797934|NCT02274558|66636872|FG001|Overall Study|Non-compliance|1|||
23797935|NCT02274558|66636873|FG002|Overall Study|Non-compliance|0|||
23797936|NCT02274558|66636871|FG000|Overall Study|Withdrawal by Subject|1|||
23797937|NCT02274558|66636872|FG001|Overall Study|Withdrawal by Subject|5|||
23797938|NCT02274558|66636873|FG002|Overall Study|Withdrawal by Subject|4|||
23797939|NCT02274558|66636871|FG000|Overall Study|Death|0|||
23797940|NCT02274558|66636872|FG001|Overall Study|Death|0|||
23797941|NCT02274558|66636873|FG002|Overall Study|Death|1|||
23797942|NCT02274558|66636871|FG000|Overall Study|Lost to Follow-up|2|||
23797943|NCT02274558|66636872|FG001|Overall Study|Lost to Follow-up|1|||
23797944|NCT02274558|66636873|FG002|Overall Study|Lost to Follow-up|1|||
23797945|NCT02274558|66636871|FG000|Overall Study|Physician Decision|0|||
23797946|NCT02274558|66636872|FG001|Overall Study|Physician Decision|2|||
23797947|NCT02274558|66636873|FG002|Overall Study|Physician Decision|1|||
23797948|NCT03136406|66636875|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
23797949|NCT03078478|66636876|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
23797950|NCT03078478|66636877|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
23797951|NCT03078478|66636876|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
23797952|NCT03078478|66636877|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
23797953|NCT03078478|66636876|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
23797954|NCT03078478|66636877|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
23797955|NCT03078478|66636876|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
23797956|NCT03078478|66636877|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
23797957|NCT03078478|66636876|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
23643285|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643286|NCT00833833|66079091|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
23643287|NCT00833833|66079092|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
23643288|NCT00833833|66079093|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
23643289|NCT00833833|66079094|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
23643290|NCT00833833|66079095|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
23643291|NCT00833833|66079096|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
23643292|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23643293|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23643294|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23643295|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23643296|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
23643297|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
23643298|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23643299|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23643300|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23643301|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23643302|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
23643303|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
23643304|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
23643305|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
23643306|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
23643307|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
23643308|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
23643309|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
23643310|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643311|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643312|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643313|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23643314|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
23643315|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
23643316|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23643317|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23643318|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23643319|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23643320|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
23643321|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
23643322|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
23643323|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
23643324|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
23643325|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
23643326|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
23643327|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
23643328|NCT00833833|66079091|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23643329|NCT00833833|66079092|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23643330|NCT00833833|66079093|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23643331|NCT00833833|66079094|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23643332|NCT00833833|66079095|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23643333|NCT00833833|66079096|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
23643334|NCT00370682|66079097|FG000|Overall Study|Moved from area|0|||
23643335|NCT00370682|66079098|FG001|Overall Study|Moved from area|2|||
23643336|NCT00370682|66079099|FG002|Overall Study|Moved from area|0|||
23643337|NCT00370682|66079097|FG000|Overall Study|Lost to Follow-up|0|||
23643338|NCT00370682|66079098|FG001|Overall Study|Lost to Follow-up|1|||
23643339|NCT00370682|66079099|FG002|Overall Study|Lost to Follow-up|1|||
23643340|NCT02581631|66079103|FG000|Overall Study|Disease progression|29|||
23643341|NCT02581631|66079104|FG001|Overall Study|Disease progression|19|||
23643342|NCT02581631|66079105|FG002|Overall Study|Disease progression|13|||
23643343|NCT02581631|66079106|FG003|Overall Study|Disease progression|5|||
23643344|NCT02581631|66079107|FG004|Overall Study|Disease progression|8|||
23643345|NCT02581631|66079103|FG000|Overall Study|Study drug toxicity|4|||
23643346|NCT02581631|66079104|FG001|Overall Study|Study drug toxicity|6|||
23643347|NCT02581631|66079105|FG002|Overall Study|Study drug toxicity|7|||
23643348|NCT02581631|66079106|FG003|Overall Study|Study drug toxicity|0|||
23643349|NCT02581631|66079107|FG004|Overall Study|Study drug toxicity|3|||
23643350|NCT02581631|66079103|FG000|Overall Study|AE unrelated to study drug|3|||
23643351|NCT02581631|66079104|FG001|Overall Study|AE unrelated to study drug|1|||
23643352|NCT02581631|66079105|FG002|Overall Study|AE unrelated to study drug|1|||
23643353|NCT02581631|66079106|FG003|Overall Study|AE unrelated to study drug|0|||
23643354|NCT02581631|66079107|FG004|Overall Study|AE unrelated to study drug|2|||
23643355|NCT02581631|66079103|FG000|Overall Study|Request to discontinue|1|||
23358777|NCT02757625|65056403|FG001|Overall Study|Adverse Event|0|||
23358778|NCT02757625|65056404|FG002|Overall Study|Adverse Event|1|||
23358779|NCT02757625|65056405|FG003|Overall Study|Adverse Event|0|||
23358780|NCT02112877|65056406|FG000|Overall Study|Withdrawal by Subject|1|||
23797958|NCT03078478|66636877|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
23797959|NCT03078478|66636876|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
23797960|NCT03078478|66636877|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
23797961|NCT03078478|66636876|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
23797962|NCT03078478|66636877|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
23797963|NCT03078478|66636876|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
23797964|NCT03078478|66636877|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
23797965|NCT04102345|66636888|FG000|Overall Study|Withdrawal by Subject|1|||
23643356|NCT02581631|66079104|FG001|Overall Study|Request to discontinue|0|||
23643357|NCT02581631|66079105|FG002|Overall Study|Request to discontinue|3|||
23643358|NCT02581631|66079106|FG003|Overall Study|Request to discontinue|0|||
23643359|NCT02581631|66079107|FG004|Overall Study|Request to discontinue|1|||
23643360|NCT02581631|66079103|FG000|Overall Study|participant withdrew consent|3|||
23797966|NCT04102345|66636889|FG001|Overall Study|Withdrawal by Subject|0|||
23797967|NCT01546519|66636890|FG000|Overall Study|Adverse Event|0|||
23797968|NCT01546519|66636891|FG001|Overall Study|Adverse Event|0|||
23797969|NCT01546519|66636892|FG002|Overall Study|Adverse Event|1|||
23797970|NCT01546519|66636893|FG003|Overall Study|Adverse Event|1|||
23797971|NCT01546519|66636890|FG000|Overall Study|Death|0|||
23797972|NCT01546519|66636891|FG001|Overall Study|Death|1|||
23797973|NCT01546519|66636892|FG002|Overall Study|Death|3|||
23797974|NCT01546519|66636893|FG003|Overall Study|Death|1|||
23797975|NCT01546519|66636890|FG000|Overall Study|related to disease progression|2|||
23797976|NCT01546519|66636891|FG001|Overall Study|related to disease progression|2|||
23797977|NCT01546519|66636892|FG002|Overall Study|related to disease progression|2|||
23797978|NCT01546519|66636893|FG003|Overall Study|related to disease progression|1|||
23797979|NCT01546519|66636890|FG000|Overall Study|Physician Decision|6|||
23797980|NCT01546519|66636891|FG001|Overall Study|Physician Decision|5|||
23797981|NCT01546519|66636892|FG002|Overall Study|Physician Decision|2|||
23797982|NCT01546519|66636893|FG003|Overall Study|Physician Decision|3|||
23797983|NCT01546519|66636890|FG000|Overall Study|Withdrawal by Subject|1|||
23797984|NCT01546519|66636891|FG001|Overall Study|Withdrawal by Subject|0|||
23797985|NCT01546519|66636892|FG002|Overall Study|Withdrawal by Subject|0|||
23797986|NCT01546519|66636893|FG003|Overall Study|Withdrawal by Subject|0|||
23797987|NCT03554317|66636894|FG000|Overall Study|Withdrawal by Subject|1|||
23797988|NCT03554317|66636894|FG000|Overall Study|PSA Progression|3|||
23358781|NCT02112877|65056407|FG001|Overall Study|Withdrawal by Subject|7|||
23358782|NCT02112877|65056406|FG000|Overall Study|Visit Missed|1|||
23358783|NCT02112877|65056407|FG001|Overall Study|Visit Missed|6|||
23358784|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23358785|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358786|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358787|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358788|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
23589918|NCT00494442|65889490|FG000|Overall Study|Lack of Efficacy|16|||
23797989|NCT03554317|66636894|FG000|Overall Study|Radiographic Progression|4|||
23797990|NCT01294449|66636895|FG000|Overall Study|Death|11|||
23797991|NCT01294449|66636896|FG001|Overall Study|Death|12|||
23797992|NCT01294449|66636895|FG000|Overall Study|Withdrawal by Subject|1|||
23797993|NCT01294449|66636896|FG001|Overall Study|Withdrawal by Subject|3|||
23797994|NCT02853331|66636897|FG000|Overall Study|Death|59|||
23589919|NCT00494442|65889491|FG001|Overall Study|Lack of Efficacy|10|||
23797995|NCT02853331|66636898|FG001|Overall Study|Death|95|||
23797996|NCT02853331|66636897|FG000|Overall Study|Withdrawal by Subject|5|||
23589920|NCT00494442|65889490|FG000|Overall Study|Adverse Event|0|||
23475615|NCT00311584|65485463|FG001|Overall Study|Physician Decision|5|||
23475616|NCT00311584|65485462|FG000|Overall Study|Withdrawal by Subject|1|||
23475617|NCT00311584|65485463|FG001|Overall Study|Withdrawal by Subject|1|||
23475618|NCT00311584|65485462|FG000|Overall Study|ineligible|2|||
23475619|NCT00311584|65485463|FG001|Overall Study|ineligible|2|||
23475620|NCT03180619|65485464|FG000|Overall Study|Withdrew Consent|5|||
23475621|NCT03180619|65485465|FG001|Overall Study|Withdrew Consent|0|||
23475622|NCT03180619|65485466|FG002|Overall Study|Withdrew Consent|2|||
23475623|NCT03180619|65485464|FG000|Overall Study|Death|2|||
23475624|NCT03180619|65485465|FG001|Overall Study|Death|1|||
23475625|NCT03180619|65485466|FG002|Overall Study|Death|2|||
23475626|NCT03180619|65485464|FG000|Overall Study|Adverse Event|2|||
23475627|NCT03180619|65485465|FG001|Overall Study|Adverse Event|0|||
23475628|NCT03180619|65485466|FG002|Overall Study|Adverse Event|1|||
23475629|NCT03180619|65485464|FG000|Overall Study|Investigator's discretion|2|||
23475630|NCT03180619|65485465|FG001|Overall Study|Investigator's discretion|0|||
23475631|NCT03180619|65485466|FG002|Overall Study|Investigator's discretion|1|||
23475632|NCT01947855|65485470|FG000|Overall Study|Withdrawal by Subject|1|||
23475633|NCT01947855|65485471|FG001|Overall Study|Withdrawal by Subject|0|||
23589921|NCT00494442|65889491|FG001|Overall Study|Adverse Event|2|||
23589922|NCT00494442|65889490|FG000|Overall Study|Physician Decision|0|||
23589923|NCT00494442|65889491|FG001|Overall Study|Physician Decision|1|||
23797997|NCT02853331|66636898|FG001|Overall Study|Withdrawal by Subject|9|||
23797998|NCT02853331|66636897|FG000|Overall Study|Ongoing in study|368|||
23797999|NCT02853331|66636898|FG001|Overall Study|Ongoing in study|325|||
23798000|NCT02010255|66636901|FG000|Overall Study|Death|0|||
23798001|NCT02010255|66636902|FG001|Overall Study|Death|1|||
23798002|NCT02010255|66636903|FG002|Overall Study|Death|4|||
23798003|NCT02010255|66636904|FG003|Overall Study|Death|4|||
23798004|NCT02010255|66636905|FG004|Overall Study|Death|2|||
23798005|NCT02010255|66636906|FG005|Overall Study|Death|0|||
23798006|NCT02010255|66636907|FG006|Overall Study|Death|1|||
23798007|NCT02010255|66636908|FG007|Overall Study|Death|1|||
23798008|NCT02010255|66636909|FG008|Overall Study|Death|1|||
23589924|NCT00494442|65889490|FG000|Overall Study|Non-compliance|0|||
23589925|NCT00494442|65889491|FG001|Overall Study|Non-compliance|1|||
23589926|NCT00494442|65889490|FG000|Overall Study|Intercurrent illness|0|||
23589927|NCT00494442|65889491|FG001|Overall Study|Intercurrent illness|1|||
23589928|NCT03257813|65889492|FG000|Overall Study|Protocol Violation|6|||
23475634|NCT01947855|65485472|FG002|Overall Study|Withdrawal by Subject|0|||
23475635|NCT03263702|65485491|FG000|Overall Study|Lost to Follow-up|2|||
23475636|NCT03263702|65485492|FG001|Overall Study|Lost to Follow-up|2|||
23589929|NCT03257813|65889493|FG001|Overall Study|Protocol Violation|3|||
23589930|NCT00754936|65889495|FG000|Overall Study|Lost to Follow-up|3|||
23798009|NCT02010255|66636910|FG009|Overall Study|Death|0|||
23798010|NCT02010255|66636911|FG010|Overall Study|Death|1|||
23475637|NCT03263702|65485491|FG000|Overall Study|Withdrawal by Subject|1|||
23475638|NCT03263702|65485492|FG001|Overall Study|Withdrawal by Subject|2|||
23589931|NCT00754936|65889495|FG000|Overall Study|Physician Decision|1|||
23798011|NCT02010255|66636912|FG011|Overall Study|Death|1|||
23798012|NCT02010255|66636913|FG012|Overall Study|Death|0|||
23643361|NCT02581631|66079104|FG001|Overall Study|participant withdrew consent|0|||
23643362|NCT02581631|66079105|FG002|Overall Study|participant withdrew consent|1|||
23643363|NCT02581631|66079106|FG003|Overall Study|participant withdrew consent|0|||
23643364|NCT02581631|66079107|FG004|Overall Study|participant withdrew consent|0|||
23643365|NCT02581631|66079103|FG000|Overall Study|Maximum clinical benefit|1|||
23643366|NCT02581631|66079104|FG001|Overall Study|Maximum clinical benefit|7|||
23643367|NCT02581631|66079105|FG002|Overall Study|Maximum clinical benefit|1|||
23643368|NCT02581631|66079106|FG003|Overall Study|Maximum clinical benefit|3|||
23643369|NCT02581631|66079107|FG004|Overall Study|Maximum clinical benefit|13|||
23643370|NCT02581631|66079103|FG000|Overall Study|Other Reasons|1|||
23643371|NCT02581631|66079104|FG001|Overall Study|Other Reasons|0|||
23643372|NCT02581631|66079105|FG002|Overall Study|Other Reasons|2|||
23643373|NCT02581631|66079106|FG003|Overall Study|Other Reasons|2|||
23643374|NCT02581631|66079107|FG004|Overall Study|Other Reasons|3|||
23643375|NCT02581631|66079103|FG000|Overall Study|Poor/Non-Compliance|0|||
23643376|NCT02581631|66079104|FG001|Overall Study|Poor/Non-Compliance|0|||
23643377|NCT02581631|66079105|FG002|Overall Study|Poor/Non-Compliance|1|||
23643378|NCT02581631|66079106|FG003|Overall Study|Poor/Non-Compliance|0|||
23643379|NCT02581631|66079107|FG004|Overall Study|Poor/Non-Compliance|0|||
23643380|NCT02387970|66079110|FG000|Overall Study|Did not complete 1-year follow up|1|||
23643381|NCT02387970|66079111|FG001|Overall Study|Did not complete 1-year follow up|2|||
23643382|NCT05114473|66079118|FG000|Overall Study|Lost to Follow-up|2|||
23643383|NCT05114473|66079119|FG001|Overall Study|Lost to Follow-up|2|||
23643384|NCT05114473|66079120|FG002|Overall Study|Lost to Follow-up|0|||
23643385|NCT00434213|66079121|FG000|Overall Study|Adverse Event|12|||
23643386|NCT00434213|66079121|FG000|Overall Study|Lack of Efficacy|9|||
23643387|NCT00434213|66079121|FG000|Overall Study|Lost to Follow-up|14|||
23643388|NCT00434213|66079121|FG000|Overall Study|Withdrawal by Subject|7|||
23643389|NCT00434213|66079121|FG000|Overall Study|Protocol Violation|3|||
23643390|NCT00434213|66079121|FG000|Overall Study|Unable to comply with study visit window|2|||
23643391|NCT00434213|66079121|FG000|Overall Study|Application site reaction|1|||
23643392|NCT00434213|66079121|FG000|Overall Study|Non-compliant to study schedule|1|||
23643393|NCT01014533|66079122|FG000|Overall Study|Protocol Violation|3|||
23643394|NCT01014533|66079123|FG001|Overall Study|Protocol Violation|2|||
23643395|NCT01014533|66079122|FG000|Overall Study|Withdrawal by Subject|2|||
23643396|NCT01014533|66079123|FG001|Overall Study|Withdrawal by Subject|0|||
23643397|NCT01014533|66079122|FG000|Overall Study|unable to come to appointment|0|||
23643398|NCT01014533|66079123|FG001|Overall Study|unable to come to appointment|3|||
23643399|NCT01820585|66079124|FG000|Overall Study|Adverse Event|9|||
23643400|NCT01820585|66079125|FG001|Overall Study|Adverse Event|13|||
23643401|NCT01820585|66079126|FG002|Overall Study|Adverse Event|23|||
23643402|NCT01820585|66079127|FG003|Overall Study|Adverse Event|34|||
23643403|NCT01820585|66079124|FG000|Overall Study|Lack of Efficacy|9|||
23643404|NCT01820585|66079125|FG001|Overall Study|Lack of Efficacy|7|||
23643405|NCT01820585|66079126|FG002|Overall Study|Lack of Efficacy|5|||
23643406|NCT01820585|66079127|FG003|Overall Study|Lack of Efficacy|1|||
23589932|NCT00754936|65889495|FG000|Overall Study|Withdrawal by Subject|2|||
23643407|NCT01820585|66079124|FG000|Overall Study|Withdrawal by Subject|3|||
23798013|NCT02010255|66636914|FG013|Overall Study|Death|0|||
23358789|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
23589933|NCT00754936|65889495|FG000|Overall Study|Side Effects|3|||
23643408|NCT01820585|66079125|FG001|Overall Study|Withdrawal by Subject|7|||
23643409|NCT01820585|66079126|FG002|Overall Study|Withdrawal by Subject|3|||
23643410|NCT01820585|66079127|FG003|Overall Study|Withdrawal by Subject|8|||
23643411|NCT01820585|66079124|FG000|Overall Study|Lost to Follow-up|3|||
23643412|NCT01820585|66079125|FG001|Overall Study|Lost to Follow-up|3|||
23643413|NCT01820585|66079126|FG002|Overall Study|Lost to Follow-up|0|||
23643414|NCT01820585|66079127|FG003|Overall Study|Lost to Follow-up|3|||
23643415|NCT01820585|66079124|FG000|Overall Study|Protocol Violation|3|||
23643416|NCT01820585|66079125|FG001|Overall Study|Protocol Violation|1|||
23643417|NCT01820585|66079126|FG002|Overall Study|Protocol Violation|1|||
23643418|NCT01820585|66079127|FG003|Overall Study|Protocol Violation|1|||
23643419|NCT01820585|66079124|FG000|Overall Study|Subject non-compliance|0|||
23643420|NCT01820585|66079125|FG001|Overall Study|Subject non-compliance|0|||
23643421|NCT01820585|66079126|FG002|Overall Study|Subject non-compliance|1|||
23643422|NCT01820585|66079127|FG003|Overall Study|Subject non-compliance|2|||
23643423|NCT01820585|66079124|FG000|Overall Study|at sponsor request|0|||
23643424|NCT01820585|66079125|FG001|Overall Study|at sponsor request|0|||
23643425|NCT01820585|66079126|FG002|Overall Study|at sponsor request|1|||
23643426|NCT01820585|66079127|FG003|Overall Study|at sponsor request|0|||
23643427|NCT01820585|66079124|FG000|Overall Study|Pregnancy|0|||
23643428|NCT01820585|66079125|FG001|Overall Study|Pregnancy|1|||
23643429|NCT01820585|66079126|FG002|Overall Study|Pregnancy|0|||
23643430|NCT01820585|66079127|FG003|Overall Study|Pregnancy|0|||
23643431|NCT05326815|66079128|FG000|Overall Study|Withdrawal by Subject|3|||
23643432|NCT05326815|66079128|FG000|Overall Study|Did not complete required labs|6|||
23643433|NCT05326815|66079128|FG000|Overall Study|Screen fail- abnormal labs|5|||
23643434|NCT00918580|66079129|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
23643435|NCT00918580|66079129|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
23643436|NCT00918580|66079129|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
23643437|NCT00918580|66079129|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
23643438|NCT00918580|66079129|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
23643439|NCT00918580|66079129|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
23643440|NCT00918580|66079129|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
23643441|NCT00923260|66079131|FG000|Overall Study|Lost to Follow-up|1|||
23643442|NCT00923260|66079132|FG001|Overall Study|Lost to Follow-up|1|||
23643443|NCT00847808|66079133|FG000|Overall Study|Adverse Event|7|||
23643444|NCT00847808|66079133|FG000|Overall Study|Protocol Violation|1|||
23643445|NCT00847808|66079133|FG000|Overall Study|Lost to Follow-up|1|||
23643446|NCT00847808|66079133|FG000|Overall Study|Withdrawal by Subject|4|||
23643447|NCT00847808|66079133|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
23643448|NCT00847808|66079133|FG000|Overall Study|Participant Took Excluded Medication|1|||
23643449|NCT02874924|66079134|FG000|Overall Study|Adverse Event|2|||
23643450|NCT02874924|66079135|FG001|Overall Study|Adverse Event|0|||
23643451|NCT02874924|66079136|FG002|Overall Study|Adverse Event|0|||
23643452|NCT02874924|66079134|FG000|Overall Study|Withdrawal by Subject|1|||
23643453|NCT02874924|66079135|FG001|Overall Study|Withdrawal by Subject|0|||
23475639|NCT01324141|65485493|FG000|Overall Study|Declined to participate before treatment started|1|||
23475640|NCT01324141|65485493|FG000|Overall Study|Disease progression on study|1|||
23475641|NCT01652469|65485495|FG000|Overall Study|Withdrawal by Subject|1|||
23475642|NCT01652469|65485496|FG001|Overall Study|Withdrawal by Subject|4|||
23475643|NCT01652469|65485495|FG000|Overall Study|Lost to Follow-up|0|||
23475644|NCT01652469|65485496|FG001|Overall Study|Lost to Follow-up|2|||
23475645|NCT04661579|65485505|FG000|Overall Study|Lost to Follow-up|19|||
23475646|NCT04661579|65485506|FG001|Overall Study|Lost to Follow-up|10|||
23475647|NCT04661579|65485507|FG002|Overall Study|Lost to Follow-up|2|||
23475648|NCT04661579|65485508|FG003|Overall Study|Lost to Follow-up|7|||
23475649|NCT04661579|65485509|FG004|Overall Study|Lost to Follow-up|11|||
23358790|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358791|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358792|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
23358793|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358794|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358795|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358796|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358797|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23358798|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23475650|NCT04661579|65485505|FG000|Overall Study|Physician Decision|2|||
23475651|NCT04661579|65485506|FG001|Overall Study|Physician Decision|0|||
23475652|NCT04661579|65485507|FG002|Overall Study|Physician Decision|0|||
23475653|NCT04661579|65485508|FG003|Overall Study|Physician Decision|1|||
23475654|NCT04661579|65485509|FG004|Overall Study|Physician Decision|0|||
23475655|NCT04661579|65485505|FG000|Overall Study|Withdrawal by Subject|1|||
23475656|NCT04661579|65485506|FG001|Overall Study|Withdrawal by Subject|4|||
23475657|NCT04661579|65485507|FG002|Overall Study|Withdrawal by Subject|0|||
23475658|NCT04661579|65485508|FG003|Overall Study|Withdrawal by Subject|2|||
23475659|NCT04661579|65485509|FG004|Overall Study|Withdrawal by Subject|0|||
23358799|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358800|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358801|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358802|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358803|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
23358804|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358805|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358806|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358807|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358808|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358809|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358810|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23475660|NCT04661579|65485505|FG000|Overall Study|Death|1|||
23475661|NCT04661579|65485506|FG001|Overall Study|Death|0|||
23475662|NCT04661579|65485507|FG002|Overall Study|Death|0|||
23475663|NCT04661579|65485508|FG003|Overall Study|Death|0|||
23475664|NCT04661579|65485509|FG004|Overall Study|Death|0|||
23475665|NCT04661579|65485505|FG000|Overall Study|Other|1|||
23475666|NCT04661579|65485506|FG001|Overall Study|Other|2|||
23475667|NCT04661579|65485507|FG002|Overall Study|Other|1|||
23475668|NCT04661579|65485508|FG003|Overall Study|Other|1|||
23475669|NCT04661579|65485509|FG004|Overall Study|Other|1|||
23798014|NCT02010255|66636901|FG000|Overall Study|Lack of Efficacy|4|||
23475670|NCT04661579|65485505|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
23475671|NCT04661579|65485506|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
23475672|NCT04661579|65485507|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
23475673|NCT04661579|65485508|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
23475674|NCT04661579|65485509|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
23475675|NCT00337675|65485510|FG000|Overall Study|Adverse Event|10|||
23475676|NCT00337675|65485511|FG001|Overall Study|Adverse Event|9|||
23475677|NCT00337675|65485512|FG002|Overall Study|Adverse Event|19|||
23475678|NCT00337675|65485510|FG000|Overall Study|Lack of Efficacy|10|||
23475679|NCT00337675|65485511|FG001|Overall Study|Lack of Efficacy|7|||
23589934|NCT00754936|65889495|FG000|Overall Study|Inter-current medical events|3|||
23589935|NCT00628862|65889496|FG000|Overall Study|Adverse Event|6|||
23589936|NCT00628862|65889497|FG001|Overall Study|Adverse Event|8|||
23589937|NCT00628862|65889498|FG002|Overall Study|Adverse Event|10|||
23589938|NCT00628862|65889496|FG000|Overall Study|Withdrawal by Subject|4|||
23589939|NCT00628862|65889497|FG001|Overall Study|Withdrawal by Subject|6|||
23589940|NCT00628862|65889498|FG002|Overall Study|Withdrawal by Subject|11|||
23475680|NCT00337675|65485512|FG002|Overall Study|Lack of Efficacy|9|||
23475681|NCT00337675|65485510|FG000|Overall Study|Lost to Follow-up|22|||
23475682|NCT00337675|65485511|FG001|Overall Study|Lost to Follow-up|19|||
23475683|NCT00337675|65485512|FG002|Overall Study|Lost to Follow-up|17|||
23475684|NCT00337675|65485510|FG000|Overall Study|Physician Decision|9|||
23475685|NCT00337675|65485511|FG001|Overall Study|Physician Decision|17|||
23475686|NCT00337675|65485512|FG002|Overall Study|Physician Decision|14|||
23475687|NCT00337675|65485510|FG000|Overall Study|Protocol Violation|21|||
23475688|NCT00337675|65485511|FG001|Overall Study|Protocol Violation|24|||
23475689|NCT00337675|65485512|FG002|Overall Study|Protocol Violation|19|||
23475690|NCT00337675|65485510|FG000|Overall Study|Withdrawal by Subject|25|||
23475691|NCT00337675|65485511|FG001|Overall Study|Withdrawal by Subject|25|||
23475692|NCT00337675|65485512|FG002|Overall Study|Withdrawal by Subject|19|||
23475693|NCT00337675|65485510|FG000|Overall Study|Progressive Disease|0|||
23475694|NCT00337675|65485511|FG001|Overall Study|Progressive Disease|2|||
23475695|NCT00337675|65485512|FG002|Overall Study|Progressive Disease|0|||
23475696|NCT00337675|65485510|FG000|Overall Study|Trial Terminated|0|||
23475697|NCT00337675|65485511|FG001|Overall Study|Trial Terminated|0|||
23475698|NCT00337675|65485512|FG002|Overall Study|Trial Terminated|2|||
23475699|NCT02881567|65485513|FG000|Overall Study|Adverse Event|1|||
23475700|NCT02881567|65485513|FG000|Overall Study|Lost to Follow-up|3|||
23589941|NCT00628862|65889496|FG000|Overall Study|Lost to Follow-up|0|||
23589942|NCT00628862|65889497|FG001|Overall Study|Lost to Follow-up|2|||
23589943|NCT00628862|65889498|FG002|Overall Study|Lost to Follow-up|1|||
23589944|NCT00628862|65889496|FG000|Overall Study|Protocol Violation|1|||
23589945|NCT00628862|65889497|FG001|Overall Study|Protocol Violation|0|||
23589946|NCT00628862|65889498|FG002|Overall Study|Protocol Violation|0|||
23589947|NCT00628862|65889496|FG000|Overall Study|COPD Exacerbation|0|||
23589948|NCT00628862|65889497|FG001|Overall Study|COPD Exacerbation|1|||
23589949|NCT00628862|65889498|FG002|Overall Study|COPD Exacerbation|0|||
23589950|NCT01505881|65889499|FG000|Overall Study|Adverse Event|0|||
23589951|NCT01505881|65889500|FG001|Overall Study|Adverse Event|1|||
23589952|NCT01505881|65889499|FG000|Overall Study|Lost to Follow-up|2|||
23589953|NCT01505881|65889500|FG001|Overall Study|Lost to Follow-up|0|||
23589954|NCT01505881|65889499|FG000|Overall Study|Withdrawal by Subject|2|||
23589955|NCT01505881|65889500|FG001|Overall Study|Withdrawal by Subject|0|||
23589956|NCT04678830|65889501|FG000|Overall Study|Lack of Efficacy|2|||
23589957|NCT04678830|65889502|FG001|Overall Study|Lack of Efficacy|0|||
23589958|NCT04678830|65889501|FG000|Overall Study|Withdrawal by Subject|0|||
23589959|NCT04678830|65889502|FG001|Overall Study|Withdrawal by Subject|1|||
23589960|NCT01251354|65889517|FG000|Overall Study|Adverse Event|1|||
23589961|NCT01251354|65889517|FG000|Overall Study|Investigator's Decision|1|||
23589962|NCT01251354|65889517|FG000|Overall Study|Disease Progression|4|||
23589963|NCT01370694|65889518|FG000|Overall Study|Switched to rituximab|4|||
23589964|NCT01370694|65889518|FG000|Overall Study|Progressive disease|2|||
23589965|NCT00970307|65889519|FG000|Overall Study|Serious Adverse Event|1|||
23589966|NCT00970307|65889520|FG001|Overall Study|Serious Adverse Event|0|||
23589967|NCT00970307|65889521|FG002|Overall Study|Serious Adverse Event|0|||
23475701|NCT02881567|65485513|FG000|Overall Study|Consent withdrawn|1|||
23589968|NCT00970307|65889519|FG000|Overall Study|Withdrawal by Subject|2|||
23589969|NCT00970307|65889520|FG001|Overall Study|Withdrawal by Subject|3|||
23475702|NCT02881567|65485513|FG000|Overall Study|Investigator decision|1|||
23475703|NCT02881567|65485513|FG000|Overall Study|Study terminated by sponsor|9|||
23475704|NCT02881567|65485513|FG000|Overall Study|Reason not Specified|3|||
23475705|NCT02270944|65485516|FG000|Overall Study|Lost to Follow-up|9|||
23475706|NCT02270944|65485517|FG001|Overall Study|Lost to Follow-up|4|||
23475707|NCT02270944|65485516|FG000|Overall Study|Withdrawal by Subject|2|||
23475708|NCT02270944|65485517|FG001|Overall Study|Withdrawal by Subject|1|||
23589970|NCT00970307|65889521|FG002|Overall Study|Withdrawal by Subject|2|||
23798015|NCT02010255|66636902|FG001|Overall Study|Lack of Efficacy|1|||
23589971|NCT01025843|65889522|FG000|Washout 4|Withdrawal by Subject|0|||
23475709|NCT02891070|65485518|FG000|Overall Study|Adverse Event|1|||
23475710|NCT02891070|65485519|FG001|Overall Study|Adverse Event|0|||
23475711|NCT02891070|65485518|FG000|Overall Study|Physician Decision|0|||
23475712|NCT02891070|65485519|FG001|Overall Study|Physician Decision|1|||
23475713|NCT02891070|65485518|FG000|Overall Study|Lost to Follow-up|4|||
23475714|NCT02891070|65485519|FG001|Overall Study|Lost to Follow-up|4|||
23358811|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358812|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23475715|NCT02891070|65485518|FG000|Overall Study|Other|1|||
23475716|NCT02891070|65485519|FG001|Overall Study|Other|0|||
23475717|NCT02891070|65485518|FG000|Overall Study|Protocol Violation|0|||
23475718|NCT02891070|65485519|FG001|Overall Study|Protocol Violation|1|||
23475719|NCT02891070|65485518|FG000|Overall Study|Withdrawal by Subject|1|||
23475720|NCT02891070|65485519|FG001|Overall Study|Withdrawal by Subject|2|||
23475721|NCT02891070|65485518|FG000|Overall Study|Death|3|||
23798016|NCT02010255|66636903|FG002|Overall Study|Lack of Efficacy|2|||
23798017|NCT02010255|66636904|FG003|Overall Study|Lack of Efficacy|1|||
23798018|NCT02010255|66636905|FG004|Overall Study|Lack of Efficacy|1|||
23798019|NCT02010255|66636906|FG005|Overall Study|Lack of Efficacy|0|||
23798020|NCT02010255|66636907|FG006|Overall Study|Lack of Efficacy|0|||
23798021|NCT02010255|66636908|FG007|Overall Study|Lack of Efficacy|0|||
23798022|NCT02010255|66636909|FG008|Overall Study|Lack of Efficacy|0|||
23798023|NCT02010255|66636910|FG009|Overall Study|Lack of Efficacy|0|||
23798024|NCT02010255|66636911|FG010|Overall Study|Lack of Efficacy|1|||
23798025|NCT02010255|66636912|FG011|Overall Study|Lack of Efficacy|0|||
23798026|NCT02010255|66636913|FG012|Overall Study|Lack of Efficacy|0|||
23798027|NCT02010255|66636914|FG013|Overall Study|Lack of Efficacy|0|||
23358813|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
23475722|NCT02891070|65485519|FG001|Overall Study|Death|0|||
23475723|NCT01168219|65485520|FG000|Overall Study|off study before starting treatment|2|||
23475724|NCT01168219|65485520|FG000|Overall Study|withdrew before transplant|1|||
23475725|NCT01168219|65485520|FG000|Overall Study|ineligible due to CML|2|||
23475726|NCT01395524|65485521|FG000|Overall Study|Non-compliance with study schedule|1|||
23475727|NCT01395524|65485522|FG001|Overall Study|Non-compliance with study schedule|0|||
23475728|NCT01395524|65485523|FG002|Overall Study|Non-compliance with study schedule|1|||
23475729|NCT01395524|65485521|FG000|Overall Study|Lost to Follow-up|3|||
23475730|NCT01395524|65485522|FG001|Overall Study|Lost to Follow-up|1|||
23475731|NCT01395524|65485523|FG002|Overall Study|Lost to Follow-up|1|||
23475732|NCT01395524|65485521|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
23475733|NCT01395524|65485522|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
23475734|NCT01395524|65485523|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
23475735|NCT01395524|65485521|FG000|Overall Study|Severe noncompliance with protocol|1|||
23643454|NCT02874924|66079136|FG002|Overall Study|Withdrawal by Subject|0|||
23643455|NCT01946438|66079146|FG000|Overall Study|Adverse Event|0|||
23643456|NCT01946438|66079147|FG001|Overall Study|Adverse Event|0|||
23643457|NCT01946438|66079148|FG002|Overall Study|Adverse Event|0|||
23643458|NCT01946438|66079149|FG003|Overall Study|Adverse Event|1|||
23643459|NCT01946438|66079146|FG000|Overall Study|Serious Adverse event|1|||
23643460|NCT01946438|66079147|FG001|Overall Study|Serious Adverse event|0|||
23643461|NCT01946438|66079148|FG002|Overall Study|Serious Adverse event|0|||
23643462|NCT01946438|66079149|FG003|Overall Study|Serious Adverse event|0|||
23643463|NCT01946438|66079146|FG000|Overall Study|Protocol Violation|0|||
23475736|NCT01395524|65485522|FG001|Overall Study|Severe noncompliance with protocol|0|||
23643464|NCT01946438|66079147|FG001|Overall Study|Protocol Violation|0|||
23643465|NCT01946438|66079148|FG002|Overall Study|Protocol Violation|1|||
23643466|NCT01946438|66079149|FG003|Overall Study|Protocol Violation|0|||
23643467|NCT01946438|66079146|FG000|Overall Study|Withdrawal by Subject|1|||
23643468|NCT01946438|66079147|FG001|Overall Study|Withdrawal by Subject|0|||
23798028|NCT02010255|66636901|FG000|Overall Study|Withdrew Consent|1|||
23798029|NCT02010255|66636902|FG001|Overall Study|Withdrew Consent|0|||
23798030|NCT02010255|66636903|FG002|Overall Study|Withdrew Consent|0|||
23475737|NCT01395524|65485523|FG002|Overall Study|Severe noncompliance with protocol|0|||
23643469|NCT01946438|66079148|FG002|Overall Study|Withdrawal by Subject|0|||
23798031|NCT02010255|66636904|FG003|Overall Study|Withdrew Consent|1|||
23798032|NCT02010255|66636905|FG004|Overall Study|Withdrew Consent|0|||
23475738|NCT01395524|65485521|FG000|Overall Study|Adverse Event|4|||
23475739|NCT01395524|65485522|FG001|Overall Study|Adverse Event|4|||
23475740|NCT01395524|65485523|FG002|Overall Study|Adverse Event|3|||
23475741|NCT01395524|65485521|FG000|Overall Study|Death|1|||
23475742|NCT01395524|65485522|FG001|Overall Study|Death|0|||
23475743|NCT01395524|65485523|FG002|Overall Study|Death|0|||
23475744|NCT01395524|65485521|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23475745|NCT01395524|65485522|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23475746|NCT01395524|65485523|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23475747|NCT01395524|65485521|FG000|Overall Study|Withdrawal by Subject|4|||
23589972|NCT01025843|65889523|FG001|Washout 4|Withdrawal by Subject|0|||
23589973|NCT01025843|65889524|FG002|Washout 4|Withdrawal by Subject|1|||
23589974|NCT01025843|65889525|FG003|Washout 4|Withdrawal by Subject|1|||
23589975|NCT01025843|65889526|FG004|Washout 4|Withdrawal by Subject|0|||
23589976|NCT01025843|65889527|FG005|Washout 4|Withdrawal by Subject|0|||
23589977|NCT01025843|65889528|FG006|Washout 4|Withdrawal by Subject|0|||
23589978|NCT01025843|65889529|FG007|Washout 4|Withdrawal by Subject|0|||
23589979|NCT01025843|65889530|FG008|Washout 4|Withdrawal by Subject|0|||
23589980|NCT01025843|65889531|FG009|Washout 4|Withdrawal by Subject|0|||
23589981|NCT00843193|65889533|FG000|Overall Study|Adverse Event|2|||
23589982|NCT00843193|65889534|FG001|Overall Study|Adverse Event|4|||
23589983|NCT00843193|65889533|FG000|Overall Study|Lack of Efficacy|1|||
23589984|NCT00843193|65889534|FG001|Overall Study|Lack of Efficacy|1|||
23589985|NCT00843193|65889533|FG000|Overall Study|Protocol Violation|1|||
23589986|NCT00843193|65889534|FG001|Overall Study|Protocol Violation|2|||
23589987|NCT00843193|65889533|FG000|Overall Study|Lost to Follow-up|1|||
23589988|NCT00843193|65889534|FG001|Overall Study|Lost to Follow-up|0|||
23589989|NCT00843193|65889533|FG000|Overall Study|Physician Decision|0|||
23589990|NCT00843193|65889534|FG001|Overall Study|Physician Decision|1|||
23589991|NCT00843193|65889533|FG000|Overall Study|Withdrawal by Subject|3|||
23589992|NCT00843193|65889534|FG001|Overall Study|Withdrawal by Subject|3|||
23589993|NCT01072357|65889537|FG000|Overall Study|Lost to Follow-up|0|||
23589994|NCT01072357|65889538|FG001|Overall Study|Lost to Follow-up|1|||
23589995|NCT01121549|65889539|FG000|Overall Study|Adverse Event|10|||
23589996|NCT01121549|65889539|FG000|Overall Study|Lack of Efficacy|11|||
23589997|NCT01121549|65889539|FG000|Overall Study|Lost to Follow-up|12|||
23643470|NCT01946438|66079149|FG003|Overall Study|Withdrawal by Subject|0|||
23643471|NCT01157676|66079150|FG000|Randomization|Death|1|||
23643472|NCT01157676|66079151|FG001|Randomization|Death|1|||
23643473|NCT01157676|66079150|FG000|Randomization|unresectable|2|||
23358814|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358815|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23589998|NCT01121549|65889539|FG000|Overall Study|Did not meet entrance criteria|9|||
23358816|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
23358817|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358818|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358819|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
23358820|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358821|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358822|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358823|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358824|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
23358825|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358826|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358827|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358828|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358829|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358830|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23358831|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23475748|NCT01395524|65485522|FG001|Overall Study|Withdrawal by Subject|8|||
23475749|NCT01395524|65485523|FG002|Overall Study|Withdrawal by Subject|8|||
23475750|NCT01395524|65485521|FG000|Overall Study|Did not receive treatment|1|||
23589999|NCT01121549|65889539|FG000|Overall Study|Study terminated by sponsor|197|||
23590000|NCT01121549|65889539|FG000|Overall Study|Pregnancy|1|||
23590001|NCT01121549|65889539|FG000|Overall Study|Protocol Violation|33|||
23590002|NCT01121549|65889539|FG000|Overall Study|Withdrawal by Subject|16|||
23590003|NCT01121549|65889539|FG000|Overall Study|Other|58|||
23590004|NCT01075217|65889540|FG000|Overall Study|Adverse Event|1|||
23643474|NCT01157676|66079151|FG001|Randomization|unresectable|3|||
23590005|NCT01075217|65889541|FG001|Overall Study|Adverse Event|1|||
23590006|NCT01075217|65889540|FG000|Overall Study|Physician Decision|1|||
23590007|NCT01075217|65889541|FG001|Overall Study|Physician Decision|0|||
23590008|NCT02371746|65889543|FG000|Overall Study|Consent withdrawn|0|||
23590009|NCT02371746|65889544|FG001|Overall Study|Consent withdrawn|0|||
23590010|NCT02371746|65889545|FG002|Overall Study|Consent withdrawn|0|||
23590011|NCT02371746|65889546|FG003|Overall Study|Consent withdrawn|0|||
23643475|NCT01157676|66079150|FG000|Randomization|Withdrawal by Subject|17|||
23475751|NCT01395524|65485522|FG001|Overall Study|Did not receive treatment|1|||
23475752|NCT01395524|65485523|FG002|Overall Study|Did not receive treatment|3|||
23475753|NCT01395524|65485521|FG000|Overall Study|Subject had spinal surgery|0|||
23358832|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23475754|NCT01395524|65485522|FG001|Overall Study|Subject had spinal surgery|0|||
23475755|NCT01395524|65485523|FG002|Overall Study|Subject had spinal surgery|1|||
23475756|NCT01794338|65485524|FG000|Overall Study|Death|2|||
23475757|NCT01794338|65485525|FG001|Overall Study|Death|0|||
23475758|NCT01794338|65485524|FG000|Overall Study|Lost to Follow-up|6|||
23475759|NCT01794338|65485525|FG001|Overall Study|Lost to Follow-up|9|||
23475760|NCT02350764|65485526|FG000|Overall Study|Adverse Event|4|||
23475761|NCT02350764|65485526|FG000|Overall Study|Death|3|||
23358833|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358834|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23475762|NCT02350764|65485526|FG000|Overall Study|Physician Decision|2|||
23475763|NCT02350764|65485526|FG000|Overall Study|Withdrawal by Subject|2|||
23475764|NCT01250496|65485529|FG000|Overall Study|Study terminated|124|||
23475765|NCT01250496|65485530|FG001|Overall Study|Study terminated|124|||
23475766|NCT00591318|65485531|FG000|Overall Study|Lack of Efficacy|2|||
23475767|NCT00591318|65485532|FG001|Overall Study|Lack of Efficacy|0|||
23475768|NCT00591318|65485531|FG000|Overall Study|Adverse Event|2|||
23475769|NCT00591318|65485532|FG001|Overall Study|Adverse Event|0|||
23358835|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358836|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358837|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358838|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358839|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358840|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358841|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358842|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358843|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358844|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
23358845|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358846|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358847|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358848|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358849|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358850|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358851|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358852|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358853|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23475770|NCT01402102|65485533|FG000|Overall Study|Protocol Violation|1|||
23475771|NCT01402102|65485534|FG001|Overall Study|Protocol Violation|0|||
23475772|NCT01402102|65485533|FG000|Overall Study|Insufficiency of compliance|1|||
23475773|NCT01402102|65485534|FG001|Overall Study|Insufficiency of compliance|1|||
23475774|NCT01402102|65485533|FG000|Overall Study|Withdrawal by Subject|0|||
23475775|NCT01402102|65485534|FG001|Overall Study|Withdrawal by Subject|2|||
23475776|NCT00200356|65485535|FG000|Overall Study|Lack of Efficacy|3|||
23475777|NCT00200356|65485536|FG001|Overall Study|Lack of Efficacy|3|||
23475778|NCT00200356|65485535|FG000|Overall Study|Protocol Violation|4|||
23475779|NCT00200356|65485536|FG001|Overall Study|Protocol Violation|4|||
23475780|NCT00200356|65485535|FG000|Overall Study|Nontreatment|1|||
23475781|NCT00200356|65485536|FG001|Overall Study|Nontreatment|0|||
23475782|NCT02756806|65485537|FG000|Overall Study|Study terminated early|5|||
23358854|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23475783|NCT00905645|65485540|FG000|Overall Study|Death (not device related)|10|||
23475784|NCT00905645|65485541|FG001|Overall Study|Death (not device related)|4|||
23475785|NCT00905645|65485542|FG002|Overall Study|Death (not device related)|15|||
23475786|NCT00905645|65485543|FG003|Overall Study|Death (not device related)|8|||
23475787|NCT00905645|65485540|FG000|Overall Study|Explantation of study device(s)|78|||
23358855|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
23358856|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358857|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
23358858|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358859|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358860|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358861|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358862|NCT01716520|65056410|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358863|NCT01716520|65056411|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358864|NCT01716520|65056412|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358865|NCT01716520|65056413|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358866|NCT01716520|65056414|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358867|NCT01716520|65056415|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
23358868|NCT01716520|65056410|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358869|NCT01716520|65056411|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358870|NCT01716520|65056412|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
23358871|NCT01716520|65056413|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358872|NCT01716520|65056414|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358873|NCT01716520|65056415|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358874|NCT03519919|65056416|FG000|Overall Study|Withdrawal by Subject|1|||
23358875|NCT03519919|65056416|FG000|Overall Study|Lack of Efficacy|1|||
23358876|NCT03519919|65056416|FG000|Overall Study|Screen Failure|1|||
23358877|NCT02144077|65056421|FG000|Overall Study|Withdrawal by Subject|3|||
23358878|NCT02144077|65056422|FG001|Overall Study|Withdrawal by Subject|3|||
23358879|NCT02144077|65056421|FG000|Overall Study|Adverse Event|2|||
23358880|NCT02144077|65056422|FG001|Overall Study|Adverse Event|3|||
23358881|NCT02144077|65056421|FG000|Overall Study|Lost to Follow-up|2|||
23358882|NCT02144077|65056422|FG001|Overall Study|Lost to Follow-up|2|||
23358883|NCT02144077|65056421|FG000|Overall Study|Protocol Violation|1|||
23358884|NCT02144077|65056422|FG001|Overall Study|Protocol Violation|2|||
23358885|NCT02144077|65056421|FG000|Overall Study|Death|0|||
23358886|NCT02144077|65056422|FG001|Overall Study|Death|1|||
23358887|NCT02144077|65056421|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
23358888|NCT02144077|65056422|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
23358889|NCT00765817|65056429|FG000|Overall Study|Adverse Event|13|||
23358890|NCT00765817|65056430|FG001|Overall Study|Adverse Event|1|||
23358891|NCT00765817|65056429|FG000|Overall Study|Death|0|||
23358892|NCT00765817|65056430|FG001|Overall Study|Death|1|||
23358893|NCT00765817|65056429|FG000|Overall Study|Entry criteria not met|2|||
23358894|NCT00765817|65056430|FG001|Overall Study|Entry criteria not met|2|||
23358895|NCT00765817|65056429|FG000|Overall Study|Loss of glucose control|0|||
23358896|NCT00765817|65056430|FG001|Overall Study|Loss of glucose control|2|||
23358897|NCT00765817|65056429|FG000|Overall Study|Lost to Follow-up|1|||
23358898|NCT00765817|65056430|FG001|Overall Study|Lost to Follow-up|3|||
23358899|NCT00765817|65056429|FG000|Overall Study|Physician Decision|2|||
23358900|NCT00765817|65056430|FG001|Overall Study|Physician Decision|1|||
23358901|NCT00765817|65056429|FG000|Overall Study|Protocol Violation|1|||
23358902|NCT00765817|65056430|FG001|Overall Study|Protocol Violation|1|||
23358903|NCT00765817|65056429|FG000|Overall Study|Subject decision|7|||
23358904|NCT00765817|65056430|FG001|Overall Study|Subject decision|11|||
23358905|NCT04035499|65059905|FG000|Overall Study|Death|2|||
23475788|NCT00905645|65485541|FG001|Overall Study|Explantation of study device(s)|47|||
23475789|NCT00905645|65485542|FG002|Overall Study|Explantation of study device(s)|28|||
23590012|NCT02371746|65889547|FG004|Overall Study|Consent withdrawn|0|||
23590013|NCT02371746|65889548|FG005|Overall Study|Consent withdrawn|0|||
23358906|NCT04035499|65059905|FG000|Overall Study|Withdrawal by Subject|1|||
23358907|NCT02998996|65059906|FG000|Overall Study|Lost to Follow-up|0|||
23358908|NCT02998996|65059907|FG001|Overall Study|Lost to Follow-up|0|||
23358909|NCT02998996|65059908|FG002|Overall Study|Lost to Follow-up|1|||
23358910|NCT02998996|65059909|FG003|Overall Study|Lost to Follow-up|0|||
23358911|NCT02998996|65059910|FG004|Overall Study|Lost to Follow-up|0|||
23358912|NCT02998996|65059911|FG005|Overall Study|Lost to Follow-up|0|||
23358913|NCT02998996|65059906|FG000|Overall Study|Pregnancy|0|||
23358914|NCT02998996|65059907|FG001|Overall Study|Pregnancy|1|||
23358915|NCT02998996|65059908|FG002|Overall Study|Pregnancy|0|||
23358916|NCT02998996|65059909|FG003|Overall Study|Pregnancy|0|||
23358917|NCT02998996|65059910|FG004|Overall Study|Pregnancy|0|||
23358918|NCT02998996|65059911|FG005|Overall Study|Pregnancy|0|||
23358919|NCT02998996|65059906|FG000|Overall Study|Family reasons|0|||
23358920|NCT02998996|65059907|FG001|Overall Study|Family reasons|0|||
23358921|NCT02998996|65059908|FG002|Overall Study|Family reasons|0|||
23358922|NCT02998996|65059909|FG003|Overall Study|Family reasons|0|||
23358923|NCT02998996|65059910|FG004|Overall Study|Family reasons|1|||
23358924|NCT02998996|65059911|FG005|Overall Study|Family reasons|0|||
23358925|NCT01121263|65059912|FG000|Overall Study|Death|3|||
23358926|NCT01121263|65059913|FG001|Overall Study|Death|2|||
23358927|NCT01121263|65059912|FG000|Overall Study|Lost to Follow-up|22|||
23358928|NCT01121263|65059913|FG001|Overall Study|Lost to Follow-up|12|||
23358929|NCT01121263|65059912|FG000|Overall Study|Withdrawal by Subject|0|||
23358930|NCT01121263|65059913|FG001|Overall Study|Withdrawal by Subject|1|||
23358931|NCT00762762|65059914|FG000|Overall Study|Did not return for appointments|6|||
23358932|NCT00762762|65059915|FG001|Overall Study|Did not return for appointments|8|||
23358933|NCT03076996|65059916|FG000|Overall Study|Withdrawal by Subject|2|||
23358934|NCT03076996|65059916|FG000|Overall Study|Lost to Follow-up|3|||
23358935|NCT03076996|65059916|FG000|Overall Study|Literacy precluded participation|1|||
23358936|NCT02098395|65059917|FG000|Overall Study|Protocol Violation|2|||
23358937|NCT02098395|65059918|FG001|Overall Study|Protocol Violation|2|||
23358938|NCT02098395|65059919|FG002|Overall Study|Protocol Violation|0|||
23358939|NCT02098395|65059920|FG003|Overall Study|Protocol Violation|7|||
23358940|NCT02098395|65059917|FG000|Overall Study|Withdrawal by Subject|10|||
23358941|NCT02098395|65059918|FG001|Overall Study|Withdrawal by Subject|10|||
23358942|NCT02098395|65059919|FG002|Overall Study|Withdrawal by Subject|5|||
23358943|NCT02098395|65059920|FG003|Overall Study|Withdrawal by Subject|13|||
23358944|NCT02098395|65059917|FG000|Overall Study|Adverse Event|12|||
23358945|NCT02098395|65059918|FG001|Overall Study|Adverse Event|19|||
23358946|NCT02098395|65059919|FG002|Overall Study|Adverse Event|34|||
23358947|NCT02098395|65059920|FG003|Overall Study|Adverse Event|2|||
23358948|NCT02098395|65059917|FG000|Overall Study|Lost to Follow-up|2|||
23358949|NCT02098395|65059918|FG001|Overall Study|Lost to Follow-up|1|||
23358950|NCT02098395|65059919|FG002|Overall Study|Lost to Follow-up|0|||
23358951|NCT02098395|65059920|FG003|Overall Study|Lost to Follow-up|3|||
23358952|NCT02098395|65059917|FG000|Overall Study|Unclassified|0|||
23358953|NCT02098395|65059918|FG001|Overall Study|Unclassified|0|||
23358954|NCT02098395|65059919|FG002|Overall Study|Unclassified|3|||
23358955|NCT02098395|65059920|FG003|Overall Study|Unclassified|2|||
23358956|NCT02501161|65059921|FG000|Overall Study|Adverse Event|2|||
23358957|NCT02501161|65059922|FG001|Overall Study|Adverse Event|6|||
23358958|NCT02501161|65059921|FG000|Overall Study|Lost to Follow-up|7|||
23358959|NCT02501161|65059922|FG001|Overall Study|Lost to Follow-up|4|||
23358960|NCT02501161|65059921|FG000|Overall Study|Withdrawal by Subject|10|||
23358961|NCT02501161|65059922|FG001|Overall Study|Withdrawal by Subject|15|||
23358962|NCT02501161|65059921|FG000|Overall Study|Other|3|||
23358963|NCT02501161|65059922|FG001|Overall Study|Other|0|||
23358964|NCT01744483|65059923|FG000|Overall Study|Death|9|||
23358965|NCT01744483|65059924|FG001|Overall Study|Death|4|||
23358966|NCT01744483|65059925|FG002|Overall Study|Death|11|||
23358967|NCT01744483|65059923|FG000|Overall Study|Lost to Follow-up|8|||
23358968|NCT01744483|65059924|FG001|Overall Study|Lost to Follow-up|9|||
23358969|NCT01744483|65059925|FG002|Overall Study|Lost to Follow-up|11|||
23358970|NCT01744483|65059923|FG000|Overall Study|Protocol Violation|1|||
23358971|NCT01744483|65059924|FG001|Overall Study|Protocol Violation|2|||
23358972|NCT01744483|65059925|FG002|Overall Study|Protocol Violation|1|||
23358973|NCT01744483|65059923|FG000|Overall Study|Withdrawal by Subject|4|||
23358974|NCT01744483|65059924|FG001|Overall Study|Withdrawal by Subject|6|||
23358975|NCT01744483|65059925|FG002|Overall Study|Withdrawal by Subject|2|||
23358976|NCT01744483|65059923|FG000|Overall Study|No ICU Admit|5|||
23358977|NCT01744483|65059924|FG001|Overall Study|No ICU Admit|1|||
23590014|NCT02371746|65889549|FG006|Overall Study|Consent withdrawn|1|||
23358978|NCT01744483|65059925|FG002|Overall Study|No ICU Admit|2|||
23358979|NCT01744483|65059923|FG000|Overall Study|Routed to OSH|2|||
23358980|NCT01744483|65059924|FG001|Overall Study|Routed to OSH|0|||
23358981|NCT01744483|65059925|FG002|Overall Study|Routed to OSH|1|||
23358982|NCT01516736|65059929|FG000|Overall Study|Withdrawal by Subject|10|||
23358983|NCT01516736|65059930|FG001|Overall Study|Withdrawal by Subject|4|||
23358984|NCT01516736|65059929|FG000|Overall Study|Adverse Event|4|||
23358985|NCT01516736|65059930|FG001|Overall Study|Adverse Event|5|||
23358986|NCT01516736|65059929|FG000|Overall Study|Death|3|||
23358987|NCT01516736|65059930|FG001|Overall Study|Death|1|||
23358988|NCT01516736|65059929|FG000|Overall Study|Physician Decision|2|||
23358989|NCT01516736|65059930|FG001|Overall Study|Physician Decision|1|||
23358990|NCT01516736|65059929|FG000|Overall Study|Lack of Efficacy|1|||
23358991|NCT01516736|65059930|FG001|Overall Study|Lack of Efficacy|0|||
23358992|NCT01516736|65059929|FG000|Overall Study|Protocol Violation|0|||
23358993|NCT01516736|65059930|FG001|Overall Study|Protocol Violation|1|||
23358994|NCT01516736|65059929|FG000|Overall Study|Other (not specified)|0|||
23358995|NCT01516736|65059930|FG001|Overall Study|Other (not specified)|1|||
23358996|NCT01951573|65059931|FG000|Washout Period|Adverse Event|0|||
23358997|NCT01951573|65059932|FG001|Washout Period|Adverse Event|1|||
23358998|NCT03727841|65059933|FG000|Overall Study|Physician Decision|3|||
23358999|NCT03727841|65059934|FG001|Overall Study|Physician Decision|1|||
23359000|NCT00048997|65059935|FG000|Overall Study|Protocol Violation|7|||
23590015|NCT00880048|65889552|FG000|Overall Study|Adverse Event|2|||
23590016|NCT00880048|65889553|FG001|Overall Study|Adverse Event|3|||
23590017|NCT00880048|65889554|FG002|Overall Study|Adverse Event|5|||
23590018|NCT00880048|65889552|FG000|Overall Study|Lack of Efficacy|1|||
23590019|NCT00880048|65889553|FG001|Overall Study|Lack of Efficacy|2|||
23590020|NCT00880048|65889554|FG002|Overall Study|Lack of Efficacy|2|||
23359001|NCT00048997|65059936|FG001|Overall Study|Protocol Violation|2|||
23359002|NCT00048997|65059935|FG000|Overall Study|Withdrawal by Subject|6|||
23359003|NCT00048997|65059936|FG001|Overall Study|Withdrawal by Subject|1|||
23359004|NCT02256917|65059937|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
23359005|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
23359006|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
23359007|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
23359008|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
23359009|NCT02821416|65059942|FG000|Overall Study|Adverse Event|0|||
23359010|NCT02821416|65059943|FG001|Overall Study|Adverse Event|1|||
23359011|NCT02821416|65059942|FG000|Overall Study|Withdrawal by Subject|2|||
23359012|NCT02821416|65059943|FG001|Overall Study|Withdrawal by Subject|0|||
23359013|NCT02821416|65059942|FG000|Overall Study|Lost to Follow-up|1|||
23359014|NCT02821416|65059943|FG001|Overall Study|Lost to Follow-up|0|||
23359015|NCT01087203|65059948|FG000|Overall Study|Lost to Follow-up|2|||
23359016|NCT01087203|65059949|FG001|Overall Study|Lost to Follow-up|0|||
23359017|NCT01087203|65059948|FG000|Overall Study|Withdrawal by Subject|2|||
23359018|NCT01087203|65059949|FG001|Overall Study|Withdrawal by Subject|6|||
23359019|NCT01087203|65059948|FG000|Overall Study|Lack of Efficacy|1|||
23359020|NCT01087203|65059949|FG001|Overall Study|Lack of Efficacy|2|||
23359021|NCT01087203|65059948|FG000|Overall Study|Study terminated by sponsor|27|||
23359022|NCT01087203|65059949|FG001|Overall Study|Study terminated by sponsor|27|||
23359023|NCT00103662|65059950|FG000|Overall Study|Entered Rescue Procedure|0|||
23359024|NCT00103662|65059951|FG001|Overall Study|Entered Rescue Procedure|7|||
23359025|NCT00103662|65059950|FG000|Overall Study|Death|7|||
23590021|NCT00880048|65889552|FG000|Overall Study|Protocol Violation|4|||
23590022|NCT00880048|65889553|FG001|Overall Study|Protocol Violation|6|||
23590023|NCT00880048|65889554|FG002|Overall Study|Protocol Violation|5|||
23590024|NCT00880048|65889552|FG000|Overall Study|Lost to Follow-up|6|||
23590025|NCT00880048|65889553|FG001|Overall Study|Lost to Follow-up|6|||
23590026|NCT00880048|65889554|FG002|Overall Study|Lost to Follow-up|5|||
23359026|NCT00103662|65059951|FG001|Overall Study|Death|7|||
23359027|NCT00103662|65059950|FG000|Overall Study|Elective Withdrawal|5|||
23359028|NCT00103662|65059951|FG001|Overall Study|Elective Withdrawal|5|||
23359029|NCT00103662|65059950|FG000|Overall Study|Lost to Follow-up|0|||
23359030|NCT00103662|65059951|FG001|Overall Study|Lost to Follow-up|1|||
23359031|NCT00103662|65059950|FG000|Overall Study|Other|6|||
23590027|NCT00880048|65889552|FG000|Overall Study|Physician Decision|1|||
23590028|NCT00880048|65889553|FG001|Overall Study|Physician Decision|1|||
23590029|NCT00880048|65889554|FG002|Overall Study|Physician Decision|7|||
23359032|NCT00103662|65059951|FG001|Overall Study|Other|9|||
23359033|NCT00103662|65059950|FG000|Overall Study|Failed mobilization|0|||
23359034|NCT00103662|65059951|FG001|Overall Study|Failed mobilization|4|||
23359035|NCT00103662|65059950|FG000|Overall Study|Intercurrent illness|1|||
23359036|NCT00103662|65059951|FG001|Overall Study|Intercurrent illness|0|||
23359037|NCT02819440|65059954|FG000|Overall Study|Adverse Event|3|||
23359038|NCT02819440|65059955|FG001|Overall Study|Adverse Event|1|||
23359039|NCT02819440|65059954|FG000|Overall Study|Lost to Follow-up|1|||
23359040|NCT02819440|65059955|FG001|Overall Study|Lost to Follow-up|3|||
23359041|NCT02819440|65059954|FG000|Overall Study|Withdrawal by Subject|9|||
23359042|NCT02819440|65059955|FG001|Overall Study|Withdrawal by Subject|8|||
23359043|NCT00992017|65059958|FG000|Overall Study|Lost to Follow-up|2|||
23359044|NCT00992017|65059958|FG000|Overall Study|Withdrawal by Subject|2|||
23359045|NCT00992017|65059958|FG000|Overall Study|Unable to get to clinic|5|||
23359046|NCT00992017|65059958|FG000|Overall Study|Not adhere to study requirements|1|||
23359047|NCT02734862|65059963|FG000|Part A|Death|3|||
23359048|NCT02734862|65059964|FG001|Part A|Death|4|||
23359049|NCT02734862|65059965|FG002|Part A|Death|6|||
23359050|NCT02734862|65059963|FG000|Part A|Lost to Follow-up|2|||
23359051|NCT02734862|65059964|FG001|Part A|Lost to Follow-up|1|||
23359052|NCT02734862|65059965|FG002|Part A|Lost to Follow-up|1|||
23359053|NCT02734862|65059963|FG000|Part A|Withdrawal by Subject|1|||
23359054|NCT02734862|65059964|FG001|Part A|Withdrawal by Subject|1|||
23359055|NCT02734862|65059965|FG002|Part A|Withdrawal by Subject|2|||
23359056|NCT02734862|65059963|FG000|Part A|Physician Decision|2|||
23359057|NCT02734862|65059964|FG001|Part A|Physician Decision|0|||
23359058|NCT02734862|65059965|FG002|Part A|Physician Decision|1|||
23359059|NCT02734862|65059963|FG000|Part A|Adverse Event|2|||
23359060|NCT02734862|65059964|FG001|Part A|Adverse Event|0|||
23359061|NCT02734862|65059965|FG002|Part A|Adverse Event|1|||
23359062|NCT02734862|65059963|FG000|Part A|Noncompliance|1|||
23359063|NCT02734862|65059964|FG001|Part A|Noncompliance|1|||
23475790|NCT00905645|65485543|FG003|Overall Study|Explantation of study device(s)|21|||
23475791|NCT00905645|65485540|FG000|Overall Study|Subject Request|41|||
23359064|NCT02734862|65059965|FG002|Part A|Noncompliance|0|||
23359065|NCT02734862|65059963|FG000|Part A|Other|1|||
23359066|NCT02734862|65059964|FG001|Part A|Other|1|||
23359067|NCT02734862|65059965|FG002|Part A|Other|3|||
23359068|NCT02734862|65059963|FG000|Part B|Death|8|||
23359069|NCT02734862|65059964|FG001|Part B|Death|3|||
23359070|NCT02734862|65059965|FG002|Part B|Death|5|||
23359071|NCT02734862|65059963|FG000|Part B|Lost to Follow-up|2|||
23359072|NCT02734862|65059964|FG001|Part B|Lost to Follow-up|2|||
23359073|NCT02734862|65059965|FG002|Part B|Lost to Follow-up|0|||
23359074|NCT02734862|65059963|FG000|Part B|Withdrawal by Subject|3|||
23359075|NCT02734862|65059964|FG001|Part B|Withdrawal by Subject|1|||
23475792|NCT00905645|65485541|FG001|Overall Study|Subject Request|17|||
23475793|NCT00905645|65485542|FG002|Overall Study|Subject Request|13|||
23475794|NCT00905645|65485543|FG003|Overall Study|Subject Request|11|||
23475795|NCT00905645|65485540|FG000|Overall Study|Lost to Follow-up|299|||
23475796|NCT00905645|65485541|FG001|Overall Study|Lost to Follow-up|103|||
23475797|NCT00905645|65485542|FG002|Overall Study|Lost to Follow-up|51|||
23475798|NCT00905645|65485543|FG003|Overall Study|Lost to Follow-up|12|||
23475799|NCT03801031|65485544|FG000|Overall Study|Lost to Follow-up|1|||
23475800|NCT03801031|65485545|FG001|Overall Study|Lost to Follow-up|0|||
23475801|NCT03801031|65485544|FG000|Overall Study|Unable to comply|1|||
23475802|NCT03801031|65485545|FG001|Overall Study|Unable to comply|0|||
23475803|NCT03801031|65485544|FG000|Overall Study|Withdrawal by Subject|0|||
23475804|NCT03801031|65485545|FG001|Overall Study|Withdrawal by Subject|1|||
23475805|NCT02880956|65485546|FG000|Overall Study|Adverse Event|3|||
23475806|NCT02880956|65485547|FG001|Overall Study|Adverse Event|6|||
23475807|NCT02880956|65485548|FG002|Overall Study|Adverse Event|5|||
23475808|NCT02880956|65485549|FG003|Overall Study|Adverse Event|4|||
23475809|NCT02880956|65485546|FG000|Overall Study|Withdrawal by Subject|9|||
23475810|NCT02880956|65485547|FG001|Overall Study|Withdrawal by Subject|4|||
23475811|NCT02880956|65485548|FG002|Overall Study|Withdrawal by Subject|6|||
23475812|NCT02880956|65485549|FG003|Overall Study|Withdrawal by Subject|11|||
23475813|NCT02880956|65485546|FG000|Overall Study|Lost to Follow-up|0|||
23475814|NCT02880956|65485547|FG001|Overall Study|Lost to Follow-up|1|||
23475815|NCT02880956|65485548|FG002|Overall Study|Lost to Follow-up|0|||
23475816|NCT02880956|65485549|FG003|Overall Study|Lost to Follow-up|0|||
23475817|NCT02880956|65485546|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23475818|NCT02880956|65485547|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
23475819|NCT02880956|65485548|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23475820|NCT02880956|65485549|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
23475821|NCT02880956|65485546|FG000|Overall Study|Other, Not Specified|4|||
23475822|NCT02880956|65485547|FG001|Overall Study|Other, Not Specified|2|||
23475823|NCT02880956|65485548|FG002|Overall Study|Other, Not Specified|0|||
23475824|NCT02880956|65485549|FG003|Overall Study|Other, Not Specified|3|||
23475825|NCT02116530|65485550|FG000|Overall Study|Withdrawal by Subject|1|||
23475826|NCT02116530|65485551|FG001|Overall Study|Withdrawal by Subject|2|||
23475827|NCT02116530|65485550|FG000|Overall Study|Adverse Event|4|||
23475828|NCT02116530|65485551|FG001|Overall Study|Adverse Event|0|||
23475829|NCT02116530|65485550|FG000|Overall Study|Physician Decision|1|||
23475830|NCT02116530|65485551|FG001|Overall Study|Physician Decision|0|||
23475831|NCT02116530|65485550|FG000|Overall Study|Lost to Follow-up|1|||
23475832|NCT02116530|65485551|FG001|Overall Study|Lost to Follow-up|0|||
23475833|NCT02116530|65485550|FG000|Overall Study|Other Medical Problems|2|||
23475834|NCT02116530|65485551|FG001|Overall Study|Other Medical Problems|2|||
23475835|NCT01024309|65485556|FG000|Overall Study|Physician Decision|4|||
23475836|NCT01024309|65485557|FG001|Overall Study|Physician Decision|0|||
23475837|NCT01024309|65485556|FG000|Overall Study|Withdrawal by Subject|4|||
23475838|NCT01024309|65485557|FG001|Overall Study|Withdrawal by Subject|4|||
23475839|NCT01981551|65485560|FG000|Overall Study|Refused further treatment|8|||
23475840|NCT01981551|65485560|FG000|Overall Study|Adverse Event|1|||
23475841|NCT01754727|65485561|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
23475842|NCT00638183|65485564|FG000|Overall Study|Adverse Event|23|||
23475843|NCT00638183|65485564|FG000|Overall Study|Lack of Efficacy|14|||
23475844|NCT00638183|65485564|FG000|Overall Study|Physician Decision|9|||
23475845|NCT00638183|65485564|FG000|Overall Study|Lost to Follow-up|46|||
23475846|NCT00638183|65485564|FG000|Overall Study|Other reason not defined above|27|||
23475847|NCT03720652|65485565|FG000|Overall Study|Withdrawal by Subject|2|||
23475848|NCT03720652|65485566|FG001|Overall Study|Withdrawal by Subject|7|||
23475849|NCT03720652|65485565|FG000|Overall Study|Lost to Follow-up|0|||
23643476|NCT01157676|66079151|FG001|Randomization|Withdrawal by Subject|13|||
23643477|NCT01157676|66079150|FG000|Randomization|Physician Decision|1|||
23475850|NCT03720652|65485566|FG001|Overall Study|Lost to Follow-up|4|||
23475851|NCT02529553|65485567|FG000|Overall Study|Progressive Disease|1|||
23475852|NCT02529553|65485568|FG001|Overall Study|Progressive Disease|0|||
23475853|NCT02529553|65485569|FG002|Overall Study|Progressive Disease|1|||
23475854|NCT02529553|65485570|FG003|Overall Study|Progressive Disease|3|||
23475855|NCT02529553|65485571|FG004|Overall Study|Progressive Disease|2|||
23475856|NCT02529553|65485572|FG005|Overall Study|Progressive Disease|3|||
23475857|NCT02529553|65485573|FG006|Overall Study|Progressive Disease|3|||
23475858|NCT02529553|65485574|FG007|Overall Study|Progressive Disease|5|||
23475859|NCT02529553|65485575|FG008|Overall Study|Progressive Disease|3|||
23475860|NCT02529553|65485567|FG000|Overall Study|Physician Decision|0|||
23643478|NCT01157676|66079151|FG001|Randomization|Physician Decision|0|||
23475861|NCT02529553|65485568|FG001|Overall Study|Physician Decision|1|||
23475862|NCT02529553|65485569|FG002|Overall Study|Physician Decision|0|||
23475863|NCT02529553|65485570|FG003|Overall Study|Physician Decision|0|||
23475864|NCT02529553|65485571|FG004|Overall Study|Physician Decision|1|||
23475865|NCT02529553|65485572|FG005|Overall Study|Physician Decision|0|||
23475866|NCT02529553|65485573|FG006|Overall Study|Physician Decision|0|||
23643479|NCT01157676|66079150|FG000|Surgery|underwent open cystectomy|0|||
23359076|NCT02734862|65059965|FG002|Part B|Withdrawal by Subject|0|||
23359077|NCT02734862|65059963|FG000|Part B|Other|0|||
23359078|NCT02734862|65059964|FG001|Part B|Other|1|||
23359079|NCT02734862|65059965|FG002|Part B|Other|0|||
23359080|NCT01344759|65059966|FG000|Overall Study|Patients failed to reach sedation level|0|||
23359081|NCT01344759|65059967|FG001|Overall Study|Patients failed to reach sedation level|2|||
23359082|NCT02348008|65059968|FG000|Overall Study|Adverse Event|2|||
23359083|NCT02348008|65059969|FG001|Overall Study|Adverse Event|3|||
23359084|NCT02348008|65059970|FG002|Overall Study|Adverse Event|3|||
23359085|NCT02348008|65059968|FG000|Overall Study|Disease Progression|1|||
23359086|NCT02348008|65059969|FG001|Overall Study|Disease Progression|5|||
23359087|NCT02348008|65059970|FG002|Overall Study|Disease Progression|16|||
23359088|NCT02348008|65059968|FG000|Overall Study|Withdrawal by Subject|0|||
23359089|NCT02348008|65059969|FG001|Overall Study|Withdrawal by Subject|1|||
23359090|NCT02348008|65059970|FG002|Overall Study|Withdrawal by Subject|0|||
23359091|NCT02348008|65059968|FG000|Overall Study|Symptomatic Deterioration|0|||
23359092|NCT02348008|65059969|FG001|Overall Study|Symptomatic Deterioration|1|||
23359093|NCT02348008|65059970|FG002|Overall Study|Symptomatic Deterioration|0|||
23359094|NCT04888494|65059971|FG000|Overall Study|Lost to Follow-up|2|||
23359095|NCT04888494|65059972|FG001|Overall Study|Lost to Follow-up|3|||
23359096|NCT04888494|65059971|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
23359097|NCT04888494|65059972|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
23359098|NCT01877668|65059976|FG000|Overall Study|Death|0|||
23359099|NCT01877668|65059977|FG001|Overall Study|Death|0|||
23359100|NCT01877668|65059978|FG002|Overall Study|Death|0|||
23359101|NCT01877668|65059979|FG003|Overall Study|Death|1|||
23359102|NCT01877668|65059980|FG004|Overall Study|Death|0|||
23359103|NCT01877668|65059976|FG000|Overall Study|No longer met study criteria|1|||
23359104|NCT01877668|65059977|FG001|Overall Study|No longer met study criteria|0|||
23359105|NCT01877668|65059978|FG002|Overall Study|No longer met study criteria|1|||
23359106|NCT01877668|65059979|FG003|Overall Study|No longer met study criteria|0|||
23359107|NCT01877668|65059980|FG004|Overall Study|No longer met study criteria|0|||
23475867|NCT02529553|65485574|FG007|Overall Study|Physician Decision|0|||
23475868|NCT02529553|65485575|FG008|Overall Study|Physician Decision|0|||
23475869|NCT02529553|65485567|FG000|Overall Study|Withdrawal by Subject|0|||
23475870|NCT02529553|65485568|FG001|Overall Study|Withdrawal by Subject|0|||
23475871|NCT02529553|65485569|FG002|Overall Study|Withdrawal by Subject|0|||
23475872|NCT02529553|65485570|FG003|Overall Study|Withdrawal by Subject|0|||
23475873|NCT02529553|65485571|FG004|Overall Study|Withdrawal by Subject|0|||
23475874|NCT02529553|65485572|FG005|Overall Study|Withdrawal by Subject|1|||
23475875|NCT02529553|65485573|FG006|Overall Study|Withdrawal by Subject|0|||
23475876|NCT02529553|65485574|FG007|Overall Study|Withdrawal by Subject|1|||
23475877|NCT02529553|65485575|FG008|Overall Study|Withdrawal by Subject|0|||
23475878|NCT04657666|65485578|FG000|Period 1|Withdrawal of participant consent|2|||
23475879|NCT04657666|65485579|FG001|Period 1|Withdrawal of participant consent|1|||
23475880|NCT04657666|65485578|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
23475881|NCT04657666|65485579|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
23475882|NCT04657666|65485578|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
23475883|NCT04657666|65485579|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
23475884|NCT04657666|65485578|FG000|Period 2|Other|2|||
23475885|NCT04657666|65485579|FG001|Period 2|Other|0|||
23475886|NCT04657666|65485578|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
23475887|NCT04657666|65485579|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
23475888|NCT01715857|65485580|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
23475889|NCT00946153|65485581|FG000|Phase 2|Adverse Event|0|||
23475890|NCT00946153|65485582|FG001|Phase 2|Adverse Event|0|||
23475891|NCT00946153|65485583|FG002|Phase 2|Adverse Event|0|||
23475892|NCT00946153|65485584|FG003|Phase 2|Adverse Event|0|||
23475893|NCT00946153|65485585|FG004|Phase 2|Adverse Event|6|||
23475894|NCT00946153|65485581|FG000|Phase 2|Need more reduction of dose|0|||
23475895|NCT00946153|65485582|FG001|Phase 2|Need more reduction of dose|0|||
23475896|NCT00946153|65485583|FG002|Phase 2|Need more reduction of dose|0|||
23475897|NCT00946153|65485584|FG003|Phase 2|Need more reduction of dose|0|||
23359108|NCT01877668|65059976|FG000|Overall Study|Insufficient clinical response|0|||
23359109|NCT01877668|65059977|FG001|Overall Study|Insufficient clinical response|1|||
23359110|NCT01877668|65059978|FG002|Overall Study|Insufficient clinical response|2|||
23475898|NCT00946153|65485585|FG004|Phase 2|Need more reduction of dose|2|||
23798033|NCT02010255|66636906|FG005|Overall Study|Withdrew Consent|0|||
23798034|NCT02010255|66636907|FG006|Overall Study|Withdrew Consent|0|||
23359111|NCT01877668|65059979|FG003|Overall Study|Insufficient clinical response|2|||
23475899|NCT00946153|65485581|FG000|Phase 2|Physician Decision|0|||
23475900|NCT00946153|65485582|FG001|Phase 2|Physician Decision|0|||
23359112|NCT01877668|65059980|FG004|Overall Study|Insufficient clinical response|0|||
23359113|NCT01877668|65059976|FG000|Overall Study|Lost to Follow-up|0|||
23359114|NCT01877668|65059977|FG001|Overall Study|Lost to Follow-up|2|||
23359115|NCT01877668|65059978|FG002|Overall Study|Lost to Follow-up|1|||
23359116|NCT01877668|65059979|FG003|Overall Study|Lost to Follow-up|0|||
23359117|NCT01877668|65059980|FG004|Overall Study|Lost to Follow-up|0|||
23359118|NCT01877668|65059976|FG000|Overall Study|Withdrawal by Subject|2|||
23359119|NCT01877668|65059977|FG001|Overall Study|Withdrawal by Subject|0|||
23359120|NCT01877668|65059978|FG002|Overall Study|Withdrawal by Subject|3|||
23359121|NCT01877668|65059979|FG003|Overall Study|Withdrawal by Subject|2|||
23359122|NCT01877668|65059980|FG004|Overall Study|Withdrawal by Subject|2|||
23475901|NCT00946153|65485583|FG002|Phase 2|Physician Decision|0|||
23475902|NCT00946153|65485584|FG003|Phase 2|Physician Decision|0|||
23475903|NCT00946153|65485585|FG004|Phase 2|Physician Decision|1|||
23475904|NCT00946153|65485581|FG000|Phase 2|14 days washout for recovery due to AE|0|||
23475905|NCT00946153|65485582|FG001|Phase 2|14 days washout for recovery due to AE|0|||
23475906|NCT00946153|65485583|FG002|Phase 2|14 days washout for recovery due to AE|0|||
23475907|NCT00946153|65485584|FG003|Phase 2|14 days washout for recovery due to AE|0|||
23475908|NCT00946153|65485585|FG004|Phase 2|14 days washout for recovery due to AE|4|||
23475909|NCT03060551|65485590|FG000|Overall Study|Withdrawal by Subject|1|||
23475910|NCT03060551|65485590|FG000|Overall Study|Adverse Event|1|||
23475911|NCT03113136|65485591|FG000|Overall Study|Lost to Follow-up|22|||
23475912|NCT03113136|65485592|FG001|Overall Study|Lost to Follow-up|47|||
23475913|NCT03113136|65485593|FG002|Overall Study|Lost to Follow-up|54|||
23475914|NCT03113136|65485591|FG000|Overall Study|Withdrawal by Subject|4|||
23475915|NCT03113136|65485592|FG001|Overall Study|Withdrawal by Subject|13|||
23475916|NCT03113136|65485593|FG002|Overall Study|Withdrawal by Subject|14|||
23475917|NCT03113136|65485591|FG000|Overall Study|Ineligible|0|||
23475918|NCT03113136|65485592|FG001|Overall Study|Ineligible|2|||
23475919|NCT03113136|65485593|FG002|Overall Study|Ineligible|1|||
23475920|NCT03113136|65485591|FG000|Overall Study|Study Team Decision|1|||
23475921|NCT03113136|65485592|FG001|Overall Study|Study Team Decision|4|||
23475922|NCT03113136|65485593|FG002|Overall Study|Study Team Decision|0|||
23475923|NCT03595228|65485594|FG000|Overall Study|Death|2|||
23475924|NCT03595228|65485594|FG000|Overall Study|Lack of Efficacy|13|||
23475925|NCT03595228|65485594|FG000|Overall Study|Withdrawal by Subject|3|||
23475926|NCT03595228|65485594|FG000|Overall Study|Withdrawal by Sponsor|1|||
23475927|NCT01155011|65485596|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
23475928|NCT01155011|65485597|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
23475929|NCT01155011|65485596|FG000|Baseline to 6 Months|investigator decision, moved|4|||
23475930|NCT01155011|65485597|FG001|Baseline to 6 Months|investigator decision, moved|5|||
23475931|NCT01155011|65485596|FG000|Baseline to 6 Months|Death|0|||
23475932|NCT01155011|65485597|FG001|Baseline to 6 Months|Death|1|||
23475933|NCT01155011|65485596|FG000|6 to 12 Months|Withdrawal by Subject|8|||
23475934|NCT01155011|65485597|FG001|6 to 12 Months|Withdrawal by Subject|5|||
23475935|NCT01155011|65485596|FG000|6 to 12 Months|Death|1|||
23475936|NCT01155011|65485597|FG001|6 to 12 Months|Death|5|||
23475937|NCT03179202|65485598|FG000|Overall Study|Screen Failure|67|||
23359123|NCT01877668|65059976|FG000|Overall Study|Other|1|||
23475938|NCT03179202|65485598|FG000|Overall Study|Subject Lost to Follow Up|12|||
23475939|NCT03179202|65485598|FG000|Overall Study|Withdrawal by Subject|7|||
23475940|NCT03179202|65485598|FG000|Overall Study|Adverse Event|3|||
23475941|NCT03179202|65485598|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
23475942|NCT03179202|65485598|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
23475943|NCT02366091|65485601|FG000|Overall Study|Withdrawal by Subject|3|||
23475944|NCT02366091|65485602|FG001|Overall Study|Withdrawal by Subject|7|||
23475945|NCT02366091|65485603|FG002|Overall Study|Withdrawal by Subject|3|||
23475946|NCT02366091|65485604|FG003|Overall Study|Withdrawal by Subject|1|||
23475947|NCT01958489|65485605|FG000|Period 2|Adverse Event|0|||
23475948|NCT01958489|65485606|FG001|Period 2|Adverse Event|1|||
23475949|NCT01381562|65485607|FG000|Overall Study|Adverse Event|0|||
23475950|NCT01381562|65485608|FG001|Overall Study|Adverse Event|1|||
23475951|NCT01381562|65485609|FG002|Overall Study|Adverse Event|0|||
23475952|NCT01014910|65485610|FG000|Overall Study|Withdrawal by Subject|0|||
23643480|NCT01157676|66079151|FG001|Surgery|underwent open cystectomy|4|||
23643481|NCT01157676|66079150|FG000|Surgery|converted to open procedure|0|||
23359124|NCT01877668|65059977|FG001|Overall Study|Other|1|||
23475953|NCT01014910|65485611|FG001|Overall Study|Withdrawal by Subject|2|||
23475954|NCT01250145|65485618|FG000|Overall Study|Adverse Event|2|||
23475955|NCT01250145|65485619|FG001|Overall Study|Adverse Event|1|||
23475956|NCT01250145|65485618|FG000|Overall Study|Withdrawal by Subject|0|||
23475957|NCT01250145|65485619|FG001|Overall Study|Withdrawal by Subject|4|||
23475958|NCT02051933|65485620|FG000|Overall Study|Physician Decision|0|||
23475959|NCT02051933|65485621|FG001|Overall Study|Physician Decision|1|||
23475960|NCT01252667|65485622|FG000|Overall Study|Transplant aborted post-conditioning|0|||
23643482|NCT01157676|66079151|FG001|Surgery|converted to open procedure|5|||
23475961|NCT01252667|65485623|FG001|Overall Study|Transplant aborted post-conditioning|0|||
23475962|NCT01252667|65485624|FG002|Overall Study|Transplant aborted post-conditioning|0|||
23475963|NCT01252667|65485625|FG003|Overall Study|Transplant aborted post-conditioning|0|||
23475964|NCT01252667|65485626|FG004|Overall Study|Transplant aborted post-conditioning|0|||
23475965|NCT01252667|65485627|FG005|Overall Study|Transplant aborted post-conditioning|1|||
23475966|NCT02874144|65485629|FG000|Overall Study|Lost to Follow-up|3|||
23475967|NCT02874144|65485630|FG001|Overall Study|Lost to Follow-up|5|||
23475968|NCT02365233|65485635|FG000|Overall Study|IRB withheld the data|1|||
23643483|NCT01157676|66079150|FG000|Surgery|underwent robotic cystectomy|1|||
23359125|NCT01877668|65059978|FG002|Overall Study|Other|1|||
23359126|NCT01877668|65059979|FG003|Overall Study|Other|1|||
23359127|NCT01877668|65059980|FG004|Overall Study|Other|3|||
23359128|NCT01877668|65059976|FG000|Overall Study|Protocol Violation|1|||
23359129|NCT01877668|65059977|FG001|Overall Study|Protocol Violation|1|||
23359130|NCT01877668|65059978|FG002|Overall Study|Protocol Violation|0|||
23359131|NCT01877668|65059979|FG003|Overall Study|Protocol Violation|0|||
23359132|NCT01877668|65059980|FG004|Overall Study|Protocol Violation|3|||
23359133|NCT01877668|65059976|FG000|Overall Study|Adverse event related to study drug|2|||
23359134|NCT01877668|65059977|FG001|Overall Study|Adverse event related to study drug|2|||
23359135|NCT01877668|65059978|FG002|Overall Study|Adverse event related to study drug|2|||
23359136|NCT01877668|65059979|FG003|Overall Study|Adverse event related to study drug|2|||
23359137|NCT01877668|65059980|FG004|Overall Study|Adverse event related to study drug|1|||
23359138|NCT01877668|65059976|FG000|Overall Study|Adverse event unrelated to study drug|4|||
23359139|NCT01877668|65059977|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23359140|NCT01877668|65059978|FG002|Overall Study|Adverse event unrelated to study drug|2|||
23359141|NCT01877668|65059979|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23359142|NCT01877668|65059980|FG004|Overall Study|Adverse event unrelated to study drug|1|||
23359143|NCT00003483|65059981|FG000|Overall Study|Not evaluable|1|||
23359144|NCT01763827|65059982|FG000|Overall Study|Withdrawal by Subject|1|||
23359145|NCT01763827|65059983|FG001|Overall Study|Withdrawal by Subject|0|||
23359146|NCT01763827|65059984|FG002|Overall Study|Withdrawal by Subject|0|||
23359147|NCT01763827|65059985|FG003|Overall Study|Withdrawal by Subject|0|||
23359148|NCT01763827|65059986|FG004|Overall Study|Withdrawal by Subject|2|||
23359149|NCT01763827|65059987|FG005|Overall Study|Withdrawal by Subject|0|||
23359150|NCT01763827|65059982|FG000|Overall Study|Decision by sponsor|2|||
23359151|NCT01763827|65059983|FG001|Overall Study|Decision by sponsor|0|||
23359152|NCT01763827|65059984|FG002|Overall Study|Decision by sponsor|3|||
23359153|NCT01763827|65059985|FG003|Overall Study|Decision by sponsor|0|||
23359154|NCT01763827|65059986|FG004|Overall Study|Decision by sponsor|2|||
23359155|NCT01763827|65059987|FG005|Overall Study|Decision by sponsor|1|||
23359156|NCT01763827|65059982|FG000|Overall Study|Lost to Follow-up|0|||
23359157|NCT01763827|65059983|FG001|Overall Study|Lost to Follow-up|1|||
23359158|NCT01763827|65059984|FG002|Overall Study|Lost to Follow-up|1|||
23359159|NCT01763827|65059985|FG003|Overall Study|Lost to Follow-up|1|||
23359160|NCT01763827|65059986|FG004|Overall Study|Lost to Follow-up|2|||
23475969|NCT02365233|65485636|FG001|Overall Study|IRB withheld the data|2|||
23475970|NCT02365233|65485637|FG002|Overall Study|IRB withheld the data|2|||
23475971|NCT02437110|65485638|FG000|Screening|Lost to Follow-up|3|||
23798035|NCT02010255|66636908|FG007|Overall Study|Withdrew Consent|0|||
23798036|NCT02010255|66636909|FG008|Overall Study|Withdrew Consent|0|||
23359161|NCT01763827|65059987|FG005|Overall Study|Lost to Follow-up|1|||
23359162|NCT02815267|65059988|FG000|Double-Blind Phase|Adverse Event|0|||
23359163|NCT02815267|65059989|FG001|Double-Blind Phase|Adverse Event|3|||
23475972|NCT02437110|65485638|FG000|Screening|Physician Decision|1|||
23359164|NCT02815267|65059988|FG000|Double-Blind Phase|Lost to Follow-up|17|||
23359165|NCT02815267|65059989|FG001|Double-Blind Phase|Lost to Follow-up|9|||
23359166|NCT02815267|65059988|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
23798037|NCT02010255|66636910|FG009|Overall Study|Withdrew Consent|0|||
23798038|NCT02010255|66636911|FG010|Overall Study|Withdrew Consent|0|||
23798039|NCT02010255|66636912|FG011|Overall Study|Withdrew Consent|0|||
23798040|NCT02010255|66636913|FG012|Overall Study|Withdrew Consent|0|||
23798041|NCT02010255|66636914|FG013|Overall Study|Withdrew Consent|0|||
23798042|NCT02010255|66636901|FG000|Overall Study|Adverse Event|1|||
23798043|NCT02010255|66636902|FG001|Overall Study|Adverse Event|0|||
23798044|NCT02010255|66636903|FG002|Overall Study|Adverse Event|0|||
23798045|NCT02010255|66636904|FG003|Overall Study|Adverse Event|0|||
23798046|NCT02010255|66636905|FG004|Overall Study|Adverse Event|0|||
23798047|NCT02010255|66636906|FG005|Overall Study|Adverse Event|0|||
23798048|NCT02010255|66636907|FG006|Overall Study|Adverse Event|0|||
23798049|NCT02010255|66636908|FG007|Overall Study|Adverse Event|0|||
23798050|NCT02010255|66636909|FG008|Overall Study|Adverse Event|0|||
23798051|NCT02010255|66636910|FG009|Overall Study|Adverse Event|0|||
23798052|NCT02010255|66636911|FG010|Overall Study|Adverse Event|0|||
23475973|NCT02437110|65485638|FG000|ART|Adverse Event|3|||
23475974|NCT02437110|65485638|FG000|ART|Protocol Violation|3|||
23475975|NCT02437110|65485638|FG000|ART|Withdrawal by Subject|4|||
23475976|NCT02437110|65485638|FG000|ART|Lost to follow-up prior to start of intervention|1|||
23475977|NCT02437110|65485638|FG000|ART|Physician decision prior to start of intervention|2|||
23475978|NCT02437110|65485638|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
23475979|NCT02437110|65485638|FG000|Post-ART|Lost to Follow-up|3|||
23475980|NCT02437110|65485638|FG000|Post-ART|Protocol Violation|4|||
23475981|NCT02437110|65485638|FG000|Post-ART|Withdrawal by Subject|3|||
23475982|NCT03890666|65485639|FG000|Overall Study|Withdrawal by Subject|0|||
23475983|NCT03890666|65485640|FG001|Overall Study|Withdrawal by Subject|1|||
23643484|NCT01157676|66079151|FG001|Surgery|underwent robotic cystectomy|0|||
23475984|NCT03890666|65485639|FG000|Overall Study|Protocol deviation|1|||
23475985|NCT03890666|65485640|FG001|Overall Study|Protocol deviation|4|||
23475986|NCT03890666|65485639|FG000|Overall Study|Lost to Follow-up|2|||
23475987|NCT03890666|65485640|FG001|Overall Study|Lost to Follow-up|5|||
23475988|NCT03890666|65485639|FG000|Overall Study|Other than specified|1|||
23475989|NCT03890666|65485640|FG001|Overall Study|Other than specified|8|||
23475990|NCT03353740|65485641|FG000|Overall Study|Images for these participants not viable|52|||
23475991|NCT03560518|65485642|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
23475992|NCT03560518|65485643|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
23475993|NCT03560518|65485644|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
23475994|NCT03560518|65485642|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
23475995|NCT03560518|65485643|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
23475996|NCT03560518|65485644|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
23475997|NCT03560518|65485642|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23475998|NCT03560518|65485643|FG001|Double Blind Treatment Period|Protocol Violation|2|||
23475999|NCT03560518|65485644|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23476000|NCT03560518|65485642|FG000|Double Blind Treatment Period|Pregnancy|0|||
23476001|NCT03560518|65485643|FG001|Double Blind Treatment Period|Pregnancy|2|||
23476002|NCT03560518|65485644|FG002|Double Blind Treatment Period|Pregnancy|0|||
23476003|NCT03560518|65485642|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
23476004|NCT03560518|65485643|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
23590030|NCT00880048|65889552|FG000|Overall Study|Withdrawal by Subject|5|||
23590031|NCT00880048|65889553|FG001|Overall Study|Withdrawal by Subject|8|||
23590032|NCT00880048|65889554|FG002|Overall Study|Withdrawal by Subject|5|||
23590033|NCT00880048|65889552|FG000|Overall Study|Study closed/terminated|9|||
23590034|NCT00880048|65889553|FG001|Overall Study|Study closed/terminated|7|||
23590035|NCT00880048|65889554|FG002|Overall Study|Study closed/terminated|6|||
23590036|NCT02955069|65889557|FG000|Overall Study|Adverse Event|7|||
23590037|NCT02955069|65889558|FG001|Overall Study|Adverse Event|2|||
23590038|NCT02955069|65889557|FG000|Overall Study|Death|7|||
23590039|NCT02955069|65889558|FG001|Overall Study|Death|3|||
23590040|NCT02955069|65889557|FG000|Overall Study|Physician Decision|10|||
23590041|NCT02955069|65889558|FG001|Overall Study|Physician Decision|2|||
23590042|NCT02955069|65889557|FG000|Overall Study|Progressive disease|64|||
23590043|NCT02955069|65889558|FG001|Overall Study|Progressive disease|13|||
23590044|NCT02955069|65889557|FG000|Overall Study|Study terminated by sponsor|4|||
23590045|NCT02955069|65889558|FG001|Overall Study|Study terminated by sponsor|0|||
23590046|NCT02955069|65889557|FG000|Overall Study|Subject/Guardian decision|3|||
23590047|NCT02955069|65889558|FG001|Overall Study|Subject/Guardian decision|1|||
23643485|NCT01489891|66079152|FG000|Overall Study|Endoscopy failure|1|||
23643486|NCT01489891|66079153|FG001|Overall Study|Endoscopy failure|0|||
23643487|NCT00196976|66079154|FG000|Primary Study|Migrated from study area|0|||
23643488|NCT00196976|66079155|FG001|Primary Study|Migrated from study area|0|||
23643489|NCT00196976|66079156|FG002|Primary Study|Migrated from study area|0|||
23643490|NCT00196976|66079157|FG003|Primary Study|Migrated from study area|0|||
23643491|NCT00196976|66079158|FG004|Primary Study|Migrated from study area|0|||
23643492|NCT00196976|66079159|FG005|Primary Study|Migrated from study area|0|||
23643493|NCT00196976|66079160|FG006|Primary Study|Migrated from study area|0|||
23643494|NCT00196976|66079161|FG007|Primary Study|Migrated from study area|1|||
23643495|NCT00196976|66079162|FG008|Primary Study|Migrated from study area|0|||
23643496|NCT00196976|66079163|FG009|Primary Study|Migrated from study area|0|||
23476005|NCT03560518|65485644|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
23476006|NCT03560518|65485642|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
23590048|NCT03070483|65889559|FG000|Overall Study|Lost to Follow-up|2|||
23590049|NCT03895034|65889560|FG000|Overall Study|Lost to Follow-up|2|||
23590050|NCT00828672|65889561|FG000|Study Treatment|Lost to Follow-up|1|||
23643497|NCT00196976|66079164|FG010|Primary Study|Migrated from study area|0|||
23476007|NCT03560518|65485643|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
23590051|NCT00828672|65889562|FG001|Study Treatment|Lost to Follow-up|0|||
23590052|NCT00828672|65889561|FG000|Study Treatment|Adverse Event|0|||
23590053|NCT00828672|65889562|FG001|Study Treatment|Adverse Event|1|||
23643498|NCT00196976|66079165|FG011|Primary Study|Migrated from study area|0|||
23643499|NCT00196976|66079166|FG012|Primary Study|Migrated from study area|0|||
23476008|NCT03560518|65485644|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
23476009|NCT03560518|65485642|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
23476010|NCT03560518|65485643|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
23643500|NCT00196976|66079167|FG013|Primary Study|Migrated from study area|0|||
23643501|NCT00196976|66079154|FG000|Primary Study|Protocol Violation|0|||
23643502|NCT00196976|66079155|FG001|Primary Study|Protocol Violation|1|||
23643503|NCT00196976|66079156|FG002|Primary Study|Protocol Violation|1|||
23643504|NCT00196976|66079157|FG003|Primary Study|Protocol Violation|0|||
23643505|NCT00196976|66079158|FG004|Primary Study|Protocol Violation|0|||
23643506|NCT00196976|66079159|FG005|Primary Study|Protocol Violation|0|||
23643507|NCT00196976|66079160|FG006|Primary Study|Protocol Violation|0|||
23643508|NCT00196976|66079161|FG007|Primary Study|Protocol Violation|0|||
23643509|NCT00196976|66079162|FG008|Primary Study|Protocol Violation|0|||
23643510|NCT00196976|66079163|FG009|Primary Study|Protocol Violation|0|||
23643511|NCT00196976|66079164|FG010|Primary Study|Protocol Violation|0|||
23643512|NCT00196976|66079165|FG011|Primary Study|Protocol Violation|0|||
23643513|NCT00196976|66079166|FG012|Primary Study|Protocol Violation|0|||
23643514|NCT00196976|66079167|FG013|Primary Study|Protocol Violation|0|||
23643515|NCT00196976|66079154|FG000|Primary Study|Withdrawal by Subject|1|||
23643516|NCT00196976|66079155|FG001|Primary Study|Withdrawal by Subject|0|||
23643517|NCT00196976|66079156|FG002|Primary Study|Withdrawal by Subject|1|||
23643518|NCT00196976|66079157|FG003|Primary Study|Withdrawal by Subject|1|||
23643519|NCT00196976|66079158|FG004|Primary Study|Withdrawal by Subject|2|||
23643520|NCT00196976|66079159|FG005|Primary Study|Withdrawal by Subject|1|||
23643521|NCT00196976|66079160|FG006|Primary Study|Withdrawal by Subject|0|||
23643522|NCT00196976|66079161|FG007|Primary Study|Withdrawal by Subject|0|||
23643523|NCT00196976|66079162|FG008|Primary Study|Withdrawal by Subject|0|||
23643524|NCT00196976|66079163|FG009|Primary Study|Withdrawal by Subject|1|||
23643525|NCT00196976|66079164|FG010|Primary Study|Withdrawal by Subject|0|||
23643526|NCT00196976|66079165|FG011|Primary Study|Withdrawal by Subject|0|||
23643527|NCT00196976|66079166|FG012|Primary Study|Withdrawal by Subject|0|||
23643528|NCT00196976|66079167|FG013|Primary Study|Withdrawal by Subject|0|||
23643529|NCT00196976|66079154|FG000|Primary Study|Lost to Follow-up|0|||
23643530|NCT00196976|66079155|FG001|Primary Study|Lost to Follow-up|0|||
23643531|NCT00196976|66079156|FG002|Primary Study|Lost to Follow-up|0|||
23643532|NCT00196976|66079157|FG003|Primary Study|Lost to Follow-up|0|||
23643533|NCT00196976|66079158|FG004|Primary Study|Lost to Follow-up|1|||
23643534|NCT00196976|66079159|FG005|Primary Study|Lost to Follow-up|1|||
23643535|NCT00196976|66079160|FG006|Primary Study|Lost to Follow-up|0|||
23643536|NCT00196976|66079161|FG007|Primary Study|Lost to Follow-up|2|||
23643537|NCT00196976|66079162|FG008|Primary Study|Lost to Follow-up|0|||
23643538|NCT00196976|66079163|FG009|Primary Study|Lost to Follow-up|0|||
23643539|NCT00196976|66079164|FG010|Primary Study|Lost to Follow-up|0|||
23643540|NCT00196976|66079165|FG011|Primary Study|Lost to Follow-up|0|||
23643541|NCT00196976|66079166|FG012|Primary Study|Lost to Follow-up|0|||
23798053|NCT02010255|66636912|FG011|Overall Study|Adverse Event|0|||
23798054|NCT02010255|66636913|FG012|Overall Study|Adverse Event|0|||
23798055|NCT02010255|66636914|FG013|Overall Study|Adverse Event|0|||
23798056|NCT02010255|66636901|FG000|Overall Study|Lost to Follow-up|0|||
23798057|NCT02010255|66636902|FG001|Overall Study|Lost to Follow-up|0|||
23476011|NCT03560518|65485644|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
23476012|NCT03560518|65485642|FG000|Double Blind Treatment Period|Adverse Event|0|||
23476013|NCT03560518|65485643|FG001|Double Blind Treatment Period|Adverse Event|3|||
23476014|NCT03560518|65485644|FG002|Double Blind Treatment Period|Adverse Event|1|||
23476015|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
23476016|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
23476017|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
23476018|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
23476019|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
23476020|NCT00490529|65485645|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
23590054|NCT00828672|65889561|FG000|Study Treatment|Complete response, no surgery|1|||
23590055|NCT00828672|65889562|FG001|Study Treatment|Complete response, no surgery|1|||
23798058|NCT02010255|66636903|FG002|Overall Study|Lost to Follow-up|1|||
23590056|NCT00828672|65889561|FG000|Post-surgery (<30 Days)|No central review materials|0|||
23590057|NCT00828672|65889562|FG001|Post-surgery (<30 Days)|No central review materials|1|||
23590058|NCT01930045|65889563|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590059|NCT01930045|65889564|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590060|NCT01930045|65889565|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590061|NCT01930045|65889566|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590062|NCT01930045|65889567|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590063|NCT01930045|65889568|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
23590064|NCT01930045|65889563|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
23590065|NCT01930045|65889564|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
23359167|NCT02815267|65059989|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
23359168|NCT02815267|65059988|FG000|Double-Blind Phase|Protocol Violation|3|||
23359169|NCT02815267|65059989|FG001|Double-Blind Phase|Protocol Violation|2|||
23476021|NCT01499368|65487976|FG000|Overall Study|Did not meet I/E criteria|8|||
23359170|NCT02815267|65059988|FG000|Double-Blind Phase|Site withdrawal|1|||
23359171|NCT02815267|65059989|FG001|Double-Blind Phase|Site withdrawal|6|||
23359172|NCT02815267|65059988|FG000|Double-Blind Phase|Received a disallowed medication|1|||
23359173|NCT02815267|65059989|FG001|Double-Blind Phase|Received a disallowed medication|1|||
23359174|NCT02815267|65059988|FG000|Open-Label Phase|Adverse Event|1|||
23359175|NCT02815267|65059989|FG001|Open-Label Phase|Adverse Event|1|||
23359176|NCT02815267|65059988|FG000|Open-Label Phase|Lost to Follow-up|23|||
23359177|NCT02815267|65059989|FG001|Open-Label Phase|Lost to Follow-up|9|||
23359178|NCT02815267|65059988|FG000|Open-Label Phase|Withdrawal by Subject|24|||
23359179|NCT02815267|65059989|FG001|Open-Label Phase|Withdrawal by Subject|13|||
23359180|NCT02815267|65059988|FG000|Open-Label Phase|Protocol Violation|0|||
23359181|NCT02815267|65059989|FG001|Open-Label Phase|Protocol Violation|1|||
23359182|NCT02815267|65059988|FG000|Open-Label Phase|Administrative|21|||
23359183|NCT02815267|65059989|FG001|Open-Label Phase|Administrative|12|||
23359184|NCT02815267|65059988|FG000|Open-Label Phase|Other|2|||
23359185|NCT02815267|65059989|FG001|Open-Label Phase|Other|5|||
23359186|NCT02029274|65059990|FG000|Overall Study|Adverse Event|1|||
23359187|NCT02029274|65059991|FG001|Overall Study|Adverse Event|0|||
23359188|NCT02029274|65059992|FG002|Overall Study|Adverse Event|2|||
23359189|NCT02029274|65059993|FG003|Overall Study|Adverse Event|2|||
23359190|NCT04676152|65059994|FG000|Overall Study|screen fail|9|||
23359191|NCT00565604|65059995|FG000|Overall Study|Failure to treat|2|||
23359192|NCT00565604|65059995|FG000|Overall Study|Lost to Follow-up|2|||
23359193|NCT02080364|65059996|FG000|Baseline Period|Protocol Violation|2|||
23359194|NCT02080364|65059997|FG001|Baseline Period|Protocol Violation|1|||
23359195|NCT02080364|65059998|FG002|Baseline Period|Protocol Violation|0|||
23359196|NCT02080364|65059999|FG003|Baseline Period|Protocol Violation|0|||
23359197|NCT02080364|65059996|FG000|Baseline Period|Other|0|||
23359198|NCT02080364|65059997|FG001|Baseline Period|Other|1|||
23359199|NCT02080364|65059998|FG002|Baseline Period|Other|1|||
23359200|NCT02080364|65059999|FG003|Baseline Period|Other|0|||
23359201|NCT02080364|65059996|FG000|Treatment Period|Adverse Event|10|||
23359202|NCT02080364|65059997|FG001|Treatment Period|Adverse Event|15|||
23359203|NCT02080364|65059998|FG002|Treatment Period|Adverse Event|11|||
23359204|NCT02080364|65059999|FG003|Treatment Period|Adverse Event|14|||
23359205|NCT02080364|65059996|FG000|Treatment Period|Lost to Follow-up|2|||
23359206|NCT02080364|65059997|FG001|Treatment Period|Lost to Follow-up|3|||
23359207|NCT02080364|65059998|FG002|Treatment Period|Lost to Follow-up|5|||
23359208|NCT02080364|65059999|FG003|Treatment Period|Lost to Follow-up|0|||
23359209|NCT02080364|65059996|FG000|Treatment Period|Protocol Violation|5|||
23359210|NCT02080364|65059997|FG001|Treatment Period|Protocol Violation|3|||
23359211|NCT02080364|65059998|FG002|Treatment Period|Protocol Violation|5|||
23359212|NCT02080364|65059999|FG003|Treatment Period|Protocol Violation|1|||
23359213|NCT02080364|65059996|FG000|Treatment Period|Withdrawal by Subject|16|||
23359214|NCT02080364|65059997|FG001|Treatment Period|Withdrawal by Subject|16|||
23359215|NCT02080364|65059998|FG002|Treatment Period|Withdrawal by Subject|15|||
23359216|NCT02080364|65059999|FG003|Treatment Period|Withdrawal by Subject|10|||
23359217|NCT02080364|65059996|FG000|Treatment Period|Study Terminated by Sponsor|0|||
23359218|NCT02080364|65059997|FG001|Treatment Period|Study Terminated by Sponsor|0|||
23359219|NCT02080364|65059998|FG002|Treatment Period|Study Terminated by Sponsor|180|||
23359220|NCT02080364|65059999|FG003|Treatment Period|Study Terminated by Sponsor|183|||
23359221|NCT02080364|65059996|FG000|Treatment Period|Other|14|||
23590066|NCT01930045|65889565|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
23643542|NCT00196976|66079167|FG013|Primary Study|Lost to Follow-up|0|||
23643543|NCT00196976|66079154|FG000|Primary Study|Other|0|||
23643544|NCT00196976|66079155|FG001|Primary Study|Other|0|||
23643545|NCT00196976|66079156|FG002|Primary Study|Other|2|||
23643546|NCT00196976|66079157|FG003|Primary Study|Other|0|||
23643547|NCT00196976|66079158|FG004|Primary Study|Other|0|||
23643548|NCT00196976|66079159|FG005|Primary Study|Other|0|||
23643549|NCT00196976|66079160|FG006|Primary Study|Other|0|||
23643550|NCT00196976|66079161|FG007|Primary Study|Other|0|||
23643551|NCT00196976|66079162|FG008|Primary Study|Other|0|||
23643552|NCT00196976|66079163|FG009|Primary Study|Other|0|||
23643553|NCT00196976|66079164|FG010|Primary Study|Other|0|||
23643554|NCT00196976|66079165|FG011|Primary Study|Other|0|||
23643555|NCT00196976|66079166|FG012|Primary Study|Other|0|||
23643556|NCT00196976|66079167|FG013|Primary Study|Other|0|||
23643557|NCT00196976|66079154|FG000|Booster Study|Withdrawal by Subject|0|||
23643558|NCT00196976|66079155|FG001|Booster Study|Withdrawal by Subject|0|||
23643559|NCT00196976|66079156|FG002|Booster Study|Withdrawal by Subject|0|||
23643560|NCT00196976|66079157|FG003|Booster Study|Withdrawal by Subject|0|||
23798059|NCT02010255|66636904|FG003|Overall Study|Lost to Follow-up|0|||
23798060|NCT02010255|66636905|FG004|Overall Study|Lost to Follow-up|1|||
23798061|NCT02010255|66636906|FG005|Overall Study|Lost to Follow-up|0|||
23798062|NCT02010255|66636907|FG006|Overall Study|Lost to Follow-up|0|||
23798063|NCT02010255|66636908|FG007|Overall Study|Lost to Follow-up|0|||
23798064|NCT02010255|66636909|FG008|Overall Study|Lost to Follow-up|0|||
23798065|NCT02010255|66636910|FG009|Overall Study|Lost to Follow-up|0|||
23590067|NCT01930045|65889566|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
23590068|NCT01930045|65889567|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
23590069|NCT01930045|65889568|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
23590070|NCT02020616|65889570|FG000|Overall Study|Adverse Event|0|||
23590071|NCT02020616|65889571|FG001|Overall Study|Adverse Event|0|||
23590072|NCT02020616|65889572|FG002|Overall Study|Adverse Event|0|||
23590073|NCT02020616|65889573|FG003|Overall Study|Adverse Event|0|||
23590074|NCT02020616|65889574|FG004|Overall Study|Adverse Event|0|||
23590075|NCT02020616|65889575|FG005|Overall Study|Adverse Event|1|||
23590076|NCT02020616|65889576|FG006|Overall Study|Adverse Event|1|||
23590077|NCT02020616|65889570|FG000|Overall Study|Physician Decision|0|||
23590078|NCT02020616|65889571|FG001|Overall Study|Physician Decision|0|||
23590079|NCT02020616|65889572|FG002|Overall Study|Physician Decision|0|||
23590080|NCT02020616|65889573|FG003|Overall Study|Physician Decision|0|||
23590081|NCT02020616|65889574|FG004|Overall Study|Physician Decision|0|||
23590082|NCT02020616|65889575|FG005|Overall Study|Physician Decision|1|||
23590083|NCT02020616|65889576|FG006|Overall Study|Physician Decision|2|||
23590084|NCT02020616|65889570|FG000|Overall Study|Withdrawal by Subject|0|||
23590085|NCT02020616|65889571|FG001|Overall Study|Withdrawal by Subject|0|||
23590086|NCT02020616|65889572|FG002|Overall Study|Withdrawal by Subject|1|||
23590087|NCT02020616|65889573|FG003|Overall Study|Withdrawal by Subject|0|||
23590088|NCT02020616|65889574|FG004|Overall Study|Withdrawal by Subject|0|||
23590089|NCT02020616|65889575|FG005|Overall Study|Withdrawal by Subject|1|||
23590090|NCT02020616|65889576|FG006|Overall Study|Withdrawal by Subject|1|||
23590091|NCT02020616|65889570|FG000|Overall Study|Lost to Follow-up|0|||
23590092|NCT02020616|65889571|FG001|Overall Study|Lost to Follow-up|1|||
23590093|NCT02020616|65889572|FG002|Overall Study|Lost to Follow-up|0|||
23590094|NCT02020616|65889573|FG003|Overall Study|Lost to Follow-up|1|||
23590095|NCT02020616|65889574|FG004|Overall Study|Lost to Follow-up|1|||
23590096|NCT02020616|65889575|FG005|Overall Study|Lost to Follow-up|1|||
23590097|NCT02020616|65889576|FG006|Overall Study|Lost to Follow-up|0|||
23590098|NCT02020616|65889570|FG000|Overall Study|Early Termination Criteria Met|0|||
23643561|NCT00196976|66079158|FG004|Booster Study|Withdrawal by Subject|0|||
23643562|NCT00196976|66079159|FG005|Booster Study|Withdrawal by Subject|0|||
23798066|NCT02010255|66636911|FG010|Overall Study|Lost to Follow-up|0|||
23798067|NCT02010255|66636912|FG011|Overall Study|Lost to Follow-up|0|||
23590099|NCT02020616|65889571|FG001|Overall Study|Early Termination Criteria Met|0|||
23590100|NCT02020616|65889572|FG002|Overall Study|Early Termination Criteria Met|1|||
23798068|NCT02010255|66636913|FG012|Overall Study|Lost to Follow-up|0|||
23643563|NCT00196976|66079160|FG006|Booster Study|Withdrawal by Subject|0|||
23798069|NCT02010255|66636914|FG013|Overall Study|Lost to Follow-up|0|||
23359222|NCT02080364|65059997|FG001|Treatment Period|Other|12|||
23359223|NCT02080364|65059998|FG002|Treatment Period|Other|21|||
23359224|NCT02080364|65059999|FG003|Treatment Period|Other|16|||
23359225|NCT02500719|65060000|FG000|Overall Study|Lost to Follow-up|2|||
23359226|NCT02500719|65060001|FG001|Overall Study|Lost to Follow-up|3|||
23359227|NCT02500719|65060000|FG000|Overall Study|Trauma history|1|||
23359228|NCT02500719|65060001|FG001|Overall Study|Trauma history|0|||
23359229|NCT02500719|65060000|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
23359230|NCT02500719|65060001|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
23359231|NCT02500719|65060000|FG000|Overall Study|Did not meet criteria for PTSD|0|||
23359232|NCT02500719|65060001|FG001|Overall Study|Did not meet criteria for PTSD|1|||
23359233|NCT02500719|65060000|FG000|Overall Study|Claustrophobia|0|||
23359234|NCT02500719|65060001|FG001|Overall Study|Claustrophobia|1|||
23359235|NCT02500719|65060000|FG000|Overall Study|History of head trauma|0|||
23359236|NCT02500719|65060001|FG001|Overall Study|History of head trauma|1|||
23359237|NCT00977613|65060002|FG000|Overall Study|Lost to Follow-up|16|||
23359238|NCT01153009|65060011|FG000|Overall Study|Adverse Event|4|||
23359239|NCT01153009|65060012|FG001|Overall Study|Adverse Event|14|||
23359240|NCT01153009|65060013|FG002|Overall Study|Adverse Event|14|||
23359241|NCT01153009|65060014|FG003|Overall Study|Adverse Event|10|||
23359242|NCT01153009|65060011|FG000|Overall Study|Lack of Efficacy|9|||
23359243|NCT01153009|65060012|FG001|Overall Study|Lack of Efficacy|0|||
23359244|NCT01153009|65060013|FG002|Overall Study|Lack of Efficacy|2|||
23359245|NCT01153009|65060014|FG003|Overall Study|Lack of Efficacy|1|||
23359246|NCT01153009|65060011|FG000|Overall Study|Noncompliance with Study Medication|1|||
23359247|NCT01153009|65060012|FG001|Overall Study|Noncompliance with Study Medication|3|||
23590101|NCT02020616|65889573|FG003|Overall Study|Early Termination Criteria Met|0|||
23359248|NCT01153009|65060013|FG002|Overall Study|Noncompliance with Study Medication|4|||
23359249|NCT01153009|65060014|FG003|Overall Study|Noncompliance with Study Medication|1|||
23359250|NCT01153009|65060011|FG000|Overall Study|Protocol Deviations|4|||
23359251|NCT01153009|65060012|FG001|Overall Study|Protocol Deviations|3|||
23359252|NCT01153009|65060013|FG002|Overall Study|Protocol Deviations|3|||
23359253|NCT01153009|65060014|FG003|Overall Study|Protocol Deviations|2|||
23359254|NCT01153009|65060011|FG000|Overall Study|Withdrawal of Consent|5|||
23359255|NCT01153009|65060012|FG001|Overall Study|Withdrawal of Consent|5|||
23359256|NCT01153009|65060013|FG002|Overall Study|Withdrawal of Consent|4|||
23359257|NCT01153009|65060014|FG003|Overall Study|Withdrawal of Consent|6|||
23359258|NCT01153009|65060011|FG000|Overall Study|Lost to Follow-up|8|||
23359259|NCT01153009|65060012|FG001|Overall Study|Lost to Follow-up|8|||
23359260|NCT01153009|65060013|FG002|Overall Study|Lost to Follow-up|11|||
23359261|NCT01153009|65060014|FG003|Overall Study|Lost to Follow-up|15|||
23359262|NCT01153009|65060011|FG000|Overall Study|Other|1|||
23359263|NCT01153009|65060012|FG001|Overall Study|Other|1|||
23359264|NCT01153009|65060013|FG002|Overall Study|Other|3|||
23359265|NCT01153009|65060014|FG003|Overall Study|Other|2|||
23359266|NCT02609984|65060018|FG000|Overall Study|Death|29|||
23359267|NCT02609984|65060019|FG001|Overall Study|Death|26|||
23359268|NCT02609984|65060018|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
23359269|NCT02609984|65060019|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
23359270|NCT02609984|65060018|FG000|Overall Study|Lost to Follow-up|1|||
23359271|NCT02609984|65060019|FG001|Overall Study|Lost to Follow-up|2|||
23359272|NCT02609984|65060018|FG000|Overall Study|Withdrawal by Subject|0|||
23359273|NCT02609984|65060019|FG001|Overall Study|Withdrawal by Subject|1|||
23359274|NCT02609984|65060018|FG000|Overall Study|Disease Progression|2|||
23359275|NCT02609984|65060019|FG001|Overall Study|Disease Progression|0|||
23359276|NCT00856999|65060022|FG000|Overall Study|Withdrawal by Subject|5|||
23359277|NCT04999085|65060027|FG000|Overall Study|Death|1|||
23359278|NCT01054222|65060030|FG000|Overall Study|Lack of Efficacy|1|||
23359279|NCT01054222|65060030|FG000|Overall Study|Lost to Follow-up|4|||
23359280|NCT01054222|65060030|FG000|Overall Study|Withdrawal by Subject|6|||
23359281|NCT00070564|65060031|FG000|Overall Study|Progression|2|||
23359282|NCT00070564|65060032|FG001|Overall Study|Progression|4|||
23359283|NCT00070564|65060033|FG002|Overall Study|Progression|7|||
23359284|NCT00070564|65060034|FG003|Overall Study|Progression|7|||
23359285|NCT00070564|65060035|FG004|Overall Study|Progression|1|||
23359286|NCT00070564|65060036|FG005|Overall Study|Progression|0|||
23359287|NCT00070564|65060031|FG000|Overall Study|Delinquent|1|||
23359288|NCT00070564|65060032|FG001|Overall Study|Delinquent|4|||
23359289|NCT00070564|65060033|FG002|Overall Study|Delinquent|2|||
23359290|NCT00070564|65060034|FG003|Overall Study|Delinquent|0|||
23359291|NCT00070564|65060035|FG004|Overall Study|Delinquent|0|||
23359292|NCT00070564|65060036|FG005|Overall Study|Delinquent|0|||
23359293|NCT00070564|65060031|FG000|Overall Study|Adverse Event|150|||
23359294|NCT00070564|65060032|FG001|Overall Study|Adverse Event|142|||
23359295|NCT00070564|65060033|FG002|Overall Study|Adverse Event|120|||
23590102|NCT02020616|65889574|FG004|Overall Study|Early Termination Criteria Met|0|||
23359296|NCT00070564|65060034|FG003|Overall Study|Adverse Event|108|||
23359297|NCT00070564|65060035|FG004|Overall Study|Adverse Event|63|||
23359298|NCT00070564|65060036|FG005|Overall Study|Adverse Event|36|||
23359299|NCT00070564|65060031|FG000|Overall Study|Death|4|||
23359300|NCT00070564|65060032|FG001|Overall Study|Death|1|||
23359301|NCT00070564|65060033|FG002|Overall Study|Death|5|||
23643564|NCT00196976|66079161|FG007|Booster Study|Withdrawal by Subject|0|||
23643565|NCT00196976|66079162|FG008|Booster Study|Withdrawal by Subject|0|||
23643566|NCT00196976|66079163|FG009|Booster Study|Withdrawal by Subject|0|||
23643567|NCT00196976|66079164|FG010|Booster Study|Withdrawal by Subject|1|||
23643568|NCT00196976|66079165|FG011|Booster Study|Withdrawal by Subject|0|||
23359302|NCT00070564|65060034|FG003|Overall Study|Death|3|||
23359303|NCT00070564|65060035|FG004|Overall Study|Death|0|||
23359304|NCT00070564|65060036|FG005|Overall Study|Death|1|||
23359305|NCT00070564|65060031|FG000|Overall Study|Other, not protocol specified|17|||
23359306|NCT00070564|65060032|FG001|Overall Study|Other, not protocol specified|15|||
23359307|NCT00070564|65060033|FG002|Overall Study|Other, not protocol specified|14|||
23359308|NCT00070564|65060034|FG003|Overall Study|Other, not protocol specified|19|||
23359309|NCT00070564|65060035|FG004|Overall Study|Other, not protocol specified|6|||
23359310|NCT00070564|65060036|FG005|Overall Study|Other, not protocol specified|7|||
23359311|NCT00070564|65060031|FG000|Overall Study|Withdrawal by Subject|26|||
23359312|NCT00070564|65060032|FG001|Overall Study|Withdrawal by Subject|37|||
23359313|NCT00070564|65060033|FG002|Overall Study|Withdrawal by Subject|23|||
23359314|NCT00070564|65060034|FG003|Overall Study|Withdrawal by Subject|30|||
23359315|NCT00070564|65060035|FG004|Overall Study|Withdrawal by Subject|8|||
23359316|NCT00070564|65060036|FG005|Overall Study|Withdrawal by Subject|8|||
23359317|NCT00070564|65060031|FG000|Overall Study|Not reported|0|||
23359318|NCT00070564|65060032|FG001|Overall Study|Not reported|0|||
23359319|NCT00070564|65060033|FG002|Overall Study|Not reported|0|||
23359320|NCT00070564|65060034|FG003|Overall Study|Not reported|0|||
23359321|NCT00070564|65060035|FG004|Overall Study|Not reported|1|||
23359322|NCT00070564|65060036|FG005|Overall Study|Not reported|0|||
23359323|NCT01990573|65060037|FG000|Overall Study|Physician Decision|0|||
23359324|NCT01990573|65060038|FG001|Overall Study|Physician Decision|0|||
23359325|NCT01990573|65060039|FG002|Overall Study|Physician Decision|1|||
23359326|NCT00571103|65060040|FG000|Overall Study|Withdrawal by Subject|1|||
23359327|NCT00571103|65060040|FG000|Overall Study|Lost to Follow-up|1|||
23359328|NCT05446142|65060046|FG000|Period 2|Adverse Event|1|||
23359329|NCT05446142|65060047|FG001|Period 2|Adverse Event|0|||
23359330|NCT05446142|65060048|FG002|Period 2|Adverse Event|0|||
23359331|NCT05446142|65060049|FG003|Period 2|Adverse Event|0|||
23359332|NCT05446142|65060050|FG004|Period 2|Adverse Event|0|||
23359333|NCT05446142|65060051|FG005|Period 2|Adverse Event|0|||
23359334|NCT02585713|65060052|FG000|Overall Study|Withdrew prior to treatment|2|||
23590103|NCT02020616|65889575|FG005|Overall Study|Early Termination Criteria Met|1|||
23590104|NCT02020616|65889576|FG006|Overall Study|Early Termination Criteria Met|0|||
23590105|NCT02020616|65889570|FG000|Overall Study|Randomized in Error|0|||
23590106|NCT02020616|65889571|FG001|Overall Study|Randomized in Error|0|||
23590107|NCT02020616|65889572|FG002|Overall Study|Randomized in Error|0|||
23590108|NCT02020616|65889573|FG003|Overall Study|Randomized in Error|1|||
23590109|NCT02020616|65889574|FG004|Overall Study|Randomized in Error|0|||
23643569|NCT00196976|66079166|FG012|Booster Study|Withdrawal by Subject|0|||
23359335|NCT02585713|65060053|FG001|Overall Study|Withdrew prior to treatment|7|||
23359336|NCT02585713|65060052|FG000|Overall Study|Other|3|||
23359337|NCT02585713|65060053|FG001|Overall Study|Other|1|||
23359338|NCT02095197|65060057|FG000|Overall Study|Lost to Follow-up|0|||
23359339|NCT02095197|65060058|FG001|Overall Study|Lost to Follow-up|3|||
23359340|NCT03077607|65060059|FG000|Period 1 (15 Days)|Adverse Event|1|||
23359341|NCT03077607|65060060|FG001|Period 1 (15 Days)|Adverse Event|0|||
23359342|NCT03077607|65060059|FG000|Period 1 (15 Days)|Death|1|||
23359343|NCT03077607|65060060|FG001|Period 1 (15 Days)|Death|0|||
23359344|NCT03077607|65060059|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
23359345|NCT03077607|65060060|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
23359346|NCT03077607|65060059|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
23590110|NCT02020616|65889575|FG005|Overall Study|Randomized in Error|0|||
23590111|NCT02020616|65889576|FG006|Overall Study|Randomized in Error|0|||
23359347|NCT03077607|65060060|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
23359348|NCT03782571|65060061|FG000|Period 1|Withdrawal by Subject|1|||
23798070|NCT02010255|66636901|FG000|Overall Study|Randomized but Not Treated|0|||
23798071|NCT02010255|66636902|FG001|Overall Study|Randomized but Not Treated|0|||
23798072|NCT02010255|66636903|FG002|Overall Study|Randomized but Not Treated|0|||
23798073|NCT02010255|66636904|FG003|Overall Study|Randomized but Not Treated|0|||
23798074|NCT02010255|66636905|FG004|Overall Study|Randomized but Not Treated|0|||
23798075|NCT02010255|66636906|FG005|Overall Study|Randomized but Not Treated|0|||
23798076|NCT02010255|66636907|FG006|Overall Study|Randomized but Not Treated|0|||
23798077|NCT02010255|66636908|FG007|Overall Study|Randomized but Not Treated|0|||
23798078|NCT02010255|66636909|FG008|Overall Study|Randomized but Not Treated|0|||
23798079|NCT02010255|66636910|FG009|Overall Study|Randomized but Not Treated|0|||
23798080|NCT02010255|66636911|FG010|Overall Study|Randomized but Not Treated|0|||
23798081|NCT02010255|66636912|FG011|Overall Study|Randomized but Not Treated|0|||
23798082|NCT02010255|66636913|FG012|Overall Study|Randomized but Not Treated|0|||
23798083|NCT02010255|66636914|FG013|Overall Study|Randomized but Not Treated|1|||
23798084|NCT01270620|66636921|FG000|Overall Study|Withdrawal by Subject|1|||
23798085|NCT01270620|66636922|FG001|Overall Study|Withdrawal by Subject|3|||
23798086|NCT02655224|66636927|FG000|Overall Study|Adverse Event|1|||
23798087|NCT02655224|66636928|FG001|Overall Study|Adverse Event|1|||
23798088|NCT01188226|66636929|FG000|Overall Study|Withdrawal by Subject|4|||
23798089|NCT00546910|66636940|FG000|Overall Study|Adverse Event|2|||
23798090|NCT00546910|66636941|FG001|Overall Study|Adverse Event|3|||
23798091|NCT00546910|66636940|FG000|Overall Study|Lack of Efficacy|5|||
23798092|NCT00546910|66636941|FG001|Overall Study|Lack of Efficacy|7|||
23798093|NCT00546910|66636940|FG000|Overall Study|Physician Decision|0|||
23798094|NCT00546910|66636941|FG001|Overall Study|Physician Decision|1|||
23798095|NCT00546910|66636940|FG000|Overall Study|Withdrawal by Subject|2|||
23798096|NCT00546910|66636941|FG001|Overall Study|Withdrawal by Subject|0|||
23798097|NCT05317195|66636942|FG000|Randomization|Withdrawal by Subject|1|||
23798098|NCT05317195|66636942|FG000|Randomization|Discontinued|6|||
23798099|NCT05317195|66636942|FG000|Admission|Withdrawal by Subject|2|||
23798100|NCT03310619|66636943|FG000|Pre-Treatment Period|Death|1|||
23798101|NCT03310619|66636944|FG001|Pre-Treatment Period|Death|0|||
23798102|NCT03310619|66636945|FG002|Pre-Treatment Period|Death|0|||
23798103|NCT03310619|66636946|FG003|Pre-Treatment Period|Death|0|||
23798104|NCT03310619|66636947|FG004|Pre-Treatment Period|Death|1|||
23798105|NCT03310619|66636948|FG005|Pre-Treatment Period|Death|0|||
23798106|NCT03310619|66636949|FG006|Pre-Treatment Period|Death|0|||
23798107|NCT03310619|66636950|FG007|Pre-Treatment Period|Death|0|||
23798108|NCT03310619|66636943|FG000|Pre-Treatment Period|Other reasons|2|||
23798109|NCT03310619|66636944|FG001|Pre-Treatment Period|Other reasons|1|||
23798110|NCT03310619|66636945|FG002|Pre-Treatment Period|Other reasons|2|||
23798111|NCT03310619|66636946|FG003|Pre-Treatment Period|Other reasons|0|||
23798112|NCT03310619|66636947|FG004|Pre-Treatment Period|Other reasons|0|||
23798113|NCT03310619|66636948|FG005|Pre-Treatment Period|Other reasons|0|||
23798114|NCT03310619|66636949|FG006|Pre-Treatment Period|Other reasons|2|||
23798115|NCT03310619|66636950|FG007|Pre-Treatment Period|Other reasons|0|||
23798116|NCT03310619|66636943|FG000|Treatment Period|Death|1|||
23798117|NCT03310619|66636944|FG001|Treatment Period|Death|2|||
23798118|NCT03310619|66636945|FG002|Treatment Period|Death|0|||
23798119|NCT03310619|66636946|FG003|Treatment Period|Death|0|||
23798120|NCT03310619|66636947|FG004|Treatment Period|Death|1|||
23798121|NCT03310619|66636948|FG005|Treatment Period|Death|0|||
23798122|NCT03310619|66636949|FG006|Treatment Period|Death|2|||
23798123|NCT03310619|66636950|FG007|Treatment Period|Death|0|||
23798124|NCT03310619|66636943|FG000|Treatment Period|Adverse Event|0|||
23798125|NCT03310619|66636944|FG001|Treatment Period|Adverse Event|1|||
23798126|NCT03310619|66636945|FG002|Treatment Period|Adverse Event|4|||
23798127|NCT03310619|66636946|FG003|Treatment Period|Adverse Event|1|||
23798128|NCT03310619|66636947|FG004|Treatment Period|Adverse Event|0|||
23798129|NCT03310619|66636948|FG005|Treatment Period|Adverse Event|0|||
23359349|NCT03782571|65060062|FG001|Period 1|Withdrawal by Subject|0|||
23359350|NCT03782571|65060063|FG002|Period 1|Withdrawal by Subject|0|||
23359351|NCT03782571|65060064|FG003|Period 1|Withdrawal by Subject|0|||
23359352|NCT03782571|65060061|FG000|Period 3|Subject Unable to Attend V5|1|||
23359353|NCT03782571|65060062|FG001|Period 3|Subject Unable to Attend V5|0|||
23359354|NCT03782571|65060063|FG002|Period 3|Subject Unable to Attend V5|0|||
23798130|NCT03310619|66636949|FG006|Treatment Period|Adverse Event|0|||
23798131|NCT03310619|66636950|FG007|Treatment Period|Adverse Event|0|||
23798132|NCT03310619|66636943|FG000|Treatment Period|Withdrawal by participant|0|||
23798133|NCT03310619|66636944|FG001|Treatment Period|Withdrawal by participant|0|||
23798134|NCT03310619|66636945|FG002|Treatment Period|Withdrawal by participant|1|||
23798135|NCT03310619|66636946|FG003|Treatment Period|Withdrawal by participant|0|||
23798136|NCT03310619|66636947|FG004|Treatment Period|Withdrawal by participant|0|||
23798137|NCT03310619|66636948|FG005|Treatment Period|Withdrawal by participant|0|||
23798138|NCT03310619|66636949|FG006|Treatment Period|Withdrawal by participant|0|||
23798139|NCT03310619|66636950|FG007|Treatment Period|Withdrawal by participant|0|||
23359355|NCT03782571|65060064|FG003|Period 3|Subject Unable to Attend V5|0|||
23359356|NCT03782571|65060061|FG000|Period 3|Adverse Event|1|||
23359357|NCT03782571|65060062|FG001|Period 3|Adverse Event|0|||
23359358|NCT03782571|65060063|FG002|Period 3|Adverse Event|0|||
23359359|NCT03782571|65060064|FG003|Period 3|Adverse Event|0|||
23359360|NCT04547140|65060065|FG000|Overall Study|Adverse Event|0|||
23359361|NCT04547140|65060066|FG001|Overall Study|Adverse Event|1|||
23359362|NCT04547140|65060065|FG000|Overall Study|Withdrawal by Subject|0|||
23359363|NCT04547140|65060066|FG001|Overall Study|Withdrawal by Subject|1|||
23359364|NCT04547140|65060065|FG000|Overall Study|Lost to Follow-up|3|||
23359365|NCT04547140|65060066|FG001|Overall Study|Lost to Follow-up|1|||
23359366|NCT04547140|65060065|FG000|Overall Study|Death|2|||
23359367|NCT04547140|65060066|FG001|Overall Study|Death|1|||
23359368|NCT04547140|65060065|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
23359369|NCT04547140|65060066|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
23798140|NCT03310619|66636943|FG000|Treatment Period|Lost to Follow-up|0|||
23798141|NCT03310619|66636944|FG001|Treatment Period|Lost to Follow-up|0|||
23476022|NCT01499368|65487977|FG001|Overall Study|Did not meet I/E criteria|4|||
23476023|NCT01499368|65487978|FG002|Overall Study|Did not meet I/E criteria|4|||
23476024|NCT01499368|65487976|FG000|Overall Study|Prohibited Concomitant medication|1|||
23359370|NCT04547140|65060065|FG000|Overall Study|Pregnancy|1|||
23359371|NCT04547140|65060066|FG001|Overall Study|Pregnancy|0|||
23359372|NCT04547140|65060065|FG000|Overall Study|Reason Not Specified|4|||
23359373|NCT04547140|65060066|FG001|Overall Study|Reason Not Specified|1|||
23359374|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
23359375|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
23476025|NCT01499368|65487977|FG001|Overall Study|Prohibited Concomitant medication|1|||
23476026|NCT01499368|65487978|FG002|Overall Study|Prohibited Concomitant medication|0|||
23359376|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
23476027|NCT01499368|65487976|FG000|Overall Study|Withdrawal by Subject|11|||
23798142|NCT03310619|66636945|FG002|Treatment Period|Lost to Follow-up|0|||
23798143|NCT03310619|66636946|FG003|Treatment Period|Lost to Follow-up|0|||
23476028|NCT01499368|65487977|FG001|Overall Study|Withdrawal by Subject|10|||
23643570|NCT00196976|66079167|FG013|Booster Study|Withdrawal by Subject|0|||
23476029|NCT01499368|65487978|FG002|Overall Study|Withdrawal by Subject|8|||
23476030|NCT01499368|65487976|FG000|Overall Study|Lost to Follow-up|3|||
23476031|NCT01499368|65487977|FG001|Overall Study|Lost to Follow-up|2|||
23476032|NCT01499368|65487978|FG002|Overall Study|Lost to Follow-up|5|||
23476033|NCT01499368|65487976|FG000|Overall Study|Adverse Event|4|||
23476034|NCT01499368|65487977|FG001|Overall Study|Adverse Event|0|||
23476035|NCT01499368|65487978|FG002|Overall Study|Adverse Event|2|||
23476036|NCT01499368|65487976|FG000|Overall Study|Physician Decision|0|||
23476037|NCT01499368|65487977|FG001|Overall Study|Physician Decision|1|||
23476038|NCT01499368|65487978|FG002|Overall Study|Physician Decision|0|||
23476039|NCT01499368|65487976|FG000|Overall Study|Deviation from visit window|0|||
23476040|NCT01499368|65487977|FG001|Overall Study|Deviation from visit window|0|||
23476041|NCT01499368|65487978|FG002|Overall Study|Deviation from visit window|1|||
23476042|NCT01499368|65487976|FG000|Overall Study|Error of Prescriptions|0|||
23476043|NCT01499368|65487977|FG001|Overall Study|Error of Prescriptions|0|||
23476044|NCT01499368|65487978|FG002|Overall Study|Error of Prescriptions|1|||
23476045|NCT00910299|65487979|FG000|Overall Study|Withdrawal by Subject|16|||
23476046|NCT00910299|65487980|FG001|Overall Study|Withdrawal by Subject|13|||
23476047|NCT00910299|65487979|FG000|Overall Study|Sponsor Decision|58|||
23476048|NCT00910299|65487980|FG001|Overall Study|Sponsor Decision|60|||
23476049|NCT00910299|65487979|FG000|Overall Study|Didn't receive any study drug|2|||
23476050|NCT00910299|65487980|FG001|Overall Study|Didn't receive any study drug|1|||
23476051|NCT02717832|65487983|FG000|Overall Study|Inability to place IV|3|||
23476052|NCT01643772|65487984|FG000|Overall Study|Protocol Violation|0|||
23476053|NCT01643772|65487985|FG001|Overall Study|Protocol Violation|0|||
23476054|NCT01643772|65487986|FG002|Overall Study|Protocol Violation|0|||
23476055|NCT01643772|65487987|FG003|Overall Study|Protocol Violation|1|||
23476056|NCT01643772|65487984|FG000|Overall Study|Adverse Event|0|||
23476057|NCT01643772|65487985|FG001|Overall Study|Adverse Event|0|||
23476058|NCT01643772|65487986|FG002|Overall Study|Adverse Event|0|||
23476059|NCT01643772|65487987|FG003|Overall Study|Adverse Event|1|||
23476060|NCT01233232|65487988|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
23643571|NCT00196976|66079154|FG000|Booster Study|Lost to Follow-up|0|||
23798144|NCT03310619|66636947|FG004|Treatment Period|Lost to Follow-up|0|||
23798145|NCT03310619|66636948|FG005|Treatment Period|Lost to Follow-up|0|||
23798146|NCT03310619|66636949|FG006|Treatment Period|Lost to Follow-up|0|||
23798147|NCT03310619|66636950|FG007|Treatment Period|Lost to Follow-up|1|||
23798148|NCT03310619|66636943|FG000|Treatment Period|Study terminated by sponsor|0|||
23798149|NCT03310619|66636944|FG001|Treatment Period|Study terminated by sponsor|0|||
23798150|NCT03310619|66636945|FG002|Treatment Period|Study terminated by sponsor|0|||
23798151|NCT03310619|66636946|FG003|Treatment Period|Study terminated by sponsor|0|||
23798152|NCT03310619|66636947|FG004|Treatment Period|Study terminated by sponsor|0|||
23798153|NCT03310619|66636948|FG005|Treatment Period|Study terminated by sponsor|0|||
23798154|NCT03310619|66636949|FG006|Treatment Period|Study terminated by sponsor|0|||
23798155|NCT03310619|66636950|FG007|Treatment Period|Study terminated by sponsor|1|||
23476061|NCT01233232|65487989|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
23476062|NCT01233232|65487990|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
23476063|NCT03658876|65487991|FG000|Overall Study|Protocol Violation|3|||
23476064|NCT03658876|65487992|FG001|Overall Study|Protocol Violation|2|||
23476065|NCT03658876|65487991|FG000|Overall Study|Withdrawal by Subject|2|||
23798156|NCT03310619|66636943|FG000|Treatment Period|Physician Decision|0|||
23798157|NCT03310619|66636944|FG001|Treatment Period|Physician Decision|0|||
23476066|NCT03658876|65487992|FG001|Overall Study|Withdrawal by Subject|0|||
23476067|NCT03658876|65487991|FG000|Overall Study|Death|0|||
23476068|NCT03658876|65487992|FG001|Overall Study|Death|1|||
23476069|NCT03658876|65487991|FG000|Overall Study|Intercurrent illness|6|||
23476070|NCT03658876|65487992|FG001|Overall Study|Intercurrent illness|4|||
23476071|NCT03658876|65487991|FG000|Overall Study|Transplantation/other operation|1|||
23798158|NCT03310619|66636945|FG002|Treatment Period|Physician Decision|0|||
23798159|NCT03310619|66636946|FG003|Treatment Period|Physician Decision|0|||
23798160|NCT03310619|66636947|FG004|Treatment Period|Physician Decision|3|||
23798161|NCT03310619|66636948|FG005|Treatment Period|Physician Decision|0|||
23798162|NCT03310619|66636949|FG006|Treatment Period|Physician Decision|0|||
23798163|NCT03310619|66636950|FG007|Treatment Period|Physician Decision|0|||
23798164|NCT03310619|66636943|FG000|Treatment Period|Other reasons|1|||
23798165|NCT03310619|66636944|FG001|Treatment Period|Other reasons|0|||
23798166|NCT03310619|66636945|FG002|Treatment Period|Other reasons|2|||
23798167|NCT03310619|66636946|FG003|Treatment Period|Other reasons|0|||
23798168|NCT03310619|66636947|FG004|Treatment Period|Other reasons|0|||
23798169|NCT03310619|66636948|FG005|Treatment Period|Other reasons|0|||
23798170|NCT03310619|66636949|FG006|Treatment Period|Other reasons|0|||
23798171|NCT03310619|66636950|FG007|Treatment Period|Other reasons|0|||
23798172|NCT03223909|66636951|FG000|Overall Study|Protocol Violation|48|||
23798173|NCT03223909|66636952|FG001|Overall Study|Protocol Violation|45|||
23798174|NCT03223909|66636953|FG002|Overall Study|Protocol Violation|16|||
23798175|NCT01523587|66636954|FG000|Overall Study|Other than listed|5|||
23476072|NCT03658876|65487992|FG001|Overall Study|Transplantation/other operation|5|||
23476073|NCT03598114|65487998|FG000|Overall Study|Staff turnover/left the program|3|||
23476074|NCT03598114|65487999|FG001|Overall Study|Staff turnover/left the program|39|||
23476075|NCT01788358|65488000|FG000|Overall Study|Other|11|||
23476076|NCT01788358|65488000|FG000|Overall Study|Logistical difficulties|1|||
23476077|NCT01788358|65488000|FG000|Overall Study|Lost to Follow-up|5|||
23476078|NCT01788358|65488000|FG000|Overall Study|Protocol Violation|3|||
23476079|NCT01788358|65488000|FG000|Overall Study|Withdrawal by Subject|26|||
23476080|NCT01788358|65488000|FG000|Overall Study|Lack of Efficacy|1|||
23476081|NCT01788358|65488000|FG000|Overall Study|Adverse Event|51|||
23476082|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
23476083|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
23476084|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
23476085|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
23476086|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
23476087|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
23798176|NCT01523587|66636955|FG001|Overall Study|Other than listed|5|||
23798177|NCT01523587|66636954|FG000|Overall Study|Worsening of underlying cancer disease|19|||
23798178|NCT01523587|66636955|FG001|Overall Study|Worsening of underlying cancer disease|34|||
23476088|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
23476089|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
23476090|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
23590112|NCT02020616|65889570|FG000|Overall Study|Lack of Efficacy|0|||
23590113|NCT02020616|65889571|FG001|Overall Study|Lack of Efficacy|0|||
23590114|NCT02020616|65889572|FG002|Overall Study|Lack of Efficacy|0|||
23590115|NCT02020616|65889573|FG003|Overall Study|Lack of Efficacy|0|||
23590116|NCT02020616|65889574|FG004|Overall Study|Lack of Efficacy|1|||
23590117|NCT02020616|65889575|FG005|Overall Study|Lack of Efficacy|0|||
23590118|NCT02020616|65889576|FG006|Overall Study|Lack of Efficacy|0|||
23590119|NCT03959241|65889577|FG000|Overall Study|Withdrawal by Subject|7|||
23590120|NCT03959241|65889578|FG001|Overall Study|Withdrawal by Subject|8|||
23590121|NCT03959241|65889577|FG000|Overall Study|Lost to Follow-up|1|||
23590122|NCT03959241|65889578|FG001|Overall Study|Lost to Follow-up|0|||
23590123|NCT03959241|65889577|FG000|Overall Study|Move to Hospice Care|1|||
23590124|NCT03959241|65889578|FG001|Overall Study|Move to Hospice Care|0|||
23590125|NCT03959241|65889577|FG000|Overall Study|Screen Failure|1|||
23643572|NCT00196976|66079155|FG001|Booster Study|Lost to Follow-up|0|||
23643573|NCT00196976|66079156|FG002|Booster Study|Lost to Follow-up|0|||
23643574|NCT00196976|66079157|FG003|Booster Study|Lost to Follow-up|0|||
23643575|NCT00196976|66079158|FG004|Booster Study|Lost to Follow-up|0|||
23798179|NCT01523587|66636954|FG000|Overall Study|Adverse Event|68|||
23798180|NCT01523587|66636955|FG001|Overall Study|Adverse Event|52|||
23798181|NCT01523587|66636954|FG000|Overall Study|Protocol Violation|5|||
23798182|NCT01523587|66636955|FG001|Overall Study|Protocol Violation|3|||
23798183|NCT01523587|66636954|FG000|Overall Study|Lost to Follow-up|2|||
23798184|NCT01523587|66636955|FG001|Overall Study|Lost to Follow-up|2|||
23476091|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
23476092|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
23476093|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
23476094|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
23476095|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
23476096|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
23476097|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
23590126|NCT03959241|65889578|FG001|Overall Study|Screen Failure|0|||
23590127|NCT03959241|65889577|FG000|Overall Study|Disease Relapse|0|||
23643576|NCT00196976|66079159|FG005|Booster Study|Lost to Follow-up|0|||
23590128|NCT03959241|65889578|FG001|Overall Study|Disease Relapse|1|||
23476098|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
23476099|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
23476100|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
23476101|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
23476102|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
23476103|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
23476104|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
23476105|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
23476106|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
23476107|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
23476108|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
23476109|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
23476110|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
23476111|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
23476112|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
23476113|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
23476114|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
23476115|NCT01087788|65488001|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
23476116|NCT01087788|65488002|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
23476117|NCT01087788|65488003|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
23476118|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
23476119|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
23476120|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
23476121|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
23476122|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
23476123|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
23476124|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
23476125|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
23476126|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
23476127|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
23476128|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
23476129|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
23476130|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
23476131|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
23476132|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
23476133|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
23476134|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
23476135|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
23590129|NCT03959241|65889577|FG000|Overall Study|Off Study|1|||
23590130|NCT03959241|65889578|FG001|Overall Study|Off Study|0|||
23590131|NCT02715258|65889579|FG000|Overall Study|Withdrawal by Subject|6|||
23590132|NCT02715258|65889580|FG001|Overall Study|Withdrawal by Subject|1|||
23590133|NCT02715258|65889579|FG000|Overall Study|Lost to Follow-up|7|||
23590134|NCT02715258|65889580|FG001|Overall Study|Lost to Follow-up|1|||
23590135|NCT02715258|65889579|FG000|Overall Study|Terminated by Sponsor|0|||
23590136|NCT02715258|65889580|FG001|Overall Study|Terminated by Sponsor|1|||
23590137|NCT02715258|65889579|FG000|Overall Study|Death|0|||
23643577|NCT00196976|66079160|FG006|Booster Study|Lost to Follow-up|0|||
23643578|NCT00196976|66079161|FG007|Booster Study|Lost to Follow-up|0|||
23476136|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
23476137|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
23476138|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
23476139|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Patient moved|0|||
23590138|NCT02715258|65889580|FG001|Overall Study|Death|1|||
23643579|NCT00196976|66079162|FG008|Booster Study|Lost to Follow-up|0|||
23590139|NCT02715258|65889579|FG000|Overall Study|Subject non-compliant|1|||
23590140|NCT02715258|65889580|FG001|Overall Study|Subject non-compliant|1|||
23590141|NCT02715258|65889579|FG000|Overall Study|GCP violation|2|||
23590142|NCT02715258|65889580|FG001|Overall Study|GCP violation|1|||
23590143|NCT00688519|65889581|FG000|Overall Study|Adverse Event|2|||
23590144|NCT00688519|65889582|FG001|Overall Study|Adverse Event|3|||
23590145|NCT00688519|65889581|FG000|Overall Study|Lost to Follow-up|3|||
23590146|NCT00688519|65889582|FG001|Overall Study|Lost to Follow-up|3|||
23590147|NCT00688519|65889581|FG000|Overall Study|Lack of Efficacy|3|||
23590148|NCT00688519|65889582|FG001|Overall Study|Lack of Efficacy|1|||
23590149|NCT00688519|65889581|FG000|Overall Study|Withdrawal by Subject|7|||
23590150|NCT00688519|65889582|FG001|Overall Study|Withdrawal by Subject|6|||
23590151|NCT00688519|65889581|FG000|Overall Study|Prohibited medication|1|||
23590152|NCT00688519|65889582|FG001|Overall Study|Prohibited medication|0|||
23643580|NCT00196976|66079163|FG009|Booster Study|Lost to Follow-up|0|||
23643581|NCT00196976|66079164|FG010|Booster Study|Lost to Follow-up|1|||
23643582|NCT00196976|66079165|FG011|Booster Study|Lost to Follow-up|2|||
23643583|NCT00196976|66079166|FG012|Booster Study|Lost to Follow-up|0|||
23643584|NCT00196976|66079167|FG013|Booster Study|Lost to Follow-up|0|||
23643585|NCT00752557|66079168|FG000|Overall Study|Withdrawal by Subject|4|||
23643586|NCT00752557|66079169|FG001|Overall Study|Withdrawal by Subject|3|||
23643587|NCT00752557|66079170|FG002|Overall Study|Withdrawal by Subject|3|||
23643588|NCT00752557|66079168|FG000|Overall Study|Unspecified resaons|0|||
23643589|NCT00752557|66079169|FG001|Overall Study|Unspecified resaons|2|||
23643590|NCT00752557|66079170|FG002|Overall Study|Unspecified resaons|2|||
23643591|NCT00752557|66079168|FG000|Overall Study|Lost to Follow-up|1|||
23643592|NCT00752557|66079169|FG001|Overall Study|Lost to Follow-up|0|||
23643593|NCT00752557|66079170|FG002|Overall Study|Lost to Follow-up|1|||
23643594|NCT01014143|66079171|FG000|Second Intervention|Lost to Follow-up|2|||
23643595|NCT01014143|66079172|FG001|Second Intervention|Lost to Follow-up|0|||
23643596|NCT01014143|66079173|FG002|Second Intervention|Lost to Follow-up|0|||
23643597|NCT03212989|66079174|FG000|Overall Study|Physician Decision|8|||
23643598|NCT01052103|66079175|FG000|Overall Study|Adverse Event|10|||
23643599|NCT01052103|66079176|FG001|Overall Study|Adverse Event|6|||
23798185|NCT01523587|66636954|FG000|Overall Study|Withdrawal by Subject|28|||
23798186|NCT01523587|66636955|FG001|Overall Study|Withdrawal by Subject|20|||
23590153|NCT00688519|65889581|FG000|Overall Study|Non-compliance|0|||
23590154|NCT00688519|65889582|FG001|Overall Study|Non-compliance|1|||
23590155|NCT00688519|65889581|FG000|Overall Study|Subject moved out of state|1|||
23590156|NCT00688519|65889582|FG001|Overall Study|Subject moved out of state|0|||
23590157|NCT00688519|65889581|FG000|Overall Study|Investigator decision|1|||
23590158|NCT00688519|65889582|FG001|Overall Study|Investigator decision|0|||
23643600|NCT01052103|66079175|FG000|Overall Study|Entry Criteria Not Met|3|||
23643601|NCT01052103|66079176|FG001|Overall Study|Entry Criteria Not Met|1|||
23643602|NCT01052103|66079175|FG000|Overall Study|Lost to Follow-up|3|||
23798187|NCT01523587|66636954|FG000|Overall Study|Withdrew due to Progressive disease|265|||
23798188|NCT01523587|66636955|FG001|Overall Study|Withdrew due to Progressive disease|279|||
23798189|NCT01523587|66636954|FG000|Overall Study|Randomised but bot treated|6|||
23798190|NCT01523587|66636955|FG001|Overall Study|Randomised but bot treated|2|||
23643603|NCT01052103|66079176|FG001|Overall Study|Lost to Follow-up|5|||
23643604|NCT01052103|66079175|FG000|Overall Study|Protocol Violation|10|||
23643605|NCT01052103|66079176|FG001|Overall Study|Protocol Violation|4|||
23643606|NCT01052103|66079175|FG000|Overall Study|Scheduling conflict|2|||
23643607|NCT01052103|66079176|FG001|Overall Study|Scheduling conflict|1|||
23643608|NCT01052103|66079175|FG000|Overall Study|Sponsor Decision|2|||
23643609|NCT01052103|66079176|FG001|Overall Study|Sponsor Decision|0|||
23643610|NCT01052103|66079175|FG000|Overall Study|Withdrawal by Subject|3|||
23643611|NCT01052103|66079176|FG001|Overall Study|Withdrawal by Subject|6|||
23643612|NCT01052103|66079175|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23643613|NCT01052103|66079176|FG001|Overall Study|Perceived Lack of Efficacy|0|||
23643614|NCT00712673|66079178|FG000|Overall Study|Adverse Event|3|||
23643615|NCT00712673|66079179|FG001|Overall Study|Adverse Event|3|||
23643616|NCT00712673|66079180|FG002|Overall Study|Adverse Event|21|||
23643617|NCT00712673|66079181|FG003|Overall Study|Adverse Event|26|||
23643618|NCT00712673|66079178|FG000|Overall Study|Lack of Efficacy|2|||
23798191|NCT00551616|66636956|FG000|Overall Study|Lost to Follow-up|48|||
23798192|NCT00551616|66636957|FG001|Overall Study|Lost to Follow-up|40|||
23590159|NCT00688519|65889581|FG000|Overall Study|Subject moved out of area|1|||
23590160|NCT00688519|65889582|FG001|Overall Study|Subject moved out of area|0|||
23590161|NCT00688519|65889581|FG000|Overall Study|Pregnancy|0|||
23643619|NCT00712673|66079179|FG001|Overall Study|Lack of Efficacy|8|||
23643620|NCT00712673|66079180|FG002|Overall Study|Lack of Efficacy|8|||
23643621|NCT00712673|66079181|FG003|Overall Study|Lack of Efficacy|6|||
23643622|NCT00712673|66079178|FG000|Overall Study|Poor Compliance to Protocol|3|||
23643623|NCT00712673|66079179|FG001|Overall Study|Poor Compliance to Protocol|3|||
23590162|NCT00688519|65889582|FG001|Overall Study|Pregnancy|1|||
23643624|NCT00712673|66079180|FG002|Overall Study|Poor Compliance to Protocol|4|||
23643625|NCT00712673|66079181|FG003|Overall Study|Poor Compliance to Protocol|16|||
23590163|NCT00436644|65889583|FG000|Overall Study|Adverse Event|2|||
23590164|NCT00436644|65889583|FG000|Overall Study|Death|1|||
23590165|NCT04340362|65889584|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
23590166|NCT02878330|65889585|FG000|Overall Study|Death|3|||
23590167|NCT02878330|65889586|FG001|Overall Study|Death|2|||
23590168|NCT02878330|65889585|FG000|Overall Study|Lost to Follow-up|11|||
23590169|NCT02878330|65889586|FG001|Overall Study|Lost to Follow-up|26|||
23590170|NCT02878330|65889585|FG000|Overall Study|Withdrawal by Subject|11|||
23590171|NCT02878330|65889586|FG001|Overall Study|Withdrawal by Subject|21|||
23590172|NCT02878330|65889585|FG000|Overall Study|Other|4|||
23590173|NCT02878330|65889586|FG001|Overall Study|Other|7|||
23590174|NCT00319436|65889587|FG000|Overall Study|Withdrawal by Subject|6|||
23590175|NCT00319436|65889588|FG001|Overall Study|Withdrawal by Subject|7|||
23590176|NCT00739102|65889589|FG000|Overall Study|Death|5|||
23590177|NCT00739102|65889589|FG000|Overall Study|Withdrawal by Subject|10|||
23590178|NCT03876457|65889590|FG000|Overall Study|Lost to Follow-up|1|||
23590179|NCT03876457|65889591|FG001|Overall Study|Lost to Follow-up|3|||
23590180|NCT01959412|65889594|FG000|Overall Study|Protocol deviation|1|||
23590181|NCT01959412|65889595|FG001|Overall Study|Protocol deviation|1|||
23590182|NCT01959412|65889596|FG002|Overall Study|Protocol deviation|0|||
23590183|NCT01959412|65889597|FG003|Overall Study|Protocol deviation|1|||
23590184|NCT01959412|65889598|FG004|Overall Study|Protocol deviation|3|||
23590185|NCT01959412|65889599|FG005|Overall Study|Protocol deviation|0|||
23590186|NCT01959412|65889594|FG000|Overall Study|Adverse Event|0|||
23590187|NCT01959412|65889595|FG001|Overall Study|Adverse Event|0|||
23590188|NCT01959412|65889596|FG002|Overall Study|Adverse Event|0|||
23590189|NCT01959412|65889597|FG003|Overall Study|Adverse Event|1|||
23590190|NCT01959412|65889598|FG004|Overall Study|Adverse Event|0|||
23590191|NCT01959412|65889599|FG005|Overall Study|Adverse Event|0|||
23590192|NCT00855465|65889600|FG000|Treatment Period|Adverse Event|4|||
23590193|NCT00855465|65889601|FG001|Treatment Period|Adverse Event|2|||
23590194|NCT00855465|65889600|FG000|Treatment Period|Death|2|||
23590195|NCT00855465|65889601|FG001|Treatment Period|Death|2|||
23590196|NCT00855465|65889600|FG000|Treatment Period|Lack of Efficacy|2|||
23590197|NCT00855465|65889601|FG001|Treatment Period|Lack of Efficacy|1|||
23590198|NCT00855465|65889600|FG000|Treatment Period|Non-compliance|1|||
23590199|NCT00855465|65889601|FG001|Treatment Period|Non-compliance|0|||
23590200|NCT00855465|65889600|FG000|Treatment Period|Protocol Violation|2|||
23590201|NCT00855465|65889601|FG001|Treatment Period|Protocol Violation|0|||
23590202|NCT00855465|65889600|FG000|Treatment Period|Withdrawal by Subject|2|||
23590203|NCT00855465|65889601|FG001|Treatment Period|Withdrawal by Subject|0|||
23590204|NCT00855465|65889600|FG000|Treatment Period|Not treated|1|||
23590205|NCT00855465|65889601|FG001|Treatment Period|Not treated|0|||
23590206|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Adverse Event|0|||
23359377|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
23359378|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
23359379|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23590207|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Adverse Event|1|||
23590208|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Death|0|||
23590209|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Death|1|||
23590210|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
23590211|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
23590212|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
23590213|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
23590214|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Missing|1|||
23590215|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Missing|0|||
23590216|NCT02031471|65889602|FG000|24 Week Treatment Period|Adverse Event|6|||
23590217|NCT02031471|65889602|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
23590218|NCT02031471|65889602|FG000|24 Week Treatment Period|Protocol Violation|1|||
23590219|NCT02031471|65889602|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
23590220|NCT02031471|65889602|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
23590221|NCT02031471|65889602|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
23359380|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23590222|NCT02031471|65889602|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
23590223|NCT01091454|65889605|FG000|Overall Study|Ineligible|1|||
23590224|NCT01510912|65889606|FG000|Overall Study|Adverse Event|99|||
23590225|NCT01510912|65889606|FG000|Overall Study|Lack of Efficacy|12|||
23590226|NCT01510912|65889606|FG000|Overall Study|Non-compliance with trial drug|23|||
23590227|NCT01510912|65889606|FG000|Overall Study|Withdrawal by Subject|49|||
23590228|NCT01510912|65889606|FG000|Overall Study|Physician Decision|1|||
23590229|NCT01510912|65889606|FG000|Overall Study|Protocol Violation|27|||
23590230|NCT01510912|65889606|FG000|Overall Study|Lost to Follow-up|26|||
23590231|NCT01510912|65889606|FG000|Overall Study|Other, including joint replacement|5|||
23590232|NCT01585558|65889614|FG000|Overall Study|Withdrawal by Subject|4|||
23590233|NCT01585558|65889615|FG001|Overall Study|Withdrawal by Subject|5|||
23590234|NCT01585558|65889616|FG002|Overall Study|Withdrawal by Subject|8|||
23359381|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23359382|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
23359383|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
23359384|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
23359385|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
23359386|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359387|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359388|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
23359389|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359390|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
23359391|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359392|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359393|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359394|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359395|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359396|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
23359397|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359398|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
23359399|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359400|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359401|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359402|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359403|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359404|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
23359405|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359406|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
23359407|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359408|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359409|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359410|NCT01639703|65060077|FG000|Overall Study|Withdrawal by Subject|5|||
23359411|NCT01639703|65060077|FG000|Overall Study|Other reason|7|||
23359412|NCT02081001|65060078|FG000|Overall Study|Adverse Event|0|||
23359413|NCT02081001|65060079|FG001|Overall Study|Adverse Event|0|||
23359414|NCT02081001|65060080|FG002|Overall Study|Adverse Event|0|||
23359415|NCT02081001|65060081|FG003|Overall Study|Adverse Event|0|||
23359416|NCT02081001|65060082|FG004|Overall Study|Adverse Event|1|||
23359417|NCT02081001|65060083|FG005|Overall Study|Adverse Event|0|||
23359418|NCT02081001|65060084|FG006|Overall Study|Adverse Event|0|||
23359419|NCT02081001|65060085|FG007|Overall Study|Adverse Event|0|||
23359420|NCT02081001|65060086|FG008|Overall Study|Adverse Event|0|||
23359421|NCT02081001|65060087|FG009|Overall Study|Adverse Event|0|||
23359422|NCT02081001|65060088|FG010|Overall Study|Adverse Event|0|||
23359423|NCT02081001|65060089|FG011|Overall Study|Adverse Event|0|||
23359424|NCT01093586|65060090|FG000|Overall Study|Failed to engraft|3|||
23359425|NCT02732015|65060091|FG000|Overall Study|Lost to Follow-up|0|||
23359426|NCT02732015|65060092|FG001|Overall Study|Lost to Follow-up|1|||
23359427|NCT04501952|65060097|FG000|Overall Study|Adverse Event|0|||
23359428|NCT04501952|65060098|FG001|Overall Study|Adverse Event|3|||
23359429|NCT04501952|65060097|FG000|Overall Study|Investigator's Discretion|0|||
23359430|NCT04501952|65060098|FG001|Overall Study|Investigator's Discretion|1|||
23643626|NCT00712673|66079178|FG000|Overall Study|Lost to Follow-up|1|||
23643627|NCT00712673|66079179|FG001|Overall Study|Lost to Follow-up|0|||
23643628|NCT00712673|66079180|FG002|Overall Study|Lost to Follow-up|2|||
23643629|NCT00712673|66079181|FG003|Overall Study|Lost to Follow-up|0|||
23643630|NCT00712673|66079178|FG000|Overall Study|Withdrawal by Subject|6|||
23643631|NCT00712673|66079179|FG001|Overall Study|Withdrawal by Subject|7|||
23643632|NCT00712673|66079180|FG002|Overall Study|Withdrawal by Subject|15|||
23643633|NCT00712673|66079181|FG003|Overall Study|Withdrawal by Subject|20|||
23643634|NCT00712673|66079178|FG000|Overall Study|Familial and Personal Reasons|5|||
23643635|NCT00712673|66079179|FG001|Overall Study|Familial and Personal Reasons|0|||
23643636|NCT00712673|66079180|FG002|Overall Study|Familial and Personal Reasons|5|||
23643637|NCT00712673|66079181|FG003|Overall Study|Familial and Personal Reasons|2|||
23643638|NCT00712673|66079178|FG000|Overall Study|Investigator's Decision|1|||
23359431|NCT04501952|65060097|FG000|Overall Study|Protocol Violation|1|||
23359432|NCT04501952|65060098|FG001|Overall Study|Protocol Violation|1|||
23359433|NCT04501952|65060097|FG000|Overall Study|Withdrew Consent|5|||
23359434|NCT04501952|65060098|FG001|Overall Study|Withdrew Consent|4|||
23359435|NCT04501952|65060097|FG000|Overall Study|Lost to Follow-up|7|||
23359436|NCT04501952|65060098|FG001|Overall Study|Lost to Follow-up|2|||
23359437|NCT04501952|65060097|FG000|Overall Study|Randomized and Never Treated|13|||
23643639|NCT00712673|66079179|FG001|Overall Study|Investigator's Decision|0|||
23590235|NCT01585558|65889614|FG000|Overall Study|Lost to Follow-up|2|||
23590236|NCT01585558|65889615|FG001|Overall Study|Lost to Follow-up|0|||
23590237|NCT01585558|65889616|FG002|Overall Study|Lost to Follow-up|3|||
23590238|NCT01585558|65889614|FG000|Overall Study|Adverse Event|3|||
23590239|NCT01585558|65889615|FG001|Overall Study|Adverse Event|4|||
23590240|NCT01585558|65889616|FG002|Overall Study|Adverse Event|1|||
23590241|NCT01585558|65889614|FG000|Overall Study|Protocol Violation|4|||
23590242|NCT01585558|65889615|FG001|Overall Study|Protocol Violation|3|||
23590243|NCT01585558|65889616|FG002|Overall Study|Protocol Violation|2|||
23590244|NCT01585558|65889614|FG000|Overall Study|Lack of Efficacy|0|||
23590245|NCT01585558|65889615|FG001|Overall Study|Lack of Efficacy|0|||
23590246|NCT01585558|65889616|FG002|Overall Study|Lack of Efficacy|1|||
23590247|NCT01212991|65889618|FG000|Double-blind|Lost to Follow-up|8|||
23590248|NCT01212991|65889619|FG001|Double-blind|Lost to Follow-up|4|||
23590249|NCT01212991|65889620|FG002|Double-blind|Lost to Follow-up|0|||
23590250|NCT01212991|65889618|FG000|Double-blind|Death|699|||
23590251|NCT01212991|65889619|FG001|Double-blind|Death|550|||
23590252|NCT01212991|65889620|FG002|Double-blind|Death|0|||
23590253|NCT01212991|65889618|FG000|Double-blind|Withdrawal by Subject|16|||
23590254|NCT01212991|65889619|FG001|Double-blind|Withdrawal by Subject|19|||
23590255|NCT01212991|65889620|FG002|Double-blind|Withdrawal by Subject|0|||
23590256|NCT01212991|65889618|FG000|Double-blind|Other|7|||
23590257|NCT01212991|65889619|FG001|Double-blind|Other|0|||
23590258|NCT01212991|65889620|FG002|Double-blind|Other|0|||
23590259|NCT01212991|65889618|FG000|Double-blind|Sponsor decision|142|||
23590260|NCT01212991|65889619|FG001|Double-blind|Sponsor decision|38|||
23590261|NCT01212991|65889620|FG002|Double-blind|Sponsor decision|0|||
23590262|NCT01212991|65889618|FG000|Open-label|Death|0|||
23590263|NCT01212991|65889619|FG001|Open-label|Death|0|||
23590264|NCT01212991|65889620|FG002|Open-label|Death|166|||
23590265|NCT01212991|65889618|FG000|Open-label|Lost to Follow-up|0|||
23590266|NCT01212991|65889619|FG001|Open-label|Lost to Follow-up|0|||
23590267|NCT01212991|65889620|FG002|Open-label|Lost to Follow-up|5|||
23590268|NCT01212991|65889618|FG000|Open-label|Withdrawal by Subject|0|||
23590269|NCT01212991|65889619|FG001|Open-label|Withdrawal by Subject|0|||
23590270|NCT01212991|65889620|FG002|Open-label|Withdrawal by Subject|7|||
23590271|NCT01212991|65889618|FG000|Open-label|Sponsor decision|0|||
23590272|NCT01212991|65889619|FG001|Open-label|Sponsor decision|0|||
23590273|NCT01212991|65889620|FG002|Open-label|Sponsor decision|53|||
23590274|NCT01212991|65889618|FG000|Open-label|Other|0|||
23590275|NCT01212991|65889619|FG001|Open-label|Other|0|||
23590276|NCT01212991|65889620|FG002|Open-label|Other|3|||
23590277|NCT02698241|65889624|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
23590278|NCT02698241|65889624|FG000|Overall Study|Screening not met|7|||
23590279|NCT02698241|65889624|FG000|Overall Study|Withdrawal by Subject|7|||
23590280|NCT02698241|65889624|FG000|Overall Study|Physician Decision|2|||
23590281|NCT02698241|65889624|FG000|Overall Study|Subject underwent system modification|2|||
23590282|NCT02698241|65889624|FG000|Overall Study|Lost to Follow-up|3|||
23590283|NCT02698241|65889624|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
23590284|NCT02698241|65889624|FG000|Overall Study|geographic and licensing issue|1|||
23590285|NCT02698241|65889624|FG000|Overall Study|Death|2|||
23590286|NCT00468910|65889626|FG000|Overall Study|Lost to Follow-up|2|||
23590287|NCT00468910|65889627|FG001|Overall Study|Lost to Follow-up|1|||
23590288|NCT00468910|65889626|FG000|Overall Study|Withdrawal by Subject|2|||
23590289|NCT00468910|65889627|FG001|Overall Study|Withdrawal by Subject|1|||
23590290|NCT00468910|65889626|FG000|Overall Study|Medical Contraindication|0|||
23590291|NCT00468910|65889627|FG001|Overall Study|Medical Contraindication|1|||
23590292|NCT02507752|65889630|FG000|Overall Study|Adverse Event|1|||
23590293|NCT02507752|65889630|FG000|Overall Study|Protocol Violation|6|||
23590294|NCT02507752|65889630|FG000|Overall Study|Lost to Follow-up|7|||
23590295|NCT02507752|65889630|FG000|Overall Study|Infusion reaction at first infusion|1|||
23590296|NCT02507752|65889630|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
23590297|NCT02507752|65889630|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
23590298|NCT00293293|65889631|FG000|Overall Study|Withdrawal by Subject|1|||
23590299|NCT00293293|65889632|FG001|Overall Study|Withdrawal by Subject|1|||
23590300|NCT00293293|65889631|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
23590301|NCT00293293|65889632|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
23590302|NCT00293293|65889631|FG000|Overall Study|Patient discontinued chemotherapy|0|||
23590303|NCT00293293|65889632|FG001|Overall Study|Patient discontinued chemotherapy|1|||
23590304|NCT00726999|65889636|FG000|Overall Study|Physician Decision|0|||
23590305|NCT00726999|65889637|FG001|Overall Study|Physician Decision|1|||
23590306|NCT00726999|65889636|FG000|Overall Study|Withdrawal by Subject|2|||
23590307|NCT00726999|65889637|FG001|Overall Study|Withdrawal by Subject|0|||
23590308|NCT00726999|65889636|FG000|Overall Study|Protocol Violation|1|||
23590309|NCT00726999|65889637|FG001|Overall Study|Protocol Violation|0|||
23590310|NCT01194154|65889643|FG000|Overall Study|Adverse Event|12|||
23590311|NCT01194154|65889644|FG001|Overall Study|Adverse Event|7|||
23590312|NCT01194154|65889643|FG000|Overall Study|Lost to Follow-up|2|||
23590313|NCT01194154|65889644|FG001|Overall Study|Lost to Follow-up|3|||
23590314|NCT01194154|65889643|FG000|Overall Study|Protocol Violation|0|||
23590315|NCT01194154|65889644|FG001|Overall Study|Protocol Violation|1|||
23590316|NCT01194154|65889643|FG000|Overall Study|Withdrawal by Subject|5|||
23590317|NCT01194154|65889644|FG001|Overall Study|Withdrawal by Subject|6|||
23590318|NCT01194154|65889643|FG000|Overall Study|Blood pressure increase|5|||
23643640|NCT00712673|66079180|FG002|Overall Study|Investigator's Decision|0|||
23643641|NCT00712673|66079181|FG003|Overall Study|Investigator's Decision|0|||
23643642|NCT00712673|66079178|FG000|Overall Study|Protocol Violation|0|||
23643643|NCT00712673|66079179|FG001|Overall Study|Protocol Violation|0|||
23643644|NCT00712673|66079180|FG002|Overall Study|Protocol Violation|2|||
23643645|NCT00712673|66079181|FG003|Overall Study|Protocol Violation|0|||
23643646|NCT03035201|66079182|FG000|Overall Study|Death|9|||
23643647|NCT03035201|66079183|FG001|Overall Study|Death|12|||
23643648|NCT03035201|66079184|FG002|Overall Study|Death|9|||
23643649|NCT03035201|66079185|FG003|Overall Study|Death|10|||
23643650|NCT03035201|66079182|FG000|Overall Study|Withdrawal by Subject|51|||
23643651|NCT03035201|66079183|FG001|Overall Study|Withdrawal by Subject|49|||
23643652|NCT03035201|66079184|FG002|Overall Study|Withdrawal by Subject|37|||
23590319|NCT01194154|65889644|FG001|Overall Study|Blood pressure increase|3|||
23590320|NCT01194154|65889643|FG000|Overall Study|Hemoglobin decrease|0|||
23590321|NCT01194154|65889644|FG001|Overall Study|Hemoglobin decrease|1|||
23590322|NCT01194154|65889643|FG000|Overall Study|Hemoglobin increase|12|||
23590323|NCT01194154|65889644|FG001|Overall Study|Hemoglobin increase|3|||
23590324|NCT01194154|65889643|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
23590325|NCT01194154|65889644|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
23590326|NCT01194154|65889643|FG000|Overall Study|Treatment with prohibited medication|4|||
23590327|NCT01194154|65889644|FG001|Overall Study|Treatment with prohibited medication|5|||
23590328|NCT01194154|65889643|FG000|Overall Study|Other|4|||
23590329|NCT01194154|65889644|FG001|Overall Study|Other|0|||
23590330|NCT01194154|65889643|FG000|Overall Study|Did not receive study medication|2|||
23590331|NCT01194154|65889644|FG001|Overall Study|Did not receive study medication|4|||
23590332|NCT01943799|65889647|FG000|Overall Study|Lost to Follow-up|0|||
23590333|NCT01943799|65889648|FG001|Overall Study|Lost to Follow-up|1|||
23590334|NCT01943799|65889649|FG002|Overall Study|Lost to Follow-up|1|||
23590335|NCT01943799|65889650|FG003|Overall Study|Lost to Follow-up|0|||
23590336|NCT01943799|65889647|FG000|Overall Study|Protocol Violation|1|||
23590337|NCT01943799|65889648|FG001|Overall Study|Protocol Violation|0|||
23590338|NCT01943799|65889649|FG002|Overall Study|Protocol Violation|0|||
23590339|NCT01943799|65889650|FG003|Overall Study|Protocol Violation|0|||
23590340|NCT01943799|65889647|FG000|Overall Study|Withdrawal by Subject|4|||
23590341|NCT01943799|65889648|FG001|Overall Study|Withdrawal by Subject|2|||
23590342|NCT01943799|65889649|FG002|Overall Study|Withdrawal by Subject|1|||
23590343|NCT01943799|65889650|FG003|Overall Study|Withdrawal by Subject|0|||
23590344|NCT00346151|65889653|FG000|Overall Study|Withdrawal by Subject|3|||
23590345|NCT05308004|65889654|FG000|Overall Study|Not seen by Palliative Care NP|0|||
23590346|NCT05308004|65889655|FG001|Overall Study|Not seen by Palliative Care NP|1|||
23590347|NCT02524288|65889660|FG000|Overall Study|Adverse Event|115|||
23590348|NCT02524288|65889660|FG000|Overall Study|Lost to Follow-up|216|||
23590349|NCT02524288|65889660|FG000|Overall Study|Non-Compliance With Protocol|32|||
23590350|NCT02524288|65889660|FG000|Overall Study|Non-Compliance With Study Drug|14|||
23590351|NCT02524288|65889660|FG000|Overall Study|Pregnancy Wish|6|||
23590352|NCT02524288|65889660|FG000|Overall Study|Protocol Violation|6|||
23590353|NCT02524288|65889660|FG000|Overall Study|Screen Failure|2|||
23590354|NCT02524288|65889660|FG000|Overall Study|Site Discontinued Study Participation|1|||
23590355|NCT02524288|65889660|FG000|Overall Study|Study Terminated By Sponsor|1417|||
23590356|NCT02524288|65889660|FG000|Overall Study|Subject Moved|32|||
23590357|NCT02524288|65889660|FG000|Overall Study|Withdrawal by Subject|76|||
23590358|NCT02524288|65889660|FG000|Overall Study|Pregnancy|22|||
23590359|NCT02524288|65889660|FG000|Overall Study|Physician Decision|2|||
23590360|NCT02888080|65889666|FG000|Overall Study|Subject / Guardian decision|1|||
23590361|NCT02888080|65889667|FG001|Overall Study|Subject / Guardian decision|3|||
23590362|NCT02888080|65889666|FG000|Overall Study|New Therapy for study indication|1|||
23590363|NCT02888080|65889667|FG001|Overall Study|New Therapy for study indication|0|||
23590364|NCT02888080|65889666|FG000|Overall Study|Lack of Efficacy|0|||
23476140|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Patient moved|0|||
23590365|NCT02888080|65889667|FG001|Overall Study|Lack of Efficacy|1|||
23590366|NCT02888080|65889666|FG000|Overall Study|Adverse Event|0|||
23590367|NCT02888080|65889667|FG001|Overall Study|Adverse Event|1|||
23643653|NCT03035201|66079185|FG003|Overall Study|Withdrawal by Subject|46|||
23643654|NCT03035201|66079182|FG000|Overall Study|Lost to Follow-up|67|||
23643655|NCT03035201|66079183|FG001|Overall Study|Lost to Follow-up|51|||
23798193|NCT02124902|66636958|FG000|Overall Study|Adverse Event|7|||
23590368|NCT00794118|65889668|FG000|Overall Study|Lost to Follow-up|16|||
23590369|NCT00794118|65889668|FG000|Overall Study|Withdrawal by Subject|9|||
23590370|NCT00794118|65889668|FG000|Overall Study|Changed hospital center|2|||
23590371|NCT03804918|65889669|FG000|Overall Study|Participant did not use the app|1|||
23643656|NCT03035201|66079184|FG002|Overall Study|Lost to Follow-up|64|||
23590372|NCT02441036|65889672|FG000|Overall Study|No tissue resected|0|||
23590373|NCT02441036|65889673|FG001|Overall Study|No tissue resected|1|||
23590374|NCT02441036|65889674|FG002|Overall Study|No tissue resected|0|||
23590375|NCT02441036|65889675|FG003|Overall Study|No tissue resected|1|||
23590376|NCT02441036|65889676|FG004|Overall Study|No tissue resected|0|||
23590377|NCT00414648|65889677|FG000|Overall Study|Adverse Event|5|||
23590378|NCT00414648|65889678|FG001|Overall Study|Adverse Event|5|||
23590379|NCT00414648|65889677|FG000|Overall Study|Death|0|||
23590380|NCT00414648|65889678|FG001|Overall Study|Death|1|||
23590381|NCT00414648|65889677|FG000|Overall Study|Lack of Efficacy|0|||
23590382|NCT00414648|65889678|FG001|Overall Study|Lack of Efficacy|2|||
23590383|NCT00414648|65889677|FG000|Overall Study|Withdrawal by Subject|0|||
23590384|NCT00414648|65889678|FG001|Overall Study|Withdrawal by Subject|1|||
23590385|NCT04353037|65889681|FG000|Overall Study|Lost to Follow-up|0|||
23590386|NCT04353037|65889682|FG001|Overall Study|Lost to Follow-up|1|||
23590387|NCT04353037|65889683|FG002|Overall Study|Lost to Follow-up|2|||
23798194|NCT02124902|66636959|FG001|Overall Study|Adverse Event|2|||
23798195|NCT02124902|66636958|FG000|Overall Study|Went to alternative treatment|4|||
23798196|NCT02124902|66636959|FG001|Overall Study|Went to alternative treatment|0|||
23798197|NCT02124902|66636958|FG000|Overall Study|Withdrawal by Subject|2|||
23590388|NCT04353037|65889684|FG003|Overall Study|Lost to Follow-up|3|||
23590389|NCT04353037|65889681|FG000|Overall Study|Withdrawal by Subject|0|||
23590390|NCT04353037|65889682|FG001|Overall Study|Withdrawal by Subject|2|||
23590391|NCT04353037|65889683|FG002|Overall Study|Withdrawal by Subject|3|||
23590392|NCT04353037|65889684|FG003|Overall Study|Withdrawal by Subject|5|||
23590393|NCT04353037|65889681|FG000|Overall Study|Adverse Event|0|||
23590394|NCT04353037|65889682|FG001|Overall Study|Adverse Event|0|||
23590395|NCT04353037|65889683|FG002|Overall Study|Adverse Event|2|||
23590396|NCT04353037|65889684|FG003|Overall Study|Adverse Event|0|||
23590397|NCT04353037|65889681|FG000|Overall Study|Exposure Change|0|||
23590398|NCT04353037|65889682|FG001|Overall Study|Exposure Change|0|||
23590399|NCT04353037|65889683|FG002|Overall Study|Exposure Change|0|||
23590400|NCT04353037|65889684|FG003|Overall Study|Exposure Change|2|||
23590401|NCT05190419|65889685|FG000|Overall Study|Lack of Efficacy|8|||
23590402|NCT05190419|65889686|FG001|Overall Study|Lack of Efficacy|0|||
23590403|NCT05190419|65889687|FG002|Overall Study|Lack of Efficacy|1|||
23590404|NCT05190419|65889688|FG003|Overall Study|Lack of Efficacy|0|||
23590405|NCT05190419|65889685|FG000|Overall Study|Withdrawal by Subject|7|||
23590406|NCT05190419|65889686|FG001|Overall Study|Withdrawal by Subject|1|||
23590407|NCT05190419|65889687|FG002|Overall Study|Withdrawal by Subject|2|||
23590408|NCT05190419|65889688|FG003|Overall Study|Withdrawal by Subject|2|||
23590409|NCT05190419|65889685|FG000|Overall Study|Adverse Event|2|||
23590410|NCT05190419|65889686|FG001|Overall Study|Adverse Event|10|||
23590411|NCT05190419|65889687|FG002|Overall Study|Adverse Event|11|||
23590412|NCT05190419|65889688|FG003|Overall Study|Adverse Event|21|||
23590413|NCT05190419|65889685|FG000|Overall Study|Lost to Follow-up|1|||
23590414|NCT05190419|65889686|FG001|Overall Study|Lost to Follow-up|2|||
23590415|NCT05190419|65889687|FG002|Overall Study|Lost to Follow-up|3|||
23590416|NCT05190419|65889688|FG003|Overall Study|Lost to Follow-up|1|||
23590417|NCT05190419|65889685|FG000|Overall Study|Other|1|||
23590418|NCT05190419|65889686|FG001|Overall Study|Other|1|||
23590419|NCT05190419|65889687|FG002|Overall Study|Other|0|||
23590420|NCT05190419|65889688|FG003|Overall Study|Other|3|||
23590421|NCT02041104|65889689|FG000|Overall Study|Lost to Follow-up|1|||
23590422|NCT02041104|65889690|FG001|Overall Study|Lost to Follow-up|4|||
23590423|NCT02041104|65889689|FG000|Overall Study|discomfort during OGTT|0|||
23590424|NCT02041104|65889690|FG001|Overall Study|discomfort during OGTT|3|||
23590425|NCT02969863|65889691|FG000|Overall Study|Physician Decision|1|||
23590426|NCT02969863|65889692|FG001|Overall Study|Physician Decision|0|||
23590427|NCT02969863|65889693|FG002|Overall Study|Physician Decision|0|||
23590428|NCT02969863|65889694|FG003|Overall Study|Physician Decision|0|||
23590429|NCT02969863|65889695|FG004|Overall Study|Physician Decision|0|||
23590430|NCT02969863|65889696|FG005|Overall Study|Physician Decision|0|||
23590431|NCT01281813|65889697|FG000|Overall Study|Adverse Event|0|||
23798198|NCT02124902|66636959|FG001|Overall Study|Withdrawal by Subject|1|||
23590432|NCT01281813|65889698|FG001|Overall Study|Adverse Event|0|||
23590433|NCT01281813|65889699|FG002|Overall Study|Adverse Event|10|||
23590434|NCT01281813|65889697|FG000|Overall Study|Lost to Follow-up|0|||
23590435|NCT01281813|65889698|FG001|Overall Study|Lost to Follow-up|0|||
23590436|NCT01281813|65889699|FG002|Overall Study|Lost to Follow-up|31|||
23590437|NCT01281813|65889697|FG000|Overall Study|Withdrawal by Subject|0|||
23798199|NCT02124902|66636958|FG000|Overall Study|Physician Decision|2|||
23798200|NCT02124902|66636959|FG001|Overall Study|Physician Decision|0|||
23590438|NCT01281813|65889698|FG001|Overall Study|Withdrawal by Subject|0|||
23590439|NCT01281813|65889699|FG002|Overall Study|Withdrawal by Subject|13|||
23590440|NCT01281813|65889697|FG000|Overall Study|Subject Non-Compliant|0|||
23798201|NCT02124902|66636958|FG000|Overall Study|Not eligible|1|||
23590441|NCT01281813|65889698|FG001|Overall Study|Subject Non-Compliant|0|||
23590442|NCT01281813|65889699|FG002|Overall Study|Subject Non-Compliant|6|||
23798202|NCT02124902|66636959|FG001|Overall Study|Not eligible|0|||
23590443|NCT01281813|65889697|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
23590444|NCT01281813|65889698|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
23590445|NCT01281813|65889699|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
23590446|NCT01281813|65889697|FG000|Overall Study|Sponsor's Decision|4|||
23590447|NCT01281813|65889698|FG001|Overall Study|Sponsor's Decision|3|||
23590448|NCT01281813|65889699|FG002|Overall Study|Sponsor's Decision|7|||
23590449|NCT01281813|65889697|FG000|Overall Study|Switched to Commercially Available Medication|0|||
23590450|NCT01281813|65889698|FG001|Overall Study|Switched to Commercially Available Medication|0|||
23643657|NCT03035201|66079185|FG003|Overall Study|Lost to Follow-up|69|||
23643658|NCT01182194|66079186|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23359438|NCT04501952|65060098|FG001|Overall Study|Randomized and Never Treated|9|||
23359439|NCT02309723|65060099|FG000|Overall Study|Withdrawal by Subject|24|||
23643659|NCT01182194|66079187|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
23643660|NCT00603304|66079188|FG000|Overall Study|Lost to Follow-up|5|||
23643661|NCT00603304|66079189|FG001|Overall Study|Lost to Follow-up|7|||
23359440|NCT02309723|65060100|FG001|Overall Study|Withdrawal by Subject|23|||
23359441|NCT02309723|65060101|FG002|Overall Study|Withdrawal by Subject|24|||
23643662|NCT00603304|66079188|FG000|Overall Study|Withdrawal by Subject|8|||
23643663|NCT00603304|66079189|FG001|Overall Study|Withdrawal by Subject|5|||
23643664|NCT00603304|66079188|FG000|Overall Study|Protocol Violation|1|||
23359442|NCT02716584|65060102|FG000|Overall Study|Lost to Follow-up|8|||
23359443|NCT02716584|65060103|FG001|Overall Study|Lost to Follow-up|5|||
23643665|NCT00603304|66079189|FG001|Overall Study|Protocol Violation|0|||
23643666|NCT00603304|66079188|FG000|Overall Study|Adverse Event|4|||
23643667|NCT00603304|66079189|FG001|Overall Study|Adverse Event|2|||
23643668|NCT00603304|66079188|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
23643669|NCT00603304|66079189|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
23643670|NCT00603304|66079188|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
23643671|NCT00603304|66079189|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
23359444|NCT03117361|65060108|FG000|Overall Study|Progressive disease|5|||
23359445|NCT03117361|65060108|FG000|Overall Study|Death|1|||
23359446|NCT03117361|65060108|FG000|Overall Study|Physician Decision|2|||
23359447|NCT03117361|65060108|FG000|Overall Study|On study treatment at the end of study|1|||
23590451|NCT01281813|65889699|FG002|Overall Study|Switched to Commercially Available Medication|26|||
23590452|NCT01281813|65889697|FG000|Overall Study|Other|0|||
23643672|NCT00603304|66079188|FG000|Overall Study|Exclusionary Medication|2|||
23643673|NCT00603304|66079189|FG001|Overall Study|Exclusionary Medication|3|||
23643674|NCT00603304|66079188|FG000|Overall Study|Non-Compliant|0|||
23643675|NCT00603304|66079189|FG001|Overall Study|Non-Compliant|1|||
23643676|NCT00603304|66079188|FG000|Overall Study|Moved Away|0|||
23643677|NCT00603304|66079189|FG001|Overall Study|Moved Away|2|||
23643678|NCT00603304|66079188|FG000|Overall Study|Other|2|||
23643679|NCT00603304|66079189|FG001|Overall Study|Other|0|||
23643680|NCT00603304|66079188|FG000|Overall Study|Patient Decision|2|||
23643681|NCT00603304|66079189|FG001|Overall Study|Patient Decision|0|||
23643682|NCT01080716|66079191|FG000|Part 1|Physician Decision|1|||
23643683|NCT01080716|66079192|FG001|Part 1|Physician Decision|0|||
23359448|NCT03117361|65060108|FG000|Overall Study|Treatment-related adverse event|1|||
23359449|NCT03334422|65060111|FG000|Overall Study|Adverse Event|1|||
23359450|NCT03334422|65060112|FG001|Overall Study|Adverse Event|3|||
23643684|NCT01080716|66079193|FG002|Part 1|Physician Decision|0|||
23643685|NCT01080716|66079194|FG003|Part 1|Physician Decision|0|||
23798203|NCT02124902|66636958|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
23798204|NCT02124902|66636959|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
23798205|NCT02443324|66636960|FG000|Overall Study|Death|4|||
23798206|NCT02443324|66636961|FG001|Overall Study|Death|1|||
23359451|NCT03334422|65060113|FG002|Overall Study|Adverse Event|2|||
23590453|NCT01281813|65889698|FG001|Overall Study|Other|1|||
23643686|NCT00626990|66079195|FG000|Overall Study|Lack of Efficacy|6|||
23643687|NCT00626990|66079196|FG001|Overall Study|Lack of Efficacy|7|||
23643688|NCT00626990|66079197|FG002|Overall Study|Lack of Efficacy|49|||
23798207|NCT02443324|66636962|FG002|Overall Study|Death|0|||
23798208|NCT02443324|66636963|FG003|Overall Study|Death|3|||
23359452|NCT03334422|65060114|FG003|Overall Study|Adverse Event|2|||
23359453|NCT03334422|65060111|FG000|Overall Study|Lack of Efficacy|10|||
23359454|NCT03334422|65060112|FG001|Overall Study|Lack of Efficacy|2|||
23359455|NCT03334422|65060113|FG002|Overall Study|Lack of Efficacy|7|||
23359456|NCT03334422|65060114|FG003|Overall Study|Lack of Efficacy|3|||
23359457|NCT03334422|65060111|FG000|Overall Study|Withdrawal by Subject|8|||
23359458|NCT03334422|65060112|FG001|Overall Study|Withdrawal by Subject|3|||
23359459|NCT03334422|65060113|FG002|Overall Study|Withdrawal by Subject|1|||
23359460|NCT03334422|65060114|FG003|Overall Study|Withdrawal by Subject|0|||
23359461|NCT03334422|65060111|FG000|Overall Study|Lost to Follow-up|0|||
23359462|NCT03334422|65060112|FG001|Overall Study|Lost to Follow-up|0|||
23359463|NCT03334422|65060113|FG002|Overall Study|Lost to Follow-up|0|||
23359464|NCT03334422|65060114|FG003|Overall Study|Lost to Follow-up|1|||
23359465|NCT03334422|65060111|FG000|Overall Study|Inability to obtain laboratory samples|0|||
23359466|NCT03334422|65060112|FG001|Overall Study|Inability to obtain laboratory samples|1|||
23359467|NCT03334422|65060113|FG002|Overall Study|Inability to obtain laboratory samples|0|||
23359468|NCT03334422|65060114|FG003|Overall Study|Inability to obtain laboratory samples|0|||
23359469|NCT03334422|65060111|FG000|Overall Study|Pregnancy|0|||
23359470|NCT03334422|65060112|FG001|Overall Study|Pregnancy|1|||
23359471|NCT03334422|65060113|FG002|Overall Study|Pregnancy|0|||
23359472|NCT03334422|65060114|FG003|Overall Study|Pregnancy|0|||
23359473|NCT03630705|65060115|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
23359474|NCT03630705|65060116|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
23359475|NCT03630705|65060117|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23359476|NCT03630705|65060118|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23359477|NCT03630705|65060115|FG000|Overall Study|Lost to Follow-up|1|||
23359478|NCT03630705|65060116|FG001|Overall Study|Lost to Follow-up|2|||
23359479|NCT03630705|65060117|FG002|Overall Study|Lost to Follow-up|0|||
23359480|NCT03630705|65060118|FG003|Overall Study|Lost to Follow-up|0|||
23359481|NCT00186485|65060127|FG000|Overall Study|Lost to Follow-up|3|||
23359482|NCT00790556|65060128|FG000|Treatment Period 1|Physician Decision|1|||
23359483|NCT00790556|65060129|FG001|Treatment Period 1|Physician Decision|0|||
23359484|NCT00790556|65060128|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23359485|NCT00790556|65060129|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23359486|NCT02087670|65060130|FG000|Overall Study|Withdrawal by Subject|3|||
23359487|NCT02087670|65060131|FG001|Overall Study|Withdrawal by Subject|2|||
23359488|NCT02308228|65060133|FG000|Overall Study|Adverse Event|3|||
23359489|NCT02308228|65060134|FG001|Overall Study|Adverse Event|4|||
23359490|NCT02308228|65060133|FG000|Overall Study|Withdrawal by Subject|5|||
23359491|NCT02308228|65060134|FG001|Overall Study|Withdrawal by Subject|3|||
23359492|NCT00460239|65060137|FG000|Overall Study|Physician Decision|0|||
23359493|NCT00460239|65060138|FG001|Overall Study|Physician Decision|1|||
23359494|NCT00460239|65060139|FG002|Overall Study|Physician Decision|0|||
23359495|NCT00460239|65060140|FG003|Overall Study|Physician Decision|0|||
23359496|NCT00460239|65060141|FG004|Overall Study|Physician Decision|0|||
23359497|NCT00460239|65060142|FG005|Overall Study|Physician Decision|2|||
23359498|NCT00460239|65060143|FG006|Overall Study|Physician Decision|0|||
23359499|NCT00460239|65060144|FG007|Overall Study|Physician Decision|0|||
23359500|NCT00460239|65060145|FG008|Overall Study|Physician Decision|0|||
23359501|NCT00460239|65060137|FG000|Overall Study|Withdrawal by Subject|0|||
23359502|NCT00460239|65060138|FG001|Overall Study|Withdrawal by Subject|0|||
23359503|NCT00460239|65060139|FG002|Overall Study|Withdrawal by Subject|0|||
23359504|NCT00460239|65060140|FG003|Overall Study|Withdrawal by Subject|0|||
23359505|NCT00460239|65060141|FG004|Overall Study|Withdrawal by Subject|0|||
23359506|NCT00460239|65060142|FG005|Overall Study|Withdrawal by Subject|1|||
23476141|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Patient moved|1|||
23476142|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
23476143|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
23476144|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
23476145|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
23476146|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
23590454|NCT01281813|65889699|FG002|Overall Study|Other|39|||
23590455|NCT00736853|65889700|FG000|Open-Label Period|Physician Decision|2|||
23643689|NCT00626990|66079198|FG003|Overall Study|Lack of Efficacy|40|||
23359507|NCT00460239|65060143|FG006|Overall Study|Withdrawal by Subject|0|||
23359508|NCT00460239|65060144|FG007|Overall Study|Withdrawal by Subject|0|||
23359509|NCT00460239|65060145|FG008|Overall Study|Withdrawal by Subject|0|||
23359510|NCT02232061|65060147|FG000|Overall Study|Administrative problems|1|||
23643690|NCT00626990|66079195|FG000|Overall Study|Adverse Event|1|||
23359511|NCT02232061|65060147|FG000|Overall Study|Withdrawal by Subject|1|||
23359512|NCT01673984|65060148|FG000|Overall Study|Adverse Event|1|||
23476147|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
23643691|NCT00626990|66079196|FG001|Overall Study|Adverse Event|7|||
23359513|NCT01673984|65060149|FG001|Overall Study|Adverse Event|0|||
23643692|NCT00626990|66079197|FG002|Overall Study|Adverse Event|14|||
23359514|NCT01673984|65060148|FG000|Overall Study|Study termination|9|||
23359515|NCT01673984|65060149|FG001|Overall Study|Study termination|6|||
23643693|NCT00626990|66079198|FG003|Overall Study|Adverse Event|28|||
23643694|NCT00626990|66079195|FG000|Overall Study|Death|0|||
23643695|NCT00626990|66079196|FG001|Overall Study|Death|1|||
23643696|NCT00626990|66079197|FG002|Overall Study|Death|0|||
23643697|NCT00626990|66079198|FG003|Overall Study|Death|0|||
23643698|NCT00626990|66079195|FG000|Overall Study|Withdrawal by Subject|3|||
23643699|NCT00626990|66079196|FG001|Overall Study|Withdrawal by Subject|1|||
23643700|NCT00626990|66079197|FG002|Overall Study|Withdrawal by Subject|5|||
23643701|NCT00626990|66079198|FG003|Overall Study|Withdrawal by Subject|11|||
23643702|NCT00626990|66079195|FG000|Overall Study|Protocol Violation|0|||
23643703|NCT00626990|66079196|FG001|Overall Study|Protocol Violation|1|||
23643704|NCT00626990|66079197|FG002|Overall Study|Protocol Violation|1|||
23643705|NCT00626990|66079198|FG003|Overall Study|Protocol Violation|0|||
23643706|NCT00626990|66079195|FG000|Overall Study|Various different reasons/missing|4|||
23643707|NCT00626990|66079196|FG001|Overall Study|Various different reasons/missing|8|||
23643708|NCT00626990|66079197|FG002|Overall Study|Various different reasons/missing|8|||
23643709|NCT00626990|66079198|FG003|Overall Study|Various different reasons/missing|16|||
23643710|NCT00141219|66079201|FG000|Overall Study|Protocol violations|5|||
23590456|NCT00736853|65889701|FG001|Open-Label Period|Physician Decision|0|||
23590457|NCT00736853|65889702|FG002|Open-Label Period|Physician Decision|0|||
23590458|NCT00736853|65889700|FG000|Open-Label Period|Adverse Event|31|||
23590459|NCT00736853|65889701|FG001|Open-Label Period|Adverse Event|0|||
23590460|NCT00736853|65889702|FG002|Open-Label Period|Adverse Event|0|||
23590461|NCT00736853|65889700|FG000|Open-Label Period|Withdrawal by Subject|16|||
23643711|NCT00141219|66079202|FG001|Overall Study|Protocol violations|4|||
23643712|NCT00141219|66079201|FG000|Overall Study|Adverse Event|8|||
23643713|NCT00141219|66079202|FG001|Overall Study|Adverse Event|6|||
23643714|NCT00141219|66079201|FG000|Overall Study|Lack of Efficacy|5|||
23643715|NCT00141219|66079202|FG001|Overall Study|Lack of Efficacy|4|||
23643716|NCT00141219|66079201|FG000|Overall Study|Withdrawal by Subject|6|||
23643717|NCT00141219|66079202|FG001|Overall Study|Withdrawal by Subject|2|||
23643718|NCT03573583|66079205|FG000|Overall Study|Lost to Follow-up|1|||
23643719|NCT03573583|66079206|FG001|Overall Study|Lost to Follow-up|0|||
23643720|NCT03573583|66079205|FG000|Overall Study|Withdrawal by Subject|1|||
23643721|NCT03573583|66079206|FG001|Overall Study|Withdrawal by Subject|1|||
23643722|NCT00910689|66079207|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
23643723|NCT00910689|66079208|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
23643724|NCT00910689|66079209|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
23643725|NCT00910689|66079210|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
23643726|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
23643727|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
23643728|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
23643729|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
23643730|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
23643731|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
23643732|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
23643733|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
23643734|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
23643735|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
23643736|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
23643737|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
23643738|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
23643739|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
23643740|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
23643741|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
23359516|NCT02497404|65060150|FG000|Overall Study|Adverse Event|1|||
23590462|NCT00736853|65889701|FG001|Open-Label Period|Withdrawal by Subject|0|||
23590463|NCT00736853|65889702|FG002|Open-Label Period|Withdrawal by Subject|0|||
23643742|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23643743|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23643744|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
23643745|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23476148|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
23476149|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
23476150|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
23643746|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
23643747|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
23643748|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
23359517|NCT03178851|65060153|FG000|Overall Study|Death|48|||
23359518|NCT03178851|65060154|FG001|Overall Study|Death|2|||
23643749|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
23643750|NCT00910689|66079207|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
23643751|NCT00910689|66079208|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
23643752|NCT00910689|66079209|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
23643753|NCT00910689|66079210|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
23643754|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
23359519|NCT03178851|65060155|FG002|Overall Study|Death|25|||
23359520|NCT03178851|65060153|FG000|Overall Study|Withdrawal by Subject|8|||
23359521|NCT03178851|65060154|FG001|Overall Study|Withdrawal by Subject|0|||
23643755|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
23359522|NCT03178851|65060155|FG002|Overall Study|Withdrawal by Subject|0|||
23359523|NCT03178851|65060153|FG000|Overall Study|Lost to Follow-up|5|||
23359524|NCT03178851|65060154|FG001|Overall Study|Lost to Follow-up|2|||
23359525|NCT03178851|65060155|FG002|Overall Study|Lost to Follow-up|0|||
23359526|NCT03178851|65060153|FG000|Overall Study|Adverse Event|0|||
23359527|NCT03178851|65060154|FG001|Overall Study|Adverse Event|0|||
23359528|NCT03178851|65060155|FG002|Overall Study|Adverse Event|1|||
23359529|NCT03178851|65060153|FG000|Overall Study|Study Termination by Sponsor|31|||
23359530|NCT03178851|65060154|FG001|Overall Study|Study Termination by Sponsor|7|||
23359531|NCT03178851|65060155|FG002|Overall Study|Study Termination by Sponsor|26|||
23359532|NCT03959527|65060165|FG000|Overall Study|Withdrawal by Subject|8|||
23359533|NCT03959527|65060166|FG001|Overall Study|Withdrawal by Subject|3|||
23359534|NCT03959527|65060165|FG000|Overall Study|Lost to Follow-up|31|||
23359535|NCT03959527|65060166|FG001|Overall Study|Lost to Follow-up|15|||
23359536|NCT03959527|65060165|FG000|Overall Study|Did not meet eligibility criteria|1|||
23359537|NCT03959527|65060166|FG001|Overall Study|Did not meet eligibility criteria|1|||
23359538|NCT03959527|65060165|FG000|Overall Study|Protocol Violation|10|||
23359539|NCT03959527|65060166|FG001|Overall Study|Protocol Violation|5|||
23359540|NCT01409915|65060169|FG000|Overall Study|Adverse Event|0|||
23359541|NCT01409915|65060170|FG001|Overall Study|Adverse Event|2|||
23359542|NCT01409915|65060169|FG000|Overall Study|Withdrawal by Subject|0|||
23359543|NCT01409915|65060170|FG001|Overall Study|Withdrawal by Subject|1|||
23359544|NCT01409915|65060169|FG000|Overall Study|Protocol Violation|1|||
23359545|NCT01409915|65060170|FG001|Overall Study|Protocol Violation|0|||
23359546|NCT03091738|65060171|FG000|Overall Study|Adverse Event|1|||
23359547|NCT03091738|65060171|FG000|Overall Study|Lost to Follow-up|1|||
23359548|NCT01272908|65060174|FG000|Initial Treatment Period|Adverse Event|1|||
23359549|NCT01272908|65060174|FG000|Initial Treatment Period|Lack of Efficacy|5|||
23359550|NCT01272908|65060174|FG000|Initial Treatment Period|Protocol Violation|1|||
23359551|NCT01272908|65060174|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
23359552|NCT01272908|65060174|FG000|Re-Treatment Period|Adverse Event|2|||
23359553|NCT01272908|65060174|FG000|Re-Treatment Period|Lack of Efficacy|3|||
23359554|NCT01272908|65060174|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
23359555|NCT00158262|65060176|FG000|Overall Study|Lost to Follow-up|1|||
23359556|NCT00158262|65060177|FG001|Overall Study|Lost to Follow-up|1|||
23359557|NCT01421147|65060178|FG000|Treatment Period|Adverse Event|2|||
23359558|NCT01421147|65060179|FG001|Treatment Period|Adverse Event|3|||
23359559|NCT01421147|65060178|FG000|Treatment Period|Lost to Follow-up|2|||
23359560|NCT01421147|65060179|FG001|Treatment Period|Lost to Follow-up|1|||
23359561|NCT01421147|65060178|FG000|Treatment Period|Physician Decision|2|||
23359562|NCT01421147|65060179|FG001|Treatment Period|Physician Decision|2|||
23359563|NCT01421147|65060178|FG000|Treatment Period|Withdrawal by Subject|10|||
23643756|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
23643757|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
23798209|NCT02443324|66636964|FG004|Overall Study|Death|1|||
23359564|NCT01421147|65060179|FG001|Treatment Period|Withdrawal by Subject|5|||
23359565|NCT01421147|65060178|FG000|Extension Period|Adverse Event|0|||
23359566|NCT01421147|65060179|FG001|Extension Period|Adverse Event|2|||
23359567|NCT01421147|65060178|FG000|Extension Period|Death|0|||
23359568|NCT01421147|65060179|FG001|Extension Period|Death|1|||
23798210|NCT02443324|66636965|FG005|Overall Study|Death|3|||
23359569|NCT01421147|65060178|FG000|Extension Period|Lost to Follow-up|2|||
23359570|NCT01421147|65060179|FG001|Extension Period|Lost to Follow-up|5|||
23359571|NCT01421147|65060178|FG000|Extension Period|Physician Decision|1|||
23359572|NCT01421147|65060179|FG001|Extension Period|Physician Decision|0|||
23359573|NCT01421147|65060178|FG000|Extension Period|Withdrawal by Subject|5|||
23359574|NCT01421147|65060179|FG001|Extension Period|Withdrawal by Subject|3|||
23359575|NCT05359952|65060180|FG000|Overall Study|Lost to Follow-up|1|||
23359576|NCT05359952|65060181|FG001|Overall Study|Lost to Follow-up|0|||
23359577|NCT00991289|65060184|FG000|Overall Study|Adverse Event|1|||
23359578|NCT00991289|65060184|FG000|Overall Study|Physician Decision|2|||
23359579|NCT00991289|65060184|FG000|Overall Study|Withdrawal by Subject|3|||
23359580|NCT00991289|65060184|FG000|Overall Study|Lost to Follow-up|4|||
23359581|NCT00991289|65060184|FG000|Overall Study|Protocol Violation|2|||
23359582|NCT00547248|65060188|FG000|Overall Study|Protocol Violation|0|||
23359583|NCT00547248|65060189|FG001|Overall Study|Protocol Violation|0|||
23359584|NCT00547248|65060190|FG002|Overall Study|Protocol Violation|1|||
23359585|NCT00547248|65060191|FG003|Overall Study|Protocol Violation|1|||
23359586|NCT00547248|65060188|FG000|Overall Study|Migrated/moved from study area|0|||
23359587|NCT00547248|65060189|FG001|Overall Study|Migrated/moved from study area|0|||
23359588|NCT00547248|65060190|FG002|Overall Study|Migrated/moved from study area|2|||
23359589|NCT00547248|65060191|FG003|Overall Study|Migrated/moved from study area|0|||
23643758|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
23643759|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
23643760|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
23643761|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
23643762|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
23643763|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23643764|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23643765|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23643766|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
23643767|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
23643768|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
23643769|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
23643770|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23643771|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23643772|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
23643773|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23643774|NCT00910689|66079207|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
23643775|NCT00910689|66079208|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
23643776|NCT00910689|66079209|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
23643777|NCT00910689|66079210|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
23798211|NCT02443324|66636966|FG006|Overall Study|Death|2|||
23798212|NCT02443324|66636960|FG000|Overall Study|Lost to Follow-up|0|||
23643778|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
23798213|NCT02443324|66636961|FG001|Overall Study|Lost to Follow-up|0|||
23798214|NCT02443324|66636962|FG002|Overall Study|Lost to Follow-up|0|||
23798215|NCT02443324|66636963|FG003|Overall Study|Lost to Follow-up|1|||
23798216|NCT02443324|66636964|FG004|Overall Study|Lost to Follow-up|0|||
23798217|NCT02443324|66636965|FG005|Overall Study|Lost to Follow-up|1|||
23359590|NCT00547248|65060188|FG000|Overall Study|Withdrawal by Subject|0|||
23359591|NCT00547248|65060189|FG001|Overall Study|Withdrawal by Subject|0|||
23359592|NCT00547248|65060190|FG002|Overall Study|Withdrawal by Subject|7|||
23359593|NCT00547248|65060191|FG003|Overall Study|Withdrawal by Subject|1|||
23359594|NCT02600923|65060192|FG000|Overall Study|Death|10|||
23359595|NCT02600923|65060192|FG000|Overall Study|Adverse Event|3|||
23359596|NCT02600923|65060192|FG000|Overall Study|Global deterioration of health status|2|||
23359597|NCT02600923|65060192|FG000|Overall Study|Insufficient clinical response|6|||
23359598|NCT02600923|65060192|FG000|Overall Study|Lost to Follow-up|1|||
23359599|NCT02600923|65060192|FG000|Overall Study|Withdrawal by Subject|5|||
23359600|NCT02600923|65060192|FG000|Overall Study|Objective progression or relapse|50|||
23359601|NCT02600923|65060192|FG000|Overall Study|Study terminated by Sponsor|53|||
23359602|NCT02600923|65060192|FG000|Overall Study|Not treated|1|||
23359603|NCT01467271|65060193|FG000|Overall Study|Death|84|||
23359604|NCT01467271|65060193|FG000|Overall Study|Lost to Follow-up|83|||
23359605|NCT01467271|65060193|FG000|Overall Study|Retraction of patient's consent|21|||
23359606|NCT01467271|65060193|FG000|Overall Study|Other reason|14|||
23359607|NCT03360019|65060194|FG000|Overall Study|Withdrawal by Subject|2|||
23359608|NCT03360019|65060195|FG001|Overall Study|Withdrawal by Subject|0|||
23359609|NCT03360019|65060196|FG002|Overall Study|Withdrawal by Subject|0|||
23359610|NCT03360019|65060194|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
23359611|NCT03360019|65060195|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
23359612|NCT03360019|65060196|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
23359613|NCT00391872|65060197|FG000|Overall Study|Protocol Violation|7|||
23359614|NCT00391872|65060198|FG001|Overall Study|Protocol Violation|2|||
23359615|NCT00391872|65060197|FG000|Overall Study|Withdrawal by Subject|296|||
23359616|NCT00391872|65060198|FG001|Overall Study|Withdrawal by Subject|249|||
23359617|NCT00391872|65060197|FG000|Overall Study|Reason unknown|2|||
23359618|NCT00391872|65060198|FG001|Overall Study|Reason unknown|4|||
23359619|NCT00391872|65060197|FG000|Overall Study|Lost to Follow-up|2|||
23359620|NCT00391872|65060198|FG001|Overall Study|Lost to Follow-up|0|||
23359621|NCT01957579|65060201|FG000|Overall Study|Withdrawal of concent|0|||
23359622|NCT01957579|65060202|FG001|Overall Study|Withdrawal of concent|1|||
23359623|NCT01957579|65060203|FG002|Overall Study|Withdrawal of concent|0|||
23359624|NCT01957579|65060204|FG003|Overall Study|Withdrawal of concent|0|||
23359625|NCT01957579|65060201|FG000|Overall Study|Death|0|||
23359626|NCT01957579|65060202|FG001|Overall Study|Death|0|||
23359627|NCT01957579|65060203|FG002|Overall Study|Death|2|||
23359628|NCT01957579|65060204|FG003|Overall Study|Death|0|||
23359629|NCT01980628|65060205|FG000|Overall Study|Adverse Event|12|||
23359630|NCT01980628|65060205|FG000|Overall Study|Physician Decision|5|||
23359631|NCT01980628|65060205|FG000|Overall Study|Withdrawal by Subject|4|||
23359632|NCT01980628|65060205|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
23359633|NCT01408901|65060207|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
23359634|NCT01408901|65060208|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
23359635|NCT01408901|65060209|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
23359636|NCT01408901|65060210|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
23359637|NCT01408901|65060207|FG000|6-Week Follow-Up|Death|1|||
23359638|NCT01408901|65060208|FG001|6-Week Follow-Up|Death|0|||
23359639|NCT01408901|65060209|FG002|6-Week Follow-Up|Death|0|||
23359640|NCT01408901|65060210|FG003|6-Week Follow-Up|Death|0|||
23359641|NCT01408901|65060207|FG000|6-Week Follow-Up|Cancelled visit|0|||
23359642|NCT01408901|65060208|FG001|6-Week Follow-Up|Cancelled visit|1|||
23359643|NCT01408901|65060209|FG002|6-Week Follow-Up|Cancelled visit|0|||
23359644|NCT01408901|65060210|FG003|6-Week Follow-Up|Cancelled visit|2|||
23359645|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359646|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359647|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359648|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
23359649|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
23476151|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
23359650|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359651|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359652|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359653|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
23359654|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
23359655|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
23476152|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
23359656|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
23359657|NCT01408901|65060207|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
23359658|NCT01408901|65060208|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
23359659|NCT01408901|65060209|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
23359660|NCT01408901|65060210|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
23359661|NCT01408901|65060207|FG000|26-Week Follow-Up|Death|0|||
23359662|NCT01408901|65060208|FG001|26-Week Follow-Up|Death|1|||
23359663|NCT01408901|65060209|FG002|26-Week Follow-Up|Death|0|||
23359664|NCT01408901|65060210|FG003|26-Week Follow-Up|Death|0|||
23359665|NCT00320788|65060211|FG000|Overall Study|Adverse Event|0|||
23359666|NCT00320788|65060212|FG001|Overall Study|Adverse Event|0|||
23359667|NCT00320788|65060213|FG002|Overall Study|Adverse Event|0|||
23359668|NCT00320788|65060214|FG003|Overall Study|Adverse Event|1|||
23359669|NCT00320788|65060215|FG004|Overall Study|Adverse Event|0|||
23359670|NCT00320788|65060211|FG000|Overall Study|Death|0|||
23359671|NCT00320788|65060212|FG001|Overall Study|Death|0|||
23359672|NCT00320788|65060213|FG002|Overall Study|Death|1|||
23359673|NCT00320788|65060214|FG003|Overall Study|Death|0|||
23359674|NCT00320788|65060215|FG004|Overall Study|Death|1|||
23359675|NCT00320788|65060211|FG000|Overall Study|Lost to Follow-up|0|||
23359676|NCT00320788|65060212|FG001|Overall Study|Lost to Follow-up|2|||
23359677|NCT00320788|65060213|FG002|Overall Study|Lost to Follow-up|1|||
23359678|NCT00320788|65060214|FG003|Overall Study|Lost to Follow-up|0|||
23359679|NCT00320788|65060215|FG004|Overall Study|Lost to Follow-up|0|||
23359680|NCT00320788|65060211|FG000|Overall Study|Decision by the Sponsor|1|||
23359681|NCT00320788|65060212|FG001|Overall Study|Decision by the Sponsor|1|||
23359682|NCT00320788|65060213|FG002|Overall Study|Decision by the Sponsor|0|||
23359683|NCT00320788|65060214|FG003|Overall Study|Decision by the Sponsor|0|||
23359684|NCT00320788|65060215|FG004|Overall Study|Decision by the Sponsor|1|||
23359685|NCT00320788|65060211|FG000|Overall Study|Other|1|||
23359686|NCT00320788|65060212|FG001|Overall Study|Other|2|||
23359687|NCT00320788|65060213|FG002|Overall Study|Other|1|||
23359688|NCT00320788|65060214|FG003|Overall Study|Other|1|||
23359689|NCT00320788|65060215|FG004|Overall Study|Other|1|||
23359690|NCT00320788|65060211|FG000|Overall Study|Physician Decision|1|||
23359691|NCT00320788|65060212|FG001|Overall Study|Physician Decision|1|||
23359692|NCT00320788|65060213|FG002|Overall Study|Physician Decision|0|||
23359693|NCT00320788|65060214|FG003|Overall Study|Physician Decision|0|||
23359694|NCT00320788|65060215|FG004|Overall Study|Physician Decision|0|||
23359695|NCT00320788|65060211|FG000|Overall Study|Protocol Violation|0|||
23359696|NCT00320788|65060212|FG001|Overall Study|Protocol Violation|0|||
23359697|NCT00320788|65060213|FG002|Overall Study|Protocol Violation|0|||
23359698|NCT00320788|65060214|FG003|Overall Study|Protocol Violation|0|||
23359699|NCT00320788|65060215|FG004|Overall Study|Protocol Violation|1|||
23359700|NCT00320788|65060211|FG000|Overall Study|Withdrawal by Subject|3|||
23359701|NCT00320788|65060212|FG001|Overall Study|Withdrawal by Subject|0|||
23359702|NCT00320788|65060213|FG002|Overall Study|Withdrawal by Subject|0|||
23359703|NCT00320788|65060214|FG003|Overall Study|Withdrawal by Subject|3|||
23359704|NCT00320788|65060215|FG004|Overall Study|Withdrawal by Subject|1|||
23359705|NCT02903420|65060218|FG000|Overall Study|Death|3|||
23359706|NCT02216214|65060224|FG000|Overall Study|Randomized Never Received Study Drug|1|||
23359707|NCT02216214|65060225|FG001|Overall Study|Randomized Never Received Study Drug|0|||
23359708|NCT02216214|65060224|FG000|Overall Study|Adverse Event|10|||
23359709|NCT02216214|65060225|FG001|Overall Study|Adverse Event|8|||
23359710|NCT02216214|65060224|FG000|Overall Study|Lack of Efficacy|2|||
23359711|NCT02216214|65060225|FG001|Overall Study|Lack of Efficacy|2|||
23359712|NCT02216214|65060224|FG000|Overall Study|Lost to Follow-up|3|||
23359713|NCT02216214|65060225|FG001|Overall Study|Lost to Follow-up|2|||
23359714|NCT02216214|65060224|FG000|Overall Study|Protocol Violation|4|||
23359715|NCT02216214|65060225|FG001|Overall Study|Protocol Violation|2|||
23359716|NCT02216214|65060224|FG000|Overall Study|Withdrawal by Subject|22|||
23359717|NCT02216214|65060225|FG001|Overall Study|Withdrawal by Subject|20|||
23359718|NCT02216214|65060224|FG000|Overall Study|Study Terminated By Sponsor|0|||
23359719|NCT02216214|65060225|FG001|Overall Study|Study Terminated By Sponsor|1|||
23359720|NCT02216214|65060224|FG000|Overall Study|Miscellaneous|1|||
23359721|NCT02216214|65060225|FG001|Overall Study|Miscellaneous|1|||
23359722|NCT02499120|65060226|FG000|Overall Study|Death|52|||
23359723|NCT02499120|65060227|FG001|Overall Study|Death|43|||
23359724|NCT02499120|65060226|FG000|Overall Study|Lost to Follow-up|1|||
23359725|NCT02499120|65060227|FG001|Overall Study|Lost to Follow-up|2|||
23359726|NCT02499120|65060226|FG000|Overall Study|Participant refused further follow-up|1|||
23359727|NCT02499120|65060227|FG001|Overall Study|Participant refused further follow-up|0|||
23359728|NCT02499120|65060226|FG000|Overall Study|Withdrawal by Subject|2|||
23359729|NCT02499120|65060227|FG001|Overall Study|Withdrawal by Subject|5|||
23359730|NCT02499120|65060226|FG000|Overall Study|Other|9|||
23359731|NCT02499120|65060227|FG001|Overall Study|Other|10|||
23359732|NCT03315455|65060228|FG000|Overall Study|Ongoing in the Study|13|||
23359733|NCT03315455|65060229|FG001|Overall Study|Ongoing in the Study|24|||
23359734|NCT03315455|65060230|FG002|Overall Study|Ongoing in the Study|17|||
23359735|NCT03315455|65060231|FG003|Overall Study|Ongoing in the Study|15|||
23359736|NCT03315455|65060228|FG000|Overall Study|Withdrawal by Subject|0|||
23359737|NCT03315455|65060229|FG001|Overall Study|Withdrawal by Subject|1|||
23359738|NCT03315455|65060230|FG002|Overall Study|Withdrawal by Subject|0|||
23643779|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
23643780|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
23643781|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
23643782|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23643783|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
23643784|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23643785|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23643786|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
23359739|NCT03315455|65060231|FG003|Overall Study|Withdrawal by Subject|0|||
23359740|NCT00524771|65062697|FG000|Overall Study|Protocol Violation|220|||
23359741|NCT00524771|65062698|FG001|Overall Study|Protocol Violation|585|||
23359742|NCT03126786|65062699|FG000|Overall Study|Adverse Event|3|||
23359743|NCT03126786|65062700|FG001|Overall Study|Adverse Event|0|||
23359744|NCT03126786|65062699|FG000|Overall Study|Lost to Follow-up|0|||
23359745|NCT03126786|65062700|FG001|Overall Study|Lost to Follow-up|1|||
23359746|NCT03126786|65062699|FG000|Overall Study|Withdrawal by Subject|3|||
23359747|NCT03126786|65062700|FG001|Overall Study|Withdrawal by Subject|1|||
23359748|NCT01223937|65062701|FG000|Overall Study|Withdrawal by Subject|3|||
23476153|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
23476154|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
23590464|NCT00736853|65889700|FG000|Open-Label Period|Started but not treated|42|||
23590465|NCT00736853|65889701|FG001|Open-Label Period|Started but not treated|0|||
23590466|NCT00736853|65889702|FG002|Open-Label Period|Started but not treated|0|||
23590467|NCT00736853|65889700|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
23643787|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23359749|NCT01223937|65062702|FG001|Overall Study|Withdrawal by Subject|2|||
23590468|NCT00736853|65889701|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
23590469|NCT00736853|65889702|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
23590470|NCT00736853|65889700|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
23590471|NCT00736853|65889701|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
23590472|NCT00736853|65889702|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
23590473|NCT00736853|65889700|FG000|Double-Blind Period|Lack of Efficacy|0|||
23590474|NCT00736853|65889701|FG001|Double-Blind Period|Lack of Efficacy|19|||
23590475|NCT00736853|65889702|FG002|Double-Blind Period|Lack of Efficacy|42|||
23590476|NCT00736853|65889700|FG000|Double-Blind Period|Adverse Event|0|||
23590477|NCT00736853|65889701|FG001|Double-Blind Period|Adverse Event|3|||
23590478|NCT00736853|65889702|FG002|Double-Blind Period|Adverse Event|2|||
23590479|NCT00736853|65889700|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23590480|NCT00736853|65889701|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23590481|NCT00736853|65889702|FG002|Double-Blind Period|Withdrawal by Subject|4|||
23590482|NCT00736853|65889700|FG000|Double-Blind Period|Ineligible to participate the study|0|||
23590483|NCT00736853|65889701|FG001|Double-Blind Period|Ineligible to participate the study|1|||
23590484|NCT00736853|65889702|FG002|Double-Blind Period|Ineligible to participate the study|0|||
23590485|NCT00463788|65889705|FG000|Overall Study|Progressive Disease|86|||
23590486|NCT00463788|65889706|FG001|Overall Study|Progressive Disease|42|||
23590487|NCT00463788|65889705|FG000|Overall Study|Adverse Event|6|||
23590488|NCT00463788|65889706|FG001|Overall Study|Adverse Event|2|||
23798218|NCT02443324|66636966|FG006|Overall Study|Lost to Follow-up|0|||
23798219|NCT02443324|66636960|FG000|Overall Study|Physician Decision|0|||
23798220|NCT02443324|66636961|FG001|Overall Study|Physician Decision|3|||
23798221|NCT02443324|66636962|FG002|Overall Study|Physician Decision|5|||
23798222|NCT02443324|66636963|FG003|Overall Study|Physician Decision|1|||
23798223|NCT02443324|66636964|FG004|Overall Study|Physician Decision|1|||
23798224|NCT02443324|66636965|FG005|Overall Study|Physician Decision|0|||
23798225|NCT02443324|66636966|FG006|Overall Study|Physician Decision|2|||
23798226|NCT02443324|66636960|FG000|Overall Study|Progressive Disease|20|||
23798227|NCT02443324|66636961|FG001|Overall Study|Progressive Disease|20|||
23798228|NCT02443324|66636962|FG002|Overall Study|Progressive Disease|13|||
23798229|NCT02443324|66636963|FG003|Overall Study|Progressive Disease|10|||
23798230|NCT02443324|66636964|FG004|Overall Study|Progressive Disease|13|||
23798231|NCT02443324|66636965|FG005|Overall Study|Progressive Disease|17|||
23798232|NCT02443324|66636966|FG006|Overall Study|Progressive Disease|10|||
23798233|NCT02443324|66636960|FG000|Overall Study|Withdrawal by Subject|0|||
23798234|NCT02443324|66636961|FG001|Overall Study|Withdrawal by Subject|0|||
23798235|NCT02443324|66636962|FG002|Overall Study|Withdrawal by Subject|3|||
23798236|NCT02443324|66636963|FG003|Overall Study|Withdrawal by Subject|1|||
23798237|NCT02443324|66636964|FG004|Overall Study|Withdrawal by Subject|1|||
23798238|NCT02443324|66636965|FG005|Overall Study|Withdrawal by Subject|0|||
23798239|NCT02443324|66636966|FG006|Overall Study|Withdrawal by Subject|1|||
23798240|NCT02443324|66636960|FG000|Overall Study|Adverse Event|0|||
23798241|NCT02443324|66636961|FG001|Overall Study|Adverse Event|1|||
23798242|NCT02443324|66636962|FG002|Overall Study|Adverse Event|3|||
23798243|NCT02443324|66636963|FG003|Overall Study|Adverse Event|0|||
23798244|NCT02443324|66636964|FG004|Overall Study|Adverse Event|4|||
23798245|NCT02443324|66636965|FG005|Overall Study|Adverse Event|3|||
23798246|NCT02443324|66636966|FG006|Overall Study|Adverse Event|3|||
23798247|NCT02443324|66636960|FG000|Overall Study|Enrolled but Never Treated|0|||
23798248|NCT02443324|66636961|FG001|Overall Study|Enrolled but Never Treated|0|||
23798249|NCT02443324|66636962|FG002|Overall Study|Enrolled but Never Treated|1|||
23643788|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23643789|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23643790|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
23643791|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
23643792|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
23643793|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
23643794|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
23643795|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
23643796|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
23643797|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
23643798|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23643799|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23643800|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23643801|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
23643802|NCT00910689|66079207|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
23643803|NCT00910689|66079208|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
23643804|NCT00910689|66079209|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
23643805|NCT00910689|66079210|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
23643806|NCT00384189|66079211|FG000|Overall Study|Reason Not Specified|50|||
23643807|NCT00384189|66079212|FG001|Overall Study|Reason Not Specified|57|||
23643808|NCT00384189|66079213|FG002|Overall Study|Reason Not Specified|58|||
23643809|NCT00384189|66079214|FG003|Overall Study|Reason Not Specified|40|||
23643810|NCT00924027|66079215|FG000|Overall Study|Lost to Further Follow-Up|4|||
23798250|NCT02443324|66636963|FG003|Overall Study|Enrolled but Never Treated|0|||
23798251|NCT02443324|66636964|FG004|Overall Study|Enrolled but Never Treated|1|||
23798252|NCT02443324|66636965|FG005|Overall Study|Enrolled but Never Treated|0|||
23798253|NCT02443324|66636966|FG006|Overall Study|Enrolled but Never Treated|1|||
23798254|NCT01117987|66636967|FG000|Overall Study|Protocol deviation|0|||
23798255|NCT01117987|66636968|FG001|Overall Study|Protocol deviation|1|||
23798256|NCT01117987|66636967|FG000|Overall Study|Subject no longer requires study drug|1|||
23643811|NCT00924027|66079216|FG001|Overall Study|Lost to Further Follow-Up|0|||
23643812|NCT00924027|66079217|FG002|Overall Study|Lost to Further Follow-Up|0|||
23643813|NCT00924027|66079218|FG003|Overall Study|Lost to Further Follow-Up|0|||
23798257|NCT01117987|66636968|FG001|Overall Study|Subject no longer requires study drug|0|||
23798258|NCT01117987|66636967|FG000|Overall Study|Lost to Follow-up|1|||
23798259|NCT01117987|66636968|FG001|Overall Study|Lost to Follow-up|1|||
23798260|NCT01117987|66636967|FG000|Overall Study|Abnormal test procedure result|2|||
23798261|NCT01117987|66636968|FG001|Overall Study|Abnormal test procedure result|0|||
23643814|NCT00924027|66079215|FG000|Overall Study|Physician Decision|1|||
23798262|NCT01117987|66636967|FG000|Overall Study|Lack of Efficacy|3|||
23798263|NCT01117987|66636968|FG001|Overall Study|Lack of Efficacy|4|||
23798264|NCT01117987|66636967|FG000|Overall Study|Death|5|||
23798265|NCT01117987|66636968|FG001|Overall Study|Death|10|||
23798266|NCT01117987|66636967|FG000|Overall Study|Withdrawal by Subject|5|||
23798267|NCT01117987|66636968|FG001|Overall Study|Withdrawal by Subject|10|||
23798268|NCT01117987|66636967|FG000|Overall Study|Adverse Event|19|||
23798269|NCT01117987|66636968|FG001|Overall Study|Adverse Event|26|||
23798270|NCT01117987|66636967|FG000|Overall Study|Administrative problems|25|||
23798271|NCT01117987|66636968|FG001|Overall Study|Administrative problems|22|||
23798272|NCT00388037|66636971|FG000|Overall Study|Protocol Violation|1|||
23798273|NCT00889252|66636972|FG000|Overall Study|Adverse Event|2|||
23798274|NCT00889252|66636973|FG001|Overall Study|Adverse Event|4|||
23798275|NCT00889252|66636972|FG000|Overall Study|Withdrawal by Subject|3|||
23798276|NCT00889252|66636973|FG001|Overall Study|Withdrawal by Subject|0|||
23798277|NCT00889252|66636972|FG000|Overall Study|Protocol Violation|2|||
23798278|NCT00889252|66636973|FG001|Overall Study|Protocol Violation|0|||
23798279|NCT02415387|66636974|FG000|Overall Study|Withdrawal by Subject|6|||
23798280|NCT02415387|66636975|FG001|Overall Study|Withdrawal by Subject|1|||
23798281|NCT02415387|66636974|FG000|Overall Study|blood draw problem|0|||
23798282|NCT02415387|66636975|FG001|Overall Study|blood draw problem|1|||
23798283|NCT02415387|66636974|FG000|Overall Study|Protocol Violation|1|||
23798284|NCT02415387|66636975|FG001|Overall Study|Protocol Violation|0|||
23798285|NCT01740427|66636976|FG000|Overall Study|Ongoing|45|||
23798286|NCT01740427|66636977|FG001|Overall Study|Ongoing|5|||
23798287|NCT01740427|66636976|FG000|Overall Study|Objective Progression or Relapse|281|||
23798288|NCT01740427|66636977|FG001|Overall Study|Objective Progression or Relapse|171|||
23798289|NCT01740427|66636976|FG000|Overall Study|Adverse Event|31|||
23798290|NCT01740427|66636977|FG001|Overall Study|Adverse Event|9|||
23798291|NCT01740427|66636976|FG000|Overall Study|Global Deterioration of Health Status|28|||
23798292|NCT01740427|66636977|FG001|Overall Study|Global Deterioration of Health Status|12|||
23798293|NCT01740427|66636976|FG000|Overall Study|Participant Refused Continued Treatment|26|||
23798294|NCT01740427|66636977|FG001|Overall Study|Participant Refused Continued Treatment|15|||
23798295|NCT01740427|66636976|FG000|Overall Study|Unspecified reasons|15|||
23798296|NCT01740427|66636977|FG001|Overall Study|Unspecified reasons|4|||
23798297|NCT01740427|66636976|FG000|Overall Study|Death|10|||
23798298|NCT01740427|66636977|FG001|Overall Study|Death|3|||
23798299|NCT01740427|66636976|FG000|Overall Study|Protocol Violation|5|||
23798300|NCT01740427|66636977|FG001|Overall Study|Protocol Violation|3|||
23798301|NCT01740427|66636976|FG000|Overall Study|Lost to Follow-up|2|||
23798302|NCT01740427|66636977|FG001|Overall Study|Lost to Follow-up|0|||
23798303|NCT01740427|66636976|FG000|Overall Study|Site Terminated by Sponsor|1|||
23590489|NCT00463788|65889705|FG000|Overall Study|Withdrawal by Subject|6|||
23590490|NCT00463788|65889706|FG001|Overall Study|Withdrawal by Subject|2|||
23590491|NCT00463788|65889705|FG000|Overall Study|Death|4|||
23590492|NCT00463788|65889706|FG001|Overall Study|Death|3|||
23590493|NCT00463788|65889705|FG000|Overall Study|Symptomatic Deterioration|2|||
23590494|NCT00463788|65889706|FG001|Overall Study|Symptomatic Deterioration|3|||
23590495|NCT00463788|65889705|FG000|Overall Study|Lost to Follow-up|1|||
23590496|NCT00463788|65889706|FG001|Overall Study|Lost to Follow-up|0|||
23590497|NCT00463788|65889705|FG000|Overall Study|Protocol Violation|0|||
23590498|NCT00463788|65889706|FG001|Overall Study|Protocol Violation|1|||
23590499|NCT00463788|65889705|FG000|Overall Study|Other|3|||
23590500|NCT00463788|65889706|FG001|Overall Study|Other|0|||
23590501|NCT00463788|65889705|FG000|Overall Study|Randomized but not treated|1|||
23590502|NCT00463788|65889706|FG001|Overall Study|Randomized but not treated|1|||
23590503|NCT00943735|65889707|FG000|Overall Study|Adverse Event|12|||
23590504|NCT00943735|65889707|FG000|Overall Study|Withdrawal by Subject|8|||
23590505|NCT00943735|65889707|FG000|Overall Study|Death|1|||
23590506|NCT00943735|65889707|FG000|Overall Study|Other|8|||
23643815|NCT00924027|66079216|FG001|Overall Study|Physician Decision|0|||
23643816|NCT00924027|66079217|FG002|Overall Study|Physician Decision|0|||
23643817|NCT00924027|66079218|FG003|Overall Study|Physician Decision|1|||
23798304|NCT01740427|66636977|FG001|Overall Study|Site Terminated by Sponsor|0|||
23590507|NCT00943735|65889707|FG000|Overall Study|Other|3|||
23590508|NCT02814643|65889710|FG000|Overall Study|Lost to Follow-up|0|||
23590509|NCT02814643|65889711|FG001|Overall Study|Lost to Follow-up|1|||
23590510|NCT02814643|65889710|FG000|Overall Study|Withdrawal by Subject|1|||
23590511|NCT02814643|65889711|FG001|Overall Study|Withdrawal by Subject|2|||
23590512|NCT01787760|65889716|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
23590513|NCT01787760|65889717|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
23590514|NCT01787760|65889718|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
23590515|NCT01787760|65889716|FG000|Overall Study|Decompensated on left exotropia|0|||
23590516|NCT01787760|65889717|FG001|Overall Study|Decompensated on left exotropia|0|||
23590517|NCT01787760|65889718|FG002|Overall Study|Decompensated on left exotropia|1|||
23590518|NCT01787760|65889716|FG000|Overall Study|Dryness|0|||
23590519|NCT01787760|65889717|FG001|Overall Study|Dryness|1|||
23590520|NCT01787760|65889718|FG002|Overall Study|Dryness|0|||
23590521|NCT01787760|65889716|FG000|Overall Study|Relocation|1|||
23590522|NCT01787760|65889717|FG001|Overall Study|Relocation|1|||
23590523|NCT01787760|65889718|FG002|Overall Study|Relocation|0|||
23590524|NCT01787760|65889716|FG000|Overall Study|Lens discomfort|3|||
23590525|NCT01787760|65889717|FG001|Overall Study|Lens discomfort|0|||
23590526|NCT01787760|65889718|FG002|Overall Study|Lens discomfort|0|||
23590527|NCT01787760|65889716|FG000|Overall Study|Lens handling difficulty|1|||
23590528|NCT01787760|65889717|FG001|Overall Study|Lens handling difficulty|2|||
23590529|NCT01787760|65889718|FG002|Overall Study|Lens handling difficulty|0|||
23590530|NCT01787760|65889716|FG000|Overall Study|Protocol Violation|6|||
23590531|NCT01787760|65889717|FG001|Overall Study|Protocol Violation|0|||
23590532|NCT01787760|65889718|FG002|Overall Study|Protocol Violation|1|||
23590533|NCT01787760|65889716|FG000|Overall Study|Withdrawal by Subject|5|||
23590534|NCT01787760|65889717|FG001|Overall Study|Withdrawal by Subject|1|||
23590535|NCT01787760|65889718|FG002|Overall Study|Withdrawal by Subject|2|||
23590536|NCT01787760|65889716|FG000|Overall Study|Lost to Follow-up|1|||
23590537|NCT01787760|65889717|FG001|Overall Study|Lost to Follow-up|0|||
23590538|NCT01787760|65889718|FG002|Overall Study|Lost to Follow-up|1|||
23590539|NCT01787760|65889716|FG000|Overall Study|Stroke|1|||
23643818|NCT00924027|66079215|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
23643819|NCT00924027|66079216|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
23798305|NCT02280187|66636978|FG000|Overall Study|Lost to Follow-up|218|||
23798306|NCT02020967|66636979|FG000|Overall Study|Withdrawal by Subject|51|||
23798307|NCT01213836|66636980|FG000|Period 1, First Intervention|Adverse Event|2|||
23798308|NCT01213836|66636981|FG001|Period 1, First Intervention|Adverse Event|1|||
23798309|NCT01213836|66636980|FG000|Period 1, First Intervention|Protocol Violation|0|||
23359750|NCT01223937|65062701|FG000|Overall Study|Lost to Follow-up|1|||
23359751|NCT01223937|65062702|FG001|Overall Study|Lost to Follow-up|4|||
23359752|NCT01223937|65062701|FG000|Overall Study|Adverse Event|1|||
23359753|NCT01223937|65062702|FG001|Overall Study|Adverse Event|4|||
23359754|NCT01223937|65062701|FG000|Overall Study|Protocol Violation|8|||
23590540|NCT01787760|65889717|FG001|Overall Study|Stroke|0|||
23590541|NCT01787760|65889718|FG002|Overall Study|Stroke|0|||
23798310|NCT01213836|66636981|FG001|Period 1, First Intervention|Protocol Violation|1|||
23798311|NCT01213836|66636980|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
23590542|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
23590543|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
23359755|NCT01223937|65062702|FG001|Overall Study|Protocol Violation|7|||
23590544|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
23590545|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory physiological response|2|||
23590546|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory physiological response|4|||
23359756|NCT01223937|65062701|FG000|Overall Study|Other|4|||
23359757|NCT01223937|65062702|FG001|Overall Study|Other|1|||
23359758|NCT01535443|65062705|FG000|Overall Study|Physician Decision|3|||
23359759|NCT04441788|65062707|FG000|Overall Study|Voluntary Withdrawl|0|||
23359760|NCT04441788|65062708|FG001|Overall Study|Voluntary Withdrawl|1|||
23359761|NCT04441788|65062709|FG002|Overall Study|Voluntary Withdrawl|0|||
23359762|NCT04441788|65062707|FG000|Overall Study|Ineligibility|1|||
23359763|NCT04441788|65062708|FG001|Overall Study|Ineligibility|0|||
23359764|NCT04441788|65062709|FG002|Overall Study|Ineligibility|0|||
23359765|NCT04441788|65062707|FG000|Overall Study|Adverse Event|0|||
23359766|NCT04441788|65062708|FG001|Overall Study|Adverse Event|0|||
23476155|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
23476156|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
23476157|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
23476158|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
23798312|NCT01213836|66636981|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
23798313|NCT00413218|66636984|FG000|Overall Study|Randomized but didn't receive study drug|2|||
23798314|NCT00413218|66636985|FG001|Overall Study|Randomized but didn't receive study drug|8|||
23798315|NCT00413218|66636984|FG000|Overall Study|Death|57|||
23798316|NCT00413218|66636985|FG001|Overall Study|Death|56|||
23798317|NCT00413218|66636984|FG000|Overall Study|Lost to Follow-up|14|||
23476159|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
23476160|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
23476161|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
23476162|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
23476163|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
23476164|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
23476165|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
23476166|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
23476167|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
23476168|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
23476169|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
23798318|NCT00413218|66636985|FG001|Overall Study|Lost to Follow-up|17|||
23798319|NCT00413218|66636984|FG000|Overall Study|Admin|20|||
23476170|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
23476171|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
23476172|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
23476173|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
23476174|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
23476175|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
23476176|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
23476177|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
23476178|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
23476179|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
23476180|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
23476181|NCT01431638|65488012|FG000|Overall Study|Adverse Event|1|||
23476182|NCT01431638|65488013|FG001|Overall Study|Adverse Event|3|||
23476183|NCT01431638|65488014|FG002|Overall Study|Adverse Event|1|||
23798320|NCT00413218|66636985|FG001|Overall Study|Admin|14|||
23798321|NCT00413218|66636984|FG000|Overall Study|Missing|1|||
23798322|NCT00413218|66636985|FG001|Overall Study|Missing|0|||
23798323|NCT00413218|66636984|FG000|Overall Study|Withdrawal by Subject|9|||
23798324|NCT00413218|66636985|FG001|Overall Study|Withdrawal by Subject|1|||
23798325|NCT03573817|66636986|FG000|Overall Study|Adverse Event|0|||
23476184|NCT01431638|65488012|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23798326|NCT03573817|66636987|FG001|Overall Study|Adverse Event|2|||
23798327|NCT03573817|66636986|FG000|Overall Study|Protocol Violation|0|||
23798328|NCT03573817|66636987|FG001|Overall Study|Protocol Violation|1|||
23359767|NCT04441788|65062709|FG002|Overall Study|Adverse Event|4|||
23359768|NCT04441788|65062707|FG000|Overall Study|Study Terminated by Sponsor|16|||
23359769|NCT04441788|65062708|FG001|Overall Study|Study Terminated by Sponsor|16|||
23476185|NCT01431638|65488013|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23476186|NCT01431638|65488014|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23798329|NCT03573817|66636986|FG000|Overall Study|Withdrawal by Subject|1|||
23798330|NCT03573817|66636987|FG001|Overall Study|Withdrawal by Subject|1|||
23798331|NCT01867606|66636988|FG000|Overall Study|Withdrawal by Subject|10|||
23798332|NCT01867606|66636989|FG001|Overall Study|Withdrawal by Subject|14|||
23798333|NCT01867606|66636988|FG000|Overall Study|Protocol Violation|0|||
23798334|NCT01867606|66636989|FG001|Overall Study|Protocol Violation|1|||
23798335|NCT03381196|66636990|FG000|Overall Study|Withdrawal by Subject|7|||
23798336|NCT03381196|66636991|FG001|Overall Study|Withdrawal by Subject|7|||
23798337|NCT03381196|66636990|FG000|Overall Study|Other|0|||
23798338|NCT03381196|66636991|FG001|Overall Study|Other|1|||
23798339|NCT03381196|66636990|FG000|Overall Study|Lost to Follow-up|5|||
23798340|NCT03381196|66636991|FG001|Overall Study|Lost to Follow-up|4|||
23476187|NCT01431638|65488012|FG000|Overall Study|Participants condition no longer requires study drug|0|||
23476188|NCT01431638|65488013|FG001|Overall Study|Participants condition no longer requires study drug|1|||
23476189|NCT01431638|65488014|FG002|Overall Study|Participants condition no longer requires study drug|0|||
23476190|NCT01431638|65488012|FG000|Overall Study|Participant withdrew consent|14|||
23476191|NCT01431638|65488013|FG001|Overall Study|Participant withdrew consent|5|||
23476192|NCT01431638|65488014|FG002|Overall Study|Participant withdrew consent|8|||
23476193|NCT01431638|65488012|FG000|Overall Study|Lost to Follow-up|7|||
23476194|NCT01431638|65488013|FG001|Overall Study|Lost to Follow-up|9|||
23476195|NCT01431638|65488014|FG002|Overall Study|Lost to Follow-up|7|||
23798341|NCT03381196|66636990|FG000|Overall Study|Death|0|||
23798342|NCT03381196|66636991|FG001|Overall Study|Death|1|||
23798343|NCT03381196|66636990|FG000|Overall Study|Adverse Event|1|||
23798344|NCT03381196|66636991|FG001|Overall Study|Adverse Event|0|||
23798345|NCT03381196|66636990|FG000|Overall Study|Randomized, not treated|3|||
23798346|NCT03381196|66636991|FG001|Overall Study|Randomized, not treated|6|||
23798347|NCT01134627|66636994|FG000|Overall Study|Adverse Event|47|||
23798348|NCT01134627|66636995|FG001|Overall Study|Adverse Event|31|||
23476196|NCT01431638|65488012|FG000|Overall Study|Administrative problems|1|||
23798349|NCT01134627|66636994|FG000|Overall Study|Lost to Follow-up|1|||
23798350|NCT01134627|66636995|FG001|Overall Study|Lost to Follow-up|2|||
23798351|NCT01134627|66636994|FG000|Overall Study|Protocol Violation|3|||
23798352|NCT01134627|66636995|FG001|Overall Study|Protocol Violation|5|||
23798353|NCT01134627|66636994|FG000|Overall Study|Lack of Efficacy|2|||
23476197|NCT01431638|65488013|FG001|Overall Study|Administrative problems|4|||
23476198|NCT01431638|65488014|FG002|Overall Study|Administrative problems|6|||
23476199|NCT01431638|65488012|FG000|Overall Study|Death|1|||
23476200|NCT01431638|65488013|FG001|Overall Study|Death|0|||
23476201|NCT01431638|65488014|FG002|Overall Study|Death|0|||
23590547|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory physiological response|0|||
23590548|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory visual response|1|||
23590549|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory visual response|1|||
23590550|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory visual response|0|||
23590551|NCT01787760|65889716|FG000|Overall Study|Near vision blur|1|||
23590552|NCT01787760|65889717|FG001|Overall Study|Near vision blur|0|||
23590553|NCT01787760|65889718|FG002|Overall Study|Near vision blur|0|||
23590554|NCT03737240|65889719|FG000|Overall Study|Lost to Follow-up|16|||
23590555|NCT03737240|65889720|FG001|Overall Study|Lost to Follow-up|15|||
23590556|NCT01956669|65889721|FG000|Overall Study|Disease Progression|12|||
23590557|NCT01956669|65889722|FG001|Overall Study|Disease Progression|7|||
23590558|NCT01956669|65889723|FG002|Overall Study|Disease Progression|7|||
23590559|NCT01956669|65889724|FG003|Overall Study|Disease Progression|8|||
23590560|NCT01956669|65889725|FG004|Overall Study|Disease Progression|4|||
23590561|NCT01956669|65889726|FG005|Overall Study|Disease Progression|3|||
23798354|NCT01134627|66636995|FG001|Overall Study|Lack of Efficacy|12|||
23798355|NCT01134627|66636994|FG000|Overall Study|Withdrawal by Subject|4|||
23798356|NCT01134627|66636995|FG001|Overall Study|Withdrawal by Subject|3|||
23476202|NCT01431638|65488012|FG000|Overall Study|Protocol deviation|1|||
23590562|NCT01956669|65889727|FG006|Overall Study|Disease Progression|5|||
23590563|NCT01956669|65889721|FG000|Overall Study|Adverse Event|0|||
23798357|NCT01134627|66636994|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
23798358|NCT01134627|66636995|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
23798359|NCT01134627|66636994|FG000|Overall Study|Other|11|||
23798360|NCT01134627|66636995|FG001|Overall Study|Other|14|||
23476203|NCT01431638|65488013|FG001|Overall Study|Protocol deviation|1|||
23476204|NCT01431638|65488014|FG002|Overall Study|Protocol deviation|4|||
23643820|NCT00924027|66079217|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
23643821|NCT00924027|66079218|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
23643822|NCT00924027|66079215|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
23643823|NCT00924027|66079216|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
23643824|NCT00924027|66079217|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
23643825|NCT00924027|66079218|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
23643826|NCT00924027|66079215|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
23643827|NCT00924027|66079216|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
23643828|NCT00924027|66079217|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
23359770|NCT04441788|65062709|FG002|Overall Study|Study Terminated by Sponsor|12|||
23359771|NCT02164318|65062716|FG000|Overall Study|Withdrawal by Subject|0|||
23359772|NCT02164318|65062717|FG001|Overall Study|Withdrawal by Subject|1|||
23359773|NCT02164318|65062718|FG002|Overall Study|Withdrawal by Subject|0|||
23359774|NCT02164318|65062719|FG003|Overall Study|Withdrawal by Subject|1|||
23359775|NCT03214679|65062721|FG000|Overall Study|Lost to Follow-up|12|||
23359776|NCT03214679|65062722|FG001|Overall Study|Lost to Follow-up|14|||
23359777|NCT03214679|65062721|FG000|Overall Study|not eligible|2|||
23359778|NCT03214679|65062722|FG001|Overall Study|not eligible|0|||
23359779|NCT01447719|65062723|FG000|Overall Study|Image acquisition failure|2|||
23359780|NCT01447719|65062723|FG000|Overall Study|Invalid image or not imaged|3|||
23359781|NCT01447719|65062723|FG000|Overall Study|Subject still living at end of study|79|||
23359782|NCT01447719|65062723|FG000|Overall Study|Withdrawal by Subject|2|||
23359783|NCT01447719|65062723|FG000|Overall Study|Family withdrew autopsy consent|7|||
23359784|NCT00339833|65062725|FG000|Overall Study|Withdrawal by Subject|1|||
23359785|NCT00339833|65062726|FG001|Overall Study|Withdrawal by Subject|2|||
23643829|NCT00924027|66079218|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
23643830|NCT00996476|66079222|FG000|Overall Study|Withdrawal by Subject|1|||
23643831|NCT00996476|66079223|FG001|Overall Study|Withdrawal by Subject|2|||
23643832|NCT00996476|66079224|FG002|Overall Study|Withdrawal by Subject|1|||
23643833|NCT00996476|66079225|FG003|Overall Study|Withdrawal by Subject|0|||
23643834|NCT00996476|66079226|FG004|Overall Study|Withdrawal by Subject|1|||
23643835|NCT00996476|66079222|FG000|Overall Study|Adverse Event|0|||
23359786|NCT00339833|65062725|FG000|Overall Study|toothache|0|||
23643836|NCT00996476|66079223|FG001|Overall Study|Adverse Event|1|||
23798361|NCT01231373|66636996|FG000|Overall Study|Withdrew consent prior to randomization|2|||
23798362|NCT01231373|66636997|FG001|Overall Study|Withdrew consent prior to randomization|1|||
23798363|NCT01231373|66636998|FG002|Overall Study|Withdrew consent prior to randomization|0|||
23798364|NCT01231373|66636999|FG003|Overall Study|Withdrew consent prior to randomization|0|||
23798365|NCT01231373|66636996|FG000|Overall Study|Lost to Follow-up|0|||
23798366|NCT01231373|66636997|FG001|Overall Study|Lost to Follow-up|0|||
23798367|NCT01231373|66636998|FG002|Overall Study|Lost to Follow-up|0|||
23798368|NCT01231373|66636999|FG003|Overall Study|Lost to Follow-up|1|||
23798369|NCT01231373|66636996|FG000|Overall Study|Withdrew Consent|1|||
23798370|NCT01231373|66636997|FG001|Overall Study|Withdrew Consent|0|||
23798371|NCT01231373|66636998|FG002|Overall Study|Withdrew Consent|0|||
23798372|NCT01231373|66636999|FG003|Overall Study|Withdrew Consent|0|||
23798373|NCT00063258|66637000|FG000|Overall Study|Physician Decision|2|||
23359787|NCT00339833|65062726|FG001|Overall Study|toothache|1|||
23798374|NCT00063258|66637001|FG001|Overall Study|Physician Decision|0|||
23359788|NCT00339833|65062725|FG000|Overall Study|indigestion|0|||
23359789|NCT00339833|65062726|FG001|Overall Study|indigestion|1|||
23359790|NCT00339833|65062725|FG000|Overall Study|Chest pain|0|||
23359791|NCT00339833|65062726|FG001|Overall Study|Chest pain|1|||
23359792|NCT00339833|65062725|FG000|Overall Study|minor infection|0|||
23359793|NCT00339833|65062726|FG001|Overall Study|minor infection|1|||
23359794|NCT00339833|65062725|FG000|Overall Study|Poor venous access|2|||
23359795|NCT00339833|65062726|FG001|Overall Study|Poor venous access|2|||
23359796|NCT00339833|65062725|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
23359797|NCT00339833|65062726|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
23476205|NCT01431638|65488012|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
23476206|NCT01431638|65488013|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
23590564|NCT01956669|65889722|FG001|Overall Study|Adverse Event|2|||
23643837|NCT00996476|66079224|FG002|Overall Study|Adverse Event|0|||
23798375|NCT00063258|66637000|FG000|Overall Study|Lack of Efficacy|2|||
23798376|NCT00063258|66637001|FG001|Overall Study|Lack of Efficacy|0|||
23359798|NCT00339833|65062725|FG000|Overall Study|Error in data records|1|||
23359799|NCT00339833|65062726|FG001|Overall Study|Error in data records|0|||
23359800|NCT03061188|65062727|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
23359801|NCT03061188|65062728|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
23359802|NCT03061188|65062729|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
23359803|NCT03061188|65062730|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
23359804|NCT03061188|65062727|FG000|On Follow-up for 3 Years|Death|0|||
23359805|NCT03061188|65062728|FG001|On Follow-up for 3 Years|Death|3|||
23798377|NCT01848210|66637004|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
23798378|NCT01848210|66637005|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
23798379|NCT01848210|66637004|FG000|Overall Study|Lost to Follow-up|24|||
23798380|NCT01848210|66637005|FG001|Overall Study|Lost to Follow-up|12|||
23798381|NCT01848210|66637004|FG000|Overall Study|Protocol Violation|3|||
23798382|NCT01848210|66637005|FG001|Overall Study|Protocol Violation|5|||
23798383|NCT01848210|66637004|FG000|Overall Study|Use of Forbidden Drugs|9|||
23798384|NCT01848210|66637005|FG001|Overall Study|Use of Forbidden Drugs|10|||
23798385|NCT01848210|66637004|FG000|Overall Study|Impedition Condition|5|||
23798386|NCT01848210|66637005|FG001|Overall Study|Impedition Condition|9|||
23798387|NCT01848210|66637004|FG000|Overall Study|Adverse Event|7|||
23798388|NCT01848210|66637005|FG001|Overall Study|Adverse Event|9|||
23798389|NCT01848210|66637004|FG000|Overall Study|Discontinuation Criterion|5|||
23798390|NCT01848210|66637005|FG001|Overall Study|Discontinuation Criterion|7|||
23798391|NCT01848210|66637004|FG000|Overall Study|Hypesensitivity|1|||
23798392|NCT01848210|66637005|FG001|Overall Study|Hypesensitivity|0|||
23798393|NCT01848210|66637004|FG000|Overall Study|Hepatic Function Alteration|4|||
23798394|NCT01848210|66637005|FG001|Overall Study|Hepatic Function Alteration|0|||
23798395|NCT01848210|66637004|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
23798396|NCT01848210|66637005|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
23798397|NCT01848210|66637004|FG000|Overall Study|Administrative|1|||
23798398|NCT01848210|66637005|FG001|Overall Study|Administrative|0|||
23798399|NCT02056652|66637006|FG000|Overall Study|Withdrawal by Subject|1|||
23798400|NCT02056652|66637007|FG001|Overall Study|Withdrawal by Subject|0|||
23798401|NCT02056652|66637006|FG000|Overall Study|Lost to Follow-up|0|||
23798402|NCT02056652|66637007|FG001|Overall Study|Lost to Follow-up|3|||
23798403|NCT00351351|66637011|FG000|Overall Study|surgical access pbs; device issues|9|||
23476207|NCT01431638|65488014|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
23476208|NCT00926029|65488015|FG000|Overall Study|Lost to Follow-up|2|||
23590565|NCT01956669|65889723|FG002|Overall Study|Adverse Event|2|||
23590566|NCT01956669|65889724|FG003|Overall Study|Adverse Event|1|||
23590567|NCT01956669|65889725|FG004|Overall Study|Adverse Event|0|||
23590568|NCT01956669|65889726|FG005|Overall Study|Adverse Event|0|||
23590569|NCT01956669|65889727|FG006|Overall Study|Adverse Event|0|||
23590570|NCT01956669|65889721|FG000|Overall Study|Physician Decision|0|||
23590571|NCT01956669|65889722|FG001|Overall Study|Physician Decision|2|||
23590572|NCT01956669|65889723|FG002|Overall Study|Physician Decision|0|||
23590573|NCT01956669|65889724|FG003|Overall Study|Physician Decision|0|||
23590574|NCT01956669|65889725|FG004|Overall Study|Physician Decision|0|||
23590575|NCT01956669|65889726|FG005|Overall Study|Physician Decision|1|||
23590576|NCT01956669|65889727|FG006|Overall Study|Physician Decision|0|||
23590577|NCT01956669|65889721|FG000|Overall Study|Withdrawal by Subject|0|||
23590578|NCT01956669|65889722|FG001|Overall Study|Withdrawal by Subject|0|||
23590579|NCT01956669|65889723|FG002|Overall Study|Withdrawal by Subject|1|||
23590580|NCT01956669|65889724|FG003|Overall Study|Withdrawal by Subject|1|||
23590581|NCT01956669|65889725|FG004|Overall Study|Withdrawal by Subject|0|||
23590582|NCT01956669|65889726|FG005|Overall Study|Withdrawal by Subject|0|||
23590583|NCT01956669|65889727|FG006|Overall Study|Withdrawal by Subject|1|||
23590584|NCT02412748|65889736|FG000|Overall Study|Lost to Follow-up|38|||
23590585|NCT02412748|65889737|FG001|Overall Study|Lost to Follow-up|39|||
23590586|NCT01111526|65889740|FG000|Overall Study|GVHD Disease Progression|0|||
23590587|NCT01111526|65889741|FG001|Overall Study|GVHD Disease Progression|1|||
23590588|NCT01111526|65889742|FG002|Overall Study|GVHD Disease Progression|2|||
23590589|NCT00079183|65889749|FG000|Overall Study|Withdrawal by Subject|4|||
23590590|NCT00079183|65889749|FG000|Overall Study|Study medication non-compliance|2|||
23590591|NCT00079183|65889749|FG000|Overall Study|Specimen collection non-compliance|1|||
23590592|NCT00746330|65892787|FG000|Period 1|Abnormal test procedure result|0|||
23590593|NCT00746330|65892788|FG001|Period 1|Abnormal test procedure result|0|||
23590594|NCT00746330|65892789|FG002|Period 1|Abnormal test procedure result|1|||
23590595|NCT00746330|65892790|FG003|Period 1|Abnormal test procedure result|0|||
23590596|NCT00102063|65892791|FG000|Overall Study|Lack of Efficacy|5|||
23590597|NCT00102063|65892792|FG001|Overall Study|Lack of Efficacy|1|||
23590598|NCT00102063|65892793|FG002|Overall Study|Lack of Efficacy|1|||
23590599|NCT00102063|65892791|FG000|Overall Study|Adverse Event|7|||
23590600|NCT00102063|65892792|FG001|Overall Study|Adverse Event|4|||
23590601|NCT00102063|65892793|FG002|Overall Study|Adverse Event|2|||
23590602|NCT00102063|65892791|FG000|Overall Study|Withdrawal by Subject|4|||
23798404|NCT00351351|66637012|FG001|Overall Study|surgical access pbs; device issues|4|||
23476209|NCT00926029|65488016|FG001|Overall Study|Lost to Follow-up|1|||
23590603|NCT00102063|65892792|FG001|Overall Study|Withdrawal by Subject|12|||
23798405|NCT03539458|66637015|FG000|Overall Study|Death|1|||
23590604|NCT00102063|65892793|FG002|Overall Study|Withdrawal by Subject|5|||
23590605|NCT00102063|65892791|FG000|Overall Study|Lost to Follow-up|0|||
23590606|NCT00102063|65892792|FG001|Overall Study|Lost to Follow-up|0|||
23798406|NCT01376037|66637016|FG000|Overall Study|Lost to Follow-up|0|||
23798407|NCT01376037|66637017|FG001|Overall Study|Lost to Follow-up|2|||
23590607|NCT00102063|65892793|FG002|Overall Study|Lost to Follow-up|1|||
23590608|NCT00102063|65892791|FG000|Overall Study|Protocol Violation|0|||
23590609|NCT00102063|65892792|FG001|Overall Study|Protocol Violation|1|||
23590610|NCT00102063|65892793|FG002|Overall Study|Protocol Violation|1|||
23590611|NCT03201562|65892794|FG000|Overall Study|Physician Decision|0|||
23590612|NCT03201562|65892795|FG001|Overall Study|Physician Decision|0|||
23798408|NCT03547635|66639945|FG000|Overall Study|Adverse Event|5|||
23798409|NCT03547635|66639946|FG001|Overall Study|Adverse Event|2|||
23590613|NCT03201562|65892796|FG002|Overall Study|Physician Decision|1|||
23590614|NCT03201562|65892794|FG000|Overall Study|Adverse Event|0|||
23590615|NCT03201562|65892795|FG001|Overall Study|Adverse Event|0|||
23590616|NCT03201562|65892796|FG002|Overall Study|Adverse Event|1|||
23590617|NCT03201562|65892794|FG000|Overall Study|Lost to Follow-up|0|||
23798410|NCT03547635|66639947|FG002|Overall Study|Adverse Event|3|||
23798411|NCT03547635|66639945|FG000|Overall Study|Lost to Follow-up|1|||
23798412|NCT03547635|66639946|FG001|Overall Study|Lost to Follow-up|3|||
23798413|NCT03547635|66639947|FG002|Overall Study|Lost to Follow-up|4|||
23798414|NCT03547635|66639945|FG000|Overall Study|Withdrawal by Subject|1|||
23798415|NCT03547635|66639946|FG001|Overall Study|Withdrawal by Subject|0|||
23798416|NCT03547635|66639947|FG002|Overall Study|Withdrawal by Subject|0|||
23798417|NCT03547635|66639945|FG000|Overall Study|Withdrawal By PI|0|||
23798418|NCT03547635|66639946|FG001|Overall Study|Withdrawal By PI|1|||
23798419|NCT03547635|66639947|FG002|Overall Study|Withdrawal By PI|0|||
23798420|NCT03547635|66639945|FG000|Overall Study|Withdrawal by Sponsor|0|||
23798421|NCT03547635|66639946|FG001|Overall Study|Withdrawal by Sponsor|0|||
23798422|NCT03547635|66639947|FG002|Overall Study|Withdrawal by Sponsor|1|||
23798423|NCT03547635|66639945|FG000|Overall Study|Errant Randomization before Treatment|0|||
23798424|NCT03547635|66639946|FG001|Overall Study|Errant Randomization before Treatment|1|||
23798425|NCT03547635|66639947|FG002|Overall Study|Errant Randomization before Treatment|0|||
23798426|NCT03547635|66639945|FG000|Overall Study|Withdrawal by Subject|1|||
23798427|NCT03547635|66639946|FG001|Overall Study|Withdrawal by Subject|0|||
23798428|NCT03547635|66639947|FG002|Overall Study|Withdrawal by Subject|0|||
23798429|NCT01363011|66639948|FG000|Main Study|Adverse Event|2|||
23798430|NCT01363011|66639949|FG001|Main Study|Adverse Event|3|||
23798431|NCT01363011|66639948|FG000|Main Study|Investigator's Discretion|1|||
23798432|NCT01363011|66639949|FG001|Main Study|Investigator's Discretion|1|||
23798433|NCT01363011|66639948|FG000|Main Study|Withdrew Consent|1|||
23798434|NCT01363011|66639949|FG001|Main Study|Withdrew Consent|4|||
23798435|NCT01363011|66639948|FG000|Main Study|Protocol Violation|0|||
23798436|NCT01363011|66639949|FG001|Main Study|Protocol Violation|1|||
23798437|NCT01363011|66639948|FG000|Extension Phase|Adverse Event|1|||
23798438|NCT01363011|66639949|FG001|Extension Phase|Adverse Event|1|||
23798439|NCT01363011|66639948|FG000|Extension Phase|Lack of Efficacy|0|||
23798440|NCT01363011|66639949|FG001|Extension Phase|Lack of Efficacy|1|||
23798441|NCT01363011|66639948|FG000|Extension Phase|Investigator's Discretion|2|||
23798442|NCT01363011|66639949|FG001|Extension Phase|Investigator's Discretion|2|||
23798443|NCT01363011|66639948|FG000|Extension Phase|Withdrew Consent|0|||
23798444|NCT01363011|66639949|FG001|Extension Phase|Withdrew Consent|1|||
23798445|NCT01363011|66639948|FG000|Extension Phase|Lost to Follow-up|0|||
23798446|NCT01363011|66639949|FG001|Extension Phase|Lost to Follow-up|2|||
23798447|NCT01363011|66639948|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
23798448|NCT01363011|66639949|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
23798449|NCT00097786|66639950|FG000|Overall Study|lost to follow-up for all-cause death|296|||
23798450|NCT00097786|66639951|FG001|Overall Study|lost to follow-up for all-cause death|292|||
23798451|NCT00097786|66639952|FG002|Overall Study|lost to follow-up for all-cause death|313|||
23798452|NCT00097786|66639953|FG003|Overall Study|lost to follow-up for all-cause death|310|||
23798453|NCT02278718|66639956|FG000|Overall Study|Adverse Event|1|||
23798454|NCT02278718|66639957|FG001|Overall Study|Adverse Event|0|||
23798455|NCT02278718|66639956|FG000|Overall Study|Lost to Follow-up|2|||
23798456|NCT02278718|66639957|FG001|Overall Study|Lost to Follow-up|4|||
23798457|NCT02278718|66639956|FG000|Overall Study|Withdrawal by Subject|1|||
23798458|NCT02278718|66639957|FG001|Overall Study|Withdrawal by Subject|4|||
23590618|NCT03201562|65892795|FG001|Overall Study|Lost to Follow-up|1|||
23590619|NCT03201562|65892796|FG002|Overall Study|Lost to Follow-up|2|||
23590620|NCT03546907|65892797|FG000|Overall Study|Lack of Efficacy|1|||
23798459|NCT02278718|66639956|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
23590621|NCT03546907|65892798|FG001|Overall Study|Lack of Efficacy|1|||
23590622|NCT03546907|65892797|FG000|Overall Study|Withdrawal by Subject|8|||
23590623|NCT03546907|65892798|FG001|Overall Study|Withdrawal by Subject|9|||
23798460|NCT02278718|66639957|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
23798461|NCT02278718|66639956|FG000|Overall Study|Missing|0|||
23798462|NCT02278718|66639957|FG001|Overall Study|Missing|1|||
23798463|NCT01355302|66639958|FG000|Phase 1b|Death|4|||
23798464|NCT01355302|66639959|FG001|Phase 1b|Death|0|||
23798465|NCT01355302|66639960|FG002|Phase 1b|Death|0|||
23798466|NCT01355302|66639958|FG000|Phase 1b|Study terminated by sponsor|2|||
23798467|NCT01355302|66639959|FG001|Phase 1b|Study terminated by sponsor|0|||
23798468|NCT01355302|66639960|FG002|Phase 1b|Study terminated by sponsor|0|||
23798469|NCT00035555|66639961|FG000|Overall Study|Adverse Event|5|||
23798470|NCT00035555|66639962|FG001|Overall Study|Adverse Event|8|||
23798471|NCT00035555|66639963|FG002|Overall Study|Adverse Event|9|||
23798472|NCT00035555|66639961|FG000|Overall Study|Allograft loss|1|||
23798473|NCT00035555|66639962|FG001|Overall Study|Allograft loss|1|||
23798474|NCT00035555|66639963|FG002|Overall Study|Allograft loss|2|||
23476210|NCT00926029|65488017|FG002|Overall Study|Lost to Follow-up|1|||
23476211|NCT04255394|65488025|FG000|Overall Study|Death|35|||
23476212|NCT04255394|65488026|FG001|Overall Study|Death|25|||
23476213|NCT04255394|65488025|FG000|Overall Study|Device removed|2|||
23476214|NCT04255394|65488026|FG001|Overall Study|Device removed|10|||
23476215|NCT04255394|65488025|FG000|Overall Study|Withdrawal by Subject|9|||
23476216|NCT04255394|65488026|FG001|Overall Study|Withdrawal by Subject|8|||
23476217|NCT04255394|65488025|FG000|Overall Study|Screen Failure/Not treated|12|||
23476218|NCT04255394|65488026|FG001|Overall Study|Screen Failure/Not treated|8|||
23476219|NCT04255394|65488025|FG000|Overall Study|Lost to Follow-up|123|||
23476220|NCT04255394|65488026|FG001|Overall Study|Lost to Follow-up|265|||
23590624|NCT03546907|65892797|FG000|Overall Study|Adverse events (AEs)|7|||
23590625|NCT03546907|65892798|FG001|Overall Study|Adverse events (AEs)|10|||
23590626|NCT03546907|65892797|FG000|Overall Study|Other-unspecified|1|||
23590627|NCT03546907|65892798|FG001|Overall Study|Other-unspecified|1|||
23590628|NCT00588666|65892799|FG000|Overall Study|Adverse Event|4|||
23590629|NCT02274493|65892802|FG000|Overall Study|Withdrawal by Subject|1|||
23590630|NCT01802632|65892803|FG000|Overall Study|Death|28|||
23590631|NCT01802632|65892804|FG001|Overall Study|Death|1|||
23798475|NCT00035555|66639961|FG000|Overall Study|Death|0|||
23590632|NCT01802632|65892805|FG002|Overall Study|Death|38|||
23798476|NCT00035555|66639962|FG001|Overall Study|Death|0|||
23798477|NCT00035555|66639963|FG002|Overall Study|Death|2|||
23798478|NCT00035555|66639961|FG000|Overall Study|Lost to Follow-up|0|||
23798479|NCT00035555|66639962|FG001|Overall Study|Lost to Follow-up|0|||
23476221|NCT04255394|65488025|FG000|Overall Study|Adverse Event|1|||
23476222|NCT04255394|65488026|FG001|Overall Study|Adverse Event|3|||
23476223|NCT00282347|65488028|FG000|Treatment Period|Death|2|||
23476224|NCT00282347|65488029|FG001|Treatment Period|Death|0|||
23798480|NCT00035555|66639963|FG002|Overall Study|Lost to Follow-up|1|||
23590633|NCT01802632|65892806|FG003|Overall Study|Death|0|||
23590634|NCT01802632|65892807|FG004|Overall Study|Death|2|||
23590635|NCT01802632|65892808|FG005|Overall Study|Death|0|||
23590636|NCT01802632|65892803|FG000|Overall Study|Withdrawal by Subject|4|||
23590637|NCT01802632|65892804|FG001|Overall Study|Withdrawal by Subject|2|||
23590638|NCT01802632|65892805|FG002|Overall Study|Withdrawal by Subject|7|||
23590639|NCT01802632|65892806|FG003|Overall Study|Withdrawal by Subject|3|||
23590640|NCT01802632|65892807|FG004|Overall Study|Withdrawal by Subject|0|||
23590641|NCT01802632|65892808|FG005|Overall Study|Withdrawal by Subject|1|||
23590642|NCT01802632|65892803|FG000|Overall Study|Objective Disease Progression|1|||
23590643|NCT01802632|65892804|FG001|Overall Study|Objective Disease Progression|12|||
23590644|NCT01802632|65892805|FG002|Overall Study|Objective Disease Progression|104|||
23590645|NCT01802632|65892806|FG003|Overall Study|Objective Disease Progression|6|||
23590646|NCT01802632|65892807|FG004|Overall Study|Objective Disease Progression|4|||
23590647|NCT01802632|65892808|FG005|Overall Study|Objective Disease Progression|4|||
23590648|NCT01802632|65892803|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
23590649|NCT01802632|65892804|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
23590650|NCT01802632|65892805|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
23590651|NCT01802632|65892806|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
23590652|NCT01802632|65892807|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
23590653|NCT01802632|65892808|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
23590654|NCT01802632|65892803|FG000|Overall Study|Other (not specified)|0|||
23590655|NCT01802632|65892804|FG001|Overall Study|Other (not specified)|0|||
23590656|NCT01802632|65892805|FG002|Overall Study|Other (not specified)|7|||
23590657|NCT01802632|65892806|FG003|Overall Study|Other (not specified)|1|||
23590658|NCT01802632|65892807|FG004|Overall Study|Other (not specified)|0|||
23590659|NCT01802632|65892808|FG005|Overall Study|Other (not specified)|1|||
23590660|NCT02631148|65892811|FG000|Overall Study|8 were ineligible|8|||
23590661|NCT02631148|65892812|FG001|Overall Study|8 were ineligible|0|||
23590662|NCT02631148|65892811|FG000|Overall Study|Withdrawal by Subject|1|||
23590663|NCT02631148|65892812|FG001|Overall Study|Withdrawal by Subject|0|||
23590664|NCT02631148|65892811|FG000|Overall Study|PAH not available to study participant|1|||
23590665|NCT02631148|65892812|FG001|Overall Study|PAH not available to study participant|0|||
23590666|NCT00028769|65892815|FG000|Overall Study|Adverse Event|2|||
23590667|NCT00028769|65892815|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
23590668|NCT00028769|65892815|FG000|Overall Study|Progression or Death|31|||
23590669|NCT00028769|65892815|FG000|Overall Study|Other - Not Protocol Specified|1|||
23590670|NCT00028769|65892815|FG000|Overall Study|Ineligible|5|||
23590671|NCT00028769|65892815|FG000|Overall Study|Not Analyzable|1|||
23590672|NCT00486330|65892827|FG000|Overall Study|Adverse Event|2|||
23590673|NCT01490086|65892828|FG000|Overall Study|Consent withdrawn|4|||
23590674|NCT01490086|65892829|FG001|Overall Study|Consent withdrawn|4|||
23590675|NCT01490086|65892830|FG002|Overall Study|Consent withdrawn|3|||
23590676|NCT01490086|65892831|FG003|Overall Study|Consent withdrawn|0|||
23590677|NCT01490086|65892832|FG004|Overall Study|Consent withdrawn|1|||
23590678|NCT01490086|65892828|FG000|Overall Study|Non-compliance|0|||
23590679|NCT01490086|65892829|FG001|Overall Study|Non-compliance|1|||
23590680|NCT01490086|65892830|FG002|Overall Study|Non-compliance|0|||
23590681|NCT01490086|65892831|FG003|Overall Study|Non-compliance|0|||
23590682|NCT01490086|65892832|FG004|Overall Study|Non-compliance|0|||
23590683|NCT01490086|65892828|FG000|Overall Study|Abnormal laboratory findings|1|||
23590684|NCT01490086|65892829|FG001|Overall Study|Abnormal laboratory findings|0|||
23590685|NCT01490086|65892830|FG002|Overall Study|Abnormal laboratory findings|0|||
23590686|NCT01490086|65892831|FG003|Overall Study|Abnormal laboratory findings|0|||
23590687|NCT01490086|65892832|FG004|Overall Study|Abnormal laboratory findings|0|||
23590688|NCT01490086|65892828|FG000|Overall Study|Lost to Follow-up|0|||
23590689|NCT01490086|65892829|FG001|Overall Study|Lost to Follow-up|0|||
23590690|NCT01490086|65892830|FG002|Overall Study|Lost to Follow-up|0|||
23590691|NCT01490086|65892831|FG003|Overall Study|Lost to Follow-up|0|||
23590692|NCT01490086|65892832|FG004|Overall Study|Lost to Follow-up|1|||
23590693|NCT01490086|65892828|FG000|Overall Study|Physician Decision|3|||
23590694|NCT01490086|65892829|FG001|Overall Study|Physician Decision|4|||
23590695|NCT01490086|65892830|FG002|Overall Study|Physician Decision|2|||
23590696|NCT01490086|65892831|FG003|Overall Study|Physician Decision|3|||
23590697|NCT01490086|65892832|FG004|Overall Study|Physician Decision|1|||
23590698|NCT01490086|65892828|FG000|Overall Study|Adverse Event|0|||
23590699|NCT01490086|65892829|FG001|Overall Study|Adverse Event|0|||
23590700|NCT01490086|65892830|FG002|Overall Study|Adverse Event|1|||
23590701|NCT01490086|65892831|FG003|Overall Study|Adverse Event|2|||
23590702|NCT01490086|65892832|FG004|Overall Study|Adverse Event|0|||
23590703|NCT01490086|65892828|FG000|Overall Study|Lack of Efficacy|0|||
23590704|NCT01490086|65892829|FG001|Overall Study|Lack of Efficacy|3|||
23590705|NCT01490086|65892830|FG002|Overall Study|Lack of Efficacy|1|||
23590706|NCT01490086|65892831|FG003|Overall Study|Lack of Efficacy|0|||
23590707|NCT01490086|65892832|FG004|Overall Study|Lack of Efficacy|8|||
23590708|NCT01490086|65892828|FG000|Overall Study|Worsening of symptoms|0|||
23590709|NCT01490086|65892829|FG001|Overall Study|Worsening of symptoms|1|||
23590710|NCT01490086|65892830|FG002|Overall Study|Worsening of symptoms|0|||
23590711|NCT01490086|65892831|FG003|Overall Study|Worsening of symptoms|1|||
23590712|NCT01490086|65892832|FG004|Overall Study|Worsening of symptoms|0|||
23590713|NCT01490086|65892828|FG000|Overall Study|Subject uncontrollable and abusive|0|||
23590714|NCT01490086|65892829|FG001|Overall Study|Subject uncontrollable and abusive|1|||
23590715|NCT01490086|65892830|FG002|Overall Study|Subject uncontrollable and abusive|0|||
23590716|NCT01490086|65892831|FG003|Overall Study|Subject uncontrollable and abusive|0|||
23590717|NCT01490086|65892832|FG004|Overall Study|Subject uncontrollable and abusive|0|||
23590718|NCT01490086|65892828|FG000|Overall Study|Subject left hospital|0|||
23590719|NCT01490086|65892829|FG001|Overall Study|Subject left hospital|1|||
23590720|NCT01490086|65892830|FG002|Overall Study|Subject left hospital|0|||
23590721|NCT01490086|65892831|FG003|Overall Study|Subject left hospital|1|||
23590722|NCT01490086|65892832|FG004|Overall Study|Subject left hospital|0|||
23590723|NCT02202499|65892836|FG000|Overall Study|Cancer diagnosis|0|||
23590724|NCT02202499|65892837|FG001|Overall Study|Cancer diagnosis|0|||
23590725|NCT02202499|65892838|FG002|Overall Study|Cancer diagnosis|1|||
23590726|NCT02202499|65892836|FG000|Overall Study|Moved from area|0|||
23590727|NCT02202499|65892837|FG001|Overall Study|Moved from area|0|||
23590728|NCT02202499|65892838|FG002|Overall Study|Moved from area|1|||
23590729|NCT02202499|65892836|FG000|Overall Study|Declined before randomization|1|||
23590730|NCT02202499|65892837|FG001|Overall Study|Declined before randomization|0|||
23590731|NCT02202499|65892838|FG002|Overall Study|Declined before randomization|0|||
23590732|NCT02202499|65892836|FG000|Overall Study|Auto accident|1|||
23590733|NCT02202499|65892837|FG001|Overall Study|Auto accident|0|||
23590734|NCT02202499|65892838|FG002|Overall Study|Auto accident|0|||
23590735|NCT01157182|65892849|FG000|Washout of 28 Days|Adverse Event|2|||
23590736|NCT01157182|65892850|FG001|Washout of 28 Days|Adverse Event|0|||
23590737|NCT00545077|65892852|FG000|Overall Study|Treatment not received|5|||
23590738|NCT00545077|65892853|FG001|Overall Study|Treatment not received|1|||
23590739|NCT00545077|65892852|FG000|Overall Study|Disease Progression|131|||
23590740|NCT00545077|65892853|FG001|Overall Study|Disease Progression|98|||
23590741|NCT00545077|65892852|FG000|Overall Study|Withdrawal by Subject|3|||
23590742|NCT00545077|65892853|FG001|Overall Study|Withdrawal by Subject|14|||
23590743|NCT00545077|65892852|FG000|Overall Study|Physician Decision|6|||
23590744|NCT00545077|65892853|FG001|Overall Study|Physician Decision|3|||
23590745|NCT00545077|65892852|FG000|Overall Study|Lost to Follow-up|2|||
23590746|NCT00545077|65892853|FG001|Overall Study|Lost to Follow-up|0|||
23590747|NCT00545077|65892852|FG000|Overall Study|Protocol Violation|1|||
23590748|NCT00545077|65892853|FG001|Overall Study|Protocol Violation|0|||
23590749|NCT00545077|65892852|FG000|Overall Study|Adverse Event|0|||
23590750|NCT00545077|65892853|FG001|Overall Study|Adverse Event|31|||
23590751|NCT00545077|65892852|FG000|Overall Study|Death|0|||
23590752|NCT00545077|65892853|FG001|Overall Study|Death|8|||
23590753|NCT02937831|65892854|FG000|Overall Study|Protocol Violation|4|||
23590754|NCT00419094|65892861|FG000|Overall Study|Adverse Event|3|||
23590755|NCT00419094|65892862|FG001|Overall Study|Adverse Event|7|||
23590756|NCT00419094|65892861|FG000|Overall Study|Lack of Efficacy|1|||
23590757|NCT00419094|65892862|FG001|Overall Study|Lack of Efficacy|0|||
23590758|NCT00419094|65892861|FG000|Overall Study|Lost to Follow-up|0|||
23590759|NCT00419094|65892862|FG001|Overall Study|Lost to Follow-up|2|||
23590760|NCT00419094|65892861|FG000|Overall Study|Protocol Violation|1|||
23590761|NCT00419094|65892862|FG001|Overall Study|Protocol Violation|14|||
23590762|NCT00419094|65892861|FG000|Overall Study|Withdrawal of consent|1|||
23590763|NCT00419094|65892862|FG001|Overall Study|Withdrawal of consent|5|||
23590764|NCT00419094|65892861|FG000|Overall Study|Other: Error determining exit criteria|1|||
23590765|NCT00419094|65892862|FG001|Overall Study|Other: Error determining exit criteria|0|||
23590766|NCT00419094|65892861|FG000|Overall Study|Other: Patient non-compliant|0|||
23590767|NCT00419094|65892862|FG001|Overall Study|Other: Patient non-compliant|1|||
23590768|NCT00419094|65892861|FG000|Overall Study|Other: No contact for extended period|0|||
23590769|NCT00419094|65892862|FG001|Overall Study|Other: No contact for extended period|1|||
23590770|NCT00101010|65892863|FG000|Overall Study|Physician Decision|1|||
23590771|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
23590772|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
23590773|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
23590774|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
23590775|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
23590776|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
23590777|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
23590778|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
23590779|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
23643838|NCT00996476|66079225|FG003|Overall Study|Adverse Event|0|||
23590780|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
23590781|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
23590782|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
23590783|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Death|7|||
23590784|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Death|4|||
23590785|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
23590786|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
23590787|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
23590788|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
23590789|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
23590790|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
23590791|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
23590792|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
23590793|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
23590794|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
23590795|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
23590796|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
23590797|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
23590798|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
23590799|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
23590800|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
23590801|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
23590802|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
23590803|NCT04480827|65892877|FG000|Overall Study|Adverse Event|0|||
23590804|NCT04480827|65892878|FG001|Overall Study|Adverse Event|0|||
23590805|NCT04480827|65892879|FG002|Overall Study|Adverse Event|0|||
23590806|NCT04480827|65892880|FG003|Overall Study|Adverse Event|0|||
23590807|NCT04480827|65892881|FG004|Overall Study|Adverse Event|0|||
23590808|NCT04480827|65892882|FG005|Overall Study|Adverse Event|1|||
23590809|NCT04480827|65892883|FG006|Overall Study|Adverse Event|0|||
23590810|NCT01883492|65892886|FG000|Overall Study|Lost to Follow-up|3|||
23590811|NCT01883492|65892887|FG001|Overall Study|Lost to Follow-up|4|||
23590812|NCT01883492|65892886|FG000|Overall Study|Surgery on contra-lateral hip|0|||
23590813|NCT01883492|65892887|FG001|Overall Study|Surgery on contra-lateral hip|1|||
23798481|NCT00035555|66639961|FG000|Overall Study|Noncompliance|0|||
23798482|NCT00035555|66639962|FG001|Overall Study|Noncompliance|1|||
23359806|NCT03061188|65062729|FG002|On Follow-up for 3 Years|Death|5|||
23359807|NCT03061188|65062730|FG003|On Follow-up for 3 Years|Death|4|||
23359808|NCT03061188|65062727|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359809|NCT03061188|65062728|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359810|NCT03061188|65062729|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359811|NCT03061188|65062730|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
23359812|NCT01462110|65062751|FG000|Overall Study|Adverse Event|1|||
23359813|NCT01462110|65062752|FG001|Overall Study|Adverse Event|0|||
23359814|NCT02020889|65062753|FG000|Overall Study|Adverse Event|0|||
23359815|NCT02020889|65062754|FG001|Overall Study|Adverse Event|1|||
23359816|NCT02020889|65062753|FG000|Overall Study|Lack of Efficacy|1|||
23359817|NCT02020889|65062754|FG001|Overall Study|Lack of Efficacy|0|||
23359818|NCT02020889|65062753|FG000|Overall Study|Lost to Follow-up|1|||
23359819|NCT02020889|65062754|FG001|Overall Study|Lost to Follow-up|0|||
23359820|NCT02020889|65062753|FG000|Overall Study|Physician Decision|2|||
23359821|NCT02020889|65062754|FG001|Overall Study|Physician Decision|0|||
23359822|NCT02020889|65062753|FG000|Overall Study|Withdrawal by Subject|3|||
23359823|NCT02020889|65062754|FG001|Overall Study|Withdrawal by Subject|2|||
23359824|NCT00520039|65062759|FG000|Overall Study|Exclusion criteria met at first visit|7|||
23590814|NCT01883492|65892886|FG000|Overall Study|Poor X-ray quality|7|||
23590815|NCT01883492|65892887|FG001|Overall Study|Poor X-ray quality|4|||
23590816|NCT01883492|65892886|FG000|Overall Study|Withdrawal by Subject|1|||
23643839|NCT00996476|66079226|FG004|Overall Study|Adverse Event|1|||
23798483|NCT00035555|66639963|FG002|Overall Study|Noncompliance|1|||
23798484|NCT00035555|66639961|FG000|Overall Study|Prohibited medication|1|||
23798485|NCT00035555|66639962|FG001|Overall Study|Prohibited medication|1|||
23798486|NCT00035555|66639963|FG002|Overall Study|Prohibited medication|0|||
23798487|NCT00035555|66639961|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
23798488|NCT00035555|66639962|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
23798489|NCT00035555|66639963|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
23798490|NCT00035555|66639961|FG000|Overall Study|Withdrawal by Subject|2|||
23359825|NCT00520039|65062760|FG001|Overall Study|Exclusion criteria met at first visit|5|||
23359826|NCT01404949|65062761|FG000|Overall Study|Not Treated|1|||
23359827|NCT00435461|65062762|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
23359828|NCT00435461|65062763|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
23359829|NCT00435461|65062764|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
23359830|NCT00435461|65062762|FG000|Overall Study|Protocol Violation|6|||
23359831|NCT00435461|65062763|FG001|Overall Study|Protocol Violation|9|||
23359832|NCT00435461|65062764|FG002|Overall Study|Protocol Violation|10|||
23359833|NCT00435461|65062762|FG000|Overall Study|Participant randomized(inadequate score)|1|||
23359834|NCT00435461|65062763|FG001|Overall Study|Participant randomized(inadequate score)|0|||
23359835|NCT00435461|65062764|FG002|Overall Study|Participant randomized(inadequate score)|0|||
23359836|NCT00435461|65062762|FG000|Overall Study|Compliance less than 80 percent|1|||
23359837|NCT00435461|65062763|FG001|Overall Study|Compliance less than 80 percent|0|||
23359838|NCT00435461|65062764|FG002|Overall Study|Compliance less than 80 percent|0|||
23359839|NCT00435461|65062762|FG000|Overall Study|In error, two study medications switched|1|||
23359840|NCT00435461|65062763|FG001|Overall Study|In error, two study medications switched|0|||
23359841|NCT00435461|65062764|FG002|Overall Study|In error, two study medications switched|0|||
23359842|NCT00435461|65062762|FG000|Overall Study|Lack of Efficacy|2|||
23359843|NCT00435461|65062763|FG001|Overall Study|Lack of Efficacy|1|||
23359844|NCT00435461|65062764|FG002|Overall Study|Lack of Efficacy|0|||
23359845|NCT00435461|65062762|FG000|Overall Study|Withdrawal by Subject|1|||
23590817|NCT01883492|65892887|FG001|Overall Study|Withdrawal by Subject|0|||
23590818|NCT01883492|65892886|FG000|Overall Study|inappropriate implant used|1|||
23590819|NCT01883492|65892887|FG001|Overall Study|inappropriate implant used|1|||
23590820|NCT01883492|65892886|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
23590821|NCT01883492|65892887|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
23590822|NCT01184508|65892888|FG000|Overall Study|Adverse Event|4|||
23643840|NCT02101385|66079227|FG000|Study Treatment|Disease Progression|9|||
23643841|NCT02101385|66079228|FG001|Study Treatment|Disease Progression|3|||
23643842|NCT02101385|66079227|FG000|Study Treatment|Alternative therapy|0|||
23643843|NCT02101385|66079228|FG001|Study Treatment|Alternative therapy|1|||
23798491|NCT00035555|66639962|FG001|Overall Study|Withdrawal by Subject|0|||
23798492|NCT00035555|66639963|FG002|Overall Study|Withdrawal by Subject|2|||
23359846|NCT00435461|65062763|FG001|Overall Study|Withdrawal by Subject|0|||
23590823|NCT01184508|65892889|FG001|Overall Study|Adverse Event|6|||
23643844|NCT02101385|66079227|FG000|Study Treatment|No treatment, per protocol criteria|0|||
23643845|NCT02101385|66079228|FG001|Study Treatment|No treatment, per protocol criteria|4|||
23798493|NCT00035555|66639961|FG000|Overall Study|Investigator deemed not a good candidate|0|||
23798494|NCT00035555|66639962|FG001|Overall Study|Investigator deemed not a good candidate|0|||
23798495|NCT00035555|66639963|FG002|Overall Study|Investigator deemed not a good candidate|1|||
23798496|NCT00035555|66639961|FG000|Overall Study|Received cyclosporin in error|0|||
23798497|NCT00035555|66639962|FG001|Overall Study|Received cyclosporin in error|0|||
23798498|NCT00035555|66639963|FG002|Overall Study|Received cyclosporin in error|1|||
23798499|NCT00939627|66639968|FG000|Overall Study|Disease Progression|16|||
23798500|NCT00939627|66639969|FG001|Overall Study|Disease Progression|12|||
23798501|NCT00939627|66639970|FG002|Overall Study|Disease Progression|0|||
23798502|NCT00939627|66639968|FG000|Overall Study|Adverse Event|6|||
23798503|NCT00939627|66639969|FG001|Overall Study|Adverse Event|7|||
23798504|NCT00939627|66639970|FG002|Overall Study|Adverse Event|0|||
23798505|NCT00939627|66639968|FG000|Overall Study|Death|0|||
23798506|NCT00939627|66639969|FG001|Overall Study|Death|2|||
23798507|NCT00939627|66639970|FG002|Overall Study|Death|0|||
23798508|NCT00939627|66639968|FG000|Overall Study|Withdrawal by Subject|2|||
23798509|NCT00939627|66639969|FG001|Overall Study|Withdrawal by Subject|4|||
23798510|NCT00939627|66639970|FG002|Overall Study|Withdrawal by Subject|0|||
23798511|NCT00939627|66639968|FG000|Overall Study|Other complicating disease|1|||
23798512|NCT00939627|66639969|FG001|Overall Study|Other complicating disease|1|||
23590824|NCT01184508|65892888|FG000|Overall Study|Lack of Efficacy|1|||
23590825|NCT01184508|65892889|FG001|Overall Study|Lack of Efficacy|1|||
23590826|NCT01184508|65892888|FG000|Overall Study|Lost to Follow-up|1|||
23590827|NCT01184508|65892889|FG001|Overall Study|Lost to Follow-up|1|||
23590828|NCT01184508|65892888|FG000|Overall Study|Physician Decision|1|||
23590829|NCT01184508|65892889|FG001|Overall Study|Physician Decision|0|||
23590830|NCT01184508|65892888|FG000|Overall Study|Protocol Violation|3|||
23798513|NCT00939627|66639970|FG002|Overall Study|Other complicating disease|0|||
23590831|NCT01184508|65892889|FG001|Overall Study|Protocol Violation|1|||
23590832|NCT01184508|65892888|FG000|Overall Study|Sponsor Decision|5|||
23798514|NCT00939627|66639968|FG000|Overall Study|Not compliant|2|||
23798515|NCT00939627|66639969|FG001|Overall Study|Not compliant|0|||
23359847|NCT00435461|65062764|FG002|Overall Study|Withdrawal by Subject|2|||
23798516|NCT00939627|66639970|FG002|Overall Study|Not compliant|0|||
23643846|NCT02101385|66079227|FG000|Study Treatment|Patient Non compliance|0|||
23643847|NCT02101385|66079228|FG001|Study Treatment|Patient Non compliance|2|||
23643848|NCT02101385|66079227|FG000|Study Treatment|Withdrawal by Subject|5|||
23643849|NCT02101385|66079228|FG001|Study Treatment|Withdrawal by Subject|2|||
23643850|NCT02101385|66079227|FG000|Study Treatment|screen failure|1|||
23643851|NCT02101385|66079228|FG001|Study Treatment|screen failure|0|||
23643852|NCT02101385|66079227|FG000|Study Treatment|AE/Side Effects/Complications|8|||
23643853|NCT02101385|66079228|FG001|Study Treatment|AE/Side Effects/Complications|0|||
23643854|NCT02101385|66079227|FG000|Study Treatment|Lost to Follow-up|1|||
23643855|NCT02101385|66079228|FG001|Study Treatment|Lost to Follow-up|0|||
23643856|NCT02101385|66079227|FG000|Study Treatment|Disease Progression before treatment|1|||
23643857|NCT02101385|66079228|FG001|Study Treatment|Disease Progression before treatment|0|||
23643858|NCT02101385|66079227|FG000|Study Treatment|Death|1|||
23643859|NCT02101385|66079228|FG001|Study Treatment|Death|0|||
23643860|NCT02101385|66079227|FG000|Follow up|Lost to Follow-up|4|||
23643861|NCT02101385|66079228|FG001|Follow up|Lost to Follow-up|9|||
23359848|NCT00435461|65062762|FG000|Overall Study|Randomized in error|1|||
23359849|NCT00435461|65062763|FG001|Overall Study|Randomized in error|0|||
23359850|NCT00435461|65062764|FG002|Overall Study|Randomized in error|0|||
23359851|NCT00435461|65062762|FG000|Overall Study|Participant could not tolerate symptoms|0|||
23359852|NCT00435461|65062763|FG001|Overall Study|Participant could not tolerate symptoms|0|||
23359853|NCT00435461|65062764|FG002|Overall Study|Participant could not tolerate symptoms|1|||
23359854|NCT00435461|65062762|FG000|Overall Study|Participant could not swallow capsule|0|||
23359855|NCT00435461|65062763|FG001|Overall Study|Participant could not swallow capsule|0|||
23359856|NCT00435461|65062764|FG002|Overall Study|Participant could not swallow capsule|1|||
23359857|NCT00435461|65062762|FG000|Overall Study|Pregnancy|2|||
23359858|NCT00435461|65062763|FG001|Overall Study|Pregnancy|0|||
23359859|NCT00435461|65062764|FG002|Overall Study|Pregnancy|0|||
23359860|NCT00435461|65062762|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
23359861|NCT00435461|65062763|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
23359862|NCT00435461|65062764|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
23359863|NCT00435461|65062762|FG000|Overall Study|Participant ended study one day early|1|||
23359864|NCT00435461|65062763|FG001|Overall Study|Participant ended study one day early|0|||
23359865|NCT00435461|65062764|FG002|Overall Study|Participant ended study one day early|0|||
23359866|NCT00435461|65062762|FG000|Overall Study|Noncompliance with study requirements|1|||
23359867|NCT00435461|65062763|FG001|Overall Study|Noncompliance with study requirements|1|||
23359868|NCT00435461|65062764|FG002|Overall Study|Noncompliance with study requirements|1|||
23359869|NCT00435461|65062762|FG000|Overall Study|Adverse Event|1|||
23643862|NCT02101385|66079227|FG000|Follow up|Refused to follow up|5|||
23643863|NCT02101385|66079228|FG001|Follow up|Refused to follow up|4|||
23643864|NCT02101385|66079227|FG000|Follow up|Death|21|||
23643865|NCT02101385|66079228|FG001|Follow up|Death|39|||
23643866|NCT02101385|66079227|FG000|Follow up|study completed|33|||
23476225|NCT00282347|65488028|FG000|Treatment Period|Lost to Follow-up|2|||
23476226|NCT00282347|65488029|FG001|Treatment Period|Lost to Follow-up|5|||
23476227|NCT00282347|65488028|FG000|Treatment Period|Withdrawal by Subject|1|||
23476228|NCT00282347|65488029|FG001|Treatment Period|Withdrawal by Subject|3|||
23476229|NCT00282347|65488028|FG000|Treatment Period|Physician Decision|0|||
23476230|NCT00282347|65488029|FG001|Treatment Period|Physician Decision|1|||
23476231|NCT00282347|65488028|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
23476232|NCT00282347|65488029|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
23476233|NCT00282347|65488028|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
23476234|NCT00282347|65488029|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
23476235|NCT00282347|65488028|FG000|Safety Follow-up Period|Physician Decision|1|||
23476236|NCT00282347|65488029|FG001|Safety Follow-up Period|Physician Decision|1|||
23476237|NCT00282347|65488028|FG000|Safety Follow-up Period|Protocol Deviation|0|||
23476238|NCT00282347|65488029|FG001|Safety Follow-up Period|Protocol Deviation|2|||
23476239|NCT00282347|65488028|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
23476240|NCT00282347|65488029|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
23476241|NCT00282347|65488028|FG000|B Cell Follow-up Period|Physician Decision|1|||
23476242|NCT00282347|65488029|FG001|B Cell Follow-up Period|Physician Decision|0|||
23476243|NCT00282347|65488028|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
23476244|NCT00282347|65488029|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
23476245|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476246|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476247|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476248|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476249|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476250|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
23476251|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23798517|NCT00939627|66639968|FG000|Overall Study|No off-tx reason given|0|||
23798518|NCT00939627|66639969|FG001|Overall Study|No off-tx reason given|2|||
23798519|NCT00939627|66639970|FG002|Overall Study|No off-tx reason given|0|||
23798520|NCT03429049|66639971|FG000|Overall Study|Adverse Event|2|||
23798521|NCT03429049|66639972|FG001|Overall Study|Adverse Event|3|||
23798522|NCT03429049|66639971|FG000|Overall Study|Death|0|||
23798523|NCT03429049|66639972|FG001|Overall Study|Death|1|||
23798524|NCT03429049|66639971|FG000|Overall Study|Lack of Efficacy|4|||
23798525|NCT03429049|66639972|FG001|Overall Study|Lack of Efficacy|2|||
23798526|NCT03429049|66639971|FG000|Overall Study|Lost to Follow-up|9|||
23798527|NCT03429049|66639972|FG001|Overall Study|Lost to Follow-up|8|||
23798528|NCT03429049|66639971|FG000|Overall Study|Physician Decision|1|||
23798529|NCT03429049|66639972|FG001|Overall Study|Physician Decision|0|||
23798530|NCT03429049|66639971|FG000|Overall Study|Protocol Violation|3|||
23798531|NCT03429049|66639972|FG001|Overall Study|Protocol Violation|0|||
23798532|NCT03429049|66639971|FG000|Overall Study|Sponsor Decision|2|||
23798533|NCT03429049|66639972|FG001|Overall Study|Sponsor Decision|0|||
23798534|NCT03429049|66639971|FG000|Overall Study|Withdrawal by Subject|4|||
23798535|NCT03429049|66639972|FG001|Overall Study|Withdrawal by Subject|20|||
23798536|NCT03429049|66639971|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
23798537|NCT03429049|66639972|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
23798538|NCT02756637|66639973|FG000|Overall Study|Not eligible for initial SWOG study|10|||
23798539|NCT02756637|66639974|FG001|Overall Study|Not eligible for initial SWOG study|10|||
23798540|NCT02756637|66639973|FG000|Overall Study|No available NLR value|44|||
23798541|NCT02756637|66639974|FG001|Overall Study|No available NLR value|44|||
23798542|NCT02756637|66639973|FG000|Overall Study|Did not complete curative therapy|33|||
23798543|NCT02756637|66639974|FG001|Overall Study|Did not complete curative therapy|0|||
23798544|NCT01619579|66639978|FG000|Overall Study|Withdrawal by Subject|0|||
23798545|NCT01619579|66639979|FG001|Overall Study|Withdrawal by Subject|3|||
23798546|NCT00631007|66639980|FG000|Overall Study|Adverse Event|0|||
23798547|NCT00631007|66639981|FG001|Overall Study|Adverse Event|2|||
23798548|NCT00631007|66639982|FG002|Overall Study|Adverse Event|0|||
23798549|NCT00631007|66639983|FG003|Overall Study|Adverse Event|2|||
23798550|NCT00631007|66639984|FG004|Overall Study|Adverse Event|3|||
23798551|NCT00631007|66639985|FG005|Overall Study|Adverse Event|2|||
23476252|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23798552|NCT00631007|66639980|FG000|Overall Study|Lost to Follow-up|2|||
23798553|NCT00631007|66639981|FG001|Overall Study|Lost to Follow-up|1|||
23798554|NCT00631007|66639982|FG002|Overall Study|Lost to Follow-up|2|||
23798555|NCT00631007|66639983|FG003|Overall Study|Lost to Follow-up|4|||
23798556|NCT00631007|66639984|FG004|Overall Study|Lost to Follow-up|5|||
23798557|NCT00631007|66639985|FG005|Overall Study|Lost to Follow-up|3|||
23798558|NCT00631007|66639980|FG000|Overall Study|Physician Decision|1|||
23798559|NCT00631007|66639981|FG001|Overall Study|Physician Decision|0|||
23798560|NCT00631007|66639982|FG002|Overall Study|Physician Decision|1|||
23798561|NCT00631007|66639983|FG003|Overall Study|Physician Decision|0|||
23798562|NCT00631007|66639984|FG004|Overall Study|Physician Decision|0|||
23798563|NCT00631007|66639985|FG005|Overall Study|Physician Decision|2|||
23798564|NCT00631007|66639980|FG000|Overall Study|Persistent Hyperglycemia|2|||
23798565|NCT00631007|66639981|FG001|Overall Study|Persistent Hyperglycemia|2|||
23798566|NCT00631007|66639982|FG002|Overall Study|Persistent Hyperglycemia|5|||
23798567|NCT00631007|66639983|FG003|Overall Study|Persistent Hyperglycemia|1|||
23798568|NCT00631007|66639984|FG004|Overall Study|Persistent Hyperglycemia|2|||
23798569|NCT00631007|66639985|FG005|Overall Study|Persistent Hyperglycemia|5|||
23798570|NCT00631007|66639980|FG000|Overall Study|Withdrawal by Subject|4|||
23798571|NCT00631007|66639981|FG001|Overall Study|Withdrawal by Subject|5|||
23798572|NCT00631007|66639982|FG002|Overall Study|Withdrawal by Subject|2|||
23798573|NCT00631007|66639983|FG003|Overall Study|Withdrawal by Subject|2|||
23798574|NCT00631007|66639984|FG004|Overall Study|Withdrawal by Subject|1|||
23798575|NCT00631007|66639985|FG005|Overall Study|Withdrawal by Subject|3|||
23798576|NCT00631007|66639980|FG000|Overall Study|Other|2|||
23798577|NCT00631007|66639981|FG001|Overall Study|Other|1|||
23798578|NCT00631007|66639982|FG002|Overall Study|Other|0|||
23798579|NCT00631007|66639983|FG003|Overall Study|Other|0|||
23798580|NCT00631007|66639984|FG004|Overall Study|Other|1|||
23798581|NCT00631007|66639985|FG005|Overall Study|Other|0|||
23798582|NCT04106817|66639986|FG000|Overall Study|Lost to Follow-up|1|||
23798583|NCT04106817|66639987|FG001|Overall Study|Lost to Follow-up|0|||
23798584|NCT04106817|66639988|FG002|Overall Study|Lost to Follow-up|0|||
23798585|NCT04406194|66639989|FG000|Period 1|Withdrawal by Subject|0|||
23798586|NCT04406194|66639990|FG001|Period 1|Withdrawal by Subject|1|||
23798587|NCT01439724|66639991|FG000|Overall Study|missing consultation|9|||
23798588|NCT01439724|66639992|FG001|Overall Study|missing consultation|8|||
23798589|NCT01223235|66639997|FG000|Overall Study|Withdrawal by Subject|1|||
23798590|NCT00508027|66639998|FG000|Dose Level 1|Lost to Follow-up|4|||
23798591|NCT00508027|66639998|FG000|Dose Level 1|Withdrawal by Subject|2|||
23798592|NCT00508027|66639998|FG000|Dose Level 1|Physician Decision|2|||
23798593|NCT00508027|66639998|FG000|Dose Level 2|Lost to Follow-up|2|||
23798594|NCT00508027|66639998|FG000|Dose Level 2|Withdrawal by Subject|2|||
23798595|NCT01009515|66639999|FG000|Overall Study|Withdrawal by Subject|3|||
23798596|NCT01937351|66640000|FG000|Overall Study|Withdrawal by Subject|4|||
23798597|NCT01937351|66640001|FG001|Overall Study|Withdrawal by Subject|2|||
23798598|NCT01937351|66640000|FG000|Overall Study|Death|1|||
23798599|NCT01937351|66640001|FG001|Overall Study|Death|0|||
23798600|NCT01937351|66640000|FG000|Overall Study|Not treated w device, per protocol fail|4|||
23798601|NCT01937351|66640001|FG001|Overall Study|Not treated w device, per protocol fail|0|||
23798602|NCT03702049|66640004|FG000|Overall Study|Lost to Follow-up|4|||
23798603|NCT03702049|66640004|FG000|Overall Study|Physician Decision|1|||
23798604|NCT00784134|66640009|FG000|Overall Study|Lost to Follow-up|3|||
23798605|NCT00784134|66640010|FG001|Overall Study|Lost to Follow-up|6|||
23798606|NCT00171340|66640011|FG000|Overall Study|Adverse Event|46|||
23798607|NCT00171340|66640012|FG001|Overall Study|Adverse Event|42|||
23798608|NCT00171340|66640011|FG000|Overall Study|Lack of Efficacy|29|||
23798609|NCT00171340|66640012|FG001|Overall Study|Lack of Efficacy|41|||
23798610|NCT00171340|66640011|FG000|Overall Study|Protocol Violation|7|||
23798611|NCT00171340|66640012|FG001|Overall Study|Protocol Violation|8|||
23798612|NCT00171340|66640011|FG000|Overall Study|Withdrawal by Subject|22|||
23476253|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23798613|NCT00171340|66640012|FG001|Overall Study|Withdrawal by Subject|19|||
23798614|NCT00171340|66640011|FG000|Overall Study|Lost to Follow-up|0|||
23798615|NCT00171340|66640012|FG001|Overall Study|Lost to Follow-up|5|||
23798616|NCT00171340|66640011|FG000|Overall Study|Abnormal Laboratory Results|2|||
23798617|NCT00171340|66640012|FG001|Overall Study|Abnormal Laboratory Results|0|||
23798618|NCT00171340|66640011|FG000|Overall Study|Abnormal Test Procedure Results|6|||
23798619|NCT00171340|66640012|FG001|Overall Study|Abnormal Test Procedure Results|11|||
23798620|NCT00171340|66640011|FG000|Overall Study|No Longer Required Study Drug|1|||
23798621|NCT00171340|66640012|FG001|Overall Study|No Longer Required Study Drug|1|||
23798622|NCT00171340|66640011|FG000|Overall Study|Administrative Problems|5|||
23798623|NCT00171340|66640012|FG001|Overall Study|Administrative Problems|2|||
23798624|NCT00171340|66640011|FG000|Overall Study|Death|6|||
23359870|NCT00435461|65062763|FG001|Overall Study|Adverse Event|2|||
23359871|NCT00435461|65062764|FG002|Overall Study|Adverse Event|6|||
23359872|NCT00435461|65062762|FG000|Overall Study|Non-Compliance of diary|2|||
23359873|NCT00435461|65062763|FG001|Overall Study|Non-Compliance of diary|0|||
23359874|NCT00435461|65062764|FG002|Overall Study|Non-Compliance of diary|1|||
23359875|NCT00435461|65062762|FG000|Overall Study|Lost to Follow-up|1|||
23359876|NCT00435461|65062763|FG001|Overall Study|Lost to Follow-up|1|||
23359877|NCT00435461|65062764|FG002|Overall Study|Lost to Follow-up|2|||
23359878|NCT03810456|65062766|FG000|Treatment|Urgent Family Matters|3|||
23359879|NCT03810456|65062767|FG001|Treatment|Urgent Family Matters|0|||
23359880|NCT03810456|65062768|FG002|Treatment|Urgent Family Matters|0|||
23359881|NCT03810456|65062766|FG000|Treatment|Scheduling Conflicts|0|||
23359882|NCT03810456|65062767|FG001|Treatment|Scheduling Conflicts|11|||
23359883|NCT03810456|65062768|FG002|Treatment|Scheduling Conflicts|0|||
23359884|NCT03810456|65062766|FG000|Treatment|No Longer Interested|0|||
23359885|NCT03810456|65062767|FG001|Treatment|No Longer Interested|12|||
23643867|NCT02101385|66079228|FG001|Follow up|study completed|52|||
23643868|NCT02101385|66079227|FG000|Follow up|screen failure|2|||
23643869|NCT02101385|66079228|FG001|Follow up|screen failure|0|||
23643870|NCT02101385|66079227|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
23643871|NCT02101385|66079228|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
23643872|NCT02101385|66079227|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
23643873|NCT02101385|66079228|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
23643874|NCT02101385|66079227|FG000|Follow up|Withdrawal by Subject|2|||
23643875|NCT02101385|66079228|FG001|Follow up|Withdrawal by Subject|2|||
23643876|NCT02101385|66079227|FG000|Follow up|PI requested closure of site|0|||
23643877|NCT02101385|66079228|FG001|Follow up|PI requested closure of site|5|||
23643878|NCT05087979|66079229|FG000|Overall Study|Converted to general anesthesia|1|||
23643879|NCT05087979|66079230|FG001|Overall Study|Converted to general anesthesia|0|||
23643880|NCT01901341|66079232|FG000|Overall Study|Adverse Event|4|||
23643881|NCT01901341|66079233|FG001|Overall Study|Adverse Event|2|||
23643882|NCT01901341|66079232|FG000|Overall Study|Lack of Efficacy|0|||
23359886|NCT03810456|65062768|FG002|Treatment|No Longer Interested|0|||
23359887|NCT03810456|65062766|FG000|Treatment|Transportation Issues|0|||
23359888|NCT03810456|65062767|FG001|Treatment|Transportation Issues|1|||
23359889|NCT03810456|65062768|FG002|Treatment|Transportation Issues|0|||
23359890|NCT03810456|65062766|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
23359891|NCT03810456|65062767|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
23359892|NCT03810456|65062768|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
23359893|NCT03810456|65062766|FG000|1 Month Follow-Up|Relocated to Different State|1|||
23359894|NCT03810456|65062767|FG001|1 Month Follow-Up|Relocated to Different State|0|||
23643883|NCT01901341|66079233|FG001|Overall Study|Lack of Efficacy|2|||
23798625|NCT00171340|66640012|FG001|Overall Study|Death|6|||
23798626|NCT00595335|66640020|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
23798627|NCT00595335|66640021|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
23798628|NCT00595335|66640020|FG000|Baseline to Six Months|Disease Progression|1|||
23798629|NCT00595335|66640021|FG001|Baseline to Six Months|Disease Progression|1|||
23798630|NCT00595335|66640020|FG000|Baseline to Six Months|Adverse Event|1|||
23798631|NCT00595335|66640021|FG001|Baseline to Six Months|Adverse Event|0|||
23798632|NCT00595335|66640020|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
23798633|NCT00595335|66640021|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
23798634|NCT00595335|66640020|FG000|Six Months to Twelve Months|Disease Progression|1|||
23798635|NCT00595335|66640021|FG001|Six Months to Twelve Months|Disease Progression|0|||
23798636|NCT00104247|66640022|FG000|Overall Study|Withdrawal by Subject|1|||
23798637|NCT00104247|66640023|FG001|Overall Study|Withdrawal by Subject|0|||
23359895|NCT03810456|65062768|FG002|1 Month Follow-Up|Relocated to Different State|1|||
23359896|NCT03810456|65062766|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
23359897|NCT03810456|65062767|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
23359898|NCT03810456|65062768|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
23359899|NCT03810456|65062766|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
23359900|NCT03810456|65062767|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
23798638|NCT00104247|66640022|FG000|Overall Study|Noncompliant with dosing|0|||
23798639|NCT00104247|66640023|FG001|Overall Study|Noncompliant with dosing|1|||
23798640|NCT02466386|66640027|FG000|Overall Study|Adverse Event|5|||
23798641|NCT02466386|66640027|FG000|Overall Study|Protocol Violation|2|||
23798642|NCT02466386|66640027|FG000|Overall Study|Withdrawal by Subject|14|||
23798643|NCT02466386|66640027|FG000|Overall Study|Lost to Follow-up|5|||
23798644|NCT02466386|66640027|FG000|Overall Study|Lack of Efficacy|8|||
23798645|NCT02466386|66640027|FG000|Overall Study|Other|10|||
23798646|NCT03135899|66640032|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798647|NCT03135899|66640033|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798648|NCT03135899|66640034|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798649|NCT03135899|66640035|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798650|NCT03135899|66640036|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798651|NCT03135899|66640037|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
23798652|NCT03135899|66640038|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
23476254|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
23476255|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476256|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476257|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476258|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476259|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
23476260|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476261|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476262|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476263|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476264|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476265|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23590833|NCT01184508|65892889|FG001|Overall Study|Sponsor Decision|2|||
23590834|NCT01184508|65892888|FG000|Overall Study|Withdrawal by Subject|1|||
23590835|NCT01184508|65892889|FG001|Overall Study|Withdrawal by Subject|3|||
23590836|NCT01184508|65892888|FG000|Overall Study|Randomized, Not Treated|0|||
23590837|NCT01184508|65892889|FG001|Overall Study|Randomized, Not Treated|1|||
23590838|NCT01063517|65892890|FG000|Overall Study|Consent withdrawal|1|||
23590839|NCT01063517|65892891|FG001|Overall Study|Consent withdrawal|0|||
23590840|NCT01063517|65892890|FG000|Overall Study|Study reached data cut-off|19|||
23590841|NCT01063517|65892891|FG001|Overall Study|Study reached data cut-off|7|||
23590842|NCT01063517|65892890|FG000|Overall Study|Lost to Follow-up|4|||
23590843|NCT01063517|65892891|FG001|Overall Study|Lost to Follow-up|3|||
23590844|NCT01063517|65892890|FG000|Overall Study|Withdrawal by Subject|1|||
23590845|NCT01063517|65892891|FG001|Overall Study|Withdrawal by Subject|2|||
23590846|NCT01063517|65892890|FG000|Overall Study|Death|33|||
23643884|NCT01901341|66079232|FG000|Overall Study|Lost to Follow-up|0|||
23643885|NCT01901341|66079233|FG001|Overall Study|Lost to Follow-up|1|||
23643886|NCT01901341|66079232|FG000|Overall Study|Protocol Violation|2|||
23643887|NCT01901341|66079233|FG001|Overall Study|Protocol Violation|0|||
23643888|NCT01901341|66079232|FG000|Overall Study|Study Terminated by Sponsor|13|||
23476266|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
23476267|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
23590847|NCT01063517|65892891|FG001|Overall Study|Death|48|||
23590848|NCT05001945|65892892|FG000|Overall Study|Adverse Event|0|||
23590849|NCT05001945|65892893|FG001|Overall Study|Adverse Event|0|||
23590850|NCT05001945|65892894|FG002|Overall Study|Adverse Event|0|||
23359901|NCT03810456|65062768|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
23590851|NCT05001945|65892895|FG003|Overall Study|Adverse Event|1|||
23590852|NCT05001945|65892896|FG004|Overall Study|Adverse Event|0|||
23643889|NCT01901341|66079233|FG001|Overall Study|Study Terminated by Sponsor|15|||
23798653|NCT03135899|66640039|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
23359902|NCT03810456|65062766|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
23359903|NCT03810456|65062767|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
23359904|NCT03810456|65062768|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
23359905|NCT03810456|65062766|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
23359906|NCT03810456|65062767|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
23359907|NCT03810456|65062768|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
23359908|NCT03810456|65062766|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
23359909|NCT03810456|65062767|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
23476268|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
23359910|NCT03810456|65062768|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
23359911|NCT02149264|65062769|FG000|Overall Study|Withdrawal by Subject|9|||
23476269|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
23798654|NCT03135899|66640032|FG000|Overall Study|Withdrawal by Subject|0|||
23798655|NCT03135899|66640033|FG001|Overall Study|Withdrawal by Subject|0|||
23798656|NCT03135899|66640034|FG002|Overall Study|Withdrawal by Subject|0|||
23798657|NCT03135899|66640035|FG003|Overall Study|Withdrawal by Subject|0|||
23798658|NCT03135899|66640036|FG004|Overall Study|Withdrawal by Subject|0|||
23798659|NCT03135899|66640037|FG005|Overall Study|Withdrawal by Subject|2|||
23798660|NCT03135899|66640038|FG006|Overall Study|Withdrawal by Subject|0|||
23798661|NCT03135899|66640039|FG007|Overall Study|Withdrawal by Subject|0|||
23798662|NCT00517192|66640040|FG000|Overall Study|Adverse Event|1|||
23798663|NCT00517192|66640041|FG001|Overall Study|Adverse Event|1|||
23798664|NCT00517192|66640040|FG000|Overall Study|Lost to Follow-up|1|||
23798665|NCT00517192|66640041|FG001|Overall Study|Lost to Follow-up|1|||
23798666|NCT00517192|66640040|FG000|Overall Study|Withdrawal by Subject|1|||
23798667|NCT00517192|66640041|FG001|Overall Study|Withdrawal by Subject|0|||
23798668|NCT00517192|66640040|FG000|Overall Study|Early termination of the trial|16|||
23798669|NCT00517192|66640041|FG001|Overall Study|Early termination of the trial|18|||
23798670|NCT00763555|66640042|FG000|Overall Study|Adverse Event|2|||
23798671|NCT00763555|66640043|FG001|Overall Study|Adverse Event|1|||
23798672|NCT00763555|66640042|FG000|Overall Study|Withdrawal by Subject|2|||
23798673|NCT00763555|66640043|FG001|Overall Study|Withdrawal by Subject|6|||
23798674|NCT00763555|66640042|FG000|Overall Study|Lost to Follow-up|0|||
23798675|NCT00763555|66640043|FG001|Overall Study|Lost to Follow-up|3|||
23798676|NCT02576717|66640044|FG000|Overall Study|Other Reasons|16|||
23798677|NCT02576717|66640045|FG001|Overall Study|Other Reasons|18|||
23798678|NCT02576717|66640046|FG002|Overall Study|Other Reasons|15|||
23798679|NCT02576717|66640044|FG000|Overall Study|Covid-19 Pandemic|0|||
23798680|NCT02576717|66640045|FG001|Overall Study|Covid-19 Pandemic|1|||
23798681|NCT02576717|66640046|FG002|Overall Study|Covid-19 Pandemic|1|||
23798682|NCT02576717|66640044|FG000|Overall Study|Sponsor Decision|0|||
23798683|NCT02576717|66640045|FG001|Overall Study|Sponsor Decision|0|||
23798684|NCT02576717|66640046|FG002|Overall Study|Sponsor Decision|1|||
23798685|NCT02576717|66640044|FG000|Overall Study|Physician Decision|3|||
23798686|NCT02576717|66640045|FG001|Overall Study|Physician Decision|8|||
23798687|NCT02576717|66640046|FG002|Overall Study|Physician Decision|9|||
23798688|NCT02576717|66640044|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
23798689|NCT02576717|66640045|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
23798690|NCT02576717|66640046|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
23798691|NCT02576717|66640044|FG000|Overall Study|Death|3|||
23798692|NCT02576717|66640045|FG001|Overall Study|Death|5|||
23798693|NCT02576717|66640046|FG002|Overall Study|Death|3|||
23798694|NCT02576717|66640044|FG000|Overall Study|Lost to Follow-up|9|||
23798695|NCT02576717|66640045|FG001|Overall Study|Lost to Follow-up|10|||
23798696|NCT02576717|66640046|FG002|Overall Study|Lost to Follow-up|19|||
23590853|NCT05001945|65892897|FG005|Overall Study|Adverse Event|0|||
23590854|NCT05001945|65892898|FG006|Overall Study|Adverse Event|0|||
23590855|NCT05001945|65892899|FG007|Overall Study|Adverse Event|0|||
23590856|NCT05001945|65892892|FG000|Overall Study|Lost to Follow-up|0|||
23590857|NCT05001945|65892893|FG001|Overall Study|Lost to Follow-up|1|||
23590858|NCT05001945|65892894|FG002|Overall Study|Lost to Follow-up|1|||
23590859|NCT05001945|65892895|FG003|Overall Study|Lost to Follow-up|2|||
23590860|NCT05001945|65892896|FG004|Overall Study|Lost to Follow-up|0|||
23590861|NCT05001945|65892897|FG005|Overall Study|Lost to Follow-up|1|||
23590862|NCT05001945|65892898|FG006|Overall Study|Lost to Follow-up|0|||
23590863|NCT05001945|65892899|FG007|Overall Study|Lost to Follow-up|0|||
23590864|NCT05001945|65892892|FG000|Overall Study|Protocol Violation|1|||
23590865|NCT05001945|65892893|FG001|Overall Study|Protocol Violation|0|||
23590866|NCT05001945|65892894|FG002|Overall Study|Protocol Violation|1|||
23590867|NCT05001945|65892895|FG003|Overall Study|Protocol Violation|1|||
23590868|NCT05001945|65892896|FG004|Overall Study|Protocol Violation|0|||
23590869|NCT05001945|65892897|FG005|Overall Study|Protocol Violation|1|||
23590870|NCT05001945|65892898|FG006|Overall Study|Protocol Violation|0|||
23590871|NCT05001945|65892899|FG007|Overall Study|Protocol Violation|0|||
23359912|NCT02149264|65062769|FG000|Overall Study|Adverse Event|7|||
23359913|NCT02149264|65062769|FG000|Overall Study|Physician Decision|3|||
23359914|NCT02149264|65062769|FG000|Overall Study|Protocol Violation|1|||
23359915|NCT01051557|65062770|FG000|Overall Study|Physician Decision|1|||
23359916|NCT01051557|65062771|FG001|Overall Study|Physician Decision|0|||
23359917|NCT01051557|65062772|FG002|Overall Study|Physician Decision|0|||
23359918|NCT01051557|65062773|FG003|Overall Study|Physician Decision|0|||
23359919|NCT01051557|65062774|FG004|Overall Study|Physician Decision|0|||
23590872|NCT05001945|65892892|FG000|Overall Study|Withdrawal by Subject|0|||
23590873|NCT05001945|65892893|FG001|Overall Study|Withdrawal by Subject|0|||
23590874|NCT05001945|65892894|FG002|Overall Study|Withdrawal by Subject|0|||
23590875|NCT05001945|65892895|FG003|Overall Study|Withdrawal by Subject|1|||
23590876|NCT05001945|65892896|FG004|Overall Study|Withdrawal by Subject|1|||
23590877|NCT05001945|65892897|FG005|Overall Study|Withdrawal by Subject|1|||
23590878|NCT05001945|65892898|FG006|Overall Study|Withdrawal by Subject|0|||
23590879|NCT05001945|65892899|FG007|Overall Study|Withdrawal by Subject|1|||
23590880|NCT05001945|65892892|FG000|Overall Study|Not specified by Investigator|0|||
23590881|NCT05001945|65892893|FG001|Overall Study|Not specified by Investigator|3|||
23590882|NCT05001945|65892894|FG002|Overall Study|Not specified by Investigator|0|||
23590883|NCT05001945|65892895|FG003|Overall Study|Not specified by Investigator|0|||
23590884|NCT05001945|65892896|FG004|Overall Study|Not specified by Investigator|1|||
23590885|NCT05001945|65892897|FG005|Overall Study|Not specified by Investigator|0|||
23590886|NCT05001945|65892898|FG006|Overall Study|Not specified by Investigator|0|||
23590887|NCT05001945|65892899|FG007|Overall Study|Not specified by Investigator|0|||
23590888|NCT02393716|65892900|FG000|Overall Study|Death|29|||
23590889|NCT02393716|65892900|FG000|Overall Study|Withdrawal by Subject|8|||
23590890|NCT02393716|65892900|FG000|Overall Study|Device Explanted|8|||
23590891|NCT02393716|65892900|FG000|Overall Study|Missed visit|16|||
23590892|NCT03923491|65892901|FG000|Overall Study|Lost to Follow-up|5|||
23590893|NCT03923491|65892902|FG001|Overall Study|Lost to Follow-up|8|||
23590894|NCT03923491|65892901|FG000|Overall Study|Withdrawal by Subject|4|||
23590895|NCT03923491|65892902|FG001|Overall Study|Withdrawal by Subject|6|||
23590896|NCT04594759|65892903|FG000|Overall Study|Lost to Follow-up|3|||
23590897|NCT00711958|65892904|FG000|Overall Study|Withdrawal by Subject|6|||
23590898|NCT00711958|65892905|FG001|Overall Study|Withdrawal by Subject|8|||
23798697|NCT02576717|66640044|FG000|Overall Study|Protocol Violation|4|||
23798698|NCT02576717|66640045|FG001|Overall Study|Protocol Violation|0|||
23798699|NCT02576717|66640046|FG002|Overall Study|Protocol Violation|5|||
23798700|NCT02576717|66640044|FG000|Overall Study|Lack of Efficacy|24|||
23798701|NCT02576717|66640045|FG001|Overall Study|Lack of Efficacy|28|||
23798702|NCT02576717|66640046|FG002|Overall Study|Lack of Efficacy|20|||
23798703|NCT02576717|66640044|FG000|Overall Study|Adverse Event|26|||
23798704|NCT02576717|66640045|FG001|Overall Study|Adverse Event|32|||
23798705|NCT02576717|66640046|FG002|Overall Study|Adverse Event|26|||
23798706|NCT04276935|66640049|FG000|Overall Study|Lost to Follow-up|3|||
23798707|NCT00399893|66640050|FG000|Overall Study|Withdrawal by Subject|1|||
23798708|NCT00399893|66640051|FG001|Overall Study|Withdrawal by Subject|0|||
23798709|NCT03701763|66640052|FG000|Placebo-controlled Phase|Adverse Event|1|||
23798710|NCT03701763|66640053|FG001|Placebo-controlled Phase|Adverse Event|5|||
23798711|NCT03701763|66640054|FG002|Placebo-controlled Phase|Adverse Event|0|||
23798712|NCT03701763|66640055|FG003|Placebo-controlled Phase|Adverse Event|0|||
23798713|NCT03701763|66640052|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
23798714|NCT03701763|66640053|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
23798715|NCT03701763|66640054|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23359920|NCT01051557|65062775|FG005|Overall Study|Physician Decision|0|||
23359921|NCT01051557|65062776|FG006|Overall Study|Physician Decision|0|||
23476270|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
23590899|NCT00711958|65892904|FG000|Overall Study|Lack of Efficacy|3|||
23798716|NCT03701763|66640055|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
23590900|NCT00711958|65892905|FG001|Overall Study|Lack of Efficacy|1|||
23590901|NCT00711958|65892904|FG000|Overall Study|Clinical deterioration|1|||
23590902|NCT00711958|65892905|FG001|Overall Study|Clinical deterioration|0|||
23590903|NCT00711958|65892904|FG000|Overall Study|Adverse Event|9|||
23590904|NCT00711958|65892905|FG001|Overall Study|Adverse Event|7|||
23590905|NCT00711958|65892904|FG000|Overall Study|Protocol Violation|1|||
23590906|NCT00711958|65892905|FG001|Overall Study|Protocol Violation|0|||
23590907|NCT00711958|65892904|FG000|Overall Study|Lost to Follow-up|2|||
23590908|NCT00711958|65892905|FG001|Overall Study|Lost to Follow-up|2|||
23590909|NCT00711958|65892904|FG000|Overall Study|Death|10|||
23590910|NCT00711958|65892905|FG001|Overall Study|Death|5|||
23798717|NCT03701763|66640052|FG000|Placebo-controlled Phase|Miscellaneous|2|||
23798718|NCT03701763|66640053|FG001|Placebo-controlled Phase|Miscellaneous|0|||
23798719|NCT03701763|66640054|FG002|Placebo-controlled Phase|Miscellaneous|0|||
23798720|NCT03701763|66640055|FG003|Placebo-controlled Phase|Miscellaneous|0|||
23798721|NCT03701763|66640052|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
23798722|NCT03701763|66640053|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
23798723|NCT03701763|66640054|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
23798724|NCT03701763|66640055|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
23798725|NCT03701763|66640052|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
23798726|NCT03701763|66640053|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
23798727|NCT03701763|66640054|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23798728|NCT03701763|66640055|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
23798729|NCT03701763|66640052|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
23798730|NCT03701763|66640053|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
23798731|NCT03701763|66640054|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23798732|NCT03701763|66640055|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
23798733|NCT03701763|66640052|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23798734|NCT03701763|66640053|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23798735|NCT03701763|66640054|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
23798736|NCT03701763|66640055|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
23798737|NCT03701763|66640052|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23798738|NCT03701763|66640053|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23798739|NCT03701763|66640054|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
23798740|NCT03701763|66640055|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
23798741|NCT03701763|66640052|FG000|Apremilast Extension Phase|Adverse Event|0|||
23798742|NCT03701763|66640053|FG001|Apremilast Extension Phase|Adverse Event|0|||
23798743|NCT03701763|66640054|FG002|Apremilast Extension Phase|Adverse Event|3|||
23798744|NCT03701763|66640055|FG003|Apremilast Extension Phase|Adverse Event|1|||
23590911|NCT00711958|65892904|FG000|Overall Study|Progression of disease|1|||
23590912|NCT00711958|65892905|FG001|Overall Study|Progression of disease|0|||
23590913|NCT00346333|65892906|FG000|Overall Study|Death|1|||
23590914|NCT00346333|65892907|FG001|Overall Study|Death|0|||
23590915|NCT00346333|65892906|FG000|Overall Study|unwilling or unable to continue|4|||
23590916|NCT00346333|65892907|FG001|Overall Study|unwilling or unable to continue|8|||
23590917|NCT03837028|65892908|FG000|Overall Study|Lost to Follow-up|4|||
23590918|NCT03837028|65892909|FG001|Overall Study|Lost to Follow-up|0|||
23359922|NCT01051557|65062770|FG000|Overall Study|disease progression|3|||
23359923|NCT01051557|65062771|FG001|Overall Study|disease progression|3|||
23359924|NCT01051557|65062772|FG002|Overall Study|disease progression|5|||
23359925|NCT01051557|65062773|FG003|Overall Study|disease progression|2|||
23359926|NCT01051557|65062774|FG004|Overall Study|disease progression|4|||
23359927|NCT01051557|65062775|FG005|Overall Study|disease progression|3|||
23359928|NCT01051557|65062776|FG006|Overall Study|disease progression|1|||
23359929|NCT01051557|65062770|FG000|Overall Study|Withdrawal by Subject|0|||
23359930|NCT01051557|65062771|FG001|Overall Study|Withdrawal by Subject|0|||
23359931|NCT01051557|65062772|FG002|Overall Study|Withdrawal by Subject|1|||
23359932|NCT01051557|65062773|FG003|Overall Study|Withdrawal by Subject|0|||
23359933|NCT01051557|65062774|FG004|Overall Study|Withdrawal by Subject|2|||
23359934|NCT01051557|65062775|FG005|Overall Study|Withdrawal by Subject|0|||
23359935|NCT01051557|65062776|FG006|Overall Study|Withdrawal by Subject|1|||
23359936|NCT01051557|65062770|FG000|Overall Study|Adverse Event|0|||
23359937|NCT01051557|65062771|FG001|Overall Study|Adverse Event|0|||
23359938|NCT01051557|65062772|FG002|Overall Study|Adverse Event|0|||
23359939|NCT01051557|65062773|FG003|Overall Study|Adverse Event|1|||
23359940|NCT01051557|65062774|FG004|Overall Study|Adverse Event|1|||
23359941|NCT01051557|65062775|FG005|Overall Study|Adverse Event|3|||
23359942|NCT01051557|65062776|FG006|Overall Study|Adverse Event|4|||
23359943|NCT05176717|65062787|FG000|Overall Study|Sponsor Decision|1|||
23359944|NCT05176717|65062788|FG001|Overall Study|Sponsor Decision|2|||
23359945|NCT05176717|65062789|FG002|Overall Study|Sponsor Decision|2|||
23359946|NCT00171158|65062790|FG000|Core Study|Death|27|||
23359947|NCT00171158|65062790|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
23359948|NCT00171158|65062790|FG000|Core Study|Protocol Violation|4|||
23798745|NCT03701763|66640052|FG000|Apremilast Extension Phase|Miscellaneous|0|||
23798746|NCT03701763|66640053|FG001|Apremilast Extension Phase|Miscellaneous|0|||
23798747|NCT03701763|66640054|FG002|Apremilast Extension Phase|Miscellaneous|2|||
23359949|NCT00171158|65062790|FG000|Core Study|Administrative problems|1|||
23359950|NCT00171158|65062790|FG000|Core Study|Adverse event, non-fatal|21|||
23359951|NCT00171158|65062790|FG000|Core Study|Consent withdrawn by subject|6|||
23359952|NCT00171158|65062790|FG000|Core Study|No longer required drug (BMT)|14|||
23359953|NCT00171158|65062790|FG000|Core Study|Abnormal Laboratory Values|2|||
23359954|NCT00171158|65062790|FG000|Core Study|Lost to Follow-up|1|||
23359955|NCT00171158|65062790|FG000|E2 Extension|Other|7|||
23359956|NCT04668209|65062793|FG000|Overall Study|Withdrawal by Subject|2|||
23359957|NCT04668209|65062794|FG001|Overall Study|Withdrawal by Subject|2|||
23359958|NCT04668209|65062793|FG000|Overall Study|Lost to Follow-up|3|||
23359959|NCT04668209|65062794|FG001|Overall Study|Lost to Follow-up|4|||
23359960|NCT04668209|65062793|FG000|Overall Study|Subject Expired|2|||
23359961|NCT04668209|65062794|FG001|Overall Study|Subject Expired|0|||
23359962|NCT04668209|65062793|FG000|Overall Study|Withdrawn from study|0|||
23359963|NCT04668209|65062794|FG001|Overall Study|Withdrawn from study|1|||
23359964|NCT04668209|65062793|FG000|Overall Study|Adverse Event|0|||
23359965|NCT04668209|65062794|FG001|Overall Study|Adverse Event|1|||
23359966|NCT01509664|65062797|FG000|Overall Study|Lost to Follow-up|15|||
23359967|NCT01509664|65062798|FG001|Overall Study|Lost to Follow-up|21|||
23359968|NCT04162795|65062801|FG000|Overall Study|Other|16|||
23359969|NCT04162795|65062801|FG000|Overall Study|Screen failures|10|||
23359970|NCT01826981|65062802|FG000|Overall Study|Lack of Efficacy|0|||
23359971|NCT01826981|65062803|FG001|Overall Study|Lack of Efficacy|1|||
23359972|NCT01826981|65062804|FG002|Overall Study|Lack of Efficacy|0|||
23359973|NCT01826981|65062805|FG003|Overall Study|Lack of Efficacy|0|||
23359974|NCT01826981|65062806|FG004|Overall Study|Lack of Efficacy|5|||
23590919|NCT03837028|65892910|FG002|Overall Study|Lost to Follow-up|2|||
23798748|NCT03701763|66640055|FG003|Apremilast Extension Phase|Miscellaneous|1|||
23359975|NCT01826981|65062807|FG005|Overall Study|Lack of Efficacy|0|||
23359976|NCT01826981|65062808|FG006|Overall Study|Lack of Efficacy|0|||
23359977|NCT01826981|65062809|FG007|Overall Study|Lack of Efficacy|8|||
23359978|NCT01826981|65062810|FG008|Overall Study|Lack of Efficacy|7|||
23590920|NCT03837028|65892911|FG003|Overall Study|Lost to Follow-up|0|||
23359979|NCT01826981|65062811|FG009|Overall Study|Lack of Efficacy|0|||
23590921|NCT03837028|65892908|FG000|Overall Study|Withdrawal by Subject|12|||
23798749|NCT03701763|66640052|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
23359980|NCT01826981|65062812|FG010|Overall Study|Lack of Efficacy|1|||
23359981|NCT01826981|65062813|FG011|Overall Study|Lack of Efficacy|0|||
23359982|NCT01826981|65062814|FG012|Overall Study|Lack of Efficacy|0|||
23359983|NCT01826981|65062815|FG013|Overall Study|Lack of Efficacy|3|||
23359984|NCT01826981|65062816|FG014|Overall Study|Lack of Efficacy|0|||
23643890|NCT01901341|66079232|FG000|Overall Study|Withdrawal by Subject|1|||
23643891|NCT01901341|66079233|FG001|Overall Study|Withdrawal by Subject|1|||
23643892|NCT02516332|66079234|FG000|Overall Study|Withdrawal by Subject|2|||
23643893|NCT02516332|66079235|FG001|Overall Study|Withdrawal by Subject|1|||
23643894|NCT02516332|66079236|FG002|Overall Study|Withdrawal by Subject|2|||
23643895|NCT01156792|66079239|FG000|Overall Study|Adverse Event|1|||
23643896|NCT01156792|66079239|FG000|Overall Study|Lack of Efficacy|36|||
23643897|NCT01156792|66079239|FG000|Overall Study|Protocol Violation|6|||
23643898|NCT01156792|66079239|FG000|Overall Study|Lost to Follow-up|3|||
23643899|NCT01156792|66079239|FG000|Overall Study|Physician Decision|3|||
23643900|NCT01156792|66079239|FG000|Overall Study|Withdrawal by Subject|9|||
23643901|NCT01156792|66079239|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
23643902|NCT01775124|66079240|FG000|Core Period|Disease Progression|0|||
23643903|NCT01775124|66079241|FG001|Core Period|Disease Progression|1|||
23643904|NCT01775124|66079240|FG000|Core Period|Physician Decision|1|||
23643905|NCT01775124|66079241|FG001|Core Period|Physician Decision|1|||
23643906|NCT01775124|66079240|FG000|Core Period|Death|0|||
23643907|NCT01775124|66079241|FG001|Core Period|Death|1|||
23643908|NCT01775124|66079240|FG000|Core Period|Administrative problems|1|||
23643909|NCT01775124|66079241|FG001|Core Period|Administrative problems|0|||
23643910|NCT01775124|66079240|FG000|Core Period|Withdrawal by Subject|4|||
23643911|NCT01775124|66079241|FG001|Core Period|Withdrawal by Subject|2|||
23643912|NCT01775124|66079240|FG000|Core Period|Adverse Event|5|||
23643913|NCT01775124|66079241|FG001|Core Period|Adverse Event|5|||
23643914|NCT01775124|66079240|FG000|Extension Period|Adverse Event|3|||
23643915|NCT01775124|66079241|FG001|Extension Period|Adverse Event|2|||
23643916|NCT01775124|66079240|FG000|Extension Period|Physician Decision|0|||
23643917|NCT01775124|66079241|FG001|Extension Period|Physician Decision|2|||
23643918|NCT01775124|66079240|FG000|Extension Period|Administrative problems|0|||
23359985|NCT01826981|65062802|FG000|Overall Study|Lost to Follow-up|0|||
23359986|NCT01826981|65062803|FG001|Overall Study|Lost to Follow-up|0|||
23359987|NCT01826981|65062804|FG002|Overall Study|Lost to Follow-up|0|||
23359988|NCT01826981|65062805|FG003|Overall Study|Lost to Follow-up|0|||
23359989|NCT01826981|65062806|FG004|Overall Study|Lost to Follow-up|1|||
23359990|NCT01826981|65062807|FG005|Overall Study|Lost to Follow-up|1|||
23359991|NCT01826981|65062808|FG006|Overall Study|Lost to Follow-up|0|||
23359992|NCT01826981|65062809|FG007|Overall Study|Lost to Follow-up|1|||
23359993|NCT01826981|65062810|FG008|Overall Study|Lost to Follow-up|0|||
23359994|NCT01826981|65062811|FG009|Overall Study|Lost to Follow-up|1|||
23359995|NCT01826981|65062812|FG010|Overall Study|Lost to Follow-up|1|||
23359996|NCT01826981|65062813|FG011|Overall Study|Lost to Follow-up|1|||
23359997|NCT01826981|65062814|FG012|Overall Study|Lost to Follow-up|1|||
23359998|NCT01826981|65062815|FG013|Overall Study|Lost to Follow-up|0|||
23359999|NCT01826981|65062816|FG014|Overall Study|Lost to Follow-up|0|||
23360000|NCT01826981|65062802|FG000|Overall Study|Withdrew Consent|0|||
23360001|NCT01826981|65062803|FG001|Overall Study|Withdrew Consent|0|||
23360002|NCT01826981|65062804|FG002|Overall Study|Withdrew Consent|0|||
23360003|NCT01826981|65062805|FG003|Overall Study|Withdrew Consent|0|||
23360004|NCT01826981|65062806|FG004|Overall Study|Withdrew Consent|0|||
23360005|NCT01826981|65062807|FG005|Overall Study|Withdrew Consent|0|||
23360006|NCT01826981|65062808|FG006|Overall Study|Withdrew Consent|1|||
23360007|NCT01826981|65062809|FG007|Overall Study|Withdrew Consent|1|||
23360008|NCT01826981|65062810|FG008|Overall Study|Withdrew Consent|0|||
23360009|NCT01826981|65062811|FG009|Overall Study|Withdrew Consent|0|||
23360010|NCT01826981|65062812|FG010|Overall Study|Withdrew Consent|0|||
23360011|NCT01826981|65062813|FG011|Overall Study|Withdrew Consent|1|||
23360012|NCT01826981|65062814|FG012|Overall Study|Withdrew Consent|0|||
23360013|NCT01826981|65062815|FG013|Overall Study|Withdrew Consent|1|||
23360014|NCT01826981|65062816|FG014|Overall Study|Withdrew Consent|0|||
23360015|NCT01826981|65062802|FG000|Overall Study|Adverse Event|0|||
23360016|NCT01826981|65062803|FG001|Overall Study|Adverse Event|0|||
23360017|NCT01826981|65062804|FG002|Overall Study|Adverse Event|0|||
23360018|NCT01826981|65062805|FG003|Overall Study|Adverse Event|0|||
23360019|NCT01826981|65062806|FG004|Overall Study|Adverse Event|1|||
23360020|NCT01826981|65062807|FG005|Overall Study|Adverse Event|0|||
23360021|NCT01826981|65062808|FG006|Overall Study|Adverse Event|0|||
23360022|NCT01826981|65062809|FG007|Overall Study|Adverse Event|0|||
23360023|NCT01826981|65062810|FG008|Overall Study|Adverse Event|0|||
23360024|NCT01826981|65062811|FG009|Overall Study|Adverse Event|0|||
23360025|NCT01826981|65062812|FG010|Overall Study|Adverse Event|0|||
23360026|NCT01826981|65062813|FG011|Overall Study|Adverse Event|0|||
23360027|NCT01826981|65062814|FG012|Overall Study|Adverse Event|0|||
23360028|NCT01826981|65062815|FG013|Overall Study|Adverse Event|0|||
23360029|NCT01826981|65062816|FG014|Overall Study|Adverse Event|0|||
23360030|NCT01826981|65062802|FG000|Overall Study|Upper G-I Haemorrhage|0|||
23360031|NCT01826981|65062803|FG001|Overall Study|Upper G-I Haemorrhage|0|||
23360032|NCT01826981|65062804|FG002|Overall Study|Upper G-I Haemorrhage|0|||
23360033|NCT01826981|65062805|FG003|Overall Study|Upper G-I Haemorrhage|0|||
23360034|NCT01826981|65062806|FG004|Overall Study|Upper G-I Haemorrhage|0|||
23360035|NCT01826981|65062807|FG005|Overall Study|Upper G-I Haemorrhage|0|||
23360036|NCT01826981|65062808|FG006|Overall Study|Upper G-I Haemorrhage|0|||
23360037|NCT01826981|65062809|FG007|Overall Study|Upper G-I Haemorrhage|0|||
23360038|NCT01826981|65062810|FG008|Overall Study|Upper G-I Haemorrhage|0|||
23360039|NCT01826981|65062811|FG009|Overall Study|Upper G-I Haemorrhage|0|||
23360040|NCT01826981|65062812|FG010|Overall Study|Upper G-I Haemorrhage|0|||
23360041|NCT01826981|65062813|FG011|Overall Study|Upper G-I Haemorrhage|0|||
23360042|NCT01826981|65062814|FG012|Overall Study|Upper G-I Haemorrhage|0|||
23360043|NCT01826981|65062815|FG013|Overall Study|Upper G-I Haemorrhage|1|||
23360044|NCT01826981|65062816|FG014|Overall Study|Upper G-I Haemorrhage|0|||
23360045|NCT01826981|65062802|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
23798750|NCT03701763|66640053|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
23360046|NCT01826981|65062803|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360047|NCT01826981|65062804|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360048|NCT01826981|65062805|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360049|NCT01826981|65062806|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360050|NCT01826981|65062807|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360051|NCT01826981|65062808|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360052|NCT01826981|65062809|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
23360053|NCT01826981|65062810|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360054|NCT01826981|65062811|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360055|NCT01826981|65062812|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360056|NCT01826981|65062813|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360057|NCT01826981|65062814|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360058|NCT01826981|65062815|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360059|NCT01826981|65062816|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360060|NCT00401193|65062817|FG000|Overall Study|Adverse Event|1|||
23590922|NCT03837028|65892909|FG001|Overall Study|Withdrawal by Subject|11|||
23590923|NCT03837028|65892910|FG002|Overall Study|Withdrawal by Subject|11|||
23590924|NCT03837028|65892911|FG003|Overall Study|Withdrawal by Subject|7|||
23590925|NCT04128319|65892912|FG000|Overall Study|Death|3|||
23590926|NCT05641311|65892913|FG000|Dosing Period 1|Adverse Event|1|||
23590927|NCT05641311|65892914|FG001|Dosing Period 1|Adverse Event|0|||
23590928|NCT02534350|65892917|FG000|Overall Study|Randomized But Not Treated|1|||
23590929|NCT02534350|65892918|FG001|Overall Study|Randomized But Not Treated|0|||
23590930|NCT02534350|65892917|FG000|Overall Study|Protocol Violation|1|||
23590931|NCT02534350|65892918|FG001|Overall Study|Protocol Violation|0|||
23590932|NCT02534350|65892917|FG000|Overall Study|Withdrew Consent|2|||
23590933|NCT02534350|65892918|FG001|Overall Study|Withdrew Consent|0|||
23590934|NCT00753012|65892921|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
23590935|NCT00753012|65892922|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
23590936|NCT00753012|65892921|FG000|Overall Study|Adverse Event|2|||
23590937|NCT00753012|65892922|FG001|Overall Study|Adverse Event|0|||
23590938|NCT00753012|65892921|FG000|Overall Study|Withdrawal by Subject|0|||
23590939|NCT00753012|65892922|FG001|Overall Study|Withdrawal by Subject|1|||
23590940|NCT00753012|65892921|FG000|Overall Study|Lost to Follow-up|4|||
23590941|NCT00753012|65892922|FG001|Overall Study|Lost to Follow-up|0|||
23590942|NCT00753012|65892921|FG000|Overall Study|Confounded endpoint data|1|||
23590943|NCT00753012|65892922|FG001|Overall Study|Confounded endpoint data|0|||
23590944|NCT04493242|65892923|FG000|Overall Study|Death|10|||
23590945|NCT04493242|65892924|FG001|Overall Study|Death|14|||
23590946|NCT04493242|65892925|FG002|Overall Study|Death|16|||
23590947|NCT04493242|65892923|FG000|Overall Study|Lost to Follow-up|1|||
23590948|NCT04493242|65892924|FG001|Overall Study|Lost to Follow-up|1|||
23590949|NCT04493242|65892925|FG002|Overall Study|Lost to Follow-up|0|||
23590950|NCT04493242|65892923|FG000|Overall Study|Withdrawal by Subject|1|||
23590951|NCT04493242|65892924|FG001|Overall Study|Withdrawal by Subject|0|||
23590952|NCT04493242|65892925|FG002|Overall Study|Withdrawal by Subject|0|||
23590953|NCT04493242|65892923|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
23590954|NCT04493242|65892924|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
23590955|NCT04493242|65892925|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
23590956|NCT04493242|65892923|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
23590957|NCT04493242|65892924|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
23590958|NCT04493242|65892925|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
23590959|NCT04504916|65892926|FG000|Overall Study|Study terminated|7|||
23590960|NCT04504916|65892927|FG001|Overall Study|Study terminated|8|||
23590961|NCT04504916|65892926|FG000|Overall Study|Death|54|||
23590962|NCT04504916|65892927|FG001|Overall Study|Death|18|||
23590963|NCT04504916|65892926|FG000|Overall Study|Lost to Follow-up|1|||
23590964|NCT04504916|65892927|FG001|Overall Study|Lost to Follow-up|1|||
23590965|NCT04504916|65892926|FG000|Overall Study|Withdrawal by Subject|8|||
23590966|NCT04504916|65892927|FG001|Overall Study|Withdrawal by Subject|4|||
23590967|NCT04504916|65892926|FG000|Overall Study|Did not agree to follow-up|0|||
23590968|NCT04504916|65892927|FG001|Overall Study|Did not agree to follow-up|1|||
23590969|NCT02754479|65892929|FG000|Overall Study|Lost to Follow-up|1|||
23590970|NCT00546871|65892930|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
23590971|NCT00546871|65892931|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
23476271|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
23476272|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
23590972|NCT00546871|65892930|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
23590973|NCT00546871|65892931|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
23590974|NCT00546871|65892930|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
23590975|NCT00546871|65892931|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
23590976|NCT00546871|65892930|FG000|Study Extension Period|Protocol Violation|1|||
23590977|NCT00546871|65892931|FG001|Study Extension Period|Protocol Violation|0|||
23590978|NCT00546871|65892930|FG000|Study Extension Period|Withdrawal by Subject|0|||
23590979|NCT00546871|65892931|FG001|Study Extension Period|Withdrawal by Subject|1|||
23590980|NCT00665444|65892932|FG000|Overall Study|Physician Decision|1|||
23360061|NCT00401193|65062818|FG001|Overall Study|Adverse Event|3|||
23476273|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23590981|NCT00665444|65892932|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
23590982|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
23590983|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590984|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
23590985|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590986|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590987|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
23590988|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590989|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
23476274|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23590990|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590991|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590992|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
23590993|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
23590994|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
23590995|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
23590996|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
23590997|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
23590998|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
23590999|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
23591000|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
23591001|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
23591002|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
23591003|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
23591004|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
23591005|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
23591006|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
23591007|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591008|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591009|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591010|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
23591011|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
23591012|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591013|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591014|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591015|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
23591016|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
23591017|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591018|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591019|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591020|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
23591021|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
23591022|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23591023|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23360062|NCT00401193|65062819|FG002|Overall Study|Adverse Event|1|||
23360063|NCT00401193|65062817|FG000|Overall Study|Protocol Violation|3|||
23360064|NCT00401193|65062818|FG001|Overall Study|Protocol Violation|1|||
23591024|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23591025|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
23591026|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
23360065|NCT00401193|65062819|FG002|Overall Study|Protocol Violation|1|||
23360066|NCT00401193|65062817|FG000|Overall Study|Lost to Follow-up|6|||
23360067|NCT00401193|65062818|FG001|Overall Study|Lost to Follow-up|5|||
23360068|NCT00401193|65062819|FG002|Overall Study|Lost to Follow-up|1|||
23360069|NCT00401193|65062817|FG000|Overall Study|Withdrawal by Subject|2|||
23360070|NCT00401193|65062818|FG001|Overall Study|Withdrawal by Subject|0|||
23360071|NCT00401193|65062819|FG002|Overall Study|Withdrawal by Subject|1|||
23360072|NCT00401193|65062817|FG000|Overall Study|Other Event|3|||
23360073|NCT00401193|65062818|FG001|Overall Study|Other Event|2|||
23360074|NCT00401193|65062819|FG002|Overall Study|Other Event|2|||
23476275|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23476276|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
23360075|NCT03746405|65062822|FG000|Overall Study|Withdrawal by Subject|3|||
23360076|NCT03746405|65062823|FG001|Overall Study|Withdrawal by Subject|0|||
23476277|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23591027|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
23360077|NCT03746405|65062822|FG000|Overall Study|technical difficulties|0|||
23360078|NCT03746405|65062823|FG001|Overall Study|technical difficulties|2|||
23360079|NCT02489448|65062826|FG000|Overall Study|Death|3|||
23360080|NCT02489448|65062826|FG000|Overall Study|Withdrawal by Subject|2|||
23360081|NCT01720524|65062832|FG000|Part A|Insufficient Clinical Response|2|||
23360082|NCT01720524|65062833|FG001|Part A|Insufficient Clinical Response|4|||
23643919|NCT01775124|66079241|FG001|Extension Period|Administrative problems|1|||
23360083|NCT01720524|65062832|FG000|Part A|Adverse Event|2|||
23360084|NCT01720524|65062833|FG001|Part A|Adverse Event|2|||
23360085|NCT01720524|65062832|FG000|Part A|Death|2|||
23591028|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
23360086|NCT01720524|65062833|FG001|Part A|Death|1|||
23360087|NCT01720524|65062832|FG000|Part A|Lost to Follow-up|0|||
23360088|NCT01720524|65062833|FG001|Part A|Lost to Follow-up|1|||
23360089|NCT01720524|65062832|FG000|Part A|Missed 28 day follow-up visit|1|||
23360090|NCT01720524|65062833|FG001|Part A|Missed 28 day follow-up visit|1|||
23591029|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
23591030|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
23591031|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
23591032|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591033|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591034|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591035|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
23591036|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
23591037|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591038|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591039|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591040|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
23591041|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
23591042|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591043|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591044|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591045|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
23591046|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
23591047|NCT01290224|65892940|FG000|Overall Study|Adverse Event|1|||
23591048|NCT01290224|65892940|FG000|Overall Study|Refused Further Treatment|4|||
23591049|NCT02808338|65892951|FG000|Screening|Screen Failure|10|||
23591050|NCT02808338|65892951|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
23591051|NCT02808338|65892951|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
23591052|NCT00057837|65892957|FG000|Overall Study|Progression/relapse|12|||
23591053|NCT00057837|65892958|FG001|Overall Study|Progression/relapse|14|||
23591054|NCT00057837|65892957|FG000|Overall Study|Adverse Event|2|||
23591055|NCT00057837|65892958|FG001|Overall Study|Adverse Event|12|||
23591056|NCT00057837|65892957|FG000|Overall Study|Death|5|||
23591057|NCT00057837|65892958|FG001|Overall Study|Death|4|||
23591058|NCT00057837|65892957|FG000|Overall Study|Withdrawal by Subject|5|||
23591059|NCT00057837|65892958|FG001|Overall Study|Withdrawal by Subject|3|||
23591060|NCT00057837|65892957|FG000|Overall Study|Alternative therapy|0|||
23591061|NCT00057837|65892958|FG001|Overall Study|Alternative therapy|1|||
23591062|NCT00057837|65892957|FG000|Overall Study|Other complicating disease|2|||
23591063|NCT00057837|65892958|FG001|Overall Study|Other complicating disease|1|||
23591064|NCT00057837|65892957|FG000|Overall Study|Physician Decision|1|||
23591065|NCT00057837|65892958|FG001|Overall Study|Physician Decision|0|||
23591066|NCT00057837|65892957|FG000|Overall Study|Ineligible|3|||
23591067|NCT00057837|65892958|FG001|Overall Study|Ineligible|3|||
23591068|NCT00057837|65892957|FG000|Overall Study|Never started treatment|1|||
23591069|NCT00057837|65892958|FG001|Overall Study|Never started treatment|1|||
23591070|NCT00367991|65892959|FG000|Overall Study|Withdrawal by Subject|1|||
23591071|NCT00367991|65892960|FG001|Overall Study|Withdrawal by Subject|1|||
23591072|NCT00367991|65892959|FG000|Overall Study|Adverse Event|1|||
23591073|NCT00367991|65892960|FG001|Overall Study|Adverse Event|1|||
23591074|NCT00666276|65892961|FG000|Overall Study|Protocol Violation|34|||
23591075|NCT00940992|65892964|FG000|Overall Study|Adverse Event|2|||
23591076|NCT00940992|65892965|FG001|Overall Study|Adverse Event|0|||
23591077|NCT00940992|65892966|FG002|Overall Study|Adverse Event|1|||
23591078|NCT00940992|65892964|FG000|Overall Study|subject request|2|||
23591079|NCT00940992|65892965|FG001|Overall Study|subject request|1|||
23591080|NCT00940992|65892966|FG002|Overall Study|subject request|0|||
23591081|NCT00940992|65892964|FG000|Overall Study|Lost to Follow-up|0|||
23591082|NCT00940992|65892965|FG001|Overall Study|Lost to Follow-up|1|||
23591083|NCT00940992|65892966|FG002|Overall Study|Lost to Follow-up|1|||
23591084|NCT04580303|65892967|FG000|Overall Study|Adverse Event|0|||
23591085|NCT04580303|65892968|FG001|Overall Study|Adverse Event|1|||
23591086|NCT04580303|65892969|FG002|Overall Study|Adverse Event|0|||
23591087|NCT04580303|65892970|FG003|Overall Study|Adverse Event|0|||
23591088|NCT04580303|65892967|FG000|Overall Study|Withdrawal by Subject|0|||
23591089|NCT04580303|65892968|FG001|Overall Study|Withdrawal by Subject|0|||
23798751|NCT03701763|66640054|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
23798752|NCT03701763|66640055|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
23591090|NCT04580303|65892969|FG002|Overall Study|Withdrawal by Subject|1|||
23591091|NCT04580303|65892970|FG003|Overall Study|Withdrawal by Subject|0|||
23591092|NCT00834834|65892975|FG000|Overall Study|Withdrawal by Subject|4|||
23591093|NCT00834834|65892976|FG001|Overall Study|Withdrawal by Subject|3|||
23591094|NCT02194933|65892978|FG000|Overall Study|Lost to Follow-up|1|||
23591095|NCT02194933|65892979|FG001|Overall Study|Lost to Follow-up|2|||
23591096|NCT02194933|65892978|FG000|Overall Study|Participant met withdrawal criteria|1|||
23591097|NCT02194933|65892979|FG001|Overall Study|Participant met withdrawal criteria|3|||
23591098|NCT02194933|65892978|FG000|Overall Study|Withdrawal by Subject|0|||
23591099|NCT02194933|65892979|FG001|Overall Study|Withdrawal by Subject|2|||
23591100|NCT02194933|65892978|FG000|Overall Study|Lack of Efficacy|1|||
23591101|NCT02194933|65892979|FG001|Overall Study|Lack of Efficacy|2|||
23643920|NCT01775124|66079240|FG000|Extension Period|Lost to Follow-up|0|||
23643921|NCT01775124|66079241|FG001|Extension Period|Lost to Follow-up|1|||
23643922|NCT01775124|66079240|FG000|Extension Period|Withdrawal by Subject|9|||
23643923|NCT01775124|66079241|FG001|Extension Period|Withdrawal by Subject|12|||
23643924|NCT01127893|66079243|FG000|Overall Study|Study Termination by the Sponsor|1|||
23643925|NCT00925132|66079244|FG000|Overall Study|Withdrawal by Subject|2|||
23643926|NCT00925132|66079245|FG001|Overall Study|Withdrawal by Subject|0|||
23643927|NCT00925132|66079246|FG002|Overall Study|Withdrawal by Subject|0|||
23643928|NCT00925132|66079247|FG003|Overall Study|Withdrawal by Subject|0|||
23643929|NCT00925132|66079248|FG004|Overall Study|Withdrawal by Subject|1|||
23643930|NCT00925132|66079244|FG000|Overall Study|Removed due to disease progression|0|||
23643931|NCT00925132|66079245|FG001|Overall Study|Removed due to disease progression|0|||
23643932|NCT00925132|66079246|FG002|Overall Study|Removed due to disease progression|0|||
23643933|NCT00925132|66079247|FG003|Overall Study|Removed due to disease progression|0|||
23643934|NCT00925132|66079248|FG004|Overall Study|Removed due to disease progression|4|||
23798753|NCT03701763|66640052|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23798754|NCT03701763|66640053|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23798755|NCT03701763|66640054|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
23798756|NCT03701763|66640055|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
23798757|NCT03701763|66640052|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
23798758|NCT03701763|66640053|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
23798759|NCT03701763|66640054|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
23798760|NCT03701763|66640055|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
23798761|NCT03701763|66640052|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23798762|NCT03701763|66640053|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23798763|NCT03701763|66640054|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
23798764|NCT03701763|66640055|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23798765|NCT03701763|66640052|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
23798766|NCT03701763|66640053|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
23798767|NCT03701763|66640054|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
23798768|NCT03701763|66640055|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
23798769|NCT03701763|66640052|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23798770|NCT03701763|66640053|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23360091|NCT01720524|65062832|FG000|Part A|Withdrawal by Subject|0|||
23476278|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
23476279|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
23476280|NCT00065429|65488030|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476281|NCT00065429|65488031|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23591102|NCT02553460|65892984|FG000|Overall Study|Death|3|||
23591103|NCT02553460|65892984|FG000|Overall Study|Withdrawal by Subject|1|||
23591104|NCT02553460|65892984|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
23591105|NCT02553460|65892984|FG000|Overall Study|Relapse or Transplant|14|||
23591106|NCT02553460|65892984|FG000|Overall Study|No response to treatment|2|||
23591107|NCT02553460|65892984|FG000|Overall Study|Still on therapy|7|||
23591108|NCT02553460|65892984|FG000|Overall Study|CAR T cells|1|||
23591109|NCT00918957|65892985|FG000|Overall Study|Adverse Event|2|||
23591110|NCT00918957|65892986|FG001|Overall Study|Adverse Event|0|||
23591111|NCT00918957|65892985|FG000|Overall Study|Withdrawal by Subject|1|||
23591112|NCT00918957|65892986|FG001|Overall Study|Withdrawal by Subject|0|||
23591113|NCT02425111|65892987|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
23591114|NCT02425111|65892987|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
23591115|NCT02425111|65892987|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
23591116|NCT02425111|65892987|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
23591117|NCT02425111|65892987|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
23591118|NCT02425111|65892987|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
23591119|NCT02341625|65892991|FG000|Overall Study|Disease Progression|2|||
23591120|NCT02341625|65892992|FG001|Overall Study|Disease Progression|2|||
23591121|NCT02341625|65892993|FG002|Overall Study|Disease Progression|3|||
23591122|NCT02341625|65892994|FG003|Overall Study|Disease Progression|6|||
23591123|NCT02341625|65892995|FG004|Overall Study|Disease Progression|7|||
23591124|NCT02341625|65892996|FG005|Overall Study|Disease Progression|7|||
23591125|NCT02341625|65892997|FG006|Overall Study|Disease Progression|28|||
23591126|NCT02341625|65892998|FG007|Overall Study|Disease Progression|5|||
23591127|NCT02341625|65892999|FG008|Overall Study|Disease Progression|4|||
23591128|NCT02341625|65893000|FG009|Overall Study|Disease Progression|19|||
23591129|NCT02341625|65892991|FG000|Overall Study|Study Drug Toxicity|0|||
23591130|NCT02341625|65892992|FG001|Overall Study|Study Drug Toxicity|0|||
23643935|NCT00658684|66079254|FG000|Overall Study|Adverse Event|10|||
23798771|NCT03701763|66640054|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
23798772|NCT03701763|66640055|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23798773|NCT03701763|66640052|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23798774|NCT03701763|66640053|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23798775|NCT03701763|66640054|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23798776|NCT03701763|66640055|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
23798777|NCT03701763|66640052|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23798778|NCT03701763|66640053|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23798779|NCT03701763|66640054|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23798780|NCT03701763|66640055|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
23798781|NCT02972515|66640058|FG000|Overall Study|Lost to Follow-up|78|||
23798782|NCT02413294|66640060|FG000|Overall Study|Withdrawal by Subject|1|||
23798783|NCT02344745|66640062|FG000|Overall Study|Data collection sheets were lost|2|||
23798784|NCT02344745|66640063|FG001|Overall Study|Data collection sheets were lost|0|||
23798785|NCT02039063|66640064|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
23798786|NCT02039063|66640065|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
23798787|NCT02039063|66640066|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
23798788|NCT02039063|66640067|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
23798789|NCT02039063|66640064|FG000|Treatment Phase|Progression of disease|0|||
23798790|NCT02039063|66640065|FG001|Treatment Phase|Progression of disease|0|||
23798791|NCT02039063|66640066|FG002|Treatment Phase|Progression of disease|1|||
23798792|NCT02039063|66640067|FG003|Treatment Phase|Progression of disease|1|||
23798793|NCT02039063|66640064|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23798794|NCT02039063|66640065|FG001|Extension Phase|Inadequate therapeutic effect|1|||
23798795|NCT02039063|66640066|FG002|Extension Phase|Inadequate therapeutic effect|2|||
23798796|NCT02039063|66640067|FG003|Extension Phase|Inadequate therapeutic effect|0|||
23798797|NCT02039063|66640064|FG000|Extension Phase|Progression of disease|0|||
23798798|NCT02039063|66640065|FG001|Extension Phase|Progression of disease|0|||
23798799|NCT02039063|66640066|FG002|Extension Phase|Progression of disease|0|||
23798800|NCT02039063|66640067|FG003|Extension Phase|Progression of disease|1|||
23798801|NCT02039063|66640064|FG000|Extension Phase|Adverse Event|0|||
23798802|NCT02039063|66640065|FG001|Extension Phase|Adverse Event|0|||
23798803|NCT02039063|66640066|FG002|Extension Phase|Adverse Event|1|||
23798804|NCT02039063|66640067|FG003|Extension Phase|Adverse Event|0|||
23798805|NCT00894933|66640068|FG000|Overall Study|Lost to Follow-up|2|||
23798806|NCT00894933|66640068|FG000|Overall Study|Cancelled Procedure|1|||
23798807|NCT00894933|66640068|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
23798808|NCT00732160|66640069|FG000|Overall Study|Adverse Event|1|||
23798809|NCT00732160|66640070|FG001|Overall Study|Adverse Event|0|||
23798810|NCT00732160|66640071|FG002|Overall Study|Adverse Event|1|||
23798811|NCT00732160|66640072|FG003|Overall Study|Adverse Event|1|||
23798812|NCT00732160|66640069|FG000|Overall Study|scheduling|4|||
23798813|NCT00732160|66640070|FG001|Overall Study|scheduling|4|||
23798814|NCT00732160|66640071|FG002|Overall Study|scheduling|2|||
23798815|NCT00732160|66640072|FG003|Overall Study|scheduling|1|||
23798816|NCT02274948|66640073|FG000|Overall Study|Lost to Follow-up|28|||
23798817|NCT02274948|66640074|FG001|Overall Study|Lost to Follow-up|25|||
23798818|NCT02274948|66640073|FG000|Overall Study|Withdrawal by Subject|64|||
23798819|NCT02274948|66640074|FG001|Overall Study|Withdrawal by Subject|58|||
23798820|NCT02274948|66640073|FG000|Overall Study|Stopped on family Practitioner advice|2|||
23798821|NCT02274948|66640074|FG001|Overall Study|Stopped on family Practitioner advice|5|||
23360092|NCT01720524|65062833|FG001|Part A|Withdrawal by Subject|1|||
23798822|NCT02274948|66640073|FG000|Overall Study|Left the area|4|||
23591131|NCT02341625|65892993|FG002|Overall Study|Study Drug Toxicity|0|||
23591132|NCT02341625|65892994|FG003|Overall Study|Study Drug Toxicity|1|||
23591133|NCT02341625|65892995|FG004|Overall Study|Study Drug Toxicity|0|||
23591134|NCT02341625|65892996|FG005|Overall Study|Study Drug Toxicity|3|||
23591135|NCT02341625|65892997|FG006|Overall Study|Study Drug Toxicity|10|||
23591136|NCT02341625|65892998|FG007|Overall Study|Study Drug Toxicity|0|||
23591137|NCT02341625|65892999|FG008|Overall Study|Study Drug Toxicity|0|||
23591138|NCT02341625|65893000|FG009|Overall Study|Study Drug Toxicity|3|||
23591139|NCT02341625|65892991|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591140|NCT02341625|65892992|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591141|NCT02341625|65892993|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591142|NCT02341625|65892994|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591143|NCT02341625|65892995|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591144|NCT02341625|65892996|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591145|NCT02341625|65892997|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23591146|NCT02341625|65892998|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23591147|NCT02341625|65892999|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591148|NCT02341625|65893000|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23591149|NCT02341625|65892991|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591150|NCT02341625|65892992|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591151|NCT02341625|65892993|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591152|NCT02341625|65892994|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591153|NCT02341625|65892995|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591154|NCT02341625|65892996|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591155|NCT02341625|65892997|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
23591156|NCT02341625|65892998|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
23591157|NCT02341625|65892999|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591158|NCT02341625|65893000|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591159|NCT02341625|65892991|FG000|Overall Study|Participant Withdrew Consent|0|||
23591160|NCT02341625|65892992|FG001|Overall Study|Participant Withdrew Consent|0|||
23591161|NCT02341625|65892993|FG002|Overall Study|Participant Withdrew Consent|0|||
23591162|NCT02341625|65892994|FG003|Overall Study|Participant Withdrew Consent|1|||
23591163|NCT02341625|65892995|FG004|Overall Study|Participant Withdrew Consent|0|||
23591164|NCT02341625|65892996|FG005|Overall Study|Participant Withdrew Consent|0|||
23591165|NCT02341625|65892997|FG006|Overall Study|Participant Withdrew Consent|0|||
23591166|NCT02341625|65892998|FG007|Overall Study|Participant Withdrew Consent|0|||
23591167|NCT02341625|65892999|FG008|Overall Study|Participant Withdrew Consent|0|||
23591168|NCT02341625|65893000|FG009|Overall Study|Participant Withdrew Consent|0|||
23591169|NCT02341625|65892991|FG000|Overall Study|Completed Treatment as per Protocol|0|||
23591170|NCT02341625|65892992|FG001|Overall Study|Completed Treatment as per Protocol|0|||
23591171|NCT02341625|65892993|FG002|Overall Study|Completed Treatment as per Protocol|0|||
23591172|NCT02341625|65892994|FG003|Overall Study|Completed Treatment as per Protocol|0|||
23591173|NCT02341625|65892995|FG004|Overall Study|Completed Treatment as per Protocol|0|||
23591174|NCT02341625|65892996|FG005|Overall Study|Completed Treatment as per Protocol|0|||
23591175|NCT02341625|65892997|FG006|Overall Study|Completed Treatment as per Protocol|0|||
23591176|NCT02341625|65892998|FG007|Overall Study|Completed Treatment as per Protocol|0|||
23591177|NCT02341625|65892999|FG008|Overall Study|Completed Treatment as per Protocol|0|||
23591178|NCT02341625|65893000|FG009|Overall Study|Completed Treatment as per Protocol|1|||
23591179|NCT02341625|65892991|FG000|Overall Study|Other Reasons|0|||
23591180|NCT02341625|65892992|FG001|Overall Study|Other Reasons|0|||
23591181|NCT02341625|65892993|FG002|Overall Study|Other Reasons|0|||
23591182|NCT02341625|65892994|FG003|Overall Study|Other Reasons|0|||
23591183|NCT02341625|65892995|FG004|Overall Study|Other Reasons|1|||
23591184|NCT02341625|65892996|FG005|Overall Study|Other Reasons|0|||
23591185|NCT02341625|65892997|FG006|Overall Study|Other Reasons|5|||
23591186|NCT02341625|65892998|FG007|Overall Study|Other Reasons|0|||
23591187|NCT02341625|65892999|FG008|Overall Study|Other Reasons|0|||
23591188|NCT02341625|65893000|FG009|Overall Study|Other Reasons|2|||
23591189|NCT02341625|65892991|FG000|Overall Study|Not Reported|0|||
23591190|NCT02341625|65892992|FG001|Overall Study|Not Reported|0|||
23591191|NCT02341625|65892993|FG002|Overall Study|Not Reported|0|||
23591192|NCT02341625|65892994|FG003|Overall Study|Not Reported|0|||
23591193|NCT02341625|65892995|FG004|Overall Study|Not Reported|0|||
23591194|NCT02341625|65892996|FG005|Overall Study|Not Reported|0|||
23591195|NCT02341625|65892997|FG006|Overall Study|Not Reported|0|||
23591196|NCT02341625|65892998|FG007|Overall Study|Not Reported|0|||
23591197|NCT02341625|65892999|FG008|Overall Study|Not Reported|0|||
23591198|NCT02341625|65893000|FG009|Overall Study|Not Reported|3|||
23591199|NCT00959946|65893001|FG000|Overall Study|Adverse Event|0|||
23591200|NCT00959946|65893002|FG001|Overall Study|Adverse Event|0|||
23591201|NCT00959946|65893003|FG002|Overall Study|Adverse Event|2|||
23591202|NCT00959946|65893004|FG003|Overall Study|Adverse Event|1|||
23591203|NCT00959946|65893005|FG004|Overall Study|Adverse Event|0|||
23591204|NCT00959946|65893006|FG005|Overall Study|Adverse Event|1|||
23591205|NCT00959946|65893007|FG006|Overall Study|Adverse Event|0|||
23591206|NCT00959946|65893008|FG007|Overall Study|Adverse Event|0|||
23591207|NCT00959946|65893001|FG000|Overall Study|Death|0|||
23591208|NCT00959946|65893002|FG001|Overall Study|Death|0|||
23591209|NCT00959946|65893003|FG002|Overall Study|Death|0|||
23591210|NCT00959946|65893004|FG003|Overall Study|Death|0|||
23591211|NCT00959946|65893005|FG004|Overall Study|Death|0|||
23591212|NCT00959946|65893006|FG005|Overall Study|Death|1|||
23591213|NCT00959946|65893007|FG006|Overall Study|Death|0|||
23591214|NCT00959946|65893008|FG007|Overall Study|Death|0|||
23591215|NCT00959946|65893001|FG000|Overall Study|Disease Progression|2|||
23591216|NCT00959946|65893002|FG001|Overall Study|Disease Progression|4|||
23591217|NCT00959946|65893003|FG002|Overall Study|Disease Progression|2|||
23591218|NCT00959946|65893004|FG003|Overall Study|Disease Progression|4|||
23591219|NCT00959946|65893005|FG004|Overall Study|Disease Progression|4|||
23591220|NCT00959946|65893006|FG005|Overall Study|Disease Progression|6|||
23591221|NCT00959946|65893007|FG006|Overall Study|Disease Progression|2|||
23591222|NCT00959946|65893008|FG007|Overall Study|Disease Progression|2|||
23591223|NCT00959946|65893001|FG000|Overall Study|Withdrawal by Subject|0|||
23591224|NCT00959946|65893002|FG001|Overall Study|Withdrawal by Subject|0|||
23591225|NCT00959946|65893003|FG002|Overall Study|Withdrawal by Subject|0|||
23591226|NCT00959946|65893004|FG003|Overall Study|Withdrawal by Subject|0|||
23591227|NCT00959946|65893005|FG004|Overall Study|Withdrawal by Subject|0|||
23591228|NCT00959946|65893006|FG005|Overall Study|Withdrawal by Subject|1|||
23591229|NCT00959946|65893007|FG006|Overall Study|Withdrawal by Subject|0|||
23591230|NCT00959946|65893008|FG007|Overall Study|Withdrawal by Subject|0|||
23591231|NCT01849055|65893011|FG000|Overall Study|Withdrawal by Subject|0|||
23591232|NCT01849055|65893012|FG001|Overall Study|Withdrawal by Subject|0|||
23591233|NCT01849055|65893013|FG002|Overall Study|Withdrawal by Subject|1|||
23591234|NCT01849055|65893014|FG003|Overall Study|Withdrawal by Subject|0|||
23591235|NCT01849055|65893015|FG004|Overall Study|Withdrawal by Subject|0|||
23591236|NCT01849055|65893016|FG005|Overall Study|Withdrawal by Subject|0|||
23591237|NCT06136897|65893017|FG000|Overall Study|Ineligible|3|||
23591238|NCT06136897|65893017|FG000|Overall Study|Mutation status not confirmed|7|||
23591239|NCT06136897|65893017|FG000|Overall Study|Adverse Event|2|||
23591240|NCT06136897|65893017|FG000|Overall Study|Death|1|||
23591241|NCT06136897|65893017|FG000|Overall Study|Disease progression|18|||
23591242|NCT06136897|65893017|FG000|Overall Study|Other complicating disease|1|||
23591243|NCT06136897|65893017|FG000|Overall Study|Withdrawal by Subject|1|||
23591244|NCT06136897|65893017|FG000|Overall Study|Still on treatment|1|||
23591245|NCT06136897|65893017|FG000|Overall Study|Lost to Follow-up|1|||
23591246|NCT01576484|65893020|FG000|Overall Study|Adverse Event|1|||
23591247|NCT01576484|65893021|FG001|Overall Study|Adverse Event|1|||
23591248|NCT01576484|65893020|FG000|Overall Study|Protocol Violation|0|||
23360093|NCT01720524|65062832|FG000|Part A|Other|0|||
23476282|NCT00065429|65488032|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476283|NCT00065429|65488033|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476284|NCT00065429|65488034|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
23476285|NCT00065429|65488035|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476286|NCT00065429|65488036|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476287|NCT00065429|65488030|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476288|NCT00065429|65488031|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476289|NCT00065429|65488032|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476290|NCT00065429|65488033|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476291|NCT00065429|65488034|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
23476292|NCT00065429|65488035|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476293|NCT00065429|65488036|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476294|NCT04364984|65488037|FG000|Overall Study|Death|2|||
23476295|NCT04364984|65488038|FG001|Overall Study|Death|2|||
23476296|NCT04364984|65488039|FG002|Overall Study|Death|0|||
23476297|NCT01028300|65488040|FG000|Overall Study|Study Terminated|4|||
23476298|NCT00978757|65488041|FG000|Overall Study|Physician Decision|1|||
23476299|NCT00978757|65488042|FG001|Overall Study|Physician Decision|3|||
23476300|NCT00899353|65488045|FG000|Overall Study|Adverse Event|2|||
23591249|NCT01576484|65893021|FG001|Overall Study|Protocol Violation|2|||
23591250|NCT01576484|65893020|FG000|Overall Study|Sponsor Decision|2|||
23591251|NCT01576484|65893021|FG001|Overall Study|Sponsor Decision|8|||
23591252|NCT01576484|65893020|FG000|Overall Study|Withdrawal by Subject|0|||
23591253|NCT01576484|65893021|FG001|Overall Study|Withdrawal by Subject|3|||
23591254|NCT01576484|65893020|FG000|Overall Study|Other|2|||
23591255|NCT01576484|65893021|FG001|Overall Study|Other|5|||
23476301|NCT00899353|65488045|FG000|Overall Study|Lost to Follow-up|1|||
23476302|NCT00899353|65488045|FG000|Overall Study|Withdrawal by Subject|2|||
23591256|NCT00716144|65893022|FG000|Overall Study|Withdrawal by Subject|4|||
23591257|NCT00716144|65893023|FG001|Overall Study|Withdrawal by Subject|2|||
23591258|NCT00716144|65893024|FG002|Overall Study|Withdrawal by Subject|6|||
23591259|NCT00716144|65893025|FG003|Overall Study|Withdrawal by Subject|6|||
23591260|NCT00716144|65893022|FG000|Overall Study|Lost to Follow-up|2|||
23591261|NCT00716144|65893023|FG001|Overall Study|Lost to Follow-up|2|||
23591262|NCT00716144|65893024|FG002|Overall Study|Lost to Follow-up|1|||
23591263|NCT00716144|65893025|FG003|Overall Study|Lost to Follow-up|2|||
23591264|NCT00716144|65893022|FG000|Overall Study|Adverse Event|0|||
23591265|NCT00716144|65893023|FG001|Overall Study|Adverse Event|0|||
23591266|NCT00716144|65893024|FG002|Overall Study|Adverse Event|0|||
23591267|NCT00716144|65893025|FG003|Overall Study|Adverse Event|2|||
23591268|NCT00716144|65893022|FG000|Overall Study|Non-compliance|1|||
23591269|NCT00716144|65893023|FG001|Overall Study|Non-compliance|0|||
23591270|NCT00716144|65893024|FG002|Overall Study|Non-compliance|0|||
23591271|NCT00716144|65893025|FG003|Overall Study|Non-compliance|0|||
23591272|NCT00716144|65893022|FG000|Overall Study|Protocol Violation|2|||
23591273|NCT00716144|65893023|FG001|Overall Study|Protocol Violation|0|||
23591274|NCT00716144|65893024|FG002|Overall Study|Protocol Violation|1|||
23591275|NCT00716144|65893025|FG003|Overall Study|Protocol Violation|0|||
23591276|NCT00716144|65893022|FG000|Overall Study|Physician Decision|0|||
23591277|NCT00716144|65893023|FG001|Overall Study|Physician Decision|1|||
23591278|NCT00716144|65893024|FG002|Overall Study|Physician Decision|2|||
23591279|NCT00716144|65893025|FG003|Overall Study|Physician Decision|2|||
23591280|NCT00716144|65893022|FG000|Overall Study|Intercurrent illness|0|||
23591281|NCT00716144|65893023|FG001|Overall Study|Intercurrent illness|0|||
23591282|NCT00716144|65893024|FG002|Overall Study|Intercurrent illness|1|||
23591283|NCT00716144|65893025|FG003|Overall Study|Intercurrent illness|0|||
23591284|NCT00716144|65893022|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
23591285|NCT00716144|65893023|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
23591286|NCT00716144|65893024|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
23591287|NCT00716144|65893025|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
23591288|NCT00716144|65893022|FG000|Overall Study|Adverse event: left foot pain|0|||
23591289|NCT00716144|65893023|FG001|Overall Study|Adverse event: left foot pain|1|||
23591290|NCT00716144|65893024|FG002|Overall Study|Adverse event: left foot pain|0|||
23591291|NCT00716144|65893025|FG003|Overall Study|Adverse event: left foot pain|0|||
23591292|NCT00716144|65893022|FG000|Overall Study|Clinical Depression|0|||
23591293|NCT00716144|65893023|FG001|Overall Study|Clinical Depression|1|||
23591294|NCT00716144|65893024|FG002|Overall Study|Clinical Depression|0|||
23591295|NCT00716144|65893025|FG003|Overall Study|Clinical Depression|0|||
23591296|NCT02139046|65893026|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23591297|NCT02139046|65893027|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
23591298|NCT02139046|65893028|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
23591299|NCT02139046|65893029|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
23591300|NCT02139046|65893030|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
23591301|NCT02139046|65893026|FG000|Overall Study|Major Protocol Deviation|9|||
23591302|NCT02139046|65893027|FG001|Overall Study|Major Protocol Deviation|10|||
23591303|NCT02139046|65893028|FG002|Overall Study|Major Protocol Deviation|16|||
23591304|NCT02139046|65893029|FG003|Overall Study|Major Protocol Deviation|12|||
23591305|NCT02139046|65893030|FG004|Overall Study|Major Protocol Deviation|6|||
23591306|NCT02139046|65893026|FG000|Overall Study|Lost to Follow-up|13|||
23591307|NCT02139046|65893027|FG001|Overall Study|Lost to Follow-up|16|||
23591308|NCT02139046|65893028|FG002|Overall Study|Lost to Follow-up|16|||
23591309|NCT02139046|65893029|FG003|Overall Study|Lost to Follow-up|18|||
23591310|NCT02139046|65893030|FG004|Overall Study|Lost to Follow-up|13|||
23591311|NCT02139046|65893026|FG000|Overall Study|Voluntary Withdrawal|20|||
23591312|NCT02139046|65893027|FG001|Overall Study|Voluntary Withdrawal|8|||
23591313|NCT02139046|65893028|FG002|Overall Study|Voluntary Withdrawal|10|||
23591314|NCT02139046|65893029|FG003|Overall Study|Voluntary Withdrawal|15|||
23591315|NCT02139046|65893030|FG004|Overall Study|Voluntary Withdrawal|16|||
23591316|NCT02139046|65893026|FG000|Overall Study|Lack of Efficacy|0|||
23591317|NCT02139046|65893027|FG001|Overall Study|Lack of Efficacy|1|||
23591318|NCT02139046|65893028|FG002|Overall Study|Lack of Efficacy|2|||
23591319|NCT02139046|65893029|FG003|Overall Study|Lack of Efficacy|1|||
23591320|NCT02139046|65893030|FG004|Overall Study|Lack of Efficacy|2|||
23591321|NCT02139046|65893026|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
23591322|NCT02139046|65893027|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
23591323|NCT02139046|65893028|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
23591324|NCT02139046|65893029|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
23591325|NCT02139046|65893030|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
23591326|NCT02139046|65893026|FG000|Overall Study|Other Miscellaneous Reasons|10|||
23591327|NCT02139046|65893027|FG001|Overall Study|Other Miscellaneous Reasons|9|||
23591328|NCT02139046|65893028|FG002|Overall Study|Other Miscellaneous Reasons|4|||
23476303|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
23591329|NCT02139046|65893029|FG003|Overall Study|Other Miscellaneous Reasons|9|||
23591330|NCT02139046|65893030|FG004|Overall Study|Other Miscellaneous Reasons|12|||
23591331|NCT00630786|65893031|FG000|Overall Study|Physician Decision|0|||
23591332|NCT00630786|65893032|FG001|Overall Study|Physician Decision|0|||
23591333|NCT00630786|65893033|FG002|Overall Study|Physician Decision|1|||
23591334|NCT00630786|65893031|FG000|Overall Study|Withdrawal by Subject|0|||
23591335|NCT00630786|65893032|FG001|Overall Study|Withdrawal by Subject|1|||
23591336|NCT00630786|65893033|FG002|Overall Study|Withdrawal by Subject|1|||
23591337|NCT00630786|65893031|FG000|Overall Study|Lost to Follow-up|0|||
23591338|NCT00630786|65893032|FG001|Overall Study|Lost to Follow-up|1|||
23591339|NCT00630786|65893033|FG002|Overall Study|Lost to Follow-up|0|||
23591340|NCT00630786|65893031|FG000|Overall Study|Other|1|||
23591341|NCT00630786|65893032|FG001|Overall Study|Other|0|||
23591342|NCT00630786|65893033|FG002|Overall Study|Other|0|||
23591343|NCT01135511|65893036|FG000|Overall Study|Adverse Event|0|||
23591344|NCT01135511|65893037|FG001|Overall Study|Adverse Event|1|||
23591345|NCT01135511|65893038|FG002|Overall Study|Adverse Event|2|||
23591346|NCT01135511|65893039|FG003|Overall Study|Adverse Event|0|||
23591347|NCT01135511|65893040|FG004|Overall Study|Adverse Event|0|||
23591348|NCT01135511|65893041|FG005|Overall Study|Adverse Event|1|||
23591349|NCT01135511|65893042|FG006|Overall Study|Adverse Event|0|||
23591350|NCT01135511|65893043|FG007|Overall Study|Adverse Event|1|||
23591351|NCT01135511|65893044|FG008|Overall Study|Adverse Event|0|||
23591352|NCT01135511|65893036|FG000|Overall Study|Lack of Efficacy|0|||
23591353|NCT01135511|65893037|FG001|Overall Study|Lack of Efficacy|1|||
23591354|NCT01135511|65893038|FG002|Overall Study|Lack of Efficacy|1|||
23798823|NCT02274948|66640074|FG001|Overall Study|Left the area|3|||
23798824|NCT00941720|66640080|FG000|Overall Study|Withdrawal by Subject|1|||
23798825|NCT00941720|66640080|FG000|Overall Study|Insurance denied participation|11|||
23798826|NCT00941720|66640080|FG000|Overall Study|ineligible|2|||
23798827|NCT02710214|66640081|FG000|Overall Study|Lost to Follow-up|1|||
23798828|NCT02710214|66640082|FG001|Overall Study|Lost to Follow-up|0|||
23798829|NCT02710214|66640081|FG000|Overall Study|Lack of Efficacy|0|||
23798830|NCT02710214|66640082|FG001|Overall Study|Lack of Efficacy|1|||
23798831|NCT02710214|66640081|FG000|Overall Study|Death|0|||
23798832|NCT02710214|66640082|FG001|Overall Study|Death|1|||
23798833|NCT03069417|66640083|FG000|Overall Study|Lost to Follow-up|2|||
23798834|NCT03069417|66640084|FG001|Overall Study|Lost to Follow-up|0|||
23798835|NCT03069417|66640083|FG000|Overall Study|Reason Unknown|4|||
23798836|NCT03069417|66640084|FG001|Overall Study|Reason Unknown|7|||
23798837|NCT04314843|66640087|FG000|Overall Study|Death|2|||
23798838|NCT04314843|66640088|FG001|Overall Study|Death|2|||
23798839|NCT04314843|66640087|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
23798840|NCT04314843|66640088|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
23798841|NCT02148445|66640089|FG000|Overall Study|Death|1|||
23798842|NCT02148445|66640090|FG001|Overall Study|Death|3|||
23798843|NCT00754052|66640091|FG000|Overall Study|Study terminated by Sponsor|5|||
23476304|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
23476305|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Adverse Event|7|||
23476306|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Adverse Event|6|||
23476307|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
23476308|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
23476309|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Physician Decision|4|||
23476310|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Physician Decision|4|||
23476311|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
23476312|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
23476313|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
23476314|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
23476315|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
23476316|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
23476317|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Non-compliance|1|||
23476318|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Non-compliance|0|||
23476319|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
23476320|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
23476321|NCT00470834|65488050|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
23476322|NCT00470834|65488051|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
23476323|NCT00470834|65488050|FG000|Extension Period (24 Months)|Adverse Event|3|||
23476324|NCT00470834|65488051|FG001|Extension Period (24 Months)|Adverse Event|4|||
23476325|NCT00470834|65488050|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
23591355|NCT01135511|65893039|FG003|Overall Study|Lack of Efficacy|2|||
23591356|NCT01135511|65893040|FG004|Overall Study|Lack of Efficacy|0|||
23591357|NCT01135511|65893041|FG005|Overall Study|Lack of Efficacy|0|||
23591358|NCT01135511|65893042|FG006|Overall Study|Lack of Efficacy|0|||
23591359|NCT01135511|65893043|FG007|Overall Study|Lack of Efficacy|0|||
23591360|NCT01135511|65893044|FG008|Overall Study|Lack of Efficacy|0|||
23591361|NCT01135511|65893036|FG000|Overall Study|Protocol Violation|0|||
23798844|NCT00754052|66640092|FG001|Overall Study|Study terminated by Sponsor|3|||
23798845|NCT02563769|66640093|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
23798846|NCT02563769|66640094|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
23798847|NCT02563769|66640095|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
23798848|NCT03785145|66640096|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
23798849|NCT03785145|66640097|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
23798850|NCT03785145|66640096|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
23798851|NCT03785145|66640097|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
23798852|NCT03785145|66640096|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
23798853|NCT03785145|66640097|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
23798854|NCT03785145|66640096|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
23798855|NCT03785145|66640097|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
23798856|NCT03785145|66640096|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
23798857|NCT03785145|66640097|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
23798858|NCT03785145|66640096|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
23798859|NCT03785145|66640097|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
23798860|NCT03785145|66640096|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
23591362|NCT01135511|65893037|FG001|Overall Study|Protocol Violation|0|||
23591363|NCT01135511|65893038|FG002|Overall Study|Protocol Violation|3|||
23591364|NCT01135511|65893039|FG003|Overall Study|Protocol Violation|0|||
23591365|NCT01135511|65893040|FG004|Overall Study|Protocol Violation|0|||
23591366|NCT01135511|65893041|FG005|Overall Study|Protocol Violation|0|||
23591367|NCT01135511|65893042|FG006|Overall Study|Protocol Violation|0|||
23591368|NCT01135511|65893043|FG007|Overall Study|Protocol Violation|0|||
23591369|NCT01135511|65893044|FG008|Overall Study|Protocol Violation|0|||
23591370|NCT01135511|65893036|FG000|Overall Study|Pregnancy|0|||
23591371|NCT01135511|65893037|FG001|Overall Study|Pregnancy|0|||
23591372|NCT01135511|65893038|FG002|Overall Study|Pregnancy|0|||
23591373|NCT01135511|65893039|FG003|Overall Study|Pregnancy|1|||
23591374|NCT01135511|65893040|FG004|Overall Study|Pregnancy|0|||
23591375|NCT01135511|65893041|FG005|Overall Study|Pregnancy|0|||
23591376|NCT01135511|65893042|FG006|Overall Study|Pregnancy|0|||
23591377|NCT01135511|65893043|FG007|Overall Study|Pregnancy|0|||
23591378|NCT01135511|65893044|FG008|Overall Study|Pregnancy|0|||
23591379|NCT01135511|65893036|FG000|Overall Study|could not visit the clinic|0|||
23591380|NCT01135511|65893037|FG001|Overall Study|could not visit the clinic|1|||
23591381|NCT01135511|65893038|FG002|Overall Study|could not visit the clinic|2|||
23591382|NCT01135511|65893039|FG003|Overall Study|could not visit the clinic|0|||
23591383|NCT01135511|65893040|FG004|Overall Study|could not visit the clinic|0|||
23591384|NCT01135511|65893041|FG005|Overall Study|could not visit the clinic|0|||
23591385|NCT01135511|65893042|FG006|Overall Study|could not visit the clinic|0|||
23591386|NCT01135511|65893043|FG007|Overall Study|could not visit the clinic|0|||
23591387|NCT01135511|65893044|FG008|Overall Study|could not visit the clinic|0|||
23591388|NCT01135511|65893036|FG000|Overall Study|noncompliance with study drug taken|0|||
23591389|NCT01135511|65893037|FG001|Overall Study|noncompliance with study drug taken|0|||
23591390|NCT01135511|65893038|FG002|Overall Study|noncompliance with study drug taken|0|||
23591391|NCT01135511|65893039|FG003|Overall Study|noncompliance with study drug taken|0|||
23591392|NCT01135511|65893040|FG004|Overall Study|noncompliance with study drug taken|1|||
23591393|NCT01135511|65893041|FG005|Overall Study|noncompliance with study drug taken|0|||
23591394|NCT01135511|65893042|FG006|Overall Study|noncompliance with study drug taken|0|||
23591395|NCT01135511|65893043|FG007|Overall Study|noncompliance with study drug taken|0|||
23591396|NCT01135511|65893044|FG008|Overall Study|noncompliance with study drug taken|0|||
23591397|NCT01135511|65893036|FG000|Overall Study|Withdrawal by Subject|0|||
23591398|NCT01135511|65893037|FG001|Overall Study|Withdrawal by Subject|0|||
23591399|NCT01135511|65893038|FG002|Overall Study|Withdrawal by Subject|0|||
23591400|NCT01135511|65893039|FG003|Overall Study|Withdrawal by Subject|0|||
23591401|NCT01135511|65893040|FG004|Overall Study|Withdrawal by Subject|0|||
23591402|NCT01135511|65893041|FG005|Overall Study|Withdrawal by Subject|0|||
23360094|NCT01720524|65062833|FG001|Part A|Other|1|||
23360095|NCT01720524|65062832|FG000|Part A|Lost to Follow-up|0|||
23591403|NCT01135511|65893042|FG006|Overall Study|Withdrawal by Subject|1|||
23591404|NCT01135511|65893043|FG007|Overall Study|Withdrawal by Subject|0|||
23591405|NCT01135511|65893044|FG008|Overall Study|Withdrawal by Subject|1|||
23798861|NCT03785145|66640097|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
23476326|NCT00470834|65488051|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
23476327|NCT00470834|65488050|FG000|Extension Period (24 Months)|Physician Decision|4|||
23360096|NCT01720524|65062833|FG001|Part A|Lost to Follow-up|1|||
23591406|NCT02613364|65893045|FG000|Overall Study|Other|19|||
23591407|NCT02613364|65893046|FG001|Overall Study|Other|29|||
23591408|NCT02613364|65893047|FG002|Overall Study|Other|17|||
23591409|NCT02613364|65893045|FG000|Overall Study|Too time consuming|21|||
23591410|NCT02613364|65893046|FG001|Overall Study|Too time consuming|26|||
23591411|NCT02613364|65893047|FG002|Overall Study|Too time consuming|26|||
23591412|NCT02613364|65893045|FG000|Overall Study|Withdrawal by Subject|13|||
23591413|NCT02613364|65893046|FG001|Overall Study|Withdrawal by Subject|18|||
23591414|NCT02613364|65893047|FG002|Overall Study|Withdrawal by Subject|17|||
23591415|NCT02613364|65893045|FG000|Overall Study|Medical|12|||
23798862|NCT03785145|66640096|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
23798863|NCT03785145|66640097|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
23798864|NCT03785145|66640096|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
23798865|NCT03785145|66640097|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
23798866|NCT03785145|66640096|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
23798867|NCT03785145|66640097|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
23798868|NCT03785145|66640096|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
23798869|NCT03785145|66640097|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
23798870|NCT02999984|66640098|FG000|Overall Study|Treatment Failure|1|||
23798871|NCT01563237|66640099|FG000|Overall Study|Lost to Follow-up|6|||
23798872|NCT01563237|66640100|FG001|Overall Study|Lost to Follow-up|0|||
23798873|NCT01563237|66640099|FG000|Overall Study|Withdrawal by Subject|1|||
23798874|NCT01563237|66640100|FG001|Overall Study|Withdrawal by Subject|0|||
23798875|NCT01563237|66640099|FG000|Overall Study|Adverse Event|1|||
23798876|NCT01563237|66640100|FG001|Overall Study|Adverse Event|0|||
23798877|NCT01563237|66640099|FG000|Overall Study|Medical Reasons|1|||
23798878|NCT01563237|66640100|FG001|Overall Study|Medical Reasons|0|||
23798879|NCT01563237|66640099|FG000|Overall Study|Death|1|||
23798880|NCT01563237|66640100|FG001|Overall Study|Death|0|||
23798881|NCT00251316|66640101|FG000|Overall Study|Physician Decision|2|||
23798882|NCT00251316|66640102|FG001|Overall Study|Physician Decision|3|||
23798883|NCT01074008|66640103|FG000|Overall Study|Adverse Event|0|||
23798884|NCT01074008|66640104|FG001|Overall Study|Adverse Event|1|||
23798885|NCT01074008|66640105|FG002|Overall Study|Adverse Event|0|||
23798886|NCT01074008|66640106|FG003|Overall Study|Adverse Event|0|||
23798887|NCT01074008|66640107|FG004|Overall Study|Adverse Event|0|||
23798888|NCT01074008|66640108|FG005|Overall Study|Adverse Event|0|||
23798889|NCT01074008|66640109|FG006|Overall Study|Adverse Event|0|||
23798890|NCT01074008|66640110|FG007|Overall Study|Adverse Event|0|||
23798891|NCT01074008|66640111|FG008|Overall Study|Adverse Event|0|||
23798892|NCT01074008|66640103|FG000|Overall Study|Withdrawal by Subject|1|||
23798893|NCT01074008|66640104|FG001|Overall Study|Withdrawal by Subject|1|||
23798894|NCT01074008|66640105|FG002|Overall Study|Withdrawal by Subject|1|||
23798895|NCT01074008|66640106|FG003|Overall Study|Withdrawal by Subject|0|||
23798896|NCT01074008|66640107|FG004|Overall Study|Withdrawal by Subject|1|||
23798897|NCT01074008|66640108|FG005|Overall Study|Withdrawal by Subject|0|||
23798898|NCT01074008|66640109|FG006|Overall Study|Withdrawal by Subject|0|||
23360097|NCT01720524|65062832|FG000|Part B|No longer willing to participate in study|1|||
23360098|NCT01720524|65062833|FG001|Part B|No longer willing to participate in study|4|||
23360099|NCT01720524|65062832|FG000|Part B|Other|2|||
23360100|NCT01720524|65062833|FG001|Part B|Other|0|||
23360101|NCT01720524|65062832|FG000|Part B|Lost to Follow-up|2|||
23360102|NCT01720524|65062833|FG001|Part B|Lost to Follow-up|3|||
23360103|NCT01720524|65062832|FG000|Part B|Death|0|||
23360104|NCT01720524|65062833|FG001|Part B|Death|2|||
23360105|NCT04399889|65062834|FG000|Overall Study|Death|5|||
23360106|NCT04399889|65062835|FG001|Overall Study|Death|1|||
23360107|NCT04399889|65062836|FG002|Overall Study|Death|1|||
23360108|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
23360109|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
23360110|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
23360111|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
23360112|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
23360113|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
23360114|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
23476328|NCT00470834|65488051|FG001|Extension Period (24 Months)|Physician Decision|3|||
23798899|NCT01074008|66640110|FG007|Overall Study|Withdrawal by Subject|0|||
23798900|NCT01074008|66640111|FG008|Overall Study|Withdrawal by Subject|0|||
23798901|NCT01074008|66640103|FG000|Overall Study|Lost to Follow-up|0|||
23798902|NCT01074008|66640104|FG001|Overall Study|Lost to Follow-up|1|||
23798903|NCT01074008|66640105|FG002|Overall Study|Lost to Follow-up|1|||
23360115|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
23360116|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
23360117|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
23798904|NCT01074008|66640106|FG003|Overall Study|Lost to Follow-up|1|||
23798905|NCT01074008|66640107|FG004|Overall Study|Lost to Follow-up|1|||
23798906|NCT01074008|66640108|FG005|Overall Study|Lost to Follow-up|0|||
23591416|NCT02613364|65893046|FG001|Overall Study|Medical|13|||
23591417|NCT02613364|65893047|FG002|Overall Study|Medical|9|||
23591418|NCT02613364|65893045|FG000|Overall Study|Disliked Study Procedure|1|||
23591419|NCT02613364|65893046|FG001|Overall Study|Disliked Study Procedure|1|||
23591420|NCT02613364|65893047|FG002|Overall Study|Disliked Study Procedure|4|||
23591421|NCT02613364|65893045|FG000|Overall Study|Disliked Intervention|0|||
23591422|NCT02613364|65893046|FG001|Overall Study|Disliked Intervention|3|||
23591423|NCT02613364|65893047|FG002|Overall Study|Disliked Intervention|3|||
23591424|NCT01350804|65893049|FG000|Core Study|Withdrawal by Subject|11|||
23591425|NCT01350804|65893050|FG001|Core Study|Withdrawal by Subject|17|||
23591426|NCT01350804|65893051|FG002|Core Study|Withdrawal by Subject|16|||
23591427|NCT01350804|65893052|FG003|Core Study|Withdrawal by Subject|7|||
23591428|NCT01350804|65893049|FG000|Core Study|Study terminated by Sponsor|0|||
23591429|NCT01350804|65893050|FG001|Core Study|Study terminated by Sponsor|0|||
23591430|NCT01350804|65893051|FG002|Core Study|Study terminated by Sponsor|0|||
23591431|NCT01350804|65893052|FG003|Core Study|Study terminated by Sponsor|2|||
23591432|NCT01350804|65893049|FG000|Core Study|Protocol deviation|1|||
23591433|NCT01350804|65893050|FG001|Core Study|Protocol deviation|0|||
23591434|NCT01350804|65893051|FG002|Core Study|Protocol deviation|1|||
23591435|NCT01350804|65893052|FG003|Core Study|Protocol deviation|0|||
23591436|NCT01350804|65893049|FG000|Core Study|Physician Decision|1|||
23591437|NCT01350804|65893050|FG001|Core Study|Physician Decision|0|||
23591438|NCT01350804|65893051|FG002|Core Study|Physician Decision|1|||
23591439|NCT01350804|65893052|FG003|Core Study|Physician Decision|3|||
23591440|NCT01350804|65893049|FG000|Core Study|Lost to Follow-up|3|||
23591441|NCT01350804|65893050|FG001|Core Study|Lost to Follow-up|0|||
23591442|NCT01350804|65893051|FG002|Core Study|Lost to Follow-up|2|||
23591443|NCT01350804|65893052|FG003|Core Study|Lost to Follow-up|1|||
23591444|NCT01350804|65893049|FG000|Core Study|Lack of Efficacy|16|||
23591445|NCT01350804|65893050|FG001|Core Study|Lack of Efficacy|19|||
23591446|NCT01350804|65893051|FG002|Core Study|Lack of Efficacy|18|||
23591447|NCT01350804|65893052|FG003|Core Study|Lack of Efficacy|5|||
23591448|NCT01350804|65893049|FG000|Core Study|Death|1|||
23591449|NCT01350804|65893050|FG001|Core Study|Death|1|||
23591450|NCT01350804|65893051|FG002|Core Study|Death|1|||
23591451|NCT01350804|65893052|FG003|Core Study|Death|0|||
23591452|NCT01350804|65893049|FG000|Core Study|Adverse Event|8|||
23591453|NCT01350804|65893050|FG001|Core Study|Adverse Event|10|||
23591454|NCT01350804|65893051|FG002|Core Study|Adverse Event|8|||
23591455|NCT01350804|65893052|FG003|Core Study|Adverse Event|8|||
23591456|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
23591457|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
23591458|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
23591459|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
23591460|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
23591461|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
23591462|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
23591463|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
23591464|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
23591465|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
23591466|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
23591467|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
23591468|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591469|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
23591470|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591471|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591472|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
23591473|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
23591474|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
23591475|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
23591476|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
23591477|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
23591478|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
23591479|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
23591480|NCT01321606|65893053|FG000|Overall Study|Lost to Follow-up|0|||
23591481|NCT01321606|65893054|FG001|Overall Study|Lost to Follow-up|0|||
23591482|NCT01321606|65893055|FG002|Overall Study|Lost to Follow-up|0|||
23591483|NCT01321606|65893056|FG003|Overall Study|Lost to Follow-up|1|||
23798907|NCT01074008|66640109|FG006|Overall Study|Lost to Follow-up|1|||
23591484|NCT00558363|65893058|FG000|Overall Study|Physician Decision|18|||
23591485|NCT00558363|65893059|FG001|Overall Study|Physician Decision|4|||
23591486|NCT00558363|65893058|FG000|Overall Study|Withdrawal by Subject|11|||
23591487|NCT00558363|65893059|FG001|Overall Study|Withdrawal by Subject|4|||
23591488|NCT00558363|65893058|FG000|Overall Study|Adverse Event|5|||
23591489|NCT00558363|65893059|FG001|Overall Study|Adverse Event|5|||
23591490|NCT00558363|65893058|FG000|Overall Study|Lack of Efficacy|2|||
23591491|NCT00558363|65893059|FG001|Overall Study|Lack of Efficacy|2|||
23591492|NCT00558363|65893058|FG000|Overall Study|Protocol Violation|2|||
23591493|NCT00558363|65893059|FG001|Overall Study|Protocol Violation|1|||
23591494|NCT00558363|65893058|FG000|Overall Study|Lost to Follow-up|0|||
23591495|NCT00558363|65893059|FG001|Overall Study|Lost to Follow-up|1|||
23591496|NCT00558363|65893058|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
23591497|NCT00558363|65893059|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
23591498|NCT00558363|65893058|FG000|Overall Study|Randomized in Error|1|||
23591499|NCT00558363|65893059|FG001|Overall Study|Randomized in Error|2|||
23591500|NCT00558363|65893058|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
23591501|NCT00558363|65893059|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
23591502|NCT00617201|65893060|FG000|Overall Study|Lost to Follow-up|9|||
23591503|NCT00617201|65893061|FG001|Overall Study|Lost to Follow-up|13|||
23591504|NCT01147341|65893062|FG000|Double Blind Period|Lack of Efficacy|1|||
23591505|NCT01147341|65893063|FG001|Double Blind Period|Lack of Efficacy|1|||
23591506|NCT01147341|65893062|FG000|Double Blind Period|Withdrawal by Subject|0|||
23591507|NCT01147341|65893063|FG001|Double Blind Period|Withdrawal by Subject|1|||
23591508|NCT01147341|65893062|FG000|Open Label Period|Lack of Efficacy|3|||
23591509|NCT01147341|65893063|FG001|Open Label Period|Lack of Efficacy|0|||
23591510|NCT01147341|65893062|FG000|Open Label Period|Subject moved|1|||
23591511|NCT01147341|65893063|FG001|Open Label Period|Subject moved|0|||
23591512|NCT00951379|65893071|FG000|Overall Study|Adverse Event|4|||
23591513|NCT00951379|65893072|FG001|Overall Study|Adverse Event|1|||
23591514|NCT00951379|65893071|FG000|Overall Study|Withdrawal by Subject|1|||
23591515|NCT00951379|65893072|FG001|Overall Study|Withdrawal by Subject|0|||
23591516|NCT00951379|65893071|FG000|Overall Study|Noncompliance|1|||
23591517|NCT00951379|65893072|FG001|Overall Study|Noncompliance|0|||
23591518|NCT00951379|65893071|FG000|Overall Study|Disease Progression|0|||
23591519|NCT00951379|65893072|FG001|Overall Study|Disease Progression|1|||
23591520|NCT03299816|65893084|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
23591521|NCT03299816|65893085|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
23591522|NCT03299816|65893084|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
23591523|NCT03299816|65893085|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
23591524|NCT03299816|65893084|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
23591525|NCT03299816|65893085|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
23591526|NCT00585533|65893086|FG000|Overall Study|objective or symptomatic progression|9|||
23591527|NCT02613871|65895940|FG000|Overall Study|Death|2|||
23591528|NCT02613871|65895940|FG000|Overall Study|Withdrew Consent|1|||
23591529|NCT00638963|65895946|FG000|Overall Study|Withdrawal by Subject|1|||
23591530|NCT00638963|65895947|FG001|Overall Study|Withdrawal by Subject|0|||
23591531|NCT01259102|65895948|FG000|Overall Study|Adverse Event|1|||
23591532|NCT01259102|65895949|FG001|Overall Study|Adverse Event|0|||
23591533|NCT01259102|65895950|FG002|Overall Study|Adverse Event|1|||
23591534|NCT01259102|65895951|FG003|Overall Study|Adverse Event|1|||
23591535|NCT01259102|65895952|FG004|Overall Study|Adverse Event|0|||
23591536|NCT01259102|65895948|FG000|Overall Study|Other|0|||
23591537|NCT01259102|65895949|FG001|Overall Study|Other|0|||
23591538|NCT01259102|65895950|FG002|Overall Study|Other|1|||
23591539|NCT01259102|65895951|FG003|Overall Study|Other|1|||
23591540|NCT01259102|65895952|FG004|Overall Study|Other|1|||
23591541|NCT03720210|65895955|FG000|Overall Study|Lost to Follow-up|1|||
23591542|NCT02694978|65895956|FG000|Overall Study|Adverse Event|10|||
23591543|NCT02694978|65895957|FG001|Overall Study|Adverse Event|9|||
23591544|NCT02694978|65895956|FG000|Overall Study|Withdrawal by Subject|22|||
23591545|NCT02694978|65895957|FG001|Overall Study|Withdrawal by Subject|19|||
23591546|NCT02694978|65895956|FG000|Overall Study|Lost to Follow-up|14|||
23591547|NCT02694978|65895957|FG001|Overall Study|Lost to Follow-up|17|||
23591548|NCT02694978|65895956|FG000|Overall Study|Death|4|||
23591549|NCT02694978|65895957|FG001|Overall Study|Death|1|||
23591550|NCT02694978|65895956|FG000|Overall Study|Other-Decision of Participant|6|||
23591551|NCT02694978|65895957|FG001|Overall Study|Other-Decision of Participant|1|||
23591552|NCT02694978|65895956|FG000|Overall Study|Other-Investigator's decision|1|||
23591553|NCT02694978|65895957|FG001|Overall Study|Other-Investigator's decision|0|||
23591554|NCT02694978|65895956|FG000|Overall Study|Other-Unable to be reached|0|||
23591555|NCT02694978|65895957|FG001|Overall Study|Other-Unable to be reached|1|||
23591556|NCT02694978|65895956|FG000|Overall Study|Other-Protocol noncompliant|2|||
23591557|NCT02694978|65895957|FG001|Overall Study|Other-Protocol noncompliant|1|||
23591558|NCT02694978|65895956|FG000|Overall Study|Other-Personal reasons|3|||
23591559|NCT02694978|65895957|FG001|Overall Study|Other-Personal reasons|3|||
23591560|NCT02694978|65895956|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
23591561|NCT02694978|65895957|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
23591562|NCT02594735|65895958|FG000|Overall Study|Adverse Event|1|||
23591563|NCT00178399|65895959|FG000|Overall Study|Physician Decision|4|||
23591564|NCT00178399|65895959|FG000|Overall Study|Withdrawal by Subject|8|||
23591565|NCT00178399|65895959|FG000|Overall Study|Lost to Follow-up|1|||
23591566|NCT02692417|65895960|FG000|Overall Study|Withdrawal by Subject|5|||
23591567|NCT02692417|65895961|FG001|Overall Study|Withdrawal by Subject|1|||
23591568|NCT02692417|65895960|FG000|Overall Study|Adverse Event|1|||
23591569|NCT02692417|65895961|FG001|Overall Study|Adverse Event|0|||
23591570|NCT01161498|65895967|FG000|Overall Study|Disease Progression|0|||
23591571|NCT01161498|65895968|FG001|Overall Study|Disease Progression|1|||
23591572|NCT01692730|65895976|FG000|Overall Study|Lost to Follow-up|225|||
23591573|NCT01692730|65895977|FG001|Overall Study|Lost to Follow-up|227|||
23591574|NCT02027558|65895978|FG000|Overall Study|Death|0|||
23591575|NCT02027558|65895979|FG001|Overall Study|Death|1|||
23591576|NCT02027558|65895978|FG000|Overall Study|Withdrawal by Subject|2|||
23591577|NCT02027558|65895979|FG001|Overall Study|Withdrawal by Subject|0|||
23591578|NCT02027558|65895978|FG000|Overall Study|Lost to Follow-up|4|||
23591579|NCT02027558|65895979|FG001|Overall Study|Lost to Follow-up|1|||
23591580|NCT02027558|65895978|FG000|Overall Study|Refused assessment|3|||
23591581|NCT02027558|65895979|FG001|Overall Study|Refused assessment|0|||
23591582|NCT00361283|65895980|FG000|Overall Study|Lost to Follow-up|27|||
23591583|NCT01458210|65895984|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
23591584|NCT01458210|65895984|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
23591585|NCT01458210|65895984|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
23591586|NCT01458210|65895984|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
23591587|NCT01104415|65895985|FG000|Core Phase|Consent withdrawn by subjects|1|||
23591588|NCT01104415|65895986|FG001|Core Phase|Consent withdrawn by subjects|0|||
23591589|NCT01104415|65895985|FG000|Extension Period|Progressive disease|0|||
23591590|NCT01104415|65895986|FG001|Extension Period|Progressive disease|4|||
23591591|NCT01104415|65895985|FG000|Extension Period|Death|0|||
23591592|NCT01104415|65895986|FG001|Extension Period|Death|1|||
23591593|NCT01104415|65895985|FG000|Extension Period|Physician Decision|0|||
23591594|NCT01104415|65895986|FG001|Extension Period|Physician Decision|1|||
23591595|NCT01104415|65895985|FG000|Extension Period|Transition to Study LX1606.302|0|||
23591596|NCT01104415|65895986|FG001|Extension Period|Transition to Study LX1606.302|4|||
23591597|NCT01104415|65895985|FG000|Extension Period|Heart surgery/feeling miserable|0|||
23591598|NCT01104415|65895986|FG001|Extension Period|Heart surgery/feeling miserable|1|||
23591599|NCT00980330|65895991|FG000|Overall Study|Adverse Event|0|||
23591600|NCT00980330|65895992|FG001|Overall Study|Adverse Event|0|||
23591601|NCT00980330|65895993|FG002|Overall Study|Adverse Event|0|||
23591602|NCT00980330|65895994|FG003|Overall Study|Adverse Event|1|||
23591603|NCT00980330|65895995|FG004|Overall Study|Adverse Event|0|||
23591604|NCT00980330|65895996|FG005|Overall Study|Adverse Event|0|||
23591605|NCT00980330|65895997|FG006|Overall Study|Adverse Event|0|||
23591606|NCT00980330|65895991|FG000|Overall Study|Lost to Follow-up|1|||
23591607|NCT00980330|65895992|FG001|Overall Study|Lost to Follow-up|1|||
23591608|NCT00980330|65895993|FG002|Overall Study|Lost to Follow-up|4|||
23591609|NCT00980330|65895994|FG003|Overall Study|Lost to Follow-up|2|||
23591610|NCT00980330|65895995|FG004|Overall Study|Lost to Follow-up|1|||
23591611|NCT00980330|65895996|FG005|Overall Study|Lost to Follow-up|1|||
23591612|NCT00980330|65895997|FG006|Overall Study|Lost to Follow-up|2|||
23798908|NCT01074008|66640110|FG007|Overall Study|Lost to Follow-up|0|||
23798909|NCT01074008|66640111|FG008|Overall Study|Lost to Follow-up|4|||
23798910|NCT04211766|66640112|FG000|Overall Study|Withdrawal by Subject|5|||
23798911|NCT04211766|66640113|FG001|Overall Study|Withdrawal by Subject|1|||
23798912|NCT00869440|66640117|FG000|Overall Study|Withdrawal by Subject|1|||
23798913|NCT00869440|66640118|FG001|Overall Study|Withdrawal by Subject|0|||
23798914|NCT00869440|66640119|FG002|Overall Study|Withdrawal by Subject|0|||
23591613|NCT00980330|65895991|FG000|Overall Study|Withdrawal by Subject|2|||
23591614|NCT00980330|65895992|FG001|Overall Study|Withdrawal by Subject|4|||
23591615|NCT00980330|65895993|FG002|Overall Study|Withdrawal by Subject|4|||
23591616|NCT00980330|65895994|FG003|Overall Study|Withdrawal by Subject|1|||
23591617|NCT00980330|65895995|FG004|Overall Study|Withdrawal by Subject|3|||
23591618|NCT00980330|65895996|FG005|Overall Study|Withdrawal by Subject|2|||
23591619|NCT00980330|65895997|FG006|Overall Study|Withdrawal by Subject|5|||
23591620|NCT00980330|65895991|FG000|Overall Study|(not specified)|2|||
23591621|NCT00980330|65895992|FG001|Overall Study|(not specified)|0|||
23591622|NCT00980330|65895993|FG002|Overall Study|(not specified)|0|||
23591623|NCT00980330|65895994|FG003|Overall Study|(not specified)|1|||
23591624|NCT00980330|65895995|FG004|Overall Study|(not specified)|1|||
23591625|NCT00980330|65895996|FG005|Overall Study|(not specified)|1|||
23591626|NCT00980330|65895997|FG006|Overall Study|(not specified)|0|||
23591627|NCT02082158|65895998|FG000|Overall Study|Withdrawal by Subject|0|||
23591628|NCT02082158|65895999|FG001|Overall Study|Withdrawal by Subject|0|||
23591629|NCT02082158|65896000|FG002|Overall Study|Withdrawal by Subject|0|||
23591630|NCT02082158|65896001|FG003|Overall Study|Withdrawal by Subject|0|||
23591631|NCT02082158|65896002|FG004|Overall Study|Withdrawal by Subject|1|||
23591632|NCT02082158|65896003|FG005|Overall Study|Withdrawal by Subject|0|||
23591633|NCT02082158|65895998|FG000|Overall Study|Failed Fit-testing|8|||
23591634|NCT02082158|65895999|FG001|Overall Study|Failed Fit-testing|8|||
23591635|NCT02082158|65896000|FG002|Overall Study|Failed Fit-testing|14|||
23591636|NCT02082158|65896001|FG003|Overall Study|Failed Fit-testing|4|||
23591637|NCT02082158|65896002|FG004|Overall Study|Failed Fit-testing|3|||
23591638|NCT02082158|65896003|FG005|Overall Study|Failed Fit-testing|7|||
23591639|NCT01039688|65896005|FG000|Overall Study|Adverse Event|38|||
23591640|NCT01039688|65896006|FG001|Overall Study|Adverse Event|39|||
23591641|NCT01039688|65896007|FG002|Overall Study|Adverse Event|24|||
23591642|NCT01039688|65896005|FG000|Overall Study|Lack of Efficacy|20|||
23591643|NCT01039688|65896006|FG001|Overall Study|Lack of Efficacy|11|||
23591644|NCT01039688|65896007|FG002|Overall Study|Lack of Efficacy|26|||
23591645|NCT01039688|65896005|FG000|Overall Study|Lost to Follow-up|11|||
23591646|NCT01039688|65896006|FG001|Overall Study|Lost to Follow-up|9|||
23591647|NCT01039688|65896007|FG002|Overall Study|Lost to Follow-up|5|||
23591648|NCT01039688|65896005|FG000|Overall Study|Other|13|||
23591649|NCT01039688|65896006|FG001|Overall Study|Other|25|||
23591650|NCT01039688|65896007|FG002|Overall Study|Other|12|||
23591651|NCT01039688|65896005|FG000|Overall Study|Withdrawal by Subject|23|||
23591652|NCT01039688|65896006|FG001|Overall Study|Withdrawal by Subject|27|||
23591653|NCT01039688|65896007|FG002|Overall Study|Withdrawal by Subject|13|||
23591654|NCT01039688|65896005|FG000|Overall Study|Death|2|||
23591655|NCT01039688|65896006|FG001|Overall Study|Death|0|||
23591656|NCT01039688|65896007|FG002|Overall Study|Death|0|||
23591657|NCT02471755|65896027|FG000|Overall Study|Withdrawal by Subject|1|||
23591658|NCT02471755|65896028|FG001|Overall Study|Withdrawal by Subject|0|||
23591659|NCT02471755|65896027|FG000|Overall Study|Lost to Follow-up|0|||
23591660|NCT02471755|65896028|FG001|Overall Study|Lost to Follow-up|1|||
23591661|NCT00658996|65896029|FG000|First Intervention|Positive slit lamp finding|1|||
23591662|NCT00658996|65896030|FG001|First Intervention|Positive slit lamp finding|0|||
23591663|NCT00658996|65896029|FG000|First Intervention|Lack of lenses|0|||
23591664|NCT00658996|65896030|FG001|First Intervention|Lack of lenses|1|||
23591665|NCT00658996|65896029|FG000|Crossover Period|Physician Decision|1|||
23591666|NCT00658996|65896030|FG001|Crossover Period|Physician Decision|0|||
23591667|NCT00658996|65896029|FG000|Crossover Period|Ineligible|1|||
23591668|NCT00658996|65896030|FG001|Crossover Period|Ineligible|1|||
23591669|NCT00658996|65896029|FG000|Second Intervention|Developed a stye on upper lid|1|||
23591670|NCT00658996|65896030|FG001|Second Intervention|Developed a stye on upper lid|0|||
23591671|NCT00658996|65896029|FG000|Second Intervention|Positive slit lamp finding|0|||
23591672|NCT00658996|65896030|FG001|Second Intervention|Positive slit lamp finding|1|||
23591673|NCT00446550|65896031|FG000|Overall Study|Adverse Event|1|||
23591674|NCT00446550|65896032|FG001|Overall Study|Adverse Event|0|||
23591675|NCT02529995|65896033|FG000|Part A|Ongoing Study at Data Cut-off|14|||
23591676|NCT02529995|65896034|FG001|Part A|Ongoing Study at Data Cut-off|16|||
23591677|NCT02529995|65896033|FG000|Part A|Discontinued Study|1|||
23591678|NCT02529995|65896034|FG001|Part A|Discontinued Study|0|||
23591679|NCT02529995|65896033|FG000|Part B|Ongoing Study at Data Cut-off|0|||
23591680|NCT02529995|65896034|FG001|Part B|Ongoing Study at Data Cut-off|7|||
23591681|NCT02529995|65896033|FG000|Part B|Discontinued Study|6|||
23591682|NCT02529995|65896034|FG001|Part B|Discontinued Study|5|||
23591683|NCT01901276|65896038|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
23643936|NCT00658684|66079255|FG001|Overall Study|Adverse Event|8|||
23643937|NCT00658684|66079256|FG002|Overall Study|Adverse Event|2|||
23643938|NCT00658684|66079257|FG003|Overall Study|Adverse Event|0|||
23643939|NCT00658684|66079254|FG000|Overall Study|Withdrawal by Subject|6|||
23643940|NCT00658684|66079255|FG001|Overall Study|Withdrawal by Subject|4|||
23643941|NCT00658684|66079256|FG002|Overall Study|Withdrawal by Subject|1|||
23643942|NCT00658684|66079257|FG003|Overall Study|Withdrawal by Subject|1|||
23643943|NCT00658684|66079254|FG000|Overall Study|Lack of Efficacy|1|||
23643944|NCT00658684|66079255|FG001|Overall Study|Lack of Efficacy|1|||
23643945|NCT00658684|66079256|FG002|Overall Study|Lack of Efficacy|0|||
23643946|NCT00658684|66079257|FG003|Overall Study|Lack of Efficacy|0|||
23643947|NCT00658684|66079254|FG000|Overall Study|Protocol Violation|1|||
23643948|NCT00658684|66079255|FG001|Overall Study|Protocol Violation|1|||
23591684|NCT01901276|65896039|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
23591685|NCT00835770|65896040|FG000|Overall Study|MS Relapse|17|||
23591686|NCT00835770|65896041|FG001|Overall Study|MS Relapse|23|||
23591687|NCT00835770|65896040|FG000|Overall Study|MS Progression|14|||
23643949|NCT00658684|66079256|FG002|Overall Study|Protocol Violation|0|||
23643950|NCT00658684|66079257|FG003|Overall Study|Protocol Violation|0|||
23360118|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
23591688|NCT00835770|65896041|FG001|Overall Study|MS Progression|9|||
23591689|NCT00835770|65896040|FG000|Overall Study|Adverse Event|113|||
23591690|NCT00835770|65896041|FG001|Overall Study|Adverse Event|124|||
23591691|NCT00835770|65896040|FG000|Overall Study|Lost to Follow-up|22|||
23591692|NCT00835770|65896041|FG001|Overall Study|Lost to Follow-up|19|||
23591693|NCT00835770|65896040|FG000|Overall Study|Consent Withdrawn|144|||
23591694|NCT00835770|65896041|FG001|Overall Study|Consent Withdrawn|156|||
23591695|NCT00835770|65896040|FG000|Overall Study|Investigator Decision|42|||
23591696|NCT00835770|65896041|FG001|Overall Study|Investigator Decision|42|||
23591697|NCT00835770|65896040|FG000|Overall Study|Participant Non-Compliance|11|||
23591698|NCT00835770|65896041|FG001|Overall Study|Participant Non-Compliance|9|||
23591699|NCT00835770|65896040|FG000|Overall Study|Death|4|||
23591700|NCT00835770|65896041|FG001|Overall Study|Death|6|||
23591701|NCT00835770|65896040|FG000|Overall Study|Other|115|||
23591702|NCT00835770|65896041|FG001|Overall Study|Other|104|||
23591703|NCT00835770|65896040|FG000|Overall Study|Other|2|||
23591704|NCT00835770|65896041|FG001|Overall Study|Other|1|||
23360119|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
23360120|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
23360121|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
23360122|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Death|1|||
23360123|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Death|0|||
23360124|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
23360125|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
23360126|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
23360127|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
23360128|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
23360129|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
23360130|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
23360131|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
23360132|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
23360133|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
23360134|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
23360135|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
23360136|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
23360137|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
23360138|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
23360139|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
23360140|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
23360141|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
23360142|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Death|0|||
23360143|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Death|0|||
23360144|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
23360145|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
23360146|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
23360147|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
23360148|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
23360149|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
23591705|NCT02547922|65896042|FG000|Overall Study|Withdrawal by Subject|9|||
23591706|NCT02547922|65896043|FG001|Overall Study|Withdrawal by Subject|6|||
23591707|NCT02547922|65896044|FG002|Overall Study|Withdrawal by Subject|10|||
23591708|NCT02547922|65896042|FG000|Overall Study|Adverse Event|3|||
23360150|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
23476329|NCT00470834|65488050|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
23591709|NCT02547922|65896043|FG001|Overall Study|Adverse Event|1|||
23591710|NCT02547922|65896044|FG002|Overall Study|Adverse Event|2|||
23591711|NCT02547922|65896042|FG000|Overall Study|Lost to Follow-up|1|||
23591712|NCT02547922|65896043|FG001|Overall Study|Lost to Follow-up|0|||
23591713|NCT02547922|65896044|FG002|Overall Study|Lost to Follow-up|0|||
23643951|NCT00658684|66079254|FG000|Overall Study|Pregnancy|1|||
23643952|NCT00658684|66079255|FG001|Overall Study|Pregnancy|1|||
23591714|NCT02547922|65896042|FG000|Overall Study|Lack of Efficacy|5|||
23591715|NCT02547922|65896043|FG001|Overall Study|Lack of Efficacy|7|||
23591716|NCT02547922|65896044|FG002|Overall Study|Lack of Efficacy|4|||
23591717|NCT02547922|65896042|FG000|Overall Study|Death|1|||
23591718|NCT02547922|65896043|FG001|Overall Study|Death|0|||
23591719|NCT02547922|65896044|FG002|Overall Study|Death|0|||
23591720|NCT02547922|65896042|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
23591721|NCT02547922|65896043|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
23591722|NCT02547922|65896044|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
23591723|NCT02547922|65896042|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
23591724|NCT02547922|65896043|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
23591725|NCT02547922|65896044|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
23591726|NCT02547922|65896042|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
23591727|NCT02547922|65896043|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
23591728|NCT02547922|65896044|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
23591729|NCT02547922|65896042|FG000|Overall Study|Physician Decision|2|||
23591730|NCT02547922|65896043|FG001|Overall Study|Physician Decision|1|||
23591731|NCT02547922|65896044|FG002|Overall Study|Physician Decision|2|||
23591732|NCT02547922|65896042|FG000|Overall Study|Patients did not receive IP|1|||
23591733|NCT02547922|65896043|FG001|Overall Study|Patients did not receive IP|1|||
23591734|NCT02547922|65896044|FG002|Overall Study|Patients did not receive IP|0|||
23591735|NCT01266265|65896045|FG000|Overall Study|Death|95|||
23591736|NCT01266265|65896046|FG001|Overall Study|Death|73|||
23591737|NCT01266265|65896045|FG000|Overall Study|Lost to Follow-up|23|||
23591738|NCT01266265|65896046|FG001|Overall Study|Lost to Follow-up|28|||
23591739|NCT01266265|65896045|FG000|Overall Study|Withdrawal by Subject|13|||
23591740|NCT01266265|65896046|FG001|Overall Study|Withdrawal by Subject|11|||
23591741|NCT01266265|65896045|FG000|Overall Study|Respiratory-related adverse event|2|||
23591742|NCT01266265|65896046|FG001|Overall Study|Respiratory-related adverse event|1|||
23591743|NCT01266265|65896045|FG000|Overall Study|Transferred care to another provider|22|||
23591744|NCT01266265|65896046|FG001|Overall Study|Transferred care to another provider|28|||
23591745|NCT01266265|65896045|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
23591746|NCT01266265|65896046|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
23591747|NCT01266265|65896045|FG000|Overall Study|Enrolled in another clinical study|15|||
23591748|NCT01266265|65896046|FG001|Overall Study|Enrolled in another clinical study|26|||
23591749|NCT01266265|65896045|FG000|Overall Study|Non-compliance|8|||
23591750|NCT01266265|65896046|FG001|Overall Study|Non-compliance|5|||
23591751|NCT01266265|65896045|FG000|Overall Study|Lung transplant|6|||
23591752|NCT01266265|65896046|FG001|Overall Study|Lung transplant|5|||
23591753|NCT01266265|65896045|FG000|Overall Study|Site closed early|4|||
23591754|NCT01266265|65896046|FG001|Overall Study|Site closed early|3|||
23591755|NCT01266265|65896045|FG000|Overall Study|Clinical worsening|1|||
23591756|NCT01266265|65896046|FG001|Overall Study|Clinical worsening|1|||
23591757|NCT02139943|65896047|FG000|Overall Study|Adverse Event|0|||
23591758|NCT02139943|65896048|FG001|Overall Study|Adverse Event|1|||
23591759|NCT02139943|65896049|FG002|Overall Study|Adverse Event|2|||
23591760|NCT02139943|65896047|FG000|Overall Study|Lost to Follow-up|3|||
23591761|NCT02139943|65896048|FG001|Overall Study|Lost to Follow-up|2|||
23591762|NCT02139943|65896049|FG002|Overall Study|Lost to Follow-up|2|||
23591763|NCT02139943|65896047|FG000|Overall Study|Withdrawal by Subject|4|||
23591764|NCT02139943|65896048|FG001|Overall Study|Withdrawal by Subject|3|||
23591765|NCT02139943|65896049|FG002|Overall Study|Withdrawal by Subject|0|||
23591766|NCT02139943|65896047|FG000|Overall Study|Other|0|||
23591767|NCT02139943|65896048|FG001|Overall Study|Other|0|||
23591768|NCT02139943|65896049|FG002|Overall Study|Other|1|||
23591769|NCT02139943|65896047|FG000|Overall Study|Participant wishes to discontinue|2|||
23591770|NCT02139943|65896048|FG001|Overall Study|Participant wishes to discontinue|0|||
23591771|NCT02139943|65896049|FG002|Overall Study|Participant wishes to discontinue|0|||
23591772|NCT02139943|65896047|FG000|Overall Study|Participant in Poor Compliance|1|||
23591773|NCT02139943|65896048|FG001|Overall Study|Participant in Poor Compliance|0|||
23591774|NCT02139943|65896049|FG002|Overall Study|Participant in Poor Compliance|1|||
23591775|NCT02139943|65896047|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
23591776|NCT02139943|65896048|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
23591777|NCT02139943|65896049|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
23360151|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
23591778|NCT00835380|65896050|FG000|Overall Study|Withdrawal by Subject|2|||
23591779|NCT00869258|65896051|FG000|Overall Study|Physician Decision|1|||
23591780|NCT00988637|65896058|FG000|Overall Study|Lost to Follow-up|2|||
23591781|NCT00988637|65896059|FG001|Overall Study|Lost to Follow-up|1|||
23591782|NCT00988637|65896058|FG000|Overall Study|Withdrawal by Subject|1|||
23798915|NCT00869440|66640120|FG003|Overall Study|Withdrawal by Subject|0|||
23798916|NCT00869440|66640117|FG000|Overall Study|Physician Decision|1|||
23798917|NCT00869440|66640118|FG001|Overall Study|Physician Decision|1|||
23798918|NCT00869440|66640119|FG002|Overall Study|Physician Decision|0|||
23798919|NCT00869440|66640120|FG003|Overall Study|Physician Decision|0|||
23798920|NCT00602537|66640121|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
23798921|NCT00602537|66640122|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
23798922|NCT00602537|66640121|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
23798923|NCT00602537|66640122|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
23798924|NCT00602537|66640121|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
23798925|NCT00602537|66640122|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
23798926|NCT00602537|66640121|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
23798927|NCT00602537|66640122|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
23798928|NCT00602537|66640121|FG000|Follow Up Study Comparison|Adverse Event|1|||
23798929|NCT00602537|66640122|FG001|Follow Up Study Comparison|Adverse Event|0|||
23798930|NCT00602537|66640121|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
23798931|NCT00602537|66640122|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
23798932|NCT00602537|66640121|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
23798933|NCT00602537|66640122|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
23798934|NCT00761176|66640123|FG000|Overall Study|Death|1|||
23798935|NCT00761176|66640124|FG001|Overall Study|Death|0|||
23798936|NCT00761176|66640123|FG000|Overall Study|Withdrawal by Subject|1|||
23798937|NCT00761176|66640124|FG001|Overall Study|Withdrawal by Subject|1|||
23798938|NCT00588731|66640125|FG000|Overall Study|Withdrawal by Subject|3|||
23798939|NCT00588731|66640126|FG001|Overall Study|Withdrawal by Subject|2|||
23798940|NCT00438659|66640127|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
23798941|NCT00438659|66640128|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
23798942|NCT00438659|66640127|FG000|Overall Study|Cancel|5|||
23798943|NCT00438659|66640128|FG001|Overall Study|Cancel|2|||
23798944|NCT03401073|66640129|FG000|Overall Study|Lost to Follow-up|1|||
23798945|NCT03401073|66640130|FG001|Overall Study|Lost to Follow-up|2|||
23798946|NCT04823130|66640134|FG000|Overall Study|Withdrawal by Subject|2|||
23798947|NCT04823130|66640135|FG001|Overall Study|Withdrawal by Subject|3|||
23798948|NCT04823130|66640134|FG000|Overall Study|Failure to meet inclusion criteria|6|||
23798949|NCT04823130|66640135|FG001|Overall Study|Failure to meet inclusion criteria|4|||
23798950|NCT04823130|66640134|FG000|Overall Study|Other-unspecified|1|||
23798951|NCT04823130|66640135|FG001|Overall Study|Other-unspecified|0|||
23798952|NCT01301482|66640140|FG000|Overall Study|Withdrawal by Subject|1|||
23798953|NCT04405739|66640141|FG000|Overall Study|Adverse Event|0|||
23798954|NCT04405739|66640142|FG001|Overall Study|Adverse Event|1|||
23798955|NCT04405739|66640143|FG002|Overall Study|Adverse Event|0|||
23798956|NCT04405739|66640144|FG003|Overall Study|Adverse Event|0|||
23798957|NCT04405739|66640141|FG000|Overall Study|Lost to Follow-up|0|||
23798958|NCT04405739|66640142|FG001|Overall Study|Lost to Follow-up|2|||
23798959|NCT04405739|66640143|FG002|Overall Study|Lost to Follow-up|1|||
23798960|NCT04405739|66640144|FG003|Overall Study|Lost to Follow-up|3|||
23798961|NCT04405739|66640141|FG000|Overall Study|Withdrawal by Subject|0|||
23798962|NCT04405739|66640142|FG001|Overall Study|Withdrawal by Subject|2|||
23798963|NCT04405739|66640143|FG002|Overall Study|Withdrawal by Subject|1|||
23798964|NCT04405739|66640144|FG003|Overall Study|Withdrawal by Subject|1|||
23798965|NCT04405739|66640141|FG000|Overall Study|Death|0|||
23798966|NCT04405739|66640142|FG001|Overall Study|Death|0|||
23798967|NCT04405739|66640143|FG002|Overall Study|Death|1|||
23798968|NCT04405739|66640144|FG003|Overall Study|Death|0|||
23798969|NCT04405739|66640141|FG000|Overall Study|Transferred to rehab|0|||
23798970|NCT04405739|66640142|FG001|Overall Study|Transferred to rehab|0|||
23798971|NCT04405739|66640143|FG002|Overall Study|Transferred to rehab|0|||
23798972|NCT04405739|66640144|FG003|Overall Study|Transferred to rehab|1|||
23798973|NCT04405739|66640141|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
23798974|NCT04405739|66640142|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
23798975|NCT04405739|66640143|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
23798976|NCT04405739|66640144|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
23798977|NCT02012452|66640145|FG000|Overall Study|Lost to Follow-up|2|||
23798978|NCT02012452|66640146|FG001|Overall Study|Lost to Follow-up|1|||
23798979|NCT02012452|66640145|FG000|Overall Study|Withdrawal by Subject|4|||
23798980|NCT02012452|66640146|FG001|Overall Study|Withdrawal by Subject|0|||
23798981|NCT01915940|66640160|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
23798982|NCT01915940|66640161|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
23798983|NCT01915940|66640162|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
23798984|NCT01915940|66640160|FG000|Treatment Period|Decision of Participant|0|||
23798985|NCT01915940|66640161|FG001|Treatment Period|Decision of Participant|1|||
23798986|NCT01915940|66640162|FG002|Treatment Period|Decision of Participant|3|||
23798987|NCT01915940|66640160|FG000|Treatment Period|Adverse Event|0|||
23798988|NCT01915940|66640161|FG001|Treatment Period|Adverse Event|9|||
23798989|NCT01915940|66640162|FG002|Treatment Period|Adverse Event|1|||
23798990|NCT01915940|66640160|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23798991|NCT01915940|66640161|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
23798992|NCT01915940|66640162|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
23798993|NCT03438006|66640163|FG000|Overall Study|Adverse Event|1|||
23798994|NCT03438006|66640163|FG000|Overall Study|Lost to Follow-up|67|||
23798995|NCT03438006|66640163|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
23798996|NCT03438006|66640163|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
23798997|NCT02839798|66640168|FG000|Overall Study|Withdrawal by Subject|2|||
23798998|NCT03756883|66640169|FG000|Overall Study|Adverse Event|2|||
23798999|NCT03756883|66640170|FG001|Overall Study|Adverse Event|2|||
23799000|NCT03756883|66640171|FG002|Overall Study|Adverse Event|2|||
23799001|NCT03756883|66640169|FG000|Overall Study|Lack of Efficacy|0|||
23799002|NCT03756883|66640170|FG001|Overall Study|Lack of Efficacy|1|||
23799003|NCT03756883|66640171|FG002|Overall Study|Lack of Efficacy|2|||
23799004|NCT03756883|66640169|FG000|Overall Study|Lost to Follow-up|3|||
23799005|NCT03756883|66640170|FG001|Overall Study|Lost to Follow-up|3|||
23799006|NCT03756883|66640171|FG002|Overall Study|Lost to Follow-up|0|||
23799007|NCT03756883|66640169|FG000|Overall Study|Protocol Violation|2|||
23799008|NCT03756883|66640170|FG001|Overall Study|Protocol Violation|0|||
23799009|NCT03756883|66640171|FG002|Overall Study|Protocol Violation|1|||
23799010|NCT03756883|66640169|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
23799011|NCT03756883|66640170|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
23799012|NCT03756883|66640171|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
23799013|NCT03756883|66640169|FG000|Overall Study|Withdrawal by Subject|4|||
23799014|NCT03756883|66640170|FG001|Overall Study|Withdrawal by Subject|1|||
23799015|NCT03756883|66640171|FG002|Overall Study|Withdrawal by Subject|0|||
23476330|NCT00470834|65488051|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
23476331|NCT00470834|65488050|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
23476332|NCT00470834|65488051|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
23643953|NCT00658684|66079256|FG002|Overall Study|Pregnancy|0|||
23643954|NCT00658684|66079257|FG003|Overall Study|Pregnancy|0|||
23643955|NCT00356408|66079258|FG000|Overall Study|Adverse Event|9|||
23643956|NCT00356408|66079258|FG000|Overall Study|Lack of Efficacy|36|||
23643957|NCT00356408|66079258|FG000|Overall Study|Lost to Follow-up|2|||
23643958|NCT00356408|66079258|FG000|Overall Study|Withdrawal by Subject|6|||
23643959|NCT00356408|66079258|FG000|Overall Study|Other: Principal investigator discretion|3|||
23643960|NCT00356408|66079258|FG000|Overall Study|Other: Sponsor request|1|||
23643961|NCT00356408|66079258|FG000|Overall Study|Other: Azathioprine stopped|1|||
23643962|NCT00356408|66079258|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
23643963|NCT00356408|66079258|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
23643964|NCT00895154|66079261|FG000|Overall Study|Lost to Follow-up|1|||
23643965|NCT00895154|66079262|FG001|Overall Study|Lost to Follow-up|1|||
23643966|NCT00895154|66079261|FG000|Overall Study|Withdrawal by Subject|0|||
23643967|NCT00895154|66079262|FG001|Overall Study|Withdrawal by Subject|1|||
23643968|NCT02297139|66079263|FG000|Overall Study|Disease progression|0|||
23643969|NCT02297139|66079264|FG001|Overall Study|Disease progression|1|||
23643970|NCT02297139|66079263|FG000|Overall Study|Study drug toxicity|0|||
23643971|NCT02297139|66079264|FG001|Overall Study|Study drug toxicity|4|||
23643972|NCT02297139|66079263|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23643973|NCT02297139|66079264|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23476333|NCT00470834|65488050|FG000|Extension Period (24 Months)|Non-compliance|0|||
23643974|NCT02297139|66079263|FG000|Overall Study|Maximum clinical benefit|1|||
23643975|NCT02297139|66079264|FG001|Overall Study|Maximum clinical benefit|0|||
23799016|NCT03756883|66640169|FG000|Overall Study|Other Reasons|2|||
23799017|NCT03756883|66640170|FG001|Overall Study|Other Reasons|4|||
23799018|NCT03756883|66640171|FG002|Overall Study|Other Reasons|0|||
23799019|NCT03449199|66640172|FG000|Overall Study|Lost to Follow-up|1|||
23799020|NCT03449199|66640173|FG001|Overall Study|Lost to Follow-up|1|||
23476334|NCT00470834|65488051|FG001|Extension Period (24 Months)|Non-compliance|1|||
23476335|NCT00470834|65488050|FG000|Extension Period (24 Months)|Disease Progression|0|||
23476336|NCT00470834|65488051|FG001|Extension Period (24 Months)|Disease Progression|1|||
23476337|NCT02184572|65488052|FG000|Overall Study|Lost to Follow-up|29|||
23476338|NCT02184572|65488053|FG001|Overall Study|Lost to Follow-up|21|||
23476339|NCT02184572|65488052|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
23476340|NCT02184572|65488053|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
23476341|NCT02184572|65488052|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
23476342|NCT02184572|65488053|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
23476343|NCT02184572|65488052|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
23476344|NCT02184572|65488053|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
23476345|NCT02184572|65488052|FG000|Overall Study|Traveling Outside The Country|1|||
23476346|NCT02184572|65488053|FG001|Overall Study|Traveling Outside The Country|0|||
23476347|NCT02184572|65488052|FG000|Overall Study|Withdrawal by Subject|14|||
23476348|NCT02184572|65488053|FG001|Overall Study|Withdrawal by Subject|9|||
23476349|NCT00874939|65488054|FG000|Overall Study|Study terminated|4|||
23476350|NCT01261780|65488055|FG000|Overall Study|Withdrawal by Subject|1|||
23476351|NCT01261780|65488056|FG001|Overall Study|Withdrawal by Subject|0|||
23476352|NCT01261780|65488055|FG000|Overall Study|Event not related to subject|1|||
23476353|NCT01261780|65488056|FG001|Overall Study|Event not related to subject|2|||
23476354|NCT01239732|65488058|FG000|Overall Study|Termination of study per protocol|667|||
23476355|NCT01239732|65488058|FG000|Overall Study|Death|226|||
23476356|NCT01239732|65488058|FG000|Overall Study|Withdrawal by Subject|87|||
23476357|NCT01239732|65488058|FG000|Overall Study|Adverse Event|6|||
23476358|NCT01239732|65488058|FG000|Overall Study|Protocol Violation|3|||
23476359|NCT01239732|65488058|FG000|Overall Study|Participant non compliance|5|||
23476360|NCT01239732|65488058|FG000|Overall Study|Study termination by sponsor|2|||
23476361|NCT01239732|65488058|FG000|Overall Study|Investigator's decision|4|||
23476362|NCT01239732|65488058|FG000|Overall Study|Treatment failure|2|||
23476363|NCT01239732|65488058|FG000|Overall Study|Other|19|||
23476364|NCT02736890|65488063|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
23476365|NCT02736890|65488064|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
23476366|NCT02736890|65488063|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
23476367|NCT02736890|65488064|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
23476368|NCT01771809|65488067|FG000|Overall Study|Adverse Event|4|||
23476369|NCT01771809|65488068|FG001|Overall Study|Adverse Event|12|||
23476370|NCT01771809|65488067|FG000|Overall Study|Protocol Violation|0|||
23476371|NCT01771809|65488068|FG001|Overall Study|Protocol Violation|1|||
23476372|NCT01771809|65488067|FG000|Overall Study|Withdrawal by Subject|34|||
23799021|NCT03449199|66640174|FG002|Overall Study|Lost to Follow-up|0|||
23476373|NCT01771809|65488068|FG001|Overall Study|Withdrawal by Subject|42|||
23476374|NCT01771809|65488067|FG000|Overall Study|Lost to Follow-up|1|||
23476375|NCT01771809|65488068|FG001|Overall Study|Lost to Follow-up|3|||
23476376|NCT01771809|65488067|FG000|Overall Study|Other (Insufficient clinical response)|22|||
23476377|NCT01771809|65488068|FG001|Overall Study|Other (Insufficient clinical response)|20|||
23476378|NCT01771809|65488067|FG000|Overall Study|Death|1|||
23476379|NCT01771809|65488068|FG001|Overall Study|Death|0|||
23476380|NCT01771809|65488067|FG000|Overall Study|Other (other)|9|||
23476381|NCT01771809|65488068|FG001|Overall Study|Other (other)|5|||
23476382|NCT02522624|65488069|FG000|Overall Study|Technical failure|1|||
23476383|NCT02522624|65488070|FG001|Overall Study|Technical failure|0|||
23476384|NCT01221285|65488071|FG000|Overall Study|Withdrawal by Subject|1|||
23476385|NCT02694757|65488072|FG000|Overall Study|Lack of Efficacy|3|||
23476386|NCT00913458|65488073|FG000|Phase 1|Non-Responder|54|||
23476387|NCT00913458|65488074|FG001|Phase 1|Non-Responder|0|||
23476388|NCT00913458|65488075|FG002|Phase 1|Non-Responder|0|||
23476389|NCT00913458|65488076|FG003|Phase 1|Non-Responder|0|||
23476390|NCT00913458|65488077|FG004|Phase 1|Non-Responder|0|||
23476391|NCT00913458|65488078|FG005|Phase 1|Non-Responder|0|||
23476392|NCT00913458|65488079|FG006|Phase 1|Non-Responder|0|||
23476393|NCT00913458|65488073|FG000|Phase 1|Subject Request|17|||
23476394|NCT00913458|65488074|FG001|Phase 1|Subject Request|0|||
23476395|NCT00913458|65488075|FG002|Phase 1|Subject Request|0|||
23476396|NCT00913458|65488076|FG003|Phase 1|Subject Request|0|||
23476397|NCT00913458|65488077|FG004|Phase 1|Subject Request|0|||
23799022|NCT03449199|66640172|FG000|Overall Study|Protocol Deviation|0|||
23799023|NCT03449199|66640173|FG001|Overall Study|Protocol Deviation|0|||
23476398|NCT00913458|65488078|FG005|Phase 1|Subject Request|0|||
23476399|NCT00913458|65488079|FG006|Phase 1|Subject Request|0|||
23476400|NCT00913458|65488073|FG000|Phase 1|Adverse Event|20|||
23476401|NCT00913458|65488074|FG001|Phase 1|Adverse Event|0|||
23476402|NCT00913458|65488075|FG002|Phase 1|Adverse Event|0|||
23476403|NCT00913458|65488076|FG003|Phase 1|Adverse Event|0|||
23476404|NCT00913458|65488077|FG004|Phase 1|Adverse Event|0|||
23476405|NCT00913458|65488078|FG005|Phase 1|Adverse Event|0|||
23476406|NCT00913458|65488079|FG006|Phase 1|Adverse Event|0|||
23643976|NCT02297139|66079263|FG000|Overall Study|Administrative reason by sponsor|0|||
23476407|NCT00913458|65488073|FG000|Phase 1|Lost to Follow-up|2|||
23799024|NCT03449199|66640174|FG002|Overall Study|Protocol Deviation|1|||
23591783|NCT00988637|65896059|FG001|Overall Study|Withdrawal by Subject|1|||
23591784|NCT00988637|65896058|FG000|Overall Study|non-compliance with study drug|0|||
23591785|NCT00988637|65896059|FG001|Overall Study|non-compliance with study drug|1|||
23591786|NCT01199705|65896062|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
23591787|NCT00004124|65896066|FG000|Overall Study|Received no protocol therapy|12|||
23591788|NCT00004124|65896067|FG001|Overall Study|Received no protocol therapy|20|||
23591789|NCT02705586|65896068|FG000|Overall Study|Health Issues|2|||
23591790|NCT02705586|65896068|FG000|Overall Study|Transportation Difficulties|5|||
23591791|NCT02705586|65896068|FG000|Overall Study|Vacation/Planned Absence|1|||
23591792|NCT04424641|65896071|FG000|Overall Study|Death|1|||
23360152|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
23360153|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
23360154|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
23360155|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
23360156|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
23360157|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
23360158|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
23360159|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
23360160|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
23360161|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
23360162|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
23360163|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
23360164|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
23591793|NCT04424641|65896072|FG001|Overall Study|Death|2|||
23591794|NCT04424641|65896073|FG002|Overall Study|Death|3|||
23591795|NCT04424641|65896074|FG003|Overall Study|Death|0|||
23591796|NCT04424641|65896075|FG004|Overall Study|Death|3|||
23591797|NCT04424641|65896076|FG005|Overall Study|Death|0|||
23591798|NCT04424641|65896077|FG006|Overall Study|Death|1|||
23591799|NCT04424641|65896078|FG007|Overall Study|Death|2|||
23591800|NCT04424641|65896071|FG000|Overall Study|Sponsor decision|0|||
23591801|NCT04424641|65896072|FG001|Overall Study|Sponsor decision|2|||
23591802|NCT04424641|65896073|FG002|Overall Study|Sponsor decision|3|||
23591803|NCT04424641|65896074|FG003|Overall Study|Sponsor decision|7|||
23591804|NCT04424641|65896075|FG004|Overall Study|Sponsor decision|2|||
23591805|NCT04424641|65896076|FG005|Overall Study|Sponsor decision|2|||
23591806|NCT04424641|65896077|FG006|Overall Study|Sponsor decision|3|||
23591807|NCT04424641|65896078|FG007|Overall Study|Sponsor decision|4|||
23591808|NCT04424641|65896071|FG000|Overall Study|Withdrawal by Subject|0|||
23591809|NCT04424641|65896072|FG001|Overall Study|Withdrawal by Subject|0|||
23591810|NCT04424641|65896073|FG002|Overall Study|Withdrawal by Subject|0|||
23591811|NCT04424641|65896074|FG003|Overall Study|Withdrawal by Subject|0|||
23591812|NCT04424641|65896075|FG004|Overall Study|Withdrawal by Subject|1|||
23591813|NCT04424641|65896076|FG005|Overall Study|Withdrawal by Subject|0|||
23591814|NCT04424641|65896077|FG006|Overall Study|Withdrawal by Subject|0|||
23591815|NCT04424641|65896078|FG007|Overall Study|Withdrawal by Subject|0|||
23591816|NCT04424641|65896071|FG000|Overall Study|Other|0|||
23591817|NCT04424641|65896072|FG001|Overall Study|Other|0|||
23591818|NCT04424641|65896073|FG002|Overall Study|Other|1|||
23591819|NCT04424641|65896074|FG003|Overall Study|Other|0|||
23591820|NCT04424641|65896075|FG004|Overall Study|Other|0|||
23591821|NCT04424641|65896076|FG005|Overall Study|Other|0|||
23799025|NCT03449199|66640172|FG000|Overall Study|Withdrawal by Subject|0|||
23799026|NCT03449199|66640173|FG001|Overall Study|Withdrawal by Subject|0|||
23799027|NCT03449199|66640174|FG002|Overall Study|Withdrawal by Subject|1|||
23799028|NCT00830167|66640175|FG000|Overall Study|Lack of Efficacy|26|||
23799029|NCT00830167|66640176|FG001|Overall Study|Lack of Efficacy|10|||
23799030|NCT00830167|66640175|FG000|Overall Study|Adverse Event|8|||
23799031|NCT00830167|66640176|FG001|Overall Study|Adverse Event|24|||
23799032|NCT00830167|66640175|FG000|Overall Study|Not meeting entrance criteria|2|||
23799033|NCT00830167|66640176|FG001|Overall Study|Not meeting entrance criteria|5|||
23799034|NCT00830167|66640175|FG000|Overall Study|Withdrawal by Subject|2|||
23799035|NCT00830167|66640176|FG001|Overall Study|Withdrawal by Subject|0|||
23799036|NCT00830167|66640175|FG000|Overall Study|Lost to Follow-up|0|||
23799037|NCT00830167|66640176|FG001|Overall Study|Lost to Follow-up|1|||
23799038|NCT00830167|66640175|FG000|Overall Study|Protocol Violation|0|||
23799039|NCT00830167|66640176|FG001|Overall Study|Protocol Violation|1|||
23799040|NCT00830167|66640175|FG000|Overall Study|Other|2|||
23799041|NCT00830167|66640176|FG001|Overall Study|Other|2|||
23799042|NCT02419573|66640178|FG000|Overall Study|Lost to Follow-up|3|||
23591822|NCT04424641|65896077|FG006|Overall Study|Other|0|||
23591823|NCT04424641|65896078|FG007|Overall Study|Other|0|||
23591824|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
23591825|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
23591826|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
23799043|NCT02419573|66640179|FG001|Overall Study|Lost to Follow-up|0|||
23591827|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
23591828|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
23591829|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
23591830|NCT02739035|65896081|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
23591831|NCT02739035|65896082|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
23591832|NCT03380390|65896083|FG000|Overall Study|Adverse Event|3|||
23591833|NCT05790408|65896090|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
23591834|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
23591835|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
23591836|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
23591837|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
23591838|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
23591839|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
23591840|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
23591841|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
23591842|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
23591843|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
23591844|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
23591845|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
23591846|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
23591847|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
23591848|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
23643977|NCT02297139|66079264|FG001|Overall Study|Administrative reason by sponsor|2|||
23476408|NCT00913458|65488074|FG001|Phase 1|Lost to Follow-up|0|||
23476409|NCT00913458|65488075|FG002|Phase 1|Lost to Follow-up|0|||
23476410|NCT00913458|65488076|FG003|Phase 1|Lost to Follow-up|0|||
23476411|NCT00913458|65488077|FG004|Phase 1|Lost to Follow-up|0|||
23476412|NCT00913458|65488078|FG005|Phase 1|Lost to Follow-up|0|||
23476413|NCT00913458|65488079|FG006|Phase 1|Lost to Follow-up|0|||
23476414|NCT00913458|65488073|FG000|Phase 1|Protocol Violation|10|||
23476415|NCT00913458|65488074|FG001|Phase 1|Protocol Violation|0|||
23476416|NCT00913458|65488075|FG002|Phase 1|Protocol Violation|0|||
23476417|NCT00913458|65488076|FG003|Phase 1|Protocol Violation|0|||
23476418|NCT00913458|65488077|FG004|Phase 1|Protocol Violation|0|||
23476419|NCT00913458|65488078|FG005|Phase 1|Protocol Violation|0|||
23476420|NCT00913458|65488079|FG006|Phase 1|Protocol Violation|0|||
23476421|NCT00913458|65488073|FG000|Phase 1|Sponsor|2|||
23476422|NCT00913458|65488074|FG001|Phase 1|Sponsor|0|||
23476423|NCT00913458|65488075|FG002|Phase 1|Sponsor|0|||
23476424|NCT00913458|65488076|FG003|Phase 1|Sponsor|0|||
23476425|NCT00913458|65488077|FG004|Phase 1|Sponsor|0|||
23476426|NCT00913458|65488078|FG005|Phase 1|Sponsor|0|||
23476427|NCT00913458|65488079|FG006|Phase 1|Sponsor|0|||
23476428|NCT00913458|65488073|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
23476429|NCT00913458|65488074|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
23476430|NCT00913458|65488075|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
23476431|NCT00913458|65488076|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
23476432|NCT00913458|65488077|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
23476433|NCT00913458|65488078|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
23476434|NCT00913458|65488079|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
23476435|NCT00913458|65488073|FG000|Phase 2|Non-Responder|0|||
23476436|NCT00913458|65488074|FG001|Phase 2|Non-Responder|5|||
23476437|NCT00913458|65488075|FG002|Phase 2|Non-Responder|7|||
23476438|NCT00913458|65488076|FG003|Phase 2|Non-Responder|12|||
23476439|NCT00913458|65488077|FG004|Phase 2|Non-Responder|0|||
23476440|NCT00913458|65488078|FG005|Phase 2|Non-Responder|0|||
23476441|NCT00913458|65488079|FG006|Phase 2|Non-Responder|0|||
23476442|NCT00913458|65488073|FG000|Phase 2|Subject Request|0|||
23476443|NCT00913458|65488074|FG001|Phase 2|Subject Request|0|||
23476444|NCT00913458|65488075|FG002|Phase 2|Subject Request|1|||
23476445|NCT00913458|65488076|FG003|Phase 2|Subject Request|2|||
23476446|NCT00913458|65488077|FG004|Phase 2|Subject Request|0|||
23476447|NCT00913458|65488078|FG005|Phase 2|Subject Request|0|||
23476448|NCT00913458|65488079|FG006|Phase 2|Subject Request|0|||
23476449|NCT00913458|65488073|FG000|Phase 2|Adverse Event|0|||
23476450|NCT00913458|65488074|FG001|Phase 2|Adverse Event|3|||
23476451|NCT00913458|65488075|FG002|Phase 2|Adverse Event|0|||
23476452|NCT00913458|65488076|FG003|Phase 2|Adverse Event|1|||
23476453|NCT00913458|65488077|FG004|Phase 2|Adverse Event|0|||
23476454|NCT00913458|65488078|FG005|Phase 2|Adverse Event|0|||
23476455|NCT00913458|65488079|FG006|Phase 2|Adverse Event|0|||
23476456|NCT00913458|65488073|FG000|Phase 2|Lost to Follow-up|0|||
23476457|NCT00913458|65488074|FG001|Phase 2|Lost to Follow-up|0|||
23476458|NCT00913458|65488075|FG002|Phase 2|Lost to Follow-up|0|||
23476459|NCT00913458|65488076|FG003|Phase 2|Lost to Follow-up|1|||
23476460|NCT00913458|65488077|FG004|Phase 2|Lost to Follow-up|0|||
23476461|NCT00913458|65488078|FG005|Phase 2|Lost to Follow-up|0|||
23476462|NCT00913458|65488079|FG006|Phase 2|Lost to Follow-up|0|||
23476463|NCT00913458|65488073|FG000|Phase 2|Protocol Violation|0|||
23476464|NCT00913458|65488074|FG001|Phase 2|Protocol Violation|2|||
23476465|NCT00913458|65488075|FG002|Phase 2|Protocol Violation|0|||
23476466|NCT00913458|65488076|FG003|Phase 2|Protocol Violation|0|||
23476467|NCT00913458|65488077|FG004|Phase 2|Protocol Violation|0|||
23476468|NCT00913458|65488078|FG005|Phase 2|Protocol Violation|0|||
23476469|NCT00913458|65488079|FG006|Phase 2|Protocol Violation|0|||
23476470|NCT00913458|65488073|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
23476471|NCT00913458|65488074|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
23476472|NCT00913458|65488075|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
23476473|NCT00913458|65488076|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
23476474|NCT00913458|65488077|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
23476475|NCT00913458|65488078|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
23476476|NCT00913458|65488079|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
23476477|NCT00913458|65488073|FG000|Phase 3|Adverse Event|0|||
23476478|NCT00913458|65488074|FG001|Phase 3|Adverse Event|0|||
23476479|NCT00913458|65488075|FG002|Phase 3|Adverse Event|0|||
23476480|NCT00913458|65488076|FG003|Phase 3|Adverse Event|0|||
23476481|NCT00913458|65488077|FG004|Phase 3|Adverse Event|5|||
23476482|NCT00913458|65488078|FG005|Phase 3|Adverse Event|4|||
23476483|NCT00913458|65488079|FG006|Phase 3|Adverse Event|1|||
23476484|NCT00913458|65488073|FG000|Phase 3|Lost to Follow-up|0|||
23476485|NCT00913458|65488074|FG001|Phase 3|Lost to Follow-up|0|||
23476486|NCT00913458|65488075|FG002|Phase 3|Lost to Follow-up|0|||
23476487|NCT00913458|65488076|FG003|Phase 3|Lost to Follow-up|0|||
23476488|NCT00913458|65488077|FG004|Phase 3|Lost to Follow-up|2|||
23476489|NCT00913458|65488078|FG005|Phase 3|Lost to Follow-up|0|||
23476490|NCT00913458|65488079|FG006|Phase 3|Lost to Follow-up|0|||
23476491|NCT00913458|65488073|FG000|Phase 3|Non-Responder|0|||
23476492|NCT00913458|65488074|FG001|Phase 3|Non-Responder|0|||
23476493|NCT00913458|65488075|FG002|Phase 3|Non-Responder|0|||
23476494|NCT00913458|65488076|FG003|Phase 3|Non-Responder|0|||
23476495|NCT00913458|65488077|FG004|Phase 3|Non-Responder|0|||
23476496|NCT00913458|65488078|FG005|Phase 3|Non-Responder|1|||
23476497|NCT00913458|65488079|FG006|Phase 3|Non-Responder|3|||
23476498|NCT00913458|65488073|FG000|Phase 3|Withdrawal by Subject|0|||
23476499|NCT00913458|65488074|FG001|Phase 3|Withdrawal by Subject|0|||
23476500|NCT00913458|65488075|FG002|Phase 3|Withdrawal by Subject|0|||
23476501|NCT00913458|65488076|FG003|Phase 3|Withdrawal by Subject|0|||
23476502|NCT00913458|65488077|FG004|Phase 3|Withdrawal by Subject|1|||
23476503|NCT00913458|65488078|FG005|Phase 3|Withdrawal by Subject|2|||
23476504|NCT00913458|65488079|FG006|Phase 3|Withdrawal by Subject|0|||
23476505|NCT00913458|65488073|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
23476506|NCT00913458|65488074|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
23476507|NCT00913458|65488075|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
23476508|NCT00913458|65488076|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
23476509|NCT00913458|65488077|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
23476510|NCT00913458|65488078|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
23476511|NCT00913458|65488079|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
23476512|NCT01853618|65488084|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
23476513|NCT01853618|65488085|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476514|NCT01853618|65488086|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476515|NCT01853618|65488087|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476516|NCT01853618|65488088|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476517|NCT01853618|65488084|FG000|Overall Study|Progressive disease|1|||
23591849|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
23591850|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
23591851|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
23591852|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
23591853|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
23591854|NCT00390299|65896101|FG000|Overall Study|Cancellation|1|||
23591855|NCT00390299|65896102|FG001|Overall Study|Cancellation|0|||
23591856|NCT00390299|65896103|FG002|Overall Study|Cancellation|0|||
23591857|NCT00390299|65896104|FG003|Overall Study|Cancellation|0|||
23591858|NCT00390299|65896105|FG004|Overall Study|Cancellation|0|||
23591859|NCT02506257|65896106|FG000|Overall Study|Adverse Event|0|||
23591860|NCT02506257|65896107|FG001|Overall Study|Adverse Event|2|||
23591861|NCT02506257|65896108|FG002|Overall Study|Adverse Event|3|||
23591862|NCT02506257|65896109|FG003|Overall Study|Adverse Event|0|||
23591863|NCT02506257|65896106|FG000|Overall Study|Protocol Violation|0|||
23591864|NCT02506257|65896107|FG001|Overall Study|Protocol Violation|0|||
23591865|NCT02506257|65896108|FG002|Overall Study|Protocol Violation|1|||
23591866|NCT02506257|65896109|FG003|Overall Study|Protocol Violation|0|||
23591867|NCT00114244|65896111|FG000|Overall Study|Adverse Event|2|||
23591868|NCT00114244|65896112|FG001|Overall Study|Adverse Event|5|||
23591869|NCT00114244|65896111|FG000|Overall Study|Withdrawal by Subject|0|||
23591870|NCT00114244|65896112|FG001|Overall Study|Withdrawal by Subject|2|||
23591871|NCT00159783|65896113|FG000|Overall Study|Adverse Event|5|||
23591872|NCT00159783|65896114|FG001|Overall Study|Adverse Event|7|||
23591873|NCT00159783|65896115|FG002|Overall Study|Adverse Event|9|||
23591874|NCT00159783|65896113|FG000|Overall Study|Lack of Efficacy|1|||
23591875|NCT00159783|65896114|FG001|Overall Study|Lack of Efficacy|2|||
23591876|NCT00159783|65896115|FG002|Overall Study|Lack of Efficacy|3|||
23591877|NCT00159783|65896113|FG000|Overall Study|Withdrawal by Subject|7|||
23591878|NCT00159783|65896114|FG001|Overall Study|Withdrawal by Subject|11|||
23591879|NCT00159783|65896115|FG002|Overall Study|Withdrawal by Subject|12|||
23591880|NCT00159783|65896113|FG000|Overall Study|Lost to Follow-up|6|||
23591881|NCT00159783|65896114|FG001|Overall Study|Lost to Follow-up|5|||
23591882|NCT00159783|65896115|FG002|Overall Study|Lost to Follow-up|11|||
23591883|NCT00159783|65896113|FG000|Overall Study|Other|0|||
23591884|NCT00159783|65896114|FG001|Overall Study|Other|2|||
23591885|NCT00159783|65896115|FG002|Overall Study|Other|4|||
23591886|NCT01202955|65896117|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
23591887|NCT01202955|65896118|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
23591888|NCT04054635|65896119|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
23591889|NCT04054635|65896120|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
23591890|NCT04054635|65896121|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
23591891|NCT04054635|65896119|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
23591892|NCT04054635|65896120|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
23591893|NCT04054635|65896121|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
23591894|NCT02448446|65896122|FG000|Overall Study|Withdrawal by Subject|1|||
23591895|NCT02448446|65896123|FG001|Overall Study|Withdrawal by Subject|0|||
23643978|NCT02297139|66079263|FG000|Overall Study|Other reasons|0|||
23476518|NCT01853618|65488085|FG001|Overall Study|Progressive disease|1|||
23643979|NCT02297139|66079264|FG001|Overall Study|Other reasons|8|||
23643980|NCT01281969|66079274|FG000|Overall Study|not randomized didn't meet criteria|0|||
23643981|NCT01281969|66079275|FG001|Overall Study|not randomized didn't meet criteria|0|||
23643982|NCT01281969|66079276|FG002|Overall Study|not randomized didn't meet criteria|7|||
23643983|NCT01281969|66079274|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
23643984|NCT01281969|66079275|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
23643985|NCT01281969|66079276|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
23643986|NCT01281969|66079274|FG000|Overall Study|not randomized, child consent not given|0|||
23643987|NCT01281969|66079275|FG001|Overall Study|not randomized, child consent not given|0|||
23643988|NCT01281969|66079276|FG002|Overall Study|not randomized, child consent not given|2|||
23643989|NCT01415531|66079278|FG000|Overall Study|Adverse Event|7|||
23643990|NCT01415531|66079279|FG001|Overall Study|Adverse Event|10|||
23643991|NCT01415531|66079278|FG000|Overall Study|Lack of Efficacy|3|||
23643992|NCT01415531|66079279|FG001|Overall Study|Lack of Efficacy|2|||
23643993|NCT01415531|66079278|FG000|Overall Study|Protocol Violation|0|||
23643994|NCT01415531|66079279|FG001|Overall Study|Protocol Violation|1|||
23643995|NCT01415531|66079278|FG000|Overall Study|Withdrawal by Subject|5|||
23643996|NCT01415531|66079279|FG001|Overall Study|Withdrawal by Subject|4|||
23643997|NCT01415531|66079278|FG000|Overall Study|Lost to Follow-up|6|||
23591896|NCT01692938|65896124|FG000|Overall Study|Protocol Deviation|1|||
23591897|NCT01692938|65896125|FG001|Overall Study|Protocol Deviation|1|||
23591898|NCT01692938|65896124|FG000|Overall Study|Study completed prior to site completion|3|||
23591899|NCT01692938|65896125|FG001|Overall Study|Study completed prior to site completion|3|||
23591900|NCT01803555|65896130|FG000|Overall Study|Adverse Event|3|||
23643998|NCT01415531|66079279|FG001|Overall Study|Lost to Follow-up|14|||
23643999|NCT01415531|66079278|FG000|Overall Study|Lack of Compliance|1|||
23799044|NCT02419573|66640178|FG000|Overall Study|Withdrawal by Subject|1|||
23476519|NCT01853618|65488086|FG002|Overall Study|Progressive disease|1|||
23476520|NCT01853618|65488087|FG003|Overall Study|Progressive disease|1|||
23476521|NCT01853618|65488088|FG004|Overall Study|Progressive disease|2|||
23476522|NCT01853618|65488084|FG000|Overall Study|Physician Decision|0|||
23476523|NCT01853618|65488085|FG001|Overall Study|Physician Decision|1|||
23476524|NCT01853618|65488086|FG002|Overall Study|Physician Decision|1|||
23476525|NCT01853618|65488087|FG003|Overall Study|Physician Decision|0|||
23476526|NCT01853618|65488088|FG004|Overall Study|Physician Decision|0|||
23476527|NCT01853618|65488084|FG000|Overall Study|Refused further treatment|0|||
23476528|NCT01853618|65488085|FG001|Overall Study|Refused further treatment|0|||
23476529|NCT01853618|65488086|FG002|Overall Study|Refused further treatment|0|||
23476530|NCT01853618|65488087|FG003|Overall Study|Refused further treatment|0|||
23476531|NCT01853618|65488088|FG004|Overall Study|Refused further treatment|1|||
23476532|NCT01639729|65488089|FG000|Overall Study|Withdrawal by Subject|1|||
23476533|NCT01639729|65488090|FG001|Overall Study|Withdrawal by Subject|0|||
23476534|NCT01639729|65488091|FG002|Overall Study|Withdrawal by Subject|1|||
23476535|NCT01639729|65488092|FG003|Overall Study|Withdrawal by Subject|1|||
23476536|NCT01639729|65488093|FG004|Overall Study|Withdrawal by Subject|0|||
23476537|NCT01639729|65488094|FG005|Overall Study|Withdrawal by Subject|0|||
23476538|NCT00361634|65488095|FG000|Overall Study|Lost to Follow-up|1|||
23476539|NCT00361634|65488095|FG000|Overall Study|Withdrawal by Subject|1|||
23476540|NCT01368562|65488096|FG000|Overall Study|Adverse Event|1|||
23476541|NCT01368562|65488096|FG000|Overall Study|Disease progression|1|||
23476542|NCT01368562|65488096|FG000|Overall Study|Lost to Follow-up|1|||
23476543|NCT01368562|65488096|FG000|Overall Study|Death|6|||
23476544|NCT01368562|65488096|FG000|Overall Study|Unresponsive to treatment|5|||
23476545|NCT01368562|65488096|FG000|Overall Study|Other|3|||
23476546|NCT01368562|65488096|FG000|Overall Study|Other than specified|2|||
23476547|NCT01317550|65488097|FG000|Overall Study|Withdrawal by Subject|1|||
23476548|NCT01317550|65488098|FG001|Overall Study|Withdrawal by Subject|0|||
23476549|NCT01317550|65488099|FG002|Overall Study|Withdrawal by Subject|0|||
23476550|NCT01317550|65488100|FG003|Overall Study|Withdrawal by Subject|0|||
23476551|NCT01317550|65488097|FG000|Overall Study|Lack of compliance study med|1|||
23476552|NCT01317550|65488098|FG001|Overall Study|Lack of compliance study med|0|||
23476553|NCT01317550|65488099|FG002|Overall Study|Lack of compliance study med|0|||
23476554|NCT01317550|65488100|FG003|Overall Study|Lack of compliance study med|0|||
23476555|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
23476556|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476557|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476558|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
23476559|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
23476560|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
23476561|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
23476562|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
23476563|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
23476564|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
23476565|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
23476566|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
23476567|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
23476568|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
23476569|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
23476570|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
23476571|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
23476572|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
23476573|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
23476574|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
23476575|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
23476576|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476577|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
23476578|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476579|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
23476580|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
23476581|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
23591901|NCT01803555|65896131|FG001|Overall Study|Adverse Event|2|||
23591902|NCT01803555|65896130|FG000|Overall Study|Withdrawal by Subject|3|||
23591903|NCT01803555|65896131|FG001|Overall Study|Withdrawal by Subject|3|||
23360165|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
23476582|NCT01149148|65488104|FG000|Overall Study|Lost to Follow-up|1|||
23476583|NCT01149148|65488105|FG001|Overall Study|Lost to Follow-up|2|||
23476584|NCT01149148|65488104|FG000|Overall Study|Death|1|||
23476585|NCT01149148|65488105|FG001|Overall Study|Death|0|||
23591904|NCT01803555|65896130|FG000|Overall Study|Non-compliance|1|||
23591905|NCT01803555|65896131|FG001|Overall Study|Non-compliance|1|||
23591906|NCT01803555|65896130|FG000|Overall Study|Protocol Violation|3|||
23591907|NCT01803555|65896131|FG001|Overall Study|Protocol Violation|5|||
23591908|NCT01803555|65896130|FG000|Overall Study|Lost to Follow-up|0|||
23591909|NCT01803555|65896131|FG001|Overall Study|Lost to Follow-up|2|||
23591910|NCT01803555|65896130|FG000|Overall Study|Other than specified|3|||
23591911|NCT01803555|65896131|FG001|Overall Study|Other than specified|5|||
23591912|NCT02423291|65896132|FG000|Overall Study|Lack of Efficacy|14|||
23591913|NCT02423291|65896132|FG000|Overall Study|Adverse Event|1|||
23591914|NCT02957136|65896133|FG000|Overall Study|Withdrawal by Subject|2|||
23591915|NCT02957136|65896134|FG001|Overall Study|Withdrawal by Subject|1|||
23591916|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
23591917|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
23591918|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
23591919|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
23591920|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
23591921|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
23591922|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
23591923|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
23591924|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
23591925|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
23591926|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
23591927|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
23591928|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
23591929|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
23591930|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
23591931|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
23591932|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
23591933|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591934|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591935|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591936|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591937|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591938|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
23591939|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
23591940|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
23591941|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
23591942|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
23591943|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
23591944|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
23591945|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
23591946|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
23591947|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
23591948|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
23591949|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591950|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
23591951|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
23591952|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
23591953|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591954|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591955|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591956|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591957|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591958|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591959|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591960|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591961|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591962|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591963|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591964|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
23591965|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591966|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591967|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591968|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591969|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591970|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23476586|NCT03595618|65488106|FG000|Overall Study|Adverse Event|16|||
23591971|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
23591972|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591973|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591974|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591975|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591976|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591977|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591978|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591979|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591980|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591981|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591982|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
23591983|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
23591984|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
23591985|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
23591986|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
23591987|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
23591988|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
23591989|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
23591990|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
23591991|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
23591992|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
23591993|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591994|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591995|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591996|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591997|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591998|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591999|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592000|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592001|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592002|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592003|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592004|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592005|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592006|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592007|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592008|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592009|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592010|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
23592011|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
23644000|NCT01415531|66079279|FG001|Overall Study|Lack of Compliance|4|||
23644001|NCT01415531|66079278|FG000|Overall Study|Other Reasons|3|||
23644002|NCT01415531|66079279|FG001|Overall Study|Other Reasons|2|||
23644003|NCT03606668|66079280|FG000|Overall Study|Screen Failure|1|||
23592012|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
23592013|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
23592014|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
23592015|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592016|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592017|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592018|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592019|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592020|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592021|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
23592022|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
23592023|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
23592024|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
23592025|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
23592026|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592027|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592028|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592029|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592030|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592031|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592032|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
23592033|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
23592034|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
23592035|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592036|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
23592037|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592038|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592039|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592040|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592041|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592042|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592043|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
23799045|NCT02419573|66640179|FG001|Overall Study|Withdrawal by Subject|0|||
23799046|NCT03417830|66640186|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
23799047|NCT03417830|66640187|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
23799048|NCT03259789|66640188|FG000|Overall Study|Adverse Event|3|||
23799049|NCT03259789|66640189|FG001|Overall Study|Adverse Event|2|||
23799050|NCT03259789|66640190|FG002|Overall Study|Adverse Event|1|||
23799051|NCT03259789|66640188|FG000|Overall Study|Withdrawal by Subject|9|||
23476587|NCT03595618|65488107|FG001|Overall Study|Adverse Event|17|||
23476588|NCT03595618|65488108|FG002|Overall Study|Adverse Event|20|||
23476589|NCT03595618|65488109|FG003|Overall Study|Adverse Event|8|||
23476590|NCT03595618|65488106|FG000|Overall Study|Withdrawal by Subject|12|||
23476591|NCT03595618|65488107|FG001|Overall Study|Withdrawal by Subject|14|||
23476592|NCT03595618|65488108|FG002|Overall Study|Withdrawal by Subject|14|||
23476593|NCT03595618|65488109|FG003|Overall Study|Withdrawal by Subject|10|||
23476594|NCT03595618|65488106|FG000|Overall Study|Lost to Follow-up|6|||
23476595|NCT03595618|65488107|FG001|Overall Study|Lost to Follow-up|4|||
23476596|NCT03595618|65488108|FG002|Overall Study|Lost to Follow-up|5|||
23476597|NCT03595618|65488109|FG003|Overall Study|Lost to Follow-up|6|||
23476598|NCT03595618|65488106|FG000|Overall Study|Protocol Violation|2|||
23476599|NCT03595618|65488107|FG001|Overall Study|Protocol Violation|0|||
23476600|NCT03595618|65488108|FG002|Overall Study|Protocol Violation|6|||
23476601|NCT03595618|65488109|FG003|Overall Study|Protocol Violation|2|||
23476602|NCT03595618|65488106|FG000|Overall Study|Physician Decision|0|||
23592044|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
23644004|NCT03606668|66079280|FG000|Overall Study|Lost to Follow-up|1|||
23799052|NCT03259789|66640189|FG001|Overall Study|Withdrawal by Subject|5|||
23799053|NCT03259789|66640190|FG002|Overall Study|Withdrawal by Subject|1|||
23799054|NCT03259789|66640188|FG000|Overall Study|Lost to Follow-up|5|||
23799055|NCT03259789|66640189|FG001|Overall Study|Lost to Follow-up|9|||
23799056|NCT03259789|66640190|FG002|Overall Study|Lost to Follow-up|4|||
23799057|NCT03259789|66640188|FG000|Overall Study|Physician Decision|0|||
23799058|NCT03259789|66640189|FG001|Overall Study|Physician Decision|1|||
23799059|NCT03259789|66640190|FG002|Overall Study|Physician Decision|0|||
23799060|NCT01949116|66640192|FG000|Overall Study|Death|2|||
23476603|NCT03595618|65488107|FG001|Overall Study|Physician Decision|0|||
23476604|NCT03595618|65488108|FG002|Overall Study|Physician Decision|1|||
23476605|NCT03595618|65488109|FG003|Overall Study|Physician Decision|2|||
23476606|NCT03595618|65488106|FG000|Overall Study|Miscellaneous|7|||
23476607|NCT03595618|65488107|FG001|Overall Study|Miscellaneous|5|||
23592045|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
23592046|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
23592047|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
23592048|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
23592049|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
23592050|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
23592051|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
23592052|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
23592053|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
23592054|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
23592055|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
23592056|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
23592057|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
23592058|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
23592059|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592060|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592061|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592062|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592063|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592064|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592065|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592066|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
23592067|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
23592068|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592069|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592070|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592071|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592072|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592073|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592074|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592075|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592076|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592077|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592078|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
23592079|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
23592080|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592081|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592082|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592083|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592084|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592085|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592086|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592087|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592088|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592089|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592090|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
23592091|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592092|NCT03069313|65896148|FG000|Overall Study|Adverse Event|5|||
23592093|NCT02013830|65896156|FG000|Overall Study|Adverse Event|3|||
23592094|NCT02013830|65896156|FG000|Overall Study|Death|1|||
23592095|NCT02013830|65896156|FG000|Overall Study|Insufficient therapeutic response|25|||
23592096|NCT02013830|65896156|FG000|Overall Study|Refused treatment|1|||
23592097|NCT00639002|65896157|FG000|Overall Study|Death|1|||
23592098|NCT00639002|65896157|FG000|Overall Study|Adverse Event|1|||
23592099|NCT00639002|65896157|FG000|Overall Study|Protocol Violation|1|||
23592100|NCT00639002|65896157|FG000|Overall Study|Disease progression|3|||
23592101|NCT00639002|65896157|FG000|Overall Study|Physician Decision|6|||
23592102|NCT00639002|65896157|FG000|Overall Study|Lack of Efficacy|1|||
23592103|NCT00223795|65896158|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
23592104|NCT00223795|65896159|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
23592105|NCT00223795|65896158|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
23592106|NCT00223795|65896159|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
23592107|NCT00756730|65896160|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
23592108|NCT00756730|65896161|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
23592109|NCT00756730|65896160|FG000|Overall Study|persistent low-level viremmia|0|||
23592110|NCT00756730|65896161|FG001|Overall Study|persistent low-level viremmia|1|||
23592111|NCT04464421|65896165|FG000|Overall Study|Lost to Follow-up|2|||
23592112|NCT04464421|65896166|FG001|Overall Study|Lost to Follow-up|2|||
23592113|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
23592114|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
23592115|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
23592116|NCT00891930|65896167|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
23592117|NCT00891930|65896167|FG000|Part 2 Panitumumab + AMG479|Death|30|||
23592118|NCT03830866|65896168|FG000|Overall Study|Death|90|||
23592119|NCT03830866|65896169|FG001|Overall Study|Death|111|||
23592120|NCT03830866|65896168|FG000|Overall Study|Lost to Follow-up|7|||
23592121|NCT03830866|65896169|FG001|Overall Study|Lost to Follow-up|7|||
23592122|NCT03830866|65896168|FG000|Overall Study|Withdrawal by Subject|19|||
23592123|NCT03830866|65896169|FG001|Overall Study|Withdrawal by Subject|16|||
23592124|NCT03830866|65896168|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
23592125|NCT03830866|65896169|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
23592126|NCT03830866|65896168|FG000|Overall Study|Other|1|||
23592127|NCT03830866|65896169|FG001|Overall Study|Other|1|||
23592128|NCT03557008|65896171|FG000|Overall Study|Withdrawal by Subject|2|||
23592129|NCT03557008|65896172|FG001|Overall Study|Withdrawal by Subject|2|||
23592130|NCT03557008|65896171|FG000|Overall Study|Early termination from study|3|||
23592131|NCT03557008|65896172|FG001|Overall Study|Early termination from study|1|||
23592132|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
23592133|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
23592134|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
23592135|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
23592136|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
23592137|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
23592138|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
23592139|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
23592140|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
23592141|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
23592142|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
23592143|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
23592144|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
23592145|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
23592146|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
23592147|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
23592148|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
23592149|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
23592150|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
23592151|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
23592152|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
23592153|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
23592154|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
23592155|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
23592156|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Death|1|||
23592157|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Death|0|||
23592158|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Death|0|||
23592159|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
23592160|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
23592161|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
23592162|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23592163|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23592164|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23592165|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
23592166|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
23592167|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
23592168|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
23592169|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
23592170|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
23592171|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
23592172|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
23592173|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
23592174|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
23592175|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
23592176|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
23644005|NCT03189745|66079281|FG000|Overall Study|Conflict in work schedule of participant|1|||
23644006|NCT03189745|66079282|FG001|Overall Study|Conflict in work schedule of participant|1|||
23644007|NCT01097707|66079283|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23644008|NCT01097707|66079284|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23644009|NCT01097707|66079285|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23644010|NCT01097707|66079286|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23644011|NCT01097707|66079287|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23644012|NCT01097707|66079283|FG000|Overall Study|Adverse Event|4|||
23644013|NCT01097707|66079284|FG001|Overall Study|Adverse Event|2|||
23644014|NCT01097707|66079285|FG002|Overall Study|Adverse Event|3|||
23799061|NCT01949116|66640193|FG001|Overall Study|Death|0|||
23799062|NCT01949116|66640192|FG000|Overall Study|Lost to Follow-up|1|||
23799063|NCT01949116|66640193|FG001|Overall Study|Lost to Follow-up|3|||
23799064|NCT01949116|66640192|FG000|Overall Study|Withdrawal by Subject|5|||
23799065|NCT01949116|66640193|FG001|Overall Study|Withdrawal by Subject|3|||
23799066|NCT02674633|66640194|FG000|Overall Study|Lost to Follow-up|3|||
23799067|NCT02674633|66640195|FG001|Overall Study|Lost to Follow-up|2|||
23799068|NCT02674633|66640194|FG000|Overall Study|Physician Decision|1|||
23799069|NCT02674633|66640195|FG001|Overall Study|Physician Decision|0|||
23799070|NCT02674633|66640194|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23799071|NCT02674633|66640195|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23799072|NCT00823199|66640196|FG000|Overall Study|Withdrawal by Subject|2|||
23799073|NCT01647711|66640197|FG000|Overall Study|Progressive disease|6|||
23799074|NCT01647711|66640198|FG001|Overall Study|Progressive disease|2|||
23799075|NCT01647711|66640199|FG002|Overall Study|Progressive disease|6|||
23799076|NCT01647711|66640200|FG003|Overall Study|Progressive disease|8|||
23799077|NCT01647711|66640201|FG004|Overall Study|Progressive disease|2|||
23799078|NCT01647711|66640197|FG000|Overall Study|Other adverse event|0|||
23799079|NCT01647711|66640198|FG001|Overall Study|Other adverse event|0|||
23799080|NCT01647711|66640199|FG002|Overall Study|Other adverse event|2|||
23799081|NCT01647711|66640200|FG003|Overall Study|Other adverse event|0|||
23799082|NCT01647711|66640201|FG004|Overall Study|Other adverse event|2|||
23799083|NCT01647711|66640197|FG000|Overall Study|Protocol Violation|0|||
23799084|NCT01647711|66640198|FG001|Overall Study|Protocol Violation|0|||
23360166|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
23799085|NCT01647711|66640199|FG002|Overall Study|Protocol Violation|0|||
23799086|NCT01647711|66640200|FG003|Overall Study|Protocol Violation|0|||
23799087|NCT01647711|66640201|FG004|Overall Study|Protocol Violation|1|||
23360167|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
23592177|NCT02880241|65896181|FG000|Overall Study|Lack of Efficacy|1|||
23476608|NCT03595618|65488108|FG002|Overall Study|Miscellaneous|10|||
23476609|NCT03595618|65488109|FG003|Overall Study|Miscellaneous|6|||
23476610|NCT01239992|65488110|FG000|Overall Study|Withdrawal by Subject|2|||
23476611|NCT02660138|65488111|FG000|Overall Study|Adverse Event|0|||
23476612|NCT02660138|65488112|FG001|Overall Study|Adverse Event|3|||
23476613|NCT02660138|65488113|FG002|Overall Study|Adverse Event|2|||
23476614|NCT02660138|65488111|FG000|Overall Study|Lack of Efficacy|1|||
23476615|NCT02660138|65488112|FG001|Overall Study|Lack of Efficacy|2|||
23476616|NCT02660138|65488113|FG002|Overall Study|Lack of Efficacy|1|||
23476617|NCT02660138|65488111|FG000|Overall Study|Withdrawal by Subject|7|||
23476618|NCT02660138|65488112|FG001|Overall Study|Withdrawal by Subject|6|||
23476619|NCT02660138|65488113|FG002|Overall Study|Withdrawal by Subject|6|||
23476620|NCT02660138|65488111|FG000|Overall Study|Lost to Follow-up|4|||
23476621|NCT02660138|65488112|FG001|Overall Study|Lost to Follow-up|4|||
23476622|NCT02660138|65488113|FG002|Overall Study|Lost to Follow-up|1|||
23476623|NCT02660138|65488111|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
23476624|NCT02660138|65488112|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
23476625|NCT02660138|65488113|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
23476626|NCT02660138|65488111|FG000|Overall Study|Other|1|||
23476627|NCT02660138|65488112|FG001|Overall Study|Other|1|||
23476628|NCT02660138|65488113|FG002|Overall Study|Other|0|||
23476629|NCT02660138|65488111|FG000|Overall Study|Not treated|0|||
23476630|NCT02660138|65488112|FG001|Overall Study|Not treated|1|||
23476631|NCT02660138|65488113|FG002|Overall Study|Not treated|0|||
23592178|NCT02880241|65896182|FG001|Overall Study|Lack of Efficacy|0|||
23592179|NCT02880241|65896183|FG002|Overall Study|Lack of Efficacy|0|||
23592180|NCT02880241|65896184|FG003|Overall Study|Lack of Efficacy|0|||
23592181|NCT02880241|65896185|FG004|Overall Study|Lack of Efficacy|0|||
23592182|NCT02880241|65896186|FG005|Overall Study|Lack of Efficacy|0|||
23592183|NCT00636207|65896187|FG000|Overall Study|Adverse Event|1|||
23592184|NCT00636207|65896188|FG001|Overall Study|Adverse Event|0|||
23592185|NCT00636207|65896189|FG002|Overall Study|Adverse Event|0|||
23592186|NCT00636207|65896190|FG003|Overall Study|Adverse Event|0|||
23592187|NCT00636207|65896191|FG004|Overall Study|Adverse Event|0|||
23592188|NCT00636207|65896192|FG005|Overall Study|Adverse Event|0|||
23644015|NCT01097707|66079286|FG003|Overall Study|Adverse Event|1|||
23476632|NCT00734747|65488114|FG000|SRS Procedure|No staples placed|3|||
23476633|NCT00734747|65488114|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
23476634|NCT02338882|65488115|FG000|Overall Study|Death|1|||
23476635|NCT02338882|65488116|FG001|Overall Study|Death|0|||
23476636|NCT02338882|65488115|FG000|Overall Study|Lost to Follow-up|6|||
23592189|NCT00636207|65896193|FG006|Overall Study|Adverse Event|0|||
23476637|NCT02338882|65488116|FG001|Overall Study|Lost to Follow-up|3|||
23476638|NCT02338232|65488117|FG000|Overall Study|Screen Failure|3|||
23644016|NCT01097707|66079287|FG004|Overall Study|Adverse Event|3|||
23476639|NCT02338232|65488117|FG000|Overall Study|Withdrawal by Subject|6|||
23476640|NCT02338232|65488117|FG000|Overall Study|Adverse Event|2|||
23476641|NCT02364336|65488123|FG000|Overall Study|Adverse Event|0|||
23476642|NCT02364336|65488124|FG001|Overall Study|Adverse Event|1|||
23476643|NCT00483756|65488125|FG000|Overall Study|Death|2|||
23476644|NCT00483756|65488126|FG001|Overall Study|Death|0|||
23476645|NCT00483756|65488127|FG002|Overall Study|Death|1|||
23476646|NCT00483756|65488125|FG000|Overall Study|Adverse Event|19|||
23476647|NCT00483756|65488126|FG001|Overall Study|Adverse Event|38|||
23476648|NCT00483756|65488127|FG002|Overall Study|Adverse Event|40|||
23476649|NCT00483756|65488125|FG000|Overall Study|Lack of Efficacy|1|||
23476650|NCT00483756|65488126|FG001|Overall Study|Lack of Efficacy|0|||
23476651|NCT00483756|65488127|FG002|Overall Study|Lack of Efficacy|0|||
23476652|NCT00483756|65488125|FG000|Overall Study|Lost to Follow-up|3|||
23476653|NCT00483756|65488126|FG001|Overall Study|Lost to Follow-up|1|||
23476654|NCT00483756|65488127|FG002|Overall Study|Lost to Follow-up|0|||
23476655|NCT00483756|65488125|FG000|Overall Study|Withdrawal by Subject|5|||
23476656|NCT00483756|65488126|FG001|Overall Study|Withdrawal by Subject|3|||
23476657|NCT00483756|65488127|FG002|Overall Study|Withdrawal by Subject|4|||
23476658|NCT00483756|65488125|FG000|Overall Study|Other|2|||
23476659|NCT00483756|65488126|FG001|Overall Study|Other|4|||
23476660|NCT00483756|65488127|FG002|Overall Study|Other|3|||
23799088|NCT01647711|66640197|FG000|Overall Study|Refused to continue taking medication|0|||
23799089|NCT01647711|66640198|FG001|Overall Study|Refused to continue taking medication|0|||
23799090|NCT01647711|66640199|FG002|Overall Study|Refused to continue taking medication|0|||
23799091|NCT01647711|66640200|FG003|Overall Study|Refused to continue taking medication|2|||
23476661|NCT00483756|65488125|FG000|Overall Study|Randomized, Not Treated|1|||
23476662|NCT00483756|65488126|FG001|Overall Study|Randomized, Not Treated|4|||
23799092|NCT01647711|66640201|FG004|Overall Study|Refused to continue taking medication|1|||
23799093|NCT01647711|66640197|FG000|Overall Study|Other reason not defined|0|||
23799094|NCT01647711|66640198|FG001|Overall Study|Other reason not defined|1|||
23799095|NCT01647711|66640199|FG002|Overall Study|Other reason not defined|1|||
23799096|NCT01647711|66640200|FG003|Overall Study|Other reason not defined|1|||
23799097|NCT01647711|66640201|FG004|Overall Study|Other reason not defined|0|||
23799098|NCT04126343|66640204|FG000|Overall Study|Adverse Event|0|||
23476663|NCT00483756|65488127|FG002|Overall Study|Randomized, Not Treated|4|||
23476664|NCT04610281|65488131|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
23476665|NCT04610281|65488132|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
23476666|NCT04644315|65488134|FG000|Overall Study|Subject withdrawal of consent|1|||
23476667|NCT01256190|65488137|FG000|Overall Study|Lost to Follow-up|2|||
23476668|NCT01256190|65488138|FG001|Overall Study|Lost to Follow-up|0|||
23476669|NCT01755026|65488145|FG000|Overall Study|Adverse Event|1|||
23476670|NCT01755026|65488146|FG001|Overall Study|Adverse Event|0|||
23476671|NCT01755026|65488145|FG000|Overall Study|Withdrawal by Subject|1|||
23476672|NCT01755026|65488146|FG001|Overall Study|Withdrawal by Subject|1|||
23476673|NCT03860818|65488151|FG000|Overall Study|Death|144|||
23476674|NCT03860818|65488152|FG001|Overall Study|Death|195|||
23476675|NCT03860818|65488151|FG000|Overall Study|Graft Loss|32|||
23476676|NCT03860818|65488152|FG001|Overall Study|Graft Loss|45|||
23476677|NCT00476008|65488155|FG000|Overall Study|Adverse Event|4|||
23476678|NCT00476008|65488156|FG001|Overall Study|Adverse Event|4|||
23476679|NCT00476008|65488155|FG000|Overall Study|Placebo concerns|2|||
23476680|NCT00476008|65488156|FG001|Overall Study|Placebo concerns|2|||
23476681|NCT00476008|65488155|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
23476682|NCT00476008|65488156|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
23476683|NCT00476008|65488155|FG000|Overall Study|Withdrawal by Subject|0|||
23476684|NCT00476008|65488156|FG001|Overall Study|Withdrawal by Subject|1|||
23476685|NCT00476008|65488155|FG000|Overall Study|Death|1|||
23476686|NCT00476008|65488156|FG001|Overall Study|Death|0|||
23644017|NCT01097707|66079283|FG000|Overall Study|Entry Criteria Not Met|2|||
23799099|NCT04126343|66640205|FG001|Overall Study|Adverse Event|0|||
23799100|NCT04126343|66640206|FG002|Overall Study|Adverse Event|0|||
23476687|NCT00934648|65488157|FG000|Overall Study|Failure to return|8|||
23476688|NCT00934648|65488157|FG000|Overall Study|Withdrawal by Subject|1|||
23476689|NCT02929498|65488160|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
23476690|NCT02929498|65488161|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
23476691|NCT02929498|65488162|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
23476692|NCT02929498|65488160|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
23592190|NCT00636207|65896187|FG000|Overall Study|Withdrawal by Subject|0|||
23592191|NCT00636207|65896188|FG001|Overall Study|Withdrawal by Subject|1|||
23592192|NCT00636207|65896189|FG002|Overall Study|Withdrawal by Subject|0|||
23592193|NCT00636207|65896190|FG003|Overall Study|Withdrawal by Subject|0|||
23592194|NCT00636207|65896191|FG004|Overall Study|Withdrawal by Subject|1|||
23592195|NCT00636207|65896192|FG005|Overall Study|Withdrawal by Subject|0|||
23592196|NCT00636207|65896193|FG006|Overall Study|Withdrawal by Subject|0|||
23592197|NCT01561989|65896198|FG000|Overall Study|accural target not met.|5|||
23592198|NCT01561989|65896199|FG001|Overall Study|accural target not met.|6|||
23592199|NCT00813904|65896200|FG000|Overall Study|Death|1|||
23592200|NCT03247543|65896201|FG000|Overall Study|Adverse Event|3|||
23592201|NCT03247543|65896202|FG001|Overall Study|Adverse Event|6|||
23592202|NCT03247543|65896203|FG002|Overall Study|Adverse Event|4|||
23592203|NCT03247543|65896201|FG000|Overall Study|Lost to Follow-up|10|||
23592204|NCT03247543|65896202|FG001|Overall Study|Lost to Follow-up|7|||
23592205|NCT03247543|65896203|FG002|Overall Study|Lost to Follow-up|8|||
23592206|NCT03247543|65896201|FG000|Overall Study|Consent withdrawn by caregiver|2|||
23592207|NCT03247543|65896202|FG001|Overall Study|Consent withdrawn by caregiver|2|||
23592208|NCT03247543|65896203|FG002|Overall Study|Consent withdrawn by caregiver|9|||
23592209|NCT03247543|65896201|FG000|Overall Study|Withdrawal by Subject|0|||
23592210|NCT03247543|65896202|FG001|Overall Study|Withdrawal by Subject|0|||
23592211|NCT03247543|65896203|FG002|Overall Study|Withdrawal by Subject|1|||
23592212|NCT03247543|65896201|FG000|Overall Study|Failure to Follow study procedures|1|||
23592213|NCT03247543|65896202|FG001|Overall Study|Failure to Follow study procedures|3|||
23592214|NCT03247543|65896203|FG002|Overall Study|Failure to Follow study procedures|1|||
23592215|NCT03247543|65896201|FG000|Overall Study|Lack of Efficacy|1|||
23476693|NCT02929498|65488161|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
23476694|NCT02929498|65488162|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
23476695|NCT00233454|65488170|FG000|Overall Study|Death|6|||
23476696|NCT02520089|65488171|FG000|Overall Study|Lost to Follow-up|3|||
23592216|NCT03247543|65896202|FG001|Overall Study|Lack of Efficacy|0|||
23592217|NCT03247543|65896203|FG002|Overall Study|Lack of Efficacy|0|||
23592218|NCT03247543|65896201|FG000|Overall Study|Non-compliance with study visits|0|||
23592219|NCT03247543|65896202|FG001|Overall Study|Non-compliance with study visits|1|||
23592220|NCT03247543|65896203|FG002|Overall Study|Non-compliance with study visits|0|||
23592221|NCT01171625|65896207|FG000|Overall Study|On-Protocol|67|||
23592222|NCT01171625|65896207|FG000|Overall Study|Death|38|||
23592223|NCT01171625|65896207|FG000|Overall Study|Withdrawal by Subject|31|||
23592224|NCT01171625|65896207|FG000|Overall Study|Explanted|10|||
23592225|NCT01171625|65896207|FG000|Overall Study|Lost to Follow-up|5|||
23592226|NCT01171625|65896207|FG000|Overall Study|Patient received valve-in-valve|3|||
23476697|NCT02520089|65488172|FG001|Overall Study|Lost to Follow-up|4|||
23476698|NCT01386970|65488173|FG000|Overall Study|Withdrawal by Subject|0|||
23476699|NCT01386970|65488174|FG001|Overall Study|Withdrawal by Subject|1|||
23476700|NCT01386970|65488173|FG000|Overall Study|Adverse Event|4|||
23476701|NCT01386970|65488174|FG001|Overall Study|Adverse Event|1|||
23476702|NCT02730793|65488179|FG000|Overall Study|Physician Decision|0|||
23476703|NCT02730793|65488180|FG001|Overall Study|Physician Decision|1|||
23476704|NCT02730793|65488179|FG000|Overall Study|Withdrawal by Subject|0|||
23476705|NCT02730793|65488180|FG001|Overall Study|Withdrawal by Subject|1|||
23476706|NCT03255629|65488181|FG000|Overall Study|Adverse Event|1|||
23592227|NCT01171625|65896207|FG000|Overall Study|Other|1|||
23592228|NCT01171625|65896207|FG000|Overall Study|Consented but did not receive device|25|||
23592229|NCT00933400|65896208|FG000|Overall Study|Withdrawal by Subject|21|||
23592230|NCT00933400|65896209|FG001|Overall Study|Withdrawal by Subject|1|||
23592231|NCT04833855|65896210|FG000|Overall Study|Decision by sponsor|0|||
23592232|NCT04833855|65896211|FG001|Overall Study|Decision by sponsor|1|||
23592233|NCT04833855|65896212|FG002|Overall Study|Decision by sponsor|0|||
23592234|NCT04833855|65896213|FG003|Overall Study|Decision by sponsor|0|||
23476707|NCT03255629|65488182|FG001|Overall Study|Adverse Event|0|||
23476708|NCT03255629|65488181|FG000|Overall Study|did not experience hypoglycemia|2|||
23592235|NCT04833855|65896210|FG000|Overall Study|Withdrawal by Subject|4|||
23592236|NCT04833855|65896211|FG001|Overall Study|Withdrawal by Subject|1|||
23592237|NCT04833855|65896212|FG002|Overall Study|Withdrawal by Subject|3|||
23592238|NCT04833855|65896213|FG003|Overall Study|Withdrawal by Subject|1|||
23476709|NCT03255629|65488182|FG001|Overall Study|did not experience hypoglycemia|1|||
23476710|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
23592239|NCT04833855|65896210|FG000|Overall Study|Lost to Follow-up|1|||
23592240|NCT04833855|65896211|FG001|Overall Study|Lost to Follow-up|0|||
23592241|NCT04833855|65896212|FG002|Overall Study|Lost to Follow-up|2|||
23592242|NCT04833855|65896213|FG003|Overall Study|Lost to Follow-up|2|||
23592243|NCT04833855|65896210|FG000|Overall Study|Protocol specified criteria|0|||
23592244|NCT04833855|65896211|FG001|Overall Study|Protocol specified criteria|0|||
23592245|NCT04833855|65896212|FG002|Overall Study|Protocol specified criteria|2|||
23592246|NCT04833855|65896213|FG003|Overall Study|Protocol specified criteria|1|||
23592247|NCT02960659|65899472|FG000|Overall Study|Withdrawal by Subject|1|||
23592248|NCT02960659|65899473|FG001|Overall Study|Withdrawal by Subject|0|||
23592249|NCT02960659|65899472|FG000|Overall Study|Poor compliance|0|||
23592250|NCT02960659|65899473|FG001|Overall Study|Poor compliance|1|||
23592251|NCT03648762|65899474|FG000|Overall Study|Lost to Follow-up|1|||
23592252|NCT03648762|65899475|FG001|Overall Study|Lost to Follow-up|2|||
23592253|NCT03648762|65899476|FG002|Overall Study|Lost to Follow-up|0|||
23592254|NCT03648762|65899474|FG000|Overall Study|Withdrawal by Subject|5|||
23592255|NCT03648762|65899475|FG001|Overall Study|Withdrawal by Subject|2|||
23592256|NCT03648762|65899476|FG002|Overall Study|Withdrawal by Subject|1|||
23592257|NCT00414544|65899484|FG000|Overall Study|Lost to Follow-up|14|||
23592258|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
23592259|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592260|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592261|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592262|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
23592263|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592264|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592265|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592266|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
23592267|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592268|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592269|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592270|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
23592271|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592272|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592273|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592274|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
23592275|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
23592276|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
23592277|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
23592278|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
23592279|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592280|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592281|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592282|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
23592283|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592284|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592285|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592286|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
23592287|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23476711|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476712|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476713|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476714|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
23476715|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
23476716|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476717|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
23476718|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
23592288|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23592289|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23592290|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
23592291|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592292|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592293|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592294|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
23592295|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23644018|NCT01097707|66079284|FG001|Overall Study|Entry Criteria Not Met|1|||
23644019|NCT01097707|66079285|FG002|Overall Study|Entry Criteria Not Met|1|||
23592296|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23592297|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23592298|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
23592299|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
23592300|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
23592301|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
23592302|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
23592303|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
23592304|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
23592305|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
23592306|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
23592307|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
23592308|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
23592309|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
23592310|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
23592311|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
23592312|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
23592313|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
23592314|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592315|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592316|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592317|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
23592318|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
23592319|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
23592320|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
23592321|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
23592322|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
23592323|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
23592324|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
23644020|NCT01097707|66079286|FG003|Overall Study|Entry Criteria Not Met|0|||
23799101|NCT04126343|66640207|FG003|Overall Study|Adverse Event|0|||
23476719|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476720|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476721|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476722|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476723|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476724|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
23476725|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476726|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
23476727|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476728|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
23476729|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476730|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476731|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476732|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476733|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476734|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
23476735|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
23476736|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
23476737|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
23476738|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
23476739|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
23476740|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
23476741|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
23476742|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23592325|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
23592326|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
23592327|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
23592328|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
23592329|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
23592330|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
23592331|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
23592332|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
23592333|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
23592334|NCT00516386|65899491|FG000|Overall Study|not interested in the study|4|||
23592335|NCT00516386|65899491|FG000|Overall Study|Lost to Follow-up|2|||
23592336|NCT01430611|65899496|FG000|Overall Study|Adverse Event|0|||
23592337|NCT01430611|65899497|FG001|Overall Study|Adverse Event|1|||
23592338|NCT01430611|65899496|FG000|Overall Study|Protocol Violation|1|||
23592339|NCT01430611|65899497|FG001|Overall Study|Protocol Violation|0|||
23592340|NCT01430611|65899496|FG000|Overall Study|Lost to Follow-up|1|||
23592341|NCT01430611|65899497|FG001|Overall Study|Lost to Follow-up|0|||
23592342|NCT01430611|65899496|FG000|Overall Study|Withdrawal by Subject|15|||
23592343|NCT01430611|65899497|FG001|Overall Study|Withdrawal by Subject|14|||
23592344|NCT01415349|65899498|FG000|Treatment Period 1|Adverse Event|0|||
23592345|NCT01415349|65899499|FG001|Treatment Period 1|Adverse Event|1|||
23592346|NCT01415349|65899498|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23592347|NCT01415349|65899499|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23592348|NCT01198275|65899504|FG000|Overall Study|Adverse Event|2|||
23592349|NCT01198275|65899505|FG001|Overall Study|Adverse Event|3|||
23592350|NCT01198275|65899504|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
23592351|NCT01198275|65899505|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
23592352|NCT01546753|65899508|FG000|Overall Study|anxiety|1|||
23592353|NCT01546753|65899509|FG001|Overall Study|anxiety|1|||
23592354|NCT01546753|65899508|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
23592355|NCT01546753|65899509|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
23592356|NCT05132478|65899513|FG000|Overall Study|did not complete survey after consent|1|||
23592357|NCT05132478|65899514|FG001|Overall Study|did not complete survey after consent|1|||
23592358|NCT05132478|65899513|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
23476743|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476744|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476745|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476746|NCT00600119|65488183|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
23476747|NCT00600119|65488184|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476748|NCT00600119|65488185|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476749|NCT00600119|65488186|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
23476750|NCT00600119|65488187|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476751|NCT00600119|65488188|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
23476752|NCT00600119|65488183|FG000|Double-blind Treatment Period|Other|0|||
23476753|NCT00600119|65488184|FG001|Double-blind Treatment Period|Other|0|||
23476754|NCT00600119|65488185|FG002|Double-blind Treatment Period|Other|0|||
23476755|NCT00600119|65488186|FG003|Double-blind Treatment Period|Other|0|||
23476756|NCT00600119|65488187|FG004|Double-blind Treatment Period|Other|2|||
23476757|NCT00600119|65488188|FG005|Double-blind Treatment Period|Other|1|||
23476758|NCT00600119|65488183|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476759|NCT00600119|65488184|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
23476760|NCT00600119|65488185|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476761|NCT00600119|65488186|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476762|NCT00600119|65488187|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
23476763|NCT00600119|65488188|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476764|NCT00600119|65488183|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476765|NCT00600119|65488184|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
23476766|NCT00600119|65488185|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476767|NCT00600119|65488186|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476768|NCT00600119|65488187|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476769|NCT00600119|65488188|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23592359|NCT05132478|65899514|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
23592360|NCT03520413|65899519|FG000|Overall Study|Lost to Follow-up|1|||
23476770|NCT00600119|65488183|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
23592361|NCT03520413|65899520|FG001|Overall Study|Lost to Follow-up|1|||
23592362|NCT03520413|65899519|FG000|Overall Study|Withdrawal by Subject|1|||
23592363|NCT03520413|65899520|FG001|Overall Study|Withdrawal by Subject|2|||
23592364|NCT03520413|65899519|FG000|Overall Study|Death|0|||
23592365|NCT03520413|65899520|FG001|Overall Study|Death|1|||
23592366|NCT03520413|65899519|FG000|Overall Study|Physician Decision|3|||
23592367|NCT03520413|65899520|FG001|Overall Study|Physician Decision|3|||
23592368|NCT03520413|65899519|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
23592369|NCT03520413|65899520|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
23592370|NCT02810080|65899523|FG000|Overall Study|Adverse Event|3|||
23592371|NCT02810080|65899524|FG001|Overall Study|Adverse Event|0|||
23799102|NCT04126343|66640208|FG004|Overall Study|Adverse Event|0|||
23799103|NCT04126343|66640209|FG005|Overall Study|Adverse Event|1|||
23476771|NCT00600119|65488184|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
23476772|NCT00600119|65488185|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
23476773|NCT00600119|65488186|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
23476774|NCT00600119|65488187|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
23476775|NCT00600119|65488188|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
23476776|NCT00600119|65488183|FG000|Double-blind Treatment Period|Physician Decision|2|||
23476777|NCT00600119|65488184|FG001|Double-blind Treatment Period|Physician Decision|0|||
23476778|NCT00600119|65488185|FG002|Double-blind Treatment Period|Physician Decision|0|||
23476779|NCT00600119|65488186|FG003|Double-blind Treatment Period|Physician Decision|0|||
23476780|NCT00600119|65488187|FG004|Double-blind Treatment Period|Physician Decision|0|||
23476781|NCT00600119|65488188|FG005|Double-blind Treatment Period|Physician Decision|0|||
23476782|NCT00600119|65488183|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23476783|NCT00600119|65488184|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23476784|NCT00600119|65488185|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23476785|NCT00600119|65488186|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23476786|NCT00600119|65488187|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
23476787|NCT00600119|65488188|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
23476788|NCT00600119|65488183|FG000|Double-blind Treatment Period|Adverse Event|1|||
23476789|NCT00600119|65488184|FG001|Double-blind Treatment Period|Adverse Event|1|||
23476790|NCT00600119|65488185|FG002|Double-blind Treatment Period|Adverse Event|0|||
23476791|NCT00600119|65488186|FG003|Double-blind Treatment Period|Adverse Event|1|||
23476792|NCT00600119|65488187|FG004|Double-blind Treatment Period|Adverse Event|2|||
23476793|NCT00600119|65488188|FG005|Double-blind Treatment Period|Adverse Event|10|||
23476794|NCT00600119|65488183|FG000|Follow-up Period|Adverse Event|0|||
23476795|NCT00600119|65488184|FG001|Follow-up Period|Adverse Event|0|||
23476796|NCT00600119|65488185|FG002|Follow-up Period|Adverse Event|0|||
23476797|NCT00600119|65488186|FG003|Follow-up Period|Adverse Event|0|||
23476798|NCT00600119|65488187|FG004|Follow-up Period|Adverse Event|0|||
23476799|NCT00600119|65488188|FG005|Follow-up Period|Adverse Event|1|||
23476800|NCT00600119|65488183|FG000|Follow-up Period|Other|1|||
23476801|NCT00600119|65488184|FG001|Follow-up Period|Other|0|||
23476802|NCT00600119|65488185|FG002|Follow-up Period|Other|0|||
23799104|NCT04126343|66640204|FG000|Overall Study|Withdrawal by Subject|0|||
23799105|NCT04126343|66640205|FG001|Overall Study|Withdrawal by Subject|0|||
23799106|NCT04126343|66640206|FG002|Overall Study|Withdrawal by Subject|0|||
23799107|NCT04126343|66640207|FG003|Overall Study|Withdrawal by Subject|1|||
23476803|NCT00600119|65488186|FG003|Follow-up Period|Other|0|||
23476804|NCT00600119|65488187|FG004|Follow-up Period|Other|0|||
23476805|NCT00600119|65488188|FG005|Follow-up Period|Other|0|||
23476806|NCT01425463|65488189|FG000|Overall Study|Adverse Event|5|||
23476807|NCT01425463|65488190|FG001|Overall Study|Adverse Event|7|||
23476808|NCT01425463|65488189|FG000|Overall Study|Lack of Efficacy|1|||
23476809|NCT01425463|65488190|FG001|Overall Study|Lack of Efficacy|1|||
23476810|NCT01425463|65488189|FG000|Overall Study|Protocol Violation|2|||
23476811|NCT01425463|65488190|FG001|Overall Study|Protocol Violation|2|||
23476812|NCT01425463|65488189|FG000|Overall Study|Lost to Follow-up|5|||
23476813|NCT01425463|65488190|FG001|Overall Study|Lost to Follow-up|2|||
23476814|NCT01425463|65488189|FG000|Overall Study|Withdrawal by Subject|7|||
23476815|NCT01425463|65488190|FG001|Overall Study|Withdrawal by Subject|5|||
23476816|NCT01425463|65488189|FG000|Overall Study|Unknown Reason|4|||
23592372|NCT02810080|65899523|FG000|Overall Study|Death|0|||
23799108|NCT04126343|66640208|FG004|Overall Study|Withdrawal by Subject|0|||
23799109|NCT04126343|66640209|FG005|Overall Study|Withdrawal by Subject|0|||
23476817|NCT01425463|65488190|FG001|Overall Study|Unknown Reason|7|||
23476818|NCT03126344|65488191|FG000|Overall Study|Lost to Follow-up|0|||
23476819|NCT03126344|65488192|FG001|Overall Study|Lost to Follow-up|0|||
23476820|NCT03126344|65488193|FG002|Overall Study|Lost to Follow-up|5|||
23476821|NCT00917644|65488194|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
23476822|NCT00917644|65488195|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
23476823|NCT00917644|65488194|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
23476824|NCT00917644|65488195|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
23476825|NCT00917644|65488194|FG000|Period 2: Second Intervention|family emergency|1|||
23476826|NCT00917644|65488195|FG001|Period 2: Second Intervention|family emergency|0|||
23476827|NCT01883453|65488198|FG000|Overall Study|No episode of common cold|25|||
23644021|NCT01097707|66079287|FG004|Overall Study|Entry Criteria Not Met|1|||
23644022|NCT01097707|66079283|FG000|Overall Study|Lack of Efficacy|1|||
23644023|NCT01097707|66079284|FG001|Overall Study|Lack of Efficacy|0|||
23644024|NCT01097707|66079285|FG002|Overall Study|Lack of Efficacy|0|||
23644025|NCT01097707|66079286|FG003|Overall Study|Lack of Efficacy|1|||
23644026|NCT01097707|66079287|FG004|Overall Study|Lack of Efficacy|0|||
23644027|NCT01097707|66079283|FG000|Overall Study|Lost to Follow-up|1|||
23644028|NCT01097707|66079284|FG001|Overall Study|Lost to Follow-up|1|||
23644029|NCT01097707|66079285|FG002|Overall Study|Lost to Follow-up|2|||
23644030|NCT01097707|66079286|FG003|Overall Study|Lost to Follow-up|0|||
23644031|NCT01097707|66079287|FG004|Overall Study|Lost to Follow-up|3|||
23644032|NCT01097707|66079283|FG000|Overall Study|Protocol Violation|2|||
23644033|NCT01097707|66079284|FG001|Overall Study|Protocol Violation|2|||
23644034|NCT01097707|66079285|FG002|Overall Study|Protocol Violation|3|||
23644035|NCT01097707|66079286|FG003|Overall Study|Protocol Violation|2|||
23644036|NCT01097707|66079287|FG004|Overall Study|Protocol Violation|2|||
23644037|NCT01097707|66079283|FG000|Overall Study|Sponsor Decision|31|||
23644038|NCT01097707|66079284|FG001|Overall Study|Sponsor Decision|31|||
23644039|NCT01097707|66079285|FG002|Overall Study|Sponsor Decision|34|||
23644040|NCT01097707|66079286|FG003|Overall Study|Sponsor Decision|35|||
23644041|NCT01097707|66079287|FG004|Overall Study|Sponsor Decision|36|||
23644042|NCT01097707|66079283|FG000|Overall Study|Withdrawal by Subject|3|||
23644043|NCT01097707|66079284|FG001|Overall Study|Withdrawal by Subject|6|||
23644044|NCT01097707|66079285|FG002|Overall Study|Withdrawal by Subject|1|||
23644045|NCT01097707|66079286|FG003|Overall Study|Withdrawal by Subject|4|||
23644046|NCT01097707|66079287|FG004|Overall Study|Withdrawal by Subject|3|||
23644047|NCT01097707|66079283|FG000|Overall Study|Reason unknown|0|||
23644048|NCT01097707|66079284|FG001|Overall Study|Reason unknown|0|||
23644049|NCT01097707|66079285|FG002|Overall Study|Reason unknown|0|||
23644050|NCT01097707|66079286|FG003|Overall Study|Reason unknown|0|||
23644051|NCT01097707|66079287|FG004|Overall Study|Reason unknown|1|||
23644052|NCT00473265|66082575|FG000|Overall Study|Unrelated adverse event|5|||
23644053|NCT00473265|66082575|FG000|Overall Study|Off treatment early|15|||
23644054|NCT01723254|66082579|FG000|Overall Study|Conflict with work schedule|0|||
23644055|NCT01723254|66082580|FG001|Overall Study|Conflict with work schedule|0|||
23476828|NCT01883453|65488199|FG001|Overall Study|No episode of common cold|23|||
23476829|NCT00097981|65488216|FG000|Overall Study|Adverse Event|31|||
23476830|NCT00097981|65488217|FG001|Overall Study|Adverse Event|44|||
23476831|NCT00097981|65488216|FG000|Overall Study|Withdrawal by Subject|10|||
23476832|NCT00097981|65488217|FG001|Overall Study|Withdrawal by Subject|8|||
23476833|NCT00097981|65488216|FG000|Overall Study|Protocol Violation|1|||
23476834|NCT00097981|65488217|FG001|Overall Study|Protocol Violation|1|||
23476835|NCT00097981|65488216|FG000|Overall Study|Death|2|||
23476836|NCT00097981|65488217|FG001|Overall Study|Death|4|||
23476837|NCT00097981|65488216|FG000|Overall Study|Physician Decision|7|||
23476838|NCT00097981|65488217|FG001|Overall Study|Physician Decision|1|||
23476839|NCT00097981|65488216|FG000|Overall Study|Disease Progression|8|||
23476840|NCT00097981|65488217|FG001|Overall Study|Disease Progression|2|||
23476841|NCT00097981|65488216|FG000|Overall Study|Transplant planned|28|||
23476842|NCT00097981|65488217|FG001|Overall Study|Transplant planned|27|||
23476843|NCT00097981|65488216|FG000|Overall Study|Other|19|||
23476844|NCT00097981|65488217|FG001|Overall Study|Other|13|||
23476845|NCT03316911|65488218|FG000|Overall Study|Lost to Follow-up|33|||
23476846|NCT03316911|65488219|FG001|Overall Study|Lost to Follow-up|29|||
23476847|NCT00870103|65491390|FG000|Overall Study|Physician Decision|2|||
23476848|NCT00870103|65491390|FG000|Overall Study|Lost to Follow-up|2|||
23476849|NCT02142387|65491391|FG000|Overall Study|<19 years old|49|||
23476850|NCT02142387|65491392|FG001|Overall Study|<19 years old|326|||
23476851|NCT02142387|65491391|FG000|Overall Study|non-cardiac etiology|504|||
23476852|NCT02142387|65491392|FG001|Overall Study|non-cardiac etiology|3431|||
23476853|NCT02142387|65491391|FG000|Overall Study|CPR not performed|74|||
23644056|NCT01723254|66082581|FG002|Overall Study|Conflict with work schedule|0|||
23644057|NCT01723254|66082582|FG003|Overall Study|Conflict with work schedule|0|||
23644058|NCT01723254|66082583|FG004|Overall Study|Conflict with work schedule|0|||
23476854|NCT02142387|65491392|FG001|Overall Study|CPR not performed|473|||
23644059|NCT01723254|66082584|FG005|Overall Study|Conflict with work schedule|0|||
23476855|NCT02142387|65491391|FG000|Overall Study|witnessed by paramedic|139|||
23476856|NCT02142387|65491392|FG001|Overall Study|witnessed by paramedic|917|||
23476857|NCT02142387|65491391|FG000|Overall Study|incomplete data|1|||
23644060|NCT01723254|66082585|FG006|Overall Study|Conflict with work schedule|0|||
23644061|NCT01723254|66082586|FG007|Overall Study|Conflict with work schedule|1|||
23644062|NCT01723254|66082579|FG000|Overall Study|Personal issues|0|||
23476858|NCT02142387|65491392|FG001|Overall Study|incomplete data|9|||
23476859|NCT02142387|65491391|FG000|Overall Study|occurred not at home|298|||
23476860|NCT02142387|65491392|FG001|Overall Study|occurred not at home|2474|||
23476861|NCT00167778|65491393|FG000|Overall Study|Withdrawal by Subject|1|||
23476862|NCT02431260|65491396|FG000|Overall Study|Subject Decision|0|||
23476863|NCT02431260|65491397|FG001|Overall Study|Subject Decision|1|||
23476864|NCT02431260|65491398|FG002|Overall Study|Subject Decision|1|||
23476865|NCT02431260|65491399|FG003|Overall Study|Subject Decision|0|||
23476866|NCT02431260|65491400|FG004|Overall Study|Subject Decision|0|||
23476867|NCT02431260|65491401|FG005|Overall Study|Subject Decision|0|||
23644063|NCT01723254|66082580|FG001|Overall Study|Personal issues|0|||
23644064|NCT01723254|66082581|FG002|Overall Study|Personal issues|0|||
23644065|NCT01723254|66082582|FG003|Overall Study|Personal issues|0|||
23644066|NCT01723254|66082583|FG004|Overall Study|Personal issues|0|||
23644067|NCT01723254|66082584|FG005|Overall Study|Personal issues|1|||
23644068|NCT01723254|66082585|FG006|Overall Study|Personal issues|0|||
23644069|NCT01723254|66082586|FG007|Overall Study|Personal issues|0|||
23644070|NCT01723254|66082579|FG000|Overall Study|No longer have time to participate|0|||
23644071|NCT01723254|66082580|FG001|Overall Study|No longer have time to participate|0|||
23644072|NCT01723254|66082581|FG002|Overall Study|No longer have time to participate|0|||
23644073|NCT01723254|66082582|FG003|Overall Study|No longer have time to participate|1|||
23799110|NCT04126343|66640204|FG000|Overall Study|Related to COVID-19 pandemic|3|||
23799111|NCT04126343|66640205|FG001|Overall Study|Related to COVID-19 pandemic|4|||
23799112|NCT04126343|66640206|FG002|Overall Study|Related to COVID-19 pandemic|3|||
23799113|NCT04126343|66640207|FG003|Overall Study|Related to COVID-19 pandemic|3|||
23799114|NCT04126343|66640208|FG004|Overall Study|Related to COVID-19 pandemic|3|||
23799115|NCT04126343|66640209|FG005|Overall Study|Related to COVID-19 pandemic|3|||
23799116|NCT00857818|66640213|FG000|Overall Study|Lack of Efficacy|1|||
23799117|NCT00857818|66640214|FG001|Overall Study|Lack of Efficacy|0|||
23799118|NCT00857818|66640213|FG000|Overall Study|Adverse Event|3|||
23799119|NCT00857818|66640214|FG001|Overall Study|Adverse Event|0|||
23799120|NCT00857818|66640213|FG000|Overall Study|Withdrawal by Subject|0|||
23799121|NCT00857818|66640214|FG001|Overall Study|Withdrawal by Subject|4|||
23799122|NCT00857818|66640213|FG000|Overall Study|Sponsor terminated study|6|||
23799123|NCT00857818|66640214|FG001|Overall Study|Sponsor terminated study|4|||
23799124|NCT00857818|66640213|FG000|Overall Study|Investigator decision|1|||
23799125|NCT00857818|66640214|FG001|Overall Study|Investigator decision|0|||
23799126|NCT01813435|66640215|FG000|Overall Study|did not finish experimental regimen|1902|||
23799127|NCT01813435|66640216|FG001|Overall Study|did not finish experimental regimen|770|||
23799128|NCT01813435|66640215|FG000|Overall Study|Lost to Follow-up|268|||
23799129|NCT01813435|66640216|FG001|Overall Study|Lost to Follow-up|237|||
23799130|NCT00983476|66640217|FG000|Overall Study|Did not receive intervention|17|||
23799131|NCT00983476|66640218|FG001|Overall Study|Did not receive intervention|22|||
23799132|NCT00983476|66640219|FG002|Overall Study|Did not receive intervention|0|||
23799133|NCT01118117|66640222|FG000|Overall Study|Death|8|||
23799134|NCT01118117|66640223|FG001|Overall Study|Death|0|||
23799135|NCT01118117|66640222|FG000|Overall Study|Lost to Follow-up|6|||
23644074|NCT01723254|66082583|FG004|Overall Study|No longer have time to participate|0|||
23799136|NCT01118117|66640223|FG001|Overall Study|Lost to Follow-up|0|||
23799137|NCT01118117|66640222|FG000|Overall Study|Missed 12 Month Visit|7|||
23799138|NCT01118117|66640223|FG001|Overall Study|Missed 12 Month Visit|0|||
23799139|NCT03840382|66640224|FG000|Overall Study|Lost to Follow-up|11|||
23799140|NCT01899326|66640225|FG000|Overall Study|Withdrawal by Subject|1|||
23799141|NCT01899326|66640225|FG000|Overall Study|Adverse Event|2|||
23799142|NCT01899326|66640225|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
23476868|NCT02431260|65491402|FG006|Overall Study|Subject Decision|0|||
23476869|NCT02431260|65491403|FG007|Overall Study|Subject Decision|0|||
23644075|NCT01723254|66082584|FG005|Overall Study|No longer have time to participate|0|||
23644076|NCT01723254|66082585|FG006|Overall Study|No longer have time to participate|0|||
23644077|NCT01723254|66082586|FG007|Overall Study|No longer have time to participate|0|||
23644078|NCT01723254|66082579|FG000|Overall Study|Move/Left to another country/city|0|||
23644079|NCT01723254|66082580|FG001|Overall Study|Move/Left to another country/city|0|||
23644080|NCT01723254|66082581|FG002|Overall Study|Move/Left to another country/city|2|||
23799143|NCT00442351|66640226|FG000|Overall Study|Administrative|6|||
23799144|NCT00442351|66640227|FG001|Overall Study|Administrative|5|||
23799145|NCT00442351|66640226|FG000|Overall Study|Did not meet protocol eligibility|1|||
23799146|NCT00442351|66640227|FG001|Overall Study|Did not meet protocol eligibility|0|||
23799147|NCT00442351|66640226|FG000|Overall Study|Other|0|||
23799148|NCT00442351|66640227|FG001|Overall Study|Other|1|||
23799149|NCT04569786|66640228|FG000|Overall Study|Lost to Follow-up|1|||
23799150|NCT04569786|66640229|FG001|Overall Study|Lost to Follow-up|0|||
23799151|NCT04569786|66640230|FG002|Overall Study|Lost to Follow-up|4|||
23799152|NCT04569786|66640231|FG003|Overall Study|Lost to Follow-up|1|||
23799153|NCT04569786|66640232|FG004|Overall Study|Lost to Follow-up|0|||
23799154|NCT04569786|66640228|FG000|Overall Study|Withdrawal by Subject|0|||
23799155|NCT04569786|66640229|FG001|Overall Study|Withdrawal by Subject|0|||
23799156|NCT04569786|66640230|FG002|Overall Study|Withdrawal by Subject|0|||
23799157|NCT04569786|66640231|FG003|Overall Study|Withdrawal by Subject|5|||
23799158|NCT04569786|66640232|FG004|Overall Study|Withdrawal by Subject|1|||
23799159|NCT04569786|66640228|FG000|Overall Study|Physician Decision|0|||
23799160|NCT04569786|66640229|FG001|Overall Study|Physician Decision|0|||
23799161|NCT04569786|66640230|FG002|Overall Study|Physician Decision|0|||
23799162|NCT04569786|66640231|FG003|Overall Study|Physician Decision|1|||
23799163|NCT04569786|66640232|FG004|Overall Study|Physician Decision|0|||
23799164|NCT00576303|66640233|FG000|Dose Titration Period|Early withdrawal|17|||
23799165|NCT00576303|66640233|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
23799166|NCT00576303|66640233|FG000|Long Term Safety Period|Early withdrawal|16|||
23799167|NCT02031237|66640234|FG000|Overall Study|Death|1|||
23799168|NCT02031237|66640235|FG001|Overall Study|Death|5|||
23799169|NCT02031237|66640236|FG002|Overall Study|Death|0|||
23799170|NCT02031237|66640234|FG000|Overall Study|Physician Decision|0|||
23799171|NCT02031237|66640235|FG001|Overall Study|Physician Decision|1|||
23799172|NCT02031237|66640236|FG002|Overall Study|Physician Decision|0|||
23799173|NCT02031237|66640234|FG000|Overall Study|Withdrawal by Subject|2|||
23799174|NCT02031237|66640235|FG001|Overall Study|Withdrawal by Subject|2|||
23799175|NCT02031237|66640236|FG002|Overall Study|Withdrawal by Subject|0|||
23799176|NCT02031237|66640234|FG000|Overall Study|Protocol Violation|2|||
23799177|NCT02031237|66640235|FG001|Overall Study|Protocol Violation|6|||
23799178|NCT02031237|66640236|FG002|Overall Study|Protocol Violation|0|||
23799179|NCT02031237|66640234|FG000|Overall Study|Alternate Treatment Given|0|||
23799180|NCT02031237|66640235|FG001|Overall Study|Alternate Treatment Given|0|||
23799181|NCT02031237|66640236|FG002|Overall Study|Alternate Treatment Given|3|||
23799182|NCT00612677|66640239|FG000|Overall Study|study closed before treatment started|1|||
23799183|NCT02608476|66640240|FG000|Overall Study|Withdrawal by Subject|30|||
23799184|NCT02608476|66640241|FG001|Overall Study|Withdrawal by Subject|37|||
23799185|NCT02608476|66640240|FG000|Overall Study|Lost to Follow-up|24|||
23799186|NCT02608476|66640241|FG001|Overall Study|Lost to Follow-up|24|||
23799187|NCT02608476|66640240|FG000|Overall Study|Adverse Event|2|||
23799188|NCT02608476|66640241|FG001|Overall Study|Adverse Event|8|||
23799189|NCT02608476|66640240|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
23799190|NCT02608476|66640241|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
23799191|NCT02608476|66640240|FG000|Overall Study|Noncompliance with treatment|1|||
23799192|NCT02608476|66640241|FG001|Overall Study|Noncompliance with treatment|5|||
23799193|NCT02608476|66640240|FG000|Overall Study|Lack of Efficacy|3|||
23799194|NCT02608476|66640241|FG001|Overall Study|Lack of Efficacy|1|||
23799195|NCT02608476|66640240|FG000|Overall Study|Other|0|||
23799196|NCT02608476|66640241|FG001|Overall Study|Other|1|||
23799197|NCT02608476|66640240|FG000|Overall Study|Physician Decision|1|||
23799198|NCT02608476|66640241|FG001|Overall Study|Physician Decision|0|||
23799199|NCT02608476|66640240|FG000|Overall Study|Pregnancy|0|||
23799200|NCT02608476|66640241|FG001|Overall Study|Pregnancy|1|||
23799201|NCT02608476|66640240|FG000|Overall Study|Progressive disease|1|||
23799202|NCT02608476|66640241|FG001|Overall Study|Progressive disease|0|||
23799203|NCT01961687|66640242|FG000|Overall Study|Lost to Follow-up|19|||
23799204|NCT01961687|66640242|FG000|Overall Study|Re-operation|17|||
23799205|NCT01961687|66640242|FG000|Overall Study|Death|7|||
23799206|NCT01961687|66640242|FG000|Overall Study|Withdrawal by Subject|6|||
23799207|NCT01961687|66640242|FG000|Overall Study|Adverse Event|6|||
23799208|NCT01961687|66640242|FG000|Overall Study|Moved to area without study site|2|||
23799209|NCT01961687|66640242|FG000|Overall Study|Sponsor decision|2|||
23799210|NCT01961687|66640242|FG000|Overall Study|Physician Decision|1|||
23799211|NCT01961687|66640242|FG000|Overall Study|Unable to meet follow-up requirements|1|||
23592373|NCT02810080|65899524|FG001|Overall Study|Death|2|||
23592374|NCT02810080|65899523|FG000|Overall Study|Physician Decision|4|||
23799212|NCT00996437|66640243|FG000|Overall Study|Death|1|||
23476870|NCT02431260|65491404|FG008|Overall Study|Subject Decision|1|||
23476871|NCT02431260|65491405|FG009|Overall Study|Subject Decision|1|||
23476872|NCT02431260|65491406|FG010|Overall Study|Subject Decision|0|||
23476873|NCT02431260|65491407|FG011|Overall Study|Subject Decision|1|||
23476874|NCT02431260|65491408|FG012|Overall Study|Subject Decision|0|||
23644081|NCT01723254|66082582|FG003|Overall Study|Move/Left to another country/city|1|||
23644082|NCT01723254|66082583|FG004|Overall Study|Move/Left to another country/city|1|||
23644083|NCT01723254|66082584|FG005|Overall Study|Move/Left to another country/city|0|||
23644084|NCT01723254|66082585|FG006|Overall Study|Move/Left to another country/city|0|||
23644085|NCT01723254|66082586|FG007|Overall Study|Move/Left to another country/city|0|||
23644086|NCT01723254|66082579|FG000|Overall Study|Protocol Violation|0|||
23644087|NCT01723254|66082580|FG001|Overall Study|Protocol Violation|1|||
23644088|NCT01723254|66082581|FG002|Overall Study|Protocol Violation|0|||
23644089|NCT01723254|66082582|FG003|Overall Study|Protocol Violation|0|||
23644090|NCT01723254|66082583|FG004|Overall Study|Protocol Violation|0|||
23799213|NCT00996437|66640244|FG001|Overall Study|Death|0|||
23799214|NCT00996437|66640243|FG000|Overall Study|Dropped|2|||
23799215|NCT00996437|66640244|FG001|Overall Study|Dropped|2|||
23799216|NCT00996437|66640243|FG000|Overall Study|Missed|2|||
23799217|NCT00996437|66640244|FG001|Overall Study|Missed|5|||
23799218|NCT00199901|66640245|FG000|Overall Study|Protocol Violation|2|||
23799219|NCT00199901|66640246|FG001|Overall Study|Protocol Violation|0|||
23799220|NCT00199901|66640245|FG000|Overall Study|Withdrawal by Subject|1|||
23799221|NCT00199901|66640246|FG001|Overall Study|Withdrawal by Subject|0|||
23799222|NCT00199901|66640245|FG000|Overall Study|Progressive Disease|24|||
23799223|NCT00199901|66640246|FG001|Overall Study|Progressive Disease|24|||
23799224|NCT00981799|66640247|FG000|Overall Study|Adverse Event|1|||
23799225|NCT00981799|66640248|FG001|Overall Study|Adverse Event|1|||
23799226|NCT00981799|66640249|FG002|Overall Study|Adverse Event|0|||
23799227|NCT00981799|66640250|FG003|Overall Study|Adverse Event|0|||
23799228|NCT00559364|66642934|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
23799229|NCT00559364|66642935|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
23799230|NCT01083680|66642936|FG000|Overall Study|Lost to Follow-up|2758|||
23799231|NCT01083680|66642936|FG000|Overall Study|Withdrawal by Subject|1086|||
23799232|NCT01258101|66642937|FG000|Overall Study|Adverse Event|5|||
23799233|NCT01258101|66642938|FG001|Overall Study|Adverse Event|6|||
23799234|NCT01258101|66642939|FG002|Overall Study|Adverse Event|0|||
23799235|NCT01258101|66642940|FG003|Overall Study|Adverse Event|0|||
23799236|NCT01258101|66642937|FG000|Overall Study|Extra exclusion criterion amended|2|||
23799237|NCT01258101|66642938|FG001|Overall Study|Extra exclusion criterion amended|1|||
23799238|NCT01258101|66642939|FG002|Overall Study|Extra exclusion criterion amended|1|||
23799239|NCT01258101|66642940|FG003|Overall Study|Extra exclusion criterion amended|1|||
23799240|NCT01258101|66642937|FG000|Overall Study|Informed consent has been withdrawn|2|||
23799241|NCT01258101|66642938|FG001|Overall Study|Informed consent has been withdrawn|2|||
23799242|NCT01258101|66642939|FG002|Overall Study|Informed consent has been withdrawn|1|||
23799243|NCT01258101|66642940|FG003|Overall Study|Informed consent has been withdrawn|1|||
23799244|NCT01258101|66642937|FG000|Overall Study|Patient is not able to attend visits|8|||
23799245|NCT01258101|66642938|FG001|Overall Study|Patient is not able to attend visits|9|||
23799246|NCT01258101|66642939|FG002|Overall Study|Patient is not able to attend visits|7|||
23644091|NCT01723254|66082584|FG005|Overall Study|Protocol Violation|0|||
23799247|NCT01258101|66642940|FG003|Overall Study|Patient is not able to attend visits|6|||
23799248|NCT01258101|66642937|FG000|Overall Study|Patient´s compliance|4|||
23799249|NCT01258101|66642938|FG001|Overall Study|Patient´s compliance|3|||
23799250|NCT01258101|66642939|FG002|Overall Study|Patient´s compliance|1|||
23799251|NCT01258101|66642940|FG003|Overall Study|Patient´s compliance|2|||
23799252|NCT01258101|66642937|FG000|Overall Study|Lost to Follow-up|5|||
23799253|NCT01258101|66642938|FG001|Overall Study|Lost to Follow-up|5|||
23799254|NCT01258101|66642939|FG002|Overall Study|Lost to Follow-up|0|||
23476875|NCT02431260|65491409|FG013|Overall Study|Subject Decision|0|||
23476876|NCT02431260|65491396|FG000|Overall Study|Death|4|||
23476877|NCT02431260|65491397|FG001|Overall Study|Death|4|||
23476878|NCT02431260|65491398|FG002|Overall Study|Death|3|||
23476879|NCT02431260|65491399|FG003|Overall Study|Death|4|||
23476880|NCT02431260|65491400|FG004|Overall Study|Death|2|||
23476881|NCT02431260|65491401|FG005|Overall Study|Death|2|||
23476882|NCT02431260|65491402|FG006|Overall Study|Death|3|||
23799255|NCT01258101|66642940|FG003|Overall Study|Lost to Follow-up|6|||
23799256|NCT01258101|66642937|FG000|Overall Study|PCR positive at week 24|0|||
23799257|NCT01258101|66642938|FG001|Overall Study|PCR positive at week 24|0|||
23476883|NCT02431260|65491403|FG007|Overall Study|Death|1|||
23476884|NCT02431260|65491404|FG008|Overall Study|Death|6|||
23476885|NCT02431260|65491405|FG009|Overall Study|Death|6|||
23476886|NCT02431260|65491406|FG010|Overall Study|Death|3|||
23592375|NCT02810080|65899524|FG001|Overall Study|Physician Decision|0|||
23592376|NCT02810080|65899523|FG000|Overall Study|Withdrawal by Subject|0|||
23592377|NCT02810080|65899524|FG001|Overall Study|Withdrawal by Subject|2|||
23592378|NCT02238483|65899525|FG000|Overall Study|Withdrawal by Subject|2|||
23592379|NCT02238483|65899526|FG001|Overall Study|Withdrawal by Subject|7|||
23592380|NCT02238483|65899525|FG000|Overall Study|Lost to Follow-up|1|||
23644092|NCT01723254|66082585|FG006|Overall Study|Protocol Violation|0|||
23799258|NCT01258101|66642939|FG002|Overall Study|PCR positive at week 24|0|||
23592381|NCT02238483|65899526|FG001|Overall Study|Lost to Follow-up|1|||
23476887|NCT02431260|65491407|FG011|Overall Study|Death|2|||
23476888|NCT02431260|65491408|FG012|Overall Study|Death|5|||
23592382|NCT02238483|65899525|FG000|Overall Study|Protocol Violation|1|||
23592383|NCT02238483|65899526|FG001|Overall Study|Protocol Violation|2|||
23592384|NCT02238483|65899525|FG000|Overall Study|Death|1|||
23592385|NCT02238483|65899526|FG001|Overall Study|Death|0|||
23592386|NCT02238483|65899525|FG000|Overall Study|Adverse Event|7|||
23592387|NCT02238483|65899526|FG001|Overall Study|Adverse Event|3|||
23592388|NCT02238483|65899525|FG000|Overall Study|Withdrawn due to physician decision|1|||
23592389|NCT02238483|65899526|FG001|Overall Study|Withdrawn due to physician decision|0|||
23592390|NCT02238483|65899525|FG000|Overall Study|Completion status not recorded|1|||
23592391|NCT02238483|65899526|FG001|Overall Study|Completion status not recorded|1|||
23592392|NCT02238483|65899525|FG000|Overall Study|Illness in family member|1|||
23592393|NCT02238483|65899526|FG001|Overall Study|Illness in family member|0|||
23592394|NCT00539292|65899535|FG000|Overall Study|Physician Decision|1|||
23592395|NCT00539292|65899536|FG001|Overall Study|Physician Decision|0|||
23592396|NCT00976937|65899538|FG000|Overall Study|Adverse Event|4|||
23592397|NCT00976937|65899539|FG001|Overall Study|Adverse Event|5|||
23592398|NCT00976937|65899538|FG000|Overall Study|Lost to Follow-up|2|||
23592399|NCT00976937|65899539|FG001|Overall Study|Lost to Follow-up|1|||
23592400|NCT00976937|65899538|FG000|Overall Study|Withdrawal by Subject|5|||
23592401|NCT00976937|65899539|FG001|Overall Study|Withdrawal by Subject|3|||
23592402|NCT00976937|65899538|FG000|Overall Study|Poor compliance to protocol|3|||
23592403|NCT00976937|65899539|FG001|Overall Study|Poor compliance to protocol|0|||
23592404|NCT00976937|65899538|FG000|Overall Study|Personal and Familial Reason|2|||
23592405|NCT00976937|65899539|FG001|Overall Study|Personal and Familial Reason|2|||
23592406|NCT02769858|65899544|FG000|Overall Study|Withdrawal by Subject|2|||
23592407|NCT02544152|65899546|FG000|Overall Study|Adverse Event|0|||
23799259|NCT01258101|66642940|FG003|Overall Study|PCR positive at week 24|1|||
23799260|NCT01258101|66642937|FG000|Overall Study|Other reason|7|||
23799261|NCT01258101|66642938|FG001|Overall Study|Other reason|8|||
23799262|NCT01258101|66642939|FG002|Overall Study|Other reason|1|||
23799263|NCT01258101|66642940|FG003|Overall Study|Other reason|8|||
23799264|NCT02310789|66642941|FG000|Overall Study|Adverse Event|1|||
23799265|NCT02457611|66642942|FG000|Overall Study|Lost to Follow-up|3|||
23799266|NCT01350934|66642943|FG000|Base Study|Adverse Event|6|||
23799267|NCT01350934|66642944|FG001|Base Study|Adverse Event|0|||
23799268|NCT01350934|66642943|FG000|Base Study|Lost to Follow-up|1|||
23799269|NCT01350934|66642944|FG001|Base Study|Lost to Follow-up|0|||
23799270|NCT01350934|66642943|FG000|Base Study|Protocol Violation|1|||
23799271|NCT01350934|66642944|FG001|Base Study|Protocol Violation|1|||
23799272|NCT01350934|66642943|FG000|Base Study|Withdrawal by Subject|1|||
23799273|NCT01350934|66642944|FG001|Base Study|Withdrawal by Subject|2|||
23799274|NCT01350934|66642943|FG000|Base Study|Non-Compliance With Study Drug|2|||
23799275|NCT01350934|66642944|FG001|Base Study|Non-Compliance With Study Drug|0|||
23799276|NCT01350934|66642943|FG000|Extension Study|Adverse Event|2|||
23799277|NCT01350934|66642944|FG001|Extension Study|Adverse Event|1|||
23799278|NCT01350934|66642943|FG000|Extension Study|Lost to Follow-up|2|||
23799279|NCT01350934|66642944|FG001|Extension Study|Lost to Follow-up|0|||
23799280|NCT01350934|66642943|FG000|Extension Study|Protocol Violation|1|||
23799281|NCT01350934|66642944|FG001|Extension Study|Protocol Violation|1|||
23799282|NCT01350934|66642943|FG000|Extension Study|Lack of Efficacy|0|||
23799283|NCT01350934|66642944|FG001|Extension Study|Lack of Efficacy|1|||
23799284|NCT01350934|66642943|FG000|Extension Study|Withdrawal by Subject|0|||
23799285|NCT01350934|66642944|FG001|Extension Study|Withdrawal by Subject|1|||
23799286|NCT00779402|66642945|FG000|Treatment Phase 1|Disease Progression|1|||
23799287|NCT00779402|66642946|FG001|Treatment Phase 1|Disease Progression|0|||
23799288|NCT00779402|66642945|FG000|Treatment Phase 1|Adverse Event|2|||
23799289|NCT00779402|66642946|FG001|Treatment Phase 1|Adverse Event|0|||
23799290|NCT00779402|66642945|FG000|Treatment Phase 1|Protocol Violation|1|||
23799291|NCT00779402|66642946|FG001|Treatment Phase 1|Protocol Violation|0|||
23799292|NCT00779402|66642945|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
23799293|NCT00779402|66642946|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
23799294|NCT00779402|66642945|FG000|Treatment Phase 1|Lost to Follow-up|0|||
23799295|NCT00779402|66642946|FG001|Treatment Phase 1|Lost to Follow-up|1|||
23799296|NCT00779402|66642945|FG000|Treatment Phase 1|Death|0|||
23799297|NCT00779402|66642946|FG001|Treatment Phase 1|Death|1|||
23799298|NCT00779402|66642945|FG000|Treatment Phase 1|Intercurrent Illness|1|||
23476889|NCT02431260|65491409|FG013|Overall Study|Death|1|||
23592408|NCT02544152|65899547|FG001|Overall Study|Adverse Event|4|||
23799299|NCT00779402|66642946|FG001|Treatment Phase 1|Intercurrent Illness|1|||
23592409|NCT02544152|65899546|FG000|Overall Study|Withdrawal by Subject|0|||
23592410|NCT02544152|65899547|FG001|Overall Study|Withdrawal by Subject|3|||
23592411|NCT02544152|65899546|FG000|Overall Study|Other|1|||
23799300|NCT00779402|66642945|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
23799301|NCT00779402|66642946|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
23799302|NCT00779402|66642945|FG000|Treatment Phase 1|Other|4|||
23799303|NCT00779402|66642946|FG001|Treatment Phase 1|Other|2|||
23799304|NCT00779402|66642945|FG000|Treatment Phase 1|Closure of Study|3|||
23799305|NCT00779402|66642946|FG001|Treatment Phase 1|Closure of Study|2|||
23592412|NCT02544152|65899547|FG001|Overall Study|Other|0|||
23592413|NCT01239316|65899549|FG000|Overall Study|Progression/Relapse|11|||
23592414|NCT01239316|65899549|FG000|Overall Study|Adverse Event|1|||
23592415|NCT00396084|65899551|FG000|Overall Study|Adverse Event|0|||
23592416|NCT00396084|65899552|FG001|Overall Study|Adverse Event|0|||
23592417|NCT00396084|65899553|FG002|Overall Study|Adverse Event|0|||
23592418|NCT00396084|65899554|FG003|Overall Study|Adverse Event|0|||
23592419|NCT00396084|65899555|FG004|Overall Study|Adverse Event|1|||
23592420|NCT00396084|65899556|FG005|Overall Study|Adverse Event|2|||
23592421|NCT00396084|65899551|FG000|Overall Study|Withdrawal by Subject|0|||
23592422|NCT00396084|65899552|FG001|Overall Study|Withdrawal by Subject|0|||
23592423|NCT00396084|65899553|FG002|Overall Study|Withdrawal by Subject|0|||
23592424|NCT00396084|65899554|FG003|Overall Study|Withdrawal by Subject|1|||
23592425|NCT00396084|65899555|FG004|Overall Study|Withdrawal by Subject|0|||
23592426|NCT00396084|65899556|FG005|Overall Study|Withdrawal by Subject|0|||
23592427|NCT00668863|65899563|FG000|Overall Study|Objective Progression or Relapse|42|||
23592428|NCT00668863|65899563|FG000|Overall Study|Adverse Event|13|||
23592429|NCT00668863|65899563|FG000|Overall Study|Study Terminated by Sponsor|8|||
23644093|NCT01723254|66082586|FG007|Overall Study|Protocol Violation|0|||
23644094|NCT01723254|66082579|FG000|Overall Study|Withdrawal by Subject|1|||
23644095|NCT01723254|66082580|FG001|Overall Study|Withdrawal by Subject|2|||
23644096|NCT01723254|66082581|FG002|Overall Study|Withdrawal by Subject|1|||
23644097|NCT01723254|66082582|FG003|Overall Study|Withdrawal by Subject|0|||
23644098|NCT01723254|66082583|FG004|Overall Study|Withdrawal by Subject|1|||
23644099|NCT01723254|66082584|FG005|Overall Study|Withdrawal by Subject|1|||
23799306|NCT00779402|66642945|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
23799307|NCT00779402|66642946|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
23799308|NCT00779402|66642945|FG000|Surveillance Phase|Protocol Violation|0|||
23799309|NCT00779402|66642946|FG001|Surveillance Phase|Protocol Violation|1|||
23799310|NCT00779402|66642945|FG000|Surveillance Phase|Patient refused to continue|22|||
23799311|NCT00779402|66642946|FG001|Surveillance Phase|Patient refused to continue|14|||
23799312|NCT00779402|66642945|FG000|Surveillance Phase|Lost to Follow-up|2|||
23799313|NCT00779402|66642946|FG001|Surveillance Phase|Lost to Follow-up|1|||
23799314|NCT00779402|66642945|FG000|Surveillance Phase|Death|0|||
23799315|NCT00779402|66642946|FG001|Surveillance Phase|Death|1|||
23799316|NCT00779402|66642945|FG000|Surveillance Phase|Intercurrent Illness|2|||
23799317|NCT00779402|66642946|FG001|Surveillance Phase|Intercurrent Illness|0|||
23799318|NCT00779402|66642945|FG000|Surveillance Phase|Other|5|||
23799319|NCT00779402|66642946|FG001|Surveillance Phase|Other|5|||
23799320|NCT00779402|66642945|FG000|Surveillance Phase|Withdrawal by Subject|4|||
23799321|NCT00779402|66642946|FG001|Surveillance Phase|Withdrawal by Subject|1|||
23799322|NCT00779402|66642945|FG000|Surveillance Phase|Closure of study|5|||
23799323|NCT00779402|66642946|FG001|Surveillance Phase|Closure of study|6|||
23799324|NCT00779402|66642945|FG000|Surveillance Phase|Completed Protocol Visits|3|||
23799325|NCT00779402|66642946|FG001|Surveillance Phase|Completed Protocol Visits|2|||
23799326|NCT00779402|66642945|FG000|Long-term Follow-up|Patient refused to continue|2|||
23799327|NCT00779402|66642946|FG001|Long-term Follow-up|Patient refused to continue|0|||
23799328|NCT00779402|66642945|FG000|Long-term Follow-up|Other|5|||
23799329|NCT00779402|66642946|FG001|Long-term Follow-up|Other|0|||
23799330|NCT00779402|66642945|FG000|Long-term Follow-up|Closure of Study|8|||
23799331|NCT00779402|66642946|FG001|Long-term Follow-up|Closure of Study|4|||
23799332|NCT00779402|66642945|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
23799333|NCT00779402|66642946|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
23799334|NCT00407745|66642950|FG000|Overall Study|Lack of Efficacy|1|||
23799335|NCT00407745|66642951|FG001|Overall Study|Lack of Efficacy|2|||
23799336|NCT00407745|66642950|FG000|Overall Study|Withdrawal by Subject|3|||
23799337|NCT00407745|66642951|FG001|Overall Study|Withdrawal by Subject|3|||
23799338|NCT00407745|66642950|FG000|Overall Study|Protocol Violation|5|||
23799339|NCT00407745|66642951|FG001|Overall Study|Protocol Violation|3|||
23799340|NCT00407745|66642950|FG000|Overall Study|Adverse Event|8|||
23799341|NCT00407745|66642951|FG001|Overall Study|Adverse Event|8|||
23799342|NCT00407745|66642950|FG000|Overall Study|Other|2|||
23799343|NCT00407745|66642951|FG001|Overall Study|Other|0|||
23799344|NCT00407745|66642950|FG000|Overall Study|Randomized, unknown if treated|0|||
23799345|NCT00407745|66642951|FG001|Overall Study|Randomized, unknown if treated|1|||
23799346|NCT01507090|66642958|FG000|Overall Study|incomplete dataset|18|||
23592430|NCT00668863|65899563|FG000|Overall Study|Global Deterioration of Health Status|4|||
23592431|NCT00668863|65899563|FG000|Overall Study|Withdrawal by Subject|1|||
23592432|NCT00668863|65899563|FG000|Overall Study|Surgery|1|||
23644100|NCT01723254|66082585|FG006|Overall Study|Withdrawal by Subject|1|||
23799347|NCT01825837|66642960|FG000|PART I|Withdrawal by Subject|0|||
23799348|NCT01825837|66642961|FG001|PART I|Withdrawal by Subject|0|||
23799349|NCT01825837|66642962|FG002|PART I|Withdrawal by Subject|0|||
23592433|NCT00668863|65899563|FG000|Overall Study|Subject's work scheduling problem|1|||
23799350|NCT01825837|66642963|FG003|PART I|Withdrawal by Subject|6|||
23799351|NCT01825837|66642960|FG000|PART I|Patient non-compliance|0|||
23799352|NCT01825837|66642961|FG001|PART I|Patient non-compliance|0|||
23799353|NCT01825837|66642962|FG002|PART I|Patient non-compliance|0|||
23799354|NCT01825837|66642963|FG003|PART I|Patient non-compliance|1|||
23799355|NCT01825837|66642960|FG000|PART I|Treatment failure|0|||
23799356|NCT01825837|66642961|FG001|PART I|Treatment failure|0|||
23799357|NCT01825837|66642962|FG002|PART I|Treatment failure|0|||
23799358|NCT01825837|66642963|FG003|PART I|Treatment failure|7|||
23799359|NCT01825837|66642960|FG000|PART I|reason unspecified|0|||
23799360|NCT01825837|66642961|FG001|PART I|reason unspecified|0|||
23799361|NCT01825837|66642962|FG002|PART I|reason unspecified|0|||
23799362|NCT01825837|66642963|FG003|PART I|reason unspecified|3|||
23799363|NCT01825837|66642960|FG000|PART II|Withdrawal by Subject|3|||
23799364|NCT01825837|66642961|FG001|PART II|Withdrawal by Subject|3|||
23799365|NCT01825837|66642962|FG002|PART II|Withdrawal by Subject|7|||
23799366|NCT01825837|66642963|FG003|PART II|Withdrawal by Subject|0|||
23799367|NCT01825837|66642960|FG000|PART II|Patient non-compliance|5|||
23799368|NCT01825837|66642961|FG001|PART II|Patient non-compliance|2|||
23799369|NCT01825837|66642962|FG002|PART II|Patient non-compliance|4|||
23799370|NCT01825837|66642963|FG003|PART II|Patient non-compliance|0|||
23799371|NCT01825837|66642960|FG000|PART II|Adverse Event|3|||
23799372|NCT01825837|66642961|FG001|PART II|Adverse Event|3|||
23799373|NCT01825837|66642962|FG002|PART II|Adverse Event|1|||
23799374|NCT01825837|66642963|FG003|PART II|Adverse Event|0|||
23799375|NCT01825837|66642960|FG000|PART II|Treatment failure|6|||
23799376|NCT01825837|66642961|FG001|PART II|Treatment failure|4|||
23799377|NCT01825837|66642962|FG002|PART II|Treatment failure|5|||
23799378|NCT01825837|66642963|FG003|PART II|Treatment failure|0|||
23799379|NCT01825837|66642960|FG000|PART II|reason unspecified|2|||
23799380|NCT01825837|66642961|FG001|PART II|reason unspecified|2|||
23799381|NCT01825837|66642962|FG002|PART II|reason unspecified|2|||
23799382|NCT01825837|66642963|FG003|PART II|reason unspecified|0|||
23799383|NCT02013531|66642966|FG000|Overall Study|Lost to Follow-up|3|||
23799384|NCT02013531|66642966|FG000|Overall Study|Met Withdrawal Criteria|1|||
23799385|NCT02013531|66642966|FG000|Overall Study|Withdrawal by Subject|1|||
23799386|NCT01115855|66642971|FG000|Overall Study|Adverse Event|16|||
23799387|NCT01115855|66642972|FG001|Overall Study|Adverse Event|18|||
23799388|NCT01115855|66642971|FG000|Overall Study|Death|6|||
23799389|NCT01115855|66642972|FG001|Overall Study|Death|5|||
23799390|NCT01115855|66642971|FG000|Overall Study|Lab Abnormality|1|||
23799391|NCT01115855|66642972|FG001|Overall Study|Lab Abnormality|1|||
23799392|NCT01115855|66642971|FG000|Overall Study|Protocol Violation|0|||
23799393|NCT01115855|66642972|FG001|Overall Study|Protocol Violation|1|||
23799394|NCT01115855|66642971|FG000|Overall Study|Withdrawal by Subject|5|||
23799395|NCT01115855|66642972|FG001|Overall Study|Withdrawal by Subject|5|||
23799396|NCT01115855|66642971|FG000|Overall Study|Other|8|||
23799397|NCT01115855|66642972|FG001|Overall Study|Other|6|||
23799398|NCT04046549|66642986|FG000|Overall Study|Adverse Event|1|||
23799399|NCT04046549|66642986|FG000|Overall Study|Physician Decision|1|||
23799400|NCT04046549|66642986|FG000|Overall Study|Withdrawal by Subject|3|||
23799401|NCT04046549|66642986|FG000|Overall Study|Other, Not Specified|5|||
23799402|NCT04974619|66642987|FG000|Overall Study|Lost to Follow-up|0|||
23799403|NCT04974619|66642988|FG001|Overall Study|Lost to Follow-up|0|||
23799404|NCT04974619|66642989|FG002|Overall Study|Lost to Follow-up|1|||
23592434|NCT00668863|65899563|FG000|Overall Study|Physician Decision|1|||
23592435|NCT00373529|65899564|FG000|Overall Study|Physician Decision|19|||
23799405|NCT04974619|66642987|FG000|Overall Study|Withdrawal by Subject|0|||
23799406|NCT04974619|66642988|FG001|Overall Study|Withdrawal by Subject|0|||
23799407|NCT04974619|66642989|FG002|Overall Study|Withdrawal by Subject|1|||
23799408|NCT04974619|66642987|FG000|Overall Study|Protocol Violation|0|||
23799409|NCT04974619|66642988|FG001|Overall Study|Protocol Violation|1|||
23799410|NCT04974619|66642989|FG002|Overall Study|Protocol Violation|0|||
23799411|NCT04768296|66642991|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
23799412|NCT04768296|66642992|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
23799413|NCT01610063|66642993|FG000|Overall Study|Lost to Follow-up|42|||
23799414|NCT01610063|66642994|FG001|Overall Study|Lost to Follow-up|20|||
23799415|NCT03689894|66642995|FG000|Overall Study|Adverse Event|1|||
23799416|NCT02351167|66642999|FG000|Overall Study|Withdrawal by Subject|19|||
23799417|NCT02351167|66643000|FG001|Overall Study|Withdrawal by Subject|18|||
23592436|NCT00373529|65899564|FG000|Overall Study|Withdrawal by Subject|7|||
23592437|NCT00373529|65899564|FG000|Overall Study|Adverse Event|7|||
23592438|NCT00373529|65899564|FG000|Overall Study|Treatment failure|36|||
23592439|NCT00373529|65899564|FG000|Overall Study|Disease recurrence|10|||
23592440|NCT00373529|65899564|FG000|Overall Study|Death|16|||
23592441|NCT00373529|65899564|FG000|Overall Study|Need for treatment prohibited by study|1|||
23592442|NCT00373529|65899564|FG000|Overall Study|Other|8|||
23592443|NCT00373529|65899564|FG000|Overall Study|Failed independent confirmation of AML|3|||
23592444|NCT00373529|65899564|FG000|Overall Study|Consent violation|1|||
23592445|NCT04057196|65899565|FG000|Overall Study|Withdrawal by Subject|3|||
23592446|NCT04057196|65899565|FG000|Overall Study|Death|3|||
23592447|NCT00206375|65899566|FG000|Overall Study|Lost to Follow-up|1|||
23592448|NCT00206375|65899567|FG001|Overall Study|Lost to Follow-up|0|||
23592449|NCT00206375|65899568|FG002|Overall Study|Lost to Follow-up|0|||
23592450|NCT00206375|65899566|FG000|Overall Study|Withdrawal by Subject|2|||
23592451|NCT00206375|65899567|FG001|Overall Study|Withdrawal by Subject|1|||
23799418|NCT02351167|66643001|FG002|Overall Study|Withdrawal by Subject|21|||
23799419|NCT03558139|66643002|FG000|Overall Study|Consent Withdrawn|1|||
23799420|NCT03558139|66643003|FG001|Overall Study|Consent Withdrawn|1|||
23799421|NCT03558139|66643004|FG002|Overall Study|Consent Withdrawn|4|||
23799422|NCT03558139|66643002|FG000|Overall Study|Death|5|||
23799423|NCT03558139|66643003|FG001|Overall Study|Death|3|||
23799424|NCT03558139|66643004|FG002|Overall Study|Death|8|||
23799425|NCT03558139|66643002|FG000|Overall Study|Lost to Follow-up|0|||
23799426|NCT03558139|66643003|FG001|Overall Study|Lost to Follow-up|0|||
23799427|NCT03558139|66643004|FG002|Overall Study|Lost to Follow-up|3|||
23799428|NCT03558139|66643002|FG000|Overall Study|Study Ended Per Protocol|0|||
23799429|NCT03558139|66643003|FG001|Overall Study|Study Ended Per Protocol|3|||
23799430|NCT03558139|66643004|FG002|Overall Study|Study Ended Per Protocol|6|||
23799431|NCT00129116|66643005|FG000|Primary Phase|Lost to Follow-up|1|||
23799432|NCT00129116|66643006|FG001|Primary Phase|Lost to Follow-up|1|||
23799433|NCT00129116|66643007|FG002|Primary Phase|Lost to Follow-up|0|||
23799434|NCT00129116|66643008|FG003|Primary Phase|Lost to Follow-up|1|||
23799435|NCT00129116|66643009|FG004|Primary Phase|Lost to Follow-up|1|||
23799436|NCT00129116|66643005|FG000|Primary Phase|Protocol Violation|0|||
23799437|NCT00129116|66643006|FG001|Primary Phase|Protocol Violation|1|||
23799438|NCT00129116|66643007|FG002|Primary Phase|Protocol Violation|0|||
23799439|NCT00129116|66643008|FG003|Primary Phase|Protocol Violation|0|||
23799440|NCT00129116|66643009|FG004|Primary Phase|Protocol Violation|0|||
23476890|NCT02431260|65491396|FG000|Overall Study|Lost to Follow-up|0|||
23592452|NCT00206375|65899568|FG002|Overall Study|Withdrawal by Subject|3|||
23799441|NCT00129116|66643005|FG000|Primary Phase|Adverse Event|1|||
23799442|NCT00129116|66643006|FG001|Primary Phase|Adverse Event|1|||
23799443|NCT00129116|66643007|FG002|Primary Phase|Adverse Event|0|||
23799444|NCT00129116|66643008|FG003|Primary Phase|Adverse Event|0|||
23799445|NCT00129116|66643009|FG004|Primary Phase|Adverse Event|0|||
23799446|NCT00129116|66643005|FG000|Primary Phase|Withdrawal by Subject|0|||
23799447|NCT00129116|66643006|FG001|Primary Phase|Withdrawal by Subject|1|||
23799448|NCT00129116|66643007|FG002|Primary Phase|Withdrawal by Subject|0|||
23799449|NCT00129116|66643008|FG003|Primary Phase|Withdrawal by Subject|0|||
23799450|NCT00129116|66643009|FG004|Primary Phase|Withdrawal by Subject|0|||
23476891|NCT02431260|65491397|FG001|Overall Study|Lost to Follow-up|0|||
23592453|NCT00206375|65899566|FG000|Overall Study|Study terminated due to lack of funds|0|||
23592454|NCT00206375|65899567|FG001|Overall Study|Study terminated due to lack of funds|1|||
23799451|NCT00129116|66643005|FG000|Primary Phase|Other|0|||
23799452|NCT00129116|66643006|FG001|Primary Phase|Other|0|||
23799453|NCT00129116|66643007|FG002|Primary Phase|Other|1|||
23476892|NCT02431260|65491398|FG002|Overall Study|Lost to Follow-up|0|||
23592455|NCT00206375|65899568|FG002|Overall Study|Study terminated due to lack of funds|1|||
23592456|NCT00494780|65899569|FG000|Overall Study|Adverse Event|1|||
23592457|NCT00494780|65899570|FG001|Overall Study|Adverse Event|0|||
23592458|NCT00494780|65899569|FG000|Overall Study|Withdrew before Dosed|0|||
23592459|NCT00494780|65899570|FG001|Overall Study|Withdrew before Dosed|1|||
23592460|NCT00494780|65899569|FG000|Overall Study|Progression of Study Disease|7|||
23592461|NCT00494780|65899570|FG001|Overall Study|Progression of Study Disease|8|||
23592462|NCT00494780|65899569|FG000|Overall Study|New Treatment|2|||
23592463|NCT00494780|65899570|FG001|Overall Study|New Treatment|2|||
23592464|NCT00494780|65899569|FG000|Overall Study|Non-compliance|1|||
23592465|NCT00494780|65899570|FG001|Overall Study|Non-compliance|0|||
23592466|NCT00494780|65899569|FG000|Overall Study|Residual Tumour Mass|0|||
23592467|NCT00494780|65899570|FG001|Overall Study|Residual Tumour Mass|1|||
23592468|NCT00494780|65899569|FG000|Overall Study|Insurance Issues|0|||
23592469|NCT00494780|65899570|FG001|Overall Study|Insurance Issues|1|||
23592470|NCT00869323|65899573|FG000|Maintenance Therapy|concurrent illness|1|||
23592471|NCT01580293|65899575|FG000|Part A_Main Trial|Adverse Event|0|||
23592472|NCT01580293|65899576|FG001|Part A_Main Trial|Adverse Event|2|||
23592473|NCT01580293|65899577|FG002|Part A_Main Trial|Adverse Event|0|||
23592474|NCT01580293|65899575|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
23592475|NCT01580293|65899576|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
23592476|NCT01580293|65899577|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
23592477|NCT01580293|65899575|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
23592478|NCT01580293|65899576|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
23592479|NCT01580293|65899577|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
23592480|NCT01580293|65899575|FG000|Part A_Extension|Adverse Event|0|||
23592481|NCT01580293|65899576|FG001|Part A_Extension|Adverse Event|2|||
23592482|NCT01580293|65899577|FG002|Part A_Extension|Adverse Event|0|||
23592483|NCT01580293|65899575|FG000|Part A_Extension|Withdrawal by Subject|0|||
23592484|NCT01580293|65899576|FG001|Part A_Extension|Withdrawal by Subject|3|||
23592485|NCT01580293|65899577|FG002|Part A_Extension|Withdrawal by Subject|0|||
23592486|NCT01580293|65899575|FG000|Part A_Extension|Lost to Follow-up|0|||
23592487|NCT01580293|65899576|FG001|Part A_Extension|Lost to Follow-up|1|||
23592488|NCT01580293|65899577|FG002|Part A_Extension|Lost to Follow-up|0|||
23592489|NCT01580293|65899575|FG000|Part A_Extension|Other Reason|0|||
23592490|NCT01580293|65899576|FG001|Part A_Extension|Other Reason|1|||
23592491|NCT01580293|65899577|FG002|Part A_Extension|Other Reason|0|||
23592492|NCT01580293|65899575|FG000|Part A_Extension|Completed Japan only|0|||
23592493|NCT01580293|65899576|FG001|Part A_Extension|Completed Japan only|5|||
23592494|NCT01580293|65899577|FG002|Part A_Extension|Completed Japan only|0|||
23592495|NCT01580293|65899575|FG000|Part B|Withdrawal by Subject|0|||
23592496|NCT01580293|65899576|FG001|Part B|Withdrawal by Subject|0|||
23592497|NCT01580293|65899577|FG002|Part B|Withdrawal by Subject|1|||
23592498|NCT01580293|65899575|FG000|Part B|Other reason|0|||
23592499|NCT01580293|65899576|FG001|Part B|Other reason|0|||
23592500|NCT01580293|65899577|FG002|Part B|Other reason|1|||
23592501|NCT02731755|65899578|FG000|First Intervention|Withdrawal by Subject|0|||
23799454|NCT00129116|66643008|FG003|Primary Phase|Other|0|||
23592502|NCT02731755|65899579|FG001|First Intervention|Withdrawal by Subject|2|||
23592503|NCT04009577|65899580|FG000|Core Study|Adverse Event|1|||
23592504|NCT04009577|65899581|FG001|Core Study|Adverse Event|0|||
23592505|NCT04009577|65899582|FG002|Core Study|Adverse Event|2|||
23592506|NCT04009577|65899583|FG003|Core Study|Adverse Event|4|||
23592507|NCT04009577|65899580|FG000|Core Study|Withdrawal by Subject|0|||
23799455|NCT00129116|66643009|FG004|Primary Phase|Other|0|||
23799456|NCT00129116|66643005|FG000|Booster Phase|Lost to Follow-up|2|||
23799457|NCT00129116|66643006|FG001|Booster Phase|Lost to Follow-up|0|||
23799458|NCT00129116|66643007|FG002|Booster Phase|Lost to Follow-up|0|||
23592508|NCT04009577|65899581|FG001|Core Study|Withdrawal by Subject|0|||
23592509|NCT04009577|65899582|FG002|Core Study|Withdrawal by Subject|2|||
23592510|NCT04009577|65899583|FG003|Core Study|Withdrawal by Subject|0|||
23592511|NCT04009577|65899580|FG000|Core Study|Other|0|||
23592512|NCT04009577|65899581|FG001|Core Study|Other|0|||
23799459|NCT00129116|66643008|FG003|Booster Phase|Lost to Follow-up|0|||
23799460|NCT00129116|66643009|FG004|Booster Phase|Lost to Follow-up|1|||
23592513|NCT04009577|65899582|FG002|Core Study|Other|0|||
23592514|NCT04009577|65899583|FG003|Core Study|Other|1|||
23592515|NCT04009577|65899580|FG000|Extension Phase|Adverse Event|0|||
23592516|NCT04009577|65899581|FG001|Extension Phase|Adverse Event|0|||
23592517|NCT04009577|65899582|FG002|Extension Phase|Adverse Event|0|||
23592518|NCT04009577|65899583|FG003|Extension Phase|Adverse Event|1|||
23592519|NCT04009577|65899580|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23592520|NCT04009577|65899581|FG001|Extension Phase|Inadequate therapeutic effect|0|||
23799461|NCT00500318|66643010|FG000|Overall Study|Adverse Event|3|||
23799462|NCT00500318|66643011|FG001|Overall Study|Adverse Event|8|||
23799463|NCT00500318|66643010|FG000|Overall Study|Protocol Violation|1|||
23799464|NCT00500318|66643011|FG001|Overall Study|Protocol Violation|3|||
23799465|NCT00500318|66643010|FG000|Overall Study|Withdrawal by Subject|1|||
23799466|NCT00500318|66643011|FG001|Overall Study|Withdrawal by Subject|2|||
23799467|NCT00500318|66643010|FG000|Overall Study|Lack of Efficacy|0|||
23592521|NCT04009577|65899582|FG002|Extension Phase|Inadequate therapeutic effect|1|||
23592522|NCT04009577|65899583|FG003|Extension Phase|Inadequate therapeutic effect|0|||
23592523|NCT04009577|65899580|FG000|Extension Phase|Withdrawal by Subject|0|||
23592524|NCT04009577|65899581|FG001|Extension Phase|Withdrawal by Subject|0|||
23592525|NCT04009577|65899582|FG002|Extension Phase|Withdrawal by Subject|1|||
23592526|NCT04009577|65899583|FG003|Extension Phase|Withdrawal by Subject|0|||
23592527|NCT04009577|65899580|FG000|Extension Phase|Not Treated|0|||
23592528|NCT04009577|65899581|FG001|Extension Phase|Not Treated|0|||
23592529|NCT04009577|65899582|FG002|Extension Phase|Not Treated|2|||
23592530|NCT04009577|65899583|FG003|Extension Phase|Not Treated|0|||
23592531|NCT03863834|65899584|FG000|Overall Study|Lost to Follow-up|3|||
23592532|NCT03712930|65899591|FG000|Overall Study|Death|7|||
23592533|NCT03712930|65899591|FG000|Overall Study|Physician Decision|1|||
23592534|NCT03712930|65899591|FG000|Overall Study|Study Terminated by Sponsor|3|||
23592535|NCT03712930|65899591|FG000|Overall Study|Progressive Disease|2|||
23592536|NCT00356265|65899594|FG000|Overall Study|Withdrawal by Subject|0|||
23592537|NCT00356265|65899595|FG001|Overall Study|Withdrawal by Subject|0|||
23592538|NCT00356265|65899596|FG002|Overall Study|Withdrawal by Subject|1|||
23592539|NCT01199575|65899597|FG000|Overall Study|Withdrawal by Subject|5|||
23592540|NCT01185782|65899601|FG000|Overall Study|Adverse Event|0|||
23592541|NCT01185782|65899602|FG001|Overall Study|Adverse Event|1|||
23592542|NCT01185782|65899601|FG000|Overall Study|Protocol Violation|1|||
23592543|NCT01185782|65899602|FG001|Overall Study|Protocol Violation|0|||
23592544|NCT01185782|65899601|FG000|Overall Study|Poor Response to Treatment|3|||
23799468|NCT00500318|66643011|FG001|Overall Study|Lack of Efficacy|3|||
23799469|NCT00500318|66643010|FG000|Overall Study|Other Reason|0|||
23799470|NCT00500318|66643011|FG001|Overall Study|Other Reason|1|||
23799471|NCT02096588|66643014|FG000|Overall Study|Lack of Efficacy|2|||
23799472|NCT02096588|66643015|FG001|Overall Study|Lack of Efficacy|0|||
23799473|NCT02096588|66643014|FG000|Overall Study|Withdrawal by Subject|0|||
23799474|NCT02096588|66643015|FG001|Overall Study|Withdrawal by Subject|1|||
23799475|NCT02147587|66643016|FG000|Overall Study|Adverse Event|9|||
23592545|NCT01185782|65899602|FG001|Overall Study|Poor Response to Treatment|1|||
23592546|NCT01185782|65899601|FG000|Overall Study|Other|2|||
23592547|NCT01185782|65899602|FG001|Overall Study|Other|5|||
23799476|NCT02147587|66643017|FG001|Overall Study|Adverse Event|4|||
23799477|NCT02147587|66643016|FG000|Overall Study|Lack of Efficacy|2|||
23799478|NCT02147587|66643017|FG001|Overall Study|Lack of Efficacy|1|||
23799479|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
23799480|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
23799481|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
23799482|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
23799483|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
23799484|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
23592548|NCT01185782|65899601|FG000|Overall Study|Randomized but not treated|0|||
23592549|NCT01185782|65899602|FG001|Overall Study|Randomized but not treated|4|||
23592550|NCT01068743|65899603|FG000|Period 3|Adverse Event|0|||
23592551|NCT01068743|65899604|FG001|Period 3|Adverse Event|1|||
23592552|NCT01068743|65899605|FG002|Period 3|Adverse Event|0|||
23799485|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
23799486|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
23799487|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
23592553|NCT01068743|65899606|FG003|Period 3|Adverse Event|0|||
23799488|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
23592554|NCT00703911|65899609|FG000|Overall Study|Death|1|||
23592555|NCT00703911|65899609|FG000|Overall Study|Physician Decision|6|||
23592556|NCT00703911|65899609|FG000|Overall Study|Lost to Follow-up|1|||
23592557|NCT00703911|65899609|FG000|Overall Study|Withdrawal by Subject|2|||
23592558|NCT03020745|65899610|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592559|NCT03020745|65899611|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592560|NCT03020745|65899612|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592561|NCT03020745|65899613|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592562|NCT03020745|65899614|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592563|NCT03020745|65899615|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592564|NCT03020745|65899616|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592565|NCT03020745|65899617|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592566|NCT03020745|65899618|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
23592567|NCT03020745|65899619|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592568|NCT03020745|65899610|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592569|NCT03020745|65899611|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592570|NCT03020745|65899612|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592571|NCT03020745|65899613|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592572|NCT03020745|65899614|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592573|NCT03020745|65899615|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592574|NCT03020745|65899616|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592575|NCT03020745|65899617|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
23799489|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
23799490|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
23799491|NCT03321526|66643018|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
23799492|NCT03321526|66643019|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
23799493|NCT03321526|66643018|FG000|Follow-up Phase (2 Weeks)|Other|24|||
23799494|NCT03321526|66643019|FG001|Follow-up Phase (2 Weeks)|Other|24|||
23799495|NCT01438476|66643036|FG000|Overall Study|Protocol Violation|1|||
23799496|NCT01438476|66643037|FG001|Overall Study|Protocol Violation|0|||
23799497|NCT01438476|66643036|FG000|Overall Study|Withdrawal by Subject|1|||
23799498|NCT01438476|66643037|FG001|Overall Study|Withdrawal by Subject|0|||
23799499|NCT01438476|66643036|FG000|Overall Study|No Surgery- Disease|8|||
23799500|NCT01438476|66643037|FG001|Overall Study|No Surgery- Disease|10|||
23799501|NCT01438476|66643036|FG000|Overall Study|Communication barrier|0|||
23799502|NCT01438476|66643037|FG001|Overall Study|Communication barrier|1|||
23799503|NCT00775528|66643040|FG000|Overall Study|Protocol Violation|1|||
23799504|NCT00255151|66643041|FG000|Overall Study|Adverse Event|10|||
23799505|NCT00255151|66643042|FG001|Overall Study|Adverse Event|6|||
23799506|NCT00255151|66643043|FG002|Overall Study|Adverse Event|9|||
23799507|NCT00255151|66643041|FG000|Overall Study|Lost to Follow-up|4|||
23799508|NCT00255151|66643042|FG001|Overall Study|Lost to Follow-up|3|||
23799509|NCT00255151|66643043|FG002|Overall Study|Lost to Follow-up|4|||
23799510|NCT00255151|66643041|FG000|Overall Study|Withdrawal by Subject|18|||
23799511|NCT00255151|66643042|FG001|Overall Study|Withdrawal by Subject|17|||
23799512|NCT00255151|66643043|FG002|Overall Study|Withdrawal by Subject|8|||
23799513|NCT00255151|66643041|FG000|Overall Study|Noncompliance|0|||
23799514|NCT00255151|66643042|FG001|Overall Study|Noncompliance|1|||
23799515|NCT00255151|66643043|FG002|Overall Study|Noncompliance|2|||
23799516|NCT00255151|66643041|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
23799517|NCT00255151|66643042|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
23799518|NCT00255151|66643043|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
23799519|NCT00255151|66643041|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
23799520|NCT00255151|66643042|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
23799521|NCT00255151|66643043|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
23799522|NCT00255151|66643041|FG000|Overall Study|Possible Barrett's Esophagus|1|||
23799523|NCT00255151|66643042|FG001|Overall Study|Possible Barrett's Esophagus|3|||
23799524|NCT00255151|66643043|FG002|Overall Study|Possible Barrett's Esophagus|8|||
23799525|NCT00255151|66643041|FG000|Overall Study|Esophageal Stricture|0|||
23799526|NCT00255151|66643042|FG001|Overall Study|Esophageal Stricture|0|||
23799527|NCT00255151|66643043|FG002|Overall Study|Esophageal Stricture|1|||
23799528|NCT00255151|66643041|FG000|Overall Study|Therapeutic Failure|11|||
23799529|NCT00255151|66643042|FG001|Overall Study|Therapeutic Failure|2|||
23799530|NCT00255151|66643043|FG002|Overall Study|Therapeutic Failure|3|||
23799531|NCT01740791|66643044|FG000|Overall Study|Randomized but never treated|5|||
23799532|NCT01740791|66643045|FG001|Overall Study|Randomized but never treated|3|||
23799533|NCT01740791|66643046|FG002|Overall Study|Randomized but never treated|2|||
23799534|NCT01740791|66643047|FG003|Overall Study|Randomized but never treated|2|||
23799535|NCT01740791|66643048|FG004|Overall Study|Randomized but never treated|1|||
23799536|NCT01740791|66643049|FG005|Overall Study|Randomized but never treated|3|||
23799537|NCT01740791|66643044|FG000|Overall Study|Lost to Follow-up|2|||
23799538|NCT01740791|66643045|FG001|Overall Study|Lost to Follow-up|0|||
23592576|NCT03020745|65899618|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592577|NCT03020745|65899619|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23799539|NCT01740791|66643046|FG002|Overall Study|Lost to Follow-up|2|||
23799540|NCT01740791|66643047|FG003|Overall Study|Lost to Follow-up|3|||
23799541|NCT01740791|66643048|FG004|Overall Study|Lost to Follow-up|2|||
23799542|NCT01740791|66643049|FG005|Overall Study|Lost to Follow-up|3|||
23799543|NCT01740791|66643044|FG000|Overall Study|Withdrew Consent|4|||
23799544|NCT01740791|66643045|FG001|Overall Study|Withdrew Consent|0|||
23799545|NCT01740791|66643046|FG002|Overall Study|Withdrew Consent|1|||
23799546|NCT01740791|66643047|FG003|Overall Study|Withdrew Consent|2|||
23799547|NCT01740791|66643048|FG004|Overall Study|Withdrew Consent|0|||
23799548|NCT01740791|66643049|FG005|Overall Study|Withdrew Consent|3|||
23799549|NCT01740791|66643044|FG000|Overall Study|Investigator's discretion|1|||
23799550|NCT01740791|66643045|FG001|Overall Study|Investigator's discretion|0|||
23799551|NCT01740791|66643046|FG002|Overall Study|Investigator's discretion|1|||
23799552|NCT01740791|66643047|FG003|Overall Study|Investigator's discretion|0|||
23799553|NCT01740791|66643048|FG004|Overall Study|Investigator's discretion|0|||
23799554|NCT01740791|66643049|FG005|Overall Study|Investigator's discretion|1|||
23799555|NCT01740791|66643044|FG000|Overall Study|Adverse Event|0|||
23799556|NCT01740791|66643045|FG001|Overall Study|Adverse Event|0|||
23799557|NCT01740791|66643046|FG002|Overall Study|Adverse Event|0|||
23799558|NCT01740791|66643047|FG003|Overall Study|Adverse Event|0|||
23799559|NCT01740791|66643048|FG004|Overall Study|Adverse Event|0|||
23799560|NCT01740791|66643049|FG005|Overall Study|Adverse Event|1|||
23799561|NCT01705717|66643053|FG000|Overall Study|Adverse Event|2|||
23799562|NCT01705717|66643054|FG001|Overall Study|Adverse Event|2|||
23799563|NCT01705717|66643053|FG000|Overall Study|Lack of Efficacy|0|||
23799564|NCT01705717|66643054|FG001|Overall Study|Lack of Efficacy|1|||
23799565|NCT01705717|66643053|FG000|Overall Study|Other|0|||
23799566|NCT01705717|66643054|FG001|Overall Study|Other|2|||
23799567|NCT00685035|66643055|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
23799568|NCT00685035|66643056|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
23799569|NCT01467479|66643057|FG000|Overall Study|No Study Medication|1|||
23799570|NCT01467479|66643058|FG001|Overall Study|No Study Medication|0|||
23476893|NCT02431260|65491399|FG003|Overall Study|Lost to Follow-up|0|||
23476894|NCT02431260|65491400|FG004|Overall Study|Lost to Follow-up|0|||
23799571|NCT01467479|66643059|FG002|Overall Study|No Study Medication|2|||
23799572|NCT01467479|66643057|FG000|Overall Study|Adverse Event|1|||
23799573|NCT01467479|66643058|FG001|Overall Study|Adverse Event|2|||
23476895|NCT02431260|65491401|FG005|Overall Study|Lost to Follow-up|1|||
23476896|NCT02431260|65491402|FG006|Overall Study|Lost to Follow-up|0|||
23476897|NCT02431260|65491403|FG007|Overall Study|Lost to Follow-up|0|||
23476898|NCT02431260|65491404|FG008|Overall Study|Lost to Follow-up|0|||
23476899|NCT02431260|65491405|FG009|Overall Study|Lost to Follow-up|0|||
23476900|NCT02431260|65491406|FG010|Overall Study|Lost to Follow-up|0|||
23476901|NCT02431260|65491407|FG011|Overall Study|Lost to Follow-up|0|||
23476902|NCT02431260|65491408|FG012|Overall Study|Lost to Follow-up|0|||
23476903|NCT02431260|65491409|FG013|Overall Study|Lost to Follow-up|0|||
23476904|NCT02431260|65491396|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23476905|NCT02431260|65491397|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23476906|NCT02431260|65491398|FG002|Overall Study|Study Terminated by the Sponsor|2|||
23476907|NCT02431260|65491399|FG003|Overall Study|Study Terminated by the Sponsor|1|||
23476908|NCT02431260|65491400|FG004|Overall Study|Study Terminated by the Sponsor|1|||
23476909|NCT02431260|65491401|FG005|Overall Study|Study Terminated by the Sponsor|0|||
23476910|NCT02431260|65491402|FG006|Overall Study|Study Terminated by the Sponsor|1|||
23476911|NCT02431260|65491403|FG007|Overall Study|Study Terminated by the Sponsor|2|||
23476912|NCT02431260|65491404|FG008|Overall Study|Study Terminated by the Sponsor|1|||
23476913|NCT02431260|65491405|FG009|Overall Study|Study Terminated by the Sponsor|1|||
23476914|NCT02431260|65491406|FG010|Overall Study|Study Terminated by the Sponsor|1|||
23476915|NCT02431260|65491407|FG011|Overall Study|Study Terminated by the Sponsor|0|||
23476916|NCT02431260|65491408|FG012|Overall Study|Study Terminated by the Sponsor|4|||
23476917|NCT02431260|65491409|FG013|Overall Study|Study Terminated by the Sponsor|0|||
23476918|NCT02431260|65491396|FG000|Overall Study|Physician Decision|0|||
23476919|NCT02431260|65491397|FG001|Overall Study|Physician Decision|0|||
23799574|NCT01467479|66643059|FG002|Overall Study|Adverse Event|0|||
23799575|NCT01467479|66643057|FG000|Overall Study|Death|0|||
23799576|NCT01467479|66643058|FG001|Overall Study|Death|0|||
23799577|NCT01467479|66643059|FG002|Overall Study|Death|1|||
23799578|NCT01467479|66643057|FG000|Overall Study|Lost to Follow-up|2|||
23799579|NCT01467479|66643058|FG001|Overall Study|Lost to Follow-up|5|||
23476920|NCT02431260|65491398|FG002|Overall Study|Physician Decision|0|||
23476921|NCT02431260|65491399|FG003|Overall Study|Physician Decision|0|||
23476922|NCT02431260|65491400|FG004|Overall Study|Physician Decision|0|||
23799580|NCT01467479|66643059|FG002|Overall Study|Lost to Follow-up|3|||
23799581|NCT01467479|66643057|FG000|Overall Study|Withdrawal of Consent|3|||
23476923|NCT02431260|65491401|FG005|Overall Study|Physician Decision|1|||
23476924|NCT02431260|65491402|FG006|Overall Study|Physician Decision|0|||
23592578|NCT03020745|65899610|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592579|NCT03020745|65899611|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592580|NCT03020745|65899612|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592581|NCT03020745|65899613|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592582|NCT03020745|65899614|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592583|NCT03020745|65899615|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
23592584|NCT03020745|65899616|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592585|NCT03020745|65899617|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592586|NCT03020745|65899618|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
23592587|NCT03020745|65899619|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592588|NCT03020745|65899610|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592589|NCT03020745|65899611|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592590|NCT03020745|65899612|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592591|NCT03020745|65899613|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592592|NCT03020745|65899614|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592593|NCT03020745|65899615|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592594|NCT03020745|65899616|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592595|NCT03020745|65899617|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592596|NCT03020745|65899618|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
23592597|NCT03020745|65899619|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592598|NCT02798835|65899627|FG000|Overall Study|Protocol Violation|0|||
23592599|NCT02798835|65899628|FG001|Overall Study|Protocol Violation|0|||
23592600|NCT02798835|65899629|FG002|Overall Study|Protocol Violation|3|||
23592601|NCT02496702|65899630|FG000|Overall Study|Lost to Follow-up|8|||
23592602|NCT02496702|65899631|FG001|Overall Study|Lost to Follow-up|6|||
23592603|NCT02496702|65899630|FG000|Overall Study|Only partially tested|0|||
23592604|NCT02496702|65899631|FG001|Overall Study|Only partially tested|2|||
23592605|NCT00949975|65899632|FG000|Overall Study|Voluntary discontinuation|6|||
23592606|NCT00949975|65899633|FG001|Overall Study|Voluntary discontinuation|5|||
23592607|NCT00949975|65899634|FG002|Overall Study|Voluntary discontinuation|3|||
23592608|NCT00949975|65899635|FG003|Overall Study|Voluntary discontinuation|6|||
23592609|NCT00949975|65899632|FG000|Overall Study|Adverse Event|11|||
23592610|NCT00949975|65899633|FG001|Overall Study|Adverse Event|11|||
23592611|NCT00949975|65899634|FG002|Overall Study|Adverse Event|10|||
23592612|NCT00949975|65899635|FG003|Overall Study|Adverse Event|10|||
23592613|NCT00949975|65899632|FG000|Overall Study|Safety reason|0|||
23592614|NCT00949975|65899633|FG001|Overall Study|Safety reason|1|||
23592615|NCT00949975|65899634|FG002|Overall Study|Safety reason|0|||
23592616|NCT00949975|65899635|FG003|Overall Study|Safety reason|0|||
23592617|NCT00949975|65899632|FG000|Overall Study|Study-specific criteria|0|||
23592618|NCT00949975|65899633|FG001|Overall Study|Study-specific criteria|1|||
23592619|NCT00949975|65899634|FG002|Overall Study|Study-specific criteria|1|||
23592620|NCT00949975|65899635|FG003|Overall Study|Study-specific criteria|0|||
23592621|NCT00949975|65899632|FG000|Overall Study|Incorrect enrolment|5|||
23592622|NCT00949975|65899633|FG001|Overall Study|Incorrect enrolment|10|||
23592623|NCT00949975|65899634|FG002|Overall Study|Incorrect enrolment|4|||
23592624|NCT00949975|65899635|FG003|Overall Study|Incorrect enrolment|7|||
23592625|NCT00949975|65899632|FG000|Overall Study|Severe non-compliance|3|||
23592626|NCT00949975|65899633|FG001|Overall Study|Severe non-compliance|1|||
23592627|NCT00949975|65899634|FG002|Overall Study|Severe non-compliance|0|||
23592628|NCT00949975|65899635|FG003|Overall Study|Severe non-compliance|2|||
23592629|NCT00949975|65899632|FG000|Overall Study|Lost to Follow-up|1|||
23592630|NCT00949975|65899633|FG001|Overall Study|Lost to Follow-up|0|||
23592631|NCT00949975|65899634|FG002|Overall Study|Lost to Follow-up|1|||
23592632|NCT00949975|65899635|FG003|Overall Study|Lost to Follow-up|3|||
23592633|NCT00949975|65899632|FG000|Overall Study|Other|1|||
23592634|NCT00949975|65899633|FG001|Overall Study|Other|0|||
23592635|NCT00949975|65899634|FG002|Overall Study|Other|0|||
23592636|NCT00949975|65899635|FG003|Overall Study|Other|0|||
23592637|NCT02570711|65899639|FG000|Overall Study|Death|1|||
23592638|NCT02570711|65899640|FG001|Overall Study|Death|0|||
23592639|NCT02570711|65899639|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
23592640|NCT02570711|65899640|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
23592641|NCT00566527|65899642|FG000|Overall Study|Reason not provided|3|||
23592642|NCT00566527|65899643|FG001|Overall Study|Reason not provided|11|||
23592643|NCT00566527|65899644|FG002|Overall Study|Reason not provided|10|||
23592644|NCT00566527|65899642|FG000|Overall Study|Adverse Event|2|||
23799582|NCT01467479|66643058|FG001|Overall Study|Withdrawal of Consent|7|||
23592645|NCT00566527|65899643|FG001|Overall Study|Adverse Event|0|||
23592646|NCT00566527|65899644|FG002|Overall Study|Adverse Event|1|||
23592647|NCT00566527|65899642|FG000|Overall Study|Physician Decision|3|||
23592648|NCT00566527|65899643|FG001|Overall Study|Physician Decision|8|||
23592649|NCT00566527|65899644|FG002|Overall Study|Physician Decision|20|||
23592650|NCT00566527|65899642|FG000|Overall Study|Lost to Follow-up|3|||
23592651|NCT00566527|65899643|FG001|Overall Study|Lost to Follow-up|4|||
23592652|NCT00566527|65899644|FG002|Overall Study|Lost to Follow-up|4|||
23592653|NCT00566527|65899642|FG000|Overall Study|Withdrawal by Subject|6|||
23592654|NCT00566527|65899643|FG001|Overall Study|Withdrawal by Subject|43|||
23592655|NCT00566527|65899644|FG002|Overall Study|Withdrawal by Subject|43|||
23592656|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
23592657|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
23592658|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
23592659|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
23592660|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
23592661|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
23592662|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
23592663|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
23592664|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
23592665|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
23592666|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23592667|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
23592668|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
23592669|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
23592670|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
23592671|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
23592672|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
23592673|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
23592674|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
23592675|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
23592676|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
23592677|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
23592678|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
23592679|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
23592680|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
23592681|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
23592682|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
23592683|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
23592684|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
23592685|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
23592686|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
23592687|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
23592688|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
23592689|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
23592690|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
23592691|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
23592692|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
23592693|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
23592694|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
23592695|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
23592696|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
23592697|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
23592698|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
23592699|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
23592700|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
23592701|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
23592702|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
23592703|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
23592704|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592705|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592706|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592707|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
23592708|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
23592709|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
23592710|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
23592711|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
23592712|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
23592713|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
23592714|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
23592715|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
23592716|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
23592717|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
23592718|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
23592719|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
23476925|NCT02431260|65491403|FG007|Overall Study|Physician Decision|0|||
23476926|NCT02431260|65491404|FG008|Overall Study|Physician Decision|0|||
23476927|NCT02431260|65491405|FG009|Overall Study|Physician Decision|0|||
23476928|NCT02431260|65491406|FG010|Overall Study|Physician Decision|0|||
23476929|NCT02431260|65491407|FG011|Overall Study|Physician Decision|0|||
23476930|NCT02431260|65491408|FG012|Overall Study|Physician Decision|0|||
23476931|NCT02431260|65491409|FG013|Overall Study|Physician Decision|0|||
23476932|NCT02431260|65491396|FG000|Overall Study|Other Unspecified|0|||
23476933|NCT02431260|65491397|FG001|Overall Study|Other Unspecified|0|||
23476934|NCT02431260|65491398|FG002|Overall Study|Other Unspecified|0|||
23476935|NCT02431260|65491399|FG003|Overall Study|Other Unspecified|0|||
23476936|NCT02431260|65491400|FG004|Overall Study|Other Unspecified|0|||
23476937|NCT02431260|65491401|FG005|Overall Study|Other Unspecified|0|||
23476938|NCT02431260|65491402|FG006|Overall Study|Other Unspecified|0|||
23476939|NCT02431260|65491403|FG007|Overall Study|Other Unspecified|0|||
23476940|NCT02431260|65491404|FG008|Overall Study|Other Unspecified|0|||
23476941|NCT02431260|65491405|FG009|Overall Study|Other Unspecified|0|||
23476942|NCT02431260|65491406|FG010|Overall Study|Other Unspecified|0|||
23476943|NCT02431260|65491407|FG011|Overall Study|Other Unspecified|1|||
23476944|NCT02431260|65491408|FG012|Overall Study|Other Unspecified|1|||
23476945|NCT02431260|65491409|FG013|Overall Study|Other Unspecified|0|||
23476946|NCT01105065|65491418|FG000|Overall Study|Adverse Event|5|||
23476947|NCT01105065|65491418|FG000|Overall Study|Technical Problems|1|||
23476948|NCT01129024|65491419|FG000|Overall Study|Physician Decision|5|||
23476949|NCT01129024|65491419|FG000|Overall Study|Study Terminated by Sponsor|8|||
23476950|NCT01129024|65491419|FG000|Overall Study|Withdrawal by Subject|2|||
23476951|NCT01129024|65491419|FG000|Overall Study|Lack of Efficacy|3|||
23476952|NCT01129024|65491419|FG000|Overall Study|Needed a Platelet Transfusion|1|||
23476953|NCT02600819|65491420|FG000|GEN Phase|Adverse Event|2|||
23476954|NCT02600819|65491421|FG001|GEN Phase|Adverse Event|0|||
23476955|NCT02600819|65491420|FG000|GEN Phase|Death|2|||
23476956|NCT02600819|65491421|FG001|GEN Phase|Death|0|||
23476957|NCT02600819|65491420|FG000|GEN Phase|Investigator's Discretion|4|||
23476958|NCT02600819|65491421|FG001|GEN Phase|Investigator's Discretion|0|||
23476959|NCT02600819|65491420|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
23592720|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
23592721|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
23592722|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
23592723|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
23592724|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
23592725|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
23592726|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
23592727|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
23592728|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
23592729|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
23592730|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
23592731|NCT03024606|65899657|FG000|Overall Study|Withdrawal by Subject|9|||
23592732|NCT03024606|65899658|FG001|Overall Study|Withdrawal by Subject|10|||
23592733|NCT00712335|65899663|FG000|Overall Study|Withdrawal by Subject|0|||
23592734|NCT00712335|65899664|FG001|Overall Study|Withdrawal by Subject|7|||
23592735|NCT00712335|65899665|FG002|Overall Study|Withdrawal by Subject|2|||
23592736|NCT00712335|65899666|FG003|Overall Study|Withdrawal by Subject|3|||
23592737|NCT00712335|65899667|FG004|Overall Study|Withdrawal by Subject|0|||
23592738|NCT00712335|65899663|FG000|Overall Study|Lost to Follow-up|2|||
23592739|NCT00712335|65899664|FG001|Overall Study|Lost to Follow-up|5|||
23592740|NCT00712335|65899665|FG002|Overall Study|Lost to Follow-up|0|||
23592741|NCT00712335|65899666|FG003|Overall Study|Lost to Follow-up|1|||
23592742|NCT00712335|65899667|FG004|Overall Study|Lost to Follow-up|0|||
23476960|NCT02600819|65491421|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
23592743|NCT00712335|65899663|FG000|Overall Study|Protocol Violation|1|||
23592744|NCT00712335|65899664|FG001|Overall Study|Protocol Violation|2|||
23592745|NCT00712335|65899665|FG002|Overall Study|Protocol Violation|1|||
23476961|NCT02600819|65491420|FG000|GEN Phase|Withdrew Consent|5|||
23476962|NCT02600819|65491421|FG001|GEN Phase|Withdrew Consent|0|||
23476963|NCT02600819|65491420|FG000|GEN Phase|Lost to Follow-up|2|||
23476964|NCT02600819|65491421|FG001|GEN Phase|Lost to Follow-up|0|||
23476965|NCT02788279|65491422|FG000|Overall Study|Death|62|||
23476966|NCT02788279|65491423|FG001|Overall Study|Death|136|||
23476967|NCT02788279|65491424|FG002|Overall Study|Death|72|||
23476968|NCT02788279|65491422|FG000|Overall Study|Withdrawal by Subject|10|||
23476969|NCT02788279|65491423|FG001|Overall Study|Withdrawal by Subject|15|||
23476970|NCT02788279|65491424|FG002|Overall Study|Withdrawal by Subject|5|||
23476971|NCT02788279|65491422|FG000|Overall Study|Lost to Follow-up|0|||
23476972|NCT02788279|65491423|FG001|Overall Study|Lost to Follow-up|3|||
23476973|NCT02788279|65491424|FG002|Overall Study|Lost to Follow-up|2|||
23592746|NCT00712335|65899666|FG003|Overall Study|Protocol Violation|0|||
23592747|NCT00712335|65899667|FG004|Overall Study|Protocol Violation|0|||
23592748|NCT00712335|65899663|FG000|Overall Study|Lack of Efficacy|0|||
23592749|NCT00712335|65899664|FG001|Overall Study|Lack of Efficacy|0|||
23592750|NCT00712335|65899665|FG002|Overall Study|Lack of Efficacy|1|||
23592751|NCT00712335|65899666|FG003|Overall Study|Lack of Efficacy|1|||
23592752|NCT00712335|65899667|FG004|Overall Study|Lack of Efficacy|0|||
23592753|NCT00712335|65899663|FG000|Overall Study|Other Reason|0|||
23592754|NCT00712335|65899664|FG001|Overall Study|Other Reason|3|||
23592755|NCT00712335|65899665|FG002|Overall Study|Other Reason|1|||
23592756|NCT00712335|65899666|FG003|Overall Study|Other Reason|0|||
23592757|NCT00712335|65899667|FG004|Overall Study|Other Reason|0|||
23592758|NCT01066923|65899670|FG000|Overall Study|Withdrawal by Subject|3|||
23592759|NCT01066923|65899671|FG001|Overall Study|Withdrawal by Subject|3|||
23592760|NCT01066923|65899672|FG002|Overall Study|Withdrawal by Subject|8|||
23592761|NCT01066923|65899673|FG003|Overall Study|Withdrawal by Subject|8|||
23592762|NCT02059980|65899674|FG000|Overall Study|Lost to Follow-up|2|||
23592763|NCT02059980|65899675|FG001|Overall Study|Lost to Follow-up|1|||
23592764|NCT00364013|65899680|FG000|Overall Study|Ineligibility determined|4|||
23592765|NCT00364013|65899681|FG001|Overall Study|Ineligibility determined|2|||
23592766|NCT00364013|65899680|FG000|Overall Study|Adverse Event|4|||
23592767|NCT00364013|65899681|FG001|Overall Study|Adverse Event|3|||
23592768|NCT00364013|65899680|FG000|Overall Study|Withdrawal by Subject|13|||
23592769|NCT00364013|65899681|FG001|Overall Study|Withdrawal by Subject|18|||
23592770|NCT00364013|65899680|FG000|Overall Study|Physician Decision|3|||
23592771|NCT00364013|65899681|FG001|Overall Study|Physician Decision|3|||
23592772|NCT00364013|65899680|FG000|Overall Study|Lost to Follow-up|10|||
23592773|NCT00364013|65899681|FG001|Overall Study|Lost to Follow-up|3|||
23592774|NCT00364013|65899680|FG000|Overall Study|Protocol-specified criteria|6|||
23592775|NCT00364013|65899681|FG001|Overall Study|Protocol-specified criteria|6|||
23592776|NCT00364013|65899680|FG000|Overall Study|Other|41|||
23592777|NCT00364013|65899681|FG001|Overall Study|Other|47|||
23592778|NCT00364013|65899680|FG000|Overall Study|Ongoing|20|||
23592779|NCT00364013|65899681|FG001|Overall Study|Ongoing|13|||
23592780|NCT02708108|65899686|FG000|Overall Study|Death|1|||
23592781|NCT02708108|65899687|FG001|Overall Study|Death|2|||
23592782|NCT02708108|65899686|FG000|Overall Study|Regimen change|1|||
23592783|NCT02708108|65899687|FG001|Overall Study|Regimen change|0|||
23592784|NCT02708108|65899686|FG000|Overall Study|No MRD and no imaging available|0|||
23592785|NCT02708108|65899687|FG001|Overall Study|No MRD and no imaging available|1|||
23592786|NCT00716859|65899691|FG000|Overall Study|Adverse Event|4|||
23592787|NCT00716859|65899692|FG001|Overall Study|Adverse Event|1|||
23592788|NCT00716859|65899691|FG000|Overall Study|Lack of Efficacy|3|||
23592789|NCT00716859|65899692|FG001|Overall Study|Lack of Efficacy|0|||
23592790|NCT00716859|65899691|FG000|Overall Study|Withdrawal by Subject|1|||
23592791|NCT00716859|65899692|FG001|Overall Study|Withdrawal by Subject|3|||
23592792|NCT00716859|65899691|FG000|Overall Study|Not treated|1|||
23592793|NCT00716859|65899692|FG001|Overall Study|Not treated|1|||
23592794|NCT01697969|65899693|FG000|Overall Study|Did not meet inc/exc criteria|3|||
23799583|NCT01467479|66643059|FG002|Overall Study|Withdrawal of Consent|7|||
23799584|NCT01467479|66643057|FG000|Overall Study|Study Terminated by Sponsor|1|||
23799585|NCT01467479|66643058|FG001|Overall Study|Study Terminated by Sponsor|3|||
23799586|NCT01467479|66643059|FG002|Overall Study|Study Terminated by Sponsor|3|||
23592795|NCT03183518|65899694|FG000|Overall Study|Other (Not specified)|2|||
23592796|NCT03183518|65899694|FG000|Overall Study|Other (Withdrawal of consent)|1|||
23592797|NCT00589667|65899695|FG000|Overall Study|Adverse Event|2|||
23592798|NCT00589667|65899695|FG000|Overall Study|Withdrawal by Subject|1|||
23592799|NCT03997916|65899696|FG000|Overall Study|Protocol Violation|35|||
23592800|NCT01236001|65899698|FG000|Overall Study|Adverse Event|5|||
23592801|NCT01236001|65899699|FG001|Overall Study|Adverse Event|14|||
23592802|NCT01236001|65899698|FG000|Overall Study|Lack of Efficacy|6|||
23592803|NCT01236001|65899699|FG001|Overall Study|Lack of Efficacy|6|||
23592804|NCT01236001|65899698|FG000|Overall Study|Lost to Follow-up|6|||
23592805|NCT01236001|65899699|FG001|Overall Study|Lost to Follow-up|1|||
23592806|NCT01236001|65899698|FG000|Overall Study|Incompliance|1|||
23592807|NCT01236001|65899699|FG001|Overall Study|Incompliance|0|||
23592808|NCT01236001|65899698|FG000|Overall Study|Planned Visit After End of Study|0|||
23592809|NCT01236001|65899699|FG001|Overall Study|Planned Visit After End of Study|1|||
23799587|NCT01467479|66643057|FG000|Overall Study|Other|1|||
23592810|NCT00391846|65899700|FG000|Overall Study|Adverse Event|4|||
23592811|NCT00391846|65899701|FG001|Overall Study|Adverse Event|1|||
23592812|NCT00391846|65899700|FG000|Overall Study|Did not meet the required elig. crit|2|||
23799588|NCT01467479|66643058|FG001|Overall Study|Other|0|||
23592813|NCT00391846|65899701|FG001|Overall Study|Did not meet the required elig. crit|2|||
23592814|NCT00391846|65899700|FG000|Overall Study|Withdrawal by Subject|2|||
23592815|NCT00391846|65899701|FG001|Overall Study|Withdrawal by Subject|3|||
23592816|NCT00391846|65899700|FG000|Overall Study|Developed study specific DC criteria|0|||
23592817|NCT00391846|65899701|FG001|Overall Study|Developed study specific DC criteria|1|||
23799589|NCT01467479|66643059|FG002|Overall Study|Other|0|||
23592818|NCT00089544|65899703|FG000|Overall Study|Ineligible|1|||
23592819|NCT00089544|65899704|FG001|Overall Study|Ineligible|0|||
23592820|NCT02477670|65899705|FG000|Stage 1|Adverse Event|2|||
23592821|NCT02477670|65899706|FG001|Stage 1|Adverse Event|7|||
23592822|NCT02477670|65899707|FG002|Stage 1|Adverse Event|0|||
23592823|NCT02477670|65899708|FG003|Stage 1|Adverse Event|0|||
23592824|NCT02477670|65899709|FG004|Stage 1|Adverse Event|0|||
23592825|NCT02477670|65899710|FG005|Stage 1|Adverse Event|0|||
23592826|NCT02477670|65899711|FG006|Stage 1|Adverse Event|0|||
23592827|NCT02477670|65899705|FG000|Stage 1|Lost to Follow-up|0|||
23592828|NCT02477670|65899706|FG001|Stage 1|Lost to Follow-up|2|||
23592829|NCT02477670|65899707|FG002|Stage 1|Lost to Follow-up|0|||
23592830|NCT02477670|65899708|FG003|Stage 1|Lost to Follow-up|0|||
23592831|NCT02477670|65899709|FG004|Stage 1|Lost to Follow-up|0|||
23592832|NCT02477670|65899710|FG005|Stage 1|Lost to Follow-up|0|||
23592833|NCT02477670|65899711|FG006|Stage 1|Lost to Follow-up|0|||
23592834|NCT02477670|65899705|FG000|Stage 1|Withdrawal by Subject|1|||
23592835|NCT02477670|65899706|FG001|Stage 1|Withdrawal by Subject|2|||
23592836|NCT02477670|65899707|FG002|Stage 1|Withdrawal by Subject|0|||
23592837|NCT02477670|65899708|FG003|Stage 1|Withdrawal by Subject|0|||
23592838|NCT02477670|65899709|FG004|Stage 1|Withdrawal by Subject|0|||
23592839|NCT02477670|65899710|FG005|Stage 1|Withdrawal by Subject|0|||
23592840|NCT02477670|65899711|FG006|Stage 1|Withdrawal by Subject|0|||
23592841|NCT02477670|65899705|FG000|Stage 1|Non-compliance with Study Drug|1|||
23592842|NCT02477670|65899706|FG001|Stage 1|Non-compliance with Study Drug|2|||
23592843|NCT02477670|65899707|FG002|Stage 1|Non-compliance with Study Drug|0|||
23592844|NCT02477670|65899708|FG003|Stage 1|Non-compliance with Study Drug|0|||
23592845|NCT02477670|65899709|FG004|Stage 1|Non-compliance with Study Drug|0|||
23592846|NCT02477670|65899710|FG005|Stage 1|Non-compliance with Study Drug|0|||
23592847|NCT02477670|65899711|FG006|Stage 1|Non-compliance with Study Drug|0|||
23592848|NCT02477670|65899705|FG000|Stage 2|Adverse Event|0|||
23592849|NCT02477670|65899706|FG001|Stage 2|Adverse Event|0|||
23592850|NCT02477670|65899707|FG002|Stage 2|Adverse Event|1|||
23592851|NCT02477670|65899708|FG003|Stage 2|Adverse Event|0|||
23592852|NCT02477670|65899709|FG004|Stage 2|Adverse Event|0|||
23592853|NCT02477670|65899710|FG005|Stage 2|Adverse Event|0|||
23592854|NCT02477670|65899711|FG006|Stage 2|Adverse Event|0|||
23592855|NCT02477670|65899705|FG000|Stage 2|Antipsychotic Medication Changed|0|||
23592856|NCT02477670|65899706|FG001|Stage 2|Antipsychotic Medication Changed|0|||
23592857|NCT02477670|65899707|FG002|Stage 2|Antipsychotic Medication Changed|1|||
23592858|NCT02477670|65899708|FG003|Stage 2|Antipsychotic Medication Changed|0|||
23592859|NCT02477670|65899709|FG004|Stage 2|Antipsychotic Medication Changed|0|||
23592860|NCT02477670|65899710|FG005|Stage 2|Antipsychotic Medication Changed|0|||
23592861|NCT02477670|65899711|FG006|Stage 2|Antipsychotic Medication Changed|0|||
23592862|NCT02477670|65899705|FG000|Stage 2|Withdrawal by Subject|0|||
23592863|NCT02477670|65899706|FG001|Stage 2|Withdrawal by Subject|0|||
23592864|NCT02477670|65899707|FG002|Stage 2|Withdrawal by Subject|0|||
23592865|NCT02477670|65899708|FG003|Stage 2|Withdrawal by Subject|1|||
23592866|NCT02477670|65899709|FG004|Stage 2|Withdrawal by Subject|0|||
23592867|NCT02477670|65899710|FG005|Stage 2|Withdrawal by Subject|0|||
23799590|NCT00348816|66643068|FG000|Overall Study|Noncompliance with radiation treatment|1|||
23799591|NCT04447287|66643069|FG000|Period 1: Run-in Period|Adverse Event|3|||
23799592|NCT04447287|66643070|FG001|Period 1: Run-in Period|Adverse Event|0|||
23799593|NCT04447287|66643071|FG002|Period 1: Run-in Period|Adverse Event|0|||
23799594|NCT04447287|66643069|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
23799595|NCT04447287|66643070|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
23799596|NCT04447287|66643071|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
23799597|NCT04447287|66643069|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
23799598|NCT04447287|66643070|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
23799599|NCT04447287|66643071|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
23799600|NCT02485158|66643072|FG000|Overall Study|Withdrawal by Subject|3|||
23799601|NCT02485158|66643072|FG000|Overall Study|expected drug side effect|1|||
23799602|NCT01662362|66643075|FG000|Overall Study|Lost to Follow-up|38|||
23799603|NCT03648879|66643076|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
23592868|NCT02477670|65899711|FG006|Stage 2|Withdrawal by Subject|0|||
23592869|NCT03102710|65899712|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
23592870|NCT03102710|65899713|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
23592871|NCT03102710|65899714|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
23592872|NCT03102710|65899712|FG000|Overall Study|Technical issues during final MRI scan|0|||
23592873|NCT03102710|65899713|FG001|Overall Study|Technical issues during final MRI scan|1|||
23592874|NCT03102710|65899714|FG002|Overall Study|Technical issues during final MRI scan|0|||
23644101|NCT01723254|66082586|FG007|Overall Study|Withdrawal by Subject|2|||
23592875|NCT03102710|65899712|FG000|Overall Study|Nausea during MRI scan|0|||
23592876|NCT03102710|65899713|FG001|Overall Study|Nausea during MRI scan|1|||
23592877|NCT03102710|65899714|FG002|Overall Study|Nausea during MRI scan|0|||
23592878|NCT03102710|65899712|FG000|Overall Study|Subject unable to attend final session|0|||
23592879|NCT03102710|65899713|FG001|Overall Study|Subject unable to attend final session|1|||
23592880|NCT03102710|65899714|FG002|Overall Study|Subject unable to attend final session|0|||
23592881|NCT00510887|65899716|FG000|Overall Study|Lost to Follow-up|1|||
23592882|NCT00955825|65899719|FG000|Overall Study|Adverse Event|15|||
23592883|NCT00955825|65899720|FG001|Overall Study|Adverse Event|2|||
23592884|NCT00955825|65899719|FG000|Overall Study|Withdrawal by Subject|4|||
23592885|NCT00955825|65899720|FG001|Overall Study|Withdrawal by Subject|6|||
23592886|NCT00955825|65899719|FG000|Overall Study|Any other reason not above-mentioned|7|||
23592887|NCT00955825|65899720|FG001|Overall Study|Any other reason not above-mentioned|9|||
23592888|NCT00632424|65899721|FG000|Overall Study|Disease Progression|17|||
23592889|NCT00632424|65899721|FG000|Overall Study|Study Drug Toxicity|1|||
23592890|NCT04048135|65899722|FG000|Overall Study|Withdrawal by Subject|1|||
23592891|NCT04048135|65899723|FG001|Overall Study|Withdrawal by Subject|1|||
23592892|NCT04048135|65899724|FG002|Overall Study|Withdrawal by Subject|1|||
23592893|NCT04048135|65899725|FG003|Overall Study|Withdrawal by Subject|2|||
23592894|NCT04048135|65899726|FG004|Overall Study|Withdrawal by Subject|0|||
23592895|NCT04048135|65899727|FG005|Overall Study|Withdrawal by Subject|0|||
23592896|NCT04048135|65899728|FG006|Overall Study|Withdrawal by Subject|1|||
23592897|NCT04048135|65899729|FG007|Overall Study|Withdrawal by Subject|1|||
23592898|NCT04048135|65899722|FG000|Overall Study|Adverse Event|0|||
23592899|NCT04048135|65899723|FG001|Overall Study|Adverse Event|0|||
23592900|NCT04048135|65899724|FG002|Overall Study|Adverse Event|0|||
23592901|NCT04048135|65899725|FG003|Overall Study|Adverse Event|1|||
23592902|NCT04048135|65899726|FG004|Overall Study|Adverse Event|1|||
23592903|NCT04048135|65899727|FG005|Overall Study|Adverse Event|0|||
23592904|NCT04048135|65899728|FG006|Overall Study|Adverse Event|0|||
23592905|NCT04048135|65899729|FG007|Overall Study|Adverse Event|0|||
23592906|NCT04048135|65899722|FG000|Overall Study|Protocol Violation|0|||
23592907|NCT04048135|65899723|FG001|Overall Study|Protocol Violation|0|||
23592908|NCT04048135|65899724|FG002|Overall Study|Protocol Violation|0|||
23592909|NCT04048135|65899725|FG003|Overall Study|Protocol Violation|0|||
23592910|NCT04048135|65899726|FG004|Overall Study|Protocol Violation|0|||
23592911|NCT04048135|65899727|FG005|Overall Study|Protocol Violation|1|||
23592912|NCT04048135|65899728|FG006|Overall Study|Protocol Violation|0|||
23592913|NCT04048135|65899729|FG007|Overall Study|Protocol Violation|0|||
23592914|NCT00457743|65899730|FG000|Overall Study|Adverse Event|0|||
23592915|NCT00457743|65899731|FG001|Overall Study|Adverse Event|4|||
23592916|NCT00457743|65899732|FG002|Overall Study|Adverse Event|0|||
23592917|NCT00457743|65899730|FG000|Overall Study|Lack of Efficacy|3|||
23592918|NCT00457743|65899731|FG001|Overall Study|Lack of Efficacy|23|||
23592919|NCT00457743|65899732|FG002|Overall Study|Lack of Efficacy|3|||
23592920|NCT03844269|65899734|FG000|Overall Study|Withdrawal pre-intervention|1|||
23592921|NCT03844269|65899734|FG000|Overall Study|Did not complete the intervention|2|||
23799604|NCT01961882|66643077|FG000|Overall Study|Adverse Event|3|||
23799605|NCT01961882|66643078|FG001|Overall Study|Adverse Event|2|||
23799606|NCT01961882|66643077|FG000|Overall Study|Physician Decision|1|||
23799607|NCT01961882|66643078|FG001|Overall Study|Physician Decision|0|||
23799608|NCT01961882|66643077|FG000|Overall Study|Withdrawal by Subject|4|||
23476974|NCT02788279|65491422|FG000|Overall Study|Sponsor decision|18|||
23476975|NCT02788279|65491423|FG001|Overall Study|Sponsor decision|29|||
23476976|NCT02788279|65491424|FG002|Overall Study|Sponsor decision|11|||
23476977|NCT02551991|65491425|FG000|Overall Study|Death|5|||
23476978|NCT02551991|65491426|FG001|Overall Study|Death|7|||
23476979|NCT02551991|65491427|FG002|Overall Study|Death|8|||
23476980|NCT02551991|65491428|FG003|Overall Study|Death|7|||
23476981|NCT02551991|65491429|FG004|Overall Study|Death|17|||
23476982|NCT02551991|65491425|FG000|Overall Study|Withdrawal by Subject|1|||
23476983|NCT02551991|65491426|FG001|Overall Study|Withdrawal by Subject|0|||
23476984|NCT02551991|65491427|FG002|Overall Study|Withdrawal by Subject|0|||
23476985|NCT02551991|65491428|FG003|Overall Study|Withdrawal by Subject|0|||
23476986|NCT02551991|65491429|FG004|Overall Study|Withdrawal by Subject|2|||
23476987|NCT02551991|65491425|FG000|Overall Study|Lost to Follow-up|0|||
23476988|NCT02551991|65491426|FG001|Overall Study|Lost to Follow-up|0|||
23476989|NCT02551991|65491427|FG002|Overall Study|Lost to Follow-up|1|||
23592922|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Adverse Event|5|||
23592923|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Adverse Event|0|||
23592924|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Adverse Event|0|||
23592925|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
23592926|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
23592927|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
23592928|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
23592929|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
23799609|NCT01961882|66643078|FG001|Overall Study|Withdrawal by Subject|1|||
23476990|NCT02551991|65491428|FG003|Overall Study|Lost to Follow-up|0|||
23476991|NCT02551991|65491429|FG004|Overall Study|Lost to Follow-up|0|||
23476992|NCT02551991|65491425|FG000|Overall Study|Sponsor Decision|1|||
23476993|NCT02551991|65491426|FG001|Overall Study|Sponsor Decision|0|||
23799610|NCT01961882|66643077|FG000|Overall Study|Relapse of AML|39|||
23799611|NCT01961882|66643078|FG001|Overall Study|Relapse of AML|37|||
23799612|NCT01961882|66643077|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
23799613|NCT01961882|66643078|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
23799614|NCT01961882|66643077|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
23799615|NCT01961882|66643078|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
23799616|NCT03062358|66643079|FG000|Overall Study|Death|220|||
23592930|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
23592931|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
23476994|NCT02551991|65491427|FG002|Overall Study|Sponsor Decision|1|||
23476995|NCT02551991|65491428|FG003|Overall Study|Sponsor Decision|0|||
23476996|NCT02551991|65491429|FG004|Overall Study|Sponsor Decision|5|||
23476997|NCT02551991|65491425|FG000|Overall Study|Other|0|||
23476998|NCT02551991|65491426|FG001|Overall Study|Other|0|||
23476999|NCT02551991|65491427|FG002|Overall Study|Other|0|||
23477000|NCT02551991|65491428|FG003|Overall Study|Other|0|||
23477001|NCT02551991|65491429|FG004|Overall Study|Other|1|||
23477002|NCT02081859|65491434|FG000|Overall Study|No fertilization|2|||
23477003|NCT02081859|65491435|FG001|Overall Study|No fertilization|2|||
23477004|NCT02081859|65491434|FG000|Overall Study|No sperm|1|||
23477005|NCT02081859|65491435|FG001|Overall Study|No sperm|0|||
23477006|NCT02081859|65491434|FG000|Overall Study|Unanticipated freeze all cycle|2|||
23477007|NCT02081859|65491435|FG001|Overall Study|Unanticipated freeze all cycle|6|||
23477008|NCT02081859|65491434|FG000|Overall Study|< 4 embryos|27|||
23477009|NCT02081859|65491435|FG001|Overall Study|< 4 embryos|23|||
23477010|NCT02081859|65491434|FG000|Overall Study|Other reasons|2|||
23477011|NCT02081859|65491435|FG001|Overall Study|Other reasons|0|||
23477012|NCT02471612|65491442|FG000|Overall Study|Lost to Follow-up|2|||
23477013|NCT03320824|65491450|FG000|Overall Study|Withdrawal by Subject|8|||
23477014|NCT03320824|65491451|FG001|Overall Study|Withdrawal by Subject|1|||
23477015|NCT03320824|65491450|FG000|Overall Study|Lost to Follow-up|10|||
23477016|NCT03320824|65491451|FG001|Overall Study|Lost to Follow-up|1|||
23477017|NCT03320824|65491450|FG000|Overall Study|moved out of state|0|||
23477018|NCT03320824|65491451|FG001|Overall Study|moved out of state|1|||
23477019|NCT03320824|65491450|FG000|Overall Study|could not complete final visit|0|||
23477020|NCT03320824|65491451|FG001|Overall Study|could not complete final visit|1|||
23477021|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
23477022|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
23477023|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
23477024|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
23477025|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
23477026|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
23799617|NCT03062358|66643080|FG001|Overall Study|Death|127|||
23799618|NCT03062358|66643079|FG000|Overall Study|Withdrawal by Subject|2|||
23799619|NCT03062358|66643080|FG001|Overall Study|Withdrawal by Subject|1|||
23799620|NCT03062358|66643079|FG000|Overall Study|Ongoing in Trial|78|||
23799621|NCT03062358|66643080|FG001|Overall Study|Ongoing in Trial|25|||
23799622|NCT01453153|66643081|FG000|Overall Study|Physician Decision|0|||
23799623|NCT01453153|66643082|FG001|Overall Study|Physician Decision|0|||
23799624|NCT01453153|66643083|FG002|Overall Study|Physician Decision|1|||
23799625|NCT01453153|66643081|FG000|Overall Study|Progressive Disease|3|||
23799626|NCT01453153|66643082|FG001|Overall Study|Progressive Disease|2|||
23799627|NCT01453153|66643083|FG002|Overall Study|Progressive Disease|16|||
23799628|NCT01453153|66643081|FG000|Overall Study|Withdrawal by Subject|0|||
23799629|NCT01453153|66643082|FG001|Overall Study|Withdrawal by Subject|1|||
23799630|NCT01453153|66643083|FG002|Overall Study|Withdrawal by Subject|2|||
23799631|NCT01453153|66643081|FG000|Overall Study|Adverse Event|1|||
23799632|NCT01453153|66643082|FG001|Overall Study|Adverse Event|1|||
23799633|NCT01453153|66643083|FG002|Overall Study|Adverse Event|1|||
23799634|NCT04117945|66643084|FG000|Overall Study|Death|1|||
23799635|NCT04117945|66643085|FG001|Overall Study|Death|0|||
23799636|NCT04117945|66643084|FG000|Overall Study|Withdrawal by Subject|3|||
23799637|NCT04117945|66643085|FG001|Overall Study|Withdrawal by Subject|1|||
23799638|NCT04117945|66643084|FG000|Overall Study|Disease Progression|0|||
23799639|NCT04117945|66643085|FG001|Overall Study|Disease Progression|2|||
23799640|NCT04117945|66643084|FG000|Overall Study|Ineligible|8|||
23799641|NCT04117945|66643085|FG001|Overall Study|Ineligible|7|||
23799642|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
23799643|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23477027|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
23477028|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
23477029|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
23477030|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
23477031|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
23477032|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
23477033|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
23477034|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
23592932|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
23592933|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
23592934|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Pregnancy|1|||
23592935|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Pregnancy|0|||
23592936|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Pregnancy|0|||
23592937|NCT01426269|65899742|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
23592938|NCT01426269|65899743|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
23592939|NCT01426269|65899744|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
23592940|NCT01426269|65899742|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
23592941|NCT01426269|65899743|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
23592942|NCT01426269|65899744|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
23592943|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Adverse Event|0|||
23799644|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799645|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799646|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799647|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799648|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799649|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799650|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23799651|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
23799652|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799653|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799654|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799655|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799656|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799657|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799658|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799659|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23799660|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
23799661|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799662|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799663|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799664|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799665|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799666|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799667|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799668|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23799669|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
23799670|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799671|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799672|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799673|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799674|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799675|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799676|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799677|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23799678|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
23799679|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799680|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799681|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23592944|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Adverse Event|1|||
23592945|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Adverse Event|2|||
23592946|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
23592947|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
23592948|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
23592949|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
23592950|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
23592951|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
23592952|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
23592953|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
23592954|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
23592955|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Site closed|0|||
23592956|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Site closed|6|||
23592957|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Site closed|5|||
23592958|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Relapsed|0|||
23592959|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Relapsed|9|||
23592960|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Relapsed|18|||
23799682|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799683|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799684|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799685|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23592961|NCT01081145|65899745|FG000|Open-Label Phase|Lack of Efficacy|56|||
23592962|NCT01081145|65899746|FG001|Open-Label Phase|Lack of Efficacy|0|||
23592963|NCT01081145|65899745|FG000|Open-Label Phase|Response criteria not met|46|||
23592964|NCT01081145|65899746|FG001|Open-Label Phase|Response criteria not met|0|||
23592965|NCT01081145|65899745|FG000|Open-Label Phase|Adverse Event|42|||
23592966|NCT01081145|65899746|FG001|Open-Label Phase|Adverse Event|0|||
23592967|NCT01081145|65899745|FG000|Open-Label Phase|Withdrawal by Subject|41|||
23592968|NCT01081145|65899746|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23592969|NCT01081145|65899745|FG000|Open-Label Phase|Other|12|||
23799686|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23799687|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
23799688|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799689|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799690|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799691|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799692|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799693|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799694|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799695|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23799696|NCT00739973|66643086|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
23799697|NCT00739973|66643087|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23799698|NCT00739973|66643088|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23799699|NCT00739973|66643089|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23799700|NCT00739973|66643090|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23644102|NCT03319849|66082587|FG000|Overall Study|Adverse Event|1|||
23644103|NCT03319849|66082588|FG001|Overall Study|Adverse Event|0|||
23644104|NCT03319849|66082587|FG000|Overall Study|Physician Decision|0|||
23644105|NCT03319849|66082588|FG001|Overall Study|Physician Decision|1|||
23644106|NCT03319849|66082587|FG000|Overall Study|Withdrawal by Subject|0|||
23644107|NCT03319849|66082588|FG001|Overall Study|Withdrawal by Subject|1|||
23644108|NCT03319849|66082587|FG000|Overall Study|COVID-19|0|||
23644109|NCT03319849|66082588|FG001|Overall Study|COVID-19|1|||
23644110|NCT03319849|66082587|FG000|Overall Study|Other|1|||
23644111|NCT03319849|66082588|FG001|Overall Study|Other|2|||
23644112|NCT03319849|66082587|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
23644113|NCT03319849|66082588|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
23644114|NCT03319849|66082587|FG000|Overall Study|Lost to Follow-up|0|||
23644115|NCT03319849|66082588|FG001|Overall Study|Lost to Follow-up|2|||
23644116|NCT04279392|66082589|FG000|Overall Study|Physician Decision|1|||
23644117|NCT04279392|66082590|FG001|Overall Study|Physician Decision|0|||
23644118|NCT02729753|66082591|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
23644119|NCT02729753|66082592|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
23644120|NCT01034176|66082593|FG000|Overall Study|Physician Decision|2|||
23644121|NCT01034176|66082594|FG001|Overall Study|Physician Decision|0|||
23644122|NCT01034176|66082593|FG000|Overall Study|Withdrawal by Subject|0|||
23644123|NCT01034176|66082594|FG001|Overall Study|Withdrawal by Subject|1|||
23644124|NCT01034176|66082593|FG000|Overall Study|Lost to Follow-up|0|||
23644125|NCT01034176|66082594|FG001|Overall Study|Lost to Follow-up|1|||
23644126|NCT00346632|66082595|FG000|Overall Study|Progressive Disease|2|||
23644127|NCT00346632|66082596|FG001|Overall Study|Progressive Disease|2|||
23644128|NCT00346632|66082597|FG002|Overall Study|Progressive Disease|4|||
23644129|NCT00346632|66082598|FG003|Overall Study|Progressive Disease|3|||
23644130|NCT00346632|66082599|FG004|Overall Study|Progressive Disease|3|||
23644131|NCT00346632|66082600|FG005|Overall Study|Progressive Disease|1|||
23799701|NCT00739973|66643091|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23799702|NCT00739973|66643092|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23592970|NCT01081145|65899746|FG001|Open-Label Phase|Other|0|||
23644132|NCT00346632|66082601|FG006|Overall Study|Progressive Disease|2|||
23644133|NCT00346632|66082602|FG007|Overall Study|Progressive Disease|2|||
23644134|NCT00346632|66082603|FG008|Overall Study|Progressive Disease|2|||
23644135|NCT00346632|66082604|FG009|Overall Study|Progressive Disease|2|||
23644136|NCT00346632|66082595|FG000|Overall Study|Adverse Event|0|||
23644137|NCT00346632|66082596|FG001|Overall Study|Adverse Event|0|||
23644138|NCT00346632|66082597|FG002|Overall Study|Adverse Event|0|||
23799703|NCT00739973|66643093|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23799704|NCT00739973|66643094|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23644139|NCT00346632|66082598|FG003|Overall Study|Adverse Event|0|||
23644140|NCT00346632|66082599|FG004|Overall Study|Adverse Event|1|||
23592971|NCT01081145|65899745|FG000|Open-Label Phase|Lost to Follow-up|11|||
23592972|NCT01081145|65899746|FG001|Open-Label Phase|Lost to Follow-up|0|||
23592973|NCT01081145|65899745|FG000|Open-Label Phase|Protocol Violation|4|||
23592974|NCT01081145|65899746|FG001|Open-Label Phase|Protocol Violation|0|||
23592975|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
23592976|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
23592977|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
23592978|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
23592979|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
23592980|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
23592981|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
23592982|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
23644141|NCT00346632|66082600|FG005|Overall Study|Adverse Event|1|||
23644142|NCT00346632|66082601|FG006|Overall Study|Adverse Event|1|||
23644143|NCT00346632|66082602|FG007|Overall Study|Adverse Event|0|||
23644144|NCT00346632|66082603|FG008|Overall Study|Adverse Event|0|||
23644145|NCT00346632|66082604|FG009|Overall Study|Adverse Event|0|||
23644146|NCT00346632|66082595|FG000|Overall Study|Death|0|||
23644147|NCT00346632|66082596|FG001|Overall Study|Death|0|||
23644148|NCT00346632|66082597|FG002|Overall Study|Death|1|||
23644149|NCT00346632|66082598|FG003|Overall Study|Death|0|||
23644150|NCT00346632|66082599|FG004|Overall Study|Death|0|||
23644151|NCT00346632|66082600|FG005|Overall Study|Death|0|||
23644152|NCT00346632|66082601|FG006|Overall Study|Death|0|||
23644153|NCT00346632|66082602|FG007|Overall Study|Death|0|||
23644154|NCT00346632|66082603|FG008|Overall Study|Death|0|||
23644155|NCT00346632|66082604|FG009|Overall Study|Death|0|||
23644156|NCT00346632|66082595|FG000|Overall Study|Protocol Violation|0|||
23644157|NCT00346632|66082596|FG001|Overall Study|Protocol Violation|0|||
23644158|NCT00346632|66082597|FG002|Overall Study|Protocol Violation|0|||
23644159|NCT00346632|66082598|FG003|Overall Study|Protocol Violation|0|||
23644160|NCT00346632|66082599|FG004|Overall Study|Protocol Violation|0|||
23644161|NCT00346632|66082600|FG005|Overall Study|Protocol Violation|0|||
23644162|NCT00346632|66082601|FG006|Overall Study|Protocol Violation|1|||
23799705|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23799706|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23799707|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
23799708|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
23799709|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
23799710|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23799711|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
23799712|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
23799713|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
23799714|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799715|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799716|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799717|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799718|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
23799719|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799720|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799721|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
23799722|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23799723|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
23592983|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
23644163|NCT00346632|66082602|FG007|Overall Study|Protocol Violation|0|||
23644164|NCT00346632|66082603|FG008|Overall Study|Protocol Violation|0|||
23644165|NCT00346632|66082604|FG009|Overall Study|Protocol Violation|0|||
23644166|NCT00346632|66082595|FG000|Overall Study|Withdrawal by Subject|0|||
23644167|NCT00346632|66082596|FG001|Overall Study|Withdrawal by Subject|0|||
23477035|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
23477036|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
23477037|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
23477038|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
23477039|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
23477040|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
23477041|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
23477042|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
23477043|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
23477044|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
23477045|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
23477046|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
23477047|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
23799724|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
23799725|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23799726|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23799727|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23799728|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23799729|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23799730|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23477048|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
23477049|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
23477050|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
23477051|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
23477052|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
23477053|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
23477054|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
23477055|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
23477056|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
23477057|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
23477058|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
23477059|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
23477060|NCT01589653|65491455|FG000|Overall Study|Protocol Violation|3|||
23477061|NCT01589653|65491456|FG001|Overall Study|Protocol Violation|1|||
23477062|NCT01589653|65491455|FG000|Overall Study|Withdrawal criteria|4|||
23477063|NCT01589653|65491456|FG001|Overall Study|Withdrawal criteria|7|||
23477064|NCT01589653|65491455|FG000|Overall Study|Unclassified|0|||
23477065|NCT01589653|65491456|FG001|Overall Study|Unclassified|3|||
23477066|NCT02745145|65491466|FG000|Overall Study|Adverse Event|1|||
23477067|NCT02745145|65491467|FG001|Overall Study|Adverse Event|0|||
23477068|NCT02745145|65491468|FG002|Overall Study|Adverse Event|0|||
23477069|NCT02745145|65491466|FG000|Overall Study|Death|0|||
23477070|NCT02745145|65491467|FG001|Overall Study|Death|1|||
23477071|NCT02745145|65491468|FG002|Overall Study|Death|0|||
23477072|NCT02745145|65491466|FG000|Overall Study|Progressive disease|0|||
23477073|NCT02745145|65491467|FG001|Overall Study|Progressive disease|0|||
23477074|NCT02745145|65491468|FG002|Overall Study|Progressive disease|1|||
23477075|NCT02745145|65491466|FG000|Overall Study|Withdrew consent|1|||
23477076|NCT02745145|65491467|FG001|Overall Study|Withdrew consent|1|||
23477077|NCT02745145|65491468|FG002|Overall Study|Withdrew consent|1|||
23477078|NCT02745145|65491466|FG000|Overall Study|Study Termination|8|||
23477079|NCT02745145|65491467|FG001|Overall Study|Study Termination|3|||
23477080|NCT02745145|65491468|FG002|Overall Study|Study Termination|7|||
23799731|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23477081|NCT01989208|65491469|FG000|200 mg (7 Days)|Protocol Violation|0|||
23477082|NCT01989208|65491470|FG001|200 mg (7 Days)|Protocol Violation|1|||
23477083|NCT02123251|65491473|FG000|Overall Study|Death|1|||
23477084|NCT02123251|65491474|FG001|Overall Study|Death|1|||
23477085|NCT02123251|65491473|FG000|Overall Study|Withdrawal by Subject|0|||
23477086|NCT02123251|65491474|FG001|Overall Study|Withdrawal by Subject|3|||
23592984|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
23592985|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
23477087|NCT02123251|65491473|FG000|Overall Study|Lost Medicaid eligibility|29|||
23477088|NCT02123251|65491474|FG001|Overall Study|Lost Medicaid eligibility|22|||
23477089|NCT02123251|65491473|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
23477090|NCT02123251|65491474|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
23477091|NCT02241889|65491475|FG000|Overall Study|device issues|0|||
23477092|NCT02241889|65491476|FG001|Overall Study|device issues|0|||
23477093|NCT02241889|65491477|FG002|Overall Study|device issues|1|||
23592986|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
23799732|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
23799733|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
23799734|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
23799735|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
23799736|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23799737|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23799738|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
23799739|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
23799740|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23799741|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799742|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799743|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
23799744|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799745|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799746|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799747|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799748|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799749|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23799750|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23799751|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
23799752|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23799753|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
23799754|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23799755|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23799756|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
23799757|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
23799758|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23799759|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
23799760|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23799761|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
23799762|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
23799763|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23799764|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23799765|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
23799766|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
23799767|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
23799768|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799769|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799770|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799771|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799772|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799773|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799774|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
23799775|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799776|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23799777|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
23799778|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23799779|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
23592987|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
23592988|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
23592989|NCT02965846|65899753|FG000|Overall Study|Lost to Follow-up|1|||
23592990|NCT02965846|65899754|FG001|Overall Study|Lost to Follow-up|0|||
23592991|NCT02965846|65899755|FG002|Overall Study|Lost to Follow-up|0|||
23592992|NCT02965846|65899753|FG000|Overall Study|Withdrawal by Subject|0|||
23592993|NCT02965846|65899754|FG001|Overall Study|Withdrawal by Subject|1|||
23592994|NCT02965846|65899755|FG002|Overall Study|Withdrawal by Subject|0|||
23592995|NCT02965846|65899753|FG000|Overall Study|Study Terminated By Sponsor|4|||
23592996|NCT02965846|65899754|FG001|Overall Study|Study Terminated By Sponsor|4|||
23592997|NCT02965846|65899755|FG002|Overall Study|Study Terminated By Sponsor|0|||
23592998|NCT02965846|65899753|FG000|Overall Study|Participants not randomized|0|||
23592999|NCT02965846|65899754|FG001|Overall Study|Participants not randomized|0|||
23593000|NCT02965846|65899755|FG002|Overall Study|Participants not randomized|33|||
23593001|NCT00177216|65902963|FG000|Overall Study|Withdrawal by Subject|6|||
23593002|NCT00177216|65902964|FG001|Overall Study|Withdrawal by Subject|3|||
23593003|NCT00177216|65902965|FG002|Overall Study|Withdrawal by Subject|1|||
23593004|NCT01400776|65902966|FG000|Overall Study|Adverse Event|7|||
23593005|NCT01400776|65902967|FG001|Overall Study|Adverse Event|2|||
23593006|NCT01400776|65902968|FG002|Overall Study|Adverse Event|9|||
23593007|NCT01400776|65902969|FG003|Overall Study|Adverse Event|2|||
23593008|NCT01400776|65902966|FG000|Overall Study|Lost to Follow-up|1|||
23593009|NCT01400776|65902967|FG001|Overall Study|Lost to Follow-up|0|||
23593010|NCT01400776|65902968|FG002|Overall Study|Lost to Follow-up|4|||
23593011|NCT01400776|65902969|FG003|Overall Study|Lost to Follow-up|1|||
23593012|NCT01400776|65902966|FG000|Overall Study|Withdrew Consent|4|||
23593013|NCT01400776|65902967|FG001|Overall Study|Withdrew Consent|2|||
23593014|NCT01400776|65902968|FG002|Overall Study|Withdrew Consent|6|||
23593015|NCT01400776|65902969|FG003|Overall Study|Withdrew Consent|1|||
23644168|NCT00346632|66082597|FG002|Overall Study|Withdrawal by Subject|0|||
23799780|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23799781|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23799782|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
23799783|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23799784|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23799785|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23477094|NCT02241889|65491478|FG003|Overall Study|device issues|0|||
23477095|NCT02241889|65491479|FG004|Overall Study|device issues|0|||
23477096|NCT02241889|65491480|FG005|Overall Study|device issues|0|||
23477097|NCT02241889|65491475|FG000|Overall Study|Withdrawal by Subject|0|||
23477098|NCT02241889|65491476|FG001|Overall Study|Withdrawal by Subject|0|||
23477099|NCT02241889|65491477|FG002|Overall Study|Withdrawal by Subject|0|||
23477100|NCT02241889|65491478|FG003|Overall Study|Withdrawal by Subject|0|||
23477101|NCT02241889|65491479|FG004|Overall Study|Withdrawal by Subject|0|||
23477102|NCT02241889|65491480|FG005|Overall Study|Withdrawal by Subject|1|||
23477103|NCT02743611|65491484|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
23477104|NCT02743611|65491485|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
23477105|NCT02743611|65491486|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
23477106|NCT02743611|65491487|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
23477107|NCT01699867|65491488|FG000|Overall Study|Screening Failure|3|||
23477108|NCT00402233|65491489|FG000|Overall Study|Adverse Event|1|||
23477109|NCT00402233|65491490|FG001|Overall Study|Adverse Event|7|||
23477110|NCT00402233|65491491|FG002|Overall Study|Adverse Event|9|||
23477111|NCT00402233|65491492|FG003|Overall Study|Adverse Event|9|||
23477112|NCT00402233|65491489|FG000|Overall Study|Protocol Violation|0|||
23477113|NCT00402233|65491490|FG001|Overall Study|Protocol Violation|1|||
23477114|NCT00402233|65491491|FG002|Overall Study|Protocol Violation|0|||
23477115|NCT00402233|65491492|FG003|Overall Study|Protocol Violation|0|||
23477116|NCT00402233|65491489|FG000|Overall Study|Withdrawal by Subject|2|||
23477117|NCT00402233|65491490|FG001|Overall Study|Withdrawal by Subject|1|||
23477118|NCT00402233|65491491|FG002|Overall Study|Withdrawal by Subject|2|||
23477119|NCT00402233|65491492|FG003|Overall Study|Withdrawal by Subject|2|||
23477120|NCT00402233|65491489|FG000|Overall Study|Worsening of disease under study|2|||
23477121|NCT00402233|65491490|FG001|Overall Study|Worsening of disease under study|0|||
23477122|NCT00402233|65491491|FG002|Overall Study|Worsening of disease under study|0|||
23477123|NCT00402233|65491492|FG003|Overall Study|Worsening of disease under study|0|||
23477124|NCT00402233|65491489|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23477125|NCT00402233|65491490|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23593016|NCT01400776|65902966|FG000|Overall Study|Protocol Deviation|6|||
23593017|NCT01400776|65902967|FG001|Overall Study|Protocol Deviation|1|||
23593018|NCT01400776|65902968|FG002|Overall Study|Protocol Deviation|5|||
23593019|NCT01400776|65902969|FG003|Overall Study|Protocol Deviation|2|||
23593020|NCT01400776|65902966|FG000|Overall Study|Reason not Specified|3|||
23593021|NCT01400776|65902967|FG001|Overall Study|Reason not Specified|0|||
23593022|NCT01400776|65902968|FG002|Overall Study|Reason not Specified|4|||
23477126|NCT00402233|65491491|FG002|Overall Study|Worsening of other pre-existing disease|0|||
23477127|NCT00402233|65491492|FG003|Overall Study|Worsening of other pre-existing disease|0|||
23477128|NCT03254108|65491493|FG000|Overall Study|Adverse Event|0|||
23799786|NCT00739973|66643086|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799787|NCT00739973|66643087|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
23799788|NCT00739973|66643088|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23593023|NCT01400776|65902969|FG003|Overall Study|Reason not Specified|3|||
23593024|NCT00941655|65902970|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
23593025|NCT00941655|65902971|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
23593026|NCT00941655|65902970|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
23593027|NCT00941655|65902971|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
23593028|NCT00941655|65902970|FG000|Overall Study|progressed while on chemo|0|||
23593029|NCT00941655|65902971|FG001|Overall Study|progressed while on chemo|2|||
23593030|NCT00941655|65902970|FG000|Overall Study|refused further treatment|0|||
23593031|NCT00941655|65902971|FG001|Overall Study|refused further treatment|1|||
23593032|NCT00941655|65902970|FG000|Overall Study|withdrew consent|0|||
23593033|NCT00941655|65902971|FG001|Overall Study|withdrew consent|1|||
23593034|NCT00941655|65902970|FG000|Overall Study|non-compliant|0|||
23593035|NCT00941655|65902971|FG001|Overall Study|non-compliant|1|||
23593036|NCT04305405|65902972|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23593037|NCT04305405|65902973|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23644169|NCT00346632|66082598|FG003|Overall Study|Withdrawal by Subject|0|||
23644170|NCT00346632|66082599|FG004|Overall Study|Withdrawal by Subject|0|||
23644171|NCT00346632|66082600|FG005|Overall Study|Withdrawal by Subject|0|||
23644172|NCT00346632|66082601|FG006|Overall Study|Withdrawal by Subject|1|||
23644173|NCT00346632|66082602|FG007|Overall Study|Withdrawal by Subject|0|||
23644174|NCT00346632|66082603|FG008|Overall Study|Withdrawal by Subject|0|||
23644175|NCT00346632|66082604|FG009|Overall Study|Withdrawal by Subject|0|||
23644176|NCT00346632|66082595|FG000|Overall Study|Switched to alternative treatment|0|||
23644177|NCT00346632|66082596|FG001|Overall Study|Switched to alternative treatment|0|||
23644178|NCT00346632|66082597|FG002|Overall Study|Switched to alternative treatment|1|||
23644179|NCT00346632|66082598|FG003|Overall Study|Switched to alternative treatment|0|||
23644180|NCT00346632|66082599|FG004|Overall Study|Switched to alternative treatment|0|||
23644181|NCT00346632|66082600|FG005|Overall Study|Switched to alternative treatment|0|||
23644182|NCT00346632|66082601|FG006|Overall Study|Switched to alternative treatment|0|||
23644183|NCT00346632|66082602|FG007|Overall Study|Switched to alternative treatment|0|||
23644184|NCT00346632|66082603|FG008|Overall Study|Switched to alternative treatment|0|||
23644185|NCT00346632|66082604|FG009|Overall Study|Switched to alternative treatment|0|||
23799789|NCT00739973|66643089|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799790|NCT00739973|66643090|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799791|NCT00739973|66643091|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799792|NCT00739973|66643092|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
23799793|NCT00739973|66643093|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799794|NCT00739973|66643094|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23799795|NCT02339090|66643095|FG000|Overall Study|Adverse Event|1|||
23593038|NCT00520546|65902974|FG000|Overall Study|Withdrawal by Subject|1|||
23593039|NCT00520546|65902974|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
23593040|NCT03740009|65902975|FG000|Overall Study|Physician Decision|9|||
23593041|NCT03740009|65902975|FG000|Overall Study|Lost to Follow-up|1|||
23593042|NCT02706717|65902976|FG000|Overall Study|Withdrawal by Subject|1|||
23593043|NCT02706717|65902977|FG001|Overall Study|Withdrawal by Subject|8|||
23593044|NCT02706717|65902976|FG000|Overall Study|Lost to Follow-up|0|||
23799796|NCT02339090|66643096|FG001|Overall Study|Adverse Event|0|||
23799797|NCT02339090|66643095|FG000|Overall Study|Lost to Follow-up|0|||
23799798|NCT02339090|66643096|FG001|Overall Study|Lost to Follow-up|1|||
23799799|NCT02339090|66643095|FG000|Overall Study|Non-compliance With Study Drug|0|||
23799800|NCT02339090|66643096|FG001|Overall Study|Non-compliance With Study Drug|1|||
23799801|NCT02339090|66643095|FG000|Overall Study|Withdrawal by Subject|2|||
23799802|NCT02339090|66643096|FG001|Overall Study|Withdrawal by Subject|1|||
23799803|NCT02339090|66643095|FG000|Overall Study|Poor Growth|3|||
23799804|NCT02339090|66643096|FG001|Overall Study|Poor Growth|0|||
23799805|NCT02339090|66643095|FG000|Overall Study|Randomized but not treated|0|||
23799806|NCT02339090|66643096|FG001|Overall Study|Randomized but not treated|2|||
23799807|NCT02443545|66643097|FG000|Overall Study|Adverse Event|1|||
23799808|NCT02443545|66643098|FG001|Overall Study|Adverse Event|1|||
23593045|NCT02706717|65902977|FG001|Overall Study|Lost to Follow-up|1|||
23593046|NCT02706717|65902976|FG000|Overall Study|Physician Decision|0|||
23644186|NCT00346632|66082595|FG000|Overall Study|Not Stated|1|||
23644187|NCT00346632|66082596|FG001|Overall Study|Not Stated|1|||
23644188|NCT00346632|66082597|FG002|Overall Study|Not Stated|0|||
23593047|NCT02706717|65902977|FG001|Overall Study|Physician Decision|1|||
23593048|NCT02706717|65902976|FG000|Overall Study|Death|0|||
23593049|NCT02706717|65902977|FG001|Overall Study|Death|1|||
23644189|NCT00346632|66082598|FG003|Overall Study|Not Stated|0|||
23644190|NCT00346632|66082599|FG004|Overall Study|Not Stated|0|||
23799809|NCT02443545|66643097|FG000|Overall Study|Lost to Follow-up|0|||
23799810|NCT02443545|66643098|FG001|Overall Study|Lost to Follow-up|2|||
23799811|NCT02443545|66643097|FG000|Overall Study|Physician Decision|3|||
23799812|NCT02443545|66643098|FG001|Overall Study|Physician Decision|0|||
23799813|NCT02443545|66643097|FG000|Overall Study|Protocol Violation|8|||
23799814|NCT02443545|66643098|FG001|Overall Study|Protocol Violation|1|||
23799815|NCT02443545|66643097|FG000|Overall Study|Pregnancy|1|||
23799816|NCT02443545|66643098|FG001|Overall Study|Pregnancy|1|||
23593050|NCT00529659|65902978|FG000|Overall Study|Adverse Event|8|||
23593051|NCT00529659|65902979|FG001|Overall Study|Adverse Event|7|||
23593052|NCT00529659|65902978|FG000|Overall Study|Lost to Follow-up|0|||
23593053|NCT00529659|65902979|FG001|Overall Study|Lost to Follow-up|2|||
23593054|NCT00529659|65902978|FG000|Overall Study|Physician Decision|0|||
23593055|NCT00529659|65902979|FG001|Overall Study|Physician Decision|2|||
23593056|NCT00529659|65902978|FG000|Overall Study|Protocol Violation|2|||
23593057|NCT00529659|65902979|FG001|Overall Study|Protocol Violation|6|||
23593058|NCT00529659|65902978|FG000|Overall Study|Withdrawal by Subject|1|||
23593059|NCT00529659|65902979|FG001|Overall Study|Withdrawal by Subject|6|||
23593060|NCT00439569|65902980|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
23593061|NCT00439569|65902980|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
23593062|NCT00439569|65902980|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
23593063|NCT03988023|65902981|FG000|Overall Study|Non-compliance|3|||
23593064|NCT03988023|65902982|FG001|Overall Study|Non-compliance|0|||
23593065|NCT03988023|65902981|FG000|Overall Study|Withdrawal by Subject|39|||
23593066|NCT03988023|65902982|FG001|Overall Study|Withdrawal by Subject|37|||
23593067|NCT03988023|65902981|FG000|Overall Study|Adverse Event|0|||
23593068|NCT03988023|65902982|FG001|Overall Study|Adverse Event|2|||
23593069|NCT03988023|65902981|FG000|Overall Study|Physician Decision|0|||
23593070|NCT03988023|65902982|FG001|Overall Study|Physician Decision|1|||
23593071|NCT03988023|65902981|FG000|Overall Study|Lost to Follow-up|5|||
23593072|NCT03988023|65902982|FG001|Overall Study|Lost to Follow-up|8|||
23593073|NCT03988023|65902981|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
23644191|NCT00346632|66082600|FG005|Overall Study|Not Stated|0|||
23644192|NCT00346632|66082601|FG006|Overall Study|Not Stated|0|||
23644193|NCT00346632|66082602|FG007|Overall Study|Not Stated|2|||
23644194|NCT00346632|66082603|FG008|Overall Study|Not Stated|2|||
23644195|NCT00346632|66082604|FG009|Overall Study|Not Stated|1|||
23644196|NCT01959334|66082608|FG000|Second Dose|Adverse Event|1|||
23593074|NCT03988023|65902982|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
23593075|NCT03988023|65902981|FG000|Overall Study|Lack of Efficacy|3|||
23593076|NCT03988023|65902982|FG001|Overall Study|Lack of Efficacy|1|||
23593077|NCT03988023|65902981|FG000|Overall Study|COVID-19 pandemic|225|||
23593078|NCT03988023|65902982|FG001|Overall Study|COVID-19 pandemic|227|||
23593079|NCT00743444|65902985|FG000|First Intervention|Catheter placement problems|0|||
23593080|NCT00743444|65902986|FG001|First Intervention|Catheter placement problems|1|||
23593081|NCT00743444|65902985|FG000|Washout Period|Adverse Event|0|||
23593082|NCT00743444|65902986|FG001|Washout Period|Adverse Event|1|||
23593083|NCT03460756|65902987|FG000|Overall Study|Adverse Event|0|||
23593084|NCT03460756|65902988|FG001|Overall Study|Adverse Event|0|||
23593085|NCT03460756|65902989|FG002|Overall Study|Adverse Event|0|||
23593086|NCT03460756|65902990|FG003|Overall Study|Adverse Event|1|||
23593087|NCT03460756|65902987|FG000|Overall Study|Lack of Efficacy|0|||
23593088|NCT03460756|65902988|FG001|Overall Study|Lack of Efficacy|0|||
23593089|NCT03460756|65902989|FG002|Overall Study|Lack of Efficacy|0|||
23593090|NCT03460756|65902990|FG003|Overall Study|Lack of Efficacy|2|||
23593091|NCT03460756|65902987|FG000|Overall Study|Lost to Follow-up|0|||
23593092|NCT03460756|65902988|FG001|Overall Study|Lost to Follow-up|1|||
23593093|NCT03460756|65902989|FG002|Overall Study|Lost to Follow-up|2|||
23593094|NCT03460756|65902990|FG003|Overall Study|Lost to Follow-up|1|||
23593095|NCT03460756|65902987|FG000|Overall Study|Pregnancy|0|||
23644197|NCT01959334|66082609|FG001|Second Dose|Adverse Event|0|||
23644198|NCT01959334|66082608|FG000|Third Dose|Adverse Event|0|||
23799817|NCT02443545|66643097|FG000|Overall Study|Withdrawal by Subject|6|||
23799818|NCT02443545|66643098|FG001|Overall Study|Withdrawal by Subject|3|||
23799819|NCT02443545|66643097|FG000|Overall Study|Termination of study|20|||
23799820|NCT02443545|66643098|FG001|Overall Study|Termination of study|11|||
23593096|NCT03460756|65902988|FG001|Overall Study|Pregnancy|0|||
23593097|NCT03460756|65902989|FG002|Overall Study|Pregnancy|0|||
23593098|NCT03460756|65902990|FG003|Overall Study|Pregnancy|1|||
23593099|NCT03460756|65902987|FG000|Overall Study|Protocol Violation|0|||
23593100|NCT03460756|65902988|FG001|Overall Study|Protocol Violation|0|||
23593101|NCT03460756|65902989|FG002|Overall Study|Protocol Violation|0|||
23644199|NCT01959334|66082609|FG001|Third Dose|Adverse Event|1|||
23593102|NCT03460756|65902990|FG003|Overall Study|Protocol Violation|1|||
23593103|NCT03460756|65902987|FG000|Overall Study|Withdrawal by Subject|0|||
23644200|NCT02121301|66082613|FG000|Overall Study|Protocol Violation|1|||
23644201|NCT02121301|66082614|FG001|Overall Study|Protocol Violation|4|||
23799821|NCT00476593|66643105|FG000|Overall Study|Lost to Follow-up|10|||
23799822|NCT00476593|66643106|FG001|Overall Study|Lost to Follow-up|2|||
23799823|NCT00476593|66643107|FG002|Overall Study|Lost to Follow-up|8|||
23477129|NCT03254108|65491494|FG001|Overall Study|Adverse Event|2|||
23477130|NCT03254108|65491495|FG002|Overall Study|Adverse Event|0|||
23477131|NCT03254108|65491496|FG003|Overall Study|Adverse Event|1|||
23477132|NCT03254108|65491497|FG004|Overall Study|Adverse Event|1|||
23477133|NCT03254108|65491493|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477134|NCT03254108|65491494|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477135|NCT03254108|65491495|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477136|NCT03254108|65491496|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477137|NCT03254108|65491497|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
23477138|NCT00145977|65491498|FG000|Overall Study|Lack of Efficacy|0|||
23477139|NCT00145977|65491499|FG001|Overall Study|Lack of Efficacy|4|||
23477140|NCT00145977|65491498|FG000|Overall Study|Lost to Follow-up|1|||
23477141|NCT00145977|65491499|FG001|Overall Study|Lost to Follow-up|0|||
23477142|NCT00145977|65491498|FG000|Overall Study|Withdrawal by Subject|1|||
23477143|NCT00145977|65491499|FG001|Overall Study|Withdrawal by Subject|0|||
23477144|NCT01155167|65491500|FG000|Overall Study|Insufficient ultrasound data|2|||
23477145|NCT01155167|65491501|FG001|Overall Study|Insufficient ultrasound data|0|||
23477146|NCT01155167|65491500|FG000|Overall Study|Access site changed to femoral artery|1|||
23477147|NCT01155167|65491501|FG001|Overall Study|Access site changed to femoral artery|0|||
23799824|NCT00476593|66643108|FG003|Overall Study|Lost to Follow-up|22|||
23799825|NCT00436917|66643111|FG000|Overall Study|Withdrawal by Subject|13|||
23799826|NCT00436917|66643111|FG000|Overall Study|Adverse Event|2|||
23799827|NCT00436917|66643111|FG000|Overall Study|Physician Decision|1|||
23799828|NCT00436917|66643111|FG000|Overall Study|Death|1|||
23477148|NCT00459056|65491502|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
23477149|NCT00459056|65491503|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
23477150|NCT02156271|65491504|FG000|Overall Study|Physician Decision|4|||
23477151|NCT02156271|65491505|FG001|Overall Study|Physician Decision|3|||
23477152|NCT00567255|65491506|FG000|Overall Study|Adverse Event|241|||
23477153|NCT00567255|65491507|FG001|Overall Study|Adverse Event|68|||
23477154|NCT00567255|65491506|FG000|Overall Study|Lost to Follow-up|77|||
23477155|NCT00567255|65491507|FG001|Overall Study|Lost to Follow-up|48|||
23477156|NCT00567255|65491506|FG000|Overall Study|Withdrawal by Subject|75|||
23477157|NCT00567255|65491507|FG001|Overall Study|Withdrawal by Subject|56|||
23477158|NCT00567255|65491506|FG000|Overall Study|Lack of Efficacy|19|||
23477159|NCT00567255|65491507|FG001|Overall Study|Lack of Efficacy|33|||
23477160|NCT00567255|65491506|FG000|Overall Study|Protocol Violation|20|||
23477161|NCT00567255|65491507|FG001|Overall Study|Protocol Violation|8|||
23477162|NCT00567255|65491506|FG000|Overall Study|Pregnancy|6|||
23477163|NCT00567255|65491507|FG001|Overall Study|Pregnancy|0|||
23477164|NCT00567255|65491506|FG000|Overall Study|Drug noncompliance,moved,other|25|||
23477165|NCT00567255|65491507|FG001|Overall Study|Drug noncompliance,moved,other|15|||
23477166|NCT01909791|65491508|FG000|Overall Study|Death|9|||
23477167|NCT01909791|65491509|FG001|Overall Study|Death|8|||
23477168|NCT01909791|65491510|FG002|Overall Study|Death|4|||
23477169|NCT01909791|65491508|FG000|Overall Study|Withdrawal by Subject|5|||
23477170|NCT01909791|65491509|FG001|Overall Study|Withdrawal by Subject|9|||
23477171|NCT01909791|65491510|FG002|Overall Study|Withdrawal by Subject|13|||
23477172|NCT01909791|65491508|FG000|Overall Study|Lost to Follow-up|5|||
23477173|NCT01909791|65491509|FG001|Overall Study|Lost to Follow-up|11|||
23477174|NCT01909791|65491510|FG002|Overall Study|Lost to Follow-up|10|||
23477175|NCT01909791|65491508|FG000|Overall Study|Missed Visit|2|||
23644202|NCT02121301|66082615|FG002|Overall Study|Protocol Violation|1|||
23799829|NCT00436917|66643111|FG000|Overall Study|Lost to Follow-up|1|||
23799830|NCT00436917|66643111|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
23799831|NCT00436917|66643111|FG000|Overall Study|Increased creatinine|1|||
23799832|NCT00436917|66643111|FG000|Overall Study|Personal conflicts of patient|1|||
23477176|NCT01909791|65491509|FG001|Overall Study|Missed Visit|0|||
23477177|NCT01909791|65491510|FG002|Overall Study|Missed Visit|1|||
23477178|NCT00444678|65491513|FG000|Overall Study|Toxicity|11|||
23477179|NCT00444678|65491513|FG000|Overall Study|Disease Progression|12|||
23477180|NCT00444678|65491513|FG000|Overall Study|Death|3|||
23477181|NCT00444678|65491513|FG000|Overall Study|Physician Decision|3|||
23477182|NCT00444678|65491513|FG000|Overall Study|Withdrawal by Subject|2|||
23477183|NCT00495040|65491514|FG000|Overall Study|Withdrawal by Subject|3|||
23477184|NCT01457352|65491515|FG000|Period 1|Adverse Event|2|||
23644203|NCT02988622|66082616|FG000|Overall Study|Lost to Follow-up|17|||
23799833|NCT00985231|66643112|FG000|Overall Study|ineligible|1|||
23644204|NCT00296400|66082618|FG000|Overall Study|Adverse Event|7|||
23477185|NCT01457352|65491516|FG001|Period 1|Adverse Event|0|||
23477186|NCT01457352|65491515|FG000|Period 1|Withdrawal by Subject|2|||
23477187|NCT01457352|65491516|FG001|Period 1|Withdrawal by Subject|0|||
23477188|NCT01457352|65491515|FG000|Period 1|Physician Decision|2|||
23477189|NCT01457352|65491516|FG001|Period 1|Physician Decision|0|||
23799834|NCT00985231|66643113|FG001|Overall Study|ineligible|0|||
23799835|NCT00985231|66643112|FG000|Overall Study|Protocol Violation|1|||
23799836|NCT00985231|66643113|FG001|Overall Study|Protocol Violation|0|||
23799837|NCT00985231|66643112|FG000|Overall Study|Withdrawal by Subject|1|||
23799838|NCT00985231|66643113|FG001|Overall Study|Withdrawal by Subject|0|||
23799839|NCT00985231|66643112|FG000|Overall Study|Lost to Follow-up|0|||
23799840|NCT00985231|66643113|FG001|Overall Study|Lost to Follow-up|1|||
23799841|NCT00985231|66643112|FG000|Overall Study|Study related symptoms & complaints|0|||
23799842|NCT00985231|66643113|FG001|Overall Study|Study related symptoms & complaints|2|||
23799843|NCT00942331|66643115|FG000|Overall Study|Did not start treatment|15|||
23799844|NCT00942331|66643116|FG001|Overall Study|Did not start treatment|22|||
23799845|NCT00707434|66643119|FG000|Overall Study|Adverse Event|1|||
23799846|NCT00298740|66643123|FG000|Overall Study|Lack of Efficacy|6|||
23799847|NCT00298740|66643123|FG000|Overall Study|Withdrawal by Subject|3|||
23799848|NCT01103479|66643128|FG000|Overall Study|Up to date with CRC screening|1|||
23799849|NCT01103479|66643129|FG001|Overall Study|Up to date with CRC screening|9|||
23799850|NCT01103479|66643130|FG002|Overall Study|Up to date with CRC screening|12|||
23799851|NCT01103479|66643128|FG000|Overall Study|Family history of CRC|1|||
23799852|NCT01103479|66643129|FG001|Overall Study|Family history of CRC|0|||
23799853|NCT01103479|66643130|FG002|Overall Study|Family history of CRC|2|||
23799854|NCT01103479|66643128|FG000|Overall Study|Active cancer|1|||
23799855|NCT01103479|66643129|FG001|Overall Study|Active cancer|0|||
23799856|NCT01103479|66643130|FG002|Overall Study|Active cancer|0|||
23799857|NCT01103479|66643128|FG000|Overall Study|Saw non-study physician|2|||
23799858|NCT01103479|66643129|FG001|Overall Study|Saw non-study physician|0|||
23799859|NCT01103479|66643130|FG002|Overall Study|Saw non-study physician|0|||
23799860|NCT01714739|66643131|FG000|Overall Study|Disease progression|3|||
23799861|NCT01714739|66643132|FG001|Overall Study|Disease progression|5|||
23799862|NCT01714739|66643133|FG002|Overall Study|Disease progression|5|||
23799863|NCT01714739|66643134|FG003|Overall Study|Disease progression|204|||
23477190|NCT01457352|65491515|FG000|Period 1|MS related disease progression|1|||
23477191|NCT01457352|65491516|FG001|Period 1|MS related disease progression|0|||
23477192|NCT01457352|65491515|FG000|Period 1|Withdrawn|1|||
23477193|NCT01457352|65491516|FG001|Period 1|Withdrawn|0|||
23477194|NCT01457352|65491515|FG000|Period 1|withdrew per sponsor|1|||
23477195|NCT01457352|65491516|FG001|Period 1|withdrew per sponsor|0|||
23477196|NCT01457352|65491515|FG000|Period 1|Protocol Violation|4|||
23477197|NCT01457352|65491516|FG001|Period 1|Protocol Violation|0|||
23644205|NCT00296400|66082619|FG001|Overall Study|Adverse Event|7|||
23644206|NCT00296400|66082620|FG002|Overall Study|Adverse Event|7|||
23477198|NCT01457352|65491515|FG000|Period 1|Did not meet eligibility criteria|3|||
23477199|NCT01457352|65491516|FG001|Period 1|Did not meet eligibility criteria|0|||
23477200|NCT01457352|65491515|FG000|Period 2|Withdrawal by Subject|23|||
23593104|NCT03460756|65902988|FG001|Overall Study|Withdrawal by Subject|4|||
23644207|NCT00296400|66082618|FG000|Overall Study|Withdrawal by Subject|5|||
23799864|NCT01714739|66643135|FG004|Overall Study|Disease progression|1|||
23477201|NCT01457352|65491516|FG001|Period 2|Withdrawal by Subject|0|||
23593105|NCT03460756|65902989|FG002|Overall Study|Withdrawal by Subject|7|||
23593106|NCT03460756|65902990|FG003|Overall Study|Withdrawal by Subject|3|||
23799865|NCT01714739|66643136|FG005|Overall Study|Disease progression|3|||
23799866|NCT01714739|66643137|FG006|Overall Study|Disease progression|5|||
23799867|NCT01714739|66643131|FG000|Overall Study|Study drug toxicity|1|||
23799868|NCT01714739|66643132|FG001|Overall Study|Study drug toxicity|1|||
23477202|NCT01457352|65491515|FG000|Period 2|Adverse Event|22|||
23477203|NCT01457352|65491516|FG001|Period 2|Adverse Event|0|||
23477204|NCT01457352|65491515|FG000|Period 2|no analysis|10|||
23593107|NCT00529516|65902991|FG000|Overall Study|Adverse Event|2|||
23799869|NCT01714739|66643133|FG002|Overall Study|Study drug toxicity|1|||
23799870|NCT01714739|66643134|FG003|Overall Study|Study drug toxicity|15|||
23799871|NCT01714739|66643135|FG004|Overall Study|Study drug toxicity|0|||
23593108|NCT00529516|65902992|FG001|Overall Study|Adverse Event|1|||
23593109|NCT00529516|65902993|FG002|Overall Study|Adverse Event|0|||
23593110|NCT00529516|65902991|FG000|Overall Study|Withdrawal by Subject|1|||
23593111|NCT00529516|65902992|FG001|Overall Study|Withdrawal by Subject|1|||
23593112|NCT00529516|65902993|FG002|Overall Study|Withdrawal by Subject|0|||
23593113|NCT00529516|65902991|FG000|Overall Study|Lost to Follow-up|0|||
23593114|NCT00529516|65902992|FG001|Overall Study|Lost to Follow-up|0|||
23593115|NCT00529516|65902993|FG002|Overall Study|Lost to Follow-up|1|||
23593116|NCT00444600|65902994|FG000|Overall Study|Death|7|||
23593117|NCT00444600|65902995|FG001|Overall Study|Death|5|||
23593118|NCT00444600|65902996|FG002|Overall Study|Death|3|||
23593119|NCT00444600|65902997|FG003|Overall Study|Death|2|||
23593120|NCT00444600|65902994|FG000|Overall Study|Dropped|11|||
23593121|NCT00444600|65902995|FG001|Overall Study|Dropped|11|||
23593122|NCT00444600|65902996|FG002|Overall Study|Dropped|7|||
23593123|NCT00444600|65902997|FG003|Overall Study|Dropped|7|||
23593124|NCT00444600|65902994|FG000|Overall Study|Missed visit|1|||
23593125|NCT00444600|65902995|FG001|Overall Study|Missed visit|0|||
23593126|NCT00444600|65902996|FG002|Overall Study|Missed visit|0|||
23593127|NCT00444600|65902997|FG003|Overall Study|Missed visit|1|||
23593128|NCT01968226|65902998|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
23593129|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
23593130|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
23593131|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593132|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593133|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593134|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
23593135|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
23593136|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593137|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593138|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593139|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
23593140|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
23593141|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593142|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593143|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593144|NCT01832480|65903013|FG000|Overall Study|Lost to Follow-up|33|||
23593145|NCT01832480|65903014|FG001|Overall Study|Lost to Follow-up|30|||
23593146|NCT01832480|65903013|FG000|Overall Study|Withdrawal by Subject|0|||
23593147|NCT01832480|65903014|FG001|Overall Study|Withdrawal by Subject|2|||
23593148|NCT01832480|65903013|FG000|Overall Study|post randomization ineligible|8|||
23593149|NCT01832480|65903014|FG001|Overall Study|post randomization ineligible|10|||
23593150|NCT00106080|65903016|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
23593151|NCT00106080|65903017|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
23593152|NCT00150176|65903018|FG000|Overall Study|Adverse Event|16|||
23593153|NCT00150176|65903019|FG001|Overall Study|Adverse Event|53|||
23593154|NCT00150176|65903018|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
23593155|NCT00150176|65903019|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
23593156|NCT00150176|65903018|FG000|Overall Study|Withdrawal by Subject|19|||
23593157|NCT00150176|65903019|FG001|Overall Study|Withdrawal by Subject|12|||
23593158|NCT00150176|65903018|FG000|Overall Study|Lost to Follow-up|3|||
23593159|NCT00150176|65903019|FG001|Overall Study|Lost to Follow-up|3|||
23593160|NCT00150176|65903018|FG000|Overall Study|OTHER|11|||
23593161|NCT00150176|65903019|FG001|Overall Study|OTHER|13|||
23593162|NCT04425629|65903025|FG000|Overall Study|Adverse Event|0|||
23593163|NCT04425629|65903026|FG001|Overall Study|Adverse Event|0|||
23593164|NCT04425629|65903027|FG002|Overall Study|Adverse Event|0|||
23593165|NCT04425629|65903028|FG003|Overall Study|Adverse Event|0|||
23593166|NCT04425629|65903029|FG004|Overall Study|Adverse Event|1|||
23593167|NCT04425629|65903030|FG005|Overall Study|Adverse Event|0|||
23593168|NCT04425629|65903031|FG006|Overall Study|Adverse Event|0|||
23593169|NCT04425629|65903032|FG007|Overall Study|Adverse Event|0|||
23644208|NCT00296400|66082619|FG001|Overall Study|Withdrawal by Subject|6|||
23593170|NCT04425629|65903033|FG008|Overall Study|Adverse Event|0|||
23593171|NCT04425629|65903034|FG009|Overall Study|Adverse Event|3|||
23593172|NCT04425629|65903035|FG010|Overall Study|Adverse Event|2|||
23593173|NCT04425629|65903036|FG011|Overall Study|Adverse Event|1|||
23593174|NCT04425629|65903037|FG012|Overall Study|Adverse Event|1|||
23593175|NCT04425629|65903038|FG013|Overall Study|Adverse Event|0|||
23593176|NCT04425629|65903039|FG014|Overall Study|Adverse Event|0|||
23593177|NCT04425629|65903040|FG015|Overall Study|Adverse Event|0|||
23593178|NCT04425629|65903041|FG016|Overall Study|Adverse Event|0|||
23593179|NCT04425629|65903042|FG017|Overall Study|Adverse Event|0|||
23799872|NCT01714739|66643136|FG005|Overall Study|Study drug toxicity|0|||
23477205|NCT01457352|65491516|FG001|Period 2|no analysis|0|||
23477206|NCT01457352|65491515|FG000|Period 2|Lack of Efficacy|8|||
23477207|NCT01457352|65491516|FG001|Period 2|Lack of Efficacy|0|||
23799873|NCT01714739|66643137|FG006|Overall Study|Study drug toxicity|5|||
23799874|NCT01714739|66643131|FG000|Overall Study|Death|0|||
23799875|NCT01714739|66643132|FG001|Overall Study|Death|0|||
23799876|NCT01714739|66643133|FG002|Overall Study|Death|0|||
23799877|NCT01714739|66643134|FG003|Overall Study|Death|1|||
23799878|NCT01714739|66643135|FG004|Overall Study|Death|0|||
23799879|NCT01714739|66643136|FG005|Overall Study|Death|0|||
23799880|NCT01714739|66643137|FG006|Overall Study|Death|0|||
23799881|NCT01714739|66643131|FG000|Overall Study|Adverse Event unrelated to drug|0|||
23799882|NCT01714739|66643132|FG001|Overall Study|Adverse Event unrelated to drug|0|||
23799883|NCT01714739|66643133|FG002|Overall Study|Adverse Event unrelated to drug|3|||
23799884|NCT01714739|66643134|FG003|Overall Study|Adverse Event unrelated to drug|21|||
23799885|NCT01714739|66643135|FG004|Overall Study|Adverse Event unrelated to drug|0|||
23799886|NCT01714739|66643136|FG005|Overall Study|Adverse Event unrelated to drug|0|||
23799887|NCT01714739|66643137|FG006|Overall Study|Adverse Event unrelated to drug|0|||
23799888|NCT01714739|66643131|FG000|Overall Study|Participant request to stop therapy|0|||
23799889|NCT01714739|66643132|FG001|Overall Study|Participant request to stop therapy|1|||
23799890|NCT01714739|66643133|FG002|Overall Study|Participant request to stop therapy|0|||
23799891|NCT01714739|66643134|FG003|Overall Study|Participant request to stop therapy|6|||
23799892|NCT01714739|66643135|FG004|Overall Study|Participant request to stop therapy|0|||
23799893|NCT01714739|66643136|FG005|Overall Study|Participant request to stop therapy|0|||
23799894|NCT01714739|66643137|FG006|Overall Study|Participant request to stop therapy|0|||
23799895|NCT01714739|66643131|FG000|Overall Study|Participant withdrew consent|0|||
23799896|NCT01714739|66643132|FG001|Overall Study|Participant withdrew consent|1|||
23799897|NCT01714739|66643133|FG002|Overall Study|Participant withdrew consent|0|||
23799898|NCT01714739|66643134|FG003|Overall Study|Participant withdrew consent|8|||
23799899|NCT01714739|66643135|FG004|Overall Study|Participant withdrew consent|0|||
23799900|NCT01714739|66643136|FG005|Overall Study|Participant withdrew consent|0|||
23799901|NCT01714739|66643137|FG006|Overall Study|Participant withdrew consent|0|||
23799902|NCT01714739|66643131|FG000|Overall Study|Lost to Follow-up|0|||
23799903|NCT01714739|66643132|FG001|Overall Study|Lost to Follow-up|0|||
23799904|NCT01714739|66643133|FG002|Overall Study|Lost to Follow-up|0|||
23799905|NCT01714739|66643134|FG003|Overall Study|Lost to Follow-up|1|||
23799906|NCT01714739|66643135|FG004|Overall Study|Lost to Follow-up|0|||
23799907|NCT01714739|66643136|FG005|Overall Study|Lost to Follow-up|0|||
23799908|NCT01714739|66643137|FG006|Overall Study|Lost to Follow-up|0|||
23799909|NCT01714739|66643131|FG000|Overall Study|Maximum clinical benefit|0|||
23799910|NCT01714739|66643132|FG001|Overall Study|Maximum clinical benefit|1|||
23799911|NCT01714739|66643133|FG002|Overall Study|Maximum clinical benefit|1|||
23799912|NCT01714739|66643134|FG003|Overall Study|Maximum clinical benefit|3|||
23799913|NCT01714739|66643135|FG004|Overall Study|Maximum clinical benefit|0|||
23799914|NCT01714739|66643136|FG005|Overall Study|Maximum clinical benefit|0|||
23593180|NCT04425629|65903043|FG018|Overall Study|Adverse Event|0|||
23593181|NCT04425629|65903025|FG000|Overall Study|Lost to Follow-up|1|||
23644209|NCT00296400|66082620|FG002|Overall Study|Withdrawal by Subject|2|||
23799915|NCT01714739|66643137|FG006|Overall Study|Maximum clinical benefit|0|||
23799916|NCT01714739|66643131|FG000|Overall Study|Poor/non-comliance|0|||
23799917|NCT01714739|66643132|FG001|Overall Study|Poor/non-comliance|1|||
23799918|NCT01714739|66643133|FG002|Overall Study|Poor/non-comliance|0|||
23799919|NCT01714739|66643134|FG003|Overall Study|Poor/non-comliance|1|||
23799920|NCT01714739|66643135|FG004|Overall Study|Poor/non-comliance|0|||
23799921|NCT01714739|66643136|FG005|Overall Study|Poor/non-comliance|0|||
23477208|NCT01457352|65491515|FG000|Period 2|Protocol Violation|4|||
23593182|NCT04425629|65903026|FG001|Overall Study|Lost to Follow-up|3|||
23593183|NCT04425629|65903027|FG002|Overall Study|Lost to Follow-up|1|||
23593184|NCT04425629|65903028|FG003|Overall Study|Lost to Follow-up|7|||
23593185|NCT04425629|65903029|FG004|Overall Study|Lost to Follow-up|1|||
23593186|NCT04425629|65903030|FG005|Overall Study|Lost to Follow-up|2|||
23593187|NCT04425629|65903031|FG006|Overall Study|Lost to Follow-up|1|||
23593188|NCT04425629|65903032|FG007|Overall Study|Lost to Follow-up|0|||
23593189|NCT04425629|65903033|FG008|Overall Study|Lost to Follow-up|1|||
23593190|NCT04425629|65903034|FG009|Overall Study|Lost to Follow-up|64|||
23593191|NCT04425629|65903035|FG010|Overall Study|Lost to Follow-up|70|||
23593192|NCT04425629|65903036|FG011|Overall Study|Lost to Follow-up|98|||
23593193|NCT04425629|65903037|FG012|Overall Study|Lost to Follow-up|30|||
23593194|NCT04425629|65903038|FG013|Overall Study|Lost to Follow-up|0|||
23593195|NCT04425629|65903039|FG014|Overall Study|Lost to Follow-up|5|||
23593196|NCT04425629|65903040|FG015|Overall Study|Lost to Follow-up|4|||
23593197|NCT04425629|65903041|FG016|Overall Study|Lost to Follow-up|0|||
23593198|NCT04425629|65903042|FG017|Overall Study|Lost to Follow-up|3|||
23593199|NCT04425629|65903043|FG018|Overall Study|Lost to Follow-up|1|||
23593200|NCT04425629|65903025|FG000|Overall Study|Subject Decision|0|||
23593201|NCT04425629|65903026|FG001|Overall Study|Subject Decision|2|||
23593202|NCT04425629|65903027|FG002|Overall Study|Subject Decision|1|||
23593203|NCT04425629|65903028|FG003|Overall Study|Subject Decision|3|||
23593204|NCT04425629|65903029|FG004|Overall Study|Subject Decision|6|||
23593205|NCT04425629|65903030|FG005|Overall Study|Subject Decision|6|||
23593206|NCT04425629|65903031|FG006|Overall Study|Subject Decision|3|||
23593207|NCT04425629|65903032|FG007|Overall Study|Subject Decision|3|||
23593208|NCT04425629|65903033|FG008|Overall Study|Subject Decision|1|||
23593209|NCT04425629|65903034|FG009|Overall Study|Subject Decision|70|||
23593210|NCT04425629|65903035|FG010|Overall Study|Subject Decision|95|||
23593211|NCT04425629|65903036|FG011|Overall Study|Subject Decision|124|||
23593212|NCT04425629|65903037|FG012|Overall Study|Subject Decision|25|||
23593213|NCT04425629|65903038|FG013|Overall Study|Subject Decision|0|||
23593214|NCT04425629|65903039|FG014|Overall Study|Subject Decision|1|||
23593215|NCT04425629|65903040|FG015|Overall Study|Subject Decision|4|||
23593216|NCT04425629|65903041|FG016|Overall Study|Subject Decision|1|||
23593217|NCT04425629|65903042|FG017|Overall Study|Subject Decision|0|||
23593218|NCT04425629|65903043|FG018|Overall Study|Subject Decision|2|||
23593219|NCT04425629|65903025|FG000|Overall Study|Death|0|||
23593220|NCT04425629|65903026|FG001|Overall Study|Death|0|||
23593221|NCT04425629|65903027|FG002|Overall Study|Death|0|||
23593222|NCT04425629|65903028|FG003|Overall Study|Death|0|||
23593223|NCT04425629|65903029|FG004|Overall Study|Death|0|||
23593224|NCT04425629|65903030|FG005|Overall Study|Death|0|||
23593225|NCT04425629|65903031|FG006|Overall Study|Death|0|||
23593226|NCT04425629|65903032|FG007|Overall Study|Death|0|||
23593227|NCT04425629|65903033|FG008|Overall Study|Death|0|||
23593228|NCT04425629|65903034|FG009|Overall Study|Death|11|||
23593229|NCT04425629|65903035|FG010|Overall Study|Death|2|||
23593230|NCT04425629|65903036|FG011|Overall Study|Death|4|||
23593231|NCT04425629|65903037|FG012|Overall Study|Death|0|||
23593232|NCT04425629|65903038|FG013|Overall Study|Death|0|||
23593233|NCT04425629|65903039|FG014|Overall Study|Death|0|||
23593234|NCT04425629|65903040|FG015|Overall Study|Death|0|||
23593235|NCT04425629|65903041|FG016|Overall Study|Death|0|||
23593236|NCT04425629|65903042|FG017|Overall Study|Death|0|||
23593237|NCT04425629|65903043|FG018|Overall Study|Death|0|||
23593238|NCT04425629|65903025|FG000|Overall Study|Sponsor Request|0|||
23593239|NCT04425629|65903026|FG001|Overall Study|Sponsor Request|0|||
23593240|NCT04425629|65903027|FG002|Overall Study|Sponsor Request|0|||
23593241|NCT04425629|65903028|FG003|Overall Study|Sponsor Request|2|||
23593242|NCT04425629|65903029|FG004|Overall Study|Sponsor Request|2|||
23593243|NCT04425629|65903030|FG005|Overall Study|Sponsor Request|2|||
23593244|NCT04425629|65903031|FG006|Overall Study|Sponsor Request|1|||
23593245|NCT04425629|65903032|FG007|Overall Study|Sponsor Request|0|||
23593246|NCT04425629|65903033|FG008|Overall Study|Sponsor Request|0|||
23593247|NCT04425629|65903034|FG009|Overall Study|Sponsor Request|9|||
23593248|NCT04425629|65903035|FG010|Overall Study|Sponsor Request|9|||
23593249|NCT04425629|65903036|FG011|Overall Study|Sponsor Request|10|||
23593250|NCT04425629|65903037|FG012|Overall Study|Sponsor Request|8|||
23593251|NCT04425629|65903038|FG013|Overall Study|Sponsor Request|0|||
23593252|NCT04425629|65903039|FG014|Overall Study|Sponsor Request|0|||
23593253|NCT04425629|65903040|FG015|Overall Study|Sponsor Request|1|||
23593254|NCT04425629|65903041|FG016|Overall Study|Sponsor Request|0|||
23593255|NCT04425629|65903042|FG017|Overall Study|Sponsor Request|0|||
23593256|NCT04425629|65903043|FG018|Overall Study|Sponsor Request|0|||
23593257|NCT04425629|65903025|FG000|Overall Study|Physician Decision|0|||
23593258|NCT04425629|65903026|FG001|Overall Study|Physician Decision|0|||
23593259|NCT04425629|65903027|FG002|Overall Study|Physician Decision|0|||
23593260|NCT04425629|65903028|FG003|Overall Study|Physician Decision|0|||
23593261|NCT04425629|65903029|FG004|Overall Study|Physician Decision|0|||
23593262|NCT04425629|65903030|FG005|Overall Study|Physician Decision|0|||
23593263|NCT04425629|65903031|FG006|Overall Study|Physician Decision|0|||
23593264|NCT04425629|65903032|FG007|Overall Study|Physician Decision|0|||
23593265|NCT04425629|65903033|FG008|Overall Study|Physician Decision|0|||
23593266|NCT04425629|65903034|FG009|Overall Study|Physician Decision|4|||
23593267|NCT04425629|65903035|FG010|Overall Study|Physician Decision|3|||
23593268|NCT04425629|65903036|FG011|Overall Study|Physician Decision|5|||
23593269|NCT04425629|65903037|FG012|Overall Study|Physician Decision|1|||
23593270|NCT04425629|65903038|FG013|Overall Study|Physician Decision|0|||
23593271|NCT04425629|65903039|FG014|Overall Study|Physician Decision|0|||
23593272|NCT04425629|65903040|FG015|Overall Study|Physician Decision|1|||
23593273|NCT04425629|65903041|FG016|Overall Study|Physician Decision|0|||
23593274|NCT04425629|65903042|FG017|Overall Study|Physician Decision|0|||
23593275|NCT04425629|65903043|FG018|Overall Study|Physician Decision|0|||
23593276|NCT04425629|65903025|FG000|Overall Study|Lack of Efficacy|0|||
23593277|NCT04425629|65903026|FG001|Overall Study|Lack of Efficacy|0|||
23593278|NCT04425629|65903027|FG002|Overall Study|Lack of Efficacy|0|||
23593279|NCT04425629|65903028|FG003|Overall Study|Lack of Efficacy|0|||
23593280|NCT04425629|65903029|FG004|Overall Study|Lack of Efficacy|0|||
23593281|NCT04425629|65903030|FG005|Overall Study|Lack of Efficacy|0|||
23593282|NCT04425629|65903031|FG006|Overall Study|Lack of Efficacy|0|||
23593283|NCT04425629|65903032|FG007|Overall Study|Lack of Efficacy|0|||
23593284|NCT04425629|65903033|FG008|Overall Study|Lack of Efficacy|0|||
23593285|NCT04425629|65903034|FG009|Overall Study|Lack of Efficacy|0|||
23593286|NCT04425629|65903035|FG010|Overall Study|Lack of Efficacy|1|||
23593287|NCT04425629|65903036|FG011|Overall Study|Lack of Efficacy|0|||
23593288|NCT04425629|65903037|FG012|Overall Study|Lack of Efficacy|0|||
23593289|NCT04425629|65903038|FG013|Overall Study|Lack of Efficacy|0|||
23593290|NCT04425629|65903039|FG014|Overall Study|Lack of Efficacy|0|||
23593291|NCT04425629|65903040|FG015|Overall Study|Lack of Efficacy|0|||
23593292|NCT04425629|65903041|FG016|Overall Study|Lack of Efficacy|0|||
23593293|NCT04425629|65903042|FG017|Overall Study|Lack of Efficacy|0|||
23593294|NCT04425629|65903043|FG018|Overall Study|Lack of Efficacy|0|||
23593295|NCT04530747|65903046|FG000|Overall Study|Withdrawal by Subject|1|||
23593296|NCT04530747|65903047|FG001|Overall Study|Withdrawal by Subject|0|||
23593297|NCT01677936|65903048|FG000|Overall Study|Lost to Follow-up|4|||
23593298|NCT01677936|65903049|FG001|Overall Study|Lost to Follow-up|1|||
23593299|NCT01677936|65903048|FG000|Overall Study|Protocol Violation|3|||
23593300|NCT01677936|65903049|FG001|Overall Study|Protocol Violation|0|||
23644210|NCT00296400|66082618|FG000|Overall Study|Incorrect enrollment|2|||
23644211|NCT00296400|66082619|FG001|Overall Study|Incorrect enrollment|0|||
23644212|NCT00296400|66082620|FG002|Overall Study|Incorrect enrollment|0|||
23644213|NCT00296400|66082618|FG000|Overall Study|Protocol Violation|1|||
23644214|NCT00296400|66082619|FG001|Overall Study|Protocol Violation|1|||
23644215|NCT00296400|66082620|FG002|Overall Study|Protocol Violation|1|||
23644216|NCT00296400|66082618|FG000|Overall Study|Lost to Follow-up|1|||
23477209|NCT01457352|65491516|FG001|Period 2|Protocol Violation|0|||
23593301|NCT01677936|65903048|FG000|Overall Study|Adverse Event|1|||
23593302|NCT01677936|65903049|FG001|Overall Study|Adverse Event|0|||
23593303|NCT01677936|65903048|FG000|Overall Study|Lost to Follow-up|1|||
23593304|NCT01677936|65903049|FG001|Overall Study|Lost to Follow-up|0|||
23593305|NCT01677936|65903048|FG000|Overall Study|Protocol Violation|0|||
23593306|NCT01677936|65903049|FG001|Overall Study|Protocol Violation|4|||
23593307|NCT03383146|65903054|FG000|Overall Study|Screen Failure|1|||
23593308|NCT03383146|65903055|FG001|Overall Study|Screen Failure|0|||
23593309|NCT03383146|65903054|FG000|Overall Study|Adverse Event|6|||
23593310|NCT03383146|65903055|FG001|Overall Study|Adverse Event|18|||
23593311|NCT03383146|65903054|FG000|Overall Study|Lack of Efficacy|0|||
23799922|NCT01714739|66643137|FG006|Overall Study|Poor/non-comliance|0|||
23799923|NCT01714739|66643131|FG000|Overall Study|No longer meets study criteria|0|||
23799924|NCT01714739|66643132|FG001|Overall Study|No longer meets study criteria|0|||
23799925|NCT01714739|66643133|FG002|Overall Study|No longer meets study criteria|0|||
23799926|NCT01714739|66643134|FG003|Overall Study|No longer meets study criteria|1|||
23799927|NCT01714739|66643135|FG004|Overall Study|No longer meets study criteria|0|||
23799928|NCT01714739|66643136|FG005|Overall Study|No longer meets study criteria|0|||
23799929|NCT01714739|66643137|FG006|Overall Study|No longer meets study criteria|0|||
23799930|NCT01714739|66643131|FG000|Overall Study|Other reason|0|||
23799931|NCT01714739|66643132|FG001|Overall Study|Other reason|0|||
23799932|NCT01714739|66643133|FG002|Overall Study|Other reason|0|||
23799933|NCT01714739|66643134|FG003|Overall Study|Other reason|3|||
23799934|NCT01714739|66643135|FG004|Overall Study|Other reason|1|||
23799935|NCT01714739|66643136|FG005|Overall Study|Other reason|0|||
23799936|NCT01714739|66643137|FG006|Overall Study|Other reason|0|||
23799937|NCT01640184|66643140|FG000|Overall Study|Death|1|||
23799938|NCT01640184|66643141|FG001|Overall Study|Death|0|||
23799939|NCT01640184|66643142|FG002|Overall Study|Death|0|||
23799940|NCT01640184|66643140|FG000|Overall Study|Lost to Follow-up|4|||
23799941|NCT01640184|66643141|FG001|Overall Study|Lost to Follow-up|1|||
23799942|NCT01640184|66643142|FG002|Overall Study|Lost to Follow-up|0|||
23799943|NCT01640184|66643140|FG000|Overall Study|Physician Decision|3|||
23799944|NCT01640184|66643141|FG001|Overall Study|Physician Decision|0|||
23477210|NCT01457352|65491515|FG000|Period 2|Sponsor's withdrawal|7|||
23477211|NCT01457352|65491516|FG001|Period 2|Sponsor's withdrawal|0|||
23477212|NCT01457352|65491515|FG000|Period 2|Lost to Follow-up|1|||
23799945|NCT01640184|66643142|FG002|Overall Study|Physician Decision|0|||
23799946|NCT01640184|66643140|FG000|Overall Study|Withdrawal by Subject|0|||
23799947|NCT01640184|66643141|FG001|Overall Study|Withdrawal by Subject|1|||
23799948|NCT01640184|66643142|FG002|Overall Study|Withdrawal by Subject|1|||
23477213|NCT01457352|65491516|FG001|Period 2|Lost to Follow-up|0|||
23477214|NCT01457352|65491515|FG000|Period 2|dose change|1|||
23477215|NCT01457352|65491516|FG001|Period 2|dose change|0|||
23477216|NCT01457352|65491515|FG000|Period 2|Physician Decision|1|||
23477217|NCT01457352|65491516|FG001|Period 2|Physician Decision|0|||
23477218|NCT01457352|65491515|FG000|Period 2|Did not meet eligibility criteria|3|||
23477219|NCT01457352|65491516|FG001|Period 2|Did not meet eligibility criteria|0|||
23477220|NCT01457352|65491515|FG000|Period 3|Adverse Event|1|||
23799949|NCT01640184|66643140|FG000|Overall Study|Protocol Violation|0|||
23799950|NCT01640184|66643141|FG001|Overall Study|Protocol Violation|0|||
23799951|NCT01640184|66643142|FG002|Overall Study|Protocol Violation|1|||
23799952|NCT01957150|66643144|FG000|Overall Study|Adverse Event|23|||
23799953|NCT01957150|66643145|FG001|Overall Study|Adverse Event|20|||
23799954|NCT01957150|66643144|FG000|Overall Study|Withdrawal by Subject|13|||
23799955|NCT01957150|66643145|FG001|Overall Study|Withdrawal by Subject|17|||
23799956|NCT01957150|66643144|FG000|Overall Study|Physician Decision|3|||
23477221|NCT01457352|65491516|FG001|Period 3|Adverse Event|1|||
23477222|NCT01457352|65491515|FG000|Period 3|Withdrawal by Subject|0|||
23477223|NCT01457352|65491516|FG001|Period 3|Withdrawal by Subject|2|||
23477224|NCT01457352|65491515|FG000|Period 3|incorrect treatment|0|||
23477225|NCT01457352|65491516|FG001|Period 3|incorrect treatment|1|||
23477226|NCT01457352|65491515|FG000|Period 3|Sponsor's withdrawal|0|||
23477227|NCT01457352|65491516|FG001|Period 3|Sponsor's withdrawal|1|||
23477228|NCT00561977|65491517|FG000|Overall Study|Withdrawal by Subject|0|||
23477229|NCT00561977|65491518|FG001|Overall Study|Withdrawal by Subject|2|||
23477230|NCT00561977|65491519|FG002|Overall Study|Withdrawal by Subject|1|||
23477231|NCT00561977|65491517|FG000|Overall Study|Pregnancy|0|||
23477232|NCT00561977|65491518|FG001|Overall Study|Pregnancy|1|||
23477233|NCT00561977|65491519|FG002|Overall Study|Pregnancy|1|||
23477234|NCT01128621|65491520|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
23477235|NCT01128621|65491521|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
23799957|NCT01957150|66643145|FG001|Overall Study|Physician Decision|6|||
23799958|NCT01957150|66643144|FG000|Overall Study|Lost to Follow-up|4|||
23799959|NCT01957150|66643145|FG001|Overall Study|Lost to Follow-up|4|||
23799960|NCT01957150|66643144|FG000|Overall Study|Protocol Violation|1|||
23799961|NCT01957150|66643145|FG001|Overall Study|Protocol Violation|0|||
23799962|NCT01957150|66643144|FG000|Overall Study|Lack of Efficacy|11|||
23799963|NCT01957150|66643145|FG001|Overall Study|Lack of Efficacy|11|||
23799964|NCT00808509|66643146|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
23477236|NCT00329901|65491526|FG000|Overall Study|Withdrawal by Subject|4|||
23477237|NCT00329901|65491527|FG001|Overall Study|Withdrawal by Subject|3|||
23477238|NCT00329901|65491528|FG002|Overall Study|Withdrawal by Subject|2|||
23799965|NCT00808509|66643147|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
23477239|NCT00329901|65491526|FG000|Overall Study|Lost to Follow-up|2|||
23477240|NCT00329901|65491527|FG001|Overall Study|Lost to Follow-up|0|||
23477241|NCT00329901|65491528|FG002|Overall Study|Lost to Follow-up|1|||
23477242|NCT00329901|65491526|FG000|Overall Study|Protocol Violation|1|||
23477243|NCT00329901|65491527|FG001|Overall Study|Protocol Violation|0|||
23593312|NCT03383146|65903055|FG001|Overall Study|Lack of Efficacy|3|||
23593313|NCT03383146|65903054|FG000|Overall Study|Withdrawal by Subject|20|||
23593314|NCT03383146|65903055|FG001|Overall Study|Withdrawal by Subject|36|||
23593315|NCT03383146|65903054|FG000|Overall Study|Lost to Follow-up|5|||
23593316|NCT03383146|65903055|FG001|Overall Study|Lost to Follow-up|15|||
23593317|NCT03383146|65903054|FG000|Overall Study|Death|0|||
23593318|NCT03383146|65903055|FG001|Overall Study|Death|2|||
23593319|NCT03383146|65903054|FG000|Overall Study|Physician Decision|0|||
23593320|NCT03383146|65903055|FG001|Overall Study|Physician Decision|1|||
23593321|NCT03383146|65903054|FG000|Overall Study|Protocol Deviation|1|||
23593322|NCT03383146|65903055|FG001|Overall Study|Protocol Deviation|8|||
23593323|NCT03383146|65903054|FG000|Overall Study|Study Terminated by the Sponsor|48|||
23593324|NCT03383146|65903055|FG001|Overall Study|Study Terminated by the Sponsor|95|||
23593325|NCT03383146|65903054|FG000|Overall Study|Reason not Specified|4|||
23593326|NCT03383146|65903055|FG001|Overall Study|Reason not Specified|6|||
23593327|NCT01376089|65903056|FG000|Overall Study|Patient received no contrast media|3|||
23593328|NCT01376089|65903057|FG001|Overall Study|Patient received no contrast media|4|||
23644217|NCT00296400|66082619|FG001|Overall Study|Lost to Follow-up|1|||
23644218|NCT00296400|66082620|FG002|Overall Study|Lost to Follow-up|2|||
23644219|NCT00296400|66082618|FG000|Overall Study|Study specific discontinuation criteria|0|||
23644220|NCT00296400|66082619|FG001|Overall Study|Study specific discontinuation criteria|0|||
23644221|NCT00296400|66082620|FG002|Overall Study|Study specific discontinuation criteria|1|||
23644222|NCT00296400|66082618|FG000|Overall Study|Visit 10 was performed earlier|0|||
23644223|NCT00296400|66082619|FG001|Overall Study|Visit 10 was performed earlier|1|||
23644224|NCT00296400|66082620|FG002|Overall Study|Visit 10 was performed earlier|0|||
23644225|NCT00296400|66082618|FG000|Overall Study|Pregnancy|1|||
23644226|NCT00296400|66082619|FG001|Overall Study|Pregnancy|2|||
23644227|NCT00296400|66082620|FG002|Overall Study|Pregnancy|0|||
23644228|NCT01880528|66082625|FG000|Overall Study|Other|1|||
23644229|NCT01880528|66082626|FG001|Overall Study|Other|1|||
23644230|NCT01642251|66082628|FG000|Overall Study|Progressive disease|0|||
23644231|NCT01642251|66082629|FG001|Overall Study|Progressive disease|0|||
23644232|NCT01642251|66082630|FG002|Overall Study|Progressive disease|3|||
23644233|NCT01642251|66082631|FG003|Overall Study|Progressive disease|3|||
23644234|NCT01642251|66082628|FG000|Overall Study|Adverse Event|0|||
23644235|NCT01642251|66082629|FG001|Overall Study|Adverse Event|0|||
23799966|NCT00808509|66643146|FG000|Randomized Phase|Reduced methotrexate dose|1|||
23799967|NCT00808509|66643147|FG001|Randomized Phase|Reduced methotrexate dose|2|||
23799968|NCT00808509|66643146|FG000|Randomized Phase|Patient refused rescue therapy|0|||
23799969|NCT00808509|66643147|FG001|Randomized Phase|Patient refused rescue therapy|3|||
23799970|NCT02788513|66643150|FG000|Overall Study|Withdrawal by Subject|3|||
23799971|NCT02788513|66643151|FG001|Overall Study|Withdrawal by Subject|0|||
23799972|NCT02788513|66643152|FG002|Overall Study|Withdrawal by Subject|2|||
23799973|NCT02788513|66643153|FG003|Overall Study|Withdrawal by Subject|3|||
23799974|NCT02788513|66643154|FG004|Overall Study|Withdrawal by Subject|1|||
23799975|NCT02788513|66643150|FG000|Overall Study|Lost to Follow-up|1|||
23799976|NCT02788513|66643151|FG001|Overall Study|Lost to Follow-up|0|||
23799977|NCT02788513|66643152|FG002|Overall Study|Lost to Follow-up|0|||
23477244|NCT00329901|65491528|FG002|Overall Study|Protocol Violation|1|||
23477245|NCT00329901|65491526|FG000|Overall Study|Unable to classify|2|||
23477246|NCT00329901|65491527|FG001|Overall Study|Unable to classify|2|||
23477247|NCT00329901|65491528|FG002|Overall Study|Unable to classify|0|||
23477248|NCT01193257|65491531|FG000|Overall Study|Death|202|||
23477249|NCT01193257|65491532|FG001|Overall Study|Death|391|||
23477250|NCT01193257|65491531|FG000|Overall Study|Study termination by sponsor|0|||
23593329|NCT02886286|65903058|FG000|Overall Study|pump motor stall|0|||
23799978|NCT02788513|66643153|FG003|Overall Study|Lost to Follow-up|0|||
23799979|NCT02788513|66643154|FG004|Overall Study|Lost to Follow-up|1|||
23799980|NCT02788513|66643150|FG000|Overall Study|Adverse Event|5|||
23799981|NCT02788513|66643151|FG001|Overall Study|Adverse Event|8|||
23799982|NCT02788513|66643152|FG002|Overall Study|Adverse Event|4|||
23799983|NCT02788513|66643153|FG003|Overall Study|Adverse Event|2|||
23799984|NCT02788513|66643154|FG004|Overall Study|Adverse Event|2|||
23799985|NCT02788513|66643150|FG000|Overall Study|Protocol Violation|0|||
23799986|NCT02788513|66643151|FG001|Overall Study|Protocol Violation|0|||
23799987|NCT02788513|66643152|FG002|Overall Study|Protocol Violation|1|||
23799988|NCT02788513|66643153|FG003|Overall Study|Protocol Violation|1|||
23477251|NCT01193257|65491532|FG001|Overall Study|Study termination by sponsor|3|||
23477252|NCT01193257|65491531|FG000|Overall Study|Withdrawal by Subject|26|||
23593330|NCT02886286|65903059|FG001|Overall Study|pump motor stall|1|||
23593331|NCT02685488|65903060|FG000|Overall Study|Withdrawal by Subject|0|||
23593332|NCT02685488|65903061|FG001|Overall Study|Withdrawal by Subject|1|||
23644236|NCT01642251|66082630|FG002|Overall Study|Adverse Event|5|||
23644237|NCT01642251|66082631|FG003|Overall Study|Adverse Event|4|||
23593333|NCT01070069|65903064|FG000|Overall Study|Death|1|||
23644238|NCT01642251|66082628|FG000|Overall Study|Death|0|||
23644239|NCT01642251|66082629|FG001|Overall Study|Death|0|||
23593334|NCT01070069|65903065|FG001|Overall Study|Death|0|||
23477253|NCT01193257|65491532|FG001|Overall Study|Withdrawal by Subject|86|||
23477254|NCT01193257|65491531|FG000|Overall Study|Lost to Follow-up|2|||
23477255|NCT01193257|65491532|FG001|Overall Study|Lost to Follow-up|3|||
23477256|NCT01193257|65491531|FG000|Overall Study|Unblinded due to futility|135|||
23477257|NCT01193257|65491532|FG001|Overall Study|Unblinded due to futility|251|||
23477258|NCT01945710|65491533|FG000|Overall Study|Progressive Disease|5|||
23477259|NCT01945710|65491534|FG001|Overall Study|Progressive Disease|4|||
23477260|NCT01945710|65491535|FG002|Overall Study|Progressive Disease|3|||
23477261|NCT01945710|65491536|FG003|Overall Study|Progressive Disease|2|||
23477262|NCT01945710|65491537|FG004|Overall Study|Progressive Disease|7|||
23477263|NCT01945710|65491538|FG005|Overall Study|Progressive Disease|3|||
23477264|NCT01945710|65491539|FG006|Overall Study|Progressive Disease|19|||
23477265|NCT01945710|65491533|FG000|Overall Study|Adverse Event|0|||
23477266|NCT01945710|65491534|FG001|Overall Study|Adverse Event|1|||
23477267|NCT01945710|65491535|FG002|Overall Study|Adverse Event|0|||
23477268|NCT01945710|65491536|FG003|Overall Study|Adverse Event|0|||
23477269|NCT01945710|65491537|FG004|Overall Study|Adverse Event|0|||
23477270|NCT01945710|65491538|FG005|Overall Study|Adverse Event|0|||
23477271|NCT01945710|65491539|FG006|Overall Study|Adverse Event|0|||
23477272|NCT01945710|65491533|FG000|Overall Study|Other|2|||
23477273|NCT01945710|65491534|FG001|Overall Study|Other|0|||
23477274|NCT01945710|65491535|FG002|Overall Study|Other|3|||
23477275|NCT01945710|65491536|FG003|Overall Study|Other|1|||
23477276|NCT01945710|65491537|FG004|Overall Study|Other|1|||
23477277|NCT01945710|65491538|FG005|Overall Study|Other|0|||
23477278|NCT01945710|65491539|FG006|Overall Study|Other|4|||
23477279|NCT01945710|65491533|FG000|Overall Study|Withdrawal by Subject|0|||
23477280|NCT01945710|65491534|FG001|Overall Study|Withdrawal by Subject|1|||
23477281|NCT01945710|65491535|FG002|Overall Study|Withdrawal by Subject|1|||
23477282|NCT01945710|65491536|FG003|Overall Study|Withdrawal by Subject|0|||
23477283|NCT01945710|65491537|FG004|Overall Study|Withdrawal by Subject|1|||
23477284|NCT01945710|65491538|FG005|Overall Study|Withdrawal by Subject|0|||
23477285|NCT01945710|65491539|FG006|Overall Study|Withdrawal by Subject|0|||
23477286|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
23477287|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
23477288|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
23477289|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
23477290|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
23477291|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
23477292|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
23477293|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
23477294|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
23477295|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
23477296|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
23477297|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
23477298|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
23477299|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
23477300|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
23477301|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
23477302|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
23477303|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
23477304|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
23477305|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
23477306|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
23477307|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
23477308|NCT03387111|65491549|FG000|Overall Study|Progressive Disease|3|||
23477309|NCT03387111|65491549|FG000|Overall Study|Other|1|||
23477310|NCT01700387|65491557|FG000|Overall Study|Withdrawal by Subject|1|||
23477311|NCT01700387|65491558|FG001|Overall Study|Withdrawal by Subject|2|||
23644240|NCT01642251|66082630|FG002|Overall Study|Death|1|||
23644241|NCT01642251|66082631|FG003|Overall Study|Death|3|||
23477312|NCT01700387|65491557|FG000|Overall Study|Adverse Event|1|||
23477313|NCT01700387|65491558|FG001|Overall Study|Adverse Event|1|||
23477314|NCT01700387|65491557|FG000|Overall Study|Lost to Follow-up|2|||
23477315|NCT01700387|65491558|FG001|Overall Study|Lost to Follow-up|1|||
23477316|NCT00796445|65491563|FG000|Overall Study|Protocol Violation|5|||
23477317|NCT00796445|65491564|FG001|Overall Study|Protocol Violation|3|||
23477318|NCT00796445|65491563|FG000|Overall Study|Adverse event, serious fatal|10|||
23477319|NCT00796445|65491564|FG001|Overall Study|Adverse event, serious fatal|5|||
23477320|NCT00796445|65491563|FG000|Overall Study|Adverse event, non-fatal|4|||
23477321|NCT00796445|65491564|FG001|Overall Study|Adverse event, non-fatal|0|||
23477322|NCT00796445|65491563|FG000|Overall Study|Disease progression/recurrence|537|||
23799989|NCT02788513|66643154|FG004|Overall Study|Protocol Violation|0|||
23799990|NCT02788513|66643150|FG000|Overall Study|Subject decided to stop taking treatment|0|||
23593335|NCT01070069|65903066|FG002|Overall Study|Death|2|||
23593336|NCT01070069|65903067|FG003|Overall Study|Death|0|||
23593337|NCT01070069|65903068|FG004|Overall Study|Death|1|||
23593338|NCT01070069|65903064|FG000|Overall Study|Withdrawal by Subject|1|||
23593339|NCT01070069|65903065|FG001|Overall Study|Withdrawal by Subject|1|||
23593340|NCT01070069|65903066|FG002|Overall Study|Withdrawal by Subject|4|||
23593341|NCT01070069|65903067|FG003|Overall Study|Withdrawal by Subject|0|||
23593342|NCT01070069|65903068|FG004|Overall Study|Withdrawal by Subject|0|||
23593343|NCT01070069|65903064|FG000|Overall Study|Lost to Follow-up|4|||
23593344|NCT01070069|65903065|FG001|Overall Study|Lost to Follow-up|1|||
23593345|NCT01070069|65903066|FG002|Overall Study|Lost to Follow-up|0|||
23593346|NCT01070069|65903067|FG003|Overall Study|Lost to Follow-up|0|||
23593347|NCT01070069|65903068|FG004|Overall Study|Lost to Follow-up|3|||
23593348|NCT02115139|65903069|FG000|Overall Study|Protocol Violation|1|||
23593349|NCT02115139|65903069|FG000|Overall Study|treatment discontinuation|6|||
23593350|NCT00393848|65903070|FG000|Overall Study|Surgical schedule|0|||
23593351|NCT00393848|65903071|FG001|Overall Study|Surgical schedule|0|||
23593352|NCT00393848|65903072|FG002|Overall Study|Surgical schedule|0|||
23593353|NCT00393848|65903073|FG003|Overall Study|Surgical schedule|1|||
23644242|NCT01642251|66082628|FG000|Overall Study|Withdrawal by Subject|0|||
23644243|NCT01642251|66082629|FG001|Overall Study|Withdrawal by Subject|0|||
23644244|NCT01642251|66082630|FG002|Overall Study|Withdrawal by Subject|1|||
23644245|NCT01642251|66082631|FG003|Overall Study|Withdrawal by Subject|3|||
23644246|NCT01642251|66082628|FG000|Overall Study|Alternative therapy|0|||
23644247|NCT01642251|66082629|FG001|Overall Study|Alternative therapy|0|||
23360192|NCT00656175|65062850|FG000|Overall Study|Adverse Event|1|||
23360193|NCT00656175|65062851|FG001|Overall Study|Adverse Event|0|||
23593354|NCT00393848|65903070|FG000|Overall Study|Personal reasons|0|||
23593355|NCT00393848|65903071|FG001|Overall Study|Personal reasons|0|||
23644248|NCT01642251|66082630|FG002|Overall Study|Alternative therapy|0|||
23644249|NCT01642251|66082631|FG003|Overall Study|Alternative therapy|2|||
23644250|NCT01642251|66082628|FG000|Overall Study|Other complicating disease|0|||
23644251|NCT01642251|66082629|FG001|Overall Study|Other complicating disease|0|||
23644252|NCT01642251|66082630|FG002|Overall Study|Other complicating disease|1|||
23644253|NCT01642251|66082631|FG003|Overall Study|Other complicating disease|0|||
23644254|NCT01642251|66082628|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
23644255|NCT01642251|66082629|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
23644256|NCT01642251|66082630|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
23644257|NCT01642251|66082631|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
23644258|NCT04075994|66082637|FG000|Overall Study|Withdrawal by Subject|8|||
23644259|NCT04075994|66082638|FG001|Overall Study|Withdrawal by Subject|9|||
23644260|NCT04075994|66082637|FG000|Overall Study|Adverse Event|2|||
23644261|NCT04075994|66082638|FG001|Overall Study|Adverse Event|2|||
23644262|NCT04075994|66082637|FG000|Overall Study|Investigator withdrew|3|||
23799991|NCT02788513|66643151|FG001|Overall Study|Subject decided to stop taking treatment|0|||
23799992|NCT02788513|66643152|FG002|Overall Study|Subject decided to stop taking treatment|1|||
23644263|NCT04075994|66082638|FG001|Overall Study|Investigator withdrew|1|||
23644264|NCT04343872|66082639|FG000|Overall Study|Lost to Follow-up|6|||
23593356|NCT00393848|65903072|FG002|Overall Study|Personal reasons|2|||
23644265|NCT04343872|66082640|FG001|Overall Study|Lost to Follow-up|3|||
23644266|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
23799993|NCT02788513|66643153|FG003|Overall Study|Subject decided to stop taking treatment|0|||
23360194|NCT00656175|65062850|FG000|Overall Study|Transportation issues|0|||
23360195|NCT00656175|65062851|FG001|Overall Study|Transportation issues|1|||
23593357|NCT00393848|65903073|FG003|Overall Study|Personal reasons|0|||
23593358|NCT04218266|65903074|FG000|Overall Study|Death|1|||
23593359|NCT04218266|65903075|FG001|Overall Study|Death|2|||
23593360|NCT04218266|65903076|FG002|Overall Study|Death|3|||
23477323|NCT00796445|65491564|FG001|Overall Study|Disease progression/recurrence|268|||
23477324|NCT00796445|65491563|FG000|Overall Study|Other|10|||
23477325|NCT00796445|65491564|FG001|Overall Study|Other|7|||
23477326|NCT00796445|65491563|FG000|Overall Study|Withdrawal by Subject|18|||
23477327|NCT00796445|65491564|FG001|Overall Study|Withdrawal by Subject|9|||
23477328|NCT00796445|65491563|FG000|Overall Study|Invalid Informed Consent Form|1|||
23477329|NCT00796445|65491564|FG001|Overall Study|Invalid Informed Consent Form|0|||
23477330|NCT02208063|65491565|FG000|Overall Study|Death|3|||
23477331|NCT02208063|65491566|FG001|Overall Study|Death|5|||
23477332|NCT02208063|65491565|FG000|Overall Study|Not Specified in report|3|||
23477333|NCT02208063|65491566|FG001|Overall Study|Not Specified in report|4|||
23477334|NCT02208063|65491565|FG000|Overall Study|Withdrawal by Subject|5|||
23477335|NCT02208063|65491566|FG001|Overall Study|Withdrawal by Subject|2|||
23477336|NCT02208063|65491565|FG000|Overall Study|Lost to Follow-up|1|||
23477337|NCT02208063|65491566|FG001|Overall Study|Lost to Follow-up|0|||
23477338|NCT00883688|65491570|FG000|Overall Study|Ineligible|2|||
23477339|NCT02122783|65491571|FG000|Overall Study|Adverse Event|0|||
23477340|NCT02122783|65491572|FG001|Overall Study|Adverse Event|1|||
23477341|NCT01022398|65491573|FG000|Overall Study|Study terminated|2|||
23477342|NCT01022398|65491574|FG001|Overall Study|Study terminated|2|||
23477343|NCT01101308|65491577|FG000|Period 1|Adverse Event|2|||
23477344|NCT01101308|65491578|FG001|Period 1|Adverse Event|1|||
23477345|NCT01101308|65491577|FG000|Period 1|Positive for cotinine|1|||
23477346|NCT01101308|65491578|FG001|Period 1|Positive for cotinine|0|||
23477347|NCT01369329|65491580|FG000|Overall Study|Withdrawal by Subject|8|||
23477348|NCT01369329|65491581|FG001|Overall Study|Withdrawal by Subject|6|||
23477349|NCT01369329|65491582|FG002|Overall Study|Withdrawal by Subject|10|||
23477350|NCT01369329|65491580|FG000|Overall Study|Lost to Follow-up|2|||
23477351|NCT01369329|65491581|FG001|Overall Study|Lost to Follow-up|2|||
23477352|NCT01369329|65491582|FG002|Overall Study|Lost to Follow-up|2|||
23477353|NCT01369329|65491580|FG000|Overall Study|Other|2|||
23477354|NCT01369329|65491581|FG001|Overall Study|Other|3|||
23477355|NCT01369329|65491582|FG002|Overall Study|Other|2|||
23477356|NCT00725842|65491583|FG000|Overall Study|Lost to Follow-up|19|||
23477357|NCT00725842|65491583|FG000|Overall Study|Death|1|||
23477358|NCT00725842|65491583|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
23477359|NCT00725842|65491583|FG000|Overall Study|Consent date prior to study start date|5|||
23477360|NCT00725842|65491583|FG000|Overall Study|Inclusion criterion not met|1|||
23477361|NCT00725842|65491583|FG000|Overall Study|No Visit 1 data|1|||
23477362|NCT03032380|65491584|FG000|Overall Study|Adverse Event|0|||
23477363|NCT03032380|65491585|FG001|Overall Study|Adverse Event|1|||
23477364|NCT03032380|65491584|FG000|Overall Study|Lack of Efficacy|1|||
23477365|NCT03032380|65491585|FG001|Overall Study|Lack of Efficacy|0|||
23477366|NCT03032380|65491584|FG000|Overall Study|Withdrawal by Subject|2|||
23477367|NCT03032380|65491585|FG001|Overall Study|Withdrawal by Subject|3|||
23477368|NCT03032380|65491584|FG000|Overall Study|Recovery|0|||
23477369|NCT03032380|65491585|FG001|Overall Study|Recovery|1|||
23477370|NCT03032380|65491584|FG000|Overall Study|Death|39|||
23477371|NCT03032380|65491585|FG001|Overall Study|Death|34|||
23477372|NCT03032380|65491584|FG000|Overall Study|Other - Miscellaneous|0|||
23477373|NCT03032380|65491585|FG001|Overall Study|Other - Miscellaneous|1|||
23477374|NCT00798759|65491586|FG000|Overall Study|Adverse Event|3|||
23477375|NCT00798759|65491587|FG001|Overall Study|Adverse Event|3|||
23477376|NCT00798759|65491586|FG000|Overall Study|Lost to Follow-up|1|||
23477377|NCT00798759|65491587|FG001|Overall Study|Lost to Follow-up|1|||
23477378|NCT00798759|65491586|FG000|Overall Study|Protocol Violation|4|||
23477379|NCT00798759|65491587|FG001|Overall Study|Protocol Violation|8|||
23477380|NCT00798759|65491586|FG000|Overall Study|Other|0|||
23477381|NCT00798759|65491587|FG001|Overall Study|Other|1|||
23477382|NCT01463007|65491588|FG000|Overall Study|Physician Decision|1|||
23477383|NCT00792571|65491589|FG000|Overall Study|Death|1|||
23477384|NCT00792571|65491589|FG000|Overall Study|Adverse Event|4|||
23477385|NCT00792571|65491589|FG000|Overall Study|Withdrawal by Subject|1|||
23477386|NCT00792571|65491589|FG000|Overall Study|Other|4|||
23477387|NCT01870076|65491590|FG000|Overall Study|Withdrawal by Subject|1|||
23477388|NCT01870076|65491591|FG001|Overall Study|Withdrawal by Subject|0|||
23477389|NCT01870076|65491592|FG002|Overall Study|Withdrawal by Subject|1|||
23477390|NCT01870076|65491593|FG003|Overall Study|Withdrawal by Subject|0|||
23477391|NCT00436501|65491594|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
23477392|NCT00436501|65491595|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
23477393|NCT00436501|65491594|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
23593361|NCT04218266|65903074|FG000|Overall Study|Adverse Event|13|||
23593362|NCT04218266|65903075|FG001|Overall Study|Adverse Event|14|||
23477394|NCT00436501|65491595|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
23477395|NCT00606905|65491596|FG000|Overall Study|No Pregnancy|9|||
23477396|NCT00606905|65491597|FG001|Overall Study|No Pregnancy|6|||
23477397|NCT00606905|65491596|FG000|Overall Study|Non-Index Pregnancy|1|||
23477398|NCT00606905|65491597|FG001|Overall Study|Non-Index Pregnancy|4|||
23477399|NCT00606905|65491596|FG000|Overall Study|Withdrew|5|||
23593363|NCT04218266|65903076|FG002|Overall Study|Adverse Event|11|||
23644267|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
23644268|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
23644269|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
23644270|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
23644271|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
23644272|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
23644273|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
23644274|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
23644275|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
23644276|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
23644277|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
23644278|NCT04493502|66082641|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
23644279|NCT04493502|66082642|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
23644280|NCT04493502|66082641|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
23644281|NCT04493502|66082642|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
23644282|NCT04493502|66082641|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
23644283|NCT04493502|66082642|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
23644284|NCT04493502|66082641|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
23644285|NCT04493502|66082642|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
23644286|NCT04493502|66082641|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
23644287|NCT04493502|66082642|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
23644288|NCT04493502|66082641|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
23644289|NCT04493502|66082642|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
23644290|NCT04493502|66082641|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
23644291|NCT04493502|66082642|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
23644292|NCT01146782|66082643|FG000|Screening Cohort|Screen Failure|187|||
23644293|NCT01146782|66082643|FG000|Screening Cohort|Lost to Follow-up|4|||
23644294|NCT01146782|66082643|FG000|Screening Cohort|Physician Decision|1|||
23644295|NCT01146782|66082643|FG000|Screening Cohort|Withdrawal by Subject|29|||
23644296|NCT01146782|66082643|FG000|Safety Cohort|Screen Failure|61|||
23644297|NCT01146782|66082643|FG000|Safety Cohort|Withdrawal by Subject|4|||
23644298|NCT01146782|66082643|FG000|Safety Cohort|Control AHI <5|4|||
23644299|NCT01146782|66082643|FG000|Safety Cohort|TST <4 hrs|14|||
23644300|NCT01146782|66082643|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
23644301|NCT01146782|66082643|FG000|Primary Endpoint Cohort|Physician Decision|1|||
23644302|NCT05086276|66082646|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
23644303|NCT05086276|66082647|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
23644304|NCT03207009|66082648|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
23644305|NCT01009580|66082649|FG000|Overall Study|Adverse Event|4|||
23644306|NCT01009580|66082650|FG001|Overall Study|Adverse Event|4|||
23644307|NCT01009580|66082649|FG000|Overall Study|Lack of Efficacy|0|||
23644308|NCT01009580|66082650|FG001|Overall Study|Lack of Efficacy|1|||
23644309|NCT01009580|66082649|FG000|Overall Study|Protocol Violation|2|||
23644310|NCT01009580|66082650|FG001|Overall Study|Protocol Violation|3|||
23644311|NCT01009580|66082649|FG000|Overall Study|Withdrawal Criteria|4|||
23644312|NCT01009580|66082650|FG001|Overall Study|Withdrawal Criteria|6|||
23644313|NCT01009580|66082649|FG000|Overall Study|Unclassified|17|||
23644314|NCT01009580|66082650|FG001|Overall Study|Unclassified|21|||
23644315|NCT01323647|66082651|FG000|Overall Study|Migrated/moved from study area|2|||
23644316|NCT01323647|66082652|FG001|Overall Study|Migrated/moved from study area|0|||
23644317|NCT01323647|66082651|FG000|Overall Study|Withdrawal by Subject|5|||
23644318|NCT01323647|66082652|FG001|Overall Study|Withdrawal by Subject|0|||
23644319|NCT01323647|66082651|FG000|Overall Study|Lost to Follow-up|2|||
23644320|NCT01323647|66082652|FG001|Overall Study|Lost to Follow-up|0|||
23644321|NCT01474434|66082653|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
23644322|NCT01474434|66082654|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
23644323|NCT01474434|66082655|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
23644324|NCT01474434|66082656|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
23644325|NCT01474434|66082653|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23644326|NCT01474434|66082654|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23644327|NCT01474434|66082655|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23644328|NCT01474434|66082656|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
23644329|NCT01474434|66082653|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
23799994|NCT02788513|66643154|FG004|Overall Study|Subject decided to stop taking treatment|0|||
23799995|NCT02788513|66643150|FG000|Overall Study|Decision by the study team|0|||
23644330|NCT01474434|66082654|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23799996|NCT02788513|66643151|FG001|Overall Study|Decision by the study team|0|||
23644331|NCT01474434|66082655|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23644332|NCT01474434|66082656|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23644333|NCT00446992|66082657|FG000|Overall Study|Adverse Event|11|||
23644334|NCT00446992|66082657|FG000|Overall Study|Lost to Follow-up|5|||
23644335|NCT03981861|66082658|FG000|Overall Study|Withdrawal by Subject|3|||
23644336|NCT01676909|66082659|FG000|Overall Study|Withdrawal by Subject|3|||
23644337|NCT01676909|66082660|FG001|Overall Study|Withdrawal by Subject|5|||
23644338|NCT01676909|66082659|FG000|Overall Study|Lost to Follow-up|15|||
23644339|NCT01676909|66082660|FG001|Overall Study|Lost to Follow-up|9|||
23644340|NCT01198756|66082661|FG000|Overall Study|Adverse Event|0|||
23644341|NCT01198756|66082662|FG001|Overall Study|Adverse Event|0|||
23644342|NCT01198756|66082663|FG002|Overall Study|Adverse Event|0|||
23644343|NCT01198756|66082664|FG003|Overall Study|Adverse Event|1|||
23644344|NCT01198756|66082661|FG000|Overall Study|Protocol Violation|0|||
23644345|NCT01198756|66082662|FG001|Overall Study|Protocol Violation|0|||
23644346|NCT01198756|66082663|FG002|Overall Study|Protocol Violation|0|||
23644347|NCT01198756|66082664|FG003|Overall Study|Protocol Violation|2|||
23644348|NCT01198756|66082661|FG000|Overall Study|Withdrawal by Subject|9|||
23644349|NCT01198756|66082662|FG001|Overall Study|Withdrawal by Subject|4|||
23644350|NCT01198756|66082663|FG002|Overall Study|Withdrawal by Subject|7|||
23644351|NCT01198756|66082664|FG003|Overall Study|Withdrawal by Subject|5|||
23644352|NCT01198756|66082661|FG000|Overall Study|Lost to Follow-up|29|||
23644353|NCT01198756|66082662|FG001|Overall Study|Lost to Follow-up|36|||
23644354|NCT01198756|66082663|FG002|Overall Study|Lost to Follow-up|23|||
23644355|NCT01198756|66082664|FG003|Overall Study|Lost to Follow-up|18|||
23644356|NCT01815138|66082666|FG000|Overall Study|Withdrawal by Subject|0|||
23644357|NCT01815138|66082667|FG001|Overall Study|Withdrawal by Subject|1|||
23644358|NCT01815138|66082666|FG000|Overall Study|Physician Decision|8|||
23644359|NCT01815138|66082667|FG001|Overall Study|Physician Decision|5|||
23644360|NCT02884908|66082668|FG000|Overall Study|Lost to Follow-up|13|||
23644361|NCT02884908|66082669|FG001|Overall Study|Lost to Follow-up|18|||
23644362|NCT01774487|66082670|FG000|Overall Study|Did not tolerate taste|4|||
23644363|NCT01774487|66082671|FG001|Overall Study|Did not tolerate taste|4|||
23644364|NCT03625895|66082672|FG000|Overall Study|Protocol Violation|585|||
23644365|NCT00194987|66082678|FG000|Overall Study|Withdrawal by Subject|0|||
23644366|NCT00194987|66082679|FG001|Overall Study|Withdrawal by Subject|3|||
23644367|NCT00574873|66082680|FG000|Overall Study|Withdrawal by Subject|18|||
23644368|NCT00574873|66082681|FG001|Overall Study|Withdrawal by Subject|19|||
23644369|NCT00574873|66082680|FG000|Overall Study|Investigator request|18|||
23644370|NCT00574873|66082681|FG001|Overall Study|Investigator request|8|||
23644371|NCT00574873|66082680|FG000|Overall Study|Death|15|||
23644372|NCT00574873|66082681|FG001|Overall Study|Death|14|||
23644373|NCT00574873|66082680|FG000|Overall Study|Lost to Follow-up|14|||
23644374|NCT00574873|66082681|FG001|Overall Study|Lost to Follow-up|5|||
23644375|NCT00574873|66082680|FG000|Overall Study|Other|40|||
23644376|NCT00574873|66082681|FG001|Overall Study|Other|4|||
23799997|NCT02788513|66643152|FG002|Overall Study|Decision by the study team|0|||
23799998|NCT02788513|66643153|FG003|Overall Study|Decision by the study team|0|||
23799999|NCT02788513|66643154|FG004|Overall Study|Decision by the study team|1|||
23800000|NCT03546647|66643157|FG000|Overall Study|Adverse Event|1|||
23800001|NCT03546647|66643158|FG001|Overall Study|Adverse Event|0|||
23593364|NCT04218266|65903074|FG000|Overall Study|Other|7|||
23593365|NCT04218266|65903075|FG001|Overall Study|Other|5|||
23593366|NCT04218266|65903076|FG002|Overall Study|Other|14|||
23593367|NCT04218266|65903074|FG000|Overall Study|Physician Decision|1|||
23593368|NCT04218266|65903075|FG001|Overall Study|Physician Decision|3|||
23593369|NCT04218266|65903076|FG002|Overall Study|Physician Decision|2|||
23593370|NCT04218266|65903074|FG000|Overall Study|Non-compliance with study drug|0|||
23593371|NCT04218266|65903075|FG001|Overall Study|Non-compliance with study drug|0|||
23593372|NCT04218266|65903076|FG002|Overall Study|Non-compliance with study drug|1|||
23593373|NCT04218266|65903074|FG000|Overall Study|Withdrawal by Subject|1|||
23800002|NCT04287868|66643159|FG000|Overall Study|Screening fail|1|||
23593374|NCT04218266|65903075|FG001|Overall Study|Withdrawal by Subject|3|||
23593375|NCT04218266|65903076|FG002|Overall Study|Withdrawal by Subject|1|||
23593376|NCT04218266|65903074|FG000|Overall Study|Study drug never administered|2|||
23593377|NCT04218266|65903075|FG001|Overall Study|Study drug never administered|0|||
23644377|NCT00574873|66082680|FG000|Overall Study|Discontinuation of study by sponsor|5|||
23644378|NCT00574873|66082681|FG001|Overall Study|Discontinuation of study by sponsor|199|||
23644379|NCT00574873|66082680|FG000|Overall Study|Blank, site closed per local regulations|2|||
23593378|NCT04218266|65903076|FG002|Overall Study|Study drug never administered|0|||
23644380|NCT00574873|66082681|FG001|Overall Study|Blank, site closed per local regulations|2|||
23644381|NCT00574873|66082680|FG000|Overall Study|Extension Study|126|||
23644382|NCT00574873|66082681|FG001|Overall Study|Extension Study|0|||
23644383|NCT05330312|66082682|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
23644384|NCT05330312|66082683|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
23644385|NCT05330312|66082684|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
23644386|NCT05330312|66082682|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
23644387|NCT05330312|66082683|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
23800003|NCT04287868|66643160|FG001|Overall Study|Screening fail|0|||
23800004|NCT02000531|66643161|FG000|Overall Study|Lost to Follow-up|1|||
23477400|NCT00606905|65491597|FG001|Overall Study|Withdrew|5|||
23477401|NCT01049009|65491598|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23477402|NCT01049009|65491599|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23477403|NCT01049009|65491598|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23477404|NCT01049009|65491599|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23477405|NCT01049009|65491598|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
23477406|NCT01049009|65491599|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
23477407|NCT01049009|65491598|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
23477408|NCT01049009|65491599|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
23477409|NCT01444092|65491600|FG000|Overall Study|Adverse Event|8|||
23477410|NCT01444092|65491600|FG000|Overall Study|Protocol Violation|1|||
23477411|NCT01444092|65491600|FG000|Overall Study|Withdrawal by Subject|1|||
23477412|NCT01444092|65491600|FG000|Overall Study|Other Eligibility criteria|7|||
23477413|NCT03412565|65491601|FG000|Overall Study|Lost to Follow-up|0|||
23477414|NCT03412565|65491602|FG001|Overall Study|Lost to Follow-up|0|||
23477415|NCT03412565|65491603|FG002|Overall Study|Lost to Follow-up|1|||
23477416|NCT03412565|65491604|FG003|Overall Study|Lost to Follow-up|0|||
23477417|NCT03412565|65491601|FG000|Overall Study|Physician Decision|0|||
23477418|NCT03412565|65491602|FG001|Overall Study|Physician Decision|0|||
23477419|NCT03412565|65491603|FG002|Overall Study|Physician Decision|0|||
23477420|NCT03412565|65491604|FG003|Overall Study|Physician Decision|1|||
23477421|NCT03412565|65491601|FG000|Overall Study|Withdrawal by Subject|0|||
23477422|NCT03412565|65491602|FG001|Overall Study|Withdrawal by Subject|4|||
23477423|NCT03412565|65491603|FG002|Overall Study|Withdrawal by Subject|5|||
23477424|NCT03412565|65491604|FG003|Overall Study|Withdrawal by Subject|5|||
23477425|NCT03412565|65491601|FG000|Overall Study|Death|1|||
23477426|NCT03412565|65491602|FG001|Overall Study|Death|3|||
23477427|NCT03412565|65491603|FG002|Overall Study|Death|4|||
23477428|NCT03412565|65491604|FG003|Overall Study|Death|5|||
23477429|NCT03412565|65491601|FG000|Overall Study|Data collection ended|0|||
23477430|NCT03412565|65491602|FG001|Overall Study|Data collection ended|41|||
23477431|NCT03412565|65491603|FG002|Overall Study|Data collection ended|41|||
23477432|NCT03412565|65491604|FG003|Overall Study|Data collection ended|40|||
23477433|NCT01578850|65491607|FG000|Period 1|Insufficient Clinical Response|1|||
23477434|NCT01578850|65491608|FG001|Period 1|Insufficient Clinical Response|0|||
23477435|NCT01578850|65491609|FG002|Period 1|Insufficient Clinical Response|0|||
23477436|NCT01578850|65491607|FG000|Period 1|Adverse Event|11|||
23477437|NCT01578850|65491608|FG001|Period 1|Adverse Event|0|||
23477438|NCT01578850|65491609|FG002|Period 1|Adverse Event|0|||
23477439|NCT01578850|65491607|FG000|Period 1|Death|1|||
23477440|NCT01578850|65491608|FG001|Period 1|Death|0|||
23477441|NCT01578850|65491609|FG002|Period 1|Death|0|||
23477442|NCT01578850|65491607|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
23477443|NCT01578850|65491608|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
23477444|NCT01578850|65491609|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
23477445|NCT01578850|65491607|FG000|Period 1|Withdrawal by Subject|9|||
23477446|NCT01578850|65491608|FG001|Period 1|Withdrawal by Subject|0|||
23477447|NCT01578850|65491609|FG002|Period 1|Withdrawal by Subject|0|||
23477448|NCT01578850|65491607|FG000|Period 1|Study Terminated by Sponsor|3|||
23477449|NCT01578850|65491608|FG001|Period 1|Study Terminated by Sponsor|0|||
23477450|NCT01578850|65491609|FG002|Period 1|Study Terminated by Sponsor|0|||
23477451|NCT01578850|65491607|FG000|Period 2|Insufficient Clinical Response|0|||
23477452|NCT01578850|65491608|FG001|Period 2|Insufficient Clinical Response|1|||
23477453|NCT01578850|65491609|FG002|Period 2|Insufficient Clinical Response|0|||
23477454|NCT01578850|65491607|FG000|Period 2|Adverse Event|0|||
23477455|NCT01578850|65491608|FG001|Period 2|Adverse Event|3|||
23477456|NCT01578850|65491609|FG002|Period 2|Adverse Event|6|||
23477457|NCT01578850|65491607|FG000|Period 2|Lost to Follow-up|0|||
23800005|NCT02000531|66643162|FG001|Overall Study|Lost to Follow-up|0|||
23477458|NCT01578850|65491608|FG001|Period 2|Lost to Follow-up|1|||
23477459|NCT01578850|65491609|FG002|Period 2|Lost to Follow-up|2|||
23477460|NCT01578850|65491607|FG000|Period 2|Withdrawal by Subject|0|||
23477461|NCT01578850|65491608|FG001|Period 2|Withdrawal by Subject|2|||
23477462|NCT01578850|65491609|FG002|Period 2|Withdrawal by Subject|2|||
23477463|NCT01578850|65491607|FG000|Period 2|Study Terminated by Sponsor|0|||
23477464|NCT01578850|65491608|FG001|Period 2|Study Terminated by Sponsor|5|||
23477465|NCT01578850|65491609|FG002|Period 2|Study Terminated by Sponsor|4|||
23477466|NCT01578850|65491607|FG000|Period 2|Unspecified Reasons|0|||
23477467|NCT01578850|65491608|FG001|Period 2|Unspecified Reasons|1|||
23477468|NCT01578850|65491609|FG002|Period 2|Unspecified Reasons|0|||
23477469|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
23477470|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
23477471|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
23477472|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
23477473|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
23477474|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
23477475|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
23644388|NCT05330312|66082684|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
23644389|NCT05330312|66082682|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
23644390|NCT05330312|66082683|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
23644391|NCT05330312|66082684|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
23644392|NCT05330312|66082682|FG000|Pivotal Investigation - Part 2|Death|1|||
23644393|NCT05330312|66082683|FG001|Pivotal Investigation - Part 2|Death|4|||
23644394|NCT05330312|66082684|FG002|Pivotal Investigation - Part 2|Death|0|||
23644395|NCT00558259|66082692|FG000|Overall Study|Adverse Event|50|||
23644396|NCT00558259|66082693|FG001|Overall Study|Adverse Event|81|||
23644397|NCT00558259|66082692|FG000|Overall Study|Protocol Violation|9|||
23644398|NCT00558259|66082693|FG001|Overall Study|Protocol Violation|5|||
23593379|NCT02807493|65903082|FG000|Overall Study|Adverse Event|5|||
23593380|NCT02807493|65903083|FG001|Overall Study|Adverse Event|2|||
23593381|NCT02807493|65903082|FG000|Overall Study|Lost to Follow-up|6|||
23593382|NCT02807493|65903083|FG001|Overall Study|Lost to Follow-up|0|||
23593383|NCT02807493|65903082|FG000|Overall Study|Physician Decision|4|||
23593384|NCT02807493|65903083|FG001|Overall Study|Physician Decision|1|||
23593385|NCT02807493|65903082|FG000|Overall Study|Protocol Violation|7|||
23593386|NCT02807493|65903083|FG001|Overall Study|Protocol Violation|0|||
23593387|NCT02807493|65903082|FG000|Overall Study|Withdrawal by Subject|17|||
23593388|NCT02807493|65903083|FG001|Overall Study|Withdrawal by Subject|10|||
23593389|NCT02807493|65903082|FG000|Overall Study|Other withdrawal|17|||
23593390|NCT02807493|65903083|FG001|Overall Study|Other withdrawal|0|||
23593391|NCT02807493|65903082|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
23593392|NCT02807493|65903083|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
23593393|NCT02512965|65903084|FG000|Overall Study|Withdrawal by Subject|0|||
23593394|NCT02512965|65903085|FG001|Overall Study|Withdrawal by Subject|4|||
23593395|NCT01000480|65903086|FG000|Induction Phase|Adverse Event|2|||
23593396|NCT01000480|65903086|FG000|Induction Phase|Lost to Follow-up|1|||
23593397|NCT01000480|65903086|FG000|Induction Phase|Physician Decision|1|||
23593398|NCT01000480|65903086|FG000|Induction Phase|Entry Criteria Not Met|3|||
23593399|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Adverse Event|4|||
23593400|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
23593401|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
23593402|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Physician Decision|1|||
23593403|NCT00507689|65903087|FG000|Pre-Randomization Period|Adverse Event|1|||
23593404|NCT00507689|65903088|FG001|Pre-Randomization Period|Adverse Event|0|||
23593405|NCT00507689|65903087|FG000|Pre-Randomization Period|Physician Decision|1|||
23593406|NCT00507689|65903088|FG001|Pre-Randomization Period|Physician Decision|0|||
23593407|NCT00507689|65903087|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
23593408|NCT00507689|65903088|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
23593409|NCT00507689|65903087|FG000|Randomized Period|Adverse Event|1|||
23644399|NCT00558259|66082692|FG000|Overall Study|Withdrawal by Subject|12|||
23644400|NCT00558259|66082693|FG001|Overall Study|Withdrawal by Subject|13|||
23644401|NCT00381615|66082698|FG000|Overall Study|Withdrawal by Subject|1|||
23644402|NCT00381615|66082699|FG001|Overall Study|Withdrawal by Subject|3|||
23644403|NCT00381615|66082700|FG002|Overall Study|Withdrawal by Subject|0|||
23644404|NCT00381615|66082701|FG003|Overall Study|Withdrawal by Subject|1|||
23644405|NCT00381615|66082698|FG000|Overall Study|Lost to Follow-up|3|||
23644406|NCT00381615|66082699|FG001|Overall Study|Lost to Follow-up|2|||
23644407|NCT00381615|66082700|FG002|Overall Study|Lost to Follow-up|0|||
23644408|NCT00381615|66082701|FG003|Overall Study|Lost to Follow-up|1|||
23644409|NCT00381615|66082698|FG000|Overall Study|Protocol Violation|0|||
23800006|NCT02000531|66643161|FG000|Overall Study|Discontinued due to data cut-off|3|||
23800007|NCT02000531|66643162|FG001|Overall Study|Discontinued due to data cut-off|8|||
23800008|NCT01647958|66646623|FG000|Initial Study|Lost to Follow-up|2|||
23800009|NCT01647958|66646624|FG001|Initial Study|Lost to Follow-up|3|||
23800010|NCT01647958|66646623|FG000|Continuation Phase|treatment received during Overall Study|39|||
23800011|NCT01647958|66646624|FG001|Continuation Phase|treatment received during Overall Study|0|||
23800012|NCT01647958|66646623|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
23800013|NCT01647958|66646624|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
23800014|NCT00544817|66646629|FG000|Combined Modality|Lack of Efficacy|2|||
23800015|NCT00544817|66646629|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
23800016|NCT00544817|66646629|FG000|Combined Modality|Adverse Event|2|||
23644410|NCT00381615|66082699|FG001|Overall Study|Protocol Violation|0|||
23593410|NCT00507689|65903088|FG001|Randomized Period|Adverse Event|1|||
23593411|NCT00507689|65903087|FG000|Randomized Period|Withdrawal by Subject|0|||
23593412|NCT00507689|65903088|FG001|Randomized Period|Withdrawal by Subject|1|||
23593413|NCT01044303|65903089|FG000|Overall Study|Lost to Follow-up|2|||
23593414|NCT01599104|65903090|FG000|Overall Study|Withdrawal by Subject|1|||
23593415|NCT01599104|65903091|FG001|Overall Study|Withdrawal by Subject|1|||
23644411|NCT00381615|66082700|FG002|Overall Study|Protocol Violation|1|||
23644412|NCT00381615|66082701|FG003|Overall Study|Protocol Violation|0|||
23644413|NCT04602221|66082705|FG000|Overall Study|Discontinuation of trial treatment|0|||
23644414|NCT04602221|66082706|FG001|Overall Study|Discontinuation of trial treatment|0|||
23644415|NCT04602221|66082707|FG002|Overall Study|Discontinuation of trial treatment|1|||
23644416|NCT04602221|66082708|FG003|Overall Study|Discontinuation of trial treatment|0|||
23644417|NCT04602221|66082709|FG004|Overall Study|Discontinuation of trial treatment|0|||
23644418|NCT04602221|66082710|FG005|Overall Study|Discontinuation of trial treatment|0|||
23644419|NCT04602221|66082711|FG006|Overall Study|Discontinuation of trial treatment|0|||
23644420|NCT04602221|66082712|FG007|Overall Study|Discontinuation of trial treatment|0|||
23644421|NCT04602221|66082713|FG008|Overall Study|Discontinuation of trial treatment|0|||
23644422|NCT04602221|66082714|FG009|Overall Study|Discontinuation of trial treatment|0|||
23644423|NCT04602221|66082715|FG010|Overall Study|Discontinuation of trial treatment|0|||
23644424|NCT04602221|66082716|FG011|Overall Study|Discontinuation of trial treatment|0|||
23644425|NCT04602221|66082717|FG012|Overall Study|Discontinuation of trial treatment|0|||
23644426|NCT04602221|66082718|FG013|Overall Study|Discontinuation of trial treatment|0|||
23644427|NCT04602221|66082719|FG014|Overall Study|Discontinuation of trial treatment|0|||
23644428|NCT04602221|66082720|FG015|Overall Study|Discontinuation of trial treatment|0|||
23644429|NCT04602221|66082721|FG016|Overall Study|Discontinuation of trial treatment|0|||
23644430|NCT04602221|66082722|FG017|Overall Study|Discontinuation of trial treatment|0|||
23644431|NCT04602221|66082705|FG000|Overall Study|Other than listed|0|||
23644432|NCT04602221|66082706|FG001|Overall Study|Other than listed|0|||
23644433|NCT04602221|66082707|FG002|Overall Study|Other than listed|0|||
23644434|NCT04602221|66082708|FG003|Overall Study|Other than listed|0|||
23644435|NCT04602221|66082709|FG004|Overall Study|Other than listed|0|||
23644436|NCT04602221|66082710|FG005|Overall Study|Other than listed|0|||
23644437|NCT04602221|66082711|FG006|Overall Study|Other than listed|0|||
23644438|NCT04602221|66082712|FG007|Overall Study|Other than listed|0|||
23644439|NCT04602221|66082713|FG008|Overall Study|Other than listed|0|||
23644440|NCT04602221|66082714|FG009|Overall Study|Other than listed|0|||
23644441|NCT04602221|66082715|FG010|Overall Study|Other than listed|0|||
23644442|NCT04602221|66082716|FG011|Overall Study|Other than listed|0|||
23644443|NCT04602221|66082717|FG012|Overall Study|Other than listed|0|||
23644444|NCT04602221|66082718|FG013|Overall Study|Other than listed|0|||
23644445|NCT04602221|66082719|FG014|Overall Study|Other than listed|0|||
23644446|NCT04602221|66082720|FG015|Overall Study|Other than listed|1|||
23800017|NCT00544817|66646629|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
23477476|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
23593416|NCT01599104|65903092|FG002|Overall Study|Withdrawal by Subject|2|||
23593417|NCT01599104|65903090|FG000|Overall Study|Technical Problems|1|||
23593418|NCT01599104|65903091|FG001|Overall Study|Technical Problems|0|||
23593419|NCT01599104|65903092|FG002|Overall Study|Technical Problems|0|||
23593420|NCT01599104|65903090|FG000|Overall Study|Physician Decision|3|||
23593421|NCT01599104|65903091|FG001|Overall Study|Physician Decision|2|||
23593422|NCT01599104|65903092|FG002|Overall Study|Physician Decision|2|||
23593423|NCT01599104|65903090|FG000|Overall Study|Non-compliance with study treatment|0|||
23593424|NCT01599104|65903091|FG001|Overall Study|Non-compliance with study treatment|1|||
23593425|NCT01599104|65903092|FG002|Overall Study|Non-compliance with study treatment|0|||
23593426|NCT01599104|65903090|FG000|Overall Study|Lack of Efficacy|4|||
23593427|NCT01599104|65903091|FG001|Overall Study|Lack of Efficacy|4|||
23593428|NCT01599104|65903092|FG002|Overall Study|Lack of Efficacy|10|||
23593429|NCT01599104|65903090|FG000|Overall Study|Adverse Event|7|||
23593430|NCT01599104|65903091|FG001|Overall Study|Adverse Event|6|||
23593431|NCT01599104|65903092|FG002|Overall Study|Adverse Event|12|||
23593432|NCT03621696|65903095|FG000|Overall Study|Not eligible|0|||
23593433|NCT03621696|65903096|FG001|Overall Study|Not eligible|0|||
23593434|NCT03621696|65903097|FG002|Overall Study|Not eligible|0|||
23593435|NCT03621696|65903098|FG003|Overall Study|Not eligible|5|||
23593436|NCT03621696|65903095|FG000|Overall Study|Withdrawal by Subject|1|||
23593437|NCT03621696|65903096|FG001|Overall Study|Withdrawal by Subject|1|||
23593438|NCT03621696|65903097|FG002|Overall Study|Withdrawal by Subject|1|||
23593439|NCT03621696|65903098|FG003|Overall Study|Withdrawal by Subject|0|||
23593440|NCT03621696|65903095|FG000|Overall Study|Physician Decision|0|||
23593441|NCT03621696|65903096|FG001|Overall Study|Physician Decision|0|||
23593442|NCT03621696|65903097|FG002|Overall Study|Physician Decision|1|||
23593443|NCT03621696|65903098|FG003|Overall Study|Physician Decision|0|||
23593444|NCT01117480|65903099|FG000|Overall Study|Protocol Violation|8|||
23593445|NCT01117480|65903099|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
23593446|NCT00480077|65903100|FG000|Overall Study|Death|19|||
23593447|NCT00480077|65903101|FG001|Overall Study|Death|15|||
23593448|NCT00480077|65903100|FG000|Overall Study|early exit|12|||
23593449|NCT00480077|65903101|FG001|Overall Study|early exit|11|||
23593450|NCT02192606|65903102|FG000|Overall Study|surgery type was changed|1|||
23593451|NCT02192606|65903103|FG001|Overall Study|surgery type was changed|1|||
23593452|NCT02192606|65903102|FG000|Overall Study|Physician Decision|1|||
23593453|NCT02192606|65903103|FG001|Overall Study|Physician Decision|2|||
23644447|NCT04602221|66082721|FG016|Overall Study|Other than listed|0|||
23644448|NCT04602221|66082722|FG017|Overall Study|Other than listed|1|||
23644449|NCT04602221|66082705|FG000|Overall Study|Withdrawal by Subject|0|||
23644450|NCT04602221|66082706|FG001|Overall Study|Withdrawal by Subject|0|||
23593454|NCT02192606|65903102|FG000|Overall Study|3D equipment rep unable to join|0|||
23593455|NCT02192606|65903103|FG001|Overall Study|3D equipment rep unable to join|1|||
23593456|NCT02577835|65903104|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
23593457|NCT01764464|65903105|FG000|First Intervention|Withdrawal by Subject|1|||
23593458|NCT01764464|65903106|FG001|First Intervention|Withdrawal by Subject|0|||
23593459|NCT01764464|65903105|FG000|First Intervention|Lost to Follow-up|1|||
23593460|NCT01764464|65903106|FG001|First Intervention|Lost to Follow-up|0|||
23593461|NCT01764464|65903105|FG000|First Intervention|Adverse Event|0|||
23593462|NCT01764464|65903106|FG001|First Intervention|Adverse Event|2|||
23593463|NCT01764464|65903105|FG000|First Intervention|did not receive study drug|0|||
23593464|NCT01764464|65903106|FG001|First Intervention|did not receive study drug|1|||
23593465|NCT01764464|65903105|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
23593466|NCT01764464|65903106|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
23593467|NCT00970359|65903107|FG000|Overall Study|Not Treated|4|||
23593468|NCT03452189|65903111|FG000|First Intervention (3 Months)|Adverse Event|1|||
23644451|NCT04602221|66082707|FG002|Overall Study|Withdrawal by Subject|0|||
23644452|NCT04602221|66082708|FG003|Overall Study|Withdrawal by Subject|0|||
23644453|NCT04602221|66082709|FG004|Overall Study|Withdrawal by Subject|0|||
23644454|NCT04602221|66082710|FG005|Overall Study|Withdrawal by Subject|0|||
23644455|NCT04602221|66082711|FG006|Overall Study|Withdrawal by Subject|0|||
23644456|NCT04602221|66082712|FG007|Overall Study|Withdrawal by Subject|0|||
23593469|NCT03452189|65903112|FG001|First Intervention (3 Months)|Adverse Event|0|||
23593470|NCT03452189|65903111|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
23593471|NCT03452189|65903112|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
23593472|NCT04484935|65903113|FG000|Overall Study|Other|0|||
23593473|NCT04484935|65903114|FG001|Overall Study|Other|1|||
23593474|NCT04484935|65903113|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23593475|NCT04484935|65903114|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23593476|NCT04484935|65903113|FG000|Overall Study|Lost to Follow-up|1|||
23593477|NCT04484935|65903114|FG001|Overall Study|Lost to Follow-up|0|||
23593478|NCT04484935|65903113|FG000|Overall Study|Death|2|||
23593479|NCT04484935|65903114|FG001|Overall Study|Death|1|||
23644457|NCT04602221|66082713|FG008|Overall Study|Withdrawal by Subject|0|||
23644458|NCT04602221|66082714|FG009|Overall Study|Withdrawal by Subject|0|||
23644459|NCT04602221|66082715|FG010|Overall Study|Withdrawal by Subject|0|||
23644460|NCT04602221|66082716|FG011|Overall Study|Withdrawal by Subject|0|||
23644461|NCT04602221|66082717|FG012|Overall Study|Withdrawal by Subject|1|||
23644462|NCT04602221|66082718|FG013|Overall Study|Withdrawal by Subject|0|||
23800018|NCT00544817|66646629|FG000|No Treatment Interval|Lack of Efficacy|8|||
23800019|NCT00544817|66646629|FG000|No Treatment Interval|Physician Decision|3|||
23800020|NCT00544817|66646629|FG000|No Treatment Interval|Adverse Event|1|||
23800021|NCT00544817|66646629|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
23800022|NCT00544817|66646629|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
23360196|NCT01843803|65062852|FG000|Overall Study|not a Veteran, did not see provider|1|||
23593480|NCT01641198|65903119|FG000|After 12 Months of Function|Lost to Follow-up|3|||
23593481|NCT01641198|65903120|FG001|After 12 Months of Function|Lost to Follow-up|2|||
23644463|NCT04602221|66082719|FG014|Overall Study|Withdrawal by Subject|0|||
23644464|NCT04602221|66082720|FG015|Overall Study|Withdrawal by Subject|0|||
23644465|NCT04602221|66082721|FG016|Overall Study|Withdrawal by Subject|0|||
23644466|NCT04602221|66082722|FG017|Overall Study|Withdrawal by Subject|0|||
23477477|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
23477478|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
23477479|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
23477480|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
23477481|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
23593482|NCT01641198|65903121|FG002|After 12 Months of Function|Lost to Follow-up|2|||
23593483|NCT01641198|65903119|FG000|After 12 Months of Function|Protocol Violation|1|||
23593484|NCT01641198|65903120|FG001|After 12 Months of Function|Protocol Violation|0|||
23593485|NCT01641198|65903121|FG002|After 12 Months of Function|Protocol Violation|0|||
23593486|NCT01641198|65903119|FG000|After 12 Months of Function|Adverse Event|0|||
23593487|NCT01641198|65903120|FG001|After 12 Months of Function|Adverse Event|1|||
23593488|NCT01641198|65903121|FG002|After 12 Months of Function|Adverse Event|0|||
23593489|NCT01641198|65903119|FG000|After 24 Months of Function|Lost to Follow-up|4|||
23593490|NCT01641198|65903120|FG001|After 24 Months of Function|Lost to Follow-up|9|||
23593491|NCT01641198|65903121|FG002|After 24 Months of Function|Lost to Follow-up|6|||
23593492|NCT01641198|65903119|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
23593493|NCT01641198|65903120|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
23593494|NCT01641198|65903121|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
23593495|NCT01641198|65903119|FG000|At 15-20 Years of Function|Death|1|||
23593496|NCT01641198|65903120|FG001|At 15-20 Years of Function|Death|0|||
23593497|NCT01641198|65903121|FG002|At 15-20 Years of Function|Death|1|||
23593498|NCT01713946|65903123|FG000|Overall Study|Death|0|||
23593499|NCT01713946|65903124|FG001|Overall Study|Death|2|||
23593500|NCT01713946|65903125|FG002|Overall Study|Death|2|||
23593501|NCT01713946|65903123|FG000|Overall Study|Adverse Event|19|||
23593502|NCT01713946|65903124|FG001|Overall Study|Adverse Event|14|||
23593503|NCT01713946|65903125|FG002|Overall Study|Adverse Event|13|||
23593504|NCT01713946|65903123|FG000|Overall Study|Withdrawal by Subject|12|||
23593505|NCT01713946|65903124|FG001|Overall Study|Withdrawal by Subject|12|||
23593506|NCT01713946|65903125|FG002|Overall Study|Withdrawal by Subject|8|||
23593507|NCT01713946|65903123|FG000|Overall Study|Lack of Efficacy|8|||
23593508|NCT01713946|65903124|FG001|Overall Study|Lack of Efficacy|8|||
23593509|NCT01713946|65903125|FG002|Overall Study|Lack of Efficacy|14|||
23593510|NCT01713946|65903123|FG000|Overall Study|Protocol Violation|2|||
23593511|NCT01713946|65903124|FG001|Overall Study|Protocol Violation|4|||
23593512|NCT01713946|65903125|FG002|Overall Study|Protocol Violation|1|||
23593513|NCT01713946|65903123|FG000|Overall Study|Lost to Follow-up|0|||
23593514|NCT01713946|65903124|FG001|Overall Study|Lost to Follow-up|0|||
23593515|NCT01713946|65903125|FG002|Overall Study|Lost to Follow-up|1|||
23593516|NCT01713946|65903123|FG000|Overall Study|Administrative problems|1|||
23593517|NCT01713946|65903124|FG001|Overall Study|Administrative problems|0|||
23593518|NCT01713946|65903125|FG002|Overall Study|Administrative problems|0|||
23593519|NCT01713946|65903123|FG000|Overall Study|Did not continue in Ext|0|||
23593520|NCT01713946|65903124|FG001|Overall Study|Did not continue in Ext|3|||
23593521|NCT01713946|65903125|FG002|Overall Study|Did not continue in Ext|0|||
23593522|NCT01713946|65903123|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
23593523|NCT01713946|65903124|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
23593524|NCT01713946|65903125|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
23593525|NCT01713946|65903123|FG000|Overall Study|Patients never switched to everolimus|0|||
23593526|NCT01713946|65903124|FG001|Overall Study|Patients never switched to everolimus|0|||
23593527|NCT01713946|65903125|FG002|Overall Study|Patients never switched to everolimus|5|||
23593528|NCT01493778|65903126|FG000|Overall Study|Withdrawal by Subject|8|||
23644467|NCT04602221|66082705|FG000|Overall Study|Lost to Follow-up|0|||
23360197|NCT01843803|65062853|FG001|Overall Study|not a Veteran, did not see provider|3|||
23477482|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
23593529|NCT03194958|65903127|FG000|Overall Study|Death|0|||
23593530|NCT03194958|65903128|FG001|Overall Study|Death|1|||
23593531|NCT03194958|65903129|FG002|Overall Study|Death|1|||
23593532|NCT03194958|65903130|FG003|Overall Study|Death|1|||
23593533|NCT03194958|65903127|FG000|Overall Study|Withdrawal by Subject|24|||
23593534|NCT03194958|65903128|FG001|Overall Study|Withdrawal by Subject|27|||
23593535|NCT03194958|65903129|FG002|Overall Study|Withdrawal by Subject|7|||
23593536|NCT03194958|65903130|FG003|Overall Study|Withdrawal by Subject|22|||
23593537|NCT03194958|65903127|FG000|Overall Study|Lost to Follow-up|168|||
23593538|NCT03194958|65903128|FG001|Overall Study|Lost to Follow-up|196|||
23593539|NCT03194958|65903129|FG002|Overall Study|Lost to Follow-up|174|||
23593540|NCT03194958|65903130|FG003|Overall Study|Lost to Follow-up|186|||
23593541|NCT02528188|65903131|FG000|Overall Study|Adverse Event|23|||
23593542|NCT02528188|65903132|FG001|Overall Study|Adverse Event|22|||
23593543|NCT02528188|65903133|FG002|Overall Study|Adverse Event|8|||
23593544|NCT02528188|65903131|FG000|Overall Study|Protocol Violation|4|||
23593545|NCT02528188|65903132|FG001|Overall Study|Protocol Violation|6|||
23593546|NCT02528188|65903133|FG002|Overall Study|Protocol Violation|4|||
23593547|NCT02528188|65903131|FG000|Overall Study|Lack of Efficacy|19|||
23593548|NCT02528188|65903132|FG001|Overall Study|Lack of Efficacy|21|||
23593549|NCT02528188|65903133|FG002|Overall Study|Lack of Efficacy|22|||
23593550|NCT02528188|65903131|FG000|Overall Study|Withdrawal by Subject|97|||
23593551|NCT02528188|65903132|FG001|Overall Study|Withdrawal by Subject|104|||
23593552|NCT02528188|65903133|FG002|Overall Study|Withdrawal by Subject|100|||
23593553|NCT02528188|65903131|FG000|Overall Study|Lost to Follow-up|25|||
23593554|NCT02528188|65903132|FG001|Overall Study|Lost to Follow-up|21|||
23593555|NCT02528188|65903133|FG002|Overall Study|Lost to Follow-up|31|||
23593556|NCT02528188|65903131|FG000|Overall Study|Death|4|||
23593557|NCT02528188|65903132|FG001|Overall Study|Death|4|||
23593558|NCT02528188|65903133|FG002|Overall Study|Death|0|||
23593559|NCT02528188|65903131|FG000|Overall Study|Other|89|||
23593560|NCT02528188|65903132|FG001|Overall Study|Other|91|||
23593561|NCT02528188|65903133|FG002|Overall Study|Other|74|||
23593562|NCT02528188|65903131|FG000|Overall Study|Randomized but not treated|6|||
23593563|NCT02528188|65903132|FG001|Overall Study|Randomized but not treated|7|||
23593564|NCT02528188|65903133|FG002|Overall Study|Randomized but not treated|12|||
23593565|NCT01595061|65903134|FG000|Overall Study|Never Treated|3|||
23593566|NCT01595061|65903134|FG000|Overall Study|Inadequate Pathology|1|||
23477483|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
23477484|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
23477485|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
23477486|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477487|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477488|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477489|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
23477490|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477491|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
23477492|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477493|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477494|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
23477495|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
23477496|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477497|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477498|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477499|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
23477500|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
23477501|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
23477502|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
23477503|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
23477504|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
23477505|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
23477506|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477507|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477508|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477509|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
23593567|NCT02988817|65903135|FG000|Overall Study|Withdrawal by Subject|1|||
23593568|NCT02988817|65903136|FG001|Overall Study|Withdrawal by Subject|0|||
23593569|NCT02988817|65903137|FG002|Overall Study|Withdrawal by Subject|0|||
23593570|NCT02988817|65903138|FG003|Overall Study|Withdrawal by Subject|1|||
23593571|NCT02988817|65903139|FG004|Overall Study|Withdrawal by Subject|3|||
23593572|NCT02988817|65903140|FG005|Overall Study|Withdrawal by Subject|1|||
23593573|NCT02988817|65903141|FG006|Overall Study|Withdrawal by Subject|2|||
23593574|NCT02988817|65903142|FG007|Overall Study|Withdrawal by Subject|1|||
23593575|NCT02988817|65903143|FG008|Overall Study|Withdrawal by Subject|1|||
23593576|NCT02988817|65903144|FG009|Overall Study|Withdrawal by Subject|1|||
23593577|NCT02988817|65903145|FG010|Overall Study|Withdrawal by Subject|1|||
23593578|NCT02988817|65903146|FG011|Overall Study|Withdrawal by Subject|12|||
23593579|NCT02988817|65903147|FG012|Overall Study|Withdrawal by Subject|6|||
23593580|NCT02988817|65903148|FG013|Overall Study|Withdrawal by Subject|6|||
23593581|NCT02988817|65903149|FG014|Overall Study|Withdrawal by Subject|4|||
23593582|NCT02988817|65903150|FG015|Overall Study|Withdrawal by Subject|5|||
23593583|NCT02988817|65903151|FG016|Overall Study|Withdrawal by Subject|4|||
23593584|NCT02988817|65903152|FG017|Overall Study|Withdrawal by Subject|11|||
23593585|NCT02988817|65903153|FG018|Overall Study|Withdrawal by Subject|4|||
23593586|NCT02988817|65903154|FG019|Overall Study|Withdrawal by Subject|2|||
23593587|NCT02988817|65903135|FG000|Overall Study|Death|0|||
23593588|NCT02988817|65903136|FG001|Overall Study|Death|1|||
23593589|NCT02988817|65903137|FG002|Overall Study|Death|3|||
23593590|NCT02988817|65903138|FG003|Overall Study|Death|1|||
23593591|NCT02988817|65903139|FG004|Overall Study|Death|6|||
23593592|NCT02988817|65903140|FG005|Overall Study|Death|10|||
23593593|NCT02988817|65903141|FG006|Overall Study|Death|1|||
23593594|NCT02988817|65903142|FG007|Overall Study|Death|2|||
23593595|NCT02988817|65903143|FG008|Overall Study|Death|1|||
23593596|NCT02988817|65903144|FG009|Overall Study|Death|5|||
23593597|NCT02988817|65903145|FG010|Overall Study|Death|1|||
23593598|NCT02988817|65903146|FG011|Overall Study|Death|8|||
23593599|NCT02988817|65903147|FG012|Overall Study|Death|9|||
23593600|NCT02988817|65903148|FG013|Overall Study|Death|17|||
23593601|NCT02988817|65903149|FG014|Overall Study|Death|18|||
23593602|NCT02988817|65903150|FG015|Overall Study|Death|30|||
23593603|NCT02988817|65903151|FG016|Overall Study|Death|17|||
23593604|NCT02988817|65903152|FG017|Overall Study|Death|38|||
23593605|NCT02988817|65903153|FG018|Overall Study|Death|14|||
23593606|NCT02988817|65903154|FG019|Overall Study|Death|16|||
23593607|NCT02988817|65903135|FG000|Overall Study|Other|0|||
23593608|NCT02988817|65903136|FG001|Overall Study|Other|0|||
23593609|NCT02988817|65903137|FG002|Overall Study|Other|0|||
23593610|NCT02988817|65903138|FG003|Overall Study|Other|1|||
23593611|NCT02988817|65903139|FG004|Overall Study|Other|1|||
23593612|NCT02988817|65903140|FG005|Overall Study|Other|0|||
23593613|NCT02988817|65903141|FG006|Overall Study|Other|0|||
23593614|NCT02988817|65903142|FG007|Overall Study|Other|0|||
23593615|NCT02988817|65903143|FG008|Overall Study|Other|0|||
23593616|NCT02988817|65903144|FG009|Overall Study|Other|0|||
23593617|NCT02988817|65903145|FG010|Overall Study|Other|0|||
23593618|NCT02988817|65903146|FG011|Overall Study|Other|0|||
23593619|NCT02988817|65903147|FG012|Overall Study|Other|0|||
23593620|NCT02988817|65903148|FG013|Overall Study|Other|0|||
23593621|NCT02988817|65903149|FG014|Overall Study|Other|0|||
23593622|NCT02988817|65903150|FG015|Overall Study|Other|1|||
23593623|NCT02988817|65903151|FG016|Overall Study|Other|0|||
23593624|NCT02988817|65903152|FG017|Overall Study|Other|0|||
23593625|NCT02988817|65903153|FG018|Overall Study|Other|0|||
23593626|NCT02988817|65903154|FG019|Overall Study|Other|0|||
23593627|NCT02988817|65903135|FG000|Overall Study|Lost to Follow-up|0|||
23593628|NCT02988817|65903136|FG001|Overall Study|Lost to Follow-up|0|||
23593629|NCT02988817|65903137|FG002|Overall Study|Lost to Follow-up|0|||
23593630|NCT02988817|65903138|FG003|Overall Study|Lost to Follow-up|0|||
23593631|NCT02988817|65903139|FG004|Overall Study|Lost to Follow-up|0|||
23593632|NCT02988817|65903140|FG005|Overall Study|Lost to Follow-up|0|||
23593633|NCT02988817|65903141|FG006|Overall Study|Lost to Follow-up|0|||
23593634|NCT02988817|65903142|FG007|Overall Study|Lost to Follow-up|0|||
23593635|NCT02988817|65903143|FG008|Overall Study|Lost to Follow-up|1|||
23593636|NCT02988817|65903144|FG009|Overall Study|Lost to Follow-up|0|||
23593637|NCT02988817|65903145|FG010|Overall Study|Lost to Follow-up|1|||
23593638|NCT02988817|65903146|FG011|Overall Study|Lost to Follow-up|1|||
23593639|NCT02988817|65903147|FG012|Overall Study|Lost to Follow-up|0|||
23593640|NCT02988817|65903148|FG013|Overall Study|Lost to Follow-up|0|||
23593641|NCT02988817|65903149|FG014|Overall Study|Lost to Follow-up|1|||
23593642|NCT02988817|65903150|FG015|Overall Study|Lost to Follow-up|1|||
23593643|NCT02988817|65903151|FG016|Overall Study|Lost to Follow-up|2|||
23593644|NCT02988817|65903152|FG017|Overall Study|Lost to Follow-up|3|||
23593645|NCT02988817|65903153|FG018|Overall Study|Lost to Follow-up|0|||
23593646|NCT02988817|65903154|FG019|Overall Study|Lost to Follow-up|0|||
23593647|NCT02988817|65903135|FG000|Overall Study|Sponsor decision|0|||
23593648|NCT02988817|65903136|FG001|Overall Study|Sponsor decision|0|||
23593649|NCT02988817|65903137|FG002|Overall Study|Sponsor decision|0|||
23593650|NCT02988817|65903138|FG003|Overall Study|Sponsor decision|0|||
23593651|NCT02988817|65903139|FG004|Overall Study|Sponsor decision|0|||
23593652|NCT02988817|65903140|FG005|Overall Study|Sponsor decision|0|||
23593653|NCT02988817|65903141|FG006|Overall Study|Sponsor decision|0|||
23593654|NCT02988817|65903142|FG007|Overall Study|Sponsor decision|0|||
23593655|NCT02988817|65903143|FG008|Overall Study|Sponsor decision|0|||
23593656|NCT02988817|65903144|FG009|Overall Study|Sponsor decision|0|||
23593657|NCT02988817|65903145|FG010|Overall Study|Sponsor decision|0|||
23593658|NCT02988817|65903146|FG011|Overall Study|Sponsor decision|1|||
23593659|NCT02988817|65903147|FG012|Overall Study|Sponsor decision|1|||
23593660|NCT02988817|65903148|FG013|Overall Study|Sponsor decision|2|||
23593661|NCT02988817|65903149|FG014|Overall Study|Sponsor decision|2|||
23593662|NCT02988817|65903150|FG015|Overall Study|Sponsor decision|6|||
23593663|NCT02988817|65903151|FG016|Overall Study|Sponsor decision|2|||
23593664|NCT02988817|65903152|FG017|Overall Study|Sponsor decision|3|||
23593665|NCT02988817|65903153|FG018|Overall Study|Sponsor decision|2|||
23593666|NCT02988817|65903154|FG019|Overall Study|Sponsor decision|7|||
23593667|NCT02988817|65903135|FG000|Overall Study|Physician Decision|0|||
23593668|NCT02988817|65903136|FG001|Overall Study|Physician Decision|0|||
23593669|NCT02988817|65903137|FG002|Overall Study|Physician Decision|0|||
23593670|NCT02988817|65903138|FG003|Overall Study|Physician Decision|0|||
23593671|NCT02988817|65903139|FG004|Overall Study|Physician Decision|0|||
23593672|NCT02988817|65903140|FG005|Overall Study|Physician Decision|0|||
23593673|NCT02988817|65903141|FG006|Overall Study|Physician Decision|0|||
23593674|NCT02988817|65903142|FG007|Overall Study|Physician Decision|0|||
23593675|NCT02988817|65903143|FG008|Overall Study|Physician Decision|0|||
23593676|NCT02988817|65903144|FG009|Overall Study|Physician Decision|0|||
23593677|NCT02988817|65903145|FG010|Overall Study|Physician Decision|0|||
23593678|NCT02988817|65903146|FG011|Overall Study|Physician Decision|0|||
23593679|NCT02988817|65903147|FG012|Overall Study|Physician Decision|0|||
23593680|NCT02988817|65903148|FG013|Overall Study|Physician Decision|0|||
23593681|NCT02988817|65903149|FG014|Overall Study|Physician Decision|0|||
23593682|NCT02988817|65903150|FG015|Overall Study|Physician Decision|1|||
23593683|NCT02988817|65903151|FG016|Overall Study|Physician Decision|0|||
23593684|NCT02988817|65903152|FG017|Overall Study|Physician Decision|0|||
23593685|NCT02988817|65903153|FG018|Overall Study|Physician Decision|1|||
23593686|NCT02988817|65903154|FG019|Overall Study|Physician Decision|1|||
23593687|NCT02568683|65903155|FG000|Overall Study|Death|0|||
23593688|NCT02568683|65903156|FG001|Overall Study|Death|2|||
23593689|NCT02568683|65903155|FG000|Overall Study|Withdrew Consent|1|||
23593690|NCT02568683|65903156|FG001|Overall Study|Withdrew Consent|0|||
23593691|NCT02568683|65903155|FG000|Overall Study|Study Terminated By Sponsor|5|||
23593692|NCT02568683|65903156|FG001|Overall Study|Study Terminated By Sponsor|2|||
23593693|NCT01563354|65903159|FG000|Core Phase|Adverse Event|5|||
23593694|NCT01563354|65903160|FG001|Core Phase|Adverse Event|15|||
23593695|NCT01563354|65903161|FG002|Core Phase|Adverse Event|13|||
23593696|NCT01563354|65903159|FG000|Core Phase|Withdrawal by Subject|1|||
23593697|NCT01563354|65903160|FG001|Core Phase|Withdrawal by Subject|0|||
23593698|NCT01563354|65903161|FG002|Core Phase|Withdrawal by Subject|3|||
23593699|NCT01563354|65903159|FG000|Core Phase|Lost to Follow-up|1|||
23593700|NCT01563354|65903160|FG001|Core Phase|Lost to Follow-up|0|||
23593701|NCT01563354|65903161|FG002|Core Phase|Lost to Follow-up|0|||
23593702|NCT01563354|65903159|FG000|Core Phase|Death|1|||
23593703|NCT01563354|65903160|FG001|Core Phase|Death|5|||
23593704|NCT01563354|65903161|FG002|Core Phase|Death|2|||
23593705|NCT01563354|65903159|FG000|Core Phase|Diseasse progression|18|||
23593706|NCT01563354|65903160|FG001|Core Phase|Diseasse progression|7|||
23593707|NCT01563354|65903161|FG002|Core Phase|Diseasse progression|8|||
23593708|NCT01563354|65903159|FG000|Core Phase|Protocol deviation|2|||
23593709|NCT01563354|65903160|FG001|Core Phase|Protocol deviation|0|||
23593710|NCT01563354|65903161|FG002|Core Phase|Protocol deviation|0|||
23593711|NCT01563354|65903159|FG000|Core Phase|PI decision - did not enter extension|0|||
23593712|NCT01563354|65903160|FG001|Core Phase|PI decision - did not enter extension|1|||
23593713|NCT01563354|65903161|FG002|Core Phase|PI decision - did not enter extension|0|||
23593714|NCT01563354|65903159|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
23593715|NCT01563354|65903160|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
23593716|NCT01563354|65903161|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
23593717|NCT01563354|65903159|FG000|Extension Phase|Adverse Event|0|||
23593718|NCT01563354|65903160|FG001|Extension Phase|Adverse Event|3|||
23593719|NCT01563354|65903161|FG002|Extension Phase|Adverse Event|2|||
23593720|NCT01563354|65903159|FG000|Extension Phase|Withdrawal by Subject|0|||
23593721|NCT01563354|65903160|FG001|Extension Phase|Withdrawal by Subject|1|||
23593722|NCT01563354|65903161|FG002|Extension Phase|Withdrawal by Subject|0|||
23593723|NCT01563354|65903159|FG000|Extension Phase|Administration problems|3|||
23593724|NCT01563354|65903160|FG001|Extension Phase|Administration problems|2|||
23593725|NCT01563354|65903161|FG002|Extension Phase|Administration problems|3|||
23593726|NCT01563354|65903159|FG000|Extension Phase|Disease progression|9|||
23593727|NCT01563354|65903160|FG001|Extension Phase|Disease progression|8|||
23593728|NCT01563354|65903161|FG002|Extension Phase|Disease progression|10|||
23593729|NCT03050814|65903164|FG000|Overall Study|Screen failures|0|||
23593730|NCT03050814|65903165|FG001|Overall Study|Screen failures|0|||
23593731|NCT03050814|65903166|FG002|Overall Study|Screen failures|4|||
23593732|NCT00423098|65903169|FG000|Overall Study|Adverse Event|1|||
23593733|NCT00423098|65903170|FG001|Overall Study|Adverse Event|2|||
23593734|NCT00423098|65903169|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23593735|NCT00423098|65903170|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23593736|NCT00423098|65903169|FG000|Overall Study|Administrative problems|0|||
23593737|NCT00423098|65903170|FG001|Overall Study|Administrative problems|1|||
23593738|NCT00423098|65903169|FG000|Overall Study|Death|2|||
23593739|NCT00423098|65903170|FG001|Overall Study|Death|0|||
23593740|NCT01118377|65903171|FG000|Overall Study|Did Not Receive Study Medication|1|||
23593741|NCT01118377|65903171|FG000|Overall Study|Death|38|||
23593742|NCT01118377|65903171|FG000|Overall Study|Failure to Return|3|||
23593743|NCT00997386|65903172|FG000|Overall Study|Death|7|||
23593744|NCT02815566|65903173|FG000|Overall Study|Adverse Event|1|||
23593745|NCT02815566|65903174|FG001|Overall Study|Adverse Event|1|||
23593746|NCT02815566|65903173|FG000|Overall Study|Withdrawal by Subject|1|||
23593747|NCT02815566|65903174|FG001|Overall Study|Withdrawal by Subject|0|||
23593748|NCT02815566|65903173|FG000|Overall Study|Lost to Follow-up|0|||
23593749|NCT02815566|65903174|FG001|Overall Study|Lost to Follow-up|1|||
23593750|NCT00065260|65903175|FG000|Overall Study|Death|0|||
23593751|NCT00065260|65903176|FG001|Overall Study|Death|1|||
23593752|NCT01538719|65903177|FG000|Overall Study|Lost to Follow-up|2|||
23593753|NCT01538719|65903178|FG001|Overall Study|Lost to Follow-up|0|||
23593754|NCT05082935|65903180|FG000|Overall Study|Lost to Follow-up|549|||
23593755|NCT05082935|65903181|FG001|Overall Study|Lost to Follow-up|631|||
23593756|NCT05082935|65903180|FG000|Overall Study|Withdrawal by Subject|27|||
23593757|NCT05082935|65903181|FG001|Overall Study|Withdrawal by Subject|58|||
23593758|NCT01359592|65903184|FG000|Initial Registration|Adverse Event|1|||
23593759|NCT01359592|65903185|FG001|Initial Registration|Adverse Event|0|||
23593760|NCT01359592|65903186|FG002|Initial Registration|Adverse Event|0|||
23593761|NCT01359592|65903187|FG003|Initial Registration|Adverse Event|0|||
23593762|NCT01359592|65903184|FG000|Initial Registration|Death|1|||
23593763|NCT01359592|65903185|FG001|Initial Registration|Death|0|||
23593764|NCT01359592|65903186|FG002|Initial Registration|Death|0|||
23593765|NCT01359592|65903187|FG003|Initial Registration|Death|0|||
23593766|NCT01359592|65903184|FG000|Initial Registration|Other reason not protocol specified|1|||
23593767|NCT01359592|65903185|FG001|Initial Registration|Other reason not protocol specified|0|||
23593768|NCT01359592|65903186|FG002|Initial Registration|Other reason not protocol specified|0|||
23593769|NCT01359592|65903187|FG003|Initial Registration|Other reason not protocol specified|0|||
23593770|NCT01359592|65903184|FG000|Initial Registration|Ineligible|26|||
23593771|NCT01359592|65903185|FG001|Initial Registration|Ineligible|0|||
23593772|NCT01359592|65903186|FG002|Initial Registration|Ineligible|0|||
23593773|NCT01359592|65903187|FG003|Initial Registration|Ineligible|0|||
23593774|NCT01359592|65903184|FG000|PET-Directed Therapy|Adverse Event|0|||
23593775|NCT01359592|65903185|FG001|PET-Directed Therapy|Adverse Event|0|||
23593776|NCT01359592|65903186|FG002|PET-Directed Therapy|Adverse Event|1|||
23593777|NCT01359592|65903187|FG003|PET-Directed Therapy|Adverse Event|0|||
23593778|NCT01359592|65903184|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593779|NCT01359592|65903185|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593780|NCT01359592|65903186|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
23593781|NCT01359592|65903187|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593782|NCT01359592|65903184|FG000|PET-Directed Therapy|Ineligible|0|||
23593783|NCT01359592|65903185|FG001|PET-Directed Therapy|Ineligible|0|||
23593784|NCT01359592|65903186|FG002|PET-Directed Therapy|Ineligible|24|||
23593785|NCT01359592|65903187|FG003|PET-Directed Therapy|Ineligible|0|||
23593786|NCT04056611|65903189|FG000|Overall Study|Physician Decision|1|||
23593787|NCT04867902|65903190|FG000|Overall Study|Lost to Follow-up|1|||
23593788|NCT04867902|65903190|FG000|Overall Study|Withdrawal by Subject|2|||
23593789|NCT04867902|65903190|FG000|Overall Study|Protocol Violation|1|||
23593790|NCT02372253|65903198|FG000|Overall Study|Non Compliance|2|||
23593791|NCT02372253|65903199|FG001|Overall Study|Non Compliance|0|||
23593792|NCT01064817|65903203|FG000|Study Completion|Physician Decision|1|||
23593793|NCT01064817|65903204|FG001|Study Completion|Physician Decision|0|||
23593794|NCT01064817|65903203|FG000|Study Completion|Withdrawal by Subject|1|||
23593795|NCT01064817|65903204|FG001|Study Completion|Withdrawal by Subject|0|||
23593796|NCT04358549|65903206|FG000|Overall Study|Adverse Event|0|||
23593797|NCT04358549|65903207|FG001|Overall Study|Adverse Event|1|||
23593798|NCT04358549|65903206|FG000|Overall Study|Death|1|||
23593799|NCT04358549|65903207|FG001|Overall Study|Death|0|||
23360198|NCT00420628|65062854|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
23593800|NCT04358549|65903206|FG000|Overall Study|Lost to Follow-up|2|||
23593801|NCT04358549|65903207|FG001|Overall Study|Lost to Follow-up|1|||
23593802|NCT04358549|65903206|FG000|Overall Study|Withdrawal by Subject|6|||
23593803|NCT04358549|65903207|FG001|Overall Study|Withdrawal by Subject|6|||
23593804|NCT04358549|65903206|FG000|Overall Study|Start remdesivir|1|||
23593805|NCT04358549|65903207|FG001|Overall Study|Start remdesivir|0|||
23593806|NCT00360698|65903209|FG000|Run-In|Physician Decision|0|||
23593807|NCT00360698|65903210|FG001|Run-In|Physician Decision|1|||
23593808|NCT00360698|65903209|FG000|Run-In|Withdrawal by Subject|0|||
23593809|NCT00360698|65903210|FG001|Run-In|Withdrawal by Subject|2|||
23593810|NCT00360698|65903209|FG000|Run-In|Non compliance with treatment procedure|0|||
23593811|NCT00360698|65903210|FG001|Run-In|Non compliance with treatment procedure|1|||
23593812|NCT00360698|65903209|FG000|Run-In|Sponsor request|0|||
23593813|NCT00360698|65903210|FG001|Run-In|Sponsor request|2|||
23593814|NCT00360698|65903209|FG000|Run-In|Patient did not meet inclusion criteria|0|||
23593815|NCT00360698|65903210|FG001|Run-In|Patient did not meet inclusion criteria|1|||
23593816|NCT00360698|65903209|FG000|Run-In|Patient personal reasons|0|||
23593817|NCT00360698|65903210|FG001|Run-In|Patient personal reasons|2|||
23593818|NCT00360698|65903209|FG000|Run-In|Need of insulin with meals|0|||
23593819|NCT00360698|65903210|FG001|Run-In|Need of insulin with meals|1|||
23593820|NCT00360698|65903209|FG000|Treatment Period|Non compliance with treatment procedure|1|||
23593821|NCT00360698|65903210|FG001|Treatment Period|Non compliance with treatment procedure|0|||
23593822|NCT00360698|65903209|FG000|Treatment Period|Early termination by error|0|||
23593823|NCT00360698|65903210|FG001|Treatment Period|Early termination by error|1|||
23593824|NCT00841035|65903211|FG000|Phase 1 Overall Study|Physician Decision|13|||
23593825|NCT01395758|65903212|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
23593826|NCT01395758|65903213|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23593827|NCT01395758|65903214|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23593828|NCT05283395|65903222|FG000|Overall Study|Adverse Event|4|||
23593829|NCT05283395|65903223|FG001|Overall Study|Adverse Event|4|||
23593830|NCT05283395|65903224|FG002|Overall Study|Adverse Event|0|||
23593831|NCT05283395|65903222|FG000|Overall Study|Patient Lost to Follow-Up|0|||
23593832|NCT05283395|65903223|FG001|Overall Study|Patient Lost to Follow-Up|0|||
23593833|NCT05283395|65903224|FG002|Overall Study|Patient Lost to Follow-Up|1|||
23593834|NCT05283395|65903222|FG000|Overall Study|Patient Withdrawal|2|||
23593835|NCT05283395|65903223|FG001|Overall Study|Patient Withdrawal|4|||
23593836|NCT05283395|65903224|FG002|Overall Study|Patient Withdrawal|2|||
23593837|NCT05283395|65903222|FG000|Overall Study|Investigator Decision|1|||
23593838|NCT05283395|65903223|FG001|Overall Study|Investigator Decision|0|||
23593839|NCT05283395|65903224|FG002|Overall Study|Investigator Decision|1|||
23593840|NCT05283395|65903222|FG000|Overall Study|Enrolled in error|0|||
23593841|NCT05283395|65903223|FG001|Overall Study|Enrolled in error|0|||
23593842|NCT05283395|65903224|FG002|Overall Study|Enrolled in error|1|||
23593843|NCT00661778|65903229|FG000|Overall Study|Disease Progression|23|||
23593844|NCT00661778|65903229|FG000|Overall Study|Adverse Event|18|||
23593845|NCT00661778|65903229|FG000|Overall Study|Reason not Specified|6|||
23593846|NCT00661778|65903229|FG000|Overall Study|Protocol Violation|2|||
23593847|NCT00661778|65903229|FG000|Overall Study|Withdrawal of Consent|1|||
23593848|NCT02320123|65903232|FG000|Overall Study|Lost to Follow-up|4|||
23593849|NCT02320123|65903233|FG001|Overall Study|Lost to Follow-up|6|||
23593850|NCT02320123|65903232|FG000|Overall Study|Death|6|||
23593851|NCT02320123|65903233|FG001|Overall Study|Death|5|||
23593852|NCT02918279|65903236|FG000|Overall Study|Lost to Follow-up|3|||
23593853|NCT02918279|65903237|FG001|Overall Study|Lost to Follow-up|6|||
23593854|NCT02918279|65903236|FG000|Overall Study|Withdrawal by Subject|5|||
23593855|NCT02918279|65903237|FG001|Overall Study|Withdrawal by Subject|15|||
23593856|NCT02918279|65903236|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23593857|NCT02918279|65903237|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23593858|NCT02918279|65903236|FG000|Overall Study|Other|3|||
23593859|NCT02918279|65903237|FG001|Overall Study|Other|1|||
23593860|NCT01041417|65903238|FG000|Overall Study|Adverse Event|5|||
23593861|NCT01041417|65903239|FG001|Overall Study|Adverse Event|2|||
23593862|NCT01041417|65903238|FG000|Overall Study|Lost to Follow-up|1|||
23593863|NCT01041417|65903239|FG001|Overall Study|Lost to Follow-up|1|||
23593864|NCT01041417|65903238|FG000|Overall Study|Death|1|||
23593865|NCT01041417|65903239|FG001|Overall Study|Death|0|||
23593866|NCT03981822|65903240|FG000|Overall Study|Lost to Follow-up|0|||
23593867|NCT03981822|65903241|FG001|Overall Study|Lost to Follow-up|1|||
23593868|NCT03981822|65903242|FG002|Overall Study|Lost to Follow-up|1|||
23593869|NCT03981822|65903243|FG003|Overall Study|Lost to Follow-up|0|||
23593870|NCT03981822|65903244|FG004|Overall Study|Lost to Follow-up|6|||
23593871|NCT03981822|65903245|FG005|Overall Study|Lost to Follow-up|4|||
23593872|NCT03981822|65903246|FG006|Overall Study|Lost to Follow-up|4|||
23593873|NCT03981822|65903247|FG007|Overall Study|Lost to Follow-up|2|||
23593874|NCT03981822|65903240|FG000|Overall Study|Withdrawal by Subject|0|||
23593875|NCT03981822|65903241|FG001|Overall Study|Withdrawal by Subject|1|||
23593876|NCT03981822|65903242|FG002|Overall Study|Withdrawal by Subject|0|||
23593877|NCT03981822|65903243|FG003|Overall Study|Withdrawal by Subject|0|||
23800023|NCT00544817|66646629|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
23593878|NCT03981822|65903244|FG004|Overall Study|Withdrawal by Subject|0|||
23593879|NCT03981822|65903245|FG005|Overall Study|Withdrawal by Subject|1|||
23593880|NCT03981822|65903246|FG006|Overall Study|Withdrawal by Subject|0|||
23593881|NCT03981822|65903247|FG007|Overall Study|Withdrawal by Subject|2|||
23593882|NCT03981822|65903240|FG000|Overall Study|COVID-19 Related|0|||
23593883|NCT03981822|65903241|FG001|Overall Study|COVID-19 Related|0|||
23593884|NCT03981822|65903242|FG002|Overall Study|COVID-19 Related|0|||
23593885|NCT03981822|65903243|FG003|Overall Study|COVID-19 Related|0|||
23593886|NCT03981822|65903244|FG004|Overall Study|COVID-19 Related|2|||
23644468|NCT04602221|66082706|FG001|Overall Study|Lost to Follow-up|0|||
23644469|NCT04602221|66082707|FG002|Overall Study|Lost to Follow-up|0|||
23644470|NCT04602221|66082708|FG003|Overall Study|Lost to Follow-up|0|||
23644471|NCT04602221|66082709|FG004|Overall Study|Lost to Follow-up|0|||
23644472|NCT04602221|66082710|FG005|Overall Study|Lost to Follow-up|1|||
23644473|NCT04602221|66082711|FG006|Overall Study|Lost to Follow-up|0|||
23644474|NCT04602221|66082712|FG007|Overall Study|Lost to Follow-up|0|||
23644475|NCT04602221|66082713|FG008|Overall Study|Lost to Follow-up|0|||
23644476|NCT04602221|66082714|FG009|Overall Study|Lost to Follow-up|0|||
23644477|NCT04602221|66082715|FG010|Overall Study|Lost to Follow-up|0|||
23644478|NCT04602221|66082716|FG011|Overall Study|Lost to Follow-up|0|||
23644479|NCT04602221|66082717|FG012|Overall Study|Lost to Follow-up|0|||
23644480|NCT04602221|66082718|FG013|Overall Study|Lost to Follow-up|0|||
23644481|NCT04602221|66082719|FG014|Overall Study|Lost to Follow-up|0|||
23644482|NCT04602221|66082720|FG015|Overall Study|Lost to Follow-up|0|||
23644483|NCT04602221|66082721|FG016|Overall Study|Lost to Follow-up|0|||
23644484|NCT04602221|66082722|FG017|Overall Study|Lost to Follow-up|0|||
23644485|NCT01590082|66082723|FG000|Overall Study|Withdrawal by Subject|1|||
23644486|NCT01590082|66082724|FG001|Overall Study|Withdrawal by Subject|0|||
23644487|NCT01590082|66082723|FG000|Overall Study|Ineligible|1|||
23644488|NCT01590082|66082724|FG001|Overall Study|Ineligible|0|||
23644489|NCT02413333|66082725|FG000|Period 1|Adverse Event|1|||
23644490|NCT02413333|66082726|FG001|Period 1|Adverse Event|0|||
23593887|NCT03981822|65903245|FG005|Overall Study|COVID-19 Related|1|||
23593888|NCT03981822|65903246|FG006|Overall Study|COVID-19 Related|2|||
23593889|NCT03981822|65903247|FG007|Overall Study|COVID-19 Related|1|||
23593890|NCT02383472|65906076|FG000|Overall Study|Withdrawal by Subject|1|||
23593891|NCT02383472|65906077|FG001|Overall Study|Withdrawal by Subject|1|||
23593892|NCT02362035|65906078|FG000|Overall Study|Death|67|||
23593893|NCT02362035|65906078|FG000|Overall Study|Lost to Follow-up|3|||
23593894|NCT02362035|65906078|FG000|Overall Study|Adverse Event|1|||
23593895|NCT02362035|65906078|FG000|Overall Study|Physician Decision|1|||
23593896|NCT02362035|65906078|FG000|Overall Study|Subject started another cancer therapy|10|||
23593897|NCT02362035|65906078|FG000|Overall Study|Study terminated by sponsor|45|||
23593898|NCT02362035|65906078|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
23593899|NCT02362035|65906078|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
23593900|NCT02362035|65906078|FG000|Overall Study|Disease progression|11|||
23593901|NCT02362035|65906078|FG000|Overall Study|Withdrawal by Subject|20|||
23593902|NCT02466516|65906079|FG000|Overall Study|Adverse Event|1|||
23593903|NCT02466516|65906080|FG001|Overall Study|Adverse Event|1|||
23593904|NCT02466516|65906081|FG002|Overall Study|Adverse Event|0|||
23593905|NCT02466516|65906082|FG003|Overall Study|Adverse Event|0|||
23593906|NCT02466516|65906083|FG004|Overall Study|Adverse Event|0|||
23593907|NCT02466516|65906079|FG000|Overall Study|Withdrew Consent|1|||
23593908|NCT02466516|65906080|FG001|Overall Study|Withdrew Consent|0|||
23593909|NCT02466516|65906081|FG002|Overall Study|Withdrew Consent|0|||
23593910|NCT02466516|65906082|FG003|Overall Study|Withdrew Consent|0|||
23593911|NCT02466516|65906083|FG004|Overall Study|Withdrew Consent|0|||
23593912|NCT02466516|65906079|FG000|Overall Study|Lost to Follow-up|2|||
23593913|NCT02466516|65906080|FG001|Overall Study|Lost to Follow-up|0|||
23593914|NCT02466516|65906081|FG002|Overall Study|Lost to Follow-up|1|||
23593915|NCT02466516|65906082|FG003|Overall Study|Lost to Follow-up|0|||
23593916|NCT02466516|65906083|FG004|Overall Study|Lost to Follow-up|0|||
23593917|NCT02299375|65906084|FG000|Overall Study|Adverse Event, serious fatal|1|||
23593918|NCT02299375|65906085|FG001|Overall Study|Adverse Event, serious fatal|3|||
23593919|NCT02299375|65906084|FG000|Overall Study|Adverse Event, non-fatal|8|||
23593920|NCT02299375|65906085|FG001|Overall Study|Adverse Event, non-fatal|9|||
23593921|NCT02299375|65906084|FG000|Overall Study|Lack of Efficacy|1|||
23593922|NCT02299375|65906085|FG001|Overall Study|Lack of Efficacy|3|||
23593923|NCT02299375|65906084|FG000|Overall Study|Protocol Violation|1|||
23593924|NCT02299375|65906085|FG001|Overall Study|Protocol Violation|3|||
23593925|NCT02299375|65906084|FG000|Overall Study|Other: Met stopping criteria|1|||
23644491|NCT02413333|66082725|FG000|Period 1|Reason Not Specified|0|||
23644492|NCT02413333|66082726|FG001|Period 1|Reason Not Specified|1|||
23644493|NCT02413333|66082725|FG000|Period 2|Protocol Deviation|1|||
23644494|NCT02413333|66082726|FG001|Period 2|Protocol Deviation|0|||
23593926|NCT02299375|65906085|FG001|Overall Study|Other: Met stopping criteria|0|||
23593927|NCT02299375|65906084|FG000|Overall Study|Other: Study closed/terminated|66|||
23593928|NCT02299375|65906085|FG001|Overall Study|Other: Study closed/terminated|55|||
23593929|NCT02299375|65906084|FG000|Overall Study|Lost to Follow-up|0|||
23593930|NCT02299375|65906085|FG001|Overall Study|Lost to Follow-up|2|||
23644495|NCT03590366|66082727|FG000|Overall Study|Adverse Event|0|||
23644496|NCT03590366|66082728|FG001|Overall Study|Adverse Event|3|||
23644497|NCT03590366|66082727|FG000|Overall Study|Lost to Follow-up|3|||
23644498|NCT03590366|66082728|FG001|Overall Study|Lost to Follow-up|3|||
23593931|NCT02299375|65906084|FG000|Overall Study|Physician Decision|1|||
23593932|NCT02299375|65906085|FG001|Overall Study|Physician Decision|1|||
23593933|NCT02299375|65906084|FG000|Overall Study|Withdrawal by Subject|1|||
23593934|NCT02299375|65906085|FG001|Overall Study|Withdrawal by Subject|4|||
23593935|NCT02983617|65906087|FG000|Overall Study|Adverse Event|0|||
23593936|NCT02983617|65906088|FG001|Overall Study|Adverse Event|7|||
23593937|NCT02983617|65906087|FG000|Overall Study|Death|0|||
23593938|NCT02983617|65906088|FG001|Overall Study|Death|1|||
23593939|NCT02983617|65906087|FG000|Overall Study|Investigator's Discretion|0|||
23593940|NCT02983617|65906088|FG001|Overall Study|Investigator's Discretion|1|||
23593941|NCT01925339|65906089|FG000|Overall Study|Adverse Event|2|||
23593942|NCT01925339|65906090|FG001|Overall Study|Adverse Event|0|||
23593943|NCT03544515|65906091|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
23593944|NCT03544515|65906092|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
23593945|NCT03544515|65906091|FG000|Overall Study|Lost to Follow-up|2|||
23593946|NCT03544515|65906092|FG001|Overall Study|Lost to Follow-up|0|||
23593947|NCT03684044|65906094|FG000|Overall Study|Adverse Event|3|||
23593948|NCT03684044|65906095|FG001|Overall Study|Adverse Event|0|||
23593949|NCT03684044|65906094|FG000|Overall Study|Death|4|||
23593950|NCT03684044|65906095|FG001|Overall Study|Death|7|||
23593951|NCT03684044|65906094|FG000|Overall Study|Lost to Follow-up|3|||
23593952|NCT03684044|65906095|FG001|Overall Study|Lost to Follow-up|2|||
23593953|NCT03684044|65906094|FG000|Overall Study|Patient Not Available|0|||
23593954|NCT03684044|65906095|FG001|Overall Study|Patient Not Available|2|||
23593955|NCT03684044|65906094|FG000|Overall Study|Physician Decision|1|||
23593956|NCT03684044|65906095|FG001|Overall Study|Physician Decision|0|||
23593957|NCT03684044|65906094|FG000|Overall Study|Withdrawal by Subject|11|||
23593958|NCT03684044|65906095|FG001|Overall Study|Withdrawal by Subject|9|||
23593959|NCT00001277|65906099|FG000|Overall Study|Adverse Event|0|||
23593960|NCT00001277|65906100|FG001|Overall Study|Adverse Event|0|||
23593961|NCT00001277|65906101|FG002|Overall Study|Adverse Event|1|||
23593962|NCT00001277|65906099|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
23593963|NCT00001277|65906100|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
23593964|NCT00001277|65906101|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
23593965|NCT01227278|65906102|FG000|Overall Study|Withdrawal by Subject|4|||
23593966|NCT01227278|65906103|FG001|Overall Study|Withdrawal by Subject|4|||
23593967|NCT01227278|65906102|FG000|Overall Study|Death|0|||
23593968|NCT01227278|65906103|FG001|Overall Study|Death|2|||
23593969|NCT01227278|65906102|FG000|Overall Study|Other|1|||
23593970|NCT01227278|65906103|FG001|Overall Study|Other|2|||
23593971|NCT02742519|65906104|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
23593972|NCT02742519|65906105|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
23593973|NCT02742519|65906106|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
23593974|NCT02742519|65906104|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
23593975|NCT02742519|65906105|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
23593976|NCT02742519|65906106|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
23593977|NCT02742519|65906104|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
23593978|NCT02742519|65906105|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
23593979|NCT02742519|65906106|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
23593980|NCT00542789|65906111|FG000|Overall Study|Adverse Event|18|||
23593981|NCT00542789|65906112|FG001|Overall Study|Adverse Event|17|||
23593982|NCT00542789|65906111|FG000|Overall Study|Withdrawal by Subject|7|||
23593983|NCT00542789|65906112|FG001|Overall Study|Withdrawal by Subject|3|||
23593984|NCT00542789|65906111|FG000|Overall Study|Protocol Violation|8|||
23593985|NCT00542789|65906112|FG001|Overall Study|Protocol Violation|1|||
23593986|NCT00542789|65906111|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
23593987|NCT00542789|65906112|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
23593988|NCT01278394|65906113|FG000|Overall Study|Lost to Follow-up|1|||
23593989|NCT01759771|65906114|FG000|Overall Study|Withdrawal by Subject|1|||
23593990|NCT01759771|65906115|FG001|Overall Study|Withdrawal by Subject|1|||
23593991|NCT00979992|65906116|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23593992|NCT00979992|65906116|FG000|Overall Study|Ineligible - wrong cell type|2|||
23800024|NCT00931463|66646630|FG000|Overall Study|Death|8|||
23593993|NCT00979992|65906116|FG000|Overall Study|Refused - Never Treated|2|||
23593994|NCT01662336|65906119|FG000|Overall Study|Adverse Event|1|||
23593995|NCT01662336|65906119|FG000|Overall Study|No longer on LPV/r|30|||
23593996|NCT01662336|65906119|FG000|Overall Study|Other|29|||
23593997|NCT01662336|65906119|FG000|Overall Study|Withdrawal by Subject|6|||
23593998|NCT04252586|65906120|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23593999|NCT04252586|65906120|FG000|Overall Study|Adverse Event|1|||
23594000|NCT04252586|65906120|FG000|Overall Study|Death|2|||
23594001|NCT04252586|65906120|FG000|Overall Study|Study terminated by sponsor|4|||
23594002|NCT04252586|65906120|FG000|Overall Study|Sponsor request|10|||
23594003|NCT04252586|65906120|FG000|Overall Study|Did not complete treatment period|1|||
23594004|NCT01823536|65906121|FG000|Overall Study|Lost to Follow-up|1|||
23644499|NCT03590366|66082727|FG000|Overall Study|Withdrawal by Subject|0|||
23644500|NCT03590366|66082728|FG001|Overall Study|Withdrawal by Subject|2|||
23644501|NCT00081497|66082731|FG000|Overall Study|Adverse Event|2|||
23644502|NCT00081497|66082732|FG001|Overall Study|Adverse Event|0|||
23644503|NCT00081497|66082731|FG000|Overall Study|Death|0|||
23594005|NCT01823536|65906122|FG001|Overall Study|Lost to Follow-up|0|||
23594006|NCT01823536|65906123|FG002|Overall Study|Lost to Follow-up|0|||
23594007|NCT01823536|65906124|FG003|Overall Study|Lost to Follow-up|1|||
23594008|NCT01823536|65906125|FG004|Overall Study|Lost to Follow-up|1|||
23594009|NCT01823536|65906126|FG005|Overall Study|Lost to Follow-up|0|||
23594010|NCT01823536|65906121|FG000|Overall Study|Protocol Violation|0|||
23594011|NCT01823536|65906122|FG001|Overall Study|Protocol Violation|1|||
23594012|NCT01823536|65906123|FG002|Overall Study|Protocol Violation|0|||
23594013|NCT01823536|65906124|FG003|Overall Study|Protocol Violation|0|||
23594014|NCT01823536|65906125|FG004|Overall Study|Protocol Violation|0|||
23800025|NCT00931463|66646631|FG001|Overall Study|Death|4|||
23800026|NCT00931463|66646630|FG000|Overall Study|Withdrawal by Subject|5|||
23800027|NCT00931463|66646631|FG001|Overall Study|Withdrawal by Subject|0|||
23800028|NCT00931463|66646630|FG000|Overall Study|Lost to Follow-up|4|||
23800029|NCT00931463|66646631|FG001|Overall Study|Lost to Follow-up|1|||
23800030|NCT02733627|66646634|FG000|Overall Study|Adverse Event|0|||
23594015|NCT01823536|65906126|FG005|Overall Study|Protocol Violation|0|||
23644504|NCT00081497|66082732|FG001|Overall Study|Death|1|||
23644505|NCT00081497|66082731|FG000|Overall Study|Withdrawal by Subject|1|||
23644506|NCT00081497|66082732|FG001|Overall Study|Withdrawal by Subject|0|||
23644507|NCT00081497|66082731|FG000|Overall Study|Non-compliance|0|||
23644508|NCT00081497|66082732|FG001|Overall Study|Non-compliance|1|||
23644509|NCT02414932|66082741|FG000|Overall Study|Withdrawal by Subject|2|||
23644510|NCT02414932|66082742|FG001|Overall Study|Withdrawal by Subject|3|||
23644511|NCT02414932|66082741|FG000|Overall Study|Adverse Event|1|||
23644512|NCT02414932|66082742|FG001|Overall Study|Adverse Event|0|||
23644513|NCT02947087|66082745|FG000|Overall Study|Withdrawal by Subject|3|||
23644514|NCT02947087|66082746|FG001|Overall Study|Withdrawal by Subject|2|||
23644515|NCT02523599|66082748|FG000|Overall Study|Adverse Event|1|||
23644516|NCT02523599|66082749|FG001|Overall Study|Adverse Event|0|||
23644517|NCT02523599|66082748|FG000|Overall Study|Physician Decision|1|||
23644518|NCT02523599|66082749|FG001|Overall Study|Physician Decision|0|||
23644519|NCT02523599|66082748|FG000|Overall Study|Lost to Follow-up|4|||
23644520|NCT02523599|66082749|FG001|Overall Study|Lost to Follow-up|1|||
23644521|NCT02523599|66082748|FG000|Overall Study|Did not return for Day 30 visit|2|||
23644522|NCT02523599|66082749|FG001|Overall Study|Did not return for Day 30 visit|0|||
23644523|NCT02424734|66082750|FG000|Overall Study|Treatment stopped to be discharged home|2|||
23644524|NCT02424734|66082751|FG001|Overall Study|Treatment stopped to be discharged home|2|||
23644525|NCT02424734|66082752|FG002|Overall Study|Treatment stopped to be discharged home|0|||
23644526|NCT00816400|66082760|FG000|Overall Study|Death|2|||
23644527|NCT00816400|66082761|FG001|Overall Study|Death|3|||
23644528|NCT00816400|66082762|FG002|Overall Study|Death|3|||
23644529|NCT00816400|66082763|FG003|Overall Study|Death|3|||
23800031|NCT02733627|66646635|FG001|Overall Study|Adverse Event|1|||
23800032|NCT02733627|66646636|FG002|Overall Study|Adverse Event|1|||
23800033|NCT02733627|66646637|FG003|Overall Study|Adverse Event|0|||
23800034|NCT02733627|66646634|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23800035|NCT02733627|66646635|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23800036|NCT02733627|66646636|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
23800037|NCT02733627|66646637|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23800038|NCT00794417|66646638|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23477510|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
23477511|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
23477512|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
23477513|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
23477514|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
23477515|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
23594016|NCT01823536|65906121|FG000|Overall Study|Withdrawal by Subject|1|||
23594017|NCT01823536|65906122|FG001|Overall Study|Withdrawal by Subject|1|||
23594018|NCT01823536|65906123|FG002|Overall Study|Withdrawal by Subject|0|||
23594019|NCT01823536|65906124|FG003|Overall Study|Withdrawal by Subject|0|||
23644530|NCT00816400|66082764|FG004|Overall Study|Death|2|||
23644531|NCT00816400|66082765|FG005|Overall Study|Death|3|||
23644532|NCT00816400|66082766|FG006|Overall Study|Death|2|||
23644533|NCT00816400|66082767|FG007|Overall Study|Death|5|||
23644534|NCT00816400|66082768|FG008|Overall Study|Death|6|||
23644535|NCT00816400|66082760|FG000|Overall Study|In hospice care at the end of the study|0|||
23644536|NCT00816400|66082761|FG001|Overall Study|In hospice care at the end of the study|0|||
23644537|NCT00816400|66082762|FG002|Overall Study|In hospice care at the end of the study|2|||
23594020|NCT01823536|65906125|FG004|Overall Study|Withdrawal by Subject|0|||
23594021|NCT01823536|65906126|FG005|Overall Study|Withdrawal by Subject|0|||
23594022|NCT01823536|65906121|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594023|NCT01823536|65906122|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594024|NCT01823536|65906123|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
23594025|NCT01823536|65906124|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594026|NCT01823536|65906125|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594027|NCT01823536|65906126|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594028|NCT01823536|65906121|FG000|Overall Study|Met exclusion criterion No 6|0|||
23594029|NCT01823536|65906122|FG001|Overall Study|Met exclusion criterion No 6|0|||
23594030|NCT01823536|65906123|FG002|Overall Study|Met exclusion criterion No 6|0|||
23594031|NCT01823536|65906124|FG003|Overall Study|Met exclusion criterion No 6|1|||
23594032|NCT01823536|65906125|FG004|Overall Study|Met exclusion criterion No 6|0|||
23594033|NCT01823536|65906126|FG005|Overall Study|Met exclusion criterion No 6|0|||
23594034|NCT01823536|65906121|FG000|Overall Study|Subject moved out of the state|0|||
23594035|NCT01823536|65906122|FG001|Overall Study|Subject moved out of the state|0|||
23594036|NCT01823536|65906123|FG002|Overall Study|Subject moved out of the state|0|||
23594037|NCT01823536|65906124|FG003|Overall Study|Subject moved out of the state|0|||
23594038|NCT01823536|65906125|FG004|Overall Study|Subject moved out of the state|1|||
23594039|NCT01823536|65906126|FG005|Overall Study|Subject moved out of the state|0|||
23594040|NCT00802464|65906130|FG000|Month 0 - Month 8|Adverse Event|0|||
23594041|NCT00802464|65906131|FG001|Month 0 - Month 8|Adverse Event|1|||
23594042|NCT00802464|65906132|FG002|Month 0 - Month 8|Adverse Event|1|||
23594043|NCT00802464|65906133|FG003|Month 0 - Month 8|Adverse Event|2|||
23594044|NCT00802464|65906130|FG000|Month 0 - Month 8|Protocol Violation|0|||
23594045|NCT00802464|65906131|FG001|Month 0 - Month 8|Protocol Violation|0|||
23594046|NCT00802464|65906132|FG002|Month 0 - Month 8|Protocol Violation|1|||
23594047|NCT00802464|65906133|FG003|Month 0 - Month 8|Protocol Violation|0|||
23594048|NCT00802464|65906130|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
23594049|NCT00802464|65906131|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
23594050|NCT00802464|65906132|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
23594051|NCT00802464|65906133|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
23594052|NCT00802464|65906130|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
23594053|NCT00802464|65906131|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
23594054|NCT00802464|65906132|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
23594055|NCT00802464|65906133|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
23594056|NCT00802464|65906130|FG000|Month 0 - Month 8|Other|0|||
23594057|NCT00802464|65906131|FG001|Month 0 - Month 8|Other|0|||
23594058|NCT00802464|65906132|FG002|Month 0 - Month 8|Other|1|||
23594059|NCT00802464|65906133|FG003|Month 0 - Month 8|Other|0|||
23594060|NCT00802464|65906130|FG000|Month 8 - Month 14|Adverse Event|0|||
23594061|NCT00802464|65906131|FG001|Month 8 - Month 14|Adverse Event|1|||
23594062|NCT00802464|65906132|FG002|Month 8 - Month 14|Adverse Event|0|||
23594063|NCT00802464|65906133|FG003|Month 8 - Month 14|Adverse Event|0|||
23594064|NCT00802464|65906130|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
23594065|NCT00802464|65906131|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
23594066|NCT00802464|65906132|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
23594067|NCT00802464|65906133|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
23594068|NCT00802464|65906130|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
23594069|NCT00802464|65906131|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
23594070|NCT00802464|65906132|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
23594071|NCT00802464|65906133|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
23594072|NCT00549848|65906134|FG000|Overall Study|Death|1|||
23594073|NCT00549848|65906135|FG001|Overall Study|Death|4|||
23594074|NCT00549848|65906136|FG002|Overall Study|Death|13|||
23594075|NCT00549848|65906134|FG000|Overall Study|Physician Decision|0|||
23594076|NCT00549848|65906135|FG001|Overall Study|Physician Decision|0|||
23594077|NCT00549848|65906136|FG002|Overall Study|Physician Decision|4|||
23594078|NCT00549848|65906134|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
23594079|NCT00549848|65906135|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
23594080|NCT00549848|65906136|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
23594081|NCT00549848|65906134|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
23360199|NCT00420628|65062855|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
23594082|NCT00549848|65906135|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
23594083|NCT00549848|65906136|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
23594084|NCT00549848|65906134|FG000|Overall Study|Participant/Family Withdraw|2|||
23594085|NCT00549848|65906135|FG001|Overall Study|Participant/Family Withdraw|3|||
23594086|NCT00549848|65906136|FG002|Overall Study|Participant/Family Withdraw|5|||
23594087|NCT00549848|65906134|FG000|Overall Study|Second Malignancy|1|||
23594088|NCT00549848|65906135|FG001|Overall Study|Second Malignancy|0|||
23594089|NCT00549848|65906136|FG002|Overall Study|Second Malignancy|0|||
23594090|NCT00549848|65906134|FG000|Overall Study|Transplant|3|||
23594091|NCT00549848|65906135|FG001|Overall Study|Transplant|3|||
23594092|NCT00549848|65906136|FG002|Overall Study|Transplant|18|||
23594093|NCT00549848|65906134|FG000|Overall Study|Unacceptable Toxicity|1|||
23360200|NCT00420628|65062854|FG000|Overall Study|Lost to Follow-up|3|||
23477516|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477517|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477518|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477519|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
23477520|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477521|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477522|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
23477523|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477524|NCT00095147|65491613|FG000|Long-term Extension Period|Death|0|||
23477525|NCT00095147|65491614|FG001|Long-term Extension Period|Death|0|||
23477526|NCT00095147|65491615|FG002|Long-term Extension Period|Death|0|||
23477527|NCT00095147|65491616|FG003|Long-term Extension Period|Death|0|||
23477528|NCT00095147|65491617|FG004|Long-term Extension Period|Death|3|||
23477529|NCT00095147|65491613|FG000|Long-term Extension Period|Adverse Event|0|||
23477530|NCT00095147|65491614|FG001|Long-term Extension Period|Adverse Event|0|||
23477531|NCT00095147|65491615|FG002|Long-term Extension Period|Adverse Event|0|||
23477532|NCT00095147|65491616|FG003|Long-term Extension Period|Adverse Event|0|||
23477533|NCT00095147|65491617|FG004|Long-term Extension Period|Adverse Event|11|||
23477534|NCT00095147|65491613|FG000|Long-term Extension Period|Lack of Efficacy|0|||
23477535|NCT00095147|65491614|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23477536|NCT00095147|65491615|FG002|Long-term Extension Period|Lack of Efficacy|0|||
23477537|NCT00095147|65491616|FG003|Long-term Extension Period|Lack of Efficacy|0|||
23477538|NCT00095147|65491617|FG004|Long-term Extension Period|Lack of Efficacy|9|||
23477539|NCT00095147|65491613|FG000|Long-term Extension Period|Lost to Follow-up|0|||
23477540|NCT00095147|65491614|FG001|Long-term Extension Period|Lost to Follow-up|0|||
23477541|NCT00095147|65491615|FG002|Long-term Extension Period|Lost to Follow-up|0|||
23477542|NCT00095147|65491616|FG003|Long-term Extension Period|Lost to Follow-up|0|||
23477543|NCT00095147|65491617|FG004|Long-term Extension Period|Lost to Follow-up|6|||
23477544|NCT00095147|65491613|FG000|Long-term Extension Period|Withdrawal of consent|0|||
23477545|NCT00095147|65491614|FG001|Long-term Extension Period|Withdrawal of consent|0|||
23477546|NCT00095147|65491615|FG002|Long-term Extension Period|Withdrawal of consent|0|||
23477547|NCT00095147|65491616|FG003|Long-term Extension Period|Withdrawal of consent|0|||
23477548|NCT00095147|65491617|FG004|Long-term Extension Period|Withdrawal of consent|12|||
23477549|NCT00095147|65491613|FG000|Long-term Extension Period|Pregnancy|0|||
23477550|NCT00095147|65491614|FG001|Long-term Extension Period|Pregnancy|0|||
23477551|NCT00095147|65491615|FG002|Long-term Extension Period|Pregnancy|0|||
23477552|NCT00095147|65491616|FG003|Long-term Extension Period|Pregnancy|0|||
23477553|NCT00095147|65491617|FG004|Long-term Extension Period|Pregnancy|1|||
23477554|NCT00095147|65491613|FG000|Long-term Extension Period|No longer meets study criteria|0|||
23477555|NCT00095147|65491614|FG001|Long-term Extension Period|No longer meets study criteria|0|||
23477556|NCT00095147|65491615|FG002|Long-term Extension Period|No longer meets study criteria|0|||
23477557|NCT00095147|65491616|FG003|Long-term Extension Period|No longer meets study criteria|0|||
23477558|NCT00095147|65491617|FG004|Long-term Extension Period|No longer meets study criteria|1|||
23477559|NCT00095147|65491613|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
23477560|NCT00095147|65491614|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
23477561|NCT00095147|65491615|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
23477562|NCT00095147|65491616|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
23477563|NCT00095147|65491617|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
23477564|NCT00095147|65491613|FG000|Long-term Extension Period|Leaving country|0|||
23477565|NCT00095147|65491614|FG001|Long-term Extension Period|Leaving country|0|||
23477566|NCT00095147|65491615|FG002|Long-term Extension Period|Leaving country|0|||
23477567|NCT00095147|65491616|FG003|Long-term Extension Period|Leaving country|0|||
23477568|NCT00095147|65491617|FG004|Long-term Extension Period|Leaving country|1|||
23477569|NCT00727441|65491618|FG000|Overall Study|Disease Progression|11|||
23477570|NCT00727441|65491619|FG001|Overall Study|Disease Progression|14|||
23477571|NCT00727441|65491620|FG002|Overall Study|Disease Progression|17|||
23477572|NCT00727441|65491618|FG000|Overall Study|Eligibility|7|||
23477573|NCT00727441|65491619|FG001|Overall Study|Eligibility|5|||
23477574|NCT00727441|65491620|FG002|Overall Study|Eligibility|7|||
23477575|NCT00727441|65491618|FG000|Overall Study|Death|0|||
23477576|NCT00727441|65491619|FG001|Overall Study|Death|1|||
23477577|NCT00727441|65491620|FG002|Overall Study|Death|1|||
23594094|NCT00549848|65906135|FG001|Overall Study|Unacceptable Toxicity|6|||
23594095|NCT00549848|65906136|FG002|Overall Study|Unacceptable Toxicity|6|||
23594096|NCT01443845|65906140|FG000|Overall Study|Protocol Violation|43|||
23594097|NCT01443845|65906141|FG001|Overall Study|Protocol Violation|45|||
23594098|NCT01443845|65906140|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
23594099|NCT01443845|65906141|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
23594100|NCT01443845|65906140|FG000|Overall Study|Deterioration in pulmonary function|1|||
23594101|NCT01443845|65906141|FG001|Overall Study|Deterioration in pulmonary function|4|||
23594102|NCT01443845|65906140|FG000|Overall Study|Lack of Efficacy|10|||
23594103|NCT01443845|65906141|FG001|Overall Study|Lack of Efficacy|5|||
23594104|NCT01443845|65906140|FG000|Overall Study|Adverse Event|64|||
23594105|NCT01443845|65906141|FG001|Overall Study|Adverse Event|138|||
23594106|NCT01443845|65906140|FG000|Overall Study|Withdrawal by Subject|63|||
23594107|NCT01443845|65906141|FG001|Overall Study|Withdrawal by Subject|67|||
23594108|NCT01443845|65906140|FG000|Overall Study|Military Conflict - Site Terminated|20|||
23594109|NCT01443845|65906141|FG001|Overall Study|Military Conflict - Site Terminated|21|||
23594110|NCT01443845|65906140|FG000|Overall Study|Lost to Follow-up|9|||
23594111|NCT01443845|65906141|FG001|Overall Study|Lost to Follow-up|13|||
23594112|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594113|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594114|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
23594115|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594116|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594117|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594118|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
23594119|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594120|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594121|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594122|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594123|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
23594124|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23594125|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
23594126|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23594127|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23594128|NCT02794480|65906144|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23594129|NCT02794480|65906145|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23594130|NCT02794480|65906146|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23594131|NCT02794480|65906147|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23594132|NCT04732338|65906153|FG000|Overall Study|Lost to Follow-up|3|||
23594133|NCT04732338|65906154|FG001|Overall Study|Lost to Follow-up|3|||
23594134|NCT05382104|65906155|FG000|Period 2 (2 Days)|Adverse Event|0|||
23594135|NCT05382104|65906156|FG001|Period 2 (2 Days)|Adverse Event|1|||
23594136|NCT05382104|65906157|FG002|Period 2 (2 Days)|Adverse Event|0|||
23594137|NCT05382104|65906158|FG003|Period 2 (2 Days)|Adverse Event|0|||
23594138|NCT05382104|65906159|FG004|Period 2 (2 Days)|Adverse Event|0|||
23594139|NCT05382104|65906160|FG005|Period 2 (2 Days)|Adverse Event|0|||
23594140|NCT00857649|65906161|FG000|Overall Study|Adverse Event|15|||
23594141|NCT00857649|65906162|FG001|Overall Study|Adverse Event|10|||
23594142|NCT00857649|65906161|FG000|Overall Study|Non-compliance|1|||
23594143|NCT00857649|65906162|FG001|Overall Study|Non-compliance|1|||
23594144|NCT00857649|65906161|FG000|Overall Study|Protocol Violation|2|||
23594145|NCT00857649|65906162|FG001|Overall Study|Protocol Violation|2|||
23594146|NCT00857649|65906161|FG000|Overall Study|Withdrawal of Consent|10|||
23594147|NCT00857649|65906162|FG001|Overall Study|Withdrawal of Consent|7|||
23594148|NCT00857649|65906161|FG000|Overall Study|Nursing Home Placement|2|||
23594149|NCT00857649|65906162|FG001|Overall Study|Nursing Home Placement|9|||
23594150|NCT00857649|65906161|FG000|Overall Study|Other Reasons|1|||
23594151|NCT00857649|65906162|FG001|Overall Study|Other Reasons|3|||
23594152|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
23594153|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
23594154|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23594155|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
23594156|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23594157|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23360201|NCT00420628|65062855|FG001|Overall Study|Lost to Follow-up|2|||
23594158|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23594159|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23594160|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
23594161|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
23594162|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594163|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23477578|NCT00727441|65491618|FG000|Overall Study|Physician Decision|0|||
23477579|NCT00727441|65491619|FG001|Overall Study|Physician Decision|1|||
23477580|NCT00727441|65491620|FG002|Overall Study|Physician Decision|0|||
23477581|NCT00727441|65491618|FG000|Overall Study|Withdrawal by Subject|0|||
23477582|NCT00727441|65491619|FG001|Overall Study|Withdrawal by Subject|1|||
23477583|NCT00727441|65491620|FG002|Overall Study|Withdrawal by Subject|0|||
23477584|NCT01037088|65491626|FG000|Overall Study|Withdrawal by Subject|3|||
23477585|NCT01236547|65491627|FG000|Overall Study|Protocol Violation|0|||
23477586|NCT01236547|65491628|FG001|Overall Study|Protocol Violation|1|||
23477587|NCT01236547|65491629|FG002|Overall Study|Protocol Violation|1|||
23477588|NCT01236547|65491630|FG003|Overall Study|Protocol Violation|6|||
23477589|NCT01236547|65491631|FG004|Overall Study|Protocol Violation|12|||
23594164|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594165|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594166|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594167|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594168|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594169|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
23644538|NCT00816400|66082763|FG003|Overall Study|In hospice care at the end of the study|0|||
23644539|NCT00816400|66082764|FG004|Overall Study|In hospice care at the end of the study|0|||
23644540|NCT00816400|66082765|FG005|Overall Study|In hospice care at the end of the study|0|||
23644541|NCT00816400|66082766|FG006|Overall Study|In hospice care at the end of the study|0|||
23644542|NCT00816400|66082767|FG007|Overall Study|In hospice care at the end of the study|0|||
23644543|NCT00816400|66082768|FG008|Overall Study|In hospice care at the end of the study|0|||
23644544|NCT00979134|66082769|FG000|Overall Study|Disease progression|18|||
23644545|NCT00979134|66082770|FG001|Overall Study|Disease progression|2|||
23644546|NCT00979134|66082771|FG002|Overall Study|Disease progression|5|||
23644547|NCT00979134|66082769|FG000|Overall Study|Adverse Event|0|||
23644548|NCT00979134|66082770|FG001|Overall Study|Adverse Event|0|||
23644549|NCT00979134|66082771|FG002|Overall Study|Adverse Event|2|||
23644550|NCT00979134|66082769|FG000|Overall Study|Withdrawal by Subject|1|||
23644551|NCT00979134|66082770|FG001|Overall Study|Withdrawal by Subject|1|||
23644552|NCT00979134|66082771|FG002|Overall Study|Withdrawal by Subject|2|||
23644553|NCT00979134|66082769|FG000|Overall Study|Lost to Follow-up|2|||
23800039|NCT00794417|66646639|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23800040|NCT00794417|66646640|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
23800041|NCT00794417|66646641|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23800042|NCT00794417|66646638|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
23800043|NCT00794417|66646639|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
23800044|NCT00794417|66646640|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
23360202|NCT00420628|65062854|FG000|Overall Study|Adverse Event|1|||
23594170|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594171|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594172|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594173|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594174|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594175|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594176|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
23594177|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
23594178|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
23594179|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
23594180|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
23594181|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
23594182|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
23594183|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
23594184|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23594185|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
23594186|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594187|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594188|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594189|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23477590|NCT01989468|65491632|FG000|Overall Study|Adverse Event|10|||
23477591|NCT01989468|65491633|FG001|Overall Study|Adverse Event|15|||
23477592|NCT01989468|65491634|FG002|Overall Study|Adverse Event|4|||
23594190|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594191|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23477593|NCT01989468|65491635|FG003|Overall Study|Adverse Event|5|||
23477594|NCT01989468|65491636|FG004|Overall Study|Adverse Event|4|||
23594192|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
23644554|NCT00979134|66082770|FG001|Overall Study|Lost to Follow-up|2|||
23644555|NCT00979134|66082771|FG002|Overall Study|Lost to Follow-up|0|||
23644556|NCT00979134|66082769|FG000|Overall Study|Death|4|||
23800045|NCT00794417|66646641|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
23800046|NCT00794417|66646638|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23800047|NCT00794417|66646639|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23800048|NCT00794417|66646640|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23800049|NCT00794417|66646641|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
23800050|NCT00794417|66646638|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23800051|NCT00794417|66646639|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23800052|NCT00794417|66646640|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23800053|NCT00794417|66646641|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
23800054|NCT00794417|66646638|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23800055|NCT00794417|66646639|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23800056|NCT00794417|66646640|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23800057|NCT00794417|66646641|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
23800058|NCT00794417|66646638|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23800059|NCT00794417|66646639|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23800060|NCT00794417|66646640|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23800061|NCT00794417|66646641|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
23800062|NCT00099268|66646646|FG000|Overall Study|Withdrawal by Subject|46|||
23800063|NCT00099268|66646647|FG001|Overall Study|Withdrawal by Subject|28|||
23477595|NCT01989468|65491632|FG000|Overall Study|Lack of Efficacy|11|||
23477596|NCT01989468|65491633|FG001|Overall Study|Lack of Efficacy|11|||
23477597|NCT01989468|65491634|FG002|Overall Study|Lack of Efficacy|7|||
23477598|NCT01989468|65491635|FG003|Overall Study|Lack of Efficacy|4|||
23477599|NCT01989468|65491636|FG004|Overall Study|Lack of Efficacy|2|||
23477600|NCT01989468|65491632|FG000|Overall Study|Lost to Follow-up|5|||
23477601|NCT01989468|65491633|FG001|Overall Study|Lost to Follow-up|2|||
23644557|NCT00979134|66082770|FG001|Overall Study|Death|0|||
23644558|NCT00979134|66082771|FG002|Overall Study|Death|26|||
23644559|NCT00979134|66082769|FG000|Overall Study|Other|8|||
23644560|NCT00979134|66082770|FG001|Overall Study|Other|1|||
23644561|NCT00979134|66082771|FG002|Overall Study|Other|5|||
23800064|NCT00099268|66646646|FG000|Overall Study|Adverse Event|19|||
23800065|NCT00099268|66646647|FG001|Overall Study|Adverse Event|19|||
23800066|NCT00099268|66646646|FG000|Overall Study|Protocol Violation|9|||
23477602|NCT01989468|65491634|FG002|Overall Study|Lost to Follow-up|0|||
23477603|NCT01989468|65491635|FG003|Overall Study|Lost to Follow-up|1|||
23594193|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594194|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594195|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594196|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594197|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
23594198|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
23594199|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
23594200|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594201|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594202|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594203|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
23594204|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594205|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594206|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594207|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
23594208|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594209|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594210|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594211|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594212|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
23594213|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594214|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594215|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
23594216|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594217|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594218|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
23644562|NCT01465347|66082772|FG000|Overall Study|Withdrawal by Subject|1|||
23644563|NCT01465347|66082773|FG001|Overall Study|Withdrawal by Subject|1|||
23594219|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594220|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594221|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594222|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594223|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594224|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594225|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594226|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594227|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
23594228|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594229|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
23594230|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594231|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594232|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594233|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594234|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594235|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
23644564|NCT01465347|66082772|FG000|Overall Study|Physician Decision|0|||
23644565|NCT01465347|66082773|FG001|Overall Study|Physician Decision|1|||
23644566|NCT01465347|66082772|FG000|Overall Study|Admitted to hospice|0|||
23644567|NCT01465347|66082773|FG001|Overall Study|Admitted to hospice|1|||
23594236|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594237|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23594238|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23594239|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
23594240|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594241|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594242|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594243|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594244|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594245|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594246|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
23594247|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
23594248|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594249|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594250|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
23594251|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
23594252|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594253|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594254|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594255|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
23594256|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594257|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594258|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594259|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594260|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594261|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594262|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594263|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
23594264|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594265|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594266|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594267|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594268|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594269|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594270|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594271|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
23594272|NCT01369498|65906171|FG000|Overall Study|Lack of Efficacy|9|||
23594273|NCT01369498|65906172|FG001|Overall Study|Lack of Efficacy|9|||
23594274|NCT01369498|65906173|FG002|Overall Study|Lack of Efficacy|1|||
23594275|NCT01369498|65906174|FG003|Overall Study|Lack of Efficacy|3|||
23594276|NCT01369498|65906171|FG000|Overall Study|Adverse Event|1|||
23644568|NCT01049217|66082774|FG000|Overall Study|Adverse Event|2|||
23644569|NCT01049217|66082775|FG001|Overall Study|Adverse Event|1|||
23360203|NCT00420628|65062855|FG001|Overall Study|Adverse Event|0|||
23594277|NCT01369498|65906172|FG001|Overall Study|Adverse Event|2|||
23594278|NCT01369498|65906173|FG002|Overall Study|Adverse Event|0|||
23644570|NCT01049217|66082774|FG000|Overall Study|Lack of Efficacy|1|||
23644571|NCT01049217|66082775|FG001|Overall Study|Lack of Efficacy|1|||
23594279|NCT01369498|65906174|FG003|Overall Study|Adverse Event|1|||
23594280|NCT01369498|65906171|FG000|Overall Study|Withdrawal of Consent|0|||
23594281|NCT01369498|65906172|FG001|Overall Study|Withdrawal of Consent|1|||
23594282|NCT01369498|65906173|FG002|Overall Study|Withdrawal of Consent|1|||
23594283|NCT01369498|65906174|FG003|Overall Study|Withdrawal of Consent|1|||
23594284|NCT01369498|65906171|FG000|Overall Study|Death|0|||
23594285|NCT01369498|65906172|FG001|Overall Study|Death|0|||
23594286|NCT01369498|65906173|FG002|Overall Study|Death|1|||
23594287|NCT01369498|65906174|FG003|Overall Study|Death|0|||
23594288|NCT01369498|65906171|FG000|Overall Study|Investigator's Discretion|1|||
23594289|NCT01369498|65906172|FG001|Overall Study|Investigator's Discretion|0|||
23594290|NCT01369498|65906173|FG002|Overall Study|Investigator's Discretion|1|||
23594291|NCT01369498|65906174|FG003|Overall Study|Investigator's Discretion|3|||
23594292|NCT01369498|65906171|FG000|Overall Study|Unknown Reason|1|||
23594293|NCT01369498|65906172|FG001|Overall Study|Unknown Reason|0|||
23594294|NCT01369498|65906173|FG002|Overall Study|Unknown Reason|11|||
23594295|NCT01369498|65906174|FG003|Overall Study|Unknown Reason|6|||
23594296|NCT01369498|65906171|FG000|Overall Study|Disease Progression|0|||
23594297|NCT01369498|65906172|FG001|Overall Study|Disease Progression|0|||
23644572|NCT01049217|66082774|FG000|Overall Study|Lost to Follow-up|3|||
23644573|NCT01049217|66082775|FG001|Overall Study|Lost to Follow-up|8|||
23644574|NCT01049217|66082774|FG000|Overall Study|Withdrawal by Subject|4|||
23644575|NCT01049217|66082775|FG001|Overall Study|Withdrawal by Subject|3|||
23644576|NCT01049217|66082774|FG000|Overall Study|Protocol Violation|1|||
23644577|NCT01049217|66082775|FG001|Overall Study|Protocol Violation|3|||
23644578|NCT01049217|66082774|FG000|Overall Study|Pregnancy|1|||
23644579|NCT01049217|66082775|FG001|Overall Study|Pregnancy|0|||
23644580|NCT01049217|66082774|FG000|Overall Study|Study Terminated by Sponsor|43|||
23644581|NCT01049217|66082775|FG001|Overall Study|Study Terminated by Sponsor|43|||
23644582|NCT01049217|66082774|FG000|Overall Study|Other|1|||
23644583|NCT01049217|66082775|FG001|Overall Study|Other|2|||
23644584|NCT01049217|66082774|FG000|Overall Study|Randomized but not Treated|0|||
23644585|NCT01049217|66082775|FG001|Overall Study|Randomized but not Treated|2|||
23644586|NCT02751320|66082776|FG000|Overall Study|Adverse Event|2|||
23644587|NCT02751320|66082776|FG000|Overall Study|Withdrawal by Subject|1|||
23644588|NCT02891408|66082778|FG000|Overall Study|Lost to Follow-up|0|||
23644589|NCT02891408|66082779|FG001|Overall Study|Lost to Follow-up|0|||
23644590|NCT02891408|66082780|FG002|Overall Study|Lost to Follow-up|1|||
23644591|NCT02891408|66082781|FG003|Overall Study|Lost to Follow-up|0|||
23644592|NCT02891408|66082782|FG004|Overall Study|Lost to Follow-up|0|||
23644593|NCT02891408|66082783|FG005|Overall Study|Lost to Follow-up|0|||
23644594|NCT02891408|66082784|FG006|Overall Study|Lost to Follow-up|0|||
23644595|NCT02533531|66082785|FG000|Overall Study|Device did not turn on|1|||
23644596|NCT00734097|66082786|FG000|Screening|Protocol Violation|12|||
23644597|NCT00734097|66082786|FG000|Screening|Withdrawal by Subject|5|||
23644598|NCT00734097|66082786|FG000|Screening|Lost to Follow-up|2|||
23644599|NCT00734097|66082786|FG000|Screening|Unconfirmed pregnancy|1|||
23644600|NCT00734097|66082786|FG000|Open Label|Lost to Follow-up|7|||
23644601|NCT00734097|66082786|FG000|Open Label|Withdrawal by Subject|5|||
23644602|NCT00734097|66082786|FG000|Open Label|Protocol Violation|4|||
23644603|NCT02929329|66082787|FG000|Overall Study|Withdrawal by Subject|24|||
23644604|NCT02929329|66082788|FG001|Overall Study|Withdrawal by Subject|21|||
23644605|NCT02929329|66082787|FG000|Overall Study|Lost to Follow-up|26|||
23644606|NCT02929329|66082788|FG001|Overall Study|Lost to Follow-up|20|||
23644607|NCT02929329|66082787|FG000|Overall Study|Death|1054|||
23644608|NCT02929329|66082788|FG001|Overall Study|Death|1051|||
23644609|NCT01139580|66082800|FG000|Overall Study|Adverse Event|5|||
23644610|NCT01139580|66082801|FG001|Overall Study|Adverse Event|4|||
23644611|NCT01139580|66082800|FG000|Overall Study|Lost to Follow-up|9|||
23644612|NCT01139580|66082801|FG001|Overall Study|Lost to Follow-up|1|||
23644613|NCT01139580|66082800|FG000|Overall Study|Lack of Efficacy|0|||
23644614|NCT01139580|66082801|FG001|Overall Study|Lack of Efficacy|2|||
23644615|NCT01139580|66082800|FG000|Overall Study|Withdrawal by Subject|6|||
23644616|NCT01139580|66082801|FG001|Overall Study|Withdrawal by Subject|9|||
23644617|NCT01139580|66082800|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
23800067|NCT00099268|66646647|FG001|Overall Study|Protocol Violation|8|||
23644618|NCT01139580|66082801|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
23644619|NCT01139580|66082800|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
23644620|NCT01139580|66082801|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
23644621|NCT01139580|66082800|FG000|Overall Study|Misrandomized|1|||
23644622|NCT01139580|66082801|FG001|Overall Study|Misrandomized|0|||
23644623|NCT01139580|66082800|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
23644624|NCT01139580|66082801|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
23594298|NCT01369498|65906173|FG002|Overall Study|Disease Progression|0|||
23594299|NCT01369498|65906174|FG003|Overall Study|Disease Progression|1|||
23594300|NCT04035668|65906181|FG000|Overall Study|Adverse Event|3|||
23594301|NCT04035668|65906182|FG001|Overall Study|Adverse Event|4|||
23594302|NCT04035668|65906183|FG002|Overall Study|Adverse Event|2|||
23644625|NCT01139580|66082800|FG000|Overall Study|Participant Randomization in Error|0|||
23644626|NCT01139580|66082801|FG001|Overall Study|Participant Randomization in Error|1|||
23644627|NCT00657020|66082802|FG000|PERIOD 1|Adverse Event|0|||
23644628|NCT00657020|66082803|FG001|PERIOD 1|Adverse Event|1|||
23644629|NCT03656510|66082804|FG000|Overall Study|Lost to Follow-up|1|||
23644630|NCT03656510|66082805|FG001|Overall Study|Lost to Follow-up|0|||
23644631|NCT03656510|66082806|FG002|Overall Study|Lost to Follow-up|0|||
23644632|NCT03656510|66082807|FG003|Overall Study|Lost to Follow-up|0|||
23644633|NCT03656510|66082808|FG004|Overall Study|Lost to Follow-up|0|||
23644634|NCT03656510|66082809|FG005|Overall Study|Lost to Follow-up|0|||
23644635|NCT03656510|66082804|FG000|Overall Study|Withdrawal by Subject|1|||
23644636|NCT03656510|66082805|FG001|Overall Study|Withdrawal by Subject|1|||
23644637|NCT03656510|66082806|FG002|Overall Study|Withdrawal by Subject|0|||
23644638|NCT03656510|66082807|FG003|Overall Study|Withdrawal by Subject|1|||
23644639|NCT03656510|66082808|FG004|Overall Study|Withdrawal by Subject|0|||
23644640|NCT03656510|66082809|FG005|Overall Study|Withdrawal by Subject|0|||
23644641|NCT01981473|66082810|FG000|Overall Study|Incorrect diagnosis of RA|0|||
23644642|NCT01981473|66082811|FG001|Overall Study|Incorrect diagnosis of RA|0|||
23644643|NCT01981473|66082812|FG002|Overall Study|Incorrect diagnosis of RA|1|||
23644644|NCT01981473|66082810|FG000|Overall Study|Received treatment for < 6 months|0|||
23644645|NCT01981473|66082811|FG001|Overall Study|Received treatment for < 6 months|0|||
23644646|NCT01981473|66082812|FG002|Overall Study|Received treatment for < 6 months|1|||
23644647|NCT01981473|66082810|FG000|Overall Study|Received treatment for >24 months|2|||
23644648|NCT01981473|66082811|FG001|Overall Study|Received treatment for >24 months|0|||
23644649|NCT01981473|66082812|FG002|Overall Study|Received treatment for >24 months|6|||
23644650|NCT01290029|66082813|FG000|Overall Study|Other|2|||
23644651|NCT04988867|66082815|FG000|Overall Study|Study terminated by Sponsor|12|||
23644652|NCT04988867|66082815|FG000|Overall Study|Adverse Event|2|||
23644653|NCT04988867|66082815|FG000|Overall Study|Study drug noncompliance|1|||
23644654|NCT02390245|66082818|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
23644655|NCT02390245|66082819|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
23644656|NCT02390245|66082820|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
23644657|NCT02390245|66082818|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
23644658|NCT02390245|66082819|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
23644659|NCT02390245|66082820|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
23644660|NCT03567434|66082822|FG000|Overall Study|Lost to Follow-up|1|||
23644661|NCT03567434|66082823|FG001|Overall Study|Lost to Follow-up|3|||
23644662|NCT00545051|66082826|FG000|Overall Study|Adverse Event|7|||
23644663|NCT00545051|66082827|FG001|Overall Study|Adverse Event|3|||
23644664|NCT00545051|66082826|FG000|Overall Study|Death|1|||
23644665|NCT00545051|66082827|FG001|Overall Study|Death|0|||
23644666|NCT00545051|66082826|FG000|Overall Study|Violation of inclusion/exclusion|0|||
23644667|NCT00545051|66082827|FG001|Overall Study|Violation of inclusion/exclusion|2|||
23644668|NCT00545051|66082826|FG000|Overall Study|Protocol Violation|1|||
23644669|NCT00545051|66082827|FG001|Overall Study|Protocol Violation|0|||
23644670|NCT00545051|66082826|FG000|Overall Study|Withdrawal by Subject|0|||
23644671|NCT00545051|66082827|FG001|Overall Study|Withdrawal by Subject|1|||
23644672|NCT00545051|66082826|FG000|Overall Study|Administrative reasons|0|||
23644673|NCT00545051|66082827|FG001|Overall Study|Administrative reasons|1|||
23644674|NCT02224690|66082828|FG000|Overall Study|Adverse Event|8|||
23800068|NCT00099268|66646646|FG000|Overall Study|Lost to Follow-up|6|||
23594303|NCT04035668|65906181|FG000|Overall Study|Lost to Follow-up|0|||
23594304|NCT04035668|65906182|FG001|Overall Study|Lost to Follow-up|1|||
23594305|NCT04035668|65906183|FG002|Overall Study|Lost to Follow-up|0|||
23594306|NCT04035668|65906181|FG000|Overall Study|Physician Decision|2|||
23594307|NCT04035668|65906182|FG001|Overall Study|Physician Decision|1|||
23594308|NCT04035668|65906183|FG002|Overall Study|Physician Decision|1|||
23594309|NCT04035668|65906181|FG000|Overall Study|Subject Decision|2|||
23594310|NCT04035668|65906182|FG001|Overall Study|Subject Decision|2|||
23594311|NCT04035668|65906183|FG002|Overall Study|Subject Decision|0|||
23594312|NCT02584829|65906184|FG000|Overall Study|Physician Decision|1|||
23594313|NCT02584829|65906185|FG001|Overall Study|Physician Decision|0|||
23594314|NCT02584829|65906184|FG000|Overall Study|Withdrawal by Subject|0|||
23594315|NCT02584829|65906185|FG001|Overall Study|Withdrawal by Subject|1|||
23644675|NCT02224690|66082829|FG001|Overall Study|Adverse Event|1|||
23644676|NCT02224690|66082828|FG000|Overall Study|Met Withdrawal Criteria|4|||
23800069|NCT00099268|66646647|FG001|Overall Study|Lost to Follow-up|4|||
23644677|NCT02224690|66082829|FG001|Overall Study|Met Withdrawal Criteria|0|||
23644678|NCT02224690|66082828|FG000|Overall Study|Use of G-tube|1|||
23644679|NCT02224690|66082829|FG001|Overall Study|Use of G-tube|0|||
23644680|NCT02224690|66082828|FG000|Overall Study|Did not meet eligibility criteria|1|||
23644681|NCT02224690|66082829|FG001|Overall Study|Did not meet eligibility criteria|0|||
23644682|NCT01535560|66082830|FG000|Overall Study|Adverse Event|12|||
23644683|NCT01535560|66082831|FG001|Overall Study|Adverse Event|7|||
23800070|NCT00099268|66646646|FG000|Overall Study|Lack of Efficacy|5|||
23594316|NCT02584829|65906184|FG000|Overall Study|Progressive Disease|0|||
23594317|NCT02584829|65906185|FG001|Overall Study|Progressive Disease|3|||
23800071|NCT00099268|66646647|FG001|Overall Study|Lack of Efficacy|18|||
23594318|NCT00761605|65906186|FG000|Overall Study|Adverse Event|26|||
23594319|NCT00761605|65906186|FG000|Overall Study|Death|2|||
23594320|NCT00761605|65906186|FG000|Overall Study|Lack of Efficacy|26|||
23594321|NCT00761605|65906186|FG000|Overall Study|Lost to Follow-up|29|||
23594322|NCT00761605|65906186|FG000|Overall Study|Withdrawal by Subject|37|||
23594323|NCT00761605|65906186|FG000|Overall Study|Other|21|||
23594324|NCT00174382|65906190|FG000|Overall Study|Death|2|||
23594325|NCT00174382|65906190|FG000|Overall Study|Adverse Event|19|||
23594326|NCT00174382|65906190|FG000|Overall Study|Withdrawal by Subject|6|||
23594327|NCT00174382|65906190|FG000|Overall Study|Protocol Violation|3|||
23594328|NCT00174382|65906190|FG000|Overall Study|Arrived early for last visit in error|1|||
23594329|NCT00174382|65906190|FG000|Overall Study|Subject felt pill not effective enough|1|||
23594330|NCT00174382|65906190|FG000|Overall Study|Lost to Follow-up|1|||
23594331|NCT00925899|65906191|FG000|Part 1|Death|1|||
23594332|NCT00925899|65906192|FG001|Part 1|Death|2|||
23594333|NCT00925899|65906191|FG000|Part 1|Withdrawal by Subject|10|||
23594334|NCT00925899|65906192|FG001|Part 1|Withdrawal by Subject|9|||
23594335|NCT02974634|65906193|FG000|Overall Study|Advanced disease|12|||
23594336|NCT02974634|65906194|FG001|Overall Study|Advanced disease|3|||
23594337|NCT02974634|65906193|FG000|Overall Study|Noncompliance|3|||
23594338|NCT02974634|65906194|FG001|Overall Study|Noncompliance|7|||
23594339|NCT02974634|65906193|FG000|Overall Study|intervention technology related issues|5|||
23594340|NCT02974634|65906194|FG001|Overall Study|intervention technology related issues|0|||
23594341|NCT02974634|65906193|FG000|Overall Study|Death|8|||
23594342|NCT02974634|65906194|FG001|Overall Study|Death|11|||
23644684|NCT01535560|66082830|FG000|Overall Study|Lost to Follow-up|1|||
23644685|NCT01535560|66082831|FG001|Overall Study|Lost to Follow-up|3|||
23594343|NCT02477605|65906195|FG000|Overall Study|Discontinued prior to treatment|1|||
23594344|NCT02477605|65906196|FG001|Overall Study|Discontinued prior to treatment|0|||
23594345|NCT02477605|65906195|FG000|Overall Study|Lost to Follow-up|0|||
23594346|NCT02477605|65906196|FG001|Overall Study|Lost to Follow-up|2|||
23594347|NCT02477605|65906195|FG000|Overall Study|Withdrawal by Subject|0|||
23594348|NCT02477605|65906196|FG001|Overall Study|Withdrawal by Subject|1|||
23594349|NCT02477605|65906195|FG000|Overall Study|Administered gas during surgery|0|||
23594350|NCT02477605|65906196|FG001|Overall Study|Administered gas during surgery|1|||
23594351|NCT01198028|65906201|FG000|Overall Study|Adverse Event|5|||
23594352|NCT01198028|65906201|FG000|Overall Study|Death|3|||
23594353|NCT01198028|65906201|FG000|Overall Study|Physician Decision|2|||
23594354|NCT03051165|65906202|FG000|Overall Study|Withdrawal by Subject|1|||
23594355|NCT03051165|65906202|FG000|Overall Study|Early termination of study|12|||
23594356|NCT03074331|65906206|FG000|Overall Study|Enrolled but Not Treated|1|||
23594357|NCT03074331|65906206|FG000|Overall Study|Lost to Follow-up|5|||
23594358|NCT03074331|65906206|FG000|Overall Study|Withdrew Consent|1|||
23594359|NCT01875848|65906213|FG000|Overall Study|Withdrawal by Subject|2|||
23594360|NCT01875848|65906214|FG001|Overall Study|Withdrawal by Subject|0|||
23594361|NCT00807937|65906215|FG000|Overall Study|Adverse Event|12|||
23594362|NCT00807937|65906216|FG001|Overall Study|Adverse Event|12|||
23594363|NCT00807937|65906217|FG002|Overall Study|Adverse Event|5|||
23594364|NCT00807937|65906218|FG003|Overall Study|Adverse Event|4|||
23594365|NCT00807937|65906215|FG000|Overall Study|Protocol Violation|4|||
23594366|NCT00807937|65906216|FG001|Overall Study|Protocol Violation|5|||
23594367|NCT00807937|65906217|FG002|Overall Study|Protocol Violation|3|||
23594368|NCT00807937|65906218|FG003|Overall Study|Protocol Violation|3|||
23594369|NCT00807937|65906215|FG000|Overall Study|Withdrawal by Subject|5|||
23594370|NCT00807937|65906216|FG001|Overall Study|Withdrawal by Subject|4|||
23594371|NCT00807937|65906217|FG002|Overall Study|Withdrawal by Subject|1|||
23594372|NCT00807937|65906218|FG003|Overall Study|Withdrawal by Subject|4|||
23594373|NCT00807937|65906215|FG000|Overall Study|Lost to Follow-up|4|||
23594374|NCT00807937|65906216|FG001|Overall Study|Lost to Follow-up|0|||
23594375|NCT00807937|65906217|FG002|Overall Study|Lost to Follow-up|2|||
23594376|NCT00807937|65906218|FG003|Overall Study|Lost to Follow-up|1|||
23594377|NCT00807937|65906215|FG000|Overall Study|Lack of Efficacy|0|||
23594378|NCT00807937|65906216|FG001|Overall Study|Lack of Efficacy|0|||
23594379|NCT00807937|65906217|FG002|Overall Study|Lack of Efficacy|1|||
23594380|NCT00807937|65906218|FG003|Overall Study|Lack of Efficacy|2|||
23594381|NCT00807937|65906215|FG000|Overall Study|Intake of prohibited medicine|0|||
23594382|NCT00807937|65906216|FG001|Overall Study|Intake of prohibited medicine|0|||
23594383|NCT00807937|65906217|FG002|Overall Study|Intake of prohibited medicine|2|||
23644686|NCT01535560|66082830|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
23594384|NCT00807937|65906218|FG003|Overall Study|Intake of prohibited medicine|0|||
23594385|NCT00807937|65906215|FG000|Overall Study|All other reasons (not provided)|2|||
23360204|NCT01490840|65062857|FG000|Phase 1|Lost to Follow-up|1|||
23594386|NCT00807937|65906216|FG001|Overall Study|All other reasons (not provided)|4|||
23594387|NCT00807937|65906217|FG002|Overall Study|All other reasons (not provided)|0|||
23644687|NCT01535560|66082831|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
23594388|NCT00807937|65906218|FG003|Overall Study|All other reasons (not provided)|1|||
23360205|NCT01490840|65062858|FG001|Phase 1|Lost to Follow-up|0|||
23594389|NCT02214160|65906219|FG000|Overall Study|Withdrawal by Subject|1|||
23594390|NCT02214160|65906220|FG001|Overall Study|Withdrawal by Subject|0|||
23594391|NCT02214160|65906221|FG002|Overall Study|Withdrawal by Subject|6|||
23594392|NCT02214160|65906219|FG000|Overall Study|Death|2|||
23594393|NCT02214160|65906220|FG001|Overall Study|Death|2|||
23594394|NCT02214160|65906221|FG002|Overall Study|Death|1|||
23594395|NCT02214160|65906219|FG000|Overall Study|Subject Non-Compliance|0|||
23594396|NCT02214160|65906220|FG001|Overall Study|Subject Non-Compliance|3|||
23594397|NCT02214160|65906221|FG002|Overall Study|Subject Non-Compliance|1|||
23594398|NCT02214160|65906219|FG000|Overall Study|Adverse Event|0|||
23594399|NCT02214160|65906220|FG001|Overall Study|Adverse Event|1|||
23594400|NCT02214160|65906221|FG002|Overall Study|Adverse Event|1|||
23594401|NCT02214160|65906219|FG000|Overall Study|Sponsor Decision|0|||
23594402|NCT02214160|65906220|FG001|Overall Study|Sponsor Decision|2|||
23594403|NCT02214160|65906221|FG002|Overall Study|Sponsor Decision|0|||
23594404|NCT02214160|65906219|FG000|Overall Study|Protocol Violation|1|||
23594405|NCT02214160|65906220|FG001|Overall Study|Protocol Violation|0|||
23644688|NCT01535560|66082830|FG000|Overall Study|Treatment Failure|21|||
23644689|NCT01535560|66082831|FG001|Overall Study|Treatment Failure|83|||
23644690|NCT01535560|66082830|FG000|Overall Study|Other|0|||
23644691|NCT01535560|66082831|FG001|Overall Study|Other|1|||
23644692|NCT01535560|66082830|FG000|Overall Study|Randomized in Error|0|||
23644693|NCT01535560|66082831|FG001|Overall Study|Randomized in Error|1|||
23644694|NCT02996474|66082832|FG000|Overall Study|Physician Decision|5|||
23644695|NCT03581825|66082833|FG000|Period 1|Lens Discomfort|1|||
23644696|NCT03581825|66082834|FG001|Period 1|Lens Discomfort|0|||
23644697|NCT03581825|66082833|FG000|Period 2|Unsatisfactory Vision to Test|0|||
23644698|NCT03581825|66082834|FG001|Period 2|Unsatisfactory Vision to Test|1|||
23644699|NCT01886378|66082836|FG000|Overall Study|Adverse Event|1|||
23644700|NCT01886378|66082836|FG000|Overall Study|Withdrawal by Subject|4|||
23644701|NCT02781844|66082837|FG000|Treatment Period 1|Adverse Event|0|||
23644702|NCT02781844|66082838|FG001|Treatment Period 1|Adverse Event|0|||
23644703|NCT02781844|66082839|FG002|Treatment Period 1|Adverse Event|0|||
23644704|NCT02781844|66082840|FG003|Treatment Period 1|Adverse Event|0|||
23644705|NCT02781844|66082841|FG004|Treatment Period 1|Adverse Event|0|||
23594406|NCT02214160|65906221|FG002|Overall Study|Protocol Violation|0|||
23594407|NCT02214160|65906219|FG000|Overall Study|Physician Decision|0|||
23594408|NCT02214160|65906220|FG001|Overall Study|Physician Decision|0|||
23594409|NCT02214160|65906221|FG002|Overall Study|Physician Decision|1|||
23594410|NCT02296424|65906222|FG000|Part 1|New therapy for study indication|0|||
23594411|NCT02296424|65906223|FG001|Part 1|New therapy for study indication|1|||
23594412|NCT02296424|65906224|FG002|Part 1|New therapy for study indication|0|||
23594413|NCT02296424|65906225|FG003|Part 1|New therapy for study indication|0|||
23594414|NCT02296424|65906222|FG000|Part 1|Protocol Violation|0|||
23594415|NCT02296424|65906223|FG001|Part 1|Protocol Violation|1|||
23594416|NCT02296424|65906224|FG002|Part 1|Protocol Violation|0|||
23594417|NCT02296424|65906225|FG003|Part 1|Protocol Violation|0|||
23594418|NCT02296424|65906222|FG000|Part 1|Withdrawal by Subject|0|||
23594419|NCT02296424|65906223|FG001|Part 1|Withdrawal by Subject|2|||
23594420|NCT02296424|65906224|FG002|Part 1|Withdrawal by Subject|0|||
23594421|NCT02296424|65906225|FG003|Part 1|Withdrawal by Subject|0|||
23594422|NCT02296424|65906222|FG000|Part 1|Study terminated by sponsor|0|||
23594423|NCT02296424|65906223|FG001|Part 1|Study terminated by sponsor|1|||
23594424|NCT02296424|65906224|FG002|Part 1|Study terminated by sponsor|0|||
23594425|NCT02296424|65906225|FG003|Part 1|Study terminated by sponsor|0|||
23594426|NCT02296424|65906222|FG000|Part 1|Adverse Event|2|||
23594427|NCT02296424|65906223|FG001|Part 1|Adverse Event|11|||
23594428|NCT02296424|65906224|FG002|Part 1|Adverse Event|0|||
23594429|NCT02296424|65906225|FG003|Part 1|Adverse Event|0|||
23594430|NCT02296424|65906222|FG000|Part 1|Lack of Efficacy|5|||
23594431|NCT02296424|65906223|FG001|Part 1|Lack of Efficacy|17|||
23594432|NCT02296424|65906224|FG002|Part 1|Lack of Efficacy|0|||
23644706|NCT02781844|66082842|FG005|Treatment Period 1|Adverse Event|1|||
23644707|NCT02781844|66082843|FG006|Treatment Period 1|Adverse Event|0|||
23800072|NCT00099268|66646646|FG000|Overall Study|Administrative problems|4|||
23800073|NCT00099268|66646647|FG001|Overall Study|Administrative problems|4|||
23800074|NCT00099268|66646646|FG000|Overall Study|Death|3|||
23800075|NCT00099268|66646647|FG001|Overall Study|Death|1|||
23800076|NCT01684215|66646648|FG000|Phase 1, Part 1|Adverse Event|1|||
23800077|NCT01684215|66646649|FG001|Phase 1, Part 1|Adverse Event|0|||
23800078|NCT01684215|66646650|FG002|Phase 1, Part 1|Adverse Event|0|||
23800079|NCT01684215|66646651|FG003|Phase 1, Part 1|Adverse Event|0|||
23800080|NCT01684215|66646648|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
23594433|NCT02296424|65906225|FG003|Part 1|Lack of Efficacy|0|||
23594434|NCT02296424|65906222|FG000|Part 1|16 directly started part II|16|||
23594435|NCT02296424|65906223|FG001|Part 1|16 directly started part II|0|||
23594436|NCT02296424|65906224|FG002|Part 1|16 directly started part II|0|||
23594437|NCT02296424|65906225|FG003|Part 1|16 directly started part II|0|||
23594438|NCT02296424|65906222|FG000|Part 2|Lack of Efficacy|0|||
23800081|NCT01684215|66646649|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
23800082|NCT01684215|66646650|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
23800083|NCT01684215|66646651|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
23644708|NCT02781844|66082844|FG007|Treatment Period 1|Adverse Event|0|||
23644709|NCT01248065|66086832|FG000|Overall Study|Lost to Follow-up|3|||
23644710|NCT01248065|66086833|FG001|Overall Study|Lost to Follow-up|5|||
23644711|NCT01248065|66086832|FG000|Overall Study|Withdrawal by Subject|14|||
23644712|NCT01248065|66086833|FG001|Overall Study|Withdrawal by Subject|11|||
23644713|NCT01248065|66086832|FG000|Overall Study|Adverse Event|3|||
23644714|NCT01248065|66086833|FG001|Overall Study|Adverse Event|0|||
23644715|NCT01248065|66086832|FG000|Overall Study|Third treatment failure event|3|||
23644716|NCT01248065|66086833|FG001|Overall Study|Third treatment failure event|1|||
23644717|NCT01248065|66086832|FG000|Overall Study|Other|3|||
23644718|NCT01248065|66086833|FG001|Overall Study|Other|5|||
23644719|NCT03256851|66086834|FG000|Overall Study|Withdrawal by Subject|1|||
23644720|NCT03256851|66086835|FG001|Overall Study|Withdrawal by Subject|0|||
23644721|NCT00598273|66086836|FG000|Overall Study|Adverse Event|4|||
23644722|NCT00598273|66086837|FG001|Overall Study|Adverse Event|5|||
23594439|NCT02296424|65906223|FG001|Part 2|Lack of Efficacy|0|||
23594440|NCT02296424|65906224|FG002|Part 2|Lack of Efficacy|1|||
23594441|NCT02296424|65906225|FG003|Part 2|Lack of Efficacy|0|||
23594442|NCT02296424|65906222|FG000|Part 2|Adverse Event|0|||
23594443|NCT02296424|65906223|FG001|Part 2|Adverse Event|0|||
23594444|NCT02296424|65906224|FG002|Part 2|Adverse Event|1|||
23594445|NCT02296424|65906225|FG003|Part 2|Adverse Event|0|||
23594446|NCT02296424|65906222|FG000|Part 2|Lost to Follow-up|0|||
23594447|NCT02296424|65906223|FG001|Part 2|Lost to Follow-up|0|||
23594448|NCT02296424|65906224|FG002|Part 2|Lost to Follow-up|1|||
23644723|NCT00598273|66086838|FG002|Overall Study|Adverse Event|2|||
23644724|NCT00598273|66086836|FG000|Overall Study|Death|6|||
23644725|NCT00598273|66086837|FG001|Overall Study|Death|12|||
23644726|NCT00598273|66086838|FG002|Overall Study|Death|8|||
23644727|NCT00598273|66086836|FG000|Overall Study|Lost to Follow-up|8|||
23644728|NCT00598273|66086837|FG001|Overall Study|Lost to Follow-up|3|||
23644729|NCT00598273|66086838|FG002|Overall Study|Lost to Follow-up|5|||
23644730|NCT00598273|66086836|FG000|Overall Study|Physician Decision|0|||
23644731|NCT00598273|66086837|FG001|Overall Study|Physician Decision|0|||
23644732|NCT00598273|66086838|FG002|Overall Study|Physician Decision|1|||
23644733|NCT00598273|66086836|FG000|Overall Study|Withdrawal by Subject|12|||
23644734|NCT00598273|66086837|FG001|Overall Study|Withdrawal by Subject|10|||
23594449|NCT02296424|65906225|FG003|Part 2|Lost to Follow-up|0|||
23594450|NCT01771731|65906229|FG000|Overall Study|Physician Decision|1|||
23594451|NCT01771731|65906230|FG001|Overall Study|Physician Decision|0|||
23594452|NCT01771731|65906229|FG000|Overall Study|Protocol Violation|0|||
23594453|NCT01771731|65906230|FG001|Overall Study|Protocol Violation|1|||
23594454|NCT01771731|65906229|FG000|Overall Study|Adverse event: Pain Crisis|1|||
23594455|NCT01771731|65906230|FG001|Overall Study|Adverse event: Pain Crisis|1|||
23594456|NCT00309907|65906237|FG000|Overall Study|Death|4|||
23594457|NCT00309907|65906237|FG000|Overall Study|Physician Decision|1|||
23594458|NCT00309907|65906237|FG000|Overall Study|Ineligible|11|||
23594459|NCT00309907|65906237|FG000|Overall Study|Major infectious event|4|||
23594460|NCT01102231|65906238|FG000|Overall Study|Protocol Violation|3|||
23644735|NCT00598273|66086838|FG002|Overall Study|Withdrawal by Subject|10|||
23644736|NCT00598273|66086836|FG000|Overall Study|Noncompliance|3|||
23644737|NCT00598273|66086837|FG001|Overall Study|Noncompliance|2|||
23644738|NCT00598273|66086838|FG002|Overall Study|Noncompliance|3|||
23644739|NCT00598273|66086836|FG000|Overall Study|Relocation|0|||
23644740|NCT00598273|66086837|FG001|Overall Study|Relocation|2|||
23644741|NCT00598273|66086838|FG002|Overall Study|Relocation|4|||
23594461|NCT01102231|65906238|FG000|Overall Study|Lack of Efficacy|2|||
23594462|NCT01102231|65906238|FG000|Overall Study|Death|2|||
23594463|NCT01102231|65906238|FG000|Overall Study|Adverse Event|3|||
23594464|NCT01102231|65906238|FG000|Overall Study|Withdrawal by Subject|1|||
23594465|NCT01102231|65906238|FG000|Overall Study|Did not received the treatment|4|||
23594466|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
23594467|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23644742|NCT00598273|66086836|FG000|Overall Study|Renal transplant|1|||
23644743|NCT00598273|66086837|FG001|Overall Study|Renal transplant|0|||
23644744|NCT00598273|66086838|FG002|Overall Study|Renal transplant|1|||
23644745|NCT00598273|66086836|FG000|Overall Study|Site elected to close|1|||
23644746|NCT00598273|66086837|FG001|Overall Study|Site elected to close|0|||
23644747|NCT00598273|66086838|FG002|Overall Study|Site elected to close|0|||
23644748|NCT00598273|66086836|FG000|Overall Study|Started dialysis|6|||
23644749|NCT00598273|66086837|FG001|Overall Study|Started dialysis|4|||
23644750|NCT00598273|66086838|FG002|Overall Study|Started dialysis|5|||
23644751|NCT00297232|66086840|FG000|Overall Study|Lack of Efficacy|7|||
23644752|NCT00297232|66086840|FG000|Overall Study|Lost to Follow-up|10|||
23594468|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23644753|NCT00297232|66086840|FG000|Overall Study|Adverse Event|63|||
23644754|NCT00297232|66086840|FG000|Overall Study|Voluntary Withdrawal|120|||
23644755|NCT00297232|66086840|FG000|Overall Study|Subject was Noncompliant|9|||
23644756|NCT00297232|66086840|FG000|Overall Study|Death|9|||
23644757|NCT00297232|66086840|FG000|Overall Study|Anti-natalizumab Positive|8|||
23644758|NCT00297232|66086840|FG000|Overall Study|Switched to Commercial Tysabri|22|||
23644759|NCT00297232|66086840|FG000|Overall Study|Disease Progression|8|||
23644760|NCT00297232|66086840|FG000|Overall Study|Fear of PML|10|||
23644761|NCT00297232|66086840|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
23644762|NCT00297232|66086840|FG000|Overall Study|Miscellaneous|5|||
23644763|NCT00297232|66086840|FG000|Overall Study|Sponsor Decision|34|||
23800084|NCT01684215|66646648|FG000|Phase 1, Part 2|Adverse Event|0|||
23800085|NCT01684215|66646649|FG001|Phase 1, Part 2|Adverse Event|0|||
23800086|NCT01684215|66646650|FG002|Phase 1, Part 2|Adverse Event|1|||
23800087|NCT01684215|66646651|FG003|Phase 1, Part 2|Adverse Event|0|||
23800088|NCT01684215|66646648|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23800089|NCT01684215|66646649|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23800090|NCT01684215|66646650|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
23800091|NCT01684215|66646651|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23800092|NCT01684215|66646648|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
23800093|NCT01684215|66646649|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
23800094|NCT01684215|66646650|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
23477604|NCT01989468|65491636|FG004|Overall Study|Lost to Follow-up|1|||
23477605|NCT01989468|65491632|FG000|Overall Study|Physician Decision|4|||
23477606|NCT01989468|65491633|FG001|Overall Study|Physician Decision|1|||
23477607|NCT01989468|65491634|FG002|Overall Study|Physician Decision|0|||
23477608|NCT01989468|65491635|FG003|Overall Study|Physician Decision|1|||
23477609|NCT01989468|65491636|FG004|Overall Study|Physician Decision|0|||
23477610|NCT01989468|65491632|FG000|Overall Study|Pregnancy|0|||
23477611|NCT01989468|65491633|FG001|Overall Study|Pregnancy|1|||
23477612|NCT01989468|65491634|FG002|Overall Study|Pregnancy|0|||
23477613|NCT01989468|65491635|FG003|Overall Study|Pregnancy|0|||
23800095|NCT01684215|66646651|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
23800096|NCT01684215|66646648|FG000|Phase 2|Death|0|||
23477614|NCT01989468|65491636|FG004|Overall Study|Pregnancy|0|||
23477615|NCT01989468|65491632|FG000|Overall Study|Technical Problems|3|||
23477616|NCT01989468|65491633|FG001|Overall Study|Technical Problems|1|||
23477617|NCT01989468|65491634|FG002|Overall Study|Technical Problems|3|||
23477618|NCT01989468|65491635|FG003|Overall Study|Technical Problems|1|||
23477619|NCT01989468|65491636|FG004|Overall Study|Technical Problems|0|||
23477620|NCT01989468|65491632|FG000|Overall Study|Subject Guardian Decision|11|||
23477621|NCT01989468|65491633|FG001|Overall Study|Subject Guardian Decision|6|||
23477622|NCT01989468|65491634|FG002|Overall Study|Subject Guardian Decision|4|||
23477623|NCT01989468|65491635|FG003|Overall Study|Subject Guardian Decision|4|||
23477624|NCT01989468|65491636|FG004|Overall Study|Subject Guardian Decision|1|||
23477625|NCT01989468|65491632|FG000|Overall Study|Death|3|||
23477626|NCT01989468|65491633|FG001|Overall Study|Death|0|||
23477627|NCT01989468|65491634|FG002|Overall Study|Death|1|||
23477628|NCT01989468|65491635|FG003|Overall Study|Death|0|||
23477629|NCT01989468|65491636|FG004|Overall Study|Death|0|||
23477630|NCT00835731|65491638|FG000|Overall Study|Withdrawal by Subject|1|||
23594469|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23594470|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23594471|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
23594472|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594473|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594474|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594475|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594476|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
23594477|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594478|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594479|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594480|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594481|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
23594482|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23800097|NCT01684215|66646649|FG001|Phase 2|Death|0|||
23477631|NCT00835731|65491639|FG001|Overall Study|Withdrawal by Subject|0|||
23477632|NCT00835731|65491638|FG000|Overall Study|Physician Decision|1|||
23477633|NCT00835731|65491639|FG001|Overall Study|Physician Decision|1|||
23477634|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
23477635|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
23644764|NCT00297232|66086840|FG000|Overall Study|Subject Relocated|7|||
23644765|NCT00297232|66086840|FG000|Overall Study|Subject Withdrew Consent|37|||
23644766|NCT00297232|66086840|FG000|Overall Study|Persistently Positive Antibodies|11|||
23644767|NCT00297232|66086840|FG000|Overall Study|Investigator Withdrew From Program|19|||
23800098|NCT01684215|66646650|FG002|Phase 2|Death|0|||
23800099|NCT01684215|66646651|FG003|Phase 2|Death|8|||
23594483|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594484|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594485|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594486|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
23594487|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594488|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594489|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594490|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594491|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
23594492|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594493|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594494|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594495|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594496|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
23594497|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594498|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594499|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594500|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594501|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
23594502|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594503|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594504|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594505|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594506|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
23594507|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594508|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594509|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594510|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594511|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
23594512|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
23594513|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
23594514|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
23594515|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
23594516|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23594517|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
23594518|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23594519|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23644768|NCT00297232|66086840|FG000|Overall Study|Did Not Enroll to Week 264|34|||
23644769|NCT00297232|66086840|FG000|Overall Study|Did Not Enroll to Week 480|17|||
23644770|NCT00297232|66086840|FG000|Overall Study|No data available after Week 264|161|||
23644771|NCT00297232|66086840|FG000|Overall Study|Other|1|||
23644772|NCT01090427|66086841|FG000|After Controlled Period|Death|0|||
23644773|NCT01090427|66086842|FG001|After Controlled Period|Death|0|||
23644774|NCT01090427|66086843|FG002|After Controlled Period|Death|0|||
23800100|NCT01684215|66646648|FG000|Phase 2|Study terminated by sponsor|0|||
23800101|NCT01684215|66646649|FG001|Phase 2|Study terminated by sponsor|0|||
23800102|NCT01684215|66646650|FG002|Phase 2|Study terminated by sponsor|0|||
23800103|NCT01684215|66646651|FG003|Phase 2|Study terminated by sponsor|30|||
23800104|NCT01684215|66646648|FG000|Phase 2|Enrolled but not treated|0|||
23800105|NCT01684215|66646649|FG001|Phase 2|Enrolled but not treated|0|||
23800106|NCT01684215|66646650|FG002|Phase 2|Enrolled but not treated|0|||
23800107|NCT01684215|66646651|FG003|Phase 2|Enrolled but not treated|1|||
23800108|NCT01684215|66646648|FG000|Phase 2|Lost to Follow-up|0|||
23800109|NCT01684215|66646649|FG001|Phase 2|Lost to Follow-up|0|||
23800110|NCT01684215|66646650|FG002|Phase 2|Lost to Follow-up|0|||
23800111|NCT01684215|66646651|FG003|Phase 2|Lost to Follow-up|4|||
23800112|NCT01478828|66646656|FG000|Overall Study|Adverse Event|1|||
23800113|NCT02808819|66646657|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
23800114|NCT02808819|66646658|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
23800115|NCT02808819|66646657|FG000|Overall Study|Withdrawal by Subject|10|||
23800116|NCT02808819|66646658|FG001|Overall Study|Withdrawal by Subject|13|||
23800117|NCT02808819|66646657|FG000|Overall Study|Site terminated by sponsor|2|||
23800118|NCT02808819|66646658|FG001|Overall Study|Site terminated by sponsor|0|||
23800119|NCT02808819|66646657|FG000|Overall Study|Pregnancy|1|||
23644775|NCT01090427|66086844|FG003|After Controlled Period|Death|0|||
23360206|NCT01490840|65062857|FG000|Phase 1|Adverse Event|2|||
23360207|NCT01490840|65062858|FG001|Phase 1|Adverse Event|1|||
23360208|NCT01490840|65062857|FG000|Phase 1|Withdrawal by Subject|6|||
23360209|NCT01490840|65062858|FG001|Phase 1|Withdrawal by Subject|5|||
23644776|NCT01090427|66086845|FG004|After Controlled Period|Death|0|||
23800120|NCT02808819|66646658|FG001|Overall Study|Pregnancy|0|||
23800121|NCT02808819|66646657|FG000|Overall Study|Lost to Follow-up|1|||
23800122|NCT02808819|66646658|FG001|Overall Study|Lost to Follow-up|6|||
23644777|NCT01090427|66086846|FG005|After Controlled Period|Death|1|||
23644778|NCT01090427|66086847|FG006|After Controlled Period|Death|0|||
23644779|NCT01090427|66086841|FG000|After Controlled Period|Lack of Efficacy|0|||
23644780|NCT01090427|66086842|FG001|After Controlled Period|Lack of Efficacy|0|||
23594520|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
23594521|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
23594522|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
23594523|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
23594524|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
23594525|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
23644781|NCT01090427|66086843|FG002|After Controlled Period|Lack of Efficacy|0|||
23644782|NCT01090427|66086844|FG003|After Controlled Period|Lack of Efficacy|0|||
23644783|NCT01090427|66086845|FG004|After Controlled Period|Lack of Efficacy|0|||
23644784|NCT01090427|66086846|FG005|After Controlled Period|Lack of Efficacy|3|||
23644785|NCT01090427|66086847|FG006|After Controlled Period|Lack of Efficacy|2|||
23644786|NCT01090427|66086841|FG000|After Controlled Period|Adverse Event|0|||
23800123|NCT02808819|66646657|FG000|Overall Study|Protocol Violation|0|||
23800124|NCT02808819|66646658|FG001|Overall Study|Protocol Violation|1|||
23800125|NCT02808819|66646657|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
23800126|NCT02808819|66646658|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
23800127|NCT02808819|66646657|FG000|Overall Study|Death|1|||
23800128|NCT02808819|66646658|FG001|Overall Study|Death|0|||
23800129|NCT02808819|66646657|FG000|Overall Study|Adverse Event|3|||
23800130|NCT02808819|66646658|FG001|Overall Study|Adverse Event|4|||
23800131|NCT00115934|66646659|FG000|Overall Study|Lost to Follow-up|1|||
23594526|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594527|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
23594528|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594529|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594530|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594531|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
23594532|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594533|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594534|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594535|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
23594536|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594537|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
23594538|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594539|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
23594540|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594541|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
23594542|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
23594543|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
23594544|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
23594545|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
23594546|NCT03811574|65906255|FG000|Overall Study|Withdrawal by Subject|2|||
23594547|NCT03811574|65906256|FG001|Overall Study|Withdrawal by Subject|4|||
23594548|NCT03811574|65906257|FG002|Overall Study|Withdrawal by Subject|0|||
23594549|NCT00465816|65906260|FG000|Overall Study|Lost to Follow-up|0|||
23594550|NCT00465816|65906261|FG001|Overall Study|Lost to Follow-up|0|||
23594551|NCT00465816|65906262|FG002|Overall Study|Lost to Follow-up|2|||
23594552|NCT01867216|65906263|FG000|Overall Study|Withdrawal by Subject|2|||
23594553|NCT01867216|65906264|FG001|Overall Study|Withdrawal by Subject|0|||
23594554|NCT01867216|65906265|FG002|Overall Study|Withdrawal by Subject|0|||
23594555|NCT01867216|65906266|FG003|Overall Study|Withdrawal by Subject|0|||
23594556|NCT01867216|65906267|FG004|Overall Study|Withdrawal by Subject|1|||
23594557|NCT01867216|65906268|FG005|Overall Study|Withdrawal by Subject|0|||
23594558|NCT01867216|65906269|FG006|Overall Study|Withdrawal by Subject|1|||
23594559|NCT01867216|65906263|FG000|Overall Study|Physician Decision|1|||
23594560|NCT01867216|65906264|FG001|Overall Study|Physician Decision|0|||
23594561|NCT01867216|65906265|FG002|Overall Study|Physician Decision|0|||
23594562|NCT01867216|65906266|FG003|Overall Study|Physician Decision|0|||
23800132|NCT00115934|66646660|FG001|Overall Study|Lost to Follow-up|0|||
23644787|NCT01090427|66086842|FG001|After Controlled Period|Adverse Event|0|||
23800133|NCT00115934|66646659|FG000|Overall Study|Did not receive intervention|3|||
23800134|NCT00115934|66646660|FG001|Overall Study|Did not receive intervention|2|||
23800135|NCT02994394|66646661|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
23800136|NCT02994394|66646662|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
23800137|NCT02994394|66646663|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
23800138|NCT02994394|66646664|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
23800139|NCT02994394|66646665|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
23800140|NCT02994394|66646666|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
23800141|NCT02994394|66646661|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
23800142|NCT02994394|66646662|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
23800143|NCT02994394|66646663|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
23800144|NCT02994394|66646664|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
23800145|NCT02994394|66646665|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
23800146|NCT02994394|66646666|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
23800147|NCT02619682|66646667|FG000|Overall Study|Withdrawal by Subject|3|||
23800148|NCT02619682|66646667|FG000|Overall Study|Lack of Efficacy|8|||
23800149|NCT02619682|66646667|FG000|Overall Study|new secondary cancer|1|||
23800150|NCT02619682|66646667|FG000|Overall Study|post surgery complications|2|||
23800151|NCT00685802|66646670|FG000|Washout Period of 7 Days|Protocol Violation|2|||
23800152|NCT00685802|66646671|FG001|Washout Period of 7 Days|Protocol Violation|0|||
23800153|NCT00685802|66646670|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23800154|NCT00685802|66646671|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23800155|NCT03718117|66646672|FG000|Overall Study|Death|12|||
23800156|NCT03718117|66646673|FG001|Overall Study|Death|11|||
23800157|NCT03718117|66646674|FG002|Overall Study|Death|0|||
23800158|NCT03718117|66646672|FG000|Overall Study|Other|0|||
23800159|NCT03718117|66646673|FG001|Overall Study|Other|1|||
23800160|NCT03718117|66646674|FG002|Overall Study|Other|0|||
23800161|NCT03718117|66646672|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
23800162|NCT03718117|66646673|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
23800163|NCT03718117|66646674|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
23800164|NCT03718117|66646672|FG000|Overall Study|Participant not met eligibility criteria|0|||
23800165|NCT03718117|66646673|FG001|Overall Study|Participant not met eligibility criteria|0|||
23800166|NCT03718117|66646674|FG002|Overall Study|Participant not met eligibility criteria|2|||
23800167|NCT00743509|66646675|FG000|Overall Study|Withdrawal by Subject|2|||
23594563|NCT01867216|65906267|FG004|Overall Study|Physician Decision|0|||
23594564|NCT01867216|65906268|FG005|Overall Study|Physician Decision|0|||
23594565|NCT01867216|65906269|FG006|Overall Study|Physician Decision|0|||
23594566|NCT01867216|65906263|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
23594567|NCT01867216|65906264|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594568|NCT01867216|65906265|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594569|NCT01867216|65906266|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594570|NCT01867216|65906267|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23644788|NCT01090427|66086843|FG002|After Controlled Period|Adverse Event|0|||
23644789|NCT01090427|66086844|FG003|After Controlled Period|Adverse Event|2|||
23800168|NCT03864042|66646678|FG000|DDI Phase|Adverse Event|2|||
23800169|NCT03864042|66646679|FG001|DDI Phase|Adverse Event|0|||
23800170|NCT03864042|66646680|FG002|DDI Phase|Adverse Event|0|||
23800171|NCT03864042|66646678|FG000|DDI Phase|Physician Decision|1|||
23800172|NCT03864042|66646679|FG001|DDI Phase|Physician Decision|0|||
23594571|NCT01867216|65906268|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594572|NCT01867216|65906269|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594573|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594574|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594575|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594576|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
23594577|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
23594578|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
23594579|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
23594580|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
23594581|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
23594582|NCT02525796|65906270|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
23594583|NCT02525796|65906271|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
23594584|NCT02525796|65906272|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
23594585|NCT02525796|65906270|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594586|NCT02525796|65906271|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594587|NCT02525796|65906272|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594588|NCT01124734|65906273|FG000|Overall Study|Disease progression|13|||
23594589|NCT01124734|65906273|FG000|Overall Study|Adverse Event|1|||
23594590|NCT01124734|65906273|FG000|Overall Study|Withdrawal by Subject|1|||
23594591|NCT01124734|65906273|FG000|Overall Study|Elected for alternative treatment|2|||
23594592|NCT02539225|65906274|FG000|Part A|Adverse Event|13|||
23594593|NCT02539225|65906275|FG001|Part A|Adverse Event|4|||
23594594|NCT02539225|65906274|FG000|Part A|Withdrawal by Subject|2|||
23594595|NCT02539225|65906275|FG001|Part A|Withdrawal by Subject|4|||
23594596|NCT02539225|65906274|FG000|Part A|Physician Decision|4|||
23594597|NCT02539225|65906275|FG001|Part A|Physician Decision|7|||
23594598|NCT02539225|65906274|FG000|Part A|Did Not Receive study Drug|1|||
23594599|NCT02539225|65906275|FG001|Part A|Did Not Receive study Drug|1|||
23594600|NCT02539225|65906274|FG000|Pre Treatment for Part B|Progressive disease|1|||
23594601|NCT02539225|65906275|FG001|Pre Treatment for Part B|Progressive disease|1|||
23594602|NCT02539225|65906274|FG000|Pre Treatment for Part B|Adverse Event|1|||
23594603|NCT02539225|65906275|FG001|Pre Treatment for Part B|Adverse Event|1|||
23644790|NCT01090427|66086845|FG004|After Controlled Period|Adverse Event|0|||
23800173|NCT03864042|66646680|FG002|DDI Phase|Physician Decision|0|||
23800174|NCT03864042|66646678|FG000|DDI Phase|Progressive Disease|1|||
23800175|NCT03864042|66646679|FG001|DDI Phase|Progressive Disease|0|||
23800176|NCT03864042|66646680|FG002|DDI Phase|Progressive Disease|0|||
23800177|NCT03864042|66646678|FG000|Post-DDI Phase|Adverse Event|5|||
23594604|NCT02539225|65906274|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
23594605|NCT02539225|65906275|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
23594606|NCT02539225|65906274|FG000|Pre Treatment for Part B|Physician Decision|2|||
23594607|NCT02539225|65906275|FG001|Pre Treatment for Part B|Physician Decision|0|||
23594608|NCT02539225|65906274|FG000|Part B|Adverse Event|4|||
23594609|NCT02539225|65906275|FG001|Part B|Adverse Event|4|||
23594610|NCT02539225|65906274|FG000|Part B|Withdrawal by Subject|0|||
23594611|NCT02539225|65906275|FG001|Part B|Withdrawal by Subject|3|||
23594612|NCT02539225|65906274|FG000|Part B|Physician Decision|0|||
23477636|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Physician Decision|1|||
23477637|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Physician Decision|1|||
23477638|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
23477639|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
23477640|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Death|4|||
23477641|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Death|3|||
23477642|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Graft loss|0|||
23477643|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Graft loss|1|||
23477644|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
23477645|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
23477646|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Physician Decision|2|||
23477647|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Physician Decision|4|||
23477648|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
23477649|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
23477650|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Death|8|||
23477651|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Death|4|||
23477652|NCT01888432|65491640|FG000|36-month Analysis (Extension)|Death|1|||
23477653|NCT01888432|65491641|FG001|36-month Analysis (Extension)|Death|0|||
23477654|NCT02785770|65491644|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477655|NCT02785770|65491645|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
23477656|NCT02785770|65491646|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477657|NCT02785770|65491647|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477658|NCT02785770|65491644|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477659|NCT02785770|65491645|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477660|NCT02785770|65491646|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
23477661|NCT02785770|65491647|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477662|NCT02785770|65491644|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477663|NCT02785770|65491645|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477664|NCT02785770|65491646|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477665|NCT02785770|65491647|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
23477666|NCT00653432|65491648|FG000|Overall Study|Adverse Event|4|||
23477667|NCT00653432|65491649|FG001|Overall Study|Adverse Event|1|||
23477668|NCT00653432|65491648|FG000|Overall Study|Withdrawal by Subject|4|||
23477669|NCT00653432|65491649|FG001|Overall Study|Withdrawal by Subject|5|||
23477670|NCT00653432|65491648|FG000|Overall Study|Lost to Follow-up|7|||
23477671|NCT00653432|65491649|FG001|Overall Study|Lost to Follow-up|6|||
23477672|NCT00653432|65491648|FG000|Overall Study|Use/Need of Con Therapy|2|||
23477673|NCT00653432|65491649|FG001|Overall Study|Use/Need of Con Therapy|1|||
23477674|NCT00653432|65491648|FG000|Overall Study|Other - Reason Not Provided|5|||
23477675|NCT00653432|65491649|FG001|Overall Study|Other - Reason Not Provided|3|||
23477676|NCT01395784|65491650|FG000|Overall Study|Lost to Follow-up|7|||
23477677|NCT01395784|65491650|FG000|Overall Study|Withdrawal by Subject|3|||
23477678|NCT01395784|65491650|FG000|Overall Study|Physician Decision|5|||
23477679|NCT00870584|65491651|FG000|Overall Study|Adverse Event|3|||
23477680|NCT00870584|65491652|FG001|Overall Study|Adverse Event|3|||
23477681|NCT00870584|65491651|FG000|Overall Study|Withdrawal by Subject|6|||
23477682|NCT00870584|65491652|FG001|Overall Study|Withdrawal by Subject|7|||
23477683|NCT00870584|65491651|FG000|Overall Study|Lost to Follow-up|5|||
23477684|NCT00870584|65491652|FG001|Overall Study|Lost to Follow-up|1|||
23477685|NCT00870584|65491651|FG000|Overall Study|Protocol Deviation|2|||
23477686|NCT00870584|65491652|FG001|Overall Study|Protocol Deviation|2|||
23477687|NCT02793622|65491655|FG000|Overall Study|Lost to Follow-up|31|||
23477688|NCT02793622|65491656|FG001|Overall Study|Lost to Follow-up|19|||
23477689|NCT02793622|65491655|FG000|Overall Study|Withdrawal by Subject|21|||
23477690|NCT02793622|65491656|FG001|Overall Study|Withdrawal by Subject|17|||
23477691|NCT02793622|65491655|FG000|Overall Study|Adverse Event|0|||
23477692|NCT02793622|65491656|FG001|Overall Study|Adverse Event|1|||
23477693|NCT02793622|65491655|FG000|Overall Study|Protocol Violation|1|||
23477694|NCT02793622|65491656|FG001|Overall Study|Protocol Violation|5|||
23477695|NCT02207946|65491657|FG000|Overall Study|Lost to Follow-up|1|||
23477696|NCT02207946|65491658|FG001|Overall Study|Lost to Follow-up|0|||
23477697|NCT02207946|65491657|FG000|Overall Study|Adverse Event|0|||
23477698|NCT02207946|65491658|FG001|Overall Study|Adverse Event|1|||
23477699|NCT00853970|65491659|FG000|Overall Study|Withdrawal by Subject|2|||
23477700|NCT00853970|65491660|FG001|Overall Study|Withdrawal by Subject|1|||
23477701|NCT00853970|65491659|FG000|Overall Study|Cancelled surgery|4|||
23477702|NCT00853970|65491660|FG001|Overall Study|Cancelled surgery|2|||
23477703|NCT03562767|65491664|FG000|Overall Study|Physician Decision|2|||
23477704|NCT03562767|65491665|FG001|Overall Study|Physician Decision|0|||
23477705|NCT03562767|65491666|FG002|Overall Study|Physician Decision|0|||
23477706|NCT03562767|65491664|FG000|Overall Study|Logistic Reason|1|||
23477707|NCT03562767|65491665|FG001|Overall Study|Logistic Reason|3|||
23477708|NCT03562767|65491666|FG002|Overall Study|Logistic Reason|0|||
23477709|NCT02650921|65491667|FG000|Overall Study|Withdrawal by Subject|4|||
23477710|NCT02650921|65491667|FG000|Overall Study|Lost to Follow-up|2|||
23477711|NCT02650921|65491667|FG000|Overall Study|Adverse Event|1|||
23477712|NCT02650921|65491667|FG000|Overall Study|Due to Medical Condition|1|||
23477713|NCT02848729|65491670|FG000|Overall Study|Withdrawal by Subject|1|||
23477714|NCT02848729|65491671|FG001|Overall Study|Withdrawal by Subject|0|||
23477715|NCT02848729|65491670|FG000|Overall Study|Emesis|15|||
23477716|NCT02848729|65491671|FG001|Overall Study|Emesis|11|||
23477717|NCT01253811|65491674|FG000|Overall Study|Withdrawal criteria|1|||
23477718|NCT05028361|65491676|FG000|Overall Study|Withdrawal by Subject|1|||
23477719|NCT05028361|65491677|FG001|Overall Study|Withdrawal by Subject|0|||
23477720|NCT01853839|65491678|FG000|Overall Study|Violated inclusion criteria|2|||
23477721|NCT01853839|65491678|FG000|Overall Study|Not meet ITT population definition|58|||
23477722|NCT01853839|65491678|FG000|Overall Study|End of treatment visit too early|33|||
23477723|NCT01853839|65491678|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
23477724|NCT03319745|65491679|FG000|Overall Study|Death|1|||
23477725|NCT03319745|65491679|FG000|Overall Study|Toxicity Precluding Surgery|1|||
23477726|NCT03462511|65491680|FG000|Overall Study|Withdrawal by Subject|2|||
23477727|NCT03462511|65491681|FG001|Overall Study|Withdrawal by Subject|3|||
23477728|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477729|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477730|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477731|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477732|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
23477733|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477734|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477735|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477736|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23594613|NCT02539225|65906275|FG001|Part B|Physician Decision|9|||
23594614|NCT05368831|65906283|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
23477737|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477738|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477739|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477740|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477741|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477742|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
23477743|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477744|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23360210|NCT01490840|65062857|FG000|Phase 1|Visit 6a omitted|1|||
23360211|NCT01490840|65062858|FG001|Phase 1|Visit 6a omitted|0|||
23477745|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477746|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23594615|NCT04218110|65906287|FG000|Overall Study|Withdrawal by Subject|0|||
23594616|NCT04218110|65906288|FG001|Overall Study|Withdrawal by Subject|0|||
23594617|NCT04218110|65906289|FG002|Overall Study|Withdrawal by Subject|0|||
23594618|NCT04218110|65906290|FG003|Overall Study|Withdrawal by Subject|1|||
23594619|NCT03703336|65906303|FG000|Overall Study|Parent withdrew consent|29|||
23594620|NCT03703336|65906304|FG001|Overall Study|Parent withdrew consent|8|||
23594621|NCT03703336|65906303|FG000|Overall Study|Migration|3|||
23594622|NCT03703336|65906304|FG001|Overall Study|Migration|3|||
23594623|NCT03703336|65906303|FG000|Overall Study|Protocol Violation|3|||
23594624|NCT03703336|65906304|FG001|Overall Study|Protocol Violation|1|||
23594625|NCT03703336|65906303|FG000|Overall Study|Physician Decision|2|||
23594626|NCT03703336|65906304|FG001|Overall Study|Physician Decision|0|||
23644791|NCT01090427|66086846|FG005|After Controlled Period|Adverse Event|1|||
23644792|NCT01090427|66086847|FG006|After Controlled Period|Adverse Event|0|||
23644793|NCT00978627|66086848|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
23644794|NCT00978627|66086849|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
23644795|NCT00978627|66086848|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
23644796|NCT00978627|66086849|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
23644797|NCT00978627|66086848|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
23644798|NCT00978627|66086849|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
23594627|NCT03703336|65906303|FG000|Overall Study|Adverse Event|0|||
23594628|NCT03703336|65906304|FG001|Overall Study|Adverse Event|2|||
23594629|NCT03703336|65906303|FG000|Overall Study|Lost to Follow-up|1|||
23594630|NCT03703336|65906304|FG001|Overall Study|Lost to Follow-up|0|||
23594631|NCT01144468|65906305|FG000|Overall Study|Lost to Follow-up|4|||
23594632|NCT01144468|65906306|FG001|Overall Study|Lost to Follow-up|7|||
23594633|NCT01144468|65906305|FG000|Overall Study|Adverse Event|3|||
23594634|NCT01144468|65906306|FG001|Overall Study|Adverse Event|2|||
23594635|NCT01144468|65906305|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
23594636|NCT01144468|65906306|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
23594637|NCT02738840|65906307|FG000|Overall Study|MRI Scan not Performed|5|||
23594638|NCT02738840|65906307|FG000|Overall Study|Lost to Follow-up|1|||
23594639|NCT02738840|65906307|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
23594640|NCT02738840|65906307|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
23594641|NCT01736215|65906313|FG000|Overall Study|Early termination of erythropoietin use|1|||
23644799|NCT00978627|66086848|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
23594642|NCT01736215|65906313|FG000|Overall Study|Adverse Event|4|||
23594643|NCT01736215|65906313|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
23594644|NCT01736215|65906313|FG000|Overall Study|Insufficient data to perform analysis|8|||
23594645|NCT00296036|65906314|FG000|Overall Study|Withdrawal by Subject|1|||
23594646|NCT00296036|65906315|FG001|Overall Study|Withdrawal by Subject|0|||
23644800|NCT00978627|66086849|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
23594647|NCT00296036|65906316|FG002|Overall Study|Withdrawal by Subject|2|||
23644801|NCT00978627|66086848|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
23594648|NCT00296036|65906317|FG003|Overall Study|Withdrawal by Subject|1|||
23644802|NCT00978627|66086849|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
23594649|NCT00296036|65906318|FG004|Overall Study|Withdrawal by Subject|2|||
23594650|NCT00296036|65906319|FG005|Overall Study|Withdrawal by Subject|1|||
23594651|NCT00296036|65906314|FG000|Overall Study|Protocol Violation|0|||
23594652|NCT00296036|65906315|FG001|Overall Study|Protocol Violation|0|||
23644803|NCT00978627|66086848|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
23594653|NCT00296036|65906316|FG002|Overall Study|Protocol Violation|0|||
23594654|NCT00296036|65906317|FG003|Overall Study|Protocol Violation|0|||
23594655|NCT00296036|65906318|FG004|Overall Study|Protocol Violation|0|||
23594656|NCT00296036|65906319|FG005|Overall Study|Protocol Violation|3|||
23594657|NCT01887600|65906321|FG000|Overall Study|Death|39|||
23594658|NCT01887600|65906322|FG001|Overall Study|Death|16|||
23594659|NCT01887600|65906321|FG000|Overall Study|Lack of Efficacy|3|||
23594660|NCT01887600|65906322|FG001|Overall Study|Lack of Efficacy|26|||
23594661|NCT01887600|65906321|FG000|Overall Study|Lost to Follow-up|5|||
23594662|NCT01887600|65906322|FG001|Overall Study|Lost to Follow-up|1|||
23594663|NCT01887600|65906321|FG000|Overall Study|Physician Decision|7|||
23594664|NCT01887600|65906322|FG001|Overall Study|Physician Decision|8|||
23594665|NCT01887600|65906321|FG000|Overall Study|Protocol Deviation|3|||
23594666|NCT01887600|65906322|FG001|Overall Study|Protocol Deviation|0|||
23594667|NCT01887600|65906321|FG000|Overall Study|Withdrawal by Subject|58|||
23644804|NCT00978627|66086849|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
23644805|NCT00978627|66086848|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
23644806|NCT00978627|66086849|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
23644807|NCT00978627|66086848|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
23644808|NCT00978627|66086849|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
23644809|NCT00978627|66086848|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
23644810|NCT00978627|66086849|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
23644811|NCT04227704|66086850|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
23644812|NCT04227704|66086851|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
23644813|NCT04227704|66086852|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
23594668|NCT01887600|65906322|FG001|Overall Study|Withdrawal by Subject|52|||
23594669|NCT01887600|65906321|FG000|Overall Study|Adverse Event|21|||
23594670|NCT01887600|65906322|FG001|Overall Study|Adverse Event|9|||
23594671|NCT01887600|65906321|FG000|Overall Study|Non-compliance with study drug|3|||
23594672|NCT01887600|65906322|FG001|Overall Study|Non-compliance with study drug|0|||
23594673|NCT01887600|65906321|FG000|Overall Study|Miscellaneous|6|||
23594674|NCT01887600|65906322|FG001|Overall Study|Miscellaneous|2|||
23594675|NCT01887600|65906321|FG000|Overall Study|Progressive Disease|1|||
23594676|NCT01887600|65906322|FG001|Overall Study|Progressive Disease|0|||
23594677|NCT00704184|65906325|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
23594678|NCT00704184|65906326|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
23594679|NCT00704184|65906327|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
23594680|NCT00704184|65906328|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
23594681|NCT00704184|65906329|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
23594682|NCT00704184|65906325|FG000|Open-Label Treatment|Adverse Event|0|||
23594683|NCT00704184|65906326|FG001|Open-Label Treatment|Adverse Event|0|||
23594684|NCT00704184|65906327|FG002|Open-Label Treatment|Adverse Event|2|||
23594685|NCT00704184|65906328|FG003|Open-Label Treatment|Adverse Event|0|||
23594686|NCT00704184|65906329|FG004|Open-Label Treatment|Adverse Event|1|||
23594687|NCT00704184|65906325|FG000|Open-Label Treatment|Lack of Efficacy|0|||
23594688|NCT00704184|65906326|FG001|Open-Label Treatment|Lack of Efficacy|2|||
23594689|NCT00704184|65906327|FG002|Open-Label Treatment|Lack of Efficacy|2|||
23594690|NCT00704184|65906328|FG003|Open-Label Treatment|Lack of Efficacy|2|||
23594691|NCT00704184|65906329|FG004|Open-Label Treatment|Lack of Efficacy|1|||
23594692|NCT00704184|65906325|FG000|Open-Label Treatment|Physician Decision|0|||
23594693|NCT00704184|65906326|FG001|Open-Label Treatment|Physician Decision|0|||
23594694|NCT00704184|65906327|FG002|Open-Label Treatment|Physician Decision|0|||
23594695|NCT00704184|65906328|FG003|Open-Label Treatment|Physician Decision|0|||
23594696|NCT00704184|65906329|FG004|Open-Label Treatment|Physician Decision|1|||
23594697|NCT00704184|65906325|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
23594698|NCT00704184|65906326|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23594699|NCT00704184|65906327|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
23644814|NCT04227704|66086850|FG000|Overall Study|due to C/S being cancelled|1|||
23644815|NCT04227704|66086851|FG001|Overall Study|due to C/S being cancelled|0|||
23594700|NCT00704184|65906328|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
23594701|NCT00704184|65906329|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
23594702|NCT04191096|65906330|FG000|Overall Study|Death|102|||
23594703|NCT04191096|65906331|FG001|Overall Study|Death|89|||
23594704|NCT04191096|65906330|FG000|Overall Study|Lost to Follow-up|1|||
23594705|NCT04191096|65906331|FG001|Overall Study|Lost to Follow-up|1|||
23594706|NCT04191096|65906330|FG000|Overall Study|Withdrawal by Subject|5|||
23594707|NCT04191096|65906331|FG001|Overall Study|Withdrawal by Subject|5|||
23594708|NCT04191096|65906330|FG000|Overall Study|Participants Ongoing|518|||
23594709|NCT04191096|65906331|FG001|Overall Study|Participants Ongoing|530|||
23594710|NCT01061671|65906332|FG000|Overall Study|Withdrawal by Subject|16|||
23594711|NCT01061671|65906333|FG001|Overall Study|Withdrawal by Subject|20|||
23594712|NCT01061671|65906332|FG000|Overall Study|Lost to Follow-up|3|||
23594713|NCT01061671|65906333|FG001|Overall Study|Lost to Follow-up|5|||
23594714|NCT01061671|65906332|FG000|Overall Study|Death|28|||
23594715|NCT01061671|65906333|FG001|Overall Study|Death|30|||
23594716|NCT01444417|65906334|FG000|Overall Study|Ineligibility Determined|0|||
23594717|NCT01444417|65906335|FG001|Overall Study|Ineligibility Determined|1|||
23594718|NCT01444417|65906334|FG000|Overall Study|Withdrawal by Subject|2|||
23644816|NCT04227704|66086852|FG002|Overall Study|due to C/S being cancelled|0|||
23644817|NCT02924064|66086856|FG000|Overall Study|Adverse Event|2|||
23644818|NCT02924064|66086857|FG001|Overall Study|Adverse Event|2|||
23644819|NCT02924064|66086856|FG000|Overall Study|Lost to Follow-up|0|||
23644820|NCT02924064|66086857|FG001|Overall Study|Lost to Follow-up|2|||
23594719|NCT01444417|65906335|FG001|Overall Study|Withdrawal by Subject|0|||
23594720|NCT01610297|65906336|FG000|Overall Study|Lost to Follow-up|1|||
23594721|NCT00482729|65906337|FG000|Overall Study|Adverse Event|29|||
23594722|NCT00482729|65906338|FG001|Overall Study|Adverse Event|33|||
23594723|NCT00482729|65906337|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
23594724|NCT00482729|65906338|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
23594725|NCT00482729|65906337|FG000|Overall Study|Hyperglycemia Criteria|7|||
23594726|NCT00482729|65906338|FG001|Overall Study|Hyperglycemia Criteria|5|||
23594727|NCT00482729|65906337|FG000|Overall Study|Lack of Efficacy|4|||
23594728|NCT00482729|65906338|FG001|Overall Study|Lack of Efficacy|16|||
23644821|NCT02924064|66086856|FG000|Overall Study|Physician Decision|0|||
23644822|NCT02924064|66086857|FG001|Overall Study|Physician Decision|2|||
23644823|NCT02924064|66086856|FG000|Overall Study|Protocol Violation|1|||
23644824|NCT02924064|66086857|FG001|Overall Study|Protocol Violation|3|||
23644825|NCT02924064|66086856|FG000|Overall Study|Withdrawal by Subject|4|||
23644826|NCT02924064|66086857|FG001|Overall Study|Withdrawal by Subject|5|||
23644827|NCT02924064|66086856|FG000|Overall Study|Other|17|||
23644828|NCT02924064|66086857|FG001|Overall Study|Other|29|||
23644829|NCT01659853|66086858|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
23644830|NCT01659853|66086859|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
23644831|NCT01659853|66086858|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
23644832|NCT01659853|66086859|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
23594729|NCT00482729|65906337|FG000|Overall Study|Lost to Follow-up|86|||
23594730|NCT00482729|65906338|FG001|Overall Study|Lost to Follow-up|66|||
23594731|NCT00482729|65906337|FG000|Overall Study|Physician Decision|10|||
23594732|NCT00482729|65906338|FG001|Overall Study|Physician Decision|7|||
23594733|NCT00482729|65906337|FG000|Overall Study|Pregnancy|4|||
23594734|NCT00482729|65906338|FG001|Overall Study|Pregnancy|2|||
23594735|NCT00482729|65906337|FG000|Overall Study|Protocol Violation|10|||
23594736|NCT00482729|65906338|FG001|Overall Study|Protocol Violation|18|||
23594737|NCT00482729|65906337|FG000|Overall Study|Withdrawal by Subject|67|||
23594738|NCT00482729|65906338|FG001|Overall Study|Withdrawal by Subject|69|||
23644833|NCT00911937|66086860|FG000|Overall Study|Death|1|||
23644834|NCT00911937|66086861|FG001|Overall Study|Death|0|||
23644835|NCT00911937|66086860|FG000|Overall Study|Lost to Follow-up|8|||
23644836|NCT00911937|66086861|FG001|Overall Study|Lost to Follow-up|5|||
23594739|NCT00094575|65906339|FG000|Overall Study|Death|146|||
23594740|NCT00094575|65906340|FG001|Overall Study|Death|146|||
23594741|NCT02271854|65906341|FG000|Overall Study|Withdrawal by Subject|2|||
23594742|NCT02271854|65906341|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
23594743|NCT02271854|65906341|FG000|Overall Study|Lost to Follow-up|1|||
23594744|NCT00610649|65906358|FG000|Overall Study|Adverse Event|1|||
23594745|NCT00610649|65906359|FG001|Overall Study|Adverse Event|0|||
23594746|NCT00610649|65906360|FG002|Overall Study|Adverse Event|0|||
23594747|NCT00610649|65906361|FG003|Overall Study|Adverse Event|0|||
23594748|NCT00610649|65906362|FG004|Overall Study|Adverse Event|0|||
23644837|NCT00911937|66086860|FG000|Overall Study|Withdrawal by Subject|10|||
23644838|NCT00911937|66086861|FG001|Overall Study|Withdrawal by Subject|7|||
23644839|NCT00911937|66086860|FG000|Overall Study|Withdrawn due to pregnancy|1|||
23594749|NCT00610649|65906363|FG005|Overall Study|Adverse Event|0|||
23594750|NCT00610649|65906364|FG006|Overall Study|Adverse Event|0|||
23644840|NCT00911937|66086861|FG001|Overall Study|Withdrawn due to pregnancy|0|||
23594751|NCT00610649|65906365|FG007|Overall Study|Adverse Event|0|||
23594752|NCT00610649|65906366|FG008|Overall Study|Adverse Event|0|||
23594753|NCT00610649|65906367|FG009|Overall Study|Adverse Event|0|||
23594754|NCT00610649|65906368|FG010|Overall Study|Adverse Event|1|||
23594755|NCT00610649|65906358|FG000|Overall Study|Family Emergency|0|||
23594756|NCT00610649|65906359|FG001|Overall Study|Family Emergency|1|||
23594757|NCT00610649|65906360|FG002|Overall Study|Family Emergency|0|||
23594758|NCT00610649|65906361|FG003|Overall Study|Family Emergency|0|||
23594759|NCT00610649|65906362|FG004|Overall Study|Family Emergency|0|||
23594760|NCT00610649|65906363|FG005|Overall Study|Family Emergency|0|||
23594761|NCT00610649|65906364|FG006|Overall Study|Family Emergency|0|||
23594762|NCT00610649|65906365|FG007|Overall Study|Family Emergency|0|||
23594763|NCT00610649|65906366|FG008|Overall Study|Family Emergency|0|||
23594764|NCT00610649|65906367|FG009|Overall Study|Family Emergency|0|||
23644841|NCT00911937|66086860|FG000|Overall Study|Adverse Event|11|||
23644842|NCT00911937|66086861|FG001|Overall Study|Adverse Event|25|||
23644843|NCT00911937|66086860|FG000|Overall Study|Lack of Efficacy|11|||
23644844|NCT00911937|66086861|FG001|Overall Study|Lack of Efficacy|6|||
23644845|NCT00911937|66086860|FG000|Overall Study|Did not meet inclusion criteria|9|||
23644846|NCT00911937|66086861|FG001|Overall Study|Did not meet inclusion criteria|11|||
23644847|NCT00911937|66086860|FG000|Overall Study|Protocol Violation|14|||
23644848|NCT00911937|66086861|FG001|Overall Study|Protocol Violation|23|||
23644849|NCT00911937|66086860|FG000|Overall Study|Randomized but not treated|13|||
23644850|NCT00911937|66086861|FG001|Overall Study|Randomized but not treated|13|||
23644851|NCT00911937|66086860|FG000|Overall Study|Other|9|||
23644852|NCT00911937|66086861|FG001|Overall Study|Other|5|||
23644853|NCT04275089|66086862|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
23644854|NCT01768637|66086866|FG000|Overall Study|Lost to Follow-up|2|||
23644855|NCT01768637|66086867|FG001|Overall Study|Lost to Follow-up|7|||
23644856|NCT01768637|66086866|FG000|Overall Study|Difficult blood draw|1|||
23644857|NCT01768637|66086867|FG001|Overall Study|Difficult blood draw|0|||
23644858|NCT00461032|66086868|FG000|Overall Study|Adverse Event|5|||
23644859|NCT00461032|66086869|FG001|Overall Study|Adverse Event|6|||
23644860|NCT00461032|66086868|FG000|Overall Study|Lack of Efficacy|5|||
23644861|NCT00461032|66086869|FG001|Overall Study|Lack of Efficacy|1|||
23644862|NCT00461032|66086868|FG000|Overall Study|Lost to Follow-up|7|||
23644863|NCT00461032|66086869|FG001|Overall Study|Lost to Follow-up|12|||
23644864|NCT00461032|66086868|FG000|Overall Study|Protocol Violation|4|||
23644865|NCT00461032|66086869|FG001|Overall Study|Protocol Violation|4|||
23644866|NCT00461032|66086868|FG000|Overall Study|Withdrawal by Subject|7|||
23644867|NCT00461032|66086869|FG001|Overall Study|Withdrawal by Subject|15|||
23644868|NCT00461032|66086868|FG000|Overall Study|Patient Moved or Relocated|2|||
23644869|NCT00461032|66086869|FG001|Overall Study|Patient Moved or Relocated|1|||
23644870|NCT00461032|66086868|FG000|Overall Study|Other|7|||
23644871|NCT00461032|66086869|FG001|Overall Study|Other|5|||
23644872|NCT02270515|66086870|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
23644873|NCT02270515|66086870|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
23644874|NCT02270515|66086870|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
23644875|NCT02270515|66086870|FG000|Intervention Period 1: 0-6 Months|Death|7|||
23644876|NCT02270515|66086870|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
23644877|NCT02270515|66086870|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
23644878|NCT02270515|66086870|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
23644879|NCT02270515|66086870|FG000|Intervention Period 2: 6-12 Months|Death|5|||
23644880|NCT02270515|66086870|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
23644881|NCT02270515|66086870|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
23644882|NCT02270515|66086870|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
23644883|NCT02270515|66086870|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
23644884|NCT02270515|66086870|FG000|Intervention Period 3: 12-18 Months|Death|3|||
23644885|NCT02270515|66086870|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
23644886|NCT00112047|66086874|FG000|Randomized Phase|Lost to Follow-up|26|||
23644887|NCT00112047|66086875|FG001|Randomized Phase|Lost to Follow-up|33|||
23644888|NCT00112047|66086874|FG000|Randomized Phase|Adverse Event|10|||
23644889|NCT00112047|66086875|FG001|Randomized Phase|Adverse Event|10|||
23644890|NCT00112047|66086874|FG000|Randomized Phase|Withrawal of consent|10|||
23594765|NCT00610649|65906368|FG010|Overall Study|Family Emergency|0|||
23594766|NCT00610649|65906358|FG000|Overall Study|Withdrawal by Subject|0|||
23644891|NCT00112047|66086875|FG001|Randomized Phase|Withrawal of consent|18|||
23644892|NCT00112047|66086874|FG000|Randomized Phase|Sub-optimal virological response|3|||
23644893|NCT00112047|66086875|FG001|Randomized Phase|Sub-optimal virological response|13|||
23644894|NCT00112047|66086874|FG000|Randomized Phase|Noncompliance|8|||
23644895|NCT00112047|66086875|FG001|Randomized Phase|Noncompliance|4|||
23594767|NCT00610649|65906359|FG001|Overall Study|Withdrawal by Subject|0|||
23594768|NCT00610649|65906360|FG002|Overall Study|Withdrawal by Subject|0|||
23644896|NCT00112047|66086874|FG000|Randomized Phase|Protocol Violation|2|||
23644897|NCT00112047|66086875|FG001|Randomized Phase|Protocol Violation|0|||
23644898|NCT00112047|66086874|FG000|Randomized Phase|Pregnancy|3|||
23644899|NCT00112047|66086875|FG001|Randomized Phase|Pregnancy|1|||
23644900|NCT00112047|66086874|FG000|Randomized Phase|Death|1|||
23644901|NCT00112047|66086875|FG001|Randomized Phase|Death|3|||
23644902|NCT00112047|66086874|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
23644903|NCT00112047|66086875|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
23644904|NCT00112047|66086874|FG000|Randomized Phase|Inability to swallow pills|0|||
23644905|NCT00112047|66086875|FG001|Randomized Phase|Inability to swallow pills|1|||
23644906|NCT00112047|66086874|FG000|Randomized Phase|Incarceration|3|||
23644907|NCT00112047|66086875|FG001|Randomized Phase|Incarceration|2|||
23644908|NCT00112047|66086874|FG000|Randomized Phase|Moved out of State|0|||
23644909|NCT00112047|66086875|FG001|Randomized Phase|Moved out of State|1|||
23644910|NCT00112047|66086874|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
23644911|NCT00112047|66086875|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
23644912|NCT00112047|66086874|FG000|Randomized Phase|High Hepatitis B DNA|0|||
23594769|NCT00610649|65906361|FG003|Overall Study|Withdrawal by Subject|0|||
23594770|NCT00610649|65906362|FG004|Overall Study|Withdrawal by Subject|0|||
23594771|NCT00610649|65906363|FG005|Overall Study|Withdrawal by Subject|0|||
23594772|NCT00610649|65906364|FG006|Overall Study|Withdrawal by Subject|0|||
23594773|NCT00610649|65906365|FG007|Overall Study|Withdrawal by Subject|0|||
23594774|NCT00610649|65906366|FG008|Overall Study|Withdrawal by Subject|0|||
23594775|NCT00610649|65906367|FG009|Overall Study|Withdrawal by Subject|1|||
23594776|NCT00610649|65906368|FG010|Overall Study|Withdrawal by Subject|0|||
23594777|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
23594778|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
23594779|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
23594780|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
23594781|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
23594782|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
23594783|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
23594784|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
23594785|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
23594786|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
23594787|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
23594788|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
23594789|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
23594790|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
23594791|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
23594792|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
23594793|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
23594794|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
23594795|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
23594796|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
23594797|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
23594798|NCT01875250|65906373|FG000|Overall Study|Adverse Event|2|||
23594799|NCT01875250|65906374|FG001|Overall Study|Adverse Event|0|||
23594800|NCT00818454|65906377|FG000|Treatment Period 1|Adverse Event|0|||
23594801|NCT00818454|65906378|FG001|Treatment Period 1|Adverse Event|1|||
23594802|NCT00818454|65906379|FG002|Treatment Period 1|Adverse Event|0|||
23594803|NCT00818454|65906380|FG003|Treatment Period 1|Adverse Event|0|||
23594804|NCT00818454|65906377|FG000|Treatment Period 1|Other|3|||
23594805|NCT00818454|65906378|FG001|Treatment Period 1|Other|0|||
23594806|NCT00818454|65906379|FG002|Treatment Period 1|Other|0|||
23594807|NCT00818454|65906380|FG003|Treatment Period 1|Other|0|||
23594808|NCT00818454|65906377|FG000|Washout Period of 1 Week|Adverse Event|1|||
23594809|NCT00818454|65906378|FG001|Washout Period of 1 Week|Adverse Event|1|||
23594810|NCT00818454|65906379|FG002|Washout Period of 1 Week|Adverse Event|0|||
23594811|NCT00818454|65906380|FG003|Washout Period of 1 Week|Adverse Event|0|||
23594812|NCT00818454|65906377|FG000|Washout Period of 1 Week|Protocol Violation|2|||
23594813|NCT00818454|65906378|FG001|Washout Period of 1 Week|Protocol Violation|0|||
23594814|NCT00818454|65906379|FG002|Washout Period of 1 Week|Protocol Violation|0|||
23594815|NCT00818454|65906380|FG003|Washout Period of 1 Week|Protocol Violation|0|||
23594816|NCT00818454|65906377|FG000|Washout Period of 1 Week|Other|1|||
23594817|NCT00818454|65906378|FG001|Washout Period of 1 Week|Other|2|||
23594818|NCT00818454|65906379|FG002|Washout Period of 1 Week|Other|0|||
23594819|NCT00818454|65906380|FG003|Washout Period of 1 Week|Other|0|||
23594820|NCT00818454|65906377|FG000|Treatment Period 2|Other|2|||
23594821|NCT00818454|65906378|FG001|Treatment Period 2|Other|1|||
23644913|NCT00112047|66086875|FG001|Randomized Phase|High Hepatitis B DNA|1|||
23644914|NCT00112047|66086874|FG000|Atripla Phase|Adverse Event|2|||
23360212|NCT01490840|65062857|FG000|Phase 2|Withdrawal by Subject|4|||
23360213|NCT01490840|65062858|FG001|Phase 2|Withdrawal by Subject|3|||
23644915|NCT00112047|66086875|FG001|Atripla Phase|Adverse Event|1|||
23644916|NCT00112047|66086874|FG000|Atripla Phase|Lost to Follow-up|5|||
23594822|NCT00818454|65906379|FG002|Treatment Period 2|Other|0|||
23594823|NCT00818454|65906380|FG003|Treatment Period 2|Other|0|||
23594824|NCT00818454|65906377|FG000|Treatment Period 3|Adverse Event|0|||
23594825|NCT00818454|65906378|FG001|Treatment Period 3|Adverse Event|0|||
23594826|NCT00818454|65906379|FG002|Treatment Period 3|Adverse Event|0|||
23594827|NCT00818454|65906380|FG003|Treatment Period 3|Adverse Event|1|||
23594828|NCT04723394|65906381|FG000|Overall Study|Adverse Event|0|||
23594829|NCT04723394|65906382|FG001|Overall Study|Adverse Event|3|||
23594830|NCT04723394|65906381|FG000|Overall Study|Death|8|||
23594831|NCT04723394|65906382|FG001|Overall Study|Death|8|||
23594832|NCT04723394|65906381|FG000|Overall Study|Lost to Follow-up|20|||
23594833|NCT04723394|65906382|FG001|Overall Study|Lost to Follow-up|17|||
23594834|NCT04723394|65906381|FG000|Overall Study|Physician Decision|1|||
23594835|NCT04723394|65906382|FG001|Overall Study|Physician Decision|0|||
23594836|NCT04723394|65906381|FG000|Overall Study|Withdrawal by Subject|20|||
23594837|NCT04723394|65906382|FG001|Overall Study|Withdrawal by Subject|34|||
23644917|NCT00112047|66086875|FG001|Atripla Phase|Lost to Follow-up|7|||
23644918|NCT00112047|66086874|FG000|Atripla Phase|Pregnancy|0|||
23644919|NCT00112047|66086875|FG001|Atripla Phase|Pregnancy|1|||
23644920|NCT00112047|66086874|FG000|Atripla Phase|Death|0|||
23644921|NCT00112047|66086875|FG001|Atripla Phase|Death|2|||
23644922|NCT00112047|66086874|FG000|Atripla Phase|Withdrew consent|7|||
23644923|NCT00112047|66086875|FG001|Atripla Phase|Withdrew consent|7|||
23644924|NCT00112047|66086874|FG000|Atripla Phase|Sub-optimal virological response|0|||
23644925|NCT00112047|66086875|FG001|Atripla Phase|Sub-optimal virological response|1|||
23644926|NCT00112047|66086874|FG000|Atripla Phase|Non-compliance|1|||
23644927|NCT00112047|66086875|FG001|Atripla Phase|Non-compliance|0|||
23644928|NCT00112047|66086874|FG000|Atripla Phase|Other|3|||
23644929|NCT00112047|66086875|FG001|Atripla Phase|Other|1|||
23644930|NCT03938545|66086876|FG000|Overall Study|Lost to Follow-up|0|||
23800178|NCT03864042|66646679|FG001|Post-DDI Phase|Adverse Event|3|||
23800179|NCT03864042|66646680|FG002|Post-DDI Phase|Adverse Event|2|||
23800180|NCT03864042|66646678|FG000|Post-DDI Phase|Progressive Disease|11|||
23800181|NCT03864042|66646679|FG001|Post-DDI Phase|Progressive Disease|6|||
23800182|NCT03864042|66646680|FG002|Post-DDI Phase|Progressive Disease|13|||
23800183|NCT03864042|66646678|FG000|Post-DDI Phase|Discretion of investigator|1|||
23800184|NCT03864042|66646679|FG001|Post-DDI Phase|Discretion of investigator|1|||
23594838|NCT04723394|65906381|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
23594839|NCT04723394|65906382|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
23594840|NCT02759016|65906385|FG000|Overall Study|Not treated with BI 836826|1|||
23594841|NCT02759016|65906386|FG001|Overall Study|Not treated with BI 836826|0|||
23594842|NCT02759016|65906385|FG000|Overall Study|Progressive disease|1|||
23644931|NCT03938545|66086877|FG001|Overall Study|Lost to Follow-up|0|||
23644932|NCT03938545|66086878|FG002|Overall Study|Lost to Follow-up|0|||
23644933|NCT03938545|66086879|FG003|Overall Study|Lost to Follow-up|1|||
23644934|NCT03938545|66086876|FG000|Overall Study|Non-compliance with study drug|0|||
23644935|NCT03938545|66086877|FG001|Overall Study|Non-compliance with study drug|0|||
23644936|NCT03938545|66086878|FG002|Overall Study|Non-compliance with study drug|1|||
23644937|NCT03938545|66086879|FG003|Overall Study|Non-compliance with study drug|0|||
23644938|NCT03938545|66086876|FG000|Overall Study|Pregnancy|1|||
23644939|NCT03938545|66086877|FG001|Overall Study|Pregnancy|0|||
23644940|NCT03938545|66086878|FG002|Overall Study|Pregnancy|0|||
23644941|NCT03938545|66086879|FG003|Overall Study|Pregnancy|0|||
23644942|NCT03938545|66086876|FG000|Overall Study|Study terminated by sponsor|6|||
23644943|NCT03938545|66086877|FG001|Overall Study|Study terminated by sponsor|4|||
23644944|NCT03938545|66086878|FG002|Overall Study|Study terminated by sponsor|2|||
23644945|NCT03938545|66086879|FG003|Overall Study|Study terminated by sponsor|4|||
23800185|NCT03864042|66646680|FG002|Post-DDI Phase|Discretion of investigator|0|||
23800186|NCT03864042|66646678|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
23594843|NCT02759016|65906386|FG001|Overall Study|Progressive disease|0|||
23594844|NCT02759016|65906385|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
23594845|NCT02759016|65906386|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
23594846|NCT02759016|65906385|FG000|Overall Study|Other not defined above|2|||
23594847|NCT02759016|65906386|FG001|Overall Study|Other not defined above|1|||
23644946|NCT03938545|66086876|FG000|Overall Study|Withdrawal by Subject|0|||
23644947|NCT03938545|66086877|FG001|Overall Study|Withdrawal by Subject|1|||
23644948|NCT03938545|66086878|FG002|Overall Study|Withdrawal by Subject|0|||
23644949|NCT03938545|66086879|FG003|Overall Study|Withdrawal by Subject|0|||
23644950|NCT03938545|66086876|FG000|Overall Study|Adverse Event|1|||
23644951|NCT03938545|66086877|FG001|Overall Study|Adverse Event|0|||
23644952|NCT03938545|66086878|FG002|Overall Study|Adverse Event|0|||
23800187|NCT03864042|66646679|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
23800188|NCT03864042|66646680|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
23800189|NCT03864042|66646678|FG000|Post-DDI Phase|Withdrawal of consent|1|||
23800190|NCT03864042|66646679|FG001|Post-DDI Phase|Withdrawal of consent|2|||
23800191|NCT03864042|66646680|FG002|Post-DDI Phase|Withdrawal of consent|0|||
23594848|NCT02178098|65906387|FG000|Overall Study|Withdrawal by Subject|0|||
23594849|NCT02178098|65906388|FG001|Overall Study|Withdrawal by Subject|6|||
23594850|NCT02178098|65906387|FG000|Overall Study|Adverse Event|1|||
23594851|NCT02178098|65906388|FG001|Overall Study|Adverse Event|2|||
23594852|NCT02178098|65906387|FG000|Overall Study|Protocol Violation|1|||
23594853|NCT02178098|65906388|FG001|Overall Study|Protocol Violation|1|||
23594854|NCT02178098|65906387|FG000|Overall Study|Lost to Follow-up|0|||
23594855|NCT02178098|65906388|FG001|Overall Study|Lost to Follow-up|1|||
23594856|NCT02178098|65906387|FG000|Overall Study|Sponsor Request|1|||
23594857|NCT02178098|65906388|FG001|Overall Study|Sponsor Request|0|||
23594858|NCT02178098|65906387|FG000|Overall Study|Other|2|||
23594859|NCT02178098|65906388|FG001|Overall Study|Other|2|||
23594860|NCT00186186|65909231|FG000|Overall Study|Lack of Efficacy|3|||
23594861|NCT00186186|65909231|FG000|Overall Study|Withdrawal by Subject|3|||
23594862|NCT00186186|65909231|FG000|Overall Study|Not reported as to reason|2|||
23594863|NCT03432858|65909233|FG000|Overall Study|Protocol Violation|2|||
23594864|NCT03432858|65909234|FG001|Overall Study|Protocol Violation|1|||
23594865|NCT03432858|65909235|FG002|Overall Study|Protocol Violation|9|||
23594866|NCT03432858|65909233|FG000|Overall Study|Withdrawal by Subject|0|||
23594867|NCT03432858|65909234|FG001|Overall Study|Withdrawal by Subject|1|||
23594868|NCT03432858|65909235|FG002|Overall Study|Withdrawal by Subject|1|||
23594869|NCT03432858|65909233|FG000|Overall Study|Procedure canceled/rescheduled|0|||
23594870|NCT03432858|65909234|FG001|Overall Study|Procedure canceled/rescheduled|9|||
23594871|NCT03432858|65909235|FG002|Overall Study|Procedure canceled/rescheduled|6|||
23594872|NCT03432858|65909233|FG000|Overall Study|Required postop mobilization with splinting|0|||
23594873|NCT03432858|65909234|FG001|Overall Study|Required postop mobilization with splinting|0|||
23594874|NCT03432858|65909235|FG002|Overall Study|Required postop mobilization with splinting|1|||
23594875|NCT04600752|65909236|FG000|Overall Study|Physician Decision|0|||
23594876|NCT04600752|65909237|FG001|Overall Study|Physician Decision|0|||
23594877|NCT04600752|65909238|FG002|Overall Study|Physician Decision|1|||
23594878|NCT04600752|65909236|FG000|Overall Study|Adverse Event|0|||
23594879|NCT04600752|65909237|FG001|Overall Study|Adverse Event|1|||
23594880|NCT04600752|65909238|FG002|Overall Study|Adverse Event|0|||
23594881|NCT04600752|65909236|FG000|Overall Study|Withdrawal by Subject|2|||
23594882|NCT04600752|65909237|FG001|Overall Study|Withdrawal by Subject|1|||
23594883|NCT04600752|65909238|FG002|Overall Study|Withdrawal by Subject|0|||
23594884|NCT04600752|65909236|FG000|Overall Study|Lack of Efficacy|1|||
23594885|NCT04600752|65909237|FG001|Overall Study|Lack of Efficacy|0|||
23594886|NCT04600752|65909238|FG002|Overall Study|Lack of Efficacy|0|||
23594887|NCT00002842|65909239|FG000|Overall Study|ineligible for surgical resection|27|||
23594888|NCT01499199|65909240|FG000|Overall Study|Adverse Event|1|||
23594889|NCT01499199|65909240|FG000|Overall Study|Lack of Efficacy|1|||
23594890|NCT00686855|65909243|FG000|Overall Study|Lost to Follow-up|1|||
23594891|NCT00686855|65909244|FG001|Overall Study|Lost to Follow-up|0|||
23594892|NCT00686855|65909243|FG000|Overall Study|Progressive GVHD|0|||
23594893|NCT00686855|65909244|FG001|Overall Study|Progressive GVHD|1|||
23594894|NCT01254188|65909245|FG000|Overall Study|Disease Progression|6|||
23594895|NCT01254188|65909245|FG000|Overall Study|Protocol Violation|6|||
23594896|NCT01254188|65909245|FG000|Overall Study|Pregnancy|2|||
23594897|NCT01254188|65909245|FG000|Overall Study|Death|4|||
23594898|NCT01254188|65909245|FG000|Overall Study|Lost to Follow-up|5|||
23594899|NCT01254188|65909245|FG000|Overall Study|Withdrawal by Subject|7|||
23594900|NCT01254188|65909245|FG000|Overall Study|Adverse Event|43|||
23594901|NCT01254188|65909245|FG000|Overall Study|per investigator discretion|20|||
23594902|NCT00411151|65909249|FG000|Overall Study|Death|38|||
23594903|NCT00411151|65909249|FG000|Overall Study|Withdrawal by Subject|2|||
23594904|NCT00411151|65909249|FG000|Overall Study|Lost to Follow-up|2|||
23594905|NCT00411151|65909249|FG000|Overall Study|Protocol Violation|1|||
23594906|NCT00411151|65909249|FG000|Overall Study|Trial prematurely closed|4|||
23594907|NCT00726596|65909253|FG000|Overall Study|Adverse Event|2|||
23594908|NCT00726596|65909254|FG001|Overall Study|Adverse Event|1|||
23594909|NCT00726596|65909253|FG000|Overall Study|Withdrawal by Subject|3|||
23594910|NCT00726596|65909254|FG001|Overall Study|Withdrawal by Subject|3|||
23594911|NCT01551355|65909257|FG000|Overall Study|Lost to Follow-up|51|||
23594912|NCT01551355|65909258|FG001|Overall Study|Lost to Follow-up|49|||
23594913|NCT01551355|65909259|FG002|Overall Study|Lost to Follow-up|34|||
23594914|NCT01551355|65909260|FG003|Overall Study|Lost to Follow-up|24|||
23594915|NCT01551355|65909261|FG004|Overall Study|Lost to Follow-up|9|||
23594916|NCT01551355|65909262|FG005|Overall Study|Lost to Follow-up|6|||
23594917|NCT03473340|65909264|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
23594918|NCT03473340|65909265|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
23594919|NCT03473340|65909264|FG000|Overall Study|Withdrawal by Subject|1|||
23594920|NCT03473340|65909265|FG001|Overall Study|Withdrawal by Subject|0|||
23594921|NCT03473340|65909264|FG000|Overall Study|Lost to Follow-up|1|||
23594922|NCT03473340|65909265|FG001|Overall Study|Lost to Follow-up|2|||
23594923|NCT01534494|65909266|FG000|Overall Study|Withdrawal by Subject|1|||
23594924|NCT03101930|65909267|FG000|Overall Study|Withdrawal by Subject|2|||
23594925|NCT03101930|65909268|FG001|Overall Study|Withdrawal by Subject|1|||
23594926|NCT03101930|65909269|FG002|Overall Study|Withdrawal by Subject|2|||
23594927|NCT03262935|65909271|FG000|Overall Study|Withdrawal by Subject|6|||
23644953|NCT03938545|66086879|FG003|Overall Study|Adverse Event|0|||
23644954|NCT01315353|66086880|FG000|Overall Study|Death|2|||
23644955|NCT01315353|66086881|FG001|Overall Study|Death|1|||
23644956|NCT01315353|66086882|FG002|Overall Study|Death|0|||
23644957|NCT01315353|66086880|FG000|Overall Study|Withdrawal by Subject|2|||
23644958|NCT01315353|66086881|FG001|Overall Study|Withdrawal by Subject|6|||
23644959|NCT01315353|66086882|FG002|Overall Study|Withdrawal by Subject|1|||
23644960|NCT01315353|66086880|FG000|Overall Study|Lost to Follow-up|13|||
23644961|NCT01315353|66086881|FG001|Overall Study|Lost to Follow-up|6|||
23594928|NCT03262935|65909272|FG001|Overall Study|Withdrawal by Subject|7|||
23594929|NCT03262935|65909271|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
23594930|NCT03262935|65909272|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
23594931|NCT03262935|65909271|FG000|Overall Study|Death|181|||
23594932|NCT03262935|65909272|FG001|Overall Study|Death|94|||
23594933|NCT03262935|65909271|FG000|Overall Study|Lost to Follow-up|9|||
23594934|NCT03262935|65909272|FG001|Overall Study|Lost to Follow-up|4|||
23594935|NCT03262935|65909271|FG000|Overall Study|Other reason|5|||
23594936|NCT03262935|65909272|FG001|Overall Study|Other reason|0|||
23594937|NCT01136876|65909274|FG000|Overall Study|Lost to Follow-up|0|||
23594938|NCT01136876|65909275|FG001|Overall Study|Lost to Follow-up|1|||
23594939|NCT01136876|65909274|FG000|Overall Study|Physician Decision|3|||
23594940|NCT01136876|65909275|FG001|Overall Study|Physician Decision|5|||
23594941|NCT01136876|65909274|FG000|Overall Study|Missing NGAL measurement|2|||
23594942|NCT01136876|65909275|FG001|Overall Study|Missing NGAL measurement|5|||
23594943|NCT02015520|65909277|FG000|Overall Study|Lack of Efficacy|1|||
23594944|NCT02015520|65909278|FG001|Overall Study|Lack of Efficacy|0|||
23594945|NCT02015520|65909279|FG002|Overall Study|Lack of Efficacy|3|||
23594946|NCT02015520|65909280|FG003|Overall Study|Lack of Efficacy|2|||
23594947|NCT02015520|65909277|FG000|Overall Study|Adverse Event|0|||
23594948|NCT02015520|65909278|FG001|Overall Study|Adverse Event|0|||
23594949|NCT02015520|65909279|FG002|Overall Study|Adverse Event|0|||
23594950|NCT02015520|65909280|FG003|Overall Study|Adverse Event|1|||
23594951|NCT02015520|65909277|FG000|Overall Study|Withdrawal by Subject|2|||
23594952|NCT02015520|65909278|FG001|Overall Study|Withdrawal by Subject|2|||
23594953|NCT02015520|65909279|FG002|Overall Study|Withdrawal by Subject|1|||
23594954|NCT02015520|65909280|FG003|Overall Study|Withdrawal by Subject|0|||
23594955|NCT02015520|65909277|FG000|Overall Study|Death|1|||
23594956|NCT02015520|65909278|FG001|Overall Study|Death|0|||
23594957|NCT02015520|65909279|FG002|Overall Study|Death|0|||
23594958|NCT02015520|65909280|FG003|Overall Study|Death|0|||
23594959|NCT02015520|65909277|FG000|Overall Study|Lost to Follow-up|0|||
23594960|NCT02015520|65909278|FG001|Overall Study|Lost to Follow-up|0|||
23594961|NCT02015520|65909279|FG002|Overall Study|Lost to Follow-up|1|||
23594962|NCT02015520|65909280|FG003|Overall Study|Lost to Follow-up|0|||
23594963|NCT02015520|65909277|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23594964|NCT02015520|65909278|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23644962|NCT01315353|66086882|FG002|Overall Study|Lost to Follow-up|6|||
23644963|NCT01315353|66086880|FG000|Overall Study|Unwilling to adhere to requirements|5|||
23644964|NCT01315353|66086881|FG001|Overall Study|Unwilling to adhere to requirements|5|||
23594965|NCT02015520|65909279|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
23594966|NCT02015520|65909280|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23594967|NCT02015520|65909277|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
23594968|NCT02015520|65909278|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
23594969|NCT02015520|65909279|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
23644965|NCT01315353|66086882|FG002|Overall Study|Unwilling to adhere to requirements|4|||
23594970|NCT02015520|65909280|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
23644966|NCT01315353|66086880|FG000|Overall Study|Site closing|7|||
23644967|NCT01315353|66086881|FG001|Overall Study|Site closing|4|||
23644968|NCT01315353|66086882|FG002|Overall Study|Site closing|0|||
23644969|NCT01315353|66086880|FG000|Overall Study|Taken off study by site in error|0|||
23644970|NCT01315353|66086881|FG001|Overall Study|Taken off study by site in error|1|||
23644971|NCT01315353|66086882|FG002|Overall Study|Taken off study by site in error|0|||
23594971|NCT00433199|65909282|FG000|Double-Blind Period|Adverse Event|0|||
23594972|NCT00433199|65909283|FG001|Double-Blind Period|Adverse Event|25|||
23594973|NCT00433199|65909282|FG000|Double-Blind Period|Lack of Efficacy|0|||
23594974|NCT00433199|65909283|FG001|Double-Blind Period|Lack of Efficacy|2|||
23594975|NCT00433199|65909282|FG000|Double-Blind Period|Lost to Follow-up|2|||
23594976|NCT00433199|65909283|FG001|Double-Blind Period|Lost to Follow-up|5|||
23594977|NCT00433199|65909282|FG000|Double-Blind Period|Withdrawal by Subject|8|||
23594978|NCT00433199|65909283|FG001|Double-Blind Period|Withdrawal by Subject|19|||
23594979|NCT00433199|65909282|FG000|Double-Blind Period|Protocol Violation|1|||
23594980|NCT00433199|65909283|FG001|Double-Blind Period|Protocol Violation|10|||
23594981|NCT00433199|65909282|FG000|Double-Blind Period|Administrative|1|||
23594982|NCT00433199|65909283|FG001|Double-Blind Period|Administrative|5|||
23594983|NCT00433199|65909282|FG000|Open-Label Period|Adverse Event|0|||
23594984|NCT00433199|65909283|FG001|Open-Label Period|Adverse Event|19|||
23594985|NCT00433199|65909282|FG000|Open-Label Period|Lack of Efficacy|0|||
23594986|NCT00433199|65909283|FG001|Open-Label Period|Lack of Efficacy|2|||
23594987|NCT00433199|65909282|FG000|Open-Label Period|Lost to Follow-up|0|||
23594988|NCT00433199|65909283|FG001|Open-Label Period|Lost to Follow-up|3|||
23594989|NCT00433199|65909282|FG000|Open-Label Period|Withdrawal by Subject|0|||
23594990|NCT00433199|65909283|FG001|Open-Label Period|Withdrawal by Subject|7|||
23594991|NCT00433199|65909282|FG000|Open-Label Period|Protocol Violation|0|||
23594992|NCT00433199|65909283|FG001|Open-Label Period|Protocol Violation|2|||
23594993|NCT00433199|65909282|FG000|Open-Label Period|Administrative|0|||
23594994|NCT00433199|65909283|FG001|Open-Label Period|Administrative|1|||
23594995|NCT03565315|65909289|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594996|NCT03565315|65909290|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594997|NCT03565315|65909291|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594998|NCT03565315|65909292|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
23594999|NCT01989455|65909293|FG000|Overall Study|Adverse Event|0|||
23595000|NCT01989455|65909294|FG001|Overall Study|Adverse Event|1|||
23595001|NCT01989455|65909295|FG002|Overall Study|Adverse Event|0|||
23644972|NCT01315353|66086880|FG000|Overall Study|Inadvertent randomization/assignment|0|||
23360214|NCT01490840|65062857|FG000|Phase 2|Permanent interruption of fingolimod|0|||
23595002|NCT01989455|65909296|FG003|Overall Study|Adverse Event|0|||
23595003|NCT01989455|65909297|FG004|Overall Study|Adverse Event|0|||
23595004|NCT01989455|65909293|FG000|Overall Study|Withdrawal by Subject|0|||
23595005|NCT01989455|65909294|FG001|Overall Study|Withdrawal by Subject|1|||
23595006|NCT01989455|65909295|FG002|Overall Study|Withdrawal by Subject|0|||
23595007|NCT01989455|65909296|FG003|Overall Study|Withdrawal by Subject|0|||
23595008|NCT01989455|65909297|FG004|Overall Study|Withdrawal by Subject|0|||
23595009|NCT01989455|65909293|FG000|Overall Study|Technical problems with infusion|0|||
23595010|NCT01989455|65909294|FG001|Overall Study|Technical problems with infusion|0|||
23595011|NCT01989455|65909295|FG002|Overall Study|Technical problems with infusion|1|||
23595012|NCT01989455|65909296|FG003|Overall Study|Technical problems with infusion|0|||
23595013|NCT01989455|65909297|FG004|Overall Study|Technical problems with infusion|1|||
23595014|NCT01170962|65909298|FG000|Treatment Period|Lack of Efficacy|96|||
23595015|NCT01170962|65909299|FG001|Treatment Period|Lack of Efficacy|91|||
23595016|NCT01170962|65909300|FG002|Treatment Period|Lack of Efficacy|7|||
23595017|NCT01170962|65909298|FG000|Treatment Period|Adverse Event|11|||
23644973|NCT01315353|66086881|FG001|Overall Study|Inadvertent randomization/assignment|0|||
23644974|NCT01315353|66086882|FG002|Overall Study|Inadvertent randomization/assignment|2|||
23644975|NCT01920854|66086885|FG000|Overall Study|Withdrawal by Subject|1|||
23644976|NCT01920854|66086886|FG001|Overall Study|Withdrawal by Subject|0|||
23644977|NCT01920854|66086887|FG002|Overall Study|Withdrawal by Subject|0|||
23644978|NCT01920854|66086888|FG003|Overall Study|Withdrawal by Subject|0|||
23644979|NCT01920854|66086889|FG004|Overall Study|Withdrawal by Subject|1|||
23644980|NCT01920854|66086890|FG005|Overall Study|Withdrawal by Subject|0|||
23595018|NCT01170962|65909299|FG001|Treatment Period|Adverse Event|12|||
23595019|NCT01170962|65909300|FG002|Treatment Period|Adverse Event|3|||
23595020|NCT01170962|65909298|FG000|Treatment Period|Withdrawal by Subject|2|||
23595021|NCT01170962|65909299|FG001|Treatment Period|Withdrawal by Subject|1|||
23595022|NCT01170962|65909300|FG002|Treatment Period|Withdrawal by Subject|0|||
23595023|NCT01170962|65909298|FG000|Treatment Period|Lost to Follow-up|1|||
23595024|NCT01170962|65909299|FG001|Treatment Period|Lost to Follow-up|1|||
23595025|NCT01170962|65909300|FG002|Treatment Period|Lost to Follow-up|1|||
23595026|NCT01170962|65909298|FG000|Treatment Period|Participant no longer meets criteria|0|||
23595027|NCT01170962|65909299|FG001|Treatment Period|Participant no longer meets criteria|1|||
23595028|NCT01170962|65909300|FG002|Treatment Period|Participant no longer meets criteria|0|||
23595029|NCT01170962|65909298|FG000|Treatment Period|Request to discontinue treatment|7|||
23595030|NCT01170962|65909299|FG001|Treatment Period|Request to discontinue treatment|3|||
23595031|NCT01170962|65909300|FG002|Treatment Period|Request to discontinue treatment|1|||
23595032|NCT01170962|65909298|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
23595033|NCT01170962|65909299|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
23595034|NCT01170962|65909300|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
23595035|NCT01170962|65909298|FG000|Follow up Period|Withdrawal by Subject|14|||
23595036|NCT01170962|65909299|FG001|Follow up Period|Withdrawal by Subject|10|||
23595037|NCT01170962|65909300|FG002|Follow up Period|Withdrawal by Subject|2|||
23595038|NCT01170962|65909298|FG000|Follow up Period|Lost to Follow-up|13|||
23595039|NCT01170962|65909299|FG001|Follow up Period|Lost to Follow-up|8|||
23595040|NCT01170962|65909300|FG002|Follow up Period|Lost to Follow-up|1|||
23644981|NCT01920854|66086891|FG006|Overall Study|Withdrawal by Subject|1|||
23644982|NCT01942785|66086892|FG000|Overall Study|Adverse Event|2|||
23644983|NCT01942785|66086892|FG000|Overall Study|Withdrawal by Subject|1|||
23644984|NCT01942785|66086892|FG000|Overall Study|Protocol Violation|1|||
23644985|NCT01236365|66086893|FG000|Overall Study|Lost to Follow-up|0|||
23644986|NCT01236365|66086894|FG001|Overall Study|Lost to Follow-up|2|||
23644987|NCT01236365|66086893|FG000|Overall Study|Moved Out of State|1|||
23595041|NCT01170962|65909298|FG000|Follow up Period|Death|2|||
23595042|NCT01170962|65909299|FG001|Follow up Period|Death|2|||
23595043|NCT01170962|65909300|FG002|Follow up Period|Death|0|||
23595044|NCT01170962|65909298|FG000|Follow up Period|Others|10|||
23595045|NCT01170962|65909299|FG001|Follow up Period|Others|7|||
23595046|NCT01170962|65909300|FG002|Follow up Period|Others|3|||
23595047|NCT01308567|65909303|FG000|Overall Study|Lost to Follow-up|2|||
23644988|NCT01236365|66086894|FG001|Overall Study|Moved Out of State|0|||
23644989|NCT01236365|66086893|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
23644990|NCT01236365|66086894|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
23595048|NCT01308567|65909304|FG001|Overall Study|Lost to Follow-up|4|||
23595049|NCT01308567|65909305|FG002|Overall Study|Lost to Follow-up|4|||
23595050|NCT01571596|65909306|FG000|Overall Study|Adverse Event|2|||
23595051|NCT01571596|65909307|FG001|Overall Study|Adverse Event|0|||
23595052|NCT01571596|65909308|FG002|Overall Study|Adverse Event|0|||
23595053|NCT01571596|65909306|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23595054|NCT01571596|65909307|FG001|Overall Study|Study Terminated by the Sponsor|1|||
23595055|NCT01571596|65909308|FG002|Overall Study|Study Terminated by the Sponsor|1|||
23595056|NCT02423798|65909315|FG000|Overall Study|Withdrawal by Subject|3|||
23595057|NCT00968149|65909316|FG000|Overall Study|Adverse Event|5|||
23595058|NCT00968149|65909317|FG001|Overall Study|Adverse Event|1|||
23595059|NCT00968149|65909316|FG000|Overall Study|Lack of Efficacy|0|||
23595060|NCT00968149|65909317|FG001|Overall Study|Lack of Efficacy|4|||
23595061|NCT00968149|65909316|FG000|Overall Study|Lost to Follow-up|0|||
23595062|NCT00968149|65909317|FG001|Overall Study|Lost to Follow-up|1|||
23595063|NCT00968149|65909316|FG000|Overall Study|Protocol Violation|4|||
23595064|NCT00968149|65909317|FG001|Overall Study|Protocol Violation|0|||
23595065|NCT00968149|65909316|FG000|Overall Study|Withdrawal by Subject|2|||
23595066|NCT00968149|65909317|FG001|Overall Study|Withdrawal by Subject|0|||
23595067|NCT00812461|65909320|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
23595068|NCT00812461|65909321|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
23595069|NCT00812461|65909320|FG000|All Treated Patients|Adverse Event|8|||
23595070|NCT00812461|65909321|FG001|All Treated Patients|Adverse Event|15|||
23595071|NCT00812461|65909320|FG000|All Treated Patients|Lack of Efficacy|13|||
23595072|NCT00812461|65909321|FG001|All Treated Patients|Lack of Efficacy|7|||
23595073|NCT00812461|65909320|FG000|All Treated Patients|Non-compliance|6|||
23595074|NCT00812461|65909321|FG001|All Treated Patients|Non-compliance|9|||
23595075|NCT00812461|65909320|FG000|All Treated Patients|Protocol Violation|36|||
23595076|NCT00812461|65909321|FG001|All Treated Patients|Protocol Violation|27|||
23595077|NCT00812461|65909320|FG000|All Treated Patients|Withdrawal by Subject|45|||
23595078|NCT00812461|65909321|FG001|All Treated Patients|Withdrawal by Subject|54|||
23595079|NCT00812461|65909320|FG000|All Treated Patients|Lost to Follow-up|11|||
23595080|NCT00812461|65909321|FG001|All Treated Patients|Lost to Follow-up|14|||
23595081|NCT00812461|65909320|FG000|All Treated Patients|Other Reason|13|||
23595082|NCT00812461|65909321|FG001|All Treated Patients|Other Reason|21|||
23595083|NCT01759264|65909331|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
23595084|NCT01759264|65909331|FG000|Overall Study|Adverse Event|1|||
23595085|NCT01759264|65909331|FG000|Overall Study|Other|2|||
23595086|NCT01759264|65909331|FG000|Overall Study|Lost to Follow-up|2|||
23595087|NCT01759264|65909331|FG000|Overall Study|Withdrawal by Subject|3|||
23595088|NCT01759264|65909331|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
23595089|NCT04452318|65909332|FG000|Overall Study|Physician Decision|1|||
23595090|NCT04452318|65909333|FG001|Overall Study|Physician Decision|2|||
23595091|NCT04452318|65909334|FG002|Overall Study|Physician Decision|0|||
23595092|NCT04452318|65909335|FG003|Overall Study|Physician Decision|2|||
23595093|NCT04452318|65909336|FG004|Overall Study|Physician Decision|0|||
23595094|NCT04452318|65909337|FG005|Overall Study|Physician Decision|2|||
23595095|NCT04452318|65909338|FG006|Overall Study|Physician Decision|5|||
23595096|NCT04452318|65909332|FG000|Overall Study|Death|2|||
23595097|NCT04452318|65909333|FG001|Overall Study|Death|3|||
23595098|NCT04452318|65909334|FG002|Overall Study|Death|0|||
23595099|NCT04452318|65909335|FG003|Overall Study|Death|0|||
23595100|NCT04452318|65909336|FG004|Overall Study|Death|0|||
23595101|NCT04452318|65909337|FG005|Overall Study|Death|0|||
23595102|NCT04452318|65909338|FG006|Overall Study|Death|0|||
23595103|NCT04452318|65909332|FG000|Overall Study|Lost to Follow-up|38|||
23595104|NCT04452318|65909333|FG001|Overall Study|Lost to Follow-up|28|||
23595105|NCT04452318|65909334|FG002|Overall Study|Lost to Follow-up|0|||
23595106|NCT04452318|65909335|FG003|Overall Study|Lost to Follow-up|3|||
23595107|NCT04452318|65909336|FG004|Overall Study|Lost to Follow-up|3|||
23595108|NCT04452318|65909337|FG005|Overall Study|Lost to Follow-up|2|||
23595109|NCT04452318|65909338|FG006|Overall Study|Lost to Follow-up|1|||
23595110|NCT04452318|65909332|FG000|Overall Study|Withdrawal by Subject|46|||
23595111|NCT04452318|65909333|FG001|Overall Study|Withdrawal by Subject|40|||
23595112|NCT04452318|65909334|FG002|Overall Study|Withdrawal by Subject|0|||
23595113|NCT04452318|65909335|FG003|Overall Study|Withdrawal by Subject|18|||
23360215|NCT01490840|65062858|FG001|Phase 2|Permanent interruption of fingolimod|1|||
23595114|NCT04452318|65909336|FG004|Overall Study|Withdrawal by Subject|6|||
23595115|NCT04452318|65909337|FG005|Overall Study|Withdrawal by Subject|8|||
23595116|NCT04452318|65909338|FG006|Overall Study|Withdrawal by Subject|6|||
23595117|NCT02928224|65909341|FG000|Overall Study|Lost to Follow-up|1|||
23595118|NCT02928224|65909342|FG001|Overall Study|Lost to Follow-up|1|||
23595119|NCT02928224|65909343|FG002|Overall Study|Lost to Follow-up|3|||
23595120|NCT02928224|65909344|FG003|Overall Study|Lost to Follow-up|0|||
23595121|NCT02928224|65909341|FG000|Overall Study|Death|30|||
23595122|NCT02928224|65909342|FG001|Overall Study|Death|209|||
23595123|NCT02928224|65909343|FG002|Overall Study|Death|193|||
23595124|NCT02928224|65909344|FG003|Overall Study|Death|198|||
23595125|NCT02928224|65909341|FG000|Overall Study|Withdrawal by Subject|0|||
23595126|NCT02928224|65909342|FG001|Overall Study|Withdrawal by Subject|3|||
23595127|NCT02928224|65909343|FG002|Overall Study|Withdrawal by Subject|7|||
23595128|NCT02928224|65909344|FG003|Overall Study|Withdrawal by Subject|20|||
23595129|NCT02928224|65909341|FG000|Overall Study|Study participation terminated by sponsor|3|||
23595130|NCT02928224|65909342|FG001|Overall Study|Study participation terminated by sponsor|8|||
23595131|NCT02928224|65909343|FG002|Overall Study|Study participation terminated by sponsor|12|||
23595132|NCT02928224|65909344|FG003|Overall Study|Study participation terminated by sponsor|3|||
23595133|NCT02928224|65909341|FG000|Overall Study|Other|3|||
23595134|NCT02928224|65909342|FG001|Overall Study|Other|3|||
23595135|NCT02928224|65909343|FG002|Overall Study|Other|5|||
23595136|NCT02928224|65909344|FG003|Overall Study|Other|0|||
23595137|NCT01747486|65909347|FG000|Stage 1|Physician Decision|3|||
23595138|NCT01747486|65909348|FG001|Stage 1|Physician Decision|0|||
23595139|NCT01747486|65909347|FG000|Stage 1|Withdrawal by Subject|4|||
23595140|NCT01747486|65909348|FG001|Stage 1|Withdrawal by Subject|3|||
23595141|NCT01747486|65909347|FG000|Stage 1|Disease progression|4|||
23595142|NCT01747486|65909348|FG001|Stage 1|Disease progression|9|||
23595143|NCT01747486|65909347|FG000|Stage 1|Death|1|||
23595144|NCT01747486|65909348|FG001|Stage 1|Death|1|||
23595145|NCT01747486|65909347|FG000|Stage 2|Physician Decision|2|||
23595146|NCT01747486|65909348|FG001|Stage 2|Physician Decision|0|||
23595147|NCT01747486|65909347|FG000|Stage 2|Withdrawal by Subject|1|||
23595148|NCT01747486|65909348|FG001|Stage 2|Withdrawal by Subject|0|||
23595149|NCT01747486|65909347|FG000|Stage 2|New Cancer Therapy|3|||
23595150|NCT01747486|65909348|FG001|Stage 2|New Cancer Therapy|0|||
23595151|NCT01747486|65909347|FG000|Stage 2|Disease Progression|3|||
23644991|NCT02656329|66086897|FG000|Overall Study|Lost to Follow-up|2|||
23644992|NCT02656329|66086898|FG001|Overall Study|Lost to Follow-up|3|||
23644993|NCT02656329|66086897|FG000|Overall Study|Withdrawal by Subject|7|||
23644994|NCT02656329|66086898|FG001|Overall Study|Withdrawal by Subject|6|||
23644995|NCT02656329|66086897|FG000|Overall Study|Study termination by Sponsor|150|||
23644996|NCT02656329|66086898|FG001|Overall Study|Study termination by Sponsor|142|||
23644997|NCT02656329|66086897|FG000|Overall Study|Other than specified above|5|||
23644998|NCT02656329|66086898|FG001|Overall Study|Other than specified above|6|||
23644999|NCT02595073|66086899|FG000|Overall Study|Progressive Disease|0|||
23645000|NCT02595073|66086900|FG001|Overall Study|Progressive Disease|1|||
23645001|NCT02595073|66086899|FG000|Overall Study|Protocol Violation|2|||
23645002|NCT02595073|66086900|FG001|Overall Study|Protocol Violation|0|||
23645003|NCT02980731|66086902|FG000|Overall Study|Death|63|||
23645004|NCT02980731|66086902|FG000|Overall Study|Withdrawal by Subject|6|||
23645005|NCT02980731|66086902|FG000|Overall Study|Lost to Follow-up|5|||
23645006|NCT02980731|66086902|FG000|Overall Study|Study terminated by Sponsor|4|||
23645007|NCT02980731|66086902|FG000|Overall Study|Completed survival follow-up period|65|||
23645008|NCT02980731|66086902|FG000|Overall Study|COVID-19 infection|1|||
23645009|NCT02980731|66086902|FG000|Overall Study|Other, not specified|66|||
23645010|NCT00249002|66086903|FG000|Overall Study|Adverse Event|2|||
23645011|NCT00249002|66086903|FG000|Overall Study|Study cancellation|3|||
23645012|NCT00249002|66086903|FG000|Overall Study|Other|2|||
23645013|NCT02433340|66086905|FG000|Overall Study|Adverse Event|0|||
23645014|NCT02433340|66086906|FG001|Overall Study|Adverse Event|0|||
23645015|NCT02433340|66086907|FG002|Overall Study|Adverse Event|1|||
23645016|NCT02433340|66086908|FG003|Overall Study|Adverse Event|0|||
23645017|NCT02433340|66086905|FG000|Overall Study|Withdrawal by Subject|1|||
23645018|NCT02433340|66086906|FG001|Overall Study|Withdrawal by Subject|0|||
23645019|NCT02433340|66086907|FG002|Overall Study|Withdrawal by Subject|1|||
23645020|NCT02433340|66086908|FG003|Overall Study|Withdrawal by Subject|2|||
23645021|NCT02433340|66086905|FG000|Overall Study|Lost to Follow-up|0|||
23595152|NCT01747486|65909348|FG001|Stage 2|Disease Progression|0|||
23645022|NCT02433340|66086906|FG001|Overall Study|Lost to Follow-up|1|||
23645023|NCT02433340|66086907|FG002|Overall Study|Lost to Follow-up|0|||
23645024|NCT02433340|66086908|FG003|Overall Study|Lost to Follow-up|0|||
23645025|NCT02433340|66086905|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
23595153|NCT01318382|65909349|FG000|Overall Study|Physician Decision|2|||
23595154|NCT01318382|65909349|FG000|Overall Study|Device Malfunction|10|||
23595155|NCT01318382|65909349|FG000|Overall Study|Protocol Violation|1|||
23595156|NCT01837966|65909350|FG000|Overall Study|Withdrawal by Subject|2|||
23595157|NCT01837966|65909351|FG001|Overall Study|Withdrawal by Subject|1|||
23595158|NCT02272816|65909352|FG000|Overall Study|Adverse Event|1|||
23595159|NCT00493649|65909353|FG000|Overall Study|Adverse Event|44|||
23477747|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477748|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
23477749|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477750|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477751|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477752|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
23477753|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477754|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477755|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477756|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477757|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477758|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477759|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477760|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
23477761|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477762|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
23477763|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477764|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477765|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477766|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477767|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477768|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477769|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477770|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477771|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477772|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
23477773|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23595160|NCT00493649|65909353|FG000|Overall Study|Patient Request|21|||
23595161|NCT00493649|65909353|FG000|Overall Study|Investigator Request|2|||
23595162|NCT00493649|65909353|FG000|Overall Study|Disease Progression|1|||
23595163|NCT00493649|65909353|FG000|Overall Study|Lost to Follow-up|1|||
23595164|NCT00493649|65909353|FG000|Overall Study|Other|13|||
23595165|NCT00761189|65909358|FG000|Overall Study|Adverse Event|42|||
23595166|NCT00761189|65909358|FG000|Overall Study|Lack of Efficacy|45|||
23595167|NCT00761189|65909358|FG000|Overall Study|Lost to Follow-up|36|||
23595168|NCT00761189|65909358|FG000|Overall Study|Withdrawal by Subject|49|||
23595169|NCT00761189|65909358|FG000|Overall Study|Other|13|||
23595170|NCT03036813|65909361|FG000|Overall Study|Adverse Event|6|||
23595171|NCT03036813|65909362|FG001|Overall Study|Adverse Event|11|||
23595172|NCT03036813|65909363|FG002|Overall Study|Adverse Event|6|||
23595173|NCT03036813|65909361|FG000|Overall Study|Withdrawal by Subject|12|||
23595174|NCT03036813|65909362|FG001|Overall Study|Withdrawal by Subject|6|||
23595175|NCT03036813|65909363|FG002|Overall Study|Withdrawal by Subject|10|||
23595176|NCT03036813|65909361|FG000|Overall Study|Lost to Follow-up|1|||
23595177|NCT03036813|65909362|FG001|Overall Study|Lost to Follow-up|1|||
23595178|NCT03036813|65909363|FG002|Overall Study|Lost to Follow-up|0|||
23595179|NCT03036813|65909361|FG000|Overall Study|Physician Decision|2|||
23595180|NCT03036813|65909362|FG001|Overall Study|Physician Decision|1|||
23595181|NCT03036813|65909363|FG002|Overall Study|Physician Decision|1|||
23595182|NCT03036813|65909361|FG000|Overall Study|Non-Compliance|1|||
23595183|NCT03036813|65909362|FG001|Overall Study|Non-Compliance|5|||
23595184|NCT03036813|65909363|FG002|Overall Study|Non-Compliance|3|||
23595185|NCT03036813|65909361|FG000|Overall Study|Pregnancy|0|||
23595186|NCT03036813|65909362|FG001|Overall Study|Pregnancy|0|||
23595187|NCT03036813|65909363|FG002|Overall Study|Pregnancy|1|||
23595188|NCT03036813|65909361|FG000|Overall Study|Other|0|||
23595189|NCT03036813|65909362|FG001|Overall Study|Other|3|||
23595190|NCT03036813|65909363|FG002|Overall Study|Other|5|||
23595191|NCT03086369|65909366|FG000|Overall Study|Lost to Follow-up|1|||
23645026|NCT02433340|66086906|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
23477774|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477775|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477776|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23595192|NCT03086369|65909367|FG001|Overall Study|Lost to Follow-up|0|||
23595193|NCT03086369|65909368|FG002|Overall Study|Lost to Follow-up|0|||
23595194|NCT03086369|65909369|FG003|Overall Study|Lost to Follow-up|2|||
23595195|NCT03086369|65909370|FG004|Overall Study|Lost to Follow-up|1|||
23595196|NCT03086369|65909366|FG000|Overall Study|Physician Decision|0|||
23595197|NCT03086369|65909367|FG001|Overall Study|Physician Decision|0|||
23645027|NCT02433340|66086907|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
23645028|NCT02433340|66086908|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
23645029|NCT02433340|66086905|FG000|Overall Study|Other|0|||
23645030|NCT02433340|66086906|FG001|Overall Study|Other|1|||
23645031|NCT02433340|66086907|FG002|Overall Study|Other|0|||
23645032|NCT02433340|66086908|FG003|Overall Study|Other|0|||
23645033|NCT01328717|66086909|FG000|Overall Study|Adverse Event|1|||
23645034|NCT01022268|66086910|FG000|Overall Study|Withdrawal by Subject|1|||
23645035|NCT01022268|66086911|FG001|Overall Study|Withdrawal by Subject|0|||
23645036|NCT01022268|66086910|FG000|Overall Study|Withdrawal by Subject|1|||
23645037|NCT01022268|66086911|FG001|Overall Study|Withdrawal by Subject|0|||
23645038|NCT03426605|66086912|FG000|Overall Study|AML relapse or progression|2|||
23645039|NCT03426605|66086913|FG001|Overall Study|AML relapse or progression|1|||
23645040|NCT03426605|66086914|FG002|Overall Study|AML relapse or progression|2|||
23645041|NCT03426605|66086915|FG003|Overall Study|AML relapse or progression|2|||
23645042|NCT03426605|66086912|FG000|Overall Study|Treatment failure|3|||
23645043|NCT03426605|66086913|FG001|Overall Study|Treatment failure|2|||
23645044|NCT03426605|66086914|FG002|Overall Study|Treatment failure|0|||
23645045|NCT03426605|66086915|FG003|Overall Study|Treatment failure|0|||
23645046|NCT03426605|66086912|FG000|Overall Study|Adverse Event|1|||
23645047|NCT03426605|66086913|FG001|Overall Study|Adverse Event|0|||
23645048|NCT03426605|66086914|FG002|Overall Study|Adverse Event|1|||
23645049|NCT03426605|66086915|FG003|Overall Study|Adverse Event|1|||
23645050|NCT03426605|66086912|FG000|Overall Study|Withdrawal by Subject|0|||
23645051|NCT03426605|66086913|FG001|Overall Study|Withdrawal by Subject|0|||
23595198|NCT03086369|65909368|FG002|Overall Study|Physician Decision|0|||
23595199|NCT03086369|65909369|FG003|Overall Study|Physician Decision|1|||
23595200|NCT03086369|65909370|FG004|Overall Study|Physician Decision|2|||
23595201|NCT03086369|65909366|FG000|Overall Study|Withdrawal by Subject|0|||
23595202|NCT03086369|65909367|FG001|Overall Study|Withdrawal by Subject|0|||
23595203|NCT03086369|65909368|FG002|Overall Study|Withdrawal by Subject|0|||
23595204|NCT03086369|65909369|FG003|Overall Study|Withdrawal by Subject|5|||
23595205|NCT03086369|65909370|FG004|Overall Study|Withdrawal by Subject|3|||
23595206|NCT03086369|65909366|FG000|Overall Study|Progressive Disease|0|||
23595207|NCT03086369|65909367|FG001|Overall Study|Progressive Disease|0|||
23595208|NCT03086369|65909368|FG002|Overall Study|Progressive Disease|0|||
23595209|NCT03086369|65909369|FG003|Overall Study|Progressive Disease|1|||
23595210|NCT03086369|65909370|FG004|Overall Study|Progressive Disease|1|||
23595211|NCT00357097|65909371|FG000|Overall Study|Did not meet inclusion criteria|5|||
23595212|NCT00357097|65909372|FG001|Overall Study|Did not meet inclusion criteria|3|||
23595213|NCT00357097|65909371|FG000|Overall Study|Adverse Event|34|||
23595214|NCT00357097|65909372|FG001|Overall Study|Adverse Event|6|||
23595215|NCT00357097|65909371|FG000|Overall Study|Withdrawal by Subject|8|||
23595216|NCT00357097|65909372|FG001|Overall Study|Withdrawal by Subject|7|||
23595217|NCT00357097|65909371|FG000|Overall Study|Non-compliance|1|||
23595218|NCT00357097|65909372|FG001|Overall Study|Non-compliance|2|||
23645052|NCT03426605|66086914|FG002|Overall Study|Withdrawal by Subject|1|||
23645053|NCT03426605|66086915|FG003|Overall Study|Withdrawal by Subject|1|||
23645054|NCT00477334|66086918|FG000|Overall Study|Discontinued prior to taking study drug|106|||
23595219|NCT00357097|65909371|FG000|Overall Study|Lack of Efficacy|2|||
23595220|NCT00357097|65909372|FG001|Overall Study|Lack of Efficacy|8|||
23595221|NCT00357097|65909371|FG000|Overall Study|Met Exclusion Criteria|3|||
23595222|NCT00357097|65909372|FG001|Overall Study|Met Exclusion Criteria|1|||
23595223|NCT00357097|65909371|FG000|Overall Study|Other|1|||
23595224|NCT00357097|65909372|FG001|Overall Study|Other|1|||
23595225|NCT00357097|65909371|FG000|Overall Study|Increase of RLS Symptoms|0|||
23595226|NCT00357097|65909372|FG001|Overall Study|Increase of RLS Symptoms|1|||
23595227|NCT00539734|65909373|FG000|Overall Study|Protocol Violation|1|||
23595228|NCT02748317|65909374|FG000|Overall Study|Withdrawal by Subject|14|||
23595229|NCT02748317|65909374|FG000|Overall Study|Lost to Follow-up|8|||
23645055|NCT00477334|66086919|FG001|Overall Study|Discontinued prior to taking study drug|53|||
23645056|NCT00477334|66086918|FG000|Overall Study|Adverse Event|1|||
23645057|NCT00477334|66086919|FG001|Overall Study|Adverse Event|2|||
23645058|NCT00477334|66086918|FG000|Overall Study|Withdrawal by Subject|2|||
23645059|NCT00477334|66086919|FG001|Overall Study|Withdrawal by Subject|1|||
23645060|NCT00477334|66086918|FG000|Overall Study|Lost to Follow-up|15|||
23595230|NCT02748317|65909374|FG000|Overall Study|Death|1|||
23595231|NCT03169244|65909375|FG000|Overall Study|Lost to Follow-up|1|||
23595232|NCT03169244|65909376|FG001|Overall Study|Lost to Follow-up|2|||
23595233|NCT03169244|65909375|FG000|Overall Study|Adverse Event|1|||
23595234|NCT03169244|65909376|FG001|Overall Study|Adverse Event|0|||
23595235|NCT03169244|65909375|FG000|Overall Study|Withdrawal by Subject|2|||
23645061|NCT00477334|66086919|FG001|Overall Study|Lost to Follow-up|4|||
23595236|NCT03169244|65909376|FG001|Overall Study|Withdrawal by Subject|2|||
23595237|NCT03169244|65909375|FG000|Overall Study|Physician Decision|1|||
23595238|NCT03169244|65909376|FG001|Overall Study|Physician Decision|0|||
23595239|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
23595240|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
23595241|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
23595242|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
23595243|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
23645062|NCT00477334|66086918|FG000|Overall Study|Administrative Problems|39|||
23800192|NCT02190279|66646683|FG000|Overall Study|Withdrawal consent|1|||
23800193|NCT02190279|66646684|FG001|Overall Study|Withdrawal consent|0|||
23800194|NCT02190279|66646685|FG002|Overall Study|Withdrawal consent|1|||
23800195|NCT02190279|66646683|FG000|Overall Study|Lost to Follow-up|2|||
23800196|NCT02190279|66646684|FG001|Overall Study|Lost to Follow-up|0|||
23800197|NCT02190279|66646685|FG002|Overall Study|Lost to Follow-up|0|||
23800198|NCT02190279|66646683|FG000|Overall Study|Refused further treatment|0|||
23800199|NCT02190279|66646684|FG001|Overall Study|Refused further treatment|0|||
23800200|NCT02190279|66646685|FG002|Overall Study|Refused further treatment|1|||
23800201|NCT02190279|66646683|FG000|Overall Study|Screening failure|0|||
23360216|NCT01490840|65062857|FG000|Phase 2|Lost to Follow-up|1|||
23595244|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
23800202|NCT02190279|66646684|FG001|Overall Study|Screening failure|0|||
23800203|NCT02190279|66646685|FG002|Overall Study|Screening failure|1|||
23800204|NCT01803269|66646688|FG000|Overall Study|Withdrawal by Subject|3|||
23800205|NCT01803269|66646689|FG001|Overall Study|Withdrawal by Subject|0|||
23360217|NCT01490840|65062858|FG001|Phase 2|Lost to Follow-up|1|||
23360218|NCT01490840|65062857|FG000|Phase 2|Adverse Event|1|||
23360219|NCT01490840|65062858|FG001|Phase 2|Adverse Event|1|||
23360220|NCT02035553|65062862|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
23360221|NCT02035553|65062863|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
23360222|NCT02035553|65062862|FG000|Overall Study|Adverse Event|10|||
23360223|NCT02035553|65062863|FG001|Overall Study|Adverse Event|6|||
23360224|NCT02035553|65062862|FG000|Overall Study|Physician Decision|3|||
23360225|NCT02035553|65062863|FG001|Overall Study|Physician Decision|2|||
23360226|NCT02035553|65062862|FG000|Overall Study|Lack of Efficacy|1|||
23360227|NCT02035553|65062863|FG001|Overall Study|Lack of Efficacy|1|||
23360228|NCT02035553|65062862|FG000|Overall Study|Withdrawal by Subject|4|||
23800206|NCT01803269|66646690|FG002|Overall Study|Withdrawal by Subject|0|||
23800207|NCT03870477|66646691|FG000|Overall Study|Early Study Termination|1|||
23800208|NCT03629028|66646692|FG000|Overall Study|Lost to Follow-up|26|||
23800209|NCT03629028|66646693|FG001|Overall Study|Lost to Follow-up|23|||
23800210|NCT03629028|66646692|FG000|Overall Study|Pregnancy|4|||
23800211|NCT03629028|66646693|FG001|Overall Study|Pregnancy|2|||
23800212|NCT03629028|66646692|FG000|Overall Study|intolerance to examination|2|||
23800213|NCT03629028|66646693|FG001|Overall Study|intolerance to examination|0|||
23800214|NCT01765751|66646694|FG000|Overall Study|Lost to Follow-up|0|||
23800215|NCT01765751|66646695|FG001|Overall Study|Lost to Follow-up|2|||
23800216|NCT01765751|66646696|FG002|Overall Study|Lost to Follow-up|1|||
23800217|NCT02244424|66646697|FG000|Overall Study|Lost to Follow-up|20|||
23800218|NCT02244424|66646698|FG001|Overall Study|Lost to Follow-up|10|||
23800219|NCT00977431|66646699|FG000|Overall Study|Other than listed|1|||
23800220|NCT00977431|66646700|FG001|Overall Study|Other than listed|0|||
23800221|NCT00977431|66646701|FG002|Overall Study|Other than listed|0|||
23800222|NCT00977431|66646702|FG003|Overall Study|Other than listed|0|||
23800223|NCT00977431|66646703|FG004|Overall Study|Other than listed|2|||
23800224|NCT00977431|66646699|FG000|Overall Study|Protocol Violation|0|||
23800225|NCT00977431|66646700|FG001|Overall Study|Protocol Violation|0|||
23800226|NCT00977431|66646701|FG002|Overall Study|Protocol Violation|1|||
23800227|NCT00977431|66646702|FG003|Overall Study|Protocol Violation|0|||
23800228|NCT00977431|66646703|FG004|Overall Study|Protocol Violation|0|||
23800229|NCT00977431|66646699|FG000|Overall Study|Adverse Event|3|||
23800230|NCT00977431|66646700|FG001|Overall Study|Adverse Event|0|||
23800231|NCT00977431|66646701|FG002|Overall Study|Adverse Event|4|||
23800232|NCT00977431|66646702|FG003|Overall Study|Adverse Event|0|||
23800233|NCT00977431|66646703|FG004|Overall Study|Adverse Event|6|||
23800234|NCT00977431|66646699|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
23800235|NCT00977431|66646700|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
23800236|NCT00977431|66646701|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
23800237|NCT00977431|66646702|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23800238|NCT00977431|66646703|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
23800239|NCT00977431|66646699|FG000|Overall Study|Progressive disease|2|||
23800240|NCT00977431|66646700|FG001|Overall Study|Progressive disease|6|||
23800241|NCT00977431|66646701|FG002|Overall Study|Progressive disease|1|||
23800242|NCT00977431|66646702|FG003|Overall Study|Progressive disease|3|||
23800243|NCT00977431|66646703|FG004|Overall Study|Progressive disease|5|||
23800244|NCT00605917|66646704|FG000|Overall Study|Protocol Violation|79|||
23800245|NCT02418455|66646705|FG000|48-Week Treatment Period|Other- Not Specified|1|||
23800246|NCT02418455|66646705|FG000|Continuation Period|Sponsor Decision|7|||
23800247|NCT02400476|66646726|FG000|Overall Study|Adverse Event|57|||
23800248|NCT02400476|66646727|FG001|Overall Study|Adverse Event|10|||
23800249|NCT02400476|66646728|FG002|Overall Study|Adverse Event|22|||
23800250|NCT02400476|66646729|FG003|Overall Study|Adverse Event|19|||
23800251|NCT02400476|66646730|FG004|Overall Study|Adverse Event|5|||
23800252|NCT02400476|66646731|FG005|Overall Study|Adverse Event|8|||
23800253|NCT02400476|66646726|FG000|Overall Study|Withdrawal by Subject|4|||
23800254|NCT02400476|66646727|FG001|Overall Study|Withdrawal by Subject|1|||
23800255|NCT02400476|66646728|FG002|Overall Study|Withdrawal by Subject|12|||
23800256|NCT02400476|66646729|FG003|Overall Study|Withdrawal by Subject|7|||
23360229|NCT02035553|65062863|FG001|Overall Study|Withdrawal by Subject|7|||
23800257|NCT02400476|66646730|FG004|Overall Study|Withdrawal by Subject|5|||
23800258|NCT02400476|66646731|FG005|Overall Study|Withdrawal by Subject|5|||
23800259|NCT02400476|66646726|FG000|Overall Study|Lost to Follow-up|0|||
23800260|NCT02400476|66646727|FG001|Overall Study|Lost to Follow-up|0|||
23800261|NCT02400476|66646728|FG002|Overall Study|Lost to Follow-up|0|||
23800262|NCT02400476|66646729|FG003|Overall Study|Lost to Follow-up|1|||
23800263|NCT02400476|66646730|FG004|Overall Study|Lost to Follow-up|3|||
23800264|NCT02400476|66646731|FG005|Overall Study|Lost to Follow-up|1|||
23800265|NCT02400476|66646726|FG000|Overall Study|Physician Decision|0|||
23360230|NCT02035553|65062862|FG000|Overall Study|Non-compliance with Study Drug|0|||
23360231|NCT02035553|65062863|FG001|Overall Study|Non-compliance with Study Drug|1|||
23360232|NCT02035553|65062862|FG000|Overall Study|Lost to Follow-up|0|||
23360233|NCT02035553|65062863|FG001|Overall Study|Lost to Follow-up|1|||
23360234|NCT02035553|65062862|FG000|Overall Study|Other Reason|0|||
23360235|NCT02035553|65062863|FG001|Overall Study|Other Reason|4|||
23360236|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
23360237|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
23645063|NCT00477334|66086919|FG001|Overall Study|Administrative Problems|15|||
23595245|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Other|1|||
23595246|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Other|2|||
23595247|NCT02200770|65909377|FG000|Open-label Period (OLP)|Adverse Event|1|||
23595248|NCT02200770|65909378|FG001|Open-label Period (OLP)|Adverse Event|2|||
23595249|NCT02200770|65909377|FG000|Open-label Period (OLP)|Death|1|||
23360238|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
23360239|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
23360240|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360241|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23360242|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
23360243|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
23360244|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360245|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23595250|NCT02200770|65909378|FG001|Open-label Period (OLP)|Death|2|||
23595251|NCT02200770|65909377|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
23595252|NCT02200770|65909378|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
23595253|NCT02200770|65909377|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
23645064|NCT00477334|66086918|FG000|Overall Study|Protocol Violation|7|||
23645065|NCT00477334|66086919|FG001|Overall Study|Protocol Violation|1|||
23645066|NCT00211185|66086924|FG000|Overall Study|Death|2|||
23645067|NCT00211185|66086924|FG000|Overall Study|Disease progression|7|||
23645068|NCT00211185|66086924|FG000|Overall Study|Withdrawal by Subject|6|||
23645069|NCT00211185|66086924|FG000|Overall Study|Physician Decision|5|||
23645070|NCT01771107|66086925|FG000|Overall Study|Adverse Event|1|||
23645071|NCT01771107|66086926|FG001|Overall Study|Adverse Event|3|||
23645072|NCT01771107|66086925|FG000|Overall Study|Withdrawal by Subject|0|||
23645073|NCT01771107|66086926|FG001|Overall Study|Withdrawal by Subject|2|||
23645074|NCT01771107|66086925|FG000|Overall Study|Lost to Follow-up|0|||
23645075|NCT01771107|66086926|FG001|Overall Study|Lost to Follow-up|1|||
23645076|NCT01771107|66086925|FG000|Overall Study|participant moved|0|||
23645077|NCT01771107|66086926|FG001|Overall Study|participant moved|1|||
23645078|NCT01771107|66086925|FG000|Overall Study|Other|0|||
23645079|NCT01771107|66086926|FG001|Overall Study|Other|1|||
23645080|NCT00192647|66086932|FG000|Overall Study|Death|1|||
23645081|NCT00192647|66086933|FG001|Overall Study|Death|1|||
23645082|NCT00192647|66086932|FG000|Overall Study|Adverse Event|35|||
23645083|NCT00192647|66086933|FG001|Overall Study|Adverse Event|29|||
23800266|NCT02400476|66646727|FG001|Overall Study|Physician Decision|0|||
23595254|NCT02200770|65909378|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
23595255|NCT02200770|65909377|FG000|Open-label Period (OLP)|Other|6|||
23595256|NCT02200770|65909378|FG001|Open-label Period (OLP)|Other|15|||
23595257|NCT03988842|65909379|FG000|Overall Study|Death|1|||
23595258|NCT00508924|65909380|FG000|Overall Study|Protocol Violation|0|||
23645084|NCT00192647|66086932|FG000|Overall Study|Laboratory Test Abnormality|4|||
23645085|NCT00192647|66086933|FG001|Overall Study|Laboratory Test Abnormality|2|||
23645086|NCT00192647|66086932|FG000|Overall Study|Insufficient Therapeutic Response|53|||
23645087|NCT00192647|66086933|FG001|Overall Study|Insufficient Therapeutic Response|83|||
23645088|NCT00192647|66086932|FG000|Overall Study|Entry Criteria Violation|6|||
23645089|NCT00192647|66086933|FG001|Overall Study|Entry Criteria Violation|6|||
23645090|NCT00192647|66086932|FG000|Overall Study|Protocol Violation|3|||
23645091|NCT00192647|66086933|FG001|Overall Study|Protocol Violation|1|||
23645092|NCT00192647|66086932|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
23645093|NCT00192647|66086933|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
23645094|NCT00192647|66086932|FG000|Overall Study|Failure to Return|11|||
23645095|NCT00192647|66086933|FG001|Overall Study|Failure to Return|13|||
23645096|NCT00192647|66086932|FG000|Overall Study|Other/Administrative|5|||
23645097|NCT00192647|66086933|FG001|Overall Study|Other/Administrative|3|||
23645098|NCT01383499|66086934|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
23645099|NCT01383499|66086935|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23360246|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
23595259|NCT00508924|65909381|FG001|Overall Study|Protocol Violation|0|||
23595260|NCT00508924|65909382|FG002|Overall Study|Protocol Violation|1|||
23595261|NCT00508924|65909383|FG003|Overall Study|Protocol Violation|1|||
23645100|NCT01383499|66086936|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23645101|NCT01383499|66086937|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23645102|NCT00906945|66086938|FG000|Overall Study|Found to be not eligible|0|||
23595262|NCT00088413|65909384|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595263|NCT00088413|65909385|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595264|NCT00088413|65909386|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
23595265|NCT00088413|65909387|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595266|NCT00088413|65909384|FG000|Overall Study|Adverse Events/Side Effects|0|||
23595267|NCT00088413|65909385|FG001|Overall Study|Adverse Events/Side Effects|1|||
23645103|NCT00906945|66086939|FG001|Overall Study|Found to be not eligible|0|||
23645104|NCT00906945|66086940|FG002|Overall Study|Found to be not eligible|0|||
23645105|NCT00906945|66086941|FG003|Overall Study|Found to be not eligible|1|||
23645106|NCT00906945|66086942|FG004|Overall Study|Found to be not eligible|1|||
23645107|NCT00906945|66086943|FG005|Overall Study|Found to be not eligible|1|||
23645108|NCT00906945|66086938|FG000|Overall Study|Physician Decision|0|||
23645109|NCT00906945|66086939|FG001|Overall Study|Physician Decision|0|||
23645110|NCT00906945|66086940|FG002|Overall Study|Physician Decision|0|||
23645111|NCT00906945|66086941|FG003|Overall Study|Physician Decision|0|||
23800267|NCT02400476|66646728|FG002|Overall Study|Physician Decision|1|||
23800268|NCT02400476|66646729|FG003|Overall Study|Physician Decision|1|||
23800269|NCT02400476|66646730|FG004|Overall Study|Physician Decision|0|||
23800270|NCT02400476|66646731|FG005|Overall Study|Physician Decision|1|||
23800271|NCT02400476|66646726|FG000|Overall Study|Other, Disease Progression|0|||
23800272|NCT02400476|66646727|FG001|Overall Study|Other, Disease Progression|1|||
23800273|NCT02400476|66646728|FG002|Overall Study|Other, Disease Progression|2|||
23800274|NCT02400476|66646729|FG003|Overall Study|Other, Disease Progression|1|||
23800275|NCT02400476|66646730|FG004|Overall Study|Other, Disease Progression|2|||
23800276|NCT02400476|66646731|FG005|Overall Study|Other, Disease Progression|1|||
23800277|NCT02400476|66646726|FG000|Overall Study|Other, Decreased Quality of Life|0|||
23800278|NCT02400476|66646727|FG001|Overall Study|Other, Decreased Quality of Life|0|||
23477777|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477778|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
23477779|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477780|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477781|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477782|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
23477783|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477784|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477785|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477786|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477787|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477788|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477789|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477790|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
23477791|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477792|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477793|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
23477794|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477795|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477796|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477797|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477798|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477799|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
23477800|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477801|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
23477802|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477803|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477804|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477805|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23595268|NCT00088413|65909386|FG002|Overall Study|Adverse Events/Side Effects|1|||
23595269|NCT00088413|65909387|FG003|Overall Study|Adverse Events/Side Effects|0|||
23595270|NCT00088413|65909384|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
23595271|NCT00088413|65909385|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
23595272|NCT00088413|65909386|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
23645112|NCT00906945|66086942|FG004|Overall Study|Physician Decision|0|||
23645113|NCT00906945|66086943|FG005|Overall Study|Physician Decision|1|||
23800279|NCT02400476|66646728|FG002|Overall Study|Other, Decreased Quality of Life|2|||
23800280|NCT02400476|66646729|FG003|Overall Study|Other, Decreased Quality of Life|0|||
23800281|NCT02400476|66646730|FG004|Overall Study|Other, Decreased Quality of Life|0|||
23477806|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477807|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477808|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23595273|NCT00088413|65909387|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
23595274|NCT00088413|65909384|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
23800282|NCT02400476|66646731|FG005|Overall Study|Other, Decreased Quality of Life|0|||
23800283|NCT02400476|66646726|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23800284|NCT02400476|66646727|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23800285|NCT02400476|66646728|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
23800286|NCT02400476|66646729|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
23800287|NCT02400476|66646730|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23800288|NCT02400476|66646731|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23645114|NCT00819390|66086944|FG000|Overall Study|Lost to Follow-up|1|||
23645115|NCT00819390|66086945|FG001|Overall Study|Lost to Follow-up|1|||
23645116|NCT00819390|66086946|FG002|Overall Study|Lost to Follow-up|0|||
23645117|NCT00819390|66086947|FG003|Overall Study|Lost to Follow-up|0|||
23645118|NCT00819390|66086944|FG000|Overall Study|Withdrawal by Subject|2|||
23645119|NCT00819390|66086945|FG001|Overall Study|Withdrawal by Subject|0|||
23645120|NCT00819390|66086946|FG002|Overall Study|Withdrawal by Subject|0|||
23645121|NCT00819390|66086947|FG003|Overall Study|Withdrawal by Subject|0|||
23645122|NCT00819390|66086944|FG000|Overall Study|Adverse Event|0|||
23645123|NCT00819390|66086945|FG001|Overall Study|Adverse Event|0|||
23645124|NCT00819390|66086946|FG002|Overall Study|Adverse Event|1|||
23645125|NCT00819390|66086947|FG003|Overall Study|Adverse Event|0|||
23645126|NCT02891837|66086949|FG000|Overall Study|Lost to Follow-up|2|||
23645127|NCT02891837|66086950|FG001|Overall Study|Lost to Follow-up|0|||
23645128|NCT02891837|66086949|FG000|Overall Study|Withdrawal by Subject|1|||
23645129|NCT02891837|66086950|FG001|Overall Study|Withdrawal by Subject|0|||
23645130|NCT00528645|66086951|FG000|Overall Study|Adverse Event|3|||
23645131|NCT01262677|66086952|FG000|Overall Study|Does not meet entrance criteria|0|||
23645132|NCT01262677|66086953|FG001|Overall Study|Does not meet entrance criteria|2|||
23645133|NCT01262677|66086954|FG002|Overall Study|Does not meet entrance criteria|0|||
23645134|NCT01262677|66086952|FG000|Overall Study|Insufficient clinical response|0|||
23645135|NCT01262677|66086953|FG001|Overall Study|Insufficient clinical response|0|||
23645136|NCT01262677|66086954|FG002|Overall Study|Insufficient clinical response|1|||
23477809|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23645137|NCT01262677|66086952|FG000|Overall Study|Lost to Follow-up|1|||
23645138|NCT01262677|66086953|FG001|Overall Study|Lost to Follow-up|0|||
23645139|NCT01262677|66086954|FG002|Overall Study|Lost to Follow-up|2|||
23645140|NCT01262677|66086952|FG000|Overall Study|No longer willing to participate|3|||
23645141|NCT01262677|66086953|FG001|Overall Study|No longer willing to participate|3|||
23645142|NCT01262677|66086954|FG002|Overall Study|No longer willing to participate|2|||
23645143|NCT01262677|66086952|FG000|Overall Study|Reason not provided|2|||
23645144|NCT01262677|66086953|FG001|Overall Study|Reason not provided|1|||
23645145|NCT01262677|66086954|FG002|Overall Study|Reason not provided|3|||
23645146|NCT01262677|66086952|FG000|Overall Study|Protocol Violation|0|||
23645147|NCT01262677|66086953|FG001|Overall Study|Protocol Violation|1|||
23645148|NCT01262677|66086954|FG002|Overall Study|Protocol Violation|1|||
23645149|NCT01262677|66086952|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
23645150|NCT01262677|66086953|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
23645151|NCT01262677|66086954|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
23645152|NCT01744392|66086955|FG000|Overall Study|Physician Decision|1|||
23645153|NCT04675151|66086960|FG000|Overall Study|Protocol Violation|1|||
23800289|NCT00892281|66646732|FG000|Overall Study|Adverse Event|65|||
23800290|NCT00892281|66646733|FG001|Overall Study|Adverse Event|8|||
23595275|NCT00088413|65909385|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
23595276|NCT00088413|65909386|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
23595277|NCT00088413|65909387|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
23595278|NCT00088413|65909384|FG000|Overall Study|Death|0|||
23595279|NCT00088413|65909385|FG001|Overall Study|Death|1|||
23595280|NCT00088413|65909386|FG002|Overall Study|Death|0|||
23595281|NCT00088413|65909387|FG003|Overall Study|Death|0|||
23595282|NCT00088413|65909384|FG000|Overall Study|Progressive disease|9|||
23595283|NCT00088413|65909385|FG001|Overall Study|Progressive disease|11|||
23595284|NCT00088413|65909386|FG002|Overall Study|Progressive disease|8|||
23800291|NCT00892281|66646732|FG000|Overall Study|Lost to Follow-up|81|||
23800292|NCT00892281|66646733|FG001|Overall Study|Lost to Follow-up|8|||
23800293|NCT00892281|66646732|FG000|Overall Study|Pregnancy|1|||
23360247|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
23360248|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
23360249|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
23800294|NCT00892281|66646733|FG001|Overall Study|Pregnancy|0|||
23800295|NCT00892281|66646732|FG000|Overall Study|Protocol Violation|7|||
23800296|NCT00892281|66646733|FG001|Overall Study|Protocol Violation|2|||
23800297|NCT00892281|66646732|FG000|Overall Study|Withdrawal by Subject|86|||
23800298|NCT00892281|66646733|FG001|Overall Study|Withdrawal by Subject|14|||
23800299|NCT00892281|66646732|FG000|Overall Study|Subject failed to return for final visit|2|||
23800300|NCT00892281|66646733|FG001|Overall Study|Subject failed to return for final visit|0|||
23800301|NCT00892281|66646732|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
23800302|NCT00892281|66646733|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
23800303|NCT00892281|66646732|FG000|Overall Study|Final visit completed 4 weeks late|0|||
23800304|NCT00892281|66646733|FG001|Overall Study|Final visit completed 4 weeks late|1|||
23800305|NCT00892281|66646732|FG000|Overall Study|Subject completed day after study closed|1|||
23800306|NCT00892281|66646733|FG001|Overall Study|Subject completed day after study closed|0|||
23360250|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
23360251|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
23360252|NCT00667992|65062864|FG000|Wash-out|Not within one doubling dilution|4|||
23800307|NCT00892281|66646732|FG000|Overall Study|Family emergency|1|||
23360253|NCT00667992|65062865|FG001|Wash-out|Not within one doubling dilution|3|||
23360254|NCT00667992|65062864|FG000|Wash-out|Failure to wash-out|2|||
23360255|NCT00667992|65062865|FG001|Wash-out|Failure to wash-out|2|||
23477810|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23595285|NCT00088413|65909387|FG003|Overall Study|Progressive disease|14|||
23800308|NCT00892281|66646733|FG001|Overall Study|Family emergency|0|||
23595286|NCT00088413|65909384|FG000|Overall Study|Other|0|||
23595287|NCT00088413|65909385|FG001|Overall Study|Other|1|||
23800309|NCT00892281|66646732|FG000|Overall Study|Last visit not done - death in family|1|||
23800310|NCT00892281|66646733|FG001|Overall Study|Last visit not done - death in family|0|||
23800311|NCT00892281|66646732|FG000|Overall Study|Did not meet incl/excl criteria|1|||
23595288|NCT00088413|65909386|FG002|Overall Study|Other|0|||
23360256|NCT00667992|65062864|FG000|Wash-out|Withdrawal by Subject|1|||
23595289|NCT00088413|65909387|FG003|Overall Study|Other|0|||
23595290|NCT00088413|65909384|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
23595291|NCT00088413|65909385|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
23595292|NCT00088413|65909386|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
23595293|NCT00088413|65909387|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
23595294|NCT00738699|65909389|FG000|Overall Study|Withdrawal by Subject|5|||
23595295|NCT00738699|65909390|FG001|Overall Study|Withdrawal by Subject|0|||
23595296|NCT00738699|65909389|FG000|Overall Study|Lost to Follow-up|1|||
23645154|NCT04675151|66086961|FG001|Overall Study|Protocol Violation|0|||
23645155|NCT04675151|66086962|FG002|Overall Study|Protocol Violation|0|||
23645156|NCT04675151|66086963|FG003|Overall Study|Protocol Violation|1|||
23360257|NCT00667992|65062865|FG001|Wash-out|Withdrawal by Subject|0|||
23360258|NCT00667992|65062864|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
23360259|NCT00667992|65062865|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
23360260|NCT00667992|65062864|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360261|NCT00667992|65062865|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23360262|NCT01949142|65062866|FG000|Overall Study|Withdrawal of consent|1|||
23360263|NCT01949142|65062867|FG001|Overall Study|Withdrawal of consent|0|||
23360264|NCT01949142|65062866|FG000|Overall Study|Lost to Follow-up|1|||
23360265|NCT01949142|65062867|FG001|Overall Study|Lost to Follow-up|1|||
23360266|NCT01949142|65062866|FG000|Overall Study|Parent changed their mind|1|||
23360267|NCT01949142|65062867|FG001|Overall Study|Parent changed their mind|0|||
23360268|NCT00004088|65062871|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
23360269|NCT00004088|65062871|FG000|Overall Study|Withdrawal by Subject|1|||
23360270|NCT00004088|65062871|FG000|Overall Study|Protocol Violation|3|||
23360271|NCT00004088|65062871|FG000|Overall Study|Physician Decision|1|||
23360272|NCT02697916|65062874|FG000|Overall Study|Death|357|||
23360273|NCT02697916|65062875|FG001|Overall Study|Death|315|||
23360274|NCT02697916|65062874|FG000|Overall Study|Withdrawal by Subject|221|||
23360275|NCT02697916|65062875|FG001|Overall Study|Withdrawal by Subject|393|||
23360276|NCT01307891|65062881|FG000|Overall Study|Progressive Disease|3|||
23360277|NCT01307891|65062882|FG001|Overall Study|Progressive Disease|1|||
23360278|NCT01383018|65062883|FG000|Overall Study|Adverse Event|14|||
23360279|NCT01383018|65062883|FG000|Overall Study|Death|10|||
23360280|NCT01383018|65062883|FG000|Overall Study|Lost to Follow-up|5|||
23360281|NCT01383018|65062883|FG000|Overall Study|Physician Decision|5|||
23360282|NCT01383018|65062883|FG000|Overall Study|Withdrawal by Subject|9|||
23360283|NCT01383018|65062883|FG000|Overall Study|Subject not implanted|76|||
23360284|NCT01383018|65062883|FG000|Overall Study|Missed Visit|247|||
23360285|NCT01383018|65062883|FG000|Overall Study|Site closed early-not compliance related|7|||
23360286|NCT01383018|65062883|FG000|Overall Study|Patient moved away from site|1|||
23360287|NCT01383018|65062883|FG000|Overall Study|Subject Incarcerated|1|||
23360288|NCT02091414|65062884|FG000|Overall Study|Withdrawal by Subject|2|||
23360289|NCT02091414|65062884|FG000|Overall Study|Death|2|||
23360290|NCT02465437|65062890|FG000|Overall Study|Physician Decision|0|||
23360291|NCT02465437|65062891|FG001|Overall Study|Physician Decision|0|||
23360292|NCT02465437|65062892|FG002|Overall Study|Physician Decision|1|||
23360293|NCT02465437|65062893|FG003|Overall Study|Physician Decision|0|||
23360294|NCT02465437|65062890|FG000|Overall Study|Withdrawal by Subject|1|||
23360295|NCT02465437|65062891|FG001|Overall Study|Withdrawal by Subject|0|||
23360296|NCT02465437|65062892|FG002|Overall Study|Withdrawal by Subject|0|||
23360297|NCT02465437|65062893|FG003|Overall Study|Withdrawal by Subject|1|||
23360298|NCT02465437|65062890|FG000|Overall Study|Adverse Event|0|||
23360299|NCT02465437|65062891|FG001|Overall Study|Adverse Event|1|||
23360300|NCT02465437|65062892|FG002|Overall Study|Adverse Event|0|||
23360301|NCT02465437|65062893|FG003|Overall Study|Adverse Event|0|||
23360302|NCT01381926|65062896|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
23360303|NCT01381926|65062897|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
23360304|NCT01381926|65062896|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
23360305|NCT01381926|65062897|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
23360306|NCT04978337|65062898|FG000|Overall Study|Withdrawal by Subject|0|||
23360307|NCT04978337|65062899|FG001|Overall Study|Withdrawal by Subject|1|||
23645157|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
23360308|NCT02609386|65062900|FG000|Overall Study|Withdrawal by Subject|6|||
23360309|NCT02609386|65062901|FG001|Overall Study|Withdrawal by Subject|1|||
23360310|NCT02609386|65062900|FG000|Overall Study|Lost to Follow-up|3|||
23360311|NCT02609386|65062901|FG001|Overall Study|Lost to Follow-up|5|||
23360312|NCT02609386|65062900|FG000|Overall Study|Death|19|||
23360313|NCT02609386|65062901|FG001|Overall Study|Death|9|||
23360314|NCT02609386|65062900|FG000|Overall Study|Physician Decision|0|||
23595297|NCT00738699|65909390|FG001|Overall Study|Lost to Follow-up|0|||
23595298|NCT00738699|65909389|FG000|Overall Study|Death|144|||
23595299|NCT00738699|65909390|FG001|Overall Study|Death|68|||
23645158|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
23645159|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
23645160|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
23645161|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
23645162|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
23645163|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
23645164|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
23645165|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
23595300|NCT00738699|65909389|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
23595301|NCT00738699|65909390|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
23595302|NCT00738699|65909389|FG000|Overall Study|Other|2|||
23595303|NCT00738699|65909390|FG001|Overall Study|Other|0|||
23595304|NCT04093752|65909392|FG000|Overall Study|Adverse Event|7|||
23595305|NCT04093752|65909393|FG001|Overall Study|Adverse Event|19|||
23595306|NCT04093752|65909394|FG002|Overall Study|Adverse Event|18|||
23595307|NCT04093752|65909395|FG003|Overall Study|Adverse Event|4|||
23595308|NCT04093752|65909392|FG000|Overall Study|Withdrawal by Subject|6|||
23595309|NCT04093752|65909393|FG001|Overall Study|Withdrawal by Subject|6|||
23595310|NCT04093752|65909394|FG002|Overall Study|Withdrawal by Subject|8|||
23595311|NCT04093752|65909395|FG003|Overall Study|Withdrawal by Subject|20|||
23595312|NCT04093752|65909392|FG000|Overall Study|Lost to Follow-up|2|||
23595313|NCT04093752|65909393|FG001|Overall Study|Lost to Follow-up|1|||
23595314|NCT04093752|65909394|FG002|Overall Study|Lost to Follow-up|1|||
23595315|NCT04093752|65909395|FG003|Overall Study|Lost to Follow-up|1|||
23595316|NCT04093752|65909392|FG000|Overall Study|Death|0|||
23595317|NCT04093752|65909393|FG001|Overall Study|Death|0|||
23595318|NCT04093752|65909394|FG002|Overall Study|Death|1|||
23595319|NCT04093752|65909395|FG003|Overall Study|Death|2|||
23595320|NCT04093752|65909392|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
23595321|NCT04093752|65909393|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
23595322|NCT04093752|65909394|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
23595323|NCT04093752|65909395|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
23595324|NCT04093752|65909392|FG000|Overall Study|Covid 19|0|||
23595325|NCT04093752|65909393|FG001|Overall Study|Covid 19|0|||
23595326|NCT04093752|65909394|FG002|Overall Study|Covid 19|0|||
23595327|NCT04093752|65909395|FG003|Overall Study|Covid 19|1|||
23595328|NCT04093752|65909392|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595329|NCT04093752|65909393|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595330|NCT04093752|65909394|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
23595331|NCT04093752|65909395|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595332|NCT04093752|65909392|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
23595333|NCT04093752|65909393|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
23595334|NCT04093752|65909394|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
23595335|NCT04093752|65909395|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
23595336|NCT04093752|65909392|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
23595337|NCT04093752|65909393|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
23595338|NCT04093752|65909394|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
23595339|NCT04093752|65909395|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
23595340|NCT00332241|65909398|FG000|Overall Study|Lack of Efficacy|6|||
23595341|NCT00332241|65909399|FG001|Overall Study|Lack of Efficacy|1|||
23595342|NCT00332241|65909398|FG000|Overall Study|Adverse Event|3|||
23595343|NCT00332241|65909399|FG001|Overall Study|Adverse Event|5|||
23595344|NCT00332241|65909398|FG000|Overall Study|Withdrawal by Subject|2|||
23595345|NCT00332241|65909399|FG001|Overall Study|Withdrawal by Subject|1|||
23595346|NCT00332241|65909398|FG000|Overall Study|Lost to Follow-up|4|||
23645166|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
23645167|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
23595347|NCT00332241|65909399|FG001|Overall Study|Lost to Follow-up|1|||
23595348|NCT04048382|65909402|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
23595349|NCT04048382|65909403|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
23595350|NCT04048382|65909402|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
23595351|NCT04048382|65909403|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
23595352|NCT04048382|65909402|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
23595353|NCT04048382|65909403|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
23595354|NCT01976312|65909404|FG000|Overall Study|Pregnancy|0|||
23595355|NCT01976312|65909405|FG001|Overall Study|Pregnancy|1|||
23595356|NCT01976312|65909404|FG000|Overall Study|Lost to Follow-up|2|||
23595357|NCT01976312|65909405|FG001|Overall Study|Lost to Follow-up|0|||
23595358|NCT01976312|65909404|FG000|Overall Study|Withdrawal by Subject|7|||
23595359|NCT01976312|65909405|FG001|Overall Study|Withdrawal by Subject|2|||
23595360|NCT01976312|65909404|FG000|Overall Study|Adverse Event|6|||
23595361|NCT01976312|65909405|FG001|Overall Study|Adverse Event|6|||
23595362|NCT01976312|65909404|FG000|Overall Study|Protocol Violation|2|||
23595363|NCT01976312|65909405|FG001|Overall Study|Protocol Violation|0|||
23595364|NCT00529100|65909406|FG000|Overall Study|Adverse Event|0|||
23595365|NCT00529100|65909407|FG001|Overall Study|Adverse Event|5|||
23595366|NCT00529100|65909406|FG000|Overall Study|Protocol Violation|0|||
23595367|NCT00529100|65909407|FG001|Overall Study|Protocol Violation|1|||
23595368|NCT00529100|65909406|FG000|Overall Study|Progressive Disease|0|||
23595369|NCT00529100|65909407|FG001|Overall Study|Progressive Disease|1|||
23595370|NCT00529100|65909406|FG000|Overall Study|Withdrawal by Subject|0|||
23595371|NCT00529100|65909407|FG001|Overall Study|Withdrawal by Subject|1|||
23595372|NCT00529100|65909406|FG000|Overall Study|Participant Ineligibility|0|||
23595373|NCT00529100|65909407|FG001|Overall Study|Participant Ineligibility|1|||
23595374|NCT01179334|65909408|FG000|Treatment Period|Adverse Event|1|||
23595375|NCT01179334|65909409|FG001|Treatment Period|Adverse Event|0|||
23645168|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
23645169|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
23645170|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
23645171|NCT00600886|66086964|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
23645172|NCT00600886|66086965|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
23645173|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
23645174|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
23645175|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
23645176|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
23645177|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
23595376|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
23595377|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
23595378|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Death|3|||
23595379|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Death|0|||
23595380|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
23595381|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
23595382|NCT02242487|65909410|FG000|Overall Study|Adverse Event|13|||
23595383|NCT02242487|65909411|FG001|Overall Study|Adverse Event|15|||
23595384|NCT02242487|65909410|FG000|Overall Study|Lack of Efficacy|4|||
23595385|NCT02242487|65909411|FG001|Overall Study|Lack of Efficacy|6|||
23595386|NCT02242487|65909410|FG000|Overall Study|Protocol Violation|2|||
23595387|NCT02242487|65909411|FG001|Overall Study|Protocol Violation|0|||
23595388|NCT02242487|65909410|FG000|Overall Study|Lost to Follow-up|2|||
23645178|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
23645179|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
23645180|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
23595389|NCT02242487|65909411|FG001|Overall Study|Lost to Follow-up|1|||
23595390|NCT02242487|65909410|FG000|Overall Study|Other - Miscellaneous|4|||
23595391|NCT02242487|65909411|FG001|Overall Study|Other - Miscellaneous|6|||
23595392|NCT02242487|65909410|FG000|Overall Study|Withdrawal by Subject|37|||
23595393|NCT02242487|65909411|FG001|Overall Study|Withdrawal by Subject|19|||
23595394|NCT01307267|65909412|FG000|Overall Study|Death|4|||
23595395|NCT01307267|65909413|FG001|Overall Study|Death|3|||
23595396|NCT01307267|65909414|FG002|Overall Study|Death|5|||
23595397|NCT01307267|65909415|FG003|Overall Study|Death|3|||
23595398|NCT01307267|65909416|FG004|Overall Study|Death|1|||
23595399|NCT01307267|65909417|FG005|Overall Study|Death|26|||
23595400|NCT01307267|65909418|FG006|Overall Study|Death|2|||
23595401|NCT01307267|65909419|FG007|Overall Study|Death|2|||
23360315|NCT02609386|65062901|FG001|Overall Study|Physician Decision|2|||
23477811|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
23477812|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477813|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477814|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
23477815|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477816|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477817|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477818|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477819|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477820|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
23477821|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
23477822|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477823|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
23477824|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
23477825|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477826|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477827|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477828|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477829|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477830|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477831|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477832|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477833|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477834|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
23477835|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477836|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477837|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477838|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477839|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477840|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477841|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477842|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477843|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477844|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477845|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
23477846|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
23477847|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
23477848|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477849|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477850|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477851|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477852|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477853|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477854|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477855|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
23477856|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
23477857|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
23477858|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477859|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477860|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477861|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477862|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477863|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477864|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477865|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
23477866|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
23595402|NCT01307267|65909420|FG008|Overall Study|Death|21|||
23595403|NCT01307267|65909421|FG009|Overall Study|Death|2|||
23595404|NCT01307267|65909422|FG010|Overall Study|Death|3|||
23595405|NCT01307267|65909423|FG011|Overall Study|Death|9|||
23360316|NCT02748057|65062902|FG000|Overall Study|Adverse Event|1|||
23595406|NCT01307267|65909424|FG012|Overall Study|Death|0|||
23595407|NCT01307267|65909425|FG013|Overall Study|Death|0|||
23595408|NCT01307267|65909426|FG014|Overall Study|Death|0|||
23595409|NCT01307267|65909427|FG015|Overall Study|Death|0|||
23595410|NCT01307267|65909428|FG016|Overall Study|Death|1|||
23595411|NCT01307267|65909429|FG017|Overall Study|Death|1|||
23595412|NCT01307267|65909430|FG018|Overall Study|Death|2|||
23595413|NCT01307267|65909431|FG019|Overall Study|Death|8|||
23595414|NCT01307267|65909432|FG020|Overall Study|Death|1|||
23595415|NCT01307267|65909433|FG021|Overall Study|Death|2|||
23595416|NCT01307267|65909434|FG022|Overall Study|Death|2|||
23595417|NCT01307267|65909412|FG000|Overall Study|Lost to Follow-up|0|||
23595418|NCT01307267|65909413|FG001|Overall Study|Lost to Follow-up|0|||
23595419|NCT01307267|65909414|FG002|Overall Study|Lost to Follow-up|0|||
23595420|NCT01307267|65909415|FG003|Overall Study|Lost to Follow-up|0|||
23595421|NCT01307267|65909416|FG004|Overall Study|Lost to Follow-up|0|||
23595422|NCT01307267|65909417|FG005|Overall Study|Lost to Follow-up|7|||
23595423|NCT01307267|65909418|FG006|Overall Study|Lost to Follow-up|0|||
23595424|NCT01307267|65909419|FG007|Overall Study|Lost to Follow-up|0|||
23595425|NCT01307267|65909420|FG008|Overall Study|Lost to Follow-up|1|||
23595426|NCT01307267|65909421|FG009|Overall Study|Lost to Follow-up|2|||
23595427|NCT01307267|65909422|FG010|Overall Study|Lost to Follow-up|1|||
23595428|NCT01307267|65909423|FG011|Overall Study|Lost to Follow-up|0|||
23595429|NCT01307267|65909424|FG012|Overall Study|Lost to Follow-up|0|||
23595430|NCT01307267|65909425|FG013|Overall Study|Lost to Follow-up|0|||
23595431|NCT01307267|65909426|FG014|Overall Study|Lost to Follow-up|0|||
23595432|NCT01307267|65909427|FG015|Overall Study|Lost to Follow-up|0|||
23595433|NCT01307267|65909428|FG016|Overall Study|Lost to Follow-up|0|||
23595434|NCT01307267|65909429|FG017|Overall Study|Lost to Follow-up|0|||
23595435|NCT01307267|65909430|FG018|Overall Study|Lost to Follow-up|0|||
23595436|NCT01307267|65909431|FG019|Overall Study|Lost to Follow-up|2|||
23595437|NCT01307267|65909432|FG020|Overall Study|Lost to Follow-up|0|||
23595438|NCT01307267|65909433|FG021|Overall Study|Lost to Follow-up|0|||
23595439|NCT01307267|65909434|FG022|Overall Study|Lost to Follow-up|0|||
23477867|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
23477868|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477869|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477870|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477871|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477872|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477873|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477874|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477875|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477876|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
23477877|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477878|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Death|0|||
23477879|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Death|0|||
23477880|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Death|0|||
23477881|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Death|0|||
23477882|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Death|0|||
23477883|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Death|0|||
23477884|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Death|0|||
23477885|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Death|0|||
23477886|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Death|0|||
23477887|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Death|1|||
23477888|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477889|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477890|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477891|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477892|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23595440|NCT01307267|65909412|FG000|Overall Study|Withdrawal by Subject|0|||
23595441|NCT01307267|65909413|FG001|Overall Study|Withdrawal by Subject|0|||
23595442|NCT01307267|65909414|FG002|Overall Study|Withdrawal by Subject|0|||
23595443|NCT01307267|65909415|FG003|Overall Study|Withdrawal by Subject|0|||
23800312|NCT00892281|66646733|FG001|Overall Study|Did not meet incl/excl criteria|0|||
23595444|NCT01307267|65909416|FG004|Overall Study|Withdrawal by Subject|0|||
23595445|NCT01307267|65909417|FG005|Overall Study|Withdrawal by Subject|1|||
23595446|NCT01307267|65909418|FG006|Overall Study|Withdrawal by Subject|0|||
23595447|NCT01307267|65909419|FG007|Overall Study|Withdrawal by Subject|1|||
23800313|NCT00892281|66646732|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
23595448|NCT01307267|65909420|FG008|Overall Study|Withdrawal by Subject|5|||
23595449|NCT01307267|65909421|FG009|Overall Study|Withdrawal by Subject|1|||
23595450|NCT01307267|65909422|FG010|Overall Study|Withdrawal by Subject|1|||
23595451|NCT01307267|65909423|FG011|Overall Study|Withdrawal by Subject|1|||
23477893|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477894|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477895|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23595452|NCT01307267|65909424|FG012|Overall Study|Withdrawal by Subject|0|||
23477896|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477897|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
23477898|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477899|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477900|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477901|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477902|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477903|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477904|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477905|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477906|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477907|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
23477908|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477909|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477910|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477911|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477912|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477913|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477914|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477915|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477916|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
23477917|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477918|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477919|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477920|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477921|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477922|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477923|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23595453|NCT01307267|65909425|FG013|Overall Study|Withdrawal by Subject|0|||
23595454|NCT01307267|65909426|FG014|Overall Study|Withdrawal by Subject|0|||
23595455|NCT01307267|65909427|FG015|Overall Study|Withdrawal by Subject|0|||
23595456|NCT01307267|65909428|FG016|Overall Study|Withdrawal by Subject|0|||
23595457|NCT01307267|65909429|FG017|Overall Study|Withdrawal by Subject|0|||
23595458|NCT01307267|65909430|FG018|Overall Study|Withdrawal by Subject|0|||
23595459|NCT01307267|65909431|FG019|Overall Study|Withdrawal by Subject|3|||
23595460|NCT01307267|65909432|FG020|Overall Study|Withdrawal by Subject|0|||
23595461|NCT01307267|65909433|FG021|Overall Study|Withdrawal by Subject|0|||
23595462|NCT01307267|65909434|FG022|Overall Study|Withdrawal by Subject|0|||
23595463|NCT01307267|65909412|FG000|Overall Study|Other|0|||
23595464|NCT01307267|65909413|FG001|Overall Study|Other|0|||
23595465|NCT01307267|65909414|FG002|Overall Study|Other|0|||
23595466|NCT01307267|65909415|FG003|Overall Study|Other|0|||
23595467|NCT01307267|65909416|FG004|Overall Study|Other|0|||
23595468|NCT01307267|65909417|FG005|Overall Study|Other|7|||
23595469|NCT01307267|65909418|FG006|Overall Study|Other|0|||
23595470|NCT01307267|65909419|FG007|Overall Study|Other|1|||
23595471|NCT01307267|65909420|FG008|Overall Study|Other|3|||
23595472|NCT01307267|65909421|FG009|Overall Study|Other|0|||
23595473|NCT01307267|65909422|FG010|Overall Study|Other|1|||
23595474|NCT01307267|65909423|FG011|Overall Study|Other|1|||
23595475|NCT01307267|65909424|FG012|Overall Study|Other|1|||
23595476|NCT01307267|65909425|FG013|Overall Study|Other|0|||
23595477|NCT01307267|65909426|FG014|Overall Study|Other|2|||
23595478|NCT01307267|65909427|FG015|Overall Study|Other|1|||
23645181|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
23645182|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
23645183|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
23645184|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
23645185|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Death|1|||
23645186|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Death|1|||
23477924|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23595479|NCT01307267|65909428|FG016|Overall Study|Other|0|||
23595480|NCT01307267|65909429|FG017|Overall Study|Other|0|||
23595481|NCT01307267|65909430|FG018|Overall Study|Other|0|||
23595482|NCT01307267|65909431|FG019|Overall Study|Other|19|||
23645187|NCT00600886|66086964|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
23477925|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
23477926|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
23595483|NCT01307267|65909432|FG020|Overall Study|Other|2|||
23595484|NCT01307267|65909433|FG021|Overall Study|Other|3|||
23595485|NCT01307267|65909434|FG022|Overall Study|Other|2|||
23595486|NCT02538107|65909435|FG000|Overall Study|Did not receive any Mircera dose|11|||
23595487|NCT02538107|65909435|FG000|Overall Study|Missing|5|||
23595488|NCT02538107|65909435|FG000|Overall Study|Necessity of dialysis|20|||
23595489|NCT02538107|65909435|FG000|Overall Study|Administration of other ESA|11|||
23595490|NCT02538107|65909435|FG000|Overall Study|No further treatment necessary|18|||
23595491|NCT02538107|65909435|FG000|Overall Study|Withdrawal by Subject|17|||
23595492|NCT02538107|65909435|FG000|Overall Study|Death|4|||
23595493|NCT02538107|65909435|FG000|Overall Study|Administrative reason|5|||
23595494|NCT02538107|65909435|FG000|Overall Study|Adverse Event|4|||
23595495|NCT02538107|65909435|FG000|Overall Study|Surgery|1|||
23595496|NCT02538107|65909435|FG000|Overall Study|Other|7|||
23595497|NCT02538107|65909435|FG000|Overall Study|Not recorded|7|||
23595498|NCT02092116|65909436|FG000|Overall Study|Withdrawal by Subject|0|||
23595499|NCT02092116|65909437|FG001|Overall Study|Withdrawal by Subject|3|||
23595500|NCT02092116|65909436|FG000|Overall Study|Adverse Event|0|||
23595501|NCT02092116|65909437|FG001|Overall Study|Adverse Event|1|||
23595502|NCT01337635|65909441|FG000|Overall Study|Lost to Follow-up|0|||
23595503|NCT01337635|65909442|FG001|Overall Study|Lost to Follow-up|1|||
23595504|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
23595505|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
23595506|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
23595507|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
23800314|NCT00892281|66646733|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
23800315|NCT00892281|66646732|FG000|Overall Study|Unable to redeem the drug voucher|1|||
23800316|NCT00892281|66646733|FG001|Overall Study|Unable to redeem the drug voucher|0|||
23800317|NCT00892281|66646732|FG000|Overall Study|Subject not good candidate for study|1|||
23800318|NCT00892281|66646733|FG001|Overall Study|Subject not good candidate for study|0|||
23800319|NCT00892281|66646732|FG000|Overall Study|Subject did not return for any visits|1|||
23800320|NCT00892281|66646733|FG001|Overall Study|Subject did not return for any visits|0|||
23800321|NCT00892281|66646732|FG000|Overall Study|Subject missed several visits/lost meds|1|||
23800322|NCT00892281|66646733|FG001|Overall Study|Subject missed several visits/lost meds|0|||
23800323|NCT00892281|66646732|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
23800324|NCT00892281|66646733|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
23800325|NCT00892281|66646732|FG000|Overall Study|Scheduled for knee replacement|0|||
23800326|NCT00892281|66646733|FG001|Overall Study|Scheduled for knee replacement|1|||
23800327|NCT00892281|66646732|FG000|Overall Study|PI complained of inadequate compensation|3|||
23800328|NCT00892281|66646733|FG001|Overall Study|PI complained of inadequate compensation|0|||
23800329|NCT00892281|66646732|FG000|Overall Study|Subject lost interest in program|0|||
23800330|NCT00892281|66646733|FG001|Overall Study|Subject lost interest in program|1|||
23800331|NCT00892281|66646732|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
23800332|NCT00892281|66646733|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
23800333|NCT00892281|66646732|FG000|Overall Study|Death in family|1|||
23800334|NCT00892281|66646733|FG001|Overall Study|Death in family|0|||
23800335|NCT00892281|66646732|FG000|Overall Study|Lack of efficacy of study product|2|||
23800336|NCT00892281|66646733|FG001|Overall Study|Lack of efficacy of study product|0|||
23800337|NCT00892281|66646732|FG000|Overall Study|Subject not seen by PI at final visit|1|||
23800338|NCT00892281|66646733|FG001|Overall Study|Subject not seen by PI at final visit|0|||
23800339|NCT00892281|66646732|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
23800340|NCT00892281|66646733|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
23800341|NCT00892281|66646732|FG000|Overall Study|Missed multiple visits|1|||
23800342|NCT00892281|66646733|FG001|Overall Study|Missed multiple visits|0|||
23800343|NCT00892281|66646732|FG000|Overall Study|Missed visits rescheduled out of window|1|||
23800344|NCT00892281|66646733|FG001|Overall Study|Missed visits rescheduled out of window|0|||
23800345|NCT00892281|66646732|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
23800346|NCT00892281|66646733|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
23800347|NCT00892281|66646732|FG000|Overall Study|Subject had history of drug abuse|1|||
23800348|NCT00892281|66646733|FG001|Overall Study|Subject had history of drug abuse|0|||
23800349|NCT00892281|66646732|FG000|Overall Study|Rash on hand|1|||
23800350|NCT00892281|66646733|FG001|Overall Study|Rash on hand|0|||
23360317|NCT02748057|65062903|FG001|Overall Study|Adverse Event|0|||
23595508|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
23800351|NCT00892281|66646732|FG000|Overall Study|Visit 4 date out of window|1|||
23800352|NCT00892281|66646733|FG001|Overall Study|Visit 4 date out of window|0|||
23800353|NCT01660022|66646736|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
23360318|NCT02748057|65062902|FG000|Overall Study|Physician Decision|0|||
23477927|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477928|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477929|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477930|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477931|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477932|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477933|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477934|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23800354|NCT01660022|66646737|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
23800355|NCT01660022|66646738|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
23800356|NCT01660022|66646739|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
23800357|NCT01660022|66646740|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
23800358|NCT01660022|66646741|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
23800359|NCT01660022|66646736|FG000|First Sequence (7 Days)|Adverse Event|0|||
23800360|NCT01660022|66646737|FG001|First Sequence (7 Days)|Adverse Event|0|||
23800361|NCT01660022|66646738|FG002|First Sequence (7 Days)|Adverse Event|0|||
23800362|NCT01660022|66646739|FG003|First Sequence (7 Days)|Adverse Event|0|||
23800363|NCT01660022|66646740|FG004|First Sequence (7 Days)|Adverse Event|1|||
23800364|NCT01660022|66646741|FG005|First Sequence (7 Days)|Adverse Event|3|||
23800365|NCT01660022|66646736|FG000|First Sequence (7 Days)|Protocol Violation|0|||
23800366|NCT01660022|66646737|FG001|First Sequence (7 Days)|Protocol Violation|0|||
23800367|NCT01660022|66646738|FG002|First Sequence (7 Days)|Protocol Violation|0|||
23800368|NCT01660022|66646739|FG003|First Sequence (7 Days)|Protocol Violation|0|||
23800369|NCT01660022|66646740|FG004|First Sequence (7 Days)|Protocol Violation|0|||
23800370|NCT01660022|66646741|FG005|First Sequence (7 Days)|Protocol Violation|1|||
23800371|NCT01522950|66646751|FG000|Overall Study|Withdrawal by Subject|3|||
23800372|NCT01522950|66646752|FG001|Overall Study|Withdrawal by Subject|2|||
23800373|NCT01522950|66646753|FG002|Overall Study|Withdrawal by Subject|1|||
23800374|NCT01522950|66646751|FG000|Overall Study|Adverse Event|3|||
23800375|NCT01522950|66646752|FG001|Overall Study|Adverse Event|1|||
23800376|NCT01522950|66646753|FG002|Overall Study|Adverse Event|1|||
23800377|NCT01522950|66646751|FG000|Overall Study|Protocol Violation|0|||
23800378|NCT01522950|66646752|FG001|Overall Study|Protocol Violation|0|||
23595509|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
23595510|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
23595511|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
23595512|NCT00522951|65909446|FG000|Period 1|body motion|0|||
23595513|NCT00522951|65909447|FG001|Period 1|body motion|1|||
23595514|NCT00522951|65909446|FG000|Washout Period|Adverse Event|0|||
23595515|NCT00522951|65909447|FG001|Washout Period|Adverse Event|1|||
23595516|NCT00522951|65909446|FG000|Washout Period|Death|0|||
23595517|NCT00522951|65909447|FG001|Washout Period|Death|1|||
23595518|NCT00522951|65909446|FG000|Period 2|Withdrawal by Subject|1|||
23595519|NCT00522951|65909447|FG001|Period 2|Withdrawal by Subject|0|||
23595520|NCT00522951|65909446|FG000|Period 2|residual contrast medium|1|||
23595521|NCT00522951|65909447|FG001|Period 2|residual contrast medium|1|||
23595522|NCT01331824|65909448|FG000|Overall Study|Adverse Event|2|||
23595523|NCT01331824|65909448|FG000|Overall Study|Death|1|||
23595524|NCT01331824|65909448|FG000|Overall Study|Disease Progression|9|||
23595525|NCT01331824|65909448|FG000|Overall Study|Withdrawal by Subject|1|||
23595526|NCT04149002|65909449|FG000|Overall Study|Lost to Follow-up|1|||
23595527|NCT04149002|65909450|FG001|Overall Study|Lost to Follow-up|0|||
23595528|NCT04149002|65909449|FG000|Overall Study|Withdrawal by Subject|1|||
23595529|NCT04149002|65909450|FG001|Overall Study|Withdrawal by Subject|0|||
23595530|NCT00807144|65909454|FG000|Overall Study|Lost to Follow-up|0|||
23595531|NCT00807144|65909455|FG001|Overall Study|Lost to Follow-up|1|||
23595532|NCT00785512|65909456|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
23595533|NCT00785512|65909457|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
23595534|NCT00785512|65909456|FG000|Overall Study|Adverse Event|0|||
23595535|NCT00785512|65909457|FG001|Overall Study|Adverse Event|0|||
23595536|NCT00785512|65909456|FG000|Overall Study|Lack of Efficacy|0|||
23595537|NCT00785512|65909457|FG001|Overall Study|Lack of Efficacy|2|||
23595538|NCT00785512|65909456|FG000|Overall Study|Withdrawal by Subject|0|||
23595539|NCT00785512|65909457|FG001|Overall Study|Withdrawal by Subject|1|||
23595540|NCT00785512|65909456|FG000|Overall Study|Lost to Follow-up|3|||
23595541|NCT00785512|65909457|FG001|Overall Study|Lost to Follow-up|0|||
23595542|NCT00785512|65909456|FG000|Overall Study|Precedure Refused|0|||
23595543|NCT00785512|65909457|FG001|Overall Study|Precedure Refused|0|||
23595544|NCT00785512|65909456|FG000|Overall Study|IVRS Programing Error|0|||
23595545|NCT00785512|65909457|FG001|Overall Study|IVRS Programing Error|0|||
23595546|NCT00785512|65909456|FG000|Overall Study|Physician Decision|0|||
23595547|NCT00785512|65909457|FG001|Overall Study|Physician Decision|0|||
23595548|NCT00785512|65909456|FG000|Overall Study|Lack of compliance|0|||
23595549|NCT00785512|65909457|FG001|Overall Study|Lack of compliance|1|||
23595550|NCT02121002|65909458|FG000|Overall Study|Physician Decision|2|||
23595551|NCT02121002|65909459|FG001|Overall Study|Physician Decision|0|||
23595552|NCT02121002|65909460|FG002|Overall Study|Physician Decision|0|||
23595553|NCT02121002|65909458|FG000|Overall Study|Withdrawal by Subject|3|||
23595554|NCT02121002|65909459|FG001|Overall Study|Withdrawal by Subject|1|||
23595555|NCT02121002|65909460|FG002|Overall Study|Withdrawal by Subject|4|||
23595556|NCT02121002|65909458|FG000|Overall Study|Protocol Violation|1|||
23595557|NCT02121002|65909459|FG001|Overall Study|Protocol Violation|2|||
23595558|NCT02121002|65909460|FG002|Overall Study|Protocol Violation|4|||
23595559|NCT02121002|65909458|FG000|Overall Study|Concomitant therapy|0|||
23595560|NCT02121002|65909459|FG001|Overall Study|Concomitant therapy|1|||
23595561|NCT02121002|65909460|FG002|Overall Study|Concomitant therapy|1|||
23595562|NCT02121002|65909458|FG000|Overall Study|Others|1|||
23595563|NCT02121002|65909459|FG001|Overall Study|Others|0|||
23595564|NCT02121002|65909460|FG002|Overall Study|Others|1|||
23595565|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
23595566|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
23595567|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
23595568|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
23595569|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
23595570|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
23595571|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
23595572|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
23595573|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
23800379|NCT01522950|66646753|FG002|Overall Study|Protocol Violation|2|||
23800380|NCT01522950|66646751|FG000|Overall Study|Death|0|||
23800381|NCT01522950|66646752|FG001|Overall Study|Death|1|||
23800382|NCT01522950|66646753|FG002|Overall Study|Death|1|||
23595574|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
23595575|NCT01424670|65909461|FG000|Continuation Period|Adverse Event|13|||
23595576|NCT01424670|65909462|FG001|Continuation Period|Adverse Event|5|||
23595577|NCT01424670|65909461|FG000|Continuation Period|Lost to Follow-up|2|||
23595578|NCT01424670|65909462|FG001|Continuation Period|Lost to Follow-up|0|||
23360319|NCT02748057|65062903|FG001|Overall Study|Physician Decision|1|||
23595579|NCT01424670|65909461|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
23595580|NCT01424670|65909462|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
23595581|NCT01424670|65909461|FG000|Continuation Period|Physician Decision|5|||
23595582|NCT01424670|65909462|FG001|Continuation Period|Physician Decision|4|||
23595583|NCT01424670|65909461|FG000|Continuation Period|Withdrawal by Subject|13|||
23595584|NCT01424670|65909462|FG001|Continuation Period|Withdrawal by Subject|4|||
23595585|NCT03527160|65909469|FG000|Overall Study|No urine collected|13|||
23595586|NCT03527160|65909469|FG000|Overall Study|No clinical serum creatinine collected|6|||
23595587|NCT03527160|65909469|FG000|Overall Study|Did not meet inclusion|2|||
23595588|NCT03762668|65909470|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
23595589|NCT03762668|65909471|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
23595590|NCT02724592|65909472|FG000|Overall Study|Lost to Follow-up|4|||
23595591|NCT02724592|65909473|FG001|Overall Study|Lost to Follow-up|1|||
23595592|NCT01943916|65912641|FG000|Overall Study|Technically invalid images|10|||
23595593|NCT01943916|65912641|FG000|Overall Study|Enrollment Failure|23|||
23595594|NCT01943916|65912641|FG000|Overall Study|Pilot Phase exclusion|100|||
23595595|NCT01943916|65912641|FG000|Overall Study|Quality Assurance Reader Fail|130|||
23595596|NCT01943916|65912641|FG000|Overall Study|Technical Failure|39|||
23595597|NCT01943916|65912641|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
23595598|NCT01943916|65912641|FG000|Overall Study|No Truth Panel Review|38|||
23595599|NCT01943916|65912641|FG000|Overall Study|Protocol Deviation|1|||
23800383|NCT01522950|66646751|FG000|Overall Study|Study Medication Sensitivity|0|||
23800384|NCT01522950|66646752|FG001|Overall Study|Study Medication Sensitivity|1|||
23800385|NCT01522950|66646753|FG002|Overall Study|Study Medication Sensitivity|0|||
23800386|NCT01701973|66646754|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800387|NCT01701973|66646755|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
23800388|NCT01701973|66646756|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800389|NCT01701973|66646757|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800390|NCT01701973|66646758|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800391|NCT01701973|66646759|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800392|NCT01701973|66646760|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800393|NCT01701973|66646761|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23800394|NCT00702208|66646767|FG000|Overall Study|Lost to Follow-up|28|||
23800395|NCT00702208|66646767|FG000|Overall Study|Did not self-lavage|1|||
23800396|NCT00702208|66646767|FG000|Overall Study|Unsatisfactory colposcopy|2|||
23800397|NCT01754376|66646768|FG000|Overall Study|Adverse Event|1|||
23800398|NCT01754376|66646768|FG000|Overall Study|Lack of Efficacy|2|||
23595600|NCT01062126|65912643|FG000|Overall Study|Death|209|||
23595601|NCT01062126|65912643|FG000|Overall Study|All Withdrawals|324|||
23595602|NCT03403413|65912645|FG000|Overall Study|Lack of Efficacy|2|||
23595603|NCT00068601|65912648|FG000|Overall Study|Ineligible|11|||
23595604|NCT00068601|65912649|FG001|Overall Study|Ineligible|13|||
23595605|NCT00068601|65912648|FG000|Overall Study|Not evaluable: withdrew consent|5|||
23645188|NCT00600886|66086965|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
23645189|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
23645190|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
23645191|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
23645192|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
23595606|NCT00068601|65912649|FG001|Overall Study|Not evaluable: withdrew consent|4|||
23800399|NCT01765270|66646769|FG000|Overall Study|Physician Decision|1|||
23800400|NCT01765270|66646770|FG001|Overall Study|Physician Decision|0|||
23800401|NCT01765270|66646769|FG000|Overall Study|Withdrawal by Subject|0|||
23595607|NCT00068601|65912648|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
23595608|NCT00068601|65912649|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
23595609|NCT00068601|65912648|FG000|Overall Study|Death|11|||
23595610|NCT00068601|65912649|FG001|Overall Study|Death|3|||
23595611|NCT00068601|65912648|FG000|Overall Study|Lost to Follow-up|3|||
23595612|NCT00068601|65912649|FG001|Overall Study|Lost to Follow-up|2|||
23595613|NCT00068601|65912648|FG000|Overall Study|Missing primary outcome data|30|||
23595614|NCT00068601|65912649|FG001|Overall Study|Missing primary outcome data|34|||
23800402|NCT01765270|66646770|FG001|Overall Study|Withdrawal by Subject|1|||
23595615|NCT02566902|65912650|FG000|Overall Study|Protocol Violation|2|||
23645193|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
23645194|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
23645195|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
23645196|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
23645197|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
23595616|NCT02566902|65912651|FG001|Overall Study|Protocol Violation|1|||
23595617|NCT00111813|65912652|FG000|Overall Study|Adverse Event|1|||
23595618|NCT00111813|65912653|FG001|Overall Study|Adverse Event|2|||
23595619|NCT00111813|65912654|FG002|Overall Study|Adverse Event|4|||
23595620|NCT00111813|65912655|FG003|Overall Study|Adverse Event|2|||
23595621|NCT00111813|65912656|FG004|Overall Study|Adverse Event|2|||
23595622|NCT00111813|65912657|FG005|Overall Study|Adverse Event|2|||
23595623|NCT00111813|65912652|FG000|Overall Study|Progressive disease|2|||
23595624|NCT00111813|65912653|FG001|Overall Study|Progressive disease|1|||
23595625|NCT00111813|65912654|FG002|Overall Study|Progressive disease|5|||
23595626|NCT00111813|65912655|FG003|Overall Study|Progressive disease|3|||
23595627|NCT00111813|65912656|FG004|Overall Study|Progressive disease|4|||
23595628|NCT00111813|65912657|FG005|Overall Study|Progressive disease|3|||
23595629|NCT00111813|65912652|FG000|Overall Study|Lack of Efficacy|0|||
23595630|NCT00111813|65912653|FG001|Overall Study|Lack of Efficacy|0|||
23595631|NCT00111813|65912654|FG002|Overall Study|Lack of Efficacy|0|||
23595632|NCT00111813|65912655|FG003|Overall Study|Lack of Efficacy|0|||
23595633|NCT00111813|65912656|FG004|Overall Study|Lack of Efficacy|0|||
23595634|NCT00111813|65912657|FG005|Overall Study|Lack of Efficacy|1|||
23595635|NCT00111813|65912652|FG000|Overall Study|Other|0|||
23595636|NCT00111813|65912653|FG001|Overall Study|Other|0|||
23595637|NCT00111813|65912654|FG002|Overall Study|Other|1|||
23595638|NCT00111813|65912655|FG003|Overall Study|Other|0|||
23595639|NCT00111813|65912656|FG004|Overall Study|Other|0|||
23595640|NCT00111813|65912657|FG005|Overall Study|Other|0|||
23595641|NCT01565148|65912660|FG000|Overall Study|Withdrawal by Subject|1|||
23595642|NCT01565148|65912661|FG001|Overall Study|Withdrawal by Subject|1|||
23595643|NCT01565148|65912662|FG002|Overall Study|Withdrawal by Subject|1|||
23595644|NCT01565148|65912663|FG003|Overall Study|Withdrawal by Subject|2|||
23595645|NCT01565148|65912660|FG000|Overall Study|Lost to Follow-up|4|||
23595646|NCT01565148|65912661|FG001|Overall Study|Lost to Follow-up|4|||
23595647|NCT01565148|65912662|FG002|Overall Study|Lost to Follow-up|0|||
23595648|NCT01565148|65912663|FG003|Overall Study|Lost to Follow-up|3|||
23595649|NCT01565148|65912660|FG000|Overall Study|Rescue Therapy|8|||
23595650|NCT01565148|65912661|FG001|Overall Study|Rescue Therapy|5|||
23595651|NCT01565148|65912662|FG002|Overall Study|Rescue Therapy|5|||
23595652|NCT01565148|65912663|FG003|Overall Study|Rescue Therapy|8|||
23595653|NCT01565148|65912660|FG000|Overall Study|Death|0|||
23595654|NCT01565148|65912661|FG001|Overall Study|Death|0|||
23595655|NCT01565148|65912662|FG002|Overall Study|Death|1|||
23595656|NCT01565148|65912663|FG003|Overall Study|Death|0|||
23595657|NCT01565148|65912660|FG000|Overall Study|Physician Decision|2|||
23595658|NCT01565148|65912661|FG001|Overall Study|Physician Decision|5|||
23595659|NCT01565148|65912662|FG002|Overall Study|Physician Decision|0|||
23595660|NCT01565148|65912663|FG003|Overall Study|Physician Decision|0|||
23595661|NCT00714714|65912664|FG000|Overall Study|Adverse Event|1|||
23595662|NCT00402246|65912665|FG000|Overall Study|Death|62|||
23595663|NCT00402246|65912666|FG001|Overall Study|Death|58|||
23595664|NCT00402246|65912665|FG000|Overall Study|Lost to Follow-up|20|||
23595665|NCT00402246|65912666|FG001|Overall Study|Lost to Follow-up|28|||
23595666|NCT00402246|65912665|FG000|Overall Study|Withdrawal by Subject|72|||
23595667|NCT00402246|65912666|FG001|Overall Study|Withdrawal by Subject|87|||
23595668|NCT00402246|65912665|FG000|Overall Study|Physician Decision|24|||
23595669|NCT00402246|65912666|FG001|Overall Study|Physician Decision|26|||
23595670|NCT00402246|65912665|FG000|Overall Study|Protocol Violation|25|||
23595671|NCT00402246|65912666|FG001|Overall Study|Protocol Violation|24|||
23595672|NCT00402246|65912665|FG000|Overall Study|Missed Final Visit|1|||
23595673|NCT00402246|65912666|FG001|Overall Study|Missed Final Visit|2|||
23595674|NCT00402246|65912665|FG000|Overall Study|Insurance Issues|2|||
23595675|NCT00402246|65912666|FG001|Overall Study|Insurance Issues|1|||
23595676|NCT00402246|65912665|FG000|Overall Study|Heart Transplant|0|||
23595677|NCT00402246|65912666|FG001|Overall Study|Heart Transplant|1|||
23595678|NCT00402246|65912665|FG000|Overall Study|Patient's device explanted|6|||
23595679|NCT00402246|65912666|FG001|Overall Study|Patient's device explanted|2|||
23595680|NCT00402246|65912665|FG000|Overall Study|Center Closure|5|||
23595681|NCT00402246|65912666|FG001|Overall Study|Center Closure|3|||
23595682|NCT00402246|65912665|FG000|Overall Study|Deterioriating Condition|3|||
23595683|NCT00402246|65912666|FG001|Overall Study|Deterioriating Condition|2|||
23595684|NCT01127373|65912671|FG000|Overall Study|Not Treated|3|||
23477935|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
23477936|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
23477937|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
23477938|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477939|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477940|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477941|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477942|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477943|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477944|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477945|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
23477946|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
23477947|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477948|NCT03459690|65491695|FG000|Overall Study|Lost to Follow-up|0|||
23477949|NCT03459690|65491696|FG001|Overall Study|Lost to Follow-up|1|||
23477950|NCT03459690|65491695|FG000|Overall Study|Withdrawal by Subject|1|||
23477951|NCT03459690|65491696|FG001|Overall Study|Withdrawal by Subject|1|||
23477952|NCT00724711|65491705|FG000|Overall Study|Adverse Event|7|||
23477953|NCT00724711|65491706|FG001|Overall Study|Adverse Event|3|||
23477954|NCT00724711|65491705|FG000|Overall Study|Pregnancy|0|||
23477955|NCT00724711|65491706|FG001|Overall Study|Pregnancy|1|||
23477956|NCT00724711|65491705|FG000|Overall Study|Lack of Efficacy|0|||
23477957|NCT00724711|65491706|FG001|Overall Study|Lack of Efficacy|1|||
23477958|NCT00724711|65491705|FG000|Overall Study|Physician Decision|0|||
23477959|NCT00724711|65491706|FG001|Overall Study|Physician Decision|3|||
23477960|NCT00724711|65491705|FG000|Overall Study|Withdrawal by Subject|5|||
23477961|NCT00724711|65491706|FG001|Overall Study|Withdrawal by Subject|4|||
23477962|NCT00724711|65491705|FG000|Overall Study|Lost to Follow-up|4|||
23477963|NCT00724711|65491706|FG001|Overall Study|Lost to Follow-up|5|||
23477964|NCT00724711|65491705|FG000|Overall Study|Protocol Violation|1|||
23477965|NCT00724711|65491706|FG001|Overall Study|Protocol Violation|0|||
23477966|NCT03565367|65491707|FG000|Overall Study|No scan due to technical issues|4|||
23477967|NCT03565367|65491708|FG001|Overall Study|No scan due to technical issues|0|||
23477968|NCT00275821|65491710|FG000|Overall Study|Adverse Event|4|||
23477969|NCT00275821|65491711|FG001|Overall Study|Adverse Event|12|||
23477970|NCT00275821|65491712|FG002|Overall Study|Adverse Event|5|||
23477971|NCT00275821|65491710|FG000|Overall Study|Administrative problems|3|||
23477972|NCT00275821|65491711|FG001|Overall Study|Administrative problems|4|||
23477973|NCT00275821|65491712|FG002|Overall Study|Administrative problems|4|||
23477974|NCT00275821|65491710|FG000|Overall Study|Withdrawal by Subject|0|||
23477975|NCT00275821|65491711|FG001|Overall Study|Withdrawal by Subject|2|||
23477976|NCT00275821|65491712|FG002|Overall Study|Withdrawal by Subject|1|||
23477977|NCT00275821|65491710|FG000|Overall Study|Lost to Follow-up|0|||
23477978|NCT00275821|65491711|FG001|Overall Study|Lost to Follow-up|1|||
23477979|NCT00275821|65491712|FG002|Overall Study|Lost to Follow-up|1|||
23477980|NCT00275821|65491710|FG000|Overall Study|Death|0|||
23477981|NCT00275821|65491711|FG001|Overall Study|Death|2|||
23477982|NCT00275821|65491712|FG002|Overall Study|Death|1|||
23477983|NCT00275821|65491710|FG000|Overall Study|Lack of Efficacy|2|||
23477984|NCT00275821|65491711|FG001|Overall Study|Lack of Efficacy|1|||
23477985|NCT00275821|65491712|FG002|Overall Study|Lack of Efficacy|0|||
23477986|NCT00275821|65491710|FG000|Overall Study|Protocol Violation|5|||
23477987|NCT00275821|65491711|FG001|Overall Study|Protocol Violation|1|||
23477988|NCT00275821|65491712|FG002|Overall Study|Protocol Violation|0|||
23477989|NCT00635024|65494388|FG000|Overall Study|Adverse Event|1|||
23477990|NCT01547780|65494391|FG000|Baseline PET Scan|Physician Decision|1|||
23477991|NCT01547780|65494392|FG001|Baseline PET Scan|Physician Decision|0|||
23477992|NCT01547780|65494393|FG002|Baseline PET Scan|Physician Decision|1|||
23477993|NCT01547780|65494394|FG003|Baseline PET Scan|Physician Decision|0|||
23477994|NCT01547780|65494391|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
23477995|NCT01547780|65494392|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
23477996|NCT01547780|65494393|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
23477997|NCT01547780|65494394|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
23477998|NCT00608569|65494398|FG000|Overall Study|Death|4|||
23477999|NCT00608569|65494399|FG001|Overall Study|Death|3|||
23478000|NCT00608569|65494398|FG000|Overall Study|Lost to Follow-up|4|||
23478001|NCT00608569|65494399|FG001|Overall Study|Lost to Follow-up|5|||
23478002|NCT00608569|65494398|FG000|Overall Study|Withdrawal by Subject|1|||
23478003|NCT00608569|65494399|FG001|Overall Study|Withdrawal by Subject|0|||
23478004|NCT00608569|65494398|FG000|Overall Study|Adverse Event|1|||
23478005|NCT00608569|65494399|FG001|Overall Study|Adverse Event|0|||
23478006|NCT00608569|65494398|FG000|Overall Study|Unable to adhere with study requirements|0|||
23478007|NCT00608569|65494399|FG001|Overall Study|Unable to adhere with study requirements|1|||
23478008|NCT03041129|65494400|FG000|Overall Study|Withdrawal by Subject|2|||
23478009|NCT03041129|65494401|FG001|Overall Study|Withdrawal by Subject|0|||
23478010|NCT03041129|65494402|FG002|Overall Study|Withdrawal by Subject|0|||
23478011|NCT03041129|65494403|FG003|Overall Study|Withdrawal by Subject|0|||
23595685|NCT01127373|65912671|FG000|Overall Study|Lost to Follow-up|7|||
23595686|NCT01127373|65912671|FG000|Overall Study|Withdrawal by Subject|1|||
23595687|NCT01127373|65912671|FG000|Overall Study|Disease progression|1|||
23595688|NCT04377308|65912672|FG000|Overall Study|Withdrawal by Subject|0|||
23595689|NCT04377308|65912673|FG001|Overall Study|Withdrawal by Subject|1|||
23595690|NCT03482635|65912677|FG000|Overall Study|Lack of Efficacy|0|||
23595691|NCT03482635|65912678|FG001|Overall Study|Lack of Efficacy|0|||
23595692|NCT03482635|65912679|FG002|Overall Study|Lack of Efficacy|1|||
23595693|NCT03482635|65912680|FG003|Overall Study|Lack of Efficacy|3|||
23595694|NCT03482635|65912677|FG000|Overall Study|Adverse Event|2|||
23595695|NCT03482635|65912678|FG001|Overall Study|Adverse Event|2|||
23595696|NCT03482635|65912679|FG002|Overall Study|Adverse Event|0|||
23595697|NCT03482635|65912680|FG003|Overall Study|Adverse Event|3|||
23595698|NCT03482635|65912677|FG000|Overall Study|Withdrawal by Subject|2|||
23595699|NCT03482635|65912678|FG001|Overall Study|Withdrawal by Subject|1|||
23595700|NCT03482635|65912679|FG002|Overall Study|Withdrawal by Subject|0|||
23595701|NCT03482635|65912680|FG003|Overall Study|Withdrawal by Subject|1|||
23595702|NCT03482635|65912677|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
23595703|NCT03482635|65912678|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
23595704|NCT03482635|65912679|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
23595705|NCT03482635|65912680|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
23595706|NCT03482635|65912677|FG000|Overall Study|Not treated|0|||
23595707|NCT03482635|65912678|FG001|Overall Study|Not treated|0|||
23595708|NCT03482635|65912679|FG002|Overall Study|Not treated|0|||
23595709|NCT03482635|65912680|FG003|Overall Study|Not treated|1|||
23595710|NCT03887650|65912684|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
23595711|NCT03887650|65912685|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
23595712|NCT03887650|65912684|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
23595713|NCT03887650|65912685|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
23595714|NCT03887650|65912684|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
23595715|NCT03887650|65912685|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
23595716|NCT01303445|65912686|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
23595717|NCT01303445|65912687|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
23595718|NCT01303445|65912686|FG000|Second Intervention (7 Days)|Adverse Event|0|||
23595719|NCT01303445|65912687|FG001|Second Intervention (7 Days)|Adverse Event|2|||
23595720|NCT01303445|65912686|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
23595721|NCT01303445|65912687|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
23595722|NCT01303445|65912686|FG000|Washout (14 Days)|Protocol Violation|1|||
23595723|NCT01303445|65912687|FG001|Washout (14 Days)|Protocol Violation|0|||
23595724|NCT01303445|65912686|FG000|Washout (14 Days)|Lost to Follow-up|0|||
23595725|NCT01303445|65912687|FG001|Washout (14 Days)|Lost to Follow-up|2|||
23595726|NCT01303445|65912686|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
23595727|NCT01303445|65912687|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
23595728|NCT01303445|65912686|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
23595729|NCT01303445|65912687|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
23595730|NCT01953692|65912688|FG000|Overall Study|Adverse Event|5|||
23595731|NCT01953692|65912689|FG001|Overall Study|Adverse Event|2|||
23595732|NCT01953692|65912690|FG002|Overall Study|Adverse Event|4|||
23595733|NCT01953692|65912691|FG003|Overall Study|Adverse Event|2|||
23595734|NCT01953692|65912692|FG004|Overall Study|Adverse Event|1|||
23595735|NCT01953692|65912693|FG005|Overall Study|Adverse Event|2|||
23595736|NCT01953692|65912694|FG006|Overall Study|Adverse Event|0|||
23595737|NCT01953692|65912695|FG007|Overall Study|Adverse Event|0|||
23595738|NCT01953692|65912696|FG008|Overall Study|Adverse Event|0|||
23595739|NCT01953692|65912688|FG000|Overall Study|Clinical Progression|0|||
23595740|NCT01953692|65912689|FG001|Overall Study|Clinical Progression|15|||
23595741|NCT01953692|65912690|FG002|Overall Study|Clinical Progression|7|||
23595742|NCT01953692|65912691|FG003|Overall Study|Clinical Progression|5|||
23595743|NCT01953692|65912692|FG004|Overall Study|Clinical Progression|0|||
23595744|NCT01953692|65912693|FG005|Overall Study|Clinical Progression|7|||
23595745|NCT01953692|65912694|FG006|Overall Study|Clinical Progression|20|||
23595746|NCT01953692|65912695|FG007|Overall Study|Clinical Progression|3|||
23595747|NCT01953692|65912696|FG008|Overall Study|Clinical Progression|3|||
23595748|NCT01953692|65912688|FG000|Overall Study|Death|5|||
23595749|NCT01953692|65912689|FG001|Overall Study|Death|0|||
23595750|NCT01953692|65912690|FG002|Overall Study|Death|2|||
23595751|NCT01953692|65912691|FG003|Overall Study|Death|2|||
23595752|NCT01953692|65912692|FG004|Overall Study|Death|1|||
23595753|NCT01953692|65912693|FG005|Overall Study|Death|3|||
23595754|NCT01953692|65912694|FG006|Overall Study|Death|6|||
23595755|NCT01953692|65912695|FG007|Overall Study|Death|2|||
23595756|NCT01953692|65912696|FG008|Overall Study|Death|1|||
23595757|NCT01953692|65912688|FG000|Overall Study|Excluded Medication|1|||
23595758|NCT01953692|65912689|FG001|Overall Study|Excluded Medication|0|||
23595759|NCT01953692|65912690|FG002|Overall Study|Excluded Medication|0|||
23595760|NCT01953692|65912691|FG003|Overall Study|Excluded Medication|0|||
23595761|NCT01953692|65912692|FG004|Overall Study|Excluded Medication|0|||
23595762|NCT01953692|65912693|FG005|Overall Study|Excluded Medication|0|||
23595763|NCT01953692|65912694|FG006|Overall Study|Excluded Medication|0|||
23595764|NCT01953692|65912695|FG007|Overall Study|Excluded Medication|0|||
23595765|NCT01953692|65912696|FG008|Overall Study|Excluded Medication|0|||
23595766|NCT01953692|65912688|FG000|Overall Study|Lost to Follow-up|1|||
23595767|NCT01953692|65912689|FG001|Overall Study|Lost to Follow-up|0|||
23595768|NCT01953692|65912690|FG002|Overall Study|Lost to Follow-up|3|||
23595769|NCT01953692|65912691|FG003|Overall Study|Lost to Follow-up|1|||
23595770|NCT01953692|65912692|FG004|Overall Study|Lost to Follow-up|0|||
23595771|NCT01953692|65912693|FG005|Overall Study|Lost to Follow-up|1|||
23800403|NCT00700817|66646773|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
23595772|NCT01953692|65912694|FG006|Overall Study|Lost to Follow-up|0|||
23595773|NCT01953692|65912695|FG007|Overall Study|Lost to Follow-up|0|||
23595774|NCT01953692|65912696|FG008|Overall Study|Lost to Follow-up|0|||
23595775|NCT01953692|65912688|FG000|Overall Study|Physician Decision|11|||
23595776|NCT01953692|65912689|FG001|Overall Study|Physician Decision|4|||
23595777|NCT01953692|65912690|FG002|Overall Study|Physician Decision|2|||
23595778|NCT01953692|65912691|FG003|Overall Study|Physician Decision|2|||
23595779|NCT01953692|65912692|FG004|Overall Study|Physician Decision|1|||
23595780|NCT01953692|65912693|FG005|Overall Study|Physician Decision|2|||
23595781|NCT01953692|65912694|FG006|Overall Study|Physician Decision|4|||
23595782|NCT01953692|65912695|FG007|Overall Study|Physician Decision|1|||
23595783|NCT01953692|65912696|FG008|Overall Study|Physician Decision|0|||
23800404|NCT00700817|66646774|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
23800405|NCT00700817|66646775|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
23800406|NCT00700817|66646776|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
23595784|NCT01953692|65912688|FG000|Overall Study|Protocol Violation|0|||
23360320|NCT02748057|65062902|FG000|Overall Study|Protocol Violation|2|||
23595785|NCT01953692|65912689|FG001|Overall Study|Protocol Violation|2|||
23595786|NCT01953692|65912690|FG002|Overall Study|Protocol Violation|1|||
23595787|NCT01953692|65912691|FG003|Overall Study|Protocol Violation|0|||
23595788|NCT01953692|65912692|FG004|Overall Study|Protocol Violation|0|||
23595789|NCT01953692|65912693|FG005|Overall Study|Protocol Violation|0|||
23595790|NCT01953692|65912694|FG006|Overall Study|Protocol Violation|0|||
23595791|NCT01953692|65912695|FG007|Overall Study|Protocol Violation|1|||
23595792|NCT01953692|65912696|FG008|Overall Study|Protocol Violation|0|||
23595793|NCT01953692|65912688|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595794|NCT01953692|65912689|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595795|NCT01953692|65912690|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23360321|NCT02748057|65062903|FG001|Overall Study|Protocol Violation|1|||
23360322|NCT02748057|65062902|FG000|Overall Study|Participant Moved|1|||
23595796|NCT01953692|65912691|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595797|NCT01953692|65912692|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595798|NCT01953692|65912693|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595799|NCT01953692|65912694|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595800|NCT01953692|65912695|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
23595801|NCT01953692|65912696|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595802|NCT01953692|65912688|FG000|Overall Study|Withdrawal by Subject|4|||
23595803|NCT01953692|65912689|FG001|Overall Study|Withdrawal by Subject|2|||
23595804|NCT01953692|65912690|FG002|Overall Study|Withdrawal by Subject|1|||
23595805|NCT01953692|65912691|FG003|Overall Study|Withdrawal by Subject|2|||
23595806|NCT01953692|65912692|FG004|Overall Study|Withdrawal by Subject|0|||
23595807|NCT01953692|65912693|FG005|Overall Study|Withdrawal by Subject|3|||
23595808|NCT01953692|65912694|FG006|Overall Study|Withdrawal by Subject|2|||
23595809|NCT01953692|65912695|FG007|Overall Study|Withdrawal by Subject|1|||
23595810|NCT01953692|65912696|FG008|Overall Study|Withdrawal by Subject|1|||
23595811|NCT01109524|65912697|FG000|Overall Study|Disease Progression|29|||
23595812|NCT01109524|65912697|FG000|Overall Study|Study Drug toxicity|6|||
23595813|NCT01109524|65912697|FG000|Overall Study|Adverse Event|4|||
23595814|NCT01109524|65912697|FG000|Overall Study|Withdrawal by Subject|2|||
23595815|NCT01109524|65912697|FG000|Overall Study|Maximum clinical benefit|3|||
23595816|NCT01109524|65912697|FG000|Overall Study|Death|2|||
23595817|NCT01109524|65912697|FG000|Overall Study|No longer meets criteria|2|||
23595818|NCT01109524|65912697|FG000|Overall Study|Participant requested to end treatment|4|||
23595819|NCT01109524|65912697|FG000|Overall Study|Other|5|||
23595820|NCT02755116|65912698|FG000|Overall Study|surgery converted to open, pt admitted|3|||
23595821|NCT02755116|65912699|FG001|Overall Study|surgery converted to open, pt admitted|1|||
23595822|NCT02574455|65912716|FG000|Overall Study|Death|197|||
23595823|NCT02574455|65912717|FG001|Overall Study|Death|210|||
23595824|NCT02574455|65912716|FG000|Overall Study|Withdrawal of Consent|11|||
23595825|NCT02574455|65912717|FG001|Overall Study|Withdrawal of Consent|28|||
23595826|NCT02574455|65912716|FG000|Overall Study|Lost to Follow-up|4|||
23595827|NCT02574455|65912717|FG001|Overall Study|Lost to Follow-up|4|||
23595828|NCT02574455|65912716|FG000|Overall Study|Sponsor's Decision|55|||
23595829|NCT02574455|65912717|FG001|Overall Study|Sponsor's Decision|20|||
23595830|NCT00593489|65912720|FG000|Allocation|did not attend workshop; allocation not|2|||
23595831|NCT00593489|65912721|FG001|Allocation|did not attend workshop; allocation not|1|||
23595832|NCT02101281|65912723|FG000|Overall Study|Adverse Event|0|||
23595833|NCT02101281|65912724|FG001|Overall Study|Adverse Event|1|||
23595834|NCT03175172|65912726|FG000|Overall Study|Death|3|||
23595835|NCT03175172|65912726|FG000|Overall Study|Withdrawal by Subject|3|||
23595836|NCT03175172|65912726|FG000|Overall Study|Lost to Follow-up|1|||
23595837|NCT03175172|65912726|FG000|Overall Study|Study Terminated by Sponsor|3|||
23595838|NCT03345901|65912727|FG000|Overall Study|The study was terminated|18|||
23595839|NCT01460446|65912728|FG000|Overall Study|Non-compliance|2|||
23595840|NCT01460446|65912729|FG001|Overall Study|Non-compliance|9|||
23595841|NCT01460446|65912728|FG000|Overall Study|Consent Withdrawn|0|||
23595842|NCT01460446|65912729|FG001|Overall Study|Consent Withdrawn|4|||
23595843|NCT01460446|65912728|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
23595844|NCT01460446|65912729|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
23595845|NCT01460446|65912728|FG000|Overall Study|Surgery/Illness|1|||
23595846|NCT01460446|65912729|FG001|Overall Study|Surgery/Illness|1|||
23595847|NCT01460446|65912728|FG000|Overall Study|Pregnancy|1|||
23595848|NCT01460446|65912729|FG001|Overall Study|Pregnancy|0|||
23595849|NCT01460446|65912728|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
23595850|NCT01460446|65912729|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
23595851|NCT02015546|65912730|FG000|Overall Study|Withdrawal by Subject|1|||
23595852|NCT02015546|65912731|FG001|Overall Study|Withdrawal by Subject|1|||
23595853|NCT02015546|65912732|FG002|Overall Study|Withdrawal by Subject|1|||
23595854|NCT02015546|65912730|FG000|Overall Study|Screem Failure|2|||
23800407|NCT00700817|66646777|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
23360323|NCT02748057|65062903|FG001|Overall Study|Participant Moved|0|||
23800408|NCT00700817|66646773|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
23360324|NCT02748057|65062902|FG000|Overall Study|Withdrawal by Subject|1|||
23360325|NCT02748057|65062903|FG001|Overall Study|Withdrawal by Subject|0|||
23360326|NCT01601496|65062906|FG000|Overall Study|Physician Decision|1|||
23360327|NCT01601496|65062906|FG000|Overall Study|Withdrawal by Subject|1|||
23595855|NCT02015546|65912731|FG001|Overall Study|Screem Failure|1|||
23595856|NCT02015546|65912732|FG002|Overall Study|Screem Failure|3|||
23595857|NCT01255670|65912737|FG000|Overall Study|Adverse Event|10|||
23595858|NCT01255670|65912738|FG001|Overall Study|Adverse Event|10|||
23595859|NCT01255670|65912737|FG000|Overall Study|Lost to Follow-up|16|||
23595860|NCT01255670|65912738|FG001|Overall Study|Lost to Follow-up|10|||
23595861|NCT00262301|65912742|FG000|Double-blind Phase|Lost to Follow-up|1|||
23595862|NCT00262301|65912743|FG001|Double-blind Phase|Lost to Follow-up|0|||
23595863|NCT00262301|65912744|FG002|Double-blind Phase|Lost to Follow-up|0|||
23800409|NCT00700817|66646774|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23478012|NCT02048241|65494404|FG000|Overall Study|Withdrawal by Subject|0|||
23478013|NCT02048241|65494405|FG001|Overall Study|Withdrawal by Subject|1|||
23478014|NCT02184455|65494411|FG000|Overall Study|Lost to Follow-up|1|||
23478015|NCT01954927|65494415|FG000|Overall Study|Withdrawal by Subject|3|||
23478016|NCT01954927|65494416|FG001|Overall Study|Withdrawal by Subject|1|||
23478017|NCT01270802|65494418|FG000|Overall Study|Withdrawal by Subject|1|||
23478018|NCT01270802|65494419|FG001|Overall Study|Withdrawal by Subject|0|||
23478019|NCT01270802|65494418|FG000|Overall Study|Adverse Event|1|||
23478020|NCT01270802|65494419|FG001|Overall Study|Adverse Event|0|||
23478021|NCT01270802|65494418|FG000|Overall Study|Lost to Follow-up|0|||
23478022|NCT01270802|65494419|FG001|Overall Study|Lost to Follow-up|1|||
23478023|NCT00422084|65494420|FG000|Overall Study|Adverse Event|21|||
23478024|NCT00422084|65494421|FG001|Overall Study|Adverse Event|7|||
23478025|NCT00422084|65494420|FG000|Overall Study|Withdrawal by Subject|12|||
23478026|NCT00422084|65494421|FG001|Overall Study|Withdrawal by Subject|9|||
23478027|NCT00422084|65494420|FG000|Overall Study|Lost to Follow-up|14|||
23478028|NCT00422084|65494421|FG001|Overall Study|Lost to Follow-up|9|||
23478029|NCT00422084|65494420|FG000|Overall Study|Protocol Violation|4|||
23478030|NCT00422084|65494421|FG001|Overall Study|Protocol Violation|1|||
23478031|NCT00422084|65494420|FG000|Overall Study|Lack of Efficacy|40|||
23478032|NCT00422084|65494421|FG001|Overall Study|Lack of Efficacy|42|||
23478033|NCT00422084|65494420|FG000|Overall Study|P. vivax infection|3|||
23478034|NCT00422084|65494421|FG001|Overall Study|P. vivax infection|6|||
23478035|NCT00422084|65494420|FG000|Overall Study|Cyesis|1|||
23478036|NCT00422084|65494421|FG001|Overall Study|Cyesis|0|||
23478037|NCT00422084|65494420|FG000|Overall Study|Withdrawn from study accidentally|1|||
23478038|NCT00422084|65494421|FG001|Overall Study|Withdrawn from study accidentally|0|||
23478039|NCT00422084|65494420|FG000|Overall Study|Non-compliance|1|||
23478040|NCT00422084|65494421|FG001|Overall Study|Non-compliance|0|||
23478041|NCT00422084|65494420|FG000|Overall Study|Re-location|0|||
23478042|NCT00422084|65494421|FG001|Overall Study|Re-location|1|||
23478043|NCT00422084|65494420|FG000|Overall Study|Not defined|1|||
23478044|NCT00422084|65494421|FG001|Overall Study|Not defined|1|||
23478045|NCT01836276|65494424|FG000|Overall Study|Lost to Follow-up|28|||
23478046|NCT01836276|65494425|FG001|Overall Study|Lost to Follow-up|51|||
23478047|NCT03579602|65494426|FG000|Overall Study|Subject unable to receive study drug|0|||
23478048|NCT03579602|65494427|FG001|Overall Study|Subject unable to receive study drug|2|||
23478049|NCT03579602|65494426|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
23478050|NCT03579602|65494427|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
23478051|NCT00308581|65494428|FG000|Induction Phase|Adverse Event|0|||
23478052|NCT00308581|65494429|FG001|Induction Phase|Adverse Event|0|||
23478053|NCT00308581|65494430|FG002|Induction Phase|Adverse Event|37|||
23478054|NCT00308581|65494428|FG000|Induction Phase|Lack of Efficacy|0|||
23478055|NCT00308581|65494429|FG001|Induction Phase|Lack of Efficacy|0|||
23478056|NCT00308581|65494430|FG002|Induction Phase|Lack of Efficacy|121|||
23478057|NCT00308581|65494428|FG000|Induction Phase|Withdrawal by Subject|0|||
23478058|NCT00308581|65494429|FG001|Induction Phase|Withdrawal by Subject|0|||
23478059|NCT00308581|65494430|FG002|Induction Phase|Withdrawal by Subject|5|||
23478060|NCT00308581|65494428|FG000|Induction Phase|Unknown reason|0|||
23478061|NCT00308581|65494429|FG001|Induction Phase|Unknown reason|0|||
23478062|NCT00308581|65494430|FG002|Induction Phase|Unknown reason|3|||
23478063|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Adverse Event|10|||
23478064|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Adverse Event|17|||
23478065|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Adverse Event|0|||
23478066|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
23478067|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
23478068|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
23478069|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
23478070|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
23478071|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
23478072|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
23478073|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
23478074|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
23360328|NCT01601496|65062906|FG000|Overall Study|Lost to Follow-up|6|||
23478075|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
23595864|NCT00262301|65912742|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
23478076|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
23478077|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
23478078|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Unknown reason|3|||
23478079|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Unknown reason|0|||
23478080|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Unknown reason|0|||
23478081|NCT00130247|65494431|FG000|Overall Study|Pregnancy|1|||
23478082|NCT00130247|65494432|FG001|Overall Study|Pregnancy|0|||
23478083|NCT00130247|65494431|FG000|Overall Study|Post-randomization exclusion|1|||
23645198|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
23645199|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
23645200|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
23645201|NCT00600886|66086964|FG000|Extension - After Crossover (CAS)|Death|1|||
23645202|NCT00600886|66086965|FG001|Extension - After Crossover (CAS)|Death|0|||
23645203|NCT00969709|66086966|FG000|Overall Study|Adverse Event|3|||
23645204|NCT00969709|66086967|FG001|Overall Study|Adverse Event|13|||
23645205|NCT00969709|66086968|FG002|Overall Study|Adverse Event|26|||
23645206|NCT00969709|66086969|FG003|Overall Study|Adverse Event|12|||
23645207|NCT00969709|66086966|FG000|Overall Study|Lack of Efficacy|7|||
23645208|NCT00969709|66086967|FG001|Overall Study|Lack of Efficacy|4|||
23645209|NCT00969709|66086968|FG002|Overall Study|Lack of Efficacy|1|||
23645210|NCT00969709|66086969|FG003|Overall Study|Lack of Efficacy|3|||
23645211|NCT00969709|66086966|FG000|Overall Study|Protocol Violation|9|||
23645212|NCT00969709|66086967|FG001|Overall Study|Protocol Violation|5|||
23645213|NCT00969709|66086968|FG002|Overall Study|Protocol Violation|9|||
23645214|NCT00969709|66086969|FG003|Overall Study|Protocol Violation|10|||
23645215|NCT00969709|66086966|FG000|Overall Study|Withdrawal by Subject|9|||
23645216|NCT00969709|66086967|FG001|Overall Study|Withdrawal by Subject|12|||
23645217|NCT00969709|66086968|FG002|Overall Study|Withdrawal by Subject|11|||
23595865|NCT00262301|65912743|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
23595866|NCT00262301|65912744|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
23595867|NCT03260140|65912745|FG000|Overall Study|Death|4|||
23595868|NCT03260140|65912746|FG001|Overall Study|Death|1|||
23595869|NCT03260140|65912745|FG000|Overall Study|Withdrawal by Subject|1|||
23595870|NCT03260140|65912746|FG001|Overall Study|Withdrawal by Subject|4|||
23595871|NCT04820686|65912747|FG000|Overall Study|Withdrawal by Subject|5|||
23595872|NCT04820686|65912748|FG001|Overall Study|Withdrawal by Subject|2|||
23595873|NCT04820686|65912749|FG002|Overall Study|Withdrawal by Subject|3|||
23595874|NCT04820686|65912747|FG000|Overall Study|Study Termination|25|||
23645218|NCT00969709|66086969|FG003|Overall Study|Withdrawal by Subject|23|||
23645219|NCT00969709|66086966|FG000|Overall Study|Lost to Follow-up|10|||
23645220|NCT00969709|66086967|FG001|Overall Study|Lost to Follow-up|14|||
23645221|NCT00969709|66086968|FG002|Overall Study|Lost to Follow-up|8|||
23645222|NCT00969709|66086969|FG003|Overall Study|Lost to Follow-up|15|||
23645223|NCT00969709|66086966|FG000|Overall Study|Other reasons|0|||
23595875|NCT04820686|65912748|FG001|Overall Study|Study Termination|13|||
23360329|NCT01601496|65062906|FG000|Overall Study|Death|4|||
23478084|NCT00130247|65494432|FG001|Overall Study|Post-randomization exclusion|2|||
23478085|NCT00130247|65494431|FG000|Overall Study|Not compliant with DOT|0|||
23595876|NCT04820686|65912749|FG002|Overall Study|Study Termination|14|||
23595877|NCT04820686|65912747|FG000|Overall Study|Adverse Event|0|||
23595878|NCT04820686|65912748|FG001|Overall Study|Adverse Event|1|||
23595879|NCT04820686|65912749|FG002|Overall Study|Adverse Event|0|||
23595880|NCT01266122|65912750|FG000|Overall Study|Lost to Follow-up|6|||
23595881|NCT01266122|65912751|FG001|Overall Study|Lost to Follow-up|6|||
23595882|NCT01636687|65912752|FG000|Induction Period|Withdrawal by Subject|1|||
23595883|NCT01636687|65912753|FG001|Induction Period|Withdrawal by Subject|0|||
23595884|NCT01636687|65912754|FG002|Induction Period|Withdrawal by Subject|0|||
23595885|NCT01636687|65912755|FG003|Induction Period|Withdrawal by Subject|0|||
23595886|NCT01636687|65912756|FG004|Induction Period|Withdrawal by Subject|0|||
23595887|NCT01636687|65912752|FG000|Induction Period|Adverse Event|1|||
23595888|NCT01636687|65912753|FG001|Induction Period|Adverse Event|0|||
23595889|NCT01636687|65912754|FG002|Induction Period|Adverse Event|0|||
23595890|NCT01636687|65912755|FG003|Induction Period|Adverse Event|0|||
23595891|NCT01636687|65912756|FG004|Induction Period|Adverse Event|1|||
23595892|NCT01636687|65912752|FG000|Induction Period|Lack of Efficacy|0|||
23595893|NCT01636687|65912753|FG001|Induction Period|Lack of Efficacy|0|||
23595894|NCT01636687|65912754|FG002|Induction Period|Lack of Efficacy|0|||
23595895|NCT01636687|65912755|FG003|Induction Period|Lack of Efficacy|0|||
23595896|NCT01636687|65912756|FG004|Induction Period|Lack of Efficacy|1|||
23645224|NCT00969709|66086967|FG001|Overall Study|Other reasons|0|||
23645225|NCT00969709|66086968|FG002|Overall Study|Other reasons|3|||
23645226|NCT00969709|66086969|FG003|Overall Study|Other reasons|0|||
23645227|NCT03562247|66086970|FG000|Overall Study|Lost to Follow-up|3|||
23645228|NCT03562247|66086971|FG001|Overall Study|Lost to Follow-up|1|||
23595897|NCT01636687|65912752|FG000|Induction Period|Physician Decision|1|||
23595898|NCT01636687|65912753|FG001|Induction Period|Physician Decision|0|||
23595899|NCT01636687|65912754|FG002|Induction Period|Physician Decision|0|||
23595900|NCT01636687|65912755|FG003|Induction Period|Physician Decision|0|||
23595901|NCT01636687|65912756|FG004|Induction Period|Physician Decision|0|||
23595902|NCT01636687|65912752|FG000|Maintenance Period|Withdrawal by Subject|2|||
23595903|NCT01636687|65912753|FG001|Maintenance Period|Withdrawal by Subject|0|||
23595904|NCT01636687|65912754|FG002|Maintenance Period|Withdrawal by Subject|2|||
23595905|NCT01636687|65912755|FG003|Maintenance Period|Withdrawal by Subject|0|||
23595906|NCT01636687|65912756|FG004|Maintenance Period|Withdrawal by Subject|0|||
23595907|NCT01636687|65912752|FG000|Maintenance Period|Adverse Event|1|||
23595908|NCT01636687|65912753|FG001|Maintenance Period|Adverse Event|0|||
23595909|NCT01636687|65912754|FG002|Maintenance Period|Adverse Event|0|||
23595910|NCT01636687|65912755|FG003|Maintenance Period|Adverse Event|0|||
23595911|NCT01636687|65912756|FG004|Maintenance Period|Adverse Event|0|||
23595912|NCT01636687|65912752|FG000|Maintenance Period|Lack of Efficacy|4|||
23595913|NCT01636687|65912753|FG001|Maintenance Period|Lack of Efficacy|1|||
23595914|NCT01636687|65912754|FG002|Maintenance Period|Lack of Efficacy|0|||
23595915|NCT01636687|65912755|FG003|Maintenance Period|Lack of Efficacy|0|||
23595916|NCT01636687|65912756|FG004|Maintenance Period|Lack of Efficacy|0|||
23595917|NCT01636687|65912752|FG000|Maintenance Period|Lost to Follow-up|1|||
23595918|NCT01636687|65912753|FG001|Maintenance Period|Lost to Follow-up|1|||
23595919|NCT01636687|65912754|FG002|Maintenance Period|Lost to Follow-up|0|||
23595920|NCT01636687|65912755|FG003|Maintenance Period|Lost to Follow-up|0|||
23595921|NCT01636687|65912756|FG004|Maintenance Period|Lost to Follow-up|1|||
23595922|NCT01636687|65912752|FG000|Maintenance Period|Physician Decision|0|||
23595923|NCT01636687|65912753|FG001|Maintenance Period|Physician Decision|0|||
23595924|NCT01636687|65912754|FG002|Maintenance Period|Physician Decision|0|||
23595925|NCT01636687|65912755|FG003|Maintenance Period|Physician Decision|0|||
23595926|NCT01636687|65912756|FG004|Maintenance Period|Physician Decision|1|||
23645229|NCT03562247|66086972|FG002|Overall Study|Lost to Follow-up|1|||
23645230|NCT03814187|66086980|FG000|Overall Study|Sponsor's Administrative Decision|0|||
23645231|NCT03814187|66086981|FG001|Overall Study|Sponsor's Administrative Decision|0|||
23645232|NCT03814187|66086982|FG002|Overall Study|Sponsor's Administrative Decision|272|||
23645233|NCT03814187|66086980|FG000|Overall Study|Death|80|||
23645234|NCT03814187|66086981|FG001|Overall Study|Death|81|||
23645235|NCT03814187|66086982|FG002|Overall Study|Death|4|||
23645236|NCT03814187|66086980|FG000|Overall Study|Withdrew Consent|77|||
23645237|NCT03814187|66086981|FG001|Overall Study|Withdrew Consent|78|||
23645238|NCT03814187|66086982|FG002|Overall Study|Withdrew Consent|2|||
23645239|NCT03814187|66086980|FG000|Overall Study|Lost to Follow-up|47|||
23645240|NCT03814187|66086981|FG001|Overall Study|Lost to Follow-up|52|||
23645241|NCT03814187|66086982|FG002|Overall Study|Lost to Follow-up|1|||
23645242|NCT03814187|66086980|FG000|Overall Study|Adverse Event|22|||
23645243|NCT03814187|66086981|FG001|Overall Study|Adverse Event|23|||
23645244|NCT03814187|66086982|FG002|Overall Study|Adverse Event|0|||
23645245|NCT03814187|66086980|FG000|Overall Study|Physician Decision|7|||
23645246|NCT03814187|66086981|FG001|Overall Study|Physician Decision|4|||
23645247|NCT03814187|66086982|FG002|Overall Study|Physician Decision|2|||
23645248|NCT03814187|66086980|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
23645249|NCT03814187|66086981|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
23645250|NCT03814187|66086982|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
23645251|NCT03814187|66086980|FG000|Overall Study|Other reasons|34|||
23645252|NCT03814187|66086981|FG001|Overall Study|Other reasons|40|||
23645253|NCT03814187|66086982|FG002|Overall Study|Other reasons|2|||
23645254|NCT01263665|66086983|FG000|Overall Study|Withdrew Consent|1|||
23645255|NCT01263665|66086983|FG000|Overall Study|Lost to Follow-up|3|||
23645256|NCT01263665|66086983|FG000|Overall Study|Death|2|||
23645257|NCT01263665|66086983|FG000|Overall Study|Amputation above the ankle|1|||
23645258|NCT01263665|66086983|FG000|Overall Study|Surgical Bypass|2|||
23645259|NCT03647488|66086984|FG000|Overall Study|Progressive disease|10|||
23645260|NCT03647488|66086985|FG001|Overall Study|Progressive disease|0|||
23645261|NCT03647488|66086986|FG002|Overall Study|Progressive disease|0|||
23595927|NCT01636687|65912752|FG000|Extension Period|technical problems|0|||
23595928|NCT01636687|65912753|FG001|Extension Period|technical problems|1|||
23595929|NCT01636687|65912754|FG002|Extension Period|technical problems|2|||
23595930|NCT01636687|65912755|FG003|Extension Period|technical problems|1|||
23595931|NCT01636687|65912756|FG004|Extension Period|technical problems|0|||
23595932|NCT01636687|65912752|FG000|Extension Period|Adverse Event|4|||
23595933|NCT01636687|65912753|FG001|Extension Period|Adverse Event|3|||
23595934|NCT01636687|65912754|FG002|Extension Period|Adverse Event|2|||
23595935|NCT01636687|65912755|FG003|Extension Period|Adverse Event|1|||
23595936|NCT01636687|65912756|FG004|Extension Period|Adverse Event|0|||
23595937|NCT01636687|65912752|FG000|Extension Period|Lack of Efficacy|7|||
23645262|NCT03647488|66086984|FG000|Overall Study|Adverse Event|5|||
23645263|NCT03647488|66086985|FG001|Overall Study|Adverse Event|0|||
23645264|NCT03647488|66086986|FG002|Overall Study|Adverse Event|0|||
23478086|NCT00130247|65494432|FG001|Overall Study|Not compliant with DOT|2|||
23478087|NCT00043550|65494434|FG000|Overall Study|Withdrawal by Subject|22|||
23478088|NCT00043550|65494435|FG001|Overall Study|Withdrawal by Subject|12|||
23478089|NCT00043550|65494436|FG002|Overall Study|Withdrawal by Subject|20|||
23478090|NCT05615935|65494439|FG000|Overall Study|Lost to Follow-up|1|||
23478091|NCT05615935|65494440|FG001|Overall Study|Lost to Follow-up|1|||
23478092|NCT01328366|65494441|FG000|Overall Study|Death|1|||
23478093|NCT01328366|65494441|FG000|Overall Study|Withdrawal by Subject|2|||
23478094|NCT01328366|65494441|FG000|Overall Study|Lost to Follow-up|7|||
23478095|NCT03751657|65494442|FG000|Overall Study|Physician Decision|0|||
23478096|NCT03751657|65494443|FG001|Overall Study|Physician Decision|1|||
23478097|NCT03751657|65494442|FG000|Overall Study|Withdrawal by Subject|1|||
23478098|NCT03751657|65494443|FG001|Overall Study|Withdrawal by Subject|1|||
23478099|NCT03751657|65494442|FG000|Overall Study|Lost to Follow-up|2|||
23478100|NCT03751657|65494443|FG001|Overall Study|Lost to Follow-up|1|||
23478101|NCT01203852|65494455|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
23478102|NCT01203852|65494455|FG000|Washout 2 Weeks|Physician Decision|46|||
23478103|NCT01357850|65494456|FG000|Overall Study|Lost to Follow-up|1|||
23478104|NCT01357850|65494457|FG001|Overall Study|Lost to Follow-up|0|||
23478105|NCT01357850|65494458|FG002|Overall Study|Lost to Follow-up|0|||
23478106|NCT01357850|65494459|FG003|Overall Study|Lost to Follow-up|0|||
23478107|NCT01903252|65494461|FG000|Double-Blind Induction|Adverse Event|20|||
23478108|NCT01903252|65494462|FG001|Double-Blind Induction|Adverse Event|18|||
23478109|NCT01903252|65494463|FG002|Double-Blind Induction|Adverse Event|0|||
23478110|NCT01903252|65494464|FG003|Double-Blind Induction|Adverse Event|0|||
23478111|NCT01903252|65494465|FG004|Double-Blind Induction|Adverse Event|0|||
23478112|NCT01903252|65494466|FG005|Double-Blind Induction|Adverse Event|0|||
23478113|NCT01903252|65494461|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
23478114|NCT01903252|65494462|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
23478115|NCT01903252|65494463|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
23478116|NCT01903252|65494464|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
23478117|NCT01903252|65494465|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
23478118|NCT01903252|65494466|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
23478119|NCT01903252|65494461|FG000|Double-Blind Induction|Physician Decision|2|||
23478120|NCT01903252|65494462|FG001|Double-Blind Induction|Physician Decision|3|||
23478121|NCT01903252|65494463|FG002|Double-Blind Induction|Physician Decision|0|||
23478122|NCT01903252|65494464|FG003|Double-Blind Induction|Physician Decision|0|||
23478123|NCT01903252|65494465|FG004|Double-Blind Induction|Physician Decision|0|||
23478124|NCT01903252|65494466|FG005|Double-Blind Induction|Physician Decision|0|||
23478125|NCT01903252|65494461|FG000|Double-Blind Induction|non-compliance,|7|||
23478126|NCT01903252|65494462|FG001|Double-Blind Induction|non-compliance,|7|||
23478127|NCT01903252|65494463|FG002|Double-Blind Induction|non-compliance,|0|||
23478128|NCT01903252|65494464|FG003|Double-Blind Induction|non-compliance,|0|||
23478129|NCT01903252|65494465|FG004|Double-Blind Induction|non-compliance,|0|||
23478130|NCT01903252|65494466|FG005|Double-Blind Induction|non-compliance,|0|||
23478131|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Adverse Event|0|||
23478132|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Adverse Event|0|||
23478133|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Adverse Event|17|||
23478134|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Adverse Event|0|||
23478135|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Adverse Event|0|||
23478136|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Adverse Event|0|||
23478137|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478138|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478139|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
23478140|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478141|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478142|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478143|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Physician Decision|0|||
23478144|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Physician Decision|0|||
23478145|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Physician Decision|1|||
23478146|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Physician Decision|0|||
23478147|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Physician Decision|0|||
23478148|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Physician Decision|0|||
23478149|NCT01903252|65494461|FG000|Maintenance, Open-Label|Adverse Event|0|||
23478150|NCT01903252|65494462|FG001|Maintenance, Open-Label|Adverse Event|0|||
23478151|NCT01903252|65494463|FG002|Maintenance, Open-Label|Adverse Event|0|||
23478152|NCT01903252|65494464|FG003|Maintenance, Open-Label|Adverse Event|3|||
23595938|NCT01636687|65912753|FG001|Extension Period|Lack of Efficacy|0|||
23478153|NCT01903252|65494465|FG004|Maintenance, Open-Label|Adverse Event|9|||
23478154|NCT01903252|65494466|FG005|Maintenance, Open-Label|Adverse Event|14|||
23478155|NCT01903252|65494461|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
23478156|NCT01903252|65494462|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
23478157|NCT01903252|65494463|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
23595939|NCT01636687|65912754|FG002|Extension Period|Lack of Efficacy|2|||
23595940|NCT01636687|65912755|FG003|Extension Period|Lack of Efficacy|1|||
23595941|NCT01636687|65912756|FG004|Extension Period|Lack of Efficacy|0|||
23595942|NCT01636687|65912752|FG000|Extension Period|Lost to Follow-up|1|||
23595943|NCT01636687|65912753|FG001|Extension Period|Lost to Follow-up|0|||
23595944|NCT01636687|65912754|FG002|Extension Period|Lost to Follow-up|1|||
23595945|NCT01636687|65912755|FG003|Extension Period|Lost to Follow-up|0|||
23595946|NCT01636687|65912756|FG004|Extension Period|Lost to Follow-up|0|||
23595947|NCT01636687|65912752|FG000|Extension Period|Physician Decision|1|||
23595948|NCT01636687|65912753|FG001|Extension Period|Physician Decision|0|||
23595949|NCT01636687|65912754|FG002|Extension Period|Physician Decision|0|||
23595950|NCT01636687|65912755|FG003|Extension Period|Physician Decision|1|||
23595951|NCT01636687|65912756|FG004|Extension Period|Physician Decision|0|||
23595952|NCT01636687|65912752|FG000|Extension Period|study terminated by sponsor|33|||
23595953|NCT01636687|65912753|FG001|Extension Period|study terminated by sponsor|50|||
23595954|NCT01636687|65912754|FG002|Extension Period|study terminated by sponsor|17|||
23595955|NCT01636687|65912755|FG003|Extension Period|study terminated by sponsor|23|||
23595956|NCT01636687|65912756|FG004|Extension Period|study terminated by sponsor|0|||
23595957|NCT01636687|65912752|FG000|Extension Period|Withdrawal by Subject|1|||
23595958|NCT01636687|65912753|FG001|Extension Period|Withdrawal by Subject|0|||
23595959|NCT01636687|65912754|FG002|Extension Period|Withdrawal by Subject|1|||
23595960|NCT01636687|65912755|FG003|Extension Period|Withdrawal by Subject|1|||
23595961|NCT01636687|65912756|FG004|Extension Period|Withdrawal by Subject|0|||
23595962|NCT01636687|65912752|FG000|Follow-up Period|Withdrawal by Subject|1|||
23595963|NCT01636687|65912753|FG001|Follow-up Period|Withdrawal by Subject|0|||
23595964|NCT01636687|65912754|FG002|Follow-up Period|Withdrawal by Subject|0|||
23595965|NCT01636687|65912755|FG003|Follow-up Period|Withdrawal by Subject|0|||
23595966|NCT01636687|65912756|FG004|Follow-up Period|Withdrawal by Subject|1|||
23595967|NCT01839331|65912760|FG000|Overall Study|Early Termination|3|||
23595968|NCT01839331|65912761|FG001|Overall Study|Early Termination|0|||
23595969|NCT01839331|65912762|FG002|Overall Study|Early Termination|1|||
23595970|NCT01839331|65912763|FG003|Overall Study|Early Termination|2|||
23595971|NCT01839331|65912760|FG000|Overall Study|Protocol Violation|1|||
23595972|NCT01839331|65912761|FG001|Overall Study|Protocol Violation|6|||
23595973|NCT01839331|65912762|FG002|Overall Study|Protocol Violation|4|||
23595974|NCT01839331|65912763|FG003|Overall Study|Protocol Violation|3|||
23595975|NCT03714815|65912764|FG000|Overall Study|Physician Decision|2|||
23595976|NCT03714815|65912764|FG000|Overall Study|Withdrawal by Subject|2|||
23595977|NCT03714815|65912764|FG000|Overall Study|Death|11|||
23595978|NCT00535145|65912767|FG000|Phase I|Adverse Event|3|||
23595979|NCT00535145|65912767|FG000|Phase I|Lost to Follow-up|7|||
23645265|NCT03647488|66086984|FG000|Overall Study|Clinical progression|2|||
23645266|NCT03647488|66086985|FG001|Overall Study|Clinical progression|0|||
23800410|NCT00700817|66646775|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
23595980|NCT00535145|65912767|FG000|Phase I|Withdrawal by Subject|6|||
23595981|NCT00535145|65912767|FG000|Phase I|(eligibility)|8|||
23595982|NCT00535145|65912767|FG000|Phase I|(protocol violation)|1|||
23595983|NCT00535145|65912767|FG000|Phase I|(PI decision)|1|||
23595984|NCT00535145|65912767|FG000|Phase I|(diagnosis)|3|||
23595985|NCT00535145|65912767|FG000|Phase II|Adverse Event|2|||
23595986|NCT00535145|65912767|FG000|Phase II|Lack of Efficacy|1|||
23595987|NCT00535145|65912767|FG000|Phase II|Lost to Follow-up|5|||
23595988|NCT00535145|65912767|FG000|Phase II|Withdrawal by Subject|5|||
23595989|NCT00535145|65912767|FG000|Phase II|Subject non-compliance|2|||
23595990|NCT00495677|65912768|FG000|Stage 1 (25 Days)|Adverse Event|0|||
23595991|NCT00495677|65912769|FG001|Stage 1 (25 Days)|Adverse Event|0|||
23800411|NCT00700817|66646776|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23800412|NCT00700817|66646777|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23800413|NCT00700817|66646773|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
23800414|NCT00700817|66646774|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
23595992|NCT00495677|65912770|FG002|Stage 1 (25 Days)|Adverse Event|1|||
23595993|NCT00495677|65912771|FG003|Stage 1 (25 Days)|Adverse Event|0|||
23595994|NCT00495677|65912772|FG004|Stage 1 (25 Days)|Adverse Event|0|||
23595995|NCT00495677|65912773|FG005|Stage 1 (25 Days)|Adverse Event|0|||
23595996|NCT00495677|65912774|FG006|Stage 1 (25 Days)|Adverse Event|0|||
23595997|NCT00031694|65912777|FG000|Overall Study|Adverse Event|12|||
23595998|NCT00031694|65912777|FG000|Overall Study|Death|2|||
23800415|NCT00700817|66646775|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
23800416|NCT00700817|66646776|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
23800417|NCT00700817|66646777|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
23800418|NCT00700817|66646773|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
23800419|NCT00700817|66646774|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
23800420|NCT00700817|66646775|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
23800421|NCT00700817|66646776|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
23800422|NCT00700817|66646777|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
23800423|NCT00700817|66646773|FG000|Week 0-26 (Main Period)|Unclassified|14|||
23800424|NCT00700817|66646774|FG001|Week 0-26 (Main Period)|Unclassified|4|||
23800425|NCT00700817|66646775|FG002|Week 0-26 (Main Period)|Unclassified|8|||
23800426|NCT00700817|66646776|FG003|Week 0-26 (Main Period)|Unclassified|0|||
23800427|NCT00700817|66646777|FG004|Week 0-26 (Main Period)|Unclassified|0|||
23800428|NCT00700817|66646773|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
23800429|NCT00700817|66646774|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
23800430|NCT00700817|66646775|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
23800431|NCT00700817|66646776|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
23800432|NCT00700817|66646777|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
23800433|NCT00700817|66646773|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
23800434|NCT00700817|66646774|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
23800435|NCT00700817|66646775|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
23800436|NCT00700817|66646776|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
23800437|NCT00700817|66646777|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
23800438|NCT00700817|66646773|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
23800439|NCT00700817|66646774|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
23800440|NCT00700817|66646775|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
23800441|NCT00700817|66646776|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
23800442|NCT00700817|66646777|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
23800443|NCT00700817|66646773|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
23800444|NCT00700817|66646774|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
23800445|NCT00700817|66646775|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
23800446|NCT00700817|66646776|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
23800447|NCT00700817|66646777|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
23800448|NCT00700817|66646773|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
23800449|NCT00700817|66646774|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
23800450|NCT00700817|66646775|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
23800451|NCT00700817|66646776|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
23800452|NCT00700817|66646777|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
23800453|NCT00700817|66646773|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23800454|NCT00700817|66646774|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
23800455|NCT00700817|66646775|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23800456|NCT00700817|66646776|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
23800457|NCT00700817|66646777|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23800458|NCT00700817|66646773|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23800459|NCT00700817|66646774|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
23800460|NCT00700817|66646775|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
23800461|NCT00700817|66646776|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23800462|NCT00700817|66646777|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23800463|NCT00700817|66646773|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
23800464|NCT00700817|66646774|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
23800465|NCT00700817|66646775|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23800466|NCT00700817|66646776|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23800467|NCT00700817|66646777|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23800468|NCT00700817|66646773|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
23800469|NCT00700817|66646774|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
23800470|NCT00700817|66646775|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
23800471|NCT00700817|66646776|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
23800472|NCT00700817|66646777|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
23800473|NCT00700817|66646773|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
23800474|NCT00700817|66646774|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
23595999|NCT00031694|65912777|FG000|Overall Study|Withdrawal by Subject|5|||
23596000|NCT01872078|65912780|FG000|Overall Study|Adverse Event|0|||
23596001|NCT01872078|65912781|FG001|Overall Study|Adverse Event|0|||
23596002|NCT01872078|65912782|FG002|Overall Study|Adverse Event|1|||
23596003|NCT01872078|65912783|FG003|Overall Study|Adverse Event|0|||
23596004|NCT01872078|65912780|FG000|Overall Study|Dose administration non-compliance|0|||
23596005|NCT01872078|65912781|FG001|Overall Study|Dose administration non-compliance|0|||
23645267|NCT03647488|66086986|FG002|Overall Study|Clinical progression|0|||
23645268|NCT03647488|66086984|FG000|Overall Study|Participant refused to take investigational product|1|||
23645269|NCT03647488|66086985|FG001|Overall Study|Participant refused to take investigational product|0|||
23645270|NCT03647488|66086986|FG002|Overall Study|Participant refused to take investigational product|0|||
23645271|NCT00232544|66086989|FG000|Overall Study|Lost to Follow-up|20|||
23800475|NCT00700817|66646775|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
23800476|NCT00700817|66646776|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
23800477|NCT00700817|66646777|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
23800478|NCT01857206|66646778|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
23800479|NCT01857206|66646779|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
23800480|NCT01857206|66646778|FG000|Overall Study|Lost to Follow-up|9|||
23800481|NCT01857206|66646779|FG001|Overall Study|Lost to Follow-up|6|||
23800482|NCT01857206|66646778|FG000|Overall Study|Unclassified|3|||
23800483|NCT01857206|66646779|FG001|Overall Study|Unclassified|3|||
23800484|NCT01857206|66646778|FG000|Overall Study|Withdrawal by Subject|1|||
23800485|NCT01857206|66646779|FG001|Overall Study|Withdrawal by Subject|0|||
23800486|NCT01020526|66646783|FG000|Overall Study|Withdrawal by Subject|5|||
23800487|NCT01020526|66646783|FG000|Overall Study|Other reasons|3|||
23800488|NCT01020526|66646783|FG000|Overall Study|Insufficient clinical response|3|||
23800489|NCT01020526|66646783|FG000|Overall Study|Lost to Follow-up|1|||
23800490|NCT01020526|66646783|FG000|Overall Study|Adverse Event|2|||
23596006|NCT01872078|65912782|FG002|Overall Study|Dose administration non-compliance|0|||
23645272|NCT00232544|66086990|FG001|Overall Study|Lost to Follow-up|15|||
23645273|NCT01967147|66086991|FG000|Overall Study|Adverse Event|5|||
23645274|NCT01967147|66086992|FG001|Overall Study|Adverse Event|2|||
23645275|NCT01967147|66086991|FG000|Overall Study|Lack of Efficacy|1|||
23645276|NCT01967147|66086992|FG001|Overall Study|Lack of Efficacy|4|||
23645277|NCT01967147|66086991|FG000|Overall Study|Lost to Follow-up|1|||
23645278|NCT01967147|66086992|FG001|Overall Study|Lost to Follow-up|2|||
23645279|NCT01967147|66086991|FG000|Overall Study|Withdrawal by Subject|2|||
23645280|NCT01967147|66086992|FG001|Overall Study|Withdrawal by Subject|4|||
23645281|NCT01967147|66086991|FG000|Overall Study|Non-compliance with Study Drug|0|||
23645282|NCT01967147|66086992|FG001|Overall Study|Non-compliance with Study Drug|3|||
23645283|NCT01967147|66086991|FG000|Overall Study|Other|4|||
23645284|NCT01967147|66086992|FG001|Overall Study|Other|5|||
23645285|NCT02585232|66086993|FG000|Overall Study|Lost to Follow-up|8|||
23645286|NCT02585232|66086994|FG001|Overall Study|Lost to Follow-up|8|||
23645287|NCT02585232|66086993|FG000|Overall Study|Withdrawal by Subject|4|||
23645288|NCT02585232|66086994|FG001|Overall Study|Withdrawal by Subject|8|||
23645289|NCT02724969|66086995|FG000|Overall Study|Lost to Follow-up|12|||
23645290|NCT02724969|66086996|FG001|Overall Study|Lost to Follow-up|6|||
23645291|NCT02724969|66086995|FG000|Overall Study|Withdrawal by Subject|3|||
23645292|NCT02724969|66086996|FG001|Overall Study|Withdrawal by Subject|3|||
23645293|NCT02724969|66086995|FG000|Overall Study|Infant demise|0|||
23645294|NCT02724969|66086996|FG001|Overall Study|Infant demise|2|||
23645295|NCT00069108|66087000|FG000|Overall Study|Withdrawal by Subject|5|||
23645296|NCT00069108|66087001|FG001|Overall Study|Withdrawal by Subject|9|||
23645297|NCT00069108|66087000|FG000|Overall Study|Adverse Event|64|||
23645298|NCT00069108|66087001|FG001|Overall Study|Adverse Event|42|||
23645299|NCT00069108|66087000|FG000|Overall Study|Death|6|||
23645300|NCT00069108|66087001|FG001|Overall Study|Death|6|||
23645301|NCT00069108|66087000|FG000|Overall Study|Administration|15|||
23800491|NCT04776746|66646784|FG000|Overall Study|Study terminated by sponsor|61|||
23800492|NCT04776746|66646784|FG000|Overall Study|Adverse Event|5|||
23596007|NCT01872078|65912783|FG003|Overall Study|Dose administration non-compliance|1|||
23596008|NCT01872078|65912780|FG000|Overall Study|Protocol Violation|0|||
23645302|NCT00069108|66087001|FG001|Overall Study|Administration|4|||
23645303|NCT00069108|66087000|FG000|Overall Study|Insufficient therapy|117|||
23596009|NCT01872078|65912781|FG001|Overall Study|Protocol Violation|0|||
23645304|NCT00069108|66087001|FG001|Overall Study|Insufficient therapy|144|||
23645305|NCT00069108|66087000|FG000|Overall Study|Violation criteria|1|||
23645306|NCT00069108|66087001|FG001|Overall Study|Violation criteria|4|||
23645307|NCT00069108|66087000|FG000|Overall Study|Refused treatment|5|||
23645308|NCT00069108|66087001|FG001|Overall Study|Refused treatment|10|||
23800493|NCT04776746|66646784|FG000|Overall Study|Death|4|||
23645309|NCT00467285|66087003|FG000|Overall Study|Lost to Follow-up|4|||
23800494|NCT04776746|66646784|FG000|Overall Study|Lack of Efficacy|3|||
23800495|NCT04776746|66646784|FG000|Overall Study|Noncompliance with study drug|2|||
23478158|NCT01903252|65494464|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
23478159|NCT01903252|65494465|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
23800496|NCT04776746|66646784|FG000|Overall Study|Not related to COVID-19|2|||
23800497|NCT01552369|66646785|FG000|Overall Study|Did not consent to extended follow up|8|||
23800498|NCT01552369|66646786|FG001|Overall Study|Did not consent to extended follow up|9|||
23800499|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
23800500|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
23800501|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
23800502|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
23800503|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
23800504|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
23800505|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
23800506|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
23800507|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
23800508|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
23800509|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
23800510|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
23800511|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
23800512|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
23800513|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
23800514|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
23800515|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
23800516|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
23800517|NCT00384293|66646791|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
23800518|NCT00384293|66646792|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
23800519|NCT00384293|66646793|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
23800520|NCT00384293|66646791|FG000|Post-randomization Period|Adverse Event|0|||
23800521|NCT00384293|66646792|FG001|Post-randomization Period|Adverse Event|23|||
23800522|NCT00384293|66646793|FG002|Post-randomization Period|Adverse Event|7|||
23800523|NCT00384293|66646791|FG000|Post-randomization Period|Lost to Follow-up|0|||
23800524|NCT00384293|66646792|FG001|Post-randomization Period|Lost to Follow-up|2|||
23800525|NCT00384293|66646793|FG002|Post-randomization Period|Lost to Follow-up|1|||
23800526|NCT00384293|66646791|FG000|Post-randomization Period|Protocol Violation|0|||
23800527|NCT00384293|66646792|FG001|Post-randomization Period|Protocol Violation|1|||
23800528|NCT00384293|66646793|FG002|Post-randomization Period|Protocol Violation|0|||
23800529|NCT00384293|66646791|FG000|Post-randomization Period|Withdrawal by Subject|0|||
23800530|NCT00384293|66646792|FG001|Post-randomization Period|Withdrawal by Subject|8|||
23800531|NCT00384293|66646793|FG002|Post-randomization Period|Withdrawal by Subject|6|||
23800532|NCT00384293|66646791|FG000|Post-randomization Period|Trial Termination|0|||
23800533|NCT00384293|66646792|FG001|Post-randomization Period|Trial Termination|180|||
23800534|NCT00384293|66646793|FG002|Post-randomization Period|Trial Termination|204|||
23800535|NCT00384293|66646791|FG000|Post-randomization Period|Patient Randomized in Error|0|||
23800536|NCT00384293|66646792|FG001|Post-randomization Period|Patient Randomized in Error|0|||
23800537|NCT00384293|66646793|FG002|Post-randomization Period|Patient Randomized in Error|1|||
23800538|NCT01220609|66646794|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
23800539|NCT01220609|66646794|FG000|Overall Study|Ineligible- Wrong cell type|1|||
23800540|NCT01220609|66646794|FG000|Overall Study|Ineligible-Never treated|1|||
23800541|NCT00412737|66646795|FG000|Overall Study|Death|1|||
23800542|NCT00412737|66646796|FG001|Overall Study|Death|0|||
23800543|NCT00412737|66646795|FG000|Overall Study|Adverse Event|3|||
23800544|NCT00412737|66646796|FG001|Overall Study|Adverse Event|2|||
23800545|NCT00412737|66646795|FG000|Overall Study|Refused Treatment|6|||
23800546|NCT00412737|66646796|FG001|Overall Study|Refused Treatment|2|||
23360330|NCT01601496|65062906|FG000|Overall Study|Other: patient refusal to continue|3|||
23360331|NCT01429298|65062907|FG000|Overall Study|Protocol Violation|4|||
23360332|NCT01429298|65062908|FG001|Overall Study|Protocol Violation|6|||
23360333|NCT01497067|65062913|FG000|Overall Study|Lost to Follow-up|56|||
23360334|NCT01497067|65062913|FG000|Overall Study|Adverse Event|3|||
23360335|NCT01497067|65062913|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
23360336|NCT01497067|65062913|FG000|Overall Study|Other|13|||
23360337|NCT01939223|65062914|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
23478160|NCT01903252|65494466|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
23478161|NCT01903252|65494461|FG000|Maintenance, Open-Label|Other|0|||
23596010|NCT01872078|65912782|FG002|Overall Study|Protocol Violation|1|||
23596011|NCT01872078|65912783|FG003|Overall Study|Protocol Violation|0|||
23596012|NCT01872078|65912780|FG000|Overall Study|Withdrawal by Subject|0|||
23360338|NCT01939223|65062915|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
23645310|NCT00467285|66087004|FG001|Overall Study|Lost to Follow-up|4|||
23645311|NCT02128542|66087005|FG000|Overall Study|Lost to Follow-up|3|||
23645312|NCT02128542|66087006|FG001|Overall Study|Lost to Follow-up|0|||
23645313|NCT02128542|66087005|FG000|Overall Study|Withdrew Consent|1|||
23645314|NCT02128542|66087006|FG001|Overall Study|Withdrew Consent|0|||
23645315|NCT03484273|66087007|FG000|Overall Study|Equipment Malfunction|1|||
23645316|NCT03484273|66087007|FG000|Overall Study|Data excluded from analysis|1|||
23645317|NCT02706899|66087008|FG000|Overall Study|Withdrawal by Subject|1|||
23645318|NCT02706899|66087009|FG001|Overall Study|Withdrawal by Subject|0|||
23800547|NCT00412737|66646795|FG000|Overall Study|Failure to Return|6|||
23800548|NCT00412737|66646796|FG001|Overall Study|Failure to Return|2|||
23800549|NCT00084799|66646797|FG000|Overall Study|Disease Progression|1|||
23596013|NCT01872078|65912781|FG001|Overall Study|Withdrawal by Subject|0|||
23596014|NCT01872078|65912782|FG002|Overall Study|Withdrawal by Subject|1|||
23596015|NCT01872078|65912783|FG003|Overall Study|Withdrawal by Subject|0|||
23596016|NCT01872078|65912780|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
23596017|NCT01872078|65912781|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
23596018|NCT01872078|65912782|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
23596019|NCT01872078|65912783|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
23596020|NCT01188655|65912784|FG000|Overall Study|Lack of Efficacy|1|||
23596021|NCT01188655|65912784|FG000|Overall Study|Lost to Follow-up|1|||
23596022|NCT01188655|65912784|FG000|Overall Study|Other|11|||
23596023|NCT00205179|65912785|FG000|Overall Study|Death|0|||
23596024|NCT00205179|65912786|FG001|Overall Study|Death|2|||
23596025|NCT00205179|65912785|FG000|Overall Study|Physician Decision|1|||
23596026|NCT00205179|65912786|FG001|Overall Study|Physician Decision|1|||
23596027|NCT00205179|65912785|FG000|Overall Study|Adverse Event|1|||
23596028|NCT00205179|65912786|FG001|Overall Study|Adverse Event|1|||
23596029|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Death|186|||
23596030|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Death|222|||
23596031|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Death|0|||
23596032|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
23596033|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
23596034|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
23596035|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
23596036|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
23596037|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
23596038|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
23596039|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
23596040|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
23596041|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Adverse Event|83|||
23596042|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Adverse Event|100|||
23596043|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Adverse Event|0|||
23596044|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Other|70|||
23596045|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Other|75|||
23596046|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Other|0|||
23596047|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
23596048|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
23645319|NCT02706899|66087008|FG000|Overall Study|Death|8|||
23800550|NCT00084799|66646798|FG001|Overall Study|Disease Progression|0|||
23800551|NCT00895037|66646800|FG000|Overall Study|Death|0|||
23800552|NCT00895037|66646801|FG001|Overall Study|Death|2|||
23800553|NCT00895037|66646802|FG002|Overall Study|Death|1|||
23800554|NCT00418522|66646804|FG000|Overall Study|Adverse Event|7|||
23800555|NCT00418522|66646805|FG001|Overall Study|Adverse Event|1|||
23800556|NCT00418522|66646804|FG000|Overall Study|Lack of Efficacy|1|||
23800557|NCT00418522|66646805|FG001|Overall Study|Lack of Efficacy|3|||
23800558|NCT00418522|66646804|FG000|Overall Study|Lost to Follow-up|10|||
23596049|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
23596050|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
23596051|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
23596052|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
23596053|NCT00232180|65912789|FG000|Open Label Phase|Death|0|||
23596054|NCT00232180|65912790|FG001|Open Label Phase|Death|0|||
23596055|NCT00232180|65912791|FG002|Open Label Phase|Death|48|||
23596056|NCT00232180|65912789|FG000|Open Label Phase|Lost to Follow-up|0|||
23645320|NCT02706899|66087009|FG001|Overall Study|Death|0|||
23645321|NCT02706899|66087008|FG000|Overall Study|Study Termination by Sponsor|4|||
23800559|NCT00418522|66646805|FG001|Overall Study|Lost to Follow-up|4|||
23596057|NCT00232180|65912790|FG001|Open Label Phase|Lost to Follow-up|0|||
23596058|NCT00232180|65912791|FG002|Open Label Phase|Lost to Follow-up|5|||
23596059|NCT00232180|65912789|FG000|Open Label Phase|Protocol Violation|0|||
23596060|NCT00232180|65912790|FG001|Open Label Phase|Protocol Violation|0|||
23596061|NCT00232180|65912791|FG002|Open Label Phase|Protocol Violation|3|||
23596062|NCT00232180|65912789|FG000|Open Label Phase|Study terminated by sponsor|0|||
23596063|NCT00232180|65912790|FG001|Open Label Phase|Study terminated by sponsor|0|||
23596064|NCT00232180|65912791|FG002|Open Label Phase|Study terminated by sponsor|3|||
23596065|NCT00232180|65912789|FG000|Open Label Phase|Withdrawal by Subject|0|||
23596066|NCT00232180|65912790|FG001|Open Label Phase|Withdrawal by Subject|0|||
23596067|NCT00232180|65912791|FG002|Open Label Phase|Withdrawal by Subject|37|||
23596068|NCT00232180|65912789|FG000|Open Label Phase|Other|0|||
23596069|NCT00232180|65912790|FG001|Open Label Phase|Other|0|||
23596070|NCT00232180|65912791|FG002|Open Label Phase|Other|16|||
23596071|NCT00232180|65912789|FG000|Open Label Phase|Adverse Event|0|||
23596072|NCT00232180|65912790|FG001|Open Label Phase|Adverse Event|0|||
23596073|NCT00232180|65912791|FG002|Open Label Phase|Adverse Event|25|||
23596074|NCT00232180|65912789|FG000|Open Label Phase|Laboratory abnormality|0|||
23596075|NCT00232180|65912790|FG001|Open Label Phase|Laboratory abnormality|0|||
23596076|NCT00232180|65912791|FG002|Open Label Phase|Laboratory abnormality|10|||
23596077|NCT00232180|65912789|FG000|Open Label Phase|Randomized but not treated|0|||
23596078|NCT00232180|65912790|FG001|Open Label Phase|Randomized but not treated|0|||
23596079|NCT00232180|65912791|FG002|Open Label Phase|Randomized but not treated|1|||
23596080|NCT00703820|65912795|FG000|Overall Study|Adverse Event|12|||
23596081|NCT00703820|65912796|FG001|Overall Study|Adverse Event|17|||
23596082|NCT00703820|65912795|FG000|Overall Study|Death|5|||
23596083|NCT00703820|65912796|FG001|Overall Study|Death|0|||
23596084|NCT00703820|65912795|FG000|Overall Study|Lack of Efficacy|11|||
23596085|NCT00703820|65912796|FG001|Overall Study|Lack of Efficacy|11|||
23596086|NCT00703820|65912795|FG000|Overall Study|Received non-protocol therapy|1|||
23596087|NCT00703820|65912796|FG001|Overall Study|Received non-protocol therapy|0|||
23596088|NCT00703820|65912795|FG000|Overall Study|Physician Decision|4|||
23478162|NCT01903252|65494462|FG001|Maintenance, Open-Label|Other|0|||
23596089|NCT00703820|65912796|FG001|Overall Study|Physician Decision|5|||
23596090|NCT00703820|65912795|FG000|Overall Study|Withdrawal by Subject|2|||
23596091|NCT00703820|65912796|FG001|Overall Study|Withdrawal by Subject|1|||
23596092|NCT01414738|65912797|FG000|Overall Study|Death|26|||
23596093|NCT01414738|65912797|FG000|Overall Study|Refused testing|5|||
23596094|NCT01414738|65912797|FG000|Overall Study|Lost to Follow-up|2|||
23596095|NCT01414738|65912797|FG000|Overall Study|Refused, disease progression|8|||
23596096|NCT01414738|65912797|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
23596097|NCT01808339|65912798|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596098|NCT01808339|65912799|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596099|NCT01808339|65912800|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596100|NCT01808339|65912801|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596101|NCT01808339|65912802|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
23596102|NCT01808339|65912803|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596103|NCT01808339|65912798|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596104|NCT01808339|65912799|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23596105|NCT01808339|65912800|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596106|NCT01808339|65912801|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23596107|NCT01808339|65912802|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23478163|NCT01903252|65494463|FG002|Maintenance, Open-Label|Other|0|||
23478164|NCT01903252|65494464|FG003|Maintenance, Open-Label|Other|2|||
23478165|NCT01903252|65494465|FG004|Maintenance, Open-Label|Other|6|||
23478166|NCT01903252|65494466|FG005|Maintenance, Open-Label|Other|2|||
23478167|NCT00729469|65494467|FG000|Overall Study|Adverse Event|14|||
23478168|NCT00729469|65494468|FG001|Overall Study|Adverse Event|25|||
23478169|NCT00729469|65494467|FG000|Overall Study|Lost to Follow-up|9|||
23478170|NCT00729469|65494468|FG001|Overall Study|Lost to Follow-up|9|||
23478171|NCT00729469|65494467|FG000|Overall Study|Protocol Violation|2|||
23478172|NCT00729469|65494468|FG001|Overall Study|Protocol Violation|1|||
23478173|NCT00729469|65494467|FG000|Overall Study|Withdrawal by Subject|19|||
23478174|NCT00729469|65494468|FG001|Overall Study|Withdrawal by Subject|8|||
23478175|NCT00729469|65494467|FG000|Overall Study|Other-Not mentioned|9|||
23478176|NCT00729469|65494468|FG001|Overall Study|Other-Not mentioned|4|||
23478177|NCT04224688|65494469|FG000|Overall Study|Withdrawal by Subject|1|||
23478178|NCT04224688|65494470|FG001|Overall Study|Withdrawal by Subject|3|||
23478179|NCT04224688|65494469|FG000|Overall Study|Lack of Efficacy|1|||
23478180|NCT04224688|65494470|FG001|Overall Study|Lack of Efficacy|1|||
23478181|NCT04224688|65494469|FG000|Overall Study|Adverse event, not fatal|0|||
23478182|NCT04224688|65494470|FG001|Overall Study|Adverse event, not fatal|2|||
23478183|NCT04224688|65494469|FG000|Overall Study|COVID-19|0|||
23478184|NCT04224688|65494470|FG001|Overall Study|COVID-19|1|||
23478185|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
23478186|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
23478187|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
23478188|NCT02536404|65494472|FG000|Overall Study|Adverse Event|5|||
23478189|NCT02536404|65494473|FG001|Overall Study|Adverse Event|0|||
23645322|NCT02706899|66087009|FG001|Overall Study|Study Termination by Sponsor|6|||
23645323|NCT01970345|66087010|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23645324|NCT01970345|66087011|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23645325|NCT01970345|66087010|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
23645326|NCT01970345|66087011|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23645327|NCT02374671|66087015|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
23645328|NCT02374671|66087016|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
23645329|NCT02374671|66087017|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
23645330|NCT02374671|66087015|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
23645331|NCT02374671|66087016|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
23645332|NCT02374671|66087017|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
23645333|NCT02374671|66087015|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
23645334|NCT02374671|66087016|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
23645335|NCT02374671|66087017|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
23645336|NCT02374671|66087015|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
23645337|NCT02374671|66087016|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
23645338|NCT02374671|66087017|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
23645339|NCT02374671|66087015|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
23645340|NCT02374671|66087016|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23645341|NCT02374671|66087017|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23645342|NCT00833261|66087020|FG000|Overall Study|Withdrawal by Subject|4|||
23800560|NCT00418522|66646804|FG000|Overall Study|Withdrawal by Subject|31|||
23800561|NCT00418522|66646805|FG001|Overall Study|Withdrawal by Subject|7|||
23800562|NCT00418522|66646804|FG000|Overall Study|Other|27|||
23478190|NCT02536404|65494472|FG000|Overall Study|Withdrawal by Subject|4|||
23478191|NCT02536404|65494473|FG001|Overall Study|Withdrawal by Subject|1|||
23478192|NCT02536404|65494472|FG000|Overall Study|Physician Decision|10|||
23478193|NCT02536404|65494473|FG001|Overall Study|Physician Decision|0|||
23478194|NCT02536404|65494472|FG000|Overall Study|Sponsor decision|1|||
23478195|NCT02536404|65494473|FG001|Overall Study|Sponsor decision|0|||
23478196|NCT02285062|65494474|FG000|Pre-Treatment Period|Protocol Violation|0|||
23478197|NCT02285062|65494475|FG001|Pre-Treatment Period|Protocol Violation|2|||
23478198|NCT02285062|65494474|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23478199|NCT02285062|65494475|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23478200|NCT00995566|65494482|FG000|Overall Study|Adverse Event|2|||
23478201|NCT00995566|65494482|FG000|Overall Study|Early study termination|52|||
23478202|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
23478203|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Adverse Event|9|||
23478204|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Death|4|||
23478205|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
23645343|NCT01145898|66087021|FG000|3-year Treatment|medication change by treating physician|3|||
23645344|NCT01145898|66087022|FG001|3-year Treatment|medication change by treating physician|16|||
23645345|NCT00605215|66087023|FG000|Overall Study|Death|0|||
23645346|NCT00605215|66087024|FG001|Overall Study|Death|0|||
23645347|NCT00605215|66087025|FG002|Overall Study|Death|1|||
23645348|NCT00605215|66087023|FG000|Overall Study|Adverse Event|19|||
23645349|NCT00605215|66087024|FG001|Overall Study|Adverse Event|21|||
23596108|NCT01808339|65912803|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596109|NCT01808339|65912798|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596110|NCT01808339|65912799|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596111|NCT01808339|65912800|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596112|NCT01808339|65912801|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596113|NCT01808339|65912802|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596114|NCT01808339|65912803|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596115|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596116|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596117|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
23596118|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596119|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
23596120|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
23596121|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
23596122|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
23596123|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23596124|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23645350|NCT00605215|66087025|FG002|Overall Study|Adverse Event|26|||
23800563|NCT00418522|66646805|FG001|Overall Study|Other|23|||
23360339|NCT01939223|65062914|FG000|Overall Study|Disease recurrence (radiological)|1|||
23360340|NCT01939223|65062915|FG001|Overall Study|Disease recurrence (radiological)|3|||
23360341|NCT01939223|65062914|FG000|Overall Study|Study stopped by Sponsor|5|||
23360342|NCT01939223|65062915|FG001|Overall Study|Study stopped by Sponsor|7|||
23360343|NCT01939223|65062914|FG000|Overall Study|Withdrawal by Subject|6|||
23360344|NCT01939223|65062915|FG001|Overall Study|Withdrawal by Subject|0|||
23360345|NCT04039204|65062916|FG000|Overall Study|Withdrawal by Subject|0|||
23478206|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
23478207|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
23478208|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Death|1|||
23478209|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
23478210|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
23478211|NCT03005873|65494492|FG000|Overall Study|Prohibited medication use post radnomization|1|||
23478212|NCT03005873|65494493|FG001|Overall Study|Prohibited medication use post radnomization|1|||
23478213|NCT03005873|65494494|FG002|Overall Study|Prohibited medication use post radnomization|1|||
23478214|NCT03005873|65494492|FG000|Overall Study|Withdrew consent|0|||
23478215|NCT03005873|65494493|FG001|Overall Study|Withdrew consent|1|||
23478216|NCT03005873|65494494|FG002|Overall Study|Withdrew consent|2|||
23478217|NCT03005873|65494492|FG000|Overall Study|Lost to Follow-up|0|||
23478218|NCT03005873|65494493|FG001|Overall Study|Lost to Follow-up|1|||
23478219|NCT03005873|65494494|FG002|Overall Study|Lost to Follow-up|0|||
23478220|NCT03005873|65494492|FG000|Overall Study|Ineligible post randomization|0|||
23478221|NCT03005873|65494493|FG001|Overall Study|Ineligible post randomization|0|||
23478222|NCT03005873|65494494|FG002|Overall Study|Ineligible post randomization|1|||
23478223|NCT00811642|65494500|FG000|Overall Study|Adverse Event|3|||
23478224|NCT00811642|65494500|FG000|Overall Study|Protocol Violation|1|||
23478225|NCT00811642|65494500|FG000|Overall Study|Death|2|||
23478226|NCT00811642|65494500|FG000|Overall Study|Withdrawal by Subject|7|||
23478227|NCT00811642|65494500|FG000|Overall Study|Cumulative use of antifungal agent|2|||
23478228|NCT02434471|65494501|FG000|Overall Study|Physician Decision|9|||
23360346|NCT04039204|65062917|FG001|Overall Study|Withdrawal by Subject|2|||
23360347|NCT05464420|65062924|FG000|Overall Study|Death|0|||
23360348|NCT05464420|65062925|FG001|Overall Study|Death|0|||
23360349|NCT05464420|65062926|FG002|Overall Study|Death|0|||
23360350|NCT05464420|65062927|FG003|Overall Study|Death|1|||
23478229|NCT03473548|65494504|FG000|Overall Study|Did not attempt HST testing|3|||
23478230|NCT03473548|65494505|FG001|Overall Study|Did not attempt HST testing|0|||
23478231|NCT04250077|65494507|FG000|Overall Study|Withdrawal by Subject|0|||
23360351|NCT05464420|65062924|FG000|Overall Study|Lost to Follow-up|16|||
23360352|NCT05464420|65062925|FG001|Overall Study|Lost to Follow-up|11|||
23360353|NCT05464420|65062926|FG002|Overall Study|Lost to Follow-up|11|||
23360354|NCT05464420|65062927|FG003|Overall Study|Lost to Follow-up|11|||
23360355|NCT05464420|65062924|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
23360356|NCT05464420|65062925|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
23360357|NCT05464420|65062926|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
23360358|NCT05464420|65062927|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
23360359|NCT05464420|65062924|FG000|Overall Study|Withdrawal by Subject|4|||
23360360|NCT05464420|65062925|FG001|Overall Study|Withdrawal by Subject|8|||
23360361|NCT05464420|65062926|FG002|Overall Study|Withdrawal by Subject|3|||
23360362|NCT05464420|65062927|FG003|Overall Study|Withdrawal by Subject|1|||
23360363|NCT05464420|65062924|FG000|Overall Study|Protocol Violation|0|||
23360364|NCT05464420|65062925|FG001|Overall Study|Protocol Violation|0|||
23360365|NCT05464420|65062926|FG002|Overall Study|Protocol Violation|1|||
23645351|NCT00605215|66087023|FG000|Overall Study|Refusal to sign the re-consent form|8|||
23645352|NCT00605215|66087024|FG001|Overall Study|Refusal to sign the re-consent form|3|||
23645353|NCT00605215|66087025|FG002|Overall Study|Refusal to sign the re-consent form|3|||
23645354|NCT00605215|66087023|FG000|Overall Study|Withdrawal by Subject|39|||
23645355|NCT00605215|66087024|FG001|Overall Study|Withdrawal by Subject|37|||
23360366|NCT05464420|65062927|FG003|Overall Study|Protocol Violation|1|||
23360367|NCT05464420|65062924|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
23360368|NCT05464420|65062925|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
23360369|NCT05464420|65062926|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
23360370|NCT05464420|65062927|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
23360371|NCT03252145|65062928|FG000|Overall Study|Withdrawal by Subject|1|||
23645356|NCT00605215|66087025|FG002|Overall Study|Withdrawal by Subject|27|||
23645357|NCT00605215|66087023|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
23645358|NCT00605215|66087024|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
23645359|NCT00605215|66087025|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
23645360|NCT00605215|66087023|FG000|Overall Study|Protocol Violation|3|||
23645361|NCT00605215|66087024|FG001|Overall Study|Protocol Violation|4|||
23645362|NCT00605215|66087025|FG002|Overall Study|Protocol Violation|1|||
23645363|NCT00605215|66087023|FG000|Overall Study|Pregnancy|8|||
23645364|NCT00605215|66087024|FG001|Overall Study|Pregnancy|5|||
23645365|NCT00605215|66087025|FG002|Overall Study|Pregnancy|4|||
23645366|NCT00605215|66087023|FG000|Overall Study|Lost to Follow-up|8|||
23645367|NCT00605215|66087024|FG001|Overall Study|Lost to Follow-up|5|||
23645368|NCT00605215|66087025|FG002|Overall Study|Lost to Follow-up|2|||
23645369|NCT00605215|66087023|FG000|Overall Study|Other than specified|0|||
23645370|NCT00605215|66087024|FG001|Overall Study|Other than specified|2|||
23645371|NCT00605215|66087025|FG002|Overall Study|Other than specified|1|||
23800564|NCT00418522|66646804|FG000|Overall Study|Randomized but did not receive treatment|7|||
23800565|NCT00418522|66646805|FG001|Overall Study|Randomized but did not receive treatment|4|||
23800566|NCT00966381|66646808|FG000|Overall Study|Withdrawal by Subject|2|||
23800567|NCT00966381|66646809|FG001|Overall Study|Withdrawal by Subject|2|||
23360372|NCT03252145|65062929|FG001|Overall Study|Withdrawal by Subject|0|||
23800568|NCT02792218|66646810|FG000|Overall Study|Patient/guardian decision|15|||
23360373|NCT03252145|65062928|FG000|Overall Study|Complicating Disease|1|||
23645372|NCT04447846|66087026|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
23645373|NCT01060540|66087027|FG000|Overall Study|Withdrawal by Subject|10|||
23645374|NCT01060540|66087028|FG001|Overall Study|Withdrawal by Subject|20|||
23645375|NCT01060540|66087027|FG000|Overall Study|Lost to Follow-up|52|||
23645376|NCT01060540|66087028|FG001|Overall Study|Lost to Follow-up|43|||
23645377|NCT01060540|66087027|FG000|Overall Study|Death|2|||
23645378|NCT01060540|66087028|FG001|Overall Study|Death|1|||
23645379|NCT01060540|66087027|FG000|Overall Study|Physician Decision|0|||
23645380|NCT01060540|66087028|FG001|Overall Study|Physician Decision|1|||
23645381|NCT02457559|66087029|FG000|Overall Study|Progressive Disease|1|||
23645382|NCT02457559|66087030|FG001|Overall Study|Progressive Disease|2|||
23645383|NCT02457559|66087031|FG002|Overall Study|Progressive Disease|3|||
23645384|NCT02457559|66087032|FG003|Overall Study|Progressive Disease|0|||
23645385|NCT02457559|66087033|FG004|Overall Study|Progressive Disease|0|||
23645386|NCT02457559|66087034|FG005|Overall Study|Progressive Disease|2|||
23645387|NCT02457559|66087035|FG006|Overall Study|Progressive Disease|1|||
23645388|NCT02457559|66087036|FG007|Overall Study|Progressive Disease|0|||
23645389|NCT02457559|66087037|FG008|Overall Study|Progressive Disease|1|||
23645390|NCT02457559|66087038|FG009|Overall Study|Progressive Disease|1|||
23645391|NCT02457559|66087039|FG010|Overall Study|Progressive Disease|1|||
23645392|NCT02457559|66087029|FG000|Overall Study|Investigator's Discretion|0|||
23596125|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
23596126|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23596127|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596128|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596129|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
23596130|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596131|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
23596132|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
23596133|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
23596134|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
23596135|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
23596136|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
23645393|NCT02457559|66087030|FG001|Overall Study|Investigator's Discretion|0|||
23645394|NCT02457559|66087031|FG002|Overall Study|Investigator's Discretion|2|||
23645395|NCT02457559|66087032|FG003|Overall Study|Investigator's Discretion|0|||
23645396|NCT02457559|66087033|FG004|Overall Study|Investigator's Discretion|1|||
23645397|NCT02457559|66087034|FG005|Overall Study|Investigator's Discretion|0|||
23645398|NCT02457559|66087035|FG006|Overall Study|Investigator's Discretion|1|||
23645399|NCT02457559|66087036|FG007|Overall Study|Investigator's Discretion|0|||
23645400|NCT02457559|66087037|FG008|Overall Study|Investigator's Discretion|1|||
23360374|NCT03252145|65062929|FG001|Overall Study|Complicating Disease|2|||
23360375|NCT02466971|65062930|FG000|Overall Study|eligible and never treated|14|||
23360376|NCT02466971|65062931|FG001|Overall Study|eligible and never treated|20|||
23360377|NCT02466971|65062930|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
23360378|NCT02466971|65062931|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
23360379|NCT02466971|65062930|FG000|Overall Study|ineligible and treated|1|||
23360380|NCT02466971|65062931|FG001|Overall Study|ineligible and treated|0|||
23360381|NCT02466971|65062930|FG000|Overall Study|ineligible and never treated|0|||
23645401|NCT02457559|66087038|FG009|Overall Study|Investigator's Discretion|0|||
23645402|NCT02457559|66087039|FG010|Overall Study|Investigator's Discretion|1|||
23645403|NCT02457559|66087029|FG000|Overall Study|Adverse Event|0|||
23645404|NCT02457559|66087030|FG001|Overall Study|Adverse Event|1|||
23360382|NCT02466971|65062931|FG001|Overall Study|ineligible and never treated|1|||
23360383|NCT00215644|65062940|FG000|Overall Study|Disease Progression|28|||
23596137|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
23596138|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
23645405|NCT02457559|66087031|FG002|Overall Study|Adverse Event|2|||
23645406|NCT02457559|66087032|FG003|Overall Study|Adverse Event|0|||
23645407|NCT02457559|66087033|FG004|Overall Study|Adverse Event|0|||
23645408|NCT02457559|66087034|FG005|Overall Study|Adverse Event|0|||
23645409|NCT02457559|66087035|FG006|Overall Study|Adverse Event|0|||
23645410|NCT02457559|66087036|FG007|Overall Study|Adverse Event|0|||
23645411|NCT02457559|66087037|FG008|Overall Study|Adverse Event|0|||
23645412|NCT02457559|66087038|FG009|Overall Study|Adverse Event|0|||
23645413|NCT02457559|66087039|FG010|Overall Study|Adverse Event|0|||
23645414|NCT02457559|66087029|FG000|Overall Study|Reason not Specified|1|||
23645415|NCT02457559|66087030|FG001|Overall Study|Reason not Specified|0|||
23645416|NCT02457559|66087031|FG002|Overall Study|Reason not Specified|0|||
23645417|NCT02457559|66087032|FG003|Overall Study|Reason not Specified|0|||
23800569|NCT02792218|66646811|FG001|Overall Study|Patient/guardian decision|42|||
23800570|NCT02792218|66646810|FG000|Overall Study|Adverse Event|15|||
23800571|NCT02792218|66646811|FG001|Overall Study|Adverse Event|14|||
23800572|NCT02792218|66646810|FG000|Overall Study|Lost to Follow-up|10|||
23800573|NCT02792218|66646811|FG001|Overall Study|Lost to Follow-up|5|||
23800574|NCT02792218|66646810|FG000|Overall Study|Lack of Efficacy|1|||
23800575|NCT02792218|66646811|FG001|Overall Study|Lack of Efficacy|12|||
23800576|NCT02792218|66646810|FG000|Overall Study|Physician Decision|4|||
23800577|NCT02792218|66646811|FG001|Overall Study|Physician Decision|4|||
23800578|NCT02792218|66646810|FG000|Overall Study|Protocol deviation|3|||
23596139|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596140|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596141|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596142|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
23596143|NCT01017146|65912811|FG000|Overall Study|Adverse Event|11|||
23596144|NCT01017146|65912812|FG001|Overall Study|Adverse Event|1|||
23596145|NCT01017146|65912811|FG000|Overall Study|Lost to Follow-up|14|||
23596146|NCT01017146|65912812|FG001|Overall Study|Lost to Follow-up|14|||
23596147|NCT01017146|65912811|FG000|Overall Study|Noncompliance with Study Product|1|||
23596148|NCT01017146|65912812|FG001|Overall Study|Noncompliance with Study Product|1|||
23596149|NCT01017146|65912811|FG000|Overall Study|Withdrawal by Subject|32|||
23596150|NCT01017146|65912812|FG001|Overall Study|Withdrawal by Subject|16|||
23596151|NCT01017146|65912811|FG000|Overall Study|Relocation|0|||
23596152|NCT01017146|65912812|FG001|Overall Study|Relocation|4|||
23596153|NCT01017146|65912811|FG000|Overall Study|Pregnancy|2|||
23596154|NCT01017146|65912812|FG001|Overall Study|Pregnancy|1|||
23596155|NCT01017146|65912811|FG000|Overall Study|Protocol Violation|2|||
23596156|NCT01017146|65912812|FG001|Overall Study|Protocol Violation|0|||
23596157|NCT01017146|65912811|FG000|Overall Study|Took Excluded Medication|2|||
23596158|NCT01017146|65912812|FG001|Overall Study|Took Excluded Medication|0|||
23596159|NCT01017146|65912811|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23596160|NCT01017146|65912812|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23596161|NCT01017146|65912811|FG000|Overall Study|Change in Work Situation|1|||
23596162|NCT01017146|65912812|FG001|Overall Study|Change in Work Situation|0|||
23596163|NCT03950622|65912813|FG000|Overall Study|Withdrawal by Subject|1|||
23596164|NCT03950622|65912814|FG001|Overall Study|Withdrawal by Subject|0|||
23596165|NCT03950622|65912813|FG000|Overall Study|Protocol Deviation|0|||
23596166|NCT03950622|65912814|FG001|Overall Study|Protocol Deviation|1|||
23596167|NCT03950622|65912813|FG000|Overall Study|Physician Decision|1|||
23596168|NCT03950622|65912814|FG001|Overall Study|Physician Decision|0|||
23596169|NCT03950622|65912813|FG000|Overall Study|Lost to Follow-up|5|||
23596170|NCT03950622|65912814|FG001|Overall Study|Lost to Follow-up|5|||
23596171|NCT03950622|65912813|FG000|Overall Study|Death|1|||
23596172|NCT03950622|65912814|FG001|Overall Study|Death|1|||
23596173|NCT02079844|65912815|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
23596174|NCT02079844|65912816|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
23596175|NCT02079844|65912817|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
23596176|NCT02079844|65912815|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
23596177|NCT02079844|65912816|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
23596178|NCT02079844|65912817|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
23596179|NCT01264679|65912818|FG000|Overall Study|Participation in Another Clinical Trial|1|||
23596180|NCT01264679|65912818|FG000|Overall Study|Physician Decision|1|||
23596181|NCT01264679|65912818|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
23596182|NCT01264679|65912818|FG000|Overall Study|Withdrawal by Subject|1|||
23596183|NCT02318134|65912819|FG000|Overall Study|Withdrawal by Subject|2|||
23596184|NCT02318134|65912820|FG001|Overall Study|Withdrawal by Subject|1|||
23596185|NCT01049503|65912825|FG000|Overall Study|Lost to Follow-up|11|||
23596186|NCT01049503|65912826|FG001|Overall Study|Lost to Follow-up|12|||
23596187|NCT01049503|65912827|FG002|Overall Study|Lost to Follow-up|24|||
23596188|NCT01049503|65912828|FG003|Overall Study|Lost to Follow-up|26|||
23596189|NCT01049503|65912829|FG004|Overall Study|Lost to Follow-up|27|||
23596190|NCT01049503|65912830|FG005|Overall Study|Lost to Follow-up|8|||
23596191|NCT03840902|65912833|FG000|Overall Study|Randomized but not treated|1|||
23596192|NCT03840902|65912834|FG001|Overall Study|Randomized but not treated|1|||
23645418|NCT02457559|66087033|FG004|Overall Study|Reason not Specified|0|||
23645419|NCT02457559|66087034|FG005|Overall Study|Reason not Specified|0|||
23645420|NCT02457559|66087035|FG006|Overall Study|Reason not Specified|0|||
23645421|NCT02457559|66087036|FG007|Overall Study|Reason not Specified|0|||
23645422|NCT02457559|66087037|FG008|Overall Study|Reason not Specified|0|||
23596193|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
23645423|NCT02457559|66087038|FG009|Overall Study|Reason not Specified|2|||
23645424|NCT02457559|66087039|FG010|Overall Study|Reason not Specified|0|||
23645425|NCT02457559|66087029|FG000|Overall Study|Death|0|||
23645426|NCT02457559|66087030|FG001|Overall Study|Death|0|||
23645427|NCT02457559|66087031|FG002|Overall Study|Death|0|||
23596194|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
23596195|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
23596196|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
23596197|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
23596198|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
23596199|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
23596200|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
23596201|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
23645428|NCT02457559|66087032|FG003|Overall Study|Death|0|||
23645429|NCT02457559|66087033|FG004|Overall Study|Death|0|||
23596202|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
23596203|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
23596204|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
23596205|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
23596206|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
23596207|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
23596208|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
23596209|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
23596210|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
23596211|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
23596212|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
23645430|NCT02457559|66087034|FG005|Overall Study|Death|0|||
23645431|NCT02457559|66087035|FG006|Overall Study|Death|0|||
23645432|NCT02457559|66087036|FG007|Overall Study|Death|0|||
23645433|NCT02457559|66087037|FG008|Overall Study|Death|1|||
23645434|NCT02457559|66087038|FG009|Overall Study|Death|1|||
23645435|NCT02457559|66087039|FG010|Overall Study|Death|0|||
23645436|NCT02689518|66087042|FG000|Overall Study|Withdrawal by Subject|3|||
23645437|NCT00986973|66087043|FG000|Overall Study|Withdrawn by study team|1|||
23645438|NCT00790751|66087044|FG000|Overall Study|Protocol non-compliance|16|||
23596213|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
23596214|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
23596215|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
23596216|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
23596217|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
23596218|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
23596219|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
23596220|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
23596221|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
23596222|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
23596223|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
23596224|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
23645439|NCT00790751|66087045|FG001|Overall Study|Protocol non-compliance|16|||
23645440|NCT00790751|66087046|FG002|Overall Study|Protocol non-compliance|10|||
23360384|NCT00215644|65062941|FG001|Overall Study|Disease Progression|10|||
23596225|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
23596226|NCT01622868|65912841|FG000|Overall Study|Protocol Violation|7|||
23596227|NCT01622868|65912842|FG001|Overall Study|Protocol Violation|0|||
23596228|NCT04956575|65912852|FG000|Overall Study|Death|1|||
23596229|NCT04956575|65912853|FG001|Overall Study|Death|0|||
23596230|NCT04956575|65912854|FG002|Overall Study|Death|0|||
23596231|NCT04956575|65912855|FG003|Overall Study|Death|0|||
23596232|NCT04956575|65912856|FG004|Overall Study|Death|0|||
23596233|NCT04956575|65912857|FG005|Overall Study|Death|0|||
23596234|NCT04956575|65912858|FG006|Overall Study|Death|0|||
23596235|NCT04956575|65912859|FG007|Overall Study|Death|1|||
23596236|NCT04956575|65912860|FG008|Overall Study|Death|0|||
23596237|NCT04956575|65912861|FG009|Overall Study|Death|1|||
23596238|NCT04956575|65912862|FG010|Overall Study|Death|0|||
23596239|NCT04956575|65912863|FG011|Overall Study|Death|0|||
23596240|NCT04956575|65912852|FG000|Overall Study|Lost to Follow-up|3|||
23596241|NCT04956575|65912853|FG001|Overall Study|Lost to Follow-up|4|||
23596242|NCT04956575|65912854|FG002|Overall Study|Lost to Follow-up|2|||
23596243|NCT04956575|65912855|FG003|Overall Study|Lost to Follow-up|3|||
23596244|NCT04956575|65912856|FG004|Overall Study|Lost to Follow-up|1|||
23596245|NCT04956575|65912857|FG005|Overall Study|Lost to Follow-up|10|||
23596246|NCT04956575|65912858|FG006|Overall Study|Lost to Follow-up|11|||
23596247|NCT04956575|65912859|FG007|Overall Study|Lost to Follow-up|7|||
23596248|NCT04956575|65912860|FG008|Overall Study|Lost to Follow-up|4|||
23596249|NCT04956575|65912861|FG009|Overall Study|Lost to Follow-up|2|||
23596250|NCT04956575|65912862|FG010|Overall Study|Lost to Follow-up|3|||
23596251|NCT04956575|65912863|FG011|Overall Study|Lost to Follow-up|8|||
23596252|NCT04956575|65912852|FG000|Overall Study|Withdrawal by Subject|1|||
23596253|NCT04956575|65912853|FG001|Overall Study|Withdrawal by Subject|2|||
23596254|NCT04956575|65912854|FG002|Overall Study|Withdrawal by Subject|1|||
23596255|NCT04956575|65912855|FG003|Overall Study|Withdrawal by Subject|4|||
23596256|NCT04956575|65912856|FG004|Overall Study|Withdrawal by Subject|2|||
23596257|NCT04956575|65912857|FG005|Overall Study|Withdrawal by Subject|8|||
23596258|NCT04956575|65912858|FG006|Overall Study|Withdrawal by Subject|5|||
23596259|NCT04956575|65912859|FG007|Overall Study|Withdrawal by Subject|1|||
23596260|NCT04956575|65912860|FG008|Overall Study|Withdrawal by Subject|1|||
23596261|NCT04956575|65912861|FG009|Overall Study|Withdrawal by Subject|0|||
23596262|NCT04956575|65912862|FG010|Overall Study|Withdrawal by Subject|3|||
23596263|NCT04956575|65912863|FG011|Overall Study|Withdrawal by Subject|1|||
23596264|NCT02224924|65912866|FG000|Overall Study|Withdrawal by Subject|7|||
23596265|NCT02224924|65912867|FG001|Overall Study|Withdrawal by Subject|6|||
23596266|NCT02224924|65912866|FG000|Overall Study|Biopsy cancelled|20|||
23596267|NCT02224924|65912867|FG001|Overall Study|Biopsy cancelled|14|||
23596268|NCT02224924|65912866|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
23596269|NCT02224924|65912867|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
23596270|NCT02224924|65912866|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
23596271|NCT02224924|65912867|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
23596272|NCT01613716|65912875|FG000|Overall Study|screen failures|3|||
23596273|NCT01613716|65912875|FG000|Overall Study|Lost to Follow-up|4|||
23596274|NCT03912831|65912878|FG000|Overall Study|Death|1|||
23596275|NCT03912831|65912879|FG001|Overall Study|Death|1|||
23596276|NCT03912831|65912880|FG002|Overall Study|Death|1|||
23596277|NCT03912831|65912881|FG003|Overall Study|Death|1|||
23596278|NCT03912831|65912882|FG004|Overall Study|Death|1|||
23596279|NCT03912831|65912883|FG005|Overall Study|Death|1|||
23596280|NCT03912831|65912878|FG000|Overall Study|Reason not Specified|0|||
23596281|NCT03912831|65912879|FG001|Overall Study|Reason not Specified|0|||
23596282|NCT03912831|65912880|FG002|Overall Study|Reason not Specified|0|||
23596283|NCT03912831|65912881|FG003|Overall Study|Reason not Specified|0|||
23596284|NCT03912831|65912882|FG004|Overall Study|Reason not Specified|1|||
23596285|NCT03912831|65912883|FG005|Overall Study|Reason not Specified|0|||
23596286|NCT03912831|65912878|FG000|Overall Study|Withdrawal by Participant|0|||
23596287|NCT03912831|65912879|FG001|Overall Study|Withdrawal by Participant|0|||
23596288|NCT03912831|65912880|FG002|Overall Study|Withdrawal by Participant|0|||
23596289|NCT03912831|65912881|FG003|Overall Study|Withdrawal by Participant|0|||
23596290|NCT03912831|65912882|FG004|Overall Study|Withdrawal by Participant|1|||
23596291|NCT03912831|65912883|FG005|Overall Study|Withdrawal by Participant|0|||
23596292|NCT02814838|65912884|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
23596293|NCT02814838|65912885|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
23596294|NCT02814838|65912884|FG000|Overall Study|Consent withdrawal|1|||
23800579|NCT02792218|66646811|FG001|Overall Study|Protocol deviation|2|||
23596295|NCT02814838|65912885|FG001|Overall Study|Consent withdrawal|1|||
23596296|NCT04766034|65912886|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596297|NCT04766034|65912887|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596298|NCT04766034|65912888|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596299|NCT04766034|65912889|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596300|NCT04766034|65912890|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
23645441|NCT00790751|66087047|FG003|Overall Study|Protocol non-compliance|11|||
23645442|NCT00790751|66087044|FG000|Overall Study|Lost to Follow-up|4|||
23645443|NCT00790751|66087045|FG001|Overall Study|Lost to Follow-up|9|||
23645444|NCT00790751|66087046|FG002|Overall Study|Lost to Follow-up|4|||
23645445|NCT00790751|66087047|FG003|Overall Study|Lost to Follow-up|5|||
23645446|NCT00790751|66087044|FG000|Overall Study|Adverse Event|5|||
23645447|NCT00790751|66087045|FG001|Overall Study|Adverse Event|3|||
23645448|NCT00790751|66087046|FG002|Overall Study|Adverse Event|5|||
23645449|NCT00790751|66087047|FG003|Overall Study|Adverse Event|4|||
23645450|NCT00790751|66087044|FG000|Overall Study|Requirement for restricted medication|0|||
23645451|NCT00790751|66087045|FG001|Overall Study|Requirement for restricted medication|2|||
23645452|NCT00790751|66087046|FG002|Overall Study|Requirement for restricted medication|0|||
23645453|NCT00790751|66087047|FG003|Overall Study|Requirement for restricted medication|0|||
23645454|NCT00790751|66087044|FG000|Overall Study|Death|0|||
23645455|NCT00790751|66087045|FG001|Overall Study|Death|0|||
23645456|NCT00790751|66087046|FG002|Overall Study|Death|1|||
23645457|NCT00790751|66087047|FG003|Overall Study|Death|0|||
23645458|NCT00790751|66087044|FG000|Overall Study|Physician Decision|0|||
23645459|NCT00790751|66087045|FG001|Overall Study|Physician Decision|0|||
23645460|NCT00790751|66087046|FG002|Overall Study|Physician Decision|0|||
23645461|NCT00790751|66087047|FG003|Overall Study|Physician Decision|1|||
23645462|NCT00432666|66087048|FG000|Main Period|Adverse Event|1|||
23596301|NCT04766034|65912886|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23645463|NCT00432666|66087049|FG001|Main Period|Adverse Event|1|||
23645464|NCT00432666|66087048|FG000|Main Period|Consent Withdrawn|1|||
23645465|NCT00432666|66087049|FG001|Main Period|Consent Withdrawn|0|||
23645466|NCT00432666|66087048|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
23645467|NCT00432666|66087049|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
23645468|NCT00432666|66087048|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
23645469|NCT00432666|66087049|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23645470|NCT00432666|66087048|FG000|Open-Label Extension Period|Adverse Event|5|||
23645471|NCT00432666|66087049|FG001|Open-Label Extension Period|Adverse Event|0|||
23596302|NCT04766034|65912887|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596303|NCT04766034|65912888|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596304|NCT04766034|65912889|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596305|NCT04766034|65912890|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
23596306|NCT04766034|65912886|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
23596307|NCT04766034|65912887|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
23596308|NCT04766034|65912888|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
23596309|NCT04766034|65912889|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
23596310|NCT04766034|65912890|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
23596311|NCT04766034|65912886|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
23596312|NCT04766034|65912887|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
23596313|NCT04766034|65912888|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
23645472|NCT00432666|66087048|FG000|Open-Label Extension Period|Consent withdrawn|10|||
23645473|NCT00432666|66087049|FG001|Open-Label Extension Period|Consent withdrawn|0|||
23645474|NCT00432666|66087048|FG000|Open-Label Extension Period|Physician Decision|3|||
23645475|NCT00432666|66087049|FG001|Open-Label Extension Period|Physician Decision|0|||
23645476|NCT02146326|66087050|FG000|Overall Study|Lost to Follow-up|3|||
23645477|NCT02146326|66087051|FG001|Overall Study|Lost to Follow-up|3|||
23645478|NCT02146326|66087052|FG002|Overall Study|Lost to Follow-up|11|||
23645479|NCT02146326|66087053|FG003|Overall Study|Lost to Follow-up|19|||
23596314|NCT04766034|65912889|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
23596315|NCT04766034|65912890|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
23596316|NCT01095796|65912891|FG000|Overall Study|Randomized but Not Treated|5|||
23596317|NCT01095796|65912892|FG001|Overall Study|Randomized but Not Treated|2|||
23596318|NCT01095796|65912891|FG000|Overall Study|Adverse Event|9|||
23596319|NCT01095796|65912892|FG001|Overall Study|Adverse Event|19|||
23596320|NCT01095796|65912891|FG000|Overall Study|Death|3|||
23596321|NCT01095796|65912892|FG001|Overall Study|Death|2|||
23596322|NCT01095796|65912891|FG000|Overall Study|Pregnancy|2|||
23596323|NCT01095796|65912892|FG001|Overall Study|Pregnancy|0|||
23596324|NCT01095796|65912891|FG000|Overall Study|Lack of Efficacy|5|||
23596325|NCT01095796|65912892|FG001|Overall Study|Lack of Efficacy|3|||
23596326|NCT01095796|65912891|FG000|Overall Study|Investigator's Discretion|7|||
23596327|NCT01095796|65912892|FG001|Overall Study|Investigator's Discretion|2|||
23596328|NCT01095796|65912891|FG000|Overall Study|Withdrew Consent|16|||
23596329|NCT01095796|65912892|FG001|Overall Study|Withdrew Consent|22|||
23596330|NCT01095796|65912891|FG000|Overall Study|Lost to Follow-up|27|||
23596331|NCT01095796|65912892|FG001|Overall Study|Lost to Follow-up|29|||
23596332|NCT01095796|65912891|FG000|Overall Study|Participant Noncompliance|5|||
23596333|NCT01095796|65912892|FG001|Overall Study|Participant Noncompliance|10|||
23645480|NCT02146326|66087050|FG000|Overall Study|Withdrawal by Subject|2|||
23645481|NCT02146326|66087051|FG001|Overall Study|Withdrawal by Subject|1|||
23800580|NCT02792218|66646810|FG000|Overall Study|New therapy for study indication|0|||
23478232|NCT04250077|65494508|FG001|Overall Study|Withdrawal by Subject|1|||
23478233|NCT04250077|65494509|FG002|Overall Study|Withdrawal by Subject|0|||
23596334|NCT01095796|65912891|FG000|Overall Study|Protocol Violation|1|||
23596335|NCT01095796|65912892|FG001|Overall Study|Protocol Violation|0|||
23596336|NCT01095796|65912891|FG000|Overall Study|Participant Transferred to Another Study|215|||
23645482|NCT02146326|66087052|FG002|Overall Study|Withdrawal by Subject|15|||
23645483|NCT02146326|66087053|FG003|Overall Study|Withdrawal by Subject|11|||
23645484|NCT02146326|66087050|FG000|Overall Study|Separated from mental health center|23|||
23645485|NCT02146326|66087051|FG001|Overall Study|Separated from mental health center|33|||
23645486|NCT02146326|66087052|FG002|Overall Study|Separated from mental health center|0|||
23645487|NCT02146326|66087053|FG003|Overall Study|Separated from mental health center|0|||
23645488|NCT02146326|66087050|FG000|Overall Study|Incarcerated|0|||
23645489|NCT02146326|66087051|FG001|Overall Study|Incarcerated|0|||
23800581|NCT02792218|66646811|FG001|Overall Study|New therapy for study indication|1|||
23800582|NCT02792218|66646810|FG000|Overall Study|Non-compliance with study treatment|0|||
23596337|NCT01095796|65912892|FG001|Overall Study|Participant Transferred to Another Study|200|||
23800583|NCT02792218|66646811|FG001|Overall Study|Non-compliance with study treatment|1|||
23800584|NCT02792218|66646810|FG000|Overall Study|Pregnancy|1|||
23800585|NCT02792218|66646811|FG001|Overall Study|Pregnancy|0|||
23800586|NCT01613378|66646820|FG000|Overall Study|Lack of Efficacy|13|||
23800587|NCT01613378|66646820|FG000|Overall Study|Adverse Event|11|||
23800588|NCT01613378|66646820|FG000|Overall Study|Withdrawal by Subject|8|||
23800589|NCT01613378|66646820|FG000|Overall Study|Death|2|||
23800590|NCT01613378|66646820|FG000|Overall Study|Lost to Follow-up|1|||
23800591|NCT01613378|66646820|FG000|Overall Study|Other Reason|4|||
23800592|NCT00442546|66646821|FG000|Overall Study|Adverse Event|11|||
23800593|NCT00442546|66646822|FG001|Overall Study|Adverse Event|17|||
23800594|NCT00442546|66646823|FG002|Overall Study|Adverse Event|13|||
23800595|NCT00442546|66646821|FG000|Overall Study|Lost to Follow-up|1|||
23800596|NCT00442546|66646822|FG001|Overall Study|Lost to Follow-up|2|||
23800597|NCT00442546|66646823|FG002|Overall Study|Lost to Follow-up|1|||
23800598|NCT00442546|66646821|FG000|Overall Study|Other|4|||
23800599|NCT00442546|66646822|FG001|Overall Study|Other|9|||
23800600|NCT00442546|66646823|FG002|Overall Study|Other|6|||
23478234|NCT04250077|65494507|FG000|Overall Study|Lost to Follow-up|2|||
23800601|NCT00442546|66646821|FG000|Overall Study|Withdrawal by Subject|5|||
23800602|NCT00442546|66646822|FG001|Overall Study|Withdrawal by Subject|5|||
23478235|NCT04250077|65494508|FG001|Overall Study|Lost to Follow-up|3|||
23478236|NCT04250077|65494509|FG002|Overall Study|Lost to Follow-up|0|||
23596338|NCT02396316|65912895|FG000|Overall Study|Physician Decision|1|||
23596339|NCT02396316|65912896|FG001|Overall Study|Physician Decision|0|||
23596340|NCT02396316|65912895|FG000|Overall Study|Progressive disease|6|||
23800603|NCT00442546|66646823|FG002|Overall Study|Withdrawal by Subject|7|||
23596341|NCT02396316|65912896|FG001|Overall Study|Progressive disease|3|||
23596342|NCT02396316|65912895|FG000|Overall Study|Protocol Violation|0|||
23645490|NCT02146326|66087052|FG002|Overall Study|Incarcerated|3|||
23645491|NCT02146326|66087053|FG003|Overall Study|Incarcerated|8|||
23645492|NCT02146326|66087050|FG000|Overall Study|Death|0|||
23645493|NCT02146326|66087051|FG001|Overall Study|Death|0|||
23645494|NCT02146326|66087052|FG002|Overall Study|Death|4|||
23645495|NCT02146326|66087053|FG003|Overall Study|Death|4|||
23645496|NCT02146326|66087050|FG000|Overall Study|Unable to complete interview|0|||
23645497|NCT02146326|66087051|FG001|Overall Study|Unable to complete interview|0|||
23645498|NCT02146326|66087052|FG002|Overall Study|Unable to complete interview|10|||
23645499|NCT02146326|66087053|FG003|Overall Study|Unable to complete interview|6|||
23645500|NCT03866473|66087054|FG000|Phase 1|Death|1|||
23645501|NCT03866473|66087055|FG001|Phase 1|Death|0|||
23645502|NCT03866473|66087054|FG000|Phase 2|Death|0|||
23645503|NCT03866473|66087055|FG001|Phase 2|Death|2|||
23645504|NCT03866473|66087054|FG000|Phase 2|Dropped|1|||
23645505|NCT03866473|66087055|FG001|Phase 2|Dropped|1|||
23645506|NCT03866473|66087054|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
23645507|NCT03866473|66087055|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
23645508|NCT05718466|66087056|FG000|Overall Study|Withdrawal by Subject|1|||
23645509|NCT05718466|66087057|FG001|Overall Study|Withdrawal by Subject|2|||
23645510|NCT05718466|66087056|FG000|Overall Study|Death|0|||
23645511|NCT05718466|66087057|FG001|Overall Study|Death|1|||
23645512|NCT00522873|66087062|FG000|Overall Study|Adverse Event|41|||
23645513|NCT00522873|66087063|FG001|Overall Study|Adverse Event|26|||
23645514|NCT00522873|66087062|FG000|Overall Study|Withdrawal by Subject|20|||
23645515|NCT00522873|66087063|FG001|Overall Study|Withdrawal by Subject|9|||
23645516|NCT00522873|66087062|FG000|Overall Study|Protocol Violation|14|||
23645517|NCT00522873|66087063|FG001|Overall Study|Protocol Violation|4|||
23645518|NCT00522873|66087062|FG000|Overall Study|Lost to Follow-up|11|||
23645519|NCT00522873|66087063|FG001|Overall Study|Lost to Follow-up|3|||
23645520|NCT00522873|66087062|FG000|Overall Study|Personal Reasons|8|||
23645521|NCT00522873|66087063|FG001|Overall Study|Personal Reasons|1|||
23645522|NCT00522873|66087062|FG000|Overall Study|Medication Errors|1|||
23645523|NCT00522873|66087063|FG001|Overall Study|Medication Errors|1|||
23645524|NCT00522873|66087062|FG000|Overall Study|Never Received Medication|1|||
23645525|NCT00522873|66087063|FG001|Overall Study|Never Received Medication|0|||
23645526|NCT05323396|66087068|FG000|Overall Study|Lost to Follow-up|1|||
23645527|NCT05323396|66087069|FG001|Overall Study|Lost to Follow-up|31|||
23645528|NCT05323396|66087068|FG000|Overall Study|Pregnancy|1|||
23645529|NCT05323396|66087069|FG001|Overall Study|Pregnancy|0|||
23645530|NCT01675479|66087071|FG000|Overall Study|Lost to Follow-up|11|||
23645531|NCT02545933|66087072|FG000|Overall Study|Adverse Event|3|||
23645532|NCT02545933|66087073|FG001|Overall Study|Adverse Event|0|||
23645533|NCT02545933|66087074|FG002|Overall Study|Adverse Event|0|||
23645534|NCT02545933|66087072|FG000|Overall Study|Withdrawal by Subject|2|||
23645535|NCT02545933|66087073|FG001|Overall Study|Withdrawal by Subject|3|||
23645536|NCT02545933|66087074|FG002|Overall Study|Withdrawal by Subject|3|||
23645537|NCT02545933|66087072|FG000|Overall Study|Protocol Violation|1|||
23645538|NCT02545933|66087073|FG001|Overall Study|Protocol Violation|0|||
23645539|NCT02545933|66087074|FG002|Overall Study|Protocol Violation|1|||
23645540|NCT02047903|66087088|FG000|Overall Study|Adverse Event|14|||
23645541|NCT02047903|66087088|FG000|Overall Study|Serious adverse event|10|||
23645542|NCT02047903|66087088|FG000|Overall Study|Withdrawal by Subject|16|||
23645543|NCT02047903|66087088|FG000|Overall Study|Lost to Follow-up|4|||
23645544|NCT02047903|66087088|FG000|Overall Study|Reason not listed|6|||
23645545|NCT02047903|66087088|FG000|Overall Study|Not Treated|9|||
23596343|NCT02396316|65912896|FG001|Overall Study|Protocol Violation|1|||
23596344|NCT02396316|65912895|FG000|Overall Study|Treatment unblinded|0|||
23596345|NCT02396316|65912896|FG001|Overall Study|Treatment unblinded|1|||
23596346|NCT00925587|65912902|FG000|Overall Study|Protocol Specified Criteria|6|||
23596347|NCT00925587|65912903|FG001|Overall Study|Protocol Specified Criteria|6|||
23596348|NCT00925587|65912902|FG000|Overall Study|Physician Decision|4|||
23596349|NCT00925587|65912903|FG001|Overall Study|Physician Decision|1|||
23645546|NCT01191268|66087089|FG000|Overall Study|Withdrawal by Subject|19|||
23645547|NCT01191268|66087090|FG001|Overall Study|Withdrawal by Subject|25|||
23645548|NCT01191268|66087091|FG002|Overall Study|Withdrawal by Subject|21|||
23645549|NCT01191268|66087089|FG000|Overall Study|Adverse Event|21|||
23645550|NCT01191268|66087090|FG001|Overall Study|Adverse Event|13|||
23645551|NCT01191268|66087091|FG002|Overall Study|Adverse Event|8|||
23645552|NCT01191268|66087089|FG000|Overall Study|Physician Decision|6|||
23645553|NCT01191268|66087090|FG001|Overall Study|Physician Decision|8|||
23645554|NCT01191268|66087091|FG002|Overall Study|Physician Decision|9|||
23645555|NCT01191268|66087089|FG000|Overall Study|Lost to Follow-up|8|||
23645556|NCT01191268|66087090|FG001|Overall Study|Lost to Follow-up|5|||
23596350|NCT00925587|65912902|FG000|Overall Study|Protocol Violation|6|||
23645557|NCT01191268|66087091|FG002|Overall Study|Lost to Follow-up|9|||
23645558|NCT01191268|66087089|FG000|Overall Study|Entry Criteria Not Met|3|||
23478237|NCT02446171|65494510|FG000|Overall Study|Withdrawal by Subject|0|||
23478238|NCT02446171|65494511|FG001|Overall Study|Withdrawal by Subject|0|||
23478239|NCT02446171|65494512|FG002|Overall Study|Withdrawal by Subject|2|||
23478240|NCT02446171|65494513|FG003|Overall Study|Withdrawal by Subject|0|||
23478241|NCT02600871|65494514|FG000|Overall Study|Lost to Follow-up|13|||
23478242|NCT02600871|65494515|FG001|Overall Study|Lost to Follow-up|10|||
23478243|NCT00528970|65494516|FG000|Overall Study|Adverse Event|6|||
23478244|NCT00528970|65494517|FG001|Overall Study|Adverse Event|8|||
23478245|NCT00528970|65494518|FG002|Overall Study|Adverse Event|5|||
23478246|NCT00528970|65494516|FG000|Overall Study|Lost to Follow-up|0|||
23478247|NCT00528970|65494517|FG001|Overall Study|Lost to Follow-up|0|||
23478248|NCT00528970|65494518|FG002|Overall Study|Lost to Follow-up|1|||
23478249|NCT00528970|65494516|FG000|Overall Study|Other than specified|2|||
23478250|NCT00528970|65494517|FG001|Overall Study|Other than specified|3|||
23478251|NCT00528970|65494518|FG002|Overall Study|Other than specified|3|||
23478252|NCT00528970|65494516|FG000|Overall Study|Protocol Violation|2|||
23478253|NCT00528970|65494517|FG001|Overall Study|Protocol Violation|1|||
23478254|NCT00528970|65494518|FG002|Overall Study|Protocol Violation|4|||
23478255|NCT00528970|65494516|FG000|Overall Study|Lack of Efficacy|0|||
23478256|NCT00528970|65494517|FG001|Overall Study|Lack of Efficacy|0|||
23478257|NCT00528970|65494518|FG002|Overall Study|Lack of Efficacy|1|||
23478258|NCT00528970|65494516|FG000|Overall Study|Withdrawal by Subject|4|||
23478259|NCT00528970|65494517|FG001|Overall Study|Withdrawal by Subject|3|||
23478260|NCT00528970|65494518|FG002|Overall Study|Withdrawal by Subject|5|||
23478261|NCT00528970|65494516|FG000|Overall Study|Randomized but not treated|0|||
23478262|NCT00528970|65494517|FG001|Overall Study|Randomized but not treated|0|||
23478263|NCT00528970|65494518|FG002|Overall Study|Randomized but not treated|1|||
23478264|NCT04620798|65494519|FG000|Overall Study|Lost to Follow-up|126|||
23478265|NCT04620798|65494520|FG001|Overall Study|Lost to Follow-up|138|||
23478266|NCT01713933|65494521|FG000|Overall Study|Lost to Follow-up|2|||
23478267|NCT01713933|65494521|FG000|Overall Study|Withdrawal by Subject|3|||
23478268|NCT01713933|65494521|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
23478269|NCT02925416|65494523|FG000|Overall Study|Adverse Event|2|||
23478270|NCT02925416|65494524|FG001|Overall Study|Adverse Event|0|||
23478271|NCT00535288|65494525|FG000|Overall Study|Adverse Event|20|||
23478272|NCT00535288|65494526|FG001|Overall Study|Adverse Event|19|||
23478273|NCT00535288|65494527|FG002|Overall Study|Adverse Event|25|||
23478274|NCT00535288|65494528|FG003|Overall Study|Adverse Event|20|||
23478275|NCT00535288|65494529|FG004|Overall Study|Adverse Event|30|||
23478276|NCT00535288|65494525|FG000|Overall Study|Lost to Follow-up|0|||
23478277|NCT00535288|65494526|FG001|Overall Study|Lost to Follow-up|3|||
23478278|NCT00535288|65494527|FG002|Overall Study|Lost to Follow-up|0|||
23478279|NCT00535288|65494528|FG003|Overall Study|Lost to Follow-up|0|||
23478280|NCT00535288|65494529|FG004|Overall Study|Lost to Follow-up|0|||
23478281|NCT00535288|65494525|FG000|Overall Study|Lack of Efficacy|26|||
23478282|NCT00535288|65494526|FG001|Overall Study|Lack of Efficacy|3|||
23478283|NCT00535288|65494527|FG002|Overall Study|Lack of Efficacy|4|||
23478284|NCT00535288|65494528|FG003|Overall Study|Lack of Efficacy|4|||
23478285|NCT00535288|65494529|FG004|Overall Study|Lack of Efficacy|7|||
23478286|NCT00535288|65494525|FG000|Overall Study|Unwilling to cooperate|6|||
23478287|NCT00535288|65494526|FG001|Overall Study|Unwilling to cooperate|6|||
23478288|NCT00535288|65494527|FG002|Overall Study|Unwilling to cooperate|3|||
23478289|NCT00535288|65494528|FG003|Overall Study|Unwilling to cooperate|3|||
23478290|NCT00535288|65494529|FG004|Overall Study|Unwilling to cooperate|4|||
23478291|NCT00535288|65494525|FG000|Overall Study|Other|2|||
23478292|NCT00535288|65494526|FG001|Overall Study|Other|1|||
23478293|NCT00535288|65494527|FG002|Overall Study|Other|1|||
23478294|NCT00535288|65494528|FG003|Overall Study|Other|2|||
23478295|NCT00535288|65494529|FG004|Overall Study|Other|1|||
23478296|NCT00505778|65494530|FG000|Overall Study|Adverse Event|2|||
23645559|NCT01191268|66087090|FG001|Overall Study|Entry Criteria Not Met|1|||
23645560|NCT01191268|66087091|FG002|Overall Study|Entry Criteria Not Met|1|||
23478297|NCT00505778|65494531|FG001|Overall Study|Adverse Event|7|||
23478298|NCT00505778|65494530|FG000|Overall Study|Physician Decision|8|||
23478299|NCT00505778|65494531|FG001|Overall Study|Physician Decision|14|||
23478300|NCT00505778|65494530|FG000|Overall Study|Lost to Follow-up|17|||
23478301|NCT00505778|65494531|FG001|Overall Study|Lost to Follow-up|23|||
23478302|NCT00505778|65494530|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
23478303|NCT00505778|65494531|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
23478304|NCT00505778|65494530|FG000|Overall Study|Protocol Violation|7|||
23478305|NCT00505778|65494531|FG001|Overall Study|Protocol Violation|9|||
23478306|NCT00505778|65494530|FG000|Overall Study|Withdrawal by Subject|29|||
23478307|NCT00505778|65494531|FG001|Overall Study|Withdrawal by Subject|14|||
23478308|NCT00505778|65494530|FG000|Overall Study|Relapse|65|||
23478309|NCT00505778|65494531|FG001|Overall Study|Relapse|65|||
23478310|NCT00505778|65494530|FG000|Overall Study|Took No Study Drug|2|||
23478311|NCT00505778|65494531|FG001|Overall Study|Took No Study Drug|2|||
23478312|NCT00910624|65494532|FG000|Treatment Phase|Adverse Event|2|||
23478313|NCT00910624|65494533|FG001|Treatment Phase|Adverse Event|6|||
23596351|NCT00925587|65912903|FG001|Overall Study|Protocol Violation|4|||
23645561|NCT01191268|66087089|FG000|Overall Study|Death|0|||
23645562|NCT01191268|66087090|FG001|Overall Study|Death|1|||
23645563|NCT01191268|66087091|FG002|Overall Study|Death|3|||
23596352|NCT00925587|65912902|FG000|Overall Study|Withdrawal by Subject|9|||
23596353|NCT00925587|65912903|FG001|Overall Study|Withdrawal by Subject|6|||
23596354|NCT00925587|65912902|FG000|Overall Study|Death|5|||
23596355|NCT00925587|65912903|FG001|Overall Study|Death|5|||
23596356|NCT00925587|65912902|FG000|Overall Study|Adverse Event|6|||
23596357|NCT00925587|65912903|FG001|Overall Study|Adverse Event|2|||
23596358|NCT00925587|65912902|FG000|Overall Study|Lost to Follow-up|0|||
23596359|NCT00925587|65912903|FG001|Overall Study|Lost to Follow-up|1|||
23596360|NCT01084707|65912904|FG000|Overall Study|Withdrawal by Subject|6|||
23596361|NCT01765543|65912905|FG000|Overall Study|Death|1|||
23596362|NCT01765543|65912905|FG000|Overall Study|Withdrawal by Subject|2|||
23596363|NCT01198145|65912907|FG000|Overall Study|Withdrawal by Subject|1|||
23596364|NCT01198145|65912908|FG001|Overall Study|Withdrawal by Subject|1|||
23596365|NCT01616459|65912913|FG000|Overall Study|Adverse Event|1|||
23596366|NCT01616459|65912914|FG001|Overall Study|Adverse Event|1|||
23596367|NCT01616459|65912915|FG002|Overall Study|Adverse Event|2|||
23596368|NCT01616459|65912916|FG003|Overall Study|Adverse Event|0|||
23596369|NCT01616459|65912913|FG000|Overall Study|Lost to Follow-up|1|||
23596370|NCT01616459|65912914|FG001|Overall Study|Lost to Follow-up|11|||
23596371|NCT01616459|65912915|FG002|Overall Study|Lost to Follow-up|3|||
23596372|NCT01616459|65912916|FG003|Overall Study|Lost to Follow-up|2|||
23596373|NCT01616459|65912913|FG000|Overall Study|Protocol Violation|0|||
23596374|NCT01616459|65912914|FG001|Overall Study|Protocol Violation|0|||
23596375|NCT01616459|65912915|FG002|Overall Study|Protocol Violation|0|||
23596376|NCT01616459|65912916|FG003|Overall Study|Protocol Violation|2|||
23596377|NCT01616459|65912913|FG000|Overall Study|Withdrawal by Subject|2|||
23596378|NCT01616459|65912914|FG001|Overall Study|Withdrawal by Subject|4|||
23596379|NCT01616459|65912915|FG002|Overall Study|Withdrawal by Subject|4|||
23596380|NCT01616459|65912916|FG003|Overall Study|Withdrawal by Subject|4|||
23596381|NCT01616459|65912913|FG000|Overall Study|Other reason|0|||
23596382|NCT01616459|65912914|FG001|Overall Study|Other reason|1|||
23596383|NCT01616459|65912915|FG002|Overall Study|Other reason|1|||
23596384|NCT01616459|65912916|FG003|Overall Study|Other reason|0|||
23596385|NCT03454529|65912918|FG000|Overall Study|Did not receive treatment|6|||
23596386|NCT03454529|65912918|FG000|Overall Study|Received < 80% doses|1|||
23596387|NCT01149369|65912919|FG000|Overall Study|Adverse Event|6|||
23596388|NCT01149369|65912920|FG001|Overall Study|Adverse Event|3|||
23596389|NCT04056624|65912921|FG000|Overall Study|Withdrawal by Subject|0|||
23596390|NCT04056624|65912922|FG001|Overall Study|Withdrawal by Subject|0|||
23596391|NCT04056624|65912923|FG002|Overall Study|Withdrawal by Subject|1|||
23596392|NCT04056624|65912921|FG000|Overall Study|Protocol Violation|1|||
23596393|NCT04056624|65912922|FG001|Overall Study|Protocol Violation|2|||
23596394|NCT04056624|65912923|FG002|Overall Study|Protocol Violation|0|||
23596395|NCT01248936|65912926|FG000|Overall Study|Sponsor Decision|259|||
23596396|NCT01248936|65912926|FG000|Overall Study|Progression of Disease|50|||
23596397|NCT01248936|65912926|FG000|Overall Study|Death|26|||
23596398|NCT01248936|65912926|FG000|Overall Study|Withdrawal of Consent|20|||
23596399|NCT01248936|65912926|FG000|Overall Study|Adverse Event|8|||
23645564|NCT01191268|66087089|FG000|Overall Study|Protocol Violation|1|||
23596400|NCT01248936|65912926|FG000|Overall Study|Lost to Follow-up|7|||
23596401|NCT01248936|65912926|FG000|Overall Study|Refused Treatment|1|||
23596402|NCT01248936|65912926|FG000|Overall Study|Other reason|3|||
23596403|NCT02556138|65912928|FG000|Overall Study|Withdrawal by Subject|1|||
23596404|NCT00632203|65912929|FG000|Overall Study|Did not start study treatment|1|||
23596405|NCT00632203|65912930|FG001|Overall Study|Did not start study treatment|0|||
23596406|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596407|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596408|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
23596409|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596410|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
23596411|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596412|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596413|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596414|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596415|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596416|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
23596417|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596418|NCT00595413|65912939|FG000|Overall Study|Adverse Event|0|||
23596419|NCT00595413|65912940|FG001|Overall Study|Adverse Event|2|||
23596420|NCT00595413|65912941|FG002|Overall Study|Adverse Event|1|||
23596421|NCT00595413|65912942|FG003|Overall Study|Adverse Event|1|||
23596422|NCT00595413|65912939|FG000|Overall Study|Lost to Follow-up|2|||
23596423|NCT00595413|65912940|FG001|Overall Study|Lost to Follow-up|2|||
23596424|NCT00595413|65912941|FG002|Overall Study|Lost to Follow-up|1|||
23596425|NCT00595413|65912942|FG003|Overall Study|Lost to Follow-up|3|||
23596426|NCT00595413|65912939|FG000|Overall Study|Death|0|||
23596427|NCT00595413|65912940|FG001|Overall Study|Death|0|||
23596428|NCT00595413|65912941|FG002|Overall Study|Death|1|||
23596429|NCT00595413|65912942|FG003|Overall Study|Death|0|||
23596430|NCT00595413|65912939|FG000|Overall Study|Other|5|||
23596431|NCT00595413|65912940|FG001|Overall Study|Other|1|||
23596432|NCT00595413|65912941|FG002|Overall Study|Other|5|||
23596433|NCT00595413|65912942|FG003|Overall Study|Other|0|||
23596434|NCT00411216|65912950|FG000|Overall Study|Ten participants were entered into the c|0|||
23596435|NCT00411216|65912951|FG001|Overall Study|Ten participants were entered into the c|2|||
23596436|NCT00683696|65912954|FG000|Overall Study|Withdrawn due to study closure|337|||
23596437|NCT00683696|65912955|FG001|Overall Study|Withdrawn due to study closure|338|||
23596438|NCT00683696|65912954|FG000|Overall Study|Withdrawn prior to study closure|13|||
23596439|NCT00683696|65912955|FG001|Overall Study|Withdrawn prior to study closure|28|||
23596440|NCT00683696|65912954|FG000|Overall Study|Lost to Follow-up|5|||
23596441|NCT00683696|65912955|FG001|Overall Study|Lost to Follow-up|6|||
23596442|NCT00683696|65912954|FG000|Overall Study|Vital status follow-up only|3|||
23596443|NCT00683696|65912955|FG001|Overall Study|Vital status follow-up only|3|||
23596444|NCT00683696|65912954|FG000|Overall Study|Death|46|||
23596445|NCT00683696|65912955|FG001|Overall Study|Death|30|||
23596446|NCT00609336|65912956|FG000|Overall Study|Protocol Violation|3|||
23478314|NCT00910624|65494534|FG002|Treatment Phase|Adverse Event|6|||
23478315|NCT00910624|65494535|FG003|Treatment Phase|Adverse Event|0|||
23478316|NCT00910624|65494532|FG000|Treatment Phase|Treatment Failure|23|||
23478317|NCT00910624|65494533|FG001|Treatment Phase|Treatment Failure|10|||
23478318|NCT00910624|65494534|FG002|Treatment Phase|Treatment Failure|0|||
23645565|NCT01191268|66087090|FG001|Overall Study|Protocol Violation|0|||
23645566|NCT01191268|66087091|FG002|Overall Study|Protocol Violation|1|||
23645567|NCT01191268|66087089|FG000|Overall Study|Sponsor Decision|0|||
23645568|NCT01191268|66087090|FG001|Overall Study|Sponsor Decision|2|||
23645569|NCT01191268|66087091|FG002|Overall Study|Sponsor Decision|0|||
23645570|NCT00190749|66087092|FG000|Overall Study|Lost to Follow-up|8|||
23645571|NCT00190749|66087093|FG001|Overall Study|Lost to Follow-up|11|||
23645572|NCT00190749|66087092|FG000|Overall Study|Withdrawal by Subject|10|||
23645573|NCT00190749|66087093|FG001|Overall Study|Withdrawal by Subject|6|||
23645574|NCT00190749|66087092|FG000|Overall Study|Protocol Violation|5|||
23645575|NCT00190749|66087093|FG001|Overall Study|Protocol Violation|4|||
23645576|NCT00190749|66087092|FG000|Overall Study|Adverse Event|0|||
23645577|NCT00190749|66087093|FG001|Overall Study|Adverse Event|5|||
23478319|NCT00910624|65494535|FG003|Treatment Phase|Treatment Failure|0|||
23478320|NCT00910624|65494532|FG000|Treatment Phase|Lost to Follow-up|0|||
23478321|NCT00910624|65494533|FG001|Treatment Phase|Lost to Follow-up|0|||
23478322|NCT00910624|65494534|FG002|Treatment Phase|Lost to Follow-up|1|||
23645578|NCT00190749|66087092|FG000|Overall Study|Lack of Efficacy|2|||
23645579|NCT00190749|66087093|FG001|Overall Study|Lack of Efficacy|3|||
23645580|NCT00190749|66087092|FG000|Overall Study|Reason Not Specified|0|||
23478323|NCT00910624|65494535|FG003|Treatment Phase|Lost to Follow-up|0|||
23478324|NCT00910624|65494532|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
23478325|NCT00910624|65494533|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
23478326|NCT00910624|65494534|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
23478327|NCT00910624|65494535|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
23478328|NCT00910624|65494532|FG000|Treatment Phase|Withdrawal by Subject|2|||
23478329|NCT00910624|65494533|FG001|Treatment Phase|Withdrawal by Subject|1|||
23478330|NCT00910624|65494534|FG002|Treatment Phase|Withdrawal by Subject|0|||
23478331|NCT00910624|65494535|FG003|Treatment Phase|Withdrawal by Subject|0|||
23478332|NCT00910624|65494532|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
23478333|NCT00910624|65494533|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
23478334|NCT00910624|65494534|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
23478335|NCT00910624|65494535|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
23478336|NCT00910624|65494532|FG000|Follow-Up Phase|Adverse Event|0|||
23478337|NCT00910624|65494533|FG001|Follow-Up Phase|Adverse Event|0|||
23478338|NCT00910624|65494534|FG002|Follow-Up Phase|Adverse Event|1|||
23478339|NCT00910624|65494535|FG003|Follow-Up Phase|Adverse Event|0|||
23478340|NCT00910624|65494532|FG000|Follow-Up Phase|Lost to Follow-up|3|||
23478341|NCT00910624|65494533|FG001|Follow-Up Phase|Lost to Follow-up|1|||
23478342|NCT00910624|65494534|FG002|Follow-Up Phase|Lost to Follow-up|2|||
23645581|NCT00190749|66087093|FG001|Overall Study|Reason Not Specified|2|||
23645582|NCT00190749|66087092|FG000|Overall Study|Sponsor Decision|1|||
23360385|NCT00215644|65062940|FG000|Overall Study|Adverse Event|2|||
23478343|NCT00910624|65494535|FG003|Follow-Up Phase|Lost to Follow-up|0|||
23478344|NCT00910624|65494532|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
23478345|NCT00910624|65494533|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
23645583|NCT00190749|66087093|FG001|Overall Study|Sponsor Decision|0|||
23645584|NCT05543187|66087094|FG000|Overall Study|Ongoing|3|||
23478346|NCT00910624|65494534|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
23478347|NCT00910624|65494535|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
23478348|NCT00910624|65494532|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
23478349|NCT00910624|65494533|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23596447|NCT00609336|65912956|FG000|Overall Study|Death|1|||
23645585|NCT05543187|66087095|FG001|Overall Study|Ongoing|2|||
23478350|NCT00910624|65494534|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
23645586|NCT00468104|66087096|FG000|First Intervention|Protocol Violation|2|||
23596448|NCT00609336|65912956|FG000|Overall Study|LA or Met at Surgery|9|||
23596449|NCT01205048|65915587|FG000|Overall Study|Withdrawal by Subject|14|||
23596450|NCT01205048|65915587|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
23596451|NCT01205048|65915587|FG000|Overall Study|Lost to Follow-up|4|||
23596452|NCT01205048|65915587|FG000|Overall Study|Other|2|||
23596453|NCT03447249|65915588|FG000|Overall Study|Adverse Event|1|||
23596454|NCT03447249|65915589|FG001|Overall Study|Adverse Event|0|||
23596455|NCT03447249|65915588|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23596456|NCT03447249|65915589|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
23596457|NCT03447249|65915588|FG000|Overall Study|Other|3|||
23596458|NCT03447249|65915589|FG001|Overall Study|Other|0|||
23596459|NCT02422615|65915590|FG000|Treatment Period|Progressive disease|314|||
23596460|NCT02422615|65915591|FG001|Treatment Period|Progressive disease|200|||
23596461|NCT02422615|65915590|FG000|Treatment Period|Adverse Event|51|||
23596462|NCT02422615|65915591|FG001|Treatment Period|Adverse Event|9|||
23596463|NCT02422615|65915590|FG000|Treatment Period|Physician Decision|32|||
23596464|NCT02422615|65915591|FG001|Treatment Period|Physician Decision|8|||
23596465|NCT02422615|65915590|FG000|Treatment Period|Subject/guardian decision|38|||
23596466|NCT02422615|65915591|FG001|Treatment Period|Subject/guardian decision|8|||
23596467|NCT02422615|65915590|FG000|Treatment Period|Death|2|||
23596468|NCT02422615|65915591|FG001|Treatment Period|Death|1|||
23596469|NCT02422615|65915590|FG000|Treatment Period|Technical problems|0|||
23596470|NCT02422615|65915591|FG001|Treatment Period|Technical problems|1|||
23596471|NCT02422615|65915590|FG000|Treatment Period|Protocol deviation|1|||
23596472|NCT02422615|65915591|FG001|Treatment Period|Protocol deviation|1|||
23596473|NCT02422615|65915590|FG000|Treatment Period|Study terminated as per protocol|46|||
23596474|NCT02422615|65915591|FG001|Treatment Period|Study terminated as per protocol|14|||
23596475|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
23596476|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23596477|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Death|2|||
23596478|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23596479|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23596480|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23596481|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
23596482|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23596483|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
23596484|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
23596485|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
23596486|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
23596487|NCT02269475|65915592|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
23596488|NCT02269475|65915593|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
23596489|NCT02269475|65915592|FG000|Overall Study|Withdrawal by Subject|0|||
23596490|NCT02269475|65915593|FG001|Overall Study|Withdrawal by Subject|1|||
23596491|NCT01494922|65915594|FG000|Overall Study|Adverse Event|1|||
23596492|NCT00434304|65915596|FG000|Overall Study|Adverse Event|14|||
23596493|NCT00434304|65915596|FG000|Overall Study|Lack of Efficacy|2|||
23596494|NCT00434304|65915596|FG000|Overall Study|Withdrawal by Subject|4|||
23596495|NCT04512482|65915599|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
23596496|NCT04512482|65915600|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
23596497|NCT01063972|65915603|FG000|Overall Study|Death|12|||
23596498|NCT01063972|65915604|FG001|Overall Study|Death|11|||
23596499|NCT01063972|65915603|FG000|Overall Study|Incarcerated|2|||
23596500|NCT01063972|65915604|FG001|Overall Study|Incarcerated|1|||
23596501|NCT00274469|65915605|FG000|Overall Study|Death|63|||
23596502|NCT00274469|65915606|FG001|Overall Study|Death|74|||
23596503|NCT00274469|65915605|FG000|Overall Study|Did not consent to OS follow-up|16|||
23596504|NCT00274469|65915606|FG001|Overall Study|Did not consent to OS follow-up|19|||
23596505|NCT01421667|65915607|FG000|Overall Study|Withdrawal by Subject|0|||
23596506|NCT01421667|65915608|FG001|Overall Study|Withdrawal by Subject|1|||
23596507|NCT01421667|65915609|FG002|Overall Study|Withdrawal by Subject|2|||
23596508|NCT01421667|65915610|FG003|Overall Study|Withdrawal by Subject|1|||
23596509|NCT01421667|65915607|FG000|Overall Study|Lost to Follow-up|0|||
23596510|NCT01421667|65915608|FG001|Overall Study|Lost to Follow-up|1|||
23596511|NCT01421667|65915609|FG002|Overall Study|Lost to Follow-up|0|||
23596512|NCT01421667|65915610|FG003|Overall Study|Lost to Follow-up|0|||
23596513|NCT01388361|65915611|FG000|Overall Study|Adverse Event|0|||
23596514|NCT01388361|65915612|FG001|Overall Study|Adverse Event|5|||
23596515|NCT01388361|65915613|FG002|Overall Study|Adverse Event|1|||
23596516|NCT01388361|65915611|FG000|Overall Study|Protocol Violation|0|||
23596517|NCT01388361|65915612|FG001|Overall Study|Protocol Violation|0|||
23596518|NCT01388361|65915613|FG002|Overall Study|Protocol Violation|2|||
23596519|NCT01388361|65915611|FG000|Overall Study|Withdrawal criteria|12|||
23596520|NCT01388361|65915612|FG001|Overall Study|Withdrawal criteria|7|||
23596521|NCT01388361|65915613|FG002|Overall Study|Withdrawal criteria|10|||
23596522|NCT01388361|65915611|FG000|Overall Study|Unclassified|0|||
23596523|NCT01388361|65915612|FG001|Overall Study|Unclassified|0|||
23596524|NCT01388361|65915613|FG002|Overall Study|Unclassified|1|||
23596525|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
23596526|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
23596527|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
23596528|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
23596529|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
23596530|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
23596531|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
23596532|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
23596533|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
23596534|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
23596535|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
23596536|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
23596537|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
23596538|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
23596539|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
23596540|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
23596541|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
23596542|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
23596543|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
23596544|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
23596545|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
23596546|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
23596547|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
23596548|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
23596549|NCT00304031|65915616|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
23596550|NCT00304031|65915617|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
23596551|NCT00304031|65915618|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
23596552|NCT03580369|65915626|FG000|Overall Study|No treatment due to mis-randomization|1|||
23596553|NCT03580369|65915627|FG001|Overall Study|No treatment due to mis-randomization|0|||
23596554|NCT03580369|65915628|FG002|Overall Study|No treatment due to mis-randomization|0|||
23596555|NCT03580369|65915629|FG003|Overall Study|No treatment due to mis-randomization|0|||
23596556|NCT03580369|65915630|FG004|Overall Study|No treatment due to mis-randomization|3|||
23596557|NCT03580369|65915631|FG005|Overall Study|No treatment due to mis-randomization|0|||
23596558|NCT03580369|65915632|FG006|Overall Study|No treatment due to mis-randomization|0|||
23596559|NCT03580369|65915633|FG007|Overall Study|No treatment due to mis-randomization|0|||
23596560|NCT03580369|65915626|FG000|Overall Study|Reason unknown|0|||
23596561|NCT03580369|65915627|FG001|Overall Study|Reason unknown|0|||
23596562|NCT03580369|65915628|FG002|Overall Study|Reason unknown|1|||
23596563|NCT03580369|65915629|FG003|Overall Study|Reason unknown|0|||
23596564|NCT03580369|65915630|FG004|Overall Study|Reason unknown|0|||
23596565|NCT03580369|65915631|FG005|Overall Study|Reason unknown|0|||
23596566|NCT03580369|65915632|FG006|Overall Study|Reason unknown|0|||
23596567|NCT03580369|65915633|FG007|Overall Study|Reason unknown|0|||
23596568|NCT03580369|65915626|FG000|Overall Study|Technical problems|0|||
23596569|NCT03580369|65915627|FG001|Overall Study|Technical problems|0|||
23596570|NCT03580369|65915628|FG002|Overall Study|Technical problems|0|||
23596571|NCT03580369|65915629|FG003|Overall Study|Technical problems|0|||
23596572|NCT03580369|65915630|FG004|Overall Study|Technical problems|1|||
23596573|NCT03580369|65915631|FG005|Overall Study|Technical problems|0|||
23596574|NCT03580369|65915632|FG006|Overall Study|Technical problems|2|||
23596575|NCT03580369|65915633|FG007|Overall Study|Technical problems|0|||
23596576|NCT03580369|65915626|FG000|Overall Study|Pregnancy|2|||
23596577|NCT03580369|65915627|FG001|Overall Study|Pregnancy|0|||
23596578|NCT03580369|65915628|FG002|Overall Study|Pregnancy|3|||
23596579|NCT03580369|65915629|FG003|Overall Study|Pregnancy|0|||
23596580|NCT03580369|65915630|FG004|Overall Study|Pregnancy|2|||
23596581|NCT03580369|65915631|FG005|Overall Study|Pregnancy|0|||
23596582|NCT03580369|65915632|FG006|Overall Study|Pregnancy|0|||
23596583|NCT03580369|65915633|FG007|Overall Study|Pregnancy|0|||
23596584|NCT03580369|65915626|FG000|Overall Study|Lost to Follow-up|2|||
23596585|NCT03580369|65915627|FG001|Overall Study|Lost to Follow-up|0|||
23645587|NCT00468104|66087097|FG001|First Intervention|Protocol Violation|1|||
23645588|NCT00468104|66087096|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
23596586|NCT03580369|65915628|FG002|Overall Study|Lost to Follow-up|2|||
23596587|NCT03580369|65915629|FG003|Overall Study|Lost to Follow-up|0|||
23596588|NCT03580369|65915630|FG004|Overall Study|Lost to Follow-up|3|||
23596589|NCT03580369|65915631|FG005|Overall Study|Lost to Follow-up|0|||
23596590|NCT03580369|65915632|FG006|Overall Study|Lost to Follow-up|1|||
23596591|NCT03580369|65915633|FG007|Overall Study|Lost to Follow-up|0|||
23596592|NCT03580369|65915626|FG000|Overall Study|Physician Decision|4|||
23596593|NCT03580369|65915627|FG001|Overall Study|Physician Decision|0|||
23596594|NCT03580369|65915628|FG002|Overall Study|Physician Decision|4|||
23596595|NCT03580369|65915629|FG003|Overall Study|Physician Decision|1|||
23596596|NCT03580369|65915630|FG004|Overall Study|Physician Decision|1|||
23596597|NCT03580369|65915631|FG005|Overall Study|Physician Decision|0|||
23596598|NCT03580369|65915632|FG006|Overall Study|Physician Decision|0|||
23596599|NCT03580369|65915633|FG007|Overall Study|Physician Decision|0|||
23596600|NCT03580369|65915626|FG000|Overall Study|Lack of Efficacy|3|||
23596601|NCT03580369|65915627|FG001|Overall Study|Lack of Efficacy|0|||
23596602|NCT03580369|65915628|FG002|Overall Study|Lack of Efficacy|7|||
23596603|NCT03580369|65915629|FG003|Overall Study|Lack of Efficacy|0|||
23596604|NCT03580369|65915630|FG004|Overall Study|Lack of Efficacy|2|||
23596605|NCT03580369|65915631|FG005|Overall Study|Lack of Efficacy|0|||
23596606|NCT03580369|65915632|FG006|Overall Study|Lack of Efficacy|3|||
23596607|NCT03580369|65915633|FG007|Overall Study|Lack of Efficacy|0|||
23596608|NCT03580369|65915626|FG000|Overall Study|Protocol Violation|6|||
23596609|NCT03580369|65915627|FG001|Overall Study|Protocol Violation|0|||
23596610|NCT03580369|65915628|FG002|Overall Study|Protocol Violation|6|||
23596611|NCT03580369|65915629|FG003|Overall Study|Protocol Violation|1|||
23596612|NCT03580369|65915630|FG004|Overall Study|Protocol Violation|8|||
23596613|NCT03580369|65915631|FG005|Overall Study|Protocol Violation|2|||
23596614|NCT03580369|65915632|FG006|Overall Study|Protocol Violation|1|||
23596615|NCT03580369|65915633|FG007|Overall Study|Protocol Violation|0|||
23596616|NCT03580369|65915626|FG000|Overall Study|Adverse Event|7|||
23596617|NCT03580369|65915627|FG001|Overall Study|Adverse Event|0|||
23596618|NCT03580369|65915628|FG002|Overall Study|Adverse Event|14|||
23596619|NCT03580369|65915629|FG003|Overall Study|Adverse Event|1|||
23596620|NCT03580369|65915630|FG004|Overall Study|Adverse Event|6|||
23596621|NCT03580369|65915631|FG005|Overall Study|Adverse Event|0|||
23596622|NCT03580369|65915632|FG006|Overall Study|Adverse Event|1|||
23596623|NCT03580369|65915633|FG007|Overall Study|Adverse Event|0|||
23596624|NCT03580369|65915626|FG000|Overall Study|Withdrawal by Subject|19|||
23596625|NCT03580369|65915627|FG001|Overall Study|Withdrawal by Subject|0|||
23596626|NCT03580369|65915628|FG002|Overall Study|Withdrawal by Subject|17|||
23596627|NCT03580369|65915629|FG003|Overall Study|Withdrawal by Subject|0|||
23596628|NCT03580369|65915630|FG004|Overall Study|Withdrawal by Subject|16|||
23596629|NCT03580369|65915631|FG005|Overall Study|Withdrawal by Subject|1|||
23596630|NCT03580369|65915632|FG006|Overall Study|Withdrawal by Subject|7|||
23596631|NCT03580369|65915633|FG007|Overall Study|Withdrawal by Subject|0|||
23596632|NCT00901901|65915634|FG000|Treatment Period|Adverse Event|120|||
23596633|NCT00901901|65915635|FG001|Treatment Period|Adverse Event|128|||
23596634|NCT00901901|65915634|FG000|Treatment Period|Withdrawal by Subject|26|||
23596635|NCT00901901|65915635|FG001|Treatment Period|Withdrawal by Subject|24|||
23596636|NCT00901901|65915634|FG000|Treatment Period|Physician Decision|2|||
23596637|NCT00901901|65915635|FG001|Treatment Period|Physician Decision|2|||
23596638|NCT00901901|65915634|FG000|Treatment Period|Lost to Follow-up|3|||
23596639|NCT00901901|65915635|FG001|Treatment Period|Lost to Follow-up|5|||
23596640|NCT00901901|65915634|FG000|Treatment Period|Noncompliance with study medication|4|||
23596641|NCT00901901|65915635|FG001|Treatment Period|Noncompliance with study medication|1|||
23596642|NCT00901901|65915634|FG000|Treatment Period|Missing|1|||
23596643|NCT00901901|65915635|FG001|Treatment Period|Missing|0|||
23596644|NCT00901901|65915634|FG000|Treatment Period|Never treated|0|||
23596645|NCT00901901|65915635|FG001|Treatment Period|Never treated|3|||
23596646|NCT00901901|65915634|FG000|Treatment Period|Protocol driven decision point|0|||
23596647|NCT00901901|65915635|FG001|Treatment Period|Protocol driven decision point|2|||
23596648|NCT00901901|65915634|FG000|Treatment Period|Study terminated by sponsor|2|||
23596649|NCT00901901|65915635|FG001|Treatment Period|Study terminated by sponsor|0|||
23596650|NCT00901901|65915634|FG000|Treatment Period|Protocol Violation|5|||
23645589|NCT00468104|66087097|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
23596651|NCT00901901|65915635|FG001|Treatment Period|Protocol Violation|9|||
23596652|NCT00901901|65915634|FG000|Treatment Period|Switch to commercial drug|1|||
23596653|NCT00901901|65915635|FG001|Treatment Period|Switch to commercial drug|1|||
23596654|NCT00901901|65915634|FG000|Treatment Period|Transfer to treatment continuation study|5|||
23596655|NCT00901901|65915635|FG001|Treatment Period|Transfer to treatment continuation study|2|||
23596656|NCT00901901|65915634|FG000|Follow-up Period|Death|181|||
23596657|NCT00901901|65915635|FG001|Follow-up Period|Death|208|||
23596658|NCT00901901|65915634|FG000|Follow-up Period|Protocol driven decision point|47|||
23596659|NCT00901901|65915635|FG001|Follow-up Period|Protocol driven decision point|36|||
23596660|NCT00901901|65915634|FG000|Follow-up Period|Withdrawal by Subject|6|||
23596661|NCT00901901|65915635|FG001|Follow-up Period|Withdrawal by Subject|9|||
23596662|NCT00901901|65915634|FG000|Follow-up Period|Lost to Follow-up|12|||
23596663|NCT00901901|65915635|FG001|Follow-up Period|Lost to Follow-up|8|||
23596664|NCT00901901|65915634|FG000|Follow-up Period|Missing|94|||
23596665|NCT00901901|65915635|FG001|Follow-up Period|Missing|80|||
23596666|NCT02267824|65915636|FG000|Overall Study|Pregnancy|1|||
23596667|NCT02267824|65915637|FG001|Overall Study|Pregnancy|1|||
23596668|NCT02267824|65915636|FG000|Overall Study|Lost to Follow-up|4|||
23596669|NCT02267824|65915637|FG001|Overall Study|Lost to Follow-up|0|||
23596670|NCT02267824|65915636|FG000|Overall Study|Protocol Violation|3|||
23596671|NCT02267824|65915637|FG001|Overall Study|Protocol Violation|0|||
23596672|NCT02267824|65915636|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
23596673|NCT02267824|65915637|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
23596674|NCT02724956|65915638|FG000|Overall Study|Physician Decision|1|||
23596675|NCT02724956|65915639|FG001|Overall Study|Physician Decision|0|||
23596676|NCT02724956|65915638|FG000|Overall Study|Lack of Efficacy|0|||
23596677|NCT02724956|65915639|FG001|Overall Study|Lack of Efficacy|1|||
23596678|NCT02724956|65915638|FG000|Overall Study|Withdrawal by Subject|0|||
23596679|NCT02724956|65915639|FG001|Overall Study|Withdrawal by Subject|1|||
23596680|NCT03485950|65915641|FG000|Overall Study|Adverse Event|1|||
23596681|NCT03485950|65915642|FG001|Overall Study|Adverse Event|0|||
23596682|NCT03485950|65915641|FG000|Overall Study|Death|3|||
23596683|NCT03485950|65915642|FG001|Overall Study|Death|2|||
23596684|NCT03485950|65915641|FG000|Overall Study|Withdrawal by Subject|3|||
23596685|NCT03485950|65915642|FG001|Overall Study|Withdrawal by Subject|0|||
23596686|NCT02797184|65915643|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
23596687|NCT02797184|65915644|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
23596688|NCT03481816|65915649|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
23596689|NCT03481816|65915650|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
23596690|NCT03481816|65915649|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
23596691|NCT03481816|65915650|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
23596692|NCT03481816|65915649|FG000|Dose Expansion|Withdrawal by Subject|0|||
23596693|NCT03481816|65915650|FG001|Dose Expansion|Withdrawal by Subject|2|||
23596694|NCT03481816|65915649|FG000|Dose Expansion|Physician Decision|0|||
23596695|NCT03481816|65915650|FG001|Dose Expansion|Physician Decision|5|||
23596696|NCT03578536|65915653|FG000|Overall Study|Lost to Follow-up|1|||
23596697|NCT03593876|65915654|FG000|Overall Study|Withdrawal by Subject|1|||
23596698|NCT03593876|65915654|FG000|Overall Study|Discharged home before intervention completion|2|||
23596699|NCT00440011|65915655|FG000|Overall Study|Adverse Event|2|||
23596700|NCT00440011|65915656|FG001|Overall Study|Adverse Event|0|||
23596701|NCT00440011|65915655|FG000|Overall Study|Lost to Follow-up|0|||
23596702|NCT00440011|65915656|FG001|Overall Study|Lost to Follow-up|2|||
23596703|NCT00440011|65915655|FG000|Overall Study|Protocol Violation|1|||
23596704|NCT00440011|65915656|FG001|Overall Study|Protocol Violation|1|||
23596705|NCT00440011|65915655|FG000|Overall Study|Withdrawal by Subject|1|||
23596706|NCT00440011|65915656|FG001|Overall Study|Withdrawal by Subject|0|||
23596707|NCT02374307|65915657|FG000|3-months Follow-up|Lost to Follow-up|1|||
23596708|NCT02374307|65915658|FG001|3-months Follow-up|Lost to Follow-up|2|||
23596709|NCT02374307|65915657|FG000|3-months Follow-up|Withdrawal by Subject|1|||
23596710|NCT02374307|65915658|FG001|3-months Follow-up|Withdrawal by Subject|4|||
23596711|NCT02374307|65915657|FG000|3-months Follow-up|Death|1|||
23596712|NCT02374307|65915658|FG001|3-months Follow-up|Death|2|||
23596713|NCT02374307|65915657|FG000|3-months Follow-up|Missed first follow-up|5|||
23596714|NCT02374307|65915658|FG001|3-months Follow-up|Missed first follow-up|1|||
23596715|NCT02374307|65915657|FG000|6-months Follow-up|Lost to Follow-up|1|||
23596716|NCT02374307|65915658|FG001|6-months Follow-up|Lost to Follow-up|2|||
23596717|NCT02374307|65915657|FG000|6-months Follow-up|Death|2|||
23596718|NCT02374307|65915658|FG001|6-months Follow-up|Death|1|||
23596719|NCT02374307|65915657|FG000|6-months Follow-up|Withdrawal by Subject|0|||
23596720|NCT02374307|65915658|FG001|6-months Follow-up|Withdrawal by Subject|3|||
23596721|NCT01036724|65915659|FG000|Overall Study|Adverse Event|1|||
23596722|NCT01036724|65915660|FG001|Overall Study|Adverse Event|2|||
23596723|NCT01036724|65915659|FG000|Overall Study|Lack of Efficacy|1|||
23596724|NCT01036724|65915660|FG001|Overall Study|Lack of Efficacy|1|||
23596725|NCT01036724|65915659|FG000|Overall Study|Protocol Violation|4|||
23596726|NCT01036724|65915660|FG001|Overall Study|Protocol Violation|5|||
23596727|NCT01185561|65915669|FG000|Overall Study|Lost to Follow-up|0|||
23596728|NCT01185561|65915670|FG001|Overall Study|Lost to Follow-up|4|||
23596729|NCT01185561|65915669|FG000|Overall Study|Withdrawal by Subject|2|||
23596730|NCT01185561|65915670|FG001|Overall Study|Withdrawal by Subject|8|||
23645590|NCT00468104|66087096|FG000|First Intervention|died within 3 weeks|1|||
23645591|NCT00468104|66087097|FG001|First Intervention|died within 3 weeks|0|||
23645592|NCT00468104|66087096|FG000|First Intervention|malposition/blocked chest tube tube|2|||
23596731|NCT00840177|65915674|FG000|Overall Study|Adverse Event|5|||
23596732|NCT00840177|65915675|FG001|Overall Study|Adverse Event|1|||
23596733|NCT00840177|65915676|FG002|Overall Study|Adverse Event|1|||
23596734|NCT00840177|65915674|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23596735|NCT00840177|65915675|FG001|Overall Study|Refusal unrelated to adverse events|0|||
23596736|NCT00840177|65915676|FG002|Overall Study|Refusal unrelated to adverse events|1|||
23596737|NCT00840177|65915674|FG000|Overall Study|Progression/relapse|2|||
23596738|NCT00840177|65915675|FG001|Overall Study|Progression/relapse|0|||
23596739|NCT00840177|65915676|FG002|Overall Study|Progression/relapse|0|||
23596740|NCT00840177|65915674|FG000|Overall Study|Death|4|||
23596741|NCT00840177|65915675|FG001|Overall Study|Death|5|||
23596742|NCT00840177|65915676|FG002|Overall Study|Death|5|||
23596743|NCT00840177|65915674|FG000|Overall Study|not protocol specified|6|||
23596744|NCT00840177|65915675|FG001|Overall Study|not protocol specified|3|||
23596745|NCT00840177|65915676|FG002|Overall Study|not protocol specified|0|||
23596746|NCT00840177|65915674|FG000|Overall Study|Ineligible|0|||
23596747|NCT00840177|65915675|FG001|Overall Study|Ineligible|0|||
23596748|NCT00840177|65915676|FG002|Overall Study|Ineligible|3|||
23596749|NCT00840177|65915674|FG000|Overall Study|Did not start treatment|0|||
23596750|NCT00840177|65915675|FG001|Overall Study|Did not start treatment|0|||
23596751|NCT00840177|65915676|FG002|Overall Study|Did not start treatment|1|||
23596752|NCT00978042|65915677|FG000|Initial Treatment Period|Treated in Error|0|||
23596753|NCT00978042|65915678|FG001|Initial Treatment Period|Treated in Error|3|||
23596754|NCT00978042|65915677|FG000|Initial Treatment Period|Ineligibility|1|||
23596755|NCT00978042|65915678|FG001|Initial Treatment Period|Ineligibility|0|||
23596756|NCT00978042|65915677|FG000|Initial Treatment Period|Lost to Follow-up|21|||
23596757|NCT00978042|65915678|FG001|Initial Treatment Period|Lost to Follow-up|3|||
23596758|NCT00978042|65915677|FG000|Initial Treatment Period|Adverse Event|2|||
23596759|NCT00978042|65915678|FG001|Initial Treatment Period|Adverse Event|0|||
23596760|NCT00978042|65915677|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
23596761|NCT00978042|65915678|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
23596762|NCT00978042|65915677|FG000|Initial Treatment Period|Consent withdrawn|22|||
23596763|NCT00978042|65915678|FG001|Initial Treatment Period|Consent withdrawn|9|||
23596764|NCT00978042|65915677|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
23596765|NCT00978042|65915678|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
23596766|NCT01184326|65915679|FG000|Overall Study|Adverse Event|1|||
23596767|NCT01184326|65915680|FG001|Overall Study|Adverse Event|2|||
23596768|NCT01184326|65915681|FG002|Overall Study|Adverse Event|0|||
23596769|NCT01184326|65915679|FG000|Overall Study|Death|0|||
23596770|NCT01184326|65915680|FG001|Overall Study|Death|0|||
23596771|NCT01184326|65915681|FG002|Overall Study|Death|1|||
23596772|NCT01184326|65915679|FG000|Overall Study|Withdrawal by Subject|0|||
23596773|NCT01184326|65915680|FG001|Overall Study|Withdrawal by Subject|0|||
23596774|NCT01184326|65915681|FG002|Overall Study|Withdrawal by Subject|1|||
23596775|NCT01184326|65915679|FG000|Overall Study|Physician Decision|1|||
23596776|NCT01184326|65915680|FG001|Overall Study|Physician Decision|1|||
23596777|NCT01184326|65915681|FG002|Overall Study|Physician Decision|0|||
23596778|NCT01184326|65915679|FG000|Overall Study|Disease Progression|1|||
23596779|NCT01184326|65915680|FG001|Overall Study|Disease Progression|3|||
23596780|NCT01184326|65915681|FG002|Overall Study|Disease Progression|12|||
23596781|NCT03582722|65915686|FG000|Overall Study|Lost to Follow-up|1|||
23596782|NCT03582722|65915687|FG001|Overall Study|Lost to Follow-up|4|||
23596783|NCT03582722|65915686|FG000|Overall Study|Withdrawal by Subject|3|||
23596784|NCT03582722|65915687|FG001|Overall Study|Withdrawal by Subject|3|||
23596785|NCT01424397|65915690|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596786|NCT01424397|65915691|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
23645593|NCT00468104|66087097|FG001|First Intervention|malposition/blocked chest tube tube|0|||
23645594|NCT00468104|66087096|FG000|First Intervention|large lung mass with minimal effusion|1|||
23645595|NCT00468104|66087097|FG001|First Intervention|large lung mass with minimal effusion|0|||
23645596|NCT00468104|66087096|FG000|First Intervention|associated prolonged pneumothorax|1|||
23645597|NCT00468104|66087097|FG001|First Intervention|associated prolonged pneumothorax|0|||
23645598|NCT00468104|66087096|FG000|First Intervention|trapped lung|1|||
23645599|NCT00468104|66087097|FG001|First Intervention|trapped lung|0|||
23645600|NCT00468104|66087096|FG000|Second Intervention|Withdrawal by Subject|5|||
23645601|NCT00468104|66087097|FG001|Second Intervention|Withdrawal by Subject|2|||
23645602|NCT00468104|66087096|FG000|Second Intervention|discarded for malposition of chest tube|0|||
23645603|NCT00468104|66087097|FG001|Second Intervention|discarded for malposition of chest tube|2|||
23645604|NCT02518490|66087098|FG000|Overall Study|Withdrawal by Subject|1|||
23645605|NCT02518490|66087099|FG001|Overall Study|Withdrawal by Subject|1|||
23596787|NCT01424397|65915692|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
23596788|NCT01424397|65915693|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596789|NCT01424397|65915694|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596790|NCT01424397|65915695|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596791|NCT01424397|65915696|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596792|NCT01424397|65915697|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596793|NCT01424397|65915698|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596794|NCT01424397|65915699|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
23645606|NCT01236534|66087100|FG000|Overall Study|Adverse Event|3|||
23645607|NCT01236534|66087101|FG001|Overall Study|Adverse Event|0|||
23645608|NCT01119105|66087105|FG000|Overall Study|Withdrawal by Subject|1|||
23645609|NCT01119105|66087106|FG001|Overall Study|Withdrawal by Subject|1|||
23645610|NCT01119105|66087107|FG002|Overall Study|Withdrawal by Subject|1|||
23645611|NCT01119105|66087105|FG000|Overall Study|Lost to Follow-up|0|||
23645612|NCT01119105|66087106|FG001|Overall Study|Lost to Follow-up|2|||
23645613|NCT01119105|66087107|FG002|Overall Study|Lost to Follow-up|5|||
23645614|NCT01119105|66087105|FG000|Overall Study|Adverse Event|1|||
23800604|NCT00442546|66646821|FG000|Overall Study|Randomized But Not Treated|5|||
23800605|NCT00442546|66646822|FG001|Overall Study|Randomized But Not Treated|4|||
23800606|NCT00442546|66646823|FG002|Overall Study|Randomized But Not Treated|6|||
23800607|NCT00567476|66646824|FG000|Overall Study|Adverse Event|2|||
23800608|NCT00567476|66646825|FG001|Overall Study|Adverse Event|0|||
23800609|NCT00567476|66646824|FG000|Overall Study|Pregnancy|1|||
23360386|NCT00215644|65062941|FG001|Overall Study|Adverse Event|9|||
23360387|NCT00215644|65062940|FG000|Overall Study|Death|1|||
23360388|NCT00215644|65062941|FG001|Overall Study|Death|2|||
23360389|NCT00215644|65062940|FG000|Overall Study|Withdrawal by Subject|1|||
23360390|NCT00215644|65062941|FG001|Overall Study|Withdrawal by Subject|0|||
23360391|NCT00215644|65062940|FG000|Overall Study|Other|3|||
23360392|NCT00215644|65062941|FG001|Overall Study|Other|15|||
23360393|NCT00215644|65062940|FG000|Overall Study|Randomized but Not Treated|1|||
23360394|NCT00215644|65062941|FG001|Overall Study|Randomized but Not Treated|0|||
23360395|NCT03046953|65062942|FG000|Overall Study|Relapse/progressive disease|21|||
23360396|NCT03046953|65062942|FG000|Overall Study|Death|2|||
23360397|NCT03046953|65062942|FG000|Overall Study|Withdrawal by Subject|3|||
23360398|NCT00426764|65062943|FG000|Overall Study|Protocol Violation|1|||
23360399|NCT00426764|65062943|FG000|Overall Study|Withdrawal by Subject|4|||
23360400|NCT00426764|65062943|FG000|Overall Study|Physician Decision|6|||
23360401|NCT00426764|65062943|FG000|Overall Study|Compassionate Use|1|||
23360402|NCT00426764|65062943|FG000|Overall Study|Progressive Disease|83|||
23360403|NCT00426764|65062943|FG000|Overall Study|Adverse Event|24|||
23360404|NCT00426764|65062943|FG000|Overall Study|Other|1|||
23360405|NCT00426764|65062943|FG000|Overall Study|Death|1|||
23360406|NCT00426764|65062943|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
23360407|NCT02781818|65062944|FG000|Overall Study|Lost to Follow-up|4|||
23360408|NCT02781818|65062945|FG001|Overall Study|Lost to Follow-up|2|||
23360409|NCT02781818|65062946|FG002|Overall Study|Lost to Follow-up|1|||
23360410|NCT02793947|65062947|FG000|Overall Study|Death|1|||
23360411|NCT02793947|65062948|FG001|Overall Study|Death|0|||
23360412|NCT02793947|65062947|FG000|Overall Study|Physician Decision|1|||
23360413|NCT02793947|65062948|FG001|Overall Study|Physician Decision|5|||
23360414|NCT01831427|65062949|FG000|Overall Study|Adverse Event|0|||
23360415|NCT01831427|65062950|FG001|Overall Study|Adverse Event|1|||
23360416|NCT01831427|65062951|FG002|Overall Study|Adverse Event|0|||
23360417|NCT01831427|65062952|FG003|Overall Study|Adverse Event|0|||
23360418|NCT01831427|65062953|FG004|Overall Study|Adverse Event|0|||
23360419|NCT01831427|65062954|FG005|Overall Study|Adverse Event|1|||
23360420|NCT01831427|65062955|FG006|Overall Study|Adverse Event|0|||
23360421|NCT01831427|65062956|FG007|Overall Study|Adverse Event|1|||
23360422|NCT01831427|65062957|FG008|Overall Study|Adverse Event|0|||
23360423|NCT01831427|65062958|FG009|Overall Study|Adverse Event|0|||
23360424|NCT01831427|65062959|FG010|Overall Study|Adverse Event|2|||
23360425|NCT01831427|65062949|FG000|Overall Study|Investigator's Discretion|0|||
23360426|NCT01831427|65062950|FG001|Overall Study|Investigator's Discretion|0|||
23360427|NCT01831427|65062951|FG002|Overall Study|Investigator's Discretion|0|||
23360428|NCT01831427|65062952|FG003|Overall Study|Investigator's Discretion|1|||
23360429|NCT01831427|65062953|FG004|Overall Study|Investigator's Discretion|0|||
23478351|NCT00910624|65494535|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
23645615|NCT01119105|66087106|FG001|Overall Study|Adverse Event|0|||
23645616|NCT01119105|66087107|FG002|Overall Study|Adverse Event|1|||
23645617|NCT01119105|66087105|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
23645618|NCT01119105|66087106|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
23645619|NCT01119105|66087107|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
23645620|NCT01119105|66087105|FG000|Overall Study|Other|1|||
23800610|NCT00567476|66646825|FG001|Overall Study|Pregnancy|0|||
23800611|NCT00567476|66646824|FG000|Overall Study|Protocol Violation|4|||
23360430|NCT01831427|65062954|FG005|Overall Study|Investigator's Discretion|0|||
23360431|NCT01831427|65062955|FG006|Overall Study|Investigator's Discretion|0|||
23360432|NCT01831427|65062956|FG007|Overall Study|Investigator's Discretion|0|||
23360433|NCT01831427|65062957|FG008|Overall Study|Investigator's Discretion|0|||
23360434|NCT01831427|65062958|FG009|Overall Study|Investigator's Discretion|0|||
23645621|NCT01119105|66087106|FG001|Overall Study|Other|1|||
23645622|NCT01119105|66087107|FG002|Overall Study|Other|0|||
23478352|NCT00910624|65494532|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
23478353|NCT00910624|65494533|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23596795|NCT01424397|65915700|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596796|NCT01424397|65915701|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596797|NCT02008916|65915702|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
23596798|NCT02008916|65915703|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
23596799|NCT02008916|65915704|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
23596800|NCT02008916|65915702|FG000|Week 16 - 156|Adverse Event|4|||
23596801|NCT02008916|65915703|FG001|Week 16 - 156|Adverse Event|2|||
23596802|NCT02008916|65915704|FG002|Week 16 - 156|Adverse Event|3|||
23596803|NCT02008916|65915702|FG000|Week 16 - 156|Withdrawal by Subject|7|||
23596804|NCT02008916|65915703|FG001|Week 16 - 156|Withdrawal by Subject|3|||
23596805|NCT02008916|65915704|FG002|Week 16 - 156|Withdrawal by Subject|5|||
23596806|NCT02008916|65915702|FG000|Week 16 - 156|No longer requires treatment|0|||
23596807|NCT02008916|65915703|FG001|Week 16 - 156|No longer requires treatment|1|||
23596808|NCT02008916|65915704|FG002|Week 16 - 156|No longer requires treatment|0|||
23596809|NCT02008916|65915702|FG000|Week 16 - 156|Lost to Follow-up|5|||
23596810|NCT02008916|65915703|FG001|Week 16 - 156|Lost to Follow-up|0|||
23596811|NCT02008916|65915704|FG002|Week 16 - 156|Lost to Follow-up|0|||
23596812|NCT02008916|65915702|FG000|Week 16 - 156|Lack of Efficacy|3|||
23596813|NCT02008916|65915703|FG001|Week 16 - 156|Lack of Efficacy|5|||
23596814|NCT02008916|65915704|FG002|Week 16 - 156|Lack of Efficacy|2|||
23596815|NCT02008916|65915702|FG000|Week 16 - 156|Pregnancy|0|||
23596816|NCT02008916|65915703|FG001|Week 16 - 156|Pregnancy|1|||
23596817|NCT02008916|65915704|FG002|Week 16 - 156|Pregnancy|0|||
23596818|NCT02008916|65915702|FG000|Week 16 - 156|Physician Decision|0|||
23596819|NCT02008916|65915703|FG001|Week 16 - 156|Physician Decision|1|||
23596820|NCT02008916|65915704|FG002|Week 16 - 156|Physician Decision|0|||
23596821|NCT01236560|65915707|FG000|Overall Study|Adverse Event|0|||
23596822|NCT01236560|65915708|FG001|Overall Study|Adverse Event|2|||
23596823|NCT01236560|65915709|FG002|Overall Study|Adverse Event|1|||
23596824|NCT01236560|65915710|FG003|Overall Study|Adverse Event|3|||
23596825|NCT01236560|65915711|FG004|Overall Study|Adverse Event|0|||
23596826|NCT01236560|65915712|FG005|Overall Study|Adverse Event|0|||
23596827|NCT01236560|65915707|FG000|Overall Study|Death|0|||
23596828|NCT01236560|65915708|FG001|Overall Study|Death|1|||
23596829|NCT01236560|65915709|FG002|Overall Study|Death|0|||
23596830|NCT01236560|65915710|FG003|Overall Study|Death|1|||
23596831|NCT01236560|65915711|FG004|Overall Study|Death|0|||
23596832|NCT01236560|65915712|FG005|Overall Study|Death|0|||
23596833|NCT01236560|65915707|FG000|Overall Study|Lost to Follow-up|0|||
23596834|NCT01236560|65915708|FG001|Overall Study|Lost to Follow-up|1|||
23596835|NCT01236560|65915709|FG002|Overall Study|Lost to Follow-up|1|||
23596836|NCT01236560|65915710|FG003|Overall Study|Lost to Follow-up|0|||
23596837|NCT01236560|65915711|FG004|Overall Study|Lost to Follow-up|0|||
23596838|NCT01236560|65915712|FG005|Overall Study|Lost to Follow-up|0|||
23596839|NCT01236560|65915707|FG000|Overall Study|Physician Decision|0|||
23596840|NCT01236560|65915708|FG001|Overall Study|Physician Decision|1|||
23596841|NCT01236560|65915709|FG002|Overall Study|Physician Decision|8|||
23596842|NCT01236560|65915710|FG003|Overall Study|Physician Decision|0|||
23596843|NCT01236560|65915711|FG004|Overall Study|Physician Decision|0|||
23596844|NCT01236560|65915712|FG005|Overall Study|Physician Decision|0|||
23596845|NCT01236560|65915707|FG000|Overall Study|Withdrawal by Subject|0|||
23596846|NCT01236560|65915708|FG001|Overall Study|Withdrawal by Subject|0|||
23596847|NCT01236560|65915709|FG002|Overall Study|Withdrawal by Subject|1|||
23596848|NCT01236560|65915710|FG003|Overall Study|Withdrawal by Subject|2|||
23596849|NCT01236560|65915711|FG004|Overall Study|Withdrawal by Subject|0|||
23596850|NCT01236560|65915712|FG005|Overall Study|Withdrawal by Subject|0|||
23596851|NCT01236560|65915707|FG000|Overall Study|Progressive disease|5|||
23596852|NCT01236560|65915708|FG001|Overall Study|Progressive disease|19|||
23596853|NCT01236560|65915709|FG002|Overall Study|Progressive disease|9|||
23596854|NCT01236560|65915710|FG003|Overall Study|Progressive disease|16|||
23596855|NCT01236560|65915711|FG004|Overall Study|Progressive disease|0|||
23596856|NCT01236560|65915712|FG005|Overall Study|Progressive disease|0|||
23596857|NCT02407249|65915713|FG000|Overall Study|Did not complete 12-month follow-up|13|||
23596858|NCT02407249|65915713|FG000|Overall Study|Not treated|13|||
23596859|NCT04210180|65915717|FG000|Overall Study|Withdrawal by Subject|2|||
23596860|NCT00799396|65915718|FG000|Clopidogrel Treatment|Adverse Event|6|||
23596861|NCT00799396|65915718|FG000|Clopidogrel Treatment|Physician Decision|5|||
23596862|NCT00799396|65915718|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
23596863|NCT00799396|65915718|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
23596864|NCT00799396|65915718|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
23596865|NCT01811706|65915719|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
23596866|NCT01811706|65915720|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
23596867|NCT03771352|65915721|FG000|Overall Study|Screen failure|2|||
23596868|NCT03771352|65915721|FG000|Overall Study|Withdrawal by Subject|2|||
23645623|NCT00309959|66087108|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
23645624|NCT02337751|66087109|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
23645625|NCT02337751|66087110|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23645626|NCT02337751|66087109|FG000|Overall Study|Voluntary Withdrawal|6|||
23645627|NCT02337751|66087110|FG001|Overall Study|Voluntary Withdrawal|8|||
23645628|NCT02337751|66087109|FG000|Overall Study|Lack of Efficacy|2|||
23645629|NCT02337751|66087110|FG001|Overall Study|Lack of Efficacy|5|||
23645630|NCT02337751|66087109|FG000|Overall Study|Investigator's Judgement|1|||
23360435|NCT01831427|65062959|FG010|Overall Study|Investigator's Discretion|0|||
23360436|NCT01831427|65062949|FG000|Overall Study|Withdrew Consent|0|||
23360437|NCT01831427|65062950|FG001|Overall Study|Withdrew Consent|0|||
23360438|NCT01831427|65062951|FG002|Overall Study|Withdrew Consent|0|||
23360439|NCT01831427|65062952|FG003|Overall Study|Withdrew Consent|0|||
23645631|NCT02337751|66087110|FG001|Overall Study|Investigator's Judgement|0|||
23645632|NCT03545503|66087111|FG000|Overall Study|Protocol Violation|14|||
23645633|NCT03545503|66087112|FG001|Overall Study|Protocol Violation|16|||
23645634|NCT02656823|66087117|FG000|Overall Study|Adverse Event|3|||
23645635|NCT02656823|66087117|FG000|Overall Study|Lost to Follow-up|2|||
23645636|NCT00513604|66087118|FG000|Overall Study|Not treated|2|||
23645637|NCT00513604|66087119|FG001|Overall Study|Not treated|0|||
23645638|NCT00513604|66087120|FG002|Overall Study|Not treated|1|||
23360440|NCT01831427|65062953|FG004|Overall Study|Withdrew Consent|0|||
23360441|NCT01831427|65062954|FG005|Overall Study|Withdrew Consent|0|||
23360442|NCT01831427|65062955|FG006|Overall Study|Withdrew Consent|2|||
23596869|NCT02932579|65915725|FG000|Overall Study|Withdrawal by Subject|4|||
23596870|NCT02932579|65915726|FG001|Overall Study|Withdrawal by Subject|1|||
23596871|NCT00858117|65915731|FG000|Treatment on Study|Adverse Event|2|||
23596872|NCT00858117|65915731|FG000|Follow up for 5 Years|Death|4|||
23596873|NCT00858117|65915731|FG000|Follow up for 5 Years|No further data collected for study|9|||
23596874|NCT02463448|65915747|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
23596875|NCT02463448|65915747|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
23596876|NCT02463448|65915747|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
23596877|NCT02463448|65915747|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
23596878|NCT02275611|65915757|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
23596879|NCT02275611|65915758|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596880|NCT02275611|65915759|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596881|NCT02275611|65915760|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596882|NCT02411084|65915763|FG000|Overall Study|Lack of Efficacy|6|||
23596883|NCT02411084|65915764|FG001|Overall Study|Lack of Efficacy|3|||
23596884|NCT02411084|65915763|FG000|Overall Study|Death|5|||
23596885|NCT02411084|65915764|FG001|Overall Study|Death|4|||
23596886|NCT02411084|65915763|FG000|Overall Study|Adverse Event|2|||
23596887|NCT02411084|65915764|FG001|Overall Study|Adverse Event|1|||
23596888|NCT02411084|65915763|FG000|Overall Study|Other reasons|0|||
23360443|NCT01831427|65062956|FG007|Overall Study|Withdrew Consent|0|||
23360444|NCT01831427|65062957|FG008|Overall Study|Withdrew Consent|0|||
23360445|NCT01831427|65062958|FG009|Overall Study|Withdrew Consent|1|||
23596889|NCT02411084|65915764|FG001|Overall Study|Other reasons|5|||
23645639|NCT00513604|66087121|FG003|Overall Study|Not treated|0|||
23645640|NCT00513604|66087122|FG004|Overall Study|Not treated|0|||
23645641|NCT00513604|66087118|FG000|Overall Study|Death during treatment|0|||
23645642|NCT00513604|66087119|FG001|Overall Study|Death during treatment|3|||
23596890|NCT00308997|65915765|FG000|Overall Study|Subject feigned clinical data|0|||
23596891|NCT00308997|65915766|FG001|Overall Study|Subject feigned clinical data|1|||
23596892|NCT00308997|65915765|FG000|Overall Study|Unable to tolerate intervention|1|||
23596893|NCT00308997|65915766|FG001|Overall Study|Unable to tolerate intervention|0|||
23645643|NCT00513604|66087120|FG002|Overall Study|Death during treatment|2|||
23645644|NCT00513604|66087121|FG003|Overall Study|Death during treatment|0|||
23645645|NCT00513604|66087122|FG004|Overall Study|Death during treatment|0|||
23645646|NCT01990560|66090881|FG000|Overall Study|Withdrawal by Subject|1|||
23645647|NCT02029846|66090882|FG000|Overall Study|n=1 each arm|1|||
23645648|NCT02029846|66090883|FG001|Overall Study|n=1 each arm|1|||
23360446|NCT01831427|65062959|FG010|Overall Study|Withdrew Consent|1|||
23596894|NCT00988858|65915767|FG000|Overall Study|Adverse Event|7|||
23596895|NCT00988858|65915767|FG000|Overall Study|Death|1|||
23596896|NCT00988858|65915767|FG000|Overall Study|Physician Decision|1|||
23596897|NCT00988858|65915767|FG000|Overall Study|Sponsor Decision|1|||
23596898|NCT01007396|65915770|FG000|Overall Study|Lost to Follow-up|47|||
23596899|NCT02554786|65915772|FG000|Overall Study|Subject/guardian decision|29|||
23596900|NCT02554786|65915773|FG001|Overall Study|Subject/guardian decision|17|||
23596901|NCT02554786|65915774|FG002|Overall Study|Subject/guardian decision|18|||
23596902|NCT02554786|65915775|FG003|Overall Study|Subject/guardian decision|30|||
23596903|NCT02554786|65915776|FG004|Overall Study|Subject/guardian decision|20|||
23596904|NCT02554786|65915772|FG000|Overall Study|Lost to Follow-up|4|||
23596905|NCT02554786|65915773|FG001|Overall Study|Lost to Follow-up|3|||
23596906|NCT02554786|65915774|FG002|Overall Study|Lost to Follow-up|4|||
23596907|NCT02554786|65915775|FG003|Overall Study|Lost to Follow-up|2|||
23596908|NCT02554786|65915776|FG004|Overall Study|Lost to Follow-up|2|||
23596909|NCT02554786|65915772|FG000|Overall Study|Protocol deviation|1|||
23596910|NCT02554786|65915773|FG001|Overall Study|Protocol deviation|3|||
23596911|NCT02554786|65915774|FG002|Overall Study|Protocol deviation|3|||
23596912|NCT02554786|65915775|FG003|Overall Study|Protocol deviation|4|||
23596913|NCT02554786|65915776|FG004|Overall Study|Protocol deviation|2|||
23596914|NCT02554786|65915772|FG000|Overall Study|Technical problems|1|||
23596915|NCT02554786|65915773|FG001|Overall Study|Technical problems|1|||
23596916|NCT02554786|65915774|FG002|Overall Study|Technical problems|0|||
23596917|NCT02554786|65915775|FG003|Overall Study|Technical problems|2|||
23596918|NCT02554786|65915776|FG004|Overall Study|Technical problems|1|||
23596919|NCT02554786|65915772|FG000|Overall Study|Adverse Event|0|||
23596920|NCT02554786|65915773|FG001|Overall Study|Adverse Event|0|||
23596921|NCT02554786|65915774|FG002|Overall Study|Adverse Event|0|||
23596922|NCT02554786|65915775|FG003|Overall Study|Adverse Event|0|||
23596923|NCT02554786|65915776|FG004|Overall Study|Adverse Event|2|||
23596924|NCT02554786|65915772|FG000|Overall Study|Death|0|||
23596925|NCT02554786|65915773|FG001|Overall Study|Death|0|||
23596926|NCT02554786|65915774|FG002|Overall Study|Death|0|||
23596927|NCT02554786|65915775|FG003|Overall Study|Death|1|||
23596928|NCT02554786|65915776|FG004|Overall Study|Death|0|||
23596929|NCT02554786|65915772|FG000|Overall Study|Non-compliance with study treatment|0|||
23596930|NCT02554786|65915773|FG001|Overall Study|Non-compliance with study treatment|1|||
23596931|NCT02554786|65915774|FG002|Overall Study|Non-compliance with study treatment|1|||
23596932|NCT02554786|65915775|FG003|Overall Study|Non-compliance with study treatment|0|||
23596933|NCT02554786|65915776|FG004|Overall Study|Non-compliance with study treatment|1|||
23596934|NCT02554786|65915772|FG000|Overall Study|Physician Decision|0|||
23596935|NCT02554786|65915773|FG001|Overall Study|Physician Decision|1|||
23596936|NCT02554786|65915774|FG002|Overall Study|Physician Decision|4|||
23596937|NCT02554786|65915775|FG003|Overall Study|Physician Decision|1|||
23596938|NCT02554786|65915776|FG004|Overall Study|Physician Decision|1|||
23596939|NCT02554786|65915772|FG000|Overall Study|Pregnancy|0|||
23596940|NCT02554786|65915773|FG001|Overall Study|Pregnancy|0|||
23596941|NCT02554786|65915774|FG002|Overall Study|Pregnancy|0|||
23596942|NCT02554786|65915775|FG003|Overall Study|Pregnancy|1|||
23596943|NCT02554786|65915776|FG004|Overall Study|Pregnancy|1|||
23596944|NCT01113931|65915777|FG000|Overall Study|Adverse Event|2|||
23596945|NCT01113931|65915778|FG001|Overall Study|Adverse Event|2|||
23596946|NCT01113931|65915777|FG000|Overall Study|Physician Decision|0|||
23645649|NCT01015560|66090885|FG000|Overall Study|Adverse Event|1|||
23360447|NCT04472494|65065715|FG000|Pre-treatment|Other reasons|2|||
23360448|NCT04472494|65065716|FG001|Pre-treatment|Other reasons|0|||
23596947|NCT01113931|65915778|FG001|Overall Study|Physician Decision|2|||
23596948|NCT01113931|65915777|FG000|Overall Study|Lost to Follow-up|12|||
23596949|NCT01113931|65915778|FG001|Overall Study|Lost to Follow-up|9|||
23596950|NCT01113931|65915777|FG000|Overall Study|Various|2|||
23596951|NCT01113931|65915778|FG001|Overall Study|Various|4|||
23596952|NCT01113931|65915777|FG000|Overall Study|Withdrawal by Subject|3|||
23360449|NCT04472494|65065715|FG000|Treatment|Death|5|||
23596953|NCT01113931|65915778|FG001|Overall Study|Withdrawal by Subject|0|||
23596954|NCT01011946|65915779|FG000|Overall Study|Transferred to another hospital|2|||
23596955|NCT01011946|65915779|FG000|Overall Study|No pathological lab value|1|||
23645650|NCT01015560|66090885|FG000|Overall Study|Not protocol specified|1|||
23800612|NCT00567476|66646825|FG001|Overall Study|Protocol Violation|1|||
23596956|NCT01078116|65915780|FG000|Overall Study|Lost to Follow-up|17|||
23596957|NCT01078116|65915780|FG000|Overall Study|Adverse Event|5|||
23596958|NCT01078116|65915780|FG000|Overall Study|Withdrawal by Subject|8|||
23596959|NCT01078116|65915780|FG000|Overall Study|Lack of effectiveness|15|||
23596960|NCT01078116|65915780|FG000|Overall Study|Case report form not completed|3|||
23596961|NCT02499159|65915781|FG000|Randomization|Protocol Violation|1|||
23596962|NCT02499159|65915782|FG001|Randomization|Protocol Violation|1|||
23478354|NCT00910624|65494534|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23596963|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
23596964|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
23596965|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
23596966|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
23596967|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
23596968|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
23596969|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Other|1|||
23596970|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Other|0|||
23596971|NCT03531840|65915783|FG000|Overall Study|Death on study|3|||
23596972|NCT03531840|65915784|FG001|Overall Study|Death on study|2|||
23596973|NCT03531840|65915785|FG002|Overall Study|Death on study|1|||
23596974|NCT03531840|65915786|FG003|Overall Study|Death on study|2|||
23596975|NCT03531840|65915783|FG000|Overall Study|Death during follow up|2|||
23596976|NCT03531840|65915784|FG001|Overall Study|Death during follow up|3|||
23596977|NCT03531840|65915785|FG002|Overall Study|Death during follow up|4|||
23596978|NCT03531840|65915786|FG003|Overall Study|Death during follow up|1|||
23596979|NCT02107261|65915796|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
23596980|NCT02107261|65915797|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
23596981|NCT02107261|65915796|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
23596982|NCT02107261|65915797|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
23596983|NCT03756571|65915802|FG000|Overall Study|Lost to Follow-up|1|||
23596984|NCT03756571|65915803|FG001|Overall Study|Lost to Follow-up|1|||
23596985|NCT00709098|65915804|FG000|Double-blind Period|Withdrawal of consent|3|||
23645651|NCT01015560|66090885|FG000|Overall Study|Withdrawal by Subject|1|||
23596986|NCT00709098|65915805|FG001|Double-blind Period|Withdrawal of consent|3|||
23596987|NCT00709098|65915806|FG002|Double-blind Period|Withdrawal of consent|0|||
23478355|NCT00910624|65494535|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23478356|NCT00910624|65494532|FG000|Follow-Up Phase|Administrative|0|||
23478357|NCT00910624|65494533|FG001|Follow-Up Phase|Administrative|1|||
23478358|NCT00910624|65494534|FG002|Follow-Up Phase|Administrative|1|||
23478359|NCT00910624|65494535|FG003|Follow-Up Phase|Administrative|0|||
23478360|NCT03472547|65494537|FG000|Overall Study|Withdrawal by Subject|30|||
23478361|NCT00393510|65494538|FG000|Overall Study|Physician Decision|3|||
23478362|NCT00393510|65494539|FG001|Overall Study|Physician Decision|9|||
23478363|NCT00450385|65494541|FG000|Overall Study|Death|3|||
23478364|NCT00450385|65494541|FG000|Overall Study|Protocol Violation|1|||
23478365|NCT00450385|65494541|FG000|Overall Study|Withdrawal by Subject|2|||
23478366|NCT00450385|65494541|FG000|Overall Study|Lack of Efficacy|2|||
23478367|NCT00450385|65494541|FG000|Overall Study|Adverse Event|1|||
23478368|NCT00450385|65494541|FG000|Overall Study|Physician Decision|1|||
23478369|NCT00450385|65494541|FG000|Overall Study|Other|3|||
23478370|NCT00588861|65494542|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
23478371|NCT00588861|65494543|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
23478372|NCT00588861|65494542|FG000|6 Months|Patients did not return for follow-up|98|||
23478373|NCT00588861|65494543|FG001|6 Months|Patients did not return for follow-up|73|||
23478374|NCT00588861|65494542|FG000|1 Year|Patients did not return for follow-up|89|||
23478375|NCT00588861|65494543|FG001|1 Year|Patients did not return for follow-up|82|||
23478376|NCT00588861|65494542|FG000|2 Years|Patients did not return for follow-up|92|||
23478377|NCT00588861|65494543|FG001|2 Years|Patients did not return for follow-up|87|||
23478378|NCT00588861|65494542|FG000|4 Years|Patients did not return for follow-up|91|||
23478379|NCT00588861|65494543|FG001|4 Years|Patients did not return for follow-up|103|||
23478380|NCT00588861|65494542|FG000|6 Years|Patients did not return for follow-up|104|||
23478381|NCT00588861|65494543|FG001|6 Years|Patients did not return for follow-up|109|||
23478382|NCT00588861|65494542|FG000|8 Years|Patients did not return for follow-up|105|||
23478383|NCT00588861|65494543|FG001|8 Years|Patients did not return for follow-up|114|||
23478384|NCT00588861|65494542|FG000|10 Years|Incomplete due to study termination|107|||
23478385|NCT00588861|65494543|FG001|10 Years|Incomplete due to study termination|114|||
23478386|NCT01001299|65494544|FG000|Overall Study|Insufficient Therapeutic Response|20|||
23478387|NCT01001299|65494544|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
23478388|NCT01001299|65494544|FG000|Overall Study|Death|1|||
23478389|NCT01001299|65494544|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
23478390|NCT01001299|65494544|FG000|Overall Study|Withdrew Consent|1|||
23478391|NCT00833417|65494545|FG000|Overall Study|Adverse Event|5|||
23478392|NCT00833417|65494546|FG001|Overall Study|Adverse Event|16|||
23478393|NCT00833417|65494545|FG000|Overall Study|Death|1|||
23478394|NCT00833417|65494546|FG001|Overall Study|Death|3|||
23478395|NCT00833417|65494545|FG000|Overall Study|Lost to Follow-up|1|||
23478396|NCT00833417|65494546|FG001|Overall Study|Lost to Follow-up|2|||
23478397|NCT00833417|65494545|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
23478398|NCT00833417|65494546|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
23478399|NCT00833417|65494545|FG000|Overall Study|Patient Decision to Withdraw|4|||
23478400|NCT00833417|65494546|FG001|Overall Study|Patient Decision to Withdraw|23|||
23478401|NCT00833417|65494545|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
23478402|NCT00833417|65494546|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
23478403|NCT00833417|65494545|FG000|Overall Study|Disease Progression|18|||
23478404|NCT00833417|65494546|FG001|Overall Study|Disease Progression|17|||
23478405|NCT00833417|65494545|FG000|Overall Study|Reason Not Specified|0|||
23478406|NCT00833417|65494546|FG001|Overall Study|Reason Not Specified|1|||
23478407|NCT00409175|65494558|FG000|Overall Study|Adverse Event|4|||
23478408|NCT00409175|65494559|FG001|Overall Study|Adverse Event|3|||
23478409|NCT00409175|65494558|FG000|Overall Study|Withdrawal by Subject|1|||
23478410|NCT00409175|65494559|FG001|Overall Study|Withdrawal by Subject|2|||
23478411|NCT00409175|65494558|FG000|Overall Study|Negative genotype|0|||
23478412|NCT00409175|65494559|FG001|Overall Study|Negative genotype|1|||
23478413|NCT00409175|65494558|FG000|Overall Study|Liver transplantation|13|||
23478414|NCT00409175|65494559|FG001|Overall Study|Liver transplantation|13|||
23596988|NCT00709098|65915804|FG000|Double-blind Period|Administrative reason|1|||
23596989|NCT00709098|65915805|FG001|Double-blind Period|Administrative reason|3|||
23596990|NCT00709098|65915806|FG002|Double-blind Period|Administrative reason|0|||
23596991|NCT00709098|65915804|FG000|Double-blind Period|Death|1|||
23596992|NCT00709098|65915805|FG001|Double-blind Period|Death|1|||
23478415|NCT01092832|65494560|FG000|Overall Study|Other|1|||
23478416|NCT01092832|65494561|FG001|Overall Study|Other|0|||
23478417|NCT04658940|65494562|FG000|Overall Study|Withdrawal by Subject|1|||
23478418|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
23478419|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23596993|NCT00709098|65915806|FG002|Double-blind Period|Death|0|||
23478420|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478421|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478422|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478423|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478424|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23596994|NCT00709098|65915804|FG000|Double-blind Period|Lost to Follow-up|1|||
23596995|NCT00709098|65915805|FG001|Double-blind Period|Lost to Follow-up|1|||
23596996|NCT00709098|65915806|FG002|Double-blind Period|Lost to Follow-up|0|||
23596997|NCT00709098|65915804|FG000|Open-label Period|Withdrawal of consent|0|||
23596998|NCT00709098|65915805|FG001|Open-label Period|Withdrawal of consent|0|||
23596999|NCT00709098|65915806|FG002|Open-label Period|Withdrawal of consent|7|||
23597000|NCT00709098|65915804|FG000|Open-label Period|Administrative reason|0|||
23597001|NCT00709098|65915805|FG001|Open-label Period|Administrative reason|0|||
23597002|NCT00709098|65915806|FG002|Open-label Period|Administrative reason|5|||
23597003|NCT00709098|65915804|FG000|Open-label Period|Death|0|||
23645652|NCT02040584|66090886|FG000|Overall Study|Adverse Event|13|||
23645653|NCT02040584|66090887|FG001|Overall Study|Adverse Event|6|||
23645654|NCT02040584|66090886|FG000|Overall Study|Protocol Violation|9|||
23645655|NCT02040584|66090887|FG001|Overall Study|Protocol Violation|11|||
23645656|NCT02040584|66090886|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23645657|NCT02040584|66090887|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23645658|NCT02040584|66090886|FG000|Overall Study|Death|6|||
23645659|NCT02040584|66090887|FG001|Overall Study|Death|3|||
23645660|NCT02040584|66090886|FG000|Overall Study|Transplant rejection/retransplant|0|||
23645661|NCT02040584|66090887|FG001|Overall Study|Transplant rejection/retransplant|1|||
23645662|NCT02040584|66090886|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
23645663|NCT02040584|66090887|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
23645664|NCT01668667|66090891|FG000|Overall Study|Adverse Event|3|||
23645665|NCT01668667|66090892|FG001|Overall Study|Adverse Event|6|||
23478425|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23597004|NCT00709098|65915805|FG001|Open-label Period|Death|0|||
23645666|NCT01668667|66090893|FG002|Overall Study|Adverse Event|4|||
23645667|NCT01668667|66090894|FG003|Overall Study|Adverse Event|4|||
23645668|NCT01668667|66090891|FG000|Overall Study|Lack of Efficacy|3|||
23645669|NCT01668667|66090892|FG001|Overall Study|Lack of Efficacy|2|||
23645670|NCT01668667|66090893|FG002|Overall Study|Lack of Efficacy|2|||
23645671|NCT01668667|66090894|FG003|Overall Study|Lack of Efficacy|3|||
23645672|NCT01668667|66090891|FG000|Overall Study|Protocol Violation|6|||
23645673|NCT01668667|66090892|FG001|Overall Study|Protocol Violation|10|||
23645674|NCT01668667|66090893|FG002|Overall Study|Protocol Violation|12|||
23645675|NCT01668667|66090894|FG003|Overall Study|Protocol Violation|5|||
23645676|NCT01668667|66090891|FG000|Overall Study|Lost to Follow-up|9|||
23645677|NCT01668667|66090892|FG001|Overall Study|Lost to Follow-up|4|||
23645678|NCT01668667|66090893|FG002|Overall Study|Lost to Follow-up|7|||
23645679|NCT01668667|66090894|FG003|Overall Study|Lost to Follow-up|6|||
23645680|NCT01668667|66090891|FG000|Overall Study|Physician Decision|3|||
23645681|NCT01668667|66090892|FG001|Overall Study|Physician Decision|0|||
23645682|NCT01668667|66090893|FG002|Overall Study|Physician Decision|1|||
23645683|NCT01668667|66090894|FG003|Overall Study|Physician Decision|0|||
23645684|NCT01668667|66090891|FG000|Overall Study|Withdrawal by Subject|7|||
23645685|NCT01668667|66090892|FG001|Overall Study|Withdrawal by Subject|4|||
23645686|NCT01668667|66090893|FG002|Overall Study|Withdrawal by Subject|5|||
23645687|NCT01668667|66090894|FG003|Overall Study|Withdrawal by Subject|5|||
23800613|NCT00567476|66646824|FG000|Overall Study|Lost to Follow-up|0|||
23597005|NCT00709098|65915806|FG002|Open-label Period|Death|1|||
23597006|NCT00709098|65915804|FG000|Open-label Period|Lost to Follow-up|0|||
23645688|NCT02003222|66090897|FG000|Induction|Never started treatment|0|||
23645689|NCT02003222|66090898|FG001|Induction|Never started treatment|0|||
23645690|NCT02003222|66090899|FG002|Induction|Never started treatment|0|||
23645691|NCT02003222|66090900|FG003|Induction|Never started treatment|0|||
23645692|NCT02003222|66090901|FG004|Induction|Never started treatment|8|||
23800614|NCT00567476|66646825|FG001|Overall Study|Lost to Follow-up|1|||
23800615|NCT00567476|66646824|FG000|Overall Study|Administrative issues|1|||
23800616|NCT00567476|66646825|FG001|Overall Study|Administrative issues|0|||
23800617|NCT00567476|66646824|FG000|Overall Study|Medical Decision|0|||
23645693|NCT02003222|66090897|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
23645694|NCT02003222|66090898|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
23645695|NCT02003222|66090899|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
23645696|NCT02003222|66090900|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
23645697|NCT02003222|66090901|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
23645698|NCT02003222|66090897|FG000|Induction|Adverse Event|0|||
23645699|NCT02003222|66090898|FG001|Induction|Adverse Event|0|||
23645700|NCT02003222|66090899|FG002|Induction|Adverse Event|0|||
23645701|NCT02003222|66090900|FG003|Induction|Adverse Event|0|||
23645702|NCT02003222|66090901|FG004|Induction|Adverse Event|13|||
23645703|NCT02003222|66090897|FG000|Induction|Alternative therapy|0|||
23645704|NCT02003222|66090898|FG001|Induction|Alternative therapy|0|||
23645705|NCT02003222|66090899|FG002|Induction|Alternative therapy|0|||
23645706|NCT02003222|66090900|FG003|Induction|Alternative therapy|0|||
23645707|NCT02003222|66090901|FG004|Induction|Alternative therapy|12|||
23645708|NCT02003222|66090897|FG000|Induction|Disease progression|0|||
23645709|NCT02003222|66090898|FG001|Induction|Disease progression|0|||
23645710|NCT02003222|66090899|FG002|Induction|Disease progression|0|||
23645711|NCT02003222|66090900|FG003|Induction|Disease progression|0|||
23645712|NCT02003222|66090901|FG004|Induction|Disease progression|22|||
23645713|NCT02003222|66090897|FG000|Induction|Death|0|||
23645714|NCT02003222|66090898|FG001|Induction|Death|0|||
23645715|NCT02003222|66090899|FG002|Induction|Death|0|||
23645716|NCT02003222|66090900|FG003|Induction|Death|0|||
23645717|NCT02003222|66090901|FG004|Induction|Death|3|||
23645718|NCT02003222|66090897|FG000|Induction|Withdrawal by Subject|0|||
23645719|NCT02003222|66090898|FG001|Induction|Withdrawal by Subject|0|||
23645720|NCT02003222|66090899|FG002|Induction|Withdrawal by Subject|0|||
23645721|NCT02003222|66090900|FG003|Induction|Withdrawal by Subject|0|||
23645722|NCT02003222|66090901|FG004|Induction|Withdrawal by Subject|8|||
23645723|NCT02003222|66090897|FG000|Induction|Other reasons|0|||
23645724|NCT02003222|66090898|FG001|Induction|Other reasons|0|||
23645725|NCT02003222|66090899|FG002|Induction|Other reasons|0|||
23645726|NCT02003222|66090900|FG003|Induction|Other reasons|0|||
23645727|NCT02003222|66090901|FG004|Induction|Other reasons|22|||
23645728|NCT02003222|66090897|FG000|Intensification|Never started treatment|0|||
23597007|NCT00709098|65915805|FG001|Open-label Period|Lost to Follow-up|0|||
23597008|NCT00709098|65915806|FG002|Open-label Period|Lost to Follow-up|1|||
23597009|NCT00585052|65915807|FG000|Overall Study|Withdrawal by Subject|1|||
23597010|NCT03621735|65915809|FG000|Overall Study|Withdrawal by Subject|13|||
23597011|NCT03621735|65915810|FG001|Overall Study|Withdrawal by Subject|13|||
23597012|NCT00424645|65915817|FG000|Overall Study|Death|1|||
23597013|NCT00424645|65915818|FG001|Overall Study|Death|0|||
23597014|NCT00274261|65915819|FG000|Overall Study|Adverse Event|19|||
23597015|NCT00274261|65915820|FG001|Overall Study|Adverse Event|11|||
23597016|NCT00274261|65915819|FG000|Overall Study|Pregnancy|114|||
23597017|NCT00274261|65915820|FG001|Overall Study|Pregnancy|83|||
23597018|NCT00274261|65915819|FG000|Overall Study|Withdrawal by Subject|179|||
23597019|NCT00274261|65915820|FG001|Overall Study|Withdrawal by Subject|126|||
23597020|NCT00274261|65915819|FG000|Overall Study|Protocol Violation|71|||
23597021|NCT00274261|65915820|FG001|Overall Study|Protocol Violation|42|||
23597022|NCT00274261|65915819|FG000|Overall Study|Lost to Follow-up|106|||
23597023|NCT00274261|65915820|FG001|Overall Study|Lost to Follow-up|75|||
23597024|NCT02058108|65915822|FG000|Overall Study|Abnormal Laboratory Values|0|||
23597025|NCT02058108|65915823|FG001|Overall Study|Abnormal Laboratory Values|1|||
23597026|NCT02058108|65915822|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
23597027|NCT02058108|65915823|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23597028|NCT02058108|65915822|FG000|Overall Study|No longer requires study drug|0|||
23597029|NCT02058108|65915823|FG001|Overall Study|No longer requires study drug|1|||
23597030|NCT02058108|65915822|FG000|Overall Study|Withdrawal by Subject|1|||
23597031|NCT02058108|65915823|FG001|Overall Study|Withdrawal by Subject|0|||
23645729|NCT02003222|66090898|FG001|Intensification|Never started treatment|0|||
23645730|NCT02003222|66090899|FG002|Intensification|Never started treatment|0|||
23645731|NCT02003222|66090900|FG003|Intensification|Never started treatment|0|||
23645732|NCT02003222|66090901|FG004|Intensification|Never started treatment|2|||
23645733|NCT02003222|66090897|FG000|Intensification|Adverse Event|0|||
23645734|NCT02003222|66090898|FG001|Intensification|Adverse Event|0|||
23360450|NCT04472494|65065716|FG001|Treatment|Death|2|||
23645735|NCT02003222|66090899|FG002|Intensification|Adverse Event|0|||
23645736|NCT02003222|66090900|FG003|Intensification|Adverse Event|0|||
23645737|NCT02003222|66090901|FG004|Intensification|Adverse Event|6|||
23645738|NCT02003222|66090897|FG000|Intensification|Alternative therapy|0|||
23360451|NCT04472494|65065715|FG000|Treatment|Hospital discharge|1|||
23360452|NCT04472494|65065716|FG001|Treatment|Hospital discharge|1|||
23360453|NCT02097823|65065717|FG000|Overall Study|Withdrawal by Subject|1|||
23360454|NCT02097823|65065718|FG001|Overall Study|Withdrawal by Subject|1|||
23360455|NCT03084302|65065719|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
23360456|NCT03084302|65065719|FG000|Overall Study|No valid objective monitor data|6|||
23360457|NCT00217581|65065720|FG000|Overall Study|Withdrawal by Subject|1|||
23360458|NCT01135524|65065725|FG000|Overall Study|Withdrawal by Subject|14|||
23360459|NCT01135524|65065725|FG000|Overall Study|Adverse Event|20|||
23360460|NCT01135524|65065725|FG000|Overall Study|Lost to Follow-up|3|||
23360461|NCT01135524|65065725|FG000|Overall Study|Administrative|151|||
23360462|NCT01135524|65065725|FG000|Overall Study|Lack of Efficacy|8|||
23360463|NCT01540981|65065726|FG000|Overall Study|Withdrawal by Subject|1|||
23360464|NCT01540981|65065727|FG001|Overall Study|Withdrawal by Subject|0|||
23360465|NCT03536663|65065728|FG000|Endexo|Protocol Violation|1|||
23360466|NCT05568797|65065737|FG000|Overall Study|Adverse Event|0|||
23360467|NCT05568797|65065738|FG001|Overall Study|Adverse Event|8|||
23360468|NCT05568797|65065737|FG000|Overall Study|Lost to Follow-up|2|||
23360469|NCT05568797|65065738|FG001|Overall Study|Lost to Follow-up|3|||
23360470|NCT05568797|65065737|FG000|Overall Study|Withdrawal by Subject|1|||
23360471|NCT05568797|65065738|FG001|Overall Study|Withdrawal by Subject|10|||
23800618|NCT00567476|66646825|FG001|Overall Study|Medical Decision|1|||
23800619|NCT00567476|66646824|FG000|Overall Study|Non-adherence to protocol|0|||
23800620|NCT00567476|66646825|FG001|Overall Study|Non-adherence to protocol|1|||
23800621|NCT02695719|66646826|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
23800622|NCT02695719|66646827|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
23800623|NCT02695719|66646826|FG000|Overall Study|Significant Protocol Deviation|0|||
23800624|NCT02695719|66646827|FG001|Overall Study|Significant Protocol Deviation|1|||
23800625|NCT02695719|66646826|FG000|Overall Study|Voluntary Withdrawal|1|||
23800626|NCT02695719|66646827|FG001|Overall Study|Voluntary Withdrawal|0|||
23800627|NCT04213209|66646829|FG000|Overall Study|Protocol Violation|1|||
23800628|NCT04213209|66646830|FG001|Overall Study|Protocol Violation|0|||
23800629|NCT04213209|66646831|FG002|Overall Study|Protocol Violation|0|||
23800630|NCT04213209|66646832|FG003|Overall Study|Protocol Violation|0|||
23800631|NCT04213209|66646833|FG004|Overall Study|Protocol Violation|0|||
23800632|NCT04213209|66646834|FG005|Overall Study|Protocol Violation|0|||
23800633|NCT01729026|66646836|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
23800634|NCT01729026|66646837|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
23800635|NCT01729026|66646836|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
23360472|NCT05568797|65065737|FG000|Overall Study|Other|2|||
23360473|NCT05568797|65065738|FG001|Overall Study|Other|2|||
23360474|NCT03374488|65065739|FG000|Overall Study|Death|13|||
23360475|NCT03374488|65065740|FG001|Overall Study|Death|13|||
23360476|NCT03374488|65065739|FG000|Overall Study|Withdrawal by Subject|3|||
23360477|NCT03374488|65065740|FG001|Overall Study|Withdrawal by Subject|1|||
23360478|NCT03374488|65065739|FG000|Overall Study|Physician Decision|3|||
23360479|NCT03374488|65065740|FG001|Overall Study|Physician Decision|0|||
23360480|NCT02058589|65065745|FG000|Overall Study|Serious Adverse Event|1|||
23360481|NCT02058589|65065746|FG001|Overall Study|Serious Adverse Event|1|||
23360482|NCT02058589|65065745|FG000|Overall Study|Non-Serious Adverse Event|1|||
23360483|NCT02058589|65065746|FG001|Overall Study|Non-Serious Adverse Event|0|||
23360484|NCT02058589|65065745|FG000|Overall Study|Withdrawal by Subject|0|||
23360485|NCT02058589|65065746|FG001|Overall Study|Withdrawal by Subject|1|||
23360486|NCT00357877|65065747|FG000|Overall Study|Death|2|||
23360487|NCT00357877|65065748|FG001|Overall Study|Death|1|||
23360488|NCT00357877|65065747|FG000|Overall Study|Lost to Follow-up|20|||
23360489|NCT00357877|65065748|FG001|Overall Study|Lost to Follow-up|23|||
23360490|NCT00357877|65065747|FG000|Overall Study|Withdrawal by Subject|3|||
23360491|NCT00357877|65065748|FG001|Overall Study|Withdrawal by Subject|3|||
23360492|NCT00357877|65065747|FG000|Overall Study|Administrative withdrawal|1|||
23360493|NCT00357877|65065748|FG001|Overall Study|Administrative withdrawal|1|||
23360494|NCT00357877|65065747|FG000|Overall Study|Other|0|||
23360495|NCT00357877|65065748|FG001|Overall Study|Other|2|||
23360496|NCT02306850|65065751|FG000|Overall Study|Lack of Efficacy|2|||
23360497|NCT01210482|65065752|FG000|Overall Study|Protocol Violation|1|||
23360498|NCT01210482|65065752|FG000|Overall Study|Case Report Forms were not collected|18|||
23360499|NCT01210482|65065752|FG000|Overall Study|Duplicated|2|||
23360500|NCT01210482|65065752|FG000|Overall Study|No Drug Administration|28|||
23360501|NCT03052920|65065753|FG000|Overall Study|Withdrawal by Subject|1|||
23360502|NCT00792909|65065755|FG000|Overall Study|Withdrawal by Subject|0|||
23800636|NCT01729026|66646837|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
23800637|NCT04403399|66646847|FG000|Period 2|Physician Decision|0|||
23800638|NCT04403399|66646848|FG001|Period 2|Physician Decision|1|||
23800639|NCT02427984|66646849|FG000|Overall Study|Lost to Follow-up|13|||
23800640|NCT02427984|66646850|FG001|Overall Study|Lost to Follow-up|5|||
23800641|NCT02427984|66646851|FG002|Overall Study|Lost to Follow-up|18|||
23360503|NCT00792909|65065756|FG001|Overall Study|Withdrawal by Subject|1|||
23645739|NCT02003222|66090898|FG001|Intensification|Alternative therapy|0|||
23645740|NCT02003222|66090899|FG002|Intensification|Alternative therapy|0|||
23645741|NCT02003222|66090900|FG003|Intensification|Alternative therapy|0|||
23645742|NCT02003222|66090901|FG004|Intensification|Alternative therapy|8|||
23645743|NCT02003222|66090897|FG000|Intensification|Disease progression|0|||
23645744|NCT02003222|66090898|FG001|Intensification|Disease progression|0|||
23645745|NCT02003222|66090899|FG002|Intensification|Disease progression|0|||
23645746|NCT02003222|66090900|FG003|Intensification|Disease progression|0|||
23645747|NCT02003222|66090901|FG004|Intensification|Disease progression|18|||
23645748|NCT02003222|66090897|FG000|Intensification|Withdrawal by Subject|0|||
23645749|NCT02003222|66090898|FG001|Intensification|Withdrawal by Subject|0|||
23645750|NCT02003222|66090899|FG002|Intensification|Withdrawal by Subject|0|||
23645751|NCT02003222|66090900|FG003|Intensification|Withdrawal by Subject|0|||
23645752|NCT02003222|66090901|FG004|Intensification|Withdrawal by Subject|5|||
23645753|NCT02003222|66090897|FG000|Intensification|Other reasons|0|||
23645754|NCT02003222|66090898|FG001|Intensification|Other reasons|0|||
23645755|NCT02003222|66090899|FG002|Intensification|Other reasons|0|||
23645756|NCT02003222|66090900|FG003|Intensification|Other reasons|0|||
23645757|NCT02003222|66090901|FG004|Intensification|Other reasons|8|||
23645758|NCT00095498|66090913|FG000|Overall Study|Physician Decision|9|||
23645759|NCT00095498|66090914|FG001|Overall Study|Physician Decision|10|||
23645760|NCT00095498|66090915|FG002|Overall Study|Physician Decision|8|||
23645761|NCT00095498|66090913|FG000|Overall Study|Adverse Event|1|||
23645762|NCT00095498|66090914|FG001|Overall Study|Adverse Event|0|||
23645763|NCT00095498|66090915|FG002|Overall Study|Adverse Event|1|||
23645764|NCT00095498|66090913|FG000|Overall Study|Withdrawal by Subject|15|||
23645765|NCT00095498|66090914|FG001|Overall Study|Withdrawal by Subject|16|||
23645766|NCT00095498|66090915|FG002|Overall Study|Withdrawal by Subject|15|||
23645767|NCT00095498|66090913|FG000|Overall Study|Disease progression|0|||
23645768|NCT00095498|66090914|FG001|Overall Study|Disease progression|1|||
23645769|NCT00095498|66090915|FG002|Overall Study|Disease progression|1|||
23645770|NCT00095498|66090913|FG000|Overall Study|Ineligibility determined|3|||
23597032|NCT02058108|65915822|FG000|Overall Study|Administrative problems|3|||
23597033|NCT02058108|65915823|FG001|Overall Study|Administrative problems|3|||
23597034|NCT02058108|65915822|FG000|Overall Study|Protocol Violation|0|||
23597035|NCT02058108|65915823|FG001|Overall Study|Protocol Violation|1|||
23597036|NCT00826280|65915824|FG000|Overall Study|Randomized but drug not received|1|||
23597037|NCT00826280|65915825|FG001|Overall Study|Randomized but drug not received|0|||
23597038|NCT00826280|65915826|FG002|Overall Study|Randomized but drug not received|1|||
23597039|NCT00826280|65915824|FG000|Overall Study|Adverse Event|1|||
23597040|NCT00826280|65915825|FG001|Overall Study|Adverse Event|3|||
23597041|NCT00826280|65915826|FG002|Overall Study|Adverse Event|0|||
23597042|NCT00826280|65915824|FG000|Overall Study|Lost to Follow-up|0|||
23597043|NCT00826280|65915825|FG001|Overall Study|Lost to Follow-up|1|||
23597044|NCT00826280|65915826|FG002|Overall Study|Lost to Follow-up|0|||
23597045|NCT00826280|65915824|FG000|Overall Study|Sponsor discontinued subject or study|1|||
23597046|NCT00826280|65915825|FG001|Overall Study|Sponsor discontinued subject or study|0|||
23597047|NCT00826280|65915826|FG002|Overall Study|Sponsor discontinued subject or study|0|||
23597048|NCT00826280|65915824|FG000|Overall Study|Reversible ischemic defect not present|43|||
23597049|NCT00826280|65915825|FG001|Overall Study|Reversible ischemic defect not present|40|||
23597050|NCT00826280|65915826|FG002|Overall Study|Reversible ischemic defect not present|44|||
23597051|NCT00826280|65915824|FG000|Overall Study|Interpretation Failure|1|||
23597052|NCT00826280|65915825|FG001|Overall Study|Interpretation Failure|0|||
23597053|NCT00826280|65915826|FG002|Overall Study|Interpretation Failure|0|||
23597054|NCT00826280|65915824|FG000|Overall Study|Machine Failure|1|||
23645771|NCT00095498|66090914|FG001|Overall Study|Ineligibility determined|0|||
23645772|NCT00095498|66090915|FG002|Overall Study|Ineligibility determined|2|||
23645773|NCT00095498|66090913|FG000|Overall Study|Lost to Follow-up|1|||
23645774|NCT00095498|66090914|FG001|Overall Study|Lost to Follow-up|1|||
23645775|NCT00095498|66090915|FG002|Overall Study|Lost to Follow-up|2|||
23645776|NCT00095498|66090913|FG000|Overall Study|Noncompliance|1|||
23645777|NCT00095498|66090914|FG001|Overall Study|Noncompliance|0|||
23645778|NCT00095498|66090915|FG002|Overall Study|Noncompliance|1|||
23645779|NCT00095498|66090913|FG000|Overall Study|Other|6|||
23645780|NCT00095498|66090914|FG001|Overall Study|Other|7|||
23645781|NCT00095498|66090915|FG002|Overall Study|Other|6|||
23645782|NCT00095498|66090913|FG000|Overall Study|Protocol Violation|0|||
23645783|NCT00095498|66090914|FG001|Overall Study|Protocol Violation|0|||
23645784|NCT00095498|66090915|FG002|Overall Study|Protocol Violation|1|||
23645785|NCT00095498|66090913|FG000|Overall Study|Requirement for alternative therapy|1|||
23645786|NCT00095498|66090914|FG001|Overall Study|Requirement for alternative therapy|0|||
23645787|NCT00095498|66090915|FG002|Overall Study|Requirement for alternative therapy|2|||
23645788|NCT00195091|66090919|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
23645789|NCT00818649|66090920|FG000|Overall Study|Declining performance status|2|||
23645790|NCT00818649|66090920|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
23645791|NCT00818649|66090920|FG000|Overall Study|Adverse Event|1|||
23645792|NCT03836716|66090921|FG000|Overall Study|Adverse Event|3|||
23645793|NCT03836716|66090921|FG000|Overall Study|Death|22|||
23645794|NCT03836716|66090921|FG000|Overall Study|Withdrawal by Subject|8|||
23645795|NCT03836716|66090921|FG000|Overall Study|Study terminated by sponsor|87|||
23645796|NCT02729831|66090925|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
23645797|NCT02729831|66090926|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
23645798|NCT02729831|66090927|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
23645799|NCT02729831|66090928|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
23645800|NCT02729831|66090925|FG000|1 Week Post-visit|Lost to Follow-up|43|||
23645801|NCT02729831|66090926|FG001|1 Week Post-visit|Lost to Follow-up|40|||
23645802|NCT02729831|66090927|FG002|1 Week Post-visit|Lost to Follow-up|38|||
23645803|NCT02729831|66090928|FG003|1 Week Post-visit|Lost to Follow-up|36|||
23645804|NCT02729831|66090925|FG000|6 Month Follow-up|Lost to Follow-up|54|||
23645805|NCT02729831|66090926|FG001|6 Month Follow-up|Lost to Follow-up|51|||
23645806|NCT02729831|66090927|FG002|6 Month Follow-up|Lost to Follow-up|48|||
23645807|NCT02729831|66090928|FG003|6 Month Follow-up|Lost to Follow-up|42|||
23645808|NCT02729831|66090925|FG000|6 Month Follow-up|Death|1|||
23645809|NCT02729831|66090926|FG001|6 Month Follow-up|Death|3|||
23645810|NCT02729831|66090927|FG002|6 Month Follow-up|Death|0|||
23645811|NCT02729831|66090928|FG003|6 Month Follow-up|Death|1|||
23645812|NCT01028027|66090930|FG000|Overall Study|Lost to Follow-up|4|||
23645813|NCT01028027|66090931|FG001|Overall Study|Lost to Follow-up|1|||
23645814|NCT01028027|66090930|FG000|Overall Study|Withdrawal by Subject|5|||
23645815|NCT01028027|66090931|FG001|Overall Study|Withdrawal by Subject|3|||
23645816|NCT01028027|66090930|FG000|Overall Study|Adverse Event|4|||
23645817|NCT01028027|66090931|FG001|Overall Study|Adverse Event|7|||
23645818|NCT01028027|66090930|FG000|Overall Study|Protocol Violation|3|||
23645819|NCT01028027|66090931|FG001|Overall Study|Protocol Violation|1|||
23645820|NCT01028027|66090930|FG000|Overall Study|Lack of Efficacy|0|||
23645821|NCT01028027|66090931|FG001|Overall Study|Lack of Efficacy|1|||
23645822|NCT01941719|66090934|FG000|Overall Study|Lost to Follow-up|20|||
23645823|NCT01941719|66090935|FG001|Overall Study|Lost to Follow-up|19|||
23645824|NCT00423943|66090945|FG000|Overall Study|Withdrawal by Subject|3|||
23645825|NCT00423943|66090946|FG001|Overall Study|Withdrawal by Subject|1|||
23645826|NCT02447172|66090949|FG000|Overall Study|Adverse Event|11|||
23645827|NCT02447172|66090950|FG001|Overall Study|Adverse Event|8|||
23645828|NCT02447172|66090951|FG002|Overall Study|Adverse Event|7|||
23645829|NCT02447172|66090949|FG000|Overall Study|Death|3|||
23645830|NCT02447172|66090950|FG001|Overall Study|Death|1|||
23645831|NCT02447172|66090951|FG002|Overall Study|Death|0|||
23645832|NCT02447172|66090949|FG000|Overall Study|Protocol Violation|2|||
23645833|NCT02447172|66090950|FG001|Overall Study|Protocol Violation|1|||
23645834|NCT02447172|66090951|FG002|Overall Study|Protocol Violation|2|||
23645835|NCT02447172|66090949|FG000|Overall Study|Lost to Follow-up|7|||
23645836|NCT02447172|66090950|FG001|Overall Study|Lost to Follow-up|4|||
23645837|NCT02447172|66090951|FG002|Overall Study|Lost to Follow-up|4|||
23645838|NCT02447172|66090949|FG000|Overall Study|Withdrawal by Subject|5|||
23645839|NCT02447172|66090950|FG001|Overall Study|Withdrawal by Subject|1|||
23645840|NCT02447172|66090951|FG002|Overall Study|Withdrawal by Subject|3|||
23645841|NCT02447172|66090949|FG000|Overall Study|protocol specific treatment unrelated|3|||
23645842|NCT02447172|66090950|FG001|Overall Study|protocol specific treatment unrelated|0|||
23645843|NCT02447172|66090951|FG002|Overall Study|protocol specific treatment unrelated|2|||
23645844|NCT00484289|66090952|FG000|Long Term Phase|Adverse Event|1|||
23645845|NCT00484289|66090953|FG001|Long Term Phase|Adverse Event|17|||
23645846|NCT00484289|66090954|FG002|Long Term Phase|Adverse Event|5|||
23645847|NCT00484289|66090952|FG000|Long Term Phase|Withdrawal by Subject|0|||
23645848|NCT00484289|66090953|FG001|Long Term Phase|Withdrawal by Subject|7|||
23645849|NCT00484289|66090954|FG002|Long Term Phase|Withdrawal by Subject|6|||
23645850|NCT00484289|66090952|FG000|Long Term Phase|Inadequate response|2|||
23645851|NCT00484289|66090953|FG001|Long Term Phase|Inadequate response|7|||
23645852|NCT00484289|66090954|FG002|Long Term Phase|Inadequate response|4|||
23645853|NCT00484289|66090952|FG000|Long Term Phase|Other Reason|0|||
23645854|NCT00484289|66090953|FG001|Long Term Phase|Other Reason|5|||
23645855|NCT00484289|66090954|FG002|Long Term Phase|Other Reason|1|||
23645856|NCT00484289|66090952|FG000|Post Marketing Phase|Adverse Event|0|||
23645857|NCT00484289|66090953|FG001|Post Marketing Phase|Adverse Event|1|||
23645858|NCT00484289|66090954|FG002|Post Marketing Phase|Adverse Event|0|||
23645859|NCT03110185|66090955|FG000|Overall Study|Death|0|||
23645860|NCT03110185|66090956|FG001|Overall Study|Death|1|||
23645861|NCT03110185|66090955|FG000|Overall Study|Withdrawal by Subject|2|||
23645862|NCT03110185|66090956|FG001|Overall Study|Withdrawal by Subject|7|||
23645863|NCT03110185|66090955|FG000|Overall Study|Time Constraints|0|||
23645864|NCT03110185|66090956|FG001|Overall Study|Time Constraints|6|||
23645865|NCT03110185|66090955|FG000|Overall Study|Conflict with care|5|||
23645866|NCT03110185|66090956|FG001|Overall Study|Conflict with care|12|||
23645867|NCT03110185|66090955|FG000|Overall Study|Protocol Violation|1|||
23645868|NCT03110185|66090956|FG001|Overall Study|Protocol Violation|4|||
23645869|NCT03110185|66090955|FG000|Overall Study|MRI Incompatible|2|||
23645870|NCT03110185|66090956|FG001|Overall Study|MRI Incompatible|0|||
23645871|NCT03110185|66090955|FG000|Overall Study|Patient Refusal|0|||
23645872|NCT03110185|66090956|FG001|Overall Study|Patient Refusal|1|||
23645873|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
23645874|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
23645875|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
23597055|NCT00826280|65915825|FG001|Overall Study|Machine Failure|1|||
23597056|NCT00826280|65915826|FG002|Overall Study|Machine Failure|0|||
23597057|NCT00826280|65915824|FG000|Overall Study|One or more non-interpretable scan|0|||
23597058|NCT00826280|65915825|FG001|Overall Study|One or more non-interpretable scan|1|||
23597059|NCT00826280|65915826|FG002|Overall Study|One or more non-interpretable scan|1|||
23597060|NCT01985334|65915827|FG000|Overall Study|Administrative problems|1|||
23597061|NCT01985334|65915828|FG001|Overall Study|Administrative problems|1|||
23597062|NCT01985334|65915829|FG002|Overall Study|Administrative problems|0|||
23597063|NCT01985334|65915830|FG003|Overall Study|Administrative problems|2|||
23597064|NCT01985334|65915831|FG004|Overall Study|Administrative problems|0|||
23597065|NCT01985334|65915832|FG005|Overall Study|Administrative problems|1|||
23597066|NCT01985334|65915833|FG006|Overall Study|Administrative problems|1|||
23597067|NCT01985334|65915834|FG007|Overall Study|Administrative problems|3|||
23597068|NCT01985334|65915827|FG000|Overall Study|Death|1|||
23597069|NCT01985334|65915828|FG001|Overall Study|Death|0|||
23597070|NCT01985334|65915829|FG002|Overall Study|Death|0|||
23597071|NCT01985334|65915830|FG003|Overall Study|Death|3|||
23597072|NCT01985334|65915831|FG004|Overall Study|Death|0|||
23645876|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
23645877|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
23645878|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
23645879|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
23645880|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
23645881|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
23645882|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
23645883|NCT01237587|66090957|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
23645884|NCT01237587|66090958|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
23645885|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
23645886|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
23645887|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
23645888|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
23645889|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
23645890|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
23645891|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
23645892|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
23645893|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
23645894|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
23645895|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
23645896|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
23645897|NCT01237587|66090957|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
23645898|NCT01237587|66090958|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
23645899|NCT01237587|66090957|FG000|Taper Phase|Adverse Event|0|||
23645900|NCT01237587|66090958|FG001|Taper Phase|Adverse Event|2|||
23597073|NCT01985334|65915832|FG005|Overall Study|Death|0|||
23645901|NCT01237587|66090957|FG000|Taper Phase|Protocol Violation|2|||
23645902|NCT01237587|66090958|FG001|Taper Phase|Protocol Violation|0|||
23645903|NCT01237587|66090957|FG000|Taper Phase|Lack of Efficacy|2|||
23360504|NCT00792909|65065757|FG002|Overall Study|Withdrawal by Subject|0|||
23597074|NCT01985334|65915833|FG006|Overall Study|Death|1|||
23645904|NCT01237587|66090958|FG001|Taper Phase|Lack of Efficacy|5|||
23597075|NCT01985334|65915834|FG007|Overall Study|Death|2|||
23597076|NCT01985334|65915827|FG000|Overall Study|Worsening of disease|0|||
23645905|NCT01237587|66090957|FG000|Taper Phase|Parent/Guardian Decision|0|||
23645906|NCT01237587|66090958|FG001|Taper Phase|Parent/Guardian Decision|2|||
23645907|NCT01237587|66090957|FG000|Taper Phase|Sponsor Decision|1|||
23645908|NCT01237587|66090958|FG001|Taper Phase|Sponsor Decision|0|||
23645909|NCT01237587|66090957|FG000|Taper Phase|Withdrawal by Subject|0|||
23645910|NCT01237587|66090958|FG001|Taper Phase|Withdrawal by Subject|1|||
23645911|NCT00156819|66090961|FG000|Overall Study|Lost to Follow-up|1|||
23645912|NCT00156819|66090962|FG001|Overall Study|Lost to Follow-up|1|||
23645913|NCT00156819|66090963|FG002|Overall Study|Lost to Follow-up|3|||
23645914|NCT00690443|66090969|FG000|Overall Study|Adverse Event|1|||
23645915|NCT00690443|66090970|FG001|Overall Study|Adverse Event|2|||
23645916|NCT02963610|66090975|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
23645917|NCT03733899|66090979|FG000|Period 1|Protocol Violation|0|||
23645918|NCT03733899|66090980|FG001|Period 1|Protocol Violation|0|||
23645919|NCT03733899|66090981|FG002|Period 1|Protocol Violation|0|||
23645920|NCT03733899|66090982|FG003|Period 1|Protocol Violation|0|||
23645921|NCT03733899|66090983|FG004|Period 1|Protocol Violation|0|||
23645922|NCT03733899|66090984|FG005|Period 1|Protocol Violation|1|||
23645923|NCT03733899|66090979|FG000|Period 2|Unscuccessful Treatment|0|||
23597077|NCT01985334|65915828|FG001|Overall Study|Worsening of disease|0|||
23597078|NCT01985334|65915829|FG002|Overall Study|Worsening of disease|0|||
23597079|NCT01985334|65915830|FG003|Overall Study|Worsening of disease|1|||
23597080|NCT01985334|65915831|FG004|Overall Study|Worsening of disease|0|||
23597081|NCT01985334|65915832|FG005|Overall Study|Worsening of disease|3|||
23597082|NCT01985334|65915833|FG006|Overall Study|Worsening of disease|0|||
23597083|NCT01985334|65915834|FG007|Overall Study|Worsening of disease|1|||
23597084|NCT01985334|65915827|FG000|Overall Study|Other|2|||
23597085|NCT01985334|65915828|FG001|Overall Study|Other|9|||
23597086|NCT01985334|65915829|FG002|Overall Study|Other|7|||
23597087|NCT01985334|65915830|FG003|Overall Study|Other|17|||
23597088|NCT01985334|65915831|FG004|Overall Study|Other|4|||
23597089|NCT01985334|65915832|FG005|Overall Study|Other|8|||
23597090|NCT01985334|65915833|FG006|Overall Study|Other|4|||
23645924|NCT03733899|66090980|FG001|Period 2|Unscuccessful Treatment|1|||
23645925|NCT03733899|66090981|FG002|Period 2|Unscuccessful Treatment|0|||
23645926|NCT03733899|66090982|FG003|Period 2|Unscuccessful Treatment|0|||
23645927|NCT03733899|66090983|FG004|Period 2|Unscuccessful Treatment|0|||
23645928|NCT03733899|66090984|FG005|Period 2|Unscuccessful Treatment|0|||
23645929|NCT03733899|66090979|FG000|Period 3|Withdrawal by Subject|1|||
23645930|NCT03733899|66090980|FG001|Period 3|Withdrawal by Subject|0|||
23645931|NCT03733899|66090981|FG002|Period 3|Withdrawal by Subject|0|||
23645932|NCT03733899|66090982|FG003|Period 3|Withdrawal by Subject|0|||
23645933|NCT03733899|66090983|FG004|Period 3|Withdrawal by Subject|0|||
23645934|NCT03733899|66090984|FG005|Period 3|Withdrawal by Subject|0|||
23645935|NCT00336895|66090987|FG000|Overall Study|diarrhea|1|||
23645936|NCT00336895|66090987|FG000|Overall Study|nausea and upset stomach|1|||
23645937|NCT00336895|66090987|FG000|Overall Study|Physician Decision|1|||
23800642|NCT00865098|66646852|FG000|Overall Study|Progressive disease|1|||
23800643|NCT02070757|66646855|FG000|Overall Study|Adverse Event|107|||
23800644|NCT02070757|66646856|FG001|Overall Study|Adverse Event|99|||
23800645|NCT02070757|66646855|FG000|Overall Study|Lost to Follow-up|7|||
23800646|NCT02070757|66646856|FG001|Overall Study|Lost to Follow-up|4|||
23800647|NCT02070757|66646855|FG000|Overall Study|Protocol Violation|0|||
23800648|NCT02070757|66646856|FG001|Overall Study|Protocol Violation|4|||
23800649|NCT02070757|66646855|FG000|Overall Study|Withdrawal by Subject|1|||
23800650|NCT02070757|66646856|FG001|Overall Study|Withdrawal by Subject|3|||
23800651|NCT02070757|66646855|FG000|Overall Study|Investigator Decision|0|||
23800652|NCT02070757|66646856|FG001|Overall Study|Investigator Decision|2|||
23800653|NCT02070757|66646855|FG000|Overall Study|Discharged from Study Hospital|2|||
23800654|NCT02070757|66646856|FG001|Overall Study|Discharged from Study Hospital|2|||
23800655|NCT02487082|66646857|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
23800656|NCT02487082|66646858|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
23800657|NCT02487082|66646857|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
23597091|NCT01985334|65915834|FG007|Overall Study|Other|7|||
23800658|NCT02487082|66646858|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
23800659|NCT01253317|66646859|FG000|Overall Study|Adverse Event|2|||
23597092|NCT01985334|65915827|FG000|Overall Study|Protocol deviation|6|||
23597093|NCT01985334|65915828|FG001|Overall Study|Protocol deviation|31|||
23597094|NCT01985334|65915829|FG002|Overall Study|Protocol deviation|25|||
23800660|NCT00708708|66646860|FG000|Overall Study|Another therapy instead of Enbrel|141|||
23800661|NCT00708708|66646860|FG000|Overall Study|Lost to Follow-up|52|||
23597095|NCT01985334|65915830|FG003|Overall Study|Protocol deviation|84|||
23597096|NCT01985334|65915831|FG004|Overall Study|Protocol deviation|17|||
23597097|NCT01985334|65915832|FG005|Overall Study|Protocol deviation|47|||
23645938|NCT00336895|66090987|FG000|Overall Study|screen failed|1|||
23645939|NCT03695237|66090991|FG000|Overall Study|Withdrawal by Subject|1|||
23645940|NCT03695237|66090992|FG001|Overall Study|Withdrawal by Subject|3|||
23645941|NCT03695237|66090991|FG000|Overall Study|Lost to Follow-up|1|||
23645942|NCT03695237|66090992|FG001|Overall Study|Lost to Follow-up|2|||
23645943|NCT03695237|66090991|FG000|Overall Study|Other, Not Specified|8|||
23645944|NCT03695237|66090992|FG001|Overall Study|Other, Not Specified|2|||
23645945|NCT02649946|66090993|FG000|Overall Study|Withdrawal by Subject|1|||
23645946|NCT02649946|66090994|FG001|Overall Study|Withdrawal by Subject|1|||
23645947|NCT02649946|66090993|FG000|Overall Study|Death|7|||
23645948|NCT02649946|66090994|FG001|Overall Study|Death|9|||
23645949|NCT02649946|66090993|FG000|Overall Study|Physician Decision|1|||
23645950|NCT02649946|66090994|FG001|Overall Study|Physician Decision|0|||
23645951|NCT02649946|66090993|FG000|Overall Study|Lost to Follow-up|2|||
23645952|NCT02649946|66090994|FG001|Overall Study|Lost to Follow-up|1|||
23645953|NCT02649946|66090993|FG000|Overall Study|Erroneously enrolled|1|||
23645954|NCT02649946|66090994|FG001|Overall Study|Erroneously enrolled|0|||
23645955|NCT02649946|66090993|FG000|Overall Study|Missed 6-month follow-up visit|0|||
23645956|NCT02649946|66090994|FG001|Overall Study|Missed 6-month follow-up visit|4|||
23645957|NCT00768079|66091001|FG000|Overall Study|Lost to Follow-up|2|||
23645958|NCT00768079|66091002|FG001|Overall Study|Lost to Follow-up|0|||
23645959|NCT00768079|66091003|FG002|Overall Study|Lost to Follow-up|4|||
23645960|NCT00768079|66091001|FG000|Overall Study|Participant incarcerated|0|||
23645961|NCT00768079|66091002|FG001|Overall Study|Participant incarcerated|1|||
23645962|NCT00768079|66091003|FG002|Overall Study|Participant incarcerated|0|||
23645963|NCT03265938|66091004|FG000|Overall Study|Withdrawal by Subject|1|||
23645964|NCT03265938|66091004|FG000|Overall Study|Physician Decision|1|||
23645965|NCT03265938|66091004|FG000|Overall Study|friable mass|6|||
23645966|NCT02730598|66091010|FG000|Overall Study|Withdrawal by Subject|3|||
23645967|NCT02730598|66091011|FG001|Overall Study|Withdrawal by Subject|3|||
23645968|NCT02730598|66091010|FG000|Overall Study|Protocol Violation|0|||
23645969|NCT02730598|66091011|FG001|Overall Study|Protocol Violation|1|||
23645970|NCT02730598|66091010|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
23645971|NCT02730598|66091011|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
23645972|NCT01323634|66091012|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
23645973|NCT01323634|66091013|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
23645974|NCT01323634|66091014|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
23645975|NCT01323634|66091012|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
23645976|NCT01323634|66091013|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
23645977|NCT01323634|66091014|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
23645978|NCT01323634|66091012|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
23645979|NCT01323634|66091013|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23645980|NCT01323634|66091014|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23645981|NCT01323634|66091012|FG000|2-week Run-in Period|Physician Decision|5|||
23645982|NCT01323634|66091013|FG001|2-week Run-in Period|Physician Decision|0|||
23645983|NCT01323634|66091014|FG002|2-week Run-in Period|Physician Decision|0|||
23645984|NCT01323634|66091012|FG000|2-week Run-in Period|Protocol Violation|1|||
23645985|NCT01323634|66091013|FG001|2-week Run-in Period|Protocol Violation|0|||
23645986|NCT01323634|66091014|FG002|2-week Run-in Period|Protocol Violation|0|||
23645987|NCT01323634|66091012|FG000|2-week Run-in Period|Adverse Event|1|||
23645988|NCT01323634|66091013|FG001|2-week Run-in Period|Adverse Event|0|||
23645989|NCT01323634|66091014|FG002|2-week Run-in Period|Adverse Event|0|||
23645990|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23645991|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
23645992|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
23645993|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23645994|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23645995|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
23645996|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23645997|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
23645998|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
23645999|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23646000|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23646001|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23646002|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
23646003|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
23646004|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
23646005|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23478426|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23646006|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
23646007|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
23646008|NCT01323634|66091012|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
23646009|NCT01323634|66091013|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
23646010|NCT01323634|66091014|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
23646011|NCT02962960|66091015|FG000|Overall Study|Withdrawal by Subject|1|||
23800662|NCT00708708|66646860|FG000|Overall Study|Withdrawal by Subject|51|||
23800663|NCT00708708|66646860|FG000|Overall Study|Intolerance|42|||
23646012|NCT02962960|66091016|FG001|Overall Study|Withdrawal by Subject|1|||
23646013|NCT02962960|66091017|FG002|Overall Study|Withdrawal by Subject|0|||
23646014|NCT02962960|66091015|FG000|Overall Study|Adverse Event|1|||
23646015|NCT02962960|66091016|FG001|Overall Study|Adverse Event|1|||
23646016|NCT02962960|66091017|FG002|Overall Study|Adverse Event|0|||
23646017|NCT02962960|66091015|FG000|Overall Study|Protocol Violation|1|||
23646018|NCT02962960|66091016|FG001|Overall Study|Protocol Violation|0|||
23646019|NCT02962960|66091017|FG002|Overall Study|Protocol Violation|0|||
23646020|NCT03607422|66091018|FG000|Overall Study|Adverse Event|7|||
23646021|NCT03607422|66091019|FG001|Overall Study|Adverse Event|3|||
23646022|NCT03607422|66091020|FG002|Overall Study|Adverse Event|2|||
23646023|NCT03607422|66091021|FG003|Overall Study|Adverse Event|0|||
23646024|NCT03607422|66091022|FG004|Overall Study|Adverse Event|2|||
23646025|NCT03607422|66091023|FG005|Overall Study|Adverse Event|0|||
23646026|NCT03607422|66091018|FG000|Overall Study|Withdrawal by Subject|11|||
23646027|NCT03607422|66091019|FG001|Overall Study|Withdrawal by Subject|3|||
23646028|NCT03607422|66091020|FG002|Overall Study|Withdrawal by Subject|6|||
23646029|NCT03607422|66091021|FG003|Overall Study|Withdrawal by Subject|2|||
23646030|NCT03607422|66091022|FG004|Overall Study|Withdrawal by Subject|0|||
23646031|NCT03607422|66091023|FG005|Overall Study|Withdrawal by Subject|0|||
23646032|NCT03607422|66091018|FG000|Overall Study|Lost to Follow-up|0|||
23646033|NCT03607422|66091019|FG001|Overall Study|Lost to Follow-up|0|||
23646034|NCT03607422|66091020|FG002|Overall Study|Lost to Follow-up|1|||
23646035|NCT03607422|66091021|FG003|Overall Study|Lost to Follow-up|0|||
23646036|NCT03607422|66091022|FG004|Overall Study|Lost to Follow-up|0|||
23646037|NCT03607422|66091023|FG005|Overall Study|Lost to Follow-up|0|||
23646038|NCT03607422|66091018|FG000|Overall Study|Other|12|||
23646039|NCT03607422|66091019|FG001|Overall Study|Other|4|||
23646040|NCT03607422|66091020|FG002|Overall Study|Other|1|||
23646041|NCT03607422|66091021|FG003|Overall Study|Other|2|||
23646042|NCT03607422|66091022|FG004|Overall Study|Other|0|||
23800664|NCT00708708|66646860|FG000|Overall Study|Another therapy along with Enbrel|15|||
23597098|NCT01985334|65915833|FG006|Overall Study|Protocol deviation|15|||
23597099|NCT01985334|65915834|FG007|Overall Study|Protocol deviation|42|||
23597100|NCT01985334|65915827|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
23597101|NCT01985334|65915828|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
23597102|NCT01985334|65915829|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
23597103|NCT01985334|65915830|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
23597104|NCT01985334|65915831|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
23597105|NCT01985334|65915832|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
23597106|NCT01985334|65915833|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
23597107|NCT01985334|65915834|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
23597108|NCT01985334|65915827|FG000|Overall Study|Subject withdrawal of consent|3|||
23597109|NCT01985334|65915828|FG001|Overall Study|Subject withdrawal of consent|6|||
23597110|NCT01985334|65915829|FG002|Overall Study|Subject withdrawal of consent|2|||
23597111|NCT01985334|65915830|FG003|Overall Study|Subject withdrawal of consent|28|||
23597112|NCT01985334|65915831|FG004|Overall Study|Subject withdrawal of consent|4|||
23597113|NCT01985334|65915832|FG005|Overall Study|Subject withdrawal of consent|19|||
23597114|NCT01985334|65915833|FG006|Overall Study|Subject withdrawal of consent|0|||
23597115|NCT01985334|65915834|FG007|Overall Study|Subject withdrawal of consent|20|||
23597116|NCT01985334|65915827|FG000|Overall Study|Adverse Event|0|||
23597117|NCT01985334|65915828|FG001|Overall Study|Adverse Event|8|||
23597118|NCT01985334|65915829|FG002|Overall Study|Adverse Event|2|||
23597119|NCT01985334|65915830|FG003|Overall Study|Adverse Event|26|||
23597120|NCT01985334|65915831|FG004|Overall Study|Adverse Event|3|||
23597121|NCT01985334|65915832|FG005|Overall Study|Adverse Event|18|||
23597122|NCT01985334|65915833|FG006|Overall Study|Adverse Event|3|||
23597123|NCT01985334|65915834|FG007|Overall Study|Adverse Event|15|||
23597124|NCT01985334|65915827|FG000|Overall Study|Other|4|||
23597125|NCT01985334|65915828|FG001|Overall Study|Other|2|||
23597126|NCT01985334|65915829|FG002|Overall Study|Other|3|||
23597127|NCT01985334|65915830|FG003|Overall Study|Other|10|||
23597128|NCT01985334|65915831|FG004|Overall Study|Other|1|||
23597129|NCT01985334|65915832|FG005|Overall Study|Other|6|||
23597130|NCT01985334|65915833|FG006|Overall Study|Other|2|||
23597131|NCT01985334|65915834|FG007|Overall Study|Other|2|||
23597132|NCT01985334|65915827|FG000|Overall Study|Medication non-compliance|0|||
23646043|NCT03607422|66091023|FG005|Overall Study|Other|2|||
23646044|NCT03607422|66091018|FG000|Overall Study|Ongoing at Time of Analysis|8|||
23646045|NCT03607422|66091019|FG001|Overall Study|Ongoing at Time of Analysis|0|||
23646046|NCT03607422|66091020|FG002|Overall Study|Ongoing at Time of Analysis|2|||
23646047|NCT03607422|66091021|FG003|Overall Study|Ongoing at Time of Analysis|1|||
23646048|NCT03607422|66091022|FG004|Overall Study|Ongoing at Time of Analysis|1|||
23646049|NCT03607422|66091023|FG005|Overall Study|Ongoing at Time of Analysis|1|||
23597133|NCT01985334|65915828|FG001|Overall Study|Medication non-compliance|4|||
23597134|NCT01985334|65915829|FG002|Overall Study|Medication non-compliance|1|||
23597135|NCT01985334|65915830|FG003|Overall Study|Medication non-compliance|6|||
23597136|NCT01985334|65915831|FG004|Overall Study|Medication non-compliance|2|||
23597137|NCT01985334|65915832|FG005|Overall Study|Medication non-compliance|3|||
23597138|NCT01985334|65915833|FG006|Overall Study|Medication non-compliance|1|||
23597139|NCT01985334|65915834|FG007|Overall Study|Medication non-compliance|3|||
23597140|NCT01985334|65915827|FG000|Overall Study|Use of prohibited treatment|1|||
23597141|NCT01985334|65915828|FG001|Overall Study|Use of prohibited treatment|4|||
23597142|NCT01985334|65915829|FG002|Overall Study|Use of prohibited treatment|1|||
23597143|NCT01985334|65915830|FG003|Overall Study|Use of prohibited treatment|2|||
23597144|NCT01985334|65915831|FG004|Overall Study|Use of prohibited treatment|1|||
23597145|NCT01985334|65915832|FG005|Overall Study|Use of prohibited treatment|6|||
23597146|NCT01985334|65915833|FG006|Overall Study|Use of prohibited treatment|2|||
23597147|NCT01985334|65915834|FG007|Overall Study|Use of prohibited treatment|0|||
23597148|NCT01985334|65915827|FG000|Overall Study|Investigator decision|0|||
23597149|NCT01985334|65915828|FG001|Overall Study|Investigator decision|3|||
23597150|NCT01985334|65915829|FG002|Overall Study|Investigator decision|0|||
23597151|NCT01985334|65915830|FG003|Overall Study|Investigator decision|7|||
23597152|NCT01985334|65915831|FG004|Overall Study|Investigator decision|1|||
23597153|NCT01985334|65915832|FG005|Overall Study|Investigator decision|1|||
23597154|NCT01985334|65915833|FG006|Overall Study|Investigator decision|0|||
23597155|NCT01985334|65915834|FG007|Overall Study|Investigator decision|4|||
23597156|NCT01985334|65915827|FG000|Overall Study|Lost to Follow-up|0|||
23597157|NCT01985334|65915828|FG001|Overall Study|Lost to Follow-up|2|||
23646050|NCT02481947|66091024|FG000|Overall Study|Withdrawal by Subject|24|||
23646051|NCT02481947|66091025|FG001|Overall Study|Withdrawal by Subject|10|||
23646052|NCT02481947|66091024|FG000|Overall Study|Lost to Follow-up|11|||
23646053|NCT02481947|66091025|FG001|Overall Study|Lost to Follow-up|5|||
23646054|NCT02481947|66091024|FG000|Overall Study|Adverse Event|6|||
23646055|NCT02481947|66091025|FG001|Overall Study|Adverse Event|11|||
23646056|NCT02481947|66091024|FG000|Overall Study|Physician Decision|4|||
23646057|NCT02481947|66091025|FG001|Overall Study|Physician Decision|5|||
23646058|NCT02481947|66091024|FG000|Overall Study|Protocol Violation|1|||
23646059|NCT02481947|66091025|FG001|Overall Study|Protocol Violation|5|||
23646060|NCT01183260|66091026|FG000|Overall Study|Intraop screen failure|2|||
23646061|NCT01183260|66091027|FG001|Overall Study|Intraop screen failure|0|||
23646062|NCT01183260|66091026|FG000|Overall Study|Withdrawal by Subject|1|||
23646063|NCT01183260|66091027|FG001|Overall Study|Withdrawal by Subject|1|||
23646064|NCT01183260|66091026|FG000|Overall Study|Revised within 30 days|0|||
23646065|NCT01183260|66091027|FG001|Overall Study|Revised within 30 days|1|||
23646066|NCT01183260|66091026|FG000|Overall Study|Death|1|||
23646067|NCT01183260|66091027|FG001|Overall Study|Death|0|||
23646068|NCT00842985|66091028|FG000|Screening|Did not meet entrance requirements|27|||
23646069|NCT00842985|66091028|FG000|First Intervention|Withdrawal by Subject|3|||
23646070|NCT00842985|66091028|FG000|First Intervention|Protocol Violation|3|||
23646071|NCT00842985|66091028|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
23646072|NCT00842985|66091028|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
23646073|NCT04684394|66091029|FG000|Overall Study|Death|1|||
23646074|NCT04684394|66091030|FG001|Overall Study|Death|2|||
23646075|NCT04684394|66091029|FG000|Overall Study|Lost to Follow-up|1|||
23646076|NCT04684394|66091030|FG001|Overall Study|Lost to Follow-up|0|||
23646077|NCT04684394|66091029|FG000|Overall Study|Withdrawal by Subject|2|||
23646078|NCT04684394|66091030|FG001|Overall Study|Withdrawal by Subject|0|||
23646079|NCT04684394|66091029|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
23646080|NCT04684394|66091030|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
23646081|NCT01776541|66091031|FG000|Overall Study|Administrative Reason|6|||
23646082|NCT01776541|66091032|FG001|Overall Study|Administrative Reason|2|||
23800665|NCT00708708|66646860|FG000|Overall Study|Other unspecified|11|||
23800666|NCT00708708|66646860|FG000|Overall Study|Good effectiveness|9|||
23800667|NCT00708708|66646860|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
23800668|NCT00708708|66646860|FG000|Overall Study|Administrative reasons|7|||
23800669|NCT00708708|66646860|FG000|Overall Study|Lack of effectiveness|4|||
23800670|NCT00708708|66646860|FG000|Overall Study|Lack of compliance|3|||
23800671|NCT00708708|66646860|FG000|Overall Study|Pregnancy|3|||
23597158|NCT01985334|65915829|FG002|Overall Study|Lost to Follow-up|0|||
23597159|NCT01985334|65915830|FG003|Overall Study|Lost to Follow-up|3|||
23597160|NCT01985334|65915831|FG004|Overall Study|Lost to Follow-up|1|||
23597161|NCT01985334|65915832|FG005|Overall Study|Lost to Follow-up|4|||
23646083|NCT01776541|66091031|FG000|Overall Study|Death|4|||
23646084|NCT01776541|66091032|FG001|Overall Study|Death|0|||
23800672|NCT00708708|66646860|FG000|Overall Study|Adverse Event|3|||
23597162|NCT01985334|65915833|FG006|Overall Study|Lost to Follow-up|0|||
23597163|NCT01985334|65915834|FG007|Overall Study|Lost to Follow-up|3|||
23646085|NCT01776541|66091031|FG000|Overall Study|Lost to Follow-up|27|||
23646086|NCT01776541|66091032|FG001|Overall Study|Lost to Follow-up|48|||
23646087|NCT01776541|66091031|FG000|Overall Study|Unclassified|5|||
23646088|NCT01776541|66091032|FG001|Overall Study|Unclassified|4|||
23646089|NCT01776541|66091031|FG000|Overall Study|Protocol Violation|2|||
23646090|NCT01776541|66091032|FG001|Overall Study|Protocol Violation|1|||
23646091|NCT01776541|66091031|FG000|Overall Study|Withdrawal by Subject|12|||
23646092|NCT01776541|66091032|FG001|Overall Study|Withdrawal by Subject|20|||
23646093|NCT02476279|66091041|FG000|Overall Study|Lost to Follow-up|1|||
23646094|NCT02476279|66091042|FG001|Overall Study|Lost to Follow-up|1|||
23646095|NCT00825825|66091043|FG000|First Medication Period (14 Days)|Adverse Event|1|||
23646096|NCT00825825|66091044|FG001|First Medication Period (14 Days)|Adverse Event|0|||
23646097|NCT00825825|66091045|FG002|First Medication Period (14 Days)|Adverse Event|0|||
23646098|NCT00825825|66091046|FG003|First Medication Period (14 Days)|Adverse Event|0|||
23646099|NCT00825825|66091047|FG004|First Medication Period (14 Days)|Adverse Event|0|||
23646100|NCT00825825|66091048|FG005|First Medication Period (14 Days)|Adverse Event|1|||
23646101|NCT00825825|66091043|FG000|First Medication Period (14 Days)|Physician Decision|2|||
23646102|NCT00825825|66091044|FG001|First Medication Period (14 Days)|Physician Decision|0|||
23646103|NCT00825825|66091045|FG002|First Medication Period (14 Days)|Physician Decision|1|||
23646104|NCT00825825|66091046|FG003|First Medication Period (14 Days)|Physician Decision|0|||
23646105|NCT00825825|66091047|FG004|First Medication Period (14 Days)|Physician Decision|0|||
23646106|NCT00825825|66091048|FG005|First Medication Period (14 Days)|Physician Decision|1|||
23360505|NCT04754542|65065758|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
23402809|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
23646107|NCT00825825|66091043|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
23646108|NCT00825825|66091044|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
23646109|NCT00825825|66091045|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
23646110|NCT00825825|66091046|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
23646111|NCT00825825|66091047|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
23646112|NCT00825825|66091048|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
23646113|NCT00825825|66091043|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
23646114|NCT00825825|66091044|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
23646115|NCT00825825|66091045|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
23646116|NCT00825825|66091046|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
23646117|NCT00825825|66091047|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
23646118|NCT00825825|66091048|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
23646119|NCT00825825|66091043|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
23646120|NCT00825825|66091044|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
23646121|NCT00825825|66091045|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
23646122|NCT00825825|66091046|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
23646123|NCT00825825|66091047|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
23646124|NCT00825825|66091048|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
23646125|NCT00825825|66091043|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
23646126|NCT00825825|66091044|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
23646127|NCT00825825|66091045|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
23646128|NCT00825825|66091046|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
23646129|NCT00825825|66091047|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
23646130|NCT00825825|66091048|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
23646131|NCT00825825|66091043|FG000|Third Medication Period (14 Days)|poor data quality|0|||
23646132|NCT00825825|66091044|FG001|Third Medication Period (14 Days)|poor data quality|1|||
23646133|NCT00825825|66091045|FG002|Third Medication Period (14 Days)|poor data quality|0|||
23646134|NCT00825825|66091046|FG003|Third Medication Period (14 Days)|poor data quality|0|||
23646135|NCT00825825|66091047|FG004|Third Medication Period (14 Days)|poor data quality|0|||
23646136|NCT00825825|66091048|FG005|Third Medication Period (14 Days)|poor data quality|0|||
23646137|NCT01103362|66091049|FG000|Overall Study|study terminated|596|||
23646138|NCT01054170|66091050|FG000|Overall Study|Protocol Violation|1|||
23646139|NCT01054170|66091051|FG001|Overall Study|Protocol Violation|0|||
23646140|NCT01054170|66091050|FG000|Overall Study|Withdrawal by Subject|3|||
23646141|NCT01054170|66091051|FG001|Overall Study|Withdrawal by Subject|2|||
23646142|NCT01054170|66091050|FG000|Overall Study|Adverse Event|0|||
23646143|NCT01054170|66091051|FG001|Overall Study|Adverse Event|4|||
23646144|NCT02533570|66091052|FG000|Overall Study|Adverse Event|0|||
23646145|NCT02533570|66091053|FG001|Overall Study|Adverse Event|1|||
23646146|NCT02533570|66091054|FG002|Overall Study|Adverse Event|1|||
23646147|NCT01257425|66091055|FG000|Overall Study|Lack of Efficacy|3|||
23646148|NCT01257425|66091056|FG001|Overall Study|Lack of Efficacy|3|||
23646149|NCT01257425|66091055|FG000|Overall Study|Adverse Event|1|||
23646150|NCT01257425|66091056|FG001|Overall Study|Adverse Event|1|||
23646151|NCT01257425|66091055|FG000|Overall Study|Protocol Violation|1|||
23646152|NCT01257425|66091056|FG001|Overall Study|Protocol Violation|1|||
23646153|NCT01257425|66091055|FG000|Overall Study|Withdrawal by Subject|0|||
23646154|NCT01257425|66091056|FG001|Overall Study|Withdrawal by Subject|1|||
23646155|NCT01257425|66091055|FG000|Overall Study|Death|1|||
23646156|NCT01257425|66091056|FG001|Overall Study|Death|0|||
23646157|NCT00903682|66091064|FG000|Overall Study|Adverse Event|6|||
23646158|NCT00903682|66091065|FG001|Overall Study|Adverse Event|13|||
23646159|NCT00903682|66091064|FG000|Overall Study|Lost to Follow-up|1|||
23646160|NCT00903682|66091065|FG001|Overall Study|Lost to Follow-up|0|||
23646161|NCT00903682|66091064|FG000|Overall Study|Withdrawal by Subject|5|||
23646162|NCT00903682|66091065|FG001|Overall Study|Withdrawal by Subject|0|||
23646163|NCT00903682|66091064|FG000|Overall Study|Pregnancy|0|||
23646164|NCT00903682|66091065|FG001|Overall Study|Pregnancy|1|||
23646165|NCT00903682|66091064|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
23646166|NCT00903682|66091065|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
23646167|NCT00903682|66091064|FG000|Overall Study|Subject Non-Compliant|1|||
23800673|NCT00708708|66646860|FG000|Overall Study|Missing values|392|||
23800674|NCT02776553|66646861|FG000|Overall Study|Lost to Follow-up|1|||
23800675|NCT02776553|66646862|FG001|Overall Study|Lost to Follow-up|0|||
23800676|NCT02776553|66646861|FG000|Overall Study|got liver transplant|1|||
23800677|NCT02776553|66646862|FG001|Overall Study|got liver transplant|2|||
23800678|NCT02776553|66646861|FG000|Overall Study|had other surgery|1|||
23800679|NCT02776553|66646862|FG001|Overall Study|had other surgery|0|||
23800680|NCT02776553|66646861|FG000|Overall Study|Protocol Violation|0|||
23800681|NCT02776553|66646862|FG001|Overall Study|Protocol Violation|1|||
23800682|NCT02148913|66646865|FG000|Overall Study|Death|0|||
23800683|NCT02148913|66646866|FG001|Overall Study|Death|1|||
23800684|NCT02148913|66646867|FG002|Overall Study|Death|0|||
23800685|NCT02148913|66646868|FG003|Overall Study|Death|0|||
23800686|NCT03297294|66646869|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
23800687|NCT03297294|66646870|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
23800688|NCT03297294|66646871|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23800689|NCT03297294|66646872|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23800690|NCT03297294|66646873|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23800691|NCT03297294|66646869|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
23800692|NCT03297294|66646870|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
23800693|NCT03297294|66646871|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23800694|NCT03297294|66646872|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23800695|NCT03297294|66646873|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23800696|NCT03297294|66646869|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
23800697|NCT03297294|66646870|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
23800698|NCT03297294|66646871|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23800699|NCT03297294|66646872|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23800700|NCT03297294|66646873|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23360506|NCT04754542|65065759|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
23360507|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
23360508|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
23360509|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
23360510|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
23646168|NCT00903682|66091065|FG001|Overall Study|Subject Non-Compliant|0|||
23646169|NCT00903682|66091064|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
23800701|NCT03297294|66646869|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23800702|NCT03297294|66646870|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23800703|NCT03297294|66646871|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23800704|NCT03297294|66646872|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23800705|NCT03297294|66646873|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23800706|NCT03297294|66646869|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23800707|NCT03297294|66646870|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23800708|NCT03297294|66646871|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23646170|NCT00903682|66091065|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
23646171|NCT00903682|66091064|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
23646172|NCT00903682|66091065|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
23646173|NCT01877837|66091066|FG000|Overall Study|Lost to Follow-up|1|||
23646174|NCT01877837|66091066|FG000|Overall Study|Ineligible|4|||
23646175|NCT05249829|66091067|FG000|Overall Study|Participant Relocation|0|||
23646176|NCT05249829|66091068|FG001|Overall Study|Participant Relocation|1|||
23646177|NCT05249829|66091069|FG002|Overall Study|Participant Relocation|2|||
23646178|NCT05249829|66091070|FG003|Overall Study|Participant Relocation|2|||
23646179|NCT05249829|66091067|FG000|Overall Study|Withdrawal by Subject|9|||
23646180|NCT05249829|66091068|FG001|Overall Study|Withdrawal by Subject|17|||
23646181|NCT05249829|66091069|FG002|Overall Study|Withdrawal by Subject|40|||
23646182|NCT05249829|66091070|FG003|Overall Study|Withdrawal by Subject|35|||
23646183|NCT05249829|66091067|FG000|Overall Study|Physician Decision|1|||
23646184|NCT05249829|66091068|FG001|Overall Study|Physician Decision|0|||
23646185|NCT05249829|66091069|FG002|Overall Study|Physician Decision|0|||
23646186|NCT05249829|66091070|FG003|Overall Study|Physician Decision|0|||
23646187|NCT05249829|66091067|FG000|Overall Study|Lost to Follow-up|16|||
23646188|NCT05249829|66091068|FG001|Overall Study|Lost to Follow-up|16|||
23646189|NCT05249829|66091069|FG002|Overall Study|Lost to Follow-up|57|||
23646190|NCT05249829|66091070|FG003|Overall Study|Lost to Follow-up|60|||
23646191|NCT05249829|66091067|FG000|Overall Study|Adverse Event|2|||
23646192|NCT05249829|66091068|FG001|Overall Study|Adverse Event|2|||
23646193|NCT05249829|66091069|FG002|Overall Study|Adverse Event|2|||
23646194|NCT05249829|66091070|FG003|Overall Study|Adverse Event|2|||
23646195|NCT05249829|66091067|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
23646196|NCT05249829|66091068|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
23646197|NCT05249829|66091069|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
23646198|NCT05249829|66091070|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
23646199|NCT05249829|66091067|FG000|Overall Study|Protocol Violation|2|||
23646200|NCT05249829|66091068|FG001|Overall Study|Protocol Violation|0|||
23646201|NCT05249829|66091069|FG002|Overall Study|Protocol Violation|5|||
23646202|NCT05249829|66091070|FG003|Overall Study|Protocol Violation|3|||
23646203|NCT05249829|66091067|FG000|Overall Study|Death|0|||
23646204|NCT05249829|66091068|FG001|Overall Study|Death|1|||
23646205|NCT05249829|66091069|FG002|Overall Study|Death|2|||
23646206|NCT05249829|66091070|FG003|Overall Study|Death|4|||
23646207|NCT03737474|66091071|FG000|Overall Study|Adverse Event|18|||
23646208|NCT03737474|66091072|FG001|Overall Study|Adverse Event|48|||
23646209|NCT03737474|66091071|FG000|Overall Study|Lack of Efficacy|1|||
23646210|NCT03737474|66091072|FG001|Overall Study|Lack of Efficacy|3|||
23646211|NCT03737474|66091071|FG000|Overall Study|Protocol Violation|0|||
23646212|NCT03737474|66091072|FG001|Overall Study|Protocol Violation|8|||
23646213|NCT03737474|66091071|FG000|Overall Study|Withdrawal by Subject|5|||
23646214|NCT03737474|66091072|FG001|Overall Study|Withdrawal by Subject|20|||
23646215|NCT03737474|66091071|FG000|Overall Study|Non-compliance With Study Drug|0|||
23646216|NCT03737474|66091072|FG001|Overall Study|Non-compliance With Study Drug|1|||
23646217|NCT03737474|66091071|FG000|Overall Study|Physician Decision|1|||
23646218|NCT03737474|66091072|FG001|Overall Study|Physician Decision|4|||
23646219|NCT04002401|66091073|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
23646220|NCT04002401|66091073|FG000|Overall Study|Death|10|||
23646221|NCT04002401|66091073|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
23646222|NCT04002401|66091073|FG000|Overall Study|Enrolled but Never Treated|1|||
23646223|NCT04002401|66091073|FG000|Overall Study|Lost to Follow-up|1|||
23646224|NCT02679508|66091074|FG000|Healing Phase|Protocol Violation|1|||
23646225|NCT02679508|66091075|FG001|Healing Phase|Protocol Violation|1|||
23646226|NCT02679508|66091074|FG000|Healing Phase|Lost to Follow-up|1|||
23646227|NCT02679508|66091075|FG001|Healing Phase|Lost to Follow-up|0|||
23646228|NCT02679508|66091074|FG000|Maintenance Phase|Adverse Event|12|||
23646229|NCT02679508|66091075|FG001|Maintenance Phase|Adverse Event|2|||
23646230|NCT02679508|66091074|FG000|Maintenance Phase|Lost to Follow-up|0|||
23646231|NCT02679508|66091075|FG001|Maintenance Phase|Lost to Follow-up|1|||
23646232|NCT02679508|66091074|FG000|Maintenance Phase|Withdrawal by Subject|15|||
23646233|NCT02679508|66091075|FG001|Maintenance Phase|Withdrawal by Subject|8|||
23646234|NCT02679508|66091074|FG000|Maintenance Phase|Other|5|||
23646235|NCT02679508|66091075|FG001|Maintenance Phase|Other|4|||
23646236|NCT03801915|66091076|FG000|Overall Study|Screen failure|0|||
23646237|NCT03801915|66091077|FG001|Overall Study|Screen failure|0|||
23646238|NCT03801915|66091078|FG002|Overall Study|Screen failure|1|||
23646239|NCT03801915|66091076|FG000|Overall Study|Ineligible|1|||
23646240|NCT03801915|66091077|FG001|Overall Study|Ineligible|0|||
23646241|NCT03801915|66091078|FG002|Overall Study|Ineligible|0|||
23646242|NCT03801915|66091076|FG000|Overall Study|Physician Decision|2|||
23646243|NCT03801915|66091077|FG001|Overall Study|Physician Decision|1|||
23646244|NCT03801915|66091078|FG002|Overall Study|Physician Decision|0|||
23646245|NCT01007448|66091079|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
23646246|NCT01007448|66091080|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
23646247|NCT01007448|66091079|FG000|Overall Study|Staph Skin Infection Flare|1|||
23646248|NCT01007448|66091080|FG001|Overall Study|Staph Skin Infection Flare|0|||
23646249|NCT01007448|66091079|FG000|Overall Study|Participant Leaving the Country|1|||
23646250|NCT01007448|66091080|FG001|Overall Study|Participant Leaving the Country|0|||
23646251|NCT01007448|66091079|FG000|Overall Study|Participant Given Prohibited Medication|1|||
23646252|NCT01007448|66091080|FG001|Overall Study|Participant Given Prohibited Medication|0|||
23646253|NCT01007448|66091079|FG000|Overall Study|Progressive Disease|1|||
23646254|NCT01007448|66091080|FG001|Overall Study|Progressive Disease|2|||
23646255|NCT01007448|66091079|FG000|Overall Study|Lack of Efficacy|2|||
23646256|NCT01007448|66091080|FG001|Overall Study|Lack of Efficacy|0|||
23646257|NCT01007448|66091079|FG000|Overall Study|Withdrawal by Subject|2|||
23646258|NCT01007448|66091080|FG001|Overall Study|Withdrawal by Subject|3|||
23646259|NCT01007448|66091079|FG000|Overall Study|Adverse Event|1|||
23646260|NCT01007448|66091080|FG001|Overall Study|Adverse Event|4|||
23646261|NCT01201265|66091085|FG000|Overall Study|Death|14|||
23646262|NCT01201265|66091085|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23646263|NCT01201265|66091085|FG000|Overall Study|Lost to Follow-up|10|||
23646264|NCT01201265|66091085|FG000|Overall Study|Withdrawal by Subject|7|||
23646265|NCT01201265|66091085|FG000|Overall Study|Disease Progression|4|||
23646266|NCT00178126|66091086|FG000|Overall Study|Lost to Follow-up|21|||
23646267|NCT00178126|66091087|FG001|Overall Study|Lost to Follow-up|21|||
23646268|NCT00178126|66091086|FG000|Overall Study|did not receive intervention|4|||
23800709|NCT03297294|66646872|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
23646269|NCT00178126|66091087|FG001|Overall Study|did not receive intervention|6|||
23646270|NCT01079663|66091088|FG000|Overall Study|Adverse Event|0|||
23646271|NCT01079663|66091089|FG001|Overall Study|Adverse Event|2|||
23646272|NCT01079663|66091088|FG000|Overall Study|Protocol Violation|0|||
23646273|NCT01079663|66091089|FG001|Overall Study|Protocol Violation|2|||
23646274|NCT00883051|66091090|FG000|Overall Study|Lost to Follow-up|0|||
23646275|NCT00883051|66091091|FG001|Overall Study|Lost to Follow-up|0|||
23800710|NCT03297294|66646873|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23800711|NCT04291508|66646875|FG000|Overall Study|Withdrawal by Subject|1|||
23360511|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
23360512|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
23646276|NCT00883051|66091092|FG002|Overall Study|Lost to Follow-up|0|||
23646277|NCT00883051|66091093|FG003|Overall Study|Lost to Follow-up|0|||
23646278|NCT00883051|66091094|FG004|Overall Study|Lost to Follow-up|1|||
23646279|NCT00883051|66091090|FG000|Overall Study|Did not use study medication|24|||
23646280|NCT00883051|66091091|FG001|Overall Study|Did not use study medication|22|||
23646281|NCT00883051|66091092|FG002|Overall Study|Did not use study medication|29|||
23597164|NCT03292913|65915841|FG000|Overall Study|Death|9|||
23597165|NCT03292913|65915842|FG001|Overall Study|Death|3|||
23597166|NCT03292913|65915841|FG000|Overall Study|Lost to Follow-up|49|||
23597167|NCT03292913|65915842|FG001|Overall Study|Lost to Follow-up|49|||
23597168|NCT03292913|65915841|FG000|Overall Study|Withdrawal by Subject|2|||
23597169|NCT03292913|65915842|FG001|Overall Study|Withdrawal by Subject|0|||
23597170|NCT03292913|65915841|FG000|Overall Study|Clinic closed due to COVID|22|||
23597171|NCT03292913|65915842|FG001|Overall Study|Clinic closed due to COVID|36|||
23597172|NCT01391832|65915843|FG000|Overall Study|Withdrawal by Subject|21|||
23597173|NCT01391832|65915844|FG001|Overall Study|Withdrawal by Subject|22|||
23597174|NCT01391832|65915843|FG000|Overall Study|Lost to Follow-up|0|||
23597175|NCT01391832|65915844|FG001|Overall Study|Lost to Follow-up|1|||
23597176|NCT03733119|65915845|FG000|Overall Study|Physician Decision|2|||
23597177|NCT03733119|65915846|FG001|Overall Study|Physician Decision|1|||
23597178|NCT03733119|65915845|FG000|Overall Study|ineligible to treat per protocol|0|||
23597179|NCT03733119|65915846|FG001|Overall Study|ineligible to treat per protocol|1|||
23597180|NCT03451721|65915849|FG000|Overall Study|Death|1|||
23597181|NCT02891915|65915850|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
23597182|NCT02891915|65915851|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
23597183|NCT02891915|65915850|FG000|Overall Study|Withdrawal by Subject|3|||
23597184|NCT02891915|65915851|FG001|Overall Study|Withdrawal by Subject|3|||
23597185|NCT02891915|65915850|FG000|Overall Study|Became Ineligible After Enrollment|2|||
23597186|NCT02891915|65915851|FG001|Overall Study|Became Ineligible After Enrollment|1|||
23597187|NCT02891915|65915850|FG000|Overall Study|Lost to Follow-up|1|||
23597188|NCT02891915|65915851|FG001|Overall Study|Lost to Follow-up|4|||
23597189|NCT02891915|65915850|FG000|Overall Study|Physician Decision|1|||
23597190|NCT02891915|65915851|FG001|Overall Study|Physician Decision|0|||
23597191|NCT01420549|65915852|FG000|Overall Study|Adverse Event|1|||
23597192|NCT01420549|65915853|FG001|Overall Study|Adverse Event|1|||
23597193|NCT01420549|65915852|FG000|Overall Study|Lost to Follow-up|2|||
23597194|NCT01420549|65915853|FG001|Overall Study|Lost to Follow-up|2|||
23597195|NCT01420549|65915852|FG000|Overall Study|Protocol Violation|0|||
23597196|NCT01420549|65915853|FG001|Overall Study|Protocol Violation|1|||
23597197|NCT01420549|65915852|FG000|Overall Study|Non-adherence to medication|4|||
23597198|NCT01420549|65915853|FG001|Overall Study|Non-adherence to medication|1|||
23597199|NCT02426138|65915854|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23597200|NCT02426138|65915855|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23597201|NCT00687219|65915856|FG000|Overall Study|Adverse Event|8|||
23597202|NCT00687219|65915856|FG000|Overall Study|Discontinuance criteria met|7|||
23597203|NCT00687219|65915856|FG000|Overall Study|HCV-RNA positive conversion|34|||
23597204|NCT00687219|65915856|FG000|Overall Study|Withdrawal by Subject|1|||
23597205|NCT00687219|65915856|FG000|Overall Study|Lack of Efficacy|1|||
23597206|NCT01951170|65915857|FG000|Overall Study|Investigator decision|1|||
23597207|NCT02978716|65915859|FG000|Overall Study|Death|25|||
23597208|NCT02978716|65915860|FG001|Overall Study|Death|13|||
23597209|NCT02978716|65915861|FG002|Overall Study|Death|20|||
23597210|NCT02978716|65915859|FG000|Overall Study|Lost to Follow-up|0|||
23597211|NCT02978716|65915860|FG001|Overall Study|Lost to Follow-up|0|||
23597212|NCT02978716|65915861|FG002|Overall Study|Lost to Follow-up|1|||
23597213|NCT02978716|65915859|FG000|Overall Study|Withdrawal by Subject|6|||
23597214|NCT02978716|65915860|FG001|Overall Study|Withdrawal by Subject|4|||
23597215|NCT02978716|65915861|FG002|Overall Study|Withdrawal by Subject|5|||
23597216|NCT02978716|65915859|FG000|Overall Study|Sponsor terminated|2|||
23597217|NCT02978716|65915860|FG001|Overall Study|Sponsor terminated|13|||
23597218|NCT02978716|65915861|FG002|Overall Study|Sponsor terminated|9|||
23597219|NCT02978716|65915859|FG000|Overall Study|Other|1|||
23597220|NCT02978716|65915860|FG001|Overall Study|Other|3|||
23597221|NCT02978716|65915861|FG002|Overall Study|Other|0|||
23597222|NCT02567656|65915862|FG000|Overall Study|Premature discontinuation due to PD|1|||
23597223|NCT02567656|65915863|FG001|Overall Study|Premature discontinuation due to PD|1|||
23597224|NCT02567656|65915864|FG002|Overall Study|Premature discontinuation due to PD|2|||
23597225|NCT02567656|65915865|FG003|Overall Study|Premature discontinuation due to PD|0|||
23597226|NCT02567656|65915866|FG004|Overall Study|Premature discontinuation due to PD|0|||
23597227|NCT02567656|65915867|FG005|Overall Study|Premature discontinuation due to PD|0|||
23597228|NCT01037985|65915868|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
23597229|NCT01037985|65915869|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
23597230|NCT01037985|65915868|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
23597231|NCT01037985|65915869|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
23597232|NCT01037985|65915868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
23597233|NCT01037985|65915869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
23597234|NCT01037985|65915868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
23597235|NCT01037985|65915869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
23597236|NCT00998881|65915872|FG000|Overall Study|Adverse Event|2|||
23597237|NCT00998881|65915873|FG001|Overall Study|Adverse Event|2|||
23597238|NCT00998881|65915872|FG000|Overall Study|Lack of Efficacy|1|||
23597239|NCT00998881|65915873|FG001|Overall Study|Lack of Efficacy|0|||
23646282|NCT00883051|66091093|FG003|Overall Study|Did not use study medication|29|||
23646283|NCT00883051|66091094|FG004|Overall Study|Did not use study medication|17|||
23646284|NCT02041520|66091103|FG000|Overall Study|Adverse Event|2|||
23646285|NCT02041520|66091104|FG001|Overall Study|Adverse Event|1|||
23646286|NCT02041520|66091103|FG000|Overall Study|Withdrawal by Subject|3|||
23646287|NCT02041520|66091104|FG001|Overall Study|Withdrawal by Subject|4|||
23646288|NCT02041520|66091103|FG000|Overall Study|Protocol Violation|1|||
23646289|NCT02041520|66091104|FG001|Overall Study|Protocol Violation|0|||
23646290|NCT02041520|66091103|FG000|Overall Study|Lost to Follow-up|0|||
23646291|NCT02041520|66091104|FG001|Overall Study|Lost to Follow-up|1|||
23646292|NCT02041520|66091103|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
23646293|NCT02041520|66091104|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
23646294|NCT04256629|66091109|FG000|Overall Study|Adverse Event|0|||
23646295|NCT04256629|66091110|FG001|Overall Study|Adverse Event|0|||
23646296|NCT04256629|66091111|FG002|Overall Study|Adverse Event|0|||
23646297|NCT04256629|66091112|FG003|Overall Study|Adverse Event|0|||
23646298|NCT04256629|66091113|FG004|Overall Study|Adverse Event|0|||
23646299|NCT04256629|66091114|FG005|Overall Study|Adverse Event|1|||
23646300|NCT04256629|66091109|FG000|Overall Study|Protocol Violation|0|||
23646301|NCT04256629|66091110|FG001|Overall Study|Protocol Violation|1|||
23646302|NCT04256629|66091111|FG002|Overall Study|Protocol Violation|0|||
23646303|NCT04256629|66091112|FG003|Overall Study|Protocol Violation|0|||
23646304|NCT04256629|66091113|FG004|Overall Study|Protocol Violation|0|||
23646305|NCT04256629|66091114|FG005|Overall Study|Protocol Violation|0|||
23646306|NCT00986674|66091118|FG000|Overall Study|Lack of Efficacy|28|||
23646307|NCT00986674|66091119|FG001|Overall Study|Lack of Efficacy|25|||
23646308|NCT00986674|66091120|FG002|Overall Study|Lack of Efficacy|23|||
23646309|NCT00986674|66091118|FG000|Overall Study|Adverse Event|4|||
23646310|NCT00986674|66091119|FG001|Overall Study|Adverse Event|8|||
23646311|NCT00986674|66091120|FG002|Overall Study|Adverse Event|9|||
23646312|NCT00986674|66091118|FG000|Overall Study|Death|5|||
23646313|NCT00986674|66091119|FG001|Overall Study|Death|0|||
23646314|NCT00986674|66091120|FG002|Overall Study|Death|4|||
23646315|NCT00986674|66091118|FG000|Overall Study|Withdrawal by Subject|6|||
23646316|NCT00986674|66091119|FG001|Overall Study|Withdrawal by Subject|2|||
23646317|NCT00986674|66091120|FG002|Overall Study|Withdrawal by Subject|1|||
23646318|NCT00986674|66091118|FG000|Overall Study|alternative therapy|0|||
23646319|NCT00986674|66091119|FG001|Overall Study|alternative therapy|0|||
23646320|NCT00986674|66091120|FG002|Overall Study|alternative therapy|1|||
23646321|NCT00986674|66091118|FG000|Overall Study|not start protocol therapy|4|||
23646322|NCT00986674|66091119|FG001|Overall Study|not start protocol therapy|3|||
23646323|NCT00986674|66091120|FG002|Overall Study|not start protocol therapy|1|||
23646324|NCT00986674|66091118|FG000|Overall Study|unknown/not specify|0|||
23646325|NCT00986674|66091119|FG001|Overall Study|unknown/not specify|7|||
23646326|NCT00986674|66091120|FG002|Overall Study|unknown/not specify|9|||
23646327|NCT01011387|66091121|FG000|Overall Study|Withdrawal by Subject|3|||
23646328|NCT01011387|66091121|FG000|Overall Study|Adverse Event|2|||
23646329|NCT01011387|66091121|FG000|Overall Study|Protocol Violation|1|||
23646330|NCT02842827|66091122|FG000|Overall Study|Adverse Event|0|||
23646331|NCT02842827|66091123|FG001|Overall Study|Adverse Event|1|||
23646332|NCT02842827|66091124|FG002|Overall Study|Adverse Event|0|||
23646333|NCT02842827|66091125|FG003|Overall Study|Adverse Event|1|||
23646334|NCT02842827|66091126|FG004|Overall Study|Adverse Event|0|||
23646335|NCT02842827|66091127|FG005|Overall Study|Adverse Event|1|||
23646336|NCT02842827|66091128|FG006|Overall Study|Adverse Event|0|||
23646337|NCT02842827|66091129|FG007|Overall Study|Adverse Event|0|||
23646338|NCT02842827|66091122|FG000|Overall Study|Death|1|||
23646339|NCT02842827|66091123|FG001|Overall Study|Death|0|||
23646340|NCT02842827|66091124|FG002|Overall Study|Death|2|||
23646341|NCT02842827|66091125|FG003|Overall Study|Death|3|||
23646342|NCT02842827|66091126|FG004|Overall Study|Death|2|||
23646343|NCT02842827|66091127|FG005|Overall Study|Death|1|||
23646344|NCT02842827|66091128|FG006|Overall Study|Death|0|||
23646345|NCT02842827|66091129|FG007|Overall Study|Death|4|||
23646346|NCT02842827|66091122|FG000|Overall Study|Physician Decision|1|||
23646347|NCT02842827|66091123|FG001|Overall Study|Physician Decision|3|||
23646348|NCT02842827|66091124|FG002|Overall Study|Physician Decision|0|||
23646349|NCT02842827|66091125|FG003|Overall Study|Physician Decision|0|||
23646350|NCT02842827|66091126|FG004|Overall Study|Physician Decision|1|||
23646351|NCT02842827|66091127|FG005|Overall Study|Physician Decision|4|||
23646352|NCT02842827|66091128|FG006|Overall Study|Physician Decision|2|||
23800712|NCT04291508|66646876|FG001|Overall Study|Withdrawal by Subject|0|||
23800713|NCT04291508|66646877|FG002|Overall Study|Withdrawal by Subject|1|||
23800714|NCT04291508|66646878|FG003|Overall Study|Withdrawal by Subject|0|||
23800715|NCT04291508|66646875|FG000|Overall Study|lost to follow up|4|||
23800716|NCT04291508|66646876|FG001|Overall Study|lost to follow up|0|||
23800717|NCT04291508|66646877|FG002|Overall Study|lost to follow up|1|||
23800718|NCT04291508|66646878|FG003|Overall Study|lost to follow up|0|||
23800719|NCT01553747|66646879|FG000|Overall Study|Protocol Violation|0|||
23800720|NCT01553747|66646880|FG001|Overall Study|Protocol Violation|2|||
23800721|NCT01553747|66646881|FG002|Overall Study|Protocol Violation|0|||
23800722|NCT01553747|66646879|FG000|Overall Study|Voluntarily withdrew|70|||
23800723|NCT01553747|66646880|FG001|Overall Study|Voluntarily withdrew|66|||
23800724|NCT01553747|66646881|FG002|Overall Study|Voluntarily withdrew|74|||
23800725|NCT01553747|66646879|FG000|Overall Study|Adverse event or SAE|32|||
23800726|NCT01553747|66646880|FG001|Overall Study|Adverse event or SAE|28|||
23800727|NCT01553747|66646881|FG002|Overall Study|Adverse event or SAE|19|||
23800728|NCT01553747|66646879|FG000|Overall Study|Physician decision: other|10|||
23800729|NCT01553747|66646880|FG001|Overall Study|Physician decision: other|8|||
23800730|NCT01553747|66646881|FG002|Overall Study|Physician decision: other|7|||
23800731|NCT01553747|66646879|FG000|Overall Study|Lost to Follow-up|11|||
23800732|NCT01553747|66646880|FG001|Overall Study|Lost to Follow-up|5|||
23800733|NCT01553747|66646881|FG002|Overall Study|Lost to Follow-up|6|||
23800734|NCT01553747|66646879|FG000|Overall Study|Sponsor decision, specify|7|||
23800735|NCT01553747|66646880|FG001|Overall Study|Sponsor decision, specify|5|||
23800736|NCT01553747|66646881|FG002|Overall Study|Sponsor decision, specify|0|||
23800737|NCT01553747|66646879|FG000|Overall Study|Physician decision: lack of efficacy|1|||
23800738|NCT01553747|66646880|FG001|Overall Study|Physician decision: lack of efficacy|5|||
23646353|NCT02842827|66091129|FG007|Overall Study|Physician Decision|1|||
23646354|NCT02842827|66091122|FG000|Overall Study|Protocol Defined Disease Progression|0|||
23800739|NCT01553747|66646881|FG002|Overall Study|Physician decision: lack of efficacy|3|||
23800740|NCT05069155|66646882|FG000|Overall Study|Withdrawal by Subject|1|||
23800741|NCT05069155|66646883|FG001|Overall Study|Withdrawal by Subject|3|||
23646355|NCT02842827|66091123|FG001|Overall Study|Protocol Defined Disease Progression|0|||
23646356|NCT02842827|66091124|FG002|Overall Study|Protocol Defined Disease Progression|0|||
23478427|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Adverse Event|5|||
23478428|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Adverse Event|0|||
23478429|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Adverse Event|0|||
23478430|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Adverse Event|0|||
23478431|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Adverse Event|0|||
23478432|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Adverse Event|0|||
23478433|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Adverse Event|0|||
23478434|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Adverse Event|0|||
23478435|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Adverse Event|0|||
23478436|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
23478437|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478438|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478439|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
23597240|NCT00998881|65915872|FG000|Overall Study|Physician Decision|3|||
23478440|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478441|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
23646357|NCT02842827|66091125|FG003|Overall Study|Protocol Defined Disease Progression|0|||
23646358|NCT02842827|66091126|FG004|Overall Study|Protocol Defined Disease Progression|0|||
23646359|NCT02842827|66091127|FG005|Overall Study|Protocol Defined Disease Progression|1|||
23646360|NCT02842827|66091128|FG006|Overall Study|Protocol Defined Disease Progression|0|||
23646361|NCT02842827|66091129|FG007|Overall Study|Protocol Defined Disease Progression|0|||
23646362|NCT02842827|66091122|FG000|Overall Study|Participant Withdrawal of Consent|1|||
23646363|NCT02842827|66091123|FG001|Overall Study|Participant Withdrawal of Consent|2|||
23646364|NCT02842827|66091124|FG002|Overall Study|Participant Withdrawal of Consent|2|||
23646365|NCT02842827|66091125|FG003|Overall Study|Participant Withdrawal of Consent|2|||
23646366|NCT02842827|66091126|FG004|Overall Study|Participant Withdrawal of Consent|2|||
23646367|NCT02842827|66091127|FG005|Overall Study|Participant Withdrawal of Consent|1|||
23646368|NCT02842827|66091128|FG006|Overall Study|Participant Withdrawal of Consent|2|||
23646369|NCT02842827|66091129|FG007|Overall Study|Participant Withdrawal of Consent|1|||
23646370|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
23646371|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
23646372|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
23646373|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
23646374|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
23646375|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
23646376|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
23646377|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
23646378|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
23646379|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
23478442|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478443|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
23646380|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
23646381|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
23646382|NCT02288247|66091130|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
23646383|NCT02288247|66091131|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
23646384|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
23646385|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
23646386|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
23646387|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
23646388|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
23646389|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
23646390|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
23646391|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
23646392|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
23800742|NCT01392326|66646887|FG000|Overall Study|Death|2|||
23800743|NCT01392326|66646888|FG001|Overall Study|Death|0|||
23800744|NCT01392326|66646889|FG002|Overall Study|Death|0|||
23800745|NCT01392326|66646887|FG000|Overall Study|Withdrawal by Subject|12|||
23800746|NCT01392326|66646888|FG001|Overall Study|Withdrawal by Subject|11|||
23800747|NCT01392326|66646889|FG002|Overall Study|Withdrawal by Subject|15|||
23800748|NCT01392326|66646887|FG000|Overall Study|Protocol Violation|2|||
23800749|NCT01392326|66646888|FG001|Overall Study|Protocol Violation|0|||
23800750|NCT01392326|66646889|FG002|Overall Study|Protocol Violation|0|||
23800751|NCT01392326|66646887|FG000|Overall Study|Pregnancy|0|||
23800752|NCT01392326|66646888|FG001|Overall Study|Pregnancy|0|||
23478444|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478445|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Death|1|||
23478446|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Death|0|||
23478447|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Death|0|||
23478448|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Death|0|||
23800753|NCT01392326|66646889|FG002|Overall Study|Pregnancy|1|||
23478449|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Death|0|||
23646393|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
23646394|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
23646395|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
23646396|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
23646397|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
23646398|NCT02288247|66091130|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
23646399|NCT02288247|66091131|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
23646400|NCT01598311|66091132|FG000|Overall Study|Physician Decision|4|||
23646401|NCT01598311|66091133|FG001|Overall Study|Physician Decision|5|||
23646402|NCT01598311|66091132|FG000|Overall Study|Adverse Event|9|||
23646403|NCT01598311|66091133|FG001|Overall Study|Adverse Event|13|||
23646404|NCT01598311|66091132|FG000|Overall Study|Lost to Follow-up|7|||
23646405|NCT01598311|66091133|FG001|Overall Study|Lost to Follow-up|12|||
23646406|NCT01598311|66091132|FG000|Overall Study|Withdrawal by Subject|9|||
23646407|NCT01598311|66091133|FG001|Overall Study|Withdrawal by Subject|13|||
23646408|NCT01598311|66091132|FG000|Overall Study|No reason provided.|0|||
23646409|NCT01598311|66091133|FG001|Overall Study|No reason provided.|5|||
23646410|NCT01598311|66091132|FG000|Overall Study|Randomized but never treated|8|||
23646411|NCT01598311|66091133|FG001|Overall Study|Randomized but never treated|5|||
23646412|NCT01598311|66091132|FG000|Overall Study|Treated but no confirmed CDAD|9|||
23646413|NCT01598311|66091133|FG001|Overall Study|Treated but no confirmed CDAD|8|||
23646414|NCT01598311|66091132|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
23646415|NCT01598311|66091133|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
23646416|NCT00591721|66091134|FG000|Overall Study|Withdrawal by Subject|10|||
23646417|NCT00591721|66091135|FG001|Overall Study|Withdrawal by Subject|10|||
23646418|NCT00591721|66091134|FG000|Overall Study|Lost to Follow-up|1|||
23646419|NCT00591721|66091135|FG001|Overall Study|Lost to Follow-up|4|||
23646420|NCT00591721|66091134|FG000|Overall Study|Intervention not received|10|||
23646421|NCT00591721|66091135|FG001|Overall Study|Intervention not received|8|||
23646422|NCT01183234|66091136|FG000|First Intervention|Adverse Event|1|||
23646423|NCT01183234|66091137|FG001|First Intervention|Adverse Event|0|||
23646424|NCT02407990|66091138|FG000|Overall Study|Death|2|||
23646425|NCT02407990|66091139|FG001|Overall Study|Death|22|||
23646426|NCT02407990|66091140|FG002|Overall Study|Death|23|||
23646427|NCT02407990|66091141|FG003|Overall Study|Death|7|||
23646428|NCT02407990|66091142|FG004|Overall Study|Death|17|||
23646429|NCT02407990|66091143|FG005|Overall Study|Death|16|||
23646430|NCT02407990|66091144|FG006|Overall Study|Death|10|||
23646431|NCT02407990|66091145|FG007|Overall Study|Death|248|||
23646432|NCT02407990|66091138|FG000|Overall Study|Lost to Follow-up|0|||
23646433|NCT02407990|66091139|FG001|Overall Study|Lost to Follow-up|1|||
23646434|NCT02407990|66091140|FG002|Overall Study|Lost to Follow-up|0|||
23646435|NCT02407990|66091141|FG003|Overall Study|Lost to Follow-up|0|||
23646436|NCT02407990|66091142|FG004|Overall Study|Lost to Follow-up|0|||
23646437|NCT02407990|66091143|FG005|Overall Study|Lost to Follow-up|0|||
23646438|NCT02407990|66091144|FG006|Overall Study|Lost to Follow-up|0|||
23646439|NCT02407990|66091145|FG007|Overall Study|Lost to Follow-up|17|||
23646440|NCT02407990|66091138|FG000|Overall Study|Progressive Disease|0|||
23646441|NCT02407990|66091139|FG001|Overall Study|Progressive Disease|0|||
23646442|NCT02407990|66091140|FG002|Overall Study|Progressive Disease|0|||
23646443|NCT02407990|66091141|FG003|Overall Study|Progressive Disease|0|||
23646444|NCT02407990|66091142|FG004|Overall Study|Progressive Disease|0|||
23646445|NCT02407990|66091143|FG005|Overall Study|Progressive Disease|0|||
23646446|NCT02407990|66091144|FG006|Overall Study|Progressive Disease|0|||
23646447|NCT02407990|66091145|FG007|Overall Study|Progressive Disease|1|||
23646448|NCT02407990|66091138|FG000|Overall Study|Withdrawal by Subject|0|||
23646449|NCT02407990|66091139|FG001|Overall Study|Withdrawal by Subject|0|||
23646450|NCT02407990|66091140|FG002|Overall Study|Withdrawal by Subject|0|||
23646451|NCT02407990|66091141|FG003|Overall Study|Withdrawal by Subject|0|||
23646452|NCT02407990|66091142|FG004|Overall Study|Withdrawal by Subject|1|||
23646453|NCT02407990|66091143|FG005|Overall Study|Withdrawal by Subject|0|||
23646454|NCT02407990|66091144|FG006|Overall Study|Withdrawal by Subject|0|||
23646455|NCT02407990|66091145|FG007|Overall Study|Withdrawal by Subject|30|||
23646456|NCT02407990|66091138|FG000|Overall Study|Study Terminated by Sponsor|1|||
23646457|NCT02407990|66091139|FG001|Overall Study|Study Terminated by Sponsor|3|||
23646458|NCT02407990|66091140|FG002|Overall Study|Study Terminated by Sponsor|3|||
23646459|NCT02407990|66091141|FG003|Overall Study|Study Terminated by Sponsor|0|||
23646460|NCT02407990|66091142|FG004|Overall Study|Study Terminated by Sponsor|3|||
23646461|NCT02407990|66091143|FG005|Overall Study|Study Terminated by Sponsor|4|||
23646462|NCT02407990|66091144|FG006|Overall Study|Study Terminated by Sponsor|3|||
23646463|NCT02407990|66091145|FG007|Overall Study|Study Terminated by Sponsor|37|||
23646464|NCT02407990|66091138|FG000|Overall Study|Logistics|0|||
23646465|NCT02407990|66091139|FG001|Overall Study|Logistics|0|||
23646466|NCT02407990|66091140|FG002|Overall Study|Logistics|0|||
23646467|NCT02407990|66091141|FG003|Overall Study|Logistics|0|||
23646468|NCT02407990|66091142|FG004|Overall Study|Logistics|0|||
23646469|NCT02407990|66091143|FG005|Overall Study|Logistics|0|||
23646470|NCT02407990|66091144|FG006|Overall Study|Logistics|0|||
23646471|NCT02407990|66091145|FG007|Overall Study|Logistics|1|||
23646472|NCT02407990|66091138|FG000|Overall Study|Rolled into long-term extension study|0|||
23646473|NCT02407990|66091139|FG001|Overall Study|Rolled into long-term extension study|0|||
23646474|NCT02407990|66091140|FG002|Overall Study|Rolled into long-term extension study|0|||
23646475|NCT02407990|66091141|FG003|Overall Study|Rolled into long-term extension study|0|||
23646476|NCT02407990|66091142|FG004|Overall Study|Rolled into long-term extension study|0|||
23646477|NCT02407990|66091143|FG005|Overall Study|Rolled into long-term extension study|0|||
23646478|NCT02407990|66091144|FG006|Overall Study|Rolled into long-term extension study|0|||
23646479|NCT02407990|66091145|FG007|Overall Study|Rolled into long-term extension study|1|||
23646480|NCT01065844|66091157|FG000|Overall Study|Adverse Event|5|||
23646481|NCT02673515|66091160|FG000|Overall Study|Lack of motivation|2|||
23646482|NCT02673515|66091161|FG001|Overall Study|Lack of motivation|1|||
23646483|NCT00985153|66091162|FG000|Overall Study|Lost to Follow-up|16|||
23646484|NCT00985153|66091163|FG001|Overall Study|Lost to Follow-up|19|||
23646485|NCT00985153|66091164|FG002|Overall Study|Lost to Follow-up|17|||
23646486|NCT00985153|66091165|FG003|Overall Study|Lost to Follow-up|20|||
23646487|NCT00985153|66091162|FG000|Overall Study|Protocol Violation|3|||
23646488|NCT00985153|66091163|FG001|Overall Study|Protocol Violation|2|||
23646489|NCT00985153|66091164|FG002|Overall Study|Protocol Violation|4|||
23646490|NCT00985153|66091165|FG003|Overall Study|Protocol Violation|3|||
23646491|NCT00985153|66091162|FG000|Overall Study|Withdrawal by Subject|6|||
23646492|NCT00985153|66091163|FG001|Overall Study|Withdrawal by Subject|11|||
23646493|NCT00985153|66091164|FG002|Overall Study|Withdrawal by Subject|11|||
23646494|NCT00985153|66091165|FG003|Overall Study|Withdrawal by Subject|10|||
23646495|NCT00985153|66091162|FG000|Overall Study|Missed One or More Bleeds|7|||
23646496|NCT00985153|66091163|FG001|Overall Study|Missed One or More Bleeds|7|||
23646497|NCT00985153|66091164|FG002|Overall Study|Missed One or More Bleeds|8|||
23646498|NCT00985153|66091165|FG003|Overall Study|Missed One or More Bleeds|10|||
23646499|NCT00985153|66091162|FG000|Overall Study|Incomplete Safety Follow-up|3|||
23646500|NCT00985153|66091163|FG001|Overall Study|Incomplete Safety Follow-up|5|||
23646501|NCT00985153|66091164|FG002|Overall Study|Incomplete Safety Follow-up|4|||
23646502|NCT00985153|66091165|FG003|Overall Study|Incomplete Safety Follow-up|4|||
23646503|NCT04097301|66091166|FG000|Overall Study|Death|1|||
23646504|NCT04097301|66091166|FG000|Overall Study|Withdrawal by Subject|1|||
23646505|NCT04097301|66091166|FG000|Overall Study|Screening Failure|5|||
23646506|NCT00321373|66091167|FG000|Overall Study|Adverse Event|0|||
23646507|NCT00321373|66091168|FG001|Overall Study|Adverse Event|0|||
23646508|NCT00321373|66091169|FG002|Overall Study|Adverse Event|1|||
23646509|NCT00321373|66091167|FG000|Overall Study|Lost to Follow-up|1|||
23646510|NCT00321373|66091168|FG001|Overall Study|Lost to Follow-up|0|||
23646511|NCT00321373|66091169|FG002|Overall Study|Lost to Follow-up|1|||
23646512|NCT00321373|66091167|FG000|Overall Study|Withdrawal by Subject|1|||
23646513|NCT00321373|66091168|FG001|Overall Study|Withdrawal by Subject|0|||
23646514|NCT00321373|66091169|FG002|Overall Study|Withdrawal by Subject|0|||
23646515|NCT00321373|66091167|FG000|Overall Study|Other|0|||
23646516|NCT00321373|66091168|FG001|Overall Study|Other|0|||
23646517|NCT00321373|66091169|FG002|Overall Study|Other|1|||
23646518|NCT01076192|66091175|FG000|Overall Study|Other|197|||
23646519|NCT02319759|66091176|FG000|Week 0 - 16|Lack of Efficacy|1|||
23646520|NCT02319759|66091177|FG001|Week 0 - 16|Lack of Efficacy|0|||
23646521|NCT02319759|66091178|FG002|Week 0 - 16|Lack of Efficacy|0|||
23646522|NCT02319759|66091179|FG003|Week 0 - 16|Lack of Efficacy|0|||
23646523|NCT02319759|66091180|FG004|Week 0 - 16|Lack of Efficacy|0|||
23646524|NCT02319759|66091176|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
23646525|NCT02319759|66091177|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
23646526|NCT02319759|66091178|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
23646527|NCT02319759|66091179|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
23646528|NCT02319759|66091180|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
23646529|NCT02319759|66091176|FG000|Week 16 - 24|Lack of Efficacy|1|||
23646530|NCT02319759|66091177|FG001|Week 16 - 24|Lack of Efficacy|0|||
23646531|NCT02319759|66091178|FG002|Week 16 - 24|Lack of Efficacy|1|||
23646532|NCT02319759|66091179|FG003|Week 16 - 24|Lack of Efficacy|0|||
23646533|NCT02319759|66091180|FG004|Week 16 - 24|Lack of Efficacy|0|||
23646534|NCT02319759|66091176|FG000|Week 16 - 24|Lost to Follow-up|1|||
23646535|NCT02319759|66091177|FG001|Week 16 - 24|Lost to Follow-up|0|||
23646536|NCT02319759|66091178|FG002|Week 16 - 24|Lost to Follow-up|0|||
23646537|NCT02319759|66091179|FG003|Week 16 - 24|Lost to Follow-up|0|||
23646538|NCT02319759|66091180|FG004|Week 16 - 24|Lost to Follow-up|0|||
23646539|NCT02319759|66091176|FG000|Week 16 - 24|Withdrawal by Subject|0|||
23646540|NCT02319759|66091177|FG001|Week 16 - 24|Withdrawal by Subject|0|||
23646541|NCT02319759|66091178|FG002|Week 16 - 24|Withdrawal by Subject|2|||
23646542|NCT02319759|66091179|FG003|Week 16 - 24|Withdrawal by Subject|0|||
23646543|NCT02319759|66091180|FG004|Week 16 - 24|Withdrawal by Subject|0|||
23646544|NCT02319759|66091176|FG000|Week 24 - 56|Adverse Event|0|||
23478450|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Death|0|||
23646545|NCT02319759|66091177|FG001|Week 24 - 56|Adverse Event|0|||
23646546|NCT02319759|66091178|FG002|Week 24 - 56|Adverse Event|2|||
23646547|NCT02319759|66091179|FG003|Week 24 - 56|Adverse Event|0|||
23646548|NCT02319759|66091180|FG004|Week 24 - 56|Adverse Event|0|||
23646549|NCT02319759|66091176|FG000|Week 24 - 56|Lack of Efficacy|0|||
23597241|NCT00998881|65915873|FG001|Overall Study|Physician Decision|0|||
23597242|NCT00998881|65915872|FG000|Overall Study|Withdrawal by Subject|1|||
23597243|NCT00998881|65915873|FG001|Overall Study|Withdrawal by Subject|0|||
23597244|NCT00998881|65915872|FG000|Overall Study|Personal matter|1|||
23597245|NCT00998881|65915873|FG001|Overall Study|Personal matter|0|||
23597246|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
23597247|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597248|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597249|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597250|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
23597251|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597252|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597253|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597254|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
23597255|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597256|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597257|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597258|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
23597259|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597260|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597261|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597262|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
23597263|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597264|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597265|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597266|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
23597267|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597268|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597269|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597270|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
23597271|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597272|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597273|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597274|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
23597275|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
23597276|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
23597277|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
23597278|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
23597279|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
23597280|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
23597281|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
23597282|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597283|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
23597284|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597285|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597286|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
23597287|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
23597288|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
23597289|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
23597290|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
23597291|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
23597292|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
23597293|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
23597294|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597295|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
23597296|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597297|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597298|NCT02730871|65919085|FG000|Overall Study|Adverse Event|6|||
23597299|NCT02730871|65919086|FG001|Overall Study|Adverse Event|0|||
23597300|NCT02204982|65919087|FG000|Overall Study|Patient ineligible-medical monitor|1|||
23646550|NCT02319759|66091177|FG001|Week 24 - 56|Lack of Efficacy|0|||
23646551|NCT02319759|66091178|FG002|Week 24 - 56|Lack of Efficacy|0|||
23646552|NCT02319759|66091179|FG003|Week 24 - 56|Lack of Efficacy|2|||
23646553|NCT02319759|66091180|FG004|Week 24 - 56|Lack of Efficacy|1|||
23646554|NCT02319759|66091176|FG000|Week 24 - 56|Withdrawal by Subject|0|||
23646555|NCT02319759|66091177|FG001|Week 24 - 56|Withdrawal by Subject|1|||
23646556|NCT02319759|66091178|FG002|Week 24 - 56|Withdrawal by Subject|0|||
23646557|NCT02319759|66091179|FG003|Week 24 - 56|Withdrawal by Subject|0|||
23646558|NCT02319759|66091180|FG004|Week 24 - 56|Withdrawal by Subject|0|||
23646559|NCT02319759|66091176|FG000|Week 24 - 56|Lost to Follow-up|0|||
23646560|NCT02319759|66091177|FG001|Week 24 - 56|Lost to Follow-up|0|||
23646561|NCT02319759|66091178|FG002|Week 24 - 56|Lost to Follow-up|0|||
23646562|NCT02319759|66091179|FG003|Week 24 - 56|Lost to Follow-up|0|||
23646563|NCT02319759|66091180|FG004|Week 24 - 56|Lost to Follow-up|1|||
23646564|NCT03170349|66091181|FG000|At 30 Days Follow-up|Death|1|||
23646565|NCT03170349|66091181|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
23646566|NCT03170349|66091181|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
23646567|NCT03170349|66091181|FG000|At 6 Months Follow-up|Death|3|||
23646568|NCT03170349|66091181|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
23646569|NCT03170349|66091181|FG000|At 1 Year Follow-up|Death|6|||
23646570|NCT03170349|66091181|FG000|At 2 Year Follow-up|Missed Visit|4|||
23646571|NCT03170349|66091181|FG000|At 2 Year Follow-up|Death|13|||
23646572|NCT03170349|66091181|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
23646573|NCT01210118|66091182|FG000|Overall Study|Lost to Follow-up|1|||
23646574|NCT01210118|66091183|FG001|Overall Study|Lost to Follow-up|1|||
23646575|NCT01210118|66091182|FG000|Overall Study|Protocol Violation|1|||
23646576|NCT01210118|66091183|FG001|Overall Study|Protocol Violation|1|||
23646577|NCT01210118|66091182|FG000|Overall Study|Spontaneous abortion|1|||
23646578|NCT01210118|66091183|FG001|Overall Study|Spontaneous abortion|3|||
23646579|NCT02257567|66091186|FG000|Overall Study|Adverse Event|0|||
23646580|NCT02257567|66091187|FG001|Overall Study|Adverse Event|0|||
23646581|NCT02257567|66091188|FG002|Overall Study|Adverse Event|0|||
23646582|NCT02257567|66091189|FG003|Overall Study|Adverse Event|1|||
23646583|NCT02257567|66091190|FG004|Overall Study|Adverse Event|1|||
23646584|NCT02257567|66091191|FG005|Overall Study|Adverse Event|0|||
23646585|NCT02257567|66091192|FG006|Overall Study|Adverse Event|0|||
23646586|NCT02257567|66091193|FG007|Overall Study|Adverse Event|0|||
23646587|NCT02257567|66091194|FG008|Overall Study|Adverse Event|1|||
23646588|NCT02257567|66091195|FG009|Overall Study|Adverse Event|0|||
23646589|NCT02257567|66091196|FG010|Overall Study|Adverse Event|0|||
23646590|NCT02257567|66091186|FG000|Overall Study|Death|2|||
23646591|NCT02257567|66091187|FG001|Overall Study|Death|2|||
23646592|NCT02257567|66091188|FG002|Overall Study|Death|2|||
23646593|NCT02257567|66091189|FG003|Overall Study|Death|4|||
23646594|NCT02257567|66091190|FG004|Overall Study|Death|15|||
23646595|NCT02257567|66091191|FG005|Overall Study|Death|11|||
23646596|NCT02257567|66091192|FG006|Overall Study|Death|26|||
23646597|NCT02257567|66091193|FG007|Overall Study|Death|30|||
23646598|NCT02257567|66091194|FG008|Overall Study|Death|2|||
23646599|NCT02257567|66091195|FG009|Overall Study|Death|18|||
23646600|NCT02257567|66091196|FG010|Overall Study|Death|65|||
23646601|NCT02257567|66091186|FG000|Overall Study|Lost to Follow-up|0|||
23646602|NCT02257567|66091187|FG001|Overall Study|Lost to Follow-up|0|||
23646603|NCT02257567|66091188|FG002|Overall Study|Lost to Follow-up|0|||
23646604|NCT02257567|66091189|FG003|Overall Study|Lost to Follow-up|0|||
23646605|NCT02257567|66091190|FG004|Overall Study|Lost to Follow-up|2|||
23646606|NCT02257567|66091191|FG005|Overall Study|Lost to Follow-up|2|||
23646607|NCT02257567|66091192|FG006|Overall Study|Lost to Follow-up|0|||
23646608|NCT02257567|66091193|FG007|Overall Study|Lost to Follow-up|0|||
23646609|NCT02257567|66091194|FG008|Overall Study|Lost to Follow-up|0|||
23646610|NCT02257567|66091195|FG009|Overall Study|Lost to Follow-up|1|||
23646611|NCT02257567|66091196|FG010|Overall Study|Lost to Follow-up|1|||
23646612|NCT02257567|66091186|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646613|NCT02257567|66091187|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646614|NCT02257567|66091188|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646615|NCT02257567|66091189|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646616|NCT02257567|66091190|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
23646617|NCT02257567|66091191|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646618|NCT02257567|66091192|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
23646619|NCT02257567|66091193|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646620|NCT02257567|66091194|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646621|NCT02257567|66091195|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646622|NCT02257567|66091196|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23646623|NCT02257567|66091186|FG000|Overall Study|Physician Decision|0|||
23646624|NCT02257567|66091187|FG001|Overall Study|Physician Decision|0|||
23646625|NCT02257567|66091188|FG002|Overall Study|Physician Decision|0|||
23646626|NCT02257567|66091189|FG003|Overall Study|Physician Decision|0|||
23646627|NCT02257567|66091190|FG004|Overall Study|Physician Decision|0|||
23646628|NCT02257567|66091191|FG005|Overall Study|Physician Decision|0|||
23646629|NCT02257567|66091192|FG006|Overall Study|Physician Decision|0|||
23646630|NCT02257567|66091193|FG007|Overall Study|Physician Decision|2|||
23646631|NCT02257567|66091194|FG008|Overall Study|Physician Decision|0|||
23646632|NCT02257567|66091195|FG009|Overall Study|Physician Decision|1|||
23646633|NCT02257567|66091196|FG010|Overall Study|Physician Decision|0|||
23646634|NCT02257567|66091186|FG000|Overall Study|Withdrawal by Subject|0|||
23646635|NCT02257567|66091187|FG001|Overall Study|Withdrawal by Subject|0|||
23646636|NCT02257567|66091188|FG002|Overall Study|Withdrawal by Subject|2|||
23646637|NCT02257567|66091189|FG003|Overall Study|Withdrawal by Subject|0|||
23646638|NCT02257567|66091190|FG004|Overall Study|Withdrawal by Subject|0|||
23646639|NCT02257567|66091191|FG005|Overall Study|Withdrawal by Subject|6|||
23646640|NCT02257567|66091192|FG006|Overall Study|Withdrawal by Subject|6|||
23646641|NCT02257567|66091193|FG007|Overall Study|Withdrawal by Subject|6|||
23646642|NCT02257567|66091194|FG008|Overall Study|Withdrawal by Subject|1|||
23646643|NCT02257567|66091195|FG009|Overall Study|Withdrawal by Subject|1|||
23646644|NCT02257567|66091196|FG010|Overall Study|Withdrawal by Subject|10|||
23646645|NCT02704754|66091199|FG000|Overall Study|Lost to Follow-up|1|||
23646646|NCT02704754|66091200|FG001|Overall Study|Lost to Follow-up|1|||
23646647|NCT02704754|66091199|FG000|Overall Study|Lack of Efficacy|1|||
23646648|NCT02704754|66091200|FG001|Overall Study|Lack of Efficacy|0|||
23646649|NCT02704754|66091199|FG000|Overall Study|Withdrawal by Subject|1|||
23646650|NCT02704754|66091200|FG001|Overall Study|Withdrawal by Subject|0|||
23646651|NCT01844687|66091204|FG000|Visit 1|Protocol Violation|3|||
23646652|NCT01844687|66091204|FG000|Visit 1|Lost to Follow-up|5|||
23646653|NCT01844687|66091204|FG000|Visit 2|Withdrawal by Subject|1|||
23646654|NCT01844687|66091204|FG000|Visit 2|Protocol Violation|1|||
23646655|NCT01844687|66091204|FG000|Visit 3|Lost to Follow-up|1|||
23646656|NCT01844687|66091204|FG000|Visit 3|Withdrawal by Subject|3|||
23646657|NCT01844687|66091204|FG000|Visit 3|child care problems|1|||
23646658|NCT01844687|66091204|FG000|Visit 4|Pregnancy|1|||
23646659|NCT01844687|66091204|FG000|Visit 4|Lost to Follow-up|1|||
23646660|NCT01844687|66091204|FG000|Visit 4|Withdrawal by Subject|2|||
23360513|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
23646661|NCT02915302|66091205|FG000|Overall Study|Adverse Event|3|||
23646662|NCT02915302|66091206|FG001|Overall Study|Adverse Event|0|||
23646663|NCT02915302|66091205|FG000|Overall Study|Protocol Violation|20|||
23646664|NCT02915302|66091206|FG001|Overall Study|Protocol Violation|27|||
23646665|NCT02915302|66091205|FG000|Overall Study|Lost to Follow-up|19|||
23646666|NCT02915302|66091206|FG001|Overall Study|Lost to Follow-up|22|||
23646667|NCT02915302|66091205|FG000|Overall Study|Withdrawal by Subject|22|||
23646668|NCT02915302|66091206|FG001|Overall Study|Withdrawal by Subject|29|||
23646669|NCT02915302|66091205|FG000|Overall Study|Other|1|||
23646670|NCT02915302|66091206|FG001|Overall Study|Other|0|||
23646671|NCT05056987|66091207|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
23360514|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
23360515|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
23597301|NCT02204982|65919088|FG001|Overall Study|Patient ineligible-medical monitor|0|||
23646672|NCT05056987|66091208|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
23646673|NCT05056987|66091207|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
23646674|NCT05056987|66091208|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
23646675|NCT02667587|66091209|FG000|Pre-Treatment|Not reported|1|||
23646676|NCT02667587|66091210|FG001|Pre-Treatment|Not reported|0|||
23646677|NCT02667587|66091209|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23646678|NCT02667587|66091210|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
23646679|NCT02667587|66091209|FG000|Pre-Treatment|Participant withdrew consent|0|||
23646680|NCT02667587|66091210|FG001|Pre-Treatment|Participant withdrew consent|1|||
23646681|NCT02667587|66091209|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23646682|NCT02667587|66091210|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
23646683|NCT02667587|66091209|FG000|End of Treatment|Other reasons|11|||
23646684|NCT02667587|66091210|FG001|End of Treatment|Other reasons|8|||
23646685|NCT02667587|66091209|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
23646686|NCT02667587|66091210|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
23646687|NCT02667587|66091209|FG000|End of Treatment|Poor/Non-Compliance|0|||
23646688|NCT02667587|66091210|FG001|End of Treatment|Poor/Non-Compliance|1|||
23646689|NCT02667587|66091209|FG000|End of Treatment|Maximum Clinical Benefit|3|||
23646690|NCT02667587|66091210|FG001|End of Treatment|Maximum Clinical Benefit|3|||
23646691|NCT02667587|66091209|FG000|End of Treatment|Participant Withdrew Consent|5|||
23646692|NCT02667587|66091210|FG001|End of Treatment|Participant Withdrew Consent|6|||
23646693|NCT02667587|66091209|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
23646694|NCT02667587|66091210|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
23646695|NCT02667587|66091209|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
23646696|NCT02667587|66091210|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
23646697|NCT02667587|66091209|FG000|End of Treatment|Death|2|||
23646698|NCT02667587|66091210|FG001|End of Treatment|Death|1|||
23646699|NCT02667587|66091209|FG000|End of Treatment|Study Drug Toxicity|74|||
23646700|NCT02667587|66091210|FG001|End of Treatment|Study Drug Toxicity|18|||
23597302|NCT02204982|65919087|FG000|Overall Study|Withdrawal by Subject|1|||
23597303|NCT02204982|65919088|FG001|Overall Study|Withdrawal by Subject|0|||
23597304|NCT02204982|65919087|FG000|Overall Study|Adverse Event|1|||
23597305|NCT02204982|65919088|FG001|Overall Study|Adverse Event|0|||
23597306|NCT02204982|65919087|FG000|Overall Study|Adverse Event and Investigator decision|1|||
23597307|NCT02204982|65919088|FG001|Overall Study|Adverse Event and Investigator decision|0|||
23597308|NCT02204982|65919087|FG000|Overall Study|Physician Decision|0|||
23597309|NCT02204982|65919088|FG001|Overall Study|Physician Decision|2|||
23597310|NCT02204982|65919087|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
23597311|NCT02204982|65919088|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
23597312|NCT02204982|65919087|FG000|Overall Study|Termination of Study bySponsor|0|||
23597313|NCT02204982|65919088|FG001|Overall Study|Termination of Study bySponsor|1|||
23597314|NCT00073749|65919089|FG000|Overall Study|Disease Progression|2|||
23597315|NCT00073749|65919090|FG001|Overall Study|Disease Progression|0|||
23597316|NCT00073749|65919091|FG002|Overall Study|Disease Progression|3|||
23597317|NCT00073749|65919092|FG003|Overall Study|Disease Progression|2|||
23597318|NCT00073749|65919093|FG004|Overall Study|Disease Progression|3|||
23597319|NCT00073749|65919094|FG005|Overall Study|Disease Progression|1|||
23597320|NCT00073749|65919095|FG006|Overall Study|Disease Progression|3|||
23597321|NCT00073749|65919089|FG000|Overall Study|Death|0|||
23597322|NCT00073749|65919090|FG001|Overall Study|Death|1|||
23597323|NCT00073749|65919091|FG002|Overall Study|Death|1|||
23597324|NCT00073749|65919092|FG003|Overall Study|Death|0|||
23597325|NCT00073749|65919093|FG004|Overall Study|Death|0|||
23597326|NCT00073749|65919094|FG005|Overall Study|Death|0|||
23597327|NCT00073749|65919095|FG006|Overall Study|Death|29|||
23597328|NCT00073749|65919089|FG000|Overall Study|Adverse Event|0|||
23597329|NCT00073749|65919090|FG001|Overall Study|Adverse Event|3|||
23597330|NCT00073749|65919091|FG002|Overall Study|Adverse Event|6|||
23597331|NCT00073749|65919092|FG003|Overall Study|Adverse Event|4|||
23597332|NCT00073749|65919093|FG004|Overall Study|Adverse Event|2|||
23360516|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
23360517|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
23478451|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Death|0|||
23597333|NCT00073749|65919094|FG005|Overall Study|Adverse Event|1|||
23597334|NCT00073749|65919095|FG006|Overall Study|Adverse Event|0|||
23597335|NCT00073749|65919089|FG000|Overall Study|Physician Decision|0|||
23597336|NCT00073749|65919090|FG001|Overall Study|Physician Decision|0|||
23597337|NCT00073749|65919091|FG002|Overall Study|Physician Decision|1|||
23597338|NCT00073749|65919092|FG003|Overall Study|Physician Decision|0|||
23597339|NCT00073749|65919093|FG004|Overall Study|Physician Decision|0|||
23646701|NCT02667587|66091209|FG000|End of Treatment|Disease progression|177|||
23646702|NCT02667587|66091210|FG001|End of Treatment|Disease progression|222|||
23646703|NCT02667587|66091209|FG000|End of Treatment|Lost to Follow-up|1|||
23646704|NCT02667587|66091210|FG001|End of Treatment|Lost to Follow-up|3|||
23646705|NCT01313117|66091211|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
23646706|NCT01313117|66091211|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
23646707|NCT01313689|66091212|FG000|24-Week Randomization 1|Adverse Event|10|||
23646708|NCT01313689|66091213|FG001|24-Week Randomization 1|Adverse Event|5|||
23646709|NCT01313689|66091214|FG002|24-Week Randomization 1|Adverse Event|0|||
23646710|NCT01313689|66091215|FG003|24-Week Randomization 1|Adverse Event|0|||
23646711|NCT01313689|66091216|FG004|24-Week Randomization 1|Adverse Event|0|||
23646712|NCT01313689|66091212|FG000|24-Week Randomization 1|Physician Decision|4|||
23646713|NCT01313689|66091213|FG001|24-Week Randomization 1|Physician Decision|5|||
23646714|NCT01313689|66091214|FG002|24-Week Randomization 1|Physician Decision|0|||
23646715|NCT01313689|66091215|FG003|24-Week Randomization 1|Physician Decision|0|||
23646716|NCT01313689|66091216|FG004|24-Week Randomization 1|Physician Decision|0|||
23646717|NCT01313689|66091212|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
23646718|NCT01313689|66091213|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
23646719|NCT01313689|66091214|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
23646720|NCT01313689|66091215|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
23646721|NCT01313689|66091216|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
23646722|NCT01313689|66091212|FG000|24-Week Randomization 2|Adverse Event|0|||
23646723|NCT01313689|66091213|FG001|24-Week Randomization 2|Adverse Event|0|||
23646724|NCT01313689|66091214|FG002|24-Week Randomization 2|Adverse Event|2|||
23646725|NCT01313689|66091215|FG003|24-Week Randomization 2|Adverse Event|0|||
23646726|NCT01313689|66091216|FG004|24-Week Randomization 2|Adverse Event|8|||
23646727|NCT01313689|66091212|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
23646728|NCT01313689|66091213|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
23646729|NCT01313689|66091214|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
23646730|NCT01313689|66091215|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
23646731|NCT01313689|66091216|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
23646732|NCT01313689|66091212|FG000|24-Week Randomization 2|Physician Decision|0|||
23646733|NCT01313689|66091213|FG001|24-Week Randomization 2|Physician Decision|0|||
23646734|NCT01313689|66091214|FG002|24-Week Randomization 2|Physician Decision|0|||
23646735|NCT01313689|66091215|FG003|24-Week Randomization 2|Physician Decision|0|||
23646736|NCT01313689|66091216|FG004|24-Week Randomization 2|Physician Decision|4|||
23646737|NCT02783768|66091218|FG000|Overall Study|Lost to Follow-up|1|||
23646738|NCT02783768|66091219|FG001|Overall Study|Lost to Follow-up|0|||
23646739|NCT03730480|66091220|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
23646740|NCT01759368|66093954|FG000|Overall Study|Lost to Follow-up|1|||
23646741|NCT01759368|66093955|FG001|Overall Study|Lost to Follow-up|0|||
23646742|NCT02679573|66093956|FG000|Overall Study|Adverse Event|13|||
23646743|NCT02679573|66093957|FG001|Overall Study|Adverse Event|6|||
23646744|NCT02679573|66093956|FG000|Overall Study|Lack of Efficacy|12|||
23646745|NCT02679573|66093957|FG001|Overall Study|Lack of Efficacy|15|||
23646746|NCT02679573|66093956|FG000|Overall Study|Could not complete required study visits|6|||
23646747|NCT02679573|66093957|FG001|Overall Study|Could not complete required study visits|2|||
23646748|NCT02679573|66093956|FG000|Overall Study|Withdrawal by Subject|2|||
23646749|NCT02679573|66093957|FG001|Overall Study|Withdrawal by Subject|9|||
23646750|NCT02679573|66093956|FG000|Overall Study|Death|2|||
23646751|NCT02679573|66093957|FG001|Overall Study|Death|0|||
23646752|NCT02679573|66093956|FG000|Overall Study|Physician Decision|2|||
23646753|NCT02679573|66093957|FG001|Overall Study|Physician Decision|4|||
23646754|NCT02679573|66093956|FG000|Overall Study|Lost to Follow-up|0|||
23646755|NCT02679573|66093957|FG001|Overall Study|Lost to Follow-up|3|||
23646756|NCT01048671|66093958|FG000|Overall Study|Protocol Violation|0|||
23646757|NCT01048671|66093959|FG001|Overall Study|Protocol Violation|1|||
23646758|NCT01048671|66093960|FG002|Overall Study|Protocol Violation|1|||
23646759|NCT03541174|66093963|FG000|Part 1 Double-Blind|Adverse Event|6|||
23646760|NCT03541174|66093964|FG001|Part 1 Double-Blind|Adverse Event|5|||
23646761|NCT03541174|66093965|FG002|Part 1 Double-Blind|Adverse Event|2|||
23646762|NCT03541174|66093966|FG003|Part 1 Double-Blind|Adverse Event|0|||
23646763|NCT03541174|66093967|FG004|Part 1 Double-Blind|Adverse Event|0|||
23646764|NCT03541174|66093968|FG005|Part 1 Double-Blind|Adverse Event|0|||
23646765|NCT03541174|66093963|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
23646766|NCT03541174|66093964|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
23646767|NCT03541174|66093965|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
23646768|NCT03541174|66093966|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
23646769|NCT03541174|66093967|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
23646770|NCT03541174|66093968|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
23646771|NCT03541174|66093963|FG000|Part 1 Double-Blind|Other reasons|3|||
23646772|NCT03541174|66093964|FG001|Part 1 Double-Blind|Other reasons|2|||
23646773|NCT03541174|66093965|FG002|Part 1 Double-Blind|Other reasons|3|||
23646774|NCT03541174|66093966|FG003|Part 1 Double-Blind|Other reasons|0|||
23646775|NCT03541174|66093967|FG004|Part 1 Double-Blind|Other reasons|0|||
23646776|NCT03541174|66093968|FG005|Part 1 Double-Blind|Other reasons|0|||
23646777|NCT03541174|66093963|FG000|Part 2 Single-Blind|Adverse Event|0|||
23646778|NCT03541174|66093964|FG001|Part 2 Single-Blind|Adverse Event|0|||
23646779|NCT03541174|66093965|FG002|Part 2 Single-Blind|Adverse Event|0|||
23646780|NCT03541174|66093966|FG003|Part 2 Single-Blind|Adverse Event|25|||
23646781|NCT03541174|66093967|FG004|Part 2 Single-Blind|Adverse Event|0|||
23646782|NCT03541174|66093968|FG005|Part 2 Single-Blind|Adverse Event|0|||
23646783|NCT03541174|66093963|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
23646784|NCT03541174|66093964|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
23646785|NCT03541174|66093965|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
23646786|NCT03541174|66093966|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
23646787|NCT03541174|66093967|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
23646788|NCT03541174|66093968|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
23646789|NCT03541174|66093963|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
23646790|NCT03541174|66093964|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
23646791|NCT03541174|66093965|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
23646792|NCT03541174|66093966|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
23646793|NCT03541174|66093967|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
23646794|NCT03541174|66093968|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
23646795|NCT03541174|66093963|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
23646796|NCT03541174|66093964|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
23646797|NCT03541174|66093965|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
23646798|NCT03541174|66093966|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
23646799|NCT03541174|66093967|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
23646800|NCT03541174|66093968|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
23646801|NCT03541174|66093963|FG000|Part 2 Single-Blind|Death|0|||
23646802|NCT03541174|66093964|FG001|Part 2 Single-Blind|Death|0|||
23646803|NCT03541174|66093965|FG002|Part 2 Single-Blind|Death|0|||
23646804|NCT03541174|66093966|FG003|Part 2 Single-Blind|Death|5|||
23646805|NCT03541174|66093967|FG004|Part 2 Single-Blind|Death|0|||
23646806|NCT03541174|66093968|FG005|Part 2 Single-Blind|Death|0|||
23646807|NCT03541174|66093963|FG000|Part 2 Single-Blind|Pregnancy|0|||
23646808|NCT03541174|66093964|FG001|Part 2 Single-Blind|Pregnancy|0|||
23646809|NCT03541174|66093965|FG002|Part 2 Single-Blind|Pregnancy|0|||
23646810|NCT03541174|66093966|FG003|Part 2 Single-Blind|Pregnancy|1|||
23646811|NCT03541174|66093967|FG004|Part 2 Single-Blind|Pregnancy|0|||
23646812|NCT03541174|66093968|FG005|Part 2 Single-Blind|Pregnancy|0|||
23646813|NCT03541174|66093963|FG000|Part 2 Single-Blind|Other reasons|0|||
23646814|NCT03541174|66093964|FG001|Part 2 Single-Blind|Other reasons|0|||
23646815|NCT03541174|66093965|FG002|Part 2 Single-Blind|Other reasons|0|||
23646816|NCT03541174|66093966|FG003|Part 2 Single-Blind|Other reasons|32|||
23646817|NCT03541174|66093967|FG004|Part 2 Single-Blind|Other reasons|0|||
23646818|NCT03541174|66093968|FG005|Part 2 Single-Blind|Other reasons|0|||
23646819|NCT03541174|66093963|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23646820|NCT03541174|66093964|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23646821|NCT03541174|66093965|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23646822|NCT03541174|66093966|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23646823|NCT03541174|66093967|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
23646824|NCT03541174|66093968|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
23646825|NCT03541174|66093963|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23646826|NCT03541174|66093964|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23646827|NCT03541174|66093965|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23646828|NCT03541174|66093966|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23646829|NCT03541174|66093967|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
23646830|NCT03541174|66093968|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
23646831|NCT03541174|66093963|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23646832|NCT03541174|66093964|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23646833|NCT03541174|66093965|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23646834|NCT03541174|66093966|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23646835|NCT03541174|66093967|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23646836|NCT03541174|66093968|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
23646837|NCT03541174|66093963|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23646838|NCT03541174|66093964|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23646839|NCT03541174|66093965|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23646840|NCT03541174|66093966|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23646841|NCT03541174|66093967|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
23478452|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Death|0|||
23646842|NCT03541174|66093968|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
23646843|NCT03541174|66093963|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23646844|NCT03541174|66093964|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23646845|NCT03541174|66093965|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23646846|NCT03541174|66093966|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23646847|NCT03541174|66093967|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
23800754|NCT01392326|66646887|FG000|Overall Study|Physician Decision|7|||
23646848|NCT03541174|66093968|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23646849|NCT01209143|66093971|FG000|Overall Study|Adverse Event|2|||
23646850|NCT01209143|66093972|FG001|Overall Study|Adverse Event|1|||
23646851|NCT01209143|66093971|FG000|Overall Study|Death|0|||
23646852|NCT01209143|66093972|FG001|Overall Study|Death|1|||
23646853|NCT01209143|66093971|FG000|Overall Study|Physician Decision|3|||
23646854|NCT01209143|66093972|FG001|Overall Study|Physician Decision|1|||
23646855|NCT01209143|66093971|FG000|Overall Study|Lost to Follow-up|1|||
23646856|NCT01209143|66093972|FG001|Overall Study|Lost to Follow-up|0|||
23646857|NCT01209143|66093971|FG000|Overall Study|Withdrawal by Subject|2|||
23646858|NCT01209143|66093972|FG001|Overall Study|Withdrawal by Subject|1|||
23646859|NCT01209143|66093971|FG000|Overall Study|Disease progression|11|||
23646860|NCT01209143|66093972|FG001|Overall Study|Disease progression|16|||
23646861|NCT00324675|66093973|FG000|Overall Study|Adverse Event|1|||
23646862|NCT00324675|66093974|FG001|Overall Study|Adverse Event|0|||
23646863|NCT01290315|66093976|FG000|Overall Study|Adverse Event|0|||
23646864|NCT01290315|66093977|FG001|Overall Study|Adverse Event|0|||
23646865|NCT01290315|66093978|FG002|Overall Study|Adverse Event|0|||
23646866|NCT01290315|66093979|FG003|Overall Study|Adverse Event|3|||
23646867|NCT01290315|66093976|FG000|Overall Study|Selection criteria/compliance|2|||
23646868|NCT01290315|66093977|FG001|Overall Study|Selection criteria/compliance|1|||
23646869|NCT01290315|66093978|FG002|Overall Study|Selection criteria/compliance|0|||
23646870|NCT01290315|66093979|FG003|Overall Study|Selection criteria/compliance|2|||
23646871|NCT01290315|66093976|FG000|Overall Study|Lost to Follow-up|0|||
23646872|NCT01290315|66093977|FG001|Overall Study|Lost to Follow-up|1|||
23646873|NCT01290315|66093978|FG002|Overall Study|Lost to Follow-up|0|||
23646874|NCT01290315|66093979|FG003|Overall Study|Lost to Follow-up|0|||
23800755|NCT01392326|66646888|FG001|Overall Study|Physician Decision|5|||
23360518|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
23597340|NCT00073749|65919094|FG005|Overall Study|Physician Decision|2|||
23597341|NCT00073749|65919095|FG006|Overall Study|Physician Decision|0|||
23597342|NCT00073749|65919089|FG000|Overall Study|Withdrawal by Subject|0|||
23597343|NCT00073749|65919090|FG001|Overall Study|Withdrawal by Subject|1|||
23597344|NCT00073749|65919091|FG002|Overall Study|Withdrawal by Subject|0|||
23597345|NCT00073749|65919092|FG003|Overall Study|Withdrawal by Subject|0|||
23597346|NCT00073749|65919093|FG004|Overall Study|Withdrawal by Subject|1|||
23597347|NCT00073749|65919094|FG005|Overall Study|Withdrawal by Subject|0|||
23597348|NCT00073749|65919095|FG006|Overall Study|Withdrawal by Subject|2|||
23597349|NCT00073749|65919089|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23597350|NCT00073749|65919090|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23597351|NCT00073749|65919091|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23597352|NCT00073749|65919092|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23597353|NCT00073749|65919093|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23597354|NCT00073749|65919094|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23597355|NCT00073749|65919095|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
23597356|NCT00073749|65919089|FG000|Overall Study|Lost to Follow-up|0|||
23597357|NCT00073749|65919090|FG001|Overall Study|Lost to Follow-up|0|||
23597358|NCT00073749|65919091|FG002|Overall Study|Lost to Follow-up|0|||
23597359|NCT00073749|65919092|FG003|Overall Study|Lost to Follow-up|0|||
23597360|NCT00073749|65919093|FG004|Overall Study|Lost to Follow-up|0|||
23597361|NCT00073749|65919094|FG005|Overall Study|Lost to Follow-up|0|||
23597362|NCT00073749|65919095|FG006|Overall Study|Lost to Follow-up|2|||
23597363|NCT00073749|65919089|FG000|Overall Study|Other|0|||
23597364|NCT00073749|65919090|FG001|Overall Study|Other|0|||
23597365|NCT00073749|65919091|FG002|Overall Study|Other|0|||
23597366|NCT00073749|65919092|FG003|Overall Study|Other|0|||
23360519|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Physician Decision|1|||
23597367|NCT00073749|65919093|FG004|Overall Study|Other|0|||
23597368|NCT00073749|65919094|FG005|Overall Study|Other|2|||
23597369|NCT00073749|65919095|FG006|Overall Study|Other|0|||
23597370|NCT03750968|65919096|FG000|Overall Study|Adverse Event|2|||
23597371|NCT03750968|65919097|FG001|Overall Study|Adverse Event|0|||
23597372|NCT03750968|65919096|FG000|Overall Study|Lost to Follow-up|1|||
23646875|NCT01290315|66093976|FG000|Overall Study|Withdrawal by Subject|1|||
23646876|NCT01290315|66093977|FG001|Overall Study|Withdrawal by Subject|1|||
23646877|NCT01290315|66093978|FG002|Overall Study|Withdrawal by Subject|0|||
23646878|NCT01290315|66093979|FG003|Overall Study|Withdrawal by Subject|0|||
23646879|NCT00848926|66093980|FG000|Treatment Period|Progressive disease|45|||
23646880|NCT00848926|66093980|FG000|Treatment Period|Adverse Event|20|||
23597373|NCT03750968|65919097|FG001|Overall Study|Lost to Follow-up|3|||
23597374|NCT02119650|65919098|FG000|Overall Study|Adverse Event|3|||
23597375|NCT02119650|65919099|FG001|Overall Study|Adverse Event|4|||
23597376|NCT02119650|65919098|FG000|Overall Study|Subject decision|2|||
23597377|NCT02119650|65919099|FG001|Overall Study|Subject decision|3|||
23597378|NCT02119650|65919098|FG000|Overall Study|Disease progression|11|||
23597379|NCT02119650|65919099|FG001|Overall Study|Disease progression|14|||
23597380|NCT02119650|65919098|FG000|Overall Study|Death|5|||
23597381|NCT02119650|65919099|FG001|Overall Study|Death|1|||
23646881|NCT00848926|66093980|FG000|Treatment Period|Physician Decision|12|||
23646882|NCT00848926|66093980|FG000|Treatment Period|Withdrawal by Subject|7|||
23646883|NCT00848926|66093980|FG000|Follow-up Period|Lost to Follow-up|7|||
23646884|NCT00848926|66093980|FG000|Follow-up Period|Withdrawal by Subject|3|||
23646885|NCT00848926|66093980|FG000|Follow-up Period|Other|2|||
23646886|NCT02292927|66093981|FG000|Overall Study|Protocol Violation|13|||
23646887|NCT02292927|66093982|FG001|Overall Study|Protocol Violation|7|||
23646888|NCT00122460|66093983|FG000|Overall Study|investigational study phase ongoing|7|||
23646889|NCT00122460|66093984|FG001|Overall Study|investigational study phase ongoing|1|||
23646890|NCT03536754|66093985|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
23646891|NCT03536754|66093986|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
23646892|NCT03536754|66093987|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
23646893|NCT03536754|66093988|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
23646894|NCT03536754|66093989|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
23646895|NCT03536754|66093985|FG000|Open Label Extension|Other|0|||
23646896|NCT03536754|66093986|FG001|Open Label Extension|Other|0|||
23646897|NCT03536754|66093987|FG002|Open Label Extension|Other|0|||
23646898|NCT03536754|66093988|FG003|Open Label Extension|Other|0|||
23646899|NCT03536754|66093989|FG004|Open Label Extension|Other|1|||
23646900|NCT00687973|66093990|FG000|Overall Study|Adverse Event|18|||
23646901|NCT00687973|66093991|FG001|Overall Study|Adverse Event|28|||
23646902|NCT00687973|66093990|FG000|Overall Study|Lack of Efficacy|2|||
23646903|NCT00687973|66093991|FG001|Overall Study|Lack of Efficacy|3|||
23646904|NCT00687973|66093990|FG000|Overall Study|Protocol Violation|1|||
23646905|NCT00687973|66093991|FG001|Overall Study|Protocol Violation|2|||
23646906|NCT00687973|66093990|FG000|Overall Study|Administrative Reasons|0|||
23646907|NCT00687973|66093991|FG001|Overall Study|Administrative Reasons|2|||
23646908|NCT00687973|66093990|FG000|Overall Study|Withdrawal by Subject|3|||
23646909|NCT00687973|66093991|FG001|Overall Study|Withdrawal by Subject|3|||
23646910|NCT00901186|66093992|FG000|Overall Study|Lack of Efficacy|0|||
23646911|NCT00901186|66093993|FG001|Overall Study|Lack of Efficacy|1|||
23646912|NCT00901186|66093992|FG000|Overall Study|Abnormal laboratory values|0|||
23646913|NCT00901186|66093993|FG001|Overall Study|Abnormal laboratory values|1|||
23646914|NCT00901186|66093992|FG000|Overall Study|Lost to Follow-up|2|||
23646915|NCT00901186|66093993|FG001|Overall Study|Lost to Follow-up|0|||
23646916|NCT00901186|66093992|FG000|Overall Study|Adverse Event|2|||
23646917|NCT00901186|66093993|FG001|Overall Study|Adverse Event|4|||
23646918|NCT00901186|66093992|FG000|Overall Study|Administration problems|0|||
23646919|NCT00901186|66093993|FG001|Overall Study|Administration problems|1|||
23646920|NCT00901186|66093992|FG000|Overall Study|Protocol deviations|5|||
23646921|NCT00901186|66093993|FG001|Overall Study|Protocol deviations|4|||
23646922|NCT01411215|66093994|FG000|Overall Study|Adverse Event|1|||
23646923|NCT01411215|66093995|FG001|Overall Study|Adverse Event|2|||
23646924|NCT01411215|66093994|FG000|Overall Study|Lack of Efficacy|2|||
23646925|NCT01411215|66093995|FG001|Overall Study|Lack of Efficacy|4|||
23646926|NCT01411215|66093994|FG000|Overall Study|Lost to Follow-up|12|||
23646927|NCT01411215|66093995|FG001|Overall Study|Lost to Follow-up|18|||
23646928|NCT01411215|66093994|FG000|Overall Study|Did not meet entrance criteria|0|||
23646929|NCT01411215|66093995|FG001|Overall Study|Did not meet entrance criteria|1|||
23646930|NCT01411215|66093994|FG000|Overall Study|Study terminated by sponsor|2|||
23646931|NCT01411215|66093995|FG001|Overall Study|Study terminated by sponsor|15|||
23646932|NCT01411215|66093994|FG000|Overall Study|Protocol Violation|3|||
23646933|NCT01411215|66093995|FG001|Overall Study|Protocol Violation|5|||
23646934|NCT01411215|66093994|FG000|Overall Study|Withdrawal by Subject|34|||
23646935|NCT01411215|66093995|FG001|Overall Study|Withdrawal by Subject|21|||
23646936|NCT01411215|66093994|FG000|Overall Study|Other|12|||
23646937|NCT01411215|66093995|FG001|Overall Study|Other|17|||
23646938|NCT01411215|66093994|FG000|Overall Study|Screen failure|0|||
23646939|NCT01411215|66093995|FG001|Overall Study|Screen failure|1|||
23646940|NCT01585987|66093996|FG000|Randomized|Withdrawal by Subject|0|||
23646941|NCT01585987|66093997|FG001|Randomized|Withdrawal by Subject|4|||
23646942|NCT01585987|66093996|FG000|Randomized|No longer met criteria|0|||
23646943|NCT01585987|66093997|FG001|Randomized|No longer met criteria|2|||
23646944|NCT01585987|66093996|FG000|Treated|Disease Progression|39|||
23646945|NCT01585987|66093997|FG001|Treated|Disease Progression|36|||
23646946|NCT01585987|66093996|FG000|Treated|Study Drug Toxicity|9|||
23646947|NCT01585987|66093997|FG001|Treated|Study Drug Toxicity|5|||
23646948|NCT01585987|66093996|FG000|Treated|Adverse Event|3|||
23646949|NCT01585987|66093997|FG001|Treated|Adverse Event|0|||
23646950|NCT01585987|66093996|FG000|Treated|Withdrawal by Subject|1|||
23646951|NCT01585987|66093997|FG001|Treated|Withdrawal by Subject|2|||
23646952|NCT01585987|66093996|FG000|Treated|Death|1|||
23646953|NCT01585987|66093997|FG001|Treated|Death|0|||
23646954|NCT01585987|66093996|FG000|Treated|Lost to Follow-up|0|||
23646955|NCT01585987|66093997|FG001|Treated|Lost to Follow-up|1|||
23646956|NCT01585987|66093996|FG000|Treated|Maximum Clinical Benefit|0|||
23646957|NCT01585987|66093997|FG001|Treated|Maximum Clinical Benefit|1|||
23646958|NCT01585987|66093996|FG000|Treated|Non-Specified|1|||
23646959|NCT01585987|66093997|FG001|Treated|Non-Specified|2|||
23646960|NCT01585987|66093996|FG000|Treated|Subject Request|0|||
23478453|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Death|0|||
23478454|NCT00045942|65494563|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
23478455|NCT00045942|65494564|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
23478456|NCT00045942|65494565|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
23478457|NCT00045942|65494566|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
23478458|NCT00045942|65494567|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
23478459|NCT00045942|65494568|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
23478460|NCT00045942|65494569|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
23478461|NCT00045942|65494570|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
23478462|NCT00045942|65494571|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
23478463|NCT00045942|65494563|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
23478464|NCT00045942|65494564|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
23478465|NCT00045942|65494565|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
23478466|NCT00045942|65494566|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
23478467|NCT00045942|65494567|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
23478468|NCT00045942|65494568|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
23478469|NCT00045942|65494569|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
23478470|NCT00045942|65494570|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
23478471|NCT00045942|65494571|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
23478472|NCT00045942|65494563|FG000|PKC412A2104E1|Lack of Efficacy|0|||
23478473|NCT00045942|65494564|FG001|PKC412A2104E1|Lack of Efficacy|11|||
23478474|NCT00045942|65494565|FG002|PKC412A2104E1|Lack of Efficacy|11|||
23478475|NCT00045942|65494566|FG003|PKC412A2104E1|Lack of Efficacy|23|||
23478476|NCT00045942|65494567|FG004|PKC412A2104E1|Lack of Efficacy|17|||
23478477|NCT00045942|65494568|FG005|PKC412A2104E1|Lack of Efficacy|0|||
23478478|NCT00045942|65494569|FG006|PKC412A2104E1|Lack of Efficacy|0|||
23478479|NCT00045942|65494570|FG007|PKC412A2104E1|Lack of Efficacy|0|||
23478480|NCT00045942|65494571|FG008|PKC412A2104E1|Lack of Efficacy|0|||
23478481|NCT00045942|65494563|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
23478482|NCT00045942|65494564|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
23478483|NCT00045942|65494565|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
23478484|NCT00045942|65494566|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
23478485|NCT00045942|65494567|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
23478486|NCT00045942|65494568|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
23478487|NCT00045942|65494569|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
23478488|NCT00045942|65494570|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
23478489|NCT00045942|65494571|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
23478490|NCT00045942|65494563|FG000|PKC412A2104E1|Adverse Event|0|||
23478491|NCT00045942|65494564|FG001|PKC412A2104E1|Adverse Event|1|||
23478492|NCT00045942|65494565|FG002|PKC412A2104E1|Adverse Event|1|||
23478493|NCT00045942|65494566|FG003|PKC412A2104E1|Adverse Event|3|||
23478494|NCT00045942|65494567|FG004|PKC412A2104E1|Adverse Event|6|||
23478495|NCT00045942|65494568|FG005|PKC412A2104E1|Adverse Event|0|||
23478496|NCT00045942|65494569|FG006|PKC412A2104E1|Adverse Event|0|||
23478497|NCT00045942|65494570|FG007|PKC412A2104E1|Adverse Event|0|||
23478498|NCT00045942|65494571|FG008|PKC412A2104E1|Adverse Event|0|||
23478499|NCT00045942|65494563|FG000|PKC412A2104E1|Death|0|||
23478500|NCT00045942|65494564|FG001|PKC412A2104E1|Death|4|||
23478501|NCT00045942|65494565|FG002|PKC412A2104E1|Death|1|||
23478502|NCT00045942|65494566|FG003|PKC412A2104E1|Death|1|||
23478503|NCT00045942|65494567|FG004|PKC412A2104E1|Death|1|||
23478504|NCT00045942|65494568|FG005|PKC412A2104E1|Death|0|||
23478505|NCT00045942|65494569|FG006|PKC412A2104E1|Death|0|||
23478506|NCT00045942|65494570|FG007|PKC412A2104E1|Death|0|||
23478507|NCT00045942|65494571|FG008|PKC412A2104E1|Death|0|||
23478508|NCT00045942|65494563|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478509|NCT00045942|65494564|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478510|NCT00045942|65494565|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
23478511|NCT00045942|65494566|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
23597382|NCT02119650|65919098|FG000|Overall Study|Noncompliance with study treatment|1|||
23597383|NCT02119650|65919099|FG001|Overall Study|Noncompliance with study treatment|1|||
23646961|NCT01585987|66093997|FG001|Treated|Subject Request|1|||
23646962|NCT01585987|66093996|FG000|Treated|Poor/Non-Compliance|0|||
23478512|NCT00045942|65494567|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478513|NCT00045942|65494568|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478514|NCT00045942|65494569|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478515|NCT00045942|65494570|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478516|NCT00045942|65494571|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478517|NCT00045942|65494563|FG000|PKC412A2104E2|Lost to Follow-up|0|||
23478518|NCT00045942|65494564|FG001|PKC412A2104E2|Lost to Follow-up|0|||
23478519|NCT00045942|65494565|FG002|PKC412A2104E2|Lost to Follow-up|0|||
23478520|NCT00045942|65494566|FG003|PKC412A2104E2|Lost to Follow-up|0|||
23478521|NCT00045942|65494567|FG004|PKC412A2104E2|Lost to Follow-up|0|||
23478522|NCT00045942|65494568|FG005|PKC412A2104E2|Lost to Follow-up|0|||
23478523|NCT00045942|65494569|FG006|PKC412A2104E2|Lost to Follow-up|0|||
23478524|NCT00045942|65494570|FG007|PKC412A2104E2|Lost to Follow-up|3|||
23597384|NCT02119650|65919098|FG000|Overall Study|Study terminated by the sponsor|1|||
23360520|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Physician Decision|0|||
23360521|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Physician Decision|0|||
23360522|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
23360523|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
23360524|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
23360525|NCT05227118|65065766|FG000|Overall Study|Adverse Event|0|||
23360526|NCT05227118|65065767|FG001|Overall Study|Adverse Event|0|||
23360527|NCT05227118|65065768|FG002|Overall Study|Adverse Event|1|||
23360528|NCT05227118|65065769|FG003|Overall Study|Adverse Event|0|||
23360529|NCT05227118|65065766|FG000|Overall Study|Withdrawal by Subject|0|||
23360530|NCT05227118|65065767|FG001|Overall Study|Withdrawal by Subject|0|||
23360531|NCT05227118|65065768|FG002|Overall Study|Withdrawal by Subject|2|||
23360532|NCT05227118|65065769|FG003|Overall Study|Withdrawal by Subject|0|||
23360533|NCT01266824|65065772|FG000|Overall Study|Study terminated prior to completion|2|||
23360534|NCT01266824|65065773|FG001|Overall Study|Study terminated prior to completion|3|||
23360535|NCT02630563|65065776|FG000|Overall Study|Administrative|1|||
23360536|NCT03512353|65065777|FG000|Overall Study|Sponsor Decision|3|||
23360537|NCT03512353|65065777|FG000|Overall Study|Death|1|||
23360538|NCT00753675|65065780|FG000|Overall Study|other reason|11|||
23360539|NCT00753675|65065781|FG001|Overall Study|other reason|12|||
23360540|NCT00753675|65065782|FG002|Overall Study|other reason|13|||
23360541|NCT00753675|65065780|FG000|Overall Study|Death|1|||
23360542|NCT00753675|65065781|FG001|Overall Study|Death|2|||
23360543|NCT00753675|65065782|FG002|Overall Study|Death|4|||
23360544|NCT00753675|65065780|FG000|Overall Study|Adverse Event|11|||
23360545|NCT00753675|65065781|FG001|Overall Study|Adverse Event|9|||
23360546|NCT00753675|65065782|FG002|Overall Study|Adverse Event|4|||
23360547|NCT00753675|65065780|FG000|Overall Study|Objective progression of disease|35|||
23360548|NCT00753675|65065781|FG001|Overall Study|Objective progression of disease|35|||
23360549|NCT00753675|65065782|FG002|Overall Study|Objective progression of disease|35|||
23360550|NCT00753675|65065780|FG000|Overall Study|Withdrawal by Subject|0|||
23360551|NCT00753675|65065781|FG001|Overall Study|Withdrawal by Subject|1|||
23360552|NCT00753675|65065782|FG002|Overall Study|Withdrawal by Subject|0|||
23360553|NCT00753675|65065780|FG000|Overall Study|Lost to Follow-up|1|||
23360554|NCT00753675|65065781|FG001|Overall Study|Lost to Follow-up|0|||
23360555|NCT00753675|65065782|FG002|Overall Study|Lost to Follow-up|0|||
23360556|NCT05027815|65065787|FG000|Overall Study|Death|2|||
23360557|NCT05027815|65065788|FG001|Overall Study|Death|1|||
23360558|NCT02420119|65065789|FG000|Overall Study|insufficient laboratory data|5|||
23360559|NCT01166750|65065791|FG000|Overall Study|Lost to Follow-up|1|||
23360560|NCT01166750|65065792|FG001|Overall Study|Lost to Follow-up|0|||
23360561|NCT00686335|65065793|FG000|Run-in Period|Adverse Event|1|||
23360562|NCT00686335|65065793|FG000|Run-in Period|asthma exacerbation|1|||
23360563|NCT00686335|65065793|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
23360564|NCT01310127|65065799|FG000|Overall Study|Protocol Violation|1|||
23360565|NCT01310127|65065800|FG001|Overall Study|Protocol Violation|1|||
23360566|NCT01310127|65065799|FG000|Overall Study|advanced psc cataract outlier|1|||
23360567|NCT01310127|65065800|FG001|Overall Study|advanced psc cataract outlier|0|||
23360568|NCT02028507|65065801|FG000|Overall Study|Progressive Disease|122|||
23360569|NCT02028507|65065802|FG001|Overall Study|Progressive Disease|90|||
23360570|NCT02028507|65065803|FG002|Overall Study|Progressive Disease|102|||
23360571|NCT02028507|65065804|FG003|Overall Study|Progressive Disease|89|||
23360572|NCT02028507|65065801|FG000|Overall Study|Adverse Event|8|||
23360573|NCT02028507|65065802|FG001|Overall Study|Adverse Event|25|||
23360574|NCT02028507|65065803|FG002|Overall Study|Adverse Event|3|||
23360575|NCT02028507|65065804|FG003|Overall Study|Adverse Event|16|||
23360576|NCT02028507|65065801|FG000|Overall Study|Withdrawal by Subject|6|||
23360577|NCT02028507|65065802|FG001|Overall Study|Withdrawal by Subject|8|||
23478525|NCT00045942|65494571|FG008|PKC412A2104E2|Lost to Follow-up|0|||
23478526|NCT00045942|65494563|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
23478527|NCT00045942|65494564|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
23478528|NCT00045942|65494565|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
23646963|NCT01585987|66093997|FG001|Treated|Poor/Non-Compliance|1|||
23646964|NCT01696942|66093998|FG000|Overall Study|Withdrawal by Subject|1|||
23478529|NCT00045942|65494566|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
23478530|NCT00045942|65494567|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
23646965|NCT01696942|66093999|FG001|Overall Study|Withdrawal by Subject|0|||
23646966|NCT01696942|66093998|FG000|Overall Study|Protocol Violation|1|||
23360578|NCT02028507|65065803|FG002|Overall Study|Withdrawal by Subject|5|||
23360579|NCT02028507|65065804|FG003|Overall Study|Withdrawal by Subject|9|||
23360580|NCT02028507|65065801|FG000|Overall Study|Protocol Violation|2|||
23360581|NCT02028507|65065802|FG001|Overall Study|Protocol Violation|4|||
23360582|NCT02028507|65065803|FG002|Overall Study|Protocol Violation|1|||
23478531|NCT00045942|65494568|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
23360583|NCT02028507|65065804|FG003|Overall Study|Protocol Violation|3|||
23360584|NCT02028507|65065801|FG000|Overall Study|Physician Decision|0|||
23478532|NCT00045942|65494569|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
23646967|NCT01696942|66093999|FG001|Overall Study|Protocol Violation|2|||
23646968|NCT01696942|66093998|FG000|Overall Study|screen failure|0|||
23646969|NCT01696942|66093999|FG001|Overall Study|screen failure|1|||
23646970|NCT01878214|66094000|FG000|Overall Study|Withdrawal by Subject|18|||
23646971|NCT01878214|66094001|FG001|Overall Study|Withdrawal by Subject|7|||
23646972|NCT01878214|66094000|FG000|Overall Study|Death|0|||
23646973|NCT01878214|66094001|FG001|Overall Study|Death|1|||
23646974|NCT01878214|66094000|FG000|Overall Study|Lost to Follow-up|35|||
23646975|NCT01878214|66094001|FG001|Overall Study|Lost to Follow-up|36|||
23646976|NCT01074216|66094003|FG000|Overall Study|Physician Decision|1|||
23646977|NCT01074216|66094003|FG000|Overall Study|Not Treated|12|||
23646978|NCT01853644|66094004|FG000|Registration and Treatment Start|Did not start treatment|1|||
23646979|NCT01853644|66094004|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
23646980|NCT01853644|66094004|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
23646981|NCT01853644|66094004|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
23646982|NCT01853644|66094004|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
23646983|NCT01853644|66094004|FG000|Continued Treatment After First Response|Adverse Event|2|||
23646984|NCT01853644|66094004|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
23646985|NCT03254485|66094006|FG000|Overall Study|Adverse Event|3|||
23646986|NCT03254485|66094007|FG001|Overall Study|Adverse Event|0|||
23646987|NCT03254485|66094008|FG002|Overall Study|Adverse Event|0|||
23646988|NCT03254485|66094009|FG003|Overall Study|Adverse Event|6|||
23646989|NCT03254485|66094006|FG000|Overall Study|Protocol Violation|6|||
23646990|NCT03254485|66094007|FG001|Overall Study|Protocol Violation|0|||
23646991|NCT03254485|66094008|FG002|Overall Study|Protocol Violation|0|||
23646992|NCT03254485|66094009|FG003|Overall Study|Protocol Violation|2|||
23646993|NCT03254485|66094006|FG000|Overall Study|Withdrawal by Subject|1|||
23646994|NCT03254485|66094007|FG001|Overall Study|Withdrawal by Subject|0|||
23646995|NCT03254485|66094008|FG002|Overall Study|Withdrawal by Subject|0|||
23646996|NCT03254485|66094009|FG003|Overall Study|Withdrawal by Subject|4|||
23646997|NCT03254485|66094006|FG000|Overall Study|Death|0|||
23646998|NCT03254485|66094007|FG001|Overall Study|Death|0|||
23646999|NCT03254485|66094008|FG002|Overall Study|Death|0|||
23647000|NCT03254485|66094009|FG003|Overall Study|Death|1|||
23647001|NCT03254485|66094006|FG000|Overall Study|Lost to Follow-up|1|||
23647002|NCT03254485|66094007|FG001|Overall Study|Lost to Follow-up|0|||
23647003|NCT03254485|66094008|FG002|Overall Study|Lost to Follow-up|0|||
23647004|NCT03254485|66094009|FG003|Overall Study|Lost to Follow-up|0|||
23647005|NCT03254485|66094006|FG000|Overall Study|Other|1|||
23647006|NCT03254485|66094007|FG001|Overall Study|Other|0|||
23647007|NCT03254485|66094008|FG002|Overall Study|Other|0|||
23647008|NCT03254485|66094009|FG003|Overall Study|Other|2|||
23647009|NCT03305731|66094011|FG000|Overall Study|Protocol Violation|1|||
23647010|NCT00682890|66094012|FG000|Overall Study|Lost to Follow-up|1|||
23647011|NCT00682890|66094013|FG001|Overall Study|Lost to Follow-up|1|||
23647012|NCT00682890|66094012|FG000|Overall Study|subject moved away|0|||
23647013|NCT00682890|66094013|FG001|Overall Study|subject moved away|1|||
23647014|NCT00682890|66094012|FG000|Overall Study|heavy menstrual bleeding|1|||
23647015|NCT00682890|66094013|FG001|Overall Study|heavy menstrual bleeding|0|||
23647016|NCT01226095|66094016|FG000|Overall Study|Poor compliance|1|||
23647017|NCT03426267|66094020|FG000|Overall Study|Physician Decision|1|||
23647018|NCT03426267|66094021|FG001|Overall Study|Physician Decision|4|||
23647019|NCT03426267|66094020|FG000|Overall Study|Lost to Follow-up|1|||
23647020|NCT03426267|66094021|FG001|Overall Study|Lost to Follow-up|0|||
23647021|NCT03426267|66094020|FG000|Overall Study|Withdrawal by Subject|4|||
23647022|NCT03426267|66094021|FG001|Overall Study|Withdrawal by Subject|10|||
23647023|NCT03426267|66094020|FG000|Overall Study|Protocol Violation|1|||
23647024|NCT03426267|66094021|FG001|Overall Study|Protocol Violation|3|||
23647025|NCT03426267|66094020|FG000|Overall Study|Adverse Event|9|||
23647026|NCT03426267|66094021|FG001|Overall Study|Adverse Event|27|||
23647027|NCT03426267|66094020|FG000|Overall Study|Prohibited Treatment Intake|2|||
23647028|NCT03426267|66094021|FG001|Overall Study|Prohibited Treatment Intake|3|||
23647029|NCT03426267|66094020|FG000|Overall Study|Lack of Efficacy|0|||
23647030|NCT03426267|66094021|FG001|Overall Study|Lack of Efficacy|25|||
23647031|NCT03426267|66094020|FG000|Overall Study|other|3|||
23647032|NCT03426267|66094021|FG001|Overall Study|other|0|||
23647033|NCT01491672|66094023|FG000|Overall Study|Lost to Follow-up|0|||
23647034|NCT01491672|66094024|FG001|Overall Study|Lost to Follow-up|4|||
23647035|NCT01491672|66094025|FG002|Overall Study|Lost to Follow-up|1|||
23647036|NCT01491672|66094023|FG000|Overall Study|Withdrawal by Subject|6|||
23647037|NCT01491672|66094024|FG001|Overall Study|Withdrawal by Subject|7|||
23647038|NCT01491672|66094025|FG002|Overall Study|Withdrawal by Subject|0|||
23647039|NCT01491672|66094023|FG000|Overall Study|Adverse Event|8|||
23647040|NCT01491672|66094024|FG001|Overall Study|Adverse Event|10|||
23647041|NCT01491672|66094025|FG002|Overall Study|Adverse Event|4|||
23647042|NCT01491672|66094023|FG000|Overall Study|Disease progression|42|||
23647043|NCT01491672|66094024|FG001|Overall Study|Disease progression|34|||
23647044|NCT01491672|66094025|FG002|Overall Study|Disease progression|6|||
23647045|NCT01491672|66094023|FG000|Overall Study|Protocol deviation|0|||
23647046|NCT01491672|66094024|FG001|Overall Study|Protocol deviation|1|||
23647047|NCT01491672|66094025|FG002|Overall Study|Protocol deviation|0|||
23647048|NCT01491672|66094023|FG000|Overall Study|Death|0|||
23647049|NCT01491672|66094024|FG001|Overall Study|Death|4|||
23647050|NCT01491672|66094025|FG002|Overall Study|Death|0|||
23647051|NCT01948908|66094028|FG000|Overall Study|Protocol Violation|1|||
23647052|NCT01948908|66094029|FG001|Overall Study|Protocol Violation|0|||
23647053|NCT01948908|66094030|FG002|Overall Study|Protocol Violation|2|||
23647054|NCT02383056|66094031|FG000|Overall Study|Adverse Event|1|||
23647055|NCT02383056|66094032|FG001|Overall Study|Adverse Event|0|||
23647056|NCT02383056|66094031|FG000|Overall Study|Lost to Follow-up|0|||
23647057|NCT02383056|66094032|FG001|Overall Study|Lost to Follow-up|2|||
23647058|NCT00323856|66094037|FG000|Overall Study|Withdrawal by Subject|1|||
23647059|NCT00323856|66094037|FG000|Overall Study|Was uncooperative and noncompliant|1|||
23647060|NCT00323856|66094037|FG000|Overall Study|Reason not specified|1|||
23647061|NCT00323856|66094037|FG000|Overall Study|Missing|2|||
23647062|NCT02630693|66094038|FG000|Overall Study|No receive treatment|0|||
23647063|NCT02630693|66094039|FG001|Overall Study|No receive treatment|1|||
23647064|NCT00252577|66094043|FG000|Overall Study|Lost to Follow-up|20|||
23647065|NCT03725085|66094044|FG000|Overall Study|Lost to Follow-up|2|||
23647066|NCT01248780|66094053|FG000|Overall Study|Lack of Efficacy|2|||
23647067|NCT01248780|66094054|FG001|Overall Study|Lack of Efficacy|0|||
23647068|NCT01248780|66094053|FG000|Overall Study|Lost to Follow-up|0|||
23647069|NCT01248780|66094054|FG001|Overall Study|Lost to Follow-up|1|||
23647070|NCT01248780|66094053|FG000|Overall Study|Death|0|||
23647071|NCT01248780|66094054|FG001|Overall Study|Death|1|||
23647072|NCT01248780|66094053|FG000|Overall Study|Adverse Event|2|||
23647073|NCT01248780|66094054|FG001|Overall Study|Adverse Event|7|||
23647074|NCT01248780|66094053|FG000|Overall Study|Protocol Violation|1|||
23647075|NCT01248780|66094054|FG001|Overall Study|Protocol Violation|1|||
23647076|NCT01248780|66094053|FG000|Overall Study|Withdrawal by Subject|4|||
23647077|NCT01248780|66094054|FG001|Overall Study|Withdrawal by Subject|4|||
23647078|NCT01248780|66094053|FG000|Overall Study|Not treated|0|||
23647079|NCT01248780|66094054|FG001|Overall Study|Not treated|1|||
23647080|NCT03271021|66094055|FG000|Overall Study|Adverse Event|3|||
23647081|NCT03271021|66094056|FG001|Overall Study|Adverse Event|2|||
23647082|NCT03271021|66094055|FG000|Overall Study|Withdrawal by Subject|36|||
23647083|NCT03271021|66094056|FG001|Overall Study|Withdrawal by Subject|53|||
23647084|NCT03271021|66094055|FG000|Overall Study|Lost to Follow-up|34|||
23647085|NCT03271021|66094056|FG001|Overall Study|Lost to Follow-up|39|||
23647086|NCT03271021|66094055|FG000|Overall Study|Protocol Violation|6|||
23647087|NCT03271021|66094056|FG001|Overall Study|Protocol Violation|4|||
23647088|NCT03271021|66094055|FG000|Overall Study|Abnormal Lab Results|1|||
23647089|NCT03271021|66094056|FG001|Overall Study|Abnormal Lab Results|0|||
23647090|NCT03271021|66094055|FG000|Overall Study|Miscellaneous|9|||
23647091|NCT03271021|66094056|FG001|Overall Study|Miscellaneous|8|||
23647092|NCT00642772|66094063|FG000|Overall Study|Lost to Follow-up|3|||
23647093|NCT00642772|66094063|FG000|Overall Study|Withdrawal by Subject|7|||
23647094|NCT00421707|66094064|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
23647095|NCT00421707|66094065|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
23647096|NCT00421707|66094064|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
23647097|NCT00421707|66094065|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
23647098|NCT00421707|66094064|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
23647099|NCT00421707|66094065|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
23647100|NCT00421707|66094064|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
23647101|NCT00421707|66094065|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
23647102|NCT00421707|66094064|FG000|Period 2: Washout|Adverse Event|1|||
23647103|NCT00421707|66094065|FG001|Period 2: Washout|Adverse Event|1|||
23478533|NCT00045942|65494570|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
23647104|NCT00421707|66094064|FG000|Period 2: Washout|Withdrawal by Subject|0|||
23647105|NCT00421707|66094065|FG001|Period 2: Washout|Withdrawal by Subject|1|||
23647106|NCT00421707|66094064|FG000|Period 2: Washout|Lost to Follow-up|0|||
23478534|NCT00045942|65494571|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
23478535|NCT00045942|65494563|FG000|PKC412A2104E2|Lack of Efficacy|0|||
23647107|NCT00421707|66094065|FG001|Period 2: Washout|Lost to Follow-up|1|||
23647108|NCT00421707|66094064|FG000|Period 2: Washout|Other: Pregnancy|0|||
23647109|NCT00421707|66094065|FG001|Period 2: Washout|Other: Pregnancy|1|||
23647110|NCT00421707|66094064|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
23647111|NCT00421707|66094065|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
23647112|NCT00421707|66094064|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
23647113|NCT00421707|66094065|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
23647114|NCT00421707|66094064|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
23647115|NCT00421707|66094065|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
23647116|NCT02009761|66094066|FG000|Overall Study|Adverse Event|4|||
23647117|NCT00618982|66094071|FG000|Overall Study|Adverse Event|23|||
23647118|NCT00618982|66094071|FG000|Overall Study|Withdrawal by Subject|1|||
23647119|NCT00618982|66094071|FG000|Overall Study|Protocol Violation|1|||
23647120|NCT00618982|66094071|FG000|Overall Study|ongoing, still treated with study med.|25|||
23647121|NCT02134977|66094072|FG000|Overall Study|Protocol Deviation|102|||
23647122|NCT00775463|66094073|FG000|Overall Study|Withdrawal by Subject|0|||
23647123|NCT00775463|66094074|FG001|Overall Study|Withdrawal by Subject|1|||
23647124|NCT00775463|66094073|FG000|Overall Study|Adverse Event|7|||
23597385|NCT02119650|65919099|FG001|Overall Study|Study terminated by the sponsor|0|||
23597386|NCT02119650|65919098|FG000|Overall Study|Physician Decision|0|||
23597387|NCT02119650|65919099|FG001|Overall Study|Physician Decision|2|||
23597388|NCT02119650|65919098|FG000|Overall Study|Multiple reasons for termination|2|||
23597389|NCT02119650|65919099|FG001|Overall Study|Multiple reasons for termination|1|||
23597390|NCT00632749|65919100|FG000|Overall Study|Progressive disease|3|||
23597391|NCT00632749|65919101|FG001|Overall Study|Progressive disease|2|||
23597392|NCT00632749|65919102|FG002|Overall Study|Progressive disease|2|||
23597393|NCT00632749|65919103|FG003|Overall Study|Progressive disease|2|||
23597394|NCT00632749|65919104|FG004|Overall Study|Progressive disease|4|||
23597395|NCT00632749|65919105|FG005|Overall Study|Progressive disease|4|||
23597396|NCT00632749|65919106|FG006|Overall Study|Progressive disease|3|||
23597397|NCT00632749|65919107|FG007|Overall Study|Progressive disease|2|||
23597398|NCT00632749|65919108|FG008|Overall Study|Progressive disease|3|||
23597399|NCT00632749|65919109|FG009|Overall Study|Progressive disease|2|||
23597400|NCT00632749|65919110|FG010|Overall Study|Progressive disease|4|||
23597401|NCT00632749|65919111|FG011|Overall Study|Progressive disease|3|||
23597402|NCT00632749|65919112|FG012|Overall Study|Progressive disease|2|||
23597403|NCT00632749|65919113|FG013|Overall Study|Progressive disease|4|||
23597404|NCT00632749|65919100|FG000|Overall Study|Other Adverse event|1|||
23597405|NCT00632749|65919101|FG001|Overall Study|Other Adverse event|1|||
23597406|NCT00632749|65919102|FG002|Overall Study|Other Adverse event|1|||
23597407|NCT00632749|65919103|FG003|Overall Study|Other Adverse event|1|||
23597408|NCT00632749|65919104|FG004|Overall Study|Other Adverse event|2|||
23597409|NCT00632749|65919105|FG005|Overall Study|Other Adverse event|4|||
23597410|NCT00632749|65919106|FG006|Overall Study|Other Adverse event|1|||
23597411|NCT00632749|65919107|FG007|Overall Study|Other Adverse event|2|||
23597412|NCT00632749|65919108|FG008|Overall Study|Other Adverse event|2|||
23597413|NCT00632749|65919109|FG009|Overall Study|Other Adverse event|0|||
23597414|NCT00632749|65919110|FG010|Overall Study|Other Adverse event|1|||
23597415|NCT00632749|65919111|FG011|Overall Study|Other Adverse event|0|||
23597416|NCT00632749|65919112|FG012|Overall Study|Other Adverse event|1|||
23597417|NCT00632749|65919113|FG013|Overall Study|Other Adverse event|0|||
23597418|NCT00632749|65919100|FG000|Overall Study|Refuse to continue medication|0|||
23597419|NCT00632749|65919101|FG001|Overall Study|Refuse to continue medication|0|||
23597420|NCT00632749|65919102|FG002|Overall Study|Refuse to continue medication|0|||
23597421|NCT00632749|65919103|FG003|Overall Study|Refuse to continue medication|1|||
23597422|NCT00632749|65919104|FG004|Overall Study|Refuse to continue medication|0|||
23597423|NCT00632749|65919105|FG005|Overall Study|Refuse to continue medication|0|||
23597424|NCT00632749|65919106|FG006|Overall Study|Refuse to continue medication|0|||
23597425|NCT00632749|65919107|FG007|Overall Study|Refuse to continue medication|0|||
23597426|NCT00632749|65919108|FG008|Overall Study|Refuse to continue medication|0|||
23597427|NCT00632749|65919109|FG009|Overall Study|Refuse to continue medication|1|||
23597428|NCT00632749|65919110|FG010|Overall Study|Refuse to continue medication|0|||
23597429|NCT00632749|65919111|FG011|Overall Study|Refuse to continue medication|0|||
23597430|NCT00632749|65919112|FG012|Overall Study|Refuse to continue medication|0|||
23597431|NCT00632749|65919113|FG013|Overall Study|Refuse to continue medication|0|||
23597432|NCT00632749|65919100|FG000|Overall Study|Reason other than those specified above|0|||
23597433|NCT00632749|65919101|FG001|Overall Study|Reason other than those specified above|2|||
23597434|NCT00632749|65919102|FG002|Overall Study|Reason other than those specified above|0|||
23597435|NCT00632749|65919103|FG003|Overall Study|Reason other than those specified above|0|||
23597436|NCT00632749|65919104|FG004|Overall Study|Reason other than those specified above|1|||
23597437|NCT00632749|65919105|FG005|Overall Study|Reason other than those specified above|0|||
23597438|NCT00632749|65919106|FG006|Overall Study|Reason other than those specified above|1|||
23597439|NCT00632749|65919107|FG007|Overall Study|Reason other than those specified above|0|||
23597440|NCT00632749|65919108|FG008|Overall Study|Reason other than those specified above|0|||
23597441|NCT00632749|65919109|FG009|Overall Study|Reason other than those specified above|0|||
23597442|NCT00632749|65919110|FG010|Overall Study|Reason other than those specified above|2|||
23647125|NCT00775463|66094074|FG001|Overall Study|Adverse Event|9|||
23647126|NCT00775463|66094073|FG000|Overall Study|Protocol Violation|2|||
23647127|NCT00775463|66094074|FG001|Overall Study|Protocol Violation|2|||
23800756|NCT01392326|66646889|FG002|Overall Study|Physician Decision|2|||
23597443|NCT00632749|65919111|FG011|Overall Study|Reason other than those specified above|1|||
23597444|NCT00632749|65919112|FG012|Overall Study|Reason other than those specified above|0|||
23597445|NCT00632749|65919113|FG013|Overall Study|Reason other than those specified above|2|||
23597446|NCT03752151|65919114|FG000|Overall Study|Withdrawal by Subject|1|||
23597447|NCT03752151|65919114|FG000|Overall Study|Protocol Violation|1|||
23597448|NCT03287622|65919115|FG000|Overall Study|Withdrawal by Subject|1|||
23597449|NCT03287622|65919116|FG001|Overall Study|Withdrawal by Subject|0|||
23597450|NCT03287622|65919115|FG000|Overall Study|Lost to Follow-up|27|||
23597451|NCT03287622|65919116|FG001|Overall Study|Lost to Follow-up|15|||
23647128|NCT00775463|66094073|FG000|Overall Study|Lost to Follow-up|1|||
23647129|NCT00775463|66094074|FG001|Overall Study|Lost to Follow-up|0|||
23647130|NCT00775463|66094073|FG000|Overall Study|Lack of Efficacy|1|||
23647131|NCT00775463|66094074|FG001|Overall Study|Lack of Efficacy|1|||
23647132|NCT00552240|66094075|FG000|Overall Study|Adverse Event|9|||
23647133|NCT00552240|66094076|FG001|Overall Study|Adverse Event|9|||
23647134|NCT00552240|66094075|FG000|Overall Study|Protocol Violation|1|||
23647135|NCT00552240|66094076|FG001|Overall Study|Protocol Violation|1|||
23647136|NCT00552240|66094075|FG000|Overall Study|Lost to Follow-up|5|||
23647137|NCT00552240|66094076|FG001|Overall Study|Lost to Follow-up|6|||
23647138|NCT00552240|66094075|FG000|Overall Study|Withdrawal by Subject|2|||
23647139|NCT00552240|66094076|FG001|Overall Study|Withdrawal by Subject|2|||
23647140|NCT00552240|66094075|FG000|Overall Study|Lack of Efficacy|6|||
23647141|NCT00552240|66094076|FG001|Overall Study|Lack of Efficacy|0|||
23647142|NCT00552240|66094075|FG000|Overall Study|Other|1|||
23647143|NCT00552240|66094076|FG001|Overall Study|Other|0|||
23647144|NCT01577745|66094079|FG000|Overall Study|Withdrawal by Subject|0|||
23647145|NCT01577745|66094080|FG001|Overall Study|Withdrawal by Subject|1|||
23647146|NCT01577745|66094081|FG002|Overall Study|Withdrawal by Subject|0|||
23647147|NCT01577745|66094082|FG003|Overall Study|Withdrawal by Subject|3|||
23647148|NCT01577745|66094083|FG004|Overall Study|Withdrawal by Subject|2|||
23647149|NCT01577745|66094084|FG005|Overall Study|Withdrawal by Subject|0|||
23647150|NCT01577745|66094079|FG000|Overall Study|Death|3|||
23647151|NCT01577745|66094080|FG001|Overall Study|Death|2|||
23647152|NCT01577745|66094081|FG002|Overall Study|Death|2|||
23647153|NCT01577745|66094082|FG003|Overall Study|Death|1|||
23647154|NCT01577745|66094083|FG004|Overall Study|Death|1|||
23647155|NCT01577745|66094084|FG005|Overall Study|Death|3|||
23647156|NCT01577745|66094079|FG000|Overall Study|Physician Decision|0|||
23647157|NCT01577745|66094080|FG001|Overall Study|Physician Decision|0|||
23647158|NCT01577745|66094081|FG002|Overall Study|Physician Decision|0|||
23647159|NCT01577745|66094082|FG003|Overall Study|Physician Decision|1|||
23647160|NCT01577745|66094083|FG004|Overall Study|Physician Decision|1|||
23647161|NCT01577745|66094084|FG005|Overall Study|Physician Decision|0|||
23647162|NCT01577745|66094079|FG000|Overall Study|Lost to Follow-up|0|||
23647163|NCT01577745|66094080|FG001|Overall Study|Lost to Follow-up|0|||
23647164|NCT01577745|66094081|FG002|Overall Study|Lost to Follow-up|0|||
23647165|NCT01577745|66094082|FG003|Overall Study|Lost to Follow-up|0|||
23647166|NCT01577745|66094083|FG004|Overall Study|Lost to Follow-up|0|||
23647167|NCT01577745|66094084|FG005|Overall Study|Lost to Follow-up|1|||
23647168|NCT01577745|66094079|FG000|Overall Study|Alternative Therapy|0|||
23647169|NCT01577745|66094080|FG001|Overall Study|Alternative Therapy|0|||
23647170|NCT01577745|66094081|FG002|Overall Study|Alternative Therapy|0|||
23647171|NCT01577745|66094082|FG003|Overall Study|Alternative Therapy|1|||
23647172|NCT01577745|66094083|FG004|Overall Study|Alternative Therapy|1|||
23647173|NCT01577745|66094084|FG005|Overall Study|Alternative Therapy|0|||
23647174|NCT00424385|66094085|FG000|Cohort 0|Withdrawal by Subject|5|||
23647175|NCT00424385|66094085|FG000|Cohort 0|Physician Decision|1|||
23647176|NCT00424385|66094085|FG000|Cohort 1|Withdrawal by Subject|1|||
23647177|NCT02910739|66094086|FG000|Overall Study|Adverse Event|1|||
23647178|NCT02910739|66094087|FG001|Overall Study|Adverse Event|0|||
23647179|NCT02910739|66094088|FG002|Overall Study|Adverse Event|0|||
23647180|NCT02910739|66094089|FG003|Overall Study|Adverse Event|0|||
23647181|NCT00055601|66094090|FG000|Overall Study|Protocol Violation|1|||
23647182|NCT00055601|66094091|FG001|Overall Study|Protocol Violation|1|||
23647183|NCT00055601|66094090|FG000|Overall Study|No protocol treatment received|1|||
23647184|NCT00055601|66094091|FG001|Overall Study|No protocol treatment received|1|||
23647185|NCT02175004|66094092|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
23647186|NCT02175004|66094093|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
23647187|NCT02175004|66094092|FG000|Overall Study|Investigator Judgment|1|||
23647188|NCT02175004|66094093|FG001|Overall Study|Investigator Judgment|4|||
23647189|NCT02175004|66094092|FG000|Overall Study|Voluntary Withdrawal|6|||
23647190|NCT02175004|66094093|FG001|Overall Study|Voluntary Withdrawal|19|||
23647191|NCT02175004|66094092|FG000|Overall Study|Liver Transplant|1|||
23647192|NCT02175004|66094093|FG001|Overall Study|Liver Transplant|0|||
23647193|NCT02175004|66094092|FG000|Overall Study|Disease Progression|1|||
23647194|NCT02175004|66094093|FG001|Overall Study|Disease Progression|0|||
23647195|NCT02175004|66094092|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
23647196|NCT02175004|66094093|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
23647197|NCT03038438|66094094|FG000|Overall Study|Death|3|||
23647198|NCT03038438|66094094|FG000|Overall Study|Lost to Follow-up|8|||
23647199|NCT03038438|66094094|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
23647200|NCT03038438|66094094|FG000|Overall Study|Withdrawal by Subject|5|||
23647201|NCT03038438|66094094|FG000|Overall Study|No 36-Month Follow-Up|18|||
23647202|NCT01773291|66094097|FG000|Overall Study|Protocol Violation|1|||
23647203|NCT01773291|66094098|FG001|Overall Study|Protocol Violation|0|||
23647204|NCT01773291|66094099|FG002|Overall Study|Protocol Violation|0|||
23647205|NCT01773291|66094097|FG000|Overall Study|Withdrawal by Subject|0|||
23647206|NCT01773291|66094098|FG001|Overall Study|Withdrawal by Subject|0|||
23647207|NCT01773291|66094099|FG002|Overall Study|Withdrawal by Subject|1|||
23647208|NCT02831387|66094103|FG000|Overall Study|Withdrawal by Subject|1|||
23647209|NCT02831387|66094104|FG001|Overall Study|Withdrawal by Subject|1|||
23647210|NCT02831387|66094103|FG000|Overall Study|Discontinued due to stock recovery|0|||
23647211|NCT02831387|66094104|FG001|Overall Study|Discontinued due to stock recovery|1|||
23647212|NCT04822597|66094105|FG000|Overall Study|Withdrawal by Subject|0|||
23647213|NCT04822597|66094106|FG001|Overall Study|Withdrawal by Subject|1|||
23647214|NCT04822597|66094107|FG002|Overall Study|Withdrawal by Subject|1|||
23647215|NCT04822597|66094108|FG003|Overall Study|Withdrawal by Subject|0|||
23647216|NCT04822597|66094105|FG000|Overall Study|Physician Decision|0|||
23647217|NCT04822597|66094106|FG001|Overall Study|Physician Decision|0|||
23647218|NCT04822597|66094107|FG002|Overall Study|Physician Decision|1|||
23647219|NCT04822597|66094108|FG003|Overall Study|Physician Decision|1|||
23647220|NCT04822597|66094105|FG000|Overall Study|Subject withdrawn after enrollment|0|||
23647221|NCT04822597|66094106|FG001|Overall Study|Subject withdrawn after enrollment|1|||
23647222|NCT04822597|66094107|FG002|Overall Study|Subject withdrawn after enrollment|0|||
23647223|NCT04822597|66094108|FG003|Overall Study|Subject withdrawn after enrollment|1|||
23647224|NCT04822597|66094105|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
23647225|NCT04822597|66094106|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23647226|NCT04822597|66094107|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23647227|NCT04822597|66094108|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23647228|NCT00427895|66094115|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647229|NCT00427895|66094116|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647230|NCT00427895|66094117|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647231|NCT00427895|66094118|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
23647232|NCT00427895|66094119|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647233|NCT00427895|66094120|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647234|NCT00427895|66094121|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647235|NCT00427895|66094122|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23647236|NCT00427895|66094115|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23360585|NCT02028507|65065802|FG001|Overall Study|Physician Decision|4|||
23478536|NCT00045942|65494564|FG001|PKC412A2104E2|Lack of Efficacy|0|||
23478537|NCT00045942|65494565|FG002|PKC412A2104E2|Lack of Efficacy|0|||
23478538|NCT00045942|65494566|FG003|PKC412A2104E2|Lack of Efficacy|0|||
23478539|NCT00045942|65494567|FG004|PKC412A2104E2|Lack of Efficacy|0|||
23478540|NCT00045942|65494568|FG005|PKC412A2104E2|Lack of Efficacy|3|||
23478541|NCT00045942|65494569|FG006|PKC412A2104E2|Lack of Efficacy|2|||
23478542|NCT00045942|65494570|FG007|PKC412A2104E2|Lack of Efficacy|2|||
23478543|NCT00045942|65494571|FG008|PKC412A2104E2|Lack of Efficacy|6|||
23478544|NCT00045942|65494563|FG000|PKC412A2104E2|Adverse Event|0|||
23478545|NCT00045942|65494564|FG001|PKC412A2104E2|Adverse Event|0|||
23478546|NCT00045942|65494565|FG002|PKC412A2104E2|Adverse Event|0|||
23478547|NCT00045942|65494566|FG003|PKC412A2104E2|Adverse Event|0|||
23478548|NCT00045942|65494567|FG004|PKC412A2104E2|Adverse Event|0|||
23478549|NCT00045942|65494568|FG005|PKC412A2104E2|Adverse Event|4|||
23478550|NCT00045942|65494569|FG006|PKC412A2104E2|Adverse Event|3|||
23478551|NCT00045942|65494570|FG007|PKC412A2104E2|Adverse Event|1|||
23478552|NCT00045942|65494571|FG008|PKC412A2104E2|Adverse Event|0|||
23478553|NCT00045942|65494563|FG000|PKC412A2104E2|Death|0|||
23478554|NCT00045942|65494564|FG001|PKC412A2104E2|Death|0|||
23478555|NCT00045942|65494565|FG002|PKC412A2104E2|Death|0|||
23478556|NCT00045942|65494566|FG003|PKC412A2104E2|Death|0|||
23478557|NCT00045942|65494567|FG004|PKC412A2104E2|Death|0|||
23478558|NCT00045942|65494568|FG005|PKC412A2104E2|Death|1|||
23478559|NCT00045942|65494569|FG006|PKC412A2104E2|Death|2|||
23478560|NCT00045942|65494570|FG007|PKC412A2104E2|Death|0|||
23478561|NCT00045942|65494571|FG008|PKC412A2104E2|Death|0|||
23647237|NCT00427895|66094116|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647238|NCT00427895|66094117|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647239|NCT00427895|66094118|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647240|NCT00427895|66094119|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647241|NCT00427895|66094120|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647242|NCT00427895|66094121|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23647243|NCT00427895|66094122|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
23647244|NCT00427895|66094115|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647245|NCT00427895|66094116|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
23478562|NCT01892384|65494572|FG000|Overall Study|Withdrawal by Subject|1|||
23478563|NCT01892384|65494573|FG001|Overall Study|Withdrawal by Subject|1|||
23478564|NCT01892384|65494574|FG002|Overall Study|Withdrawal by Subject|0|||
23478565|NCT01892384|65494575|FG003|Overall Study|Withdrawal by Subject|0|||
23478566|NCT03077087|65494576|FG000|Overall Study|Physician Decision|2|||
23478567|NCT00281658|65494577|FG000|Randomized Phase|Adverse Event|0|||
23478568|NCT00281658|65494578|FG001|Randomized Phase|Adverse Event|2|||
23647246|NCT00427895|66094117|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647247|NCT00427895|66094118|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647248|NCT00427895|66094119|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647249|NCT00427895|66094120|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647250|NCT00427895|66094121|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
23647251|NCT00427895|66094122|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
23647252|NCT00427895|66094115|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
23647253|NCT00427895|66094116|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
23647254|NCT00427895|66094117|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
23647255|NCT00427895|66094118|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
23647256|NCT00427895|66094119|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
23647257|NCT00427895|66094120|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
23647258|NCT00427895|66094121|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
23647259|NCT00427895|66094122|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
23647260|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23647261|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
23647262|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
23647263|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
23647264|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23647265|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23647266|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23647267|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23647268|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
23647269|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23647270|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
23647271|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
23647272|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23647273|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23647274|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23647275|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23647276|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
23647277|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
23647278|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647279|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647280|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647281|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647282|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647283|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23647284|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
23647285|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
23647286|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
23647287|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
23647288|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23647289|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23647290|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23647291|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23647292|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647293|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647294|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647295|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
23647296|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647297|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647298|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647299|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23647300|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
23647301|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
23647302|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
23647303|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
23647304|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23647305|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23647306|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23800757|NCT01392326|66646887|FG000|Overall Study|Lost to Follow-up|1|||
23597452|NCT03287622|65919115|FG000|Overall Study|No prescripion after surgery|28|||
23597453|NCT03287622|65919116|FG001|Overall Study|No prescripion after surgery|31|||
23597454|NCT03287622|65919115|FG000|Overall Study|prolonged Length of stay|2|||
23597455|NCT03287622|65919116|FG001|Overall Study|prolonged Length of stay|0|||
23597456|NCT03287622|65919115|FG000|Overall Study|surgery related|0|||
23597457|NCT03287622|65919116|FG001|Overall Study|surgery related|2|||
23597458|NCT01599793|65919117|FG000|Overall Study|Adverse Event|2|||
23597459|NCT02622568|65919118|FG000|Overall Study|Lost to Follow-up|5|||
23597460|NCT02622568|65919119|FG001|Overall Study|Lost to Follow-up|5|||
23597461|NCT03475316|65919121|FG000|6 Month Intervention|Adverse Event|2|||
23597462|NCT03475316|65919122|FG001|6 Month Intervention|Adverse Event|1|||
23597463|NCT03475316|65919121|FG000|6 Month Intervention|Withdrawal by Subject|2|||
23597464|NCT03475316|65919122|FG001|6 Month Intervention|Withdrawal by Subject|0|||
23597465|NCT03475316|65919121|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
23597466|NCT03475316|65919122|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
23597467|NCT03475316|65919121|FG000|9 Months|Study stopped due to COVID pandemic|3|||
23597468|NCT03475316|65919122|FG001|9 Months|Study stopped due to COVID pandemic|4|||
23597469|NCT02006758|65919123|FG000|Overall Study|Protocol Violation|1|||
23597470|NCT02006758|65919123|FG000|Overall Study|Death|1|||
23597471|NCT02006758|65919123|FG000|Overall Study|Lost to Follow-up|4|||
23597472|NCT02006758|65919123|FG000|Overall Study|Withdrawal by Subject|4|||
23597473|NCT02006758|65919123|FG000|Overall Study|Procedurally excluded|1|||
23597474|NCT02006758|65919123|FG000|Overall Study|Other|2|||
23597475|NCT00546754|65919124|FG000|Overall Study|Serious Adverse Event|1|||
23597476|NCT00546754|65919125|FG001|Overall Study|Serious Adverse Event|1|||
23597477|NCT00546754|65919124|FG000|Overall Study|Adverse Event|11|||
23597478|NCT00546754|65919125|FG001|Overall Study|Adverse Event|16|||
23597479|NCT00546754|65919124|FG000|Overall Study|Lack of Efficacy|1|||
23597480|NCT00546754|65919125|FG001|Overall Study|Lack of Efficacy|1|||
23597481|NCT00546754|65919124|FG000|Overall Study|Lost to Follow-up|9|||
23597482|NCT00546754|65919125|FG001|Overall Study|Lost to Follow-up|15|||
23597483|NCT00546754|65919124|FG000|Overall Study|Protocol Violation|3|||
23597484|NCT00546754|65919125|FG001|Overall Study|Protocol Violation|0|||
23597485|NCT00546754|65919124|FG000|Overall Study|Withdrawal by Subject|6|||
23597486|NCT00546754|65919125|FG001|Overall Study|Withdrawal by Subject|7|||
23597487|NCT00546754|65919124|FG000|Overall Study|Dyspnea|1|||
23597488|NCT00546754|65919125|FG001|Overall Study|Dyspnea|0|||
23597489|NCT00546754|65919124|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
23597490|NCT00546754|65919125|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
23597491|NCT00546754|65919124|FG000|Overall Study|Hip Replacement|1|||
23597492|NCT00546754|65919125|FG001|Overall Study|Hip Replacement|0|||
23597493|NCT00546754|65919124|FG000|Overall Study|Suicide|1|||
23597494|NCT00546754|65919125|FG001|Overall Study|Suicide|0|||
23597495|NCT00546754|65919124|FG000|Overall Study|Missing Cooperation|1|||
23597496|NCT00546754|65919125|FG001|Overall Study|Missing Cooperation|0|||
23597497|NCT00546754|65919124|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
23597498|NCT00546754|65919125|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
23597499|NCT00546754|65919124|FG000|Overall Study|Patient's Decision|0|||
23597500|NCT00546754|65919125|FG001|Overall Study|Patient's Decision|1|||
23597501|NCT00546754|65919124|FG000|Overall Study|Missing|14|||
23597502|NCT00546754|65919125|FG001|Overall Study|Missing|7|||
23597503|NCT03246724|65919126|FG000|Overall Study|Withdrawal by Subject|5|||
23597504|NCT03246724|65919127|FG001|Overall Study|Withdrawal by Subject|2|||
23597505|NCT03246724|65919128|FG002|Overall Study|Withdrawal by Subject|4|||
23597506|NCT03246724|65919129|FG003|Overall Study|Withdrawal by Subject|2|||
23597507|NCT03246724|65919126|FG000|Overall Study|Ineligible on day of surgery|7|||
23597508|NCT03246724|65919127|FG001|Overall Study|Ineligible on day of surgery|2|||
23597509|NCT03246724|65919128|FG002|Overall Study|Ineligible on day of surgery|0|||
23597510|NCT03246724|65919129|FG003|Overall Study|Ineligible on day of surgery|3|||
23597511|NCT03246724|65919126|FG000|Overall Study|Study completed before surgical date|2|||
23597512|NCT03246724|65919127|FG001|Overall Study|Study completed before surgical date|1|||
23597513|NCT03246724|65919128|FG002|Overall Study|Study completed before surgical date|8|||
23597514|NCT03246724|65919129|FG003|Overall Study|Study completed before surgical date|1|||
23597515|NCT03246724|65919126|FG000|Overall Study|Transferred to other arm|0|||
23597516|NCT03246724|65919127|FG001|Overall Study|Transferred to other arm|0|||
23597517|NCT03246724|65919128|FG002|Overall Study|Transferred to other arm|1|||
23597518|NCT03246724|65919129|FG003|Overall Study|Transferred to other arm|0|||
23597519|NCT03246724|65919126|FG000|Overall Study|Unable to obtain medication timely|0|||
23597520|NCT03246724|65919127|FG001|Overall Study|Unable to obtain medication timely|2|||
23597521|NCT03246724|65919128|FG002|Overall Study|Unable to obtain medication timely|2|||
23597522|NCT03246724|65919129|FG003|Overall Study|Unable to obtain medication timely|1|||
23597523|NCT03246724|65919126|FG000|Overall Study|Re-consented to participate|0|||
23597524|NCT03246724|65919127|FG001|Overall Study|Re-consented to participate|0|||
23597525|NCT03246724|65919128|FG002|Overall Study|Re-consented to participate|0|||
23597526|NCT03246724|65919129|FG003|Overall Study|Re-consented to participate|1|||
23478569|NCT00281658|65494579|FG002|Randomized Phase|Adverse Event|0|||
23478570|NCT00281658|65494580|FG003|Randomized Phase|Adverse Event|0|||
23478571|NCT00281658|65494577|FG000|Randomized Phase|Lost to Follow-up|34|||
23478572|NCT00281658|65494578|FG001|Randomized Phase|Lost to Follow-up|27|||
23478573|NCT00281658|65494579|FG002|Randomized Phase|Lost to Follow-up|0|||
23478574|NCT00281658|65494580|FG003|Randomized Phase|Lost to Follow-up|0|||
23478575|NCT00281658|65494577|FG000|Randomized Phase|Withdrawal by Subject|8|||
23478576|NCT00281658|65494578|FG001|Randomized Phase|Withdrawal by Subject|7|||
23478577|NCT00281658|65494579|FG002|Randomized Phase|Withdrawal by Subject|0|||
23478578|NCT00281658|65494580|FG003|Randomized Phase|Withdrawal by Subject|0|||
23478579|NCT00281658|65494577|FG000|Randomized Phase|Study closed/terminated|1|||
23478580|NCT00281658|65494578|FG001|Randomized Phase|Study closed/terminated|1|||
23478581|NCT00281658|65494579|FG002|Randomized Phase|Study closed/terminated|0|||
23478582|NCT00281658|65494580|FG003|Randomized Phase|Study closed/terminated|0|||
23478583|NCT00281658|65494577|FG000|Randomized Phase|Disease progression|36|||
23478584|NCT00281658|65494578|FG001|Randomized Phase|Disease progression|27|||
23478585|NCT00281658|65494579|FG002|Randomized Phase|Disease progression|0|||
23478586|NCT00281658|65494580|FG003|Randomized Phase|Disease progression|0|||
23478587|NCT00281658|65494577|FG000|Randomized Phase|Physician Decision|1|||
23478588|NCT00281658|65494578|FG001|Randomized Phase|Physician Decision|1|||
23478589|NCT00281658|65494579|FG002|Randomized Phase|Physician Decision|0|||
23478590|NCT00281658|65494580|FG003|Randomized Phase|Physician Decision|0|||
23478591|NCT00281658|65494577|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
23478592|NCT00281658|65494578|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
23478593|NCT00281658|65494579|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
23478594|NCT00281658|65494580|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
23478595|NCT00281658|65494577|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
23478596|NCT00281658|65494578|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
23478597|NCT00281658|65494579|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
23478598|NCT00281658|65494580|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
23647307|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23647308|NCT00427895|66094115|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647309|NCT00427895|66094116|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647310|NCT00427895|66094117|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
23647311|NCT00427895|66094118|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
23647312|NCT00427895|66094119|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647313|NCT00427895|66094120|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647314|NCT00427895|66094121|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647315|NCT00427895|66094122|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23647316|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23647317|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
23647318|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
23647319|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
23647320|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23647321|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23647322|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23647323|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23647324|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
23647325|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
23647326|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23478599|NCT00281658|65494577|FG000|Randomized Phase|Treatment ongoing|1|||
23478600|NCT00281658|65494578|FG001|Randomized Phase|Treatment ongoing|0|||
23647327|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
23647328|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23360586|NCT02028507|65065803|FG002|Overall Study|Physician Decision|0|||
23478601|NCT00281658|65494579|FG002|Randomized Phase|Treatment ongoing|0|||
23647329|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23647330|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23647331|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23647332|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
23478602|NCT00281658|65494580|FG003|Randomized Phase|Treatment ongoing|0|||
23478603|NCT00281658|65494577|FG000|Open Label Phase|Adverse Event|0|||
23597527|NCT00774852|65919142|FG000|Overall Study|Adverse Event|9|||
23597528|NCT00774852|65919143|FG001|Overall Study|Adverse Event|6|||
23597529|NCT00774852|65919142|FG000|Overall Study|Death|2|||
23597530|NCT00774852|65919143|FG001|Overall Study|Death|1|||
23597531|NCT00774852|65919142|FG000|Overall Study|Lack of Efficacy|3|||
23597532|NCT00774852|65919143|FG001|Overall Study|Lack of Efficacy|7|||
23360587|NCT02028507|65065804|FG003|Overall Study|Physician Decision|0|||
23478604|NCT00281658|65494578|FG001|Open Label Phase|Adverse Event|0|||
23478605|NCT00281658|65494579|FG002|Open Label Phase|Adverse Event|1|||
23478606|NCT00281658|65494580|FG003|Open Label Phase|Adverse Event|0|||
23478607|NCT00281658|65494577|FG000|Open Label Phase|Lost to Follow-up|0|||
23478608|NCT00281658|65494578|FG001|Open Label Phase|Lost to Follow-up|0|||
23647333|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
23647334|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
23478609|NCT00281658|65494579|FG002|Open Label Phase|Lost to Follow-up|16|||
23478610|NCT00281658|65494580|FG003|Open Label Phase|Lost to Follow-up|2|||
23478611|NCT00281658|65494577|FG000|Open Label Phase|Withdrawal by Subject|0|||
23478612|NCT00281658|65494578|FG001|Open Label Phase|Withdrawal by Subject|0|||
23478613|NCT00281658|65494579|FG002|Open Label Phase|Withdrawal by Subject|3|||
23478614|NCT00281658|65494580|FG003|Open Label Phase|Withdrawal by Subject|2|||
23597533|NCT00774852|65919142|FG000|Overall Study|Lost to Follow-up|9|||
23597534|NCT00774852|65919143|FG001|Overall Study|Lost to Follow-up|5|||
23597535|NCT00774852|65919142|FG000|Overall Study|Physician Decision|2|||
23597536|NCT00774852|65919143|FG001|Overall Study|Physician Decision|6|||
23597537|NCT00774852|65919142|FG000|Overall Study|Pregnancy|1|||
23597538|NCT00774852|65919143|FG001|Overall Study|Pregnancy|2|||
23597539|NCT00774852|65919142|FG000|Overall Study|Withdrawal by Subject|2|||
23597540|NCT00774852|65919143|FG001|Overall Study|Withdrawal by Subject|2|||
23597541|NCT00774852|65919142|FG000|Overall Study|Non-responder|15|||
23597542|NCT00774852|65919143|FG001|Overall Study|Non-responder|11|||
23597543|NCT00774852|65919142|FG000|Overall Study|Subject non-compliance|0|||
23597544|NCT00774852|65919143|FG001|Overall Study|Subject non-compliance|1|||
23597545|NCT00774852|65919142|FG000|Overall Study|Protocol Violation|1|||
23597546|NCT00774852|65919143|FG001|Overall Study|Protocol Violation|0|||
23597547|NCT00774852|65919142|FG000|Overall Study|Subject received prohibited medication|1|||
23597548|NCT00774852|65919143|FG001|Overall Study|Subject received prohibited medication|0|||
23597549|NCT02140645|65919145|FG000|Overall Study|Not linked|5489|||
23597550|NCT02140645|65919146|FG001|Overall Study|Not linked|61654|||
23597551|NCT02140645|65919147|FG002|Overall Study|Not linked|4236|||
23597552|NCT02140645|65919148|FG003|Overall Study|Not linked|13833|||
23597553|NCT02140645|65919149|FG004|Overall Study|Not linked|3286|||
23597554|NCT02140645|65919150|FG005|Overall Study|Not linked|70896|||
23597555|NCT00468052|65919152|FG000|Overall Study|Protocol Violation|7|||
23597556|NCT00468052|65919153|FG001|Overall Study|Protocol Violation|8|||
23597557|NCT00945321|65919155|FG000|Period 1|Adverse Event|0|||
23597558|NCT00945321|65919156|FG001|Period 1|Adverse Event|0|||
23597559|NCT00945321|65919157|FG002|Period 1|Adverse Event|0|||
23597560|NCT00945321|65919158|FG003|Period 1|Adverse Event|0|||
23597561|NCT00945321|65919159|FG004|Period 1|Adverse Event|1|||
23597562|NCT00945321|65919160|FG005|Period 1|Adverse Event|0|||
23597563|NCT00945321|65919155|FG000|Period 4|Lost to Follow-up|0|||
23597564|NCT00945321|65919156|FG001|Period 4|Lost to Follow-up|0|||
23597565|NCT00945321|65919157|FG002|Period 4|Lost to Follow-up|0|||
23597566|NCT00945321|65919158|FG003|Period 4|Lost to Follow-up|0|||
23597567|NCT00945321|65919159|FG004|Period 4|Lost to Follow-up|0|||
23597568|NCT00945321|65919160|FG005|Period 4|Lost to Follow-up|1|||
23597569|NCT03394885|65919161|FG000|Overall Study|Adverse Event|4|||
23597570|NCT03394885|65919161|FG000|Overall Study|Lack of Efficacy|1|||
23597571|NCT03394885|65919161|FG000|Overall Study|Physician Decision|1|||
23597572|NCT03394885|65919161|FG000|Overall Study|Withdrawal by Subject|8|||
23597573|NCT03394885|65919161|FG000|Overall Study|Alternative Therapy|1|||
23597574|NCT04425863|65919162|FG000|Overall Study|Death|0|||
23597575|NCT04425863|65919163|FG001|Overall Study|Death|0|||
23597576|NCT04425863|65919164|FG002|Overall Study|Death|1|||
23597577|NCT00249769|65919167|FG000|Overall Study|Withdrawal by Subject|1|||
23597578|NCT00249769|65919168|FG001|Overall Study|Withdrawal by Subject|10|||
23597579|NCT00249769|65919169|FG002|Overall Study|Withdrawal by Subject|6|||
23597580|NCT00249769|65919167|FG000|Overall Study|Migration from Study Area|1|||
23597581|NCT00249769|65919168|FG001|Overall Study|Migration from Study Area|3|||
23597582|NCT00249769|65919169|FG002|Overall Study|Migration from Study Area|14|||
23597583|NCT00249769|65919167|FG000|Overall Study|Miscellaneous|0|||
23597584|NCT00249769|65919168|FG001|Overall Study|Miscellaneous|2|||
23597585|NCT00249769|65919169|FG002|Overall Study|Miscellaneous|2|||
23597586|NCT00249769|65919167|FG000|Overall Study|Adverse Event|0|||
23597587|NCT00249769|65919168|FG001|Overall Study|Adverse Event|0|||
23597588|NCT00249769|65919169|FG002|Overall Study|Adverse Event|1|||
23597589|NCT00249769|65919167|FG000|Overall Study|Physician Decision|0|||
23597590|NCT00249769|65919168|FG001|Overall Study|Physician Decision|0|||
23597591|NCT00249769|65919169|FG002|Overall Study|Physician Decision|2|||
23597592|NCT00249769|65919167|FG000|Overall Study|Lost to Follow-up|0|||
23597593|NCT00249769|65919168|FG001|Overall Study|Lost to Follow-up|0|||
23597594|NCT00249769|65919169|FG002|Overall Study|Lost to Follow-up|3|||
23597595|NCT01250769|65919170|FG000|Overall Study|Withdrawal by Subject|0|||
23647335|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
23647336|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23647337|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23647338|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23647339|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23647340|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647341|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
23647342|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647343|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647344|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647345|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647346|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647347|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23647348|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Death|1|||
23647349|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Death|0|||
23647350|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Death|0|||
23647351|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Death|0|||
23647352|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Death|0|||
23647353|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Death|0|||
23647354|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Death|0|||
23647355|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Death|0|||
23647356|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23647357|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23647358|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
23647359|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
23647360|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23478615|NCT00281658|65494577|FG000|Open Label Phase|Disease progression|0|||
23478616|NCT00281658|65494578|FG001|Open Label Phase|Disease progression|0|||
23647361|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23647362|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23647363|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23647364|NCT00427895|66094115|FG000|Vax 1/Year 1 Follow-up|Other|0|||
23647365|NCT00427895|66094116|FG001|Vax 1/Year 1 Follow-up|Other|0|||
23647366|NCT00427895|66094117|FG002|Vax 1/Year 1 Follow-up|Other|0|||
23647367|NCT00427895|66094118|FG003|Vax 1/Year 1 Follow-up|Other|2|||
23647368|NCT00427895|66094119|FG004|Vax 1/Year 1 Follow-up|Other|0|||
23647369|NCT00427895|66094120|FG005|Vax 1/Year 1 Follow-up|Other|0|||
23647370|NCT00427895|66094121|FG006|Vax 1/Year 1 Follow-up|Other|0|||
23647371|NCT00427895|66094122|FG007|Vax 1/Year 1 Follow-up|Other|0|||
23647372|NCT00427895|66094115|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
23647373|NCT00427895|66094116|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
23647374|NCT00427895|66094117|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
23647375|NCT00427895|66094118|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
23647376|NCT00427895|66094119|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23647377|NCT00427895|66094120|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23478617|NCT00281658|65494579|FG002|Open Label Phase|Disease progression|18|||
23478618|NCT00281658|65494580|FG003|Open Label Phase|Disease progression|0|||
23478619|NCT00281658|65494577|FG000|Open Label Phase|Physician Decision|0|||
23478620|NCT00281658|65494578|FG001|Open Label Phase|Physician Decision|0|||
23478621|NCT00281658|65494579|FG002|Open Label Phase|Physician Decision|1|||
23478622|NCT00281658|65494580|FG003|Open Label Phase|Physician Decision|0|||
23597596|NCT01250769|65919171|FG001|Overall Study|Withdrawal by Subject|1|||
23597597|NCT01250769|65919172|FG002|Overall Study|Withdrawal by Subject|1|||
23597598|NCT01250769|65919173|FG003|Overall Study|Withdrawal by Subject|0|||
23597599|NCT01250769|65919170|FG000|Overall Study|Adverse Event|0|||
23597600|NCT01250769|65919171|FG001|Overall Study|Adverse Event|0|||
23597601|NCT01250769|65919172|FG002|Overall Study|Adverse Event|1|||
23597602|NCT01250769|65919173|FG003|Overall Study|Adverse Event|0|||
23597603|NCT00503906|65919174|FG000|Overall Study|Withdrawal by Subject|1|||
23597604|NCT02852824|65919175|FG000|Overall Study|Withdrawal by Subject|1|||
23597605|NCT02852824|65919176|FG001|Overall Study|Withdrawal by Subject|0|||
23597606|NCT02852824|65919177|FG002|Overall Study|Withdrawal by Subject|0|||
23597607|NCT02852824|65919178|FG003|Overall Study|Withdrawal by Subject|0|||
23597608|NCT02852824|65919179|FG004|Overall Study|Withdrawal by Subject|0|||
23597609|NCT02852824|65919180|FG005|Overall Study|Withdrawal by Subject|0|||
23597610|NCT02852824|65919181|FG006|Overall Study|Withdrawal by Subject|0|||
23597611|NCT02852824|65919175|FG000|Overall Study|Adverse Event|0|||
23597612|NCT02852824|65919176|FG001|Overall Study|Adverse Event|0|||
23597613|NCT02852824|65919177|FG002|Overall Study|Adverse Event|0|||
23597614|NCT02852824|65919178|FG003|Overall Study|Adverse Event|0|||
23597615|NCT02852824|65919179|FG004|Overall Study|Adverse Event|2|||
23597616|NCT02852824|65919180|FG005|Overall Study|Adverse Event|0|||
23597617|NCT02852824|65919181|FG006|Overall Study|Adverse Event|0|||
23478623|NCT00281658|65494577|FG000|Open Label Phase|Relocation of patient|0|||
23647378|NCT00427895|66094121|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23647379|NCT00427895|66094122|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23647380|NCT02372136|66094123|FG000|Overall Study|Death|3|||
23647381|NCT02372136|66094124|FG001|Overall Study|Death|1|||
23647382|NCT04375761|66094125|FG000|Overall Study|Death|1|||
23647383|NCT04375761|66094126|FG001|Overall Study|Death|2|||
23647384|NCT04375761|66094125|FG000|Overall Study|Lost to Follow-up|203|||
23647385|NCT04375761|66094126|FG001|Overall Study|Lost to Follow-up|380|||
23647386|NCT04375761|66094125|FG000|Overall Study|Withdrawal by Subject|47|||
23647387|NCT04375761|66094126|FG001|Overall Study|Withdrawal by Subject|98|||
23647388|NCT04375761|66094125|FG000|Overall Study|Noncompliance with study procedure|121|||
23360588|NCT02028507|65065801|FG000|Overall Study|Death|1|||
23360589|NCT02028507|65065802|FG001|Overall Study|Death|0|||
23360590|NCT02028507|65065803|FG002|Overall Study|Death|1|||
23360591|NCT02028507|65065804|FG003|Overall Study|Death|3|||
23360592|NCT02028507|65065801|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
23360593|NCT02028507|65065802|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
23360594|NCT02028507|65065803|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
23360595|NCT02028507|65065804|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
23360596|NCT02028507|65065801|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
23647389|NCT04375761|66094126|FG001|Overall Study|Noncompliance with study procedure|251|||
23647390|NCT04375761|66094125|FG000|Overall Study|Reimbursement not enough|1|||
23647391|NCT04375761|66094126|FG001|Overall Study|Reimbursement not enough|2|||
23647392|NCT04375761|66094125|FG000|Overall Study|Unforeseen family circumstances|1|||
23647393|NCT04375761|66094126|FG001|Overall Study|Unforeseen family circumstances|3|||
23647394|NCT04375761|66094125|FG000|Overall Study|Test too painful|1|||
23647395|NCT04375761|66094126|FG001|Overall Study|Test too painful|1|||
23647396|NCT04375761|66094125|FG000|Overall Study|Moved|0|||
23647397|NCT04375761|66094126|FG001|Overall Study|Moved|2|||
23647398|NCT04375761|66094125|FG000|Overall Study|Nonresponsive|0|||
23647399|NCT04375761|66094126|FG001|Overall Study|Nonresponsive|5|||
23647400|NCT02924428|66094127|FG000|Overall Study|Adverse Event|1|||
23647401|NCT02924428|66094128|FG001|Overall Study|Adverse Event|0|||
23647402|NCT02924428|66094127|FG000|Overall Study|Physician Decision|1|||
23647403|NCT02924428|66094128|FG001|Overall Study|Physician Decision|0|||
23647404|NCT02924428|66094127|FG000|Overall Study|Lost to Follow-up|2|||
23647405|NCT02924428|66094128|FG001|Overall Study|Lost to Follow-up|4|||
23647406|NCT02924428|66094127|FG000|Overall Study|Pregnancy|0|||
23647407|NCT02924428|66094128|FG001|Overall Study|Pregnancy|1|||
23647408|NCT04882995|66094129|FG000|Overall Study|Withdrawal by Subject|1|||
23647409|NCT04882995|66094130|FG001|Overall Study|Withdrawal by Subject|2|||
23647410|NCT04882995|66094129|FG000|Overall Study|Protocol Violation|4|||
23647411|NCT04882995|66094130|FG001|Overall Study|Protocol Violation|4|||
23647412|NCT04882995|66094129|FG000|Overall Study|Surgery postponed due to COVID|1|||
23647413|NCT04882995|66094130|FG001|Overall Study|Surgery postponed due to COVID|1|||
23647414|NCT02951767|66094131|FG000|Overall Study|Study Terminated By Sponsor|9|||
23647415|NCT02951767|66094131|FG000|Overall Study|Withdrawal by Subject|11|||
23647416|NCT02951767|66094131|FG000|Overall Study|Death|96|||
23647417|NCT02951767|66094131|FG000|Overall Study|Lost to Follow-up|2|||
23647418|NCT02951767|66094131|FG000|Overall Study|Physician Decision|1|||
23647419|NCT03616977|66094132|FG000|Period 1|Physician Decision|0|||
23647420|NCT03616977|66094133|FG001|Period 1|Physician Decision|1|||
23647421|NCT03616977|66094132|FG000|Period 3|Adverse Event|1|||
23647422|NCT03616977|66094133|FG001|Period 3|Adverse Event|1|||
23647423|NCT01178385|66094135|FG000|Overall Study|Withdrawal by Subject|2|||
23647424|NCT01178385|66094136|FG001|Overall Study|Withdrawal by Subject|0|||
23647425|NCT03401229|66094137|FG000|Overall Study|Lost to Follow-up|2|||
23647426|NCT03401229|66094138|FG001|Overall Study|Lost to Follow-up|1|||
23647427|NCT03401229|66094137|FG000|Overall Study|Other|1|||
23647428|NCT03401229|66094138|FG001|Overall Study|Other|3|||
23647429|NCT03401229|66094137|FG000|Overall Study|Adverse Event|8|||
23647430|NCT03401229|66094138|FG001|Overall Study|Adverse Event|6|||
23360597|NCT02028507|65065802|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
23360598|NCT02028507|65065803|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
23360599|NCT02028507|65065804|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
23647431|NCT03401229|66094137|FG000|Overall Study|Withdrawal by Subject|29|||
23647432|NCT03401229|66094138|FG001|Overall Study|Withdrawal by Subject|26|||
23647433|NCT03401229|66094137|FG000|Overall Study|COVID-19|0|||
23360600|NCT02028507|65065801|FG000|Overall Study|Randomized But Not Treated|3|||
23360601|NCT02028507|65065802|FG001|Overall Study|Randomized But Not Treated|6|||
23647434|NCT03401229|66094138|FG001|Overall Study|COVID-19|1|||
23647435|NCT02502799|66094139|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23647436|NCT02502799|66094140|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23647437|NCT02502799|66094141|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23647438|NCT02502799|66094142|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
23647439|NCT02502799|66094139|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23800758|NCT01392326|66646888|FG001|Overall Study|Lost to Follow-up|3|||
23647440|NCT02502799|66094140|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23647441|NCT02502799|66094141|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23647442|NCT02502799|66094142|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
23647443|NCT02502799|66094139|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
23647444|NCT02502799|66094140|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
23647445|NCT02502799|66094141|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
23647446|NCT02502799|66094142|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
23647447|NCT02502799|66094139|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
23647448|NCT02502799|66094140|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
23647449|NCT02502799|66094141|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
23647450|NCT02502799|66094142|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
23647451|NCT02502799|66094139|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
23647452|NCT02502799|66094140|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
23647453|NCT02502799|66094141|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
23647454|NCT02502799|66094142|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
23647455|NCT00825916|66094143|FG000|Overall Study|Lost to Follow-up|4|||
23647456|NCT00825916|66094144|FG001|Overall Study|Lost to Follow-up|2|||
23647457|NCT00825916|66094145|FG002|Overall Study|Lost to Follow-up|1|||
23647458|NCT02571049|66094148|FG000|Screening|Did not meet entry criteria|2|||
23647459|NCT02571049|66094149|FG001|Screening|Did not meet entry criteria|2|||
23647460|NCT02571049|66094148|FG000|Randomization|No migraine attack|0|||
23647461|NCT02571049|66094149|FG001|Randomization|No migraine attack|1|||
23647462|NCT02571049|66094148|FG000|Randomization|Adverse Event|0|||
23647463|NCT02571049|66094149|FG001|Randomization|Adverse Event|1|||
23647464|NCT03010176|66094155|FG000|Overall Study|Death|21|||
23647465|NCT03010176|66094156|FG001|Overall Study|Death|35|||
23647466|NCT03010176|66094157|FG002|Overall Study|Death|19|||
23647467|NCT03010176|66094158|FG003|Overall Study|Death|19|||
23647468|NCT03010176|66094159|FG004|Overall Study|Death|14|||
23647469|NCT03010176|66094160|FG005|Overall Study|Death|0|||
23647470|NCT03010176|66094155|FG000|Overall Study|Lost to Follow-up|0|||
23647471|NCT03010176|66094156|FG001|Overall Study|Lost to Follow-up|0|||
23647472|NCT03010176|66094157|FG002|Overall Study|Lost to Follow-up|0|||
23647473|NCT03010176|66094158|FG003|Overall Study|Lost to Follow-up|0|||
23647474|NCT03010176|66094159|FG004|Overall Study|Lost to Follow-up|1|||
23647475|NCT03010176|66094160|FG005|Overall Study|Lost to Follow-up|0|||
23647476|NCT03010176|66094155|FG000|Overall Study|Physician Decision|0|||
23647477|NCT03010176|66094156|FG001|Overall Study|Physician Decision|4|||
23647478|NCT03010176|66094157|FG002|Overall Study|Physician Decision|0|||
23647479|NCT03010176|66094158|FG003|Overall Study|Physician Decision|1|||
23647480|NCT03010176|66094159|FG004|Overall Study|Physician Decision|0|||
23647481|NCT03010176|66094160|FG005|Overall Study|Physician Decision|0|||
23647482|NCT03010176|66094155|FG000|Overall Study|Sponsor Decision|0|||
23647483|NCT03010176|66094156|FG001|Overall Study|Sponsor Decision|4|||
23647484|NCT03010176|66094157|FG002|Overall Study|Sponsor Decision|4|||
23647485|NCT03010176|66094158|FG003|Overall Study|Sponsor Decision|1|||
23647486|NCT03010176|66094159|FG004|Overall Study|Sponsor Decision|6|||
23647487|NCT03010176|66094160|FG005|Overall Study|Sponsor Decision|0|||
23647488|NCT03010176|66094155|FG000|Overall Study|Withdrawal by Subject|11|||
23647489|NCT03010176|66094156|FG001|Overall Study|Withdrawal by Subject|9|||
23647490|NCT03010176|66094157|FG002|Overall Study|Withdrawal by Subject|3|||
23647491|NCT03010176|66094158|FG003|Overall Study|Withdrawal by Subject|0|||
23647492|NCT03010176|66094159|FG004|Overall Study|Withdrawal by Subject|4|||
23647493|NCT03010176|66094160|FG005|Overall Study|Withdrawal by Subject|0|||
23647494|NCT01012713|66094161|FG000|Overall Study|Lack of Efficacy|3|||
23647495|NCT01012739|66094166|FG000|Treatment Period 1|Adverse Event|0|||
23647496|NCT01012739|66094167|FG001|Treatment Period 1|Adverse Event|0|||
23647497|NCT01012739|66094168|FG002|Treatment Period 1|Adverse Event|0|||
23647498|NCT01012739|66094169|FG003|Treatment Period 1|Adverse Event|1|||
23647499|NCT01012739|66094166|FG000|Treatment Period 2|Abnormal test procedure results|0|||
23647500|NCT01012739|66094167|FG001|Treatment Period 2|Abnormal test procedure results|0|||
23647501|NCT01012739|66094168|FG002|Treatment Period 2|Abnormal test procedure results|0|||
23647502|NCT01012739|66094169|FG003|Treatment Period 2|Abnormal test procedure results|1|||
23647503|NCT01210664|66094173|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23647504|NCT01210664|66094174|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23647505|NCT01210664|66094175|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
23647506|NCT01210664|66094176|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23647507|NCT01210664|66094173|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23647508|NCT01210664|66094174|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23647509|NCT01210664|66094175|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
23647510|NCT01210664|66094176|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23647511|NCT01210664|66094173|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23647512|NCT01210664|66094174|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23800759|NCT01392326|66646889|FG002|Overall Study|Lost to Follow-up|4|||
23647513|NCT01210664|66094175|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23647514|NCT01210664|66094176|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
23647515|NCT02572882|66094179|FG000|Overall Study|Withdrawal by Subject|1|||
23647516|NCT02572882|66094179|FG000|Overall Study|Participant received kidney transplant|1|||
23647517|NCT01227577|66094180|FG000|Overall Study|Protocol deviation|3|||
23647518|NCT01227577|66094180|FG000|Overall Study|Death|3|||
23647519|NCT01227577|66094180|FG000|Overall Study|Administrative problems|2|||
23647520|NCT01227577|66094180|FG000|Overall Study|Lost to Follow-up|1|||
23647521|NCT01227577|66094180|FG000|Overall Study|Withdrawal by Subject|4|||
23647522|NCT01227577|66094180|FG000|Overall Study|Lack of Efficacy|5|||
23647523|NCT01227577|66094180|FG000|Overall Study|Adverse Event|17|||
23647524|NCT01078454|66094181|FG000|Overall Study|Adverse Event|1|||
23647525|NCT01078454|66094182|FG001|Overall Study|Adverse Event|1|||
23647526|NCT01078454|66094181|FG000|Overall Study|Death|0|||
23647527|NCT01078454|66094182|FG001|Overall Study|Death|1|||
23647528|NCT01874431|66094183|FG000|Overall Study|Physician Decision|0|||
23647529|NCT01874431|66094184|FG001|Overall Study|Physician Decision|0|||
23647530|NCT01874431|66094185|FG002|Overall Study|Physician Decision|1|||
23647531|NCT01874431|66094186|FG003|Overall Study|Physician Decision|0|||
23647532|NCT01874431|66094187|FG004|Overall Study|Physician Decision|0|||
23647533|NCT01874431|66094188|FG005|Overall Study|Physician Decision|0|||
23647534|NCT01874431|66094189|FG006|Overall Study|Physician Decision|0|||
23647535|NCT01874431|66094190|FG007|Overall Study|Physician Decision|0|||
23647536|NCT01874431|66094183|FG000|Overall Study|Adverse Event|5|||
23647537|NCT01874431|66094184|FG001|Overall Study|Adverse Event|4|||
23647538|NCT01874431|66094185|FG002|Overall Study|Adverse Event|6|||
23647539|NCT01874431|66094186|FG003|Overall Study|Adverse Event|5|||
23647540|NCT01874431|66094187|FG004|Overall Study|Adverse Event|2|||
23647541|NCT01874431|66094188|FG005|Overall Study|Adverse Event|8|||
23647542|NCT01874431|66094189|FG006|Overall Study|Adverse Event|2|||
23647543|NCT01874431|66094190|FG007|Overall Study|Adverse Event|3|||
23647544|NCT01874431|66094183|FG000|Overall Study|Protocol Violation|1|||
23647545|NCT01874431|66094184|FG001|Overall Study|Protocol Violation|1|||
23647546|NCT01874431|66094185|FG002|Overall Study|Protocol Violation|1|||
23647547|NCT01874431|66094186|FG003|Overall Study|Protocol Violation|0|||
23647548|NCT01874431|66094187|FG004|Overall Study|Protocol Violation|3|||
23647549|NCT01874431|66094188|FG005|Overall Study|Protocol Violation|2|||
23647550|NCT01874431|66094189|FG006|Overall Study|Protocol Violation|1|||
23647551|NCT01874431|66094190|FG007|Overall Study|Protocol Violation|1|||
23647552|NCT01874431|66094183|FG000|Overall Study|Non-compliance|0|||
23647553|NCT01874431|66094184|FG001|Overall Study|Non-compliance|0|||
23647554|NCT01874431|66094185|FG002|Overall Study|Non-compliance|0|||
23647555|NCT01874431|66094186|FG003|Overall Study|Non-compliance|0|||
23647556|NCT01874431|66094187|FG004|Overall Study|Non-compliance|1|||
23647557|NCT01874431|66094188|FG005|Overall Study|Non-compliance|0|||
23647558|NCT01874431|66094189|FG006|Overall Study|Non-compliance|1|||
23647559|NCT01874431|66094190|FG007|Overall Study|Non-compliance|0|||
23647560|NCT01874431|66094183|FG000|Overall Study|Logistical difficulties|0|||
23647561|NCT01874431|66094184|FG001|Overall Study|Logistical difficulties|0|||
23647562|NCT01874431|66094185|FG002|Overall Study|Logistical difficulties|0|||
23647563|NCT01874431|66094186|FG003|Overall Study|Logistical difficulties|0|||
23647564|NCT01874431|66094187|FG004|Overall Study|Logistical difficulties|0|||
23647565|NCT01874431|66094188|FG005|Overall Study|Logistical difficulties|0|||
23647566|NCT01874431|66094189|FG006|Overall Study|Logistical difficulties|1|||
23647567|NCT01874431|66094190|FG007|Overall Study|Logistical difficulties|0|||
23647568|NCT01874431|66094183|FG000|Overall Study|Withdrawal by Subject|0|||
23647569|NCT01874431|66094184|FG001|Overall Study|Withdrawal by Subject|0|||
23647570|NCT01874431|66094185|FG002|Overall Study|Withdrawal by Subject|1|||
23647571|NCT01874431|66094186|FG003|Overall Study|Withdrawal by Subject|2|||
23647572|NCT01874431|66094187|FG004|Overall Study|Withdrawal by Subject|1|||
23800760|NCT01392326|66646887|FG000|Overall Study|Lack of Efficacy|14|||
23800761|NCT01392326|66646888|FG001|Overall Study|Lack of Efficacy|10|||
23800762|NCT01392326|66646889|FG002|Overall Study|Lack of Efficacy|15|||
23800763|NCT01392326|66646887|FG000|Overall Study|Adverse Event|9|||
23647573|NCT01874431|66094188|FG005|Overall Study|Withdrawal by Subject|1|||
23647574|NCT01874431|66094189|FG006|Overall Study|Withdrawal by Subject|3|||
23647575|NCT01874431|66094190|FG007|Overall Study|Withdrawal by Subject|0|||
23647576|NCT01874431|66094183|FG000|Overall Study|Sponsor decision|0|||
23800764|NCT01392326|66646888|FG001|Overall Study|Adverse Event|6|||
23647577|NCT01874431|66094184|FG001|Overall Study|Sponsor decision|0|||
23647578|NCT01874431|66094185|FG002|Overall Study|Sponsor decision|0|||
23647579|NCT01874431|66094186|FG003|Overall Study|Sponsor decision|0|||
23800765|NCT01392326|66646889|FG002|Overall Study|Adverse Event|11|||
23647580|NCT01874431|66094187|FG004|Overall Study|Sponsor decision|1|||
23647581|NCT01874431|66094188|FG005|Overall Study|Sponsor decision|0|||
23647582|NCT01874431|66094189|FG006|Overall Study|Sponsor decision|0|||
23647583|NCT01874431|66094190|FG007|Overall Study|Sponsor decision|0|||
23647584|NCT01874431|66094183|FG000|Overall Study|Lost to Follow-up|0|||
23647585|NCT01874431|66094184|FG001|Overall Study|Lost to Follow-up|0|||
23647586|NCT01874431|66094185|FG002|Overall Study|Lost to Follow-up|1|||
23647587|NCT01874431|66094186|FG003|Overall Study|Lost to Follow-up|0|||
23647588|NCT01874431|66094187|FG004|Overall Study|Lost to Follow-up|0|||
23647589|NCT01874431|66094188|FG005|Overall Study|Lost to Follow-up|0|||
23647590|NCT01874431|66094189|FG006|Overall Study|Lost to Follow-up|0|||
23647591|NCT01874431|66094190|FG007|Overall Study|Lost to Follow-up|0|||
23647592|NCT00812331|66094191|FG000|Overall Study|Adverse Event|1|||
23647593|NCT00812331|66094192|FG001|Overall Study|Adverse Event|0|||
23647594|NCT00812331|66094193|FG002|Overall Study|Adverse Event|0|||
23647595|NCT00812331|66094194|FG003|Overall Study|Adverse Event|0|||
23647596|NCT00812331|66094195|FG004|Overall Study|Adverse Event|0|||
23647597|NCT00717067|66097317|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23647598|NCT00717067|66097318|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23647599|NCT00717067|66097319|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
23647600|NCT00717067|66097320|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23647601|NCT00717067|66097321|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23647602|NCT00645801|66097322|FG000|Overall Study|unclear if patient took all the medication.|1|||
23647603|NCT00645801|66097323|FG001|Overall Study|unclear if patient took all the medication.|0|||
23647604|NCT00645801|66097322|FG000|Overall Study|Lost to Follow-up|19|||
23647605|NCT00645801|66097323|FG001|Overall Study|Lost to Follow-up|15|||
23647606|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
23647607|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
23647608|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
23647609|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
23647610|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
23647611|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
23647612|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
23647613|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23647614|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23647615|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23647616|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23647617|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23647618|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Death|1|||
23647619|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Death|2|||
23647620|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Death|2|||
23647621|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Death|0|||
23647622|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Death|0|||
23647623|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Death|0|||
23647624|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23647625|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
23647626|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
23647627|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23647628|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23647629|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23647630|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
23647631|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23647632|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23647633|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23647634|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23647635|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23647636|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
23647637|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23647638|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23647639|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23647640|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23647641|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23647642|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
23647643|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23647644|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23647645|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23647646|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23647647|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23647648|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23647649|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
23647650|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23647651|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23647652|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23647653|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23647654|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
23647655|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
23647656|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
23647657|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
23647658|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
23647659|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
23647660|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23647661|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23647662|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
23647663|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23647664|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23647665|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23647666|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Site closure|0|||
23647667|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Site closure|0|||
23647668|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Site closure|1|||
23647669|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Site closure|0|||
23647670|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Site closure|0|||
23647671|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Site closure|0|||
23647672|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
23647673|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
23647674|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
23647675|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
23647676|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
23647677|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
23647678|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
23647679|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
23647680|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
23647681|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
23647682|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
23647683|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
23647684|NCT03439254|66097324|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
23647685|NCT03439254|66097325|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
23647686|NCT03439254|66097326|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
23647687|NCT03439254|66097327|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23647688|NCT03439254|66097328|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23647689|NCT03439254|66097329|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23647690|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23647691|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23647692|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23647693|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
23647694|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
23647695|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
23647696|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23647697|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23647698|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23647699|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
23647700|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23647701|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
23647702|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23647703|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23647704|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23647705|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23647706|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23647707|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
23647708|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23647709|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23647710|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23647711|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23647712|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
23647713|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23647714|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23647715|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23647716|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23647717|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23647718|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
23647719|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23647720|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23647721|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23647722|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23647723|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23647724|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23647725|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
23478624|NCT00281658|65494578|FG001|Open Label Phase|Relocation of patient|0|||
23478625|NCT00281658|65494579|FG002|Open Label Phase|Relocation of patient|1|||
23478626|NCT00281658|65494580|FG003|Open Label Phase|Relocation of patient|0|||
23478627|NCT00281658|65494577|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
23478628|NCT00281658|65494578|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
23478629|NCT00281658|65494579|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
23478630|NCT00281658|65494580|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
23647726|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23647727|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23647728|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23647729|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
23647730|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23647731|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23647732|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23647733|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23647734|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23647735|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
23647736|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
23647737|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23647738|NCT03439254|66097324|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23647739|NCT03439254|66097325|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23647740|NCT03439254|66097326|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23647741|NCT03439254|66097327|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
23647742|NCT03439254|66097328|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
23647743|NCT03439254|66097329|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
23647744|NCT00551460|66097332|FG000|Overall Study|Adverse Event|1|||
23647745|NCT00551460|66097332|FG000|Overall Study|Withdrawal by Subject|1|||
23647746|NCT00551460|66097332|FG000|Overall Study|Physician Decision|1|||
23647747|NCT00551460|66097332|FG000|Overall Study|Death|7|||
23647748|NCT00551460|66097332|FG000|Overall Study|Ineligible|4|||
23647749|NCT00551460|66097332|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
23647750|NCT00946101|66097335|FG000|Overall Study|Lost to Follow-up|2|||
23647751|NCT00946101|66097336|FG001|Overall Study|Lost to Follow-up|1|||
23647752|NCT00946101|66097335|FG000|Overall Study|Withdrawal of consent|2|||
23647753|NCT00946101|66097336|FG001|Overall Study|Withdrawal of consent|0|||
23647754|NCT00946101|66097335|FG000|Overall Study|Physician Decision|0|||
23478631|NCT01306929|65494581|FG000|Overall Study|Withdrawal by Subject|23|||
23647755|NCT00946101|66097336|FG001|Overall Study|Physician Decision|1|||
23647756|NCT00153062|66097337|FG000|Overall Study|Death|360|||
23647757|NCT00153062|66097338|FG001|Overall Study|Death|352|||
23597618|NCT00999167|65919184|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
23597619|NCT00999167|65919185|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
23597620|NCT00999167|65919186|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
23597621|NCT00999167|65919184|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
23597622|NCT00999167|65919185|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
23597623|NCT00999167|65919186|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
23597624|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
23597625|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
23597626|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
23597627|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
23597628|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
23597629|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
23597630|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
23597631|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
23597632|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
23597633|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
23597634|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
23597635|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
23597636|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
23597637|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
23597638|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
23597639|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
23597640|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
23597641|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
23597642|NCT01121991|65919187|FG000|Overall Study|Lack of Ovarian Response|2|||
23597643|NCT01121991|65919187|FG000|Overall Study|No Oocytes Retrieved|3|||
23597644|NCT01121991|65919187|FG000|Overall Study|No Fertilization|1|||
23597645|NCT00792636|65919215|FG000|Overall Study|Protocol Violation|17|||
23597646|NCT00792636|65919216|FG001|Overall Study|Protocol Violation|23|||
23597647|NCT00792636|65919217|FG002|Overall Study|Protocol Violation|20|||
23597648|NCT00792636|65919215|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
23597649|NCT00792636|65919216|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
23597650|NCT00792636|65919217|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
23597651|NCT00792636|65919215|FG000|Overall Study|Lost to Follow-up|13|||
23597652|NCT00792636|65919216|FG001|Overall Study|Lost to Follow-up|19|||
23597653|NCT00792636|65919217|FG002|Overall Study|Lost to Follow-up|14|||
23597654|NCT00792636|65919215|FG000|Overall Study|Withdrew Consent|10|||
23597655|NCT00792636|65919216|FG001|Overall Study|Withdrew Consent|13|||
23597656|NCT00792636|65919217|FG002|Overall Study|Withdrew Consent|9|||
23597657|NCT00792636|65919215|FG000|Overall Study|Lack of Efficacy|3|||
23597658|NCT00792636|65919216|FG001|Overall Study|Lack of Efficacy|4|||
23597659|NCT00792636|65919217|FG002|Overall Study|Lack of Efficacy|13|||
23597660|NCT00792636|65919215|FG000|Overall Study|Adverse Event|4|||
23597661|NCT00792636|65919216|FG001|Overall Study|Adverse Event|2|||
23597662|NCT00792636|65919217|FG002|Overall Study|Adverse Event|3|||
23597663|NCT00792636|65919215|FG000|Overall Study|Investigator Discretion|2|||
23597664|NCT00792636|65919216|FG001|Overall Study|Investigator Discretion|0|||
23597665|NCT00792636|65919217|FG002|Overall Study|Investigator Discretion|2|||
23597666|NCT02251652|65919218|FG000|Overall Study|Withdrawal by Subject|1|||
23597667|NCT00670046|65919219|FG000|Overall Study|Lost to Follow-up|1|||
23597668|NCT00670046|65919220|FG001|Overall Study|Lost to Follow-up|1|||
23597669|NCT00670046|65919219|FG000|Overall Study|Withdrawal by Subject|0|||
23597670|NCT00670046|65919220|FG001|Overall Study|Withdrawal by Subject|1|||
23597671|NCT00145470|65919222|FG000|Overall Study|Adverse Event|19|||
23597672|NCT00145470|65919223|FG001|Overall Study|Adverse Event|25|||
23597673|NCT00145470|65919222|FG000|Overall Study|Lack of Efficacy|27|||
23597674|NCT00145470|65919223|FG001|Overall Study|Lack of Efficacy|13|||
23597675|NCT00145470|65919222|FG000|Overall Study|Withdrawal by Subject|36|||
23597676|NCT00145470|65919223|FG001|Overall Study|Withdrawal by Subject|34|||
23597677|NCT00145470|65919222|FG000|Overall Study|Lost to Follow-up|21|||
23597678|NCT00145470|65919223|FG001|Overall Study|Lost to Follow-up|17|||
23597679|NCT00145470|65919222|FG000|Overall Study|Reason Not Reported|9|||
23597680|NCT00145470|65919223|FG001|Overall Study|Reason Not Reported|9|||
23597681|NCT01083316|65919226|FG000|Overall Study|Adverse Event|2|||
23647758|NCT00153062|66097339|FG002|Overall Study|Death|369|||
23647759|NCT00153062|66097340|FG003|Overall Study|Death|365|||
23647760|NCT00153062|66097337|FG000|Overall Study|Withdrawal by Subject|14|||
23647761|NCT00153062|66097338|FG001|Overall Study|Withdrawal by Subject|30|||
23647762|NCT00153062|66097339|FG002|Overall Study|Withdrawal by Subject|27|||
23647763|NCT00153062|66097340|FG003|Overall Study|Withdrawal by Subject|28|||
23647764|NCT00153062|66097337|FG000|Overall Study|Lost to Follow-up|12|||
23647765|NCT00153062|66097338|FG001|Overall Study|Lost to Follow-up|20|||
23647766|NCT00153062|66097339|FG002|Overall Study|Lost to Follow-up|15|||
23647767|NCT00153062|66097340|FG003|Overall Study|Lost to Follow-up|16|||
23647768|NCT00153062|66097337|FG000|Overall Study|Adverse Event|0|||
23647769|NCT00153062|66097338|FG001|Overall Study|Adverse Event|1|||
23647770|NCT00153062|66097339|FG002|Overall Study|Adverse Event|1|||
23647771|NCT00153062|66097340|FG003|Overall Study|Adverse Event|0|||
23647772|NCT00153062|66097337|FG000|Overall Study|Protocol Violation|0|||
23647773|NCT00153062|66097338|FG001|Overall Study|Protocol Violation|2|||
23647774|NCT00153062|66097339|FG002|Overall Study|Protocol Violation|1|||
23647775|NCT00153062|66097340|FG003|Overall Study|Protocol Violation|1|||
23647776|NCT00153062|66097337|FG000|Overall Study|No disposition data available|1|||
23647777|NCT00153062|66097338|FG001|Overall Study|No disposition data available|1|||
23647778|NCT00153062|66097339|FG002|Overall Study|No disposition data available|1|||
23647779|NCT00153062|66097340|FG003|Overall Study|No disposition data available|1|||
23647780|NCT00153062|66097337|FG000|Overall Study|Other|0|||
23647781|NCT00153062|66097338|FG001|Overall Study|Other|0|||
23647782|NCT00153062|66097339|FG002|Overall Study|Other|1|||
23647783|NCT00153062|66097340|FG003|Overall Study|Other|0|||
23647784|NCT03169101|66097341|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
23647785|NCT03169101|66097342|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
23647786|NCT03169101|66097343|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
23647787|NCT03169101|66097344|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
23647788|NCT04161495|66097353|FG000|Overall Study|Withdrawal by Subject|3|||
23647789|NCT04161495|66097354|FG001|Overall Study|Withdrawal by Subject|0|||
23647790|NCT04161495|66097353|FG000|Overall Study|Protocol Violation|1|||
23647791|NCT04161495|66097354|FG001|Overall Study|Protocol Violation|0|||
23647792|NCT04161495|66097353|FG000|Overall Study|Prohibited concomitant medication|3|||
23647793|NCT04161495|66097354|FG001|Overall Study|Prohibited concomitant medication|0|||
23647794|NCT04161495|66097353|FG000|Overall Study|Adverse Event|1|||
23800766|NCT04234464|66646893|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
23800767|NCT04234464|66646894|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
23800768|NCT01049412|66646897|FG000|Period I|Withdrawal by Subject|4|||
23478632|NCT01306929|65494581|FG000|Overall Study|Adverse Event|21|||
23478633|NCT01306929|65494581|FG000|Overall Study|Physician Decision|13|||
23478634|NCT01306929|65494581|FG000|Overall Study|Death|8|||
23478635|NCT01306929|65494581|FG000|Overall Study|Withdrawal by parent/guardian|5|||
23478636|NCT01306929|65494581|FG000|Overall Study|Protocol Violation|3|||
23478637|NCT01306929|65494581|FG000|Overall Study|Non-compliance with study drug|2|||
23478638|NCT01306929|65494581|FG000|Overall Study|Lost to Follow-up|2|||
23478639|NCT01306929|65494581|FG000|Overall Study|Various|17|||
23478640|NCT02730195|65494582|FG000|Overall Study|Withdrawal by Subject|1|||
23800769|NCT01049412|66646898|FG001|Period I|Withdrawal by Subject|6|||
23800770|NCT01049412|66646897|FG000|Period I|Lost to Follow-up|2|||
23800771|NCT01049412|66646898|FG001|Period I|Lost to Follow-up|2|||
23800772|NCT01049412|66646897|FG000|Period I|Physician Decision|0|||
23800773|NCT01049412|66646898|FG001|Period I|Physician Decision|3|||
23800774|NCT01049412|66646897|FG000|Period I|Protocol Violation|1|||
23800775|NCT01049412|66646898|FG001|Period I|Protocol Violation|2|||
23800776|NCT01049412|66646897|FG000|Period I|Adverse Event|1|||
23800777|NCT01049412|66646898|FG001|Period I|Adverse Event|0|||
23800778|NCT01049412|66646897|FG000|Period II|Withdrawal by Subject|2|||
23800779|NCT01049412|66646898|FG001|Period II|Withdrawal by Subject|3|||
23800780|NCT01049412|66646897|FG000|Period II|Adverse Event|1|||
23800781|NCT01049412|66646898|FG001|Period II|Adverse Event|0|||
23800782|NCT01049412|66646897|FG000|Period II|Lost to Follow-up|1|||
23800783|NCT01049412|66646898|FG001|Period II|Lost to Follow-up|0|||
23800784|NCT00202839|66646913|FG000|Overall Study|Adverse Event|1|||
23478641|NCT01009840|65494583|FG000|Overall Study|Lost to Follow-up|1|||
23647795|NCT04161495|66097354|FG001|Overall Study|Adverse Event|0|||
23800785|NCT00202839|66646914|FG001|Overall Study|Adverse Event|5|||
23800786|NCT00202839|66646913|FG000|Overall Study|Physician Decision|12|||
23800787|NCT00202839|66646914|FG001|Overall Study|Physician Decision|0|||
23647796|NCT04161495|66097353|FG000|Overall Study|Other - Unspecified|1|||
23647797|NCT04161495|66097354|FG001|Overall Study|Other - Unspecified|0|||
23647798|NCT04161495|66097353|FG000|Overall Study|Death|0|||
23647799|NCT04161495|66097354|FG001|Overall Study|Death|1|||
23647800|NCT00705679|66097357|FG000|Overall Study|Adverse Event|1|||
23800788|NCT00202839|66646913|FG000|Overall Study|Withdrawal by Subject|6|||
23647801|NCT00705679|66097358|FG001|Overall Study|Adverse Event|1|||
23478642|NCT01009840|65494583|FG000|Overall Study|Adverse Event|4|||
23478643|NCT01009840|65494583|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
23800789|NCT00202839|66646914|FG001|Overall Study|Withdrawal by Subject|2|||
23647802|NCT00705679|66097359|FG002|Overall Study|Adverse Event|0|||
23647803|NCT00705679|66097360|FG003|Overall Study|Adverse Event|0|||
23647804|NCT00705679|66097361|FG004|Overall Study|Adverse Event|0|||
23647805|NCT00705679|66097357|FG000|Overall Study|Death|0|||
23647806|NCT00705679|66097358|FG001|Overall Study|Death|0|||
23647807|NCT00705679|66097359|FG002|Overall Study|Death|3|||
23647808|NCT00705679|66097360|FG003|Overall Study|Death|2|||
23647809|NCT00705679|66097361|FG004|Overall Study|Death|1|||
23647810|NCT00705679|66097357|FG000|Overall Study|Lost to Follow-up|32|||
23647811|NCT00705679|66097358|FG001|Overall Study|Lost to Follow-up|60|||
23647812|NCT00705679|66097359|FG002|Overall Study|Lost to Follow-up|44|||
23647813|NCT00705679|66097360|FG003|Overall Study|Lost to Follow-up|30|||
23647814|NCT00705679|66097361|FG004|Overall Study|Lost to Follow-up|35|||
23647815|NCT00705679|66097357|FG000|Overall Study|Physician Decision|0|||
23647816|NCT00705679|66097358|FG001|Overall Study|Physician Decision|1|||
23647817|NCT00705679|66097359|FG002|Overall Study|Physician Decision|0|||
23647818|NCT00705679|66097360|FG003|Overall Study|Physician Decision|1|||
23647819|NCT00705679|66097361|FG004|Overall Study|Physician Decision|0|||
23647820|NCT00705679|66097357|FG000|Overall Study|Withdrawal by Subject|32|||
23647821|NCT00705679|66097358|FG001|Overall Study|Withdrawal by Subject|77|||
23647822|NCT00705679|66097359|FG002|Overall Study|Withdrawal by Subject|68|||
23647823|NCT00705679|66097360|FG003|Overall Study|Withdrawal by Subject|47|||
23647824|NCT00705679|66097361|FG004|Overall Study|Withdrawal by Subject|33|||
23647825|NCT02054741|66097362|FG000|Overall Study|Protocol Violation|13|||
23647826|NCT02054741|66097363|FG001|Overall Study|Protocol Violation|2|||
23647827|NCT02054741|66097362|FG000|Overall Study|Withdrawal by Subject|10|||
23647828|NCT02054741|66097363|FG001|Overall Study|Withdrawal by Subject|5|||
23647829|NCT02054741|66097362|FG000|Overall Study|Death|94|||
23647830|NCT02054741|66097363|FG001|Overall Study|Death|90|||
23647831|NCT02054741|66097362|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
23647832|NCT02054741|66097363|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
23647833|NCT00757783|66097368|FG000|Overall Study|Adverse Event|0|||
23647834|NCT00757783|66097369|FG001|Overall Study|Adverse Event|2|||
23647835|NCT00757783|66097368|FG000|Overall Study|Lost to Follow-up|1|||
23647836|NCT00757783|66097369|FG001|Overall Study|Lost to Follow-up|1|||
23647837|NCT00757783|66097368|FG000|Overall Study|Protocol Violation|1|||
23647838|NCT00757783|66097369|FG001|Overall Study|Protocol Violation|0|||
23647839|NCT00757783|66097368|FG000|Overall Study|Withdrawal by Subject|2|||
23647840|NCT00757783|66097369|FG001|Overall Study|Withdrawal by Subject|1|||
23647841|NCT00757783|66097368|FG000|Overall Study|Other|1|||
23647842|NCT00757783|66097369|FG001|Overall Study|Other|2|||
23647843|NCT02709096|66097370|FG000|Overall Study|non-compliance|1|||
23647844|NCT02709096|66097371|FG001|Overall Study|non-compliance|1|||
23647845|NCT01853137|66097372|FG000|Overall Study|Lost to Follow-up|4|||
23647846|NCT01853137|66097373|FG001|Overall Study|Lost to Follow-up|1|||
23647847|NCT00591370|66097374|FG000|Overall Study|Not Treated|2|||
23647848|NCT00709852|66097375|FG000|Period 1|Adverse Event|2|||
23647849|NCT00709852|66097376|FG001|Period 1|Adverse Event|0|||
23647850|NCT00709852|66097375|FG000|Period 1|Withdrawal by Subject|4|||
23647851|NCT00709852|66097376|FG001|Period 1|Withdrawal by Subject|2|||
23647852|NCT00709852|66097375|FG000|Period 1|Protocol Violation|1|||
23647853|NCT00709852|66097376|FG001|Period 1|Protocol Violation|0|||
23647854|NCT00709852|66097375|FG000|Period 1|Defective scanner|0|||
23647855|NCT00709852|66097376|FG001|Period 1|Defective scanner|1|||
23647856|NCT00709852|66097375|FG000|Period 1|Lost to Follow-up|1|||
23647857|NCT00709852|66097376|FG001|Period 1|Lost to Follow-up|0|||
23647858|NCT00709852|66097375|FG000|Period 2|Protocol Violation|4|||
23647859|NCT00709852|66097376|FG001|Period 2|Protocol Violation|1|||
23647860|NCT00709852|66097375|FG000|Period 2|Adverse Event|1|||
23647861|NCT00709852|66097376|FG001|Period 2|Adverse Event|1|||
23647862|NCT00709852|66097375|FG000|Period 2|Lost to Follow-up|1|||
23647863|NCT00709852|66097376|FG001|Period 2|Lost to Follow-up|0|||
23647864|NCT00709852|66097375|FG000|Period 2|No 72-hour follow-up|3|||
23647865|NCT00709852|66097376|FG001|Period 2|No 72-hour follow-up|0|||
23478644|NCT01009840|65494583|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
23647866|NCT03278106|66097377|FG000|Overall Study|No protocol treatment|1|||
23647867|NCT03241225|66097379|FG000|Overall Study|Lost to Follow-up|2|||
23647868|NCT03241225|66097380|FG001|Overall Study|Lost to Follow-up|1|||
23647869|NCT03241225|66097379|FG000|Overall Study|Protocol Violation|4|||
23647870|NCT03241225|66097380|FG001|Overall Study|Protocol Violation|1|||
23647871|NCT03241225|66097379|FG000|Overall Study|Withdrawal by Subject|1|||
23647872|NCT03241225|66097380|FG001|Overall Study|Withdrawal by Subject|0|||
23647873|NCT03536143|66097381|FG000|Overall Study|Early termination, Sponsor decision|1|||
23647874|NCT01575028|66097382|FG000|Overall Study|Physician Decision|0|||
23647875|NCT01575028|66097383|FG001|Overall Study|Physician Decision|1|||
23647876|NCT02090959|66097384|FG000|Overall Study|Withdrawal by Subject|10|||
23647877|NCT02090959|66097384|FG000|Overall Study|Adverse Event|1|||
23647878|NCT02090959|66097384|FG000|Overall Study|Investigator decision|2|||
23647879|NCT02090959|66097384|FG000|Overall Study|Study termination|6|||
23647880|NCT02090959|66097384|FG000|Overall Study|Enrolled but not treated|1|||
23647881|NCT02090959|66097384|FG000|Overall Study|Transfer for compassionate use medicine|4|||
23647882|NCT02090959|66097384|FG000|Overall Study|Move to medical need program|3|||
23647883|NCT02090959|66097384|FG000|Overall Study|Entered in to other study|34|||
23647884|NCT02090959|66097384|FG000|Overall Study|Switched to commercial supply|88|||
23800790|NCT00202839|66646913|FG000|Overall Study|Protocol Violation|2|||
23800791|NCT00202839|66646914|FG001|Overall Study|Protocol Violation|1|||
23800792|NCT00202839|66646913|FG000|Overall Study|Lost to Follow-up|3|||
23800793|NCT00202839|66646914|FG001|Overall Study|Lost to Follow-up|2|||
23800794|NCT00810602|66646915|FG000|Overall Study|Withdrawal by Subject|8|||
23800795|NCT00810602|66646916|FG001|Overall Study|Withdrawal by Subject|3|||
23800796|NCT03176784|66646917|FG000|Overall Study|Lost to Follow-up|77|||
23800797|NCT03176784|66646918|FG001|Overall Study|Lost to Follow-up|79|||
23800798|NCT03176784|66646919|FG002|Overall Study|Lost to Follow-up|79|||
23800799|NCT03176784|66646920|FG003|Overall Study|Lost to Follow-up|49|||
23800800|NCT03176784|66646917|FG000|Overall Study|Withdrawal by Subject|28|||
23800801|NCT03176784|66646918|FG001|Overall Study|Withdrawal by Subject|34|||
23800802|NCT03176784|66646919|FG002|Overall Study|Withdrawal by Subject|34|||
23800803|NCT03176784|66646920|FG003|Overall Study|Withdrawal by Subject|21|||
23800804|NCT01885182|66646928|FG000|Overall Study|Adverse Event|11|||
23800805|NCT01885182|66646929|FG001|Overall Study|Adverse Event|13|||
23800806|NCT01885182|66646928|FG000|Overall Study|Withdrawal by Subject|13|||
23800807|NCT01885182|66646929|FG001|Overall Study|Withdrawal by Subject|6|||
23800808|NCT01885182|66646928|FG000|Overall Study|Lost to Follow-up|2|||
23800809|NCT01885182|66646929|FG001|Overall Study|Lost to Follow-up|2|||
23800810|NCT01885182|66646928|FG000|Overall Study|Lack of Efficacy|8|||
23800811|NCT01885182|66646929|FG001|Overall Study|Lack of Efficacy|1|||
23800812|NCT02751827|66646930|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
23800813|NCT02751827|66646931|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
23800814|NCT02751827|66646932|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
23800815|NCT02846883|66649798|FG000|Overall Study|Death|0|||
23800816|NCT02846883|66649799|FG001|Overall Study|Death|1|||
23800817|NCT02846883|66649800|FG002|Overall Study|Death|1|||
23800818|NCT02846883|66649798|FG000|Overall Study|Lost to Follow-up|0|||
23800819|NCT02846883|66649799|FG001|Overall Study|Lost to Follow-up|0|||
23800820|NCT02846883|66649800|FG002|Overall Study|Lost to Follow-up|1|||
23800821|NCT02846883|66649798|FG000|Overall Study|Withdrawal by Subject|1|||
23800822|NCT02846883|66649799|FG001|Overall Study|Withdrawal by Subject|0|||
23800823|NCT02846883|66649800|FG002|Overall Study|Withdrawal by Subject|0|||
23800824|NCT02846883|66649798|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
23800825|NCT02846883|66649799|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
23800826|NCT02846883|66649800|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
23800827|NCT02846883|66649798|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
23800828|NCT02846883|66649799|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
23800829|NCT02846883|66649800|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
23800830|NCT01257581|66649801|FG000|Overall Study|Early Termination|3|||
23800831|NCT01257581|66649802|FG001|Overall Study|Early Termination|1|||
23800832|NCT01257581|66649803|FG002|Overall Study|Early Termination|2|||
23800833|NCT01257581|66649801|FG000|Overall Study|Death|2|||
23800834|NCT01257581|66649802|FG001|Overall Study|Death|2|||
23800835|NCT01257581|66649803|FG002|Overall Study|Death|4|||
23800836|NCT03166124|66649811|FG000|Treatment Period 1|Adverse Event|0|||
23800837|NCT03166124|66649812|FG001|Treatment Period 1|Adverse Event|0|||
23800838|NCT03166124|66649813|FG002|Treatment Period 1|Adverse Event|1|||
23800839|NCT03166124|66649814|FG003|Treatment Period 1|Adverse Event|0|||
23800840|NCT03166124|66649811|FG000|Wash-out Period|Withdrawal by Subject|0|||
23800841|NCT03166124|66649812|FG001|Wash-out Period|Withdrawal by Subject|1|||
23800842|NCT03166124|66649813|FG002|Wash-out Period|Withdrawal by Subject|0|||
23800843|NCT03166124|66649814|FG003|Wash-out Period|Withdrawal by Subject|1|||
23800844|NCT03166124|66649811|FG000|Wash-out Period|Adverse Event|0|||
23800845|NCT03166124|66649812|FG001|Wash-out Period|Adverse Event|1|||
23800846|NCT03166124|66649813|FG002|Wash-out Period|Adverse Event|1|||
23800847|NCT03166124|66649814|FG003|Wash-out Period|Adverse Event|0|||
23800848|NCT04798482|66649815|FG000|Overall Study|Physician Decision|1|||
23800849|NCT04798482|66649815|FG000|Overall Study|Lost eligibility|1|||
23800850|NCT03395639|66649816|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
23800851|NCT03395639|66649817|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
23800852|NCT03395639|66649818|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
23800853|NCT03395639|66649816|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
23647885|NCT02090959|66097384|FG000|Overall Study|Other than specified|2|||
23647886|NCT00081770|66097385|FG000|Overall Study|Adverse Event|130|||
23647887|NCT00081770|66097386|FG001|Overall Study|Adverse Event|98|||
23647888|NCT00081770|66097387|FG002|Overall Study|Adverse Event|136|||
23647889|NCT00081770|66097385|FG000|Overall Study|Lack of Efficacy|262|||
23647890|NCT00081770|66097386|FG001|Overall Study|Lack of Efficacy|357|||
23647891|NCT00081770|66097387|FG002|Overall Study|Lack of Efficacy|211|||
23647892|NCT00081770|66097385|FG000|Overall Study|Lost to Follow-up|45|||
23647893|NCT00081770|66097386|FG001|Overall Study|Lost to Follow-up|34|||
23647894|NCT00081770|66097387|FG002|Overall Study|Lost to Follow-up|45|||
23647895|NCT00081770|66097385|FG000|Overall Study|Protocol Violation|15|||
23647896|NCT00081770|66097386|FG001|Overall Study|Protocol Violation|10|||
23647897|NCT00081770|66097387|FG002|Overall Study|Protocol Violation|10|||
23647898|NCT00081770|66097385|FG000|Overall Study|Withdrawal by Subject|45|||
23647899|NCT00081770|66097386|FG001|Overall Study|Withdrawal by Subject|40|||
23647900|NCT00081770|66097387|FG002|Overall Study|Withdrawal by Subject|42|||
23647901|NCT00081770|66097385|FG000|Overall Study|Did not meet protocol eligibility|2|||
23647902|NCT00081770|66097386|FG001|Overall Study|Did not meet protocol eligibility|0|||
23647903|NCT00081770|66097387|FG002|Overall Study|Did not meet protocol eligibility|3|||
23647904|NCT00081770|66097385|FG000|Overall Study|Administrative|1|||
23647905|NCT00081770|66097386|FG001|Overall Study|Administrative|0|||
23647906|NCT00081770|66097387|FG002|Overall Study|Administrative|1|||
23647907|NCT00081770|66097385|FG000|Overall Study|Other|2|||
23647908|NCT00081770|66097386|FG001|Overall Study|Other|7|||
23647909|NCT00081770|66097387|FG002|Overall Study|Other|8|||
23647910|NCT00368992|66097388|FG000|Overall Study|Ineligible|5|||
23647911|NCT00368992|66097388|FG000|Overall Study|Refused treatment|3|||
23647912|NCT00368992|66097388|FG000|Overall Study|Lack of Efficacy|63|||
23647913|NCT00368992|66097388|FG000|Overall Study|Adverse Event|26|||
23647914|NCT00368992|66097388|FG000|Overall Study|Death|4|||
23647915|NCT00368992|66097388|FG000|Overall Study|Other|9|||
23647916|NCT02678247|66097394|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
23647917|NCT02678247|66097395|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
23647918|NCT02678247|66097394|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
23647919|NCT02678247|66097395|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
23647920|NCT02678247|66097394|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
23647921|NCT02678247|66097395|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
23647922|NCT02678247|66097394|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
23647923|NCT02678247|66097395|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
23647924|NCT02678247|66097394|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
23647925|NCT02678247|66097395|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
23647926|NCT02678247|66097394|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
23647927|NCT02678247|66097395|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
23647928|NCT03037931|66097396|FG000|Overall Study|Death|354|||
23647929|NCT03037931|66097397|FG001|Overall Study|Death|367|||
23647930|NCT03037931|66097396|FG000|Overall Study|Lost to Follow-up|7|||
23647931|NCT03037931|66097397|FG001|Overall Study|Lost to Follow-up|4|||
23647932|NCT03037931|66097396|FG000|Overall Study|Withdrawal by Subject|48|||
23647933|NCT03037931|66097397|FG001|Overall Study|Withdrawal by Subject|41|||
23647934|NCT00896051|66097399|FG000|Overall Study|Adverse Event|2|||
23647935|NCT00896051|66097400|FG001|Overall Study|Adverse Event|1|||
23647936|NCT00896051|66097399|FG000|Overall Study|Lost to Follow-up|3|||
23647937|NCT00896051|66097400|FG001|Overall Study|Lost to Follow-up|2|||
23647938|NCT00896051|66097399|FG000|Overall Study|Withdrawal by Subject|3|||
23647939|NCT00896051|66097400|FG001|Overall Study|Withdrawal by Subject|2|||
23647940|NCT00896051|66097399|FG000|Overall Study|Subject noncompliant|1|||
23647941|NCT00896051|66097400|FG001|Overall Study|Subject noncompliant|3|||
23647942|NCT00896051|66097399|FG000|Overall Study|Other|1|||
23647943|NCT00896051|66097400|FG001|Overall Study|Other|1|||
23647944|NCT02578862|66097404|FG000|Overall Study|Withdrawal by Subject|0|||
23360602|NCT02028507|65065803|FG002|Overall Study|Randomized But Not Treated|0|||
23360603|NCT02028507|65065804|FG003|Overall Study|Randomized But Not Treated|4|||
23360604|NCT02028507|65065801|FG000|Overall Study|Enzyme defect|0|||
23360605|NCT02028507|65065802|FG001|Overall Study|Enzyme defect|0|||
23647945|NCT02578862|66097405|FG001|Overall Study|Withdrawal by Subject|1|||
23647946|NCT02578862|66097404|FG000|Overall Study|Unplanned unilateral procedure|0|||
23647947|NCT02578862|66097405|FG001|Overall Study|Unplanned unilateral procedure|1|||
23647948|NCT03527173|66097406|FG000|Overall Study|Lost to Follow-up|4|||
23647949|NCT03527173|66097407|FG001|Overall Study|Lost to Follow-up|2|||
23647950|NCT03527173|66097406|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
23647951|NCT03527173|66097407|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
23647952|NCT03527173|66097406|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23647953|NCT03527173|66097407|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
23647954|NCT03527173|66097406|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23647955|NCT03527173|66097407|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23647956|NCT02483585|66097409|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
23647957|NCT02483585|66097410|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
23647958|NCT02483585|66097409|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23647959|NCT02483585|66097410|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23647960|NCT02483585|66097409|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
23647961|NCT02483585|66097410|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
23647962|NCT02483585|66097409|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
23647963|NCT02483585|66097410|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
23647964|NCT02483585|66097409|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
23647965|NCT02483585|66097410|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
23647966|NCT02483585|66097409|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
23647967|NCT02483585|66097410|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
23647968|NCT02483585|66097409|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
23647969|NCT02483585|66097410|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
23647970|NCT02668185|66097411|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
23647971|NCT02668185|66097412|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
23647972|NCT02668185|66097411|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
23647973|NCT02668185|66097412|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
23647974|NCT02668185|66097411|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
23647975|NCT02668185|66097412|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
23647976|NCT02668185|66097411|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
23647977|NCT02668185|66097412|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
23647978|NCT02634346|66097413|FG000|Overall Study|Withdrawal by Subject|8|||
23647979|NCT02634346|66097414|FG001|Overall Study|Withdrawal by Subject|9|||
23647980|NCT02634346|66097415|FG002|Overall Study|Withdrawal by Subject|8|||
23647981|NCT02634346|66097413|FG000|Overall Study|Adverse Event|2|||
23647982|NCT02634346|66097414|FG001|Overall Study|Adverse Event|2|||
23647983|NCT02634346|66097415|FG002|Overall Study|Adverse Event|7|||
23647984|NCT02634346|66097413|FG000|Overall Study|Lack of Efficacy|1|||
23647985|NCT02634346|66097414|FG001|Overall Study|Lack of Efficacy|2|||
23647986|NCT02634346|66097415|FG002|Overall Study|Lack of Efficacy|8|||
23647987|NCT02634346|66097413|FG000|Overall Study|Lost to Follow-up|1|||
23647988|NCT02634346|66097414|FG001|Overall Study|Lost to Follow-up|0|||
23647989|NCT02634346|66097415|FG002|Overall Study|Lost to Follow-up|0|||
23647990|NCT02634346|66097413|FG000|Overall Study|Protocol Violation|0|||
23647991|NCT02634346|66097414|FG001|Overall Study|Protocol Violation|1|||
23647992|NCT02634346|66097415|FG002|Overall Study|Protocol Violation|0|||
23647993|NCT01828073|66097417|FG000|Overall Study|Lost to Follow-up|1|||
23647994|NCT01828073|66097418|FG001|Overall Study|Lost to Follow-up|2|||
23647995|NCT00423930|66097421|FG000|Overall Study|Withdrawal by Subject|2|||
23647996|NCT01689337|66097422|FG000|Overall Study|Study Discontinuation|1|||
23647997|NCT01116882|66097425|FG000|30-day|Lost to Follow-up|50|||
23647998|NCT01116882|66097426|FG001|30-day|Lost to Follow-up|21|||
23647999|NCT01116882|66097425|FG000|30-day|Withdrawal by Subject|2|||
23648000|NCT01116882|66097426|FG001|30-day|Withdrawal by Subject|4|||
23648001|NCT01116882|66097425|FG000|30-day|Other Reasons|16|||
23648002|NCT01116882|66097426|FG001|30-day|Other Reasons|6|||
23800854|NCT03395639|66649817|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
23800855|NCT03395639|66649818|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
23360606|NCT02028507|65065803|FG002|Overall Study|Enzyme defect|0|||
23478645|NCT01009840|65494583|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
23478646|NCT00362180|65494586|FG000|Treated Period|Withdrawal by Subject|1|||
23478647|NCT00362180|65494587|FG001|Treated Period|Withdrawal by Subject|0|||
23478648|NCT00362180|65494588|FG002|Treated Period|Withdrawal by Subject|0|||
23648003|NCT01116882|66097425|FG000|12-month|Lost to Follow-up|111|||
23648004|NCT01116882|66097426|FG001|12-month|Lost to Follow-up|42|||
23648005|NCT01116882|66097425|FG000|12-month|Other Reasons|151|||
23648006|NCT01116882|66097426|FG001|12-month|Other Reasons|49|||
23648007|NCT01116882|66097425|FG000|12-month|Withdrawal by Subject|5|||
23648008|NCT01116882|66097426|FG001|12-month|Withdrawal by Subject|8|||
23648009|NCT00738582|66097429|FG000|Combination Therapy|Completed Combination Therapy|1|||
23648010|NCT00738582|66097430|FG001|Combination Therapy|Completed Combination Therapy|0|||
23648011|NCT00738582|66097429|FG000|Combination Therapy|Physician Decision|1|||
23648012|NCT00738582|66097430|FG001|Combination Therapy|Physician Decision|0|||
23478649|NCT00362180|65494589|FG003|Treated Period|Withdrawal by Subject|0|||
23648013|NCT00738582|66097429|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
23648014|NCT00738582|66097430|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
23648015|NCT00738582|66097429|FG000|Combination Therapy|Other|5|||
23648016|NCT00738582|66097430|FG001|Combination Therapy|Other|0|||
23648017|NCT00738582|66097429|FG000|Combination Therapy|Adverse Event|16|||
23648018|NCT00738582|66097430|FG001|Combination Therapy|Adverse Event|0|||
23648019|NCT00738582|66097429|FG000|Combination Therapy|Progressive Disease|9|||
23648020|NCT00738582|66097430|FG001|Combination Therapy|Progressive Disease|0|||
23648021|NCT00738582|66097429|FG000|Maintenance Therapy|Other|0|||
23648022|NCT00738582|66097430|FG001|Maintenance Therapy|Other|2|||
23648023|NCT00738582|66097429|FG000|Maintenance Therapy|Adverse Event|0|||
23648024|NCT00738582|66097430|FG001|Maintenance Therapy|Adverse Event|6|||
23648025|NCT00738582|66097429|FG000|Maintenance Therapy|Progressive Disease|0|||
23648026|NCT00738582|66097430|FG001|Maintenance Therapy|Progressive Disease|47|||
23648027|NCT00738582|66097429|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
23648028|NCT00738582|66097430|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
23648029|NCT00784693|66097435|FG000|Overall Study|Lost to Follow-up|0|||
23648030|NCT00784693|66097436|FG001|Overall Study|Lost to Follow-up|1|||
23648031|NCT00784693|66097435|FG000|Overall Study|Lack of Efficacy|1|||
23648032|NCT00784693|66097436|FG001|Overall Study|Lack of Efficacy|1|||
23648033|NCT00784693|66097435|FG000|Overall Study|Withdrawal by Subject|0|||
23648034|NCT00784693|66097436|FG001|Overall Study|Withdrawal by Subject|4|||
23648035|NCT00784693|66097435|FG000|Overall Study|Randomized but not Treated|1|||
23648036|NCT00784693|66097436|FG001|Overall Study|Randomized but not Treated|0|||
23648037|NCT00784693|66097435|FG000|Overall Study|Other|1|||
23648038|NCT00784693|66097436|FG001|Overall Study|Other|0|||
23648039|NCT01047293|66097440|FG000|Overall Study|DLT criteria not fulfilled|1|||
23648040|NCT01047293|66097441|FG001|Overall Study|DLT criteria not fulfilled|1|||
23648041|NCT01047293|66097442|FG002|Overall Study|DLT criteria not fulfilled|0|||
23648042|NCT01047293|66097443|FG003|Overall Study|DLT criteria not fulfilled|0|||
23648043|NCT02240693|66097444|FG000|Overall Study|Adverse Event|0|||
23648044|NCT02240693|66097445|FG001|Overall Study|Adverse Event|0|||
23648045|NCT02240693|66097446|FG002|Overall Study|Adverse Event|0|||
23648046|NCT02240693|66097447|FG003|Overall Study|Adverse Event|0|||
23648047|NCT02240693|66097448|FG004|Overall Study|Adverse Event|1|||
23648048|NCT02240693|66097444|FG000|Overall Study|Withdrawal by Subject|0|||
23648049|NCT02240693|66097445|FG001|Overall Study|Withdrawal by Subject|0|||
23648050|NCT02240693|66097446|FG002|Overall Study|Withdrawal by Subject|2|||
23648051|NCT02240693|66097447|FG003|Overall Study|Withdrawal by Subject|1|||
23648052|NCT02240693|66097448|FG004|Overall Study|Withdrawal by Subject|0|||
23648053|NCT02240693|66097444|FG000|Overall Study|Other than specified|0|||
23648054|NCT02240693|66097445|FG001|Overall Study|Other than specified|0|||
23648055|NCT02240693|66097446|FG002|Overall Study|Other than specified|2|||
23648056|NCT02240693|66097447|FG003|Overall Study|Other than specified|0|||
23648057|NCT02240693|66097448|FG004|Overall Study|Other than specified|0|||
23648058|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
23648059|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
23648060|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
23648061|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
23648062|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
23648063|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
23648064|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
23648065|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
23648066|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
23648067|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
23648068|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
23648069|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
23648070|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
23648071|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
23648072|NCT00757588|66097449|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
23648073|NCT00757588|66097450|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
23648074|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
23648075|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
23648076|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
23648077|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
23648078|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
23648079|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
23597682|NCT01083316|65919226|FG000|Overall Study|Withdrawal by Subject|1|||
23597683|NCT01227265|65919227|FG000|Overall Study|Did Not Receive Treatment|1|||
23597684|NCT01227265|65919228|FG001|Overall Study|Did Not Receive Treatment|2|||
23597685|NCT01227265|65919229|FG002|Overall Study|Did Not Receive Treatment|0|||
23597686|NCT01227265|65919227|FG000|Overall Study|Administrative|1|||
23597687|NCT01227265|65919228|FG001|Overall Study|Administrative|0|||
23597688|NCT01227265|65919229|FG002|Overall Study|Administrative|2|||
23597689|NCT01227265|65919227|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23597690|NCT01227265|65919228|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23648080|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
23648081|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
23648082|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
23648083|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
23648084|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
23648085|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
23648086|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
23648087|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
23648088|NCT00757588|66097449|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
23648089|NCT00757588|66097450|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
23648090|NCT01801735|66097451|FG000|Overall Study|Adverse Event|79|||
23648091|NCT01801735|66097451|FG000|Overall Study|Lack of Efficacy|28|||
23648092|NCT01801735|66097451|FG000|Overall Study|Withdrawal by Subject|27|||
23648093|NCT01801735|66097451|FG000|Overall Study|Protocol Violation|25|||
23648094|NCT01801735|66097451|FG000|Overall Study|Lost to Follow-up|15|||
23648095|NCT01801735|66097451|FG000|Overall Study|Non-compliance with Trial Drug|13|||
23648096|NCT01801735|66097451|FG000|Overall Study|Physician Decision|3|||
23648097|NCT01801735|66097451|FG000|Overall Study|Death|1|||
23648098|NCT01801735|66097451|FG000|Overall Study|Other, including site closure|19|||
23648099|NCT02875977|66097452|FG000|Overall Study|Lost to Follow-up|42|||
23648100|NCT02875977|66097453|FG001|Overall Study|Lost to Follow-up|29|||
23648101|NCT03945825|66097454|FG000|Overall Study|Enrolled but treatment not administered|0|||
23648102|NCT03945825|66097455|FG001|Overall Study|Enrolled but treatment not administered|0|||
23648103|NCT03945825|66097456|FG002|Overall Study|Enrolled but treatment not administered|0|||
23648104|NCT03945825|66097457|FG003|Overall Study|Enrolled but treatment not administered|0|||
23648105|NCT03945825|66097458|FG004|Overall Study|Enrolled but treatment not administered|1|||
23648106|NCT03945825|66097459|FG005|Overall Study|Enrolled but treatment not administered|0|||
23648107|NCT03945825|66097454|FG000|Overall Study|Lost to Follow-up|1|||
23648108|NCT03945825|66097455|FG001|Overall Study|Lost to Follow-up|5|||
23648109|NCT03945825|66097456|FG002|Overall Study|Lost to Follow-up|0|||
23648110|NCT03945825|66097457|FG003|Overall Study|Lost to Follow-up|1|||
23648111|NCT03945825|66097458|FG004|Overall Study|Lost to Follow-up|2|||
23648112|NCT03945825|66097459|FG005|Overall Study|Lost to Follow-up|2|||
23648113|NCT03945825|66097454|FG000|Overall Study|Withdrawal by Subject|1|||
23648114|NCT03945825|66097455|FG001|Overall Study|Withdrawal by Subject|0|||
23648115|NCT03945825|66097456|FG002|Overall Study|Withdrawal by Subject|1|||
23648116|NCT03945825|66097457|FG003|Overall Study|Withdrawal by Subject|1|||
23648117|NCT03945825|66097458|FG004|Overall Study|Withdrawal by Subject|0|||
23648118|NCT03945825|66097459|FG005|Overall Study|Withdrawal by Subject|1|||
23648119|NCT02354508|66097462|FG000|Period 1: Core Phase|Adverse Event|1|||
23648120|NCT02354508|66097463|FG001|Period 1: Core Phase|Adverse Event|1|||
23648121|NCT02354508|66097464|FG002|Period 1: Core Phase|Adverse Event|2|||
23648122|NCT02354508|66097462|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
23648123|NCT02354508|66097463|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
23648124|NCT02354508|66097464|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
23648125|NCT02354508|66097462|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
23648126|NCT02354508|66097463|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
23648127|NCT02354508|66097464|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
23648128|NCT02354508|66097462|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
23648129|NCT02354508|66097463|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
23648130|NCT02354508|66097464|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
23648131|NCT02354508|66097462|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
23648132|NCT02354508|66097463|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
23648133|NCT02354508|66097464|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
23648134|NCT02354508|66097462|FG000|Period 2: Extension Phase|Physician Decision|5|||
23648135|NCT02354508|66097463|FG001|Period 2: Extension Phase|Physician Decision|0|||
23648136|NCT02354508|66097464|FG002|Period 2: Extension Phase|Physician Decision|1|||
23648137|NCT02354508|66097462|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
23648138|NCT02354508|66097463|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
23648139|NCT02354508|66097464|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
23648140|NCT02354508|66097462|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
23648141|NCT02354508|66097463|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
23648142|NCT02354508|66097464|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
23648143|NCT02354508|66097462|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
23648144|NCT02354508|66097463|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
23648145|NCT02354508|66097464|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
23648146|NCT00448279|66097465|FG000|Overall Study|Lost to Follow-up|2|||
23648147|NCT00448279|66097466|FG001|Overall Study|Lost to Follow-up|2|||
23648148|NCT00448279|66097465|FG000|Overall Study|Adverse Event|1|||
23648149|NCT00448279|66097466|FG001|Overall Study|Adverse Event|1|||
23648150|NCT00448279|66097465|FG000|Overall Study|Disease progression|16|||
23648151|NCT00448279|66097466|FG001|Overall Study|Disease progression|18|||
23648152|NCT00448279|66097465|FG000|Overall Study|Withdrawal by Subject|4|||
23648153|NCT00448279|66097466|FG001|Overall Study|Withdrawal by Subject|3|||
23648154|NCT00448279|66097465|FG000|Overall Study|Other|6|||
23648155|NCT00448279|66097466|FG001|Overall Study|Other|4|||
23648156|NCT00448279|66097465|FG000|Overall Study|Protocol Violation|0|||
23648157|NCT00448279|66097466|FG001|Overall Study|Protocol Violation|1|||
23648158|NCT03929757|66097467|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
23648159|NCT03929757|66097468|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
23648160|NCT03929757|66097469|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
23648161|NCT03929757|66097467|FG000|Main Study: Up to Day 365|Other|1|||
23648162|NCT03929757|66097468|FG001|Main Study: Up to Day 365|Other|0|||
23648163|NCT03929757|66097469|FG002|Main Study: Up to Day 365|Other|0|||
23648164|NCT03929757|66097467|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
23648165|NCT03929757|66097468|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
23648166|NCT03929757|66097469|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
23648167|NCT00824161|66097472|FG000|Overall Study|Withdrawal by Subject|1|||
23648168|NCT00824161|66097472|FG000|Overall Study|Screen Failure|1|||
23648169|NCT00585195|66097473|FG000|Overall Study|Adverse Event|0|||
23648170|NCT00585195|66097474|FG001|Overall Study|Adverse Event|0|||
23648171|NCT00585195|66097475|FG002|Overall Study|Adverse Event|0|||
23648172|NCT00585195|66097476|FG003|Overall Study|Adverse Event|0|||
23648173|NCT00585195|66097477|FG004|Overall Study|Adverse Event|2|||
23648174|NCT00585195|66097478|FG005|Overall Study|Adverse Event|1|||
23648175|NCT00585195|66097479|FG006|Overall Study|Adverse Event|0|||
23648176|NCT00585195|66097480|FG007|Overall Study|Adverse Event|1|||
23648177|NCT00585195|66097481|FG008|Overall Study|Adverse Event|0|||
23648178|NCT00585195|66097482|FG009|Overall Study|Adverse Event|0|||
23648179|NCT00585195|66097483|FG010|Overall Study|Adverse Event|3|||
23648180|NCT00585195|66097484|FG011|Overall Study|Adverse Event|0|||
23648181|NCT00585195|66097485|FG012|Overall Study|Adverse Event|8|||
23648182|NCT00585195|66097486|FG013|Overall Study|Adverse Event|6|||
23648183|NCT00585195|66097487|FG014|Overall Study|Adverse Event|4|||
23648184|NCT00585195|66097488|FG015|Overall Study|Adverse Event|1|||
23648185|NCT00585195|66097489|FG016|Overall Study|Adverse Event|14|||
23648186|NCT00585195|66097490|FG017|Overall Study|Adverse Event|9|||
23597691|NCT01227265|65919229|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
23597692|NCT01227265|65919227|FG000|Overall Study|Protocol Violation|2|||
23597693|NCT01227265|65919228|FG001|Overall Study|Protocol Violation|1|||
23597694|NCT01227265|65919229|FG002|Overall Study|Protocol Violation|0|||
23597695|NCT01227265|65919227|FG000|Overall Study|Withdrawal by Subject|7|||
23597696|NCT01227265|65919228|FG001|Overall Study|Withdrawal by Subject|7|||
23597697|NCT01227265|65919229|FG002|Overall Study|Withdrawal by Subject|3|||
23597698|NCT01227265|65919227|FG000|Overall Study|Lost to Follow-up|2|||
23597699|NCT01227265|65919228|FG001|Overall Study|Lost to Follow-up|0|||
23597700|NCT01227265|65919229|FG002|Overall Study|Lost to Follow-up|3|||
23597701|NCT01227265|65919227|FG000|Overall Study|Adverse Event|6|||
23597702|NCT01227265|65919228|FG001|Overall Study|Adverse Event|10|||
23597703|NCT01227265|65919229|FG002|Overall Study|Adverse Event|5|||
23597704|NCT02754596|65919232|FG000|Overall Study|Withdrawal by Subject|3|||
23597705|NCT02754596|65919233|FG001|Overall Study|Withdrawal by Subject|4|||
23800856|NCT03395639|66649816|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
23800857|NCT03395639|66649817|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
23800858|NCT03395639|66649818|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
23800859|NCT03395639|66649816|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
23800860|NCT03395639|66649817|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
23800861|NCT03395639|66649818|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
23800862|NCT03395639|66649816|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
23800863|NCT03395639|66649817|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
23800864|NCT03395639|66649818|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
23800865|NCT01909934|66649827|FG000|Overall Study|Ongoing|23|||
23800866|NCT01909934|66649827|FG000|Overall Study|Withdrawal by Subject|3|||
23800867|NCT01909934|66649827|FG000|Overall Study|Lost to Follow-up|1|||
23800868|NCT01909934|66649827|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23800869|NCT01909934|66649827|FG000|Overall Study|Death|22|||
23800870|NCT02985398|66649828|FG000|Overall Study|Adverse Event|1|||
23648187|NCT00585195|66097491|FG018|Overall Study|Adverse Event|2|||
23648188|NCT00585195|66097492|FG019|Overall Study|Adverse Event|3|||
23648189|NCT00585195|66097493|FG020|Overall Study|Adverse Event|1|||
23800871|NCT02985398|66649828|FG000|Overall Study|Lost to Follow-up|4|||
23800872|NCT02985398|66649828|FG000|Overall Study|Withdrawal by Subject|8|||
23648190|NCT00585195|66097473|FG000|Overall Study|Progressive Disease|2|||
23648191|NCT00585195|66097474|FG001|Overall Study|Progressive Disease|2|||
23648192|NCT00585195|66097475|FG002|Overall Study|Progressive Disease|5|||
23648193|NCT00585195|66097476|FG003|Overall Study|Progressive Disease|4|||
23648194|NCT00585195|66097477|FG004|Overall Study|Progressive Disease|6|||
23648195|NCT00585195|66097478|FG005|Overall Study|Progressive Disease|4|||
23648196|NCT00585195|66097479|FG006|Overall Study|Progressive Disease|6|||
23648197|NCT00585195|66097480|FG007|Overall Study|Progressive Disease|3|||
23648198|NCT00585195|66097481|FG008|Overall Study|Progressive Disease|0|||
23648199|NCT00585195|66097482|FG009|Overall Study|Progressive Disease|5|||
23648200|NCT00585195|66097483|FG010|Overall Study|Progressive Disease|2|||
23648201|NCT00585195|66097484|FG011|Overall Study|Progressive Disease|25|||
23648202|NCT00585195|66097485|FG012|Overall Study|Progressive Disease|29|||
23648203|NCT00585195|66097486|FG013|Overall Study|Progressive Disease|26|||
23648204|NCT00585195|66097487|FG014|Overall Study|Progressive Disease|21|||
23648205|NCT00585195|66097488|FG015|Overall Study|Progressive Disease|12|||
23648206|NCT00585195|66097489|FG016|Overall Study|Progressive Disease|94|||
23648207|NCT00585195|66097490|FG017|Overall Study|Progressive Disease|42|||
23648208|NCT00585195|66097491|FG018|Overall Study|Progressive Disease|4|||
23648209|NCT00585195|66097492|FG019|Overall Study|Progressive Disease|9|||
23648210|NCT00585195|66097493|FG020|Overall Study|Progressive Disease|8|||
23648211|NCT00585195|66097473|FG000|Overall Study|Withdrawal by Subject|1|||
23648212|NCT00585195|66097474|FG001|Overall Study|Withdrawal by Subject|1|||
23648213|NCT00585195|66097475|FG002|Overall Study|Withdrawal by Subject|2|||
23648214|NCT00585195|66097476|FG003|Overall Study|Withdrawal by Subject|2|||
23648215|NCT00585195|66097477|FG004|Overall Study|Withdrawal by Subject|0|||
23648216|NCT00585195|66097478|FG005|Overall Study|Withdrawal by Subject|0|||
23648217|NCT00585195|66097479|FG006|Overall Study|Withdrawal by Subject|0|||
23648218|NCT00585195|66097480|FG007|Overall Study|Withdrawal by Subject|1|||
23648219|NCT00585195|66097481|FG008|Overall Study|Withdrawal by Subject|0|||
23648220|NCT00585195|66097482|FG009|Overall Study|Withdrawal by Subject|0|||
23648221|NCT00585195|66097483|FG010|Overall Study|Withdrawal by Subject|3|||
23648222|NCT00585195|66097484|FG011|Overall Study|Withdrawal by Subject|8|||
23648223|NCT00585195|66097485|FG012|Overall Study|Withdrawal by Subject|15|||
23648224|NCT00585195|66097486|FG013|Overall Study|Withdrawal by Subject|0|||
23648225|NCT00585195|66097487|FG014|Overall Study|Withdrawal by Subject|3|||
23648226|NCT00585195|66097488|FG015|Overall Study|Withdrawal by Subject|0|||
23648227|NCT00585195|66097489|FG016|Overall Study|Withdrawal by Subject|7|||
23648228|NCT00585195|66097490|FG017|Overall Study|Withdrawal by Subject|1|||
23648229|NCT00585195|66097491|FG018|Overall Study|Withdrawal by Subject|2|||
23648230|NCT00585195|66097492|FG019|Overall Study|Withdrawal by Subject|2|||
23648231|NCT00585195|66097493|FG020|Overall Study|Withdrawal by Subject|0|||
23648232|NCT00585195|66097473|FG000|Overall Study|Other|0|||
23648233|NCT00585195|66097474|FG001|Overall Study|Other|1|||
23648234|NCT00585195|66097475|FG002|Overall Study|Other|1|||
23648235|NCT00585195|66097476|FG003|Overall Study|Other|1|||
23648236|NCT00585195|66097477|FG004|Overall Study|Other|0|||
23648237|NCT00585195|66097478|FG005|Overall Study|Other|1|||
23648238|NCT00585195|66097479|FG006|Overall Study|Other|0|||
23648239|NCT00585195|66097480|FG007|Overall Study|Other|0|||
23648240|NCT00585195|66097481|FG008|Overall Study|Other|2|||
23648241|NCT00585195|66097482|FG009|Overall Study|Other|1|||
23648242|NCT00585195|66097483|FG010|Overall Study|Other|0|||
23648243|NCT00585195|66097484|FG011|Overall Study|Other|19|||
23648244|NCT00585195|66097485|FG012|Overall Study|Other|24|||
23648245|NCT00585195|66097486|FG013|Overall Study|Other|7|||
23597706|NCT02754596|65919234|FG002|Overall Study|Withdrawal by Subject|0|||
23597707|NCT02754596|65919232|FG000|Overall Study|Physician Decision|1|||
23597708|NCT02754596|65919233|FG001|Overall Study|Physician Decision|1|||
23597709|NCT02754596|65919234|FG002|Overall Study|Physician Decision|1|||
23597710|NCT02754596|65919232|FG000|Overall Study|Lost to Follow-up|1|||
23597711|NCT02754596|65919233|FG001|Overall Study|Lost to Follow-up|1|||
23597712|NCT02754596|65919234|FG002|Overall Study|Lost to Follow-up|2|||
23597713|NCT02754596|65919232|FG000|Overall Study|Death|0|||
23597714|NCT02754596|65919233|FG001|Overall Study|Death|2|||
23597715|NCT02754596|65919234|FG002|Overall Study|Death|0|||
23597716|NCT02754596|65919232|FG000|Overall Study|Adverse Event|1|||
23597717|NCT02754596|65919233|FG001|Overall Study|Adverse Event|0|||
23597718|NCT02754596|65919234|FG002|Overall Study|Adverse Event|1|||
23597719|NCT02754596|65919232|FG000|Overall Study|Other|1|||
23597720|NCT02754596|65919233|FG001|Overall Study|Other|0|||
23597721|NCT02754596|65919234|FG002|Overall Study|Other|0|||
23597722|NCT00557492|65919236|FG000|Overall Study|Change in health insurance|1|||
23597723|NCT03664960|65919237|FG000|Overall Study|Adverse Event|0|||
23648246|NCT00585195|66097487|FG014|Overall Study|Other|11|||
23648247|NCT00585195|66097488|FG015|Overall Study|Other|3|||
23597724|NCT03664960|65919238|FG001|Overall Study|Adverse Event|3|||
23597725|NCT03664960|65919237|FG000|Overall Study|Lost to Follow-up|3|||
23597726|NCT03664960|65919238|FG001|Overall Study|Lost to Follow-up|2|||
23648248|NCT00585195|66097489|FG016|Overall Study|Other|28|||
23648249|NCT00585195|66097490|FG017|Overall Study|Other|12|||
23648250|NCT00585195|66097491|FG018|Overall Study|Other|10|||
23648251|NCT00585195|66097492|FG019|Overall Study|Other|4|||
23648252|NCT00585195|66097493|FG020|Overall Study|Other|2|||
23648253|NCT00585195|66097473|FG000|Overall Study|Randomized not treated|0|||
23648254|NCT00585195|66097474|FG001|Overall Study|Randomized not treated|0|||
23648255|NCT00585195|66097475|FG002|Overall Study|Randomized not treated|1|||
23648256|NCT00585195|66097476|FG003|Overall Study|Randomized not treated|0|||
23478650|NCT00362180|65494590|FG004|Treated Period|Withdrawal by Subject|0|||
23478651|NCT00362180|65494591|FG005|Treated Period|Withdrawal by Subject|0|||
23478652|NCT00362180|65494592|FG006|Treated Period|Withdrawal by Subject|0|||
23478653|NCT00362180|65494593|FG007|Treated Period|Withdrawal by Subject|0|||
23478654|NCT00362180|65494594|FG008|Treated Period|Withdrawal by Subject|0|||
23478655|NCT00362180|65494586|FG000|Treated Period|Adverse Event|0|||
23478656|NCT00362180|65494587|FG001|Treated Period|Adverse Event|0|||
23478657|NCT00362180|65494588|FG002|Treated Period|Adverse Event|0|||
23478658|NCT00362180|65494589|FG003|Treated Period|Adverse Event|0|||
23478659|NCT00362180|65494590|FG004|Treated Period|Adverse Event|0|||
23478660|NCT00362180|65494591|FG005|Treated Period|Adverse Event|1|||
23478661|NCT00362180|65494592|FG006|Treated Period|Adverse Event|0|||
23478662|NCT00362180|65494593|FG007|Treated Period|Adverse Event|1|||
23478663|NCT00362180|65494594|FG008|Treated Period|Adverse Event|0|||
23478664|NCT00492063|65494595|FG000|Overall Study|Death|0|||
23478665|NCT00492063|65494596|FG001|Overall Study|Death|0|||
23478666|NCT00492063|65494597|FG002|Overall Study|Death|1|||
23478667|NCT00492063|65494598|FG003|Overall Study|Death|2|||
23478668|NCT00492063|65494595|FG000|Overall Study|Withdrawal by Subject|4|||
23478669|NCT00492063|65494596|FG001|Overall Study|Withdrawal by Subject|3|||
23478670|NCT00492063|65494597|FG002|Overall Study|Withdrawal by Subject|5|||
23478671|NCT00492063|65494598|FG003|Overall Study|Withdrawal by Subject|4|||
23478672|NCT00492063|65494595|FG000|Overall Study|Lost to Follow-up|6|||
23478673|NCT00492063|65494596|FG001|Overall Study|Lost to Follow-up|11|||
23478674|NCT00492063|65494597|FG002|Overall Study|Lost to Follow-up|5|||
23478675|NCT00492063|65494598|FG003|Overall Study|Lost to Follow-up|3|||
23478676|NCT00492063|65494595|FG000|Overall Study|Protocol Violation|0|||
23478677|NCT00492063|65494596|FG001|Overall Study|Protocol Violation|0|||
23478678|NCT00492063|65494597|FG002|Overall Study|Protocol Violation|0|||
23478679|NCT00492063|65494598|FG003|Overall Study|Protocol Violation|1|||
23478680|NCT00412373|65494599|FG000|Overall Study|Adverse Event|8|||
23478681|NCT00412373|65494600|FG001|Overall Study|Adverse Event|13|||
23478682|NCT00412373|65494599|FG000|Overall Study|Lack of Efficacy|16|||
23478683|NCT00412373|65494600|FG001|Overall Study|Lack of Efficacy|22|||
23478684|NCT00412373|65494599|FG000|Overall Study|Lost to Follow-up|7|||
23478685|NCT00412373|65494600|FG001|Overall Study|Lost to Follow-up|13|||
23478686|NCT00412373|65494599|FG000|Overall Study|Withdrawal by Subject|8|||
23478687|NCT00412373|65494600|FG001|Overall Study|Withdrawal by Subject|27|||
23478688|NCT00412373|65494599|FG000|Overall Study|Other|2|||
23478689|NCT00412373|65494600|FG001|Overall Study|Other|2|||
23478690|NCT01806662|65494604|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
23478691|NCT01806662|65494605|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
23478692|NCT01806662|65494604|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
23478693|NCT01806662|65494605|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
23478694|NCT01806662|65494604|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
23478695|NCT01806662|65494605|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
23478696|NCT01806662|65494604|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
23478697|NCT01806662|65494605|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
23478698|NCT01129583|65494608|FG000|Overall Study|Death|1|||
23478699|NCT01129583|65494609|FG001|Overall Study|Death|0|||
23478700|NCT01129583|65494608|FG000|Overall Study|Lost to Follow-up|1|||
23478701|NCT01129583|65494609|FG001|Overall Study|Lost to Follow-up|1|||
23648257|NCT00585195|66097477|FG004|Overall Study|Randomized not treated|1|||
23648258|NCT00585195|66097478|FG005|Overall Study|Randomized not treated|0|||
23648259|NCT00585195|66097479|FG006|Overall Study|Randomized not treated|1|||
23648260|NCT00585195|66097480|FG007|Overall Study|Randomized not treated|0|||
23648261|NCT00585195|66097481|FG008|Overall Study|Randomized not treated|0|||
23648262|NCT00585195|66097482|FG009|Overall Study|Randomized not treated|0|||
23648263|NCT00585195|66097483|FG010|Overall Study|Randomized not treated|2|||
23648264|NCT00585195|66097484|FG011|Overall Study|Randomized not treated|0|||
23648265|NCT00585195|66097485|FG012|Overall Study|Randomized not treated|0|||
23648266|NCT00585195|66097486|FG013|Overall Study|Randomized not treated|0|||
23648267|NCT00585195|66097487|FG014|Overall Study|Randomized not treated|0|||
23648268|NCT00585195|66097488|FG015|Overall Study|Randomized not treated|1|||
23648269|NCT00585195|66097489|FG016|Overall Study|Randomized not treated|0|||
23648270|NCT00585195|66097490|FG017|Overall Study|Randomized not treated|1|||
23648271|NCT00585195|66097491|FG018|Overall Study|Randomized not treated|3|||
23648272|NCT00585195|66097492|FG019|Overall Study|Randomized not treated|0|||
23648273|NCT00585195|66097493|FG020|Overall Study|Randomized not treated|2|||
23648274|NCT00585195|66097473|FG000|Overall Study|Death|0|||
23648275|NCT00585195|66097474|FG001|Overall Study|Death|0|||
23648276|NCT00585195|66097475|FG002|Overall Study|Death|0|||
23648277|NCT00585195|66097476|FG003|Overall Study|Death|0|||
23648278|NCT00585195|66097477|FG004|Overall Study|Death|0|||
23648279|NCT00585195|66097478|FG005|Overall Study|Death|0|||
23648280|NCT00585195|66097479|FG006|Overall Study|Death|0|||
23648281|NCT00585195|66097480|FG007|Overall Study|Death|0|||
23648282|NCT00585195|66097481|FG008|Overall Study|Death|1|||
23648283|NCT00585195|66097482|FG009|Overall Study|Death|0|||
23648284|NCT00585195|66097483|FG010|Overall Study|Death|1|||
23648285|NCT00585195|66097484|FG011|Overall Study|Death|1|||
23648286|NCT00585195|66097485|FG012|Overall Study|Death|7|||
23648287|NCT00585195|66097486|FG013|Overall Study|Death|2|||
23648288|NCT00585195|66097487|FG014|Overall Study|Death|8|||
23648289|NCT00585195|66097488|FG015|Overall Study|Death|2|||
23648290|NCT00585195|66097489|FG016|Overall Study|Death|11|||
23648291|NCT00585195|66097490|FG017|Overall Study|Death|0|||
23648292|NCT00585195|66097491|FG018|Overall Study|Death|0|||
23648293|NCT00585195|66097492|FG019|Overall Study|Death|0|||
23648294|NCT00585195|66097493|FG020|Overall Study|Death|1|||
23648295|NCT00585195|66097473|FG000|Overall Study|Lost to Follow-up|0|||
23648296|NCT00585195|66097474|FG001|Overall Study|Lost to Follow-up|0|||
23648297|NCT00585195|66097475|FG002|Overall Study|Lost to Follow-up|0|||
23648298|NCT00585195|66097476|FG003|Overall Study|Lost to Follow-up|0|||
23648299|NCT00585195|66097477|FG004|Overall Study|Lost to Follow-up|0|||
23648300|NCT00585195|66097478|FG005|Overall Study|Lost to Follow-up|0|||
23648301|NCT00585195|66097479|FG006|Overall Study|Lost to Follow-up|0|||
23648302|NCT00585195|66097480|FG007|Overall Study|Lost to Follow-up|0|||
23648303|NCT00585195|66097481|FG008|Overall Study|Lost to Follow-up|0|||
23648304|NCT00585195|66097482|FG009|Overall Study|Lost to Follow-up|0|||
23648305|NCT00585195|66097483|FG010|Overall Study|Lost to Follow-up|0|||
23648306|NCT00585195|66097484|FG011|Overall Study|Lost to Follow-up|0|||
23648307|NCT00585195|66097485|FG012|Overall Study|Lost to Follow-up|1|||
23648308|NCT00585195|66097486|FG013|Overall Study|Lost to Follow-up|0|||
23648309|NCT00585195|66097487|FG014|Overall Study|Lost to Follow-up|0|||
23648310|NCT00585195|66097488|FG015|Overall Study|Lost to Follow-up|0|||
23648311|NCT00585195|66097489|FG016|Overall Study|Lost to Follow-up|0|||
23648312|NCT00585195|66097490|FG017|Overall Study|Lost to Follow-up|2|||
23648313|NCT00585195|66097491|FG018|Overall Study|Lost to Follow-up|0|||
23648314|NCT00585195|66097492|FG019|Overall Study|Lost to Follow-up|0|||
23648315|NCT00585195|66097493|FG020|Overall Study|Lost to Follow-up|0|||
23648316|NCT00585195|66097473|FG000|Overall Study|Site Terminated by Sponsor|0|||
23648317|NCT00585195|66097474|FG001|Overall Study|Site Terminated by Sponsor|0|||
23648318|NCT00585195|66097475|FG002|Overall Study|Site Terminated by Sponsor|0|||
23648319|NCT00585195|66097476|FG003|Overall Study|Site Terminated by Sponsor|0|||
23648320|NCT00585195|66097477|FG004|Overall Study|Site Terminated by Sponsor|0|||
23648321|NCT00585195|66097478|FG005|Overall Study|Site Terminated by Sponsor|0|||
23648322|NCT00585195|66097479|FG006|Overall Study|Site Terminated by Sponsor|0|||
23648323|NCT00585195|66097480|FG007|Overall Study|Site Terminated by Sponsor|0|||
23648324|NCT00585195|66097481|FG008|Overall Study|Site Terminated by Sponsor|0|||
23648325|NCT00585195|66097482|FG009|Overall Study|Site Terminated by Sponsor|0|||
23648326|NCT00585195|66097483|FG010|Overall Study|Site Terminated by Sponsor|0|||
23648327|NCT00585195|66097484|FG011|Overall Study|Site Terminated by Sponsor|0|||
23648328|NCT00585195|66097485|FG012|Overall Study|Site Terminated by Sponsor|1|||
23648329|NCT00585195|66097486|FG013|Overall Study|Site Terminated by Sponsor|0|||
23648330|NCT00585195|66097487|FG014|Overall Study|Site Terminated by Sponsor|0|||
23648331|NCT00585195|66097488|FG015|Overall Study|Site Terminated by Sponsor|0|||
23648332|NCT00585195|66097489|FG016|Overall Study|Site Terminated by Sponsor|0|||
23648333|NCT00585195|66097490|FG017|Overall Study|Site Terminated by Sponsor|0|||
23648334|NCT00585195|66097491|FG018|Overall Study|Site Terminated by Sponsor|0|||
23648335|NCT00585195|66097492|FG019|Overall Study|Site Terminated by Sponsor|0|||
23648336|NCT00585195|66097493|FG020|Overall Study|Site Terminated by Sponsor|0|||
23648337|NCT00585195|66097473|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
23648338|NCT00585195|66097474|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
23648339|NCT00585195|66097475|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
23648340|NCT00585195|66097476|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
23648341|NCT00585195|66097477|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
23648342|NCT00585195|66097478|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
23648343|NCT00585195|66097479|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
23648344|NCT00585195|66097480|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
23648345|NCT00585195|66097481|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
23648346|NCT00585195|66097482|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
23648347|NCT00585195|66097483|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
23648348|NCT00585195|66097484|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
23648349|NCT00585195|66097485|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
23648350|NCT00585195|66097486|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
23648351|NCT00585195|66097487|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
23648352|NCT00585195|66097488|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
23648353|NCT00585195|66097489|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
23648354|NCT00585195|66097490|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
23648355|NCT00585195|66097491|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
23648356|NCT00585195|66097492|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
23648357|NCT00585195|66097493|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
23648358|NCT01347762|66097495|FG000|Overall Study|Lost to Follow-up|0|||
23648359|NCT01347762|66097496|FG001|Overall Study|Lost to Follow-up|1|||
23648360|NCT01347762|66097497|FG002|Overall Study|Lost to Follow-up|6|||
23648361|NCT01347762|66097498|FG003|Overall Study|Lost to Follow-up|5|||
23648362|NCT01347762|66097495|FG000|Overall Study|Withdrawal by Subject|4|||
23648363|NCT01347762|66097496|FG001|Overall Study|Withdrawal by Subject|1|||
23648364|NCT01347762|66097497|FG002|Overall Study|Withdrawal by Subject|3|||
23648365|NCT01347762|66097498|FG003|Overall Study|Withdrawal by Subject|3|||
23648366|NCT01340651|66097499|FG000|Overall Study|Adverse Event|3|||
23648367|NCT01340651|66097499|FG000|Overall Study|Consent Withdrawn|2|||
23648368|NCT01340651|66097499|FG000|Overall Study|Commercial Supply per Sponsor|12|||
23648369|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
23648370|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
23648371|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
23648372|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
23648373|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
23648374|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
23648375|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
23648376|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
23648377|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
23648378|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
23648379|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
23648380|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
23648381|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
23648382|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
23648383|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
23648384|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
23648385|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
23648386|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
23648387|NCT02480153|66097500|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
23648388|NCT02480153|66097501|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
23648389|NCT02480153|66097502|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
23648390|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
23648391|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
23648392|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
23648393|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
23648394|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
23648395|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
23648396|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
23648397|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
23648398|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
23648399|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
23648400|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
23648401|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
23648402|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
23648403|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
23648404|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
23648405|NCT02480153|66097500|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
23648406|NCT02480153|66097501|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
23648407|NCT02480153|66097502|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
23648408|NCT02480153|66097500|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
23648409|NCT02480153|66097501|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
23648410|NCT02480153|66097502|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
23648411|NCT02480153|66097500|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
23648412|NCT02480153|66097501|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
23648413|NCT02480153|66097502|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
23648414|NCT02480153|66097500|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
23648415|NCT02480153|66097501|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
23648416|NCT02480153|66097502|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
23648417|NCT02480153|66097500|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
23648418|NCT02480153|66097501|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
23648419|NCT02480153|66097502|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
23648420|NCT02480153|66097500|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
23648421|NCT02480153|66097501|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
23648422|NCT02480153|66097502|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
23648423|NCT00932113|66097507|FG000|Overall Study|Lost to Follow-up|1|||
23648424|NCT00932113|66097508|FG001|Overall Study|Lost to Follow-up|0|||
23648425|NCT01201317|66097520|FG000|Overall Study|Withdrawal by Subject|5|||
23648426|NCT01201317|66097521|FG001|Overall Study|Withdrawal by Subject|0|||
23648427|NCT01201317|66097522|FG002|Overall Study|Withdrawal by Subject|3|||
23648428|NCT01201317|66097520|FG000|Overall Study|Adverse Event|2|||
23648429|NCT01201317|66097521|FG001|Overall Study|Adverse Event|2|||
23648430|NCT01201317|66097522|FG002|Overall Study|Adverse Event|2|||
23648431|NCT01201317|66097520|FG000|Overall Study|Screen failure|1|||
23648432|NCT01201317|66097521|FG001|Overall Study|Screen failure|1|||
23648433|NCT01201317|66097522|FG002|Overall Study|Screen failure|0|||
23648434|NCT01201317|66097520|FG000|Overall Study|Protocol Violation|0|||
23648435|NCT01201317|66097521|FG001|Overall Study|Protocol Violation|1|||
23648436|NCT01201317|66097522|FG002|Overall Study|Protocol Violation|1|||
23648437|NCT01201317|66097520|FG000|Overall Study|Death|0|||
23648438|NCT01201317|66097521|FG001|Overall Study|Death|1|||
23648439|NCT01201317|66097522|FG002|Overall Study|Death|0|||
23648440|NCT01201317|66097520|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23648441|NCT01201317|66097521|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23648442|NCT01201317|66097522|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23648443|NCT01201317|66097520|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
23648444|NCT01201317|66097521|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
23648445|NCT01201317|66097522|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
23648446|NCT01201317|66097520|FG000|Overall Study|Decrease in renal function|0|||
23478702|NCT01129583|65494608|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
23478703|NCT01129583|65494609|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
23478704|NCT00745849|65494612|FG000|First Intervention|Withdrawal by Subject|0|||
23478705|NCT00745849|65494613|FG001|First Intervention|Withdrawal by Subject|1|||
23478706|NCT00745849|65494612|FG000|First Intervention|Lost to Follow-up|1|||
23478707|NCT00745849|65494613|FG001|First Intervention|Lost to Follow-up|1|||
23597727|NCT03664960|65919237|FG000|Overall Study|Physician Decision|1|||
23597728|NCT03664960|65919238|FG001|Overall Study|Physician Decision|0|||
23597729|NCT03664960|65919237|FG000|Overall Study|Withdrawal by Subject|3|||
23597730|NCT03664960|65919238|FG001|Overall Study|Withdrawal by Subject|14|||
23597731|NCT03664960|65919237|FG000|Overall Study|Sponsor Decision|1|||
23597732|NCT03664960|65919238|FG001|Overall Study|Sponsor Decision|1|||
23597733|NCT03664960|65919237|FG000|Overall Study|Other|1|||
23597734|NCT03664960|65919238|FG001|Overall Study|Other|2|||
23597735|NCT03951805|65919239|FG000|Overall Study|Adverse Event|1|||
23597736|NCT03951805|65919240|FG001|Overall Study|Adverse Event|0|||
23597737|NCT03951805|65919241|FG002|Overall Study|Adverse Event|0|||
23597738|NCT03951805|65919242|FG003|Overall Study|Adverse Event|0|||
23597739|NCT02379819|65919244|FG000|Overall Study|Withdrawal by Subject|10|||
23597740|NCT02379819|65919244|FG000|Overall Study|Death|2|||
23597741|NCT02379819|65919244|FG000|Overall Study|Lack of Efficacy|1|||
23597742|NCT02379819|65919244|FG000|Overall Study|Lost to Follow-up|1|||
23597743|NCT00229658|65919245|FG000|Overall Study|Administrative|2|||
23597744|NCT00229658|65919246|FG001|Overall Study|Administrative|1|||
23597745|NCT00229658|65919245|FG000|Overall Study|Investigator decision|13|||
23597746|NCT00229658|65919246|FG001|Overall Study|Investigator decision|10|||
23648447|NCT01201317|66097521|FG001|Overall Study|Decrease in renal function|1|||
23648448|NCT01201317|66097522|FG002|Overall Study|Decrease in renal function|0|||
23597747|NCT00229658|65919245|FG000|Overall Study|Other|80|||
23648449|NCT01201317|66097520|FG000|Overall Study|Lack of Efficacy|1|||
23648450|NCT01201317|66097521|FG001|Overall Study|Lack of Efficacy|0|||
23648451|NCT01201317|66097522|FG002|Overall Study|Lack of Efficacy|0|||
23648452|NCT01201317|66097520|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
23648453|NCT01201317|66097521|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
23648454|NCT01201317|66097522|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
23648455|NCT01639495|66097523|FG000|Overall Study|Lost to Follow-up|6|||
23648456|NCT01639495|66097523|FG000|Overall Study|Consented but didn't have study catheter|4|||
23648457|NCT01639495|66097523|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
23648458|NCT01639495|66097523|FG000|Overall Study|No radiofrequency energy applied|2|||
23648459|NCT03343301|66097524|FG000|Overall Study|Withdrawal by Subject|1|||
23648460|NCT03343301|66097525|FG001|Overall Study|Withdrawal by Subject|1|||
23648461|NCT03343301|66097524|FG000|Overall Study|Death|0|||
23648462|NCT03343301|66097525|FG001|Overall Study|Death|2|||
23648463|NCT03343301|66097524|FG000|Overall Study|Other|0|||
23648464|NCT03343301|66097525|FG001|Overall Study|Other|6|||
23648465|NCT03343301|66097524|FG000|Overall Study|Missing|2|||
23648466|NCT03343301|66097525|FG001|Overall Study|Missing|0|||
23648467|NCT01296347|66097527|FG000|Allocation|Withdrawal by Subject|1|||
23648468|NCT01296347|66097528|FG001|Allocation|Withdrawal by Subject|2|||
23648469|NCT01296347|66097527|FG000|Allocation|Lack of Efficacy|1|||
23648470|NCT01296347|66097528|FG001|Allocation|Lack of Efficacy|2|||
23648471|NCT01296347|66097527|FG000|Allocation|not received infusion|1|||
23648472|NCT01296347|66097528|FG001|Allocation|not received infusion|0|||
23648473|NCT01296347|66097527|FG000|6 Week Follow up|Death|0|||
23648474|NCT01296347|66097528|FG001|6 Week Follow up|Death|1|||
23648475|NCT01296347|66097527|FG000|3 Month Follow up|Death|1|||
23648476|NCT01296347|66097528|FG001|3 Month Follow up|Death|0|||
23648477|NCT01296347|66097527|FG000|3 Month Follow up|Lost to Follow-up|0|||
23648478|NCT01296347|66097528|FG001|3 Month Follow up|Lost to Follow-up|1|||
23648479|NCT01296347|66097527|FG000|6 Month Follow up|Death|2|||
23648480|NCT01296347|66097528|FG001|6 Month Follow up|Death|1|||
23648481|NCT01296347|66097527|FG000|6 Month Follow up|Lost to Follow-up|0|||
23648482|NCT01296347|66097528|FG001|6 Month Follow up|Lost to Follow-up|1|||
23648483|NCT01296347|66097527|FG000|12 Month Follow up|Lost to Follow-up|3|||
23648484|NCT01296347|66097528|FG001|12 Month Follow up|Lost to Follow-up|1|||
23648485|NCT01296347|66097527|FG000|12 Month Follow up|Death|1|||
23648486|NCT01296347|66097528|FG001|12 Month Follow up|Death|1|||
23648487|NCT01296347|66097527|FG000|12 Month Follow up|Withdrawal by Subject|0|||
23648488|NCT01296347|66097528|FG001|12 Month Follow up|Withdrawal by Subject|1|||
23648489|NCT00495586|66097529|FG000|Overall Study|Withdrawal by Subject|4|||
23648490|NCT00495586|66097530|FG001|Overall Study|Withdrawal by Subject|4|||
23648491|NCT02768870|66097534|FG000|Overall Study|Death|1|||
23648492|NCT02768870|66097534|FG000|Overall Study|Reoperation|6|||
23648493|NCT02768870|66097534|FG000|Overall Study|Lost to Follow-up|1|||
23648494|NCT02768870|66097534|FG000|Overall Study|Exit|4|||
23648495|NCT01650246|66097535|FG000|Overall Study|Adverse Event|23|||
23648496|NCT01650246|66097535|FG000|Overall Study|Protocol Violation|5|||
23648497|NCT01650246|66097535|FG000|Overall Study|Sponsor terminated study|53|||
23648498|NCT01650246|66097535|FG000|Overall Study|Lost to Follow-up|5|||
23648499|NCT01650246|66097535|FG000|Overall Study|Withdrawal by Subject|26|||
23648500|NCT01650246|66097535|FG000|Overall Study|Death|1|||
23648501|NCT01650246|66097535|FG000|Overall Study|Lack of Efficacy|30|||
23648502|NCT03143166|66097537|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
23648503|NCT00560066|66097538|FG000|Overall Study|Death|2|||
23648504|NCT00560066|66097539|FG001|Overall Study|Death|1|||
23648505|NCT00560066|66097538|FG000|Overall Study|Withdrawal by Subject|0|||
23648506|NCT00560066|66097539|FG001|Overall Study|Withdrawal by Subject|3|||
23648507|NCT00560066|66097538|FG000|Overall Study|Lost to Follow-up|4|||
23648508|NCT00560066|66097539|FG001|Overall Study|Lost to Follow-up|10|||
23648509|NCT00560066|66097538|FG000|Overall Study|Protocol Violation|0|||
23648510|NCT00560066|66097539|FG001|Overall Study|Protocol Violation|1|||
23648511|NCT00560066|66097538|FG000|Overall Study|Administrative reason|0|||
23648512|NCT00560066|66097539|FG001|Overall Study|Administrative reason|5|||
23648513|NCT00560066|66097538|FG000|Overall Study|Missing primary reason|0|||
23648514|NCT00560066|66097539|FG001|Overall Study|Missing primary reason|2|||
23648515|NCT00959647|66097542|FG000|Overall Study|Adverse Event|2|||
23648516|NCT00959647|66097542|FG000|Overall Study|Progressive disease|6|||
23648517|NCT00959647|66097542|FG000|Overall Study|Study terminated by sponsor|4|||
23648518|NCT00959647|66097542|FG000|Overall Study|Withdrawal by Subject|7|||
23648519|NCT01952054|66097543|FG000|Overall Study|Physician Decision|1|||
23648520|NCT00983931|66097546|FG000|14 Day Washout Period|Physician Decision|1|||
23648521|NCT02217332|66097547|FG000|Overall Study|Adverse Event|3|||
23648522|NCT02217332|66097547|FG000|Overall Study|Dose interruption >1 month|1|||
23648523|NCT02217332|66097547|FG000|Overall Study|Protocol Violation (eligibility)|1|||
23360607|NCT02028507|65065804|FG003|Overall Study|Enzyme defect|1|||
23648524|NCT02217332|66097547|FG000|Overall Study|Withdrawal by Subject|1|||
23648525|NCT02217332|66097547|FG000|Overall Study|Lost to Follow-up|1|||
23648526|NCT01813929|66097550|FG000|Overall Study|Withdrawal by Subject|0|||
23478708|NCT00745849|65494612|FG000|Second Intervention|Lost to Follow-up|2|||
23478709|NCT00745849|65494613|FG001|Second Intervention|Lost to Follow-up|1|||
23478710|NCT00779259|65494618|FG000|Quinine Alone|Adverse Event|2|||
23478711|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
23478712|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
23478713|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
23478714|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
23478715|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23478716|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
23478717|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
23478718|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
23478719|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
23478720|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
23478721|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
23478722|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
23478723|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
23478724|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
23478725|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
23478726|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
23478727|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
23478728|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
23478729|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
23478730|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
23478731|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
23478732|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
23478733|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
23478734|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
23478735|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
23597748|NCT00229658|65919246|FG001|Overall Study|Other|60|||
23597749|NCT00229658|65919245|FG000|Overall Study|Lost to Follow-up|82|||
23597750|NCT00229658|65919246|FG001|Overall Study|Lost to Follow-up|55|||
23597751|NCT00229658|65919245|FG000|Overall Study|Serious Adverse Event|2|||
23597752|NCT00229658|65919246|FG001|Overall Study|Serious Adverse Event|2|||
23597753|NCT00229658|65919245|FG000|Overall Study|Withdrawal of consent|46|||
23597754|NCT00229658|65919246|FG001|Overall Study|Withdrawal of consent|39|||
23597755|NCT00586313|65919247|FG000|Overall Study|Lack of Efficacy|2|||
23597756|NCT02538341|65919249|FG000|Overall Study|Lost to Follow-up|51|||
23597757|NCT02538341|65919250|FG001|Overall Study|Lost to Follow-up|46|||
23597758|NCT02538341|65919249|FG000|Overall Study|Withdrawal by Subject|3|||
23597759|NCT02538341|65919250|FG001|Overall Study|Withdrawal by Subject|1|||
23597760|NCT02538341|65919249|FG000|Overall Study|Death|2|||
23597761|NCT02538341|65919250|FG001|Overall Study|Death|0|||
23478736|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
23478737|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
23648527|NCT01813929|66097551|FG001|Overall Study|Withdrawal by Subject|1|||
23648528|NCT01079130|66097554|FG000|Overall Study|Adverse Event|1|||
23648529|NCT01079130|66097555|FG001|Overall Study|Adverse Event|1|||
23648530|NCT01079130|66097556|FG002|Overall Study|Adverse Event|0|||
23648531|NCT01079130|66097557|FG003|Overall Study|Adverse Event|1|||
23648532|NCT01079130|66097558|FG004|Overall Study|Adverse Event|5|||
23648533|NCT01079130|66097559|FG005|Overall Study|Adverse Event|1|||
23648534|NCT01079130|66097554|FG000|Overall Study|Administrative problems|1|||
23648535|NCT01079130|66097555|FG001|Overall Study|Administrative problems|3|||
23648536|NCT01079130|66097556|FG002|Overall Study|Administrative problems|0|||
23648537|NCT01079130|66097557|FG003|Overall Study|Administrative problems|0|||
23648538|NCT01079130|66097558|FG004|Overall Study|Administrative problems|0|||
23648539|NCT01079130|66097559|FG005|Overall Study|Administrative problems|1|||
23648540|NCT01079130|66097554|FG000|Overall Study|Withdrawal by Subject|0|||
23478738|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
23478739|NCT01120782|65494621|FG000|Overall Study|Test article shipping error|11|||
23478740|NCT00938886|65494623|FG000|Overall Study|Death|0|||
23478741|NCT00938886|65494624|FG001|Overall Study|Death|1|||
23478742|NCT00938886|65494623|FG000|Overall Study|Withdrawal by Subject|4|||
23478743|NCT00938886|65494624|FG001|Overall Study|Withdrawal by Subject|7|||
23478744|NCT00938886|65494623|FG000|Overall Study|Lost to Follow-up|3|||
23478745|NCT00938886|65494624|FG001|Overall Study|Lost to Follow-up|2|||
23478746|NCT00220779|65494625|FG000|Overall Study|Adverse Event|1|||
23478747|NCT00220779|65494626|FG001|Overall Study|Adverse Event|0|||
23478748|NCT00220779|65494627|FG002|Overall Study|Adverse Event|0|||
23478749|NCT00220779|65494625|FG000|Overall Study|Withdrawal by Subject|1|||
23597762|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597763|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
23597764|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597765|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
23597766|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597767|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597768|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597769|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597770|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597771|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597772|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
23597773|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597774|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597775|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597776|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597777|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597778|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597779|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
23597780|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
23648541|NCT01079130|66097555|FG001|Overall Study|Withdrawal by Subject|1|||
23648542|NCT01079130|66097556|FG002|Overall Study|Withdrawal by Subject|0|||
23648543|NCT01079130|66097557|FG003|Overall Study|Withdrawal by Subject|0|||
23648544|NCT01079130|66097558|FG004|Overall Study|Withdrawal by Subject|1|||
23648545|NCT01079130|66097559|FG005|Overall Study|Withdrawal by Subject|3|||
23648546|NCT01079130|66097554|FG000|Overall Study|Protocol deviation|0|||
23648547|NCT01079130|66097555|FG001|Overall Study|Protocol deviation|2|||
23648548|NCT01079130|66097556|FG002|Overall Study|Protocol deviation|1|||
23648549|NCT01079130|66097557|FG003|Overall Study|Protocol deviation|2|||
23648550|NCT01079130|66097558|FG004|Overall Study|Protocol deviation|0|||
23648551|NCT01079130|66097559|FG005|Overall Study|Protocol deviation|0|||
23648552|NCT01079130|66097554|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23648553|NCT01079130|66097555|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23648554|NCT01079130|66097556|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23648555|NCT01079130|66097557|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23648556|NCT01079130|66097558|FG004|Overall Study|Abnormal test procedure result(s)|1|||
23648557|NCT01079130|66097559|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23648558|NCT01079130|66097554|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23648559|NCT01079130|66097555|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23648560|NCT01079130|66097556|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23648561|NCT01079130|66097557|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23648562|NCT01079130|66097558|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
23648563|NCT01079130|66097559|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
23648564|NCT01079130|66097554|FG000|Overall Study|Lost to Follow-up|0|||
23648565|NCT01079130|66097555|FG001|Overall Study|Lost to Follow-up|0|||
23648566|NCT01079130|66097556|FG002|Overall Study|Lost to Follow-up|0|||
23648567|NCT01079130|66097557|FG003|Overall Study|Lost to Follow-up|0|||
23648568|NCT01079130|66097558|FG004|Overall Study|Lost to Follow-up|1|||
23648569|NCT01079130|66097559|FG005|Overall Study|Lost to Follow-up|0|||
23648570|NCT02121834|66097571|FG000|Overall Study|Protocol Violation|0|||
23648571|NCT02121834|66097572|FG001|Overall Study|Protocol Violation|1|||
23648572|NCT02121834|66097573|FG002|Overall Study|Protocol Violation|0|||
23648573|NCT02121834|66097574|FG003|Overall Study|Protocol Violation|0|||
23648574|NCT02121834|66097575|FG004|Overall Study|Protocol Violation|0|||
23648575|NCT02121834|66097576|FG005|Overall Study|Protocol Violation|0|||
23648576|NCT02121834|66097577|FG006|Overall Study|Protocol Violation|0|||
23648577|NCT02121834|66097571|FG000|Overall Study|Withdrawal by Subject|0|||
23648578|NCT02121834|66097572|FG001|Overall Study|Withdrawal by Subject|1|||
23648579|NCT02121834|66097573|FG002|Overall Study|Withdrawal by Subject|1|||
23648580|NCT02121834|66097574|FG003|Overall Study|Withdrawal by Subject|0|||
23648581|NCT02121834|66097575|FG004|Overall Study|Withdrawal by Subject|0|||
23648582|NCT02121834|66097576|FG005|Overall Study|Withdrawal by Subject|0|||
23648583|NCT02121834|66097577|FG006|Overall Study|Withdrawal by Subject|0|||
23648584|NCT02121834|66097571|FG000|Overall Study|Lost to Follow-up|0|||
23648585|NCT02121834|66097572|FG001|Overall Study|Lost to Follow-up|0|||
23648586|NCT02121834|66097573|FG002|Overall Study|Lost to Follow-up|1|||
23648587|NCT02121834|66097574|FG003|Overall Study|Lost to Follow-up|0|||
23648588|NCT02121834|66097575|FG004|Overall Study|Lost to Follow-up|0|||
23478750|NCT00220779|65494626|FG001|Overall Study|Withdrawal by Subject|4|||
23478751|NCT00220779|65494627|FG002|Overall Study|Withdrawal by Subject|1|||
23478752|NCT00220779|65494625|FG000|Overall Study|Non-compliance|1|||
23478753|NCT00220779|65494626|FG001|Overall Study|Non-compliance|0|||
23478754|NCT00220779|65494627|FG002|Overall Study|Non-compliance|0|||
23478755|NCT00220779|65494625|FG000|Overall Study|Too time consuming|1|||
23478756|NCT00220779|65494626|FG001|Overall Study|Too time consuming|0|||
23478757|NCT00220779|65494627|FG002|Overall Study|Too time consuming|0|||
23478758|NCT00220779|65494625|FG000|Overall Study|Pregnancy|0|||
23648589|NCT02121834|66097576|FG005|Overall Study|Lost to Follow-up|0|||
23648590|NCT02121834|66097577|FG006|Overall Study|Lost to Follow-up|0|||
23648591|NCT00394082|66097578|FG000|Overall Study|Unacceptable toxicity|15|||
23648592|NCT00394082|66097578|FG000|Overall Study|Adverse Event|4|||
23648593|NCT00394082|66097578|FG000|Overall Study|Physician Decision|4|||
23648594|NCT00394082|66097578|FG000|Overall Study|Withdrawal by Subject|2|||
23648595|NCT00394082|66097578|FG000|Overall Study|Other|1|||
23648596|NCT00640133|66097579|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
23648597|NCT00640133|66097580|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
23478759|NCT00220779|65494626|FG001|Overall Study|Pregnancy|0|||
23478760|NCT00220779|65494627|FG002|Overall Study|Pregnancy|2|||
23648598|NCT00640133|66097579|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
23648599|NCT00640133|66097580|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
23648600|NCT00640133|66097579|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
23478761|NCT00220779|65494625|FG000|Overall Study|Lack of Efficacy|3|||
23478762|NCT00220779|65494626|FG001|Overall Study|Lack of Efficacy|0|||
23648601|NCT00640133|66097580|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
23648602|NCT01590017|66097581|FG000|Overall Study|Adverse Event|1|||
23478763|NCT00220779|65494627|FG002|Overall Study|Lack of Efficacy|1|||
23648603|NCT01590017|66097581|FG000|Overall Study|Withdrawal by Subject|1|||
23648604|NCT01590017|66097581|FG000|Overall Study|Lack of Efficacy|1|||
23648605|NCT01590017|66097581|FG000|Overall Study|Physician Decision|1|||
23648606|NCT01506609|66097584|FG000|Overall Study|Adverse Event Related to Progression|0|||
23648607|NCT01506609|66097585|FG001|Overall Study|Adverse Event Related to Progression|0|||
23648608|NCT01506609|66097586|FG002|Overall Study|Adverse Event Related to Progression|0|||
23648609|NCT01506609|66097587|FG003|Overall Study|Adverse Event Related to Progression|3|||
23648610|NCT01506609|66097588|FG004|Overall Study|Adverse Event Related to Progression|7|||
23648611|NCT01506609|66097589|FG005|Overall Study|Adverse Event Related to Progression|3|||
23648612|NCT01506609|66097584|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
23648613|NCT01506609|66097585|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
23648614|NCT01506609|66097586|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
23648615|NCT01506609|66097587|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
23648616|NCT01506609|66097588|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
23648617|NCT01506609|66097589|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
23648618|NCT01506609|66097584|FG000|Overall Study|Withdrawal by Subject|0|||
23648619|NCT01506609|66097585|FG001|Overall Study|Withdrawal by Subject|0|||
23648620|NCT01506609|66097586|FG002|Overall Study|Withdrawal by Subject|0|||
23648621|NCT01506609|66097587|FG003|Overall Study|Withdrawal by Subject|9|||
23648622|NCT01506609|66097588|FG004|Overall Study|Withdrawal by Subject|7|||
23648623|NCT01506609|66097589|FG005|Overall Study|Withdrawal by Subject|7|||
23648624|NCT01506609|66097584|FG000|Overall Study|Lost to Follow-up|0|||
23648625|NCT01506609|66097585|FG001|Overall Study|Lost to Follow-up|0|||
23648626|NCT01506609|66097586|FG002|Overall Study|Lost to Follow-up|0|||
23648627|NCT01506609|66097587|FG003|Overall Study|Lost to Follow-up|1|||
23648628|NCT01506609|66097588|FG004|Overall Study|Lost to Follow-up|2|||
23648629|NCT01506609|66097589|FG005|Overall Study|Lost to Follow-up|0|||
23648630|NCT01506609|66097584|FG000|Overall Study|Sponsor Discontinued Study|0|||
23648631|NCT01506609|66097585|FG001|Overall Study|Sponsor Discontinued Study|0|||
23648632|NCT01506609|66097586|FG002|Overall Study|Sponsor Discontinued Study|0|||
23648633|NCT01506609|66097587|FG003|Overall Study|Sponsor Discontinued Study|2|||
23648634|NCT01506609|66097588|FG004|Overall Study|Sponsor Discontinued Study|2|||
23648635|NCT01506609|66097589|FG005|Overall Study|Sponsor Discontinued Study|0|||
23648636|NCT01506609|66097584|FG000|Overall Study|Progressive Disease per Protocol|1|||
23648637|NCT01506609|66097585|FG001|Overall Study|Progressive Disease per Protocol|0|||
23648638|NCT01506609|66097586|FG002|Overall Study|Progressive Disease per Protocol|0|||
23648639|NCT01506609|66097587|FG003|Overall Study|Progressive Disease per Protocol|64|||
23648640|NCT01506609|66097588|FG004|Overall Study|Progressive Disease per Protocol|57|||
23648641|NCT01506609|66097589|FG005|Overall Study|Progressive Disease per Protocol|74|||
23648642|NCT01506609|66097584|FG000|Overall Study|Other, Not Specified|0|||
23648643|NCT01506609|66097585|FG001|Overall Study|Other, Not Specified|0|||
23648644|NCT01506609|66097586|FG002|Overall Study|Other, Not Specified|0|||
23648645|NCT01506609|66097587|FG003|Overall Study|Other, Not Specified|10|||
23648646|NCT01506609|66097588|FG004|Overall Study|Other, Not Specified|7|||
23648647|NCT01506609|66097589|FG005|Overall Study|Other, Not Specified|3|||
23648648|NCT01506609|66097584|FG000|Overall Study|Missing / Unknown Reason|1|||
23648649|NCT01506609|66097585|FG001|Overall Study|Missing / Unknown Reason|0|||
23648650|NCT01506609|66097586|FG002|Overall Study|Missing / Unknown Reason|1|||
23648651|NCT01506609|66097587|FG003|Overall Study|Missing / Unknown Reason|4|||
23648652|NCT01506609|66097588|FG004|Overall Study|Missing / Unknown Reason|4|||
23648653|NCT01506609|66097589|FG005|Overall Study|Missing / Unknown Reason|2|||
23648654|NCT00158860|66097590|FG000|Overall Study|Adverse Event|3|||
23648655|NCT00158860|66097591|FG001|Overall Study|Adverse Event|6|||
23648656|NCT00158860|66097590|FG000|Overall Study|Lost to Follow-up|11|||
23648657|NCT00158860|66097591|FG001|Overall Study|Lost to Follow-up|17|||
23648658|NCT00158860|66097590|FG000|Overall Study|Protocol Violation|8|||
23648659|NCT00158860|66097591|FG001|Overall Study|Protocol Violation|23|||
23648660|NCT00158860|66097590|FG000|Overall Study|Withdrawal by Subject|7|||
23800873|NCT02985398|66649828|FG000|Overall Study|Study Burden|9|||
23800874|NCT00706992|66649829|FG000|Overall Study|Study termination|5|||
23800875|NCT00706992|66649830|FG001|Overall Study|Study termination|5|||
23648661|NCT00158860|66097591|FG001|Overall Study|Withdrawal by Subject|17|||
23648662|NCT00158860|66097590|FG000|Overall Study|MOVING OUT OF STATE|1|||
23648663|NCT00158860|66097591|FG001|Overall Study|MOVING OUT OF STATE|0|||
23648664|NCT00158860|66097590|FG000|Overall Study|Pregnancy|3|||
23648665|NCT00158860|66097591|FG001|Overall Study|Pregnancy|3|||
23648666|NCT00158860|66097590|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
23648667|NCT00158860|66097591|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
23648668|NCT00158860|66097590|FG000|Overall Study|SPONSOR REQUEST|0|||
23648669|NCT00158860|66097591|FG001|Overall Study|SPONSOR REQUEST|1|||
23648670|NCT00158860|66097590|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
23648671|NCT00158860|66097591|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
23478764|NCT00053898|65494628|FG000|Overall Study|No follow-up data from any source|9|||
23478765|NCT00053898|65494629|FG001|Overall Study|No follow-up data from any source|12|||
23478766|NCT00053898|65494628|FG000|Overall Study|Follow-up from telephone contact only|5|||
23478767|NCT00053898|65494629|FG001|Overall Study|Follow-up from telephone contact only|1|||
23478768|NCT00329849|65494630|FG000|Overall Study|Withdrawal by Subject|6|||
23478769|NCT00329849|65494631|FG001|Overall Study|Withdrawal by Subject|4|||
23478770|NCT00662532|65494632|FG000|Overall Study|Adverse Event|0|||
23478771|NCT00662532|65494633|FG001|Overall Study|Adverse Event|1|||
23478772|NCT00662532|65494632|FG000|Overall Study|Lost to Follow-up|0|||
23478773|NCT00662532|65494633|FG001|Overall Study|Lost to Follow-up|1|||
23478774|NCT02395302|65494636|FG000|Overall Study|Screen Failure|3|||
23478775|NCT02395302|65494636|FG000|Overall Study|Run In Failure|7|||
23478776|NCT02395302|65494636|FG000|Overall Study|Withdrawal by Subject|2|||
23478777|NCT02395302|65494636|FG000|Overall Study|Physician Decision|2|||
23478778|NCT03499964|65494637|FG000|Overall Study|Lack of Efficacy|6|||
23478779|NCT03499964|65494638|FG001|Overall Study|Lack of Efficacy|26|||
23478780|NCT03499964|65494637|FG000|Overall Study|Adverse Event|1|||
23478781|NCT03499964|65494638|FG001|Overall Study|Adverse Event|0|||
23478782|NCT03499964|65494637|FG000|Overall Study|Death|1|||
23478783|NCT03499964|65494638|FG001|Overall Study|Death|0|||
23478784|NCT03499964|65494637|FG000|Overall Study|Withdrawal by Subject|2|||
23478785|NCT03499964|65494638|FG001|Overall Study|Withdrawal by Subject|1|||
23478786|NCT03499964|65494637|FG000|Overall Study|Lost to Follow-up|1|||
23478787|NCT03499964|65494638|FG001|Overall Study|Lost to Follow-up|0|||
23478788|NCT00510653|65494650|FG000|Overall Study|Withdrawal by Subject|8|||
23478789|NCT00510653|65494650|FG000|Overall Study|Monetary|3|||
23478790|NCT01139008|65494651|FG000|Overall Study|Withdrawal by Subject|5|||
23478791|NCT01139008|65494651|FG000|Overall Study|Non-compliant, lost product|1|||
23478792|NCT00265148|65494655|FG000|Overall Study|Adverse Event|2|||
23478793|NCT00265148|65494656|FG001|Overall Study|Adverse Event|2|||
23478794|NCT00265148|65494655|FG000|Overall Study|Lack of Efficacy|0|||
23478795|NCT00265148|65494656|FG001|Overall Study|Lack of Efficacy|2|||
23478796|NCT00265148|65494655|FG000|Overall Study|Protocol Violation|3|||
23478797|NCT00265148|65494656|FG001|Overall Study|Protocol Violation|2|||
23478798|NCT00265148|65494655|FG000|Overall Study|Lost to Follow-up|0|||
23478799|NCT00265148|65494656|FG001|Overall Study|Lost to Follow-up|1|||
23478800|NCT00265148|65494655|FG000|Overall Study|Withdrawal by Subject|2|||
23478801|NCT00265148|65494656|FG001|Overall Study|Withdrawal by Subject|1|||
23478802|NCT00265148|65494655|FG000|Overall Study|Physician Decision|1|||
23478803|NCT00265148|65494656|FG001|Overall Study|Physician Decision|0|||
23478804|NCT00265148|65494655|FG000|Overall Study|Increasing frailty|0|||
23478805|NCT00265148|65494656|FG001|Overall Study|Increasing frailty|1|||
23478806|NCT00265148|65494655|FG000|Overall Study|Subject chose to change of the dose|1|||
23478807|NCT00265148|65494656|FG001|Overall Study|Subject chose to change of the dose|0|||
23478808|NCT00958438|65494658|FG000|Overall Study|Protocol Violation|3|||
23478809|NCT00958438|65494659|FG001|Overall Study|Protocol Violation|2|||
23478810|NCT00958438|65494660|FG002|Overall Study|Protocol Violation|2|||
23478811|NCT00958438|65494658|FG000|Overall Study|Withdrawal by Subject|4|||
23478812|NCT00958438|65494659|FG001|Overall Study|Withdrawal by Subject|2|||
23478813|NCT00958438|65494660|FG002|Overall Study|Withdrawal by Subject|1|||
23478814|NCT00958438|65494658|FG000|Overall Study|Adverse Event|0|||
23478815|NCT00958438|65494659|FG001|Overall Study|Adverse Event|3|||
23478816|NCT00958438|65494660|FG002|Overall Study|Adverse Event|0|||
23478817|NCT00958438|65494658|FG000|Overall Study|Physician Decision|1|||
23478818|NCT00958438|65494659|FG001|Overall Study|Physician Decision|0|||
23478819|NCT00958438|65494660|FG002|Overall Study|Physician Decision|1|||
23478820|NCT00958438|65494658|FG000|Overall Study|Other than specified above|2|||
23478821|NCT00958438|65494659|FG001|Overall Study|Other than specified above|3|||
23597781|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597782|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23478822|NCT00958438|65494660|FG002|Overall Study|Other than specified above|2|||
23478823|NCT00864916|65494661|FG000|Overall Study|Lost to Follow-up|4|||
23478824|NCT00864916|65494662|FG001|Overall Study|Lost to Follow-up|4|||
23478825|NCT00864916|65494661|FG000|Overall Study|Protocol Violation|1|||
23478826|NCT00864916|65494662|FG001|Overall Study|Protocol Violation|0|||
23478827|NCT00864916|65494661|FG000|Overall Study|Withdrawal by Subject|1|||
23478828|NCT00864916|65494662|FG001|Overall Study|Withdrawal by Subject|0|||
23478829|NCT01589770|65494663|FG000|Overall Study|EGFR <60ml/min|6|||
23478830|NCT01589770|65494664|FG001|Overall Study|EGFR <60ml/min|4|||
23478831|NCT01589770|65494663|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
23478832|NCT01589770|65494664|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
23478833|NCT04214288|65494665|FG000|Overall Study|Ongoing in the study|41|||
23478834|NCT04214288|65494666|FG001|Overall Study|Ongoing in the study|51|||
23478835|NCT04214288|65494667|FG002|Overall Study|Ongoing in the study|12|||
23648672|NCT00158860|66097590|FG000|Overall Study|Closed per sponsor|0|||
23648673|NCT00158860|66097591|FG001|Overall Study|Closed per sponsor|1|||
23648674|NCT01411839|66097592|FG000|Overall Study|Lost to Follow-up|4|||
23648675|NCT01411839|66097593|FG001|Overall Study|Lost to Follow-up|3|||
23648676|NCT01945060|66097594|FG000|Overall Study|Lost to follow up|1|||
23648677|NCT01945060|66097595|FG001|Overall Study|Lost to follow up|0|||
23648678|NCT01945060|66097594|FG000|Overall Study|Distress related to IV access|0|||
23648679|NCT01945060|66097595|FG001|Overall Study|Distress related to IV access|1|||
23648680|NCT01337115|66100696|FG000|Overall Study|Protocol Violation|2|||
23648681|NCT01337115|66100697|FG001|Overall Study|Protocol Violation|0|||
23648682|NCT00679627|66100698|FG000|Overall Study|Death|41|||
23648683|NCT00679627|66100699|FG001|Overall Study|Death|29|||
23648684|NCT00679627|66100698|FG000|Overall Study|Adverse Event|43|||
23648685|NCT00679627|66100699|FG001|Overall Study|Adverse Event|53|||
23648686|NCT00679627|66100698|FG000|Overall Study|Withdrawal by Subject|168|||
23648687|NCT00679627|66100699|FG001|Overall Study|Withdrawal by Subject|172|||
23648688|NCT00679627|66100698|FG000|Overall Study|Lost to Follow-up|22|||
23648689|NCT00679627|66100699|FG001|Overall Study|Lost to Follow-up|26|||
23648690|NCT00679627|66100698|FG000|Overall Study|Early Study Closure|425|||
23648691|NCT00679627|66100699|FG001|Overall Study|Early Study Closure|405|||
23648692|NCT02208999|66100700|FG000|Overall Study|Lost to Follow-up|1|||
23648693|NCT01777269|66100701|FG000|Overall Study|Adverse Event|24|||
23648694|NCT01777269|66100702|FG001|Overall Study|Adverse Event|33|||
23648695|NCT01777269|66100701|FG000|Overall Study|Lack of Efficacy|8|||
23648696|NCT01777269|66100702|FG001|Overall Study|Lack of Efficacy|10|||
23648697|NCT01777269|66100701|FG000|Overall Study|Protocol Violation|4|||
23648698|NCT01777269|66100702|FG001|Overall Study|Protocol Violation|4|||
23648699|NCT01777269|66100701|FG000|Overall Study|Participants reached stopping criteria|1|||
23648700|NCT01777269|66100702|FG001|Overall Study|Participants reached stopping criteria|1|||
23648701|NCT01777269|66100701|FG000|Overall Study|Lost to Follow-up|4|||
23648702|NCT01777269|66100702|FG001|Overall Study|Lost to Follow-up|0|||
23648703|NCT01777269|66100701|FG000|Overall Study|Physician Decision|5|||
23648704|NCT01777269|66100702|FG001|Overall Study|Physician Decision|2|||
23648705|NCT01777269|66100701|FG000|Overall Study|Withdrawal by Subject|9|||
23648706|NCT01777269|66100702|FG001|Overall Study|Withdrawal by Subject|9|||
23648707|NCT01498679|66100705|FG000|Overall Study|Adverse Event|1|||
23648708|NCT01498679|66100706|FG001|Overall Study|Adverse Event|4|||
23648709|NCT01498679|66100705|FG000|Overall Study|Lack of Efficacy|72|||
23648710|NCT01498679|66100706|FG001|Overall Study|Lack of Efficacy|12|||
23648711|NCT01498679|66100705|FG000|Overall Study|Protocol Violation|4|||
23648712|NCT01498679|66100706|FG001|Overall Study|Protocol Violation|0|||
23648713|NCT01498679|66100705|FG000|Overall Study|Physician Decision|0|||
23648714|NCT01498679|66100706|FG001|Overall Study|Physician Decision|2|||
23648715|NCT01498679|66100705|FG000|Overall Study|Withdrawal by Subject|12|||
23648716|NCT01498679|66100706|FG001|Overall Study|Withdrawal by Subject|4|||
23648717|NCT00744523|66100710|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
23648718|NCT00744523|66100711|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
23648719|NCT02294227|66100712|FG000|Overall Study|Death|0|||
23648720|NCT02294227|66100713|FG001|Overall Study|Death|0|||
23648721|NCT02294227|66100714|FG002|Overall Study|Death|1|||
23648722|NCT02294227|66100712|FG000|Overall Study|Subject/Guardian Decision|6|||
23648723|NCT02294227|66100713|FG001|Overall Study|Subject/Guardian Decision|3|||
23648724|NCT02294227|66100714|FG002|Overall Study|Subject/Guardian Decision|7|||
23648725|NCT02294227|66100712|FG000|Overall Study|Physician Decision|1|||
23648726|NCT02294227|66100713|FG001|Overall Study|Physician Decision|2|||
23648727|NCT02294227|66100714|FG002|Overall Study|Physician Decision|1|||
23648728|NCT02294227|66100712|FG000|Overall Study|Lost to Follow-up|1|||
23648729|NCT02294227|66100713|FG001|Overall Study|Lost to Follow-up|0|||
23648730|NCT02294227|66100714|FG002|Overall Study|Lost to Follow-up|0|||
23648731|NCT02294227|66100712|FG000|Overall Study|Lack of Efficacy|11|||
23648732|NCT02294227|66100713|FG001|Overall Study|Lack of Efficacy|12|||
23648733|NCT02294227|66100714|FG002|Overall Study|Lack of Efficacy|8|||
23648734|NCT02294227|66100712|FG000|Overall Study|Adverse Event|6|||
23648735|NCT02294227|66100713|FG001|Overall Study|Adverse Event|8|||
23648736|NCT02294227|66100714|FG002|Overall Study|Adverse Event|2|||
23648737|NCT01122862|66100723|FG000|Period 1|Protocol Violation|0|||
23648738|NCT01122862|66100724|FG001|Period 1|Protocol Violation|1|||
23648739|NCT01122862|66100725|FG002|Period 1|Protocol Violation|0|||
23648740|NCT01122862|66100723|FG000|Period 2|Adverse Event|0|||
23648741|NCT01122862|66100724|FG001|Period 2|Adverse Event|0|||
23648742|NCT01122862|66100725|FG002|Period 2|Adverse Event|1|||
23648743|NCT03603028|66100726|FG000|Overall Study|Withdrawal by Subject|1|||
23648744|NCT02054520|66100727|FG000|Overall Study|Adverse Event|1|||
23648745|NCT02054520|66100728|FG001|Overall Study|Adverse Event|4|||
23648746|NCT02054520|66100729|FG002|Overall Study|Adverse Event|2|||
23648747|NCT02054520|66100730|FG003|Overall Study|Adverse Event|1|||
23648748|NCT02054520|66100731|FG004|Overall Study|Adverse Event|1|||
23648749|NCT02054520|66100732|FG005|Overall Study|Adverse Event|0|||
23648750|NCT02054520|66100727|FG000|Overall Study|Lack of Efficacy|7|||
23648751|NCT02054520|66100728|FG001|Overall Study|Lack of Efficacy|0|||
23648752|NCT02054520|66100729|FG002|Overall Study|Lack of Efficacy|2|||
23648753|NCT02054520|66100730|FG003|Overall Study|Lack of Efficacy|1|||
23648754|NCT02054520|66100731|FG004|Overall Study|Lack of Efficacy|3|||
23648755|NCT02054520|66100732|FG005|Overall Study|Lack of Efficacy|2|||
23648756|NCT02054520|66100727|FG000|Overall Study|Withdrawal by Subject|1|||
23648757|NCT02054520|66100728|FG001|Overall Study|Withdrawal by Subject|0|||
23648758|NCT02054520|66100729|FG002|Overall Study|Withdrawal by Subject|0|||
23648759|NCT02054520|66100730|FG003|Overall Study|Withdrawal by Subject|2|||
23648760|NCT02054520|66100731|FG004|Overall Study|Withdrawal by Subject|1|||
23648761|NCT02054520|66100732|FG005|Overall Study|Withdrawal by Subject|0|||
23648762|NCT02054520|66100727|FG000|Overall Study|Physician Decision|0|||
23648763|NCT02054520|66100728|FG001|Overall Study|Physician Decision|1|||
23648764|NCT02054520|66100729|FG002|Overall Study|Physician Decision|0|||
23648765|NCT02054520|66100730|FG003|Overall Study|Physician Decision|1|||
23648766|NCT02054520|66100731|FG004|Overall Study|Physician Decision|0|||
23648767|NCT02054520|66100732|FG005|Overall Study|Physician Decision|1|||
23648768|NCT02054520|66100727|FG000|Overall Study|Study terminated by Sponsor|0|||
23648769|NCT02054520|66100728|FG001|Overall Study|Study terminated by Sponsor|0|||
23648770|NCT02054520|66100729|FG002|Overall Study|Study terminated by Sponsor|2|||
23648771|NCT02054520|66100730|FG003|Overall Study|Study terminated by Sponsor|1|||
23648772|NCT02054520|66100731|FG004|Overall Study|Study terminated by Sponsor|0|||
23648773|NCT02054520|66100732|FG005|Overall Study|Study terminated by Sponsor|0|||
23648774|NCT02344004|66100733|FG000|Overall Study|Adverse Event|11|||
23648775|NCT02344004|66100734|FG001|Overall Study|Adverse Event|1|||
23648776|NCT02344004|66100733|FG000|Overall Study|Death|9|||
23648777|NCT02344004|66100734|FG001|Overall Study|Death|7|||
23648778|NCT02344004|66100733|FG000|Overall Study|Physician Decision|4|||
23648779|NCT02344004|66100734|FG001|Overall Study|Physician Decision|1|||
23648780|NCT02344004|66100733|FG000|Overall Study|Withdrawal by Subject|22|||
23648781|NCT02344004|66100734|FG001|Overall Study|Withdrawal by Subject|5|||
23648782|NCT02344004|66100733|FG000|Overall Study|Rescue Medication|2|||
23648783|NCT02344004|66100734|FG001|Overall Study|Rescue Medication|0|||
23648784|NCT02344004|66100733|FG000|Overall Study|Other Not Specified|12|||
23648785|NCT02344004|66100734|FG001|Overall Study|Other Not Specified|0|||
23648786|NCT02344004|66100733|FG000|Overall Study|Protocol Violation|1|||
23648787|NCT02344004|66100734|FG001|Overall Study|Protocol Violation|0|||
23648788|NCT01098097|66100735|FG000|Overall Study|Adverse Event|17|||
23648789|NCT01098097|66100735|FG000|Overall Study|Lost to Follow-up|18|||
23648790|NCT01098097|66100735|FG000|Overall Study|Status unknown|16|||
23648791|NCT01098097|66100735|FG000|Overall Study|No reason reported|31|||
23648792|NCT00262951|66100736|FG000|Overall Study|Progressive disease/relapse|3|||
23648793|NCT00262951|66100736|FG000|Overall Study|Adverse Event|7|||
23648794|NCT00262951|66100736|FG000|Overall Study|Death|1|||
23648795|NCT00262951|66100736|FG000|Overall Study|Withdrawal by Subject|1|||
23648796|NCT00262951|66100736|FG000|Overall Study|Alternative treatment|3|||
23648797|NCT00262951|66100736|FG000|Overall Study|Off treatment for other disease|1|||
23648798|NCT01211288|66100737|FG000|Overall Study|Lost to Follow-up|1|||
23648799|NCT01211288|66100738|FG001|Overall Study|Lost to Follow-up|1|||
23648800|NCT01912456|66100739|FG000|Period 1|Physician Decision|0|||
23648801|NCT01912456|66100740|FG001|Period 1|Physician Decision|0|||
23648802|NCT01912456|66100741|FG002|Period 1|Physician Decision|1|||
23648803|NCT01912456|66100742|FG003|Period 1|Physician Decision|0|||
23648804|NCT01912456|66100739|FG000|Period 1|non-compliance|1|||
23648805|NCT01912456|66100740|FG001|Period 1|non-compliance|0|||
23648806|NCT01912456|66100741|FG002|Period 1|non-compliance|0|||
23648807|NCT01912456|66100742|FG003|Period 1|non-compliance|1|||
23648808|NCT01912456|66100739|FG000|Period 1|Adverse Event|1|||
23648809|NCT01912456|66100740|FG001|Period 1|Adverse Event|0|||
23648810|NCT01912456|66100741|FG002|Period 1|Adverse Event|0|||
23648811|NCT01912456|66100742|FG003|Period 1|Adverse Event|1|||
23648812|NCT01912456|66100739|FG000|Period 1|Withdrawal by Subject|0|||
23648813|NCT01912456|66100740|FG001|Period 1|Withdrawal by Subject|1|||
23648814|NCT01912456|66100741|FG002|Period 1|Withdrawal by Subject|1|||
23648815|NCT01912456|66100742|FG003|Period 1|Withdrawal by Subject|1|||
23648816|NCT01912456|66100739|FG000|Period 2|Lack of Efficacy|0|||
23648817|NCT01912456|66100740|FG001|Period 2|Lack of Efficacy|2|||
23648818|NCT01912456|66100741|FG002|Period 2|Lack of Efficacy|0|||
23648819|NCT01912456|66100742|FG003|Period 2|Lack of Efficacy|0|||
23648820|NCT01912456|66100739|FG000|Period 2|Adverse Event|0|||
23648821|NCT01912456|66100740|FG001|Period 2|Adverse Event|0|||
23648822|NCT01912456|66100741|FG002|Period 2|Adverse Event|0|||
23648823|NCT01912456|66100742|FG003|Period 2|Adverse Event|1|||
23648824|NCT04975438|66100743|FG000|Overall Study|Lost to Follow-up|1|||
23648825|NCT04975438|66100744|FG001|Overall Study|Lost to Follow-up|0|||
23648826|NCT04975438|66100745|FG002|Overall Study|Lost to Follow-up|1|||
23648827|NCT04975438|66100746|FG003|Overall Study|Lost to Follow-up|0|||
23648828|NCT04975438|66100743|FG000|Overall Study|Withdrawal by Subject|1|||
23648829|NCT04975438|66100744|FG001|Overall Study|Withdrawal by Subject|0|||
23597783|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
23597784|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597785|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597786|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597787|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597788|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597789|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597790|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597791|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
23597792|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
23597793|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
23597794|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
23597795|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
23597796|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
23597797|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
23597798|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597799|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597800|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
23597801|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597802|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
23597803|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597804|NCT02392234|65919254|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
23597805|NCT02392234|65919255|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597806|NCT02392234|65919256|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597807|NCT02392234|65919257|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597808|NCT02392234|65919258|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597809|NCT02392234|65919259|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597810|NCT02616900|65919266|FG000|Overall Study|Lack of Efficacy|7|||
23597811|NCT02616900|65919266|FG000|Overall Study|Lost to Follow-up|2|||
23597812|NCT02616900|65919266|FG000|Overall Study|Protocol Violation|5|||
23597813|NCT02616900|65919266|FG000|Overall Study|Withdrawal by Subject|3|||
23597814|NCT02616900|65919266|FG000|Overall Study|Incomplete data|6|||
23597815|NCT00421889|65919268|FG000|Overall Study|Adverse Event|1|||
23597816|NCT00421889|65919269|FG001|Overall Study|Adverse Event|0|||
23597817|NCT00421889|65919270|FG002|Overall Study|Adverse Event|1|||
23597818|NCT00421889|65919271|FG003|Overall Study|Adverse Event|1|||
23597819|NCT00421889|65919272|FG004|Overall Study|Adverse Event|1|||
23597820|NCT00421889|65919273|FG005|Overall Study|Adverse Event|4|||
23597821|NCT00421889|65919274|FG006|Overall Study|Adverse Event|1|||
23597822|NCT00421889|65919275|FG007|Overall Study|Adverse Event|0|||
23597823|NCT00421889|65919276|FG008|Overall Study|Adverse Event|2|||
23597824|NCT00421889|65919268|FG000|Overall Study|Withdrawal by Subject|1|||
23597825|NCT00421889|65919269|FG001|Overall Study|Withdrawal by Subject|3|||
23597826|NCT00421889|65919270|FG002|Overall Study|Withdrawal by Subject|0|||
23597827|NCT00421889|65919271|FG003|Overall Study|Withdrawal by Subject|0|||
23597828|NCT00421889|65919272|FG004|Overall Study|Withdrawal by Subject|2|||
23597829|NCT00421889|65919273|FG005|Overall Study|Withdrawal by Subject|0|||
23597830|NCT00421889|65919274|FG006|Overall Study|Withdrawal by Subject|0|||
23597831|NCT00421889|65919275|FG007|Overall Study|Withdrawal by Subject|0|||
23597832|NCT00421889|65919276|FG008|Overall Study|Withdrawal by Subject|0|||
23597833|NCT00421889|65919268|FG000|Overall Study|Death|0|||
23597834|NCT00421889|65919269|FG001|Overall Study|Death|0|||
23597835|NCT00421889|65919270|FG002|Overall Study|Death|0|||
23597836|NCT00421889|65919271|FG003|Overall Study|Death|0|||
23597837|NCT00421889|65919272|FG004|Overall Study|Death|1|||
23597838|NCT00421889|65919273|FG005|Overall Study|Death|1|||
23597839|NCT00421889|65919274|FG006|Overall Study|Death|0|||
23597840|NCT00421889|65919275|FG007|Overall Study|Death|0|||
23597841|NCT00421889|65919276|FG008|Overall Study|Death|0|||
23597842|NCT00421889|65919268|FG000|Overall Study|Progressive disease|3|||
23597843|NCT00421889|65919269|FG001|Overall Study|Progressive disease|2|||
23597844|NCT00421889|65919270|FG002|Overall Study|Progressive disease|2|||
23597845|NCT00421889|65919271|FG003|Overall Study|Progressive disease|3|||
23597846|NCT00421889|65919272|FG004|Overall Study|Progressive disease|2|||
23597847|NCT00421889|65919273|FG005|Overall Study|Progressive disease|21|||
23597848|NCT00421889|65919274|FG006|Overall Study|Progressive disease|3|||
23597849|NCT00421889|65919275|FG007|Overall Study|Progressive disease|1|||
23597850|NCT00421889|65919276|FG008|Overall Study|Progressive disease|5|||
23597851|NCT00421889|65919268|FG000|Overall Study|Patient/Investigator request|0|||
23597852|NCT00421889|65919269|FG001|Overall Study|Patient/Investigator request|0|||
23597853|NCT00421889|65919270|FG002|Overall Study|Patient/Investigator request|0|||
23597854|NCT00421889|65919271|FG003|Overall Study|Patient/Investigator request|0|||
23597855|NCT00421889|65919272|FG004|Overall Study|Patient/Investigator request|0|||
23597856|NCT00421889|65919273|FG005|Overall Study|Patient/Investigator request|9|||
23597857|NCT00421889|65919274|FG006|Overall Study|Patient/Investigator request|0|||
23597858|NCT00421889|65919275|FG007|Overall Study|Patient/Investigator request|1|||
23478836|NCT04214288|65494668|FG003|Overall Study|Ongoing in the study|39|||
23478837|NCT04214288|65494665|FG000|Overall Study|Adverse Event|1|||
23478838|NCT04214288|65494666|FG001|Overall Study|Adverse Event|0|||
23478839|NCT04214288|65494667|FG002|Overall Study|Adverse Event|0|||
23478840|NCT04214288|65494668|FG003|Overall Study|Adverse Event|0|||
23478841|NCT04214288|65494665|FG000|Overall Study|Death|22|||
23478842|NCT04214288|65494666|FG001|Overall Study|Death|13|||
23478843|NCT04214288|65494667|FG002|Overall Study|Death|7|||
23478844|NCT04214288|65494668|FG003|Overall Study|Death|19|||
23478845|NCT04214288|65494665|FG000|Overall Study|Lost to Follow-up|1|||
23478846|NCT04214288|65494666|FG001|Overall Study|Lost to Follow-up|2|||
23478847|NCT04214288|65494667|FG002|Overall Study|Lost to Follow-up|1|||
23478848|NCT04214288|65494668|FG003|Overall Study|Lost to Follow-up|0|||
23478849|NCT04214288|65494665|FG000|Overall Study|Other|1|||
23478850|NCT04214288|65494666|FG001|Overall Study|Other|2|||
23478851|NCT04214288|65494667|FG002|Overall Study|Other|0|||
23478852|NCT04214288|65494668|FG003|Overall Study|Other|6|||
23478853|NCT04214288|65494665|FG000|Overall Study|Protocol Violation|0|||
23478854|NCT04214288|65494666|FG001|Overall Study|Protocol Violation|1|||
23478855|NCT04214288|65494667|FG002|Overall Study|Protocol Violation|0|||
23478856|NCT04214288|65494668|FG003|Overall Study|Protocol Violation|0|||
23478857|NCT04214288|65494665|FG000|Overall Study|Withdrawal by Subject|8|||
23478858|NCT04214288|65494666|FG001|Overall Study|Withdrawal by Subject|4|||
23478859|NCT04214288|65494667|FG002|Overall Study|Withdrawal by Subject|0|||
23478860|NCT04214288|65494668|FG003|Overall Study|Withdrawal by Subject|9|||
23478861|NCT00852371|65494669|FG000|Overall Study|Lost to Follow-up|2|||
23478862|NCT00852371|65494670|FG001|Overall Study|Lost to Follow-up|3|||
23478863|NCT00852371|65494671|FG002|Overall Study|Lost to Follow-up|4|||
23478864|NCT00852371|65494672|FG003|Overall Study|Lost to Follow-up|2|||
23478865|NCT00534313|65494673|FG000|Short-term Period|Adverse Event|1|||
23478866|NCT00534313|65494674|FG001|Short-term Period|Adverse Event|2|||
23478867|NCT00534313|65494675|FG002|Short-term Period|Adverse Event|1|||
23478868|NCT00534313|65494676|FG003|Short-term Period|Adverse Event|3|||
23478869|NCT00534313|65494673|FG000|Short-term Period|Lack of Efficacy|3|||
23478870|NCT00534313|65494674|FG001|Short-term Period|Lack of Efficacy|4|||
23478871|NCT00534313|65494675|FG002|Short-term Period|Lack of Efficacy|0|||
23478872|NCT00534313|65494676|FG003|Short-term Period|Lack of Efficacy|3|||
23478873|NCT00534313|65494673|FG000|Short-term Period|Participant not meeting study criteria|0|||
23478874|NCT00534313|65494674|FG001|Short-term Period|Participant not meeting study criteria|0|||
23478875|NCT00534313|65494675|FG002|Short-term Period|Participant not meeting study criteria|0|||
23478876|NCT00534313|65494676|FG003|Short-term Period|Participant not meeting study criteria|1|||
23478877|NCT00534313|65494673|FG000|Short-term Period|Participant withdrew consent|2|||
23478878|NCT00534313|65494674|FG001|Short-term Period|Participant withdrew consent|0|||
23478879|NCT00534313|65494675|FG002|Short-term Period|Participant withdrew consent|0|||
23478880|NCT00534313|65494676|FG003|Short-term Period|Participant withdrew consent|2|||
23478881|NCT00534313|65494673|FG000|Short-term Period|Pregnancy|0|||
23478882|NCT00534313|65494674|FG001|Short-term Period|Pregnancy|0|||
23478883|NCT00534313|65494675|FG002|Short-term Period|Pregnancy|1|||
23478884|NCT00534313|65494676|FG003|Short-term Period|Pregnancy|0|||
23478885|NCT00534313|65494673|FG000|Long-term Period|Adverse Event|2|||
23478886|NCT00534313|65494674|FG001|Long-term Period|Adverse Event|1|||
23478887|NCT00534313|65494675|FG002|Long-term Period|Adverse Event|0|||
23478888|NCT00534313|65494676|FG003|Long-term Period|Adverse Event|1|||
23478889|NCT00534313|65494673|FG000|Long-term Period|Lack of Efficacy|14|||
23478890|NCT00534313|65494674|FG001|Long-term Period|Lack of Efficacy|10|||
23800876|NCT00706992|66649831|FG002|Overall Study|Study termination|6|||
23800877|NCT00706992|66649832|FG003|Overall Study|Study termination|2|||
23800878|NCT00706992|66649833|FG004|Overall Study|Study termination|3|||
23800879|NCT00706992|66649834|FG005|Overall Study|Study termination|2|||
23800880|NCT00706992|66649835|FG006|Overall Study|Study termination|3|||
23800881|NCT00706992|66649829|FG000|Overall Study|Disease progression before treatment|0|||
23800882|NCT00706992|66649830|FG001|Overall Study|Disease progression before treatment|0|||
23800883|NCT00706992|66649831|FG002|Overall Study|Disease progression before treatment|0|||
23360608|NCT02028507|65065801|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23478891|NCT00534313|65494675|FG002|Long-term Period|Lack of Efficacy|14|||
23478892|NCT00534313|65494676|FG003|Long-term Period|Lack of Efficacy|12|||
23478893|NCT00534313|65494673|FG000|Long-term Period|Lost to Follow-up|1|||
23478894|NCT00534313|65494674|FG001|Long-term Period|Lost to Follow-up|2|||
23478895|NCT00534313|65494675|FG002|Long-term Period|Lost to Follow-up|0|||
23478896|NCT00534313|65494676|FG003|Long-term Period|Lost to Follow-up|0|||
23478897|NCT00534313|65494673|FG000|Long-term Period|Withdrawal by Subject|2|||
23478898|NCT00534313|65494674|FG001|Long-term Period|Withdrawal by Subject|2|||
23478899|NCT00534313|65494675|FG002|Long-term Period|Withdrawal by Subject|0|||
23478900|NCT00534313|65494676|FG003|Long-term Period|Withdrawal by Subject|0|||
23478901|NCT00534313|65494673|FG000|Long-term Period|No longer meets study criteria|0|||
23478902|NCT00534313|65494674|FG001|Long-term Period|No longer meets study criteria|1|||
23478903|NCT00534313|65494675|FG002|Long-term Period|No longer meets study criteria|0|||
23478904|NCT00534313|65494676|FG003|Long-term Period|No longer meets study criteria|0|||
23478905|NCT00534313|65494673|FG000|Long-term Period|Poor compliance/noncompliance|0|||
23478906|NCT00534313|65494674|FG001|Long-term Period|Poor compliance/noncompliance|1|||
23478907|NCT00534313|65494675|FG002|Long-term Period|Poor compliance/noncompliance|1|||
23478908|NCT00534313|65494676|FG003|Long-term Period|Poor compliance/noncompliance|0|||
23478909|NCT00534313|65494673|FG000|Long-term Period|Administrative reason by sponsor|17|||
23478910|NCT00534313|65494674|FG001|Long-term Period|Administrative reason by sponsor|15|||
23478911|NCT00534313|65494675|FG002|Long-term Period|Administrative reason by sponsor|26|||
23478912|NCT00534313|65494676|FG003|Long-term Period|Administrative reason by sponsor|18|||
23478913|NCT00534313|65494673|FG000|Long-term Period|Other|1|||
23478914|NCT00534313|65494674|FG001|Long-term Period|Other|2|||
23478915|NCT00534313|65494675|FG002|Long-term Period|Other|2|||
23478916|NCT00534313|65494676|FG003|Long-term Period|Other|2|||
23478917|NCT01966432|65494677|FG000|Overall Study|Lost to Follow-up|3|||
23478918|NCT01966432|65494678|FG001|Overall Study|Lost to Follow-up|2|||
23648830|NCT04975438|66100745|FG002|Overall Study|Withdrawal by Subject|0|||
23648831|NCT04975438|66100746|FG003|Overall Study|Withdrawal by Subject|0|||
23648832|NCT02075541|66100747|FG000|Overall Study|Serious Adverse Event|1|||
23648833|NCT02075541|66100748|FG001|Overall Study|Serious Adverse Event|4|||
23648834|NCT02075541|66100747|FG000|Overall Study|Protocol Violation|1|||
23648835|NCT02075541|66100748|FG001|Overall Study|Protocol Violation|0|||
23648836|NCT02075541|66100747|FG000|Overall Study|Withdrawal by Subject|1|||
23648837|NCT02075541|66100748|FG001|Overall Study|Withdrawal by Subject|3|||
23648838|NCT02075541|66100747|FG000|Overall Study|Sponsor study termination|0|||
23648839|NCT02075541|66100748|FG001|Overall Study|Sponsor study termination|1|||
23648840|NCT02075541|66100747|FG000|Overall Study|Other- unable to perform study procedure|1|||
23648841|NCT02075541|66100748|FG001|Overall Study|Other- unable to perform study procedure|0|||
23648842|NCT00609765|66100749|FG000|Overall Study|Study ended prior to 12 months|1|||
23648843|NCT04875676|66100750|FG000|Overall Study|Lost to Follow-up|1|||
23648844|NCT04875676|66100751|FG001|Overall Study|Lost to Follow-up|0|||
23648845|NCT04875676|66100752|FG002|Overall Study|Lost to Follow-up|0|||
23648846|NCT01324440|66100753|FG000|Overall Study|Subject moved|0|||
23648847|NCT01324440|66100754|FG001|Overall Study|Subject moved|1|||
23648848|NCT01139021|66100755|FG000|Overall Study|Adverse Event|0|||
23648849|NCT01139021|66100756|FG001|Overall Study|Adverse Event|0|||
23648850|NCT01139021|66100757|FG002|Overall Study|Adverse Event|0|||
23648851|NCT01139021|66100758|FG003|Overall Study|Adverse Event|0|||
23648852|NCT01139021|66100759|FG004|Overall Study|Adverse Event|1|||
23648853|NCT01139021|66100760|FG005|Overall Study|Adverse Event|0|||
23648854|NCT01139021|66100755|FG000|Overall Study|Lost to Follow-up|0|||
23648855|NCT01139021|66100756|FG001|Overall Study|Lost to Follow-up|0|||
23648856|NCT01139021|66100757|FG002|Overall Study|Lost to Follow-up|0|||
23648857|NCT01139021|66100758|FG003|Overall Study|Lost to Follow-up|0|||
23648858|NCT01139021|66100759|FG004|Overall Study|Lost to Follow-up|2|||
23648859|NCT01139021|66100760|FG005|Overall Study|Lost to Follow-up|0|||
23648860|NCT01139021|66100755|FG000|Overall Study|Protocol Violation|1|||
23648861|NCT01139021|66100756|FG001|Overall Study|Protocol Violation|0|||
23648862|NCT01139021|66100757|FG002|Overall Study|Protocol Violation|0|||
23648863|NCT01139021|66100758|FG003|Overall Study|Protocol Violation|0|||
23648864|NCT01139021|66100759|FG004|Overall Study|Protocol Violation|2|||
23648865|NCT01139021|66100760|FG005|Overall Study|Protocol Violation|0|||
23648866|NCT01139021|66100755|FG000|Overall Study|Withdrawal by Subject|0|||
23648867|NCT01139021|66100756|FG001|Overall Study|Withdrawal by Subject|0|||
23648868|NCT01139021|66100757|FG002|Overall Study|Withdrawal by Subject|0|||
23648869|NCT01139021|66100758|FG003|Overall Study|Withdrawal by Subject|1|||
23648870|NCT01139021|66100759|FG004|Overall Study|Withdrawal by Subject|4|||
23648871|NCT01139021|66100760|FG005|Overall Study|Withdrawal by Subject|0|||
23648872|NCT00596427|66100762|FG000|Overall Study|Withdrawal by Subject|2|||
23648873|NCT00596427|66100763|FG001|Overall Study|Withdrawal by Subject|2|||
23648874|NCT00596427|66100762|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
23478919|NCT01966432|65494679|FG002|Overall Study|Lost to Follow-up|5|||
23478920|NCT01966432|65494677|FG000|Overall Study|Withdrawal by Subject|1|||
23478921|NCT01966432|65494678|FG001|Overall Study|Withdrawal by Subject|3|||
23648875|NCT00596427|66100763|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
23648876|NCT00596427|66100762|FG000|Overall Study|Protocol Violation|1|||
23648877|NCT00596427|66100763|FG001|Overall Study|Protocol Violation|0|||
23648878|NCT00372229|66100764|FG000|Study Phase|Graft loss|0|||
23648879|NCT00372229|66100765|FG001|Study Phase|Graft loss|3|||
23648880|NCT00372229|66100764|FG000|Study Phase|Protocol Violation|3|||
23648881|NCT00372229|66100765|FG001|Study Phase|Protocol Violation|4|||
23648882|NCT00372229|66100764|FG000|Study Phase|Consent withdrawn|16|||
23648883|NCT00372229|66100765|FG001|Study Phase|Consent withdrawn|14|||
23478922|NCT01966432|65494679|FG002|Overall Study|Withdrawal by Subject|0|||
23648884|NCT00372229|66100764|FG000|Study Phase|Refused treatment/did not cooperate|3|||
23648885|NCT00372229|66100765|FG001|Study Phase|Refused treatment/did not cooperate|1|||
23648886|NCT00372229|66100764|FG000|Study Phase|Death|3|||
23648887|NCT00372229|66100765|FG001|Study Phase|Death|2|||
23648888|NCT00372229|66100764|FG000|Study Phase|Reason not specified|3|||
23648889|NCT00372229|66100765|FG001|Study Phase|Reason not specified|2|||
23648890|NCT00372229|66100764|FG000|Study Phase|Lost to Follow-up|3|||
23648891|NCT00372229|66100765|FG001|Study Phase|Lost to Follow-up|3|||
23648892|NCT00372229|66100764|FG000|Follow-Up Phase|Graft loss|8|||
23648893|NCT00372229|66100765|FG001|Follow-Up Phase|Graft loss|7|||
23648894|NCT00372229|66100764|FG000|Follow-Up Phase|Consent withdrawn|13|||
23648895|NCT00372229|66100765|FG001|Follow-Up Phase|Consent withdrawn|19|||
23648896|NCT00372229|66100764|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
23648897|NCT00372229|66100765|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
23648898|NCT00372229|66100764|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
23648899|NCT00372229|66100765|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
23648900|NCT00372229|66100764|FG000|Follow-Up Phase|Death|9|||
23648901|NCT00372229|66100765|FG001|Follow-Up Phase|Death|12|||
23648902|NCT00372229|66100764|FG000|Follow-Up Phase|Administrative|1|||
23648903|NCT00372229|66100765|FG001|Follow-Up Phase|Administrative|0|||
23648904|NCT00372229|66100764|FG000|Follow-Up Phase|Reason not specified|2|||
23648905|NCT00372229|66100765|FG001|Follow-Up Phase|Reason not specified|3|||
23648906|NCT00372229|66100764|FG000|Follow-Up Phase|Lost to Follow-up|12|||
23648907|NCT00372229|66100765|FG001|Follow-Up Phase|Lost to Follow-up|10|||
23648908|NCT03291587|66100766|FG000|Overall Study|Lost to Follow-up|62|||
23648909|NCT03291587|66100767|FG001|Overall Study|Lost to Follow-up|43|||
23648910|NCT03291587|66100766|FG000|Overall Study|Refused to Answer|5|||
23648911|NCT03291587|66100767|FG001|Overall Study|Refused to Answer|2|||
23648912|NCT03291587|66100766|FG000|Overall Study|Death|2|||
23648913|NCT03291587|66100767|FG001|Overall Study|Death|4|||
23648914|NCT03291587|66100766|FG000|Overall Study|Not interested in participating|8|||
23648915|NCT03291587|66100767|FG001|Overall Study|Not interested in participating|6|||
23648916|NCT03291587|66100766|FG000|Overall Study|Too busy to participate|4|||
23648917|NCT03291587|66100767|FG001|Overall Study|Too busy to participate|2|||
23648918|NCT00031551|66100768|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
23648919|NCT00031551|66100769|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
23648920|NCT00723021|66100770|FG000|Intervention Period 4|Adverse Event|0|||
23648921|NCT00723021|66100771|FG001|Intervention Period 4|Adverse Event|0|||
23648922|NCT00723021|66100772|FG002|Intervention Period 4|Adverse Event|0|||
23648923|NCT00723021|66100773|FG003|Intervention Period 4|Adverse Event|0|||
23648924|NCT00723021|66100774|FG004|Intervention Period 4|Adverse Event|1|||
23648925|NCT01435616|66100775|FG000|Overall Study|Adverse Event|39|||
23648926|NCT01435616|66100776|FG001|Overall Study|Adverse Event|21|||
23648927|NCT01435616|66100775|FG000|Overall Study|Death|7|||
23648928|NCT01435616|66100776|FG001|Overall Study|Death|2|||
23648929|NCT01435616|66100775|FG000|Overall Study|Lost to Follow-up|22|||
23648930|NCT01435616|66100776|FG001|Overall Study|Lost to Follow-up|13|||
23648931|NCT01435616|66100775|FG000|Overall Study|Protocol Violation|16|||
23648932|NCT01435616|66100776|FG001|Overall Study|Protocol Violation|13|||
23648933|NCT01435616|66100775|FG000|Overall Study|Withdrawal by Subject|66|||
23648934|NCT01435616|66100776|FG001|Overall Study|Withdrawal by Subject|24|||
23648935|NCT01435616|66100775|FG000|Overall Study|Physician Decision|20|||
23648936|NCT01435616|66100776|FG001|Overall Study|Physician Decision|7|||
23648937|NCT01435616|66100775|FG000|Overall Study|Sponsor Decision|1|||
23648938|NCT01435616|66100776|FG001|Overall Study|Sponsor Decision|0|||
23648939|NCT01635920|66100777|FG000|Overall Study|Adverse Event|1|||
23648940|NCT01635920|66100778|FG001|Overall Study|Adverse Event|0|||
23648941|NCT01635920|66100777|FG000|Overall Study|Lost to Follow-up|0|||
23648942|NCT01635920|66100778|FG001|Overall Study|Lost to Follow-up|1|||
23648943|NCT01635920|66100777|FG000|Overall Study|Subject decision|2|||
23648944|NCT01635920|66100778|FG001|Overall Study|Subject decision|0|||
23648945|NCT00770341|66100779|FG000|Overall Study|Did not meet eligibility criteria|1|||
23648946|NCT00770341|66100780|FG001|Overall Study|Did not meet eligibility criteria|0|||
23648947|NCT00770341|66100781|FG002|Overall Study|Did not meet eligibility criteria|0|||
23800884|NCT00706992|66649832|FG003|Overall Study|Disease progression before treatment|0|||
23478923|NCT01966432|65494677|FG000|Overall Study|Subject Incarcerated|0|||
23597859|NCT00421889|65919276|FG008|Overall Study|Patient/Investigator request|3|||
23648948|NCT00770341|66100779|FG000|Overall Study|Withdrawal by Subject|0|||
23648949|NCT00770341|66100780|FG001|Overall Study|Withdrawal by Subject|1|||
23648950|NCT00770341|66100781|FG002|Overall Study|Withdrawal by Subject|0|||
23648951|NCT00770341|66100779|FG000|Overall Study|Clinical Adverse Event|3|||
23648952|NCT00770341|66100780|FG001|Overall Study|Clinical Adverse Event|1|||
23648953|NCT00770341|66100781|FG002|Overall Study|Clinical Adverse Event|2|||
23648954|NCT00770341|66100779|FG000|Overall Study|Laboratory adverse event|3|||
23648955|NCT00770341|66100780|FG001|Overall Study|Laboratory adverse event|3|||
23648956|NCT00770341|66100781|FG002|Overall Study|Laboratory adverse event|0|||
23648957|NCT00770341|66100779|FG000|Overall Study|Lack of Efficacy|3|||
23648958|NCT00770341|66100780|FG001|Overall Study|Lack of Efficacy|0|||
23648959|NCT00770341|66100781|FG002|Overall Study|Lack of Efficacy|1|||
23648960|NCT00770341|66100779|FG000|Overall Study|Other|1|||
23648961|NCT00770341|66100780|FG001|Overall Study|Other|0|||
23648962|NCT00770341|66100781|FG002|Overall Study|Other|0|||
23648963|NCT00770341|66100779|FG000|Overall Study|Not treated|1|||
23648964|NCT00770341|66100780|FG001|Overall Study|Not treated|0|||
23648965|NCT00770341|66100781|FG002|Overall Study|Not treated|0|||
23648966|NCT01442779|66100782|FG000|Overall Study|Withdrawal by Subject|3|||
23648967|NCT01442779|66100782|FG000|Overall Study|Death|3|||
23648968|NCT01442779|66100782|FG000|Overall Study|Non-compliance|1|||
23648969|NCT03587974|66100783|FG000|Overall Study|caregiver demented, care recipient died|3|||
23648970|NCT03587974|66100784|FG001|Overall Study|caregiver demented, care recipient died|3|||
23648971|NCT03587974|66100783|FG000|Overall Study|Withdrawal by Subject|2|||
23648972|NCT03587974|66100784|FG001|Overall Study|Withdrawal by Subject|1|||
23648973|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
23648974|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
23648975|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Death|0|||
23648976|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Death|2|||
23648977|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23648978|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
23648979|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
23648980|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
23648981|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
23648982|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
23648983|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
23648984|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
23648985|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
23648986|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
23648987|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
23648988|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
23648989|NCT00343252|66100785|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
23648990|NCT00343252|66100786|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
23648991|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
23648992|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
23648993|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Death|3|||
23648994|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Death|3|||
23648995|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23648996|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23648997|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
23648998|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
23648999|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
23649000|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
23649001|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
23649002|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
23649003|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
23649004|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
23649005|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
23649006|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
23649007|NCT00343252|66100785|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
23649008|NCT00343252|66100786|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
23649009|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
23649010|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
23649011|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Death|4|||
23649012|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Death|5|||
23649013|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
23649014|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23360609|NCT02028507|65065802|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23360610|NCT02028507|65065803|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23360611|NCT02028507|65065804|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
23360612|NCT02028507|65065801|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
23360613|NCT02028507|65065802|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
23360614|NCT02028507|65065803|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
23360615|NCT02028507|65065804|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
23360616|NCT04613739|65065805|FG000|Overall Study|Lost to Follow-up|6|||
23478924|NCT01966432|65494678|FG001|Overall Study|Subject Incarcerated|0|||
23649015|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
23649016|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
23649017|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
23649018|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
23649019|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
23649020|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
23649021|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
23649022|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
23649023|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
23649024|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
23649025|NCT00343252|66100785|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
23649026|NCT00343252|66100786|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
23649027|NCT00903630|66100787|FG000|Phase 2|Adverse Event|0|||
23649028|NCT00903630|66100788|FG001|Phase 2|Adverse Event|0|||
23649029|NCT00903630|66100789|FG002|Phase 2|Adverse Event|1|||
23649030|NCT01589237|66100790|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
23649031|NCT01589237|66100791|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
23649032|NCT01589237|66100792|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
23649033|NCT01589237|66100793|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
23649034|NCT01589237|66100790|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23649035|NCT01589237|66100791|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
23649036|NCT01589237|66100792|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23649037|NCT01589237|66100793|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23649038|NCT01589237|66100790|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
23649039|NCT01589237|66100791|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
23649040|NCT01589237|66100792|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
23649041|NCT01589237|66100793|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
23649042|NCT01589237|66100790|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23649043|NCT01589237|66100791|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23649044|NCT01589237|66100792|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23649045|NCT01589237|66100793|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
23649046|NCT01966471|66100796|FG000|Overall Study|Death|44|||
23649047|NCT01966471|66100797|FG001|Overall Study|Death|56|||
23649048|NCT01966471|66100796|FG000|Overall Study|Lost to Follow-up|46|||
23649049|NCT01966471|66100797|FG001|Overall Study|Lost to Follow-up|39|||
23649050|NCT01966471|66100796|FG000|Overall Study|Various reasons|4|||
23649051|NCT01966471|66100797|FG001|Overall Study|Various reasons|4|||
23649052|NCT01966471|66100796|FG000|Overall Study|Physician Decision|7|||
23649053|NCT01966471|66100797|FG001|Overall Study|Physician Decision|5|||
23649054|NCT01966471|66100796|FG000|Overall Study|Study Terminated By Sponsor|758|||
23649055|NCT01966471|66100797|FG001|Overall Study|Study Terminated By Sponsor|773|||
23649056|NCT01966471|66100796|FG000|Overall Study|Withdrawal by Subject|59|||
23649057|NCT01966471|66100797|FG001|Overall Study|Withdrawal by Subject|51|||
23649058|NCT03235284|66100798|FG000|Overall Study|Adverse Event|1|||
23649059|NCT03235284|66100799|FG001|Overall Study|Adverse Event|2|||
23478925|NCT01966432|65494679|FG002|Overall Study|Subject Incarcerated|1|||
23649060|NCT03235284|66100800|FG002|Overall Study|Adverse Event|1|||
23649061|NCT02680002|66100811|FG000|Overall Study|Lost to Follow-up|5|||
23649062|NCT02680002|66100812|FG001|Overall Study|Lost to Follow-up|1|||
23649063|NCT02680002|66100813|FG002|Overall Study|Lost to Follow-up|4|||
23800885|NCT00706992|66649833|FG004|Overall Study|Disease progression before treatment|1|||
23800886|NCT00706992|66649834|FG005|Overall Study|Disease progression before treatment|0|||
23800887|NCT00706992|66649835|FG006|Overall Study|Disease progression before treatment|0|||
23800888|NCT03581188|66649836|FG000|Overall Study|Inclusion criteria not met|3|||
23800889|NCT03581188|66649837|FG001|Overall Study|Inclusion criteria not met|2|||
23800890|NCT03581188|66649836|FG000|Overall Study|Lost to Follow-up|5|||
23800891|NCT03581188|66649837|FG001|Overall Study|Lost to Follow-up|5|||
23800892|NCT03581188|66649836|FG000|Overall Study|Discontinued intervention|11|||
23800893|NCT03581188|66649837|FG001|Overall Study|Discontinued intervention|8|||
23800894|NCT01933919|66649838|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
23800895|NCT01933919|66649839|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
23800896|NCT01933919|66649838|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
23800897|NCT01933919|66649839|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
23800898|NCT01933919|66649838|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
23800899|NCT01933919|66649839|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
23800900|NCT01933919|66649838|FG000|Open-label Long-term Phase|Adverse Event|2|||
23800901|NCT01933919|66649839|FG001|Open-label Long-term Phase|Adverse Event|0|||
23800902|NCT01933919|66649838|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
23800903|NCT01933919|66649839|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
23800904|NCT01933919|66649838|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
23800905|NCT01933919|66649839|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
23649064|NCT02680002|66100814|FG003|Overall Study|Lost to Follow-up|2|||
23649065|NCT02680002|66100815|FG004|Overall Study|Lost to Follow-up|0|||
23649066|NCT02680002|66100816|FG005|Overall Study|Lost to Follow-up|2|||
23649067|NCT02680002|66100811|FG000|Overall Study|Physician Decision|5|||
23649068|NCT02680002|66100812|FG001|Overall Study|Physician Decision|1|||
23649069|NCT02680002|66100813|FG002|Overall Study|Physician Decision|1|||
23649070|NCT02680002|66100814|FG003|Overall Study|Physician Decision|1|||
23649071|NCT02680002|66100815|FG004|Overall Study|Physician Decision|1|||
23649072|NCT02680002|66100816|FG005|Overall Study|Physician Decision|1|||
23649073|NCT02680002|66100811|FG000|Overall Study|Protocol Violation|1|||
23649074|NCT02680002|66100812|FG001|Overall Study|Protocol Violation|0|||
23649075|NCT02680002|66100813|FG002|Overall Study|Protocol Violation|1|||
23649076|NCT02680002|66100814|FG003|Overall Study|Protocol Violation|0|||
23649077|NCT02680002|66100815|FG004|Overall Study|Protocol Violation|1|||
23649078|NCT02680002|66100816|FG005|Overall Study|Protocol Violation|2|||
23649079|NCT02680002|66100811|FG000|Overall Study|Withdrawal by Subject|0|||
23649080|NCT02680002|66100812|FG001|Overall Study|Withdrawal by Subject|0|||
23649081|NCT02680002|66100813|FG002|Overall Study|Withdrawal by Subject|1|||
23649082|NCT02680002|66100814|FG003|Overall Study|Withdrawal by Subject|0|||
23649083|NCT02680002|66100815|FG004|Overall Study|Withdrawal by Subject|2|||
23649084|NCT02680002|66100816|FG005|Overall Study|Withdrawal by Subject|2|||
23649085|NCT02680002|66100811|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
23649086|NCT02680002|66100812|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
23649087|NCT02680002|66100813|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
23649088|NCT02680002|66100814|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
23649089|NCT02680002|66100815|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
23649090|NCT02680002|66100816|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
23649091|NCT02680002|66100811|FG000|Overall Study|Other|0|||
23649092|NCT02680002|66100812|FG001|Overall Study|Other|1|||
23649093|NCT02680002|66100813|FG002|Overall Study|Other|0|||
23649094|NCT02680002|66100814|FG003|Overall Study|Other|0|||
23649095|NCT02680002|66100815|FG004|Overall Study|Other|1|||
23649096|NCT02680002|66100816|FG005|Overall Study|Other|0|||
23649097|NCT02680002|66100811|FG000|Overall Study|Adverse Event|0|||
23649098|NCT02680002|66100812|FG001|Overall Study|Adverse Event|0|||
23649099|NCT02680002|66100813|FG002|Overall Study|Adverse Event|0|||
23649100|NCT02680002|66100814|FG003|Overall Study|Adverse Event|0|||
23649101|NCT02680002|66100815|FG004|Overall Study|Adverse Event|1|||
23649102|NCT02680002|66100816|FG005|Overall Study|Adverse Event|2|||
23649103|NCT04335812|66100822|FG000|Overall Study|Withdrawal by Subject|1|||
23649104|NCT04335812|66100823|FG001|Overall Study|Withdrawal by Subject|3|||
23649105|NCT04335812|66100822|FG000|Overall Study|Lost to Follow-up|12|||
23649106|NCT04335812|66100823|FG001|Overall Study|Lost to Follow-up|12|||
23649107|NCT04335812|66100822|FG000|Overall Study|Did not engage in the intervention|22|||
23649108|NCT04335812|66100823|FG001|Overall Study|Did not engage in the intervention|18|||
23649109|NCT02647320|66100824|FG000|Overall Study|Adverse Event|0|||
23649110|NCT02647320|66100825|FG001|Overall Study|Adverse Event|1|||
23649111|NCT02647320|66100826|FG002|Overall Study|Adverse Event|3|||
23649112|NCT02647320|66100827|FG003|Overall Study|Adverse Event|2|||
23649113|NCT02647320|66100828|FG004|Overall Study|Adverse Event|1|||
23597860|NCT00421889|65919268|FG000|Overall Study|Lost to Follow-up|0|||
23597861|NCT00421889|65919269|FG001|Overall Study|Lost to Follow-up|0|||
23597862|NCT00421889|65919270|FG002|Overall Study|Lost to Follow-up|0|||
23597863|NCT00421889|65919271|FG003|Overall Study|Lost to Follow-up|0|||
23597864|NCT00421889|65919272|FG004|Overall Study|Lost to Follow-up|0|||
23597865|NCT00421889|65919273|FG005|Overall Study|Lost to Follow-up|0|||
23597866|NCT00421889|65919274|FG006|Overall Study|Lost to Follow-up|0|||
23597867|NCT00421889|65919275|FG007|Overall Study|Lost to Follow-up|0|||
23597868|NCT00421889|65919276|FG008|Overall Study|Lost to Follow-up|1|||
23649114|NCT02647320|66100824|FG000|Overall Study|Protocol Violation|0|||
23649115|NCT02647320|66100825|FG001|Overall Study|Protocol Violation|0|||
23649116|NCT02647320|66100826|FG002|Overall Study|Protocol Violation|3|||
23649117|NCT02647320|66100827|FG003|Overall Study|Protocol Violation|0|||
23649118|NCT02647320|66100828|FG004|Overall Study|Protocol Violation|0|||
23649119|NCT02647320|66100824|FG000|Overall Study|Withdrawal by Subject|7|||
23649120|NCT02647320|66100825|FG001|Overall Study|Withdrawal by Subject|4|||
23649121|NCT02647320|66100826|FG002|Overall Study|Withdrawal by Subject|2|||
23649122|NCT02647320|66100827|FG003|Overall Study|Withdrawal by Subject|2|||
23649123|NCT02647320|66100828|FG004|Overall Study|Withdrawal by Subject|7|||
23649124|NCT02647320|66100824|FG000|Overall Study|Persistent hyperglycemia|0|||
23649125|NCT02647320|66100825|FG001|Overall Study|Persistent hyperglycemia|1|||
23649126|NCT02647320|66100826|FG002|Overall Study|Persistent hyperglycemia|1|||
23649127|NCT02647320|66100827|FG003|Overall Study|Persistent hyperglycemia|1|||
23649128|NCT02647320|66100828|FG004|Overall Study|Persistent hyperglycemia|1|||
23649129|NCT02647320|66100824|FG000|Overall Study|Study terminated by sponsor|1|||
23649130|NCT02647320|66100825|FG001|Overall Study|Study terminated by sponsor|1|||
23597869|NCT03803475|65919279|FG000|Overall Study|Physician Decision|1|||
23649131|NCT02647320|66100826|FG002|Overall Study|Study terminated by sponsor|1|||
23649132|NCT02647320|66100827|FG003|Overall Study|Study terminated by sponsor|1|||
23649133|NCT02647320|66100828|FG004|Overall Study|Study terminated by sponsor|2|||
23649134|NCT02647320|66100824|FG000|Overall Study|Reason not provided|0|||
23649135|NCT02647320|66100825|FG001|Overall Study|Reason not provided|0|||
23649136|NCT02647320|66100826|FG002|Overall Study|Reason not provided|1|||
23597870|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
23597871|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
23597872|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597873|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597874|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597875|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
23597876|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597877|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
23597878|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597879|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597880|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597881|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597882|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
23597883|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
23597884|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597885|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597886|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597887|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597888|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597889|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597890|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597891|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597892|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
23597893|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
23597894|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597895|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
23597896|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597897|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597898|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597899|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597900|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597901|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597902|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597903|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597904|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597905|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
23597906|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
23597907|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597908|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597909|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597910|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597911|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597912|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597913|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
23597914|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597915|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597916|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597917|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597918|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597919|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
23597920|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597921|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597922|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
23597923|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597924|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
23597925|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
23597926|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
23597927|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597928|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597929|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597930|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597931|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
23597932|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597933|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597934|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Other|2|||
23597935|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Other|1|||
23649137|NCT02647320|66100827|FG003|Overall Study|Reason not provided|0|||
23649138|NCT02647320|66100828|FG004|Overall Study|Reason not provided|2|||
23597936|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Other|0|||
23597937|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Other|0|||
23597938|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Other|1|||
23597939|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Other|1|||
23597940|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Other|0|||
23597941|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Other|0|||
23597942|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
23597943|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
23597944|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597945|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597946|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
23597947|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
23597948|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597949|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
23597950|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597951|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597952|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597953|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597954|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
23597955|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597956|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597957|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597958|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
23597959|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597960|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597961|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597962|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597963|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597964|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
23597965|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
23597966|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597967|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597968|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597969|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
23597970|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
23597971|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597972|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597973|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597974|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597975|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
23597976|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597977|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597978|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597979|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597980|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597981|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597982|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597983|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597984|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597985|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597986|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597987|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
23597988|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597989|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597990|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Other|1|||
23597991|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Other|1|||
23597992|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Other|0|||
23597993|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Other|0|||
23597994|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Other|0|||
23800906|NCT01933919|66649838|FG000|Open-label Long-term Phase|Other|1|||
23800907|NCT01933919|66649839|FG001|Open-label Long-term Phase|Other|2|||
23800908|NCT00880087|66649840|FG000|Overall Study|Lost to Follow-up|0|||
23800909|NCT00880087|66649841|FG001|Overall Study|Lost to Follow-up|2|||
23800910|NCT02858726|66649849|FG000|Overall Study|Adverse Event|4|||
23597995|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Other|0|||
23597996|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Other|0|||
23597997|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Other|0|||
23597998|NCT00818246|65919290|FG000|Overall Study|Impossible to match pictures|5|||
23597999|NCT02500758|65919291|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
23598000|NCT02500758|65919292|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
23598001|NCT02500758|65919291|FG000|Washout (1 Week)|Lost to Follow-up|2|||
23800911|NCT02858726|66649850|FG001|Overall Study|Adverse Event|4|||
23649139|NCT02647320|66100824|FG000|Overall Study|Lost to Follow-up|1|||
23649140|NCT02647320|66100825|FG001|Overall Study|Lost to Follow-up|1|||
23649141|NCT02647320|66100826|FG002|Overall Study|Lost to Follow-up|0|||
23649142|NCT02647320|66100827|FG003|Overall Study|Lost to Follow-up|0|||
23649143|NCT02647320|66100828|FG004|Overall Study|Lost to Follow-up|0|||
23649144|NCT02647320|66100824|FG000|Overall Study|Develop anemia|1|||
23649145|NCT02647320|66100825|FG001|Overall Study|Develop anemia|0|||
23649146|NCT02647320|66100826|FG002|Overall Study|Develop anemia|0|||
23649147|NCT02647320|66100827|FG003|Overall Study|Develop anemia|0|||
23649148|NCT02647320|66100828|FG004|Overall Study|Develop anemia|0|||
23649149|NCT02647320|66100824|FG000|Overall Study|Lack of Efficacy|0|||
23649150|NCT02647320|66100825|FG001|Overall Study|Lack of Efficacy|0|||
23649151|NCT02647320|66100826|FG002|Overall Study|Lack of Efficacy|0|||
23649152|NCT02647320|66100827|FG003|Overall Study|Lack of Efficacy|1|||
23649153|NCT02647320|66100828|FG004|Overall Study|Lack of Efficacy|0|||
23649154|NCT02647320|66100824|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
23649155|NCT02647320|66100825|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
23649156|NCT02647320|66100826|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
23649157|NCT02647320|66100827|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
23649158|NCT02647320|66100828|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
23649159|NCT04025580|66100831|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
23649160|NCT04025580|66100832|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
23649161|NCT04025580|66100833|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
23478926|NCT01966432|65494677|FG000|Overall Study|SBIRT program ended|1|||
23478927|NCT01966432|65494678|FG001|Overall Study|SBIRT program ended|8|||
23478928|NCT01966432|65494679|FG002|Overall Study|SBIRT program ended|20|||
23478929|NCT00388583|65494680|FG000|Overall Study|Protocol Violation|1|||
23478930|NCT00388583|65494681|FG001|Overall Study|Protocol Violation|0|||
23478931|NCT00388583|65494680|FG000|Overall Study|Withdrawal by Subject|3|||
23478932|NCT00388583|65494681|FG001|Overall Study|Withdrawal by Subject|3|||
23478933|NCT00388583|65494680|FG000|Overall Study|Serious Adverse Event|2|||
23478934|NCT00388583|65494681|FG001|Overall Study|Serious Adverse Event|0|||
23478935|NCT00388583|65494680|FG000|Overall Study|Did not receive vaccine|0|||
23478936|NCT00388583|65494681|FG001|Overall Study|Did not receive vaccine|1|||
23478937|NCT03104816|65498297|FG000|Overall Study|Lack of Efficacy|0|||
23478938|NCT03104816|65498298|FG001|Overall Study|Lack of Efficacy|2|||
23478939|NCT03104816|65498299|FG002|Overall Study|Lack of Efficacy|0|||
23478940|NCT03104816|65498297|FG000|Overall Study|Protocol Violation|2|||
23478941|NCT03104816|65498298|FG001|Overall Study|Protocol Violation|0|||
23478942|NCT03104816|65498299|FG002|Overall Study|Protocol Violation|2|||
23649162|NCT01275131|66100835|FG000|Period 1|Withdrawal by Subject|1|||
23649163|NCT01275131|66100836|FG001|Period 1|Withdrawal by Subject|0|||
23478943|NCT01350544|65498304|FG000|Overall Study|Administrative Withdrawal|0|||
23478944|NCT01350544|65498305|FG001|Overall Study|Administrative Withdrawal|1|||
23478945|NCT01350544|65498304|FG000|Overall Study|Death|1|||
23478946|NCT01350544|65498305|FG001|Overall Study|Death|2|||
23478947|NCT01350544|65498304|FG000|Overall Study|Moved out of LA County|2|||
23649164|NCT01275131|66100837|FG002|Period 1|Withdrawal by Subject|3|||
23649165|NCT01275131|66100838|FG003|Period 1|Withdrawal by Subject|2|||
23649166|NCT01275131|66100835|FG000|Period 1|Physician Decision|1|||
23649167|NCT01275131|66100836|FG001|Period 1|Physician Decision|0|||
23649168|NCT01275131|66100837|FG002|Period 1|Physician Decision|0|||
23649169|NCT01275131|66100838|FG003|Period 1|Physician Decision|0|||
23649170|NCT01275131|66100835|FG000|Period 2 (Crossover)|Adverse Event|0|||
23649171|NCT01275131|66100836|FG001|Period 2 (Crossover)|Adverse Event|1|||
23649172|NCT01275131|66100837|FG002|Period 2 (Crossover)|Adverse Event|0|||
23649173|NCT01275131|66100838|FG003|Period 2 (Crossover)|Adverse Event|0|||
23649174|NCT01275131|66100835|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
23649175|NCT01275131|66100836|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
23649176|NCT01275131|66100837|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
23649177|NCT01275131|66100838|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
23649178|NCT01222507|66100839|FG000|Overall Study|Physician Decision|1|||
23649179|NCT01222507|66100839|FG000|Overall Study|Withdrawal by Subject|1|||
23649180|NCT01898923|66100841|FG000|Overall Study|Lack of Efficacy|5|||
23649181|NCT01898923|66100842|FG001|Overall Study|Lack of Efficacy|6|||
23649182|NCT01898923|66100841|FG000|Overall Study|Adverse Event|3|||
23649183|NCT01898923|66100842|FG001|Overall Study|Adverse Event|1|||
23649184|NCT01898923|66100841|FG000|Overall Study|Lost to Follow-up|0|||
23649185|NCT01898923|66100842|FG001|Overall Study|Lost to Follow-up|1|||
23649186|NCT01898923|66100841|FG000|Overall Study|Withdrawal by Subject|4|||
23800912|NCT02858726|66649851|FG002|Overall Study|Adverse Event|9|||
23800913|NCT02858726|66649852|FG003|Overall Study|Adverse Event|1|||
23800914|NCT02858726|66649849|FG000|Overall Study|Physician Decision|0|||
23800915|NCT02858726|66649850|FG001|Overall Study|Physician Decision|0|||
23800916|NCT02858726|66649851|FG002|Overall Study|Physician Decision|1|||
23800917|NCT02858726|66649852|FG003|Overall Study|Physician Decision|0|||
23800918|NCT02858726|66649849|FG000|Overall Study|Protocol Violation|0|||
23800919|NCT02858726|66649850|FG001|Overall Study|Protocol Violation|0|||
23800920|NCT02858726|66649851|FG002|Overall Study|Protocol Violation|0|||
23800921|NCT02858726|66649852|FG003|Overall Study|Protocol Violation|1|||
23800922|NCT02858726|66649849|FG000|Overall Study|Study Terminated by Sponsor|0|||
23800923|NCT02858726|66649850|FG001|Overall Study|Study Terminated by Sponsor|0|||
23800924|NCT02858726|66649851|FG002|Overall Study|Study Terminated by Sponsor|0|||
23800925|NCT02858726|66649852|FG003|Overall Study|Study Terminated by Sponsor|1|||
23800926|NCT02858726|66649849|FG000|Overall Study|Withdrawal by Subject|1|||
23800927|NCT02858726|66649850|FG001|Overall Study|Withdrawal by Subject|2|||
23800928|NCT02858726|66649851|FG002|Overall Study|Withdrawal by Subject|1|||
23800929|NCT02858726|66649852|FG003|Overall Study|Withdrawal by Subject|0|||
23800930|NCT02858726|66649849|FG000|Overall Study|Noncompliance|0|||
23800931|NCT02858726|66649850|FG001|Overall Study|Noncompliance|1|||
23800932|NCT02858726|66649851|FG002|Overall Study|Noncompliance|0|||
23800933|NCT02858726|66649852|FG003|Overall Study|Noncompliance|0|||
23800934|NCT04675775|66649853|FG000|Overall Study|Withdrawal by Subject|7|||
23800935|NCT01239472|66649854|FG000|Overall Study|Withdrawal by Subject|5|||
23800936|NCT01239472|66649855|FG001|Overall Study|Withdrawal by Subject|1|||
23800937|NCT01239472|66649854|FG000|Overall Study|Adverse Event|0|||
23800938|NCT01239472|66649855|FG001|Overall Study|Adverse Event|1|||
23800939|NCT01239472|66649854|FG000|Overall Study|Lack of Efficacy|0|||
23800940|NCT01239472|66649855|FG001|Overall Study|Lack of Efficacy|1|||
23800941|NCT02220725|66649860|FG000|Overall Study|Lost to Follow-up|0|||
23800942|NCT02220725|66649861|FG001|Overall Study|Lost to Follow-up|0|||
23800943|NCT02220725|66649862|FG002|Overall Study|Lost to Follow-up|0|||
23800944|NCT02220725|66649863|FG003|Overall Study|Lost to Follow-up|1|||
23649187|NCT01898923|66100842|FG001|Overall Study|Withdrawal by Subject|7|||
23800945|NCT02220725|66649860|FG000|Overall Study|Withdrawal by Subject|0|||
23800946|NCT02220725|66649861|FG001|Overall Study|Withdrawal by Subject|0|||
23800947|NCT02220725|66649862|FG002|Overall Study|Withdrawal by Subject|0|||
23800948|NCT02220725|66649863|FG003|Overall Study|Withdrawal by Subject|1|||
23800949|NCT00114231|66649864|FG000|Overall Study|No consent|2|||
23649188|NCT01898923|66100841|FG000|Overall Study|Physician Decision|3|||
23649189|NCT01898923|66100842|FG001|Overall Study|Physician Decision|4|||
23649190|NCT01898923|66100841|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
23649191|NCT01898923|66100842|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
23649192|NCT02019927|66100845|FG000|Overall Study|Lost to Follow-up|2|||
23649193|NCT02019927|66100846|FG001|Overall Study|Lost to Follow-up|4|||
23649194|NCT02019927|66100847|FG002|Overall Study|Lost to Follow-up|1|||
23649195|NCT02019927|66100848|FG003|Overall Study|Lost to Follow-up|2|||
23649196|NCT02019927|66100849|FG004|Overall Study|Lost to Follow-up|3|||
23649197|NCT02019927|66100850|FG005|Overall Study|Lost to Follow-up|1|||
23649198|NCT00561951|66100851|FG000|Overall Study|Adverse Event|11|||
23649199|NCT00561951|66100852|FG001|Overall Study|Adverse Event|14|||
23649200|NCT00561951|66100853|FG002|Overall Study|Adverse Event|14|||
23649201|NCT00561951|66100851|FG000|Overall Study|Lack of Efficacy|5|||
23649202|NCT00561951|66100852|FG001|Overall Study|Lack of Efficacy|3|||
23649203|NCT00561951|66100853|FG002|Overall Study|Lack of Efficacy|2|||
23649204|NCT00561951|66100851|FG000|Overall Study|Lost to Follow-up|1|||
23649205|NCT00561951|66100852|FG001|Overall Study|Lost to Follow-up|1|||
23649206|NCT00561951|66100853|FG002|Overall Study|Lost to Follow-up|0|||
23649207|NCT00561951|66100851|FG000|Overall Study|Withdrawal by Subject|10|||
23649208|NCT00561951|66100852|FG001|Overall Study|Withdrawal by Subject|9|||
23649209|NCT00561951|66100853|FG002|Overall Study|Withdrawal by Subject|10|||
23649210|NCT00561951|66100851|FG000|Overall Study|Protocol Violation|4|||
23649211|NCT00561951|66100852|FG001|Overall Study|Protocol Violation|3|||
23649212|NCT00561951|66100853|FG002|Overall Study|Protocol Violation|4|||
23598002|NCT02500758|65919292|FG001|Washout (1 Week)|Lost to Follow-up|2|||
23598003|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
23598004|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
23598005|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
23598006|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
23598007|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
23598008|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
23649213|NCT00561951|66100851|FG000|Overall Study|Physician Decision|1|||
23649214|NCT00561951|66100852|FG001|Overall Study|Physician Decision|0|||
23649215|NCT00561951|66100853|FG002|Overall Study|Physician Decision|0|||
23649216|NCT00561951|66100851|FG000|Overall Study|Pregnancy|0|||
23649217|NCT00561951|66100852|FG001|Overall Study|Pregnancy|1|||
23649218|NCT00561951|66100853|FG002|Overall Study|Pregnancy|0|||
23649219|NCT00561951|66100851|FG000|Overall Study|Meet Withdrawal Criterion|0|||
23649220|NCT00561951|66100852|FG001|Overall Study|Meet Withdrawal Criterion|1|||
23649221|NCT00561951|66100853|FG002|Overall Study|Meet Withdrawal Criterion|1|||
23649222|NCT00561951|66100851|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
23649223|NCT00561951|66100852|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
23649224|NCT00561951|66100853|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
23649225|NCT02325557|66100854|FG000|Overall Study|Progressive disease|1|||
23649226|NCT02325557|66100855|FG001|Overall Study|Progressive disease|0|||
23649227|NCT02325557|66100856|FG002|Overall Study|Progressive disease|0|||
23649228|NCT02325557|66100857|FG003|Overall Study|Progressive disease|0|||
23649229|NCT02325557|66100854|FG000|Overall Study|Withdrawal by Subject|4|||
23649230|NCT02325557|66100855|FG001|Overall Study|Withdrawal by Subject|0|||
23649231|NCT02325557|66100856|FG002|Overall Study|Withdrawal by Subject|0|||
23649232|NCT02325557|66100857|FG003|Overall Study|Withdrawal by Subject|15|||
23649233|NCT02325557|66100854|FG000|Overall Study|Death|5|||
23649234|NCT02325557|66100855|FG001|Overall Study|Death|1|||
23649235|NCT02325557|66100856|FG002|Overall Study|Death|1|||
23649236|NCT02325557|66100857|FG003|Overall Study|Death|16|||
23649237|NCT02325557|66100854|FG000|Overall Study|Lost to Follow-up|0|||
23649238|NCT02325557|66100855|FG001|Overall Study|Lost to Follow-up|0|||
23649239|NCT02325557|66100856|FG002|Overall Study|Lost to Follow-up|1|||
23649240|NCT02325557|66100857|FG003|Overall Study|Lost to Follow-up|1|||
23649241|NCT02325557|66100854|FG000|Overall Study|Other|0|||
23649242|NCT02325557|66100855|FG001|Overall Study|Other|0|||
23649243|NCT02325557|66100856|FG002|Overall Study|Other|0|||
23478948|NCT01350544|65498305|FG001|Overall Study|Moved out of LA County|2|||
23598009|NCT00448669|65919297|FG000|Overall Study|Lost to Follow-up|52|||
23649244|NCT02325557|66100857|FG003|Overall Study|Other|5|||
23649245|NCT02164383|66100858|FG000|Overall Study|Lost to Follow-up|1|||
23649246|NCT02164383|66100859|FG001|Overall Study|Lost to Follow-up|0|||
23649247|NCT00390910|66100860|FG000|Overall Study|Adverse Event|1|||
23649248|NCT00390910|66100861|FG001|Overall Study|Adverse Event|0|||
23649249|NCT00390910|66100862|FG002|Overall Study|Adverse Event|0|||
23649250|NCT00390910|66100860|FG000|Overall Study|Lost to Follow-up|0|||
23649251|NCT00390910|66100861|FG001|Overall Study|Lost to Follow-up|1|||
23649252|NCT00390910|66100862|FG002|Overall Study|Lost to Follow-up|5|||
23649253|NCT00390910|66100860|FG000|Overall Study|Withdrawal by Subject|1|||
23649254|NCT00390910|66100861|FG001|Overall Study|Withdrawal by Subject|3|||
23649255|NCT00390910|66100862|FG002|Overall Study|Withdrawal by Subject|2|||
23649256|NCT00390910|66100860|FG000|Overall Study|Migrated/moved from study area|0|||
23649257|NCT00390910|66100861|FG001|Overall Study|Migrated/moved from study area|0|||
23649258|NCT00390910|66100862|FG002|Overall Study|Migrated/moved from study area|3|||
23649259|NCT00777946|66100864|FG000|Overall Study|Adverse Event|11|||
23649260|NCT00777946|66100865|FG001|Overall Study|Adverse Event|1|||
23649261|NCT00777946|66100866|FG002|Overall Study|Adverse Event|3|||
23649262|NCT00777946|66100864|FG000|Overall Study|Lack of Efficacy|0|||
23649263|NCT00777946|66100865|FG001|Overall Study|Lack of Efficacy|0|||
23649264|NCT00777946|66100866|FG002|Overall Study|Lack of Efficacy|9|||
23649265|NCT00777946|66100864|FG000|Overall Study|Condition no longer required study drug|1|||
23649266|NCT00777946|66100865|FG001|Overall Study|Condition no longer required study drug|0|||
23649267|NCT00777946|66100866|FG002|Overall Study|Condition no longer required study drug|0|||
23649268|NCT00777946|66100864|FG000|Overall Study|Patient withdrew consent|3|||
23649269|NCT00777946|66100865|FG001|Overall Study|Patient withdrew consent|2|||
23649270|NCT00777946|66100866|FG002|Overall Study|Patient withdrew consent|3|||
23649271|NCT00777946|66100864|FG000|Overall Study|Lost to Follow-up|3|||
23649272|NCT00777946|66100865|FG001|Overall Study|Lost to Follow-up|1|||
23649273|NCT00777946|66100866|FG002|Overall Study|Lost to Follow-up|0|||
23649274|NCT00777946|66100864|FG000|Overall Study|Protocol deviation|2|||
23649275|NCT00777946|66100865|FG001|Overall Study|Protocol deviation|1|||
23649276|NCT00777946|66100866|FG002|Overall Study|Protocol deviation|1|||
23649277|NCT00777946|66100864|FG000|Overall Study|Randomized in error|1|||
23649278|NCT00777946|66100865|FG001|Overall Study|Randomized in error|1|||
23649279|NCT00777946|66100866|FG002|Overall Study|Randomized in error|0|||
23649280|NCT01127139|66100867|FG000|Overall Study|Adverse Event|40|||
23649281|NCT01127139|66100867|FG000|Overall Study|Incompliance|12|||
23649282|NCT01127139|66100867|FG000|Overall Study|Lack of Efficacy|4|||
23649283|NCT01127139|66100867|FG000|Overall Study|Reason not specified|1|||
23649284|NCT00690820|66100868|FG000|Period 1|Withdrawal by Subject|0|||
23649285|NCT00690820|66100869|FG001|Period 1|Withdrawal by Subject|1|||
23649286|NCT01236339|66100870|FG000|Overall Study|Termination of study by sponsor|11|||
23649287|NCT01236339|66100871|FG001|Overall Study|Termination of study by sponsor|13|||
23649288|NCT00899548|66100874|FG000|Overall Study|Physician Decision|3|||
23649289|NCT02683876|66100875|FG000|Overall Study|samples damaged during shipping|2|||
23649290|NCT02683876|66100876|FG001|Overall Study|samples damaged during shipping|0|||
23649291|NCT02893930|66100877|FG000|Overall Study|Adverse Event|3|||
23649292|NCT02893930|66100877|FG000|Overall Study|Death|1|||
23649293|NCT02893930|66100877|FG000|Overall Study|Disease progression|5|||
23649294|NCT02893930|66100877|FG000|Overall Study|Withdrawal by Subject|2|||
23649295|NCT02893930|66100877|FG000|Overall Study|Physician Decision|1|||
23649296|NCT02893930|66100877|FG000|Overall Study|Ineligible|1|||
23649297|NCT04634825|66100878|FG000|Overall Study|Death|10|||
23649298|NCT04634825|66100879|FG001|Overall Study|Death|3|||
23649299|NCT04634825|66100878|FG000|Overall Study|Lost to Follow-up|1|||
23649300|NCT04634825|66100879|FG001|Overall Study|Lost to Follow-up|0|||
23649301|NCT04634825|66100878|FG000|Overall Study|Study terminated by sponsor|35|||
23649302|NCT04634825|66100879|FG001|Overall Study|Study terminated by sponsor|11|||
23649303|NCT04634825|66100878|FG000|Overall Study|Withdrawal by Subject|2|||
23649304|NCT04634825|66100879|FG001|Overall Study|Withdrawal by Subject|0|||
23649305|NCT00505284|66100880|FG000|Overall Study|Adverse Event|3|||
23649306|NCT00505284|66100881|FG001|Overall Study|Adverse Event|7|||
23649307|NCT00505284|66100882|FG002|Overall Study|Adverse Event|9|||
23649308|NCT00505284|66100883|FG003|Overall Study|Adverse Event|14|||
23649309|NCT00505284|66100884|FG004|Overall Study|Adverse Event|22|||
23649310|NCT00505284|66100880|FG000|Overall Study|Protocol Violation|0|||
23649311|NCT00505284|66100881|FG001|Overall Study|Protocol Violation|1|||
23649312|NCT00505284|66100882|FG002|Overall Study|Protocol Violation|1|||
23649313|NCT00505284|66100883|FG003|Overall Study|Protocol Violation|0|||
23649314|NCT00505284|66100884|FG004|Overall Study|Protocol Violation|0|||
23649315|NCT00505284|66100880|FG000|Overall Study|Withdrawal by Subject|2|||
23649316|NCT00505284|66100881|FG001|Overall Study|Withdrawal by Subject|6|||
23649317|NCT00505284|66100882|FG002|Overall Study|Withdrawal by Subject|1|||
23649318|NCT00505284|66100883|FG003|Overall Study|Withdrawal by Subject|0|||
23649319|NCT00505284|66100884|FG004|Overall Study|Withdrawal by Subject|6|||
23649320|NCT00505284|66100880|FG000|Overall Study|Lack of Efficacy|0|||
23649321|NCT00505284|66100881|FG001|Overall Study|Lack of Efficacy|1|||
23649322|NCT00505284|66100882|FG002|Overall Study|Lack of Efficacy|1|||
23649323|NCT00505284|66100883|FG003|Overall Study|Lack of Efficacy|1|||
23649324|NCT00505284|66100884|FG004|Overall Study|Lack of Efficacy|1|||
23649325|NCT00505284|66100880|FG000|Overall Study|Physician Decision|0|||
23649326|NCT00505284|66100881|FG001|Overall Study|Physician Decision|1|||
23649327|NCT00505284|66100882|FG002|Overall Study|Physician Decision|0|||
23649328|NCT00505284|66100883|FG003|Overall Study|Physician Decision|0|||
23649329|NCT00505284|66100884|FG004|Overall Study|Physician Decision|0|||
23649330|NCT00505284|66100880|FG000|Overall Study|Other|5|||
23649331|NCT00505284|66100881|FG001|Overall Study|Other|0|||
23649332|NCT00505284|66100882|FG002|Overall Study|Other|0|||
23649333|NCT00505284|66100883|FG003|Overall Study|Other|4|||
23649334|NCT00505284|66100884|FG004|Overall Study|Other|4|||
23649335|NCT01403610|66100887|FG000|Overall Study|Withdrawal by Subject|2|||
23649336|NCT01403610|66100888|FG001|Overall Study|Withdrawal by Subject|0|||
23649337|NCT01403610|66100889|FG002|Overall Study|Withdrawal by Subject|0|||
23649338|NCT01403610|66100890|FG003|Overall Study|Withdrawal by Subject|0|||
23649339|NCT01403610|66100887|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
23649340|NCT01403610|66100888|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
23649341|NCT01403610|66100889|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
23649342|NCT01403610|66100890|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
23649343|NCT00938860|66100891|FG000|Overall Study|Adverse Event|2|||
23649344|NCT00938860|66100892|FG001|Overall Study|Adverse Event|1|||
23800950|NCT00114231|66649865|FG001|Overall Study|No consent|0|||
23598010|NCT00448669|65919298|FG001|Overall Study|Lost to Follow-up|63|||
23598011|NCT00448669|65919297|FG000|Overall Study|Withdrawal by Subject|90|||
23598012|NCT00448669|65919298|FG001|Overall Study|Withdrawal by Subject|74|||
23598013|NCT00448669|65919297|FG000|Overall Study|Relocated|49|||
23598014|NCT00448669|65919298|FG001|Overall Study|Relocated|36|||
23598015|NCT00448669|65919297|FG000|Overall Study|Were withdrawn by investigator|10|||
23598016|NCT00448669|65919298|FG001|Overall Study|Were withdrawn by investigator|6|||
23598017|NCT00448669|65919297|FG000|Overall Study|Death|2|||
23598018|NCT00448669|65919298|FG001|Overall Study|Death|4|||
23598019|NCT00448669|65919297|FG000|Overall Study|Had other reasons|5|||
23598020|NCT00448669|65919298|FG001|Overall Study|Had other reasons|6|||
23598021|NCT00448669|65919297|FG000|Overall Study|HIV-infected at enrollment|1|||
23598022|NCT00448669|65919298|FG001|Overall Study|HIV-infected at enrollment|2|||
23598023|NCT00448669|65919297|FG000|Overall Study|Never started drug|9|||
23598024|NCT00448669|65919298|FG001|Overall Study|Never started drug|7|||
23598025|NCT00220740|65919302|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
23598026|NCT00220740|65919303|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
23598027|NCT00220740|65919302|FG000|Efficacy Period|Adverse Event|1|||
23598028|NCT00220740|65919303|FG001|Efficacy Period|Adverse Event|1|||
23598029|NCT00220740|65919302|FG000|Efficacy Period|Withdrawal by Subject|1|||
23598030|NCT00220740|65919303|FG001|Efficacy Period|Withdrawal by Subject|0|||
23598031|NCT00220740|65919302|FG000|Efficacy Period|Protocol Violation|1|||
23598032|NCT00220740|65919303|FG001|Efficacy Period|Protocol Violation|0|||
23598033|NCT00220740|65919302|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
23598034|NCT00220740|65919303|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
23598035|NCT02910713|65919306|FG000|Overall Study|Protocol Violation|2|||
23598036|NCT02910713|65919306|FG000|Overall Study|Subject Choice|4|||
23598037|NCT02910713|65919306|FG000|Overall Study|Received One Application|10|||
23598038|NCT02910713|65919306|FG000|Overall Study|Received Neither Application|18|||
23598039|NCT02910713|65919306|FG000|Overall Study|Enrollment cap|7|||
23598040|NCT02910713|65919306|FG000|Overall Study|Investigator Discretion|1|||
23598041|NCT02374463|65919308|FG000|Overall Study|Withdrawal by Subject|3|||
23598042|NCT02374463|65919309|FG001|Overall Study|Withdrawal by Subject|3|||
23598043|NCT00431834|65919313|FG000|Overall Study|Withdrawal by Subject|7|||
23598044|NCT00431834|65919313|FG000|Overall Study|Death|3|||
23598045|NCT00431834|65919313|FG000|Overall Study|Missed Endpoint Visit|2|||
23598046|NCT00431834|65919313|FG000|Overall Study|Lost to Follow-up|1|||
23598047|NCT00505934|65919314|FG000|Overall Study|Adverse Event|1|||
23598048|NCT00505934|65919314|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
23598049|NCT00505934|65919314|FG000|Overall Study|Other: IV dose needed to be changed|1|||
23598050|NCT04638816|65919317|FG000|Overall Study|Withdrawal by Subject|0|||
23598051|NCT04638816|65919318|FG001|Overall Study|Withdrawal by Subject|1|||
23598052|NCT04638816|65919317|FG000|Overall Study|Lost to Follow-up|0|||
23598053|NCT04638816|65919318|FG001|Overall Study|Lost to Follow-up|1|||
23598054|NCT04436289|65919321|FG000|Overall Study|Death prior to hospital discharge|8|||
23598055|NCT04436289|65919322|FG001|Overall Study|Death prior to hospital discharge|5|||
23598056|NCT04436289|65919323|FG002|Overall Study|Death prior to hospital discharge|0|||
23598057|NCT04436289|65919324|FG003|Overall Study|Death prior to hospital discharge|1|||
23800951|NCT00114231|66649864|FG000|Overall Study|QARC requirement not met|1|||
23598058|NCT04436289|65919321|FG000|Overall Study|Withdrawal by Subject|0|||
23598059|NCT04436289|65919322|FG001|Overall Study|Withdrawal by Subject|1|||
23598060|NCT04436289|65919323|FG002|Overall Study|Withdrawal by Subject|4|||
23598061|NCT04436289|65919324|FG003|Overall Study|Withdrawal by Subject|0|||
23598062|NCT04436289|65919321|FG000|Overall Study|Extended hospital stay|0|||
23598063|NCT04436289|65919322|FG001|Overall Study|Extended hospital stay|1|||
23598064|NCT04436289|65919323|FG002|Overall Study|Extended hospital stay|0|||
23598065|NCT04436289|65919324|FG003|Overall Study|Extended hospital stay|0|||
23598066|NCT04436289|65919321|FG000|Overall Study|Lost to Follow-up|0|||
23598067|NCT04436289|65919322|FG001|Overall Study|Lost to Follow-up|4|||
23649345|NCT00938860|66100891|FG000|Overall Study|Abnormal laboratory values|2|||
23649346|NCT00938860|66100892|FG001|Overall Study|Abnormal laboratory values|2|||
23598068|NCT04436289|65919323|FG002|Overall Study|Lost to Follow-up|1|||
23478949|NCT01350544|65498304|FG000|Overall Study|Medical Issues|1|||
23478950|NCT01350544|65498305|FG001|Overall Study|Medical Issues|1|||
23478951|NCT01350544|65498304|FG000|Overall Study|Withdrawal by Subject|0|||
23478952|NCT01350544|65498305|FG001|Overall Study|Withdrawal by Subject|1|||
23478953|NCT01350544|65498304|FG000|Overall Study|Incarceration|1|||
23478954|NCT01350544|65498305|FG001|Overall Study|Incarceration|0|||
23478955|NCT01350544|65498304|FG000|Overall Study|Lost to Follow-up|18|||
23478956|NCT01350544|65498305|FG001|Overall Study|Lost to Follow-up|15|||
23478957|NCT02282293|65498306|FG000|Overall Study|Lost to Follow-up|2|||
23478958|NCT02282293|65498307|FG001|Overall Study|Lost to Follow-up|2|||
23478959|NCT02282293|65498306|FG000|Overall Study|Unable to comply with study procedures|1|||
23478960|NCT02282293|65498307|FG001|Overall Study|Unable to comply with study procedures|0|||
23478961|NCT02282293|65498306|FG000|Overall Study|Moved out of study area|0|||
23478962|NCT02282293|65498307|FG001|Overall Study|Moved out of study area|1|||
23478963|NCT02386189|65498312|FG000|Overall Study|Lost to Follow-up|2|||
23478964|NCT02386189|65498313|FG001|Overall Study|Lost to Follow-up|3|||
23478965|NCT02386189|65498312|FG000|Overall Study|Withdrawal by Subject|1|||
23478966|NCT02386189|65498313|FG001|Overall Study|Withdrawal by Subject|0|||
23478967|NCT02386189|65498312|FG000|Overall Study|Death|1|||
23478968|NCT02386189|65498313|FG001|Overall Study|Death|0|||
23478969|NCT01144299|65498314|FG000|Overall Study|Lost to Follow-up|1|||
23478970|NCT01144299|65498315|FG001|Overall Study|Lost to Follow-up|0|||
23478971|NCT01144299|65498314|FG000|Overall Study|Withdrawal by Subject|1|||
23478972|NCT01144299|65498315|FG001|Overall Study|Withdrawal by Subject|0|||
23478973|NCT00952380|65498316|FG000|Overall Study|Other|0|||
23478974|NCT00952380|65498317|FG001|Overall Study|Other|0|||
23478975|NCT00952380|65498318|FG002|Overall Study|Other|0|||
23478976|NCT00952380|65498319|FG003|Overall Study|Other|0|||
23478977|NCT00952380|65498320|FG004|Overall Study|Other|1|||
23478978|NCT00952380|65498316|FG000|Overall Study|Withdrawal by Subject|0|||
23478979|NCT00952380|65498317|FG001|Overall Study|Withdrawal by Subject|0|||
23478980|NCT00952380|65498318|FG002|Overall Study|Withdrawal by Subject|1|||
23478981|NCT00952380|65498319|FG003|Overall Study|Withdrawal by Subject|0|||
23478982|NCT00952380|65498320|FG004|Overall Study|Withdrawal by Subject|2|||
23478983|NCT00952380|65498316|FG000|Overall Study|Adverse Event|0|||
23478984|NCT00952380|65498317|FG001|Overall Study|Adverse Event|1|||
23478985|NCT00952380|65498318|FG002|Overall Study|Adverse Event|0|||
23478986|NCT00952380|65498319|FG003|Overall Study|Adverse Event|0|||
23478987|NCT00952380|65498320|FG004|Overall Study|Adverse Event|3|||
23478988|NCT00952380|65498316|FG000|Overall Study|Physician Decision|0|||
23478989|NCT00952380|65498317|FG001|Overall Study|Physician Decision|0|||
23478990|NCT00952380|65498318|FG002|Overall Study|Physician Decision|1|||
23478991|NCT00952380|65498319|FG003|Overall Study|Physician Decision|2|||
23478992|NCT00952380|65498320|FG004|Overall Study|Physician Decision|0|||
23598069|NCT04436289|65919324|FG003|Overall Study|Lost to Follow-up|3|||
23598070|NCT00975585|65919333|FG000|Overall Study|Adverse Event|0|||
23598071|NCT00975585|65919334|FG001|Overall Study|Adverse Event|4|||
23598072|NCT00975585|65919333|FG000|Overall Study|Lost to Follow-up|3|||
23598073|NCT00975585|65919334|FG001|Overall Study|Lost to Follow-up|5|||
23598074|NCT00975585|65919333|FG000|Overall Study|Withdrawal by Subject|2|||
23598075|NCT00975585|65919334|FG001|Overall Study|Withdrawal by Subject|1|||
23598076|NCT00975585|65919333|FG000|Overall Study|Lens issue|2|||
23598077|NCT00975585|65919334|FG001|Overall Study|Lens issue|2|||
23598078|NCT03764475|65919335|FG000|Overall Study|Adverse Event|11|||
23598079|NCT03764475|65919336|FG001|Overall Study|Adverse Event|2|||
23598080|NCT03764475|65919335|FG000|Overall Study|Lost to Follow-up|24|||
23598081|NCT03764475|65919336|FG001|Overall Study|Lost to Follow-up|10|||
23649347|NCT00938860|66100891|FG000|Overall Study|Withdrawal by Subject|11|||
23478993|NCT00952380|65498316|FG000|Overall Study|Non-compliant to protocol|0|||
23478994|NCT00952380|65498317|FG001|Overall Study|Non-compliant to protocol|0|||
23478995|NCT00952380|65498318|FG002|Overall Study|Non-compliant to protocol|0|||
23478996|NCT00952380|65498319|FG003|Overall Study|Non-compliant to protocol|1|||
23478997|NCT00952380|65498320|FG004|Overall Study|Non-compliant to protocol|0|||
23478998|NCT02586506|65498334|FG000|Overall Study|Protocol Violation|6|||
23478999|NCT02586506|65498334|FG000|Overall Study|Lost to Follow-up|1|||
23598082|NCT03764475|65919335|FG000|Overall Study|Withdrawal by Subject|26|||
23598083|NCT03764475|65919336|FG001|Overall Study|Withdrawal by Subject|10|||
23598084|NCT03764475|65919335|FG000|Overall Study|Lack of Efficacy|3|||
23598085|NCT03764475|65919336|FG001|Overall Study|Lack of Efficacy|0|||
23598086|NCT03764475|65919335|FG000|Overall Study|COVID-19 Disruption|2|||
23598087|NCT03764475|65919336|FG001|Overall Study|COVID-19 Disruption|0|||
23598088|NCT02291913|65919337|FG000|Overall Study|Progressive Disease|32|||
23598089|NCT02291913|65919337|FG000|Overall Study|Adverse Event|11|||
23598090|NCT02291913|65919337|FG000|Overall Study|Death|2|||
23598091|NCT02291913|65919337|FG000|Overall Study|Physician Decision|1|||
23598092|NCT02291913|65919337|FG000|Overall Study|Withdrawal by Subject|1|||
23598093|NCT02291913|65919337|FG000|Overall Study|Protocol Violation|1|||
23598094|NCT03283371|65919338|FG000|Placebo-controlled|Adverse Event|1|||
23598095|NCT03283371|65919339|FG001|Placebo-controlled|Adverse Event|1|||
23598096|NCT03283371|65919340|FG002|Placebo-controlled|Adverse Event|0|||
23598097|NCT03283371|65919341|FG003|Placebo-controlled|Adverse Event|0|||
23598098|NCT03283371|65919338|FG000|Placebo-controlled|Lack of Efficacy|1|||
23598099|NCT03283371|65919339|FG001|Placebo-controlled|Lack of Efficacy|0|||
23598100|NCT03283371|65919340|FG002|Placebo-controlled|Lack of Efficacy|0|||
23598101|NCT03283371|65919341|FG003|Placebo-controlled|Lack of Efficacy|0|||
23598102|NCT03283371|65919338|FG000|Placebo-controlled|Withdrawal by Subject|1|||
23598103|NCT03283371|65919339|FG001|Placebo-controlled|Withdrawal by Subject|1|||
23598104|NCT03283371|65919340|FG002|Placebo-controlled|Withdrawal by Subject|0|||
23598105|NCT03283371|65919341|FG003|Placebo-controlled|Withdrawal by Subject|0|||
23598106|NCT03283371|65919338|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598107|NCT03283371|65919339|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
23598108|NCT03283371|65919340|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598109|NCT03283371|65919341|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598110|NCT03283371|65919338|FG000|Open-label Phase|Adverse Event|0|||
23598111|NCT03283371|65919339|FG001|Open-label Phase|Adverse Event|0|||
23598112|NCT03283371|65919340|FG002|Open-label Phase|Adverse Event|2|||
23598113|NCT03283371|65919341|FG003|Open-label Phase|Adverse Event|0|||
23598114|NCT03283371|65919338|FG000|Open-label Phase|Withdrawal by Subject|0|||
23598115|NCT03283371|65919339|FG001|Open-label Phase|Withdrawal by Subject|0|||
23598116|NCT03283371|65919340|FG002|Open-label Phase|Withdrawal by Subject|1|||
23598117|NCT03283371|65919341|FG003|Open-label Phase|Withdrawal by Subject|0|||
23598118|NCT03283371|65919338|FG000|Open-label Phase|Other|0|||
23598119|NCT03283371|65919339|FG001|Open-label Phase|Other|0|||
23598120|NCT03283371|65919340|FG002|Open-label Phase|Other|1|||
23598121|NCT03283371|65919341|FG003|Open-label Phase|Other|1|||
23598122|NCT01737021|65919342|FG000|Overall Study|Lost to Follow-up|5|||
23598123|NCT01737021|65919343|FG001|Overall Study|Lost to Follow-up|3|||
23598124|NCT00931710|65919346|FG000|Overall Study|Adverse Event|16|||
23598125|NCT00931710|65919347|FG001|Overall Study|Adverse Event|10|||
23598126|NCT00931710|65919346|FG000|Overall Study|Abnormal test procedure results|2|||
23598127|NCT00931710|65919347|FG001|Overall Study|Abnormal test procedure results|0|||
23598128|NCT00931710|65919346|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
23598129|NCT00931710|65919347|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
23598130|NCT00931710|65919346|FG000|Overall Study|Patient withdrew consent|4|||
23598131|NCT00931710|65919347|FG001|Overall Study|Patient withdrew consent|9|||
23598132|NCT00931710|65919346|FG000|Overall Study|Lost to Follow-up|6|||
23598133|NCT00931710|65919347|FG001|Overall Study|Lost to Follow-up|5|||
23598134|NCT00931710|65919346|FG000|Overall Study|Protocol deviation|1|||
23598135|NCT00931710|65919347|FG001|Overall Study|Protocol deviation|2|||
23598136|NCT01972724|65919350|FG000|Double-Blind|Rescue Criteria Met|1|||
23598137|NCT01972724|65919351|FG001|Double-Blind|Rescue Criteria Met|0|||
23598138|NCT01972724|65919352|FG002|Double-Blind|Rescue Criteria Met|0|||
23598139|NCT01972724|65919350|FG000|Double-Blind|Adverse Event|1|||
23598140|NCT01972724|65919351|FG001|Double-Blind|Adverse Event|0|||
23598141|NCT01972724|65919352|FG002|Double-Blind|Adverse Event|0|||
23598142|NCT01972724|65919350|FG000|Double-Blind|Withdrawal of Consent|2|||
23598143|NCT01972724|65919351|FG001|Double-Blind|Withdrawal of Consent|1|||
23598144|NCT01972724|65919352|FG002|Double-Blind|Withdrawal of Consent|0|||
23598145|NCT01972724|65919350|FG000|Double-Blind|Significant Protocol Deviation|5|||
23598146|NCT01972724|65919351|FG001|Double-Blind|Significant Protocol Deviation|8|||
23598147|NCT01972724|65919352|FG002|Double-Blind|Significant Protocol Deviation|0|||
23598148|NCT01972724|65919350|FG000|Open-Label|Withdrew Consent|0|||
23598149|NCT01972724|65919351|FG001|Open-Label|Withdrew Consent|0|||
23598150|NCT01972724|65919352|FG002|Open-Label|Withdrew Consent|3|||
23598151|NCT01972724|65919350|FG000|Open-Label|Significant Protocol Deviation|0|||
23598152|NCT01972724|65919351|FG001|Open-Label|Significant Protocol Deviation|0|||
23598153|NCT01972724|65919352|FG002|Open-Label|Significant Protocol Deviation|2|||
23598154|NCT03785405|65919353|FG000|Overall Study|Adverse Event|16|||
23598155|NCT03785405|65919354|FG001|Overall Study|Adverse Event|1|||
23598156|NCT03785405|65919353|FG000|Overall Study|Death|6|||
23598157|NCT03785405|65919354|FG001|Overall Study|Death|4|||
23598158|NCT03785405|65919353|FG000|Overall Study|Guardian decision|4|||
23598159|NCT03785405|65919354|FG001|Overall Study|Guardian decision|1|||
23598160|NCT03785405|65919353|FG000|Overall Study|Lost to Follow-up|1|||
23598161|NCT03785405|65919354|FG001|Overall Study|Lost to Follow-up|0|||
23598162|NCT03785405|65919353|FG000|Overall Study|Physician Decision|8|||
23598163|NCT03785405|65919354|FG001|Overall Study|Physician Decision|5|||
23598164|NCT03785405|65919353|FG000|Overall Study|Participant decision|2|||
23649348|NCT00938860|66100892|FG001|Overall Study|Withdrawal by Subject|8|||
23649349|NCT00938860|66100891|FG000|Overall Study|Lost to Follow-up|4|||
23649350|NCT00938860|66100892|FG001|Overall Study|Lost to Follow-up|4|||
23649351|NCT00938860|66100891|FG000|Overall Study|Administration problems|2|||
23649352|NCT00938860|66100892|FG001|Overall Study|Administration problems|0|||
23649353|NCT00938860|66100891|FG000|Overall Study|Death|1|||
23649354|NCT00938860|66100892|FG001|Overall Study|Death|1|||
23649355|NCT00938860|66100891|FG000|Overall Study|Protocol Violation|3|||
23649356|NCT00938860|66100892|FG001|Overall Study|Protocol Violation|1|||
23649357|NCT02520284|66100895|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
23649358|NCT02520284|66100896|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
23649359|NCT02520284|66100897|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
23649360|NCT02520284|66100895|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23649361|NCT02520284|66100896|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23649362|NCT02520284|66100897|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23649363|NCT02520284|66100895|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
23649364|NCT02520284|66100896|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
23649365|NCT02520284|66100897|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
23649366|NCT02520284|66100895|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
23649367|NCT02520284|66100896|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
23649368|NCT02520284|66100897|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
23649369|NCT02520284|66100895|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
23649370|NCT02520284|66100896|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
23649371|NCT02520284|66100897|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
23649372|NCT02520284|66100895|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
23649373|NCT02520284|66100896|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
23649374|NCT02520284|66100897|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
23649375|NCT02520284|66100895|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
23649376|NCT02520284|66100896|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
23649377|NCT02520284|66100897|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
23649378|NCT02520284|66100895|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
23649379|NCT02520284|66100896|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
23649380|NCT02520284|66100897|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
23649381|NCT02520284|66100895|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
23649382|NCT02520284|66100896|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
23649383|NCT02520284|66100897|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
23649384|NCT02520284|66100895|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
23649385|NCT02520284|66100896|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
23649386|NCT02520284|66100897|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
23649387|NCT02520284|66100895|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
23649388|NCT02520284|66100896|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
23649389|NCT02520284|66100897|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
23649390|NCT02401867|66100898|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
23649391|NCT02401867|66100898|FG000|Analysis|Cervical assay could not be conducted|9|||
23649392|NCT01036763|66100899|FG000|Overall Study|Adverse Event|25|||
23649393|NCT01036763|66100899|FG000|Overall Study|Lost to Follow-up|28|||
23649394|NCT01036763|66100899|FG000|Overall Study|Other reason (not specified)|40|||
23649395|NCT00406653|66100900|FG000|Induction Period|Adverse Event|1|||
23649396|NCT00406653|66100901|FG001|Induction Period|Adverse Event|10|||
23649397|NCT00406653|66100902|FG002|Induction Period|Adverse Event|4|||
23649398|NCT00406653|66100903|FG003|Induction Period|Adverse Event|11|||
23649399|NCT00406653|66100904|FG004|Induction Period|Adverse Event|0|||
23649400|NCT00406653|66100905|FG005|Induction Period|Adverse Event|0|||
23649401|NCT00406653|66100906|FG006|Induction Period|Adverse Event|0|||
23649402|NCT00406653|66100900|FG000|Induction Period|Lack of Efficacy|11|||
23649403|NCT00406653|66100901|FG001|Induction Period|Lack of Efficacy|14|||
23649404|NCT00406653|66100902|FG002|Induction Period|Lack of Efficacy|8|||
23649405|NCT00406653|66100903|FG003|Induction Period|Lack of Efficacy|10|||
23649406|NCT00406653|66100904|FG004|Induction Period|Lack of Efficacy|0|||
23649407|NCT00406653|66100905|FG005|Induction Period|Lack of Efficacy|0|||
23649408|NCT00406653|66100906|FG006|Induction Period|Lack of Efficacy|0|||
23649409|NCT00406653|66100900|FG000|Induction Period|Lost to Follow-up|0|||
23649410|NCT00406653|66100901|FG001|Induction Period|Lost to Follow-up|2|||
23649411|NCT00406653|66100902|FG002|Induction Period|Lost to Follow-up|0|||
23649412|NCT00406653|66100903|FG003|Induction Period|Lost to Follow-up|0|||
23649413|NCT00406653|66100904|FG004|Induction Period|Lost to Follow-up|0|||
23649414|NCT00406653|66100905|FG005|Induction Period|Lost to Follow-up|0|||
23649415|NCT00406653|66100906|FG006|Induction Period|Lost to Follow-up|0|||
23649416|NCT00406653|66100900|FG000|Induction Period|Withdrawal of Consent|2|||
23649417|NCT00406653|66100901|FG001|Induction Period|Withdrawal of Consent|5|||
23649418|NCT00406653|66100902|FG002|Induction Period|Withdrawal of Consent|1|||
23649419|NCT00406653|66100903|FG003|Induction Period|Withdrawal of Consent|2|||
23649420|NCT00406653|66100904|FG004|Induction Period|Withdrawal of Consent|0|||
23649421|NCT00406653|66100905|FG005|Induction Period|Withdrawal of Consent|0|||
23649422|NCT00406653|66100906|FG006|Induction Period|Withdrawal of Consent|0|||
23649423|NCT00406653|66100900|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649424|NCT00406653|66100901|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649425|NCT00406653|66100902|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649426|NCT00406653|66100903|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
23649427|NCT00406653|66100904|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649428|NCT00406653|66100905|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649429|NCT00406653|66100906|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
23649430|NCT00406653|66100900|FG000|Induction Period|Pregnancy|1|||
23649431|NCT00406653|66100901|FG001|Induction Period|Pregnancy|0|||
23649432|NCT00406653|66100902|FG002|Induction Period|Pregnancy|0|||
23649433|NCT00406653|66100903|FG003|Induction Period|Pregnancy|0|||
23649434|NCT00406653|66100904|FG004|Induction Period|Pregnancy|0|||
23649435|NCT00406653|66100905|FG005|Induction Period|Pregnancy|0|||
23649436|NCT00406653|66100906|FG006|Induction Period|Pregnancy|0|||
23649437|NCT00406653|66100900|FG000|Induction Period|Declined participation but followup done|0|||
23649438|NCT00406653|66100901|FG001|Induction Period|Declined participation but followup done|2|||
23649439|NCT00406653|66100902|FG002|Induction Period|Declined participation but followup done|1|||
23649440|NCT00406653|66100903|FG003|Induction Period|Declined participation but followup done|1|||
23649441|NCT00406653|66100904|FG004|Induction Period|Declined participation but followup done|0|||
23649442|NCT00406653|66100905|FG005|Induction Period|Declined participation but followup done|0|||
23649443|NCT00406653|66100906|FG006|Induction Period|Declined participation but followup done|0|||
23649444|NCT00406653|66100900|FG000|Induction Period|Given prohibited drug|0|||
23649445|NCT00406653|66100901|FG001|Induction Period|Given prohibited drug|1|||
23649446|NCT00406653|66100902|FG002|Induction Period|Given prohibited drug|2|||
23649447|NCT00406653|66100903|FG003|Induction Period|Given prohibited drug|0|||
23649448|NCT00406653|66100904|FG004|Induction Period|Given prohibited drug|0|||
23649449|NCT00406653|66100905|FG005|Induction Period|Given prohibited drug|0|||
23649450|NCT00406653|66100906|FG006|Induction Period|Given prohibited drug|0|||
23649451|NCT00406653|66100900|FG000|Induction Period|Incarcerated|0|||
23649452|NCT00406653|66100901|FG001|Induction Period|Incarcerated|0|||
23649453|NCT00406653|66100902|FG002|Induction Period|Incarcerated|1|||
23649454|NCT00406653|66100903|FG003|Induction Period|Incarcerated|0|||
23649455|NCT00406653|66100904|FG004|Induction Period|Incarcerated|0|||
23649456|NCT00406653|66100905|FG005|Induction Period|Incarcerated|0|||
23649457|NCT00406653|66100906|FG006|Induction Period|Incarcerated|0|||
23649458|NCT00406653|66100900|FG000|Induction Period|Patient relocated|0|||
23649459|NCT00406653|66100901|FG001|Induction Period|Patient relocated|0|||
23649460|NCT00406653|66100902|FG002|Induction Period|Patient relocated|1|||
23649461|NCT00406653|66100903|FG003|Induction Period|Patient relocated|0|||
23649462|NCT00406653|66100904|FG004|Induction Period|Patient relocated|0|||
23649463|NCT00406653|66100905|FG005|Induction Period|Patient relocated|0|||
23649464|NCT00406653|66100906|FG006|Induction Period|Patient relocated|0|||
23649465|NCT00406653|66100900|FG000|Maintenance Period|Adverse Event|0|||
23649466|NCT00406653|66100901|FG001|Maintenance Period|Adverse Event|0|||
23649467|NCT00406653|66100902|FG002|Maintenance Period|Adverse Event|0|||
23649468|NCT00406653|66100903|FG003|Maintenance Period|Adverse Event|0|||
23649469|NCT00406653|66100904|FG004|Maintenance Period|Adverse Event|1|||
23649470|NCT00406653|66100905|FG005|Maintenance Period|Adverse Event|1|||
23649471|NCT00406653|66100906|FG006|Maintenance Period|Adverse Event|0|||
23649472|NCT00406653|66100900|FG000|Maintenance Period|Lack of Efficacy|0|||
23649473|NCT00406653|66100901|FG001|Maintenance Period|Lack of Efficacy|0|||
23649474|NCT00406653|66100902|FG002|Maintenance Period|Lack of Efficacy|0|||
23649475|NCT00406653|66100903|FG003|Maintenance Period|Lack of Efficacy|0|||
23649476|NCT00406653|66100904|FG004|Maintenance Period|Lack of Efficacy|20|||
23649477|NCT00406653|66100905|FG005|Maintenance Period|Lack of Efficacy|26|||
23649478|NCT00406653|66100906|FG006|Maintenance Period|Lack of Efficacy|0|||
23649479|NCT00406653|66100900|FG000|Maintenance Period|Lost to Follow-up|0|||
23649480|NCT00406653|66100901|FG001|Maintenance Period|Lost to Follow-up|0|||
23649481|NCT00406653|66100902|FG002|Maintenance Period|Lost to Follow-up|0|||
23649482|NCT00406653|66100903|FG003|Maintenance Period|Lost to Follow-up|0|||
23649483|NCT00406653|66100904|FG004|Maintenance Period|Lost to Follow-up|2|||
23649484|NCT00406653|66100905|FG005|Maintenance Period|Lost to Follow-up|1|||
23649485|NCT00406653|66100906|FG006|Maintenance Period|Lost to Follow-up|0|||
23649486|NCT00406653|66100900|FG000|Maintenance Period|Withdrawal of Consent|0|||
23649487|NCT00406653|66100901|FG001|Maintenance Period|Withdrawal of Consent|0|||
23649488|NCT00406653|66100902|FG002|Maintenance Period|Withdrawal of Consent|0|||
23649489|NCT00406653|66100903|FG003|Maintenance Period|Withdrawal of Consent|0|||
23649490|NCT00406653|66100904|FG004|Maintenance Period|Withdrawal of Consent|2|||
23649491|NCT00406653|66100905|FG005|Maintenance Period|Withdrawal of Consent|0|||
23649492|NCT00406653|66100906|FG006|Maintenance Period|Withdrawal of Consent|0|||
23649493|NCT00406653|66100900|FG000|Maintenance Period|Pregnancy|0|||
23649494|NCT00406653|66100901|FG001|Maintenance Period|Pregnancy|0|||
23649495|NCT00406653|66100902|FG002|Maintenance Period|Pregnancy|0|||
23649496|NCT00406653|66100903|FG003|Maintenance Period|Pregnancy|0|||
23649497|NCT00406653|66100904|FG004|Maintenance Period|Pregnancy|0|||
23649498|NCT00406653|66100905|FG005|Maintenance Period|Pregnancy|1|||
23649499|NCT00406653|66100906|FG006|Maintenance Period|Pregnancy|0|||
23649500|NCT00406653|66100900|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
23649501|NCT00406653|66100901|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
23649502|NCT00406653|66100902|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
23649503|NCT00406653|66100903|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
23649504|NCT00406653|66100904|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
23649505|NCT00406653|66100905|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
23649506|NCT00406653|66100906|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
23649507|NCT00406653|66100900|FG000|Maintenance Period|Error in disease score evaluation|0|||
23649508|NCT00406653|66100901|FG001|Maintenance Period|Error in disease score evaluation|0|||
23649509|NCT00406653|66100902|FG002|Maintenance Period|Error in disease score evaluation|0|||
23649510|NCT00406653|66100903|FG003|Maintenance Period|Error in disease score evaluation|0|||
23649511|NCT00406653|66100904|FG004|Maintenance Period|Error in disease score evaluation|1|||
23649512|NCT00406653|66100905|FG005|Maintenance Period|Error in disease score evaluation|0|||
23649513|NCT00406653|66100906|FG006|Maintenance Period|Error in disease score evaluation|0|||
23649514|NCT00406653|66100900|FG000|Open-Label Period|Death|0|||
23649515|NCT00406653|66100901|FG001|Open-Label Period|Death|0|||
23649516|NCT00406653|66100902|FG002|Open-Label Period|Death|0|||
23649517|NCT00406653|66100903|FG003|Open-Label Period|Death|0|||
23649518|NCT00406653|66100904|FG004|Open-Label Period|Death|0|||
23649519|NCT00406653|66100905|FG005|Open-Label Period|Death|0|||
23649520|NCT00406653|66100906|FG006|Open-Label Period|Death|1|||
23649521|NCT00406653|66100900|FG000|Open-Label Period|Adverse Event|0|||
23649522|NCT00406653|66100901|FG001|Open-Label Period|Adverse Event|0|||
23649523|NCT00406653|66100902|FG002|Open-Label Period|Adverse Event|0|||
23649524|NCT00406653|66100903|FG003|Open-Label Period|Adverse Event|0|||
23649525|NCT00406653|66100904|FG004|Open-Label Period|Adverse Event|0|||
23649526|NCT00406653|66100905|FG005|Open-Label Period|Adverse Event|0|||
23800952|NCT00114231|66649865|FG001|Overall Study|QARC requirement not met|0|||
23800953|NCT00114231|66649864|FG000|Overall Study|Suspected metastatic disease|1|||
23800954|NCT00114231|66649865|FG001|Overall Study|Suspected metastatic disease|0|||
23800955|NCT00114231|66649864|FG000|Overall Study|No adenocarcinoma|1|||
23800956|NCT00114231|66649865|FG001|Overall Study|No adenocarcinoma|0|||
23800957|NCT00114231|66649864|FG000|Overall Study|Low creatinine clearance|0|||
23800958|NCT00114231|66649865|FG001|Overall Study|Low creatinine clearance|1|||
23800959|NCT00114231|66649864|FG000|Overall Study|Tumor size > 4cm|1|||
23800960|NCT00114231|66649865|FG001|Overall Study|Tumor size > 4cm|0|||
23800961|NCT00114231|66649864|FG000|Overall Study|Tumor fixed on digital exam|0|||
23800962|NCT00114231|66649865|FG001|Overall Study|Tumor fixed on digital exam|1|||
23800963|NCT00114231|66649864|FG000|Overall Study|No Absolute Neutrophil Count|2|||
23649527|NCT00406653|66100906|FG006|Open-Label Period|Adverse Event|18|||
23649528|NCT00406653|66100900|FG000|Open-Label Period|Lack of Efficacy|0|||
23649529|NCT00406653|66100901|FG001|Open-Label Period|Lack of Efficacy|0|||
23800964|NCT00114231|66649865|FG001|Overall Study|No Absolute Neutrophil Count|0|||
23800965|NCT00114231|66649864|FG000|Overall Study|Biopsy done after registration|1|||
23649530|NCT00406653|66100902|FG002|Open-Label Period|Lack of Efficacy|0|||
23649531|NCT00406653|66100903|FG003|Open-Label Period|Lack of Efficacy|0|||
23649532|NCT00406653|66100904|FG004|Open-Label Period|Lack of Efficacy|0|||
23649533|NCT00406653|66100905|FG005|Open-Label Period|Lack of Efficacy|0|||
23649534|NCT00406653|66100906|FG006|Open-Label Period|Lack of Efficacy|160|||
23649535|NCT00406653|66100900|FG000|Open-Label Period|Lost to Follow-up|0|||
23649536|NCT00406653|66100901|FG001|Open-Label Period|Lost to Follow-up|0|||
23649537|NCT00406653|66100902|FG002|Open-Label Period|Lost to Follow-up|0|||
23649538|NCT00406653|66100903|FG003|Open-Label Period|Lost to Follow-up|0|||
23649539|NCT00406653|66100904|FG004|Open-Label Period|Lost to Follow-up|0|||
23649540|NCT00406653|66100905|FG005|Open-Label Period|Lost to Follow-up|0|||
23649541|NCT00406653|66100906|FG006|Open-Label Period|Lost to Follow-up|6|||
23649542|NCT00406653|66100900|FG000|Open-Label Period|Withdrawal of Consent|0|||
23649543|NCT00406653|66100901|FG001|Open-Label Period|Withdrawal of Consent|0|||
23598165|NCT03785405|65919354|FG001|Overall Study|Participant decision|0|||
23598166|NCT03785405|65919353|FG000|Overall Study|Other|1|||
23598167|NCT03785405|65919354|FG001|Overall Study|Other|0|||
23598168|NCT03785405|65919353|FG000|Overall Study|No treatment was received|0|||
23598169|NCT03785405|65919354|FG001|Overall Study|No treatment was received|1|||
23598170|NCT02034916|65919356|FG000|Overall Study|Death|39|||
23598171|NCT02034916|65919357|FG001|Overall Study|Death|28|||
23598172|NCT02034916|65919356|FG000|Overall Study|Withdrawal by Subject|2|||
23598173|NCT02034916|65919357|FG001|Overall Study|Withdrawal by Subject|1|||
23598174|NCT02034916|65919356|FG000|Overall Study|Lost to Follow-up|4|||
23598175|NCT02034916|65919357|FG001|Overall Study|Lost to Follow-up|1|||
23598176|NCT02034916|65919356|FG000|Overall Study|Study terminated by sponsor|4|||
23598177|NCT02034916|65919357|FG001|Overall Study|Study terminated by sponsor|5|||
23598178|NCT00914589|65919358|FG000|Overall Study|Adverse Event|1|||
23598179|NCT00914589|65919359|FG001|Overall Study|Adverse Event|0|||
23598180|NCT00914589|65919360|FG002|Overall Study|Adverse Event|1|||
23598181|NCT00914589|65919358|FG000|Overall Study|Protocol Violation|8|||
23598182|NCT00914589|65919359|FG001|Overall Study|Protocol Violation|6|||
23598183|NCT00914589|65919360|FG002|Overall Study|Protocol Violation|3|||
23598184|NCT00914589|65919358|FG000|Overall Study|unclassified|16|||
23598185|NCT00914589|65919359|FG001|Overall Study|unclassified|9|||
23598186|NCT00914589|65919360|FG002|Overall Study|unclassified|7|||
23598187|NCT00914589|65919358|FG000|Overall Study|Death|0|||
23598188|NCT00914589|65919359|FG001|Overall Study|Death|1|||
23598189|NCT00914589|65919360|FG002|Overall Study|Death|1|||
23598190|NCT03644849|65919361|FG000|Overall Study|Lost to Follow-up|1|||
23598191|NCT03644849|65919362|FG001|Overall Study|Lost to Follow-up|3|||
23598192|NCT00087139|65919363|FG000|Overall Study|Adverse Event|18|||
23598193|NCT00087139|65919364|FG001|Overall Study|Adverse Event|17|||
23598194|NCT00087139|65919365|FG002|Overall Study|Adverse Event|13|||
23598195|NCT00087139|65919363|FG000|Overall Study|Death|2|||
23598196|NCT00087139|65919364|FG001|Overall Study|Death|1|||
23598197|NCT00087139|65919365|FG002|Overall Study|Death|0|||
23598198|NCT00087139|65919363|FG000|Overall Study|Withdrawal by Subject|3|||
23598199|NCT00087139|65919364|FG001|Overall Study|Withdrawal by Subject|2|||
23598200|NCT00087139|65919365|FG002|Overall Study|Withdrawal by Subject|2|||
23598201|NCT00087139|65919363|FG000|Overall Study|Physician Decision|1|||
23598202|NCT00087139|65919364|FG001|Overall Study|Physician Decision|1|||
23598203|NCT00087139|65919365|FG002|Overall Study|Physician Decision|1|||
23598204|NCT00087139|65919363|FG000|Overall Study|Disease progression|9|||
23598205|NCT00087139|65919364|FG001|Overall Study|Disease progression|19|||
23598206|NCT00087139|65919365|FG002|Overall Study|Disease progression|12|||
23598207|NCT00087139|65919363|FG000|Overall Study|Ineligible|4|||
23598208|NCT00087139|65919364|FG001|Overall Study|Ineligible|7|||
23598209|NCT00087139|65919365|FG002|Overall Study|Ineligible|4|||
23598210|NCT00087139|65919363|FG000|Overall Study|Symptomatic deterioration|1|||
23598211|NCT00087139|65919364|FG001|Overall Study|Symptomatic deterioration|1|||
23598212|NCT00087139|65919365|FG002|Overall Study|Symptomatic deterioration|3|||
23598213|NCT00087139|65919363|FG000|Overall Study|Use of coumadin|1|||
23598214|NCT00087139|65919364|FG001|Overall Study|Use of coumadin|0|||
23598215|NCT00087139|65919365|FG002|Overall Study|Use of coumadin|0|||
23598216|NCT00087139|65919363|FG000|Overall Study|Response achieved|0|||
23598217|NCT00087139|65919364|FG001|Overall Study|Response achieved|1|||
23598218|NCT00087139|65919365|FG002|Overall Study|Response achieved|0|||
23598219|NCT00087139|65919363|FG000|Overall Study|Extradural disease|0|||
23598220|NCT00087139|65919364|FG001|Overall Study|Extradural disease|0|||
23598221|NCT00087139|65919365|FG002|Overall Study|Extradural disease|1|||
23598222|NCT03892564|65919367|FG000|Overall Study|Withdrawal by Subject|2|||
23649544|NCT00406653|66100902|FG002|Open-Label Period|Withdrawal of Consent|0|||
23649545|NCT00406653|66100903|FG003|Open-Label Period|Withdrawal of Consent|0|||
23360617|NCT04613739|65065806|FG001|Overall Study|Lost to Follow-up|9|||
23598223|NCT00203411|65919368|FG000|Follow-up|Progressive Disease|4|||
23598224|NCT02601820|65919369|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
23598225|NCT02601820|65919369|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
23598226|NCT02601820|65919369|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
23598227|NCT02601820|65919369|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
23598228|NCT00150813|65919370|FG000|Overall Study|Adverse Event|1|||
23649546|NCT00406653|66100904|FG004|Open-Label Period|Withdrawal of Consent|0|||
23598229|NCT00150813|65919370|FG000|Overall Study|Lack of Efficacy|1|||
23598230|NCT00150813|65919370|FG000|Overall Study|Lost to Follow-up|5|||
23598231|NCT00150813|65919370|FG000|Overall Study|Withdrawal by Subject|5|||
23598232|NCT00150813|65919370|FG000|Overall Study|Remission|3|||
23598233|NCT00150813|65919370|FG000|Overall Study|Planned pregancy|1|||
23598234|NCT00150813|65919370|FG000|Overall Study|Switch to commercially available LEV|2|||
23598235|NCT01582100|65919371|FG000|Overall Study|Adverse Event|1|||
23598236|NCT01582100|65919371|FG000|Overall Study|Withdrawal by Subject|1|||
23598237|NCT01808534|65919372|FG000|Overall Study|Disease progression|3|||
23598238|NCT01808534|65919372|FG000|Overall Study|Physician Decision|1|||
23598239|NCT00243503|65919373|FG000|Overall Study|Adverse Event|11|||
23598240|NCT00243503|65919373|FG000|Overall Study|Withdrawal by Subject|1|||
23598241|NCT00243503|65919373|FG000|Overall Study|Lack of Efficacy|44|||
23598242|NCT00243503|65919373|FG000|Overall Study|Death|1|||
23598243|NCT00243503|65919373|FG000|Overall Study|Other|1|||
23598244|NCT00823472|65919374|FG000|Overall Study|Physician Decision|24|||
23598245|NCT00823472|65919375|FG001|Overall Study|Physician Decision|28|||
23598246|NCT03655262|65919376|FG000|Overall Study|Withdrawal by Subject|0|||
23598247|NCT03655262|65919377|FG001|Overall Study|Withdrawal by Subject|0|||
23598248|NCT03655262|65919378|FG002|Overall Study|Withdrawal by Subject|1|||
23598249|NCT05262738|65919379|FG000|Overall Study|Withdrawal by Subject|1|||
23598250|NCT05262738|65919380|FG001|Overall Study|Withdrawal by Subject|0|||
23598251|NCT00093496|65919383|FG000|Overall Study|Protocol Violation|1|||
23598252|NCT00093496|65919384|FG001|Overall Study|Protocol Violation|3|||
23598253|NCT02647905|65919385|FG000|Overall Study|Lost to Follow-up|1|||
23598254|NCT02647905|65919385|FG000|Overall Study|Withdrawal by Subject|2|||
23598255|NCT01579916|65919390|FG000|Overall Study|Lost to Follow-up|6|||
23598256|NCT01579916|65919391|FG001|Overall Study|Lost to Follow-up|1|||
23598257|NCT01579916|65919390|FG000|Overall Study|Withdrawal by Subject|1|||
23649547|NCT00406653|66100905|FG005|Open-Label Period|Withdrawal of Consent|0|||
23649548|NCT00406653|66100906|FG006|Open-Label Period|Withdrawal of Consent|11|||
23649549|NCT00406653|66100900|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649550|NCT00406653|66100901|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649551|NCT00406653|66100902|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649552|NCT00406653|66100903|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649553|NCT00406653|66100904|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649554|NCT00406653|66100905|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23649555|NCT00406653|66100906|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
23649556|NCT00406653|66100900|FG000|Open-Label Period|Pregnancy|0|||
23649557|NCT00406653|66100901|FG001|Open-Label Period|Pregnancy|0|||
23649558|NCT00406653|66100902|FG002|Open-Label Period|Pregnancy|0|||
23598258|NCT01579916|65919391|FG001|Overall Study|Withdrawal by Subject|1|||
23598259|NCT01579916|65919390|FG000|Overall Study|Death|1|||
23598260|NCT01579916|65919391|FG001|Overall Study|Death|0|||
23598261|NCT02590432|65919392|FG000|Open-label Treatment Period|Adverse Event|97|||
23598262|NCT02590432|65919393|FG001|Open-label Treatment Period|Adverse Event|79|||
23598263|NCT02590432|65919394|FG002|Open-label Treatment Period|Adverse Event|0|||
23598264|NCT02590432|65919395|FG003|Open-label Treatment Period|Adverse Event|0|||
23598265|NCT02590432|65919396|FG004|Open-label Treatment Period|Adverse Event|0|||
23649559|NCT00406653|66100903|FG003|Open-Label Period|Pregnancy|0|||
23649560|NCT00406653|66100904|FG004|Open-Label Period|Pregnancy|0|||
23649561|NCT00406653|66100905|FG005|Open-Label Period|Pregnancy|0|||
23649562|NCT00406653|66100906|FG006|Open-Label Period|Pregnancy|2|||
23649563|NCT00406653|66100900|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
23649564|NCT00406653|66100901|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
23649565|NCT00406653|66100902|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
23649566|NCT00406653|66100903|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
23649567|NCT00406653|66100904|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
23649568|NCT00406653|66100905|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
23649569|NCT00406653|66100906|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
23649570|NCT00406653|66100900|FG000|Open-Label Period|Declined participation but followup done|0|||
23649571|NCT00406653|66100901|FG001|Open-Label Period|Declined participation but followup done|0|||
23649572|NCT00406653|66100902|FG002|Open-Label Period|Declined participation but followup done|0|||
23649573|NCT00406653|66100903|FG003|Open-Label Period|Declined participation but followup done|0|||
23800966|NCT00114231|66649865|FG001|Overall Study|Biopsy done after registration|0|||
23598266|NCT02590432|65919397|FG005|Open-label Treatment Period|Adverse Event|0|||
23598267|NCT02590432|65919398|FG006|Open-label Treatment Period|Adverse Event|0|||
23598268|NCT02590432|65919399|FG007|Open-label Treatment Period|Adverse Event|0|||
23649574|NCT00406653|66100904|FG004|Open-Label Period|Declined participation but followup done|0|||
23649575|NCT00406653|66100905|FG005|Open-Label Period|Declined participation but followup done|0|||
23598269|NCT02590432|65919400|FG008|Open-label Treatment Period|Adverse Event|0|||
23598270|NCT02590432|65919392|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
23598271|NCT02590432|65919393|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
23649576|NCT00406653|66100906|FG006|Open-Label Period|Declined participation but followup done|8|||
23649577|NCT00406653|66100900|FG000|Open-Label Period|Discontinued by Sponsor|0|||
23649578|NCT00406653|66100901|FG001|Open-Label Period|Discontinued by Sponsor|0|||
23649579|NCT00406653|66100902|FG002|Open-Label Period|Discontinued by Sponsor|0|||
23649580|NCT00406653|66100903|FG003|Open-Label Period|Discontinued by Sponsor|0|||
23649581|NCT00406653|66100904|FG004|Open-Label Period|Discontinued by Sponsor|0|||
23649582|NCT00406653|66100905|FG005|Open-Label Period|Discontinued by Sponsor|0|||
23649583|NCT00406653|66100906|FG006|Open-Label Period|Discontinued by Sponsor|1|||
23649584|NCT00406653|66100900|FG000|Open-Label Period|Refused followup|0|||
23649585|NCT00406653|66100901|FG001|Open-Label Period|Refused followup|0|||
23649586|NCT00406653|66100902|FG002|Open-Label Period|Refused followup|0|||
23649587|NCT00406653|66100903|FG003|Open-Label Period|Refused followup|0|||
23649588|NCT00406653|66100904|FG004|Open-Label Period|Refused followup|0|||
23649589|NCT00406653|66100905|FG005|Open-Label Period|Refused followup|0|||
23649590|NCT00406653|66100906|FG006|Open-Label Period|Refused followup|1|||
23649591|NCT00346268|66100910|FG000|Overall Study|Adverse Event|1|||
23649592|NCT00346268|66100911|FG001|Overall Study|Adverse Event|0|||
23649593|NCT00346268|66100910|FG000|Overall Study|Protocol Violation|1|||
23649594|NCT00346268|66100911|FG001|Overall Study|Protocol Violation|0|||
23649595|NCT00346268|66100910|FG000|Overall Study|Participant refused|0|||
23649596|NCT00346268|66100911|FG001|Overall Study|Participant refused|3|||
23649597|NCT01174160|66100912|FG000|Overall Study|Adverse Event|1|||
23598272|NCT02590432|65919394|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
23598273|NCT02590432|65919395|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
23598274|NCT02590432|65919396|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
23598275|NCT02590432|65919397|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
23598276|NCT02590432|65919398|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
23598277|NCT02590432|65919399|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
23598278|NCT02590432|65919400|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
23598279|NCT02590432|65919392|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
23598280|NCT02590432|65919393|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
23598281|NCT02590432|65919394|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
23598282|NCT02590432|65919395|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
23598283|NCT02590432|65919396|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
23598284|NCT02590432|65919397|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
23598285|NCT02590432|65919398|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
23598286|NCT02590432|65919399|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
23598287|NCT02590432|65919400|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
23598288|NCT02590432|65919392|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
23598289|NCT02590432|65919393|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
23598290|NCT02590432|65919394|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23598291|NCT02590432|65919395|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23598292|NCT02590432|65919396|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
23598293|NCT02590432|65919397|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
23598294|NCT02590432|65919398|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
23598295|NCT02590432|65919399|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
23598296|NCT02590432|65919400|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
23598297|NCT02590432|65919392|FG000|Open-label Treatment Period|Protocol Violation|10|||
23598298|NCT02590432|65919393|FG001|Open-label Treatment Period|Protocol Violation|4|||
23598299|NCT02590432|65919394|FG002|Open-label Treatment Period|Protocol Violation|0|||
23598300|NCT02590432|65919395|FG003|Open-label Treatment Period|Protocol Violation|0|||
23598301|NCT02590432|65919396|FG004|Open-label Treatment Period|Protocol Violation|0|||
23598302|NCT02590432|65919397|FG005|Open-label Treatment Period|Protocol Violation|0|||
23598303|NCT02590432|65919398|FG006|Open-label Treatment Period|Protocol Violation|0|||
23598304|NCT02590432|65919399|FG007|Open-label Treatment Period|Protocol Violation|0|||
23598305|NCT02590432|65919400|FG008|Open-label Treatment Period|Protocol Violation|0|||
23598306|NCT02590432|65919392|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
23598307|NCT02590432|65919393|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
23598308|NCT02590432|65919394|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598309|NCT02590432|65919395|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598310|NCT02590432|65919396|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598311|NCT02590432|65919397|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598312|NCT02590432|65919398|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598313|NCT02590432|65919399|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598314|NCT02590432|65919400|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598315|NCT02590432|65919392|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
23598316|NCT02590432|65919393|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
23649598|NCT01174160|66100913|FG001|Overall Study|Adverse Event|0|||
23649599|NCT01174160|66100912|FG000|Overall Study|Lost to Follow-up|1|||
23649600|NCT01174160|66100913|FG001|Overall Study|Lost to Follow-up|0|||
23649601|NCT01174160|66100912|FG000|Overall Study|Physician Decision|1|||
23800967|NCT00684567|66649866|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
23598317|NCT02590432|65919394|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598318|NCT02590432|65919395|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598319|NCT02590432|65919396|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598320|NCT02590432|65919397|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598321|NCT02590432|65919398|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598322|NCT02590432|65919399|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598323|NCT02590432|65919400|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598324|NCT02590432|65919392|FG000|Double-blind Treatment Period|Adverse Event|0|||
23598325|NCT02590432|65919393|FG001|Double-blind Treatment Period|Adverse Event|0|||
23598326|NCT02590432|65919394|FG002|Double-blind Treatment Period|Adverse Event|14|||
23598327|NCT02590432|65919395|FG003|Double-blind Treatment Period|Adverse Event|12|||
23598328|NCT02590432|65919396|FG004|Double-blind Treatment Period|Adverse Event|6|||
23598329|NCT02590432|65919397|FG005|Double-blind Treatment Period|Adverse Event|22|||
23598330|NCT02590432|65919398|FG006|Double-blind Treatment Period|Adverse Event|20|||
23598331|NCT02590432|65919399|FG007|Double-blind Treatment Period|Adverse Event|0|||
23598332|NCT02590432|65919400|FG008|Double-blind Treatment Period|Adverse Event|0|||
23598333|NCT02590432|65919392|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23598334|NCT02590432|65919393|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23598335|NCT02590432|65919394|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23598336|NCT02590432|65919395|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23598337|NCT02590432|65919396|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
23598338|NCT02590432|65919397|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
23598339|NCT02590432|65919398|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
23598340|NCT02590432|65919399|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
23598341|NCT02590432|65919400|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
23598342|NCT02590432|65919392|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598343|NCT02590432|65919393|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598344|NCT02590432|65919394|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598345|NCT02590432|65919395|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
23598346|NCT02590432|65919396|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
23598347|NCT02590432|65919397|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598348|NCT02590432|65919398|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598349|NCT02590432|65919399|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598350|NCT02590432|65919400|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598351|NCT02590432|65919392|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23598352|NCT02590432|65919393|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23598353|NCT02590432|65919394|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23598354|NCT02590432|65919395|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23598355|NCT02590432|65919396|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
23598356|NCT02590432|65919397|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
23598357|NCT02590432|65919398|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
23598358|NCT02590432|65919399|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
23598359|NCT02590432|65919400|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
23598360|NCT02590432|65919392|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598361|NCT02590432|65919393|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598362|NCT02590432|65919394|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598363|NCT02590432|65919395|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598364|NCT02590432|65919396|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598365|NCT02590432|65919397|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
23598366|NCT02590432|65919398|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598367|NCT02590432|65919399|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598368|NCT02590432|65919400|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598369|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598370|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598371|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598372|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598373|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598374|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598375|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598376|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
23598377|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
23598378|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23800968|NCT00684567|66649866|FG000|Monotherapy Period|Adverse Event|2|||
23800969|NCT00684567|66649866|FG000|Monotherapy Period|Death|1|||
23649602|NCT01174160|66100913|FG001|Overall Study|Physician Decision|0|||
23649603|NCT01174160|66100912|FG000|Overall Study|Protocol Violation|4|||
23649604|NCT01174160|66100913|FG001|Overall Study|Protocol Violation|6|||
23649605|NCT01174160|66100912|FG000|Overall Study|Withdrawal by Subject|1|||
23649606|NCT01174160|66100913|FG001|Overall Study|Withdrawal by Subject|0|||
23649607|NCT03658668|66100916|FG000|Overall Study|Time Commitment|1|||
23649608|NCT03658668|66100917|FG001|Overall Study|Time Commitment|1|||
23649609|NCT01853982|66100918|FG000|Overall Study|Withdrawal by Subject|1|||
23800970|NCT00684567|66649866|FG000|Monotherapy Period|Progression of primary disease|11|||
23800971|NCT00988208|66649870|FG000|Overall Study|Adverse Event|71|||
23800972|NCT00988208|66649871|FG001|Overall Study|Adverse Event|122|||
23800973|NCT00988208|66649870|FG000|Overall Study|Disease Progression|103|||
23800974|NCT00988208|66649871|FG001|Overall Study|Disease Progression|89|||
23800975|NCT00988208|66649870|FG000|Overall Study|Withdrawal by Subject|50|||
23800976|NCT00988208|66649871|FG001|Overall Study|Withdrawal by Subject|57|||
23800977|NCT00988208|66649870|FG000|Overall Study|Death|9|||
23800978|NCT00988208|66649871|FG001|Overall Study|Death|15|||
23800979|NCT00988208|66649870|FG000|Overall Study|Lost to Follow-up|2|||
23800980|NCT00988208|66649871|FG001|Overall Study|Lost to Follow-up|3|||
23800981|NCT00988208|66649870|FG000|Overall Study|Protocol Violation|9|||
23800982|NCT00988208|66649871|FG001|Overall Study|Protocol Violation|2|||
23800983|NCT00988208|66649870|FG000|Overall Study|Sponsor Decision|102|||
23800984|NCT00988208|66649871|FG001|Overall Study|Sponsor Decision|78|||
23800985|NCT00988208|66649870|FG000|Overall Study|Clinical Progression|17|||
23800986|NCT00988208|66649871|FG001|Overall Study|Clinical Progression|16|||
23800987|NCT00988208|66649870|FG000|Overall Study|Biochemical Progression|21|||
23800988|NCT00988208|66649871|FG001|Overall Study|Biochemical Progression|7|||
23800989|NCT00988208|66649870|FG000|Overall Study|Clinical Deterioration|7|||
23800990|NCT00988208|66649871|FG001|Overall Study|Clinical Deterioration|14|||
23800991|NCT00988208|66649870|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
23800992|NCT00988208|66649871|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
23800993|NCT00988208|66649870|FG000|Overall Study|Other|8|||
23800994|NCT00988208|66649871|FG001|Overall Study|Other|3|||
23800995|NCT00515034|66649876|FG000|Overall Study|Adverse Event|2|||
23800996|NCT00515034|66649877|FG001|Overall Study|Adverse Event|0|||
23800997|NCT00515034|66649878|FG002|Overall Study|Adverse Event|1|||
23800998|NCT00515034|66649879|FG003|Overall Study|Adverse Event|0|||
23800999|NCT00515034|66649876|FG000|Overall Study|Death|4|||
23801000|NCT00515034|66649877|FG001|Overall Study|Death|2|||
23801001|NCT00515034|66649878|FG002|Overall Study|Death|1|||
23801002|NCT00515034|66649879|FG003|Overall Study|Death|3|||
23801003|NCT00515034|66649876|FG000|Overall Study|Withdrawal by Subject|1|||
23801004|NCT00515034|66649877|FG001|Overall Study|Withdrawal by Subject|0|||
23801005|NCT00515034|66649878|FG002|Overall Study|Withdrawal by Subject|3|||
23801006|NCT00515034|66649879|FG003|Overall Study|Withdrawal by Subject|0|||
23801007|NCT00515034|66649876|FG000|Overall Study|Physician Decision|0|||
23801008|NCT00515034|66649877|FG001|Overall Study|Physician Decision|0|||
23801009|NCT00515034|66649878|FG002|Overall Study|Physician Decision|1|||
23801010|NCT00515034|66649879|FG003|Overall Study|Physician Decision|1|||
23801011|NCT00515034|66649876|FG000|Overall Study|Other|1|||
23801012|NCT00515034|66649877|FG001|Overall Study|Other|0|||
23801013|NCT00515034|66649878|FG002|Overall Study|Other|2|||
23801014|NCT00515034|66649879|FG003|Overall Study|Other|1|||
23801015|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
23801016|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
23801017|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
23801018|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
23801019|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
23801020|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
23649610|NCT01853982|66100919|FG001|Overall Study|Withdrawal by Subject|0|||
23801021|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
23801022|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
23801023|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
23801024|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
23801025|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Subject decision|1|||
23801026|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Subject decision|1|||
23801027|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
23801028|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
23801029|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
23801030|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
23801031|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
23801032|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
23801033|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
23649611|NCT01853982|66100918|FG000|Overall Study|Death|1|||
23649612|NCT01853982|66100919|FG001|Overall Study|Death|0|||
23801034|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
23801035|NCT00518882|66649882|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
23649613|NCT01853982|66100918|FG000|Overall Study|Lost to Follow-up|0|||
23649614|NCT01853982|66100919|FG001|Overall Study|Lost to Follow-up|1|||
23649615|NCT01688830|66100920|FG000|Overall Study|Lost to Follow-up|0|||
23649616|NCT01688830|66100921|FG001|Overall Study|Lost to Follow-up|0|||
23649617|NCT01688830|66100922|FG002|Overall Study|Lost to Follow-up|0|||
23649618|NCT01688830|66100923|FG003|Overall Study|Lost to Follow-up|0|||
23649619|NCT01688830|66100924|FG004|Overall Study|Lost to Follow-up|0|||
23649620|NCT01688830|66100925|FG005|Overall Study|Lost to Follow-up|0|||
23649621|NCT01688830|66100926|FG006|Overall Study|Lost to Follow-up|0|||
23649622|NCT01688830|66100927|FG007|Overall Study|Lost to Follow-up|0|||
23649623|NCT01688830|66100928|FG008|Overall Study|Lost to Follow-up|0|||
23649624|NCT01688830|66100929|FG009|Overall Study|Lost to Follow-up|0|||
23649625|NCT01688830|66100930|FG010|Overall Study|Lost to Follow-up|1|||
23649626|NCT01688830|66100931|FG011|Overall Study|Lost to Follow-up|0|||
23649627|NCT01688830|66100932|FG012|Overall Study|Lost to Follow-up|0|||
23649628|NCT01688830|66100933|FG013|Overall Study|Lost to Follow-up|0|||
23649629|NCT01688830|66100934|FG014|Overall Study|Lost to Follow-up|0|||
23649630|NCT01688830|66100935|FG015|Overall Study|Lost to Follow-up|0|||
23649631|NCT01688830|66100936|FG016|Overall Study|Lost to Follow-up|0|||
23649632|NCT01688830|66100937|FG017|Overall Study|Lost to Follow-up|0|||
23649633|NCT01688830|66100938|FG018|Overall Study|Lost to Follow-up|0|||
23649634|NCT01688830|66100939|FG019|Overall Study|Lost to Follow-up|0|||
23649635|NCT01688830|66100940|FG020|Overall Study|Lost to Follow-up|0|||
23649636|NCT00372385|66100941|FG000|Overall Study|Adverse Event|6|||
23649637|NCT00372385|66100942|FG001|Overall Study|Adverse Event|11|||
23649638|NCT00372385|66100943|FG002|Overall Study|Adverse Event|9|||
23649639|NCT00372385|66100944|FG003|Overall Study|Adverse Event|7|||
23649640|NCT00372385|66100941|FG000|Overall Study|Noncompliance|0|||
23649641|NCT00372385|66100942|FG001|Overall Study|Noncompliance|1|||
23649642|NCT00372385|66100943|FG002|Overall Study|Noncompliance|1|||
23649643|NCT00372385|66100944|FG003|Overall Study|Noncompliance|1|||
23649644|NCT00372385|66100941|FG000|Overall Study|Physician Decision|1|||
23649645|NCT00372385|66100942|FG001|Overall Study|Physician Decision|0|||
23649646|NCT00372385|66100943|FG002|Overall Study|Physician Decision|0|||
23649647|NCT00372385|66100944|FG003|Overall Study|Physician Decision|0|||
23649648|NCT00372385|66100941|FG000|Overall Study|Lost to Follow-up|2|||
23649649|NCT00372385|66100942|FG001|Overall Study|Lost to Follow-up|0|||
23649650|NCT00372385|66100943|FG002|Overall Study|Lost to Follow-up|0|||
23649651|NCT00372385|66100944|FG003|Overall Study|Lost to Follow-up|0|||
23649652|NCT00372385|66100941|FG000|Overall Study|Withdrawal by Subject|2|||
23649653|NCT00372385|66100942|FG001|Overall Study|Withdrawal by Subject|1|||
23649654|NCT00372385|66100943|FG002|Overall Study|Withdrawal by Subject|0|||
23649655|NCT00372385|66100944|FG003|Overall Study|Withdrawal by Subject|0|||
23649656|NCT00372385|66100941|FG000|Overall Study|Refusal of Treatment|3|||
23649657|NCT00372385|66100942|FG001|Overall Study|Refusal of Treatment|6|||
23649658|NCT00372385|66100943|FG002|Overall Study|Refusal of Treatment|0|||
23649659|NCT00372385|66100944|FG003|Overall Study|Refusal of Treatment|0|||
23649660|NCT00372385|66100941|FG000|Overall Study|No Response|1|||
23649661|NCT00372385|66100942|FG001|Overall Study|No Response|1|||
23649662|NCT00372385|66100943|FG002|Overall Study|No Response|0|||
23649663|NCT00372385|66100944|FG003|Overall Study|No Response|0|||
23649664|NCT00372385|66100941|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
23649665|NCT00372385|66100942|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23649666|NCT00372385|66100943|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23649667|NCT00372385|66100944|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23649668|NCT00372385|66100941|FG000|Overall Study|Virologic Stopping Rule|17|||
23649669|NCT00372385|66100942|FG001|Overall Study|Virologic Stopping Rule|0|||
23649670|NCT00372385|66100943|FG002|Overall Study|Virologic Stopping Rule|0|||
23649671|NCT00372385|66100944|FG003|Overall Study|Virologic Stopping Rule|0|||
23649672|NCT02699983|66100947|FG000|Overall Study|Withdrawal by Subject|1|||
23649673|NCT02699983|66100948|FG001|Overall Study|Withdrawal by Subject|0|||
23649674|NCT00731120|66100949|FG000|Overall Study|Adverse Event|7|||
23649675|NCT00731120|66100950|FG001|Overall Study|Adverse Event|6|||
23649676|NCT00731120|66100951|FG002|Overall Study|Adverse Event|8|||
23649677|NCT00731120|66100949|FG000|Overall Study|Lack of Efficacy|4|||
23649678|NCT00731120|66100950|FG001|Overall Study|Lack of Efficacy|5|||
23649679|NCT00731120|66100951|FG002|Overall Study|Lack of Efficacy|4|||
23649680|NCT00731120|66100949|FG000|Overall Study|Noncompliance with Study Drug|3|||
23649681|NCT00731120|66100950|FG001|Overall Study|Noncompliance with Study Drug|3|||
23649682|NCT00731120|66100951|FG002|Overall Study|Noncompliance with Study Drug|1|||
23649683|NCT00731120|66100949|FG000|Overall Study|Protocol Deviations|1|||
23649684|NCT00731120|66100950|FG001|Overall Study|Protocol Deviations|6|||
23649685|NCT00731120|66100951|FG002|Overall Study|Protocol Deviations|1|||
23649686|NCT00731120|66100949|FG000|Overall Study|Withdrawal of Consent|13|||
23649687|NCT00731120|66100950|FG001|Overall Study|Withdrawal of Consent|8|||
23649688|NCT00731120|66100951|FG002|Overall Study|Withdrawal of Consent|4|||
23649689|NCT00731120|66100949|FG000|Overall Study|Lost to Follow-up|10|||
23649690|NCT00731120|66100950|FG001|Overall Study|Lost to Follow-up|15|||
23649691|NCT00731120|66100951|FG002|Overall Study|Lost to Follow-up|17|||
23649692|NCT00731120|66100949|FG000|Overall Study|Other|4|||
23649693|NCT00731120|66100950|FG001|Overall Study|Other|0|||
23649694|NCT00731120|66100951|FG002|Overall Study|Other|1|||
23649695|NCT00370331|66100952|FG000|Overall Study|Adverse Event|4|||
23649696|NCT00370331|66100953|FG001|Overall Study|Adverse Event|13|||
23649697|NCT00370331|66100952|FG000|Overall Study|Withdrawal by Subject|2|||
23649698|NCT00370331|66100953|FG001|Overall Study|Withdrawal by Subject|4|||
23649699|NCT00370331|66100952|FG000|Overall Study|Lost to Follow-up|0|||
23649700|NCT00370331|66100953|FG001|Overall Study|Lost to Follow-up|3|||
23649701|NCT00370331|66100952|FG000|Overall Study|Lack of Efficacy|0|||
23649702|NCT00370331|66100953|FG001|Overall Study|Lack of Efficacy|1|||
23649703|NCT00370331|66100952|FG000|Overall Study|Non-compliance|0|||
23649704|NCT00370331|66100953|FG001|Overall Study|Non-compliance|1|||
23649705|NCT00370331|66100952|FG000|Overall Study|Protocol Violation|1|||
23649706|NCT00370331|66100953|FG001|Overall Study|Protocol Violation|1|||
23649707|NCT02499770|66100954|FG000|Overall Study|Death|17|||
23649708|NCT02499770|66100955|FG001|Overall Study|Death|56|||
23649709|NCT02499770|66100954|FG000|Overall Study|Study completion|1|||
23649710|NCT02499770|66100955|FG001|Overall Study|Study completion|10|||
23649711|NCT02499770|66100954|FG000|Overall Study|Withdrawal by Subject|0|||
23649712|NCT02499770|66100955|FG001|Overall Study|Withdrawal by Subject|7|||
23649713|NCT02499770|66100954|FG000|Overall Study|Lost to Follow-up|0|||
23649714|NCT02499770|66100955|FG001|Overall Study|Lost to Follow-up|2|||
23649715|NCT02499770|66100954|FG000|Overall Study|Subject declined further treatment|1|||
23649716|NCT02499770|66100955|FG001|Overall Study|Subject declined further treatment|0|||
23649717|NCT02499770|66100954|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
23649718|NCT02499770|66100955|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
23649719|NCT02499770|66100954|FG000|Overall Study|Randomized but not enrolled|0|||
23649720|NCT02499770|66100955|FG001|Overall Study|Randomized but not enrolled|1|||
23649721|NCT00753272|66100958|FG000|Overall Study|Adverse Event|878|||
23649722|NCT00753272|66100959|FG001|Overall Study|Adverse Event|869|||
23649723|NCT00753272|66100958|FG000|Overall Study|Protocol Violation|28|||
23649724|NCT00753272|66100959|FG001|Overall Study|Protocol Violation|46|||
23649725|NCT00753272|66100958|FG000|Overall Study|Withdrawal by Subject|2481|||
23649726|NCT00753272|66100959|FG001|Overall Study|Withdrawal by Subject|2407|||
23649727|NCT00753272|66100958|FG000|Overall Study|Lost to Follow-up|491|||
23649728|NCT00753272|66100959|FG001|Overall Study|Lost to Follow-up|497|||
23649729|NCT00753272|66100958|FG000|Overall Study|Other|1104|||
23649730|NCT00753272|66100959|FG001|Overall Study|Other|1088|||
23649731|NCT00577473|66100962|FG000|Overall Study|Protocol Violation|1|||
23649732|NCT00577473|66100963|FG001|Overall Study|Protocol Violation|4|||
23649733|NCT00577473|66100962|FG000|Overall Study|Adverse Event|8|||
23649734|NCT00577473|66100963|FG001|Overall Study|Adverse Event|5|||
23649735|NCT00577473|66100962|FG000|Overall Study|Withdrawal by Subject|2|||
23649736|NCT00577473|66100963|FG001|Overall Study|Withdrawal by Subject|6|||
23649737|NCT00577473|66100962|FG000|Overall Study|Physician Decision|2|||
23649738|NCT00577473|66100963|FG001|Overall Study|Physician Decision|2|||
23649739|NCT00577473|66100962|FG000|Overall Study|Lack of Efficacy|8|||
23649740|NCT00577473|66100963|FG001|Overall Study|Lack of Efficacy|7|||
23649741|NCT01506453|66100969|FG000|Overall Study|Withdrawal prior to treatment|0|||
23649742|NCT01506453|66100970|FG001|Overall Study|Withdrawal prior to treatment|2|||
23649743|NCT01439360|66100971|FG000|Overall Study|Adverse Event|4|||
23649744|NCT01439360|66100972|FG001|Overall Study|Adverse Event|16|||
23649745|NCT01439360|66100971|FG000|Overall Study|Lost to Follow-up|43|||
23649746|NCT01439360|66100972|FG001|Overall Study|Lost to Follow-up|58|||
23649747|NCT01439360|66100971|FG000|Overall Study|Others|10|||
23649748|NCT01439360|66100972|FG001|Overall Study|Others|5|||
23649749|NCT01439360|66100971|FG000|Overall Study|Protocol Violation|1|||
23649750|NCT01439360|66100972|FG001|Overall Study|Protocol Violation|0|||
23649751|NCT01439360|66100971|FG000|Overall Study|Withdrawal by Subject|140|||
23649752|NCT01439360|66100972|FG001|Overall Study|Withdrawal by Subject|129|||
23649753|NCT00966277|66100973|FG000|Overall Study|Withdrawal by Subject|3|||
23649754|NCT00966277|66100974|FG001|Overall Study|Withdrawal by Subject|0|||
23649755|NCT00966277|66100973|FG000|Overall Study|Ineligible|1|||
23649756|NCT00966277|66100974|FG001|Overall Study|Ineligible|3|||
23649757|NCT00966277|66100973|FG000|Overall Study|Treatment Plan Changed|0|||
23649758|NCT00966277|66100974|FG001|Overall Study|Treatment Plan Changed|1|||
23649759|NCT00511901|66100975|FG000|Overall Study|Withdrawal by Subject|1|||
23649760|NCT00511901|66100976|FG001|Overall Study|Withdrawal by Subject|3|||
23649761|NCT00799513|66100977|FG000|Overall Study|Physician Decision|1|||
23649762|NCT00799513|66100977|FG000|Overall Study|Adverse Event|1|||
23649763|NCT00319839|66100982|FG000|Overall Study|Adverse Event|5|||
23649764|NCT00319839|66100982|FG000|Overall Study|Withdrawal by Subject|1|||
23649765|NCT01919814|66100983|FG000|Overall Study|Adverse Event|1|||
23649766|NCT01919814|66100984|FG001|Overall Study|Adverse Event|0|||
23649767|NCT01919814|66100983|FG000|Overall Study|Protocol Violation|1|||
23649768|NCT01919814|66100984|FG001|Overall Study|Protocol Violation|0|||
23649769|NCT01919814|66100983|FG000|Overall Study|Withdrawal by Subject|1|||
23649770|NCT01919814|66100984|FG001|Overall Study|Withdrawal by Subject|0|||
23649771|NCT00759915|66100985|FG000|Overall Study|Withdrawal by Subject|1|||
23649772|NCT00759915|66100986|FG001|Overall Study|Withdrawal by Subject|0|||
23649773|NCT00759915|66100985|FG000|Overall Study|Adverse Event|0|||
23649774|NCT00759915|66100986|FG001|Overall Study|Adverse Event|1|||
23649775|NCT01217957|66100987|FG000|Phase 1|Withdrawal by Patient|1|||
23649776|NCT01217957|66100988|FG001|Phase 1|Withdrawal by Patient|0|||
23649777|NCT01217957|66100989|FG002|Phase 1|Withdrawal by Patient|1|||
23649778|NCT01217957|66100990|FG003|Phase 1|Withdrawal by Patient|1|||
23649779|NCT01217957|66100991|FG004|Phase 1|Withdrawal by Patient|0|||
23649780|NCT01217957|66100987|FG000|Phase 2|Withdrawal by Patient|0|||
23649781|NCT01217957|66100988|FG001|Phase 2|Withdrawal by Patient|0|||
23649782|NCT01217957|66100989|FG002|Phase 2|Withdrawal by Patient|0|||
23649783|NCT01217957|66100990|FG003|Phase 2|Withdrawal by Patient|0|||
23649784|NCT01217957|66100991|FG004|Phase 2|Withdrawal by Patient|1|||
23649785|NCT01768117|66100992|FG000|Overall Study|Lost to Follow-up|1|||
23649786|NCT01768117|66100992|FG000|Overall Study|Withdrawal by Subject|2|||
23649787|NCT01768117|66100992|FG000|Overall Study|Protocol Violation|3|||
23649788|NCT00887432|66100993|FG000|Overall Study|Start Excluded Therapy|3|||
23649789|NCT00887432|66100994|FG001|Overall Study|Start Excluded Therapy|0|||
23649790|NCT00887432|66100993|FG000|Overall Study|Did not complete treatment|6|||
23649791|NCT00887432|66100994|FG001|Overall Study|Did not complete treatment|8|||
23649792|NCT00887432|66100993|FG000|Overall Study|Protocol Violation|2|||
23649793|NCT00887432|66100994|FG001|Overall Study|Protocol Violation|3|||
23649794|NCT00887432|66100993|FG000|Overall Study|Withdrawal by Subject|3|||
23649795|NCT00887432|66100994|FG001|Overall Study|Withdrawal by Subject|2|||
23649796|NCT00887432|66100993|FG000|Overall Study|Lost to Follow-up|1|||
23649797|NCT00887432|66100994|FG001|Overall Study|Lost to Follow-up|0|||
23649798|NCT00887432|66100993|FG000|Overall Study|No reason provided|0|||
23649799|NCT00887432|66100994|FG001|Overall Study|No reason provided|1|||
23649800|NCT01745848|66100995|FG000|Overall Study|Adverse Event|6|||
23649801|NCT01154010|66100996|FG000|Overall Study|Lost to Follow-up|0|||
23649802|NCT01154010|66100997|FG001|Overall Study|Lost to Follow-up|1|||
23649803|NCT00409773|66100999|FG000|Overall Study|Adverse Event|3|||
23649804|NCT00409773|66101000|FG001|Overall Study|Adverse Event|4|||
23649805|NCT00409773|66101001|FG002|Overall Study|Adverse Event|4|||
23649806|NCT00409773|66101002|FG003|Overall Study|Adverse Event|2|||
23649807|NCT00409773|66101003|FG004|Overall Study|Adverse Event|6|||
23649808|NCT00409773|66100999|FG000|Overall Study|Lost to Follow-up|6|||
23649809|NCT00409773|66101000|FG001|Overall Study|Lost to Follow-up|1|||
23801036|NCT00518882|66649883|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
23801037|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
23801038|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
23801039|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
23801040|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
23801041|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
23479000|NCT02586506|65498334|FG000|Overall Study|Other Reason|2|||
23598379|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598380|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598381|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598382|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598383|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598384|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598385|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
23598386|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598387|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598388|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598389|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598390|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598391|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598392|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598393|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598394|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
23598395|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
23598396|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598397|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598398|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598399|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23649810|NCT00409773|66101001|FG002|Overall Study|Lost to Follow-up|2|||
23649811|NCT00409773|66101002|FG003|Overall Study|Lost to Follow-up|3|||
23649812|NCT00409773|66101003|FG004|Overall Study|Lost to Follow-up|1|||
23649813|NCT00409773|66100999|FG000|Overall Study|Physician Decision|0|||
23649814|NCT00409773|66101000|FG001|Overall Study|Physician Decision|0|||
23649815|NCT00409773|66101001|FG002|Overall Study|Physician Decision|0|||
23598400|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598401|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598402|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598403|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598404|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
23598405|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598406|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598407|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598408|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598409|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598410|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598411|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23360618|NCT04613739|65065805|FG000|Overall Study|potentially duplicative/fraudulent|1|||
23360619|NCT04613739|65065806|FG001|Overall Study|potentially duplicative/fraudulent|3|||
23360620|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
23598412|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598413|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
23598414|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598415|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598416|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598417|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598418|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598419|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598420|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598421|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
23649816|NCT00409773|66101002|FG003|Overall Study|Physician Decision|2|||
23360621|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
23360622|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
23360623|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
23360624|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
23360625|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
23360626|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
23360627|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
23360628|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
23360629|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
23360630|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
23360631|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
23360632|NCT02169505|65065809|FG000|Overall Study|Withdrawal by Subject|1|||
23360633|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
23360634|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
23360635|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
23360636|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
23360637|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
23360638|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
23649817|NCT00409773|66101003|FG004|Overall Study|Physician Decision|0|||
23649818|NCT00409773|66100999|FG000|Overall Study|Protocol Violation|0|||
23649819|NCT00409773|66101000|FG001|Overall Study|Protocol Violation|2|||
23649820|NCT00409773|66101001|FG002|Overall Study|Protocol Violation|3|||
23479001|NCT02810444|65498335|FG000|Overall Study|Screen Failures|14|||
23479002|NCT02810444|65498335|FG000|Overall Study|Withdrawal by Subject|4|||
23479003|NCT02810444|65498335|FG000|Overall Study|Adverse Event|3|||
23479004|NCT00357760|65498336|FG000|Overall Study|Disease progression|44|||
23479005|NCT00357760|65498337|FG001|Overall Study|Disease progression|17|||
23479006|NCT00357760|65498336|FG000|Overall Study|Adverse Event|10|||
23479007|NCT00357760|65498337|FG001|Overall Study|Adverse Event|7|||
23479008|NCT00357760|65498336|FG000|Overall Study|Death|0|||
23479009|NCT00357760|65498337|FG001|Overall Study|Death|3|||
23479010|NCT00357760|65498336|FG000|Overall Study|Alternative therapy|1|||
23479011|NCT00357760|65498337|FG001|Overall Study|Alternative therapy|0|||
23479012|NCT00357760|65498336|FG000|Overall Study|Withdrawal by Subject|0|||
23479013|NCT00357760|65498337|FG001|Overall Study|Withdrawal by Subject|2|||
23479014|NCT00357760|65498336|FG000|Overall Study|Never started treatment|2|||
23479015|NCT00357760|65498337|FG001|Overall Study|Never started treatment|1|||
23479016|NCT00357760|65498336|FG000|Overall Study|Ineligible|0|||
23479017|NCT00357760|65498337|FG001|Overall Study|Ineligible|2|||
23479018|NCT00357760|65498336|FG000|Overall Study|Physician Decision|2|||
23479019|NCT00357760|65498337|FG001|Overall Study|Physician Decision|1|||
23479020|NCT00357760|65498336|FG000|Overall Study|Protocol Violation|0|||
23479021|NCT00357760|65498337|FG001|Overall Study|Protocol Violation|1|||
23479022|NCT00357760|65498336|FG000|Overall Study|To receive hospice care|0|||
23479023|NCT00357760|65498337|FG001|Overall Study|To receive hospice care|1|||
23479024|NCT02518464|65498343|FG000|Overall Study|Adverse Event|2|||
23479025|NCT02527200|65498345|FG000|Overall Study|Withdrawal by Subject|3|||
23479026|NCT02527200|65498346|FG001|Overall Study|Withdrawal by Subject|2|||
23479027|NCT02527200|65498347|FG002|Overall Study|Withdrawal by Subject|1|||
23479028|NCT02527200|65498348|FG003|Overall Study|Withdrawal by Subject|0|||
23479029|NCT02527200|65498345|FG000|Overall Study|Unclassified|0|||
23479030|NCT02527200|65498346|FG001|Overall Study|Unclassified|1|||
23479031|NCT02527200|65498347|FG002|Overall Study|Unclassified|0|||
23479032|NCT02527200|65498348|FG003|Overall Study|Unclassified|0|||
23479033|NCT02527200|65498345|FG000|Overall Study|Lost to Follow-up|0|||
23479034|NCT02527200|65498346|FG001|Overall Study|Lost to Follow-up|0|||
23801042|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
23801043|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
23801044|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
23801045|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
23801046|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
23801047|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
23801048|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
23801049|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
23801050|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
23801051|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
23801052|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
23801053|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
23801054|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
23801055|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
23801056|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
23801057|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
23801058|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
23801059|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
23801060|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
23801061|NCT00518882|66649882|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
23801062|NCT00518882|66649883|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
23801063|NCT01559935|66649884|FG000|Car Phase|Toxicity|4|||
23479035|NCT02527200|65498347|FG002|Overall Study|Lost to Follow-up|1|||
23649821|NCT00409773|66101002|FG003|Overall Study|Protocol Violation|3|||
23649822|NCT00409773|66101003|FG004|Overall Study|Protocol Violation|1|||
23649823|NCT00409773|66100999|FG000|Overall Study|Withdrawal by Subject|0|||
23801064|NCT01559935|66649884|FG000|Car Phase|Death|1|||
23801065|NCT01559935|66649884|FG000|Car Phase|Lack of Efficacy|2|||
23801066|NCT01559935|66649884|FG000|Car Phase|Lost to Follow-up|1|||
23801067|NCT01559935|66649884|FG000|Car Phase|Physician Decision|1|||
23801068|NCT01559935|66649884|FG000|Car Phase|Withdrawal by Subject|2|||
23801069|NCT01559935|66649884|FG000|Car Phase|Per protocol|1|||
23801070|NCT01559935|66649884|FG000|Car Phase|Insurance|1|||
23479036|NCT02527200|65498348|FG003|Overall Study|Lost to Follow-up|0|||
23479037|NCT02168387|65498351|FG000|Overall Study|Planned exubation|6|||
23479038|NCT02168387|65498352|FG001|Overall Study|Planned exubation|3|||
23479039|NCT02168387|65498351|FG000|Overall Study|Death|1|||
23479040|NCT02168387|65498352|FG001|Overall Study|Death|0|||
23479041|NCT03700684|65498353|FG000|Overall Study|COVID-19|0|||
23479042|NCT03700684|65498354|FG001|Overall Study|COVID-19|0|||
23479043|NCT03700684|65498355|FG002|Overall Study|COVID-19|2|||
23479044|NCT01143389|65498359|FG000|Overall Study|Lost to Follow-up|26|||
23649824|NCT00409773|66101000|FG001|Overall Study|Withdrawal by Subject|0|||
23649825|NCT00409773|66101001|FG002|Overall Study|Withdrawal by Subject|0|||
23649826|NCT00409773|66101002|FG003|Overall Study|Withdrawal by Subject|2|||
23649827|NCT00409773|66101003|FG004|Overall Study|Withdrawal by Subject|1|||
23598422|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598423|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598424|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598425|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598426|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598427|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598428|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598429|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598430|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
23598431|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598432|NCT00739908|65919401|FG000|Overall Study|Adverse Event|5|||
23598433|NCT00739908|65919402|FG001|Overall Study|Adverse Event|6|||
23598434|NCT00739908|65919401|FG000|Overall Study|Withdrawal by Subject|4|||
23598435|NCT00739908|65919402|FG001|Overall Study|Withdrawal by Subject|2|||
23598436|NCT00739908|65919401|FG000|Overall Study|Lost to Follow-up|14|||
23598437|NCT00739908|65919402|FG001|Overall Study|Lost to Follow-up|9|||
23598438|NCT00739908|65919401|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
23598439|NCT00739908|65919402|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
23598440|NCT00739908|65919401|FG000|Overall Study|Non-Compliance With Study Medication|0|||
23598441|NCT00739908|65919402|FG001|Overall Study|Non-Compliance With Study Medication|3|||
23598442|NCT00739908|65919401|FG000|Overall Study|Lack of Efficacy|0|||
23598443|NCT00739908|65919402|FG001|Overall Study|Lack of Efficacy|1|||
23598444|NCT00739908|65919401|FG000|Overall Study|Relocation|0|||
23598445|NCT00739908|65919402|FG001|Overall Study|Relocation|1|||
23598446|NCT00409838|65919403|FG000|Short-term Period|Adverse Event|0|||
23598447|NCT00409838|65919404|FG001|Short-term Period|Adverse Event|1|||
23598448|NCT00409838|65919403|FG000|Short-term Period|Lost to Follow-up|0|||
23598449|NCT00409838|65919404|FG001|Short-term Period|Lost to Follow-up|1|||
23598450|NCT00409838|65919403|FG000|Short-term Period|Withdrawal by Subject|2|||
23598451|NCT00409838|65919404|FG001|Short-term Period|Withdrawal by Subject|3|||
23598452|NCT00409838|65919403|FG000|Short-term Period|Never Treated|1|||
23598453|NCT00409838|65919404|FG001|Short-term Period|Never Treated|0|||
23598454|NCT00409838|65919403|FG000|Long-term Extension Period|Adverse Event|10|||
23598455|NCT00409838|65919404|FG001|Long-term Extension Period|Adverse Event|0|||
23598456|NCT00409838|65919403|FG000|Long-term Extension Period|Death|1|||
23598457|NCT00409838|65919404|FG001|Long-term Extension Period|Death|0|||
23598458|NCT00409838|65919403|FG000|Long-term Extension Period|Lack of Efficacy|2|||
23598459|NCT00409838|65919404|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23598460|NCT00409838|65919403|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
23598461|NCT00409838|65919404|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
23598462|NCT00409838|65919403|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
23598463|NCT00409838|65919404|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
23598464|NCT00409838|65919403|FG000|Long-term Extension Period|Pregnancy|1|||
23598465|NCT00409838|65919404|FG001|Long-term Extension Period|Pregnancy|0|||
23598466|NCT00642850|65919405|FG000|Overall Study|Death|7|||
23598467|NCT00642850|65919405|FG000|Overall Study|Adverse Event|2|||
23598468|NCT00642850|65919405|FG000|Overall Study|Lack of Efficacy|1|||
23598469|NCT00642850|65919405|FG000|Overall Study|Protocol Violation|2|||
23598470|NCT00642850|65919405|FG000|Overall Study|Kidney transplantation|8|||
23598471|NCT00642850|65919405|FG000|Overall Study|Blood transfusion|6|||
23598472|NCT00642850|65919405|FG000|Overall Study|Other reasons|7|||
23598473|NCT01376700|65919413|FG000|Overall Study|Sponsor terminated study early|8|||
23598474|NCT01376700|65919413|FG000|Overall Study|Low or high titer inhibitor|8|||
23598475|NCT02376790|65919416|FG000|Overall Study|Withdrawal by Subject|43|||
23598476|NCT02376790|65919417|FG001|Overall Study|Withdrawal by Subject|36|||
23598477|NCT02376790|65919418|FG002|Overall Study|Withdrawal by Subject|37|||
23598478|NCT02376790|65919416|FG000|Overall Study|Decision by Sponsor|2|||
23598479|NCT02376790|65919417|FG001|Overall Study|Decision by Sponsor|1|||
23598480|NCT02376790|65919418|FG002|Overall Study|Decision by Sponsor|4|||
23598481|NCT02376790|65919416|FG000|Overall Study|Lost to Follow-up|15|||
23598482|NCT02376790|65919417|FG001|Overall Study|Lost to Follow-up|10|||
23598483|NCT02376790|65919418|FG002|Overall Study|Lost to Follow-up|12|||
23598484|NCT01510717|65919419|FG000|Overall Study|Adverse Event|1|||
23598485|NCT01510717|65919420|FG001|Overall Study|Adverse Event|2|||
23598486|NCT01510717|65919419|FG000|Overall Study|Death|1|||
23649828|NCT00409773|66100999|FG000|Overall Study|Lack of Eligibility|0|||
23598487|NCT01510717|65919420|FG001|Overall Study|Death|0|||
23598488|NCT01510717|65919419|FG000|Overall Study|Lost to Follow-up|0|||
23598489|NCT01510717|65919420|FG001|Overall Study|Lost to Follow-up|1|||
23598490|NCT01510717|65919419|FG000|Overall Study|Withdrawal by Subject|0|||
23649829|NCT00409773|66101000|FG001|Overall Study|Lack of Eligibility|0|||
23649830|NCT00409773|66101001|FG002|Overall Study|Lack of Eligibility|0|||
23649831|NCT00409773|66101002|FG003|Overall Study|Lack of Eligibility|0|||
23649832|NCT00409773|66101003|FG004|Overall Study|Lack of Eligibility|1|||
23649833|NCT01249274|66104222|FG000|Overall Study|Lost to Follow-up|3|||
23649834|NCT01249274|66104223|FG001|Overall Study|Lost to Follow-up|4|||
23649835|NCT01249274|66104222|FG000|Overall Study|Received inpatient substance treatment|1|||
23649836|NCT01249274|66104223|FG001|Overall Study|Received inpatient substance treatment|2|||
23649837|NCT01272804|66104224|FG000|Overall Study|Adverse Event|1|||
23649838|NCT01272804|66104225|FG001|Overall Study|Adverse Event|0|||
23649839|NCT01272804|66104226|FG002|Overall Study|Adverse Event|0|||
23479045|NCT01143389|65498360|FG001|Overall Study|Lost to Follow-up|25|||
23479046|NCT02015221|65498362|FG000|Overall Study|Withdrawal by Subject|8|||
23479047|NCT02015221|65498363|FG001|Overall Study|Withdrawal by Subject|6|||
23479048|NCT02015221|65498362|FG000|Overall Study|Lost to Follow-up|1|||
23479049|NCT02015221|65498363|FG001|Overall Study|Lost to Follow-up|0|||
23479050|NCT04473235|65498364|FG000|Overall Study|Lost to Follow-up|6|||
23479051|NCT04473235|65498365|FG001|Overall Study|Lost to Follow-up|5|||
23479052|NCT04473235|65498364|FG000|Overall Study|Declined continuation|2|||
23479053|NCT04473235|65498365|FG001|Overall Study|Declined continuation|0|||
23649840|NCT01272804|66104227|FG003|Overall Study|Adverse Event|0|||
23649841|NCT01272804|66104228|FG004|Overall Study|Adverse Event|2|||
23649842|NCT01272804|66104229|FG005|Overall Study|Adverse Event|1|||
23649843|NCT02409368|66104236|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
23649844|NCT02409368|66104237|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
23649845|NCT02409368|66104238|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
23649846|NCT02409368|66104239|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
23649847|NCT02409368|66104236|FG000|ECOG Reclassification|Death|1|||
23649848|NCT02409368|66104237|FG001|ECOG Reclassification|Death|5|||
23649849|NCT02409368|66104238|FG002|ECOG Reclassification|Death|0|||
23649850|NCT02409368|66104239|FG003|ECOG Reclassification|Death|0|||
23649851|NCT02409368|66104236|FG000|ECOG Reclassification|Disease Progression|113|||
23479054|NCT04473235|65498364|FG000|Overall Study|Physician Decision|1|||
23479055|NCT04473235|65498365|FG001|Overall Study|Physician Decision|1|||
23479056|NCT04473235|65498364|FG000|Overall Study|Protocol Violation|10|||
23598491|NCT01510717|65919420|FG001|Overall Study|Withdrawal by Subject|2|||
23598492|NCT00003222|65919421|FG000|Overall Study|Physician Decision|0|||
23598493|NCT00003222|65919422|FG001|Overall Study|Physician Decision|1|||
23598494|NCT00529789|65919423|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
23598495|NCT00529789|65919423|FG000|Study Period II/III|Adverse Event|3|||
23598496|NCT00529789|65919423|FG000|Study Period II/III|Lack of Efficacy|2|||
23598497|NCT00529789|65919423|FG000|Study Period II/III|Withdrawal by Subject|1|||
23598498|NCT00529789|65919423|FG000|Study Period II/III|Protocol Violation|3|||
23598499|NCT00529789|65919423|FG000|Study Period II/III|Physician Decision|3|||
23598500|NCT00529789|65919423|FG000|Study Period II/III|Lost to Follow-up|3|||
23598501|NCT00529789|65919423|FG000|Study Period IV|Parent/Caregiver Decision|1|||
23598502|NCT00529789|65919423|FG000|Study Period IV|Adverse Event|1|||
23598503|NCT00529789|65919423|FG000|Study Period IV|Lack of Efficacy|1|||
23598504|NCT00529789|65919423|FG000|Study Period IV|Lost to Follow-up|3|||
23598505|NCT00623194|65922244|FG000|Overall Study|Lack of Efficacy|1|||
23598506|NCT00623194|65922244|FG000|Overall Study|Protocol Violation|3|||
23598507|NCT00623194|65922244|FG000|Overall Study|Unclassified|1|||
23598508|NCT00640159|65922245|FG000|Overall Study|Lost to Follow-up|2|||
23598509|NCT01094184|65922248|FG000|Overall Study|Death|35|||
23598510|NCT01094184|65922249|FG001|Overall Study|Death|11|||
23598511|NCT01532388|65922268|FG000|3-month Follow-up|Lost to Follow-up|68|||
23598512|NCT01532388|65922269|FG001|3-month Follow-up|Lost to Follow-up|68|||
23598513|NCT01532388|65922268|FG000|6-month Follow-up|Lost to Follow-up|74|||
23598514|NCT01532388|65922269|FG001|6-month Follow-up|Lost to Follow-up|66|||
23598515|NCT01532388|65922268|FG000|12-month Follow-up|Lost to Follow-up|69|||
23598516|NCT01532388|65922269|FG001|12-month Follow-up|Lost to Follow-up|67|||
23598517|NCT03101371|65922270|FG000|Overall Study|Physician Decision|0|||
23598518|NCT03101371|65922271|FG001|Overall Study|Physician Decision|1|||
23649852|NCT02409368|66104237|FG001|ECOG Reclassification|Disease Progression|382|||
23649853|NCT02409368|66104238|FG002|ECOG Reclassification|Disease Progression|70|||
23649854|NCT02409368|66104239|FG003|ECOG Reclassification|Disease Progression|1|||
23649855|NCT02409368|66104236|FG000|ECOG Reclassification|Lost to Follow-up|1|||
23649856|NCT02409368|66104237|FG001|ECOG Reclassification|Lost to Follow-up|5|||
23479057|NCT04473235|65498365|FG001|Overall Study|Protocol Violation|6|||
23479058|NCT00075270|65498366|FG000|Overall Study|Withdrawal by Subject|28|||
23598519|NCT03101371|65922270|FG000|Overall Study|Lost to Follow-up|1|||
23598520|NCT03101371|65922271|FG001|Overall Study|Lost to Follow-up|4|||
23598521|NCT03101371|65922270|FG000|Overall Study|Did not meet eligibility criteria|2|||
23598522|NCT03101371|65922271|FG001|Overall Study|Did not meet eligibility criteria|1|||
23598523|NCT01367236|65922273|FG000|Overall Study|Withdrawal by Subject|3|||
23598524|NCT01367236|65922274|FG001|Overall Study|Withdrawal by Subject|1|||
23649857|NCT02409368|66104238|FG002|ECOG Reclassification|Lost to Follow-up|0|||
23479059|NCT00075270|65498367|FG001|Overall Study|Withdrawal by Subject|21|||
23479060|NCT00075270|65498366|FG000|Overall Study|Lost to Follow-up|25|||
23479061|NCT00075270|65498367|FG001|Overall Study|Lost to Follow-up|28|||
23479062|NCT00075270|65498366|FG000|Overall Study|Protocol Violation|0|||
23479063|NCT00075270|65498367|FG001|Overall Study|Protocol Violation|2|||
23479064|NCT00075270|65498366|FG000|Overall Study|Death|198|||
23479065|NCT00075270|65498367|FG001|Overall Study|Death|215|||
23479066|NCT00075270|65498366|FG000|Overall Study|Other/Unknown|9|||
23479067|NCT00075270|65498367|FG001|Overall Study|Other/Unknown|5|||
23479068|NCT00075270|65498366|FG000|Overall Study|Missing|26|||
23479069|NCT00075270|65498367|FG001|Overall Study|Missing|13|||
23479070|NCT00868517|65498370|FG000|Overall Study|Withdrawal by Subject|3|||
23479071|NCT00868517|65498371|FG001|Overall Study|Withdrawal by Subject|3|||
23479072|NCT00868517|65498372|FG002|Overall Study|Withdrawal by Subject|2|||
23479073|NCT00868517|65498370|FG000|Overall Study|Protocol Violation|1|||
23479074|NCT00868517|65498371|FG001|Overall Study|Protocol Violation|1|||
23801071|NCT01559935|66649884|FG000|Car Phase|non-compliance|1|||
23801072|NCT01559935|66649884|FG000|BiRD Phase|Toxicity|1|||
23801073|NCT01559935|66649884|FG000|BiRD Phase|Lack of Efficacy|1|||
23801074|NCT01559935|66649884|FG000|BiRD Phase|Withdrawal by Subject|2|||
23801075|NCT01559935|66649884|FG000|Maintenance Phase|Remains on study|28|||
23801076|NCT01559935|66649884|FG000|Maintenance Phase|Toxicity|1|||
23801077|NCT01559935|66649884|FG000|Maintenance Phase|Lack of Efficacy|18|||
23801078|NCT01559935|66649884|FG000|Maintenance Phase|Withdrawal by Subject|5|||
23479075|NCT00868517|65498372|FG002|Overall Study|Protocol Violation|0|||
23479076|NCT01119937|65498373|FG000|Overall Study|Adverse Event|11|||
23479077|NCT01119937|65498374|FG001|Overall Study|Adverse Event|5|||
23479078|NCT01119937|65498373|FG000|Overall Study|Protocol deviation|3|||
23479079|NCT01119937|65498374|FG001|Overall Study|Protocol deviation|1|||
23479080|NCT01119937|65498373|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23479081|NCT01119937|65498374|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23479082|NCT01119937|65498373|FG000|Overall Study|Withdrawal by Subject|2|||
23479083|NCT01119937|65498374|FG001|Overall Study|Withdrawal by Subject|1|||
23479084|NCT05315908|65498375|FG000|Overall Study|Lost to Follow-up|4477|||
23479085|NCT05315908|65498376|FG001|Overall Study|Lost to Follow-up|4606|||
23479086|NCT04931888|65498377|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
23479087|NCT04931888|65498378|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
23479088|NCT04931888|65498379|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
23479089|NCT04931888|65498380|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
23479090|NCT03996369|65498384|FG000|Overall Study|Protocol deviation|1|||
23479091|NCT03996369|65498385|FG001|Overall Study|Protocol deviation|1|||
23479092|NCT03996369|65498384|FG000|Overall Study|Physician Decision|4|||
23479093|NCT03996369|65498385|FG001|Overall Study|Physician Decision|2|||
23479094|NCT03996369|65498384|FG000|Overall Study|Participant decision|0|||
23479095|NCT03996369|65498385|FG001|Overall Study|Participant decision|1|||
23801079|NCT01559935|66649884|FG000|Maintenance Phase|Non-compliance|2|||
23479096|NCT03996369|65498384|FG000|Overall Study|Lack of Efficacy|4|||
23479097|NCT03996369|65498385|FG001|Overall Study|Lack of Efficacy|0|||
23479098|NCT03996369|65498384|FG000|Overall Study|Adverse Event|9|||
23801080|NCT02752802|66649885|FG000|Overall Study|Contrast Volume Not Collected|1|||
23479099|NCT03996369|65498385|FG001|Overall Study|Adverse Event|0|||
23479100|NCT03996369|65498384|FG000|Overall Study|Withdrawal by Subject|6|||
23479101|NCT03996369|65498385|FG001|Overall Study|Withdrawal by Subject|8|||
23598525|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
23598526|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598527|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598528|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598529|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598530|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
23598531|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598532|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598533|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598534|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598535|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
23598536|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598537|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598538|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598539|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598540|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
23598541|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598542|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598543|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598544|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598545|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
23598546|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598547|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598548|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598549|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598550|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
23598551|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598552|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598553|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598554|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598555|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
23598556|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598557|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598558|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598559|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598560|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
23598561|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598562|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598563|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598564|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598565|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
23598566|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598567|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598568|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598569|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598570|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
23598571|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
23598572|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
23598573|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
23598574|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
23598575|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598576|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598577|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598578|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
23598579|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598580|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
23598581|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
23598582|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
23598583|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
23598584|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
23598585|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23649858|NCT02409368|66104239|FG003|ECOG Reclassification|Lost to Follow-up|0|||
23649859|NCT02409368|66104236|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
23598586|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
23598587|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
23598588|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23598589|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23598590|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
23649860|NCT02409368|66104237|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
23649861|NCT02409368|66104238|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
23649862|NCT02409368|66104239|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
23598591|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
23801081|NCT02752802|66649886|FG001|Overall Study|Contrast Volume Not Collected|0|||
23801082|NCT02219308|66649887|FG000|Overall Study|Withdrawal by Subject|1|||
23801083|NCT02219308|66649888|FG001|Overall Study|Withdrawal by Subject|2|||
23801084|NCT02181296|66649889|FG000|Overall Study|Lost to Follow-up|7|||
23801085|NCT02181296|66649890|FG001|Overall Study|Lost to Follow-up|6|||
23801086|NCT00868296|66649891|FG000|Overall Study|Adverse Event|0|||
23801087|NCT00868296|66649892|FG001|Overall Study|Adverse Event|2|||
23801088|NCT00868296|66649891|FG000|Overall Study|Withdrawal by Subject|0|||
23801089|NCT00868296|66649892|FG001|Overall Study|Withdrawal by Subject|1|||
23801090|NCT02014441|66649897|FG000|Overall Study|Withdrawal by Subject|12|||
23801091|NCT04241133|66649900|FG000|Overall Study|COVID19 Precautions|14|||
23801092|NCT04241133|66649901|FG001|Overall Study|COVID19 Precautions|34|||
23801093|NCT00897949|66649902|FG000|Overall Study|Adverse Event|1|||
23801094|NCT00897949|66649903|FG001|Overall Study|Adverse Event|1|||
23801095|NCT00897949|66649904|FG002|Overall Study|Adverse Event|0|||
23801096|NCT00897949|66649902|FG000|Overall Study|Lost to Follow-up|0|||
23801097|NCT00897949|66649903|FG001|Overall Study|Lost to Follow-up|2|||
23801098|NCT00897949|66649904|FG002|Overall Study|Lost to Follow-up|1|||
23801099|NCT00897949|66649902|FG000|Overall Study|Protocol Violation|6|||
23801100|NCT00897949|66649903|FG001|Overall Study|Protocol Violation|3|||
23801101|NCT00897949|66649904|FG002|Overall Study|Protocol Violation|1|||
23801102|NCT00897949|66649902|FG000|Overall Study|Withdrawal by Subject|1|||
23801103|NCT00897949|66649903|FG001|Overall Study|Withdrawal by Subject|2|||
23598592|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
23598593|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
23598594|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
23598595|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598596|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598597|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
23598598|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598599|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
23598600|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598601|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598602|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
23598603|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598604|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598605|NCT02132949|65922283|FG000|Overall Study|Death|7|||
23598606|NCT02132949|65922284|FG001|Overall Study|Death|13|||
23598607|NCT02132949|65922283|FG000|Overall Study|Lost to Follow-up|14|||
23598608|NCT02132949|65922284|FG001|Overall Study|Lost to Follow-up|4|||
23598609|NCT02132949|65922283|FG000|Overall Study|Withdrawal by Subject|6|||
23598610|NCT02132949|65922284|FG001|Overall Study|Withdrawal by Subject|5|||
23598611|NCT02132949|65922283|FG000|Overall Study|Noncompliance|5|||
23598612|NCT02132949|65922284|FG001|Overall Study|Noncompliance|1|||
23598613|NCT02132949|65922283|FG000|Overall Study|Physician Decision|3|||
23598614|NCT02132949|65922284|FG001|Overall Study|Physician Decision|1|||
23598615|NCT02132949|65922283|FG000|Overall Study|Disease Progression|3|||
23598616|NCT02132949|65922284|FG001|Overall Study|Disease Progression|0|||
23598617|NCT02132949|65922283|FG000|Overall Study|Adverse Event|2|||
23598618|NCT02132949|65922284|FG001|Overall Study|Adverse Event|1|||
23598619|NCT02132949|65922283|FG000|Overall Study|Withdrew Prior to Treatment|1|||
23598620|NCT02132949|65922284|FG001|Overall Study|Withdrew Prior to Treatment|2|||
23598621|NCT02132949|65922283|FG000|Overall Study|Reason Unspecified|0|||
23598622|NCT02132949|65922284|FG001|Overall Study|Reason Unspecified|1|||
23598623|NCT01721291|65922285|FG000|Overall Study|Withdrawal by Subject|1|||
23598624|NCT01721291|65922286|FG001|Overall Study|Withdrawal by Subject|0|||
23598625|NCT01721291|65922285|FG000|Overall Study|did not like the treatment|1|||
23598626|NCT01721291|65922286|FG001|Overall Study|did not like the treatment|0|||
23598627|NCT01400958|65922292|FG000|Overall Study|Physician Decision|0|||
23598628|NCT01400958|65922293|FG001|Overall Study|Physician Decision|1|||
23649863|NCT02409368|66104236|FG000|ECOG Reclassification|Poor/non-compliance|0|||
23649864|NCT02409368|66104237|FG001|ECOG Reclassification|Poor/non-compliance|3|||
23649865|NCT02409368|66104238|FG002|ECOG Reclassification|Poor/non-compliance|2|||
23801104|NCT00897949|66649904|FG002|Overall Study|Withdrawal by Subject|0|||
23801105|NCT00897949|66649902|FG000|Overall Study|Patient Uncoorperative|0|||
23360639|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23479102|NCT03996369|65498384|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
23479103|NCT03996369|65498385|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
23479104|NCT03996369|65498384|FG000|Overall Study|Lost to Follow-up|0|||
23479105|NCT03996369|65498385|FG001|Overall Study|Lost to Follow-up|1|||
23479106|NCT01917656|65498390|FG000|Overall Study|Adverse Event|11|||
23479107|NCT01917656|65498391|FG001|Overall Study|Adverse Event|0|||
23479108|NCT01917656|65498390|FG000|Overall Study|Withdrawal criteria|8|||
23479109|NCT01917656|65498391|FG001|Overall Study|Withdrawal criteria|14|||
23479110|NCT01917656|65498390|FG000|Overall Study|Unclassified|0|||
23479111|NCT01917656|65498391|FG001|Overall Study|Unclassified|3|||
23479112|NCT01917656|65498390|FG000|Overall Study|Withdrawal by Subject|4|||
23479113|NCT01917656|65498391|FG001|Overall Study|Withdrawal by Subject|3|||
23479114|NCT01917656|65498390|FG000|Overall Study|Lost to Follow-up|3|||
23479115|NCT01917656|65498391|FG001|Overall Study|Lost to Follow-up|4|||
23479116|NCT01343901|65498392|FG000|Overall Study|Death|85|||
23479117|NCT01343901|65498392|FG000|Overall Study|Physician Decision|4|||
23479118|NCT01343901|65498392|FG000|Overall Study|Lost to Follow-up|12|||
23479119|NCT01343901|65498392|FG000|Overall Study|Management by another medical team|11|||
23479120|NCT01343901|65498392|FG000|Overall Study|Participant decision|1|||
23479121|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
23479122|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
23479123|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
23479124|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
23479125|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479126|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479127|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
23479128|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479129|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
23479130|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479131|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479132|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479133|NCT00369629|65498393|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
23479134|NCT00369629|65498394|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
23479135|NCT00369629|65498395|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
23479136|NCT00369629|65498396|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
23479137|NCT00369629|65498393|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
23479138|NCT00369629|65498394|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
23479139|NCT00369629|65498395|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
23479140|NCT00369629|65498396|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
23479141|NCT00369629|65498393|FG000|Completed 4 More Cycles|Progressive disease|2|||
23479142|NCT00369629|65498394|FG001|Completed 4 More Cycles|Progressive disease|1|||
23479143|NCT00369629|65498395|FG002|Completed 4 More Cycles|Progressive disease|2|||
23479144|NCT00369629|65498396|FG003|Completed 4 More Cycles|Progressive disease|0|||
23479145|NCT00369629|65498393|FG000|Follow up for 1 Year|Death|2|||
23479146|NCT00369629|65498394|FG001|Follow up for 1 Year|Death|1|||
23479147|NCT00369629|65498395|FG002|Follow up for 1 Year|Death|1|||
23479148|NCT00369629|65498396|FG003|Follow up for 1 Year|Death|0|||
23479149|NCT00369629|65498393|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
23479150|NCT00369629|65498394|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
23479151|NCT00369629|65498395|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
23479152|NCT00369629|65498396|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
23598629|NCT01400958|65922292|FG000|Overall Study|Withdrawal by Subject|0|||
23598630|NCT01400958|65922293|FG001|Overall Study|Withdrawal by Subject|1|||
23360640|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
23479153|NCT00369629|65498393|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
23649866|NCT02409368|66104239|FG003|ECOG Reclassification|Poor/non-compliance|0|||
23649867|NCT02409368|66104236|FG000|ECOG Reclassification|Study drug toxicity|17|||
23649868|NCT02409368|66104237|FG001|ECOG Reclassification|Study drug toxicity|42|||
23649869|NCT02409368|66104238|FG002|ECOG Reclassification|Study drug toxicity|7|||
23649870|NCT02409368|66104239|FG003|ECOG Reclassification|Study drug toxicity|0|||
23649871|NCT02409368|66104236|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
23649872|NCT02409368|66104237|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
23649873|NCT02409368|66104238|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
23649874|NCT02409368|66104239|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
23649875|NCT02409368|66104236|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
23649876|NCT02409368|66104237|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
23649877|NCT02409368|66104238|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
23649878|NCT02409368|66104239|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
23649879|NCT02409368|66104236|FG000|ECOG Reclassification|Participant withdrew consent|2|||
23649880|NCT02409368|66104237|FG001|ECOG Reclassification|Participant withdrew consent|3|||
23649881|NCT02409368|66104238|FG002|ECOG Reclassification|Participant withdrew consent|4|||
23649882|NCT02409368|66104239|FG003|ECOG Reclassification|Participant withdrew consent|0|||
23649883|NCT02409368|66104236|FG000|ECOG Reclassification|Other Reasons|5|||
23649884|NCT02409368|66104237|FG001|ECOG Reclassification|Other Reasons|26|||
23649885|NCT02409368|66104238|FG002|ECOG Reclassification|Other Reasons|2|||
23649886|NCT02409368|66104239|FG003|ECOG Reclassification|Other Reasons|0|||
23649887|NCT02409368|66104236|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
23649888|NCT02409368|66104237|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
23649889|NCT02409368|66104238|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
23649890|NCT02409368|66104239|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
23649891|NCT00320541|66104246|FG000|Overall Study|Adverse Event|21|||
23649892|NCT00320541|66104247|FG001|Overall Study|Adverse Event|19|||
23649893|NCT00320541|66104246|FG000|Overall Study|Protocol Violation|0|||
23649894|NCT00320541|66104247|FG001|Overall Study|Protocol Violation|1|||
23649895|NCT00320541|66104246|FG000|Overall Study|Withdrawal by Subject|12|||
23649896|NCT00320541|66104247|FG001|Overall Study|Withdrawal by Subject|16|||
23649897|NCT00320541|66104246|FG000|Overall Study|Physician Decision|9|||
23649898|NCT00320541|66104247|FG001|Overall Study|Physician Decision|13|||
23649899|NCT00320541|66104246|FG000|Overall Study|Other|3|||
23649900|NCT00320541|66104247|FG001|Overall Study|Other|4|||
23649901|NCT00320541|66104246|FG000|Overall Study|Sponsor Decision|2|||
23649902|NCT00320541|66104247|FG001|Overall Study|Sponsor Decision|1|||
23649903|NCT00320541|66104246|FG000|Overall Study|Death due to Study Disease|1|||
23649904|NCT00320541|66104247|FG001|Overall Study|Death due to Study Disease|3|||
23649905|NCT00320541|66104246|FG000|Overall Study|Death due to Adverse Event(s)|1|||
23649906|NCT00320541|66104247|FG001|Overall Study|Death due to Adverse Event(s)|0|||
23649907|NCT00320541|66104246|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
23649908|NCT00320541|66104247|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
23649909|NCT00413972|66104248|FG000|Overall Study|Adverse Event|2|||
23649910|NCT00413972|66104249|FG001|Overall Study|Adverse Event|1|||
23649911|NCT00413972|66104250|FG002|Overall Study|Adverse Event|0|||
23649912|NCT00413972|66104251|FG003|Overall Study|Adverse Event|0|||
23649913|NCT00413972|66104248|FG000|Overall Study|Lost to Follow-up|1|||
23649914|NCT00413972|66104249|FG001|Overall Study|Lost to Follow-up|2|||
23649915|NCT00413972|66104250|FG002|Overall Study|Lost to Follow-up|1|||
23649916|NCT00413972|66104251|FG003|Overall Study|Lost to Follow-up|0|||
23649917|NCT00413972|66104248|FG000|Overall Study|Withdrawal by Subject|4|||
23649918|NCT00413972|66104249|FG001|Overall Study|Withdrawal by Subject|5|||
23649919|NCT00413972|66104250|FG002|Overall Study|Withdrawal by Subject|7|||
23649920|NCT00413972|66104251|FG003|Overall Study|Withdrawal by Subject|2|||
23649921|NCT00413972|66104248|FG000|Overall Study|Protocol Violation|0|||
23649922|NCT00413972|66104249|FG001|Overall Study|Protocol Violation|0|||
23649923|NCT00413972|66104250|FG002|Overall Study|Protocol Violation|2|||
23649924|NCT00413972|66104251|FG003|Overall Study|Protocol Violation|0|||
23649925|NCT00413972|66104248|FG000|Overall Study|Other|0|||
23649926|NCT00413972|66104249|FG001|Overall Study|Other|0|||
23649927|NCT00413972|66104250|FG002|Overall Study|Other|0|||
23649928|NCT00413972|66104251|FG003|Overall Study|Other|1|||
23649929|NCT01209780|66104252|FG000|Overall Study|Adverse Event|0|||
23649930|NCT01209780|66104253|FG001|Overall Study|Adverse Event|1|||
23649931|NCT01209780|66104254|FG002|Overall Study|Adverse Event|0|||
23649932|NCT01209780|66104255|FG003|Overall Study|Adverse Event|0|||
23649933|NCT01209780|66104256|FG004|Overall Study|Adverse Event|0|||
23649934|NCT01209780|66104252|FG000|Overall Study|Withdrawal by Subject|9|||
23649935|NCT01209780|66104253|FG001|Overall Study|Withdrawal by Subject|2|||
23649936|NCT01209780|66104254|FG002|Overall Study|Withdrawal by Subject|1|||
23649937|NCT01209780|66104255|FG003|Overall Study|Withdrawal by Subject|1|||
23649938|NCT01209780|66104256|FG004|Overall Study|Withdrawal by Subject|0|||
23649939|NCT01209780|66104252|FG000|Overall Study|Lost to Follow-up|17|||
23649940|NCT01209780|66104253|FG001|Overall Study|Lost to Follow-up|12|||
23649941|NCT01209780|66104254|FG002|Overall Study|Lost to Follow-up|3|||
23649942|NCT01209780|66104255|FG003|Overall Study|Lost to Follow-up|9|||
23649943|NCT01209780|66104256|FG004|Overall Study|Lost to Follow-up|4|||
23649944|NCT01209780|66104252|FG000|Overall Study|Protocol Violation|0|||
23649945|NCT01209780|66104253|FG001|Overall Study|Protocol Violation|1|||
23649946|NCT01209780|66104254|FG002|Overall Study|Protocol Violation|0|||
23649947|NCT01209780|66104255|FG003|Overall Study|Protocol Violation|0|||
23649948|NCT01209780|66104256|FG004|Overall Study|Protocol Violation|0|||
23649949|NCT01209780|66104252|FG000|Overall Study|Inappropriate enrollment|0|||
23649950|NCT01209780|66104253|FG001|Overall Study|Inappropriate enrollment|2|||
23649951|NCT01209780|66104254|FG002|Overall Study|Inappropriate enrollment|0|||
23649952|NCT01209780|66104255|FG003|Overall Study|Inappropriate enrollment|0|||
23649953|NCT01209780|66104256|FG004|Overall Study|Inappropriate enrollment|1|||
23649954|NCT04214600|66104257|FG000|Overall Study|Lost to Follow-up|9|||
23649955|NCT04214600|66104258|FG001|Overall Study|Lost to Follow-up|14|||
23649956|NCT00796120|66104259|FG000|Overall Study|Death|3|||
23649957|NCT00796120|66104260|FG001|Overall Study|Death|0|||
23649958|NCT00796120|66104259|FG000|Overall Study|Adverse Event|11|||
23649959|NCT00796120|66104260|FG001|Overall Study|Adverse Event|6|||
23649960|NCT00796120|66104259|FG000|Overall Study|Progressive disease|22|||
23649961|NCT00796120|66104260|FG001|Overall Study|Progressive disease|13|||
23649962|NCT00796120|66104259|FG000|Overall Study|Participant refusal|3|||
23649963|NCT00796120|66104260|FG001|Overall Study|Participant refusal|4|||
23649964|NCT00796120|66104259|FG000|Overall Study|Other|6|||
23649965|NCT00796120|66104260|FG001|Overall Study|Other|17|||
23649966|NCT00796120|66104259|FG000|Overall Study|Physician Decision|16|||
23649967|NCT00796120|66104260|FG001|Overall Study|Physician Decision|17|||
23649968|NCT00796120|66104259|FG000|Overall Study|Randomized but not treated|0|||
23649969|NCT00796120|66104260|FG001|Overall Study|Randomized but not treated|3|||
23649970|NCT01271803|66104264|FG000|Overall Study|Progressive disease|0|||
23649971|NCT01271803|66104265|FG001|Overall Study|Progressive disease|0|||
23649972|NCT01271803|66104266|FG002|Overall Study|Progressive disease|2|||
23649973|NCT01271803|66104264|FG000|Overall Study|Death|53|||
23649974|NCT01271803|66104265|FG001|Overall Study|Death|34|||
23649975|NCT01271803|66104266|FG002|Overall Study|Death|0|||
23649976|NCT01271803|66104264|FG000|Overall Study|Withdrawal by Subject|1|||
23649977|NCT01271803|66104265|FG001|Overall Study|Withdrawal by Subject|5|||
23649978|NCT01271803|66104266|FG002|Overall Study|Withdrawal by Subject|0|||
23649979|NCT01271803|66104264|FG000|Overall Study|Lost to Follow-up|1|||
23649980|NCT01271803|66104265|FG001|Overall Study|Lost to Follow-up|0|||
23649981|NCT01271803|66104266|FG002|Overall Study|Lost to Follow-up|0|||
23649982|NCT00504881|66104275|FG000|Overall Study|Lack of Efficacy|1|||
23649983|NCT00504881|66104276|FG001|Overall Study|Lack of Efficacy|5|||
23649984|NCT00504881|66104275|FG000|Overall Study|Lost to Follow-up|0|||
23649985|NCT00504881|66104276|FG001|Overall Study|Lost to Follow-up|2|||
23649986|NCT00504881|66104275|FG000|Overall Study|Withdrawal by Subject|1|||
23649987|NCT00504881|66104276|FG001|Overall Study|Withdrawal by Subject|4|||
23649988|NCT00504881|66104275|FG000|Overall Study|Non-Compliance|1|||
23649989|NCT00504881|66104276|FG001|Overall Study|Non-Compliance|0|||
23649990|NCT00504881|66104275|FG000|Overall Study|No Birth Control|0|||
23649991|NCT00504881|66104276|FG001|Overall Study|No Birth Control|1|||
23649992|NCT00504881|66104275|FG000|Overall Study|Safety Visit not performed|0|||
23649993|NCT00504881|66104276|FG001|Overall Study|Safety Visit not performed|1|||
23649994|NCT00504881|66104275|FG000|Overall Study|AE, serious fatal|0|||
23649995|NCT00504881|66104276|FG001|Overall Study|AE, serious fatal|1|||
23649996|NCT00504881|66104275|FG000|Overall Study|SAE, non-fatal|2|||
23649997|NCT00504881|66104276|FG001|Overall Study|SAE, non-fatal|6|||
23649998|NCT00504881|66104275|FG000|Overall Study|AE, non-serious non-fatal|4|||
23649999|NCT00504881|66104276|FG001|Overall Study|AE, non-serious non-fatal|14|||
23650000|NCT00504881|66104275|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23650001|NCT00504881|66104276|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
23650002|NCT00504881|66104275|FG000|Overall Study|AE of unknown type|1|||
23650003|NCT00504881|66104276|FG001|Overall Study|AE of unknown type|0|||
23650004|NCT04507126|66104277|FG000|Overall Study|Withdrawal by Subject|1|||
23650005|NCT04507126|66104277|FG000|Overall Study|Protocol Violation|2|||
23650006|NCT04507126|66104277|FG000|Overall Study|Physician Decision|1|||
23650007|NCT03513588|66104278|FG000|Overall Study|Lost to Follow-up|0|||
23650008|NCT03513588|66104279|FG001|Overall Study|Lost to Follow-up|1|||
23650009|NCT03513588|66104280|FG002|Overall Study|Lost to Follow-up|1|||
23650010|NCT03513588|66104278|FG000|Overall Study|Study dosing paused by sponsor|1|||
23650011|NCT03513588|66104279|FG001|Overall Study|Study dosing paused by sponsor|1|||
23650012|NCT03513588|66104280|FG002|Overall Study|Study dosing paused by sponsor|0|||
23650013|NCT03513588|66104278|FG000|Overall Study|Death|0|||
23650014|NCT03513588|66104279|FG001|Overall Study|Death|0|||
23650015|NCT03513588|66104280|FG002|Overall Study|Death|1|||
23650016|NCT03809429|66104286|FG000|Overall Study|Withdrawal by Subject|7|||
23650017|NCT03809429|66104287|FG001|Overall Study|Withdrawal by Subject|3|||
23650018|NCT03809429|66104286|FG000|Overall Study|Adverse Event|6|||
23650019|NCT03809429|66104287|FG001|Overall Study|Adverse Event|9|||
23650020|NCT03809429|66104286|FG000|Overall Study|COVID-19|3|||
23650021|NCT03809429|66104287|FG001|Overall Study|COVID-19|1|||
23650022|NCT03809429|66104286|FG000|Overall Study|Participant was discontinued by investigator|12|||
23650023|NCT03809429|66104287|FG001|Overall Study|Participant was discontinued by investigator|7|||
23650024|NCT01614197|66104290|FG000|Overall Study|Withdrawal by Subject|0|||
23650025|NCT01614197|66104291|FG001|Overall Study|Withdrawal by Subject|1|||
23650026|NCT01614197|66104292|FG002|Overall Study|Withdrawal by Subject|0|||
23650027|NCT01614197|66104293|FG003|Overall Study|Withdrawal by Subject|0|||
23650028|NCT02527343|66104298|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
23650029|NCT02527343|66104299|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23650030|NCT02527343|66104300|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23650031|NCT02527343|66104301|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23650032|NCT02527343|66104302|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23650033|NCT02527343|66104303|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23650034|NCT02527343|66104298|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
23650035|NCT02527343|66104299|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23650036|NCT02527343|66104300|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23650037|NCT02527343|66104301|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23650038|NCT02527343|66104302|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23650039|NCT02527343|66104303|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23650040|NCT02527343|66104298|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23650041|NCT02527343|66104299|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
23650042|NCT02527343|66104300|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23650043|NCT02527343|66104301|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23650044|NCT02527343|66104302|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23650045|NCT02527343|66104303|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23650046|NCT02527343|66104298|FG000|RT Period: Weeks 1 to 52|Other|4|||
23650047|NCT02527343|66104299|FG001|RT Period: Weeks 1 to 52|Other|3|||
23650048|NCT02527343|66104300|FG002|RT Period: Weeks 1 to 52|Other|0|||
23650049|NCT02527343|66104301|FG003|RT Period: Weeks 1 to 52|Other|0|||
23650050|NCT02527343|66104302|FG004|RT Period: Weeks 1 to 52|Other|0|||
23650051|NCT02527343|66104303|FG005|RT Period: Weeks 1 to 52|Other|0|||
23650052|NCT02527343|66104298|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23650053|NCT02527343|66104299|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23650054|NCT02527343|66104300|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
23650055|NCT02527343|66104301|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23650056|NCT02527343|66104302|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23650057|NCT02527343|66104303|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23650058|NCT02527343|66104298|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23650059|NCT02527343|66104299|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23650060|NCT02527343|66104300|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23650061|NCT02527343|66104301|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
23650062|NCT02527343|66104302|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23650063|NCT02527343|66104303|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23650064|NCT02527343|66104298|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23650065|NCT02527343|66104299|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23650066|NCT02527343|66104300|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23650067|NCT02527343|66104301|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23650068|NCT02527343|66104302|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
23650069|NCT02527343|66104303|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23650070|NCT02527343|66104298|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23650071|NCT02527343|66104299|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23650072|NCT02527343|66104300|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23650073|NCT02527343|66104301|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23650074|NCT02527343|66104302|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
23650075|NCT02527343|66104303|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
23650076|NCT02527343|66104298|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23650077|NCT02527343|66104299|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23650078|NCT02527343|66104300|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23650079|NCT02527343|66104301|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23650080|NCT02527343|66104302|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
23650081|NCT02527343|66104303|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
23801106|NCT00897949|66649903|FG001|Overall Study|Patient Uncoorperative|2|||
23801107|NCT00897949|66649904|FG002|Overall Study|Patient Uncoorperative|1|||
23479154|NCT00369629|65498394|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
23650082|NCT02527343|66104298|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
23650083|NCT02527343|66104299|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
23650084|NCT02527343|66104300|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
23650085|NCT02527343|66104301|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
23650086|NCT02527343|66104302|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
23650087|NCT02527343|66104303|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
23598631|NCT01400958|65922292|FG000|Overall Study|Adverse Event|1|||
23598632|NCT01400958|65922293|FG001|Overall Study|Adverse Event|0|||
23598633|NCT00331136|65922294|FG000|Overall Study|Adverse Event|3|||
23598634|NCT00331136|65922295|FG001|Overall Study|Adverse Event|5|||
23598635|NCT00331136|65922296|FG002|Overall Study|Adverse Event|0|||
23598636|NCT00331136|65922297|FG003|Overall Study|Adverse Event|1|||
23598637|NCT00331136|65922294|FG000|Overall Study|Withdrawal by Subject|0|||
23598638|NCT00331136|65922295|FG001|Overall Study|Withdrawal by Subject|1|||
23598639|NCT00331136|65922296|FG002|Overall Study|Withdrawal by Subject|0|||
23598640|NCT00331136|65922297|FG003|Overall Study|Withdrawal by Subject|0|||
23598641|NCT00331136|65922294|FG000|Overall Study|Lost to Follow-up|0|||
23598642|NCT00331136|65922295|FG001|Overall Study|Lost to Follow-up|1|||
23598643|NCT00331136|65922296|FG002|Overall Study|Lost to Follow-up|0|||
23598644|NCT00331136|65922297|FG003|Overall Study|Lost to Follow-up|0|||
23598645|NCT00331136|65922294|FG000|Overall Study|Protocol Violation|1|||
23598646|NCT00331136|65922295|FG001|Overall Study|Protocol Violation|0|||
23598647|NCT00331136|65922296|FG002|Overall Study|Protocol Violation|0|||
23598648|NCT00331136|65922297|FG003|Overall Study|Protocol Violation|0|||
23598649|NCT00331136|65922294|FG000|Overall Study|Not treated|1|||
23598650|NCT00331136|65922295|FG001|Overall Study|Not treated|0|||
23598651|NCT00331136|65922296|FG002|Overall Study|Not treated|0|||
23598652|NCT00331136|65922297|FG003|Overall Study|Not treated|0|||
23598653|NCT00371787|65922298|FG000|Overall Study|Withdrawal by Subject|3|||
23598654|NCT00371787|65922299|FG001|Overall Study|Withdrawal by Subject|1|||
23598655|NCT02555215|65922300|FG000|Overall Study|Other|1|||
23598656|NCT02555215|65922300|FG000|Overall Study|Investigator Decision|2|||
23598657|NCT04121546|65922301|FG000|Overall Study|Lost to Follow-up|1|||
23598658|NCT04121546|65922302|FG001|Overall Study|Lost to Follow-up|3|||
23598659|NCT04860505|65922307|FG000|Overall Study|Lost to Follow-up|2|||
23598660|NCT02147093|65922308|FG000|Period 1|Lost to Follow-up|0|||
23598661|NCT02147093|65922309|FG001|Period 1|Lost to Follow-up|1|||
23598662|NCT02147093|65922308|FG000|Period 2|Protocol Violation|2|||
23598663|NCT02147093|65922309|FG001|Period 2|Protocol Violation|0|||
23650088|NCT02527343|66104298|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
23801108|NCT00897949|66649902|FG000|Overall Study|Lost to Follow-up|30|||
23801109|NCT00897949|66649903|FG001|Overall Study|Lost to Follow-up|23|||
23801110|NCT00897949|66649904|FG002|Overall Study|Lost to Follow-up|17|||
23801111|NCT00897949|66649902|FG000|Overall Study|Withdrawal by Subject|24|||
23801112|NCT00897949|66649903|FG001|Overall Study|Withdrawal by Subject|31|||
23801113|NCT00897949|66649904|FG002|Overall Study|Withdrawal by Subject|17|||
23801114|NCT00897949|66649902|FG000|Overall Study|Abnormal Prestudy Labs|2|||
23801115|NCT00897949|66649903|FG001|Overall Study|Abnormal Prestudy Labs|3|||
23801116|NCT00897949|66649904|FG002|Overall Study|Abnormal Prestudy Labs|4|||
23801117|NCT00897949|66649902|FG000|Overall Study|Abnormal Baseline ECG|2|||
23801118|NCT00897949|66649903|FG001|Overall Study|Abnormal Baseline ECG|2|||
23801119|NCT00897949|66649904|FG002|Overall Study|Abnormal Baseline ECG|4|||
23801120|NCT00897949|66649902|FG000|Overall Study|Need for Concom. Med.|0|||
23801121|NCT00897949|66649903|FG001|Overall Study|Need for Concom. Med.|1|||
23801122|NCT00897949|66649904|FG002|Overall Study|Need for Concom. Med.|1|||
23801123|NCT00897949|66649902|FG000|Overall Study|Lack of Migraine Attack|29|||
23479155|NCT00369629|65498395|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
23479156|NCT00369629|65498396|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
23479157|NCT01470989|65498397|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
23479158|NCT01470989|65498398|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
23479159|NCT01470989|65498397|FG000|Overall Study|Adverse Event|2|||
23479160|NCT01470989|65498398|FG001|Overall Study|Adverse Event|5|||
23479161|NCT01470989|65498397|FG000|Overall Study|Abnormal laboratory value|1|||
23479162|NCT01470989|65498398|FG001|Overall Study|Abnormal laboratory value|1|||
23801124|NCT00897949|66649903|FG001|Overall Study|Lack of Migraine Attack|30|||
23801125|NCT00897949|66649904|FG002|Overall Study|Lack of Migraine Attack|19|||
23801126|NCT00897949|66649902|FG000|Overall Study|Did not take study drug|9|||
23479163|NCT01470989|65498397|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23479164|NCT01470989|65498398|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23598664|NCT01079949|65922310|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
23598665|NCT01079949|65922311|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
23598666|NCT01079949|65922310|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
23598667|NCT01079949|65922311|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
23598668|NCT01079949|65922310|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
23598669|NCT01079949|65922311|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
23598670|NCT01079949|65922310|FG000|Overall Study|Randomized but not treated|1|||
23479165|NCT01470989|65498397|FG000|Overall Study|Withdrawal by Subject|19|||
23479166|NCT01470989|65498398|FG001|Overall Study|Withdrawal by Subject|17|||
23479167|NCT01470989|65498397|FG000|Overall Study|Lost to Follow-up|18|||
23650089|NCT02527343|66104299|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
23650090|NCT02527343|66104300|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
23650091|NCT02527343|66104301|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
23650092|NCT02527343|66104302|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
23650093|NCT02527343|66104303|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
23650094|NCT02527343|66104298|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23650095|NCT02527343|66104299|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23650096|NCT02527343|66104300|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23650097|NCT02527343|66104301|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23650098|NCT02527343|66104302|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
23650099|NCT02527343|66104303|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23650100|NCT02527343|66104298|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
23650101|NCT02527343|66104299|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
23650102|NCT02527343|66104300|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
23650103|NCT02527343|66104301|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
23650104|NCT02527343|66104302|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
23650105|NCT02527343|66104303|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
23650106|NCT01759407|66104304|FG000|Overall Study|Protocol Violation|0|||
23650107|NCT01759407|66104305|FG001|Overall Study|Protocol Violation|2|||
23650108|NCT03384654|66104306|FG000|Overall Study|Withdrawal by Subject|0|||
23650109|NCT03384654|66104307|FG001|Overall Study|Withdrawal by Subject|0|||
23650110|NCT03384654|66104308|FG002|Overall Study|Withdrawal by Subject|1|||
23650111|NCT03384654|66104309|FG003|Overall Study|Withdrawal by Subject|0|||
23650112|NCT01190514|66104313|FG000|First Intervention (Period 1)|Adverse Event|1|||
23650113|NCT01190514|66104314|FG001|First Intervention (Period 1)|Adverse Event|0|||
23650114|NCT01190514|66104315|FG002|First Intervention (Period 1)|Adverse Event|0|||
23650115|NCT01190514|66104316|FG003|First Intervention (Period 1)|Adverse Event|0|||
23650116|NCT01190514|66104313|FG000|Third Intervention (Period 3)|Adverse Event|1|||
23650117|NCT01190514|66104314|FG001|Third Intervention (Period 3)|Adverse Event|0|||
23650118|NCT01190514|66104315|FG002|Third Intervention (Period 3)|Adverse Event|0|||
23650119|NCT01190514|66104316|FG003|Third Intervention (Period 3)|Adverse Event|0|||
23650120|NCT01602562|66104318|FG000|Overall Study|Adverse Event|3|||
23650121|NCT01602562|66104319|FG001|Overall Study|Adverse Event|1|||
23650122|NCT01602562|66104318|FG000|Overall Study|Physician Decision|1|||
23650123|NCT01602562|66104319|FG001|Overall Study|Physician Decision|1|||
23650124|NCT01602562|66104318|FG000|Overall Study|Withdrawal by Subject|1|||
23650125|NCT01602562|66104319|FG001|Overall Study|Withdrawal by Subject|1|||
23650126|NCT04751656|66104321|FG000|Overall Study|Lost to Follow-up|1|||
23650127|NCT02043678|66104322|FG000|Overall Study|Never treated|11|||
23650128|NCT02043678|66104323|FG001|Overall Study|Never treated|9|||
23650129|NCT02043678|66104322|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
23650130|NCT02043678|66104323|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
23650131|NCT02043678|66104322|FG000|Overall Study|AE without clinical PD|51|||
23650132|NCT02043678|66104323|FG001|Overall Study|AE without clinical PD|34|||
23650133|NCT02043678|66104322|FG000|Overall Study|Lost to Follow-up|1|||
23650134|NCT02043678|66104323|FG001|Overall Study|Lost to Follow-up|1|||
23650135|NCT02043678|66104322|FG000|Overall Study|Other|19|||
23479168|NCT01470989|65498398|FG001|Overall Study|Lost to Follow-up|13|||
23479169|NCT01470989|65498397|FG000|Overall Study|Administrative problems|2|||
23479170|NCT01470989|65498398|FG001|Overall Study|Administrative problems|4|||
23479171|NCT01470989|65498397|FG000|Overall Study|Death|2|||
23479172|NCT01470989|65498398|FG001|Overall Study|Death|2|||
23479173|NCT01470989|65498397|FG000|Overall Study|Protocol deviation|1|||
23479174|NCT01470989|65498398|FG001|Overall Study|Protocol deviation|2|||
23479175|NCT01561898|65498399|FG000|Overall Study|Withdrawal by Subject|0|||
23479176|NCT01561898|65498400|FG001|Overall Study|Withdrawal by Subject|8|||
23479177|NCT01561898|65498401|FG002|Overall Study|Withdrawal by Subject|12|||
23479178|NCT01561898|65498402|FG003|Overall Study|Withdrawal by Subject|5|||
23479179|NCT01561898|65498399|FG000|Overall Study|Lack of Efficacy|0|||
23479180|NCT01561898|65498400|FG001|Overall Study|Lack of Efficacy|8|||
23479181|NCT01561898|65498401|FG002|Overall Study|Lack of Efficacy|10|||
23479182|NCT01561898|65498402|FG003|Overall Study|Lack of Efficacy|5|||
23650136|NCT02043678|66104323|FG001|Overall Study|Other|16|||
23650137|NCT02043678|66104322|FG000|Overall Study|Clinical PD|108|||
23650138|NCT02043678|66104323|FG001|Overall Study|Clinical PD|138|||
23650139|NCT02043678|66104322|FG000|Overall Study|Radiological PD|91|||
23650140|NCT02043678|66104323|FG001|Overall Study|Radiological PD|80|||
23479183|NCT01561898|65498399|FG000|Overall Study|Worsening of complications|0|||
23650141|NCT02043678|66104322|FG000|Overall Study|Protocol-driven decision point|56|||
23650142|NCT02043678|66104323|FG001|Overall Study|Protocol-driven decision point|56|||
23650143|NCT02043678|66104322|FG000|Overall Study|Withdrawal by Subject|12|||
23650144|NCT02043678|66104323|FG001|Overall Study|Withdrawal by Subject|15|||
23650145|NCT02043678|66104322|FG000|Overall Study|Ongoing with treatment|34|||
23650146|NCT02043678|66104323|FG001|Overall Study|Ongoing with treatment|38|||
23650147|NCT02318797|66104324|FG000|Overall Study|Death|3|||
23650148|NCT02318797|66104325|FG001|Overall Study|Death|6|||
23650149|NCT02318797|66104324|FG000|Overall Study|Lost to Follow-up|85|||
23650150|NCT02318797|66104325|FG001|Overall Study|Lost to Follow-up|96|||
23650151|NCT02186223|66104326|FG000|Overall Study|Not eligible for device placement|6|||
23650152|NCT02186223|66104326|FG000|Overall Study|Unable to obtain femoral access|3|||
23650153|NCT02186223|66104326|FG000|Overall Study|Death|3|||
23650154|NCT02186223|66104326|FG000|Overall Study|Device in place less than 48 hours|9|||
23650155|NCT01839487|66104327|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
23650156|NCT01839487|66104328|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23650157|NCT01839487|66104329|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23650158|NCT01839487|66104330|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23650159|NCT01839487|66104331|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23650160|NCT01839487|66104332|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23650161|NCT01839487|66104327|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
23650162|NCT01839487|66104328|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
23650163|NCT01839487|66104329|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23650164|NCT01839487|66104330|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23650165|NCT01839487|66104331|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23650166|NCT01839487|66104332|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23650167|NCT01839487|66104327|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23650168|NCT01839487|66104328|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
23650169|NCT01839487|66104329|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23650170|NCT01839487|66104330|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23650171|NCT01839487|66104331|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23650172|NCT01839487|66104332|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23650173|NCT01839487|66104327|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
23650174|NCT01839487|66104328|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23650175|NCT01839487|66104329|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23650176|NCT01839487|66104330|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23650177|NCT01839487|66104331|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23650178|NCT01839487|66104332|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23650179|NCT01839487|66104327|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
23650180|NCT01839487|66104328|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
23650181|NCT01839487|66104329|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
23650182|NCT01839487|66104330|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
23650183|NCT01839487|66104331|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
23650184|NCT01839487|66104332|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
23650185|NCT01839487|66104327|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
23650186|NCT01839487|66104328|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
23650187|NCT01839487|66104329|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
23650188|NCT01839487|66104330|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
23650189|NCT01839487|66104331|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
23650190|NCT01839487|66104332|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
23650191|NCT01839487|66104327|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23650192|NCT01839487|66104328|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23650193|NCT01839487|66104329|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
23650194|NCT01839487|66104330|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23650195|NCT01839487|66104331|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
23650196|NCT01839487|66104332|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23650197|NCT01839487|66104327|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23650198|NCT01839487|66104328|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23650199|NCT01839487|66104329|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23650200|NCT01839487|66104330|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
23650201|NCT01839487|66104331|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
23650202|NCT01839487|66104332|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
23650203|NCT01839487|66104327|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
23650204|NCT01839487|66104328|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
23650205|NCT01839487|66104329|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
23650206|NCT01839487|66104330|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
23650207|NCT01839487|66104331|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
23598671|NCT01079949|65922311|FG001|Overall Study|Randomized but not treated|0|||
23598672|NCT03014453|65922312|FG000|Overall Study|Lost to Follow-up|12|||
23598673|NCT03014453|65922312|FG000|Overall Study|Discontinued GER|3|||
23598674|NCT03014453|65922312|FG000|Overall Study|Excluded|19|||
23801127|NCT00897949|66649903|FG001|Overall Study|Did not take study drug|3|||
23360641|NCT00960804|65065819|FG000|Overall Study|Adverse Event|1|||
23479184|NCT01561898|65498400|FG001|Overall Study|Worsening of complications|1|||
23479185|NCT01561898|65498401|FG002|Overall Study|Worsening of complications|0|||
23479186|NCT01561898|65498402|FG003|Overall Study|Worsening of complications|0|||
23479187|NCT01561898|65498399|FG000|Overall Study|Lost to Follow-up|0|||
23479188|NCT01561898|65498400|FG001|Overall Study|Lost to Follow-up|0|||
23479189|NCT01561898|65498401|FG002|Overall Study|Lost to Follow-up|1|||
23479190|NCT01561898|65498402|FG003|Overall Study|Lost to Follow-up|0|||
23479191|NCT01561898|65498399|FG000|Overall Study|Adverse Event|1|||
23479192|NCT01561898|65498400|FG001|Overall Study|Adverse Event|19|||
23479193|NCT01561898|65498401|FG002|Overall Study|Adverse Event|14|||
23479194|NCT01561898|65498402|FG003|Overall Study|Adverse Event|9|||
23479195|NCT01561898|65498399|FG000|Overall Study|Physician Decision|1|||
23479196|NCT01561898|65498400|FG001|Overall Study|Physician Decision|5|||
23479197|NCT01561898|65498401|FG002|Overall Study|Physician Decision|7|||
23479198|NCT01561898|65498402|FG003|Overall Study|Physician Decision|1|||
23479199|NCT01566214|65498403|FG000|Overall Study|Lost to Follow-up|3|||
23479200|NCT01566214|65498404|FG001|Overall Study|Lost to Follow-up|0|||
23479201|NCT00129311|65498407|FG000|Overall Study|Withdrawal by Subject|12|||
23479202|NCT00129311|65498408|FG001|Overall Study|Withdrawal by Subject|19|||
23479203|NCT00890045|65498409|FG000|Overall Study|Death|0|||
23479204|NCT00890045|65498410|FG001|Overall Study|Death|1|||
23479205|NCT00890045|65498409|FG000|Overall Study|Did not receive HeRO Graft|0|||
23479206|NCT00890045|65498410|FG001|Overall Study|Did not receive HeRO Graft|2|||
23479207|NCT00890045|65498409|FG000|Overall Study|Lost to Follow-up|5|||
23479208|NCT00890045|65498410|FG001|Overall Study|Lost to Follow-up|7|||
23479209|NCT03452527|65498415|FG000|Overall Study|Withdrawal by Subject|1|||
23479210|NCT03452527|65498416|FG001|Overall Study|Withdrawal by Subject|1|||
23479211|NCT03452527|65498415|FG000|Overall Study|Study Terminated|2|||
23479212|NCT03452527|65498416|FG001|Overall Study|Study Terminated|3|||
23479213|NCT00879879|65498418|FG000|Overall Study|Death|1|||
23479214|NCT00879879|65498418|FG000|Overall Study|Withdrawal by Subject|1|||
23479215|NCT00879879|65498418|FG000|Overall Study|Physician Decision|1|||
23479216|NCT01106092|65498421|FG000|Overall Study|Withdrawal by Subject|0|||
23479217|NCT01106092|65498422|FG001|Overall Study|Withdrawal by Subject|0|||
23479218|NCT01106092|65498423|FG002|Overall Study|Withdrawal by Subject|0|||
23479219|NCT01106092|65498424|FG003|Overall Study|Withdrawal by Subject|1|||
23479220|NCT01642732|65498433|FG000|Overall Study|Withdrawal by Subject|1|||
23479221|NCT02683746|65498444|FG000|Overall Study|Adverse Event|3|||
23479222|NCT02683746|65498445|FG001|Overall Study|Adverse Event|2|||
23479223|NCT02683746|65498444|FG000|Overall Study|Lost to Follow-up|5|||
23479224|NCT02683746|65498445|FG001|Overall Study|Lost to Follow-up|6|||
23479225|NCT02683746|65498444|FG000|Overall Study|Withdrawal by Subject|6|||
23479226|NCT02683746|65498445|FG001|Overall Study|Withdrawal by Subject|5|||
23479227|NCT02683746|65498444|FG000|Overall Study|Physician Decision|2|||
23479228|NCT02683746|65498445|FG001|Overall Study|Physician Decision|1|||
23479229|NCT01579812|65498447|FG000|Overall Study|Ineligible after treatment start|40|||
23479230|NCT01579812|65498447|FG000|Overall Study|Patient choice|3|||
23479231|NCT01579812|65498447|FG000|Overall Study|Noncompliance|3|||
23479232|NCT01579812|65498447|FG000|Overall Study|Withdrawal by Subject|6|||
23479233|NCT01375075|65498448|FG000|Overall Study|Adverse Event|0|||
23479234|NCT01375075|65498449|FG001|Overall Study|Adverse Event|0|||
23479235|NCT01375075|65498450|FG002|Overall Study|Adverse Event|3|||
23479236|NCT01375075|65498451|FG003|Overall Study|Adverse Event|1|||
23479237|NCT01375075|65498452|FG004|Overall Study|Adverse Event|0|||
23479238|NCT01375075|65498453|FG005|Overall Study|Adverse Event|1|||
23479239|NCT01375075|65498448|FG000|Overall Study|Entry Criterion Not Met|1|||
23479240|NCT01375075|65498449|FG001|Overall Study|Entry Criterion Not Met|0|||
23479241|NCT01375075|65498450|FG002|Overall Study|Entry Criterion Not Met|0|||
23479242|NCT01375075|65498451|FG003|Overall Study|Entry Criterion Not Met|0|||
23479243|NCT01375075|65498452|FG004|Overall Study|Entry Criterion Not Met|0|||
23479244|NCT01375075|65498453|FG005|Overall Study|Entry Criterion Not Met|1|||
23479245|NCT01375075|65498448|FG000|Overall Study|Withdrawal by Subject|0|||
23479246|NCT01375075|65498449|FG001|Overall Study|Withdrawal by Subject|1|||
23598675|NCT03014453|65922312|FG000|Overall Study|Refused to take part in|37|||
23598676|NCT00943917|65922313|FG000|Stage I|Adverse Event|1|||
23479247|NCT01375075|65498450|FG002|Overall Study|Withdrawal by Subject|0|||
23479248|NCT01375075|65498451|FG003|Overall Study|Withdrawal by Subject|0|||
23479249|NCT01375075|65498452|FG004|Overall Study|Withdrawal by Subject|0|||
23479250|NCT01375075|65498453|FG005|Overall Study|Withdrawal by Subject|1|||
23479251|NCT04136444|65498456|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
23479252|NCT04136444|65498457|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
23479253|NCT02923921|65498459|FG000|Overall Study|Sponsor Decision|39|||
23650208|NCT01839487|66104332|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
23650209|NCT00835120|66104339|FG000|Overall Study|Lack of Efficacy|1|||
23650210|NCT00835120|66104339|FG000|Overall Study|Lost to Follow-up|3|||
23650211|NCT00835120|66104339|FG000|Overall Study|Adverse Event|2|||
23650212|NCT00835120|66104339|FG000|Overall Study|Withdrawal by Subject|2|||
23650213|NCT02935452|66104340|FG000|Overall Study|work and life commintment|3|||
23650214|NCT02935452|66104341|FG001|Overall Study|work and life commintment|1|||
23650215|NCT03333837|66104342|FG000|Overall Study|Adverse Event|2|||
23650216|NCT03333837|66104343|FG001|Overall Study|Adverse Event|1|||
23650217|NCT03333837|66104344|FG002|Overall Study|Adverse Event|1|||
23650218|NCT03333837|66104345|FG003|Overall Study|Adverse Event|1|||
23650219|NCT03333837|66104346|FG004|Overall Study|Adverse Event|0|||
23650220|NCT03333837|66104342|FG000|Overall Study|Caregiver withdrew|0|||
23650221|NCT03333837|66104343|FG001|Overall Study|Caregiver withdrew|2|||
23650222|NCT03333837|66104344|FG002|Overall Study|Caregiver withdrew|1|||
23650223|NCT03333837|66104345|FG003|Overall Study|Caregiver withdrew|0|||
23650224|NCT03333837|66104346|FG004|Overall Study|Caregiver withdrew|0|||
23650225|NCT03333837|66104342|FG000|Overall Study|Withdrawal by Subject|0|||
23650226|NCT03333837|66104343|FG001|Overall Study|Withdrawal by Subject|0|||
23650227|NCT03333837|66104344|FG002|Overall Study|Withdrawal by Subject|1|||
23650228|NCT03333837|66104345|FG003|Overall Study|Withdrawal by Subject|1|||
23650229|NCT03333837|66104346|FG004|Overall Study|Withdrawal by Subject|3|||
23650230|NCT03333837|66104342|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23650231|NCT03333837|66104343|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23650232|NCT03333837|66104344|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
23650233|NCT03333837|66104345|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23650234|NCT03333837|66104346|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23650235|NCT02752074|66104347|FG000|Overall Study|Lost to Follow-up|1|||
23650236|NCT02752074|66104348|FG001|Overall Study|Lost to Follow-up|4|||
23650237|NCT02752074|66104347|FG000|Overall Study|Death|146|||
23650238|NCT02752074|66104348|FG001|Overall Study|Death|129|||
23650239|NCT02752074|66104347|FG000|Overall Study|Withdrawal by Subject|9|||
23650240|NCT02752074|66104348|FG001|Overall Study|Withdrawal by Subject|10|||
23650241|NCT01193920|66104351|FG000|Overall Study|Withdrawal by Subject|1|||
23650242|NCT01193920|66104352|FG001|Overall Study|Withdrawal by Subject|0|||
23650243|NCT01193920|66104353|FG002|Overall Study|Withdrawal by Subject|5|||
23650244|NCT01193920|66104354|FG003|Overall Study|Withdrawal by Subject|1|||
23650245|NCT01193920|66104355|FG004|Overall Study|Withdrawal by Subject|3|||
23650246|NCT01193920|66104356|FG005|Overall Study|Withdrawal by Subject|1|||
23650247|NCT01193920|66104357|FG006|Overall Study|Withdrawal by Subject|3|||
23650248|NCT01193920|66104358|FG007|Overall Study|Withdrawal by Subject|0|||
23650249|NCT01193920|66104359|FG008|Overall Study|Withdrawal by Subject|1|||
23650250|NCT01193920|66104360|FG009|Overall Study|Withdrawal by Subject|0|||
23650251|NCT01193920|66104351|FG000|Overall Study|Lost to Follow-up|1|||
23650252|NCT01193920|66104352|FG001|Overall Study|Lost to Follow-up|0|||
23650253|NCT01193920|66104353|FG002|Overall Study|Lost to Follow-up|1|||
23650254|NCT01193920|66104354|FG003|Overall Study|Lost to Follow-up|1|||
23650255|NCT01193920|66104355|FG004|Overall Study|Lost to Follow-up|3|||
23650256|NCT01193920|66104356|FG005|Overall Study|Lost to Follow-up|3|||
23650257|NCT01193920|66104357|FG006|Overall Study|Lost to Follow-up|1|||
23650258|NCT01193920|66104358|FG007|Overall Study|Lost to Follow-up|0|||
23650259|NCT01193920|66104359|FG008|Overall Study|Lost to Follow-up|2|||
23650260|NCT01193920|66104360|FG009|Overall Study|Lost to Follow-up|3|||
23650261|NCT01193920|66104351|FG000|Overall Study|Protocol Violation|1|||
23650262|NCT01193920|66104352|FG001|Overall Study|Protocol Violation|0|||
23650263|NCT01193920|66104353|FG002|Overall Study|Protocol Violation|0|||
23650264|NCT01193920|66104354|FG003|Overall Study|Protocol Violation|0|||
23650265|NCT01193920|66104355|FG004|Overall Study|Protocol Violation|0|||
23650266|NCT01193920|66104356|FG005|Overall Study|Protocol Violation|0|||
23650267|NCT01193920|66104357|FG006|Overall Study|Protocol Violation|0|||
23650268|NCT01193920|66104358|FG007|Overall Study|Protocol Violation|0|||
23650269|NCT01193920|66104359|FG008|Overall Study|Protocol Violation|0|||
23650270|NCT01193920|66104360|FG009|Overall Study|Protocol Violation|0|||
23650271|NCT01193920|66104351|FG000|Overall Study|Death|0|||
23650272|NCT01193920|66104352|FG001|Overall Study|Death|0|||
23650273|NCT01193920|66104353|FG002|Overall Study|Death|0|||
23650274|NCT01193920|66104354|FG003|Overall Study|Death|1|||
23650275|NCT01193920|66104355|FG004|Overall Study|Death|0|||
23650276|NCT01193920|66104356|FG005|Overall Study|Death|0|||
23650277|NCT01193920|66104357|FG006|Overall Study|Death|2|||
23650278|NCT01193920|66104358|FG007|Overall Study|Death|3|||
23650279|NCT01193920|66104359|FG008|Overall Study|Death|2|||
23650280|NCT01193920|66104360|FG009|Overall Study|Death|4|||
23650281|NCT01193920|66104351|FG000|Overall Study|Unable to classify|0|||
23650282|NCT01193920|66104352|FG001|Overall Study|Unable to classify|0|||
23650283|NCT01193920|66104353|FG002|Overall Study|Unable to classify|0|||
23650284|NCT01193920|66104354|FG003|Overall Study|Unable to classify|1|||
23650285|NCT01193920|66104355|FG004|Overall Study|Unable to classify|0|||
23650286|NCT01193920|66104356|FG005|Overall Study|Unable to classify|0|||
23650287|NCT01193920|66104357|FG006|Overall Study|Unable to classify|0|||
23650288|NCT01193920|66104358|FG007|Overall Study|Unable to classify|1|||
23650289|NCT01193920|66104359|FG008|Overall Study|Unable to classify|0|||
23650290|NCT01193920|66104360|FG009|Overall Study|Unable to classify|0|||
23650291|NCT01350336|66104363|FG000|Overall Study|Lost to Follow-up|31|||
23650292|NCT01350336|66104363|FG000|Overall Study|Withdrawal by Subject|14|||
23650293|NCT01350336|66104363|FG000|Overall Study|Physician Decision|8|||
23650294|NCT01350336|66104363|FG000|Overall Study|Death|4|||
23650295|NCT00810394|66104366|FG000|Overall Study|Withdrawal by Subject|3|||
23650296|NCT01658826|66104368|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
23650297|NCT01658826|66104369|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
23650298|NCT01658826|66104368|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
23598677|NCT00943917|65922314|FG001|Stage I|Adverse Event|2|||
23598678|NCT00943917|65922315|FG002|Stage I|Adverse Event|2|||
23598679|NCT00943917|65922316|FG003|Stage I|Adverse Event|0|||
23598680|NCT00943917|65922317|FG004|Stage I|Adverse Event|0|||
23598681|NCT00943917|65922318|FG005|Stage I|Adverse Event|0|||
23598682|NCT00943917|65922319|FG006|Stage I|Adverse Event|0|||
23598683|NCT00943917|65922320|FG007|Stage I|Adverse Event|0|||
23598684|NCT00943917|65922321|FG008|Stage I|Adverse Event|0|||
23598685|NCT00943917|65922322|FG009|Stage I|Adverse Event|0|||
23598686|NCT00943917|65922323|FG010|Stage I|Adverse Event|0|||
23598687|NCT00943917|65922324|FG011|Stage I|Adverse Event|0|||
23598688|NCT00943917|65922325|FG012|Stage I|Adverse Event|0|||
23598689|NCT00943917|65922326|FG013|Stage I|Adverse Event|0|||
23598690|NCT00943917|65922327|FG014|Stage I|Adverse Event|0|||
23598691|NCT00943917|65922313|FG000|Stage I|Lost to Follow-up|0|||
23598692|NCT00943917|65922314|FG001|Stage I|Lost to Follow-up|0|||
23598693|NCT00943917|65922315|FG002|Stage I|Lost to Follow-up|1|||
23598694|NCT00943917|65922316|FG003|Stage I|Lost to Follow-up|0|||
23598695|NCT00943917|65922317|FG004|Stage I|Lost to Follow-up|0|||
23598696|NCT00943917|65922318|FG005|Stage I|Lost to Follow-up|0|||
23598697|NCT00943917|65922319|FG006|Stage I|Lost to Follow-up|0|||
23598698|NCT00943917|65922320|FG007|Stage I|Lost to Follow-up|0|||
23598699|NCT00943917|65922321|FG008|Stage I|Lost to Follow-up|0|||
23598700|NCT00943917|65922322|FG009|Stage I|Lost to Follow-up|0|||
23598701|NCT00943917|65922323|FG010|Stage I|Lost to Follow-up|0|||
23598702|NCT00943917|65922324|FG011|Stage I|Lost to Follow-up|0|||
23598703|NCT00943917|65922325|FG012|Stage I|Lost to Follow-up|0|||
23598704|NCT00943917|65922326|FG013|Stage I|Lost to Follow-up|0|||
23598705|NCT00943917|65922327|FG014|Stage I|Lost to Follow-up|0|||
23598706|NCT00943917|65922313|FG000|Stage I|hyperglycemia|0|||
23598707|NCT00943917|65922314|FG001|Stage I|hyperglycemia|0|||
23598708|NCT00943917|65922315|FG002|Stage I|hyperglycemia|1|||
23598709|NCT00943917|65922316|FG003|Stage I|hyperglycemia|0|||
23598710|NCT00943917|65922317|FG004|Stage I|hyperglycemia|0|||
23598711|NCT00943917|65922318|FG005|Stage I|hyperglycemia|0|||
23598712|NCT00943917|65922319|FG006|Stage I|hyperglycemia|0|||
23598713|NCT00943917|65922320|FG007|Stage I|hyperglycemia|0|||
23598714|NCT00943917|65922321|FG008|Stage I|hyperglycemia|0|||
23598715|NCT00943917|65922322|FG009|Stage I|hyperglycemia|0|||
23598716|NCT00943917|65922323|FG010|Stage I|hyperglycemia|0|||
23598717|NCT00943917|65922324|FG011|Stage I|hyperglycemia|0|||
23598718|NCT00943917|65922325|FG012|Stage I|hyperglycemia|0|||
23598719|NCT00943917|65922326|FG013|Stage I|hyperglycemia|0|||
23598720|NCT00943917|65922327|FG014|Stage I|hyperglycemia|0|||
23598721|NCT00943917|65922313|FG000|Stage I|A1C elevation|1|||
23598722|NCT00943917|65922314|FG001|Stage I|A1C elevation|0|||
23598723|NCT00943917|65922315|FG002|Stage I|A1C elevation|0|||
23598724|NCT00943917|65922316|FG003|Stage I|A1C elevation|0|||
23598725|NCT00943917|65922317|FG004|Stage I|A1C elevation|0|||
23598726|NCT00943917|65922318|FG005|Stage I|A1C elevation|0|||
23598727|NCT00943917|65922319|FG006|Stage I|A1C elevation|0|||
23598728|NCT00943917|65922320|FG007|Stage I|A1C elevation|0|||
23598729|NCT00943917|65922321|FG008|Stage I|A1C elevation|0|||
23598730|NCT00943917|65922322|FG009|Stage I|A1C elevation|0|||
23598731|NCT00943917|65922323|FG010|Stage I|A1C elevation|0|||
23598732|NCT00943917|65922324|FG011|Stage I|A1C elevation|0|||
23598733|NCT00943917|65922325|FG012|Stage I|A1C elevation|0|||
23598734|NCT00943917|65922326|FG013|Stage I|A1C elevation|0|||
23598735|NCT00943917|65922327|FG014|Stage I|A1C elevation|0|||
23598736|NCT00943917|65922313|FG000|Stage I|Withdrawal by Subject|2|||
23598737|NCT00943917|65922314|FG001|Stage I|Withdrawal by Subject|1|||
23598738|NCT00943917|65922315|FG002|Stage I|Withdrawal by Subject|2|||
23598739|NCT00943917|65922316|FG003|Stage I|Withdrawal by Subject|0|||
23598740|NCT00943917|65922317|FG004|Stage I|Withdrawal by Subject|0|||
23598741|NCT00943917|65922318|FG005|Stage I|Withdrawal by Subject|0|||
23598742|NCT00943917|65922319|FG006|Stage I|Withdrawal by Subject|0|||
23598743|NCT00943917|65922320|FG007|Stage I|Withdrawal by Subject|0|||
23598744|NCT00943917|65922321|FG008|Stage I|Withdrawal by Subject|0|||
23598745|NCT00943917|65922322|FG009|Stage I|Withdrawal by Subject|0|||
23598746|NCT00943917|65922323|FG010|Stage I|Withdrawal by Subject|0|||
23598747|NCT00943917|65922324|FG011|Stage I|Withdrawal by Subject|0|||
23598748|NCT00943917|65922325|FG012|Stage I|Withdrawal by Subject|0|||
23650299|NCT01658826|66104369|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
23650300|NCT01658826|66104368|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
23650301|NCT01658826|66104369|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
23650302|NCT01658826|66104368|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
23650303|NCT01658826|66104369|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
23650304|NCT01658826|66104368|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
23650305|NCT01658826|66104369|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
23650306|NCT01658826|66104368|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
23650307|NCT01658826|66104369|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
23650308|NCT01658826|66104368|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
23650309|NCT01658826|66104369|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
23650310|NCT01658826|66104368|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
23650311|NCT01658826|66104369|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
23650312|NCT01658826|66104368|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
23650313|NCT01658826|66104369|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
23598749|NCT00943917|65922326|FG013|Stage I|Withdrawal by Subject|0|||
23598750|NCT00943917|65922327|FG014|Stage I|Withdrawal by Subject|0|||
23650314|NCT01502631|66104371|FG000|Overall Study|Adverse Event|5|||
23650315|NCT01502631|66104372|FG001|Overall Study|Adverse Event|8|||
23650316|NCT01502631|66104371|FG000|Overall Study|Lost to Follow-up|2|||
23650317|NCT01502631|66104372|FG001|Overall Study|Lost to Follow-up|2|||
23650318|NCT01502631|66104371|FG000|Overall Study|Participant withdrew consent|2|||
23650319|NCT01502631|66104372|FG001|Overall Study|Participant withdrew consent|4|||
23650320|NCT01502631|66104371|FG000|Overall Study|Participant non-compliant|1|||
23650321|NCT01502631|66104372|FG001|Overall Study|Participant non-compliant|0|||
23650322|NCT01502631|66104371|FG000|Overall Study|Investigator's decision|0|||
23650323|NCT01502631|66104372|FG001|Overall Study|Investigator's decision|1|||
23650324|NCT01502631|66104371|FG000|Overall Study|Other|10|||
23650325|NCT01502631|66104372|FG001|Overall Study|Other|5|||
23650326|NCT00866723|66104373|FG000|Overall Study|Withdrawal by Subject|1|||
23650327|NCT00866723|66104373|FG000|Overall Study|Disease Progression|4|||
23650328|NCT03214094|66104374|FG000|Overall Study|Case Report Forms Uncollected|14|||
23650329|NCT03214094|66104374|FG000|Overall Study|Protocol Deviation|46|||
23650330|NCT01636960|66104377|FG000|Induction Phase|Adverse Event|2|||
23650331|NCT01636960|66104377|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
23650332|NCT01636960|66104377|FG000|Maintenance Phase|Adverse Event|3|||
23650333|NCT01636960|66104377|FG000|Maintenance Phase|Progressive disease|1|||
23650334|NCT00511472|66104378|FG000|Overall Study|Clinical Adverse Event|1|||
23650335|NCT00511472|66104379|FG001|Overall Study|Clinical Adverse Event|2|||
23650336|NCT00511472|66104378|FG000|Overall Study|Laboratory Adverse Event|0|||
23650337|NCT00511472|66104379|FG001|Overall Study|Laboratory Adverse Event|2|||
23650338|NCT00511472|66104378|FG000|Overall Study|Not reported|2|||
23650339|NCT00511472|66104379|FG001|Overall Study|Not reported|2|||
23650340|NCT01163916|66104380|FG000|Overall Study|Withdrawal by Subject|2|||
23650341|NCT01163916|66104381|FG001|Overall Study|Withdrawal by Subject|0|||
23650342|NCT01163916|66104382|FG002|Overall Study|Withdrawal by Subject|2|||
23598751|NCT00943917|65922313|FG000|Stage II|Adverse Event|0|||
23598752|NCT00943917|65922314|FG001|Stage II|Adverse Event|0|||
23598753|NCT00943917|65922315|FG002|Stage II|Adverse Event|0|||
23598754|NCT00943917|65922316|FG003|Stage II|Adverse Event|0|||
23598755|NCT00943917|65922317|FG004|Stage II|Adverse Event|0|||
23598756|NCT00943917|65922318|FG005|Stage II|Adverse Event|1|||
23598757|NCT00943917|65922319|FG006|Stage II|Adverse Event|3|||
23598758|NCT00943917|65922320|FG007|Stage II|Adverse Event|0|||
23598759|NCT00943917|65922321|FG008|Stage II|Adverse Event|1|||
23598760|NCT00943917|65922322|FG009|Stage II|Adverse Event|0|||
23598761|NCT00943917|65922323|FG010|Stage II|Adverse Event|0|||
23598762|NCT00943917|65922324|FG011|Stage II|Adverse Event|0|||
23598763|NCT00943917|65922325|FG012|Stage II|Adverse Event|0|||
23598764|NCT00943917|65922326|FG013|Stage II|Adverse Event|0|||
23598765|NCT00943917|65922327|FG014|Stage II|Adverse Event|0|||
23598766|NCT00943917|65922313|FG000|Stage II|Withdrawal by Subject|0|||
23598767|NCT00943917|65922314|FG001|Stage II|Withdrawal by Subject|0|||
23598768|NCT00943917|65922315|FG002|Stage II|Withdrawal by Subject|0|||
23598769|NCT00943917|65922316|FG003|Stage II|Withdrawal by Subject|0|||
23598770|NCT00943917|65922317|FG004|Stage II|Withdrawal by Subject|0|||
23598771|NCT00943917|65922318|FG005|Stage II|Withdrawal by Subject|1|||
23598772|NCT00943917|65922319|FG006|Stage II|Withdrawal by Subject|0|||
23598773|NCT00943917|65922320|FG007|Stage II|Withdrawal by Subject|0|||
23598774|NCT00943917|65922321|FG008|Stage II|Withdrawal by Subject|0|||
23598775|NCT00943917|65922322|FG009|Stage II|Withdrawal by Subject|0|||
23598776|NCT00943917|65922323|FG010|Stage II|Withdrawal by Subject|0|||
23650343|NCT01163916|66104380|FG000|Overall Study|Adverse Event|2|||
23650344|NCT01163916|66104381|FG001|Overall Study|Adverse Event|0|||
23650345|NCT01163916|66104382|FG002|Overall Study|Adverse Event|1|||
23650346|NCT01163916|66104380|FG000|Overall Study|Lack of Efficacy|2|||
23650347|NCT01163916|66104381|FG001|Overall Study|Lack of Efficacy|0|||
23650348|NCT01163916|66104382|FG002|Overall Study|Lack of Efficacy|1|||
23650349|NCT01163916|66104380|FG000|Overall Study|Other|24|||
23650350|NCT01163916|66104381|FG001|Overall Study|Other|4|||
23650351|NCT01163916|66104382|FG002|Overall Study|Other|16|||
23650352|NCT01259284|66104383|FG000|Overall Study|Study Termination|2|||
23650353|NCT01259284|66104384|FG001|Overall Study|Study Termination|0|||
23650354|NCT01259284|66104385|FG002|Overall Study|Study Termination|0|||
23650355|NCT00950950|66104388|FG000|Overall Study|Adverse Event|1|||
23650356|NCT00950950|66104389|FG001|Overall Study|Adverse Event|0|||
23650357|NCT00950950|66104388|FG000|Overall Study|Withdrawal by Subject|0|||
23650358|NCT00950950|66104389|FG001|Overall Study|Withdrawal by Subject|1|||
23650359|NCT01588496|66104390|FG000|Overall Study|Withdrawal by Subject|0|||
23650360|NCT01588496|66104391|FG001|Overall Study|Withdrawal by Subject|1|||
23650361|NCT01588496|66104392|FG002|Overall Study|Withdrawal by Subject|0|||
23650362|NCT02513745|66104396|FG000|Overall Study|Criteria at time of surgery not met.|3|||
23650363|NCT02513745|66104397|FG001|Overall Study|Criteria at time of surgery not met.|3|||
23650364|NCT02092220|66104398|FG000|Period 1|Unrelated Illness|0|||
23650365|NCT02092220|66104399|FG001|Period 1|Unrelated Illness|2|||
23650366|NCT02092220|66104398|FG000|Period 2|Severe Hypoglycaemia|1|||
23650367|NCT02092220|66104399|FG001|Period 2|Severe Hypoglycaemia|0|||
23650368|NCT02092220|66104398|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
23650369|NCT02092220|66104399|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
23650370|NCT02966301|66104402|FG000|Overall Study|Death|2|||
23650371|NCT02966301|66104402|FG000|Overall Study|Withdrawal by Subject|1|||
23650372|NCT00985946|66104403|FG000|Overall Study|Lost to Follow-up|6|||
23650373|NCT00985946|66104403|FG000|Overall Study|Withdrawal by Subject|1|||
23650374|NCT03628898|66104404|FG000|Overall Study|Device deficiency|1|||
23650375|NCT04788511|66104415|FG000|Overall Study|Withdrawal by Subject|2|||
23650376|NCT04788511|66104416|FG001|Overall Study|Withdrawal by Subject|1|||
23650377|NCT04788511|66104415|FG000|Overall Study|Lost to Follow-up|2|||
23650378|NCT04788511|66104416|FG001|Overall Study|Lost to Follow-up|7|||
23650379|NCT04788511|66104415|FG000|Overall Study|Death|3|||
23650380|NCT04788511|66104416|FG001|Overall Study|Death|4|||
23650381|NCT03435497|66104417|FG000|Overall Study|Lost to Follow-up|1|||
23650382|NCT03435497|66104418|FG001|Overall Study|Lost to Follow-up|0|||
23650383|NCT03435497|66104417|FG000|Overall Study|Death|1|||
23650384|NCT03435497|66104418|FG001|Overall Study|Death|0|||
23650385|NCT03435497|66104417|FG000|Overall Study|Withdrawal by Subject|0|||
23650386|NCT03435497|66104418|FG001|Overall Study|Withdrawal by Subject|4|||
23650387|NCT03435497|66104417|FG000|Overall Study|Wrong survey administered|0|||
23650388|NCT03435497|66104418|FG001|Overall Study|Wrong survey administered|2|||
23650389|NCT02640157|66104419|FG000|Overall Study|Adverse Event|2|||
23650390|NCT02640157|66104420|FG001|Overall Study|Adverse Event|2|||
23650391|NCT02640157|66104421|FG002|Overall Study|Adverse Event|1|||
23650392|NCT02640157|66104419|FG000|Overall Study|Withdrew consent|2|||
23650393|NCT02640157|66104420|FG001|Overall Study|Withdrew consent|0|||
23650394|NCT02640157|66104421|FG002|Overall Study|Withdrew consent|2|||
23650395|NCT02640157|66104419|FG000|Overall Study|Lost to Follow-up|9|||
23650396|NCT02640157|66104420|FG001|Overall Study|Lost to Follow-up|2|||
23650397|NCT02640157|66104421|FG002|Overall Study|Lost to Follow-up|7|||
23650398|NCT02640157|66104419|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
23650399|NCT02640157|66104420|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
23650400|NCT02640157|66104421|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
23650401|NCT01270971|66104422|FG000|Overall Study|Withdrawal by Subject|24|||
23650402|NCT01270971|66104423|FG001|Overall Study|Withdrawal by Subject|11|||
23650403|NCT01270971|66104422|FG000|Overall Study|Lost to Follow-up|18|||
23650404|NCT01270971|66104423|FG001|Overall Study|Lost to Follow-up|5|||
23650405|NCT01270971|66104422|FG000|Overall Study|Adverse Event|1|||
23650406|NCT01270971|66104423|FG001|Overall Study|Adverse Event|2|||
23650407|NCT01270971|66104422|FG000|Overall Study|Non compliance|2|||
23650408|NCT01270971|66104423|FG001|Overall Study|Non compliance|2|||
23650409|NCT01270971|66104422|FG000|Overall Study|Non-specific|7|||
23650410|NCT01270971|66104423|FG001|Overall Study|Non-specific|3|||
23650411|NCT00871780|66104426|FG000|Overall Study|Enrolled But Not Treated|6|||
23650412|NCT00871780|66104426|FG000|Overall Study|Withdrawal by Subject|9|||
23650413|NCT00871780|66104426|FG000|Overall Study|Adverse Event|6|||
23650414|NCT00871780|66104426|FG000|Overall Study|Voluntary Discontinuation|4|||
23650415|NCT00871780|66104426|FG000|Overall Study|Death|1|||
23650416|NCT00871780|66104426|FG000|Overall Study|Physician Decision|1|||
23650417|NCT01013597|66104431|FG000|Overall Study|Withdrawal by Subject|1|||
23650418|NCT04058366|66104435|FG000|Overall Study|Adverse Event|14|||
23650419|NCT04058366|66104435|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
23650420|NCT04058366|66104435|FG000|Overall Study|Commercial drug is available for participants|6|||
23650421|NCT04058366|66104435|FG000|Overall Study|Death|1|||
23650422|NCT04058366|66104435|FG000|Overall Study|Other non-compliance|2|||
23650423|NCT04058366|66104435|FG000|Overall Study|Other|6|||
23650424|NCT03240874|66104441|FG000|Overall Study|Lost to Follow-up|0|||
23650425|NCT03240874|66104442|FG001|Overall Study|Lost to Follow-up|2|||
23650426|NCT03240874|66104443|FG002|Overall Study|Lost to Follow-up|4|||
23650427|NCT03240874|66104444|FG003|Overall Study|Lost to Follow-up|1|||
23650428|NCT03213457|66104445|FG000|Overall Study|Not Treated|1|||
23650429|NCT03213457|66104446|FG001|Overall Study|Not Treated|1|||
23650430|NCT03213457|66104447|FG002|Overall Study|Not Treated|0|||
23650431|NCT03213457|66104445|FG000|Overall Study|Adverse Event|16|||
23650432|NCT03213457|66104446|FG001|Overall Study|Adverse Event|9|||
23650433|NCT03213457|66104447|FG002|Overall Study|Adverse Event|41|||
23650434|NCT03213457|66104445|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23650435|NCT03213457|66104446|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23650436|NCT03213457|66104447|FG002|Overall Study|Non-Compliance With Study Drug|7|||
23650437|NCT03213457|66104445|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
23650438|NCT03213457|66104446|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
23650439|NCT03213457|66104447|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
23650440|NCT03213457|66104445|FG000|Overall Study|Withdrawal by Subject|18|||
23598777|NCT00943917|65922324|FG011|Stage II|Withdrawal by Subject|0|||
23598778|NCT00943917|65922325|FG012|Stage II|Withdrawal by Subject|0|||
23598779|NCT00943917|65922326|FG013|Stage II|Withdrawal by Subject|0|||
23598780|NCT00943917|65922327|FG014|Stage II|Withdrawal by Subject|0|||
23598781|NCT00943917|65922313|FG000|Stage II|Pregnancy|0|||
23598782|NCT00943917|65922314|FG001|Stage II|Pregnancy|0|||
23598783|NCT00943917|65922315|FG002|Stage II|Pregnancy|0|||
23598784|NCT00943917|65922316|FG003|Stage II|Pregnancy|0|||
23598785|NCT00943917|65922317|FG004|Stage II|Pregnancy|0|||
23598786|NCT00943917|65922318|FG005|Stage II|Pregnancy|1|||
23598787|NCT00943917|65922319|FG006|Stage II|Pregnancy|0|||
23598788|NCT00943917|65922320|FG007|Stage II|Pregnancy|0|||
23598789|NCT00943917|65922321|FG008|Stage II|Pregnancy|0|||
23598790|NCT00943917|65922322|FG009|Stage II|Pregnancy|0|||
23650441|NCT03213457|66104446|FG001|Overall Study|Withdrawal by Subject|7|||
23650442|NCT03213457|66104447|FG002|Overall Study|Withdrawal by Subject|35|||
23650443|NCT03213457|66104445|FG000|Overall Study|Lost to Follow-up|12|||
23650444|NCT03213457|66104446|FG001|Overall Study|Lost to Follow-up|12|||
23650445|NCT03213457|66104447|FG002|Overall Study|Lost to Follow-up|33|||
23650446|NCT03213457|66104445|FG000|Overall Study|Pregnancy|11|||
23360642|NCT00960804|65065820|FG001|Overall Study|Adverse Event|0|||
23360643|NCT00960804|65065821|FG002|Overall Study|Adverse Event|0|||
23360644|NCT00960804|65065819|FG000|Overall Study|Withdrawal by Subject|1|||
23360645|NCT00960804|65065820|FG001|Overall Study|Withdrawal by Subject|0|||
23360646|NCT00960804|65065821|FG002|Overall Study|Withdrawal by Subject|0|||
23360647|NCT00960804|65065819|FG000|Overall Study|Study terminated by the sponsor|5|||
23360648|NCT00960804|65065820|FG001|Overall Study|Study terminated by the sponsor|4|||
23598791|NCT00943917|65922323|FG010|Stage II|Pregnancy|0|||
23650447|NCT03213457|66104446|FG001|Overall Study|Pregnancy|0|||
23650448|NCT03213457|66104447|FG002|Overall Study|Pregnancy|7|||
23650449|NCT03213457|66104445|FG000|Overall Study|Protocol Violation|1|||
23650450|NCT03213457|66104446|FG001|Overall Study|Protocol Violation|1|||
23650451|NCT03213457|66104447|FG002|Overall Study|Protocol Violation|6|||
23650452|NCT03213457|66104445|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
23650453|NCT03213457|66104446|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
23650454|NCT03213457|66104447|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
23650455|NCT03213457|66104445|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
23650456|NCT03213457|66104446|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
23650457|NCT03213457|66104447|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
23650458|NCT03213457|66104445|FG000|Overall Study|Lack of Efficacy|12|||
23650459|NCT03213457|66104446|FG001|Overall Study|Lack of Efficacy|2|||
23650460|NCT03213457|66104447|FG002|Overall Study|Lack of Efficacy|9|||
23650461|NCT03213457|66104445|FG000|Overall Study|Other, Not Specified|11|||
23650462|NCT03213457|66104446|FG001|Overall Study|Other, Not Specified|3|||
23650463|NCT03213457|66104447|FG002|Overall Study|Other, Not Specified|26|||
23650464|NCT00960531|66104448|FG000|Overall Study|Lack of Efficacy|1|||
23650465|NCT00960531|66104449|FG001|Overall Study|Lack of Efficacy|0|||
23598792|NCT00943917|65922324|FG011|Stage II|Pregnancy|0|||
23598793|NCT00943917|65922325|FG012|Stage II|Pregnancy|0|||
23598794|NCT00943917|65922326|FG013|Stage II|Pregnancy|0|||
23598795|NCT00943917|65922327|FG014|Stage II|Pregnancy|0|||
23650466|NCT00960531|66104450|FG002|Overall Study|Lack of Efficacy|0|||
23650467|NCT00960531|66104451|FG003|Overall Study|Lack of Efficacy|0|||
23650468|NCT00960531|66104452|FG004|Overall Study|Lack of Efficacy|0|||
23650469|NCT00960531|66104453|FG005|Overall Study|Lack of Efficacy|0|||
23650470|NCT00960531|66104454|FG006|Overall Study|Lack of Efficacy|0|||
23650471|NCT00960531|66104455|FG007|Overall Study|Lack of Efficacy|0|||
23650472|NCT00960531|66104456|FG008|Overall Study|Lack of Efficacy|0|||
23650473|NCT00960531|66104457|FG009|Overall Study|Lack of Efficacy|0|||
23650474|NCT00960531|66104448|FG000|Overall Study|Withdrawal by Subject|1|||
23650475|NCT00960531|66104449|FG001|Overall Study|Withdrawal by Subject|0|||
23650476|NCT00960531|66104450|FG002|Overall Study|Withdrawal by Subject|5|||
23650477|NCT00960531|66104451|FG003|Overall Study|Withdrawal by Subject|2|||
23650478|NCT00960531|66104452|FG004|Overall Study|Withdrawal by Subject|0|||
23650479|NCT00960531|66104453|FG005|Overall Study|Withdrawal by Subject|0|||
23650480|NCT00960531|66104454|FG006|Overall Study|Withdrawal by Subject|2|||
23650481|NCT00960531|66104455|FG007|Overall Study|Withdrawal by Subject|0|||
23650482|NCT00960531|66104456|FG008|Overall Study|Withdrawal by Subject|1|||
23650483|NCT00960531|66104457|FG009|Overall Study|Withdrawal by Subject|0|||
23650484|NCT00960531|66104448|FG000|Overall Study|Caregiver Request|2|||
23650485|NCT00960531|66104449|FG001|Overall Study|Caregiver Request|0|||
23650486|NCT00960531|66104450|FG002|Overall Study|Caregiver Request|6|||
23650487|NCT00960531|66104451|FG003|Overall Study|Caregiver Request|5|||
23650488|NCT00960531|66104452|FG004|Overall Study|Caregiver Request|0|||
23650489|NCT00960531|66104453|FG005|Overall Study|Caregiver Request|2|||
23650490|NCT00960531|66104454|FG006|Overall Study|Caregiver Request|3|||
23650491|NCT00960531|66104455|FG007|Overall Study|Caregiver Request|1|||
23650492|NCT00960531|66104456|FG008|Overall Study|Caregiver Request|3|||
23650493|NCT00960531|66104457|FG009|Overall Study|Caregiver Request|0|||
23650494|NCT00960531|66104448|FG000|Overall Study|Investigator Request|0|||
23650495|NCT00960531|66104449|FG001|Overall Study|Investigator Request|0|||
23650496|NCT00960531|66104450|FG002|Overall Study|Investigator Request|1|||
23650497|NCT00960531|66104451|FG003|Overall Study|Investigator Request|0|||
23650498|NCT00960531|66104452|FG004|Overall Study|Investigator Request|0|||
23650499|NCT00960531|66104453|FG005|Overall Study|Investigator Request|0|||
23650500|NCT00960531|66104454|FG006|Overall Study|Investigator Request|0|||
23650501|NCT00960531|66104455|FG007|Overall Study|Investigator Request|0|||
23650502|NCT00960531|66104456|FG008|Overall Study|Investigator Request|0|||
23650503|NCT00960531|66104457|FG009|Overall Study|Investigator Request|0|||
23650504|NCT00960531|66104448|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23650505|NCT00960531|66104449|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23650506|NCT00960531|66104450|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23650507|NCT00960531|66104451|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23650508|NCT00960531|66104452|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23650509|NCT00960531|66104453|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23650510|NCT00960531|66104454|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
23650511|NCT00960531|66104455|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
23650512|NCT00960531|66104456|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
23650513|NCT00960531|66104457|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
23650514|NCT00960531|66104448|FG000|Overall Study|Lost to Follow-up|0|||
23650515|NCT00960531|66104449|FG001|Overall Study|Lost to Follow-up|0|||
23650516|NCT00960531|66104450|FG002|Overall Study|Lost to Follow-up|1|||
23650517|NCT00960531|66104451|FG003|Overall Study|Lost to Follow-up|0|||
23650518|NCT00960531|66104452|FG004|Overall Study|Lost to Follow-up|0|||
23650519|NCT00960531|66104453|FG005|Overall Study|Lost to Follow-up|0|||
23650520|NCT00960531|66104454|FG006|Overall Study|Lost to Follow-up|1|||
23650521|NCT00960531|66104455|FG007|Overall Study|Lost to Follow-up|0|||
23650522|NCT00960531|66104456|FG008|Overall Study|Lost to Follow-up|0|||
23650523|NCT00960531|66104457|FG009|Overall Study|Lost to Follow-up|0|||
23650524|NCT00960531|66104448|FG000|Overall Study|Failed to Return|2|||
23650525|NCT00960531|66104449|FG001|Overall Study|Failed to Return|0|||
23650526|NCT00960531|66104450|FG002|Overall Study|Failed to Return|0|||
23650527|NCT00960531|66104451|FG003|Overall Study|Failed to Return|0|||
23650528|NCT00960531|66104452|FG004|Overall Study|Failed to Return|0|||
23650529|NCT00960531|66104453|FG005|Overall Study|Failed to Return|0|||
23650530|NCT00960531|66104454|FG006|Overall Study|Failed to Return|0|||
23650531|NCT00960531|66104455|FG007|Overall Study|Failed to Return|2|||
23650532|NCT00960531|66104456|FG008|Overall Study|Failed to Return|0|||
23650533|NCT00960531|66104457|FG009|Overall Study|Failed to Return|0|||
23650534|NCT00960531|66104448|FG000|Overall Study|Adverse Event (AE)|2|||
23650535|NCT00960531|66104449|FG001|Overall Study|Adverse Event (AE)|0|||
23650536|NCT00960531|66104450|FG002|Overall Study|Adverse Event (AE)|0|||
23650537|NCT00960531|66104451|FG003|Overall Study|Adverse Event (AE)|0|||
23650538|NCT00960531|66104452|FG004|Overall Study|Adverse Event (AE)|0|||
23650539|NCT00960531|66104453|FG005|Overall Study|Adverse Event (AE)|1|||
23650540|NCT00960531|66104454|FG006|Overall Study|Adverse Event (AE)|2|||
23650541|NCT00960531|66104455|FG007|Overall Study|Adverse Event (AE)|0|||
23650542|NCT00960531|66104456|FG008|Overall Study|Adverse Event (AE)|2|||
23650543|NCT00960531|66104457|FG009|Overall Study|Adverse Event (AE)|0|||
23650544|NCT00960531|66104448|FG000|Overall Study|Reason not Specified|2|||
23650545|NCT00960531|66104449|FG001|Overall Study|Reason not Specified|1|||
23650546|NCT00960531|66104450|FG002|Overall Study|Reason not Specified|13|||
23650547|NCT00960531|66104451|FG003|Overall Study|Reason not Specified|1|||
23650548|NCT00960531|66104452|FG004|Overall Study|Reason not Specified|2|||
23650549|NCT00960531|66104453|FG005|Overall Study|Reason not Specified|0|||
23650550|NCT00960531|66104454|FG006|Overall Study|Reason not Specified|16|||
23650551|NCT00960531|66104455|FG007|Overall Study|Reason not Specified|0|||
23650552|NCT00960531|66104456|FG008|Overall Study|Reason not Specified|8|||
23650553|NCT00960531|66104457|FG009|Overall Study|Reason not Specified|1|||
23360649|NCT00960804|65065821|FG002|Overall Study|Study terminated by the sponsor|10|||
23650554|NCT00953407|66104458|FG000|Overall Study|Failed inclusion criteria|1|||
23650555|NCT00953407|66104459|FG001|Overall Study|Failed inclusion criteria|1|||
23650556|NCT00953407|66104460|FG002|Overall Study|Failed inclusion criteria|1|||
23650557|NCT00953407|66104461|FG003|Overall Study|Failed inclusion criteria|1|||
23650558|NCT00953407|66104462|FG004|Overall Study|Failed inclusion criteria|1|||
23650559|NCT00953407|66104458|FG000|Overall Study|Lost to Follow-up|0|||
23650560|NCT00953407|66104459|FG001|Overall Study|Lost to Follow-up|0|||
23650561|NCT00953407|66104460|FG002|Overall Study|Lost to Follow-up|0|||
23650562|NCT00953407|66104461|FG003|Overall Study|Lost to Follow-up|1|||
23650563|NCT00953407|66104462|FG004|Overall Study|Lost to Follow-up|0|||
23650564|NCT01580969|66104463|FG000|Overall Study|Physician Decision|3|||
23650565|NCT01580969|66104464|FG001|Overall Study|Physician Decision|0|||
23650566|NCT01580969|66104465|FG002|Overall Study|Physician Decision|0|||
23650567|NCT01145755|66104473|FG000|Overall Study|Adverse Event|2|||
23650568|NCT01145755|66104474|FG001|Overall Study|Adverse Event|4|||
23650569|NCT01145755|66104475|FG002|Overall Study|Adverse Event|2|||
23650570|NCT01145755|66104473|FG000|Overall Study|Withdrawal by Subject|2|||
23650571|NCT01145755|66104474|FG001|Overall Study|Withdrawal by Subject|2|||
23650572|NCT01145755|66104475|FG002|Overall Study|Withdrawal by Subject|2|||
23650573|NCT01145755|66104473|FG000|Overall Study|Lost to Follow-up|2|||
23650574|NCT01145755|66104474|FG001|Overall Study|Lost to Follow-up|3|||
23650575|NCT01145755|66104475|FG002|Overall Study|Lost to Follow-up|1|||
23650576|NCT01145755|66104473|FG000|Overall Study|Protocol Violation|0|||
23650577|NCT01145755|66104474|FG001|Overall Study|Protocol Violation|3|||
23650578|NCT01145755|66104475|FG002|Overall Study|Protocol Violation|1|||
23650579|NCT01145755|66104473|FG000|Overall Study|Study Closure|14|||
23650580|NCT01145755|66104474|FG001|Overall Study|Study Closure|14|||
23650581|NCT01145755|66104475|FG002|Overall Study|Study Closure|17|||
23650582|NCT01145755|66104473|FG000|Overall Study|Lack of Efficacy|0|||
23650583|NCT01145755|66104474|FG001|Overall Study|Lack of Efficacy|1|||
23650584|NCT01145755|66104475|FG002|Overall Study|Lack of Efficacy|0|||
23650585|NCT01145755|66104473|FG000|Overall Study|Patient could not swollow medication|0|||
23650586|NCT01145755|66104474|FG001|Overall Study|Patient could not swollow medication|0|||
23650587|NCT01145755|66104475|FG002|Overall Study|Patient could not swollow medication|1|||
23650588|NCT01145755|66104473|FG000|Overall Study|Withdrawal by Subject|0|||
23650589|NCT01145755|66104474|FG001|Overall Study|Withdrawal by Subject|0|||
23650590|NCT01145755|66104475|FG002|Overall Study|Withdrawal by Subject|1|||
23650591|NCT01145755|66104473|FG000|Overall Study|Positive urine ethanol|0|||
23650592|NCT01145755|66104474|FG001|Overall Study|Positive urine ethanol|1|||
23650593|NCT01145755|66104475|FG002|Overall Study|Positive urine ethanol|0|||
23650594|NCT01485354|66104477|FG000|Overall Study|Withdrawal by Subject|5|||
23650595|NCT02084056|66104478|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23650596|NCT02084056|66104479|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23650597|NCT02084056|66104480|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23650598|NCT02084056|66104481|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23650599|NCT02084056|66104478|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
23650600|NCT02084056|66104479|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23650601|NCT02084056|66104480|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23650602|NCT02084056|66104481|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23650603|NCT00252733|66104488|FG000|Overall Study|Withdrawal by Subject|73|||
23598796|NCT00943917|65922313|FG000|Stage II Continuation|Adverse Event|0|||
23598797|NCT00943917|65922314|FG001|Stage II Continuation|Adverse Event|0|||
23598798|NCT00943917|65922315|FG002|Stage II Continuation|Adverse Event|0|||
23598799|NCT00943917|65922316|FG003|Stage II Continuation|Adverse Event|0|||
23598800|NCT00943917|65922317|FG004|Stage II Continuation|Adverse Event|0|||
23598801|NCT00943917|65922318|FG005|Stage II Continuation|Adverse Event|0|||
23598802|NCT00943917|65922319|FG006|Stage II Continuation|Adverse Event|0|||
23598803|NCT00943917|65922320|FG007|Stage II Continuation|Adverse Event|0|||
23598804|NCT00943917|65922321|FG008|Stage II Continuation|Adverse Event|0|||
23598805|NCT00943917|65922322|FG009|Stage II Continuation|Adverse Event|0|||
23598806|NCT00943917|65922323|FG010|Stage II Continuation|Adverse Event|0|||
23598807|NCT00943917|65922324|FG011|Stage II Continuation|Adverse Event|1|||
23598808|NCT00943917|65922325|FG012|Stage II Continuation|Adverse Event|2|||
23598809|NCT00943917|65922326|FG013|Stage II Continuation|Adverse Event|1|||
23598810|NCT00943917|65922327|FG014|Stage II Continuation|Adverse Event|1|||
23598811|NCT00943917|65922313|FG000|Stage II Continuation|Withdrawal by Subject|0|||
23598812|NCT00943917|65922314|FG001|Stage II Continuation|Withdrawal by Subject|0|||
23598813|NCT00943917|65922315|FG002|Stage II Continuation|Withdrawal by Subject|0|||
23598814|NCT00943917|65922316|FG003|Stage II Continuation|Withdrawal by Subject|0|||
23598815|NCT00943917|65922317|FG004|Stage II Continuation|Withdrawal by Subject|0|||
23598816|NCT00943917|65922318|FG005|Stage II Continuation|Withdrawal by Subject|0|||
23598817|NCT00943917|65922319|FG006|Stage II Continuation|Withdrawal by Subject|0|||
23598818|NCT00943917|65922320|FG007|Stage II Continuation|Withdrawal by Subject|0|||
23598819|NCT00943917|65922321|FG008|Stage II Continuation|Withdrawal by Subject|0|||
23598820|NCT00943917|65922322|FG009|Stage II Continuation|Withdrawal by Subject|0|||
23598821|NCT00943917|65922323|FG010|Stage II Continuation|Withdrawal by Subject|0|||
23598822|NCT00943917|65922324|FG011|Stage II Continuation|Withdrawal by Subject|0|||
23598823|NCT00943917|65922325|FG012|Stage II Continuation|Withdrawal by Subject|0|||
23598824|NCT00943917|65922326|FG013|Stage II Continuation|Withdrawal by Subject|1|||
23598825|NCT00943917|65922327|FG014|Stage II Continuation|Withdrawal by Subject|3|||
23598826|NCT00943917|65922313|FG000|Stage II Continuation|Protocol Violation|0|||
23598827|NCT00943917|65922314|FG001|Stage II Continuation|Protocol Violation|0|||
23598828|NCT00943917|65922315|FG002|Stage II Continuation|Protocol Violation|0|||
23598829|NCT00943917|65922316|FG003|Stage II Continuation|Protocol Violation|0|||
23598830|NCT00943917|65922317|FG004|Stage II Continuation|Protocol Violation|0|||
23598831|NCT00943917|65922318|FG005|Stage II Continuation|Protocol Violation|0|||
23598832|NCT00943917|65922319|FG006|Stage II Continuation|Protocol Violation|0|||
23598833|NCT00943917|65922320|FG007|Stage II Continuation|Protocol Violation|0|||
23598834|NCT00943917|65922321|FG008|Stage II Continuation|Protocol Violation|0|||
23598835|NCT00943917|65922322|FG009|Stage II Continuation|Protocol Violation|1|||
23598836|NCT00943917|65922323|FG010|Stage II Continuation|Protocol Violation|0|||
23598837|NCT00943917|65922324|FG011|Stage II Continuation|Protocol Violation|1|||
23598838|NCT00943917|65922325|FG012|Stage II Continuation|Protocol Violation|0|||
23598839|NCT00943917|65922326|FG013|Stage II Continuation|Protocol Violation|0|||
23598840|NCT00943917|65922327|FG014|Stage II Continuation|Protocol Violation|0|||
23598841|NCT00943917|65922313|FG000|Stage II Continuation|hypoglycemia|0|||
23598842|NCT00943917|65922314|FG001|Stage II Continuation|hypoglycemia|0|||
23598843|NCT00943917|65922315|FG002|Stage II Continuation|hypoglycemia|0|||
23598844|NCT00943917|65922316|FG003|Stage II Continuation|hypoglycemia|0|||
23598845|NCT00943917|65922317|FG004|Stage II Continuation|hypoglycemia|0|||
23598846|NCT00943917|65922318|FG005|Stage II Continuation|hypoglycemia|0|||
23598847|NCT00943917|65922319|FG006|Stage II Continuation|hypoglycemia|0|||
23598848|NCT00943917|65922320|FG007|Stage II Continuation|hypoglycemia|0|||
23598849|NCT00943917|65922321|FG008|Stage II Continuation|hypoglycemia|0|||
23598850|NCT00943917|65922322|FG009|Stage II Continuation|hypoglycemia|0|||
23598851|NCT00943917|65922323|FG010|Stage II Continuation|hypoglycemia|0|||
23598852|NCT00943917|65922324|FG011|Stage II Continuation|hypoglycemia|0|||
23598853|NCT00943917|65922325|FG012|Stage II Continuation|hypoglycemia|1|||
23598854|NCT00943917|65922326|FG013|Stage II Continuation|hypoglycemia|0|||
23598855|NCT00943917|65922327|FG014|Stage II Continuation|hypoglycemia|0|||
23598856|NCT00943917|65922313|FG000|Stage II Continuation|A1C elevation|0|||
23598857|NCT00943917|65922314|FG001|Stage II Continuation|A1C elevation|0|||
23598858|NCT00943917|65922315|FG002|Stage II Continuation|A1C elevation|0|||
23598859|NCT00943917|65922316|FG003|Stage II Continuation|A1C elevation|0|||
23598860|NCT00943917|65922317|FG004|Stage II Continuation|A1C elevation|0|||
23598861|NCT00943917|65922318|FG005|Stage II Continuation|A1C elevation|0|||
23598862|NCT00943917|65922319|FG006|Stage II Continuation|A1C elevation|0|||
23598863|NCT00943917|65922320|FG007|Stage II Continuation|A1C elevation|0|||
23598864|NCT00943917|65922321|FG008|Stage II Continuation|A1C elevation|0|||
23598865|NCT00943917|65922322|FG009|Stage II Continuation|A1C elevation|0|||
23598866|NCT00943917|65922323|FG010|Stage II Continuation|A1C elevation|0|||
23598867|NCT00943917|65922324|FG011|Stage II Continuation|A1C elevation|0|||
23598868|NCT00943917|65922325|FG012|Stage II Continuation|A1C elevation|0|||
23598869|NCT00943917|65922326|FG013|Stage II Continuation|A1C elevation|1|||
23650604|NCT00252733|66104489|FG001|Overall Study|Withdrawal by Subject|67|||
23650605|NCT00252733|66104488|FG000|Overall Study|Death|7|||
23650606|NCT00252733|66104489|FG001|Overall Study|Death|5|||
23650607|NCT00252733|66104488|FG000|Overall Study|Lost to Follow-up|12|||
23650608|NCT00252733|66104489|FG001|Overall Study|Lost to Follow-up|6|||
23650609|NCT00252733|66104488|FG000|Overall Study|Multiple Reasons|14|||
23650610|NCT00252733|66104489|FG001|Overall Study|Multiple Reasons|14|||
23650611|NCT02958267|66104492|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
23650612|NCT02958267|66104493|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
23650613|NCT02958267|66104492|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
23650614|NCT02958267|66104493|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
23650615|NCT02958267|66104492|FG000|Follow-up Visits|Additional treatment pursued|2|||
23650616|NCT02958267|66104493|FG001|Follow-up Visits|Additional treatment pursued|1|||
23650617|NCT04187989|66104494|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
23650618|NCT04187989|66104495|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
23650619|NCT04187989|66104494|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
23650620|NCT04187989|66104495|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
23650621|NCT01718353|66104505|FG000|Overall Study|Lost to Follow-up|0|||
23650622|NCT01718353|66104506|FG001|Overall Study|Lost to Follow-up|1|||
23650623|NCT01718353|66104505|FG000|Overall Study|Principal Investigator's Decision|10|||
23650624|NCT01718353|66104506|FG001|Overall Study|Principal Investigator's Decision|4|||
23650625|NCT01718353|66104505|FG000|Overall Study|Randomized but not treated|2|||
23650626|NCT01718353|66104506|FG001|Overall Study|Randomized but not treated|0|||
23479254|NCT02923921|65498460|FG001|Overall Study|Sponsor Decision|38|||
23598870|NCT00943917|65922327|FG014|Stage II Continuation|A1C elevation|0|||
23598871|NCT03102034|65922328|FG000|Overall Study|Withdrawal by Subject|1|||
23598872|NCT03102034|65922329|FG001|Overall Study|Withdrawal by Subject|0|||
23598873|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Death|0|||
23598874|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Death|3|||
23598875|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Death|1|||
23598876|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Death|0|||
23598877|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Death|0|||
23598878|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
23598879|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
23598880|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
23598881|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
23598882|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
23598883|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Other|0|||
23598884|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Other|0|||
23598885|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Other|1|||
23598886|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Other|0|||
23598887|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Other|0|||
23598888|NCT01939899|65922330|FG000|Phase 2|Withdrawal by Subject|0|||
23598889|NCT01939899|65922331|FG001|Phase 2|Withdrawal by Subject|0|||
23598890|NCT01939899|65922332|FG002|Phase 2|Withdrawal by Subject|0|||
23598891|NCT01939899|65922333|FG003|Phase 2|Withdrawal by Subject|2|||
23598892|NCT01939899|65922334|FG004|Phase 2|Withdrawal by Subject|0|||
23598893|NCT01939899|65922330|FG000|Phase 2|Disease Progression|0|||
23598894|NCT01939899|65922331|FG001|Phase 2|Disease Progression|0|||
23598895|NCT01939899|65922332|FG002|Phase 2|Disease Progression|0|||
23598896|NCT01939899|65922333|FG003|Phase 2|Disease Progression|9|||
23598897|NCT01939899|65922334|FG004|Phase 2|Disease Progression|1|||
23598898|NCT00093015|65922336|FG000|Overall Study|Withdrawal by Subject|194|||
23598899|NCT00093015|65922337|FG001|Overall Study|Withdrawal by Subject|171|||
23598900|NCT00093015|65922336|FG000|Overall Study|Lost to Follow-up|96|||
23598901|NCT00093015|65922337|FG001|Overall Study|Lost to Follow-up|108|||
23598902|NCT00093015|65922336|FG000|Overall Study|Death|375|||
23598903|NCT00093015|65922337|FG001|Overall Study|Death|385|||
23598904|NCT02962284|65922338|FG000|Overall Study|Death|2|||
23598905|NCT02962284|65922339|FG001|Overall Study|Death|0|||
23598906|NCT02962284|65922338|FG000|Overall Study|Progressive disease|2|||
23598907|NCT02962284|65922339|FG001|Overall Study|Progressive disease|3|||
23598908|NCT02962284|65922338|FG000|Overall Study|Withdrawal by Subject|1|||
23650627|NCT02342743|66104507|FG000|Baseline Period|Withdrawal by Subject|3|||
23650628|NCT02342743|66104507|FG000|Baseline Period|Lost to Follow-up|2|||
23598909|NCT02962284|65922339|FG001|Overall Study|Withdrawal by Subject|0|||
23598910|NCT00112359|65922340|FG000|Overall Study|Unrelated adverse event|16|||
23598911|NCT00112359|65922341|FG001|Overall Study|Unrelated adverse event|8|||
23598912|NCT00112359|65922340|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
23598913|NCT00112359|65922341|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
23598914|NCT00112359|65922340|FG000|Overall Study|Related adverse event|5|||
23598915|NCT00112359|65922341|FG001|Overall Study|Related adverse event|3|||
23598916|NCT00112359|65922340|FG000|Overall Study|Lost to Follow-up|0|||
23598917|NCT00112359|65922341|FG001|Overall Study|Lost to Follow-up|1|||
23598918|NCT00112359|65922340|FG000|Overall Study|Personal/administrative|1|||
23598919|NCT00112359|65922341|FG001|Overall Study|Personal/administrative|1|||
23650629|NCT02342743|66104507|FG000|Baseline Period|Change in prophylactic medication|3|||
23650630|NCT02342743|66104507|FG000|Baseline Period|Screening failure regarding baseline|7|||
23650631|NCT02342743|66104507|FG000|Treatment Period|Withdrawal by Subject|2|||
23650632|NCT02342743|66104507|FG000|Treatment Period|Lost to Follow-up|8|||
23650633|NCT02342743|66104507|FG000|Treatment Period|Change in prophylactic medication|1|||
23650634|NCT04754477|66104508|FG000|Overall Study|Withdrawal by Subject|1|||
23650635|NCT02937454|66104509|FG000|Overall Study|Adverse Event|0|||
23650636|NCT02937454|66104510|FG001|Overall Study|Adverse Event|1|||
23650637|NCT02937454|66104509|FG000|Overall Study|Death|98|||
23650638|NCT02937454|66104510|FG001|Overall Study|Death|95|||
23650639|NCT02937454|66104509|FG000|Overall Study|Lost to Follow-up|1|||
23650640|NCT02937454|66104510|FG001|Overall Study|Lost to Follow-up|1|||
23650641|NCT02937454|66104509|FG000|Overall Study|Physician Decision|0|||
23650642|NCT02937454|66104510|FG001|Overall Study|Physician Decision|1|||
23650643|NCT02937454|66104509|FG000|Overall Study|Protocol Violation|6|||
23650644|NCT02937454|66104510|FG001|Overall Study|Protocol Violation|10|||
23650645|NCT02937454|66104509|FG000|Overall Study|Withdrawal by Subject|27|||
23650646|NCT02937454|66104510|FG001|Overall Study|Withdrawal by Subject|15|||
23650647|NCT02937454|66104509|FG000|Overall Study|Other|8|||
23650648|NCT02937454|66104510|FG001|Overall Study|Other|5|||
23650649|NCT02216357|66104511|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
23650650|NCT02216357|66104512|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
23650651|NCT03057977|66104513|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
23650652|NCT03057977|66104514|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
23650653|NCT03057977|66104513|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
23650654|NCT03057977|66104514|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
23650655|NCT03057977|66104513|FG000|Discontinuation From Treatment|Protocol Violation|6|||
23650656|NCT03057977|66104514|FG001|Discontinuation From Treatment|Protocol Violation|5|||
23650657|NCT03057977|66104513|FG000|Discontinuation From Treatment|Not treated|4|||
23650658|NCT03057977|66104514|FG001|Discontinuation From Treatment|Not treated|0|||
23650659|NCT03057977|66104513|FG000|Discontinuation From Treatment|Adverse Event|343|||
23650660|NCT03057977|66104514|FG001|Discontinuation From Treatment|Adverse Event|337|||
23650661|NCT03057977|66104513|FG000|Discontinuation From Treatment|Reason Unknown|0|||
23650662|NCT03057977|66104514|FG001|Discontinuation From Treatment|Reason Unknown|1|||
23650663|NCT03057977|66104513|FG000|Discontinuation From Treatment|Personal Reasons|1|||
23650664|NCT03057977|66104514|FG001|Discontinuation From Treatment|Personal Reasons|1|||
23650665|NCT03057977|66104513|FG000|Discontinuation From Treatment|Unblinded medication|1|||
23650666|NCT03057977|66104514|FG001|Discontinuation From Treatment|Unblinded medication|0|||
23650667|NCT03057977|66104513|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
23650668|NCT03057977|66104514|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
23650669|NCT03057977|66104513|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
23650670|NCT03057977|66104514|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
23650671|NCT03057977|66104513|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
23650672|NCT03057977|66104514|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
23650673|NCT03057977|66104513|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
23650674|NCT03057977|66104514|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
23650675|NCT03057977|66104513|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
23650676|NCT03057977|66104514|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
23650677|NCT03057977|66104513|FG000|Discontinuation From Treatment|Not attending study visit|3|||
23650678|NCT03057977|66104514|FG001|Discontinuation From Treatment|Not attending study visit|10|||
23360650|NCT03318003|65065822|FG000|Overall Study|Withdrawal by Subject|1|||
23598920|NCT00112359|65922340|FG000|Overall Study|Other|3|||
23650679|NCT03057977|66104513|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
23598921|NCT00112359|65922341|FG001|Overall Study|Other|0|||
23598922|NCT01063881|65922342|FG000|Overall Study|Adverse Event|12|||
23598923|NCT01063881|65922343|FG001|Overall Study|Adverse Event|2|||
23598924|NCT01063881|65922344|FG002|Overall Study|Adverse Event|0|||
23598925|NCT01063881|65922342|FG000|Overall Study|Lost to Follow-up|13|||
23598926|NCT01063881|65922343|FG001|Overall Study|Lost to Follow-up|7|||
23598927|NCT01063881|65922344|FG002|Overall Study|Lost to Follow-up|1|||
23598928|NCT01063881|65922342|FG000|Overall Study|Withdrawal by Subject|25|||
23598929|NCT01063881|65922343|FG001|Overall Study|Withdrawal by Subject|1|||
23598930|NCT01063881|65922344|FG002|Overall Study|Withdrawal by Subject|0|||
23598931|NCT01063881|65922342|FG000|Overall Study|Reason for not completed not specified|5|||
23598932|NCT01063881|65922343|FG001|Overall Study|Reason for not completed not specified|1|||
23598933|NCT01063881|65922344|FG002|Overall Study|Reason for not completed not specified|0|||
23598934|NCT00879710|65922353|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
23360651|NCT03318003|65065823|FG001|Overall Study|Withdrawal by Subject|1|||
23598935|NCT00879710|65922354|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
23598936|NCT00879710|65922355|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
23598937|NCT00879710|65922356|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
23650680|NCT03057977|66104514|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
23650681|NCT03057977|66104513|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
23650682|NCT03057977|66104514|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
23650683|NCT03057977|66104513|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
23650684|NCT03057977|66104514|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
23650685|NCT03057977|66104513|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
23650686|NCT03057977|66104514|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
23650687|NCT03057977|66104513|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
23650688|NCT03057977|66104514|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
23650689|NCT00063154|66104515|FG000|Overall Study|Disease progression|27|||
23650690|NCT00063154|66104515|FG000|Overall Study|Adverse Event|2|||
23650691|NCT00063154|66104515|FG000|Overall Study|Physician Decision|10|||
23650692|NCT00063154|66104515|FG000|Overall Study|Death|3|||
23650693|NCT00063154|66104515|FG000|Overall Study|Reason unspecified|1|||
23650694|NCT00063154|66104515|FG000|Overall Study|Did not receive treatment|8|||
23650695|NCT00701779|66104516|FG000|Overall Study|Adverse Event|6|||
23650696|NCT00701779|66104516|FG000|Overall Study|Lost to Follow-up|1|||
23650697|NCT00701779|66104516|FG000|Overall Study|Withdrawal by Subject|2|||
23650698|NCT02076178|66104517|FG000|Oral Phase|Adverse Event|0|||
23650699|NCT02076178|66104518|FG001|Oral Phase|Adverse Event|7|||
23650700|NCT02076178|66104517|FG000|Oral Phase|Withdrawal by Subject|0|||
23650701|NCT02076178|66104518|FG001|Oral Phase|Withdrawal by Subject|4|||
23650702|NCT02076178|66104517|FG000|Oral Phase|Physician Decision|0|||
23650703|NCT02076178|66104518|FG001|Oral Phase|Physician Decision|1|||
23650704|NCT02076178|66104517|FG000|Injection Phase|Protocol defined stopping criteria|1|||
23801128|NCT00897949|66649904|FG002|Overall Study|Did not take study drug|4|||
23801129|NCT02843659|66649905|FG000|Overall Study|Subject Withdrew Consent|0|||
23801130|NCT02843659|66649906|FG001|Overall Study|Subject Withdrew Consent|0|||
23801131|NCT02843659|66649907|FG002|Overall Study|Subject Withdrew Consent|1|||
23801132|NCT02843659|66649905|FG000|Overall Study|Administrative Reason by Sponsor|4|||
23801133|NCT02843659|66649906|FG001|Overall Study|Administrative Reason by Sponsor|5|||
23801134|NCT02843659|66649907|FG002|Overall Study|Administrative Reason by Sponsor|4|||
23801135|NCT02843659|66649905|FG000|Overall Study|Adverse Event|0|||
23801136|NCT02843659|66649906|FG001|Overall Study|Adverse Event|1|||
23801137|NCT02843659|66649907|FG002|Overall Study|Adverse Event|0|||
23801138|NCT05506358|66649908|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
23801139|NCT05506358|66649909|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23801140|NCT05506358|66649910|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23801141|NCT05506358|66649911|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23801142|NCT05506358|66649912|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23801143|NCT05506358|66649908|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
23801144|NCT05506358|66649909|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23801145|NCT05506358|66649910|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23801146|NCT05506358|66649911|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23801147|NCT05506358|66649912|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23801148|NCT05506358|66649908|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23801149|NCT05506358|66649909|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23801150|NCT05506358|66649910|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23801151|NCT05506358|66649911|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
23650705|NCT02076178|66104518|FG001|Injection Phase|Protocol defined stopping criteria|0|||
23650706|NCT02076178|66104517|FG000|Injection Phase|Withdrawal by Subject|0|||
23650707|NCT02076178|66104518|FG001|Injection Phase|Withdrawal by Subject|3|||
23650708|NCT02076178|66104517|FG000|Injection Phase|Physician Decision|0|||
23650709|NCT02076178|66104518|FG001|Injection Phase|Physician Decision|3|||
23650710|NCT02076178|66104517|FG000|Injection Phase|Lost to Follow-up|0|||
23650711|NCT02076178|66104518|FG001|Injection Phase|Lost to Follow-up|1|||
23650712|NCT03718533|66104521|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
23650713|NCT03718533|66104521|FG000|Overall Study|Protocol deviation|1|||
23650714|NCT03718533|66104521|FG000|Overall Study|Disease progression|1|||
23650715|NCT03718533|66104521|FG000|Overall Study|Relapse|1|||
23650716|NCT03718533|66104521|FG000|Overall Study|Physician Decision|2|||
23650717|NCT03718533|66104521|FG000|Overall Study|Physician Decision and Adverse Event|1|||
23650718|NCT01136811|66104522|FG000|Overall Study|Physician Decision|11|||
23650719|NCT01285609|66104524|FG000|Randomized|Progressive Disease|41|||
23650720|NCT01285609|66104525|FG001|Randomized|Progressive Disease|61|||
23650721|NCT01285609|66104524|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
23650722|NCT01285609|66104525|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
23650723|NCT01285609|66104524|FG000|Randomized|Study Drug Toxicity|13|||
23650724|NCT01285609|66104525|FG001|Randomized|Study Drug Toxicity|14|||
23650725|NCT01285609|66104524|FG000|Randomized|Death|5|||
23650726|NCT01285609|66104525|FG001|Randomized|Death|7|||
23650727|NCT01285609|66104524|FG000|Randomized|Withdrawal by Subject|8|||
23650728|NCT01285609|66104525|FG001|Randomized|Withdrawal by Subject|11|||
23650729|NCT01285609|66104524|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
23650730|NCT01285609|66104525|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
23650731|NCT01285609|66104524|FG000|Randomized|Undisclosed Reasons|1|||
23650732|NCT01285609|66104525|FG001|Randomized|Undisclosed Reasons|0|||
23650733|NCT01285609|66104524|FG000|Randomized|Randomized but not Treated|4|||
23650734|NCT01285609|66104525|FG001|Randomized|Randomized but not Treated|4|||
23650735|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
23598938|NCT00879710|65922353|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
23598939|NCT00879710|65922354|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
23650736|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
23650737|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
23650738|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
23650739|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
23650740|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
23650741|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
23650742|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
23650743|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Death|11|||
23650744|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Death|3|||
23650745|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
23650746|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
23650747|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Not Reported|0|||
23650748|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Not Reported|2|||
23650749|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
23650750|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
23650751|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
23650752|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
23650753|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
23650754|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
23650755|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
23650756|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
23650757|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
23650758|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
23650759|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
23650760|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
23650761|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
23650762|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
23650763|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
23650764|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
23650765|NCT01285609|66104524|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
23650766|NCT01285609|66104525|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
23650767|NCT01285609|66104524|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
23650768|NCT01285609|66104525|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
23650769|NCT03170154|66104526|FG000|Overall Study|Lost to Follow-up|4|||
23650770|NCT03170154|66104526|FG000|Overall Study|Death|2|||
23650771|NCT03170154|66104526|FG000|Overall Study|Withdrawal by Subject|2|||
23650772|NCT00601419|66104532|FG000|Overall Study|Lost to Follow-up|3|||
23650773|NCT00601419|66104532|FG000|Overall Study|Missed Visits|1|||
23650774|NCT00400985|66104533|FG000|Overall Study|Withdrawal by Subject|5|||
23650775|NCT00400985|66104533|FG000|Overall Study|system modification|8|||
23650776|NCT00400985|66104533|FG000|Overall Study|Death|30|||
23801152|NCT05506358|66649912|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23801153|NCT05506358|66649908|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
23801154|NCT05506358|66649909|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
23598940|NCT00879710|65922355|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
23598941|NCT00879710|65922356|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
23598942|NCT03781375|65922363|FG000|Double-blind Phase|Adverse Event|0|||
23598943|NCT03781375|65922364|FG001|Double-blind Phase|Adverse Event|1|||
23598944|NCT03781375|65922363|FG000|Double-blind Phase|Lack of Response|6|||
23598945|NCT03781375|65922364|FG001|Double-blind Phase|Lack of Response|2|||
23598946|NCT03781375|65922363|FG000|Double-blind Phase|Other|1|||
23598947|NCT03781375|65922364|FG001|Double-blind Phase|Other|3|||
23598948|NCT03781375|65922363|FG000|Open-label Phase|Protocol Issues|0|||
23598949|NCT03781375|65922364|FG001|Open-label Phase|Protocol Issues|1|||
23598950|NCT03781375|65922363|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
23360652|NCT03318003|65065822|FG000|Overall Study|fetal loss|0|||
23598951|NCT03781375|65922364|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
23598952|NCT03781375|65922363|FG000|Open-label Phase|Other|2|||
23598953|NCT03781375|65922364|FG001|Open-label Phase|Other|2|||
23650777|NCT00400985|66104533|FG000|Overall Study|Lost to Follow-up|9|||
23650778|NCT00995020|66104534|FG000|Overall Study|margin analysis not performed|2|||
23650779|NCT00995020|66104535|FG001|Overall Study|margin analysis not performed|5|||
23650780|NCT00995020|66104534|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
23650781|NCT00995020|66104535|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
23479255|NCT02923921|65498459|FG000|Overall Study|Lost to Follow-up|1|||
23479256|NCT02923921|65498460|FG001|Overall Study|Lost to Follow-up|0|||
23479257|NCT02923921|65498459|FG000|Overall Study|Withdrawal by Subject|6|||
23479258|NCT02923921|65498460|FG001|Overall Study|Withdrawal by Subject|13|||
23479259|NCT02923921|65498459|FG000|Overall Study|Unknown, Not Collected|7|||
23479260|NCT02923921|65498460|FG001|Overall Study|Unknown, Not Collected|6|||
23479261|NCT04518995|65498464|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
23479262|NCT04518995|65498465|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
23479263|NCT04518995|65498466|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
23479264|NCT04518995|65498464|FG000|Overall Study|Lack of Efficacy|2|||
23479265|NCT04518995|65498465|FG001|Overall Study|Lack of Efficacy|1|||
23479266|NCT04518995|65498466|FG002|Overall Study|Lack of Efficacy|0|||
23479267|NCT04518995|65498464|FG000|Overall Study|Non-compliance With Study Drug|0|||
23479268|NCT04518995|65498465|FG001|Overall Study|Non-compliance With Study Drug|3|||
23479269|NCT04518995|65498466|FG002|Overall Study|Non-compliance With Study Drug|2|||
23479270|NCT04518995|65498464|FG000|Overall Study|Pregnancy|0|||
23479271|NCT04518995|65498465|FG001|Overall Study|Pregnancy|0|||
23479272|NCT04518995|65498466|FG002|Overall Study|Pregnancy|1|||
23479273|NCT04518995|65498464|FG000|Overall Study|Protocol Violation|2|||
23479274|NCT04518995|65498465|FG001|Overall Study|Protocol Violation|0|||
23479275|NCT04518995|65498466|FG002|Overall Study|Protocol Violation|1|||
23479276|NCT04518995|65498464|FG000|Overall Study|Reason not Specified|4|||
23479277|NCT04518995|65498465|FG001|Overall Study|Reason not Specified|11|||
23479278|NCT04518995|65498466|FG002|Overall Study|Reason not Specified|2|||
23479279|NCT04518995|65498464|FG000|Overall Study|Lost to Follow-up|1|||
23479280|NCT04518995|65498465|FG001|Overall Study|Lost to Follow-up|10|||
23479281|NCT04518995|65498466|FG002|Overall Study|Lost to Follow-up|6|||
23479282|NCT01403948|65498467|FG000|Overall Study|Progressive disease|0|||
23479283|NCT01403948|65498468|FG001|Overall Study|Progressive disease|2|||
23479284|NCT01403948|65498469|FG002|Overall Study|Progressive disease|2|||
23479285|NCT01403948|65498470|FG003|Overall Study|Progressive disease|4|||
23479286|NCT01403948|65498471|FG004|Overall Study|Progressive disease|2|||
23479287|NCT01403948|65498472|FG005|Overall Study|Progressive disease|6|||
23479288|NCT01403948|65498473|FG006|Overall Study|Progressive disease|2|||
23479289|NCT01403948|65498474|FG007|Overall Study|Progressive disease|4|||
23479290|NCT01403948|65498475|FG008|Overall Study|Progressive disease|5|||
23479291|NCT01403948|65498476|FG009|Overall Study|Progressive disease|5|||
23479292|NCT01403948|65498467|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479293|NCT01403948|65498468|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479294|NCT01403948|65498469|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479295|NCT01403948|65498470|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479296|NCT01403948|65498471|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
23479297|NCT01403948|65498472|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479298|NCT01403948|65498473|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
23479299|NCT01403948|65498474|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479300|NCT01403948|65498475|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
23479301|NCT01403948|65498476|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479302|NCT01403948|65498467|FG000|Overall Study|Lost to Follow-up|0|||
23479303|NCT01403948|65498468|FG001|Overall Study|Lost to Follow-up|0|||
23479304|NCT01403948|65498469|FG002|Overall Study|Lost to Follow-up|0|||
23479305|NCT01403948|65498470|FG003|Overall Study|Lost to Follow-up|0|||
23479306|NCT01403948|65498471|FG004|Overall Study|Lost to Follow-up|0|||
23598954|NCT01609218|65922367|FG000|Period 1|Adverse Event|3|||
23598955|NCT01609218|65922368|FG001|Period 1|Adverse Event|5|||
23598956|NCT01609218|65922367|FG000|Period 1|Sponsor Decision|0|||
23598957|NCT01609218|65922368|FG001|Period 1|Sponsor Decision|1|||
23598958|NCT01609218|65922367|FG000|Period 2|Adverse Event|1|||
23598959|NCT01609218|65922368|FG001|Period 2|Adverse Event|0|||
23650782|NCT03118674|66104536|FG000|Overall Study|Lost to Follow-up|2|||
23479307|NCT01403948|65498472|FG005|Overall Study|Lost to Follow-up|0|||
23479308|NCT01403948|65498473|FG006|Overall Study|Lost to Follow-up|0|||
23479309|NCT01403948|65498474|FG007|Overall Study|Lost to Follow-up|0|||
23479310|NCT01403948|65498475|FG008|Overall Study|Lost to Follow-up|0|||
23479311|NCT01403948|65498476|FG009|Overall Study|Lost to Follow-up|1|||
23479312|NCT01403948|65498467|FG000|Overall Study|Refused cont. medication|0|||
23479313|NCT01403948|65498468|FG001|Overall Study|Refused cont. medication|0|||
23479314|NCT01403948|65498469|FG002|Overall Study|Refused cont. medication|0|||
23479315|NCT01403948|65498470|FG003|Overall Study|Refused cont. medication|0|||
23479316|NCT01403948|65498471|FG004|Overall Study|Refused cont. medication|1|||
23598960|NCT02438137|65922369|FG000|Overall Study|Lost to Follow-up|3|||
23598961|NCT02438137|65922370|FG001|Overall Study|Lost to Follow-up|2|||
23650783|NCT03118674|66104536|FG000|Overall Study|Screen Faliure|8|||
23650784|NCT03118674|66104536|FG000|Overall Study|Withdrawal by Subject|5|||
23650785|NCT04526197|66104537|FG000|Period 1|Adverse Event|0|||
23650786|NCT04526197|66104538|FG001|Period 1|Adverse Event|1|||
23650787|NCT04526197|66104537|FG000|Period 1|Withdrawal by Subject|1|||
23650788|NCT04526197|66104538|FG001|Period 1|Withdrawal by Subject|0|||
23650789|NCT04526197|66104537|FG000|Period 2|Adverse Event|0|||
23650790|NCT04526197|66104538|FG001|Period 2|Adverse Event|1|||
23650791|NCT04526197|66104537|FG000|Period 2|Withdrawal by Subject|0|||
23650792|NCT04526197|66104538|FG001|Period 2|Withdrawal by Subject|1|||
23650793|NCT00711529|66107019|FG000|Overall Study|Protocol Violation|2|||
23650794|NCT00711529|66107020|FG001|Overall Study|Protocol Violation|0|||
23650795|NCT00711529|66107019|FG000|Overall Study|Withdrawal by Subject|2|||
23650796|NCT00711529|66107020|FG001|Overall Study|Withdrawal by Subject|6|||
23650797|NCT02973048|66107021|FG000|Overall Study|Epidural catheter insertion failure|1|||
23650798|NCT02973048|66107022|FG001|Overall Study|Epidural catheter insertion failure|0|||
23650799|NCT02973048|66107021|FG000|Overall Study|Withdrawal by Subject|0|||
23650800|NCT02973048|66107022|FG001|Overall Study|Withdrawal by Subject|3|||
23650801|NCT02027623|66107023|FG000|Overall Study|Lost to Follow-up|3|||
23650802|NCT02027623|66107024|FG001|Overall Study|Lost to Follow-up|3|||
23650803|NCT02027623|66107023|FG000|Overall Study|Withdrawal by Subject|6|||
23650804|NCT02027623|66107024|FG001|Overall Study|Withdrawal by Subject|9|||
23650805|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
23650806|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
23360653|NCT03318003|65065823|FG001|Overall Study|fetal loss|1|||
23360654|NCT02372383|65065824|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
23360655|NCT02372383|65065825|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
23360656|NCT02372383|65065826|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
23360657|NCT00672633|65065846|FG000|Overall Study|Withdrawal by Subject|0|||
23360658|NCT00672633|65065847|FG001|Overall Study|Withdrawal by Subject|1|||
23479317|NCT01403948|65498472|FG005|Overall Study|Refused cont. medication|0|||
23598962|NCT02438137|65922369|FG000|Overall Study|Adverse Event|1|||
23598963|NCT02438137|65922370|FG001|Overall Study|Adverse Event|0|||
23598964|NCT02438137|65922369|FG000|Overall Study|Withdrawal by Subject|4|||
23598965|NCT02438137|65922370|FG001|Overall Study|Withdrawal by Subject|3|||
23598966|NCT02438137|65922369|FG000|Overall Study|Physician Decision|0|||
23598967|NCT02438137|65922370|FG001|Overall Study|Physician Decision|1|||
23598968|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
23598969|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
23598970|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
23598971|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
23598972|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
23598973|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
23598974|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
23598975|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
23598976|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
23598977|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
23598978|NCT03939312|65922378|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
23598979|NCT03939312|65922378|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
23598980|NCT02866942|65922379|FG000|Overall Study|Invalid consent|1|||
23598981|NCT01932970|65922382|FG000|Overall Study|Withdrawal by Subject|5|||
23598982|NCT01932970|65922382|FG000|Overall Study|Death|1|||
23598983|NCT01932970|65922382|FG000|Overall Study|Lost to Follow-up|2|||
23598984|NCT01932970|65922382|FG000|Overall Study|Protocol Specified Criteria|10|||
23598985|NCT04110054|65922384|FG000|Overall Study|COVID-19 reason other than AE|0|||
23598986|NCT04110054|65922385|FG001|Overall Study|COVID-19 reason other than AE|0|||
23598987|NCT04110054|65922386|FG002|Overall Study|COVID-19 reason other than AE|2|||
23598988|NCT04110054|65922387|FG003|Overall Study|COVID-19 reason other than AE|0|||
23598989|NCT04110054|65922384|FG000|Overall Study|Withdrawal by Subject|0|||
23598990|NCT04110054|65922385|FG001|Overall Study|Withdrawal by Subject|3|||
23598991|NCT04110054|65922386|FG002|Overall Study|Withdrawal by Subject|2|||
23598992|NCT04110054|65922387|FG003|Overall Study|Withdrawal by Subject|0|||
23598993|NCT04110054|65922384|FG000|Overall Study|Adverse Event|1|||
23598994|NCT04110054|65922385|FG001|Overall Study|Adverse Event|1|||
23598995|NCT04110054|65922386|FG002|Overall Study|Adverse Event|4|||
23598996|NCT04110054|65922387|FG003|Overall Study|Adverse Event|3|||
23598997|NCT02128113|65922393|FG000|Overall Study|Withdrawal by Subject|3|||
23598998|NCT02128113|65922394|FG001|Overall Study|Withdrawal by Subject|1|||
23598999|NCT02128113|65922395|FG002|Overall Study|Withdrawal by Subject|0|||
23599000|NCT02128113|65922393|FG000|Overall Study|Protocol Violation|0|||
23599001|NCT02128113|65922394|FG001|Overall Study|Protocol Violation|1|||
23599002|NCT02128113|65922395|FG002|Overall Study|Protocol Violation|0|||
23599003|NCT02128113|65922393|FG000|Overall Study|Surgery cancelled|0|||
23599004|NCT02128113|65922394|FG001|Overall Study|Surgery cancelled|1|||
23599005|NCT02128113|65922395|FG002|Overall Study|Surgery cancelled|0|||
23360659|NCT00803712|65065855|FG000|Overall Study|Noncompliance|3|||
23360660|NCT00803712|65065856|FG001|Overall Study|Noncompliance|0|||
23360661|NCT00803712|65065855|FG000|Overall Study|Adverse Event|5|||
23360662|NCT00803712|65065856|FG001|Overall Study|Adverse Event|0|||
23650807|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Death|0|||
23650808|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Death|1|||
23650809|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
23650810|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
23650811|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
23650812|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
23650813|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
23650814|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
23650815|NCT00323297|66107025|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
23650816|NCT00323297|66107026|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
23650817|NCT00323297|66107025|FG000|Part B (Open-label)|Death|0|||
23650818|NCT00323297|66107026|FG001|Part B (Open-label)|Death|1|||
23650819|NCT00323297|66107025|FG000|Part B (Open-label)|Reason unspecified|0|||
23650820|NCT00323297|66107026|FG001|Part B (Open-label)|Reason unspecified|1|||
23650821|NCT00323297|66107025|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
23650822|NCT00323297|66107026|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
23650823|NCT00323297|66107025|FG000|Part B (Open-label)|Lack of Efficacy|3|||
23650824|NCT00323297|66107026|FG001|Part B (Open-label)|Lack of Efficacy|1|||
23650825|NCT00323297|66107025|FG000|Part B (Open-label)|Adverse Event|5|||
23650826|NCT00323297|66107026|FG001|Part B (Open-label)|Adverse Event|5|||
23650827|NCT00323297|66107025|FG000|Part B (Open-label)|Protocol Violation|0|||
23650828|NCT00323297|66107026|FG001|Part B (Open-label)|Protocol Violation|1|||
23650829|NCT03451162|66107032|FG000|Overall Study|Lost to Follow-up|1|||
23650830|NCT03451162|66107033|FG001|Overall Study|Lost to Follow-up|0|||
23650831|NCT03451162|66107034|FG002|Overall Study|Lost to Follow-up|0|||
23650832|NCT03451162|66107035|FG003|Overall Study|Lost to Follow-up|0|||
23650833|NCT03451162|66107036|FG004|Overall Study|Lost to Follow-up|0|||
23650834|NCT03451162|66107032|FG000|Overall Study|Physician Decision|0|||
23650835|NCT03451162|66107033|FG001|Overall Study|Physician Decision|1|||
23599006|NCT02128113|65922393|FG000|Overall Study|Adverse Event|0|||
23599007|NCT02128113|65922394|FG001|Overall Study|Adverse Event|0|||
23599008|NCT02128113|65922395|FG002|Overall Study|Adverse Event|1|||
23599009|NCT00589875|65922400|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
23599010|NCT00589875|65922400|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
23599011|NCT00676091|65922406|FG000|Infant Series|Parent or legal guardian request|10|||
23599012|NCT00676091|65922407|FG001|Infant Series|Parent or legal guardian request|8|||
23599013|NCT00676091|65922406|FG000|Infant Series|Protocol Violation|6|||
23599014|NCT00676091|65922407|FG001|Infant Series|Protocol Violation|3|||
23599015|NCT00676091|65922406|FG000|Infant Series|Adverse Event|2|||
23599016|NCT00676091|65922407|FG001|Infant Series|Adverse Event|3|||
23599017|NCT00676091|65922406|FG000|Infant Series|Failed to return|1|||
23599018|NCT00676091|65922407|FG001|Infant Series|Failed to return|3|||
23599019|NCT00676091|65922406|FG000|Infant Series|Lost to Follow-up|1|||
23599020|NCT00676091|65922407|FG001|Infant Series|Lost to Follow-up|0|||
23599021|NCT00676091|65922406|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
23599022|NCT00676091|65922407|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
23599023|NCT00676091|65922406|FG000|After Infant Series|Adverse Event|0|||
23599024|NCT00676091|65922407|FG001|After Infant Series|Adverse Event|1|||
23599025|NCT00676091|65922406|FG000|After Infant Series|Protocol Violation|0|||
23599026|NCT00676091|65922407|FG001|After Infant Series|Protocol Violation|1|||
23599027|NCT00676091|65922406|FG000|After Infant Series|Failed to return|1|||
23599028|NCT00676091|65922407|FG001|After Infant Series|Failed to return|1|||
23599029|NCT00676091|65922406|FG000|Toddler Dose|Failed to return|2|||
23599030|NCT00676091|65922407|FG001|Toddler Dose|Failed to return|0|||
23599031|NCT00676091|65922406|FG000|Toddler Dose|Parent or legal guardian request|1|||
23599032|NCT00676091|65922407|FG001|Toddler Dose|Parent or legal guardian request|0|||
23599033|NCT00446459|65922408|FG000|8 Months|Protocol Violation|12|||
23599034|NCT00446459|65922408|FG000|12 Months|Protocol Violation|4|||
23599035|NCT00446459|65922408|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
23599036|NCT00976495|65922409|FG000|Overall Study|Withdrawal by Subject|0|||
23599037|NCT00976495|65922410|FG001|Overall Study|Withdrawal by Subject|1|||
23599038|NCT00976495|65922411|FG002|Overall Study|Withdrawal by Subject|0|||
23599039|NCT00611559|65922412|FG000|Overall Study|Lost to Follow-up|0|||
23599040|NCT00611559|65922413|FG001|Overall Study|Lost to Follow-up|1|||
23599041|NCT00611559|65922414|FG002|Overall Study|Lost to Follow-up|0|||
23599042|NCT00611559|65922412|FG000|Overall Study|Protocol Violation|1|||
23599043|NCT00611559|65922413|FG001|Overall Study|Protocol Violation|0|||
23599044|NCT00611559|65922414|FG002|Overall Study|Protocol Violation|1|||
23599045|NCT00277355|65922415|FG000|Overall Study|Withdrawal by Subject|3|||
23599046|NCT00277355|65922416|FG001|Overall Study|Withdrawal by Subject|3|||
23650836|NCT03451162|66107034|FG002|Overall Study|Physician Decision|0|||
23360663|NCT00803712|65065855|FG000|Overall Study|Death|8|||
23650837|NCT03451162|66107035|FG003|Overall Study|Physician Decision|0|||
23650838|NCT03451162|66107036|FG004|Overall Study|Physician Decision|0|||
23650839|NCT03451162|66107032|FG000|Overall Study|Withdrawal by Subject|1|||
23650840|NCT03451162|66107033|FG001|Overall Study|Withdrawal by Subject|1|||
23650841|NCT03451162|66107034|FG002|Overall Study|Withdrawal by Subject|0|||
23650842|NCT03451162|66107035|FG003|Overall Study|Withdrawal by Subject|0|||
23650843|NCT03451162|66107036|FG004|Overall Study|Withdrawal by Subject|0|||
23650844|NCT00537485|66107037|FG000|Overall Study|Adverse Event|10|||
23650845|NCT00537485|66107038|FG001|Overall Study|Adverse Event|5|||
23650846|NCT00537485|66107037|FG000|Overall Study|Withdrawal by Subject|3|||
23650847|NCT00537485|66107038|FG001|Overall Study|Withdrawal by Subject|2|||
23650848|NCT00537485|66107037|FG000|Overall Study|Withdrawal by Subject|1|||
23650849|NCT00537485|66107038|FG001|Overall Study|Withdrawal by Subject|3|||
23650850|NCT00537485|66107037|FG000|Overall Study|Physician Decision|1|||
23650851|NCT00537485|66107038|FG001|Overall Study|Physician Decision|0|||
23650852|NCT00928447|66107039|FG000|Overall Study|Withdrawal by Subject|1|||
23650853|NCT00928447|66107039|FG000|Overall Study|Investigator's decision|1|||
23650854|NCT03215810|66107043|FG000|Overall Study|Still responding to nivolumab|1|||
23650855|NCT03215810|66107043|FG000|Overall Study|Insufficient TIL growth|1|||
23650856|NCT03215810|66107043|FG000|Overall Study|Decline in performance status|1|||
23650857|NCT03215810|66107043|FG000|Overall Study|Withdrawal by Subject|1|||
23650858|NCT04281004|66107046|FG000|Overall Study|Physician Decision|1|||
23650859|NCT04281004|66107047|FG001|Overall Study|Physician Decision|0|||
23650860|NCT00686725|66107048|FG000|Overall Study|Adverse Event|1|||
23650861|NCT00686725|66107049|FG001|Overall Study|Adverse Event|1|||
23650862|NCT00686725|66107048|FG000|Overall Study|Progressive Disease|17|||
23650863|NCT00686725|66107049|FG001|Overall Study|Progressive Disease|23|||
23650864|NCT00686725|66107048|FG000|Overall Study|Lost to Follow-up|7|||
23650865|NCT00686725|66107049|FG001|Overall Study|Lost to Follow-up|5|||
23650866|NCT00686725|66107048|FG000|Overall Study|Death|6|||
23650867|NCT00686725|66107049|FG001|Overall Study|Death|3|||
23650868|NCT00686725|66107048|FG000|Overall Study|Withdrawal by Subject|13|||
23650869|NCT00686725|66107049|FG001|Overall Study|Withdrawal by Subject|4|||
23650870|NCT00686725|66107048|FG000|Overall Study|Protocol Violation|1|||
23650871|NCT00686725|66107049|FG001|Overall Study|Protocol Violation|3|||
23650872|NCT00686725|66107048|FG000|Overall Study|Other|1|||
23650873|NCT00686725|66107049|FG001|Overall Study|Other|3|||
23650874|NCT00141726|66107050|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
23650875|NCT01802567|66107051|FG000|Overall Study|Withdrawal by Subject|2|||
23650876|NCT01802567|66107051|FG000|Overall Study|Physician Decision|1|||
23650877|NCT01802567|66107051|FG000|Overall Study|Lack of Efficacy|7|||
23360664|NCT00803712|65065856|FG001|Overall Study|Death|7|||
23360665|NCT00803712|65065855|FG000|Overall Study|Lost to Follow-up|3|||
23360666|NCT00803712|65065856|FG001|Overall Study|Lost to Follow-up|1|||
23360667|NCT00803712|65065855|FG000|Overall Study|Withdrawal by Subject|2|||
23360668|NCT00803712|65065856|FG001|Overall Study|Withdrawal by Subject|4|||
23360669|NCT00803712|65065855|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
23360670|NCT00803712|65065856|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
23360671|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (other)|0|||
23360672|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (other)|2|||
23360673|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
23360674|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
23360675|NCT00803712|65065855|FG000|Overall Study|Administrative decision|2|||
23360676|NCT00803712|65065856|FG001|Overall Study|Administrative decision|3|||
23360677|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
23360678|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
23360679|NCT00996034|65065857|FG000|Overall Study|Lost to Follow-up|2|||
23360680|NCT00996034|65065857|FG000|Overall Study|withdrawn by PI|1|||
23360681|NCT01845597|65065858|FG000|Overall Study|Death|8|||
23360682|NCT01845597|65065858|FG000|Overall Study|Lost to Follow-up|22|||
23360683|NCT04633226|65065863|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23650878|NCT01802567|66107051|FG000|Overall Study|Consented but did not start therapy|7|||
23650879|NCT01802567|66107051|FG000|Overall Study|Protocol Violation|1|||
23650880|NCT01340196|66107054|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
23650881|NCT00547365|66107055|FG000|Overall Study|Physician Decision|1|||
23650882|NCT00547365|66107055|FG000|Overall Study|Lost to Follow-up|1|||
23650883|NCT00547365|66107055|FG000|Overall Study|Protocol Violation|2|||
23650884|NCT00547365|66107055|FG000|Overall Study|death (not related to study)|4|||
23360684|NCT04633226|65065863|FG000|Overall Study|Randomized by mistake without study treatment|1|||
23360685|NCT00943592|65065864|FG000|Overall Study|Death|3|||
23650885|NCT02960854|66107058|FG000|Overall Study|Not Disclosed|2|||
23650886|NCT02960854|66107059|FG001|Overall Study|Not Disclosed|2|||
23650887|NCT02960854|66107058|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
23650888|NCT02960854|66107059|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
23650889|NCT02960854|66107058|FG000|Overall Study|Subject Withdrew Consent|0|||
23801155|NCT05506358|66649910|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
23650890|NCT02960854|66107059|FG001|Overall Study|Subject Withdrew Consent|1|||
23650891|NCT02960854|66107058|FG000|Overall Study|Death|4|||
23650892|NCT02960854|66107059|FG001|Overall Study|Death|6|||
23650893|NCT01959516|66107062|FG000|Epoch 1|Adverse Event|4|||
23650894|NCT01959516|66107063|FG001|Epoch 1|Adverse Event|1|||
23650895|NCT01959516|66107062|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
23650896|NCT01959516|66107063|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
23650897|NCT01959516|66107062|FG000|Epoch 1|Subject withdrew consent|3|||
23650898|NCT01959516|66107063|FG001|Epoch 1|Subject withdrew consent|2|||
23650899|NCT01959516|66107062|FG000|Epoch 1|Administrative problems|1|||
23650900|NCT01959516|66107063|FG001|Epoch 1|Administrative problems|0|||
23650901|NCT01959516|66107062|FG000|Epoch 1|Use of prohibited treatment|1|||
23650902|NCT01959516|66107063|FG001|Epoch 1|Use of prohibited treatment|0|||
23650903|NCT01959516|66107062|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
23650904|NCT01959516|66107063|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
23650905|NCT01959516|66107062|FG000|Epoch 1|Protocol deviation|0|||
23650906|NCT01959516|66107063|FG001|Epoch 1|Protocol deviation|1|||
23650907|NCT01959516|66107062|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
23650908|NCT01959516|66107063|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
23650909|NCT01959516|66107062|FG000|Epoch 2|Subject withdrew consent|1|||
23650910|NCT01959516|66107063|FG001|Epoch 2|Subject withdrew consent|0|||
23650911|NCT01959516|66107062|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
23650912|NCT01959516|66107063|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
23650913|NCT04615247|66107064|FG000|Overall Study|Adverse Event|0|||
23650914|NCT04615247|66107065|FG001|Overall Study|Adverse Event|2|||
23650915|NCT04615247|66107064|FG000|Overall Study|Withdrawal by Subject|1|||
23650916|NCT04615247|66107065|FG001|Overall Study|Withdrawal by Subject|1|||
23650917|NCT02435966|66107066|FG000|Overall Study|Withdrawal by Subject|0|||
23650918|NCT02435966|66107067|FG001|Overall Study|Withdrawal by Subject|1|||
23650919|NCT02435966|66107068|FG002|Overall Study|Withdrawal by Subject|0|||
23650920|NCT01313637|66107073|FG000|Overall Study|Adverse Event|17|||
23650921|NCT01313637|66107074|FG001|Overall Study|Adverse Event|24|||
23650922|NCT01313637|66107075|FG002|Overall Study|Adverse Event|25|||
23650923|NCT01313637|66107076|FG003|Overall Study|Adverse Event|18|||
23650924|NCT01313637|66107073|FG000|Overall Study|Lack of Efficacy|44|||
23650925|NCT01313637|66107074|FG001|Overall Study|Lack of Efficacy|38|||
23650926|NCT01313637|66107075|FG002|Overall Study|Lack of Efficacy|37|||
23650927|NCT01313637|66107076|FG003|Overall Study|Lack of Efficacy|24|||
23650928|NCT01313637|66107073|FG000|Overall Study|Protocol Violation|4|||
23650929|NCT01313637|66107074|FG001|Overall Study|Protocol Violation|3|||
23650930|NCT01313637|66107075|FG002|Overall Study|Protocol Violation|11|||
23650931|NCT01313637|66107076|FG003|Overall Study|Protocol Violation|5|||
23650932|NCT01313637|66107073|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
23650933|NCT01313637|66107074|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
23650934|NCT01313637|66107075|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
23650935|NCT01313637|66107076|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
23650936|NCT01313637|66107073|FG000|Overall Study|Lost to Follow-up|0|||
23650937|NCT01313637|66107074|FG001|Overall Study|Lost to Follow-up|2|||
23650938|NCT01313637|66107075|FG002|Overall Study|Lost to Follow-up|1|||
23650939|NCT01313637|66107076|FG003|Overall Study|Lost to Follow-up|3|||
23650940|NCT01313637|66107073|FG000|Overall Study|Withdrawal by Subject|11|||
23650941|NCT01313637|66107074|FG001|Overall Study|Withdrawal by Subject|13|||
23650942|NCT01313637|66107075|FG002|Overall Study|Withdrawal by Subject|18|||
23650943|NCT01313637|66107076|FG003|Overall Study|Withdrawal by Subject|15|||
23650944|NCT00494481|66107077|FG000|Overall Study|Condition under investigation worsened|11|||
23650945|NCT00494481|66107078|FG001|Overall Study|Condition under investigation worsened|13|||
23650946|NCT00494481|66107077|FG000|Overall Study|Adverse Event|15|||
23650947|NCT00494481|66107078|FG001|Overall Study|Adverse Event|11|||
23650948|NCT00494481|66107077|FG000|Overall Study|Other|1|||
23650949|NCT00494481|66107078|FG001|Overall Study|Other|0|||
23360686|NCT00540644|65065865|FG000|Overall Study|Adverse Event|3|||
23360687|NCT00540644|65065866|FG001|Overall Study|Adverse Event|1|||
23360688|NCT00540644|65065865|FG000|Overall Study|Disease Progression|3|||
23360689|NCT00540644|65065866|FG001|Overall Study|Disease Progression|1|||
23479318|NCT01403948|65498473|FG006|Overall Study|Refused cont. medication|0|||
23479319|NCT01403948|65498474|FG007|Overall Study|Refused cont. medication|0|||
23650950|NCT00494481|66107077|FG000|Overall Study|Never received IP|2|||
23650951|NCT00494481|66107078|FG001|Overall Study|Never received IP|0|||
23650952|NCT00836095|66107087|FG000|Overall Study|Physician Decision|0|||
23650953|NCT00836095|66107088|FG001|Overall Study|Physician Decision|3|||
23650954|NCT03226275|66107091|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23650955|NCT03226275|66107092|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23650956|NCT03226275|66107093|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
23650957|NCT03226275|66107094|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23650958|NCT03226275|66107091|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23650959|NCT03226275|66107092|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23650960|NCT03226275|66107093|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23650961|NCT03226275|66107094|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
23650962|NCT02684357|66107095|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
23650963|NCT02684357|66107096|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
23650964|NCT02684357|66107097|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
23650965|NCT02684357|66107098|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
23650966|NCT02684357|66107099|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
23650967|NCT02684357|66107100|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
23650968|NCT02684357|66107095|FG000|Part A|Lost to Follow-up|0|||
23650969|NCT02684357|66107096|FG001|Part A|Lost to Follow-up|2|||
23650970|NCT02684357|66107097|FG002|Part A|Lost to Follow-up|2|||
23650971|NCT02684357|66107098|FG003|Part A|Lost to Follow-up|0|||
23650972|NCT02684357|66107099|FG004|Part A|Lost to Follow-up|0|||
23650973|NCT02684357|66107100|FG005|Part A|Lost to Follow-up|0|||
23650974|NCT02684357|66107095|FG000|Part A|Withdrawal by Subject|3|||
23650975|NCT02684357|66107096|FG001|Part A|Withdrawal by Subject|0|||
23650976|NCT02684357|66107097|FG002|Part A|Withdrawal by Subject|0|||
23650977|NCT02684357|66107098|FG003|Part A|Withdrawal by Subject|0|||
23650978|NCT02684357|66107099|FG004|Part A|Withdrawal by Subject|0|||
23650979|NCT02684357|66107100|FG005|Part A|Withdrawal by Subject|0|||
23650980|NCT02684357|66107095|FG000|Part A|Other|0|||
23650981|NCT02684357|66107096|FG001|Part A|Other|1|||
23650982|NCT02684357|66107097|FG002|Part A|Other|0|||
23650983|NCT02684357|66107098|FG003|Part A|Other|0|||
23650984|NCT02684357|66107099|FG004|Part A|Other|0|||
23650985|NCT02684357|66107100|FG005|Part A|Other|0|||
23650986|NCT02684357|66107095|FG000|Part B|Adverse Event (Other)|0|||
23650987|NCT02684357|66107096|FG001|Part B|Adverse Event (Other)|0|||
23650988|NCT02684357|66107097|FG002|Part B|Adverse Event (Other)|0|||
23650989|NCT02684357|66107098|FG003|Part B|Adverse Event (Other)|1|||
23650990|NCT02684357|66107099|FG004|Part B|Adverse Event (Other)|1|||
23650991|NCT02684357|66107100|FG005|Part B|Adverse Event (Other)|1|||
23650992|NCT02684357|66107095|FG000|Part B|Lost to Follow-up|0|||
23650993|NCT02684357|66107096|FG001|Part B|Lost to Follow-up|0|||
23650994|NCT02684357|66107097|FG002|Part B|Lost to Follow-up|0|||
23650995|NCT02684357|66107098|FG003|Part B|Lost to Follow-up|1|||
23650996|NCT02684357|66107099|FG004|Part B|Lost to Follow-up|1|||
23650997|NCT02684357|66107100|FG005|Part B|Lost to Follow-up|7|||
23650998|NCT02684357|66107095|FG000|Part B|Withdrawal by Subject|0|||
23650999|NCT02684357|66107096|FG001|Part B|Withdrawal by Subject|0|||
23651000|NCT02684357|66107097|FG002|Part B|Withdrawal by Subject|0|||
23651001|NCT02684357|66107098|FG003|Part B|Withdrawal by Subject|0|||
23651002|NCT02684357|66107099|FG004|Part B|Withdrawal by Subject|2|||
23651003|NCT02684357|66107100|FG005|Part B|Withdrawal by Subject|4|||
23651004|NCT02684357|66107095|FG000|Part B|Other|0|||
23651005|NCT02684357|66107096|FG001|Part B|Other|0|||
23651006|NCT02684357|66107097|FG002|Part B|Other|0|||
23651007|NCT02684357|66107098|FG003|Part B|Other|1|||
23651008|NCT02684357|66107099|FG004|Part B|Other|0|||
23651009|NCT02684357|66107100|FG005|Part B|Other|1|||
23651010|NCT03740997|66107104|FG000|Overall Study|Withdrawal by Subject|1|||
23651011|NCT03740997|66107105|FG001|Overall Study|Withdrawal by Subject|0|||
23651012|NCT03740997|66107104|FG000|Overall Study|Participant was unable to complete study procedures|1|||
23651013|NCT03740997|66107105|FG001|Overall Study|Participant was unable to complete study procedures|0|||
23651014|NCT04433585|66107106|FG000|Overall Study|Withdrawal by Subject|15|||
23651015|NCT04433585|66107107|FG001|Overall Study|Withdrawal by Subject|3|||
23651016|NCT04433585|66107108|FG002|Overall Study|Withdrawal by Subject|15|||
23651017|NCT04433585|66107109|FG003|Overall Study|Withdrawal by Subject|6|||
23651018|NCT04433585|66107106|FG000|Overall Study|Adverse Event|10|||
23651019|NCT04433585|66107107|FG001|Overall Study|Adverse Event|4|||
23651020|NCT04433585|66107108|FG002|Overall Study|Adverse Event|1|||
23651021|NCT04433585|66107109|FG003|Overall Study|Adverse Event|0|||
23651022|NCT04433585|66107106|FG000|Overall Study|Due to the conflict in Ukraine|2|||
23651023|NCT04433585|66107107|FG001|Overall Study|Due to the conflict in Ukraine|1|||
23651024|NCT04433585|66107108|FG002|Overall Study|Due to the conflict in Ukraine|1|||
23651025|NCT04433585|66107109|FG003|Overall Study|Due to the conflict in Ukraine|2|||
23651026|NCT04433585|66107106|FG000|Overall Study|Physician Decision|1|||
23651027|NCT04433585|66107107|FG001|Overall Study|Physician Decision|2|||
23651028|NCT04433585|66107108|FG002|Overall Study|Physician Decision|0|||
23651029|NCT04433585|66107109|FG003|Overall Study|Physician Decision|0|||
23651030|NCT04433585|66107106|FG000|Overall Study|Lost to Follow-up|1|||
23651031|NCT04433585|66107107|FG001|Overall Study|Lost to Follow-up|1|||
23651032|NCT04433585|66107108|FG002|Overall Study|Lost to Follow-up|1|||
23651033|NCT04433585|66107109|FG003|Overall Study|Lost to Follow-up|0|||
23651034|NCT04433585|66107106|FG000|Overall Study|Lack of Efficacy|0|||
23651035|NCT04433585|66107107|FG001|Overall Study|Lack of Efficacy|1|||
23651036|NCT04433585|66107108|FG002|Overall Study|Lack of Efficacy|1|||
23651037|NCT04433585|66107109|FG003|Overall Study|Lack of Efficacy|1|||
23651038|NCT04433585|66107106|FG000|Overall Study|Death|0|||
23651039|NCT04433585|66107107|FG001|Overall Study|Death|1|||
23651040|NCT04433585|66107108|FG002|Overall Study|Death|0|||
23651041|NCT04433585|66107109|FG003|Overall Study|Death|0|||
23801156|NCT05506358|66649911|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
23801157|NCT05506358|66649912|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
23801158|NCT05506358|66649908|FG000|Overall Study|HbE trait|0|||
23479320|NCT01403948|65498475|FG008|Overall Study|Refused cont. medication|0|||
23599047|NCT00277355|65922415|FG000|Overall Study|Lost to Follow-up|2|||
23599048|NCT00277355|65922416|FG001|Overall Study|Lost to Follow-up|2|||
23599049|NCT00277355|65922415|FG000|Overall Study|Adverse Event|5|||
23599050|NCT00277355|65922416|FG001|Overall Study|Adverse Event|0|||
23599051|NCT00277355|65922415|FG000|Overall Study|Death|3|||
23599052|NCT00277355|65922416|FG001|Overall Study|Death|0|||
23599053|NCT00277355|65922415|FG000|Overall Study|Physician Decision|1|||
23599054|NCT00277355|65922416|FG001|Overall Study|Physician Decision|0|||
23599055|NCT02919449|65922420|FG000|Overall Study|Withdrawal by Subject|1|||
23599056|NCT02919449|65922420|FG000|Overall Study|Investigator decision|1|||
23599057|NCT03801148|65922421|FG000|Period 1 (2 Days)|Adverse Event|1|||
23599058|NCT03801148|65922422|FG001|Period 1 (2 Days)|Adverse Event|1|||
23599059|NCT03801148|65922423|FG002|Period 1 (2 Days)|Adverse Event|0|||
23599060|NCT03801148|65922424|FG003|Period 1 (2 Days)|Adverse Event|0|||
23599061|NCT03801148|65922421|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599062|NCT03801148|65922422|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599063|NCT03801148|65922423|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599064|NCT03801148|65922424|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
23599065|NCT03801148|65922421|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599066|NCT03801148|65922422|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599067|NCT03801148|65922423|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23599068|NCT03801148|65922424|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599069|NCT03801148|65922421|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
23599070|NCT03801148|65922422|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
23599071|NCT03801148|65922423|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
23599072|NCT03801148|65922424|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
23599073|NCT00350792|65922433|FG000|Overall Study|Adverse Event|11|||
23599074|NCT00350792|65922433|FG000|Overall Study|Death from Study Disease|1|||
23599075|NCT00350792|65922433|FG000|Overall Study|Death from Study Drug Toxicity|1|||
23599076|NCT00350792|65922433|FG000|Overall Study|Death Not Study Drug Related|2|||
23599077|NCT00350792|65922433|FG000|Overall Study|Protocol Violation|1|||
23599078|NCT00350792|65922433|FG000|Overall Study|Withdrawal by Subject|4|||
23599079|NCT00350792|65922433|FG000|Overall Study|Physician Decision|2|||
23599080|NCT00350792|65922433|FG000|Overall Study|Lack of Efficacy|11|||
23599081|NCT02928172|65922434|FG000|Overall Study|Device did not record data|1|||
23599082|NCT01040689|65922435|FG000|Overall Study|Adverse Event|0|||
23599083|NCT01040689|65922436|FG001|Overall Study|Adverse Event|0|||
23599084|NCT01040689|65922437|FG002|Overall Study|Adverse Event|2|||
23599085|NCT01040689|65922438|FG003|Overall Study|Adverse Event|4|||
23599086|NCT01040689|65922435|FG000|Overall Study|Lack of Efficacy|0|||
23599087|NCT01040689|65922436|FG001|Overall Study|Lack of Efficacy|0|||
23599088|NCT01040689|65922437|FG002|Overall Study|Lack of Efficacy|1|||
23599089|NCT01040689|65922438|FG003|Overall Study|Lack of Efficacy|0|||
23599090|NCT01040689|65922435|FG000|Overall Study|Lost to Follow-up|1|||
23599091|NCT01040689|65922436|FG001|Overall Study|Lost to Follow-up|0|||
23599092|NCT01040689|65922437|FG002|Overall Study|Lost to Follow-up|0|||
23801159|NCT05506358|66649909|FG001|Overall Study|HbE trait|0|||
23801160|NCT05506358|66649910|FG002|Overall Study|HbE trait|0|||
23801161|NCT05506358|66649911|FG003|Overall Study|HbE trait|1|||
23801162|NCT05506358|66649912|FG004|Overall Study|HbE trait|0|||
23801163|NCT02087176|66649913|FG000|Overall Study|Withdrawal by Subject|1|||
23801164|NCT02087176|66649913|FG000|Overall Study|Death|10|||
23801165|NCT02087176|66649913|FG000|Overall Study|Censored|19|||
23801166|NCT02087176|66649913|FG000|Overall Study|Study Terminated by Sponsor|2|||
23801167|NCT01297322|66649914|FG000|Overall Study|Lost to Follow-up|1|||
23801168|NCT01297322|66649915|FG001|Overall Study|Lost to Follow-up|0|||
23801169|NCT01297322|66649914|FG000|Overall Study|Withdrawal by Subject|0|||
23801170|NCT01297322|66649915|FG001|Overall Study|Withdrawal by Subject|1|||
23801171|NCT01297322|66649914|FG000|Overall Study|Protocol Violation|0|||
23599093|NCT01040689|65922438|FG003|Overall Study|Lost to Follow-up|0|||
23599094|NCT01040689|65922435|FG000|Overall Study|Withdrawal by Subject|2|||
23651042|NCT00593957|66107113|FG000|Overall Study|Physician Decision|0|||
23651043|NCT00593957|66107114|FG001|Overall Study|Physician Decision|1|||
23801172|NCT01297322|66649915|FG001|Overall Study|Protocol Violation|3|||
23651044|NCT00593957|66107115|FG002|Overall Study|Physician Decision|2|||
23651045|NCT00852540|66107116|FG000|Overall Study|Adverse Event|10|||
23651046|NCT00852540|66107117|FG001|Overall Study|Adverse Event|3|||
23651047|NCT00852540|66107116|FG000|Overall Study|Lack of Efficacy|15|||
23651048|NCT00852540|66107117|FG001|Overall Study|Lack of Efficacy|3|||
23651049|NCT00852540|66107116|FG000|Overall Study|Protocol Violation|1|||
23651050|NCT00852540|66107117|FG001|Overall Study|Protocol Violation|2|||
23651051|NCT00852540|66107116|FG000|Overall Study|Lost to Follow-up|2|||
23651052|NCT00852540|66107117|FG001|Overall Study|Lost to Follow-up|3|||
23651053|NCT00852540|66107116|FG000|Overall Study|Investigator Discretion|2|||
23651054|NCT00852540|66107117|FG001|Overall Study|Investigator Discretion|3|||
23651055|NCT00852540|66107116|FG000|Overall Study|Withdrawal by Subject|3|||
23651056|NCT00852540|66107117|FG001|Overall Study|Withdrawal by Subject|1|||
23651057|NCT00852540|66107116|FG000|Overall Study|Did Not Receive Study Drug|3|||
23651058|NCT00852540|66107117|FG001|Overall Study|Did Not Receive Study Drug|3|||
23651059|NCT03371381|66107118|FG000|Overall Study|Death|5|||
23651060|NCT03371381|66107118|FG000|Overall Study|Study terminated by sponsor|3|||
23651061|NCT03371381|66107118|FG000|Overall Study|Other|4|||
23651062|NCT02434939|66107119|FG000|Overall Study|Lack of Efficacy|34|||
23651063|NCT02434939|66107120|FG001|Overall Study|Lack of Efficacy|48|||
23651064|NCT02434939|66107119|FG000|Overall Study|Withdrawal by Subject|3|||
23651065|NCT02434939|66107120|FG001|Overall Study|Withdrawal by Subject|0|||
23651066|NCT02434939|66107119|FG000|Overall Study|Adverse Event|0|||
23651067|NCT02434939|66107120|FG001|Overall Study|Adverse Event|1|||
23651068|NCT01001832|66107127|FG000|Short-term Period|Adverse Event|2|||
23651069|NCT01001832|66107128|FG001|Short-term Period|Adverse Event|3|||
23651070|NCT01001832|66107127|FG000|Long-term Period|Adverse Event|2|||
23651071|NCT01001832|66107128|FG001|Long-term Period|Adverse Event|1|||
23651072|NCT01001832|66107127|FG000|Long-term Period|Withdrawal by Subject|1|||
23651073|NCT01001832|66107128|FG001|Long-term Period|Withdrawal by Subject|0|||
23651074|NCT01001832|66107127|FG000|Long-term Period|Lack of Efficacy|0|||
23651075|NCT01001832|66107128|FG001|Long-term Period|Lack of Efficacy|2|||
23651076|NCT01001832|66107127|FG000|Long-term Period|Other|1|||
23651077|NCT01001832|66107128|FG001|Long-term Period|Other|2|||
23651078|NCT01001832|66107127|FG000|Follow-up Period|Withdrawal by Subject|1|||
23651079|NCT01001832|66107128|FG001|Follow-up Period|Withdrawal by Subject|0|||
23651080|NCT01001832|66107127|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
23651081|NCT01001832|66107128|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
23651082|NCT01001832|66107127|FG000|Follow-up Period|Other|2|||
23651083|NCT01001832|66107128|FG001|Follow-up Period|Other|1|||
23651084|NCT00971932|66107129|FG000|Overall Study|Withdrawal by Subject|1|||
23651085|NCT00971932|66107129|FG000|Overall Study|Investigator's decision|2|||
23651086|NCT00971932|66107129|FG000|Overall Study|Ongoing|4|||
23651087|NCT01030198|66107130|FG000|Overall Study|Could not measure efficacy accurately|0|||
23599095|NCT01040689|65922436|FG001|Overall Study|Withdrawal by Subject|1|||
23599096|NCT01040689|65922437|FG002|Overall Study|Withdrawal by Subject|1|||
23599097|NCT01040689|65922438|FG003|Overall Study|Withdrawal by Subject|0|||
23599098|NCT01040689|65922435|FG000|Overall Study|Other reasons not listed above|0|||
23599099|NCT01040689|65922436|FG001|Overall Study|Other reasons not listed above|1|||
23599100|NCT01040689|65922437|FG002|Overall Study|Other reasons not listed above|0|||
23599101|NCT01040689|65922438|FG003|Overall Study|Other reasons not listed above|0|||
23599102|NCT00680771|65922441|FG000|Overall Study|Withdrawal by Subject|1|||
23599103|NCT00680771|65922442|FG001|Overall Study|Withdrawal by Subject|0|||
23599104|NCT00680771|65922441|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
23599105|NCT00680771|65922442|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
23599106|NCT00680771|65922441|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
23599107|NCT00680771|65922442|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
23651088|NCT01030198|66107131|FG001|Overall Study|Could not measure efficacy accurately|7|||
23651089|NCT00332189|66107132|FG000|Overall Study|Adverse Event|3|||
23651090|NCT00332189|66107132|FG000|Overall Study|Uncooperative/Noncompliant|3|||
23651091|NCT00332189|66107132|FG000|Overall Study|Withdrawal by Subject|9|||
23651092|NCT00332189|66107132|FG000|Overall Study|Lack of Efficacy|4|||
23651093|NCT00332189|66107132|FG000|Overall Study|Moved out of country|2|||
23651094|NCT03588728|66107133|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
23651095|NCT03588728|66107134|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
23599108|NCT02252042|65922443|FG000|Overall Study|Adverse Event|9|||
23599109|NCT02252042|65922444|FG001|Overall Study|Adverse Event|6|||
23599110|NCT02252042|65922443|FG000|Overall Study|Death|209|||
23599111|NCT02252042|65922444|FG001|Overall Study|Death|217|||
23651096|NCT03588728|66107135|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
23651097|NCT03588728|66107136|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
23651098|NCT03588728|66107133|FG000|Overall Study|Lab shut down due to COVID-19|0|||
23651099|NCT03588728|66107134|FG001|Overall Study|Lab shut down due to COVID-19|0|||
23651100|NCT03588728|66107135|FG002|Overall Study|Lab shut down due to COVID-19|0|||
23651101|NCT03588728|66107136|FG003|Overall Study|Lab shut down due to COVID-19|1|||
23651102|NCT03588728|66107133|FG000|Overall Study|multiple technical issues|1|||
23651103|NCT03588728|66107134|FG001|Overall Study|multiple technical issues|0|||
23651104|NCT03588728|66107135|FG002|Overall Study|multiple technical issues|0|||
23651105|NCT03588728|66107136|FG003|Overall Study|multiple technical issues|0|||
23651106|NCT03588728|66107133|FG000|Overall Study|Hospitalized for COVID|1|||
23651107|NCT03588728|66107134|FG001|Overall Study|Hospitalized for COVID|0|||
23651108|NCT03588728|66107135|FG002|Overall Study|Hospitalized for COVID|0|||
23651109|NCT03588728|66107136|FG003|Overall Study|Hospitalized for COVID|0|||
23651110|NCT03588728|66107133|FG000|Overall Study|Schedule change unable to attend sessions|1|||
23651111|NCT03588728|66107134|FG001|Overall Study|Schedule change unable to attend sessions|0|||
23651112|NCT03588728|66107135|FG002|Overall Study|Schedule change unable to attend sessions|0|||
23651113|NCT03588728|66107136|FG003|Overall Study|Schedule change unable to attend sessions|0|||
23651114|NCT02057523|66107137|FG000|Overall Study|Withdrawal by Subject|1|||
23651115|NCT02057523|66107137|FG000|Overall Study|Lack of Efficacy|1|||
23651116|NCT02647866|66107138|FG000|Overall Study|Adverse Event|0|||
23651117|NCT02647866|66107139|FG001|Overall Study|Adverse Event|0|||
23651118|NCT02647866|66107140|FG002|Overall Study|Adverse Event|2|||
23651119|NCT02647866|66107141|FG003|Overall Study|Adverse Event|2|||
23651120|NCT02647866|66107142|FG004|Overall Study|Adverse Event|1|||
23651121|NCT02647866|66107138|FG000|Overall Study|Disease Worsening|3|||
23651122|NCT02647866|66107139|FG001|Overall Study|Disease Worsening|1|||
23651123|NCT02647866|66107140|FG002|Overall Study|Disease Worsening|0|||
23651124|NCT02647866|66107141|FG003|Overall Study|Disease Worsening|0|||
23651125|NCT02647866|66107142|FG004|Overall Study|Disease Worsening|1|||
23651126|NCT02647866|66107138|FG000|Overall Study|Withdrawal by Subject|1|||
23651127|NCT02647866|66107139|FG001|Overall Study|Withdrawal by Subject|1|||
23651128|NCT02647866|66107140|FG002|Overall Study|Withdrawal by Subject|2|||
23651129|NCT02647866|66107141|FG003|Overall Study|Withdrawal by Subject|4|||
23651130|NCT02647866|66107142|FG004|Overall Study|Withdrawal by Subject|4|||
23651131|NCT02647866|66107138|FG000|Overall Study|Physician Decision|0|||
23651132|NCT02647866|66107139|FG001|Overall Study|Physician Decision|1|||
23651133|NCT02647866|66107140|FG002|Overall Study|Physician Decision|1|||
23479321|NCT01403948|65498476|FG009|Overall Study|Refused cont. medication|1|||
23479322|NCT01403948|65498467|FG000|Overall Study|other than above|1|||
23651134|NCT02647866|66107141|FG003|Overall Study|Physician Decision|0|||
23651135|NCT02647866|66107142|FG004|Overall Study|Physician Decision|2|||
23651136|NCT02647866|66107138|FG000|Overall Study|Death|0|||
23651137|NCT02647866|66107139|FG001|Overall Study|Death|1|||
23651138|NCT02647866|66107140|FG002|Overall Study|Death|0|||
23651139|NCT02647866|66107141|FG003|Overall Study|Death|0|||
23651140|NCT02647866|66107142|FG004|Overall Study|Death|0|||
23651141|NCT02647866|66107138|FG000|Overall Study|Subject moved to different country|1|||
23651142|NCT02647866|66107139|FG001|Overall Study|Subject moved to different country|0|||
23651143|NCT02647866|66107140|FG002|Overall Study|Subject moved to different country|0|||
23651144|NCT02647866|66107141|FG003|Overall Study|Subject moved to different country|0|||
23651145|NCT02647866|66107142|FG004|Overall Study|Subject moved to different country|0|||
23651146|NCT00069238|66107148|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
23651147|NCT00069238|66107149|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
23651148|NCT00069238|66107150|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
23651149|NCT00069238|66107148|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
23651150|NCT00069238|66107149|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
23651151|NCT00069238|66107150|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
23651152|NCT00069238|66107148|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
23651153|NCT00069238|66107149|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
23651154|NCT00069238|66107150|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
23651155|NCT00701220|66107154|FG000|Overall Study|Withdrawal by Subject|0|||
23651156|NCT00701220|66107155|FG001|Overall Study|Withdrawal by Subject|2|||
23651157|NCT00701220|66107154|FG000|Overall Study|Protocol Violation|2|||
23651158|NCT00701220|66107155|FG001|Overall Study|Protocol Violation|0|||
23651159|NCT00743275|66107156|FG000|Overall Study|Protocol Violation|0|||
23651160|NCT00743275|66107157|FG001|Overall Study|Protocol Violation|1|||
23651161|NCT00838929|66107158|FG000|Overall Study|Protocol Violation|0|||
23651162|NCT00838929|66107159|FG001|Overall Study|Protocol Violation|1|||
23651163|NCT00838929|66107160|FG002|Overall Study|Protocol Violation|0|||
23651164|NCT00838929|66107158|FG000|Overall Study|Disease progression|0|||
23651165|NCT00838929|66107159|FG001|Overall Study|Disease progression|2|||
23651166|NCT00838929|66107160|FG002|Overall Study|Disease progression|1|||
23651167|NCT03646656|66107161|FG000|Overall Study|Lost to Follow-up|1|||
23479323|NCT01403948|65498468|FG001|Overall Study|other than above|2|||
23651168|NCT03646656|66107162|FG001|Overall Study|Lost to Follow-up|0|||
23651169|NCT03646656|66107161|FG000|Overall Study|Withdrawal by Subject|2|||
23651170|NCT03646656|66107162|FG001|Overall Study|Withdrawal by Subject|0|||
23651171|NCT00221195|66107163|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
23651172|NCT00221195|66107164|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
23651173|NCT00221195|66107163|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
23651174|NCT00221195|66107164|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
23651175|NCT00221195|66107163|FG000|Washout Period (Months 7-9)|Death|0|||
23651176|NCT00221195|66107164|FG001|Washout Period (Months 7-9)|Death|1|||
23651177|NCT00221195|66107163|FG000|Therapy 2 (Months 10-15)|Death|1|||
23651178|NCT00221195|66107164|FG001|Therapy 2 (Months 10-15)|Death|0|||
23651179|NCT00221195|66107163|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
23651180|NCT00221195|66107164|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
23651181|NCT00093808|66107172|FG000|Overall Study|Cancel participation before receiving tx|1|||
23651182|NCT00093808|66107172|FG000|Overall Study|Protocol Violation|1|||
23651183|NCT01658150|66107173|FG000|Overall Study|Withdrawal by Subject|1|||
23651184|NCT00448123|66107174|FG000|Overall Study|Lost to Follow-up|9|||
23651185|NCT00448123|66107175|FG001|Overall Study|Lost to Follow-up|6|||
23651186|NCT00448123|66107174|FG000|Overall Study|Physician Decision|6|||
23651187|NCT00448123|66107175|FG001|Overall Study|Physician Decision|6|||
23651188|NCT00203476|66107181|FG000|Overall Study|Lost to Follow-up|1|||
23651189|NCT00203476|66107182|FG001|Overall Study|Lost to Follow-up|0|||
23651190|NCT00203476|66107183|FG002|Overall Study|Lost to Follow-up|0|||
23651191|NCT00203476|66107181|FG000|Overall Study|Withdrawal by Subject|0|||
23651192|NCT00203476|66107182|FG001|Overall Study|Withdrawal by Subject|1|||
23651193|NCT00203476|66107183|FG002|Overall Study|Withdrawal by Subject|0|||
23651194|NCT01388790|66107184|FG000|Overall Study|Ongoing at data cut-off date|8|||
23651195|NCT05105789|66107185|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
23651196|NCT01440374|66107188|FG000|Part 1: Open-label Phase|Adverse Event|5|||
23651197|NCT01440374|66107189|FG001|Part 1: Open-label Phase|Adverse Event|0|||
23651198|NCT01440374|66107190|FG002|Part 1: Open-label Phase|Adverse Event|0|||
23651199|NCT01440374|66107191|FG003|Part 1: Open-label Phase|Adverse Event|0|||
23651200|NCT01440374|66107188|FG000|Part 1: Open-label Phase|Physician Decision|1|||
23651201|NCT01440374|66107189|FG001|Part 1: Open-label Phase|Physician Decision|0|||
23651202|NCT01440374|66107190|FG002|Part 1: Open-label Phase|Physician Decision|0|||
23651203|NCT01440374|66107191|FG003|Part 1: Open-label Phase|Physician Decision|0|||
23651204|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
23651205|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
23651206|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
23651207|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
23651208|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
23651209|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
23599112|NCT02252042|65922443|FG000|Overall Study|Physician Decision|0|||
23599113|NCT02252042|65922444|FG001|Overall Study|Physician Decision|2|||
23599114|NCT02252042|65922443|FG000|Overall Study|Transferred to Extension Study|7|||
23599115|NCT02252042|65922444|FG001|Overall Study|Transferred to Extension Study|1|||
23599116|NCT02252042|65922443|FG000|Overall Study|Did Not Continue on Extension Study|7|||
23599117|NCT02252042|65922444|FG001|Overall Study|Did Not Continue on Extension Study|2|||
23599118|NCT02252042|65922443|FG000|Overall Study|Withdrawal by Subject|15|||
23599119|NCT02252042|65922444|FG001|Overall Study|Withdrawal by Subject|20|||
23599120|NCT02698475|65922445|FG000|Main Study Period|Lack of Efficacy|1|||
23599121|NCT02698475|65922445|FG000|Main Study Period|Protocol Violation|2|||
23599122|NCT02698475|65922445|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
23651210|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
23651211|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
23651212|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
23651213|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
23651214|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
23651215|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
23599123|NCT02698475|65922445|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
23651216|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23651217|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
23599124|NCT02698475|65922445|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
23599125|NCT02698475|65922445|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
23599126|NCT02698475|65922445|FG000|Long-Term Extension Period|Other|1|||
23599127|NCT01629589|65922456|FG000|Overall Study|Protocol Violation|4|||
23599128|NCT01629589|65922457|FG001|Overall Study|Protocol Violation|2|||
23599129|NCT01629589|65922456|FG000|Overall Study|Lost to Follow-up|2|||
23599130|NCT01629589|65922457|FG001|Overall Study|Lost to Follow-up|1|||
23599131|NCT01629589|65922456|FG000|Overall Study|Withdrawal by Subject|2|||
23360690|NCT00540644|65065865|FG000|Overall Study|Physician Decision|0|||
23360691|NCT00540644|65065866|FG001|Overall Study|Physician Decision|5|||
23360692|NCT00540644|65065865|FG000|Overall Study|Withdrawal by Subject|2|||
23360693|NCT00540644|65065866|FG001|Overall Study|Withdrawal by Subject|2|||
23360694|NCT00540644|65065865|FG000|Overall Study|Noncomplilance|1|||
23360695|NCT00540644|65065866|FG001|Overall Study|Noncomplilance|0|||
23360696|NCT01004978|65065867|FG000|Overall Study|Disease progression|31|||
23360697|NCT01004978|65065868|FG001|Overall Study|Disease progression|48|||
23360698|NCT01004978|65065867|FG000|Overall Study|Adverse Event|42|||
23360699|NCT01004978|65065868|FG001|Overall Study|Adverse Event|22|||
23360700|NCT01004978|65065867|FG000|Overall Study|Death|3|||
23360701|NCT01004978|65065868|FG001|Overall Study|Death|2|||
23360702|NCT01004978|65065867|FG000|Overall Study|Withdrawal by Subject|16|||
23360703|NCT01004978|65065868|FG001|Overall Study|Withdrawal by Subject|16|||
23360704|NCT01004978|65065867|FG000|Overall Study|Alternative therapy|4|||
23360705|NCT01004978|65065868|FG001|Overall Study|Alternative therapy|8|||
23360706|NCT01004978|65065867|FG000|Overall Study|Physician Decision|6|||
23360707|NCT01004978|65065868|FG001|Overall Study|Physician Decision|3|||
23360708|NCT01004978|65065867|FG000|Overall Study|Other complicating disease|2|||
23360709|NCT01004978|65065868|FG001|Overall Study|Other complicating disease|2|||
23360710|NCT01004978|65065867|FG000|Overall Study|Protocol Violation|2|||
23360711|NCT01004978|65065868|FG001|Overall Study|Protocol Violation|3|||
23360712|NCT01004978|65065867|FG000|Overall Study|Non-compliance|3|||
23360713|NCT01004978|65065868|FG001|Overall Study|Non-compliance|2|||
23360714|NCT01004978|65065867|FG000|Overall Study|Ineligible|1|||
23360715|NCT01004978|65065868|FG001|Overall Study|Ineligible|0|||
23360716|NCT01004978|65065867|FG000|Overall Study|Unblinded|0|||
23360717|NCT01004978|65065868|FG001|Overall Study|Unblinded|1|||
23360718|NCT01004978|65065867|FG000|Overall Study|Performance status worsening|0|||
23360719|NCT01004978|65065868|FG001|Overall Study|Performance status worsening|1|||
23360720|NCT01004978|65065867|FG000|Overall Study|Never started treatment|8|||
23360721|NCT01004978|65065868|FG001|Overall Study|Never started treatment|9|||
23360722|NCT01827592|65065869|FG000|Overall Study|Adverse Event|11|||
23360723|NCT01827592|65065870|FG001|Overall Study|Adverse Event|9|||
23360724|NCT01827592|65065871|FG002|Overall Study|Adverse Event|2|||
23360725|NCT01827592|65065869|FG000|Overall Study|Physician Decision|0|||
23360726|NCT01827592|65065870|FG001|Overall Study|Physician Decision|2|||
23360727|NCT01827592|65065871|FG002|Overall Study|Physician Decision|1|||
23360728|NCT01827592|65065869|FG000|Overall Study|Protocol Violation|2|||
23360729|NCT01827592|65065870|FG001|Overall Study|Protocol Violation|1|||
23360730|NCT01827592|65065871|FG002|Overall Study|Protocol Violation|0|||
23360731|NCT01827592|65065869|FG000|Overall Study|Lost to Follow-up|1|||
23360732|NCT01827592|65065870|FG001|Overall Study|Lost to Follow-up|2|||
23360733|NCT01827592|65065871|FG002|Overall Study|Lost to Follow-up|2|||
23599132|NCT01629589|65922457|FG001|Overall Study|Withdrawal by Subject|3|||
23360734|NCT01827592|65065869|FG000|Overall Study|Withdrawal by Subject|12|||
23360735|NCT01827592|65065870|FG001|Overall Study|Withdrawal by Subject|11|||
23360736|NCT01827592|65065871|FG002|Overall Study|Withdrawal by Subject|11|||
23360737|NCT01827592|65065869|FG000|Overall Study|Patient's substantial non-compliance|1|||
23360738|NCT01827592|65065870|FG001|Overall Study|Patient's substantial non-compliance|1|||
23360739|NCT01827592|65065871|FG002|Overall Study|Patient's substantial non-compliance|6|||
23651218|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23651219|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23651220|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
23651221|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
23651222|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
23651223|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
23651224|NCT01440374|66107188|FG000|Part 2; Double-blind Phase|Not treated|0|||
23651225|NCT01440374|66107189|FG001|Part 2; Double-blind Phase|Not treated|0|||
23651226|NCT01440374|66107190|FG002|Part 2; Double-blind Phase|Not treated|1|||
23651227|NCT01440374|66107191|FG003|Part 2; Double-blind Phase|Not treated|0|||
23651228|NCT01440374|66107188|FG000|Part 3: Extension|Withdrawal by Subject|0|||
23651229|NCT01440374|66107189|FG001|Part 3: Extension|Withdrawal by Subject|0|||
23651230|NCT01440374|66107190|FG002|Part 3: Extension|Withdrawal by Subject|0|||
23651231|NCT01440374|66107191|FG003|Part 3: Extension|Withdrawal by Subject|5|||
23651232|NCT01440374|66107188|FG000|Part 3: Extension|Adverse Event|0|||
23651233|NCT01440374|66107189|FG001|Part 3: Extension|Adverse Event|0|||
23651234|NCT01440374|66107190|FG002|Part 3: Extension|Adverse Event|0|||
23651235|NCT01440374|66107191|FG003|Part 3: Extension|Adverse Event|13|||
23651236|NCT01440374|66107188|FG000|Part 3: Extension|Physician Decision|0|||
23651237|NCT01440374|66107189|FG001|Part 3: Extension|Physician Decision|0|||
23651238|NCT01440374|66107190|FG002|Part 3: Extension|Physician Decision|0|||
23651239|NCT01440374|66107191|FG003|Part 3: Extension|Physician Decision|14|||
23651240|NCT00705523|66107194|FG000|Overall Study|Lost to Follow-up|2|||
23651241|NCT00705523|66107195|FG001|Overall Study|Lost to Follow-up|3|||
23651242|NCT04964414|66107196|FG000|Overall Study|Lost to Follow-up|10|||
23651243|NCT04964414|66107197|FG001|Overall Study|Lost to Follow-up|8|||
23651244|NCT04964414|66107196|FG000|Overall Study|Withdrawal by Subject|1|||
23651245|NCT04964414|66107197|FG001|Overall Study|Withdrawal by Subject|1|||
23651246|NCT01672723|66107198|FG000|First Intervention|Adverse Event|3|||
23651247|NCT01672723|66107199|FG001|First Intervention|Adverse Event|0|||
23651248|NCT00007345|66107200|FG000|Overall Study|Refused further treatment|0|||
23801173|NCT03253094|66649916|FG000|Overall Study|Adverse Event|2|||
23801174|NCT03253094|66649917|FG001|Overall Study|Adverse Event|0|||
23801175|NCT03253094|66649918|FG002|Overall Study|Adverse Event|0|||
23801176|NCT03253094|66649919|FG003|Overall Study|Adverse Event|0|||
23801177|NCT03253094|66649920|FG004|Overall Study|Adverse Event|0|||
23801178|NCT03253094|66649921|FG005|Overall Study|Adverse Event|0|||
23801179|NCT03253094|66649916|FG000|Overall Study|Lack of Efficacy|0|||
23801180|NCT03253094|66649917|FG001|Overall Study|Lack of Efficacy|0|||
23801181|NCT03253094|66649918|FG002|Overall Study|Lack of Efficacy|2|||
23801182|NCT03253094|66649919|FG003|Overall Study|Lack of Efficacy|1|||
23801183|NCT03253094|66649920|FG004|Overall Study|Lack of Efficacy|2|||
23801184|NCT03253094|66649921|FG005|Overall Study|Lack of Efficacy|1|||
23801185|NCT03253094|66649916|FG000|Overall Study|Lost to Follow-up|0|||
23801186|NCT03253094|66649917|FG001|Overall Study|Lost to Follow-up|0|||
23801187|NCT03253094|66649918|FG002|Overall Study|Lost to Follow-up|1|||
23801188|NCT03253094|66649919|FG003|Overall Study|Lost to Follow-up|1|||
23801189|NCT03253094|66649920|FG004|Overall Study|Lost to Follow-up|0|||
23801190|NCT03253094|66649921|FG005|Overall Study|Lost to Follow-up|1|||
23801191|NCT03253094|66649916|FG000|Overall Study|Physician Decision|1|||
23801192|NCT03253094|66649917|FG001|Overall Study|Physician Decision|0|||
23801193|NCT03253094|66649918|FG002|Overall Study|Physician Decision|0|||
23801194|NCT03253094|66649919|FG003|Overall Study|Physician Decision|1|||
23801195|NCT03253094|66649920|FG004|Overall Study|Physician Decision|0|||
23801196|NCT03253094|66649921|FG005|Overall Study|Physician Decision|2|||
23801197|NCT03253094|66649916|FG000|Overall Study|Withdrawal by Subject|1|||
23801198|NCT03253094|66649917|FG001|Overall Study|Withdrawal by Subject|2|||
23801199|NCT03253094|66649918|FG002|Overall Study|Withdrawal by Subject|1|||
23801200|NCT03253094|66649919|FG003|Overall Study|Withdrawal by Subject|0|||
23801201|NCT03253094|66649920|FG004|Overall Study|Withdrawal by Subject|3|||
23801202|NCT03253094|66649921|FG005|Overall Study|Withdrawal by Subject|0|||
23651249|NCT00007345|66107201|FG001|Overall Study|Refused further treatment|7|||
23651250|NCT00007345|66107200|FG000|Overall Study|Switched to alternative treatment|0|||
23651251|NCT00007345|66107201|FG001|Overall Study|Switched to alternative treatment|3|||
23479324|NCT01403948|65498469|FG002|Overall Study|other than above|1|||
23651252|NCT00007345|66107200|FG000|Overall Study|Intercurrent illness|1|||
23651253|NCT00007345|66107201|FG001|Overall Study|Intercurrent illness|0|||
23651254|NCT00007345|66107200|FG000|Overall Study|Death on study|1|||
23801203|NCT03253094|66649916|FG000|Overall Study|Other|0|||
23801204|NCT03253094|66649917|FG001|Overall Study|Other|1|||
23651255|NCT00007345|66107201|FG001|Overall Study|Death on study|1|||
23651256|NCT01146054|66107202|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
23651257|NCT01146054|66107202|FG000|Overall Study|Rapid tumor progression|2|||
23651258|NCT01146054|66107202|FG000|Overall Study|Other illness precluded treatment|2|||
23651259|NCT01146054|66107202|FG000|Overall Study|Lost to Follow-up|1|||
23651260|NCT01211522|66107203|FG000|Overall Study|Withdrawal by Subject|3|||
23651261|NCT01211522|66107204|FG001|Overall Study|Withdrawal by Subject|7|||
23651262|NCT01211522|66107205|FG002|Overall Study|Withdrawal by Subject|5|||
23651263|NCT01664598|66107206|FG000|Overall Study|Sponsor Decision|1|||
23651264|NCT01664598|66107206|FG000|Overall Study|Withdrawal of Informed Consent|4|||
23651265|NCT01664598|66107206|FG000|Overall Study|Adverse Event|1|||
23651266|NCT03486457|66107209|FG000|Up to Month 3|Adverse Event|2|||
23651267|NCT03486457|66107210|FG001|Up to Month 3|Adverse Event|5|||
23651268|NCT03486457|66107209|FG000|Up to Month 3|Lack of Efficacy|1|||
23651269|NCT03486457|66107210|FG001|Up to Month 3|Lack of Efficacy|0|||
23651270|NCT03486457|66107209|FG000|Up to Month 3|Withdrawal by Subject|1|||
23651271|NCT03486457|66107210|FG001|Up to Month 3|Withdrawal by Subject|0|||
23651272|NCT03486457|66107209|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
23651273|NCT03486457|66107210|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
23651274|NCT03486457|66107209|FG000|Up to Month 3|Other|1|||
23651275|NCT03486457|66107210|FG001|Up to Month 3|Other|0|||
23651276|NCT03486457|66107209|FG000|Month 3 to Month 6|Adverse Event|2|||
23651277|NCT03486457|66107210|FG001|Month 3 to Month 6|Adverse Event|0|||
23651278|NCT03486457|66107209|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
23651279|NCT03486457|66107210|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
23651280|NCT03486457|66107209|FG000|Month 3 to Month 6|Pregnancy|0|||
23651281|NCT03486457|66107210|FG001|Month 3 to Month 6|Pregnancy|1|||
23651282|NCT03486457|66107209|FG000|Month 3 to Month 6|Other|1|||
23651283|NCT03486457|66107210|FG001|Month 3 to Month 6|Other|0|||
23651284|NCT03357952|66107211|FG000|Overall Study|Withdrawal by Subject|0|||
23651285|NCT03357952|66107212|FG001|Overall Study|Withdrawal by Subject|1|||
23651286|NCT03357952|66107211|FG000|Overall Study|Sponsor Decision|9|||
23651287|NCT03357952|66107212|FG001|Overall Study|Sponsor Decision|0|||
23651288|NCT01100034|66107215|FG000|Overall Study|Lost to Follow-up|11|||
23651289|NCT01100034|66107215|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
23651290|NCT01100034|66107215|FG000|Overall Study|Withdrawal by Subject|4|||
23651291|NCT01100034|66107215|FG000|Overall Study|Sponsor decision|21|||
23651292|NCT01100034|66107215|FG000|Overall Study|Participated in another clinical trial|1|||
23651293|NCT01100034|66107215|FG000|Overall Study|Participants moved to another hospital|4|||
23651294|NCT01100034|66107215|FG000|Overall Study|Site closed due to non-responsiveness|1|||
23651295|NCT00381303|66107217|FG000|Overall Study|Lost to Follow-up|25|||
23651296|NCT00381303|66107218|FG001|Overall Study|Lost to Follow-up|9|||
23651297|NCT00381303|66107217|FG000|Overall Study|AE/HIV-related event|22|||
23651298|NCT00381303|66107218|FG001|Overall Study|AE/HIV-related event|6|||
23651299|NCT00381303|66107217|FG000|Overall Study|Non-Adherence|13|||
23651300|NCT00381303|66107218|FG001|Overall Study|Non-Adherence|6|||
23651301|NCT00381303|66107217|FG000|Overall Study|Withdrawal by Subject|13|||
23651302|NCT00381303|66107218|FG001|Overall Study|Withdrawal by Subject|6|||
23651303|NCT00381303|66107217|FG000|Overall Study|Virologic failure|6|||
23651304|NCT00381303|66107218|FG001|Overall Study|Virologic failure|4|||
23651305|NCT00381303|66107217|FG000|Overall Study|Ineligible to continue the trial|2|||
23651306|NCT00381303|66107218|FG001|Overall Study|Ineligible to continue the trial|1|||
23651307|NCT00381303|66107217|FG000|Overall Study|Pregnancy|2|||
23651308|NCT00381303|66107218|FG001|Overall Study|Pregnancy|0|||
23651309|NCT00381303|66107217|FG000|Overall Study|Physician Decision|1|||
23651310|NCT00381303|66107218|FG001|Overall Study|Physician Decision|0|||
23651311|NCT00381303|66107217|FG000|Overall Study|Physician's decision to close the site|3|||
23651312|NCT00381303|66107218|FG001|Overall Study|Physician's decision to close the site|1|||
23651313|NCT00381303|66107217|FG000|Overall Study|Subject moved out of state|2|||
23651314|NCT00381303|66107218|FG001|Overall Study|Subject moved out of state|0|||
23651315|NCT00381303|66107217|FG000|Overall Study|Subject taking too many different meds|1|||
23651316|NCT00381303|66107218|FG001|Overall Study|Subject taking too many different meds|0|||
23651317|NCT00381303|66107217|FG000|Overall Study|No virologic response by week 12|1|||
23651318|NCT00381303|66107218|FG001|Overall Study|No virologic response by week 12|0|||
23479325|NCT01403948|65498470|FG003|Overall Study|other than above|0|||
23651319|NCT00381303|66107217|FG000|Overall Study|Subject was too busy for appointments|1|||
23651320|NCT00381303|66107218|FG001|Overall Study|Subject was too busy for appointments|0|||
23651321|NCT00381303|66107217|FG000|Overall Study|Subject did not continue visits|1|||
23651322|NCT00381303|66107218|FG001|Overall Study|Subject did not continue visits|0|||
23651323|NCT00381303|66107217|FG000|Overall Study|Subject primary physician's decision|1|||
23651324|NCT00381303|66107218|FG001|Overall Study|Subject primary physician's decision|0|||
23651325|NCT02070588|66107230|FG000|Overall Study|Withdrawal by Subject|29|||
23651326|NCT02070588|66107231|FG001|Overall Study|Withdrawal by Subject|1|||
23651327|NCT02070588|66107232|FG002|Overall Study|Withdrawal by Subject|0|||
23651328|NCT02070588|66107230|FG000|Overall Study|Writhdrawal due to early termination|9|||
23651329|NCT02070588|66107231|FG001|Overall Study|Writhdrawal due to early termination|0|||
23651330|NCT02070588|66107232|FG002|Overall Study|Writhdrawal due to early termination|0|||
23651331|NCT02070588|66107230|FG000|Overall Study|Adverse Event|1|||
23651332|NCT02070588|66107231|FG001|Overall Study|Adverse Event|0|||
23651333|NCT02070588|66107232|FG002|Overall Study|Adverse Event|0|||
23651334|NCT01037244|66107233|FG000|Overall Study|Adverse Event|3|||
23651335|NCT01037244|66107234|FG001|Overall Study|Adverse Event|2|||
23651336|NCT01037244|66107235|FG002|Overall Study|Adverse Event|6|||
23651337|NCT01037244|66107236|FG003|Overall Study|Adverse Event|3|||
23651338|NCT01037244|66107233|FG000|Overall Study|Lack of Efficacy|1|||
23651339|NCT01037244|66107234|FG001|Overall Study|Lack of Efficacy|1|||
23651340|NCT01037244|66107235|FG002|Overall Study|Lack of Efficacy|0|||
23651341|NCT01037244|66107236|FG003|Overall Study|Lack of Efficacy|1|||
23651342|NCT01037244|66107233|FG000|Overall Study|Lost to Follow-up|3|||
23651343|NCT01037244|66107234|FG001|Overall Study|Lost to Follow-up|3|||
23651344|NCT01037244|66107235|FG002|Overall Study|Lost to Follow-up|4|||
23651345|NCT01037244|66107236|FG003|Overall Study|Lost to Follow-up|4|||
23651346|NCT01037244|66107233|FG000|Overall Study|Withdrawal by Subject|1|||
23651347|NCT01037244|66107234|FG001|Overall Study|Withdrawal by Subject|5|||
23651348|NCT01037244|66107235|FG002|Overall Study|Withdrawal by Subject|3|||
23651349|NCT01037244|66107236|FG003|Overall Study|Withdrawal by Subject|5|||
23651350|NCT01037244|66107233|FG000|Overall Study|Partner Withdrew Consent|2|||
23651351|NCT01037244|66107234|FG001|Overall Study|Partner Withdrew Consent|1|||
23651352|NCT01037244|66107235|FG002|Overall Study|Partner Withdrew Consent|0|||
23651353|NCT01037244|66107236|FG003|Overall Study|Partner Withdrew Consent|0|||
23651354|NCT01037244|66107233|FG000|Overall Study|Various|3|||
23651355|NCT01037244|66107234|FG001|Overall Study|Various|2|||
23651356|NCT01037244|66107235|FG002|Overall Study|Various|1|||
23651357|NCT01037244|66107236|FG003|Overall Study|Various|1|||
23651358|NCT01026454|66107237|FG000|Second Intervention|Pregnancy|1|||
23651359|NCT01026454|66107238|FG001|Second Intervention|Pregnancy|1|||
23651360|NCT01640054|66107239|FG000|Overall Study|Study-specific disc criteria|1|||
23651361|NCT01640054|66107239|FG000|Overall Study|Lack of Efficacy|3|||
23651362|NCT01640054|66107239|FG000|Overall Study|Adverse Event|2|||
23651363|NCT01003990|66107240|FG000|Overall Study|Adverse Event|8|||
23651364|NCT01003990|66107241|FG001|Overall Study|Adverse Event|5|||
23651365|NCT01003990|66107242|FG002|Overall Study|Adverse Event|11|||
23651366|NCT01003990|66107240|FG000|Overall Study|Death|0|||
23651367|NCT01003990|66107241|FG001|Overall Study|Death|8|||
23651368|NCT01003990|66107242|FG002|Overall Study|Death|1|||
23651369|NCT01003990|66107240|FG000|Overall Study|Lack of Efficacy|10|||
23651370|NCT01003990|66107241|FG001|Overall Study|Lack of Efficacy|2|||
23651371|NCT01003990|66107242|FG002|Overall Study|Lack of Efficacy|3|||
23651372|NCT01003990|66107240|FG000|Overall Study|Lost to Follow-up|30|||
23651373|NCT01003990|66107241|FG001|Overall Study|Lost to Follow-up|12|||
23651374|NCT01003990|66107242|FG002|Overall Study|Lost to Follow-up|7|||
23651375|NCT01003990|66107240|FG000|Overall Study|Reasons Not Identified|14|||
23651376|NCT01003990|66107241|FG001|Overall Study|Reasons Not Identified|13|||
23651377|NCT01003990|66107242|FG002|Overall Study|Reasons Not Identified|8|||
23651378|NCT01003990|66107240|FG000|Overall Study|Poor/Non-compliance|4|||
23651379|NCT01003990|66107241|FG001|Overall Study|Poor/Non-compliance|3|||
23651380|NCT01003990|66107242|FG002|Overall Study|Poor/Non-compliance|2|||
23651381|NCT01003990|66107240|FG000|Overall Study|Pregnancy|10|||
23651382|NCT01003990|66107241|FG001|Overall Study|Pregnancy|2|||
23651383|NCT01003990|66107242|FG002|Overall Study|Pregnancy|4|||
23651384|NCT01003990|66107240|FG000|Overall Study|No Longer Met Study Criteria|4|||
23651385|NCT01003990|66107241|FG001|Overall Study|No Longer Met Study Criteria|1|||
23651386|NCT01003990|66107242|FG002|Overall Study|No Longer Met Study Criteria|0|||
23651387|NCT01003990|66107240|FG000|Overall Study|Subject Withdrew Consent|12|||
23651388|NCT01003990|66107241|FG001|Overall Study|Subject Withdrew Consent|5|||
23651389|NCT01003990|66107242|FG002|Overall Study|Subject Withdrew Consent|7|||
23651390|NCT03353350|66107250|FG000|30-week Core Treatment Period|Protocol Violation|1|||
23651391|NCT03353350|66107251|FG001|30-week Core Treatment Period|Protocol Violation|1|||
23801205|NCT03253094|66649918|FG002|Overall Study|Other|2|||
23801206|NCT03253094|66649919|FG003|Overall Study|Other|1|||
23651392|NCT03353350|66107252|FG002|30-week Core Treatment Period|Protocol Violation|1|||
23651393|NCT03353350|66107253|FG003|30-week Core Treatment Period|Protocol Violation|0|||
23651394|NCT03353350|66107250|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23801207|NCT03253094|66649920|FG004|Overall Study|Other|0|||
23651395|NCT03353350|66107251|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23651396|NCT03353350|66107252|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23651397|NCT03353350|66107253|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
23651398|NCT03353350|66107250|FG000|30-week Core Treatment Period|Adverse Event|0|||
23651399|NCT03353350|66107251|FG001|30-week Core Treatment Period|Adverse Event|4|||
23651400|NCT03353350|66107252|FG002|30-week Core Treatment Period|Adverse Event|2|||
23651401|NCT03353350|66107253|FG003|30-week Core Treatment Period|Adverse Event|3|||
23651402|NCT03353350|66107250|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
23651403|NCT03353350|66107251|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
23651404|NCT03353350|66107252|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
23651405|NCT03353350|66107253|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
23651406|NCT03353350|66107250|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
23651407|NCT03353350|66107251|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
23651408|NCT03353350|66107252|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
23651409|NCT03353350|66107253|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
23651410|NCT03353350|66107250|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
23651411|NCT03353350|66107251|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
23651412|NCT03353350|66107252|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
23651413|NCT03353350|66107253|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
23651414|NCT03353350|66107250|FG000|26-week Treatment Extension Period|Adverse Event|1|||
23651415|NCT03353350|66107251|FG001|26-week Treatment Extension Period|Adverse Event|0|||
23651416|NCT03353350|66107252|FG002|26-week Treatment Extension Period|Adverse Event|0|||
23651417|NCT03353350|66107253|FG003|26-week Treatment Extension Period|Adverse Event|1|||
23651418|NCT03353350|66107250|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
23651419|NCT03353350|66107251|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
23651420|NCT03353350|66107252|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
23651421|NCT03353350|66107253|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
23651422|NCT00666679|66107254|FG000|First Intervention|Lost to Follow-up|1|||
23651423|NCT00666679|66107255|FG001|First Intervention|Lost to Follow-up|0|||
23651424|NCT00666679|66107254|FG000|First Intervention|Protocol Violation|1|||
23651425|NCT00666679|66107255|FG001|First Intervention|Protocol Violation|0|||
23651426|NCT00666679|66107254|FG000|First Intervention|Withdrawal by Subject|1|||
23651427|NCT00666679|66107255|FG001|First Intervention|Withdrawal by Subject|0|||
23651428|NCT00666679|66107254|FG000|First Intervention|Randomized did not start treatment|1|||
23651429|NCT00666679|66107255|FG001|First Intervention|Randomized did not start treatment|1|||
23651430|NCT00666679|66107254|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
23651431|NCT00666679|66107255|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
23651432|NCT00666679|66107254|FG000|Washout Period of 1 Week|Protocol Violation|0|||
23651433|NCT00666679|66107255|FG001|Washout Period of 1 Week|Protocol Violation|1|||
23651434|NCT00666679|66107254|FG000|Second Intervention|Adverse Event|1|||
23651435|NCT00666679|66107255|FG001|Second Intervention|Adverse Event|0|||
23651436|NCT00666679|66107254|FG000|Second Intervention|Death|0|||
23651437|NCT00666679|66107255|FG001|Second Intervention|Death|1|||
23651438|NCT01139658|66110625|FG000|Overall Study|Adverse Event|10|||
23651439|NCT01139658|66110626|FG001|Overall Study|Adverse Event|27|||
23651440|NCT01139658|66110625|FG000|Overall Study|Lack of Efficacy|15|||
23651441|NCT01139658|66110626|FG001|Overall Study|Lack of Efficacy|7|||
23651442|NCT01139658|66110625|FG000|Overall Study|Withdrawal by Subject|2|||
23651443|NCT01139658|66110626|FG001|Overall Study|Withdrawal by Subject|4|||
23651444|NCT01139658|66110625|FG000|Overall Study|No documentation of treatment|1|||
23651445|NCT01139658|66110626|FG001|Overall Study|No documentation of treatment|0|||
23651446|NCT01139658|66110625|FG000|Overall Study|Other|28|||
23651447|NCT01139658|66110626|FG001|Overall Study|Other|75|||
23651448|NCT02074553|66110627|FG000|Intervention Period 1|Family Emergency|0|||
23651449|NCT02074553|66110628|FG001|Intervention Period 1|Family Emergency|0|||
23651450|NCT02074553|66110629|FG002|Intervention Period 1|Family Emergency|0|||
23651451|NCT02074553|66110630|FG003|Intervention Period 1|Family Emergency|1|||
23651452|NCT02074553|66110631|FG004|Intervention Period 1|Family Emergency|0|||
23651453|NCT02074553|66110632|FG005|Intervention Period 1|Family Emergency|0|||
23651454|NCT02074553|66110633|FG006|Intervention Period 1|Family Emergency|0|||
23651455|NCT02074553|66110634|FG007|Intervention Period 1|Family Emergency|0|||
23651456|NCT02074553|66110627|FG000|Washout Period 1|Adverse Event|1|||
23651457|NCT02074553|66110628|FG001|Washout Period 1|Adverse Event|0|||
23651458|NCT02074553|66110629|FG002|Washout Period 1|Adverse Event|0|||
23651459|NCT02074553|66110630|FG003|Washout Period 1|Adverse Event|0|||
23651460|NCT02074553|66110631|FG004|Washout Period 1|Adverse Event|0|||
23651461|NCT02074553|66110632|FG005|Washout Period 1|Adverse Event|0|||
23651462|NCT02074553|66110633|FG006|Washout Period 1|Adverse Event|0|||
23651463|NCT02074553|66110634|FG007|Washout Period 1|Adverse Event|0|||
23651464|NCT02074553|66110627|FG000|Washout Period 1|Physician Decision|0|||
23651465|NCT02074553|66110628|FG001|Washout Period 1|Physician Decision|0|||
23651466|NCT02074553|66110629|FG002|Washout Period 1|Physician Decision|0|||
23651467|NCT02074553|66110630|FG003|Washout Period 1|Physician Decision|1|||
23651468|NCT02074553|66110631|FG004|Washout Period 1|Physician Decision|0|||
23651469|NCT02074553|66110632|FG005|Washout Period 1|Physician Decision|0|||
23651470|NCT02074553|66110633|FG006|Washout Period 1|Physician Decision|0|||
23651471|NCT02074553|66110634|FG007|Washout Period 1|Physician Decision|0|||
23651472|NCT02074553|66110627|FG000|Washout Period 1|Other|0|||
23651473|NCT02074553|66110628|FG001|Washout Period 1|Other|0|||
23651474|NCT02074553|66110629|FG002|Washout Period 1|Other|0|||
23651475|NCT02074553|66110630|FG003|Washout Period 1|Other|0|||
23651476|NCT02074553|66110631|FG004|Washout Period 1|Other|0|||
23479326|NCT01403948|65498471|FG004|Overall Study|other than above|1|||
23479327|NCT01403948|65498472|FG005|Overall Study|other than above|1|||
23479328|NCT01403948|65498473|FG006|Overall Study|other than above|2|||
23479329|NCT01403948|65498474|FG007|Overall Study|other than above|0|||
23479330|NCT01403948|65498475|FG008|Overall Study|other than above|0|||
23479331|NCT01403948|65498476|FG009|Overall Study|other than above|0|||
23479332|NCT03149848|65498479|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
23479333|NCT03149848|65498479|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
23479334|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
23479335|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
23479336|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
23479337|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
23479338|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
23479339|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
23479340|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
23479341|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
23479342|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
23479343|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
23479344|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
23479345|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
23479346|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
23479347|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
23479348|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
23479349|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
23479350|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
23479351|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
23479352|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
23479353|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
23479354|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
23479355|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
23479356|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
23479357|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
23479358|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
23479359|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
23479360|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
23479361|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
23479362|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
23479363|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
23479364|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
23479365|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
23479366|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
23479367|NCT04987944|65498483|FG000|Overall Study|Adverse Event|0|||
23479368|NCT04987944|65498484|FG001|Overall Study|Adverse Event|1|||
23479369|NCT04987944|65498483|FG000|Overall Study|Withdrawal by Subject|0|||
23479370|NCT04987944|65498484|FG001|Overall Study|Withdrawal by Subject|1|||
23479371|NCT00395343|65498487|FG000|Overall Study|Adverse Event|13|||
23479372|NCT00395343|65498488|FG001|Overall Study|Adverse Event|5|||
23479373|NCT00395343|65498487|FG000|Overall Study|Lack of Efficacy|0|||
23479374|NCT00395343|65498488|FG001|Overall Study|Lack of Efficacy|1|||
23479375|NCT00395343|65498487|FG000|Overall Study|Lost to Follow-up|4|||
23479376|NCT00395343|65498488|FG001|Overall Study|Lost to Follow-up|4|||
23479377|NCT00395343|65498487|FG000|Overall Study|Physician Decision|2|||
23479378|NCT00395343|65498488|FG001|Overall Study|Physician Decision|4|||
23479379|NCT00395343|65498487|FG000|Overall Study|Protocol Violation|6|||
23479380|NCT00395343|65498488|FG001|Overall Study|Protocol Violation|8|||
23479381|NCT00395343|65498487|FG000|Overall Study|Withdrawal by Subject|11|||
23479382|NCT00395343|65498488|FG001|Overall Study|Withdrawal by Subject|12|||
23479383|NCT00395343|65498487|FG000|Overall Study|Other|5|||
23479384|NCT00395343|65498488|FG001|Overall Study|Other|2|||
23479385|NCT05277337|65498489|FG000|Overall Study|Lost to Follow-up|2|||
23479386|NCT05277337|65498490|FG001|Overall Study|Lost to Follow-up|0|||
23479387|NCT05277337|65498489|FG000|Overall Study|Withdrawal by Subject|1|||
23479388|NCT05277337|65498490|FG001|Overall Study|Withdrawal by Subject|0|||
23479389|NCT01782469|65498491|FG000|Overall Study|Lost to Follow-up|1|||
23479390|NCT01029405|65498492|FG000|Overall Study|Withdrawal by Subject|0|||
23479391|NCT01029405|65498493|FG001|Overall Study|Withdrawal by Subject|1|||
23479392|NCT01029405|65498494|FG002|Overall Study|Withdrawal by Subject|2|||
23479393|NCT01029405|65498495|FG003|Overall Study|Withdrawal by Subject|0|||
23479394|NCT01029405|65498492|FG000|Overall Study|Protocol Violation|0|||
23479395|NCT01029405|65498493|FG001|Overall Study|Protocol Violation|0|||
23651477|NCT02074553|66110632|FG005|Washout Period 1|Other|1|||
23651478|NCT02074553|66110633|FG006|Washout Period 1|Other|0|||
23651479|NCT02074553|66110634|FG007|Washout Period 1|Other|0|||
23651480|NCT02074553|66110627|FG000|Washout Period 2|Adverse Event|0|||
23651481|NCT02074553|66110628|FG001|Washout Period 2|Adverse Event|0|||
23651482|NCT02074553|66110629|FG002|Washout Period 2|Adverse Event|0|||
23651483|NCT02074553|66110630|FG003|Washout Period 2|Adverse Event|0|||
23651484|NCT02074553|66110631|FG004|Washout Period 2|Adverse Event|0|||
23651485|NCT02074553|66110632|FG005|Washout Period 2|Adverse Event|0|||
23651486|NCT02074553|66110633|FG006|Washout Period 2|Adverse Event|1|||
23651487|NCT02074553|66110634|FG007|Washout Period 2|Adverse Event|0|||
23651488|NCT02074553|66110627|FG000|Washout Period 2|Physician Decision|0|||
23651489|NCT02074553|66110628|FG001|Washout Period 2|Physician Decision|0|||
23651490|NCT02074553|66110629|FG002|Washout Period 2|Physician Decision|0|||
23651491|NCT02074553|66110630|FG003|Washout Period 2|Physician Decision|0|||
23651492|NCT02074553|66110631|FG004|Washout Period 2|Physician Decision|0|||
23651493|NCT02074553|66110632|FG005|Washout Period 2|Physician Decision|1|||
23651494|NCT02074553|66110633|FG006|Washout Period 2|Physician Decision|0|||
23651495|NCT02074553|66110634|FG007|Washout Period 2|Physician Decision|0|||
23651496|NCT02074553|66110627|FG000|Washout Period 2|Lost to Follow-up|0|||
23651497|NCT02074553|66110628|FG001|Washout Period 2|Lost to Follow-up|0|||
23651498|NCT02074553|66110629|FG002|Washout Period 2|Lost to Follow-up|1|||
23599133|NCT01629589|65922456|FG000|Overall Study|Did not receive study vaccine|0|||
23599134|NCT01629589|65922457|FG001|Overall Study|Did not receive study vaccine|1|||
23599135|NCT01968967|65922458|FG000|Treatment Period|Other|22|||
23599136|NCT01968967|65922459|FG001|Treatment Period|Other|22|||
23599137|NCT01968967|65922460|FG002|Treatment Period|Other|0|||
23599138|NCT01968967|65922461|FG003|Treatment Period|Other|0|||
23599139|NCT01968967|65922462|FG004|Treatment Period|Other|0|||
23599140|NCT01968967|65922458|FG000|Treatment Period|Withdrawal by Subject|71|||
23599141|NCT01968967|65922459|FG001|Treatment Period|Withdrawal by Subject|61|||
23599142|NCT01968967|65922460|FG002|Treatment Period|Withdrawal by Subject|0|||
23599143|NCT01968967|65922461|FG003|Treatment Period|Withdrawal by Subject|0|||
23599144|NCT01968967|65922462|FG004|Treatment Period|Withdrawal by Subject|0|||
23599145|NCT01968967|65922458|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
23599146|NCT01968967|65922459|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
23599147|NCT01968967|65922460|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599148|NCT01968967|65922461|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599149|NCT01968967|65922462|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599150|NCT01968967|65922458|FG000|Treatment Period|Lost to Follow-up|26|||
23599151|NCT01968967|65922459|FG001|Treatment Period|Lost to Follow-up|31|||
23599152|NCT01968967|65922460|FG002|Treatment Period|Lost to Follow-up|0|||
23599153|NCT01968967|65922461|FG003|Treatment Period|Lost to Follow-up|0|||
23599154|NCT01968967|65922462|FG004|Treatment Period|Lost to Follow-up|0|||
23599155|NCT01968967|65922458|FG000|Treatment Period|Protocol Violation|1|||
23599156|NCT01968967|65922459|FG001|Treatment Period|Protocol Violation|2|||
23599157|NCT01968967|65922460|FG002|Treatment Period|Protocol Violation|0|||
23599158|NCT01968967|65922461|FG003|Treatment Period|Protocol Violation|0|||
23599159|NCT01968967|65922462|FG004|Treatment Period|Protocol Violation|0|||
23599160|NCT01968967|65922458|FG000|Treatment Period|Adverse Event|9|||
23599161|NCT01968967|65922459|FG001|Treatment Period|Adverse Event|8|||
23599162|NCT01968967|65922460|FG002|Treatment Period|Adverse Event|0|||
23599163|NCT01968967|65922461|FG003|Treatment Period|Adverse Event|0|||
23599164|NCT01968967|65922462|FG004|Treatment Period|Adverse Event|0|||
23599165|NCT01968967|65922458|FG000|Treatment Period|Death|9|||
23599166|NCT01968967|65922459|FG001|Treatment Period|Death|2|||
23599167|NCT01968967|65922460|FG002|Treatment Period|Death|0|||
23599168|NCT01968967|65922461|FG003|Treatment Period|Death|0|||
23599169|NCT01968967|65922462|FG004|Treatment Period|Death|0|||
23599170|NCT01968967|65922458|FG000|Treatment Period|Randomized Not Treated|6|||
23599171|NCT01968967|65922459|FG001|Treatment Period|Randomized Not Treated|5|||
23651499|NCT02074553|66110630|FG003|Washout Period 2|Lost to Follow-up|0|||
23651500|NCT02074553|66110631|FG004|Washout Period 2|Lost to Follow-up|0|||
23651501|NCT02074553|66110632|FG005|Washout Period 2|Lost to Follow-up|0|||
23651502|NCT02074553|66110633|FG006|Washout Period 2|Lost to Follow-up|0|||
23599172|NCT01968967|65922460|FG002|Treatment Period|Randomized Not Treated|0|||
23599173|NCT01968967|65922461|FG003|Treatment Period|Randomized Not Treated|0|||
23599174|NCT01968967|65922462|FG004|Treatment Period|Randomized Not Treated|0|||
23599175|NCT01968967|65922458|FG000|Extension Period|Withdrew Consent|0|||
23599176|NCT01968967|65922459|FG001|Extension Period|Withdrew Consent|0|||
23599177|NCT01968967|65922460|FG002|Extension Period|Withdrew Consent|2|||
23599178|NCT01968967|65922461|FG003|Extension Period|Withdrew Consent|0|||
23651503|NCT02074553|66110634|FG007|Washout Period 2|Lost to Follow-up|0|||
23651504|NCT02074553|66110627|FG000|Washout Period 3|Physician Decision|0|||
23599179|NCT01968967|65922462|FG004|Extension Period|Withdrew Consent|5|||
23651505|NCT02074553|66110628|FG001|Washout Period 3|Physician Decision|0|||
23651506|NCT02074553|66110629|FG002|Washout Period 3|Physician Decision|0|||
23651507|NCT02074553|66110630|FG003|Washout Period 3|Physician Decision|0|||
23651508|NCT02074553|66110631|FG004|Washout Period 3|Physician Decision|0|||
23651509|NCT02074553|66110632|FG005|Washout Period 3|Physician Decision|0|||
23651510|NCT02074553|66110633|FG006|Washout Period 3|Physician Decision|0|||
23651511|NCT02074553|66110634|FG007|Washout Period 3|Physician Decision|1|||
23651512|NCT02319525|66110635|FG000|Overall Study|Withdrawal by Subject|2|||
23651513|NCT02319525|66110636|FG001|Overall Study|Withdrawal by Subject|1|||
23651514|NCT00756470|66110640|FG000|Overall Study|Withdrawal by Subject|1|||
23651515|NCT00756470|66110640|FG000|Overall Study|Adverse Event|4|||
23651516|NCT01155375|66110645|FG000|Overall Study|Adverse Event|1|||
23651517|NCT01155375|66110646|FG001|Overall Study|Adverse Event|0|||
23651518|NCT01551212|66110649|FG000|Overall Study|Graft loss/Retransplantation|0|||
23651519|NCT01551212|66110650|FG001|Overall Study|Graft loss/Retransplantation|1|||
23651520|NCT01551212|66110649|FG000|Overall Study|Administrative problems|1|||
23651521|NCT01551212|66110650|FG001|Overall Study|Administrative problems|2|||
23651522|NCT01551212|66110649|FG000|Overall Study|Lost to Follow-up|0|||
23651523|NCT01551212|66110650|FG001|Overall Study|Lost to Follow-up|1|||
23651524|NCT01551212|66110649|FG000|Overall Study|Protocol Violation|0|||
23651525|NCT01551212|66110650|FG001|Overall Study|Protocol Violation|1|||
23651526|NCT01551212|66110649|FG000|Overall Study|Withdrawal by Subject|0|||
23651527|NCT01551212|66110650|FG001|Overall Study|Withdrawal by Subject|7|||
23651528|NCT01551212|66110649|FG000|Overall Study|Death|2|||
23651529|NCT01551212|66110650|FG001|Overall Study|Death|4|||
23651530|NCT01551212|66110649|FG000|Overall Study|Never Received Study Treatment|2|||
23651531|NCT01551212|66110650|FG001|Overall Study|Never Received Study Treatment|4|||
23651532|NCT00846391|66110653|FG000|Overall Study|Physician Decision|0|||
23651533|NCT00846391|66110654|FG001|Overall Study|Physician Decision|0|||
23651534|NCT00846391|66110655|FG002|Overall Study|Physician Decision|1|||
23651535|NCT00846391|66110653|FG000|Overall Study|Study Terminated by Sponsor|1|||
23651536|NCT00846391|66110654|FG001|Overall Study|Study Terminated by Sponsor|2|||
23651537|NCT00846391|66110655|FG002|Overall Study|Study Terminated by Sponsor|2|||
23651538|NCT01230788|66110663|FG000|Overall Study|Prescribed exclusion drug|1|||
23651539|NCT01906346|66110668|FG000|Overall Study|AEs|1|||
23651540|NCT01142596|66110669|FG000|Overall Study|Withdrawal by Subject|9|||
23651541|NCT01142596|66110670|FG001|Overall Study|Withdrawal by Subject|35|||
23651542|NCT01142596|66110669|FG000|Overall Study|Adverse Event|8|||
23651543|NCT01142596|66110670|FG001|Overall Study|Adverse Event|35|||
23651544|NCT01142596|66110669|FG000|Overall Study|Lack of Efficacy|5|||
23651545|NCT01142596|66110670|FG001|Overall Study|Lack of Efficacy|9|||
23651546|NCT01142596|66110669|FG000|Overall Study|Lost to Follow-up|2|||
23651547|NCT01142596|66110670|FG001|Overall Study|Lost to Follow-up|3|||
23651548|NCT01142596|66110669|FG000|Overall Study|Other reason (not specified)|5|||
23651549|NCT01142596|66110670|FG001|Overall Study|Other reason (not specified)|4|||
23651550|NCT00985166|66110671|FG000|Overall Study|Lost to Follow-up|3|||
23651551|NCT00985166|66110672|FG001|Overall Study|Lost to Follow-up|2|||
23651552|NCT00985166|66110673|FG002|Overall Study|Lost to Follow-up|2|||
23651553|NCT00985166|66110671|FG000|Overall Study|Withdrawal by Subject|3|||
23651554|NCT00985166|66110672|FG001|Overall Study|Withdrawal by Subject|2|||
23599180|NCT02285270|65922463|FG000|Overall Study|Lost to Follow-up|1|||
23599181|NCT02285270|65922463|FG000|Overall Study|Physician Decision|3|||
23599182|NCT02285270|65922463|FG000|Overall Study|Determined to be ineligible|1|||
23599183|NCT03257410|65922464|FG000|Overall Study|Adverse Event|2|||
23599184|NCT03257410|65922465|FG001|Overall Study|Adverse Event|3|||
23599185|NCT03257410|65922464|FG000|Overall Study|Protocol Violation|1|||
23599186|NCT03257410|65922465|FG001|Overall Study|Protocol Violation|2|||
23599187|NCT03257410|65922464|FG000|Overall Study|Lost to Follow-up|1|||
23599188|NCT03257410|65922465|FG001|Overall Study|Lost to Follow-up|0|||
23651555|NCT00985166|66110673|FG002|Overall Study|Withdrawal by Subject|0|||
23651556|NCT00985166|66110671|FG000|Overall Study|Test not done|2|||
23651557|NCT00985166|66110672|FG001|Overall Study|Test not done|0|||
23651558|NCT00985166|66110673|FG002|Overall Study|Test not done|4|||
23651559|NCT00985166|66110671|FG000|Overall Study|Other|1|||
23651560|NCT00985166|66110672|FG001|Overall Study|Other|0|||
23651561|NCT00985166|66110673|FG002|Overall Study|Other|1|||
23651562|NCT00639223|66110676|FG000|Overall Study|Lost to Follow-up|0|||
23651563|NCT00639223|66110677|FG001|Overall Study|Lost to Follow-up|2|||
23651564|NCT00718640|66110678|FG000|Overall Study|Adverse Event|4|||
23651565|NCT00718640|66110678|FG000|Overall Study|Death|1|||
23651566|NCT00718640|66110678|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
23651567|NCT01054846|66110680|FG000|Overall Study|Lost to Follow-up|76|||
23651568|NCT01054846|66110681|FG001|Overall Study|Lost to Follow-up|17|||
23651569|NCT03604523|66110682|FG000|Overall Study|Physician Decision|1|||
23651570|NCT03604523|66110683|FG001|Overall Study|Physician Decision|0|||
23651571|NCT03681951|66110684|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
23651572|NCT03681951|66110685|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651573|NCT03681951|66110686|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651574|NCT03681951|66110687|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651575|NCT03681951|66110688|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651576|NCT03681951|66110689|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651577|NCT03681951|66110690|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651578|NCT03681951|66110691|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23651579|NCT03681951|66110684|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
23651580|NCT03681951|66110685|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651581|NCT03681951|66110686|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651582|NCT03681951|66110687|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651583|NCT03681951|66110688|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651584|NCT03681951|66110689|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651585|NCT03681951|66110690|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651586|NCT03681951|66110691|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23651587|NCT03681951|66110684|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
23651588|NCT03681951|66110685|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651589|NCT03681951|66110686|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651590|NCT03681951|66110687|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651591|NCT03681951|66110688|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651592|NCT03681951|66110689|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651593|NCT03681951|66110690|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651594|NCT03681951|66110691|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23651595|NCT00250679|66110695|FG000|Overall Study|Adverse Event|12|||
23651596|NCT00250679|66110696|FG001|Overall Study|Adverse Event|15|||
23651597|NCT00250679|66110697|FG002|Overall Study|Adverse Event|16|||
23651598|NCT00250679|66110695|FG000|Overall Study|Protocol Violation|2|||
23651599|NCT00250679|66110696|FG001|Overall Study|Protocol Violation|4|||
23651600|NCT00250679|66110697|FG002|Overall Study|Protocol Violation|3|||
23651601|NCT00250679|66110695|FG000|Overall Study|Withdrawal by Subject|15|||
23599189|NCT03257410|65922464|FG000|Overall Study|Withdrawal by Subject|1|||
23599190|NCT03257410|65922465|FG001|Overall Study|Withdrawal by Subject|2|||
23599191|NCT03257410|65922464|FG000|Overall Study|Physician Decision|1|||
23599192|NCT03257410|65922465|FG001|Overall Study|Physician Decision|1|||
23599193|NCT03257410|65922464|FG000|Overall Study|Renal transplantation|2|||
23599194|NCT03257410|65922465|FG001|Overall Study|Renal transplantation|0|||
23599195|NCT03257410|65922464|FG000|Overall Study|Switch to peritoneal dialysis|1|||
23599196|NCT03257410|65922465|FG001|Overall Study|Switch to peritoneal dialysis|0|||
23599197|NCT03257410|65922464|FG000|Overall Study|Death|3|||
23599198|NCT03257410|65922465|FG001|Overall Study|Death|2|||
23599199|NCT03257410|65922464|FG000|Overall Study|Change to another dialysis center|2|||
23599200|NCT03257410|65922465|FG001|Overall Study|Change to another dialysis center|2|||
23599201|NCT03257410|65922464|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
23599202|NCT03257410|65922465|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
23599203|NCT03257410|65922464|FG000|Overall Study|Miscellaneous|2|||
23599204|NCT03257410|65922465|FG001|Overall Study|Miscellaneous|2|||
23599205|NCT03257410|65922464|FG000|Overall Study|Other|0|||
23599206|NCT03257410|65922465|FG001|Overall Study|Other|1|||
23599207|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23599208|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23599209|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23599210|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23599211|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23599212|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23599213|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
23599214|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23599215|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
23599216|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
23651602|NCT00250679|66110696|FG001|Overall Study|Withdrawal by Subject|18|||
23651603|NCT00250679|66110697|FG002|Overall Study|Withdrawal by Subject|15|||
23651604|NCT00250679|66110695|FG000|Overall Study|Lost to Follow-up|3|||
23651605|NCT00250679|66110696|FG001|Overall Study|Lost to Follow-up|4|||
23651606|NCT00250679|66110697|FG002|Overall Study|Lost to Follow-up|2|||
23479396|NCT01029405|65498494|FG002|Overall Study|Protocol Violation|0|||
23479397|NCT01029405|65498495|FG003|Overall Study|Protocol Violation|1|||
23479398|NCT01029405|65498492|FG000|Overall Study|Adverse Event|0|||
23479399|NCT01029405|65498493|FG001|Overall Study|Adverse Event|0|||
23479400|NCT01029405|65498494|FG002|Overall Study|Adverse Event|1|||
23479401|NCT01029405|65498495|FG003|Overall Study|Adverse Event|1|||
23479402|NCT01029405|65498492|FG000|Overall Study|Lost to Follow-up|2|||
23479403|NCT01029405|65498493|FG001|Overall Study|Lost to Follow-up|1|||
23479404|NCT01029405|65498494|FG002|Overall Study|Lost to Follow-up|1|||
23479405|NCT01029405|65498495|FG003|Overall Study|Lost to Follow-up|2|||
23479406|NCT01029405|65498492|FG000|Overall Study|Other|0|||
23479407|NCT01029405|65498493|FG001|Overall Study|Other|1|||
23479408|NCT01029405|65498494|FG002|Overall Study|Other|0|||
23479409|NCT01029405|65498495|FG003|Overall Study|Other|1|||
23479410|NCT02545543|65498496|FG000|Overall Study|Lost to Follow-up|67|||
23479411|NCT02545543|65498497|FG001|Overall Study|Lost to Follow-up|25|||
23479412|NCT02545543|65498496|FG000|Overall Study|Physician Decision|3|||
23479413|NCT02545543|65498497|FG001|Overall Study|Physician Decision|0|||
23479414|NCT02545543|65498496|FG000|Overall Study|Withdrawal by Subject|9|||
23479415|NCT02545543|65498497|FG001|Overall Study|Withdrawal by Subject|8|||
23479416|NCT02545543|65498496|FG000|Overall Study|Noncomplaince|1|||
23651607|NCT00250679|66110695|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
23651608|NCT00250679|66110696|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
23651609|NCT00250679|66110697|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
23651610|NCT00250679|66110695|FG000|Overall Study|Lack of Efficacy|0|||
23651611|NCT00250679|66110696|FG001|Overall Study|Lack of Efficacy|1|||
23651612|NCT00250679|66110697|FG002|Overall Study|Lack of Efficacy|3|||
23651613|NCT00250679|66110695|FG000|Overall Study|Technical Holter issues|1|||
23651614|NCT00250679|66110696|FG001|Overall Study|Technical Holter issues|0|||
23651615|NCT00250679|66110697|FG002|Overall Study|Technical Holter issues|2|||
23651616|NCT00250679|66110695|FG000|Overall Study|Moved|1|||
23651617|NCT00250679|66110696|FG001|Overall Study|Moved|1|||
23651618|NCT00250679|66110697|FG002|Overall Study|Moved|0|||
23651619|NCT00250679|66110695|FG000|Overall Study|Non-compliance|1|||
23651620|NCT00250679|66110696|FG001|Overall Study|Non-compliance|1|||
23651621|NCT00250679|66110697|FG002|Overall Study|Non-compliance|0|||
23651622|NCT00250679|66110695|FG000|Overall Study|various single events: hip surgery,diary|3|||
23651623|NCT00250679|66110696|FG001|Overall Study|various single events: hip surgery,diary|1|||
23651624|NCT00250679|66110697|FG002|Overall Study|various single events: hip surgery,diary|1|||
23651625|NCT00447382|66110698|FG000|Overall Study|Adverse Event|1|||
23651626|NCT00447382|66110699|FG001|Overall Study|Adverse Event|1|||
23651627|NCT00447382|66110698|FG000|Overall Study|Lack of Efficacy|1|||
23651628|NCT00447382|66110699|FG001|Overall Study|Lack of Efficacy|0|||
23651629|NCT00447382|66110698|FG000|Overall Study|Protocol Violation|2|||
23651630|NCT00447382|66110699|FG001|Overall Study|Protocol Violation|0|||
23651631|NCT00447382|66110698|FG000|Overall Study|Unclassified|2|||
23651632|NCT00447382|66110699|FG001|Overall Study|Unclassified|5|||
23651633|NCT01029652|66110700|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
23651634|NCT01029652|66110701|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
23651635|NCT01029652|66110700|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
23651636|NCT01029652|66110701|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
23651637|NCT01029652|66110700|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
23651638|NCT01029652|66110701|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
23651639|NCT01029652|66110700|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
23651640|NCT01029652|66110701|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
23651641|NCT01029652|66110700|FG000|Core Study (0-12 Weeks)|Death|0|||
23651642|NCT01029652|66110701|FG001|Core Study (0-12 Weeks)|Death|1|||
23651643|NCT01029652|66110700|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
23651644|NCT01029652|66110701|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
23651645|NCT01029652|66110700|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
23651646|NCT01029652|66110701|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
23651647|NCT01029652|66110700|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
23651648|NCT01029652|66110701|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
23651649|NCT01029652|66110700|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
23651650|NCT01029652|66110701|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
23651651|NCT01029652|66110700|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
23651652|NCT01029652|66110701|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
23651653|NCT01029652|66110700|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
23651654|NCT01029652|66110701|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
23651655|NCT01029652|66110700|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
23651656|NCT01029652|66110701|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
23651657|NCT01596621|66110702|FG000|Overall Study|Death|4|||
23651658|NCT01596621|66110702|FG000|Overall Study|Withdrawal by Subject|9|||
23651659|NCT01596621|66110702|FG000|Overall Study|Disease Progression|49|||
23651660|NCT01596621|66110702|FG000|Overall Study|Lost to Follow-up|3|||
23651661|NCT01596621|66110702|FG000|Overall Study|Other than specified|13|||
23651662|NCT00688181|66110713|FG000|Overall Study|Lost to Follow-up|17|||
23651663|NCT00688181|66110713|FG000|Overall Study|Unknown Reason|4|||
23651664|NCT00688181|66110713|FG000|Overall Study|Non-clinical Reason|2|||
23651665|NCT00104676|66110714|FG000|Overall Study|Death|3|||
23651666|NCT00104676|66110715|FG001|Overall Study|Death|2|||
23651667|NCT00104676|66110714|FG000|Overall Study|Withdrawal by Subject|0|||
23651668|NCT00104676|66110715|FG001|Overall Study|Withdrawal by Subject|2|||
23651669|NCT00104676|66110714|FG000|Overall Study|treatment interruption|4|||
23651670|NCT00104676|66110715|FG001|Overall Study|treatment interruption|10|||
23651671|NCT00091169|66110716|FG000|Overall Study|Disease progression|3|||
23651672|NCT00091169|66110717|FG001|Overall Study|Disease progression|1|||
23651673|NCT00091169|66110716|FG000|Overall Study|Adverse Event|11|||
23651674|NCT00091169|66110717|FG001|Overall Study|Adverse Event|17|||
23651675|NCT00091169|66110716|FG000|Overall Study|Death|4|||
23651676|NCT00091169|66110717|FG001|Overall Study|Death|1|||
23651677|NCT00091169|66110716|FG000|Overall Study|Withdrawal by Subject|10|||
23651678|NCT00091169|66110717|FG001|Overall Study|Withdrawal by Subject|13|||
23651679|NCT00091169|66110716|FG000|Overall Study|Other|3|||
23651680|NCT00091169|66110717|FG001|Overall Study|Other|4|||
23651681|NCT00091169|66110716|FG000|Overall Study|Not start protocol therapy|26|||
23651682|NCT00091169|66110717|FG001|Overall Study|Not start protocol therapy|17|||
23651683|NCT00607022|66110718|FG000|Overall Study|Withdrawal by Subject|1|||
23651684|NCT00607022|66110719|FG001|Overall Study|Withdrawal by Subject|0|||
23651685|NCT00607022|66110720|FG002|Overall Study|Withdrawal by Subject|0|||
23651686|NCT01498653|66110721|FG000|Overall Study|Adverse Event|2|||
23651687|NCT01498653|66110722|FG001|Overall Study|Adverse Event|2|||
23651688|NCT01498653|66110721|FG000|Overall Study|Lack of Efficacy|12|||
23651689|NCT01498653|66110722|FG001|Overall Study|Lack of Efficacy|26|||
23651690|NCT01498653|66110721|FG000|Overall Study|Protocol Violation|0|||
23651691|NCT01498653|66110722|FG001|Overall Study|Protocol Violation|4|||
23651692|NCT01498653|66110721|FG000|Overall Study|Lost to Follow-up|1|||
23651693|NCT01498653|66110722|FG001|Overall Study|Lost to Follow-up|0|||
23651694|NCT01498653|66110721|FG000|Overall Study|Physician Decision|2|||
23651695|NCT01498653|66110722|FG001|Overall Study|Physician Decision|0|||
23651696|NCT01498653|66110721|FG000|Overall Study|Withdrawal by Subject|2|||
23651697|NCT01498653|66110722|FG001|Overall Study|Withdrawal by Subject|3|||
23651698|NCT00876694|66110724|FG000|Overall Study|Adverse Event|10|||
23651699|NCT00876694|66110725|FG001|Overall Study|Adverse Event|7|||
23651700|NCT00876694|66110724|FG000|Overall Study|Subject withdrew consent|6|||
23651701|NCT00876694|66110725|FG001|Overall Study|Subject withdrew consent|4|||
23651702|NCT00876694|66110724|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23651703|NCT00876694|66110725|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23651704|NCT00876694|66110724|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23651705|NCT00876694|66110725|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23479417|NCT02545543|65498497|FG001|Overall Study|Noncomplaince|0|||
23479418|NCT02545543|65498496|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
23479419|NCT02545543|65498497|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
23479420|NCT00509262|65498501|FG000|Overall Study|Adverse Event|16|||
23479421|NCT00509262|65498502|FG001|Overall Study|Adverse Event|18|||
23479422|NCT00509262|65498501|FG000|Overall Study|Other|2|||
23479423|NCT00509262|65498502|FG001|Overall Study|Other|2|||
23479424|NCT00509262|65498501|FG000|Overall Study|Lack of Efficacy|1|||
23479425|NCT00509262|65498502|FG001|Overall Study|Lack of Efficacy|0|||
23479426|NCT00509262|65498501|FG000|Overall Study|Lost to Follow-up|1|||
23479427|NCT00509262|65498502|FG001|Overall Study|Lost to Follow-up|6|||
23479428|NCT00509262|65498501|FG000|Overall Study|Physician Decision|1|||
23479429|NCT00509262|65498502|FG001|Overall Study|Physician Decision|3|||
23479430|NCT00509262|65498501|FG000|Overall Study|Protocol Violation|2|||
23479431|NCT00509262|65498502|FG001|Overall Study|Protocol Violation|2|||
23479432|NCT00509262|65498501|FG000|Overall Study|Withdrawal by Subject|24|||
23651706|NCT00876694|66110724|FG000|Overall Study|Administrative problems|1|||
23651707|NCT00876694|66110725|FG001|Overall Study|Administrative problems|1|||
23651708|NCT00876694|66110724|FG000|Overall Study|Death|1|||
23651709|NCT00876694|66110725|FG001|Overall Study|Death|0|||
23651710|NCT01620255|66110728|FG000|Overall Study|Withdrawal by Subject|4|||
23651711|NCT01620255|66110729|FG001|Overall Study|Withdrawal by Subject|1|||
23479433|NCT00509262|65498502|FG001|Overall Study|Withdrawal by Subject|11|||
23479434|NCT01030666|65498503|FG000|Overall Study|Lost to Follow-up|3|||
23479435|NCT01030666|65498504|FG001|Overall Study|Lost to Follow-up|2|||
23479436|NCT03044574|65498505|FG000|Overall Study|Lost to Follow-up|37|||
23479437|NCT03044574|65498506|FG001|Overall Study|Lost to Follow-up|45|||
23479438|NCT00420641|65498507|FG000|Overall Study|Adverse Event|3|||
23479439|NCT00420641|65498508|FG001|Overall Study|Adverse Event|25|||
23479440|NCT00420641|65498509|FG002|Overall Study|Adverse Event|10|||
23479441|NCT00420641|65498507|FG000|Overall Study|Lost to Follow-up|2|||
23479442|NCT00420641|65498508|FG001|Overall Study|Lost to Follow-up|4|||
23479443|NCT00420641|65498509|FG002|Overall Study|Lost to Follow-up|2|||
23479444|NCT00420641|65498507|FG000|Overall Study|Protocol Violation|8|||
23479445|NCT00420641|65498508|FG001|Overall Study|Protocol Violation|8|||
23651712|NCT01620255|66110730|FG002|Overall Study|Withdrawal by Subject|1|||
23651713|NCT01620255|66110731|FG003|Overall Study|Withdrawal by Subject|2|||
23651714|NCT01620255|66110732|FG004|Overall Study|Withdrawal by Subject|4|||
23651715|NCT01620255|66110728|FG000|Overall Study|Participant underwent fecal transplant|0|||
23651716|NCT01620255|66110729|FG001|Overall Study|Participant underwent fecal transplant|0|||
23651717|NCT01620255|66110730|FG002|Overall Study|Participant underwent fecal transplant|1|||
23651718|NCT01620255|66110731|FG003|Overall Study|Participant underwent fecal transplant|0|||
23651719|NCT01620255|66110732|FG004|Overall Study|Participant underwent fecal transplant|0|||
23651720|NCT01620255|66110728|FG000|Overall Study|Non-compliance|0|||
23651721|NCT01620255|66110729|FG001|Overall Study|Non-compliance|1|||
23651722|NCT01620255|66110730|FG002|Overall Study|Non-compliance|0|||
23651723|NCT01620255|66110731|FG003|Overall Study|Non-compliance|0|||
23651724|NCT01620255|66110732|FG004|Overall Study|Non-compliance|0|||
23479446|NCT00420641|65498509|FG002|Overall Study|Protocol Violation|7|||
23479447|NCT00420641|65498507|FG000|Overall Study|Withdrawal by Subject|15|||
23479448|NCT00420641|65498508|FG001|Overall Study|Withdrawal by Subject|21|||
23479449|NCT00420641|65498509|FG002|Overall Study|Withdrawal by Subject|14|||
23651725|NCT01620255|66110728|FG000|Overall Study|Adverse Event|0|||
23651726|NCT01620255|66110729|FG001|Overall Study|Adverse Event|4|||
23651727|NCT01620255|66110730|FG002|Overall Study|Adverse Event|0|||
23651728|NCT01620255|66110731|FG003|Overall Study|Adverse Event|1|||
23651729|NCT01620255|66110732|FG004|Overall Study|Adverse Event|1|||
23651730|NCT01620255|66110728|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
23651731|NCT01620255|66110729|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
23651732|NCT01620255|66110730|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
23651733|NCT01620255|66110731|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
23651734|NCT01620255|66110732|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
23651735|NCT00820027|66110733|FG000|Overall Study|Adverse Event|15|||
23651736|NCT00820027|66110734|FG001|Overall Study|Adverse Event|8|||
23651737|NCT00820027|66110735|FG002|Overall Study|Adverse Event|10|||
23651738|NCT00820027|66110736|FG003|Overall Study|Adverse Event|5|||
23651739|NCT00820027|66110733|FG000|Overall Study|Lack of Efficacy|2|||
23651740|NCT00820027|66110734|FG001|Overall Study|Lack of Efficacy|1|||
23651741|NCT00820027|66110735|FG002|Overall Study|Lack of Efficacy|2|||
23651742|NCT00820027|66110736|FG003|Overall Study|Lack of Efficacy|2|||
23651743|NCT00820027|66110733|FG000|Overall Study|Physician Decision|0|||
23651744|NCT00820027|66110734|FG001|Overall Study|Physician Decision|1|||
23651745|NCT00820027|66110735|FG002|Overall Study|Physician Decision|1|||
23651746|NCT00820027|66110736|FG003|Overall Study|Physician Decision|0|||
23651747|NCT00820027|66110733|FG000|Overall Study|Protocol Violation|3|||
23651748|NCT00820027|66110734|FG001|Overall Study|Protocol Violation|0|||
23651749|NCT00820027|66110735|FG002|Overall Study|Protocol Violation|4|||
23651750|NCT00820027|66110736|FG003|Overall Study|Protocol Violation|0|||
23651751|NCT00820027|66110733|FG000|Overall Study|Withdrawal by Subject|6|||
23651752|NCT00820027|66110734|FG001|Overall Study|Withdrawal by Subject|4|||
23651753|NCT00820027|66110735|FG002|Overall Study|Withdrawal by Subject|4|||
23651754|NCT00820027|66110736|FG003|Overall Study|Withdrawal by Subject|6|||
23651755|NCT01259726|66110737|FG000|Overall Study|Death|1|||
23651756|NCT01259726|66110738|FG001|Overall Study|Death|0|||
23651757|NCT01259726|66110739|FG002|Overall Study|Death|0|||
23651758|NCT01259726|66110740|FG003|Overall Study|Death|0|||
23651759|NCT01259726|66110737|FG000|Overall Study|Physician Decision|2|||
23651760|NCT01259726|66110738|FG001|Overall Study|Physician Decision|0|||
23651761|NCT01259726|66110739|FG002|Overall Study|Physician Decision|1|||
23651762|NCT01259726|66110740|FG003|Overall Study|Physician Decision|1|||
23651763|NCT01259726|66110737|FG000|Overall Study|Withdrawal by Subject|1|||
23651764|NCT01259726|66110738|FG001|Overall Study|Withdrawal by Subject|3|||
23651765|NCT01259726|66110739|FG002|Overall Study|Withdrawal by Subject|2|||
23651766|NCT01259726|66110740|FG003|Overall Study|Withdrawal by Subject|1|||
23651767|NCT01259726|66110737|FG000|Overall Study|Lost to Follow-up|1|||
23651768|NCT01259726|66110738|FG001|Overall Study|Lost to Follow-up|1|||
23651769|NCT01259726|66110739|FG002|Overall Study|Lost to Follow-up|1|||
23651770|NCT01259726|66110740|FG003|Overall Study|Lost to Follow-up|3|||
23651771|NCT01444456|66110741|FG000|Overall Study|Withdrawal by Subject|21|||
23651772|NCT01444456|66110741|FG000|Overall Study|Physician Decision|9|||
23651773|NCT01444456|66110741|FG000|Overall Study|Lost to Follow-up|37|||
23651774|NCT01444456|66110741|FG000|Overall Study|Death|73|||
23651775|NCT01444456|66110741|FG000|Overall Study|Ineligibility determined|23|||
23651776|NCT01444456|66110741|FG000|Overall Study|Other|18|||
23651777|NCT01444456|66110741|FG000|Overall Study|Not treated|104|||
23651778|NCT02095951|66110742|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
23651779|NCT02095951|66110743|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
23651780|NCT01136772|66110750|FG000|Overall Study|Adverse Event|15|||
23651781|NCT01136772|66110751|FG001|Overall Study|Adverse Event|14|||
23651782|NCT01136772|66110750|FG000|Overall Study|Lack of Efficacy|42|||
23651783|NCT01136772|66110751|FG001|Overall Study|Lack of Efficacy|39|||
23651784|NCT01136772|66110750|FG000|Overall Study|Administrative|14|||
23651785|NCT01136772|66110751|FG001|Overall Study|Administrative|12|||
23651786|NCT01136772|66110750|FG000|Overall Study|Withdrawal by Subject|33|||
23651787|NCT01136772|66110751|FG001|Overall Study|Withdrawal by Subject|36|||
23651788|NCT01136772|66110750|FG000|Overall Study|Did not receive injection|10|||
23651789|NCT01136772|66110751|FG001|Overall Study|Did not receive injection|7|||
23651790|NCT01136772|66110750|FG000|Overall Study|Did not follow up after first injection|2|||
23651791|NCT01136772|66110751|FG001|Overall Study|Did not follow up after first injection|2|||
23651792|NCT04508023|66110753|FG000|Overall Study|Withdrawal by Subject|1|||
23651793|NCT04508023|66110754|FG001|Overall Study|Withdrawal by Subject|2|||
23651794|NCT03019185|66110759|FG000|Overall Study|Lost to Follow-up|3|||
23651795|NCT03019185|66110760|FG001|Overall Study|Lost to Follow-up|0|||
23651796|NCT03019185|66110761|FG002|Overall Study|Lost to Follow-up|2|||
23651797|NCT03019185|66110759|FG000|Overall Study|Withdrawal by Subject|1|||
23651798|NCT03019185|66110760|FG001|Overall Study|Withdrawal by Subject|1|||
23651799|NCT03019185|66110761|FG002|Overall Study|Withdrawal by Subject|0|||
23651800|NCT03019185|66110759|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
23705487|NCT03382899|66297517|FG001|Overall Study|Withdrawal by Subject|5|||
23651801|NCT03019185|66110760|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
23651802|NCT03019185|66110761|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
23651803|NCT03019185|66110759|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
23651804|NCT03019185|66110760|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
23651805|NCT03019185|66110761|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
23651806|NCT01079741|66110773|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23651807|NCT01079741|66110774|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
23651808|NCT01079741|66110775|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23651809|NCT01079741|66110776|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23651810|NCT01079741|66110777|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23651811|NCT01079741|66110773|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23651812|NCT01079741|66110774|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23651813|NCT01079741|66110775|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23651814|NCT01079741|66110776|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23651815|NCT01079741|66110777|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
23651816|NCT03739437|66110778|FG000|Overall Study|Lost to Follow-up|2|||
23651817|NCT03739437|66110779|FG001|Overall Study|Lost to Follow-up|5|||
23651818|NCT01890148|66110783|FG000|Overall Study|Adverse Event|1|||
23651819|NCT00402363|66110784|FG000|Overall Study|Adverse Event|9|||
23651820|NCT00402363|66110785|FG001|Overall Study|Adverse Event|14|||
23651821|NCT00402363|66110786|FG002|Overall Study|Adverse Event|2|||
23651822|NCT00402363|66110787|FG003|Overall Study|Adverse Event|2|||
23651823|NCT00402363|66110784|FG000|Overall Study|Withdrew Consent|10|||
23651824|NCT00402363|66110785|FG001|Overall Study|Withdrew Consent|5|||
23651825|NCT00402363|66110786|FG002|Overall Study|Withdrew Consent|2|||
23651826|NCT00402363|66110787|FG003|Overall Study|Withdrew Consent|1|||
23651827|NCT00402363|66110784|FG000|Overall Study|Protocol Violation|3|||
23651828|NCT00402363|66110785|FG001|Overall Study|Protocol Violation|5|||
23651829|NCT00402363|66110786|FG002|Overall Study|Protocol Violation|0|||
23651830|NCT00402363|66110787|FG003|Overall Study|Protocol Violation|3|||
23651831|NCT00402363|66110784|FG000|Overall Study|Lost to Follow-up|5|||
23651832|NCT00402363|66110785|FG001|Overall Study|Lost to Follow-up|4|||
23651833|NCT00402363|66110786|FG002|Overall Study|Lost to Follow-up|0|||
23651834|NCT00402363|66110787|FG003|Overall Study|Lost to Follow-up|2|||
23651835|NCT00402363|66110784|FG000|Overall Study|"Captured as Other"|6|||
23651836|NCT00402363|66110785|FG001|Overall Study|"Captured as Other"|2|||
23651837|NCT00402363|66110786|FG002|Overall Study|"Captured as Other"|2|||
23651838|NCT00402363|66110787|FG003|Overall Study|"Captured as Other"|2|||
23651839|NCT00232141|66110788|FG000|Overall Study|Adverse Event|9|||
23651840|NCT00232141|66110789|FG001|Overall Study|Adverse Event|4|||
23651841|NCT00232141|66110788|FG000|Overall Study|Lack of Efficacy|0|||
23651842|NCT00232141|66110789|FG001|Overall Study|Lack of Efficacy|3|||
23651843|NCT00232141|66110788|FG000|Overall Study|Lost to Follow-up|9|||
23651844|NCT00232141|66110789|FG001|Overall Study|Lost to Follow-up|6|||
23651845|NCT00232141|66110788|FG000|Overall Study|Other|8|||
23651846|NCT00232141|66110789|FG001|Overall Study|Other|10|||
23651847|NCT00232141|66110788|FG000|Overall Study|Withdrawal by Subject|5|||
23651848|NCT00232141|66110789|FG001|Overall Study|Withdrawal by Subject|3|||
23651849|NCT02795429|66110790|FG000|Overall Study|Adverse Event|1|||
23651850|NCT02795429|66110791|FG001|Overall Study|Adverse Event|2|||
23651851|NCT02795429|66110792|FG002|Overall Study|Adverse Event|1|||
23651852|NCT02795429|66110793|FG003|Overall Study|Adverse Event|2|||
23479450|NCT00420641|65498507|FG000|Overall Study|Lack of Efficacy|6|||
23651853|NCT02795429|66110794|FG004|Overall Study|Adverse Event|1|||
23651854|NCT02795429|66110790|FG000|Overall Study|Death|1|||
23651855|NCT02795429|66110791|FG001|Overall Study|Death|0|||
23651856|NCT02795429|66110792|FG002|Overall Study|Death|1|||
23651857|NCT02795429|66110793|FG003|Overall Study|Death|2|||
23651858|NCT02795429|66110794|FG004|Overall Study|Death|1|||
23651859|NCT02795429|66110790|FG000|Overall Study|Physician Decision|0|||
23651860|NCT02795429|66110791|FG001|Overall Study|Physician Decision|0|||
23651861|NCT02795429|66110792|FG002|Overall Study|Physician Decision|2|||
23651862|NCT02795429|66110793|FG003|Overall Study|Physician Decision|1|||
23651863|NCT02795429|66110794|FG004|Overall Study|Physician Decision|5|||
23651864|NCT02795429|66110790|FG000|Overall Study|Progressive disease|3|||
23479451|NCT00420641|65498508|FG001|Overall Study|Lack of Efficacy|5|||
23479452|NCT00420641|65498509|FG002|Overall Study|Lack of Efficacy|4|||
23479453|NCT00420641|65498507|FG000|Overall Study|Non-compliance|7|||
23479454|NCT00420641|65498508|FG001|Overall Study|Non-compliance|5|||
23479455|NCT00420641|65498509|FG002|Overall Study|Non-compliance|4|||
23599217|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
23599218|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
23599219|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
23599220|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
23599221|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
23599222|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
23599223|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
23599224|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
23599225|NCT03333109|65922466|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
23599226|NCT03333109|65922467|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
23599227|NCT03333109|65922468|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
23599228|NCT03333109|65922466|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
23599229|NCT03333109|65922467|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
23599230|NCT03333109|65922468|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
23599231|NCT02633215|65922469|FG000|Overall Study|Lost to Follow-up|2|||
23599232|NCT02633215|65922470|FG001|Overall Study|Lost to Follow-up|3|||
23599233|NCT00701701|65922472|FG000|Overall Study|Withdrawal by Subject|0|||
23599234|NCT00701701|65922473|FG001|Overall Study|Withdrawal by Subject|1|||
23599235|NCT00701701|65922472|FG000|Overall Study|Adverse Event|0|||
23599236|NCT00701701|65922473|FG001|Overall Study|Adverse Event|1|||
23599237|NCT01952366|65922474|FG000|Overall Study|Death|22|||
23599238|NCT01952366|65922474|FG000|Overall Study|Withdrawal by Subject|9|||
23599239|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
23599240|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
23599241|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
23599242|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
23599243|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
23599244|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
23599245|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
23599246|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
23801208|NCT03253094|66649921|FG005|Overall Study|Other|0|||
23801209|NCT04059549|66649925|FG000|Overall Study|Withdrawal by Subject|2|||
23801210|NCT04059549|66649926|FG001|Overall Study|Withdrawal by Subject|0|||
23801211|NCT00346164|66649927|FG000|Overall Study|Adverse Event|0|||
23801212|NCT00346164|66649928|FG001|Overall Study|Adverse Event|0|||
23801213|NCT00346164|66649929|FG002|Overall Study|Adverse Event|0|||
23801214|NCT00346164|66649930|FG003|Overall Study|Adverse Event|1|||
23801215|NCT00346164|66649927|FG000|Overall Study|Lack of Efficacy|0|||
23801216|NCT00346164|66649928|FG001|Overall Study|Lack of Efficacy|1|||
23801217|NCT00346164|66649929|FG002|Overall Study|Lack of Efficacy|7|||
23801218|NCT00346164|66649930|FG003|Overall Study|Lack of Efficacy|25|||
23801219|NCT00346164|66649927|FG000|Overall Study|Physician Decision|0|||
23801220|NCT00346164|66649928|FG001|Overall Study|Physician Decision|1|||
23801221|NCT00346164|66649929|FG002|Overall Study|Physician Decision|2|||
23801222|NCT00346164|66649930|FG003|Overall Study|Physician Decision|27|||
23801223|NCT00346164|66649927|FG000|Overall Study|Protocol Violation|6|||
23801224|NCT00346164|66649928|FG001|Overall Study|Protocol Violation|2|||
23801225|NCT00346164|66649929|FG002|Overall Study|Protocol Violation|10|||
23801226|NCT00346164|66649930|FG003|Overall Study|Protocol Violation|4|||
23801227|NCT00346164|66649927|FG000|Overall Study|Withdrawal by Subject|0|||
23599247|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
23599248|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
23599249|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
23599250|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
23801228|NCT00346164|66649928|FG001|Overall Study|Withdrawal by Subject|0|||
23801229|NCT00346164|66649929|FG002|Overall Study|Withdrawal by Subject|2|||
23801230|NCT00346164|66649930|FG003|Overall Study|Withdrawal by Subject|0|||
23801231|NCT00346164|66649927|FG000|Overall Study|Ineligible|11|||
23801232|NCT00346164|66649928|FG001|Overall Study|Ineligible|2|||
23801233|NCT00346164|66649929|FG002|Overall Study|Ineligible|2|||
23479456|NCT00420641|65498507|FG000|Overall Study|Other|4|||
23479457|NCT00420641|65498508|FG001|Overall Study|Other|4|||
23479458|NCT00420641|65498509|FG002|Overall Study|Other|3|||
23479459|NCT00484185|65498510|FG000|Overall Study|Lost to Follow-up|44|||
23479460|NCT00484185|65498510|FG000|Overall Study|Other|20|||
23479461|NCT00484185|65498510|FG000|Overall Study|Randomized but not treated|5|||
23479462|NCT00484185|65498510|FG000|Overall Study|Death|2|||
23479463|NCT03254459|65498511|FG000|Overall Study|Adverse Event|7|||
23479464|NCT03254459|65498512|FG001|Overall Study|Adverse Event|20|||
23479465|NCT03254459|65498511|FG000|Overall Study|Withdrawal by Subject Consent|3|||
23479466|NCT03254459|65498512|FG001|Overall Study|Withdrawal by Subject Consent|1|||
23479467|NCT03254459|65498511|FG000|Overall Study|Lost to Follow-up|0|||
23801234|NCT00346164|66649930|FG003|Overall Study|Ineligible|23|||
23801235|NCT00346164|66649927|FG000|Overall Study|Refusal of further protocol therapy|0|||
23801236|NCT00346164|66649928|FG001|Overall Study|Refusal of further protocol therapy|1|||
23801237|NCT00346164|66649929|FG002|Overall Study|Refusal of further protocol therapy|3|||
23801238|NCT00346164|66649930|FG003|Overall Study|Refusal of further protocol therapy|15|||
23801239|NCT00346164|66649927|FG000|Overall Study|Inability to start week 16 tx on time|0|||
23801240|NCT00346164|66649928|FG001|Overall Study|Inability to start week 16 tx on time|0|||
23801241|NCT00346164|66649929|FG002|Overall Study|Inability to start week 16 tx on time|0|||
23801242|NCT00346164|66649930|FG003|Overall Study|Inability to start week 16 tx on time|11|||
23801243|NCT02457819|66649931|FG000|Overall Study|reason not given|8|||
23801244|NCT02457819|66649931|FG000|Overall Study|Withdrawal by Subject|24|||
23801245|NCT02457819|66649931|FG000|Overall Study|Protocol Violation|1|||
23801246|NCT02457819|66649931|FG000|Overall Study|non compliance with study drug|4|||
23801247|NCT02457819|66649931|FG000|Overall Study|Lost to Follow-up|10|||
23801248|NCT02457819|66649931|FG000|Overall Study|Lack of Efficacy|19|||
23801249|NCT02457819|66649931|FG000|Overall Study|Adverse Event|33|||
23801250|NCT01098110|66649932|FG000|Overall Study|Withdrawal by Subject|14|||
23801251|NCT01098110|66649933|FG001|Overall Study|Withdrawal by Subject|24|||
23801252|NCT01098110|66649934|FG002|Overall Study|Withdrawal by Subject|19|||
23801253|NCT01098110|66649932|FG000|Overall Study|Adverse Event|30|||
23801254|NCT01098110|66649933|FG001|Overall Study|Adverse Event|32|||
23801255|NCT01098110|66649934|FG002|Overall Study|Adverse Event|43|||
23801256|NCT01098110|66649932|FG000|Overall Study|Lack of Efficacy|13|||
23801257|NCT01098110|66649933|FG001|Overall Study|Lack of Efficacy|9|||
23801258|NCT01098110|66649934|FG002|Overall Study|Lack of Efficacy|27|||
23801259|NCT01098110|66649932|FG000|Overall Study|Other|4|||
23801260|NCT01098110|66649933|FG001|Overall Study|Other|7|||
23801261|NCT01098110|66649934|FG002|Overall Study|Other|5|||
23801262|NCT01098110|66649932|FG000|Overall Study|Untreated|1|||
23801263|NCT01098110|66649933|FG001|Overall Study|Untreated|1|||
23801264|NCT01098110|66649934|FG002|Overall Study|Untreated|0|||
23801265|NCT02508116|66649939|FG000|Overall Study|Lost to Follow-up|2|||
23801266|NCT02508116|66649940|FG001|Overall Study|Lost to Follow-up|3|||
23801267|NCT02508116|66649939|FG000|Overall Study|Withdrawal by Subject|3|||
23801268|NCT02508116|66649940|FG001|Overall Study|Withdrawal by Subject|2|||
23801269|NCT02508116|66649939|FG000|Overall Study|Protocol Violation|1|||
23801270|NCT02508116|66649940|FG001|Overall Study|Protocol Violation|2|||
23801271|NCT02508116|66649939|FG000|Overall Study|Physician Decision|2|||
23801272|NCT02508116|66649940|FG001|Overall Study|Physician Decision|0|||
23801273|NCT02663882|66649947|FG000|Overall Study|Lost to Follow-up|4|||
23801274|NCT02663882|66649948|FG001|Overall Study|Lost to Follow-up|2|||
23801275|NCT00296491|66649949|FG000|Overall Study|Low Pollen Counts|18|||
23801276|NCT00296491|66649950|FG001|Overall Study|Low Pollen Counts|26|||
23479468|NCT03254459|65498512|FG001|Overall Study|Lost to Follow-up|1|||
23479469|NCT03254459|65498511|FG000|Overall Study|Miscellaneous|0|||
23479470|NCT03254459|65498512|FG001|Overall Study|Miscellaneous|1|||
23599251|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
23599252|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
23599253|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
23801277|NCT00296491|66649951|FG002|Overall Study|Low Pollen Counts|25|||
23801278|NCT00296491|66649952|FG003|Overall Study|Low Pollen Counts|16|||
23801279|NCT00296491|66649949|FG000|Overall Study|Protocol Violation|4|||
23801280|NCT00296491|66649950|FG001|Overall Study|Protocol Violation|6|||
23479471|NCT03467152|65498516|FG000|Overall Study|Adverse Event|4|||
23599254|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
23801281|NCT00296491|66649951|FG002|Overall Study|Protocol Violation|2|||
23801282|NCT00296491|66649952|FG003|Overall Study|Protocol Violation|3|||
23801283|NCT00296491|66649949|FG000|Overall Study|Adverse Event|1|||
23801284|NCT00296491|66649950|FG001|Overall Study|Adverse Event|3|||
23801285|NCT00296491|66649951|FG002|Overall Study|Adverse Event|1|||
23801286|NCT00296491|66649952|FG003|Overall Study|Adverse Event|4|||
23801287|NCT00296491|66649949|FG000|Overall Study|Withdrawn due to Asthma|0|||
23651865|NCT02795429|66110791|FG001|Overall Study|Progressive disease|7|||
23651866|NCT02795429|66110792|FG002|Overall Study|Progressive disease|6|||
23651867|NCT02795429|66110793|FG003|Overall Study|Progressive disease|26|||
23651868|NCT02795429|66110794|FG004|Overall Study|Progressive disease|20|||
23651869|NCT02795429|66110790|FG000|Overall Study|Subject/guardian decision|1|||
23651870|NCT02795429|66110791|FG001|Overall Study|Subject/guardian decision|1|||
23651871|NCT02795429|66110792|FG002|Overall Study|Subject/guardian decision|1|||
23651872|NCT02795429|66110793|FG003|Overall Study|Subject/guardian decision|1|||
23651873|NCT02795429|66110794|FG004|Overall Study|Subject/guardian decision|3|||
23651874|NCT00634010|66110799|FG000|Overall Study|Adverse Event|2|||
23651875|NCT00634010|66110800|FG001|Overall Study|Adverse Event|5|||
23651876|NCT00634010|66110799|FG000|Overall Study|Withdrawal by Subject|5|||
23651877|NCT00634010|66110800|FG001|Overall Study|Withdrawal by Subject|6|||
23651878|NCT00634010|66110799|FG000|Overall Study|Physician Decision|1|||
23651879|NCT00634010|66110800|FG001|Overall Study|Physician Decision|1|||
23651880|NCT00634010|66110799|FG000|Overall Study|Disease Progression|1|||
23651881|NCT00634010|66110800|FG001|Overall Study|Disease Progression|1|||
23651882|NCT00634010|66110799|FG000|Overall Study|Non-Compliant|1|||
23651883|NCT00634010|66110800|FG001|Overall Study|Non-Compliant|1|||
23651884|NCT02313233|66110801|FG000|Overall Study|Withdrawal by Subject|1|||
23651885|NCT02313233|66110802|FG001|Overall Study|Withdrawal by Subject|2|||
23651886|NCT02313233|66110801|FG000|Overall Study|Administrative reason|1|||
23651887|NCT02313233|66110802|FG001|Overall Study|Administrative reason|1|||
23651888|NCT02808143|66110803|FG000|Maintenance Phase|Disease recurrence|1|||
23651889|NCT02808143|66110804|FG001|Maintenance Phase|Disease recurrence|3|||
23651890|NCT02808143|66110803|FG000|Maintenance Phase|Disease progression|1|||
23651891|NCT02808143|66110804|FG001|Maintenance Phase|Disease progression|2|||
23651892|NCT02808143|66110803|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
23651893|NCT02808143|66110804|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
23651894|NCT02808143|66110803|FG000|Survival Follow-Up|Disease recurrence|0|||
23651895|NCT02808143|66110804|FG001|Survival Follow-Up|Disease recurrence|2|||
23651896|NCT02808143|66110803|FG000|Survival Follow-Up|Adverse Event|0|||
23651897|NCT02808143|66110804|FG001|Survival Follow-Up|Adverse Event|1|||
23651898|NCT02808143|66110803|FG000|Survival Follow-Up|Death|1|||
23651899|NCT02808143|66110804|FG001|Survival Follow-Up|Death|0|||
23651900|NCT00762970|66110805|FG000|Overall Study|Withdrawal by Subject|7|||
23651901|NCT00762970|66110806|FG001|Overall Study|Withdrawal by Subject|4|||
23651902|NCT00762970|66110807|FG002|Overall Study|Withdrawal by Subject|0|||
23651903|NCT00762970|66110805|FG000|Overall Study|Protocol Violation|3|||
23651904|NCT00762970|66110806|FG001|Overall Study|Protocol Violation|1|||
23651905|NCT00762970|66110807|FG002|Overall Study|Protocol Violation|1|||
23651906|NCT00762970|66110805|FG000|Overall Study|Lost to Follow-up|1|||
23651907|NCT00762970|66110806|FG001|Overall Study|Lost to Follow-up|2|||
23651908|NCT00762970|66110807|FG002|Overall Study|Lost to Follow-up|0|||
23651909|NCT00762970|66110805|FG000|Overall Study|Difficulty of handling lens|1|||
23651910|NCT00762970|66110806|FG001|Overall Study|Difficulty of handling lens|2|||
23651911|NCT00762970|66110807|FG002|Overall Study|Difficulty of handling lens|0|||
23651912|NCT02147353|66110811|FG000|Overall Study|Lost to Follow-up|2|||
23651913|NCT02147353|66110812|FG001|Overall Study|Lost to Follow-up|0|||
23651914|NCT02147353|66110811|FG000|Overall Study|unable to make visits|4|||
23651915|NCT02147353|66110812|FG001|Overall Study|unable to make visits|0|||
23651916|NCT02147353|66110811|FG000|Overall Study|medication noncompliance|3|||
23651917|NCT02147353|66110812|FG001|Overall Study|medication noncompliance|0|||
23651918|NCT00440700|66110815|FG000|Overall Study|Withdrawal by Subject|8|||
23651919|NCT00440700|66110816|FG001|Overall Study|Withdrawal by Subject|8|||
23651920|NCT00440700|66110817|FG002|Overall Study|Withdrawal by Subject|4|||
23360740|NCT01827592|65065869|FG000|Overall Study|Trial terminated by Sponsor|47|||
23360741|NCT01827592|65065870|FG001|Overall Study|Trial terminated by Sponsor|53|||
23360742|NCT01827592|65065871|FG002|Overall Study|Trial terminated by Sponsor|51|||
23360743|NCT01827592|65065869|FG000|Overall Study|Others|0|||
23360744|NCT01827592|65065870|FG001|Overall Study|Others|1|||
23651921|NCT02196714|66110820|FG000|Overall Study|Protocol Violation|0|||
23651922|NCT02196714|66110821|FG001|Overall Study|Protocol Violation|0|||
23651923|NCT02196714|66110822|FG002|Overall Study|Protocol Violation|1|||
23651924|NCT02196714|66110823|FG003|Overall Study|Protocol Violation|0|||
23651925|NCT01313650|66110824|FG000|Overall Study|Adverse Event|9|||
23651926|NCT01313650|66110825|FG001|Overall Study|Adverse Event|34|||
23651927|NCT01313650|66110826|FG002|Overall Study|Adverse Event|24|||
23651928|NCT01313650|66110827|FG003|Overall Study|Adverse Event|23|||
23651929|NCT01313650|66110824|FG000|Overall Study|Lack of Efficacy|37|||
23651930|NCT01313650|66110825|FG001|Overall Study|Lack of Efficacy|20|||
23651931|NCT01313650|66110826|FG002|Overall Study|Lack of Efficacy|32|||
23651932|NCT01313650|66110827|FG003|Overall Study|Lack of Efficacy|20|||
23651933|NCT01313650|66110824|FG000|Overall Study|Lost to Follow-up|1|||
23651934|NCT01313650|66110825|FG001|Overall Study|Lost to Follow-up|0|||
23479472|NCT03467152|65498517|FG001|Overall Study|Adverse Event|5|||
23479473|NCT03467152|65498518|FG002|Overall Study|Adverse Event|0|||
23479474|NCT03467152|65498516|FG000|Overall Study|Subject Choice|1|||
23479475|NCT03467152|65498517|FG001|Overall Study|Subject Choice|3|||
23479476|NCT03467152|65498518|FG002|Overall Study|Subject Choice|0|||
23479477|NCT03467152|65498516|FG000|Overall Study|Lost to Follow-up|1|||
23479478|NCT03467152|65498517|FG001|Overall Study|Lost to Follow-up|0|||
23479479|NCT03467152|65498518|FG002|Overall Study|Lost to Follow-up|0|||
23479480|NCT03467152|65498516|FG000|Overall Study|Withdrawal by Subject|4|||
23479481|NCT03467152|65498517|FG001|Overall Study|Withdrawal by Subject|2|||
23479482|NCT03467152|65498518|FG002|Overall Study|Withdrawal by Subject|0|||
23479483|NCT03467152|65498516|FG000|Overall Study|Others|3|||
23479484|NCT03467152|65498517|FG001|Overall Study|Others|0|||
23479485|NCT03467152|65498518|FG002|Overall Study|Others|0|||
23479486|NCT03467152|65498516|FG000|Overall Study|Not treated|3|||
23479487|NCT03467152|65498517|FG001|Overall Study|Not treated|1|||
23479488|NCT03467152|65498518|FG002|Overall Study|Not treated|6|||
23479489|NCT02009384|65498519|FG000|Overall Study|Death|2|||
23479490|NCT01268579|65498520|FG000|Overall Study|Adverse Event|1|||
23479491|NCT01268579|65498520|FG000|Overall Study|Withdrawal by Subject|2|||
23479492|NCT02093351|65498521|FG000|Part A|Adverse Event|0|||
23479493|NCT02093351|65498522|FG001|Part A|Adverse Event|1|||
23479494|NCT02093351|65498523|FG002|Part A|Adverse Event|1|||
23479495|NCT02093351|65498524|FG003|Part A|Adverse Event|0|||
23479496|NCT02093351|65498521|FG000|Part A|Condition under investigation worsened|2|||
23479497|NCT02093351|65498522|FG001|Part A|Condition under investigation worsened|0|||
23479498|NCT02093351|65498523|FG002|Part A|Condition under investigation worsened|2|||
23479499|NCT02093351|65498524|FG003|Part A|Condition under investigation worsened|0|||
23479500|NCT02093351|65498521|FG000|Part A|Death|0|||
23479501|NCT02093351|65498522|FG001|Part A|Death|1|||
23479502|NCT02093351|65498523|FG002|Part A|Death|0|||
23479503|NCT02093351|65498524|FG003|Part A|Death|0|||
23479504|NCT02093351|65498521|FG000|Part B|Patient decision|0|||
23479505|NCT02093351|65498522|FG001|Part B|Patient decision|0|||
23479506|NCT02093351|65498523|FG002|Part B|Patient decision|0|||
23479507|NCT02093351|65498524|FG003|Part B|Patient decision|3|||
23479508|NCT02093351|65498521|FG000|Part B|Disease progression|0|||
23479509|NCT02093351|65498522|FG001|Part B|Disease progression|0|||
23479510|NCT02093351|65498523|FG002|Part B|Disease progression|0|||
23479511|NCT02093351|65498524|FG003|Part B|Disease progression|4|||
23479512|NCT02093351|65498521|FG000|Part B|Complete response|0|||
23651935|NCT01313650|66110826|FG002|Overall Study|Lost to Follow-up|3|||
23651936|NCT01313650|66110827|FG003|Overall Study|Lost to Follow-up|2|||
23651937|NCT01313650|66110824|FG000|Overall Study|Withdrawal by Subject|16|||
23651938|NCT01313650|66110825|FG001|Overall Study|Withdrawal by Subject|20|||
23651939|NCT01313650|66110826|FG002|Overall Study|Withdrawal by Subject|15|||
23801288|NCT00296491|66649950|FG001|Overall Study|Withdrawn due to Asthma|0|||
23801289|NCT00296491|66649951|FG002|Overall Study|Withdrawn due to Asthma|0|||
23801290|NCT00296491|66649952|FG003|Overall Study|Withdrawn due to Asthma|4|||
23801291|NCT00296491|66649949|FG000|Overall Study|Withdrawal by Subject|7|||
23801292|NCT00296491|66649950|FG001|Overall Study|Withdrawal by Subject|3|||
23801293|NCT00296491|66649951|FG002|Overall Study|Withdrawal by Subject|3|||
23801294|NCT00296491|66649952|FG003|Overall Study|Withdrawal by Subject|2|||
23801295|NCT00296491|66649949|FG000|Overall Study|Non-Compliance|12|||
23801296|NCT00296491|66649950|FG001|Overall Study|Non-Compliance|13|||
23801297|NCT00296491|66649951|FG002|Overall Study|Non-Compliance|10|||
23801298|NCT00296491|66649952|FG003|Overall Study|Non-Compliance|14|||
23801299|NCT00296491|66649949|FG000|Overall Study|Lost to Follow-up|0|||
23801300|NCT00296491|66649950|FG001|Overall Study|Lost to Follow-up|2|||
23801301|NCT00296491|66649951|FG002|Overall Study|Lost to Follow-up|2|||
23801302|NCT00296491|66649952|FG003|Overall Study|Lost to Follow-up|0|||
23801303|NCT01286558|66649953|FG000|Overall Study|Adverse Event|1|||
23801304|NCT01286558|66649954|FG001|Overall Study|Adverse Event|1|||
23801305|NCT01286558|66649953|FG000|Overall Study|Withdrawal by Subject|0|||
23801306|NCT01286558|66649954|FG001|Overall Study|Withdrawal by Subject|1|||
23801307|NCT00003531|66649957|FG000|Overall Study|Not evaluable|10|||
23801308|NCT00918463|66649958|FG000|Overall Study|Death|1|||
23479513|NCT02093351|65498522|FG001|Part B|Complete response|0|||
23479514|NCT02093351|65498523|FG002|Part B|Complete response|0|||
23651940|NCT01313650|66110827|FG003|Overall Study|Withdrawal by Subject|15|||
23801309|NCT00918463|66649958|FG000|Overall Study|Lack of Efficacy|1|||
23801310|NCT04025684|66649960|FG000|Overall Study|Withdrawal by Subject|1|||
23651941|NCT01313650|66110824|FG000|Overall Study|Protocol Violation|4|||
23479515|NCT02093351|65498524|FG003|Part B|Complete response|1|||
23479516|NCT02093351|65498521|FG000|Part B|Adverse event + disease progression|0|||
23651942|NCT01313650|66110825|FG001|Overall Study|Protocol Violation|7|||
23801311|NCT04025684|66649961|FG001|Overall Study|Withdrawal by Subject|1|||
23801312|NCT04025684|66649962|FG002|Overall Study|Withdrawal by Subject|0|||
23479517|NCT02093351|65498522|FG001|Part B|Adverse event + disease progression|0|||
23479518|NCT02093351|65498523|FG002|Part B|Adverse event + disease progression|0|||
23479519|NCT02093351|65498524|FG003|Part B|Adverse event + disease progression|1|||
23651943|NCT01313650|66110826|FG002|Overall Study|Protocol Violation|5|||
23651944|NCT01313650|66110827|FG003|Overall Study|Protocol Violation|6|||
23651945|NCT01313650|66110824|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
23651946|NCT01313650|66110825|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
23651947|NCT01313650|66110826|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
23651948|NCT01313650|66110827|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
23651949|NCT03610165|66110828|FG000|Overall Study|Device didn't work|0|||
23651950|NCT03610165|66110829|FG001|Overall Study|Device didn't work|1|||
23651951|NCT00512317|66110830|FG000|Overall Study|Insufficient clinical response|36|||
23651952|NCT00512317|66110830|FG000|Overall Study|Withdrawal by Subject|23|||
23651953|NCT00512317|66110830|FG000|Overall Study|Sponsor closure of study|21|||
23651954|NCT00512317|66110830|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
23651955|NCT00512317|66110830|FG000|Overall Study|Adverse Event|13|||
23651956|NCT00512317|66110830|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
23651957|NCT00512317|66110830|FG000|Overall Study|Lost to Follow-up|2|||
23651958|NCT00512317|66110830|FG000|Overall Study|Other|2|||
23651959|NCT03040622|66110831|FG000|Overall Study|unable to implant device|3|||
23651960|NCT00807235|66110832|FG000|Overall Study|Adverse Event|1|||
23651961|NCT00807235|66110833|FG001|Overall Study|Adverse Event|0|||
23651962|NCT02349360|66110834|FG000|Overall Study|Withdrawal by Subject|0|||
23651963|NCT02349360|66110835|FG001|Overall Study|Withdrawal by Subject|1|||
23651964|NCT01699789|66110836|FG000|Overall Study|Withdrawal by Subject|18|||
23651965|NCT01699789|66110837|FG001|Overall Study|Withdrawal by Subject|23|||
23651966|NCT01699789|66110836|FG000|Overall Study|Death|1|||
23651967|NCT01699789|66110837|FG001|Overall Study|Death|2|||
23651968|NCT01699789|66110836|FG000|Overall Study|Lost to Follow-up|83|||
23599255|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
23599256|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
23599257|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
23651969|NCT01699789|66110837|FG001|Overall Study|Lost to Follow-up|101|||
23651970|NCT02720536|66110838|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
23651971|NCT02720536|66110838|FG000|Overall Study|PR - pregnancy|2|||
23651972|NCT02720536|66110838|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
23651973|NCT02720536|66110838|FG000|Overall Study|PR - death|1|||
23651974|NCT02720536|66110838|FG000|Overall Study|PR - adverse event|1|||
23651975|NCT02720536|66110838|FG000|Overall Study|PR - abnormal lab value(s)|1|||
23651976|NCT02720536|66110838|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
23651977|NCT02569957|66110839|FG000|Overall Study|Withdrawal by Subject|0|||
23651978|NCT02569957|66110840|FG001|Overall Study|Withdrawal by Subject|1|||
23651979|NCT01778023|66110841|FG000|Overall Study|Withdrawal by Subject|0|||
23651980|NCT01778023|66110842|FG001|Overall Study|Withdrawal by Subject|3|||
23651981|NCT01111474|66110859|FG000|Overall Study|Lost to Follow-up|12|||
23651982|NCT00971243|66110862|FG000|Double Blind Period|Adverse Event|2|||
23651983|NCT00971243|66110863|FG001|Double Blind Period|Adverse Event|3|||
23651984|NCT00971243|66110864|FG002|Double Blind Period|Adverse Event|2|||
23651985|NCT00971243|66110865|FG003|Double Blind Period|Adverse Event|2|||
23651986|NCT00971243|66110866|FG004|Double Blind Period|Adverse Event|3|||
23651987|NCT00971243|66110862|FG000|Double Blind Period|Lost to Follow-up|0|||
23651988|NCT00971243|66110863|FG001|Double Blind Period|Lost to Follow-up|1|||
23651989|NCT00971243|66110864|FG002|Double Blind Period|Lost to Follow-up|1|||
23651990|NCT00971243|66110865|FG003|Double Blind Period|Lost to Follow-up|0|||
23651991|NCT00971243|66110866|FG004|Double Blind Period|Lost to Follow-up|1|||
23651992|NCT00971243|66110862|FG000|Double Blind Period|Physician Decision|10|||
23651993|NCT00971243|66110863|FG001|Double Blind Period|Physician Decision|6|||
23651994|NCT00971243|66110864|FG002|Double Blind Period|Physician Decision|7|||
23651995|NCT00971243|66110865|FG003|Double Blind Period|Physician Decision|6|||
23651996|NCT00971243|66110866|FG004|Double Blind Period|Physician Decision|7|||
23651997|NCT00971243|66110862|FG000|Double Blind Period|Protocol Violation|2|||
23651998|NCT00971243|66110863|FG001|Double Blind Period|Protocol Violation|0|||
23651999|NCT00971243|66110864|FG002|Double Blind Period|Protocol Violation|3|||
23652000|NCT00971243|66110865|FG003|Double Blind Period|Protocol Violation|2|||
23652001|NCT00971243|66110866|FG004|Double Blind Period|Protocol Violation|2|||
23652002|NCT00971243|66110862|FG000|Double Blind Period|Withdrawal by Subject|4|||
23652003|NCT00971243|66110863|FG001|Double Blind Period|Withdrawal by Subject|1|||
23360745|NCT01827592|65065871|FG002|Overall Study|Others|3|||
23652004|NCT00971243|66110864|FG002|Double Blind Period|Withdrawal by Subject|4|||
23652005|NCT00971243|66110865|FG003|Double Blind Period|Withdrawal by Subject|4|||
23652006|NCT00971243|66110866|FG004|Double Blind Period|Withdrawal by Subject|4|||
23652007|NCT00971243|66110862|FG000|Double Blind Period|Other reasons|1|||
23652008|NCT00971243|66110863|FG001|Double Blind Period|Other reasons|0|||
23652009|NCT00971243|66110864|FG002|Double Blind Period|Other reasons|2|||
23652010|NCT00971243|66110865|FG003|Double Blind Period|Other reasons|0|||
23652011|NCT00971243|66110866|FG004|Double Blind Period|Other reasons|1|||
23652012|NCT00971243|66110862|FG000|Open-label Period|Adverse Event|1|||
23652013|NCT00971243|66110863|FG001|Open-label Period|Adverse Event|0|||
23801313|NCT04025684|66649963|FG003|Overall Study|Withdrawal by Subject|0|||
23652014|NCT00971243|66110864|FG002|Open-label Period|Adverse Event|1|||
23652015|NCT00971243|66110865|FG003|Open-label Period|Adverse Event|1|||
23652016|NCT00971243|66110866|FG004|Open-label Period|Adverse Event|0|||
23652017|NCT00971243|66110862|FG000|Open-label Period|Physician Decision|5|||
23652018|NCT00971243|66110863|FG001|Open-label Period|Physician Decision|9|||
23652019|NCT00971243|66110864|FG002|Open-label Period|Physician Decision|3|||
23652020|NCT00971243|66110865|FG003|Open-label Period|Physician Decision|7|||
23652021|NCT00971243|66110866|FG004|Open-label Period|Physician Decision|2|||
23652022|NCT00971243|66110862|FG000|Open-label Period|Protocol Violation|1|||
23652023|NCT00971243|66110863|FG001|Open-label Period|Protocol Violation|1|||
23652024|NCT00971243|66110864|FG002|Open-label Period|Protocol Violation|1|||
23652025|NCT00971243|66110865|FG003|Open-label Period|Protocol Violation|0|||
23652026|NCT00971243|66110866|FG004|Open-label Period|Protocol Violation|1|||
23652027|NCT00971243|66110862|FG000|Open-label Period|Withdrawal by Subject|1|||
23652028|NCT00971243|66110863|FG001|Open-label Period|Withdrawal by Subject|0|||
23652029|NCT00971243|66110864|FG002|Open-label Period|Withdrawal by Subject|0|||
23652030|NCT00971243|66110865|FG003|Open-label Period|Withdrawal by Subject|2|||
23652031|NCT00971243|66110866|FG004|Open-label Period|Withdrawal by Subject|1|||
23652032|NCT00971243|66110862|FG000|Open-label Period|Other reason|0|||
23652033|NCT00971243|66110863|FG001|Open-label Period|Other reason|0|||
23652034|NCT00971243|66110864|FG002|Open-label Period|Other reason|0|||
23652035|NCT00971243|66110865|FG003|Open-label Period|Other reason|0|||
23652036|NCT00971243|66110866|FG004|Open-label Period|Other reason|2|||
23652037|NCT02370043|66110874|FG000|Overall Study|Withdrawal by Subject|0|||
23652038|NCT02370043|66110875|FG001|Overall Study|Withdrawal by Subject|0|||
23652039|NCT02370043|66110876|FG002|Overall Study|Withdrawal by Subject|0|||
23652040|NCT02370043|66110877|FG003|Overall Study|Withdrawal by Subject|0|||
23652041|NCT02370043|66110878|FG004|Overall Study|Withdrawal by Subject|1|||
23652042|NCT02370043|66110879|FG005|Overall Study|Withdrawal by Subject|1|||
23652043|NCT02245672|66110885|FG000|Overall Study|Adverse Event|4|||
23652044|NCT02245672|66110886|FG001|Overall Study|Adverse Event|4|||
23652045|NCT02245672|66110887|FG002|Overall Study|Adverse Event|4|||
23652046|NCT02245672|66110885|FG000|Overall Study|Lost to Follow-up|3|||
23801314|NCT04025684|66649960|FG000|Overall Study|Multiple reasons|1|||
23801315|NCT04025684|66649961|FG001|Overall Study|Multiple reasons|3|||
23479520|NCT02093351|65498521|FG000|Part B|Lack of therapeutic response|0|||
23479521|NCT02093351|65498522|FG001|Part B|Lack of therapeutic response|0|||
23479522|NCT02093351|65498523|FG002|Part B|Lack of therapeutic response|0|||
23801316|NCT04025684|66649962|FG002|Overall Study|Multiple reasons|0|||
23801317|NCT04025684|66649963|FG003|Overall Study|Multiple reasons|1|||
23801318|NCT03433755|66649964|FG000|Overall Study|Lost to Follow-up|1|||
23801319|NCT03433755|66649965|FG001|Overall Study|Lost to Follow-up|0|||
23801320|NCT03433755|66649966|FG002|Overall Study|Lost to Follow-up|0|||
23801321|NCT03433755|66649967|FG003|Overall Study|Lost to Follow-up|0|||
23801322|NCT03433755|66649964|FG000|Overall Study|Decision by Sponsor|1|||
23801323|NCT03433755|66649965|FG001|Overall Study|Decision by Sponsor|0|||
23801324|NCT03433755|66649966|FG002|Overall Study|Decision by Sponsor|0|||
23801325|NCT03433755|66649967|FG003|Overall Study|Decision by Sponsor|0|||
23801326|NCT02737592|66649968|FG000|Overall Study|Withdrawal by Subject|1|||
23801327|NCT04403763|66649972|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
23801328|NCT04403763|66649973|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
23801329|NCT04403763|66649974|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
23801330|NCT04403763|66649975|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
23801331|NCT04403763|66649976|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
23801332|NCT04403763|66649977|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
23801333|NCT04403763|66649978|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
23801334|NCT04403763|66649972|FG000|Stage 1|Early termination due to PK tube failure|0|||
23801335|NCT04403763|66649973|FG001|Stage 1|Early termination due to PK tube failure|0|||
23801336|NCT04403763|66649974|FG002|Stage 1|Early termination due to PK tube failure|1|||
23801337|NCT04403763|66649975|FG003|Stage 1|Early termination due to PK tube failure|0|||
23801338|NCT04403763|66649976|FG004|Stage 1|Early termination due to PK tube failure|0|||
23801339|NCT04403763|66649977|FG005|Stage 1|Early termination due to PK tube failure|0|||
23801340|NCT04403763|66649978|FG006|Stage 1|Early termination due to PK tube failure|0|||
23479523|NCT02093351|65498524|FG003|Part B|Lack of therapeutic response|12|||
23599258|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
23652047|NCT02245672|66110886|FG001|Overall Study|Lost to Follow-up|5|||
23652048|NCT02245672|66110887|FG002|Overall Study|Lost to Follow-up|1|||
23652049|NCT02245672|66110885|FG000|Overall Study|Withdrawal by Subject|6|||
23652050|NCT02245672|66110886|FG001|Overall Study|Withdrawal by Subject|3|||
23652051|NCT02245672|66110887|FG002|Overall Study|Withdrawal by Subject|0|||
23652052|NCT02245672|66110885|FG000|Overall Study|Randomized in error (not treated)|0|||
23801341|NCT04403763|66649972|FG000|Stage 2A|Adverse Event|0|||
23360746|NCT00398047|65065874|FG000|Overall Study|all patient progressed before completion|3|||
23360747|NCT02072941|65065875|FG000|Overall Study|Withdrawal by Subject|29|||
23360748|NCT02072941|65065876|FG001|Overall Study|Withdrawal by Subject|21|||
23360749|NCT02072941|65065875|FG000|Overall Study|Lost to Follow-up|4|||
23360750|NCT02072941|65065876|FG001|Overall Study|Lost to Follow-up|4|||
23599259|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
23599260|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
23599261|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
23599262|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
23599263|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
23599264|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
23599265|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
23599266|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
23599267|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
23599268|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
23599269|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
23599270|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
23599271|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
23599272|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
23599273|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
23599274|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
23599275|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
23599276|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
23599277|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
23599278|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
23599279|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
23599280|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
23360751|NCT02072941|65065875|FG000|Overall Study|Death|3|||
23599281|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
23599282|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
23599283|NCT01639131|65922477|FG000|Overall Study|Disease Progression|6|||
23599284|NCT00822120|65922478|FG000|Initial Registration|Adverse Event|1|||
23599285|NCT00822120|65922479|FG001|Initial Registration|Adverse Event|0|||
23599286|NCT00822120|65922480|FG002|Initial Registration|Adverse Event|0|||
23599287|NCT00822120|65922481|FG003|Initial Registration|Adverse Event|0|||
23599288|NCT00822120|65922482|FG004|Initial Registration|Adverse Event|0|||
23599289|NCT00822120|65922483|FG005|Initial Registration|Adverse Event|0|||
23599290|NCT00822120|65922478|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
23599291|NCT00822120|65922479|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599292|NCT00822120|65922480|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599293|NCT00822120|65922481|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599294|NCT00822120|65922482|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599295|NCT00822120|65922483|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599296|NCT00822120|65922478|FG000|Initial Registration|Reasons not Protocol Specified|2|||
23599297|NCT00822120|65922479|FG001|Initial Registration|Reasons not Protocol Specified|0|||
23599298|NCT00822120|65922480|FG002|Initial Registration|Reasons not Protocol Specified|0|||
23599299|NCT00822120|65922481|FG003|Initial Registration|Reasons not Protocol Specified|0|||
23599300|NCT00822120|65922482|FG004|Initial Registration|Reasons not Protocol Specified|0|||
23599301|NCT00822120|65922483|FG005|Initial Registration|Reasons not Protocol Specified|0|||
23599302|NCT00822120|65922478|FG000|Initial Registration|Ineligible|22|||
23599303|NCT00822120|65922479|FG001|Initial Registration|Ineligible|1|||
23599304|NCT00822120|65922480|FG002|Initial Registration|Ineligible|0|||
23360752|NCT02072941|65065876|FG001|Overall Study|Death|2|||
23360753|NCT02072941|65065875|FG000|Overall Study|Removed by Study Staff|2|||
23479524|NCT02093351|65498521|FG000|Part B|Condition under investigation worsened|0|||
23479525|NCT02093351|65498522|FG001|Part B|Condition under investigation worsened|0|||
23479526|NCT02093351|65498523|FG002|Part B|Condition under investigation worsened|0|||
23479527|NCT02093351|65498524|FG003|Part B|Condition under investigation worsened|39|||
23479528|NCT02093351|65498521|FG000|Part B|Adverse Event|0|||
23479529|NCT02093351|65498522|FG001|Part B|Adverse Event|0|||
23479530|NCT02093351|65498523|FG002|Part B|Adverse Event|0|||
23479531|NCT02093351|65498524|FG003|Part B|Adverse Event|2|||
23479532|NCT02093351|65498521|FG000|Part B|Death|0|||
23479533|NCT02093351|65498522|FG001|Part B|Death|0|||
23479534|NCT02093351|65498523|FG002|Part B|Death|0|||
23479535|NCT02093351|65498524|FG003|Part B|Death|1|||
23479536|NCT00843778|65498525|FG000|Overall Study|Adverse Event|15|||
23479537|NCT00843778|65498525|FG000|Overall Study|Lack of Efficacy|14|||
23479538|NCT00843778|65498525|FG000|Overall Study|Loss of efficacy|2|||
23479539|NCT00843778|65498525|FG000|Overall Study|Withdrawal by Subject|4|||
23479540|NCT00722371|65498528|FG000|Overall Study|Adverse Event|6|||
23479541|NCT00722371|65498529|FG001|Overall Study|Adverse Event|13|||
23479542|NCT00722371|65498530|FG002|Overall Study|Adverse Event|9|||
23479543|NCT00722371|65498531|FG003|Overall Study|Adverse Event|10|||
23479544|NCT00722371|65498532|FG004|Overall Study|Adverse Event|6|||
23479545|NCT00722371|65498533|FG005|Overall Study|Adverse Event|8|||
23479546|NCT00722371|65498534|FG006|Overall Study|Adverse Event|4|||
23479547|NCT00722371|65498528|FG000|Overall Study|Contraindication|0|||
23479548|NCT00722371|65498529|FG001|Overall Study|Contraindication|0|||
23479549|NCT00722371|65498530|FG002|Overall Study|Contraindication|1|||
23479550|NCT00722371|65498531|FG003|Overall Study|Contraindication|0|||
23479551|NCT00722371|65498532|FG004|Overall Study|Contraindication|0|||
23479552|NCT00722371|65498533|FG005|Overall Study|Contraindication|0|||
23479553|NCT00722371|65498534|FG006|Overall Study|Contraindication|0|||
23479554|NCT00722371|65498528|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
23479555|NCT00722371|65498529|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
23479556|NCT00722371|65498530|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
23479557|NCT00722371|65498531|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
23479558|NCT00722371|65498532|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
23479559|NCT00722371|65498533|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
23479560|NCT00722371|65498534|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
23479561|NCT00722371|65498528|FG000|Overall Study|Excluded medication|0|||
23479562|NCT00722371|65498529|FG001|Overall Study|Excluded medication|1|||
23479563|NCT00722371|65498530|FG002|Overall Study|Excluded medication|1|||
23479564|NCT00722371|65498531|FG003|Overall Study|Excluded medication|0|||
23479565|NCT00722371|65498532|FG004|Overall Study|Excluded medication|0|||
23479566|NCT00722371|65498533|FG005|Overall Study|Excluded medication|0|||
23479567|NCT00722371|65498534|FG006|Overall Study|Excluded medication|1|||
23479568|NCT00722371|65498528|FG000|Overall Study|Hyperglycemia|2|||
23479569|NCT00722371|65498529|FG001|Overall Study|Hyperglycemia|6|||
23479570|NCT00722371|65498530|FG002|Overall Study|Hyperglycemia|4|||
23599305|NCT00822120|65922481|FG003|Initial Registration|Ineligible|0|||
23599306|NCT00822120|65922482|FG004|Initial Registration|Ineligible|0|||
23599307|NCT00822120|65922483|FG005|Initial Registration|Ineligible|0|||
23599308|NCT00822120|65922478|FG000|PET-directed Therapy|Adverse Event|0|||
23599309|NCT00822120|65922479|FG001|PET-directed Therapy|Adverse Event|0|||
23599310|NCT00822120|65922480|FG002|PET-directed Therapy|Adverse Event|0|||
23599311|NCT00822120|65922481|FG003|PET-directed Therapy|Adverse Event|1|||
23599312|NCT00822120|65922482|FG004|PET-directed Therapy|Adverse Event|0|||
23599313|NCT00822120|65922483|FG005|PET-directed Therapy|Adverse Event|0|||
23599314|NCT00822120|65922478|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599315|NCT00822120|65922479|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599316|NCT00822120|65922480|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599317|NCT00822120|65922481|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
23599318|NCT00822120|65922482|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599319|NCT00822120|65922483|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599320|NCT00822120|65922478|FG000|PET-directed Therapy|Death|0|||
23599321|NCT00822120|65922479|FG001|PET-directed Therapy|Death|0|||
23599322|NCT00822120|65922480|FG002|PET-directed Therapy|Death|0|||
23479571|NCT00722371|65498531|FG003|Overall Study|Hyperglycemia|2|||
23479572|NCT00722371|65498532|FG004|Overall Study|Hyperglycemia|5|||
23479573|NCT00722371|65498533|FG005|Overall Study|Hyperglycemia|1|||
23479574|NCT00722371|65498534|FG006|Overall Study|Hyperglycemia|1|||
23599323|NCT00822120|65922481|FG003|PET-directed Therapy|Death|2|||
23479575|NCT00722371|65498528|FG000|Overall Study|Hypoglycemia|1|||
23479576|NCT00722371|65498529|FG001|Overall Study|Hypoglycemia|0|||
23479577|NCT00722371|65498530|FG002|Overall Study|Hypoglycemia|0|||
23599324|NCT00822120|65922482|FG004|PET-directed Therapy|Death|0|||
23479578|NCT00722371|65498531|FG003|Overall Study|Hypoglycemia|0|||
23479579|NCT00722371|65498532|FG004|Overall Study|Hypoglycemia|0|||
23479580|NCT00722371|65498533|FG005|Overall Study|Hypoglycemia|0|||
23479581|NCT00722371|65498534|FG006|Overall Study|Hypoglycemia|0|||
23479582|NCT00722371|65498528|FG000|Overall Study|Lack of Efficacy|4|||
23479583|NCT00722371|65498529|FG001|Overall Study|Lack of Efficacy|6|||
23479584|NCT00722371|65498530|FG002|Overall Study|Lack of Efficacy|6|||
23479585|NCT00722371|65498531|FG003|Overall Study|Lack of Efficacy|6|||
23479586|NCT00722371|65498532|FG004|Overall Study|Lack of Efficacy|2|||
23479587|NCT00722371|65498533|FG005|Overall Study|Lack of Efficacy|3|||
23479588|NCT00722371|65498534|FG006|Overall Study|Lack of Efficacy|0|||
23479589|NCT00722371|65498528|FG000|Overall Study|Lost to Follow-up|11|||
23479590|NCT00722371|65498529|FG001|Overall Study|Lost to Follow-up|14|||
23479591|NCT00722371|65498530|FG002|Overall Study|Lost to Follow-up|21|||
23479592|NCT00722371|65498531|FG003|Overall Study|Lost to Follow-up|13|||
23479593|NCT00722371|65498532|FG004|Overall Study|Lost to Follow-up|8|||
23479594|NCT00722371|65498533|FG005|Overall Study|Lost to Follow-up|16|||
23479595|NCT00722371|65498534|FG006|Overall Study|Lost to Follow-up|13|||
23479596|NCT00722371|65498528|FG000|Overall Study|Physician Decision|5|||
23479597|NCT00722371|65498529|FG001|Overall Study|Physician Decision|2|||
23479598|NCT00722371|65498530|FG002|Overall Study|Physician Decision|2|||
23479599|NCT00722371|65498531|FG003|Overall Study|Physician Decision|5|||
23479600|NCT00722371|65498532|FG004|Overall Study|Physician Decision|2|||
23479601|NCT00722371|65498533|FG005|Overall Study|Physician Decision|3|||
23479602|NCT00722371|65498534|FG006|Overall Study|Physician Decision|4|||
23479603|NCT00722371|65498528|FG000|Overall Study|Pregnancy|1|||
23479604|NCT00722371|65498529|FG001|Overall Study|Pregnancy|1|||
23479605|NCT00722371|65498530|FG002|Overall Study|Pregnancy|0|||
23479606|NCT00722371|65498531|FG003|Overall Study|Pregnancy|0|||
23479607|NCT00722371|65498532|FG004|Overall Study|Pregnancy|0|||
23479608|NCT00722371|65498533|FG005|Overall Study|Pregnancy|1|||
23479609|NCT00722371|65498534|FG006|Overall Study|Pregnancy|0|||
23479610|NCT00722371|65498528|FG000|Overall Study|Protocol Violation|6|||
23479611|NCT00722371|65498529|FG001|Overall Study|Protocol Violation|1|||
23479612|NCT00722371|65498530|FG002|Overall Study|Protocol Violation|0|||
23479613|NCT00722371|65498531|FG003|Overall Study|Protocol Violation|1|||
23652053|NCT02245672|66110886|FG001|Overall Study|Randomized in error (not treated)|1|||
23801342|NCT04403763|66649973|FG001|Stage 2A|Adverse Event|0|||
23801343|NCT04403763|66649974|FG002|Stage 2A|Adverse Event|0|||
23801344|NCT04403763|66649975|FG003|Stage 2A|Adverse Event|0|||
23801345|NCT04403763|66649976|FG004|Stage 2A|Adverse Event|0|||
23801346|NCT04403763|66649977|FG005|Stage 2A|Adverse Event|0|||
23801347|NCT04403763|66649978|FG006|Stage 2A|Adverse Event|1|||
23801348|NCT05158140|66649979|FG000|Overall Study|Death|0|||
23801349|NCT05158140|66649980|FG001|Overall Study|Death|0|||
23801350|NCT05158140|66649981|FG002|Overall Study|Death|0|||
23801351|NCT05158140|66649982|FG003|Overall Study|Death|1|||
23801352|NCT05158140|66649979|FG000|Overall Study|Lost to Follow-up|3|||
23801353|NCT05158140|66649980|FG001|Overall Study|Lost to Follow-up|6|||
23801354|NCT05158140|66649981|FG002|Overall Study|Lost to Follow-up|4|||
23801355|NCT05158140|66649982|FG003|Overall Study|Lost to Follow-up|3|||
23801356|NCT05158140|66649979|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23801357|NCT05158140|66649980|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23801358|NCT05158140|66649981|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
23801359|NCT05158140|66649982|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23801360|NCT05158140|66649979|FG000|Overall Study|Withdrawal by Subject|3|||
23801361|NCT05158140|66649980|FG001|Overall Study|Withdrawal by Subject|7|||
23801362|NCT05158140|66649981|FG002|Overall Study|Withdrawal by Subject|3|||
23801363|NCT05158140|66649982|FG003|Overall Study|Withdrawal by Subject|7|||
23801364|NCT00373425|66649992|FG000|Overall Study|Relapse of NSCLC|116|||
23801365|NCT00373425|66649993|FG001|Overall Study|Relapse of NSCLC|104|||
23801366|NCT00373425|66649994|FG002|Overall Study|Relapse of NSCLC|19|||
23801367|NCT00373425|66649995|FG003|Overall Study|Relapse of NSCLC|2|||
23801368|NCT00373425|66649996|FG004|Overall Study|Relapse of NSCLC|26|||
23801369|NCT00373425|66649992|FG000|Overall Study|Adverse Event|191|||
23801370|NCT00373425|66649993|FG001|Overall Study|Adverse Event|22|||
23801371|NCT00373425|66649994|FG002|Overall Study|Adverse Event|59|||
23801372|NCT00373425|66649995|FG003|Overall Study|Adverse Event|0|||
23801373|NCT00373425|66649996|FG004|Overall Study|Adverse Event|34|||
23479614|NCT00722371|65498532|FG004|Overall Study|Protocol Violation|4|||
23801374|NCT00373425|66649992|FG000|Overall Study|Patient request|35|||
23801375|NCT00373425|66649993|FG001|Overall Study|Patient request|18|||
23479615|NCT00722371|65498533|FG005|Overall Study|Protocol Violation|2|||
23479616|NCT00722371|65498534|FG006|Overall Study|Protocol Violation|1|||
23479617|NCT00722371|65498528|FG000|Overall Study|Withdrawal by Subject|18|||
23479618|NCT00722371|65498529|FG001|Overall Study|Withdrawal by Subject|27|||
23479619|NCT00722371|65498530|FG002|Overall Study|Withdrawal by Subject|19|||
23479620|NCT00722371|65498531|FG003|Overall Study|Withdrawal by Subject|23|||
23479621|NCT00722371|65498532|FG004|Overall Study|Withdrawal by Subject|19|||
23479622|NCT00722371|65498533|FG005|Overall Study|Withdrawal by Subject|18|||
23479623|NCT00722371|65498534|FG006|Overall Study|Withdrawal by Subject|26|||
23479624|NCT01227629|65498535|FG000|Overall Study|Adverse Event|2|||
23479625|NCT01227629|65498536|FG001|Overall Study|Adverse Event|2|||
23479626|NCT01227629|65498537|FG002|Overall Study|Adverse Event|1|||
23479627|NCT01227629|65498538|FG003|Overall Study|Adverse Event|6|||
23479628|NCT01227629|65498539|FG004|Overall Study|Adverse Event|1|||
23479629|NCT01227629|65498540|FG005|Overall Study|Adverse Event|1|||
23479630|NCT01227629|65498541|FG006|Overall Study|Adverse Event|6|||
23479631|NCT01227629|65498542|FG007|Overall Study|Adverse Event|6|||
23479632|NCT01227629|65498543|FG008|Overall Study|Adverse Event|4|||
23479633|NCT01227629|65498544|FG009|Overall Study|Adverse Event|0|||
23479634|NCT01227629|65498535|FG000|Overall Study|Protocol Violation|0|||
23479635|NCT01227629|65498536|FG001|Overall Study|Protocol Violation|0|||
23479636|NCT01227629|65498537|FG002|Overall Study|Protocol Violation|0|||
23479637|NCT01227629|65498538|FG003|Overall Study|Protocol Violation|1|||
23479638|NCT01227629|65498539|FG004|Overall Study|Protocol Violation|0|||
23479639|NCT01227629|65498540|FG005|Overall Study|Protocol Violation|0|||
23479640|NCT01227629|65498541|FG006|Overall Study|Protocol Violation|0|||
23479641|NCT01227629|65498542|FG007|Overall Study|Protocol Violation|0|||
23479642|NCT01227629|65498543|FG008|Overall Study|Protocol Violation|0|||
23479643|NCT01227629|65498544|FG009|Overall Study|Protocol Violation|0|||
23479644|NCT01227629|65498535|FG000|Overall Study|Lost to Follow-up|0|||
23479645|NCT01227629|65498536|FG001|Overall Study|Lost to Follow-up|0|||
23479646|NCT01227629|65498537|FG002|Overall Study|Lost to Follow-up|0|||
23479647|NCT01227629|65498538|FG003|Overall Study|Lost to Follow-up|0|||
23479648|NCT01227629|65498539|FG004|Overall Study|Lost to Follow-up|1|||
23479649|NCT01227629|65498540|FG005|Overall Study|Lost to Follow-up|0|||
23479650|NCT01227629|65498541|FG006|Overall Study|Lost to Follow-up|0|||
23479651|NCT01227629|65498542|FG007|Overall Study|Lost to Follow-up|0|||
23479652|NCT01227629|65498543|FG008|Overall Study|Lost to Follow-up|0|||
23479653|NCT01227629|65498544|FG009|Overall Study|Lost to Follow-up|0|||
23479654|NCT01227629|65498535|FG000|Overall Study|Withdrawal by Subject|0|||
23479655|NCT01227629|65498536|FG001|Overall Study|Withdrawal by Subject|0|||
23479656|NCT01227629|65498537|FG002|Overall Study|Withdrawal by Subject|0|||
23479657|NCT01227629|65498538|FG003|Overall Study|Withdrawal by Subject|0|||
23479658|NCT01227629|65498539|FG004|Overall Study|Withdrawal by Subject|0|||
23479659|NCT01227629|65498540|FG005|Overall Study|Withdrawal by Subject|0|||
23479660|NCT01227629|65498541|FG006|Overall Study|Withdrawal by Subject|2|||
23801376|NCT00373425|66649994|FG002|Overall Study|Patient request|43|||
23801377|NCT00373425|66649995|FG003|Overall Study|Patient request|6|||
23801378|NCT00373425|66649996|FG004|Overall Study|Patient request|7|||
23801379|NCT00373425|66649992|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
23801380|NCT00373425|66649993|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
23652054|NCT02245672|66110887|FG002|Overall Study|Randomized in error (not treated)|0|||
23652055|NCT02471833|66110888|FG000|Overall Study|Lost to Follow-up|1|||
23652056|NCT02471833|66110889|FG001|Overall Study|Lost to Follow-up|0|||
23652057|NCT02471833|66110890|FG002|Overall Study|Lost to Follow-up|0|||
23652058|NCT02471833|66110888|FG000|Overall Study|Withdrawal by Subject|2|||
23801381|NCT00373425|66649994|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
23801382|NCT00373425|66649995|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
23801383|NCT00373425|66649996|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
23801384|NCT00373425|66649992|FG000|Overall Study|Death|7|||
23801385|NCT00373425|66649993|FG001|Overall Study|Death|0|||
23801386|NCT00373425|66649994|FG002|Overall Study|Death|3|||
23801387|NCT00373425|66649995|FG003|Overall Study|Death|1|||
23801388|NCT00373425|66649996|FG004|Overall Study|Death|0|||
23801389|NCT03653026|66649997|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
23801390|NCT03653026|66649998|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
23801391|NCT03653026|66649999|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
23801392|NCT03653026|66650000|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
23801393|NCT03653026|66649997|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
23801394|NCT03653026|66649998|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
23801395|NCT03653026|66649999|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23801396|NCT03653026|66650000|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23801397|NCT03653026|66649997|FG000|Part 1: Placebo-controlled Period|Other|0|||
23801398|NCT03653026|66649998|FG001|Part 1: Placebo-controlled Period|Other|3|||
23801399|NCT03653026|66649999|FG002|Part 1: Placebo-controlled Period|Other|0|||
23801400|NCT03653026|66650000|FG003|Part 1: Placebo-controlled Period|Other|0|||
23801401|NCT03653026|66649997|FG000|Part 2: Open-label Extension|Adverse Event|0|||
23479661|NCT01227629|65498542|FG007|Overall Study|Withdrawal by Subject|0|||
23652059|NCT02471833|66110889|FG001|Overall Study|Withdrawal by Subject|1|||
23801402|NCT03653026|66649998|FG001|Part 2: Open-label Extension|Adverse Event|0|||
23801403|NCT03653026|66649999|FG002|Part 2: Open-label Extension|Adverse Event|1|||
23801404|NCT03653026|66650000|FG003|Part 2: Open-label Extension|Adverse Event|1|||
23479662|NCT01227629|65498543|FG008|Overall Study|Withdrawal by Subject|0|||
23479663|NCT01227629|65498544|FG009|Overall Study|Withdrawal by Subject|1|||
23652060|NCT02471833|66110890|FG002|Overall Study|Withdrawal by Subject|5|||
23652061|NCT01175356|66110891|FG000|Overall Study|Death|1|||
23652062|NCT01175356|66110891|FG000|Overall Study|Lack of Efficacy|12|||
23652063|NCT01175356|66110891|FG000|Overall Study|Lost to Follow-up|1|||
23652064|NCT01175356|66110891|FG000|Overall Study|Physician Decision|23|||
23652065|NCT01175356|66110891|FG000|Overall Study|Ineligible|1|||
23652066|NCT01175356|66110891|FG000|Overall Study|Treatment Slot Not Available|18|||
23652067|NCT01175356|66110891|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
23652068|NCT01175356|66110891|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
23652069|NCT01175356|66110891|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
23652070|NCT01175356|66110891|FG000|Overall Study|Inadequate stem cell for transplant|1|||
23652071|NCT01175356|66110891|FG000|Overall Study|Initiation other tx prior to completion|9|||
23652072|NCT03021954|66110892|FG000|Overall Study|Lost to Follow-up|10|||
23652073|NCT03021954|66110893|FG001|Overall Study|Lost to Follow-up|43|||
23652074|NCT03021954|66110892|FG000|Overall Study|Subjects had avulsion trauma|4|||
23652075|NCT03021954|66110893|FG001|Overall Study|Subjects had avulsion trauma|1|||
23652076|NCT03153137|66110894|FG000|Overall Study|Lost to Follow-up|1|||
23652077|NCT03153137|66110895|FG001|Overall Study|Lost to Follow-up|0|||
23652078|NCT03153137|66110894|FG000|Overall Study|Withdrawal by Subject|2|||
23652079|NCT03153137|66110895|FG001|Overall Study|Withdrawal by Subject|1|||
23652080|NCT03153137|66110894|FG000|Overall Study|Physician Decision|0|||
23652081|NCT03153137|66110895|FG001|Overall Study|Physician Decision|3|||
23652082|NCT01971203|66110896|FG000|Overall Study|Protocol Violation|3|||
23652083|NCT01971203|66110897|FG001|Overall Study|Protocol Violation|2|||
23652084|NCT01971203|66110896|FG000|Overall Study|Withdrawal by Subject|5|||
23652085|NCT01971203|66110897|FG001|Overall Study|Withdrawal by Subject|6|||
23652086|NCT01971203|66110896|FG000|Overall Study|Adverse Event|1|||
23652087|NCT01971203|66110897|FG001|Overall Study|Adverse Event|0|||
23652088|NCT02038543|66110898|FG000|Overall Study|Screen Failure|0|||
23652089|NCT02038543|66110899|FG001|Overall Study|Screen Failure|0|||
23652090|NCT02038543|66110900|FG002|Overall Study|Screen Failure|0|||
23652091|NCT02038543|66110901|FG003|Overall Study|Screen Failure|1|||
23652092|NCT02038543|66110898|FG000|Overall Study|Withdrawal by Subject|0|||
23652093|NCT02038543|66110899|FG001|Overall Study|Withdrawal by Subject|0|||
23652094|NCT02038543|66110900|FG002|Overall Study|Withdrawal by Subject|0|||
23652095|NCT02038543|66110901|FG003|Overall Study|Withdrawal by Subject|1|||
23652096|NCT02170389|66110902|FG000|Overall Study|Study terminated prior to start of treat|1|||
23652097|NCT03442985|66110903|FG000|Overall Study|Sponsor Request|55|||
23652098|NCT03442985|66110904|FG001|Overall Study|Sponsor Request|60|||
23652099|NCT03442985|66110905|FG002|Overall Study|Sponsor Request|54|||
23652100|NCT03442985|66110903|FG000|Overall Study|Lost to Follow-up|5|||
23652101|NCT03442985|66110904|FG001|Overall Study|Lost to Follow-up|2|||
23652102|NCT03442985|66110905|FG002|Overall Study|Lost to Follow-up|7|||
23652103|NCT03442985|66110903|FG000|Overall Study|Withdrawal by Subject|2|||
23652104|NCT03442985|66110904|FG001|Overall Study|Withdrawal by Subject|3|||
23652105|NCT03442985|66110905|FG002|Overall Study|Withdrawal by Subject|4|||
23652106|NCT03442985|66110903|FG000|Overall Study|Adverse Event|0|||
23652107|NCT03442985|66110904|FG001|Overall Study|Adverse Event|1|||
23652108|NCT03442985|66110905|FG002|Overall Study|Adverse Event|0|||
23652109|NCT00395460|66110906|FG000|Overall Study|Withdrawal by Subject|1|||
23652110|NCT00395460|66110907|FG001|Overall Study|Withdrawal by Subject|0|||
23652111|NCT00940108|66110910|FG000|Overall Study|Adverse Event|2|||
23652112|NCT00940108|66110911|FG001|Overall Study|Adverse Event|4|||
23652113|NCT00940108|66110912|FG002|Overall Study|Adverse Event|0|||
23652114|NCT00940108|66110913|FG003|Overall Study|Adverse Event|2|||
23652115|NCT00940108|66110910|FG000|Overall Study|Withdrew Consent|2|||
23652116|NCT00940108|66110911|FG001|Overall Study|Withdrew Consent|1|||
23652117|NCT00940108|66110912|FG002|Overall Study|Withdrew Consent|0|||
23652118|NCT00940108|66110913|FG003|Overall Study|Withdrew Consent|1|||
23652119|NCT00940108|66110910|FG000|Overall Study|Dose 2 contraindicated|1|||
23652120|NCT00940108|66110911|FG001|Overall Study|Dose 2 contraindicated|1|||
23652121|NCT00940108|66110912|FG002|Overall Study|Dose 2 contraindicated|0|||
23652122|NCT00940108|66110913|FG003|Overall Study|Dose 2 contraindicated|1|||
23652123|NCT00940108|66110910|FG000|Overall Study|Declined further vaccination|0|||
23652124|NCT00940108|66110911|FG001|Overall Study|Declined further vaccination|1|||
23652125|NCT00940108|66110912|FG002|Overall Study|Declined further vaccination|3|||
23652126|NCT00940108|66110913|FG003|Overall Study|Declined further vaccination|0|||
23652127|NCT00940108|66110910|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
23652128|NCT00940108|66110911|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
23652129|NCT00940108|66110912|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
23652130|NCT00940108|66110913|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
23652131|NCT00940108|66110910|FG000|Overall Study|Viral illness after Dose 1|0|||
23652132|NCT00940108|66110911|FG001|Overall Study|Viral illness after Dose 1|1|||
23652133|NCT00940108|66110912|FG002|Overall Study|Viral illness after Dose 1|0|||
23705488|NCT02371759|66297519|FG000|Overall Study|Protocol Violation|3|||
23652134|NCT00940108|66110913|FG003|Overall Study|Viral illness after Dose 1|0|||
23652135|NCT00940108|66110910|FG000|Overall Study|Diagnosed with H1N1|0|||
23652136|NCT00940108|66110911|FG001|Overall Study|Diagnosed with H1N1|0|||
23652137|NCT00940108|66110912|FG002|Overall Study|Diagnosed with H1N1|0|||
23652138|NCT00940108|66110913|FG003|Overall Study|Diagnosed with H1N1|1|||
23652139|NCT02796560|66110914|FG000|Overall Study|Adverse Event|2|||
23652140|NCT02796560|66110915|FG001|Overall Study|Adverse Event|0|||
23652141|NCT02796560|66110914|FG000|Overall Study|Withdrawal by Subject|2|||
23652142|NCT02796560|66110915|FG001|Overall Study|Withdrawal by Subject|2|||
23652143|NCT00926211|66110916|FG000|Overall Study|Lost to Follow-up|1|||
23652144|NCT03707925|66110917|FG000|Overall Study|Inevaluable|1|||
23652145|NCT01177787|66110918|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
23652146|NCT01177787|66110918|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
23652147|NCT01177787|66110918|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
23652148|NCT02502097|66110920|FG000|Period 1|Adverse Event|0|||
23652149|NCT02502097|66110921|FG001|Period 1|Adverse Event|0|||
23652150|NCT02502097|66110922|FG002|Period 1|Adverse Event|1|||
23652151|NCT02502097|66110923|FG003|Period 1|Adverse Event|0|||
23652152|NCT02502097|66110920|FG000|Wash Out Period|Adverse Event|0|||
23652153|NCT02502097|66110921|FG001|Wash Out Period|Adverse Event|1|||
23652154|NCT02502097|66110922|FG002|Wash Out Period|Adverse Event|1|||
23652155|NCT02502097|66110923|FG003|Wash Out Period|Adverse Event|1|||
23652156|NCT02502097|66110920|FG000|Period 2|Adverse Event|0|||
23652157|NCT02502097|66110921|FG001|Period 2|Adverse Event|0|||
23652158|NCT02502097|66110922|FG002|Period 2|Adverse Event|1|||
23652159|NCT02502097|66110923|FG003|Period 2|Adverse Event|0|||
23652160|NCT01740323|66110925|FG000|Overall Study|Adverse Event|1|||
23652161|NCT01740323|66110926|FG001|Overall Study|Adverse Event|0|||
23652162|NCT01740323|66110925|FG000|Overall Study|Randomized but did not take study drug|1|||
23652163|NCT01740323|66110926|FG001|Overall Study|Randomized but did not take study drug|0|||
23652164|NCT00881608|66110929|FG000|Overall Study|Study prematurely terminated|11|||
23652165|NCT01376349|66110930|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
23652166|NCT01376349|66110931|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
23652167|NCT01376349|66110932|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
23652168|NCT01376349|66110930|FG000|Raondomized Treatment|Adverse Event|13|||
23652169|NCT01376349|66110931|FG001|Raondomized Treatment|Adverse Event|17|||
23652170|NCT01376349|66110932|FG002|Raondomized Treatment|Adverse Event|14|||
23652171|NCT01376349|66110930|FG000|Raondomized Treatment|Unkown|1|||
23652172|NCT01376349|66110931|FG001|Raondomized Treatment|Unkown|2|||
23652173|NCT01376349|66110932|FG002|Raondomized Treatment|Unkown|1|||
23652174|NCT01376349|66110930|FG000|Raondomized Treatment|Alternative Treatment|0|||
23652175|NCT01376349|66110931|FG001|Raondomized Treatment|Alternative Treatment|0|||
23652176|NCT01376349|66110932|FG002|Raondomized Treatment|Alternative Treatment|1|||
23652177|NCT01480284|66110933|FG000|Overall Study|Withdrawal by Subject|2|||
23652178|NCT01480284|66110934|FG001|Overall Study|Withdrawal by Subject|0|||
23652179|NCT01480284|66110933|FG000|Overall Study|Adverse Event|1|||
23652180|NCT01480284|66110934|FG001|Overall Study|Adverse Event|0|||
23652181|NCT01480284|66110933|FG000|Overall Study|Study closed/terminated|3|||
23652182|NCT01480284|66110934|FG001|Overall Study|Study closed/terminated|0|||
23652183|NCT01480284|66110933|FG000|Overall Study|Lost to Follow-up|1|||
23652184|NCT01480284|66110934|FG001|Overall Study|Lost to Follow-up|0|||
23652185|NCT01480284|66110933|FG000|Overall Study|Physician Decision|1|||
23652186|NCT01480284|66110934|FG001|Overall Study|Physician Decision|0|||
23652187|NCT01298518|66114414|FG000|Overall Study|Withdrawal by Subject|0|||
23652188|NCT01298518|66114415|FG001|Overall Study|Withdrawal by Subject|0|||
23652189|NCT01298518|66114416|FG002|Overall Study|Withdrawal by Subject|1|||
23652190|NCT02359877|66114417|FG000|Overall Study|Withdrawal by Subject|1|||
23652191|NCT02359877|66114418|FG001|Overall Study|Withdrawal by Subject|0|||
23652192|NCT02359877|66114419|FG002|Overall Study|Withdrawal by Subject|0|||
23652193|NCT02359877|66114420|FG003|Overall Study|Withdrawal by Subject|2|||
23652194|NCT02359877|66114417|FG000|Overall Study|Adverse Event|0|||
23652195|NCT02359877|66114418|FG001|Overall Study|Adverse Event|0|||
23652196|NCT02359877|66114419|FG002|Overall Study|Adverse Event|0|||
23652197|NCT02359877|66114420|FG003|Overall Study|Adverse Event|1|||
23652198|NCT01794923|66114421|FG000|Overall Study|Adverse Event|0|||
23652199|NCT01794923|66114422|FG001|Overall Study|Adverse Event|0|||
23652200|NCT01794923|66114423|FG002|Overall Study|Adverse Event|1|||
23801405|NCT03653026|66649997|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23801406|NCT03653026|66649998|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23801407|NCT03653026|66649999|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
23801408|NCT03653026|66650000|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
23801409|NCT03653026|66649997|FG000|Part 2: Open-label Extension|Other|0|||
23652201|NCT01211197|66114424|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23652202|NCT01211197|66114425|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23652203|NCT01211197|66114426|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23652204|NCT01211197|66114427|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23652205|NCT01211197|66114428|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23652206|NCT01211197|66114429|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23652207|NCT01211197|66114424|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
23652208|NCT01211197|66114425|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
23652209|NCT01211197|66114426|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
23652210|NCT01211197|66114427|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
23652211|NCT01211197|66114428|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
23652212|NCT01211197|66114429|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
23652213|NCT02027701|66114430|FG000|Overall Study|Adverse Event|3|||
23652214|NCT02027701|66114430|FG000|Overall Study|Lack of Efficacy|8|||
23652215|NCT02027701|66114430|FG000|Overall Study|Physician Decision|2|||
23652216|NCT02027701|66114430|FG000|Overall Study|Withdrawal by Subject|3|||
23652217|NCT01862640|66114431|FG000|Overall Study|Adverse Event|4|||
23652218|NCT01862640|66114432|FG001|Overall Study|Adverse Event|10|||
23652219|NCT01862640|66114433|FG002|Overall Study|Adverse Event|6|||
23652220|NCT01862640|66114434|FG003|Overall Study|Adverse Event|8|||
23652221|NCT01862640|66114431|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23652222|NCT01862640|66114432|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23652223|NCT01862640|66114433|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
23652224|NCT01862640|66114434|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23652225|NCT01862640|66114431|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
23652226|NCT01862640|66114432|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
23479664|NCT01227629|65498535|FG000|Overall Study|Other|0|||
23479665|NCT01227629|65498536|FG001|Overall Study|Other|0|||
23479666|NCT01227629|65498537|FG002|Overall Study|Other|0|||
23479667|NCT01227629|65498538|FG003|Overall Study|Other|1|||
23479668|NCT01227629|65498539|FG004|Overall Study|Other|0|||
23479669|NCT01227629|65498540|FG005|Overall Study|Other|0|||
23479670|NCT01227629|65498541|FG006|Overall Study|Other|0|||
23479671|NCT01227629|65498542|FG007|Overall Study|Other|0|||
23479672|NCT01227629|65498543|FG008|Overall Study|Other|2|||
23479673|NCT01227629|65498544|FG009|Overall Study|Other|1|||
23479674|NCT01700439|65498545|FG000|Overall Study|Lost to Follow-up|47|||
23479675|NCT01700439|65498545|FG000|Overall Study|Withdrawal by Subject|183|||
23479676|NCT01700439|65498545|FG000|Overall Study|Death|186|||
23479677|NCT03051620|65498552|FG000|Overall Study|Lost to Follow-up|6|||
23479678|NCT03051620|65498552|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
23479679|NCT01215916|65498559|FG000|Overall Study|Progressive Disease|0|||
23479680|NCT01215916|65498560|FG001|Overall Study|Progressive Disease|2|||
23479681|NCT01215916|65498561|FG002|Overall Study|Progressive Disease|1|||
23479682|NCT01215916|65498562|FG003|Overall Study|Progressive Disease|2|||
23479683|NCT01215916|65498563|FG004|Overall Study|Progressive Disease|5|||
23479684|NCT01215916|65498564|FG005|Overall Study|Progressive Disease|4|||
23479685|NCT01215916|65498565|FG006|Overall Study|Progressive Disease|5|||
23479686|NCT01215916|65498566|FG007|Overall Study|Progressive Disease|3|||
23479687|NCT01215916|65498567|FG008|Overall Study|Progressive Disease|1|||
23479688|NCT01215916|65498559|FG000|Overall Study|Adverse Event|1|||
23479689|NCT01215916|65498560|FG001|Overall Study|Adverse Event|1|||
23479690|NCT01215916|65498561|FG002|Overall Study|Adverse Event|0|||
23479691|NCT01215916|65498562|FG003|Overall Study|Adverse Event|1|||
23479692|NCT01215916|65498563|FG004|Overall Study|Adverse Event|0|||
23479693|NCT01215916|65498564|FG005|Overall Study|Adverse Event|0|||
23479694|NCT01215916|65498565|FG006|Overall Study|Adverse Event|3|||
23479695|NCT01215916|65498566|FG007|Overall Study|Adverse Event|0|||
23479696|NCT01215916|65498567|FG008|Overall Study|Adverse Event|0|||
23479697|NCT01215916|65498559|FG000|Overall Study|Withdrawal by Subject|0|||
23652227|NCT01862640|66114433|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
23652228|NCT01862640|66114434|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
23652229|NCT01862640|66114431|FG000|Overall Study|Withdrawal by Subject|2|||
23652230|NCT01862640|66114432|FG001|Overall Study|Withdrawal by Subject|4|||
23652231|NCT01862640|66114433|FG002|Overall Study|Withdrawal by Subject|8|||
23652232|NCT01862640|66114434|FG003|Overall Study|Withdrawal by Subject|5|||
23652233|NCT01862640|66114431|FG000|Overall Study|Protocol Deviation|0|||
23652234|NCT01862640|66114432|FG001|Overall Study|Protocol Deviation|0|||
23479698|NCT01215916|65498560|FG001|Overall Study|Withdrawal by Subject|1|||
23479699|NCT01215916|65498561|FG002|Overall Study|Withdrawal by Subject|1|||
23479700|NCT01215916|65498562|FG003|Overall Study|Withdrawal by Subject|2|||
23479701|NCT01215916|65498563|FG004|Overall Study|Withdrawal by Subject|0|||
23479702|NCT01215916|65498564|FG005|Overall Study|Withdrawal by Subject|0|||
23479703|NCT01215916|65498565|FG006|Overall Study|Withdrawal by Subject|1|||
23479704|NCT01215916|65498566|FG007|Overall Study|Withdrawal by Subject|0|||
23479705|NCT01215916|65498567|FG008|Overall Study|Withdrawal by Subject|0|||
23652235|NCT01862640|66114433|FG002|Overall Study|Protocol Deviation|1|||
23652236|NCT01862640|66114434|FG003|Overall Study|Protocol Deviation|0|||
23801410|NCT03653026|66649998|FG001|Part 2: Open-label Extension|Other|0|||
23479706|NCT01215916|65498559|FG000|Overall Study|Death|0|||
23479707|NCT01215916|65498560|FG001|Overall Study|Death|1|||
23652237|NCT03602066|66114435|FG000|Overall Study|Withdrawal by Subject|2|||
23652238|NCT03602066|66114436|FG001|Overall Study|Withdrawal by Subject|0|||
23652239|NCT03602066|66114435|FG000|Overall Study|Physician Decision|1|||
23652240|NCT03602066|66114436|FG001|Overall Study|Physician Decision|0|||
23652241|NCT02079610|66114437|FG000|Overall Study|Withdrawal by Subject|1|||
23652242|NCT02079610|66114438|FG001|Overall Study|Withdrawal by Subject|1|||
23652243|NCT02446886|66114439|FG000|Overall Study|Adverse Event|1|||
23652244|NCT02446886|66114440|FG001|Overall Study|Adverse Event|3|||
23652245|NCT02446886|66114439|FG000|Overall Study|Withdrawal by Subject|1|||
23652246|NCT02446886|66114440|FG001|Overall Study|Withdrawal by Subject|1|||
23652247|NCT01607554|66114443|FG000|Overall Study|Disease progression|2|||
23652248|NCT05220254|66114446|FG000|Overall Study|Withdrawal by Subject|4|||
23652249|NCT05220254|66114446|FG000|Overall Study|Removed due to ineligibility|1|||
23652250|NCT05220254|66114446|FG000|Overall Study|Lost to Follow-up|7|||
23652251|NCT01369511|66114449|FG000|Overall Study|Adverse Event|1|||
23652252|NCT01369511|66114450|FG001|Overall Study|Adverse Event|1|||
23652253|NCT01369511|66114451|FG002|Overall Study|Adverse Event|5|||
23652254|NCT01369511|66114452|FG003|Overall Study|Adverse Event|0|||
23652255|NCT01369511|66114449|FG000|Overall Study|Entry criteria not met|2|||
23652256|NCT01369511|66114450|FG001|Overall Study|Entry criteria not met|0|||
23652257|NCT01369511|66114451|FG002|Overall Study|Entry criteria not met|0|||
23652258|NCT01369511|66114452|FG003|Overall Study|Entry criteria not met|1|||
23652259|NCT01369511|66114449|FG000|Overall Study|Lost to Follow-up|0|||
23652260|NCT01369511|66114450|FG001|Overall Study|Lost to Follow-up|1|||
23652261|NCT01369511|66114451|FG002|Overall Study|Lost to Follow-up|1|||
23652262|NCT01369511|66114452|FG003|Overall Study|Lost to Follow-up|2|||
23652263|NCT01369511|66114449|FG000|Overall Study|Protocol Violation|0|||
23652264|NCT01369511|66114450|FG001|Overall Study|Protocol Violation|1|||
23652265|NCT01369511|66114451|FG002|Overall Study|Protocol Violation|0|||
23652266|NCT01369511|66114452|FG003|Overall Study|Protocol Violation|2|||
23652267|NCT01369511|66114449|FG000|Overall Study|Physician Decision|3|||
23652268|NCT01369511|66114450|FG001|Overall Study|Physician Decision|4|||
23652269|NCT01369511|66114451|FG002|Overall Study|Physician Decision|0|||
23652270|NCT01369511|66114452|FG003|Overall Study|Physician Decision|0|||
23652271|NCT01369511|66114449|FG000|Overall Study|Sponsor decision|2|||
23652272|NCT01369511|66114450|FG001|Overall Study|Sponsor decision|0|||
23652273|NCT01369511|66114451|FG002|Overall Study|Sponsor decision|1|||
23652274|NCT01369511|66114452|FG003|Overall Study|Sponsor decision|0|||
23652275|NCT01369511|66114449|FG000|Overall Study|Withdrawal by Subject|5|||
23652276|NCT01369511|66114450|FG001|Overall Study|Withdrawal by Subject|6|||
23652277|NCT01369511|66114451|FG002|Overall Study|Withdrawal by Subject|4|||
23652278|NCT01369511|66114452|FG003|Overall Study|Withdrawal by Subject|6|||
23652279|NCT00975507|66114454|FG000|Overall Study|Adverse Event|1|||
23652280|NCT00975507|66114455|FG001|Overall Study|Adverse Event|0|||
23652281|NCT00975507|66114454|FG000|Overall Study|Lost to Follow-up|7|||
23652282|NCT00975507|66114455|FG001|Overall Study|Lost to Follow-up|1|||
23652283|NCT00975507|66114454|FG000|Overall Study|Protocol Violation|2|||
23652284|NCT00975507|66114455|FG001|Overall Study|Protocol Violation|0|||
23652285|NCT00975507|66114454|FG000|Overall Study|Withdrawal by Subject|10|||
23652286|NCT00975507|66114455|FG001|Overall Study|Withdrawal by Subject|3|||
23652287|NCT00171704|66114460|FG000|Overall Study|Adverse Event|24|||
23652288|NCT00171704|66114461|FG001|Overall Study|Adverse Event|33|||
23652289|NCT00171704|66114460|FG000|Overall Study|Disease Progression|14|||
23652290|NCT00171704|66114461|FG001|Overall Study|Disease Progression|9|||
23652291|NCT00171704|66114460|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
23652292|NCT00171704|66114461|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
23652293|NCT00171704|66114460|FG000|Overall Study|Administrative Problems|2|||
23652294|NCT00171704|66114461|FG001|Overall Study|Administrative Problems|1|||
23652295|NCT00171704|66114460|FG000|Overall Study|Death|2|||
23652296|NCT00171704|66114461|FG001|Overall Study|Death|2|||
23652297|NCT00171704|66114460|FG000|Overall Study|Withdrawal by Subject|1|||
23652298|NCT00171704|66114461|FG001|Overall Study|Withdrawal by Subject|3|||
23652299|NCT00171704|66114460|FG000|Overall Study|Protocol Violation|0|||
23652300|NCT00171704|66114461|FG001|Overall Study|Protocol Violation|1|||
23652301|NCT00764751|66114462|FG000|Overall Study|Adverse Event|1|||
23801411|NCT03653026|66649999|FG002|Part 2: Open-label Extension|Other|1|||
23801412|NCT03653026|66650000|FG003|Part 2: Open-label Extension|Other|2|||
23801413|NCT03005067|66650002|FG000|Overall Study|Withdrawal by Subject|3|||
23801414|NCT03005067|66650003|FG001|Overall Study|Withdrawal by Subject|2|||
23801415|NCT03005067|66650002|FG000|Overall Study|Adverse Event|4|||
23801416|NCT03005067|66650003|FG001|Overall Study|Adverse Event|3|||
23360754|NCT02072941|65065876|FG001|Overall Study|Removed by Study Staff|2|||
23360755|NCT00587795|65065877|FG000|Overall Study|Withdrawal by Subject|1|||
23652302|NCT00764751|66114463|FG001|Overall Study|Adverse Event|1|||
23652303|NCT00764751|66114462|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
23652304|NCT00764751|66114463|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
23652305|NCT01498289|66114468|FG000|Overall Study|Adverse Event|16|||
23652306|NCT01498289|66114469|FG001|Overall Study|Adverse Event|18|||
23652307|NCT01498289|66114468|FG000|Overall Study|Death|6|||
23652308|NCT01498289|66114469|FG001|Overall Study|Death|8|||
23652309|NCT01498289|66114468|FG000|Overall Study|Withdrawal unrelated to AE|16|||
23652310|NCT01498289|66114469|FG001|Overall Study|Withdrawal unrelated to AE|16|||
23652311|NCT01498289|66114468|FG000|Overall Study|Progression/relapse|53|||
23652312|NCT01498289|66114469|FG001|Overall Study|Progression/relapse|59|||
23652313|NCT01498289|66114468|FG000|Overall Study|Not protocol specified|7|||
23652314|NCT01498289|66114469|FG001|Overall Study|Not protocol specified|2|||
23652315|NCT01498289|66114468|FG000|Overall Study|Reason under review|0|||
23652316|NCT01498289|66114469|FG001|Overall Study|Reason under review|1|||
23652317|NCT00912964|66114470|FG000|Overall Study|Eligibility criterion not met|1|||
23652318|NCT00912964|66114471|FG001|Overall Study|Eligibility criterion not met|1|||
23652319|NCT00912964|66114472|FG002|Overall Study|Eligibility criterion not met|0|||
23652320|NCT00912964|66114470|FG000|Overall Study|Adverse Event|15|||
23652321|NCT00912964|66114471|FG001|Overall Study|Adverse Event|18|||
23479708|NCT01215916|65498561|FG002|Overall Study|Death|0|||
23479709|NCT01215916|65498562|FG003|Overall Study|Death|0|||
23479710|NCT01215916|65498563|FG004|Overall Study|Death|1|||
23479711|NCT01215916|65498564|FG005|Overall Study|Death|0|||
23479712|NCT01215916|65498565|FG006|Overall Study|Death|0|||
23479713|NCT01215916|65498566|FG007|Overall Study|Death|0|||
23479714|NCT01215916|65498567|FG008|Overall Study|Death|1|||
23479715|NCT01215916|65498559|FG000|Overall Study|Physician Decision|0|||
23479716|NCT01215916|65498560|FG001|Overall Study|Physician Decision|0|||
23479717|NCT01215916|65498561|FG002|Overall Study|Physician Decision|1|||
23479718|NCT01215916|65498562|FG003|Overall Study|Physician Decision|1|||
23479719|NCT01215916|65498563|FG004|Overall Study|Physician Decision|0|||
23479720|NCT01215916|65498564|FG005|Overall Study|Physician Decision|0|||
23479721|NCT01215916|65498565|FG006|Overall Study|Physician Decision|0|||
23479722|NCT01215916|65498566|FG007|Overall Study|Physician Decision|0|||
23479723|NCT01215916|65498567|FG008|Overall Study|Physician Decision|0|||
23479724|NCT01038869|65498568|FG000|Overall Study|Withdrawal by Subject|1|||
23479725|NCT01038869|65498568|FG000|Overall Study|Lost to Follow-up|6|||
23652322|NCT00912964|66114472|FG002|Overall Study|Adverse Event|12|||
23652323|NCT00912964|66114470|FG000|Overall Study|Lack of Efficacy|11|||
23652324|NCT00912964|66114471|FG001|Overall Study|Lack of Efficacy|4|||
23652325|NCT00912964|66114472|FG002|Overall Study|Lack of Efficacy|3|||
23652326|NCT00912964|66114470|FG000|Overall Study|Withdrawal by Subject|20|||
23652327|NCT00912964|66114471|FG001|Overall Study|Withdrawal by Subject|12|||
23801417|NCT03005067|66650002|FG000|Overall Study|Other (reason not specified)|3|||
23801418|NCT03005067|66650003|FG001|Overall Study|Other (reason not specified)|1|||
23801419|NCT03005067|66650002|FG000|Overall Study|Protocol Violation|0|||
23801420|NCT03005067|66650003|FG001|Overall Study|Protocol Violation|1|||
23801421|NCT02458092|66650009|FG000|Overall Study|Withdrawal by Subject|1|||
23801422|NCT02458092|66650010|FG001|Overall Study|Withdrawal by Subject|0|||
23801423|NCT00493779|66650011|FG000|Overall Study|Logistical issue at site|1|||
23801424|NCT03212794|66650012|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
23801425|NCT03212794|66650013|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
23801426|NCT03212794|66650012|FG000|Overall Study|Lost to Follow-up|5|||
23801427|NCT03212794|66650013|FG001|Overall Study|Lost to Follow-up|6|||
23801428|NCT03212794|66650012|FG000|Overall Study|Incarcerated; unable to participate|2|||
23801429|NCT03212794|66650013|FG001|Overall Study|Incarcerated; unable to participate|0|||
23801430|NCT03212794|66650012|FG000|Overall Study|Withdrawal by Subject|1|||
23801431|NCT03212794|66650013|FG001|Overall Study|Withdrawal by Subject|0|||
23801432|NCT03212794|66650012|FG000|Overall Study|Death|0|||
23801433|NCT03212794|66650013|FG001|Overall Study|Death|1|||
23801434|NCT03212794|66650012|FG000|Overall Study|Found to be ineligible after allocation|0|||
23801435|NCT03212794|66650013|FG001|Overall Study|Found to be ineligible after allocation|1|||
23801436|NCT03212794|66650012|FG000|Overall Study|Relocated out of area|2|||
23801437|NCT03212794|66650013|FG001|Overall Study|Relocated out of area|0|||
23801438|NCT02502734|66650022|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
23801439|NCT02502734|66650023|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
23801440|NCT02502734|66650022|FG000|Washout Period|Adverse Event|1|||
23801441|NCT02502734|66650023|FG001|Washout Period|Adverse Event|0|||
23801442|NCT00854373|66650024|FG000|Overall Study|Withdrawal by Subject|1|||
23801443|NCT00854373|66650025|FG001|Overall Study|Withdrawal by Subject|3|||
23801444|NCT00854373|66650024|FG000|Overall Study|Forgot to take study drug|1|||
23479726|NCT00686634|65498569|FG000|Overall Study|Protocol Violation|6|||
23479727|NCT03584373|65498570|FG000|Overall Study|Lost to Follow-up|7|||
23479728|NCT03584373|65498571|FG001|Overall Study|Lost to Follow-up|8|||
23479729|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23479730|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23599325|NCT00822120|65922483|FG005|PET-directed Therapy|Death|0|||
23479731|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23652328|NCT00912964|66114472|FG002|Overall Study|Withdrawal by Subject|18|||
23652329|NCT00912964|66114470|FG000|Overall Study|Lost to Follow-up|4|||
23652330|NCT00912964|66114471|FG001|Overall Study|Lost to Follow-up|3|||
23652331|NCT00912964|66114472|FG002|Overall Study|Lost to Follow-up|3|||
23652332|NCT00912964|66114470|FG000|Overall Study|Protocol Violation|5|||
23652333|NCT00912964|66114471|FG001|Overall Study|Protocol Violation|3|||
23652334|NCT00912964|66114472|FG002|Overall Study|Protocol Violation|8|||
23652335|NCT00912964|66114470|FG000|Overall Study|Taking exclusionary medications|7|||
23652336|NCT00912964|66114471|FG001|Overall Study|Taking exclusionary medications|4|||
23652337|NCT00912964|66114472|FG002|Overall Study|Taking exclusionary medications|8|||
23652338|NCT00912964|66114470|FG000|Overall Study|Medical History|1|||
23652339|NCT00912964|66114471|FG001|Overall Study|Medical History|0|||
23652340|NCT00912964|66114472|FG002|Overall Study|Medical History|0|||
23652341|NCT00912964|66114470|FG000|Overall Study|Non-compliance with study procedures|2|||
23652342|NCT00912964|66114471|FG001|Overall Study|Non-compliance with study procedures|0|||
23652343|NCT00912964|66114472|FG002|Overall Study|Non-compliance with study procedures|0|||
23652344|NCT00912964|66114470|FG000|Overall Study|Violation of exclusion criterion|0|||
23652345|NCT00912964|66114471|FG001|Overall Study|Violation of exclusion criterion|0|||
23652346|NCT00912964|66114472|FG002|Overall Study|Violation of exclusion criterion|2|||
23652347|NCT00912964|66114470|FG000|Overall Study|Randomized but never received study drug|0|||
23652348|NCT00912964|66114471|FG001|Overall Study|Randomized but never received study drug|1|||
23652349|NCT00912964|66114472|FG002|Overall Study|Randomized but never received study drug|0|||
23652350|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
23652351|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
23652352|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
23652353|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
23652354|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
23652355|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
23652356|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
23652357|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
23652358|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
23652359|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
23652360|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
23652361|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
23652362|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
23652363|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
23652364|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
23652365|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
23652366|NCT01231516|66114474|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
23652367|NCT01231516|66114475|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
23652368|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
23652369|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
23652370|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
23652371|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
23652372|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
23705489|NCT02371759|66297520|FG001|Overall Study|Protocol Violation|1|||
23801445|NCT00854373|66650025|FG001|Overall Study|Forgot to take study drug|1|||
23599326|NCT00822120|65922478|FG000|PET-directed Therapy|Protocol Violation|0|||
23599327|NCT00822120|65922479|FG001|PET-directed Therapy|Protocol Violation|0|||
23599328|NCT00822120|65922480|FG002|PET-directed Therapy|Protocol Violation|0|||
23599329|NCT00822120|65922481|FG003|PET-directed Therapy|Protocol Violation|6|||
23599330|NCT00822120|65922482|FG004|PET-directed Therapy|Protocol Violation|0|||
23599331|NCT00822120|65922483|FG005|PET-directed Therapy|Protocol Violation|0|||
23599332|NCT04019444|65922484|FG000|Overall Study|Withdrawal by Subject|0|||
23599333|NCT04019444|65922485|FG001|Overall Study|Withdrawal by Subject|1|||
23599334|NCT04019444|65922486|FG002|Overall Study|Withdrawal by Subject|0|||
23599335|NCT04019444|65922487|FG003|Overall Study|Withdrawal by Subject|1|||
23599336|NCT04019444|65922484|FG000|Overall Study|Solicited Event|0|||
23599337|NCT04019444|65922485|FG001|Overall Study|Solicited Event|0|||
23599338|NCT04019444|65922486|FG002|Overall Study|Solicited Event|2|||
23599339|NCT04019444|65922487|FG003|Overall Study|Solicited Event|0|||
23599340|NCT02029235|65922499|FG000|Overall Study|Non-compliance with study meds or diary|4|||
23599341|NCT02029235|65922500|FG001|Overall Study|Non-compliance with study meds or diary|1|||
23599342|NCT01303510|65922501|FG000|Overall Study|Lost to Follow-up|1|||
23599343|NCT01303510|65922502|FG001|Overall Study|Lost to Follow-up|0|||
23599344|NCT03861052|65922503|FG000|Overall Study|Adverse Event|1|||
23599345|NCT03861052|65922504|FG001|Overall Study|Adverse Event|1|||
23599346|NCT03861052|65922505|FG002|Overall Study|Adverse Event|2|||
23599347|NCT03861052|65922506|FG003|Overall Study|Adverse Event|4|||
23599348|NCT03861052|65922503|FG000|Overall Study|Lost to Follow-up|0|||
23599349|NCT03861052|65922504|FG001|Overall Study|Lost to Follow-up|0|||
23599350|NCT03861052|65922505|FG002|Overall Study|Lost to Follow-up|0|||
23652373|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
23652374|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
23652375|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
23652376|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
23652377|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
23652378|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
23652379|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
23652380|NCT01231516|66114474|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
23652381|NCT01231516|66114475|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
23652382|NCT01603082|66114478|FG000|Overall Study|Adverse Event|0|||
23652383|NCT01603082|66114479|FG001|Overall Study|Adverse Event|1|||
23652384|NCT01603082|66114478|FG000|Overall Study|Withdrawal by Subject|1|||
23652385|NCT01603082|66114479|FG001|Overall Study|Withdrawal by Subject|0|||
23652386|NCT01603082|66114478|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
23652387|NCT01603082|66114479|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
23652388|NCT00475033|66114482|FG000|Infant Series|Failed to return|3|||
23652389|NCT00475033|66114483|FG001|Infant Series|Failed to return|4|||
23652390|NCT00475033|66114482|FG000|Infant Series|Parent or legal guardian request|1|||
23652391|NCT00475033|66114483|FG001|Infant Series|Parent or legal guardian request|5|||
23652392|NCT00475033|66114482|FG000|Infant Series|Protocol Violation|1|||
23652393|NCT00475033|66114483|FG001|Infant Series|Protocol Violation|2|||
23652394|NCT00475033|66114482|FG000|Infant Series|Lost to Follow-up|2|||
23360756|NCT00587795|65065878|FG001|Overall Study|Withdrawal by Subject|0|||
23360757|NCT02658669|65065879|FG000|Overall Study|Lost to Follow-up|7|||
23360758|NCT02658669|65065880|FG001|Overall Study|Lost to Follow-up|5|||
23652395|NCT00475033|66114483|FG001|Infant Series|Lost to Follow-up|0|||
23360759|NCT00878800|65065881|FG000|Overall Study|Adverse Event|0|||
23360760|NCT00878800|65065882|FG001|Overall Study|Adverse Event|0|||
23360761|NCT00878800|65065883|FG002|Overall Study|Adverse Event|2|||
23360762|NCT00878800|65065884|FG003|Overall Study|Adverse Event|0|||
23652396|NCT00475033|66114482|FG000|Infant Series|Adverse Event|0|||
23652397|NCT00475033|66114483|FG001|Infant Series|Adverse Event|2|||
23652398|NCT00475033|66114482|FG000|After the Infant Series|Adverse Event|0|||
23652399|NCT00475033|66114483|FG001|After the Infant Series|Adverse Event|4|||
23360763|NCT00878800|65065885|FG004|Overall Study|Adverse Event|1|||
23360764|NCT00878800|65065881|FG000|Overall Study|Progressive disease|1|||
23360765|NCT00878800|65065882|FG001|Overall Study|Progressive disease|5|||
23360766|NCT00878800|65065883|FG002|Overall Study|Progressive disease|6|||
23652400|NCT00475033|66114482|FG000|After the Infant Series|Parent or legal guardian request|2|||
23360767|NCT00878800|65065884|FG003|Overall Study|Progressive disease|5|||
23360768|NCT00878800|65065885|FG004|Overall Study|Progressive disease|13|||
23360769|NCT00878800|65065881|FG000|Overall Study|Withdrew consent|1|||
23360770|NCT00878800|65065882|FG001|Overall Study|Withdrew consent|1|||
23360771|NCT00878800|65065883|FG002|Overall Study|Withdrew consent|0|||
23360772|NCT00878800|65065884|FG003|Overall Study|Withdrew consent|1|||
23360773|NCT00878800|65065885|FG004|Overall Study|Withdrew consent|1|||
23360774|NCT00878800|65065881|FG000|Overall Study|Death|0|||
23360775|NCT00878800|65065882|FG001|Overall Study|Death|0|||
23360776|NCT00878800|65065883|FG002|Overall Study|Death|1|||
23360777|NCT00878800|65065884|FG003|Overall Study|Death|0|||
23360778|NCT00878800|65065885|FG004|Overall Study|Death|0|||
23360779|NCT00878800|65065881|FG000|Overall Study|Other|1|||
23360780|NCT00878800|65065882|FG001|Overall Study|Other|1|||
23652401|NCT00475033|66114483|FG001|After the Infant Series|Parent or legal guardian request|2|||
23652402|NCT00475033|66114482|FG000|After the Infant Series|Failed to return|2|||
23652403|NCT00475033|66114483|FG001|After the Infant Series|Failed to return|1|||
23652404|NCT00475033|66114482|FG000|After the Infant Series|Protocol Violation|1|||
23652405|NCT00475033|66114483|FG001|After the Infant Series|Protocol Violation|0|||
23652406|NCT00475033|66114482|FG000|After the Infant Series|Lost to Follow-up|1|||
23652407|NCT00475033|66114483|FG001|After the Infant Series|Lost to Follow-up|0|||
23652408|NCT00475033|66114482|FG000|After the Infant Series|Other|0|||
23652409|NCT00475033|66114483|FG001|After the Infant Series|Other|1|||
23652410|NCT00475033|66114482|FG000|Toddler Dose|Parent or legal guardian request|2|||
23652411|NCT00475033|66114483|FG001|Toddler Dose|Parent or legal guardian request|0|||
23652412|NCT00475033|66114482|FG000|Toddler Dose|Failed to return|1|||
23652413|NCT00475033|66114483|FG001|Toddler Dose|Failed to return|0|||
23652414|NCT00475033|66114482|FG000|Toddler Dose|Lost to Follow-up|1|||
23652415|NCT00475033|66114483|FG001|Toddler Dose|Lost to Follow-up|0|||
23652416|NCT01716117|66114485|FG000|Overall Study|Death|5|||
23652417|NCT01716117|66114486|FG001|Overall Study|Death|2|||
23652418|NCT01716117|66114485|FG000|Overall Study|Withdrawal by Subject|2|||
23652419|NCT01716117|66114486|FG001|Overall Study|Withdrawal by Subject|0|||
23652420|NCT03097133|66114493|FG000|Overall Study|Lost to Follow-up|3|||
23652421|NCT03097133|66114494|FG001|Overall Study|Lost to Follow-up|2|||
23652422|NCT03097133|66114493|FG000|Overall Study|Withdrawal by Subject|2|||
23652423|NCT03097133|66114494|FG001|Overall Study|Withdrawal by Subject|5|||
23652424|NCT03097133|66114493|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
23652425|NCT03097133|66114494|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
23652426|NCT03097133|66114493|FG000|Overall Study|Other|3|||
23652427|NCT03097133|66114494|FG001|Overall Study|Other|2|||
23652428|NCT03097133|66114493|FG000|Overall Study|Adverse Event|1|||
23652429|NCT03097133|66114494|FG001|Overall Study|Adverse Event|0|||
23652430|NCT01272947|66114495|FG000|Overall Study|Abnormal Laboratory Value|2|||
23652431|NCT01272947|66114496|FG001|Overall Study|Abnormal Laboratory Value|2|||
23652432|NCT02141074|66114497|FG000|Pre-prophylaxis|Adverse Event|3|||
23652433|NCT02141074|66114498|FG001|Pre-prophylaxis|Adverse Event|0|||
23652434|NCT02141074|66114497|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
23652435|NCT02141074|66114498|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
23652436|NCT02141074|66114497|FG000|Prophylaxis|Adverse Event|0|||
23652437|NCT02141074|66114498|FG001|Prophylaxis|Adverse Event|4|||
23652438|NCT02141074|66114497|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
23652439|NCT02141074|66114498|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
23652440|NCT02141074|66114497|FG000|Prophylaxis|Withdrawal by Subject|0|||
23652441|NCT02141074|66114498|FG001|Prophylaxis|Withdrawal by Subject|1|||
23652442|NCT01637623|66114509|FG000|Overall Study|Lost to Follow-up|0|||
23652443|NCT01637623|66114510|FG001|Overall Study|Lost to Follow-up|0|||
23652444|NCT01637623|66114511|FG002|Overall Study|Lost to Follow-up|2|||
23652445|NCT01637623|66114509|FG000|Overall Study|Physician Decision|1|||
23652446|NCT01637623|66114510|FG001|Overall Study|Physician Decision|0|||
23652447|NCT01637623|66114511|FG002|Overall Study|Physician Decision|1|||
23652448|NCT01280812|66114512|FG000|Overall Study|Withdrawal by Subject|2|||
23652449|NCT01280812|66114513|FG001|Overall Study|Withdrawal by Subject|1|||
23652450|NCT01280812|66114514|FG002|Overall Study|Withdrawal by Subject|0|||
23652451|NCT01280812|66114512|FG000|Overall Study|Lost to Follow-up|1|||
23652452|NCT01280812|66114513|FG001|Overall Study|Lost to Follow-up|1|||
23652453|NCT01280812|66114514|FG002|Overall Study|Lost to Follow-up|1|||
23652454|NCT01929980|66114515|FG000|Overall Study|Physician Decision|1|||
23652455|NCT03231943|66114516|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652456|NCT03231943|66114517|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
23652457|NCT03231943|66114518|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
23652458|NCT03231943|66114519|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652459|NCT03231943|66114520|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652460|NCT03231943|66114521|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652461|NCT03231943|66114522|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652462|NCT03231943|66114523|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652463|NCT03231943|66114524|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652464|NCT03231943|66114525|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652465|NCT03231943|66114526|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652466|NCT03231943|66114527|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23801446|NCT00766831|66650031|FG000|Overall Study|Withdrawal by Subject|4|||
23652467|NCT03231943|66114528|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23652468|NCT03231943|66114516|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652469|NCT03231943|66114517|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
23652470|NCT03231943|66114518|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652471|NCT03231943|66114519|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652472|NCT03231943|66114520|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652473|NCT03231943|66114521|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652474|NCT03231943|66114522|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652475|NCT03231943|66114523|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652476|NCT03231943|66114524|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652477|NCT03231943|66114525|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652478|NCT03231943|66114526|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652479|NCT03231943|66114527|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652480|NCT03231943|66114528|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23652481|NCT03231943|66114516|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
23652482|NCT03231943|66114517|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652483|NCT03231943|66114518|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652484|NCT03231943|66114519|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652485|NCT03231943|66114520|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652486|NCT03231943|66114521|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652487|NCT03231943|66114522|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652488|NCT03231943|66114523|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652489|NCT03231943|66114524|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652490|NCT03231943|66114525|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652491|NCT03231943|66114526|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652492|NCT03231943|66114527|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652493|NCT03231943|66114528|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23652494|NCT03231943|66114516|FG000|Part 2|Adverse Event|0|||
23652495|NCT03231943|66114517|FG001|Part 2|Adverse Event|0|||
23652496|NCT03231943|66114518|FG002|Part 2|Adverse Event|0|||
23652497|NCT03231943|66114519|FG003|Part 2|Adverse Event|0|||
23652498|NCT03231943|66114520|FG004|Part 2|Adverse Event|0|||
23652499|NCT03231943|66114521|FG005|Part 2|Adverse Event|0|||
23652500|NCT03231943|66114522|FG006|Part 2|Adverse Event|0|||
23652501|NCT03231943|66114523|FG007|Part 2|Adverse Event|0|||
23652502|NCT03231943|66114524|FG008|Part 2|Adverse Event|0|||
23652503|NCT03231943|66114525|FG009|Part 2|Adverse Event|0|||
23652504|NCT03231943|66114526|FG010|Part 2|Adverse Event|1|||
23652505|NCT03231943|66114527|FG011|Part 2|Adverse Event|0|||
23652506|NCT03231943|66114528|FG012|Part 2|Adverse Event|0|||
23652507|NCT03231943|66114516|FG000|Part 2|Withdrawal by Subject|0|||
23652508|NCT03231943|66114517|FG001|Part 2|Withdrawal by Subject|0|||
23652509|NCT03231943|66114518|FG002|Part 2|Withdrawal by Subject|0|||
23652510|NCT03231943|66114519|FG003|Part 2|Withdrawal by Subject|0|||
23652511|NCT03231943|66114520|FG004|Part 2|Withdrawal by Subject|0|||
23652512|NCT03231943|66114521|FG005|Part 2|Withdrawal by Subject|0|||
23652513|NCT03231943|66114522|FG006|Part 2|Withdrawal by Subject|0|||
23652514|NCT03231943|66114523|FG007|Part 2|Withdrawal by Subject|0|||
23652515|NCT03231943|66114524|FG008|Part 2|Withdrawal by Subject|0|||
23652516|NCT03231943|66114525|FG009|Part 2|Withdrawal by Subject|0|||
23652517|NCT03231943|66114526|FG010|Part 2|Withdrawal by Subject|0|||
23652518|NCT03231943|66114527|FG011|Part 2|Withdrawal by Subject|1|||
23652519|NCT03231943|66114528|FG012|Part 2|Withdrawal by Subject|0|||
23652520|NCT00706433|66114531|FG000|Overall Study|Lost to Follow-up|3|||
23652521|NCT00706433|66114532|FG001|Overall Study|Lost to Follow-up|1|||
23652522|NCT00706433|66114533|FG002|Overall Study|Lost to Follow-up|6|||
23652523|NCT00706433|66114534|FG003|Overall Study|Lost to Follow-up|0|||
23652524|NCT00706433|66114531|FG000|Overall Study|Withdrawal by Subject|1|||
23652525|NCT00706433|66114532|FG001|Overall Study|Withdrawal by Subject|2|||
23652526|NCT00706433|66114533|FG002|Overall Study|Withdrawal by Subject|3|||
23652527|NCT00706433|66114534|FG003|Overall Study|Withdrawal by Subject|1|||
23652528|NCT00706433|66114531|FG000|Overall Study|Adverse Event|0|||
23652529|NCT00706433|66114532|FG001|Overall Study|Adverse Event|0|||
23652530|NCT00706433|66114533|FG002|Overall Study|Adverse Event|1|||
23652531|NCT00706433|66114534|FG003|Overall Study|Adverse Event|0|||
23652532|NCT00706433|66114531|FG000|Overall Study|Protocol Violation|1|||
23652533|NCT00706433|66114532|FG001|Overall Study|Protocol Violation|0|||
23652534|NCT00706433|66114533|FG002|Overall Study|Protocol Violation|0|||
23652535|NCT00706433|66114534|FG003|Overall Study|Protocol Violation|0|||
23652536|NCT00706433|66114531|FG000|Overall Study|new job|0|||
23652537|NCT00706433|66114532|FG001|Overall Study|new job|0|||
23652538|NCT00706433|66114533|FG002|Overall Study|new job|0|||
23652539|NCT00706433|66114534|FG003|Overall Study|new job|1|||
23652540|NCT01422850|66114535|FG000|Overall Study|Physician Decision|3|||
23652541|NCT00138671|66114536|FG000|Overall Study|Death|0|||
23652542|NCT00138671|66114537|FG001|Overall Study|Death|3|||
23652543|NCT00138671|66114536|FG000|Overall Study|Adverse Event|6|||
23652544|NCT00138671|66114537|FG001|Overall Study|Adverse Event|3|||
23652545|NCT00138671|66114536|FG000|Overall Study|Lost to Follow-up|1|||
23652546|NCT00138671|66114537|FG001|Overall Study|Lost to Follow-up|2|||
23479732|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23652547|NCT00138671|66114536|FG000|Overall Study|Withdrawal by Subject|3|||
23652548|NCT00138671|66114537|FG001|Overall Study|Withdrawal by Subject|5|||
23652549|NCT00138671|66114536|FG000|Overall Study|Other|3|||
23652550|NCT00138671|66114537|FG001|Overall Study|Other|3|||
23652551|NCT01774110|66114542|FG000|Overall Study|Lost to Follow-up|7|||
23652552|NCT03618823|66114544|FG000|Overall Study|Lost to Follow-up|63|||
23479733|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
23479734|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
23479735|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23479736|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479737|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479738|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479739|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23479740|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
23479741|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479742|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479743|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479744|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23479745|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479746|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23479747|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479748|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
23479749|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479750|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479751|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
23479752|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479753|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
23479754|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479755|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479756|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23479757|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479758|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23479759|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23479760|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
23479761|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23479762|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
23479763|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23479764|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23479765|NCT01328444|65498583|FG000|Washout Period (14 Days)|Adverse Event|1|||
23479766|NCT01328444|65498584|FG001|Washout Period (14 Days)|Adverse Event|1|||
23479767|NCT01328444|65498585|FG002|Washout Period (14 Days)|Adverse Event|0|||
23479768|NCT01328444|65498586|FG003|Washout Period (14 Days)|Adverse Event|1|||
23479769|NCT01328444|65498587|FG004|Washout Period (14 Days)|Adverse Event|1|||
23479770|NCT01328444|65498588|FG005|Washout Period (14 Days)|Adverse Event|2|||
23479771|NCT01328444|65498583|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
23479772|NCT01328444|65498584|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
23479773|NCT01328444|65498585|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
23479774|NCT01328444|65498586|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
23479775|NCT01328444|65498587|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
23479776|NCT01328444|65498588|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
23479777|NCT01328444|65498583|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479778|NCT01328444|65498584|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479779|NCT01328444|65498585|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479780|NCT01328444|65498586|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479781|NCT01328444|65498587|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479782|NCT01328444|65498588|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
23479783|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
23479784|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23479785|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479786|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479787|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479788|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23652553|NCT03618823|66114545|FG001|Overall Study|Lost to Follow-up|61|||
23652554|NCT04079803|66114546|FG000|Overall Study|Withdrawal by Subject|0|||
23652555|NCT04079803|66114547|FG001|Overall Study|Withdrawal by Subject|0|||
23652556|NCT04079803|66114548|FG002|Overall Study|Withdrawal by Subject|1|||
23652557|NCT04744285|66114557|FG000|Overall Study|Withdrawal by Subject|1|||
23652558|NCT04744285|66114558|FG001|Overall Study|Withdrawal by Subject|1|||
23652559|NCT04744285|66114559|FG002|Overall Study|Withdrawal by Subject|2|||
23652560|NCT04744285|66114560|FG003|Overall Study|Withdrawal by Subject|1|||
23652561|NCT02739360|66114563|FG000|Overall Study|Adverse Event|1|||
23652562|NCT02739360|66114563|FG000|Overall Study|Study terminated by Sponsor|2|||
23652563|NCT00300781|66114575|FG000|Overall Study|Disease Progression|55|||
23652564|NCT00300781|66114576|FG001|Overall Study|Disease Progression|52|||
23652565|NCT00300781|66114575|FG000|Overall Study|Adverse Event|5|||
23652566|NCT00300781|66114576|FG001|Overall Study|Adverse Event|6|||
23652567|NCT00300781|66114575|FG000|Overall Study|Withdrawal by Subject|1|||
23652568|NCT00300781|66114576|FG001|Overall Study|Withdrawal by Subject|2|||
23652569|NCT00300781|66114575|FG000|Overall Study|Physician Decision|1|||
23652570|NCT00300781|66114576|FG001|Overall Study|Physician Decision|0|||
23652571|NCT00300781|66114575|FG000|Overall Study|Not Recorded|0|||
23652572|NCT00300781|66114576|FG001|Overall Study|Not Recorded|1|||
23652573|NCT00300781|66114575|FG000|Overall Study|Symptomatic Deterioration|1|||
23652574|NCT00300781|66114576|FG001|Overall Study|Symptomatic Deterioration|0|||
23652575|NCT00300781|66114575|FG000|Overall Study|Lost to Follow-up|0|||
23652576|NCT00300781|66114576|FG001|Overall Study|Lost to Follow-up|1|||
23652577|NCT03645057|66114582|FG000|Randomization to Baseline|Lost to Follow-up|1|||
23652578|NCT03645057|66114583|FG001|Randomization to Baseline|Lost to Follow-up|0|||
23652579|NCT03645057|66114584|FG002|Randomization to Baseline|Lost to Follow-up|1|||
23652580|NCT03645057|66114585|FG003|Randomization to Baseline|Lost to Follow-up|0|||
23652581|NCT03645057|66114582|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
23652582|NCT03645057|66114583|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
23652583|NCT03645057|66114584|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
23652584|NCT03645057|66114585|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
23652585|NCT03645057|66114582|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
23652586|NCT03645057|66114583|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
23652587|NCT03645057|66114584|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
23652588|NCT03645057|66114585|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
23652589|NCT03645057|66114582|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
23652590|NCT03645057|66114583|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
23652591|NCT03645057|66114584|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
23652592|NCT03645057|66114585|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
23652593|NCT01557283|66114586|FG000|Overall Study|Lost to Follow-up|7|||
23652594|NCT01557283|66114586|FG000|Overall Study|Non-responder|19|||
23652595|NCT01557283|66114586|FG000|Overall Study|Adverse Event|7|||
23652596|NCT01557283|66114586|FG000|Overall Study|Lack of Efficacy|1|||
23652597|NCT01557283|66114586|FG000|Overall Study|Non-compliance|1|||
23652598|NCT01557283|66114586|FG000|Overall Study|Withdrawal by Subject|1|||
23652599|NCT01557283|66114586|FG000|Overall Study|Participant's weight too high for dose|1|||
23652600|NCT01557283|66114586|FG000|Overall Study|Worsening of psoriasis|1|||
23652601|NCT01557283|66114586|FG000|Overall Study|Other|6|||
23652602|NCT00628251|66114589|FG000|Randomised Part|Withdrawal by Subject|0|||
23652603|NCT00628251|66114590|FG001|Randomised Part|Withdrawal by Subject|0|||
23652604|NCT00628251|66114591|FG002|Randomised Part|Withdrawal by Subject|1|||
23652605|NCT00628251|66114589|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
23652606|NCT00628251|66114590|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
23652607|NCT00628251|66114591|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
23652608|NCT00628251|66114589|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
23652609|NCT00628251|66114590|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
23652610|NCT00628251|66114591|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
23652611|NCT00628251|66114589|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
23652612|NCT00628251|66114590|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
23652613|NCT00628251|66114591|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
23652614|NCT00628251|66114589|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
23652615|NCT00628251|66114590|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
23652616|NCT00628251|66114591|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
23652617|NCT00628251|66114589|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
23652618|NCT00628251|66114590|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
23652619|NCT00628251|66114591|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
23652620|NCT02101034|66114592|FG000|Overall Study|Enrolled but did not start treatment|0|||
23652621|NCT02101034|66114593|FG001|Overall Study|Enrolled but did not start treatment|0|||
23652622|NCT02101034|66114594|FG002|Overall Study|Enrolled but did not start treatment|1|||
23360781|NCT00878800|65065883|FG002|Overall Study|Other|0|||
23652623|NCT02101034|66114595|FG003|Overall Study|Enrolled but did not start treatment|0|||
23705490|NCT02371759|66297521|FG002|Overall Study|Protocol Violation|1|||
23652624|NCT02101034|66114596|FG004|Overall Study|Enrolled but did not start treatment|0|||
23652625|NCT04051827|66114597|FG000|Overall Study|Death|1|||
23652626|NCT04051827|66114597|FG000|Overall Study|Withdrawal by Subject|4|||
23652627|NCT04051827|66114597|FG000|Overall Study|Progressive disease|16|||
23652628|NCT04051827|66114597|FG000|Overall Study|Physician Decision|1|||
23652629|NCT04051827|66114597|FG000|Overall Study|Other|4|||
23652630|NCT01214187|66114598|FG000|Overall Study|Adverse Event|6|||
23652631|NCT01214187|66114599|FG001|Overall Study|Adverse Event|2|||
23652632|NCT01214187|66114598|FG000|Overall Study|Death|1|||
23652633|NCT01214187|66114599|FG001|Overall Study|Death|1|||
23652634|NCT01214187|66114598|FG000|Overall Study|Withdrawal by Subject|0|||
23652635|NCT01214187|66114599|FG001|Overall Study|Withdrawal by Subject|3|||
23652636|NCT01592864|66114600|FG000|Overall Study|Withdrawal by Subject|0|||
23652637|NCT01592864|66114601|FG001|Overall Study|Withdrawal by Subject|1|||
23652638|NCT04484831|66114602|FG000|Overall Study|Withdrawal by Subject|1|||
23652639|NCT04484831|66114603|FG001|Overall Study|Withdrawal by Subject|0|||
23652640|NCT03575143|66114604|FG000|Overall Study|Lost to Follow-up|0|||
23652641|NCT03575143|66114605|FG001|Overall Study|Lost to Follow-up|0|||
23652642|NCT03575143|66114606|FG002|Overall Study|Lost to Follow-up|4|||
23652643|NCT03575143|66114604|FG000|Overall Study|Withdrawal by Subject|0|||
23652644|NCT03575143|66114605|FG001|Overall Study|Withdrawal by Subject|0|||
23652645|NCT03575143|66114606|FG002|Overall Study|Withdrawal by Subject|5|||
23652646|NCT03575143|66114604|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
23652647|NCT03575143|66114605|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
23652648|NCT03575143|66114606|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
23652649|NCT03678103|66114608|FG000|Overall Study|Withdrawn prior to completion|4|||
23652650|NCT03103763|66114609|FG000|Overall Study|Death|15|||
23652651|NCT03103763|66114610|FG001|Overall Study|Death|5|||
23652652|NCT03103763|66114611|FG002|Overall Study|Death|5|||
23652653|NCT03103763|66114609|FG000|Overall Study|Withdrawal by Subject|0|||
23652654|NCT03103763|66114610|FG001|Overall Study|Withdrawal by Subject|3|||
23652655|NCT03103763|66114611|FG002|Overall Study|Withdrawal by Subject|2|||
23652656|NCT01390181|66114612|FG000|Overall Study|Lost to Follow-up|1|||
23652657|NCT01390181|66114612|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
23652658|NCT02080221|66114621|FG000|Overall Study|Withdrawal by Subject|1|||
23652659|NCT02080221|66114621|FG000|Overall Study|Clinical Progression of Disease|1|||
23652660|NCT02824263|66114625|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
23652661|NCT02824263|66114626|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
23652662|NCT02824263|66114625|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
23652663|NCT02824263|66114626|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
23652664|NCT00760669|66114627|FG000|Overall Study|Not assessed for overall improvement|18|||
23652665|NCT00760669|66114627|FG000|Overall Study|Participants missing efficacy assessment|6|||
23652666|NCT00760669|66114627|FG000|Overall Study|Participants with overlapping cases|1|||
23652667|NCT00760669|66114627|FG000|Overall Study|Took drug before entering in contract|5|||
23652668|NCT01295034|66114632|FG000|Overall Study|Lost to Follow-up|5|||
23652669|NCT01295034|66114633|FG001|Overall Study|Lost to Follow-up|5|||
23652670|NCT01480674|66114634|FG000|Overall Study|Death|23|||
23652671|NCT01480674|66114634|FG000|Overall Study|Lost to Follow-up|2|||
23652672|NCT01480674|66114634|FG000|Overall Study|visit not done|10|||
23652673|NCT00728481|66114635|FG000|Overall Study|Withdrawal by Subject|0|||
23652674|NCT00728481|66114636|FG001|Overall Study|Withdrawal by Subject|1|||
23652675|NCT00728481|66114635|FG000|Overall Study|Adverse Event|0|||
23360782|NCT00878800|65065884|FG003|Overall Study|Other|0|||
23360783|NCT00878800|65065885|FG004|Overall Study|Other|1|||
23652676|NCT00728481|66114636|FG001|Overall Study|Adverse Event|1|||
23652677|NCT00728481|66114635|FG000|Overall Study|Study medication non-compliance|0|||
23652678|NCT00728481|66114636|FG001|Overall Study|Study medication non-compliance|2|||
23652679|NCT00728481|66114635|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
23652680|NCT00728481|66114636|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
23652681|NCT00394953|66114637|FG000|First Treatment Period|Adverse Event|1|||
23652682|NCT00394953|66114638|FG001|First Treatment Period|Adverse Event|2|||
23652683|NCT00394953|66114637|FG000|First Treatment Period|Death|6|||
23652684|NCT00394953|66114638|FG001|First Treatment Period|Death|7|||
23652685|NCT00394953|66114637|FG000|First Treatment Period|Lack of Efficacy|1|||
23652686|NCT00394953|66114638|FG001|First Treatment Period|Lack of Efficacy|1|||
23652687|NCT00394953|66114637|FG000|First Treatment Period|Withdrawal by Subject|6|||
23479789|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
23479790|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23479791|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23479792|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23479793|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
23479794|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
23360784|NCT01890759|65065892|FG000|Overall Study|Protocol Violation|0|||
23360785|NCT01890759|65065893|FG001|Overall Study|Protocol Violation|2|||
23479795|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
23479796|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479797|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479798|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479799|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
23479800|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479801|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479802|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479803|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479804|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23479805|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23479806|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479807|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23479808|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23479809|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479810|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479811|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479812|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
23479813|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479814|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479815|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479816|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479817|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23599351|NCT03861052|65922506|FG003|Overall Study|Lost to Follow-up|1|||
23801447|NCT00766831|66650031|FG000|Overall Study|Lost to Follow-up|3|||
23360786|NCT01890759|65065892|FG000|Overall Study|Lost to Follow-up|0|||
23360787|NCT01890759|65065893|FG001|Overall Study|Lost to Follow-up|2|||
23360788|NCT01890759|65065892|FG000|Overall Study|Withdrawal by Subject|2|||
23360789|NCT01890759|65065893|FG001|Overall Study|Withdrawal by Subject|8|||
23360790|NCT01968811|65065897|FG000|Overall Study|Protocol Violation|4|||
23360791|NCT01968811|65065897|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
23360792|NCT04086121|65065899|FG000|Overall Study|Other than listed|8|||
23360793|NCT04086121|65065899|FG000|Overall Study|Withdrawal by Subject|3|||
23360794|NCT04086121|65065899|FG000|Overall Study|Lost to Follow-up|2|||
23360795|NCT04086121|65065899|FG000|Overall Study|Adverse Event|1|||
23360796|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
23360797|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
23360798|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
23360799|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
23360800|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
23360801|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
23360802|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
23360803|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
23360804|NCT04001803|65065902|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
23360805|NCT04001803|65065902|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
23360806|NCT05285787|65065908|FG000|Overall Study|Withdrawal by Subject|1|||
23360807|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
23360808|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
23360809|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
23360810|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
23360811|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Other|1|||
23360812|NCT00412932|65065911|FG000|Olmesartan 40 mg|Adverse Event|4|||
23360813|NCT00412932|65065911|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
23360814|NCT00412932|65065911|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
23479818|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23479819|NCT01820260|65498598|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479820|NCT01820260|65498599|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479821|NCT01820260|65498600|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479822|NCT01820260|65498601|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479823|NCT01820260|65498602|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23360815|NCT00412932|65065911|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
23479824|NCT01820260|65498603|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23599352|NCT03861052|65922503|FG000|Overall Study|Physician Decision|0|||
23360816|NCT00412932|65065911|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
23360817|NCT00412932|65065911|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
23360818|NCT00412932|65065911|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
23479825|NCT01820260|65498604|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
23599353|NCT03861052|65922504|FG001|Overall Study|Physician Decision|1|||
23652688|NCT00394953|66114638|FG001|First Treatment Period|Withdrawal by Subject|3|||
23652689|NCT00394953|66114637|FG000|First Treatment Period|Lost to Follow-up|0|||
23652690|NCT00394953|66114638|FG001|First Treatment Period|Lost to Follow-up|1|||
23652691|NCT00394953|66114637|FG000|First Treatment Period|Renal transplant|11|||
23652692|NCT00394953|66114638|FG001|First Treatment Period|Renal transplant|7|||
23652693|NCT00394953|66114637|FG000|First Treatment Period|Not defined|4|||
23652694|NCT00394953|66114638|FG001|First Treatment Period|Not defined|1|||
23652695|NCT00394953|66114637|FG000|Second Treatment Period|Adverse Event|2|||
23652696|NCT00394953|66114638|FG001|Second Treatment Period|Adverse Event|5|||
23652697|NCT00394953|66114637|FG000|Second Treatment Period|Death|8|||
23652698|NCT00394953|66114638|FG001|Second Treatment Period|Death|4|||
23652699|NCT00394953|66114637|FG000|Second Treatment Period|Lack of Efficacy|9|||
23652700|NCT00394953|66114638|FG001|Second Treatment Period|Lack of Efficacy|47|||
23801448|NCT00766831|66650031|FG000|Overall Study|Adverse Event|20|||
23599354|NCT03861052|65922505|FG002|Overall Study|Physician Decision|0|||
23599355|NCT03861052|65922506|FG003|Overall Study|Physician Decision|0|||
23599356|NCT03861052|65922503|FG000|Overall Study|Withdrawal by Subject|2|||
23599357|NCT03861052|65922504|FG001|Overall Study|Withdrawal by Subject|5|||
23599358|NCT03861052|65922505|FG002|Overall Study|Withdrawal by Subject|3|||
23599359|NCT03861052|65922506|FG003|Overall Study|Withdrawal by Subject|0|||
23599360|NCT03861052|65922503|FG000|Overall Study|Relocation to other city|1|||
23599361|NCT03861052|65922504|FG001|Overall Study|Relocation to other city|0|||
23599362|NCT03861052|65922505|FG002|Overall Study|Relocation to other city|0|||
23599363|NCT03861052|65922506|FG003|Overall Study|Relocation to other city|0|||
23599364|NCT00174252|65922513|FG000|Overall Study|Protocol Violation|2|||
23599365|NCT00566735|65922515|FG000|Overall Study|Withdrawal by Subject|0|||
23599366|NCT00566735|65922516|FG001|Overall Study|Withdrawal by Subject|1|||
23599367|NCT00566735|65922515|FG000|Overall Study|Refused neuropsychological testing|2|||
23599368|NCT00566735|65922516|FG001|Overall Study|Refused neuropsychological testing|5|||
23599369|NCT00566735|65922515|FG000|Overall Study|Switched into a manic episode|0|||
23599370|NCT00566735|65922516|FG001|Overall Study|Switched into a manic episode|1|||
23599371|NCT01324310|65925557|FG000|Overall Study|Adverse Event|1|||
23599372|NCT01324310|65925557|FG000|Overall Study|Disease Progression|1|||
23599373|NCT01854385|65925560|FG000|Pre-Treatment|Withdrawal by Subject|4|||
23599374|NCT01854385|65925560|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
23599375|NCT01854385|65925560|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
23599376|NCT01854385|65925560|FG000|Pre-Treatment|Unable to come for study visits|1|||
23599377|NCT01854385|65925560|FG000|Treatment|Lost to Follow-up|1|||
23599378|NCT01750684|65925561|FG000|Overall Study|Death|1|||
23599379|NCT01750684|65925562|FG001|Overall Study|Death|0|||
23599380|NCT01750684|65925561|FG000|Overall Study|Non-compliance with Study Drug|0|||
23599381|NCT01750684|65925562|FG001|Overall Study|Non-compliance with Study Drug|1|||
23599382|NCT01750684|65925561|FG000|Overall Study|Withdrawn by Sponsor|0|||
23599383|NCT01750684|65925562|FG001|Overall Study|Withdrawn by Sponsor|1|||
23599384|NCT01750684|65925561|FG000|Overall Study|Protocol Violation|1|||
23599385|NCT01750684|65925562|FG001|Overall Study|Protocol Violation|0|||
23599386|NCT01288443|65925565|FG000|Overall Study|Adverse Event|0|||
23599387|NCT01288443|65925566|FG001|Overall Study|Adverse Event|0|||
23599388|NCT01288443|65925567|FG002|Overall Study|Adverse Event|1|||
23599389|NCT01288443|65925568|FG003|Overall Study|Adverse Event|1|||
23599390|NCT01288443|65925569|FG004|Overall Study|Adverse Event|3|||
23599391|NCT01288443|65925570|FG005|Overall Study|Adverse Event|1|||
23599392|NCT01288443|65925565|FG000|Overall Study|Poor compliance to protocol|0|||
23599393|NCT01288443|65925566|FG001|Overall Study|Poor compliance to protocol|0|||
23599394|NCT01288443|65925567|FG002|Overall Study|Poor compliance to protocol|0|||
23599395|NCT01288443|65925568|FG003|Overall Study|Poor compliance to protocol|0|||
23599396|NCT01288443|65925569|FG004|Overall Study|Poor compliance to protocol|0|||
23599397|NCT01288443|65925570|FG005|Overall Study|Poor compliance to protocol|1|||
23599398|NCT01288443|65925565|FG000|Overall Study|Participant Moved|0|||
23599399|NCT01288443|65925566|FG001|Overall Study|Participant Moved|0|||
23599400|NCT01288443|65925567|FG002|Overall Study|Participant Moved|0|||
23652701|NCT00394953|66114637|FG000|Second Treatment Period|Withdrawal by Subject|3|||
23652702|NCT00394953|66114638|FG001|Second Treatment Period|Withdrawal by Subject|3|||
23652703|NCT00394953|66114637|FG000|Second Treatment Period|Lost to Follow-up|0|||
23652704|NCT00394953|66114638|FG001|Second Treatment Period|Lost to Follow-up|1|||
23599401|NCT01288443|65925568|FG003|Overall Study|Participant Moved|1|||
23599402|NCT01288443|65925569|FG004|Overall Study|Participant Moved|2|||
23652705|NCT00394953|66114637|FG000|Second Treatment Period|Renal transplant|4|||
23652706|NCT00394953|66114638|FG001|Second Treatment Period|Renal transplant|6|||
23652707|NCT00394953|66114637|FG000|Second Treatment Period|Not defined|3|||
23652708|NCT00394953|66114638|FG001|Second Treatment Period|Not defined|8|||
23652709|NCT03421431|66114639|FG000|Overall Study|Adverse Event|2|||
23652710|NCT03421431|66114640|FG001|Overall Study|Adverse Event|1|||
23652711|NCT03421431|66114641|FG002|Overall Study|Adverse Event|12|||
23652712|NCT03421431|66114639|FG000|Overall Study|Lost to Follow-up|1|||
23652713|NCT03421431|66114640|FG001|Overall Study|Lost to Follow-up|1|||
23652714|NCT03421431|66114641|FG002|Overall Study|Lost to Follow-up|1|||
23652715|NCT03421431|66114639|FG000|Overall Study|Withdrawal by Subject|3|||
23652716|NCT03421431|66114640|FG001|Overall Study|Withdrawal by Subject|2|||
23652717|NCT03421431|66114641|FG002|Overall Study|Withdrawal by Subject|1|||
23652718|NCT03421431|66114639|FG000|Overall Study|Protocol Violation|0|||
23652719|NCT03421431|66114640|FG001|Overall Study|Protocol Violation|1|||
23652720|NCT03421431|66114641|FG002|Overall Study|Protocol Violation|0|||
23652721|NCT03421431|66114639|FG000|Overall Study|Participant met Stopping Rules|0|||
23652722|NCT03421431|66114640|FG001|Overall Study|Participant met Stopping Rules|1|||
23652723|NCT03421431|66114641|FG002|Overall Study|Participant met Stopping Rules|0|||
23652724|NCT01013285|66114643|FG000|Overall Study|Death|48|||
23652725|NCT01013285|66114644|FG001|Overall Study|Death|89|||
23652726|NCT01386788|66114645|FG000|Overall Study|Lost to Follow-up|2|||
23652727|NCT01016964|66114646|FG000|Overall Study|Lost to Follow-up|3|||
23652728|NCT01016964|66114647|FG001|Overall Study|Lost to Follow-up|3|||
23652729|NCT01020448|66114655|FG000|Pre-assignment|Adverse Event|6|||
23652730|NCT01020448|66114655|FG000|Pre-assignment|Withdrawal by Subject|5|||
23652731|NCT01020448|66114655|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
23652732|NCT01020448|66114655|FG000|Treatment|Adverse Event|11|||
23652733|NCT01020448|66114655|FG000|Treatment|Consent Withdrawn|3|||
23652734|NCT01020448|66114655|FG000|Treatment|Disease Progression|2|||
23360819|NCT03335813|65065912|FG000|Overall Study|Withdrawal by Subject|1|||
23360820|NCT00184002|65065913|FG000|Overall Study|Adverse Event|9|||
23360821|NCT00184002|65065913|FG000|Overall Study|Death|3|||
23360822|NCT00184002|65065913|FG000|Overall Study|Physician Decision|1|||
23360823|NCT00184002|65065913|FG000|Overall Study|Withdrawal by Subject|4|||
23360824|NCT01909804|65065915|FG000|Overall Study|Randomized but Never Treated|0|||
23360825|NCT01909804|65065916|FG001|Overall Study|Randomized but Never Treated|0|||
23360826|NCT01909804|65065917|FG002|Overall Study|Randomized but Never Treated|0|||
23360827|NCT01909804|65065918|FG003|Overall Study|Randomized but Never Treated|0|||
23360828|NCT01909804|65065919|FG004|Overall Study|Randomized but Never Treated|0|||
23360829|NCT01909804|65065920|FG005|Overall Study|Randomized but Never Treated|0|||
23360830|NCT01909804|65065921|FG006|Overall Study|Randomized but Never Treated|1|||
23360831|NCT01909804|65065922|FG007|Overall Study|Randomized but Never Treated|0|||
23360832|NCT01909804|65065923|FG008|Overall Study|Randomized but Never Treated|0|||
23360833|NCT01909804|65065924|FG009|Overall Study|Randomized but Never Treated|0|||
23360834|NCT01909804|65065925|FG010|Overall Study|Randomized but Never Treated|0|||
23360835|NCT01909804|65065926|FG011|Overall Study|Randomized but Never Treated|1|||
23360836|NCT01909804|65065915|FG000|Overall Study|Death|0|||
23360837|NCT01909804|65065916|FG001|Overall Study|Death|0|||
23360838|NCT01909804|65065917|FG002|Overall Study|Death|0|||
23360839|NCT01909804|65065918|FG003|Overall Study|Death|0|||
23360840|NCT01909804|65065919|FG004|Overall Study|Death|0|||
23652735|NCT01020448|66114655|FG000|Treatment|Lack of Efficacy|8|||
23652736|NCT01020448|66114655|FG000|Treatment|Lost to Follow-up|2|||
23652737|NCT02054325|66114656|FG000|Overall Study|Lost to Follow-up|8|||
23652738|NCT02054325|66114657|FG001|Overall Study|Lost to Follow-up|5|||
23652739|NCT01215175|66114658|FG000|Overall Study|Lost to Follow-up|0|||
23652740|NCT01215175|66114659|FG001|Overall Study|Lost to Follow-up|1|||
23652741|NCT01215175|66114660|FG002|Overall Study|Lost to Follow-up|0|||
23360841|NCT01909804|65065920|FG005|Overall Study|Death|0|||
23360842|NCT01909804|65065921|FG006|Overall Study|Death|0|||
23360843|NCT01909804|65065922|FG007|Overall Study|Death|0|||
23360844|NCT01909804|65065923|FG008|Overall Study|Death|0|||
23360845|NCT01909804|65065924|FG009|Overall Study|Death|0|||
23652742|NCT01215175|66114661|FG003|Overall Study|Lost to Follow-up|1|||
23652743|NCT01215175|66114662|FG004|Overall Study|Lost to Follow-up|0|||
23652744|NCT05208866|66114663|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
23652745|NCT01072877|66114671|FG000|Overall Study|Lost to Follow-up|1|||
23652746|NCT01072877|66114672|FG001|Overall Study|Lost to Follow-up|1|||
23652747|NCT01072877|66114673|FG002|Overall Study|Lost to Follow-up|0|||
23652748|NCT01072877|66114674|FG003|Overall Study|Lost to Follow-up|2|||
23652749|NCT01072877|66114675|FG004|Overall Study|Lost to Follow-up|0|||
23652750|NCT02901041|66114678|FG000|Overall Study|Withdrawal by PI|4|||
23360846|NCT01909804|65065925|FG010|Overall Study|Death|1|||
23360847|NCT01909804|65065926|FG011|Overall Study|Death|0|||
23360848|NCT01909804|65065915|FG000|Overall Study|Lack of Efficacy|4|||
23360849|NCT01909804|65065916|FG001|Overall Study|Lack of Efficacy|1|||
23360850|NCT01909804|65065917|FG002|Overall Study|Lack of Efficacy|0|||
23360851|NCT01909804|65065918|FG003|Overall Study|Lack of Efficacy|0|||
23479826|NCT01820260|65498605|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479827|NCT01820260|65498606|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479828|NCT01820260|65498607|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479829|NCT01820260|65498608|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479830|NCT01820260|65498609|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479831|NCT01820260|65498610|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479832|NCT01820260|65498611|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479833|NCT01820260|65498598|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479834|NCT01820260|65498599|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479835|NCT01820260|65498600|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479836|NCT01820260|65498601|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479837|NCT01820260|65498602|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479838|NCT01820260|65498603|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479839|NCT01820260|65498604|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479840|NCT01820260|65498605|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479841|NCT01820260|65498606|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479842|NCT01820260|65498607|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
23479843|NCT01820260|65498608|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479844|NCT01820260|65498609|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479845|NCT01820260|65498610|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479846|NCT01820260|65498611|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479847|NCT05347147|65498613|FG000|Overall Study|Lost to Follow-up|0|||
23479848|NCT05347147|65498614|FG001|Overall Study|Lost to Follow-up|1|||
23479849|NCT05347147|65498613|FG000|Overall Study|Sponsor request|3|||
23479850|NCT05347147|65498614|FG001|Overall Study|Sponsor request|3|||
23479851|NCT05347147|65498613|FG000|Overall Study|Study termination|2|||
23479852|NCT05347147|65498614|FG001|Overall Study|Study termination|1|||
23479853|NCT04381988|65501814|FG000|Overall Study|The study was terminated|4|||
23479854|NCT04381988|65501815|FG001|Overall Study|The study was terminated|0|||
23479855|NCT03680742|65501822|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
23479856|NCT03821844|65501829|FG000|Overall Study|Death|37|||
23479857|NCT03821844|65501830|FG001|Overall Study|Death|31|||
23479858|NCT03821844|65501829|FG000|Overall Study|Discharged|10|||
23479859|NCT03821844|65501830|FG001|Overall Study|Discharged|14|||
23479860|NCT03821844|65501829|FG000|Overall Study|Not present in facility at followup|2|||
23479861|NCT03821844|65501830|FG001|Overall Study|Not present in facility at followup|3|||
23479862|NCT03007888|65501831|FG000|First Intervention (14 Days)|Adverse Event|1|||
23479863|NCT03007888|65501832|FG001|First Intervention (14 Days)|Adverse Event|0|||
23479864|NCT01993836|65501835|FG000|Overall Study|Surgery Cancelled|3|||
23479865|NCT01993836|65501836|FG001|Overall Study|Surgery Cancelled|0|||
23479866|NCT01993836|65501837|FG002|Overall Study|Surgery Cancelled|0|||
23479867|NCT01993836|65501835|FG000|Overall Study|Physician Decision|2|||
23479868|NCT01993836|65501836|FG001|Overall Study|Physician Decision|1|||
23479869|NCT01993836|65501837|FG002|Overall Study|Physician Decision|0|||
23479870|NCT01993836|65501835|FG000|Overall Study|Death|0|||
23479871|NCT01993836|65501836|FG001|Overall Study|Death|2|||
23479872|NCT01993836|65501837|FG002|Overall Study|Death|0|||
23479873|NCT01993836|65501835|FG000|Overall Study|Withdrawal by Subject|12|||
23479874|NCT01993836|65501836|FG001|Overall Study|Withdrawal by Subject|10|||
23479875|NCT01993836|65501837|FG002|Overall Study|Withdrawal by Subject|5|||
23479876|NCT02656680|65501838|FG000|Overall Study|Lost to Follow-up|0|||
23479877|NCT02656680|65501839|FG001|Overall Study|Lost to Follow-up|1|||
23479878|NCT02656680|65501840|FG002|Overall Study|Lost to Follow-up|7|||
23479879|NCT02296138|65501843|FG000|Overall Study|Adverse Event|348|||
23479880|NCT02296138|65501844|FG001|Overall Study|Adverse Event|259|||
23479881|NCT02296138|65501843|FG000|Overall Study|Lack of Efficacy|59|||
23479882|NCT02296138|65501844|FG001|Overall Study|Lack of Efficacy|37|||
23479883|NCT02296138|65501843|FG000|Overall Study|Protocol Violation|35|||
23479884|NCT02296138|65501844|FG001|Overall Study|Protocol Violation|36|||
23479885|NCT02296138|65501843|FG000|Overall Study|Lost to Follow-up|9|||
23479886|NCT02296138|65501844|FG001|Overall Study|Lost to Follow-up|12|||
23479887|NCT02296138|65501843|FG000|Overall Study|Withdrawal by Subject|184|||
23479888|NCT02296138|65501844|FG001|Overall Study|Withdrawal by Subject|131|||
23479889|NCT02296138|65501843|FG000|Overall Study|Not Treated|1|||
23652751|NCT02901041|66114679|FG001|Overall Study|Withdrawal by PI|8|||
23479890|NCT02296138|65501844|FG001|Overall Study|Not Treated|1|||
23479891|NCT02296138|65501843|FG000|Overall Study|Patients with data irregularities|10|||
23479892|NCT02296138|65501844|FG001|Overall Study|Patients with data irregularities|11|||
23479893|NCT02296138|65501843|FG000|Overall Study|Other than specified|15|||
23479894|NCT02296138|65501844|FG001|Overall Study|Other than specified|13|||
23479895|NCT00348933|65501848|FG000|Overall Study|Withdrawal by Subject|10|||
23479896|NCT00348933|65501848|FG000|Overall Study|Lost to Follow-up|6|||
23479897|NCT00348933|65501848|FG000|Overall Study|Protocol Violation|2|||
23479898|NCT00348933|65501848|FG000|Overall Study|Adverse Event|7|||
23652752|NCT02901041|66114678|FG000|Overall Study|Withdrawal by Subject|7|||
23652753|NCT02901041|66114679|FG001|Overall Study|Withdrawal by Subject|3|||
23652754|NCT00876928|66114680|FG000|Overall Study|Lost to Follow-up|2|||
23652755|NCT00876928|66114681|FG001|Overall Study|Lost to Follow-up|5|||
23652756|NCT00876928|66114680|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
23652757|NCT00876928|66114681|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
23652758|NCT02308020|66114684|FG000|Overall Study|Lost to Follow-up|1|||
23652759|NCT02308020|66114685|FG001|Overall Study|Lost to Follow-up|7|||
23652760|NCT02308020|66114686|FG002|Overall Study|Lost to Follow-up|0|||
23652761|NCT02308020|66114687|FG003|Overall Study|Lost to Follow-up|0|||
23652762|NCT02308020|66114688|FG004|Overall Study|Lost to Follow-up|1|||
23652763|NCT02308020|66114689|FG005|Overall Study|Lost to Follow-up|2|||
23652764|NCT02308020|66114684|FG000|Overall Study|Sponsor Decision|0|||
23652765|NCT02308020|66114685|FG001|Overall Study|Sponsor Decision|8|||
23652766|NCT02308020|66114686|FG002|Overall Study|Sponsor Decision|0|||
23652767|NCT02308020|66114687|FG003|Overall Study|Sponsor Decision|2|||
23652768|NCT02308020|66114688|FG004|Overall Study|Sponsor Decision|2|||
23360852|NCT01909804|65065919|FG004|Overall Study|Lack of Efficacy|7|||
23652769|NCT02308020|66114689|FG005|Overall Study|Sponsor Decision|1|||
23652770|NCT02308020|66114684|FG000|Overall Study|Withdrawal by Subject|3|||
23652771|NCT02308020|66114685|FG001|Overall Study|Withdrawal by Subject|5|||
23652772|NCT02308020|66114686|FG002|Overall Study|Withdrawal by Subject|3|||
23652773|NCT02308020|66114687|FG003|Overall Study|Withdrawal by Subject|2|||
23652774|NCT02308020|66114688|FG004|Overall Study|Withdrawal by Subject|1|||
23652775|NCT02308020|66114689|FG005|Overall Study|Withdrawal by Subject|2|||
23652776|NCT00402597|66114690|FG000|Overall Study|Death|15|||
23652777|NCT00402597|66114691|FG001|Overall Study|Death|7|||
23652778|NCT00402597|66114692|FG002|Overall Study|Death|6|||
23652779|NCT00402597|66114693|FG003|Overall Study|Death|4|||
23652780|NCT00402597|66114694|FG004|Overall Study|Death|6|||
23652781|NCT00402597|66114690|FG000|Overall Study|Adverse Event|81|||
23652782|NCT00402597|66114691|FG001|Overall Study|Adverse Event|18|||
23652783|NCT00402597|66114692|FG002|Overall Study|Adverse Event|106|||
23652784|NCT00402597|66114693|FG003|Overall Study|Adverse Event|39|||
23652785|NCT00402597|66114694|FG004|Overall Study|Adverse Event|71|||
23652786|NCT00402597|66114690|FG000|Overall Study|Lost to Follow-up|8|||
23652787|NCT00402597|66114691|FG001|Overall Study|Lost to Follow-up|1|||
23652788|NCT00402597|66114692|FG002|Overall Study|Lost to Follow-up|8|||
23652789|NCT00402597|66114693|FG003|Overall Study|Lost to Follow-up|2|||
23652790|NCT00402597|66114694|FG004|Overall Study|Lost to Follow-up|3|||
23652791|NCT00402597|66114690|FG000|Overall Study|Withdrawal by Subject|57|||
23652792|NCT00402597|66114691|FG001|Overall Study|Withdrawal by Subject|16|||
23652793|NCT00402597|66114692|FG002|Overall Study|Withdrawal by Subject|65|||
23652794|NCT00402597|66114693|FG003|Overall Study|Withdrawal by Subject|15|||
23652795|NCT00402597|66114694|FG004|Overall Study|Withdrawal by Subject|24|||
23652796|NCT00402597|66114690|FG000|Overall Study|reason not specified|30|||
23652797|NCT00402597|66114691|FG001|Overall Study|reason not specified|4|||
23652798|NCT00402597|66114692|FG002|Overall Study|reason not specified|27|||
23652799|NCT00402597|66114693|FG003|Overall Study|reason not specified|14|||
23652800|NCT00402597|66114694|FG004|Overall Study|reason not specified|20|||
23652801|NCT00084266|66114695|FG000|Overall Study|Death|42|||
23652802|NCT00084266|66114696|FG001|Overall Study|Death|39|||
23652803|NCT00084266|66114695|FG000|Overall Study|Adverse Event|8|||
23652804|NCT00084266|66114696|FG001|Overall Study|Adverse Event|5|||
23652805|NCT00084266|66114695|FG000|Overall Study|Lack of Efficacy|2|||
23652806|NCT00084266|66114696|FG001|Overall Study|Lack of Efficacy|4|||
23652807|NCT00084266|66114695|FG000|Overall Study|Lost to Follow-up|5|||
23652808|NCT00084266|66114696|FG001|Overall Study|Lost to Follow-up|3|||
23652809|NCT00084266|66114695|FG000|Overall Study|Participant not willing to participate|3|||
23652810|NCT00084266|66114696|FG001|Overall Study|Participant not willing to participate|8|||
23652811|NCT00084266|66114695|FG000|Overall Study|Other|360|||
23652812|NCT00084266|66114696|FG001|Overall Study|Other|344|||
23652813|NCT00084266|66114695|FG000|Overall Study|Randomized not treated|21|||
23652814|NCT00084266|66114696|FG001|Overall Study|Randomized not treated|20|||
23652815|NCT01016977|66114697|FG000|Overall Study|Lost to Follow-up|1|||
23652816|NCT01016977|66114698|FG001|Overall Study|Lost to Follow-up|0|||
23652817|NCT01016977|66114697|FG000|Overall Study|Withdrawal by Subject|2|||
23652818|NCT01016977|66114698|FG001|Overall Study|Withdrawal by Subject|2|||
23652819|NCT01324323|66114702|FG000|Overall Study|Withdrawal by Subject|1|||
23801449|NCT00766831|66650031|FG000|Overall Study|Protocol Violation|15|||
23652820|NCT01078675|66114706|FG000|Overall Study|Withdrawal by Subject|7|||
23652821|NCT01078675|66114707|FG001|Overall Study|Withdrawal by Subject|3|||
23652822|NCT01078675|66114706|FG000|Overall Study|Protocol Violation|56|||
23652823|NCT01078675|66114707|FG001|Overall Study|Protocol Violation|0|||
23652824|NCT01078675|66114706|FG000|Overall Study|Provided in CRF for specific reasons|2|||
23652825|NCT01078675|66114707|FG001|Overall Study|Provided in CRF for specific reasons|3|||
23652826|NCT01078675|66114706|FG000|Overall Study|Adverse Event|3|||
23652827|NCT01078675|66114707|FG001|Overall Study|Adverse Event|0|||
23652828|NCT03437278|66114708|FG000|Overall Study|Adverse Event|0|||
23801450|NCT00766831|66650031|FG000|Overall Study|Physician Decision|5|||
23652829|NCT03437278|66114709|FG001|Overall Study|Adverse Event|0|||
23652830|NCT03437278|66114710|FG002|Overall Study|Adverse Event|1|||
23652831|NCT03437278|66114708|FG000|Overall Study|Progressive disease|1|||
23652832|NCT03437278|66114709|FG001|Overall Study|Progressive disease|0|||
23652833|NCT03437278|66114710|FG002|Overall Study|Progressive disease|0|||
23652834|NCT03437278|66114708|FG000|Overall Study|Physician Decision|1|||
23652835|NCT03437278|66114709|FG001|Overall Study|Physician Decision|0|||
23652836|NCT03437278|66114710|FG002|Overall Study|Physician Decision|1|||
23652837|NCT00655863|66114711|FG000|Overall Study|Lost to Follow-up|0|||
23652838|NCT00655863|66114712|FG001|Overall Study|Lost to Follow-up|0|||
23652839|NCT00655863|66114713|FG002|Overall Study|Lost to Follow-up|1|||
23652840|NCT00107120|66114714|FG000|Overall Study|Adverse Event|4|||
23652841|NCT00107120|66114715|FG001|Overall Study|Adverse Event|1|||
23652842|NCT00107120|66114714|FG000|Overall Study|Lack of Efficacy|5|||
23652843|NCT00107120|66114715|FG001|Overall Study|Lack of Efficacy|5|||
23652844|NCT00107120|66114714|FG000|Overall Study|Protocol Violation|3|||
23652845|NCT00107120|66114715|FG001|Overall Study|Protocol Violation|0|||
23652846|NCT00107120|66114714|FG000|Overall Study|Withdrawal by Subject|8|||
23652847|NCT00107120|66114715|FG001|Overall Study|Withdrawal by Subject|9|||
23652848|NCT00107120|66114714|FG000|Overall Study|Lost to Follow-up|8|||
23652849|NCT00107120|66114715|FG001|Overall Study|Lost to Follow-up|6|||
23652850|NCT00107120|66114714|FG000|Overall Study|Pregnancy|0|||
23652851|NCT00107120|66114715|FG001|Overall Study|Pregnancy|1|||
23652852|NCT00107120|66114714|FG000|Overall Study|moving away from site|1|||
23652853|NCT00107120|66114715|FG001|Overall Study|moving away from site|1|||
23652854|NCT00107120|66114714|FG000|Overall Study|death of parent|0|||
23652855|NCT00107120|66114715|FG001|Overall Study|death of parent|1|||
23652856|NCT02683941|66114716|FG000|Double-blind Phase|Adverse Event|0|||
23652857|NCT02683941|66114717|FG001|Double-blind Phase|Adverse Event|1|||
23652858|NCT02683941|66114716|FG000|Double-blind Phase|Withdrawal by Subject|4|||
23652859|NCT02683941|66114717|FG001|Double-blind Phase|Withdrawal by Subject|2|||
23652860|NCT02683941|66114716|FG000|Double-blind Phase|Lost to Follow-up|1|||
23652861|NCT02683941|66114717|FG001|Double-blind Phase|Lost to Follow-up|0|||
23652862|NCT02683941|66114716|FG000|Double-blind Phase|Disease Progression|5|||
23652863|NCT02683941|66114717|FG001|Double-blind Phase|Disease Progression|2|||
23652864|NCT02683941|66114716|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
23652865|NCT02683941|66114717|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
23652866|NCT02683941|66114716|FG000|Open-label Treatment Phase|Disease Progression|1|||
23652867|NCT02683941|66114717|FG001|Open-label Treatment Phase|Disease Progression|2|||
23652868|NCT02683941|66114716|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
23652869|NCT02683941|66114717|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
23652870|NCT02683941|66114716|FG000|Open-label Treatment Phase|Other|1|||
23652871|NCT02683941|66114717|FG001|Open-label Treatment Phase|Other|0|||
23652872|NCT02683941|66114716|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
23652873|NCT02683941|66114717|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
23652874|NCT02683941|66114716|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
23652875|NCT02683941|66114717|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
23652876|NCT02683941|66114716|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
23652877|NCT02683941|66114717|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
23652878|NCT02683941|66114716|FG000|Open-label Follow-up Phase|Other|8|||
23652879|NCT02683941|66114717|FG001|Open-label Follow-up Phase|Other|1|||
23652880|NCT03406260|66114718|FG000|Period 1|Adverse Event|0|||
23652881|NCT03406260|66114719|FG001|Period 1|Adverse Event|0|||
23652882|NCT03406260|66114720|FG002|Period 1|Adverse Event|0|||
23652883|NCT03406260|66114721|FG003|Period 1|Adverse Event|0|||
23652884|NCT03406260|66114722|FG004|Period 1|Adverse Event|1|||
23652885|NCT03406260|66114723|FG005|Period 1|Adverse Event|0|||
23652886|NCT01000636|66114724|FG000|Overall Study|Withdrawal by Subject|1|||
23652887|NCT01000636|66114724|FG000|Overall Study|Adverse Event|1|||
23652888|NCT02349451|66114726|FG000|Overall Study|Withdrawal by Subject|0|||
23652889|NCT02349451|66114727|FG001|Overall Study|Withdrawal by Subject|1|||
23652890|NCT02349451|66114728|FG002|Overall Study|Withdrawal by Subject|2|||
23652891|NCT02349451|66114729|FG003|Overall Study|Withdrawal by Subject|1|||
23652892|NCT01201343|66114731|FG000|Overall Study|Adverse Event|6|||
23652893|NCT01201343|66114731|FG000|Overall Study|Withdrawal by Subject|5|||
23652894|NCT01201343|66114731|FG000|Overall Study|Lost to Follow-up|2|||
23652895|NCT01201343|66114731|FG000|Overall Study|Lack of Efficacy|2|||
23652896|NCT01201343|66114731|FG000|Overall Study|Participant wrongly included in trial|1|||
23652897|NCT01201343|66114731|FG000|Overall Study|Randomized, not treated|3|||
23652898|NCT01786174|66114732|FG000|Overall Study|Discontinued Study Drug|2|||
23652899|NCT01786174|66114733|FG001|Overall Study|Discontinued Study Drug|0|||
23652900|NCT00001962|66117489|FG000|Overall Study|Lack of Efficacy|18|||
23652901|NCT00001962|66117489|FG000|Overall Study|Lack of Accrual|6|||
23652902|NCT00001962|66117489|FG000|Overall Study|Death|1|||
23652903|NCT00001962|66117489|FG000|Overall Study|Lost to Follow-up|2|||
23652904|NCT00001962|66117489|FG000|Overall Study|Adverse Event|1|||
23652905|NCT00455325|66117490|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
23652906|NCT00455325|66117491|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
23652907|NCT00455325|66117492|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
23652908|NCT00455325|66117493|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
23652909|NCT00455325|66117490|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
23652910|NCT00455325|66117491|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
23652911|NCT00455325|66117492|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
23652912|NCT00455325|66117493|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
23652913|NCT00455325|66117490|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
23652914|NCT00455325|66117491|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
23652915|NCT00455325|66117492|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
23652916|NCT00455325|66117493|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
23652917|NCT00455325|66117490|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
23652918|NCT00455325|66117491|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23652919|NCT00455325|66117492|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23652920|NCT00455325|66117493|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23652921|NCT00455325|66117490|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
23652922|NCT00455325|66117491|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23652923|NCT00455325|66117492|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23652924|NCT00455325|66117493|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23652925|NCT00455325|66117490|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23652926|NCT00455325|66117491|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
23652927|NCT00455325|66117492|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23652928|NCT00455325|66117493|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23652929|NCT00455325|66117490|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23652930|NCT00455325|66117491|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23652931|NCT00455325|66117492|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
23652932|NCT00455325|66117493|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23652933|NCT01448213|66117494|FG000|Overall Study|Lost to Follow-up|12|||
23652934|NCT01448213|66117495|FG001|Overall Study|Lost to Follow-up|10|||
23652935|NCT01448213|66117494|FG000|Overall Study|Adverse Event|4|||
23652936|NCT01448213|66117495|FG001|Overall Study|Adverse Event|10|||
23652937|NCT01448213|66117494|FG000|Overall Study|Protocol Violation|1|||
23652938|NCT01448213|66117495|FG001|Overall Study|Protocol Violation|2|||
23652939|NCT01933113|66117496|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
23652940|NCT00275262|66117497|FG000|Overall Study|Adverse Event|2|||
23652941|NCT00275262|66117498|FG001|Overall Study|Adverse Event|0|||
23652942|NCT00275262|66117497|FG000|Overall Study|Disease progression|2|||
23652943|NCT00275262|66117498|FG001|Overall Study|Disease progression|5|||
23652944|NCT00275262|66117497|FG000|Overall Study|Lost to Follow-up|0|||
23652945|NCT00275262|66117498|FG001|Overall Study|Lost to Follow-up|2|||
23652946|NCT00275262|66117497|FG000|Overall Study|Protocol Violation|0|||
23652947|NCT00275262|66117498|FG001|Overall Study|Protocol Violation|2|||
23652948|NCT00275262|66117497|FG000|Overall Study|Death|1|||
23652949|NCT00275262|66117498|FG001|Overall Study|Death|0|||
23652950|NCT00275262|66117497|FG000|Overall Study|Started Chemotherapy|1|||
23652951|NCT00275262|66117498|FG001|Overall Study|Started Chemotherapy|0|||
23652952|NCT00412971|66117499|FG000|Overall Study|Lost to Follow-up|17|||
23652953|NCT00412971|66117500|FG001|Overall Study|Lost to Follow-up|9|||
23652954|NCT00412971|66117499|FG000|Overall Study|Protocol Violation|13|||
23652955|NCT00412971|66117500|FG001|Overall Study|Protocol Violation|1|||
23652956|NCT00640016|66117501|FG000|Overall Study|Withdrawal by Subject|0|||
23652957|NCT00640016|66117502|FG001|Overall Study|Withdrawal by Subject|1|||
23652958|NCT00640016|66117503|FG002|Overall Study|Withdrawal by Subject|0|||
23652959|NCT00640016|66117504|FG003|Overall Study|Withdrawal by Subject|0|||
23652960|NCT00640016|66117501|FG000|Overall Study|Study termination|2|||
23652961|NCT00640016|66117502|FG001|Overall Study|Study termination|1|||
23652962|NCT00640016|66117503|FG002|Overall Study|Study termination|3|||
23652963|NCT00640016|66117504|FG003|Overall Study|Study termination|2|||
23652964|NCT00640016|66117501|FG000|Overall Study|Adverse Event|0|||
23652965|NCT00640016|66117502|FG001|Overall Study|Adverse Event|0|||
23652966|NCT00640016|66117503|FG002|Overall Study|Adverse Event|0|||
23652967|NCT00640016|66117504|FG003|Overall Study|Adverse Event|1|||
23652968|NCT02187809|66117505|FG000|Overall Study|The study was terminated|3|||
23652969|NCT01067326|66117506|FG000|Overall Study|Adverse Event|0|||
23652970|NCT01067326|66117507|FG001|Overall Study|Adverse Event|2|||
23652971|NCT01067326|66117506|FG000|Overall Study|Withdrawal by Subject|1|||
23652972|NCT01067326|66117507|FG001|Overall Study|Withdrawal by Subject|0|||
23652973|NCT01067326|66117506|FG000|Overall Study|Early Study Termination|1|||
23360853|NCT01909804|65065920|FG005|Overall Study|Lack of Efficacy|3|||
23652974|NCT01067326|66117507|FG001|Overall Study|Early Study Termination|1|||
23652975|NCT01256658|66117510|FG000|Period 1|Lost to Follow-up|837|||
23652976|NCT01256658|66117511|FG001|Period 1|Lost to Follow-up|661|||
23652977|NCT01256658|66117510|FG000|Period 1|Withdrawal by Subject|35|||
23652978|NCT01256658|66117511|FG001|Period 1|Withdrawal by Subject|43|||
23652979|NCT01256658|66117510|FG000|Period 1|Death|48|||
23652980|NCT01256658|66117511|FG001|Period 1|Death|44|||
23652981|NCT03346057|66117512|FG000|Overall Study|Death|1|||
23652982|NCT03346057|66117513|FG001|Overall Study|Death|2|||
23652983|NCT03346057|66117514|FG002|Overall Study|Death|0|||
23652984|NCT03346057|66117515|FG003|Overall Study|Death|0|||
23652985|NCT03346057|66117512|FG000|Overall Study|Lost to Follow-up|0|||
23652986|NCT03346057|66117513|FG001|Overall Study|Lost to Follow-up|2|||
23652987|NCT03346057|66117514|FG002|Overall Study|Lost to Follow-up|1|||
23652988|NCT03346057|66117515|FG003|Overall Study|Lost to Follow-up|0|||
23652989|NCT03346057|66117512|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
23652990|NCT03346057|66117513|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
23652991|NCT03346057|66117514|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
23652992|NCT03346057|66117515|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
23652993|NCT03346057|66117512|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
23652994|NCT03346057|66117513|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
23652995|NCT03346057|66117514|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
23652996|NCT03346057|66117515|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
23652997|NCT03346057|66117512|FG000|Overall Study|Physician Decision|3|||
23652998|NCT03346057|66117513|FG001|Overall Study|Physician Decision|2|||
23652999|NCT03346057|66117514|FG002|Overall Study|Physician Decision|0|||
23653000|NCT03346057|66117515|FG003|Overall Study|Physician Decision|2|||
23653001|NCT03346057|66117512|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
23653002|NCT03346057|66117513|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
23653003|NCT03346057|66117514|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
23653004|NCT03346057|66117515|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
23653005|NCT03346057|66117512|FG000|Overall Study|Withdrawal by Subject|1|||
23653006|NCT03346057|66117513|FG001|Overall Study|Withdrawal by Subject|0|||
23653007|NCT03346057|66117514|FG002|Overall Study|Withdrawal by Subject|0|||
23653008|NCT03346057|66117515|FG003|Overall Study|Withdrawal by Subject|0|||
23653009|NCT01488487|66117516|FG000|Overall Study|Adverse Event|6|||
23653010|NCT01488487|66117516|FG000|Overall Study|Death|1|||
23653011|NCT01488487|66117516|FG000|Overall Study|Withdrawal by Subject|2|||
23653012|NCT00655486|66117517|FG000|Overall Study|Adverse Event|10|||
23653013|NCT00655486|66117517|FG000|Overall Study|Lack of Efficacy|8|||
23653014|NCT00655486|66117517|FG000|Overall Study|Withdrawal by Subject|4|||
23653015|NCT00655486|66117517|FG000|Overall Study|Protocol Violation|1|||
23653016|NCT00655486|66117517|FG000|Overall Study|Unsatisfactory compliance|2|||
23653017|NCT00655486|66117517|FG000|Overall Study|Other: Pregnancy|1|||
23653018|NCT00655486|66117517|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
23653019|NCT00655486|66117517|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
23653020|NCT03907410|66117520|FG000|Overall Study|Lost to Follow-up|4|||
23653021|NCT03907410|66117521|FG001|Overall Study|Lost to Follow-up|1|||
23653022|NCT03907410|66117522|FG002|Overall Study|Lost to Follow-up|1|||
23653023|NCT03907410|66117520|FG000|Overall Study|Lost to follow-up and research burden|0|||
23653024|NCT03907410|66117521|FG001|Overall Study|Lost to follow-up and research burden|0|||
23653025|NCT03907410|66117522|FG002|Overall Study|Lost to follow-up and research burden|1|||
23653026|NCT02982187|66117523|FG000|Overall Study|Withdrawal by Subject|0|||
23653027|NCT02982187|66117524|FG001|Overall Study|Withdrawal by Subject|0|||
23653028|NCT02982187|66117525|FG002|Overall Study|Withdrawal by Subject|0|||
23653029|NCT02982187|66117526|FG003|Overall Study|Withdrawal by Subject|0|||
23653030|NCT02982187|66117527|FG004|Overall Study|Withdrawal by Subject|0|||
23653031|NCT02982187|66117528|FG005|Overall Study|Withdrawal by Subject|0|||
23653032|NCT02982187|66117529|FG006|Overall Study|Withdrawal by Subject|1|||
23653033|NCT02982187|66117530|FG007|Overall Study|Withdrawal by Subject|0|||
23653034|NCT05266586|66117534|FG000|Overall Study|Adverse Event|2|||
23653035|NCT05266586|66117535|FG001|Overall Study|Adverse Event|2|||
23653036|NCT05266586|66117536|FG002|Overall Study|Adverse Event|1|||
23653037|NCT05266586|66117534|FG000|Overall Study|Withdrawal by Subject|1|||
23653038|NCT05266586|66117535|FG001|Overall Study|Withdrawal by Subject|0|||
23653039|NCT05266586|66117536|FG002|Overall Study|Withdrawal by Subject|1|||
23653040|NCT05266586|66117534|FG000|Overall Study|Non-compliance with study drug|0|||
23653041|NCT05266586|66117535|FG001|Overall Study|Non-compliance with study drug|1|||
23653042|NCT05266586|66117536|FG002|Overall Study|Non-compliance with study drug|0|||
23653043|NCT05266586|66117534|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
23653044|NCT05266586|66117535|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
23653045|NCT05266586|66117536|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
23653046|NCT00352885|66117539|FG000|Overall Study|Withdrawal by Subject|0|||
23653047|NCT00352885|66117540|FG001|Overall Study|Withdrawal by Subject|3|||
23653048|NCT00352885|66117539|FG000|Overall Study|Development of major depression|0|||
23653049|NCT00352885|66117540|FG001|Overall Study|Development of major depression|1|||
23653050|NCT00352885|66117539|FG000|Overall Study|Progression of metastatic melanoma|5|||
23653051|NCT00352885|66117540|FG001|Overall Study|Progression of metastatic melanoma|3|||
23653052|NCT00352885|66117539|FG000|Overall Study|Side effects of IL-2 administration|1|||
23653053|NCT00352885|66117540|FG001|Overall Study|Side effects of IL-2 administration|0|||
23653054|NCT02411578|66117541|FG000|Crossover Trial Phase|Pregnancy|0|||
23653055|NCT02411578|66117542|FG001|Crossover Trial Phase|Pregnancy|1|||
23653056|NCT00892723|66117543|FG000|Overall Study|Lost to Follow-up|1|||
23653057|NCT00892723|66117544|FG001|Overall Study|Lost to Follow-up|3|||
23653058|NCT00892723|66117545|FG002|Overall Study|Lost to Follow-up|1|||
23653059|NCT00892723|66117543|FG000|Overall Study|Withdrawal by Subject|1|||
23653060|NCT00892723|66117544|FG001|Overall Study|Withdrawal by Subject|1|||
23653061|NCT00892723|66117545|FG002|Overall Study|Withdrawal by Subject|1|||
23653062|NCT00066742|66117546|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
23653063|NCT00066742|66117546|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
23653064|NCT00066742|66117546|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
23653065|NCT00066742|66117546|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
23653066|NCT00066742|66117546|FG000|Induction Chemoradiotherapy|Ineligible|3|||
23653067|NCT00066742|66117546|FG000|Consolidation Chemotherapy|not protocol specified|1|||
23653068|NCT00066742|66117546|FG000|Consolidation Chemotherapy|Ineligible|2|||
23653069|NCT00147823|66117552|FG000|Overall Study|Lost to Follow-up|6|||
23653070|NCT00147823|66117553|FG001|Overall Study|Lost to Follow-up|12|||
23653071|NCT00147823|66117552|FG000|Overall Study|Physician Decision|1|||
23653072|NCT00147823|66117553|FG001|Overall Study|Physician Decision|0|||
23653073|NCT00147823|66117552|FG000|Overall Study|Withdrawal by Subject|0|||
23653074|NCT00147823|66117553|FG001|Overall Study|Withdrawal by Subject|1|||
23653075|NCT00147823|66117552|FG000|Overall Study|Did not receive vitoss due to infection|6|||
23653076|NCT00147823|66117553|FG001|Overall Study|Did not receive vitoss due to infection|2|||
23653077|NCT02986334|66117555|FG000|Overall Study|Withdrawal by Subject|0|||
23653078|NCT02986334|66117556|FG001|Overall Study|Withdrawal by Subject|1|||
23653079|NCT02986334|66117557|FG002|Overall Study|Withdrawal by Subject|2|||
23653080|NCT02986334|66117555|FG000|Overall Study|Lost to Follow-up|1|||
23653081|NCT02986334|66117556|FG001|Overall Study|Lost to Follow-up|2|||
23599403|NCT01288443|65925570|FG005|Overall Study|Participant Moved|1|||
23599404|NCT01288443|65925565|FG000|Overall Study|Consent withdrawn by Participant|0|||
23599405|NCT01288443|65925566|FG001|Overall Study|Consent withdrawn by Participant|0|||
23599406|NCT01288443|65925567|FG002|Overall Study|Consent withdrawn by Participant|0|||
23599407|NCT01288443|65925568|FG003|Overall Study|Consent withdrawn by Participant|0|||
23599408|NCT01288443|65925569|FG004|Overall Study|Consent withdrawn by Participant|0|||
23599409|NCT01288443|65925570|FG005|Overall Study|Consent withdrawn by Participant|1|||
23599410|NCT01288443|65925565|FG000|Overall Study|Lost to Follow-up|0|||
23599411|NCT01288443|65925566|FG001|Overall Study|Lost to Follow-up|1|||
23599412|NCT01288443|65925567|FG002|Overall Study|Lost to Follow-up|0|||
23599413|NCT01288443|65925568|FG003|Overall Study|Lost to Follow-up|0|||
23599414|NCT01288443|65925569|FG004|Overall Study|Lost to Follow-up|0|||
23599415|NCT01288443|65925570|FG005|Overall Study|Lost to Follow-up|0|||
23599416|NCT01288443|65925565|FG000|Overall Study|Study drug auto-injector administration|0|||
23599417|NCT01288443|65925566|FG001|Overall Study|Study drug auto-injector administration|0|||
23599418|NCT01288443|65925567|FG002|Overall Study|Study drug auto-injector administration|0|||
23599419|NCT01288443|65925568|FG003|Overall Study|Study drug auto-injector administration|0|||
23599420|NCT01288443|65925569|FG004|Overall Study|Study drug auto-injector administration|1|||
23599421|NCT01288443|65925570|FG005|Overall Study|Study drug auto-injector administration|1|||
23599422|NCT01288443|65925565|FG000|Overall Study|Other than above|0|||
23599423|NCT01288443|65925566|FG001|Overall Study|Other than above|0|||
23599424|NCT01288443|65925567|FG002|Overall Study|Other than above|0|||
23599425|NCT01288443|65925568|FG003|Overall Study|Other than above|2|||
23599426|NCT01288443|65925569|FG004|Overall Study|Other than above|1|||
23599427|NCT01288443|65925570|FG005|Overall Study|Other than above|0|||
23599428|NCT00795184|65925571|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
23599429|NCT00795184|65925572|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
23599430|NCT02844439|65925574|FG000|Overall Study|Withdrawal by Subject|1|||
23599431|NCT02844439|65925574|FG000|Overall Study|Lost to Follow-up|2|||
23599432|NCT02844439|65925574|FG000|Overall Study|Termination by Sponsor|4|||
23599433|NCT02844439|65925574|FG000|Overall Study|Death|28|||
23599434|NCT02844439|65925574|FG000|Overall Study|Other|5|||
23599435|NCT01823224|65925576|FG000|Overall Study|Lost to Follow-up|5|||
23599436|NCT01823224|65925577|FG001|Overall Study|Lost to Follow-up|6|||
23599437|NCT01823224|65925576|FG000|Overall Study|didn't qualify|1|||
23599438|NCT01823224|65925577|FG001|Overall Study|didn't qualify|2|||
23599439|NCT01823224|65925576|FG000|Overall Study|pharmacy error|0|||
23599440|NCT01823224|65925577|FG001|Overall Study|pharmacy error|1|||
23599441|NCT01823224|65925576|FG000|Overall Study|missed med dose|0|||
23599442|NCT01823224|65925577|FG001|Overall Study|missed med dose|1|||
23599443|NCT01823224|65925576|FG000|Overall Study|Withdrawal by Subject|0|||
23653082|NCT02986334|66117557|FG002|Overall Study|Lost to Follow-up|1|||
23653083|NCT02986334|66117555|FG000|Overall Study|Adverse Event|0|||
23599444|NCT01823224|65925577|FG001|Overall Study|Withdrawal by Subject|1|||
23599445|NCT02652442|65925578|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
23599446|NCT01637402|65925586|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
23599447|NCT01637402|65925587|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
23653084|NCT02986334|66117556|FG001|Overall Study|Adverse Event|2|||
23653085|NCT02986334|66117557|FG002|Overall Study|Adverse Event|1|||
23653086|NCT02986334|66117555|FG000|Overall Study|non compliance in phone ratings|2|||
23653087|NCT02986334|66117556|FG001|Overall Study|non compliance in phone ratings|1|||
23653088|NCT02986334|66117557|FG002|Overall Study|non compliance in phone ratings|2|||
23653089|NCT02986334|66117555|FG000|Overall Study|undisclosed comorbidities|0|||
23653090|NCT02986334|66117556|FG001|Overall Study|undisclosed comorbidities|1|||
23653091|NCT02986334|66117557|FG002|Overall Study|undisclosed comorbidities|1|||
23653092|NCT02604433|66117558|FG000|Overall Study|Withdrawal by Subject|37|||
23653093|NCT02604433|66117559|FG001|Overall Study|Withdrawal by Subject|16|||
23653094|NCT02604433|66117558|FG000|Overall Study|Adverse Event|4|||
23653095|NCT02604433|66117559|FG001|Overall Study|Adverse Event|0|||
23653096|NCT02604433|66117558|FG000|Overall Study|Other reasons|3|||
23653097|NCT02604433|66117559|FG001|Overall Study|Other reasons|5|||
23653098|NCT02604433|66117558|FG000|Overall Study|Death|4|||
23653099|NCT02604433|66117559|FG001|Overall Study|Death|1|||
23653100|NCT02604433|66117558|FG000|Overall Study|Transition to Rollover Protocol|169|||
23653101|NCT02604433|66117559|FG001|Overall Study|Transition to Rollover Protocol|82|||
23653102|NCT02604433|66117558|FG000|Overall Study|Physician Decision|1|||
23653103|NCT02604433|66117559|FG001|Overall Study|Physician Decision|1|||
23653104|NCT02604433|66117558|FG000|Overall Study|Lack of Efficacy|0|||
23653105|NCT02604433|66117559|FG001|Overall Study|Lack of Efficacy|1|||
23653106|NCT02260882|66117560|FG000|Overall Study|Protocol Violation|0|||
23653107|NCT02260882|66117561|FG001|Overall Study|Protocol Violation|1|||
23653108|NCT04217590|66117562|FG000|Overall Study|Other|1|||
23653109|NCT04217590|66117563|FG001|Overall Study|Other|1|||
23653110|NCT04217590|66117562|FG000|Overall Study|Withdrawal by Subject|3|||
23653111|NCT04217590|66117563|FG001|Overall Study|Withdrawal by Subject|1|||
23653112|NCT04217590|66117562|FG000|Overall Study|Death|0|||
23653113|NCT04217590|66117563|FG001|Overall Study|Death|1|||
23653114|NCT05211739|66117564|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
23653115|NCT05211739|66117565|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
23653116|NCT05211739|66117564|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
23653117|NCT05211739|66117565|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
23653118|NCT05211739|66117564|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
23653119|NCT05211739|66117565|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
23653120|NCT05211739|66117564|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
23653121|NCT05211739|66117565|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
23653122|NCT00888433|66117567|FG000|Overall Study|Withdrawal by Subject|1|||
23653123|NCT00888433|66117568|FG001|Overall Study|Withdrawal by Subject|2|||
23653124|NCT00888433|66117567|FG000|Overall Study|Missed Visit|2|||
23653125|NCT00888433|66117568|FG001|Overall Study|Missed Visit|1|||
23653126|NCT00823901|66117571|FG000|Overall Study|Adverse Event|1|||
23653127|NCT00823901|66117572|FG001|Overall Study|Adverse Event|1|||
23653128|NCT00823901|66117571|FG000|Overall Study|Lack of Efficacy|1|||
23653129|NCT00823901|66117572|FG001|Overall Study|Lack of Efficacy|0|||
23653130|NCT00823901|66117571|FG000|Overall Study|Lost to Follow-up|2|||
23653131|NCT00823901|66117572|FG001|Overall Study|Lost to Follow-up|1|||
23653132|NCT00528866|66117573|FG000|Overall Study|Protocol Violation|6|||
23653133|NCT01233869|66117574|FG000|Initial Treatment Period (24 Months)|Death|1|||
23653134|NCT01233869|66117575|FG001|Initial Treatment Period (24 Months)|Death|0|||
23653135|NCT01233869|66117576|FG002|Initial Treatment Period (24 Months)|Death|0|||
23653136|NCT01233869|66117577|FG003|Initial Treatment Period (24 Months)|Death|0|||
23653137|NCT01233869|66117574|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
23653138|NCT01233869|66117575|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
23653139|NCT01233869|66117576|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
23653140|NCT01233869|66117577|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
23653141|NCT01233869|66117574|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
23653142|NCT01233869|66117575|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
23653143|NCT01233869|66117576|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
23653144|NCT01233869|66117577|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
23653145|NCT01233869|66117574|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23653146|NCT01233869|66117575|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23801451|NCT00766831|66650031|FG000|Overall Study|Withdrawal of consent|26|||
23801452|NCT00766831|66650031|FG000|Overall Study|Non cooperation by participants|14|||
23801453|NCT00766831|66650031|FG000|Overall Study|Other|28|||
23801454|NCT00063882|66650032|FG000|Overall Study|Protocol Violation|3|||
23360854|NCT01909804|65065921|FG006|Overall Study|Lack of Efficacy|1|||
23801455|NCT00063882|66650033|FG001|Overall Study|Protocol Violation|3|||
23653147|NCT01233869|66117576|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23653148|NCT01233869|66117577|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
23653149|NCT01233869|66117574|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
23653150|NCT01233869|66117575|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
23653151|NCT01233869|66117576|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
23653152|NCT01233869|66117577|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
23653153|NCT01233869|66117574|FG000|Extended Treatment Period (46 Months)|Other|3|||
23653154|NCT01233869|66117575|FG001|Extended Treatment Period (46 Months)|Other|0|||
23653155|NCT01233869|66117576|FG002|Extended Treatment Period (46 Months)|Other|0|||
23653156|NCT01233869|66117577|FG003|Extended Treatment Period (46 Months)|Other|3|||
23653157|NCT01233869|66117574|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
23653158|NCT01233869|66117575|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
23653159|NCT01233869|66117576|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
23653160|NCT01233869|66117577|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
23653161|NCT00041067|66117578|FG000|Overall Study|Adverse Event|20|||
23653162|NCT00041067|66117578|FG000|Overall Study|Progression|19|||
23653163|NCT00041067|66117578|FG000|Overall Study|Patient refusal|12|||
23653164|NCT00041067|66117578|FG000|Overall Study|Other reasons|23|||
23653165|NCT00041067|66117578|FG000|Overall Study|Ineligible|2|||
23653166|NCT01920594|66117579|FG000|Overall Study|Adverse Event|4|||
23653167|NCT01920594|66117580|FG001|Overall Study|Adverse Event|2|||
23653168|NCT01920594|66117579|FG000|Overall Study|Lost to Follow-up|1|||
23653169|NCT01920594|66117580|FG001|Overall Study|Lost to Follow-up|0|||
23653170|NCT01920594|66117579|FG000|Overall Study|Recovery|2|||
23653171|NCT01920594|66117580|FG001|Overall Study|Recovery|0|||
23653172|NCT01920594|66117579|FG000|Overall Study|Investigator discretion|0|||
23653173|NCT01920594|66117580|FG001|Overall Study|Investigator discretion|1|||
23653174|NCT01019317|66117582|FG000|Overall Study|Not Eligible|4|||
23653175|NCT04427501|66117583|FG000|Overall Study|Death|0|||
23653176|NCT04427501|66117584|FG001|Overall Study|Death|0|||
23653177|NCT04427501|66117585|FG002|Overall Study|Death|0|||
23653178|NCT04427501|66117586|FG003|Overall Study|Death|0|||
23653179|NCT04427501|66117587|FG004|Overall Study|Death|0|||
23653180|NCT04427501|66117588|FG005|Overall Study|Death|15|||
23653181|NCT04427501|66117589|FG006|Overall Study|Death|0|||
23653182|NCT04427501|66117590|FG007|Overall Study|Death|0|||
23653183|NCT04427501|66117591|FG008|Overall Study|Death|0|||
23653184|NCT04427501|66117592|FG009|Overall Study|Death|0|||
23653185|NCT04427501|66117593|FG010|Overall Study|Death|0|||
23653186|NCT04427501|66117594|FG011|Overall Study|Death|0|||
23653187|NCT04427501|66117583|FG000|Overall Study|Lost to Follow-up|5|||
23653188|NCT04427501|66117584|FG001|Overall Study|Lost to Follow-up|1|||
23653189|NCT04427501|66117585|FG002|Overall Study|Lost to Follow-up|2|||
23653190|NCT04427501|66117586|FG003|Overall Study|Lost to Follow-up|0|||
23653191|NCT04427501|66117587|FG004|Overall Study|Lost to Follow-up|2|||
23653192|NCT04427501|66117588|FG005|Overall Study|Lost to Follow-up|11|||
23653193|NCT04427501|66117589|FG006|Overall Study|Lost to Follow-up|10|||
23653194|NCT04427501|66117590|FG007|Overall Study|Lost to Follow-up|10|||
23653195|NCT04427501|66117591|FG008|Overall Study|Lost to Follow-up|2|||
23653196|NCT04427501|66117592|FG009|Overall Study|Lost to Follow-up|5|||
23653197|NCT04427501|66117593|FG010|Overall Study|Lost to Follow-up|2|||
23653198|NCT04427501|66117594|FG011|Overall Study|Lost to Follow-up|0|||
23653199|NCT04427501|66117583|FG000|Overall Study|Physician Decision|0|||
23653200|NCT04427501|66117584|FG001|Overall Study|Physician Decision|3|||
23653201|NCT04427501|66117585|FG002|Overall Study|Physician Decision|0|||
23653202|NCT04427501|66117586|FG003|Overall Study|Physician Decision|0|||
23801456|NCT00063882|66650032|FG000|Overall Study|Withdrawal by Subject|2|||
23801457|NCT00063882|66650033|FG001|Overall Study|Withdrawal by Subject|1|||
23801458|NCT02747004|66650036|FG000|Overall Study|Withdrawal by Subject|8|||
23801459|NCT02747004|66650037|FG001|Overall Study|Withdrawal by Subject|5|||
23801460|NCT02747004|66650038|FG002|Overall Study|Withdrawal by Subject|4|||
23801461|NCT02747004|66650036|FG000|Overall Study|Lost to Follow-up|1|||
23801462|NCT02747004|66650037|FG001|Overall Study|Lost to Follow-up|2|||
23801463|NCT02747004|66650038|FG002|Overall Study|Lost to Follow-up|2|||
23801464|NCT02747004|66650036|FG000|Overall Study|on study treatment/follow-up|48|||
23801465|NCT02747004|66650037|FG001|Overall Study|on study treatment/follow-up|42|||
23801466|NCT02747004|66650038|FG002|Overall Study|on study treatment/follow-up|41|||
23653203|NCT04427501|66117587|FG004|Overall Study|Physician Decision|0|||
23653204|NCT04427501|66117588|FG005|Overall Study|Physician Decision|0|||
23801467|NCT04034355|66650042|FG000|Overall Study|Study terminated by Sponsor|10|||
23801468|NCT04034355|66650043|FG001|Overall Study|Study terminated by Sponsor|17|||
23653205|NCT04427501|66117589|FG006|Overall Study|Physician Decision|2|||
23653206|NCT04427501|66117590|FG007|Overall Study|Physician Decision|0|||
23653207|NCT04427501|66117591|FG008|Overall Study|Physician Decision|0|||
23653208|NCT04427501|66117592|FG009|Overall Study|Physician Decision|0|||
23653209|NCT04427501|66117593|FG010|Overall Study|Physician Decision|0|||
23653210|NCT04427501|66117594|FG011|Overall Study|Physician Decision|0|||
23653211|NCT04427501|66117583|FG000|Overall Study|Withdrawal by Subject|9|||
23653212|NCT04427501|66117584|FG001|Overall Study|Withdrawal by Subject|2|||
23653213|NCT04427501|66117585|FG002|Overall Study|Withdrawal by Subject|2|||
23653214|NCT04427501|66117586|FG003|Overall Study|Withdrawal by Subject|3|||
23653215|NCT04427501|66117587|FG004|Overall Study|Withdrawal by Subject|7|||
23653216|NCT04427501|66117588|FG005|Overall Study|Withdrawal by Subject|25|||
23653217|NCT04427501|66117589|FG006|Overall Study|Withdrawal by Subject|15|||
23653218|NCT04427501|66117590|FG007|Overall Study|Withdrawal by Subject|7|||
23653219|NCT04427501|66117591|FG008|Overall Study|Withdrawal by Subject|4|||
23653220|NCT04427501|66117592|FG009|Overall Study|Withdrawal by Subject|1|||
23653221|NCT04427501|66117593|FG010|Overall Study|Withdrawal by Subject|4|||
23653222|NCT04427501|66117594|FG011|Overall Study|Withdrawal by Subject|0|||
23653223|NCT04427501|66117583|FG000|Overall Study|Other - as reported by the investigator|1|||
23653224|NCT04427501|66117584|FG001|Overall Study|Other - as reported by the investigator|0|||
23653225|NCT04427501|66117585|FG002|Overall Study|Other - as reported by the investigator|0|||
23653226|NCT04427501|66117586|FG003|Overall Study|Other - as reported by the investigator|0|||
23653227|NCT04427501|66117587|FG004|Overall Study|Other - as reported by the investigator|0|||
23653228|NCT04427501|66117588|FG005|Overall Study|Other - as reported by the investigator|6|||
23653229|NCT04427501|66117589|FG006|Overall Study|Other - as reported by the investigator|6|||
23653230|NCT04427501|66117590|FG007|Overall Study|Other - as reported by the investigator|0|||
23653231|NCT04427501|66117591|FG008|Overall Study|Other - as reported by the investigator|0|||
23653232|NCT04427501|66117592|FG009|Overall Study|Other - as reported by the investigator|0|||
23653233|NCT04427501|66117593|FG010|Overall Study|Other - as reported by the investigator|0|||
23653234|NCT04427501|66117594|FG011|Overall Study|Other - as reported by the investigator|0|||
23653235|NCT04427501|66117583|FG000|Overall Study|Other|0|||
23653236|NCT04427501|66117584|FG001|Overall Study|Other|0|||
23653237|NCT04427501|66117585|FG002|Overall Study|Other|0|||
23653238|NCT04427501|66117586|FG003|Overall Study|Other|0|||
23653239|NCT04427501|66117587|FG004|Overall Study|Other|0|||
23653240|NCT04427501|66117588|FG005|Overall Study|Other|0|||
23653241|NCT04427501|66117589|FG006|Overall Study|Other|0|||
23653242|NCT04427501|66117590|FG007|Overall Study|Other|0|||
23653243|NCT04427501|66117591|FG008|Overall Study|Other|0|||
23653244|NCT04427501|66117592|FG009|Overall Study|Other|0|||
23653245|NCT04427501|66117593|FG010|Overall Study|Other|0|||
23653246|NCT04427501|66117594|FG011|Overall Study|Other|1|||
23653247|NCT04824521|66117598|FG000|Overall Study|Lost to Follow-up|1|||
23653248|NCT03334409|66117599|FG000|Overall Study|Did not meet inclusion criteria|1|||
23653249|NCT03334409|66117600|FG001|Overall Study|Did not meet inclusion criteria|0|||
23653250|NCT01978262|66117601|FG000|Overall Study|Withdrawal by Subject|9|||
23653251|NCT01978262|66117601|FG000|Overall Study|Lost to Follow-up|2|||
23653252|NCT00908232|66117602|FG000|Cycle 1 to 4|Death|5|||
23479899|NCT02969408|65501849|FG000|Overall Study|Adverse Event|2|||
23479900|NCT02969408|65501849|FG000|Overall Study|Withdrawal by Subject|8|||
23479901|NCT02969408|65501849|FG000|Overall Study|Lost to Follow-up|4|||
23479902|NCT02969408|65501849|FG000|Overall Study|Protocol Violation|1|||
23479903|NCT02969408|65501849|FG000|Overall Study|Other than specified|1|||
23479904|NCT00945906|65501853|FG000|Overall Study|Withdrawal by Subject|1|||
23479905|NCT00945906|65501853|FG000|Overall Study|Did not want to return for last visit|2|||
23479906|NCT00945906|65501853|FG000|Overall Study|Unable to return for last visit|2|||
23479907|NCT00945906|65501853|FG000|Overall Study|Moved to another country|2|||
23479908|NCT04604132|65501854|FG000|Overall Study|Adverse Event|2|||
23479909|NCT04604132|65501855|FG001|Overall Study|Adverse Event|0|||
23479910|NCT04604132|65501856|FG002|Overall Study|Adverse Event|0|||
23479911|NCT04604132|65501857|FG003|Overall Study|Adverse Event|1|||
23479912|NCT04604132|65501858|FG004|Overall Study|Adverse Event|2|||
23479913|NCT04604132|65501854|FG000|Overall Study|Study terminated by sponsor|0|||
23479914|NCT04604132|65501855|FG001|Overall Study|Study terminated by sponsor|0|||
23479915|NCT04604132|65501856|FG002|Overall Study|Study terminated by sponsor|0|||
23479916|NCT04604132|65501857|FG003|Overall Study|Study terminated by sponsor|0|||
23479917|NCT04604132|65501858|FG004|Overall Study|Study terminated by sponsor|1|||
23479918|NCT04604132|65501854|FG000|Overall Study|Progressive disease: Clinical progression|0|||
23479919|NCT04604132|65501855|FG001|Overall Study|Progressive disease: Clinical progression|0|||
23479920|NCT04604132|65501856|FG002|Overall Study|Progressive disease: Clinical progression|1|||
23479921|NCT04604132|65501857|FG003|Overall Study|Progressive disease: Clinical progression|0|||
23479922|NCT04604132|65501858|FG004|Overall Study|Progressive disease: Clinical progression|0|||
23479923|NCT04604132|65501854|FG000|Overall Study|Progressive disease: Radiological progression|8|||
23479924|NCT04604132|65501855|FG001|Overall Study|Progressive disease: Radiological progression|7|||
23479925|NCT04604132|65501856|FG002|Overall Study|Progressive disease: Radiological progression|10|||
23479926|NCT04604132|65501857|FG003|Overall Study|Progressive disease: Radiological progression|4|||
23479927|NCT04604132|65501858|FG004|Overall Study|Progressive disease: Radiological progression|3|||
23479928|NCT04604132|65501854|FG000|Overall Study|Death|3|||
23479929|NCT04604132|65501855|FG001|Overall Study|Death|1|||
23479930|NCT04604132|65501856|FG002|Overall Study|Death|2|||
23479931|NCT04604132|65501857|FG003|Overall Study|Death|1|||
23479932|NCT04604132|65501858|FG004|Overall Study|Death|0|||
23479933|NCT03859973|65501860|FG000|Overall Study|Other reason than listed|3|||
23479934|NCT03859973|65501861|FG001|Overall Study|Other reason than listed|2|||
23479935|NCT03859973|65501860|FG000|Overall Study|COVID-19 related, not due to AE|3|||
23479936|NCT03859973|65501861|FG001|Overall Study|COVID-19 related, not due to AE|4|||
23479937|NCT03859973|65501860|FG000|Overall Study|Withdrawal by Subject|8|||
23479938|NCT03859973|65501861|FG001|Overall Study|Withdrawal by Subject|9|||
23479939|NCT03859973|65501860|FG000|Overall Study|Lost to Follow-up|2|||
23479940|NCT03859973|65501861|FG001|Overall Study|Lost to Follow-up|3|||
23479941|NCT03859973|65501860|FG000|Overall Study|Protocol Violation|1|||
23479942|NCT03859973|65501861|FG001|Overall Study|Protocol Violation|3|||
23479943|NCT03859973|65501860|FG000|Overall Study|Adverse Event|3|||
23479944|NCT03859973|65501861|FG001|Overall Study|Adverse Event|5|||
23479945|NCT02047318|65501862|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
23479946|NCT02047318|65501862|FG000|Core Study Period|Adverse Event|1|||
23479947|NCT02047318|65501862|FG000|Core Study Period|Withdrawal by caregiver|3|||
23479948|NCT02047318|65501862|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
23479949|NCT00327470|65501867|FG000|Overall Study|Randomized, but not treated|0|||
23479950|NCT00327470|65501868|FG001|Overall Study|Randomized, but not treated|2|||
23479951|NCT00327470|65501867|FG000|Overall Study|Adverse Event|9|||
23479952|NCT00327470|65501868|FG001|Overall Study|Adverse Event|14|||
23479953|NCT00327470|65501867|FG000|Overall Study|Lack of Efficacy|7|||
23479954|NCT00327470|65501868|FG001|Overall Study|Lack of Efficacy|19|||
23479955|NCT00327470|65501867|FG000|Overall Study|Other|5|||
23479956|NCT00327470|65501868|FG001|Overall Study|Other|9|||
23479957|NCT00327470|65501867|FG000|Overall Study|Lost to Follow-up|1|||
23479958|NCT00327470|65501868|FG001|Overall Study|Lost to Follow-up|3|||
23479959|NCT00327470|65501867|FG000|Overall Study|Withdrawal by Subject|6|||
23479960|NCT00327470|65501868|FG001|Overall Study|Withdrawal by Subject|12|||
23479961|NCT00327470|65501867|FG000|Overall Study|Death|1|||
23479962|NCT00327470|65501868|FG001|Overall Study|Death|4|||
23479963|NCT01120067|65501869|FG000|Overall Study|Lost to Follow-up|3|||
23479964|NCT01120067|65501870|FG001|Overall Study|Lost to Follow-up|1|||
23479965|NCT01120067|65501869|FG000|Overall Study|fail to engage >3 sessions|2|||
23479966|NCT01120067|65501870|FG001|Overall Study|fail to engage >3 sessions|0|||
23479967|NCT03400956|65501871|FG000|Treatment Period 1|Adverse Event|0|||
23479968|NCT03400956|65501872|FG001|Treatment Period 1|Adverse Event|1|||
23653253|NCT00908232|66117603|FG001|Cycle 1 to 4|Death|0|||
23653254|NCT00908232|66117604|FG002|Cycle 1 to 4|Death|0|||
23653255|NCT00908232|66117605|FG003|Cycle 1 to 4|Death|0|||
23653256|NCT00908232|66117602|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
23653257|NCT00908232|66117603|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
23653258|NCT00908232|66117604|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
23653259|NCT00908232|66117605|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
23653260|NCT00908232|66117602|FG000|Cycle 1 to 4|Progressive Disease|6|||
23653261|NCT00908232|66117603|FG001|Cycle 1 to 4|Progressive Disease|0|||
23653262|NCT00908232|66117604|FG002|Cycle 1 to 4|Progressive Disease|0|||
23653263|NCT00908232|66117605|FG003|Cycle 1 to 4|Progressive Disease|0|||
23653264|NCT00908232|66117602|FG000|Cycle 1 to 4|Adverse Event|12|||
23653265|NCT00908232|66117603|FG001|Cycle 1 to 4|Adverse Event|0|||
23653266|NCT00908232|66117604|FG002|Cycle 1 to 4|Adverse Event|0|||
23653267|NCT00908232|66117605|FG003|Cycle 1 to 4|Adverse Event|0|||
23653268|NCT00908232|66117602|FG000|Cycle 1 to 4|Other|1|||
23653269|NCT00908232|66117603|FG001|Cycle 1 to 4|Other|0|||
23653270|NCT00908232|66117604|FG002|Cycle 1 to 4|Other|0|||
23653271|NCT00908232|66117605|FG003|Cycle 1 to 4|Other|0|||
23653272|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
23653273|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23653274|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23653275|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23653276|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
23653277|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23653278|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23653279|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23653280|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
23653281|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
23653282|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
23653283|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
23653284|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
23653285|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
23653286|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
23653287|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
23653288|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
23653289|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
23653290|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
23653291|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
23653292|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
23653293|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23653294|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23653295|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23653296|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
23653297|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
23653298|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
23653299|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
23653300|NCT00908232|66117602|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
23653301|NCT00908232|66117603|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23653302|NCT00908232|66117604|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23653303|NCT00908232|66117605|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23653304|NCT00564018|66117606|FG000|Overall Study|Withdrawal by Subject|2|||
23653305|NCT00564018|66117607|FG001|Overall Study|Withdrawal by Subject|3|||
23653306|NCT00564018|66117608|FG002|Overall Study|Withdrawal by Subject|1|||
23653307|NCT01295281|66117610|FG000|First Intervention (7 Days)|Death|0|||
23653308|NCT01295281|66117611|FG001|First Intervention (7 Days)|Death|1|||
23653309|NCT00822172|66117612|FG000|Overall Study|Adverse Event|10|||
23653310|NCT00822172|66117613|FG001|Overall Study|Adverse Event|12|||
23653311|NCT00822172|66117612|FG000|Overall Study|Death|1|||
23801469|NCT04034355|66650042|FG000|Overall Study|Withdrawal by Subject|12|||
23801470|NCT04034355|66650043|FG001|Overall Study|Withdrawal by Subject|11|||
23801471|NCT04034355|66650042|FG000|Overall Study|Site terminated by Sponsor|4|||
23653312|NCT00822172|66117613|FG001|Overall Study|Death|0|||
23653313|NCT00822172|66117612|FG000|Overall Study|Lost to Follow-up|3|||
23653314|NCT00822172|66117613|FG001|Overall Study|Lost to Follow-up|1|||
23653315|NCT00822172|66117612|FG000|Overall Study|Withdrawal by Subject|1|||
23653316|NCT00822172|66117613|FG001|Overall Study|Withdrawal by Subject|4|||
23653317|NCT00822172|66117612|FG000|Overall Study|site closed|0|||
23653318|NCT00822172|66117613|FG001|Overall Study|site closed|1|||
23653319|NCT00822172|66117612|FG000|Overall Study|Other|0|||
23653320|NCT00822172|66117613|FG001|Overall Study|Other|1|||
23653321|NCT00195507|66117614|FG000|Overall Study|Adverse Event|24|||
23653322|NCT00195507|66117615|FG001|Overall Study|Adverse Event|13|||
23653323|NCT00195507|66117614|FG000|Overall Study|Death|0|||
23653324|NCT00195507|66117615|FG001|Overall Study|Death|1|||
23599448|NCT01637402|65925586|FG000|Standard Dose Regimen|Adverse Event|1|||
23599449|NCT01637402|65925587|FG001|Standard Dose Regimen|Adverse Event|0|||
23599450|NCT01637402|65925586|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
23599451|NCT01637402|65925587|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
23599452|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
23599453|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
23599454|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
23599455|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
23599456|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
23599457|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
23599458|NCT00879333|65925589|FG000|Overall Study|Adverse Event|94|||
23599459|NCT00879333|65925590|FG001|Overall Study|Adverse Event|34|||
23599460|NCT00879333|65925589|FG000|Overall Study|Abnormal Laboratory Value|1|||
23599461|NCT00879333|65925590|FG001|Overall Study|Abnormal Laboratory Value|0|||
23599462|NCT00879333|65925589|FG000|Overall Study|Withdrawal by Subject|20|||
23599463|NCT00879333|65925590|FG001|Overall Study|Withdrawal by Subject|7|||
23599464|NCT00879333|65925589|FG000|Overall Study|Lost to Follow-up|2|||
23599465|NCT00879333|65925590|FG001|Overall Study|Lost to Follow-up|1|||
23599466|NCT00879333|65925589|FG000|Overall Study|Administrative Problems|2|||
23599467|NCT00879333|65925590|FG001|Overall Study|Administrative Problems|0|||
23599468|NCT00879333|65925589|FG000|Overall Study|Death|16|||
23599469|NCT00879333|65925590|FG001|Overall Study|Death|5|||
23599470|NCT00879333|65925589|FG000|Overall Study|Disease Progression|292|||
23599471|NCT00879333|65925590|FG001|Overall Study|Disease Progression|169|||
23599472|NCT00879333|65925589|FG000|Overall Study|Protocol Violation|1|||
23599473|NCT00879333|65925590|FG001|Overall Study|Protocol Violation|1|||
23599474|NCT00774397|65925594|FG000|Overall Study|Adverse Event|1|||
23599475|NCT00774397|65925595|FG001|Overall Study|Adverse Event|3|||
23599476|NCT00774397|65925596|FG002|Overall Study|Adverse Event|16|||
23599477|NCT00774397|65925597|FG003|Overall Study|Adverse Event|8|||
23599478|NCT00774397|65925598|FG004|Overall Study|Adverse Event|8|||
23599479|NCT00774397|65925599|FG005|Overall Study|Adverse Event|3|||
23599480|NCT00774397|65925600|FG006|Overall Study|Adverse Event|16|||
23599481|NCT00774397|65925594|FG000|Overall Study|Lack of Efficacy|11|||
23599482|NCT00774397|65925595|FG001|Overall Study|Lack of Efficacy|4|||
23599483|NCT00774397|65925596|FG002|Overall Study|Lack of Efficacy|5|||
23599484|NCT00774397|65925597|FG003|Overall Study|Lack of Efficacy|3|||
23599485|NCT00774397|65925598|FG004|Overall Study|Lack of Efficacy|27|||
23599486|NCT00774397|65925599|FG005|Overall Study|Lack of Efficacy|15|||
23599487|NCT00774397|65925600|FG006|Overall Study|Lack of Efficacy|9|||
23599488|NCT00774397|65925594|FG000|Overall Study|Protocol Violation|0|||
23599489|NCT00774397|65925595|FG001|Overall Study|Protocol Violation|1|||
23599490|NCT00774397|65925596|FG002|Overall Study|Protocol Violation|3|||
23599491|NCT00774397|65925597|FG003|Overall Study|Protocol Violation|1|||
23599492|NCT00774397|65925598|FG004|Overall Study|Protocol Violation|2|||
23599493|NCT00774397|65925599|FG005|Overall Study|Protocol Violation|1|||
23599494|NCT00774397|65925600|FG006|Overall Study|Protocol Violation|0|||
23599495|NCT00774397|65925594|FG000|Overall Study|Lost to Follow-up|0|||
23599496|NCT00774397|65925595|FG001|Overall Study|Lost to Follow-up|1|||
23599497|NCT00774397|65925596|FG002|Overall Study|Lost to Follow-up|1|||
23599498|NCT00774397|65925597|FG003|Overall Study|Lost to Follow-up|1|||
23599499|NCT00774397|65925598|FG004|Overall Study|Lost to Follow-up|0|||
23599500|NCT00774397|65925599|FG005|Overall Study|Lost to Follow-up|1|||
23599501|NCT00774397|65925600|FG006|Overall Study|Lost to Follow-up|0|||
23599502|NCT00774397|65925594|FG000|Overall Study|Refused to continue trial medication|1|||
23599503|NCT00774397|65925595|FG001|Overall Study|Refused to continue trial medication|3|||
23599504|NCT00774397|65925596|FG002|Overall Study|Refused to continue trial medication|2|||
23599505|NCT00774397|65925597|FG003|Overall Study|Refused to continue trial medication|2|||
23599506|NCT00774397|65925598|FG004|Overall Study|Refused to continue trial medication|6|||
23599507|NCT00774397|65925599|FG005|Overall Study|Refused to continue trial medication|2|||
23599508|NCT00774397|65925600|FG006|Overall Study|Refused to continue trial medication|3|||
23599509|NCT00774397|65925594|FG000|Overall Study|Not treated|0|||
23599510|NCT00774397|65925595|FG001|Overall Study|Not treated|0|||
23599511|NCT00774397|65925596|FG002|Overall Study|Not treated|0|||
23599512|NCT00774397|65925597|FG003|Overall Study|Not treated|0|||
23599513|NCT00774397|65925598|FG004|Overall Study|Not treated|1|||
23599514|NCT00774397|65925599|FG005|Overall Study|Not treated|0|||
23599515|NCT00774397|65925600|FG006|Overall Study|Not treated|1|||
23599516|NCT00774397|65925594|FG000|Overall Study|Other than those stated above|1|||
23599517|NCT00774397|65925595|FG001|Overall Study|Other than those stated above|1|||
23599518|NCT00774397|65925596|FG002|Overall Study|Other than those stated above|3|||
23599519|NCT00774397|65925597|FG003|Overall Study|Other than those stated above|2|||
23599520|NCT00774397|65925598|FG004|Overall Study|Other than those stated above|2|||
23653325|NCT00195507|66117614|FG000|Overall Study|Failed to Return|4|||
23653326|NCT00195507|66117615|FG001|Overall Study|Failed to Return|3|||
23653327|NCT00195507|66117614|FG000|Overall Study|Physician Decision|1|||
23653328|NCT00195507|66117615|FG001|Overall Study|Physician Decision|2|||
23653329|NCT00195507|66117614|FG000|Overall Study|Lost to Follow-up|3|||
23653330|NCT00195507|66117615|FG001|Overall Study|Lost to Follow-up|2|||
23653331|NCT00195507|66117614|FG000|Overall Study|Protocol Violation|5|||
23653332|NCT00195507|66117615|FG001|Overall Study|Protocol Violation|4|||
23653333|NCT00195507|66117614|FG000|Overall Study|Lack of Efficacy|40|||
23653334|NCT00195507|66117615|FG001|Overall Study|Lack of Efficacy|67|||
23653335|NCT00195507|66117614|FG000|Overall Study|Withdrawal by Subject|16|||
23653336|NCT00195507|66117615|FG001|Overall Study|Withdrawal by Subject|23|||
23653337|NCT00195507|66117614|FG000|Overall Study|Protocol Deviation|6|||
23653338|NCT00195507|66117615|FG001|Overall Study|Protocol Deviation|3|||
23653339|NCT01395316|66117620|FG000|Overall Study|Lost to Follow-up|2|||
23653340|NCT01395316|66117620|FG000|Overall Study|poor MRI quality|1|||
23653341|NCT00795951|66117621|FG000|Overall Study|Lost to Follow-up|1|||
23653342|NCT00795951|66117621|FG000|Overall Study|Withdrawal by Subject|1|||
23653343|NCT02594163|66117622|FG000|Treatment Period|Progressive disease|2|||
23653344|NCT02594163|66117623|FG001|Treatment Period|Progressive disease|3|||
23653345|NCT02594163|66117622|FG000|Treatment Period|Adverse Event|1|||
23653346|NCT02594163|66117623|FG001|Treatment Period|Adverse Event|5|||
23653347|NCT02594163|66117622|FG000|Treatment Period|Physician Decision|1|||
23653348|NCT02594163|66117623|FG001|Treatment Period|Physician Decision|3|||
23653349|NCT02594163|66117622|FG000|Treatment Period|Study termination by sponsor|2|||
23653350|NCT02594163|66117623|FG001|Treatment Period|Study termination by sponsor|1|||
23653351|NCT02594163|66117622|FG000|Treatment Period|Other, Non-AE|1|||
23653352|NCT02594163|66117623|FG001|Treatment Period|Other, Non-AE|0|||
23653353|NCT02594163|66117622|FG000|Follow-up Period|Withdrawal by Subject|0|||
23653354|NCT02594163|66117623|FG001|Follow-up Period|Withdrawal by Subject|1|||
23653355|NCT02594163|66117622|FG000|Follow-up Period|Study Termination by Sponsor|6|||
23479969|NCT03400956|65501873|FG002|Treatment Period 1|Adverse Event|0|||
23599521|NCT00774397|65925599|FG005|Overall Study|Other than those stated above|0|||
23599522|NCT00774397|65925600|FG006|Overall Study|Other than those stated above|1|||
23599523|NCT04876417|65925601|FG000|Overall Study|Lost to Follow-up|5|||
23599524|NCT04876417|65925602|FG001|Overall Study|Lost to Follow-up|8|||
23599525|NCT04876417|65925603|FG002|Overall Study|Lost to Follow-up|0|||
23599526|NCT04876417|65925604|FG003|Overall Study|Lost to Follow-up|0|||
23599527|NCT01290341|65925605|FG000|Overall Study|Protocol Violation|7|||
23599528|NCT01290341|65925606|FG001|Overall Study|Protocol Violation|3|||
23599529|NCT01290341|65925605|FG000|Overall Study|Adverse Event|1|||
23599530|NCT01290341|65925606|FG001|Overall Study|Adverse Event|0|||
23599531|NCT01290341|65925605|FG000|Overall Study|Lost to Follow-up|21|||
23599532|NCT01290341|65925606|FG001|Overall Study|Lost to Follow-up|10|||
23599533|NCT01290341|65925605|FG000|Overall Study|Withdrawal by Subject|19|||
23599534|NCT01290341|65925606|FG001|Overall Study|Withdrawal by Subject|5|||
23599535|NCT01290341|65925605|FG000|Overall Study|Negative baseline culture and others|44|||
23599536|NCT01290341|65925606|FG001|Overall Study|Negative baseline culture and others|11|||
23599537|NCT02638337|65925614|FG000|Overall Study|Adverse Event|6|||
23599538|NCT02638337|65925615|FG001|Overall Study|Adverse Event|10|||
23599539|NCT02638337|65925614|FG000|Overall Study|Protocol Violation|3|||
23599540|NCT02638337|65925615|FG001|Overall Study|Protocol Violation|0|||
23599541|NCT02638337|65925614|FG000|Overall Study|Withdrawal by Subject|13|||
23599542|NCT02638337|65925615|FG001|Overall Study|Withdrawal by Subject|16|||
23599543|NCT02638337|65925614|FG000|Overall Study|Lost to Follow-up|7|||
23599544|NCT02638337|65925615|FG001|Overall Study|Lost to Follow-up|7|||
23599545|NCT02638337|65925614|FG000|Overall Study|Other - Miscellaneous|4|||
23599546|NCT02638337|65925615|FG001|Overall Study|Other - Miscellaneous|3|||
23599547|NCT02075554|65925618|FG000|Overall Study|Lost to Follow-up|7|||
23599548|NCT02075554|65925618|FG000|Overall Study|Withdrawal by Subject|5|||
23599549|NCT02075554|65925618|FG000|Overall Study|Physician Decision|3|||
23599550|NCT02462759|65925619|FG000|Part 1: Double Blind|Death|1|||
23599551|NCT02462759|65925620|FG001|Part 1: Double Blind|Death|0|||
23653356|NCT02594163|66117623|FG001|Follow-up Period|Study Termination by Sponsor|4|||
23653357|NCT02594163|66117622|FG000|Follow-up Period|Lost to Follow-up|1|||
23653358|NCT02594163|66117623|FG001|Follow-up Period|Lost to Follow-up|0|||
23653359|NCT02594163|66117622|FG000|Follow-up Period|Death|2|||
23479970|NCT03400956|65501871|FG000|Treatment Period 1|Lost to Follow-up|0|||
23599552|NCT02462759|65925621|FG002|Part 1: Double Blind|Death|0|||
23599553|NCT04337931|65925622|FG000|Overall Study|Death|4|||
23599554|NCT04337931|65925623|FG001|Overall Study|Death|1|||
23599555|NCT04337931|65925624|FG002|Overall Study|Death|7|||
23599556|NCT04337931|65925622|FG000|Overall Study|Withdrawal by Subject|0|||
23599557|NCT04337931|65925623|FG001|Overall Study|Withdrawal by Subject|1|||
23599558|NCT04337931|65925624|FG002|Overall Study|Withdrawal by Subject|0|||
23653360|NCT02594163|66117623|FG001|Follow-up Period|Death|5|||
23599559|NCT04337931|65925622|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
23599560|NCT04337931|65925623|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
23653361|NCT02594163|66117622|FG000|Follow-up Period|Adverse Event|0|||
23653362|NCT02594163|66117623|FG001|Follow-up Period|Adverse Event|1|||
23653363|NCT02594163|66117622|FG000|Follow-up Period|Progressive Disease|2|||
23653364|NCT02594163|66117623|FG001|Follow-up Period|Progressive Disease|0|||
23653365|NCT02594163|66117622|FG000|Follow-up Period|Physician Decision|0|||
23653366|NCT02594163|66117623|FG001|Follow-up Period|Physician Decision|1|||
23653367|NCT00769860|66117624|FG000|Overall Study|Withdrawal by Subject|2|||
23653368|NCT00769860|66117625|FG001|Overall Study|Withdrawal by Subject|0|||
23653369|NCT00162032|66117626|FG000|Overall Study|Lost to Follow-up|4|||
23653370|NCT00162032|66117627|FG001|Overall Study|Lost to Follow-up|2|||
23653371|NCT00162032|66117626|FG000|Overall Study|Reason not specified|1|||
23653372|NCT00162032|66117627|FG001|Overall Study|Reason not specified|0|||
23653373|NCT04201821|66117633|FG000|Overall Study|Withdrawal by Subject|2|||
23653374|NCT01723774|66117634|FG000|Neoadjuvant|Ki67 > 10%|4|||
23653375|NCT01723774|66117635|FG001|Neoadjuvant|Ki67 > 10%|0|||
23653376|NCT01723774|66117636|FG002|Neoadjuvant|Ki67 > 10%|10|||
23653377|NCT01723774|66117637|FG003|Neoadjuvant|Ki67 > 10%|0|||
23653378|NCT01723774|66117634|FG000|Neoadjuvant|Withdrawal by Subject|3|||
23653379|NCT01723774|66117635|FG001|Neoadjuvant|Withdrawal by Subject|1|||
23653380|NCT01723774|66117636|FG002|Neoadjuvant|Withdrawal by Subject|0|||
23653381|NCT01723774|66117637|FG003|Neoadjuvant|Withdrawal by Subject|0|||
23653382|NCT01723774|66117634|FG000|Neoadjuvant|Disease progression|0|||
23653383|NCT01723774|66117635|FG001|Neoadjuvant|Disease progression|1|||
23653384|NCT01723774|66117636|FG002|Neoadjuvant|Disease progression|1|||
23653385|NCT01723774|66117637|FG003|Neoadjuvant|Disease progression|0|||
23653386|NCT01723774|66117634|FG000|Neoadjuvant|Adverse Event|0|||
23653387|NCT01723774|66117635|FG001|Neoadjuvant|Adverse Event|1|||
23653388|NCT01723774|66117636|FG002|Neoadjuvant|Adverse Event|2|||
23653389|NCT01723774|66117637|FG003|Neoadjuvant|Adverse Event|0|||
23653390|NCT01723774|66117634|FG000|Neoadjuvant|High estradiol|0|||
23653391|NCT01723774|66117635|FG001|Neoadjuvant|High estradiol|1|||
23653392|NCT01723774|66117636|FG002|Neoadjuvant|High estradiol|0|||
23653393|NCT01723774|66117637|FG003|Neoadjuvant|High estradiol|0|||
23653394|NCT01206777|66117638|FG000|Overall Study|Death|1|||
23653395|NCT01206777|66117638|FG000|Overall Study|Adverse Event|1|||
23653396|NCT00536809|66117639|FG000|Phase II|Adverse Event|1|||
23653397|NCT00536809|66117639|FG000|Phase II|Referred for surgical resection|1|||
23653398|NCT00803270|66117640|FG000|Overall Study|Lost to Follow-up|1|||
23653399|NCT00803270|66117641|FG001|Overall Study|Lost to Follow-up|2|||
23653400|NCT03566810|66117642|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23653401|NCT03566810|66117643|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
23653402|NCT03566810|66117644|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23653403|NCT03566810|66117645|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23653404|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
23653405|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
23653406|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
23653407|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
23653408|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
23653409|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
23653410|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
23653411|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
23653412|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
23653413|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
23653414|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
23653415|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
23653416|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
23653417|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
23653418|NCT01294683|66117646|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
23653419|NCT01294683|66117647|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
23653420|NCT01294683|66117646|FG000|Post Crossover (Period III)|Adverse Event|6|||
23653421|NCT01294683|66117647|FG001|Post Crossover (Period III)|Adverse Event|6|||
23653422|NCT01294683|66117646|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
23653423|NCT01294683|66117647|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
23653424|NCT01294683|66117646|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
23653425|NCT01294683|66117647|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
23653426|NCT01294683|66117646|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
23653427|NCT01294683|66117647|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
23653428|NCT02279862|66117654|FG000|Overall Study|Study drug toxicity|3|||
23653429|NCT02279862|66117655|FG001|Overall Study|Study drug toxicity|6|||
23653430|NCT02279862|66117654|FG000|Overall Study|No longer meets criteria|0|||
23653431|NCT02279862|66117655|FG001|Overall Study|No longer meets criteria|1|||
23653432|NCT02279862|66117654|FG000|Overall Study|Administrative reason by sponsor|0|||
23653433|NCT02279862|66117655|FG001|Overall Study|Administrative reason by sponsor|1|||
23653434|NCT02279862|66117654|FG000|Overall Study|Disease progression|5|||
23653435|NCT02279862|66117655|FG001|Overall Study|Disease progression|2|||
23653436|NCT02279862|66117654|FG000|Overall Study|Study closed by sponsor|16|||
23653437|NCT02279862|66117655|FG001|Overall Study|Study closed by sponsor|13|||
23653438|NCT02279862|66117654|FG000|Overall Study|Other|1|||
23653439|NCT02279862|66117655|FG001|Overall Study|Other|2|||
23653440|NCT02279862|66117654|FG000|Overall Study|Withdrawal by Subject|1|||
23653441|NCT02279862|66117655|FG001|Overall Study|Withdrawal by Subject|0|||
23653442|NCT02244996|66117656|FG000|Overall Study|Lack of Efficacy|2|||
23653443|NCT02244996|66117657|FG001|Overall Study|Lack of Efficacy|6|||
23653444|NCT04209621|66117658|FG000|Overall Study|Death|1|||
23653445|NCT04209621|66117658|FG000|Overall Study|Study Terminated Early|2|||
23653446|NCT01372410|66117659|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23653447|NCT01372410|66117660|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23653448|NCT01372410|66117661|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23653449|NCT01372410|66117662|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23653450|NCT01372410|66117663|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23653451|NCT01372410|66117664|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23653452|NCT01372410|66117665|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23653453|NCT01372410|66117666|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23653454|NCT01372410|66117659|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653455|NCT01372410|66117660|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
23653456|NCT01372410|66117661|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653457|NCT01372410|66117662|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653458|NCT01372410|66117663|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653459|NCT01372410|66117664|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653460|NCT01372410|66117665|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
23653461|NCT01372410|66117666|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
23653462|NCT01372410|66117659|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653463|NCT01372410|66117660|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653464|NCT01372410|66117661|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653465|NCT01372410|66117662|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653466|NCT01372410|66117663|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
23653467|NCT01372410|66117664|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653468|NCT01372410|66117665|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653469|NCT01372410|66117666|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23653470|NCT01372410|66117659|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653471|NCT01372410|66117660|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653472|NCT01372410|66117661|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653473|NCT01372410|66117662|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653474|NCT01372410|66117663|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653475|NCT01372410|66117664|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653476|NCT01372410|66117665|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
23653477|NCT01372410|66117666|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23653478|NCT01372410|66117659|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
23653479|NCT01372410|66117660|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653480|NCT01372410|66117661|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653481|NCT01372410|66117662|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653482|NCT01372410|66117663|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653483|NCT01372410|66117664|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653484|NCT01372410|66117665|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23653485|NCT01372410|66117666|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
23653486|NCT01372410|66117659|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653487|NCT01372410|66117660|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653488|NCT01372410|66117661|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653489|NCT01372410|66117662|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653490|NCT01372410|66117663|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
23653491|NCT01372410|66117664|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653492|NCT01372410|66117665|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653493|NCT01372410|66117666|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23653494|NCT01372410|66117659|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23653495|NCT01372410|66117660|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23653496|NCT01372410|66117661|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23653497|NCT01372410|66117662|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23653498|NCT01372410|66117663|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23479971|NCT03400956|65501872|FG001|Treatment Period 1|Lost to Follow-up|0|||
23653499|NCT01372410|66117664|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23653500|NCT01372410|66117665|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23653501|NCT01372410|66117666|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23653502|NCT01372410|66117659|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653503|NCT01372410|66117660|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653504|NCT01372410|66117661|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653505|NCT01372410|66117662|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653506|NCT01372410|66117663|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653507|NCT01372410|66117664|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653508|NCT01372410|66117665|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23653509|NCT01372410|66117666|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
23653510|NCT01372410|66117659|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653511|NCT01372410|66117660|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653512|NCT01372410|66117661|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
23653513|NCT01372410|66117662|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653514|NCT01372410|66117663|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653515|NCT01372410|66117664|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653516|NCT01372410|66117665|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653517|NCT01372410|66117666|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
23653518|NCT01372410|66117659|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653519|NCT01372410|66117660|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653520|NCT01372410|66117661|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653521|NCT01372410|66117662|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653522|NCT01372410|66117663|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653523|NCT01372410|66117664|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
23653524|NCT01372410|66117665|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653525|NCT01372410|66117666|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23653526|NCT03294109|66117667|FG000|Overall Study|Withdrawal by Subject|6|||
23653527|NCT03294109|66117668|FG001|Overall Study|Withdrawal by Subject|5|||
23653528|NCT03756350|66117669|FG000|Overall Study|Lost to Follow-up|1|||
23653529|NCT00051363|66117670|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
23653530|NCT00051363|66117671|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
23653531|NCT00051363|66117670|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
23653532|NCT00051363|66117671|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
23653533|NCT00051363|66117670|FG000|Overall Study|Death|2|||
23653534|NCT00051363|66117671|FG001|Overall Study|Death|2|||
23653535|NCT00051363|66117670|FG000|Overall Study|Excluded Pre-Randomization|2|||
23653536|NCT00051363|66117671|FG001|Overall Study|Excluded Pre-Randomization|5|||
23653537|NCT02301936|66117672|FG000|Overall Study|Lost to Follow-up|1|||
23653538|NCT02301936|66117673|FG001|Overall Study|Lost to Follow-up|0|||
23653539|NCT01831856|66117678|FG000|Overall Study|Adverse Event|5|||
23653540|NCT01831856|66117679|FG001|Overall Study|Adverse Event|8|||
23653541|NCT01831856|66117678|FG000|Overall Study|Lack of Efficacy|13|||
23653542|NCT01831856|66117679|FG001|Overall Study|Lack of Efficacy|11|||
23653543|NCT01831856|66117678|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
23653544|NCT01831856|66117679|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
23653545|NCT01143038|66117680|FG000|Overall Study|Withdrawal by Subject|4|||
23653546|NCT01143038|66117680|FG000|Overall Study|Requirement for alternative therapy|5|||
23653547|NCT01143038|66117680|FG000|Overall Study|Adverse Event|3|||
23653548|NCT01143038|66117680|FG000|Overall Study|Lost to Follow-up|2|||
23653549|NCT01143038|66117680|FG000|Overall Study|Protocol Deviation|1|||
23653550|NCT01143038|66117680|FG000|Overall Study|Death|1|||
23653551|NCT02178553|66117681|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
23653552|NCT02178553|66117682|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
23653553|NCT02178553|66117681|FG000|Overall Study|Physician Decision|0|||
23653554|NCT02178553|66117682|FG001|Overall Study|Physician Decision|4|||
23653555|NCT02178553|66117681|FG000|Overall Study|Technical problem with injection|1|||
23653556|NCT02178553|66117682|FG001|Overall Study|Technical problem with injection|3|||
23653557|NCT00583024|66117689|FG000|Overall Study|Lost to Follow-up|4|||
23653558|NCT00568321|66117690|FG000|Overall Study|Adverse Event|1|||
23653559|NCT00568321|66117691|FG001|Overall Study|Adverse Event|0|||
23653560|NCT00568321|66117692|FG002|Overall Study|Adverse Event|0|||
23653561|NCT00568321|66117690|FG000|Overall Study|Lack of Efficacy|8|||
23653562|NCT00568321|66117691|FG001|Overall Study|Lack of Efficacy|5|||
23653563|NCT00568321|66117692|FG002|Overall Study|Lack of Efficacy|6|||
23653564|NCT00568321|66117690|FG000|Overall Study|Lost to Follow-up|0|||
23653565|NCT00568321|66117691|FG001|Overall Study|Lost to Follow-up|0|||
23653566|NCT00568321|66117692|FG002|Overall Study|Lost to Follow-up|1|||
23653567|NCT00568321|66117690|FG000|Overall Study|Withdrawal by Subject|2|||
23653568|NCT00568321|66117691|FG001|Overall Study|Withdrawal by Subject|0|||
23653569|NCT00568321|66117692|FG002|Overall Study|Withdrawal by Subject|0|||
23653570|NCT00568321|66117690|FG000|Overall Study|Protocol Violation|0|||
23653571|NCT00568321|66117691|FG001|Overall Study|Protocol Violation|0|||
23653572|NCT00568321|66117692|FG002|Overall Study|Protocol Violation|1|||
23653573|NCT00568321|66117690|FG000|Overall Study|Randomized, not treated|2|||
23653574|NCT00568321|66117691|FG001|Overall Study|Randomized, not treated|0|||
23653575|NCT00568321|66117692|FG002|Overall Study|Randomized, not treated|1|||
23653576|NCT02273726|66117695|FG000|Overall Study|Death|70|||
23653577|NCT02273726|66117696|FG001|Overall Study|Death|62|||
23360855|NCT01909804|65065922|FG007|Overall Study|Lack of Efficacy|1|||
23360856|NCT01909804|65065923|FG008|Overall Study|Lack of Efficacy|0|||
23360857|NCT01909804|65065924|FG009|Overall Study|Lack of Efficacy|1|||
23360858|NCT01909804|65065925|FG010|Overall Study|Lack of Efficacy|0|||
23360859|NCT01909804|65065926|FG011|Overall Study|Lack of Efficacy|1|||
23360860|NCT01909804|65065915|FG000|Overall Study|Withdrew Consent|0|||
23360861|NCT01909804|65065916|FG001|Overall Study|Withdrew Consent|0|||
23360862|NCT01909804|65065917|FG002|Overall Study|Withdrew Consent|0|||
23360863|NCT01909804|65065918|FG003|Overall Study|Withdrew Consent|0|||
23360864|NCT01909804|65065919|FG004|Overall Study|Withdrew Consent|1|||
23360865|NCT01909804|65065920|FG005|Overall Study|Withdrew Consent|1|||
23360866|NCT01909804|65065921|FG006|Overall Study|Withdrew Consent|0|||
23360867|NCT01909804|65065922|FG007|Overall Study|Withdrew Consent|0|||
23360868|NCT01909804|65065923|FG008|Overall Study|Withdrew Consent|0|||
23360869|NCT01909804|65065924|FG009|Overall Study|Withdrew Consent|0|||
23360870|NCT01909804|65065925|FG010|Overall Study|Withdrew Consent|0|||
23360871|NCT01909804|65065926|FG011|Overall Study|Withdrew Consent|0|||
23360872|NCT01909804|65065915|FG000|Overall Study|Protocol Violation|0|||
23360873|NCT01909804|65065916|FG001|Overall Study|Protocol Violation|0|||
23360874|NCT01909804|65065917|FG002|Overall Study|Protocol Violation|0|||
23360875|NCT01909804|65065918|FG003|Overall Study|Protocol Violation|0|||
23360876|NCT01909804|65065919|FG004|Overall Study|Protocol Violation|0|||
23360877|NCT01909804|65065920|FG005|Overall Study|Protocol Violation|0|||
23360878|NCT01909804|65065921|FG006|Overall Study|Protocol Violation|0|||
23360879|NCT01909804|65065922|FG007|Overall Study|Protocol Violation|0|||
23360880|NCT01909804|65065923|FG008|Overall Study|Protocol Violation|0|||
23360881|NCT01909804|65065924|FG009|Overall Study|Protocol Violation|0|||
23360882|NCT01909804|65065925|FG010|Overall Study|Protocol Violation|0|||
23360883|NCT01909804|65065926|FG011|Overall Study|Protocol Violation|1|||
23360884|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
23360885|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360886|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
23360887|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360888|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360889|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360890|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360891|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360892|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360893|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360894|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360895|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360896|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
23360897|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360898|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360899|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360900|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360901|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360902|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360903|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360904|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
23360905|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
23360906|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
23360907|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360908|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360909|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360910|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360911|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360912|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360913|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23705491|NCT02371759|66297522|FG003|Overall Study|Protocol Violation|0|||
23360914|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360915|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
23360916|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360917|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360918|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360919|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360920|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360921|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360922|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360923|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23479972|NCT03400956|65501873|FG002|Treatment Period 1|Lost to Follow-up|1|||
23479973|NCT03400956|65501871|FG000|Treatment Period 1|Protocol Violation|0|||
23479974|NCT03400956|65501872|FG001|Treatment Period 1|Protocol Violation|2|||
23479975|NCT03400956|65501873|FG002|Treatment Period 1|Protocol Violation|0|||
23479976|NCT03400956|65501871|FG000|Treatment Period 1|Study terminated by sponsor|3|||
23479977|NCT03400956|65501872|FG001|Treatment Period 1|Study terminated by sponsor|1|||
23479978|NCT03400956|65501873|FG002|Treatment Period 1|Study terminated by sponsor|1|||
23479979|NCT03400956|65501871|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23479980|NCT03400956|65501872|FG001|Treatment Period 1|Withdrawal by Subject|2|||
23479981|NCT03400956|65501873|FG002|Treatment Period 1|Withdrawal by Subject|4|||
23479982|NCT03400956|65501871|FG000|Treatment Period 1|Other|1|||
23479983|NCT03400956|65501872|FG001|Treatment Period 1|Other|2|||
23479984|NCT03400956|65501873|FG002|Treatment Period 1|Other|3|||
23479985|NCT03400956|65501871|FG000|Post-treatment Period 1|Adverse Event|0|||
23479986|NCT03400956|65501872|FG001|Post-treatment Period 1|Adverse Event|0|||
23479987|NCT03400956|65501873|FG002|Post-treatment Period 1|Adverse Event|1|||
23479988|NCT03400956|65501871|FG000|Post-treatment Period 1|Physician Decision|2|||
23479989|NCT03400956|65501872|FG001|Post-treatment Period 1|Physician Decision|3|||
23479990|NCT03400956|65501873|FG002|Post-treatment Period 1|Physician Decision|0|||
23479991|NCT03400956|65501871|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
23479992|NCT03400956|65501872|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
23479993|NCT03400956|65501873|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
23479994|NCT03400956|65501871|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
23479995|NCT03400956|65501872|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
23479996|NCT03400956|65501873|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
23479997|NCT03400956|65501871|FG000|Post-treatment Period 1|Other|4|||
23479998|NCT03400956|65501872|FG001|Post-treatment Period 1|Other|3|||
23479999|NCT03400956|65501873|FG002|Post-treatment Period 1|Other|4|||
23480000|NCT03400956|65501871|FG000|Treatment Period 2|Adverse Event|2|||
23480001|NCT03400956|65501872|FG001|Treatment Period 2|Adverse Event|1|||
23480002|NCT03400956|65501873|FG002|Treatment Period 2|Adverse Event|1|||
23480003|NCT03400956|65501871|FG000|Treatment Period 2|Lost to Follow-up|1|||
23801472|NCT04034355|66650043|FG001|Overall Study|Site terminated by Sponsor|5|||
23801473|NCT04034355|66650042|FG000|Overall Study|Adverse Event|2|||
23801474|NCT04034355|66650043|FG001|Overall Study|Adverse Event|0|||
23801475|NCT04034355|66650042|FG000|Overall Study|Death|1|||
23801476|NCT04034355|66650043|FG001|Overall Study|Death|1|||
23801477|NCT04034355|66650042|FG000|Overall Study|Not reported|2|||
23801478|NCT04034355|66650043|FG001|Overall Study|Not reported|0|||
23801479|NCT04034355|66650042|FG000|Overall Study|Lost to Follow-up|1|||
23801480|NCT04034355|66650043|FG001|Overall Study|Lost to Follow-up|0|||
23801481|NCT04034355|66650042|FG000|Overall Study|Physician Decision|1|||
23801482|NCT04034355|66650043|FG001|Overall Study|Physician Decision|0|||
23801483|NCT04034355|66650042|FG000|Overall Study|Protocol Violation|0|||
23801484|NCT04034355|66650043|FG001|Overall Study|Protocol Violation|1|||
23801485|NCT04034355|66650042|FG000|Overall Study|Progressive disease|1|||
23801486|NCT04034355|66650043|FG001|Overall Study|Progressive disease|0|||
23801487|NCT05816200|66650046|FG000|Overall Study|Lost to Follow-up|2|||
23801488|NCT05816200|66650047|FG001|Overall Study|Lost to Follow-up|1|||
23801489|NCT00653159|66650051|FG000|Overall Study|Adverse Event|4|||
23801490|NCT00653159|66650052|FG001|Overall Study|Adverse Event|1|||
23801491|NCT00653159|66650051|FG000|Overall Study|Lost to Follow-up|1|||
23801492|NCT00653159|66650052|FG001|Overall Study|Lost to Follow-up|2|||
23801493|NCT01230892|66650053|FG000|Overall Study|Withdrawal by Subject|1|||
23801494|NCT01230892|66650054|FG001|Overall Study|Withdrawal by Subject|1|||
23801495|NCT01230892|66650053|FG000|Overall Study|Lost to Follow-up|2|||
23801496|NCT01230892|66650054|FG001|Overall Study|Lost to Follow-up|0|||
23801497|NCT00802178|66650055|FG000|Overall Study|Lack of Efficacy|36|||
23801498|NCT00802178|66650055|FG000|Overall Study|Insufficient tolerability (IT)|17|||
23801499|NCT00802178|66650055|FG000|Overall Study|Withdrawal by Subject|18|||
23801500|NCT00802178|66650055|FG000|Overall Study|Other|32|||
23801501|NCT00802178|66650055|FG000|Overall Study|Lack of efficacy and patient wish|1|||
23801502|NCT00802178|66650055|FG000|Overall Study|IT and patient wish|8|||
23801503|NCT00802178|66650055|FG000|Overall Study|Patients wish and other reason|1|||
23801504|NCT01730040|66650056|FG000|Overall Study|Randomized but not treated|0|||
23801505|NCT01730040|66650057|FG001|Overall Study|Randomized but not treated|0|||
23801506|NCT01730040|66650058|FG002|Overall Study|Randomized but not treated|0|||
23801507|NCT01730040|66650059|FG003|Overall Study|Randomized but not treated|0|||
23801508|NCT01730040|66650060|FG004|Overall Study|Randomized but not treated|0|||
23801509|NCT01730040|66650061|FG005|Overall Study|Randomized but not treated|1|||
23801510|NCT01730040|66650062|FG006|Overall Study|Randomized but not treated|0|||
23801511|NCT01730040|66650056|FG000|Overall Study|Subject moved|0|||
23653578|NCT02273726|66117695|FG000|Overall Study|Withdrawal by Subject|41|||
23653579|NCT02273726|66117696|FG001|Overall Study|Withdrawal by Subject|29|||
23653580|NCT02273726|66117695|FG000|Overall Study|Kidney transplant|31|||
23653581|NCT02273726|66117696|FG001|Overall Study|Kidney transplant|39|||
23653582|NCT02273726|66117695|FG000|Overall Study|Physician Decision|30|||
23653583|NCT02273726|66117696|FG001|Overall Study|Physician Decision|15|||
23653584|NCT02273726|66117695|FG000|Overall Study|Adverse Event|27|||
23653585|NCT02273726|66117696|FG001|Overall Study|Adverse Event|9|||
23653586|NCT02273726|66117695|FG000|Overall Study|Lost to Follow-up|6|||
23653587|NCT02273726|66117696|FG001|Overall Study|Lost to Follow-up|3|||
23653588|NCT02273726|66117695|FG000|Overall Study|Lack of Efficacy|6|||
23653589|NCT02273726|66117696|FG001|Overall Study|Lack of Efficacy|1|||
23653590|NCT02273726|66117695|FG000|Overall Study|Protocol Violation|4|||
23653591|NCT02273726|66117696|FG001|Overall Study|Protocol Violation|0|||
23653592|NCT02273726|66117695|FG000|Overall Study|Other than specified|28|||
23653593|NCT02273726|66117696|FG001|Overall Study|Other than specified|30|||
23653594|NCT01840605|66117699|FG000|Overall Study|Adverse Event|0|||
23653595|NCT01840605|66117700|FG001|Overall Study|Adverse Event|1|||
23653596|NCT01840605|66117699|FG000|Overall Study|Physician Decision|2|||
23653597|NCT01840605|66117700|FG001|Overall Study|Physician Decision|1|||
23653598|NCT02038920|66117701|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
23653599|NCT02038920|66117702|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
23653600|NCT02038920|66117703|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23653601|NCT02038920|66117704|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23653602|NCT02038920|66117705|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23653603|NCT02038920|66117706|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23653604|NCT02038920|66117701|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
23653605|NCT02038920|66117702|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23653606|NCT02038920|66117703|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23653607|NCT02038920|66117704|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23653608|NCT02038920|66117705|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23653609|NCT02038920|66117706|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23801512|NCT01730040|66650057|FG001|Overall Study|Subject moved|0|||
23801513|NCT01730040|66650058|FG002|Overall Study|Subject moved|1|||
23801514|NCT01730040|66650059|FG003|Overall Study|Subject moved|0|||
23599561|NCT04337931|65925624|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
23599562|NCT04337931|65925622|FG000|Overall Study|Study terminated by sponsor|3|||
23599563|NCT04337931|65925623|FG001|Overall Study|Study terminated by sponsor|6|||
23599564|NCT04337931|65925624|FG002|Overall Study|Study terminated by sponsor|2|||
23599565|NCT04337931|65925622|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
23599566|NCT04337931|65925623|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
23599567|NCT04337931|65925624|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
23599568|NCT04337931|65925622|FG000|Overall Study|Colorectal cancer treatment|1|||
23599569|NCT04337931|65925623|FG001|Overall Study|Colorectal cancer treatment|0|||
23599570|NCT04337931|65925624|FG002|Overall Study|Colorectal cancer treatment|0|||
23599571|NCT04337931|65925622|FG000|Overall Study|Participant decision|0|||
23599572|NCT04337931|65925623|FG001|Overall Study|Participant decision|1|||
23599573|NCT04337931|65925624|FG002|Overall Study|Participant decision|0|||
23599574|NCT02964741|65925625|FG000|Overall Study|Protocol Violation|1|||
23599575|NCT02964741|65925626|FG001|Overall Study|Protocol Violation|0|||
23599576|NCT02964741|65925627|FG002|Overall Study|Protocol Violation|0|||
23599577|NCT02964741|65925625|FG000|Overall Study|Withdrawal by Subject|0|||
23599578|NCT02964741|65925626|FG001|Overall Study|Withdrawal by Subject|1|||
23599579|NCT02964741|65925627|FG002|Overall Study|Withdrawal by Subject|0|||
23599580|NCT02964741|65925625|FG000|Overall Study|claustrophobia|1|||
23599581|NCT02964741|65925626|FG001|Overall Study|claustrophobia|0|||
23599582|NCT02964741|65925627|FG002|Overall Study|claustrophobia|0|||
23599583|NCT02157116|65925628|FG000|Overall Study|Withdrawal by Subject|4|||
23599584|NCT02157116|65925628|FG000|Overall Study|Physician Decision|3|||
23599585|NCT02157116|65925628|FG000|Overall Study|Failed Screening|2|||
23599586|NCT00077675|65925630|FG000|Overall Study|Adverse Event|1|||
23599587|NCT00077675|65925631|FG001|Overall Study|Adverse Event|2|||
23599588|NCT00077675|65925630|FG000|Overall Study|Lost to Follow-up|6|||
23599589|NCT00077675|65925631|FG001|Overall Study|Lost to Follow-up|3|||
23599590|NCT00077675|65925630|FG000|Overall Study|Withdrawal by Subject|1|||
23599591|NCT00077675|65925631|FG001|Overall Study|Withdrawal by Subject|0|||
23599592|NCT00077675|65925630|FG000|Overall Study|Other|0|||
23599593|NCT00077675|65925631|FG001|Overall Study|Other|1|||
23599594|NCT00077675|65925630|FG000|Overall Study|Never received study treatment|3|||
23599595|NCT00077675|65925631|FG001|Overall Study|Never received study treatment|3|||
23653610|NCT02038920|66117701|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
23653611|NCT02038920|66117702|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
23653612|NCT02038920|66117703|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23653613|NCT02038920|66117704|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23653614|NCT02038920|66117705|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23653615|NCT02038920|66117706|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23653616|NCT02038920|66117701|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23653617|NCT02038920|66117702|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23653618|NCT02038920|66117703|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
23653619|NCT02038920|66117704|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
23653620|NCT02038920|66117705|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
23653621|NCT02038920|66117706|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23653622|NCT02038920|66117701|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23653623|NCT02038920|66117702|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23653624|NCT02038920|66117703|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
23653625|NCT02038920|66117704|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23801515|NCT01730040|66650060|FG004|Overall Study|Subject moved|0|||
23801516|NCT01730040|66650061|FG005|Overall Study|Subject moved|0|||
23801517|NCT01730040|66650062|FG006|Overall Study|Subject moved|1|||
23801518|NCT01730040|66650056|FG000|Overall Study|Physician Decision|0|||
23360924|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360925|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23360926|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360927|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360928|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360929|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360930|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360931|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360932|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360933|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360934|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360935|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360936|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
23360937|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360938|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23801519|NCT01730040|66650057|FG001|Overall Study|Physician Decision|0|||
23801520|NCT01730040|66650058|FG002|Overall Study|Physician Decision|0|||
23801521|NCT01730040|66650059|FG003|Overall Study|Physician Decision|0|||
23801522|NCT01730040|66650060|FG004|Overall Study|Physician Decision|0|||
23801523|NCT01730040|66650061|FG005|Overall Study|Physician Decision|1|||
23801524|NCT01730040|66650062|FG006|Overall Study|Physician Decision|1|||
23801525|NCT01730040|66650056|FG000|Overall Study|Other than specified|7|||
23801526|NCT01730040|66650057|FG001|Overall Study|Other than specified|8|||
23801527|NCT01730040|66650058|FG002|Overall Study|Other than specified|5|||
23801528|NCT01730040|66650059|FG003|Overall Study|Other than specified|5|||
23801529|NCT01730040|66650060|FG004|Overall Study|Other than specified|5|||
23801530|NCT01730040|66650061|FG005|Overall Study|Other than specified|4|||
23801531|NCT01730040|66650062|FG006|Overall Study|Other than specified|4|||
23801532|NCT01730040|66650056|FG000|Overall Study|Adverse Event|4|||
23801533|NCT01730040|66650057|FG001|Overall Study|Adverse Event|3|||
23801534|NCT01730040|66650058|FG002|Overall Study|Adverse Event|5|||
23801535|NCT01730040|66650059|FG003|Overall Study|Adverse Event|3|||
23801536|NCT01730040|66650060|FG004|Overall Study|Adverse Event|1|||
23801537|NCT01730040|66650061|FG005|Overall Study|Adverse Event|1|||
23801538|NCT01730040|66650062|FG006|Overall Study|Adverse Event|2|||
23801539|NCT01730040|66650056|FG000|Overall Study|Poor compliance to protocol|2|||
23801540|NCT01730040|66650057|FG001|Overall Study|Poor compliance to protocol|4|||
23801541|NCT01730040|66650058|FG002|Overall Study|Poor compliance to protocol|0|||
23653626|NCT02038920|66117705|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23653627|NCT02038920|66117706|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23653628|NCT02038920|66117701|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23653629|NCT02038920|66117702|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23653630|NCT02038920|66117703|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
23653631|NCT02038920|66117704|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
23653632|NCT02038920|66117705|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
23653633|NCT02038920|66117706|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23653634|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23653635|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23653636|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23653637|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23653638|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23653639|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
23653640|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23653641|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23653642|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23653643|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23653644|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23653645|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
23653646|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23653647|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23653648|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23653649|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23653650|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23653651|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
23653652|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23653653|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23653654|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23653655|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23653656|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23653657|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
23653658|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23653659|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23653660|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23653661|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23653662|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23653663|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
23653664|NCT02038920|66117701|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23653665|NCT02038920|66117702|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23653666|NCT02038920|66117703|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23653667|NCT02038920|66117704|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23653668|NCT02038920|66117705|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23653669|NCT02038920|66117706|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
23653670|NCT01326533|66117714|FG000|Overall Study|Lost to Follow-up|2|||
23653671|NCT01326533|66117715|FG001|Overall Study|Lost to Follow-up|0|||
23653672|NCT01326533|66117714|FG000|Overall Study|Withdrawal by Subject|1|||
23653673|NCT01326533|66117715|FG001|Overall Study|Withdrawal by Subject|0|||
23653674|NCT01326533|66117714|FG000|Overall Study|Adverse Event|1|||
23653675|NCT01326533|66117715|FG001|Overall Study|Adverse Event|0|||
23653676|NCT01176773|66117716|FG000|Overall Study|Screen Failure|2|||
23653677|NCT01176773|66117716|FG000|Overall Study|Withdrew consent|1|||
23653678|NCT01128738|66117717|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
23653679|NCT01128738|66117718|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
23653680|NCT01128738|66117717|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
23653681|NCT01128738|66117718|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
23653682|NCT01128738|66117717|FG000|Second TP|Lost to Follow-up|0|||
23653683|NCT01128738|66117718|FG001|Second TP|Lost to Follow-up|1|||
23653684|NCT01128738|66117717|FG000|Second TP|Withdrawal by Subject|0|||
23653685|NCT01128738|66117718|FG001|Second TP|Withdrawal by Subject|2|||
23653686|NCT00938470|66117719|FG000|Overall Study|Disease Progression|3|||
23653687|NCT00938470|66117720|FG001|Overall Study|Disease Progression|0|||
23653688|NCT00938470|66117719|FG000|Overall Study|Alternate Treatment|1|||
23653689|NCT00938470|66117720|FG001|Overall Study|Alternate Treatment|0|||
23653690|NCT00938470|66117719|FG000|Overall Study|Death|3|||
23653691|NCT00938470|66117720|FG001|Overall Study|Death|2|||
23653692|NCT00938470|66117719|FG000|Overall Study|Other Reason|0|||
23653693|NCT00938470|66117720|FG001|Overall Study|Other Reason|1|||
23653694|NCT00026208|66117721|FG000|Overall Study|Complications of auto accident|1|||
23653695|NCT00026208|66117722|FG001|Overall Study|Complications of auto accident|0|||
23653696|NCT01477333|66117725|FG000|Overall Study|Adverse Event|1|||
23653697|NCT01477333|66117725|FG000|Overall Study|Withdrawal by Subject|1|||
23653698|NCT01477333|66117725|FG000|Overall Study|Clinical Deterioration|1|||
23653699|NCT01184053|66117726|FG000|Overall Study|progression while on treatment|3|||
23653700|NCT04014361|66117727|FG000|Period 2|Physician Decision|0|||
23653701|NCT04014361|66117728|FG001|Period 2|Physician Decision|0|||
23653702|NCT04014361|66117729|FG002|Period 2|Physician Decision|0|||
23653703|NCT04014361|66117730|FG003|Period 2|Physician Decision|1|||
23653704|NCT04014361|66117731|FG004|Period 2|Physician Decision|0|||
23653705|NCT04014361|66117732|FG005|Period 2|Physician Decision|0|||
23653706|NCT04014361|66117733|FG006|Period 2|Physician Decision|0|||
23653707|NCT04014361|66117734|FG007|Period 2|Physician Decision|0|||
23653708|NCT01387230|66117738|FG000|Overall Study|Adverse Event|0|||
23653709|NCT01387230|66117739|FG001|Overall Study|Adverse Event|1|||
23653710|NCT01387230|66117740|FG002|Overall Study|Adverse Event|3|||
23653711|NCT01387230|66117738|FG000|Overall Study|Lack of Efficacy|8|||
23653712|NCT01387230|66117739|FG001|Overall Study|Lack of Efficacy|5|||
23653713|NCT01387230|66117740|FG002|Overall Study|Lack of Efficacy|4|||
23653714|NCT01387230|66117738|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
23653715|NCT01387230|66117739|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23653716|NCT01387230|66117740|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
23653717|NCT01387230|66117738|FG000|Overall Study|Lost to Follow-up|0|||
23653718|NCT01387230|66117739|FG001|Overall Study|Lost to Follow-up|0|||
23653719|NCT01387230|66117740|FG002|Overall Study|Lost to Follow-up|1|||
23653720|NCT01387230|66117738|FG000|Overall Study|Withdrawal by Subject|4|||
23653721|NCT01387230|66117739|FG001|Overall Study|Withdrawal by Subject|1|||
23653722|NCT01387230|66117740|FG002|Overall Study|Withdrawal by Subject|0|||
23653723|NCT01174238|66117741|FG000|Overall Study|Lost to Follow-up|2|||
23653724|NCT00705432|66117742|FG000|Treatment Period|Adverse Event|45|||
23653725|NCT00705432|66117743|FG001|Treatment Period|Adverse Event|37|||
23653726|NCT00705432|66117744|FG002|Treatment Period|Adverse Event|51|||
23653727|NCT00705432|66117745|FG003|Treatment Period|Adverse Event|12|||
23653728|NCT00705432|66117746|FG004|Treatment Period|Adverse Event|8|||
23653729|NCT00705432|66117747|FG005|Treatment Period|Adverse Event|9|||
23653730|NCT00705432|66117742|FG000|Treatment Period|Treatment failure|92|||
23653731|NCT00705432|66117743|FG001|Treatment Period|Treatment failure|42|||
23653732|NCT00705432|66117744|FG002|Treatment Period|Treatment failure|33|||
23653733|NCT00705432|66117745|FG003|Treatment Period|Treatment failure|25|||
23653734|NCT00705432|66117746|FG004|Treatment Period|Treatment failure|13|||
23653735|NCT00705432|66117747|FG005|Treatment Period|Treatment failure|14|||
23653736|NCT00705432|66117742|FG000|Treatment Period|Non medical reason|26|||
23653737|NCT00705432|66117743|FG001|Treatment Period|Non medical reason|32|||
23653738|NCT00705432|66117744|FG002|Treatment Period|Non medical reason|37|||
23653739|NCT00705432|66117745|FG003|Treatment Period|Non medical reason|4|||
23653740|NCT00705432|66117746|FG004|Treatment Period|Non medical reason|7|||
23653741|NCT00705432|66117747|FG005|Treatment Period|Non medical reason|7|||
23653742|NCT00705432|66117742|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
23653743|NCT00705432|66117743|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
23653744|NCT00705432|66117744|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
23653745|NCT00705432|66117745|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23653746|NCT00705432|66117746|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23653747|NCT00705432|66117747|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23653748|NCT00705432|66117742|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
23653749|NCT00705432|66117743|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
23653750|NCT00705432|66117744|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
23653751|NCT00705432|66117745|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
23653752|NCT00705432|66117746|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
23653753|NCT00705432|66117747|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
23653754|NCT00288509|66117748|FG000|Treatment Cycle 1|Adverse Event|1|||
23653755|NCT00288509|66117748|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
23653756|NCT00288509|66117748|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
23653757|NCT00288509|66117748|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
23653758|NCT00288509|66117748|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
23653759|NCT00288509|66117748|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
23653760|NCT00288509|66117748|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
23653761|NCT00288509|66117748|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
23653762|NCT00288509|66117748|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
23653763|NCT00288509|66117748|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
23653764|NCT00288509|66117748|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
23653765|NCT00288509|66117748|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
23653766|NCT00288509|66117748|FG000|Treatment Cycle 4|Physician Decision|4|||
23653767|NCT00288509|66117748|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
23653768|NCT01940354|66117758|FG000|Overall Study|Withdrawal by Subject|4|||
23653769|NCT01940354|66117759|FG001|Overall Study|Withdrawal by Subject|2|||
23653770|NCT01765192|66117762|FG000|Treatment Period 1|Adverse Event|0|||
23653771|NCT01765192|66117763|FG001|Treatment Period 1|Adverse Event|1|||
23653772|NCT01765192|66117762|FG000|Washout Period|Voluntary Withdrawal|1|||
23653773|NCT01765192|66117763|FG001|Washout Period|Voluntary Withdrawal|1|||
23653774|NCT01765192|66117762|FG000|Washout Period|Reason not specified|1|||
23653775|NCT01765192|66117763|FG001|Washout Period|Reason not specified|0|||
23653776|NCT01765192|66117762|FG000|Treatment Period 2|Reason not specified|0|||
23653777|NCT01765192|66117763|FG001|Treatment Period 2|Reason not specified|2|||
23653778|NCT01765192|66117762|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
23653779|NCT01765192|66117763|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
23653780|NCT04936841|66117764|FG000|Overall Study|Death|1|||
23653781|NCT00528567|66117767|FG000|Overall Study|Death|4|||
23653782|NCT00528567|66117768|FG001|Overall Study|Death|5|||
23653783|NCT00528567|66117767|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
23653784|NCT00528567|66117768|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
23653785|NCT00528567|66117767|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
23653786|NCT00528567|66117768|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
23653787|NCT00528567|66117767|FG000|Overall Study|Violation Criteria at Entry|3|||
23653788|NCT00528567|66117768|FG001|Overall Study|Violation Criteria at Entry|17|||
23653789|NCT00528567|66117767|FG000|Overall Study|Withdrew Consent|59|||
23653790|NCT00528567|66117768|FG001|Overall Study|Withdrew Consent|55|||
23653791|NCT00528567|66117767|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
23653792|NCT00528567|66117768|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
23653793|NCT00528567|66117767|FG000|Overall Study|Failure to Return|1|||
23599596|NCT03220724|65925641|FG000|Overall Study|Lost to Follow-up|2|||
23599597|NCT03220724|65925642|FG001|Overall Study|Lost to Follow-up|2|||
23599598|NCT03220724|65925643|FG002|Overall Study|Lost to Follow-up|0|||
23599599|NCT03220724|65925644|FG003|Overall Study|Lost to Follow-up|3|||
23599600|NCT03220724|65925645|FG004|Overall Study|Lost to Follow-up|1|||
23599601|NCT03220724|65925646|FG005|Overall Study|Lost to Follow-up|0|||
23599602|NCT03220724|65925647|FG006|Overall Study|Lost to Follow-up|2|||
23599603|NCT03220724|65925648|FG007|Overall Study|Lost to Follow-up|1|||
23599604|NCT03220724|65925649|FG008|Overall Study|Lost to Follow-up|0|||
23599605|NCT03220724|65925641|FG000|Overall Study|Withdrawal by Subject|1|||
23599606|NCT03220724|65925642|FG001|Overall Study|Withdrawal by Subject|0|||
23599607|NCT03220724|65925643|FG002|Overall Study|Withdrawal by Subject|1|||
23599608|NCT03220724|65925644|FG003|Overall Study|Withdrawal by Subject|0|||
23599609|NCT03220724|65925645|FG004|Overall Study|Withdrawal by Subject|0|||
23599610|NCT03220724|65925646|FG005|Overall Study|Withdrawal by Subject|0|||
23599611|NCT03220724|65925647|FG006|Overall Study|Withdrawal by Subject|0|||
23599612|NCT03220724|65925648|FG007|Overall Study|Withdrawal by Subject|0|||
23599613|NCT03220724|65925649|FG008|Overall Study|Withdrawal by Subject|0|||
23599614|NCT03113409|65925650|FG000|Overall Study|Withdrawal by Subject|5|||
23599615|NCT03113409|65925651|FG001|Overall Study|Withdrawal by Subject|0|||
23599616|NCT03113409|65925652|FG002|Overall Study|Withdrawal by Subject|0|||
23599617|NCT01260896|65925653|FG000|First Intervention|Withdrawn Due to Emesis|2|||
23599618|NCT01260896|65925654|FG001|First Intervention|Withdrawn Due to Emesis|0|||
23599619|NCT02564744|65925659|FG000|Overall Study|Investigator decision|0|||
23599620|NCT02564744|65925660|FG001|Overall Study|Investigator decision|0|||
23599621|NCT02564744|65925661|FG002|Overall Study|Investigator decision|0|||
23599622|NCT02564744|65925662|FG003|Overall Study|Investigator decision|0|||
23599623|NCT02564744|65925663|FG004|Overall Study|Investigator decision|1|||
23599624|NCT02564744|65925659|FG000|Overall Study|Death|10|||
23599625|NCT02564744|65925660|FG001|Overall Study|Death|5|||
23599626|NCT02564744|65925661|FG002|Overall Study|Death|4|||
23599627|NCT02564744|65925662|FG003|Overall Study|Death|16|||
23599628|NCT02564744|65925663|FG004|Overall Study|Death|16|||
23599629|NCT02564744|65925659|FG000|Overall Study|End of study Page Missing|0|||
23599630|NCT02564744|65925660|FG001|Overall Study|End of study Page Missing|0|||
23599631|NCT02564744|65925661|FG002|Overall Study|End of study Page Missing|3|||
23599632|NCT02564744|65925662|FG003|Overall Study|End of study Page Missing|3|||
23653794|NCT00528567|66117768|FG001|Overall Study|Failure to Return|4|||
23653795|NCT00528567|66117767|FG000|Overall Study|Other Protocol Violation|5|||
23653796|NCT00528567|66117768|FG001|Overall Study|Other Protocol Violation|21|||
23653797|NCT00528567|66117767|FG000|Overall Study|Administrative/Other|22|||
23801542|NCT01730040|66650059|FG003|Overall Study|Poor compliance to protocol|0|||
23801543|NCT01730040|66650060|FG004|Overall Study|Poor compliance to protocol|0|||
23801544|NCT01730040|66650061|FG005|Overall Study|Poor compliance to protocol|0|||
23801545|NCT01730040|66650062|FG006|Overall Study|Poor compliance to protocol|1|||
23599633|NCT02564744|65925663|FG004|Overall Study|End of study Page Missing|0|||
23599634|NCT02564744|65925659|FG000|Overall Study|Subject Withdrew Consent|1|||
23599635|NCT02564744|65925660|FG001|Overall Study|Subject Withdrew Consent|1|||
23599636|NCT02564744|65925661|FG002|Overall Study|Subject Withdrew Consent|1|||
23599637|NCT02564744|65925662|FG003|Overall Study|Subject Withdrew Consent|0|||
23599638|NCT02564744|65925663|FG004|Overall Study|Subject Withdrew Consent|2|||
23599639|NCT02564744|65925659|FG000|Overall Study|Lost to Follow-up|0|||
23653798|NCT00528567|66117768|FG001|Overall Study|Administrative/Other|75|||
23705492|NCT02371759|66297523|FG004|Overall Study|Protocol Violation|3|||
23705493|NCT02371759|66297524|FG005|Overall Study|Protocol Violation|1|||
23705494|NCT02371759|66297525|FG006|Overall Study|Protocol Violation|0|||
23705495|NCT02371759|66297526|FG007|Overall Study|Protocol Violation|3|||
23705496|NCT02371759|66297519|FG000|Overall Study|Withdrawal by Subject|0|||
23705497|NCT02371759|66297520|FG001|Overall Study|Withdrawal by Subject|0|||
23705498|NCT02371759|66297521|FG002|Overall Study|Withdrawal by Subject|0|||
23705499|NCT02371759|66297522|FG003|Overall Study|Withdrawal by Subject|0|||
23705500|NCT02371759|66297523|FG004|Overall Study|Withdrawal by Subject|0|||
23705501|NCT02371759|66297524|FG005|Overall Study|Withdrawal by Subject|0|||
23705502|NCT02371759|66297525|FG006|Overall Study|Withdrawal by Subject|0|||
23705503|NCT02371759|66297526|FG007|Overall Study|Withdrawal by Subject|1|||
23705504|NCT00698516|66297527|FG000|Overall Study|Study Termination|2|||
23705505|NCT00698516|66297527|FG000|Overall Study|Withdrawal by Subject|3|||
23705506|NCT00421343|66297529|FG000|Overall Study|Death|1|||
23705507|NCT00421343|66297529|FG000|Overall Study|Withdrawal by Subject|2|||
23705508|NCT00421343|66297529|FG000|Overall Study|Lost to Follow-up|3|||
23705509|NCT00237796|66297530|FG000|Overall Study|Baseline and one other ILSS required|10|||
23705510|NCT00237796|66297531|FG001|Overall Study|Baseline and one other ILSS required|5|||
23705511|NCT03987620|66297536|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
23705512|NCT03987620|66297537|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
23705513|NCT03987620|66297536|FG000|Overall Study|Adverse Event|3|||
23705514|NCT03987620|66297537|FG001|Overall Study|Adverse Event|0|||
23705515|NCT03987620|66297536|FG000|Overall Study|Lost to Follow-up|1|||
23705516|NCT03987620|66297537|FG001|Overall Study|Lost to Follow-up|2|||
23705517|NCT03987620|66297536|FG000|Overall Study|Physician Decision|0|||
23705518|NCT03987620|66297537|FG001|Overall Study|Physician Decision|1|||
23705519|NCT03987620|66297536|FG000|Overall Study|Pregnancy|1|||
23705520|NCT03987620|66297537|FG001|Overall Study|Pregnancy|0|||
23705521|NCT03987620|66297536|FG000|Overall Study|Withdrawal by Subject|7|||
23705522|NCT03987620|66297537|FG001|Overall Study|Withdrawal by Subject|1|||
23705523|NCT03987620|66297536|FG000|Overall Study|Other|2|||
23705524|NCT03987620|66297537|FG001|Overall Study|Other|5|||
23705525|NCT00883558|66297538|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
23705526|NCT00883558|66297539|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
23705527|NCT00883558|66297540|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
23705528|NCT00883558|66297538|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
23705529|NCT00883558|66297539|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
23705530|NCT00883558|66297540|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
23705531|NCT00883558|66297538|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
23705532|NCT00883558|66297539|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
23705533|NCT00883558|66297540|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
23705534|NCT00883558|66297538|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
23705535|NCT00883558|66297539|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
23705536|NCT00883558|66297540|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
23705537|NCT00883558|66297538|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
23705538|NCT00883558|66297539|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
23705539|NCT00883558|66297540|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
23705540|NCT00960440|66297541|FG000|Overall Study|Death|0|||
23801546|NCT02575339|66650063|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23801547|NCT02575339|66650064|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23801548|NCT02575339|66650065|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23801549|NCT02575339|66650063|FG000|Study Treatment|Disease Progression|5|||
23480004|NCT03400956|65501872|FG001|Treatment Period 2|Lost to Follow-up|1|||
23480005|NCT03400956|65501873|FG002|Treatment Period 2|Lost to Follow-up|0|||
23801550|NCT02575339|66650064|FG001|Study Treatment|Disease Progression|2|||
23801551|NCT02575339|66650065|FG002|Study Treatment|Disease Progression|0|||
23801552|NCT02575339|66650063|FG000|Study Treatment|Adverse Event|1|||
23801553|NCT02575339|66650064|FG001|Study Treatment|Adverse Event|2|||
23705541|NCT00960440|66297542|FG001|Overall Study|Death|0|||
23705542|NCT00960440|66297543|FG002|Overall Study|Death|0|||
23705543|NCT00960440|66297544|FG003|Overall Study|Death|1|||
23705544|NCT00960440|66297541|FG000|Overall Study|Adverse Event|12|||
23705545|NCT00960440|66297542|FG001|Overall Study|Adverse Event|12|||
23705546|NCT00960440|66297543|FG002|Overall Study|Adverse Event|4|||
23705547|NCT00960440|66297544|FG003|Overall Study|Adverse Event|4|||
23705548|NCT00960440|66297541|FG000|Overall Study|Lack of Efficacy|2|||
23705549|NCT00960440|66297542|FG001|Overall Study|Lack of Efficacy|5|||
23705550|NCT00960440|66297543|FG002|Overall Study|Lack of Efficacy|3|||
23705551|NCT00960440|66297544|FG003|Overall Study|Lack of Efficacy|8|||
23653799|NCT00821431|66121091|FG000|Overall Study|Adverse Event|6|||
23653800|NCT00821431|66121092|FG001|Overall Study|Adverse Event|3|||
23653801|NCT00821431|66121091|FG000|Overall Study|Withdrawal by Subject|5|||
23653802|NCT00821431|66121092|FG001|Overall Study|Withdrawal by Subject|0|||
23653803|NCT00821431|66121091|FG000|Overall Study|Lost to Follow-up|1|||
23653804|NCT00821431|66121092|FG001|Overall Study|Lost to Follow-up|0|||
23653805|NCT00821431|66121091|FG000|Overall Study|Protocol Violation|3|||
23653806|NCT00821431|66121092|FG001|Overall Study|Protocol Violation|1|||
23653807|NCT00821431|66121091|FG000|Overall Study|Physician Decision|0|||
23653808|NCT00821431|66121092|FG001|Overall Study|Physician Decision|1|||
23653809|NCT01251120|66121098|FG000|Overall Study|Lack of Efficacy|0|||
23653810|NCT01251120|66121099|FG001|Overall Study|Lack of Efficacy|1|||
23653811|NCT00601250|66121102|FG000|Overall Study|Adverse Event|3|||
23653812|NCT00601250|66121103|FG001|Overall Study|Adverse Event|9|||
23653813|NCT00601250|66121102|FG000|Overall Study|Protocol Violation|3|||
23653814|NCT00601250|66121103|FG001|Overall Study|Protocol Violation|2|||
23653815|NCT00601250|66121102|FG000|Overall Study|Lost to Follow-up|2|||
23653816|NCT00601250|66121103|FG001|Overall Study|Lost to Follow-up|6|||
23653817|NCT00601250|66121102|FG000|Overall Study|Withdrawal by Subject|4|||
23653818|NCT00601250|66121103|FG001|Overall Study|Withdrawal by Subject|13|||
23653819|NCT00601250|66121102|FG000|Overall Study|Other incl. lack of efficacy|2|||
23360939|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360940|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360941|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360942|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360943|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360944|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
23360945|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
23360946|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
23360947|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360948|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360949|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360950|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360951|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360952|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360953|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360954|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360955|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360956|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360957|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
23360958|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360959|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
23360960|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360961|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360962|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360963|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360964|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360965|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360966|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360967|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
23360968|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23360969|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
23360970|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360971|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23653820|NCT00601250|66121103|FG001|Overall Study|Other incl. lack of efficacy|9|||
23653821|NCT00293722|66121105|FG000|Overall Study|Other|427|||
23653822|NCT01176968|66121106|FG000|Overall Study|Adverse Event|10|||
23653823|NCT01176968|66121107|FG001|Overall Study|Adverse Event|11|||
23653824|NCT01176968|66121106|FG000|Overall Study|Death|2|||
23653825|NCT01176968|66121107|FG001|Overall Study|Death|3|||
23653826|NCT01176968|66121106|FG000|Overall Study|Lack of Efficacy|0|||
23653827|NCT01176968|66121107|FG001|Overall Study|Lack of Efficacy|1|||
23653828|NCT01176968|66121106|FG000|Overall Study|Lost to Follow-up|16|||
23653829|NCT01176968|66121107|FG001|Overall Study|Lost to Follow-up|14|||
23801554|NCT02575339|66650065|FG002|Study Treatment|Adverse Event|0|||
23653830|NCT01176968|66121106|FG000|Overall Study|Withdrawal by Subject|48|||
23653831|NCT01176968|66121107|FG001|Overall Study|Withdrawal by Subject|48|||
23653832|NCT01176968|66121106|FG000|Overall Study|Protocol Violation|2|||
23801555|NCT02575339|66650063|FG000|Follow up|Death|6|||
23801556|NCT02575339|66650064|FG001|Follow up|Death|2|||
23653833|NCT01176968|66121107|FG001|Overall Study|Protocol Violation|1|||
23653834|NCT01176968|66121106|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23653835|NCT01176968|66121107|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23653836|NCT01176968|66121106|FG000|Overall Study|Study terminated by sponsor|0|||
23653837|NCT01176968|66121107|FG001|Overall Study|Study terminated by sponsor|1|||
23653838|NCT01176968|66121106|FG000|Overall Study|Reason not defined|5|||
23653839|NCT01176968|66121107|FG001|Overall Study|Reason not defined|3|||
23653840|NCT02374021|66121110|FG000|Overall Study|Adverse Event|1|||
23653841|NCT02374021|66121111|FG001|Overall Study|Adverse Event|0|||
23653842|NCT02374021|66121110|FG000|Overall Study|Lost to Follow-up|3|||
23653843|NCT02374021|66121111|FG001|Overall Study|Lost to Follow-up|2|||
23653844|NCT02374021|66121110|FG000|Overall Study|Physician Decision|0|||
23653845|NCT02374021|66121111|FG001|Overall Study|Physician Decision|3|||
23653846|NCT02374021|66121110|FG000|Overall Study|Withdrawal by Subject|6|||
23653847|NCT02374021|66121111|FG001|Overall Study|Withdrawal by Subject|5|||
23653848|NCT02374021|66121110|FG000|Overall Study|Poor Adherence|0|||
23653849|NCT02374021|66121111|FG001|Overall Study|Poor Adherence|1|||
23653850|NCT02374021|66121110|FG000|Overall Study|Scan protocol not followed|0|||
23653851|NCT02374021|66121111|FG001|Overall Study|Scan protocol not followed|1|||
23653852|NCT02374021|66121110|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
23653853|NCT02374021|66121111|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
23653854|NCT01163721|66121114|FG000|Overall Study|Adverse Event|5|||
23653855|NCT01163721|66121115|FG001|Overall Study|Adverse Event|6|||
23653856|NCT01163721|66121114|FG000|Overall Study|Withdrawal by Subject|3|||
23653857|NCT01163721|66121115|FG001|Overall Study|Withdrawal by Subject|4|||
23653858|NCT01163721|66121114|FG000|Overall Study|Lost to Follow-up|0|||
23653859|NCT01163721|66121115|FG001|Overall Study|Lost to Follow-up|1|||
23653860|NCT01163721|66121114|FG000|Overall Study|Physician Decision|0|||
23653861|NCT01163721|66121115|FG001|Overall Study|Physician Decision|1|||
23653862|NCT02745392|66121116|FG000|Overall Study|Lost to Follow-up|0|||
23653863|NCT02745392|66121117|FG001|Overall Study|Lost to Follow-up|1|||
23653864|NCT02745392|66121118|FG002|Overall Study|Lost to Follow-up|0|||
23653865|NCT02745392|66121119|FG003|Overall Study|Lost to Follow-up|0|||
23653866|NCT01009034|66121120|FG000|Overall Study|Lost to Follow-up|2|||
23653867|NCT01009034|66121120|FG000|Overall Study|Withdrawal by Subject|2|||
23653868|NCT01178671|66121121|FG000|Overall Study|Adverse Event|4|||
23653869|NCT01178671|66121122|FG001|Overall Study|Adverse Event|6|||
23653870|NCT01178671|66121121|FG000|Overall Study|Protocol Violation|1|||
23653871|NCT01178671|66121122|FG001|Overall Study|Protocol Violation|1|||
23653872|NCT01178671|66121121|FG000|Overall Study|Lack of Efficacy|0|||
23653873|NCT01178671|66121122|FG001|Overall Study|Lack of Efficacy|1|||
23653874|NCT01178671|66121121|FG000|Overall Study|Lost to Follow-up|3|||
23653875|NCT01178671|66121122|FG001|Overall Study|Lost to Follow-up|1|||
23653876|NCT01178671|66121121|FG000|Overall Study|Physician Decision|4|||
23653877|NCT01178671|66121122|FG001|Overall Study|Physician Decision|6|||
23653878|NCT01791803|66121134|FG000|Overall Study|Withdrawal by Subject|0|||
23653879|NCT01791803|66121135|FG001|Overall Study|Withdrawal by Subject|0|||
23653880|NCT01791803|66121136|FG002|Overall Study|Withdrawal by Subject|0|||
23653881|NCT01791803|66121137|FG003|Overall Study|Withdrawal by Subject|2|||
23653882|NCT01791803|66121134|FG000|Overall Study|Physician Decision|0|||
23653883|NCT01791803|66121135|FG001|Overall Study|Physician Decision|2|||
23653884|NCT01791803|66121136|FG002|Overall Study|Physician Decision|0|||
23653885|NCT01791803|66121137|FG003|Overall Study|Physician Decision|1|||
23653886|NCT01791803|66121134|FG000|Overall Study|Death|0|||
23653887|NCT01791803|66121135|FG001|Overall Study|Death|0|||
23653888|NCT01791803|66121136|FG002|Overall Study|Death|2|||
23653889|NCT01791803|66121137|FG003|Overall Study|Death|2|||
23653890|NCT01526551|66121138|FG000|Overall Study|Lack of returned parental consent form|424|||
23653891|NCT01572922|66121139|FG000|Overall Study|Adverse Event|1|||
23653892|NCT01572922|66121139|FG000|Overall Study|Protocol Violation|1|||
23653893|NCT01572922|66121139|FG000|Overall Study|Death|1|||
23653894|NCT00567268|66121140|FG000|Overall Study|Protocol Violation|7|||
23653895|NCT00567268|66121140|FG000|Overall Study|Lost to Follow-up|36|||
23653896|NCT00567268|66121140|FG000|Overall Study|No Visit After First Day of Treatment|2|||
23653897|NCT00567268|66121140|FG000|Overall Study|No Drug Administration|4|||
23653898|NCT00567268|66121140|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
23653899|NCT01106404|66121147|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
23653900|NCT01106404|66121148|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
23653901|NCT01106404|66121147|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
23653902|NCT01106404|66121148|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
23653903|NCT01106404|66121147|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
23653904|NCT01106404|66121148|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
23653905|NCT01106404|66121147|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
23653906|NCT01106404|66121148|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
23653907|NCT00887250|66121150|FG000|Overall Study|Adverse Event|3|||
23653908|NCT00887250|66121151|FG001|Overall Study|Adverse Event|0|||
23653909|NCT00887250|66121152|FG002|Overall Study|Adverse Event|7|||
23653910|NCT00887250|66121150|FG000|Overall Study|Lack of Efficacy|9|||
23653911|NCT00887250|66121151|FG001|Overall Study|Lack of Efficacy|6|||
23360972|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360973|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360974|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360975|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360976|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360977|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360978|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
23360979|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360980|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360981|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23599640|NCT02564744|65925660|FG001|Overall Study|Lost to Follow-up|1|||
23599641|NCT02564744|65925661|FG002|Overall Study|Lost to Follow-up|0|||
23599642|NCT02564744|65925662|FG003|Overall Study|Lost to Follow-up|0|||
23599643|NCT02564744|65925663|FG004|Overall Study|Lost to Follow-up|1|||
23599644|NCT02564744|65925659|FG000|Overall Study|Reason not specified|1|||
23599645|NCT02564744|65925660|FG001|Overall Study|Reason not specified|0|||
23599646|NCT02564744|65925661|FG002|Overall Study|Reason not specified|0|||
23599647|NCT02564744|65925662|FG003|Overall Study|Reason not specified|0|||
23599648|NCT02564744|65925663|FG004|Overall Study|Reason not specified|0|||
23653912|NCT00887250|66121152|FG002|Overall Study|Lack of Efficacy|1|||
23653913|NCT00887250|66121150|FG000|Overall Study|Lost to Follow-up|2|||
23653914|NCT00887250|66121151|FG001|Overall Study|Lost to Follow-up|3|||
23653915|NCT00887250|66121152|FG002|Overall Study|Lost to Follow-up|1|||
23653916|NCT00887250|66121150|FG000|Overall Study|Protocol Violation|2|||
23653917|NCT00887250|66121151|FG001|Overall Study|Protocol Violation|2|||
23653918|NCT00887250|66121152|FG002|Overall Study|Protocol Violation|1|||
23653919|NCT00887250|66121150|FG000|Overall Study|Withdrawal by Subject|2|||
23653920|NCT00887250|66121151|FG001|Overall Study|Withdrawal by Subject|1|||
23653921|NCT00887250|66121152|FG002|Overall Study|Withdrawal by Subject|2|||
23653922|NCT00887250|66121150|FG000|Overall Study|Patient uncooperative|0|||
23653923|NCT00887250|66121151|FG001|Overall Study|Patient uncooperative|0|||
23653924|NCT00887250|66121152|FG002|Overall Study|Patient uncooperative|1|||
23653925|NCT02469896|66121158|FG000|Overall Study|Withdrawal by Subject|2|||
23653926|NCT02469896|66121159|FG001|Overall Study|Withdrawal by Subject|0|||
23653927|NCT00117845|66121160|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
23653928|NCT00730171|66121165|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
23653929|NCT00730171|66121165|FG000|Overall Study|Adverse Event|193|||
23653930|NCT00730171|66121165|FG000|Overall Study|Protocol Violation|48|||
23653931|NCT00730171|66121165|FG000|Overall Study|Withdrawal by Subject|202|||
23653932|NCT00730171|66121165|FG000|Overall Study|Lost to Follow-up|121|||
23653933|NCT00730171|66121165|FG000|Overall Study|Insufficient Therapeutic Response|141|||
23653934|NCT00730171|66121165|FG000|Overall Study|Other|61|||
23653935|NCT01330914|66121166|FG000|Overall Study|Withdrawal by Subject|4|||
23653936|NCT01330914|66121166|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
23653937|NCT01106027|66121167|FG000|Overall Study|Lost graft early, discontinued|1|||
23653938|NCT03064035|66121168|FG000|Overall Study|Did not receive allocated intervention|4|||
23653939|NCT03064035|66121169|FG001|Overall Study|Did not receive allocated intervention|2|||
23653940|NCT03064035|66121168|FG000|Overall Study|Lost to Follow-up|1|||
23653941|NCT03064035|66121169|FG001|Overall Study|Lost to Follow-up|1|||
23653942|NCT02234323|66121170|FG000|All Enrolled|Not Treated: Completed study in database|2|||
23653943|NCT02234323|66121170|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
23653944|NCT02234323|66121170|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
23653945|NCT02234323|66121170|FG000|All Treated|Death|1|||
23653946|NCT02234323|66121170|FG000|All Treated|Physician Decision|5|||
23653947|NCT02234323|66121170|FG000|All Treated|Lack of Efficacy|3|||
23653948|NCT02234323|66121170|FG000|All Treated|Exceeded lab value limit|2|||
23653949|NCT02234323|66121170|FG000|All Treated|Other|7|||
23653950|NCT02804178|66121173|FG000|Overall Study|Adverse Event|1|||
23653951|NCT00898443|66121174|FG000|Overall Study|Withdrawal by Subject|1|||
23653952|NCT00898443|66121175|FG001|Overall Study|Withdrawal by Subject|0|||
23599649|NCT01211184|65925666|FG000|Overall Study|Withdrawal by Subject|0|||
23599650|NCT01211184|65925667|FG001|Overall Study|Withdrawal by Subject|2|||
23653953|NCT01881750|66121176|FG000|Overall Study|Changes in concomitant therapies|2|||
23653954|NCT01881750|66121177|FG001|Overall Study|Changes in concomitant therapies|3|||
23653955|NCT01881750|66121176|FG000|Overall Study|Lost to Follow-up|0|||
23653956|NCT01881750|66121177|FG001|Overall Study|Lost to Follow-up|1|||
23653957|NCT01810016|66121178|FG000|Overall Study|Progressive disease|1|||
23653958|NCT01810016|66121179|FG001|Overall Study|Progressive disease|1|||
23653959|NCT01810016|66121180|FG002|Overall Study|Progressive disease|0|||
23653960|NCT01810016|66121178|FG000|Overall Study|Death|0|||
23653961|NCT01810016|66121179|FG001|Overall Study|Death|0|||
23653962|NCT01810016|66121180|FG002|Overall Study|Death|1|||
23653963|NCT03881553|66121181|FG000|Overall Study|Discharged prior to participation|1|||
23653964|NCT03881553|66121182|FG001|Overall Study|Discharged prior to participation|1|||
23653965|NCT03881553|66121183|FG002|Overall Study|Discharged prior to participation|0|||
23653966|NCT03881553|66121181|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
23653967|NCT03881553|66121182|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
23653968|NCT03881553|66121183|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
23653969|NCT01822522|66121187|FG000|Overall Study|Adverse Event|1|||
23653970|NCT01822522|66121188|FG001|Overall Study|Adverse Event|1|||
23653971|NCT01822522|66121189|FG002|Overall Study|Adverse Event|1|||
23653972|NCT01822522|66121190|FG003|Overall Study|Adverse Event|0|||
23653973|NCT01822522|66121191|FG004|Overall Study|Adverse Event|0|||
23653974|NCT01822522|66121192|FG005|Overall Study|Adverse Event|1|||
23653975|NCT01822522|66121187|FG000|Overall Study|Death|3|||
23653976|NCT01822522|66121188|FG001|Overall Study|Death|0|||
23653977|NCT01822522|66121189|FG002|Overall Study|Death|2|||
23653978|NCT01822522|66121190|FG003|Overall Study|Death|0|||
23653979|NCT01822522|66121191|FG004|Overall Study|Death|0|||
23653980|NCT01822522|66121192|FG005|Overall Study|Death|0|||
23653981|NCT01822522|66121187|FG000|Overall Study|Lost to Follow-up|0|||
23653982|NCT01822522|66121188|FG001|Overall Study|Lost to Follow-up|0|||
23653983|NCT01822522|66121189|FG002|Overall Study|Lost to Follow-up|1|||
23653984|NCT01822522|66121190|FG003|Overall Study|Lost to Follow-up|1|||
23653985|NCT01822522|66121191|FG004|Overall Study|Lost to Follow-up|0|||
23653986|NCT01822522|66121192|FG005|Overall Study|Lost to Follow-up|1|||
23653987|NCT01822522|66121187|FG000|Overall Study|Withdrawal by Subject|0|||
23653988|NCT01822522|66121188|FG001|Overall Study|Withdrawal by Subject|0|||
23653989|NCT01822522|66121189|FG002|Overall Study|Withdrawal by Subject|0|||
23653990|NCT01822522|66121190|FG003|Overall Study|Withdrawal by Subject|1|||
23653991|NCT01822522|66121191|FG004|Overall Study|Withdrawal by Subject|0|||
23653992|NCT01822522|66121192|FG005|Overall Study|Withdrawal by Subject|0|||
23653993|NCT01822522|66121187|FG000|Overall Study|Lack of Efficacy|0|||
23653994|NCT01822522|66121188|FG001|Overall Study|Lack of Efficacy|0|||
23653995|NCT01822522|66121189|FG002|Overall Study|Lack of Efficacy|0|||
23653996|NCT01822522|66121190|FG003|Overall Study|Lack of Efficacy|0|||
23653997|NCT01822522|66121191|FG004|Overall Study|Lack of Efficacy|0|||
23653998|NCT01822522|66121192|FG005|Overall Study|Lack of Efficacy|2|||
23653999|NCT02336178|66121193|FG000|Overall Study|Lost to Follow-up|1|||
23654000|NCT02336178|66121193|FG000|Overall Study|Protocol Violation|1|||
23654001|NCT02336178|66121193|FG000|Overall Study|Withdrawal by Subject|1|||
23654002|NCT02336178|66121193|FG000|Overall Study|Other|1|||
23654003|NCT00092495|66121196|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
23654004|NCT00092495|66121197|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
23654005|NCT00092495|66121198|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23654006|NCT00092495|66121199|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
23654007|NCT00092495|66121200|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23654008|NCT00092495|66121196|FG000|Base Study Vaccination Period|Extended|0|||
23654009|NCT00092495|66121197|FG001|Base Study Vaccination Period|Extended|0|||
23654010|NCT00092495|66121198|FG002|Base Study Vaccination Period|Extended|0|||
23654011|NCT00092495|66121199|FG003|Base Study Vaccination Period|Extended|1|||
23654012|NCT00092495|66121200|FG004|Base Study Vaccination Period|Extended|0|||
23654013|NCT00092495|66121196|FG000|Base Study Vaccination Period|*Clinical AE|1|||
23654014|NCT00092495|66121197|FG001|Base Study Vaccination Period|*Clinical AE|0|||
23654015|NCT00092495|66121198|FG002|Base Study Vaccination Period|*Clinical AE|1|||
23654016|NCT00092495|66121199|FG003|Base Study Vaccination Period|*Clinical AE|2|||
23654017|NCT00092495|66121200|FG004|Base Study Vaccination Period|*Clinical AE|0|||
23801557|NCT02575339|66650065|FG002|Follow up|Death|0|||
23654018|NCT00092495|66121196|FG000|Base Study Vaccination Period|*Other reasons|1|||
23654019|NCT00092495|66121197|FG001|Base Study Vaccination Period|*Other reasons|0|||
23654020|NCT00092495|66121198|FG002|Base Study Vaccination Period|*Other reasons|0|||
23360982|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23654021|NCT00092495|66121199|FG003|Base Study Vaccination Period|*Other reasons|1|||
23654022|NCT00092495|66121200|FG004|Base Study Vaccination Period|*Other reasons|0|||
23654023|NCT00092495|66121196|FG000|Base Study Vaccination Period|*Pregnancy|0|||
23654024|NCT00092495|66121197|FG001|Base Study Vaccination Period|*Pregnancy|2|||
23654025|NCT00092495|66121198|FG002|Base Study Vaccination Period|*Pregnancy|5|||
23654026|NCT00092495|66121199|FG003|Base Study Vaccination Period|*Pregnancy|7|||
23801558|NCT02575339|66650063|FG000|Follow up|Study Terminated|0|||
23654027|NCT00092495|66121200|FG004|Base Study Vaccination Period|*Pregnancy|0|||
23654028|NCT00092495|66121196|FG000|Base Study Vaccination Period|Adverse Event|1|||
23480006|NCT03400956|65501871|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23480007|NCT03400956|65501872|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23480008|NCT03400956|65501873|FG002|Treatment Period 2|Withdrawal by Subject|3|||
23480009|NCT03400956|65501871|FG000|Treatment Period 2|Other|1|||
23480010|NCT03400956|65501872|FG001|Treatment Period 2|Other|1|||
23480011|NCT03400956|65501873|FG002|Treatment Period 2|Other|0|||
23480012|NCT03400956|65501871|FG000|Follow-up Period|Withdrawal by Subject|0|||
23480013|NCT03400956|65501872|FG001|Follow-up Period|Withdrawal by Subject|0|||
23480014|NCT03400956|65501873|FG002|Follow-up Period|Withdrawal by Subject|1|||
23480015|NCT03400956|65501871|FG000|Follow-up Period|Other|0|||
23480016|NCT03400956|65501872|FG001|Follow-up Period|Other|0|||
23480017|NCT03400956|65501873|FG002|Follow-up Period|Other|1|||
23480018|NCT03234881|65501874|FG000|Overall Study|Lost to Follow-up|9|||
23480019|NCT03234881|65501875|FG001|Overall Study|Lost to Follow-up|3|||
23480020|NCT01659554|65501878|FG000|Overall Study|Study Termination|4|||
23480021|NCT03206788|65501879|FG000|Overall Study|Withdrawal by Subject|0|||
23480022|NCT03206788|65501880|FG001|Overall Study|Withdrawal by Subject|1|||
23480023|NCT03206788|65501879|FG000|Overall Study|Adverse Event|0|||
23480024|NCT03206788|65501880|FG001|Overall Study|Adverse Event|1|||
23480025|NCT03206788|65501879|FG000|Overall Study|Physician Decision|0|||
23480026|NCT03206788|65501880|FG001|Overall Study|Physician Decision|1|||
23480027|NCT00592774|65501881|FG000|Overall Study|Adverse Event|5|||
23480028|NCT00592774|65501882|FG001|Overall Study|Adverse Event|19|||
23480029|NCT00592774|65501883|FG002|Overall Study|Adverse Event|2|||
23480030|NCT00592774|65501884|FG003|Overall Study|Adverse Event|14|||
23480031|NCT00592774|65501885|FG004|Overall Study|Adverse Event|8|||
23480032|NCT00592774|65501881|FG000|Overall Study|Protocol Violation|0|||
23480033|NCT00592774|65501882|FG001|Overall Study|Protocol Violation|1|||
23480034|NCT00592774|65501883|FG002|Overall Study|Protocol Violation|0|||
23480035|NCT00592774|65501884|FG003|Overall Study|Protocol Violation|0|||
23480036|NCT00592774|65501885|FG004|Overall Study|Protocol Violation|1|||
23480037|NCT00592774|65501881|FG000|Overall Study|Withdrawal by Subject|3|||
23480038|NCT00592774|65501882|FG001|Overall Study|Withdrawal by Subject|7|||
23480039|NCT00592774|65501883|FG002|Overall Study|Withdrawal by Subject|0|||
23801559|NCT02575339|66650064|FG001|Follow up|Study Terminated|2|||
23801560|NCT02575339|66650065|FG002|Follow up|Study Terminated|0|||
23801561|NCT02575339|66650063|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
23801562|NCT02575339|66650064|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
23801563|NCT02575339|66650065|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
23801564|NCT00307931|66654588|FG000|Overall Study|Adverse Event|1|||
23801565|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
23801566|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
23801567|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
23801568|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
23801569|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
23801570|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
23801571|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
23801572|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
23480040|NCT00592774|65501884|FG003|Overall Study|Withdrawal by Subject|0|||
23801573|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
23480041|NCT00592774|65501885|FG004|Overall Study|Withdrawal by Subject|0|||
23480042|NCT00592774|65501881|FG000|Overall Study|Lack of Efficacy|3|||
23480043|NCT00592774|65501882|FG001|Overall Study|Lack of Efficacy|3|||
23480044|NCT00592774|65501883|FG002|Overall Study|Lack of Efficacy|0|||
23480045|NCT00592774|65501884|FG003|Overall Study|Lack of Efficacy|0|||
23480046|NCT00592774|65501885|FG004|Overall Study|Lack of Efficacy|2|||
23480047|NCT00592774|65501881|FG000|Overall Study|Physician Decision|0|||
23654029|NCT00092495|66121197|FG001|Base Study Vaccination Period|Adverse Event|0|||
23654030|NCT00092495|66121198|FG002|Base Study Vaccination Period|Adverse Event|0|||
23654031|NCT00092495|66121199|FG003|Base Study Vaccination Period|Adverse Event|3|||
23654032|NCT00092495|66121200|FG004|Base Study Vaccination Period|Adverse Event|0|||
23654033|NCT00092495|66121196|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
23654034|NCT00092495|66121197|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
23654035|NCT00092495|66121198|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
23654036|NCT00092495|66121199|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
23654037|NCT00092495|66121200|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23654038|NCT00092495|66121196|FG000|Base Study Vaccination Period|Moved|3|||
23654039|NCT00092495|66121197|FG001|Base Study Vaccination Period|Moved|1|||
23654040|NCT00092495|66121198|FG002|Base Study Vaccination Period|Moved|2|||
23654041|NCT00092495|66121199|FG003|Base Study Vaccination Period|Moved|2|||
23654042|NCT00092495|66121200|FG004|Base Study Vaccination Period|Moved|0|||
23654043|NCT00092495|66121196|FG000|Base Study Vaccination Period|Other|1|||
23654044|NCT00092495|66121197|FG001|Base Study Vaccination Period|Other|1|||
23654045|NCT00092495|66121198|FG002|Base Study Vaccination Period|Other|0|||
23654046|NCT00092495|66121199|FG003|Base Study Vaccination Period|Other|2|||
23654047|NCT00092495|66121200|FG004|Base Study Vaccination Period|Other|0|||
23654048|NCT00092495|66121196|FG000|Base Study Vaccination Period|Pregnancy|2|||
23654049|NCT00092495|66121197|FG001|Base Study Vaccination Period|Pregnancy|0|||
23654050|NCT00092495|66121198|FG002|Base Study Vaccination Period|Pregnancy|0|||
23654051|NCT00092495|66121199|FG003|Base Study Vaccination Period|Pregnancy|0|||
23654052|NCT00092495|66121200|FG004|Base Study Vaccination Period|Pregnancy|0|||
23654053|NCT00092495|66121196|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23654054|NCT00092495|66121197|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23654055|NCT00092495|66121198|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23654056|NCT00092495|66121199|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
23654057|NCT00092495|66121200|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
23654058|NCT00092495|66121196|FG000|Base Study Vaccination Period|Protocol Violation|1|||
23654059|NCT00092495|66121197|FG001|Base Study Vaccination Period|Protocol Violation|0|||
23654060|NCT00092495|66121198|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23654061|NCT00092495|66121199|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23654062|NCT00092495|66121200|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23654063|NCT00092495|66121196|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
23654064|NCT00092495|66121197|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
23654065|NCT00092495|66121198|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
23654066|NCT00092495|66121199|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
23654067|NCT00092495|66121200|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23654068|NCT00092495|66121196|FG000|Base Study Follow-up Period|Extended|0|||
23654069|NCT00092495|66121197|FG001|Base Study Follow-up Period|Extended|0|||
23654070|NCT00092495|66121198|FG002|Base Study Follow-up Period|Extended|1|||
23654071|NCT00092495|66121199|FG003|Base Study Follow-up Period|Extended|2|||
23654072|NCT00092495|66121200|FG004|Base Study Follow-up Period|Extended|0|||
23654073|NCT00092495|66121196|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
23654074|NCT00092495|66121197|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
23654075|NCT00092495|66121198|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
23654076|NCT00092495|66121199|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
23654077|NCT00092495|66121200|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23654078|NCT00092495|66121196|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
23654079|NCT00092495|66121197|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
23654080|NCT00092495|66121198|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23654081|NCT00092495|66121199|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23654082|NCT00092495|66121200|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23654083|NCT00937833|66121204|FG000|Overall Study|Protocol Violation|1|||
23654084|NCT00937833|66121205|FG001|Overall Study|Protocol Violation|2|||
23654085|NCT00937833|66121204|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
23654086|NCT00937833|66121205|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
23654087|NCT00937833|66121204|FG000|Overall Study|Lost to Follow-up|10|||
23654088|NCT00937833|66121205|FG001|Overall Study|Lost to Follow-up|8|||
23654089|NCT00937833|66121204|FG000|Overall Study|Withdrawal by Subject|4|||
23654090|NCT00937833|66121205|FG001|Overall Study|Withdrawal by Subject|6|||
23654091|NCT03431857|66121208|FG000|Overall Study|Death|6|||
23654092|NCT03431857|66121208|FG000|Overall Study|Lost to Follow-up|41|||
23654093|NCT03431857|66121208|FG000|Overall Study|Adverse Event|6|||
23654094|NCT03431857|66121208|FG000|Overall Study|Withdrawal by Subject|1|||
23654095|NCT01351623|66121209|FG000|Overall Study|Protocol Violation|2|||
23654096|NCT01351623|66121209|FG000|Overall Study|Adverse Event|4|||
23654097|NCT01351623|66121209|FG000|Overall Study|Withdrawal by Subject|1|||
23654098|NCT01351623|66121209|FG000|Overall Study|Death|2|||
23654099|NCT04540133|66121210|FG000|Overall Study|Lost to Follow-up|1|||
23654100|NCT04540133|66121211|FG001|Overall Study|Lost to Follow-up|0|||
23654101|NCT01955122|66121212|FG000|Overall Study|Physician Decision|5|||
23654102|NCT01955122|66121213|FG001|Overall Study|Physician Decision|5|||
23654103|NCT01423253|66121214|FG000|Overall Study|Adverse Event|2|||
23654104|NCT01423253|66121214|FG000|Overall Study|Lack of Efficacy|2|||
23654105|NCT01423253|66121214|FG000|Overall Study|Lost to Follow-up|1|||
23654106|NCT01423253|66121214|FG000|Overall Study|Protocol Violation|2|||
23654107|NCT01423253|66121214|FG000|Overall Study|Withdrawal by Subject|2|||
23654108|NCT02881957|66121215|FG000|Overall Study|Comfort care|0|||
23654109|NCT02881957|66121216|FG001|Overall Study|Comfort care|1|||
23654110|NCT02881957|66121215|FG000|Overall Study|Concurrent trial enrollment|0|||
23654111|NCT02881957|66121216|FG001|Overall Study|Concurrent trial enrollment|1|||
23654112|NCT02881957|66121215|FG000|Overall Study|Discharged within 48 hours|0|||
23654113|NCT02881957|66121216|FG001|Overall Study|Discharged within 48 hours|1|||
23654114|NCT02881957|66121215|FG000|Overall Study|Withdrawal by Subject|2|||
23654115|NCT02881957|66121216|FG001|Overall Study|Withdrawal by Subject|1|||
23654116|NCT02881957|66121215|FG000|Overall Study|Protocol Violation|1|||
23654117|NCT02881957|66121216|FG001|Overall Study|Protocol Violation|0|||
23654118|NCT00364156|66121218|FG000|Overall Study|Withdrawal by Subject|73|||
23654119|NCT00364156|66121219|FG001|Overall Study|Withdrawal by Subject|80|||
23654120|NCT00364156|66121218|FG000|Overall Study|Protocol Violation|6|||
23654121|NCT00364156|66121219|FG001|Overall Study|Protocol Violation|1|||
23654122|NCT02921269|66121231|FG000|Overall Study|Did not complete DLT period|1|||
23654123|NCT01446016|66121232|FG000|Overall Study|Lost to Follow-up|3|||
23654124|NCT01446016|66121232|FG000|Overall Study|Withdrawal by Subject|1|||
23654125|NCT01446016|66121232|FG000|Overall Study|Toxicity|3|||
23654126|NCT00792805|66121233|FG000|Overall Study|Adverse Event|12|||
23654127|NCT00792805|66121234|FG001|Overall Study|Adverse Event|10|||
23654128|NCT00792805|66121235|FG002|Overall Study|Adverse Event|10|||
23654129|NCT00792805|66121233|FG000|Overall Study|Subject withdrew consent|5|||
23654130|NCT00792805|66121234|FG001|Overall Study|Subject withdrew consent|6|||
23654131|NCT00792805|66121235|FG002|Overall Study|Subject withdrew consent|5|||
23654132|NCT00792805|66121233|FG000|Overall Study|Administrative problems|2|||
23654133|NCT00792805|66121234|FG001|Overall Study|Administrative problems|0|||
23654134|NCT00792805|66121235|FG002|Overall Study|Administrative problems|4|||
23654135|NCT00792805|66121233|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23654136|NCT00792805|66121234|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23360983|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23654137|NCT00792805|66121235|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23654138|NCT00792805|66121233|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23654139|NCT00792805|66121234|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23654140|NCT00792805|66121235|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23654141|NCT00792805|66121233|FG000|Overall Study|Lost to Follow-up|1|||
23654142|NCT00792805|66121234|FG001|Overall Study|Lost to Follow-up|1|||
23654143|NCT00792805|66121235|FG002|Overall Study|Lost to Follow-up|6|||
23654144|NCT00792805|66121233|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23654145|NCT00792805|66121234|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23654146|NCT00792805|66121235|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23654147|NCT00792805|66121233|FG000|Overall Study|Protocol deviation|0|||
23654148|NCT00792805|66121234|FG001|Overall Study|Protocol deviation|1|||
23654149|NCT00792805|66121235|FG002|Overall Study|Protocol deviation|1|||
23654150|NCT01133379|66121236|FG000|Overall Study|Withdrawal by Subject|0|||
23654151|NCT01133379|66121237|FG001|Overall Study|Withdrawal by Subject|1|||
23654152|NCT01133379|66121238|FG002|Overall Study|Withdrawal by Subject|1|||
23654153|NCT01133379|66121236|FG000|Overall Study|Lost to Follow-up|1|||
23654154|NCT01133379|66121237|FG001|Overall Study|Lost to Follow-up|1|||
23654155|NCT01133379|66121238|FG002|Overall Study|Lost to Follow-up|1|||
23654156|NCT00047320|66121239|FG000|Overall Study|Lack of Efficacy|8|||
23654157|NCT00047320|66121239|FG000|Overall Study|Lost to Follow-up|1|||
23654158|NCT00047320|66121239|FG000|Overall Study|Physician Decision|8|||
23654159|NCT00047320|66121239|FG000|Overall Study|Withdrawal by Subject|9|||
23360984|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23654160|NCT00047320|66121239|FG000|Overall Study|Ineligible|2|||
23480048|NCT00592774|65501882|FG001|Overall Study|Physician Decision|1|||
23654161|NCT04448756|66121240|FG000|Overall Study|Adverse Event|0|||
23654162|NCT04448756|66121241|FG001|Overall Study|Adverse Event|1|||
23654163|NCT04448756|66121242|FG002|Overall Study|Adverse Event|0|||
23654164|NCT04448756|66121240|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
23654165|NCT04448756|66121241|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
23654166|NCT04448756|66121242|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
23654167|NCT04448756|66121240|FG000|Overall Study|Withdrawal by Subject|0|||
23654168|NCT04448756|66121241|FG001|Overall Study|Withdrawal by Subject|3|||
23654169|NCT04448756|66121242|FG002|Overall Study|Withdrawal by Subject|1|||
23654170|NCT04448756|66121240|FG000|Overall Study|Death|2|||
23654171|NCT04448756|66121241|FG001|Overall Study|Death|1|||
23654172|NCT04448756|66121242|FG002|Overall Study|Death|0|||
23654173|NCT01101477|66121243|FG000|Overall Study|Protocol Violation|5|||
23654174|NCT01101477|66121244|FG001|Overall Study|Protocol Violation|3|||
23654175|NCT01101477|66121245|FG002|Overall Study|Protocol Violation|1|||
23654176|NCT01019980|66121264|FG000|Overall Study|Drug not available.|2|||
23654177|NCT01019980|66121265|FG001|Overall Study|Drug not available.|0|||
23654178|NCT01383161|66121266|FG000|Overall Study|Adverse Event|5|||
23654179|NCT01383161|66121267|FG001|Overall Study|Adverse Event|1|||
23654180|NCT01383161|66121266|FG000|Overall Study|Withdrawal by Subject|0|||
23654181|NCT01383161|66121267|FG001|Overall Study|Withdrawal by Subject|2|||
23654182|NCT01383161|66121266|FG000|Overall Study|Lack of Efficacy|0|||
23654183|NCT01383161|66121267|FG001|Overall Study|Lack of Efficacy|1|||
23654184|NCT00261846|66121269|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
23654185|NCT00261846|66121270|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
23654186|NCT00261846|66121271|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
23654187|NCT00261846|66121272|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654188|NCT00261846|66121273|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654189|NCT00261846|66121274|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654190|NCT00261846|66121275|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654191|NCT00261846|66121276|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654192|NCT00261846|66121277|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654193|NCT00261846|66121278|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654194|NCT00261846|66121279|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654195|NCT00261846|66121280|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23654196|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654197|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654198|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654199|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
23654200|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654201|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654202|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654203|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654204|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
23654205|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654206|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654207|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23654208|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654209|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654210|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654211|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
23654212|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
23654213|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
23654214|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
23654215|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
23654216|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654217|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
23654218|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654219|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23654220|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654221|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654222|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654223|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
23654224|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23654225|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654226|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23654227|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654228|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
23654229|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23654230|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23654231|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23654232|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
23654233|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
23801574|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
23801575|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
23654234|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
23654235|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
23801576|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
23360985|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360986|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23654236|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
23654237|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
23480049|NCT00592774|65501883|FG002|Overall Study|Physician Decision|1|||
23480050|NCT00592774|65501884|FG003|Overall Study|Physician Decision|0|||
23480051|NCT00592774|65501885|FG004|Overall Study|Physician Decision|1|||
23480052|NCT00592774|65501881|FG000|Overall Study|Other|0|||
23480053|NCT00592774|65501882|FG001|Overall Study|Other|1|||
23480054|NCT00592774|65501883|FG002|Overall Study|Other|1|||
23480055|NCT00592774|65501884|FG003|Overall Study|Other|0|||
23480056|NCT00592774|65501885|FG004|Overall Study|Other|2|||
23480057|NCT00731042|65501886|FG000|Second Intervention|Did not meet inclusion criteria|0|||
23480058|NCT00731042|65501887|FG001|Second Intervention|Did not meet inclusion criteria|2|||
23480059|NCT04575597|65501888|FG000|Overall Study|Death|0|||
23480060|NCT04575597|65501889|FG001|Overall Study|Death|0|||
23480061|NCT04575597|65501890|FG002|Overall Study|Death|0|||
23480062|NCT04575597|65501891|FG003|Overall Study|Death|1|||
23480063|NCT04575597|65501892|FG004|Overall Study|Death|3|||
23480064|NCT04575597|65501893|FG005|Overall Study|Death|14|||
23480065|NCT04575597|65501888|FG000|Overall Study|Lost to Follow-up|2|||
23480066|NCT04575597|65501889|FG001|Overall Study|Lost to Follow-up|1|||
23480067|NCT04575597|65501890|FG002|Overall Study|Lost to Follow-up|1|||
23480068|NCT04575597|65501891|FG003|Overall Study|Lost to Follow-up|2|||
23480069|NCT04575597|65501892|FG004|Overall Study|Lost to Follow-up|10|||
23480070|NCT04575597|65501893|FG005|Overall Study|Lost to Follow-up|8|||
23480071|NCT04575597|65501888|FG000|Overall Study|Withdrawal by Subject|2|||
23480072|NCT04575597|65501889|FG001|Overall Study|Withdrawal by Subject|2|||
23480073|NCT04575597|65501890|FG002|Overall Study|Withdrawal by Subject|4|||
23480074|NCT04575597|65501891|FG003|Overall Study|Withdrawal by Subject|2|||
23480075|NCT04575597|65501892|FG004|Overall Study|Withdrawal by Subject|25|||
23480076|NCT04575597|65501893|FG005|Overall Study|Withdrawal by Subject|28|||
23480077|NCT04575597|65501888|FG000|Overall Study|Not Recorded|0|||
23480078|NCT04575597|65501889|FG001|Overall Study|Not Recorded|0|||
23480079|NCT04575597|65501890|FG002|Overall Study|Not Recorded|0|||
23480080|NCT04575597|65501891|FG003|Overall Study|Not Recorded|0|||
23480081|NCT04575597|65501892|FG004|Overall Study|Not Recorded|0|||
23480082|NCT04575597|65501893|FG005|Overall Study|Not Recorded|2|||
23480083|NCT04575597|65501888|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480084|NCT04575597|65501889|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480085|NCT04575597|65501890|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480086|NCT04575597|65501891|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480087|NCT04575597|65501892|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
23480088|NCT04575597|65501893|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
23480089|NCT01715129|65501894|FG000|Overall Study|Adverse Event, fatal|1|||
23480090|NCT01715129|65501894|FG000|Overall Study|Lack of Efficacy|3|||
23480091|NCT01715129|65501894|FG000|Overall Study|Protocol Violation|1|||
23480092|NCT01715129|65501894|FG000|Overall Study|Consent Withdrawn|2|||
23480093|NCT01715129|65501894|FG000|Overall Study|Lost to Follow-up|1|||
23480094|NCT01715129|65501894|FG000|Overall Study|Other|1|||
23480095|NCT02742246|65501895|FG000|Overall Study|Never initiated treatment|5|||
23480096|NCT02742246|65501896|FG001|Overall Study|Never initiated treatment|3|||
23480097|NCT02742246|65501897|FG002|Overall Study|Never initiated treatment|1|||
23480098|NCT02742246|65501895|FG000|Overall Study|dropped out during treatment|7|||
23480099|NCT02742246|65501896|FG001|Overall Study|dropped out during treatment|13|||
23480100|NCT02742246|65501897|FG002|Overall Study|dropped out during treatment|10|||
23480101|NCT02742246|65501895|FG000|Overall Study|Death|1|||
23480102|NCT02742246|65501896|FG001|Overall Study|Death|0|||
23480103|NCT02742246|65501897|FG002|Overall Study|Death|0|||
23480104|NCT00927940|65501898|FG000|Overall Study|Death|1|||
23480105|NCT00527488|65501899|FG000|Overall Study|Withdrawn prior to dosing|0|||
23480106|NCT00527488|65501900|FG001|Overall Study|Withdrawn prior to dosing|1|||
23480107|NCT00527488|65501901|FG002|Overall Study|Withdrawn prior to dosing|1|||
23480108|NCT00527488|65501902|FG003|Overall Study|Withdrawn prior to dosing|0|||
23480109|NCT01146860|65501903|FG000|Overall Study|Withdrawal by Subject|0|||
23480110|NCT01146860|65501904|FG001|Overall Study|Withdrawal by Subject|1|||
23480111|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
23480112|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
23480113|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
23480114|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
23480115|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
23480116|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
23654238|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
23654239|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
23654240|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
23654241|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
23654242|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
23654243|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
23654244|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
23654245|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
23654246|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
23654247|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
23654248|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
23654249|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
23654250|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
23654251|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
23654252|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
23654253|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
23654254|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
23654255|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
23654256|NCT00261846|66121269|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
23654257|NCT00261846|66121270|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
23654258|NCT00261846|66121271|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
23654259|NCT00261846|66121272|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
23654260|NCT00261846|66121273|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
23654261|NCT00261846|66121274|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
23654262|NCT00261846|66121275|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
23654263|NCT00261846|66121276|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
23654264|NCT00261846|66121277|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
23654265|NCT00261846|66121278|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
23654266|NCT00261846|66121279|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
23654267|NCT00261846|66121280|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
23654268|NCT03181451|66121281|FG000|Overall Study|Adverse Event|0|||
23654269|NCT03181451|66121282|FG001|Overall Study|Adverse Event|1|||
23654270|NCT03181451|66121283|FG002|Overall Study|Adverse Event|0|||
23654271|NCT03181451|66121281|FG000|Overall Study|Withdrawal by Subject|0|||
23654272|NCT03181451|66121282|FG001|Overall Study|Withdrawal by Subject|1|||
23654273|NCT03181451|66121283|FG002|Overall Study|Withdrawal by Subject|0|||
23654274|NCT03310268|66121284|FG000|Overall Study|(Not specified)|1|||
23654275|NCT03310268|66121285|FG001|Overall Study|(Not specified)|5|||
23654276|NCT03310268|66121286|FG002|Overall Study|(Not specified)|0|||
23654277|NCT02225353|66121287|FG000|Overall Study|Lost to Follow-up|0|||
23654278|NCT02225353|66121288|FG001|Overall Study|Lost to Follow-up|1|||
23654279|NCT02225353|66121289|FG002|Overall Study|Lost to Follow-up|3|||
23654280|NCT02225353|66121287|FG000|Overall Study|Protocol Violation|4|||
23654281|NCT02225353|66121288|FG001|Overall Study|Protocol Violation|5|||
23654282|NCT02225353|66121289|FG002|Overall Study|Protocol Violation|12|||
23654283|NCT00388154|66121290|FG000|Overall Study|Withdrawal by Subject|1|||
23654284|NCT01119001|66121291|FG000|Overall Study|Withdrawal by Subject|2|||
23654285|NCT03873493|66121292|FG000|Overall Study|Withdrawal by Subject|1|||
23654286|NCT03873493|66121292|FG000|Overall Study|Death|9|||
23654287|NCT03873493|66121292|FG000|Overall Study|Lost to Follow-up|1|||
23654288|NCT03873493|66121292|FG000|Overall Study|Study Terminated by Sponsor|1|||
23654289|NCT03873493|66121292|FG000|Overall Study|Other|2|||
23654290|NCT01436071|66121293|FG000|Overall Study|Adverse Event|1|||
23654291|NCT01436071|66121294|FG001|Overall Study|Adverse Event|0|||
23654292|NCT01436071|66121293|FG000|Overall Study|Lack of Efficacy|16|||
23654293|NCT01436071|66121294|FG001|Overall Study|Lack of Efficacy|7|||
23654294|NCT01436071|66121293|FG000|Overall Study|Protocol Violation|0|||
23654295|NCT01436071|66121294|FG001|Overall Study|Protocol Violation|1|||
23654296|NCT01436071|66121293|FG000|Overall Study|Lost to Follow-up|3|||
23654297|NCT01436071|66121294|FG001|Overall Study|Lost to Follow-up|1|||
23654298|NCT01436071|66121293|FG000|Overall Study|Physician Decision|1|||
23654299|NCT01436071|66121294|FG001|Overall Study|Physician Decision|0|||
23654300|NCT01436071|66121293|FG000|Overall Study|Withdrawal by Subject|2|||
23654301|NCT01436071|66121294|FG001|Overall Study|Withdrawal by Subject|2|||
23654302|NCT01436071|66121293|FG000|Overall Study|Did Not Receive Trial Medication|3|||
23654303|NCT01436071|66121294|FG001|Overall Study|Did Not Receive Trial Medication|3|||
23654304|NCT00307125|66121295|FG000|Screening Phase|Adverse Event|1|||
23654305|NCT00307125|66121296|FG001|Screening Phase|Adverse Event|0|||
23654306|NCT00307125|66121297|FG002|Screening Phase|Adverse Event|0|||
23654307|NCT00307125|66121295|FG000|Screening Phase|Protocol Violation|27|||
23654308|NCT00307125|66121296|FG001|Screening Phase|Protocol Violation|0|||
23654309|NCT00307125|66121297|FG002|Screening Phase|Protocol Violation|0|||
23654310|NCT00307125|66121295|FG000|Screening Phase|Lost to Follow-up|87|||
23654311|NCT00307125|66121296|FG001|Screening Phase|Lost to Follow-up|0|||
23654312|NCT00307125|66121297|FG002|Screening Phase|Lost to Follow-up|0|||
23654313|NCT00307125|66121295|FG000|Screening Phase|Death|10|||
23654314|NCT00307125|66121296|FG001|Screening Phase|Death|0|||
23654315|NCT00307125|66121297|FG002|Screening Phase|Death|0|||
23654316|NCT00307125|66121295|FG000|Screening Phase|Withdrawal by Subject|77|||
23654317|NCT00307125|66121296|FG001|Screening Phase|Withdrawal by Subject|0|||
23654318|NCT00307125|66121297|FG002|Screening Phase|Withdrawal by Subject|0|||
23654319|NCT00307125|66121295|FG000|Screening Phase|Physician Decision|26|||
23654320|NCT00307125|66121296|FG001|Screening Phase|Physician Decision|0|||
23654321|NCT00307125|66121297|FG002|Screening Phase|Physician Decision|0|||
23654322|NCT00307125|66121295|FG000|Screening Phase|Sponsor Decision|4|||
23654323|NCT00307125|66121296|FG001|Screening Phase|Sponsor Decision|0|||
23654324|NCT00307125|66121297|FG002|Screening Phase|Sponsor Decision|0|||
23654325|NCT00307125|66121295|FG000|Screening Phase|Study Terminated|17|||
23654326|NCT00307125|66121296|FG001|Screening Phase|Study Terminated|0|||
23654327|NCT00307125|66121297|FG002|Screening Phase|Study Terminated|0|||
23654328|NCT00307125|66121295|FG000|Screening Phase|Graft Loss|3|||
23654329|NCT00307125|66121296|FG001|Screening Phase|Graft Loss|0|||
23654330|NCT00307125|66121297|FG002|Screening Phase|Graft Loss|0|||
23654331|NCT00307125|66121295|FG000|Screening Phase|Graft Failure|8|||
23654332|NCT00307125|66121296|FG001|Screening Phase|Graft Failure|0|||
23654333|NCT00307125|66121297|FG002|Screening Phase|Graft Failure|0|||
23654334|NCT00307125|66121295|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
23654335|NCT00307125|66121296|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
23654336|NCT00307125|66121297|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
23654337|NCT00307125|66121295|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
23654338|NCT00307125|66121296|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
23654339|NCT00307125|66121297|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
23654340|NCT00307125|66121295|FG000|Screening Phase|Moved or transferred facilities|34|||
23654341|NCT00307125|66121296|FG001|Screening Phase|Moved or transferred facilities|0|||
23654342|NCT00307125|66121297|FG002|Screening Phase|Moved or transferred facilities|0|||
23654343|NCT00307125|66121295|FG000|Screening Phase|Received Pancreas Transplant|8|||
23654344|NCT00307125|66121296|FG001|Screening Phase|Received Pancreas Transplant|0|||
23654345|NCT00307125|66121297|FG002|Screening Phase|Received Pancreas Transplant|0|||
23654346|NCT00307125|66121295|FG000|Screening Phase|Ineligible for pilot|4|||
23654347|NCT00307125|66121296|FG001|Screening Phase|Ineligible for pilot|0|||
23654348|NCT00307125|66121297|FG002|Screening Phase|Ineligible for pilot|0|||
23654349|NCT00307125|66121295|FG000|Screening Phase|Try to get pregnant|1|||
23654350|NCT00307125|66121296|FG001|Screening Phase|Try to get pregnant|0|||
23654351|NCT00307125|66121297|FG002|Screening Phase|Try to get pregnant|0|||
23654352|NCT00307125|66121295|FG000|Screening Phase|Developed acute leukemia|1|||
23654353|NCT00307125|66121296|FG001|Screening Phase|Developed acute leukemia|0|||
23654354|NCT00307125|66121297|FG002|Screening Phase|Developed acute leukemia|0|||
23654355|NCT00307125|66121295|FG000|Screening Phase|Metastatic colon cancer|1|||
23654356|NCT00307125|66121296|FG001|Screening Phase|Metastatic colon cancer|0|||
23654357|NCT00307125|66121297|FG002|Screening Phase|Metastatic colon cancer|0|||
23654358|NCT00307125|66121295|FG000|Screening Phase|Malignancy|1|||
23654359|NCT00307125|66121296|FG001|Screening Phase|Malignancy|0|||
23654360|NCT00307125|66121297|FG002|Screening Phase|Malignancy|0|||
23654361|NCT00307125|66121295|FG000|Screening Phase|PAK|1|||
23654362|NCT00307125|66121296|FG001|Screening Phase|PAK|0|||
23654363|NCT00307125|66121297|FG002|Screening Phase|PAK|0|||
23654364|NCT00307125|66121295|FG000|Screening Phase|Ineligible|1|||
23654365|NCT00307125|66121296|FG001|Screening Phase|Ineligible|0|||
23654366|NCT00307125|66121297|FG002|Screening Phase|Ineligible|0|||
23654367|NCT00307125|66121295|FG000|Screening Phase|Screen Error|1|||
23654368|NCT00307125|66121296|FG001|Screening Phase|Screen Error|0|||
23654369|NCT00307125|66121297|FG002|Screening Phase|Screen Error|0|||
23654370|NCT00307125|66121295|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
23654371|NCT00307125|66121296|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
23654372|NCT00307125|66121297|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
23654373|NCT00307125|66121295|FG000|Screening Phase|AMR and treated with rituximab|1|||
23654374|NCT00307125|66121296|FG001|Screening Phase|AMR and treated with rituximab|0|||
23654375|NCT00307125|66121297|FG002|Screening Phase|AMR and treated with rituximab|0|||
23654376|NCT00307125|66121295|FG000|Screening Phase|Coronary artery bypass|1|||
23654377|NCT00307125|66121296|FG001|Screening Phase|Coronary artery bypass|0|||
23654378|NCT00307125|66121297|FG002|Screening Phase|Coronary artery bypass|0|||
23801577|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
23801578|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
23654379|NCT00307125|66121295|FG000|Pilot Phase|Lost to Follow-up|0|||
23654380|NCT00307125|66121296|FG001|Pilot Phase|Lost to Follow-up|1|||
23654381|NCT00307125|66121297|FG002|Pilot Phase|Lost to Follow-up|0|||
23654382|NCT00307125|66121295|FG000|Pilot Phase|Withdrawal by Subject|0|||
23654383|NCT00307125|66121296|FG001|Pilot Phase|Withdrawal by Subject|1|||
23654384|NCT00307125|66121297|FG002|Pilot Phase|Withdrawal by Subject|1|||
23654385|NCT00719563|66121300|FG000|Overall Study|Adverse Event|16|||
23654386|NCT00719563|66121301|FG001|Overall Study|Adverse Event|13|||
23654387|NCT00719563|66121300|FG000|Overall Study|Medical condition changed|3|||
23654388|NCT00719563|66121301|FG001|Overall Study|Medical condition changed|5|||
23801579|NCT02510014|66654595|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
23801580|NCT02510014|66654596|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
23801581|NCT02510014|66654595|FG000|Treatment Period|Adverse Event|11|||
23801582|NCT02510014|66654596|FG001|Treatment Period|Adverse Event|4|||
23801583|NCT02510014|66654595|FG000|Treatment Period|Withdrawal symptoms|3|||
23801584|NCT02510014|66654596|FG001|Treatment Period|Withdrawal symptoms|0|||
23360987|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360988|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360989|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
23360990|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360991|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23599651|NCT01211184|65925668|FG002|Overall Study|Withdrawal by Subject|1|||
23599652|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
23801585|NCT02510014|66654595|FG000|Treatment Period|Lost to Follow-up|80|||
23801586|NCT02510014|66654596|FG001|Treatment Period|Lost to Follow-up|19|||
23801587|NCT02510014|66654595|FG000|Treatment Period|Physician Decision|5|||
23599653|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Adverse Event|2|||
23801588|NCT02510014|66654596|FG001|Treatment Period|Physician Decision|0|||
23801589|NCT02510014|66654595|FG000|Treatment Period|Withdrawal by Subject|67|||
23801590|NCT02510014|66654596|FG001|Treatment Period|Withdrawal by Subject|24|||
23599654|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
23801591|NCT02510014|66654595|FG000|Treatment Period|Withdrawn by the investigator|7|||
23801592|NCT02510014|66654596|FG001|Treatment Period|Withdrawn by the investigator|1|||
23801593|NCT02510014|66654595|FG000|Treatment Period|Protocol Violation|4|||
23801594|NCT02510014|66654596|FG001|Treatment Period|Protocol Violation|4|||
23801595|NCT02510014|66654595|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
23801596|NCT02510014|66654596|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
23801597|NCT00112294|66654600|FG000|Overall Study|Still on study|5|||
23801598|NCT00112294|66654601|FG001|Overall Study|Still on study|0|||
23801599|NCT02284347|66654602|FG000|Overall Study|Lost to Follow-up|2|||
23801600|NCT02284347|66654602|FG000|Overall Study|Withdrawn prior to treatment|1|||
23801601|NCT01396421|66654603|FG000|Overall Study|Lost to Follow-up|0|||
23801602|NCT01396421|66654604|FG001|Overall Study|Lost to Follow-up|0|||
23801603|NCT01396421|66654605|FG002|Overall Study|Lost to Follow-up|0|||
23801604|NCT01396421|66654606|FG003|Overall Study|Lost to Follow-up|1|||
23801605|NCT01396421|66654603|FG000|Overall Study|Adverse Event|17|||
23801606|NCT01396421|66654604|FG001|Overall Study|Adverse Event|15|||
23801607|NCT01396421|66654605|FG002|Overall Study|Adverse Event|12|||
23801608|NCT01396421|66654606|FG003|Overall Study|Adverse Event|32|||
23801609|NCT01396421|66654603|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23801610|NCT01396421|66654604|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
23801611|NCT01396421|66654605|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
23801612|NCT01396421|66654606|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
23801613|NCT01396421|66654603|FG000|Overall Study|Physician Decision|1|||
23801614|NCT01396421|66654604|FG001|Overall Study|Physician Decision|1|||
23801615|NCT01396421|66654605|FG002|Overall Study|Physician Decision|0|||
23801616|NCT01396421|66654606|FG003|Overall Study|Physician Decision|3|||
23801617|NCT01396421|66654603|FG000|Overall Study|Withdrawal by Subject|31|||
23801618|NCT01396421|66654604|FG001|Overall Study|Withdrawal by Subject|24|||
23801619|NCT01396421|66654605|FG002|Overall Study|Withdrawal by Subject|13|||
23801620|NCT01396421|66654606|FG003|Overall Study|Withdrawal by Subject|21|||
23801621|NCT01396421|66654603|FG000|Overall Study|Protocol Deviation|2|||
23801622|NCT01396421|66654604|FG001|Overall Study|Protocol Deviation|1|||
23801623|NCT01396421|66654605|FG002|Overall Study|Protocol Deviation|1|||
23801624|NCT01396421|66654606|FG003|Overall Study|Protocol Deviation|0|||
23801625|NCT01396421|66654603|FG000|Overall Study|Lack of Efficacy|7|||
23801626|NCT01396421|66654604|FG001|Overall Study|Lack of Efficacy|17|||
23801627|NCT01396421|66654605|FG002|Overall Study|Lack of Efficacy|7|||
23801628|NCT01396421|66654606|FG003|Overall Study|Lack of Efficacy|18|||
23801629|NCT00303667|66654607|FG000|Overall Study|Death|0|||
23801630|NCT00303667|66654608|FG001|Overall Study|Death|4|||
23801631|NCT01682148|66654613|FG000|Overall Study|Withdrawal by Subject|2|||
23801632|NCT01682148|66654614|FG001|Overall Study|Withdrawal by Subject|0|||
23801633|NCT01682148|66654613|FG000|Overall Study|Lost to Follow-up|1|||
23801634|NCT01682148|66654614|FG001|Overall Study|Lost to Follow-up|2|||
23801635|NCT01682148|66654613|FG000|Overall Study|Protocol Violation|1|||
23801636|NCT01682148|66654614|FG001|Overall Study|Protocol Violation|1|||
23801637|NCT01652729|66654616|FG000|Overall Study|Withdrawal by Subject|14|||
23801638|NCT01652729|66654617|FG001|Overall Study|Withdrawal by Subject|7|||
23801639|NCT01652729|66654618|FG002|Overall Study|Withdrawal by Subject|7|||
23801640|NCT01652729|66654616|FG000|Overall Study|Adverse Event|4|||
23801641|NCT01652729|66654617|FG001|Overall Study|Adverse Event|0|||
23360992|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360993|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360994|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360995|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360996|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360997|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
23360998|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360999|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23361000|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23361001|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23599655|NCT00419341|65925672|FG000|Efficacy Period|Withdrawal by Subject|6|||
23599656|NCT00419341|65925672|FG000|Efficacy Period|Protocol Violation|1|||
23599657|NCT00419341|65925672|FG000|Efficacy Period|Lost to Follow-up|1|||
23599658|NCT00419341|65925672|FG000|Efficacy Period|Non-compliance|1|||
23599659|NCT00419341|65925672|FG000|Efficacy Period|Termination of study site|1|||
23599660|NCT02755805|65925673|FG000|Overall Study|Lost to Follow-up|1|||
23801642|NCT01652729|66654618|FG002|Overall Study|Adverse Event|3|||
23801643|NCT01652729|66654616|FG000|Overall Study|Physician Decision|1|||
23801644|NCT01652729|66654617|FG001|Overall Study|Physician Decision|0|||
23801645|NCT01652729|66654618|FG002|Overall Study|Physician Decision|1|||
23801646|NCT01652729|66654616|FG000|Overall Study|Protocol Violation|1|||
23801647|NCT01652729|66654617|FG001|Overall Study|Protocol Violation|0|||
23801648|NCT01652729|66654618|FG002|Overall Study|Protocol Violation|0|||
23801649|NCT01652729|66654616|FG000|Overall Study|Lost to Follow-up|6|||
23801650|NCT01652729|66654617|FG001|Overall Study|Lost to Follow-up|6|||
23801651|NCT01652729|66654618|FG002|Overall Study|Lost to Follow-up|3|||
23801652|NCT01652729|66654616|FG000|Overall Study|Administrative|1|||
23480117|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
23480118|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
23480119|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
23480120|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
23480121|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
23480122|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
23480123|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
23599661|NCT02755805|65925674|FG001|Overall Study|Lost to Follow-up|2|||
23361002|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23599662|NCT02755805|65925673|FG000|Overall Study|Refused assessments|1|||
23599663|NCT02755805|65925674|FG001|Overall Study|Refused assessments|0|||
23654389|NCT00719563|66121300|FG000|Overall Study|Lack of Efficacy|3|||
23654390|NCT00719563|66121301|FG001|Overall Study|Lack of Efficacy|7|||
23654391|NCT00719563|66121300|FG000|Overall Study|Personal reasons|6|||
23654392|NCT00719563|66121301|FG001|Overall Study|Personal reasons|7|||
23654393|NCT00719563|66121300|FG000|Overall Study|Unknown reasons|4|||
23654394|NCT00719563|66121301|FG001|Overall Study|Unknown reasons|6|||
23654395|NCT00719563|66121300|FG000|Overall Study|Noncompliant|1|||
23654396|NCT00719563|66121301|FG001|Overall Study|Noncompliant|1|||
23654397|NCT00719563|66121300|FG000|Overall Study|Lost to Follow-up|5|||
23654398|NCT00719563|66121301|FG001|Overall Study|Lost to Follow-up|3|||
23654399|NCT02141984|66121302|FG000|Overall Study|Lack of Efficacy|2|||
23654400|NCT02120625|66121303|FG000|Overall Study|Physician Decision|2|||
23654401|NCT00523718|66121304|FG000|Overall Study|Withdrawal by Subject|1|||
23654402|NCT00523718|66121305|FG001|Overall Study|Withdrawal by Subject|0|||
23654403|NCT00523718|66121304|FG000|Overall Study|Protocol Violation|2|||
23654404|NCT00523718|66121305|FG001|Overall Study|Protocol Violation|0|||
23654405|NCT02742766|66121306|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654406|NCT02742766|66121307|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654407|NCT02742766|66121308|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654408|NCT02742766|66121309|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654409|NCT02742766|66121310|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654410|NCT02742766|66121311|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654411|NCT02742766|66121312|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654412|NCT02742766|66121313|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654413|NCT02742766|66121314|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654414|NCT02742766|66121315|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654415|NCT02742766|66121316|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654416|NCT02742766|66121317|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654417|NCT02742766|66121318|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654418|NCT02742766|66121319|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
23654419|NCT02742766|66121320|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654420|NCT02742766|66121321|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654421|NCT02742766|66121322|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654422|NCT02742766|66121323|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654423|NCT02742766|66121324|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23654424|NCT02742766|66121306|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654425|NCT02742766|66121307|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654426|NCT02742766|66121308|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654427|NCT02742766|66121309|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654428|NCT02742766|66121310|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654429|NCT02742766|66121311|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654430|NCT02742766|66121312|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654431|NCT02742766|66121313|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654432|NCT02742766|66121314|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654433|NCT02742766|66121315|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654434|NCT02742766|66121316|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654435|NCT02742766|66121317|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654436|NCT02742766|66121318|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
23654437|NCT02742766|66121319|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
23654438|NCT02742766|66121320|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654439|NCT02742766|66121321|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
23654440|NCT02742766|66121322|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654441|NCT02742766|66121323|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654442|NCT02742766|66121324|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
23654443|NCT01118325|66121325|FG000|Overall Study|Adverse Event|1|||
23654444|NCT01118325|66121326|FG001|Overall Study|Adverse Event|0|||
23654445|NCT01118325|66121327|FG002|Overall Study|Adverse Event|1|||
23654446|NCT00999713|66121328|FG000|Overall Study|Physician Decision|2|||
23654447|NCT00999713|66121329|FG001|Overall Study|Physician Decision|0|||
23654448|NCT01601847|66121333|FG000|Overall Study|Death|1|||
23654449|NCT01601847|66121334|FG001|Overall Study|Death|0|||
23654450|NCT01601847|66121333|FG000|Overall Study|Withdrawal by Subject|11|||
23654451|NCT01601847|66121334|FG001|Overall Study|Withdrawal by Subject|7|||
23654452|NCT01601847|66121333|FG000|Overall Study|Lost to Follow-up|1|||
23654453|NCT01601847|66121334|FG001|Overall Study|Lost to Follow-up|3|||
23654454|NCT02168842|66121337|FG000|Overall Study|Withdrawal by Subject|5|||
23654455|NCT02168842|66121338|FG001|Overall Study|Withdrawal by Subject|3|||
23654456|NCT02168842|66121337|FG000|Overall Study|Lost to Follow-up|0|||
23654457|NCT02168842|66121338|FG001|Overall Study|Lost to Follow-up|2|||
23654458|NCT02168842|66121337|FG000|Overall Study|Death|2|||
23654459|NCT02168842|66121338|FG001|Overall Study|Death|1|||
23654460|NCT02168842|66121337|FG000|Overall Study|Physician Decision|1|||
23654461|NCT02168842|66121338|FG001|Overall Study|Physician Decision|2|||
23654462|NCT04178967|66121339|FG000|Induction Period|Adverse Event|4|||
23654463|NCT04178967|66121340|FG001|Induction Period|Adverse Event|6|||
23654464|NCT04178967|66121341|FG002|Induction Period|Adverse Event|0|||
23654465|NCT04178967|66121342|FG003|Induction Period|Adverse Event|0|||
23654466|NCT04178967|66121343|FG004|Induction Period|Adverse Event|0|||
23654467|NCT04178967|66121344|FG005|Induction Period|Adverse Event|0|||
23654468|NCT04178967|66121345|FG006|Induction Period|Adverse Event|0|||
23654469|NCT04178967|66121346|FG007|Induction Period|Adverse Event|0|||
23654470|NCT04178967|66121347|FG008|Induction Period|Adverse Event|0|||
23654471|NCT04178967|66121348|FG009|Induction Period|Adverse Event|0|||
23654472|NCT04178967|66121349|FG010|Induction Period|Adverse Event|0|||
23654473|NCT04178967|66121339|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
23654474|NCT04178967|66121340|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
23654475|NCT04178967|66121341|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
23654476|NCT04178967|66121342|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
23654477|NCT04178967|66121343|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
23654478|NCT04178967|66121344|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
23654479|NCT04178967|66121345|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
23654480|NCT04178967|66121346|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
23654481|NCT04178967|66121347|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
23654482|NCT04178967|66121348|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
23654483|NCT04178967|66121349|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
23654484|NCT04178967|66121339|FG000|Induction Period|Lack of Efficacy|4|||
23654485|NCT04178967|66121340|FG001|Induction Period|Lack of Efficacy|1|||
23654486|NCT04178967|66121341|FG002|Induction Period|Lack of Efficacy|0|||
23654487|NCT04178967|66121342|FG003|Induction Period|Lack of Efficacy|0|||
23654488|NCT04178967|66121343|FG004|Induction Period|Lack of Efficacy|0|||
23654489|NCT04178967|66121344|FG005|Induction Period|Lack of Efficacy|0|||
23654490|NCT04178967|66121345|FG006|Induction Period|Lack of Efficacy|0|||
23654491|NCT04178967|66121346|FG007|Induction Period|Lack of Efficacy|0|||
23654492|NCT04178967|66121347|FG008|Induction Period|Lack of Efficacy|0|||
23654493|NCT04178967|66121348|FG009|Induction Period|Lack of Efficacy|0|||
23654494|NCT04178967|66121349|FG010|Induction Period|Lack of Efficacy|0|||
23654495|NCT04178967|66121339|FG000|Induction Period|Protocol Violation|0|||
23654496|NCT04178967|66121340|FG001|Induction Period|Protocol Violation|6|||
23654497|NCT04178967|66121341|FG002|Induction Period|Protocol Violation|0|||
23654498|NCT04178967|66121342|FG003|Induction Period|Protocol Violation|0|||
23654499|NCT04178967|66121343|FG004|Induction Period|Protocol Violation|0|||
23654500|NCT04178967|66121344|FG005|Induction Period|Protocol Violation|0|||
23654501|NCT04178967|66121345|FG006|Induction Period|Protocol Violation|0|||
23654502|NCT04178967|66121346|FG007|Induction Period|Protocol Violation|0|||
23654503|NCT04178967|66121347|FG008|Induction Period|Protocol Violation|0|||
23654504|NCT04178967|66121348|FG009|Induction Period|Protocol Violation|0|||
23654505|NCT04178967|66121349|FG010|Induction Period|Protocol Violation|0|||
23654506|NCT04178967|66121339|FG000|Induction Period|Withdrawal by Subject|6|||
23654507|NCT04178967|66121340|FG001|Induction Period|Withdrawal by Subject|4|||
23654508|NCT04178967|66121341|FG002|Induction Period|Withdrawal by Subject|0|||
23654509|NCT04178967|66121342|FG003|Induction Period|Withdrawal by Subject|0|||
23654510|NCT04178967|66121343|FG004|Induction Period|Withdrawal by Subject|0|||
23654511|NCT04178967|66121344|FG005|Induction Period|Withdrawal by Subject|0|||
23654512|NCT04178967|66121345|FG006|Induction Period|Withdrawal by Subject|0|||
23654513|NCT04178967|66121346|FG007|Induction Period|Withdrawal by Subject|0|||
23654514|NCT04178967|66121347|FG008|Induction Period|Withdrawal by Subject|0|||
23654515|NCT04178967|66121348|FG009|Induction Period|Withdrawal by Subject|0|||
23654516|NCT04178967|66121349|FG010|Induction Period|Withdrawal by Subject|0|||
23654517|NCT04178967|66121339|FG000|Induction Period|Lost to Follow-up|2|||
23654518|NCT04178967|66121340|FG001|Induction Period|Lost to Follow-up|0|||
23654519|NCT04178967|66121341|FG002|Induction Period|Lost to Follow-up|0|||
23654520|NCT04178967|66121342|FG003|Induction Period|Lost to Follow-up|0|||
23654521|NCT04178967|66121343|FG004|Induction Period|Lost to Follow-up|0|||
23654522|NCT04178967|66121344|FG005|Induction Period|Lost to Follow-up|0|||
23654523|NCT04178967|66121345|FG006|Induction Period|Lost to Follow-up|0|||
23654524|NCT04178967|66121346|FG007|Induction Period|Lost to Follow-up|0|||
23654525|NCT04178967|66121347|FG008|Induction Period|Lost to Follow-up|0|||
23654526|NCT04178967|66121348|FG009|Induction Period|Lost to Follow-up|0|||
23654527|NCT04178967|66121349|FG010|Induction Period|Lost to Follow-up|0|||
23654528|NCT04178967|66121339|FG000|Induction Period|Participant Missed Study Visits|0|||
23654529|NCT04178967|66121340|FG001|Induction Period|Participant Missed Study Visits|1|||
23480124|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
23654530|NCT04178967|66121341|FG002|Induction Period|Participant Missed Study Visits|0|||
23654531|NCT04178967|66121342|FG003|Induction Period|Participant Missed Study Visits|0|||
23654532|NCT04178967|66121343|FG004|Induction Period|Participant Missed Study Visits|0|||
23654533|NCT04178967|66121344|FG005|Induction Period|Participant Missed Study Visits|0|||
23654534|NCT04178967|66121345|FG006|Induction Period|Participant Missed Study Visits|0|||
23654535|NCT04178967|66121346|FG007|Induction Period|Participant Missed Study Visits|0|||
23654536|NCT04178967|66121347|FG008|Induction Period|Participant Missed Study Visits|0|||
23654537|NCT04178967|66121348|FG009|Induction Period|Participant Missed Study Visits|0|||
23654538|NCT04178967|66121349|FG010|Induction Period|Participant Missed Study Visits|0|||
23654539|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654540|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654541|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654542|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654543|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654544|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
23361003|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23361004|NCT02757352|65065930|FG000|Follow-Up Period|Adverse Event|0|||
23361005|NCT02757352|65065931|FG001|Follow-Up Period|Adverse Event|0|||
23361006|NCT02757352|65065932|FG002|Follow-Up Period|Adverse Event|0|||
23361007|NCT02757352|65065933|FG003|Follow-Up Period|Adverse Event|0|||
23361008|NCT02757352|65065934|FG004|Follow-Up Period|Adverse Event|0|||
23361009|NCT02757352|65065935|FG005|Follow-Up Period|Adverse Event|0|||
23361010|NCT02757352|65065936|FG006|Follow-Up Period|Adverse Event|1|||
23361011|NCT02757352|65065937|FG007|Follow-Up Period|Adverse Event|0|||
23361012|NCT02757352|65065938|FG008|Follow-Up Period|Adverse Event|2|||
23361013|NCT02757352|65065939|FG009|Follow-Up Period|Adverse Event|0|||
23361014|NCT02757352|65065930|FG000|Follow-Up Period|Lost to Follow-up|0|||
23361015|NCT02757352|65065931|FG001|Follow-Up Period|Lost to Follow-up|0|||
23361016|NCT02757352|65065932|FG002|Follow-Up Period|Lost to Follow-up|0|||
23361017|NCT02757352|65065933|FG003|Follow-Up Period|Lost to Follow-up|0|||
23654545|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
23654546|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
23654547|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654548|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
23654549|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
23801653|NCT01652729|66654617|FG001|Overall Study|Administrative|0|||
23801654|NCT01652729|66654618|FG002|Overall Study|Administrative|0|||
23801655|NCT01796964|66654619|FG000|Overall Study|Adverse Event|1|||
23801656|NCT01796964|66654620|FG001|Overall Study|Adverse Event|1|||
23801657|NCT01796964|66654619|FG000|Overall Study|Death|1|||
23599664|NCT02755805|65925673|FG000|Overall Study|Withdrawal by Subject|0|||
23599665|NCT02755805|65925674|FG001|Overall Study|Withdrawal by Subject|2|||
23599666|NCT02461628|65925675|FG000|Overall Study|Refused to complete survey|4|||
23599667|NCT02461628|65925676|FG001|Overall Study|Refused to complete survey|7|||
23599668|NCT00439270|65925677|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
23599669|NCT00439270|65925678|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
23599670|NCT00439270|65925679|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
23599671|NCT00439270|65925680|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
23599672|NCT00439270|65925681|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
23599673|NCT00439270|65925677|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599674|NCT00439270|65925678|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
23599675|NCT00439270|65925679|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599676|NCT00439270|65925680|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599677|NCT00439270|65925681|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599678|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
23599679|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
23599680|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
23599681|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
23599682|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
23599683|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599684|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599685|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599686|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
23599687|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599688|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599689|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599690|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23654550|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23801658|NCT01796964|66654620|FG001|Overall Study|Death|0|||
23801659|NCT01796964|66654619|FG000|Overall Study|Protocol Violation|0|||
23361018|NCT02757352|65065934|FG004|Follow-Up Period|Lost to Follow-up|0|||
23361019|NCT02757352|65065935|FG005|Follow-Up Period|Lost to Follow-up|0|||
23361020|NCT02757352|65065936|FG006|Follow-Up Period|Lost to Follow-up|0|||
23361021|NCT02757352|65065937|FG007|Follow-Up Period|Lost to Follow-up|0|||
23361022|NCT02757352|65065938|FG008|Follow-Up Period|Lost to Follow-up|1|||
23361023|NCT02757352|65065939|FG009|Follow-Up Period|Lost to Follow-up|0|||
23599691|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
23599692|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599693|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599694|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23801660|NCT01796964|66654620|FG001|Overall Study|Protocol Violation|1|||
23480125|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
23480126|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
23480127|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
23480128|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
23480129|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
23480130|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
23480131|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
23480132|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
23480133|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
23480134|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
23480135|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
23480136|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
23480137|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
23480138|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
23480139|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
23480140|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
23480141|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
23480142|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
23480143|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
23480144|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
23480145|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
23480146|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
23480147|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
23480148|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
23480149|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
23480150|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
23480151|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
23480152|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
23480153|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
23480154|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
23480155|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
23480156|NCT00797966|65501914|FG000|Phase A|Lost to Follow-up|0|||
23480157|NCT00797966|65501915|FG001|Phase A|Lost to Follow-up|0|||
23480158|NCT00797966|65501916|FG002|Phase A|Lost to Follow-up|0|||
23480159|NCT00797966|65501917|FG003|Phase A|Lost to Follow-up|0|||
23480160|NCT00797966|65501918|FG004|Phase A|Lost to Follow-up|33|||
23599695|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599696|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
23599697|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599698|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599699|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599700|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599701|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
23599702|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599703|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599704|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599705|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599706|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
23599707|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599708|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599709|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599710|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599711|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
23705552|NCT00960440|66297541|FG000|Overall Study|Protocol Violation|2|||
23361024|NCT02757352|65065930|FG000|Follow-Up Period|Lack of Efficacy|0|||
23361025|NCT02757352|65065931|FG001|Follow-Up Period|Lack of Efficacy|0|||
23361026|NCT02757352|65065932|FG002|Follow-Up Period|Lack of Efficacy|0|||
23361027|NCT02757352|65065933|FG003|Follow-Up Period|Lack of Efficacy|0|||
23361028|NCT02757352|65065934|FG004|Follow-Up Period|Lack of Efficacy|0|||
23361029|NCT02757352|65065935|FG005|Follow-Up Period|Lack of Efficacy|0|||
23361030|NCT02757352|65065936|FG006|Follow-Up Period|Lack of Efficacy|0|||
23361031|NCT02757352|65065937|FG007|Follow-Up Period|Lack of Efficacy|0|||
23361032|NCT02757352|65065938|FG008|Follow-Up Period|Lack of Efficacy|1|||
23361033|NCT02757352|65065939|FG009|Follow-Up Period|Lack of Efficacy|1|||
23361034|NCT02757352|65065930|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23361035|NCT02757352|65065931|FG001|Follow-Up Period|Withdrawal by Subject|0|||
23361036|NCT02757352|65065932|FG002|Follow-Up Period|Withdrawal by Subject|0|||
23361037|NCT02757352|65065933|FG003|Follow-Up Period|Withdrawal by Subject|0|||
23654551|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654552|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654553|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654554|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654555|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
23654556|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654557|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654558|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654559|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654560|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23654561|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654562|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654563|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654564|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23654565|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654566|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654567|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654568|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654569|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654570|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654571|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23654572|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654573|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654574|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654575|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654576|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654577|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654578|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
23654579|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654580|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654581|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654582|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
23654583|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654584|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654585|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654586|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654587|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
23654588|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
23654589|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654590|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
23654591|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654592|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654593|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23654594|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23654595|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23654596|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23654597|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23654598|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23654599|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23654600|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
23654601|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
23654602|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23654603|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23654604|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23654605|NCT04178967|66121339|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654606|NCT04178967|66121340|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654607|NCT04178967|66121341|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23599712|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599713|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599714|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599715|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599716|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
23599717|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23654608|NCT04178967|66121342|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23654609|NCT04178967|66121343|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654610|NCT04178967|66121344|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
23654611|NCT04178967|66121345|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23654612|NCT04178967|66121346|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
23654613|NCT04178967|66121347|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654614|NCT04178967|66121348|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654615|NCT04178967|66121349|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23654616|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654617|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654618|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654619|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654620|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654621|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654622|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654623|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654624|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
23654625|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
23654626|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23654627|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654628|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654629|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654630|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654631|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654632|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654633|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654634|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23654635|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
23654636|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
23654637|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
23654638|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654639|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654640|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654641|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654642|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654643|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654644|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654645|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654646|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654647|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
23654648|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23654649|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654650|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654651|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654652|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654653|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654654|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654655|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654656|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23654657|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
23654658|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
23654659|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23654660|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654661|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654662|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654663|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654664|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654665|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654666|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654667|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654668|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654669|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
23654670|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23654671|NCT04178967|66121339|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654672|NCT04178967|66121340|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654673|NCT04178967|66121341|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654674|NCT04178967|66121342|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654675|NCT04178967|66121343|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654676|NCT04178967|66121344|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654677|NCT04178967|66121345|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654678|NCT04178967|66121346|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654679|NCT04178967|66121347|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654680|NCT04178967|66121348|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
23654681|NCT04178967|66121349|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23654682|NCT03359590|66121350|FG000|First Intervention|Withdrawal by Subject|1|||
23654683|NCT03359590|66121351|FG001|First Intervention|Withdrawal by Subject|1|||
23654684|NCT03359590|66121350|FG000|First Intervention|Protocol Violation|0|||
23654685|NCT03359590|66121351|FG001|First Intervention|Protocol Violation|1|||
23654686|NCT00462865|66121352|FG000|Overall Study|Adverse Event|1|||
23654687|NCT04620811|66121353|FG000|Overall Study|Withdrawal by Subject|18|||
23654688|NCT04620811|66121354|FG001|Overall Study|Withdrawal by Subject|15|||
23654689|NCT04620811|66121353|FG000|Overall Study|Adverse Event|6|||
23654690|NCT04620811|66121354|FG001|Overall Study|Adverse Event|11|||
23654691|NCT04620811|66121353|FG000|Overall Study|Lost to Follow-up|4|||
23654692|NCT04620811|66121354|FG001|Overall Study|Lost to Follow-up|8|||
23654693|NCT04620811|66121353|FG000|Overall Study|Physician Decision|1|||
23654694|NCT04620811|66121354|FG001|Overall Study|Physician Decision|4|||
23654695|NCT04620811|66121353|FG000|Overall Study|Sponsor Decision|0|||
23654696|NCT04620811|66121354|FG001|Overall Study|Sponsor Decision|1|||
23654697|NCT04620811|66121353|FG000|Overall Study|Elevation of ALT or AST|1|||
23654698|NCT04620811|66121354|FG001|Overall Study|Elevation of ALT or AST|0|||
23654699|NCT04620811|66121353|FG000|Overall Study|Other|3|||
23654700|NCT04620811|66121354|FG001|Overall Study|Other|5|||
23654701|NCT03872453|66121355|FG000|Overall Study|Adverse Event|1|||
23654702|NCT03872453|66121356|FG001|Overall Study|Adverse Event|1|||
23654703|NCT03872453|66121357|FG002|Overall Study|Adverse Event|0|||
23654704|NCT03872453|66121358|FG003|Overall Study|Adverse Event|0|||
23654705|NCT03872453|66121355|FG000|Overall Study|Lost to Follow-up|8|||
23654706|NCT03872453|66121356|FG001|Overall Study|Lost to Follow-up|7|||
23654707|NCT03872453|66121357|FG002|Overall Study|Lost to Follow-up|4|||
23654708|NCT03872453|66121358|FG003|Overall Study|Lost to Follow-up|4|||
23654709|NCT03872453|66121355|FG000|Overall Study|Never Treated Migraine|19|||
23654710|NCT03872453|66121356|FG001|Overall Study|Never Treated Migraine|17|||
23654711|NCT03872453|66121357|FG002|Overall Study|Never Treated Migraine|13|||
23654712|NCT03872453|66121358|FG003|Overall Study|Never Treated Migraine|12|||
23654713|NCT03872453|66121355|FG000|Overall Study|Pregnancy|1|||
23654714|NCT03872453|66121356|FG001|Overall Study|Pregnancy|0|||
23801661|NCT01796964|66654619|FG000|Overall Study|Withdrawal by Subject|1|||
23801662|NCT01796964|66654620|FG001|Overall Study|Withdrawal by Subject|1|||
23801663|NCT00949988|66654625|FG000|Overall Study|Withdrawal by Subject|3|||
23801664|NCT00792623|66654626|FG000|Overall Study|Adverse Event|2|||
23801665|NCT00792623|66654626|FG000|Overall Study|Withdrawal by Subject|5|||
23801666|NCT02340221|66654627|FG000|Overall Study|Death|100|||
23801667|NCT02340221|66654628|FG001|Overall Study|Death|197|||
23801668|NCT02340221|66654627|FG000|Overall Study|Withdrawal by Participant|24|||
23801669|NCT02340221|66654628|FG001|Overall Study|Withdrawal by Participant|37|||
23801670|NCT02340221|66654627|FG000|Overall Study|Lost to Follow-up|4|||
23801671|NCT02340221|66654628|FG001|Overall Study|Lost to Follow-up|15|||
23801672|NCT02340221|66654627|FG000|Overall Study|Reason Not Specified|85|||
23801673|NCT02340221|66654628|FG001|Overall Study|Reason Not Specified|165|||
23801674|NCT02340221|66654627|FG000|Overall Study|Study Terminated by Sponsor|1|||
23801675|NCT02340221|66654628|FG001|Overall Study|Study Terminated by Sponsor|3|||
23801676|NCT00710749|66654629|FG000|First Intervention|Withdrawal by Subject|1|||
23801677|NCT00710749|66654630|FG001|First Intervention|Withdrawal by Subject|0|||
23801678|NCT02459418|66654633|FG000|Overall Study|Exclusion Criteria|4|||
23801679|NCT02459418|66654634|FG001|Overall Study|Exclusion Criteria|0|||
23801680|NCT02459418|66654633|FG000|Overall Study|Protocol Violation|0|||
23801681|NCT02459418|66654634|FG001|Overall Study|Protocol Violation|2|||
23801682|NCT02459418|66654633|FG000|Overall Study|Physician Decision|0|||
23654715|NCT03872453|66121357|FG002|Overall Study|Pregnancy|0|||
23654716|NCT03872453|66121358|FG003|Overall Study|Pregnancy|0|||
23654717|NCT03872453|66121355|FG000|Overall Study|Protocol Deviation|2|||
23654718|NCT03872453|66121356|FG001|Overall Study|Protocol Deviation|0|||
23654719|NCT03872453|66121357|FG002|Overall Study|Protocol Deviation|0|||
23801683|NCT02459418|66654634|FG001|Overall Study|Physician Decision|2|||
23801684|NCT02459418|66654633|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
23801685|NCT02459418|66654634|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
23801686|NCT02459418|66654633|FG000|Overall Study|Adverse Event|0|||
23801687|NCT02459418|66654634|FG001|Overall Study|Adverse Event|1|||
23801688|NCT02459418|66654633|FG000|Overall Study|Withdrawal by Subject|1|||
23654720|NCT03872453|66121358|FG003|Overall Study|Protocol Deviation|2|||
23654721|NCT03872453|66121355|FG000|Overall Study|Withdrawal by Subject|0|||
23654722|NCT03872453|66121356|FG001|Overall Study|Withdrawal by Subject|1|||
23654723|NCT03872453|66121357|FG002|Overall Study|Withdrawal by Subject|2|||
23654724|NCT03872453|66121358|FG003|Overall Study|Withdrawal by Subject|0|||
23654725|NCT03872453|66121355|FG000|Overall Study|Other Than Specified|1|||
23654726|NCT03872453|66121356|FG001|Overall Study|Other Than Specified|0|||
23654727|NCT03872453|66121357|FG002|Overall Study|Other Than Specified|0|||
23654728|NCT03872453|66121358|FG003|Overall Study|Other Than Specified|0|||
23654729|NCT01774084|66121359|FG000|Overall Study|Personal reasons|1|||
23654730|NCT01774084|66121360|FG001|Overall Study|Personal reasons|0|||
23654731|NCT02460497|66121361|FG000|Overall Study|Participant Requested Withdrawal|4|||
23654732|NCT02460497|66121361|FG000|Overall Study|Non-Compliance|1|||
23654733|NCT02460497|66121361|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
23654734|NCT02460497|66121361|FG000|Overall Study|Lost to Follow-up|2|||
23654735|NCT02460497|66121361|FG000|Overall Study|Investigator Decision|1|||
23654736|NCT01117857|66121362|FG000|Overall Study|Lost to Follow-up|4|||
23654737|NCT01117857|66121362|FG000|Overall Study|Withdrawal by Subject|4|||
23654738|NCT01117857|66121362|FG000|Overall Study|Physician Decision|1|||
23654739|NCT03085758|66121363|FG000|Overall Study|Death|26|||
23654740|NCT03085758|66121364|FG001|Overall Study|Death|24|||
23801689|NCT02459418|66654634|FG001|Overall Study|Withdrawal by Subject|1|||
23801690|NCT02459418|66654633|FG000|Overall Study|Elevated Creatine Kinase|1|||
23801691|NCT02459418|66654634|FG001|Overall Study|Elevated Creatine Kinase|0|||
23801692|NCT02459418|66654633|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
23801693|NCT02459418|66654634|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
23801694|NCT00613834|66654644|FG000|Overall Study|Withdrawal by Subject|0|||
23801695|NCT00613834|66654645|FG001|Overall Study|Withdrawal by Subject|3|||
23801696|NCT04223778|66654647|FG000|Overall Study|Ongoing|322|||
23801697|NCT04223778|66654648|FG001|Overall Study|Ongoing|326|||
23801698|NCT04223778|66654647|FG000|Overall Study|Death|0|||
23801699|NCT04223778|66654648|FG001|Overall Study|Death|1|||
23801700|NCT04223778|66654647|FG000|Overall Study|Lost to Follow-up|1|||
23801701|NCT04223778|66654648|FG001|Overall Study|Lost to Follow-up|5|||
23801702|NCT04223778|66654647|FG000|Overall Study|Physician Decision|3|||
23801703|NCT04223778|66654648|FG001|Overall Study|Physician Decision|1|||
23801704|NCT04223778|66654647|FG000|Overall Study|Withdrawal by Subject|10|||
23801705|NCT04223778|66654648|FG001|Overall Study|Withdrawal by Subject|1|||
23801706|NCT04223778|66654647|FG000|Overall Study|Lack of Efficacy|0|||
23801707|NCT04223778|66654648|FG001|Overall Study|Lack of Efficacy|2|||
23801708|NCT00852917|66654649|FG000|Overall Study|Adverse Event|13|||
23801709|NCT00852917|66654650|FG001|Overall Study|Adverse Event|20|||
23801710|NCT00852917|66654651|FG002|Overall Study|Adverse Event|35|||
23801711|NCT00852917|66654652|FG003|Overall Study|Adverse Event|17|||
23801712|NCT00852917|66654649|FG000|Overall Study|Lack of Efficacy|21|||
23801713|NCT00852917|66654650|FG001|Overall Study|Lack of Efficacy|11|||
23801714|NCT00852917|66654651|FG002|Overall Study|Lack of Efficacy|11|||
23801715|NCT00852917|66654652|FG003|Overall Study|Lack of Efficacy|47|||
23801716|NCT00852917|66654649|FG000|Overall Study|Withdrawal by Subject|4|||
23801717|NCT00852917|66654650|FG001|Overall Study|Withdrawal by Subject|8|||
23801718|NCT00852917|66654651|FG002|Overall Study|Withdrawal by Subject|10|||
23801719|NCT00852917|66654652|FG003|Overall Study|Withdrawal by Subject|9|||
23801720|NCT00852917|66654649|FG000|Overall Study|Physician Decision|6|||
23801721|NCT00852917|66654650|FG001|Overall Study|Physician Decision|7|||
23801722|NCT00852917|66654651|FG002|Overall Study|Physician Decision|2|||
23361038|NCT02757352|65065934|FG004|Follow-Up Period|Withdrawal by Subject|0|||
23361039|NCT02757352|65065935|FG005|Follow-Up Period|Withdrawal by Subject|0|||
23361040|NCT02757352|65065936|FG006|Follow-Up Period|Withdrawal by Subject|0|||
23361041|NCT02757352|65065937|FG007|Follow-Up Period|Withdrawal by Subject|1|||
23361042|NCT02757352|65065938|FG008|Follow-Up Period|Withdrawal by Subject|6|||
23480161|NCT00797966|65501919|FG005|Phase A|Lost to Follow-up|0|||
23480162|NCT00797966|65501914|FG000|Phase A|Adverse Event|0|||
23654741|NCT03085758|66121365|FG002|Overall Study|Death|53|||
23801723|NCT00852917|66654652|FG003|Overall Study|Physician Decision|19|||
23801724|NCT00852917|66654649|FG000|Overall Study|Death|0|||
23801725|NCT00852917|66654650|FG001|Overall Study|Death|0|||
23801726|NCT00852917|66654651|FG002|Overall Study|Death|0|||
23801727|NCT00852917|66654652|FG003|Overall Study|Death|1|||
23801728|NCT01807117|66654653|FG000|Overall Study|Physician Decision|2|||
23801729|NCT01807117|66654653|FG000|Overall Study|Disease diagnosis not a study disease|1|||
23801730|NCT01546922|66654654|FG000|First Period of 10 Weeks|Protocol Violation|3|||
23801731|NCT01546922|66654655|FG001|First Period of 10 Weeks|Protocol Violation|1|||
23480163|NCT00797966|65501915|FG001|Phase A|Adverse Event|0|||
23480164|NCT00797966|65501916|FG002|Phase A|Adverse Event|0|||
23654742|NCT03085758|66121363|FG000|Overall Study|Lost to Follow-up|1|||
23654743|NCT03085758|66121364|FG001|Overall Study|Lost to Follow-up|1|||
23654744|NCT03085758|66121365|FG002|Overall Study|Lost to Follow-up|1|||
23801732|NCT01546922|66654654|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
23801733|NCT01546922|66654655|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
23361043|NCT02757352|65065939|FG009|Follow-Up Period|Withdrawal by Subject|2|||
23654745|NCT03085758|66121363|FG000|Overall Study|Withdrawal by Subject|2|||
23801734|NCT01546922|66654654|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
23801735|NCT01546922|66654655|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
23801736|NCT01546922|66654654|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
23801737|NCT01546922|66654655|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
23801738|NCT01546922|66654654|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
23801739|NCT01546922|66654655|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
23801740|NCT00319046|66654661|FG000|Overall Study|withdrawal of subject's consent|7|||
23801741|NCT00319046|66654661|FG000|Overall Study|administrative reason|1|||
23801742|NCT02924376|66654665|FG000|Overall Study|Progressive Disease|4|||
23801743|NCT02924376|66654666|FG001|Overall Study|Progressive Disease|0|||
23801744|NCT02924376|66654667|FG002|Overall Study|Progressive Disease|1|||
23801745|NCT02924376|66654668|FG003|Overall Study|Progressive Disease|0|||
23801746|NCT02924376|66654665|FG000|Overall Study|Death|73|||
23801747|NCT02924376|66654666|FG001|Overall Study|Death|18|||
23801748|NCT02924376|66654667|FG002|Overall Study|Death|15|||
23801749|NCT02924376|66654668|FG003|Overall Study|Death|2|||
23801750|NCT02924376|66654665|FG000|Overall Study|Lost to Follow-up|3|||
23801751|NCT02924376|66654666|FG001|Overall Study|Lost to Follow-up|0|||
23801752|NCT02924376|66654667|FG002|Overall Study|Lost to Follow-up|0|||
23801753|NCT02924376|66654668|FG003|Overall Study|Lost to Follow-up|0|||
23801754|NCT02924376|66654665|FG000|Overall Study|Study Terminated by Sponsor|19|||
23801755|NCT02924376|66654666|FG001|Overall Study|Study Terminated by Sponsor|0|||
23801756|NCT02924376|66654667|FG002|Overall Study|Study Terminated by Sponsor|0|||
23801757|NCT02924376|66654668|FG003|Overall Study|Study Terminated by Sponsor|0|||
23801758|NCT02924376|66654665|FG000|Overall Study|Physician Decision|1|||
23801759|NCT02924376|66654666|FG001|Overall Study|Physician Decision|0|||
23801760|NCT02924376|66654667|FG002|Overall Study|Physician Decision|0|||
23801761|NCT02924376|66654668|FG003|Overall Study|Physician Decision|0|||
23801762|NCT02924376|66654665|FG000|Overall Study|Withdrawal by Subject|7|||
23801763|NCT02924376|66654666|FG001|Overall Study|Withdrawal by Subject|2|||
23801764|NCT02924376|66654667|FG002|Overall Study|Withdrawal by Subject|1|||
23801765|NCT02924376|66654668|FG003|Overall Study|Withdrawal by Subject|0|||
23801766|NCT02924376|66654665|FG000|Overall Study|Rolled Over to Another Study|1|||
23801767|NCT02924376|66654666|FG001|Overall Study|Rolled Over to Another Study|0|||
23801768|NCT02924376|66654667|FG002|Overall Study|Rolled Over to Another Study|0|||
23801769|NCT02924376|66654668|FG003|Overall Study|Rolled Over to Another Study|0|||
23801770|NCT03827018|66654669|FG000|Overall Study|Adverse Event|1|||
23801771|NCT03827018|66654670|FG001|Overall Study|Adverse Event|0|||
23801772|NCT03827018|66654669|FG000|Overall Study|Withdrawal by Subject|2|||
23801773|NCT03827018|66654670|FG001|Overall Study|Withdrawal by Subject|2|||
23801774|NCT03827018|66654669|FG000|Overall Study|Lack of Efficacy|0|||
23801775|NCT03827018|66654670|FG001|Overall Study|Lack of Efficacy|1|||
23801776|NCT00094094|66654672|FG000|Overall Study|Death|2|||
23801777|NCT00094094|66654672|FG000|Overall Study|Lack of Efficacy|23|||
23801778|NCT00094094|66654672|FG000|Overall Study|Adverse Event|7|||
23801779|NCT00537199|66654673|FG000|Overall Study|Study Terminated|1|||
23801780|NCT00706355|66654674|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
23801781|NCT00706355|66654675|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23801782|NCT00706355|66654676|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23801783|NCT00706355|66654677|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23801784|NCT00706355|66654674|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
23361044|NCT00110357|65065940|FG000|Overall Study|Deterioration without progression|2|||
23654746|NCT03085758|66121364|FG001|Overall Study|Withdrawal by Subject|2|||
23654747|NCT03085758|66121365|FG002|Overall Study|Withdrawal by Subject|1|||
23654748|NCT03085758|66121363|FG000|Overall Study|Refusal to recall it up to day 90|0|||
23654749|NCT03085758|66121364|FG001|Overall Study|Refusal to recall it up to day 90|0|||
23654750|NCT03085758|66121365|FG002|Overall Study|Refusal to recall it up to day 90|1|||
23654751|NCT03085758|66121363|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
23654752|NCT03085758|66121364|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
23654753|NCT03085758|66121365|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
23654754|NCT00972777|66121366|FG000|Overall Study|Adverse Event|3|||
23654755|NCT00972777|66121367|FG001|Overall Study|Adverse Event|2|||
23654756|NCT00972777|66121366|FG000|Overall Study|Lost to Follow-up|0|||
23801785|NCT00706355|66654675|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23801786|NCT00706355|66654676|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23801787|NCT00706355|66654677|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23801788|NCT00706355|66654674|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23801789|NCT00706355|66654675|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
23801790|NCT00706355|66654676|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23801791|NCT00706355|66654677|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23801792|NCT00706355|66654674|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23801793|NCT00706355|66654675|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
23801794|NCT00706355|66654676|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23801795|NCT00706355|66654677|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23801796|NCT00706355|66654674|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23801797|NCT00706355|66654675|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
23801798|NCT00706355|66654676|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23801799|NCT00706355|66654677|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23801800|NCT00706355|66654674|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23801801|NCT00706355|66654675|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23801802|NCT00706355|66654676|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
23801803|NCT00706355|66654677|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23801804|NCT00706355|66654674|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23801805|NCT00706355|66654675|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23801806|NCT00706355|66654676|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
23801807|NCT00706355|66654677|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23801808|NCT00706355|66654674|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23801809|NCT00706355|66654675|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23801810|NCT00706355|66654676|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23801811|NCT00706355|66654677|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
23801812|NCT00706355|66654674|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23801813|NCT00706355|66654675|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23801814|NCT00706355|66654676|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23801815|NCT00706355|66654677|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
23801816|NCT01640873|66654678|FG000|Overall Study|Protocol Violation|2|||
23801817|NCT01640873|66654679|FG001|Overall Study|Protocol Violation|1|||
23801818|NCT05016622|66654680|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
23801819|NCT05016622|66654680|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
23361045|NCT00110357|65065941|FG001|Overall Study|Deterioration without progression|0|||
23361046|NCT00110357|65065940|FG000|Overall Study|Disease progression/relapse|20|||
23361047|NCT00110357|65065941|FG001|Overall Study|Disease progression/relapse|15|||
23361048|NCT00110357|65065940|FG000|Overall Study|Study Closure|1|||
23361049|NCT00110357|65065941|FG001|Overall Study|Study Closure|0|||
23361050|NCT00110357|65065940|FG000|Overall Study|Study Drug Toxicity|1|||
23361051|NCT00110357|65065941|FG001|Overall Study|Study Drug Toxicity|3|||
23361052|NCT00110357|65065940|FG000|Overall Study|Withdrawal by Subject|3|||
23361053|NCT00110357|65065941|FG001|Overall Study|Withdrawal by Subject|1|||
23654757|NCT00972777|66121367|FG001|Overall Study|Lost to Follow-up|4|||
23654758|NCT00972777|66121366|FG000|Overall Study|Withdrawal by Subject|4|||
23654759|NCT00972777|66121367|FG001|Overall Study|Withdrawal by Subject|5|||
23654760|NCT00972777|66121366|FG000|Overall Study|Physician Decision|4|||
23654761|NCT00972777|66121367|FG001|Overall Study|Physician Decision|0|||
23654762|NCT00972777|66121366|FG000|Overall Study|Protocol Violation|0|||
23654763|NCT00972777|66121367|FG001|Overall Study|Protocol Violation|2|||
23654764|NCT00972777|66121366|FG000|Overall Study|Screening Failure|2|||
23654765|NCT00972777|66121367|FG001|Overall Study|Screening Failure|1|||
23654766|NCT00972777|66121366|FG000|Overall Study|Missed visit|1|||
23654767|NCT00972777|66121367|FG001|Overall Study|Missed visit|0|||
23654768|NCT03267940|66121368|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
23654769|NCT03267940|66121369|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
23654770|NCT03267940|66121370|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23654771|NCT03267940|66121371|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23654772|NCT03267940|66121372|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23654773|NCT03267940|66121373|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23654774|NCT03267940|66121368|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23654775|NCT03267940|66121369|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
23654776|NCT03267940|66121370|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23654777|NCT03267940|66121371|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23654778|NCT03267940|66121372|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23361054|NCT05259163|65065942|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
23361055|NCT05259163|65065943|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
23599718|NCT01268306|65925682|FG000|Overall Study|Lost to Follow-up|1|||
23599719|NCT01738438|65925685|FG000|Overall Study|Disease Progression|32|||
23599720|NCT01738438|65925685|FG000|Overall Study|Adverse Event|3|||
23599721|NCT03709706|65925686|FG000|Overall Study|Adverse Event|0|||
23599722|NCT03709706|65925687|FG001|Overall Study|Adverse Event|1|||
23599723|NCT03709706|65925686|FG000|Overall Study|Physician Decision|14|||
23599724|NCT03709706|65925687|FG001|Overall Study|Physician Decision|8|||
23801820|NCT01567826|66654684|FG000|Overall Study|Lost to Follow-up|3|||
23801821|NCT01567826|66654685|FG001|Overall Study|Lost to Follow-up|2|||
23801822|NCT02631876|66654687|FG000|Overall Study|Death|96|||
23801823|NCT02631876|66654688|FG001|Overall Study|Death|50|||
23801824|NCT02631876|66654687|FG000|Overall Study|Investigator's discretion|1|||
23801825|NCT02631876|66654688|FG001|Overall Study|Investigator's discretion|0|||
23801826|NCT02631876|66654687|FG000|Overall Study|Lost to Follow-up|2|||
23801827|NCT02631876|66654688|FG001|Overall Study|Lost to Follow-up|0|||
23801828|NCT02631876|66654687|FG000|Overall Study|Withdrawal by Subject|16|||
23801829|NCT02631876|66654688|FG001|Overall Study|Withdrawal by Subject|9|||
23801830|NCT02631876|66654687|FG000|Overall Study|Other than specified|4|||
23801831|NCT02631876|66654688|FG001|Overall Study|Other than specified|4|||
23801832|NCT00330460|66654692|FG000|Overall Study|Physician Decision|1|||
23801833|NCT00330460|66654693|FG001|Overall Study|Physician Decision|0|||
23801834|NCT00330460|66654692|FG000|Overall Study|Adverse Event|10|||
23801835|NCT00330460|66654693|FG001|Overall Study|Adverse Event|8|||
23801836|NCT00330460|66654692|FG000|Overall Study|Withdrawal by Subject|18|||
23801837|NCT00330460|66654693|FG001|Overall Study|Withdrawal by Subject|17|||
23801838|NCT00330460|66654692|FG000|Overall Study|Death|1|||
23801839|NCT00330460|66654693|FG001|Overall Study|Death|1|||
23801840|NCT00330460|66654692|FG000|Overall Study|Ineligibility determined|1|||
23801841|NCT00330460|66654693|FG001|Overall Study|Ineligibility determined|3|||
23801842|NCT00330460|66654692|FG000|Overall Study|Lost to Follow-up|8|||
23801843|NCT00330460|66654693|FG001|Overall Study|Lost to Follow-up|3|||
23801844|NCT00330460|66654692|FG000|Overall Study|Noncompliance|2|||
23801845|NCT00330460|66654693|FG001|Overall Study|Noncompliance|1|||
23801846|NCT00330460|66654692|FG000|Overall Study|Other|1|||
23801847|NCT00330460|66654693|FG001|Overall Study|Other|0|||
23801848|NCT01045707|66654694|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
23801849|NCT01045707|66654695|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
23801850|NCT01045707|66654694|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
23801851|NCT01045707|66654695|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
23801852|NCT01045707|66654694|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
23801853|NCT01045707|66654695|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
23801854|NCT01045707|66654694|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
23801855|NCT01045707|66654695|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
23801856|NCT01045707|66654694|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
23801857|NCT01045707|66654695|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
23801858|NCT01045707|66654694|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
23801859|NCT01045707|66654695|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
23801860|NCT01045707|66654694|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
23801861|NCT01045707|66654695|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
23801862|NCT01045707|66654694|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
23801863|NCT01045707|66654695|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
23801864|NCT01045707|66654694|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
23801865|NCT01045707|66654695|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
23801866|NCT03165955|66654701|FG000|Treatment|Withdrawal by Subject|3|||
23801867|NCT03165955|66654701|FG000|Treatment|Death|1|||
23801868|NCT03165955|66654701|FG000|Treatment|Adverse Event|1|||
23801869|NCT03165955|66654701|FG000|Treatment|Progressive disease|3|||
23801870|NCT01998243|66654704|FG000|Overall Study|Pregnancy|0|||
23801871|NCT01998243|66654705|FG001|Overall Study|Pregnancy|1|||
23801872|NCT01998243|66654704|FG000|Overall Study|Protocol Violation|5|||
23801873|NCT01998243|66654705|FG001|Overall Study|Protocol Violation|2|||
23801874|NCT01998243|66654704|FG000|Overall Study|Withdrawal by Subject|3|||
23801875|NCT01998243|66654705|FG001|Overall Study|Withdrawal by Subject|4|||
23801876|NCT01189500|66654707|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
23801877|NCT01189500|66654707|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
23801878|NCT02450526|66654708|FG000|DB Period (Cycle 1)|Adverse Event|0|||
23801879|NCT02450526|66654709|FG001|DB Period (Cycle 1)|Adverse Event|0|||
23801880|NCT02450526|66654710|FG002|DB Period (Cycle 1)|Adverse Event|2|||
23801881|NCT02450526|66654711|FG003|DB Period (Cycle 1)|Adverse Event|0|||
23801882|NCT02450526|66654712|FG004|DB Period (Cycle 1)|Adverse Event|0|||
23801883|NCT02450526|66654708|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
23801884|NCT02450526|66654709|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
23801885|NCT02450526|66654710|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
23801886|NCT02450526|66654711|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
23801887|NCT02450526|66654712|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
23801888|NCT02450526|66654708|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
23801889|NCT02450526|66654709|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
23801890|NCT02450526|66654710|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
23801891|NCT02450526|66654711|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
23801892|NCT02450526|66654712|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
23801893|NCT02450526|66654708|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
23801894|NCT02450526|66654709|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
23801895|NCT02450526|66654710|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
23801896|NCT02450526|66654711|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
23801897|NCT02450526|66654712|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
23801898|NCT02450526|66654708|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
23801899|NCT02450526|66654709|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
23801900|NCT02450526|66654710|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
23801901|NCT02450526|66654711|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
23801902|NCT02450526|66654712|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
23801903|NCT02450526|66654708|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23801904|NCT02450526|66654709|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23801905|NCT02450526|66654710|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23801906|NCT02450526|66654711|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23801907|NCT02450526|66654712|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
23599725|NCT03709706|65925686|FG000|Overall Study|Withdrawal by Subject|2|||
23599726|NCT03709706|65925687|FG001|Overall Study|Withdrawal by Subject|1|||
23599727|NCT03709706|65925686|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
23599728|NCT03709706|65925687|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
23599729|NCT00960141|65925688|FG000|Overall Study|Adverse Event|4|||
23599730|NCT00960141|65925689|FG001|Overall Study|Adverse Event|8|||
23599731|NCT00960141|65925690|FG002|Overall Study|Adverse Event|2|||
23599732|NCT00960141|65925688|FG000|Overall Study|Lack of Efficacy|3|||
23599733|NCT00960141|65925689|FG001|Overall Study|Lack of Efficacy|4|||
23599734|NCT00960141|65925690|FG002|Overall Study|Lack of Efficacy|2|||
23599735|NCT00960141|65925688|FG000|Overall Study|Lost to Follow-up|1|||
23599736|NCT00960141|65925689|FG001|Overall Study|Lost to Follow-up|0|||
23599737|NCT00960141|65925690|FG002|Overall Study|Lost to Follow-up|0|||
23599738|NCT00960141|65925688|FG000|Overall Study|Protocol Violation|1|||
23599739|NCT00960141|65925689|FG001|Overall Study|Protocol Violation|3|||
23599740|NCT00960141|65925690|FG002|Overall Study|Protocol Violation|2|||
23599741|NCT00960141|65925688|FG000|Overall Study|Withdrawal by Subject|1|||
23599742|NCT00960141|65925689|FG001|Overall Study|Withdrawal by Subject|2|||
23599743|NCT00960141|65925690|FG002|Overall Study|Withdrawal by Subject|1|||
23599744|NCT01700205|65925693|FG000|Overall Study|Withdrawal by Subject|13|||
23599745|NCT01700205|65925694|FG001|Overall Study|Withdrawal by Subject|13|||
23599746|NCT01700205|65925693|FG000|Overall Study|Protocol Violation|2|||
23599747|NCT01700205|65925694|FG001|Overall Study|Protocol Violation|2|||
23599748|NCT01075152|65925697|FG000|Overall Study|Withdrawal by Subject|1|||
23599749|NCT01075152|65925698|FG001|Overall Study|Withdrawal by Subject|0|||
23599750|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
23599751|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
23801908|NCT02450526|66654708|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23801909|NCT02450526|66654709|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23599752|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
23599753|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
23599754|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
23599755|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
23599756|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
23599757|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
23801910|NCT02450526|66654710|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23361056|NCT00807885|65065946|FG000|Overall Study|Lost to Follow-up|0|||
23654779|NCT03267940|66121373|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23654780|NCT03267940|66121368|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23654781|NCT03267940|66121369|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
23654782|NCT03267940|66121370|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23654783|NCT03267940|66121371|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23654784|NCT03267940|66121372|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23654785|NCT03267940|66121373|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23654786|NCT03267940|66121368|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
23654787|NCT03267940|66121369|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
23654788|NCT03267940|66121370|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23654789|NCT03267940|66121371|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23654790|NCT03267940|66121372|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23654791|NCT03267940|66121373|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23654792|NCT03267940|66121368|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23654793|NCT03267940|66121369|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23654794|NCT03267940|66121370|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23654795|NCT03267940|66121371|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
23654796|NCT03267940|66121372|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
23654797|NCT03267940|66121373|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23654798|NCT03267940|66121368|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23654799|NCT03267940|66121369|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23654800|NCT03267940|66121370|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
23654801|NCT03267940|66121371|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
23654802|NCT03267940|66121372|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
23654803|NCT03267940|66121373|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23654804|NCT03267940|66121368|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
23654805|NCT03267940|66121369|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
23654806|NCT03267940|66121370|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
23654807|NCT03267940|66121371|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23654808|NCT03267940|66121372|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23654809|NCT03267940|66121373|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23654810|NCT03267940|66121368|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
23654811|NCT03267940|66121369|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
23654812|NCT03267940|66121370|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
23654813|NCT03267940|66121371|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
23654814|NCT03267940|66121372|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
23654815|NCT03267940|66121373|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
23654816|NCT03267940|66121368|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23654817|NCT03267940|66121369|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23654818|NCT03267940|66121370|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
23801911|NCT02450526|66654711|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23801912|NCT02450526|66654712|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
23801913|NCT02450526|66654708|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
23801914|NCT02450526|66654709|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
23801915|NCT02450526|66654710|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
23801916|NCT02450526|66654711|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
23801917|NCT02450526|66654712|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
23801918|NCT01132664|66654713|FG000|Phase lb|Adverse Event|0|||
23801919|NCT01132664|66654714|FG001|Phase lb|Adverse Event|1|||
23801920|NCT01132664|66654715|FG002|Phase lb|Adverse Event|0|||
23801921|NCT01132664|66654716|FG003|Phase lb|Adverse Event|0|||
23801922|NCT01132664|66654717|FG004|Phase lb|Adverse Event|0|||
23801923|NCT01132664|66654713|FG000|Phase lb|Withdrawal by Subject|1|||
23801924|NCT01132664|66654714|FG001|Phase lb|Withdrawal by Subject|2|||
23801925|NCT01132664|66654715|FG002|Phase lb|Withdrawal by Subject|0|||
23801926|NCT01132664|66654716|FG003|Phase lb|Withdrawal by Subject|0|||
23801927|NCT01132664|66654717|FG004|Phase lb|Withdrawal by Subject|0|||
23801928|NCT01132664|66654713|FG000|Phase lb|Disease Progression|4|||
23801929|NCT01132664|66654714|FG001|Phase lb|Disease Progression|9|||
23801930|NCT01132664|66654715|FG002|Phase lb|Disease Progression|0|||
23801931|NCT01132664|66654716|FG003|Phase lb|Disease Progression|0|||
23801932|NCT01132664|66654717|FG004|Phase lb|Disease Progression|0|||
23801933|NCT01132664|66654713|FG000|Phase ll|Death|0|||
23801934|NCT01132664|66654714|FG001|Phase ll|Death|0|||
23801935|NCT01132664|66654715|FG002|Phase ll|Death|2|||
23801936|NCT01132664|66654716|FG003|Phase ll|Death|0|||
23480165|NCT00797966|65501917|FG003|Phase A|Adverse Event|0|||
23480166|NCT00797966|65501918|FG004|Phase A|Adverse Event|46|||
23480167|NCT00797966|65501919|FG005|Phase A|Adverse Event|0|||
23480168|NCT00797966|65501914|FG000|Phase A|Met withdrawal criteria|0|||
23801937|NCT01132664|66654717|FG004|Phase ll|Death|0|||
23801938|NCT01132664|66654713|FG000|Phase ll|Adverse Event|0|||
23801939|NCT01132664|66654714|FG001|Phase ll|Adverse Event|0|||
23801940|NCT01132664|66654715|FG002|Phase ll|Adverse Event|10|||
23801941|NCT01132664|66654716|FG003|Phase ll|Adverse Event|0|||
23801942|NCT01132664|66654717|FG004|Phase ll|Adverse Event|0|||
23801943|NCT01132664|66654713|FG000|Phase ll|Withdrawal by Subject|0|||
23801944|NCT01132664|66654714|FG001|Phase ll|Withdrawal by Subject|0|||
23801945|NCT01132664|66654715|FG002|Phase ll|Withdrawal by Subject|3|||
23801946|NCT01132664|66654716|FG003|Phase ll|Withdrawal by Subject|0|||
23801947|NCT01132664|66654717|FG004|Phase ll|Withdrawal by Subject|0|||
23801948|NCT01132664|66654713|FG000|Phase ll|Disease progression|0|||
23801949|NCT01132664|66654714|FG001|Phase ll|Disease progression|0|||
23801950|NCT01132664|66654715|FG002|Phase ll|Disease progression|35|||
23801951|NCT01132664|66654716|FG003|Phase ll|Disease progression|0|||
23801952|NCT01132664|66654717|FG004|Phase ll|Disease progression|0|||
23801953|NCT01132664|66654713|FG000|BM Cohort|Disease progression|0|||
23801954|NCT01132664|66654714|FG001|BM Cohort|Disease progression|0|||
23801955|NCT01132664|66654715|FG002|BM Cohort|Disease progression|0|||
23801956|NCT01132664|66654716|FG003|BM Cohort|Disease progression|3|||
23801957|NCT01132664|66654717|FG004|BM Cohort|Disease progression|4|||
23801958|NCT01132664|66654713|FG000|BM Cohort|Adverse Event|0|||
23801959|NCT01132664|66654714|FG001|BM Cohort|Adverse Event|0|||
23801960|NCT01132664|66654715|FG002|BM Cohort|Adverse Event|0|||
23801961|NCT01132664|66654716|FG003|BM Cohort|Adverse Event|0|||
23801962|NCT01132664|66654717|FG004|BM Cohort|Adverse Event|1|||
23801963|NCT01132664|66654713|FG000|BM Cohort|Withdrawal by Subject|0|||
23801964|NCT01132664|66654714|FG001|BM Cohort|Withdrawal by Subject|0|||
23801965|NCT01132664|66654715|FG002|BM Cohort|Withdrawal by Subject|0|||
23801966|NCT01132664|66654716|FG003|BM Cohort|Withdrawal by Subject|0|||
23801967|NCT01132664|66654717|FG004|BM Cohort|Withdrawal by Subject|1|||
23801968|NCT00977548|66654718|FG000|Overall Study|Ineligible|4|||
23801969|NCT00977548|66654718|FG000|Overall Study|Adverse Event|8|||
23801970|NCT00977548|66654718|FG000|Overall Study|Withdrawal by Subject|1|||
23480169|NCT00797966|65501915|FG001|Phase A|Met withdrawal criteria|0|||
23801971|NCT00483548|66654719|FG000|Overall Study|Randomized; not treated with study drug|1|||
23801972|NCT00483548|66654720|FG001|Overall Study|Randomized; not treated with study drug|3|||
23480170|NCT00797966|65501916|FG002|Phase A|Met withdrawal criteria|0|||
23801973|NCT00483548|66654719|FG000|Overall Study|Adverse Event|25|||
23801974|NCT00483548|66654720|FG001|Overall Study|Adverse Event|14|||
23801975|NCT00483548|66654719|FG000|Overall Study|Laboratory abnormality|1|||
23801976|NCT00483548|66654720|FG001|Overall Study|Laboratory abnormality|2|||
23801977|NCT00483548|66654719|FG000|Overall Study|Lack of Efficacy|4|||
23801978|NCT00483548|66654720|FG001|Overall Study|Lack of Efficacy|8|||
23801979|NCT00483548|66654719|FG000|Overall Study|Protocol Violation|11|||
23801980|NCT00483548|66654720|FG001|Overall Study|Protocol Violation|7|||
23801981|NCT00483548|66654719|FG000|Overall Study|Pregnancy|1|||
23801982|NCT00483548|66654720|FG001|Overall Study|Pregnancy|0|||
23801983|NCT00483548|66654719|FG000|Overall Study|Protocol required discontinuation|6|||
23801984|NCT00483548|66654720|FG001|Overall Study|Protocol required discontinuation|6|||
23801985|NCT00483548|66654719|FG000|Overall Study|Unable to comply with protocol schedule|1|||
23801986|NCT00483548|66654720|FG001|Overall Study|Unable to comply with protocol schedule|0|||
23801987|NCT00483548|66654719|FG000|Overall Study|Non-compliance with medication|2|||
23801988|NCT00483548|66654720|FG001|Overall Study|Non-compliance with medication|0|||
23801989|NCT00483548|66654719|FG000|Overall Study|Lost to Follow-up|3|||
23801990|NCT00483548|66654720|FG001|Overall Study|Lost to Follow-up|4|||
23801991|NCT00483548|66654719|FG000|Overall Study|Withdrawal by Subject|5|||
23801992|NCT00483548|66654720|FG001|Overall Study|Withdrawal by Subject|2|||
23801993|NCT00396331|66654724|FG000|Overall Study|Failed to mobilize - no transplant|8|||
23801994|NCT00396331|66654724|FG000|Overall Study|Did not go on to transplant|5|||
23801995|NCT00396331|66654724|FG000|Overall Study|Lost to Follow-up|3|||
23801996|NCT00396331|66654724|FG000|Overall Study|Death|16|||
23801997|NCT00987831|66654725|FG000|Overall Study|Never flared in 12 months|1|||
23801998|NCT00987831|66654726|FG001|Overall Study|Never flared in 12 months|0|||
23801999|NCT00987831|66654727|FG002|Overall Study|Never flared in 12 months|0|||
23802000|NCT00987831|66654725|FG000|Overall Study|Lost to Follow-up|0|||
23802001|NCT00987831|66654726|FG001|Overall Study|Lost to Follow-up|3|||
23802002|NCT00987831|66654727|FG002|Overall Study|Lost to Follow-up|0|||
23802003|NCT01813071|66654731|FG000|Overall Study|Protocol Violation|0|||
23802004|NCT01813071|66654732|FG001|Overall Study|Protocol Violation|0|||
23802005|NCT01813071|66654733|FG002|Overall Study|Protocol Violation|0|||
23802006|NCT01813071|66654734|FG003|Overall Study|Protocol Violation|0|||
23802007|NCT01813071|66654735|FG004|Overall Study|Protocol Violation|1|||
23802008|NCT01813071|66654736|FG005|Overall Study|Protocol Violation|4|||
23802009|NCT01813071|66654737|FG006|Overall Study|Protocol Violation|2|||
23802010|NCT01813071|66654738|FG007|Overall Study|Protocol Violation|4|||
23802011|NCT01813071|66654739|FG008|Overall Study|Protocol Violation|2|||
23802012|NCT01813071|66654731|FG000|Overall Study|Withdrawal by Subject|0|||
23802013|NCT01813071|66654732|FG001|Overall Study|Withdrawal by Subject|0|||
23802014|NCT01813071|66654733|FG002|Overall Study|Withdrawal by Subject|0|||
23802015|NCT01813071|66654734|FG003|Overall Study|Withdrawal by Subject|0|||
23802016|NCT01813071|66654735|FG004|Overall Study|Withdrawal by Subject|0|||
23802017|NCT01813071|66654736|FG005|Overall Study|Withdrawal by Subject|1|||
23802018|NCT01813071|66654737|FG006|Overall Study|Withdrawal by Subject|0|||
23802019|NCT01813071|66654738|FG007|Overall Study|Withdrawal by Subject|0|||
23802020|NCT01813071|66654739|FG008|Overall Study|Withdrawal by Subject|0|||
23802021|NCT01813071|66654731|FG000|Overall Study|Adverse Event|0|||
23802022|NCT01813071|66654732|FG001|Overall Study|Adverse Event|0|||
23802023|NCT01813071|66654733|FG002|Overall Study|Adverse Event|0|||
23802024|NCT01813071|66654734|FG003|Overall Study|Adverse Event|0|||
23802025|NCT01813071|66654735|FG004|Overall Study|Adverse Event|0|||
23802026|NCT01813071|66654736|FG005|Overall Study|Adverse Event|1|||
23802027|NCT01813071|66654737|FG006|Overall Study|Adverse Event|0|||
23802028|NCT01813071|66654738|FG007|Overall Study|Adverse Event|0|||
23802029|NCT01813071|66654739|FG008|Overall Study|Adverse Event|0|||
23361057|NCT00807885|65065947|FG001|Overall Study|Lost to Follow-up|0|||
23361058|NCT00807885|65065948|FG002|Overall Study|Lost to Follow-up|0|||
23361059|NCT00807885|65065949|FG003|Overall Study|Lost to Follow-up|0|||
23361060|NCT00807885|65065950|FG004|Overall Study|Lost to Follow-up|0|||
23361061|NCT00807885|65065951|FG005|Overall Study|Lost to Follow-up|1|||
23361062|NCT00807885|65065952|FG006|Overall Study|Lost to Follow-up|0|||
23361063|NCT00807885|65065953|FG007|Overall Study|Lost to Follow-up|0|||
23802030|NCT01813071|66654731|FG000|Overall Study|Physician Decision|0|||
23802031|NCT01813071|66654732|FG001|Overall Study|Physician Decision|0|||
23802032|NCT01813071|66654733|FG002|Overall Study|Physician Decision|0|||
23802033|NCT01813071|66654734|FG003|Overall Study|Physician Decision|0|||
23802034|NCT01813071|66654735|FG004|Overall Study|Physician Decision|0|||
23802035|NCT01813071|66654736|FG005|Overall Study|Physician Decision|0|||
23802036|NCT01813071|66654737|FG006|Overall Study|Physician Decision|1|||
23802037|NCT01813071|66654738|FG007|Overall Study|Physician Decision|0|||
23802038|NCT01813071|66654739|FG008|Overall Study|Physician Decision|0|||
23802039|NCT01813071|66654731|FG000|Overall Study|Met inc/exc criteria|0|||
23361064|NCT00807885|65065954|FG008|Overall Study|Lost to Follow-up|0|||
23361065|NCT03311841|65065957|FG000|14-day Wash-out|Adverse Event|0|||
23361066|NCT03311841|65065958|FG001|14-day Wash-out|Adverse Event|1|||
23361067|NCT03311841|65065959|FG002|14-day Wash-out|Adverse Event|0|||
23361068|NCT03311841|65065960|FG003|14-day Wash-out|Adverse Event|0|||
23599758|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
23654819|NCT03267940|66121371|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
23802040|NCT01813071|66654732|FG001|Overall Study|Met inc/exc criteria|0|||
23802041|NCT01813071|66654733|FG002|Overall Study|Met inc/exc criteria|0|||
23802042|NCT01813071|66654734|FG003|Overall Study|Met inc/exc criteria|0|||
23361069|NCT03311841|65065961|FG004|14-day Wash-out|Adverse Event|0|||
23802043|NCT01813071|66654735|FG004|Overall Study|Met inc/exc criteria|0|||
23654820|NCT03267940|66121372|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23802044|NCT01813071|66654736|FG005|Overall Study|Met inc/exc criteria|1|||
23802045|NCT01813071|66654737|FG006|Overall Study|Met inc/exc criteria|0|||
23802046|NCT01813071|66654738|FG007|Overall Study|Met inc/exc criteria|1|||
23802047|NCT01813071|66654739|FG008|Overall Study|Met inc/exc criteria|1|||
23802048|NCT01221090|66654740|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
23802049|NCT01221090|66654741|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
23802050|NCT01221090|66654742|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
23802051|NCT01221090|66654743|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
23802052|NCT01221090|66654740|FG000|Overall Study|Withdrawal by Subject|0|||
23802053|NCT01221090|66654741|FG001|Overall Study|Withdrawal by Subject|22|||
23802054|NCT01221090|66654742|FG002|Overall Study|Withdrawal by Subject|27|||
23802055|NCT01221090|66654743|FG003|Overall Study|Withdrawal by Subject|2|||
23802056|NCT00456495|66654744|FG000|Overall Study|Physician Decision|2|||
23802057|NCT01546649|66654749|FG000|Overall Study|Adverse Event|4|||
23802058|NCT01546649|66654750|FG001|Overall Study|Adverse Event|5|||
23802059|NCT01546649|66654749|FG000|Overall Study|Protocol Violation|1|||
23802060|NCT01546649|66654750|FG001|Overall Study|Protocol Violation|0|||
23802061|NCT01546649|66654749|FG000|Overall Study|Lack of Efficacy|1|||
23802062|NCT01546649|66654750|FG001|Overall Study|Lack of Efficacy|0|||
23802063|NCT01546649|66654749|FG000|Overall Study|Recurrence|1|||
23802064|NCT01546649|66654750|FG001|Overall Study|Recurrence|1|||
23802065|NCT01546649|66654749|FG000|Overall Study|Discovery of secondary cancer|0|||
23802066|NCT01546649|66654750|FG001|Overall Study|Discovery of secondary cancer|1|||
23802067|NCT01546649|66654749|FG000|Overall Study|Withdrawal by Subject|1|||
23802068|NCT01546649|66654750|FG001|Overall Study|Withdrawal by Subject|2|||
23802069|NCT00733369|66654751|FG000|Overall Study|Lost to Follow-up|2|||
23802070|NCT00733369|66654752|FG001|Overall Study|Lost to Follow-up|1|||
23802071|NCT00733369|66654751|FG000|Overall Study|Adverse Event|4|||
23802072|NCT00733369|66654752|FG001|Overall Study|Adverse Event|4|||
23802073|NCT00733369|66654751|FG000|Overall Study|Protocol Violation|4|||
23802074|NCT00733369|66654752|FG001|Overall Study|Protocol Violation|4|||
23802075|NCT02429934|66654754|FG000|Overall Study|Withdrawal by Subject|0|||
23802076|NCT02429934|66654755|FG001|Overall Study|Withdrawal by Subject|2|||
23802077|NCT02429934|66654754|FG000|Overall Study|Adverse Event|2|||
23802078|NCT02429934|66654755|FG001|Overall Study|Adverse Event|0|||
23802079|NCT02429934|66654754|FG000|Overall Study|Lost to Follow-up|1|||
23802080|NCT02429934|66654755|FG001|Overall Study|Lost to Follow-up|1|||
23802081|NCT02429934|66654754|FG000|Overall Study|Physician Decision|1|||
23802082|NCT02429934|66654755|FG001|Overall Study|Physician Decision|0|||
23802083|NCT02021318|66654758|FG000|Overall Study|Adverse Event|2|||
23802084|NCT02021318|66654759|FG001|Overall Study|Adverse Event|1|||
23802085|NCT02021318|66654758|FG000|Overall Study|Death|33|||
23802086|NCT02021318|66654759|FG001|Overall Study|Death|34|||
23802087|NCT02021318|66654758|FG000|Overall Study|Lost to Follow-up|3|||
23802088|NCT02021318|66654759|FG001|Overall Study|Lost to Follow-up|3|||
23802089|NCT02021318|66654758|FG000|Overall Study|Progressive Disease|0|||
23802090|NCT02021318|66654759|FG001|Overall Study|Progressive Disease|1|||
23802091|NCT02021318|66654758|FG000|Overall Study|Withdrawal by Subject|30|||
23802092|NCT02021318|66654759|FG001|Overall Study|Withdrawal by Subject|18|||
23802093|NCT02021318|66654758|FG000|Overall Study|Physician Decision|3|||
23802094|NCT02021318|66654759|FG001|Overall Study|Physician Decision|3|||
23802095|NCT02021318|66654758|FG000|Overall Study|Miscellaneous|2|||
23802096|NCT02021318|66654759|FG001|Overall Study|Miscellaneous|3|||
23802097|NCT01684878|66654761|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
23802098|NCT01684878|66654762|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
23802099|NCT01684878|66654763|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
23802100|NCT01684878|66654764|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
23802101|NCT01684878|66654761|FG000|Part 1: Safety Run in Phase|Death|15|||
23802102|NCT01684878|66654762|FG001|Part 1: Safety Run in Phase|Death|20|||
23802103|NCT01684878|66654763|FG002|Part 1: Safety Run in Phase|Death|0|||
23802104|NCT01684878|66654764|FG003|Part 1: Safety Run in Phase|Death|0|||
23802105|NCT01684878|66654761|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23802106|NCT01684878|66654762|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
23802107|NCT01684878|66654763|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23802108|NCT01684878|66654764|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23802109|NCT01684878|66654761|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
23802110|NCT01684878|66654762|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
23802111|NCT01684878|66654763|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
23802112|NCT01684878|66654764|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
23802113|NCT01684878|66654761|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
23802114|NCT01684878|66654762|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
23802115|NCT01684878|66654763|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
23802116|NCT01684878|66654764|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
23802117|NCT01684878|66654761|FG000|Part 2: Randomized Phase|Death|0|||
23802118|NCT01684878|66654762|FG001|Part 2: Randomized Phase|Death|0|||
23802119|NCT01684878|66654763|FG002|Part 2: Randomized Phase|Death|62|||
23802120|NCT01684878|66654764|FG003|Part 2: Randomized Phase|Death|68|||
23802121|NCT01684878|66654761|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
23802122|NCT01684878|66654762|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
23802123|NCT01684878|66654763|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
23361070|NCT03311841|65065957|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
23802124|NCT01684878|66654764|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
23802125|NCT01684878|66654761|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
23802126|NCT01684878|66654762|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
23802127|NCT01684878|66654763|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
23802128|NCT01684878|66654764|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
23802129|NCT00206102|66654774|FG000|Overall Study|Adverse Event|119|||
23802130|NCT00206102|66654775|FG001|Overall Study|Adverse Event|82|||
23802131|NCT00206102|66654774|FG000|Overall Study|Protocol Violation|0|||
23802132|NCT00206102|66654775|FG001|Overall Study|Protocol Violation|2|||
23802133|NCT00206102|66654774|FG000|Overall Study|Lack of therapeutic response|16|||
23802134|NCT00206102|66654775|FG001|Overall Study|Lack of therapeutic response|11|||
23802135|NCT00206102|66654774|FG000|Overall Study|Lost to Follow-up|95|||
23802136|NCT00206102|66654775|FG001|Overall Study|Lost to Follow-up|66|||
23802137|NCT00206102|66654774|FG000|Overall Study|Withdrawal by Subject|118|||
23802138|NCT00206102|66654775|FG001|Overall Study|Withdrawal by Subject|101|||
23802139|NCT00206102|66654774|FG000|Overall Study|Study-specific discontinuation criteria|18|||
23802140|NCT00206102|66654775|FG001|Overall Study|Study-specific discontinuation criteria|17|||
23802141|NCT00206102|66654774|FG000|Overall Study|None of those categories|42|||
23802142|NCT00206102|66654775|FG001|Overall Study|None of those categories|36|||
23802143|NCT02985879|66654776|FG000|Overall Study|Adverse Event|7|||
23802144|NCT02985879|66654777|FG001|Overall Study|Adverse Event|9|||
23802145|NCT02985879|66654778|FG002|Overall Study|Adverse Event|7|||
23802146|NCT02985879|66654776|FG000|Overall Study|Withdrew consent|6|||
23802147|NCT02985879|66654777|FG001|Overall Study|Withdrew consent|8|||
23802148|NCT02985879|66654778|FG002|Overall Study|Withdrew consent|10|||
23802149|NCT02985879|66654776|FG000|Overall Study|Lost to Follow-up|1|||
23802150|NCT02985879|66654777|FG001|Overall Study|Lost to Follow-up|0|||
23802151|NCT02985879|66654778|FG002|Overall Study|Lost to Follow-up|2|||
23802152|NCT02985879|66654776|FG000|Overall Study|Other, not specified|62|||
23802153|NCT02985879|66654777|FG001|Overall Study|Other, not specified|58|||
23802154|NCT02985879|66654778|FG002|Overall Study|Other, not specified|58|||
23802155|NCT03087786|66654787|FG000|Overall Study|Withdrawal by Subject|2|||
23802156|NCT03087786|66654788|FG001|Overall Study|Withdrawal by Subject|0|||
23802157|NCT00885677|66654789|FG000|Overall Study|Death|40|||
23802158|NCT00885677|66654790|FG001|Overall Study|Death|34|||
23802159|NCT00885677|66654789|FG000|Overall Study|Lost to Follow-up|15|||
23802160|NCT00885677|66654790|FG001|Overall Study|Lost to Follow-up|13|||
23802161|NCT00885677|66654789|FG000|Overall Study|Protocol Violation|54|||
23802162|NCT00885677|66654790|FG001|Overall Study|Protocol Violation|54|||
23802163|NCT00885677|66654789|FG000|Overall Study|premature study closure|41|||
23802164|NCT00885677|66654790|FG001|Overall Study|premature study closure|44|||
23802165|NCT00885677|66654789|FG000|Overall Study|device/lead revision or replacement|7|||
23802166|NCT00885677|66654790|FG001|Overall Study|device/lead revision or replacement|6|||
23802167|NCT00885677|66654789|FG000|Overall Study|Heart transplantation|1|||
23802168|NCT00885677|66654790|FG001|Overall Study|Heart transplantation|0|||
23802169|NCT00885677|66654789|FG000|Overall Study|Inclusion/exclusion not met|25|||
23802170|NCT00885677|66654790|FG001|Overall Study|Inclusion/exclusion not met|27|||
23802171|NCT02744755|66654791|FG000|Study Period 1|Protocol Violation|2|||
23802172|NCT02744755|66654792|FG001|Study Period 1|Protocol Violation|1|||
23802173|NCT02744755|66654791|FG000|Study Period 1|not defined|0|||
23802174|NCT02744755|66654792|FG001|Study Period 1|not defined|1|||
23802175|NCT02744755|66654791|FG000|Study Period 1|Pregnancy|1|||
23802176|NCT02744755|66654792|FG001|Study Period 1|Pregnancy|0|||
23802177|NCT02744755|66654791|FG000|Study Period 1|Adverse Event|1|||
23802178|NCT02744755|66654792|FG001|Study Period 1|Adverse Event|1|||
23802179|NCT02744755|66654791|FG000|Study Period 1|Lost to Follow-up|1|||
23802180|NCT02744755|66654792|FG001|Study Period 1|Lost to Follow-up|1|||
23802181|NCT02744755|66654791|FG000|Study Period 1|Lack of Efficacy|1|||
23802182|NCT02744755|66654792|FG001|Study Period 1|Lack of Efficacy|0|||
23802183|NCT02744755|66654791|FG000|Study Period 1|Withdrawal by Subject|8|||
23802184|NCT02744755|66654792|FG001|Study Period 1|Withdrawal by Subject|4|||
23802185|NCT02744755|66654791|FG000|Study Period 2|Adverse Event|5|||
23802186|NCT02744755|66654792|FG001|Study Period 2|Adverse Event|0|||
23802187|NCT02744755|66654791|FG000|Study Period 2|Protocol Violation|1|||
23802188|NCT02744755|66654792|FG001|Study Period 2|Protocol Violation|0|||
23802189|NCT02744755|66654791|FG000|Study Period 2|not defined|3|||
23802190|NCT02744755|66654792|FG001|Study Period 2|not defined|2|||
23802191|NCT02744755|66654791|FG000|Study Period 2|Lost to Follow-up|0|||
23802192|NCT02744755|66654792|FG001|Study Period 2|Lost to Follow-up|2|||
23802193|NCT02744755|66654791|FG000|Study Period 2|Withdrawal by Subject|2|||
23802194|NCT02744755|66654792|FG001|Study Period 2|Withdrawal by Subject|2|||
23802195|NCT02744755|66654791|FG000|Study Period 2|Lack of Efficacy|3|||
23802196|NCT02744755|66654792|FG001|Study Period 2|Lack of Efficacy|2|||
23802197|NCT01010750|66654795|FG000|Second Intervention|Adverse Event|0|||
23802198|NCT01010750|66654796|FG001|Second Intervention|Adverse Event|1|||
23802199|NCT01010750|66654797|FG002|Second Intervention|Adverse Event|0|||
23802200|NCT01010750|66654798|FG003|Second Intervention|Adverse Event|0|||
23802201|NCT01010750|66654799|FG004|Second Intervention|Adverse Event|0|||
23802202|NCT01010750|66654800|FG005|Second Intervention|Adverse Event|0|||
23802203|NCT01010126|66654804|FG000|Overall Study|Withdrawal by Subject|1|||
23802204|NCT01010126|66654805|FG001|Overall Study|Withdrawal by Subject|0|||
23802205|NCT01010126|66654806|FG002|Overall Study|Withdrawal by Subject|1|||
23802206|NCT01010126|66654807|FG003|Overall Study|Withdrawal by Subject|0|||
23802207|NCT01010126|66654808|FG004|Overall Study|Withdrawal by Subject|3|||
23802208|NCT01010126|66654809|FG005|Overall Study|Withdrawal by Subject|0|||
23802209|NCT00466726|66654810|FG000|Overall Study|Not evaluable for response|14|||
23802210|NCT02674386|66654813|FG000|Overall Study|Lost to Follow-up|0|||
23802211|NCT02674386|66654814|FG001|Overall Study|Lost to Follow-up|1|||
23802212|NCT02674386|66654815|FG002|Overall Study|Lost to Follow-up|1|||
23802213|NCT02674386|66654813|FG000|Overall Study|Withdrawal by Subject|0|||
23802214|NCT02674386|66654814|FG001|Overall Study|Withdrawal by Subject|4|||
23802215|NCT02674386|66654815|FG002|Overall Study|Withdrawal by Subject|0|||
23802216|NCT02674386|66654813|FG000|Overall Study|Other|0|||
23802217|NCT02674386|66654814|FG001|Overall Study|Other|1|||
23802218|NCT02674386|66654815|FG002|Overall Study|Other|0|||
23802219|NCT02674386|66654813|FG000|Overall Study|Enrolled but not evaluated|0|||
23802220|NCT02674386|66654814|FG001|Overall Study|Enrolled but not evaluated|4|||
23802221|NCT02674386|66654815|FG002|Overall Study|Enrolled but not evaluated|0|||
23802222|NCT01302847|66654816|FG000|Overall Study|Ongoing|0|||
23802223|NCT01302847|66654817|FG001|Overall Study|Ongoing|0|||
23802224|NCT01302847|66654818|FG002|Overall Study|Ongoing|0|||
23802225|NCT01302847|66654819|FG003|Overall Study|Ongoing|0|||
23802226|NCT01302847|66654820|FG004|Overall Study|Ongoing|0|||
23802227|NCT01302847|66654821|FG005|Overall Study|Ongoing|27|||
23802228|NCT01302847|66654822|FG006|Overall Study|Ongoing|22|||
23802229|NCT01302847|66654823|FG007|Overall Study|Ongoing|17|||
23802230|NCT01302847|66654816|FG000|Overall Study|Death|0|||
23802231|NCT01302847|66654817|FG001|Overall Study|Death|1|||
23802232|NCT01302847|66654818|FG002|Overall Study|Death|0|||
23802233|NCT01302847|66654819|FG003|Overall Study|Death|0|||
23802234|NCT01302847|66654820|FG004|Overall Study|Death|0|||
23802235|NCT01302847|66654821|FG005|Overall Study|Death|1|||
23802236|NCT01302847|66654822|FG006|Overall Study|Death|1|||
23802237|NCT01302847|66654823|FG007|Overall Study|Death|0|||
23802238|NCT01302847|66654816|FG000|Overall Study|Pregnancy|2|||
23802239|NCT01302847|66654817|FG001|Overall Study|Pregnancy|0|||
23802240|NCT01302847|66654818|FG002|Overall Study|Pregnancy|0|||
23802241|NCT01302847|66654819|FG003|Overall Study|Pregnancy|0|||
23802242|NCT01302847|66654820|FG004|Overall Study|Pregnancy|0|||
23802243|NCT01302847|66654821|FG005|Overall Study|Pregnancy|0|||
23802244|NCT01302847|66654822|FG006|Overall Study|Pregnancy|0|||
23802245|NCT01302847|66654823|FG007|Overall Study|Pregnancy|0|||
23802246|NCT01302847|66654816|FG000|Overall Study|Virologic failure|0|||
23802247|NCT01302847|66654817|FG001|Overall Study|Virologic failure|2|||
23802248|NCT01302847|66654818|FG002|Overall Study|Virologic failure|2|||
23802249|NCT01302847|66654819|FG003|Overall Study|Virologic failure|0|||
23802250|NCT01302847|66654820|FG004|Overall Study|Virologic failure|1|||
23802251|NCT01302847|66654821|FG005|Overall Study|Virologic failure|1|||
23802252|NCT01302847|66654822|FG006|Overall Study|Virologic failure|0|||
23802253|NCT01302847|66654823|FG007|Overall Study|Virologic failure|2|||
23802254|NCT01302847|66654816|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23802255|NCT01302847|66654817|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23802256|NCT01302847|66654818|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23802257|NCT01302847|66654819|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23802258|NCT01302847|66654820|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23802259|NCT01302847|66654821|FG005|Overall Study|Severe debilitation, unable to continue|1|||
23802260|NCT01302847|66654822|FG006|Overall Study|Severe debilitation, unable to continue|1|||
23802261|NCT01302847|66654823|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23802262|NCT01302847|66654816|FG000|Overall Study|Not able to get to clinic|1|||
23802263|NCT01302847|66654817|FG001|Overall Study|Not able to get to clinic|1|||
23802264|NCT01302847|66654818|FG002|Overall Study|Not able to get to clinic|0|||
23361071|NCT03311841|65065958|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
23802265|NCT01302847|66654819|FG003|Overall Study|Not able to get to clinic|0|||
23802266|NCT01302847|66654820|FG004|Overall Study|Not able to get to clinic|0|||
23802267|NCT01302847|66654821|FG005|Overall Study|Not able to get to clinic|0|||
23802268|NCT01302847|66654822|FG006|Overall Study|Not able to get to clinic|0|||
23802269|NCT01302847|66654823|FG007|Overall Study|Not able to get to clinic|0|||
23802270|NCT01302847|66654816|FG000|Overall Study|Site closing|2|||
23802271|NCT01302847|66654817|FG001|Overall Study|Site closing|2|||
23802272|NCT01302847|66654818|FG002|Overall Study|Site closing|0|||
23802273|NCT01302847|66654819|FG003|Overall Study|Site closing|0|||
23802274|NCT01302847|66654820|FG004|Overall Study|Site closing|0|||
23802275|NCT01302847|66654821|FG005|Overall Study|Site closing|0|||
23802276|NCT01302847|66654822|FG006|Overall Study|Site closing|0|||
23802277|NCT01302847|66654823|FG007|Overall Study|Site closing|0|||
23802278|NCT01302847|66654816|FG000|Overall Study|Withdrawal by Subject|1|||
23802279|NCT01302847|66654817|FG001|Overall Study|Withdrawal by Subject|0|||
23802280|NCT01302847|66654818|FG002|Overall Study|Withdrawal by Subject|0|||
23802281|NCT01302847|66654819|FG003|Overall Study|Withdrawal by Subject|0|||
23802282|NCT01302847|66654820|FG004|Overall Study|Withdrawal by Subject|1|||
23802283|NCT01302847|66654821|FG005|Overall Study|Withdrawal by Subject|0|||
23802284|NCT01302847|66654822|FG006|Overall Study|Withdrawal by Subject|0|||
23802285|NCT01302847|66654823|FG007|Overall Study|Withdrawal by Subject|1|||
23802286|NCT01302847|66654816|FG000|Overall Study|Not willing to adhere to requirements|5|||
23802287|NCT01302847|66654817|FG001|Overall Study|Not willing to adhere to requirements|0|||
23802288|NCT01302847|66654818|FG002|Overall Study|Not willing to adhere to requirements|0|||
23802289|NCT01302847|66654819|FG003|Overall Study|Not willing to adhere to requirements|1|||
23802290|NCT01302847|66654820|FG004|Overall Study|Not willing to adhere to requirements|0|||
23802291|NCT01302847|66654821|FG005|Overall Study|Not willing to adhere to requirements|0|||
23802292|NCT01302847|66654822|FG006|Overall Study|Not willing to adhere to requirements|0|||
23802293|NCT01302847|66654823|FG007|Overall Study|Not willing to adhere to requirements|2|||
23802294|NCT01302847|66654816|FG000|Overall Study|Site unable to contact participant|2|||
23802295|NCT01302847|66654817|FG001|Overall Study|Site unable to contact participant|1|||
23802296|NCT01302847|66654818|FG002|Overall Study|Site unable to contact participant|0|||
23802297|NCT01302847|66654819|FG003|Overall Study|Site unable to contact participant|0|||
23802298|NCT01302847|66654820|FG004|Overall Study|Site unable to contact participant|0|||
23802299|NCT01302847|66654821|FG005|Overall Study|Site unable to contact participant|0|||
23802300|NCT01302847|66654822|FG006|Overall Study|Site unable to contact participant|2|||
23802301|NCT01302847|66654823|FG007|Overall Study|Site unable to contact participant|0|||
23802302|NCT04364737|66654824|FG000|Overall Study|Withdrawal by Subject|4|||
23802303|NCT04364737|66654825|FG001|Overall Study|Withdrawal by Subject|9|||
23802304|NCT04364737|66654824|FG000|Overall Study|Lost to Follow-up|1|||
23802305|NCT04364737|66654825|FG001|Overall Study|Lost to Follow-up|1|||
23802306|NCT02746627|66654832|FG000|Overall Study|Withdrawal by Subject|1|||
23802307|NCT02746627|66654833|FG001|Overall Study|Withdrawal by Subject|1|||
23802308|NCT02746627|66654834|FG002|Overall Study|Withdrawal by Subject|1|||
23802309|NCT00611884|66654836|FG000|Overall Study|Adverse Event|1|||
23802310|NCT00611884|66654837|FG001|Overall Study|Adverse Event|0|||
23802311|NCT00611884|66654838|FG002|Overall Study|Adverse Event|0|||
23802312|NCT00611884|66654839|FG003|Overall Study|Adverse Event|1|||
23802313|NCT00611884|66654836|FG000|Overall Study|Non-Compliance|1|||
23802314|NCT00611884|66654837|FG001|Overall Study|Non-Compliance|4|||
23802315|NCT00611884|66654838|FG002|Overall Study|Non-Compliance|2|||
23802316|NCT00611884|66654839|FG003|Overall Study|Non-Compliance|2|||
23802317|NCT00611884|66654836|FG000|Overall Study|Lack of Efficacy|0|||
23802318|NCT00611884|66654837|FG001|Overall Study|Lack of Efficacy|1|||
23802319|NCT00611884|66654838|FG002|Overall Study|Lack of Efficacy|0|||
23802320|NCT00611884|66654839|FG003|Overall Study|Lack of Efficacy|0|||
23802321|NCT00611884|66654836|FG000|Overall Study|Unclassified|7|||
23802322|NCT00611884|66654837|FG001|Overall Study|Unclassified|4|||
23802323|NCT00611884|66654838|FG002|Overall Study|Unclassified|2|||
23802324|NCT00611884|66654839|FG003|Overall Study|Unclassified|3|||
23802325|NCT02315066|66654840|FG000|Overall Study|Lost to Follow-up|0|||
23802326|NCT02315066|66654841|FG001|Overall Study|Lost to Follow-up|1|||
23802327|NCT02315066|66654842|FG002|Overall Study|Lost to Follow-up|1|||
23802328|NCT02315066|66654843|FG003|Overall Study|Lost to Follow-up|0|||
23802329|NCT02315066|66654844|FG004|Overall Study|Lost to Follow-up|1|||
23802330|NCT02315066|66654845|FG005|Overall Study|Lost to Follow-up|0|||
23802331|NCT02315066|66654846|FG006|Overall Study|Lost to Follow-up|2|||
23802332|NCT02315066|66654847|FG007|Overall Study|Lost to Follow-up|1|||
23802333|NCT02315066|66654848|FG008|Overall Study|Lost to Follow-up|0|||
23802334|NCT02315066|66654849|FG009|Overall Study|Lost to Follow-up|0|||
23802335|NCT02315066|66654850|FG010|Overall Study|Lost to Follow-up|1|||
23480171|NCT00797966|65501917|FG003|Phase A|Met withdrawal criteria|0|||
23802336|NCT02315066|66654851|FG011|Overall Study|Lost to Follow-up|2|||
23802337|NCT02315066|66654852|FG012|Overall Study|Lost to Follow-up|0|||
23802338|NCT02315066|66654853|FG013|Overall Study|Lost to Follow-up|4|||
23802339|NCT02315066|66654840|FG000|Overall Study|Death|2|||
23802340|NCT02315066|66654841|FG001|Overall Study|Death|7|||
23480172|NCT00797966|65501918|FG004|Phase A|Met withdrawal criteria|4|||
23802341|NCT02315066|66654842|FG002|Overall Study|Death|6|||
23802342|NCT02315066|66654843|FG003|Overall Study|Death|11|||
23802343|NCT02315066|66654844|FG004|Overall Study|Death|10|||
23802344|NCT02315066|66654845|FG005|Overall Study|Death|3|||
23802345|NCT02315066|66654846|FG006|Overall Study|Death|9|||
23802346|NCT02315066|66654847|FG007|Overall Study|Death|9|||
23802347|NCT02315066|66654848|FG008|Overall Study|Death|10|||
23802348|NCT02315066|66654849|FG009|Overall Study|Death|8|||
23802349|NCT02315066|66654850|FG010|Overall Study|Death|10|||
23802350|NCT02315066|66654851|FG011|Overall Study|Death|7|||
23802351|NCT02315066|66654852|FG012|Overall Study|Death|8|||
23802352|NCT02315066|66654853|FG013|Overall Study|Death|21|||
23802353|NCT02315066|66654840|FG000|Overall Study|Other|0|||
23802354|NCT02315066|66654841|FG001|Overall Study|Other|0|||
23802355|NCT02315066|66654842|FG002|Overall Study|Other|0|||
23802356|NCT02315066|66654843|FG003|Overall Study|Other|0|||
23802357|NCT02315066|66654844|FG004|Overall Study|Other|0|||
23802358|NCT02315066|66654845|FG005|Overall Study|Other|0|||
23802359|NCT02315066|66654846|FG006|Overall Study|Other|0|||
23802360|NCT02315066|66654847|FG007|Overall Study|Other|1|||
23802361|NCT02315066|66654848|FG008|Overall Study|Other|1|||
23802362|NCT02315066|66654849|FG009|Overall Study|Other|2|||
23802363|NCT02315066|66654850|FG010|Overall Study|Other|0|||
23802364|NCT02315066|66654851|FG011|Overall Study|Other|0|||
23802365|NCT02315066|66654852|FG012|Overall Study|Other|0|||
23802366|NCT02315066|66654853|FG013|Overall Study|Other|0|||
23802367|NCT02315066|66654840|FG000|Overall Study|Subject refused further follow-up|0|||
23802368|NCT02315066|66654841|FG001|Overall Study|Subject refused further follow-up|2|||
23802369|NCT02315066|66654842|FG002|Overall Study|Subject refused further follow-up|2|||
23802370|NCT02315066|66654843|FG003|Overall Study|Subject refused further follow-up|0|||
23802371|NCT02315066|66654844|FG004|Overall Study|Subject refused further follow-up|0|||
23802372|NCT02315066|66654845|FG005|Overall Study|Subject refused further follow-up|0|||
23802373|NCT02315066|66654846|FG006|Overall Study|Subject refused further follow-up|2|||
23802374|NCT02315066|66654847|FG007|Overall Study|Subject refused further follow-up|3|||
23802375|NCT02315066|66654848|FG008|Overall Study|Subject refused further follow-up|0|||
23802376|NCT02315066|66654849|FG009|Overall Study|Subject refused further follow-up|1|||
23802377|NCT02315066|66654850|FG010|Overall Study|Subject refused further follow-up|1|||
23802378|NCT02315066|66654851|FG011|Overall Study|Subject refused further follow-up|2|||
23802379|NCT02315066|66654852|FG012|Overall Study|Subject refused further follow-up|2|||
23654821|NCT03267940|66121373|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
23654822|NCT04464265|66121374|FG000|Overall Study|Physician Decision|2|||
23654823|NCT02941926|66121376|FG000|Core Phase|Progressive disease|1109|||
23654824|NCT02941926|66121376|FG000|Core Phase|Adverse Event|504|||
23654825|NCT02941926|66121376|FG000|Core Phase|Subject/guardian decision|127|||
23654826|NCT02941926|66121376|FG000|Core Phase|Physician Decision|112|||
23654827|NCT02941926|66121376|FG000|Core Phase|Death|46|||
23654828|NCT02941926|66121376|FG000|Core Phase|Protocol deviation|34|||
23654829|NCT02941926|66121376|FG000|Core Phase|Lost to Follow-up|8|||
23654830|NCT02941926|66121376|FG000|Core Phase|Technical problems|5|||
23654831|NCT02941926|66121376|FG000|Extension Phase|Physician Decision|155|||
23654832|NCT02941926|66121376|FG000|Extension Phase|Progressive disease|115|||
23654833|NCT02941926|66121376|FG000|Extension Phase|Adverse Event|13|||
23802380|NCT02315066|66654853|FG013|Overall Study|Subject refused further follow-up|4|||
23802381|NCT02315066|66654840|FG000|Overall Study|Study ongoing at date of cut-off|0|||
23802382|NCT02315066|66654841|FG001|Overall Study|Study ongoing at date of cut-off|0|||
23802383|NCT02315066|66654842|FG002|Overall Study|Study ongoing at date of cut-off|0|||
23802384|NCT02315066|66654843|FG003|Overall Study|Study ongoing at date of cut-off|0|||
23802385|NCT02315066|66654844|FG004|Overall Study|Study ongoing at date of cut-off|0|||
23802386|NCT02315066|66654845|FG005|Overall Study|Study ongoing at date of cut-off|0|||
23802387|NCT02315066|66654846|FG006|Overall Study|Study ongoing at date of cut-off|0|||
23802388|NCT02315066|66654847|FG007|Overall Study|Study ongoing at date of cut-off|0|||
23802389|NCT02315066|66654848|FG008|Overall Study|Study ongoing at date of cut-off|0|||
23802390|NCT02315066|66654849|FG009|Overall Study|Study ongoing at date of cut-off|0|||
23654834|NCT02941926|66121376|FG000|Extension Phase|Subject/Guardian decision|12|||
23802391|NCT02315066|66654850|FG010|Overall Study|Study ongoing at date of cut-off|0|||
23654835|NCT02941926|66121376|FG000|Extension Phase|Death|6|||
23802392|NCT02315066|66654851|FG011|Overall Study|Study ongoing at date of cut-off|0|||
23802393|NCT02315066|66654852|FG012|Overall Study|Study ongoing at date of cut-off|0|||
23802394|NCT02315066|66654853|FG013|Overall Study|Study ongoing at date of cut-off|1|||
23802395|NCT00108082|66654854|FG000|Overall Study|Adverse Event|14|||
23802396|NCT00108082|66654855|FG001|Overall Study|Adverse Event|12|||
23802397|NCT00108082|66654856|FG002|Overall Study|Adverse Event|17|||
23802398|NCT00108082|66654854|FG000|Overall Study|Lost to Follow-up|6|||
23802399|NCT00108082|66654855|FG001|Overall Study|Lost to Follow-up|3|||
23802400|NCT00108082|66654856|FG002|Overall Study|Lost to Follow-up|7|||
23802401|NCT00108082|66654854|FG000|Overall Study|Consent Withdrawn|3|||
23802402|NCT00108082|66654855|FG001|Overall Study|Consent Withdrawn|3|||
23802403|NCT00108082|66654856|FG002|Overall Study|Consent Withdrawn|5|||
23802404|NCT00108082|66654854|FG000|Overall Study|Protocol Violation|1|||
23802405|NCT00108082|66654855|FG001|Overall Study|Protocol Violation|2|||
23361072|NCT03311841|65065959|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
23802406|NCT00108082|66654856|FG002|Overall Study|Protocol Violation|0|||
23802407|NCT00108082|66654854|FG000|Overall Study|Lack of Efficacy|3|||
23802408|NCT00108082|66654855|FG001|Overall Study|Lack of Efficacy|1|||
23802409|NCT00108082|66654856|FG002|Overall Study|Lack of Efficacy|2|||
23802410|NCT00108082|66654854|FG000|Overall Study|Amendment 4: > Month 12|5|||
23802411|NCT00108082|66654855|FG001|Overall Study|Amendment 4: > Month 12|7|||
23599759|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
23599760|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
23599761|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
23599762|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Other|1|||
23599763|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Other|0|||
23599764|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Other|0|||
23599765|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
23599766|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
23599767|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
23599768|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
23599769|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
23599770|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
23599771|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
23705553|NCT00960440|66297542|FG001|Overall Study|Protocol Violation|8|||
23361073|NCT03311841|65065960|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
23361074|NCT03311841|65065961|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
23599772|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
23599773|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
23599774|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
23599775|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
23705554|NCT00960440|66297543|FG002|Overall Study|Protocol Violation|3|||
23705555|NCT00960440|66297544|FG003|Overall Study|Protocol Violation|4|||
23705556|NCT00960440|66297541|FG000|Overall Study|Withdrawal by Subject|9|||
23705557|NCT00960440|66297542|FG001|Overall Study|Withdrawal by Subject|5|||
23705558|NCT00960440|66297543|FG002|Overall Study|Withdrawal by Subject|2|||
23705559|NCT00960440|66297544|FG003|Overall Study|Withdrawal by Subject|1|||
23705560|NCT00960440|66297541|FG000|Overall Study|Other|1|||
23705561|NCT00960440|66297542|FG001|Overall Study|Other|1|||
23705562|NCT00960440|66297543|FG002|Overall Study|Other|1|||
23705563|NCT00960440|66297544|FG003|Overall Study|Other|0|||
23705564|NCT00601523|66297556|FG000|Overall Study|Adverse Event|42|||
23705565|NCT00601523|66297557|FG001|Overall Study|Adverse Event|14|||
23705566|NCT00601523|66297556|FG000|Overall Study|Lack of Efficacy|3|||
23705567|NCT00601523|66297557|FG001|Overall Study|Lack of Efficacy|0|||
23705568|NCT00601523|66297556|FG000|Overall Study|Protocol Violation|5|||
23705569|NCT00601523|66297557|FG001|Overall Study|Protocol Violation|1|||
23705570|NCT00601523|66297556|FG000|Overall Study|Lost to Follow-up|0|||
23705571|NCT00601523|66297557|FG001|Overall Study|Lost to Follow-up|1|||
23705572|NCT00601523|66297556|FG000|Overall Study|Withdrawal by Subject|18|||
23705573|NCT00601523|66297557|FG001|Overall Study|Withdrawal by Subject|9|||
23705574|NCT00601523|66297556|FG000|Overall Study|Other|9|||
23705575|NCT00601523|66297557|FG001|Overall Study|Other|1|||
23705576|NCT00488033|66297558|FG000|Overall Study|Withdrawal by Subject|1|||
23705577|NCT00488033|66297559|FG001|Overall Study|Withdrawal by Subject|0|||
23705578|NCT04230486|66297560|FG000|Overall Study|Screen Failure|1|||
23705579|NCT00632463|66297564|FG000|Overall Study|Adverse Event|0|||
23705580|NCT00632463|66297565|FG001|Overall Study|Adverse Event|1|||
23705581|NCT00632463|66297566|FG002|Overall Study|Adverse Event|0|||
23705582|NCT03259334|66297567|FG000|Overall Study|Adverse Event|3|||
23705583|NCT03259334|66297568|FG001|Overall Study|Adverse Event|8|||
23705584|NCT03259334|66297569|FG002|Overall Study|Adverse Event|5|||
23705585|NCT03259334|66297567|FG000|Overall Study|Withdrawal by Subject|4|||
23705586|NCT03259334|66297568|FG001|Overall Study|Withdrawal by Subject|2|||
23705587|NCT03259334|66297569|FG002|Overall Study|Withdrawal by Subject|4|||
23802412|NCT00108082|66654856|FG002|Overall Study|Amendment 4: > Month 12|5|||
23802413|NCT00108082|66654854|FG000|Overall Study|Woman of Child-bearing Potential|2|||
23802414|NCT00108082|66654855|FG001|Overall Study|Woman of Child-bearing Potential|0|||
23802415|NCT00108082|66654856|FG002|Overall Study|Woman of Child-bearing Potential|2|||
23802416|NCT00108082|66654854|FG000|Overall Study|Incorrectly Randomized|0|||
23802417|NCT00108082|66654855|FG001|Overall Study|Incorrectly Randomized|0|||
23802418|NCT00108082|66654856|FG002|Overall Study|Incorrectly Randomized|2|||
23802419|NCT00108082|66654854|FG000|Overall Study|Non-compliance|1|||
23802420|NCT00108082|66654855|FG001|Overall Study|Non-compliance|0|||
23802421|NCT00108082|66654856|FG002|Overall Study|Non-compliance|2|||
23802422|NCT00108082|66654854|FG000|Overall Study|Stopped Study Medication|0|||
23802423|NCT00108082|66654855|FG001|Overall Study|Stopped Study Medication|0|||
23802424|NCT00108082|66654856|FG002|Overall Study|Stopped Study Medication|1|||
23802425|NCT00108082|66654854|FG000|Overall Study|Site Closed Study|0|||
23802426|NCT00108082|66654855|FG001|Overall Study|Site Closed Study|2|||
23802427|NCT00108082|66654856|FG002|Overall Study|Site Closed Study|0|||
23802428|NCT00108082|66654854|FG000|Overall Study|Protocol Amendment|0|||
23802429|NCT00108082|66654855|FG001|Overall Study|Protocol Amendment|1|||
23802430|NCT00108082|66654856|FG002|Overall Study|Protocol Amendment|0|||
23802431|NCT00108082|66654854|FG000|Overall Study|Study Medication Not Tapered|0|||
23802432|NCT00108082|66654855|FG001|Overall Study|Study Medication Not Tapered|1|||
23802433|NCT00108082|66654856|FG002|Overall Study|Study Medication Not Tapered|0|||
23802434|NCT00108082|66654854|FG000|Overall Study|Subject Left Site Location|1|||
23802435|NCT00108082|66654855|FG001|Overall Study|Subject Left Site Location|0|||
23802436|NCT00108082|66654856|FG002|Overall Study|Subject Left Site Location|0|||
23802437|NCT00108082|66654854|FG000|Overall Study|Investigator Not at Site|1|||
23802438|NCT00108082|66654855|FG001|Overall Study|Investigator Not at Site|0|||
23802439|NCT00108082|66654856|FG002|Overall Study|Investigator Not at Site|0|||
23802440|NCT00108082|66654854|FG000|Overall Study|Blood Pressure Not Controlled|1|||
23802441|NCT00108082|66654855|FG001|Overall Study|Blood Pressure Not Controlled|0|||
23802442|NCT00108082|66654856|FG002|Overall Study|Blood Pressure Not Controlled|0|||
23802443|NCT01615263|66654858|FG000|Overall Study|Post-randomization exclusion|0|||
23802444|NCT01615263|66654859|FG001|Overall Study|Post-randomization exclusion|2|||
23802445|NCT03451006|66654860|FG000|Overall Study|Withdrawal by Subject|2|||
23802446|NCT03451006|66654861|FG001|Overall Study|Withdrawal by Subject|2|||
23802447|NCT00873119|66654862|FG000|Overall Study|Patient request|4|||
23802448|NCT00873119|66654863|FG001|Overall Study|Patient request|2|||
23802449|NCT00873119|66654862|FG000|Overall Study|Adverse Event|8|||
23802450|NCT00873119|66654863|FG001|Overall Study|Adverse Event|0|||
23802451|NCT00873119|66654862|FG000|Overall Study|Progressive disease|26|||
23802452|NCT00873119|66654863|FG001|Overall Study|Progressive disease|18|||
23802453|NCT00873119|66654862|FG000|Overall Study|Death|2|||
23802454|NCT00873119|66654863|FG001|Overall Study|Death|1|||
23802455|NCT00873119|66654862|FG000|Overall Study|Other|2|||
23802456|NCT00873119|66654863|FG001|Overall Study|Other|5|||
23802457|NCT00873119|66654862|FG000|Overall Study|Not treated|2|||
23802458|NCT00873119|66654863|FG001|Overall Study|Not treated|0|||
23802459|NCT03330236|66654864|FG000|Overall Study|Death|2|||
23802460|NCT03330236|66654865|FG001|Overall Study|Death|1|||
23802461|NCT03330236|66654864|FG000|Overall Study|Withdrawal by Subject|2|||
23802462|NCT03330236|66654865|FG001|Overall Study|Withdrawal by Subject|4|||
23802463|NCT03330236|66654864|FG000|Overall Study|Lost to Follow-up|0|||
23802464|NCT03330236|66654865|FG001|Overall Study|Lost to Follow-up|2|||
23802465|NCT03330236|66654864|FG000|Overall Study|Physician Decision|2|||
23802466|NCT03330236|66654865|FG001|Overall Study|Physician Decision|0|||
23802467|NCT03330236|66654864|FG000|Overall Study|Protocol Violation|4|||
23802468|NCT03330236|66654865|FG001|Overall Study|Protocol Violation|3|||
23802469|NCT03330236|66654864|FG000|Overall Study|SedLine malfunction/blinding|19|||
23802470|NCT03330236|66654865|FG001|Overall Study|SedLine malfunction/blinding|14|||
23802471|NCT03330236|66654864|FG000|Overall Study|Volatile anesthetics used|11|||
23802472|NCT03330236|66654865|FG001|Overall Study|Volatile anesthetics used|8|||
23802473|NCT03330236|66654864|FG000|Overall Study|Surgery aborted/converted to open|60|||
23802474|NCT03330236|66654865|FG001|Overall Study|Surgery aborted/converted to open|52|||
23802475|NCT02039414|66654866|FG000|Overall Study|Delivered|1|||
23361075|NCT04058028|65065962|FG000|Overall Study|Withdrawal of Consent from Study|12|||
23361076|NCT04058028|65065963|FG001|Overall Study|Withdrawal of Consent from Study|8|||
23361077|NCT04058028|65065964|FG002|Overall Study|Withdrawal of Consent from Study|6|||
23802476|NCT02039414|66654867|FG001|Overall Study|Delivered|1|||
23802477|NCT02039414|66654866|FG000|Overall Study|Lost to Follow-up|2|||
23802478|NCT02039414|66654867|FG001|Overall Study|Lost to Follow-up|0|||
23802479|NCT02039414|66654866|FG000|Overall Study|Protocol Violation|3|||
23802480|NCT02039414|66654867|FG001|Overall Study|Protocol Violation|1|||
23802481|NCT01042535|66654868|FG000|Overall Study|disease progression prior to treatment|3|||
23802482|NCT01042535|66654868|FG000|Overall Study|disease progression during treatment|3|||
23802483|NCT01042535|66654868|FG000|Overall Study|complications from other disease|2|||
23802484|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
23802485|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
23802486|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
23802487|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
23802488|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
23802489|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
23802490|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
23802491|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
23802492|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
23802493|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
23802494|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
23802495|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
23802496|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802497|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802498|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23802499|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23802500|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
23802501|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
23802502|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
23802503|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
23802504|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
23802505|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
23802506|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
23802507|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
23802508|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
23802509|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
23802510|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
23802511|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
23802512|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Death|0|||
23802513|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Death|1|||
23802514|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Death|0|||
23802515|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Death|0|||
23802516|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23802517|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
23802518|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23802519|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23802520|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
23802521|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
23802522|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
23802523|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
23802524|NCT02990806|66654869|FG000|Stage 1 (22 Weeks)|Other|1|||
23802525|NCT02990806|66654870|FG001|Stage 1 (22 Weeks)|Other|3|||
23802526|NCT02990806|66654871|FG002|Stage 1 (22 Weeks)|Other|0|||
23802527|NCT02990806|66654872|FG003|Stage 1 (22 Weeks)|Other|0|||
23802528|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
23802529|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
23802530|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
23802531|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
23802532|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Death|1|||
23802533|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Death|0|||
23802534|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Death|0|||
23802535|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Death|0|||
23802536|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
23802537|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
23802538|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
23802539|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
23802540|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
23802541|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
23802542|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
23802543|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
23802544|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23802545|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
23802546|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23802547|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23802548|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
23802549|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
23802550|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
23802551|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
23802552|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802553|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23802554|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
23802555|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
23802556|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
23802557|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
23802558|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
23802559|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
23802560|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
23802561|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
23802562|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
23802563|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
23802564|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
23802565|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
23802566|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
23802567|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
23802568|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
23802569|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
23802570|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
23802571|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
23802572|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Other|3|||
23802573|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Other|0|||
23802574|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Other|4|||
23802575|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Other|1|||
23802576|NCT02990806|66654869|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23802577|NCT02990806|66654870|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23802578|NCT02990806|66654871|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23802579|NCT02990806|66654872|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
23802580|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
23802581|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
23802582|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
23802583|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
23802584|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23802585|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
23802586|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23802587|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23802588|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802589|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23802590|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802591|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23802592|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
23802593|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
23802594|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
23802595|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
23802596|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
23802597|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
23802598|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
23802599|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
23802600|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23802601|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23802602|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
23802603|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23802604|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23802605|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23802606|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23802607|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
23802608|NCT02990806|66654869|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23802609|NCT02990806|66654870|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23802610|NCT02990806|66654871|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
23802611|NCT02990806|66654872|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23802612|NCT01232491|66654873|FG000|Overall Study|Adverse Event|13|||
23802613|NCT01232491|66654874|FG001|Overall Study|Adverse Event|8|||
23802614|NCT01232491|66654873|FG000|Overall Study|Lack of Efficacy|1|||
23802615|NCT01232491|66654874|FG001|Overall Study|Lack of Efficacy|5|||
23802616|NCT01232491|66654873|FG000|Overall Study|Protocol Violation|13|||
23802617|NCT01232491|66654874|FG001|Overall Study|Protocol Violation|11|||
23802618|NCT01232491|66654873|FG000|Overall Study|Withdrawal Criteria|12|||
23802619|NCT01232491|66654874|FG001|Overall Study|Withdrawal Criteria|21|||
23802620|NCT01232491|66654873|FG000|Overall Study|Other|21|||
23802621|NCT01232491|66654874|FG001|Overall Study|Other|18|||
23802622|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23802623|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23802624|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
23802625|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23802626|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
23802627|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
23802628|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23802629|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23802630|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
23802631|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
23802632|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
23802633|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
23802634|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23802635|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23802636|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23802637|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23802638|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23802639|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23802640|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
23802641|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23802642|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
23802643|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
23802644|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
23802645|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
23802646|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
23802647|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23802648|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
23802649|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23802650|NCT03227224|66654875|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
23802651|NCT03227224|66654876|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
23802652|NCT03227224|66654877|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
23802653|NCT03227224|66654878|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
23802654|NCT03227224|66654875|FG000|Follow-up Phase (2 Weeks)|Other|4|||
23802655|NCT03227224|66654876|FG001|Follow-up Phase (2 Weeks)|Other|4|||
23802656|NCT03227224|66654877|FG002|Follow-up Phase (2 Weeks)|Other|6|||
23802657|NCT03227224|66654878|FG003|Follow-up Phase (2 Weeks)|Other|3|||
23802658|NCT00890552|66654879|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
23802659|NCT00890552|66654879|FG000|On-treatment|Early prog disease/ death|10|||
23802660|NCT01316419|66654887|FG000|Overall Study|Not treated|103|||
23802661|NCT01316419|66654887|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
23802662|NCT01316419|66654887|FG000|Overall Study|Lost to Follow-up|19|||
23802663|NCT01844531|66654888|FG000|Overall Study|Withdrawal by Subject|0|||
23802664|NCT01844531|66654889|FG001|Overall Study|Withdrawal by Subject|1|||
23802665|NCT01844531|66654890|FG002|Overall Study|Withdrawal by Subject|0|||
23802666|NCT01844531|66654891|FG003|Overall Study|Withdrawal by Subject|0|||
23599776|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
23705588|NCT03259334|66297567|FG000|Overall Study|Physician Decision|1|||
23705589|NCT03259334|66297568|FG001|Overall Study|Physician Decision|0|||
23705590|NCT03259334|66297569|FG002|Overall Study|Physician Decision|0|||
23705591|NCT03259334|66297567|FG000|Overall Study|Lost to Follow-up|0|||
23705592|NCT03259334|66297568|FG001|Overall Study|Lost to Follow-up|2|||
23705593|NCT03259334|66297569|FG002|Overall Study|Lost to Follow-up|1|||
23705594|NCT03259334|66297567|FG000|Overall Study|Protocol Deviation|0|||
23705595|NCT03259334|66297568|FG001|Overall Study|Protocol Deviation|3|||
23705596|NCT03259334|66297569|FG002|Overall Study|Protocol Deviation|2|||
23705597|NCT03259334|66297567|FG000|Overall Study|Lack of Efficacy|2|||
23705598|NCT03259334|66297568|FG001|Overall Study|Lack of Efficacy|0|||
23705599|NCT03259334|66297569|FG002|Overall Study|Lack of Efficacy|1|||
23705600|NCT03259334|66297567|FG000|Overall Study|Randomized but never treated|0|||
23705601|NCT03259334|66297568|FG001|Overall Study|Randomized but never treated|2|||
23705602|NCT03259334|66297569|FG002|Overall Study|Randomized but never treated|0|||
23705603|NCT01514188|66297570|FG000|Overall Study|Adverse Event|3|||
23705604|NCT01514188|66297571|FG001|Overall Study|Adverse Event|5|||
23705605|NCT01514188|66297570|FG000|Overall Study|Withdrawal by Subject|2|||
23705606|NCT01514188|66297571|FG001|Overall Study|Withdrawal by Subject|4|||
23705607|NCT01514188|66297570|FG000|Overall Study|Protocol Violation|2|||
23705608|NCT01514188|66297571|FG001|Overall Study|Protocol Violation|4|||
23705609|NCT01514188|66297570|FG000|Overall Study|Physician Decision|0|||
23705610|NCT01514188|66297571|FG001|Overall Study|Physician Decision|2|||
23705611|NCT01514188|66297570|FG000|Overall Study|Disease Progression|13|||
23705612|NCT01514188|66297571|FG001|Overall Study|Disease Progression|14|||
23705613|NCT01514188|66297570|FG000|Overall Study|Death|1|||
23705614|NCT01514188|66297571|FG001|Overall Study|Death|3|||
23705615|NCT01514188|66297570|FG000|Overall Study|Other|2|||
23705616|NCT01514188|66297571|FG001|Overall Study|Other|1|||
23705617|NCT00620321|66297572|FG000|Overall Study|Adverse Event|1|||
23705618|NCT00620321|66297573|FG001|Overall Study|Adverse Event|1|||
23705619|NCT00620321|66297572|FG000|Overall Study|Death|1|||
23705620|NCT00620321|66297573|FG001|Overall Study|Death|1|||
23705621|NCT00620321|66297572|FG000|Overall Study|Physician Decision|0|||
23705622|NCT00620321|66297573|FG001|Overall Study|Physician Decision|7|||
23705623|NCT00620321|66297572|FG000|Overall Study|Progressive Disease|5|||
23705624|NCT00620321|66297573|FG001|Overall Study|Progressive Disease|5|||
23705625|NCT00620321|66297572|FG000|Overall Study|Sponsor Decision|0|||
23705626|NCT00620321|66297573|FG001|Overall Study|Sponsor Decision|1|||
23705627|NCT00620321|66297572|FG000|Overall Study|Withdrawal by Subject|1|||
23705628|NCT00620321|66297573|FG001|Overall Study|Withdrawal by Subject|1|||
23705629|NCT01989546|66297574|FG000|Overall Study|Clinical Progression|1|||
23705630|NCT01989546|66297574|FG000|Overall Study|Disease progression on study|8|||
23705631|NCT02402218|66297577|FG000|Overall Study|Did not pickup study medication|12|||
23705632|NCT02402218|66297578|FG001|Overall Study|Did not pickup study medication|9|||
23705633|NCT02402218|66297579|FG002|Overall Study|Did not pickup study medication|13|||
23705634|NCT02402218|66297577|FG000|Overall Study|Lack of Efficacy|0|||
23705635|NCT02402218|66297578|FG001|Overall Study|Lack of Efficacy|1|||
23705636|NCT02402218|66297579|FG002|Overall Study|Lack of Efficacy|1|||
23705637|NCT02402218|66297577|FG000|Overall Study|Death|1|||
23705638|NCT02402218|66297578|FG001|Overall Study|Death|0|||
23705639|NCT02402218|66297579|FG002|Overall Study|Death|0|||
23705640|NCT02402218|66297577|FG000|Overall Study|Reinfection|0|||
23705641|NCT02402218|66297578|FG001|Overall Study|Reinfection|0|||
23705642|NCT02402218|66297579|FG002|Overall Study|Reinfection|1|||
23705643|NCT02402218|66297577|FG000|Overall Study|Adverse Event|0|||
23705644|NCT02402218|66297578|FG001|Overall Study|Adverse Event|2|||
23705645|NCT02402218|66297579|FG002|Overall Study|Adverse Event|1|||
23705646|NCT02402218|66297577|FG000|Overall Study|Withdrawal by Subject|1|||
23802667|NCT01056640|66654893|FG000|Overall Study|Withdrawal by Subject|11|||
23802668|NCT01056640|66654894|FG001|Overall Study|Withdrawal by Subject|8|||
23802669|NCT01056640|66654893|FG000|Overall Study|Death|15|||
23802670|NCT01056640|66654894|FG001|Overall Study|Death|4|||
23802671|NCT00848042|66654895|FG000|Overall Study|Death|1|||
23802672|NCT00848042|66654896|FG001|Overall Study|Death|2|||
23802673|NCT00848042|66654897|FG002|Overall Study|Death|0|||
23802674|NCT00848042|66654895|FG000|Overall Study|Other Therapy|3|||
23802675|NCT00848042|66654896|FG001|Overall Study|Other Therapy|0|||
23802676|NCT00848042|66654897|FG002|Overall Study|Other Therapy|0|||
23802677|NCT02953678|66654900|FG000|Overall Study|Adverse Event|20|||
23802678|NCT02953678|66654900|FG000|Overall Study|Death|7|||
23802679|NCT02953678|66654900|FG000|Overall Study|Physician Decision|23|||
23802680|NCT02953678|66654900|FG000|Overall Study|Progressive Disease of GVHD|7|||
23802681|NCT02953678|66654900|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
23802682|NCT02953678|66654900|FG000|Overall Study|Withdrawal by participant|3|||
23802683|NCT02953678|66654900|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
23802684|NCT02953678|66654900|FG000|Overall Study|Participants were transferred to commercial product.|3|||
23802685|NCT00824369|66654901|FG000|Overall Study|Nolonger willing to participate in study|1|||
23802686|NCT00824369|66654902|FG001|Overall Study|Nolonger willing to participate in study|0|||
23802687|NCT00824369|66654903|FG002|Overall Study|Nolonger willing to participate in study|1|||
23802688|NCT00824369|66654904|FG003|Overall Study|Nolonger willing to participate in study|2|||
23802689|NCT00824369|66654905|FG004|Overall Study|Nolonger willing to participate in study|0|||
23802690|NCT00824369|66654906|FG005|Overall Study|Nolonger willing to participate in study|1|||
23802691|NCT00824369|66654901|FG000|Overall Study|Lost to Follow-up|0|||
23802692|NCT00824369|66654902|FG001|Overall Study|Lost to Follow-up|0|||
23802693|NCT00824369|66654903|FG002|Overall Study|Lost to Follow-up|0|||
23802694|NCT00824369|66654904|FG003|Overall Study|Lost to Follow-up|0|||
23802695|NCT00824369|66654905|FG004|Overall Study|Lost to Follow-up|1|||
23802696|NCT00824369|66654906|FG005|Overall Study|Lost to Follow-up|0|||
23802697|NCT01546142|66654907|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
23802698|NCT01546142|66654908|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
23802699|NCT01546142|66654907|FG000|Overall Study|Subject Noncompliance|1|||
23802700|NCT01546142|66654908|FG001|Overall Study|Subject Noncompliance|1|||
23802701|NCT01546142|66654907|FG000|Overall Study|Adverse Event|6|||
23802702|NCT01546142|66654908|FG001|Overall Study|Adverse Event|3|||
23802703|NCT01546142|66654907|FG000|Overall Study|Lost to Follow-up|20|||
23802704|NCT01546142|66654908|FG001|Overall Study|Lost to Follow-up|15|||
23802705|NCT01546142|66654907|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
23802706|NCT01546142|66654908|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
23802707|NCT01546142|66654907|FG000|Overall Study|Subject Randomized but Not Treated|1|||
23802708|NCT01546142|66654908|FG001|Overall Study|Subject Randomized but Not Treated|0|||
23802709|NCT00955721|66654909|FG000|Overall Study|Physician Decision|1|||
23802710|NCT00955721|66654910|FG001|Overall Study|Physician Decision|0|||
23802711|NCT00955721|66654909|FG000|Overall Study|Death|1|||
23802712|NCT00955721|66654910|FG001|Overall Study|Death|0|||
23802713|NCT00955721|66654909|FG000|Overall Study|Withdrawal by Subject|1|||
23802714|NCT00955721|66654910|FG001|Overall Study|Withdrawal by Subject|0|||
23802715|NCT00285584|66654915|FG000|Month 3|Lost to Follow-up|3|||
23802716|NCT00285584|66654916|FG001|Month 3|Lost to Follow-up|3|||
23802717|NCT00285584|66654915|FG000|Month 3|Withdrawal by Subject|1|||
23802718|NCT00285584|66654916|FG001|Month 3|Withdrawal by Subject|0|||
23802719|NCT00285584|66654915|FG000|Month 6|Lost to Follow-up|0|||
23802720|NCT00285584|66654916|FG001|Month 6|Lost to Follow-up|1|||
23802721|NCT03336242|66654917|FG000|Overall Study|Adverse Event|0|||
23802722|NCT03336242|66654918|FG001|Overall Study|Adverse Event|1|||
23802723|NCT03739138|66654919|FG000|Overall Study|Death|0|||
23802724|NCT03739138|66654920|FG001|Overall Study|Death|7|||
23802725|NCT03739138|66654921|FG002|Overall Study|Death|4|||
23802726|NCT03739138|66654922|FG003|Overall Study|Death|13|||
23802727|NCT03739138|66654923|FG004|Overall Study|Death|0|||
23802728|NCT03739138|66654919|FG000|Overall Study|Lost to Follow-up|0|||
23802729|NCT03739138|66654920|FG001|Overall Study|Lost to Follow-up|0|||
23802730|NCT03739138|66654921|FG002|Overall Study|Lost to Follow-up|1|||
23802731|NCT03739138|66654922|FG003|Overall Study|Lost to Follow-up|0|||
23802732|NCT03739138|66654923|FG004|Overall Study|Lost to Follow-up|0|||
23802733|NCT03739138|66654919|FG000|Overall Study|Study Terminated By Sponsor|0|||
23802734|NCT03739138|66654920|FG001|Overall Study|Study Terminated By Sponsor|0|||
23802735|NCT03739138|66654921|FG002|Overall Study|Study Terminated By Sponsor|0|||
23802736|NCT03739138|66654922|FG003|Overall Study|Study Terminated By Sponsor|4|||
23802737|NCT03739138|66654923|FG004|Overall Study|Study Terminated By Sponsor|0|||
23480173|NCT00797966|65501919|FG005|Phase A|Met withdrawal criteria|0|||
23654836|NCT03285178|66121383|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
23654837|NCT03285178|66121384|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654838|NCT03285178|66121385|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654839|NCT03285178|66121386|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654840|NCT03285178|66121387|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654841|NCT03285178|66121388|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654842|NCT03285178|66121389|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23654843|NCT03285178|66121383|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
23654844|NCT03285178|66121384|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23654845|NCT03285178|66121385|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23480174|NCT00797966|65501914|FG000|Phase A|Physician Decision|0|||
23480175|NCT00797966|65501915|FG001|Phase A|Physician Decision|0|||
23480176|NCT00797966|65501916|FG002|Phase A|Physician Decision|0|||
23480177|NCT00797966|65501917|FG003|Phase A|Physician Decision|0|||
23480178|NCT00797966|65501918|FG004|Phase A|Physician Decision|13|||
23480179|NCT00797966|65501919|FG005|Phase A|Physician Decision|0|||
23480180|NCT00797966|65501914|FG000|Phase A|Withdrawal by Subject|0|||
23480181|NCT00797966|65501915|FG001|Phase A|Withdrawal by Subject|0|||
23480182|NCT00797966|65501916|FG002|Phase A|Withdrawal by Subject|0|||
23480183|NCT00797966|65501917|FG003|Phase A|Withdrawal by Subject|0|||
23480184|NCT00797966|65501918|FG004|Phase A|Withdrawal by Subject|33|||
23480185|NCT00797966|65501919|FG005|Phase A|Withdrawal by Subject|0|||
23480186|NCT00797966|65501914|FG000|Phase A|Protocol deviation|0|||
23480187|NCT00797966|65501915|FG001|Phase A|Protocol deviation|0|||
23480188|NCT00797966|65501916|FG002|Phase A|Protocol deviation|0|||
23480189|NCT00797966|65501917|FG003|Phase A|Protocol deviation|0|||
23480190|NCT00797966|65501918|FG004|Phase A|Protocol deviation|56|||
23480191|NCT00797966|65501919|FG005|Phase A|Protocol deviation|0|||
23480192|NCT00797966|65501914|FG000|Phase B|Lost to Follow-up|0|||
23480193|NCT00797966|65501915|FG001|Phase B|Lost to Follow-up|1|||
23480194|NCT00797966|65501916|FG002|Phase B|Lost to Follow-up|3|||
23480195|NCT00797966|65501917|FG003|Phase B|Lost to Follow-up|0|||
23480196|NCT00797966|65501918|FG004|Phase B|Lost to Follow-up|0|||
23480197|NCT00797966|65501919|FG005|Phase B|Lost to Follow-up|0|||
23480198|NCT00797966|65501914|FG000|Phase B|Adverse Event|2|||
23480199|NCT00797966|65501915|FG001|Phase B|Adverse Event|1|||
23480200|NCT00797966|65501916|FG002|Phase B|Adverse Event|3|||
23480201|NCT00797966|65501917|FG003|Phase B|Adverse Event|1|||
23480202|NCT00797966|65501918|FG004|Phase B|Adverse Event|0|||
23480203|NCT00797966|65501919|FG005|Phase B|Adverse Event|0|||
23480204|NCT00797966|65501914|FG000|Phase B|Met Withdrawal Criteria|3|||
23480205|NCT00797966|65501915|FG001|Phase B|Met Withdrawal Criteria|3|||
23480206|NCT00797966|65501916|FG002|Phase B|Met Withdrawal Criteria|6|||
23480207|NCT00797966|65501917|FG003|Phase B|Met Withdrawal Criteria|1|||
23480208|NCT00797966|65501918|FG004|Phase B|Met Withdrawal Criteria|0|||
23480209|NCT00797966|65501919|FG005|Phase B|Met Withdrawal Criteria|0|||
23480210|NCT00797966|65501914|FG000|Phase B|Physician Decision|1|||
23480211|NCT00797966|65501915|FG001|Phase B|Physician Decision|0|||
23480212|NCT00797966|65501916|FG002|Phase B|Physician Decision|3|||
23480213|NCT00797966|65501917|FG003|Phase B|Physician Decision|1|||
23480214|NCT00797966|65501918|FG004|Phase B|Physician Decision|0|||
23480215|NCT00797966|65501919|FG005|Phase B|Physician Decision|0|||
23480216|NCT00797966|65501914|FG000|Phase B|Withdrawal by Subject|1|||
23480217|NCT00797966|65501915|FG001|Phase B|Withdrawal by Subject|4|||
23480218|NCT00797966|65501916|FG002|Phase B|Withdrawal by Subject|3|||
23480219|NCT00797966|65501917|FG003|Phase B|Withdrawal by Subject|3|||
23480220|NCT00797966|65501918|FG004|Phase B|Withdrawal by Subject|0|||
23480221|NCT00797966|65501919|FG005|Phase B|Withdrawal by Subject|0|||
23480222|NCT00797966|65501914|FG000|Phase B|Protocol Deviation|4|||
23480223|NCT00797966|65501915|FG001|Phase B|Protocol Deviation|8|||
23480224|NCT00797966|65501916|FG002|Phase B|Protocol Deviation|2|||
23480225|NCT00797966|65501917|FG003|Phase B|Protocol Deviation|6|||
23480226|NCT00797966|65501918|FG004|Phase B|Protocol Deviation|0|||
23480227|NCT00797966|65501919|FG005|Phase B|Protocol Deviation|0|||
23480228|NCT00797966|65501914|FG000|Phase B|Lack of Efficacy|0|||
23480229|NCT00797966|65501915|FG001|Phase B|Lack of Efficacy|1|||
23480230|NCT00797966|65501916|FG002|Phase B|Lack of Efficacy|1|||
23480231|NCT00797966|65501917|FG003|Phase B|Lack of Efficacy|4|||
23480232|NCT00797966|65501918|FG004|Phase B|Lack of Efficacy|0|||
23480233|NCT00797966|65501919|FG005|Phase B|Lack of Efficacy|0|||
23802738|NCT03739138|66654919|FG000|Overall Study|Withdrawal by Subject|0|||
23802739|NCT03739138|66654920|FG001|Overall Study|Withdrawal by Subject|0|||
23802740|NCT03739138|66654921|FG002|Overall Study|Withdrawal by Subject|0|||
23802741|NCT03739138|66654922|FG003|Overall Study|Withdrawal by Subject|1|||
23802742|NCT03739138|66654923|FG004|Overall Study|Withdrawal by Subject|0|||
23802743|NCT00991510|66654925|FG000|Period I (Days 1-14)|Adverse Event|1|||
23802744|NCT00991510|66654926|FG001|Period I (Days 1-14)|Adverse Event|0|||
23802745|NCT00991510|66654925|FG000|Period III (Days 29-112)|Adverse Event|1|||
23802746|NCT00991510|66654926|FG001|Period III (Days 29-112)|Adverse Event|1|||
23802747|NCT03341000|66654927|FG000|Overall Study|Adverse Event|1|||
23802748|NCT04932941|66654928|FG000|Overall Study|Lost to Follow-up|3|||
23802749|NCT04932941|66654929|FG001|Overall Study|Lost to Follow-up|1|||
23802750|NCT04932941|66654928|FG000|Overall Study|Withdrawal by Subject|7|||
23802751|NCT04932941|66654929|FG001|Overall Study|Withdrawal by Subject|4|||
23802752|NCT04932941|66654928|FG000|Overall Study|Other|4|||
23802753|NCT04932941|66654929|FG001|Overall Study|Other|2|||
23802754|NCT01131299|66658442|FG000|Overall Study|Withdrawal by Subject|4|||
23802755|NCT01131299|66658443|FG001|Overall Study|Withdrawal by Subject|7|||
23802756|NCT00484419|66658444|FG000|Overall Study|Adverse Event|3|||
23802757|NCT00484419|66658445|FG001|Overall Study|Adverse Event|0|||
23802758|NCT00484419|66658446|FG002|Overall Study|Adverse Event|0|||
23802759|NCT00484419|66658444|FG000|Overall Study|Lost to Follow-up|1|||
23802760|NCT00484419|66658445|FG001|Overall Study|Lost to Follow-up|0|||
23802761|NCT00484419|66658446|FG002|Overall Study|Lost to Follow-up|2|||
23802762|NCT00484419|66658444|FG000|Overall Study|Withdrawal by Subject|3|||
23802763|NCT00484419|66658445|FG001|Overall Study|Withdrawal by Subject|1|||
23802764|NCT00484419|66658446|FG002|Overall Study|Withdrawal by Subject|1|||
23802765|NCT00484419|66658444|FG000|Overall Study|subject met discontinuation criteria|2|||
23802766|NCT00484419|66658445|FG001|Overall Study|subject met discontinuation criteria|2|||
23802767|NCT00484419|66658446|FG002|Overall Study|subject met discontinuation criteria|4|||
23802768|NCT00484419|66658444|FG000|Overall Study|required restricted medication|1|||
23802769|NCT00484419|66658445|FG001|Overall Study|required restricted medication|0|||
23802770|NCT00484419|66658446|FG002|Overall Study|required restricted medication|1|||
23802771|NCT00484419|66658444|FG000|Overall Study|Physician Decision|1|||
23802772|NCT00484419|66658445|FG001|Overall Study|Physician Decision|1|||
23802773|NCT00484419|66658446|FG002|Overall Study|Physician Decision|1|||
23802774|NCT00484419|66658444|FG000|Overall Study|subject unable to receive medication|1|||
23802775|NCT00484419|66658445|FG001|Overall Study|subject unable to receive medication|0|||
23802776|NCT00484419|66658446|FG002|Overall Study|subject unable to receive medication|0|||
23802777|NCT00484419|66658444|FG000|Overall Study|subject relocated|0|||
23802778|NCT00484419|66658445|FG001|Overall Study|subject relocated|1|||
23802779|NCT00484419|66658446|FG002|Overall Study|subject relocated|0|||
23802780|NCT00484419|66658444|FG000|Overall Study|sponsor decision, randomized in error|0|||
23802781|NCT00484419|66658445|FG001|Overall Study|sponsor decision, randomized in error|0|||
23802782|NCT00484419|66658446|FG002|Overall Study|sponsor decision, randomized in error|2|||
23802783|NCT03891329|66658447|FG000|Overall Study|Death|5|||
23802784|NCT03891329|66658447|FG000|Overall Study|Lost to Follow-up|4|||
23802785|NCT03891329|66658447|FG000|Overall Study|Physician Decision|4|||
23802786|NCT03891329|66658447|FG000|Overall Study|Device explanted|3|||
23802787|NCT03891329|66658447|FG000|Overall Study|No study device implanted|3|||
23802788|NCT03686150|66658448|FG000|Overall Study|Withdrawal by Subject|1|||
23802789|NCT03686150|66658449|FG001|Overall Study|Withdrawal by Subject|1|||
23802790|NCT03686150|66658450|FG002|Overall Study|Withdrawal by Subject|1|||
23802791|NCT03686150|66658451|FG003|Overall Study|Withdrawal by Subject|0|||
23802792|NCT03686150|66658452|FG004|Overall Study|Withdrawal by Subject|1|||
23802793|NCT03686150|66658453|FG005|Overall Study|Withdrawal by Subject|2|||
23802794|NCT03686150|66658448|FG000|Overall Study|Physician Decision|1|||
23802795|NCT03686150|66658449|FG001|Overall Study|Physician Decision|0|||
23802796|NCT03686150|66658450|FG002|Overall Study|Physician Decision|0|||
23802797|NCT03686150|66658451|FG003|Overall Study|Physician Decision|0|||
23802798|NCT03686150|66658452|FG004|Overall Study|Physician Decision|0|||
23802799|NCT03686150|66658453|FG005|Overall Study|Physician Decision|1|||
23802800|NCT03686150|66658448|FG000|Overall Study|Lost to Follow-up|0|||
23802801|NCT03686150|66658449|FG001|Overall Study|Lost to Follow-up|1|||
23802802|NCT03686150|66658450|FG002|Overall Study|Lost to Follow-up|0|||
23802803|NCT03686150|66658451|FG003|Overall Study|Lost to Follow-up|0|||
23802804|NCT03686150|66658452|FG004|Overall Study|Lost to Follow-up|0|||
23480234|NCT00797966|65501914|FG000|Phase A+|Lost to Follow-up|0|||
23802805|NCT03686150|66658453|FG005|Overall Study|Lost to Follow-up|0|||
23802806|NCT01138826|66658456|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23802807|NCT01138826|66658457|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23802808|NCT01138826|66658458|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23480235|NCT00797966|65501915|FG001|Phase A+|Lost to Follow-up|0|||
23802809|NCT01138826|66658459|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23802810|NCT01138826|66658460|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23802811|NCT01138826|66658461|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23802812|NCT00969124|66658462|FG000|Overall Study|Protocol Violation|2|||
23802813|NCT00969124|66658462|FG000|Overall Study|Inadequate bowel preparation|15|||
23802814|NCT00969124|66658462|FG000|Overall Study|Inability to reach cecum|9|||
23802815|NCT00969124|66658462|FG000|Overall Study|Previously unrecognized disease|3|||
23802816|NCT00969124|66658462|FG000|Overall Study|Technical error|1|||
23802817|NCT00767520|66658463|FG000|Overall Study|Participants still on treatment|11|||
23802818|NCT00767520|66658464|FG001|Overall Study|Participants still on treatment|15|||
23802819|NCT00767520|66658463|FG000|Overall Study|Randomized in error and Never treated|0|||
23802820|NCT00767520|66658464|FG001|Overall Study|Randomized in error and Never treated|2|||
23802821|NCT02709486|66658471|FG000|Overall Study|Adverse Event|2|||
23802822|NCT02709486|66658472|FG001|Overall Study|Adverse Event|5|||
23802823|NCT02709486|66658473|FG002|Overall Study|Adverse Event|3|||
23802824|NCT02709486|66658471|FG000|Overall Study|Death|0|||
23802825|NCT02709486|66658472|FG001|Overall Study|Death|0|||
23802826|NCT02709486|66658473|FG002|Overall Study|Death|2|||
23802827|NCT02709486|66658471|FG000|Overall Study|Insufficient clinical response|7|||
23802828|NCT02709486|66658472|FG001|Overall Study|Insufficient clinical response|3|||
23802829|NCT02709486|66658473|FG002|Overall Study|Insufficient clinical response|3|||
23802830|NCT02709486|66658471|FG000|Overall Study|Lost to Follow-up|3|||
23802831|NCT02709486|66658472|FG001|Overall Study|Lost to Follow-up|2|||
23802832|NCT02709486|66658473|FG002|Overall Study|Lost to Follow-up|2|||
23802833|NCT02709486|66658471|FG000|Overall Study|Other|0|||
23802834|NCT02709486|66658472|FG001|Overall Study|Other|2|||
23802835|NCT02709486|66658473|FG002|Overall Study|Other|3|||
23802836|NCT02709486|66658471|FG000|Overall Study|Withdrawal by Subject|32|||
23802837|NCT02709486|66658472|FG001|Overall Study|Withdrawal by Subject|22|||
23802838|NCT02709486|66658473|FG002|Overall Study|Withdrawal by Subject|32|||
23802839|NCT00369382|66658474|FG000|Overall Study|Death|0|||
23802840|NCT00369382|66658475|FG001|Overall Study|Death|2|||
23802841|NCT00369382|66658474|FG000|Overall Study|Physician Decision|2|||
23802842|NCT00369382|66658475|FG001|Overall Study|Physician Decision|1|||
23802843|NCT00369382|66658474|FG000|Overall Study|Withdrawal by Subject|5|||
23802844|NCT00369382|66658475|FG001|Overall Study|Withdrawal by Subject|0|||
23802845|NCT00369382|66658474|FG000|Overall Study|Randomized, not treated|2|||
23802846|NCT00369382|66658475|FG001|Overall Study|Randomized, not treated|0|||
23802847|NCT00369382|66658474|FG000|Overall Study|Other|1|||
23802848|NCT00369382|66658475|FG001|Overall Study|Other|0|||
23802849|NCT04039919|66658476|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23361078|NCT04058028|65065965|FG003|Overall Study|Withdrawal of Consent from Study|7|||
23802850|NCT04039919|66658477|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23802851|NCT04039919|66658478|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23802852|NCT04039919|66658479|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23802853|NCT04039919|66658480|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23802854|NCT04039919|66658476|FG000|Treatment Period 1|Sponsor's decision|0|||
23802855|NCT04039919|66658477|FG001|Treatment Period 1|Sponsor's decision|0|||
23802856|NCT04039919|66658478|FG002|Treatment Period 1|Sponsor's decision|0|||
23802857|NCT04039919|66658479|FG003|Treatment Period 1|Sponsor's decision|0|||
23802858|NCT04039919|66658480|FG004|Treatment Period 1|Sponsor's decision|16|||
23802859|NCT04039919|66658476|FG000|Treatment Period 5|Withdrawal by Subject|1|||
23802860|NCT04039919|66658477|FG001|Treatment Period 5|Withdrawal by Subject|0|||
23802861|NCT04039919|66658478|FG002|Treatment Period 5|Withdrawal by Subject|0|||
23802862|NCT04039919|66658479|FG003|Treatment Period 5|Withdrawal by Subject|0|||
23802863|NCT04039919|66658480|FG004|Treatment Period 5|Withdrawal by Subject|0|||
23802864|NCT03235479|66658481|FG000|Overall Study|Lost to Follow-up|8|||
23802865|NCT03235479|66658482|FG001|Overall Study|Lost to Follow-up|11|||
23802866|NCT03235479|66658481|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
23802867|NCT03235479|66658482|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
23802868|NCT03235479|66658481|FG000|Overall Study|Pregnancy|1|||
23802869|NCT03235479|66658482|FG001|Overall Study|Pregnancy|0|||
23802870|NCT03235479|66658481|FG000|Overall Study|Protocol Deviation|1|||
23802871|NCT03235479|66658482|FG001|Overall Study|Protocol Deviation|3|||
23802872|NCT03235479|66658481|FG000|Overall Study|Technical Problems|3|||
23802873|NCT03235479|66658482|FG001|Overall Study|Technical Problems|2|||
23802874|NCT03235479|66658481|FG000|Overall Study|Withdrawal by Subject|2|||
23802875|NCT03235479|66658482|FG001|Overall Study|Withdrawal by Subject|2|||
23802876|NCT03235479|66658481|FG000|Overall Study|Other Reasons|3|||
23802877|NCT03235479|66658482|FG001|Overall Study|Other Reasons|5|||
23802878|NCT03585959|66658483|FG000|Overall Study|Physician Decision|1|||
23802879|NCT03585959|66658483|FG000|Overall Study|Unsuccessful Procedure|2|||
23802880|NCT04233879|66658484|FG000|Overall Study|Death|2|||
23802881|NCT04233879|66658485|FG001|Overall Study|Death|0|||
23802882|NCT04233879|66658484|FG000|Overall Study|Lost to Follow-up|3|||
23802883|NCT04233879|66658485|FG001|Overall Study|Lost to Follow-up|8|||
23802884|NCT04233879|66658484|FG000|Overall Study|Physician Decision|4|||
23802885|NCT04233879|66658485|FG001|Overall Study|Physician Decision|4|||
23802886|NCT04233879|66658484|FG000|Overall Study|Withdrawal by Subject|7|||
23802887|NCT04233879|66658485|FG001|Overall Study|Withdrawal by Subject|10|||
23802888|NCT04233879|66658484|FG000|Overall Study|Other|281|||
23802889|NCT04233879|66658485|FG001|Overall Study|Other|279|||
23802890|NCT00359788|66658486|FG000|Overall Study|Adverse Event|11|||
23802891|NCT00359788|66658487|FG001|Overall Study|Adverse Event|10|||
23802892|NCT00359788|66658486|FG000|Overall Study|Lack of Efficacy|1|||
23802893|NCT00359788|66658487|FG001|Overall Study|Lack of Efficacy|2|||
23802894|NCT00359788|66658486|FG000|Overall Study|Lost to Follow-up|3|||
23802895|NCT00359788|66658487|FG001|Overall Study|Lost to Follow-up|2|||
23802896|NCT00359788|66658486|FG000|Overall Study|Withdrawal by Subject|4|||
23802897|NCT00359788|66658487|FG001|Overall Study|Withdrawal by Subject|1|||
23802898|NCT00359788|66658486|FG000|Overall Study|Protocol Violation|4|||
23802899|NCT00359788|66658487|FG001|Overall Study|Protocol Violation|2|||
23802900|NCT00293202|66658488|FG000|Overall Study|Withdrawal by Subject|1|||
23802901|NCT00293202|66658489|FG001|Overall Study|Withdrawal by Subject|2|||
23802902|NCT00293202|66658488|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
23802903|NCT00293202|66658489|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
23802904|NCT00293202|66658488|FG000|Overall Study|on-hold due to fistula maturation time|1|||
23802905|NCT00293202|66658489|FG001|Overall Study|on-hold due to fistula maturation time|0|||
23802906|NCT00103402|66658492|FG000|Overall Study|Adverse Event|3|||
23802907|NCT00103402|66658493|FG001|Overall Study|Adverse Event|4|||
23802908|NCT00103402|66658492|FG000|Overall Study|Lost to Follow-up|8|||
23802909|NCT00103402|66658493|FG001|Overall Study|Lost to Follow-up|7|||
23802910|NCT00103402|66658492|FG000|Overall Study|Dissatisfied/No longer interested|6|||
23802911|NCT00103402|66658493|FG001|Overall Study|Dissatisfied/No longer interested|6|||
23599777|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
23802912|NCT00103402|66658492|FG000|Overall Study|Personal constraints/Other|5|||
23599778|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
23802913|NCT00103402|66658493|FG001|Overall Study|Personal constraints/Other|0|||
23802914|NCT00690482|66658498|FG000|Overall Study|Adverse Event|2|||
23802915|NCT00690482|66658499|FG001|Overall Study|Adverse Event|1|||
23802916|NCT00690482|66658498|FG000|Overall Study|Incorrect enrolment|0|||
23802917|NCT00690482|66658499|FG001|Overall Study|Incorrect enrolment|1|||
23802918|NCT00690482|66658498|FG000|Overall Study|Study-specific discontinuation criteria|1|||
23802919|NCT00690482|66658499|FG001|Overall Study|Study-specific discontinuation criteria|0|||
23802920|NCT00690482|66658498|FG000|Overall Study|Intake of prohibited medicine|1|||
23802921|NCT00690482|66658499|FG001|Overall Study|Intake of prohibited medicine|0|||
23802922|NCT00690482|66658498|FG000|Overall Study|withdrew consent at rand.day|0|||
23802923|NCT00690482|66658499|FG001|Overall Study|withdrew consent at rand.day|1|||
23802924|NCT01491035|66658504|FG000|Overall Study|Lost to Follow-up|0|||
23802925|NCT01491035|66658505|FG001|Overall Study|Lost to Follow-up|0|||
23802926|NCT01491035|66658506|FG002|Overall Study|Lost to Follow-up|0|||
23802927|NCT01491035|66658507|FG003|Overall Study|Lost to Follow-up|0|||
23802928|NCT01491035|66658508|FG004|Overall Study|Lost to Follow-up|1|||
23802929|NCT01491035|66658509|FG005|Overall Study|Lost to Follow-up|0|||
23802930|NCT01491035|66658510|FG006|Overall Study|Lost to Follow-up|0|||
23802931|NCT01491035|66658511|FG007|Overall Study|Lost to Follow-up|0|||
23802932|NCT01048502|66658513|FG000|Overall Study|Lost to Follow-up|2|||
23802933|NCT01048502|66658514|FG001|Overall Study|Lost to Follow-up|0|||
23802934|NCT01048502|66658515|FG002|Overall Study|Lost to Follow-up|0|||
23802935|NCT01048502|66658516|FG003|Overall Study|Lost to Follow-up|0|||
23802936|NCT01048502|66658513|FG000|Overall Study|Adverse Event|1|||
23802937|NCT01048502|66658514|FG001|Overall Study|Adverse Event|0|||
23802938|NCT01048502|66658515|FG002|Overall Study|Adverse Event|0|||
23802939|NCT01048502|66658516|FG003|Overall Study|Adverse Event|0|||
23802940|NCT01048502|66658513|FG000|Overall Study|Withdrawal by Subject|1|||
23802941|NCT01048502|66658514|FG001|Overall Study|Withdrawal by Subject|4|||
23802942|NCT01048502|66658515|FG002|Overall Study|Withdrawal by Subject|5|||
23802943|NCT01048502|66658516|FG003|Overall Study|Withdrawal by Subject|3|||
23802944|NCT01048502|66658513|FG000|Overall Study|Physician Decision|0|||
23802945|NCT01048502|66658514|FG001|Overall Study|Physician Decision|3|||
23802946|NCT01048502|66658515|FG002|Overall Study|Physician Decision|0|||
23802947|NCT01048502|66658516|FG003|Overall Study|Physician Decision|1|||
23802948|NCT02492841|66658517|FG000|Overall Study|Lost to Follow-up|34|||
23802949|NCT02492841|66658518|FG001|Overall Study|Lost to Follow-up|31|||
23802950|NCT02492841|66658519|FG002|Overall Study|Lost to Follow-up|35|||
23802951|NCT03545191|66658520|FG000|Overall Study|Death|1|||
23802952|NCT03545191|66658521|FG001|Overall Study|Death|0|||
23802953|NCT03545191|66658522|FG002|Overall Study|Death|0|||
23802954|NCT03545191|66658520|FG000|Overall Study|Adverse Event|4|||
23802955|NCT03545191|66658521|FG001|Overall Study|Adverse Event|2|||
23802956|NCT03545191|66658522|FG002|Overall Study|Adverse Event|7|||
23802957|NCT03545191|66658520|FG000|Overall Study|Other reasons|3|||
23802958|NCT03545191|66658521|FG001|Overall Study|Other reasons|11|||
23802959|NCT03545191|66658522|FG002|Overall Study|Other reasons|8|||
23802960|NCT03545191|66658520|FG000|Overall Study|Withdrawal by Subject|13|||
23802961|NCT03545191|66658521|FG001|Overall Study|Withdrawal by Subject|10|||
23802962|NCT03545191|66658522|FG002|Overall Study|Withdrawal by Subject|12|||
23802963|NCT03545191|66658520|FG000|Overall Study|Lost to Follow-up|1|||
23802964|NCT03545191|66658521|FG001|Overall Study|Lost to Follow-up|2|||
23802965|NCT03545191|66658522|FG002|Overall Study|Lost to Follow-up|3|||
23802966|NCT01194973|66658523|FG000|Screening Period|Screen Failure|3|||
23802967|NCT01194973|66658523|FG000|26 Week Treatment Period|Adverse Event|1|||
23802968|NCT01194973|66658523|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
23802969|NCT01194973|66658523|FG000|26 Week Treatment Period|Pregnancy|1|||
23802970|NCT00720226|66658524|FG000|Overall Study|Withdrawal by Subject|7|||
23802971|NCT00720226|66658525|FG001|Overall Study|Withdrawal by Subject|4|||
23802972|NCT02224573|66658526|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
23802973|NCT02224573|66658527|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
23802974|NCT02224573|66658526|FG000|Treatment Phase|Started on Other IMP|1|||
23802975|NCT02224573|66658527|FG001|Treatment Phase|Started on Other IMP|0|||
23802976|NCT02224573|66658526|FG000|Treatment Phase|Participant Discontinued IMP|0|||
23802977|NCT02224573|66658527|FG001|Treatment Phase|Participant Discontinued IMP|1|||
23802978|NCT02224573|66658526|FG000|Treatment Phase|Lack of Efficacy|15|||
23802979|NCT02224573|66658527|FG001|Treatment Phase|Lack of Efficacy|8|||
23802980|NCT02224573|66658526|FG000|Treatment Phase|Began Commercial Product|1|||
23802981|NCT02224573|66658527|FG001|Treatment Phase|Began Commercial Product|0|||
23802982|NCT02224573|66658526|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
23802983|NCT02224573|66658527|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
23361079|NCT04058028|65065962|FG000|Overall Study|Decision by Sponsor|13|||
23802984|NCT02224573|66658526|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
23802985|NCT02224573|66658527|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
23802986|NCT02224573|66658526|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
23802987|NCT02224573|66658527|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
23802988|NCT02224573|66658526|FG000|Treatment Phase|Continued Compassionate Use|1|||
23361080|NCT04058028|65065963|FG001|Overall Study|Decision by Sponsor|4|||
23361081|NCT04058028|65065964|FG002|Overall Study|Decision by Sponsor|1|||
23802989|NCT02224573|66658527|FG001|Treatment Phase|Continued Compassionate Use|0|||
23802990|NCT02224573|66658526|FG000|Treatment Phase|Lack of Efficiency|2|||
23802991|NCT02224573|66658527|FG001|Treatment Phase|Lack of Efficiency|1|||
23802992|NCT02224573|66658526|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
23802993|NCT02224573|66658527|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
23802994|NCT02224573|66658526|FG000|Treatment Phase|Participant Moved|2|||
23802995|NCT02224573|66658527|FG001|Treatment Phase|Participant Moved|0|||
23802996|NCT02224573|66658526|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
23802997|NCT02224573|66658527|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
23802998|NCT02224573|66658526|FG000|Treatment Phase|Refused Medication|1|||
23802999|NCT02224573|66658527|FG001|Treatment Phase|Refused Medication|1|||
23480236|NCT00797966|65501916|FG002|Phase A+|Lost to Follow-up|0|||
23480237|NCT00797966|65501917|FG003|Phase A+|Lost to Follow-up|0|||
23480238|NCT00797966|65501918|FG004|Phase A+|Lost to Follow-up|0|||
23480239|NCT00797966|65501919|FG005|Phase A+|Lost to Follow-up|9|||
23480240|NCT00797966|65501914|FG000|Phase A+|Met withdrawal criteria|0|||
23480241|NCT00797966|65501915|FG001|Phase A+|Met withdrawal criteria|0|||
23480242|NCT00797966|65501916|FG002|Phase A+|Met withdrawal criteria|0|||
23480243|NCT00797966|65501917|FG003|Phase A+|Met withdrawal criteria|0|||
23480244|NCT00797966|65501918|FG004|Phase A+|Met withdrawal criteria|0|||
23480245|NCT00797966|65501919|FG005|Phase A+|Met withdrawal criteria|5|||
23480246|NCT00797966|65501914|FG000|Phase A+|Withdrawal by Subject|0|||
23480247|NCT00797966|65501915|FG001|Phase A+|Withdrawal by Subject|0|||
23480248|NCT00797966|65501916|FG002|Phase A+|Withdrawal by Subject|0|||
23480249|NCT00797966|65501917|FG003|Phase A+|Withdrawal by Subject|0|||
23480250|NCT00797966|65501918|FG004|Phase A+|Withdrawal by Subject|0|||
23480251|NCT00797966|65501919|FG005|Phase A+|Withdrawal by Subject|6|||
23480252|NCT00797966|65501914|FG000|Phase A+|Adverse Event|0|||
23480253|NCT00797966|65501915|FG001|Phase A+|Adverse Event|0|||
23480254|NCT00797966|65501916|FG002|Phase A+|Adverse Event|0|||
23480255|NCT00797966|65501917|FG003|Phase A+|Adverse Event|0|||
23480256|NCT00797966|65501918|FG004|Phase A+|Adverse Event|0|||
23480257|NCT00797966|65501919|FG005|Phase A+|Adverse Event|4|||
23480258|NCT00797966|65501914|FG000|Phase A+|Protocol deviation|0|||
23480259|NCT00797966|65501915|FG001|Phase A+|Protocol deviation|0|||
23480260|NCT00797966|65501916|FG002|Phase A+|Protocol deviation|0|||
23480261|NCT00797966|65501917|FG003|Phase A+|Protocol deviation|0|||
23480262|NCT00797966|65501918|FG004|Phase A+|Protocol deviation|0|||
23480263|NCT00797966|65501919|FG005|Phase A+|Protocol deviation|4|||
23480264|NCT01527357|65501920|FG000|Overall Study|Death|8|||
23480265|NCT01527357|65501921|FG001|Overall Study|Death|2|||
23480266|NCT01527357|65501920|FG000|Overall Study|Lost to Follow-up|6|||
23480267|NCT01527357|65501921|FG001|Overall Study|Lost to Follow-up|4|||
23480268|NCT01527357|65501920|FG000|Overall Study|Withdrew Consent|1|||
23480269|NCT01527357|65501921|FG001|Overall Study|Withdrew Consent|1|||
23480270|NCT01527357|65501920|FG000|Overall Study|Non-compliance|0|||
23480271|NCT01527357|65501921|FG001|Overall Study|Non-compliance|1|||
23480272|NCT01527357|65501920|FG000|Overall Study|No Day 29 Visit|0|||
23480273|NCT01527357|65501921|FG001|Overall Study|No Day 29 Visit|1|||
23480274|NCT01527357|65501920|FG000|Overall Study|Did Not Receive Treatment|2|||
23480275|NCT01527357|65501921|FG001|Overall Study|Did Not Receive Treatment|0|||
23480276|NCT00710762|65501925|FG000|Overall Study|Progressive disease|27|||
23480277|NCT00710762|65501926|FG001|Overall Study|Progressive disease|30|||
23480278|NCT00710762|65501925|FG000|Overall Study|Adverse Event other disease worsening|2|||
23480279|NCT00710762|65501926|FG001|Overall Study|Adverse Event other disease worsening|1|||
23480280|NCT00710762|65501925|FG000|Overall Study|Other Adverse Event|7|||
23480281|NCT00710762|65501926|FG001|Overall Study|Other Adverse Event|7|||
23480282|NCT00710762|65501925|FG000|Overall Study|Lost to Follow-up|1|||
23480283|NCT00710762|65501926|FG001|Overall Study|Lost to Follow-up|0|||
23480284|NCT00710762|65501925|FG000|Overall Study|Reason other than listed above|2|||
23480285|NCT00710762|65501926|FG001|Overall Study|Reason other than listed above|2|||
23480286|NCT00217464|65501929|FG000|Overall Study|Progression|15|||
23480287|NCT00217464|65501929|FG000|Overall Study|Other|2|||
23480288|NCT00266877|65501930|FG000|Overall Study|Death|1|||
23480289|NCT00266877|65501931|FG001|Overall Study|Death|1|||
23480290|NCT00266877|65501932|FG002|Overall Study|Death|1|||
23480291|NCT00266877|65501930|FG000|Overall Study|Adverse Event|6|||
23480292|NCT00266877|65501931|FG001|Overall Study|Adverse Event|4|||
23480293|NCT00266877|65501932|FG002|Overall Study|Adverse Event|1|||
23480294|NCT00266877|65501930|FG000|Overall Study|Physician Decision|2|||
23480295|NCT00266877|65501931|FG001|Overall Study|Physician Decision|1|||
23480296|NCT00266877|65501932|FG002|Overall Study|Physician Decision|1|||
23480297|NCT00266877|65501930|FG000|Overall Study|Withdrawal by Subject|3|||
23654846|NCT03285178|66121386|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23480298|NCT00266877|65501931|FG001|Overall Study|Withdrawal by Subject|1|||
23480299|NCT00266877|65501932|FG002|Overall Study|Withdrawal by Subject|1|||
23480300|NCT00266877|65501930|FG000|Overall Study|Disease Progression|72|||
23480301|NCT00266877|65501931|FG001|Overall Study|Disease Progression|37|||
23480302|NCT00266877|65501932|FG002|Overall Study|Disease Progression|23|||
23480303|NCT00266877|65501930|FG000|Overall Study|Symptomatic Deterioration|6|||
23480304|NCT00266877|65501931|FG001|Overall Study|Symptomatic Deterioration|3|||
23480305|NCT00266877|65501932|FG002|Overall Study|Symptomatic Deterioration|1|||
23480306|NCT00266877|65501930|FG000|Overall Study|Hospitalization|1|||
23480307|NCT00266877|65501931|FG001|Overall Study|Hospitalization|0|||
23480308|NCT00266877|65501932|FG002|Overall Study|Hospitalization|0|||
23480309|NCT00266877|65501930|FG000|Overall Study|Concomitant Radiotherapy|0|||
23480310|NCT00266877|65501931|FG001|Overall Study|Concomitant Radiotherapy|1|||
23480311|NCT00266877|65501932|FG002|Overall Study|Concomitant Radiotherapy|0|||
23480312|NCT03338959|65501933|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
23480313|NCT03338959|65501933|FG000|Overall Study|Physician Decision|1|||
23803000|NCT02224573|66658526|FG000|Treatment Phase|Adverse Event|26|||
23803001|NCT02224573|66658527|FG001|Treatment Phase|Adverse Event|38|||
23803002|NCT02224573|66658526|FG000|Treatment Phase|Placed in Group Home|0|||
23803003|NCT02224573|66658527|FG001|Treatment Phase|Placed in Group Home|1|||
23803004|NCT02224573|66658526|FG000|Treatment Phase|Pursued Other Trials|1|||
23803005|NCT02224573|66658527|FG001|Treatment Phase|Pursued Other Trials|0|||
23803006|NCT02224573|66658526|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
23803007|NCT02224573|66658527|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
23803008|NCT02224573|66658526|FG000|Treatment Phase|Lost to Follow-up|2|||
23803009|NCT02224573|66658527|FG001|Treatment Phase|Lost to Follow-up|1|||
23803010|NCT02224573|66658526|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
23803011|NCT02224573|66658527|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
23803012|NCT02224573|66658526|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
23803013|NCT02224573|66658527|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
23803014|NCT02224573|66658526|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
23803015|NCT02224573|66658527|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
23803016|NCT02224573|66658526|FG000|Taper Phase|Adverse Event|1|||
23803017|NCT02224573|66658527|FG001|Taper Phase|Adverse Event|1|||
23803018|NCT02083926|66658528|FG000|Overall Study|Withdrawal by Subject|1|||
23803019|NCT02083926|66658529|FG001|Overall Study|Withdrawal by Subject|0|||
23803020|NCT02075606|66658530|FG000|Overall Study|Adverse Event|5|||
23803021|NCT02075606|66658530|FG000|Overall Study|Withdrawal by Subject|1|||
23803022|NCT02075606|66658530|FG000|Overall Study|Death|1|||
23803023|NCT02075606|66658530|FG000|Overall Study|Investigator's decision|1|||
23803024|NCT02075606|66658530|FG000|Overall Study|Symptom management|1|||
23803025|NCT02075606|66658530|FG000|Overall Study|Increasing Symptoms|1|||
23803026|NCT03903159|66658531|FG000|Overall Study|Discharged with Staff Approval|2|||
23803027|NCT03903159|66658531|FG000|Overall Study|Discharged at Staff Request|2|||
23803028|NCT03903159|66658531|FG000|Overall Study|Discharged Against Staff Advice|1|||
23803029|NCT01557582|66658532|FG000|Overall Study|Protocol Violation|4|||
23803030|NCT01557582|66658532|FG000|Overall Study|Operator error|2|||
23803031|NCT01207440|66658533|FG000|Overall Study|Adverse Event|46|||
23803032|NCT01207440|66658534|FG001|Overall Study|Adverse Event|11|||
23803033|NCT01207440|66658535|FG002|Overall Study|Adverse Event|7|||
23803034|NCT01207440|66658536|FG003|Overall Study|Adverse Event|2|||
23803035|NCT01207440|66658537|FG004|Overall Study|Adverse Event|6|||
23803036|NCT01207440|66658538|FG005|Overall Study|Adverse Event|6|||
23803037|NCT01207440|66658539|FG006|Overall Study|Adverse Event|2|||
23803038|NCT01207440|66658533|FG000|Overall Study|Death|6|||
23803039|NCT01207440|66658534|FG001|Overall Study|Death|3|||
23803040|NCT01207440|66658535|FG002|Overall Study|Death|2|||
23803041|NCT01207440|66658536|FG003|Overall Study|Death|2|||
23803042|NCT01207440|66658537|FG004|Overall Study|Death|7|||
23803043|NCT01207440|66658538|FG005|Overall Study|Death|5|||
23803044|NCT01207440|66658539|FG006|Overall Study|Death|1|||
23803045|NCT01207440|66658533|FG000|Overall Study|Lack of Efficacy|13|||
23803046|NCT01207440|66658534|FG001|Overall Study|Lack of Efficacy|2|||
23803047|NCT01207440|66658535|FG002|Overall Study|Lack of Efficacy|5|||
23803048|NCT01207440|66658536|FG003|Overall Study|Lack of Efficacy|1|||
23803049|NCT01207440|66658537|FG004|Overall Study|Lack of Efficacy|2|||
23803050|NCT01207440|66658538|FG005|Overall Study|Lack of Efficacy|3|||
23803051|NCT01207440|66658539|FG006|Overall Study|Lack of Efficacy|0|||
23803052|NCT01207440|66658533|FG000|Overall Study|Lost to Follow-up|0|||
23803053|NCT01207440|66658534|FG001|Overall Study|Lost to Follow-up|0|||
23803054|NCT01207440|66658535|FG002|Overall Study|Lost to Follow-up|2|||
23803055|NCT01207440|66658536|FG003|Overall Study|Lost to Follow-up|1|||
23803056|NCT01207440|66658537|FG004|Overall Study|Lost to Follow-up|0|||
23803057|NCT01207440|66658538|FG005|Overall Study|Lost to Follow-up|0|||
23803058|NCT01207440|66658539|FG006|Overall Study|Lost to Follow-up|0|||
23803059|NCT01207440|66658533|FG000|Overall Study|Non-compliance with Study Drug|3|||
23803060|NCT01207440|66658534|FG001|Overall Study|Non-compliance with Study Drug|0|||
23803061|NCT01207440|66658535|FG002|Overall Study|Non-compliance with Study Drug|1|||
23803062|NCT01207440|66658536|FG003|Overall Study|Non-compliance with Study Drug|0|||
23803063|NCT01207440|66658537|FG004|Overall Study|Non-compliance with Study Drug|0|||
23803064|NCT01207440|66658538|FG005|Overall Study|Non-compliance with Study Drug|0|||
23480314|NCT00246571|65501934|FG000|Overall Study|Adverse Event|7|||
23480315|NCT00246571|65501935|FG001|Overall Study|Adverse Event|0|||
23803065|NCT01207440|66658539|FG006|Overall Study|Non-compliance with Study Drug|0|||
23803066|NCT01207440|66658533|FG000|Overall Study|Physician Decision|6|||
23803067|NCT01207440|66658534|FG001|Overall Study|Physician Decision|5|||
23803068|NCT01207440|66658535|FG002|Overall Study|Physician Decision|5|||
23803069|NCT01207440|66658536|FG003|Overall Study|Physician Decision|0|||
23803070|NCT01207440|66658537|FG004|Overall Study|Physician Decision|1|||
23803071|NCT01207440|66658538|FG005|Overall Study|Physician Decision|0|||
23803072|NCT01207440|66658539|FG006|Overall Study|Physician Decision|0|||
23803073|NCT01207440|66658533|FG000|Overall Study|Progressive Disease|19|||
23803074|NCT01207440|66658534|FG001|Overall Study|Progressive Disease|10|||
23803075|NCT01207440|66658535|FG002|Overall Study|Progressive Disease|19|||
23803076|NCT01207440|66658536|FG003|Overall Study|Progressive Disease|7|||
23803077|NCT01207440|66658537|FG004|Overall Study|Progressive Disease|23|||
23803078|NCT01207440|66658538|FG005|Overall Study|Progressive Disease|27|||
23803079|NCT01207440|66658539|FG006|Overall Study|Progressive Disease|0|||
23803080|NCT01207440|66658533|FG000|Overall Study|Protocol Violation|2|||
23803081|NCT01207440|66658534|FG001|Overall Study|Protocol Violation|0|||
23803082|NCT01207440|66658535|FG002|Overall Study|Protocol Violation|0|||
23803083|NCT01207440|66658536|FG003|Overall Study|Protocol Violation|0|||
23803084|NCT01207440|66658537|FG004|Overall Study|Protocol Violation|0|||
23803085|NCT01207440|66658538|FG005|Overall Study|Protocol Violation|0|||
23803086|NCT01207440|66658539|FG006|Overall Study|Protocol Violation|0|||
23803087|NCT01207440|66658533|FG000|Overall Study|Site Terminated by Sponsor|69|||
23803088|NCT01207440|66658534|FG001|Overall Study|Site Terminated by Sponsor|19|||
23803089|NCT01207440|66658535|FG002|Overall Study|Site Terminated by Sponsor|12|||
23803090|NCT01207440|66658536|FG003|Overall Study|Site Terminated by Sponsor|2|||
23803091|NCT01207440|66658537|FG004|Overall Study|Site Terminated by Sponsor|3|||
23803092|NCT01207440|66658538|FG005|Overall Study|Site Terminated by Sponsor|0|||
23803093|NCT01207440|66658539|FG006|Overall Study|Site Terminated by Sponsor|2|||
23803094|NCT01207440|66658533|FG000|Overall Study|Withdrawal by Subject|29|||
23803095|NCT01207440|66658534|FG001|Overall Study|Withdrawal by Subject|4|||
23803096|NCT01207440|66658535|FG002|Overall Study|Withdrawal by Subject|5|||
23803097|NCT01207440|66658536|FG003|Overall Study|Withdrawal by Subject|3|||
23803098|NCT01207440|66658537|FG004|Overall Study|Withdrawal by Subject|2|||
23803099|NCT01207440|66658538|FG005|Overall Study|Withdrawal by Subject|2|||
23803100|NCT01207440|66658539|FG006|Overall Study|Withdrawal by Subject|0|||
23803101|NCT01207440|66658533|FG000|Overall Study|Reason Not Specified|10|||
23803102|NCT01207440|66658534|FG001|Overall Study|Reason Not Specified|10|||
23803103|NCT01207440|66658535|FG002|Overall Study|Reason Not Specified|7|||
23803104|NCT01207440|66658536|FG003|Overall Study|Reason Not Specified|0|||
23803105|NCT01207440|66658537|FG004|Overall Study|Reason Not Specified|4|||
23803106|NCT01207440|66658538|FG005|Overall Study|Reason Not Specified|3|||
23803107|NCT01207440|66658539|FG006|Overall Study|Reason Not Specified|0|||
23803108|NCT01345318|66658546|FG000|Overall Study|Adverse Event|16|||
23803109|NCT01345318|66658546|FG000|Overall Study|Lack of Efficacy|17|||
23803110|NCT01345318|66658546|FG000|Overall Study|Lost to Follow-up|2|||
23803111|NCT01345318|66658546|FG000|Overall Study|Protocol Violation|1|||
23803112|NCT01345318|66658546|FG000|Overall Study|Withdrawal by Subject|41|||
23803113|NCT01345318|66658546|FG000|Overall Study|Other|3|||
23803114|NCT00834899|66658547|FG000|Overall Study|Withdrawal by Subject|1|||
23803115|NCT00834899|66658548|FG001|Overall Study|Withdrawal by Subject|1|||
23803116|NCT00268892|66658549|FG000|Overall Study|Adverse Event|14|||
23803117|NCT00268892|66658550|FG001|Overall Study|Adverse Event|17|||
23803118|NCT00268892|66658551|FG002|Overall Study|Adverse Event|20|||
23803119|NCT00268892|66658549|FG000|Overall Study|Lack of Efficacy|1|||
23803120|NCT00268892|66658550|FG001|Overall Study|Lack of Efficacy|3|||
23803121|NCT00268892|66658551|FG002|Overall Study|Lack of Efficacy|0|||
23803122|NCT00268892|66658549|FG000|Overall Study|Withdrawal by Subject|14|||
23803123|NCT00268892|66658550|FG001|Overall Study|Withdrawal by Subject|15|||
23803124|NCT00268892|66658551|FG002|Overall Study|Withdrawal by Subject|13|||
23803125|NCT00268892|66658549|FG000|Overall Study|Physician Decision|0|||
23803126|NCT00268892|66658550|FG001|Overall Study|Physician Decision|1|||
23803127|NCT00268892|66658551|FG002|Overall Study|Physician Decision|0|||
23803128|NCT00268892|66658549|FG000|Overall Study|Lost to Follow-up|5|||
23803129|NCT00268892|66658550|FG001|Overall Study|Lost to Follow-up|2|||
23803130|NCT00268892|66658551|FG002|Overall Study|Lost to Follow-up|4|||
23803131|NCT00268892|66658549|FG000|Overall Study|Protocol Violation|0|||
23803132|NCT00268892|66658550|FG001|Overall Study|Protocol Violation|1|||
23803133|NCT00268892|66658551|FG002|Overall Study|Protocol Violation|0|||
23803134|NCT00268892|66658549|FG000|Overall Study|Disease Progression|1|||
23803135|NCT00268892|66658550|FG001|Overall Study|Disease Progression|1|||
23803136|NCT00268892|66658551|FG002|Overall Study|Disease Progression|0|||
23803137|NCT00268892|66658549|FG000|Overall Study|Trial Site Closed|4|||
23654847|NCT03285178|66121387|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23803138|NCT00268892|66658550|FG001|Overall Study|Trial Site Closed|2|||
23803139|NCT00268892|66658551|FG002|Overall Study|Trial Site Closed|2|||
23803140|NCT00725621|66658552|FG000|Overall Study|Adverse Event|25|||
23803141|NCT00725621|66658552|FG000|Overall Study|Lack of Efficacy|46|||
23803142|NCT00725621|66658552|FG000|Overall Study|Withdrawal by Subject|57|||
23803143|NCT00725621|66658552|FG000|Overall Study|Physician Decision|19|||
23803144|NCT00725621|66658552|FG000|Overall Study|Lost to Follow-up|52|||
23803145|NCT00725621|66658552|FG000|Overall Study|Non-compliance|8|||
23803146|NCT00725621|66658552|FG000|Overall Study|Continued treatment by other physician|6|||
23803147|NCT00725621|66658552|FG000|Overall Study|Switched to other study|1|||
23803148|NCT00725621|66658552|FG000|Overall Study|Switched to other drug|1|||
23803149|NCT00725621|66658552|FG000|Overall Study|Prepared for elective surgery|1|||
23803150|NCT00725621|66658552|FG000|Overall Study|Reason not specified|55|||
23803151|NCT02037165|66658553|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23803152|NCT02037165|66658554|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23803153|NCT02037165|66658555|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23803154|NCT02037165|66658556|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23803155|NCT02037165|66658557|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
23803156|NCT01673698|66658558|FG000|Overall Study|Lost to Follow-up|51|||
23803157|NCT01673698|66658559|FG001|Overall Study|Lost to Follow-up|13|||
23803158|NCT00479388|66658563|FG000|Overall Study|Adverse Event|90|||
23803159|NCT00479388|66658564|FG001|Overall Study|Adverse Event|45|||
23803160|NCT00479388|66658563|FG000|Overall Study|Lost to Follow-up|0|||
23803161|NCT00479388|66658564|FG001|Overall Study|Lost to Follow-up|2|||
23803162|NCT00479388|66658563|FG000|Overall Study|Protocol Violation|10|||
23803163|NCT00479388|66658564|FG001|Overall Study|Protocol Violation|9|||
23803164|NCT00479388|66658563|FG000|Overall Study|Withdrawal by Subject|32|||
23803165|NCT00479388|66658564|FG001|Overall Study|Withdrawal by Subject|17|||
23803166|NCT00653991|66658569|FG000|3 Month Follow-up|Participant would not respond|150|||
23803167|NCT00653991|66658570|FG001|3 Month Follow-up|Participant would not respond|157|||
23803168|NCT00653991|66658569|FG000|6 Month Follow-up|Participant would not respond|133|||
23803169|NCT00653991|66658570|FG001|6 Month Follow-up|Participant would not respond|141|||
23803170|NCT02938520|66658571|FG000|Overall Study|On-going at the time of analysis|258|||
23803171|NCT02938520|66658572|FG001|Overall Study|On-going at the time of analysis|261|||
23803172|NCT02938520|66658571|FG000|Overall Study|Physician Decision|2|||
23803173|NCT02938520|66658572|FG001|Overall Study|Physician Decision|5|||
23803174|NCT02938520|66658571|FG000|Overall Study|Lost to Follow-up|2|||
23803175|NCT02938520|66658572|FG001|Overall Study|Lost to Follow-up|2|||
23803176|NCT02938520|66658571|FG000|Overall Study|Withdrawal by Subject|7|||
23803177|NCT02938520|66658572|FG001|Overall Study|Withdrawal by Subject|7|||
23803178|NCT02938520|66658571|FG000|Overall Study|Protocol Violation|0|||
23803179|NCT02938520|66658572|FG001|Overall Study|Protocol Violation|1|||
23803180|NCT02938520|66658571|FG000|Overall Study|Lack of Efficacy|5|||
23803181|NCT02938520|66658572|FG001|Overall Study|Lack of Efficacy|3|||
23803182|NCT02938520|66658571|FG000|Overall Study|Adverse Event|9|||
23803183|NCT02938520|66658572|FG001|Overall Study|Adverse Event|4|||
23803184|NCT02104817|66658573|FG000|Overall Study|Death|363|||
23803185|NCT02104817|66658574|FG001|Overall Study|Death|330|||
23803186|NCT02104817|66658573|FG000|Overall Study|Lost to Follow-up|3|||
23803187|NCT02104817|66658574|FG001|Overall Study|Lost to Follow-up|2|||
23803188|NCT02104817|66658573|FG000|Overall Study|Protocol Violation|0|||
23803189|NCT02104817|66658574|FG001|Overall Study|Protocol Violation|1|||
23803190|NCT02104817|66658573|FG000|Overall Study|Study terminated by sponsor|5854|||
23803191|NCT02104817|66658574|FG001|Overall Study|Study terminated by sponsor|5901|||
23803192|NCT02104817|66658573|FG000|Overall Study|Withdrawal by Subject|111|||
23803193|NCT02104817|66658574|FG001|Overall Study|Withdrawal by Subject|78|||
23803194|NCT02104817|66658573|FG000|Overall Study|Other reasons|128|||
23803195|NCT02104817|66658574|FG001|Overall Study|Other reasons|135|||
23803196|NCT00290251|66658579|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23803197|NCT00290251|66658580|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23803198|NCT00290251|66658581|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23803199|NCT00290251|66658582|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23803200|NCT00290251|66658583|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23803201|NCT00290251|66658584|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
23803202|NCT00290251|66658579|FG000|Treatment 1 (Months 2-4)|headache|0|||
23803203|NCT00290251|66658580|FG001|Treatment 1 (Months 2-4)|headache|0|||
23803204|NCT00290251|66658581|FG002|Treatment 1 (Months 2-4)|headache|0|||
23803205|NCT00290251|66658582|FG003|Treatment 1 (Months 2-4)|headache|0|||
23803206|NCT00290251|66658583|FG004|Treatment 1 (Months 2-4)|headache|1|||
23803207|NCT00290251|66658584|FG005|Treatment 1 (Months 2-4)|headache|0|||
23803208|NCT00290251|66658579|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
23803209|NCT00290251|66658580|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
23803210|NCT00290251|66658581|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
23803211|NCT00290251|66658582|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
23803212|NCT00290251|66658583|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
23803213|NCT00290251|66658584|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
23803214|NCT01583218|66658585|FG000|Overall Study|Withdrawal by Subject|43|||
23803215|NCT01583218|66658586|FG001|Overall Study|Withdrawal by Subject|29|||
23803216|NCT01583218|66658585|FG000|Overall Study|Death|206|||
23803217|NCT01583218|66658586|FG001|Overall Study|Death|211|||
23803218|NCT01583218|66658585|FG000|Overall Study|Lost to Follow-up|11|||
23803219|NCT01583218|66658586|FG001|Overall Study|Lost to Follow-up|17|||
23803220|NCT01583218|66658585|FG000|Overall Study|Adverse event or serious adverse event|3|||
23803221|NCT01583218|66658586|FG001|Overall Study|Adverse event or serious adverse event|3|||
23803222|NCT01583218|66658585|FG000|Overall Study|Patient /Family decision|3|||
23803223|NCT01583218|66658586|FG001|Overall Study|Patient /Family decision|0|||
23803224|NCT01583218|66658585|FG000|Overall Study|Cannot contact patient directly|1|||
23803225|NCT01583218|66658586|FG001|Overall Study|Cannot contact patient directly|2|||
23803226|NCT01583218|66658585|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
23803227|NCT01583218|66658586|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
23803228|NCT01583218|66658585|FG000|Overall Study|Patient did not wish to attend visits|0|||
23803229|NCT01583218|66658586|FG001|Overall Study|Patient did not wish to attend visits|1|||
23803230|NCT01583218|66658585|FG000|Overall Study|Patient randomized but not dosed|17|||
23803231|NCT01583218|66658586|FG001|Overall Study|Patient randomized but not dosed|16|||
23803232|NCT01583218|66658585|FG000|Overall Study|Patient was assessed via phone in person|1|||
23803233|NCT01583218|66658586|FG001|Overall Study|Patient was assessed via phone in person|0|||
23803234|NCT01583218|66658585|FG000|Overall Study|Patient deemed ineligible after random|2|||
23803235|NCT01583218|66658586|FG001|Overall Study|Patient deemed ineligible after random|0|||
23803236|NCT01583218|66658585|FG000|Overall Study|Patient was early terminated from study|0|||
23803237|NCT01583218|66658586|FG001|Overall Study|Patient was early terminated from study|1|||
23803238|NCT01583218|66658585|FG000|Overall Study|Patient was randomized due to mistake|1|||
23803239|NCT01583218|66658586|FG001|Overall Study|Patient was randomized due to mistake|0|||
23803240|NCT01583218|66658585|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
23803241|NCT01583218|66658586|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
23803242|NCT01583218|66658585|FG000|Overall Study|Withdraw of consent on day of random|1|||
23803243|NCT01583218|66658586|FG001|Overall Study|Withdraw of consent on day of random|0|||
23803244|NCT01371994|66658587|FG000|Overall Study|Adverse Event|3|||
23803245|NCT01371994|66658588|FG001|Overall Study|Adverse Event|6|||
23803246|NCT01371994|66658587|FG000|Overall Study|Lack of Efficacy|3|||
23803247|NCT01371994|66658588|FG001|Overall Study|Lack of Efficacy|0|||
23803248|NCT01371994|66658587|FG000|Overall Study|Withdrawal by Subject|13|||
23803249|NCT01371994|66658588|FG001|Overall Study|Withdrawal by Subject|7|||
23803250|NCT01371994|66658587|FG000|Overall Study|Lost to Follow-up|1|||
23803251|NCT01371994|66658588|FG001|Overall Study|Lost to Follow-up|1|||
23803252|NCT01371994|66658587|FG000|Overall Study|Protocol Violation|24|||
23803253|NCT01371994|66658588|FG001|Overall Study|Protocol Violation|17|||
23803254|NCT01371994|66658587|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
23803255|NCT01371994|66658588|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
23803256|NCT01371994|66658587|FG000|Overall Study|Physician Decision|1|||
23803257|NCT01371994|66658588|FG001|Overall Study|Physician Decision|1|||
23803258|NCT01371994|66658587|FG000|Overall Study|Miscellaneous Reasons|6|||
23803259|NCT01371994|66658588|FG001|Overall Study|Miscellaneous Reasons|4|||
23803260|NCT01929395|66658591|FG000|Overall Study|Did not complete - non-related toxicity|1|||
23803261|NCT01929395|66658592|FG001|Overall Study|Did not complete - non-related toxicity|0|||
23803262|NCT01929395|66658593|FG002|Overall Study|Did not complete - non-related toxicity|0|||
23803263|NCT01929395|66658591|FG000|Overall Study|Withdrawal by Subject|0|||
23803264|NCT01929395|66658592|FG001|Overall Study|Withdrawal by Subject|1|||
23803265|NCT01929395|66658593|FG002|Overall Study|Withdrawal by Subject|0|||
23803266|NCT01929395|66658591|FG000|Overall Study|Screen Fail|0|||
23803267|NCT01929395|66658592|FG001|Overall Study|Screen Fail|0|||
23803268|NCT01929395|66658593|FG002|Overall Study|Screen Fail|1|||
23803269|NCT04553913|66658594|FG000|Overall Study|patient's block resolved prior to PACU|1|||
23803270|NCT04553913|66658594|FG000|Overall Study|did not use the device properly|5|||
23803271|NCT04349631|66658597|FG000|Overall Study|Lost to Follow-up|3|||
23803272|NCT04349631|66658597|FG000|Overall Study|Withdrawal by Subject|7|||
23803273|NCT00094458|66658598|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
23803274|NCT00094458|66658599|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
23803275|NCT00094458|66658600|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
23803276|NCT00094458|66658601|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
23803277|NCT00094458|66658602|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
23803278|NCT00094458|66658603|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
23803279|NCT00094458|66658598|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
23803280|NCT00094458|66658599|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
23803281|NCT00094458|66658600|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
23803282|NCT00094458|66658601|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
23803283|NCT00094458|66658602|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
23803284|NCT00094458|66658603|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
23803285|NCT00094458|66658598|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
23803286|NCT00094458|66658599|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
23803287|NCT00094458|66658600|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
23803288|NCT00094458|66658601|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
23803289|NCT00094458|66658602|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
23803290|NCT00094458|66658603|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
23803291|NCT00094458|66658598|FG000|Main Study: Through Week 30|Adverse Event|38|||
23803292|NCT00094458|66658599|FG001|Main Study: Through Week 30|Adverse Event|20|||
23803293|NCT00094458|66658600|FG002|Main Study: Through Week 30|Adverse Event|28|||
23803294|NCT00094458|66658601|FG003|Main Study: Through Week 30|Adverse Event|0|||
23803295|NCT00094458|66658602|FG004|Main Study: Through Week 30|Adverse Event|0|||
23803296|NCT00094458|66658603|FG005|Main Study: Through Week 30|Adverse Event|0|||
23803297|NCT00094458|66658598|FG000|Main Study: Through Week 30|Death|1|||
23803298|NCT00094458|66658599|FG001|Main Study: Through Week 30|Death|0|||
23803299|NCT00094458|66658600|FG002|Main Study: Through Week 30|Death|0|||
23803300|NCT00094458|66658601|FG003|Main Study: Through Week 30|Death|0|||
23803301|NCT00094458|66658602|FG004|Main Study: Through Week 30|Death|0|||
23803302|NCT00094458|66658603|FG005|Main Study: Through Week 30|Death|0|||
23803303|NCT00094458|66658598|FG000|Main Study: Through Week 30|Other|19|||
23803304|NCT00094458|66658599|FG001|Main Study: Through Week 30|Other|16|||
23803305|NCT00094458|66658600|FG002|Main Study: Through Week 30|Other|9|||
23803306|NCT00094458|66658601|FG003|Main Study: Through Week 30|Other|0|||
23803307|NCT00094458|66658602|FG004|Main Study: Through Week 30|Other|0|||
23803308|NCT00094458|66658603|FG005|Main Study: Through Week 30|Other|0|||
23803309|NCT00094458|66658598|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
23803310|NCT00094458|66658599|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
23803311|NCT00094458|66658600|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
23803312|NCT00094458|66658601|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23803313|NCT00094458|66658602|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23803314|NCT00094458|66658603|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23803315|NCT00094458|66658598|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
23803316|NCT00094458|66658599|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23803317|NCT00094458|66658600|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
23803318|NCT00094458|66658601|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23803319|NCT00094458|66658602|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23803320|NCT00094458|66658603|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23803321|NCT00094458|66658598|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
23803322|NCT00094458|66658599|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
23803323|NCT00094458|66658600|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
23803324|NCT00094458|66658601|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23803325|NCT00094458|66658602|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23803326|NCT00094458|66658603|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23803327|NCT00094458|66658598|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
23803328|NCT00094458|66658599|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
23803329|NCT00094458|66658600|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
23803330|NCT00094458|66658601|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
23803331|NCT00094458|66658602|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
23803332|NCT00094458|66658603|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
23803333|NCT00094458|66658598|FG000|OLE: Open-Label Extension|Adverse Event|0|||
23803334|NCT00094458|66658599|FG001|OLE: Open-Label Extension|Adverse Event|0|||
23803335|NCT00094458|66658600|FG002|OLE: Open-Label Extension|Adverse Event|0|||
23803336|NCT00094458|66658601|FG003|OLE: Open-Label Extension|Adverse Event|0|||
23803337|NCT00094458|66658602|FG004|OLE: Open-Label Extension|Adverse Event|3|||
23803338|NCT00094458|66658603|FG005|OLE: Open-Label Extension|Adverse Event|4|||
23803339|NCT00094458|66658598|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23803340|NCT00094458|66658599|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23803341|NCT00094458|66658600|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23803342|NCT00094458|66658601|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
23803343|NCT00094458|66658602|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
23803344|NCT00094458|66658603|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23803345|NCT00094458|66658598|FG000|OLE: Open-Label Extension|Patient decision|0|||
23803346|NCT00094458|66658599|FG001|OLE: Open-Label Extension|Patient decision|0|||
23803347|NCT00094458|66658600|FG002|OLE: Open-Label Extension|Patient decision|0|||
23803348|NCT00094458|66658601|FG003|OLE: Open-Label Extension|Patient decision|0|||
23803349|NCT00094458|66658602|FG004|OLE: Open-Label Extension|Patient decision|1|||
23803350|NCT00094458|66658603|FG005|OLE: Open-Label Extension|Patient decision|0|||
23803351|NCT00502801|66658606|FG000|Treatment Period|Withdrawal by Subject|3|||
23803352|NCT00502801|66658606|FG000|Treatment Period|Adverse Event|7|||
23803353|NCT00502801|66658606|FG000|Treatment Period|Death|14|||
23803354|NCT00502801|66658606|FG000|Treatment Period|OTHER|30|||
23803355|NCT00502801|66658606|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
23803356|NCT00502801|66658606|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
23803357|NCT00502801|66658606|FG000|End of Therapy to Test of Cure|Death|3|||
23803358|NCT00502801|66658606|FG000|End of Therapy to Test of Cure|OTHER|2|||
23803359|NCT02356211|66658607|FG000|Overall Study|Withdrawal by Subject|2|||
23803360|NCT02356211|66658608|FG001|Overall Study|Withdrawal by Subject|2|||
23803361|NCT02356211|66658607|FG000|Overall Study|ineligible|1|||
23803362|NCT02356211|66658608|FG001|Overall Study|ineligible|8|||
23803363|NCT03123783|66658609|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803364|NCT03123783|66658610|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
23803365|NCT03123783|66658611|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803366|NCT03123783|66658612|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803367|NCT03123783|66658613|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803368|NCT03123783|66658614|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803369|NCT03123783|66658615|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23803370|NCT03123783|66658609|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
23803371|NCT03123783|66658610|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
23803372|NCT03123783|66658611|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
23803373|NCT03123783|66658612|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
23803374|NCT03123783|66658613|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
23803375|NCT03123783|66658614|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
23803376|NCT03123783|66658615|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
23803377|NCT03123783|66658609|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
23803378|NCT03123783|66658610|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
23803379|NCT03123783|66658611|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
23803380|NCT03123783|66658612|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
23803381|NCT03123783|66658613|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
23803382|NCT03123783|66658614|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
23803383|NCT03123783|66658615|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
23803384|NCT03123783|66658609|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803385|NCT03123783|66658610|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803386|NCT03123783|66658611|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803387|NCT03123783|66658612|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803388|NCT03123783|66658613|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
23803389|NCT03123783|66658614|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803390|NCT03123783|66658615|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23803391|NCT01663727|66658623|FG000|Overall Study|Death|161|||
23803392|NCT01663727|66658624|FG001|Overall Study|Death|155|||
23803393|NCT01663727|66658623|FG000|Overall Study|Lost to Follow-up|10|||
23803394|NCT01663727|66658624|FG001|Overall Study|Lost to Follow-up|8|||
23803395|NCT01663727|66658623|FG000|Overall Study|Withdrawal by Subject|18|||
23803396|NCT01663727|66658624|FG001|Overall Study|Withdrawal by Subject|25|||
23803397|NCT01663727|66658623|FG000|Overall Study|Study Terminated|51|||
23803398|NCT01663727|66658624|FG001|Overall Study|Study Terminated|50|||
23803399|NCT01663727|66658623|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
23803400|NCT01663727|66658624|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
23803401|NCT01663727|66658623|FG000|Overall Study|Withdrawal prior to dosing.|1|||
23803402|NCT01663727|66658624|FG001|Overall Study|Withdrawal prior to dosing.|0|||
23803403|NCT03042468|66658625|FG000|Overall Study|Death|0|||
23803404|NCT03042468|66658626|FG001|Overall Study|Death|1|||
23803405|NCT03042468|66658627|FG002|Overall Study|Death|1|||
23803406|NCT03042468|66658628|FG003|Overall Study|Death|0|||
23803407|NCT03042468|66658629|FG004|Overall Study|Death|0|||
23803408|NCT03042468|66658630|FG005|Overall Study|Death|0|||
23803409|NCT03042468|66658625|FG000|Overall Study|Withdrawal by Subject|0|||
23803410|NCT03042468|66658626|FG001|Overall Study|Withdrawal by Subject|0|||
23803411|NCT03042468|66658627|FG002|Overall Study|Withdrawal by Subject|0|||
23803412|NCT03042468|66658628|FG003|Overall Study|Withdrawal by Subject|0|||
23803413|NCT03042468|66658629|FG004|Overall Study|Withdrawal by Subject|0|||
23803414|NCT03042468|66658630|FG005|Overall Study|Withdrawal by Subject|1|||
23803415|NCT03042468|66658625|FG000|Overall Study|Lost to Follow-up|0|||
23803416|NCT03042468|66658626|FG001|Overall Study|Lost to Follow-up|0|||
23803417|NCT03042468|66658627|FG002|Overall Study|Lost to Follow-up|0|||
23803418|NCT03042468|66658628|FG003|Overall Study|Lost to Follow-up|0|||
23803419|NCT03042468|66658629|FG004|Overall Study|Lost to Follow-up|1|||
23803420|NCT03042468|66658630|FG005|Overall Study|Lost to Follow-up|1|||
23803421|NCT03978091|66658635|FG000|Overall Study|Lost to Follow-up|0|||
23803422|NCT03978091|66658636|FG001|Overall Study|Lost to Follow-up|0|||
23803423|NCT03978091|66658637|FG002|Overall Study|Lost to Follow-up|1|||
23803424|NCT03978091|66658638|FG003|Overall Study|Lost to Follow-up|0|||
23803425|NCT03978091|66658639|FG004|Overall Study|Lost to Follow-up|0|||
23803426|NCT03978091|66658640|FG005|Overall Study|Lost to Follow-up|0|||
23803427|NCT03978091|66658635|FG000|Overall Study|Withdrawal by Subject|0|||
23803428|NCT03978091|66658636|FG001|Overall Study|Withdrawal by Subject|0|||
23803429|NCT03978091|66658637|FG002|Overall Study|Withdrawal by Subject|0|||
23803430|NCT03978091|66658638|FG003|Overall Study|Withdrawal by Subject|1|||
23803431|NCT03978091|66658639|FG004|Overall Study|Withdrawal by Subject|1|||
23803432|NCT03978091|66658640|FG005|Overall Study|Withdrawal by Subject|0|||
23803433|NCT04142242|66658641|FG000|Stage I|Non-compliance with the protocol|1|||
23803434|NCT04142242|66658642|FG001|Stage I|Non-compliance with the protocol|0|||
23803435|NCT04142242|66658643|FG002|Stage I|Non-compliance with the protocol|0|||
23803436|NCT04142242|66658644|FG003|Stage I|Non-compliance with the protocol|0|||
23803437|NCT04142242|66658645|FG004|Stage I|Non-compliance with the protocol|0|||
23803438|NCT04142242|66658646|FG005|Stage I|Non-compliance with the protocol|1|||
23803439|NCT04142242|66658641|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23803440|NCT04142242|66658642|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
23803441|NCT04142242|66658643|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23803442|NCT04142242|66658644|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23803443|NCT04142242|66658645|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23803444|NCT04142242|66658646|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23803445|NCT04142242|66658641|FG000|Stage II|Non-compliance with the protocol|0|||
23803446|NCT04142242|66658642|FG001|Stage II|Non-compliance with the protocol|0|||
23803447|NCT04142242|66658643|FG002|Stage II|Non-compliance with the protocol|0|||
23803448|NCT04142242|66658644|FG003|Stage II|Non-compliance with the protocol|2|||
23803449|NCT04142242|66658645|FG004|Stage II|Non-compliance with the protocol|0|||
23803450|NCT04142242|66658646|FG005|Stage II|Non-compliance with the protocol|0|||
23803451|NCT04142242|66658641|FG000|Stage II|Lost to Follow-up|0|||
23803452|NCT04142242|66658642|FG001|Stage II|Lost to Follow-up|0|||
23803453|NCT04142242|66658643|FG002|Stage II|Lost to Follow-up|1|||
23803454|NCT04142242|66658644|FG003|Stage II|Lost to Follow-up|2|||
23803455|NCT04142242|66658645|FG004|Stage II|Lost to Follow-up|0|||
23803456|NCT04142242|66658646|FG005|Stage II|Lost to Follow-up|0|||
23803457|NCT04142242|66658641|FG000|Stage II|Withdrawal by Subject|0|||
23803458|NCT04142242|66658642|FG001|Stage II|Withdrawal by Subject|0|||
23803459|NCT04142242|66658643|FG002|Stage II|Withdrawal by Subject|5|||
23803460|NCT04142242|66658644|FG003|Stage II|Withdrawal by Subject|9|||
23803461|NCT04142242|66658645|FG004|Stage II|Withdrawal by Subject|0|||
23803462|NCT04142242|66658646|FG005|Stage II|Withdrawal by Subject|0|||
23803463|NCT03921151|66658647|FG000|Overall Study|Withdrawal by Subject|11|||
23803464|NCT03921151|66658648|FG001|Overall Study|Withdrawal by Subject|16|||
23803465|NCT00257920|66658651|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
23803466|NCT00257920|66658652|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
23803467|NCT00257920|66658651|FG000|Period: Second Intervention|Other|2|||
23803468|NCT00257920|66658652|FG001|Period: Second Intervention|Other|1|||
23803469|NCT02777918|66658655|FG000|Overall Study|Medical reasons|1|||
23361082|NCT04058028|65065965|FG003|Overall Study|Decision by Sponsor|35|||
23803470|NCT02777918|66658656|FG001|Overall Study|Medical reasons|2|||
23803471|NCT02777918|66658655|FG000|Overall Study|Too busy / stressed|1|||
23803472|NCT02777918|66658656|FG001|Overall Study|Too busy / stressed|1|||
23803473|NCT02777918|66658655|FG000|Overall Study|Withdrawal by Subject|1|||
23803474|NCT02777918|66658656|FG001|Overall Study|Withdrawal by Subject|1|||
23803475|NCT00233987|66658657|FG000|Overall Study|Withdrawal by Subject|1|||
23803476|NCT00233987|66658657|FG000|Overall Study|Lack of Efficacy|2|||
23803477|NCT00233987|66658657|FG000|Overall Study|Reason Under Review|1|||
23803478|NCT00233987|66658657|FG000|Overall Study|Other - Not Protocol Specified|5|||
23803479|NCT00233987|66658657|FG000|Overall Study|Eligible but No Treatment Received|2|||
23803480|NCT00233987|66658657|FG000|Overall Study|Ineligible|4|||
23803481|NCT01272921|66658660|FG000|Overall Study|Protocol Violation|2|||
23803482|NCT01272921|66658661|FG001|Overall Study|Protocol Violation|1|||
23803483|NCT01351350|66658662|FG000|Overall Study|Disease Progression|5|||
23803484|NCT01351350|66658663|FG001|Overall Study|Disease Progression|13|||
23803485|NCT01351350|66658664|FG002|Overall Study|Disease Progression|6|||
23803486|NCT01351350|66658665|FG003|Overall Study|Disease Progression|8|||
23803487|NCT01351350|66658666|FG004|Overall Study|Disease Progression|5|||
23803488|NCT01351350|66658662|FG000|Overall Study|Adverse Event|1|||
23803489|NCT01351350|66658663|FG001|Overall Study|Adverse Event|10|||
23803490|NCT01351350|66658664|FG002|Overall Study|Adverse Event|1|||
23803491|NCT01351350|66658665|FG003|Overall Study|Adverse Event|2|||
23803492|NCT01351350|66658666|FG004|Overall Study|Adverse Event|0|||
23803493|NCT01351350|66658662|FG000|Overall Study|Participant Decision|2|||
23803494|NCT01351350|66658663|FG001|Overall Study|Participant Decision|6|||
23803495|NCT01351350|66658664|FG002|Overall Study|Participant Decision|3|||
23803496|NCT01351350|66658665|FG003|Overall Study|Participant Decision|3|||
23803497|NCT01351350|66658666|FG004|Overall Study|Participant Decision|2|||
23803498|NCT01351350|66658662|FG000|Overall Study|Enrolled but not Treated|0|||
23803499|NCT01351350|66658663|FG001|Overall Study|Enrolled but not Treated|0|||
23803500|NCT01351350|66658664|FG002|Overall Study|Enrolled but not Treated|1|||
23803501|NCT01351350|66658665|FG003|Overall Study|Enrolled but not Treated|0|||
23803502|NCT01351350|66658666|FG004|Overall Study|Enrolled but not Treated|0|||
23803503|NCT03201211|66658667|FG000|Overall Study|Adverse Event|1|||
23803504|NCT03201211|66658668|FG001|Overall Study|Adverse Event|0|||
23803505|NCT03201211|66658669|FG002|Overall Study|Adverse Event|0|||
23803506|NCT03201211|66658667|FG000|Overall Study|Protocol Violation|1|||
23803507|NCT03201211|66658668|FG001|Overall Study|Protocol Violation|0|||
23803508|NCT03201211|66658669|FG002|Overall Study|Protocol Violation|0|||
23803509|NCT03201211|66658667|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23803510|NCT03201211|66658668|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23803511|NCT03201211|66658669|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23803512|NCT03201211|66658667|FG000|Overall Study|OTHER unknown reasons|0|||
23803513|NCT03201211|66658668|FG001|Overall Study|OTHER unknown reasons|1|||
23803514|NCT03201211|66658669|FG002|Overall Study|OTHER unknown reasons|0|||
23803515|NCT03407118|66658670|FG000|Period 2|Withdrawal by Subject|1|||
23803516|NCT03407118|66658671|FG001|Period 2|Withdrawal by Subject|0|||
23803517|NCT01832402|66658672|FG000|Overall Study|Lost to Follow-up|2|||
23803518|NCT01832402|66658673|FG001|Overall Study|Lost to Follow-up|0|||
23803519|NCT01832402|66658672|FG000|Overall Study|Withdrawal by Subject|3|||
23803520|NCT01832402|66658673|FG001|Overall Study|Withdrawal by Subject|3|||
23803521|NCT01832402|66658672|FG000|Overall Study|Declining Performance status|2|||
23803522|NCT01832402|66658673|FG001|Overall Study|Declining Performance status|1|||
23803523|NCT00359632|66658674|FG000|Overall Study|Death|2|||
23803524|NCT00359632|66658675|FG001|Overall Study|Death|0|||
23803525|NCT00359632|66658674|FG000|Overall Study|Adverse Event|1|||
23803526|NCT00359632|66658675|FG001|Overall Study|Adverse Event|0|||
23803527|NCT00359632|66658674|FG000|Overall Study|Non-compliance with visit schedule|1|||
23803528|NCT00359632|66658675|FG001|Overall Study|Non-compliance with visit schedule|0|||
23803529|NCT01534078|66658676|FG000|Overall Study|Death|1|||
23803530|NCT01534078|66658676|FG000|Overall Study|Withdrawal by Subject|1|||
23803531|NCT00337428|66658677|FG000|Overall Study|Withdrawal by Subject|1|||
23803532|NCT00337428|66658678|FG001|Overall Study|Withdrawal by Subject|2|||
23803533|NCT00337428|66658677|FG000|Overall Study|Lack of Time|1|||
23803534|NCT00337428|66658678|FG001|Overall Study|Lack of Time|1|||
23480316|NCT00246571|65501934|FG000|Overall Study|Protocol Violation|0|||
23480317|NCT00246571|65501935|FG001|Overall Study|Protocol Violation|1|||
23480318|NCT00246571|65501934|FG000|Overall Study|Withdrawal by Subject|2|||
23803535|NCT00337428|66658677|FG000|Overall Study|Unwilling to Continue|1|||
23803536|NCT00337428|66658678|FG001|Overall Study|Unwilling to Continue|0|||
23803537|NCT00337428|66658677|FG000|Overall Study|Anorexia|1|||
23803538|NCT00337428|66658678|FG001|Overall Study|Anorexia|0|||
23803539|NCT00995085|66658683|FG000|Overall Study|Withdrawal by Subject|5|||
23803540|NCT01976728|66658684|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
23803541|NCT01976728|66658685|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
23803542|NCT01976728|66658686|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
23803543|NCT01976728|66658687|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
23803544|NCT02954159|66658693|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
23803545|NCT02954159|66658694|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
23803546|NCT02954159|66658693|FG000|Overall Study|Withdrawal by Subject|0|||
23803547|NCT02954159|66658694|FG001|Overall Study|Withdrawal by Subject|1|||
23803548|NCT01376310|66658695|FG000|Overall Study|Study closed/terminated|1|||
23803549|NCT01376310|66658696|FG001|Overall Study|Study closed/terminated|2|||
23803550|NCT01376310|66658695|FG000|Overall Study|Withdrawal by Subject|8|||
23803551|NCT01376310|66658696|FG001|Overall Study|Withdrawal by Subject|2|||
23803552|NCT01376310|66658695|FG000|Overall Study|Physician Decision|26|||
23803553|NCT01376310|66658696|FG001|Overall Study|Physician Decision|7|||
23803554|NCT01376310|66658695|FG000|Overall Study|Lost to Follow-up|1|||
23803555|NCT01376310|66658696|FG001|Overall Study|Lost to Follow-up|0|||
23803556|NCT00467831|66658698|FG000|Overall Study|Death|2|||
23803557|NCT00467831|66658698|FG000|Overall Study|Withdrawal by Subject|1|||
23803558|NCT00058214|66658701|FG000|Overall Study|Adverse Event|1|||
23803559|NCT00493246|66658702|FG000|Overall Study|Withdrawal by Subject|0|||
23803560|NCT00493246|66658703|FG001|Overall Study|Withdrawal by Subject|0|||
23803561|NCT00493246|66658704|FG002|Overall Study|Withdrawal by Subject|0|||
23803562|NCT00493246|66658705|FG003|Overall Study|Withdrawal by Subject|0|||
23803563|NCT00493246|66658706|FG004|Overall Study|Withdrawal by Subject|1|||
23803564|NCT00493246|66658707|FG005|Overall Study|Withdrawal by Subject|0|||
23803565|NCT00493246|66658708|FG006|Overall Study|Withdrawal by Subject|0|||
23803566|NCT00493246|66658709|FG007|Overall Study|Withdrawal by Subject|0|||
23803567|NCT00493246|66658702|FG000|Overall Study|No access to draw blood|0|||
23803568|NCT00493246|66658703|FG001|Overall Study|No access to draw blood|0|||
23803569|NCT00493246|66658704|FG002|Overall Study|No access to draw blood|0|||
23803570|NCT00493246|66658705|FG003|Overall Study|No access to draw blood|0|||
23803571|NCT00493246|66658706|FG004|Overall Study|No access to draw blood|0|||
23803572|NCT00493246|66658707|FG005|Overall Study|No access to draw blood|1|||
23803573|NCT00493246|66658708|FG006|Overall Study|No access to draw blood|0|||
23803574|NCT00493246|66658709|FG007|Overall Study|No access to draw blood|0|||
23803575|NCT00493246|66658702|FG000|Overall Study|Lost to Follow-up|0|||
23803576|NCT00493246|66658703|FG001|Overall Study|Lost to Follow-up|0|||
23803577|NCT00493246|66658704|FG002|Overall Study|Lost to Follow-up|0|||
23803578|NCT00493246|66658705|FG003|Overall Study|Lost to Follow-up|0|||
23803579|NCT00493246|66658706|FG004|Overall Study|Lost to Follow-up|0|||
23803580|NCT00493246|66658707|FG005|Overall Study|Lost to Follow-up|0|||
23803581|NCT00493246|66658708|FG006|Overall Study|Lost to Follow-up|1|||
23803582|NCT00493246|66658709|FG007|Overall Study|Lost to Follow-up|0|||
23803583|NCT02696031|66658712|FG000|Up to Week 24|Adverse Event|2|||
23803584|NCT02696031|66658713|FG001|Up to Week 24|Adverse Event|4|||
23803585|NCT02696031|66658714|FG002|Up to Week 24|Adverse Event|2|||
23803586|NCT02696031|66658715|FG003|Up to Week 24|Adverse Event|0|||
23803587|NCT02696031|66658716|FG004|Up to Week 24|Adverse Event|0|||
23480319|NCT00246571|65501935|FG001|Overall Study|Withdrawal by Subject|3|||
23480320|NCT00246571|65501934|FG000|Overall Study|Lack of Efficacy|84|||
23803588|NCT02696031|66658717|FG005|Up to Week 24|Adverse Event|0|||
23803589|NCT02696031|66658712|FG000|Up to Week 24|Lack of Efficacy|2|||
23803590|NCT02696031|66658713|FG001|Up to Week 24|Lack of Efficacy|1|||
23803591|NCT02696031|66658714|FG002|Up to Week 24|Lack of Efficacy|2|||
23803592|NCT02696031|66658715|FG003|Up to Week 24|Lack of Efficacy|0|||
23803593|NCT02696031|66658716|FG004|Up to Week 24|Lack of Efficacy|0|||
23803594|NCT02696031|66658717|FG005|Up to Week 24|Lack of Efficacy|0|||
23803595|NCT02696031|66658712|FG000|Up to Week 24|Lost to Follow-up|0|||
23803596|NCT02696031|66658713|FG001|Up to Week 24|Lost to Follow-up|1|||
23803597|NCT02696031|66658714|FG002|Up to Week 24|Lost to Follow-up|1|||
23803598|NCT02696031|66658715|FG003|Up to Week 24|Lost to Follow-up|0|||
23803599|NCT02696031|66658716|FG004|Up to Week 24|Lost to Follow-up|0|||
23803600|NCT02696031|66658717|FG005|Up to Week 24|Lost to Follow-up|0|||
23803601|NCT02696031|66658712|FG000|Up to Week 24|Physician Decision|1|||
23803602|NCT02696031|66658713|FG001|Up to Week 24|Physician Decision|0|||
23803603|NCT02696031|66658714|FG002|Up to Week 24|Physician Decision|1|||
23803604|NCT02696031|66658715|FG003|Up to Week 24|Physician Decision|0|||
23361083|NCT04058028|65065962|FG000|Overall Study|Lost to Follow-up|1|||
23803605|NCT02696031|66658716|FG004|Up to Week 24|Physician Decision|0|||
23803606|NCT02696031|66658717|FG005|Up to Week 24|Physician Decision|0|||
23480321|NCT00246571|65501935|FG001|Overall Study|Lack of Efficacy|21|||
23480322|NCT00246571|65501934|FG000|Overall Study|Death|17|||
23480323|NCT00246571|65501935|FG001|Overall Study|Death|3|||
23480324|NCT00246571|65501934|FG000|Overall Study|Sponsor|0|||
23480325|NCT00246571|65501935|FG001|Overall Study|Sponsor|1|||
23480326|NCT00246571|65501934|FG000|Overall Study|Did not meet entrance criteria|2|||
23480327|NCT00246571|65501935|FG001|Overall Study|Did not meet entrance criteria|1|||
23480328|NCT00246571|65501934|FG000|Overall Study|Laboratory abnormalities|1|||
23480329|NCT00246571|65501935|FG001|Overall Study|Laboratory abnormalities|0|||
23480330|NCT00246571|65501934|FG000|Overall Study|Crossover participants|0|||
23480331|NCT00246571|65501935|FG001|Overall Study|Crossover participants|74|||
23480332|NCT03739242|65501938|FG000|Overall Study|Withdrawal by Subject|1|||
23480333|NCT03739242|65501939|FG001|Overall Study|Withdrawal by Subject|1|||
23480334|NCT03739242|65501938|FG000|Overall Study|Protocol Violation|0|||
23480335|NCT03739242|65501939|FG001|Overall Study|Protocol Violation|1|||
23480336|NCT00617669|65501952|FG000|Overall Study|Withdrawal by Subject|71|||
23480337|NCT00617669|65501953|FG001|Overall Study|Withdrawal by Subject|77|||
23480338|NCT00617669|65501952|FG000|Overall Study|Lost to Follow-up|3|||
23480339|NCT00617669|65501953|FG001|Overall Study|Lost to Follow-up|2|||
23480340|NCT00617669|65501952|FG000|Overall Study|Adverse Event|87|||
23480341|NCT00617669|65501953|FG001|Overall Study|Adverse Event|76|||
23480342|NCT00617669|65501952|FG000|Overall Study|Protocol Violation|2|||
23599779|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
23599780|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
23599781|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
23599782|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
23599783|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Other|1|||
23599784|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Other|0|||
23599785|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Other|0|||
23599786|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
23599787|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
23599788|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
23599789|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
23599790|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
23599791|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
23599792|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
23599793|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
23599794|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
23599795|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
23599796|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
23599797|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
23480343|NCT00617669|65501953|FG001|Overall Study|Protocol Violation|3|||
23480344|NCT00617669|65501952|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
23480345|NCT00617669|65501953|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
23599798|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
23803607|NCT02696031|66658712|FG000|Up to Week 24|Protocol Violation|1|||
23803608|NCT02696031|66658713|FG001|Up to Week 24|Protocol Violation|0|||
23803609|NCT02696031|66658714|FG002|Up to Week 24|Protocol Violation|0|||
23803610|NCT02696031|66658715|FG003|Up to Week 24|Protocol Violation|0|||
23803611|NCT02696031|66658716|FG004|Up to Week 24|Protocol Violation|0|||
23803612|NCT02696031|66658717|FG005|Up to Week 24|Protocol Violation|0|||
23803613|NCT02696031|66658712|FG000|Up to Week 24|Withdrawal by Subject|4|||
23803614|NCT02696031|66658713|FG001|Up to Week 24|Withdrawal by Subject|1|||
23803615|NCT02696031|66658714|FG002|Up to Week 24|Withdrawal by Subject|5|||
23803616|NCT02696031|66658715|FG003|Up to Week 24|Withdrawal by Subject|0|||
23803617|NCT02696031|66658716|FG004|Up to Week 24|Withdrawal by Subject|0|||
23803618|NCT02696031|66658717|FG005|Up to Week 24|Withdrawal by Subject|0|||
23803619|NCT02696031|66658712|FG000|Up to Week 52|Adverse Event|4|||
23803620|NCT02696031|66658713|FG001|Up to Week 52|Adverse Event|5|||
23803621|NCT02696031|66658714|FG002|Up to Week 52|Adverse Event|3|||
23803622|NCT02696031|66658715|FG003|Up to Week 52|Adverse Event|0|||
23803623|NCT02696031|66658716|FG004|Up to Week 52|Adverse Event|0|||
23803624|NCT02696031|66658717|FG005|Up to Week 52|Adverse Event|0|||
23803625|NCT02696031|66658712|FG000|Up to Week 52|Lack of Efficacy|10|||
23803626|NCT02696031|66658713|FG001|Up to Week 52|Lack of Efficacy|7|||
23803627|NCT02696031|66658714|FG002|Up to Week 52|Lack of Efficacy|11|||
23803628|NCT02696031|66658715|FG003|Up to Week 52|Lack of Efficacy|0|||
23803629|NCT02696031|66658716|FG004|Up to Week 52|Lack of Efficacy|0|||
23803630|NCT02696031|66658717|FG005|Up to Week 52|Lack of Efficacy|0|||
23803631|NCT02696031|66658712|FG000|Up to Week 52|Lost to Follow-up|1|||
23803632|NCT02696031|66658713|FG001|Up to Week 52|Lost to Follow-up|1|||
23803633|NCT02696031|66658714|FG002|Up to Week 52|Lost to Follow-up|1|||
23803634|NCT02696031|66658715|FG003|Up to Week 52|Lost to Follow-up|0|||
23803635|NCT02696031|66658716|FG004|Up to Week 52|Lost to Follow-up|0|||
23803636|NCT02696031|66658717|FG005|Up to Week 52|Lost to Follow-up|0|||
23803637|NCT02696031|66658712|FG000|Up to Week 52|Physician Decision|1|||
23803638|NCT02696031|66658713|FG001|Up to Week 52|Physician Decision|1|||
23803639|NCT02696031|66658714|FG002|Up to Week 52|Physician Decision|2|||
23803640|NCT02696031|66658715|FG003|Up to Week 52|Physician Decision|0|||
23803641|NCT02696031|66658716|FG004|Up to Week 52|Physician Decision|0|||
23803642|NCT02696031|66658717|FG005|Up to Week 52|Physician Decision|0|||
23803643|NCT02696031|66658712|FG000|Up to Week 52|Pregnancy|0|||
23803644|NCT02696031|66658713|FG001|Up to Week 52|Pregnancy|2|||
23803645|NCT02696031|66658714|FG002|Up to Week 52|Pregnancy|0|||
23803646|NCT02696031|66658715|FG003|Up to Week 52|Pregnancy|0|||
23803647|NCT02696031|66658716|FG004|Up to Week 52|Pregnancy|0|||
23803648|NCT02696031|66658717|FG005|Up to Week 52|Pregnancy|0|||
23803649|NCT02696031|66658712|FG000|Up to Week 52|Protocol Violation|1|||
23803650|NCT02696031|66658713|FG001|Up to Week 52|Protocol Violation|0|||
23803651|NCT02696031|66658714|FG002|Up to Week 52|Protocol Violation|0|||
23803652|NCT02696031|66658715|FG003|Up to Week 52|Protocol Violation|0|||
23803653|NCT02696031|66658716|FG004|Up to Week 52|Protocol Violation|0|||
23803654|NCT02696031|66658717|FG005|Up to Week 52|Protocol Violation|0|||
23803655|NCT02696031|66658712|FG000|Up to Week 52|Withdrawal by Subject|12|||
23803656|NCT02696031|66658713|FG001|Up to Week 52|Withdrawal by Subject|3|||
23803657|NCT02696031|66658714|FG002|Up to Week 52|Withdrawal by Subject|9|||
23803658|NCT02696031|66658715|FG003|Up to Week 52|Withdrawal by Subject|0|||
23803659|NCT02696031|66658716|FG004|Up to Week 52|Withdrawal by Subject|0|||
23803660|NCT02696031|66658717|FG005|Up to Week 52|Withdrawal by Subject|0|||
23803661|NCT02696031|66658712|FG000|Up to Week 104|Pregnancy|0|||
23803662|NCT02696031|66658713|FG001|Up to Week 104|Pregnancy|2|||
23803663|NCT02696031|66658714|FG002|Up to Week 104|Pregnancy|1|||
23803664|NCT02696031|66658715|FG003|Up to Week 104|Pregnancy|0|||
23803665|NCT02696031|66658716|FG004|Up to Week 104|Pregnancy|0|||
23803666|NCT02696031|66658717|FG005|Up to Week 104|Pregnancy|0|||
23803667|NCT02696031|66658712|FG000|Up to Week 104|Withdrawal by Subject|15|||
23480346|NCT00617669|65501952|FG000|Overall Study|Patients randomized but not treated|2|||
23599799|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
23803668|NCT02696031|66658713|FG001|Up to Week 104|Withdrawal by Subject|10|||
23803669|NCT02696031|66658714|FG002|Up to Week 104|Withdrawal by Subject|16|||
23803670|NCT02696031|66658715|FG003|Up to Week 104|Withdrawal by Subject|0|||
23803671|NCT02696031|66658716|FG004|Up to Week 104|Withdrawal by Subject|0|||
23803672|NCT02696031|66658717|FG005|Up to Week 104|Withdrawal by Subject|0|||
23803673|NCT02696031|66658712|FG000|Up to Week 104|Protocol Violation|1|||
23803674|NCT02696031|66658713|FG001|Up to Week 104|Protocol Violation|0|||
23803675|NCT02696031|66658714|FG002|Up to Week 104|Protocol Violation|0|||
23803676|NCT02696031|66658715|FG003|Up to Week 104|Protocol Violation|0|||
23803677|NCT02696031|66658716|FG004|Up to Week 104|Protocol Violation|0|||
23803678|NCT02696031|66658717|FG005|Up to Week 104|Protocol Violation|0|||
23803679|NCT02696031|66658712|FG000|Up to Week 104|Physician Decision|1|||
23803680|NCT02696031|66658713|FG001|Up to Week 104|Physician Decision|2|||
23803681|NCT02696031|66658714|FG002|Up to Week 104|Physician Decision|3|||
23803682|NCT02696031|66658715|FG003|Up to Week 104|Physician Decision|0|||
23803683|NCT02696031|66658716|FG004|Up to Week 104|Physician Decision|0|||
23803684|NCT02696031|66658717|FG005|Up to Week 104|Physician Decision|0|||
23803685|NCT02696031|66658712|FG000|Up to Week 104|Lost to Follow-up|2|||
23480347|NCT00617669|65501953|FG001|Overall Study|Patients randomized but not treated|3|||
23480348|NCT01330017|65501954|FG000|Overall Study|Adverse Event|0|||
23803686|NCT02696031|66658713|FG001|Up to Week 104|Lost to Follow-up|3|||
23803687|NCT02696031|66658714|FG002|Up to Week 104|Lost to Follow-up|1|||
23803688|NCT02696031|66658715|FG003|Up to Week 104|Lost to Follow-up|0|||
23803689|NCT02696031|66658716|FG004|Up to Week 104|Lost to Follow-up|0|||
23803690|NCT02696031|66658717|FG005|Up to Week 104|Lost to Follow-up|0|||
23803691|NCT02696031|66658712|FG000|Up to Week 104|Lack of Efficacy|13|||
23803692|NCT02696031|66658713|FG001|Up to Week 104|Lack of Efficacy|12|||
23803693|NCT02696031|66658714|FG002|Up to Week 104|Lack of Efficacy|11|||
23803694|NCT02696031|66658715|FG003|Up to Week 104|Lack of Efficacy|0|||
23803695|NCT02696031|66658716|FG004|Up to Week 104|Lack of Efficacy|0|||
23803696|NCT02696031|66658717|FG005|Up to Week 104|Lack of Efficacy|0|||
23803697|NCT02696031|66658712|FG000|Up to Week 104|Adverse Event|7|||
23803698|NCT02696031|66658713|FG001|Up to Week 104|Adverse Event|11|||
23803699|NCT02696031|66658714|FG002|Up to Week 104|Adverse Event|5|||
23803700|NCT02696031|66658715|FG003|Up to Week 104|Adverse Event|0|||
23803701|NCT02696031|66658716|FG004|Up to Week 104|Adverse Event|0|||
23803702|NCT02696031|66658717|FG005|Up to Week 104|Adverse Event|0|||
23803703|NCT02696031|66658712|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23803704|NCT02696031|66658713|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
23803705|NCT02696031|66658714|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23803706|NCT02696031|66658715|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23803707|NCT02696031|66658716|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23803708|NCT02696031|66658717|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23803709|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23803710|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23803711|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23803712|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
23803713|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
23803714|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
23803715|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23803716|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23803717|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23803718|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
23803719|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
23803720|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23803721|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23803722|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23803723|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23803724|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
23803725|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23803726|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23803727|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23803728|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23803729|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23803730|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23803731|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
23803732|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23803733|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23803734|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23803735|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23803736|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
23803737|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
23803738|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
23803739|NCT02696031|66658712|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23803740|NCT02696031|66658713|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23803741|NCT02696031|66658714|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23803742|NCT02696031|66658715|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
23803743|NCT02696031|66658716|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
23803744|NCT02696031|66658717|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
23803745|NCT02326974|66658718|FG000|Overall Study|Withdrawal by Subject|2|||
23480349|NCT01330017|65501955|FG001|Overall Study|Adverse Event|1|||
23803746|NCT02326974|66658718|FG000|Overall Study|failed heterogenity evaluation|5|||
23803747|NCT03856593|66658719|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
23803748|NCT03856593|66658720|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
23803749|NCT04412057|66658721|FG000|Overall Study|Death|3|||
23803750|NCT04412057|66658722|FG001|Overall Study|Death|7|||
23803751|NCT04412057|66658721|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
23803752|NCT04412057|66658722|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
23803753|NCT01715896|66658724|FG000|Overall Study|Lost to Follow-up|0|||
23803754|NCT01715896|66658725|FG001|Overall Study|Lost to Follow-up|2|||
23803755|NCT01715896|66658724|FG000|Overall Study|Withdrawal by Subject|1|||
23803756|NCT01715896|66658725|FG001|Overall Study|Withdrawal by Subject|4|||
23803757|NCT01715896|66658724|FG000|Overall Study|Other|2|||
23803758|NCT01715896|66658725|FG001|Overall Study|Other|5|||
23803759|NCT05212883|66661540|FG000|Overall Study|Invalid test result|125|||
23803760|NCT00831623|66661541|FG000|Overall Study|Withdrawal by Subject|9|||
23803761|NCT00831623|66661541|FG000|Overall Study|Lost to Follow-up|1|||
23803762|NCT00831623|66661541|FG000|Overall Study|Not 2 years post-treatment|12|||
23803763|NCT01299805|66661543|FG000|Overall Study|Adverse Event|2|||
23803764|NCT01299805|66661544|FG001|Overall Study|Adverse Event|0|||
23803765|NCT00857259|66661545|FG000|Overall Study|Protocol Violation|1|||
23803766|NCT00857259|66661546|FG001|Overall Study|Protocol Violation|0|||
23803767|NCT00857259|66661547|FG002|Overall Study|Protocol Violation|1|||
23803768|NCT03499119|66661548|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
23803769|NCT03499119|66661549|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
23803770|NCT03499119|66661550|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
23803771|NCT03499119|66661551|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
23803772|NCT03499119|66661548|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
23803773|NCT03499119|66661549|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
23803774|NCT03499119|66661550|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
23803775|NCT03499119|66661551|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
23803776|NCT03499119|66661548|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
23803777|NCT03499119|66661549|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
23803778|NCT03499119|66661550|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
23803779|NCT03499119|66661551|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
23803780|NCT03499119|66661548|FG000|Optional Extension Phase|Lost to Follow-up|0|||
23803781|NCT03499119|66661549|FG001|Optional Extension Phase|Lost to Follow-up|0|||
23803782|NCT03499119|66661550|FG002|Optional Extension Phase|Lost to Follow-up|0|||
23803783|NCT03499119|66661551|FG003|Optional Extension Phase|Lost to Follow-up|1|||
23803784|NCT03499119|66661548|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
23803785|NCT03499119|66661549|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
23803786|NCT03499119|66661550|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
23803787|NCT03499119|66661551|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
23803788|NCT03499119|66661548|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
23803789|NCT03499119|66661549|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
23803790|NCT03499119|66661550|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
23803791|NCT03499119|66661551|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
23803792|NCT04086641|66661552|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
23803793|NCT04086641|66661553|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
23803794|NCT02701413|66661559|FG000|Overall Study|Withdrawal by Subject|7|||
23803795|NCT02701413|66661560|FG001|Overall Study|Withdrawal by Subject|11|||
23803796|NCT00532935|66661566|FG000|Overall Study|Adverse Event|11|||
23803797|NCT00532935|66661567|FG001|Overall Study|Adverse Event|12|||
23803798|NCT00532935|66661566|FG000|Overall Study|Lack of Efficacy|0|||
23803799|NCT00532935|66661567|FG001|Overall Study|Lack of Efficacy|3|||
23803800|NCT00532935|66661566|FG000|Overall Study|Lost to Follow-up|10|||
23803801|NCT00532935|66661567|FG001|Overall Study|Lost to Follow-up|6|||
23803802|NCT00532935|66661566|FG000|Overall Study|Physician Decision|4|||
23803803|NCT00532935|66661567|FG001|Overall Study|Physician Decision|5|||
23803804|NCT00532935|66661566|FG000|Overall Study|Pregnancy|1|||
23803805|NCT00532935|66661567|FG001|Overall Study|Pregnancy|0|||
23803806|NCT00532935|66661566|FG000|Overall Study|Protocol Violation|4|||
23803807|NCT00532935|66661567|FG001|Overall Study|Protocol Violation|2|||
23361084|NCT04058028|65065963|FG001|Overall Study|Lost to Follow-up|1|||
23803808|NCT00532935|66661566|FG000|Overall Study|Withdrawal by Subject|10|||
23803809|NCT00532935|66661567|FG001|Overall Study|Withdrawal by Subject|9|||
23803810|NCT00532935|66661566|FG000|Overall Study|Protocol Specific Criteria|11|||
23803811|NCT00532935|66661567|FG001|Overall Study|Protocol Specific Criteria|15|||
23803812|NCT03832738|66661568|FG000|Overall Study|Withdrawal by Subject|6|||
23803813|NCT03832738|66661569|FG001|Overall Study|Withdrawal by Subject|7|||
23803814|NCT03832738|66661570|FG002|Overall Study|Withdrawal by Subject|16|||
23803815|NCT03832738|66661568|FG000|Overall Study|Physician Decision|0|||
23803816|NCT03832738|66661569|FG001|Overall Study|Physician Decision|1|||
23803817|NCT03832738|66661570|FG002|Overall Study|Physician Decision|2|||
23803818|NCT03832738|66661568|FG000|Overall Study|Adverse Event|2|||
23803819|NCT03832738|66661569|FG001|Overall Study|Adverse Event|3|||
23803820|NCT03832738|66661570|FG002|Overall Study|Adverse Event|1|||
23803821|NCT03832738|66661568|FG000|Overall Study|Pregnancy|0|||
23803822|NCT03832738|66661569|FG001|Overall Study|Pregnancy|1|||
23803823|NCT03832738|66661570|FG002|Overall Study|Pregnancy|0|||
23803824|NCT00865514|66661579|FG000|Overall Study|Infusion cost exceeded funding|2|||
23803825|NCT01014624|66661580|FG000|Overall Study|Adverse Event|0|||
23803826|NCT01014624|66661581|FG001|Overall Study|Adverse Event|1|||
23803827|NCT01014624|66661580|FG000|Overall Study|Protocol Violation|1|||
23803828|NCT01014624|66661581|FG001|Overall Study|Protocol Violation|0|||
23803829|NCT01014624|66661580|FG000|Overall Study|Withdrawal by Subject|1|||
23654848|NCT03285178|66121388|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23803830|NCT01014624|66661581|FG001|Overall Study|Withdrawal by Subject|0|||
23803831|NCT00904748|66661585|FG000|Overall Study|Withdrawal by Subject|1|||
23803832|NCT00904748|66661586|FG001|Overall Study|Withdrawal by Subject|1|||
23803833|NCT00904748|66661587|FG002|Overall Study|Withdrawal by Subject|1|||
23803834|NCT00904748|66661588|FG003|Overall Study|Withdrawal by Subject|2|||
23803835|NCT00904748|66661589|FG004|Overall Study|Withdrawal by Subject|0|||
23803836|NCT00904748|66661590|FG005|Overall Study|Withdrawal by Subject|0|||
23803837|NCT00904748|66661585|FG000|Overall Study|Adverse Event|0|||
23803838|NCT00904748|66661586|FG001|Overall Study|Adverse Event|0|||
23803839|NCT00904748|66661587|FG002|Overall Study|Adverse Event|0|||
23803840|NCT00904748|66661588|FG003|Overall Study|Adverse Event|0|||
23803841|NCT00904748|66661589|FG004|Overall Study|Adverse Event|1|||
23803842|NCT00904748|66661590|FG005|Overall Study|Adverse Event|0|||
23803843|NCT02940730|66661591|FG000|Intervention 2|Physician Decision|7|||
23803844|NCT02940730|66661592|FG001|Intervention 2|Physician Decision|0|||
23803845|NCT00518622|66661599|FG000|Overall Study|Lost to Follow-up|0|||
23803846|NCT00518622|66661600|FG001|Overall Study|Lost to Follow-up|0|||
23803847|NCT00518622|66661601|FG002|Overall Study|Lost to Follow-up|1|||
23803848|NCT00518622|66661602|FG003|Overall Study|Lost to Follow-up|0|||
23361085|NCT04058028|65065964|FG002|Overall Study|Lost to Follow-up|1|||
23803849|NCT00518622|66661603|FG004|Overall Study|Lost to Follow-up|0|||
23803850|NCT00518622|66661604|FG005|Overall Study|Lost to Follow-up|0|||
23803851|NCT00518622|66661605|FG006|Overall Study|Lost to Follow-up|0|||
23803852|NCT00518622|66661606|FG007|Overall Study|Lost to Follow-up|0|||
23803853|NCT00518622|66661599|FG000|Overall Study|Study medication taken incorrectly|0|||
23803854|NCT00518622|66661600|FG001|Overall Study|Study medication taken incorrectly|1|||
23803855|NCT00518622|66661601|FG002|Overall Study|Study medication taken incorrectly|0|||
23654849|NCT03285178|66121389|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23803856|NCT00518622|66661602|FG003|Overall Study|Study medication taken incorrectly|0|||
23803857|NCT00518622|66661603|FG004|Overall Study|Study medication taken incorrectly|0|||
23803858|NCT00518622|66661604|FG005|Overall Study|Study medication taken incorrectly|0|||
23803859|NCT00518622|66661605|FG006|Overall Study|Study medication taken incorrectly|0|||
23803860|NCT00518622|66661606|FG007|Overall Study|Study medication taken incorrectly|0|||
23803861|NCT01725282|66661607|FG000|Overall Study|Adverse Event|1|||
23803862|NCT01725282|66661608|FG001|Overall Study|Adverse Event|3|||
23803863|NCT01725282|66661609|FG002|Overall Study|Adverse Event|6|||
23803864|NCT01725282|66661610|FG003|Overall Study|Adverse Event|4|||
23803865|NCT01725282|66661607|FG000|Overall Study|Exacerbation of Target Disease|1|||
23803866|NCT01725282|66661608|FG001|Overall Study|Exacerbation of Target Disease|0|||
23803867|NCT01725282|66661609|FG002|Overall Study|Exacerbation of Target Disease|0|||
23803868|NCT01725282|66661610|FG003|Overall Study|Exacerbation of Target Disease|1|||
23803869|NCT01725282|66661607|FG000|Overall Study|Met Exclusion Criteria|0|||
23803870|NCT01725282|66661608|FG001|Overall Study|Met Exclusion Criteria|0|||
23803871|NCT01725282|66661609|FG002|Overall Study|Met Exclusion Criteria|1|||
23803872|NCT01725282|66661610|FG003|Overall Study|Met Exclusion Criteria|0|||
23803873|NCT01725282|66661607|FG000|Overall Study|Study Site Withdrawal|0|||
23803874|NCT01725282|66661608|FG001|Overall Study|Study Site Withdrawal|1|||
23803875|NCT01725282|66661609|FG002|Overall Study|Study Site Withdrawal|0|||
23803876|NCT01725282|66661610|FG003|Overall Study|Study Site Withdrawal|0|||
23803877|NCT01725282|66661607|FG000|Overall Study|Withdrawal by Subject|0|||
23803878|NCT01725282|66661608|FG001|Overall Study|Withdrawal by Subject|0|||
23803879|NCT01725282|66661609|FG002|Overall Study|Withdrawal by Subject|1|||
23803880|NCT01725282|66661610|FG003|Overall Study|Withdrawal by Subject|1|||
23803881|NCT01725282|66661607|FG000|Overall Study|Lack of Efficacy|0|||
23803882|NCT01725282|66661608|FG001|Overall Study|Lack of Efficacy|1|||
23803883|NCT01725282|66661609|FG002|Overall Study|Lack of Efficacy|0|||
23803884|NCT01725282|66661610|FG003|Overall Study|Lack of Efficacy|1|||
23803885|NCT00869024|66661611|FG000|Overall Study|Death|2|||
23803886|NCT00869024|66661612|FG001|Overall Study|Death|3|||
23803887|NCT00869024|66661611|FG000|Overall Study|Lost to Follow-up|0|||
23803888|NCT00869024|66661612|FG001|Overall Study|Lost to Follow-up|1|||
23803889|NCT00869024|66661611|FG000|Overall Study|Protocol Violation|0|||
23803890|NCT00869024|66661612|FG001|Overall Study|Protocol Violation|1|||
23803891|NCT01688726|66661613|FG000|Overall Study|Adverse Event|1|||
23803892|NCT01688726|66661614|FG001|Overall Study|Adverse Event|0|||
23803893|NCT01688726|66661613|FG000|Overall Study|Relocated abroad|0|||
23803894|NCT01688726|66661614|FG001|Overall Study|Relocated abroad|1|||
23803895|NCT00062751|66661615|FG000|Overall Study|Disease progression|24|||
23803896|NCT00062751|66661616|FG001|Overall Study|Disease progression|17|||
23803897|NCT00062751|66661617|FG002|Overall Study|Disease progression|24|||
23803898|NCT00062751|66661618|FG003|Overall Study|Disease progression|2|||
23803899|NCT00062751|66661619|FG004|Overall Study|Disease progression|2|||
23803900|NCT00062751|66661615|FG000|Overall Study|Adverse Event|4|||
23803901|NCT00062751|66661616|FG001|Overall Study|Adverse Event|7|||
23803902|NCT00062751|66661617|FG002|Overall Study|Adverse Event|2|||
23803903|NCT00062751|66661618|FG003|Overall Study|Adverse Event|2|||
23803904|NCT00062751|66661619|FG004|Overall Study|Adverse Event|2|||
23480350|NCT01330017|65501956|FG002|Overall Study|Adverse Event|1|||
23803905|NCT00062751|66661615|FG000|Overall Study|Other|2|||
23803906|NCT00062751|66661616|FG001|Overall Study|Other|3|||
23803907|NCT00062751|66661617|FG002|Overall Study|Other|1|||
23803908|NCT00062751|66661618|FG003|Overall Study|Other|0|||
23803909|NCT00062751|66661619|FG004|Overall Study|Other|1|||
23803910|NCT00062751|66661615|FG000|Overall Study|Withdrawal by Subject|1|||
23803911|NCT00062751|66661616|FG001|Overall Study|Withdrawal by Subject|2|||
23803912|NCT00062751|66661617|FG002|Overall Study|Withdrawal by Subject|2|||
23803913|NCT00062751|66661618|FG003|Overall Study|Withdrawal by Subject|1|||
23803914|NCT00062751|66661619|FG004|Overall Study|Withdrawal by Subject|0|||
23803915|NCT00062751|66661615|FG000|Overall Study|Symptomatic deterioration|1|||
23803916|NCT00062751|66661616|FG001|Overall Study|Symptomatic deterioration|1|||
23803917|NCT00062751|66661617|FG002|Overall Study|Symptomatic deterioration|0|||
23803918|NCT00062751|66661618|FG003|Overall Study|Symptomatic deterioration|0|||
23803919|NCT00062751|66661619|FG004|Overall Study|Symptomatic deterioration|1|||
23803920|NCT00062751|66661615|FG000|Overall Study|Death|1|||
23803921|NCT00062751|66661616|FG001|Overall Study|Death|0|||
23803922|NCT00062751|66661617|FG002|Overall Study|Death|1|||
23803923|NCT00062751|66661618|FG003|Overall Study|Death|0|||
23803924|NCT00062751|66661619|FG004|Overall Study|Death|0|||
23803925|NCT01564459|66661620|FG000|Run-In|Adverse Event|7|||
23803926|NCT01564459|66661621|FG001|Run-In|Adverse Event|0|||
23803927|NCT01564459|66661622|FG002|Run-In|Adverse Event|0|||
23803928|NCT01564459|66661620|FG000|Run-In|Lost to Follow-up|1|||
23803929|NCT01564459|66661621|FG001|Run-In|Lost to Follow-up|0|||
23803930|NCT01564459|66661622|FG002|Run-In|Lost to Follow-up|0|||
23803931|NCT01564459|66661620|FG000|Run-In|Non-compliance with study drug|2|||
23803932|NCT01564459|66661621|FG001|Run-In|Non-compliance with study drug|0|||
23803933|NCT01564459|66661622|FG002|Run-In|Non-compliance with study drug|0|||
23803934|NCT01564459|66661620|FG000|Run-In|Protocol Violation|1|||
23803935|NCT01564459|66661621|FG001|Run-In|Protocol Violation|0|||
23803936|NCT01564459|66661622|FG002|Run-In|Protocol Violation|0|||
23803937|NCT01564459|66661620|FG000|Run-In|Withdrawal by Subject|1|||
23803938|NCT01564459|66661621|FG001|Run-In|Withdrawal by Subject|0|||
23803939|NCT01564459|66661622|FG002|Run-In|Withdrawal by Subject|0|||
23803940|NCT01564459|66661620|FG000|Double-blind Treatment|Adverse Event|0|||
23803941|NCT01564459|66661621|FG001|Double-blind Treatment|Adverse Event|0|||
23803942|NCT01564459|66661622|FG002|Double-blind Treatment|Adverse Event|1|||
23803943|NCT02691741|66661625|FG000|Overall Study|Adverse Event|0|||
23803944|NCT02691741|66661626|FG001|Overall Study|Adverse Event|2|||
23803945|NCT02691741|66661625|FG000|Overall Study|Lost to Follow-up|1|||
23803946|NCT02691741|66661626|FG001|Overall Study|Lost to Follow-up|0|||
23803947|NCT02691741|66661625|FG000|Overall Study|Physician Decision|0|||
23803948|NCT02691741|66661626|FG001|Overall Study|Physician Decision|1|||
23803949|NCT02691741|66661625|FG000|Overall Study|Withdrawal by Subject|0|||
23803950|NCT02691741|66661626|FG001|Overall Study|Withdrawal by Subject|4|||
23803951|NCT02100319|66661629|FG000|Overall Study|Case Report Forms Uncollected|11|||
23803952|NCT02100319|66661629|FG000|Overall Study|Protocol Deviation|5|||
23803953|NCT03078582|66661630|FG000|Overall Study|Adverse Event|0|||
23803954|NCT03078582|66661631|FG001|Overall Study|Adverse Event|8|||
23803955|NCT00227266|66661632|FG000|Overall Study|Withdrawal by Subject|0|||
23803956|NCT00227266|66661633|FG001|Overall Study|Withdrawal by Subject|0|||
23803957|NCT00227266|66661634|FG002|Overall Study|Withdrawal by Subject|1|||
23803958|NCT00227266|66661632|FG000|Overall Study|Protocol Violation|1|||
23803959|NCT00227266|66661633|FG001|Overall Study|Protocol Violation|0|||
23803960|NCT00227266|66661634|FG002|Overall Study|Protocol Violation|1|||
23803961|NCT00227266|66661632|FG000|Overall Study|Excessive weight gain|0|||
23803962|NCT00227266|66661633|FG001|Overall Study|Excessive weight gain|0|||
23803963|NCT00227266|66661634|FG002|Overall Study|Excessive weight gain|2|||
23803964|NCT01000610|66661635|FG000|Overall Study|Adverse Event|1|||
23803965|NCT01000610|66661635|FG000|Overall Study|Lost to Follow-up|4|||
23803966|NCT01000610|66661635|FG000|Overall Study|Treatment failure|1|||
23803967|NCT00983918|66661636|FG000|Overall Study|conversion to open cholecystectomy|0|||
23803968|NCT00983918|66661637|FG001|Overall Study|conversion to open cholecystectomy|2|||
23803969|NCT00983918|66661638|FG002|Overall Study|conversion to open cholecystectomy|2|||
23803970|NCT00983918|66661639|FG003|Overall Study|conversion to open cholecystectomy|2|||
23803971|NCT01901848|66661640|FG000|Randomized and Treated|Lost to Follow-up|3|||
23803972|NCT01901848|66661641|FG001|Randomized and Treated|Lost to Follow-up|6|||
23803973|NCT01901848|66661640|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
23803974|NCT01901848|66661641|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
23803975|NCT02610816|66661642|FG000|Phase 1|Withdrawal by Subject|2|||
23803976|NCT02610816|66661643|FG001|Phase 1|Withdrawal by Subject|6|||
23803977|NCT02610816|66661644|FG002|Phase 1|Withdrawal by Subject|0|||
23803978|NCT02610816|66661645|FG003|Phase 1|Withdrawal by Subject|0|||
23803979|NCT02610816|66661642|FG000|Phase 1|Lost to Follow-up|2|||
23803980|NCT02610816|66661643|FG001|Phase 1|Lost to Follow-up|1|||
23803981|NCT02610816|66661644|FG002|Phase 1|Lost to Follow-up|0|||
23803982|NCT02610816|66661645|FG003|Phase 1|Lost to Follow-up|0|||
23803983|NCT02610816|66661642|FG000|Phase 1|Physician Decision|0|||
23803984|NCT02610816|66661643|FG001|Phase 1|Physician Decision|1|||
23803985|NCT02610816|66661644|FG002|Phase 1|Physician Decision|0|||
23803986|NCT02610816|66661645|FG003|Phase 1|Physician Decision|0|||
23803987|NCT02610816|66661642|FG000|Phase 2|Withdrawal by Subject|0|||
23803988|NCT02610816|66661643|FG001|Phase 2|Withdrawal by Subject|0|||
23803989|NCT02610816|66661644|FG002|Phase 2|Withdrawal by Subject|9|||
23803990|NCT02610816|66661645|FG003|Phase 2|Withdrawal by Subject|3|||
23803991|NCT02610816|66661642|FG000|Phase 2|Lost to Follow-up|0|||
23803992|NCT02610816|66661643|FG001|Phase 2|Lost to Follow-up|0|||
23803993|NCT02610816|66661644|FG002|Phase 2|Lost to Follow-up|2|||
23803994|NCT02610816|66661645|FG003|Phase 2|Lost to Follow-up|0|||
23803995|NCT02610816|66661642|FG000|Phase 2|Physician Decision|0|||
23803996|NCT02610816|66661643|FG001|Phase 2|Physician Decision|0|||
23803997|NCT02610816|66661644|FG002|Phase 2|Physician Decision|0|||
23803998|NCT02610816|66661645|FG003|Phase 2|Physician Decision|2|||
23803999|NCT02610816|66661642|FG000|Phase 2|Pregnancy|0|||
23804000|NCT02610816|66661643|FG001|Phase 2|Pregnancy|0|||
23804001|NCT02610816|66661644|FG002|Phase 2|Pregnancy|0|||
23804002|NCT02610816|66661645|FG003|Phase 2|Pregnancy|1|||
23804003|NCT02357342|66661648|FG000|First 6 Months|Death|2|||
23804004|NCT02357342|66661649|FG001|First 6 Months|Death|0|||
23804005|NCT01560507|66661650|FG000|Overall Study|Lost to Follow-up|3|||
23804006|NCT01560507|66661651|FG001|Overall Study|Lost to Follow-up|1|||
23804007|NCT01560507|66661652|FG002|Overall Study|Lost to Follow-up|2|||
23804008|NCT01560507|66661650|FG000|Overall Study|Withdrawal by Subject|1|||
23804009|NCT01560507|66661651|FG001|Overall Study|Withdrawal by Subject|1|||
23804010|NCT01560507|66661652|FG002|Overall Study|Withdrawal by Subject|0|||
23804011|NCT02470091|66661653|FG000|Overall Study|Withdrawal by Subject|1|||
23804012|NCT02470091|66661654|FG001|Overall Study|Withdrawal by Subject|0|||
23804013|NCT02470091|66661653|FG000|Overall Study|Ineligible|0|||
23804014|NCT02470091|66661654|FG001|Overall Study|Ineligible|2|||
23804015|NCT00788593|66661655|FG000|Placebo Run-in Phase|Adverse Event|2|||
23804016|NCT00788593|66661656|FG001|Placebo Run-in Phase|Adverse Event|0|||
23804017|NCT00788593|66661657|FG002|Placebo Run-in Phase|Adverse Event|0|||
23804018|NCT00788593|66661655|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
23804019|NCT00788593|66661656|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
23804020|NCT00788593|66661657|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
23804021|NCT00788593|66661655|FG000|Placebo Run-in Phase|Protocol Violation|2|||
23804022|NCT00788593|66661656|FG001|Placebo Run-in Phase|Protocol Violation|0|||
23804023|NCT00788593|66661657|FG002|Placebo Run-in Phase|Protocol Violation|0|||
23804024|NCT00788593|66661655|FG000|First Intervention Period|Adverse Event|0|||
23804025|NCT00788593|66661656|FG001|First Intervention Period|Adverse Event|1|||
23804026|NCT00788593|66661657|FG002|First Intervention Period|Adverse Event|0|||
23804027|NCT00788593|66661655|FG000|Second Intervention Period|Lost to Follow-up|0|||
23804028|NCT00788593|66661656|FG001|Second Intervention Period|Lost to Follow-up|1|||
23804029|NCT00788593|66661657|FG002|Second Intervention Period|Lost to Follow-up|0|||
23804030|NCT00788593|66661655|FG000|Second Intervention Period|Other|0|||
23804031|NCT00788593|66661656|FG001|Second Intervention Period|Other|0|||
23804032|NCT00788593|66661657|FG002|Second Intervention Period|Other|1|||
23804033|NCT01355159|66661660|FG000|Overall Study|Withdrew consent|39|||
23804034|NCT01355159|66661661|FG001|Overall Study|Withdrew consent|47|||
23804035|NCT01355159|66661660|FG000|Overall Study|No primary outcome data|17|||
23804036|NCT01355159|66661661|FG001|Overall Study|No primary outcome data|11|||
23804037|NCT01355159|66661660|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
23804038|NCT01355159|66661661|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
23804039|NCT01355159|66661660|FG000|Overall Study|Early intrauterine fetal death|6|||
23804040|NCT01355159|66661661|FG001|Overall Study|Early intrauterine fetal death|6|||
23804041|NCT00754442|66661663|FG000|Overall Study|Withdrawal by Subject|5|||
23804042|NCT00754442|66661664|FG001|Overall Study|Withdrawal by Subject|3|||
23804043|NCT00126126|66661665|FG000|Overall Study|Lost to Follow-up|0|||
23804044|NCT00126126|66661666|FG001|Overall Study|Lost to Follow-up|2|||
23804045|NCT02531594|66661668|FG000|Overall Study|Withdrawal by Subject|7|||
23804046|NCT02531594|66661669|FG001|Overall Study|Withdrawal by Subject|8|||
23804047|NCT01791153|66661670|FG000|Part 1: Blinded Period|Adverse Event|7|||
23804048|NCT01791153|66661671|FG001|Part 1: Blinded Period|Adverse Event|3|||
23804049|NCT01791153|66661672|FG002|Part 1: Blinded Period|Adverse Event|2|||
23804050|NCT01791153|66661673|FG003|Part 1: Blinded Period|Adverse Event|0|||
23804051|NCT01791153|66661674|FG004|Part 1: Blinded Period|Adverse Event|0|||
23804052|NCT01791153|66661675|FG005|Part 1: Blinded Period|Adverse Event|0|||
23804053|NCT01791153|66661676|FG006|Part 1: Blinded Period|Adverse Event|0|||
23804054|NCT01791153|66661677|FG007|Part 1: Blinded Period|Adverse Event|0|||
23804055|NCT01791153|66661670|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
23804056|NCT01791153|66661671|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
23804057|NCT01791153|66661672|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
23804058|NCT01791153|66661673|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
23804059|NCT01791153|66661674|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
23804060|NCT01791153|66661675|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
23804061|NCT01791153|66661676|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
23804062|NCT01791153|66661677|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
23804063|NCT01791153|66661670|FG000|Part 1: Blinded Period|Non-Compliance|1|||
23804064|NCT01791153|66661671|FG001|Part 1: Blinded Period|Non-Compliance|0|||
23804065|NCT01791153|66661672|FG002|Part 1: Blinded Period|Non-Compliance|0|||
23804066|NCT01791153|66661673|FG003|Part 1: Blinded Period|Non-Compliance|0|||
23804067|NCT01791153|66661674|FG004|Part 1: Blinded Period|Non-Compliance|0|||
23804068|NCT01791153|66661675|FG005|Part 1: Blinded Period|Non-Compliance|0|||
23804069|NCT01791153|66661676|FG006|Part 1: Blinded Period|Non-Compliance|0|||
23804070|NCT01791153|66661677|FG007|Part 1: Blinded Period|Non-Compliance|0|||
23804071|NCT01791153|66661670|FG000|Part 1: Blinded Period|Physician Decision|0|||
23804072|NCT01791153|66661671|FG001|Part 1: Blinded Period|Physician Decision|0|||
23804073|NCT01791153|66661672|FG002|Part 1: Blinded Period|Physician Decision|0|||
23804074|NCT01791153|66661673|FG003|Part 1: Blinded Period|Physician Decision|1|||
23804075|NCT01791153|66661674|FG004|Part 1: Blinded Period|Physician Decision|0|||
23804076|NCT01791153|66661675|FG005|Part 1: Blinded Period|Physician Decision|0|||
23804077|NCT01791153|66661676|FG006|Part 1: Blinded Period|Physician Decision|0|||
23804078|NCT01791153|66661677|FG007|Part 1: Blinded Period|Physician Decision|0|||
23804079|NCT01791153|66661670|FG000|Part 1: Blinded Period|Protocol Violation|0|||
23804080|NCT01791153|66661671|FG001|Part 1: Blinded Period|Protocol Violation|0|||
23804081|NCT01791153|66661672|FG002|Part 1: Blinded Period|Protocol Violation|0|||
23804082|NCT01791153|66661673|FG003|Part 1: Blinded Period|Protocol Violation|1|||
23804083|NCT01791153|66661674|FG004|Part 1: Blinded Period|Protocol Violation|0|||
23804084|NCT01791153|66661675|FG005|Part 1: Blinded Period|Protocol Violation|0|||
23804085|NCT01791153|66661676|FG006|Part 1: Blinded Period|Protocol Violation|0|||
23804086|NCT01791153|66661677|FG007|Part 1: Blinded Period|Protocol Violation|0|||
23804087|NCT01791153|66661670|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
23804088|NCT01791153|66661671|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
23804089|NCT01791153|66661672|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
23804090|NCT01791153|66661673|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
23804091|NCT01791153|66661674|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
23804092|NCT01791153|66661675|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
23804093|NCT01791153|66661676|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
23804094|NCT01791153|66661677|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
23804095|NCT01791153|66661670|FG000|Part 2: Open-label Period|Adverse Event|0|||
23804096|NCT01791153|66661671|FG001|Part 2: Open-label Period|Adverse Event|0|||
23804097|NCT01791153|66661672|FG002|Part 2: Open-label Period|Adverse Event|0|||
23804098|NCT01791153|66661673|FG003|Part 2: Open-label Period|Adverse Event|0|||
23804099|NCT01791153|66661674|FG004|Part 2: Open-label Period|Adverse Event|0|||
23804100|NCT01791153|66661675|FG005|Part 2: Open-label Period|Adverse Event|1|||
23804101|NCT01791153|66661676|FG006|Part 2: Open-label Period|Adverse Event|1|||
23804102|NCT01791153|66661677|FG007|Part 2: Open-label Period|Adverse Event|2|||
23804103|NCT01791153|66661670|FG000|Part 2: Open-label Period|Death|0|||
23804104|NCT01791153|66661671|FG001|Part 2: Open-label Period|Death|0|||
23804105|NCT01791153|66661672|FG002|Part 2: Open-label Period|Death|0|||
23804106|NCT01791153|66661673|FG003|Part 2: Open-label Period|Death|0|||
23804107|NCT01791153|66661674|FG004|Part 2: Open-label Period|Death|0|||
23804108|NCT01791153|66661675|FG005|Part 2: Open-label Period|Death|1|||
23599800|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
23599801|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
23599802|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
23599803|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
23599804|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Other|30|||
23599805|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Other|0|||
23599806|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Other|0|||
23599807|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
23804109|NCT01791153|66661676|FG006|Part 2: Open-label Period|Death|1|||
23804110|NCT01791153|66661677|FG007|Part 2: Open-label Period|Death|1|||
23804111|NCT01791153|66661670|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
23804112|NCT01791153|66661671|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
23804113|NCT01791153|66661672|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
23804114|NCT01791153|66661673|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
23804115|NCT01791153|66661674|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
23804116|NCT01791153|66661675|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
23804117|NCT01791153|66661676|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
23804118|NCT01791153|66661677|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
23804119|NCT01791153|66661670|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
23804120|NCT01791153|66661671|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
23804121|NCT01791153|66661672|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
23804122|NCT01791153|66661673|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
23804123|NCT01791153|66661674|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
23361086|NCT04058028|65065965|FG003|Overall Study|Lost to Follow-up|0|||
23599808|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
23599809|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
23804124|NCT01791153|66661675|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
23804125|NCT01791153|66661676|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
23804126|NCT01791153|66661677|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
23804127|NCT01791153|66661670|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
23804128|NCT01791153|66661671|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
23804129|NCT01791153|66661672|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
23804130|NCT01791153|66661673|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
23804131|NCT01791153|66661674|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
23804132|NCT01791153|66661675|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
23804133|NCT01791153|66661676|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
23804134|NCT01791153|66661677|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
23804135|NCT01791153|66661670|FG000|Part 2: Open-label Period|Physician Decision|0|||
23804136|NCT01791153|66661671|FG001|Part 2: Open-label Period|Physician Decision|0|||
23804137|NCT01791153|66661672|FG002|Part 2: Open-label Period|Physician Decision|0|||
23804138|NCT01791153|66661673|FG003|Part 2: Open-label Period|Physician Decision|0|||
23804139|NCT01791153|66661674|FG004|Part 2: Open-label Period|Physician Decision|1|||
23804140|NCT01791153|66661675|FG005|Part 2: Open-label Period|Physician Decision|1|||
23804141|NCT01791153|66661676|FG006|Part 2: Open-label Period|Physician Decision|0|||
23804142|NCT01791153|66661677|FG007|Part 2: Open-label Period|Physician Decision|0|||
23804143|NCT00536484|66661678|FG000|Overall Study|Adverse Event|21|||
23804144|NCT00536484|66661679|FG001|Overall Study|Adverse Event|34|||
23804145|NCT00536484|66661678|FG000|Overall Study|Withdrawal by Subject|11|||
23804146|NCT00536484|66661679|FG001|Overall Study|Withdrawal by Subject|11|||
23804147|NCT00536484|66661678|FG000|Overall Study|Lost to Follow-up|8|||
23804148|NCT00536484|66661679|FG001|Overall Study|Lost to Follow-up|6|||
23804149|NCT00536484|66661678|FG000|Overall Study|Lack of Efficacy|16|||
23804150|NCT00536484|66661679|FG001|Overall Study|Lack of Efficacy|5|||
23804151|NCT00536484|66661678|FG000|Overall Study|Other|4|||
23804152|NCT00536484|66661679|FG001|Overall Study|Other|0|||
23804153|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
23804154|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
23804155|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
23804156|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
23804157|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
23804158|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
23804159|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
23804160|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
23804161|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
23804162|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23804163|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23804164|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23804165|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
23804166|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
23804167|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
23804168|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
23804169|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23804170|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23804171|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
23804172|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23804173|NCT02960438|66661680|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
23804174|NCT02960438|66661681|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
23804175|NCT02960438|66661682|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
23804176|NCT02960438|66661683|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
23804177|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
23804178|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
23804179|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
23804180|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
23804181|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23804182|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23804183|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
23804184|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23804185|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23804186|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23804187|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
23804188|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23804189|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
23804190|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
23804191|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
23654850|NCT03285178|66121383|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
23654851|NCT03285178|66121384|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
23654852|NCT03285178|66121385|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
23654853|NCT03285178|66121386|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
23654854|NCT03285178|66121387|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
23654855|NCT03285178|66121388|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
23654856|NCT03285178|66121389|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
23654857|NCT03285178|66121383|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
23654858|NCT03285178|66121384|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654859|NCT03285178|66121385|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654860|NCT03285178|66121386|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654861|NCT03285178|66121387|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654862|NCT03285178|66121388|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654863|NCT03285178|66121389|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23654864|NCT03285178|66121383|FG000|Single-Blind Run-In Period|Physician Decision|2|||
23654865|NCT03285178|66121384|FG001|Single-Blind Run-In Period|Physician Decision|0|||
23654866|NCT03285178|66121385|FG002|Single-Blind Run-In Period|Physician Decision|0|||
23654867|NCT03285178|66121386|FG003|Single-Blind Run-In Period|Physician Decision|0|||
23654868|NCT03285178|66121387|FG004|Single-Blind Run-In Period|Physician Decision|0|||
23654869|NCT03285178|66121388|FG005|Single-Blind Run-In Period|Physician Decision|0|||
23654870|NCT03285178|66121389|FG006|Single-Blind Run-In Period|Physician Decision|0|||
23654871|NCT03285178|66121383|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23654872|NCT03285178|66121384|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
23654873|NCT03285178|66121385|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
23654874|NCT03285178|66121386|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23654875|NCT03285178|66121387|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23654876|NCT03285178|66121388|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23654877|NCT03285178|66121389|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23654878|NCT03285178|66121383|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23654879|NCT03285178|66121384|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23654880|NCT03285178|66121385|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23654881|NCT03285178|66121386|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23654882|NCT03285178|66121387|FG004|Double-Blind Treatment Period|Adverse Event|0|||
23654883|NCT03285178|66121388|FG005|Double-Blind Treatment Period|Adverse Event|0|||
23654884|NCT03285178|66121389|FG006|Double-Blind Treatment Period|Adverse Event|2|||
23654885|NCT03285178|66121383|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23654886|NCT03285178|66121384|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23654887|NCT03285178|66121385|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
23654888|NCT03285178|66121386|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
23654889|NCT03285178|66121387|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
23804192|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
23804193|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
23804194|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
23804195|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
23804196|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
23804197|NCT02960438|66661680|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
23804198|NCT02960438|66661681|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
23804199|NCT02960438|66661682|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
23654890|NCT03285178|66121388|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
23654891|NCT03285178|66121389|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
23654892|NCT03285178|66121383|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23654893|NCT03285178|66121384|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23654894|NCT03285178|66121385|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23654895|NCT03285178|66121386|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23654896|NCT03285178|66121387|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23654897|NCT03285178|66121388|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23804200|NCT02960438|66661683|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
23804201|NCT01425723|66661684|FG000|Overall Study|Lack of Efficacy|0|||
23804202|NCT01425723|66661685|FG001|Overall Study|Lack of Efficacy|1|||
23480351|NCT01330017|65501957|FG003|Overall Study|Adverse Event|4|||
23654898|NCT03285178|66121389|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23804203|NCT01425723|66661684|FG000|Overall Study|Withdrawal by Subject|1|||
23804204|NCT01425723|66661685|FG001|Overall Study|Withdrawal by Subject|4|||
23804205|NCT01425723|66661684|FG000|Overall Study|Lost to Follow-up|0|||
23804206|NCT01425723|66661685|FG001|Overall Study|Lost to Follow-up|3|||
23804207|NCT01425723|66661684|FG000|Overall Study|Physician Decision|2|||
23804208|NCT01425723|66661685|FG001|Overall Study|Physician Decision|0|||
23804209|NCT01425723|66661684|FG000|Overall Study|Other|1|||
23804210|NCT01425723|66661685|FG001|Overall Study|Other|10|||
23804211|NCT02225665|66661686|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
23804212|NCT02225665|66661687|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
23804213|NCT02225665|66661686|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
23804214|NCT02225665|66661687|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
23804215|NCT05261490|66661688|FG000|Overall Study|Other|1|||
23804216|NCT05261490|66661689|FG001|Overall Study|Other|0|||
23804217|NCT05261490|66661690|FG002|Overall Study|Other|0|||
23804218|NCT05261490|66661688|FG000|Overall Study|Study Terminated by Sponsor|1|||
23804219|NCT05261490|66661689|FG001|Overall Study|Study Terminated by Sponsor|1|||
23804220|NCT05261490|66661690|FG002|Overall Study|Study Terminated by Sponsor|4|||
23804221|NCT05261490|66661688|FG000|Overall Study|Death|1|||
23804222|NCT05261490|66661689|FG001|Overall Study|Death|2|||
23804223|NCT05261490|66661690|FG002|Overall Study|Death|0|||
23804224|NCT00619359|66661693|FG000|Overall Study|Adverse Event|32|||
23804225|NCT00619359|66661694|FG001|Overall Study|Adverse Event|36|||
23804226|NCT00619359|66661693|FG000|Overall Study|Lost to Follow-up|12|||
23804227|NCT00619359|66661694|FG001|Overall Study|Lost to Follow-up|16|||
23804228|NCT00619359|66661693|FG000|Overall Study|Physician Decision|0|||
23804229|NCT00619359|66661694|FG001|Overall Study|Physician Decision|7|||
23804230|NCT00619359|66661693|FG000|Overall Study|Protocol Violation|1|||
23804231|NCT00619359|66661694|FG001|Overall Study|Protocol Violation|1|||
23804232|NCT00619359|66661693|FG000|Overall Study|Withdrawal by Subject|19|||
23804233|NCT00619359|66661694|FG001|Overall Study|Withdrawal by Subject|20|||
23804234|NCT00619359|66661693|FG000|Overall Study|Progressive Disease|3|||
23804235|NCT00619359|66661694|FG001|Overall Study|Progressive Disease|1|||
23804236|NCT00389831|66661695|FG000|Overall Study|Lack of Efficacy|0|||
23804237|NCT00389831|66661696|FG001|Overall Study|Lack of Efficacy|2|||
23804238|NCT00389831|66661695|FG000|Overall Study|Did not receive treatment.|0|||
23804239|NCT00389831|66661696|FG001|Overall Study|Did not receive treatment.|2|||
23804240|NCT00389831|66661695|FG000|Overall Study|Other reasons|0|||
23654899|NCT03285178|66121383|FG000|Double-Blind Treatment Period|COVID-19|0|||
23654900|NCT03285178|66121384|FG001|Double-Blind Treatment Period|COVID-19|0|||
23804241|NCT00389831|66661696|FG001|Overall Study|Other reasons|2|||
23804242|NCT00389831|66661695|FG000|Overall Study|Lost to Follow-up|0|||
23804243|NCT00389831|66661696|FG001|Overall Study|Lost to Follow-up|1|||
23804244|NCT00573157|66661697|FG000|Overall Study|Adverse Event|3|||
23804245|NCT00573157|66661698|FG001|Overall Study|Adverse Event|1|||
23804246|NCT00573157|66661697|FG000|Overall Study|Other|1|||
23654901|NCT03285178|66121385|FG002|Double-Blind Treatment Period|COVID-19|1|||
23654902|NCT03285178|66121386|FG003|Double-Blind Treatment Period|COVID-19|0|||
23654903|NCT03285178|66121387|FG004|Double-Blind Treatment Period|COVID-19|0|||
23654904|NCT03285178|66121388|FG005|Double-Blind Treatment Period|COVID-19|0|||
23654905|NCT03285178|66121389|FG006|Double-Blind Treatment Period|COVID-19|0|||
23654906|NCT04226833|66121393|FG000|Overall Study|Death|0|||
23654907|NCT04226833|66121394|FG001|Overall Study|Death|0|||
23654908|NCT04226833|66121395|FG002|Overall Study|Death|1|||
23654909|NCT04226833|66121396|FG003|Overall Study|Death|0|||
23654910|NCT01287065|66121401|FG000|Treatment Period 1|Adverse Event|0|||
23654911|NCT01287065|66121402|FG001|Treatment Period 1|Adverse Event|0|||
23654912|NCT01287065|66121403|FG002|Treatment Period 1|Adverse Event|0|||
23654913|NCT01287065|66121404|FG003|Treatment Period 1|Adverse Event|0|||
23654914|NCT01287065|66121405|FG004|Treatment Period 1|Adverse Event|1|||
23654915|NCT01287065|66121406|FG005|Treatment Period 1|Adverse Event|0|||
23654916|NCT01287065|66121401|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23654917|NCT01287065|66121402|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23654918|NCT01287065|66121403|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23654919|NCT01287065|66121404|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23654920|NCT01287065|66121405|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23654921|NCT01287065|66121406|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23654922|NCT00866697|66121407|FG000|Overall Study|Study closed/terminated|156|||
23654923|NCT00866697|66121408|FG001|Overall Study|Study closed/terminated|138|||
23654924|NCT00866697|66121407|FG000|Overall Study|Lost to Follow-up|22|||
23654925|NCT00866697|66121408|FG001|Overall Study|Lost to Follow-up|28|||
23654926|NCT00866697|66121407|FG000|Overall Study|Physician Decision|3|||
23654927|NCT00866697|66121408|FG001|Overall Study|Physician Decision|5|||
23654928|NCT00866697|66121407|FG000|Overall Study|Withdrawal by Subject|33|||
23654929|NCT00866697|66121408|FG001|Overall Study|Withdrawal by Subject|57|||
23654930|NCT01975428|66121410|FG000|Overall Study|Lost to Follow-up|17|||
23654931|NCT01975428|66121411|FG001|Overall Study|Lost to Follow-up|4|||
23654932|NCT01975428|66121410|FG000|Overall Study|Withdrawal by Subject|3|||
23654933|NCT01975428|66121411|FG001|Overall Study|Withdrawal by Subject|10|||
23654934|NCT00833911|66121412|FG000|Titration|Adverse Event|18|||
23654935|NCT00833911|66121412|FG000|Titration|Withdrawal by Subject|3|||
23654936|NCT00833911|66121412|FG000|Maintenance Phase I|Adverse Event|73|||
23654937|NCT00833911|66121412|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
23654938|NCT00833911|66121412|FG000|Maintenance Phase I|Physician Decision|10|||
23654939|NCT00833911|66121412|FG000|Maintenance Phase I|Lack of Efficacy|4|||
23654940|NCT00833911|66121412|FG000|Maintenance Phase II|Adverse Event|6|||
23654941|NCT00833911|66121412|FG000|Maintenance Phase II|Physician Decision|2|||
23654942|NCT00833911|66121412|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
23654943|NCT00833911|66121412|FG000|Maintenance Phase II|Lack of Efficacy|1|||
23654944|NCT00973362|66121422|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
23654945|NCT00973362|66121423|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
23654946|NCT00973362|66121422|FG000|Baseline Evaluation|No colposcopy visit|62|||
23654947|NCT00973362|66121423|FG001|Baseline Evaluation|No colposcopy visit|0|||
23654948|NCT00973362|66121422|FG000|Baseline Evaluation|Inevaluable|686|||
23654949|NCT00973362|66121423|FG001|Baseline Evaluation|Inevaluable|223|||
23654950|NCT00973362|66121422|FG000|3-Year Follow-up|Lost to Follow-up|17|||
23654951|NCT00973362|66121423|FG001|3-Year Follow-up|Lost to Follow-up|0|||
23654952|NCT00174265|66121425|FG000|Overall Study|Adverse Event|7|||
23654953|NCT00174265|66121426|FG001|Overall Study|Adverse Event|4|||
23654954|NCT00174265|66121425|FG000|Overall Study|Lack of Efficacy|2|||
23654955|NCT00174265|66121426|FG001|Overall Study|Lack of Efficacy|2|||
23654956|NCT00174265|66121425|FG000|Overall Study|Withdrawal by Subject|3|||
23654957|NCT00174265|66121426|FG001|Overall Study|Withdrawal by Subject|5|||
23654958|NCT00174265|66121425|FG000|Overall Study|Lost to Follow-up|1|||
23804247|NCT00573157|66661698|FG001|Overall Study|Other|1|||
23804248|NCT00493454|66661702|FG000|Overall Study|Withdrawal by Subject|1|||
23804249|NCT03919448|66661703|FG000|Overall Study|Withdrawal by Subject|1|||
23804250|NCT03919448|66661704|FG001|Overall Study|Withdrawal by Subject|0|||
23654959|NCT00174265|66121426|FG001|Overall Study|Lost to Follow-up|0|||
23654960|NCT00174265|66121425|FG000|Overall Study|Other (Not specified)|16|||
23654961|NCT00174265|66121426|FG001|Overall Study|Other (Not specified)|10|||
23654962|NCT02547233|66121427|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23654963|NCT02547233|66121428|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23654964|NCT02547233|66121427|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
23654965|NCT02547233|66121428|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
23654966|NCT02547233|66121427|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
23654967|NCT02547233|66121428|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
23654968|NCT02547233|66121427|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
23654969|NCT02547233|66121428|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23654970|NCT02547233|66121427|FG000|12-month Follow-up|Withdrawal by Subject|10|||
23654971|NCT02547233|66121428|FG001|12-month Follow-up|Withdrawal by Subject|10|||
23804251|NCT03919448|66661705|FG002|Overall Study|Withdrawal by Subject|0|||
23654972|NCT02547233|66121427|FG000|12-month Follow-up|Lost to Follow-up|3|||
23654973|NCT02547233|66121428|FG001|12-month Follow-up|Lost to Follow-up|3|||
23654974|NCT02547233|66121427|FG000|12-month Follow-up|Lack of Efficacy|1|||
23654975|NCT02547233|66121428|FG001|12-month Follow-up|Lack of Efficacy|2|||
23654976|NCT02547233|66121427|FG000|12-month Follow-up|Protocol Violation|0|||
23654977|NCT02547233|66121428|FG001|12-month Follow-up|Protocol Violation|1|||
23654978|NCT02547233|66121427|FG000|12-month Follow-up|Other|0|||
23654979|NCT02547233|66121428|FG001|12-month Follow-up|Other|1|||
23654980|NCT01605253|66121431|FG000|Overall Study|Physician Decision|3|||
23654981|NCT01605253|66121432|FG001|Overall Study|Physician Decision|2|||
23654982|NCT01605253|66121431|FG000|Overall Study|Lost to Follow-up|3|||
23654983|NCT01605253|66121432|FG001|Overall Study|Lost to Follow-up|1|||
23654984|NCT00708175|66125262|FG000|Overall Study|Adverse Event|4|||
23654985|NCT00708175|66125263|FG001|Overall Study|Adverse Event|5|||
23654986|NCT00708175|66125262|FG000|Overall Study|Protocol Violation|2|||
23654987|NCT00708175|66125263|FG001|Overall Study|Protocol Violation|3|||
23654988|NCT00708175|66125262|FG000|Overall Study|Lost to Follow-up|5|||
23654989|NCT00708175|66125263|FG001|Overall Study|Lost to Follow-up|3|||
23654990|NCT00708175|66125262|FG000|Overall Study|Withdrawal by Subject|5|||
23654991|NCT00708175|66125263|FG001|Overall Study|Withdrawal by Subject|7|||
23654992|NCT00708175|66125262|FG000|Overall Study|BMD loss >7%|2|||
23654993|NCT00708175|66125263|FG001|Overall Study|BMD loss >7%|3|||
23654994|NCT02653300|66125265|FG000|Overall Study|Withdrawal by Subject|2|||
23654995|NCT00056862|66125266|FG000|Overall Study|Protocol Violation|1|||
23654996|NCT00056862|66125267|FG001|Overall Study|Protocol Violation|0|||
23654997|NCT00909792|66125273|FG000|Period 1|Did not meet inclusion criteria|0|||
23654998|NCT00909792|66125274|FG001|Period 1|Did not meet inclusion criteria|1|||
23654999|NCT00909792|66125273|FG000|Period 2|Biomicroscopy|1|||
23655000|NCT00909792|66125274|FG001|Period 2|Biomicroscopy|0|||
23655001|NCT00909792|66125273|FG000|Period 2|Lost to Follow-up|0|||
23655002|NCT00909792|66125274|FG001|Period 2|Lost to Follow-up|1|||
23655003|NCT04399122|66125275|FG000|Overall Study|Lost to Follow-up|2|||
23655004|NCT04399122|66125276|FG001|Overall Study|Lost to Follow-up|0|||
23655005|NCT04399122|66125275|FG000|Overall Study|Withdrawal by Subject|1|||
23655006|NCT04399122|66125276|FG001|Overall Study|Withdrawal by Subject|0|||
23655007|NCT01478360|66125277|FG000|Overall Study|Lost to Follow-up|1|||
23655008|NCT01478360|66125278|FG001|Overall Study|Lost to Follow-up|0|||
23655009|NCT01478360|66125277|FG000|Overall Study|Adverse Event|0|||
23655010|NCT01478360|66125278|FG001|Overall Study|Adverse Event|1|||
23655011|NCT01478360|66125277|FG000|Overall Study|Administrative problems|1|||
23655012|NCT01478360|66125278|FG001|Overall Study|Administrative problems|2|||
23655013|NCT00887679|66125279|FG000|Overall Study|Withdrawal by Subject|1|||
23655014|NCT00887679|66125279|FG000|Overall Study|Lost to Follow-up|4|||
23655015|NCT00887679|66125279|FG000|Overall Study|Physician Decision|5|||
23655016|NCT03093350|66125286|FG000|Overall Study|Death|1|||
23655017|NCT03093350|66125286|FG000|Overall Study|Signed consent, never began treartment|1|||
23655018|NCT00235326|66125287|FG000|Overall Study|Lost to Follow-up|746|||
23655019|NCT00235326|66125288|FG001|Overall Study|Lost to Follow-up|1400|||
23655020|NCT04223830|66125292|FG000|Overall Study|Lost to Follow-up|9|||
23655021|NCT04223830|66125292|FG000|Overall Study|Adverse Event|1|||
23655022|NCT01096342|66125295|FG000|Overall Study|Protocol Violation|1|||
23655023|NCT01873495|66125296|FG000|Overall Study|Withdrawal by Subject|1|||
23655024|NCT01873495|66125296|FG000|Overall Study|Physician Decision|3|||
23655025|NCT01873495|66125296|FG000|Overall Study|Adverse Event|1|||
23655026|NCT01873495|66125296|FG000|Overall Study|Removed for Transplantation|1|||
23655027|NCT01873495|66125296|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
23655028|NCT02540538|66125307|FG000|Overall Study|Pregnancy|0|||
23655029|NCT02540538|66125308|FG001|Overall Study|Pregnancy|1|||
23655030|NCT02540538|66125309|FG002|Overall Study|Pregnancy|0|||
23655031|NCT01829425|66125310|FG000|Overall Study|Withdrawal by Subject|4|||
23655032|NCT01829425|66125311|FG001|Overall Study|Withdrawal by Subject|3|||
23655033|NCT01829425|66125310|FG000|Overall Study|Lost to Follow-up|2|||
23655034|NCT01829425|66125311|FG001|Overall Study|Lost to Follow-up|1|||
23655035|NCT02864381|66125312|FG000|Overall Study|Death|58|||
23655036|NCT02864381|66125313|FG001|Overall Study|Death|61|||
23655037|NCT02864381|66125312|FG000|Overall Study|Withdrew Consent|5|||
23655038|NCT02864381|66125313|FG001|Overall Study|Withdrew Consent|6|||
23655039|NCT02864381|66125312|FG000|Overall Study|Reason Unknown|7|||
23804252|NCT01298778|66661706|FG000|Overall Study|Lost to Follow-up|2|||
23655040|NCT02864381|66125313|FG001|Overall Study|Reason Unknown|3|||
23804253|NCT01298778|66661707|FG001|Overall Study|Lost to Follow-up|3|||
23804254|NCT01298778|66661706|FG000|Overall Study|Incorrect use of VAS|1|||
23655041|NCT02864381|66125312|FG000|Overall Study|Lost to Follow-up|1|||
23655042|NCT02864381|66125313|FG001|Overall Study|Lost to Follow-up|1|||
23655043|NCT02864381|66125312|FG000|Overall Study|Investigator's Discretion|1|||
23655044|NCT02864381|66125313|FG001|Overall Study|Investigator's Discretion|0|||
23655045|NCT02864381|66125312|FG000|Overall Study|Protocol Violation|0|||
23655046|NCT02864381|66125313|FG001|Overall Study|Protocol Violation|1|||
23655047|NCT03123250|66125314|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
23599810|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
23599811|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
23599812|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
23599813|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Adverse Event|0|||
23599814|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Adverse Event|7|||
23599815|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Adverse Event|2|||
23599816|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Failed to return|0|||
23599817|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Failed to return|2|||
23599818|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Failed to return|2|||
23599819|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
23599820|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
23599821|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
23480352|NCT01330017|65501958|FG004|Overall Study|Adverse Event|0|||
23480353|NCT01330017|65501954|FG000|Overall Study|Withdrawal by Subject|0|||
23599822|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
23599823|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
23599824|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
23599825|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Other|0|||
23655048|NCT00108069|66125315|FG000|Overall Study|Never rec'd study drug|0|||
23655049|NCT00108069|66125316|FG001|Overall Study|Never rec'd study drug|1|||
23655050|NCT00108069|66125315|FG000|Overall Study|Adverse Event|1|||
23655051|NCT00108069|66125316|FG001|Overall Study|Adverse Event|1|||
23655052|NCT00108069|66125315|FG000|Overall Study|Withdrawal by Subject|1|||
23655053|NCT00108069|66125316|FG001|Overall Study|Withdrawal by Subject|0|||
23655054|NCT00108069|66125315|FG000|Overall Study|Death|1|||
23655055|NCT00108069|66125316|FG001|Overall Study|Death|0|||
23655056|NCT00108069|66125315|FG000|Overall Study|Progessive disease|27|||
23655057|NCT00108069|66125316|FG001|Overall Study|Progessive disease|11|||
23655058|NCT01026142|66125317|FG000|Overall Study|Death|136|||
23655059|NCT01026142|66125318|FG001|Overall Study|Death|134|||
23655060|NCT01026142|66125317|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
23655061|NCT01026142|66125318|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
23655062|NCT02684279|66125319|FG000|Overall Study|Adverse Event|87|||
23655063|NCT02684279|66125319|FG000|Overall Study|Lack of Efficacy|4|||
23655064|NCT02684279|66125319|FG000|Overall Study|Lost to Follow-up|61|||
23655065|NCT02684279|66125319|FG000|Overall Study|Protocol Violation|6|||
23655066|NCT02684279|66125319|FG000|Overall Study|Pregnancy|8|||
23655067|NCT02684279|66125319|FG000|Overall Study|Withdrawal by Subject|92|||
23655068|NCT02684279|66125319|FG000|Overall Study|non-compliance with study drug|9|||
23655069|NCT02684279|66125319|FG000|Overall Study|non compliance with study visits|2|||
23655070|NCT02684279|66125319|FG000|Overall Study|subject to have surgery|1|||
23655071|NCT02684279|66125319|FG000|Overall Study|family emergency|1|||
23655072|NCT02684279|66125319|FG000|Overall Study|Site closures|7|||
23655073|NCT02684279|66125319|FG000|Overall Study|Physician Decision|1|||
23655074|NCT00294554|66125320|FG000|Overall Study|Lack of Efficacy|0|||
23655075|NCT00294554|66125321|FG001|Overall Study|Lack of Efficacy|1|||
23655076|NCT00294554|66125320|FG000|Overall Study|Physician Decision|0|||
23655077|NCT00294554|66125321|FG001|Overall Study|Physician Decision|1|||
23655078|NCT01137955|66125323|FG000|Overall Study|Withdrawal by Subject|5|||
23655079|NCT01137955|66125324|FG001|Overall Study|Withdrawal by Subject|4|||
23655080|NCT03044886|66125327|FG000|Overall Study|Lost to Follow-up|15|||
23655081|NCT03044886|66125328|FG001|Overall Study|Lost to Follow-up|10|||
23655082|NCT03044886|66125329|FG002|Overall Study|Lost to Follow-up|12|||
23655083|NCT03836807|66125330|FG000|Overall Study|Physician Decision|1|||
23655084|NCT03836807|66125331|FG001|Overall Study|Physician Decision|0|||
23655085|NCT03249714|66125332|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
23655086|NCT03249714|66125333|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
23655087|NCT03249714|66125332|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
23655088|NCT03249714|66125333|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
23655089|NCT03249714|66125332|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
23655090|NCT03249714|66125333|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
23655091|NCT03249714|66125332|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
23655092|NCT03249714|66125333|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
23655093|NCT01028222|66125334|FG000|Overall Study|Protocol deviation|1|||
23655094|NCT01028222|66125335|FG001|Overall Study|Protocol deviation|0|||
23655095|NCT01028222|66125334|FG000|Overall Study|Disease progression|33|||
23655096|NCT01028222|66125335|FG001|Overall Study|Disease progression|9|||
23655097|NCT01028222|66125334|FG000|Overall Study|Administrative problems|1|||
23655098|NCT01028222|66125335|FG001|Overall Study|Administrative problems|1|||
23655099|NCT01028222|66125334|FG000|Overall Study|Lost to Follow-up|0|||
23655100|NCT01028222|66125335|FG001|Overall Study|Lost to Follow-up|1|||
23655101|NCT01028222|66125334|FG000|Overall Study|Withdrawal by Subject|1|||
23655102|NCT01028222|66125335|FG001|Overall Study|Withdrawal by Subject|0|||
23655103|NCT01028222|66125334|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
23655104|NCT01028222|66125335|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
23655105|NCT01028222|66125334|FG000|Overall Study|Adverse Event|2|||
23655106|NCT01028222|66125335|FG001|Overall Study|Adverse Event|0|||
23655107|NCT00752622|66125336|FG000|Induction Phase|Adverse Event|3|||
23655108|NCT00752622|66125336|FG000|Induction Phase|Other|3|||
23655109|NCT00752622|66125336|FG000|Induction Phase|Non-responder|14|||
23655110|NCT00752622|66125336|FG000|Induction Phase|Withdrawal by Subject|1|||
23655111|NCT00752622|66125336|FG000|Induction Phase|Premature study termination|14|||
23655112|NCT00752622|66125336|FG000|Observational Phase|Premature Study Termination|36|||
23655113|NCT00752622|66125336|FG000|Observational Phase|Non-responder|2|||
23655114|NCT00752622|66125336|FG000|Observational Phase|Withdrawal by Subject|2|||
23655115|NCT00752622|66125336|FG000|Observational Phase|Adverse Event|1|||
23655116|NCT00752622|66125336|FG000|Observational Phase|Other|2|||
23655117|NCT00752622|66125336|FG000|Interventional Phase|Non-responder|2|||
23655118|NCT00752622|66125336|FG000|Interventional Phase|Physician Decision|1|||
23655119|NCT00752622|66125336|FG000|Interventional Phase|Premature Study Termination|5|||
23655120|NCT00702845|66125337|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
23655121|NCT00702845|66125338|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
23655122|NCT00702845|66125337|FG000|Overall Study|Too high ovarian response|5|||
23655123|NCT00702845|66125338|FG001|Overall Study|Too high ovarian response|1|||
23655124|NCT00702845|66125337|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
23655125|NCT00702845|66125338|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
23655126|NCT00702845|66125337|FG000|Overall Study|Insufficient ovarian response|1|||
23655127|NCT00702845|66125338|FG001|Overall Study|Insufficient ovarian response|0|||
23804255|NCT01298778|66661707|FG001|Overall Study|Incorrect use of VAS|0|||
23804256|NCT01298778|66661706|FG000|Overall Study|Withdrawal by Subject|0|||
23804257|NCT01298778|66661707|FG001|Overall Study|Withdrawal by Subject|1|||
23804258|NCT01298778|66661706|FG000|Overall Study|Protocol Violation|0|||
23804259|NCT01298778|66661707|FG001|Overall Study|Protocol Violation|1|||
23804260|NCT01298778|66661706|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
23804261|NCT01298778|66661707|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
23804262|NCT00140413|66661710|FG000|Overall Study|Lost to Follow-up|1|||
23804263|NCT00140413|66661711|FG001|Overall Study|Lost to Follow-up|0|||
23804264|NCT00140413|66661710|FG000|Overall Study|Withdrawal by Subject|2|||
23804265|NCT00140413|66661711|FG001|Overall Study|Withdrawal by Subject|0|||
23804266|NCT00614822|66661712|FG000|Overall Study|Adverse Event|3|||
23804267|NCT01674647|66661716|FG000|Treatment Period|Death|4|||
23804268|NCT01674647|66661717|FG001|Treatment Period|Death|1|||
23804269|NCT01674647|66661716|FG000|Treatment Period|Efficacy outcome reached|0|||
23804270|NCT01674647|66661717|FG001|Treatment Period|Efficacy outcome reached|1|||
23804271|NCT01674647|66661716|FG000|Treatment Period|Physician Decision|3|||
23804272|NCT01674647|66661717|FG001|Treatment Period|Physician Decision|1|||
23804273|NCT01674647|66661716|FG000|Treatment Period|Adverse Event|60|||
23804274|NCT01674647|66661717|FG001|Treatment Period|Adverse Event|22|||
23804275|NCT01674647|66661716|FG000|Treatment Period|Non-compliance with study drug|3|||
23804276|NCT01674647|66661717|FG001|Treatment Period|Non-compliance with study drug|0|||
23804277|NCT01674647|66661716|FG000|Treatment Period|Lost to Follow-up|1|||
23804278|NCT01674647|66661717|FG001|Treatment Period|Lost to Follow-up|1|||
23804279|NCT01674647|66661716|FG000|Treatment Period|Withdrawal by Subject|19|||
23804280|NCT01674647|66661717|FG001|Treatment Period|Withdrawal by Subject|16|||
23804281|NCT01674647|66661716|FG000|Treatment Period|Switching to other therapy|5|||
23804282|NCT01674647|66661717|FG001|Treatment Period|Switching to other therapy|2|||
23804283|NCT01674647|66661716|FG000|Treatment Period|Logistical difficulties|5|||
23804284|NCT01674647|66661717|FG001|Treatment Period|Logistical difficulties|8|||
23804285|NCT01674647|66661716|FG000|Treatment Period|Treatment failure|0|||
23804286|NCT01674647|66661717|FG001|Treatment Period|Treatment failure|14|||
23804287|NCT01674647|66661716|FG000|Treatment Period|Protocol Violation|56|||
23804288|NCT01674647|66661717|FG001|Treatment Period|Protocol Violation|36|||
23804289|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Death|3|||
23804290|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Death|2|||
23804291|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
23804292|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
23804293|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
23804294|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
23804295|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
23804296|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
23804297|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
23804298|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
23804299|NCT01674647|66661716|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
23804300|NCT01674647|66661717|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
23804301|NCT02243293|66661718|FG000|Overall Study|Adverse Event|1|||
23804302|NCT02243293|66661719|FG001|Overall Study|Adverse Event|0|||
23804303|NCT02243293|66661720|FG002|Overall Study|Adverse Event|0|||
23804304|NCT02243293|66661721|FG003|Overall Study|Adverse Event|0|||
23804305|NCT02243293|66661722|FG004|Overall Study|Adverse Event|0|||
23804306|NCT02243293|66661723|FG005|Overall Study|Adverse Event|0|||
23361087|NCT04058028|65065962|FG000|Overall Study|Death|0|||
23804307|NCT02243293|66661724|FG006|Overall Study|Adverse Event|0|||
23804308|NCT02243293|66661725|FG007|Overall Study|Adverse Event|0|||
23804309|NCT02243293|66661726|FG008|Overall Study|Adverse Event|0|||
23804310|NCT02243293|66661727|FG009|Overall Study|Adverse Event|0|||
23804311|NCT02243293|66661728|FG010|Overall Study|Adverse Event|0|||
23804312|NCT02243293|66661729|FG011|Overall Study|Adverse Event|0|||
23804313|NCT02243293|66661730|FG012|Overall Study|Adverse Event|0|||
23804314|NCT02243293|66661731|FG013|Overall Study|Adverse Event|0|||
23804315|NCT02243293|66661732|FG014|Overall Study|Adverse Event|0|||
23804316|NCT02243293|66661733|FG015|Overall Study|Adverse Event|1|||
23804317|NCT02243293|66661734|FG016|Overall Study|Adverse Event|0|||
23804318|NCT02243293|66661735|FG017|Overall Study|Adverse Event|0|||
23804319|NCT02243293|66661736|FG018|Overall Study|Adverse Event|0|||
23804320|NCT02243293|66661737|FG019|Overall Study|Adverse Event|0|||
23804321|NCT02243293|66661738|FG020|Overall Study|Adverse Event|1|||
23804322|NCT02243293|66661739|FG021|Overall Study|Adverse Event|0|||
23804323|NCT02243293|66661718|FG000|Overall Study|Withdrawal by Subject|1|||
23804324|NCT02243293|66661719|FG001|Overall Study|Withdrawal by Subject|0|||
23804325|NCT02243293|66661720|FG002|Overall Study|Withdrawal by Subject|0|||
23804326|NCT02243293|66661721|FG003|Overall Study|Withdrawal by Subject|0|||
23804327|NCT02243293|66661722|FG004|Overall Study|Withdrawal by Subject|0|||
23804328|NCT02243293|66661723|FG005|Overall Study|Withdrawal by Subject|0|||
23804329|NCT02243293|66661724|FG006|Overall Study|Withdrawal by Subject|0|||
23804330|NCT02243293|66661725|FG007|Overall Study|Withdrawal by Subject|0|||
23804331|NCT02243293|66661726|FG008|Overall Study|Withdrawal by Subject|0|||
23804332|NCT02243293|66661727|FG009|Overall Study|Withdrawal by Subject|1|||
23804333|NCT02243293|66661728|FG010|Overall Study|Withdrawal by Subject|0|||
23804334|NCT02243293|66661729|FG011|Overall Study|Withdrawal by Subject|1|||
23804335|NCT02243293|66661730|FG012|Overall Study|Withdrawal by Subject|0|||
23804336|NCT02243293|66661731|FG013|Overall Study|Withdrawal by Subject|0|||
23804337|NCT02243293|66661732|FG014|Overall Study|Withdrawal by Subject|0|||
23804338|NCT02243293|66661733|FG015|Overall Study|Withdrawal by Subject|0|||
23804339|NCT02243293|66661734|FG016|Overall Study|Withdrawal by Subject|0|||
23804340|NCT02243293|66661735|FG017|Overall Study|Withdrawal by Subject|0|||
23804341|NCT02243293|66661736|FG018|Overall Study|Withdrawal by Subject|0|||
23804342|NCT02243293|66661737|FG019|Overall Study|Withdrawal by Subject|0|||
23804343|NCT02243293|66661738|FG020|Overall Study|Withdrawal by Subject|0|||
23804344|NCT02243293|66661739|FG021|Overall Study|Withdrawal by Subject|1|||
23804345|NCT02243293|66661718|FG000|Overall Study|Lost to Follow-up|0|||
23804346|NCT02243293|66661719|FG001|Overall Study|Lost to Follow-up|1|||
23804347|NCT02243293|66661720|FG002|Overall Study|Lost to Follow-up|1|||
23804348|NCT02243293|66661721|FG003|Overall Study|Lost to Follow-up|1|||
23804349|NCT02243293|66661722|FG004|Overall Study|Lost to Follow-up|0|||
23804350|NCT02243293|66661723|FG005|Overall Study|Lost to Follow-up|0|||
23804351|NCT02243293|66661724|FG006|Overall Study|Lost to Follow-up|3|||
23804352|NCT02243293|66661725|FG007|Overall Study|Lost to Follow-up|0|||
23804353|NCT02243293|66661726|FG008|Overall Study|Lost to Follow-up|0|||
23804354|NCT02243293|66661727|FG009|Overall Study|Lost to Follow-up|0|||
23804355|NCT02243293|66661728|FG010|Overall Study|Lost to Follow-up|0|||
23804356|NCT02243293|66661729|FG011|Overall Study|Lost to Follow-up|2|||
23804357|NCT02243293|66661730|FG012|Overall Study|Lost to Follow-up|0|||
23804358|NCT02243293|66661731|FG013|Overall Study|Lost to Follow-up|0|||
23804359|NCT02243293|66661732|FG014|Overall Study|Lost to Follow-up|0|||
23804360|NCT02243293|66661733|FG015|Overall Study|Lost to Follow-up|0|||
23804361|NCT02243293|66661734|FG016|Overall Study|Lost to Follow-up|3|||
23804362|NCT02243293|66661735|FG017|Overall Study|Lost to Follow-up|1|||
23804363|NCT02243293|66661736|FG018|Overall Study|Lost to Follow-up|0|||
23804364|NCT02243293|66661737|FG019|Overall Study|Lost to Follow-up|0|||
23655128|NCT00702845|66125337|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
23655129|NCT00702845|66125338|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
23655130|NCT00702845|66125337|FG000|Overall Study|No or abnormal fertilization|4|||
23655131|NCT00702845|66125338|FG001|Overall Study|No or abnormal fertilization|2|||
23655132|NCT00702845|66125337|FG000|Overall Study|Patient's decision|2|||
23655133|NCT00702845|66125338|FG001|Overall Study|Patient's decision|1|||
23655134|NCT00702845|66125337|FG000|Overall Study|Not randomized|0|||
23655135|NCT00702845|66125338|FG001|Overall Study|Not randomized|1|||
23655136|NCT00874770|66125341|FG000|Overall Study|Lack of Efficacy|2|||
23655137|NCT00874770|66125342|FG001|Overall Study|Lack of Efficacy|0|||
23804365|NCT02243293|66661738|FG020|Overall Study|Lost to Follow-up|1|||
23655138|NCT00874770|66125343|FG002|Overall Study|Lack of Efficacy|0|||
23655139|NCT00874770|66125344|FG003|Overall Study|Lack of Efficacy|2|||
23655140|NCT00874770|66125341|FG000|Overall Study|Adverse Event|1|||
23655141|NCT00874770|66125342|FG001|Overall Study|Adverse Event|1|||
23804366|NCT02243293|66661739|FG021|Overall Study|Lost to Follow-up|2|||
23804367|NCT02243293|66661718|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
23804368|NCT02243293|66661719|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
23655142|NCT00874770|66125343|FG002|Overall Study|Adverse Event|4|||
23655143|NCT00874770|66125344|FG003|Overall Study|Adverse Event|2|||
23655144|NCT00874770|66125341|FG000|Overall Study|Lost to Follow-up|1|||
23655145|NCT00874770|66125342|FG001|Overall Study|Lost to Follow-up|0|||
23655146|NCT00874770|66125343|FG002|Overall Study|Lost to Follow-up|0|||
23655147|NCT00874770|66125344|FG003|Overall Study|Lost to Follow-up|1|||
23655148|NCT00874770|66125341|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
23655149|NCT00874770|66125342|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
23655150|NCT00874770|66125343|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
23655151|NCT00874770|66125344|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
23655152|NCT03716050|66125345|FG000|Overall Study|Lost to Follow-up|0|||
23655153|NCT03716050|66125346|FG001|Overall Study|Lost to Follow-up|0|||
23655154|NCT03716050|66125347|FG002|Overall Study|Lost to Follow-up|1|||
23655155|NCT03716050|66125348|FG003|Overall Study|Lost to Follow-up|0|||
23655156|NCT03716050|66125349|FG004|Overall Study|Lost to Follow-up|0|||
23655157|NCT03716050|66125350|FG005|Overall Study|Lost to Follow-up|0|||
23655158|NCT03716050|66125351|FG006|Overall Study|Lost to Follow-up|0|||
23655159|NCT03716050|66125352|FG007|Overall Study|Lost to Follow-up|0|||
23655160|NCT03716050|66125345|FG000|Overall Study|Physician Decision|0|||
23655161|NCT03716050|66125346|FG001|Overall Study|Physician Decision|0|||
23655162|NCT03716050|66125347|FG002|Overall Study|Physician Decision|0|||
23655163|NCT03716050|66125348|FG003|Overall Study|Physician Decision|1|||
23655164|NCT03716050|66125349|FG004|Overall Study|Physician Decision|0|||
23655165|NCT03716050|66125350|FG005|Overall Study|Physician Decision|0|||
23655166|NCT03716050|66125351|FG006|Overall Study|Physician Decision|0|||
23655167|NCT03716050|66125352|FG007|Overall Study|Physician Decision|0|||
23655168|NCT03716050|66125345|FG000|Overall Study|Protocol Violation|0|||
23655169|NCT03716050|66125346|FG001|Overall Study|Protocol Violation|0|||
23655170|NCT03716050|66125347|FG002|Overall Study|Protocol Violation|0|||
23655171|NCT03716050|66125348|FG003|Overall Study|Protocol Violation|1|||
23655172|NCT03716050|66125349|FG004|Overall Study|Protocol Violation|0|||
23655173|NCT03716050|66125350|FG005|Overall Study|Protocol Violation|0|||
23655174|NCT03716050|66125351|FG006|Overall Study|Protocol Violation|0|||
23655175|NCT03716050|66125352|FG007|Overall Study|Protocol Violation|2|||
23655176|NCT01241552|66125353|FG000|Overall Study|Lack of Efficacy|1|||
23655177|NCT01241552|66125354|FG001|Overall Study|Lack of Efficacy|0|||
23655178|NCT01241552|66125355|FG002|Overall Study|Lack of Efficacy|0|||
23655179|NCT01241552|66125356|FG003|Overall Study|Lack of Efficacy|0|||
23655180|NCT01241552|66125353|FG000|Overall Study|Death|26|||
23655181|NCT01241552|66125354|FG001|Overall Study|Death|30|||
23655182|NCT01241552|66125355|FG002|Overall Study|Death|20|||
23655183|NCT01241552|66125356|FG003|Overall Study|Death|25|||
23655184|NCT01241552|66125353|FG000|Overall Study|Adverse Event|1|||
23804369|NCT02243293|66661720|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
23804370|NCT02243293|66661721|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
23804371|NCT02243293|66661722|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
23804372|NCT02243293|66661723|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
23655185|NCT01241552|66125354|FG001|Overall Study|Adverse Event|1|||
23655186|NCT01241552|66125355|FG002|Overall Study|Adverse Event|0|||
23655187|NCT01241552|66125356|FG003|Overall Study|Adverse Event|0|||
23655188|NCT01241552|66125353|FG000|Overall Study|Technical Problems|2|||
23655189|NCT01241552|66125354|FG001|Overall Study|Technical Problems|0|||
23655190|NCT01241552|66125355|FG002|Overall Study|Technical Problems|2|||
23655191|NCT01241552|66125356|FG003|Overall Study|Technical Problems|2|||
23655192|NCT01241552|66125353|FG000|Overall Study|Progressive Disease|0|||
23655193|NCT01241552|66125354|FG001|Overall Study|Progressive Disease|0|||
23655194|NCT01241552|66125355|FG002|Overall Study|Progressive Disease|1|||
23655195|NCT01241552|66125356|FG003|Overall Study|Progressive Disease|2|||
23655196|NCT01241552|66125353|FG000|Overall Study|Protocol Violation|0|||
23655197|NCT01241552|66125354|FG001|Overall Study|Protocol Violation|2|||
23655198|NCT01241552|66125355|FG002|Overall Study|Protocol Violation|6|||
23655199|NCT01241552|66125356|FG003|Overall Study|Protocol Violation|1|||
23655200|NCT01241552|66125353|FG000|Overall Study|Withdrawal by Subject|7|||
23655201|NCT01241552|66125354|FG001|Overall Study|Withdrawal by Subject|15|||
23655202|NCT01241552|66125355|FG002|Overall Study|Withdrawal by Subject|14|||
23655203|NCT01241552|66125356|FG003|Overall Study|Withdrawal by Subject|15|||
23655204|NCT01241552|66125353|FG000|Overall Study|Physician Decision|2|||
23655205|NCT01241552|66125354|FG001|Overall Study|Physician Decision|4|||
23655206|NCT01241552|66125355|FG002|Overall Study|Physician Decision|2|||
23655207|NCT01241552|66125356|FG003|Overall Study|Physician Decision|3|||
23655208|NCT01241552|66125353|FG000|Overall Study|Lost to Follow-up|2|||
23655209|NCT01241552|66125354|FG001|Overall Study|Lost to Follow-up|11|||
23655210|NCT01241552|66125355|FG002|Overall Study|Lost to Follow-up|15|||
23655211|NCT01241552|66125356|FG003|Overall Study|Lost to Follow-up|16|||
23655212|NCT01444651|66125360|FG000|Overall Study|Adverse Event|3|||
23655213|NCT01444651|66125361|FG001|Overall Study|Adverse Event|2|||
23655214|NCT01444651|66125360|FG000|Overall Study|Lost to Follow-up|5|||
23655215|NCT01444651|66125361|FG001|Overall Study|Lost to Follow-up|5|||
23655216|NCT01444651|66125360|FG000|Overall Study|Non-fasting|2|||
23655217|NCT01444651|66125361|FG001|Overall Study|Non-fasting|1|||
23655218|NCT01444651|66125360|FG000|Overall Study|Missing data|1|||
23655219|NCT01444651|66125361|FG001|Overall Study|Missing data|1|||
23655220|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
23655221|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
23655222|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
23655223|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
23655224|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
23655225|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
23655226|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
23655227|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
23655228|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
23655229|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
23655230|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
23655231|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
23655232|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
23655233|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
23655234|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
23655235|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
23655236|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
23655237|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
23655238|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
23655239|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
23655240|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
23655241|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
23655242|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
23655243|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
23655244|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
23655245|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
23655246|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
23655247|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
23655248|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
23655249|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
23655250|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Other|10|||
23655251|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Other|7|||
23804373|NCT02243293|66661724|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
23804374|NCT02243293|66661725|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
23804375|NCT02243293|66661726|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
23804376|NCT02243293|66661727|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
23804377|NCT02243293|66661728|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
23804378|NCT02243293|66661729|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
23804379|NCT02243293|66661730|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
23804380|NCT02243293|66661731|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
23804381|NCT02243293|66661732|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
23804382|NCT02243293|66661733|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
23804383|NCT02243293|66661734|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
23804384|NCT02243293|66661735|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
23804385|NCT02243293|66661736|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
23804386|NCT02243293|66661737|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
23804387|NCT02243293|66661738|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
23804388|NCT02243293|66661739|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
23804389|NCT02243293|66661718|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
23804390|NCT02243293|66661719|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
23804391|NCT02243293|66661720|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
23804392|NCT02243293|66661721|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
23804393|NCT02243293|66661722|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
23804394|NCT02243293|66661723|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
23804395|NCT02243293|66661724|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
23804396|NCT02243293|66661725|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
23804397|NCT02243293|66661726|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
23804398|NCT02243293|66661727|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
23804399|NCT02243293|66661728|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
23804400|NCT02243293|66661729|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
23804401|NCT02243293|66661730|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
23804402|NCT02243293|66661731|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
23804403|NCT02243293|66661732|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
23804404|NCT02243293|66661733|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
23804405|NCT02243293|66661734|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
23804406|NCT02243293|66661735|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
23804407|NCT02243293|66661736|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
23804408|NCT02243293|66661737|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
23361088|NCT04058028|65065963|FG001|Overall Study|Death|1|||
23655252|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Other|8|||
23655253|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Other|8|||
23655254|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Other|0|||
23655255|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
23655256|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
23655257|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
23655258|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
23655259|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
23804409|NCT02243293|66661738|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
23804410|NCT02243293|66661739|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
23804411|NCT02370914|66661740|FG000|Overall Study|Protocol Violation|2|||
23804412|NCT02556307|66661741|FG000|Overall Study|Premature treatment interruption|11|||
23804413|NCT02556307|66661741|FG000|Overall Study|Lost to Follow-up|36|||
23804414|NCT02556307|66661741|FG000|Overall Study|Change to triple therapy|4|||
23804415|NCT02556307|66661741|FG000|Overall Study|Enrolled but not treated|2|||
23804416|NCT03827564|66661748|FG000|Overall Study|Discontinued due to Study Termination|1|||
23804417|NCT03827564|66661749|FG001|Overall Study|Discontinued due to Study Termination|0|||
23804418|NCT01782482|66661756|FG000|Overall Study|Adverse Event|2|||
23804419|NCT01782482|66661757|FG001|Overall Study|Adverse Event|1|||
23804420|NCT01782482|66661756|FG000|Overall Study|Lost to Follow-up|2|||
23804421|NCT01782482|66661757|FG001|Overall Study|Lost to Follow-up|3|||
23804422|NCT01782482|66661756|FG000|Overall Study|Physician Decision|1|||
23804423|NCT01782482|66661757|FG001|Overall Study|Physician Decision|0|||
23804424|NCT01782482|66661756|FG000|Overall Study|Protocol Violation|1|||
23804425|NCT01782482|66661757|FG001|Overall Study|Protocol Violation|0|||
23804426|NCT01782482|66661756|FG000|Overall Study|Withdrawal by Subject|2|||
23804427|NCT01782482|66661757|FG001|Overall Study|Withdrawal by Subject|3|||
23804428|NCT01782482|66661756|FG000|Overall Study|Randomized in Error|2|||
23804429|NCT01782482|66661757|FG001|Overall Study|Randomized in Error|2|||
23804430|NCT01782482|66661756|FG000|Overall Study|Habitually wearing toric lens OS|0|||
23804431|NCT01782482|66661757|FG001|Overall Study|Habitually wearing toric lens OS|1|||
23804432|NCT02221037|66661763|FG000|Overall Study|Physician Decision|0|||
23804433|NCT02221037|66661764|FG001|Overall Study|Physician Decision|0|||
23804434|NCT02221037|66661765|FG002|Overall Study|Physician Decision|1|||
23804435|NCT02221037|66661766|FG003|Overall Study|Physician Decision|0|||
23804436|NCT01311557|66661769|FG000|Overall Study|Serious adverse event|0|||
23804437|NCT01311557|66661770|FG001|Overall Study|Serious adverse event|1|||
23804438|NCT01311557|66661769|FG000|Overall Study|Protocol Violation|4|||
23804439|NCT01311557|66661770|FG001|Overall Study|Protocol Violation|2|||
23804440|NCT01311557|66661769|FG000|Overall Study|Lost to Follow-up|0|||
23804441|NCT01311557|66661770|FG001|Overall Study|Lost to Follow-up|1|||
23804442|NCT01311557|66661769|FG000|Overall Study|Withdrawal by Subject|1|||
23804443|NCT01311557|66661770|FG001|Overall Study|Withdrawal by Subject|2|||
23804444|NCT01201759|66661771|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
23804445|NCT01201759|66661772|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
23804446|NCT01201759|66661771|FG000|Visit 3 - Washout|Adverse Event|0|||
23804447|NCT01201759|66661772|FG001|Visit 3 - Washout|Adverse Event|3|||
23804448|NCT01201759|66661771|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
23804449|NCT01201759|66661772|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
23804450|NCT01201759|66661771|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
23655260|NCT00615836|66125362|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
23655261|NCT00615836|66125363|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23655262|NCT00615836|66125364|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23655263|NCT00615836|66125365|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23655264|NCT00615836|66125366|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23655265|NCT00928746|66125371|FG000|Overall Study|Adverse Event|2|||
23655266|NCT00928746|66125371|FG000|Overall Study|Protocol Violation|1|||
23655267|NCT00928746|66125371|FG000|Overall Study|Withdrawal by Subject|1|||
23804451|NCT01201759|66661772|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
23599826|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Other|2|||
23599827|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Other|0|||
23599828|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
23599829|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
23599830|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
23599831|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
23599832|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
23804452|NCT02676284|66661773|FG000|Overall Study|Withdrawal by Subject|1|||
23804453|NCT01884688|66661774|FG000|Overall Study|Screen Failure|2|||
23804454|NCT00430950|66661784|FG000|Overall Study|Adverse Event|7|||
23804455|NCT00430950|66661785|FG001|Overall Study|Adverse Event|6|||
23804456|NCT00430950|66661784|FG000|Overall Study|Withdrawal by Subject|1|||
23804457|NCT00430950|66661785|FG001|Overall Study|Withdrawal by Subject|0|||
23804458|NCT00430950|66661784|FG000|Overall Study|concomitant medication,etc.|5|||
23804459|NCT00430950|66661785|FG001|Overall Study|concomitant medication,etc.|7|||
23804460|NCT03710590|66661789|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
23804461|NCT03710590|66661790|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
23804462|NCT01366443|66661791|FG000|Overall Study|Lost to Follow-up|2|||
23804463|NCT01366443|66661791|FG000|Overall Study|Under 18 yo|1|||
23804464|NCT00606502|66661792|FG000|Randomization|Randomized but not treated|3|||
23804465|NCT00606502|66661793|FG001|Randomization|Randomized but not treated|0|||
23804466|NCT00606502|66661792|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
23804467|NCT00606502|66661793|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
23804468|NCT00842530|66661794|FG000|Overall Study|Serious adverse event|0|||
23804469|NCT00842530|66661795|FG001|Overall Study|Serious adverse event|6|||
23599833|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
23599834|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
23599835|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
23599836|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
23599837|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
23599838|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
23599839|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
23599840|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
23599841|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
23599842|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
23599843|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
23599844|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
23599845|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
23599846|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
23599847|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
23599848|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
23599849|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
23599850|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
23599851|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
23599852|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
23599853|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
23599854|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
23599855|NCT04679675|65925702|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
23599856|NCT04679675|65925703|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
23599857|NCT04679675|65925704|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
23599858|NCT04679675|65925705|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
23599859|NCT04679675|65925702|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
23599860|NCT04679675|65925703|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
23599861|NCT04679675|65925704|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
23655268|NCT00928746|66125371|FG000|Overall Study|Other|2|||
23804470|NCT00842530|66661794|FG000|Overall Study|Other adverse event|6|||
23804471|NCT00842530|66661795|FG001|Overall Study|Other adverse event|1|||
23804472|NCT00842530|66661794|FG000|Overall Study|Protocol Violation|32|||
23804473|NCT00842530|66661795|FG001|Overall Study|Protocol Violation|14|||
23804474|NCT00842530|66661794|FG000|Overall Study|Lost to Follow-up|6|||
23804475|NCT00842530|66661795|FG001|Overall Study|Lost to Follow-up|8|||
23804476|NCT00842530|66661794|FG000|Overall Study|Withdrawal by Subject|73|||
23804477|NCT00842530|66661795|FG001|Overall Study|Withdrawal by Subject|28|||
23804478|NCT02133001|66661796|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
23804479|NCT02133001|66661797|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
23804480|NCT02133001|66661796|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
23804481|NCT02133001|66661797|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
23804482|NCT02133001|66661796|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
23804483|NCT02133001|66661797|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
23804484|NCT02133001|66661796|FG000|Double Blind (Day 1-25)|Other|2|||
23804485|NCT02133001|66661797|FG001|Double Blind (Day 1-25)|Other|2|||
23804486|NCT02133001|66661796|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
23804487|NCT02133001|66661797|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
23804488|NCT02133001|66661796|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
23655269|NCT03690141|66125372|FG000|Overall Study|Adverse Event|5|||
23655270|NCT03690141|66125372|FG000|Overall Study|Withdrawal by Subject|3|||
23655271|NCT03690141|66125372|FG000|Overall Study|Physician Decision|4|||
23655272|NCT03690141|66125372|FG000|Overall Study|Disease progression|4|||
23655273|NCT01310803|66125379|FG000|Overall Study|Subject terminated by Sponsor|1|||
23655274|NCT01310803|66125380|FG001|Overall Study|Subject terminated by Sponsor|0|||
23655275|NCT04142450|66125385|FG000|Overall Study|Screen Failure|1|||
23655276|NCT04142450|66125385|FG000|Overall Study|Lost to Follow-up|1|||
23655277|NCT01357577|66125386|FG000|Overall Study|Lost to Follow-up|20|||
23655278|NCT01357577|66125387|FG001|Overall Study|Lost to Follow-up|16|||
23655279|NCT01357577|66125386|FG000|Overall Study|Withdrawal by Subject|16|||
23655280|NCT01357577|66125387|FG001|Overall Study|Withdrawal by Subject|8|||
23655281|NCT01357577|66125386|FG000|Overall Study|look at data in database?|1|||
23655282|NCT01357577|66125387|FG001|Overall Study|look at data in database?|2|||
23655283|NCT00800683|66125388|FG000|Overall Study|Adverse Event|11|||
23655284|NCT00800683|66125389|FG001|Overall Study|Adverse Event|8|||
23655285|NCT00800683|66125388|FG000|Overall Study|Lost to Follow-up|3|||
23655286|NCT00800683|66125389|FG001|Overall Study|Lost to Follow-up|1|||
23655287|NCT00800683|66125388|FG000|Overall Study|Withdrawal by Subject|1|||
23655288|NCT00800683|66125389|FG001|Overall Study|Withdrawal by Subject|7|||
23655289|NCT00800683|66125388|FG000|Overall Study|Lack of Efficacy|1|||
23655290|NCT00800683|66125389|FG001|Overall Study|Lack of Efficacy|1|||
23655291|NCT00800683|66125388|FG000|Overall Study|Other|1|||
23655292|NCT00800683|66125389|FG001|Overall Study|Other|2|||
23655293|NCT05116046|66125393|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23655294|NCT05116046|66125394|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23655295|NCT05116046|66125395|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23655296|NCT05116046|66125393|FG000|Overall Study|Study terminated by sponsor|14|||
23655297|NCT05116046|66125394|FG001|Overall Study|Study terminated by sponsor|16|||
23655298|NCT05116046|66125395|FG002|Overall Study|Study terminated by sponsor|1|||
23655299|NCT02743819|66125397|FG000|Overall Study|Lack of Efficacy|5|||
23655300|NCT02743819|66125397|FG000|Overall Study|Death|2|||
23655301|NCT02743819|66125397|FG000|Overall Study|Adverse Event|1|||
23655302|NCT01130051|66125398|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
23804489|NCT02133001|66661797|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
23804490|NCT02133001|66661796|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
23804491|NCT02133001|66661797|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
23804492|NCT02133001|66661796|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
23804493|NCT02133001|66661797|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
23655303|NCT01130051|66125399|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
23655304|NCT01130051|66125398|FG000|Washout Period of 14 Days|Protocol Violation|1|||
23655305|NCT01130051|66125399|FG001|Washout Period of 14 Days|Protocol Violation|1|||
23655306|NCT03986866|66125402|FG000|Overall Study|Withdrawal by Subject|0|||
23655307|NCT03986866|66125403|FG001|Overall Study|Withdrawal by Subject|3|||
23655308|NCT03986866|66125402|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
23655309|NCT03986866|66125403|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
23655310|NCT00993915|66125410|FG000|Overall Study|Insufficient clinical response|3|||
23655311|NCT00993915|66125410|FG000|Overall Study|Withdrawal by Subject|2|||
23655312|NCT00993915|66125410|FG000|Overall Study|Other|1|||
23655313|NCT00993915|66125410|FG000|Overall Study|Ongoing|3|||
23655314|NCT04880447|66125414|FG000|Overall Study|No vaccination information|1|||
23655315|NCT04880447|66125414|FG000|Overall Study|No adverse event information (missing information)|1|||
23655316|NCT04880447|66125414|FG000|Overall Study|Disease not covered in this study|35|||
23655317|NCT02598557|66125415|FG000|Overall Study|Withdrawal by Subject|1|||
23655318|NCT02598557|66125416|FG001|Overall Study|Withdrawal by Subject|0|||
23655319|NCT02598557|66125417|FG002|Overall Study|Withdrawal by Subject|1|||
23655320|NCT02598557|66125415|FG000|Overall Study|Participant did not start treatment|2|||
23655321|NCT02598557|66125416|FG001|Overall Study|Participant did not start treatment|1|||
23655322|NCT02598557|66125417|FG002|Overall Study|Participant did not start treatment|1|||
23655323|NCT02598557|66125415|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
23655324|NCT02598557|66125416|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
23655325|NCT02598557|66125417|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
23655326|NCT02598557|66125415|FG000|Overall Study|Adverse Event|1|||
23655327|NCT02598557|66125416|FG001|Overall Study|Adverse Event|1|||
23655328|NCT02598557|66125417|FG002|Overall Study|Adverse Event|0|||
23804494|NCT01045421|66661798|FG000|Phase 1|Progressive Disease|0|||
23804495|NCT01045421|66661799|FG001|Phase 1|Progressive Disease|0|||
23804496|NCT01045421|66661800|FG002|Phase 1|Progressive Disease|0|||
23804497|NCT01045421|66661801|FG003|Phase 1|Progressive Disease|0|||
23804498|NCT01045421|66661802|FG004|Phase 1|Progressive Disease|1|||
23804499|NCT01045421|66661803|FG005|Phase 1|Progressive Disease|0|||
23804500|NCT01045421|66661804|FG006|Phase 1|Progressive Disease|0|||
23804501|NCT01045421|66661805|FG007|Phase 1|Progressive Disease|0|||
23804502|NCT01045421|66661806|FG008|Phase 1|Progressive Disease|0|||
23804503|NCT01045421|66661807|FG009|Phase 1|Progressive Disease|0|||
23804504|NCT01045421|66661808|FG010|Phase 1|Progressive Disease|0|||
23804505|NCT01045421|66661798|FG000|Phase 1|Withdrawal by Subject|0|||
23804506|NCT01045421|66661799|FG001|Phase 1|Withdrawal by Subject|0|||
23804507|NCT01045421|66661800|FG002|Phase 1|Withdrawal by Subject|0|||
23804508|NCT01045421|66661801|FG003|Phase 1|Withdrawal by Subject|1|||
23804509|NCT01045421|66661802|FG004|Phase 1|Withdrawal by Subject|0|||
23804510|NCT01045421|66661803|FG005|Phase 1|Withdrawal by Subject|0|||
23804511|NCT01045421|66661804|FG006|Phase 1|Withdrawal by Subject|0|||
23804512|NCT01045421|66661805|FG007|Phase 1|Withdrawal by Subject|0|||
23804513|NCT01045421|66661806|FG008|Phase 1|Withdrawal by Subject|0|||
23804514|NCT01045421|66661807|FG009|Phase 1|Withdrawal by Subject|0|||
23804515|NCT01045421|66661808|FG010|Phase 1|Withdrawal by Subject|0|||
23804516|NCT01045421|66661798|FG000|Phase 2|Progressive Disease|0|||
23804517|NCT01045421|66661799|FG001|Phase 2|Progressive Disease|0|||
23599862|NCT04679675|65925705|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
23599863|NCT02161146|65925706|FG000|Overall Study|Adverse Event|1|||
23599864|NCT02161146|65925707|FG001|Overall Study|Adverse Event|1|||
23599865|NCT02161146|65925708|FG002|Overall Study|Adverse Event|0|||
23599866|NCT02161146|65925709|FG003|Overall Study|Adverse Event|1|||
23599867|NCT02161146|65925710|FG004|Overall Study|Adverse Event|0|||
23599868|NCT02161146|65925706|FG000|Overall Study|Lost to Follow-up|0|||
23599869|NCT02161146|65925707|FG001|Overall Study|Lost to Follow-up|1|||
23599870|NCT02161146|65925708|FG002|Overall Study|Lost to Follow-up|0|||
23599871|NCT02161146|65925709|FG003|Overall Study|Lost to Follow-up|0|||
23655329|NCT00604279|66125418|FG000|Overall Study|Lack of Efficacy|22|||
23655330|NCT00604279|66125419|FG001|Overall Study|Lack of Efficacy|9|||
23655331|NCT00604279|66125418|FG000|Overall Study|Lost to Follow-up|9|||
23655332|NCT00604279|66125419|FG001|Overall Study|Lost to Follow-up|14|||
23655333|NCT00604279|66125418|FG000|Overall Study|Pregnancy|2|||
23804518|NCT01045421|66661800|FG002|Phase 2|Progressive Disease|0|||
23804519|NCT01045421|66661801|FG003|Phase 2|Progressive Disease|0|||
23804520|NCT01045421|66661802|FG004|Phase 2|Progressive Disease|0|||
23804521|NCT01045421|66661803|FG005|Phase 2|Progressive Disease|0|||
23804522|NCT01045421|66661804|FG006|Phase 2|Progressive Disease|0|||
23804523|NCT01045421|66661805|FG007|Phase 2|Progressive Disease|1|||
23804524|NCT01045421|66661806|FG008|Phase 2|Progressive Disease|1|||
23361089|NCT04058028|65065964|FG002|Overall Study|Death|0|||
23599872|NCT02161146|65925710|FG004|Overall Study|Lost to Follow-up|0|||
23599873|NCT02161146|65925706|FG000|Overall Study|Personal Reasons|0|||
23804525|NCT01045421|66661807|FG009|Phase 2|Progressive Disease|1|||
23804526|NCT01045421|66661808|FG010|Phase 2|Progressive Disease|1|||
23655334|NCT00604279|66125419|FG001|Overall Study|Pregnancy|0|||
23655335|NCT00604279|66125418|FG000|Overall Study|Protocol Violation|3|||
23655336|NCT00604279|66125419|FG001|Overall Study|Protocol Violation|1|||
23655337|NCT00604279|66125418|FG000|Overall Study|Withdrawal by Subject|16|||
23655338|NCT00604279|66125419|FG001|Overall Study|Withdrawal by Subject|5|||
23655339|NCT00604279|66125418|FG000|Overall Study|Adverse Event|4|||
23655340|NCT00604279|66125419|FG001|Overall Study|Adverse Event|5|||
23655341|NCT00604279|66125418|FG000|Overall Study|Other|8|||
23655342|NCT00604279|66125419|FG001|Overall Study|Other|4|||
23655343|NCT00775450|66125420|FG000|Overall Study|Serious Adverse Event|2|||
23655344|NCT00775450|66125421|FG001|Overall Study|Serious Adverse Event|0|||
23804527|NCT01045421|66661798|FG000|Phase 2|Death|0|||
23599874|NCT02161146|65925707|FG001|Overall Study|Personal Reasons|1|||
23655345|NCT00775450|66125422|FG002|Overall Study|Serious Adverse Event|0|||
23804528|NCT01045421|66661799|FG001|Phase 2|Death|0|||
23804529|NCT01045421|66661800|FG002|Phase 2|Death|0|||
23804530|NCT01045421|66661801|FG003|Phase 2|Death|0|||
23804531|NCT01045421|66661802|FG004|Phase 2|Death|0|||
23804532|NCT01045421|66661803|FG005|Phase 2|Death|0|||
23804533|NCT01045421|66661804|FG006|Phase 2|Death|0|||
23804534|NCT01045421|66661805|FG007|Phase 2|Death|1|||
23804535|NCT01045421|66661806|FG008|Phase 2|Death|1|||
23804536|NCT01045421|66661807|FG009|Phase 2|Death|2|||
23804537|NCT01045421|66661808|FG010|Phase 2|Death|0|||
23804538|NCT01045421|66661798|FG000|Phase 2|Other|0|||
23804539|NCT01045421|66661799|FG001|Phase 2|Other|0|||
23804540|NCT01045421|66661800|FG002|Phase 2|Other|0|||
23804541|NCT01045421|66661801|FG003|Phase 2|Other|0|||
23804542|NCT01045421|66661802|FG004|Phase 2|Other|0|||
23804543|NCT01045421|66661803|FG005|Phase 2|Other|0|||
23804544|NCT01045421|66661804|FG006|Phase 2|Other|0|||
23804545|NCT01045421|66661805|FG007|Phase 2|Other|3|||
23804546|NCT01045421|66661806|FG008|Phase 2|Other|0|||
23804547|NCT01045421|66661807|FG009|Phase 2|Other|0|||
23804548|NCT01045421|66661808|FG010|Phase 2|Other|1|||
23804549|NCT01091103|66661811|FG000|Overall Study|Adverse Event|1|||
23804550|NCT01091103|66661811|FG000|Overall Study|Progressive Disease|3|||
23804551|NCT02377921|66661812|FG000|Overall Study|Subject non-compliance|1|||
23655346|NCT00775450|66125423|FG003|Overall Study|Serious Adverse Event|0|||
23655347|NCT00775450|66125424|FG004|Overall Study|Serious Adverse Event|0|||
23804552|NCT02377921|66661813|FG001|Overall Study|Subject non-compliance|1|||
23804553|NCT04920916|66661816|FG000|Phase IIa 60 Day Study|Death|2|||
23804554|NCT04920916|66661817|FG001|Phase IIa 60 Day Study|Death|5|||
23804555|NCT04920916|66661816|FG000|1 Year Follow up (Phone Call)|Death|1|||
23655348|NCT00775450|66125420|FG000|Overall Study|Protocol Violation|0|||
23655349|NCT00775450|66125421|FG001|Overall Study|Protocol Violation|0|||
23655350|NCT00775450|66125422|FG002|Overall Study|Protocol Violation|0|||
23655351|NCT00775450|66125423|FG003|Overall Study|Protocol Violation|0|||
23655352|NCT00775450|66125424|FG004|Overall Study|Protocol Violation|1|||
23804556|NCT04920916|66661817|FG001|1 Year Follow up (Phone Call)|Death|3|||
23804557|NCT04920916|66661816|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
23804558|NCT04920916|66661817|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
23804559|NCT00248170|66661818|FG000|Overall Study|Withdrawal by Subject|71|||
23804560|NCT00248170|66661819|FG001|Overall Study|Withdrawal by Subject|79|||
23804561|NCT00248170|66661818|FG000|Overall Study|Protocol Violation|35|||
23804562|NCT00248170|66661819|FG001|Overall Study|Protocol Violation|30|||
23804563|NCT00248170|66661818|FG000|Overall Study|Lost to Follow-up|28|||
23804564|NCT00248170|66661819|FG001|Overall Study|Lost to Follow-up|35|||
23804565|NCT00248170|66661818|FG000|Overall Study|Disease progression|196|||
23804566|NCT00248170|66661819|FG001|Overall Study|Disease progression|216|||
23804567|NCT00248170|66661818|FG000|Overall Study|Death|28|||
23804568|NCT00248170|66661819|FG001|Overall Study|Death|47|||
23804569|NCT00248170|66661818|FG000|Overall Study|Adverse Event|311|||
23804570|NCT00248170|66661819|FG001|Overall Study|Adverse Event|296|||
23804571|NCT00248170|66661818|FG000|Overall Study|Administrative problems|22|||
23804572|NCT00248170|66661819|FG001|Overall Study|Administrative problems|25|||
23804573|NCT00248170|66661818|FG000|Overall Study|Abnormal test procedure(s) result|49|||
23804574|NCT00248170|66661819|FG001|Overall Study|Abnormal test procedure(s) result|61|||
23804575|NCT00248170|66661818|FG000|Overall Study|Abnormal laboratory values|4|||
23804576|NCT00248170|66661819|FG001|Overall Study|Abnormal laboratory values|0|||
23804577|NCT00248170|66661818|FG000|Overall Study|Protocol deviation|17|||
23804578|NCT00248170|66661819|FG001|Overall Study|Protocol deviation|19|||
23804579|NCT00573170|66661820|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
23804580|NCT00573170|66661821|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
23804581|NCT00573170|66661822|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
23804582|NCT00573170|66661823|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
23804583|NCT00573170|66661824|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
23804584|NCT00573170|66661825|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
23804585|NCT00573170|66661820|FG000|First Washout Period|Adverse Event|1|||
23804586|NCT00573170|66661821|FG001|First Washout Period|Adverse Event|1|||
23804587|NCT00573170|66661822|FG002|First Washout Period|Adverse Event|0|||
23804588|NCT00573170|66661823|FG003|First Washout Period|Adverse Event|0|||
23804589|NCT00573170|66661824|FG004|First Washout Period|Adverse Event|0|||
23804590|NCT00573170|66661825|FG005|First Washout Period|Adverse Event|1|||
23804591|NCT00573170|66661820|FG000|First Washout Period|Lack of Efficacy|0|||
23804592|NCT00573170|66661821|FG001|First Washout Period|Lack of Efficacy|0|||
23804593|NCT00573170|66661822|FG002|First Washout Period|Lack of Efficacy|0|||
23804594|NCT00573170|66661823|FG003|First Washout Period|Lack of Efficacy|0|||
23804595|NCT00573170|66661824|FG004|First Washout Period|Lack of Efficacy|0|||
23804596|NCT00573170|66661825|FG005|First Washout Period|Lack of Efficacy|1|||
23804597|NCT00573170|66661820|FG000|First Washout Period|Lost to Follow-up|1|||
23804598|NCT00573170|66661821|FG001|First Washout Period|Lost to Follow-up|1|||
23804599|NCT00573170|66661822|FG002|First Washout Period|Lost to Follow-up|0|||
23804600|NCT00573170|66661823|FG003|First Washout Period|Lost to Follow-up|2|||
23804601|NCT00573170|66661824|FG004|First Washout Period|Lost to Follow-up|0|||
23804602|NCT00573170|66661825|FG005|First Washout Period|Lost to Follow-up|2|||
23804603|NCT00573170|66661820|FG000|First Washout Period|Withdrawal by Subject|2|||
23804604|NCT00573170|66661821|FG001|First Washout Period|Withdrawal by Subject|0|||
23804605|NCT00573170|66661822|FG002|First Washout Period|Withdrawal by Subject|0|||
23804606|NCT00573170|66661823|FG003|First Washout Period|Withdrawal by Subject|2|||
23804607|NCT00573170|66661824|FG004|First Washout Period|Withdrawal by Subject|3|||
23804608|NCT00573170|66661825|FG005|First Washout Period|Withdrawal by Subject|3|||
23804609|NCT00573170|66661820|FG000|First Washout Period|Other|4|||
23804610|NCT00573170|66661821|FG001|First Washout Period|Other|0|||
23804611|NCT00573170|66661822|FG002|First Washout Period|Other|1|||
23804612|NCT00573170|66661823|FG003|First Washout Period|Other|1|||
23599875|NCT02161146|65925708|FG002|Overall Study|Personal Reasons|0|||
23599876|NCT02161146|65925709|FG003|Overall Study|Personal Reasons|2|||
23599877|NCT02161146|65925710|FG004|Overall Study|Personal Reasons|1|||
23599878|NCT02161146|65925706|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23804613|NCT00573170|66661824|FG004|First Washout Period|Other|0|||
23804614|NCT00573170|66661825|FG005|First Washout Period|Other|0|||
23804615|NCT00573170|66661820|FG000|Second Washout Period|Adverse Event|1|||
23804616|NCT00573170|66661821|FG001|Second Washout Period|Adverse Event|0|||
23804617|NCT00573170|66661822|FG002|Second Washout Period|Adverse Event|0|||
23804618|NCT00573170|66661823|FG003|Second Washout Period|Adverse Event|0|||
23655353|NCT00775450|66125420|FG000|Overall Study|Withdrawal by Subject|1|||
23655354|NCT00775450|66125421|FG001|Overall Study|Withdrawal by Subject|0|||
23804619|NCT00573170|66661824|FG004|Second Washout Period|Adverse Event|1|||
23804620|NCT00573170|66661825|FG005|Second Washout Period|Adverse Event|0|||
23804621|NCT00573170|66661820|FG000|Second Washout Period|Protocol Violation|2|||
23804622|NCT00573170|66661821|FG001|Second Washout Period|Protocol Violation|1|||
23804623|NCT00573170|66661822|FG002|Second Washout Period|Protocol Violation|1|||
23804624|NCT00573170|66661823|FG003|Second Washout Period|Protocol Violation|0|||
23804625|NCT00573170|66661824|FG004|Second Washout Period|Protocol Violation|0|||
23804626|NCT00573170|66661825|FG005|Second Washout Period|Protocol Violation|0|||
23804627|NCT00573170|66661820|FG000|Second Washout Period|Withdrawal by Subject|1|||
23804628|NCT00573170|66661821|FG001|Second Washout Period|Withdrawal by Subject|1|||
23804629|NCT00573170|66661822|FG002|Second Washout Period|Withdrawal by Subject|2|||
23804630|NCT00573170|66661823|FG003|Second Washout Period|Withdrawal by Subject|0|||
23804631|NCT00573170|66661824|FG004|Second Washout Period|Withdrawal by Subject|1|||
23804632|NCT00573170|66661825|FG005|Second Washout Period|Withdrawal by Subject|0|||
23804633|NCT00573170|66661820|FG000|Second Washout Period|Lost to Follow-up|0|||
23804634|NCT00573170|66661821|FG001|Second Washout Period|Lost to Follow-up|0|||
23804635|NCT00573170|66661822|FG002|Second Washout Period|Lost to Follow-up|0|||
23804636|NCT00573170|66661823|FG003|Second Washout Period|Lost to Follow-up|1|||
23804637|NCT00573170|66661824|FG004|Second Washout Period|Lost to Follow-up|0|||
23804638|NCT00573170|66661825|FG005|Second Washout Period|Lost to Follow-up|0|||
23804639|NCT00573170|66661820|FG000|Second Washout Period|Other|1|||
23804640|NCT00573170|66661821|FG001|Second Washout Period|Other|2|||
23804641|NCT00573170|66661822|FG002|Second Washout Period|Other|1|||
23804642|NCT00573170|66661823|FG003|Second Washout Period|Other|4|||
23804643|NCT00573170|66661824|FG004|Second Washout Period|Other|6|||
23804644|NCT00573170|66661825|FG005|Second Washout Period|Other|2|||
23804645|NCT00573170|66661820|FG000|Third Treatment Period|Withdrawal by Subject|1|||
23804646|NCT00573170|66661821|FG001|Third Treatment Period|Withdrawal by Subject|0|||
23804647|NCT00573170|66661822|FG002|Third Treatment Period|Withdrawal by Subject|0|||
23804648|NCT00573170|66661823|FG003|Third Treatment Period|Withdrawal by Subject|0|||
23804649|NCT00573170|66661824|FG004|Third Treatment Period|Withdrawal by Subject|0|||
23804650|NCT00573170|66661825|FG005|Third Treatment Period|Withdrawal by Subject|0|||
23804651|NCT00573170|66661820|FG000|Third Treatment Period|Lost to Follow-up|0|||
23804652|NCT00573170|66661821|FG001|Third Treatment Period|Lost to Follow-up|0|||
23804653|NCT00573170|66661822|FG002|Third Treatment Period|Lost to Follow-up|0|||
23804654|NCT00573170|66661823|FG003|Third Treatment Period|Lost to Follow-up|0|||
23804655|NCT00573170|66661824|FG004|Third Treatment Period|Lost to Follow-up|0|||
23804656|NCT00573170|66661825|FG005|Third Treatment Period|Lost to Follow-up|2|||
23804657|NCT00952276|66661826|FG000|Overall Study|Withdrawal by Subject|1|||
23804658|NCT00952276|66661827|FG001|Overall Study|Withdrawal by Subject|0|||
23804659|NCT00952276|66661828|FG002|Overall Study|Withdrawal by Subject|0|||
23804660|NCT00952276|66661829|FG003|Overall Study|Withdrawal by Subject|1|||
23804661|NCT00952276|66661830|FG004|Overall Study|Withdrawal by Subject|0|||
23804662|NCT00731549|66661831|FG000|Overall Study|Lost to Follow-up|19|||
23804663|NCT00731549|66661831|FG000|Overall Study|Met withdrawal criteria|24|||
23804664|NCT00731549|66661831|FG000|Overall Study|Physician Decision|16|||
23804665|NCT00731549|66661831|FG000|Overall Study|Withdrawal by Subject|89|||
23804666|NCT00731549|66661831|FG000|Overall Study|Protocol deviation|1|||
23804667|NCT00731549|66661831|FG000|Overall Study|Adverse Event|31|||
23804668|NCT00731549|66661831|FG000|Overall Study|Lack of efficacy with AE|37|||
23804669|NCT00731549|66661831|FG000|Overall Study|Lack of efficacy without AE|6|||
23804670|NCT01333072|66661832|FG000|Overall Study|Lost to Follow-up|3|||
23804671|NCT01333072|66661833|FG001|Overall Study|Lost to Follow-up|0|||
23804672|NCT01333072|66661832|FG000|Overall Study|Adverse Event|2|||
23804673|NCT01333072|66661833|FG001|Overall Study|Adverse Event|4|||
23804674|NCT01333072|66661832|FG000|Overall Study|Physician Decision|1|||
23804675|NCT01333072|66661833|FG001|Overall Study|Physician Decision|0|||
23804676|NCT03487848|66661834|FG000|Overall Study|Lost to Follow-up|1|||
23804677|NCT01005329|66661835|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
23804678|NCT00107042|66661836|FG000|Overall Study|Lost to Follow-up|9|||
23804679|NCT00107042|66661837|FG001|Overall Study|Lost to Follow-up|7|||
23804680|NCT00107042|66661836|FG000|Overall Study|Withdrawal by Subject|6|||
23804681|NCT00107042|66661837|FG001|Overall Study|Withdrawal by Subject|1|||
23804682|NCT00107042|66661836|FG000|Overall Study|Moved out of area|5|||
23804683|NCT00107042|66661837|FG001|Overall Study|Moved out of area|3|||
23804684|NCT00107042|66661836|FG000|Overall Study|Pregnancy|1|||
23804685|NCT00107042|66661837|FG001|Overall Study|Pregnancy|1|||
23804686|NCT00107042|66661836|FG000|Overall Study|Inadvertent enrollment|0|||
23804687|NCT00107042|66661837|FG001|Overall Study|Inadvertent enrollment|1|||
23804688|NCT00107042|66661836|FG000|Overall Study|vaccinated outside window|1|||
23804689|NCT00107042|66661837|FG001|Overall Study|vaccinated outside window|1|||
23804690|NCT00107042|66661836|FG000|Overall Study|Disallowed medications|0|||
23804691|NCT00107042|66661837|FG001|Overall Study|Disallowed medications|2|||
23804692|NCT01124695|66661838|FG000|Overall Study|Disease progression|77|||
23804693|NCT01124695|66661838|FG000|Overall Study|Adverse Event|11|||
23804694|NCT01124695|66661838|FG000|Overall Study|Death|1|||
23804695|NCT01124695|66661838|FG000|Overall Study|Withdrawal by Subject|7|||
23804696|NCT01124695|66661838|FG000|Overall Study|Physician Decision|3|||
23655355|NCT00775450|66125422|FG002|Overall Study|Withdrawal by Subject|0|||
23655356|NCT00775450|66125423|FG003|Overall Study|Withdrawal by Subject|0|||
23655357|NCT00775450|66125424|FG004|Overall Study|Withdrawal by Subject|1|||
23655358|NCT01159912|66125425|FG000|Overall Study|Adverse Event|2|||
23655359|NCT01159912|66125426|FG001|Overall Study|Adverse Event|2|||
23655360|NCT01159912|66125427|FG002|Overall Study|Adverse Event|3|||
23655361|NCT01159912|66125425|FG000|Overall Study|Lack of Efficacy|23|||
23655362|NCT01159912|66125426|FG001|Overall Study|Lack of Efficacy|15|||
23655363|NCT01159912|66125427|FG002|Overall Study|Lack of Efficacy|14|||
23655364|NCT01159912|66125425|FG000|Overall Study|Protocol Violation|1|||
23655365|NCT01159912|66125426|FG001|Overall Study|Protocol Violation|2|||
23655366|NCT01159912|66125427|FG002|Overall Study|Protocol Violation|3|||
23655367|NCT01159912|66125425|FG000|Overall Study|Lost to Follow-up|4|||
23655368|NCT01159912|66125426|FG001|Overall Study|Lost to Follow-up|0|||
23599879|NCT02161146|65925707|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23599880|NCT02161146|65925708|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23599881|NCT02161146|65925709|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23599882|NCT02161146|65925710|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23361090|NCT04058028|65065965|FG003|Overall Study|Death|0|||
23361091|NCT00410072|65065968|FG000|Day 1 to Week 48|Adverse Event|1|||
23361092|NCT00410072|65065969|FG001|Day 1 to Week 48|Adverse Event|2|||
23599883|NCT03274076|65925712|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
23599884|NCT03274076|65925713|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
23599885|NCT03274076|65925714|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
23599886|NCT03274076|65925715|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
23599887|NCT03274076|65925712|FG000|24 Weeks Open Label|Adverse Event|0|||
23804697|NCT01124695|66661838|FG000|Overall Study|Alternative therapy|9|||
23804698|NCT01124695|66661838|FG000|Overall Study|No documentation that patient went off treatment|4|||
23804699|NCT01124695|66661838|FG000|Overall Study|Ineligible|9|||
23804700|NCT01124695|66661838|FG000|Overall Study|Ineligible and never start treatment|2|||
23804701|NCT00407758|66661839|FG000|Overall Study|ineligible -improper prior treatment|1|||
23804702|NCT00402025|66661842|FG000|Overall Study|Adverse Event|0|||
23804703|NCT00402025|66661843|FG001|Overall Study|Adverse Event|0|||
23804704|NCT00402025|66661844|FG002|Overall Study|Adverse Event|2|||
23804705|NCT00402025|66661842|FG000|Overall Study|Death|0|||
23804706|NCT00402025|66661843|FG001|Overall Study|Death|1|||
23804707|NCT00402025|66661844|FG002|Overall Study|Death|5|||
23804708|NCT00402025|66661842|FG000|Overall Study|Disease Progression|1|||
23804709|NCT00402025|66661843|FG001|Overall Study|Disease Progression|1|||
23804710|NCT00402025|66661844|FG002|Overall Study|Disease Progression|2|||
23804711|NCT00402025|66661842|FG000|Overall Study|Physician Decision|1|||
23804712|NCT00402025|66661843|FG001|Overall Study|Physician Decision|1|||
23804713|NCT00402025|66661844|FG002|Overall Study|Physician Decision|0|||
23804714|NCT00402025|66661842|FG000|Overall Study|Participant Decision|0|||
23804715|NCT00402025|66661843|FG001|Overall Study|Participant Decision|0|||
23804716|NCT00402025|66661844|FG002|Overall Study|Participant Decision|1|||
23804717|NCT04440449|66661846|FG000|Overall Study|Lost to Follow-up|2|||
23804718|NCT04440449|66661847|FG001|Overall Study|Lost to Follow-up|0|||
23804719|NCT01787279|66661848|FG000|Overall Study|Lost to Follow-up|2|||
23804720|NCT01787279|66661848|FG000|Overall Study|Lack of Efficacy|1|||
23804721|NCT01557842|66661849|FG000|Overall Study|Lost to Follow-up|0|||
23804722|NCT01557842|66661850|FG001|Overall Study|Lost to Follow-up|1|||
23804723|NCT01557842|66661849|FG000|Overall Study|Death|1|||
23804724|NCT01557842|66661850|FG001|Overall Study|Death|0|||
23804725|NCT01557842|66661849|FG000|Overall Study|Lack of Efficacy|0|||
23804726|NCT01557842|66661850|FG001|Overall Study|Lack of Efficacy|1|||
23804727|NCT01557842|66661849|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
23804728|NCT01557842|66661850|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
23804729|NCT01557842|66661849|FG000|Overall Study|Study Terminated by Sponsor|3|||
23804730|NCT01557842|66661850|FG001|Overall Study|Study Terminated by Sponsor|4|||
23804731|NCT01557842|66661849|FG000|Overall Study|Not Ablated|2|||
23804732|NCT01557842|66661850|FG001|Overall Study|Not Ablated|0|||
23804733|NCT04633642|66661857|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
23804734|NCT04633642|66661858|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
23804735|NCT01917968|66661861|FG000|Overall Study|Death|3|||
23804736|NCT01917968|66661862|FG001|Overall Study|Death|2|||
23804737|NCT01917968|66661861|FG000|Overall Study|Lost to Follow-up|21|||
23804738|NCT01917968|66661862|FG001|Overall Study|Lost to Follow-up|39|||
23804739|NCT01917968|66661861|FG000|Overall Study|Physician Decision|1|||
23804740|NCT01917968|66661862|FG001|Overall Study|Physician Decision|2|||
23804741|NCT01917968|66661861|FG000|Overall Study|Withdrawal by Subject|20|||
23804742|NCT01917968|66661862|FG001|Overall Study|Withdrawal by Subject|35|||
23804743|NCT01917968|66661861|FG000|Overall Study|Subject Relocation|5|||
23804744|NCT01917968|66661862|FG001|Overall Study|Subject Relocation|1|||
23804745|NCT01917968|66661861|FG000|Overall Study|36M Missed Visit|3|||
23804746|NCT01917968|66661862|FG001|Overall Study|36M Missed Visit|2|||
23804747|NCT01917968|66661861|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
23804748|NCT01917968|66661862|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
23804749|NCT01917968|66661861|FG000|Overall Study|Change in Family Circumstances|0|||
23804750|NCT01917968|66661862|FG001|Overall Study|Change in Family Circumstances|1|||
23804751|NCT01917968|66661861|FG000|Overall Study|No Data Available|0|||
23804752|NCT01917968|66661862|FG001|Overall Study|No Data Available|2|||
23804753|NCT02201290|66661866|FG000|Overall Study|Withdrawal by Subject|2|||
23804754|NCT02201290|66661866|FG000|Overall Study|Lack of Efficacy|2|||
23804755|NCT02201290|66661866|FG000|Overall Study|Adverse Event|1|||
23804756|NCT01790113|66661869|FG000|Overall Study|Adverse Event|2|||
23804757|NCT01790113|66661870|FG001|Overall Study|Adverse Event|7|||
23804758|NCT01790113|66661869|FG000|Overall Study|Study ended due to FDA clearance|1|||
23804759|NCT01790113|66661870|FG001|Overall Study|Study ended due to FDA clearance|68|||
23804760|NCT02697773|66664742|FG000|Overall Study|Adverse Event|2|||
23804761|NCT02697773|66664743|FG001|Overall Study|Adverse Event|1|||
23804762|NCT02697773|66664744|FG002|Overall Study|Adverse Event|2|||
23804763|NCT02697773|66664742|FG000|Overall Study|Death|0|||
23804764|NCT02697773|66664743|FG001|Overall Study|Death|0|||
23804765|NCT02697773|66664744|FG002|Overall Study|Death|2|||
23804766|NCT02697773|66664742|FG000|Overall Study|Lack of Efficacy|4|||
23804767|NCT02697773|66664743|FG001|Overall Study|Lack of Efficacy|6|||
23804768|NCT02697773|66664744|FG002|Overall Study|Lack of Efficacy|6|||
23804769|NCT02697773|66664742|FG000|Overall Study|Lost to Follow-up|5|||
23804770|NCT02697773|66664743|FG001|Overall Study|Lost to Follow-up|5|||
23804771|NCT02697773|66664744|FG002|Overall Study|Lost to Follow-up|7|||
23804772|NCT02697773|66664742|FG000|Overall Study|Other|15|||
23804773|NCT02697773|66664743|FG001|Overall Study|Other|11|||
23804774|NCT02697773|66664744|FG002|Overall Study|Other|10|||
23804775|NCT02697773|66664742|FG000|Overall Study|Protocol Violation|1|||
23804776|NCT02697773|66664743|FG001|Overall Study|Protocol Violation|1|||
23804777|NCT02697773|66664744|FG002|Overall Study|Protocol Violation|0|||
23804778|NCT02697773|66664742|FG000|Overall Study|Withdrawal by Subject|10|||
23804779|NCT02697773|66664743|FG001|Overall Study|Withdrawal by Subject|13|||
23804780|NCT02697773|66664744|FG002|Overall Study|Withdrawal by Subject|13|||
23804781|NCT02697773|66664742|FG000|Overall Study|Randomized but not treated|1|||
23804782|NCT02697773|66664743|FG001|Overall Study|Randomized but not treated|1|||
23804783|NCT02697773|66664744|FG002|Overall Study|Randomized but not treated|0|||
23804784|NCT00588640|66664745|FG000|Overall Study|Physician Decision|1|||
23804785|NCT00588640|66664745|FG000|Overall Study|Ineligible Patient|1|||
23804786|NCT02694549|66664746|FG000|Overall Study|screen failures|2|||
23804787|NCT00841906|66664748|FG000|Overall Study|Withdrawal by Subject|2|||
23804788|NCT00841906|66664749|FG001|Overall Study|Withdrawal by Subject|0|||
23804789|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
23804790|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
23804791|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
23804792|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
23804793|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
23804794|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
23804795|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
23599888|NCT03274076|65925713|FG001|24 Weeks Open Label|Adverse Event|0|||
23599889|NCT03274076|65925714|FG002|24 Weeks Open Label|Adverse Event|2|||
23599890|NCT03274076|65925715|FG003|24 Weeks Open Label|Adverse Event|0|||
23599891|NCT03274076|65925712|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
23599892|NCT03274076|65925713|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
23599893|NCT03274076|65925714|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
23599894|NCT03274076|65925715|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
23361093|NCT00410072|65065968|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
23361094|NCT00410072|65065969|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
23361095|NCT00410072|65065968|FG000|Day 1 to Week 48|Other|0|||
23361096|NCT00410072|65065969|FG001|Day 1 to Week 48|Other|1|||
23599895|NCT04579250|65925720|FG000|Overall Study|Withdrawal by Subject|1|||
23599896|NCT04579250|65925721|FG001|Overall Study|Withdrawal by Subject|1|||
23599897|NCT04579250|65925722|FG002|Overall Study|Withdrawal by Subject|0|||
23599898|NCT04579250|65925720|FG000|Overall Study|Lost to Follow-up|1|||
23599899|NCT04579250|65925721|FG001|Overall Study|Lost to Follow-up|1|||
23599900|NCT04579250|65925722|FG002|Overall Study|Lost to Follow-up|0|||
23599901|NCT04579250|65925720|FG000|Overall Study|Moved from area|0|||
23599902|NCT04579250|65925721|FG001|Overall Study|Moved from area|1|||
23599903|NCT04579250|65925722|FG002|Overall Study|Moved from area|2|||
23599904|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
23599905|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
23599906|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
23599907|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
23599908|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
23599909|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
23655369|NCT01159912|66125427|FG002|Overall Study|Lost to Follow-up|0|||
23655370|NCT01159912|66125425|FG000|Overall Study|Physician Decision|0|||
23655371|NCT01159912|66125426|FG001|Overall Study|Physician Decision|0|||
23599910|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
23599911|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
23599912|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
23599913|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
23599914|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
23599915|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
23599916|NCT01588951|65925733|FG000|Overall Study|Ineligible in retrospect|0|||
23599917|NCT01588951|65925734|FG001|Overall Study|Ineligible in retrospect|0|||
23599918|NCT01588951|65925735|FG002|Overall Study|Ineligible in retrospect|1|||
23599919|NCT01574716|65925736|FG000|Part 1|Death|3|||
23599920|NCT01574716|65925737|FG001|Part 1|Death|1|||
23599921|NCT01574716|65925738|FG002|Part 1|Death|8|||
23599922|NCT01574716|65925739|FG003|Part 1|Death|0|||
23599923|NCT01574716|65925740|FG004|Part 1|Death|0|||
23599924|NCT01574716|65925736|FG000|Part 1|Discontinuation of study by sponsor|0|||
23599925|NCT01574716|65925737|FG001|Part 1|Discontinuation of study by sponsor|0|||
23599926|NCT01574716|65925738|FG002|Part 1|Discontinuation of study by sponsor|1|||
23599927|NCT01574716|65925739|FG003|Part 1|Discontinuation of study by sponsor|0|||
23599928|NCT01574716|65925740|FG004|Part 1|Discontinuation of study by sponsor|0|||
23599929|NCT01574716|65925736|FG000|Part 1|Withdrawal by Subject|0|||
23599930|NCT01574716|65925737|FG001|Part 1|Withdrawal by Subject|2|||
23599931|NCT01574716|65925738|FG002|Part 1|Withdrawal by Subject|0|||
23599932|NCT01574716|65925739|FG003|Part 1|Withdrawal by Subject|0|||
23599933|NCT01574716|65925740|FG004|Part 1|Withdrawal by Subject|0|||
23599934|NCT01574716|65925736|FG000|Part 1|Lost to Follow-up|0|||
23599935|NCT01574716|65925737|FG001|Part 1|Lost to Follow-up|1|||
23599936|NCT01574716|65925738|FG002|Part 1|Lost to Follow-up|0|||
23599937|NCT01574716|65925739|FG003|Part 1|Lost to Follow-up|0|||
23599938|NCT01574716|65925740|FG004|Part 1|Lost to Follow-up|0|||
23599939|NCT01574716|65925736|FG000|Part 2|Progressive disease|0|||
23599940|NCT01574716|65925737|FG001|Part 2|Progressive disease|0|||
23599941|NCT01574716|65925738|FG002|Part 2|Progressive disease|0|||
23599942|NCT01574716|65925739|FG003|Part 2|Progressive disease|1|||
23599943|NCT01574716|65925740|FG004|Part 2|Progressive disease|0|||
23599944|NCT01574716|65925736|FG000|Part 2|Death|0|||
23599945|NCT01574716|65925737|FG001|Part 2|Death|0|||
23599946|NCT01574716|65925738|FG002|Part 2|Death|0|||
23599947|NCT01574716|65925739|FG003|Part 2|Death|76|||
23599948|NCT01574716|65925740|FG004|Part 2|Death|35|||
23599949|NCT01574716|65925736|FG000|Part 2|Discontinuation of study by sponsor|0|||
23599950|NCT01574716|65925737|FG001|Part 2|Discontinuation of study by sponsor|0|||
23599951|NCT01574716|65925738|FG002|Part 2|Discontinuation of study by sponsor|0|||
23599952|NCT01574716|65925739|FG003|Part 2|Discontinuation of study by sponsor|51|||
23599953|NCT01574716|65925740|FG004|Part 2|Discontinuation of study by sponsor|31|||
23599954|NCT01574716|65925736|FG000|Part 2|Withdrawal by Subject|0|||
23599955|NCT01574716|65925737|FG001|Part 2|Withdrawal by Subject|0|||
23599956|NCT01574716|65925738|FG002|Part 2|Withdrawal by Subject|0|||
23599957|NCT01574716|65925739|FG003|Part 2|Withdrawal by Subject|5|||
23599958|NCT01574716|65925740|FG004|Part 2|Withdrawal by Subject|4|||
23599959|NCT01574716|65925736|FG000|Part 2|Brain metastases|0|||
23599960|NCT01574716|65925737|FG001|Part 2|Brain metastases|0|||
23599961|NCT01574716|65925738|FG002|Part 2|Brain metastases|0|||
23599962|NCT01574716|65925739|FG003|Part 2|Brain metastases|1|||
23599963|NCT01574716|65925740|FG004|Part 2|Brain metastases|0|||
23599964|NCT01574716|65925736|FG000|Part 2|Lost to Follow-up|0|||
23599965|NCT01574716|65925737|FG001|Part 2|Lost to Follow-up|0|||
23599966|NCT01574716|65925738|FG002|Part 2|Lost to Follow-up|0|||
23599967|NCT01574716|65925739|FG003|Part 2|Lost to Follow-up|3|||
23599968|NCT01574716|65925740|FG004|Part 2|Lost to Follow-up|0|||
23599969|NCT04048681|65925741|FG000|Overall Study|family emergency|0|||
23599970|NCT04048681|65925742|FG001|Overall Study|family emergency|0|||
23599971|NCT04048681|65925743|FG002|Overall Study|family emergency|0|||
23599972|NCT04048681|65925744|FG003|Overall Study|family emergency|1|||
23599973|NCT04048681|65925745|FG004|Overall Study|family emergency|0|||
23599974|NCT02023866|65925753|FG000|Overall Study|Non-compliance|2|||
23599975|NCT02023866|65925753|FG000|Overall Study|Adverse Event|3|||
23599976|NCT02023866|65925753|FG000|Overall Study|Withdrawal by Subject|1|||
23599977|NCT01964300|65925754|FG000|Overall Study|Ineligible after enrollment|0|||
23599978|NCT01964300|65925755|FG001|Overall Study|Ineligible after enrollment|1|||
23599979|NCT01964300|65925754|FG000|Overall Study|Adverse Event|1|||
23599980|NCT01964300|65925755|FG001|Overall Study|Adverse Event|1|||
23599981|NCT01964300|65925754|FG000|Overall Study|Lack of Efficacy|3|||
23599982|NCT01964300|65925755|FG001|Overall Study|Lack of Efficacy|5|||
23599983|NCT01964300|65925754|FG000|Overall Study|Withdrawal by Subject|0|||
23599984|NCT01964300|65925755|FG001|Overall Study|Withdrawal by Subject|1|||
23599985|NCT01964300|65925754|FG000|Overall Study|To receive alternative therapy|1|||
23655372|NCT01159912|66125427|FG002|Overall Study|Physician Decision|3|||
23804796|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
23804797|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23804798|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23804799|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
23804800|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
23804801|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
23804802|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
23804803|NCT04740931|66664753|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
23804804|NCT04740931|66664754|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
23804805|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
23804806|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
23804807|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
23804808|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
23804809|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
23804810|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
23804811|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
23804812|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
23804813|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
23804814|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
23804815|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
23804816|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
23804817|NCT04740931|66664753|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
23804818|NCT04740931|66664754|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
23804819|NCT04568031|66664757|FG000|Overall Study|Lost to Follow-up|1|||
23804820|NCT04568031|66664758|FG001|Overall Study|Lost to Follow-up|0|||
23804821|NCT04568031|66664759|FG002|Overall Study|Lost to Follow-up|0|||
23804822|NCT04568031|66664760|FG003|Overall Study|Lost to Follow-up|0|||
23804823|NCT04568031|66664757|FG000|Overall Study|Physician Decision|1|||
23804824|NCT04568031|66664758|FG001|Overall Study|Physician Decision|0|||
23804825|NCT04568031|66664759|FG002|Overall Study|Physician Decision|1|||
23804826|NCT04568031|66664760|FG003|Overall Study|Physician Decision|0|||
23804827|NCT04568031|66664757|FG000|Overall Study|Withdrawal by Subject|1|||
23804828|NCT04568031|66664758|FG001|Overall Study|Withdrawal by Subject|0|||
23804829|NCT04568031|66664759|FG002|Overall Study|Withdrawal by Subject|4|||
23804830|NCT04568031|66664760|FG003|Overall Study|Withdrawal by Subject|1|||
23804831|NCT01568866|66664761|FG000|Overall Study|Disease Progression|208|||
23804832|NCT01568866|66664762|FG001|Overall Study|Disease Progression|183|||
23804833|NCT01568866|66664761|FG000|Overall Study|Adverse Event|94|||
23804834|NCT01568866|66664762|FG001|Overall Study|Adverse Event|96|||
23804835|NCT01568866|66664761|FG000|Overall Study|Patient Request|55|||
23804836|NCT01568866|66664762|FG001|Overall Study|Patient Request|71|||
23804837|NCT01568866|66664761|FG000|Overall Study|Physician Decision|40|||
23804838|NCT01568866|66664762|FG001|Overall Study|Physician Decision|32|||
23804839|NCT01568866|66664761|FG000|Overall Study|Withdrawal by Subject|19|||
23804840|NCT01568866|66664762|FG001|Overall Study|Withdrawal by Subject|11|||
23804841|NCT01568866|66664761|FG000|Overall Study|Death|10|||
23804842|NCT01568866|66664762|FG001|Overall Study|Death|18|||
23804843|NCT01568866|66664761|FG000|Overall Study|Protocol Non-compliance|2|||
23804844|NCT01568866|66664762|FG001|Overall Study|Protocol Non-compliance|4|||
23804845|NCT01568866|66664761|FG000|Overall Study|Lost to Follow-up|1|||
23804846|NCT01568866|66664762|FG001|Overall Study|Lost to Follow-up|0|||
23804847|NCT01568866|66664761|FG000|Overall Study|Randomized but Not Dosed|9|||
23804848|NCT01568866|66664762|FG001|Overall Study|Randomized but Not Dosed|1|||
23804849|NCT05855616|66664766|FG000|Overall Study|Lost to Follow-up|1|||
23804850|NCT05855616|66664767|FG001|Overall Study|Lost to Follow-up|2|||
23804851|NCT00375492|66664773|FG000|Overall Study|Adverse Event|4|||
23804852|NCT00375492|66664774|FG001|Overall Study|Adverse Event|5|||
23804853|NCT00375492|66664773|FG000|Overall Study|Entry Criteria Not Met|0|||
23804854|NCT00375492|66664774|FG001|Overall Study|Entry Criteria Not Met|1|||
23804855|NCT00375492|66664773|FG000|Overall Study|Loss of Glucose Control|0|||
23804856|NCT00375492|66664774|FG001|Overall Study|Loss of Glucose Control|1|||
23804857|NCT00375492|66664773|FG000|Overall Study|Lost to Follow-up|10|||
23804858|NCT00375492|66664774|FG001|Overall Study|Lost to Follow-up|5|||
23804859|NCT00375492|66664773|FG000|Overall Study|Physician Decision|0|||
23804860|NCT00375492|66664774|FG001|Overall Study|Physician Decision|4|||
23804861|NCT00375492|66664773|FG000|Overall Study|Protocol Violation|6|||
23804862|NCT00375492|66664774|FG001|Overall Study|Protocol Violation|3|||
23804863|NCT00375492|66664773|FG000|Overall Study|Sponsor Decision|0|||
23804864|NCT00375492|66664774|FG001|Overall Study|Sponsor Decision|1|||
23804865|NCT00375492|66664773|FG000|Overall Study|Withdrawal by Subject|6|||
23804866|NCT00375492|66664774|FG001|Overall Study|Withdrawal by Subject|6|||
23804867|NCT00513682|66664775|FG000|Washout Phase|Adverse Event|2|||
23804868|NCT00925301|66664776|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23804869|NCT00925301|66664777|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
23804870|NCT00925301|66664778|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23804871|NCT00925301|66664779|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23655373|NCT01159912|66125425|FG000|Overall Study|Withdrawal by Subject|10|||
23655374|NCT01159912|66125426|FG001|Overall Study|Withdrawal by Subject|3|||
23655375|NCT01159912|66125427|FG002|Overall Study|Withdrawal by Subject|3|||
23655376|NCT01979835|66125428|FG000|Primary Outcome SA Measurment|failed insertion|18|||
23655377|NCT01979835|66125428|FG000|Follow-up|Lost to Follow-up|32|||
23655378|NCT00892177|66125429|FG000|Phase II|Ineligible|0|||
23655379|NCT00892177|66125430|FG001|Phase II|Ineligible|0|||
23655380|NCT00892177|66125431|FG002|Phase II|Ineligible|0|||
23655381|NCT00892177|66125432|FG003|Phase II|Ineligible|0|||
23655382|NCT00892177|66125433|FG004|Phase II|Ineligible|1|||
23804872|NCT00925301|66664776|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23361097|NCT00410072|65065968|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
23655383|NCT00892177|66125434|FG005|Phase II|Ineligible|1|||
23655384|NCT00892177|66125429|FG000|Phase II|Withdrawal by Subject|0|||
23655385|NCT00892177|66125430|FG001|Phase II|Withdrawal by Subject|0|||
23655386|NCT00892177|66125431|FG002|Phase II|Withdrawal by Subject|0|||
23655387|NCT00892177|66125432|FG003|Phase II|Withdrawal by Subject|0|||
23655388|NCT00892177|66125433|FG004|Phase II|Withdrawal by Subject|4|||
23655389|NCT00892177|66125434|FG005|Phase II|Withdrawal by Subject|1|||
23655390|NCT01674712|66125435|FG000|Overall Study|Adverse Event|5|||
23655391|NCT01674712|66125436|FG001|Overall Study|Adverse Event|6|||
23655392|NCT01674712|66125437|FG002|Overall Study|Adverse Event|3|||
23655393|NCT01674712|66125438|FG003|Overall Study|Adverse Event|4|||
23655394|NCT01674712|66125439|FG004|Overall Study|Adverse Event|6|||
23655395|NCT01674712|66125435|FG000|Overall Study|Lost to Follow-up|1|||
23655396|NCT01674712|66125436|FG001|Overall Study|Lost to Follow-up|0|||
23655397|NCT01674712|66125437|FG002|Overall Study|Lost to Follow-up|0|||
23655398|NCT01674712|66125438|FG003|Overall Study|Lost to Follow-up|0|||
23655399|NCT01674712|66125439|FG004|Overall Study|Lost to Follow-up|0|||
23655400|NCT01674712|66125435|FG000|Overall Study|Protocol Violation|2|||
23655401|NCT01674712|66125436|FG001|Overall Study|Protocol Violation|0|||
23655402|NCT01674712|66125437|FG002|Overall Study|Protocol Violation|0|||
23655403|NCT01674712|66125438|FG003|Overall Study|Protocol Violation|0|||
23655404|NCT01674712|66125439|FG004|Overall Study|Protocol Violation|0|||
23655405|NCT01674712|66125435|FG000|Overall Study|Withdrawal by Subject|2|||
23655406|NCT01674712|66125436|FG001|Overall Study|Withdrawal by Subject|2|||
23655407|NCT01674712|66125437|FG002|Overall Study|Withdrawal by Subject|5|||
23655408|NCT01674712|66125438|FG003|Overall Study|Withdrawal by Subject|4|||
23655409|NCT01674712|66125439|FG004|Overall Study|Withdrawal by Subject|3|||
23655410|NCT01674712|66125435|FG000|Overall Study|Administrative|0|||
23655411|NCT01674712|66125436|FG001|Overall Study|Administrative|1|||
23655412|NCT01674712|66125437|FG002|Overall Study|Administrative|0|||
23655413|NCT01674712|66125438|FG003|Overall Study|Administrative|0|||
23655414|NCT01674712|66125439|FG004|Overall Study|Administrative|1|||
23655415|NCT01674712|66125435|FG000|Overall Study|Lack of Efficacy|0|||
23655416|NCT01674712|66125436|FG001|Overall Study|Lack of Efficacy|0|||
23655417|NCT01674712|66125437|FG002|Overall Study|Lack of Efficacy|1|||
23655418|NCT01674712|66125438|FG003|Overall Study|Lack of Efficacy|0|||
23655419|NCT01674712|66125439|FG004|Overall Study|Lack of Efficacy|1|||
23655420|NCT00671554|66125442|FG000|Overall Study|Disease progression|3|||
23655421|NCT01128894|66125443|FG000|Overall Study|Adverse Event|31|||
23655422|NCT01128894|66125444|FG001|Overall Study|Adverse Event|41|||
23655423|NCT01128894|66125443|FG000|Overall Study|Protocol Violation|2|||
23655424|NCT01128894|66125444|FG001|Overall Study|Protocol Violation|1|||
23655425|NCT01128894|66125443|FG000|Overall Study|Noncompliance|4|||
23655426|NCT01128894|66125444|FG001|Overall Study|Noncompliance|5|||
23655427|NCT01128894|66125443|FG000|Overall Study|Lost to Follow-up|8|||
23655428|NCT01128894|66125444|FG001|Overall Study|Lost to Follow-up|8|||
23655429|NCT01128894|66125443|FG000|Overall Study|Withdrawal by Subject|10|||
23655430|NCT01128894|66125444|FG001|Overall Study|Withdrawal by Subject|12|||
23655431|NCT01128894|66125443|FG000|Overall Study|Physician Decision|2|||
23655432|NCT01128894|66125444|FG001|Overall Study|Physician Decision|1|||
23655433|NCT01128894|66125443|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
23655434|NCT01128894|66125444|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
23655435|NCT02249767|66125449|FG000|Overall Study|Did not use medication|8|||
23655436|NCT02249767|66125450|FG001|Overall Study|Did not use medication|9|||
23655437|NCT02249767|66125451|FG002|Overall Study|Did not use medication|8|||
23655438|NCT01180998|66125452|FG000|Overall Study|Poor Vision|0|||
23655439|NCT01180998|66125453|FG001|Overall Study|Poor Vision|2|||
23655440|NCT01180998|66125454|FG002|Overall Study|Poor Vision|2|||
23655441|NCT01180998|66125452|FG000|Overall Study|Lost to Follow-up|0|||
23655442|NCT01180998|66125453|FG001|Overall Study|Lost to Follow-up|0|||
23655443|NCT01180998|66125454|FG002|Overall Study|Lost to Follow-up|1|||
23655444|NCT01180998|66125452|FG000|Overall Study|Protocol Violation|1|||
23655445|NCT01180998|66125453|FG001|Overall Study|Protocol Violation|2|||
23655446|NCT01180998|66125454|FG002|Overall Study|Protocol Violation|0|||
23655447|NCT01180998|66125452|FG000|Overall Study|Withdrawal by Subject|0|||
23480354|NCT01330017|65501955|FG001|Overall Study|Withdrawal by Subject|0|||
23655448|NCT01180998|66125453|FG001|Overall Study|Withdrawal by Subject|0|||
23655449|NCT01180998|66125454|FG002|Overall Study|Withdrawal by Subject|1|||
23655450|NCT01180998|66125452|FG000|Overall Study|Poor comfort|3|||
23655451|NCT01180998|66125453|FG001|Overall Study|Poor comfort|0|||
23655452|NCT01180998|66125454|FG002|Overall Study|Poor comfort|4|||
23480355|NCT01330017|65501956|FG002|Overall Study|Withdrawal by Subject|1|||
23655453|NCT01180998|66125452|FG000|Overall Study|Poor lens handling|0|||
23655454|NCT01180998|66125453|FG001|Overall Study|Poor lens handling|0|||
23655455|NCT01180998|66125454|FG002|Overall Study|Poor lens handling|2|||
23655456|NCT00120406|66125455|FG000|Overall Study|Death|9|||
23655457|NCT00120406|66125456|FG001|Overall Study|Death|4|||
23655458|NCT00120406|66125455|FG000|Overall Study|Withdrawal by Subject|5|||
23655459|NCT00120406|66125456|FG001|Overall Study|Withdrawal by Subject|7|||
23655460|NCT00120406|66125455|FG000|Overall Study|Lost to Follow-up|5|||
23655461|NCT00120406|66125456|FG001|Overall Study|Lost to Follow-up|2|||
23655462|NCT00120406|66125455|FG000|Overall Study|received non-study stent|0|||
23655463|NCT00120406|66125456|FG001|Overall Study|received non-study stent|2|||
23655464|NCT00120406|66125455|FG000|Overall Study|patient moved but has not withdrawn|0|||
23655465|NCT00120406|66125456|FG001|Overall Study|patient moved but has not withdrawn|1|||
23655466|NCT01729156|66125457|FG000|Overall Study|Withdrawal by Subject|1|||
23655467|NCT01729156|66125458|FG001|Overall Study|Withdrawal by Subject|0|||
23655468|NCT01729156|66125459|FG002|Overall Study|Withdrawal by Subject|0|||
23655469|NCT00778622|66125460|FG000|Overall Study|Adverse Event|5|||
23655470|NCT00778622|66125461|FG001|Overall Study|Adverse Event|4|||
23655471|NCT00778622|66125462|FG002|Overall Study|Adverse Event|7|||
23655472|NCT00778622|66125460|FG000|Overall Study|Withdrawal by Subject|4|||
23655473|NCT00778622|66125461|FG001|Overall Study|Withdrawal by Subject|5|||
23655474|NCT00778622|66125462|FG002|Overall Study|Withdrawal by Subject|5|||
23655475|NCT00778622|66125460|FG000|Overall Study|Lost to Follow-up|3|||
23361098|NCT00410072|65065969|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
23361099|NCT00410072|65065968|FG000|Day 1 to Week 48|Pregnancy|0|||
23655476|NCT00778622|66125461|FG001|Overall Study|Lost to Follow-up|3|||
23655477|NCT00778622|66125462|FG002|Overall Study|Lost to Follow-up|2|||
23361100|NCT00410072|65065969|FG001|Day 1 to Week 48|Pregnancy|2|||
23655478|NCT00778622|66125460|FG000|Overall Study|Protocol Violation|0|||
23655479|NCT00778622|66125461|FG001|Overall Study|Protocol Violation|3|||
23361101|NCT00410072|65065968|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
23361102|NCT00410072|65065969|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
23361103|NCT00410072|65065968|FG000|After Week 48 to Week 96|Adverse Event|1|||
23361104|NCT00410072|65065969|FG001|After Week 48 to Week 96|Adverse Event|2|||
23361105|NCT00410072|65065968|FG000|After Week 48 to Week 96|Death|0|||
23804873|NCT00925301|66664777|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
23804874|NCT00925301|66664778|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23804875|NCT00925301|66664779|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23804876|NCT00925301|66664776|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23804877|NCT00925301|66664777|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23804878|NCT00925301|66664778|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
23804879|NCT00925301|66664779|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23804880|NCT00925301|66664776|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
23804881|NCT00925301|66664777|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
23804882|NCT00925301|66664778|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
23804883|NCT00925301|66664779|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
23804884|NCT00925301|66664776|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23804885|NCT00925301|66664777|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23804886|NCT00925301|66664778|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23804887|NCT00925301|66664779|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
23804888|NCT00925301|66664776|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23804889|NCT00925301|66664777|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23804890|NCT00925301|66664778|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23804891|NCT00925301|66664779|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
23804892|NCT00925301|66664776|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23804893|NCT00925301|66664777|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23804894|NCT00925301|66664778|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23804895|NCT00925301|66664779|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
23804896|NCT01280617|66664780|FG000|Overall Study|Adverse Event|0|||
23804897|NCT01280617|66664781|FG001|Overall Study|Adverse Event|1|||
23804898|NCT04647383|66664785|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
23804899|NCT04647383|66664786|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
23804900|NCT04647383|66664787|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
23804901|NCT04647383|66664788|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
23804902|NCT00251641|66664789|FG000|Overall Study|Adverse Event|80|||
23804903|NCT00251641|66664790|FG001|Overall Study|Adverse Event|8|||
23804904|NCT00251641|66664789|FG000|Overall Study|Lack of Efficacy|2|||
23804905|NCT00251641|66664790|FG001|Overall Study|Lack of Efficacy|1|||
23804906|NCT00251641|66664789|FG000|Overall Study|Progression of Disease|0|||
23804907|NCT00251641|66664790|FG001|Overall Study|Progression of Disease|2|||
23804908|NCT00251641|66664789|FG000|Overall Study|Lost to Follow-up|3|||
23804909|NCT00251641|66664790|FG001|Overall Study|Lost to Follow-up|3|||
23804910|NCT00251641|66664789|FG000|Overall Study|Withdrawal by Subject|6|||
23804911|NCT00251641|66664790|FG001|Overall Study|Withdrawal by Subject|8|||
23804912|NCT00251641|66664789|FG000|Overall Study|Protocol Violation|10|||
23804913|NCT00251641|66664790|FG001|Overall Study|Protocol Violation|2|||
23804914|NCT00251641|66664789|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
23804915|NCT00251641|66664790|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
23804916|NCT00251641|66664789|FG000|Overall Study|Switched Treatment|9|||
23804917|NCT00251641|66664790|FG001|Overall Study|Switched Treatment|63|||
23804918|NCT01481324|66664791|FG000|Overall Study|Missing Data|0|||
23804919|NCT01481324|66664792|FG001|Overall Study|Missing Data|2|||
23804920|NCT01481324|66664793|FG002|Overall Study|Missing Data|2|||
23804921|NCT04109313|66664794|FG000|Overall Study|Pregnancy|1|||
23655480|NCT00778622|66125462|FG002|Overall Study|Protocol Violation|0|||
23655481|NCT00778622|66125460|FG000|Overall Study|Lack of Efficacy|2|||
23655482|NCT00778622|66125461|FG001|Overall Study|Lack of Efficacy|0|||
23599986|NCT01964300|65925755|FG001|Overall Study|To receive alternative therapy|2|||
23599987|NCT01964300|65925754|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
23655483|NCT00778622|66125462|FG002|Overall Study|Lack of Efficacy|0|||
23655484|NCT00778622|66125460|FG000|Overall Study|immigration|1|||
23655485|NCT00778622|66125461|FG001|Overall Study|immigration|0|||
23655486|NCT00778622|66125462|FG002|Overall Study|immigration|0|||
23655487|NCT00778622|66125460|FG000|Overall Study|Other|1|||
23655488|NCT00778622|66125461|FG001|Overall Study|Other|0|||
23655489|NCT00778622|66125462|FG002|Overall Study|Other|1|||
23655490|NCT02003014|66125463|FG000|Overall Study|Case report forms uncollected|9|||
23655491|NCT02003014|66125463|FG000|Overall Study|Treatment started after contract period|1|||
23655492|NCT02003014|66125463|FG000|Overall Study|Patient did not visit the study site|5|||
23655493|NCT02003014|66125463|FG000|Overall Study|Investigator's transfer|4|||
23599988|NCT01964300|65925755|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
23599989|NCT01964300|65925754|FG000|Overall Study|Weight criteria not met|0|||
23599990|NCT01964300|65925755|FG001|Overall Study|Weight criteria not met|1|||
23599991|NCT00727909|65925759|FG000|Overall Study|Withdrawal by Subject|5|||
23599992|NCT00727909|65925760|FG001|Overall Study|Withdrawal by Subject|11|||
23599993|NCT00727909|65925761|FG002|Overall Study|Withdrawal by Subject|8|||
23599994|NCT00727909|65925762|FG003|Overall Study|Withdrawal by Subject|5|||
23599995|NCT00727909|65925759|FG000|Overall Study|Death|0|||
23599996|NCT00727909|65925760|FG001|Overall Study|Death|0|||
23599997|NCT00727909|65925761|FG002|Overall Study|Death|1|||
23599998|NCT00727909|65925762|FG003|Overall Study|Death|0|||
23599999|NCT02816398|65925765|FG000|Overall Study|Death|5|||
23600000|NCT02816398|65925765|FG000|Overall Study|Lack of Efficacy|8|||
23600001|NCT02816398|65925765|FG000|Overall Study|Lost to Follow-up|1|||
23600002|NCT03057600|65925770|FG000|Overall Study|Adverse Event|0|||
23600003|NCT03057600|65925771|FG001|Overall Study|Adverse Event|0|||
23600004|NCT03057600|65925772|FG002|Overall Study|Adverse Event|4|||
23600005|NCT03057600|65925773|FG003|Overall Study|Adverse Event|0|||
23600006|NCT03057600|65925770|FG000|Overall Study|Radiologic Disease Progression|8|||
23600007|NCT03057600|65925771|FG001|Overall Study|Radiologic Disease Progression|7|||
23600008|NCT03057600|65925772|FG002|Overall Study|Radiologic Disease Progression|13|||
23600009|NCT03057600|65925773|FG003|Overall Study|Radiologic Disease Progression|10|||
23600010|NCT03057600|65925770|FG000|Overall Study|Symptomatic Deterioration|0|||
23600011|NCT03057600|65925771|FG001|Overall Study|Symptomatic Deterioration|1|||
23600012|NCT03057600|65925772|FG002|Overall Study|Symptomatic Deterioration|1|||
23600013|NCT03057600|65925773|FG003|Overall Study|Symptomatic Deterioration|0|||
23600014|NCT03057600|65925770|FG000|Overall Study|Investigator Decision|0|||
23600015|NCT03057600|65925771|FG001|Overall Study|Investigator Decision|0|||
23600016|NCT03057600|65925772|FG002|Overall Study|Investigator Decision|1|||
23600017|NCT03057600|65925773|FG003|Overall Study|Investigator Decision|0|||
23600018|NCT03057600|65925770|FG000|Overall Study|Study Termination by Sponsor|0|||
23600019|NCT03057600|65925771|FG001|Overall Study|Study Termination by Sponsor|0|||
23600020|NCT03057600|65925772|FG002|Overall Study|Study Termination by Sponsor|0|||
23600021|NCT03057600|65925773|FG003|Overall Study|Study Termination by Sponsor|2|||
23600022|NCT03057600|65925770|FG000|Overall Study|Withdrawal by Subject|0|||
23600023|NCT03057600|65925771|FG001|Overall Study|Withdrawal by Subject|1|||
23600024|NCT03057600|65925772|FG002|Overall Study|Withdrawal by Subject|0|||
23600025|NCT03057600|65925773|FG003|Overall Study|Withdrawal by Subject|0|||
23600026|NCT03057600|65925770|FG000|Overall Study|Other, Not Specified|1|||
23600027|NCT03057600|65925771|FG001|Overall Study|Other, Not Specified|1|||
23600028|NCT03057600|65925772|FG002|Overall Study|Other, Not Specified|1|||
23600029|NCT03057600|65925773|FG003|Overall Study|Other, Not Specified|1|||
23600030|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
23600031|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
23600032|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
23600033|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
23600034|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
23600035|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
23600036|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
23655494|NCT01423812|66125465|FG000|Overall Study|Lost to Follow-up|2|||
23655495|NCT01423812|66125466|FG001|Overall Study|Lost to Follow-up|2|||
23655496|NCT01423812|66125465|FG000|Overall Study|Withdrawal by Subject|1|||
23655497|NCT01423812|66125466|FG001|Overall Study|Withdrawal by Subject|2|||
23655498|NCT02544217|66125469|FG000|Overall Study|Withdrawal by Subject|1|||
23655499|NCT02544217|66125470|FG001|Overall Study|Withdrawal by Subject|1|||
23600037|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
23600038|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
23600039|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
23600040|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
23804922|NCT04109313|66664794|FG000|Overall Study|Adverse Event|11|||
23804923|NCT04109313|66664794|FG000|Overall Study|Lack of Efficacy|11|||
23804924|NCT04109313|66664794|FG000|Overall Study|Lost to Follow-up|1|||
23804925|NCT04109313|66664794|FG000|Overall Study|Physician Decision|2|||
23804926|NCT04109313|66664794|FG000|Overall Study|Subject Decision|13|||
23804927|NCT04109313|66664794|FG000|Overall Study|Covid-19 situation|2|||
23804928|NCT02041091|66664795|FG000|Treatment|Adverse Event|3|||
23804929|NCT02041091|66664796|FG001|Treatment|Adverse Event|3|||
23804930|NCT02041091|66664795|FG000|Treatment|Withdrawal by Subject|2|||
23804931|NCT02041091|66664796|FG001|Treatment|Withdrawal by Subject|4|||
23804932|NCT02041091|66664795|FG000|Treatment|Physician Decision|1|||
23804933|NCT02041091|66664796|FG001|Treatment|Physician Decision|0|||
23804934|NCT02041091|66664795|FG000|Treatment|Sponsor Decision|15|||
23804935|NCT02041091|66664796|FG001|Treatment|Sponsor Decision|16|||
23804936|NCT02041091|66664795|FG000|Treatment|Lost to Follow-up|1|||
23804937|NCT02041091|66664796|FG001|Treatment|Lost to Follow-up|0|||
23804938|NCT02041091|66664795|FG000|Optional Safety Extension Period|Adverse Event|4|||
23804939|NCT02041091|66664796|FG001|Optional Safety Extension Period|Adverse Event|2|||
23804940|NCT02041091|66664795|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
23361106|NCT00410072|65065969|FG001|After Week 48 to Week 96|Death|1|||
23361107|NCT00410072|65065968|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
23361108|NCT00410072|65065969|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
23361109|NCT00410072|65065968|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
23361110|NCT00410072|65065969|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
23361111|NCT00410072|65065968|FG000|After Week 48 to Week 96|Other|2|||
23804941|NCT02041091|66664796|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
23804942|NCT02041091|66664795|FG000|Optional Safety Extension Period|Protocol Violation|2|||
23804943|NCT02041091|66664796|FG001|Optional Safety Extension Period|Protocol Violation|0|||
23804944|NCT02041091|66664795|FG000|Optional Safety Extension Period|Physician Decision|2|||
23804945|NCT02041091|66664796|FG001|Optional Safety Extension Period|Physician Decision|1|||
23804946|NCT02041091|66664795|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
23804947|NCT02041091|66664796|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
23804948|NCT02041091|66664795|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
23804949|NCT02041091|66664796|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
23804950|NCT02549573|66664799|FG000|Overall Study|Withdrawal by Subject|0|||
23804951|NCT02549573|66664800|FG001|Overall Study|Withdrawal by Subject|2|||
23804952|NCT02549573|66664799|FG000|Overall Study|Protocol Violation|0|||
23804953|NCT02549573|66664800|FG001|Overall Study|Protocol Violation|1|||
23804954|NCT01930175|66664801|FG000|Core Study|Lost to Follow-up|0|||
23804955|NCT01930175|66664802|FG001|Core Study|Lost to Follow-up|1|||
23804956|NCT01930175|66664803|FG002|Core Study|Lost to Follow-up|0|||
23804957|NCT01930175|66664801|FG000|Core Study|Adverse Event|0|||
23804958|NCT01930175|66664802|FG001|Core Study|Adverse Event|0|||
23804959|NCT01930175|66664803|FG002|Core Study|Adverse Event|1|||
23804960|NCT01408563|66664806|FG000|Overall Study|Ineligible after consent/ registration|2|||
23804961|NCT03346070|66664807|FG000|Overall Study|Death|0|||
23804962|NCT03346070|66664808|FG001|Overall Study|Death|0|||
23804963|NCT03346070|66664809|FG002|Overall Study|Death|0|||
23804964|NCT03346070|66664810|FG003|Overall Study|Death|0|||
23804965|NCT03346070|66664811|FG004|Overall Study|Death|1|||
23804966|NCT03346070|66664807|FG000|Overall Study|Lost to Follow-up|0|||
23804967|NCT03346070|66664808|FG001|Overall Study|Lost to Follow-up|1|||
23804968|NCT03346070|66664809|FG002|Overall Study|Lost to Follow-up|2|||
23804969|NCT03346070|66664810|FG003|Overall Study|Lost to Follow-up|0|||
23804970|NCT03346070|66664811|FG004|Overall Study|Lost to Follow-up|0|||
23804971|NCT03346070|66664807|FG000|Overall Study|Physician Decision|0|||
23804972|NCT03346070|66664808|FG001|Overall Study|Physician Decision|0|||
23804973|NCT03346070|66664809|FG002|Overall Study|Physician Decision|0|||
23804974|NCT03346070|66664810|FG003|Overall Study|Physician Decision|1|||
23804975|NCT03346070|66664811|FG004|Overall Study|Physician Decision|1|||
23804976|NCT03346070|66664807|FG000|Overall Study|Withdrawal by Subject|1|||
23804977|NCT03346070|66664808|FG001|Overall Study|Withdrawal by Subject|0|||
23804978|NCT03346070|66664809|FG002|Overall Study|Withdrawal by Subject|0|||
23804979|NCT03346070|66664810|FG003|Overall Study|Withdrawal by Subject|1|||
23804980|NCT03346070|66664811|FG004|Overall Study|Withdrawal by Subject|0|||
23804981|NCT03346070|66664807|FG000|Overall Study|Study medication not received as planned|2|||
23804982|NCT03346070|66664808|FG001|Overall Study|Study medication not received as planned|3|||
23804983|NCT03346070|66664809|FG002|Overall Study|Study medication not received as planned|2|||
23804984|NCT03346070|66664810|FG003|Overall Study|Study medication not received as planned|3|||
23804985|NCT03346070|66664811|FG004|Overall Study|Study medication not received as planned|2|||
23804986|NCT03346070|66664807|FG000|Overall Study|Screen Failure|0|||
23804987|NCT03346070|66664808|FG001|Overall Study|Screen Failure|0|||
23804988|NCT03346070|66664809|FG002|Overall Study|Screen Failure|0|||
23804989|NCT03346070|66664810|FG003|Overall Study|Screen Failure|1|||
23804990|NCT03346070|66664811|FG004|Overall Study|Screen Failure|1|||
23804991|NCT03180801|66664812|FG000|Overall Study|Physician Decision|3|||
23804992|NCT03180801|66664813|FG001|Overall Study|Physician Decision|3|||
23804993|NCT03180801|66664814|FG002|Overall Study|Physician Decision|1|||
23804994|NCT03180801|66664812|FG000|Overall Study|Non-compliance|1|||
23804995|NCT03180801|66664813|FG001|Overall Study|Non-compliance|4|||
23804996|NCT03180801|66664814|FG002|Overall Study|Non-compliance|0|||
23804997|NCT03180801|66664812|FG000|Overall Study|Inoculation Target Reached|1|||
23804998|NCT03180801|66664813|FG001|Overall Study|Inoculation Target Reached|1|||
23804999|NCT03180801|66664814|FG002|Overall Study|Inoculation Target Reached|3|||
23805000|NCT03180801|66664812|FG000|Overall Study|Adverse Event|1|||
23805001|NCT03180801|66664813|FG001|Overall Study|Adverse Event|0|||
23805002|NCT03180801|66664814|FG002|Overall Study|Adverse Event|2|||
23655500|NCT02544217|66125471|FG002|Overall Study|Withdrawal by Subject|0|||
23655501|NCT02544217|66125472|FG003|Overall Study|Withdrawal by Subject|0|||
23655502|NCT02544217|66125473|FG004|Overall Study|Withdrawal by Subject|0|||
23655503|NCT02544217|66125474|FG005|Overall Study|Withdrawal by Subject|0|||
23655504|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23655505|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23805003|NCT03180801|66664812|FG000|Overall Study|Withdrawal by Subject|2|||
23805004|NCT03180801|66664813|FG001|Overall Study|Withdrawal by Subject|2|||
23805005|NCT03180801|66664814|FG002|Overall Study|Withdrawal by Subject|1|||
23805006|NCT03180801|66664812|FG000|Overall Study|Lost to Follow-up|0|||
23805007|NCT03180801|66664813|FG001|Overall Study|Lost to Follow-up|2|||
23805008|NCT03180801|66664814|FG002|Overall Study|Lost to Follow-up|3|||
23805009|NCT02065713|66664815|FG000|Overall Study|Adverse Event|0|||
23805010|NCT02065713|66664816|FG001|Overall Study|Adverse Event|1|||
23805011|NCT02065713|66664815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23805012|NCT02065713|66664816|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23805013|NCT02692482|66664817|FG000|Overall Study|Death|2|||
23805014|NCT02692482|66664818|FG001|Overall Study|Death|2|||
23805015|NCT02692482|66664817|FG000|Overall Study|Withdrawal by Subject|1|||
23805016|NCT02692482|66664818|FG001|Overall Study|Withdrawal by Subject|2|||
23805017|NCT03351231|66664819|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
23805018|NCT03351231|66664819|FG000|Combination Therapy Period|Disease progression|2|||
23805019|NCT03351231|66664819|FG000|Combination Therapy Period|Study drug toxicity|1|||
23805020|NCT03351231|66664819|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
23805021|NCT03351231|66664819|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
23805022|NCT03351231|66664819|FG000|Safety Follow-Up Period|Other reason|2|||
23805023|NCT03438227|66664822|FG000|Overall Study|Withdrawal by Subject|10|||
23805024|NCT03438227|66664823|FG001|Overall Study|Withdrawal by Subject|5|||
23805025|NCT00608517|66664824|FG000|Overall Study|Death|1|||
23805026|NCT00608517|66664825|FG001|Overall Study|Death|0|||
23805027|NCT00608517|66664826|FG002|Overall Study|Death|0|||
23805028|NCT02080832|66664830|FG000|Overall Study|Excluded from analysis by MRI|9|||
23805029|NCT02080832|66664831|FG001|Overall Study|Excluded from analysis by MRI|10|||
23805030|NCT02080832|66664832|FG002|Overall Study|Excluded from analysis by MRI|14|||
23805031|NCT02080832|66664830|FG000|Overall Study|Lost to Follow-up|0|||
23805032|NCT02080832|66664831|FG001|Overall Study|Lost to Follow-up|2|||
23805033|NCT02080832|66664832|FG002|Overall Study|Lost to Follow-up|2|||
23805034|NCT01202877|66664833|FG000|Overall Study|Disease Progression|0|||
23805035|NCT01202877|66664834|FG001|Overall Study|Disease Progression|1|||
23805036|NCT01202877|66664835|FG002|Overall Study|Disease Progression|2|||
23805037|NCT01202877|66664833|FG000|Overall Study|Adverse Event|0|||
23805038|NCT01202877|66664834|FG001|Overall Study|Adverse Event|0|||
23805039|NCT01202877|66664835|FG002|Overall Study|Adverse Event|2|||
23805040|NCT01202877|66664833|FG000|Overall Study|Withdrawal by Subject|0|||
23805041|NCT01202877|66664834|FG001|Overall Study|Withdrawal by Subject|0|||
23805042|NCT01202877|66664835|FG002|Overall Study|Withdrawal by Subject|1|||
23805043|NCT01202877|66664833|FG000|Overall Study|Death|0|||
23805044|NCT01202877|66664834|FG001|Overall Study|Death|0|||
23805045|NCT01202877|66664835|FG002|Overall Study|Death|1|||
23805046|NCT03097588|66664836|FG000|Overall Study|Adverse Event|1|||
23805047|NCT00292188|66664837|FG000|Single-Blind|Adverse Event|14|||
23805048|NCT00292188|66664838|FG001|Single-Blind|Adverse Event|0|||
23805049|NCT00292188|66664839|FG002|Single-Blind|Adverse Event|0|||
23805050|NCT00292188|66664837|FG000|Single-Blind|Lack of Efficacy|2|||
23805051|NCT00292188|66664838|FG001|Single-Blind|Lack of Efficacy|0|||
23805052|NCT00292188|66664839|FG002|Single-Blind|Lack of Efficacy|0|||
23805053|NCT00292188|66664837|FG000|Single-Blind|Laboratory Abnormality|5|||
23805054|NCT00292188|66664838|FG001|Single-Blind|Laboratory Abnormality|0|||
23805055|NCT00292188|66664839|FG002|Single-Blind|Laboratory Abnormality|0|||
23805056|NCT00292188|66664837|FG000|Single-Blind|Lost to Follow-up|3|||
23805057|NCT00292188|66664838|FG001|Single-Blind|Lost to Follow-up|0|||
23805058|NCT00292188|66664839|FG002|Single-Blind|Lost to Follow-up|0|||
23805059|NCT00292188|66664837|FG000|Single-Blind|Other|77|||
23805060|NCT00292188|66664838|FG001|Single-Blind|Other|0|||
23805061|NCT00292188|66664839|FG002|Single-Blind|Other|0|||
23805062|NCT00292188|66664837|FG000|Single-Blind|Withdrawal by Subject|12|||
23805063|NCT00292188|66664838|FG001|Single-Blind|Withdrawal by Subject|0|||
23805064|NCT00292188|66664839|FG002|Single-Blind|Withdrawal by Subject|0|||
23805065|NCT00292188|66664837|FG000|Single-Blind|Did not receive treatment|1|||
23655506|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
23805066|NCT00292188|66664838|FG001|Single-Blind|Did not receive treatment|0|||
23805067|NCT00292188|66664839|FG002|Single-Blind|Did not receive treatment|0|||
23805068|NCT00292188|66664837|FG000|Double-Blind|Adverse Event|0|||
23805069|NCT00292188|66664838|FG001|Double-Blind|Adverse Event|25|||
23805070|NCT00292188|66664839|FG002|Double-Blind|Adverse Event|9|||
23805071|NCT00292188|66664837|FG000|Double-Blind|Lack of Efficacy|0|||
23805072|NCT00292188|66664838|FG001|Double-Blind|Lack of Efficacy|2|||
23480356|NCT01330017|65501957|FG003|Overall Study|Withdrawal by Subject|0|||
23655507|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23480357|NCT01330017|65501958|FG004|Overall Study|Withdrawal by Subject|1|||
23655508|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
23655509|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
23655510|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
23655511|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
23655512|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
23655513|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
23655514|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
23655515|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
23655516|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
23655517|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
23655518|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
23655519|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
23655520|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
23655521|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
23805073|NCT00292188|66664839|FG002|Double-Blind|Lack of Efficacy|12|||
23805074|NCT00292188|66664837|FG000|Double-Blind|Lost to Follow-up|0|||
23805075|NCT00292188|66664838|FG001|Double-Blind|Lost to Follow-up|1|||
23805076|NCT00292188|66664839|FG002|Double-Blind|Lost to Follow-up|0|||
23805077|NCT00292188|66664837|FG000|Double-Blind|Other|0|||
23805078|NCT00292188|66664838|FG001|Double-Blind|Other|3|||
23805079|NCT00292188|66664839|FG002|Double-Blind|Other|4|||
23805080|NCT00292188|66664837|FG000|Double-Blind|Withdrawal by Subject|0|||
23805081|NCT00292188|66664838|FG001|Double-Blind|Withdrawal by Subject|0|||
23805082|NCT00292188|66664839|FG002|Double-Blind|Withdrawal by Subject|3|||
23805083|NCT00292188|66664837|FG000|Double-Blind|Laboratory Abnormality|0|||
23805084|NCT00292188|66664838|FG001|Double-Blind|Laboratory Abnormality|0|||
23805085|NCT00292188|66664839|FG002|Double-Blind|Laboratory Abnormality|1|||
23805086|NCT00103038|66664840|FG000|Overall Study|Withdrawal by Subject|8|||
23805087|NCT00103038|66664840|FG000|Overall Study|Screen failure|3|||
23805088|NCT00103038|66664840|FG000|Overall Study|Death|1|||
23805089|NCT00103038|66664840|FG000|Overall Study|Physician Decision|1|||
23805090|NCT03465436|66664841|FG000|Period 1|Protocol Violation|0|||
23805091|NCT03465436|66664842|FG001|Period 1|Protocol Violation|0|||
23805092|NCT03465436|66664843|FG002|Period 1|Protocol Violation|1|||
23805093|NCT03465436|66664844|FG003|Period 1|Protocol Violation|0|||
23805094|NCT03465436|66664841|FG000|Period 2|Protocol Violation|0|||
23805095|NCT03465436|66664842|FG001|Period 2|Protocol Violation|1|||
23805096|NCT03465436|66664843|FG002|Period 2|Protocol Violation|0|||
23805097|NCT03465436|66664844|FG003|Period 2|Protocol Violation|0|||
23805098|NCT03465436|66664841|FG000|Period 3|Protocol Violation|1|||
23805099|NCT03465436|66664842|FG001|Period 3|Protocol Violation|1|||
23805100|NCT03465436|66664843|FG002|Period 3|Protocol Violation|0|||
23805101|NCT03465436|66664844|FG003|Period 3|Protocol Violation|0|||
23805102|NCT03465436|66664841|FG000|Period 4|Protocol Violation|0|||
23805103|NCT03465436|66664842|FG001|Period 4|Protocol Violation|0|||
23805104|NCT03465436|66664843|FG002|Period 4|Protocol Violation|1|||
23805105|NCT03465436|66664844|FG003|Period 4|Protocol Violation|0|||
23805106|NCT01435031|66664849|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
23805107|NCT01435031|66664849|FG000|ITT at 1 Month|Death|1|||
23655522|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
23655523|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
23655524|NCT01641809|66125481|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
23655525|NCT01641809|66125482|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
23655526|NCT01641809|66125483|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
23655527|NCT01641809|66125484|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
23655528|NCT01641809|66125481|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
23655529|NCT01641809|66125482|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
23655530|NCT01641809|66125483|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
23655531|NCT01641809|66125484|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
23655532|NCT01641809|66125481|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23655533|NCT01641809|66125482|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
23655534|NCT01641809|66125483|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23655535|NCT01641809|66125484|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23655536|NCT01641809|66125481|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
23655537|NCT01641809|66125482|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
23655538|NCT01641809|66125483|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
23655539|NCT01641809|66125484|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
23655540|NCT01641809|66125481|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
23655541|NCT01641809|66125482|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
23655542|NCT01641809|66125483|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
23655543|NCT01641809|66125484|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
23655544|NCT01641809|66125481|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
23361112|NCT00410072|65065969|FG001|After Week 48 to Week 96|Other|0|||
23655545|NCT01641809|66125482|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
23655546|NCT01641809|66125483|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
23655547|NCT01641809|66125484|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
23655548|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
23655549|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
23655550|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
23655551|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
23655552|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
23655553|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
23655554|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
23655555|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
23655556|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
23655557|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
23655558|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
23655559|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
23655560|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
23655561|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
23655562|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
23655563|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
23655564|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
23655565|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
23655566|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
23805108|NCT01435031|66664849|FG000|ITT at 1 Month|Lost to Follow-up|4|||
23805109|NCT01435031|66664849|FG000|ITT at 6 Months|Death|2|||
23805110|NCT01435031|66664849|FG000|ITT at 6 Months|Lost to Follow-up|3|||
23805111|NCT01435031|66664849|FG000|ITT at 1 Year|Death|1|||
23805112|NCT01435031|66664849|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
23805113|NCT01435031|66664849|FG000|ITT at 1 Year|Lost to Follow-up|6|||
23805114|NCT01435031|66664849|FG000|ITT at 2 Years|Death|7|||
23805115|NCT01435031|66664849|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
23805116|NCT01435031|66664849|FG000|ITT at 2 Years|Lost to Follow-up|4|||
23805117|NCT01435031|66664849|FG000|ITT at 3 Years|Death|5|||
23805118|NCT01435031|66664849|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
23805119|NCT01435031|66664849|FG000|ITT at 3 Years|Lost to Follow-up|4|||
23805120|NCT01435031|66664849|FG000|ITT at 4 Years|Death|4|||
23805121|NCT01435031|66664849|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
23805122|NCT01435031|66664849|FG000|ITT at 4 Years|Lost to Follow-up|1|||
23805123|NCT00355472|66664850|FG000|Overall Study|Physician Decision|1|||
23805124|NCT00804141|66664851|FG000|Overall Study|Adverse Event|157|||
23655567|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
23655568|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
23805125|NCT00804141|66664851|FG000|Overall Study|Death|4|||
23805126|NCT00804141|66664851|FG000|Overall Study|Failed to return|96|||
23805127|NCT00804141|66664851|FG000|Overall Study|Investigator request|8|||
23805128|NCT00804141|66664851|FG000|Overall Study|Protocol Violation|85|||
23805129|NCT00804141|66664851|FG000|Overall Study|Withdrawal by Subject|131|||
23655569|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
23655570|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
23655571|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
23655572|NCT01641809|66125481|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
23655573|NCT01641809|66125482|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
23655574|NCT01641809|66125483|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
23655575|NCT01641809|66125484|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
23655576|NCT01009554|66125485|FG000|Overall Study|Adverse Event|1|||
23655577|NCT01009554|66125486|FG001|Overall Study|Adverse Event|1|||
23655578|NCT01009554|66125485|FG000|Overall Study|Withdrawal by Subject|1|||
23655579|NCT01009554|66125486|FG001|Overall Study|Withdrawal by Subject|3|||
23655580|NCT01009554|66125485|FG000|Overall Study|Noncompliant with Study Product|0|||
23655581|NCT01009554|66125486|FG001|Overall Study|Noncompliant with Study Product|3|||
23655582|NCT00954421|66125491|FG000|Screening|screen failures|3|||
23655583|NCT00954421|66125491|FG000|6 Months of DBS|Withdrawal by Subject|1|||
23655584|NCT00954421|66125491|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
23655585|NCT02456662|66125494|FG000|Overall Study|Lost to Follow-up|2|||
23655586|NCT02456662|66125495|FG001|Overall Study|Lost to Follow-up|1|||
23655587|NCT01672788|66125496|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
23655588|NCT01672788|66125497|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
23655589|NCT01672788|66125498|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
23655590|NCT01672788|66125499|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
23655591|NCT01431534|66125500|FG000|Treatment Phase|Adverse Event|0|||
23655592|NCT01431534|66125501|FG001|Treatment Phase|Adverse Event|0|||
23655593|NCT01431534|66125502|FG002|Treatment Phase|Adverse Event|1|||
23655594|NCT01431534|66125500|FG000|Treatment Phase|Progressive Disease|4|||
23655595|NCT01431534|66125501|FG001|Treatment Phase|Progressive Disease|3|||
23655596|NCT01431534|66125502|FG002|Treatment Phase|Progressive Disease|10|||
23655597|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
23655598|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
23655599|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
23655600|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
23655601|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
23655602|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
23655603|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
23655604|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
23655605|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
23655606|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
23655607|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
23361113|NCT00410072|65065968|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
23361114|NCT00410072|65065969|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
23361115|NCT00410072|65065968|FG000|After Week 48 to Week 96|Pregnancy|0|||
23361116|NCT00410072|65065969|FG001|After Week 48 to Week 96|Pregnancy|2|||
23655608|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
23655609|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Death|3|||
23655610|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Death|1|||
23655611|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
23655612|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
23655613|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Adverse Event|7|||
23655614|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Adverse Event|8|||
23655615|NCT03236246|66125503|FG000|24-Week Dose Titration Period|Captured as Other|1|||
23655616|NCT03236246|66125504|FG001|24-Week Dose Titration Period|Captured as Other|2|||
23655617|NCT03236246|66125503|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
23655618|NCT03236246|66125504|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
23655619|NCT03236246|66125503|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
23655620|NCT03236246|66125504|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
23655621|NCT03236246|66125503|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
23655622|NCT03236246|66125504|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
23655623|NCT03236246|66125503|FG000|24-Week Dose Maintenance Period|Death|0|||
23805130|NCT00804141|66664851|FG000|Overall Study|Lack of Efficacy|46|||
23805131|NCT00804141|66664851|FG000|Overall Study|Other than specified|30|||
23805132|NCT00804141|66664851|FG000|Overall Study|Enrolled but not treated|6|||
23805133|NCT01360866|66664852|FG000|Overall Study|Lost to Follow-up|11|||
23805134|NCT01360866|66664853|FG001|Overall Study|Lost to Follow-up|28|||
23361117|NCT00410072|65065968|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
23361118|NCT00410072|65065969|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
23361119|NCT02105285|65065970|FG000|Overall Study|Adverse Event|1|||
23361120|NCT02105285|65065971|FG001|Overall Study|Adverse Event|1|||
23361121|NCT02105285|65065972|FG002|Overall Study|Adverse Event|0|||
23805135|NCT01360866|66664854|FG002|Overall Study|Lost to Follow-up|41|||
23805136|NCT01360866|66664855|FG003|Overall Study|Lost to Follow-up|0|||
23805137|NCT01360866|66664852|FG000|Overall Study|Adverse Event|56|||
23655624|NCT03236246|66125504|FG001|24-Week Dose Maintenance Period|Death|1|||
23655625|NCT03236246|66125503|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
23655626|NCT03236246|66125504|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
23805138|NCT01360866|66664853|FG001|Overall Study|Adverse Event|61|||
23805139|NCT01360866|66664854|FG002|Overall Study|Adverse Event|134|||
23361122|NCT02105285|65065970|FG000|Overall Study|Protocol Violation|0|||
23361123|NCT02105285|65065971|FG001|Overall Study|Protocol Violation|1|||
23361124|NCT02105285|65065972|FG002|Overall Study|Protocol Violation|0|||
23655627|NCT01290601|66125506|FG000|Overall Study|Adverse Event|0|||
23655628|NCT01290601|66125507|FG001|Overall Study|Adverse Event|2|||
23655629|NCT01290601|66125508|FG002|Overall Study|Adverse Event|0|||
23655630|NCT01290601|66125509|FG003|Overall Study|Adverse Event|0|||
23655631|NCT01290601|66125506|FG000|Overall Study|Lack of Efficacy|2|||
23655632|NCT01290601|66125507|FG001|Overall Study|Lack of Efficacy|1|||
23655633|NCT01290601|66125508|FG002|Overall Study|Lack of Efficacy|0|||
23655634|NCT01290601|66125509|FG003|Overall Study|Lack of Efficacy|0|||
23805140|NCT01360866|66664855|FG003|Overall Study|Adverse Event|6|||
23805141|NCT01360866|66664852|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
23805142|NCT01360866|66664853|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
23805143|NCT01360866|66664854|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
23805144|NCT01360866|66664855|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
23805145|NCT01360866|66664852|FG000|Overall Study|Withdrawn by Investigator|9|||
23805146|NCT01360866|66664853|FG001|Overall Study|Withdrawn by Investigator|8|||
23805147|NCT01360866|66664854|FG002|Overall Study|Withdrawn by Investigator|31|||
23805148|NCT01360866|66664855|FG003|Overall Study|Withdrawn by Investigator|2|||
23805149|NCT01360866|66664852|FG000|Overall Study|Withdrawal by participant|79|||
23361125|NCT02105285|65065970|FG000|Overall Study|Withdrawal by Subject|1|||
23480358|NCT01330017|65501954|FG000|Overall Study|Lost to Follow-up|0|||
23805150|NCT01360866|66664853|FG001|Overall Study|Withdrawal by participant|89|||
23805151|NCT01360866|66664854|FG002|Overall Study|Withdrawal by participant|168|||
23805152|NCT01360866|66664855|FG003|Overall Study|Withdrawal by participant|8|||
23805153|NCT01360866|66664852|FG000|Overall Study|Protocol Deviation|25|||
23805154|NCT01360866|66664853|FG001|Overall Study|Protocol Deviation|33|||
23361126|NCT02105285|65065971|FG001|Overall Study|Withdrawal by Subject|0|||
23805155|NCT01360866|66664854|FG002|Overall Study|Protocol Deviation|61|||
23805156|NCT01360866|66664855|FG003|Overall Study|Protocol Deviation|2|||
23805157|NCT01360866|66664852|FG000|Overall Study|Lack of Efficacy|30|||
23805158|NCT01360866|66664853|FG001|Overall Study|Lack of Efficacy|40|||
23805159|NCT01360866|66664854|FG002|Overall Study|Lack of Efficacy|30|||
23805160|NCT01360866|66664855|FG003|Overall Study|Lack of Efficacy|4|||
23805161|NCT00317642|66664867|FG000|Overall Study|Not Received Either Study Drug|1|||
23805162|NCT00317642|66664868|FG001|Overall Study|Not Received Either Study Drug|3|||
23805163|NCT00317642|66664867|FG000|Overall Study|Physician Decision|15|||
23805164|NCT00317642|66664868|FG001|Overall Study|Physician Decision|7|||
23805165|NCT00317642|66664867|FG000|Overall Study|Participant declined treatment|14|||
23805166|NCT00317642|66664868|FG001|Overall Study|Participant declined treatment|3|||
23805167|NCT00317642|66664867|FG000|Overall Study|Adverse Event|17|||
23805168|NCT00317642|66664868|FG001|Overall Study|Adverse Event|5|||
23805169|NCT00317642|66664867|FG000|Overall Study|Treatment Failure|56|||
23805170|NCT00317642|66664868|FG001|Overall Study|Treatment Failure|102|||
23805171|NCT00317642|66664867|FG000|Overall Study|Disease Recurrence|1|||
23805172|NCT00317642|66664868|FG001|Overall Study|Disease Recurrence|2|||
23805173|NCT00317642|66664867|FG000|Overall Study|Death|14|||
23805174|NCT00317642|66664868|FG001|Overall Study|Death|7|||
23805175|NCT00317642|66664867|FG000|Overall Study|Not Continue to Consolidation|2|||
23805176|NCT00317642|66664868|FG001|Overall Study|Not Continue to Consolidation|0|||
23805177|NCT00317642|66664867|FG000|Overall Study|Withdrawal by Subject|0|||
23805178|NCT00317642|66664868|FG001|Overall Study|Withdrawal by Subject|1|||
23805179|NCT00317642|66664867|FG000|Overall Study|Referred For Transplantation|1|||
23805180|NCT00317642|66664868|FG001|Overall Study|Referred For Transplantation|0|||
23805181|NCT00317642|66664867|FG000|Overall Study|AML Not Centrally Confirmed|1|||
23805182|NCT00317642|66664868|FG001|Overall Study|AML Not Centrally Confirmed|5|||
23805183|NCT03438539|66664869|FG000|Overall Study|Lost to Follow-up|8|||
23805184|NCT03438539|66664870|FG001|Overall Study|Lost to Follow-up|4|||
23805185|NCT03438539|66664871|FG002|Overall Study|Lost to Follow-up|10|||
23805186|NCT03438539|66664872|FG003|Overall Study|Lost to Follow-up|9|||
23805187|NCT03438539|66664873|FG004|Overall Study|Lost to Follow-up|3|||
23805188|NCT03438539|66664874|FG005|Overall Study|Lost to Follow-up|8|||
23805189|NCT01846273|66664875|FG000|Overall Study|Adverse Event|9|||
23805190|NCT01846273|66664876|FG001|Overall Study|Adverse Event|7|||
23805191|NCT01846273|66664877|FG002|Overall Study|Adverse Event|0|||
23805192|NCT01846273|66664875|FG000|Overall Study|Subject withdrew consent|5|||
23805193|NCT01846273|66664876|FG001|Overall Study|Subject withdrew consent|8|||
23805194|NCT01846273|66664877|FG002|Overall Study|Subject withdrew consent|0|||
23805195|NCT01846273|66664875|FG000|Overall Study|Lost to Follow-up|2|||
23805196|NCT01846273|66664876|FG001|Overall Study|Lost to Follow-up|1|||
23805197|NCT01846273|66664877|FG002|Overall Study|Lost to Follow-up|0|||
23805198|NCT01846273|66664875|FG000|Overall Study|Administrative problems|1|||
23805199|NCT01846273|66664876|FG001|Overall Study|Administrative problems|0|||
23805200|NCT01846273|66664877|FG002|Overall Study|Administrative problems|0|||
23805201|NCT01846273|66664875|FG000|Overall Study|Death|2|||
23805202|NCT01846273|66664876|FG001|Overall Study|Death|1|||
23805203|NCT01846273|66664877|FG002|Overall Study|Death|0|||
23805204|NCT01846273|66664875|FG000|Overall Study|Disease Progression|0|||
23805205|NCT01846273|66664876|FG001|Overall Study|Disease Progression|4|||
23805206|NCT01846273|66664877|FG002|Overall Study|Disease Progression|0|||
23805207|NCT01846273|66664875|FG000|Overall Study|Protocol Deviation|2|||
23805208|NCT01846273|66664876|FG001|Overall Study|Protocol Deviation|3|||
23805209|NCT01846273|66664877|FG002|Overall Study|Protocol Deviation|0|||
23805210|NCT01846273|66664875|FG000|Overall Study|Physician Decision|1|||
23805211|NCT01846273|66664876|FG001|Overall Study|Physician Decision|2|||
23805212|NCT01846273|66664877|FG002|Overall Study|Physician Decision|0|||
23805213|NCT00724373|66664880|FG000|Overall Study|Adverse Event|41|||
23805214|NCT00724373|66664880|FG000|Overall Study|Lack of Efficacy|82|||
23361127|NCT02105285|65065972|FG002|Overall Study|Withdrawal by Subject|0|||
23361128|NCT02532283|65065973|FG000|Overall Study|Adverse Event|0|||
23361129|NCT02532283|65065974|FG001|Overall Study|Adverse Event|1|||
23600041|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
23600042|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
23600043|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
23600044|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
23600045|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
23600046|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
23600047|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
23600048|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
23805215|NCT00724373|66664880|FG000|Overall Study|Lost to Follow-up|7|||
23805216|NCT00724373|66664880|FG000|Overall Study|Non-compliance|2|||
23805217|NCT00724373|66664880|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
23805218|NCT00724373|66664880|FG000|Overall Study|Participant moved away|1|||
23805219|NCT00724373|66664880|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
23805220|NCT00724373|66664880|FG000|Overall Study|Only to have 24 week regimen|1|||
23805221|NCT00724373|66664880|FG000|Overall Study|Viral Relapse|1|||
23805222|NCT00724373|66664880|FG000|Overall Study|Acute HCV infection|1|||
23805223|NCT00724373|66664880|FG000|Overall Study|Drug Relapse|1|||
23805224|NCT00724373|66664880|FG000|Overall Study|Tolerability|23|||
23805225|NCT01020799|66664881|FG000|Overall Study|Adverse Event|4|||
23805226|NCT01020799|66664882|FG001|Overall Study|Adverse Event|3|||
23805227|NCT01020799|66664883|FG002|Overall Study|Adverse Event|2|||
23805228|NCT01020799|66664881|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
23805229|NCT01020799|66664882|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
23805230|NCT01020799|66664883|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
23805231|NCT01020799|66664881|FG000|Overall Study|Protocol Violation|3|||
23805232|NCT01020799|66664882|FG001|Overall Study|Protocol Violation|2|||
23805233|NCT01020799|66664883|FG002|Overall Study|Protocol Violation|0|||
23805234|NCT01020799|66664881|FG000|Overall Study|Withdrawal by Subject|2|||
23805235|NCT01020799|66664882|FG001|Overall Study|Withdrawal by Subject|2|||
23805236|NCT01020799|66664883|FG002|Overall Study|Withdrawal by Subject|3|||
23805237|NCT01020799|66664881|FG000|Overall Study|Lost to Follow-up|6|||
23805238|NCT01020799|66664882|FG001|Overall Study|Lost to Follow-up|4|||
23805239|NCT01020799|66664883|FG002|Overall Study|Lost to Follow-up|2|||
23805240|NCT00059787|66664890|FG000|Overall Study|Adverse Event|13|||
23805241|NCT00059787|66664890|FG000|Overall Study|disease progression|2|||
23805242|NCT00059787|66664890|FG000|Overall Study|ineligible|1|||
23805243|NCT00059787|66664890|FG000|Overall Study|Other|4|||
23805244|NCT01157897|66664891|FG000|Overall Study|Lost to Follow-up|2|||
23805245|NCT01157897|66664892|FG001|Overall Study|Lost to Follow-up|0|||
23805246|NCT01157897|66664893|FG002|Overall Study|Lost to Follow-up|0|||
23805247|NCT01157897|66664894|FG003|Overall Study|Lost to Follow-up|1|||
23805248|NCT01157897|66664891|FG000|Overall Study|Relocated|0|||
23805249|NCT01157897|66664892|FG001|Overall Study|Relocated|2|||
23805250|NCT01157897|66664893|FG002|Overall Study|Relocated|0|||
23805251|NCT01157897|66664894|FG003|Overall Study|Relocated|0|||
23805252|NCT01475253|66664895|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
23805253|NCT01475253|66664896|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
23805254|NCT01475253|66664897|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
23805255|NCT01475253|66664898|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
23805256|NCT01475253|66664895|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
23805257|NCT01475253|66664896|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
23805258|NCT01475253|66664897|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
23805259|NCT01475253|66664898|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
23805260|NCT02522403|66664903|FG000|Overall Study|Lost to Follow-up|2|||
23805261|NCT02522403|66664904|FG001|Overall Study|Lost to Follow-up|2|||
23805262|NCT02522403|66664903|FG000|Overall Study|Withdrawal by Subject|2|||
23805263|NCT02522403|66664904|FG001|Overall Study|Withdrawal by Subject|4|||
23805264|NCT01506908|66664905|FG000|Overall Study|Adverse Event|1|||
23805265|NCT01506908|66664906|FG001|Overall Study|Adverse Event|0|||
23805266|NCT02792959|66664907|FG000|Overall Study|Protocol Violation|1|||
23805267|NCT03812991|66664908|FG000|Overall Study|Lost to Follow-up|3|||
23805268|NCT03812991|66664909|FG001|Overall Study|Lost to Follow-up|1|||
23805269|NCT01382251|66664914|FG000|Overall Study|Surgeries cancelled or delayed|16|||
23805270|NCT01382251|66664915|FG001|Overall Study|Surgeries cancelled or delayed|16|||
23600049|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
23361130|NCT02532283|65065973|FG000|Overall Study|Death|1|||
23805271|NCT01382251|66664914|FG000|Overall Study|Lost to Follow-up|4|||
23805272|NCT01382251|66664915|FG001|Overall Study|Lost to Follow-up|4|||
23805273|NCT01382251|66664914|FG000|Overall Study|Contacted after study closed|1|||
23805274|NCT01382251|66664915|FG001|Overall Study|Contacted after study closed|1|||
23805275|NCT00958126|66664918|FG000|Overall Study|Serious Adverse Event|0|||
23805276|NCT00958126|66664919|FG001|Overall Study|Serious Adverse Event|2|||
23361131|NCT02532283|65065974|FG001|Overall Study|Death|0|||
23361132|NCT02532283|65065973|FG000|Overall Study|Lost to Follow-up|0|||
23361133|NCT02532283|65065974|FG001|Overall Study|Lost to Follow-up|1|||
23361134|NCT02532283|65065973|FG000|Overall Study|Withdrawal by Subject|8|||
23361135|NCT02532283|65065974|FG001|Overall Study|Withdrawal by Subject|3|||
23655635|NCT01290601|66125506|FG000|Overall Study|Lost to Follow-up|7|||
23655636|NCT01290601|66125507|FG001|Overall Study|Lost to Follow-up|2|||
23361136|NCT02532257|65065975|FG000|Overall Study|Adverse Event|2|||
23361137|NCT02532257|65065975|FG000|Overall Study|Physician Decision|4|||
23805277|NCT00958126|66664920|FG002|Overall Study|Serious Adverse Event|0|||
23805278|NCT00958126|66664921|FG003|Overall Study|Serious Adverse Event|0|||
23805279|NCT00958126|66664922|FG004|Overall Study|Serious Adverse Event|0|||
23805280|NCT00958126|66664923|FG005|Overall Study|Serious Adverse Event|0|||
23805281|NCT00958126|66664924|FG006|Overall Study|Serious Adverse Event|1|||
23805282|NCT00958126|66664925|FG007|Overall Study|Serious Adverse Event|0|||
23805283|NCT00958126|66664918|FG000|Overall Study|Withdrawal by Subject|0|||
23805284|NCT00958126|66664919|FG001|Overall Study|Withdrawal by Subject|2|||
23805285|NCT00958126|66664920|FG002|Overall Study|Withdrawal by Subject|0|||
23805286|NCT00958126|66664921|FG003|Overall Study|Withdrawal by Subject|0|||
23805287|NCT00958126|66664922|FG004|Overall Study|Withdrawal by Subject|0|||
23805288|NCT00958126|66664923|FG005|Overall Study|Withdrawal by Subject|0|||
23805289|NCT00958126|66664924|FG006|Overall Study|Withdrawal by Subject|0|||
23805290|NCT00958126|66664925|FG007|Overall Study|Withdrawal by Subject|0|||
23805291|NCT00958126|66664918|FG000|Overall Study|Moved away from study area|0|||
23805292|NCT00958126|66664919|FG001|Overall Study|Moved away from study area|0|||
23805293|NCT00958126|66664920|FG002|Overall Study|Moved away from study area|1|||
23805294|NCT00958126|66664921|FG003|Overall Study|Moved away from study area|1|||
23805295|NCT00958126|66664922|FG004|Overall Study|Moved away from study area|0|||
23805296|NCT00958126|66664923|FG005|Overall Study|Moved away from study area|0|||
23805297|NCT00958126|66664924|FG006|Overall Study|Moved away from study area|0|||
23805298|NCT00958126|66664925|FG007|Overall Study|Moved away from study area|0|||
23805299|NCT00958126|66664918|FG000|Overall Study|Lost to Follow-up|1|||
23805300|NCT00958126|66664919|FG001|Overall Study|Lost to Follow-up|5|||
23805301|NCT00958126|66664920|FG002|Overall Study|Lost to Follow-up|9|||
23805302|NCT00958126|66664921|FG003|Overall Study|Lost to Follow-up|8|||
23805303|NCT00958126|66664922|FG004|Overall Study|Lost to Follow-up|0|||
23805304|NCT00958126|66664923|FG005|Overall Study|Lost to Follow-up|0|||
23805305|NCT00958126|66664924|FG006|Overall Study|Lost to Follow-up|0|||
23805306|NCT00958126|66664925|FG007|Overall Study|Lost to Follow-up|0|||
23805307|NCT00958126|66664918|FG000|Overall Study|Sponsor/Investigator decision|0|||
23805308|NCT00958126|66664919|FG001|Overall Study|Sponsor/Investigator decision|0|||
23805309|NCT00958126|66664920|FG002|Overall Study|Sponsor/Investigator decision|0|||
23805310|NCT00958126|66664921|FG003|Overall Study|Sponsor/Investigator decision|1|||
23805311|NCT00958126|66664922|FG004|Overall Study|Sponsor/Investigator decision|0|||
23805312|NCT00958126|66664923|FG005|Overall Study|Sponsor/Investigator decision|0|||
23805313|NCT00958126|66664924|FG006|Overall Study|Sponsor/Investigator decision|0|||
23805314|NCT00958126|66664925|FG007|Overall Study|Sponsor/Investigator decision|0|||
23805315|NCT00958126|66664918|FG000|Overall Study|Other Reason|0|||
23805316|NCT00958126|66664919|FG001|Overall Study|Other Reason|0|||
23805317|NCT00958126|66664920|FG002|Overall Study|Other Reason|0|||
23805318|NCT00958126|66664921|FG003|Overall Study|Other Reason|1|||
23805319|NCT00958126|66664922|FG004|Overall Study|Other Reason|0|||
23805320|NCT00958126|66664923|FG005|Overall Study|Other Reason|1|||
23805321|NCT00958126|66664924|FG006|Overall Study|Other Reason|0|||
23805322|NCT00958126|66664925|FG007|Overall Study|Other Reason|0|||
23805323|NCT03510182|66664926|FG000|Overall Study|Withdrawal by Subject|2|||
23805324|NCT03656874|66664930|FG000|Overall Study|Lost to Follow-up|3|||
23805325|NCT03656874|66664931|FG001|Overall Study|Lost to Follow-up|17|||
23805326|NCT02903238|66664934|FG000|Overall Study|Lost to Follow-up|4|||
23805327|NCT03977701|66664935|FG000|Overall Study|COVID-19 pandemic|0|||
23805328|NCT03977701|66664936|FG001|Overall Study|COVID-19 pandemic|0|||
23805329|NCT03977701|66664937|FG002|Overall Study|COVID-19 pandemic|0|||
23805330|NCT03977701|66664938|FG003|Overall Study|COVID-19 pandemic|0|||
23805331|NCT03977701|66664939|FG004|Overall Study|COVID-19 pandemic|0|||
23480359|NCT01330017|65501955|FG001|Overall Study|Lost to Follow-up|0|||
23805332|NCT03977701|66664940|FG005|Overall Study|COVID-19 pandemic|1|||
23805333|NCT03977701|66664941|FG006|Overall Study|COVID-19 pandemic|0|||
23805334|NCT03977701|66664942|FG007|Overall Study|COVID-19 pandemic|1|||
23805335|NCT03977701|66664943|FG008|Overall Study|COVID-19 pandemic|0|||
23805336|NCT03977701|66664944|FG009|Overall Study|COVID-19 pandemic|0|||
23805337|NCT02668822|66664946|FG000|Overall Study|Protocol Violation|2|||
23805338|NCT02668822|66664947|FG001|Overall Study|Protocol Violation|0|||
23805339|NCT02668822|66664946|FG000|Overall Study|Study Terminated by Sponsor|7|||
23805340|NCT02668822|66664947|FG001|Overall Study|Study Terminated by Sponsor|9|||
23805341|NCT02129647|66664948|FG000|Overall Study|Adverse Event|2|||
23805342|NCT02129647|66664948|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
23805343|NCT02072824|66664957|FG000|Overall Study|Insufficient clinical response|1|||
23655637|NCT01290601|66125508|FG002|Overall Study|Lost to Follow-up|0|||
23655638|NCT01290601|66125509|FG003|Overall Study|Lost to Follow-up|0|||
23655639|NCT01290601|66125506|FG000|Overall Study|Other|1|||
23655640|NCT01290601|66125507|FG001|Overall Study|Other|0|||
23655641|NCT01290601|66125508|FG002|Overall Study|Other|0|||
23655642|NCT01290601|66125509|FG003|Overall Study|Other|0|||
23655643|NCT01290601|66125506|FG000|Overall Study|Protocol Violation|1|||
23655644|NCT01290601|66125507|FG001|Overall Study|Protocol Violation|0|||
23655645|NCT01290601|66125508|FG002|Overall Study|Protocol Violation|0|||
23655646|NCT01290601|66125509|FG003|Overall Study|Protocol Violation|0|||
23655647|NCT00975715|66125510|FG000|Titration Period|Adverse Event|6|||
23655648|NCT00975715|66125511|FG001|Titration Period|Adverse Event|0|||
23655649|NCT00975715|66125510|FG000|Titration Period|Protocol Violation|1|||
23655650|NCT00975715|66125511|FG001|Titration Period|Protocol Violation|0|||
23655651|NCT00975715|66125510|FG000|Maintenance Period|Adverse Event|2|||
23655652|NCT00975715|66125511|FG001|Maintenance Period|Adverse Event|1|||
23655653|NCT00059839|66125512|FG000|Overall Study|Death|1|||
23655654|NCT00059839|66125513|FG001|Overall Study|Death|1|||
23655655|NCT00059839|66125512|FG000|Overall Study|Lack of Efficacy|6|||
23655656|NCT00059839|66125513|FG001|Overall Study|Lack of Efficacy|5|||
23361138|NCT02532257|65065975|FG000|Overall Study|Withdrawal by Subject|3|||
23361139|NCT02532257|65065975|FG000|Overall Study|Progressive Disease|10|||
23480360|NCT01330017|65501956|FG002|Overall Study|Lost to Follow-up|1|||
23655657|NCT00059839|66125512|FG000|Overall Study|Lost to Follow-up|2|||
23655658|NCT00059839|66125513|FG001|Overall Study|Lost to Follow-up|0|||
23655659|NCT00059839|66125512|FG000|Overall Study|Physician Decision|1|||
23655660|NCT00059839|66125513|FG001|Overall Study|Physician Decision|2|||
23655661|NCT00059839|66125512|FG000|Overall Study|Withdrawal by Subject|1|||
23655662|NCT00059839|66125513|FG001|Overall Study|Withdrawal by Subject|6|||
23655663|NCT00059839|66125512|FG000|Overall Study|Ineligible|1|||
23655664|NCT00059839|66125513|FG001|Overall Study|Ineligible|3|||
23655665|NCT00757003|66125518|FG000|Overall Study|Death|33|||
23655666|NCT00757003|66125518|FG000|Overall Study|Lost to Follow-up|9|||
23655667|NCT00757003|66125518|FG000|Overall Study|Withdrawal by Subject|4|||
23655668|NCT00757003|66125518|FG000|Overall Study|Surgically explanted|2|||
23655669|NCT00757003|66125518|FG000|Overall Study|Not implanted|1|||
23655670|NCT03434353|66125519|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
23655671|NCT03434353|66125520|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
23655672|NCT03434353|66125521|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
23655673|NCT03434353|66125522|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
23655674|NCT03434353|66125523|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
23655675|NCT03434353|66125519|FG000|Overall Study|Withdrew consent|1|||
23655676|NCT03434353|66125520|FG001|Overall Study|Withdrew consent|0|||
23655677|NCT03434353|66125521|FG002|Overall Study|Withdrew consent|3|||
23655678|NCT03434353|66125522|FG003|Overall Study|Withdrew consent|0|||
23655679|NCT03434353|66125523|FG004|Overall Study|Withdrew consent|0|||
23655680|NCT03434353|66125519|FG000|Overall Study|Adverse Event|1|||
23655681|NCT03434353|66125520|FG001|Overall Study|Adverse Event|0|||
23655682|NCT03434353|66125521|FG002|Overall Study|Adverse Event|0|||
23655683|NCT03434353|66125522|FG003|Overall Study|Adverse Event|0|||
23655684|NCT03434353|66125523|FG004|Overall Study|Adverse Event|1|||
23655685|NCT03434353|66125519|FG000|Overall Study|Lost to Follow-up|2|||
23655686|NCT03434353|66125520|FG001|Overall Study|Lost to Follow-up|0|||
23655687|NCT03434353|66125521|FG002|Overall Study|Lost to Follow-up|0|||
23655688|NCT03434353|66125522|FG003|Overall Study|Lost to Follow-up|0|||
23655689|NCT03434353|66125523|FG004|Overall Study|Lost to Follow-up|0|||
23655690|NCT04875533|66125524|FG000|Overall Study|Adverse Event|6|||
23655691|NCT04875533|66125525|FG001|Overall Study|Adverse Event|4|||
23655692|NCT04875533|66125524|FG000|Overall Study|Protocol Violation|4|||
23655693|NCT04875533|66125525|FG001|Overall Study|Protocol Violation|0|||
23655694|NCT04875533|66125524|FG000|Overall Study|Withdrawal by Subject|8|||
23655695|NCT04875533|66125525|FG001|Overall Study|Withdrawal by Subject|5|||
23655696|NCT04875533|66125524|FG000|Overall Study|No longer meets eligibility criteria|1|||
23655697|NCT04875533|66125525|FG001|Overall Study|No longer meets eligibility criteria|0|||
23655698|NCT04875533|66125524|FG000|Overall Study|Other|0|||
23655699|NCT04875533|66125525|FG001|Overall Study|Other|2|||
23655700|NCT01309230|66125526|FG000|Overall Study|Withdrawal by Subject|0|||
23655701|NCT01309230|66125527|FG001|Overall Study|Withdrawal by Subject|2|||
23655702|NCT01309230|66125526|FG000|Overall Study|Observation arm closed|0|||
23655703|NCT01309230|66125527|FG001|Overall Study|Observation arm closed|2|||
23655704|NCT02593786|66125528|FG000|Overall Study|Disease progression|12|||
23655705|NCT02593786|66125529|FG001|Overall Study|Disease progression|16|||
23655706|NCT02593786|66125530|FG002|Overall Study|Disease progression|10|||
23655707|NCT02593786|66125531|FG003|Overall Study|Disease progression|7|||
23655708|NCT02593786|66125528|FG000|Overall Study|Study drug toxicity|1|||
23655709|NCT02593786|66125529|FG001|Overall Study|Study drug toxicity|0|||
23655710|NCT02593786|66125530|FG002|Overall Study|Study drug toxicity|0|||
23655711|NCT02593786|66125531|FG003|Overall Study|Study drug toxicity|0|||
23655712|NCT02593786|66125528|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23655713|NCT02593786|66125529|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23655714|NCT02593786|66125530|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23655715|NCT02593786|66125531|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23655716|NCT02593786|66125528|FG000|Overall Study|Participant request to discontinue study therapy|0|||
23655717|NCT02593786|66125529|FG001|Overall Study|Participant request to discontinue study therapy|2|||
23655718|NCT02593786|66125530|FG002|Overall Study|Participant request to discontinue study therapy|0|||
23655719|NCT02593786|66125531|FG003|Overall Study|Participant request to discontinue study therapy|0|||
23655720|NCT02593786|66125528|FG000|Overall Study|Other reasons|1|||
23655721|NCT02593786|66125529|FG001|Overall Study|Other reasons|1|||
23655722|NCT02593786|66125530|FG002|Overall Study|Other reasons|0|||
23655723|NCT02593786|66125531|FG003|Overall Study|Other reasons|5|||
23655724|NCT03049735|66125532|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
23655725|NCT03049735|66125533|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
23655726|NCT03049735|66125534|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
23655727|NCT03049735|66125532|FG000|Overall Study|Other|5|||
23655728|NCT03049735|66125533|FG001|Overall Study|Other|3|||
23655729|NCT03049735|66125534|FG002|Overall Study|Other|1|||
23655730|NCT03049735|66125532|FG000|Overall Study|Lack of Efficacy|4|||
23655731|NCT03049735|66125533|FG001|Overall Study|Lack of Efficacy|0|||
23655732|NCT03049735|66125534|FG002|Overall Study|Lack of Efficacy|3|||
23655733|NCT03049735|66125532|FG000|Overall Study|Protocol deviation|1|||
23655734|NCT03049735|66125533|FG001|Overall Study|Protocol deviation|0|||
23655735|NCT03049735|66125534|FG002|Overall Study|Protocol deviation|0|||
23655736|NCT03049735|66125532|FG000|Overall Study|Pregnancy|0|||
23655737|NCT03049735|66125533|FG001|Overall Study|Pregnancy|0|||
23655738|NCT03049735|66125534|FG002|Overall Study|Pregnancy|1|||
23655739|NCT03049735|66125532|FG000|Overall Study|Adverse Event|7|||
23655740|NCT03049735|66125533|FG001|Overall Study|Adverse Event|18|||
23655741|NCT03049735|66125534|FG002|Overall Study|Adverse Event|5|||
23655742|NCT03049735|66125532|FG000|Overall Study|Withdrawal by Subject|10|||
23655743|NCT03049735|66125533|FG001|Overall Study|Withdrawal by Subject|3|||
23655744|NCT03049735|66125534|FG002|Overall Study|Withdrawal by Subject|7|||
23655745|NCT03049735|66125532|FG000|Overall Study|Lost to Follow-up|1|||
23655746|NCT03049735|66125533|FG001|Overall Study|Lost to Follow-up|5|||
23655747|NCT03049735|66125534|FG002|Overall Study|Lost to Follow-up|5|||
23655748|NCT05085665|66125539|FG000|Overall Study|Physician Decision|2|||
23655749|NCT01296035|66125545|FG000|Overall Study|Withdrawal by Subject|1|||
23655750|NCT02952001|66128827|FG000|Overall Study|Adverse Event|3|||
23655751|NCT02952001|66128828|FG001|Overall Study|Adverse Event|0|||
23655752|NCT02952001|66128827|FG000|Overall Study|Prohibited therapy|10|||
23655753|NCT02952001|66128828|FG001|Overall Study|Prohibited therapy|3|||
23655754|NCT02952001|66128827|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
23655755|NCT02952001|66128828|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
23655756|NCT01177722|66128829|FG000|Overall Study|Serious Adverse Event|0|||
23655757|NCT01177722|66128830|FG001|Overall Study|Serious Adverse Event|0|||
23655758|NCT01177722|66128831|FG002|Overall Study|Serious Adverse Event|1|||
23655759|NCT01177722|66128832|FG003|Overall Study|Serious Adverse Event|0|||
23655760|NCT01177722|66128829|FG000|Overall Study|Protocol Violation|0|||
23655761|NCT01177722|66128830|FG001|Overall Study|Protocol Violation|0|||
23361140|NCT03293394|65065977|FG000|Follow-up (6 Months)|Adverse Event|4|||
23361141|NCT03293394|65065978|FG001|Follow-up (6 Months)|Adverse Event|2|||
23361142|NCT02861664|65065979|FG000|Overall Study|Withdrawal of Consent|0|||
23600050|NCT01499849|65925776|FG000|Overall Study|Adverse Event|28|||
23600051|NCT01499849|65925777|FG001|Overall Study|Adverse Event|32|||
23600052|NCT01499849|65925776|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
23600053|NCT01499849|65925777|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
23600054|NCT01499849|65925776|FG000|Overall Study|Withdrawal by Subject|43|||
23600055|NCT01499849|65925777|FG001|Overall Study|Withdrawal by Subject|43|||
23600056|NCT01499849|65925776|FG000|Overall Study|Death|5|||
23600057|NCT01499849|65925777|FG001|Overall Study|Death|7|||
23600058|NCT01499849|65925776|FG000|Overall Study|Disease Progression|11|||
23600059|NCT01499849|65925777|FG001|Overall Study|Disease Progression|10|||
23600060|NCT01499849|65925776|FG000|Overall Study|Protocol Violation|11|||
23600061|NCT01499849|65925777|FG001|Overall Study|Protocol Violation|11|||
23600062|NCT01499849|65925776|FG000|Overall Study|Physician Decision|20|||
23600063|NCT01499849|65925777|FG001|Overall Study|Physician Decision|19|||
23600064|NCT01499849|65925776|FG000|Overall Study|Lack of Efficacy|3|||
23600065|NCT01499849|65925777|FG001|Overall Study|Lack of Efficacy|4|||
23600066|NCT01499849|65925776|FG000|Overall Study|Lost to Follow-up|6|||
23600067|NCT01499849|65925777|FG001|Overall Study|Lost to Follow-up|3|||
23600068|NCT01499849|65925776|FG000|Overall Study|Other Reasons|27|||
23600069|NCT01499849|65925777|FG001|Overall Study|Other Reasons|30|||
23600070|NCT01701401|65925788|FG000|Overall Study|Randomized But Not Treated|3|||
23600071|NCT01701401|65925789|FG001|Overall Study|Randomized But Not Treated|1|||
23600072|NCT01701401|65925790|FG002|Overall Study|Randomized But Not Treated|0|||
23600073|NCT01701401|65925791|FG003|Overall Study|Randomized But Not Treated|1|||
23600074|NCT01701401|65925788|FG000|Overall Study|Lost to Follow-up|5|||
23600075|NCT01701401|65925789|FG001|Overall Study|Lost to Follow-up|5|||
23600076|NCT01701401|65925790|FG002|Overall Study|Lost to Follow-up|1|||
23600077|NCT01701401|65925791|FG003|Overall Study|Lost to Follow-up|3|||
23805344|NCT02072824|66664958|FG001|Overall Study|Insufficient clinical response|0|||
23805345|NCT02072824|66664959|FG002|Overall Study|Insufficient clinical response|1|||
23805346|NCT02072824|66664957|FG000|Overall Study|No longer willing to participate|1|||
23805347|NCT02072824|66664958|FG001|Overall Study|No longer willing to participate|0|||
23805348|NCT02072824|66664959|FG002|Overall Study|No longer willing to participate|1|||
23805349|NCT02072824|66664957|FG000|Overall Study|Medication error|0|||
23805350|NCT02072824|66664958|FG001|Overall Study|Medication error|1|||
23805351|NCT02072824|66664959|FG002|Overall Study|Medication error|0|||
23805352|NCT02072824|66664957|FG000|Overall Study|Adverse Event|0|||
23805353|NCT02072824|66664958|FG001|Overall Study|Adverse Event|0|||
23805354|NCT02072824|66664959|FG002|Overall Study|Adverse Event|1|||
23805355|NCT02211014|66664960|FG000|Overall Study|Adverse Event|0|||
23805356|NCT02211014|66664961|FG001|Overall Study|Adverse Event|2|||
23805357|NCT02211014|66664960|FG000|Overall Study|Physician Decision|1|||
23805358|NCT02211014|66664961|FG001|Overall Study|Physician Decision|2|||
23805359|NCT02211014|66664960|FG000|Overall Study|Started another cancer therapy|1|||
23805360|NCT02211014|66664961|FG001|Overall Study|Started another cancer therapy|0|||
23805361|NCT02211014|66664960|FG000|Overall Study|Withdrawal by Subject|0|||
23805362|NCT02211014|66664961|FG001|Overall Study|Withdrawal by Subject|1|||
23805363|NCT02211014|66664960|FG000|Overall Study|In agreement with patient, no benefit|0|||
23805364|NCT02211014|66664961|FG001|Overall Study|In agreement with patient, no benefit|1|||
23805365|NCT03276780|66664962|FG000|Overall Study|Withdrawal by Subject|5|||
23805366|NCT03276780|66664963|FG001|Overall Study|Withdrawal by Subject|3|||
23805367|NCT03276780|66664962|FG000|Overall Study|Lost to Follow-up|3|||
23805368|NCT03276780|66664963|FG001|Overall Study|Lost to Follow-up|5|||
23805369|NCT03276780|66664962|FG000|Overall Study|Moved out of state|1|||
23805370|NCT03276780|66664963|FG001|Overall Study|Moved out of state|1|||
23805371|NCT03276780|66664962|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
23361143|NCT02861664|65065980|FG001|Overall Study|Withdrawal of Consent|1|||
23361144|NCT02030119|65065981|FG000|Overall Study|Withdrawal by Subject|3|||
23805372|NCT03276780|66664963|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
23805373|NCT03276780|66664962|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
23600078|NCT01701401|65925788|FG000|Overall Study|Withdrew Consent|0|||
23600079|NCT01701401|65925789|FG001|Overall Study|Withdrew Consent|3|||
23600080|NCT01701401|65925790|FG002|Overall Study|Withdrew Consent|1|||
23600081|NCT01701401|65925791|FG003|Overall Study|Withdrew Consent|2|||
23600082|NCT01701401|65925788|FG000|Overall Study|Lack of Efficacy|1|||
23600083|NCT01701401|65925789|FG001|Overall Study|Lack of Efficacy|0|||
23480361|NCT01330017|65501957|FG003|Overall Study|Lost to Follow-up|0|||
23655762|NCT01177722|66128831|FG002|Overall Study|Protocol Violation|1|||
23655763|NCT01177722|66128832|FG003|Overall Study|Protocol Violation|0|||
23655764|NCT01177722|66128829|FG000|Overall Study|Lost to Follow-up|3|||
23655765|NCT01177722|66128830|FG001|Overall Study|Lost to Follow-up|4|||
23655766|NCT01177722|66128831|FG002|Overall Study|Lost to Follow-up|3|||
23655767|NCT01177722|66128832|FG003|Overall Study|Lost to Follow-up|1|||
23655768|NCT01177722|66128829|FG000|Overall Study|Withdrawal by Subject|10|||
23655769|NCT01177722|66128830|FG001|Overall Study|Withdrawal by Subject|6|||
23655770|NCT01177722|66128831|FG002|Overall Study|Withdrawal by Subject|4|||
23655771|NCT01177722|66128832|FG003|Overall Study|Withdrawal by Subject|6|||
23655772|NCT00445068|66128833|FG000|Overall Study|Disease progression|26|||
23805374|NCT03276780|66664963|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
23805375|NCT01901874|66664964|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
23805376|NCT01901874|66664964|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
23805377|NCT01901874|66664964|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
23805378|NCT01901874|66664964|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
23805379|NCT01901874|66664964|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
23805380|NCT01901874|66664964|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
23805381|NCT03438396|66664965|FG000|Overall Study|Reason Not Specified|9|||
23805382|NCT03438396|66664965|FG000|Overall Study|Withdrawal by Subject|5|||
23805383|NCT03438396|66664965|FG000|Overall Study|Lost to Follow-up|2|||
23805384|NCT03438396|66664965|FG000|Overall Study|Death|85|||
23805385|NCT03438396|66664965|FG000|Overall Study|Not treated|1|||
23805386|NCT00891371|66664966|FG000|Pre-assignment|Inclusion/exclusion|5|||
23805387|NCT00891371|66664966|FG000|Pre-assignment|Consent withdrawal|1|||
23805388|NCT00891371|66664966|FG000|Treatment|Lack of Efficacy|5|||
23805389|NCT00891371|66664966|FG000|Treatment|Adverse Event|2|||
23805390|NCT00891371|66664966|FG000|Treatment|Death|1|||
23805391|NCT00891371|66664966|FG000|Treatment|Lost to Follow-up|1|||
23805392|NCT05132569|66664968|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
23361145|NCT02030119|65065982|FG001|Overall Study|Withdrawal by Subject|1|||
23361146|NCT02030119|65065983|FG002|Overall Study|Withdrawal by Subject|5|||
23361147|NCT02030119|65065984|FG003|Overall Study|Withdrawal by Subject|3|||
23361148|NCT02030119|65065981|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
23361149|NCT02030119|65065982|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
23361150|NCT02030119|65065983|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
23361151|NCT02030119|65065984|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
23361152|NCT01254656|65065987|FG000|Overall Study|Discontinued due to termination of study|40|||
23361153|NCT01254656|65065988|FG001|Overall Study|Discontinued due to termination of study|39|||
23361154|NCT01254656|65065989|FG002|Overall Study|Discontinued due to termination of study|13|||
23361155|NCT01254656|65065987|FG000|Overall Study|Lack of Efficacy|3|||
23361156|NCT01254656|65065988|FG001|Overall Study|Lack of Efficacy|0|||
23361157|NCT01254656|65065989|FG002|Overall Study|Lack of Efficacy|0|||
23361158|NCT01254656|65065987|FG000|Overall Study|Lost to Follow-up|1|||
23361159|NCT01254656|65065988|FG001|Overall Study|Lost to Follow-up|0|||
23361160|NCT01254656|65065989|FG002|Overall Study|Lost to Follow-up|2|||
23361161|NCT01254656|65065987|FG000|Overall Study|Withdrawal by Subject|2|||
23361162|NCT01254656|65065988|FG001|Overall Study|Withdrawal by Subject|2|||
23361163|NCT01254656|65065989|FG002|Overall Study|Withdrawal by Subject|1|||
23361164|NCT01254656|65065987|FG000|Overall Study|Pregnancy|0|||
23361165|NCT01254656|65065988|FG001|Overall Study|Pregnancy|0|||
23361166|NCT01254656|65065989|FG002|Overall Study|Pregnancy|2|||
23361167|NCT01254656|65065987|FG000|Overall Study|Adverse Event|1|||
23361168|NCT01254656|65065988|FG001|Overall Study|Adverse Event|1|||
23361169|NCT01254656|65065989|FG002|Overall Study|Adverse Event|0|||
23361170|NCT01254656|65065987|FG000|Overall Study|Death|0|||
23361171|NCT01254656|65065988|FG001|Overall Study|Death|1|||
23361172|NCT01254656|65065989|FG002|Overall Study|Death|0|||
23361173|NCT00196105|65065990|FG000|Overall Study|Lost to Follow-up|4|||
23361174|NCT00196105|65065991|FG001|Overall Study|Lost to Follow-up|5|||
23361175|NCT00196105|65065992|FG002|Overall Study|Lost to Follow-up|7|||
23361176|NCT00905567|65065995|FG000|Washout|Withdrawal by Subject|0|||
23361177|NCT00905567|65065996|FG001|Washout|Withdrawal by Subject|1|||
23361178|NCT03300050|65069628|FG000|Overall Study|Lost to Follow-up|2|||
23361179|NCT03300050|65069629|FG001|Overall Study|Lost to Follow-up|1|||
23361180|NCT03300050|65069630|FG002|Overall Study|Lost to Follow-up|0|||
23361181|NCT03300050|65069631|FG003|Overall Study|Lost to Follow-up|0|||
23361182|NCT03300050|65069632|FG004|Overall Study|Lost to Follow-up|1|||
23361183|NCT03300050|65069628|FG000|Overall Study|Withdrawal by Subject|1|||
23361184|NCT03300050|65069629|FG001|Overall Study|Withdrawal by Subject|1|||
23361185|NCT03300050|65069630|FG002|Overall Study|Withdrawal by Subject|1|||
23361186|NCT03300050|65069631|FG003|Overall Study|Withdrawal by Subject|0|||
23655773|NCT00445068|66128833|FG000|Overall Study|Adverse Event|5|||
23361187|NCT03300050|65069632|FG004|Overall Study|Withdrawal by Subject|0|||
23361188|NCT03300050|65069628|FG000|Overall Study|Death|0|||
23361189|NCT03300050|65069629|FG001|Overall Study|Death|0|||
23361190|NCT03300050|65069630|FG002|Overall Study|Death|1|||
23600084|NCT01701401|65925790|FG002|Overall Study|Lack of Efficacy|2|||
23600085|NCT01701401|65925791|FG003|Overall Study|Lack of Efficacy|0|||
23805393|NCT05132569|66664969|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
23805394|NCT05132569|66664968|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
23805395|NCT05132569|66664969|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
23600086|NCT01701401|65925788|FG000|Overall Study|Adverse Event|1|||
23600087|NCT01701401|65925789|FG001|Overall Study|Adverse Event|0|||
23600088|NCT01701401|65925790|FG002|Overall Study|Adverse Event|0|||
23600089|NCT01701401|65925791|FG003|Overall Study|Adverse Event|0|||
23805396|NCT05132569|66664968|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
23805397|NCT05132569|66664969|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
23805398|NCT02384850|66664972|FG000|Overall Study|Withdrawal by Subject|2|||
23805399|NCT02384850|66664973|FG001|Overall Study|Withdrawal by Subject|2|||
23805400|NCT00775606|66664974|FG000|Overall Study|Study sponsor terminated funding|3|||
23805401|NCT00775606|66664975|FG001|Overall Study|Study sponsor terminated funding|0|||
23805402|NCT00652028|66664976|FG000|Overall Study|Adverse Event|1|||
23805403|NCT00652028|66664977|FG001|Overall Study|Adverse Event|0|||
23805404|NCT00652028|66664978|FG002|Overall Study|Adverse Event|0|||
23805405|NCT00652028|66664979|FG003|Overall Study|Adverse Event|0|||
23805406|NCT00652028|66664976|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
23805407|NCT00652028|66664977|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
23805408|NCT00652028|66664978|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
23805409|NCT00652028|66664979|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
23805410|NCT00652028|66664976|FG000|Overall Study|Physician Decision|0|||
23805411|NCT00652028|66664977|FG001|Overall Study|Physician Decision|0|||
23805412|NCT00652028|66664978|FG002|Overall Study|Physician Decision|1|||
23805413|NCT00652028|66664979|FG003|Overall Study|Physician Decision|0|||
23805414|NCT03604341|66664982|FG000|Overall Study|Withdrawal by Subject|1|||
23805415|NCT03604341|66664983|FG001|Overall Study|Withdrawal by Subject|1|||
23805416|NCT03604341|66664982|FG000|Overall Study|Adverse Event|1|||
23805417|NCT03604341|66664983|FG001|Overall Study|Adverse Event|0|||
23805418|NCT03604341|66664982|FG000|Overall Study|Protocol Violation|0|||
23805419|NCT03604341|66664983|FG001|Overall Study|Protocol Violation|1|||
23805420|NCT02698865|66664984|FG000|Overall Study|Other|11|||
23805421|NCT02698865|66664985|FG001|Overall Study|Other|11|||
23805422|NCT02698865|66664984|FG000|Overall Study|Withdrawal by Subject|20|||
23805423|NCT02698865|66664985|FG001|Overall Study|Withdrawal by Subject|16|||
23805424|NCT02698865|66664984|FG000|Overall Study|Physician Decision|0|||
23805425|NCT02698865|66664985|FG001|Overall Study|Physician Decision|4|||
23805426|NCT02698865|66664984|FG000|Overall Study|Lost to Follow-up|4|||
23805427|NCT02698865|66664985|FG001|Overall Study|Lost to Follow-up|2|||
23805428|NCT00594646|66664987|FG000|Overall Study|Withdrawal by Subject|1|||
23805429|NCT00594646|66664987|FG000|Overall Study|Lost to Follow-up|15|||
23805430|NCT00049842|66664988|FG000|Treatment Phase|Adverse Event|47|||
23805431|NCT00049842|66664989|FG001|Treatment Phase|Adverse Event|12|||
23805432|NCT00049842|66664988|FG000|Treatment Phase|Withdrawal by Subject|35|||
23805433|NCT00049842|66664989|FG001|Treatment Phase|Withdrawal by Subject|46|||
23805434|NCT00049842|66664988|FG000|Treatment Phase|Non-compliance with protocol|7|||
23805435|NCT00049842|66664989|FG001|Treatment Phase|Non-compliance with protocol|8|||
23805436|NCT00049842|66664988|FG000|Treatment Phase|Lost to Follow-up|4|||
23805437|NCT00049842|66664989|FG001|Treatment Phase|Lost to Follow-up|8|||
23805438|NCT00049842|66664988|FG000|Treatment Phase|Administrative|0|||
23600090|NCT01701401|65925788|FG000|Overall Study|Protocol Violation|0|||
23805439|NCT00049842|66664989|FG001|Treatment Phase|Administrative|3|||
23805440|NCT00049842|66664988|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
23805441|NCT00049842|66664989|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
23805442|NCT00049842|66664988|FG000|Follow-up Phase|Adverse Event|6|||
23805443|NCT00049842|66664989|FG001|Follow-up Phase|Adverse Event|1|||
23805444|NCT00049842|66664988|FG000|Follow-up Phase|Other|1|||
23361191|NCT03300050|65069631|FG003|Overall Study|Death|0|||
23361192|NCT03300050|65069632|FG004|Overall Study|Death|0|||
23361193|NCT03300050|65069628|FG000|Overall Study|Not Eligible at Randomization|0|||
23361194|NCT03300050|65069629|FG001|Overall Study|Not Eligible at Randomization|0|||
23361195|NCT03300050|65069630|FG002|Overall Study|Not Eligible at Randomization|1|||
23655774|NCT00445068|66128833|FG000|Overall Study|Abnormal laboratory value|2|||
23655775|NCT00445068|66128833|FG000|Overall Study|Withdrawal by Subject|2|||
23655776|NCT00445068|66128833|FG000|Overall Study|Death|1|||
23655777|NCT02202551|66128834|FG000|Overall Study|Adverse Event|8|||
23655778|NCT02202551|66128835|FG001|Overall Study|Adverse Event|19|||
23361196|NCT03300050|65069631|FG003|Overall Study|Not Eligible at Randomization|1|||
23361197|NCT03300050|65069632|FG004|Overall Study|Not Eligible at Randomization|0|||
23361198|NCT00130689|65069633|FG000|Overall Study|Progressive Disease|29|||
23361199|NCT00130689|65069633|FG000|Overall Study|Death|1|||
23361200|NCT00130689|65069633|FG000|Overall Study|Clinical Deterioration|4|||
23361201|NCT00130689|65069633|FG000|Overall Study|Withdrawal by Subject|3|||
23361202|NCT00130689|65069633|FG000|Overall Study|Ineligible|6|||
23361203|NCT02258659|65069637|FG000|Overall Study|Withdrawal by Subject|1|||
23600091|NCT01701401|65925789|FG001|Overall Study|Protocol Violation|0|||
23600092|NCT01701401|65925790|FG002|Overall Study|Protocol Violation|1|||
23361206|NCT01188668|65069640|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
23361207|NCT01188668|65069640|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
23361208|NCT01188668|65069640|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
23361209|NCT00673257|65069641|FG000|Overall Study|Withdrawal by Subject|4|||
23361210|NCT00673257|65069641|FG000|Overall Study|Unable to obtain specimen|1|||
23361211|NCT01098162|65069642|FG000|Overall Study|Adverse Event|37|||
23655779|NCT02202551|66128836|FG002|Overall Study|Adverse Event|5|||
23655780|NCT02202551|66128837|FG003|Overall Study|Adverse Event|9|||
23361212|NCT01098162|65069642|FG000|Overall Study|Lack of Efficacy|4|||
23361213|NCT01098162|65069642|FG000|Overall Study|Wish of Patient|7|||
23361214|NCT01098162|65069642|FG000|Overall Study|Lost to Follow-up|9|||
23361215|NCT01098162|65069642|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
23361216|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
23361217|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
23655781|NCT02202551|66128834|FG000|Overall Study|Death|3|||
23655782|NCT02202551|66128835|FG001|Overall Study|Death|2|||
23655783|NCT02202551|66128836|FG002|Overall Study|Death|1|||
23655784|NCT02202551|66128837|FG003|Overall Study|Death|1|||
23655785|NCT02202551|66128834|FG000|Overall Study|Lost to Follow-up|0|||
23655786|NCT02202551|66128835|FG001|Overall Study|Lost to Follow-up|1|||
23655787|NCT02202551|66128836|FG002|Overall Study|Lost to Follow-up|0|||
23655788|NCT02202551|66128837|FG003|Overall Study|Lost to Follow-up|1|||
23655789|NCT02202551|66128834|FG000|Overall Study|Needed to take excluded medication|0|||
23655790|NCT02202551|66128835|FG001|Overall Study|Needed to take excluded medication|2|||
23655791|NCT02202551|66128836|FG002|Overall Study|Needed to take excluded medication|0|||
23655792|NCT02202551|66128837|FG003|Overall Study|Needed to take excluded medication|1|||
23655793|NCT02202551|66128834|FG000|Overall Study|Subject moved away|0|||
23655794|NCT02202551|66128835|FG001|Overall Study|Subject moved away|1|||
23655795|NCT02202551|66128836|FG002|Overall Study|Subject moved away|0|||
23655796|NCT02202551|66128837|FG003|Overall Study|Subject moved away|0|||
23655797|NCT02202551|66128834|FG000|Overall Study|DBS surgery|3|||
23655798|NCT02202551|66128835|FG001|Overall Study|DBS surgery|0|||
23655799|NCT02202551|66128836|FG002|Overall Study|DBS surgery|0|||
23655800|NCT02202551|66128837|FG003|Overall Study|DBS surgery|0|||
23655801|NCT02202551|66128834|FG000|Overall Study|Dyskinesia upon taper|1|||
23655802|NCT02202551|66128835|FG001|Overall Study|Dyskinesia upon taper|0|||
23805445|NCT00049842|66664989|FG001|Follow-up Phase|Other|4|||
23805446|NCT03401450|66664992|FG000|Overall Study|Lost to Follow-up|4|||
23805447|NCT03401450|66664993|FG001|Overall Study|Lost to Follow-up|6|||
23805448|NCT03401450|66664992|FG000|Overall Study|Anesthesia plan changed|2|||
23805449|NCT03401450|66664993|FG001|Overall Study|Anesthesia plan changed|2|||
23805450|NCT03401450|66664992|FG000|Overall Study|Did not complete medication diary|4|||
23805451|NCT03401450|66664993|FG001|Overall Study|Did not complete medication diary|2|||
23805452|NCT03401450|66664992|FG000|Overall Study|post surgery medication change|2|||
23805453|NCT03401450|66664993|FG001|Overall Study|post surgery medication change|1|||
23805454|NCT03401450|66664992|FG000|Overall Study|Cancelled surgery|0|||
23805455|NCT03401450|66664993|FG001|Overall Study|Cancelled surgery|2|||
23805456|NCT01534637|66664994|FG000|Overall Study|Physician Decision|3|||
23805457|NCT01534637|66664994|FG000|Overall Study|Lack of Efficacy|3|||
23805458|NCT01534637|66664994|FG000|Overall Study|Withdrawal by Subject|1|||
23805459|NCT01534637|66664994|FG000|Overall Study|Adverse Event|1|||
23805460|NCT01534637|66664994|FG000|Overall Study|Liver Mets before treatment|1|||
23805461|NCT02972502|66664995|FG000|Overall Study|Lost to Follow-up|3|||
23805462|NCT02972502|66664996|FG001|Overall Study|Lost to Follow-up|1|||
23805463|NCT02972502|66664995|FG000|Overall Study|Withdrawal by Subject|1|||
23805464|NCT02972502|66664996|FG001|Overall Study|Withdrawal by Subject|1|||
23805465|NCT00620659|66664997|FG000|Treatment Period 1|Adverse Event|1|||
23805466|NCT00620659|66664998|FG001|Treatment Period 1|Adverse Event|0|||
23805467|NCT00620659|66664999|FG002|Treatment Period 1|Adverse Event|0|||
23805468|NCT00620659|66665000|FG003|Treatment Period 1|Adverse Event|3|||
23805469|NCT00620659|66665001|FG004|Treatment Period 1|Adverse Event|0|||
23805470|NCT00620659|66665002|FG005|Treatment Period 1|Adverse Event|0|||
23805471|NCT00620659|66664997|FG000|Treatment Period 1|Protocol Violation|1|||
23805472|NCT00620659|66664998|FG001|Treatment Period 1|Protocol Violation|0|||
23805473|NCT00620659|66664999|FG002|Treatment Period 1|Protocol Violation|0|||
23805474|NCT00620659|66665000|FG003|Treatment Period 1|Protocol Violation|0|||
23805475|NCT00620659|66665001|FG004|Treatment Period 1|Protocol Violation|0|||
23805476|NCT00620659|66665002|FG005|Treatment Period 1|Protocol Violation|0|||
23805477|NCT00620659|66664997|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23805478|NCT00620659|66664998|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23805479|NCT00620659|66664999|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23805480|NCT00620659|66665000|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23805481|NCT00620659|66665001|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23805482|NCT00620659|66665002|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23805483|NCT00620659|66664997|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
23805484|NCT00620659|66664998|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
23805485|NCT00620659|66664999|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
23805486|NCT00620659|66665000|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
23805487|NCT00620659|66665001|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
23361218|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
23655803|NCT02202551|66128836|FG002|Overall Study|Dyskinesia upon taper|0|||
23655804|NCT02202551|66128837|FG003|Overall Study|Dyskinesia upon taper|0|||
23805488|NCT00620659|66665002|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
23805489|NCT00620659|66664997|FG000|Treatment Period 2|Adverse Event|0|||
23655805|NCT02202551|66128834|FG000|Overall Study|Lack of Efficacy|0|||
23655806|NCT02202551|66128835|FG001|Overall Study|Lack of Efficacy|1|||
23805490|NCT00620659|66664998|FG001|Treatment Period 2|Adverse Event|3|||
23655807|NCT02202551|66128836|FG002|Overall Study|Lack of Efficacy|0|||
23655808|NCT02202551|66128837|FG003|Overall Study|Lack of Efficacy|0|||
23655809|NCT02202551|66128834|FG000|Overall Study|Physician Decision|1|||
23655810|NCT02202551|66128835|FG001|Overall Study|Physician Decision|0|||
23655811|NCT02202551|66128836|FG002|Overall Study|Physician Decision|0|||
23655812|NCT02202551|66128837|FG003|Overall Study|Physician Decision|0|||
23655813|NCT02202551|66128834|FG000|Overall Study|Site closure|3|||
23655814|NCT02202551|66128835|FG001|Overall Study|Site closure|0|||
23655815|NCT02202551|66128836|FG002|Overall Study|Site closure|0|||
23655816|NCT02202551|66128837|FG003|Overall Study|Site closure|1|||
23655817|NCT02202551|66128834|FG000|Overall Study|Unable to complete visits per protocol|1|||
23655818|NCT02202551|66128835|FG001|Overall Study|Unable to complete visits per protocol|0|||
23655819|NCT02202551|66128836|FG002|Overall Study|Unable to complete visits per protocol|0|||
23655820|NCT02202551|66128837|FG003|Overall Study|Unable to complete visits per protocol|0|||
23655821|NCT02202551|66128834|FG000|Overall Study|Worsening Dyskinesia|0|||
23655822|NCT02202551|66128835|FG001|Overall Study|Worsening Dyskinesia|0|||
23655823|NCT02202551|66128836|FG002|Overall Study|Worsening Dyskinesia|0|||
23655824|NCT02202551|66128837|FG003|Overall Study|Worsening Dyskinesia|1|||
23655825|NCT02202551|66128834|FG000|Overall Study|Protocol Violation|0|||
23655826|NCT02202551|66128835|FG001|Overall Study|Protocol Violation|1|||
23655827|NCT02202551|66128836|FG002|Overall Study|Protocol Violation|0|||
23655828|NCT02202551|66128837|FG003|Overall Study|Protocol Violation|0|||
23655829|NCT02202551|66128834|FG000|Overall Study|Sponsor's decision|2|||
23655830|NCT02202551|66128835|FG001|Overall Study|Sponsor's decision|0|||
23655831|NCT02202551|66128836|FG002|Overall Study|Sponsor's decision|0|||
23655832|NCT02202551|66128837|FG003|Overall Study|Sponsor's decision|0|||
23655833|NCT02202551|66128834|FG000|Overall Study|Subject unwilling to proceed|1|||
23655834|NCT02202551|66128835|FG001|Overall Study|Subject unwilling to proceed|5|||
23655835|NCT02202551|66128836|FG002|Overall Study|Subject unwilling to proceed|3|||
23655836|NCT02202551|66128837|FG003|Overall Study|Subject unwilling to proceed|5|||
23655837|NCT02202551|66128834|FG000|Overall Study|Subject consent withdrawn|0|||
23655838|NCT02202551|66128835|FG001|Overall Study|Subject consent withdrawn|3|||
23655839|NCT02202551|66128836|FG002|Overall Study|Subject consent withdrawn|1|||
23655840|NCT02202551|66128837|FG003|Overall Study|Subject consent withdrawn|2|||
23655841|NCT02202551|66128834|FG000|Overall Study|eGFR<50mL/min/m2|2|||
23655842|NCT02202551|66128835|FG001|Overall Study|eGFR<50mL/min/m2|2|||
23655843|NCT02202551|66128836|FG002|Overall Study|eGFR<50mL/min/m2|0|||
23655844|NCT02202551|66128837|FG003|Overall Study|eGFR<50mL/min/m2|1|||
23655845|NCT00504153|66128838|FG000|Overall Study|Withdrawal by Subject|1|||
23655846|NCT00504153|66128838|FG000|Overall Study|Adverse Event|4|||
23655847|NCT00504153|66128838|FG000|Overall Study|Death|1|||
23655848|NCT01009203|66128839|FG000|Overall Study|Withdrawal by Subject|1|||
23655849|NCT01009203|66128839|FG000|Overall Study|Adverse Event|5|||
23655850|NCT01009203|66128839|FG000|Overall Study|Treatment-unrelated death|1|||
23655851|NCT01032382|66128840|FG000|Overall Study|Disease dissemination|1|||
23655852|NCT01032382|66128841|FG001|Overall Study|Disease dissemination|1|||
23655853|NCT01032382|66128840|FG000|Overall Study|Treatment failure|3|||
23655854|NCT01032382|66128841|FG001|Overall Study|Treatment failure|1|||
23655855|NCT01032382|66128840|FG000|Overall Study|Index lesion relapse|1|||
23655856|NCT01032382|66128841|FG001|Overall Study|Index lesion relapse|3|||
23655857|NCT03933397|66128842|FG000|Overall Study|No emergency department visit|65|||
23655858|NCT03933397|66128843|FG001|Overall Study|No emergency department visit|71|||
23655859|NCT03933397|66128842|FG000|Overall Study|Missed emergency department visit|25|||
23480362|NCT01330017|65501958|FG004|Overall Study|Lost to Follow-up|0|||
23480363|NCT01330017|65501954|FG000|Overall Study|Protocol Violation|0|||
23655860|NCT03933397|66128843|FG001|Overall Study|Missed emergency department visit|30|||
23655861|NCT03933397|66128842|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
23655862|NCT03933397|66128843|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
23655863|NCT03933397|66128842|FG000|Overall Study|Withdrawal by Subject|1|||
23655864|NCT03933397|66128843|FG001|Overall Study|Withdrawal by Subject|0|||
23655865|NCT03933397|66128842|FG000|Overall Study|Physician Decision|1|||
23655866|NCT03933397|66128843|FG001|Overall Study|Physician Decision|1|||
23655867|NCT03933397|66128842|FG000|Overall Study|missing pain score|1|||
23655868|NCT03933397|66128843|FG001|Overall Study|missing pain score|1|||
23655869|NCT03933397|66128842|FG000|Overall Study|Confirmed COVID-19|1|||
23655870|NCT03933397|66128843|FG001|Overall Study|Confirmed COVID-19|2|||
23655871|NCT02308007|66128845|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
23655872|NCT02308007|66128846|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
23655873|NCT02308007|66128847|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
23655874|NCT02308007|66128845|FG000|Overall Study|Positive for STD at Baseline|7|||
23655875|NCT02308007|66128846|FG001|Overall Study|Positive for STD at Baseline|11|||
23655876|NCT02308007|66128847|FG002|Overall Study|Positive for STD at Baseline|7|||
23361219|NCT01098162|65069642|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
23480364|NCT01330017|65501955|FG001|Overall Study|Protocol Violation|0|||
23655877|NCT02308007|66128845|FG000|Overall Study|Lost to Follow-up|3|||
23655878|NCT02308007|66128846|FG001|Overall Study|Lost to Follow-up|0|||
23655879|NCT02308007|66128847|FG002|Overall Study|Lost to Follow-up|1|||
23805491|NCT00620659|66664999|FG002|Treatment Period 2|Adverse Event|0|||
23805492|NCT00620659|66665000|FG003|Treatment Period 2|Adverse Event|0|||
23805493|NCT00620659|66665001|FG004|Treatment Period 2|Adverse Event|2|||
23805494|NCT00620659|66665002|FG005|Treatment Period 2|Adverse Event|0|||
23805495|NCT00620659|66664997|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23805496|NCT00620659|66664998|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23805497|NCT00620659|66664999|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23805498|NCT00620659|66665000|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23805499|NCT00620659|66665001|FG004|Treatment Period 2|Withdrawal by Subject|3|||
23805500|NCT00620659|66665002|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23805501|NCT00620659|66664997|FG000|Placebo Washout Period 2|Adverse Event|2|||
23805502|NCT00620659|66664998|FG001|Placebo Washout Period 2|Adverse Event|0|||
23805503|NCT00620659|66664999|FG002|Placebo Washout Period 2|Adverse Event|0|||
23805504|NCT00620659|66665000|FG003|Placebo Washout Period 2|Adverse Event|0|||
23805505|NCT00620659|66665001|FG004|Placebo Washout Period 2|Adverse Event|0|||
23805506|NCT00620659|66665002|FG005|Placebo Washout Period 2|Adverse Event|0|||
23805507|NCT00620659|66664997|FG000|Treatment Period 3|Adverse Event|0|||
23805508|NCT00620659|66664998|FG001|Treatment Period 3|Adverse Event|2|||
23805509|NCT00620659|66664999|FG002|Treatment Period 3|Adverse Event|0|||
23805510|NCT00620659|66665000|FG003|Treatment Period 3|Adverse Event|0|||
23805511|NCT00620659|66665001|FG004|Treatment Period 3|Adverse Event|0|||
23805512|NCT00620659|66665002|FG005|Treatment Period 3|Adverse Event|0|||
23805513|NCT00620659|66664997|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23805514|NCT00620659|66664998|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23805515|NCT00620659|66664999|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23805516|NCT00620659|66665000|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23805517|NCT00620659|66665001|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23805518|NCT00620659|66665002|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23805519|NCT00679913|66665003|FG000|Overall Study|Protocol Violation|18|||
23805520|NCT00679913|66665004|FG001|Overall Study|Protocol Violation|13|||
23805521|NCT00906373|66665005|FG000|Overall Study|Withdrawal by Subject|0|||
23805522|NCT00906373|66665006|FG001|Overall Study|Withdrawal by Subject|5|||
23805523|NCT00906373|66665005|FG000|Overall Study|Other|0|||
23805524|NCT00906373|66665006|FG001|Overall Study|Other|1|||
23805525|NCT00906373|66665005|FG000|Overall Study|Still on treatment at cutoff date|0|||
23805526|NCT00906373|66665006|FG001|Overall Study|Still on treatment at cutoff date|2|||
23805527|NCT00911807|66665007|FG000|Overall Study|Adverse Event|2|||
23805528|NCT00911807|66665008|FG001|Overall Study|Adverse Event|1|||
23805529|NCT00911807|66665009|FG002|Overall Study|Adverse Event|5|||
23805530|NCT00911807|66665007|FG000|Overall Study|Death|0|||
23805531|NCT00911807|66665008|FG001|Overall Study|Death|0|||
23655880|NCT02020863|66128850|FG000|Overall Study|Discovery of Metastatic disease|4|||
23655881|NCT02020863|66128850|FG000|Overall Study|Team chose not to place an a line|1|||
23805532|NCT00911807|66665009|FG002|Overall Study|Death|1|||
23805533|NCT00911807|66665007|FG000|Overall Study|Protocol Violation|6|||
23805534|NCT00911807|66665008|FG001|Overall Study|Protocol Violation|4|||
23805535|NCT00911807|66665009|FG002|Overall Study|Protocol Violation|9|||
23805536|NCT00911807|66665007|FG000|Overall Study|Withdrawal by Subject|8|||
23805537|NCT00911807|66665008|FG001|Overall Study|Withdrawal by Subject|10|||
23805538|NCT00911807|66665009|FG002|Overall Study|Withdrawal by Subject|7|||
23805539|NCT00911807|66665007|FG000|Overall Study|Organizational reasons|1|||
23805540|NCT00911807|66665008|FG001|Overall Study|Organizational reasons|3|||
23805541|NCT00911807|66665009|FG002|Overall Study|Organizational reasons|1|||
23805542|NCT00680186|66665010|FG000|Overall Study|Adverse Event|47|||
23805543|NCT00680186|66665011|FG001|Overall Study|Adverse Event|44|||
23805544|NCT00680186|66665010|FG000|Overall Study|Protocol Violation|31|||
23805545|NCT00680186|66665011|FG001|Overall Study|Protocol Violation|26|||
23805546|NCT00680186|66665010|FG000|Overall Study|Lost to Follow-up|11|||
23805547|NCT00680186|66665011|FG001|Overall Study|Lost to Follow-up|6|||
23805548|NCT00680186|66665010|FG000|Overall Study|Withdrawal by Subject|32|||
23805549|NCT00680186|66665011|FG001|Overall Study|Withdrawal by Subject|39|||
23805550|NCT00680186|66665010|FG000|Overall Study|Other|4|||
23805551|NCT00680186|66665011|FG001|Overall Study|Other|1|||
23805552|NCT02459665|66668675|FG000|Overall Study|Withdrawal by Subject|0|||
23805553|NCT02459665|66668676|FG001|Overall Study|Withdrawal by Subject|1|||
23805554|NCT02459665|66668677|FG002|Overall Study|Withdrawal by Subject|1|||
23805555|NCT02459665|66668678|FG003|Overall Study|Withdrawal by Subject|2|||
23805556|NCT00693225|66668680|FG000|Overall Study|Lost to Follow-up|1|||
23805557|NCT00693225|66668681|FG001|Overall Study|Lost to Follow-up|2|||
23805558|NCT00693225|66668680|FG000|Overall Study|Adverse Event|1|||
23805559|NCT00693225|66668681|FG001|Overall Study|Adverse Event|3|||
23805560|NCT00109837|66668682|FG000|Overall Study|Adverse Event|2|||
23805561|NCT00109837|66668682|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
23805562|NCT00109837|66668682|FG000|Overall Study|Death|1|||
23805563|NCT00109837|66668682|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
23805564|NCT00109837|66668682|FG000|Overall Study|Not treated|1|||
23805565|NCT00109837|66668682|FG000|Overall Study|Ineligible|1|||
23805566|NCT00507546|66668685|FG000|Overall Study|Withdrawal by Subject|1|||
23805567|NCT00507546|66668686|FG001|Overall Study|Withdrawal by Subject|0|||
23805568|NCT00507546|66668685|FG000|Overall Study|Protocol Violation|1|||
23805569|NCT00507546|66668686|FG001|Overall Study|Protocol Violation|0|||
23805570|NCT00507546|66668685|FG000|Overall Study|Physician Decision|0|||
23805571|NCT00507546|66668686|FG001|Overall Study|Physician Decision|1|||
23805572|NCT05020249|66668689|FG000|Overall Study|Protocol Violation|1|||
23805573|NCT05020249|66668690|FG001|Overall Study|Protocol Violation|0|||
23805574|NCT01843348|66668692|FG000|Overall Study|Withdrawal by Subject|4|||
23805575|NCT01843348|66668693|FG001|Overall Study|Withdrawal by Subject|16|||
23805576|NCT01843348|66668694|FG002|Overall Study|Withdrawal by Subject|18|||
23805577|NCT01843348|66668692|FG000|Overall Study|Lost to Follow-up|5|||
23805578|NCT01843348|66668693|FG001|Overall Study|Lost to Follow-up|4|||
23805579|NCT01843348|66668694|FG002|Overall Study|Lost to Follow-up|2|||
23805580|NCT01843348|66668692|FG000|Overall Study|Death|5|||
23805581|NCT01843348|66668693|FG001|Overall Study|Death|3|||
23805582|NCT01843348|66668694|FG002|Overall Study|Death|4|||
23805583|NCT01843348|66668692|FG000|Overall Study|Graft loss/retransplantation|5|||
23805584|NCT01843348|66668693|FG001|Overall Study|Graft loss/retransplantation|8|||
23805585|NCT01843348|66668694|FG002|Overall Study|Graft loss/retransplantation|11|||
23805586|NCT01843348|66668692|FG000|Overall Study|Various reasons|4|||
23805587|NCT01843348|66668693|FG001|Overall Study|Various reasons|9|||
23805588|NCT01843348|66668694|FG002|Overall Study|Various reasons|6|||
23805589|NCT01045993|66668695|FG000|Overall Study|Treated-later found eligibility not met|0|||
23805590|NCT01045993|66668696|FG001|Overall Study|Treated-later found eligibility not met|1|||
23805591|NCT01045993|66668697|FG002|Overall Study|Treated-later found eligibility not met|0|||
23805592|NCT01045993|66668698|FG003|Overall Study|Treated-later found eligibility not met|0|||
23805593|NCT02017860|66668699|FG000|Overall Study|Adverse Event|1|||
23805594|NCT02017860|66668699|FG000|Overall Study|Withdrawal by Subject|1|||
23805595|NCT02333487|66668700|FG000|Overall Study|Adverse Event|0|||
23805596|NCT02333487|66668701|FG001|Overall Study|Adverse Event|2|||
23805597|NCT02333487|66668702|FG002|Overall Study|Adverse Event|0|||
23805598|NCT02013375|66668704|FG000|Overall Study|Did not engraft|1|||
23480365|NCT01330017|65501956|FG002|Overall Study|Protocol Violation|0|||
23805599|NCT02013375|66668704|FG000|Overall Study|Did not engraft|1|||
23805600|NCT01244061|66668707|FG000|Overall Study|Death|1|||
23805601|NCT01244061|66668708|FG001|Overall Study|Death|0|||
23805602|NCT01244061|66668707|FG000|Overall Study|Did not meet entrance criteria|1|||
23805603|NCT01244061|66668708|FG001|Overall Study|Did not meet entrance criteria|0|||
23805604|NCT01244061|66668707|FG000|Overall Study|Lack of Efficacy|1|||
23655882|NCT01910116|66128852|FG000|Overall Study|Adverse Event|0|||
23805605|NCT01244061|66668708|FG001|Overall Study|Lack of Efficacy|3|||
23600093|NCT01701401|65925791|FG003|Overall Study|Protocol Violation|0|||
23600094|NCT01953224|65925799|FG000|Overall Study|Lost to Follow-up|1|||
23600095|NCT01953224|65925800|FG001|Overall Study|Lost to Follow-up|1|||
23600096|NCT01953224|65925799|FG000|Overall Study|Withdrawal by Subject|1|||
23600097|NCT01953224|65925800|FG001|Overall Study|Withdrawal by Subject|2|||
23600098|NCT02111096|65925801|FG000|Overall Study|Adverse Event|4|||
23805606|NCT01244061|66668707|FG000|Overall Study|Lost to Follow-up|34|||
23805607|NCT01244061|66668708|FG001|Overall Study|Lost to Follow-up|30|||
23805608|NCT01244061|66668707|FG000|Overall Study|Withdrawal by Subject|29|||
23805609|NCT01244061|66668708|FG001|Overall Study|Withdrawal by Subject|46|||
23600099|NCT02111096|65925802|FG001|Overall Study|Adverse Event|1|||
23655883|NCT01910116|66128853|FG001|Overall Study|Adverse Event|3|||
23655884|NCT01910116|66128852|FG000|Overall Study|Lack of Efficacy|3|||
23655885|NCT01910116|66128853|FG001|Overall Study|Lack of Efficacy|4|||
23655886|NCT01910116|66128852|FG000|Overall Study|Lost to Follow-up|1|||
23655887|NCT01910116|66128853|FG001|Overall Study|Lost to Follow-up|0|||
23655888|NCT01910116|66128852|FG000|Overall Study|Protocol Violation|1|||
23655889|NCT01910116|66128853|FG001|Overall Study|Protocol Violation|2|||
23655890|NCT01910116|66128852|FG000|Overall Study|Withdrawal by Subject|8|||
23655891|NCT01910116|66128853|FG001|Overall Study|Withdrawal by Subject|3|||
23655892|NCT01910116|66128852|FG000|Overall Study|uncertain allocation|1|||
23655893|NCT01910116|66128853|FG001|Overall Study|uncertain allocation|3|||
23655894|NCT01910116|66128852|FG000|Overall Study|incomplete data|0|||
23655895|NCT01910116|66128853|FG001|Overall Study|incomplete data|1|||
23655896|NCT01130974|66128854|FG000|Overall Study|Protocol Violation|10|||
23655897|NCT01130974|66128855|FG001|Overall Study|Protocol Violation|10|||
23655898|NCT01130974|66128854|FG000|Overall Study|Withdrawal by Subject|0|||
23655899|NCT01130974|66128855|FG001|Overall Study|Withdrawal by Subject|1|||
23655900|NCT01130974|66128854|FG000|Overall Study|Ineligibility criteria|5|||
23655901|NCT01130974|66128855|FG001|Overall Study|Ineligibility criteria|2|||
23655902|NCT00954174|66128856|FG000|Overall Study|Adverse Event|28|||
23655903|NCT00954174|66128857|FG001|Overall Study|Adverse Event|23|||
23655904|NCT00954174|66128858|FG002|Overall Study|Adverse Event|4|||
23655905|NCT00954174|66128859|FG003|Overall Study|Adverse Event|9|||
23655906|NCT00954174|66128856|FG000|Overall Study|Death|4|||
23655907|NCT00954174|66128857|FG001|Overall Study|Death|2|||
23655908|NCT00954174|66128858|FG002|Overall Study|Death|0|||
23655909|NCT00954174|66128859|FG003|Overall Study|Death|0|||
23655910|NCT00954174|66128856|FG000|Overall Study|Lack of Efficacy|32|||
23655911|NCT00954174|66128857|FG001|Overall Study|Lack of Efficacy|22|||
23655912|NCT00954174|66128858|FG002|Overall Study|Lack of Efficacy|8|||
23805610|NCT01244061|66668707|FG000|Overall Study|Other|8|||
23655913|NCT00954174|66128859|FG003|Overall Study|Lack of Efficacy|6|||
23655914|NCT00954174|66128856|FG000|Overall Study|Withdrawal by Subject|14|||
23655915|NCT00954174|66128857|FG001|Overall Study|Withdrawal by Subject|10|||
23655916|NCT00954174|66128858|FG002|Overall Study|Withdrawal by Subject|4|||
23655917|NCT00954174|66128859|FG003|Overall Study|Withdrawal by Subject|3|||
23655918|NCT00954174|66128856|FG000|Overall Study|Medical Reason|4|||
23655919|NCT00954174|66128857|FG001|Overall Study|Medical Reason|2|||
23655920|NCT00954174|66128858|FG002|Overall Study|Medical Reason|1|||
23805611|NCT01244061|66668708|FG001|Overall Study|Other|19|||
23805612|NCT01244061|66668707|FG000|Overall Study|Protocol Violation|1|||
23805613|NCT01244061|66668708|FG001|Overall Study|Protocol Violation|1|||
23805614|NCT01244061|66668707|FG000|Overall Study|Adverse Event|5|||
23805615|NCT01244061|66668708|FG001|Overall Study|Adverse Event|2|||
23805616|NCT01244061|66668707|FG000|Overall Study|Randomized but not treated|2|||
23805617|NCT01244061|66668708|FG001|Overall Study|Randomized but not treated|2|||
23805618|NCT00350402|66668709|FG000|Overall Study|Lost to Follow-up|1|||
23805619|NCT00350402|66668710|FG001|Overall Study|Lost to Follow-up|1|||
23805620|NCT02615171|66668711|FG000|Overall Study|Lost to Follow-up|2|||
23480366|NCT01330017|65501957|FG003|Overall Study|Protocol Violation|1|||
23600100|NCT02111096|65925803|FG002|Overall Study|Adverse Event|2|||
23655921|NCT00954174|66128859|FG003|Overall Study|Medical Reason|0|||
23655922|NCT00954174|66128856|FG000|Overall Study|Ineligible|40|||
23655923|NCT00954174|66128857|FG001|Overall Study|Ineligible|47|||
23655924|NCT00954174|66128858|FG002|Overall Study|Ineligible|7|||
23655925|NCT00954174|66128859|FG003|Overall Study|Ineligible|4|||
23655926|NCT00954174|66128856|FG000|Overall Study|Never Treated|4|||
23655927|NCT00954174|66128857|FG001|Overall Study|Never Treated|17|||
23655928|NCT00954174|66128858|FG002|Overall Study|Never Treated|0|||
23655929|NCT00954174|66128859|FG003|Overall Study|Never Treated|3|||
23655930|NCT01678209|66128860|FG000|Overall Study|could not scan twice|1|||
23655931|NCT01678209|66128861|FG001|Overall Study|could not scan twice|1|||
23805621|NCT02615171|66668712|FG001|Overall Study|Lost to Follow-up|1|||
23805622|NCT00003138|66668717|FG000|Step 1|Reasons off treatment not documented|60|||
23805623|NCT00003138|66668718|FG001|Step 1|Reasons off treatment not documented|57|||
23655932|NCT01678209|66128862|FG002|Overall Study|could not scan twice|1|||
23655933|NCT01678209|66128860|FG000|Overall Study|scheduling conflicts|0|||
23805624|NCT00003138|66668717|FG000|Step 1|Never started treatment|1|||
23805625|NCT00003138|66668718|FG001|Step 1|Never started treatment|0|||
23361220|NCT01098162|65069642|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
23600101|NCT02111096|65925801|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23655934|NCT01678209|66128861|FG001|Overall Study|scheduling conflicts|0|||
23600102|NCT02111096|65925802|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23600103|NCT02111096|65925803|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23600104|NCT02111096|65925801|FG000|Overall Study|Lost to Follow Up|1|||
23600105|NCT02111096|65925802|FG001|Overall Study|Lost to Follow Up|1|||
23600106|NCT02111096|65925803|FG002|Overall Study|Lost to Follow Up|1|||
23600107|NCT02111096|65925801|FG000|Overall Study|Physician Decision|0|||
23600108|NCT02111096|65925802|FG001|Overall Study|Physician Decision|1|||
23600109|NCT02111096|65925803|FG002|Overall Study|Physician Decision|0|||
23600110|NCT02111096|65925801|FG000|Overall Study|Protocol Violation|1|||
23600111|NCT02111096|65925802|FG001|Overall Study|Protocol Violation|0|||
23600112|NCT02111096|65925803|FG002|Overall Study|Protocol Violation|1|||
23600113|NCT02111096|65925801|FG000|Overall Study|Terminated by Sponsor|53|||
23600114|NCT02111096|65925802|FG001|Overall Study|Terminated by Sponsor|35|||
23600115|NCT02111096|65925803|FG002|Overall Study|Terminated by Sponsor|54|||
23600116|NCT02111096|65925801|FG000|Overall Study|Withdrawal by Subject|4|||
23600117|NCT02111096|65925802|FG001|Overall Study|Withdrawal by Subject|2|||
23600118|NCT02111096|65925803|FG002|Overall Study|Withdrawal by Subject|8|||
23600119|NCT04334317|65925806|FG000|Overall Study|Adverse Event|1|||
23600120|NCT04334317|65925807|FG001|Overall Study|Adverse Event|2|||
23600121|NCT04334317|65925808|FG002|Overall Study|Adverse Event|0|||
23600122|NCT04334317|65925809|FG003|Overall Study|Adverse Event|0|||
23655935|NCT01678209|66128862|FG002|Overall Study|scheduling conflicts|1|||
23655936|NCT01678209|66128860|FG000|Overall Study|screen fail|16|||
23655937|NCT01678209|66128861|FG001|Overall Study|screen fail|17|||
23655938|NCT01678209|66128862|FG002|Overall Study|screen fail|16|||
23655939|NCT02536755|66128867|FG000|Overall Study|Adverse Event|4|||
23655940|NCT01170039|66128868|FG000|Overall Study|Withdrawal by Subject|5|||
23655941|NCT01170039|66128869|FG001|Overall Study|Withdrawal by Subject|3|||
23655942|NCT01170039|66128868|FG000|Overall Study|Lack of funding, drug not available|3|||
23655943|NCT01170039|66128869|FG001|Overall Study|Lack of funding, drug not available|3|||
23655944|NCT02973425|66128872|FG000|Overall Study|Lost to Follow-up|49|||
23655945|NCT02973425|66128873|FG001|Overall Study|Lost to Follow-up|53|||
23655946|NCT01790126|66128874|FG000|Overall Study|PSA Progression|12|||
23655947|NCT01790126|66128875|FG001|Overall Study|PSA Progression|16|||
23655948|NCT01790126|66128876|FG002|Overall Study|PSA Progression|16|||
23655949|NCT01790126|66128874|FG000|Overall Study|Other|5|||
23655950|NCT01790126|66128875|FG001|Overall Study|Other|4|||
23655951|NCT01790126|66128876|FG002|Overall Study|Other|8|||
23655952|NCT01790126|66128874|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
23655953|NCT01790126|66128875|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
23655954|NCT01790126|66128876|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
23655955|NCT01790126|66128874|FG000|Overall Study|Withdrawal by Physician|1|||
23655956|NCT01790126|66128875|FG001|Overall Study|Withdrawal by Physician|1|||
23655957|NCT01790126|66128876|FG002|Overall Study|Withdrawal by Physician|2|||
23655958|NCT01790126|66128874|FG000|Overall Study|Withdrawal by Subject|3|||
23655959|NCT01790126|66128875|FG001|Overall Study|Withdrawal by Subject|1|||
23655960|NCT01790126|66128876|FG002|Overall Study|Withdrawal by Subject|2|||
23655961|NCT01790126|66128874|FG000|Overall Study|Lost to Follow-up|1|||
23655962|NCT01790126|66128875|FG001|Overall Study|Lost to Follow-up|0|||
23655963|NCT01790126|66128876|FG002|Overall Study|Lost to Follow-up|1|||
23655964|NCT01790126|66128874|FG000|Overall Study|Adverse Event|0|||
23655965|NCT01790126|66128875|FG001|Overall Study|Adverse Event|2|||
23655966|NCT01790126|66128876|FG002|Overall Study|Adverse Event|0|||
23655967|NCT01790126|66128874|FG000|Overall Study|Death|2|||
23655968|NCT01790126|66128875|FG001|Overall Study|Death|0|||
23655969|NCT01790126|66128876|FG002|Overall Study|Death|0|||
23655970|NCT01790126|66128874|FG000|Overall Study|Radiographic Progression|3|||
23655971|NCT01790126|66128875|FG001|Overall Study|Radiographic Progression|1|||
23655972|NCT01790126|66128876|FG002|Overall Study|Radiographic Progression|0|||
23655973|NCT01505010|66128877|FG000|Overall Study|Protocol Violation|0|||
23600123|NCT04334317|65925806|FG000|Overall Study|Protocol Deviation|0|||
23600124|NCT04334317|65925807|FG001|Overall Study|Protocol Deviation|1|||
23600125|NCT04334317|65925808|FG002|Overall Study|Protocol Deviation|0|||
23600126|NCT04334317|65925809|FG003|Overall Study|Protocol Deviation|0|||
23655974|NCT01505010|66128878|FG001|Overall Study|Protocol Violation|1|||
23655975|NCT01505010|66128877|FG000|Overall Study|Lost to Follow-up|0|||
23655976|NCT01505010|66128878|FG001|Overall Study|Lost to Follow-up|1|||
23655977|NCT03037619|66128880|FG000|Overall Study|Lost to Follow-up|0|||
23655978|NCT03037619|66128881|FG001|Overall Study|Lost to Follow-up|1|||
23655979|NCT02072434|66128882|FG000|Overall Study|Protocol Violation|10|||
23655980|NCT02072434|66128883|FG001|Overall Study|Protocol Violation|9|||
23361221|NCT01098162|65069642|FG000|Overall Study|Other Reason|1|||
23600127|NCT04334317|65925806|FG000|Overall Study|Withdrawal by Subject|2|||
23600128|NCT04334317|65925807|FG001|Overall Study|Withdrawal by Subject|2|||
23655981|NCT02072434|66128882|FG000|Overall Study|Physician Decision|5|||
23655982|NCT02072434|66128883|FG001|Overall Study|Physician Decision|10|||
23361222|NCT01098162|65069642|FG000|Overall Study|Reason Unknown|26|||
23361223|NCT01073163|65069643|FG000|Overall Study|Adverse Event|1|||
23361224|NCT01073163|65069643|FG000|Overall Study|Disease Progression|1|||
23361225|NCT01073163|65069643|FG000|Overall Study|Early termination|1|||
23361226|NCT01021332|65069646|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
23361227|NCT01021332|65069646|FG000|Overall Study|Adverse Event|43|||
23480367|NCT01330017|65501958|FG004|Overall Study|Protocol Violation|0|||
23480368|NCT01330017|65501954|FG000|Overall Study|Unknown Reason|5|||
23361228|NCT01021332|65069646|FG000|Overall Study|Lack of Efficacy|19|||
23361229|NCT01021332|65069646|FG000|Overall Study|Withdrawal of Consent|23|||
23361230|NCT01021332|65069646|FG000|Overall Study|Lost to Follow-up|4|||
23361231|NCT01021332|65069646|FG000|Overall Study|Protocol Violation|9|||
23480369|NCT01330017|65501955|FG001|Overall Study|Unknown Reason|3|||
23655983|NCT02072434|66128882|FG000|Overall Study|Adverse event, serious fatal|1|||
23655984|NCT02072434|66128883|FG001|Overall Study|Adverse event, serious fatal|6|||
23655985|NCT02072434|66128882|FG000|Overall Study|Adverse Event|7|||
23655986|NCT02072434|66128883|FG001|Overall Study|Adverse Event|6|||
23655987|NCT02072434|66128882|FG000|Overall Study|Withdrawal by Subject|17|||
23655988|NCT02072434|66128883|FG001|Overall Study|Withdrawal by Subject|29|||
23655989|NCT02072434|66128882|FG000|Overall Study|Other|14|||
23655990|NCT02072434|66128883|FG001|Overall Study|Other|29|||
23655991|NCT02072434|66128882|FG000|Overall Study|Lost to Follow-up|0|||
23805626|NCT00003138|66668717|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
23805627|NCT00003138|66668718|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
23805628|NCT00003138|66668717|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
23805629|NCT00003138|66668718|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
23805630|NCT00003138|66668717|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
23805631|NCT00003138|66668718|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
23805632|NCT00003138|66668717|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
23805633|NCT00003138|66668718|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
23805634|NCT03463993|66668719|FG000|Overall Study|Lost to Follow-up|7|||
23805635|NCT03463993|66668720|FG001|Overall Study|Lost to Follow-up|8|||
23805636|NCT03463993|66668719|FG000|Overall Study|Withdrawal by Subject|2|||
23805637|NCT03463993|66668720|FG001|Overall Study|Withdrawal by Subject|0|||
23805638|NCT03463993|66668719|FG000|Overall Study|Protocol Violation|4|||
23805639|NCT03463993|66668720|FG001|Overall Study|Protocol Violation|1|||
23805640|NCT03463993|66668719|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
23805641|NCT03463993|66668720|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
23805642|NCT03463993|66668719|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
23805643|NCT03463993|66668720|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
23805644|NCT02138136|66668724|FG000|Overall Study|Protocol Violation|4|||
23805645|NCT02138136|66668724|FG000|Overall Study|Physician Decision|7|||
23805646|NCT02138136|66668724|FG000|Overall Study|Lack of Efficacy|35|||
23805647|NCT02138136|66668724|FG000|Overall Study|Pregnancy|2|||
23805648|NCT02138136|66668724|FG000|Overall Study|Adverse Event|18|||
23805649|NCT02138136|66668724|FG000|Overall Study|Withdrawal by Subject|36|||
23805650|NCT02138136|66668724|FG000|Overall Study|Lost to Follow-up|32|||
23805651|NCT02138136|66668724|FG000|Overall Study|Withdrawn by Sponsor|5|||
23805652|NCT01462318|66668725|FG000|Main Study / TP-DI Study|Other|2|||
23805653|NCT01462318|66668726|FG001|Main Study / TP-DI Study|Other|0|||
23805654|NCT01462318|66668727|FG002|Main Study / TP-DI Study|Other|0|||
23805655|NCT01462318|66668725|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
23805656|NCT01462318|66668726|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
23805657|NCT01462318|66668727|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
23805658|NCT01462318|66668725|FG000|Main Study / TP-DI Study|Adverse Event|4|||
23805659|NCT01462318|66668726|FG001|Main Study / TP-DI Study|Adverse Event|0|||
23805660|NCT01462318|66668727|FG002|Main Study / TP-DI Study|Adverse Event|0|||
23805661|NCT01462318|66668725|FG000|Extension Phase|Lost to Follow-up|0|||
23805662|NCT01462318|66668726|FG001|Extension Phase|Lost to Follow-up|0|||
23805663|NCT01462318|66668727|FG002|Extension Phase|Lost to Follow-up|1|||
23805664|NCT01462318|66668725|FG000|Extension Phase|Other|0|||
23805665|NCT01462318|66668726|FG001|Extension Phase|Other|0|||
23805666|NCT01462318|66668727|FG002|Extension Phase|Other|1|||
23805667|NCT01462318|66668725|FG000|Extension Phase|Disease Progression|0|||
23805668|NCT01462318|66668726|FG001|Extension Phase|Disease Progression|0|||
23805669|NCT01462318|66668727|FG002|Extension Phase|Disease Progression|1|||
23805670|NCT01462318|66668725|FG000|Extension Phase|Withdrawal by Subject|0|||
23805671|NCT01462318|66668726|FG001|Extension Phase|Withdrawal by Subject|0|||
23805672|NCT01462318|66668727|FG002|Extension Phase|Withdrawal by Subject|15|||
23805673|NCT01462318|66668725|FG000|Extension Phase|Investigator Decision|0|||
23805674|NCT01462318|66668726|FG001|Extension Phase|Investigator Decision|0|||
23805675|NCT01462318|66668727|FG002|Extension Phase|Investigator Decision|5|||
23805676|NCT01462318|66668725|FG000|Extension Phase|Adverse Event|0|||
23805677|NCT01462318|66668726|FG001|Extension Phase|Adverse Event|0|||
23805678|NCT01462318|66668727|FG002|Extension Phase|Adverse Event|22|||
23805679|NCT03064438|66668728|FG000|Overall Study|Lost to Follow-up|1|||
23655992|NCT02072434|66128883|FG001|Overall Study|Lost to Follow-up|1|||
23655993|NCT03189862|66128891|FG000|Overall Study|Withdrawal by Subject|1|||
23655994|NCT03189862|66128892|FG001|Overall Study|Withdrawal by Subject|0|||
23655995|NCT03189862|66128891|FG000|Overall Study|Lost to Follow-up|54|||
23655996|NCT03189862|66128892|FG001|Overall Study|Lost to Follow-up|62|||
23655997|NCT02366728|66128893|FG000|Overall Study|Death|0|||
23655998|NCT02366728|66128894|FG001|Overall Study|Death|0|||
23655999|NCT02366728|66128895|FG002|Overall Study|Death|1|||
23656000|NCT02366728|66128893|FG000|Overall Study|Adverse Event|1|||
23656001|NCT02366728|66128894|FG001|Overall Study|Adverse Event|0|||
23656002|NCT02366728|66128895|FG002|Overall Study|Adverse Event|0|||
23656003|NCT02366728|66128893|FG000|Overall Study|Screen Failure|2|||
23656004|NCT02366728|66128894|FG001|Overall Study|Screen Failure|1|||
23656005|NCT02366728|66128895|FG002|Overall Study|Screen Failure|0|||
23656006|NCT02366728|66128893|FG000|Overall Study|Only yielded 2 vaccines|1|||
23656007|NCT02366728|66128894|FG001|Overall Study|Only yielded 2 vaccines|0|||
23656008|NCT02366728|66128895|FG002|Overall Study|Only yielded 2 vaccines|0|||
23656009|NCT00651157|66128903|FG000|Overall Study|Death|1|||
23656010|NCT00651157|66128903|FG000|Overall Study|Protocol Violation|1|||
23656011|NCT00150969|66128904|FG000|24 Month Main Study|Adverse Event|3|||
23656012|NCT00150969|66128905|FG001|24 Month Main Study|Adverse Event|4|||
23656013|NCT00150969|66128904|FG000|24 Month Main Study|Death|1|||
23656014|NCT00150969|66128905|FG001|24 Month Main Study|Death|1|||
23656015|NCT00150969|66128904|FG000|24 Month Main Study|Lack of Efficacy|1|||
23656016|NCT00150969|66128905|FG001|24 Month Main Study|Lack of Efficacy|8|||
23656017|NCT00150969|66128904|FG000|24 Month Main Study|Lost to Follow-up|3|||
23656018|NCT00150969|66128905|FG001|24 Month Main Study|Lost to Follow-up|2|||
23656019|NCT00150969|66128904|FG000|24 Month Main Study|Protocol Violation|4|||
23656020|NCT00150969|66128905|FG001|24 Month Main Study|Protocol Violation|2|||
23656021|NCT00150969|66128904|FG000|24 Month Main Study|Withdrawal by Subject|7|||
23656022|NCT00150969|66128905|FG001|24 Month Main Study|Withdrawal by Subject|4|||
23656023|NCT00150969|66128904|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
23656024|NCT00150969|66128905|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
23656025|NCT00150969|66128904|FG000|24-48 Month Extension|Lack of Efficacy|0|||
23656026|NCT00150969|66128905|FG001|24-48 Month Extension|Lack of Efficacy|1|||
23656027|NCT00150969|66128904|FG000|24-48 Month Extension|Adverse Event|1|||
23656028|NCT00150969|66128905|FG001|24-48 Month Extension|Adverse Event|3|||
23656029|NCT00150969|66128904|FG000|24-48 Month Extension|Other Reason|81|||
23656030|NCT00150969|66128905|FG001|24-48 Month Extension|Other Reason|91|||
23656031|NCT01765179|66128913|FG000|Overall Study|Adverse Event|3|||
23656032|NCT01765179|66128913|FG000|Overall Study|Lost to Follow-up|5|||
23656033|NCT01765179|66128913|FG000|Overall Study|Non-compliance with study drug|2|||
23656034|NCT01765179|66128913|FG000|Overall Study|Protocol Violation|1|||
23656035|NCT01765179|66128913|FG000|Overall Study|Withdrawal by Subject|8|||
23656036|NCT01765179|66128913|FG000|Overall Study|Hematocrit >54%|3|||
23656037|NCT01765179|66128913|FG000|Overall Study|prohibited med|1|||
23656038|NCT01765179|66128913|FG000|Overall Study|Out of country unable to finish study|1|||
23656039|NCT01765179|66128913|FG000|Overall Study|lack of venous access|1|||
23656040|NCT01765179|66128913|FG000|Overall Study|work conflict|1|||
23656041|NCT01765179|66128913|FG000|Overall Study|Ca elevated 10.6|1|||
23656042|NCT00597753|66128917|FG000|Overall Study|Adverse Event|6|||
23656043|NCT00597753|66128918|FG001|Overall Study|Adverse Event|2|||
23656044|NCT00597753|66128917|FG000|Overall Study|Death|55|||
23656045|NCT00597753|66128918|FG001|Overall Study|Death|29|||
23656046|NCT00597753|66128917|FG000|Overall Study|Lack of Efficacy|2|||
23656047|NCT00597753|66128918|FG001|Overall Study|Lack of Efficacy|0|||
23656048|NCT00597753|66128917|FG000|Overall Study|Lost to Follow-up|10|||
23656049|NCT00597753|66128918|FG001|Overall Study|Lost to Follow-up|3|||
23656050|NCT00597753|66128917|FG000|Overall Study|Physician Decision|5|||
23805680|NCT03064438|66668729|FG001|Overall Study|Lost to Follow-up|0|||
23805681|NCT03064438|66668728|FG000|Overall Study|Withdrawal by Subject|0|||
23805682|NCT03064438|66668729|FG001|Overall Study|Withdrawal by Subject|1|||
23805683|NCT03254602|66668732|FG000|Overall Study|Lost to Follow-up|4|||
23361232|NCT01021332|65069646|FG000|Overall Study|Miscellaneous|3|||
23480370|NCT01330017|65501956|FG002|Overall Study|Unknown Reason|5|||
23480371|NCT01330017|65501957|FG003|Overall Study|Unknown Reason|7|||
23656051|NCT00597753|66128918|FG001|Overall Study|Physician Decision|1|||
23656052|NCT00597753|66128917|FG000|Overall Study|Pregnancy|1|||
23656053|NCT00597753|66128918|FG001|Overall Study|Pregnancy|0|||
23656054|NCT00597753|66128917|FG000|Overall Study|Withdrawal by Subject|35|||
23656055|NCT00597753|66128918|FG001|Overall Study|Withdrawal by Subject|12|||
23656056|NCT00597753|66128917|FG000|Overall Study|Discontinued Dialysis|0|||
23361233|NCT01001520|65069647|FG000|Medication Period 1|Withdrawal by Subject|2|||
23480372|NCT01330017|65501958|FG004|Overall Study|Unknown Reason|2|||
23656057|NCT00597753|66128918|FG001|Overall Study|Discontinued Dialysis|1|||
23656058|NCT00597753|66128917|FG000|Overall Study|Never dosed|2|||
23656059|NCT00597753|66128918|FG001|Overall Study|Never dosed|0|||
23656060|NCT00597753|66128917|FG000|Overall Study|Noncompliance|2|||
23656061|NCT00597753|66128918|FG001|Overall Study|Noncompliance|1|||
23600129|NCT04334317|65925808|FG002|Overall Study|Withdrawal by Subject|0|||
23600130|NCT04334317|65925809|FG003|Overall Study|Withdrawal by Subject|0|||
23600131|NCT02148705|65925810|FG000|Overall Study|Death|2|||
23600132|NCT02148705|65925811|FG001|Overall Study|Death|0|||
23600133|NCT02148705|65925812|FG002|Overall Study|Death|0|||
23600134|NCT02148705|65925810|FG000|Overall Study|Lost to Follow-up|13|||
23600135|NCT02148705|65925811|FG001|Overall Study|Lost to Follow-up|4|||
23805684|NCT00876018|66668735|FG000|Overall Study|Lost to Follow-up|0|||
23805685|NCT00876018|66668736|FG001|Overall Study|Lost to Follow-up|1|||
23805686|NCT00876018|66668737|FG002|Overall Study|Lost to Follow-up|1|||
23805687|NCT00876018|66668735|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
23805688|NCT00876018|66668736|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
23805689|NCT00876018|66668737|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
23805690|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
23805691|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
23805692|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
23805693|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
23805694|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
23805695|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
23805696|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
23805697|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
23805698|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
23805699|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
23805700|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
23805701|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
23805702|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
23805703|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
23805704|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
23805705|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
23600136|NCT02148705|65925812|FG002|Overall Study|Lost to Follow-up|10|||
23805706|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
23805707|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
23805708|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
23480373|NCT01829243|65501959|FG000|First Intervention|Screen Failure|4|||
23805709|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
23805710|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
23805711|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
23361234|NCT01001520|65069648|FG001|Medication Period 1|Withdrawal by Subject|2|||
23600137|NCT02148705|65925810|FG000|Overall Study|Withdrawal by Subject|3|||
23600138|NCT02148705|65925811|FG001|Overall Study|Withdrawal by Subject|0|||
23600139|NCT02148705|65925812|FG002|Overall Study|Withdrawal by Subject|2|||
23600140|NCT02148705|65925810|FG000|Overall Study|Not Treated|0|||
23600141|NCT02148705|65925811|FG001|Overall Study|Not Treated|1|||
23600142|NCT02148705|65925812|FG002|Overall Study|Not Treated|5|||
23600143|NCT01485887|65925814|FG000|Overall Study|Withdrawal by Subject|2|||
23600144|NCT01485887|65925814|FG000|Overall Study|Adverse Event|8|||
23600145|NCT01485887|65925814|FG000|Overall Study|Deterioration of primary disease|1|||
23805712|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
23805713|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
23805714|NCT01421342|66668739|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
23805715|NCT01421342|66668740|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
23805716|NCT01421342|66668741|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
23805717|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
23805718|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
23805719|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
23361235|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
23600146|NCT01485887|65925814|FG000|Overall Study|Primary disease markedly improved|1|||
23656062|NCT00597753|66128917|FG000|Overall Study|Relocation|17|||
23656063|NCT00597753|66128918|FG001|Overall Study|Relocation|6|||
23656064|NCT00597753|66128917|FG000|Overall Study|Renal transplant|10|||
23656065|NCT00597753|66128918|FG001|Overall Study|Renal transplant|3|||
23656066|NCT00597753|66128917|FG000|Overall Study|Site closed by sponsor|19|||
23656067|NCT00597753|66128918|FG001|Overall Study|Site closed by sponsor|7|||
23656068|NCT00597753|66128917|FG000|Overall Study|Site elected to close|2|||
23656069|NCT00597753|66128918|FG001|Overall Study|Site elected to close|4|||
23361236|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
23656070|NCT02401412|66128919|FG000|Overall Study|Lost to Follow-up|1|||
23656071|NCT02401412|66128920|FG001|Overall Study|Lost to Follow-up|0|||
23656072|NCT02401412|66128919|FG000|Overall Study|Discontinued Intervention|15|||
23656073|NCT02401412|66128920|FG001|Overall Study|Discontinued Intervention|21|||
23656074|NCT02401412|66128919|FG000|Overall Study|Withdrawal by Subject|4|||
23656075|NCT02401412|66128920|FG001|Overall Study|Withdrawal by Subject|4|||
23656076|NCT02401412|66128919|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
23656077|NCT02401412|66128920|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
23656078|NCT02401412|66128919|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
23656079|NCT02401412|66128920|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
23656080|NCT00974090|66128921|FG000|Period 1: Double Blind Period|Adverse Event|2|||
23656081|NCT00974090|66128922|FG001|Period 1: Double Blind Period|Adverse Event|1|||
23656082|NCT00974090|66128921|FG000|Period 1: Double Blind Period|Physician Decision|1|||
23656083|NCT00974090|66128922|FG001|Period 1: Double Blind Period|Physician Decision|0|||
23656084|NCT00974090|66128921|FG000|Period 2: Open-label Period|Adverse Event|4|||
23656085|NCT00974090|66128922|FG001|Period 2: Open-label Period|Adverse Event|6|||
23656086|NCT00974090|66128921|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
23656087|NCT00974090|66128922|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
23656088|NCT00974090|66128921|FG000|Period 2: Open-label Period|Physician Decision|0|||
23656089|NCT00974090|66128922|FG001|Period 2: Open-label Period|Physician Decision|3|||
23656090|NCT00974090|66128921|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
23656091|NCT00974090|66128922|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
23656092|NCT01708291|66128930|FG000|Overall Study|fighting|2|||
23656093|NCT01708291|66128931|FG001|Overall Study|fighting|1|||
23656094|NCT00659529|66128932|FG000|Overall Study|Withdrawal by Subject|4|||
23656095|NCT00659529|66128932|FG000|Overall Study|Protocol Violation|3|||
23656096|NCT00659529|66128932|FG000|Overall Study|Screen failure|9|||
23656097|NCT01776424|66128933|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
23656098|NCT01776424|66128934|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
23656099|NCT01776424|66128935|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
23656100|NCT01776424|66128933|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
23656101|NCT01776424|66128934|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
23656102|NCT01776424|66128935|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
23656103|NCT01776424|66128933|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
23656104|NCT01776424|66128934|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
23656105|NCT01776424|66128935|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
23656106|NCT01776424|66128933|FG000|LTOLE Part (Open Label)|Refused|5|||
23656107|NCT01776424|66128934|FG001|LTOLE Part (Open Label)|Refused|2|||
23656108|NCT01776424|66128935|FG002|LTOLE Part (Open Label)|Refused|11|||
23656109|NCT01776424|66128933|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
23656110|NCT01776424|66128934|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
23656111|NCT01776424|66128935|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
23656112|NCT01891721|66128936|FG000|Overall Study|Lost to Follow-up|10|||
23656113|NCT01891721|66128937|FG001|Overall Study|Lost to Follow-up|5|||
23656114|NCT01891721|66128938|FG002|Overall Study|Lost to Follow-up|1|||
23656115|NCT00992511|66128941|FG000|Overall Study|Migrated/moved from study area|1|||
23656116|NCT00992511|66128942|FG001|Overall Study|Migrated/moved from study area|0|||
23656117|NCT00992511|66128943|FG002|Overall Study|Migrated/moved from study area|1|||
23656118|NCT00992511|66128944|FG003|Overall Study|Migrated/moved from study area|2|||
23656119|NCT00992511|66128941|FG000|Overall Study|Lost to Follow-up|1|||
23656120|NCT00992511|66128942|FG001|Overall Study|Lost to Follow-up|0|||
23656121|NCT00992511|66128943|FG002|Overall Study|Lost to Follow-up|0|||
23656122|NCT00992511|66128944|FG003|Overall Study|Lost to Follow-up|2|||
23656123|NCT00992511|66128941|FG000|Overall Study|Withdrawal by Subject|0|||
23656124|NCT00992511|66128942|FG001|Overall Study|Withdrawal by Subject|0|||
23656125|NCT00992511|66128943|FG002|Overall Study|Withdrawal by Subject|1|||
23656126|NCT00992511|66128944|FG003|Overall Study|Withdrawal by Subject|1|||
23656127|NCT01103245|66128945|FG000|Overall Study|Withdrawal by Subject|1|||
23656128|NCT01103245|66128946|FG001|Overall Study|Withdrawal by Subject|0|||
23656129|NCT01103245|66128947|FG002|Overall Study|Withdrawal by Subject|3|||
23656130|NCT01103245|66128948|FG003|Overall Study|Withdrawal by Subject|0|||
23656131|NCT01103245|66128945|FG000|Overall Study|Inadequate IV access|1|||
23656132|NCT01103245|66128946|FG001|Overall Study|Inadequate IV access|0|||
23656133|NCT01103245|66128947|FG002|Overall Study|Inadequate IV access|0|||
23656134|NCT01103245|66128948|FG003|Overall Study|Inadequate IV access|0|||
23656135|NCT01103245|66128945|FG000|Overall Study|Adverse Event|0|||
23656136|NCT01103245|66128946|FG001|Overall Study|Adverse Event|2|||
23656137|NCT01103245|66128947|FG002|Overall Study|Adverse Event|1|||
23656138|NCT01103245|66128948|FG003|Overall Study|Adverse Event|0|||
23656139|NCT01103245|66128945|FG000|Overall Study|Physician Decision|1|||
23656140|NCT01103245|66128946|FG001|Overall Study|Physician Decision|0|||
23656141|NCT01103245|66128947|FG002|Overall Study|Physician Decision|0|||
23656142|NCT01103245|66128948|FG003|Overall Study|Physician Decision|0|||
23656143|NCT00928564|66128951|FG000|Overall Study|Lost to Follow-up|6|||
23656144|NCT00928564|66128952|FG001|Overall Study|Lost to Follow-up|0|||
23656145|NCT01990534|66128957|FG000|Overall Study|Death|22|||
23656146|NCT01990534|66128957|FG000|Overall Study|Progressive disease|3|||
23656147|NCT01990534|66128957|FG000|Overall Study|Protocol Violation|1|||
23656148|NCT01990534|66128957|FG000|Overall Study|Withdrawal of Informed Consent|2|||
23656149|NCT01990534|66128957|FG000|Overall Study|Symptomatic Deterioration|1|||
23656150|NCT01990534|66128957|FG000|Overall Study|Withdrawal by Subject|3|||
23656151|NCT01990534|66128957|FG000|Overall Study|Reason not Specified|2|||
23656152|NCT01990534|66128957|FG000|Overall Study|Lost to Follow-up|1|||
23656153|NCT02678416|66128960|FG000|Part 1|Withdrawal by Subject|1|||
23656154|NCT02678416|66128960|FG000|Part 2|Adverse Event|2|||
23656155|NCT02678416|66128960|FG000|Part 2|Withdrawal by Subject|1|||
23656156|NCT01383096|66128961|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23656157|NCT01383096|66128962|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23656158|NCT01383096|66128963|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
23656159|NCT01383096|66128961|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23656160|NCT01383096|66128962|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23656161|NCT01383096|66128963|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23656162|NCT01383096|66128961|FG000|Third Intervention (8 Days)|Elevated AST|0|||
23656163|NCT01383096|66128962|FG001|Third Intervention (8 Days)|Elevated AST|1|||
23656164|NCT01383096|66128963|FG002|Third Intervention (8 Days)|Elevated AST|0|||
23656165|NCT01383096|66128961|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
23656166|NCT01383096|66128962|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
23656167|NCT01383096|66128963|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23656168|NCT01383096|66128961|FG000|Third Intervention (8 Days)|Adverse Event|1|||
23656169|NCT01383096|66128962|FG001|Third Intervention (8 Days)|Adverse Event|0|||
23656170|NCT01383096|66128963|FG002|Third Intervention (8 Days)|Adverse Event|0|||
23656171|NCT01383096|66128961|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
23656172|NCT01383096|66128962|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
23656173|NCT01383096|66128963|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
23656174|NCT01383096|66128961|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
23656175|NCT01383096|66128962|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23656176|NCT01383096|66128963|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23805720|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
23805721|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
23805722|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
23805723|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
23805724|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
23805725|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
23805726|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
23805727|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
23805728|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
23805729|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
23805730|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
23805731|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
23805732|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
23805733|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
23805734|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
23805735|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
23805736|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
23805737|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
23805738|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
23805739|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
23805740|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
23805741|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
23805742|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
23805743|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
23805744|NCT01421342|66668739|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
23805745|NCT01421342|66668740|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
23805746|NCT01421342|66668741|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
23805747|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
23805748|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
23805749|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
23805750|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
23805751|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
23805752|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
23656177|NCT01383096|66128961|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23656178|NCT01383096|66128962|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23656179|NCT01383096|66128963|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23656180|NCT01383096|66128961|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
23656181|NCT01383096|66128962|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23656182|NCT01383096|66128963|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23656183|NCT01383096|66128961|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
23656184|NCT01383096|66128962|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
23656185|NCT01383096|66128963|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
23656186|NCT01383096|66128961|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
23656187|NCT01383096|66128962|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
23656188|NCT01383096|66128963|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
23656189|NCT02383589|66128966|FG000|Treatment Period|Adverse Event|1|||
23656190|NCT02383589|66128967|FG001|Treatment Period|Adverse Event|3|||
23656191|NCT02383589|66128966|FG000|Treatment Period|Lost to Follow-up|0|||
23656192|NCT02383589|66128967|FG001|Treatment Period|Lost to Follow-up|1|||
23656193|NCT02383589|66128966|FG000|Treatment Period|Withdrawal by Subject|0|||
23656194|NCT02383589|66128967|FG001|Treatment Period|Withdrawal by Subject|5|||
23656195|NCT02383589|66128966|FG000|Treatment Period|Non-compliance with study drug|0|||
23656196|NCT02383589|66128967|FG001|Treatment Period|Non-compliance with study drug|1|||
23656197|NCT02383589|66128966|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
23656198|NCT02383589|66128967|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
23656199|NCT02383589|66128966|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
23656200|NCT02383589|66128967|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
23656201|NCT02383589|66128966|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
23656202|NCT02383589|66128967|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
23656203|NCT04585646|66128968|FG000|First Intervention|Physician Decision|1|||
23656204|NCT04585646|66128969|FG001|First Intervention|Physician Decision|0|||
23656205|NCT04585646|66128968|FG000|First Intervention|Lost to Follow-up|0|||
23656206|NCT04585646|66128969|FG001|First Intervention|Lost to Follow-up|3|||
23656207|NCT04585646|66128968|FG000|First Intervention|Withdrawal by Subject|0|||
23656208|NCT04585646|66128969|FG001|First Intervention|Withdrawal by Subject|1|||
23656209|NCT02982239|66128973|FG000|Overall Study|Lost to Follow-up|3|||
23656210|NCT02982239|66128974|FG001|Overall Study|Lost to Follow-up|2|||
23656211|NCT01667107|66128975|FG000|Overall Study|Adverse Event|4|||
23656212|NCT01667107|66128976|FG001|Overall Study|Adverse Event|3|||
23656213|NCT01667107|66128975|FG000|Overall Study|Tolerability issues|0|||
23656214|NCT01667107|66128976|FG001|Overall Study|Tolerability issues|2|||
23656215|NCT01667107|66128975|FG000|Overall Study|Protocol Violation|0|||
23656216|NCT01667107|66128976|FG001|Overall Study|Protocol Violation|1|||
23656217|NCT01667107|66128975|FG000|Overall Study|Lack of Efficacy|0|||
23656218|NCT01667107|66128976|FG001|Overall Study|Lack of Efficacy|1|||
23656219|NCT01854645|66128977|FG000|Overall Study|Protocol-Specified Criteria|13|||
23656220|NCT01854645|66128978|FG001|Overall Study|Protocol-Specified Criteria|10|||
23656221|NCT01854645|66128979|FG002|Overall Study|Protocol-Specified Criteria|8|||
23656222|NCT01854645|66128980|FG003|Overall Study|Protocol-Specified Criteria|5|||
23656223|NCT01854645|66128981|FG004|Overall Study|Protocol-Specified Criteria|7|||
23656224|NCT01854645|66128977|FG000|Overall Study|Administrative Reasons / Missing|0|||
23656225|NCT01854645|66128978|FG001|Overall Study|Administrative Reasons / Missing|0|||
23656226|NCT01854645|66128979|FG002|Overall Study|Administrative Reasons / Missing|0|||
23656227|NCT01854645|66128980|FG003|Overall Study|Administrative Reasons / Missing|1|||
23656228|NCT01854645|66128981|FG004|Overall Study|Administrative Reasons / Missing|1|||
23656229|NCT01854645|66128977|FG000|Overall Study|Protocol Violation|3|||
23656230|NCT01854645|66128978|FG001|Overall Study|Protocol Violation|0|||
23656231|NCT01854645|66128979|FG002|Overall Study|Protocol Violation|5|||
23480374|NCT01829243|65501960|FG001|First Intervention|Screen Failure|2|||
23480375|NCT02342418|65501961|FG000|Overall Study|Adverse Event|0|||
23480376|NCT02342418|65501962|FG001|Overall Study|Adverse Event|1|||
23480377|NCT02195011|65501963|FG000|Overall Study|Adverse Event|4|||
23480378|NCT02195011|65501964|FG001|Overall Study|Adverse Event|0|||
23480379|NCT02195011|65501963|FG000|Overall Study|Progressive Disease|18|||
23480380|NCT02195011|65501964|FG001|Overall Study|Progressive Disease|1|||
23480381|NCT02195011|65501963|FG000|Overall Study|Withdrawal by Subject|3|||
23480382|NCT02195011|65501964|FG001|Overall Study|Withdrawal by Subject|0|||
23480383|NCT00266864|65501965|FG000|Overall Study|Lost to Follow-up|4|||
23480384|NCT00266864|65501966|FG001|Overall Study|Lost to Follow-up|1|||
23480385|NCT00266864|65501965|FG000|Overall Study|Withdrawal by Subject|1|||
23480386|NCT00266864|65501966|FG001|Overall Study|Withdrawal by Subject|1|||
23600147|NCT00692913|65925815|FG000|Overall Study|Adverse Event|8|||
23600148|NCT00692913|65925816|FG001|Overall Study|Adverse Event|4|||
23600149|NCT00692913|65925815|FG000|Overall Study|Lost to Follow-up|3|||
23600150|NCT00692913|65925816|FG001|Overall Study|Lost to Follow-up|5|||
23600151|NCT00692913|65925815|FG000|Overall Study|Physician Decision|2|||
23600152|NCT00692913|65925816|FG001|Overall Study|Physician Decision|0|||
23600153|NCT00692913|65925815|FG000|Overall Study|Protocol Violation|1|||
23600154|NCT00692913|65925816|FG001|Overall Study|Protocol Violation|1|||
23600155|NCT00692913|65925815|FG000|Overall Study|Withdrawal by Subject|15|||
23600156|NCT00692913|65925816|FG001|Overall Study|Withdrawal by Subject|20|||
23600157|NCT02701296|65925822|FG000|Overall Study|Incomplete Data|0|||
23600158|NCT02701296|65925823|FG001|Overall Study|Incomplete Data|2|||
23600159|NCT02130557|65925829|FG000|Overall Study|Withdrawal by Subject|12|||
23600160|NCT02130557|65925830|FG001|Overall Study|Withdrawal by Subject|12|||
23600161|NCT02130557|65925829|FG000|Overall Study|Investigator Request|0|||
23600162|NCT02130557|65925830|FG001|Overall Study|Investigator Request|2|||
23600163|NCT02130557|65925829|FG000|Overall Study|Deceased|14|||
23600164|NCT02130557|65925830|FG001|Overall Study|Deceased|14|||
23600165|NCT02130557|65925829|FG000|Overall Study|Lost to Follow-up|6|||
23600166|NCT02130557|65925830|FG001|Overall Study|Lost to Follow-up|7|||
23600167|NCT02130557|65925829|FG000|Overall Study|Other|2|||
23600168|NCT02130557|65925830|FG001|Overall Study|Other|1|||
23656232|NCT01854645|66128980|FG003|Overall Study|Protocol Violation|4|||
23656233|NCT01854645|66128981|FG004|Overall Study|Protocol Violation|1|||
23656234|NCT01854645|66128977|FG000|Overall Study|Lost to Follow-up|10|||
23656235|NCT01854645|66128978|FG001|Overall Study|Lost to Follow-up|7|||
23656236|NCT01854645|66128979|FG002|Overall Study|Lost to Follow-up|8|||
23656237|NCT01854645|66128980|FG003|Overall Study|Lost to Follow-up|5|||
23656238|NCT01854645|66128981|FG004|Overall Study|Lost to Follow-up|0|||
23656239|NCT01854645|66128977|FG000|Overall Study|Physician Decision|1|||
23805753|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
23805754|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
23805755|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
23805756|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
23805757|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
23805758|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
23805759|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
23805760|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
23805761|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
23805762|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
23805763|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
23805764|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
23805765|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
23805766|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
23805767|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
23805768|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23805769|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23805770|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23805771|NCT01421342|66668739|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
23805772|NCT01421342|66668740|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
23805773|NCT01421342|66668741|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
23805774|NCT03001219|66668742|FG000|Proof of Concept|Study Termination by Sponsor|0|||
23805775|NCT03001219|66668743|FG001|Proof of Concept|Study Termination by Sponsor|1|||
23805776|NCT03001219|66668742|FG000|Proof of Concept|Withdrawal by Subject|0|||
23805777|NCT03001219|66668743|FG001|Proof of Concept|Withdrawal by Subject|4|||
23805778|NCT03001219|66668742|FG000|Proof of Concept|Protocol Deviation|0|||
23805779|NCT03001219|66668743|FG001|Proof of Concept|Protocol Deviation|1|||
23805780|NCT03001219|66668742|FG000|Proof of Concept|Adverse Event|1|||
23805781|NCT03001219|66668743|FG001|Proof of Concept|Adverse Event|1|||
23805782|NCT03001219|66668742|FG000|Proof of Concept|Physician Decision|1|||
23805783|NCT03001219|66668743|FG001|Proof of Concept|Physician Decision|0|||
23805784|NCT03001219|66668742|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
23805785|NCT03001219|66668743|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
23805786|NCT03001219|66668742|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
23805787|NCT03001219|66668743|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
23805788|NCT03001219|66668742|FG000|Extension Period Analysis|Physician Decision|0|||
23600169|NCT02130557|65925829|FG000|Overall Study|Missing|2|||
23600170|NCT02130557|65925830|FG001|Overall Study|Missing|1|||
23600171|NCT00116649|65925831|FG000|Overall Study|Adverse Event|20|||
23656240|NCT01854645|66128978|FG001|Overall Study|Physician Decision|5|||
23656241|NCT01854645|66128979|FG002|Overall Study|Physician Decision|3|||
23656242|NCT01854645|66128980|FG003|Overall Study|Physician Decision|3|||
23656243|NCT01854645|66128981|FG004|Overall Study|Physician Decision|7|||
23656244|NCT01854645|66128977|FG000|Overall Study|Withdrawal by Subject|31|||
23656245|NCT01854645|66128978|FG001|Overall Study|Withdrawal by Subject|41|||
23656246|NCT01854645|66128979|FG002|Overall Study|Withdrawal by Subject|30|||
23600172|NCT00116649|65925831|FG000|Overall Study|Lack of Efficacy|1|||
23600173|NCT00116649|65925831|FG000|Overall Study|Lost to Follow-up|32|||
23600174|NCT00116649|65925831|FG000|Overall Study|Withdrawal by Subject|68|||
23600175|NCT00116649|65925831|FG000|Overall Study|Local Skin Reaction|9|||
23600176|NCT00116649|65925831|FG000|Overall Study|Various Reasons|18|||
23600177|NCT00116649|65925831|FG000|Overall Study|Protocol Specified|7|||
23600178|NCT00146172|65925834|FG000|Overall Study|Adverse Event|0|||
23600179|NCT00146172|65925835|FG001|Overall Study|Adverse Event|0|||
23600180|NCT00146172|65925836|FG002|Overall Study|Adverse Event|1|||
23656247|NCT01854645|66128980|FG003|Overall Study|Withdrawal by Subject|21|||
23656248|NCT01854645|66128981|FG004|Overall Study|Withdrawal by Subject|24|||
23480387|NCT00727532|65501967|FG000|Overall Study|Adverse Event|1|||
23600181|NCT00146172|65925837|FG003|Overall Study|Adverse Event|1|||
23656249|NCT01854645|66128977|FG000|Overall Study|Lack of Efficacy|7|||
23600182|NCT00146172|65925838|FG004|Overall Study|Adverse Event|0|||
23600183|NCT00146172|65925839|FG005|Overall Study|Adverse Event|2|||
23600184|NCT00146172|65925840|FG006|Overall Study|Adverse Event|3|||
23600185|NCT00146172|65925841|FG007|Overall Study|Adverse Event|10|||
23600186|NCT00146172|65925834|FG000|Overall Study|Lost to Follow-up|0|||
23600187|NCT00146172|65925835|FG001|Overall Study|Lost to Follow-up|0|||
23600188|NCT00146172|65925836|FG002|Overall Study|Lost to Follow-up|0|||
23600189|NCT00146172|65925837|FG003|Overall Study|Lost to Follow-up|0|||
23600190|NCT00146172|65925838|FG004|Overall Study|Lost to Follow-up|0|||
23600191|NCT00146172|65925839|FG005|Overall Study|Lost to Follow-up|0|||
23600192|NCT00146172|65925840|FG006|Overall Study|Lost to Follow-up|0|||
23600193|NCT00146172|65925841|FG007|Overall Study|Lost to Follow-up|1|||
23600194|NCT00146172|65925834|FG000|Overall Study|Disease Progression|2|||
23600195|NCT00146172|65925835|FG001|Overall Study|Disease Progression|4|||
23600196|NCT00146172|65925836|FG002|Overall Study|Disease Progression|2|||
23600197|NCT00146172|65925837|FG003|Overall Study|Disease Progression|5|||
23600198|NCT00146172|65925838|FG004|Overall Study|Disease Progression|2|||
23600199|NCT00146172|65925839|FG005|Overall Study|Disease Progression|2|||
23600200|NCT00146172|65925840|FG006|Overall Study|Disease Progression|1|||
23600201|NCT00146172|65925841|FG007|Overall Study|Disease Progression|22|||
23600202|NCT00146172|65925834|FG000|Overall Study|Death|0|||
23600203|NCT00146172|65925835|FG001|Overall Study|Death|0|||
23600204|NCT00146172|65925836|FG002|Overall Study|Death|0|||
23600205|NCT00146172|65925837|FG003|Overall Study|Death|0|||
23600206|NCT00146172|65925838|FG004|Overall Study|Death|0|||
23600207|NCT00146172|65925839|FG005|Overall Study|Death|0|||
23600208|NCT00146172|65925840|FG006|Overall Study|Death|1|||
23600209|NCT00146172|65925841|FG007|Overall Study|Death|0|||
23600210|NCT00146172|65925834|FG000|Overall Study|Physician Decision|0|||
23600211|NCT00146172|65925835|FG001|Overall Study|Physician Decision|0|||
23600212|NCT00146172|65925836|FG002|Overall Study|Physician Decision|0|||
23600213|NCT00146172|65925837|FG003|Overall Study|Physician Decision|0|||
23600214|NCT00146172|65925838|FG004|Overall Study|Physician Decision|0|||
23600215|NCT00146172|65925839|FG005|Overall Study|Physician Decision|0|||
23600216|NCT00146172|65925840|FG006|Overall Study|Physician Decision|0|||
23600217|NCT00146172|65925841|FG007|Overall Study|Physician Decision|1|||
23480388|NCT00727532|65501967|FG000|Overall Study|Withdrawal by Subject|1|||
23480389|NCT02216812|65501968|FG000|Overall Study|Lost to Follow-up|10|||
23600218|NCT00146172|65925834|FG000|Overall Study|Withdrawal by Subject|0|||
23600219|NCT00146172|65925835|FG001|Overall Study|Withdrawal by Subject|0|||
23600220|NCT00146172|65925836|FG002|Overall Study|Withdrawal by Subject|0|||
23600221|NCT00146172|65925837|FG003|Overall Study|Withdrawal by Subject|0|||
23600222|NCT00146172|65925838|FG004|Overall Study|Withdrawal by Subject|0|||
23600223|NCT00146172|65925839|FG005|Overall Study|Withdrawal by Subject|1|||
23600224|NCT00146172|65925840|FG006|Overall Study|Withdrawal by Subject|1|||
23600225|NCT00146172|65925841|FG007|Overall Study|Withdrawal by Subject|4|||
23600226|NCT00146172|65925834|FG000|Overall Study|Symptomatic Deterioration|1|||
23600227|NCT00146172|65925835|FG001|Overall Study|Symptomatic Deterioration|0|||
23600228|NCT00146172|65925836|FG002|Overall Study|Symptomatic Deterioration|1|||
23600229|NCT00146172|65925837|FG003|Overall Study|Symptomatic Deterioration|0|||
23656250|NCT01854645|66128978|FG001|Overall Study|Lack of Efficacy|12|||
23656251|NCT01854645|66128979|FG002|Overall Study|Lack of Efficacy|9|||
23656252|NCT01854645|66128980|FG003|Overall Study|Lack of Efficacy|3|||
23656253|NCT01854645|66128981|FG004|Overall Study|Lack of Efficacy|9|||
23656254|NCT01854645|66128977|FG000|Overall Study|Adverse Event|33|||
23656255|NCT01854645|66128978|FG001|Overall Study|Adverse Event|31|||
23656256|NCT01854645|66128979|FG002|Overall Study|Adverse Event|19|||
23656257|NCT01854645|66128980|FG003|Overall Study|Adverse Event|20|||
23656258|NCT01854645|66128981|FG004|Overall Study|Adverse Event|11|||
23656259|NCT01230554|66128984|FG000|Overall Study|Lost to Follow-up|2|||
23656260|NCT01230554|66128984|FG000|Overall Study|Inability to maintain visit schedule|1|||
23656261|NCT00129623|66128988|FG000|Overall Study|Adverse Event|3|||
23656262|NCT00129623|66128989|FG001|Overall Study|Adverse Event|7|||
23656263|NCT00129623|66128988|FG000|Overall Study|Refused Treatment|5|||
23656264|NCT00129623|66128989|FG001|Overall Study|Refused Treatment|3|||
23656265|NCT00129623|66128988|FG000|Overall Study|Failure to Return|1|||
23656266|NCT00129623|66128989|FG001|Overall Study|Failure to Return|1|||
23656267|NCT00129623|66128988|FG000|Overall Study|Relocated job out of state|1|||
23656268|NCT00129623|66128989|FG001|Overall Study|Relocated job out of state|0|||
23656269|NCT00129623|66128988|FG000|Overall Study|Uncertainty to return|0|||
23656270|NCT00129623|66128989|FG001|Overall Study|Uncertainty to return|1|||
23361237|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
23656271|NCT00146328|66128990|FG000|Overall Study|Adverse Event|39|||
23656272|NCT00146328|66128991|FG001|Overall Study|Adverse Event|48|||
23656273|NCT00146328|66128992|FG002|Overall Study|Adverse Event|79|||
23656274|NCT00146328|66128990|FG000|Overall Study|Protocol Violation|11|||
23656275|NCT00146328|66128991|FG001|Overall Study|Protocol Violation|6|||
23656276|NCT00146328|66128992|FG002|Overall Study|Protocol Violation|12|||
23656277|NCT00146328|66128990|FG000|Overall Study|Lost to Follow-up|7|||
23656278|NCT00146328|66128991|FG001|Overall Study|Lost to Follow-up|4|||
23656279|NCT00146328|66128992|FG002|Overall Study|Lost to Follow-up|7|||
23656280|NCT00146328|66128990|FG000|Overall Study|Withdrawal by Subject|16|||
23656281|NCT00146328|66128991|FG001|Overall Study|Withdrawal by Subject|16|||
23656282|NCT00146328|66128992|FG002|Overall Study|Withdrawal by Subject|22|||
23656283|NCT00146328|66128990|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
23656284|NCT00146328|66128991|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
23805789|NCT03001219|66668743|FG001|Extension Period Analysis|Physician Decision|1|||
23805790|NCT03001219|66668742|FG000|Extension Period Analysis|Adverse Event|1|||
23805791|NCT03001219|66668743|FG001|Extension Period Analysis|Adverse Event|1|||
23805792|NCT03001219|66668742|FG000|Extension Period Analysis|Protocol Deviation|0|||
23805793|NCT03001219|66668743|FG001|Extension Period Analysis|Protocol Deviation|1|||
23805794|NCT03001219|66668742|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
23805795|NCT03001219|66668743|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
23805796|NCT02595008|66668744|FG000|Overall Study|Enrolled In Error|1|||
23805797|NCT02595008|66668745|FG001|Overall Study|Enrolled In Error|0|||
23805798|NCT01386684|66668746|FG000|Overall Study|Lost to Follow-up|51|||
23805799|NCT01386684|66668746|FG000|Overall Study|Other|51|||
23805800|NCT01386684|66668746|FG000|Overall Study|Death|47|||
23805801|NCT01386684|66668746|FG000|Overall Study|Withdrawal of Consent|44|||
23805802|NCT01386684|66668746|FG000|Overall Study|Alternative Therapy Required|37|||
23805803|NCT01386684|66668746|FG000|Overall Study|Disease Progression|28|||
23805804|NCT01386684|66668746|FG000|Overall Study|Adverse Event|20|||
23805805|NCT01386684|66668746|FG000|Overall Study|Noncompliance|8|||
23805806|NCT01386684|66668746|FG000|Overall Study|Protocol Violation|4|||
23805807|NCT01386684|66668746|FG000|Overall Study|Missing|3|||
23805808|NCT01659736|66668752|FG000|Treatment Period|Adverse Event|1|||
23805809|NCT01659736|66668753|FG001|Treatment Period|Adverse Event|1|||
23805810|NCT01659736|66668752|FG000|Treatment Period|Protocol Violation|3|||
23805811|NCT01659736|66668753|FG001|Treatment Period|Protocol Violation|1|||
23361238|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
23656285|NCT00146328|66128992|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
23805812|NCT01659736|66668752|FG000|Treatment Period|Withdrawal by Subject|1|||
23805813|NCT01659736|66668753|FG001|Treatment Period|Withdrawal by Subject|0|||
23656286|NCT00146328|66128990|FG000|Overall Study|Trial ended/site closed|8|||
23656287|NCT00146328|66128991|FG001|Overall Study|Trial ended/site closed|2|||
23656288|NCT00146328|66128992|FG002|Overall Study|Trial ended/site closed|19|||
23656289|NCT00146328|66128990|FG000|Overall Study|Patient decision to end|0|||
23656290|NCT00146328|66128991|FG001|Overall Study|Patient decision to end|1|||
23656291|NCT00146328|66128992|FG002|Overall Study|Patient decision to end|6|||
23656292|NCT00146328|66128990|FG000|Overall Study|Enroll into other trial|2|||
23361239|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
23600230|NCT00146172|65925838|FG004|Overall Study|Symptomatic Deterioration|1|||
23600231|NCT00146172|65925839|FG005|Overall Study|Symptomatic Deterioration|2|||
23600232|NCT00146172|65925840|FG006|Overall Study|Symptomatic Deterioration|0|||
23600233|NCT00146172|65925841|FG007|Overall Study|Symptomatic Deterioration|2|||
23600234|NCT00753545|65925844|FG000|Overall Study|Death|98|||
23600235|NCT00753545|65925845|FG001|Overall Study|Death|112|||
23600236|NCT00753545|65925844|FG000|Overall Study|Lost to Follow-up|2|||
23600237|NCT00753545|65925845|FG001|Overall Study|Lost to Follow-up|3|||
23600238|NCT00753545|65925844|FG000|Overall Study|Protocol Violation|1|||
23600239|NCT00753545|65925845|FG001|Overall Study|Protocol Violation|0|||
23600240|NCT00753545|65925844|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
23600241|NCT00753545|65925845|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
23600242|NCT00914966|65925850|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
23600243|NCT00914966|65925850|FG000|Step 1: 1500 Units|Physician Decision|1|||
23600244|NCT00914966|65925850|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
23600245|NCT03624972|65925851|FG000|Overall Study|Lost to Follow-up|2|||
23600246|NCT03624972|65925852|FG001|Overall Study|Lost to Follow-up|0|||
23600247|NCT03624972|65925853|FG002|Overall Study|Lost to Follow-up|0|||
23600248|NCT03624972|65925851|FG000|Overall Study|Withdrawal by Subject|0|||
23600249|NCT03624972|65925852|FG001|Overall Study|Withdrawal by Subject|2|||
23600250|NCT03624972|65925853|FG002|Overall Study|Withdrawal by Subject|0|||
23600251|NCT04075396|65925854|FG000|Overall Study|Death|11|||
23600252|NCT04075396|65925855|FG001|Overall Study|Death|9|||
23600253|NCT04075396|65925854|FG000|Overall Study|Withdrawal by Subject|1|||
23600254|NCT04075396|65925855|FG001|Overall Study|Withdrawal by Subject|2|||
23600255|NCT04075396|65925854|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
23600256|NCT04075396|65925855|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
23600257|NCT04075396|65925854|FG000|Overall Study|Enrolled but not-treated|0|||
23600258|NCT04075396|65925855|FG001|Overall Study|Enrolled but not-treated|1|||
23600259|NCT01000805|65925856|FG000|Overall Study|Adverse Event|21|||
23600260|NCT01000805|65925857|FG001|Overall Study|Adverse Event|9|||
23600261|NCT01000805|65925856|FG000|Overall Study|Lack of Efficacy|5|||
23600262|NCT01000805|65925857|FG001|Overall Study|Lack of Efficacy|16|||
23600263|NCT01000805|65925856|FG000|Overall Study|Lost to Follow-up|16|||
23600264|NCT01000805|65925857|FG001|Overall Study|Lost to Follow-up|21|||
23600265|NCT01000805|65925856|FG000|Overall Study|Physician Decision|0|||
23600266|NCT01000805|65925857|FG001|Overall Study|Physician Decision|1|||
23600267|NCT01000805|65925856|FG000|Overall Study|Protocol Violation|12|||
23600268|NCT01000805|65925857|FG001|Overall Study|Protocol Violation|8|||
23600269|NCT01000805|65925856|FG000|Overall Study|Withdrawal by Subject|16|||
23600270|NCT01000805|65925857|FG001|Overall Study|Withdrawal by Subject|6|||
23600271|NCT01000805|65925856|FG000|Overall Study|Sponsor Decision|0|||
23600272|NCT01000805|65925857|FG001|Overall Study|Sponsor Decision|1|||
23600273|NCT02568215|65925858|FG000|Overall Study|Death|1|||
23656293|NCT00146328|66128991|FG001|Overall Study|Enroll into other trial|4|||
23361240|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
23361241|NCT01001520|65069647|FG000|Washout Period|Withdrawal by Subject|2|||
23656294|NCT00146328|66128992|FG002|Overall Study|Enroll into other trial|2|||
23656295|NCT00146328|66128990|FG000|Overall Study|Death|0|||
23656296|NCT00146328|66128991|FG001|Overall Study|Death|1|||
23656297|NCT00146328|66128992|FG002|Overall Study|Death|1|||
23656298|NCT00146328|66128990|FG000|Overall Study|Moved|2|||
23656299|NCT00146328|66128991|FG001|Overall Study|Moved|0|||
23656300|NCT00146328|66128992|FG002|Overall Study|Moved|0|||
23656301|NCT00146328|66128990|FG000|Overall Study|Interaction with other medication|2|||
23656302|NCT00146328|66128991|FG001|Overall Study|Interaction with other medication|0|||
23656303|NCT00146328|66128992|FG002|Overall Study|Interaction with other medication|1|||
23656304|NCT00596934|66128993|FG000|Overall Study|Protocol Violation|1|||
23656305|NCT00596934|66128993|FG000|Overall Study|Withdrawal by Subject|1|||
23656306|NCT01479829|66128994|FG000|Overall Study|Withdrawal by Subject|8|||
23656307|NCT01479829|66128995|FG001|Overall Study|Withdrawal by Subject|10|||
23656308|NCT00685685|66128996|FG000|Washout Period of 7 Days|Adverse Event|2|||
23656309|NCT00685685|66128997|FG001|Washout Period of 7 Days|Adverse Event|0|||
23656310|NCT00685685|66128996|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23656311|NCT00685685|66128997|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23656312|NCT01138007|66129001|FG000|Overall Study|Adverse Event|4|||
23656313|NCT01138007|66129002|FG001|Overall Study|Adverse Event|12|||
23656314|NCT01138007|66129003|FG002|Overall Study|Adverse Event|9|||
23656315|NCT01138007|66129001|FG000|Overall Study|Lack of Efficacy|2|||
23656316|NCT01138007|66129002|FG001|Overall Study|Lack of Efficacy|0|||
23656317|NCT01138007|66129003|FG002|Overall Study|Lack of Efficacy|6|||
23656318|NCT01138007|66129001|FG000|Overall Study|Protocol Violation|2|||
23656319|NCT01138007|66129002|FG001|Overall Study|Protocol Violation|3|||
23656320|NCT01138007|66129003|FG002|Overall Study|Protocol Violation|2|||
23656321|NCT01138007|66129001|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
23656322|NCT01138007|66129002|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
23656323|NCT01138007|66129003|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
23656324|NCT01138007|66129001|FG000|Overall Study|Lost to Follow-up|3|||
23656325|NCT01138007|66129002|FG001|Overall Study|Lost to Follow-up|3|||
23656326|NCT01138007|66129003|FG002|Overall Study|Lost to Follow-up|5|||
23656327|NCT01138007|66129001|FG000|Overall Study|Physician Decision|0|||
23656328|NCT01138007|66129002|FG001|Overall Study|Physician Decision|5|||
23656329|NCT01138007|66129003|FG002|Overall Study|Physician Decision|3|||
23656330|NCT01138007|66129001|FG000|Overall Study|Withdrawal by Subject|5|||
23656331|NCT01138007|66129002|FG001|Overall Study|Withdrawal by Subject|6|||
23656332|NCT01138007|66129003|FG002|Overall Study|Withdrawal by Subject|15|||
23656333|NCT03606980|66129004|FG000|Overall Study|Lost to Follow-up|3|||
23656334|NCT03606980|66129005|FG001|Overall Study|Lost to Follow-up|2|||
23656335|NCT03606980|66129006|FG002|Overall Study|Lost to Follow-up|3|||
23656336|NCT03606980|66129004|FG000|Overall Study|Withdrawal by Subject|1|||
23656337|NCT03606980|66129005|FG001|Overall Study|Withdrawal by Subject|0|||
23656338|NCT03606980|66129006|FG002|Overall Study|Withdrawal by Subject|4|||
23656339|NCT02495233|66129007|FG000|Overall Study|Miscellaneous|0|||
23656340|NCT02495233|66129008|FG001|Overall Study|Miscellaneous|1|||
23656341|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
23656342|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
23656343|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
23656344|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
23656345|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
23656346|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
23656347|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
23656348|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
23656349|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Death|1|||
23656350|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Death|1|||
23656351|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
23656352|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
23656353|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
23656354|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
23656355|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
23656356|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
23656357|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
23656358|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
23656359|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
23656360|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
23656361|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
23656362|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
23656363|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
23656364|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
23656365|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
23656366|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
23656367|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
23656368|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
23656369|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
23656370|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
23656371|NCT00559585|66129009|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
23656372|NCT00559585|66129010|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
23656373|NCT00559585|66129009|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
23656374|NCT00559585|66129010|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
23656375|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
23656376|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
23656377|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
23656378|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
23480390|NCT02216812|65501969|FG001|Overall Study|Lost to Follow-up|5|||
23480391|NCT01673347|65501975|FG000|Overall Study|failure of allograft|7|||
23480392|NCT02635646|65501976|FG000|Overall Study|Lost to Follow-up|24|||
23480393|NCT02635646|65501977|FG001|Overall Study|Lost to Follow-up|25|||
23480394|NCT02635646|65501976|FG000|Overall Study|Pregnancy|1|||
23600274|NCT02568215|65925859|FG001|Overall Study|Death|2|||
23600275|NCT02568215|65925860|FG002|Overall Study|Death|0|||
23600276|NCT02568215|65925858|FG000|Overall Study|Physician Decision|2|||
23600277|NCT02568215|65925859|FG001|Overall Study|Physician Decision|2|||
23600278|NCT02568215|65925860|FG002|Overall Study|Physician Decision|2|||
23600279|NCT02568215|65925858|FG000|Overall Study|Lost to Follow-up|29|||
23361242|NCT01001520|65069648|FG001|Washout Period|Withdrawal by Subject|1|||
23480395|NCT02635646|65501977|FG001|Overall Study|Pregnancy|1|||
23480396|NCT01604278|65501982|FG000|Overall Study|Lack of Efficacy|0|||
23600280|NCT02568215|65925859|FG001|Overall Study|Lost to Follow-up|32|||
23600281|NCT02568215|65925860|FG002|Overall Study|Lost to Follow-up|41|||
23600282|NCT02568215|65925858|FG000|Overall Study|Withdrawal by Subject|21|||
23361243|NCT01001520|65069647|FG000|Medication Period 2|Withdrawal by Subject|0|||
23361244|NCT01001520|65069648|FG001|Medication Period 2|Withdrawal by Subject|3|||
23805814|NCT01659736|66668752|FG000|3-month Follow-up|Lost to Follow-up|0|||
23805815|NCT01659736|66668753|FG001|3-month Follow-up|Lost to Follow-up|1|||
23805816|NCT04969861|66668754|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
23805817|NCT04969861|66668755|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
23805818|NCT03407430|66668763|FG000|Washout|Protocol Violation|1|||
23805819|NCT03407430|66668764|FG001|Washout|Protocol Violation|0|||
23805820|NCT00597116|66668765|FG000|Overall Study|Adverse Event|2|||
23805821|NCT00597116|66668766|FG001|Overall Study|Adverse Event|1|||
23805822|NCT00597116|66668765|FG000|Overall Study|Withdrawal by Subject|0|||
23805823|NCT00597116|66668766|FG001|Overall Study|Withdrawal by Subject|2|||
23805824|NCT00597116|66668765|FG000|Overall Study|Physician Decision|0|||
23805825|NCT00597116|66668766|FG001|Overall Study|Physician Decision|1|||
23805826|NCT00597116|66668765|FG000|Overall Study|Death|0|||
23805827|NCT00597116|66668766|FG001|Overall Study|Death|1|||
23805828|NCT00597116|66668765|FG000|Overall Study|Lost to Follow-up|1|||
23805829|NCT00597116|66668766|FG001|Overall Study|Lost to Follow-up|0|||
23805830|NCT00597116|66668765|FG000|Overall Study|Progressive disease|11|||
23805831|NCT00597116|66668766|FG001|Overall Study|Progressive disease|6|||
23805832|NCT03852459|66668769|FG000|Overall Study|Adverse Event|2|||
23805833|NCT03852459|66668770|FG001|Overall Study|Adverse Event|2|||
23805834|NCT03852459|66668769|FG000|Overall Study|Withdrawal by Subject|1|||
23805835|NCT03852459|66668770|FG001|Overall Study|Withdrawal by Subject|1|||
23805836|NCT04718194|66668773|FG000|Overall Study|Withdrawal by Subject|3|||
23805837|NCT04718194|66668774|FG001|Overall Study|Withdrawal by Subject|0|||
23805838|NCT04718194|66668773|FG000|Overall Study|Lost to Follow-up|3|||
23805839|NCT04718194|66668774|FG001|Overall Study|Lost to Follow-up|0|||
23805840|NCT02442271|66668775|FG000|Overall Study|Adverse Event|1|||
23805841|NCT02442271|66668775|FG000|Overall Study|Withdrew Consent|1|||
23805842|NCT02442271|66668775|FG000|Overall Study|Lost to Follow-up|1|||
23805843|NCT02442271|66668775|FG000|Overall Study|Other|1|||
23600283|NCT02568215|65925859|FG001|Overall Study|Withdrawal by Subject|19|||
23600284|NCT02568215|65925860|FG002|Overall Study|Withdrawal by Subject|22|||
23600285|NCT02568215|65925858|FG000|Overall Study|Protocol Violation|1|||
23600286|NCT02568215|65925859|FG001|Overall Study|Protocol Violation|1|||
23600287|NCT02568215|65925860|FG002|Overall Study|Protocol Violation|0|||
23600288|NCT02568215|65925858|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
23600289|NCT02568215|65925859|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
23600290|NCT02568215|65925860|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
23600291|NCT02568215|65925858|FG000|Overall Study|Other|0|||
23600292|NCT02568215|65925859|FG001|Overall Study|Other|1|||
23600293|NCT02568215|65925860|FG002|Overall Study|Other|4|||
23361245|NCT03839394|65069649|FG000|Overall Study|Lost to Follow-up|6|||
23361246|NCT03839394|65069650|FG001|Overall Study|Lost to Follow-up|8|||
23805844|NCT00136318|66668776|FG000|Overall Study|Adverse Event|5|||
23805845|NCT00136318|66668777|FG001|Overall Study|Adverse Event|5|||
23805846|NCT00136318|66668776|FG000|Overall Study|Withdrawal by Subject|2|||
23805847|NCT00136318|66668777|FG001|Overall Study|Withdrawal by Subject|2|||
23805848|NCT04317599|66668778|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
23805849|NCT04317599|66668778|FG000|Overall Study|treatment outside standard of care|4|||
23805850|NCT01370213|66668779|FG000|Overall Study|Early Death|1|||
23805851|NCT01370213|66668780|FG001|Overall Study|Early Death|0|||
23805852|NCT01370213|66668781|FG002|Overall Study|Early Death|0|||
23805853|NCT01370213|66668779|FG000|Overall Study|Not evaluable|0|||
23805854|NCT01370213|66668780|FG001|Overall Study|Not evaluable|2|||
23805855|NCT01370213|66668781|FG002|Overall Study|Not evaluable|0|||
23805856|NCT03250299|66668783|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
23805857|NCT03250299|66668784|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
23805858|NCT03250299|66668785|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
23805859|NCT03250299|66668786|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
23805860|NCT03250299|66668787|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
23805861|NCT03250299|66668783|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
23805862|NCT03250299|66668784|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
23805863|NCT03250299|66668785|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
23805864|NCT03250299|66668786|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
23361247|NCT03839394|65069649|FG000|Overall Study|Withdrawal by Subject|0|||
23361248|NCT03839394|65069650|FG001|Overall Study|Withdrawal by Subject|2|||
23361249|NCT00760487|65069652|FG000|Overall Study|Unilateral implantation|3|||
23361250|NCT00369343|65069653|FG000|Double-blind Phase|Adverse Event|19|||
23361251|NCT00369343|65069654|FG001|Double-blind Phase|Adverse Event|4|||
23361252|NCT00369343|65069653|FG000|Double-blind Phase|Failed to return|2|||
23361253|NCT00369343|65069654|FG001|Double-blind Phase|Failed to return|0|||
23361254|NCT00369343|65069653|FG000|Double-blind Phase|Lost to Follow-up|9|||
23361255|NCT00369343|65069654|FG001|Double-blind Phase|Lost to Follow-up|2|||
23361256|NCT00369343|65069653|FG000|Double-blind Phase|Protocol Violation|2|||
23600294|NCT03489369|65925861|FG000|Overall Study|Documented Progressive Disease|3|||
23600295|NCT03489369|65925862|FG001|Overall Study|Documented Progressive Disease|2|||
23361257|NCT00369343|65069654|FG001|Double-blind Phase|Protocol Violation|0|||
23361258|NCT00369343|65069653|FG000|Double-blind Phase|Withdrawal by Subject|8|||
23361259|NCT00369343|65069654|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23361260|NCT00369343|65069653|FG000|Double-blind Phase|Lack of Efficacy|0|||
23361261|NCT00369343|65069654|FG001|Double-blind Phase|Lack of Efficacy|4|||
23361262|NCT00369343|65069653|FG000|Double-blind Phase|Protocol deviation|4|||
23600296|NCT03489369|65925863|FG002|Overall Study|Documented Progressive Disease|3|||
23361263|NCT00369343|65069654|FG001|Double-blind Phase|Protocol deviation|0|||
23805865|NCT03250299|66668787|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
23361264|NCT00369343|65069653|FG000|Open-label Phase|Adverse Event|19|||
23805866|NCT03250299|66668783|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23805867|NCT03250299|66668784|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23361265|NCT00369343|65069654|FG001|Open-label Phase|Adverse Event|7|||
23361266|NCT00369343|65069653|FG000|Open-label Phase|Failed to return|4|||
23600297|NCT03489369|65925864|FG003|Overall Study|Documented Progressive Disease|6|||
23600298|NCT03489369|65925861|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600299|NCT03489369|65925862|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
23600300|NCT03489369|65925863|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600301|NCT03489369|65925864|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600302|NCT03205566|65925865|FG000|Phase 1|Protocol Violation|1|||
23600303|NCT03205566|65925866|FG001|Phase 1|Protocol Violation|1|||
23600304|NCT02408887|65929626|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
23600305|NCT02408887|65929627|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
23600306|NCT02408887|65929626|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
23600307|NCT02408887|65929627|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
23600308|NCT00090519|65929628|FG000|Overall Study|Adverse Event|5|||
23600309|NCT00090519|65929629|FG001|Overall Study|Adverse Event|4|||
23600310|NCT00090519|65929628|FG000|Overall Study|Death|9|||
23600311|NCT00090519|65929629|FG001|Overall Study|Death|9|||
23600312|NCT00090519|65929628|FG000|Overall Study|Lost to Follow-up|26|||
23600313|NCT00090519|65929629|FG001|Overall Study|Lost to Follow-up|29|||
23600314|NCT00090519|65929628|FG000|Overall Study|Withdrawal by Subject|28|||
23600315|NCT00090519|65929629|FG001|Overall Study|Withdrawal by Subject|29|||
23600316|NCT00090519|65929628|FG000|Overall Study|Physician Decision|2|||
23600317|NCT00090519|65929629|FG001|Overall Study|Physician Decision|3|||
23600318|NCT00090519|65929628|FG000|Overall Study|Sponsor Decision|3|||
23600319|NCT00090519|65929629|FG001|Overall Study|Sponsor Decision|1|||
23600320|NCT00293397|65929630|FG000|Overall Study|Death|2|||
23600321|NCT02513667|65929631|FG000|Overall Study|Withdrawal by Subject|0|||
23600322|NCT02513667|65929632|FG001|Overall Study|Withdrawal by Subject|1|||
23600323|NCT03675321|65929637|FG000|Overall Study|Lack of Efficacy|2|||
23600324|NCT03675321|65929638|FG001|Overall Study|Lack of Efficacy|2|||
23600325|NCT03675321|65929637|FG000|Overall Study|Withdrawal by Subject|1|||
23600326|NCT03675321|65929638|FG001|Overall Study|Withdrawal by Subject|3|||
23600327|NCT01084694|65929639|FG000|Overall Study|Withdrawal by Subject|2|||
23600328|NCT01084694|65929640|FG001|Overall Study|Withdrawal by Subject|1|||
23600329|NCT01084694|65929639|FG000|Overall Study|Death|2|||
23600330|NCT01084694|65929640|FG001|Overall Study|Death|12|||
23600331|NCT01084694|65929639|FG000|Overall Study|eligibility not maintained|2|||
23600332|NCT01084694|65929640|FG001|Overall Study|eligibility not maintained|7|||
23600333|NCT00894543|65929642|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
23600334|NCT00894543|65929643|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
23600335|NCT00894543|65929642|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
23600336|NCT00894543|65929643|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
23600337|NCT02765100|65929644|FG000|Overall Study|subject found ineligible after baseline|1|||
23600338|NCT02765100|65929645|FG001|Overall Study|subject found ineligible after baseline|1|||
23361267|NCT00369343|65069654|FG001|Open-label Phase|Failed to return|0|||
23600339|NCT02765100|65929644|FG000|Overall Study|Lost to Follow-up|0|||
23361268|NCT00369343|65069653|FG000|Open-label Phase|Physician Decision|2|||
23600340|NCT02765100|65929645|FG001|Overall Study|Lost to Follow-up|1|||
23600341|NCT02561195|65929651|FG000|Vaccination 1 to 3|Adverse Event|4|||
23600342|NCT02561195|65929652|FG001|Vaccination 1 to 3|Adverse Event|5|||
23600343|NCT02561195|65929653|FG002|Vaccination 1 to 3|Adverse Event|0|||
23480397|NCT01604278|65501983|FG001|Overall Study|Lack of Efficacy|1|||
23480398|NCT01604278|65501982|FG000|Overall Study|Lost to Follow-up|1|||
23480399|NCT01604278|65501983|FG001|Overall Study|Lost to Follow-up|0|||
23480400|NCT01604278|65501982|FG000|Overall Study|Administrative problems|2|||
23480401|NCT01604278|65501983|FG001|Overall Study|Administrative problems|1|||
23480402|NCT01604278|65501982|FG000|Overall Study|Withdrawal by Subject|3|||
23480403|NCT01604278|65501983|FG001|Overall Study|Withdrawal by Subject|3|||
23480404|NCT01604278|65501982|FG000|Overall Study|Adverse Event|3|||
23480405|NCT01604278|65501983|FG001|Overall Study|Adverse Event|5|||
23480406|NCT01604278|65501982|FG000|Overall Study|Protocol Deviation|5|||
23480407|NCT01604278|65501983|FG001|Overall Study|Protocol Deviation|3|||
23480408|NCT02217527|65501984|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
23480409|NCT02217527|65501985|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
23480410|NCT02217527|65501984|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
23480411|NCT02217527|65501985|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
23480412|NCT00392379|65501989|FG000|Overall Study|Withdrawal by Subject|17|||
23480413|NCT00392379|65501990|FG001|Overall Study|Withdrawal by Subject|28|||
23480414|NCT00392379|65501989|FG000|Overall Study|Lost to Follow-up|4|||
23480415|NCT00392379|65501990|FG001|Overall Study|Lost to Follow-up|9|||
23480416|NCT00392379|65501989|FG000|Overall Study|Adverse Event|1|||
23480417|NCT00392379|65501990|FG001|Overall Study|Adverse Event|1|||
23480418|NCT04585009|65501991|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
23480419|NCT04585009|65501992|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480420|NCT04585009|65501993|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480421|NCT04585009|65501994|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480422|NCT04585009|65501995|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480423|NCT04585009|65501996|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480424|NCT04585009|65501997|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480425|NCT04585009|65501998|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480426|NCT04585009|65501999|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480427|NCT04585009|65502000|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480428|NCT04585009|65502001|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480429|NCT04585009|65502002|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480430|NCT04585009|65501991|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
23480431|NCT04585009|65501992|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480432|NCT04585009|65501993|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480433|NCT04585009|65501994|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480434|NCT04585009|65501995|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480435|NCT04585009|65501996|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480436|NCT04585009|65501997|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480437|NCT04585009|65501998|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480438|NCT04585009|65501999|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480439|NCT04585009|65502000|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480440|NCT04585009|65502001|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480441|NCT04585009|65502002|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480442|NCT04585009|65501991|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480443|NCT04585009|65501992|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480444|NCT04585009|65501993|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480445|NCT04585009|65501994|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480446|NCT04585009|65501995|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480447|NCT04585009|65501996|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480448|NCT04585009|65501997|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480449|NCT04585009|65501998|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
23480450|NCT04585009|65501999|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480451|NCT04585009|65502000|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480452|NCT04585009|65502001|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480453|NCT04585009|65502002|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480454|NCT04585009|65501991|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480455|NCT04585009|65501992|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480456|NCT04585009|65501993|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23805868|NCT03250299|66668785|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
23805869|NCT03250299|66668786|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23480457|NCT04585009|65501994|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480458|NCT04585009|65501995|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
23480459|NCT04585009|65501996|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480460|NCT04585009|65501997|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23600344|NCT02561195|65929654|FG003|Vaccination 1 to 3|Adverse Event|3|||
23600345|NCT02561195|65929655|FG004|Vaccination 1 to 3|Adverse Event|4|||
23600346|NCT02561195|65929656|FG005|Vaccination 1 to 3|Adverse Event|0|||
23600347|NCT02561195|65929657|FG006|Vaccination 1 to 3|Adverse Event|0|||
23805870|NCT03250299|66668787|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23805871|NCT03250299|66668783|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
23805872|NCT03250299|66668784|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
23805873|NCT03250299|66668785|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
23805874|NCT03250299|66668786|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
23805875|NCT03250299|66668787|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
23805876|NCT03314662|66668788|FG000|Overall Study|Withdrawal by Subject|1|||
23805877|NCT03314662|66668789|FG001|Overall Study|Withdrawal by Subject|1|||
23805878|NCT03314662|66668790|FG002|Overall Study|Withdrawal by Subject|1|||
23805879|NCT03314662|66668788|FG000|Overall Study|Lost to Follow-up|5|||
23805880|NCT03314662|66668789|FG001|Overall Study|Lost to Follow-up|4|||
23805881|NCT03314662|66668790|FG002|Overall Study|Lost to Follow-up|4|||
23805882|NCT03314662|66668788|FG000|Overall Study|Death|2|||
23805883|NCT03314662|66668789|FG001|Overall Study|Death|0|||
23805884|NCT03314662|66668790|FG002|Overall Study|Death|0|||
23805885|NCT02939014|66668794|FG000|Overall Study|Lost to Follow-up|1|||
23805886|NCT02939014|66668795|FG001|Overall Study|Lost to Follow-up|0|||
23805887|NCT02939014|66668794|FG000|Overall Study|Death|4|||
23805888|NCT02939014|66668795|FG001|Overall Study|Death|3|||
23805889|NCT02865395|66668799|FG000|Overall Study|Physician Decision|6|||
23805890|NCT02865395|66668800|FG001|Overall Study|Physician Decision|10|||
23805891|NCT02865395|66668801|FG002|Overall Study|Physician Decision|7|||
23805892|NCT04551911|66668809|FG000|Overall Study|Lost to Follow-up|2|||
23805893|NCT04551911|66668810|FG001|Overall Study|Lost to Follow-up|1|||
23805894|NCT04551911|66668809|FG000|Overall Study|Withdrawal by Subject|10|||
23805895|NCT04551911|66668810|FG001|Overall Study|Withdrawal by Subject|10|||
23805896|NCT04551911|66668809|FG000|Overall Study|Did not receive the study drug|3|||
23805897|NCT04551911|66668810|FG001|Overall Study|Did not receive the study drug|4|||
23805898|NCT01300923|66668811|FG000|Overall Study|Physician Decision|0|||
23805899|NCT01300923|66668812|FG001|Overall Study|Physician Decision|2|||
23805900|NCT01833533|66668821|FG000|Overall Study|Adverse Event|0|||
23805901|NCT01833533|66668822|FG001|Overall Study|Adverse Event|1|||
23805902|NCT01833533|66668821|FG000|Overall Study|Lost to Follow-up|4|||
23805903|NCT01833533|66668822|FG001|Overall Study|Lost to Follow-up|9|||
23805904|NCT01833533|66668821|FG000|Overall Study|To Enter an Extension Study|0|||
23805905|NCT01833533|66668822|FG001|Overall Study|To Enter an Extension Study|4|||
23805906|NCT01833533|66668821|FG000|Overall Study|Other|2|||
23805907|NCT01833533|66668822|FG001|Overall Study|Other|7|||
23805908|NCT02310646|66668823|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
23805909|NCT02310646|66668824|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
23805910|NCT02310646|66668823|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
23805911|NCT02310646|66668824|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
23805912|NCT01079832|66668825|FG000|Overall Study|Withdrawal by Subject|1|||
23805913|NCT02622113|66668829|FG000|Overall Study|Adverse Event|4|||
23805914|NCT02622113|66668830|FG001|Overall Study|Adverse Event|4|||
23805915|NCT02622113|66668829|FG000|Overall Study|Physician Decision|0|||
23805916|NCT02622113|66668830|FG001|Overall Study|Physician Decision|1|||
23805917|NCT02622113|66668829|FG000|Overall Study|Withdrawal by Subject|0|||
23805918|NCT02622113|66668830|FG001|Overall Study|Withdrawal by Subject|2|||
23805919|NCT02622113|66668829|FG000|Overall Study|Stopping Criteria|1|||
23805920|NCT02622113|66668830|FG001|Overall Study|Stopping Criteria|3|||
23805921|NCT03043560|66668831|FG000|Overall Study|Discontinued Intervention|1|||
23805922|NCT03043560|66668832|FG001|Overall Study|Discontinued Intervention|2|||
23805923|NCT03043560|66668831|FG000|Overall Study|Lost to Follow-up|0|||
23805924|NCT03043560|66668832|FG001|Overall Study|Lost to Follow-up|1|||
23805925|NCT03979820|66668835|FG000|Overall Study|Protocol Violation|1|||
23805926|NCT03979820|66668836|FG001|Overall Study|Protocol Violation|0|||
23805927|NCT03979820|66668837|FG002|Overall Study|Protocol Violation|0|||
23805928|NCT03979820|66668838|FG003|Overall Study|Protocol Violation|0|||
23805929|NCT03979820|66668835|FG000|Overall Study|Withdrawal by Subject|0|||
23805930|NCT03979820|66668836|FG001|Overall Study|Withdrawal by Subject|0|||
23805931|NCT03979820|66668837|FG002|Overall Study|Withdrawal by Subject|1|||
23805932|NCT03979820|66668838|FG003|Overall Study|Withdrawal by Subject|0|||
23805933|NCT03979820|66668835|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
23805934|NCT03979820|66668836|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
23805935|NCT03979820|66668837|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
23805936|NCT03979820|66668838|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
23805937|NCT02916693|66668839|FG000|Overall Study|Lost to Follow-up|7|||
23805938|NCT00770692|66668840|FG000|Overall Study|Withdrawal by Subject|7|||
23805939|NCT00770692|66668841|FG001|Overall Study|Withdrawal by Subject|9|||
23805940|NCT00770692|66668842|FG002|Overall Study|Withdrawal by Subject|9|||
23805941|NCT00770692|66668843|FG003|Overall Study|Withdrawal by Subject|6|||
23805942|NCT00770692|66668840|FG000|Overall Study|Adverse Event|3|||
23805943|NCT00770692|66668841|FG001|Overall Study|Adverse Event|0|||
23805944|NCT00770692|66668842|FG002|Overall Study|Adverse Event|4|||
23805945|NCT00770692|66668843|FG003|Overall Study|Adverse Event|4|||
23480461|NCT04585009|65501998|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23600348|NCT02561195|65929658|FG007|Vaccination 1 to 3|Adverse Event|0|||
23600349|NCT02561195|65929659|FG008|Vaccination 1 to 3|Adverse Event|0|||
23805946|NCT00770692|66668840|FG000|Overall Study|Investigator judgment|2|||
23805947|NCT00770692|66668841|FG001|Overall Study|Investigator judgment|0|||
23805948|NCT00770692|66668842|FG002|Overall Study|Investigator judgment|1|||
23805949|NCT00770692|66668843|FG003|Overall Study|Investigator judgment|1|||
23805950|NCT04209205|66668844|FG000|Overall Study|Adverse Event|2|||
23805951|NCT04209205|66668845|FG001|Overall Study|Adverse Event|3|||
23805952|NCT04209205|66668844|FG000|Overall Study|Lost to Follow-up|3|||
23805953|NCT04209205|66668845|FG001|Overall Study|Lost to Follow-up|1|||
23805954|NCT04209205|66668844|FG000|Overall Study|Physician Decision|1|||
23805955|NCT04209205|66668845|FG001|Overall Study|Physician Decision|1|||
23805956|NCT04209205|66668844|FG000|Overall Study|Subject decision|10|||
23805957|NCT04209205|66668845|FG001|Overall Study|Subject decision|10|||
23805958|NCT04209205|66668844|FG000|Overall Study|Progressive disease|1|||
23805959|NCT04209205|66668845|FG001|Overall Study|Progressive disease|0|||
23805960|NCT04209205|66668844|FG000|Overall Study|Protocol deviation|0|||
23805961|NCT04209205|66668845|FG001|Overall Study|Protocol deviation|1|||
23805962|NCT04209205|66668844|FG000|Overall Study|New therapy for study indication|1|||
23805963|NCT04209205|66668845|FG001|Overall Study|New therapy for study indication|0|||
23805964|NCT04209205|66668844|FG000|Overall Study|Adverse event - placebo not switched|0|||
23805965|NCT04209205|66668845|FG001|Overall Study|Adverse event - placebo not switched|1|||
23805966|NCT04209205|66668844|FG000|Overall Study|Subject decision - placebo not switched|0|||
23805967|NCT04209205|66668845|FG001|Overall Study|Subject decision - placebo not switched|5|||
23805968|NCT04209205|66668844|FG000|Overall Study|Death - placebo not switched|0|||
23805969|NCT04209205|66668845|FG001|Overall Study|Death - placebo not switched|1|||
23805970|NCT03188718|66668849|FG000|Overall Study|Participant noncompliance|4|||
23805971|NCT03188718|66668849|FG000|Overall Study|Withdrawal by Subject|1|||
23805972|NCT03188718|66668849|FG000|Overall Study|Device failure|3|||
23805973|NCT01338987|66668850|FG000|Overall Study|enrolled on new protocol|0|||
23805974|NCT01338987|66668851|FG001|Overall Study|enrolled on new protocol|0|||
23805975|NCT01338987|66668852|FG002|Overall Study|enrolled on new protocol|1|||
23805976|NCT01338987|66668853|FG003|Overall Study|enrolled on new protocol|0|||
23805977|NCT01338987|66668854|FG004|Overall Study|enrolled on new protocol|0|||
23805978|NCT01338987|66668850|FG000|Overall Study|Disease progression on study|2|||
23805979|NCT01338987|66668851|FG001|Overall Study|Disease progression on study|1|||
23805980|NCT01338987|66668852|FG002|Overall Study|Disease progression on study|1|||
23805981|NCT01338987|66668853|FG003|Overall Study|Disease progression on study|0|||
23805982|NCT01338987|66668854|FG004|Overall Study|Disease progression on study|0|||
23805983|NCT01366092|66668855|FG000|Overall Study|Progressive cGVHD|2|||
23805984|NCT01366092|66668855|FG000|Overall Study|Physician Decision|1|||
23805985|NCT01366092|66668855|FG000|Overall Study|Withdrawal by Subject|1|||
23805986|NCT02621034|66668860|FG000|Overall Study|Lost to Follow-up|3|||
23805987|NCT02621034|66668861|FG001|Overall Study|Lost to Follow-up|2|||
23805988|NCT02621034|66668862|FG002|Overall Study|Lost to Follow-up|5|||
23805989|NCT04965389|66668865|FG000|Overall Study|Other reasons|1|||
23805990|NCT04965389|66668866|FG001|Overall Study|Other reasons|0|||
23805991|NCT04965389|66668867|FG002|Overall Study|Other reasons|0|||
23805992|NCT04965389|66668868|FG003|Overall Study|Other reasons|0|||
23805993|NCT04965389|66668865|FG000|Overall Study|Participant withdrew consent|0|||
23805994|NCT04965389|66668866|FG001|Overall Study|Participant withdrew consent|1|||
23805995|NCT04965389|66668867|FG002|Overall Study|Participant withdrew consent|0|||
23805996|NCT04965389|66668868|FG003|Overall Study|Participant withdrew consent|0|||
23805997|NCT04965389|66668865|FG000|Overall Study|Poor/Non-compliance|0|||
23805998|NCT04965389|66668866|FG001|Overall Study|Poor/Non-compliance|1|||
23805999|NCT04965389|66668867|FG002|Overall Study|Poor/Non-compliance|0|||
23806000|NCT04965389|66668868|FG003|Overall Study|Poor/Non-compliance|0|||
23806001|NCT03456960|66668869|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23806002|NCT03456960|66668870|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23806003|NCT03456960|66668871|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
23806004|NCT03456960|66668872|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
23806005|NCT03456960|66668873|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23600350|NCT02561195|65929660|FG009|Vaccination 1 to 3|Adverse Event|0|||
23806006|NCT03456960|66668874|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23806007|NCT03456960|66668869|FG000|Period 2 (1 Day)|Adverse Event|1|||
23806008|NCT03456960|66668870|FG001|Period 2 (1 Day)|Adverse Event|0|||
23806009|NCT03456960|66668871|FG002|Period 2 (1 Day)|Adverse Event|0|||
23806010|NCT03456960|66668872|FG003|Period 2 (1 Day)|Adverse Event|1|||
23806011|NCT03456960|66668873|FG004|Period 2 (1 Day)|Adverse Event|0|||
23806012|NCT03456960|66668874|FG005|Period 2 (1 Day)|Adverse Event|0|||
23806013|NCT00307034|66668882|FG000|Overall Study|Adverse Event|1|||
23806014|NCT00307034|66668883|FG001|Overall Study|Adverse Event|2|||
23806015|NCT00307034|66668882|FG000|Overall Study|Withdrawal by Subject|1|||
23806016|NCT00307034|66668883|FG001|Overall Study|Withdrawal by Subject|2|||
23806017|NCT00307034|66668882|FG000|Overall Study|Lost to Follow-up|0|||
23806018|NCT00307034|66668883|FG001|Overall Study|Lost to Follow-up|3|||
23806019|NCT02547766|66668886|FG000|Overall Study|Withdrawal by Subject|1|||
23806020|NCT04132336|66668890|FG000|Overall Study|Investigator Decision|0|||
23361269|NCT00369343|65069654|FG001|Open-label Phase|Physician Decision|0|||
23361270|NCT00369343|65069653|FG000|Open-label Phase|Lost to Follow-up|5|||
23361271|NCT00369343|65069654|FG001|Open-label Phase|Lost to Follow-up|3|||
23361272|NCT00369343|65069653|FG000|Open-label Phase|inadvertently reported study completers|3|||
23361273|NCT00369343|65069654|FG001|Open-label Phase|inadvertently reported study completers|2|||
23361274|NCT00369343|65069653|FG000|Open-label Phase|Protocol Violation|1|||
23361275|NCT00369343|65069654|FG001|Open-label Phase|Protocol Violation|3|||
23361276|NCT00369343|65069653|FG000|Open-label Phase|Withdrawal by Subject|15|||
23361277|NCT00369343|65069654|FG001|Open-label Phase|Withdrawal by Subject|6|||
23361278|NCT00369343|65069653|FG000|Open-label Phase|Lack of Efficacy|4|||
23361279|NCT00369343|65069654|FG001|Open-label Phase|Lack of Efficacy|3|||
23361280|NCT00369343|65069653|FG000|Open-label Phase|Lack of continuance tolerability|3|||
23361281|NCT00369343|65069654|FG001|Open-label Phase|Lack of continuance tolerability|4|||
23361282|NCT00369343|65069653|FG000|Open-label Phase|did not take study drug|1|||
23361283|NCT00369343|65069654|FG001|Open-label Phase|did not take study drug|2|||
23361284|NCT03014206|65069655|FG000|Overall Study|Registration Violation|12|||
23361285|NCT00715299|65069656|FG000|Overall Study|Withdrawal by Subject|1|||
23361286|NCT00715299|65069656|FG000|Overall Study|Adverse Event|3|||
23361287|NCT00715299|65069656|FG000|Overall Study|failed the pre-screen exercise test|2|||
23361288|NCT02989402|65069657|FG000|Overall Study|Adverse event, or serious adverse event|4|||
23361289|NCT02989402|65069657|FG000|Overall Study|Death|2|||
23361290|NCT02989402|65069657|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
23361291|NCT02989402|65069657|FG000|Overall Study|Lost to Follow-up|8|||
23361292|NCT02989402|65069657|FG000|Overall Study|Patient no longer on monotherapy|1|||
23361293|NCT02989402|65069657|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
23361294|NCT02989402|65069657|FG000|Overall Study|Withdrawal by Subject|7|||
23361295|NCT02989402|65069657|FG000|Overall Study|Other|2|||
23361296|NCT00837967|65069658|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
23361297|NCT00837967|65069659|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
23361298|NCT00149396|65069663|FG000|Overall Study|Death|15|||
23361299|NCT00149396|65069663|FG000|Overall Study|Withdrawal by Subject|1|||
23361300|NCT00149396|65069663|FG000|Overall Study|Subject noncompliance|2|||
23361301|NCT00149396|65069663|FG000|Overall Study|other treatment|5|||
23361302|NCT01738919|65069671|FG000|Overall Study|Lost to Follow-up|1|||
23361303|NCT01738919|65069672|FG001|Overall Study|Lost to Follow-up|0|||
23361304|NCT01738919|65069671|FG000|Overall Study|Immigrated|0|||
23361305|NCT01738919|65069672|FG001|Overall Study|Immigrated|1|||
23361306|NCT01738919|65069671|FG000|Overall Study|Withdrawal by Subject|0|||
23361307|NCT01738919|65069672|FG001|Overall Study|Withdrawal by Subject|1|||
23361308|NCT01738919|65069671|FG000|Overall Study|Not treated in accordance to guidelines|0|||
23361309|NCT01738919|65069672|FG001|Overall Study|Not treated in accordance to guidelines|1|||
23361310|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
23361311|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
23361312|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
23361313|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
23361314|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
23361315|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
23361316|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
23806021|NCT04132336|66668891|FG001|Overall Study|Investigator Decision|1|||
23806022|NCT04132336|66668892|FG002|Overall Study|Investigator Decision|0|||
23806023|NCT04132336|66668893|FG003|Overall Study|Investigator Decision|0|||
23806024|NCT04132336|66668894|FG004|Overall Study|Investigator Decision|0|||
23361317|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361318|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361319|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361320|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361321|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361322|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
23806025|NCT04132336|66668895|FG005|Overall Study|Investigator Decision|0|||
23480462|NCT04585009|65501999|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480463|NCT04585009|65502000|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480464|NCT04585009|65502001|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480465|NCT04585009|65502002|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480466|NCT04585009|65501991|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480467|NCT04585009|65501992|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480468|NCT04585009|65501993|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480469|NCT04585009|65501994|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480470|NCT04585009|65501995|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23806026|NCT04132336|66668896|FG006|Overall Study|Investigator Decision|0|||
23806027|NCT00809965|66668897|FG000|Overall Study|Death|194|||
23806028|NCT00809965|66668898|FG001|Overall Study|Death|147|||
23806029|NCT00809965|66668899|FG002|Overall Study|Death|196|||
23806030|NCT00809965|66668897|FG000|Overall Study|Lost to Follow-up|17|||
23806031|NCT00809965|66668898|FG001|Overall Study|Lost to Follow-up|10|||
23806032|NCT00809965|66668899|FG002|Overall Study|Lost to Follow-up|18|||
23806033|NCT00809965|66668897|FG000|Overall Study|Withdrawal by Subject|405|||
23806034|NCT00809965|66668898|FG001|Overall Study|Withdrawal by Subject|448|||
23806035|NCT00809965|66668899|FG002|Overall Study|Withdrawal by Subject|441|||
23806036|NCT00809965|66668897|FG000|Overall Study|Other Reason|167|||
23806037|NCT00809965|66668898|FG001|Overall Study|Other Reason|170|||
23806038|NCT00809965|66668899|FG002|Overall Study|Other Reason|189|||
23806039|NCT03185013|66668902|FG000|Overall Study|Withdrawal by Subject|5|||
23806040|NCT03185013|66668903|FG001|Overall Study|Withdrawal by Subject|3|||
23806041|NCT03185013|66668902|FG000|Overall Study|Adverse Event|1|||
23806042|NCT03185013|66668903|FG001|Overall Study|Adverse Event|0|||
23806043|NCT03185013|66668902|FG000|Overall Study|Progressive Disease|1|||
23806044|NCT03185013|66668903|FG001|Overall Study|Progressive Disease|0|||
23600351|NCT02561195|65929661|FG010|Vaccination 1 to 3|Adverse Event|0|||
23600352|NCT02561195|65929662|FG011|Vaccination 1 to 3|Adverse Event|0|||
23600353|NCT02561195|65929663|FG012|Vaccination 1 to 3|Adverse Event|0|||
23600354|NCT02561195|65929664|FG013|Vaccination 1 to 3|Adverse Event|0|||
23600355|NCT02561195|65929651|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
23600356|NCT02561195|65929652|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
23600357|NCT02561195|65929653|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
23600358|NCT02561195|65929654|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
23600359|NCT02561195|65929655|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
23600360|NCT02561195|65929656|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
23600361|NCT02561195|65929657|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
23600362|NCT02561195|65929658|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
23600363|NCT02561195|65929659|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
23600364|NCT02561195|65929660|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
23600365|NCT02561195|65929661|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
23600366|NCT02561195|65929662|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
23600367|NCT02561195|65929663|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
23600368|NCT02561195|65929664|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
23600369|NCT02561195|65929651|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600370|NCT02561195|65929652|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
23600371|NCT02561195|65929653|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600372|NCT02561195|65929654|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
23600373|NCT02561195|65929655|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
23600374|NCT02561195|65929656|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
23600375|NCT02561195|65929657|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600376|NCT02561195|65929658|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600377|NCT02561195|65929659|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600378|NCT02561195|65929660|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600379|NCT02561195|65929661|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600380|NCT02561195|65929662|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600381|NCT02561195|65929663|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600382|NCT02561195|65929664|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600383|NCT02561195|65929651|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
23600384|NCT02561195|65929652|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
23600385|NCT02561195|65929653|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
23806045|NCT03185013|66668902|FG000|Overall Study|Lost to Follow-up|8|||
23806046|NCT03185013|66668903|FG001|Overall Study|Lost to Follow-up|2|||
23806047|NCT03185013|66668902|FG000|Overall Study|Physician Decision|1|||
23600386|NCT02561195|65929654|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
23600387|NCT02561195|65929655|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
23600388|NCT02561195|65929656|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
23361323|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23806048|NCT03185013|66668903|FG001|Overall Study|Physician Decision|0|||
23806049|NCT03185013|66668902|FG000|Overall Study|Protocol Deviation|2|||
23656379|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
23656380|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
23656381|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
23656382|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
23656383|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
23656384|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
23361324|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361325|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361326|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23600389|NCT02561195|65929657|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
23600390|NCT02561195|65929658|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
23600391|NCT02561195|65929659|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
23600392|NCT02561195|65929660|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
23600393|NCT02561195|65929661|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
23656385|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
23656386|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
23656387|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
23600394|NCT02561195|65929662|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
23600395|NCT02561195|65929663|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
23600396|NCT02561195|65929664|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
23600397|NCT02561195|65929651|FG000|Vaccination 1 to 3|Other|7|||
23600398|NCT02561195|65929652|FG001|Vaccination 1 to 3|Other|3|||
23600399|NCT02561195|65929653|FG002|Vaccination 1 to 3|Other|1|||
23600400|NCT02561195|65929654|FG003|Vaccination 1 to 3|Other|7|||
23600401|NCT02561195|65929655|FG004|Vaccination 1 to 3|Other|5|||
23600402|NCT02561195|65929656|FG005|Vaccination 1 to 3|Other|1|||
23600403|NCT02561195|65929657|FG006|Vaccination 1 to 3|Other|0|||
23600404|NCT02561195|65929658|FG007|Vaccination 1 to 3|Other|0|||
23600405|NCT02561195|65929659|FG008|Vaccination 1 to 3|Other|0|||
23600406|NCT02561195|65929660|FG009|Vaccination 1 to 3|Other|0|||
23600407|NCT02561195|65929661|FG010|Vaccination 1 to 3|Other|0|||
23600408|NCT02561195|65929662|FG011|Vaccination 1 to 3|Other|0|||
23806050|NCT03185013|66668903|FG001|Overall Study|Protocol Deviation|0|||
23806051|NCT03185013|66668902|FG000|Overall Study|Reason not Specified|3|||
23806052|NCT03185013|66668903|FG001|Overall Study|Reason not Specified|2|||
23806053|NCT03185013|66668902|FG000|Overall Study|Death|1|||
23806054|NCT03185013|66668903|FG001|Overall Study|Death|0|||
23806055|NCT00252174|66668906|FG000|Overall Study|Withdrawal by Subject|0|||
23806056|NCT00252174|66668907|FG001|Overall Study|Withdrawal by Subject|1|||
23806057|NCT00252174|66668908|FG002|Overall Study|Withdrawal by Subject|0|||
23806058|NCT01432574|66668909|FG000|Overall Study|Moved|2|||
23806059|NCT01432574|66668909|FG000|Overall Study|Not interested|1|||
23806060|NCT00973765|66668910|FG000|Overall Study|Lost to Follow-up|8|||
23806061|NCT00973765|66668911|FG001|Overall Study|Lost to Follow-up|14|||
23806062|NCT01621191|66668914|FG000|Overall Study|Adverse Event|9|||
23806063|NCT01621191|66668914|FG000|Overall Study|Withdrawal by Subject|8|||
23806064|NCT01621191|66668914|FG000|Overall Study|Lack of Efficacy|6|||
23806065|NCT01621191|66668914|FG000|Overall Study|Lost to Follow-up|1|||
23806066|NCT01621191|66668914|FG000|Overall Study|Site Removed From Study|1|||
23806067|NCT01138111|66668915|FG000|Overall Study|Withdrawal by Subject|5|||
23806068|NCT01138111|66668915|FG000|Overall Study|Adverse Event|1|||
23806069|NCT01138111|66668915|FG000|Overall Study|Death|1|||
23806070|NCT01138111|66668915|FG000|Overall Study|Lost to Follow-up|2|||
23806071|NCT01064531|66668916|FG000|Overall Study|Lost to Follow-up|0|||
23806072|NCT01064531|66668917|FG001|Overall Study|Lost to Follow-up|2|||
23806073|NCT01064531|66668916|FG000|Overall Study|Physician Decision|0|||
23806074|NCT01064531|66668917|FG001|Overall Study|Physician Decision|1|||
23806075|NCT01064531|66668916|FG000|Overall Study|Withdrawal by Subject|2|||
23806076|NCT01064531|66668917|FG001|Overall Study|Withdrawal by Subject|2|||
23806077|NCT01064531|66668916|FG000|Overall Study|Revision due to femoral stem loosening|1|||
23806078|NCT01064531|66668917|FG001|Overall Study|Revision due to femoral stem loosening|0|||
23361327|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361328|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
23361329|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361330|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361331|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361332|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361333|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23600409|NCT02561195|65929663|FG012|Vaccination 1 to 3|Other|0|||
23600410|NCT02561195|65929664|FG013|Vaccination 1 to 3|Other|0|||
23600411|NCT02561195|65929651|FG000|Vaccination 1 to 3|Protocol Violation|1|||
23600412|NCT02561195|65929652|FG001|Vaccination 1 to 3|Protocol Violation|0|||
23656388|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
23806079|NCT01064531|66668916|FG000|Overall Study|Revision due to dislocation|0|||
23806080|NCT01064531|66668917|FG001|Overall Study|Revision due to dislocation|1|||
23656389|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
23656390|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
23656391|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
23656392|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
23656393|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
23656394|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
23656395|NCT00559585|66129009|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
23656396|NCT00559585|66129010|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
23656397|NCT03503513|66129011|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
23656398|NCT03503513|66129011|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
23656399|NCT03503513|66129011|FG000|Overall Study|Physician Decision|3|||
23656400|NCT03503513|66129011|FG000|Overall Study|Withdrawal by Subject|2|||
23656401|NCT03503513|66129011|FG000|Overall Study|Lost to Follow-up|1|||
23656402|NCT00325039|66129016|FG000|Overall Study|Lost to Follow-up|18|||
23656403|NCT00325039|66129017|FG001|Overall Study|Lost to Follow-up|14|||
23656404|NCT01179672|66129018|FG000|Overall Study|Adverse Event|17|||
23656405|NCT01179672|66129019|FG001|Overall Study|Adverse Event|8|||
23656406|NCT01179672|66129018|FG000|Overall Study|Withdrawal by Subject|10|||
23656407|NCT01179672|66129019|FG001|Overall Study|Withdrawal by Subject|12|||
23656408|NCT01179672|66129018|FG000|Overall Study|Entry Criteria Not Met|0|||
23656409|NCT01179672|66129019|FG001|Overall Study|Entry Criteria Not Met|2|||
23656410|NCT01179672|66129018|FG000|Overall Study|Lost to Follow-up|0|||
23656411|NCT01179672|66129019|FG001|Overall Study|Lost to Follow-up|1|||
23656412|NCT01179672|66129018|FG000|Overall Study|Protocol Violation|2|||
23656413|NCT01179672|66129019|FG001|Overall Study|Protocol Violation|2|||
23656414|NCT01179672|66129018|FG000|Overall Study|Physician Decision|1|||
23656415|NCT01179672|66129019|FG001|Overall Study|Physician Decision|1|||
23656416|NCT00369785|66129020|FG000|Overall Study|Physician Decision|3|||
23656417|NCT00369785|66129021|FG001|Overall Study|Physician Decision|2|||
23656418|NCT00369785|66129020|FG000|Overall Study|Death|1|||
23656419|NCT00369785|66129021|FG001|Overall Study|Death|2|||
23656420|NCT00369785|66129020|FG000|Overall Study|Withdrawal by Subject|7|||
23656421|NCT00369785|66129021|FG001|Overall Study|Withdrawal by Subject|6|||
23656422|NCT00369785|66129020|FG000|Overall Study|Toxicity|6|||
23656423|NCT00369785|66129021|FG001|Overall Study|Toxicity|4|||
23656424|NCT00369785|66129020|FG000|Overall Study|Never started|0|||
23656425|NCT00369785|66129021|FG001|Overall Study|Never started|2|||
23656426|NCT00369785|66129020|FG000|Overall Study|Progression|4|||
23656427|NCT00369785|66129021|FG001|Overall Study|Progression|4|||
23656428|NCT00369785|66129020|FG000|Overall Study|Multiple reasons|6|||
23656429|NCT00369785|66129021|FG001|Overall Study|Multiple reasons|5|||
23656430|NCT00375219|66129022|FG000|Overall Study|Failure to achieve a response|16|||
23656431|NCT00375219|66129023|FG001|Overall Study|Failure to achieve a response|2|||
23656432|NCT00375219|66129024|FG002|Overall Study|Failure to achieve a response|0|||
23361334|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
23361335|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23656433|NCT00375219|66129022|FG000|Overall Study|Adverse Event|8|||
23656434|NCT00375219|66129023|FG001|Overall Study|Adverse Event|2|||
23656435|NCT00375219|66129024|FG002|Overall Study|Adverse Event|1|||
23656436|NCT00375219|66129022|FG000|Overall Study|Protocol Violation|1|||
23656437|NCT00375219|66129023|FG001|Overall Study|Protocol Violation|0|||
23656438|NCT00375219|66129024|FG002|Overall Study|Protocol Violation|1|||
23656439|NCT00375219|66129022|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
23656440|NCT00375219|66129023|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
23600413|NCT02561195|65929653|FG002|Vaccination 1 to 3|Protocol Violation|1|||
23600414|NCT02561195|65929654|FG003|Vaccination 1 to 3|Protocol Violation|2|||
23600415|NCT02561195|65929655|FG004|Vaccination 1 to 3|Protocol Violation|5|||
23600416|NCT02561195|65929656|FG005|Vaccination 1 to 3|Protocol Violation|2|||
23600417|NCT02561195|65929657|FG006|Vaccination 1 to 3|Protocol Violation|0|||
23600418|NCT02561195|65929658|FG007|Vaccination 1 to 3|Protocol Violation|0|||
23600419|NCT02561195|65929659|FG008|Vaccination 1 to 3|Protocol Violation|0|||
23600420|NCT02561195|65929660|FG009|Vaccination 1 to 3|Protocol Violation|0|||
23600421|NCT02561195|65929661|FG010|Vaccination 1 to 3|Protocol Violation|0|||
23600422|NCT02561195|65929662|FG011|Vaccination 1 to 3|Protocol Violation|0|||
23600423|NCT02561195|65929663|FG012|Vaccination 1 to 3|Protocol Violation|0|||
23656441|NCT00375219|66129024|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
23656442|NCT00375219|66129022|FG000|Overall Study|Lost to Follow-up|1|||
23656443|NCT00375219|66129023|FG001|Overall Study|Lost to Follow-up|1|||
23656444|NCT00375219|66129024|FG002|Overall Study|Lost to Follow-up|0|||
23656445|NCT00375219|66129022|FG000|Overall Study|Disease progression|18|||
23656446|NCT00375219|66129023|FG001|Overall Study|Disease progression|9|||
23656447|NCT00375219|66129024|FG002|Overall Study|Disease progression|12|||
23656448|NCT00375219|66129022|FG000|Overall Study|Death|4|||
23656449|NCT00375219|66129023|FG001|Overall Study|Death|3|||
23656450|NCT00375219|66129024|FG002|Overall Study|Death|7|||
23656451|NCT00375219|66129022|FG000|Overall Study|Hematologic resistance|1|||
23656452|NCT00375219|66129023|FG001|Overall Study|Hematologic resistance|0|||
23656453|NCT00375219|66129024|FG002|Overall Study|Hematologic resistance|0|||
23656454|NCT00375219|66129022|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
23656455|NCT00375219|66129023|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
23656456|NCT00375219|66129024|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
23656457|NCT00375219|66129022|FG000|Overall Study|Allograft|2|||
23600424|NCT02561195|65929664|FG013|Vaccination 1 to 3|Protocol Violation|0|||
23656458|NCT00375219|66129023|FG001|Overall Study|Allograft|0|||
23656459|NCT00375219|66129024|FG002|Overall Study|Allograft|0|||
23656460|NCT00375219|66129022|FG000|Overall Study|Cord blood transplantation|1|||
23656461|NCT00375219|66129023|FG001|Overall Study|Cord blood transplantation|0|||
23656462|NCT00375219|66129024|FG002|Overall Study|Cord blood transplantation|0|||
23656463|NCT00375219|66129022|FG000|Overall Study|Withdrawal by Subject|1|||
23656464|NCT00375219|66129023|FG001|Overall Study|Withdrawal by Subject|0|||
23656465|NCT00375219|66129024|FG002|Overall Study|Withdrawal by Subject|0|||
23656466|NCT01055262|66129028|FG000|Overall Study|Adverse Event|5|||
23656467|NCT01055262|66129028|FG000|Overall Study|Protocol Violation|3|||
23656468|NCT01055262|66129028|FG000|Overall Study|Uncooperativeness|1|||
23656469|NCT00616434|66129029|FG000|Overall Study|Adverse Event|5|||
23656470|NCT00616434|66129030|FG001|Overall Study|Adverse Event|2|||
23656471|NCT00616434|66129029|FG000|Overall Study|Physician Decision|0|||
23656472|NCT00616434|66129030|FG001|Overall Study|Physician Decision|4|||
23656473|NCT00616434|66129029|FG000|Overall Study|Withdrawal by Subject|1|||
23656474|NCT00616434|66129030|FG001|Overall Study|Withdrawal by Subject|1|||
23656475|NCT00616434|66129029|FG000|Overall Study|Protocol deviation|0|||
23656476|NCT00616434|66129030|FG001|Overall Study|Protocol deviation|1|||
23656477|NCT03952806|66129031|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
23656478|NCT03952806|66129032|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
23656479|NCT03952806|66129031|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
23656480|NCT03952806|66129032|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
23656481|NCT03952806|66129031|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
23656482|NCT03952806|66129032|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
23656483|NCT03952806|66129031|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
23656484|NCT03952806|66129032|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
23656485|NCT03952806|66129031|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
23656486|NCT03952806|66129032|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
23656487|NCT03952806|66129031|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
23656488|NCT03952806|66129032|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
23656489|NCT03952806|66129031|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
23656490|NCT03952806|66129032|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
23656491|NCT03952806|66129031|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
23656492|NCT03952806|66129032|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
23656493|NCT03952806|66129031|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
23656494|NCT03952806|66129032|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
23656495|NCT03952806|66129031|FG000|OLE Phase (48 Weeks)|Other|16|||
23656496|NCT03952806|66129032|FG001|OLE Phase (48 Weeks)|Other|13|||
23656497|NCT04695392|66129034|FG000|Overall Study|Withdrawn by parent/guardian|0|||
23361336|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361337|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361338|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361339|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361340|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Other|119|||
23361341|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Other|0|||
23361342|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Other|0|||
23361343|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Other|0|||
23361344|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Other|0|||
23361345|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Other|0|||
23361346|NCT01435759|65069673|FG000|Double-blind Phase|Adverse Event|7|||
23361347|NCT01435759|65069674|FG001|Double-blind Phase|Adverse Event|0|||
23361348|NCT01435759|65069675|FG002|Double-blind Phase|Adverse Event|1|||
23806081|NCT01064531|66668916|FG000|Overall Study|Death|0|||
23806082|NCT01064531|66668917|FG001|Overall Study|Death|1|||
23806083|NCT02132754|66668922|FG000|Overall Study|Adverse Event|0|||
23806084|NCT02132754|66668923|FG001|Overall Study|Adverse Event|0|||
23806085|NCT02132754|66668924|FG002|Overall Study|Adverse Event|0|||
23806086|NCT02132754|66668925|FG003|Overall Study|Adverse Event|0|||
23806087|NCT02132754|66668926|FG004|Overall Study|Adverse Event|0|||
23806088|NCT02132754|66668927|FG005|Overall Study|Adverse Event|0|||
23806089|NCT02132754|66668928|FG006|Overall Study|Adverse Event|0|||
23806090|NCT02132754|66668929|FG007|Overall Study|Adverse Event|0|||
23806091|NCT02132754|66668930|FG008|Overall Study|Adverse Event|0|||
23806092|NCT02132754|66668931|FG009|Overall Study|Adverse Event|0|||
23806093|NCT02132754|66668932|FG010|Overall Study|Adverse Event|0|||
23806094|NCT02132754|66668933|FG011|Overall Study|Adverse Event|0|||
23806095|NCT02132754|66668934|FG012|Overall Study|Adverse Event|0|||
23806096|NCT02132754|66668935|FG013|Overall Study|Adverse Event|0|||
23806097|NCT02132754|66668936|FG014|Overall Study|Adverse Event|0|||
23806098|NCT02132754|66668937|FG015|Overall Study|Adverse Event|0|||
23806099|NCT02132754|66668938|FG016|Overall Study|Adverse Event|0|||
23806100|NCT02132754|66668939|FG017|Overall Study|Adverse Event|1|||
23806101|NCT02132754|66668940|FG018|Overall Study|Adverse Event|0|||
23806102|NCT02132754|66668941|FG019|Overall Study|Adverse Event|0|||
23806103|NCT02132754|66668942|FG020|Overall Study|Adverse Event|0|||
23806104|NCT02132754|66668943|FG021|Overall Study|Adverse Event|0|||
23806105|NCT02132754|66668944|FG022|Overall Study|Adverse Event|0|||
23806106|NCT02132754|66668945|FG023|Overall Study|Adverse Event|0|||
23806107|NCT02132754|66668946|FG024|Overall Study|Adverse Event|0|||
23806108|NCT02132754|66668947|FG025|Overall Study|Adverse Event|1|||
23806109|NCT02132754|66668948|FG026|Overall Study|Adverse Event|1|||
23806110|NCT02132754|66668949|FG027|Overall Study|Adverse Event|0|||
23806111|NCT02132754|66668950|FG028|Overall Study|Adverse Event|0|||
23806112|NCT02132754|66668951|FG029|Overall Study|Adverse Event|0|||
23806113|NCT02132754|66668952|FG030|Overall Study|Adverse Event|1|||
23806114|NCT02132754|66668953|FG031|Overall Study|Adverse Event|0|||
23806115|NCT02132754|66668954|FG032|Overall Study|Adverse Event|1|||
23806116|NCT02132754|66668955|FG033|Overall Study|Adverse Event|1|||
23806117|NCT02132754|66668922|FG000|Overall Study|Clinical Progression|0|||
23806118|NCT02132754|66668923|FG001|Overall Study|Clinical Progression|0|||
23361349|NCT01435759|65069676|FG003|Double-blind Phase|Adverse Event|1|||
23361350|NCT01435759|65069677|FG004|Double-blind Phase|Adverse Event|1|||
23656498|NCT04695392|66129035|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23656499|NCT04695392|66129034|FG000|Overall Study|Withdrawn by physician|0|||
23806119|NCT02132754|66668924|FG002|Overall Study|Clinical Progression|0|||
23806120|NCT02132754|66668925|FG003|Overall Study|Clinical Progression|0|||
23806121|NCT02132754|66668926|FG004|Overall Study|Clinical Progression|0|||
23806122|NCT02132754|66668927|FG005|Overall Study|Clinical Progression|0|||
23806123|NCT02132754|66668928|FG006|Overall Study|Clinical Progression|0|||
23806124|NCT02132754|66668929|FG007|Overall Study|Clinical Progression|0|||
23361351|NCT01435759|65069678|FG005|Double-blind Phase|Adverse Event|3|||
23361352|NCT01435759|65069673|FG000|Double-blind Phase|Protocol Violation|2|||
23656500|NCT04695392|66129035|FG001|Overall Study|Withdrawn by physician|1|||
23656501|NCT03239483|66129036|FG000|Overall Study|Lost to Follow-up|1|||
23656502|NCT03239483|66129037|FG001|Overall Study|Lost to Follow-up|0|||
23656503|NCT03239483|66129036|FG000|Overall Study|Withdrawal by Subject|1|||
23656504|NCT03239483|66129037|FG001|Overall Study|Withdrawal by Subject|0|||
23656505|NCT02525861|66129040|FG000|Overall Study|Adverse Event|1|||
23656506|NCT02525861|66129041|FG001|Overall Study|Adverse Event|0|||
23656507|NCT02525861|66129040|FG000|Overall Study|Withdrawal by Subject|0|||
23656508|NCT02525861|66129041|FG001|Overall Study|Withdrawal by Subject|1|||
23656509|NCT02525861|66129040|FG000|Overall Study|Physician Decision|0|||
23656510|NCT02525861|66129041|FG001|Overall Study|Physician Decision|1|||
23656511|NCT02224599|66129044|FG000|Overall Study|Physician Decision|1|||
23656512|NCT02224599|66129044|FG000|Overall Study|Progression of Disease|1|||
23656513|NCT00458341|66129045|FG000|Cycle 1|Adverse Event|1|||
23656514|NCT00458341|66129046|FG001|Cycle 1|Adverse Event|0|||
23656515|NCT00935272|66129058|FG000|Overall Study|Lost to Follow-up|10|||
23656516|NCT00935272|66129059|FG001|Overall Study|Lost to Follow-up|3|||
23656517|NCT00935272|66129058|FG000|Overall Study|Withdrawal by Subject|8|||
23656518|NCT00935272|66129059|FG001|Overall Study|Withdrawal by Subject|2|||
23656519|NCT00935272|66129058|FG000|Overall Study|Physician Decision|1|||
23656520|NCT00935272|66129059|FG001|Overall Study|Physician Decision|0|||
23656521|NCT00935272|66129058|FG000|Overall Study|Protocol Violation|0|||
23656522|NCT00935272|66129059|FG001|Overall Study|Protocol Violation|1|||
23656523|NCT00292461|66129063|FG000|Overall Study|Adverse Event|4|||
23656524|NCT00292461|66129064|FG001|Overall Study|Adverse Event|2|||
23656525|NCT00292461|66129063|FG000|Overall Study|Lack of Efficacy|1|||
23656526|NCT00292461|66129064|FG001|Overall Study|Lack of Efficacy|0|||
23656527|NCT00292461|66129063|FG000|Overall Study|Withdrawal by Subject|0|||
23656528|NCT00292461|66129064|FG001|Overall Study|Withdrawal by Subject|1|||
23656529|NCT00292461|66129063|FG000|Overall Study|Protocol Violation|4|||
23656530|NCT00292461|66129064|FG001|Overall Study|Protocol Violation|3|||
23656531|NCT00292461|66129063|FG000|Overall Study|Lost to Follow-up|1|||
23656532|NCT00292461|66129064|FG001|Overall Study|Lost to Follow-up|0|||
23656533|NCT01034540|66129065|FG000|Overall Study|Adverse Event|0|||
23656534|NCT01034540|66129066|FG001|Overall Study|Adverse Event|1|||
23656535|NCT02805725|66129067|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
23656536|NCT02805725|66129068|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
23656537|NCT02805725|66129069|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
23656538|NCT02805725|66129070|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
23656539|NCT02805725|66129071|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
23656540|NCT02805725|66129067|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
23656541|NCT02805725|66129068|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
23656542|NCT02805725|66129069|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
23656543|NCT02805725|66129070|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
23656544|NCT02805725|66129071|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
23656545|NCT02805725|66129067|FG000|Phase II|Protocol Violation|0|||
23656546|NCT02805725|66129068|FG001|Phase II|Protocol Violation|0|||
23656547|NCT02805725|66129069|FG002|Phase II|Protocol Violation|0|||
23656548|NCT02805725|66129070|FG003|Phase II|Protocol Violation|0|||
23656549|NCT02805725|66129071|FG004|Phase II|Protocol Violation|6|||
23656550|NCT03250832|66129072|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
23656551|NCT03250832|66129073|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
23656552|NCT03250832|66129074|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
23656553|NCT03250832|66129075|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
23656554|NCT03250832|66129076|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
23656555|NCT03250832|66129077|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
23656556|NCT03250832|66129078|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
23656557|NCT03250832|66129079|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
23656558|NCT03250832|66129080|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
23656559|NCT03250832|66129081|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
23656560|NCT03250832|66129082|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
23656561|NCT03250832|66129083|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
23656562|NCT03250832|66129072|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
23656563|NCT03250832|66129073|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
23656564|NCT03250832|66129074|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
23656565|NCT03250832|66129075|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
23656566|NCT03250832|66129076|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
23656567|NCT03250832|66129077|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
23656568|NCT03250832|66129078|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
23656569|NCT03250832|66129079|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23656570|NCT03250832|66129080|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23656571|NCT03250832|66129081|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23656572|NCT03250832|66129082|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23656573|NCT03250832|66129083|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23656574|NCT03250832|66129072|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656575|NCT03250832|66129073|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656576|NCT03250832|66129074|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
23656577|NCT03250832|66129075|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656578|NCT03250832|66129076|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656579|NCT03250832|66129077|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656580|NCT03250832|66129078|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656581|NCT03250832|66129079|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656582|NCT03250832|66129080|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656583|NCT03250832|66129081|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656584|NCT03250832|66129082|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656585|NCT03250832|66129083|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23656586|NCT03250832|66129072|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656587|NCT03250832|66129073|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656588|NCT03250832|66129074|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656589|NCT03250832|66129075|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656590|NCT03250832|66129076|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656591|NCT03250832|66129077|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656592|NCT03250832|66129078|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656593|NCT03250832|66129079|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
23656594|NCT03250832|66129080|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656595|NCT03250832|66129081|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656596|NCT03250832|66129082|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656597|NCT03250832|66129083|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
23656598|NCT03250832|66129072|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656599|NCT03250832|66129073|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656600|NCT03250832|66129074|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656601|NCT03250832|66129075|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656602|NCT03250832|66129076|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656603|NCT03250832|66129077|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656604|NCT03250832|66129078|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656605|NCT03250832|66129079|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
23656606|NCT03250832|66129080|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656607|NCT03250832|66129081|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656608|NCT03250832|66129082|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656609|NCT03250832|66129083|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23656610|NCT03250832|66129072|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656611|NCT03250832|66129073|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656612|NCT03250832|66129074|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656613|NCT03250832|66129075|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656614|NCT03250832|66129076|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656615|NCT03250832|66129077|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656616|NCT03250832|66129078|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656617|NCT03250832|66129079|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
23656618|NCT03250832|66129080|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656619|NCT03250832|66129081|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656620|NCT03250832|66129082|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656621|NCT03250832|66129083|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23656622|NCT03250832|66129072|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656623|NCT03250832|66129073|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656624|NCT03250832|66129074|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656625|NCT03250832|66129075|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656626|NCT03250832|66129076|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656627|NCT03250832|66129077|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656628|NCT03250832|66129078|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656629|NCT03250832|66129079|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
23656630|NCT03250832|66129080|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656631|NCT03250832|66129081|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656632|NCT03250832|66129082|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656633|NCT03250832|66129083|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23656634|NCT03250832|66129072|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656635|NCT03250832|66129073|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656636|NCT03250832|66129074|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656637|NCT03250832|66129075|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656638|NCT03250832|66129076|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656639|NCT03250832|66129077|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656640|NCT03250832|66129078|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656641|NCT03250832|66129079|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
23656642|NCT03250832|66129080|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656643|NCT03250832|66129081|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656644|NCT03250832|66129082|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656645|NCT03250832|66129083|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
23656646|NCT03250832|66129072|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656647|NCT03250832|66129073|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656648|NCT03250832|66129074|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656649|NCT03250832|66129075|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656650|NCT03250832|66129076|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656651|NCT03250832|66129077|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656652|NCT03250832|66129078|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656653|NCT03250832|66129079|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656654|NCT03250832|66129080|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
23656655|NCT03250832|66129081|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
23656656|NCT03250832|66129082|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656657|NCT03250832|66129083|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
23656658|NCT03250832|66129072|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656659|NCT03250832|66129073|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656660|NCT03250832|66129074|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656661|NCT03250832|66129075|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656662|NCT03250832|66129076|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656663|NCT03250832|66129077|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656664|NCT03250832|66129078|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656665|NCT03250832|66129079|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656666|NCT03250832|66129080|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
23656667|NCT03250832|66129081|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
23656668|NCT03250832|66129082|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656669|NCT03250832|66129083|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23656670|NCT03250832|66129072|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656671|NCT03250832|66129073|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656672|NCT03250832|66129074|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656673|NCT03250832|66129075|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656674|NCT03250832|66129076|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656675|NCT03250832|66129077|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656676|NCT03250832|66129078|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656677|NCT03250832|66129079|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656678|NCT03250832|66129080|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
23361353|NCT01435759|65069674|FG001|Double-blind Phase|Protocol Violation|0|||
23361354|NCT01435759|65069675|FG002|Double-blind Phase|Protocol Violation|1|||
23656679|NCT03250832|66129081|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
23656680|NCT03250832|66129082|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656681|NCT03250832|66129083|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23656682|NCT03250832|66129072|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656683|NCT03250832|66129073|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656684|NCT03250832|66129074|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656685|NCT03250832|66129075|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656686|NCT03250832|66129076|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656687|NCT03250832|66129077|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656688|NCT03250832|66129078|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656689|NCT03250832|66129079|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656690|NCT03250832|66129080|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656691|NCT03250832|66129081|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656692|NCT03250832|66129082|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23656693|NCT03250832|66129083|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
23656694|NCT01008696|66129084|FG000|Overall Study|Participant's evasion of hospital visit|5|||
23656695|NCT01008696|66129085|FG001|Overall Study|Participant's evasion of hospital visit|4|||
23656696|NCT01008696|66129084|FG000|Overall Study|Withdrawal by Subject|2|||
23656697|NCT01008696|66129085|FG001|Overall Study|Withdrawal by Subject|4|||
23656698|NCT01008696|66129084|FG000|Overall Study|Physician Decision|5|||
23656699|NCT01008696|66129085|FG001|Overall Study|Physician Decision|1|||
23656700|NCT01008696|66129084|FG000|Overall Study|Adverse Event|1|||
23656701|NCT01008696|66129085|FG001|Overall Study|Adverse Event|0|||
23806125|NCT02132754|66668930|FG008|Overall Study|Clinical Progression|0|||
23600425|NCT02561195|65929651|FG000|Vaccination 1 to 3|Death|2|||
23600426|NCT02561195|65929652|FG001|Vaccination 1 to 3|Death|1|||
23600427|NCT02561195|65929653|FG002|Vaccination 1 to 3|Death|0|||
23600428|NCT02561195|65929654|FG003|Vaccination 1 to 3|Death|2|||
23600429|NCT02561195|65929655|FG004|Vaccination 1 to 3|Death|0|||
23600430|NCT02561195|65929656|FG005|Vaccination 1 to 3|Death|0|||
23600431|NCT02561195|65929657|FG006|Vaccination 1 to 3|Death|0|||
23600432|NCT02561195|65929658|FG007|Vaccination 1 to 3|Death|0|||
23600433|NCT02561195|65929659|FG008|Vaccination 1 to 3|Death|0|||
23600434|NCT02561195|65929660|FG009|Vaccination 1 to 3|Death|0|||
23600435|NCT02561195|65929661|FG010|Vaccination 1 to 3|Death|0|||
23600436|NCT02561195|65929662|FG011|Vaccination 1 to 3|Death|0|||
23600437|NCT02561195|65929663|FG012|Vaccination 1 to 3|Death|0|||
23600438|NCT02561195|65929664|FG013|Vaccination 1 to 3|Death|0|||
23600439|NCT02561195|65929651|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
23600440|NCT02561195|65929652|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
23600441|NCT02561195|65929653|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
23600442|NCT02561195|65929654|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
23806126|NCT02132754|66668931|FG009|Overall Study|Clinical Progression|1|||
23806127|NCT02132754|66668932|FG010|Overall Study|Clinical Progression|0|||
23600443|NCT02561195|65929655|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
23600444|NCT02561195|65929656|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600445|NCT02561195|65929657|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600446|NCT02561195|65929658|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600447|NCT02561195|65929659|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600448|NCT02561195|65929660|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600449|NCT02561195|65929661|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600450|NCT02561195|65929662|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600451|NCT02561195|65929663|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600452|NCT02561195|65929664|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600453|NCT02561195|65929651|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
23600454|NCT02561195|65929652|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
23600455|NCT02561195|65929653|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
23600456|NCT02561195|65929654|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
23600457|NCT02561195|65929655|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
23600458|NCT02561195|65929656|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
23600459|NCT02561195|65929657|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
23600460|NCT02561195|65929658|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
23600461|NCT02561195|65929659|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
23600462|NCT02561195|65929660|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
23600463|NCT02561195|65929661|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
23600464|NCT02561195|65929662|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
23600465|NCT02561195|65929663|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
23600466|NCT02561195|65929664|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
23600467|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600468|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600469|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23806128|NCT02132754|66668933|FG011|Overall Study|Clinical Progression|0|||
23806129|NCT02132754|66668934|FG012|Overall Study|Clinical Progression|0|||
23806130|NCT02132754|66668935|FG013|Overall Study|Clinical Progression|0|||
23806131|NCT02132754|66668936|FG014|Overall Study|Clinical Progression|0|||
23806132|NCT02132754|66668937|FG015|Overall Study|Clinical Progression|0|||
23806133|NCT02132754|66668938|FG016|Overall Study|Clinical Progression|1|||
23806134|NCT02132754|66668939|FG017|Overall Study|Clinical Progression|1|||
23806135|NCT02132754|66668940|FG018|Overall Study|Clinical Progression|0|||
23806136|NCT02132754|66668941|FG019|Overall Study|Clinical Progression|1|||
23806137|NCT02132754|66668942|FG020|Overall Study|Clinical Progression|0|||
23806138|NCT02132754|66668943|FG021|Overall Study|Clinical Progression|0|||
23806139|NCT02132754|66668944|FG022|Overall Study|Clinical Progression|1|||
23806140|NCT02132754|66668945|FG023|Overall Study|Clinical Progression|0|||
23806141|NCT02132754|66668946|FG024|Overall Study|Clinical Progression|1|||
23806142|NCT02132754|66668947|FG025|Overall Study|Clinical Progression|1|||
23806143|NCT02132754|66668948|FG026|Overall Study|Clinical Progression|0|||
23806144|NCT02132754|66668949|FG027|Overall Study|Clinical Progression|1|||
23806145|NCT02132754|66668950|FG028|Overall Study|Clinical Progression|1|||
23600470|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600471|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600472|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600473|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600474|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600475|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
23600476|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
23656702|NCT01008696|66129084|FG000|Overall Study|Participants' non-cooperation|2|||
23656703|NCT01008696|66129085|FG001|Overall Study|Participants' non-cooperation|3|||
23656704|NCT01008696|66129084|FG000|Overall Study|Other|2|||
23656705|NCT01008696|66129085|FG001|Overall Study|Other|3|||
23656706|NCT01008696|66129084|FG000|Overall Study|Other|0|||
23656707|NCT01008696|66129085|FG001|Overall Study|Other|2|||
23656708|NCT00826111|66129086|FG000|Overall Study|Lost to Follow-up|0|||
23656709|NCT00826111|66129087|FG001|Overall Study|Lost to Follow-up|1|||
23656710|NCT00826111|66129086|FG000|Overall Study|Protocol Violation|1|||
23361355|NCT01435759|65069676|FG003|Double-blind Phase|Protocol Violation|2|||
23361356|NCT01435759|65069677|FG004|Double-blind Phase|Protocol Violation|0|||
23361357|NCT01435759|65069678|FG005|Double-blind Phase|Protocol Violation|1|||
23361358|NCT01435759|65069673|FG000|Double-blind Phase|Withdrawal by Subject|17|||
23361359|NCT01435759|65069674|FG001|Double-blind Phase|Withdrawal by Subject|4|||
23361360|NCT01435759|65069675|FG002|Double-blind Phase|Withdrawal by Subject|3|||
23361361|NCT01435759|65069676|FG003|Double-blind Phase|Withdrawal by Subject|4|||
23361362|NCT01435759|65069677|FG004|Double-blind Phase|Withdrawal by Subject|2|||
23600477|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
23600478|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
23600479|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
23600480|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600481|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600482|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600483|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600484|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600485|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600486|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600487|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600488|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600489|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600490|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600491|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600492|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600493|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600494|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
23600495|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Death|0|||
23600496|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Death|0|||
23600497|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Death|0|||
23600498|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Death|0|||
23600499|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Death|0|||
23600500|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Death|0|||
23600501|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Death|0|||
23600502|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Death|0|||
23600503|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Death|0|||
23600504|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Death|1|||
23600505|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Death|0|||
23600506|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Death|0|||
23600507|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Death|0|||
23600508|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Death|0|||
23600509|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600510|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600511|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600512|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600513|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600514|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600515|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600516|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600517|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600518|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23361363|NCT01435759|65069678|FG005|Double-blind Phase|Withdrawal by Subject|2|||
23361364|NCT01435759|65069673|FG000|Double-blind Phase|Lost to Follow-up|31|||
23361365|NCT01435759|65069674|FG001|Double-blind Phase|Lost to Follow-up|1|||
23600519|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
23600520|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600521|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
23600522|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600523|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23656711|NCT00826111|66129087|FG001|Overall Study|Protocol Violation|0|||
23600524|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600525|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600526|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600527|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23656712|NCT00826111|66129086|FG000|Overall Study|Withdrawal by Subject|5|||
23656713|NCT00826111|66129087|FG001|Overall Study|Withdrawal by Subject|0|||
23656714|NCT00826111|66129086|FG000|Overall Study|Physician Decision|1|||
23656715|NCT00826111|66129087|FG001|Overall Study|Physician Decision|1|||
23656716|NCT00860951|66129088|FG000|Overall Study|Withdrawal by Subject|2|||
23656717|NCT00860951|66129088|FG000|Overall Study|Lost to Follow-up|5|||
23656718|NCT02119325|66129090|FG000|Washout Period 1|Adverse Event|0|||
23656719|NCT02119325|66129091|FG001|Washout Period 1|Adverse Event|1|||
23656720|NCT03224325|66129092|FG000|Overall Study|Adverse Event|1|||
23656721|NCT03224325|66129093|FG001|Overall Study|Adverse Event|0|||
23656722|NCT03224325|66129094|FG002|Overall Study|Adverse Event|0|||
23656723|NCT03224325|66129095|FG003|Overall Study|Adverse Event|0|||
23656724|NCT03224325|66129096|FG004|Overall Study|Adverse Event|0|||
23656725|NCT03224325|66129097|FG005|Overall Study|Adverse Event|0|||
23806146|NCT02132754|66668951|FG029|Overall Study|Clinical Progression|0|||
23806147|NCT02132754|66668952|FG030|Overall Study|Clinical Progression|1|||
23806148|NCT02132754|66668953|FG031|Overall Study|Clinical Progression|0|||
23806149|NCT02132754|66668954|FG032|Overall Study|Clinical Progression|0|||
23806150|NCT02132754|66668955|FG033|Overall Study|Clinical Progression|2|||
23806151|NCT02132754|66668922|FG000|Overall Study|Death|0|||
23806152|NCT02132754|66668923|FG001|Overall Study|Death|0|||
23806153|NCT02132754|66668924|FG002|Overall Study|Death|0|||
23806154|NCT02132754|66668925|FG003|Overall Study|Death|0|||
23806155|NCT02132754|66668926|FG004|Overall Study|Death|0|||
23806156|NCT02132754|66668927|FG005|Overall Study|Death|0|||
23806157|NCT02132754|66668928|FG006|Overall Study|Death|0|||
23806158|NCT02132754|66668929|FG007|Overall Study|Death|0|||
23361366|NCT01435759|65069675|FG002|Double-blind Phase|Lost to Follow-up|2|||
23361367|NCT01435759|65069676|FG003|Double-blind Phase|Lost to Follow-up|0|||
23600528|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600529|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600530|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600531|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600532|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600533|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600534|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600535|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600536|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600537|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Other|0|||
23806159|NCT02132754|66668930|FG008|Overall Study|Death|0|||
23806160|NCT02132754|66668931|FG009|Overall Study|Death|0|||
23806161|NCT02132754|66668932|FG010|Overall Study|Death|0|||
23806162|NCT02132754|66668933|FG011|Overall Study|Death|0|||
23806163|NCT02132754|66668934|FG012|Overall Study|Death|0|||
23806164|NCT02132754|66668935|FG013|Overall Study|Death|0|||
23806165|NCT02132754|66668936|FG014|Overall Study|Death|0|||
23806166|NCT02132754|66668937|FG015|Overall Study|Death|1|||
23806167|NCT02132754|66668938|FG016|Overall Study|Death|0|||
23806168|NCT02132754|66668939|FG017|Overall Study|Death|0|||
23806169|NCT02132754|66668940|FG018|Overall Study|Death|0|||
23806170|NCT02132754|66668941|FG019|Overall Study|Death|1|||
23806171|NCT02132754|66668942|FG020|Overall Study|Death|0|||
23806172|NCT02132754|66668943|FG021|Overall Study|Death|1|||
23806173|NCT02132754|66668944|FG022|Overall Study|Death|0|||
23806174|NCT02132754|66668945|FG023|Overall Study|Death|0|||
23806175|NCT02132754|66668946|FG024|Overall Study|Death|0|||
23600538|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Other|0|||
23600539|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Other|0|||
23600540|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Other|0|||
23600541|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Other|0|||
23600542|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Other|0|||
23656726|NCT03224325|66129098|FG006|Overall Study|Adverse Event|1|||
23806176|NCT02132754|66668947|FG025|Overall Study|Death|0|||
23806177|NCT02132754|66668948|FG026|Overall Study|Death|1|||
23806178|NCT02132754|66668949|FG027|Overall Study|Death|0|||
23600543|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Other|0|||
23656727|NCT03224325|66129092|FG000|Overall Study|Withdrawal by Subject|0|||
23806179|NCT02132754|66668950|FG028|Overall Study|Death|0|||
23806180|NCT02132754|66668951|FG029|Overall Study|Death|0|||
23806181|NCT02132754|66668952|FG030|Overall Study|Death|0|||
23806182|NCT02132754|66668953|FG031|Overall Study|Death|0|||
23806183|NCT02132754|66668954|FG032|Overall Study|Death|0|||
23806184|NCT02132754|66668955|FG033|Overall Study|Death|2|||
23361368|NCT01435759|65069677|FG004|Double-blind Phase|Lost to Follow-up|3|||
23600544|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Other|0|||
23806185|NCT02132754|66668922|FG000|Overall Study|Excluded Medication|0|||
23806186|NCT02132754|66668923|FG001|Overall Study|Excluded Medication|0|||
23806187|NCT02132754|66668924|FG002|Overall Study|Excluded Medication|0|||
23656728|NCT03224325|66129093|FG001|Overall Study|Withdrawal by Subject|0|||
23656729|NCT03224325|66129094|FG002|Overall Study|Withdrawal by Subject|0|||
23656730|NCT03224325|66129095|FG003|Overall Study|Withdrawal by Subject|1|||
23656731|NCT03224325|66129096|FG004|Overall Study|Withdrawal by Subject|0|||
23656732|NCT03224325|66129097|FG005|Overall Study|Withdrawal by Subject|0|||
23656733|NCT03224325|66129098|FG006|Overall Study|Withdrawal by Subject|0|||
23656734|NCT01749540|66129105|FG000|Overall Study|Protocol Violation|0|||
23656735|NCT01749540|66129106|FG001|Overall Study|Protocol Violation|0|||
23656736|NCT01749540|66129107|FG002|Overall Study|Protocol Violation|0|||
23656737|NCT01749540|66129108|FG003|Overall Study|Protocol Violation|0|||
23656738|NCT01749540|66129109|FG004|Overall Study|Protocol Violation|0|||
23656739|NCT01749540|66129110|FG005|Overall Study|Protocol Violation|1|||
23656740|NCT01749540|66129111|FG006|Overall Study|Protocol Violation|1|||
23656741|NCT01749540|66129105|FG000|Overall Study|Withdrawal by Subject|0|||
23656742|NCT01749540|66129106|FG001|Overall Study|Withdrawal by Subject|0|||
23656743|NCT01749540|66129107|FG002|Overall Study|Withdrawal by Subject|0|||
23656744|NCT01749540|66129108|FG003|Overall Study|Withdrawal by Subject|1|||
23656745|NCT01749540|66129109|FG004|Overall Study|Withdrawal by Subject|0|||
23656746|NCT01749540|66129110|FG005|Overall Study|Withdrawal by Subject|0|||
23656747|NCT01749540|66129111|FG006|Overall Study|Withdrawal by Subject|0|||
23656748|NCT01749540|66129105|FG000|Overall Study|Initiated into extension study A536-06|0|||
23656749|NCT01749540|66129106|FG001|Overall Study|Initiated into extension study A536-06|0|||
23656750|NCT01749540|66129107|FG002|Overall Study|Initiated into extension study A536-06|0|||
23806188|NCT02132754|66668925|FG003|Overall Study|Excluded Medication|0|||
23806189|NCT02132754|66668926|FG004|Overall Study|Excluded Medication|0|||
23806190|NCT02132754|66668927|FG005|Overall Study|Excluded Medication|0|||
23806191|NCT02132754|66668928|FG006|Overall Study|Excluded Medication|0|||
23806192|NCT02132754|66668929|FG007|Overall Study|Excluded Medication|0|||
23806193|NCT02132754|66668930|FG008|Overall Study|Excluded Medication|0|||
23806194|NCT02132754|66668931|FG009|Overall Study|Excluded Medication|0|||
23806195|NCT02132754|66668932|FG010|Overall Study|Excluded Medication|0|||
23806196|NCT02132754|66668933|FG011|Overall Study|Excluded Medication|0|||
23806197|NCT02132754|66668934|FG012|Overall Study|Excluded Medication|0|||
23806198|NCT02132754|66668935|FG013|Overall Study|Excluded Medication|0|||
23806199|NCT02132754|66668936|FG014|Overall Study|Excluded Medication|0|||
23806200|NCT02132754|66668937|FG015|Overall Study|Excluded Medication|0|||
23806201|NCT02132754|66668938|FG016|Overall Study|Excluded Medication|0|||
23806202|NCT02132754|66668939|FG017|Overall Study|Excluded Medication|0|||
23806203|NCT02132754|66668940|FG018|Overall Study|Excluded Medication|0|||
23806204|NCT02132754|66668941|FG019|Overall Study|Excluded Medication|0|||
23806205|NCT02132754|66668942|FG020|Overall Study|Excluded Medication|1|||
23806206|NCT02132754|66668943|FG021|Overall Study|Excluded Medication|0|||
23806207|NCT02132754|66668944|FG022|Overall Study|Excluded Medication|0|||
23806208|NCT02132754|66668945|FG023|Overall Study|Excluded Medication|0|||
23806209|NCT02132754|66668946|FG024|Overall Study|Excluded Medication|0|||
23806210|NCT02132754|66668947|FG025|Overall Study|Excluded Medication|0|||
23806211|NCT02132754|66668948|FG026|Overall Study|Excluded Medication|0|||
23806212|NCT02132754|66668949|FG027|Overall Study|Excluded Medication|0|||
23806213|NCT02132754|66668950|FG028|Overall Study|Excluded Medication|0|||
23806214|NCT02132754|66668951|FG029|Overall Study|Excluded Medication|0|||
23806215|NCT02132754|66668952|FG030|Overall Study|Excluded Medication|0|||
23806216|NCT02132754|66668953|FG031|Overall Study|Excluded Medication|0|||
23806217|NCT02132754|66668954|FG032|Overall Study|Excluded Medication|0|||
23806218|NCT02132754|66668955|FG033|Overall Study|Excluded Medication|1|||
23806219|NCT02132754|66668922|FG000|Overall Study|Physician Decision|0|||
23806220|NCT02132754|66668923|FG001|Overall Study|Physician Decision|0|||
23806221|NCT02132754|66668924|FG002|Overall Study|Physician Decision|0|||
23806222|NCT02132754|66668925|FG003|Overall Study|Physician Decision|0|||
23806223|NCT02132754|66668926|FG004|Overall Study|Physician Decision|0|||
23806224|NCT02132754|66668927|FG005|Overall Study|Physician Decision|0|||
23806225|NCT02132754|66668928|FG006|Overall Study|Physician Decision|0|||
23806226|NCT02132754|66668929|FG007|Overall Study|Physician Decision|0|||
23806227|NCT02132754|66668930|FG008|Overall Study|Physician Decision|0|||
23806228|NCT02132754|66668931|FG009|Overall Study|Physician Decision|1|||
23806229|NCT02132754|66668932|FG010|Overall Study|Physician Decision|0|||
23806230|NCT02132754|66668933|FG011|Overall Study|Physician Decision|1|||
23806231|NCT02132754|66668934|FG012|Overall Study|Physician Decision|1|||
23806232|NCT02132754|66668935|FG013|Overall Study|Physician Decision|0|||
23806233|NCT02132754|66668936|FG014|Overall Study|Physician Decision|0|||
23806234|NCT02132754|66668937|FG015|Overall Study|Physician Decision|1|||
23806235|NCT02132754|66668938|FG016|Overall Study|Physician Decision|0|||
23806236|NCT02132754|66668939|FG017|Overall Study|Physician Decision|0|||
23806237|NCT02132754|66668940|FG018|Overall Study|Physician Decision|0|||
23806238|NCT02132754|66668941|FG019|Overall Study|Physician Decision|0|||
23806239|NCT02132754|66668942|FG020|Overall Study|Physician Decision|0|||
23806240|NCT02132754|66668943|FG021|Overall Study|Physician Decision|0|||
23806241|NCT02132754|66668944|FG022|Overall Study|Physician Decision|0|||
23806242|NCT02132754|66668945|FG023|Overall Study|Physician Decision|0|||
23806243|NCT02132754|66668946|FG024|Overall Study|Physician Decision|1|||
23806244|NCT02132754|66668947|FG025|Overall Study|Physician Decision|0|||
23806245|NCT02132754|66668948|FG026|Overall Study|Physician Decision|0|||
23806246|NCT02132754|66668949|FG027|Overall Study|Physician Decision|0|||
23806247|NCT02132754|66668950|FG028|Overall Study|Physician Decision|0|||
23806248|NCT02132754|66668951|FG029|Overall Study|Physician Decision|0|||
23806249|NCT02132754|66668952|FG030|Overall Study|Physician Decision|0|||
23361369|NCT01435759|65069678|FG005|Double-blind Phase|Lost to Follow-up|3|||
23361370|NCT01435759|65069673|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
23656751|NCT01749540|66129108|FG003|Overall Study|Initiated into extension study A536-06|0|||
23806250|NCT02132754|66668953|FG031|Overall Study|Physician Decision|1|||
23806251|NCT02132754|66668954|FG032|Overall Study|Physician Decision|0|||
23806252|NCT02132754|66668955|FG033|Overall Study|Physician Decision|3|||
23806253|NCT02132754|66668922|FG000|Overall Study|Progressive Disease|1|||
23806254|NCT02132754|66668923|FG001|Overall Study|Progressive Disease|1|||
23806255|NCT02132754|66668924|FG002|Overall Study|Progressive Disease|1|||
23806256|NCT02132754|66668925|FG003|Overall Study|Progressive Disease|1|||
23806257|NCT02132754|66668926|FG004|Overall Study|Progressive Disease|1|||
23806258|NCT02132754|66668927|FG005|Overall Study|Progressive Disease|1|||
23806259|NCT02132754|66668928|FG006|Overall Study|Progressive Disease|1|||
23806260|NCT02132754|66668929|FG007|Overall Study|Progressive Disease|1|||
23806261|NCT02132754|66668930|FG008|Overall Study|Progressive Disease|1|||
23806262|NCT02132754|66668931|FG009|Overall Study|Progressive Disease|3|||
23806263|NCT02132754|66668932|FG010|Overall Study|Progressive Disease|3|||
23806264|NCT02132754|66668933|FG011|Overall Study|Progressive Disease|2|||
23806265|NCT02132754|66668934|FG012|Overall Study|Progressive Disease|2|||
23806266|NCT02132754|66668935|FG013|Overall Study|Progressive Disease|3|||
23806267|NCT02132754|66668936|FG014|Overall Study|Progressive Disease|2|||
23806268|NCT02132754|66668937|FG015|Overall Study|Progressive Disease|1|||
23806269|NCT02132754|66668938|FG016|Overall Study|Progressive Disease|2|||
23806270|NCT02132754|66668939|FG017|Overall Study|Progressive Disease|1|||
23806271|NCT02132754|66668940|FG018|Overall Study|Progressive Disease|3|||
23656752|NCT01749540|66129109|FG004|Overall Study|Initiated into extension study A536-06|0|||
23656753|NCT01749540|66129110|FG005|Overall Study|Initiated into extension study A536-06|2|||
23656754|NCT01749540|66129111|FG006|Overall Study|Initiated into extension study A536-06|24|||
23656755|NCT01215422|66129118|FG000|Overall Study|Relocation|1|||
23656756|NCT01215422|66129119|FG001|Overall Study|Relocation|0|||
23656757|NCT01215422|66129120|FG002|Overall Study|Relocation|0|||
23656758|NCT01215422|66129121|FG003|Overall Study|Relocation|0|||
23656759|NCT01215422|66129118|FG000|Overall Study|Failed intubations|0|||
23656760|NCT01215422|66129119|FG001|Overall Study|Failed intubations|0|||
23656761|NCT01215422|66129120|FG002|Overall Study|Failed intubations|3|||
23656762|NCT01215422|66129121|FG003|Overall Study|Failed intubations|8|||
23656763|NCT01215422|66129118|FG000|Overall Study|Did not complete all intubations|7|||
23656764|NCT01215422|66129119|FG001|Overall Study|Did not complete all intubations|0|||
23656765|NCT01215422|66129120|FG002|Overall Study|Did not complete all intubations|0|||
23656766|NCT01215422|66129121|FG003|Overall Study|Did not complete all intubations|0|||
23656767|NCT00517751|66129122|FG000|Overall Study|Death|3|||
23656768|NCT00517751|66129122|FG000|Overall Study|Withdrawal by Subject|37|||
23656769|NCT00517751|66129122|FG000|Overall Study|Lost to Follow-up|4|||
23656770|NCT00517751|66129122|FG000|Overall Study|patient not over due|6|||
23656771|NCT00517751|66129122|FG000|Overall Study|Patient not due for visit|76|||
23656772|NCT00517751|66129122|FG000|Overall Study|Missing|3|||
23656773|NCT05395104|66129123|FG000|Overall Study|Met Liver Stopping Criteria|1|||
23656774|NCT05395104|66129123|FG000|Overall Study|Withdrawal by Subject|1|||
23656775|NCT03144804|66129124|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
23656776|NCT01386658|66129125|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
23656777|NCT01386658|66129126|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
23656778|NCT01386658|66129125|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
23656779|NCT01386658|66129126|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
23656780|NCT02545322|66129127|FG000|Overall Study|Withdrawal by Subject|3|||
23656781|NCT00448435|66129131|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
23656782|NCT00448435|66129132|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23656783|NCT01289821|66129133|FG000|Treatment Period|Withdrawal by Subject|1|||
23806272|NCT02132754|66668941|FG019|Overall Study|Progressive Disease|1|||
23806273|NCT02132754|66668942|FG020|Overall Study|Progressive Disease|1|||
23806274|NCT02132754|66668943|FG021|Overall Study|Progressive Disease|3|||
23806275|NCT02132754|66668944|FG022|Overall Study|Progressive Disease|2|||
23806276|NCT02132754|66668945|FG023|Overall Study|Progressive Disease|3|||
23806277|NCT02132754|66668946|FG024|Overall Study|Progressive Disease|0|||
23806278|NCT02132754|66668947|FG025|Overall Study|Progressive Disease|1|||
23806279|NCT02132754|66668948|FG026|Overall Study|Progressive Disease|2|||
23806280|NCT02132754|66668949|FG027|Overall Study|Progressive Disease|1|||
23806281|NCT02132754|66668950|FG028|Overall Study|Progressive Disease|2|||
23806282|NCT02132754|66668951|FG029|Overall Study|Progressive Disease|3|||
23806283|NCT02132754|66668952|FG030|Overall Study|Progressive Disease|1|||
23806284|NCT02132754|66668953|FG031|Overall Study|Progressive Disease|1|||
23806285|NCT02132754|66668954|FG032|Overall Study|Progressive Disease|3|||
23806286|NCT02132754|66668955|FG033|Overall Study|Progressive Disease|6|||
23806287|NCT02132754|66668922|FG000|Overall Study|Screen Failure|0|||
23806288|NCT02132754|66668923|FG001|Overall Study|Screen Failure|0|||
23806289|NCT02132754|66668924|FG002|Overall Study|Screen Failure|0|||
23806290|NCT02132754|66668925|FG003|Overall Study|Screen Failure|0|||
23806291|NCT02132754|66668926|FG004|Overall Study|Screen Failure|0|||
23806292|NCT02132754|66668927|FG005|Overall Study|Screen Failure|0|||
23806293|NCT02132754|66668928|FG006|Overall Study|Screen Failure|0|||
23806294|NCT02132754|66668929|FG007|Overall Study|Screen Failure|0|||
23806295|NCT02132754|66668930|FG008|Overall Study|Screen Failure|0|||
23806296|NCT02132754|66668931|FG009|Overall Study|Screen Failure|0|||
23806297|NCT02132754|66668932|FG010|Overall Study|Screen Failure|0|||
23806298|NCT02132754|66668933|FG011|Overall Study|Screen Failure|0|||
23806299|NCT02132754|66668934|FG012|Overall Study|Screen Failure|0|||
23806300|NCT02132754|66668935|FG013|Overall Study|Screen Failure|0|||
23806301|NCT02132754|66668936|FG014|Overall Study|Screen Failure|0|||
23806302|NCT02132754|66668937|FG015|Overall Study|Screen Failure|0|||
23806303|NCT02132754|66668938|FG016|Overall Study|Screen Failure|0|||
23806304|NCT02132754|66668939|FG017|Overall Study|Screen Failure|0|||
23806305|NCT02132754|66668940|FG018|Overall Study|Screen Failure|0|||
23806306|NCT02132754|66668941|FG019|Overall Study|Screen Failure|1|||
23806307|NCT02132754|66668942|FG020|Overall Study|Screen Failure|0|||
23806308|NCT02132754|66668943|FG021|Overall Study|Screen Failure|1|||
23806309|NCT02132754|66668944|FG022|Overall Study|Screen Failure|0|||
23806310|NCT02132754|66668945|FG023|Overall Study|Screen Failure|0|||
23806311|NCT02132754|66668946|FG024|Overall Study|Screen Failure|0|||
23361371|NCT01435759|65069674|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23656784|NCT01289821|66129133|FG000|Treatment Period|Physician Decision|3|||
23656785|NCT01289821|66129133|FG000|Treatment Period|Adverse Event|4|||
23656786|NCT01289821|66129133|FG000|Treatment Period|Radiological Progression|43|||
23656787|NCT01289821|66129133|FG000|Treatment Period|Clinical Progression|2|||
23656788|NCT01289821|66129133|FG000|Treatment Period|Therapeutic procedure required|1|||
23656789|NCT01289821|66129133|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
23656790|NCT01289821|66129133|FG000|Safety Follow-up Period|Protocol Violation|3|||
23656791|NCT01289821|66129133|FG000|Safety Follow-up Period|Unspecified reason|1|||
23656792|NCT01289821|66129133|FG000|Survival Follow-up Period|Protocol Violation|1|||
23656793|NCT01289821|66129133|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
23656794|NCT01289821|66129133|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
23656795|NCT00404066|66129134|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
23656796|NCT00404066|66129134|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
23656797|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
23656798|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
23656799|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
23656800|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
23656801|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
23656802|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
23656803|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
23656804|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
23656805|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
23656806|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
23806312|NCT02132754|66668947|FG025|Overall Study|Screen Failure|0|||
23806313|NCT02132754|66668948|FG026|Overall Study|Screen Failure|0|||
23806314|NCT02132754|66668949|FG027|Overall Study|Screen Failure|0|||
23806315|NCT02132754|66668950|FG028|Overall Study|Screen Failure|0|||
23656807|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
23656808|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
23806316|NCT02132754|66668951|FG029|Overall Study|Screen Failure|0|||
23806317|NCT02132754|66668952|FG030|Overall Study|Screen Failure|0|||
23806318|NCT02132754|66668953|FG031|Overall Study|Screen Failure|0|||
23806319|NCT02132754|66668954|FG032|Overall Study|Screen Failure|0|||
23806320|NCT02132754|66668955|FG033|Overall Study|Screen Failure|0|||
23806321|NCT02132754|66668922|FG000|Overall Study|Transferred to Extension Study|0|||
23806322|NCT02132754|66668923|FG001|Overall Study|Transferred to Extension Study|0|||
23806323|NCT02132754|66668924|FG002|Overall Study|Transferred to Extension Study|0|||
23806324|NCT02132754|66668925|FG003|Overall Study|Transferred to Extension Study|0|||
23806325|NCT02132754|66668926|FG004|Overall Study|Transferred to Extension Study|0|||
23806326|NCT02132754|66668927|FG005|Overall Study|Transferred to Extension Study|0|||
23806327|NCT02132754|66668928|FG006|Overall Study|Transferred to Extension Study|0|||
23806328|NCT02132754|66668929|FG007|Overall Study|Transferred to Extension Study|0|||
23806329|NCT02132754|66668930|FG008|Overall Study|Transferred to Extension Study|0|||
23806330|NCT02132754|66668931|FG009|Overall Study|Transferred to Extension Study|0|||
23806331|NCT02132754|66668932|FG010|Overall Study|Transferred to Extension Study|0|||
23806332|NCT02132754|66668933|FG011|Overall Study|Transferred to Extension Study|0|||
23806333|NCT02132754|66668934|FG012|Overall Study|Transferred to Extension Study|0|||
23806334|NCT02132754|66668935|FG013|Overall Study|Transferred to Extension Study|0|||
23806335|NCT02132754|66668936|FG014|Overall Study|Transferred to Extension Study|0|||
23806336|NCT02132754|66668937|FG015|Overall Study|Transferred to Extension Study|0|||
23806337|NCT02132754|66668938|FG016|Overall Study|Transferred to Extension Study|0|||
23806338|NCT02132754|66668939|FG017|Overall Study|Transferred to Extension Study|0|||
23806339|NCT02132754|66668940|FG018|Overall Study|Transferred to Extension Study|0|||
23806340|NCT02132754|66668941|FG019|Overall Study|Transferred to Extension Study|0|||
23806341|NCT02132754|66668942|FG020|Overall Study|Transferred to Extension Study|0|||
23806342|NCT02132754|66668943|FG021|Overall Study|Transferred to Extension Study|0|||
23806343|NCT02132754|66668944|FG022|Overall Study|Transferred to Extension Study|0|||
23806344|NCT02132754|66668945|FG023|Overall Study|Transferred to Extension Study|0|||
23806345|NCT02132754|66668946|FG024|Overall Study|Transferred to Extension Study|0|||
23806346|NCT02132754|66668947|FG025|Overall Study|Transferred to Extension Study|0|||
23806347|NCT02132754|66668948|FG026|Overall Study|Transferred to Extension Study|0|||
23806348|NCT02132754|66668949|FG027|Overall Study|Transferred to Extension Study|0|||
23806349|NCT02132754|66668950|FG028|Overall Study|Transferred to Extension Study|0|||
23806350|NCT02132754|66668951|FG029|Overall Study|Transferred to Extension Study|0|||
23806351|NCT02132754|66668952|FG030|Overall Study|Transferred to Extension Study|0|||
23806352|NCT02132754|66668953|FG031|Overall Study|Transferred to Extension Study|0|||
23806353|NCT02132754|66668954|FG032|Overall Study|Transferred to Extension Study|0|||
23806354|NCT02132754|66668955|FG033|Overall Study|Transferred to Extension Study|6|||
23806355|NCT02132754|66668922|FG000|Overall Study|Withdrawal by Subject|0|||
23806356|NCT02132754|66668923|FG001|Overall Study|Withdrawal by Subject|0|||
23806357|NCT02132754|66668924|FG002|Overall Study|Withdrawal by Subject|0|||
23806358|NCT02132754|66668925|FG003|Overall Study|Withdrawal by Subject|0|||
23806359|NCT02132754|66668926|FG004|Overall Study|Withdrawal by Subject|0|||
23806360|NCT02132754|66668927|FG005|Overall Study|Withdrawal by Subject|0|||
23806361|NCT02132754|66668928|FG006|Overall Study|Withdrawal by Subject|0|||
23806362|NCT02132754|66668929|FG007|Overall Study|Withdrawal by Subject|0|||
23806363|NCT02132754|66668930|FG008|Overall Study|Withdrawal by Subject|0|||
23806364|NCT02132754|66668931|FG009|Overall Study|Withdrawal by Subject|1|||
23806365|NCT02132754|66668932|FG010|Overall Study|Withdrawal by Subject|0|||
23806366|NCT02132754|66668933|FG011|Overall Study|Withdrawal by Subject|0|||
23806367|NCT02132754|66668934|FG012|Overall Study|Withdrawal by Subject|1|||
23806368|NCT02132754|66668935|FG013|Overall Study|Withdrawal by Subject|0|||
23806369|NCT02132754|66668936|FG014|Overall Study|Withdrawal by Subject|1|||
23806370|NCT02132754|66668937|FG015|Overall Study|Withdrawal by Subject|2|||
23806371|NCT02132754|66668938|FG016|Overall Study|Withdrawal by Subject|1|||
23806372|NCT02132754|66668939|FG017|Overall Study|Withdrawal by Subject|0|||
23806373|NCT02132754|66668940|FG018|Overall Study|Withdrawal by Subject|0|||
23806374|NCT02132754|66668941|FG019|Overall Study|Withdrawal by Subject|0|||
23806375|NCT02132754|66668942|FG020|Overall Study|Withdrawal by Subject|1|||
23806376|NCT02132754|66668943|FG021|Overall Study|Withdrawal by Subject|0|||
23806377|NCT02132754|66668944|FG022|Overall Study|Withdrawal by Subject|0|||
23806378|NCT02132754|66668945|FG023|Overall Study|Withdrawal by Subject|0|||
23806379|NCT02132754|66668946|FG024|Overall Study|Withdrawal by Subject|1|||
23806380|NCT02132754|66668947|FG025|Overall Study|Withdrawal by Subject|0|||
23806381|NCT02132754|66668948|FG026|Overall Study|Withdrawal by Subject|0|||
23806382|NCT02132754|66668949|FG027|Overall Study|Withdrawal by Subject|1|||
23806383|NCT02132754|66668950|FG028|Overall Study|Withdrawal by Subject|0|||
23806384|NCT02132754|66668951|FG029|Overall Study|Withdrawal by Subject|0|||
23806385|NCT02132754|66668952|FG030|Overall Study|Withdrawal by Subject|0|||
23806386|NCT02132754|66668953|FG031|Overall Study|Withdrawal by Subject|1|||
23806387|NCT02132754|66668954|FG032|Overall Study|Withdrawal by Subject|0|||
23806388|NCT02132754|66668955|FG033|Overall Study|Withdrawal by Subject|2|||
23806389|NCT02478320|66668956|FG000|Overall Study|Adverse Event|2|||
23806390|NCT02478320|66668957|FG001|Overall Study|Adverse Event|0|||
23806391|NCT02478320|66668956|FG000|Overall Study|Death|1|||
23806392|NCT02478320|66668957|FG001|Overall Study|Death|0|||
23806393|NCT02478320|66668956|FG000|Overall Study|Lack of Efficacy|4|||
23806394|NCT02478320|66668957|FG001|Overall Study|Lack of Efficacy|0|||
23806395|NCT02478320|66668956|FG000|Overall Study|Withdrawal by Subject|2|||
23806396|NCT02478320|66668957|FG001|Overall Study|Withdrawal by Subject|0|||
23806397|NCT02478320|66668956|FG000|Overall Study|Screen Failure|3|||
23806398|NCT02478320|66668957|FG001|Overall Study|Screen Failure|0|||
23806399|NCT02813421|66668958|FG000|Overall Study|Withdrawal by Subject|1|||
23806400|NCT02813421|66668959|FG001|Overall Study|Withdrawal by Subject|2|||
23806401|NCT02813421|66668958|FG000|Overall Study|Lost to Follow-up|1|||
23806402|NCT02813421|66668959|FG001|Overall Study|Lost to Follow-up|1|||
23806403|NCT01763918|66668960|FG000|Overall Study|Withdrawal by Subject|2|||
23806404|NCT01763918|66668961|FG001|Overall Study|Withdrawal by Subject|1|||
23806405|NCT01763918|66668962|FG002|Overall Study|Withdrawal by Subject|1|||
23656809|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
23656810|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
23656811|NCT03548987|66129135|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
23656812|NCT03548987|66129136|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
23656813|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
23656814|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
23656815|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
23656816|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
23656817|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
23656818|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
23656819|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
23656820|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
23656821|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
23656822|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
23656823|NCT03548987|66129135|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
23656824|NCT03548987|66129136|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
23656825|NCT02974088|66129139|FG000|Overall Study|Lost to Follow-up|0|||
23656826|NCT02974088|66129140|FG001|Overall Study|Lost to Follow-up|2|||
23656827|NCT02974088|66129139|FG000|Overall Study|Adverse Event|0|||
23656828|NCT02974088|66129140|FG001|Overall Study|Adverse Event|1|||
23656829|NCT01211535|66132652|FG000|Overall Study|Adverse Event|0|||
23656830|NCT01211535|66132653|FG001|Overall Study|Adverse Event|1|||
23656831|NCT02464228|66132654|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
23656832|NCT02464228|66132655|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
23656833|NCT02464228|66132656|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
23656834|NCT02464228|66132657|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
23656835|NCT02464228|66132654|FG000|Overall Study|Physician Decision|2|||
23656836|NCT02464228|66132655|FG001|Overall Study|Physician Decision|0|||
23656837|NCT02464228|66132656|FG002|Overall Study|Physician Decision|1|||
23656838|NCT02464228|66132657|FG003|Overall Study|Physician Decision|0|||
23656839|NCT02464228|66132654|FG000|Overall Study|Miscellaneous|1|||
23656840|NCT02464228|66132655|FG001|Overall Study|Miscellaneous|0|||
23656841|NCT02464228|66132656|FG002|Overall Study|Miscellaneous|1|||
23656842|NCT02464228|66132657|FG003|Overall Study|Miscellaneous|0|||
23656843|NCT02464228|66132654|FG000|Overall Study|Adverse Event|9|||
23656844|NCT02464228|66132655|FG001|Overall Study|Adverse Event|0|||
23656845|NCT02464228|66132656|FG002|Overall Study|Adverse Event|3|||
23656846|NCT02464228|66132657|FG003|Overall Study|Adverse Event|0|||
23656847|NCT02464228|66132654|FG000|Overall Study|Withdrawal by Subject|1|||
23656848|NCT02464228|66132655|FG001|Overall Study|Withdrawal by Subject|1|||
23656849|NCT02464228|66132656|FG002|Overall Study|Withdrawal by Subject|1|||
23656850|NCT02464228|66132657|FG003|Overall Study|Withdrawal by Subject|0|||
23656851|NCT02464228|66132654|FG000|Overall Study|Disease Progression|22|||
23656852|NCT02464228|66132655|FG001|Overall Study|Disease Progression|12|||
23361372|NCT01435759|65069675|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361373|NCT01435759|65069676|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23600545|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Other|0|||
23600546|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Other|0|||
23600547|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Other|2|||
23600548|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Other|2|||
23600549|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Other|1|||
23600550|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Other|0|||
23600551|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23656853|NCT02464228|66132656|FG002|Overall Study|Disease Progression|5|||
23600552|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23361374|NCT01435759|65069677|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
23656854|NCT02464228|66132657|FG003|Overall Study|Disease Progression|2|||
23656855|NCT01886313|66132662|FG000|Overall Study|Adverse Event|1|||
23656856|NCT01886313|66132663|FG001|Overall Study|Adverse Event|1|||
23656857|NCT01717989|66132664|FG000|Overall Study|Ineligibility determined|6|||
23656858|NCT01717989|66132664|FG000|Overall Study|Protocol deviation|6|||
23656859|NCT01717989|66132664|FG000|Overall Study|Withdrawal by Subject|11|||
23656860|NCT01717989|66132664|FG000|Overall Study|Physician Decision|2|||
23656861|NCT01717989|66132664|FG000|Overall Study|Lost to Follow-up|11|||
23656862|NCT01717989|66132664|FG000|Overall Study|Death|439|||
23656863|NCT01717989|66132664|FG000|Overall Study|Protocol-specified criteria|551|||
23656864|NCT01717989|66132664|FG000|Overall Study|Other|40|||
23656865|NCT01399190|66132668|FG000|Overall Study|Not Eligible for Final Analysis|5|||
23656866|NCT01399190|66132668|FG000|Overall Study|Adverse Event|8|||
23656867|NCT01399190|66132668|FG000|Overall Study|Participant's Request|5|||
23656868|NCT01399190|66132668|FG000|Overall Study|Physician Decision|2|||
23656869|NCT04166383|66132675|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
23656870|NCT04166383|66132675|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
23656871|NCT04166383|66132675|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
23656872|NCT00907257|66132677|FG000|Overall Study|Adverse Event|0|||
23656873|NCT00907257|66132678|FG001|Overall Study|Adverse Event|4|||
23656874|NCT00907257|66132677|FG000|Overall Study|Protocol Violation|1|||
23656875|NCT00907257|66132678|FG001|Overall Study|Protocol Violation|2|||
23656876|NCT00907257|66132677|FG000|Overall Study|Lost to Follow-up|3|||
23806406|NCT01763918|66668963|FG003|Overall Study|Withdrawal by Subject|2|||
23806407|NCT01763918|66668960|FG000|Overall Study|Sponsor Decision|4|||
23806408|NCT01763918|66668961|FG001|Overall Study|Sponsor Decision|0|||
23806409|NCT01763918|66668962|FG002|Overall Study|Sponsor Decision|9|||
23806410|NCT01763918|66668963|FG003|Overall Study|Sponsor Decision|0|||
23806411|NCT01277718|66668964|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
23806412|NCT01277718|66668965|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
23806413|NCT01277718|66668964|FG000|Period 2 - Second Intervention|Physician Decision|0|||
23806414|NCT01277718|66668965|FG001|Period 2 - Second Intervention|Physician Decision|2|||
23806415|NCT02780167|66668966|FG000|Overall Study|Adverse Event|9|||
23806416|NCT02780167|66668967|FG001|Overall Study|Adverse Event|8|||
23806417|NCT02780167|66668968|FG002|Overall Study|Adverse Event|8|||
23806418|NCT02780167|66668969|FG003|Overall Study|Adverse Event|12|||
23806419|NCT02780167|66668970|FG004|Overall Study|Adverse Event|8|||
23806420|NCT02780167|66668966|FG000|Overall Study|Lack of Efficacy|6|||
23806421|NCT02780167|66668967|FG001|Overall Study|Lack of Efficacy|5|||
23806422|NCT02780167|66668968|FG002|Overall Study|Lack of Efficacy|6|||
23806423|NCT02780167|66668969|FG003|Overall Study|Lack of Efficacy|1|||
23806424|NCT02780167|66668970|FG004|Overall Study|Lack of Efficacy|0|||
23806425|NCT02780167|66668966|FG000|Overall Study|Lost to Follow-up|2|||
23806426|NCT02780167|66668967|FG001|Overall Study|Lost to Follow-up|0|||
23806427|NCT02780167|66668968|FG002|Overall Study|Lost to Follow-up|1|||
23806428|NCT02780167|66668969|FG003|Overall Study|Lost to Follow-up|0|||
23806429|NCT02780167|66668970|FG004|Overall Study|Lost to Follow-up|0|||
23806430|NCT02780167|66668966|FG000|Overall Study|Does not meet entrance criteria|0|||
23806431|NCT02780167|66668967|FG001|Overall Study|Does not meet entrance criteria|0|||
23806432|NCT02780167|66668968|FG002|Overall Study|Does not meet entrance criteria|1|||
23806433|NCT02780167|66668969|FG003|Overall Study|Does not meet entrance criteria|0|||
23806434|NCT02780167|66668970|FG004|Overall Study|Does not meet entrance criteria|0|||
23806435|NCT02780167|66668966|FG000|Overall Study|No longer meets eligibility criteria|0|||
23806436|NCT02780167|66668967|FG001|Overall Study|No longer meets eligibility criteria|0|||
23806437|NCT02780167|66668968|FG002|Overall Study|No longer meets eligibility criteria|0|||
23806438|NCT02780167|66668969|FG003|Overall Study|No longer meets eligibility criteria|1|||
23806439|NCT02780167|66668970|FG004|Overall Study|No longer meets eligibility criteria|1|||
23806440|NCT02780167|66668966|FG000|Overall Study|Protocol Violation|5|||
23806441|NCT02780167|66668967|FG001|Overall Study|Protocol Violation|5|||
23806442|NCT02780167|66668968|FG002|Overall Study|Protocol Violation|1|||
23806443|NCT02780167|66668969|FG003|Overall Study|Protocol Violation|1|||
23806444|NCT02780167|66668970|FG004|Overall Study|Protocol Violation|2|||
23806445|NCT02780167|66668966|FG000|Overall Study|Withdrawal by Subject|6|||
23806446|NCT02780167|66668967|FG001|Overall Study|Withdrawal by Subject|4|||
23806447|NCT02780167|66668968|FG002|Overall Study|Withdrawal by Subject|4|||
23806448|NCT02780167|66668969|FG003|Overall Study|Withdrawal by Subject|3|||
23806449|NCT02780167|66668970|FG004|Overall Study|Withdrawal by Subject|4|||
23806450|NCT02780167|66668966|FG000|Overall Study|Other|0|||
23806451|NCT02780167|66668967|FG001|Overall Study|Other|0|||
23806452|NCT02780167|66668968|FG002|Overall Study|Other|3|||
23806453|NCT02780167|66668969|FG003|Overall Study|Other|1|||
23656877|NCT00907257|66132678|FG001|Overall Study|Lost to Follow-up|3|||
23656878|NCT00907257|66132677|FG000|Overall Study|Withdrawal by Subject|1|||
23656879|NCT00907257|66132678|FG001|Overall Study|Withdrawal by Subject|2|||
23656880|NCT00907257|66132677|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
23656881|NCT00907257|66132678|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
23656882|NCT00907257|66132677|FG000|Overall Study|Moved|1|||
23656883|NCT00907257|66132678|FG001|Overall Study|Moved|0|||
23656884|NCT00907257|66132677|FG000|Overall Study|Personal Reasons|6|||
23656885|NCT00907257|66132678|FG001|Overall Study|Personal Reasons|1|||
23656886|NCT01660451|66132679|FG000|Overall Study|Protocol Violation|0|||
23656887|NCT01660451|66132680|FG001|Overall Study|Protocol Violation|1|||
23656888|NCT01660451|66132681|FG002|Overall Study|Protocol Violation|1|||
23656889|NCT01660451|66132679|FG000|Overall Study|AE not associated with clinical disease progression|13|||
23656890|NCT01660451|66132680|FG001|Overall Study|AE not associated with clinical disease progression|10|||
23656891|NCT01660451|66132681|FG002|Overall Study|AE not associated with clinical disease progression|40|||
23656892|NCT01660451|66132679|FG000|Overall Study|AE associated with clinical disease progression|1|||
23656893|NCT01660451|66132680|FG001|Overall Study|AE associated with clinical disease progression|3|||
23656894|NCT01660451|66132681|FG002|Overall Study|AE associated with clinical disease progression|11|||
23656895|NCT01660451|66132679|FG000|Overall Study|Sponsor Decision|0|||
23656896|NCT01660451|66132680|FG001|Overall Study|Sponsor Decision|0|||
23656897|NCT01660451|66132681|FG002|Overall Study|Sponsor Decision|1|||
23656898|NCT01660451|66132679|FG000|Overall Study|Protocol Deviation|0|||
23806454|NCT02780167|66668970|FG004|Overall Study|Other|2|||
23806455|NCT00446199|66668971|FG000|Overall Study|Adverse Event|7|||
23806456|NCT00446199|66668972|FG001|Overall Study|Adverse Event|4|||
23806457|NCT00446199|66668973|FG002|Overall Study|Adverse Event|6|||
23806458|NCT00446199|66668974|FG003|Overall Study|Adverse Event|4|||
23806459|NCT00446199|66668971|FG000|Overall Study|Lost to Follow-up|4|||
23806460|NCT00446199|66668972|FG001|Overall Study|Lost to Follow-up|5|||
23806461|NCT00446199|66668973|FG002|Overall Study|Lost to Follow-up|2|||
23806462|NCT00446199|66668974|FG003|Overall Study|Lost to Follow-up|6|||
23806463|NCT00446199|66668971|FG000|Overall Study|Protocol Violation|1|||
23806464|NCT00446199|66668972|FG001|Overall Study|Protocol Violation|2|||
23806465|NCT00446199|66668973|FG002|Overall Study|Protocol Violation|1|||
23806466|NCT00446199|66668974|FG003|Overall Study|Protocol Violation|3|||
23806467|NCT00446199|66668971|FG000|Overall Study|Withdrawal by Subject|2|||
23806468|NCT00446199|66668972|FG001|Overall Study|Withdrawal by Subject|5|||
23806469|NCT00446199|66668973|FG002|Overall Study|Withdrawal by Subject|9|||
23806470|NCT00446199|66668974|FG003|Overall Study|Withdrawal by Subject|10|||
23806471|NCT00446199|66668971|FG000|Overall Study|Site termination|2|||
23806472|NCT00446199|66668972|FG001|Overall Study|Site termination|0|||
23806473|NCT00446199|66668973|FG002|Overall Study|Site termination|0|||
23806474|NCT00446199|66668974|FG003|Overall Study|Site termination|1|||
23806475|NCT00446199|66668971|FG000|Overall Study|Randomization in Error|2|||
23806476|NCT00446199|66668972|FG001|Overall Study|Randomization in Error|0|||
23806477|NCT00446199|66668973|FG002|Overall Study|Randomization in Error|1|||
23806478|NCT00446199|66668974|FG003|Overall Study|Randomization in Error|1|||
23806479|NCT00446199|66668971|FG000|Overall Study|Lack of Efficacy|1|||
23806480|NCT00446199|66668972|FG001|Overall Study|Lack of Efficacy|0|||
23806481|NCT00446199|66668973|FG002|Overall Study|Lack of Efficacy|0|||
23806482|NCT00446199|66668974|FG003|Overall Study|Lack of Efficacy|1|||
23806483|NCT00446199|66668971|FG000|Overall Study|Non-compliant with study drug|1|||
23806484|NCT00446199|66668972|FG001|Overall Study|Non-compliant with study drug|0|||
23806485|NCT00446199|66668973|FG002|Overall Study|Non-compliant with study drug|5|||
23806486|NCT00446199|66668974|FG003|Overall Study|Non-compliant with study drug|0|||
23806487|NCT00446199|66668971|FG000|Overall Study|Non-compliant with visit schedule|1|||
23806488|NCT00446199|66668972|FG001|Overall Study|Non-compliant with visit schedule|1|||
23806489|NCT00446199|66668973|FG002|Overall Study|Non-compliant with visit schedule|1|||
23806490|NCT00446199|66668974|FG003|Overall Study|Non-compliant with visit schedule|2|||
23806491|NCT00446199|66668971|FG000|Overall Study|Hormone fear|0|||
23806492|NCT00446199|66668972|FG001|Overall Study|Hormone fear|0|||
23806493|NCT00446199|66668973|FG002|Overall Study|Hormone fear|0|||
23806494|NCT00446199|66668974|FG003|Overall Study|Hormone fear|1|||
23656899|NCT01660451|66132680|FG001|Overall Study|Protocol Deviation|0|||
23806495|NCT00446199|66668971|FG000|Overall Study|Lost interest in study participation|0|||
23806496|NCT00446199|66668972|FG001|Overall Study|Lost interest in study participation|1|||
23806497|NCT00446199|66668973|FG002|Overall Study|Lost interest in study participation|0|||
23806498|NCT00446199|66668974|FG003|Overall Study|Lost interest in study participation|0|||
23656900|NCT01660451|66132681|FG002|Overall Study|Protocol Deviation|1|||
23656901|NCT01660451|66132679|FG000|Overall Study|Physician Decision|1|||
23656902|NCT01660451|66132680|FG001|Overall Study|Physician Decision|2|||
23806499|NCT00446199|66668971|FG000|Overall Study|In-/Exclusion criterion violated|2|||
23806500|NCT00446199|66668972|FG001|Overall Study|In-/Exclusion criterion violated|1|||
23806501|NCT00446199|66668973|FG002|Overall Study|In-/Exclusion criterion violated|2|||
23806502|NCT00446199|66668974|FG003|Overall Study|In-/Exclusion criterion violated|1|||
23806503|NCT00446199|66668971|FG000|Overall Study|Move|0|||
23656903|NCT01660451|66132681|FG002|Overall Study|Physician Decision|5|||
23656904|NCT01660451|66132679|FG000|Overall Study|Withdrawal by Subject|1|||
23656905|NCT01660451|66132680|FG001|Overall Study|Withdrawal by Subject|1|||
23806504|NCT00446199|66668972|FG001|Overall Study|Move|1|||
23656906|NCT01660451|66132681|FG002|Overall Study|Withdrawal by Subject|20|||
23656907|NCT01660451|66132679|FG000|Overall Study|Trial closure.|0|||
23656908|NCT01660451|66132680|FG001|Overall Study|Trial closure.|0|||
23656909|NCT01660451|66132681|FG002|Overall Study|Trial closure.|1|||
23656910|NCT01660451|66132679|FG000|Overall Study|Switching to other therapy|0|||
23656911|NCT01660451|66132680|FG001|Overall Study|Switching to other therapy|1|||
23656912|NCT01660451|66132681|FG002|Overall Study|Switching to other therapy|1|||
23656913|NCT01660451|66132679|FG000|Overall Study|Progressive disease - clinical progression|4|||
23656914|NCT01660451|66132680|FG001|Overall Study|Progressive disease - clinical progression|10|||
23656915|NCT01660451|66132681|FG002|Overall Study|Progressive disease - clinical progression|9|||
23656916|NCT01660451|66132679|FG000|Overall Study|Progressive disease - radiological progression|12|||
23656917|NCT01660451|66132680|FG001|Overall Study|Progressive disease - radiological progression|23|||
23656918|NCT01660451|66132681|FG002|Overall Study|Progressive disease - radiological progression|50|||
23656919|NCT01660451|66132679|FG000|Overall Study|Death|1|||
23806505|NCT00446199|66668973|FG002|Overall Study|Move|0|||
23480471|NCT04585009|65501996|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480472|NCT04585009|65501997|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23806506|NCT00446199|66668974|FG003|Overall Study|Move|0|||
23806507|NCT02025751|66668976|FG000|Overall Study|Lost to Follow-up|1|||
23806508|NCT02025751|66668977|FG001|Overall Study|Lost to Follow-up|0|||
23806509|NCT02025751|66668976|FG000|Overall Study|Adverse Event|0|||
23806510|NCT02025751|66668977|FG001|Overall Study|Adverse Event|1|||
23806511|NCT02025751|66668976|FG000|Overall Study|Physician Decision|0|||
23806512|NCT02025751|66668977|FG001|Overall Study|Physician Decision|1|||
23806513|NCT02025751|66668976|FG000|Overall Study|Withdrawal by Subject|0|||
23806514|NCT02025751|66668977|FG001|Overall Study|Withdrawal by Subject|1|||
23806515|NCT01875471|66668984|FG000|Overall Study|Adverse Event|0|||
23806516|NCT01875471|66668985|FG001|Overall Study|Adverse Event|1|||
23806517|NCT01875471|66668984|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
23806518|NCT01875471|66668985|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
23806519|NCT03036839|66668986|FG000|Overall Study|Adverse Event|0|||
23806520|NCT03036839|66668987|FG001|Overall Study|Adverse Event|0|||
23806521|NCT03036839|66668988|FG002|Overall Study|Adverse Event|1|||
23806522|NCT03036839|66668986|FG000|Overall Study|Death|3|||
23806523|NCT03036839|66668987|FG001|Overall Study|Death|0|||
23806524|NCT03036839|66668988|FG002|Overall Study|Death|3|||
23806525|NCT03036839|66668986|FG000|Overall Study|Withdrew Consent|0|||
23806526|NCT03036839|66668987|FG001|Overall Study|Withdrew Consent|0|||
23806527|NCT03036839|66668988|FG002|Overall Study|Withdrew Consent|1|||
23600553|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600554|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600555|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600556|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600557|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600558|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600559|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600560|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600561|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
23600562|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600563|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600564|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600565|NCT02022657|65929666|FG000|Overall Study|Withdrawal by Subject|2|||
23600566|NCT02022657|65929667|FG001|Overall Study|Withdrawal by Subject|0|||
23600567|NCT02022657|65929668|FG002|Overall Study|Withdrawal by Subject|1|||
23600568|NCT02022657|65929669|FG003|Overall Study|Withdrawal by Subject|0|||
23600569|NCT02022657|65929670|FG004|Overall Study|Withdrawal by Subject|0|||
23600570|NCT02022657|65929671|FG005|Overall Study|Withdrawal by Subject|0|||
23600571|NCT02022657|65929666|FG000|Overall Study|Physician Decision|0|||
23600572|NCT02022657|65929667|FG001|Overall Study|Physician Decision|0|||
23600573|NCT02022657|65929668|FG002|Overall Study|Physician Decision|0|||
23600574|NCT02022657|65929669|FG003|Overall Study|Physician Decision|0|||
23600575|NCT02022657|65929670|FG004|Overall Study|Physician Decision|0|||
23600576|NCT02022657|65929671|FG005|Overall Study|Physician Decision|1|||
23600577|NCT02675244|65929672|FG000|Overall Study|Death|9|||
23806528|NCT00546572|66668994|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
23806529|NCT00546572|66668995|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
23806530|NCT00546572|66668994|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
23806531|NCT00546572|66668995|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
23600578|NCT02675244|65929673|FG001|Overall Study|Death|6|||
23600579|NCT02675244|65929672|FG000|Overall Study|Withdrawal by Subject|3|||
23600580|NCT02675244|65929673|FG001|Overall Study|Withdrawal by Subject|6|||
23656920|NCT01660451|66132680|FG001|Overall Study|Death|0|||
23656921|NCT01660451|66132681|FG002|Overall Study|Death|1|||
23656922|NCT01660451|66132679|FG000|Overall Study|Other|0|||
23656923|NCT01660451|66132680|FG001|Overall Study|Other|0|||
23806532|NCT00546572|66668994|FG000|Vax 1 / Year 0|Protocol Violation|3|||
23806533|NCT00546572|66668995|FG001|Vax 1 / Year 0|Protocol Violation|4|||
23806534|NCT00546572|66668994|FG000|Vax 1 / Year 0|Death|2|||
23806535|NCT00546572|66668995|FG001|Vax 1 / Year 0|Death|2|||
23806536|NCT00546572|66668994|FG000|Vax 1 / Year 0|Adverse Event|0|||
23806537|NCT00546572|66668995|FG001|Vax 1 / Year 0|Adverse Event|1|||
23806538|NCT00546572|66668994|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
23806539|NCT00546572|66668995|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
23806540|NCT00546572|66668994|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
23806541|NCT00546572|66668995|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
23806542|NCT00546572|66668994|FG000|Vax 2 / Year 1|Other|1|||
23806543|NCT00546572|66668995|FG001|Vax 2 / Year 1|Other|1|||
23806544|NCT00546572|66668994|FG000|Vax 2 / Year 1|Adverse Event|1|||
23806545|NCT00546572|66668995|FG001|Vax 2 / Year 1|Adverse Event|0|||
23806546|NCT00546572|66668994|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
23806547|NCT00546572|66668995|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
23600581|NCT02675244|65929672|FG000|Overall Study|Lost to Follow-up|1|||
23600582|NCT02675244|65929673|FG001|Overall Study|Lost to Follow-up|1|||
23600583|NCT02675244|65929672|FG000|Overall Study|Ongoing at 2 Years|190|||
23600584|NCT02675244|65929673|FG001|Overall Study|Ongoing at 2 Years|185|||
23600585|NCT03653364|65929677|FG000|Overall Study|Withdrawal by Subject|1|||
23600586|NCT03653364|65929677|FG000|Overall Study|Enrolled in Error|1|||
23600587|NCT03653364|65929677|FG000|Overall Study|Death|1|||
23656924|NCT01660451|66132681|FG002|Overall Study|Other|1|||
23600588|NCT03478969|65929681|FG000|Overall Study|Withdrawal by Subject|4|||
23656925|NCT00993954|66132684|FG000|Overall Study|Protocol Violation|21|||
23361375|NCT01435759|65069678|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361376|NCT01435759|65069673|FG000|Double-blind Phase|Other|8|||
23361377|NCT01435759|65069674|FG001|Double-blind Phase|Other|2|||
23361378|NCT01435759|65069675|FG002|Double-blind Phase|Other|0|||
23361379|NCT01435759|65069676|FG003|Double-blind Phase|Other|2|||
23600589|NCT03478969|65929682|FG001|Overall Study|Withdrawal by Subject|7|||
23600590|NCT03478969|65929683|FG002|Overall Study|Withdrawal by Subject|6|||
23600591|NCT03478969|65929681|FG000|Overall Study|Adverse Event|2|||
23600592|NCT03478969|65929682|FG001|Overall Study|Adverse Event|0|||
23600593|NCT03478969|65929683|FG002|Overall Study|Adverse Event|1|||
23656926|NCT00993954|66132685|FG001|Overall Study|Protocol Violation|2|||
23806548|NCT00821873|66672513|FG000|Overall Study|Lost to Follow-up|4|||
23806549|NCT01301508|66672518|FG000|Overall Study|Withdrawal by Subject|1|||
23806550|NCT01301508|66672519|FG001|Overall Study|Withdrawal by Subject|2|||
23806551|NCT01301508|66672518|FG000|Overall Study|Lost to Follow-up|0|||
23806552|NCT01301508|66672519|FG001|Overall Study|Lost to Follow-up|1|||
23806553|NCT03095118|66672522|FG000|Overall Study|Adverse Event|1|||
23806554|NCT03095118|66672522|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
23806555|NCT02991430|66672523|FG000|Treatment Period 1|Adverse Event|1|||
23806556|NCT02991430|66672524|FG001|Treatment Period 1|Adverse Event|0|||
23806557|NCT02991430|66672525|FG002|Treatment Period 1|Adverse Event|2|||
23806558|NCT02991430|66672523|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23806559|NCT02991430|66672524|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23806560|NCT02991430|66672525|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23806561|NCT02991430|66672523|FG000|Treatment Period 2|Study Termination|6|||
23806562|NCT02991430|66672524|FG001|Treatment Period 2|Study Termination|3|||
23806563|NCT02991430|66672525|FG002|Treatment Period 2|Study Termination|3|||
23806564|NCT02991430|66672523|FG000|Treatment Period 2|Lost to Follow-up|0|||
23806565|NCT02991430|66672524|FG001|Treatment Period 2|Lost to Follow-up|0|||
23806566|NCT02991430|66672525|FG002|Treatment Period 2|Lost to Follow-up|1|||
23806567|NCT02991430|66672523|FG000|Post-treatment Observation Period|Study Termination|3|||
23806568|NCT02991430|66672524|FG001|Post-treatment Observation Period|Study Termination|6|||
23806569|NCT02991430|66672525|FG002|Post-treatment Observation Period|Study Termination|5|||
23806570|NCT00186043|66672526|FG000|Overall Study|Lack of Efficacy|1|||
23806571|NCT00186043|66672527|FG001|Overall Study|Lack of Efficacy|3|||
23806572|NCT00186043|66672526|FG000|Overall Study|Lost to Follow-up|4|||
23806573|NCT00186043|66672527|FG001|Overall Study|Lost to Follow-up|6|||
23806574|NCT00186043|66672526|FG000|Overall Study|Withdrawal by Subject|1|||
23806575|NCT00186043|66672527|FG001|Overall Study|Withdrawal by Subject|0|||
23806576|NCT00186043|66672526|FG000|Overall Study|Adverse Event|7|||
23806577|NCT00186043|66672527|FG001|Overall Study|Adverse Event|3|||
23806578|NCT00186043|66672526|FG000|Overall Study|Protocol Violation|2|||
23806579|NCT00186043|66672527|FG001|Overall Study|Protocol Violation|1|||
23806580|NCT02562482|66672528|FG000|Overall Study|Enrolled, but did not receive product|4|||
23806581|NCT02562482|66672529|FG001|Overall Study|Enrolled, but did not receive product|0|||
23806582|NCT02562482|66672528|FG000|Overall Study|Lost to Follow-up|9|||
23806583|NCT02562482|66672529|FG001|Overall Study|Lost to Follow-up|6|||
23806584|NCT02562482|66672528|FG000|Overall Study|Moved from area|2|||
23806585|NCT02562482|66672529|FG001|Overall Study|Moved from area|3|||
23806586|NCT02562482|66672528|FG000|Overall Study|Withdrawal by Subject|5|||
23806587|NCT02562482|66672529|FG001|Overall Study|Withdrawal by Subject|3|||
23806588|NCT02562482|66672528|FG000|Overall Study|Physician Decision|1|||
23806589|NCT02562482|66672529|FG001|Overall Study|Physician Decision|3|||
23806590|NCT02562482|66672528|FG000|Overall Study|Illness/Injury unrelated to product|0|||
23806591|NCT02562482|66672529|FG001|Overall Study|Illness/Injury unrelated to product|1|||
23806592|NCT01859130|66672530|FG000|Overall Study|Death|4|||
23806593|NCT01859130|66672530|FG000|Overall Study|Lost to Follow-up|16|||
23806594|NCT01859130|66672530|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
23806595|NCT01859130|66672530|FG000|Overall Study|Physician Decision|6|||
23806596|NCT01859130|66672530|FG000|Overall Study|Withdrawal by Subject|17|||
23806597|NCT01859130|66672530|FG000|Overall Study|Adverse Event|11|||
23806598|NCT04146363|66672531|FG000|Induction Period|Adverse Event|1|||
23806599|NCT04146363|66672532|FG001|Induction Period|Adverse Event|2|||
23806600|NCT04146363|66672533|FG002|Induction Period|Adverse Event|0|||
23600594|NCT03478969|65929681|FG000|Overall Study|Pregnancy|1|||
23806601|NCT04146363|66672534|FG003|Induction Period|Adverse Event|0|||
23806602|NCT04146363|66672535|FG004|Induction Period|Adverse Event|0|||
23806603|NCT04146363|66672536|FG005|Induction Period|Adverse Event|0|||
23361380|NCT01435759|65069677|FG004|Double-blind Phase|Other|0|||
23361381|NCT01435759|65069678|FG005|Double-blind Phase|Other|0|||
23361382|NCT00463801|65069679|FG000|Overall Study|Protocol Violation|1|||
23361383|NCT00463801|65069679|FG000|Overall Study|Lack of Efficacy|2|||
23361384|NCT00463801|65069679|FG000|Overall Study|Adverse Event|4|||
23361385|NCT00463801|65069679|FG000|Overall Study|Lost to Follow-up|5|||
23361386|NCT00463801|65069679|FG000|Overall Study|No longer require therapy|1|||
23361387|NCT03243305|65069680|FG000|Overall Study|Lost to Follow-up|250|||
23361388|NCT03243305|65069680|FG000|Overall Study|Withdrawal by Subject|170|||
23361389|NCT03243305|65069680|FG000|Overall Study|Pregnancy|104|||
23361390|NCT03243305|65069680|FG000|Overall Study|Non-Compliance with Study Drug|38|||
23361391|NCT03243305|65069680|FG000|Overall Study|Adverse Event|23|||
23361392|NCT03243305|65069680|FG000|Overall Study|No sexually active|26|||
23361393|NCT03243305|65069680|FG000|Overall Study|Physician Decision|22|||
23361394|NCT03243305|65069680|FG000|Overall Study|Protocol Violation|22|||
23361395|NCT03243305|65069680|FG000|Overall Study|Study method no longer primary method|12|||
23361396|NCT03243305|65069680|FG000|Overall Study|Study Terminated by Sponsor|1|||
23361397|NCT03243305|65069680|FG000|Overall Study|Early terminations|267|||
23361398|NCT00810069|65069684|FG000|Lead-in Period I|Adverse Event|43|||
23361399|NCT00810069|65069685|FG001|Lead-in Period I|Adverse Event|0|||
23361400|NCT00810069|65069686|FG002|Lead-in Period I|Adverse Event|0|||
23361401|NCT00810069|65069684|FG000|Lead-in Period I|Lack of Efficacy|1|||
23361402|NCT00810069|65069685|FG001|Lead-in Period I|Lack of Efficacy|0|||
23361403|NCT00810069|65069686|FG002|Lead-in Period I|Lack of Efficacy|0|||
23361404|NCT00810069|65069684|FG000|Lead-in Period I|Lost to Follow-up|19|||
23361405|NCT00810069|65069685|FG001|Lead-in Period I|Lost to Follow-up|0|||
23361406|NCT00810069|65069686|FG002|Lead-in Period I|Lost to Follow-up|0|||
23361407|NCT00810069|65069684|FG000|Lead-in Period I|Physician Decision|1|||
23361408|NCT00810069|65069685|FG001|Lead-in Period I|Physician Decision|0|||
23361409|NCT00810069|65069686|FG002|Lead-in Period I|Physician Decision|0|||
23361410|NCT00810069|65069684|FG000|Lead-in Period I|Protocol Violation|1|||
23361411|NCT00810069|65069685|FG001|Lead-in Period I|Protocol Violation|0|||
23600595|NCT03478969|65929682|FG001|Overall Study|Pregnancy|0|||
23361412|NCT00810069|65069686|FG002|Lead-in Period I|Protocol Violation|0|||
23361413|NCT00810069|65069684|FG000|Lead-in Period I|Withdrawal by Subject|46|||
23361414|NCT00810069|65069685|FG001|Lead-in Period I|Withdrawal by Subject|0|||
23600596|NCT03478969|65929683|FG002|Overall Study|Pregnancy|0|||
23361415|NCT00810069|65069686|FG002|Lead-in Period I|Withdrawal by Subject|0|||
23656927|NCT02708095|66132688|FG000|Overall Study|Adverse Event|4|||
23656928|NCT02708095|66132689|FG001|Overall Study|Adverse Event|10|||
23656929|NCT02708095|66132690|FG002|Overall Study|Adverse Event|11|||
23656930|NCT02708095|66132688|FG000|Overall Study|Lack of Efficacy|9|||
23656931|NCT02708095|66132689|FG001|Overall Study|Lack of Efficacy|3|||
23656932|NCT02708095|66132690|FG002|Overall Study|Lack of Efficacy|0|||
23656933|NCT02708095|66132688|FG000|Overall Study|Lost to Follow-up|2|||
23656934|NCT02708095|66132689|FG001|Overall Study|Lost to Follow-up|0|||
23480473|NCT04585009|65501998|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23656935|NCT02708095|66132690|FG002|Overall Study|Lost to Follow-up|0|||
23656936|NCT02708095|66132688|FG000|Overall Study|Physician Decision|2|||
23656937|NCT02708095|66132689|FG001|Overall Study|Physician Decision|3|||
23656938|NCT02708095|66132690|FG002|Overall Study|Physician Decision|2|||
23656939|NCT02708095|66132688|FG000|Overall Study|Protocol Violation|0|||
23656940|NCT02708095|66132689|FG001|Overall Study|Protocol Violation|0|||
23656941|NCT02708095|66132690|FG002|Overall Study|Protocol Violation|1|||
23656942|NCT02708095|66132688|FG000|Overall Study|Withdrawal by Subject|5|||
23656943|NCT02708095|66132689|FG001|Overall Study|Withdrawal by Subject|3|||
23656944|NCT02708095|66132690|FG002|Overall Study|Withdrawal by Subject|4|||
23656945|NCT03471871|66132694|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23656946|NCT03471871|66132695|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23656947|NCT03471871|66132696|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
23656948|NCT03471871|66132697|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23656949|NCT03471871|66132698|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23656950|NCT03471871|66132694|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23656951|NCT03471871|66132695|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23656952|NCT03471871|66132696|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23656953|NCT03471871|66132697|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
23656954|NCT03471871|66132698|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
23656955|NCT03471871|66132694|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23656956|NCT03471871|66132695|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23656957|NCT03471871|66132696|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23656958|NCT03471871|66132697|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23656959|NCT03471871|66132698|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
23656960|NCT03471871|66132694|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23656961|NCT03471871|66132695|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23656962|NCT03471871|66132696|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23656963|NCT03471871|66132697|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23656964|NCT03471871|66132698|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
23361416|NCT00810069|65069684|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
23656965|NCT03471871|66132694|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23656966|NCT03471871|66132695|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23656967|NCT03471871|66132696|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23656968|NCT03471871|66132697|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
23656969|NCT03471871|66132698|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23656970|NCT00890929|66132699|FG000|Overall Study|Death before treatment|2|||
23656971|NCT00890929|66132699|FG000|Overall Study|Withdrawal by Subject|3|||
23656972|NCT00890929|66132699|FG000|Overall Study|Physician Decision|1|||
23656973|NCT02877927|66132700|FG000|Overall Study|Adverse Event|1|||
23656974|NCT02877927|66132701|FG001|Overall Study|Adverse Event|0|||
23656975|NCT02877927|66132700|FG000|Overall Study|Lost to Follow-up|37|||
23656976|NCT02877927|66132701|FG001|Overall Study|Lost to Follow-up|38|||
23656977|NCT02877927|66132700|FG000|Overall Study|Withdrawal by Subject|11|||
23361417|NCT00810069|65069685|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
23656978|NCT02877927|66132701|FG001|Overall Study|Withdrawal by Subject|12|||
23656979|NCT02877927|66132700|FG000|Overall Study|Physician Decision|0|||
23656980|NCT02877927|66132701|FG001|Overall Study|Physician Decision|1|||
23656981|NCT02877927|66132700|FG000|Overall Study|Missed EOT/PTE Visit|5|||
23656982|NCT02877927|66132701|FG001|Overall Study|Missed EOT/PTE Visit|6|||
23656983|NCT03492554|66132702|FG000|Overall Study|Protocol Violation|0|||
23656984|NCT03492554|66132703|FG001|Overall Study|Protocol Violation|14|||
23656985|NCT01303965|66132704|FG000|Overall Study|Adverse Event|1|||
23656986|NCT01303965|66132705|FG001|Overall Study|Adverse Event|1|||
23656987|NCT01303965|66132704|FG000|Overall Study|Death|0|||
23656988|NCT01303965|66132705|FG001|Overall Study|Death|3|||
23656989|NCT01303965|66132704|FG000|Overall Study|Withdrawal by Subject|1|||
23656990|NCT01303965|66132705|FG001|Overall Study|Withdrawal by Subject|0|||
23656991|NCT01303965|66132704|FG000|Overall Study|Disease Progression|1|||
23656992|NCT01303965|66132705|FG001|Overall Study|Disease Progression|6|||
23656993|NCT02066051|66132706|FG000|Overall Study|Subject developed active GVHD|1|||
23656994|NCT02092350|66132707|FG000|Overall Study|Adverse Event|0|||
23656995|NCT02092350|66132708|FG001|Overall Study|Adverse Event|3|||
23656996|NCT02092350|66132707|FG000|Overall Study|Death|2|||
23656997|NCT02092350|66132708|FG001|Overall Study|Death|5|||
23656998|NCT02092350|66132707|FG000|Overall Study|Lost to Follow-up|3|||
23656999|NCT02092350|66132708|FG001|Overall Study|Lost to Follow-up|1|||
23657000|NCT02092350|66132707|FG000|Overall Study|Protocol Violation|1|||
23657001|NCT02092350|66132708|FG001|Overall Study|Protocol Violation|0|||
23657002|NCT02092350|66132707|FG000|Overall Study|Physician Decision|1|||
23657003|NCT02092350|66132708|FG001|Overall Study|Physician Decision|1|||
23657004|NCT02092350|66132707|FG000|Overall Study|Screen Failure|1|||
23657005|NCT02092350|66132708|FG001|Overall Study|Screen Failure|0|||
23657006|NCT02092350|66132707|FG000|Overall Study|Withdrawal by Subject|2|||
23657007|NCT02092350|66132708|FG001|Overall Study|Withdrawal by Subject|2|||
23657008|NCT01428661|66132709|FG000|Double-Masked Phase|Protocol Violation|9|||
23657009|NCT01428661|66132710|FG001|Double-Masked Phase|Protocol Violation|4|||
23657010|NCT01428661|66132711|FG002|Double-Masked Phase|Protocol Violation|0|||
23657011|NCT01428661|66132709|FG000|Double-Masked Phase|Adverse Event|13|||
23657012|NCT01428661|66132710|FG001|Double-Masked Phase|Adverse Event|4|||
23657013|NCT01428661|66132711|FG002|Double-Masked Phase|Adverse Event|0|||
23657014|NCT01428661|66132709|FG000|Double-Masked Phase|Lost to Follow-up|14|||
23657015|NCT01428661|66132710|FG001|Double-Masked Phase|Lost to Follow-up|14|||
23361418|NCT00810069|65069686|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
23361419|NCT00810069|65069684|FG000|Lead-in Period I|Randomization criteria not met|158|||
23361420|NCT00810069|65069685|FG001|Lead-in Period I|Randomization criteria not met|0|||
23361421|NCT00810069|65069686|FG002|Lead-in Period I|Randomization criteria not met|0|||
23361422|NCT00810069|65069684|FG000|Double-Blind Period II|Adverse Event|0|||
23361423|NCT00810069|65069685|FG001|Double-Blind Period II|Adverse Event|9|||
23361424|NCT00810069|65069686|FG002|Double-Blind Period II|Adverse Event|8|||
23361425|NCT00810069|65069684|FG000|Double-Blind Period II|Lack of Efficacy|0|||
23361426|NCT00810069|65069685|FG001|Double-Blind Period II|Lack of Efficacy|7|||
23361427|NCT00810069|65069686|FG002|Double-Blind Period II|Lack of Efficacy|12|||
23361428|NCT00810069|65069684|FG000|Double-Blind Period II|Lost to Follow-up|0|||
23361429|NCT00810069|65069685|FG001|Double-Blind Period II|Lost to Follow-up|9|||
23361430|NCT00810069|65069686|FG002|Double-Blind Period II|Lost to Follow-up|9|||
23361431|NCT00810069|65069684|FG000|Double-Blind Period II|Physician Decision|0|||
23361432|NCT00810069|65069685|FG001|Double-Blind Period II|Physician Decision|0|||
23361433|NCT00810069|65069686|FG002|Double-Blind Period II|Physician Decision|1|||
23361434|NCT00810069|65069684|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
23361435|NCT00810069|65069685|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
23361436|NCT00810069|65069686|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
23657016|NCT01428661|66132711|FG002|Double-Masked Phase|Lost to Follow-up|0|||
23657017|NCT01428661|66132709|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
23657018|NCT01428661|66132710|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
23657019|NCT01428661|66132711|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
23657020|NCT01428661|66132709|FG000|Double-Masked Phase|Lack of Efficacy|2|||
23361437|NCT00810069|65069684|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
23361438|NCT00810069|65069685|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
23361439|NCT00810069|65069686|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
23657021|NCT01428661|66132710|FG001|Double-Masked Phase|Lack of Efficacy|1|||
23657022|NCT01428661|66132711|FG002|Double-Masked Phase|Lack of Efficacy|0|||
23657023|NCT01428661|66132709|FG000|Double-Masked Phase|*Various|1|||
23657024|NCT01428661|66132710|FG001|Double-Masked Phase|*Various|6|||
23657025|NCT01428661|66132711|FG002|Double-Masked Phase|*Various|0|||
23361440|NCT00810069|65069684|FG000|Double-Blind Period II|Clinical relapse|0|||
23361441|NCT00810069|65069685|FG001|Double-Blind Period II|Clinical relapse|3|||
23361442|NCT00810069|65069686|FG002|Double-Blind Period II|Clinical relapse|0|||
23361443|NCT00810069|65069684|FG000|Double-Blind Period II|Protocol Violation|0|||
23361444|NCT00810069|65069685|FG001|Double-Blind Period II|Protocol Violation|7|||
23361445|NCT00810069|65069686|FG002|Double-Blind Period II|Protocol Violation|6|||
23361446|NCT03012841|65069687|FG000|Overall Study|Protocol Violation|0|||
23361447|NCT03012841|65069688|FG001|Overall Study|Protocol Violation|10|||
23657026|NCT01428661|66132709|FG000|Open Label Extension|Protocol Violation|0|||
23657027|NCT01428661|66132710|FG001|Open Label Extension|Protocol Violation|0|||
23657028|NCT01428661|66132711|FG002|Open Label Extension|Protocol Violation|9|||
23657029|NCT01428661|66132709|FG000|Open Label Extension|Adverse Event|0|||
23657030|NCT01428661|66132710|FG001|Open Label Extension|Adverse Event|0|||
23657031|NCT01428661|66132711|FG002|Open Label Extension|Adverse Event|15|||
23657032|NCT01428661|66132709|FG000|Open Label Extension|Lost to Follow-up|0|||
23657033|NCT01428661|66132710|FG001|Open Label Extension|Lost to Follow-up|0|||
23657034|NCT01428661|66132711|FG002|Open Label Extension|Lost to Follow-up|38|||
23657035|NCT01428661|66132709|FG000|Open Label Extension|Withdrawal by Subject|0|||
23657036|NCT01428661|66132710|FG001|Open Label Extension|Withdrawal by Subject|0|||
23657037|NCT01428661|66132711|FG002|Open Label Extension|Withdrawal by Subject|49|||
23657038|NCT01428661|66132709|FG000|Open Label Extension|Lack of Efficacy|0|||
23657039|NCT01428661|66132710|FG001|Open Label Extension|Lack of Efficacy|0|||
23657040|NCT01428661|66132711|FG002|Open Label Extension|Lack of Efficacy|24|||
23657041|NCT01428661|66132709|FG000|Open Label Extension|**Various|0|||
23657042|NCT01428661|66132710|FG001|Open Label Extension|**Various|0|||
23657043|NCT01428661|66132711|FG002|Open Label Extension|**Various|185|||
23657044|NCT01610687|66132712|FG000|Overall Study|Lack of Efficacy|26|||
23657045|NCT01610687|66132712|FG000|Overall Study|Adverse Event|18|||
23657046|NCT01610687|66132712|FG000|Overall Study|Moved out of area|6|||
23657047|NCT01610687|66132712|FG000|Overall Study|Withdrawal by Subject|7|||
23657048|NCT01610687|66132712|FG000|Overall Study|Lost to Follow-up|4|||
23657049|NCT01610687|66132712|FG000|Overall Study|Symptom control without study medication|2|||
23657050|NCT01610687|66132712|FG000|Overall Study|Unable to make journey|1|||
23657051|NCT01610687|66132712|FG000|Overall Study|Death|1|||
23657052|NCT01610687|66132712|FG000|Overall Study|Cannabis affecting job|1|||
23657053|NCT01610687|66132712|FG000|Overall Study|Felt more alter without study medication|1|||
23657054|NCT00667355|66132718|FG000|Overall Study|Adverse Event|5|||
23657055|NCT00667355|66132718|FG000|Overall Study|Lost to Follow-up|1|||
23657056|NCT00667355|66132718|FG000|Overall Study|Other reason was not specified|5|||
23657057|NCT01210690|66132719|FG000|Overall Study|Adverse Event|7|||
23657058|NCT01210690|66132719|FG000|Overall Study|Lack of Efficacy|12|||
23657059|NCT01210690|66132719|FG000|Overall Study|Lost to Follow-up|3|||
23657060|NCT01210690|66132719|FG000|Overall Study|Disease Remission|1|||
23657061|NCT01210690|66132719|FG000|Overall Study|Withdrawal by Subject|1|||
23657062|NCT01210690|66132719|FG000|Overall Study|Patient refused to swallow|1|||
23657063|NCT01210690|66132719|FG000|Overall Study|Patient could not take glucose|1|||
23657064|NCT02608879|66132720|FG000|Overall Study|Lost to Follow-up|1|||
23657065|NCT02608879|66132721|FG001|Overall Study|Lost to Follow-up|0|||
23657066|NCT02608879|66132722|FG002|Overall Study|Lost to Follow-up|0|||
23657067|NCT02608879|66132720|FG000|Overall Study|Did not meet continuation criteria|0|||
23361448|NCT03012841|65069687|FG000|Overall Study|Lost to Follow-up|6|||
23361449|NCT03012841|65069688|FG001|Overall Study|Lost to Follow-up|1|||
23361450|NCT03012841|65069687|FG000|Overall Study|Withdrawal by Subject|6|||
23361451|NCT03012841|65069688|FG001|Overall Study|Withdrawal by Subject|0|||
23361452|NCT03012841|65069687|FG000|Overall Study|Unable to complete 12 month visit|6|||
23361453|NCT03012841|65069688|FG001|Overall Study|Unable to complete 12 month visit|0|||
23361454|NCT03012841|65069687|FG000|Overall Study|Subject relocation|1|||
23361455|NCT03012841|65069688|FG001|Overall Study|Subject relocation|0|||
23657068|NCT02608879|66132721|FG001|Overall Study|Did not meet continuation criteria|0|||
23657069|NCT02608879|66132722|FG002|Overall Study|Did not meet continuation criteria|3|||
23657070|NCT04439071|66132723|FG000|Overall Study|Lost to Follow-up|0|||
23361456|NCT03012841|65069687|FG000|Overall Study|Seasonal winter travel|1|||
23361457|NCT03012841|65069688|FG001|Overall Study|Seasonal winter travel|0|||
23361458|NCT03012841|65069687|FG000|Overall Study|Physician Decision|0|||
23361459|NCT03012841|65069688|FG001|Overall Study|Physician Decision|2|||
23361460|NCT03012841|65069687|FG000|Overall Study|No ablation performed|0|||
23361461|NCT03012841|65069688|FG001|Overall Study|No ablation performed|2|||
23361462|NCT03012841|65069687|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
23361463|NCT03012841|65069688|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
23657071|NCT04439071|66132724|FG001|Overall Study|Lost to Follow-up|3|||
23657072|NCT04439071|66132723|FG000|Overall Study|Withdrawal by Subject|3|||
23657073|NCT04439071|66132724|FG001|Overall Study|Withdrawal by Subject|8|||
23657074|NCT04439071|66132723|FG000|Overall Study|Death|6|||
23657075|NCT04439071|66132724|FG001|Overall Study|Death|4|||
23657076|NCT04439071|66132723|FG000|Overall Study|Other than specified|3|||
23657077|NCT04439071|66132724|FG001|Overall Study|Other than specified|3|||
23361464|NCT03012841|65069687|FG000|Overall Study|Insurance change|0|||
23361465|NCT03012841|65069688|FG001|Overall Study|Insurance change|1|||
23361466|NCT04826484|65069689|FG000|Overall Study|Lost to Follow-up|2|||
23361467|NCT04826484|65069690|FG001|Overall Study|Lost to Follow-up|0|||
23361468|NCT00943397|65069693|FG000|Overall Study|Adverse Event|0|||
23361469|NCT00943397|65069694|FG001|Overall Study|Adverse Event|6|||
23361470|NCT00943397|65069693|FG000|Overall Study|Lost to Follow-up|0|||
23361471|NCT00943397|65069694|FG001|Overall Study|Lost to Follow-up|4|||
23361472|NCT00943397|65069693|FG000|Overall Study|Protocol Violation|2|||
23361473|NCT00943397|65069694|FG001|Overall Study|Protocol Violation|5|||
23361474|NCT00943397|65069693|FG000|Overall Study|Withdrawal by Subject|1|||
23361475|NCT00943397|65069694|FG001|Overall Study|Withdrawal by Subject|1|||
23361476|NCT00943397|65069693|FG000|Overall Study|Site terminated and other|12|||
23361477|NCT00943397|65069694|FG001|Overall Study|Site terminated and other|56|||
23361478|NCT00536510|65069695|FG000|Overall Study|Adverse Event|27|||
23657078|NCT04439071|66132723|FG000|Overall Study|Randomized but not treated|2|||
23657079|NCT04439071|66132724|FG001|Overall Study|Randomized but not treated|0|||
23657080|NCT00727649|66132725|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
23657081|NCT00727649|66132726|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
23657082|NCT00727649|66132725|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
23657083|NCT00727649|66132726|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
23657084|NCT00727649|66132725|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
23600597|NCT03478969|65929681|FG000|Overall Study|Personal Reasons|1|||
23657085|NCT00727649|66132726|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
23361479|NCT00536510|65069696|FG001|Overall Study|Adverse Event|4|||
23361480|NCT00536510|65069695|FG000|Overall Study|Lost to Follow-up|11|||
23361481|NCT00536510|65069696|FG001|Overall Study|Lost to Follow-up|8|||
23361482|NCT00536510|65069695|FG000|Overall Study|Protocol Violation|4|||
23600598|NCT03478969|65929682|FG001|Overall Study|Personal Reasons|0|||
23657086|NCT00727649|66132725|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
23657087|NCT00727649|66132726|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
23657088|NCT00727649|66132725|FG000|Second Intervention (4-weeks)|Death|1|||
23657089|NCT00727649|66132726|FG001|Second Intervention (4-weeks)|Death|0|||
23657090|NCT00727649|66132725|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
23657091|NCT00727649|66132726|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
23657092|NCT00727649|66132725|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
23657093|NCT00727649|66132726|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
23657094|NCT02717754|66132727|FG000|Overall Study|Incorrect Infusion Duration|0|||
23657095|NCT02717754|66132728|FG001|Overall Study|Incorrect Infusion Duration|0|||
23657096|NCT02717754|66132729|FG002|Overall Study|Incorrect Infusion Duration|0|||
23657097|NCT02717754|66132730|FG003|Overall Study|Incorrect Infusion Duration|10|||
23657098|NCT02717754|66132731|FG004|Overall Study|Incorrect Infusion Duration|20|||
23657099|NCT02717754|66132732|FG005|Overall Study|Incorrect Infusion Duration|20|||
23657100|NCT00986440|66132733|FG000|Overall Study|Progressive disease|27|||
23657101|NCT00986440|66132734|FG001|Overall Study|Progressive disease|37|||
23657102|NCT00986440|66132733|FG000|Overall Study|Serious adverse event or adverse event|9|||
23657103|NCT00986440|66132734|FG001|Overall Study|Serious adverse event or adverse event|2|||
23657104|NCT00986440|66132733|FG000|Overall Study|Withdrawal by Subject|1|||
23657105|NCT00986440|66132734|FG001|Overall Study|Withdrawal by Subject|2|||
23657106|NCT00986440|66132733|FG000|Overall Study|Screen failure (not dosed)|4|||
23657107|NCT00986440|66132734|FG001|Overall Study|Screen failure (not dosed)|2|||
23657108|NCT04556136|66132736|FG000|Overall Study|Lost to Follow-up|6|||
23657109|NCT04556136|66132737|FG001|Overall Study|Lost to Follow-up|6|||
23657110|NCT04556136|66132736|FG000|Overall Study|Physician Decision|2|||
23657111|NCT04556136|66132737|FG001|Overall Study|Physician Decision|1|||
23657112|NCT04556136|66132736|FG000|Overall Study|Withdrawal by Subject|2|||
23657113|NCT04556136|66132737|FG001|Overall Study|Withdrawal by Subject|1|||
23657114|NCT02409290|66132738|FG000|Overall Study|Protocol Violation|3|||
23657115|NCT02409290|66132739|FG001|Overall Study|Protocol Violation|6|||
23657116|NCT02409290|66132740|FG002|Overall Study|Protocol Violation|9|||
23657117|NCT02409290|66132741|FG003|Overall Study|Protocol Violation|4|||
23657118|NCT02409290|66132738|FG000|Overall Study|No positive culture/no baseline sample|3|||
23657119|NCT02409290|66132739|FG001|Overall Study|No positive culture/no baseline sample|9|||
23657120|NCT02409290|66132740|FG002|Overall Study|No positive culture/no baseline sample|6|||
23657121|NCT02409290|66132741|FG003|Overall Study|No positive culture/no baseline sample|5|||
23657122|NCT02409290|66132738|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
23657123|NCT02409290|66132739|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23657124|NCT02409290|66132740|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23657125|NCT02409290|66132741|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23657126|NCT00529451|66132742|FG000|Overall Study|Subject withdrew consent|16|||
23657127|NCT00529451|66132743|FG001|Overall Study|Subject withdrew consent|21|||
23657128|NCT00529451|66132744|FG002|Overall Study|Subject withdrew consent|13|||
23657129|NCT00529451|66132745|FG003|Overall Study|Subject withdrew consent|12|||
23657130|NCT00529451|66132742|FG000|Overall Study|Adverse Event|9|||
23657131|NCT00529451|66132743|FG001|Overall Study|Adverse Event|16|||
23657132|NCT00529451|66132744|FG002|Overall Study|Adverse Event|14|||
23657133|NCT00529451|66132745|FG003|Overall Study|Adverse Event|8|||
23657134|NCT00529451|66132742|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
23657135|NCT00529451|66132743|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
23657136|NCT00529451|66132744|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
23657137|NCT00529451|66132745|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
23657138|NCT00529451|66132742|FG000|Overall Study|Lost to Follow-up|4|||
23657139|NCT00529451|66132743|FG001|Overall Study|Lost to Follow-up|7|||
23657140|NCT00529451|66132744|FG002|Overall Study|Lost to Follow-up|4|||
23657141|NCT00529451|66132745|FG003|Overall Study|Lost to Follow-up|4|||
23657142|NCT00529451|66132742|FG000|Overall Study|Protocol deviation|1|||
23657143|NCT00529451|66132743|FG001|Overall Study|Protocol deviation|1|||
23657144|NCT00529451|66132744|FG002|Overall Study|Protocol deviation|4|||
23657145|NCT00529451|66132745|FG003|Overall Study|Protocol deviation|1|||
23657146|NCT00529451|66132742|FG000|Overall Study|Administrative problems|1|||
23657147|NCT00529451|66132743|FG001|Overall Study|Administrative problems|1|||
23657148|NCT00529451|66132744|FG002|Overall Study|Administrative problems|0|||
23657149|NCT00529451|66132745|FG003|Overall Study|Administrative problems|2|||
23657150|NCT02113579|66132746|FG000|Overall Study|Adverse Event|1|||
23657151|NCT02113579|66132747|FG001|Overall Study|Adverse Event|0|||
23657152|NCT02113579|66132746|FG000|Overall Study|Withdrawal by Subject|3|||
23657153|NCT02113579|66132747|FG001|Overall Study|Withdrawal by Subject|2|||
23657154|NCT02113579|66132746|FG000|Overall Study|Lost to Follow-up|6|||
23657155|NCT02113579|66132747|FG001|Overall Study|Lost to Follow-up|2|||
23657156|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
23657157|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23657158|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23806604|NCT04146363|66672537|FG006|Induction Period|Adverse Event|0|||
23657159|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23657160|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23657161|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
23657162|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23657163|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23657164|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23600599|NCT03478969|65929683|FG002|Overall Study|Personal Reasons|1|||
23600600|NCT03478969|65929681|FG000|Overall Study|Covid-19|1|||
23600601|NCT03478969|65929682|FG001|Overall Study|Covid-19|4|||
23600602|NCT03478969|65929683|FG002|Overall Study|Covid-19|3|||
23600603|NCT03478969|65929681|FG000|Overall Study|Multiple Reasons|0|||
23600604|NCT03478969|65929682|FG001|Overall Study|Multiple Reasons|1|||
23657165|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23806605|NCT04146363|66672538|FG007|Induction Period|Adverse Event|0|||
23806606|NCT04146363|66672539|FG008|Induction Period|Adverse Event|0|||
23806607|NCT04146363|66672540|FG009|Induction Period|Adverse Event|0|||
23806608|NCT04146363|66672541|FG010|Induction Period|Adverse Event|0|||
23806609|NCT04146363|66672531|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
23806610|NCT04146363|66672532|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
23806611|NCT04146363|66672533|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
23806612|NCT04146363|66672534|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
23806613|NCT04146363|66672535|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
23806614|NCT04146363|66672536|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
23806615|NCT04146363|66672537|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
23657166|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
23657167|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23657168|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23806616|NCT04146363|66672538|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
23806617|NCT04146363|66672539|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
23806618|NCT04146363|66672540|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
23806619|NCT04146363|66672541|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
23600605|NCT03478969|65929683|FG002|Overall Study|Multiple Reasons|1|||
23600606|NCT03478969|65929681|FG000|Overall Study|Eligibility Criteria|0|||
23600607|NCT03478969|65929682|FG001|Overall Study|Eligibility Criteria|0|||
23657169|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23657170|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23657171|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
23657172|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23657173|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23657174|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23657175|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23657176|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
23657177|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23657178|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23657179|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23657180|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23657181|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
23657182|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23657183|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23657184|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23657185|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23657186|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
23657187|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23657188|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23657189|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23806620|NCT04146363|66672531|FG000|Induction Period|Lack of Efficacy|7|||
23806621|NCT04146363|66672532|FG001|Induction Period|Lack of Efficacy|2|||
23806622|NCT04146363|66672533|FG002|Induction Period|Lack of Efficacy|0|||
23806623|NCT04146363|66672534|FG003|Induction Period|Lack of Efficacy|0|||
23806624|NCT04146363|66672535|FG004|Induction Period|Lack of Efficacy|0|||
23806625|NCT04146363|66672536|FG005|Induction Period|Lack of Efficacy|0|||
23806626|NCT04146363|66672537|FG006|Induction Period|Lack of Efficacy|0|||
23806627|NCT04146363|66672538|FG007|Induction Period|Lack of Efficacy|0|||
23806628|NCT04146363|66672539|FG008|Induction Period|Lack of Efficacy|0|||
23806629|NCT04146363|66672540|FG009|Induction Period|Lack of Efficacy|0|||
23806630|NCT04146363|66672541|FG010|Induction Period|Lack of Efficacy|0|||
23806631|NCT04146363|66672531|FG000|Induction Period|Lost to Follow-up|1|||
23806632|NCT04146363|66672532|FG001|Induction Period|Lost to Follow-up|4|||
23806633|NCT04146363|66672533|FG002|Induction Period|Lost to Follow-up|0|||
23806634|NCT04146363|66672534|FG003|Induction Period|Lost to Follow-up|0|||
23806635|NCT04146363|66672535|FG004|Induction Period|Lost to Follow-up|0|||
23361483|NCT00536510|65069696|FG001|Overall Study|Protocol Violation|5|||
23657190|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23657191|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
23657192|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23657193|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23657194|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23657195|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23657196|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
23657197|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23657198|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23657199|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23657200|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23657201|NCT03627767|66132750|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
23657202|NCT03627767|66132751|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23657203|NCT03627767|66132752|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23657204|NCT03627767|66132753|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23657205|NCT03627767|66132754|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23657206|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
23657207|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
23657208|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
23657209|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
23806636|NCT04146363|66672536|FG005|Induction Period|Lost to Follow-up|0|||
23806637|NCT04146363|66672537|FG006|Induction Period|Lost to Follow-up|0|||
23806638|NCT04146363|66672538|FG007|Induction Period|Lost to Follow-up|0|||
23806639|NCT04146363|66672539|FG008|Induction Period|Lost to Follow-up|0|||
23806640|NCT04146363|66672540|FG009|Induction Period|Lost to Follow-up|0|||
23806641|NCT04146363|66672541|FG010|Induction Period|Lost to Follow-up|0|||
23806642|NCT04146363|66672531|FG000|Induction Period|Positive quantiferon test|0|||
23806643|NCT04146363|66672532|FG001|Induction Period|Positive quantiferon test|1|||
23657210|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
23657211|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23657212|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23657213|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
23657214|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
23657215|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23806644|NCT04146363|66672533|FG002|Induction Period|Positive quantiferon test|0|||
23806645|NCT04146363|66672534|FG003|Induction Period|Positive quantiferon test|0|||
23806646|NCT04146363|66672535|FG004|Induction Period|Positive quantiferon test|0|||
23806647|NCT04146363|66672536|FG005|Induction Period|Positive quantiferon test|0|||
23806648|NCT04146363|66672537|FG006|Induction Period|Positive quantiferon test|0|||
23806649|NCT04146363|66672538|FG007|Induction Period|Positive quantiferon test|0|||
23806650|NCT04146363|66672539|FG008|Induction Period|Positive quantiferon test|0|||
23806651|NCT04146363|66672540|FG009|Induction Period|Positive quantiferon test|0|||
23806652|NCT04146363|66672541|FG010|Induction Period|Positive quantiferon test|0|||
23806653|NCT04146363|66672531|FG000|Induction Period|Protocol Deviation|5|||
23806654|NCT04146363|66672532|FG001|Induction Period|Protocol Deviation|6|||
23806655|NCT04146363|66672533|FG002|Induction Period|Protocol Deviation|0|||
23806656|NCT04146363|66672534|FG003|Induction Period|Protocol Deviation|0|||
23806657|NCT04146363|66672535|FG004|Induction Period|Protocol Deviation|0|||
23806658|NCT04146363|66672536|FG005|Induction Period|Protocol Deviation|0|||
23806659|NCT04146363|66672537|FG006|Induction Period|Protocol Deviation|0|||
23806660|NCT04146363|66672538|FG007|Induction Period|Protocol Deviation|0|||
23806661|NCT04146363|66672539|FG008|Induction Period|Protocol Deviation|0|||
23806662|NCT04146363|66672540|FG009|Induction Period|Protocol Deviation|0|||
23806663|NCT04146363|66672541|FG010|Induction Period|Protocol Deviation|0|||
23806664|NCT04146363|66672531|FG000|Induction Period|Withdrawal by Subject|6|||
23806665|NCT04146363|66672532|FG001|Induction Period|Withdrawal by Subject|3|||
23806666|NCT04146363|66672533|FG002|Induction Period|Withdrawal by Subject|0|||
23806667|NCT04146363|66672534|FG003|Induction Period|Withdrawal by Subject|0|||
23806668|NCT04146363|66672535|FG004|Induction Period|Withdrawal by Subject|0|||
23806669|NCT04146363|66672536|FG005|Induction Period|Withdrawal by Subject|0|||
23806670|NCT04146363|66672537|FG006|Induction Period|Withdrawal by Subject|0|||
23806671|NCT04146363|66672538|FG007|Induction Period|Withdrawal by Subject|0|||
23806672|NCT04146363|66672539|FG008|Induction Period|Withdrawal by Subject|0|||
23806673|NCT04146363|66672540|FG009|Induction Period|Withdrawal by Subject|0|||
23806674|NCT04146363|66672541|FG010|Induction Period|Withdrawal by Subject|0|||
23806675|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806676|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806677|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806678|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806679|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806680|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806681|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
23806682|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
23806683|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806684|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806685|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
23806686|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806687|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806688|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806689|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806690|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806691|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806692|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806693|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
23806694|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806695|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806696|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23806697|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806698|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23657216|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
23806699|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806700|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806701|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806702|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806703|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23806704|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23361484|NCT00536510|65069695|FG000|Overall Study|Withdrawal by Subject|16|||
23361485|NCT00536510|65069696|FG001|Overall Study|Withdrawal by Subject|9|||
23361486|NCT00536510|65069695|FG000|Overall Study|Flushing with Product|20|||
23600608|NCT03478969|65929683|FG002|Overall Study|Eligibility Criteria|5|||
23600609|NCT03478969|65929681|FG000|Overall Study|Lost to Follow-up|0|||
23600610|NCT03478969|65929682|FG001|Overall Study|Lost to Follow-up|0|||
23600611|NCT03478969|65929683|FG002|Overall Study|Lost to Follow-up|1|||
23600612|NCT01212744|65929684|FG000|Overall Study|Withdrawal by Subject|1|||
23600613|NCT01596972|65929685|FG000|Overall Study|Physician Decision|1|||
23600614|NCT01596972|65929686|FG001|Overall Study|Physician Decision|9|||
23600615|NCT01596972|65929685|FG000|Overall Study|Lost to Follow-up|0|||
23600616|NCT01596972|65929686|FG001|Overall Study|Lost to Follow-up|4|||
23600617|NCT01596972|65929685|FG000|Overall Study|Withdrawal by Subject|0|||
23600618|NCT01596972|65929686|FG001|Overall Study|Withdrawal by Subject|1|||
23600619|NCT01555138|65929687|FG000|Overall Study|Death|0|||
23600620|NCT01555138|65929688|FG001|Overall Study|Death|1|||
23600621|NCT01555138|65929687|FG000|Overall Study|Lost to Follow-up|1|||
23600622|NCT01555138|65929688|FG001|Overall Study|Lost to Follow-up|0|||
23600623|NCT01555138|65929687|FG000|Overall Study|Abnormal Lab reults|1|||
23600624|NCT01555138|65929688|FG001|Overall Study|Abnormal Lab reults|3|||
23600625|NCT01555138|65929687|FG000|Overall Study|Lack of Efficacy|2|||
23600626|NCT01555138|65929688|FG001|Overall Study|Lack of Efficacy|2|||
23600627|NCT01555138|65929687|FG000|Overall Study|Protocol Violation|5|||
23600628|NCT01555138|65929688|FG001|Overall Study|Protocol Violation|3|||
23600629|NCT01555138|65929687|FG000|Overall Study|Administrative problems|8|||
23600630|NCT01555138|65929688|FG001|Overall Study|Administrative problems|0|||
23600631|NCT01555138|65929687|FG000|Overall Study|Withdrawal by Subject|16|||
23600632|NCT01555138|65929688|FG001|Overall Study|Withdrawal by Subject|15|||
23600633|NCT01555138|65929687|FG000|Overall Study|Adverse Event|14|||
23361487|NCT00536510|65069696|FG001|Overall Study|Flushing with Product|0|||
23361488|NCT00536510|65069695|FG000|Overall Study|Laboratory Adverse Event|2|||
23361489|NCT00536510|65069696|FG001|Overall Study|Laboratory Adverse Event|1|||
23361490|NCT00536510|65069695|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
23657217|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
23657218|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
23361491|NCT00536510|65069696|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
23806705|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23361492|NCT02998151|65069697|FG000|Overall Study|Withdrawal by Subject|3|||
23361493|NCT02998151|65069697|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
23361494|NCT02998151|65069697|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
23361495|NCT04878055|65069703|FG000|Overall Study|Patient transferred in another department|0|||
23361496|NCT04878055|65069704|FG001|Overall Study|Patient transferred in another department|2|||
23361497|NCT04878055|65069703|FG000|Overall Study|Physician Decision|1|||
23361498|NCT04878055|65069704|FG001|Overall Study|Physician Decision|1|||
23361499|NCT04878055|65069703|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
23361500|NCT04878055|65069704|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
23361501|NCT04878055|65069703|FG000|Overall Study|Adverse Event|12|||
23361502|NCT04878055|65069704|FG001|Overall Study|Adverse Event|7|||
23361503|NCT04878055|65069703|FG000|Overall Study|Other|5|||
23361504|NCT04878055|65069704|FG001|Overall Study|Other|0|||
23361505|NCT04878055|65069703|FG000|Overall Study|Withdrawal by Subject|7|||
23361506|NCT04878055|65069704|FG001|Overall Study|Withdrawal by Subject|3|||
23361507|NCT04878055|65069703|FG000|Overall Study|Lost to Follow-up|10|||
23361508|NCT04878055|65069704|FG001|Overall Study|Lost to Follow-up|1|||
23361509|NCT02207400|65069705|FG000|Overall Study|Adverse Event|1|||
23806706|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806707|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23806708|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806709|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806710|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
23806711|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806712|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806713|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
23806714|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806715|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806716|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806717|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806718|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
23806719|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23806720|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23806721|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23806722|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23806723|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
23806724|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
23806725|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
23806726|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
23806727|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23361510|NCT02207400|65069706|FG001|Overall Study|Adverse Event|1|||
23361511|NCT02207400|65069705|FG000|Overall Study|Lost to Follow-up|6|||
23361512|NCT02207400|65069706|FG001|Overall Study|Lost to Follow-up|7|||
23361513|NCT02207400|65069705|FG000|Overall Study|Protocol Violation|1|||
23657219|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
23657220|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
23657221|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23657222|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
23657223|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
23657224|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
23657225|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23657226|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23657227|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23657228|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
23657229|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23657230|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23657231|NCT03627767|66132750|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
23657232|NCT03627767|66132751|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
23657233|NCT03627767|66132752|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
23361514|NCT02207400|65069706|FG001|Overall Study|Protocol Violation|1|||
23657234|NCT03627767|66132753|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
23600634|NCT01555138|65929688|FG001|Overall Study|Adverse Event|14|||
23657235|NCT03627767|66132754|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
23657236|NCT03627767|66132750|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23657237|NCT03627767|66132751|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23657238|NCT03627767|66132752|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23657239|NCT03627767|66132753|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23657240|NCT03627767|66132754|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
23657241|NCT03627767|66132750|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23657242|NCT03627767|66132751|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23657243|NCT03627767|66132752|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23657244|NCT03627767|66132753|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23657245|NCT03627767|66132754|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
23657246|NCT03627767|66132750|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23657247|NCT03627767|66132751|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23657248|NCT03627767|66132752|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23657249|NCT03627767|66132753|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23657250|NCT03627767|66132754|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
23657251|NCT03627767|66132750|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
23657252|NCT03627767|66132751|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
23657253|NCT03627767|66132752|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
23657254|NCT03627767|66132753|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
23657255|NCT03627767|66132754|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
23657256|NCT02811549|66132755|FG000|Overall Study|Lost to Follow-up|1|||
23657257|NCT02811549|66132755|FG000|Overall Study|Withdrawal by Subject|3|||
23657258|NCT02811549|66132755|FG000|Overall Study|Subject screen failed|4|||
23657259|NCT02811549|66132755|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
23657260|NCT01102803|66132759|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
23657261|NCT01102803|66132760|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
23657262|NCT01102803|66132759|FG000|Post to Follow-Up|Lost to Follow-up|1|||
23657263|NCT01102803|66132760|FG001|Post to Follow-Up|Lost to Follow-up|3|||
23657264|NCT00617604|66132761|FG000|Overall Study|Death|2|||
23657265|NCT00617604|66132762|FG001|Overall Study|Death|1|||
23657266|NCT00617604|66132761|FG000|Overall Study|Lost to Follow-up|1|||
23657267|NCT00617604|66132762|FG001|Overall Study|Lost to Follow-up|0|||
23657268|NCT00617604|66132761|FG000|Overall Study|Miscellaneous Reasons|8|||
23657269|NCT00617604|66132762|FG001|Overall Study|Miscellaneous Reasons|10|||
23657270|NCT00617604|66132761|FG000|Overall Study|Withdrawal by Subject|4|||
23657271|NCT00617604|66132762|FG001|Overall Study|Withdrawal by Subject|6|||
23657272|NCT00617604|66132761|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
23657273|NCT00617604|66132762|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
23657274|NCT03715153|66132771|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
23657275|NCT03715153|66132772|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
23657276|NCT03715153|66132771|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
23657277|NCT03715153|66132772|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
23657278|NCT03715153|66132771|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
23657279|NCT03715153|66132772|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
23657280|NCT03715153|66132771|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
23657281|NCT03715153|66132772|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
23657282|NCT03715153|66132771|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
23657283|NCT03715153|66132772|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
23657284|NCT03715153|66132771|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
23657285|NCT03715153|66132772|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
23657286|NCT02700997|66132773|FG000|Overall Study|Did not undergo CT imaging|1|||
23657287|NCT02700997|66132773|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
23657288|NCT04004429|66132774|FG000|Overall Study|Protocol Violation|1|||
23657289|NCT04004429|66132775|FG001|Overall Study|Protocol Violation|0|||
23657290|NCT04004429|66132776|FG002|Overall Study|Protocol Violation|0|||
23657291|NCT04004429|66132774|FG000|Overall Study|Physician Decision|0|||
23657292|NCT04004429|66132775|FG001|Overall Study|Physician Decision|1|||
23657293|NCT04004429|66132776|FG002|Overall Study|Physician Decision|1|||
23657294|NCT04004429|66132774|FG000|Overall Study|Withdrawal by Subject|1|||
23657295|NCT04004429|66132775|FG001|Overall Study|Withdrawal by Subject|1|||
23657296|NCT04004429|66132776|FG002|Overall Study|Withdrawal by Subject|1|||
23657297|NCT02030405|66132777|FG000|Overall Study|Withdrawal by Subject|1|||
23657298|NCT02030405|66132777|FG000|Overall Study|Lost to Follow-up|1|||
23657299|NCT03785678|66132778|FG000|Overall Study|Death|44|||
23657300|NCT03785678|66132779|FG001|Overall Study|Death|42|||
23657301|NCT03785678|66132778|FG000|Overall Study|Lost to Follow-up|4|||
23657302|NCT03785678|66132779|FG001|Overall Study|Lost to Follow-up|2|||
23657303|NCT03785678|66132778|FG000|Overall Study|Physician Decision|0|||
23657304|NCT03785678|66132779|FG001|Overall Study|Physician Decision|2|||
23657305|NCT03785678|66132778|FG000|Overall Study|Withdrawal by Subject|5|||
23806728|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23361515|NCT02207400|65069705|FG000|Overall Study|Withdrawal by Subject|8|||
23361516|NCT02207400|65069706|FG001|Overall Study|Withdrawal by Subject|4|||
23361517|NCT02207400|65069705|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
23657306|NCT03785678|66132779|FG001|Overall Study|Withdrawal by Subject|3|||
23657307|NCT01105091|66132780|FG000|Overall Study|Death|2|||
23657308|NCT01105091|66132781|FG001|Overall Study|Death|0|||
23657309|NCT03027557|66132782|FG000|Overall Study|Adverse Event|1|||
23657310|NCT03027557|66132783|FG001|Overall Study|Adverse Event|0|||
23657311|NCT03027557|66132784|FG002|Overall Study|Adverse Event|0|||
23657312|NCT01849497|66132785|FG000|Overall Study|Withdrawal by Subject|1|||
23657313|NCT01849497|66132786|FG001|Overall Study|Withdrawal by Subject|2|||
23657314|NCT01849497|66132785|FG000|Overall Study|Sponsor Decision|0|||
23657315|NCT01849497|66132786|FG001|Overall Study|Sponsor Decision|1|||
23657316|NCT01849497|66132785|FG000|Overall Study|Lost to Follow-up|0|||
23657317|NCT01849497|66132786|FG001|Overall Study|Lost to Follow-up|1|||
23657318|NCT04195581|66132787|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
23657319|NCT04195581|66132787|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
23657320|NCT04195581|66132787|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
23657321|NCT04195581|66132787|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
23657322|NCT04195581|66132787|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
23657323|NCT04195581|66132787|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
23657324|NCT02465463|66132789|FG000|Overall Study|Lost to Follow-up|2|||
23657325|NCT02465463|66132790|FG001|Overall Study|Lost to Follow-up|1|||
23657326|NCT02465463|66132789|FG000|Overall Study|Death|1|||
23657327|NCT02465463|66132790|FG001|Overall Study|Death|0|||
23657328|NCT02465463|66132789|FG000|Overall Study|Protocol Violation|1|||
23657329|NCT02465463|66132790|FG001|Overall Study|Protocol Violation|0|||
23657330|NCT02289352|66132795|FG000|Overall Study|Withdrawal by Subject|1|||
23657331|NCT02289352|66132796|FG001|Overall Study|Withdrawal by Subject|1|||
23657332|NCT02289352|66132797|FG002|Overall Study|Withdrawal by Subject|0|||
23657333|NCT02592018|66132801|FG000|Overall Study|Adverse Event|1|||
23657334|NCT02592018|66132801|FG000|Overall Study|Lost to Follow-up|1|||
23657335|NCT03739762|66132803|FG000|Overall Study|Lost to Follow-up|1|||
23657336|NCT03739762|66132804|FG001|Overall Study|Lost to Follow-up|1|||
23657337|NCT03739762|66132803|FG000|Overall Study|Withdrawal by Subject|2|||
23657338|NCT03739762|66132804|FG001|Overall Study|Withdrawal by Subject|6|||
23657339|NCT00709111|66132805|FG000|Overall Study|Withdrawal by Subject|1|||
23657340|NCT00709111|66132805|FG000|Overall Study|Unable to attend clinic visits|1|||
23657341|NCT01494350|66132806|FG000|Overall Study|Worsening of lesion|1|||
23657342|NCT02966223|66132809|FG000|Overall Study|Physician Decision|3|||
23657343|NCT02966223|66132809|FG000|Overall Study|Withdrawal by Subject|11|||
23361518|NCT02207400|65069706|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
23657344|NCT02966223|66132809|FG000|Overall Study|Lost to Follow-up|1|||
23657345|NCT01717768|66132811|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657346|NCT01717768|66132812|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
23657347|NCT01717768|66132813|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657348|NCT01717768|66132814|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657349|NCT01717768|66132815|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657350|NCT01717768|66132816|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657351|NCT01717768|66132817|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657352|NCT01717768|66132818|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657353|NCT01717768|66132819|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23600635|NCT02740231|65929689|FG000|Overall Study|Withdrawal by Subject|1|||
23600636|NCT02740231|65929690|FG001|Overall Study|Withdrawal by Subject|1|||
23600637|NCT02740231|65929691|FG002|Overall Study|Withdrawal by Subject|1|||
23600638|NCT02740231|65929692|FG003|Overall Study|Withdrawal by Subject|0|||
23600639|NCT02740231|65929689|FG000|Overall Study|Lack of Efficacy|0|||
23600640|NCT02740231|65929690|FG001|Overall Study|Lack of Efficacy|1|||
23600641|NCT02740231|65929691|FG002|Overall Study|Lack of Efficacy|0|||
23600642|NCT02740231|65929692|FG003|Overall Study|Lack of Efficacy|4|||
23600643|NCT02740231|65929689|FG000|Overall Study|Lost to Follow-up|1|||
23600644|NCT02740231|65929690|FG001|Overall Study|Lost to Follow-up|3|||
23600645|NCT02740231|65929691|FG002|Overall Study|Lost to Follow-up|0|||
23600646|NCT02740231|65929692|FG003|Overall Study|Lost to Follow-up|3|||
23600647|NCT02740231|65929689|FG000|Overall Study|Adverse Event|0|||
23600648|NCT02740231|65929690|FG001|Overall Study|Adverse Event|1|||
23600649|NCT02740231|65929691|FG002|Overall Study|Adverse Event|0|||
23600650|NCT02740231|65929692|FG003|Overall Study|Adverse Event|1|||
23600651|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
23600652|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
23600653|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
23600654|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
23600655|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
23600656|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23657354|NCT01717768|66132820|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23657355|NCT01717768|66132821|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23600657|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23657356|NCT01717768|66132822|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23600658|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
23600659|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23480474|NCT04585009|65501999|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23600660|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23480475|NCT04585009|65502000|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
23361519|NCT00873730|65069707|FG000|Overall Study|Protocol Deviation|5|||
23361520|NCT00873730|65069708|FG001|Overall Study|Protocol Deviation|2|||
23361521|NCT00873730|65069707|FG000|Overall Study|Adverse Event|0|||
23361522|NCT00873730|65069708|FG001|Overall Study|Adverse Event|2|||
23361523|NCT00873730|65069707|FG000|Overall Study|Withdrawal by Subject|0|||
23361524|NCT00873730|65069708|FG001|Overall Study|Withdrawal by Subject|1|||
23361525|NCT00873730|65069707|FG000|Overall Study|Sponsor decision|1|||
23361526|NCT00873730|65069708|FG001|Overall Study|Sponsor decision|0|||
23361527|NCT01768559|65069709|FG000|Overall Study|Randomized but not treated|0|||
23361528|NCT01768559|65069710|FG001|Overall Study|Randomized but not treated|0|||
23361529|NCT01768559|65069711|FG002|Overall Study|Randomized but not treated|1|||
23361530|NCT01768559|65069709|FG000|Overall Study|Adverse Event|15|||
23361531|NCT01768559|65069710|FG001|Overall Study|Adverse Event|2|||
23361532|NCT01768559|65069711|FG002|Overall Study|Adverse Event|5|||
23361533|NCT01768559|65069709|FG000|Overall Study|Lack of Efficacy|6|||
23361534|NCT01768559|65069710|FG001|Overall Study|Lack of Efficacy|4|||
23361535|NCT01768559|65069711|FG002|Overall Study|Lack of Efficacy|0|||
23361536|NCT01768559|65069709|FG000|Overall Study|Poor compliance to protocol|0|||
23361537|NCT01768559|65069710|FG001|Overall Study|Poor compliance to protocol|3|||
23361538|NCT01768559|65069711|FG002|Overall Study|Poor compliance to protocol|2|||
23361539|NCT01768559|65069709|FG000|Overall Study|Other than specified|9|||
23361540|NCT01768559|65069710|FG001|Overall Study|Other than specified|8|||
23361541|NCT01768559|65069711|FG002|Overall Study|Other than specified|5|||
23361542|NCT00846053|65069712|FG000|Overall Study|Physician Decision|3|||
23361543|NCT00846053|65069713|FG001|Overall Study|Physician Decision|0|||
23361544|NCT02281955|65069719|FG000|Overall Study|Death|1|||
23361545|NCT03193047|65069720|FG000|Overall Study|Physician Decision|1|||
23361546|NCT03193047|65069721|FG001|Overall Study|Physician Decision|0|||
23361547|NCT03193047|65069720|FG000|Overall Study|Participant Left State|1|||
23361548|NCT03193047|65069721|FG001|Overall Study|Participant Left State|0|||
23361549|NCT00618826|65069730|FG000|Overall Study|Adverse Event|1|||
23361550|NCT01395810|65069739|FG000|Overall Study|Adverse Event|0|||
23361551|NCT01395810|65069740|FG001|Overall Study|Adverse Event|1|||
23361552|NCT01395810|65069741|FG002|Overall Study|Adverse Event|0|||
23361553|NCT01395810|65069742|FG003|Overall Study|Adverse Event|0|||
23361554|NCT01395810|65069739|FG000|Overall Study|Lack of Efficacy|0|||
23361555|NCT01395810|65069740|FG001|Overall Study|Lack of Efficacy|1|||
23361556|NCT01395810|65069741|FG002|Overall Study|Lack of Efficacy|0|||
23361557|NCT01395810|65069742|FG003|Overall Study|Lack of Efficacy|0|||
23361558|NCT01395810|65069739|FG000|Overall Study|Withdrawal criteria|0|||
23361559|NCT01395810|65069740|FG001|Overall Study|Withdrawal criteria|2|||
23361560|NCT01395810|65069741|FG002|Overall Study|Withdrawal criteria|0|||
23657357|NCT01717768|66132811|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657358|NCT01717768|66132812|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657359|NCT01717768|66132813|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657360|NCT01717768|66132814|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657361|NCT01717768|66132815|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657362|NCT01717768|66132816|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657363|NCT01717768|66132817|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657364|NCT01717768|66132818|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657365|NCT01717768|66132819|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657366|NCT01717768|66132820|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657367|NCT01717768|66132821|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23657368|NCT01717768|66132822|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
23657369|NCT01717768|66132811|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657370|NCT01717768|66132812|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657371|NCT01717768|66132813|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657372|NCT01717768|66132814|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657373|NCT01717768|66132815|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657374|NCT01717768|66132816|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657375|NCT01717768|66132817|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657376|NCT01717768|66132818|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
23657377|NCT01717768|66132819|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657378|NCT01717768|66132820|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657379|NCT01717768|66132821|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657380|NCT01717768|66132822|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23657381|NCT01717768|66132811|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657382|NCT01717768|66132812|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657383|NCT01717768|66132813|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657384|NCT01717768|66132814|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657385|NCT01717768|66132815|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657386|NCT01717768|66132816|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657387|NCT01717768|66132817|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657388|NCT01717768|66132818|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657389|NCT01717768|66132819|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23361561|NCT01395810|65069742|FG003|Overall Study|Withdrawal criteria|0|||
23480476|NCT04585009|65502001|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480477|NCT04585009|65502002|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23600661|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
23600662|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
23361562|NCT01395810|65069739|FG000|Overall Study|Unclassified|2|||
23657390|NCT01717768|66132820|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
23657391|NCT01717768|66132821|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657392|NCT01717768|66132822|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23657393|NCT03374995|66132823|FG000|Overall Study|Withdrawal by Subject|0|||
23657394|NCT03374995|66132824|FG001|Overall Study|Withdrawal by Subject|1|||
23657395|NCT01109173|66132833|FG000|Overall Study|Adverse Event|15|||
23657396|NCT01109173|66132834|FG001|Overall Study|Adverse Event|17|||
23657397|NCT01109173|66132835|FG002|Overall Study|Adverse Event|9|||
23657398|NCT01109173|66132836|FG003|Overall Study|Adverse Event|6|||
23657399|NCT01109173|66132833|FG000|Overall Study|Lost to Follow-up|0|||
23657400|NCT01109173|66132834|FG001|Overall Study|Lost to Follow-up|1|||
23657401|NCT01109173|66132835|FG002|Overall Study|Lost to Follow-up|0|||
23657402|NCT01109173|66132836|FG003|Overall Study|Lost to Follow-up|0|||
23657403|NCT01109173|66132833|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
23657404|NCT01109173|66132834|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
23657405|NCT01109173|66132835|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
23657406|NCT01109173|66132836|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
23657407|NCT01109173|66132833|FG000|Overall Study|Noncompliance|0|||
23657408|NCT01109173|66132834|FG001|Overall Study|Noncompliance|1|||
23657409|NCT01109173|66132835|FG002|Overall Study|Noncompliance|0|||
23657410|NCT01109173|66132836|FG003|Overall Study|Noncompliance|0|||
23657411|NCT01109173|66132833|FG000|Overall Study|Treatment Failure|25|||
23657412|NCT01109173|66132834|FG001|Overall Study|Treatment Failure|32|||
23657413|NCT01109173|66132835|FG002|Overall Study|Treatment Failure|69|||
23657414|NCT01109173|66132836|FG003|Overall Study|Treatment Failure|64|||
23657415|NCT01109173|66132833|FG000|Overall Study|Protocol Violation|4|||
23657416|NCT01109173|66132834|FG001|Overall Study|Protocol Violation|5|||
23657417|NCT01109173|66132835|FG002|Overall Study|Protocol Violation|1|||
23657418|NCT01109173|66132836|FG003|Overall Study|Protocol Violation|2|||
23657419|NCT01109173|66132833|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
23600663|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
23600664|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
23600665|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
23600666|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23600667|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
23600668|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
23600669|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23600670|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23657420|NCT01109173|66132834|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
23657421|NCT01109173|66132835|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
23657422|NCT01109173|66132836|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
23657423|NCT01109173|66132833|FG000|Overall Study|Not Specifiied|5|||
23657424|NCT01109173|66132834|FG001|Overall Study|Not Specifiied|4|||
23361563|NCT01395810|65069740|FG001|Overall Study|Unclassified|0|||
23657425|NCT01109173|66132835|FG002|Overall Study|Not Specifiied|9|||
23657426|NCT01109173|66132836|FG003|Overall Study|Not Specifiied|14|||
23657427|NCT00355056|66132837|FG000|Randomization Period|Early Termination|4|||
23657428|NCT00355056|66132838|FG001|Randomization Period|Early Termination|6|||
23657429|NCT00146757|66132841|FG000|Overall Study|Death|1|||
23657430|NCT00146757|66132842|FG001|Overall Study|Death|0|||
23657431|NCT00146757|66132841|FG000|Overall Study|Adverse Event|1|||
23657432|NCT00146757|66132842|FG001|Overall Study|Adverse Event|0|||
23657433|NCT02566577|66132845|FG000|Overall Study|Withdrawal by Subject|1|||
23657434|NCT02566577|66132846|FG001|Overall Study|Withdrawal by Subject|1|||
23657435|NCT02566577|66132845|FG000|Overall Study|Equipment failure|1|||
23657436|NCT02566577|66132846|FG001|Overall Study|Equipment failure|1|||
23657437|NCT02566577|66132845|FG000|Overall Study|Physical limitation|1|||
23657438|NCT02566577|66132846|FG001|Overall Study|Physical limitation|0|||
23657439|NCT02322229|66132847|FG000|Overall Study|Physician Decision|2|||
23657440|NCT00216203|66132848|FG000|Overall Study|Withdrawal by Subject|2|||
23657441|NCT00932425|66132849|FG000|Overall Study|Lost to Follow-up|0|||
23657442|NCT00932425|66132850|FG001|Overall Study|Lost to Follow-up|1|||
23657443|NCT00932425|66132849|FG000|Overall Study|Withdrawal by Subject|0|||
23657444|NCT00932425|66132850|FG001|Overall Study|Withdrawal by Subject|1|||
23657445|NCT02673619|66132851|FG000|Overall Study|Lost to Follow-up|1|||
23657446|NCT02673619|66132852|FG001|Overall Study|Lost to Follow-up|0|||
23657447|NCT02673619|66132853|FG002|Overall Study|Lost to Follow-up|0|||
23657448|NCT02673619|66132854|FG003|Overall Study|Lost to Follow-up|0|||
23657449|NCT02673619|66132851|FG000|Overall Study|Withdrawal by Subject|1|||
23806729|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23806730|NCT04146363|66672531|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806731|NCT04146363|66672532|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806732|NCT04146363|66672533|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23806733|NCT04146363|66672534|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806734|NCT04146363|66672535|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806735|NCT04146363|66672536|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
23806736|NCT04146363|66672537|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
23806737|NCT04146363|66672538|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
23806738|NCT04146363|66672539|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806739|NCT04146363|66672540|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806740|NCT04146363|66672541|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23806741|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806742|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806743|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806744|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806745|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806746|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806747|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806748|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806749|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
23806750|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
23806751|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23806752|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806753|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806754|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806755|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806756|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806757|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806758|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23806759|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23600671|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
23600672|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
23600673|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
23600674|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
23600675|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
23600676|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600677|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600678|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
23600679|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600680|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600681|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600682|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
23657450|NCT02673619|66132852|FG001|Overall Study|Withdrawal by Subject|1|||
23657451|NCT02673619|66132853|FG002|Overall Study|Withdrawal by Subject|1|||
23657452|NCT02673619|66132854|FG003|Overall Study|Withdrawal by Subject|0|||
23657453|NCT02673619|66132851|FG000|Overall Study|Adverse Event|0|||
23657454|NCT02673619|66132852|FG001|Overall Study|Adverse Event|0|||
23657455|NCT02673619|66132853|FG002|Overall Study|Adverse Event|1|||
23657456|NCT02673619|66132854|FG003|Overall Study|Adverse Event|0|||
23657457|NCT02673619|66132851|FG000|Overall Study|Lack of Efficacy|0|||
23657458|NCT02673619|66132852|FG001|Overall Study|Lack of Efficacy|0|||
23657459|NCT02673619|66132853|FG002|Overall Study|Lack of Efficacy|1|||
23657460|NCT02673619|66132854|FG003|Overall Study|Lack of Efficacy|0|||
23657461|NCT01098812|66132855|FG000|Overall Study|Death|2|||
23657462|NCT01098812|66132856|FG001|Overall Study|Death|0|||
23657463|NCT01098812|66132857|FG002|Overall Study|Death|1|||
23657464|NCT01098812|66132855|FG000|Overall Study|Lost to Follow-up|0|||
23657465|NCT01098812|66132856|FG001|Overall Study|Lost to Follow-up|1|||
23657466|NCT01098812|66132857|FG002|Overall Study|Lost to Follow-up|0|||
23657467|NCT01807923|66132860|FG000|Overall Study|Adverse Event|2|||
23657468|NCT01807923|66132861|FG001|Overall Study|Adverse Event|1|||
23657469|NCT01807923|66132862|FG002|Overall Study|Adverse Event|2|||
23657470|NCT01807923|66132860|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23657471|NCT01807923|66132861|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23657472|NCT01807923|66132862|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
23657473|NCT01807923|66132860|FG000|Overall Study|Physician Decision|0|||
23657474|NCT01807923|66132861|FG001|Overall Study|Physician Decision|0|||
23657475|NCT01807923|66132862|FG002|Overall Study|Physician Decision|1|||
23657476|NCT01807923|66132860|FG000|Overall Study|Not Eligible (Genotype)|0|||
23657477|NCT01807923|66132861|FG001|Overall Study|Not Eligible (Genotype)|0|||
23657478|NCT01807923|66132862|FG002|Overall Study|Not Eligible (Genotype)|1|||
23657479|NCT01807923|66132860|FG000|Overall Study|Randomized But Not Treated|3|||
23657480|NCT01807923|66132861|FG001|Overall Study|Randomized But Not Treated|2|||
23657481|NCT01807923|66132862|FG002|Overall Study|Randomized But Not Treated|5|||
23657482|NCT05097716|66132863|FG000|Period 1|Adverse Event|1|||
23657483|NCT05097716|66132863|FG000|Period 1|Close contact with highly-transmissible infection|1|||
23657484|NCT01117454|66132864|FG000|Overall Study|Pregnancy|0|||
23657485|NCT01117454|66132865|FG001|Overall Study|Pregnancy|1|||
23657486|NCT01294150|66132867|FG000|Overall Study|Physician Decision|2|||
23657487|NCT01294150|66132868|FG001|Overall Study|Physician Decision|2|||
23657488|NCT01630434|66132870|FG000|Overall Study|Donor lungs turned down|1|||
23657489|NCT01630434|66132871|FG001|Overall Study|Donor lungs turned down|0|||
23806760|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
23806761|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
23806762|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
23806763|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806764|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806765|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806766|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806767|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806768|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806769|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806770|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806771|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
23806772|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
23806773|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23806774|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806775|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
23657490|NCT01630434|66132870|FG000|Overall Study|Protocol Violation|9|||
23657491|NCT01630434|66132871|FG001|Overall Study|Protocol Violation|4|||
23657492|NCT01630434|66132870|FG000|Overall Study|Death|20|||
23657493|NCT01630434|66132871|FG001|Overall Study|Death|26|||
23657494|NCT03675776|66132872|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
23657495|NCT03675776|66132873|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
23657496|NCT03675776|66132874|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
23657497|NCT03675776|66132872|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23657498|NCT03675776|66132873|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23806776|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806777|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806778|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806779|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806780|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806781|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
23361564|NCT01395810|65069741|FG002|Overall Study|Unclassified|0|||
23361565|NCT01395810|65069742|FG003|Overall Study|Unclassified|0|||
23657499|NCT03675776|66132874|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23361566|NCT04530838|65069743|FG000|Overall Study|Other|2|||
23361567|NCT04530838|65069744|FG001|Overall Study|Other|1|||
23361568|NCT04530838|65069745|FG002|Overall Study|Other|0|||
23657500|NCT04029961|66132875|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
23657501|NCT04029961|66132876|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
23657502|NCT04029961|66132875|FG000|Overall Study|Change in Treatment Course|0|||
23657503|NCT04029961|66132876|FG001|Overall Study|Change in Treatment Course|1|||
23657504|NCT02060383|66132877|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
23657505|NCT02060383|66132878|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
23657506|NCT02060383|66132879|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
23657507|NCT02060383|66132880|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
23657508|NCT02060383|66132881|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
23657509|NCT02060383|66132877|FG000|Core Phase|Adverse Event|2|||
23657510|NCT02060383|66132878|FG001|Core Phase|Adverse Event|0|||
23657511|NCT02060383|66132879|FG002|Core Phase|Adverse Event|0|||
23657512|NCT02060383|66132880|FG003|Core Phase|Adverse Event|2|||
23657513|NCT02060383|66132881|FG004|Core Phase|Adverse Event|6|||
23657514|NCT02060383|66132877|FG000|Core Phase|Administrative problems|0|||
23657515|NCT02060383|66132878|FG001|Core Phase|Administrative problems|1|||
23657516|NCT02060383|66132879|FG002|Core Phase|Administrative problems|0|||
23657517|NCT02060383|66132880|FG003|Core Phase|Administrative problems|0|||
23657518|NCT02060383|66132881|FG004|Core Phase|Administrative problems|0|||
23806782|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
23806783|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
23806784|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
23806785|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806786|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806787|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806788|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23657519|NCT02060383|66132877|FG000|Core Phase|Protocol Violation|0|||
23657520|NCT02060383|66132878|FG001|Core Phase|Protocol Violation|0|||
23657521|NCT02060383|66132879|FG002|Core Phase|Protocol Violation|0|||
23657522|NCT02060383|66132880|FG003|Core Phase|Protocol Violation|1|||
23657523|NCT02060383|66132881|FG004|Core Phase|Protocol Violation|0|||
23657524|NCT02060383|66132877|FG000|Core Phase|Withdrawal by Subject|0|||
23657525|NCT02060383|66132878|FG001|Core Phase|Withdrawal by Subject|0|||
23657526|NCT02060383|66132879|FG002|Core Phase|Withdrawal by Subject|0|||
23657527|NCT02060383|66132880|FG003|Core Phase|Withdrawal by Subject|4|||
23657528|NCT02060383|66132881|FG004|Core Phase|Withdrawal by Subject|2|||
23361569|NCT04530838|65069743|FG000|Overall Study|Physician Decision|0|||
23361570|NCT04530838|65069744|FG001|Overall Study|Physician Decision|0|||
23361571|NCT04530838|65069745|FG002|Overall Study|Physician Decision|1|||
23480478|NCT04585009|65501991|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480479|NCT04585009|65501992|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480480|NCT04585009|65501993|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480481|NCT04585009|65501994|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480482|NCT04585009|65501995|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480483|NCT04585009|65501996|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480484|NCT04585009|65501997|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480485|NCT04585009|65501998|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23657529|NCT02060383|66132877|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
23657530|NCT02060383|66132878|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
23657531|NCT02060383|66132879|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23657532|NCT02060383|66132880|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
23806789|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806790|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806791|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806792|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23806793|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
23806794|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
23806795|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
23806796|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806797|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806798|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806799|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806800|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806801|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806802|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806803|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806804|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806805|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
23806806|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
23806807|NCT04146363|66672531|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806808|NCT04146363|66672532|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806809|NCT04146363|66672533|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806810|NCT04146363|66672534|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806811|NCT04146363|66672535|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806812|NCT04146363|66672536|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806813|NCT04146363|66672537|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806814|NCT04146363|66672538|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806815|NCT04146363|66672539|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806816|NCT04146363|66672540|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
23806817|NCT04146363|66672541|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23806818|NCT01206816|66672545|FG000|Overall Study|Protocol Violation|0|||
23806819|NCT01206816|66672546|FG001|Overall Study|Protocol Violation|0|||
23806820|NCT01206816|66672547|FG002|Overall Study|Protocol Violation|1|||
23806821|NCT01206816|66672548|FG003|Overall Study|Protocol Violation|0|||
23806822|NCT01206816|66672549|FG004|Overall Study|Protocol Violation|0|||
23806823|NCT01206816|66672550|FG005|Overall Study|Protocol Violation|0|||
23806824|NCT01206816|66672551|FG006|Overall Study|Protocol Violation|0|||
23806825|NCT01206816|66672545|FG000|Overall Study|Withdrawal by Subject|0|||
23806826|NCT01206816|66672546|FG001|Overall Study|Withdrawal by Subject|0|||
23806827|NCT01206816|66672547|FG002|Overall Study|Withdrawal by Subject|1|||
23806828|NCT01206816|66672548|FG003|Overall Study|Withdrawal by Subject|0|||
23806829|NCT01206816|66672549|FG004|Overall Study|Withdrawal by Subject|0|||
23806830|NCT01206816|66672550|FG005|Overall Study|Withdrawal by Subject|0|||
23806831|NCT01206816|66672551|FG006|Overall Study|Withdrawal by Subject|0|||
23806832|NCT01206816|66672545|FG000|Overall Study|Progressive disease|3|||
23806833|NCT01206816|66672546|FG001|Overall Study|Progressive disease|3|||
23600683|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600684|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23806834|NCT01206816|66672547|FG002|Overall Study|Progressive disease|13|||
23806835|NCT01206816|66672548|FG003|Overall Study|Progressive disease|3|||
23361572|NCT04530838|65069743|FG000|Overall Study|Death|0|||
23480486|NCT04585009|65501999|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23806836|NCT01206816|66672549|FG004|Overall Study|Progressive disease|3|||
23806837|NCT01206816|66672550|FG005|Overall Study|Progressive disease|16|||
23806838|NCT01206816|66672551|FG006|Overall Study|Progressive disease|3|||
23806839|NCT01206816|66672545|FG000|Overall Study|Other AE|0|||
23806840|NCT01206816|66672546|FG001|Overall Study|Other AE|0|||
23806841|NCT01206816|66672547|FG002|Overall Study|Other AE|4|||
23806842|NCT01206816|66672548|FG003|Overall Study|Other AE|0|||
23806843|NCT01206816|66672549|FG004|Overall Study|Other AE|0|||
23806844|NCT01206816|66672550|FG005|Overall Study|Other AE|3|||
23806845|NCT01206816|66672551|FG006|Overall Study|Other AE|2|||
23806846|NCT01206816|66672545|FG000|Overall Study|other than stated above|0|||
23806847|NCT01206816|66672546|FG001|Overall Study|other than stated above|0|||
23806848|NCT01206816|66672547|FG002|Overall Study|other than stated above|1|||
23806849|NCT01206816|66672548|FG003|Overall Study|other than stated above|0|||
23806850|NCT01206816|66672549|FG004|Overall Study|other than stated above|0|||
23806851|NCT01206816|66672550|FG005|Overall Study|other than stated above|0|||
23806852|NCT01206816|66672551|FG006|Overall Study|other than stated above|1|||
23806853|NCT02302859|66672557|FG000|Overall Study|Lost Phone|1|||
23806854|NCT02302859|66672558|FG001|Overall Study|Lost Phone|1|||
23806855|NCT02302859|66672557|FG000|Overall Study|Withdrawal by Subject|0|||
23806856|NCT02302859|66672558|FG001|Overall Study|Withdrawal by Subject|1|||
23806857|NCT00706381|66672559|FG000|Overall Study|Lost to Follow-up|0|||
23806858|NCT00706381|66672560|FG001|Overall Study|Lost to Follow-up|1|||
23806859|NCT00706381|66672561|FG002|Overall Study|Lost to Follow-up|1|||
23806860|NCT00706381|66672562|FG003|Overall Study|Lost to Follow-up|0|||
23806861|NCT01102374|66672573|FG000|Overall Study|Death|9|||
23806862|NCT01102374|66672574|FG001|Overall Study|Death|13|||
23806863|NCT01102374|66672573|FG000|Overall Study|Lost to Follow-up|7|||
23806864|NCT01102374|66672574|FG001|Overall Study|Lost to Follow-up|6|||
23806865|NCT01393730|66672575|FG000|Overall Study|Withdrawal by Subject|3|||
23806866|NCT01393730|66672575|FG000|Overall Study|Other|2|||
23806867|NCT01393730|66672575|FG000|Overall Study|Adverse Event|1|||
23806868|NCT02980874|66672582|FG000|Overall Study|Adverse Event|2|||
23600685|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600686|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23600687|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23600688|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23361573|NCT04530838|65069744|FG001|Overall Study|Death|0|||
23361574|NCT04530838|65069745|FG002|Overall Study|Death|1|||
23361575|NCT04530838|65069743|FG000|Overall Study|Adverse Event|0|||
23361576|NCT04530838|65069744|FG001|Overall Study|Adverse Event|1|||
23361577|NCT04530838|65069745|FG002|Overall Study|Adverse Event|0|||
23361578|NCT04530838|65069743|FG000|Overall Study|No longer meets eligibility criteria|1|||
23361579|NCT04530838|65069744|FG001|Overall Study|No longer meets eligibility criteria|0|||
23361580|NCT04530838|65069745|FG002|Overall Study|No longer meets eligibility criteria|2|||
23361581|NCT04530838|65069743|FG000|Overall Study|Withdrawal by parent/guardian|5|||
23361582|NCT04530838|65069744|FG001|Overall Study|Withdrawal by parent/guardian|2|||
23361583|NCT04530838|65069745|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23361584|NCT04235504|65069748|FG000|Study Phase|Withdrawal by Subject|5|||
23361585|NCT04235504|65069749|FG001|Study Phase|Withdrawal by Subject|2|||
23361586|NCT04235504|65069750|FG002|Study Phase|Withdrawal by Subject|0|||
23361587|NCT04235504|65069751|FG003|Study Phase|Withdrawal by Subject|0|||
23361588|NCT04235504|65069748|FG000|Continuation Phase|Withdrawal by Subject|0|||
23361589|NCT04235504|65069749|FG001|Continuation Phase|Withdrawal by Subject|4|||
23361590|NCT04235504|65069750|FG002|Continuation Phase|Withdrawal by Subject|0|||
23361591|NCT04235504|65069751|FG003|Continuation Phase|Withdrawal by Subject|0|||
23361592|NCT04235504|65069748|FG000|Continuation Phase|Adverse Event|0|||
23361593|NCT04235504|65069749|FG001|Continuation Phase|Adverse Event|1|||
23361594|NCT04235504|65069750|FG002|Continuation Phase|Adverse Event|0|||
23361595|NCT04235504|65069751|FG003|Continuation Phase|Adverse Event|0|||
23361596|NCT04235504|65069748|FG000|Continuation Phase|Physician Decision|1|||
23361597|NCT04235504|65069749|FG001|Continuation Phase|Physician Decision|2|||
23361598|NCT04235504|65069750|FG002|Continuation Phase|Physician Decision|1|||
23361599|NCT04235504|65069751|FG003|Continuation Phase|Physician Decision|0|||
23361600|NCT02421419|65069752|FG000|Overall Study|Physician Decision|0|||
23361601|NCT02421419|65069753|FG001|Overall Study|Physician Decision|0|||
23361602|NCT02421419|65069754|FG002|Overall Study|Physician Decision|1|||
23361603|NCT00497146|65069755|FG000|Treatment Period|Adverse Event|6|||
23361604|NCT00497146|65069756|FG001|Treatment Period|Adverse Event|2|||
23361605|NCT00497146|65069755|FG000|Treatment Period|Withdrawal by Subject|5|||
23361606|NCT00497146|65069756|FG001|Treatment Period|Withdrawal by Subject|9|||
23361607|NCT00497146|65069755|FG000|Treatment Period|Lost to Follow-up|1|||
23361608|NCT00497146|65069756|FG001|Treatment Period|Lost to Follow-up|3|||
23361609|NCT00497146|65069755|FG000|Treatment Period|Required dialysis|4|||
23361610|NCT00497146|65069756|FG001|Treatment Period|Required dialysis|1|||
23361611|NCT00497146|65069755|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
23361612|NCT00497146|65069756|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
23361613|NCT00497146|65069755|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
23361614|NCT00497146|65069756|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
23361615|NCT00497146|65069755|FG000|Treatment Period|Other Reason|2|||
23361616|NCT00497146|65069756|FG001|Treatment Period|Other Reason|3|||
23361617|NCT00497146|65069755|FG000|Long-term Follow-up Period|Adverse Event|2|||
23361618|NCT00497146|65069756|FG001|Long-term Follow-up Period|Adverse Event|2|||
23361619|NCT00497146|65069755|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
23361620|NCT00497146|65069756|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
23361621|NCT00497146|65069755|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
23361622|NCT00497146|65069756|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
23361623|NCT00497146|65069755|FG000|Long-term Follow-up Period|Other|0|||
23361624|NCT00497146|65069756|FG001|Long-term Follow-up Period|Other|1|||
23361625|NCT02384538|65069760|FG000|Overall Study|Adverse Event|1|||
23361626|NCT02384538|65069761|FG001|Overall Study|Adverse Event|4|||
23806869|NCT02980874|66672583|FG001|Overall Study|Adverse Event|7|||
23806870|NCT02980874|66672582|FG000|Overall Study|Withdrawal by Subject|7|||
23806871|NCT02980874|66672583|FG001|Overall Study|Withdrawal by Subject|2|||
23806872|NCT02980874|66672582|FG000|Overall Study|Lost to Follow-up|5|||
23806873|NCT02980874|66672583|FG001|Overall Study|Lost to Follow-up|5|||
23806874|NCT02980874|66672582|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
23806875|NCT02980874|66672583|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
23806876|NCT02980874|66672582|FG000|Overall Study|Unknown study completion status|1|||
23806877|NCT02980874|66672583|FG001|Overall Study|Unknown study completion status|0|||
23361627|NCT02384538|65069760|FG000|Overall Study|Lack of Efficacy|4|||
23806878|NCT00622466|66672584|FG000|Overall Study|Death|1|||
23806879|NCT00622466|66672584|FG000|Overall Study|Adverse Event|1|||
23361628|NCT02384538|65069761|FG001|Overall Study|Lack of Efficacy|4|||
23361629|NCT02384538|65069760|FG000|Overall Study|Withdrew Consent|0|||
23361630|NCT02384538|65069761|FG001|Overall Study|Withdrew Consent|4|||
23361631|NCT02384538|65069760|FG000|Overall Study|Other|1|||
23361632|NCT02384538|65069761|FG001|Overall Study|Other|3|||
23361633|NCT03479008|65069762|FG000|Overall Study|Withdrawal by Subject|3|||
23361634|NCT03560869|65069764|FG000|Overall Study|Withdrawal by Subject|3|||
23361635|NCT03560869|65069765|FG001|Overall Study|Withdrawal by Subject|4|||
23361636|NCT03560869|65069764|FG000|Overall Study|Screening failure|4|||
23361637|NCT03560869|65069765|FG001|Overall Study|Screening failure|4|||
23361638|NCT03560869|65069764|FG000|Overall Study|Withdrawal by PI|0|||
23361639|NCT03560869|65069765|FG001|Overall Study|Withdrawal by PI|1|||
23361640|NCT01938846|65069769|FG000|Overall Study|Progressive disease|26|||
23361641|NCT01938846|65069770|FG001|Overall Study|Progressive disease|18|||
23361642|NCT01938846|65069771|FG002|Overall Study|Progressive disease|16|||
23361643|NCT01938846|65069769|FG000|Overall Study|Adverse Event|8|||
23361644|NCT01938846|65069770|FG001|Overall Study|Adverse Event|4|||
23361645|NCT01938846|65069771|FG002|Overall Study|Adverse Event|3|||
23361646|NCT01938846|65069769|FG000|Overall Study|Withdrawal by Subject|2|||
23361647|NCT01938846|65069770|FG001|Overall Study|Withdrawal by Subject|2|||
23361648|NCT01938846|65069771|FG002|Overall Study|Withdrawal by Subject|1|||
23361649|NCT01938846|65069769|FG000|Overall Study|Other than listed|5|||
23361650|NCT01938846|65069770|FG001|Overall Study|Other than listed|1|||
23361651|NCT01938846|65069771|FG002|Overall Study|Other than listed|4|||
23361652|NCT02360280|65069772|FG000|Overall Study|Withdrawal by Subject|2|||
23361653|NCT02360280|65069773|FG001|Overall Study|Withdrawal by Subject|0|||
23361654|NCT02360280|65069772|FG000|Overall Study|Adverse Event|0|||
23361655|NCT02360280|65069773|FG001|Overall Study|Adverse Event|1|||
23361656|NCT02360280|65069772|FG000|Overall Study|Lost to Follow-up|1|||
23361657|NCT02360280|65069773|FG001|Overall Study|Lost to Follow-up|0|||
23361658|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Adverse Event|2|||
23361659|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Adverse Event|0|||
23361660|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Adverse Event|0|||
23361661|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Adverse Event|0|||
23361662|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Adverse Event|0|||
23361663|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Adverse Event|0|||
23361664|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
23361665|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
23361666|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
23361667|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
23361668|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
23361669|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
23361670|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Other|10|||
23361671|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Other|11|||
23361672|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Other|0|||
23361673|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Other|0|||
23361674|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Other|0|||
23361675|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Other|0|||
23361676|NCT00436826|65069778|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361677|NCT00436826|65069779|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361678|NCT00436826|65069780|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361679|NCT00436826|65069781|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
23600689|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
23600690|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
23600691|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600692|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600693|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600694|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600695|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
23600696|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600697|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600698|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600699|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
23600700|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
23600701|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600702|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600703|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600704|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
23600705|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
23600706|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600707|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600708|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600709|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
23600710|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
23600711|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600712|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600713|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600714|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
23600715|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
23600716|NCT02079649|65929698|FG000|Overall Study|Lost to Follow-up|0|||
23600717|NCT02079649|65929699|FG001|Overall Study|Lost to Follow-up|0|||
23600718|NCT02079649|65929700|FG002|Overall Study|Lost to Follow-up|0|||
23600719|NCT02079649|65929701|FG003|Overall Study|Lost to Follow-up|1|||
23600720|NCT02079649|65929698|FG000|Overall Study|Withdrawal by Subject|0|||
23600721|NCT02079649|65929699|FG001|Overall Study|Withdrawal by Subject|0|||
23600722|NCT02079649|65929700|FG002|Overall Study|Withdrawal by Subject|0|||
23600723|NCT02079649|65929701|FG003|Overall Study|Withdrawal by Subject|1|||
23600724|NCT02079649|65929698|FG000|Overall Study|Randomization error (prior to treatment)|1|||
23600725|NCT02079649|65929699|FG001|Overall Study|Randomization error (prior to treatment)|0|||
23600726|NCT02079649|65929700|FG002|Overall Study|Randomization error (prior to treatment)|1|||
23806880|NCT00622466|66672584|FG000|Overall Study|Withdrawal by Subject|2|||
23806881|NCT03970837|66672585|FG000|Overall Study|Adverse Event|23|||
23806882|NCT03970837|66672586|FG001|Overall Study|Adverse Event|20|||
23806883|NCT03970837|66672587|FG002|Overall Study|Adverse Event|16|||
23806884|NCT03970837|66672588|FG003|Overall Study|Adverse Event|6|||
23806885|NCT03970837|66672589|FG004|Overall Study|Adverse Event|4|||
23806886|NCT03970837|66672590|FG005|Overall Study|Adverse Event|5|||
23806887|NCT03970837|66672591|FG006|Overall Study|Adverse Event|1|||
23806888|NCT03970837|66672592|FG007|Overall Study|Adverse Event|5|||
23806889|NCT03970837|66672593|FG008|Overall Study|Adverse Event|0|||
23806890|NCT03970837|66672594|FG009|Overall Study|Adverse Event|0|||
23806891|NCT03970837|66672595|FG010|Overall Study|Adverse Event|1|||
23806892|NCT03970837|66672596|FG011|Overall Study|Adverse Event|1|||
23806893|NCT03970837|66672585|FG000|Overall Study|Lack of Efficacy|14|||
23806894|NCT03970837|66672586|FG001|Overall Study|Lack of Efficacy|12|||
23806895|NCT03970837|66672587|FG002|Overall Study|Lack of Efficacy|1|||
23806896|NCT03970837|66672588|FG003|Overall Study|Lack of Efficacy|2|||
23806897|NCT03970837|66672589|FG004|Overall Study|Lack of Efficacy|3|||
23806898|NCT03970837|66672590|FG005|Overall Study|Lack of Efficacy|4|||
23806899|NCT03970837|66672591|FG006|Overall Study|Lack of Efficacy|6|||
23806900|NCT03970837|66672592|FG007|Overall Study|Lack of Efficacy|1|||
23806901|NCT03970837|66672593|FG008|Overall Study|Lack of Efficacy|1|||
23657533|NCT02060383|66132881|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
23361680|NCT00436826|65069782|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361681|NCT00436826|65069783|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23657534|NCT02060383|66132877|FG000|Extension Phase|Adverse Event|1|||
23361682|NCT00436826|65069778|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361683|NCT00436826|65069779|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361684|NCT00436826|65069780|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
23361685|NCT00436826|65069781|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
23361686|NCT00436826|65069782|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361687|NCT00436826|65069783|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361688|NCT00436826|65069778|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361689|NCT00436826|65069779|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361690|NCT00436826|65069780|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361691|NCT00436826|65069781|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361692|NCT00436826|65069782|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
23361693|NCT00436826|65069783|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
23361694|NCT03518086|65069784|FG000|Overall Study|Adverse Event|23|||
23361695|NCT03518086|65069785|FG001|Overall Study|Adverse Event|15|||
23361696|NCT03518086|65069786|FG002|Overall Study|Adverse Event|0|||
23361697|NCT03518086|65069787|FG003|Overall Study|Adverse Event|0|||
23361698|NCT03518086|65069784|FG000|Overall Study|Withdrawal by Subject|8|||
23361699|NCT03518086|65069785|FG001|Overall Study|Withdrawal by Subject|5|||
23361700|NCT03518086|65069786|FG002|Overall Study|Withdrawal by Subject|0|||
23361701|NCT03518086|65069787|FG003|Overall Study|Withdrawal by Subject|0|||
23361702|NCT03518086|65069784|FG000|Overall Study|Lack of Efficacy|5|||
23361703|NCT03518086|65069785|FG001|Overall Study|Lack of Efficacy|5|||
23361704|NCT03518086|65069786|FG002|Overall Study|Lack of Efficacy|0|||
23361705|NCT03518086|65069787|FG003|Overall Study|Lack of Efficacy|0|||
23361706|NCT03518086|65069784|FG000|Overall Study|Protocol Violation|1|||
23361707|NCT03518086|65069785|FG001|Overall Study|Protocol Violation|5|||
23361708|NCT03518086|65069786|FG002|Overall Study|Protocol Violation|0|||
23361709|NCT03518086|65069787|FG003|Overall Study|Protocol Violation|0|||
23361710|NCT03518086|65069784|FG000|Overall Study|Lost to Follow-up|0|||
23361711|NCT03518086|65069785|FG001|Overall Study|Lost to Follow-up|3|||
23361712|NCT03518086|65069786|FG002|Overall Study|Lost to Follow-up|0|||
23361713|NCT03518086|65069787|FG003|Overall Study|Lost to Follow-up|0|||
23361714|NCT03518086|65069784|FG000|Overall Study|Insufficient Diary Data|0|||
23600727|NCT02079649|65929701|FG003|Overall Study|Randomization error (prior to treatment)|0|||
23600728|NCT01532648|65929702|FG000|Overall Study|Lost to Follow-up|3|||
23600729|NCT01532648|65929703|FG001|Overall Study|Lost to Follow-up|4|||
23600730|NCT01532648|65929702|FG000|Overall Study|Lack of Efficacy|4|||
23600731|NCT01532648|65929703|FG001|Overall Study|Lack of Efficacy|1|||
23600732|NCT01532648|65929702|FG000|Overall Study|Protocol Violation|1|||
23600733|NCT01532648|65929703|FG001|Overall Study|Protocol Violation|1|||
23600734|NCT01532648|65929702|FG000|Overall Study|Adverse Event|12|||
23600735|NCT01532648|65929703|FG001|Overall Study|Adverse Event|9|||
23600736|NCT01532648|65929702|FG000|Overall Study|Withdrawal by Subject|16|||
23600737|NCT01532648|65929703|FG001|Overall Study|Withdrawal by Subject|2|||
23657535|NCT02060383|66132878|FG001|Extension Phase|Adverse Event|1|||
23361715|NCT03518086|65069785|FG001|Overall Study|Insufficient Diary Data|2|||
23361716|NCT03518086|65069786|FG002|Overall Study|Insufficient Diary Data|0|||
23361717|NCT03518086|65069787|FG003|Overall Study|Insufficient Diary Data|0|||
23361718|NCT03518086|65069784|FG000|Overall Study|Non- compliance to Protocol|0|||
23361719|NCT03518086|65069785|FG001|Overall Study|Non- compliance to Protocol|1|||
23361720|NCT03518086|65069786|FG002|Overall Study|Non- compliance to Protocol|0|||
23361721|NCT03518086|65069787|FG003|Overall Study|Non- compliance to Protocol|0|||
23600738|NCT04220775|65929705|FG000|Overall Study|Adverse Event|1|||
23600739|NCT04220775|65929706|FG001|Overall Study|Adverse Event|0|||
23600740|NCT04220775|65929705|FG000|Overall Study|Disease Progression|1|||
23361722|NCT03518086|65069784|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
23361723|NCT03518086|65069785|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
23480487|NCT04585009|65502000|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480488|NCT04585009|65502001|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480489|NCT04585009|65502002|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
23480490|NCT04839562|65502006|FG000|Overall Study|Withdrawal by Subject|0|||
23657536|NCT02060383|66132879|FG002|Extension Phase|Adverse Event|2|||
23657537|NCT02060383|66132880|FG003|Extension Phase|Adverse Event|0|||
23657538|NCT02060383|66132881|FG004|Extension Phase|Adverse Event|1|||
23657539|NCT02060383|66132877|FG000|Extension Phase|Withdrawal by Subject|0|||
23657540|NCT02060383|66132878|FG001|Extension Phase|Withdrawal by Subject|1|||
23657541|NCT02060383|66132879|FG002|Extension Phase|Withdrawal by Subject|0|||
23657542|NCT02060383|66132880|FG003|Extension Phase|Withdrawal by Subject|0|||
23657543|NCT02060383|66132881|FG004|Extension Phase|Withdrawal by Subject|2|||
23657544|NCT02060383|66132877|FG000|Extension Phase|Administrative problems|1|||
23657545|NCT02060383|66132878|FG001|Extension Phase|Administrative problems|0|||
23657546|NCT02060383|66132879|FG002|Extension Phase|Administrative problems|0|||
23657547|NCT02060383|66132880|FG003|Extension Phase|Administrative problems|0|||
23657548|NCT02060383|66132881|FG004|Extension Phase|Administrative problems|0|||
23657549|NCT02060383|66132877|FG000|Extension Phase|Death|0|||
23657550|NCT02060383|66132878|FG001|Extension Phase|Death|0|||
23657551|NCT02060383|66132879|FG002|Extension Phase|Death|1|||
23657552|NCT02060383|66132880|FG003|Extension Phase|Death|0|||
23657553|NCT02060383|66132881|FG004|Extension Phase|Death|1|||
23657554|NCT02060383|66132877|FG000|Extension Phase|Protocol Violation|0|||
23657555|NCT02060383|66132878|FG001|Extension Phase|Protocol Violation|0|||
23361724|NCT03518086|65069786|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
23361725|NCT03518086|65069787|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
23361726|NCT03518086|65069784|FG000|Overall Study|Site Terminated by Sponsor|0|||
23361727|NCT03518086|65069785|FG001|Overall Study|Site Terminated by Sponsor|1|||
23361728|NCT03518086|65069786|FG002|Overall Study|Site Terminated by Sponsor|0|||
23361729|NCT03518086|65069787|FG003|Overall Study|Site Terminated by Sponsor|0|||
23361730|NCT00621257|65069788|FG000|Overall Study|Lost to Follow-up|4|||
23361731|NCT00621257|65069789|FG001|Overall Study|Lost to Follow-up|0|||
23361732|NCT00621257|65069790|FG002|Overall Study|Lost to Follow-up|2|||
23361733|NCT00621257|65069791|FG003|Overall Study|Lost to Follow-up|4|||
23361734|NCT00621257|65069792|FG004|Overall Study|Lost to Follow-up|7|||
23480491|NCT04839562|65502007|FG001|Overall Study|Withdrawal by Subject|1|||
23480492|NCT04839562|65502006|FG000|Overall Study|Physician Decision|0|||
23480493|NCT04839562|65502007|FG001|Overall Study|Physician Decision|1|||
23480494|NCT00775203|65502008|FG000|Overall Study|Adverse Event|25|||
23480495|NCT00775203|65502009|FG001|Overall Study|Adverse Event|6|||
23480496|NCT00775203|65502008|FG000|Overall Study|Lack of Efficacy|8|||
23480497|NCT00775203|65502009|FG001|Overall Study|Lack of Efficacy|9|||
23361735|NCT00621257|65069788|FG000|Overall Study|Adverse Event|0|||
23480498|NCT00775203|65502008|FG000|Overall Study|Withdrawal by Subject|11|||
23657556|NCT02060383|66132879|FG002|Extension Phase|Protocol Violation|0|||
23657557|NCT02060383|66132880|FG003|Extension Phase|Protocol Violation|0|||
23480499|NCT00775203|65502009|FG001|Overall Study|Withdrawal by Subject|9|||
23657558|NCT02060383|66132881|FG004|Extension Phase|Protocol Violation|1|||
23657559|NCT01284062|66132882|FG000|Overall Study|Adverse Event|4|||
23657560|NCT01284062|66132883|FG001|Overall Study|Adverse Event|5|||
23361736|NCT00621257|65069789|FG001|Overall Study|Adverse Event|1|||
23361737|NCT00621257|65069790|FG002|Overall Study|Adverse Event|1|||
23361738|NCT00621257|65069791|FG003|Overall Study|Adverse Event|0|||
23361739|NCT00621257|65069792|FG004|Overall Study|Adverse Event|0|||
23361740|NCT00621257|65069788|FG000|Overall Study|Physician Decision|0|||
23361741|NCT00621257|65069789|FG001|Overall Study|Physician Decision|2|||
23361742|NCT00621257|65069790|FG002|Overall Study|Physician Decision|0|||
23361743|NCT00621257|65069791|FG003|Overall Study|Physician Decision|1|||
23361744|NCT00621257|65069792|FG004|Overall Study|Physician Decision|1|||
23361745|NCT00621257|65069788|FG000|Overall Study|Withdrawal by Subject|0|||
23361746|NCT00621257|65069789|FG001|Overall Study|Withdrawal by Subject|0|||
23806902|NCT03970837|66672594|FG009|Overall Study|Lack of Efficacy|0|||
23806903|NCT03970837|66672595|FG010|Overall Study|Lack of Efficacy|0|||
23806904|NCT03970837|66672596|FG011|Overall Study|Lack of Efficacy|0|||
23806905|NCT03970837|66672585|FG000|Overall Study|Lost to Follow-up|6|||
23806906|NCT03970837|66672586|FG001|Overall Study|Lost to Follow-up|5|||
23806907|NCT03970837|66672587|FG002|Overall Study|Lost to Follow-up|5|||
23806908|NCT03970837|66672588|FG003|Overall Study|Lost to Follow-up|1|||
23806909|NCT03970837|66672589|FG004|Overall Study|Lost to Follow-up|0|||
23806910|NCT03970837|66672590|FG005|Overall Study|Lost to Follow-up|2|||
23806911|NCT03970837|66672591|FG006|Overall Study|Lost to Follow-up|0|||
23806912|NCT03970837|66672592|FG007|Overall Study|Lost to Follow-up|0|||
23806913|NCT03970837|66672593|FG008|Overall Study|Lost to Follow-up|0|||
23806914|NCT03970837|66672594|FG009|Overall Study|Lost to Follow-up|0|||
23806915|NCT03970837|66672595|FG010|Overall Study|Lost to Follow-up|0|||
23806916|NCT03970837|66672596|FG011|Overall Study|Lost to Follow-up|0|||
23806917|NCT03970837|66672585|FG000|Overall Study|Protocol Violation|1|||
23806918|NCT03970837|66672586|FG001|Overall Study|Protocol Violation|0|||
23806919|NCT03970837|66672587|FG002|Overall Study|Protocol Violation|0|||
23361747|NCT00621257|65069790|FG002|Overall Study|Withdrawal by Subject|0|||
23361748|NCT00621257|65069791|FG003|Overall Study|Withdrawal by Subject|1|||
23361749|NCT00621257|65069792|FG004|Overall Study|Withdrawal by Subject|1|||
23806920|NCT03970837|66672588|FG003|Overall Study|Protocol Violation|0|||
23806921|NCT03970837|66672589|FG004|Overall Study|Protocol Violation|0|||
23361750|NCT00397189|65069800|FG000|3 Weeks Period|Lost to Follow-up|5|||
23361751|NCT00397189|65069801|FG001|3 Weeks Period|Lost to Follow-up|4|||
23806922|NCT03970837|66672590|FG005|Overall Study|Protocol Violation|0|||
23806923|NCT03970837|66672591|FG006|Overall Study|Protocol Violation|0|||
23806924|NCT03970837|66672592|FG007|Overall Study|Protocol Violation|0|||
23361752|NCT00397189|65069800|FG000|3 Weeks Period|Adverse Event|3|||
23600741|NCT04220775|65929706|FG001|Overall Study|Disease Progression|0|||
23657561|NCT01284062|66132884|FG002|Overall Study|Adverse Event|0|||
23657562|NCT01284062|66132885|FG003|Overall Study|Adverse Event|5|||
23657563|NCT01284062|66132882|FG000|Overall Study|Lack of Efficacy|3|||
23657564|NCT01284062|66132883|FG001|Overall Study|Lack of Efficacy|2|||
23657565|NCT01284062|66132884|FG002|Overall Study|Lack of Efficacy|2|||
23657566|NCT01284062|66132885|FG003|Overall Study|Lack of Efficacy|1|||
23657567|NCT01284062|66132882|FG000|Overall Study|Medication error without adverse event|0|||
23657568|NCT01284062|66132883|FG001|Overall Study|Medication error without adverse event|0|||
23657569|NCT01284062|66132884|FG002|Overall Study|Medication error without adverse event|1|||
23657570|NCT01284062|66132885|FG003|Overall Study|Medication error without adverse event|0|||
23657571|NCT01284062|66132882|FG000|Overall Study|Protocol Violation|1|||
23657572|NCT01284062|66132883|FG001|Overall Study|Protocol Violation|0|||
23657573|NCT01284062|66132884|FG002|Overall Study|Protocol Violation|0|||
23657574|NCT01284062|66132885|FG003|Overall Study|Protocol Violation|2|||
23657575|NCT01284062|66132882|FG000|Overall Study|Withdrawal by Subject|3|||
23806925|NCT03970837|66672593|FG008|Overall Study|Protocol Violation|0|||
23806926|NCT03970837|66672594|FG009|Overall Study|Protocol Violation|0|||
23806927|NCT03970837|66672595|FG010|Overall Study|Protocol Violation|0|||
23806928|NCT03970837|66672596|FG011|Overall Study|Protocol Violation|0|||
23806929|NCT03970837|66672585|FG000|Overall Study|Physician Decision|5|||
23806930|NCT03970837|66672586|FG001|Overall Study|Physician Decision|8|||
23806931|NCT03970837|66672587|FG002|Overall Study|Physician Decision|4|||
23806932|NCT03970837|66672588|FG003|Overall Study|Physician Decision|1|||
23657576|NCT01284062|66132883|FG001|Overall Study|Withdrawal by Subject|1|||
23806933|NCT03970837|66672589|FG004|Overall Study|Physician Decision|5|||
23657577|NCT01284062|66132884|FG002|Overall Study|Withdrawal by Subject|2|||
23806934|NCT03970837|66672590|FG005|Overall Study|Physician Decision|2|||
23806935|NCT03970837|66672591|FG006|Overall Study|Physician Decision|4|||
23806936|NCT03970837|66672592|FG007|Overall Study|Physician Decision|5|||
23361753|NCT00397189|65069801|FG001|3 Weeks Period|Adverse Event|2|||
23361754|NCT00397189|65069800|FG000|3 Weeks Period|Withdrawal by Subject|13|||
23657578|NCT01284062|66132885|FG003|Overall Study|Withdrawal by Subject|5|||
23657579|NCT01284062|66132882|FG000|Overall Study|Other|0|||
23657580|NCT01284062|66132883|FG001|Overall Study|Other|0|||
23657581|NCT01284062|66132884|FG002|Overall Study|Other|0|||
23657582|NCT01284062|66132885|FG003|Overall Study|Other|1|||
23657583|NCT01284062|66132882|FG000|Overall Study|Site Closed|0|||
23657584|NCT01284062|66132883|FG001|Overall Study|Site Closed|0|||
23657585|NCT01284062|66132884|FG002|Overall Study|Site Closed|1|||
23657586|NCT01284062|66132885|FG003|Overall Study|Site Closed|0|||
23657587|NCT03942406|66132900|FG000|Overall Study|Lost to Follow-up|4|||
23657588|NCT03942406|66132901|FG001|Overall Study|Lost to Follow-up|5|||
23657589|NCT03942406|66132902|FG002|Overall Study|Lost to Follow-up|3|||
23657590|NCT03942406|66132903|FG003|Overall Study|Lost to Follow-up|7|||
23657591|NCT03942406|66132904|FG004|Overall Study|Lost to Follow-up|1|||
23657592|NCT03942406|66132905|FG005|Overall Study|Lost to Follow-up|0|||
23657593|NCT03942406|66132906|FG006|Overall Study|Lost to Follow-up|0|||
23657594|NCT03942406|66132900|FG000|Overall Study|Withdrawal by Subject|3|||
23657595|NCT03942406|66132901|FG001|Overall Study|Withdrawal by Subject|1|||
23657596|NCT03942406|66132902|FG002|Overall Study|Withdrawal by Subject|1|||
23657597|NCT03942406|66132903|FG003|Overall Study|Withdrawal by Subject|3|||
23657598|NCT03942406|66132904|FG004|Overall Study|Withdrawal by Subject|0|||
23657599|NCT03942406|66132905|FG005|Overall Study|Withdrawal by Subject|0|||
23657600|NCT03942406|66132906|FG006|Overall Study|Withdrawal by Subject|0|||
23657601|NCT03942406|66132900|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
23657602|NCT03942406|66132901|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
23657603|NCT03942406|66132902|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
23657604|NCT03942406|66132903|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
23657605|NCT03942406|66132904|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
23657606|NCT03942406|66132905|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
23657607|NCT03942406|66132906|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
23657608|NCT01681628|66132907|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
23657609|NCT01681628|66132908|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
23361755|NCT00397189|65069801|FG001|3 Weeks Period|Withdrawal by Subject|9|||
23361756|NCT00397189|65069800|FG000|3 Weeks Period|Physician Decision|0|||
23361757|NCT00397189|65069801|FG001|3 Weeks Period|Physician Decision|2|||
23361758|NCT00397189|65069800|FG000|3 Weeks Period|Protocol Violation|0|||
23361759|NCT00397189|65069801|FG001|3 Weeks Period|Protocol Violation|3|||
23361760|NCT00397189|65069800|FG000|3 Weeks Period|Other|0|||
23657610|NCT01681628|66132907|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
23657611|NCT01681628|66132908|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
23657612|NCT01681628|66132907|FG000|19 Months Follow-up|Death|1|||
23657613|NCT01681628|66132908|FG001|19 Months Follow-up|Death|0|||
23657614|NCT01681628|66132907|FG000|19 Months Follow-up|Lost to Follow-up|61|||
23657615|NCT01681628|66132908|FG001|19 Months Follow-up|Lost to Follow-up|43|||
23657616|NCT00509067|66132911|FG000|Overall Study|Lost to Follow-up|1|||
23657617|NCT00509067|66132912|FG001|Overall Study|Lost to Follow-up|1|||
23657618|NCT00509067|66132911|FG000|Overall Study|Adverse Event|3|||
23657619|NCT00509067|66132912|FG001|Overall Study|Adverse Event|1|||
23361761|NCT00397189|65069801|FG001|3 Weeks Period|Other|2|||
23361762|NCT05401565|65069808|FG000|Overall Study|Lost to Follow-up|1|||
23657620|NCT00509067|66132911|FG000|Overall Study|Protocol Violation|0|||
23657621|NCT00509067|66132912|FG001|Overall Study|Protocol Violation|3|||
23657622|NCT01301456|66132913|FG000|Stage 1|Withdrawal by Subject|0|||
23657623|NCT01301456|66132914|FG001|Stage 1|Withdrawal by Subject|0|||
23657624|NCT01301456|66132915|FG002|Stage 1|Withdrawal by Subject|1|||
23657625|NCT01301456|66132916|FG003|Stage 1|Withdrawal by Subject|0|||
23657626|NCT01301456|66132917|FG004|Stage 1|Withdrawal by Subject|1|||
23657627|NCT01301456|66132918|FG005|Stage 1|Withdrawal by Subject|0|||
23657628|NCT01301456|66132919|FG006|Stage 1|Withdrawal by Subject|0|||
23657629|NCT01301456|66132920|FG007|Stage 1|Withdrawal by Subject|0|||
23657630|NCT01301456|66132921|FG008|Stage 1|Withdrawal by Subject|0|||
23657631|NCT01301456|66132922|FG009|Stage 1|Withdrawal by Subject|0|||
23657632|NCT01301456|66132923|FG010|Stage 1|Withdrawal by Subject|0|||
23657633|NCT01301456|66132924|FG011|Stage 1|Withdrawal by Subject|0|||
23657634|NCT01301456|66132913|FG000|Stage 1|Randomized but not treated|0|||
23657635|NCT01301456|66132914|FG001|Stage 1|Randomized but not treated|0|||
23657636|NCT01301456|66132915|FG002|Stage 1|Randomized but not treated|0|||
23657637|NCT01301456|66132916|FG003|Stage 1|Randomized but not treated|0|||
23657638|NCT01301456|66132917|FG004|Stage 1|Randomized but not treated|0|||
23657639|NCT01301456|66132918|FG005|Stage 1|Randomized but not treated|0|||
23657640|NCT01301456|66132919|FG006|Stage 1|Randomized but not treated|1|||
23657641|NCT01301456|66132920|FG007|Stage 1|Randomized but not treated|0|||
23657642|NCT01301456|66132921|FG008|Stage 1|Randomized but not treated|0|||
23657643|NCT01301456|66132922|FG009|Stage 1|Randomized but not treated|0|||
23657644|NCT01301456|66132923|FG010|Stage 1|Randomized but not treated|0|||
23657645|NCT01301456|66132924|FG011|Stage 1|Randomized but not treated|0|||
23657646|NCT01301456|66132913|FG000|Stage 2|Adverse Event|0|||
23657647|NCT01301456|66132914|FG001|Stage 2|Adverse Event|0|||
23657648|NCT01301456|66132915|FG002|Stage 2|Adverse Event|0|||
23657649|NCT01301456|66132916|FG003|Stage 2|Adverse Event|0|||
23657650|NCT01301456|66132917|FG004|Stage 2|Adverse Event|0|||
23657651|NCT01301456|66132918|FG005|Stage 2|Adverse Event|0|||
23657652|NCT01301456|66132919|FG006|Stage 2|Adverse Event|0|||
23657653|NCT01301456|66132920|FG007|Stage 2|Adverse Event|0|||
23657654|NCT01301456|66132921|FG008|Stage 2|Adverse Event|0|||
23657655|NCT01301456|66132922|FG009|Stage 2|Adverse Event|0|||
23657656|NCT01301456|66132923|FG010|Stage 2|Adverse Event|1|||
23657657|NCT01301456|66132924|FG011|Stage 2|Adverse Event|0|||
23657658|NCT01770912|66132925|FG000|Overall Study|Lost to Follow-up|2|||
23657659|NCT01770912|66132926|FG001|Overall Study|Lost to Follow-up|0|||
23657660|NCT00234494|66132932|FG000|Overall Study|Protocol Violation|2|||
23657661|NCT01557348|66132933|FG000|Overall Study|Adverse Event|6|||
23657662|NCT01557348|66132934|FG001|Overall Study|Adverse Event|16|||
23657663|NCT01557348|66132933|FG000|Overall Study|Infusion reaction event|5|||
23657664|NCT01557348|66132934|FG001|Overall Study|Infusion reaction event|5|||
23657665|NCT01557348|66132933|FG000|Overall Study|Death|7|||
23657666|NCT01557348|66132934|FG001|Overall Study|Death|4|||
23657667|NCT01557348|66132933|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23657668|NCT01557348|66132934|FG001|Overall Study|Insufficient Therapeutic Response|28|||
23657669|NCT01557348|66132933|FG000|Overall Study|Withdrawal by Subject|5|||
23657670|NCT01557348|66132934|FG001|Overall Study|Withdrawal by Subject|4|||
23657671|NCT01557348|66132933|FG000|Overall Study|Lost to Follow-up|26|||
23657672|NCT01557348|66132934|FG001|Overall Study|Lost to Follow-up|22|||
23657673|NCT01557348|66132933|FG000|Overall Study|Administrative|18|||
23657674|NCT01557348|66132934|FG001|Overall Study|Administrative|11|||
23657675|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
23657676|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
23657677|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
23657678|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
23657679|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
23657680|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
23657681|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
23657682|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
23657683|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
23657684|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
23657685|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
23657686|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
23657687|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
23657688|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
23657689|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
23657690|NCT01323621|66132938|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
23657691|NCT01323621|66132939|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
23705647|NCT02402218|66297578|FG001|Overall Study|Withdrawal by Subject|1|||
23361763|NCT05401565|65069809|FG001|Overall Study|Lost to Follow-up|0|||
23657692|NCT01323621|66132940|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
23657693|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
23657694|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
23806937|NCT03970837|66672593|FG008|Overall Study|Physician Decision|0|||
23806938|NCT03970837|66672594|FG009|Overall Study|Physician Decision|1|||
23806939|NCT03970837|66672595|FG010|Overall Study|Physician Decision|0|||
23806940|NCT03970837|66672596|FG011|Overall Study|Physician Decision|0|||
23806941|NCT03970837|66672585|FG000|Overall Study|Withdrawal by Subject|32|||
23806942|NCT03970837|66672586|FG001|Overall Study|Withdrawal by Subject|35|||
23806943|NCT03970837|66672587|FG002|Overall Study|Withdrawal by Subject|12|||
23806944|NCT03970837|66672588|FG003|Overall Study|Withdrawal by Subject|8|||
23806945|NCT03970837|66672589|FG004|Overall Study|Withdrawal by Subject|6|||
23806946|NCT03970837|66672590|FG005|Overall Study|Withdrawal by Subject|8|||
23806947|NCT03970837|66672591|FG006|Overall Study|Withdrawal by Subject|2|||
23806948|NCT03970837|66672592|FG007|Overall Study|Withdrawal by Subject|3|||
23806949|NCT03970837|66672593|FG008|Overall Study|Withdrawal by Subject|0|||
23806950|NCT03970837|66672594|FG009|Overall Study|Withdrawal by Subject|0|||
23806951|NCT03970837|66672595|FG010|Overall Study|Withdrawal by Subject|0|||
23806952|NCT03970837|66672596|FG011|Overall Study|Withdrawal by Subject|1|||
23806953|NCT03970837|66672585|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
23806954|NCT03970837|66672586|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
23806955|NCT03970837|66672587|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
23806956|NCT03970837|66672588|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23806957|NCT03970837|66672589|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
23806958|NCT03970837|66672590|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23806959|NCT03970837|66672591|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23806960|NCT03970837|66672592|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23806961|NCT03970837|66672593|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23806962|NCT03970837|66672594|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23806963|NCT03970837|66672595|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23806964|NCT03970837|66672596|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23806965|NCT03970837|66672585|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806966|NCT03970837|66672586|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806967|NCT03970837|66672587|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806968|NCT03970837|66672588|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806969|NCT03970837|66672589|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806970|NCT03970837|66672590|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23806971|NCT03970837|66672591|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
23806972|NCT03970837|66672592|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
23806973|NCT03970837|66672593|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
23806974|NCT03970837|66672594|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
23806975|NCT03970837|66672595|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
23806976|NCT03970837|66672596|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
23806977|NCT02973321|66672597|FG000|Overall Study|Other than specified|0|||
23806978|NCT02973321|66672598|FG001|Overall Study|Other than specified|5|||
23806979|NCT02973321|66672599|FG002|Overall Study|Other than specified|3|||
23806980|NCT02973321|66672600|FG003|Overall Study|Other than specified|3|||
23806981|NCT02973321|66672601|FG004|Overall Study|Other than specified|1|||
23806982|NCT02973321|66672597|FG000|Overall Study|Lack of Efficacy|0|||
23806983|NCT02973321|66672598|FG001|Overall Study|Lack of Efficacy|0|||
23806984|NCT02973321|66672599|FG002|Overall Study|Lack of Efficacy|0|||
23806985|NCT02973321|66672600|FG003|Overall Study|Lack of Efficacy|0|||
23806986|NCT02973321|66672601|FG004|Overall Study|Lack of Efficacy|1|||
23806987|NCT02973321|66672597|FG000|Overall Study|Adverse Event|1|||
23806988|NCT02973321|66672598|FG001|Overall Study|Adverse Event|10|||
23361764|NCT05401565|65069808|FG000|Overall Study|Adverse Event|2|||
23361765|NCT05401565|65069809|FG001|Overall Study|Adverse Event|0|||
23361766|NCT05404711|65069811|FG000|Completed Study Visit|Withdrawal by Subject|1|||
23361767|NCT05404711|65069811|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
23600742|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
23657695|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
23657696|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23657697|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
23657698|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
23657699|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
23657700|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
23657701|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
23657702|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23657703|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23657704|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23657705|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
23657706|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
23657707|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
23657708|NCT01323621|66132938|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23657709|NCT01323621|66132939|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
23657710|NCT01323621|66132940|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
23657711|NCT00931944|66132941|FG000|Overall Study|Adverse Event|4|||
23600743|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
23600744|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
23600745|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
23806989|NCT02973321|66672599|FG002|Overall Study|Adverse Event|11|||
23806990|NCT02973321|66672600|FG003|Overall Study|Adverse Event|13|||
23806991|NCT02973321|66672601|FG004|Overall Study|Adverse Event|3|||
23806992|NCT01215513|66672602|FG000|Overall Study|Not completed CS42|9|||
23806993|NCT01215513|66672602|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
23806994|NCT01215513|66672602|FG000|Overall Study|Adverse event (CS42A)|2|||
23806995|NCT01215513|66672602|FG000|Overall Study|Physician decision (CS42A)|6|||
23806996|NCT01215513|66672602|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
23806997|NCT01215513|66672602|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
23806998|NCT03493542|66672603|FG000|Overall Study|Ongoing|2|||
23806999|NCT03493542|66672604|FG001|Overall Study|Ongoing|3|||
23807000|NCT03493542|66672603|FG000|Overall Study|Withdrawal by parent or guardian|3|||
23807001|NCT03493542|66672604|FG001|Overall Study|Withdrawal by parent or guardian|0|||
23807002|NCT03493542|66672603|FG000|Overall Study|Withdrawal by Subject|2|||
23807003|NCT03493542|66672604|FG001|Overall Study|Withdrawal by Subject|6|||
23807004|NCT02206620|66672605|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23807005|NCT02206620|66672606|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23807006|NCT02206620|66672605|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23807007|NCT02206620|66672606|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
23807008|NCT04700280|66672615|FG000|Overall Study|Adverse Event|4|||
23807009|NCT04700280|66672616|FG001|Overall Study|Adverse Event|0|||
23807010|NCT04700280|66672615|FG000|Overall Study|Lack of Efficacy|1|||
23807011|NCT04700280|66672616|FG001|Overall Study|Lack of Efficacy|0|||
23807012|NCT04700280|66672615|FG000|Overall Study|Study terminated by sponsor|5|||
23807013|NCT04700280|66672616|FG001|Overall Study|Study terminated by sponsor|3|||
23807014|NCT04700280|66672615|FG000|Overall Study|Other than specified|1|||
23807015|NCT04700280|66672616|FG001|Overall Study|Other than specified|0|||
23807016|NCT04397445|66672619|FG000|Overall Study|Withdrawal by Subject|1|||
23807017|NCT04397445|66672620|FG001|Overall Study|Withdrawal by Subject|0|||
23807018|NCT04397445|66672621|FG002|Overall Study|Withdrawal by Subject|0|||
23807019|NCT04397445|66672622|FG003|Overall Study|Withdrawal by Subject|0|||
23807020|NCT02500641|66672625|FG000|Overall Study|Adverse Event|0|||
23807021|NCT02500641|66672626|FG001|Overall Study|Adverse Event|2|||
23807022|NCT02500641|66672625|FG000|Overall Study|Withdrawal by Subject|4|||
23807023|NCT02500641|66672626|FG001|Overall Study|Withdrawal by Subject|5|||
23807024|NCT02500641|66672625|FG000|Overall Study|Unable to follow study procedures|3|||
23807025|NCT02500641|66672626|FG001|Overall Study|Unable to follow study procedures|2|||
23807026|NCT02500641|66672625|FG000|Overall Study|Protocol Violation|1|||
23807027|NCT02500641|66672626|FG001|Overall Study|Protocol Violation|2|||
23807028|NCT02500641|66672625|FG000|Overall Study|Lost to Follow-up|1|||
23807029|NCT02500641|66672626|FG001|Overall Study|Lost to Follow-up|0|||
23807030|NCT02500641|66672625|FG000|Overall Study|Sponsor decision|1|||
23807031|NCT02500641|66672626|FG001|Overall Study|Sponsor decision|0|||
23807032|NCT02500641|66672625|FG000|Overall Study|Non compliance to study drug|0|||
23807033|NCT02500641|66672626|FG001|Overall Study|Non compliance to study drug|1|||
23807034|NCT04556552|66672627|FG000|Overall Study|Lost to Follow-up|1|||
23807035|NCT04556552|66672628|FG001|Overall Study|Lost to Follow-up|0|||
23807036|NCT04556552|66672627|FG000|Overall Study|Claustrophobia|0|||
23807037|NCT04556552|66672628|FG001|Overall Study|Claustrophobia|1|||
23807038|NCT04556552|66672627|FG000|Overall Study|Inability to continue|0|||
23807039|NCT04556552|66672628|FG001|Overall Study|Inability to continue|1|||
23807040|NCT01195272|66672629|FG000|Overall Study|Adverse Event|1|||
23807041|NCT01195272|66672629|FG000|Overall Study|Lack of Efficacy|3|||
23807042|NCT02269163|66672630|FG000|Overall Study|Lost to Follow-up|1|||
23807043|NCT02269163|66672631|FG001|Overall Study|Lost to Follow-up|0|||
23807044|NCT02269163|66672630|FG000|Overall Study|Major protocol violation|0|||
23807045|NCT02269163|66672631|FG001|Overall Study|Major protocol violation|1|||
23807046|NCT02269163|66672630|FG000|Overall Study|Other|2|||
23807047|NCT02269163|66672631|FG001|Overall Study|Other|2|||
23807048|NCT02269163|66672630|FG000|Overall Study|Withdrawal by Subject|0|||
23807049|NCT02269163|66672631|FG001|Overall Study|Withdrawal by Subject|3|||
23600746|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
23807050|NCT02269163|66672630|FG000|Overall Study|Physician Decision|0|||
23807051|NCT02269163|66672631|FG001|Overall Study|Physician Decision|1|||
23807052|NCT02618408|66672632|FG000|Overall Study|Withdrawal by Subject|1|||
23807053|NCT02618408|66672633|FG001|Overall Study|Withdrawal by Subject|0|||
23807054|NCT02618408|66672634|FG002|Overall Study|Withdrawal by Subject|4|||
23807055|NCT02618408|66672632|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
23807056|NCT02618408|66672633|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
23807057|NCT02618408|66672634|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
23807058|NCT02618408|66672632|FG000|Overall Study|Lost to Follow-up|4|||
23807059|NCT02618408|66672633|FG001|Overall Study|Lost to Follow-up|2|||
23807060|NCT02618408|66672634|FG002|Overall Study|Lost to Follow-up|6|||
23807061|NCT02618408|66672632|FG000|Overall Study|Adverse Event|4|||
23807062|NCT02618408|66672633|FG001|Overall Study|Adverse Event|0|||
23807063|NCT02618408|66672634|FG002|Overall Study|Adverse Event|10|||
23807064|NCT02618408|66672632|FG000|Overall Study|Physician Decision|1|||
23807065|NCT02618408|66672633|FG001|Overall Study|Physician Decision|1|||
23807066|NCT02618408|66672634|FG002|Overall Study|Physician Decision|2|||
23807067|NCT02618408|66672632|FG000|Overall Study|Protocol Violation|1|||
23807068|NCT02618408|66672633|FG001|Overall Study|Protocol Violation|1|||
23807069|NCT02618408|66672634|FG002|Overall Study|Protocol Violation|2|||
23807070|NCT02618408|66672632|FG000|Overall Study|Other, Multiple Categories|0|||
23807071|NCT02618408|66672633|FG001|Overall Study|Other, Multiple Categories|0|||
23807072|NCT02618408|66672634|FG002|Overall Study|Other, Multiple Categories|4|||
23807073|NCT01334710|66672635|FG000|Overall Study|Trial was terminated|3|||
23807074|NCT00871741|66672638|FG000|Overall Study|Premature study termination|9|||
23807075|NCT00871741|66672639|FG001|Overall Study|Premature study termination|7|||
23807076|NCT02377063|66672640|FG000|Overall Study|Non-compliance|5|||
23807077|NCT03197558|66672656|FG000|Overall Study|Tubes not placed|1|||
23807078|NCT01144364|66672661|FG000|Induction Phase|Disease progression|14|||
23807079|NCT01144364|66672662|FG001|Induction Phase|Disease progression|0|||
23807080|NCT01144364|66672663|FG002|Induction Phase|Disease progression|0|||
23807081|NCT01144364|66672661|FG000|Induction Phase|Adverse Event|9|||
23807082|NCT01144364|66672662|FG001|Induction Phase|Adverse Event|0|||
23807083|NCT01144364|66672663|FG002|Induction Phase|Adverse Event|0|||
23807084|NCT01144364|66672661|FG000|Induction Phase|Death|1|||
23807085|NCT01144364|66672662|FG001|Induction Phase|Death|0|||
23807086|NCT01144364|66672663|FG002|Induction Phase|Death|0|||
23807087|NCT01144364|66672661|FG000|Induction Phase|Withdrawal by Subject|1|||
23807088|NCT01144364|66672662|FG001|Induction Phase|Withdrawal by Subject|0|||
23807089|NCT01144364|66672663|FG002|Induction Phase|Withdrawal by Subject|0|||
23807090|NCT01144364|66672661|FG000|Induction Phase|Lost to Follow-up|2|||
23807091|NCT01144364|66672662|FG001|Induction Phase|Lost to Follow-up|0|||
23807092|NCT01144364|66672663|FG002|Induction Phase|Lost to Follow-up|0|||
23807093|NCT01144364|66672661|FG000|Induction Phase|Physician Decision|1|||
23807094|NCT01144364|66672662|FG001|Induction Phase|Physician Decision|0|||
23807095|NCT01144364|66672663|FG002|Induction Phase|Physician Decision|0|||
23807096|NCT01144364|66672661|FG000|Induction Phase|Stable disease|2|||
23807097|NCT01144364|66672662|FG001|Induction Phase|Stable disease|0|||
23807098|NCT01144364|66672663|FG002|Induction Phase|Stable disease|0|||
23807099|NCT01144364|66672661|FG000|Induction Phase|Secondary neoplasia|1|||
23807100|NCT01144364|66672662|FG001|Induction Phase|Secondary neoplasia|0|||
23807101|NCT01144364|66672663|FG002|Induction Phase|Secondary neoplasia|0|||
23807102|NCT01144364|66672661|FG000|Induction Phase|Protocol Violation|1|||
23807103|NCT01144364|66672662|FG001|Induction Phase|Protocol Violation|0|||
23807104|NCT01144364|66672663|FG002|Induction Phase|Protocol Violation|0|||
23807105|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
23807106|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
23361768|NCT05404711|65069811|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
23807107|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
23807108|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
23807109|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
23600747|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
23600748|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
23361769|NCT05404711|65069811|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
23361770|NCT05404711|65069811|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
23361771|NCT05404711|65069811|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
23361772|NCT01979523|65069816|FG000|Overall Study|Withdrawal by Subject|1|||
23361773|NCT01979523|65069817|FG001|Overall Study|Withdrawal by Subject|0|||
23361774|NCT03915626|65069818|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
23361775|NCT02768792|65069819|FG000|Overall Study|Adverse Event|1|||
23361776|NCT01081626|65069820|FG000|Overall Study|Dosing error|1|||
23361777|NCT01081626|65069821|FG001|Overall Study|Dosing error|1|||
23657712|NCT00931944|66132941|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
23657713|NCT00931944|66132941|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
23361778|NCT01081626|65069820|FG000|Overall Study|Missing Estradiol|25|||
23657714|NCT00931944|66132941|FG000|Overall Study|Death|28|||
23361779|NCT01081626|65069821|FG001|Overall Study|Missing Estradiol|28|||
23361780|NCT01081626|65069820|FG000|Overall Study|Low antral follicle count|1|||
23361781|NCT01081626|65069821|FG001|Overall Study|Low antral follicle count|0|||
23361782|NCT01081626|65069820|FG000|Overall Study|Overstimulation|0|||
23361783|NCT01081626|65069821|FG001|Overall Study|Overstimulation|1|||
23361784|NCT01081626|65069820|FG000|Overall Study|Lost to Follow-up|0|||
23361785|NCT01081626|65069821|FG001|Overall Study|Lost to Follow-up|1|||
23657715|NCT00931944|66132941|FG000|Overall Study|Other|2|||
23361786|NCT01081626|65069820|FG000|Overall Study|Other|33|||
23361787|NCT01081626|65069821|FG001|Overall Study|Other|30|||
23657716|NCT01798992|66132942|FG000|Overall Study|Administrative withdrawal|0|||
23657717|NCT01798992|66132943|FG001|Overall Study|Administrative withdrawal|1|||
23657718|NCT01798992|66132944|FG002|Overall Study|Administrative withdrawal|0|||
23657719|NCT01798992|66132945|FG003|Overall Study|Administrative withdrawal|1|||
23657720|NCT01798992|66132942|FG000|Overall Study|Lost to Follow-up|0|||
23657721|NCT01798992|66132943|FG001|Overall Study|Lost to Follow-up|1|||
23657722|NCT01798992|66132944|FG002|Overall Study|Lost to Follow-up|1|||
23657723|NCT01798992|66132945|FG003|Overall Study|Lost to Follow-up|0|||
23657724|NCT01798992|66132942|FG000|Overall Study|Insufficient biopsy tissue|0|||
23657725|NCT01798992|66132943|FG001|Overall Study|Insufficient biopsy tissue|0|||
23657726|NCT01798992|66132944|FG002|Overall Study|Insufficient biopsy tissue|1|||
23657727|NCT01798992|66132945|FG003|Overall Study|Insufficient biopsy tissue|0|||
23657728|NCT01050205|66132947|FG000|Overall Study|Lost to Follow-up|7|||
23657729|NCT01050205|66132948|FG001|Overall Study|Lost to Follow-up|1|||
23657730|NCT01050205|66132947|FG000|Overall Study|Withdrawal by Subject|1|||
23657731|NCT01050205|66132948|FG001|Overall Study|Withdrawal by Subject|1|||
23657732|NCT01050205|66132947|FG000|Overall Study|Relocated from area|1|||
23657733|NCT01050205|66132948|FG001|Overall Study|Relocated from area|2|||
23657734|NCT01050205|66132947|FG000|Overall Study|Discontinued Intervention|2|||
23657735|NCT01050205|66132948|FG001|Overall Study|Discontinued Intervention|0|||
23657736|NCT01326728|66132950|FG000|Overall Study|Death|13|||
23657737|NCT01326728|66132951|FG001|Overall Study|Death|0|||
23657738|NCT01326728|66132950|FG000|Overall Study|Early closure of study|34|||
23657739|NCT01326728|66132951|FG001|Overall Study|Early closure of study|9|||
23657740|NCT01521897|66132952|FG000|Overall Study|Protocol Violation|18|||
23657741|NCT01521897|66132952|FG000|Overall Study|Lost to Follow-up|5|||
23657742|NCT00633061|66132953|FG000|Overall Study|Study closed|86|||
23657743|NCT00633061|66132954|FG001|Overall Study|Study closed|0|||
23657744|NCT00576836|66132955|FG000|Overall Study|Death|0|||
23657745|NCT00576836|66132956|FG001|Overall Study|Death|1|||
23657746|NCT00576836|66132955|FG000|Overall Study|Physician Decision|0|||
23657747|NCT00576836|66132956|FG001|Overall Study|Physician Decision|1|||
23657748|NCT00068588|66132957|FG000|Overall Study|Adverse Event|0|||
23657749|NCT00068588|66132958|FG001|Overall Study|Adverse Event|0|||
23657750|NCT00068588|66132959|FG002|Overall Study|Adverse Event|2|||
23657751|NCT00068588|66132957|FG000|Overall Study|Withdrawal by Subject|0|||
23657752|NCT00068588|66132958|FG001|Overall Study|Withdrawal by Subject|0|||
23657753|NCT00068588|66132959|FG002|Overall Study|Withdrawal by Subject|1|||
23657754|NCT00068588|66132957|FG000|Overall Study|Poor KPS|0|||
23657755|NCT00068588|66132958|FG001|Overall Study|Poor KPS|0|||
23657756|NCT00068588|66132959|FG002|Overall Study|Poor KPS|1|||
23657757|NCT00631189|66132960|FG000|Initial Phase|Protocol Violation|347|||
23657758|NCT00631189|66132961|FG001|Initial Phase|Protocol Violation|0|||
23657759|NCT00631189|66132962|FG002|Initial Phase|Protocol Violation|0|||
23657760|NCT00631189|66132963|FG003|Initial Phase|Protocol Violation|0|||
23657761|NCT00631189|66132960|FG000|Initial Phase|Withdrawal by Subject|4|||
23657762|NCT00631189|66132961|FG001|Initial Phase|Withdrawal by Subject|0|||
23657763|NCT00631189|66132962|FG002|Initial Phase|Withdrawal by Subject|0|||
23657764|NCT00631189|66132963|FG003|Initial Phase|Withdrawal by Subject|0|||
23657765|NCT00631189|66132960|FG000|Treatment Phase|Withdrawal by Subject|0|||
23657766|NCT00631189|66132961|FG001|Treatment Phase|Withdrawal by Subject|2|||
23657767|NCT00631189|66132962|FG002|Treatment Phase|Withdrawal by Subject|1|||
23657768|NCT00631189|66132963|FG003|Treatment Phase|Withdrawal by Subject|1|||
23657769|NCT00631189|66132960|FG000|Treatment Phase|Protocol Violation|0|||
23657770|NCT00631189|66132961|FG001|Treatment Phase|Protocol Violation|1|||
23657771|NCT00631189|66132962|FG002|Treatment Phase|Protocol Violation|6|||
23807110|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
23807111|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Death|0|||
23807112|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Death|2|||
23807113|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Death|0|||
23807114|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
23807115|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
23807116|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
23807117|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
23807118|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
23361788|NCT00613366|65069822|FG000|Overall Study|Withdrawal by Subject|3|||
23657772|NCT00631189|66132963|FG003|Treatment Phase|Protocol Violation|2|||
23657773|NCT00631189|66132960|FG000|Treatment Phase|Adverse Event|0|||
23657774|NCT00631189|66132961|FG001|Treatment Phase|Adverse Event|3|||
23657775|NCT00631189|66132962|FG002|Treatment Phase|Adverse Event|2|||
23657776|NCT00631189|66132963|FG003|Treatment Phase|Adverse Event|4|||
23657777|NCT00631189|66132960|FG000|Treatment Phase|Lost to Follow-up|0|||
23657778|NCT00631189|66132961|FG001|Treatment Phase|Lost to Follow-up|1|||
23657779|NCT00631189|66132962|FG002|Treatment Phase|Lost to Follow-up|0|||
23657780|NCT00631189|66132963|FG003|Treatment Phase|Lost to Follow-up|0|||
23657781|NCT00631189|66132960|FG000|Treatment Phase|Pregnancy|0|||
23657782|NCT00631189|66132961|FG001|Treatment Phase|Pregnancy|0|||
23657783|NCT00631189|66132962|FG002|Treatment Phase|Pregnancy|1|||
23657784|NCT00631189|66132963|FG003|Treatment Phase|Pregnancy|0|||
23361789|NCT00613366|65069823|FG001|Overall Study|Withdrawal by Subject|2|||
23361790|NCT01211145|65069825|FG000|Overall Study|Reason not specified|3|||
23600749|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
23600750|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
23600751|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
23600752|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
23600753|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
23600754|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
23600755|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
23600756|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
23600757|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
23600758|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
23600759|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
23600760|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
23600761|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
23600762|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
23600763|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
23600764|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
23600765|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
23600766|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
23600767|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
23600768|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
23600769|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
23600770|NCT01988402|65929709|FG000|Overall Study|Adverse Event|1|||
23600771|NCT01988402|65929710|FG001|Overall Study|Adverse Event|2|||
23600772|NCT01988402|65929709|FG000|Overall Study|Withdrawal by Subject|1|||
23600773|NCT01988402|65929710|FG001|Overall Study|Withdrawal by Subject|0|||
23600774|NCT02767765|65929713|FG000|Overall Study|Adverse Event|4|||
23600775|NCT02767765|65929713|FG000|Overall Study|Death|1|||
23600776|NCT02767765|65929713|FG000|Overall Study|Insufficient response|1|||
23600777|NCT02767765|65929713|FG000|Overall Study|Lost to Follow-up|2|||
23600778|NCT02767765|65929713|FG000|Overall Study|Investigator decision|1|||
23600779|NCT02767765|65929713|FG000|Overall Study|Non-Compliance|1|||
23600780|NCT02767765|65929713|FG000|Overall Study|Withdrawal by Subject|1|||
23600781|NCT01827839|65929714|FG000|Overall Study|Adverse Event|1|||
23600782|NCT01827839|65929714|FG000|Overall Study|Consent Withdrawal|2|||
23600783|NCT02189759|65929715|FG000|Overall Study|Lost to Follow-up|0|||
23600784|NCT02189759|65929716|FG001|Overall Study|Lost to Follow-up|0|||
23600785|NCT02189759|65929717|FG002|Overall Study|Lost to Follow-up|2|||
23600786|NCT02189759|65929718|FG003|Overall Study|Lost to Follow-up|5|||
23600787|NCT01057433|65929719|FG000|Overall Study|Adverse Event|1|||
23600788|NCT01426412|65929724|FG000|Overall Study|Withdrawal by Subject|1|||
23600789|NCT01426412|65929725|FG001|Overall Study|Withdrawal by Subject|0|||
23600790|NCT01426412|65929726|FG002|Overall Study|Withdrawal by Subject|0|||
23600791|NCT01426412|65929727|FG003|Overall Study|Withdrawal by Subject|0|||
23600792|NCT01426412|65929728|FG004|Overall Study|Withdrawal by Subject|1|||
23600793|NCT01426412|65929729|FG005|Overall Study|Withdrawal by Subject|0|||
23600794|NCT01426412|65929730|FG006|Overall Study|Withdrawal by Subject|0|||
23600795|NCT01426412|65929731|FG007|Overall Study|Withdrawal by Subject|3|||
23600796|NCT01426412|65929732|FG008|Overall Study|Withdrawal by Subject|1|||
23600797|NCT02189252|65929745|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600798|NCT02189252|65929746|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
23600799|NCT02189252|65929747|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600800|NCT02189252|65929748|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600801|NCT02189252|65929745|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600802|NCT02189252|65929746|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
23600803|NCT02189252|65929747|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600804|NCT02189252|65929748|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600805|NCT03539952|65929751|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
23600806|NCT03539952|65929752|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
23600807|NCT03539952|65929751|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
23600808|NCT03539952|65929752|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
23600809|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
23600810|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
23600811|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
23600812|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
23600813|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
23600814|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
23361791|NCT01211145|65069826|FG001|Overall Study|Reason not specified|2|||
23361792|NCT01211145|65069827|FG002|Overall Study|Reason not specified|2|||
23807119|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
23807120|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
23807121|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
23807122|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
23807123|NCT01144364|66672661|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
23807124|NCT01144364|66672662|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
23807125|NCT01144364|66672663|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
23807126|NCT00655850|66672664|FG000|Overall Study|Death|2|||
23807127|NCT00655850|66672664|FG000|Overall Study|Withdrawal by Subject|1|||
23807128|NCT01304693|66672665|FG000|Overall Study|Adverse Event|0|||
23807129|NCT01304693|66672666|FG001|Overall Study|Adverse Event|0|||
23807130|NCT01304693|66672667|FG002|Overall Study|Adverse Event|0|||
23807131|NCT01304693|66672668|FG003|Overall Study|Adverse Event|0|||
23807132|NCT01304693|66672669|FG004|Overall Study|Adverse Event|1|||
23807133|NCT01304693|66672665|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
23807134|NCT01304693|66672666|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
23807135|NCT01304693|66672667|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
23807136|NCT01304693|66672668|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
23807137|NCT01304693|66672669|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
23807138|NCT03578237|66672670|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
23807139|NCT03578237|66672671|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
23807140|NCT01000493|66672672|FG000|Overall Study|Adverse Event|3|||
23807141|NCT01000493|66672673|FG001|Overall Study|Adverse Event|6|||
23807142|NCT01000493|66672672|FG000|Overall Study|Lack of Efficacy|1|||
23807143|NCT01000493|66672673|FG001|Overall Study|Lack of Efficacy|1|||
23807144|NCT01000493|66672672|FG000|Overall Study|Protocol Violation|1|||
23807145|NCT01000493|66672673|FG001|Overall Study|Protocol Violation|8|||
23807146|NCT01000493|66672672|FG000|Overall Study|Study closed/terminated|25|||
23807147|NCT01000493|66672673|FG001|Overall Study|Study closed/terminated|23|||
23807148|NCT01000493|66672672|FG000|Overall Study|Lost to Follow-up|5|||
23807149|NCT01000493|66672673|FG001|Overall Study|Lost to Follow-up|9|||
23807150|NCT01000493|66672672|FG000|Overall Study|Physician Decision|1|||
23807151|NCT01000493|66672673|FG001|Overall Study|Physician Decision|1|||
23807152|NCT01000493|66672672|FG000|Overall Study|Withdrawal by Subject|3|||
23807153|NCT01000493|66672673|FG001|Overall Study|Withdrawal by Subject|7|||
23807154|NCT00448136|66672674|FG000|Overall Study|Death|3|||
23361793|NCT01211145|65069828|FG003|Overall Study|Reason not specified|1|||
23361794|NCT01211145|65069825|FG000|Overall Study|Lost to Follow-up|3|||
23361795|NCT01211145|65069826|FG001|Overall Study|Lost to Follow-up|2|||
23600815|NCT03539952|65929751|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
23600816|NCT03539952|65929752|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
23600817|NCT03539952|65929751|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
23600818|NCT03539952|65929752|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
23600819|NCT00210106|65929753|FG000|Overall Study|Death|1|||
23600820|NCT00210106|65929753|FG000|Overall Study|Protocol Violation|13|||
23600821|NCT02941549|65929754|FG000|Overall Study|Adverse Event|1|||
23600822|NCT02941549|65929755|FG001|Overall Study|Adverse Event|0|||
23600823|NCT02941549|65929756|FG002|Overall Study|Adverse Event|0|||
23600824|NCT02941549|65929754|FG000|Overall Study|Withdrawal by Subject|2|||
23600825|NCT02941549|65929755|FG001|Overall Study|Withdrawal by Subject|1|||
23600826|NCT02941549|65929756|FG002|Overall Study|Withdrawal by Subject|2|||
23600827|NCT01340066|65929757|FG000|Placebo Run in Period|Screen Failures|27|||
23600828|NCT01340066|65929758|FG001|Placebo Run in Period|Screen Failures|0|||
23600829|NCT01340066|65929759|FG002|Placebo Run in Period|Screen Failures|0|||
23807155|NCT00448136|66672675|FG001|Overall Study|Death|8|||
23807156|NCT00448136|66672674|FG000|Overall Study|Investigator's decision (progression)|1|||
23807157|NCT00448136|66672675|FG001|Overall Study|Investigator's decision (progression)|0|||
23807158|NCT02558231|66672679|FG000|Overall Study|Death|4|||
23807159|NCT02558231|66672680|FG001|Overall Study|Death|12|||
23807160|NCT02558231|66672679|FG000|Overall Study|Lost to Follow-up|7|||
23807161|NCT02558231|66672680|FG001|Overall Study|Lost to Follow-up|4|||
23807162|NCT02558231|66672679|FG000|Overall Study|Withdrawal by Subject|7|||
23807163|NCT02558231|66672680|FG001|Overall Study|Withdrawal by Subject|4|||
23807164|NCT02558231|66672679|FG000|Overall Study|Physician Decision|7|||
23807165|NCT02558231|66672680|FG001|Overall Study|Physician Decision|5|||
23361796|NCT01211145|65069827|FG002|Overall Study|Lost to Follow-up|1|||
23361797|NCT01211145|65069828|FG003|Overall Study|Lost to Follow-up|2|||
23361798|NCT01211145|65069825|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23361799|NCT01211145|65069826|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23361800|NCT01211145|65069827|FG002|Overall Study|Study-specific withdrawal criteria|0|||
23361801|NCT01211145|65069828|FG003|Overall Study|Study-specific withdrawal criteria|0|||
23361802|NCT01211145|65069825|FG000|Overall Study|Severe noncompliance to protocol|1|||
23361803|NCT01211145|65069826|FG001|Overall Study|Severe noncompliance to protocol|0|||
23361804|NCT01211145|65069827|FG002|Overall Study|Severe noncompliance to protocol|0|||
23361805|NCT01211145|65069828|FG003|Overall Study|Severe noncompliance to protocol|0|||
23361806|NCT01211145|65069825|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
23361807|NCT01211145|65069826|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
23361808|NCT01211145|65069827|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
23361809|NCT01211145|65069828|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
23361810|NCT01211145|65069825|FG000|Overall Study|Patient decision|2|||
23361811|NCT01211145|65069826|FG001|Overall Study|Patient decision|1|||
23361812|NCT01211145|65069827|FG002|Overall Study|Patient decision|0|||
23361813|NCT01211145|65069828|FG003|Overall Study|Patient decision|2|||
23361814|NCT02735980|65069829|FG000|Overall Study|Adverse Event|0|||
23361815|NCT02735980|65069830|FG001|Overall Study|Adverse Event|4|||
23361816|NCT02735980|65069831|FG002|Overall Study|Adverse Event|1|||
23361817|NCT02735980|65069829|FG000|Overall Study|Death|5|||
23361818|NCT02735980|65069830|FG001|Overall Study|Death|4|||
23361819|NCT02735980|65069831|FG002|Overall Study|Death|0|||
23807166|NCT02558231|66672679|FG000|Overall Study|Sponsor Decision|0|||
23361820|NCT02735980|65069829|FG000|Overall Study|Physician Decision|3|||
23361821|NCT02735980|65069830|FG001|Overall Study|Physician Decision|1|||
23361822|NCT02735980|65069831|FG002|Overall Study|Physician Decision|0|||
23361823|NCT02735980|65069829|FG000|Overall Study|Screen failure|1|||
23361824|NCT02735980|65069830|FG001|Overall Study|Screen failure|0|||
23361825|NCT02735980|65069831|FG002|Overall Study|Screen failure|0|||
23361826|NCT02735980|65069829|FG000|Overall Study|Withdrawal by Subject|1|||
23361827|NCT02735980|65069830|FG001|Overall Study|Withdrawal by Subject|2|||
23361828|NCT02735980|65069831|FG002|Overall Study|Withdrawal by Subject|0|||
23361829|NCT00758498|65069832|FG000|Overall Study|Adverse Event|2|||
23361830|NCT00758498|65069833|FG001|Overall Study|Adverse Event|2|||
23361831|NCT00758498|65069834|FG002|Overall Study|Adverse Event|3|||
23361832|NCT00758498|65069832|FG000|Overall Study|Subject legally detained out of state|1|||
23361833|NCT00758498|65069833|FG001|Overall Study|Subject legally detained out of state|0|||
23361834|NCT00758498|65069834|FG002|Overall Study|Subject legally detained out of state|0|||
23361835|NCT00758498|65069832|FG000|Overall Study|Withdrawal by Subject|0|||
23361836|NCT00758498|65069833|FG001|Overall Study|Withdrawal by Subject|0|||
23361837|NCT00758498|65069834|FG002|Overall Study|Withdrawal by Subject|1|||
23361838|NCT00758498|65069832|FG000|Overall Study|Noncompliance to study procedures|0|||
23361839|NCT00758498|65069833|FG001|Overall Study|Noncompliance to study procedures|0|||
23361840|NCT00758498|65069834|FG002|Overall Study|Noncompliance to study procedures|1|||
23361841|NCT02227784|65069842|FG000|Double-Blind Phase|Adverse Event|3|||
23361842|NCT02227784|65069843|FG001|Double-Blind Phase|Adverse Event|2|||
23657785|NCT00631189|66132960|FG000|Treatment Phase|patient did not take pravastatin|0|||
23657786|NCT00631189|66132961|FG001|Treatment Phase|patient did not take pravastatin|0|||
23657787|NCT00631189|66132962|FG002|Treatment Phase|patient did not take pravastatin|1|||
23657788|NCT00631189|66132963|FG003|Treatment Phase|patient did not take pravastatin|0|||
23657789|NCT01704287|66132965|FG000|Initial Treatment Period|Death|139|||
23657790|NCT01704287|66132966|FG001|Initial Treatment Period|Death|129|||
23657791|NCT01704287|66132967|FG002|Initial Treatment Period|Death|71|||
23657792|NCT01704287|66132968|FG003|Initial Treatment Period|Death|0|||
23657793|NCT01704287|66132969|FG004|Initial Treatment Period|Death|0|||
23657794|NCT01704287|66132965|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
23807167|NCT02558231|66672680|FG001|Overall Study|Sponsor Decision|1|||
23807168|NCT01829113|66672681|FG000|Overall Study|Disease Progression|37|||
23807169|NCT01829113|66672682|FG001|Overall Study|Disease Progression|48|||
23807170|NCT01829113|66672681|FG000|Overall Study|Adverse Event|14|||
23807171|NCT01829113|66672682|FG001|Overall Study|Adverse Event|10|||
23807172|NCT01829113|66672681|FG000|Overall Study|Withdrawal by Subject|17|||
23807173|NCT01829113|66672682|FG001|Overall Study|Withdrawal by Subject|10|||
23807174|NCT01829113|66672681|FG000|Overall Study|Death|4|||
23807175|NCT01829113|66672682|FG001|Overall Study|Death|6|||
23807176|NCT01829113|66672681|FG000|Overall Study|Sponsor Decision|1|||
23807177|NCT01829113|66672682|FG001|Overall Study|Sponsor Decision|1|||
23807178|NCT01829113|66672681|FG000|Overall Study|No Study Treatment Received|3|||
23807179|NCT01829113|66672682|FG001|Overall Study|No Study Treatment Received|2|||
23807180|NCT01829113|66672681|FG000|Overall Study|Physician Decision|1|||
23807181|NCT01829113|66672682|FG001|Overall Study|Physician Decision|1|||
23807182|NCT00560937|66672683|FG000|Overall Study|Withdrawal by Subject|0|||
23807183|NCT00560937|66672684|FG001|Overall Study|Withdrawal by Subject|1|||
23807184|NCT00560937|66672683|FG000|Overall Study|Physician Decision|1|||
23807185|NCT00560937|66672684|FG001|Overall Study|Physician Decision|1|||
23807186|NCT03828448|66672687|FG000|Overall Study|Sponsor's Discretion|34|||
23807187|NCT01660334|66672688|FG000|Overall Study|Lost to Follow-up|1|||
23807188|NCT02238626|66672689|FG000|Overall Study|Adverse Event|3|||
23807189|NCT02238626|66672690|FG001|Overall Study|Adverse Event|5|||
23807190|NCT02238626|66672691|FG002|Overall Study|Adverse Event|0|||
23657795|NCT01704287|66132966|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
23657796|NCT01704287|66132967|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
23807191|NCT02238626|66672692|FG003|Overall Study|Adverse Event|3|||
23361843|NCT02227784|65069844|FG002|Double-Blind Phase|Adverse Event|1|||
23361844|NCT02227784|65069845|FG003|Double-Blind Phase|Adverse Event|3|||
23361845|NCT02227784|65069846|FG004|Double-Blind Phase|Adverse Event|0|||
23361846|NCT02227784|65069842|FG000|Double-Blind Phase|Physician Decision|1|||
23361847|NCT02227784|65069843|FG001|Double-Blind Phase|Physician Decision|0|||
23361848|NCT02227784|65069844|FG002|Double-Blind Phase|Physician Decision|0|||
23361849|NCT02227784|65069845|FG003|Double-Blind Phase|Physician Decision|1|||
23361850|NCT02227784|65069846|FG004|Double-Blind Phase|Physician Decision|0|||
23361851|NCT02227784|65069842|FG000|Double-Blind Phase|Protocol Violation|0|||
23361852|NCT02227784|65069843|FG001|Double-Blind Phase|Protocol Violation|0|||
23361853|NCT02227784|65069844|FG002|Double-Blind Phase|Protocol Violation|1|||
23361854|NCT02227784|65069845|FG003|Double-Blind Phase|Protocol Violation|1|||
23361855|NCT02227784|65069846|FG004|Double-Blind Phase|Protocol Violation|0|||
23361856|NCT02227784|65069842|FG000|Double-Blind Phase|Sponsor Decision|34|||
23361857|NCT02227784|65069843|FG001|Double-Blind Phase|Sponsor Decision|15|||
23361858|NCT02227784|65069844|FG002|Double-Blind Phase|Sponsor Decision|14|||
23361859|NCT02227784|65069845|FG003|Double-Blind Phase|Sponsor Decision|32|||
23361860|NCT02227784|65069846|FG004|Double-Blind Phase|Sponsor Decision|0|||
23361861|NCT02227784|65069842|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23361862|NCT02227784|65069843|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23361863|NCT02227784|65069844|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
23361864|NCT02227784|65069845|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
23361865|NCT02227784|65069846|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23361866|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361867|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361868|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361869|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23480500|NCT00775203|65502008|FG000|Overall Study|Lost to Follow-up|11|||
23480501|NCT00775203|65502009|FG001|Overall Study|Lost to Follow-up|15|||
23480502|NCT00775203|65502008|FG000|Overall Study|Administrative reason|2|||
23480503|NCT00775203|65502009|FG001|Overall Study|Administrative reason|0|||
23480504|NCT00775203|65502008|FG000|Overall Study|Noncompliance|4|||
23480505|NCT00775203|65502009|FG001|Overall Study|Noncompliance|2|||
23480506|NCT00775203|65502008|FG000|Overall Study|Protocol Violation|0|||
23480507|NCT00775203|65502009|FG001|Overall Study|Protocol Violation|1|||
23480508|NCT00775203|65502008|FG000|Overall Study|Entered other study|1|||
23480509|NCT00775203|65502009|FG001|Overall Study|Entered other study|0|||
23480510|NCT00775203|65502008|FG000|Overall Study|Physician Decision|0|||
23480511|NCT00775203|65502009|FG001|Overall Study|Physician Decision|1|||
23480512|NCT02186301|65502012|FG000|Overall Study|Progressive Disease|7|||
23480513|NCT02186301|65502013|FG001|Overall Study|Progressive Disease|22|||
23480514|NCT02186301|65502014|FG002|Overall Study|Progressive Disease|27|||
23480515|NCT02186301|65502012|FG000|Overall Study|Adverse Event|5|||
23480516|NCT02186301|65502013|FG001|Overall Study|Adverse Event|5|||
23480517|NCT02186301|65502014|FG002|Overall Study|Adverse Event|5|||
23480518|NCT02186301|65502012|FG000|Overall Study|Death|1|||
23480519|NCT02186301|65502013|FG001|Overall Study|Death|0|||
23480520|NCT02186301|65502014|FG002|Overall Study|Death|0|||
23807192|NCT02238626|66672689|FG000|Overall Study|Lost to Follow-up|2|||
23807193|NCT02238626|66672690|FG001|Overall Study|Lost to Follow-up|4|||
23807194|NCT02238626|66672691|FG002|Overall Study|Lost to Follow-up|2|||
23807195|NCT02238626|66672692|FG003|Overall Study|Lost to Follow-up|2|||
23807196|NCT02238626|66672689|FG000|Overall Study|Withdrawal by Subject|0|||
23600830|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
23600831|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
23807197|NCT02238626|66672690|FG001|Overall Study|Withdrawal by Subject|3|||
23361870|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
23361871|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Death|0|||
23361872|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Death|0|||
23361873|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Death|0|||
23480521|NCT02186301|65502012|FG000|Overall Study|Withdrawal by Subject|5|||
23480522|NCT02186301|65502013|FG001|Overall Study|Withdrawal by Subject|1|||
23480523|NCT02186301|65502014|FG002|Overall Study|Withdrawal by Subject|3|||
23807198|NCT02238626|66672691|FG002|Overall Study|Withdrawal by Subject|0|||
23480524|NCT02186301|65502012|FG000|Overall Study|Physician Decision|1|||
23361874|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Death|0|||
23361875|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Death|1|||
23807199|NCT02238626|66672692|FG003|Overall Study|Withdrawal by Subject|1|||
23807200|NCT02238626|66672689|FG000|Overall Study|Death|0|||
23807201|NCT02238626|66672690|FG001|Overall Study|Death|0|||
23807202|NCT02238626|66672691|FG002|Overall Study|Death|1|||
23807203|NCT02238626|66672692|FG003|Overall Study|Death|1|||
23807204|NCT02238626|66672689|FG000|Overall Study|Other|0|||
23807205|NCT02238626|66672690|FG001|Overall Study|Other|2|||
23807206|NCT02238626|66672691|FG002|Overall Study|Other|0|||
23807207|NCT02238626|66672692|FG003|Overall Study|Other|0|||
23807208|NCT03176459|66672695|FG000|Overall Study|Lost to Follow-up|5|||
23807209|NCT03176459|66672696|FG001|Overall Study|Lost to Follow-up|7|||
23807210|NCT00986570|66672697|FG000|Overall Study|Lost to Follow-up|6|||
23807211|NCT00986570|66672697|FG000|Overall Study|Potential bias for objective assessment|1|||
23807212|NCT00912093|66672698|FG000|The Controlled Phase|Death|0|||
23807213|NCT00912093|66672699|FG001|The Controlled Phase|Death|1|||
23807214|NCT00912093|66672700|FG002|The Controlled Phase|Death|0|||
23807215|NCT00912093|66672701|FG003|The Controlled Phase|Death|0|||
23807216|NCT00912093|66672702|FG004|The Controlled Phase|Death|0|||
23807217|NCT00912093|66672698|FG000|The Controlled Phase|Medical Condition|0|||
23807218|NCT00912093|66672699|FG001|The Controlled Phase|Medical Condition|1|||
23807219|NCT00912093|66672700|FG002|The Controlled Phase|Medical Condition|0|||
23807220|NCT00912093|66672701|FG003|The Controlled Phase|Medical Condition|0|||
23807221|NCT00912093|66672702|FG004|The Controlled Phase|Medical Condition|0|||
23807222|NCT00912093|66672698|FG000|The Controlled Phase|Lost to Follow-up|0|||
23807223|NCT00912093|66672699|FG001|The Controlled Phase|Lost to Follow-up|0|||
23807224|NCT00912093|66672700|FG002|The Controlled Phase|Lost to Follow-up|0|||
23807225|NCT00912093|66672701|FG003|The Controlled Phase|Lost to Follow-up|0|||
23807226|NCT00912093|66672702|FG004|The Controlled Phase|Lost to Follow-up|1|||
23807227|NCT01460901|66672703|FG000|Overall Study|Withdrawal by Subject|2|||
23807228|NCT03575871|66672713|FG000|Overall Study|Adverse Event|5|||
23807229|NCT03575871|66672714|FG001|Overall Study|Adverse Event|5|||
23807230|NCT03575871|66672715|FG002|Overall Study|Adverse Event|8|||
23807231|NCT03575871|66672713|FG000|Overall Study|Death|1|||
23807232|NCT03575871|66672714|FG001|Overall Study|Death|0|||
23807233|NCT03575871|66672715|FG002|Overall Study|Death|0|||
23807234|NCT03575871|66672713|FG000|Overall Study|Lack of Efficacy|5|||
23807235|NCT03575871|66672714|FG001|Overall Study|Lack of Efficacy|4|||
23807236|NCT03575871|66672715|FG002|Overall Study|Lack of Efficacy|7|||
23807237|NCT03575871|66672713|FG000|Overall Study|Lost to Follow-up|1|||
23807238|NCT03575871|66672714|FG001|Overall Study|Lost to Follow-up|1|||
23807239|NCT03575871|66672715|FG002|Overall Study|Lost to Follow-up|1|||
23807240|NCT03575871|66672713|FG000|Overall Study|Protocol Deviation|1|||
23807241|NCT03575871|66672714|FG001|Overall Study|Protocol Deviation|1|||
23807242|NCT03575871|66672715|FG002|Overall Study|Protocol Deviation|1|||
23807243|NCT03575871|66672713|FG000|Overall Study|Withdrawal by Subject|6|||
23807244|NCT03575871|66672714|FG001|Overall Study|Withdrawal by Subject|1|||
23807245|NCT03575871|66672715|FG002|Overall Study|Withdrawal by Subject|9|||
23807246|NCT03575871|66672713|FG000|Overall Study|Other than specified|2|||
23807247|NCT03575871|66672714|FG001|Overall Study|Other than specified|2|||
23807248|NCT03575871|66672715|FG002|Overall Study|Other than specified|0|||
23807249|NCT02722148|66672716|FG000|Overall Study|Lost to Follow-up|2|||
23807250|NCT02722148|66672716|FG000|Overall Study|Non compliant with treatment regimen|3|||
23807251|NCT03285308|66672717|FG000|Overall Study|Adverse Event|3|||
23807252|NCT03285308|66672718|FG001|Overall Study|Adverse Event|7|||
23807253|NCT03285308|66672717|FG000|Overall Study|Withdrawal by Subject|8|||
23807254|NCT03285308|66672718|FG001|Overall Study|Withdrawal by Subject|9|||
23807255|NCT03285308|66672717|FG000|Overall Study|Lost to Follow-up|3|||
23807256|NCT03285308|66672718|FG001|Overall Study|Lost to Follow-up|1|||
23807257|NCT03285308|66672717|FG000|Overall Study|Protocol Deviation|6|||
23807258|NCT03285308|66672718|FG001|Overall Study|Protocol Deviation|5|||
23807259|NCT03285308|66672717|FG000|Overall Study|Reason not Specified|0|||
23807260|NCT03285308|66672718|FG001|Overall Study|Reason not Specified|1|||
23361876|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23807261|NCT01558297|66672719|FG000|Overall Study|Withdrawal by Subject|2|||
23807262|NCT01558297|66672720|FG001|Overall Study|Withdrawal by Subject|2|||
23807263|NCT01558297|66672721|FG002|Overall Study|Withdrawal by Subject|1|||
23807264|NCT04322149|66672722|FG000|Overall Study|Adverse Event|1|||
23361877|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361878|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361879|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361880|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
23361881|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361882|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361883|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361884|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361885|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
23361886|NCT03280056|65069851|FG000|Overall Study|Withdrawal by Subject|12|||
23361887|NCT03280056|65069852|FG001|Overall Study|Withdrawal by Subject|14|||
23361888|NCT03280056|65069851|FG000|Overall Study|Death|9|||
23361889|NCT03280056|65069852|FG001|Overall Study|Death|2|||
23361890|NCT03280056|65069851|FG000|Overall Study|Adverse Event|1|||
23361891|NCT03280056|65069852|FG001|Overall Study|Adverse Event|3|||
23361892|NCT03280056|65069851|FG000|Overall Study|Lost to Follow-up|1|||
23361893|NCT03280056|65069852|FG001|Overall Study|Lost to Follow-up|1|||
23361894|NCT03280056|65069851|FG000|Overall Study|Physician Decision|0|||
23361895|NCT03280056|65069852|FG001|Overall Study|Physician Decision|1|||
23361896|NCT03280056|65069851|FG000|Overall Study|Early Discontinuation|1|||
23361897|NCT03280056|65069852|FG001|Overall Study|Early Discontinuation|0|||
23361898|NCT00905632|65069853|FG000|Overall Study|Adverse Event|0|||
23361899|NCT00905632|65069854|FG001|Overall Study|Adverse Event|0|||
23361900|NCT00905632|65069855|FG002|Overall Study|Adverse Event|0|||
23361901|NCT00905632|65069856|FG003|Overall Study|Adverse Event|0|||
23361902|NCT00905632|65069857|FG004|Overall Study|Adverse Event|0|||
23361903|NCT00905632|65069858|FG005|Overall Study|Adverse Event|1|||
23361904|NCT00905632|65069859|FG006|Overall Study|Adverse Event|4|||
23361905|NCT05279131|65069860|FG000|Overall Study|Lost to Follow-up|1|||
23361906|NCT05279131|65069860|FG000|Overall Study|Death|1|||
23361907|NCT05279131|65069860|FG000|Overall Study|Physician Decision|1|||
23361908|NCT04265261|65069861|FG000|Overall Study|Adverse Event|2|||
23361909|NCT04265261|65069862|FG001|Overall Study|Adverse Event|0|||
23361910|NCT04265261|65069863|FG002|Overall Study|Adverse Event|0|||
23361911|NCT04265261|65069861|FG000|Overall Study|Death|1|||
23361912|NCT04265261|65069862|FG001|Overall Study|Death|0|||
23807265|NCT04322149|66672723|FG001|Overall Study|Adverse Event|1|||
23807266|NCT04322149|66672724|FG002|Overall Study|Adverse Event|0|||
23807267|NCT04322149|66672725|FG003|Overall Study|Adverse Event|0|||
23807268|NCT04322149|66672722|FG000|Overall Study|Withdrawal by Subject|0|||
23807269|NCT04322149|66672723|FG001|Overall Study|Withdrawal by Subject|0|||
23807270|NCT04322149|66672724|FG002|Overall Study|Withdrawal by Subject|0|||
23807271|NCT04322149|66672725|FG003|Overall Study|Withdrawal by Subject|2|||
23807272|NCT04322149|66672722|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23807273|NCT04322149|66672723|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
23807274|NCT04322149|66672724|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23807275|NCT04322149|66672725|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23807276|NCT03365011|66672726|FG000|Overall Study|Withdrawal by Subject|1|||
23807277|NCT03365011|66672727|FG001|Overall Study|Withdrawal by Subject|2|||
23807278|NCT03512262|66672728|FG000|Overall Study|Adverse Event|8|||
23807279|NCT03512262|66672729|FG001|Overall Study|Adverse Event|3|||
23807280|NCT03512262|66672728|FG000|Overall Study|Death (non-treatment emergent)|1|||
23807281|NCT03512262|66672729|FG001|Overall Study|Death (non-treatment emergent)|0|||
23807282|NCT03512262|66672728|FG000|Overall Study|Withdrawal by Subject|17|||
23807283|NCT03512262|66672729|FG001|Overall Study|Withdrawal by Subject|9|||
23807284|NCT03512262|66672728|FG000|Overall Study|Lost to Follow-up|7|||
23807285|NCT03512262|66672729|FG001|Overall Study|Lost to Follow-up|1|||
23807286|NCT03512262|66672728|FG000|Overall Study|Other than Specified|2|||
23807287|NCT03512262|66672729|FG001|Overall Study|Other than Specified|2|||
23807288|NCT03567382|66672730|FG000|Overall Study|Lost to Follow-up|1|||
23807289|NCT03567382|66672731|FG001|Overall Study|Lost to Follow-up|21|||
23807290|NCT03567382|66672732|FG002|Overall Study|Lost to Follow-up|1|||
23361913|NCT04265261|65069863|FG002|Overall Study|Death|0|||
23361914|NCT04265261|65069861|FG000|Overall Study|Lost to Follow-up|4|||
23361915|NCT04265261|65069862|FG001|Overall Study|Lost to Follow-up|1|||
23361916|NCT04265261|65069863|FG002|Overall Study|Lost to Follow-up|3|||
23657797|NCT01704287|66132968|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
23657798|NCT01704287|66132969|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
23657799|NCT01704287|66132965|FG000|Initial Treatment Period|Lost to Follow-up|5|||
23657800|NCT01704287|66132966|FG001|Initial Treatment Period|Lost to Follow-up|3|||
23657801|NCT01704287|66132967|FG002|Initial Treatment Period|Lost to Follow-up|0|||
23657802|NCT01704287|66132968|FG003|Initial Treatment Period|Lost to Follow-up|0|||
23657803|NCT01704287|66132969|FG004|Initial Treatment Period|Lost to Follow-up|0|||
23657804|NCT01704287|66132965|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
23657805|NCT01704287|66132966|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
23657806|NCT01704287|66132967|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
23657807|NCT01704287|66132968|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
23657808|NCT01704287|66132969|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
23657809|NCT01704287|66132965|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23657810|NCT01704287|66132966|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23657811|NCT01704287|66132967|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23657812|NCT01704287|66132968|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
23657813|NCT01704287|66132969|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
23657814|NCT01704287|66132965|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
23657815|NCT01704287|66132966|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
23657816|NCT01704287|66132967|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
23657817|NCT01704287|66132968|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
23657818|NCT01704287|66132969|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
23657819|NCT01704287|66132965|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23657820|NCT01704287|66132966|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23657821|NCT01704287|66132967|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23657822|NCT01704287|66132968|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
23657823|NCT01704287|66132969|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23657824|NCT00995007|66132970|FG000|Overall Study|Withdrew consent|1|||
23657825|NCT00995007|66132971|FG001|Overall Study|Withdrew consent|0|||
23657826|NCT00995007|66132970|FG000|Overall Study|Refused further treatment|8|||
23657827|NCT00995007|66132971|FG001|Overall Study|Refused further treatment|2|||
23657828|NCT00995007|66132970|FG000|Overall Study|Toxicity|8|||
23657829|NCT00995007|66132971|FG001|Overall Study|Toxicity|0|||
23657830|NCT01968070|66132975|FG000|Period 1|Withdrawal by Subject|0|||
23657831|NCT01968070|66132976|FG001|Period 1|Withdrawal by Subject|1|||
23361917|NCT04265261|65069861|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23657832|NCT01968070|66132977|FG002|Period 1|Withdrawal by Subject|0|||
23657833|NCT01968070|66132978|FG003|Period 1|Withdrawal by Subject|0|||
23657834|NCT01968070|66132979|FG004|Period 1|Withdrawal by Subject|0|||
23361918|NCT04265261|65069862|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23361919|NCT04265261|65069863|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23657835|NCT01968070|66132980|FG005|Period 1|Withdrawal by Subject|0|||
23657836|NCT01968070|66132981|FG006|Period 1|Withdrawal by Subject|1|||
23657837|NCT01968070|66132982|FG007|Period 1|Withdrawal by Subject|0|||
23657838|NCT01968070|66132983|FG008|Period 1|Withdrawal by Subject|0|||
23657839|NCT01968070|66132984|FG009|Period 1|Withdrawal by Subject|0|||
23657840|NCT01968070|66132985|FG010|Period 1|Withdrawal by Subject|0|||
23657841|NCT01968070|66132986|FG011|Period 1|Withdrawal by Subject|0|||
23657842|NCT01968070|66132987|FG012|Period 1|Withdrawal by Subject|0|||
23657843|NCT01968070|66132988|FG013|Period 1|Withdrawal by Subject|0|||
23657844|NCT01968070|66132989|FG014|Period 1|Withdrawal by Subject|0|||
23657845|NCT01968070|66132990|FG015|Period 1|Withdrawal by Subject|1|||
23657846|NCT01968070|66132991|FG016|Period 1|Withdrawal by Subject|0|||
23657847|NCT01968070|66132992|FG017|Period 1|Withdrawal by Subject|0|||
23657848|NCT01968070|66132975|FG000|Period 1|Protocol Violation|0|||
23657849|NCT01968070|66132976|FG001|Period 1|Protocol Violation|0|||
23657850|NCT01968070|66132977|FG002|Period 1|Protocol Violation|0|||
23657851|NCT01968070|66132978|FG003|Period 1|Protocol Violation|1|||
23657852|NCT01968070|66132979|FG004|Period 1|Protocol Violation|1|||
23657853|NCT01968070|66132980|FG005|Period 1|Protocol Violation|0|||
23657854|NCT01968070|66132981|FG006|Period 1|Protocol Violation|0|||
23361920|NCT04265261|65069861|FG000|Overall Study|Physician Decision|0|||
23657855|NCT01968070|66132982|FG007|Period 1|Protocol Violation|0|||
23657856|NCT01968070|66132983|FG008|Period 1|Protocol Violation|0|||
23657857|NCT01968070|66132984|FG009|Period 1|Protocol Violation|0|||
23657858|NCT01968070|66132985|FG010|Period 1|Protocol Violation|0|||
23657859|NCT01968070|66132986|FG011|Period 1|Protocol Violation|0|||
23657860|NCT01968070|66132987|FG012|Period 1|Protocol Violation|0|||
23361921|NCT04265261|65069862|FG001|Overall Study|Physician Decision|0|||
23361922|NCT04265261|65069863|FG002|Overall Study|Physician Decision|1|||
23657861|NCT01968070|66132988|FG013|Period 1|Protocol Violation|0|||
23657862|NCT01968070|66132989|FG014|Period 1|Protocol Violation|0|||
23657863|NCT01968070|66132990|FG015|Period 1|Protocol Violation|0|||
23657864|NCT01968070|66132991|FG016|Period 1|Protocol Violation|0|||
23657865|NCT01968070|66132992|FG017|Period 1|Protocol Violation|0|||
23657866|NCT01968070|66132975|FG000|Period 1|Lost to Follow-up|0|||
23657867|NCT01968070|66132976|FG001|Period 1|Lost to Follow-up|0|||
23657868|NCT01968070|66132977|FG002|Period 1|Lost to Follow-up|0|||
23657869|NCT01968070|66132978|FG003|Period 1|Lost to Follow-up|1|||
23657870|NCT01968070|66132979|FG004|Period 1|Lost to Follow-up|0|||
23657871|NCT01968070|66132980|FG005|Period 1|Lost to Follow-up|0|||
23657872|NCT01968070|66132981|FG006|Period 1|Lost to Follow-up|0|||
23657873|NCT01968070|66132982|FG007|Period 1|Lost to Follow-up|0|||
23657874|NCT01968070|66132983|FG008|Period 1|Lost to Follow-up|0|||
23657875|NCT01968070|66132984|FG009|Period 1|Lost to Follow-up|0|||
23657876|NCT01968070|66132985|FG010|Period 1|Lost to Follow-up|0|||
23657877|NCT01968070|66132986|FG011|Period 1|Lost to Follow-up|0|||
23657878|NCT01968070|66132987|FG012|Period 1|Lost to Follow-up|0|||
23657879|NCT01968070|66132988|FG013|Period 1|Lost to Follow-up|0|||
23657880|NCT01968070|66132989|FG014|Period 1|Lost to Follow-up|0|||
23657881|NCT01968070|66132990|FG015|Period 1|Lost to Follow-up|0|||
23657882|NCT01968070|66132991|FG016|Period 1|Lost to Follow-up|0|||
23361923|NCT04265261|65069861|FG000|Overall Study|Protocol Deviation|0|||
23361924|NCT04265261|65069862|FG001|Overall Study|Protocol Deviation|2|||
23361925|NCT04265261|65069863|FG002|Overall Study|Protocol Deviation|0|||
23657883|NCT01968070|66132992|FG017|Period 1|Lost to Follow-up|0|||
23657884|NCT01968070|66132975|FG000|Period 1|Adverse Event|0|||
23657885|NCT01968070|66132976|FG001|Period 1|Adverse Event|0|||
23657886|NCT01968070|66132977|FG002|Period 1|Adverse Event|0|||
23657887|NCT01968070|66132978|FG003|Period 1|Adverse Event|0|||
23361926|NCT04265261|65069861|FG000|Overall Study|Withdrawal by Subject|2|||
23657888|NCT01968070|66132979|FG004|Period 1|Adverse Event|0|||
23657889|NCT01968070|66132980|FG005|Period 1|Adverse Event|0|||
23657890|NCT01968070|66132981|FG006|Period 1|Adverse Event|1|||
23657891|NCT01968070|66132982|FG007|Period 1|Adverse Event|0|||
23480525|NCT02186301|65502013|FG001|Overall Study|Physician Decision|0|||
23657892|NCT01968070|66132983|FG008|Period 1|Adverse Event|0|||
23657893|NCT01968070|66132984|FG009|Period 1|Adverse Event|0|||
23657894|NCT01968070|66132985|FG010|Period 1|Adverse Event|0|||
23657895|NCT01968070|66132986|FG011|Period 1|Adverse Event|0|||
23657896|NCT01968070|66132987|FG012|Period 1|Adverse Event|0|||
23657897|NCT01968070|66132988|FG013|Period 1|Adverse Event|0|||
23657898|NCT01968070|66132989|FG014|Period 1|Adverse Event|0|||
23657899|NCT01968070|66132990|FG015|Period 1|Adverse Event|0|||
23657900|NCT01968070|66132991|FG016|Period 1|Adverse Event|0|||
23657901|NCT01968070|66132992|FG017|Period 1|Adverse Event|0|||
23657902|NCT01968070|66132975|FG000|Period 1|Physician Decision|0|||
23657903|NCT01968070|66132976|FG001|Period 1|Physician Decision|0|||
23657904|NCT01968070|66132977|FG002|Period 1|Physician Decision|0|||
23657905|NCT01968070|66132978|FG003|Period 1|Physician Decision|0|||
23657906|NCT01968070|66132979|FG004|Period 1|Physician Decision|0|||
23657907|NCT01968070|66132980|FG005|Period 1|Physician Decision|0|||
23657908|NCT01968070|66132981|FG006|Period 1|Physician Decision|0|||
23657909|NCT01968070|66132982|FG007|Period 1|Physician Decision|0|||
23657910|NCT01968070|66132983|FG008|Period 1|Physician Decision|0|||
23657911|NCT01968070|66132984|FG009|Period 1|Physician Decision|0|||
23657912|NCT01968070|66132985|FG010|Period 1|Physician Decision|0|||
23657913|NCT01968070|66132986|FG011|Period 1|Physician Decision|1|||
23657914|NCT01968070|66132987|FG012|Period 1|Physician Decision|0|||
23657915|NCT01968070|66132988|FG013|Period 1|Physician Decision|0|||
23657916|NCT01968070|66132989|FG014|Period 1|Physician Decision|0|||
23657917|NCT01968070|66132990|FG015|Period 1|Physician Decision|0|||
23657918|NCT01968070|66132991|FG016|Period 1|Physician Decision|0|||
23657919|NCT01968070|66132992|FG017|Period 1|Physician Decision|0|||
23657920|NCT01968070|66132975|FG000|Period 2|Withdrawal by Subject|0|||
23657921|NCT01968070|66132976|FG001|Period 2|Withdrawal by Subject|0|||
23657922|NCT01968070|66132977|FG002|Period 2|Withdrawal by Subject|0|||
23657923|NCT01968070|66132978|FG003|Period 2|Withdrawal by Subject|0|||
23657924|NCT01968070|66132979|FG004|Period 2|Withdrawal by Subject|1|||
23657925|NCT01968070|66132980|FG005|Period 2|Withdrawal by Subject|0|||
23657926|NCT01968070|66132981|FG006|Period 2|Withdrawal by Subject|0|||
23807291|NCT03567382|66672733|FG003|Overall Study|Lost to Follow-up|21|||
23657927|NCT01968070|66132982|FG007|Period 2|Withdrawal by Subject|0|||
23657928|NCT01968070|66132983|FG008|Period 2|Withdrawal by Subject|0|||
23657929|NCT01968070|66132984|FG009|Period 2|Withdrawal by Subject|0|||
23657930|NCT01968070|66132985|FG010|Period 2|Withdrawal by Subject|0|||
23657931|NCT01968070|66132986|FG011|Period 2|Withdrawal by Subject|0|||
23657932|NCT01968070|66132987|FG012|Period 2|Withdrawal by Subject|0|||
23657933|NCT01968070|66132988|FG013|Period 2|Withdrawal by Subject|0|||
23657934|NCT01968070|66132989|FG014|Period 2|Withdrawal by Subject|0|||
23657935|NCT01968070|66132990|FG015|Period 2|Withdrawal by Subject|0|||
23657936|NCT01968070|66132991|FG016|Period 2|Withdrawal by Subject|0|||
23657937|NCT01968070|66132992|FG017|Period 2|Withdrawal by Subject|0|||
23657938|NCT00929656|66132993|FG000|Overall Study|Lost to Follow-up|0|||
23657939|NCT00929656|66132994|FG001|Overall Study|Lost to Follow-up|1|||
23657940|NCT01186939|66133019|FG000|Overall Study|Death|7|||
23657941|NCT01186939|66133019|FG000|Overall Study|Withdrawal by Subject|2|||
23657942|NCT01186939|66133019|FG000|Overall Study|No longer receiving clinical benefit|17|||
23657943|NCT01186939|66133019|FG000|Overall Study|Program closed|5|||
23657944|NCT01186939|66133019|FG000|Overall Study|Sponsor decision|4|||
23657945|NCT01186939|66133019|FG000|Overall Study|Started additional treatment|1|||
23657946|NCT01186939|66133019|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
23657947|NCT01186939|66133019|FG000|Overall Study|Myocardial infarction|1|||
23657948|NCT01186939|66133019|FG000|Overall Study|Bone marrow transplant|1|||
23657949|NCT01186939|66133019|FG000|Overall Study|Transformation to AML|1|||
23657950|NCT01829360|66133020|FG000|Overall Study|Protocol Violation|0|||
23657951|NCT01829360|66133021|FG001|Overall Study|Protocol Violation|0|||
23657952|NCT01829360|66133022|FG002|Overall Study|Protocol Violation|1|||
23657953|NCT01829360|66133023|FG003|Overall Study|Protocol Violation|0|||
23657954|NCT00387764|66136069|FG000|Overall Study|Adverse Event|12|||
23657955|NCT00387764|66136069|FG000|Overall Study|Withdrawal by Subject|8|||
23657956|NCT00387764|66136069|FG000|Overall Study|Sponsor Terminated Study|1|||
23657957|NCT00387764|66136069|FG000|Overall Study|Physician Decision|1|||
23657958|NCT00387764|66136069|FG000|Overall Study|Other|2|||
23657959|NCT00387764|66136069|FG000|Overall Study|Death|7|||
23657960|NCT01555151|66136070|FG000|Overall Study|Withdrawal by Subject|6|||
23657961|NCT01555151|66136071|FG001|Overall Study|Withdrawal by Subject|2|||
23657962|NCT01555151|66136072|FG002|Overall Study|Withdrawal by Subject|0|||
23807292|NCT03567382|66672730|FG000|Overall Study|Withdrawal by Subject|2|||
23657963|NCT01555151|66136073|FG003|Overall Study|Withdrawal by Subject|2|||
23807293|NCT03567382|66672731|FG001|Overall Study|Withdrawal by Subject|14|||
23807294|NCT03567382|66672732|FG002|Overall Study|Withdrawal by Subject|1|||
23807295|NCT03567382|66672733|FG003|Overall Study|Withdrawal by Subject|12|||
23807296|NCT01117766|66672734|FG000|First Intervention|Adverse Event|0|||
23807297|NCT01117766|66672735|FG001|First Intervention|Adverse Event|1|||
23807298|NCT01117766|66672734|FG000|First Intervention|Protocol Violation|1|||
23807299|NCT01117766|66672735|FG001|First Intervention|Protocol Violation|0|||
23807300|NCT01117766|66672734|FG000|Washout Period|Protocol Violation|0|||
23807301|NCT01117766|66672735|FG001|Washout Period|Protocol Violation|2|||
23807302|NCT01117766|66672734|FG000|Second Intervention|Lost to Follow-up|1|||
23807303|NCT01117766|66672735|FG001|Second Intervention|Lost to Follow-up|0|||
23807304|NCT01117766|66672734|FG000|Second Intervention|Other|1|||
23807305|NCT01117766|66672735|FG001|Second Intervention|Other|2|||
23657964|NCT01555151|66136070|FG000|Overall Study|Administrative|3|||
23657965|NCT01555151|66136071|FG001|Overall Study|Administrative|1|||
23657966|NCT01555151|66136072|FG002|Overall Study|Administrative|2|||
23657967|NCT01555151|66136073|FG003|Overall Study|Administrative|0|||
23657968|NCT01555151|66136070|FG000|Overall Study|Protocol Violation|3|||
23657969|NCT01555151|66136071|FG001|Overall Study|Protocol Violation|3|||
23657970|NCT01555151|66136072|FG002|Overall Study|Protocol Violation|3|||
23657971|NCT01555151|66136073|FG003|Overall Study|Protocol Violation|5|||
23657972|NCT01555151|66136070|FG000|Overall Study|Adverse Event|1|||
23657973|NCT01555151|66136071|FG001|Overall Study|Adverse Event|2|||
23657974|NCT01555151|66136072|FG002|Overall Study|Adverse Event|1|||
23657975|NCT01555151|66136073|FG003|Overall Study|Adverse Event|2|||
23657976|NCT01555151|66136070|FG000|Overall Study|Lost to Follow-up|0|||
23657977|NCT01555151|66136071|FG001|Overall Study|Lost to Follow-up|0|||
23657978|NCT01555151|66136072|FG002|Overall Study|Lost to Follow-up|0|||
23657979|NCT01555151|66136073|FG003|Overall Study|Lost to Follow-up|1|||
23657980|NCT01524133|66136076|FG000|Treatment Phase|Withdrawal by Subject|13|||
23657981|NCT01524133|66136077|FG001|Treatment Phase|Withdrawal by Subject|28|||
23657982|NCT01524133|66136078|FG002|Treatment Phase|Withdrawal by Subject|31|||
23657983|NCT01524133|66136076|FG000|Treatment Phase|Physician Decision|6|||
23657984|NCT01524133|66136077|FG001|Treatment Phase|Physician Decision|3|||
23657985|NCT01524133|66136078|FG002|Treatment Phase|Physician Decision|3|||
23657986|NCT01524133|66136076|FG000|Treatment Phase|Lost to Follow-up|0|||
23657987|NCT01524133|66136077|FG001|Treatment Phase|Lost to Follow-up|1|||
23657988|NCT01524133|66136078|FG002|Treatment Phase|Lost to Follow-up|2|||
23657989|NCT01524133|66136076|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
23657990|NCT01524133|66136077|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
23657991|NCT01524133|66136078|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
23657992|NCT01524133|66136076|FG000|Overall Study 52 Weeks|Physician Decision|1|||
23657993|NCT01524133|66136077|FG001|Overall Study 52 Weeks|Physician Decision|0|||
23657994|NCT01524133|66136078|FG002|Overall Study 52 Weeks|Physician Decision|2|||
23807306|NCT01117766|66672734|FG000|Second Intervention|Adverse Event|0|||
23657995|NCT01524133|66136076|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
23657996|NCT01524133|66136077|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
23657997|NCT01524133|66136078|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
23657998|NCT04060563|66136083|FG000|Overall Study|Lost to Follow-up|1|||
23657999|NCT04060563|66136084|FG001|Overall Study|Lost to Follow-up|1|||
23658000|NCT04060563|66136083|FG000|Overall Study|Physician Decision|0|||
23658001|NCT04060563|66136084|FG001|Overall Study|Physician Decision|1|||
23658002|NCT01970488|66136085|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
23658003|NCT01970488|66136086|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
23658004|NCT01970488|66136087|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23658005|NCT01970488|66136088|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23658006|NCT01970488|66136089|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23658007|NCT01970488|66136085|FG000|Part 1: Through Week 16|Protocol Violation|1|||
23658008|NCT01970488|66136086|FG001|Part 1: Through Week 16|Protocol Violation|2|||
23658009|NCT01970488|66136087|FG002|Part 1: Through Week 16|Protocol Violation|0|||
23658010|NCT01970488|66136088|FG003|Part 1: Through Week 16|Protocol Violation|0|||
23658011|NCT01970488|66136089|FG004|Part 1: Through Week 16|Protocol Violation|0|||
23658012|NCT01970488|66136085|FG000|Part 1: Through Week 16|Adverse Event|6|||
23658013|NCT01970488|66136086|FG001|Part 1: Through Week 16|Adverse Event|5|||
23658014|NCT01970488|66136087|FG002|Part 1: Through Week 16|Adverse Event|0|||
23658015|NCT01970488|66136088|FG003|Part 1: Through Week 16|Adverse Event|0|||
23658016|NCT01970488|66136089|FG004|Part 1: Through Week 16|Adverse Event|0|||
23658017|NCT01970488|66136085|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
23807307|NCT01117766|66672735|FG001|Second Intervention|Adverse Event|2|||
23658018|NCT01970488|66136086|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
23658019|NCT01970488|66136087|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
23658020|NCT01970488|66136088|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
23658021|NCT01970488|66136089|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
23658022|NCT01970488|66136085|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
23658023|NCT01970488|66136086|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
23658024|NCT01970488|66136087|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
23658025|NCT01970488|66136088|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
23658026|NCT01970488|66136089|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
23658027|NCT01970488|66136085|FG000|Part 2: Post Week 16|Physician Decision|0|||
23658028|NCT01970488|66136086|FG001|Part 2: Post Week 16|Physician Decision|0|||
23658029|NCT01970488|66136087|FG002|Part 2: Post Week 16|Physician Decision|0|||
23658030|NCT01970488|66136088|FG003|Part 2: Post Week 16|Physician Decision|0|||
23658031|NCT01970488|66136089|FG004|Part 2: Post Week 16|Physician Decision|1|||
23658032|NCT01970488|66136085|FG000|Part 2: Post Week 16|Non-compliance|0|||
23600832|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
23600833|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
23600834|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
23600835|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
23600836|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
23600837|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
23600838|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
23658033|NCT01970488|66136086|FG001|Part 2: Post Week 16|Non-compliance|0|||
23658034|NCT01970488|66136087|FG002|Part 2: Post Week 16|Non-compliance|1|||
23658035|NCT01970488|66136088|FG003|Part 2: Post Week 16|Non-compliance|0|||
23658036|NCT01970488|66136089|FG004|Part 2: Post Week 16|Non-compliance|0|||
23658037|NCT01970488|66136085|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
23658038|NCT01970488|66136086|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
23361927|NCT04265261|65069862|FG001|Overall Study|Withdrawal by Subject|1|||
23600839|NCT02972359|65929762|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
23361928|NCT04265261|65069863|FG002|Overall Study|Withdrawal by Subject|4|||
23658039|NCT01970488|66136087|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
23658040|NCT01970488|66136088|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
23658041|NCT01970488|66136089|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
23658042|NCT01970488|66136085|FG000|Part 2: Post Week 16|Adverse Event|0|||
23658043|NCT01970488|66136086|FG001|Part 2: Post Week 16|Adverse Event|0|||
23658044|NCT01970488|66136087|FG002|Part 2: Post Week 16|Adverse Event|5|||
23658045|NCT01970488|66136088|FG003|Part 2: Post Week 16|Adverse Event|1|||
23658046|NCT01970488|66136089|FG004|Part 2: Post Week 16|Adverse Event|1|||
23658047|NCT01970488|66136085|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
23658048|NCT01970488|66136086|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
23658049|NCT01970488|66136087|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
23658050|NCT01970488|66136088|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
23658051|NCT01970488|66136089|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
23658052|NCT01970488|66136085|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
23807308|NCT01117766|66672734|FG000|Second Intervention|Withdrawal by Subject|0|||
23807309|NCT01117766|66672735|FG001|Second Intervention|Withdrawal by Subject|1|||
23807310|NCT01855048|66672736|FG000|Overall Study|Withdrawal by Subject|0|||
23807311|NCT01855048|66672737|FG001|Overall Study|Withdrawal by Subject|1|||
23807312|NCT01855048|66672738|FG002|Overall Study|Withdrawal by Subject|0|||
23807313|NCT01855048|66672739|FG003|Overall Study|Withdrawal by Subject|0|||
23807314|NCT01855048|66672740|FG004|Overall Study|Withdrawal by Subject|1|||
23807315|NCT01855048|66672741|FG005|Overall Study|Withdrawal by Subject|0|||
23807316|NCT01705236|66672742|FG000|Overall Study|Lost to Follow-up|1|||
23807317|NCT01705236|66672742|FG000|Overall Study|Administrative problems|2|||
23807318|NCT01705236|66672742|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23807319|NCT01705236|66672742|FG000|Overall Study|Protocol Violation|3|||
23807320|NCT01705236|66672742|FG000|Overall Study|Abnormal test procedure result(s)|4|||
23807321|NCT01705236|66672742|FG000|Overall Study|Abnormal laboratory value(s)|4|||
23807322|NCT01705236|66672742|FG000|Overall Study|Withdrawal by Subject|5|||
23807323|NCT01705236|66672742|FG000|Overall Study|Adverse Event|5|||
23807324|NCT02091141|66672743|FG000|Overall Study|Death|280|||
23807325|NCT02091141|66672744|FG001|Overall Study|Death|118|||
23807326|NCT02091141|66672745|FG002|Overall Study|Death|46|||
23807327|NCT02091141|66672746|FG003|Overall Study|Death|13|||
23807328|NCT02091141|66672747|FG004|Overall Study|Death|31|||
23807329|NCT02091141|66672748|FG005|Overall Study|Death|16|||
23807330|NCT02091141|66672749|FG006|Overall Study|Death|12|||
23807331|NCT02091141|66672743|FG000|Overall Study|Withdrawal by Subject|21|||
23807332|NCT02091141|66672744|FG001|Overall Study|Withdrawal by Subject|13|||
23807333|NCT02091141|66672745|FG002|Overall Study|Withdrawal by Subject|3|||
23807334|NCT02091141|66672746|FG003|Overall Study|Withdrawal by Subject|2|||
23807335|NCT02091141|66672747|FG004|Overall Study|Withdrawal by Subject|2|||
23807336|NCT02091141|66672748|FG005|Overall Study|Withdrawal by Subject|3|||
23807337|NCT02091141|66672749|FG006|Overall Study|Withdrawal by Subject|0|||
23807338|NCT02091141|66672743|FG000|Overall Study|Lost to Follow-up|21|||
23807339|NCT02091141|66672744|FG001|Overall Study|Lost to Follow-up|5|||
23807340|NCT02091141|66672745|FG002|Overall Study|Lost to Follow-up|1|||
23807341|NCT02091141|66672746|FG003|Overall Study|Lost to Follow-up|0|||
23807342|NCT02091141|66672747|FG004|Overall Study|Lost to Follow-up|1|||
23807343|NCT02091141|66672748|FG005|Overall Study|Lost to Follow-up|2|||
23600840|NCT02972359|65929762|FG000|Overall Study|Lack of Efficacy|1|||
23600841|NCT02972359|65929762|FG000|Overall Study|Adverse Event|4|||
23600842|NCT02972359|65929762|FG000|Overall Study|Death|1|||
23600843|NCT02972359|65929762|FG000|Overall Study|Withdrawal by Subject|30|||
23600844|NCT02972359|65929762|FG000|Overall Study|Protocol Violation|1|||
23658053|NCT01970488|66136086|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
23658054|NCT01970488|66136087|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
23658055|NCT01970488|66136088|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
23658056|NCT01970488|66136089|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
23658057|NCT05093322|66136092|FG000|Overall Study|Death|6|||
23658058|NCT05093322|66136093|FG001|Overall Study|Death|2|||
23658059|NCT05093322|66136092|FG000|Overall Study|Other|4|||
23658060|NCT05093322|66136093|FG001|Overall Study|Other|1|||
23658061|NCT00867113|66136094|FG000|Treatment Period|Adverse Event|15|||
23658062|NCT00867113|66136094|FG000|Treatment Period|Death|2|||
23658063|NCT00867113|66136094|FG000|Treatment Period|Withdrawal by Subject|19|||
23658064|NCT00867113|66136094|FG000|Treatment Period|Lost to Follow-up|3|||
23658065|NCT00867113|66136094|FG000|Treatment Period|Administrative problems|1|||
23658066|NCT00867113|66136094|FG000|Treatment Period|Disease progression/relapse|1|||
23658067|NCT00867113|66136094|FG000|Treatment Period|Protocol Violation|4|||
23658068|NCT00867113|66136094|FG000|Post Treatment After Survival Follow-up|Death|1|||
23658069|NCT00867113|66136094|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
23658070|NCT00867113|66136094|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
23658071|NCT00867113|66136094|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
23658072|NCT01519934|66136097|FG000|Overall Study|Lost to Follow-up|3|||
23658073|NCT01122576|66136100|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
23658074|NCT01122576|66136101|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
23361929|NCT02335346|65069864|FG000|Overall Study|Adverse Event|11|||
23361930|NCT02335346|65069864|FG000|Overall Study|Withdrawal by Subject|1|||
23361931|NCT02155309|65069865|FG000|Overall Study|Protocol Violation|0|||
23361932|NCT02155309|65069866|FG001|Overall Study|Protocol Violation|0|||
23361933|NCT02155309|65069867|FG002|Overall Study|Protocol Violation|1|||
23361934|NCT01091246|65069868|FG000|Overall Study|Lost to Follow-up|23|||
23361935|NCT01091246|65069869|FG001|Overall Study|Lost to Follow-up|11|||
23361936|NCT01091246|65069870|FG002|Overall Study|Lost to Follow-up|7|||
23361937|NCT01091246|65069868|FG000|Overall Study|Adverse Event|1|||
23361938|NCT01091246|65069869|FG001|Overall Study|Adverse Event|0|||
23361939|NCT01091246|65069870|FG002|Overall Study|Adverse Event|1|||
23361940|NCT01091246|65069868|FG000|Overall Study|Withdrawal by Subject|9|||
23361941|NCT01091246|65069869|FG001|Overall Study|Withdrawal by Subject|5|||
23361942|NCT01091246|65069870|FG002|Overall Study|Withdrawal by Subject|4|||
23361943|NCT01091246|65069868|FG000|Overall Study|Subject not dosed|2|||
23361944|NCT01091246|65069869|FG001|Overall Study|Subject not dosed|0|||
23361945|NCT01091246|65069870|FG002|Overall Study|Subject not dosed|1|||
23361946|NCT03339713|65069871|FG000|Overall Study|Lost to Follow-up|2|||
23361947|NCT03339713|65069872|FG001|Overall Study|Lost to Follow-up|1|||
23361948|NCT03339713|65069871|FG000|Overall Study|Protocol Violation|1|||
23361949|NCT03339713|65069872|FG001|Overall Study|Protocol Violation|0|||
23361950|NCT03339713|65069871|FG000|Overall Study|Withdrawal by Subject|1|||
23658075|NCT01122576|66136102|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
23658076|NCT01122576|66136100|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
23658077|NCT01122576|66136101|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
23658078|NCT01122576|66136102|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
23658079|NCT01122576|66136100|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
23658080|NCT01122576|66136101|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
23658081|NCT01122576|66136102|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
23658082|NCT02876835|66136103|FG000|Treatment Period (51.1 Month)|Other|1|||
23658083|NCT02876835|66136104|FG001|Treatment Period (51.1 Month)|Other|0|||
23658084|NCT02876835|66136103|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
23658085|NCT02876835|66136104|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
23658086|NCT02876835|66136103|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
23658087|NCT02876835|66136104|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
23658088|NCT02876835|66136103|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
23658089|NCT02876835|66136104|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
23658090|NCT00791258|66136107|FG000|Overall Study|Adverse Event|87|||
23658091|NCT00791258|66136107|FG000|Overall Study|Lost to Follow-up|18|||
23658092|NCT00791258|66136107|FG000|Overall Study|Protocol Violation|109|||
23658093|NCT00791258|66136107|FG000|Overall Study|Withdrawal by Subject|40|||
23658094|NCT00791258|66136107|FG000|Overall Study|Did not take medication for >3 days|1|||
23658095|NCT00791258|66136107|FG000|Overall Study|subject left area|2|||
23658096|NCT00791258|66136107|FG000|Overall Study|non-compliance|3|||
23658097|NCT00791258|66136107|FG000|Overall Study|Subject incarcerated|1|||
23658098|NCT00791258|66136107|FG000|Overall Study|Subject required restricted medication|1|||
23658099|NCT00791258|66136107|FG000|Overall Study|Lack of Efficacy|1|||
23658100|NCT04042740|66136112|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
23658101|NCT04042740|66136112|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
23658102|NCT04411628|66136113|FG000|Overall Study|Withdrawal by Subject|1|||
23658103|NCT04411628|66136114|FG001|Overall Study|Withdrawal by Subject|1|||
23658104|NCT04411628|66136115|FG002|Overall Study|Withdrawal by Subject|2|||
23658105|NCT04411628|66136116|FG003|Overall Study|Withdrawal by Subject|0|||
23658106|NCT04411628|66136113|FG000|Overall Study|Lost to Follow-up|0|||
23658107|NCT04411628|66136114|FG001|Overall Study|Lost to Follow-up|1|||
23658108|NCT04411628|66136115|FG002|Overall Study|Lost to Follow-up|0|||
23658109|NCT04411628|66136116|FG003|Overall Study|Lost to Follow-up|0|||
23658110|NCT04490395|66136119|FG000|Overall Study|Lost to Follow-up|0|||
23658111|NCT04490395|66136120|FG001|Overall Study|Lost to Follow-up|1|||
23658112|NCT00884325|66136121|FG000|Overall Study|Lost to Follow-up|1|||
23658113|NCT00884325|66136122|FG001|Overall Study|Lost to Follow-up|2|||
23658114|NCT00884325|66136121|FG000|Overall Study|Lack of Efficacy|0|||
23658115|NCT00884325|66136122|FG001|Overall Study|Lack of Efficacy|1|||
23658116|NCT00884325|66136121|FG000|Overall Study|Withdrawal by Subject|1|||
23658117|NCT00884325|66136122|FG001|Overall Study|Withdrawal by Subject|1|||
23658118|NCT00884325|66136121|FG000|Overall Study|Not provided|1|||
23658119|NCT00884325|66136122|FG001|Overall Study|Not provided|0|||
23658120|NCT01650285|66136123|FG000|Overall Study|Adverse Event|1|||
23658121|NCT04340557|66136124|FG000|Overall Study|Transferred to ICU and/or death|1|||
23658122|NCT04340557|66136125|FG001|Overall Study|Transferred to ICU and/or death|2|||
23658123|NCT00088907|66136126|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
23658124|NCT00088907|66136127|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
23658125|NCT00088907|66136126|FG000|Randomized Study (Step 1)|Adverse Event|14|||
23658126|NCT00088907|66136127|FG001|Randomized Study (Step 1)|Adverse Event|19|||
23658127|NCT00088907|66136126|FG000|Randomized Study (Step 1)|Death|11|||
23658128|NCT00088907|66136127|FG001|Randomized Study (Step 1)|Death|12|||
23658129|NCT00088907|66136126|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
23658130|NCT00088907|66136127|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
23658131|NCT00088907|66136126|FG000|Randomized Study (Step 1)|complicating disease|3|||
23658132|NCT00088907|66136127|FG001|Randomized Study (Step 1)|complicating disease|1|||
23658133|NCT00088907|66136126|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
23658134|NCT00088907|66136127|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
23658135|NCT00088907|66136126|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
23658136|NCT00088907|66136127|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
23658137|NCT00088907|66136126|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
23658138|NCT00088907|66136127|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
23658139|NCT00088907|66136126|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
23658140|NCT00088907|66136127|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
23658141|NCT00088907|66136126|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
23658142|NCT00088907|66136127|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
23658143|NCT00088907|66136126|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
23658144|NCT00088907|66136127|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
23658145|NCT00521053|66136131|FG000|Observation Phase|Disease Progression|55|||
23658146|NCT00521053|66136131|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
23658147|NCT00521053|66136131|FG000|Observation Phase|Death|2|||
23658148|NCT00521053|66136131|FG000|Observation Phase|Adverse Event|1|||
23658149|NCT00521053|66136131|FG000|Observation Phase|Other non-study melanoma treatment|1|||
23658150|NCT00521053|66136131|FG000|Observation Phase|Physician Decision|1|||
23658151|NCT00865904|66136133|FG000|Overall Study|Randomized but not Treated|2|||
23658152|NCT00865904|66136134|FG001|Overall Study|Randomized but not Treated|0|||
23658153|NCT00865904|66136135|FG002|Overall Study|Randomized but not Treated|0|||
23658154|NCT00865904|66136136|FG003|Overall Study|Randomized but not Treated|1|||
23658155|NCT00865904|66136137|FG004|Overall Study|Randomized but not Treated|1|||
23658156|NCT01145495|66136138|FG000|Overall Study|Adverse Event|6|||
23658157|NCT01145495|66136138|FG000|Overall Study|Withdrawal by Subject|6|||
23658158|NCT01145495|66136138|FG000|Overall Study|Disease progression after respone|2|||
23658159|NCT02511678|66136139|FG000|Overall Study|Withdrawal by Subject|2|||
23658160|NCT02511678|66136139|FG000|Overall Study|Lost to Follow-up|4|||
23658161|NCT02511678|66136139|FG000|Overall Study|Death|19|||
23658162|NCT02511678|66136139|FG000|Overall Study|Adverse Event|1|||
23658163|NCT02511678|66136139|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
23658164|NCT02511678|66136139|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
23658165|NCT02511678|66136139|FG000|Overall Study|Required Radiofrequency Ablation|1|||
23658166|NCT02511678|66136139|FG000|Overall Study|Biopsy was Negative|1|||
23658167|NCT02511678|66136139|FG000|Overall Study|Protocol Violation|1|||
23658168|NCT02511678|66136139|FG000|Overall Study|Received Radiation Treatment|1|||
23807344|NCT02091141|66672749|FG006|Overall Study|Lost to Follow-up|0|||
23658169|NCT00578136|66136140|FG000|Overall Study|Not given intervention|1|||
23658170|NCT00578136|66136141|FG001|Overall Study|Not given intervention|1|||
23658171|NCT05513625|66136150|FG000|Overall Study|Withdrawal by Subject|1|||
23658172|NCT03370471|66136151|FG000|Overall Study|Withdrawal by Subject|6|||
23658173|NCT03370471|66136152|FG001|Overall Study|Withdrawal by Subject|1|||
23658174|NCT03370471|66136151|FG000|Overall Study|Unable to access veins for blood draw|0|||
23658175|NCT03370471|66136152|FG001|Overall Study|Unable to access veins for blood draw|1|||
23658176|NCT03370471|66136151|FG000|Overall Study|Screen fail|1|||
23658177|NCT03370471|66136152|FG001|Overall Study|Screen fail|0|||
23658178|NCT01472380|66136153|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
23658179|NCT01472380|66136153|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
23658180|NCT00210184|66136154|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
23658181|NCT00041080|66136155|FG000|Overall Study|Adverse Event|21|||
23658182|NCT00041080|66136156|FG001|Overall Study|Adverse Event|1|||
23658183|NCT00041080|66136155|FG000|Overall Study|Withdrawal by Subject|6|||
23658184|NCT00041080|66136156|FG001|Overall Study|Withdrawal by Subject|6|||
23658185|NCT00041080|66136155|FG000|Overall Study|Concommitant Illness/Other|1|||
23658186|NCT00041080|66136156|FG001|Overall Study|Concommitant Illness/Other|2|||
23658187|NCT00041080|66136155|FG000|Overall Study|Did not start therapy|1|||
23658188|NCT00041080|66136156|FG001|Overall Study|Did not start therapy|1|||
23658189|NCT00041080|66136155|FG000|Overall Study|Ineligible|1|||
23658190|NCT00041080|66136156|FG001|Overall Study|Ineligible|0|||
23658191|NCT02303704|66136157|FG000|Overall Study|Protocol Violation|5|||
23658192|NCT02303704|66136158|FG001|Overall Study|Protocol Violation|9|||
23658193|NCT01087957|66136159|FG000|Overall Study|Death|2|||
23658194|NCT01087957|66136160|FG001|Overall Study|Death|2|||
23658195|NCT01087957|66136159|FG000|Overall Study|Lost to Follow-up|3|||
23658196|NCT01087957|66136160|FG001|Overall Study|Lost to Follow-up|4|||
23658197|NCT01087957|66136159|FG000|Overall Study|Protocol Violation|13|||
23361951|NCT03339713|65069872|FG001|Overall Study|Withdrawal by Subject|1|||
23361952|NCT00547157|65069875|FG000|Overall Study|Other|1|||
23361953|NCT00547157|65069876|FG001|Overall Study|Other|0|||
23361954|NCT00547157|65069875|FG000|Overall Study|Death|38|||
23658198|NCT01087957|66136160|FG001|Overall Study|Protocol Violation|25|||
23658199|NCT01087957|66136159|FG000|Overall Study|Withdrawal by Subject|18|||
23658200|NCT01087957|66136160|FG001|Overall Study|Withdrawal by Subject|15|||
23658201|NCT01087957|66136159|FG000|Overall Study|Physician Decision|5|||
23658202|NCT01087957|66136160|FG001|Overall Study|Physician Decision|9|||
23658203|NCT00908583|66136161|FG000|Phase 1|Withdrawal by Subject|1|||
23658204|NCT00908583|66136161|FG000|Phase 1|Adverse Event|4|||
23658205|NCT00908583|66136161|FG000|Phase 2|Physician Decision|1|||
23361955|NCT00547157|65069876|FG001|Overall Study|Death|18|||
23658206|NCT00908583|66136161|FG000|Phase 2|Adverse Event|1|||
23658207|NCT00908583|66136161|FG000|Phase 3|Adverse Event|2|||
23658208|NCT00908583|66136161|FG000|Phase 4|Adverse Event|1|||
23658209|NCT00908583|66136161|FG000|Phase 4|Physician Decision|1|||
23658210|NCT00908583|66136161|FG000|Phase 5|Adverse Event|3|||
23658211|NCT02615470|66136162|FG000|Overall Study|Lost to Follow-up|21|||
23658212|NCT02615470|66136163|FG001|Overall Study|Lost to Follow-up|32|||
23658213|NCT00732251|66136164|FG000|Overall Study|Lost to Follow-up|3|||
23658214|NCT00732251|66136164|FG000|Overall Study|Withdrawal by Subject|3|||
23658215|NCT00732251|66136164|FG000|Overall Study|Early Term due to Site Closure|1|||
23658216|NCT01177384|66136167|FG000|Overall Study|Adverse Event|6|||
23658217|NCT01177384|66136168|FG001|Overall Study|Adverse Event|4|||
23658218|NCT01177384|66136167|FG000|Overall Study|Lack of Efficacy|0|||
23658219|NCT01177384|66136168|FG001|Overall Study|Lack of Efficacy|1|||
23658220|NCT01177384|66136167|FG000|Overall Study|Lost to Follow-up|3|||
23658221|NCT01177384|66136168|FG001|Overall Study|Lost to Follow-up|4|||
23600845|NCT02972359|65929762|FG000|Overall Study|Lost to Follow-up|26|||
23600846|NCT02972359|65929762|FG000|Overall Study|Other reasons|5|||
23600847|NCT02972359|65929762|FG000|Overall Study|Missing|1|||
23600848|NCT03905642|65929763|FG000|Overall Study|Withdrawal by Subject|3|||
23600849|NCT03905642|65929763|FG000|Overall Study|Pregnancy|1|||
23600850|NCT03905642|65929763|FG000|Overall Study|Adverse Event|1|||
23600851|NCT03905642|65929763|FG000|Overall Study|Lack of Efficacy|1|||
23600852|NCT03905642|65929763|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
23600853|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
23658222|NCT01177384|66136167|FG000|Overall Study|Physician Decision|0|||
23658223|NCT01177384|66136168|FG001|Overall Study|Physician Decision|3|||
23658224|NCT01177384|66136167|FG000|Overall Study|Protocol Violation|0|||
23658225|NCT01177384|66136168|FG001|Overall Study|Protocol Violation|2|||
23658226|NCT01177384|66136167|FG000|Overall Study|Withdrawal by Subject|5|||
23600854|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
23658227|NCT01177384|66136168|FG001|Overall Study|Withdrawal by Subject|12|||
23658228|NCT01237340|66136170|FG000|Overall Study|Adverse Event|3|||
23807345|NCT02091141|66672743|FG000|Overall Study|Reason Not Specified|6|||
23807346|NCT02091141|66672744|FG001|Overall Study|Reason Not Specified|5|||
23807347|NCT02091141|66672745|FG002|Overall Study|Reason Not Specified|2|||
23658229|NCT01237340|66136170|FG000|Overall Study|Withdrawal by Subject|1|||
23658230|NCT01237340|66136170|FG000|Overall Study|Early termination of the trial|36|||
23658231|NCT02129205|66136175|FG000|Overall Study|Withdrawal by Subject|0|||
23658232|NCT02129205|66136176|FG001|Overall Study|Withdrawal by Subject|0|||
23658233|NCT02129205|66136177|FG002|Overall Study|Withdrawal by Subject|0|||
23658234|NCT02129205|66136178|FG003|Overall Study|Withdrawal by Subject|0|||
23658235|NCT02129205|66136179|FG004|Overall Study|Withdrawal by Subject|1|||
23658236|NCT02129205|66136180|FG005|Overall Study|Withdrawal by Subject|1|||
23658237|NCT02129205|66136181|FG006|Overall Study|Withdrawal by Subject|1|||
23658238|NCT02129205|66136182|FG007|Overall Study|Withdrawal by Subject|0|||
23658239|NCT02129205|66136183|FG008|Overall Study|Withdrawal by Subject|1|||
23658240|NCT02129205|66136184|FG009|Overall Study|Withdrawal by Subject|0|||
23658241|NCT02129205|66136175|FG000|Overall Study|Other|1|||
23658242|NCT02129205|66136176|FG001|Overall Study|Other|0|||
23658243|NCT02129205|66136177|FG002|Overall Study|Other|0|||
23658244|NCT02129205|66136178|FG003|Overall Study|Other|0|||
23658245|NCT02129205|66136179|FG004|Overall Study|Other|2|||
23658246|NCT02129205|66136180|FG005|Overall Study|Other|3|||
23658247|NCT02129205|66136181|FG006|Overall Study|Other|3|||
23658248|NCT02129205|66136182|FG007|Overall Study|Other|2|||
23658249|NCT02129205|66136183|FG008|Overall Study|Other|1|||
23658250|NCT02129205|66136184|FG009|Overall Study|Other|0|||
23658251|NCT00385203|66136190|FG000|Overall Study|Adverse Event|5|||
23658252|NCT00385203|66136191|FG001|Overall Study|Adverse Event|4|||
23658253|NCT00385203|66136190|FG000|Overall Study|Death|1|||
23658254|NCT00385203|66136191|FG001|Overall Study|Death|0|||
23658255|NCT00385203|66136190|FG000|Overall Study|Condition under investigation worsened|18|||
23658256|NCT00385203|66136191|FG001|Overall Study|Condition under investigation worsened|3|||
23658257|NCT00385203|66136190|FG000|Overall Study|Incorrect enrollment|2|||
23658258|NCT00385203|66136191|FG001|Overall Study|Incorrect enrollment|0|||
23658259|NCT04906616|66136192|FG000|Overall Study|Divorce|3|||
23658260|NCT04906616|66136193|FG001|Overall Study|Divorce|2|||
23658261|NCT02108964|66136196|FG000|Overall Study|Progressive disease|12|||
23658262|NCT02108964|66136197|FG001|Overall Study|Progressive disease|25|||
23658263|NCT02108964|66136198|FG002|Overall Study|Progressive disease|50|||
23658264|NCT02108964|66136199|FG003|Overall Study|Progressive disease|6|||
23658265|NCT02108964|66136200|FG004|Overall Study|Progressive disease|18|||
23658266|NCT02108964|66136201|FG005|Overall Study|Progressive disease|5|||
23658267|NCT02108964|66136202|FG006|Overall Study|Progressive disease|7|||
23658268|NCT02108964|66136203|FG007|Overall Study|Progressive disease|9|||
23658269|NCT02108964|66136196|FG000|Overall Study|Physician Decision|1|||
23658270|NCT02108964|66136197|FG001|Overall Study|Physician Decision|5|||
23658271|NCT02108964|66136198|FG002|Overall Study|Physician Decision|6|||
23658272|NCT02108964|66136199|FG003|Overall Study|Physician Decision|0|||
23658273|NCT02108964|66136200|FG004|Overall Study|Physician Decision|1|||
23658274|NCT02108964|66136201|FG005|Overall Study|Physician Decision|0|||
23658275|NCT02108964|66136202|FG006|Overall Study|Physician Decision|0|||
23658276|NCT02108964|66136203|FG007|Overall Study|Physician Decision|0|||
23658277|NCT02108964|66136196|FG000|Overall Study|Adverse Event|0|||
23658278|NCT02108964|66136197|FG001|Overall Study|Adverse Event|0|||
23658279|NCT02108964|66136198|FG002|Overall Study|Adverse Event|4|||
23658280|NCT02108964|66136199|FG003|Overall Study|Adverse Event|0|||
23658281|NCT02108964|66136200|FG004|Overall Study|Adverse Event|1|||
23658282|NCT02108964|66136201|FG005|Overall Study|Adverse Event|0|||
23658283|NCT02108964|66136202|FG006|Overall Study|Adverse Event|3|||
23658284|NCT02108964|66136203|FG007|Overall Study|Adverse Event|1|||
23658285|NCT02108964|66136196|FG000|Overall Study|Death|1|||
23658286|NCT02108964|66136197|FG001|Overall Study|Death|1|||
23658287|NCT02108964|66136198|FG002|Overall Study|Death|2|||
23658288|NCT02108964|66136199|FG003|Overall Study|Death|0|||
23658289|NCT02108964|66136200|FG004|Overall Study|Death|3|||
23658290|NCT02108964|66136201|FG005|Overall Study|Death|0|||
23658291|NCT02108964|66136202|FG006|Overall Study|Death|0|||
23658292|NCT02108964|66136203|FG007|Overall Study|Death|1|||
23658293|NCT02108964|66136196|FG000|Overall Study|Subject/Guardian decision|0|||
23658294|NCT02108964|66136197|FG001|Overall Study|Subject/Guardian decision|1|||
23658295|NCT02108964|66136198|FG002|Overall Study|Subject/Guardian decision|3|||
23658296|NCT02108964|66136199|FG003|Overall Study|Subject/Guardian decision|0|||
23658297|NCT02108964|66136200|FG004|Overall Study|Subject/Guardian decision|2|||
23658298|NCT02108964|66136201|FG005|Overall Study|Subject/Guardian decision|0|||
23658299|NCT02108964|66136202|FG006|Overall Study|Subject/Guardian decision|1|||
23658300|NCT02108964|66136203|FG007|Overall Study|Subject/Guardian decision|1|||
23658301|NCT03496012|66136204|FG000|Overall Study|Withdrawal by Subject|2|||
23658302|NCT03496012|66136205|FG001|Overall Study|Withdrawal by Subject|0|||
23658303|NCT03496012|66136206|FG002|Overall Study|Withdrawal by Subject|2|||
23600855|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600856|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
23600857|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600858|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600859|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600860|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600861|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
23600862|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600863|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600864|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600865|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600866|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600867|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Death|1|||
23600868|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Death|2|||
23600869|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Death|0|||
23600870|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Death|1|||
23600871|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Death|0|||
23600872|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Death|0|||
23600873|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Death|0|||
23600874|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
23600875|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
23600876|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
23600877|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
23600878|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
23600879|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
23480526|NCT02186301|65502014|FG002|Overall Study|Physician Decision|1|||
23600880|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
23600881|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23600882|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
23600883|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23361956|NCT00547157|65069875|FG000|Overall Study|Withdrawal by Subject|3|||
23361957|NCT00547157|65069876|FG001|Overall Study|Withdrawal by Subject|1|||
23361958|NCT00547157|65069875|FG000|Overall Study|Administrative decision|3|||
23361959|NCT00547157|65069876|FG001|Overall Study|Administrative decision|2|||
23361960|NCT00547157|65069875|FG000|Overall Study|Lost to Follow-up|4|||
23361961|NCT00547157|65069876|FG001|Overall Study|Lost to Follow-up|2|||
23480527|NCT02186301|65502012|FG000|Overall Study|Study Terminated by Sponsor|1|||
23480528|NCT02186301|65502013|FG001|Overall Study|Study Terminated by Sponsor|0|||
23361962|NCT01556997|65069880|FG000|Overall Study|Adverse Event|10|||
23361963|NCT01556997|65069881|FG001|Overall Study|Adverse Event|12|||
23600884|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23480529|NCT02186301|65502014|FG002|Overall Study|Study Terminated by Sponsor|11|||
23361964|NCT01556997|65069882|FG002|Overall Study|Adverse Event|12|||
23361965|NCT01556997|65069880|FG000|Overall Study|Lost to Follow-up|6|||
23361966|NCT01556997|65069881|FG001|Overall Study|Lost to Follow-up|6|||
23361967|NCT01556997|65069882|FG002|Overall Study|Lost to Follow-up|4|||
23361968|NCT01556997|65069880|FG000|Overall Study|Physician Decision|1|||
23361969|NCT01556997|65069881|FG001|Overall Study|Physician Decision|1|||
23361970|NCT01556997|65069882|FG002|Overall Study|Physician Decision|1|||
23361971|NCT01556997|65069880|FG000|Overall Study|Withdrawal by Subject|7|||
23361972|NCT01556997|65069881|FG001|Overall Study|Withdrawal by Subject|6|||
23361973|NCT01556997|65069882|FG002|Overall Study|Withdrawal by Subject|8|||
23361974|NCT01556997|65069880|FG000|Overall Study|Other|2|||
23361975|NCT01556997|65069881|FG001|Overall Study|Other|3|||
23361976|NCT01556997|65069882|FG002|Overall Study|Other|7|||
23361977|NCT00571662|65069883|FG000|Overall Study|Withdrawal by Subject|2|||
23480530|NCT02186301|65502012|FG000|Overall Study|Protocol Deviation|0|||
23480531|NCT02186301|65502013|FG001|Overall Study|Protocol Deviation|2|||
23480532|NCT02186301|65502014|FG002|Overall Study|Protocol Deviation|0|||
23480533|NCT02186301|65502012|FG000|Overall Study|Missing|0|||
23480534|NCT02186301|65502013|FG001|Overall Study|Missing|0|||
23480535|NCT02186301|65502014|FG002|Overall Study|Missing|2|||
23480536|NCT02186301|65502012|FG000|Overall Study|Other|0|||
23480537|NCT02186301|65502013|FG001|Overall Study|Other|0|||
23480538|NCT02186301|65502014|FG002|Overall Study|Other|1|||
23480539|NCT00770146|65502015|FG000|Treatment Period|Withdrawal by Subject|6|||
23480540|NCT00770146|65502016|FG001|Treatment Period|Withdrawal by Subject|13|||
23480541|NCT00770146|65502015|FG000|Treatment Period|Adverse Event|2|||
23480542|NCT00770146|65502016|FG001|Treatment Period|Adverse Event|26|||
23480543|NCT00770146|65502015|FG000|Treatment Period|Other|1|||
23480544|NCT00770146|65502016|FG001|Treatment Period|Other|5|||
23480545|NCT00770146|65502015|FG000|Treatment Period|Protocol non-compliance|0|||
23480546|NCT00770146|65502016|FG001|Treatment Period|Protocol non-compliance|1|||
23480547|NCT00770146|65502015|FG000|Follow-up Period|Withdrawal by Subject|7|||
23480548|NCT00770146|65502016|FG001|Follow-up Period|Withdrawal by Subject|13|||
23480549|NCT00770146|65502015|FG000|Follow-up Period|Adverse Event|0|||
23480550|NCT00770146|65502016|FG001|Follow-up Period|Adverse Event|2|||
23480551|NCT00770146|65502015|FG000|Follow-up Period|Other|4|||
23480552|NCT00770146|65502016|FG001|Follow-up Period|Other|5|||
23480553|NCT03874429|65502017|FG000|Overall Study|Adverse Event|2|||
23480554|NCT03874429|65502018|FG001|Overall Study|Adverse Event|2|||
23480555|NCT03874429|65502017|FG000|Overall Study|Lack of Efficacy|0|||
23480556|NCT03874429|65502018|FG001|Overall Study|Lack of Efficacy|1|||
23600885|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23361978|NCT00571662|65069883|FG000|Overall Study|psychiatric instability|1|||
23361979|NCT00571662|65069883|FG000|Overall Study|Adverse Event|5|||
23480557|NCT03874429|65502017|FG000|Overall Study|Covid-19 pandemic|4|||
23480558|NCT03874429|65502018|FG001|Overall Study|Covid-19 pandemic|2|||
23361980|NCT03365934|65069884|FG000|Overall Study|Adverse Event|1|||
23361981|NCT03365934|65069884|FG000|Overall Study|Withdrawal by Subject|1|||
23480559|NCT02248675|65502020|FG000|Overall Study|Lost to Follow-up|3|||
23480560|NCT02248675|65502021|FG001|Overall Study|Lost to Follow-up|1|||
23480561|NCT00998764|65502022|FG000|Overall Study|Lack of Efficacy|3|||
23480562|NCT00998764|65502023|FG001|Overall Study|Lack of Efficacy|6|||
23480563|NCT00998764|65502022|FG000|Overall Study|Adverse Event|17|||
23361982|NCT02493517|65069885|FG000|Overall Study|Protocol Violation|1|||
23361983|NCT02493517|65069886|FG001|Overall Study|Protocol Violation|2|||
23361984|NCT02493517|65069885|FG000|Overall Study|Withdrawal by Subject|1|||
23361985|NCT02493517|65069886|FG001|Overall Study|Withdrawal by Subject|2|||
23361986|NCT02493517|65069885|FG000|Overall Study|Adverse Event|0|||
23361987|NCT02493517|65069886|FG001|Overall Study|Adverse Event|2|||
23361988|NCT02493517|65069885|FG000|Overall Study|Missed study visit|0|||
23361989|NCT02493517|65069886|FG001|Overall Study|Missed study visit|1|||
23361990|NCT02329327|65069888|FG000|Overall Study|Death|78|||
23361991|NCT02329327|65069889|FG001|Overall Study|Death|0|||
23361992|NCT02329327|65069888|FG000|Overall Study|Withdrawal by Subject|3|||
23361993|NCT02329327|65069889|FG001|Overall Study|Withdrawal by Subject|0|||
23361994|NCT02329327|65069888|FG000|Overall Study|Lost to Follow-up|4|||
23361995|NCT02329327|65069889|FG001|Overall Study|Lost to Follow-up|0|||
23361996|NCT05225389|65069891|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
23361997|NCT01854697|65069892|FG000|Overall Study|Adverse Event|1|||
23361998|NCT01854697|65069893|FG001|Overall Study|Adverse Event|0|||
23361999|NCT01854697|65069894|FG002|Overall Study|Adverse Event|0|||
23362000|NCT01854697|65069895|FG003|Overall Study|Adverse Event|0|||
23362001|NCT01854697|65069896|FG004|Overall Study|Adverse Event|1|||
23362002|NCT01854697|65069892|FG000|Overall Study|Lost to Follow-up|4|||
23362003|NCT01854697|65069893|FG001|Overall Study|Lost to Follow-up|1|||
23362004|NCT01854697|65069894|FG002|Overall Study|Lost to Follow-up|1|||
23362005|NCT01854697|65069895|FG003|Overall Study|Lost to Follow-up|2|||
23362006|NCT01854697|65069896|FG004|Overall Study|Lost to Follow-up|0|||
23362007|NCT01854697|65069892|FG000|Overall Study|To enter another AbbVie study|1|||
23362008|NCT01854697|65069893|FG001|Overall Study|To enter another AbbVie study|0|||
23362009|NCT01854697|65069894|FG002|Overall Study|To enter another AbbVie study|0|||
23362010|NCT01854697|65069895|FG003|Overall Study|To enter another AbbVie study|0|||
23362011|NCT01854697|65069896|FG004|Overall Study|To enter another AbbVie study|1|||
23362012|NCT01854697|65069892|FG000|Overall Study|Withdrew Consent|0|||
23362013|NCT01854697|65069893|FG001|Overall Study|Withdrew Consent|1|||
23362014|NCT01854697|65069894|FG002|Overall Study|Withdrew Consent|0|||
23362015|NCT01854697|65069895|FG003|Overall Study|Withdrew Consent|1|||
23362016|NCT01854697|65069896|FG004|Overall Study|Withdrew Consent|0|||
23362017|NCT01854697|65069892|FG000|Overall Study|Other|0|||
23362018|NCT01854697|65069893|FG001|Overall Study|Other|1|||
23362019|NCT01854697|65069894|FG002|Overall Study|Other|1|||
23362020|NCT01854697|65069895|FG003|Overall Study|Other|0|||
23362021|NCT01854697|65069896|FG004|Overall Study|Other|0|||
23362022|NCT01922258|65069897|FG000|Overall Study|Lost to Follow-up|1|||
23362023|NCT01922258|65069898|FG001|Overall Study|Lost to Follow-up|1|||
23362024|NCT01922258|65069897|FG000|Overall Study|Adverse Event|9|||
23362025|NCT01922258|65069898|FG001|Overall Study|Adverse Event|2|||
23362026|NCT01922258|65069897|FG000|Overall Study|Met Withdrawal Criteria|0|||
23362027|NCT01922258|65069898|FG001|Overall Study|Met Withdrawal Criteria|4|||
23362028|NCT01922258|65069897|FG000|Overall Study|Withdrawn by the Investigator|1|||
23362029|NCT01922258|65069898|FG001|Overall Study|Withdrawn by the Investigator|4|||
23658304|NCT03496012|66136204|FG000|Overall Study|Adverse Event|0|||
23362030|NCT01922258|65069897|FG000|Overall Study|Withdrawal by participant|5|||
23362031|NCT01922258|65069898|FG001|Overall Study|Withdrawal by participant|5|||
23362032|NCT03283930|65069899|FG000|Overall Study|Scheduling conflict|8|||
23362033|NCT03283930|65069900|FG001|Overall Study|Scheduling conflict|10|||
23362034|NCT03283930|65069899|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
23362035|NCT03283930|65069900|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
23362036|NCT03283930|65069899|FG000|Overall Study|Technical software issue|2|||
23362037|NCT03283930|65069900|FG001|Overall Study|Technical software issue|2|||
23362038|NCT01411319|65069901|FG000|Overall Study|Lost to Follow-up|1|||
23362039|NCT00762034|65069903|FG000|Induction Period|Protocol Violation|1|||
23480564|NCT00998764|65502023|FG001|Overall Study|Adverse Event|12|||
23362040|NCT00762034|65069904|FG001|Induction Period|Protocol Violation|2|||
23362041|NCT00762034|65069903|FG000|Induction Period|Entry Criterion Not Met|12|||
23658305|NCT03496012|66136205|FG001|Overall Study|Adverse Event|0|||
23658306|NCT03496012|66136206|FG002|Overall Study|Adverse Event|1|||
23658307|NCT03496012|66136204|FG000|Overall Study|Reason Not Specified|2|||
23658308|NCT03496012|66136205|FG001|Overall Study|Reason Not Specified|0|||
23658309|NCT03496012|66136206|FG002|Overall Study|Reason Not Specified|1|||
23658310|NCT03876171|66136209|FG000|Overall Study|Withdrawal by Subject|3|||
23658311|NCT03876171|66136210|FG001|Overall Study|Withdrawal by Subject|3|||
23362042|NCT00762034|65069904|FG001|Induction Period|Entry Criterion Not Met|11|||
23658312|NCT03876171|66136209|FG000|Overall Study|Re-arrest|0|||
23362043|NCT00762034|65069903|FG000|Induction Period|Adverse Event|27|||
23362044|NCT00762034|65069904|FG001|Induction Period|Adverse Event|38|||
23362045|NCT00762034|65069903|FG000|Induction Period|Lost to Follow-up|1|||
23362046|NCT00762034|65069904|FG001|Induction Period|Lost to Follow-up|1|||
23658313|NCT03876171|66136210|FG001|Overall Study|Re-arrest|4|||
23658314|NCT03065023|66136211|FG000|Overall Study|Progressive Disease|0|||
23362047|NCT00762034|65069903|FG000|Induction Period|Progressive Disease|73|||
23362048|NCT00762034|65069904|FG001|Induction Period|Progressive Disease|55|||
23658315|NCT03065023|66136212|FG001|Overall Study|Progressive Disease|1|||
23658316|NCT03065023|66136213|FG002|Overall Study|Progressive Disease|0|||
23658317|NCT03065023|66136214|FG003|Overall Study|Progressive Disease|0|||
23658318|NCT03065023|66136215|FG004|Overall Study|Progressive Disease|0|||
23658319|NCT03065023|66136211|FG000|Overall Study|Death|2|||
23658320|NCT03065023|66136212|FG001|Overall Study|Death|0|||
23658321|NCT03065023|66136213|FG002|Overall Study|Death|1|||
23658322|NCT03065023|66136214|FG003|Overall Study|Death|1|||
23658323|NCT03065023|66136215|FG004|Overall Study|Death|0|||
23658324|NCT03065023|66136211|FG000|Overall Study|Lost to Follow-up|0|||
23658325|NCT03065023|66136212|FG001|Overall Study|Lost to Follow-up|1|||
23658326|NCT03065023|66136213|FG002|Overall Study|Lost to Follow-up|0|||
23658327|NCT03065023|66136214|FG003|Overall Study|Lost to Follow-up|0|||
23658328|NCT03065023|66136215|FG004|Overall Study|Lost to Follow-up|0|||
23658329|NCT03065023|66136211|FG000|Overall Study|Participant Decision|0|||
23658330|NCT03065023|66136212|FG001|Overall Study|Participant Decision|0|||
23658331|NCT03065023|66136213|FG002|Overall Study|Participant Decision|0|||
23658332|NCT03065023|66136214|FG003|Overall Study|Participant Decision|1|||
23658333|NCT03065023|66136215|FG004|Overall Study|Participant Decision|0|||
23658334|NCT03065023|66136211|FG000|Overall Study|Withdrawal by Subject|0|||
23658335|NCT03065023|66136212|FG001|Overall Study|Withdrawal by Subject|0|||
23658336|NCT03065023|66136213|FG002|Overall Study|Withdrawal by Subject|0|||
23658337|NCT03065023|66136214|FG003|Overall Study|Withdrawal by Subject|1|||
23658338|NCT03065023|66136215|FG004|Overall Study|Withdrawal by Subject|0|||
23658339|NCT02710136|66136216|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
23658340|NCT02710136|66136217|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
23658341|NCT03047551|66136218|FG000|Overall Study|Did not receive TAS|1|||
23658342|NCT03047551|66136219|FG001|Overall Study|Did not receive TAS|0|||
23658343|NCT03047551|66136218|FG000|Overall Study|Physician Decision|1|||
23658344|NCT03047551|66136219|FG001|Overall Study|Physician Decision|0|||
23658345|NCT03047551|66136218|FG000|Overall Study|Withdrawal by Subject|0|||
23658346|NCT03047551|66136219|FG001|Overall Study|Withdrawal by Subject|1|||
23658347|NCT03047551|66136218|FG000|Overall Study|Probe malfunction|0|||
23658348|NCT03047551|66136219|FG001|Overall Study|Probe malfunction|1|||
23658349|NCT03047551|66136218|FG000|Overall Study|Ineligible|0|||
23658350|NCT03047551|66136219|FG001|Overall Study|Ineligible|1|||
23658351|NCT00436618|66136223|FG000|Overall Study|Withdrawal by Subject|5|||
23658352|NCT00436618|66136224|FG001|Overall Study|Withdrawal by Subject|8|||
23658353|NCT00436618|66136225|FG002|Overall Study|Withdrawal by Subject|11|||
23807348|NCT02091141|66672746|FG003|Overall Study|Reason Not Specified|0|||
23807349|NCT02091141|66672747|FG004|Overall Study|Reason Not Specified|0|||
23807350|NCT02091141|66672748|FG005|Overall Study|Reason Not Specified|0|||
23807351|NCT02091141|66672749|FG006|Overall Study|Reason Not Specified|1|||
23807352|NCT02091141|66672743|FG000|Overall Study|Study Ended by Sponsor|1|||
23807353|NCT02091141|66672744|FG001|Overall Study|Study Ended by Sponsor|9|||
23807354|NCT02091141|66672745|FG002|Overall Study|Study Ended by Sponsor|0|||
23807355|NCT02091141|66672746|FG003|Overall Study|Study Ended by Sponsor|0|||
23807356|NCT02091141|66672747|FG004|Overall Study|Study Ended by Sponsor|0|||
23807357|NCT02091141|66672748|FG005|Overall Study|Study Ended by Sponsor|0|||
23807358|NCT02091141|66672749|FG006|Overall Study|Study Ended by Sponsor|0|||
23807359|NCT02091141|66672743|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807360|NCT02091141|66672744|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
23807361|NCT02091141|66672745|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807362|NCT02091141|66672746|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807363|NCT02091141|66672747|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807364|NCT02091141|66672748|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807365|NCT02091141|66672749|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
23807366|NCT00974974|66672750|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
23807367|NCT00974974|66672751|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
23807368|NCT00974974|66672750|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
23362049|NCT00762034|65069903|FG000|Induction Period|Physician Decision|21|||
23362050|NCT00762034|65069904|FG001|Induction Period|Physician Decision|20|||
23600886|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23600887|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23600888|NCT02234141|65929767|FG000|Long-Term Treatment Period|Death|0|||
23600889|NCT02234141|65929768|FG001|Long-Term Treatment Period|Death|0|||
23600890|NCT02234141|65929769|FG002|Long-Term Treatment Period|Death|0|||
23600891|NCT02234141|65929770|FG003|Long-Term Treatment Period|Death|0|||
23600892|NCT02234141|65929771|FG004|Long-Term Treatment Period|Death|0|||
23600893|NCT02234141|65929772|FG005|Long-Term Treatment Period|Death|1|||
23600894|NCT02234141|65929773|FG006|Long-Term Treatment Period|Death|0|||
23600895|NCT02234141|65929767|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
23600896|NCT02234141|65929768|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
23600897|NCT02234141|65929769|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
23600898|NCT02234141|65929770|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
23600899|NCT02234141|65929771|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
23600900|NCT02234141|65929772|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
23600901|NCT02234141|65929773|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
23658354|NCT00436618|66136223|FG000|Overall Study|Adverse Event|8|||
23362051|NCT00762034|65069903|FG000|Induction Period|Withdrawal by Subject|15|||
23362052|NCT00762034|65069904|FG001|Induction Period|Withdrawal by Subject|19|||
23362053|NCT00762034|65069903|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
23362054|NCT00762034|65069904|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
23362055|NCT00762034|65069903|FG000|Induction Period|Deaths Due to Study Disease|9|||
23362056|NCT00762034|65069904|FG001|Induction Period|Deaths Due to Study Disease|9|||
23362057|NCT00762034|65069903|FG000|Maintenance Period|Protocol Violation|1|||
23362058|NCT00762034|65069904|FG001|Maintenance Period|Protocol Violation|3|||
23362059|NCT00762034|65069903|FG000|Maintenance Period|Entry Criterion Not Met|0|||
23362060|NCT00762034|65069904|FG001|Maintenance Period|Entry Criterion Not Met|2|||
23362061|NCT00762034|65069903|FG000|Maintenance Period|Adverse Event|42|||
23362062|NCT00762034|65069904|FG001|Maintenance Period|Adverse Event|26|||
23362063|NCT00762034|65069903|FG000|Maintenance Period|Progressive Disease|186|||
23362064|NCT00762034|65069904|FG001|Maintenance Period|Progressive Disease|224|||
23362065|NCT00762034|65069903|FG000|Maintenance Period|Physician Decision|25|||
23362066|NCT00762034|65069904|FG001|Maintenance Period|Physician Decision|20|||
23362067|NCT00762034|65069903|FG000|Maintenance Period|Withdrawal by Subject|34|||
23362068|NCT00762034|65069904|FG001|Maintenance Period|Withdrawal by Subject|14|||
23362069|NCT00762034|65069903|FG000|Maintenance Period|Death not due to study disease|2|||
23362070|NCT00762034|65069904|FG001|Maintenance Period|Death not due to study disease|5|||
23362071|NCT00762034|65069903|FG000|Maintenance Period|Death due to study disease|3|||
23362072|NCT00762034|65069904|FG001|Maintenance Period|Death due to study disease|3|||
23362073|NCT00762034|65069903|FG000|Maintenance Period|Other|1|||
23362074|NCT00762034|65069904|FG001|Maintenance Period|Other|1|||
23362075|NCT00707980|65069906|FG000|Overall Study|Adverse Event|49|||
23362076|NCT00707980|65069906|FG000|Overall Study|Lack of Efficacy|35|||
23362077|NCT00707980|65069906|FG000|Overall Study|Non-Compliance with Study Drug|28|||
23362078|NCT00707980|65069906|FG000|Overall Study|Protocol Deviations|19|||
23362079|NCT00707980|65069906|FG000|Overall Study|Withdrawal of Consent|81|||
23362080|NCT00707980|65069906|FG000|Overall Study|Lost to Follow-up|59|||
23362081|NCT00707980|65069906|FG000|Overall Study|Other|39|||
23362082|NCT00549549|65069907|FG000|Overall Study|Adverse Event|5|||
23362083|NCT00549549|65069908|FG001|Overall Study|Adverse Event|3|||
23362084|NCT00549549|65069909|FG002|Overall Study|Adverse Event|1|||
23362085|NCT00549549|65069910|FG003|Overall Study|Adverse Event|9|||
23362086|NCT00549549|65069907|FG000|Overall Study|Lack of Efficacy|9|||
23362087|NCT00549549|65069908|FG001|Overall Study|Lack of Efficacy|6|||
23362088|NCT00549549|65069909|FG002|Overall Study|Lack of Efficacy|4|||
23362089|NCT00549549|65069910|FG003|Overall Study|Lack of Efficacy|2|||
23362090|NCT00549549|65069907|FG000|Overall Study|Lost to Follow-up|1|||
23362091|NCT00549549|65069908|FG001|Overall Study|Lost to Follow-up|0|||
23362092|NCT00549549|65069909|FG002|Overall Study|Lost to Follow-up|1|||
23362093|NCT00549549|65069910|FG003|Overall Study|Lost to Follow-up|2|||
23362094|NCT00549549|65069907|FG000|Overall Study|Withdrawal by Subject|0|||
23362095|NCT00549549|65069908|FG001|Overall Study|Withdrawal by Subject|4|||
23362096|NCT00549549|65069909|FG002|Overall Study|Withdrawal by Subject|1|||
23362097|NCT00549549|65069910|FG003|Overall Study|Withdrawal by Subject|0|||
23362098|NCT00549549|65069907|FG000|Overall Study|Other|9|||
23362099|NCT00549549|65069908|FG001|Overall Study|Other|9|||
23362100|NCT00549549|65069909|FG002|Overall Study|Other|9|||
23362101|NCT00549549|65069910|FG003|Overall Study|Other|11|||
23362102|NCT00549549|65069907|FG000|Overall Study|Randomized but not treated|0|||
23362103|NCT00549549|65069908|FG001|Overall Study|Randomized but not treated|0|||
23362104|NCT00549549|65069909|FG002|Overall Study|Randomized but not treated|1|||
23362105|NCT00549549|65069910|FG003|Overall Study|Randomized but not treated|1|||
23362106|NCT00807612|65069913|FG000|Overall Study|Death|8|||
23362107|NCT00807612|65069913|FG000|Overall Study|Study early termination|5|||
23362108|NCT00807612|65069913|FG000|Overall Study|Withdrawal by Subject|1|||
23362109|NCT02019550|65069915|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23362110|NCT02019550|65069916|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23362111|NCT01473940|65069917|FG000|Induction Therapy|Death|0|||
23362112|NCT01473940|65069918|FG001|Induction Therapy|Death|0|||
23362113|NCT01473940|65069919|FG002|Induction Therapy|Death|1|||
23362114|NCT01473940|65069920|FG003|Induction Therapy|Death|1|||
23362115|NCT01473940|65069917|FG000|Induction Therapy|Progressive Disease|0|||
23362116|NCT01473940|65069918|FG001|Induction Therapy|Progressive Disease|1|||
23362117|NCT01473940|65069919|FG002|Induction Therapy|Progressive Disease|1|||
23362118|NCT01473940|65069920|FG003|Induction Therapy|Progressive Disease|0|||
23362119|NCT01473940|65069917|FG000|Maintenance Therapy|Progressive Disease|1|||
23362120|NCT01473940|65069918|FG001|Maintenance Therapy|Progressive Disease|2|||
23362121|NCT01473940|65069919|FG002|Maintenance Therapy|Progressive Disease|1|||
23362122|NCT01473940|65069920|FG003|Maintenance Therapy|Progressive Disease|4|||
23362123|NCT02256839|65072726|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
23362124|NCT02256839|65072727|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
23362125|NCT01951417|65072728|FG000|Overall Study|Withdrawal by Subject|1|||
23362126|NCT01951417|65072728|FG000|Overall Study|Protocol Violation|2|||
23362127|NCT01951417|65072728|FG000|Overall Study|Lost to Follow-up|6|||
23362128|NCT02143024|65072733|FG000|Overall Study|Lost to Follow-up|1|||
23362129|NCT02143024|65072734|FG001|Overall Study|Lost to Follow-up|1|||
23362130|NCT02143024|65072733|FG000|Overall Study|Withdrawal by Subject|1|||
23362131|NCT02143024|65072734|FG001|Overall Study|Withdrawal by Subject|0|||
23362132|NCT02317991|65072736|FG000|Overall Study|Adverse Event|12|||
23362133|NCT02317991|65072736|FG000|Overall Study|Death|4|||
23362134|NCT02317991|65072736|FG000|Overall Study|Withdrawal by Subject|8|||
23362135|NCT02317991|65072736|FG000|Overall Study|Progressive Disease|41|||
23362136|NCT00482170|65072737|FG000|Overall Study|Adverse Event|5|||
23362137|NCT00482170|65072738|FG001|Overall Study|Adverse Event|14|||
23362138|NCT00482170|65072737|FG000|Overall Study|Withdrawal by Subject|6|||
23362139|NCT00482170|65072738|FG001|Overall Study|Withdrawal by Subject|1|||
23362140|NCT00482170|65072737|FG000|Overall Study|Protocol Violation|2|||
23362141|NCT00482170|65072738|FG001|Overall Study|Protocol Violation|3|||
23362142|NCT00482170|65072737|FG000|Overall Study|Lost to Follow-up|2|||
23362143|NCT00482170|65072738|FG001|Overall Study|Lost to Follow-up|0|||
23362144|NCT00482170|65072737|FG000|Overall Study|Unspecified reason|0|||
23362145|NCT00482170|65072738|FG001|Overall Study|Unspecified reason|2|||
23658355|NCT00436618|66136224|FG001|Overall Study|Adverse Event|8|||
23362146|NCT01051817|65072739|FG000|Overall Study|Adverse Event|0|||
23362147|NCT01051817|65072740|FG001|Overall Study|Adverse Event|2|||
23362148|NCT01051817|65072739|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
23362149|NCT01051817|65072740|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
23362150|NCT01051817|65072739|FG000|Overall Study|Withdrawal by Subject|3|||
23362151|NCT01051817|65072740|FG001|Overall Study|Withdrawal by Subject|5|||
23362152|NCT01051817|65072739|FG000|Overall Study|Protocol Violation|0|||
23362153|NCT01051817|65072740|FG001|Overall Study|Protocol Violation|1|||
23362154|NCT00227539|65072742|FG000|Overall Study|Protocol Violation|1|||
23362155|NCT03421379|65072743|FG000|Period 1|Withdrawal by Subject|0|||
23362156|NCT03421379|65072744|FG001|Period 1|Withdrawal by Subject|1|||
23362157|NCT03421379|65072743|FG000|Period 1|Physician Decision|1|||
23362158|NCT03421379|65072744|FG001|Period 1|Physician Decision|1|||
23362159|NCT03421379|65072743|FG000|Period 1|Did not receive treatment|1|||
23362160|NCT03421379|65072744|FG001|Period 1|Did not receive treatment|2|||
23362161|NCT01302418|65072749|FG000|Overall Study|Protocol Violation|9|||
23362162|NCT01302418|65072749|FG000|Overall Study|Non-evaluable|9|||
23362163|NCT01419535|65072755|FG000|Overall Study|could not maintain iv line|1|||
23362164|NCT01419535|65072756|FG001|Overall Study|could not maintain iv line|1|||
23362165|NCT01419535|65072755|FG000|Overall Study|Withdrawal by Subject|0|||
23658356|NCT00436618|66136225|FG002|Overall Study|Adverse Event|9|||
23658357|NCT00436618|66136223|FG000|Overall Study|Alternate Treatment|3|||
23658358|NCT00436618|66136224|FG001|Overall Study|Alternate Treatment|4|||
23658359|NCT00436618|66136225|FG002|Overall Study|Alternate Treatment|12|||
23658360|NCT00436618|66136223|FG000|Overall Study|Other Medical Problems|3|||
23658361|NCT00436618|66136224|FG001|Overall Study|Other Medical Problems|1|||
23658362|NCT00436618|66136225|FG002|Overall Study|Other Medical Problems|7|||
23658363|NCT00436618|66136223|FG000|Overall Study|Death|4|||
23658364|NCT00436618|66136224|FG001|Overall Study|Death|2|||
23658365|NCT00436618|66136225|FG002|Overall Study|Death|3|||
23362166|NCT01419535|65072756|FG001|Overall Study|Withdrawal by Subject|1|||
23362167|NCT00766597|65072759|FG000|Overall Study|Unexpected closure of study|4|||
23658366|NCT00436618|66136223|FG000|Overall Study|New Primary or Other Reasons|6|||
23658367|NCT00436618|66136224|FG001|Overall Study|New Primary or Other Reasons|2|||
23658368|NCT00436618|66136225|FG002|Overall Study|New Primary or Other Reasons|12|||
23658369|NCT00436618|66136223|FG000|Overall Study|Still on treatment|1|||
23658370|NCT00436618|66136224|FG001|Overall Study|Still on treatment|2|||
23658371|NCT00436618|66136225|FG002|Overall Study|Still on treatment|7|||
23658372|NCT01069172|66136226|FG000|Overall Study|Withdrawal by Subject|1|||
23362168|NCT00766597|65072759|FG000|Overall Study|Without CCR5-tropic virus|5|||
23362169|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23362170|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23362171|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23362172|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23362173|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23362174|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Adverse Event|1|||
23362175|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
23362176|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
23362177|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
23362178|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
23362179|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
23362180|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
23362181|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Other Reasons|2|||
23362182|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Other Reasons|0|||
23362183|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Other Reasons|0|||
23362184|NCT04613518|65072764|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
23362185|NCT04613518|65072765|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
23362186|NCT04613518|65072766|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23362187|NCT04613518|65072764|FG000|Open-Label Treatment Period|Adverse Event|1|||
23362188|NCT04613518|65072765|FG001|Open-Label Treatment Period|Adverse Event|0|||
23362189|NCT04613518|65072766|FG002|Open-Label Treatment Period|Adverse Event|3|||
23362190|NCT04613518|65072764|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
23362191|NCT04613518|65072765|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
23362192|NCT04613518|65072766|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
23362193|NCT04613518|65072764|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
23362194|NCT04613518|65072765|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
23362195|NCT04613518|65072766|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
23362196|NCT04613518|65072764|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
23362197|NCT04613518|65072765|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
23362198|NCT04613518|65072766|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
23362199|NCT04613518|65072764|FG000|Open-Label Treatment Period|Other reasons|1|||
23362200|NCT04613518|65072765|FG001|Open-Label Treatment Period|Other reasons|0|||
23362201|NCT04613518|65072766|FG002|Open-Label Treatment Period|Other reasons|0|||
23362202|NCT00588146|65072767|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
23362203|NCT00588146|65072768|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
23362204|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
23362205|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
23362206|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
23362207|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
23362208|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
23362209|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
23362210|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
23362211|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
23362212|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
23600902|NCT02234141|65929767|FG000|Long-Term Treatment Period|Adverse Event|4|||
23600903|NCT02234141|65929768|FG001|Long-Term Treatment Period|Adverse Event|0|||
23600904|NCT02234141|65929769|FG002|Long-Term Treatment Period|Adverse Event|5|||
23600905|NCT02234141|65929770|FG003|Long-Term Treatment Period|Adverse Event|0|||
23600906|NCT02234141|65929771|FG004|Long-Term Treatment Period|Adverse Event|1|||
23600907|NCT02234141|65929772|FG005|Long-Term Treatment Period|Adverse Event|1|||
23600908|NCT02234141|65929773|FG006|Long-Term Treatment Period|Adverse Event|1|||
23600909|NCT02234141|65929767|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
23658373|NCT01069172|66136227|FG001|Overall Study|Withdrawal by Subject|0|||
23658374|NCT01306890|66136228|FG000|Overall Study|Adverse Event|2|||
23658375|NCT01306890|66136228|FG000|Overall Study|Death|1223|||
23658376|NCT01306890|66136228|FG000|Overall Study|Lost to Follow-up|58|||
23658377|NCT01306890|66136228|FG000|Overall Study|Withdrawal by Subject|88|||
23658378|NCT01306890|66136228|FG000|Overall Study|Unspecified reasons|104|||
23658379|NCT01306890|66136228|FG000|Overall Study|Study Termination|3|||
23658380|NCT01306890|66136228|FG000|Overall Study|No discontinuation documentation|41|||
23658381|NCT00418665|66136231|FG000|Treatment Period|Ineligibility determined|1|||
23658382|NCT00418665|66136232|FG001|Treatment Period|Ineligibility determined|1|||
23658383|NCT00418665|66136233|FG002|Treatment Period|Ineligibility determined|0|||
23658384|NCT00418665|66136231|FG000|Treatment Period|Adverse Event|2|||
23658385|NCT00418665|66136232|FG001|Treatment Period|Adverse Event|2|||
23658386|NCT00418665|66136233|FG002|Treatment Period|Adverse Event|0|||
23658387|NCT00418665|66136231|FG000|Treatment Period|Withdrawal by Subject|0|||
23658388|NCT00418665|66136232|FG001|Treatment Period|Withdrawal by Subject|3|||
23658389|NCT00418665|66136233|FG002|Treatment Period|Withdrawal by Subject|1|||
23658390|NCT00418665|66136231|FG000|Treatment Period|Requirement for alternative therapy|1|||
23658391|NCT00418665|66136232|FG001|Treatment Period|Requirement for alternative therapy|0|||
23658392|NCT00418665|66136233|FG002|Treatment Period|Requirement for alternative therapy|0|||
23658393|NCT00418665|66136231|FG000|Treatment Period|Physician Decision|1|||
23658394|NCT00418665|66136232|FG001|Treatment Period|Physician Decision|0|||
23658395|NCT00418665|66136233|FG002|Treatment Period|Physician Decision|3|||
23658396|NCT00418665|66136231|FG000|Treatment Extension|Adverse Event|1|||
23658397|NCT00418665|66136232|FG001|Treatment Extension|Adverse Event|0|||
23658398|NCT00418665|66136233|FG002|Treatment Extension|Adverse Event|0|||
23658399|NCT00418665|66136231|FG000|Treatment Extension|Withdrawal by Subject|1|||
23658400|NCT00418665|66136232|FG001|Treatment Extension|Withdrawal by Subject|0|||
23658401|NCT00418665|66136233|FG002|Treatment Extension|Withdrawal by Subject|0|||
23658402|NCT00418665|66136231|FG000|Treatment Extension|Requirement for alternative therapy|2|||
23658403|NCT00418665|66136232|FG001|Treatment Extension|Requirement for alternative therapy|2|||
23658404|NCT00418665|66136233|FG002|Treatment Extension|Requirement for alternative therapy|0|||
23658405|NCT00418665|66136231|FG000|Treatment Extension|Physician Decision|2|||
23658406|NCT00418665|66136232|FG001|Treatment Extension|Physician Decision|2|||
23658407|NCT00418665|66136233|FG002|Treatment Extension|Physician Decision|1|||
23658408|NCT00418665|66136231|FG000|Treatment Extension|Death|0|||
23658409|NCT00418665|66136232|FG001|Treatment Extension|Death|0|||
23658410|NCT00418665|66136233|FG002|Treatment Extension|Death|1|||
23658411|NCT01195545|66136234|FG000|Overall Study|Protocol Violation|4|||
23658412|NCT02247960|66136235|FG000|Patient Consent and Randomization|Physician Decision|2|||
23658413|NCT02247960|66136236|FG001|Patient Consent and Randomization|Physician Decision|2|||
23658414|NCT02247960|66136235|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
23658415|NCT02247960|66136236|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
23658416|NCT02247960|66136235|FG000|Catheter Removed|Lost to Follow-up|7|||
23658417|NCT02247960|66136236|FG001|Catheter Removed|Lost to Follow-up|10|||
23658418|NCT00786565|66136243|FG000|Enrollment Prior to Surgery|Site Closed|3|||
23658419|NCT00786565|66136243|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
23658420|NCT00786565|66136243|FG000|Post Surgery|Abnormal macular pucker|1|||
23658421|NCT00786565|66136243|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
23658422|NCT03427125|66136247|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
23658423|NCT03427125|66136248|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
23658424|NCT03427125|66136249|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
23658425|NCT00607880|66136259|FG000|Overall Study|Unable to place port due to occlusion|1|||
23658426|NCT00607880|66136260|FG001|Overall Study|Unable to place port due to occlusion|0|||
23658427|NCT02281357|66136261|FG000|Overall Study|Adverse Event|2|||
23658428|NCT02281357|66136262|FG001|Overall Study|Adverse Event|1|||
23658429|NCT02281357|66136261|FG000|Overall Study|Lost to Follow-up|1|||
23658430|NCT02281357|66136262|FG001|Overall Study|Lost to Follow-up|0|||
23600910|NCT02234141|65929768|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
23600911|NCT02234141|65929769|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
23600912|NCT02234141|65929770|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
23600913|NCT02234141|65929771|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
23600914|NCT02234141|65929772|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
23600915|NCT02234141|65929773|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
23600916|NCT02234141|65929767|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
23600917|NCT02234141|65929768|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
23658431|NCT02281357|66136261|FG000|Overall Study|Withdrawal by Subject|4|||
23658432|NCT02281357|66136262|FG001|Overall Study|Withdrawal by Subject|3|||
23658433|NCT01132612|66136263|FG000|Overall Study|Death|0|||
23480565|NCT00998764|65502022|FG000|Overall Study|Withdrawal by Subject|19|||
23600918|NCT02234141|65929769|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
23600919|NCT02234141|65929770|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
23658434|NCT01132612|66136264|FG001|Overall Study|Death|0|||
23658435|NCT01132612|66136265|FG002|Overall Study|Death|1|||
23658436|NCT01132612|66136263|FG000|Overall Study|Protocol deviation|0|||
23658437|NCT01132612|66136264|FG001|Overall Study|Protocol deviation|0|||
23658438|NCT01132612|66136265|FG002|Overall Study|Protocol deviation|3|||
23658439|NCT01132612|66136263|FG000|Overall Study|Lost to Follow-up|2|||
23658440|NCT01132612|66136264|FG001|Overall Study|Lost to Follow-up|2|||
23362213|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
23362214|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
23362215|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
23362216|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
23362217|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
23362218|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
23362219|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
23362220|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
23362221|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
23362222|NCT01971567|65072779|FG000|Overall Study|Withdrawal by Subject|3|||
23362223|NCT01971567|65072780|FG001|Overall Study|Withdrawal by Subject|2|||
23362224|NCT01971567|65072779|FG000|Overall Study|Lost to Follow-up|1|||
23362225|NCT01971567|65072780|FG001|Overall Study|Lost to Follow-up|0|||
23362226|NCT02710084|65072781|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
23362227|NCT02710084|65072782|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
23362228|NCT00485069|65072784|FG000|Overall Study|Adverse Event|10|||
23362229|NCT00485069|65072785|FG001|Overall Study|Adverse Event|4|||
23362230|NCT00485069|65072784|FG000|Overall Study|Lack of Efficacy|2|||
23362231|NCT00485069|65072785|FG001|Overall Study|Lack of Efficacy|1|||
23362232|NCT00485069|65072784|FG000|Overall Study|Protocol Violation|0|||
23362233|NCT00485069|65072785|FG001|Overall Study|Protocol Violation|1|||
23362234|NCT00485069|65072784|FG000|Overall Study|Withdrawal by Subject|6|||
23362235|NCT00485069|65072785|FG001|Overall Study|Withdrawal by Subject|6|||
23362236|NCT00169104|65072786|FG000|Overall Study|Withdrawal by Subject|2|||
23362237|NCT00169104|65072787|FG001|Overall Study|Withdrawal by Subject|0|||
23362238|NCT00169104|65072786|FG000|Overall Study|Protocol Violation|0|||
23362239|NCT00169104|65072787|FG001|Overall Study|Protocol Violation|1|||
23362240|NCT00169104|65072786|FG000|Overall Study|Physician Decision|0|||
23362241|NCT00169104|65072787|FG001|Overall Study|Physician Decision|1|||
23362242|NCT02250300|65072788|FG000|Expansion Phase|Death|6|||
23362243|NCT02250300|65072789|FG001|Expansion Phase|Death|7|||
23362244|NCT02250300|65072790|FG002|Expansion Phase|Death|0|||
23362245|NCT02250300|65072791|FG003|Expansion Phase|Death|0|||
23362246|NCT02959918|65072792|FG000|Overall Study|Adverse Event|1|||
23362247|NCT02959918|65072793|FG001|Overall Study|Adverse Event|1|||
23362248|NCT02959918|65072794|FG002|Overall Study|Adverse Event|2|||
23362249|NCT02959918|65072795|FG003|Overall Study|Adverse Event|0|||
23362250|NCT02959918|65072796|FG004|Overall Study|Adverse Event|0|||
23362251|NCT02959918|65072797|FG005|Overall Study|Adverse Event|2|||
23362252|NCT02959918|65072798|FG006|Overall Study|Adverse Event|2|||
23362253|NCT02959918|65072799|FG007|Overall Study|Adverse Event|1|||
23362254|NCT02959918|65072800|FG008|Overall Study|Adverse Event|2|||
23362255|NCT02959918|65072801|FG009|Overall Study|Adverse Event|1|||
23362256|NCT02959918|65072802|FG010|Overall Study|Adverse Event|1|||
23362257|NCT02959918|65072803|FG011|Overall Study|Adverse Event|3|||
23362258|NCT02959918|65072804|FG012|Overall Study|Adverse Event|2|||
23362259|NCT02959918|65072805|FG013|Overall Study|Adverse Event|4|||
23600920|NCT02234141|65929771|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
23600921|NCT02234141|65929772|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
23600922|NCT02234141|65929773|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
23600923|NCT00463229|65929774|FG000|Overall Study|Lost to Follow-up|5|||
23600924|NCT00463229|65929775|FG001|Overall Study|Lost to Follow-up|7|||
23600925|NCT00463229|65929774|FG000|Overall Study|Death|4|||
23600926|NCT00463229|65929775|FG001|Overall Study|Death|3|||
23600927|NCT00109031|65929776|FG000|Overall Study|Adverse Event|0|||
23600928|NCT00109031|65929777|FG001|Overall Study|Adverse Event|0|||
23362260|NCT02959918|65072792|FG000|Overall Study|Lost to Follow-up|0|||
23600929|NCT00109031|65929778|FG002|Overall Study|Adverse Event|1|||
23600930|NCT00109031|65929779|FG003|Overall Study|Adverse Event|0|||
23600931|NCT00109031|65929776|FG000|Overall Study|Withdrawal by Subject|0|||
23658441|NCT01132612|66136265|FG002|Overall Study|Lost to Follow-up|7|||
23362261|NCT02959918|65072793|FG001|Overall Study|Lost to Follow-up|0|||
23600932|NCT00109031|65929777|FG001|Overall Study|Withdrawal by Subject|1|||
23600933|NCT00109031|65929778|FG002|Overall Study|Withdrawal by Subject|0|||
23600934|NCT00109031|65929779|FG003|Overall Study|Withdrawal by Subject|0|||
23600935|NCT00109031|65929776|FG000|Overall Study|Physician Decision|0|||
23362262|NCT02959918|65072794|FG002|Overall Study|Lost to Follow-up|0|||
23600936|NCT00109031|65929777|FG001|Overall Study|Physician Decision|1|||
23600937|NCT00109031|65929778|FG002|Overall Study|Physician Decision|0|||
23600938|NCT00109031|65929779|FG003|Overall Study|Physician Decision|0|||
23600939|NCT00109031|65929776|FG000|Overall Study|Protocol Violation|0|||
23600940|NCT00109031|65929777|FG001|Overall Study|Protocol Violation|0|||
23600941|NCT00109031|65929778|FG002|Overall Study|Protocol Violation|1|||
23600942|NCT00109031|65929779|FG003|Overall Study|Protocol Violation|0|||
23600943|NCT03547167|65929780|FG000|Overall Study|Withdrawal by Subject|34|||
23600944|NCT03547167|65929781|FG001|Overall Study|Withdrawal by Subject|12|||
23600945|NCT03547167|65929780|FG000|Overall Study|Screen Failure|0|||
23600946|NCT03547167|65929781|FG001|Overall Study|Screen Failure|1|||
23600947|NCT03547167|65929780|FG000|Overall Study|Lost to Follow-up|59|||
23600948|NCT03547167|65929781|FG001|Overall Study|Lost to Follow-up|15|||
23600949|NCT03547167|65929780|FG000|Overall Study|Death|4|||
23600950|NCT03547167|65929781|FG001|Overall Study|Death|2|||
23600951|NCT01673594|65929790|FG000|Overall Study|Adverse Event|3|||
23600952|NCT01673594|65929791|FG001|Overall Study|Adverse Event|1|||
23362263|NCT02959918|65072795|FG003|Overall Study|Lost to Follow-up|0|||
23600953|NCT01673594|65929790|FG000|Overall Study|Lost to Follow-up|1|||
23600954|NCT01673594|65929791|FG001|Overall Study|Lost to Follow-up|0|||
23600955|NCT01673594|65929790|FG000|Overall Study|Physician Decision|2|||
23362264|NCT02959918|65072796|FG004|Overall Study|Lost to Follow-up|0|||
23362265|NCT02959918|65072797|FG005|Overall Study|Lost to Follow-up|0|||
23362266|NCT02959918|65072798|FG006|Overall Study|Lost to Follow-up|0|||
23362267|NCT02959918|65072799|FG007|Overall Study|Lost to Follow-up|0|||
23362268|NCT02959918|65072800|FG008|Overall Study|Lost to Follow-up|0|||
23362269|NCT02959918|65072801|FG009|Overall Study|Lost to Follow-up|1|||
23362270|NCT02959918|65072802|FG010|Overall Study|Lost to Follow-up|0|||
23362271|NCT02959918|65072803|FG011|Overall Study|Lost to Follow-up|0|||
23362272|NCT02959918|65072804|FG012|Overall Study|Lost to Follow-up|1|||
23362273|NCT02959918|65072805|FG013|Overall Study|Lost to Follow-up|0|||
23362274|NCT02959918|65072792|FG000|Overall Study|Withdrawal by Subject|0|||
23362275|NCT02959918|65072793|FG001|Overall Study|Withdrawal by Subject|0|||
23362276|NCT02959918|65072794|FG002|Overall Study|Withdrawal by Subject|1|||
23362277|NCT02959918|65072795|FG003|Overall Study|Withdrawal by Subject|2|||
23362278|NCT02959918|65072796|FG004|Overall Study|Withdrawal by Subject|0|||
23362279|NCT02959918|65072797|FG005|Overall Study|Withdrawal by Subject|0|||
23362280|NCT02959918|65072798|FG006|Overall Study|Withdrawal by Subject|1|||
23362281|NCT02959918|65072799|FG007|Overall Study|Withdrawal by Subject|0|||
23362282|NCT02959918|65072800|FG008|Overall Study|Withdrawal by Subject|1|||
23362283|NCT02959918|65072801|FG009|Overall Study|Withdrawal by Subject|1|||
23362284|NCT02959918|65072802|FG010|Overall Study|Withdrawal by Subject|2|||
23362285|NCT02959918|65072803|FG011|Overall Study|Withdrawal by Subject|3|||
23362286|NCT02959918|65072804|FG012|Overall Study|Withdrawal by Subject|1|||
23362287|NCT02959918|65072805|FG013|Overall Study|Withdrawal by Subject|1|||
23362288|NCT02959918|65072792|FG000|Overall Study|Protocol Violation|0|||
23362289|NCT02959918|65072793|FG001|Overall Study|Protocol Violation|0|||
23362290|NCT02959918|65072794|FG002|Overall Study|Protocol Violation|1|||
23362291|NCT02959918|65072795|FG003|Overall Study|Protocol Violation|0|||
23362292|NCT02959918|65072796|FG004|Overall Study|Protocol Violation|0|||
23362293|NCT02959918|65072797|FG005|Overall Study|Protocol Violation|1|||
23362294|NCT02959918|65072798|FG006|Overall Study|Protocol Violation|0|||
23362295|NCT02959918|65072799|FG007|Overall Study|Protocol Violation|0|||
23362296|NCT02959918|65072800|FG008|Overall Study|Protocol Violation|2|||
23362297|NCT02959918|65072801|FG009|Overall Study|Protocol Violation|1|||
23362298|NCT02959918|65072802|FG010|Overall Study|Protocol Violation|0|||
23658442|NCT01132612|66136263|FG000|Overall Study|Adverse Event|5|||
23362299|NCT02959918|65072803|FG011|Overall Study|Protocol Violation|1|||
23362300|NCT02959918|65072804|FG012|Overall Study|Protocol Violation|1|||
23362301|NCT02959918|65072805|FG013|Overall Study|Protocol Violation|0|||
23362302|NCT02959918|65072792|FG000|Overall Study|Stopping Rule Met|1|||
23362303|NCT02959918|65072793|FG001|Overall Study|Stopping Rule Met|0|||
23362304|NCT02959918|65072794|FG002|Overall Study|Stopping Rule Met|3|||
23362305|NCT02959918|65072795|FG003|Overall Study|Stopping Rule Met|4|||
23362306|NCT02959918|65072796|FG004|Overall Study|Stopping Rule Met|5|||
23362307|NCT02959918|65072797|FG005|Overall Study|Stopping Rule Met|3|||
23362308|NCT02959918|65072798|FG006|Overall Study|Stopping Rule Met|2|||
23362309|NCT02959918|65072799|FG007|Overall Study|Stopping Rule Met|4|||
23362310|NCT02959918|65072800|FG008|Overall Study|Stopping Rule Met|1|||
23362311|NCT02959918|65072801|FG009|Overall Study|Stopping Rule Met|1|||
23362312|NCT02959918|65072802|FG010|Overall Study|Stopping Rule Met|3|||
23362313|NCT02959918|65072803|FG011|Overall Study|Stopping Rule Met|5|||
23362314|NCT02959918|65072804|FG012|Overall Study|Stopping Rule Met|2|||
23362315|NCT02959918|65072805|FG013|Overall Study|Stopping Rule Met|1|||
23362316|NCT02959918|65072792|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
23362317|NCT02959918|65072793|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
23362318|NCT02959918|65072794|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
23362319|NCT02959918|65072795|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
23362320|NCT02959918|65072796|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362321|NCT02959918|65072797|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362322|NCT02959918|65072798|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362323|NCT02959918|65072799|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362324|NCT02959918|65072800|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23480566|NCT00998764|65502023|FG001|Overall Study|Withdrawal by Subject|25|||
23480567|NCT00998764|65502022|FG000|Overall Study|Physician Decision|3|||
23480568|NCT00998764|65502023|FG001|Overall Study|Physician Decision|3|||
23480569|NCT00998764|65502022|FG000|Overall Study|Death|3|||
23362325|NCT02959918|65072801|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362326|NCT02959918|65072802|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362327|NCT02959918|65072803|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362328|NCT02959918|65072804|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23480570|NCT00998764|65502023|FG001|Overall Study|Death|1|||
23362329|NCT02959918|65072805|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362330|NCT02959918|65072792|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362331|NCT02959918|65072793|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362332|NCT02959918|65072794|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362333|NCT02959918|65072795|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362334|NCT02959918|65072796|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362335|NCT02959918|65072797|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362336|NCT02959918|65072798|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362337|NCT02959918|65072799|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
23362338|NCT02959918|65072800|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362339|NCT02959918|65072801|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362340|NCT02959918|65072802|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362341|NCT02959918|65072803|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362342|NCT02959918|65072804|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362343|NCT02959918|65072805|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362344|NCT02959918|65072792|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362345|NCT02959918|65072793|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362346|NCT02959918|65072794|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362347|NCT02959918|65072795|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362348|NCT02959918|65072796|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362349|NCT02959918|65072797|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362350|NCT02959918|65072798|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362351|NCT02959918|65072799|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362352|NCT02959918|65072800|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
23362353|NCT02959918|65072801|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362354|NCT02959918|65072802|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362355|NCT02959918|65072803|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362356|NCT02959918|65072804|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362357|NCT02959918|65072805|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362358|NCT02959918|65072792|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362359|NCT02959918|65072793|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362360|NCT02959918|65072794|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362361|NCT02959918|65072795|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362362|NCT02959918|65072796|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362363|NCT02959918|65072797|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362364|NCT02959918|65072798|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362365|NCT02959918|65072799|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362366|NCT02959918|65072800|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362367|NCT02959918|65072801|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
23362368|NCT02959918|65072802|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362369|NCT02959918|65072803|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362370|NCT02959918|65072804|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362371|NCT02959918|65072805|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362372|NCT02689804|65072806|FG000|Overall Study|Withdrawal by Subject|2|||
23600956|NCT01673594|65929791|FG001|Overall Study|Physician Decision|4|||
23600957|NCT01673594|65929790|FG000|Overall Study|Withdrawal by Subject|0|||
23600958|NCT01673594|65929791|FG001|Overall Study|Withdrawal by Subject|1|||
23362373|NCT02689804|65072807|FG001|Overall Study|Withdrawal by Subject|0|||
23362374|NCT02964338|65072809|FG000|Overall Study|Sponsor terminated study for futility|12|||
23362375|NCT02964338|65072810|FG001|Overall Study|Sponsor terminated study for futility|15|||
23362376|NCT02964338|65072811|FG002|Overall Study|Sponsor terminated study for futility|14|||
23362377|NCT02964338|65072809|FG000|Overall Study|Lack of Efficacy|0|||
23362378|NCT02964338|65072810|FG001|Overall Study|Lack of Efficacy|3|||
23362379|NCT02964338|65072811|FG002|Overall Study|Lack of Efficacy|0|||
23362380|NCT02964338|65072809|FG000|Overall Study|Lost to Follow-up|1|||
23362381|NCT02964338|65072810|FG001|Overall Study|Lost to Follow-up|0|||
23362382|NCT02964338|65072811|FG002|Overall Study|Lost to Follow-up|3|||
23362383|NCT02964338|65072809|FG000|Overall Study|Protocol Violation|0|||
23362384|NCT02964338|65072810|FG001|Overall Study|Protocol Violation|1|||
23362385|NCT02964338|65072811|FG002|Overall Study|Protocol Violation|0|||
23362386|NCT02964338|65072809|FG000|Overall Study|Withdrawal by Subject|1|||
23658443|NCT01132612|66136264|FG001|Overall Study|Adverse Event|2|||
23658444|NCT01132612|66136265|FG002|Overall Study|Adverse Event|15|||
23658445|NCT01132612|66136263|FG000|Overall Study|Withdrawal by Subject|5|||
23658446|NCT01132612|66136264|FG001|Overall Study|Withdrawal by Subject|8|||
23658447|NCT01132612|66136265|FG002|Overall Study|Withdrawal by Subject|19|||
23658448|NCT01132612|66136263|FG000|Overall Study|Administrative problems|5|||
23658449|NCT01132612|66136264|FG001|Overall Study|Administrative problems|1|||
23658450|NCT01132612|66136265|FG002|Overall Study|Administrative problems|52|||
23658451|NCT01132612|66136263|FG000|Overall Study|Lack of Efficacy|23|||
23362387|NCT02964338|65072810|FG001|Overall Study|Withdrawal by Subject|3|||
23658452|NCT01132612|66136264|FG001|Overall Study|Lack of Efficacy|22|||
23658453|NCT01132612|66136265|FG002|Overall Study|Lack of Efficacy|73|||
23362388|NCT02964338|65072811|FG002|Overall Study|Withdrawal by Subject|1|||
23362389|NCT02964338|65072809|FG000|Overall Study|Adverse Event|2|||
23362390|NCT02964338|65072810|FG001|Overall Study|Adverse Event|1|||
23362391|NCT02964338|65072811|FG002|Overall Study|Adverse Event|1|||
23658454|NCT01536951|66136268|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23362392|NCT02964338|65072809|FG000|Overall Study|Non-compliant with e-diary|0|||
23362393|NCT02964338|65072810|FG001|Overall Study|Non-compliant with e-diary|1|||
23362394|NCT02964338|65072811|FG002|Overall Study|Non-compliant with e-diary|0|||
23362395|NCT02964338|65072809|FG000|Overall Study|Did not meet criteria|1|||
23362396|NCT02964338|65072810|FG001|Overall Study|Did not meet criteria|0|||
23362397|NCT02964338|65072811|FG002|Overall Study|Did not meet criteria|0|||
23362398|NCT01465230|65072812|FG000|Overall Study|Withdrawal by Subject|2|||
23362399|NCT01676012|65072813|FG000|Overall Study|Adverse Event|2|||
23362400|NCT01676012|65072813|FG000|Overall Study|incomplete set of videos|1|||
23362401|NCT03146741|65072814|FG000|Overall Study|Txp with non-HCV+ heart|4|||
23362402|NCT03146741|65072814|FG000|Overall Study|Listeted for MOT|2|||
23362403|NCT03146741|65072814|FG000|Overall Study|Physician Decision|2|||
23362404|NCT03146741|65072814|FG000|Overall Study|Awaiting txp|2|||
23362405|NCT02346877|65072815|FG000|Overall Study|Adverse Event|1|||
23362406|NCT02346877|65072816|FG001|Overall Study|Adverse Event|0|||
23362407|NCT02346877|65072815|FG000|Overall Study|Administrative Decision|1|||
23362408|NCT02346877|65072816|FG001|Overall Study|Administrative Decision|0|||
23362409|NCT02346877|65072815|FG000|Overall Study|Sponsor Decision|12|||
23362410|NCT02346877|65072816|FG001|Overall Study|Sponsor Decision|0|||
23362411|NCT02346877|65072815|FG000|Overall Study|Missing|5|||
23362412|NCT02346877|65072816|FG001|Overall Study|Missing|0|||
23362413|NCT02542397|65072824|FG000|Overall Study|Death|2|||
23362414|NCT02542397|65072824|FG000|Overall Study|Physician Decision|6|||
23362415|NCT02542397|65072824|FG000|Overall Study|Withdrawal by Subject|6|||
23658455|NCT01536951|66136269|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658456|NCT01536951|66136270|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
23658457|NCT01536951|66136271|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658458|NCT01536951|66136272|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658459|NCT01536951|66136273|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658460|NCT01536951|66136274|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658461|NCT01536951|66136275|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658462|NCT01536951|66136276|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23658463|NCT01536951|66136268|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
23658464|NCT01536951|66136269|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
23658465|NCT01536951|66136270|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
23658466|NCT01536951|66136271|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
23658467|NCT01536951|66136272|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
23658468|NCT01536951|66136273|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
23658469|NCT01536951|66136274|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
23362416|NCT02542397|65072824|FG000|Overall Study|Lost to Follow-up|2|||
23362417|NCT01025284|65072825|FG000|Overall Study|Investigator Decision|0|||
23362418|NCT01025284|65072826|FG001|Overall Study|Investigator Decision|1|||
23362419|NCT01025284|65072827|FG002|Overall Study|Investigator Decision|0|||
23362420|NCT01025284|65072825|FG000|Overall Study|Withdrawal by Subject|0|||
23362421|NCT01025284|65072826|FG001|Overall Study|Withdrawal by Subject|1|||
23362422|NCT01025284|65072827|FG002|Overall Study|Withdrawal by Subject|0|||
23362423|NCT04158219|65072828|FG000|Overall Study|Lost to Follow-up|1|||
23362424|NCT02948829|65072841|FG000|Overall Study|Lost to Follow-up|2|||
23600959|NCT03905512|65929792|FG000|Overall Study|Withdrawal by Subject|9|||
23600960|NCT03905512|65929793|FG001|Overall Study|Withdrawal by Subject|8|||
23600961|NCT03905512|65929792|FG000|Overall Study|Adverse Event|1|||
23600962|NCT03905512|65929793|FG001|Overall Study|Adverse Event|2|||
23600963|NCT03905512|65929792|FG000|Overall Study|Lost to Follow-up|4|||
23600964|NCT03905512|65929793|FG001|Overall Study|Lost to Follow-up|3|||
23600965|NCT03905512|65929792|FG000|Overall Study|Other than Specified|7|||
23600966|NCT03905512|65929793|FG001|Overall Study|Other than Specified|4|||
23600967|NCT02593149|65929796|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
23600968|NCT02593149|65929797|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
23600969|NCT02593149|65929796|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
23600970|NCT02593149|65929797|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
23600971|NCT02823574|65929798|FG000|Randomization|Disease Progression|0|||
23658470|NCT01536951|66136275|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
23658471|NCT01536951|66136276|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
23658472|NCT00805025|66136277|FG000|Overall Study|Screened but not enrolled/treated|42|||
23362425|NCT02948829|65072841|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
23362426|NCT02948829|65072841|FG000|Overall Study|Pregnancy|1|||
23480571|NCT00998764|65502022|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
23658473|NCT00805025|66136277|FG000|Overall Study|Adverse Event|4|||
23658474|NCT00805025|66136277|FG000|Overall Study|Withdrawal by Subject|2|||
23658475|NCT00805025|66136277|FG000|Overall Study|Physician Decision|1|||
23658476|NCT01817751|66136278|FG000|Overall Study|Physician Decision|1|||
23658477|NCT00283049|66136279|FG000|Overall Study|Adverse Event|6|||
23658478|NCT00283049|66136280|FG001|Overall Study|Adverse Event|1|||
23658479|NCT00283049|66136281|FG002|Overall Study|Adverse Event|4|||
23658480|NCT00283049|66136279|FG000|Overall Study|Protocol Violation|3|||
23362427|NCT02948829|65072841|FG000|Overall Study|Other: Reason not Specified|8|||
23600972|NCT02823574|65929799|FG001|Randomization|Disease Progression|0|||
23658481|NCT00283049|66136280|FG001|Overall Study|Protocol Violation|0|||
23362428|NCT00181883|65072842|FG000|Overall Study|Lack of Efficacy|2|||
23362429|NCT00181883|65072842|FG000|Overall Study|Treatment Limiting AEs|3|||
23362430|NCT00181883|65072842|FG000|Overall Study|Withdrawal by Subject|4|||
23362431|NCT00181883|65072842|FG000|Overall Study|Lost to Follow-up|1|||
23362432|NCT00613821|65072843|FG000|Overall Study|Withdrawal by Subject|1|||
23362433|NCT00613821|65072844|FG001|Overall Study|Withdrawal by Subject|0|||
23362434|NCT00613821|65072843|FG000|Overall Study|Physician Decision|1|||
23362435|NCT00613821|65072844|FG001|Overall Study|Physician Decision|1|||
23362436|NCT01247350|65072847|FG000|Overall Study|Adverse Event|0|||
23362437|NCT01247350|65072848|FG001|Overall Study|Adverse Event|0|||
23362438|NCT01247350|65072849|FG002|Overall Study|Adverse Event|1|||
23362439|NCT01247350|65072850|FG003|Overall Study|Adverse Event|0|||
23362440|NCT01247350|65072851|FG004|Overall Study|Adverse Event|0|||
23362441|NCT01247350|65072847|FG000|Overall Study|Withdrawal by Subject|0|||
23362442|NCT01247350|65072848|FG001|Overall Study|Withdrawal by Subject|0|||
23362443|NCT01247350|65072849|FG002|Overall Study|Withdrawal by Subject|0|||
23362444|NCT01247350|65072850|FG003|Overall Study|Withdrawal by Subject|1|||
23362445|NCT01247350|65072851|FG004|Overall Study|Withdrawal by Subject|0|||
23362446|NCT01247350|65072847|FG000|Overall Study|Entry criteria not met|0|||
23362447|NCT01247350|65072848|FG001|Overall Study|Entry criteria not met|0|||
23362448|NCT01247350|65072849|FG002|Overall Study|Entry criteria not met|0|||
23362449|NCT01247350|65072850|FG003|Overall Study|Entry criteria not met|0|||
23362450|NCT01247350|65072851|FG004|Overall Study|Entry criteria not met|1|||
23362451|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Other than specified|2|||
23362452|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Other than specified|4|||
23362453|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
23362454|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
23362455|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Pregnancy|0|||
23362456|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Pregnancy|2|||
23362457|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Physician Decision|1|||
23362458|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Physician Decision|1|||
23362459|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
23362460|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
23362461|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Adverse Event|2|||
23362462|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Adverse Event|1|||
23362463|NCT04110314|65072854|FG000|Overall Study|Did not meet inclusion criteria|35255|||
23362464|NCT04110314|65072855|FG001|Overall Study|Did not meet inclusion criteria|35104|||
23362465|NCT04110314|65072856|FG002|Overall Study|Did not meet inclusion criteria|35636|||
23362466|NCT04110314|65072857|FG003|Overall Study|Did not meet inclusion criteria|35135|||
23362467|NCT04110314|65072858|FG004|Overall Study|Did not meet inclusion criteria|35247|||
23362468|NCT04110314|65072859|FG005|Overall Study|Did not meet inclusion criteria|35727|||
23362469|NCT03284853|65072860|FG000|Overall Study|Adverse Event|40|||
23362470|NCT03284853|65072861|FG001|Overall Study|Adverse Event|4|||
23362471|NCT03284853|65072860|FG000|Overall Study|Withdrawal by Subject|5|||
23362472|NCT03284853|65072861|FG001|Overall Study|Withdrawal by Subject|1|||
23362473|NCT03284853|65072860|FG000|Overall Study|Lost to Follow-up|1|||
23362474|NCT03284853|65072861|FG001|Overall Study|Lost to Follow-up|0|||
23362475|NCT03284853|65072860|FG000|Overall Study|Lack of Efficacy|1|||
23362476|NCT03284853|65072861|FG001|Overall Study|Lack of Efficacy|0|||
23362477|NCT03284853|65072860|FG000|Overall Study|Disallowed Concurrent Medication|1|||
23362478|NCT03284853|65072861|FG001|Overall Study|Disallowed Concurrent Medication|1|||
23362479|NCT03284853|65072860|FG000|Overall Study|Protocol Violation|3|||
23362480|NCT03284853|65072861|FG001|Overall Study|Protocol Violation|3|||
23362481|NCT03284853|65072860|FG000|Overall Study|Death|0|||
23362482|NCT03284853|65072861|FG001|Overall Study|Death|1|||
23362483|NCT03284853|65072860|FG000|Overall Study|Other - Reason not reported in CSR|4|||
23362484|NCT03284853|65072861|FG001|Overall Study|Other - Reason not reported in CSR|3|||
23362485|NCT02302846|65072864|FG000|Overall Study|Withdrawal by Subject|1|||
23362486|NCT00490919|65072866|FG000|Open-label Run-in Period|Adverse Event|239|||
23362487|NCT00490919|65072867|FG001|Open-label Run-in Period|Adverse Event|0|||
23362488|NCT00490919|65072868|FG002|Open-label Run-in Period|Adverse Event|0|||
23362489|NCT00490919|65072866|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
23362490|NCT00490919|65072867|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23362491|NCT00490919|65072868|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23362492|NCT00490919|65072866|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
23362493|NCT00490919|65072867|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23362494|NCT00490919|65072868|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23362495|NCT00490919|65072866|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
23362496|NCT00490919|65072867|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23362497|NCT00490919|65072868|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23362498|NCT00490919|65072866|FG000|Open-label Run-in Period|Administrative|40|||
23362499|NCT00490919|65072867|FG001|Open-label Run-in Period|Administrative|0|||
23362500|NCT00490919|65072868|FG002|Open-label Run-in Period|Administrative|0|||
23362501|NCT00490919|65072866|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
23600973|NCT02823574|65929800|FG002|Randomization|Disease Progression|1|||
23362502|NCT00490919|65072867|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
23362503|NCT00490919|65072868|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
23362504|NCT00490919|65072866|FG000|Double-blind Phase|Adverse Event|0|||
23362505|NCT00490919|65072867|FG001|Double-blind Phase|Adverse Event|40|||
23362506|NCT00490919|65072868|FG002|Double-blind Phase|Adverse Event|20|||
23362507|NCT00490919|65072866|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23362508|NCT00490919|65072867|FG001|Double-blind Phase|Withdrawal by Subject|10|||
23362509|NCT00490919|65072868|FG002|Double-blind Phase|Withdrawal by Subject|11|||
23362510|NCT00490919|65072866|FG000|Double-blind Phase|Lost to Follow-up|0|||
23362511|NCT00490919|65072867|FG001|Double-blind Phase|Lost to Follow-up|8|||
23362512|NCT00490919|65072868|FG002|Double-blind Phase|Lost to Follow-up|11|||
23362513|NCT00490919|65072866|FG000|Double-blind Phase|Lack of Efficacy|0|||
23362514|NCT00490919|65072867|FG001|Double-blind Phase|Lack of Efficacy|22|||
23362515|NCT00490919|65072868|FG002|Double-blind Phase|Lack of Efficacy|36|||
23362516|NCT00490919|65072866|FG000|Double-blind Phase|Administrative|0|||
23362517|NCT00490919|65072867|FG001|Double-blind Phase|Administrative|6|||
23362518|NCT00490919|65072868|FG002|Double-blind Phase|Administrative|6|||
23362519|NCT04529538|65072869|FG000|Overall Study|Lost to Follow-up|3|||
23362520|NCT04529538|65072870|FG001|Overall Study|Lost to Follow-up|2|||
23362521|NCT04529538|65072871|FG002|Overall Study|Lost to Follow-up|1|||
23362522|NCT04529538|65072872|FG003|Overall Study|Lost to Follow-up|0|||
23362523|NCT04529538|65072873|FG004|Overall Study|Lost to Follow-up|1|||
23362524|NCT04529538|65072874|FG005|Overall Study|Lost to Follow-up|1|||
23362525|NCT04529538|65072875|FG006|Overall Study|Lost to Follow-up|2|||
23362526|NCT04529538|65072876|FG007|Overall Study|Lost to Follow-up|0|||
23362527|NCT04529538|65072869|FG000|Overall Study|Not eligible at enrollment|0|||
23362528|NCT04529538|65072870|FG001|Overall Study|Not eligible at enrollment|1|||
23362529|NCT04529538|65072871|FG002|Overall Study|Not eligible at enrollment|2|||
23362530|NCT04529538|65072872|FG003|Overall Study|Not eligible at enrollment|1|||
23362531|NCT04529538|65072873|FG004|Overall Study|Not eligible at enrollment|0|||
23362532|NCT04529538|65072874|FG005|Overall Study|Not eligible at enrollment|0|||
23362533|NCT04529538|65072875|FG006|Overall Study|Not eligible at enrollment|0|||
23362534|NCT04529538|65072876|FG007|Overall Study|Not eligible at enrollment|1|||
23362535|NCT04529538|65072869|FG000|Overall Study|Withdrawal by Subject|0|||
23362536|NCT04529538|65072870|FG001|Overall Study|Withdrawal by Subject|1|||
23362537|NCT04529538|65072871|FG002|Overall Study|Withdrawal by Subject|1|||
23362538|NCT04529538|65072872|FG003|Overall Study|Withdrawal by Subject|2|||
23362539|NCT04529538|65072873|FG004|Overall Study|Withdrawal by Subject|0|||
23362540|NCT04529538|65072874|FG005|Overall Study|Withdrawal by Subject|2|||
23362541|NCT04529538|65072875|FG006|Overall Study|Withdrawal by Subject|3|||
23362542|NCT04529538|65072876|FG007|Overall Study|Withdrawal by Subject|0|||
23362543|NCT04529538|65072869|FG000|Overall Study|Other|0|||
23362544|NCT04529538|65072870|FG001|Overall Study|Other|1|||
23362545|NCT04529538|65072871|FG002|Overall Study|Other|0|||
23362546|NCT04529538|65072872|FG003|Overall Study|Other|0|||
23362547|NCT04529538|65072873|FG004|Overall Study|Other|0|||
23362548|NCT04529538|65072874|FG005|Overall Study|Other|0|||
23362549|NCT04529538|65072875|FG006|Overall Study|Other|0|||
23362550|NCT04529538|65072876|FG007|Overall Study|Other|0|||
23362551|NCT04529538|65072869|FG000|Overall Study|Adverse Event|0|||
23362552|NCT04529538|65072870|FG001|Overall Study|Adverse Event|0|||
23362553|NCT04529538|65072871|FG002|Overall Study|Adverse Event|0|||
23362554|NCT04529538|65072872|FG003|Overall Study|Adverse Event|1|||
23362555|NCT04529538|65072873|FG004|Overall Study|Adverse Event|0|||
23362556|NCT04529538|65072874|FG005|Overall Study|Adverse Event|0|||
23362557|NCT04529538|65072875|FG006|Overall Study|Adverse Event|0|||
23362558|NCT04529538|65072876|FG007|Overall Study|Adverse Event|0|||
23362559|NCT04529538|65072869|FG000|Overall Study|Protocol Deviation|0|||
23362560|NCT04529538|65072870|FG001|Overall Study|Protocol Deviation|0|||
23362561|NCT04529538|65072871|FG002|Overall Study|Protocol Deviation|0|||
23362562|NCT04529538|65072872|FG003|Overall Study|Protocol Deviation|1|||
23362563|NCT04529538|65072873|FG004|Overall Study|Protocol Deviation|0|||
23362564|NCT04529538|65072874|FG005|Overall Study|Protocol Deviation|0|||
23362565|NCT04529538|65072875|FG006|Overall Study|Protocol Deviation|0|||
23362566|NCT04529538|65072876|FG007|Overall Study|Protocol Deviation|0|||
23362567|NCT04529538|65072869|FG000|Overall Study|Physician Decision|0|||
23362568|NCT04529538|65072870|FG001|Overall Study|Physician Decision|0|||
23600974|NCT02823574|65929801|FG003|Randomization|Disease Progression|0|||
23600975|NCT02823574|65929798|FG000|Randomization|AE unrelated to Study Drug|1|||
23362569|NCT04529538|65072871|FG002|Overall Study|Physician Decision|0|||
23600976|NCT02823574|65929799|FG001|Randomization|AE unrelated to Study Drug|0|||
23362570|NCT04529538|65072872|FG003|Overall Study|Physician Decision|0|||
23362571|NCT04529538|65072873|FG004|Overall Study|Physician Decision|0|||
23600977|NCT02823574|65929800|FG002|Randomization|AE unrelated to Study Drug|0|||
23658482|NCT00283049|66136281|FG002|Overall Study|Protocol Violation|3|||
23362572|NCT04529538|65072874|FG005|Overall Study|Physician Decision|1|||
23362573|NCT04529538|65072875|FG006|Overall Study|Physician Decision|0|||
23362574|NCT04529538|65072876|FG007|Overall Study|Physician Decision|1|||
23362575|NCT02688933|65072877|FG000|Overall Study|Adverse Event|3|||
23658483|NCT00283049|66136279|FG000|Overall Study|Death|1|||
23658484|NCT00283049|66136280|FG001|Overall Study|Death|1|||
23658485|NCT00283049|66136281|FG002|Overall Study|Death|1|||
23658486|NCT00283049|66136279|FG000|Overall Study|Lack of Efficacy|0|||
23658487|NCT00283049|66136280|FG001|Overall Study|Lack of Efficacy|1|||
23658488|NCT00283049|66136281|FG002|Overall Study|Lack of Efficacy|1|||
23658489|NCT00283049|66136279|FG000|Overall Study|Lost to Follow-up|4|||
23658490|NCT00283049|66136280|FG001|Overall Study|Lost to Follow-up|2|||
23658491|NCT00283049|66136281|FG002|Overall Study|Lost to Follow-up|5|||
23658492|NCT00283049|66136279|FG000|Overall Study|Withdrawal by Subject|26|||
23658493|NCT00283049|66136280|FG001|Overall Study|Withdrawal by Subject|24|||
23658494|NCT00283049|66136281|FG002|Overall Study|Withdrawal by Subject|19|||
23658495|NCT00283049|66136279|FG000|Overall Study|Discontinuation of Study|18|||
23658496|NCT00283049|66136280|FG001|Overall Study|Discontinuation of Study|16|||
23658497|NCT00283049|66136281|FG002|Overall Study|Discontinuation of Study|20|||
23658498|NCT00283049|66136279|FG000|Overall Study|No longer requires study treatment|0|||
23658499|NCT00283049|66136280|FG001|Overall Study|No longer requires study treatment|0|||
23658500|NCT00283049|66136281|FG002|Overall Study|No longer requires study treatment|1|||
23658501|NCT00233363|66136282|FG000|Overall Study|Adverse Event|1|||
23658502|NCT00233363|66136283|FG001|Overall Study|Adverse Event|2|||
23658503|NCT00233363|66136282|FG000|Overall Study|Lack of Efficacy|0|||
23658504|NCT00233363|66136283|FG001|Overall Study|Lack of Efficacy|2|||
23658505|NCT00233363|66136282|FG000|Overall Study|Withdrawal by Subject|1|||
23362576|NCT02688933|65072878|FG001|Overall Study|Adverse Event|1|||
23362577|NCT02688933|65072877|FG000|Overall Study|Lack of Efficacy|2|||
23362578|NCT02688933|65072878|FG001|Overall Study|Lack of Efficacy|2|||
23362579|NCT02688933|65072877|FG000|Overall Study|Poor compliance to protocol|7|||
23362580|NCT02688933|65072878|FG001|Overall Study|Poor compliance to protocol|4|||
23362581|NCT02688933|65072877|FG000|Overall Study|Hypoglycemia|2|||
23362582|NCT02688933|65072878|FG001|Overall Study|Hypoglycemia|0|||
23362583|NCT02688933|65072877|FG000|Overall Study|Other than Specified|14|||
23362584|NCT02688933|65072878|FG001|Overall Study|Other than Specified|25|||
23362585|NCT02688933|65072877|FG000|Overall Study|Lost to Follow-up|1|||
23362586|NCT02688933|65072878|FG001|Overall Study|Lost to Follow-up|5|||
23362587|NCT02291029|65072882|FG000|Overall Study|Withdrawal by Subject|0|||
23362588|NCT02291029|65072883|FG001|Overall Study|Withdrawal by Subject|0|||
23362589|NCT02291029|65072884|FG002|Overall Study|Withdrawal by Subject|1|||
23362590|NCT02291029|65072885|FG003|Overall Study|Withdrawal by Subject|0|||
23362591|NCT02291029|65072886|FG004|Overall Study|Withdrawal by Subject|0|||
23362592|NCT02291029|65072887|FG005|Overall Study|Withdrawal by Subject|0|||
23362593|NCT02291029|65072882|FG000|Overall Study|Adverse Event|0|||
23362594|NCT02291029|65072883|FG001|Overall Study|Adverse Event|1|||
23362595|NCT02291029|65072884|FG002|Overall Study|Adverse Event|0|||
23362596|NCT02291029|65072885|FG003|Overall Study|Adverse Event|0|||
23362597|NCT02291029|65072886|FG004|Overall Study|Adverse Event|0|||
23362598|NCT02291029|65072887|FG005|Overall Study|Adverse Event|0|||
23362599|NCT02322749|65072890|FG000|Period 2|Adverse Event|0|||
23362600|NCT02322749|65072891|FG001|Period 2|Adverse Event|0|||
23362601|NCT02322749|65072892|FG002|Period 2|Adverse Event|0|||
23362602|NCT02322749|65072893|FG003|Period 2|Adverse Event|1|||
23362603|NCT02322749|65072894|FG004|Period 2|Adverse Event|0|||
23362604|NCT02322749|65072895|FG005|Period 2|Adverse Event|0|||
23362605|NCT02322749|65072890|FG000|Period 2|Withdrawal by Subject|0|||
23362606|NCT02322749|65072891|FG001|Period 2|Withdrawal by Subject|0|||
23362607|NCT02322749|65072892|FG002|Period 2|Withdrawal by Subject|0|||
23362608|NCT02322749|65072893|FG003|Period 2|Withdrawal by Subject|1|||
23362609|NCT02322749|65072894|FG004|Period 2|Withdrawal by Subject|0|||
23362610|NCT02322749|65072895|FG005|Period 2|Withdrawal by Subject|0|||
23362611|NCT02322749|65072890|FG000|Period 3|Withdrawal by Subject|0|||
23362612|NCT02322749|65072891|FG001|Period 3|Withdrawal by Subject|0|||
23658506|NCT00233363|66136283|FG001|Overall Study|Withdrawal by Subject|1|||
23658507|NCT00233363|66136282|FG000|Overall Study|Aggravation of complication|1|||
23658508|NCT00233363|66136283|FG001|Overall Study|Aggravation of complication|0|||
23362613|NCT02322749|65072892|FG002|Period 3|Withdrawal by Subject|1|||
23362614|NCT02322749|65072893|FG003|Period 3|Withdrawal by Subject|0|||
23362615|NCT02322749|65072894|FG004|Period 3|Withdrawal by Subject|0|||
23362616|NCT02322749|65072895|FG005|Period 3|Withdrawal by Subject|0|||
23362617|NCT05502302|65072897|FG000|Overall Study|Lost to Follow-up|6|||
23362618|NCT05502302|65072897|FG000|Overall Study|Death|2|||
23362619|NCT01675492|65072898|FG000|Overall Study|study completed early - product approval|42|||
23362620|NCT02090283|65072899|FG000|Overall Study|Withdrawal by Subject|6|||
23658509|NCT00024167|66136289|FG000|Overall Study|Death|53|||
23362621|NCT02090283|65072900|FG001|Overall Study|Withdrawal by Subject|6|||
23658510|NCT00024167|66136290|FG001|Overall Study|Death|47|||
23362622|NCT02090283|65072901|FG002|Overall Study|Withdrawal by Subject|6|||
23362623|NCT02090283|65072899|FG000|Overall Study|Sponsor Terminated Study|6|||
23362624|NCT02090283|65072900|FG001|Overall Study|Sponsor Terminated Study|6|||
23362625|NCT02090283|65072901|FG002|Overall Study|Sponsor Terminated Study|1|||
23362626|NCT02090283|65072899|FG000|Overall Study|Lost to Follow-up|2|||
23362627|NCT02090283|65072900|FG001|Overall Study|Lost to Follow-up|2|||
23362628|NCT02090283|65072901|FG002|Overall Study|Lost to Follow-up|3|||
23362629|NCT02090283|65072899|FG000|Overall Study|Adverse Event|1|||
23362630|NCT02090283|65072900|FG001|Overall Study|Adverse Event|1|||
23362631|NCT02090283|65072901|FG002|Overall Study|Adverse Event|0|||
23362632|NCT02090283|65072899|FG000|Overall Study|Protocol Violation|2|||
23362633|NCT02090283|65072900|FG001|Overall Study|Protocol Violation|0|||
23362634|NCT02090283|65072901|FG002|Overall Study|Protocol Violation|0|||
23362635|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
23362636|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
23362637|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
23362638|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
23362639|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
23362640|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
23362641|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
23362642|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
23362643|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
23362644|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
23362645|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
23362646|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
23362647|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
23362648|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
23362649|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
23362650|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
23362651|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
23362652|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
23362653|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
23362654|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
23362655|NCT00534248|65072904|FG000|Overall Study|Adverse Event|19|||
23362656|NCT00534248|65072905|FG001|Overall Study|Adverse Event|29|||
23362657|NCT00534248|65072904|FG000|Overall Study|Lost to Follow-up|353|||
23362658|NCT00534248|65072905|FG001|Overall Study|Lost to Follow-up|375|||
23362659|NCT00534248|65072904|FG000|Overall Study|Other protocol specified criteria|13|||
23362660|NCT00534248|65072905|FG001|Overall Study|Other protocol specified criteria|3|||
23362661|NCT00534248|65072904|FG000|Overall Study|Physician Decision|10|||
23362662|NCT00534248|65072905|FG001|Overall Study|Physician Decision|7|||
23362663|NCT00534248|65072904|FG000|Overall Study|Protocol Violation|3|||
23362664|NCT00534248|65072905|FG001|Overall Study|Protocol Violation|4|||
23362665|NCT00534248|65072904|FG000|Overall Study|Withdrawal by Subject|263|||
23362666|NCT00534248|65072905|FG001|Overall Study|Withdrawal by Subject|255|||
23362667|NCT04877990|65072906|FG000|Treatment|Other reasons|3|||
23362668|NCT04877990|65072907|FG001|Treatment|Other reasons|1|||
23362669|NCT04877990|65072906|FG000|Treatment|Administrative reasons by sponsor|17|||
23362670|NCT04877990|65072907|FG001|Treatment|Administrative reasons by sponsor|33|||
23362671|NCT04877990|65072906|FG000|Treatment|Withdrawal by Subject|2|||
23362672|NCT04877990|65072907|FG001|Treatment|Withdrawal by Subject|6|||
23362673|NCT04877990|65072906|FG000|Treatment|Adverse Event|2|||
23362674|NCT04877990|65072907|FG001|Treatment|Adverse Event|1|||
23362675|NCT01450813|65072908|FG000|Overall Study|Physician Decision|1|||
23658511|NCT01022502|66136294|FG000|Overall Study|Adverse Event|1|||
23658512|NCT01022502|66136294|FG000|Overall Study|employment related reasons|1|||
23658513|NCT01022502|66136294|FG000|Overall Study|Withdrawal by Subject|1|||
23658514|NCT00911625|66136297|FG000|Overall Study|Lost to Follow-up|7|||
23658515|NCT00911625|66136298|FG001|Overall Study|Lost to Follow-up|0|||
23658516|NCT01458366|66136299|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
23658517|NCT01458366|66136300|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
23658518|NCT01458366|66136301|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
23658519|NCT01458366|66136302|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
23658520|NCT01458366|66136303|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
23658521|NCT01458366|66136299|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23658522|NCT01458366|66136300|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23658523|NCT01458366|66136301|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23658524|NCT01458366|66136302|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23658525|NCT01458366|66136303|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
23658526|NCT01843972|66136304|FG000|Overall Study|Withdrawal by Subject|0|||
23658527|NCT01843972|66136305|FG001|Overall Study|Withdrawal by Subject|0|||
23362676|NCT01450813|65072909|FG001|Overall Study|Physician Decision|1|||
23362677|NCT01450813|65072910|FG002|Overall Study|Physician Decision|0|||
23362678|NCT01450813|65072911|FG003|Overall Study|Physician Decision|3|||
23362679|NCT01853748|65072912|FG000|Allocation|Withdrawal by Subject|1|||
23362680|NCT01853748|65072913|FG001|Allocation|Withdrawal by Subject|13|||
23362681|NCT01853748|65072912|FG000|Allocation|not sufficient to receive intervention|0|||
23658528|NCT01843972|66136306|FG002|Overall Study|Withdrawal by Subject|0|||
23658529|NCT01843972|66136307|FG003|Overall Study|Withdrawal by Subject|0|||
23658530|NCT01843972|66136308|FG004|Overall Study|Withdrawal by Subject|1|||
23658531|NCT01843972|66136309|FG005|Overall Study|Withdrawal by Subject|0|||
23658532|NCT01843972|66136310|FG006|Overall Study|Withdrawal by Subject|0|||
23362682|NCT01853748|65072913|FG001|Allocation|not sufficient to receive intervention|1|||
23362683|NCT01853748|65072912|FG000|Follow-Up|Withdrawal by Subject|7|||
23362684|NCT01853748|65072913|FG001|Follow-Up|Withdrawal by Subject|6|||
23480572|NCT00998764|65502023|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
23600978|NCT02823574|65929801|FG003|Randomization|AE unrelated to Study Drug|0|||
23600979|NCT02823574|65929798|FG000|Treatment Period|Poor/Non Compliance|1|||
23600980|NCT02823574|65929799|FG001|Treatment Period|Poor/Non Compliance|0|||
23600981|NCT02823574|65929800|FG002|Treatment Period|Poor/Non Compliance|0|||
23600982|NCT02823574|65929801|FG003|Treatment Period|Poor/Non Compliance|1|||
23600983|NCT02823574|65929798|FG000|Treatment Period|Maximum Clinical Benefit|8|||
23600984|NCT02823574|65929799|FG001|Treatment Period|Maximum Clinical Benefit|4|||
23600985|NCT02823574|65929800|FG002|Treatment Period|Maximum Clinical Benefit|7|||
23600986|NCT02823574|65929801|FG003|Treatment Period|Maximum Clinical Benefit|1|||
23600987|NCT02823574|65929798|FG000|Treatment Period|Lost to Follow-up|1|||
23600988|NCT02823574|65929799|FG001|Treatment Period|Lost to Follow-up|1|||
23600989|NCT02823574|65929800|FG002|Treatment Period|Lost to Follow-up|0|||
23600990|NCT02823574|65929801|FG003|Treatment Period|Lost to Follow-up|0|||
23600991|NCT02823574|65929798|FG000|Treatment Period|Participant withdrew consent|4|||
23600992|NCT02823574|65929799|FG001|Treatment Period|Participant withdrew consent|0|||
23600993|NCT02823574|65929800|FG002|Treatment Period|Participant withdrew consent|0|||
23600994|NCT02823574|65929801|FG003|Treatment Period|Participant withdrew consent|1|||
23600995|NCT02823574|65929798|FG000|Treatment Period|Participant request to discontinue|5|||
23600996|NCT02823574|65929799|FG001|Treatment Period|Participant request to discontinue|0|||
23600997|NCT02823574|65929800|FG002|Treatment Period|Participant request to discontinue|3|||
23600998|NCT02823574|65929801|FG003|Treatment Period|Participant request to discontinue|2|||
23362685|NCT01853748|65072912|FG000|Follow-Up|Adverse Event|67|||
23658533|NCT01843972|66136311|FG007|Overall Study|Withdrawal by Subject|0|||
23362686|NCT01853748|65072913|FG001|Follow-Up|Adverse Event|7|||
23362687|NCT01853748|65072912|FG000|Follow-Up|not available for data collection|16|||
23362688|NCT01853748|65072913|FG001|Follow-Up|not available for data collection|4|||
23362689|NCT02324361|65072915|FG000|Overall Study|Lost to Follow-up|5|||
23362690|NCT02324361|65072916|FG001|Overall Study|Lost to Follow-up|2|||
23362691|NCT00807365|65072917|FG000|Overall Study|Study Terminated|5|||
23362692|NCT03654729|65072918|FG000|Overall Study|Death|9|||
23362693|NCT03654729|65072919|FG001|Overall Study|Death|9|||
23362694|NCT03654729|65072920|FG002|Overall Study|Death|16|||
23362695|NCT03654729|65072918|FG000|Overall Study|Withdrawal by Subject|8|||
23362696|NCT03654729|65072919|FG001|Overall Study|Withdrawal by Subject|6|||
23362697|NCT03654729|65072920|FG002|Overall Study|Withdrawal by Subject|4|||
23362698|NCT03654729|65072918|FG000|Overall Study|Study terminated by Sponsor|3|||
23362699|NCT03654729|65072919|FG001|Overall Study|Study terminated by Sponsor|5|||
23362700|NCT03654729|65072920|FG002|Overall Study|Study terminated by Sponsor|4|||
23362701|NCT03654729|65072918|FG000|Overall Study|Not reported|2|||
23362702|NCT03654729|65072919|FG001|Overall Study|Not reported|4|||
23362703|NCT03654729|65072920|FG002|Overall Study|Not reported|5|||
23362704|NCT03654729|65072918|FG000|Overall Study|Progressive disease|3|||
23362705|NCT03654729|65072919|FG001|Overall Study|Progressive disease|0|||
23362706|NCT03654729|65072920|FG002|Overall Study|Progressive disease|0|||
23362707|NCT03654729|65072918|FG000|Overall Study|Lost to Follow-up|2|||
23362708|NCT03654729|65072919|FG001|Overall Study|Lost to Follow-up|0|||
23362709|NCT03654729|65072920|FG002|Overall Study|Lost to Follow-up|0|||
23362710|NCT03654729|65072918|FG000|Overall Study|Physician Decision|2|||
23362711|NCT03654729|65072919|FG001|Overall Study|Physician Decision|0|||
23362712|NCT03654729|65072920|FG002|Overall Study|Physician Decision|0|||
23362713|NCT03654729|65072918|FG000|Overall Study|Protocol Violation|1|||
23362714|NCT03654729|65072919|FG001|Overall Study|Protocol Violation|1|||
23362715|NCT03654729|65072920|FG002|Overall Study|Protocol Violation|0|||
23658534|NCT01843972|66136312|FG008|Overall Study|Withdrawal by Subject|0|||
23362716|NCT03654729|65072918|FG000|Overall Study|Non-compliance with study drug|0|||
23362717|NCT03654729|65072919|FG001|Overall Study|Non-compliance with study drug|1|||
23362718|NCT03654729|65072920|FG002|Overall Study|Non-compliance with study drug|0|||
23362719|NCT03654729|65072918|FG000|Overall Study|Site terminated by Sponsor|1|||
23658535|NCT01843972|66136313|FG009|Overall Study|Withdrawal by Subject|0|||
23362720|NCT03654729|65072919|FG001|Overall Study|Site terminated by Sponsor|0|||
23362721|NCT03654729|65072920|FG002|Overall Study|Site terminated by Sponsor|0|||
23362722|NCT01421641|65072931|FG000|Overall Study|Protocol Violation|2|||
23362723|NCT01421641|65072932|FG001|Overall Study|Protocol Violation|2|||
23362724|NCT02221648|65072933|FG000|Overall Study|Withdrawal by Subject|3|||
23362725|NCT02221648|65072934|FG001|Overall Study|Withdrawal by Subject|3|||
23362726|NCT00527826|65072937|FG000|Overall Study|Adverse Event|10|||
23362727|NCT00527826|65072938|FG001|Overall Study|Adverse Event|10|||
23600999|NCT02823574|65929798|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
23601000|NCT02823574|65929799|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
23601001|NCT02823574|65929800|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
23601002|NCT02823574|65929801|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
23601003|NCT02823574|65929798|FG000|Treatment Period|Study Drug Toxicity|11|||
23601004|NCT02823574|65929799|FG001|Treatment Period|Study Drug Toxicity|2|||
23601005|NCT02823574|65929800|FG002|Treatment Period|Study Drug Toxicity|14|||
23601006|NCT02823574|65929801|FG003|Treatment Period|Study Drug Toxicity|4|||
23601007|NCT02823574|65929798|FG000|Treatment Period|Disease Progression|113|||
23601008|NCT02823574|65929799|FG001|Treatment Period|Disease Progression|64|||
23601009|NCT02823574|65929800|FG002|Treatment Period|Disease Progression|82|||
23601010|NCT02823574|65929801|FG003|Treatment Period|Disease Progression|43|||
23601011|NCT02823574|65929798|FG000|Treatment Period|Other reasons|5|||
23601012|NCT02823574|65929799|FG001|Treatment Period|Other reasons|9|||
23658536|NCT01438151|66136316|FG000|Overall Study|study terminated|8|||
23658537|NCT01221727|66136317|FG000|Overall Study|Physician Decision|2|||
23658538|NCT01221727|66136318|FG001|Overall Study|Physician Decision|0|||
23658539|NCT01221727|66136317|FG000|Overall Study|Withdrawal by Subject|1|||
23658540|NCT01221727|66136318|FG001|Overall Study|Withdrawal by Subject|1|||
23658541|NCT02043548|66136319|FG000|Overall Study|Lack of Efficacy|1|||
23658542|NCT02043548|66136320|FG001|Overall Study|Lack of Efficacy|0|||
23658543|NCT02043548|66136319|FG000|Overall Study|Adverse Event|0|||
23658544|NCT02043548|66136320|FG001|Overall Study|Adverse Event|1|||
23658545|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
23658546|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
23658547|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
23658548|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
23658549|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
23658550|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
23362728|NCT00527826|65072937|FG000|Overall Study|Lost to Follow-up|3|||
23362729|NCT00527826|65072938|FG001|Overall Study|Lost to Follow-up|2|||
23362730|NCT00527826|65072937|FG000|Overall Study|Withdrawal by Subject|5|||
23362731|NCT00527826|65072938|FG001|Overall Study|Withdrawal by Subject|8|||
23362732|NCT00527826|65072937|FG000|Overall Study|Inclusion Criteria Not Met|3|||
23362733|NCT00527826|65072938|FG001|Overall Study|Inclusion Criteria Not Met|3|||
23362734|NCT00527826|65072937|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
23362735|NCT00527826|65072938|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
23362736|NCT00527826|65072937|FG000|Overall Study|Additional Intake of Viani forte|0|||
23362737|NCT00527826|65072938|FG001|Overall Study|Additional Intake of Viani forte|1|||
23362738|NCT00527826|65072937|FG000|Overall Study|Participant moved away|0|||
23362739|NCT00527826|65072938|FG001|Overall Study|Participant moved away|1|||
23362740|NCT02714036|65072945|FG000|Overall Study|Adverse Event|9|||
23362741|NCT02714036|65072946|FG001|Overall Study|Adverse Event|2|||
23362742|NCT02714036|65072945|FG000|Overall Study|Withdrawal by Subject|3|||
23362743|NCT02714036|65072946|FG001|Overall Study|Withdrawal by Subject|2|||
23362744|NCT00096538|65072947|FG000|Overall Study|Withdrawal by Subject|1|||
23362745|NCT00751140|65072948|FG000|Overall Study|benign angioma excluded from analysis|1|||
23362746|NCT01711983|65072949|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
23362747|NCT01711983|65072949|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
23362748|NCT01711983|65072949|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
23362749|NCT01711983|65072949|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
23362750|NCT02472886|65072950|FG000|Overall Study|Lack of Efficacy|0|||
23362751|NCT02472886|65072951|FG001|Overall Study|Lack of Efficacy|2|||
23362752|NCT02472886|65072952|FG002|Overall Study|Lack of Efficacy|1|||
23362753|NCT00905424|65072955|FG000|Overall Study|Lost to Follow-up|3|||
23362754|NCT00905424|65072956|FG001|Overall Study|Lost to Follow-up|3|||
23362755|NCT00905424|65072955|FG000|Overall Study|Withdrawal by Subject|1|||
23362756|NCT00905424|65072956|FG001|Overall Study|Withdrawal by Subject|2|||
23362757|NCT00905424|65072955|FG000|Overall Study|Adverse Event|4|||
23362758|NCT00905424|65072956|FG001|Overall Study|Adverse Event|2|||
23362759|NCT00905424|65072955|FG000|Overall Study|Non-compliance with study medication|2|||
23362760|NCT00905424|65072956|FG001|Overall Study|Non-compliance with study medication|0|||
23658551|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
23362761|NCT00905424|65072955|FG000|Overall Study|Sponsor decision|1|||
23362762|NCT00905424|65072956|FG001|Overall Study|Sponsor decision|0|||
23362763|NCT00905424|65072955|FG000|Overall Study|Positive urine drug screen|0|||
23362764|NCT00905424|65072956|FG001|Overall Study|Positive urine drug screen|1|||
23362765|NCT00905424|65072955|FG000|Overall Study|Non-adherence to visit schedule|0|||
23362766|NCT00905424|65072956|FG001|Overall Study|Non-adherence to visit schedule|1|||
23362767|NCT02155985|65072959|FG000|Overall Study|Withdrawal by Subject|0|||
23362768|NCT02155985|65072960|FG001|Overall Study|Withdrawal by Subject|0|||
23362769|NCT02155985|65072961|FG002|Overall Study|Withdrawal by Subject|1|||
23362770|NCT02155985|65072959|FG000|Overall Study|Lost to Follow-up|1|||
23362771|NCT02155985|65072960|FG001|Overall Study|Lost to Follow-up|0|||
23362772|NCT02155985|65072961|FG002|Overall Study|Lost to Follow-up|0|||
23362773|NCT00697593|65072962|FG000|Overall Study|Adverse Event|3|||
23362774|NCT00697593|65072962|FG000|Overall Study|Protocol Violation|1|||
23362775|NCT00697593|65072962|FG000|Overall Study|Lack of Efficacy|3|||
23362776|NCT00697593|65072962|FG000|Overall Study|Suspension of the study by sponsor|12|||
23362777|NCT01964989|65072967|FG000|Overall Study|Protocol Violation|3|||
23362778|NCT01964989|65072968|FG001|Overall Study|Protocol Violation|4|||
23601013|NCT02823574|65929800|FG002|Treatment Period|Other reasons|3|||
23601014|NCT02823574|65929801|FG003|Treatment Period|Other reasons|6|||
23601015|NCT02823574|65929798|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23601016|NCT02823574|65929799|FG001|Treatment Period|Participant no longer meets study criteria|0|||
23601017|NCT02823574|65929800|FG002|Treatment Period|Participant no longer meets study criteria|1|||
23601018|NCT02823574|65929801|FG003|Treatment Period|Participant no longer meets study criteria|0|||
23601019|NCT02823574|65929798|FG000|Treatment Period|Death|0|||
23601020|NCT02823574|65929799|FG001|Treatment Period|Death|0|||
23601021|NCT02823574|65929800|FG002|Treatment Period|Death|3|||
23362779|NCT01964989|65072967|FG000|Overall Study|Administrative Reason|103|||
23362780|NCT01964989|65072968|FG001|Overall Study|Administrative Reason|95|||
23601022|NCT02823574|65929801|FG003|Treatment Period|Death|1|||
23362781|NCT01964989|65072967|FG000|Overall Study|Adverse Event|0|||
23601023|NCT02613403|65929802|FG000|Overall Study|Lost to Follow-up|0|||
23362782|NCT01964989|65072968|FG001|Overall Study|Adverse Event|1|||
23362783|NCT01964989|65072967|FG000|Overall Study|Death|1|||
23362784|NCT01964989|65072968|FG001|Overall Study|Death|3|||
23362785|NCT01964989|65072967|FG000|Overall Study|Withdrawal by Subject|156|||
23362786|NCT01964989|65072968|FG001|Overall Study|Withdrawal by Subject|160|||
23362787|NCT01964989|65072967|FG000|Overall Study|Lost to Follow-up|254|||
23362788|NCT01964989|65072968|FG001|Overall Study|Lost to Follow-up|232|||
23362789|NCT01964989|65072967|FG000|Overall Study|Other|267|||
23362790|NCT01964989|65072968|FG001|Overall Study|Other|252|||
23362791|NCT01249417|65072969|FG000|Randomised Population|Study treatment not received|0|||
23362792|NCT01249417|65072970|FG001|Randomised Population|Study treatment not received|0|||
23362793|NCT01249417|65072971|FG002|Randomised Population|Study treatment not received|2|||
23362794|NCT01249417|65072969|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
23362795|NCT01249417|65072970|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
23362796|NCT01249417|65072971|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
23362797|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Other|0|||
23362798|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Other|0|||
23362799|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Other|1|||
23362800|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
23362801|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
23362802|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
23362803|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
23362804|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
23362805|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
23362806|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
23362807|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
23362808|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
23362809|NCT01585246|65072974|FG000|Overall Study|Lost to Follow-up|0|||
23362810|NCT01585246|65072975|FG001|Overall Study|Lost to Follow-up|0|||
23362811|NCT01585246|65072976|FG002|Overall Study|Lost to Follow-up|2|||
23362812|NCT01585246|65072977|FG003|Overall Study|Lost to Follow-up|1|||
23362813|NCT01585246|65072978|FG004|Overall Study|Lost to Follow-up|0|||
23362814|NCT01585246|65072974|FG000|Overall Study|Protocol Violation|0|||
23362815|NCT01585246|65072975|FG001|Overall Study|Protocol Violation|0|||
23362816|NCT01585246|65072976|FG002|Overall Study|Protocol Violation|0|||
23362817|NCT01585246|65072977|FG003|Overall Study|Protocol Violation|0|||
23362818|NCT01585246|65072978|FG004|Overall Study|Protocol Violation|1|||
23362819|NCT01585246|65072974|FG000|Overall Study|Withdrawal by Subject|0|||
23362820|NCT01585246|65072975|FG001|Overall Study|Withdrawal by Subject|0|||
23362821|NCT01585246|65072976|FG002|Overall Study|Withdrawal by Subject|1|||
23362822|NCT01585246|65072977|FG003|Overall Study|Withdrawal by Subject|2|||
23362823|NCT01585246|65072978|FG004|Overall Study|Withdrawal by Subject|1|||
23362824|NCT01585246|65072974|FG000|Overall Study|Other|0|||
23362825|NCT01585246|65072975|FG001|Overall Study|Other|1|||
23362826|NCT01585246|65072976|FG002|Overall Study|Other|1|||
23362827|NCT01585246|65072977|FG003|Overall Study|Other|1|||
23362828|NCT01585246|65072978|FG004|Overall Study|Other|0|||
23658552|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
23362829|NCT00424593|65072983|FG000|Acute Double-Blind Period|Adverse Event|16|||
23362830|NCT00424593|65072984|FG001|Acute Double-Blind Period|Adverse Event|7|||
23362831|NCT00424593|65072983|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
23362832|NCT00424593|65072984|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
23362833|NCT00424593|65072983|FG000|Acute Double-Blind Period|Protocol Violation|2|||
23362834|NCT00424593|65072984|FG001|Acute Double-Blind Period|Protocol Violation|2|||
23362835|NCT00424593|65072983|FG000|Acute Double-Blind Period|Physician Decision|1|||
23362836|NCT00424593|65072984|FG001|Acute Double-Blind Period|Physician Decision|2|||
23362837|NCT00424593|65072983|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
23362838|NCT00424593|65072984|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
23362839|NCT00424593|65072983|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
23362840|NCT00424593|65072984|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
23362841|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
23362842|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
23362843|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Adverse Event|18|||
23362844|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Adverse Event|0|||
23362845|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
23362846|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
23362847|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
23362848|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
23362849|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
23362850|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
23362851|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Physician Decision|3|||
23362852|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Physician Decision|0|||
23362853|NCT02420262|65072985|FG000|Overall Study|Adverse Event|1|||
23362854|NCT02420262|65072986|FG001|Overall Study|Adverse Event|0|||
23362855|NCT02420262|65072985|FG000|Overall Study|Withdrawal by Subject|1|||
23362856|NCT02420262|65072986|FG001|Overall Study|Withdrawal by Subject|4|||
23362857|NCT02420262|65072985|FG000|Overall Study|Unclassified|0|||
23362858|NCT02420262|65072986|FG001|Overall Study|Unclassified|1|||
23362859|NCT02213380|65073004|FG000|Underwent Randomization|Withdrawal by Subject|2|||
23658553|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
23362860|NCT02213380|65073005|FG001|Underwent Randomization|Withdrawal by Subject|0|||
23362861|NCT02213380|65073004|FG000|Underwent Randomization|Not treated|3|||
23362862|NCT02213380|65073005|FG001|Underwent Randomization|Not treated|3|||
23362863|NCT02213380|65073004|FG000|Per-protocol Analysis|Protocol Violation|32|||
23362864|NCT02213380|65073005|FG001|Per-protocol Analysis|Protocol Violation|36|||
23362865|NCT02111174|65073006|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
23362866|NCT02111174|65073007|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
23362867|NCT02111174|65073006|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
23362868|NCT02111174|65073007|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
23362869|NCT02111174|65073006|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
23362870|NCT02111174|65073007|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
23362871|NCT02111174|65073006|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
23362872|NCT02111174|65073007|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
23362873|NCT02824627|65073010|FG000|Overall Study|Adverse Event|1|||
23362874|NCT02824627|65073011|FG001|Overall Study|Adverse Event|2|||
23362875|NCT02824627|65073010|FG000|Overall Study|Lost to Follow-up|2|||
23362876|NCT02824627|65073011|FG001|Overall Study|Lost to Follow-up|1|||
23362877|NCT03113968|65073012|FG000|Overall Study|Withdrawal by Subject|31|||
23362878|NCT03113968|65073013|FG001|Overall Study|Withdrawal by Subject|4|||
23362879|NCT00327717|65073014|FG000|Overall Study|Adverse Event|6|||
23362880|NCT00327717|65073015|FG001|Overall Study|Adverse Event|6|||
23362881|NCT00327717|65073014|FG000|Overall Study|Lack of Efficacy|0|||
23362882|NCT00327717|65073015|FG001|Overall Study|Lack of Efficacy|1|||
23362883|NCT00327717|65073014|FG000|Overall Study|Withdrawal by Subject|3|||
23362884|NCT00327717|65073015|FG001|Overall Study|Withdrawal by Subject|7|||
23362885|NCT01005901|65073017|FG000|Overall Study|Withdrawal by Subject|38|||
23601024|NCT02613403|65929803|FG001|Overall Study|Lost to Follow-up|1|||
23362886|NCT01005901|65073018|FG001|Overall Study|Withdrawal by Subject|14|||
23362887|NCT01005901|65073017|FG000|Overall Study|Adverse Event|30|||
23362888|NCT01005901|65073018|FG001|Overall Study|Adverse Event|16|||
23362889|NCT01005901|65073017|FG000|Overall Study|Administrative problems|21|||
23362890|NCT01005901|65073018|FG001|Overall Study|Administrative problems|13|||
23362891|NCT01005901|65073017|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23362892|NCT01005901|65073018|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23362893|NCT01005901|65073017|FG000|Overall Study|Protocol Violation|4|||
23362894|NCT01005901|65073018|FG001|Overall Study|Protocol Violation|3|||
23362895|NCT01005901|65073017|FG000|Overall Study|Death|2|||
23362896|NCT01005901|65073018|FG001|Overall Study|Death|3|||
23362897|NCT01005901|65073017|FG000|Overall Study|Lost to Follow-up|1|||
23362898|NCT01005901|65073018|FG001|Overall Study|Lost to Follow-up|2|||
23362899|NCT01005901|65073017|FG000|Overall Study|Patient's inability to use the device|1|||
23362900|NCT01005901|65073018|FG001|Overall Study|Patient's inability to use the device|1|||
23362901|NCT01005901|65073017|FG000|Overall Study|No longer requires study drug|0|||
23362902|NCT01005901|65073018|FG001|Overall Study|No longer requires study drug|1|||
23362903|NCT02620787|65073024|FG000|Overall Study|Adverse Event|1|||
23362904|NCT02620787|65073025|FG001|Overall Study|Adverse Event|0|||
23362905|NCT02620787|65073024|FG000|Overall Study|Eligibility Criteria Not Met|1|||
23362906|NCT02620787|65073025|FG001|Overall Study|Eligibility Criteria Not Met|0|||
23362907|NCT00770913|65073026|FG000|Overall Study|Adverse Event|1|||
23362908|NCT00770913|65073027|FG001|Overall Study|Adverse Event|3|||
23362909|NCT00770913|65073028|FG002|Overall Study|Adverse Event|6|||
23362910|NCT00770913|65073026|FG000|Overall Study|Refusal to continue participation|6|||
23362911|NCT00770913|65073027|FG001|Overall Study|Refusal to continue participation|4|||
23362912|NCT00770913|65073028|FG002|Overall Study|Refusal to continue participation|5|||
23362913|NCT00770913|65073026|FG000|Overall Study|Physician Decision|0|||
23362914|NCT00770913|65073027|FG001|Overall Study|Physician Decision|1|||
23362915|NCT00770913|65073028|FG002|Overall Study|Physician Decision|1|||
23658554|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
23362916|NCT00770913|65073026|FG000|Overall Study|Protocol Violation|3|||
23362917|NCT00770913|65073027|FG001|Overall Study|Protocol Violation|0|||
23362918|NCT00770913|65073028|FG002|Overall Study|Protocol Violation|1|||
23362919|NCT00770913|65073026|FG000|Overall Study|Incorrect drug was allocated|1|||
23362920|NCT00770913|65073027|FG001|Overall Study|Incorrect drug was allocated|0|||
23658555|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
23658556|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
23658557|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
23658558|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
23658559|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
23658560|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
23658561|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
23658562|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
23658563|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Early termination|0|||
23658564|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Early termination|0|||
23658565|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Early termination|34|||
23658566|NCT01493557|66136321|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
23658567|NCT01493557|66136322|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
23658568|NCT01493557|66136323|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
23658569|NCT01493557|66136321|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
23658570|NCT01493557|66136322|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
23658571|NCT01493557|66136323|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
23658572|NCT01493557|66136321|FG000|Randomized to Management Strategies|Other adverse event|8|||
23658573|NCT01493557|66136322|FG001|Randomized to Management Strategies|Other adverse event|5|||
23658574|NCT01493557|66136323|FG002|Randomized to Management Strategies|Other adverse event|0|||
23658575|NCT01493557|66136321|FG000|Randomized to Management Strategies|Protocol Violation|3|||
23658576|NCT01493557|66136322|FG001|Randomized to Management Strategies|Protocol Violation|0|||
23658577|NCT01493557|66136323|FG002|Randomized to Management Strategies|Protocol Violation|0|||
23658578|NCT01493557|66136321|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
23658579|NCT01493557|66136322|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
23658580|NCT01493557|66136323|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
23658581|NCT01493557|66136321|FG000|Randomized to Management Strategies|Other than stated above|1|||
23658582|NCT01493557|66136322|FG001|Randomized to Management Strategies|Other than stated above|3|||
23658583|NCT01493557|66136323|FG002|Randomized to Management Strategies|Other than stated above|0|||
23658584|NCT01493557|66136321|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
23658585|NCT01493557|66136322|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
23658586|NCT01493557|66136323|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
23658587|NCT01493557|66136321|FG000|Adding the Second Strategy|Other adverse event|1|||
23658588|NCT01493557|66136322|FG001|Adding the Second Strategy|Other adverse event|2|||
23658589|NCT01493557|66136323|FG002|Adding the Second Strategy|Other adverse event|0|||
23658590|NCT01493557|66136321|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
23658591|NCT01493557|66136322|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
23658592|NCT01493557|66136323|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
23658593|NCT02606461|66136326|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23658594|NCT02606461|66136327|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23658595|NCT02606461|66136328|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
23658596|NCT02606461|66136329|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23658597|NCT02606461|66136330|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23658598|NCT02606461|66136331|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23658599|NCT00381563|66136334|FG000|Overall Study|Withdrawal by Subject|5|||
23658600|NCT00381563|66136335|FG001|Overall Study|Withdrawal by Subject|5|||
23658601|NCT00381563|66136334|FG000|Overall Study|Lost to Follow-up|2|||
23658602|NCT00381563|66136335|FG001|Overall Study|Lost to Follow-up|0|||
23658603|NCT00381563|66136334|FG000|Overall Study|Protocol Violation|0|||
23658604|NCT00381563|66136335|FG001|Overall Study|Protocol Violation|1|||
23362921|NCT00770913|65073028|FG002|Overall Study|Incorrect drug was allocated|0|||
23362922|NCT00509899|65073034|FG000|Overall Study|Progressive disease|1|||
23362923|NCT00509899|65073035|FG001|Overall Study|Progressive disease|3|||
23362924|NCT00509899|65073036|FG002|Overall Study|Progressive disease|5|||
23362925|NCT00509899|65073037|FG003|Overall Study|Progressive disease|1|||
23658605|NCT04422990|66136338|FG000|Overall Study|Withdrawal by Subject|0|||
23658606|NCT04422990|66136339|FG001|Overall Study|Withdrawal by Subject|1|||
23658607|NCT04422990|66136338|FG000|Overall Study|Travel|3|||
23658608|NCT04422990|66136339|FG001|Overall Study|Travel|0|||
23658609|NCT00493220|66136342|FG000|Third Intervention|Withdrawal by Subject|1|||
23362926|NCT00509899|65073038|FG004|Overall Study|Progressive disease|0|||
23362927|NCT00509899|65073039|FG005|Overall Study|Progressive disease|1|||
23658610|NCT00493220|66136343|FG001|Third Intervention|Withdrawal by Subject|0|||
23658611|NCT00493220|66136344|FG002|Third Intervention|Withdrawal by Subject|0|||
23362928|NCT00509899|65073040|FG006|Overall Study|Progressive disease|0|||
23362929|NCT00509899|65073041|FG007|Overall Study|Progressive disease|0|||
23362930|NCT00509899|65073034|FG000|Overall Study|Unacceptable Toxicity|1|||
23362931|NCT00509899|65073035|FG001|Overall Study|Unacceptable Toxicity|0|||
23658612|NCT00493220|66136345|FG003|Third Intervention|Withdrawal by Subject|0|||
23658613|NCT00493220|66136346|FG004|Third Intervention|Withdrawal by Subject|0|||
23658614|NCT00493220|66136347|FG005|Third Intervention|Withdrawal by Subject|0|||
23362932|NCT00509899|65073036|FG002|Overall Study|Unacceptable Toxicity|0|||
23658615|NCT03842163|66136355|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
23658616|NCT03842163|66136355|FG000|Overall Study|Scintigraphy was not performed|44|||
23658617|NCT00698451|66136356|FG000|Overall Study|Adverse Event|22|||
23658618|NCT00698451|66136356|FG000|Overall Study|Physician Decision|2|||
23658619|NCT00698451|66136356|FG000|Overall Study|Protocol Violation|6|||
23658620|NCT00698451|66136356|FG000|Overall Study|Withdrawal by Subject|6|||
23658621|NCT00698451|66136356|FG000|Overall Study|Disease progression|3|||
23658622|NCT00773136|66136358|FG000|Overall Study|Physician Decision|2|||
23658623|NCT01754857|66136359|FG000|Overall Study|Adverse Event|7|||
23658624|NCT01754857|66136359|FG000|Overall Study|Disease progression|3|||
23658625|NCT01754857|66136359|FG000|Overall Study|Physician Decision|2|||
23658626|NCT01754857|66136359|FG000|Overall Study|Withdrawal by Subject|3|||
23658627|NCT01754857|66136359|FG000|Overall Study|other complicating disease|1|||
23658628|NCT01754857|66136359|FG000|Overall Study|ineligible to continue onto maintenance|1|||
23658629|NCT01754857|66136359|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
23658630|NCT01754857|66136359|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
23658631|NCT00882310|66136360|FG000|Overall Study|Screen Failure|10|||
23658632|NCT00882310|66136360|FG000|Overall Study|Never received treatment|1|||
23658633|NCT00882310|66136360|FG000|Overall Study|Death|6|||
23658634|NCT00882310|66136360|FG000|Overall Study|Progression of disease|4|||
23658635|NCT00882310|66136360|FG000|Overall Study|Adverse Event|1|||
23658636|NCT00726622|66136361|FG000|Overall Study|Withdrawal by Subject|16|||
23658637|NCT00726622|66136362|FG001|Overall Study|Withdrawal by Subject|2|||
23658638|NCT00726622|66136361|FG000|Overall Study|Physician Decision|0|||
23362933|NCT00509899|65073037|FG003|Overall Study|Unacceptable Toxicity|2|||
23362934|NCT00509899|65073038|FG004|Overall Study|Unacceptable Toxicity|0|||
23658639|NCT00726622|66136362|FG001|Overall Study|Physician Decision|1|||
23658640|NCT00726622|66136361|FG000|Overall Study|Metastasis|2|||
23658641|NCT00726622|66136362|FG001|Overall Study|Metastasis|0|||
23658642|NCT01093625|66139026|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
23658643|NCT01093625|66139027|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
23658644|NCT01093625|66139026|FG000|2-Week Visit|Withdrawal by Subject|1|||
23658645|NCT01093625|66139027|FG001|2-Week Visit|Withdrawal by Subject|0|||
23658646|NCT01093625|66139026|FG000|1-Month Visit|Lost to Follow-up|2|||
23658647|NCT01093625|66139027|FG001|1-Month Visit|Lost to Follow-up|0|||
23658648|NCT01093625|66139026|FG000|3-Month Visit|Lost to Follow-up|2|||
23658649|NCT01093625|66139027|FG001|3-Month Visit|Lost to Follow-up|0|||
23658650|NCT01093625|66139026|FG000|6-Month Visit|Withdrawal by Subject|6|||
23658651|NCT01093625|66139027|FG001|6-Month Visit|Withdrawal by Subject|7|||
23658652|NCT01093625|66139026|FG000|6-Month Visit|Lost to Follow-up|2|||
23658653|NCT01093625|66139027|FG001|6-Month Visit|Lost to Follow-up|2|||
23658654|NCT01093625|66139026|FG000|1-Year Visit|Lost to Follow-up|5|||
23658655|NCT01093625|66139027|FG001|1-Year Visit|Lost to Follow-up|3|||
23658656|NCT02012296|66139037|FG000|Overall Study|Lack of Efficacy|0|||
23658657|NCT02012296|66139038|FG001|Overall Study|Lack of Efficacy|0|||
23658658|NCT02012296|66139039|FG002|Overall Study|Lack of Efficacy|15|||
23362935|NCT00509899|65073039|FG005|Overall Study|Unacceptable Toxicity|0|||
23362936|NCT00509899|65073040|FG006|Overall Study|Unacceptable Toxicity|0|||
23658659|NCT02012296|66139037|FG000|Overall Study|Adverse Event|0|||
23658660|NCT02012296|66139038|FG001|Overall Study|Adverse Event|0|||
23658661|NCT02012296|66139039|FG002|Overall Study|Adverse Event|2|||
23658662|NCT02012296|66139037|FG000|Overall Study|Early study closure|0|||
23658663|NCT02012296|66139038|FG001|Overall Study|Early study closure|0|||
23658664|NCT02012296|66139039|FG002|Overall Study|Early study closure|5|||
23362937|NCT00509899|65073041|FG007|Overall Study|Unacceptable Toxicity|0|||
23362938|NCT00509899|65073034|FG000|Overall Study|Withdrawal by Subject|6|||
23362939|NCT00509899|65073035|FG001|Overall Study|Withdrawal by Subject|2|||
23362940|NCT00509899|65073036|FG002|Overall Study|Withdrawal by Subject|3|||
23362941|NCT00509899|65073037|FG003|Overall Study|Withdrawal by Subject|0|||
23362942|NCT00509899|65073038|FG004|Overall Study|Withdrawal by Subject|3|||
23362943|NCT00509899|65073039|FG005|Overall Study|Withdrawal by Subject|2|||
23362944|NCT00509899|65073040|FG006|Overall Study|Withdrawal by Subject|0|||
23362945|NCT00509899|65073041|FG007|Overall Study|Withdrawal by Subject|0|||
23362946|NCT00509899|65073034|FG000|Overall Study|Physician Decision|4|||
23362947|NCT00509899|65073035|FG001|Overall Study|Physician Decision|2|||
23362948|NCT00509899|65073036|FG002|Overall Study|Physician Decision|7|||
23362949|NCT00509899|65073037|FG003|Overall Study|Physician Decision|0|||
23362950|NCT00509899|65073038|FG004|Overall Study|Physician Decision|1|||
23362951|NCT00509899|65073039|FG005|Overall Study|Physician Decision|4|||
23362952|NCT00509899|65073040|FG006|Overall Study|Physician Decision|0|||
23362953|NCT00509899|65073041|FG007|Overall Study|Physician Decision|0|||
23362954|NCT00509899|65073034|FG000|Overall Study|Intercurrent Illness|1|||
23362955|NCT00509899|65073035|FG001|Overall Study|Intercurrent Illness|0|||
23362956|NCT00509899|65073036|FG002|Overall Study|Intercurrent Illness|0|||
23362957|NCT00509899|65073037|FG003|Overall Study|Intercurrent Illness|1|||
23362958|NCT00509899|65073038|FG004|Overall Study|Intercurrent Illness|0|||
23362959|NCT00509899|65073039|FG005|Overall Study|Intercurrent Illness|1|||
23601025|NCT02613403|65929804|FG002|Overall Study|Lost to Follow-up|0|||
23601026|NCT02613403|65929805|FG003|Overall Study|Lost to Follow-up|0|||
23601027|NCT02613403|65929806|FG004|Overall Study|Lost to Follow-up|0|||
23601028|NCT02613403|65929802|FG000|Overall Study|Withdrawal by Subject|2|||
23601029|NCT02613403|65929803|FG001|Overall Study|Withdrawal by Subject|0|||
23601030|NCT02613403|65929804|FG002|Overall Study|Withdrawal by Subject|0|||
23601031|NCT02613403|65929805|FG003|Overall Study|Withdrawal by Subject|0|||
23601032|NCT02613403|65929806|FG004|Overall Study|Withdrawal by Subject|0|||
23601033|NCT01170208|65929807|FG000|Overall Study|Withdrawal by Subject|5|||
23601034|NCT01170208|65929808|FG001|Overall Study|Withdrawal by Subject|0|||
23601035|NCT01170208|65929809|FG002|Overall Study|Withdrawal by Subject|1|||
23601036|NCT01170208|65929807|FG000|Overall Study|Protocol Violation|1|||
23601037|NCT01170208|65929808|FG001|Overall Study|Protocol Violation|0|||
23601038|NCT01170208|65929809|FG002|Overall Study|Protocol Violation|1|||
23601039|NCT00246805|65929810|FG000|Phase 1|Lost to Follow-up|1|||
23601040|NCT00246805|65929811|FG001|Phase 1|Lost to Follow-up|0|||
23601041|NCT03577106|65929812|FG000|Overall Study|Withdrawal by Subject|3|||
23601042|NCT02284113|65929823|FG000|Overall Study|Adverse Event|1|||
23601043|NCT02284113|65929824|FG001|Overall Study|Adverse Event|0|||
23601044|NCT02284113|65929823|FG000|Overall Study|non-compliance|0|||
23601045|NCT02284113|65929824|FG001|Overall Study|non-compliance|1|||
23601046|NCT02284113|65929823|FG000|Overall Study|Withdrawal by Subject|0|||
23601047|NCT02284113|65929824|FG001|Overall Study|Withdrawal by Subject|1|||
23601048|NCT02284113|65929823|FG000|Overall Study|not provided|0|||
23601049|NCT02284113|65929824|FG001|Overall Study|not provided|1|||
23601050|NCT02284113|65929823|FG000|Overall Study|surgery cancelled|2|||
23601051|NCT02284113|65929824|FG001|Overall Study|surgery cancelled|0|||
23601052|NCT01627561|65929825|FG000|Overall Study|Lost to Follow-up|1|||
23601053|NCT01627561|65929826|FG001|Overall Study|Lost to Follow-up|0|||
23601054|NCT01627561|65929825|FG000|Overall Study|Withdrawal by Subject|0|||
23601055|NCT01627561|65929826|FG001|Overall Study|Withdrawal by Subject|1|||
23601056|NCT01627561|65929825|FG000|Overall Study|Migrated/moved from study area|0|||
23601057|NCT01627561|65929826|FG001|Overall Study|Migrated/moved from study area|2|||
23601058|NCT01437319|65929839|FG000|Phase I|Lost to Follow-up|2|||
23601059|NCT01437319|65929840|FG001|Phase I|Lost to Follow-up|0|||
23601060|NCT01437319|65929841|FG002|Phase I|Lost to Follow-up|0|||
23601061|NCT01437319|65929839|FG000|Phase I|Protocol Violation|1|||
23601062|NCT01437319|65929840|FG001|Phase I|Protocol Violation|0|||
23601063|NCT01437319|65929841|FG002|Phase I|Protocol Violation|0|||
23601064|NCT01437319|65929839|FG000|Phase I|Study related symptoms/complaints|27|||
23601065|NCT01437319|65929840|FG001|Phase I|Study related symptoms/complaints|0|||
23601066|NCT01437319|65929841|FG002|Phase I|Study related symptoms/complaints|0|||
23601067|NCT01437319|65929839|FG000|Phase I|Withdrawal by Subject|25|||
23601068|NCT01437319|65929840|FG001|Phase I|Withdrawal by Subject|0|||
23658665|NCT02012296|66139037|FG000|Overall Study|Protocol Violation|0|||
23658666|NCT02012296|66139038|FG001|Overall Study|Protocol Violation|1|||
23658667|NCT02012296|66139039|FG002|Overall Study|Protocol Violation|0|||
23658668|NCT00478933|66139043|FG000|Overall Study|Protocol Violation|22|||
23658669|NCT00478933|66139043|FG000|Overall Study|Informed consent not verified|3|||
23658670|NCT00478933|66139043|FG000|Overall Study|Inadequate data available|53|||
23658671|NCT01207596|66139044|FG000|Overall Study|Physician Decision|4|||
23658672|NCT01207596|66139044|FG000|Overall Study|Lack of Efficacy|1|||
23658673|NCT01207596|66139044|FG000|Overall Study|Adverse Event|3|||
23658674|NCT01207596|66139044|FG000|Overall Study|Withdrawal by Subject|1|||
23658675|NCT00403754|66139045|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
23658676|NCT00403754|66139046|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
23658677|NCT00403754|66139047|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
23658678|NCT00403754|66139048|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
23658679|NCT00403754|66139045|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
23658680|NCT00403754|66139046|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
23658681|NCT00403754|66139047|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
23658682|NCT00403754|66139048|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
23658683|NCT02906787|66139049|FG000|Overall Study|Withdrawal by Subject|12|||
23362960|NCT00509899|65073040|FG006|Overall Study|Intercurrent Illness|0|||
23362961|NCT00509899|65073041|FG007|Overall Study|Intercurrent Illness|0|||
23362962|NCT00509899|65073034|FG000|Overall Study|Death|2|||
23362963|NCT00509899|65073035|FG001|Overall Study|Death|2|||
23362964|NCT00509899|65073036|FG002|Overall Study|Death|3|||
23362965|NCT00509899|65073037|FG003|Overall Study|Death|0|||
23658684|NCT02906787|66139050|FG001|Overall Study|Withdrawal by Subject|10|||
23658685|NCT02906787|66139049|FG000|Overall Study|Missed|24|||
23658686|NCT02906787|66139050|FG001|Overall Study|Missed|22|||
23362966|NCT00509899|65073038|FG004|Overall Study|Death|1|||
23362967|NCT00509899|65073039|FG005|Overall Study|Death|1|||
23362968|NCT00509899|65073040|FG006|Overall Study|Death|1|||
23362969|NCT00509899|65073041|FG007|Overall Study|Death|1|||
23362970|NCT00509899|65073034|FG000|Overall Study|Lack of Efficacy|1|||
23362971|NCT00509899|65073035|FG001|Overall Study|Lack of Efficacy|0|||
23362972|NCT00509899|65073036|FG002|Overall Study|Lack of Efficacy|2|||
23362973|NCT00509899|65073037|FG003|Overall Study|Lack of Efficacy|0|||
23362974|NCT00509899|65073038|FG004|Overall Study|Lack of Efficacy|0|||
23362975|NCT00509899|65073039|FG005|Overall Study|Lack of Efficacy|1|||
23362976|NCT00509899|65073040|FG006|Overall Study|Lack of Efficacy|0|||
23362977|NCT00509899|65073041|FG007|Overall Study|Lack of Efficacy|0|||
23362978|NCT02750332|65073042|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23362979|NCT02750332|65073043|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23362980|NCT00402727|65073044|FG000|Overall Study|Adverse Event|10|||
23362981|NCT00402727|65073045|FG001|Overall Study|Adverse Event|6|||
23362982|NCT00402727|65073044|FG000|Overall Study|Death|1|||
23362983|NCT00402727|65073045|FG001|Overall Study|Death|0|||
23362984|NCT00402727|65073044|FG000|Overall Study|Lack of Efficacy|1|||
23362985|NCT00402727|65073045|FG001|Overall Study|Lack of Efficacy|3|||
23362986|NCT00402727|65073044|FG000|Overall Study|Lost to Follow-up|24|||
23362987|NCT00402727|65073045|FG001|Overall Study|Lost to Follow-up|11|||
23362988|NCT00402727|65073044|FG000|Overall Study|Physician Decision|1|||
23362989|NCT00402727|65073045|FG001|Overall Study|Physician Decision|1|||
23362990|NCT00402727|65073044|FG000|Overall Study|Protocol Violation|0|||
23362991|NCT00402727|65073045|FG001|Overall Study|Protocol Violation|4|||
23362992|NCT00402727|65073044|FG000|Overall Study|Withdrawal by Subject|3|||
23362993|NCT00402727|65073045|FG001|Overall Study|Withdrawal by Subject|7|||
23362994|NCT00402727|65073044|FG000|Overall Study|supply problems|2|||
23362995|NCT00402727|65073045|FG001|Overall Study|supply problems|1|||
23362996|NCT00402727|65073044|FG000|Overall Study|non-compliance|0|||
23362997|NCT00402727|65073045|FG001|Overall Study|non-compliance|1|||
23362998|NCT00735943|65073046|FG000|Overall Study|Lost to Follow-up|1|||
23362999|NCT00735943|65073046|FG000|Overall Study|Adverse Event|1|||
23363000|NCT04004260|65073047|FG000|Overall Study|Withdrawal by Subject|7|||
23363001|NCT04004260|65073048|FG001|Overall Study|Withdrawal by Subject|3|||
23363002|NCT04004260|65073047|FG000|Overall Study|Lost to Follow-up|22|||
23363003|NCT04004260|65073048|FG001|Overall Study|Lost to Follow-up|12|||
23363004|NCT04004260|65073047|FG000|Overall Study|Did not engage in intervention|13|||
23363005|NCT04004260|65073048|FG001|Overall Study|Did not engage in intervention|17|||
23363006|NCT04577794|65073052|FG000|Overall Study|Adverse Event|1|||
23363007|NCT04577794|65073053|FG001|Overall Study|Adverse Event|1|||
23363008|NCT01000974|65076914|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
23363009|NCT01000974|65076915|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
23363010|NCT01000974|65076916|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
23363011|NCT01000974|65076914|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
23363012|NCT01000974|65076915|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
23363013|NCT01000974|65076916|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
23363014|NCT01000974|65076914|FG000|Primary Vaccination Phase|Protocol Violation|40|||
23658687|NCT00122681|66139051|FG000|Overall Study|Adverse Event|20|||
23658688|NCT00122681|66139052|FG001|Overall Study|Adverse Event|16|||
23658689|NCT00122681|66139051|FG000|Overall Study|Lost to Follow-up|1080|||
23363015|NCT01000974|65076915|FG001|Primary Vaccination Phase|Protocol Violation|3|||
23363016|NCT01000974|65076916|FG002|Primary Vaccination Phase|Protocol Violation|2|||
23363017|NCT01000974|65076914|FG000|Primary Vaccination Phase|Adverse Event|14|||
23363018|NCT01000974|65076915|FG001|Primary Vaccination Phase|Adverse Event|2|||
23363019|NCT01000974|65076916|FG002|Primary Vaccination Phase|Adverse Event|2|||
23363020|NCT01000974|65076914|FG000|Primary Vaccination Phase|Other|4|||
23363021|NCT01000974|65076915|FG001|Primary Vaccination Phase|Other|9|||
23363022|NCT01000974|65076916|FG002|Primary Vaccination Phase|Other|12|||
23363023|NCT01000974|65076914|FG000|Booster Vaccination Phase|Protocol Violation|0|||
23363024|NCT01000974|65076915|FG001|Booster Vaccination Phase|Protocol Violation|0|||
23363025|NCT01000974|65076916|FG002|Booster Vaccination Phase|Protocol Violation|2|||
23363026|NCT01000974|65076914|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
23363027|NCT01000974|65076915|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
23363028|NCT01000974|65076916|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
23363029|NCT01000974|65076914|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
23363030|NCT01000974|65076915|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
23363031|NCT01000974|65076916|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
23363032|NCT01000974|65076914|FG000|Booster Vaccination Phase|Other|24|||
23363033|NCT01000974|65076915|FG001|Booster Vaccination Phase|Other|6|||
23363034|NCT01000974|65076916|FG002|Booster Vaccination Phase|Other|4|||
23363035|NCT01128400|65076917|FG000|Overall Study|Lost to Follow-up|1|||
23363036|NCT01128400|65076918|FG001|Overall Study|Lost to Follow-up|0|||
23363037|NCT01128400|65076919|FG002|Overall Study|Lost to Follow-up|1|||
23363038|NCT01128400|65076917|FG000|Overall Study|Screening failure|1|||
23363039|NCT01128400|65076918|FG001|Overall Study|Screening failure|0|||
23363040|NCT01128400|65076919|FG002|Overall Study|Screening failure|0|||
23363041|NCT01128400|65076917|FG000|Overall Study|were not invited to participate on taste|0|||
23363042|NCT01128400|65076918|FG001|Overall Study|were not invited to participate on taste|0|||
23363043|NCT01128400|65076919|FG002|Overall Study|were not invited to participate on taste|15|||
23363044|NCT01128400|65076917|FG000|Overall Study|Excluded due to sinus problems|0|||
23363045|NCT01128400|65076918|FG001|Overall Study|Excluded due to sinus problems|1|||
23363046|NCT01128400|65076919|FG002|Overall Study|Excluded due to sinus problems|0|||
23363047|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
23363048|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
23363049|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
23363050|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
23363051|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
23363052|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
23363053|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
23363054|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
23363055|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
23363056|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
23363057|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
23363058|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
23363059|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
23363060|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363061|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363062|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363063|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
23363064|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
23363065|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
23363066|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
23363067|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
23363068|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363069|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363070|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363071|NCT01801111|65076924|FG000|Overall Study|Adverse Event|12|||
23363072|NCT01801111|65076924|FG000|Overall Study|Death|8|||
23363073|NCT01801111|65076924|FG000|Overall Study|Physician Decision|5|||
23363074|NCT01801111|65076924|FG000|Overall Study|Other|1|||
23363075|NCT01801111|65076924|FG000|Overall Study|Withdrawal by Subject|4|||
23363076|NCT01801111|65076924|FG000|Overall Study|Study Terminated by Sponsor|27|||
23363077|NCT01801111|65076924|FG000|Overall Study|Progressive Disease|81|||
23363078|NCT02895295|65076927|FG000|Overall Study|Survey Non-response|71|||
23363079|NCT02895295|65076928|FG001|Overall Study|Survey Non-response|94|||
23363080|NCT02895295|65076929|FG002|Overall Study|Survey Non-response|92|||
23363081|NCT04131712|65076932|FG000|Overall Study|COVID related|0|||
23363082|NCT04131712|65076933|FG001|Overall Study|COVID related|0|||
23363083|NCT04131712|65076934|FG002|Overall Study|COVID related|2|||
23363084|NCT04131712|65076935|FG003|Overall Study|COVID related|0|||
23363085|NCT04131712|65076932|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363086|NCT04131712|65076933|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363087|NCT04131712|65076934|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
23480573|NCT00998764|65502022|FG000|Overall Study|Protocol Violation|0|||
23363088|NCT04131712|65076935|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363089|NCT04194489|65076943|FG000|Overall Study|Withdrawal by Subject|5|||
23363090|NCT04194489|65076943|FG000|Overall Study|Lost to Follow-up|48|||
23363091|NCT02557399|65076944|FG000|Overall Study|Adverse Event|6|||
23363092|NCT02557399|65076945|FG001|Overall Study|Adverse Event|5|||
23363093|NCT02557399|65076944|FG000|Overall Study|Protocol Violation|0|||
23363094|NCT02557399|65076945|FG001|Overall Study|Protocol Violation|1|||
23363095|NCT02557399|65076944|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23363096|NCT02557399|65076945|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23363097|NCT02557399|65076944|FG000|Overall Study|Withdrawal by Subject|1|||
23363098|NCT02557399|65076945|FG001|Overall Study|Withdrawal by Subject|1|||
23363099|NCT00715559|65076947|FG000|Overall Study|medication not tolerated - nausea|1|||
23363100|NCT01639144|65076950|FG000|Overall Study|Withdrawal by Subject|4|||
23363101|NCT01639144|65076951|FG001|Overall Study|Withdrawal by Subject|2|||
23363102|NCT01639144|65076950|FG000|Overall Study|Physician Decision|2|||
23363103|NCT01639144|65076951|FG001|Overall Study|Physician Decision|0|||
23363104|NCT01639144|65076950|FG000|Overall Study|Met postoperative exclusion criteria|4|||
23363105|NCT01639144|65076951|FG001|Overall Study|Met postoperative exclusion criteria|3|||
23363106|NCT02504320|65076953|FG000|Treatment Period 1|Positive Drug Screen|0|||
23363107|NCT02504320|65076954|FG001|Treatment Period 1|Positive Drug Screen|0|||
23363108|NCT02504320|65076955|FG002|Treatment Period 1|Positive Drug Screen|1|||
23363109|NCT02504320|65076956|FG003|Treatment Period 1|Positive Drug Screen|0|||
23363110|NCT02504320|65076953|FG000|Treatment Period 2|Positive Drug Screen|0|||
23363111|NCT02504320|65076954|FG001|Treatment Period 2|Positive Drug Screen|1|||
23363112|NCT02504320|65076955|FG002|Treatment Period 2|Positive Drug Screen|0|||
23363113|NCT02504320|65076956|FG003|Treatment Period 2|Positive Drug Screen|0|||
23363114|NCT02504320|65076953|FG000|Treatment Period 3|Positive Drug Screen|0|||
23363115|NCT02504320|65076954|FG001|Treatment Period 3|Positive Drug Screen|0|||
23363116|NCT02504320|65076955|FG002|Treatment Period 3|Positive Drug Screen|0|||
23363117|NCT02504320|65076956|FG003|Treatment Period 3|Positive Drug Screen|1|||
23363118|NCT02504320|65076953|FG000|Treatment Period 3|Adverse Event|0|||
23363119|NCT02504320|65076954|FG001|Treatment Period 3|Adverse Event|0|||
23363120|NCT02504320|65076955|FG002|Treatment Period 3|Adverse Event|1|||
23363121|NCT02504320|65076956|FG003|Treatment Period 3|Adverse Event|0|||
23363122|NCT00685360|65076957|FG000|Overall Study|Lost to Follow-up|0|||
23363123|NCT00685360|65076958|FG001|Overall Study|Lost to Follow-up|1|||
23363124|NCT00685360|65076959|FG002|Overall Study|Lost to Follow-up|2|||
23363125|NCT00685360|65076957|FG000|Overall Study|Adverse Event|4|||
23363126|NCT00685360|65076958|FG001|Overall Study|Adverse Event|6|||
23363127|NCT00685360|65076959|FG002|Overall Study|Adverse Event|4|||
23363128|NCT00685360|65076957|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
23363129|NCT00685360|65076958|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
23363130|NCT00685360|65076959|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
23363131|NCT00685360|65076957|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
23363132|NCT00685360|65076958|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
23363133|NCT00685360|65076959|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
23363134|NCT00685360|65076957|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
23363135|NCT00685360|65076958|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
23363136|NCT00685360|65076959|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
23363137|NCT00685360|65076957|FG000|Overall Study|Protocol Deviation|0|||
23363138|NCT00685360|65076958|FG001|Overall Study|Protocol Deviation|1|||
23363139|NCT00685360|65076959|FG002|Overall Study|Protocol Deviation|1|||
23363140|NCT02718911|65076960|FG000|Overall Study|Adverse Event|0|||
23363141|NCT02718911|65076961|FG001|Overall Study|Adverse Event|0|||
23363142|NCT02718911|65076962|FG002|Overall Study|Adverse Event|0|||
23363143|NCT02718911|65076963|FG003|Overall Study|Adverse Event|0|||
23363144|NCT02718911|65076964|FG004|Overall Study|Adverse Event|0|||
23363145|NCT02718911|65076965|FG005|Overall Study|Adverse Event|0|||
23363146|NCT02718911|65076966|FG006|Overall Study|Adverse Event|0|||
23363147|NCT02718911|65076967|FG007|Overall Study|Adverse Event|0|||
23363148|NCT02718911|65076968|FG008|Overall Study|Adverse Event|0|||
23363149|NCT02718911|65076969|FG009|Overall Study|Adverse Event|2|||
23363150|NCT02718911|65076960|FG000|Overall Study|Death|2|||
23363151|NCT02718911|65076961|FG001|Overall Study|Death|3|||
23363152|NCT02718911|65076962|FG002|Overall Study|Death|1|||
23363153|NCT02718911|65076963|FG003|Overall Study|Death|0|||
23363154|NCT02718911|65076964|FG004|Overall Study|Death|1|||
23363155|NCT02718911|65076965|FG005|Overall Study|Death|3|||
23363156|NCT02718911|65076966|FG006|Overall Study|Death|1|||
23363157|NCT02718911|65076967|FG007|Overall Study|Death|1|||
23363158|NCT02718911|65076968|FG008|Overall Study|Death|4|||
23363159|NCT02718911|65076969|FG009|Overall Study|Death|3|||
23363160|NCT02718911|65076960|FG000|Overall Study|Lost to Follow-up|0|||
23363161|NCT02718911|65076961|FG001|Overall Study|Lost to Follow-up|0|||
23363162|NCT02718911|65076962|FG002|Overall Study|Lost to Follow-up|0|||
23363163|NCT02718911|65076963|FG003|Overall Study|Lost to Follow-up|0|||
23363164|NCT02718911|65076964|FG004|Overall Study|Lost to Follow-up|0|||
23363165|NCT02718911|65076965|FG005|Overall Study|Lost to Follow-up|0|||
23363166|NCT02718911|65076966|FG006|Overall Study|Lost to Follow-up|0|||
23363167|NCT02718911|65076967|FG007|Overall Study|Lost to Follow-up|0|||
23363168|NCT02718911|65076968|FG008|Overall Study|Lost to Follow-up|1|||
23363169|NCT02718911|65076969|FG009|Overall Study|Lost to Follow-up|0|||
23363170|NCT02718911|65076960|FG000|Overall Study|Physician Decision|2|||
23363171|NCT02718911|65076961|FG001|Overall Study|Physician Decision|0|||
23363172|NCT02718911|65076962|FG002|Overall Study|Physician Decision|1|||
23363173|NCT02718911|65076963|FG003|Overall Study|Physician Decision|1|||
23363174|NCT02718911|65076964|FG004|Overall Study|Physician Decision|0|||
23363175|NCT02718911|65076965|FG005|Overall Study|Physician Decision|0|||
23363176|NCT02718911|65076966|FG006|Overall Study|Physician Decision|0|||
23363177|NCT02718911|65076967|FG007|Overall Study|Physician Decision|1|||
23363178|NCT02718911|65076968|FG008|Overall Study|Physician Decision|2|||
23363179|NCT02718911|65076969|FG009|Overall Study|Physician Decision|1|||
23363180|NCT02718911|65076960|FG000|Overall Study|Withdrawal by Subject|0|||
23363181|NCT02718911|65076961|FG001|Overall Study|Withdrawal by Subject|0|||
23363182|NCT02718911|65076962|FG002|Overall Study|Withdrawal by Subject|0|||
23363183|NCT02718911|65076963|FG003|Overall Study|Withdrawal by Subject|0|||
23363184|NCT02718911|65076964|FG004|Overall Study|Withdrawal by Subject|1|||
23363185|NCT02718911|65076965|FG005|Overall Study|Withdrawal by Subject|0|||
23363186|NCT02718911|65076966|FG006|Overall Study|Withdrawal by Subject|0|||
23363187|NCT02718911|65076967|FG007|Overall Study|Withdrawal by Subject|0|||
23363188|NCT02718911|65076968|FG008|Overall Study|Withdrawal by Subject|1|||
23363189|NCT02718911|65076969|FG009|Overall Study|Withdrawal by Subject|4|||
23363190|NCT02718911|65076960|FG000|Overall Study|Reason Not Collected|0|||
23363191|NCT02718911|65076961|FG001|Overall Study|Reason Not Collected|0|||
23363192|NCT02718911|65076962|FG002|Overall Study|Reason Not Collected|1|||
23363193|NCT02718911|65076963|FG003|Overall Study|Reason Not Collected|0|||
23363194|NCT02718911|65076964|FG004|Overall Study|Reason Not Collected|0|||
23363195|NCT02718911|65076965|FG005|Overall Study|Reason Not Collected|0|||
23363196|NCT02718911|65076966|FG006|Overall Study|Reason Not Collected|2|||
23363197|NCT02718911|65076967|FG007|Overall Study|Reason Not Collected|1|||
23363198|NCT02718911|65076968|FG008|Overall Study|Reason Not Collected|4|||
23363199|NCT02718911|65076969|FG009|Overall Study|Reason Not Collected|9|||
23363200|NCT05137717|65076970|FG000|Overall Study|Death|2|||
23363201|NCT05137717|65076970|FG000|Overall Study|Withdrawal by Subject|6|||
23363202|NCT00369915|65076972|FG000|Overall Study|expected side effects|2|||
23363203|NCT00369915|65076973|FG001|Overall Study|expected side effects|1|||
23363204|NCT00369915|65076972|FG000|Overall Study|Withdrawal by Subject|4|||
23363205|NCT00369915|65076973|FG001|Overall Study|Withdrawal by Subject|1|||
23363206|NCT00369915|65076972|FG000|Overall Study|W/drawl by investigators|0|||
23363207|NCT00369915|65076973|FG001|Overall Study|W/drawl by investigators|1|||
23363208|NCT03669549|65076976|FG000|Overall Study|Adverse Event|4|||
23363209|NCT03669549|65076976|FG000|Overall Study|Withdrawal by Subject|1|||
23363210|NCT03669549|65076976|FG000|Overall Study|Study terminated by the Sponsor|1|||
23363211|NCT04249427|65076977|FG000|Overall Study|Adverse Event|3|||
23363212|NCT04249427|65076978|FG001|Overall Study|Adverse Event|1|||
23363213|NCT04249427|65076977|FG000|Overall Study|Lack of Efficacy|0|||
23363214|NCT04249427|65076978|FG001|Overall Study|Lack of Efficacy|1|||
23363215|NCT04249427|65076977|FG000|Overall Study|Withdrawal by Subject|1|||
23363216|NCT04249427|65076978|FG001|Overall Study|Withdrawal by Subject|2|||
23363217|NCT03066830|65076979|FG000|Overall Study|At the Participant's own Request|16|||
23363218|NCT03066830|65076980|FG001|Overall Study|At the Participant's own Request|17|||
23363219|NCT03066830|65076979|FG000|Overall Study|Other|3|||
23363220|NCT03066830|65076980|FG001|Overall Study|Other|0|||
23363221|NCT03066830|65076979|FG000|Overall Study|Poor Compliance to Protocol|1|||
23363222|NCT03066830|65076980|FG001|Overall Study|Poor Compliance to Protocol|0|||
23363223|NCT03066830|65076979|FG000|Overall Study|Adverse Event|2|||
23363224|NCT03066830|65076980|FG001|Overall Study|Adverse Event|2|||
23363225|NCT03066830|65076979|FG000|Overall Study|Lost to Follow-up|11|||
23363226|NCT03066830|65076980|FG001|Overall Study|Lost to Follow-up|3|||
23363227|NCT02061813|65076982|FG000|Overall Study|Withdrawal by Subject|1|||
23363228|NCT02061813|65076982|FG000|Overall Study|Protocol Violation|2|||
23363229|NCT04378569|65076983|FG000|Overall Study|Adverse Event|0|||
23363230|NCT04378569|65076984|FG001|Overall Study|Adverse Event|0|||
23363231|NCT04378569|65076985|FG002|Overall Study|Adverse Event|2|||
23363232|NCT04378569|65076986|FG003|Overall Study|Adverse Event|0|||
23363233|NCT04378569|65076987|FG004|Overall Study|Adverse Event|3|||
23363234|NCT04378569|65076988|FG005|Overall Study|Adverse Event|3|||
23363235|NCT04378569|65076983|FG000|Overall Study|Lost to Follow-up|0|||
23363236|NCT04378569|65076984|FG001|Overall Study|Lost to Follow-up|3|||
23363237|NCT04378569|65076985|FG002|Overall Study|Lost to Follow-up|1|||
23363238|NCT04378569|65076986|FG003|Overall Study|Lost to Follow-up|0|||
23363239|NCT04378569|65076987|FG004|Overall Study|Lost to Follow-up|1|||
23363240|NCT04378569|65076988|FG005|Overall Study|Lost to Follow-up|1|||
23363241|NCT04378569|65076983|FG000|Overall Study|Protocol Violation|0|||
23480574|NCT00998764|65502023|FG001|Overall Study|Protocol Violation|1|||
23480575|NCT00998764|65502022|FG000|Overall Study|Failed to Return|1|||
23480576|NCT00998764|65502023|FG001|Overall Study|Failed to Return|1|||
23480577|NCT00998764|65502022|FG000|Overall Study|Lost to Follow-up|1|||
23480578|NCT00998764|65502023|FG001|Overall Study|Lost to Follow-up|1|||
23480579|NCT00998764|65502022|FG000|Overall Study|Loss of Caregiver|0|||
23480580|NCT00998764|65502023|FG001|Overall Study|Loss of Caregiver|3|||
23480581|NCT00998764|65502022|FG000|Overall Study|Other|4|||
23480582|NCT00998764|65502023|FG001|Overall Study|Other|4|||
23480583|NCT00998764|65502022|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
23480584|NCT00998764|65502023|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
23480585|NCT03339297|65502024|FG000|Overall Study|Relapse of Hematologic Disease|1|||
23480586|NCT03339297|65502025|FG001|Overall Study|Relapse of Hematologic Disease|0|||
23480587|NCT03339297|65502024|FG000|Overall Study|Death|10|||
23480588|NCT03339297|65502025|FG001|Overall Study|Death|7|||
23480589|NCT03339297|65502024|FG000|Overall Study|Hepatic Candidosis|1|||
23480590|NCT03339297|65502025|FG001|Overall Study|Hepatic Candidosis|0|||
23480591|NCT03339297|65502024|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
23480592|NCT03339297|65502025|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
23480593|NCT03339297|65502024|FG000|Overall Study|Consent Withdrawn by Participant|3|||
23480594|NCT03339297|65502025|FG001|Overall Study|Consent Withdrawn by Participant|3|||
23480595|NCT03339297|65502024|FG000|Overall Study|Disease Relapse|2|||
23480596|NCT03339297|65502025|FG001|Overall Study|Disease Relapse|0|||
23480597|NCT03339297|65502024|FG000|Overall Study|Physician Decision|1|||
23480598|NCT03339297|65502025|FG001|Overall Study|Physician Decision|1|||
23480599|NCT03339297|65502024|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
23480600|NCT03339297|65502025|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
23480601|NCT03339297|65502024|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
23480602|NCT03339297|65502025|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
23480603|NCT03339297|65502024|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
23480604|NCT03339297|65502025|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
23480605|NCT03339297|65502024|FG000|Overall Study|Adverse Event, Non-fatal|1|||
23363242|NCT04378569|65076984|FG001|Overall Study|Protocol Violation|0|||
23363243|NCT04378569|65076985|FG002|Overall Study|Protocol Violation|0|||
23363244|NCT04378569|65076986|FG003|Overall Study|Protocol Violation|0|||
23363245|NCT04378569|65076987|FG004|Overall Study|Protocol Violation|0|||
23363246|NCT04378569|65076988|FG005|Overall Study|Protocol Violation|1|||
23363247|NCT04378569|65076983|FG000|Overall Study|Withdrawal by Subject|0|||
23363248|NCT04378569|65076984|FG001|Overall Study|Withdrawal by Subject|6|||
23363249|NCT04378569|65076985|FG002|Overall Study|Withdrawal by Subject|7|||
23363250|NCT04378569|65076986|FG003|Overall Study|Withdrawal by Subject|4|||
23363251|NCT04378569|65076987|FG004|Overall Study|Withdrawal by Subject|5|||
23363252|NCT04378569|65076988|FG005|Overall Study|Withdrawal by Subject|4|||
23363253|NCT04378569|65076983|FG000|Overall Study|Lack of response|0|||
23363254|NCT04378569|65076984|FG001|Overall Study|Lack of response|0|||
23363255|NCT04378569|65076985|FG002|Overall Study|Lack of response|1|||
23363256|NCT04378569|65076986|FG003|Overall Study|Lack of response|0|||
23363257|NCT04378569|65076987|FG004|Overall Study|Lack of response|1|||
23363258|NCT04378569|65076988|FG005|Overall Study|Lack of response|1|||
23363259|NCT02922153|65076989|FG000|Overall Study|Death|8|||
23363260|NCT02922153|65076990|FG001|Overall Study|Death|1|||
23363261|NCT02922153|65076989|FG000|Overall Study|Lost to Follow-up|1|||
23363262|NCT02922153|65076990|FG001|Overall Study|Lost to Follow-up|0|||
23363263|NCT02922153|65076989|FG000|Overall Study|Physician Decision|1|||
23363264|NCT02922153|65076990|FG001|Overall Study|Physician Decision|1|||
23363265|NCT02526160|65076991|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
23363266|NCT02526160|65076992|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
23480606|NCT03339297|65502025|FG001|Overall Study|Adverse Event, Non-fatal|0|||
23480607|NCT03339297|65502024|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
23480608|NCT03339297|65502025|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
23480609|NCT03339297|65502024|FG000|Overall Study|Patient Was Not Eligible|1|||
23480610|NCT03339297|65502025|FG001|Overall Study|Patient Was Not Eligible|0|||
23480611|NCT01743001|65502027|FG000|Overall Study|Physician Decision|1|||
23480612|NCT01743001|65502028|FG001|Overall Study|Physician Decision|0|||
23363267|NCT02526160|65076991|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
23363268|NCT02526160|65076992|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
23363269|NCT02526160|65076991|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
23480613|NCT01743001|65502027|FG000|Overall Study|Pregnancy|1|||
23480614|NCT01743001|65502028|FG001|Overall Study|Pregnancy|0|||
23480615|NCT01743001|65502027|FG000|Overall Study|Death|1|||
23480616|NCT01743001|65502028|FG001|Overall Study|Death|0|||
23480617|NCT02984943|65502029|FG000|Overall Study|Withdrawal by Subject|3|||
23480618|NCT02984943|65502029|FG000|Overall Study|Physician Decision|1|||
23363270|NCT02526160|65076992|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
23363271|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Death|0|||
23363272|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Death|1|||
23363273|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
23363274|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
23363275|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
23363276|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
23363277|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
23363278|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
23363279|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
23363280|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
23363281|NCT00723229|65076993|FG000|First Intervention|Lost to Follow-up|7|||
23363282|NCT00723229|65076994|FG001|First Intervention|Lost to Follow-up|3|||
23363283|NCT01921517|65076997|FG000|Overall Study|Lost to Follow-up|5|||
23363284|NCT01921517|65076998|FG001|Overall Study|Lost to Follow-up|0|||
23363285|NCT01921517|65076997|FG000|Overall Study|Newly diagnosed health concern|2|||
23363286|NCT01921517|65076998|FG001|Overall Study|Newly diagnosed health concern|0|||
23363287|NCT01921517|65076997|FG000|Overall Study|Physician Decision|0|||
23363288|NCT01921517|65076998|FG001|Overall Study|Physician Decision|2|||
23363289|NCT01921517|65076997|FG000|Overall Study|Withdrawal by Subject|7|||
23363290|NCT01921517|65076998|FG001|Overall Study|Withdrawal by Subject|3|||
23363291|NCT01921517|65076997|FG000|Overall Study|Subject missed final imaging|1|||
23363292|NCT01921517|65076998|FG001|Overall Study|Subject missed final imaging|4|||
23363293|NCT00458003|65076999|FG000|Overall Study|Non protocol spinal anesthesia|1|||
23363294|NCT00458003|65077000|FG001|Overall Study|Non protocol spinal anesthesia|1|||
23363295|NCT01367249|65077001|FG000|Overall Study|Withdrawal by Subject|6|||
23480619|NCT01904773|65502030|FG000|Screen|Screen failure|3|||
23480620|NCT01904773|65502031|FG001|Screen|Screen failure|0|||
23480621|NCT01904773|65502032|FG002|Screen|Screen failure|0|||
23480622|NCT01904773|65502033|FG003|Screen|Screen failure|0|||
23480623|NCT01904773|65502034|FG004|Screen|Screen failure|0|||
23480624|NCT01904773|65502035|FG005|Screen|Screen failure|0|||
23363296|NCT01367249|65077002|FG001|Overall Study|Withdrawal by Subject|6|||
23363297|NCT01367249|65077001|FG000|Overall Study|Other|3|||
23363298|NCT01367249|65077002|FG001|Overall Study|Other|10|||
23363299|NCT02219685|65077003|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
23363300|NCT02219685|65077004|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
23363301|NCT02219685|65077003|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
23363302|NCT02219685|65077004|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
23363303|NCT01038687|65077005|FG000|Overall Study|Adverse Event|0|||
23363304|NCT01038687|65077006|FG001|Overall Study|Adverse Event|2|||
23363305|NCT01038687|65077007|FG002|Overall Study|Adverse Event|1|||
23363306|NCT02131064|65077008|FG000|Overall Study|Death|5|||
23480625|NCT01904773|65502036|FG006|Screen|Screen failure|0|||
23480626|NCT01904773|65502037|FG007|Screen|Screen failure|0|||
23480627|NCT01904773|65502038|FG008|Screen|Screen failure|0|||
23480628|NCT01904773|65502030|FG000|Screen|Withdrawal by Subject|1|||
23480629|NCT01904773|65502031|FG001|Screen|Withdrawal by Subject|0|||
23480630|NCT01904773|65502032|FG002|Screen|Withdrawal by Subject|0|||
23480631|NCT01904773|65502033|FG003|Screen|Withdrawal by Subject|0|||
23480632|NCT01904773|65502034|FG004|Screen|Withdrawal by Subject|0|||
23480633|NCT01904773|65502035|FG005|Screen|Withdrawal by Subject|0|||
23480634|NCT01904773|65502036|FG006|Screen|Withdrawal by Subject|0|||
23363307|NCT02131064|65077009|FG001|Overall Study|Death|6|||
23363308|NCT02131064|65077008|FG000|Overall Study|Lost to Follow-up|4|||
23363309|NCT02131064|65077009|FG001|Overall Study|Lost to Follow-up|8|||
23363310|NCT02131064|65077008|FG000|Overall Study|Withdrawal by Subject|14|||
23363311|NCT02131064|65077009|FG001|Overall Study|Withdrawal by Subject|18|||
23363312|NCT02131064|65077008|FG000|Overall Study|Other|2|||
23480635|NCT01904773|65502037|FG007|Screen|Withdrawal by Subject|0|||
23480636|NCT01904773|65502038|FG008|Screen|Withdrawal by Subject|0|||
23363313|NCT02131064|65077009|FG001|Overall Study|Other|2|||
23363314|NCT00954122|65077010|FG000|Overall Study|Withdrawal by Subject|5|||
23363315|NCT00954122|65077010|FG000|Overall Study|Adverse Event|1|||
23363316|NCT00954122|65077010|FG000|Overall Study|Safety Reason|1|||
23363317|NCT02485483|65077011|FG000|Overall Study|Depression at baseline|15|||
23363318|NCT02485483|65077012|FG001|Overall Study|Depression at baseline|0|||
23363319|NCT02485483|65077011|FG000|Overall Study|Discontinued after baseline|39|||
23363320|NCT02485483|65077012|FG001|Overall Study|Discontinued after baseline|0|||
23480637|NCT01904773|65502030|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
23480638|NCT01904773|65502031|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23658690|NCT00122681|66139052|FG001|Overall Study|Lost to Follow-up|1097|||
23480639|NCT01904773|65502032|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480640|NCT01904773|65502033|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480641|NCT01904773|65502034|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480642|NCT01904773|65502035|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480643|NCT01904773|65502036|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23601069|NCT01437319|65929841|FG002|Phase I|Withdrawal by Subject|0|||
23480644|NCT01904773|65502037|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480645|NCT01904773|65502038|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480646|NCT01904773|65502030|FG000|First Intervention|Adverse Event|0|||
23480647|NCT01904773|65502031|FG001|First Intervention|Adverse Event|0|||
23480648|NCT01904773|65502032|FG002|First Intervention|Adverse Event|0|||
23480649|NCT01904773|65502033|FG003|First Intervention|Adverse Event|0|||
23480650|NCT01904773|65502034|FG004|First Intervention|Adverse Event|0|||
23480651|NCT01904773|65502035|FG005|First Intervention|Adverse Event|0|||
23480652|NCT01904773|65502036|FG006|First Intervention|Adverse Event|1|||
23480653|NCT01904773|65502037|FG007|First Intervention|Adverse Event|0|||
23480654|NCT01904773|65502038|FG008|First Intervention|Adverse Event|0|||
23480655|NCT01904773|65502030|FG000|Placebo Washout First Intervention|Condition worsened|0|||
23480656|NCT01904773|65502031|FG001|Placebo Washout First Intervention|Condition worsened|1|||
23480657|NCT01904773|65502032|FG002|Placebo Washout First Intervention|Condition worsened|0|||
23480658|NCT01904773|65502033|FG003|Placebo Washout First Intervention|Condition worsened|0|||
23480659|NCT01904773|65502034|FG004|Placebo Washout First Intervention|Condition worsened|0|||
23480660|NCT01904773|65502035|FG005|Placebo Washout First Intervention|Condition worsened|0|||
23480661|NCT01904773|65502036|FG006|Placebo Washout First Intervention|Condition worsened|0|||
23480662|NCT01904773|65502037|FG007|Placebo Washout First Intervention|Condition worsened|0|||
23480663|NCT01904773|65502038|FG008|Placebo Washout First Intervention|Condition worsened|0|||
23480664|NCT01904773|65502030|FG000|Fifth Intervention|Adverse Event|0|||
23480665|NCT01904773|65502031|FG001|Fifth Intervention|Adverse Event|0|||
23480666|NCT01904773|65502032|FG002|Fifth Intervention|Adverse Event|0|||
23480667|NCT01904773|65502033|FG003|Fifth Intervention|Adverse Event|0|||
23480668|NCT01904773|65502034|FG004|Fifth Intervention|Adverse Event|0|||
23480669|NCT01904773|65502035|FG005|Fifth Intervention|Adverse Event|0|||
23480670|NCT01904773|65502036|FG006|Fifth Intervention|Adverse Event|0|||
23480671|NCT01904773|65502037|FG007|Fifth Intervention|Adverse Event|1|||
23480672|NCT01904773|65502038|FG008|Fifth Intervention|Adverse Event|0|||
23480673|NCT01904773|65502030|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480674|NCT01904773|65502031|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
23480675|NCT01904773|65502032|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480676|NCT01904773|65502033|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480677|NCT01904773|65502034|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480678|NCT01904773|65502035|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480679|NCT01904773|65502036|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480680|NCT01904773|65502037|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480681|NCT01904773|65502038|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480682|NCT00984620|65502039|FG000|Overall Study|Adverse Event|5|||
23480683|NCT00984620|65502040|FG001|Overall Study|Adverse Event|5|||
23480684|NCT00984620|65502039|FG000|Overall Study|Lost to Follow-up|1|||
23480685|NCT00984620|65502040|FG001|Overall Study|Lost to Follow-up|1|||
23480686|NCT00984620|65502039|FG000|Overall Study|Withdrawal by Subject|0|||
23480687|NCT00984620|65502040|FG001|Overall Study|Withdrawal by Subject|2|||
23480688|NCT00984620|65502039|FG000|Overall Study|reason other than listed above|0|||
23480689|NCT00984620|65502040|FG001|Overall Study|reason other than listed above|4|||
23480690|NCT01122264|65502041|FG000|Overall Study|Adverse Event|6|||
23480691|NCT01122264|65502042|FG001|Overall Study|Adverse Event|5|||
23480692|NCT01122264|65502043|FG002|Overall Study|Adverse Event|7|||
23480693|NCT01122264|65502041|FG000|Overall Study|Death|1|||
23480694|NCT01122264|65502042|FG001|Overall Study|Death|0|||
23480695|NCT01122264|65502043|FG002|Overall Study|Death|0|||
23480696|NCT01122264|65502041|FG000|Overall Study|Lost to Follow-up|5|||
23480697|NCT01122264|65502042|FG001|Overall Study|Lost to Follow-up|9|||
23480698|NCT01122264|65502043|FG002|Overall Study|Lost to Follow-up|13|||
23480699|NCT01122264|65502041|FG000|Overall Study|Entry Criteria Not Met|1|||
23480700|NCT01122264|65502042|FG001|Overall Study|Entry Criteria Not Met|0|||
23480701|NCT01122264|65502043|FG002|Overall Study|Entry Criteria Not Met|0|||
23480702|NCT01122264|65502041|FG000|Overall Study|Protocol Violation|7|||
23480703|NCT01122264|65502042|FG001|Overall Study|Protocol Violation|7|||
23480704|NCT01122264|65502043|FG002|Overall Study|Protocol Violation|9|||
23480705|NCT01122264|65502041|FG000|Overall Study|Withdrawal by Subject|6|||
23480706|NCT01122264|65502042|FG001|Overall Study|Withdrawal by Subject|6|||
23480707|NCT01122264|65502043|FG002|Overall Study|Withdrawal by Subject|16|||
23480708|NCT01122264|65502041|FG000|Overall Study|Physician Decision|3|||
23480709|NCT01122264|65502042|FG001|Overall Study|Physician Decision|1|||
23480710|NCT01122264|65502043|FG002|Overall Study|Physician Decision|1|||
23480711|NCT01122264|65502041|FG000|Overall Study|Lack of Efficacy|3|||
23480712|NCT01122264|65502042|FG001|Overall Study|Lack of Efficacy|1|||
23480713|NCT01122264|65502043|FG002|Overall Study|Lack of Efficacy|1|||
23480714|NCT00718237|65502044|FG000|Overall Study|Adverse Event|1|||
23480715|NCT00718237|65502045|FG001|Overall Study|Adverse Event|3|||
23480716|NCT00718237|65502044|FG000|Overall Study|Lost to Follow-up|2|||
23480717|NCT00718237|65502045|FG001|Overall Study|Lost to Follow-up|2|||
23480718|NCT00718237|65502044|FG000|Overall Study|Physician Decision|1|||
23480719|NCT00718237|65502045|FG001|Overall Study|Physician Decision|0|||
23480720|NCT00718237|65502044|FG000|Overall Study|Withdrawal by Subject|9|||
23480721|NCT00718237|65502045|FG001|Overall Study|Withdrawal by Subject|10|||
23480722|NCT03985878|65502047|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
23480723|NCT03985878|65502047|FG000|Overall Study|Study Terminated by Sponsor|12|||
23480724|NCT03985878|65502047|FG000|Overall Study|Withdrawal by Subject|1|||
23480725|NCT01534182|65502048|FG000|Overall Study|Administrative problems|1|||
23480726|NCT01534182|65502049|FG001|Overall Study|Administrative problems|0|||
23480727|NCT01534182|65502048|FG000|Overall Study|Withdrawal by Subject|4|||
23601070|NCT01437319|65929839|FG000|Phase II|Withdrawal by Subject|0|||
23601071|NCT01437319|65929840|FG001|Phase II|Withdrawal by Subject|8|||
23601072|NCT01437319|65929841|FG002|Phase II|Withdrawal by Subject|16|||
23601073|NCT01437319|65929839|FG000|Phase II|Lost to Follow-up|0|||
23601074|NCT01437319|65929840|FG001|Phase II|Lost to Follow-up|7|||
23601075|NCT01437319|65929841|FG002|Phase II|Lost to Follow-up|2|||
23601076|NCT01437319|65929839|FG000|Phase II|Study related symptoms/complaints|0|||
23601077|NCT01437319|65929840|FG001|Phase II|Study related symptoms/complaints|28|||
23601078|NCT01437319|65929841|FG002|Phase II|Study related symptoms/complaints|19|||
23480728|NCT01534182|65502049|FG001|Overall Study|Withdrawal by Subject|7|||
23480729|NCT01534182|65502048|FG000|Overall Study|Adverse Event|7|||
23601079|NCT01437319|65929839|FG000|Phase II|Protocol Violation|0|||
23658691|NCT00122681|66139051|FG000|Overall Study|Protocol Violation|7|||
23658692|NCT00122681|66139052|FG001|Overall Study|Protocol Violation|10|||
23658693|NCT00122681|66139051|FG000|Overall Study|Withdrawal by Subject|257|||
23658694|NCT00122681|66139052|FG001|Overall Study|Withdrawal by Subject|251|||
23480730|NCT01534182|65502049|FG001|Overall Study|Adverse Event|3|||
23480731|NCT04022733|65502059|FG000|Overall Study|conversion to open surgery|3|||
23480732|NCT04022733|65502060|FG001|Overall Study|conversion to open surgery|2|||
23480733|NCT04022733|65502059|FG000|Overall Study|bradycardia|0|||
23480734|NCT04022733|65502060|FG001|Overall Study|bradycardia|1|||
23480735|NCT03011892|65502061|FG000|Double Blind (DB) Period|Adverse Event|0|||
23480736|NCT03011892|65502062|FG001|Double Blind (DB) Period|Adverse Event|1|||
23480737|NCT03011892|65502063|FG002|Double Blind (DB) Period|Adverse Event|1|||
23480738|NCT03011892|65502064|FG003|Double Blind (DB) Period|Adverse Event|0|||
23480739|NCT03011892|65502065|FG004|Double Blind (DB) Period|Adverse Event|0|||
23480740|NCT03011892|65502066|FG005|Double Blind (DB) Period|Adverse Event|0|||
23480741|NCT03011892|65502067|FG006|Double Blind (DB) Period|Adverse Event|0|||
23480742|NCT03011892|65502068|FG007|Double Blind (DB) Period|Adverse Event|0|||
23480743|NCT03011892|65502069|FG008|Double Blind (DB) Period|Adverse Event|0|||
23480744|NCT03011892|65502070|FG009|Double Blind (DB) Period|Adverse Event|0|||
23480745|NCT03011892|65502071|FG010|Double Blind (DB) Period|Adverse Event|0|||
23480746|NCT03011892|65502072|FG011|Double Blind (DB) Period|Adverse Event|0|||
23480747|NCT03011892|65502061|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
23480748|NCT03011892|65502062|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
23480749|NCT03011892|65502063|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
23480750|NCT03011892|65502064|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
23480751|NCT03011892|65502065|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
23480752|NCT03011892|65502066|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
23480753|NCT03011892|65502067|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
23658695|NCT00122681|66139051|FG000|Overall Study|Personal reasons|150|||
23480754|NCT03011892|65502068|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
23480755|NCT03011892|65502069|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
23480756|NCT03011892|65502070|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
23480757|NCT03011892|65502071|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
23658696|NCT00122681|66139052|FG001|Overall Study|Personal reasons|147|||
23658697|NCT01252810|66139055|FG000|Overall Study|Withdrawal by Subject|4|||
23658698|NCT01252810|66139056|FG001|Overall Study|Withdrawal by Subject|1|||
23658699|NCT01252810|66139055|FG000|Overall Study|Lost to Follow-up|0|||
23658700|NCT01252810|66139056|FG001|Overall Study|Lost to Follow-up|1|||
23363321|NCT02053493|65077016|FG000|Overall Study|Withdrawal by Subject|1|||
23363322|NCT02053493|65077017|FG001|Overall Study|Withdrawal by Subject|1|||
23363323|NCT02283658|65077025|FG000|Overall Study|Withdrawal by Subject|1|||
23363324|NCT02753816|65077028|FG000|Overall Study|Protocol Violation|0|||
23363325|NCT02753816|65077029|FG001|Overall Study|Protocol Violation|1|||
23363326|NCT02753816|65077030|FG002|Overall Study|Protocol Violation|0|||
23363327|NCT00931632|65077031|FG000|Overall Study|Withdrawal by Subject|2|||
23363328|NCT00931632|65077032|FG001|Overall Study|Withdrawal by Subject|3|||
23363329|NCT00931632|65077031|FG000|Overall Study|Adverse Event|19|||
23658701|NCT01252810|66139055|FG000|Overall Study|Physician Decision|2|||
23363330|NCT00931632|65077032|FG001|Overall Study|Adverse Event|15|||
23363331|NCT02492165|65077033|FG000|Overall Study|Withdrawal by Subject|0|||
23363332|NCT02492165|65077034|FG001|Overall Study|Withdrawal by Subject|1|||
23363333|NCT02492165|65077035|FG002|Overall Study|Withdrawal by Subject|0|||
23363334|NCT02492165|65077036|FG003|Overall Study|Withdrawal by Subject|0|||
23363335|NCT00707057|65077039|FG000|Overall Study|Withdrawal by Subject|8|||
23363336|NCT00707057|65077040|FG001|Overall Study|Withdrawal by Subject|3|||
23363337|NCT00707057|65077039|FG000|Overall Study|Dosed incorrectly|0|||
23363338|NCT00707057|65077040|FG001|Overall Study|Dosed incorrectly|1|||
23363339|NCT00447902|65077041|FG000|Overall Study|Adverse Event|0|||
23480758|NCT03011892|65502072|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
23658702|NCT01252810|66139056|FG001|Overall Study|Physician Decision|1|||
23658703|NCT01252810|66139055|FG000|Overall Study|Various reasons|8|||
23658704|NCT01252810|66139056|FG001|Overall Study|Various reasons|0|||
23480759|NCT03011892|65502061|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
23480760|NCT03011892|65502062|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
23480761|NCT03011892|65502063|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
23480762|NCT03011892|65502064|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
23480763|NCT03011892|65502065|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
23480764|NCT03011892|65502066|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
23480765|NCT03011892|65502067|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
23480766|NCT03011892|65502068|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
23480767|NCT03011892|65502069|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
23480768|NCT03011892|65502070|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
23480769|NCT03011892|65502071|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
23480770|NCT03011892|65502072|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
23480771|NCT03011892|65502061|FG000|Double Blind (DB) Period|Other|1|||
23480772|NCT03011892|65502062|FG001|Double Blind (DB) Period|Other|1|||
23658705|NCT02170779|66139060|FG000|Overall Study|Withdrawal by Subject|1|||
23658706|NCT02170779|66139061|FG001|Overall Study|Withdrawal by Subject|0|||
23658707|NCT02170779|66139060|FG000|Overall Study|Lost to Follow-up|0|||
23658708|NCT02170779|66139061|FG001|Overall Study|Lost to Follow-up|1|||
23658709|NCT01101438|66139064|FG000|Overall Study|Withdrawal by Subject|8|||
23658710|NCT01101438|66139065|FG001|Overall Study|Withdrawal by Subject|9|||
23658711|NCT02194062|66139066|FG000|Overall Study|Lost to Follow-up|2|||
23658712|NCT02194062|66139067|FG001|Overall Study|Lost to Follow-up|2|||
23658713|NCT02194062|66139068|FG002|Overall Study|Lost to Follow-up|5|||
23658714|NCT01514136|66139069|FG000|Test Period 1; Test A|Protocol Violation|1|||
23658715|NCT01514136|66139070|FG001|Test Period 1; Test A|Protocol Violation|0|||
23658716|NCT01514136|66139071|FG002|Test Period 1; Test A|Protocol Violation|0|||
23658717|NCT01514136|66139072|FG003|Test Period 1; Test A|Protocol Violation|0|||
23658718|NCT01514136|66139073|FG004|Test Period 1; Test A|Protocol Violation|0|||
23363340|NCT00447902|65077042|FG001|Overall Study|Adverse Event|3|||
23363341|NCT00447902|65077041|FG000|Overall Study|Protocol Violation|1|||
23480773|NCT03011892|65502063|FG002|Double Blind (DB) Period|Other|1|||
23480774|NCT03011892|65502064|FG003|Double Blind (DB) Period|Other|0|||
23480775|NCT03011892|65502065|FG004|Double Blind (DB) Period|Other|1|||
23480776|NCT03011892|65502066|FG005|Double Blind (DB) Period|Other|0|||
23480777|NCT03011892|65502067|FG006|Double Blind (DB) Period|Other|0|||
23480778|NCT03011892|65502068|FG007|Double Blind (DB) Period|Other|0|||
23480779|NCT03011892|65502069|FG008|Double Blind (DB) Period|Other|0|||
23658719|NCT01514136|66139074|FG005|Test Period 1; Test A|Protocol Violation|0|||
23658720|NCT01514136|66139075|FG006|Test Period 1; Test A|Protocol Violation|0|||
23658721|NCT01514136|66139076|FG007|Test Period 1; Test A|Protocol Violation|0|||
23363342|NCT00447902|65077042|FG001|Overall Study|Protocol Violation|0|||
23363343|NCT00447902|65077041|FG000|Overall Study|Withdrawal by Subject|0|||
23480780|NCT03011892|65502070|FG009|Double Blind (DB) Period|Other|0|||
23480781|NCT03011892|65502071|FG010|Double Blind (DB) Period|Other|0|||
23480782|NCT03011892|65502072|FG011|Double Blind (DB) Period|Other|0|||
23480783|NCT03011892|65502061|FG000|Double Blind (DB) Period|Physician Decision|1|||
23658722|NCT01514136|66139069|FG000|Test Period 1; Test A|Break from study holiday|2|||
23658723|NCT01514136|66139070|FG001|Test Period 1; Test A|Break from study holiday|0|||
23363344|NCT00447902|65077042|FG001|Overall Study|Withdrawal by Subject|1|||
23363345|NCT00447902|65077041|FG000|Overall Study|included patients who discontinued|1|||
23363346|NCT00447902|65077042|FG001|Overall Study|included patients who discontinued|1|||
23363347|NCT00447902|65077041|FG000|Overall Study|Lack of Efficacy|2|||
23363348|NCT00447902|65077042|FG001|Overall Study|Lack of Efficacy|1|||
23363349|NCT02581488|65077043|FG000|Overall Study|Adverse Event|6|||
23363350|NCT02581488|65077044|FG001|Overall Study|Adverse Event|7|||
23363351|NCT02581488|65077043|FG000|Overall Study|Lost to Follow-up|1|||
23363352|NCT02581488|65077044|FG001|Overall Study|Lost to Follow-up|0|||
23363353|NCT02581488|65077043|FG000|Overall Study|Withdrawal by Subject|1|||
23363354|NCT02581488|65077044|FG001|Overall Study|Withdrawal by Subject|0|||
23363355|NCT02581488|65077043|FG000|Overall Study|Non-Compliance|1|||
23363356|NCT02581488|65077044|FG001|Overall Study|Non-Compliance|0|||
23363357|NCT02581488|65077043|FG000|Overall Study|Protocol Violation|0|||
23363358|NCT02581488|65077044|FG001|Overall Study|Protocol Violation|4|||
23363359|NCT00379899|65077045|FG000|Overall Study|Adverse Event|7|||
23363360|NCT00379899|65077046|FG001|Overall Study|Adverse Event|3|||
23658724|NCT01514136|66139071|FG002|Test Period 1; Test A|Break from study holiday|0|||
23658725|NCT01514136|66139072|FG003|Test Period 1; Test A|Break from study holiday|0|||
23658726|NCT01514136|66139073|FG004|Test Period 1; Test A|Break from study holiday|0|||
23658727|NCT01514136|66139074|FG005|Test Period 1; Test A|Break from study holiday|0|||
23658728|NCT01514136|66139075|FG006|Test Period 1; Test A|Break from study holiday|0|||
23658729|NCT01514136|66139076|FG007|Test Period 1; Test A|Break from study holiday|0|||
23658730|NCT01514136|66139069|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
23658731|NCT01514136|66139070|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
23658732|NCT01514136|66139071|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
23658733|NCT01514136|66139072|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
23363361|NCT00379899|65077045|FG000|Overall Study|Death|10|||
23363362|NCT00379899|65077046|FG001|Overall Study|Death|10|||
23363363|NCT00379899|65077045|FG000|Overall Study|Lost to Follow-up|2|||
23363364|NCT00379899|65077046|FG001|Overall Study|Lost to Follow-up|4|||
23363365|NCT00379899|65077045|FG000|Overall Study|Physician Decision|3|||
23363366|NCT00379899|65077046|FG001|Overall Study|Physician Decision|4|||
23363367|NCT00379899|65077045|FG000|Overall Study|Withdrawal by Subject|5|||
23363368|NCT00379899|65077046|FG001|Overall Study|Withdrawal by Subject|5|||
23363369|NCT00379899|65077045|FG000|Overall Study|Ineligibility determined|0|||
23363370|NCT00379899|65077046|FG001|Overall Study|Ineligibility determined|1|||
23363371|NCT00379899|65077045|FG000|Overall Study|Noncompliance|1|||
23363372|NCT00379899|65077046|FG001|Overall Study|Noncompliance|1|||
23363373|NCT00379899|65077045|FG000|Overall Study|Parathyroidectomy|0|||
23363374|NCT00379899|65077046|FG001|Overall Study|Parathyroidectomy|2|||
23363375|NCT00379899|65077045|FG000|Overall Study|Renal transplantation|5|||
23363376|NCT00379899|65077046|FG001|Overall Study|Renal transplantation|4|||
23363377|NCT00379899|65077045|FG000|Overall Study|Coronary artery bypass graft|1|||
23363378|NCT00379899|65077046|FG001|Overall Study|Coronary artery bypass graft|1|||
23363379|NCT00379899|65077045|FG000|Overall Study|Other protocol-specified criteria|3|||
23363380|NCT00379899|65077046|FG001|Overall Study|Other protocol-specified criteria|4|||
23363381|NCT00379899|65077045|FG000|Overall Study|Other|3|||
23363382|NCT00379899|65077046|FG001|Overall Study|Other|1|||
23658734|NCT01514136|66139073|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
23658735|NCT01514136|66139074|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
23363383|NCT01158261|65077048|FG000|Overall Study|Lost to Follow-up|9|||
23363384|NCT01158261|65077048|FG000|Overall Study|Death|7|||
23363385|NCT01158261|65077048|FG000|Overall Study|Withdrawal by Subject|1|||
23363386|NCT02576977|65077049|FG000|Overall Study|Adverse Event|13|||
23363387|NCT02576977|65077050|FG001|Overall Study|Adverse Event|2|||
23363388|NCT02576977|65077049|FG000|Overall Study|Death|73|||
23363389|NCT02576977|65077050|FG001|Overall Study|Death|60|||
23363390|NCT02576977|65077049|FG000|Overall Study|Screen failure|1|||
23363391|NCT02576977|65077050|FG001|Overall Study|Screen failure|0|||
23658736|NCT01514136|66139075|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
23658737|NCT01514136|66139076|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
23658738|NCT01514136|66139069|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658739|NCT01514136|66139070|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658740|NCT01514136|66139071|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658741|NCT01514136|66139072|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
23658742|NCT01514136|66139073|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658743|NCT01514136|66139074|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658744|NCT01514136|66139075|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658745|NCT01514136|66139076|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
23658746|NCT01514136|66139069|FG000|Test Period 2; Test A*|Adverse Event|0|||
23658747|NCT01514136|66139070|FG001|Test Period 2; Test A*|Adverse Event|0|||
23658748|NCT01514136|66139071|FG002|Test Period 2; Test A*|Adverse Event|0|||
23658749|NCT01514136|66139072|FG003|Test Period 2; Test A*|Adverse Event|0|||
23658750|NCT01514136|66139073|FG004|Test Period 2; Test A*|Adverse Event|1|||
23658751|NCT01514136|66139074|FG005|Test Period 2; Test A*|Adverse Event|0|||
23658752|NCT01514136|66139075|FG006|Test Period 2; Test A*|Adverse Event|0|||
23658753|NCT01514136|66139076|FG007|Test Period 2; Test A*|Adverse Event|0|||
23658754|NCT01514136|66139069|FG000|Test Period 2; Test A*|Holiday|0|||
23658755|NCT01514136|66139070|FG001|Test Period 2; Test A*|Holiday|0|||
23480784|NCT03011892|65502062|FG001|Double Blind (DB) Period|Physician Decision|0|||
23658756|NCT01514136|66139071|FG002|Test Period 2; Test A*|Holiday|0|||
23658757|NCT01514136|66139072|FG003|Test Period 2; Test A*|Holiday|0|||
23658758|NCT01514136|66139073|FG004|Test Period 2; Test A*|Holiday|1|||
23658759|NCT01514136|66139074|FG005|Test Period 2; Test A*|Holiday|0|||
23658760|NCT01514136|66139075|FG006|Test Period 2; Test A*|Holiday|0|||
23658761|NCT01514136|66139076|FG007|Test Period 2; Test A*|Holiday|0|||
23658762|NCT01514136|66139069|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658763|NCT01514136|66139070|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658764|NCT01514136|66139071|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658765|NCT01514136|66139072|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658766|NCT01514136|66139073|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658767|NCT01514136|66139074|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
23658768|NCT01514136|66139075|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658769|NCT01514136|66139076|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
23658770|NCT01514136|66139069|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658771|NCT01514136|66139070|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658772|NCT01514136|66139071|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658773|NCT01514136|66139072|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658774|NCT01514136|66139073|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658775|NCT01514136|66139074|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658776|NCT01514136|66139075|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
23658777|NCT01514136|66139076|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
23658778|NCT01514136|66139069|FG000|Test Period 2; Test C*|holiday|0|||
23480785|NCT03011892|65502063|FG002|Double Blind (DB) Period|Physician Decision|1|||
23480786|NCT03011892|65502064|FG003|Double Blind (DB) Period|Physician Decision|0|||
23480787|NCT03011892|65502065|FG004|Double Blind (DB) Period|Physician Decision|0|||
23480788|NCT03011892|65502066|FG005|Double Blind (DB) Period|Physician Decision|0|||
23480789|NCT03011892|65502067|FG006|Double Blind (DB) Period|Physician Decision|0|||
23480790|NCT03011892|65502068|FG007|Double Blind (DB) Period|Physician Decision|0|||
23480791|NCT03011892|65502069|FG008|Double Blind (DB) Period|Physician Decision|0|||
23480792|NCT03011892|65502070|FG009|Double Blind (DB) Period|Physician Decision|0|||
23480793|NCT03011892|65502071|FG010|Double Blind (DB) Period|Physician Decision|0|||
23480794|NCT03011892|65502072|FG011|Double Blind (DB) Period|Physician Decision|0|||
23480795|NCT03011892|65502061|FG000|Double Blind (DB) Period|Pregnancy|0|||
23480796|NCT03011892|65502062|FG001|Double Blind (DB) Period|Pregnancy|0|||
23480797|NCT03011892|65502063|FG002|Double Blind (DB) Period|Pregnancy|0|||
23480798|NCT03011892|65502064|FG003|Double Blind (DB) Period|Pregnancy|0|||
23480799|NCT03011892|65502065|FG004|Double Blind (DB) Period|Pregnancy|1|||
23658779|NCT01514136|66139070|FG001|Test Period 2; Test C*|holiday|0|||
23658780|NCT01514136|66139071|FG002|Test Period 2; Test C*|holiday|0|||
23480800|NCT03011892|65502066|FG005|Double Blind (DB) Period|Pregnancy|0|||
23658781|NCT01514136|66139072|FG003|Test Period 2; Test C*|holiday|0|||
23658782|NCT01514136|66139073|FG004|Test Period 2; Test C*|holiday|0|||
23658783|NCT01514136|66139074|FG005|Test Period 2; Test C*|holiday|0|||
23658784|NCT01514136|66139075|FG006|Test Period 2; Test C*|holiday|1|||
23658785|NCT01514136|66139076|FG007|Test Period 2; Test C*|holiday|0|||
23658786|NCT01514136|66139069|FG000|Test Period 2; Test C*|Protocol Violation|0|||
23658787|NCT01514136|66139070|FG001|Test Period 2; Test C*|Protocol Violation|0|||
23480801|NCT03011892|65502067|FG006|Double Blind (DB) Period|Pregnancy|0|||
23480802|NCT03011892|65502068|FG007|Double Blind (DB) Period|Pregnancy|0|||
23480803|NCT03011892|65502069|FG008|Double Blind (DB) Period|Pregnancy|0|||
23480804|NCT03011892|65502070|FG009|Double Blind (DB) Period|Pregnancy|0|||
23363392|NCT02576977|65077049|FG000|Overall Study|Study Terminated at Selected Sites|27|||
23363393|NCT02576977|65077050|FG001|Overall Study|Study Terminated at Selected Sites|50|||
23363394|NCT02576977|65077049|FG000|Overall Study|Withdrawal by Subject|11|||
23363395|NCT02576977|65077050|FG001|Overall Study|Withdrawal by Subject|11|||
23363396|NCT02576977|65077049|FG000|Overall Study|Final Disposition Unknown|0|||
23363397|NCT02576977|65077050|FG001|Overall Study|Final Disposition Unknown|1|||
23363398|NCT02576977|65077049|FG000|Overall Study|Lost to Follow-up|1|||
23480805|NCT03011892|65502071|FG010|Double Blind (DB) Period|Pregnancy|0|||
23480806|NCT03011892|65502072|FG011|Double Blind (DB) Period|Pregnancy|0|||
23480807|NCT03011892|65502061|FG000|Double Blind (DB) Period|Protocol Violation|1|||
23480808|NCT03011892|65502062|FG001|Double Blind (DB) Period|Protocol Violation|0|||
23480809|NCT03011892|65502063|FG002|Double Blind (DB) Period|Protocol Violation|0|||
23480810|NCT03011892|65502064|FG003|Double Blind (DB) Period|Protocol Violation|0|||
23480811|NCT03011892|65502065|FG004|Double Blind (DB) Period|Protocol Violation|0|||
23480812|NCT03011892|65502066|FG005|Double Blind (DB) Period|Protocol Violation|0|||
23480813|NCT03011892|65502067|FG006|Double Blind (DB) Period|Protocol Violation|0|||
23480814|NCT03011892|65502068|FG007|Double Blind (DB) Period|Protocol Violation|0|||
23480815|NCT03011892|65502069|FG008|Double Blind (DB) Period|Protocol Violation|0|||
23480816|NCT03011892|65502070|FG009|Double Blind (DB) Period|Protocol Violation|0|||
23480817|NCT03011892|65502071|FG010|Double Blind (DB) Period|Protocol Violation|0|||
23480818|NCT03011892|65502072|FG011|Double Blind (DB) Period|Protocol Violation|0|||
23480819|NCT03011892|65502061|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
23658788|NCT01514136|66139071|FG002|Test Period 2; Test C*|Protocol Violation|0|||
23658789|NCT01514136|66139072|FG003|Test Period 2; Test C*|Protocol Violation|0|||
23658790|NCT01514136|66139073|FG004|Test Period 2; Test C*|Protocol Violation|0|||
23658791|NCT01514136|66139074|FG005|Test Period 2; Test C*|Protocol Violation|0|||
23658792|NCT01514136|66139075|FG006|Test Period 2; Test C*|Protocol Violation|1|||
23658793|NCT01514136|66139076|FG007|Test Period 2; Test C*|Protocol Violation|0|||
23658794|NCT00430482|66139077|FG000|Completed Treatment|Insufficient Treatment|7|||
23363399|NCT02576977|65077050|FG001|Overall Study|Lost to Follow-up|0|||
23480820|NCT03011892|65502062|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
23480821|NCT03011892|65502063|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
23480822|NCT03011892|65502064|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
23658795|NCT00430482|66139078|FG001|Completed Treatment|Insufficient Treatment|11|||
23363400|NCT02576977|65077049|FG000|Overall Study|Progressive Disease|0|||
23363401|NCT02576977|65077050|FG001|Overall Study|Progressive Disease|1|||
23363402|NCT03771963|65077051|FG000|Overall Study|Lost to Follow-up|22|||
23363403|NCT03771963|65077051|FG000|Overall Study|Withdrawal of Consent|10|||
23363404|NCT02277028|65077052|FG000|Overall Study|Lost to Follow-up|1|||
23363405|NCT02277028|65077053|FG001|Overall Study|Lost to Follow-up|0|||
23363406|NCT02277028|65077052|FG000|Overall Study|Withdrawal by Subject|0|||
23363407|NCT02277028|65077053|FG001|Overall Study|Withdrawal by Subject|1|||
23363408|NCT04069715|65077054|FG000|Overall Study|Lost to Follow-up|1|||
23363409|NCT04069715|65077055|FG001|Overall Study|Lost to Follow-up|1|||
23363410|NCT04069715|65077054|FG000|Overall Study|Physician Decision|1|||
23363411|NCT04069715|65077055|FG001|Overall Study|Physician Decision|1|||
23363412|NCT04069715|65077054|FG000|Overall Study|Withdrawal by Subject|3|||
23363413|NCT04069715|65077055|FG001|Overall Study|Withdrawal by Subject|3|||
23363414|NCT03160716|65077061|FG000|Overall Study|Lost to Follow-up|1|||
23658796|NCT03426787|66139081|FG000|Overall Study|Withdrawal by Subject|6|||
23658797|NCT03426787|66139081|FG000|Overall Study|Lost to Follow-up|7|||
23658798|NCT03426787|66139081|FG000|Overall Study|Unrelated to intervention death|1|||
23658799|NCT02357134|66139082|FG000|Overall Study|Lost to Follow-up|1|||
23658800|NCT02357134|66139083|FG001|Overall Study|Lost to Follow-up|0|||
23658801|NCT02357134|66139084|FG002|Overall Study|Lost to Follow-up|0|||
23658802|NCT02357134|66139085|FG003|Overall Study|Lost to Follow-up|0|||
23658803|NCT00916149|66139088|FG000|Overall Study|Lost to Follow-up|3|||
23658804|NCT00916149|66139089|FG001|Overall Study|Lost to Follow-up|2|||
23658805|NCT00916149|66139090|FG002|Overall Study|Lost to Follow-up|0|||
23658806|NCT00916149|66139088|FG000|Overall Study|Unable to place scalp EEG leads|1|||
23658807|NCT00916149|66139089|FG001|Overall Study|Unable to place scalp EEG leads|0|||
23658808|NCT00916149|66139090|FG002|Overall Study|Unable to place scalp EEG leads|0|||
23658809|NCT02973087|66139091|FG000|Overall Study|Withdrawal by Subject|2|||
23658810|NCT02973087|66139092|FG001|Overall Study|Withdrawal by Subject|1|||
23658811|NCT02973087|66139091|FG000|Overall Study|Adverse Event|1|||
23658812|NCT02973087|66139092|FG001|Overall Study|Adverse Event|0|||
23658813|NCT02973087|66139091|FG000|Overall Study|other|1|||
23658814|NCT02973087|66139092|FG001|Overall Study|other|1|||
23658815|NCT00943579|66139093|FG000|Overall Study|Adverse Event|4|||
23658816|NCT00943579|66139094|FG001|Overall Study|Adverse Event|3|||
23658817|NCT00943579|66139093|FG000|Overall Study|Lack of Efficacy|2|||
23658818|NCT00943579|66139094|FG001|Overall Study|Lack of Efficacy|2|||
23658819|NCT02019420|66139095|FG000|Overall Study|Did not receive study drug|2|||
23658820|NCT02019420|66139096|FG001|Overall Study|Did not receive study drug|2|||
23658821|NCT02019420|66139095|FG000|Overall Study|Withdrawal by Subject|1|||
23658822|NCT02019420|66139096|FG001|Overall Study|Withdrawal by Subject|3|||
23658823|NCT02019420|66139095|FG000|Overall Study|At request of sponsor or investigator|0|||
23658824|NCT02019420|66139096|FG001|Overall Study|At request of sponsor or investigator|1|||
23658825|NCT02019420|66139095|FG000|Overall Study|Death|104|||
23658826|NCT02019420|66139096|FG001|Overall Study|Death|99|||
23658827|NCT02019420|66139095|FG000|Overall Study|Transferred to other care facility|1|||
23658828|NCT02019420|66139096|FG001|Overall Study|Transferred to other care facility|1|||
23658829|NCT01235793|66139099|FG000|Overall Study|Death|6|||
23658830|NCT02818920|66139100|FG000|Overall Study|Unresectable|4|||
23658831|NCT02818920|66139100|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
23658832|NCT02818920|66139100|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
23658833|NCT02818920|66139100|FG000|Overall Study|Adverse Event|3|||
23658834|NCT02818920|66139100|FG000|Overall Study|Developed Other Disease|1|||
23363415|NCT03755518|65077063|FG000|Overall Study|Adverse Event|6|||
23363416|NCT03755518|65077063|FG000|Overall Study|Lack of Efficacy|6|||
23658835|NCT02818920|66139100|FG000|Overall Study|Refused Further Treatment|1|||
23658836|NCT00702325|66139106|FG000|Overall Study|Adverse Event|1|||
23658837|NCT00702325|66139107|FG001|Overall Study|Adverse Event|0|||
23658838|NCT00702325|66139106|FG000|Overall Study|Withdrawal by Subject|7|||
23658839|NCT00702325|66139107|FG001|Overall Study|Withdrawal by Subject|7|||
23658840|NCT00702325|66139106|FG000|Overall Study|Lost to Follow-up|3|||
23658841|NCT00702325|66139107|FG001|Overall Study|Lost to Follow-up|4|||
23658842|NCT00702325|66139106|FG000|Overall Study|Incorrect enrollment|5|||
23658843|NCT00702325|66139107|FG001|Overall Study|Incorrect enrollment|7|||
23363417|NCT03755518|65077063|FG000|Overall Study|Bone Marrow Transplant|4|||
23363418|NCT03755518|65077063|FG000|Overall Study|Withdrawal by participant|4|||
23363419|NCT03755518|65077063|FG000|Overall Study|Progressive Disease|2|||
23363420|NCT03755518|65077063|FG000|Overall Study|Death|1|||
23658844|NCT00702325|66139106|FG000|Overall Study|Developed study discontinuation criteria|18|||
23658845|NCT00702325|66139107|FG001|Overall Study|Developed study discontinuation criteria|28|||
23658846|NCT00702325|66139106|FG000|Overall Study|Severe noncompliance to protocol|3|||
23658847|NCT00702325|66139107|FG001|Overall Study|Severe noncompliance to protocol|3|||
23658848|NCT00702325|66139106|FG000|Overall Study|Termination due to lab results|1|||
23658849|NCT00702325|66139107|FG001|Overall Study|Termination due to lab results|0|||
23658850|NCT00702325|66139106|FG000|Overall Study|Didn't follow study medication dosage|0|||
23658851|NCT00702325|66139107|FG001|Overall Study|Didn't follow study medication dosage|2|||
23658852|NCT00702325|66139106|FG000|Overall Study|Withdrew consent|0|||
23658853|NCT00702325|66139107|FG001|Overall Study|Withdrew consent|1|||
23658854|NCT00702325|66139106|FG000|Overall Study|Incorrectly Discontinued|0|||
23658855|NCT00702325|66139107|FG001|Overall Study|Incorrectly Discontinued|1|||
23658856|NCT03472924|66139112|FG000|Overall Study|Adverse Event|1|||
23658857|NCT03472924|66139113|FG001|Overall Study|Adverse Event|0|||
23658858|NCT01335009|66139114|FG000|Overall Study|Too ill to travel to study sites|1|||
23658859|NCT01335009|66139115|FG001|Overall Study|Too ill to travel to study sites|0|||
23363421|NCT03755518|65077063|FG000|Overall Study|Physician Decision|1|||
23363422|NCT03755518|65077063|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
23363423|NCT01683604|65077092|FG000|Overall Study|Adverse Event|2|||
23363424|NCT01683604|65077092|FG000|Overall Study|Lack of Efficacy|1|||
23363425|NCT01683604|65077092|FG000|Overall Study|Other|2|||
23363426|NCT02573259|65077093|FG000|Overall Study|Death|1|||
23363427|NCT02573259|65077094|FG001|Overall Study|Death|6|||
23363428|NCT02573259|65077095|FG002|Overall Study|Death|5|||
23363429|NCT02573259|65077096|FG003|Overall Study|Death|6|||
23363430|NCT02573259|65077097|FG004|Overall Study|Death|9|||
23363431|NCT02573259|65077098|FG005|Overall Study|Death|32|||
23363432|NCT02573259|65077099|FG006|Overall Study|Death|21|||
23363433|NCT02573259|65077093|FG000|Overall Study|Lost to Follow-up|0|||
23363434|NCT02573259|65077094|FG001|Overall Study|Lost to Follow-up|0|||
23363435|NCT02573259|65077095|FG002|Overall Study|Lost to Follow-up|0|||
23363436|NCT02573259|65077096|FG003|Overall Study|Lost to Follow-up|0|||
23363437|NCT02573259|65077097|FG004|Overall Study|Lost to Follow-up|0|||
23363438|NCT02573259|65077098|FG005|Overall Study|Lost to Follow-up|2|||
23363439|NCT02573259|65077099|FG006|Overall Study|Lost to Follow-up|1|||
23363440|NCT02573259|65077093|FG000|Overall Study|Participant refused further follow-up|0|||
23363441|NCT02573259|65077094|FG001|Overall Study|Participant refused further follow-up|2|||
23363442|NCT02573259|65077095|FG002|Overall Study|Participant refused further follow-up|1|||
23363443|NCT02573259|65077096|FG003|Overall Study|Participant refused further follow-up|0|||
23363444|NCT02573259|65077097|FG004|Overall Study|Participant refused further follow-up|3|||
23363445|NCT02573259|65077098|FG005|Overall Study|Participant refused further follow-up|20|||
23363446|NCT02573259|65077099|FG006|Overall Study|Participant refused further follow-up|7|||
23363447|NCT02573259|65077093|FG000|Overall Study|Other|0|||
23363448|NCT02573259|65077094|FG001|Overall Study|Other|0|||
23363449|NCT02573259|65077095|FG002|Overall Study|Other|0|||
23363450|NCT02573259|65077096|FG003|Overall Study|Other|0|||
23363451|NCT02573259|65077097|FG004|Overall Study|Other|1|||
23363452|NCT02573259|65077098|FG005|Overall Study|Other|4|||
23363453|NCT02573259|65077099|FG006|Overall Study|Other|5|||
23363454|NCT00248651|65077103|FG000|Overall Study|Withdrawal by Subject|28|||
23363455|NCT00248651|65077104|FG001|Overall Study|Withdrawal by Subject|40|||
23363456|NCT00248651|65077105|FG002|Overall Study|Withdrawal by Subject|32|||
23363457|NCT00101868|65077106|FG000|Overall Study|Death|10|||
23363458|NCT00101868|65077107|FG001|Overall Study|Death|10|||
23363459|NCT00101868|65077106|FG000|Overall Study|Withdrawal by Subject|8|||
23363460|NCT00101868|65077107|FG001|Overall Study|Withdrawal by Subject|9|||
23363461|NCT00101868|65077106|FG000|Overall Study|Protocol Violation|3|||
23363462|NCT00101868|65077107|FG001|Overall Study|Protocol Violation|0|||
23363463|NCT00101868|65077106|FG000|Overall Study|Lost to Follow-up|8|||
23363464|NCT00101868|65077107|FG001|Overall Study|Lost to Follow-up|13|||
23363465|NCT00003471|65077108|FG000|Overall Study|Not evaluable|4|||
23363466|NCT02039778|65077109|FG000|Overall Study|Death|2|||
23363467|NCT02039778|65077109|FG000|Overall Study|Withdrawal by Subject|1|||
23363468|NCT02039778|65077109|FG000|Overall Study|Never started the protocol treatment|1|||
23363469|NCT02106351|65077110|FG000|Treatment Cycle 1|Adverse Event|2|||
23363470|NCT02106351|65077111|FG001|Treatment Cycle 1|Adverse Event|0|||
23363471|NCT02106351|65077112|FG002|Treatment Cycle 1|Adverse Event|0|||
23363472|NCT02106351|65077110|FG000|Treatment Cycle 1|Consent withdrawn|1|||
23363473|NCT02106351|65077111|FG001|Treatment Cycle 1|Consent withdrawn|0|||
23363474|NCT02106351|65077112|FG002|Treatment Cycle 1|Consent withdrawn|2|||
23363475|NCT02106351|65077110|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23363476|NCT02106351|65077111|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
23363477|NCT02106351|65077112|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
23363478|NCT02106351|65077110|FG000|Treatment Cycle 1|Other|0|||
23363479|NCT02106351|65077111|FG001|Treatment Cycle 1|Other|3|||
23480823|NCT03011892|65502065|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
23480824|NCT03011892|65502066|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
23363480|NCT02106351|65077112|FG002|Treatment Cycle 1|Other|1|||
23363481|NCT02106351|65077110|FG000|Treatment Cycle 1|Randomised but not treated|1|||
23363482|NCT02106351|65077111|FG001|Treatment Cycle 1|Randomised but not treated|0|||
23363483|NCT02106351|65077112|FG002|Treatment Cycle 1|Randomised but not treated|1|||
23363484|NCT02106351|65077110|FG000|Treatment Cycle 2|Adverse Event|0|||
23480825|NCT03011892|65502067|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480826|NCT03011892|65502068|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480827|NCT03011892|65502069|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
23658860|NCT01335009|66139114|FG000|Overall Study|Death|28|||
23480828|NCT03011892|65502070|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480829|NCT03011892|65502071|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480830|NCT03011892|65502072|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480831|NCT03011892|65502061|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
23480832|NCT03011892|65502062|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
23480833|NCT03011892|65502063|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
23480834|NCT03011892|65502064|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
23480835|NCT03011892|65502065|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
23480836|NCT03011892|65502066|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
23480837|NCT03011892|65502067|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
23480838|NCT03011892|65502068|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
23480839|NCT03011892|65502069|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
23480840|NCT03011892|65502070|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
23480841|NCT03011892|65502071|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
23480842|NCT03011892|65502072|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
23480843|NCT03011892|65502061|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
23480844|NCT03011892|65502062|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
23480845|NCT03011892|65502063|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
23480846|NCT03011892|65502064|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
23480847|NCT03011892|65502065|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
23480848|NCT03011892|65502066|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
23480849|NCT03011892|65502067|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
23480850|NCT03011892|65502068|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
23480851|NCT03011892|65502069|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
23480852|NCT03011892|65502070|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
23480853|NCT03011892|65502071|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
23480854|NCT03011892|65502072|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
23480855|NCT03011892|65502061|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
23480856|NCT03011892|65502062|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
23480857|NCT03011892|65502063|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
23480858|NCT03011892|65502064|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
23480859|NCT03011892|65502065|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
23480860|NCT03011892|65502066|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
23480861|NCT03011892|65502067|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
23480862|NCT03011892|65502068|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
23480863|NCT03011892|65502069|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
23480864|NCT03011892|65502070|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
23480865|NCT03011892|65502071|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
23480866|NCT03011892|65502072|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
23480867|NCT03011892|65502061|FG000|Open Label (OL) Period|Reason not specified|0|||
23480868|NCT03011892|65502062|FG001|Open Label (OL) Period|Reason not specified|0|||
23480869|NCT03011892|65502063|FG002|Open Label (OL) Period|Reason not specified|0|||
23480870|NCT03011892|65502064|FG003|Open Label (OL) Period|Reason not specified|0|||
23480871|NCT03011892|65502065|FG004|Open Label (OL) Period|Reason not specified|0|||
23480872|NCT03011892|65502066|FG005|Open Label (OL) Period|Reason not specified|0|||
23480873|NCT03011892|65502067|FG006|Open Label (OL) Period|Reason not specified|0|||
23480874|NCT03011892|65502068|FG007|Open Label (OL) Period|Reason not specified|1|||
23480875|NCT03011892|65502069|FG008|Open Label (OL) Period|Reason not specified|0|||
23480876|NCT03011892|65502070|FG009|Open Label (OL) Period|Reason not specified|0|||
23363485|NCT02106351|65077111|FG001|Treatment Cycle 2|Adverse Event|2|||
23363486|NCT02106351|65077112|FG002|Treatment Cycle 2|Adverse Event|0|||
23363487|NCT02106351|65077110|FG000|Treatment Cycle 2|Consent withdrawn|0|||
23363488|NCT02106351|65077111|FG001|Treatment Cycle 2|Consent withdrawn|1|||
23363489|NCT02106351|65077112|FG002|Treatment Cycle 2|Consent withdrawn|1|||
23480877|NCT03011892|65502071|FG010|Open Label (OL) Period|Reason not specified|0|||
23480878|NCT03011892|65502072|FG011|Open Label (OL) Period|Reason not specified|0|||
23480879|NCT00523367|65502073|FG000|Overall Study|19 screen failures|19|||
23480880|NCT00523367|65502073|FG000|Overall Study|4 Withdrawn by PI|4|||
23480881|NCT01107379|65502076|FG000|Overall Study|Withdrawal by Subject|18|||
23658861|NCT01335009|66139115|FG001|Overall Study|Death|32|||
23480882|NCT01107379|65502076|FG000|Overall Study|Lost to Follow-up|3|||
23480883|NCT00713310|65502080|FG000|Overall Study|Adverse Event|5|||
23480884|NCT00713310|65502081|FG001|Overall Study|Adverse Event|2|||
23480885|NCT00713310|65502080|FG000|Overall Study|Lack of Efficacy|0|||
23480886|NCT00713310|65502081|FG001|Overall Study|Lack of Efficacy|2|||
23480887|NCT00713310|65502080|FG000|Overall Study|Withdrawal by Subject|0|||
23480888|NCT00713310|65502081|FG001|Overall Study|Withdrawal by Subject|2|||
23480889|NCT01974765|65502082|FG000|Overall Study|Withdrawal by Subject|1|||
23480890|NCT01974765|65502082|FG000|Overall Study|Death|1|||
23480891|NCT01974765|65502082|FG000|Overall Study|Adverse Event|2|||
23480892|NCT02412488|65502089|FG000|Overall Study|Lost to Follow-up|10|||
23480893|NCT02412488|65502089|FG000|Overall Study|Withdrawal by Subject|5|||
23480894|NCT02412488|65502089|FG000|Overall Study|Physician Decision|1|||
23480895|NCT02412488|65502089|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
23480896|NCT02412488|65502089|FG000|Overall Study|Reveal LINQ explant|1|||
23480897|NCT01104376|65502090|FG000|Overall Study|Withdrawal by Subject|15|||
23480898|NCT01104376|65502090|FG000|Overall Study|Consented but excluded after labs|13|||
23480899|NCT02095132|65502091|FG000|Overall Study|Adverse Event|0|||
23658862|NCT01335009|66139114|FG000|Overall Study|Withdrawal by Subject|1|||
23658863|NCT01335009|66139115|FG001|Overall Study|Withdrawal by Subject|1|||
23363490|NCT02106351|65077110|FG000|Treatment Cycle 2|Other|0|||
23363491|NCT02106351|65077111|FG001|Treatment Cycle 2|Other|2|||
23363492|NCT02106351|65077112|FG002|Treatment Cycle 2|Other|2|||
23363493|NCT02106351|65077110|FG000|Treatment Cycle 3|Adverse Event|0|||
23363494|NCT02106351|65077111|FG001|Treatment Cycle 3|Adverse Event|1|||
23480900|NCT02095132|65502092|FG001|Overall Study|Adverse Event|0|||
23480901|NCT02095132|65502093|FG002|Overall Study|Adverse Event|0|||
23480902|NCT02095132|65502094|FG003|Overall Study|Adverse Event|0|||
23480903|NCT02095132|65502095|FG004|Overall Study|Adverse Event|1|||
23480904|NCT02095132|65502096|FG005|Overall Study|Adverse Event|0|||
23480905|NCT02095132|65502097|FG006|Overall Study|Adverse Event|1|||
23480906|NCT02095132|65502098|FG007|Overall Study|Adverse Event|0|||
23480907|NCT02095132|65502099|FG008|Overall Study|Adverse Event|0|||
23480908|NCT02095132|65502091|FG000|Overall Study|Death|0|||
23480909|NCT02095132|65502092|FG001|Overall Study|Death|0|||
23480910|NCT02095132|65502093|FG002|Overall Study|Death|0|||
23480911|NCT02095132|65502094|FG003|Overall Study|Death|0|||
23480912|NCT02095132|65502095|FG004|Overall Study|Death|0|||
23480913|NCT02095132|65502096|FG005|Overall Study|Death|0|||
23480914|NCT02095132|65502097|FG006|Overall Study|Death|1|||
23480915|NCT02095132|65502098|FG007|Overall Study|Death|0|||
23480916|NCT02095132|65502099|FG008|Overall Study|Death|0|||
23480917|NCT02095132|65502091|FG000|Overall Study|Lack of Efficacy|3|||
23480918|NCT02095132|65502092|FG001|Overall Study|Lack of Efficacy|5|||
23480919|NCT02095132|65502093|FG002|Overall Study|Lack of Efficacy|2|||
23480920|NCT02095132|65502094|FG003|Overall Study|Lack of Efficacy|8|||
23480921|NCT02095132|65502095|FG004|Overall Study|Lack of Efficacy|3|||
23480922|NCT02095132|65502096|FG005|Overall Study|Lack of Efficacy|6|||
23480923|NCT02095132|65502097|FG006|Overall Study|Lack of Efficacy|10|||
23480924|NCT02095132|65502098|FG007|Overall Study|Lack of Efficacy|9|||
23480925|NCT02095132|65502099|FG008|Overall Study|Lack of Efficacy|8|||
23480926|NCT02095132|65502091|FG000|Overall Study|Physician Decision|1|||
23480927|NCT02095132|65502092|FG001|Overall Study|Physician Decision|0|||
23480928|NCT02095132|65502093|FG002|Overall Study|Physician Decision|0|||
23480929|NCT02095132|65502094|FG003|Overall Study|Physician Decision|0|||
23480930|NCT02095132|65502095|FG004|Overall Study|Physician Decision|0|||
23480931|NCT02095132|65502096|FG005|Overall Study|Physician Decision|0|||
23480932|NCT02095132|65502097|FG006|Overall Study|Physician Decision|1|||
23480933|NCT02095132|65502098|FG007|Overall Study|Physician Decision|0|||
23480934|NCT02095132|65502099|FG008|Overall Study|Physician Decision|2|||
23658864|NCT01335009|66139114|FG000|Overall Study|Lost to Follow-up|1|||
23658865|NCT01335009|66139115|FG001|Overall Study|Lost to Follow-up|0|||
23658866|NCT02459769|66139120|FG000|Overall Study|Withdrawal by Subject|7|||
23658867|NCT02459769|66139121|FG001|Overall Study|Withdrawal by Subject|4|||
23658868|NCT02459769|66139122|FG002|Overall Study|Withdrawal by Subject|8|||
23658869|NCT02459769|66139123|FG003|Overall Study|Withdrawal by Subject|5|||
23363495|NCT02106351|65077112|FG002|Treatment Cycle 3|Adverse Event|0|||
23480935|NCT02095132|65502091|FG000|Overall Study|Withdrawal by Subject|0|||
23480936|NCT02095132|65502092|FG001|Overall Study|Withdrawal by Subject|0|||
23480937|NCT02095132|65502093|FG002|Overall Study|Withdrawal by Subject|2|||
23480938|NCT02095132|65502094|FG003|Overall Study|Withdrawal by Subject|2|||
23480939|NCT02095132|65502095|FG004|Overall Study|Withdrawal by Subject|3|||
23480940|NCT02095132|65502096|FG005|Overall Study|Withdrawal by Subject|0|||
23480941|NCT02095132|65502097|FG006|Overall Study|Withdrawal by Subject|5|||
23480942|NCT02095132|65502098|FG007|Overall Study|Withdrawal by Subject|0|||
23480943|NCT02095132|65502099|FG008|Overall Study|Withdrawal by Subject|0|||
23480944|NCT03761797|65502100|FG000|Overall Study|Changing hospital|11|||
23480945|NCT03761797|65502100|FG000|Overall Study|Improvement/remission|6|||
23480946|NCT03761797|65502100|FG000|Overall Study|Withdrawal by Subject|19|||
23480947|NCT03761797|65502100|FG000|Overall Study|Lost to Follow-up|33|||
23363496|NCT02106351|65077110|FG000|Treatment Cycle 3|Consent withdrawn|0|||
23363497|NCT02106351|65077111|FG001|Treatment Cycle 3|Consent withdrawn|0|||
23363498|NCT02106351|65077112|FG002|Treatment Cycle 3|Consent withdrawn|2|||
23363499|NCT02106351|65077110|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
23363500|NCT02106351|65077111|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
23363501|NCT02106351|65077112|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
23363502|NCT02106351|65077110|FG000|Treatment Cycle 3|Other|0|||
23363503|NCT02106351|65077111|FG001|Treatment Cycle 3|Other|2|||
23363504|NCT02106351|65077112|FG002|Treatment Cycle 3|Other|3|||
23363505|NCT02106351|65077110|FG000|Treatment Cycle 4|Consent withdrawn|0|||
23363506|NCT02106351|65077111|FG001|Treatment Cycle 4|Consent withdrawn|0|||
23363507|NCT02106351|65077112|FG002|Treatment Cycle 4|Consent withdrawn|2|||
23363508|NCT02106351|65077110|FG000|Treatment Cycle 4|Other|0|||
23363509|NCT02106351|65077111|FG001|Treatment Cycle 4|Other|1|||
23363510|NCT02106351|65077112|FG002|Treatment Cycle 4|Other|0|||
23363511|NCT00922116|65077113|FG000|Overall Study|Adverse Event|4|||
23363512|NCT00922116|65077113|FG000|Overall Study|Death|1|||
23363513|NCT00922116|65077113|FG000|Overall Study|Lost to Follow-up|1|||
23363514|NCT00922116|65077113|FG000|Overall Study|Withdrawal by Subject|4|||
23363515|NCT00922116|65077113|FG000|Overall Study|Other|5|||
23363516|NCT03225170|65077114|FG000|Overall Study|Lost to Follow-up|4|||
23363517|NCT03225170|65077115|FG001|Overall Study|Lost to Follow-up|4|||
23363518|NCT03225170|65077116|FG002|Overall Study|Lost to Follow-up|0|||
23363519|NCT03225170|65077114|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
23363520|NCT03225170|65077115|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
23363521|NCT03225170|65077116|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
23363522|NCT01932697|65077117|FG000|Overall Study|Received a different amount of tx|1|||
23363523|NCT01932697|65077118|FG001|Overall Study|Received a different amount of tx|0|||
23363524|NCT01932697|65077117|FG000|Overall Study|Ineligible|1|||
23363525|NCT01932697|65077118|FG001|Overall Study|Ineligible|0|||
23363526|NCT02686164|65077125|FG000|Overall Study|Adverse Event|1|||
23363527|NCT02686164|65077125|FG000|Overall Study|Withdrawal of consent|1|||
23363528|NCT02686164|65077125|FG000|Overall Study|Clinical progression|1|||
23363529|NCT04202497|65077126|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
23363530|NCT04202497|65077127|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363531|NCT04202497|65077128|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363532|NCT04202497|65077129|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363533|NCT00810199|65077132|FG000|Overall Study|Adverse Event|24|||
23363534|NCT00810199|65077133|FG001|Overall Study|Adverse Event|26|||
23363535|NCT00810199|65077132|FG000|Overall Study|Death|4|||
23363536|NCT00810199|65077133|FG001|Overall Study|Death|6|||
23363537|NCT00810199|65077132|FG000|Overall Study|Withdrew consent|9|||
23363538|NCT00810199|65077133|FG001|Overall Study|Withdrew consent|12|||
23363539|NCT00810199|65077132|FG000|Overall Study|Insufficient therapeutic response|5|||
23363540|NCT00810199|65077133|FG001|Overall Study|Insufficient therapeutic response|14|||
23363541|NCT00810199|65077132|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
23363542|NCT00810199|65077133|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
23363543|NCT00810199|65077132|FG000|Overall Study|Administrative/Other|5|||
23363544|NCT00810199|65077133|FG001|Overall Study|Administrative/Other|6|||
23363545|NCT00810199|65077132|FG000|Overall Study|Protocol Violation|2|||
23363546|NCT00810199|65077133|FG001|Overall Study|Protocol Violation|6|||
23363547|NCT00810199|65077132|FG000|Overall Study|Failure to return|1|||
23363548|NCT00810199|65077133|FG001|Overall Study|Failure to return|4|||
23363549|NCT00810199|65077132|FG000|Overall Study|Did not receive study drug|2|||
23363550|NCT00810199|65077133|FG001|Overall Study|Did not receive study drug|1|||
23363551|NCT02907463|65077134|FG000|Overall Study|Lost to Follow-up|17|||
23363552|NCT02907463|65077134|FG000|Overall Study|Death|10|||
23363553|NCT02907463|65077134|FG000|Overall Study|Withdrawal by Subject|4|||
23363554|NCT02907463|65077134|FG000|Overall Study|MIS Approach was not used|2|||
23363555|NCT02907463|65077134|FG000|Overall Study|Not Implanted with Study Device|2|||
23363556|NCT02907463|65077134|FG000|Overall Study|Device Explanted|1|||
23363557|NCT02907463|65077134|FG000|Overall Study|Missing Exit Form|1|||
23363558|NCT01724177|65077135|FG000|Overall Study|Adverse Event|8|||
23363559|NCT01724177|65077135|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
23363560|NCT01724177|65077135|FG000|Overall Study|Nervous participant|1|||
23363561|NCT01724177|65077135|FG000|Overall Study|Serious Adverse Event Related|1|||
23480948|NCT03761797|65502100|FG000|Overall Study|Adverse Event|37|||
23363562|NCT04157088|65077136|FG000|Overall Study|Study terminated by sponsor|23|||
23363563|NCT04157088|65077136|FG000|Overall Study|Withdrawal by Subject|4|||
23363564|NCT04157088|65077136|FG000|Overall Study|Lost to Follow-up|2|||
23363565|NCT04157088|65077136|FG000|Overall Study|Death|1|||
23363566|NCT02895347|65077137|FG000|Overall Study|Withdrawal by Subject|3|||
23363567|NCT02895347|65077138|FG001|Overall Study|Withdrawal by Subject|1|||
23363568|NCT03786380|65077139|FG000|Overall Study|Adverse Event|1|||
23363569|NCT03786380|65077140|FG001|Overall Study|Adverse Event|0|||
23363570|NCT03786380|65077141|FG002|Overall Study|Adverse Event|0|||
23363571|NCT03786380|65077142|FG003|Overall Study|Adverse Event|3|||
23363572|NCT03786380|65077143|FG004|Overall Study|Adverse Event|1|||
23363573|NCT03786380|65077139|FG000|Overall Study|Lack of Efficacy|0|||
23363574|NCT03786380|65077140|FG001|Overall Study|Lack of Efficacy|0|||
23363575|NCT03786380|65077141|FG002|Overall Study|Lack of Efficacy|0|||
23363576|NCT03786380|65077142|FG003|Overall Study|Lack of Efficacy|0|||
23363577|NCT03786380|65077143|FG004|Overall Study|Lack of Efficacy|1|||
23363578|NCT03786380|65077139|FG000|Overall Study|Withdrawal by Subject|1|||
23363579|NCT03786380|65077140|FG001|Overall Study|Withdrawal by Subject|2|||
23363580|NCT03786380|65077141|FG002|Overall Study|Withdrawal by Subject|2|||
23363581|NCT03786380|65077142|FG003|Overall Study|Withdrawal by Subject|1|||
23363582|NCT03786380|65077143|FG004|Overall Study|Withdrawal by Subject|2|||
23363583|NCT03786380|65077139|FG000|Overall Study|Lost to Follow-up|3|||
23363584|NCT03786380|65077140|FG001|Overall Study|Lost to Follow-up|0|||
23363585|NCT03786380|65077141|FG002|Overall Study|Lost to Follow-up|1|||
23363586|NCT03786380|65077142|FG003|Overall Study|Lost to Follow-up|2|||
23363587|NCT03786380|65077143|FG004|Overall Study|Lost to Follow-up|0|||
23363588|NCT03786380|65077139|FG000|Overall Study|Physician Decision|0|||
23363589|NCT03786380|65077140|FG001|Overall Study|Physician Decision|0|||
23363590|NCT03786380|65077141|FG002|Overall Study|Physician Decision|1|||
23363591|NCT03786380|65077142|FG003|Overall Study|Physician Decision|0|||
23363592|NCT03786380|65077143|FG004|Overall Study|Physician Decision|0|||
23363593|NCT03786380|65077139|FG000|Overall Study|Study Terminated by the Sponsor|30|||
23363594|NCT03786380|65077140|FG001|Overall Study|Study Terminated by the Sponsor|20|||
23363595|NCT03786380|65077141|FG002|Overall Study|Study Terminated by the Sponsor|50|||
23658870|NCT02459769|66139120|FG000|Overall Study|Lost to Follow-up|1|||
23658871|NCT02459769|66139121|FG001|Overall Study|Lost to Follow-up|0|||
23658872|NCT02459769|66139122|FG002|Overall Study|Lost to Follow-up|1|||
23658873|NCT02459769|66139123|FG003|Overall Study|Lost to Follow-up|0|||
23658874|NCT01200238|66139124|FG000|Overall Study|Adverse Event|2|||
23658875|NCT01200238|66139125|FG001|Overall Study|Adverse Event|1|||
23658876|NCT01200238|66139124|FG000|Overall Study|Progressive Disease|5|||
23480949|NCT03761797|65502100|FG000|Overall Study|Case report form (CRF) not collected|5|||
23480950|NCT03761797|65502100|FG000|Overall Study|No patient visit after entry|13|||
23480951|NCT03761797|65502100|FG000|Overall Study|Switch to other diabetes medication|10|||
23658877|NCT01200238|66139125|FG001|Overall Study|Progressive Disease|8|||
23658878|NCT01200238|66139124|FG000|Overall Study|Withdrawal by Subject|0|||
23658879|NCT01200238|66139125|FG001|Overall Study|Withdrawal by Subject|1|||
23658880|NCT03974334|66139126|FG000|Overall Study|Lost to Follow-up|1|||
23658881|NCT00851682|66139134|FG000|Overall Study|screen failure|5|||
23363596|NCT03786380|65077142|FG003|Overall Study|Study Terminated by the Sponsor|57|||
23363597|NCT03786380|65077143|FG004|Overall Study|Study Terminated by the Sponsor|23|||
23363598|NCT03786380|65077139|FG000|Overall Study|Reason Not Specified|0|||
23363599|NCT03786380|65077140|FG001|Overall Study|Reason Not Specified|0|||
23363600|NCT03786380|65077141|FG002|Overall Study|Reason Not Specified|0|||
23363601|NCT03786380|65077142|FG003|Overall Study|Reason Not Specified|0|||
23363602|NCT03786380|65077143|FG004|Overall Study|Reason Not Specified|1|||
23658882|NCT00851682|66139135|FG001|Overall Study|screen failure|0|||
23658883|NCT00880555|66139142|FG000|Overall Study|Physician Decision|0|||
23658884|NCT00880555|66139143|FG001|Overall Study|Physician Decision|8|||
23658885|NCT00880555|66139144|FG002|Overall Study|Physician Decision|0|||
23658886|NCT00880555|66139145|FG003|Overall Study|Physician Decision|2|||
23658887|NCT00880555|66139146|FG004|Overall Study|Physician Decision|1|||
23658888|NCT00880555|66139147|FG005|Overall Study|Physician Decision|0|||
23658889|NCT00880555|66139142|FG000|Overall Study|Withdrawal by Subject|1|||
23480952|NCT03761797|65502100|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
23480953|NCT03761797|65502100|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
23480954|NCT03761797|65502100|FG000|Overall Study|Insufficient effectives|2|||
23658890|NCT00880555|66139143|FG001|Overall Study|Withdrawal by Subject|1|||
23658891|NCT00880555|66139144|FG002|Overall Study|Withdrawal by Subject|0|||
23658892|NCT00880555|66139145|FG003|Overall Study|Withdrawal by Subject|0|||
23658893|NCT00880555|66139146|FG004|Overall Study|Withdrawal by Subject|0|||
23658894|NCT00880555|66139147|FG005|Overall Study|Withdrawal by Subject|0|||
23658895|NCT00880555|66139142|FG000|Overall Study|Lack of resources (hired rater)|9|||
23658896|NCT00880555|66139143|FG001|Overall Study|Lack of resources (hired rater)|7|||
23658897|NCT00880555|66139144|FG002|Overall Study|Lack of resources (hired rater)|5|||
23658898|NCT00880555|66139145|FG003|Overall Study|Lack of resources (hired rater)|0|||
23658899|NCT00880555|66139146|FG004|Overall Study|Lack of resources (hired rater)|0|||
23658900|NCT00880555|66139147|FG005|Overall Study|Lack of resources (hired rater)|0|||
23363603|NCT02007720|65077144|FG000|Overall Study|Withdrawal by Subject|9|||
23363604|NCT02007720|65077145|FG001|Overall Study|Withdrawal by Subject|11|||
23363605|NCT02007720|65077144|FG000|Overall Study|study terminated by sponsor|58|||
23363606|NCT02007720|65077145|FG001|Overall Study|study terminated by sponsor|54|||
23363607|NCT02007720|65077144|FG000|Overall Study|technical problem|4|||
23363608|NCT02007720|65077145|FG001|Overall Study|technical problem|2|||
23363609|NCT02007720|65077144|FG000|Overall Study|patient followd less than 165 days|11|||
23658901|NCT00880555|66139142|FG000|Overall Study|Death|0|||
23658902|NCT00880555|66139143|FG001|Overall Study|Death|0|||
23658903|NCT00880555|66139144|FG002|Overall Study|Death|0|||
23658904|NCT00880555|66139145|FG003|Overall Study|Death|0|||
23658905|NCT00880555|66139146|FG004|Overall Study|Death|0|||
23658906|NCT00880555|66139147|FG005|Overall Study|Death|1|||
23658907|NCT00880555|66139142|FG000|Overall Study|Lost to Follow-up|0|||
23658908|NCT00880555|66139143|FG001|Overall Study|Lost to Follow-up|1|||
23658909|NCT00880555|66139144|FG002|Overall Study|Lost to Follow-up|0|||
23658910|NCT00880555|66139145|FG003|Overall Study|Lost to Follow-up|0|||
23658911|NCT00880555|66139146|FG004|Overall Study|Lost to Follow-up|0|||
23658912|NCT00880555|66139147|FG005|Overall Study|Lost to Follow-up|0|||
23658913|NCT00798135|66139154|FG000|Overall Study|Disease progression, relapse|11|||
23658914|NCT00798135|66139154|FG000|Overall Study|Disease progression, refractory|1|||
23658915|NCT00798135|66139154|FG000|Overall Study|Physician Decision|1|||
23658916|NCT00938717|66139155|FG000|Overall Study|Adverse Event|10|||
23658917|NCT00938717|66139156|FG001|Overall Study|Adverse Event|41|||
23658918|NCT00938717|66139155|FG000|Overall Study|Protocol Violation|11|||
23658919|NCT00938717|66139156|FG001|Overall Study|Protocol Violation|8|||
23658920|NCT00938717|66139155|FG000|Overall Study|Withdrawal by Subject|26|||
23658921|NCT00938717|66139156|FG001|Overall Study|Withdrawal by Subject|24|||
23658922|NCT00938717|66139155|FG000|Overall Study|Lost to Follow-up|13|||
23658923|NCT00938717|66139156|FG001|Overall Study|Lost to Follow-up|18|||
23658924|NCT00938717|66139155|FG000|Overall Study|Lack of Efficacy|33|||
23658925|NCT00938717|66139156|FG001|Overall Study|Lack of Efficacy|15|||
23658926|NCT00938717|66139155|FG000|Overall Study|Other reason|5|||
23658927|NCT00938717|66139156|FG001|Overall Study|Other reason|2|||
23658928|NCT00832117|66139157|FG000|Overall Study|Death|1|||
23658929|NCT00832117|66139157|FG000|Overall Study|Disease Progression|11|||
23658930|NCT01509079|66139160|FG000|Overall Study|Lack of Efficacy|0|||
23658931|NCT01509079|66139161|FG001|Overall Study|Lack of Efficacy|2|||
23658932|NCT01509079|66139160|FG000|Overall Study|started an excluded medication|0|||
23658933|NCT01509079|66139161|FG001|Overall Study|started an excluded medication|1|||
23658934|NCT01358760|66139162|FG000|Overall Study|Adverse Event|3|||
23658935|NCT01358760|66139163|FG001|Overall Study|Adverse Event|4|||
23658936|NCT01358760|66139164|FG002|Overall Study|Adverse Event|3|||
23658937|NCT01358760|66139162|FG000|Overall Study|Lost to Follow-up|1|||
23658938|NCT01358760|66139163|FG001|Overall Study|Lost to Follow-up|1|||
23658939|NCT01358760|66139164|FG002|Overall Study|Lost to Follow-up|3|||
23658940|NCT01358760|66139162|FG000|Overall Study|Withdrawal by Subject|5|||
23658941|NCT01358760|66139163|FG001|Overall Study|Withdrawal by Subject|3|||
23658942|NCT01358760|66139164|FG002|Overall Study|Withdrawal by Subject|2|||
23658943|NCT01358760|66139162|FG000|Overall Study|Physician Decision|1|||
23658944|NCT01358760|66139163|FG001|Overall Study|Physician Decision|0|||
23658945|NCT01358760|66139164|FG002|Overall Study|Physician Decision|1|||
23363610|NCT02007720|65077145|FG001|Overall Study|patient followd less than 165 days|5|||
23363611|NCT00048035|65077151|FG000|Core Period|Early Withdrawals|4|||
23658946|NCT01358760|66139162|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
23658947|NCT01358760|66139163|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
23658948|NCT01358760|66139164|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
23658949|NCT00818389|66139165|FG000|Overall Study|Death|1|||
23658950|NCT00818389|66139166|FG001|Overall Study|Death|3|||
23658951|NCT00818389|66139165|FG000|Overall Study|ALS Disease Progression|1|||
23658952|NCT00818389|66139166|FG001|Overall Study|ALS Disease Progression|0|||
23658953|NCT00818389|66139165|FG000|Overall Study|Withdrawal by Subject|2|||
23658954|NCT00818389|66139166|FG001|Overall Study|Withdrawal by Subject|2|||
23658955|NCT00818389|66139165|FG000|Overall Study|Adverse Event|0|||
23658956|NCT00818389|66139166|FG001|Overall Study|Adverse Event|1|||
23658957|NCT01129921|66139167|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
23601080|NCT01437319|65929840|FG001|Phase II|Protocol Violation|1|||
23601081|NCT01437319|65929841|FG002|Phase II|Protocol Violation|0|||
23601082|NCT01471691|65929845|FG000|Overall Study|Lack of Efficacy|0|||
23601083|NCT01471691|65929846|FG001|Overall Study|Lack of Efficacy|1|||
23363612|NCT00048035|65077152|FG001|Core Period|Early Withdrawals|2|||
23363613|NCT00048035|65077153|FG002|Core Period|Early Withdrawals|1|||
23363614|NCT00048035|65077154|FG003|Core Period|Early Withdrawals|1|||
23363615|NCT00048035|65077155|FG004|Core Period|Early Withdrawals|1|||
23363616|NCT00048035|65077156|FG005|Core Period|Early Withdrawals|1|||
23363617|NCT00048035|65077157|FG006|Core Period|Early Withdrawals|0|||
23363618|NCT00048035|65077158|FG007|Core Period|Early Withdrawals|0|||
23363619|NCT00048035|65077151|FG000|Extension Year 1|Early Withdrawals|0|||
23363620|NCT00048035|65077152|FG001|Extension Year 1|Early Withdrawals|0|||
23363621|NCT00048035|65077153|FG002|Extension Year 1|Early Withdrawals|0|||
23363622|NCT00048035|65077154|FG003|Extension Year 1|Early Withdrawals|0|||
23363623|NCT00048035|65077155|FG004|Extension Year 1|Early Withdrawals|0|||
23363624|NCT00048035|65077156|FG005|Extension Year 1|Early Withdrawals|0|||
23363625|NCT00048035|65077157|FG006|Extension Year 1|Early Withdrawals|11|||
23363626|NCT00048035|65077158|FG007|Extension Year 1|Early Withdrawals|11|||
23363627|NCT00048035|65077151|FG000|Extension Year 2|Early Withdrawals|0|||
23363628|NCT00048035|65077152|FG001|Extension Year 2|Early Withdrawals|0|||
23363629|NCT00048035|65077153|FG002|Extension Year 2|Early Withdrawals|0|||
23363630|NCT00048035|65077154|FG003|Extension Year 2|Early Withdrawals|0|||
23363631|NCT00048035|65077155|FG004|Extension Year 2|Early Withdrawals|0|||
23363632|NCT00048035|65077156|FG005|Extension Year 2|Early Withdrawals|0|||
23363633|NCT00048035|65077157|FG006|Extension Year 2|Early Withdrawals|3|||
23363634|NCT00048035|65077158|FG007|Extension Year 2|Early Withdrawals|3|||
23363635|NCT05415462|65077159|FG000|Overall Study|Death|18|||
23363636|NCT05415462|65077160|FG001|Overall Study|Death|10|||
23601084|NCT02404441|65929851|FG000|Phase 1 Part|Adverse Event|1|||
23601085|NCT02404441|65929852|FG001|Phase 1 Part|Adverse Event|0|||
23601086|NCT02404441|65929853|FG002|Phase 1 Part|Adverse Event|0|||
23601087|NCT02404441|65929854|FG003|Phase 1 Part|Adverse Event|0|||
23601088|NCT02404441|65929855|FG004|Phase 1 Part|Adverse Event|0|||
23363637|NCT05415462|65077159|FG000|Overall Study|Lost to Follow-up|72|||
23363638|NCT05415462|65077160|FG001|Overall Study|Lost to Follow-up|64|||
23363639|NCT05415462|65077159|FG000|Overall Study|Physician Decision|5|||
23363640|NCT05415462|65077160|FG001|Overall Study|Physician Decision|5|||
23363641|NCT05415462|65077159|FG000|Overall Study|Protocol Deviation|1|||
23363642|NCT05415462|65077160|FG001|Overall Study|Protocol Deviation|0|||
23363643|NCT05415462|65077159|FG000|Overall Study|Withdrawal by Subject|129|||
23363644|NCT05415462|65077160|FG001|Overall Study|Withdrawal by Subject|101|||
23363645|NCT05415462|65077159|FG000|Overall Study|Other Than Specified|8|||
23363646|NCT05415462|65077160|FG001|Overall Study|Other Than Specified|8|||
23363647|NCT01419314|65077161|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
23363648|NCT01419314|65077162|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
23363649|NCT01419314|65077161|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
23480955|NCT03761797|65502100|FG000|Overall Study|Excessive alcohol intake|1|||
23480956|NCT02609503|65502101|FG000|Overall Study|Adverse Event|1|||
23480957|NCT02609503|65502101|FG000|Overall Study|Death|1|||
23480958|NCT02609503|65502101|FG000|Overall Study|Withdrawal by Subject|1|||
23480959|NCT02609503|65502101|FG000|Overall Study|Disease progression|1|||
23480960|NCT00813943|65502103|FG000|Overall Study|Ongoing at cut-off date|5|||
23480961|NCT00813943|65502104|FG001|Overall Study|Ongoing at cut-off date|5|||
23480962|NCT00813943|65502105|FG002|Overall Study|Ongoing at cut-off date|3|||
23480963|NCT04322539|65502106|FG000|Overall Study|Withdrawal of consent|14|||
23480964|NCT04322539|65502107|FG001|Overall Study|Withdrawal of consent|8|||
23480965|NCT04322539|65502106|FG000|Overall Study|Death|317|||
23480966|NCT04322539|65502107|FG001|Overall Study|Death|173|||
23480967|NCT04322539|65502106|FG000|Overall Study|Adverse Event|1|||
23480968|NCT04322539|65502107|FG001|Overall Study|Adverse Event|0|||
23480969|NCT04322539|65502106|FG000|Overall Study|Lost to Follow-up|3|||
23480970|NCT04322539|65502107|FG001|Overall Study|Lost to Follow-up|0|||
23480971|NCT04322539|65502106|FG000|Overall Study|Other|2|||
23480972|NCT04322539|65502107|FG001|Overall Study|Other|3|||
23480973|NCT04322539|65502106|FG000|Overall Study|Ongoing|124|||
23480974|NCT04322539|65502107|FG001|Overall Study|Ongoing|46|||
23480975|NCT02694718|65502108|FG000|Overall Study|Death|1|||
23480976|NCT02694718|65502108|FG000|Overall Study|Withdrawal by Subject|1|||
23480977|NCT00711516|65502109|FG000|Overall Study|Adverse Event|1|||
23601089|NCT02404441|65929856|FG005|Phase 1 Part|Adverse Event|0|||
23601090|NCT02404441|65929857|FG006|Phase 1 Part|Adverse Event|0|||
23601091|NCT02404441|65929858|FG007|Phase 1 Part|Adverse Event|0|||
23601092|NCT02404441|65929859|FG008|Phase 1 Part|Adverse Event|0|||
23601093|NCT02404441|65929860|FG009|Phase 1 Part|Adverse Event|0|||
23601094|NCT02404441|65929851|FG000|Phase 1 Part|Physician Decision|0|||
23601095|NCT02404441|65929852|FG001|Phase 1 Part|Physician Decision|1|||
23601096|NCT02404441|65929853|FG002|Phase 1 Part|Physician Decision|0|||
23601097|NCT02404441|65929854|FG003|Phase 1 Part|Physician Decision|0|||
23658958|NCT01129921|66139168|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
23363650|NCT01419314|65077162|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
23480978|NCT00711516|65502110|FG001|Overall Study|Adverse Event|1|||
23480979|NCT00711516|65502109|FG000|Overall Study|Withdrawal by Subject|0|||
23601098|NCT02404441|65929855|FG004|Phase 1 Part|Physician Decision|0|||
23480980|NCT00711516|65502110|FG001|Overall Study|Withdrawal by Subject|1|||
23480981|NCT00711516|65502109|FG000|Overall Study|Protocol Violation|0|||
23480982|NCT00711516|65502110|FG001|Overall Study|Protocol Violation|1|||
23480983|NCT01075191|65502113|FG000|Overall Study|Death|1|||
23480984|NCT01075191|65502113|FG000|Overall Study|Intensification|3|||
23480985|NCT01075191|65502113|FG000|Overall Study|Co-morbidities|1|||
23480986|NCT01075191|65502113|FG000|Overall Study|Adverse Event|4|||
23480987|NCT01075191|65502113|FG000|Overall Study|Noncompliance|3|||
23480988|NCT01075191|65502113|FG000|Overall Study|Therapy Break|3|||
23480989|NCT01075191|65502113|FG000|Overall Study|Patient's Wish|2|||
23480990|NCT01075191|65502113|FG000|Overall Study|Unknown Reasons|1|||
23480991|NCT02674854|65502114|FG000|Overall Study|Adverse Event|17|||
23480992|NCT02674854|65502115|FG001|Overall Study|Adverse Event|15|||
23363651|NCT01419314|65077161|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
23363652|NCT01419314|65077162|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
23363653|NCT01265394|65077165|FG000|Overall Study|Subjects withdrawn|37|||
23363654|NCT04249362|65077166|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|34|||
23363655|NCT04249362|65077167|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|25|||
23363656|NCT02699996|65077168|FG000|Overall Study|Withdrawal by Subject|5|||
23363657|NCT02699996|65077169|FG001|Overall Study|Withdrawal by Subject|2|||
23363658|NCT03382418|65077170|FG000|Overall Study|Withdrawal by Subject|1|||
23363659|NCT03382418|65077171|FG001|Overall Study|Withdrawal by Subject|0|||
23363660|NCT03382418|65077172|FG002|Overall Study|Withdrawal by Subject|0|||
23363661|NCT03382418|65077170|FG000|Overall Study|Lost to Follow-up|2|||
23363662|NCT03382418|65077171|FG001|Overall Study|Lost to Follow-up|3|||
23363663|NCT03382418|65077172|FG002|Overall Study|Lost to Follow-up|0|||
23363664|NCT03872843|65077173|FG000|Overall Study|Lost to Follow-up|5|||
23363665|NCT03872843|65077174|FG001|Overall Study|Lost to Follow-up|7|||
23363666|NCT00752089|65077175|FG000|Overall Study|Adverse Event|1|||
23363667|NCT00752089|65077175|FG000|Overall Study|Protocol Deviation|2|||
23363668|NCT00752089|65077175|FG000|Overall Study|Could not attend visit 9|1|||
23363669|NCT00752089|65077175|FG000|Overall Study|Not capable of wearing partial denture|1|||
23363670|NCT00752089|65077175|FG000|Overall Study|Cannot continue the study|1|||
23363671|NCT01076543|65077178|FG000|Overall Study|Withdrawal by Subject|2|||
23363672|NCT01076543|65077179|FG001|Overall Study|Withdrawal by Subject|0|||
23363673|NCT01076543|65077180|FG002|Overall Study|Withdrawal by Subject|0|||
23363674|NCT01076543|65077181|FG003|Overall Study|Withdrawal by Subject|0|||
23363675|NCT01076543|65077182|FG004|Overall Study|Withdrawal by Subject|0|||
23363676|NCT01076543|65077183|FG005|Overall Study|Withdrawal by Subject|0|||
23363677|NCT00490971|65077196|FG000|Acute/Continuation|Adverse Event|62|||
23363678|NCT00490971|65077197|FG001|Acute/Continuation|Adverse Event|13|||
23363679|NCT00490971|65077198|FG002|Acute/Continuation|Adverse Event|0|||
23363680|NCT00490971|65077199|FG003|Acute/Continuation|Adverse Event|0|||
23363681|NCT00490971|65077200|FG004|Acute/Continuation|Adverse Event|0|||
23363682|NCT00490971|65077196|FG000|Acute/Continuation|Death|2|||
23363683|NCT00490971|65077197|FG001|Acute/Continuation|Death|0|||
23363684|NCT00490971|65077198|FG002|Acute/Continuation|Death|0|||
23363685|NCT00490971|65077199|FG003|Acute/Continuation|Death|0|||
23363686|NCT00490971|65077200|FG004|Acute/Continuation|Death|0|||
23363687|NCT00490971|65077196|FG000|Acute/Continuation|Lack of Efficacy|106|||
23363688|NCT00490971|65077197|FG001|Acute/Continuation|Lack of Efficacy|12|||
23480993|NCT02674854|65502116|FG002|Overall Study|Adverse Event|5|||
23480994|NCT02674854|65502114|FG000|Overall Study|Withdrawal by Subject|1|||
23480995|NCT02674854|65502115|FG001|Overall Study|Withdrawal by Subject|5|||
23363689|NCT00490971|65077198|FG002|Acute/Continuation|Lack of Efficacy|0|||
23480996|NCT02674854|65502116|FG002|Overall Study|Withdrawal by Subject|4|||
23601099|NCT02404441|65929856|FG005|Phase 1 Part|Physician Decision|0|||
23601100|NCT02404441|65929857|FG006|Phase 1 Part|Physician Decision|0|||
23601101|NCT02404441|65929858|FG007|Phase 1 Part|Physician Decision|0|||
23601102|NCT02404441|65929859|FG008|Phase 1 Part|Physician Decision|0|||
23601103|NCT02404441|65929860|FG009|Phase 1 Part|Physician Decision|0|||
23601104|NCT02404441|65929851|FG000|Phase 1 Part|Progressive Disease|14|||
23601105|NCT02404441|65929852|FG001|Phase 1 Part|Progressive Disease|11|||
23480997|NCT02674854|65502114|FG000|Overall Study|No-compliant subject|1|||
23601106|NCT02404441|65929853|FG002|Phase 1 Part|Progressive Disease|7|||
23601107|NCT02404441|65929854|FG003|Phase 1 Part|Progressive Disease|6|||
23601108|NCT02404441|65929855|FG004|Phase 1 Part|Progressive Disease|9|||
23363690|NCT00490971|65077199|FG003|Acute/Continuation|Lack of Efficacy|0|||
23363691|NCT00490971|65077200|FG004|Acute/Continuation|Lack of Efficacy|0|||
23363692|NCT00490971|65077196|FG000|Acute/Continuation|Lost to Follow-up|23|||
23363693|NCT00490971|65077197|FG001|Acute/Continuation|Lost to Follow-up|7|||
23363694|NCT00490971|65077198|FG002|Acute/Continuation|Lost to Follow-up|0|||
23363695|NCT00490971|65077199|FG003|Acute/Continuation|Lost to Follow-up|0|||
23363696|NCT00490971|65077200|FG004|Acute/Continuation|Lost to Follow-up|0|||
23480998|NCT02674854|65502115|FG001|Overall Study|No-compliant subject|0|||
23480999|NCT02674854|65502116|FG002|Overall Study|No-compliant subject|1|||
23481000|NCT02674854|65502114|FG000|Overall Study|Lost to Follow-up|1|||
23481001|NCT02674854|65502115|FG001|Overall Study|Lost to Follow-up|0|||
23481002|NCT02674854|65502116|FG002|Overall Study|Lost to Follow-up|2|||
23481003|NCT02674854|65502114|FG000|Overall Study|Lack of Efficacy|0|||
23481004|NCT02674854|65502115|FG001|Overall Study|Lack of Efficacy|3|||
23481005|NCT02674854|65502116|FG002|Overall Study|Lack of Efficacy|0|||
23481006|NCT02674854|65502114|FG000|Overall Study|Disallowed Concurrent Medication|2|||
23481007|NCT02674854|65502115|FG001|Overall Study|Disallowed Concurrent Medication|2|||
23481008|NCT02674854|65502116|FG002|Overall Study|Disallowed Concurrent Medication|0|||
23481009|NCT02674854|65502114|FG000|Overall Study|Protocol Violation|1|||
23481010|NCT02674854|65502115|FG001|Overall Study|Protocol Violation|1|||
23481011|NCT02674854|65502116|FG002|Overall Study|Protocol Violation|2|||
23481012|NCT02674854|65502114|FG000|Overall Study|Death|0|||
23481013|NCT02674854|65502115|FG001|Overall Study|Death|1|||
23481014|NCT02674854|65502116|FG002|Overall Study|Death|0|||
23481015|NCT02674854|65502114|FG000|Overall Study|Subject missed V6.2|1|||
23481016|NCT02674854|65502115|FG001|Overall Study|Subject missed V6.2|0|||
23481017|NCT02674854|65502116|FG002|Overall Study|Subject missed V6.2|0|||
23481018|NCT01262352|65502119|FG000|Period 1|Illness after randomization|1|||
23481019|NCT01262352|65502120|FG001|Period 1|Illness after randomization|0|||
23481020|NCT01262352|65502119|FG000|Washout|Adverse Event|1|||
23481021|NCT01262352|65502120|FG001|Washout|Adverse Event|1|||
23481022|NCT01262352|65502119|FG000|Washout|Extended Washout|0|||
23481023|NCT01262352|65502120|FG001|Washout|Extended Washout|1|||
23481024|NCT00934843|65502121|FG000|Overall Study|Protocol Violation|0|||
23481025|NCT00934843|65502122|FG001|Overall Study|Protocol Violation|1|||
23481026|NCT02279407|65502123|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481027|NCT02279407|65502124|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481028|NCT02279407|65502125|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
23481029|NCT02279407|65502126|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481030|NCT02279407|65502123|FG000|Overall Study|Withdrawal by Subject|1|||
23481031|NCT02279407|65502124|FG001|Overall Study|Withdrawal by Subject|0|||
23481032|NCT02279407|65502125|FG002|Overall Study|Withdrawal by Subject|1|||
23481033|NCT02279407|65502126|FG003|Overall Study|Withdrawal by Subject|1|||
23601109|NCT02404441|65929856|FG005|Phase 1 Part|Progressive Disease|0|||
23601110|NCT02404441|65929857|FG006|Phase 1 Part|Progressive Disease|0|||
23601111|NCT02404441|65929858|FG007|Phase 1 Part|Progressive Disease|0|||
23601112|NCT02404441|65929859|FG008|Phase 1 Part|Progressive Disease|0|||
23601113|NCT02404441|65929860|FG009|Phase 1 Part|Progressive Disease|0|||
23601114|NCT02404441|65929851|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
23601115|NCT02404441|65929852|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
23601116|NCT02404441|65929853|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
23601117|NCT02404441|65929854|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
23601118|NCT02404441|65929855|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
23601119|NCT02404441|65929856|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
23601120|NCT02404441|65929857|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
23601121|NCT02404441|65929858|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
23601122|NCT02404441|65929859|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
23601123|NCT02404441|65929860|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
23601124|NCT02404441|65929851|FG000|Phase 1 Part|Death|1|||
23601125|NCT02404441|65929852|FG001|Phase 1 Part|Death|1|||
23601126|NCT02404441|65929853|FG002|Phase 1 Part|Death|1|||
23601127|NCT02404441|65929854|FG003|Phase 1 Part|Death|0|||
23363697|NCT00490971|65077196|FG000|Acute/Continuation|Protocol Violation|10|||
23363698|NCT00490971|65077197|FG001|Acute/Continuation|Protocol Violation|2|||
23601128|NCT02404441|65929855|FG004|Phase 1 Part|Death|1|||
23601129|NCT02404441|65929856|FG005|Phase 1 Part|Death|0|||
23363699|NCT00490971|65077198|FG002|Acute/Continuation|Protocol Violation|0|||
23481034|NCT02279407|65502123|FG000|Overall Study|Adverse Event|1|||
23481035|NCT02279407|65502124|FG001|Overall Study|Adverse Event|1|||
23481036|NCT02279407|65502125|FG002|Overall Study|Adverse Event|2|||
23481037|NCT02279407|65502126|FG003|Overall Study|Adverse Event|0|||
23481038|NCT02151773|65502127|FG000|Overall Study|Protocol Deviation|64|||
23481039|NCT04905498|65502128|FG000|Overall Study|Lost to Follow-up|0|||
23481040|NCT04905498|65502129|FG001|Overall Study|Lost to Follow-up|2|||
23481041|NCT04905498|65502128|FG000|Overall Study|COVID lockdown|1|||
23481042|NCT04905498|65502129|FG001|Overall Study|COVID lockdown|0|||
23601130|NCT02404441|65929857|FG006|Phase 1 Part|Death|0|||
23601131|NCT02404441|65929858|FG007|Phase 1 Part|Death|0|||
23601132|NCT02404441|65929859|FG008|Phase 1 Part|Death|0|||
23601133|NCT02404441|65929860|FG009|Phase 1 Part|Death|0|||
23601134|NCT02404441|65929851|FG000|Phase 2 Part|Adverse Event|0|||
23601135|NCT02404441|65929852|FG001|Phase 2 Part|Adverse Event|0|||
23601136|NCT02404441|65929853|FG002|Phase 2 Part|Adverse Event|0|||
23601137|NCT02404441|65929854|FG003|Phase 2 Part|Adverse Event|0|||
23601138|NCT02404441|65929855|FG004|Phase 2 Part|Adverse Event|0|||
23601139|NCT02404441|65929856|FG005|Phase 2 Part|Adverse Event|2|||
23601140|NCT02404441|65929857|FG006|Phase 2 Part|Adverse Event|3|||
23601141|NCT02404441|65929858|FG007|Phase 2 Part|Adverse Event|3|||
23601142|NCT02404441|65929859|FG008|Phase 2 Part|Adverse Event|6|||
23601143|NCT02404441|65929860|FG009|Phase 2 Part|Adverse Event|1|||
23601144|NCT02404441|65929851|FG000|Phase 2 Part|Physician Decision|0|||
23601145|NCT02404441|65929852|FG001|Phase 2 Part|Physician Decision|0|||
23601146|NCT02404441|65929853|FG002|Phase 2 Part|Physician Decision|0|||
23601147|NCT02404441|65929854|FG003|Phase 2 Part|Physician Decision|0|||
23601148|NCT02404441|65929855|FG004|Phase 2 Part|Physician Decision|0|||
23601149|NCT02404441|65929856|FG005|Phase 2 Part|Physician Decision|7|||
23601150|NCT02404441|65929857|FG006|Phase 2 Part|Physician Decision|9|||
23601151|NCT02404441|65929858|FG007|Phase 2 Part|Physician Decision|2|||
23601152|NCT02404441|65929859|FG008|Phase 2 Part|Physician Decision|1|||
23601153|NCT02404441|65929860|FG009|Phase 2 Part|Physician Decision|3|||
23601154|NCT02404441|65929851|FG000|Phase 2 Part|Progressive disease|0|||
23601155|NCT02404441|65929852|FG001|Phase 2 Part|Progressive disease|0|||
23601156|NCT02404441|65929853|FG002|Phase 2 Part|Progressive disease|0|||
23601157|NCT02404441|65929854|FG003|Phase 2 Part|Progressive disease|0|||
23601158|NCT02404441|65929855|FG004|Phase 2 Part|Progressive disease|0|||
23601159|NCT02404441|65929856|FG005|Phase 2 Part|Progressive disease|43|||
23601160|NCT02404441|65929857|FG006|Phase 2 Part|Progressive disease|32|||
23363700|NCT00490971|65077199|FG003|Acute/Continuation|Protocol Violation|0|||
23363701|NCT00490971|65077200|FG004|Acute/Continuation|Protocol Violation|0|||
23363702|NCT00490971|65077196|FG000|Acute/Continuation|Withdrawal by Subject|92|||
23363703|NCT00490971|65077197|FG001|Acute/Continuation|Withdrawal by Subject|24|||
23363704|NCT00490971|65077198|FG002|Acute/Continuation|Withdrawal by Subject|0|||
23363705|NCT00490971|65077199|FG003|Acute/Continuation|Withdrawal by Subject|0|||
23601161|NCT02404441|65929858|FG007|Phase 2 Part|Progressive disease|31|||
23601162|NCT02404441|65929859|FG008|Phase 2 Part|Progressive disease|39|||
23601163|NCT02404441|65929860|FG009|Phase 2 Part|Progressive disease|27|||
23601164|NCT02404441|65929851|FG000|Phase 2 Part|Subject/guardian decision|0|||
23601165|NCT02404441|65929852|FG001|Phase 2 Part|Subject/guardian decision|0|||
23601166|NCT02404441|65929853|FG002|Phase 2 Part|Subject/guardian decision|0|||
23601167|NCT02404441|65929854|FG003|Phase 2 Part|Subject/guardian decision|0|||
23601168|NCT02404441|65929855|FG004|Phase 2 Part|Subject/guardian decision|0|||
23601169|NCT02404441|65929856|FG005|Phase 2 Part|Subject/guardian decision|3|||
23601170|NCT02404441|65929857|FG006|Phase 2 Part|Subject/guardian decision|9|||
23601171|NCT02404441|65929858|FG007|Phase 2 Part|Subject/guardian decision|0|||
23601172|NCT02404441|65929859|FG008|Phase 2 Part|Subject/guardian decision|3|||
23601173|NCT02404441|65929860|FG009|Phase 2 Part|Subject/guardian decision|2|||
23601174|NCT02404441|65929851|FG000|Phase 2 Part|Death|0|||
23601175|NCT02404441|65929852|FG001|Phase 2 Part|Death|0|||
23601176|NCT02404441|65929853|FG002|Phase 2 Part|Death|0|||
23601177|NCT02404441|65929854|FG003|Phase 2 Part|Death|0|||
23601178|NCT02404441|65929855|FG004|Phase 2 Part|Death|0|||
23601179|NCT02404441|65929856|FG005|Phase 2 Part|Death|4|||
23601180|NCT02404441|65929857|FG006|Phase 2 Part|Death|8|||
23363706|NCT00490971|65077200|FG004|Acute/Continuation|Withdrawal by Subject|0|||
23601181|NCT02404441|65929858|FG007|Phase 2 Part|Death|4|||
23601182|NCT02404441|65929859|FG008|Phase 2 Part|Death|10|||
23601183|NCT02404441|65929860|FG009|Phase 2 Part|Death|9|||
23601184|NCT00603954|65929867|FG000|Overall Study|Protocol Violation|1|||
23363707|NCT00490971|65077196|FG000|Acute/Continuation|Other|11|||
23601185|NCT00603954|65929868|FG001|Overall Study|Protocol Violation|2|||
23601186|NCT04492475|65929869|FG000|Overall Study|Enrolled but not treated|8|||
23601187|NCT04492475|65929870|FG001|Overall Study|Enrolled but not treated|8|||
23601188|NCT04492475|65929869|FG000|Overall Study|Withdrawal by Subject|4|||
23601189|NCT04492475|65929870|FG001|Overall Study|Withdrawal by Subject|0|||
23601190|NCT04492475|65929869|FG000|Overall Study|Became ineligible after enrollment|2|||
23601191|NCT04492475|65929870|FG001|Overall Study|Became ineligible after enrollment|0|||
23601192|NCT00391898|65929876|FG000|Overall Study|Adverse Event|3|||
23601193|NCT00391898|65929877|FG001|Overall Study|Adverse Event|0|||
23601194|NCT00391898|65929876|FG000|Overall Study|Other|8|||
23363708|NCT00490971|65077197|FG001|Acute/Continuation|Other|4|||
23363709|NCT00490971|65077198|FG002|Acute/Continuation|Other|0|||
23601195|NCT00391898|65929877|FG001|Overall Study|Other|10|||
23601196|NCT00939510|65929878|FG000|Overall Study|Withdrawal by Subject|1|||
23601197|NCT03689946|65929879|FG000|Overall Study|Withdrawal by Subject|3|||
23601198|NCT03689946|65929879|FG000|Overall Study|Lost to Follow-up|3|||
23601199|NCT03689946|65929879|FG000|Overall Study|Data corruption|2|||
23601200|NCT00336505|65929880|FG000|Overall Study|Adverse Event|10|||
23363710|NCT00490971|65077199|FG003|Acute/Continuation|Other|0|||
23363711|NCT00490971|65077200|FG004|Acute/Continuation|Other|0|||
23363712|NCT00490971|65077196|FG000|Maintenance|Adverse Event|0|||
23363713|NCT00490971|65077197|FG001|Maintenance|Adverse Event|0|||
23363714|NCT00490971|65077198|FG002|Maintenance|Adverse Event|4|||
23363715|NCT00490971|65077199|FG003|Maintenance|Adverse Event|5|||
23363716|NCT00490971|65077200|FG004|Maintenance|Adverse Event|7|||
23363717|NCT00490971|65077196|FG000|Maintenance|Death|0|||
23363718|NCT00490971|65077197|FG001|Maintenance|Death|0|||
23363719|NCT00490971|65077198|FG002|Maintenance|Death|0|||
23363720|NCT00490971|65077199|FG003|Maintenance|Death|2|||
23363721|NCT00490971|65077200|FG004|Maintenance|Death|0|||
23363722|NCT00490971|65077196|FG000|Maintenance|Lost to Follow-up|0|||
23363723|NCT00490971|65077197|FG001|Maintenance|Lost to Follow-up|0|||
23363724|NCT00490971|65077198|FG002|Maintenance|Lost to Follow-up|5|||
23363725|NCT00490971|65077199|FG003|Maintenance|Lost to Follow-up|8|||
23363726|NCT00490971|65077200|FG004|Maintenance|Lost to Follow-up|10|||
23363727|NCT00490971|65077196|FG000|Maintenance|Pregnancy|0|||
23363728|NCT00490971|65077197|FG001|Maintenance|Pregnancy|0|||
23363729|NCT00490971|65077198|FG002|Maintenance|Pregnancy|1|||
23363730|NCT00490971|65077199|FG003|Maintenance|Pregnancy|0|||
23363731|NCT00490971|65077200|FG004|Maintenance|Pregnancy|0|||
23363732|NCT00490971|65077196|FG000|Maintenance|Protocol Violation|0|||
23363733|NCT00490971|65077197|FG001|Maintenance|Protocol Violation|0|||
23363734|NCT00490971|65077198|FG002|Maintenance|Protocol Violation|4|||
23363735|NCT00490971|65077199|FG003|Maintenance|Protocol Violation|1|||
23363736|NCT00490971|65077200|FG004|Maintenance|Protocol Violation|1|||
23363737|NCT00490971|65077196|FG000|Maintenance|Withdrawal by Subject|0|||
23363738|NCT00490971|65077197|FG001|Maintenance|Withdrawal by Subject|0|||
23363739|NCT00490971|65077198|FG002|Maintenance|Withdrawal by Subject|26|||
23363740|NCT00490971|65077199|FG003|Maintenance|Withdrawal by Subject|28|||
23363741|NCT00490971|65077200|FG004|Maintenance|Withdrawal by Subject|18|||
23363742|NCT00490971|65077196|FG000|Maintenance|Other|0|||
23363743|NCT00490971|65077197|FG001|Maintenance|Other|0|||
23363744|NCT00490971|65077198|FG002|Maintenance|Other|11|||
23363745|NCT00490971|65077199|FG003|Maintenance|Other|9|||
23363746|NCT00490971|65077200|FG004|Maintenance|Other|3|||
23363747|NCT02171429|65077207|FG000|Overall Study|Other|0|||
23363748|NCT02171429|65077208|FG001|Overall Study|Other|1|||
23363749|NCT02171429|65077209|FG002|Overall Study|Other|1|||
23363750|NCT02171429|65077207|FG000|Overall Study|Non-Compliance|0|||
23363751|NCT02171429|65077208|FG001|Overall Study|Non-Compliance|0|||
23363752|NCT02171429|65077209|FG002|Overall Study|Non-Compliance|1|||
23363753|NCT02171429|65077207|FG000|Overall Study|Physician Decision|0|||
23363754|NCT02171429|65077208|FG001|Overall Study|Physician Decision|0|||
23363755|NCT02171429|65077209|FG002|Overall Study|Physician Decision|1|||
23363756|NCT02171429|65077207|FG000|Overall Study|Withdrawal by Subject|1|||
23363757|NCT02171429|65077208|FG001|Overall Study|Withdrawal by Subject|1|||
23363758|NCT02171429|65077209|FG002|Overall Study|Withdrawal by Subject|1|||
23363759|NCT02171429|65077207|FG000|Overall Study|Lost to Follow-up|0|||
23363760|NCT02171429|65077208|FG001|Overall Study|Lost to Follow-up|1|||
23363761|NCT02171429|65077209|FG002|Overall Study|Lost to Follow-up|0|||
23363762|NCT02171429|65077207|FG000|Overall Study|Death|0|||
23363763|NCT02171429|65077208|FG001|Overall Study|Death|0|||
23363764|NCT02171429|65077209|FG002|Overall Study|Death|1|||
23363765|NCT03143101|65077210|FG000|Overall Study|Withdrawal by Subject|0|||
23363766|NCT03143101|65077211|FG001|Overall Study|Withdrawal by Subject|1|||
23363767|NCT03143101|65077212|FG002|Overall Study|Withdrawal by Subject|0|||
23363768|NCT03143101|65077210|FG000|Overall Study|Lost to Follow-up|2|||
23363769|NCT03143101|65077211|FG001|Overall Study|Lost to Follow-up|2|||
23363770|NCT03143101|65077212|FG002|Overall Study|Lost to Follow-up|0|||
23363771|NCT00872521|65077213|FG000|Completed PAD Induction|Patient choice|0|||
23363772|NCT00872521|65077214|FG001|Completed PAD Induction|Patient choice|1|||
23363773|NCT00872521|65077215|FG002|Completed PAD Induction|Patient choice|0|||
23363774|NCT00872521|65077213|FG000|Completed PAD Induction|Disease progression|0|||
23363775|NCT00872521|65077214|FG001|Completed PAD Induction|Disease progression|2|||
23363776|NCT00872521|65077215|FG002|Completed PAD Induction|Disease progression|0|||
23363777|NCT00872521|65077213|FG000|Completed PAD Induction|Adverse Event|4|||
23363778|NCT00872521|65077214|FG001|Completed PAD Induction|Adverse Event|0|||
23363779|NCT00872521|65077215|FG002|Completed PAD Induction|Adverse Event|0|||
23363780|NCT00872521|65077213|FG000|Completed PAD Induction|Death|1|||
23363781|NCT00872521|65077214|FG001|Completed PAD Induction|Death|1|||
23363782|NCT00872521|65077215|FG002|Completed PAD Induction|Death|0|||
23363783|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Other|1|||
23363784|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Other|2|||
23363785|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Other|0|||
23363786|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Patient choice|0|||
23363787|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Patient choice|1|||
23363788|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Patient choice|0|||
23363789|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
23363790|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
23363791|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
23363792|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Patient response missing|0|||
23363793|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Patient response missing|0|||
23363794|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Patient response missing|1|||
23363795|NCT00872521|65077213|FG000|Completed 3-month Follow up|Other|0|||
23363796|NCT00872521|65077214|FG001|Completed 3-month Follow up|Other|2|||
23363797|NCT00872521|65077215|FG002|Completed 3-month Follow up|Other|0|||
23363798|NCT00872521|65077213|FG000|Completed 3-month Follow up|Physician Decision|0|||
23363799|NCT00872521|65077214|FG001|Completed 3-month Follow up|Physician Decision|1|||
23363800|NCT00872521|65077215|FG002|Completed 3-month Follow up|Physician Decision|0|||
23363801|NCT00872521|65077213|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
23363802|NCT00872521|65077214|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
23363803|NCT00872521|65077215|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
23363804|NCT02370511|65077216|FG000|Overall Study|Death|10|||
23363805|NCT02370511|65077217|FG001|Overall Study|Death|7|||
23363806|NCT02370511|65077218|FG002|Overall Study|Death|1|||
23363807|NCT02370511|65077216|FG000|Overall Study|Withdrawal by Subject|2|||
23363808|NCT02370511|65077217|FG001|Overall Study|Withdrawal by Subject|0|||
23363809|NCT02370511|65077218|FG002|Overall Study|Withdrawal by Subject|0|||
23363810|NCT02370511|65077216|FG000|Overall Study|Lost to Follow-up|0|||
23363811|NCT02370511|65077217|FG001|Overall Study|Lost to Follow-up|4|||
23363812|NCT02370511|65077218|FG002|Overall Study|Lost to Follow-up|0|||
23363813|NCT00206427|65077221|FG000|Overall Study|Adverse Event|2|||
23363814|NCT02144701|65077222|FG000|Overall Study|development of relapse, GVHD or death|9|||
23363815|NCT02144701|65077223|FG001|Overall Study|development of relapse, GVHD or death|3|||
23363816|NCT04147247|65077224|FG000|Overall Study|Progressive disease|3|||
23363817|NCT04147247|65077225|FG001|Overall Study|Progressive disease|3|||
23363818|NCT04147247|65077226|FG002|Overall Study|Progressive disease|4|||
23363819|NCT04147247|65077227|FG003|Overall Study|Progressive disease|4|||
23363820|NCT04147247|65077228|FG004|Overall Study|Progressive disease|3|||
23363821|NCT04147247|65077224|FG000|Overall Study|Physician Decision|0|||
23363822|NCT04147247|65077225|FG001|Overall Study|Physician Decision|1|||
23363823|NCT04147247|65077226|FG002|Overall Study|Physician Decision|0|||
23363824|NCT04147247|65077227|FG003|Overall Study|Physician Decision|0|||
23363825|NCT04147247|65077228|FG004|Overall Study|Physician Decision|0|||
23363826|NCT04147247|65077224|FG000|Overall Study|Clinical Disease Progression|0|||
23363827|NCT04147247|65077225|FG001|Overall Study|Clinical Disease Progression|0|||
23363828|NCT04147247|65077226|FG002|Overall Study|Clinical Disease Progression|0|||
23363829|NCT04147247|65077227|FG003|Overall Study|Clinical Disease Progression|0|||
23363830|NCT04147247|65077228|FG004|Overall Study|Clinical Disease Progression|1|||
23363831|NCT04147247|65077224|FG000|Overall Study|Adverse Event|0|||
23363832|NCT04147247|65077225|FG001|Overall Study|Adverse Event|0|||
23363833|NCT04147247|65077226|FG002|Overall Study|Adverse Event|1|||
23363834|NCT04147247|65077227|FG003|Overall Study|Adverse Event|0|||
23363835|NCT04147247|65077228|FG004|Overall Study|Adverse Event|1|||
23363836|NCT00115778|65077236|FG000|Overall Study|Withdrawal by Subject|0|||
23363837|NCT00115778|65077237|FG001|Overall Study|Withdrawal by Subject|1|||
23363838|NCT01935089|65077260|FG000|Overall Study|Adverse Event|2|||
23363839|NCT01935089|65077260|FG000|Overall Study|Withdrawal by Subject|1|||
23363840|NCT02864407|65077261|FG000|Overall Study|Protocol Violation|3|||
23363841|NCT02864407|65077261|FG000|Overall Study|Lost to Follow-up|115|||
23363842|NCT02864407|65077261|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
23363843|NCT02864407|65077261|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
23363844|NCT02864407|65077261|FG000|Overall Study|Consent prior to the contract date|1|||
23363845|NCT01152996|65077262|FG000|Overall Study|Withdrawal by Subject|142|||
23363846|NCT01152996|65077262|FG000|Overall Study|Adverse Event|115|||
23363847|NCT01152996|65077262|FG000|Overall Study|Lost to Follow-up|112|||
23363848|NCT01152996|65077262|FG000|Overall Study|Lack of Efficacy|68|||
23363849|NCT01152996|65077262|FG000|Overall Study|Noncompliance|41|||
23363850|NCT01152996|65077262|FG000|Overall Study|Other|36|||
23363851|NCT01152996|65077262|FG000|Overall Study|Protocol Violation|22|||
23363852|NCT01152996|65077262|FG000|Overall Study|Elevated liver enzymes|1|||
23363853|NCT02849743|65077263|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
23363854|NCT02849743|65077264|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
23363855|NCT02849743|65077263|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23363856|NCT02849743|65077264|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23363857|NCT02824224|65077265|FG000|Overall Study|Discontinued, IUS expulsion|0|||
23363858|NCT02824224|65077266|FG001|Overall Study|Discontinued, IUS expulsion|1|||
23363859|NCT02824224|65077265|FG000|Overall Study|Did not show up for allocation visit|2|||
23363860|NCT02824224|65077266|FG001|Overall Study|Did not show up for allocation visit|0|||
23363861|NCT00128661|65081027|FG000|Overall Study|Adverse Event|14|||
23363862|NCT00128661|65081028|FG001|Overall Study|Adverse Event|11|||
23363863|NCT00128661|65081027|FG000|Overall Study|Lost to Follow-up|10|||
23363864|NCT00128661|65081028|FG001|Overall Study|Lost to Follow-up|7|||
23363865|NCT00128661|65081027|FG000|Overall Study|Withdrawal by Subject|243|||
23363866|NCT00128661|65081028|FG001|Overall Study|Withdrawal by Subject|232|||
23363867|NCT00128661|65081027|FG000|Overall Study|Other|7|||
23363868|NCT00128661|65081028|FG001|Overall Study|Other|8|||
23363869|NCT02104895|65081031|FG000|Overall Study|Withdrawal by Subject|0|||
23363870|NCT02104895|65081032|FG001|Overall Study|Withdrawal by Subject|14|||
23363871|NCT02239640|65081036|FG000|Overall Study|Withdrawal by Subject|3|||
23363872|NCT02239640|65081036|FG000|Overall Study|Lost to Follow-up|72|||
23363873|NCT02239640|65081036|FG000|Overall Study|Death|142|||
23363874|NCT01059773|65081041|FG000|Overall Study|Adverse Event|2|||
23363875|NCT01059773|65081042|FG001|Overall Study|Adverse Event|2|||
23363876|NCT01059773|65081041|FG000|Overall Study|Withdrawal by Subject|1|||
23363877|NCT01059773|65081042|FG001|Overall Study|Withdrawal by Subject|5|||
23363878|NCT01059773|65081041|FG000|Overall Study|Lost to Follow-up|1|||
23363879|NCT01059773|65081042|FG001|Overall Study|Lost to Follow-up|1|||
23363880|NCT01059773|65081041|FG000|Overall Study|Pregnancy|1|||
23363881|NCT01059773|65081042|FG001|Overall Study|Pregnancy|1|||
23363882|NCT01059773|65081041|FG000|Overall Study|Protocol Violation|6|||
23363883|NCT01059773|65081042|FG001|Overall Study|Protocol Violation|2|||
23363884|NCT01059773|65081041|FG000|Overall Study|Physician Decision|5|||
23363885|NCT01059773|65081042|FG001|Overall Study|Physician Decision|4|||
23363886|NCT01059773|65081041|FG000|Overall Study|Lack of Efficacy|3|||
23363887|NCT01059773|65081042|FG001|Overall Study|Lack of Efficacy|3|||
23363888|NCT01059773|65081041|FG000|Overall Study|Death|0|||
23363889|NCT01059773|65081042|FG001|Overall Study|Death|1|||
23363890|NCT01059773|65081041|FG000|Overall Study|Malignancy including squamous cell skin|0|||
23363891|NCT01059773|65081042|FG001|Overall Study|Malignancy including squamous cell skin|1|||
23363892|NCT01059773|65081041|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
23363893|NCT01059773|65081042|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
23363894|NCT01059773|65081041|FG000|Overall Study|Other|1|||
23363895|NCT01059773|65081042|FG001|Overall Study|Other|3|||
23363896|NCT00784719|65081045|FG000|Overall Study|Adverse Event|0|||
23363897|NCT00784719|65081046|FG001|Overall Study|Adverse Event|2|||
23363898|NCT00784719|65081047|FG002|Overall Study|Adverse Event|0|||
23363899|NCT00784719|65081048|FG003|Overall Study|Adverse Event|0|||
23363900|NCT00784719|65081049|FG004|Overall Study|Adverse Event|1|||
23363901|NCT00784719|65081050|FG005|Overall Study|Adverse Event|1|||
23363902|NCT00784719|65081051|FG006|Overall Study|Adverse Event|1|||
23363903|NCT00784719|65081045|FG000|Overall Study|Lost to Follow-up|0|||
23363904|NCT00784719|65081046|FG001|Overall Study|Lost to Follow-up|0|||
23363905|NCT00784719|65081047|FG002|Overall Study|Lost to Follow-up|0|||
23363906|NCT00784719|65081048|FG003|Overall Study|Lost to Follow-up|0|||
23363907|NCT00784719|65081049|FG004|Overall Study|Lost to Follow-up|1|||
23363908|NCT00784719|65081050|FG005|Overall Study|Lost to Follow-up|1|||
23363909|NCT00784719|65081051|FG006|Overall Study|Lost to Follow-up|0|||
23363910|NCT00784719|65081045|FG000|Overall Study|Other|2|||
23363911|NCT00784719|65081046|FG001|Overall Study|Other|1|||
23363912|NCT00784719|65081047|FG002|Overall Study|Other|1|||
23363913|NCT00784719|65081048|FG003|Overall Study|Other|0|||
23363914|NCT00784719|65081049|FG004|Overall Study|Other|2|||
23363915|NCT00784719|65081050|FG005|Overall Study|Other|1|||
23481043|NCT03915860|65502130|FG000|Overall Study|Adverse Event|3|||
23363916|NCT00784719|65081051|FG006|Overall Study|Other|3|||
23363917|NCT00784719|65081045|FG000|Overall Study|Withdrawal by Subject|1|||
23363918|NCT00784719|65081046|FG001|Overall Study|Withdrawal by Subject|0|||
23363919|NCT00784719|65081047|FG002|Overall Study|Withdrawal by Subject|0|||
23363920|NCT00784719|65081048|FG003|Overall Study|Withdrawal by Subject|0|||
23363921|NCT00784719|65081049|FG004|Overall Study|Withdrawal by Subject|2|||
23363922|NCT00784719|65081050|FG005|Overall Study|Withdrawal by Subject|0|||
23363923|NCT00784719|65081051|FG006|Overall Study|Withdrawal by Subject|1|||
23363924|NCT01691378|65081052|FG000|Overall Study|Withdrawal by Subject|2|||
23363925|NCT01691378|65081053|FG001|Overall Study|Withdrawal by Subject|0|||
23363926|NCT01691378|65081052|FG000|Overall Study|Lost to Follow-up|5|||
23363927|NCT01691378|65081053|FG001|Overall Study|Lost to Follow-up|2|||
23363928|NCT01178125|65081059|FG000|Overall Study|Lost to Follow-up|397|||
23363929|NCT01178125|65081059|FG000|Overall Study|Adverse Event|244|||
23363930|NCT01178125|65081059|FG000|Overall Study|Withdrawal by Subject|209|||
23363931|NCT01178125|65081059|FG000|Overall Study|Noncompliance|184|||
23601201|NCT00336505|65929881|FG001|Overall Study|Adverse Event|9|||
23601202|NCT00336505|65929880|FG000|Overall Study|Lack of Efficacy|8|||
23601203|NCT00336505|65929881|FG001|Overall Study|Lack of Efficacy|4|||
23601204|NCT00336505|65929880|FG000|Overall Study|Lost to Follow-up|7|||
23601205|NCT00336505|65929881|FG001|Overall Study|Lost to Follow-up|4|||
23601206|NCT00336505|65929880|FG000|Overall Study|Withdrawal by Subject|5|||
23601207|NCT00336505|65929881|FG001|Overall Study|Withdrawal by Subject|3|||
23601208|NCT00336505|65929880|FG000|Overall Study|Other|7|||
23601209|NCT00336505|65929881|FG001|Overall Study|Other|7|||
23601210|NCT01736475|65929882|FG000|Overall Study|Adverse Event|4|||
23601211|NCT01736475|65929883|FG001|Overall Study|Adverse Event|0|||
23658959|NCT01129921|66139167|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
23658960|NCT01129921|66139168|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
23658961|NCT01129921|66139167|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
23658962|NCT01129921|66139168|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
23601212|NCT01736475|65929882|FG000|Overall Study|Withdrawal by Subject|2|||
23601213|NCT01736475|65929883|FG001|Overall Study|Withdrawal by Subject|0|||
23658963|NCT01129921|66139167|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
23658964|NCT01129921|66139168|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
23601214|NCT01736475|65929882|FG000|Overall Study|Protocol Violation|4|||
23601215|NCT01736475|65929883|FG001|Overall Study|Protocol Violation|0|||
23658965|NCT04275297|66139169|FG000|Overall Study|Lost to Follow-up|1|||
23363932|NCT01178125|65081059|FG000|Overall Study|Pregnancy|55|||
23481044|NCT03915860|65502130|FG000|Overall Study|Withdrawal by Subject|6|||
23481045|NCT03915860|65502130|FG000|Overall Study|Lost to Follow-up|2|||
23481046|NCT03915860|65502130|FG000|Overall Study|Other than specified|3|||
23481047|NCT00393042|65505057|FG000|First Intervention|Withdrawal by Subject|1|||
23481048|NCT00393042|65505058|FG001|First Intervention|Withdrawal by Subject|2|||
23481049|NCT00393042|65505057|FG000|First Intervention|Lost to Follow-up|3|||
23481050|NCT00393042|65505058|FG001|First Intervention|Lost to Follow-up|3|||
23481051|NCT00393042|65505057|FG000|First Intervention|Protocol Violation|1|||
23481052|NCT00393042|65505058|FG001|First Intervention|Protocol Violation|0|||
23481053|NCT00393042|65505057|FG000|First Intervention|Adverse Event|0|||
23481054|NCT00393042|65505058|FG001|First Intervention|Adverse Event|1|||
23481055|NCT00393042|65505057|FG000|Second Intervetion|Adverse Event|0|||
23481056|NCT00393042|65505058|FG001|Second Intervetion|Adverse Event|3|||
23481057|NCT00393042|65505057|FG000|Second Intervetion|Withdrawal by Subject|0|||
23481058|NCT00393042|65505058|FG001|Second Intervetion|Withdrawal by Subject|2|||
23363933|NCT01178125|65081059|FG000|Overall Study|Other Reason|39|||
23363934|NCT01178125|65081059|FG000|Overall Study|Sponsor Decision|28|||
23481059|NCT00393042|65505057|FG000|Second Intervetion|Lack of Efficacy|1|||
23481060|NCT00393042|65505058|FG001|Second Intervetion|Lack of Efficacy|0|||
23481061|NCT00393042|65505057|FG000|Second Intervetion|Lost to Follow-up|0|||
23481062|NCT00393042|65505058|FG001|Second Intervetion|Lost to Follow-up|2|||
23481063|NCT00393042|65505057|FG000|Second Intervetion|Protocol Violation|1|||
23481064|NCT00393042|65505058|FG001|Second Intervetion|Protocol Violation|1|||
23481065|NCT00538785|65505059|FG000|Overall Study|Death|9|||
23658966|NCT04275297|66139170|FG001|Overall Study|Lost to Follow-up|1|||
23363935|NCT01178125|65081059|FG000|Overall Study|Protocol Violation|17|||
23363936|NCT01178125|65081059|FG000|Overall Study|Investigator Decision|5|||
23363937|NCT02848664|65081062|FG000|Overall Study|Withdrawal by Subject|2|||
23363938|NCT02848664|65081062|FG000|Overall Study|Adverse Event|1|||
23363939|NCT02848664|65081062|FG000|Overall Study|no assistance for device training|1|||
23363940|NCT04552132|65081063|FG000|Overall Study|Lost to Follow-up|4|||
23363941|NCT04552132|65081064|FG001|Overall Study|Lost to Follow-up|3|||
23363942|NCT04552132|65081063|FG000|Overall Study|Protocol Violation|1|||
23363943|NCT04552132|65081064|FG001|Overall Study|Protocol Violation|0|||
23363944|NCT01223404|65081065|FG000|First Intervention (1 Day)|Adverse Event|0|||
23363945|NCT01223404|65081066|FG001|First Intervention (1 Day)|Adverse Event|0|||
23363946|NCT01223404|65081067|FG002|First Intervention (1 Day)|Adverse Event|0|||
23481066|NCT00538785|65505060|FG001|Overall Study|Death|10|||
23481067|NCT00538785|65505059|FG000|Overall Study|Withdrawal of consent|9|||
23481068|NCT00538785|65505060|FG001|Overall Study|Withdrawal of consent|7|||
23601216|NCT01736475|65929882|FG000|Overall Study|Other - Screen failure|1|||
23658967|NCT04498169|66139171|FG000|Study Completion|Adverse Event|1|||
23658968|NCT04498169|66139172|FG001|Study Completion|Adverse Event|1|||
23658969|NCT01576172|66139181|FG000|Overall Study|Ineligible|2|||
23658970|NCT01576172|66139182|FG001|Overall Study|Ineligible|1|||
23363947|NCT01223404|65081068|FG003|First Intervention (1 Day)|Adverse Event|1|||
23363948|NCT01223404|65081069|FG004|First Intervention (1 Day)|Adverse Event|0|||
23363949|NCT01223404|65081070|FG005|First Intervention (1 Day)|Adverse Event|0|||
23481069|NCT00538785|65505059|FG000|Overall Study|Lost to Follow-up|1|||
23481070|NCT00538785|65505060|FG001|Overall Study|Lost to Follow-up|0|||
23481071|NCT00621621|65505061|FG000|Overall Study|Subjects were exited at EP study|30|||
23481072|NCT00621621|65505062|FG001|Overall Study|Subjects were exited at EP study|0|||
23481073|NCT00584740|65505063|FG000|Overall Study|Adverse Event|1|||
23601217|NCT01736475|65929883|FG001|Overall Study|Other - Screen failure|0|||
23363950|NCT01223404|65081065|FG000|Second Intervention (1 Day)|Adverse Event|1|||
23363951|NCT01223404|65081066|FG001|Second Intervention (1 Day)|Adverse Event|0|||
23363952|NCT01223404|65081067|FG002|Second Intervention (1 Day)|Adverse Event|0|||
23363953|NCT01223404|65081068|FG003|Second Intervention (1 Day)|Adverse Event|0|||
23363954|NCT01223404|65081069|FG004|Second Intervention (1 Day)|Adverse Event|0|||
23363955|NCT01223404|65081070|FG005|Second Intervention (1 Day)|Adverse Event|0|||
23363956|NCT01223404|65081065|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363957|NCT01223404|65081066|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363958|NCT01223404|65081067|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363959|NCT01223404|65081068|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
23363960|NCT01223404|65081069|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363961|NCT01223404|65081070|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363962|NCT00666211|65081071|FG000|Overall Study|Withdrawal by Subject|10|||
23363963|NCT00666211|65081072|FG001|Overall Study|Withdrawal by Subject|13|||
23363964|NCT00666211|65081071|FG000|Overall Study|went off medication, no more pain|1|||
23363965|NCT00666211|65081072|FG001|Overall Study|went off medication, no more pain|0|||
23363966|NCT00666211|65081071|FG000|Overall Study|patient non-compliant|6|||
23363967|NCT00666211|65081072|FG001|Overall Study|patient non-compliant|6|||
23363968|NCT00666211|65081071|FG000|Overall Study|disease progression|1|||
23363969|NCT00666211|65081072|FG001|Overall Study|disease progression|8|||
23363970|NCT00666211|65081071|FG000|Overall Study|Lost to Follow-up|2|||
23363971|NCT00666211|65081072|FG001|Overall Study|Lost to Follow-up|0|||
23363972|NCT00666211|65081071|FG000|Overall Study|toxicity|0|||
23363973|NCT00666211|65081072|FG001|Overall Study|toxicity|2|||
23363974|NCT00666211|65081071|FG000|Overall Study|hospital admission|0|||
23363975|NCT00666211|65081072|FG001|Overall Study|hospital admission|5|||
23363976|NCT00666211|65081071|FG000|Overall Study|Death|0|||
23363977|NCT00666211|65081072|FG001|Overall Study|Death|2|||
23363978|NCT00666211|65081071|FG000|Overall Study|off tx for other complicating disease|0|||
23363979|NCT00666211|65081072|FG001|Overall Study|off tx for other complicating disease|1|||
23363980|NCT00666211|65081071|FG000|Overall Study|Physician Decision|0|||
23363981|NCT00666211|65081072|FG001|Overall Study|Physician Decision|1|||
23363982|NCT02521792|65081073|FG000|Overall Study|Study Terminated|6|||
23363983|NCT03586050|65081077|FG000|Overall Study|Death|3|||
23363984|NCT03586050|65081077|FG000|Overall Study|Withdrawal by Subject|2|||
23363985|NCT02616783|65081078|FG000|Overall Study|Randomized but Not Treated|1|||
23363986|NCT02616783|65081079|FG001|Overall Study|Randomized but Not Treated|0|||
23363987|NCT02616783|65081078|FG000|Overall Study|Adverse Event|1|||
23601218|NCT01736475|65929882|FG000|Overall Study|Other - Surgical procedure|1|||
23601219|NCT01736475|65929883|FG001|Overall Study|Other - Surgical procedure|0|||
23363988|NCT02616783|65081079|FG001|Overall Study|Adverse Event|0|||
23363989|NCT02616783|65081078|FG000|Overall Study|Death|1|||
23363990|NCT02616783|65081079|FG001|Overall Study|Death|0|||
23363991|NCT02616783|65081078|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23363992|NCT02616783|65081079|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23363993|NCT02616783|65081078|FG000|Overall Study|Protocol Violation|1|||
23363994|NCT02616783|65081079|FG001|Overall Study|Protocol Violation|1|||
23363995|NCT02616783|65081078|FG000|Overall Study|Withdrew Consent|1|||
23363996|NCT02616783|65081079|FG001|Overall Study|Withdrew Consent|1|||
23363997|NCT00522548|65081080|FG000|Overall Study|Adverse Event|2|||
23601220|NCT02432274|65929884|FG000|Overall Study|Death|2|||
23363998|NCT00522548|65081081|FG001|Overall Study|Adverse Event|2|||
23363999|NCT00522548|65081080|FG000|Overall Study|Withdrawal by Subject|0|||
23364000|NCT00522548|65081081|FG001|Overall Study|Withdrawal by Subject|2|||
23364001|NCT01275144|65081082|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
23364002|NCT01275144|65081083|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
23364003|NCT01673178|65081086|FG000|Overall Study|Lost to Follow-up|0|||
23364004|NCT01673178|65081087|FG001|Overall Study|Lost to Follow-up|1|||
23481074|NCT00584740|65505064|FG001|Overall Study|Adverse Event|1|||
23481075|NCT00584740|65505063|FG000|Overall Study|Lack of Efficacy|8|||
23481076|NCT00584740|65505064|FG001|Overall Study|Lack of Efficacy|2|||
23481077|NCT00584740|65505063|FG000|Overall Study|Withdrawal by Subject|3|||
23481078|NCT00584740|65505064|FG001|Overall Study|Withdrawal by Subject|2|||
23481079|NCT00584740|65505063|FG000|Overall Study|Lost to Follow-up|0|||
23481080|NCT00584740|65505064|FG001|Overall Study|Lost to Follow-up|1|||
23364005|NCT01673178|65081088|FG002|Overall Study|Lost to Follow-up|0|||
23364006|NCT01673178|65081089|FG003|Overall Study|Lost to Follow-up|0|||
23364007|NCT01673178|65081090|FG004|Overall Study|Lost to Follow-up|0|||
23364008|NCT01673178|65081086|FG000|Overall Study|Withdrawal by Subject|0|||
23364009|NCT01673178|65081087|FG001|Overall Study|Withdrawal by Subject|0|||
23364010|NCT01673178|65081088|FG002|Overall Study|Withdrawal by Subject|1|||
23364011|NCT01673178|65081089|FG003|Overall Study|Withdrawal by Subject|4|||
23364012|NCT01673178|65081090|FG004|Overall Study|Withdrawal by Subject|2|||
23364013|NCT01673178|65081086|FG000|Overall Study|Protocol Violation|1|||
23364014|NCT01673178|65081087|FG001|Overall Study|Protocol Violation|1|||
23364015|NCT01673178|65081088|FG002|Overall Study|Protocol Violation|0|||
23364016|NCT01673178|65081089|FG003|Overall Study|Protocol Violation|1|||
23364017|NCT01673178|65081090|FG004|Overall Study|Protocol Violation|0|||
23364018|NCT01673178|65081086|FG000|Overall Study|Adverse Event|1|||
23364019|NCT01673178|65081087|FG001|Overall Study|Adverse Event|0|||
23364020|NCT01673178|65081088|FG002|Overall Study|Adverse Event|0|||
23364021|NCT01673178|65081089|FG003|Overall Study|Adverse Event|2|||
23364022|NCT01673178|65081090|FG004|Overall Study|Adverse Event|0|||
23364023|NCT01673178|65081086|FG000|Overall Study|Other|1|||
23364024|NCT01673178|65081087|FG001|Overall Study|Other|0|||
23364025|NCT01673178|65081088|FG002|Overall Study|Other|2|||
23364026|NCT01673178|65081089|FG003|Overall Study|Other|1|||
23364027|NCT01673178|65081090|FG004|Overall Study|Other|0|||
23364028|NCT01441973|65081091|FG000|Overall Study|Disease progression|8|||
23364029|NCT01441973|65081092|FG001|Overall Study|Disease progression|6|||
23364030|NCT01441973|65081091|FG000|Overall Study|Adverse event unrelated to study drug|3|||
23364031|NCT01441973|65081092|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23364032|NCT01441973|65081091|FG000|Overall Study|Participant request to discontinue|1|||
23364033|NCT01441973|65081092|FG001|Overall Study|Participant request to discontinue|1|||
23364034|NCT01441973|65081091|FG000|Overall Study|Poor compliance/noncompliance|0|||
23364035|NCT01441973|65081092|FG001|Overall Study|Poor compliance/noncompliance|1|||
23364036|NCT01441973|65081091|FG000|Overall Study|Administrative reason by sponsor|3|||
23364037|NCT01441973|65081092|FG001|Overall Study|Administrative reason by sponsor|5|||
23364038|NCT01441973|65081091|FG000|Overall Study|Participant withdrew consent|0|||
23364039|NCT01441973|65081092|FG001|Overall Study|Participant withdrew consent|1|||
23364040|NCT01657162|65081093|FG000|Overall Study|Adverse Event|26|||
23364041|NCT01657162|65081094|FG001|Overall Study|Adverse Event|36|||
23364042|NCT01657162|65081093|FG000|Overall Study|Withdrawal by Subject|13|||
23481081|NCT00830869|65505069|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
23481082|NCT00830869|65505070|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
23364043|NCT01657162|65081094|FG001|Overall Study|Withdrawal by Subject|13|||
23364044|NCT01657162|65081093|FG000|Overall Study|Continuing Significant Deterioration|9|||
23364045|NCT01657162|65081094|FG001|Overall Study|Continuing Significant Deterioration|3|||
23364046|NCT01657162|65081093|FG000|Overall Study|Refusal of Treatment|4|||
23364047|NCT01657162|65081094|FG001|Overall Study|Refusal of Treatment|6|||
23364048|NCT01657162|65081093|FG000|Overall Study|Lost to Follow-up|3|||
23807369|NCT00974974|66672751|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
23364049|NCT01657162|65081094|FG001|Overall Study|Lost to Follow-up|4|||
23364050|NCT01657162|65081093|FG000|Overall Study|Death|2|||
23481083|NCT00830869|65505071|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
23481084|NCT00830869|65505072|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
23481085|NCT00830869|65505073|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
23481086|NCT00830869|65505074|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
23481087|NCT00830869|65505075|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
23481088|NCT00830869|65505076|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
23481089|NCT00830869|65505077|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
23481090|NCT00830869|65505078|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
23481091|NCT00830869|65505079|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
23481092|NCT00830869|65505080|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
23481093|NCT00830869|65505069|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
23481094|NCT00830869|65505070|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
23481095|NCT00830869|65505071|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
23481096|NCT00830869|65505072|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
23481097|NCT00830869|65505073|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
23481098|NCT00830869|65505074|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
23481099|NCT00830869|65505075|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
23481100|NCT00830869|65505076|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
23481101|NCT00830869|65505077|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
23481102|NCT00830869|65505078|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
23481103|NCT00830869|65505079|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
23481104|NCT00830869|65505080|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
23481105|NCT00830869|65505069|FG000|Period 1: Part 1|Adverse Event|0|||
23481106|NCT00830869|65505070|FG001|Period 1: Part 1|Adverse Event|0|||
23481107|NCT00830869|65505071|FG002|Period 1: Part 1|Adverse Event|0|||
23481108|NCT00830869|65505072|FG003|Period 1: Part 1|Adverse Event|0|||
23658971|NCT01576172|66139181|FG000|Overall Study|Withdrawal by Subject|2|||
23481109|NCT00830869|65505073|FG004|Period 1: Part 1|Adverse Event|0|||
23481110|NCT00830869|65505074|FG005|Period 1: Part 1|Adverse Event|1|||
23481111|NCT00830869|65505075|FG006|Period 1: Part 1|Adverse Event|1|||
23481112|NCT00830869|65505076|FG007|Period 1: Part 1|Adverse Event|0|||
23481113|NCT00830869|65505077|FG008|Period 1: Part 1|Adverse Event|0|||
23481114|NCT00830869|65505078|FG009|Period 1: Part 1|Adverse Event|0|||
23481115|NCT00830869|65505079|FG010|Period 1: Part 1|Adverse Event|0|||
23481116|NCT00830869|65505080|FG011|Period 1: Part 1|Adverse Event|0|||
23481117|NCT00830869|65505069|FG000|Period 1: Part 1|Progressive disease|1|||
23481118|NCT00830869|65505070|FG001|Period 1: Part 1|Progressive disease|0|||
23481119|NCT00830869|65505071|FG002|Period 1: Part 1|Progressive disease|1|||
23481120|NCT00830869|65505072|FG003|Period 1: Part 1|Progressive disease|6|||
23481121|NCT00830869|65505073|FG004|Period 1: Part 1|Progressive disease|4|||
23601221|NCT02432274|65929885|FG001|Overall Study|Death|6|||
23601222|NCT02432274|65929886|FG002|Overall Study|Death|7|||
23658972|NCT01576172|66139182|FG001|Overall Study|Withdrawal by Subject|0|||
23658973|NCT01576172|66139181|FG000|Overall Study|Insurance issue|1|||
23658974|NCT01576172|66139182|FG001|Overall Study|Insurance issue|0|||
23658975|NCT00078325|66139183|FG000|Overall Study|Adverse Event|15|||
23658976|NCT00078325|66139184|FG001|Overall Study|Adverse Event|10|||
23658977|NCT00078325|66139185|FG002|Overall Study|Adverse Event|5|||
23658978|NCT00078325|66139183|FG000|Overall Study|Protocol Violation|2|||
23658979|NCT00078325|66139184|FG001|Overall Study|Protocol Violation|2|||
23658980|NCT00078325|66139185|FG002|Overall Study|Protocol Violation|0|||
23658981|NCT00078325|66139183|FG000|Overall Study|Withdrawal by Subject|1|||
23658982|NCT00078325|66139184|FG001|Overall Study|Withdrawal by Subject|5|||
23481122|NCT00830869|65505074|FG005|Period 1: Part 1|Progressive disease|4|||
23481123|NCT00830869|65505075|FG006|Period 1: Part 1|Progressive disease|1|||
23481124|NCT00830869|65505076|FG007|Period 1: Part 1|Progressive disease|0|||
23481125|NCT00830869|65505077|FG008|Period 1: Part 1|Progressive disease|0|||
23481126|NCT00830869|65505078|FG009|Period 1: Part 1|Progressive disease|0|||
23481127|NCT00830869|65505079|FG010|Period 1: Part 1|Progressive disease|0|||
23481128|NCT00830869|65505080|FG011|Period 1: Part 1|Progressive disease|0|||
23481129|NCT00830869|65505069|FG000|Period 2: Part 2|Protocol Violation|0|||
23481130|NCT00830869|65505070|FG001|Period 2: Part 2|Protocol Violation|0|||
23601223|NCT02432274|65929887|FG003|Overall Study|Death|0|||
23601224|NCT02432274|65929888|FG004|Overall Study|Death|27|||
23601225|NCT02432274|65929889|FG005|Overall Study|Death|7|||
23601226|NCT02432274|65929890|FG006|Overall Study|Death|9|||
23601227|NCT02432274|65929891|FG007|Overall Study|Death|14|||
23601228|NCT02432274|65929884|FG000|Overall Study|Withdrawal of Consent|0|||
23601229|NCT02432274|65929885|FG001|Overall Study|Withdrawal of Consent|0|||
23601230|NCT02432274|65929886|FG002|Overall Study|Withdrawal of Consent|0|||
23601231|NCT02432274|65929887|FG003|Overall Study|Withdrawal of Consent|0|||
23601232|NCT02432274|65929888|FG004|Overall Study|Withdrawal of Consent|2|||
23601233|NCT02432274|65929889|FG005|Overall Study|Withdrawal of Consent|0|||
23601234|NCT02432274|65929890|FG006|Overall Study|Withdrawal of Consent|1|||
23601235|NCT02432274|65929891|FG007|Overall Study|Withdrawal of Consent|2|||
23601236|NCT02185794|65929894|FG000|Overall Study|Enrolled but Never Dosed|1|||
23601237|NCT02185794|65929895|FG001|Overall Study|Enrolled but Never Dosed|6|||
23658983|NCT00078325|66139185|FG002|Overall Study|Withdrawal by Subject|3|||
23658984|NCT00078325|66139183|FG000|Overall Study|Lost to Follow-up|0|||
23658985|NCT00078325|66139184|FG001|Overall Study|Lost to Follow-up|1|||
23658986|NCT00078325|66139185|FG002|Overall Study|Lost to Follow-up|1|||
23658987|NCT00078325|66139183|FG000|Overall Study|Physician Decision|2|||
23658988|NCT00078325|66139184|FG001|Overall Study|Physician Decision|0|||
23658989|NCT00078325|66139185|FG002|Overall Study|Physician Decision|1|||
23658990|NCT00078325|66139183|FG000|Overall Study|Miscellaneous|1|||
23658991|NCT00078325|66139184|FG001|Overall Study|Miscellaneous|1|||
23658992|NCT00078325|66139185|FG002|Overall Study|Miscellaneous|1|||
23658993|NCT03583450|66139189|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
23658994|NCT03583450|66139190|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
23658995|NCT01265615|66139191|FG000|Overall Study|Protocol Violation|2|||
23658996|NCT01265615|66139192|FG001|Overall Study|Protocol Violation|2|||
23658997|NCT01265615|66139193|FG002|Overall Study|Protocol Violation|4|||
23658998|NCT01265615|66139194|FG003|Overall Study|Protocol Violation|3|||
23658999|NCT00356889|66139195|FG000|Overall Study|Protocol Violation|2|||
23659000|NCT00356889|66139195|FG000|Overall Study|Adverse Event|1|||
23659001|NCT00574145|66139196|FG000|Overall Study|Withdrawal by Subject|2|||
23659002|NCT00574145|66139197|FG001|Overall Study|Withdrawal by Subject|1|||
23659003|NCT03713034|66139211|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
23659004|NCT03713034|66139212|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
23659005|NCT04029116|66139215|FG000|Overall Study|Adverse Event|0|||
23659006|NCT04029116|66139216|FG001|Overall Study|Adverse Event|2|||
23659007|NCT04029116|66139215|FG000|Overall Study|Lost to Follow-up|3|||
23659008|NCT04029116|66139216|FG001|Overall Study|Lost to Follow-up|5|||
23659009|NCT04029116|66139215|FG000|Overall Study|Physician Decision|2|||
23659010|NCT04029116|66139216|FG001|Overall Study|Physician Decision|0|||
23659011|NCT04029116|66139215|FG000|Overall Study|Pregnancy|1|||
23601238|NCT02185794|65929896|FG002|Overall Study|Enrolled but Never Dosed|3|||
23601239|NCT02185794|65929897|FG003|Overall Study|Enrolled but Never Dosed|1|||
23601240|NCT02185794|65929898|FG004|Overall Study|Enrolled but Never Dosed|1|||
23601241|NCT02185794|65929899|FG005|Overall Study|Enrolled but Never Dosed|0|||
23601242|NCT02185794|65929894|FG000|Overall Study|Investigator's Discretion|1|||
23601243|NCT02185794|65929895|FG001|Overall Study|Investigator's Discretion|0|||
23601244|NCT02185794|65929896|FG002|Overall Study|Investigator's Discretion|1|||
23601245|NCT02185794|65929897|FG003|Overall Study|Investigator's Discretion|2|||
23601246|NCT02185794|65929898|FG004|Overall Study|Investigator's Discretion|2|||
23601247|NCT02185794|65929899|FG005|Overall Study|Investigator's Discretion|15|||
23601248|NCT02185794|65929894|FG000|Overall Study|Withdrew Consent|2|||
23601249|NCT02185794|65929895|FG001|Overall Study|Withdrew Consent|5|||
23601250|NCT02185794|65929896|FG002|Overall Study|Withdrew Consent|10|||
23601251|NCT02185794|65929897|FG003|Overall Study|Withdrew Consent|2|||
23601252|NCT02185794|65929898|FG004|Overall Study|Withdrew Consent|0|||
23659012|NCT04029116|66139216|FG001|Overall Study|Pregnancy|2|||
23659013|NCT04029116|66139215|FG000|Overall Study|Withdrawal by Subject|4|||
23659014|NCT04029116|66139216|FG001|Overall Study|Withdrawal by Subject|6|||
23659015|NCT04029116|66139215|FG000|Overall Study|Other|2|||
23659016|NCT04029116|66139216|FG001|Overall Study|Other|1|||
23659017|NCT01987960|66139218|FG000|Period 1|Adverse Event|24|||
23659018|NCT01987960|66139219|FG001|Period 1|Adverse Event|0|||
23659019|NCT01987960|66139220|FG002|Period 1|Adverse Event|0|||
23659020|NCT01987960|66139221|FG003|Period 1|Adverse Event|0|||
23659021|NCT01987960|66139218|FG000|Period 1|Lack of Efficacy|4|||
23659022|NCT01987960|66139219|FG001|Period 1|Lack of Efficacy|0|||
23659023|NCT01987960|66139220|FG002|Period 1|Lack of Efficacy|0|||
23659024|NCT01987960|66139221|FG003|Period 1|Lack of Efficacy|0|||
23659025|NCT01987960|66139218|FG000|Period 1|Non-compliance with IMP|6|||
23659026|NCT01987960|66139219|FG001|Period 1|Non-compliance with IMP|0|||
23659027|NCT01987960|66139220|FG002|Period 1|Non-compliance with IMP|0|||
23659028|NCT01987960|66139221|FG003|Period 1|Non-compliance with IMP|0|||
23659029|NCT01987960|66139218|FG000|Period 1|Protocol Violation|12|||
23659030|NCT01987960|66139219|FG001|Period 1|Protocol Violation|0|||
23659031|NCT01987960|66139220|FG002|Period 1|Protocol Violation|0|||
23659032|NCT01987960|66139221|FG003|Period 1|Protocol Violation|0|||
23659033|NCT01987960|66139218|FG000|Period 1|Withdrawal by Subject|21|||
23659034|NCT01987960|66139219|FG001|Period 1|Withdrawal by Subject|0|||
23659035|NCT01987960|66139220|FG002|Period 1|Withdrawal by Subject|0|||
23601253|NCT02185794|65929899|FG005|Overall Study|Withdrew Consent|0|||
23601254|NCT02185794|65929894|FG000|Overall Study|Lost to Follow-up|1|||
23601255|NCT02185794|65929895|FG001|Overall Study|Lost to Follow-up|2|||
23659036|NCT01987960|66139221|FG003|Period 1|Withdrawal by Subject|0|||
23659037|NCT01987960|66139218|FG000|Period 1|Lost to Follow-up|40|||
23659038|NCT01987960|66139219|FG001|Period 1|Lost to Follow-up|0|||
23659039|NCT01987960|66139220|FG002|Period 1|Lost to Follow-up|0|||
23659040|NCT01987960|66139221|FG003|Period 1|Lost to Follow-up|0|||
23601256|NCT02185794|65929896|FG002|Overall Study|Lost to Follow-up|2|||
23659041|NCT01987960|66139218|FG000|Period 1|administrative or other reason|75|||
23659042|NCT01987960|66139219|FG001|Period 1|administrative or other reason|0|||
23659043|NCT01987960|66139220|FG002|Period 1|administrative or other reason|0|||
23481131|NCT00830869|65505071|FG002|Period 2: Part 2|Protocol Violation|0|||
23481132|NCT00830869|65505072|FG003|Period 2: Part 2|Protocol Violation|0|||
23481133|NCT00830869|65505073|FG004|Period 2: Part 2|Protocol Violation|0|||
23481134|NCT00830869|65505074|FG005|Period 2: Part 2|Protocol Violation|0|||
23481135|NCT00830869|65505075|FG006|Period 2: Part 2|Protocol Violation|0|||
23481136|NCT00830869|65505076|FG007|Period 2: Part 2|Protocol Violation|1|||
23481137|NCT00830869|65505077|FG008|Period 2: Part 2|Protocol Violation|0|||
23481138|NCT00830869|65505078|FG009|Period 2: Part 2|Protocol Violation|1|||
23481139|NCT00830869|65505079|FG010|Period 2: Part 2|Protocol Violation|0|||
23481140|NCT00830869|65505080|FG011|Period 2: Part 2|Protocol Violation|0|||
23481141|NCT00830869|65505069|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
23481142|NCT00830869|65505070|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
23481143|NCT00830869|65505071|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
23481144|NCT00830869|65505072|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
23481145|NCT00830869|65505073|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
23481146|NCT00830869|65505074|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
23481147|NCT00830869|65505075|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
23481148|NCT00830869|65505076|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
23481149|NCT00830869|65505077|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
23481150|NCT00830869|65505078|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
23481151|NCT00830869|65505079|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
23481152|NCT00830869|65505080|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
23481153|NCT00830869|65505069|FG000|Period 2: Part 2|Adverse Event|0|||
23481154|NCT00830869|65505070|FG001|Period 2: Part 2|Adverse Event|0|||
23481155|NCT00830869|65505071|FG002|Period 2: Part 2|Adverse Event|0|||
23481156|NCT00830869|65505072|FG003|Period 2: Part 2|Adverse Event|0|||
23481157|NCT00830869|65505073|FG004|Period 2: Part 2|Adverse Event|0|||
23481158|NCT00830869|65505074|FG005|Period 2: Part 2|Adverse Event|0|||
23481159|NCT00830869|65505075|FG006|Period 2: Part 2|Adverse Event|0|||
23481160|NCT00830869|65505076|FG007|Period 2: Part 2|Adverse Event|4|||
23481161|NCT00830869|65505077|FG008|Period 2: Part 2|Adverse Event|3|||
23481162|NCT00830869|65505078|FG009|Period 2: Part 2|Adverse Event|2|||
23481163|NCT00830869|65505079|FG010|Period 2: Part 2|Adverse Event|2|||
23481164|NCT00830869|65505080|FG011|Period 2: Part 2|Adverse Event|0|||
23481165|NCT00830869|65505069|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
23481166|NCT00830869|65505070|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
23481167|NCT00830869|65505071|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
23481168|NCT00830869|65505072|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
23481169|NCT00830869|65505073|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
23481170|NCT00830869|65505074|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
23481171|NCT00830869|65505075|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
23481172|NCT00830869|65505076|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
23481173|NCT00830869|65505077|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
23481174|NCT00830869|65505078|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
23481175|NCT00830869|65505079|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
23481176|NCT00830869|65505080|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
23481177|NCT00830869|65505069|FG000|Period 2: Part 2|Progressive disease|0|||
23481178|NCT00830869|65505070|FG001|Period 2: Part 2|Progressive disease|0|||
23481179|NCT00830869|65505071|FG002|Period 2: Part 2|Progressive disease|0|||
23481180|NCT00830869|65505072|FG003|Period 2: Part 2|Progressive disease|0|||
23481181|NCT00830869|65505073|FG004|Period 2: Part 2|Progressive disease|0|||
23481182|NCT00830869|65505074|FG005|Period 2: Part 2|Progressive disease|0|||
23481183|NCT00830869|65505075|FG006|Period 2: Part 2|Progressive disease|0|||
23481184|NCT00830869|65505076|FG007|Period 2: Part 2|Progressive disease|14|||
23481185|NCT00830869|65505077|FG008|Period 2: Part 2|Progressive disease|11|||
23481186|NCT00830869|65505078|FG009|Period 2: Part 2|Progressive disease|12|||
23481187|NCT00830869|65505079|FG010|Period 2: Part 2|Progressive disease|8|||
23481188|NCT00830869|65505080|FG011|Period 2: Part 2|Progressive disease|15|||
23481189|NCT00830869|65505069|FG000|Period 2: Part 2|Other|0|||
23481190|NCT00830869|65505070|FG001|Period 2: Part 2|Other|0|||
23659044|NCT01987960|66139221|FG003|Period 1|administrative or other reason|0|||
23364051|NCT01657162|65081094|FG001|Overall Study|Death|3|||
23364052|NCT01657162|65081093|FG000|Overall Study|Inability to Complete Study Procedures|1|||
23481191|NCT00830869|65505071|FG002|Period 2: Part 2|Other|0|||
23481192|NCT00830869|65505072|FG003|Period 2: Part 2|Other|0|||
23481193|NCT00830869|65505073|FG004|Period 2: Part 2|Other|0|||
23481194|NCT00830869|65505074|FG005|Period 2: Part 2|Other|0|||
23481195|NCT00830869|65505075|FG006|Period 2: Part 2|Other|0|||
23481196|NCT00830869|65505076|FG007|Period 2: Part 2|Other|0|||
23481197|NCT00830869|65505077|FG008|Period 2: Part 2|Other|0|||
23481198|NCT00830869|65505078|FG009|Period 2: Part 2|Other|1|||
23481199|NCT00830869|65505079|FG010|Period 2: Part 2|Other|0|||
23481200|NCT00830869|65505080|FG011|Period 2: Part 2|Other|0|||
23481201|NCT03774823|65505087|FG000|Overall Study|Withdrawal by Subject|1|||
23481202|NCT03774823|65505088|FG001|Overall Study|Withdrawal by Subject|1|||
23481203|NCT00137839|65505089|FG000|Overall Study|Adverse Event|7|||
23481204|NCT00137839|65505089|FG000|Overall Study|Physician Decision|7|||
23659045|NCT01987960|66139218|FG000|Period 1|Withdrawal of consent before treatment|4|||
23659046|NCT01987960|66139219|FG001|Period 1|Withdrawal of consent before treatment|0|||
23659047|NCT01987960|66139220|FG002|Period 1|Withdrawal of consent before treatment|0|||
23659048|NCT01987960|66139221|FG003|Period 1|Withdrawal of consent before treatment|0|||
23659049|NCT01987960|66139218|FG000|Period 2|Adverse Event|0|||
23659050|NCT01987960|66139219|FG001|Period 2|Adverse Event|0|||
23659051|NCT01987960|66139220|FG002|Period 2|Adverse Event|1|||
23659052|NCT01987960|66139221|FG003|Period 2|Adverse Event|0|||
23659053|NCT01987960|66139218|FG000|Period 2|Withdrawal by Subject|0|||
23659054|NCT01987960|66139219|FG001|Period 2|Withdrawal by Subject|0|||
23659055|NCT01987960|66139220|FG002|Period 2|Withdrawal by Subject|1|||
23659056|NCT01987960|66139221|FG003|Period 2|Withdrawal by Subject|0|||
23659057|NCT01987960|66139218|FG000|Period 2|Administrative or other reason|0|||
23659058|NCT01987960|66139219|FG001|Period 2|Administrative or other reason|5|||
23481205|NCT00137839|65505089|FG000|Overall Study|Death|8|||
23481206|NCT00137839|65505089|FG000|Overall Study|Disease Progression|60|||
23481207|NCT00137839|65505089|FG000|Overall Study|Not Start Treatment|1|||
23481208|NCT00137839|65505089|FG000|Overall Study|Prolonged Treatment Delay|1|||
23481209|NCT02604017|65505090|FG000|Overall Study|Withdrew Consent|0|||
23481210|NCT02604017|65505091|FG001|Overall Study|Withdrew Consent|2|||
23481211|NCT02604017|65505090|FG000|Overall Study|Lost to Follow-up|5|||
23481212|NCT02604017|65505091|FG001|Overall Study|Lost to Follow-up|6|||
23481213|NCT02604017|65505090|FG000|Overall Study|Other|1|||
23481214|NCT02604017|65505091|FG001|Overall Study|Other|0|||
23481215|NCT00913692|65505096|FG000|Screening (4 Months)|Physician Decision|3|||
23481216|NCT00913692|65505096|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
23481217|NCT00913692|65505096|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
23481218|NCT00991952|65505098|FG000|Overall Study|Adverse Event|0|||
23481219|NCT00991952|65505099|FG001|Overall Study|Adverse Event|1|||
23481220|NCT04140227|65505100|FG000|Overall Study|Withdrawal by Subject|26|||
23481221|NCT04140227|65505100|FG000|Overall Study|Lost to Follow-up|8|||
23481222|NCT04140227|65505100|FG000|Overall Study|Adverse Event|8|||
23481223|NCT04140227|65505100|FG000|Overall Study|Death|1|||
23481224|NCT04140227|65505100|FG000|Overall Study|Other|3|||
23481225|NCT04140227|65505100|FG000|Overall Study|Protocol Violation|2|||
23481226|NCT02522871|65505101|FG000|Overall Study|Protocol Violation|1|||
23659059|NCT01987960|66139220|FG002|Period 2|Administrative or other reason|7|||
23659060|NCT01987960|66139221|FG003|Period 2|Administrative or other reason|0|||
23364053|NCT01657162|65081094|FG001|Overall Study|Inability to Complete Study Procedures|7|||
23364054|NCT01657162|65081093|FG000|Overall Study|Protocol Violation|1|||
23364055|NCT01657162|65081094|FG001|Overall Study|Protocol Violation|0|||
23659061|NCT01987960|66139218|FG000|Period 3|Adverse Event|0|||
23659062|NCT01987960|66139219|FG001|Period 3|Adverse Event|0|||
23659063|NCT01987960|66139220|FG002|Period 3|Adverse Event|0|||
23659064|NCT01987960|66139221|FG003|Period 3|Adverse Event|7|||
23481227|NCT02522871|65505102|FG001|Overall Study|Protocol Violation|4|||
23481228|NCT02522871|65505101|FG000|Overall Study|Treated without randomization|1|||
23481229|NCT02522871|65505102|FG001|Overall Study|Treated without randomization|0|||
23481230|NCT02522871|65505101|FG000|Overall Study|Death|9|||
23481231|NCT02522871|65505102|FG001|Overall Study|Death|9|||
23659065|NCT01987960|66139218|FG000|Period 3|Non-compliance with IMP|0|||
23659066|NCT01987960|66139219|FG001|Period 3|Non-compliance with IMP|0|||
23659067|NCT01987960|66139220|FG002|Period 3|Non-compliance with IMP|0|||
23364056|NCT01657162|65081093|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
23481232|NCT02522871|65505101|FG000|Overall Study|Died in operating room prior to transplant|0|||
23481233|NCT02522871|65505102|FG001|Overall Study|Died in operating room prior to transplant|1|||
23481234|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
23481235|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
23481236|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
23481237|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
23481238|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
23481239|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
23481240|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
23481241|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
23481242|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
23481243|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
23481244|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
23481245|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
23481246|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
23481247|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23481248|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23481249|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Other|107|||
23481250|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Other|0|||
23481251|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Other|0|||
23481252|NCT01436162|65505103|FG000|Randomized Phase|Adverse Event|1|||
23481253|NCT01436162|65505104|FG001|Randomized Phase|Adverse Event|5|||
23481254|NCT01436162|65505105|FG002|Randomized Phase|Adverse Event|6|||
23481255|NCT01436162|65505103|FG000|Randomized Phase|Protocol Violation|4|||
23481256|NCT01436162|65505104|FG001|Randomized Phase|Protocol Violation|4|||
23481257|NCT01436162|65505105|FG002|Randomized Phase|Protocol Violation|2|||
23481258|NCT01436162|65505103|FG000|Randomized Phase|Withdrawal by Subject|16|||
23481259|NCT01436162|65505104|FG001|Randomized Phase|Withdrawal by Subject|9|||
23481260|NCT01436162|65505105|FG002|Randomized Phase|Withdrawal by Subject|8|||
23481261|NCT01436162|65505103|FG000|Randomized Phase|Lost to Follow-up|17|||
23481262|NCT01436162|65505104|FG001|Randomized Phase|Lost to Follow-up|5|||
23481263|NCT01436162|65505105|FG002|Randomized Phase|Lost to Follow-up|4|||
23481264|NCT01436162|65505103|FG000|Randomized Phase|Lack of Efficacy|0|||
23481265|NCT01436162|65505104|FG001|Randomized Phase|Lack of Efficacy|1|||
23481266|NCT01436162|65505105|FG002|Randomized Phase|Lack of Efficacy|1|||
23481267|NCT01436162|65505103|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
23481268|NCT01436162|65505104|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
23481269|NCT01436162|65505105|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23481270|NCT01436162|65505103|FG000|Randomized Phase|Other|2|||
23481271|NCT01436162|65505104|FG001|Randomized Phase|Other|5|||
23481272|NCT01436162|65505105|FG002|Randomized Phase|Other|4|||
23481273|NCT02617485|65505106|FG000|Treatment and Observation Period|Adverse Event|9|||
23601257|NCT02185794|65929897|FG003|Overall Study|Lost to Follow-up|3|||
23601258|NCT02185794|65929898|FG004|Overall Study|Lost to Follow-up|0|||
23601259|NCT02185794|65929899|FG005|Overall Study|Lost to Follow-up|1|||
23601260|NCT00811941|65929900|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
23601261|NCT00811941|65929901|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
23601262|NCT00811941|65929900|FG000|All Treated Patients|Adverse Event|2|||
23601263|NCT00811941|65929901|FG001|All Treated Patients|Adverse Event|43|||
23601264|NCT00811941|65929900|FG000|All Treated Patients|Lack of Efficacy|2|||
23601265|NCT00811941|65929901|FG001|All Treated Patients|Lack of Efficacy|3|||
23601266|NCT00811941|65929900|FG000|All Treated Patients|Non-compliance|1|||
23601267|NCT00811941|65929901|FG001|All Treated Patients|Non-compliance|8|||
23601268|NCT00811941|65929900|FG000|All Treated Patients|Protocol Violation|5|||
23601269|NCT00811941|65929901|FG001|All Treated Patients|Protocol Violation|17|||
23364057|NCT01657162|65081094|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
23481274|NCT02617485|65505107|FG001|Treatment and Observation Period|Adverse Event|1|||
23481275|NCT02617485|65505106|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
23659068|NCT01987960|66139221|FG003|Period 3|Non-compliance with IMP|1|||
23659069|NCT01987960|66139218|FG000|Period 3|Protocol Violation|0|||
23659070|NCT01987960|66139219|FG001|Period 3|Protocol Violation|0|||
23659071|NCT01987960|66139220|FG002|Period 3|Protocol Violation|0|||
23659072|NCT01987960|66139221|FG003|Period 3|Protocol Violation|6|||
23659073|NCT01987960|66139218|FG000|Period 3|Withdrawal by Subject|0|||
23659074|NCT01987960|66139219|FG001|Period 3|Withdrawal by Subject|0|||
23659075|NCT01987960|66139220|FG002|Period 3|Withdrawal by Subject|0|||
23659076|NCT01987960|66139221|FG003|Period 3|Withdrawal by Subject|9|||
23659077|NCT01987960|66139218|FG000|Period 3|Lost to Follow-up|0|||
23659078|NCT01987960|66139219|FG001|Period 3|Lost to Follow-up|0|||
23659079|NCT01987960|66139220|FG002|Period 3|Lost to Follow-up|0|||
23659080|NCT01987960|66139221|FG003|Period 3|Lost to Follow-up|5|||
23659081|NCT01987960|66139218|FG000|Period 3|Administrative or other reason|0|||
23659082|NCT01987960|66139219|FG001|Period 3|Administrative or other reason|0|||
23659083|NCT01987960|66139220|FG002|Period 3|Administrative or other reason|0|||
23659084|NCT01987960|66139221|FG003|Period 3|Administrative or other reason|43|||
23659085|NCT00888381|66139224|FG000|Overall Study|Lost to Follow-up|0|||
23659086|NCT00888381|66139225|FG001|Overall Study|Lost to Follow-up|1|||
23659087|NCT01177683|66139226|FG000|Study Treatment|Disease Progressions during treatment|2|||
23659088|NCT01177683|66139227|FG001|Study Treatment|Disease Progressions during treatment|0|||
23659089|NCT01177683|66139228|FG002|Study Treatment|Disease Progressions during treatment|3|||
23659090|NCT01177683|66139226|FG000|Study Treatment|Adverse Event|0|||
23659091|NCT01177683|66139227|FG001|Study Treatment|Adverse Event|1|||
23659092|NCT01177683|66139228|FG002|Study Treatment|Adverse Event|12|||
23659093|NCT01177683|66139226|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23659094|NCT01177683|66139227|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
23659095|NCT01177683|66139228|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23659096|NCT01177683|66139226|FG000|Study Treatment|Alternative therapy|0|||
23659097|NCT01177683|66139227|FG001|Study Treatment|Alternative therapy|0|||
23659098|NCT01177683|66139228|FG002|Study Treatment|Alternative therapy|4|||
23481276|NCT02617485|65505107|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
23481277|NCT02617485|65505106|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
23659099|NCT01177683|66139226|FG000|Study Treatment|Physician Decision|1|||
23659100|NCT01177683|66139227|FG001|Study Treatment|Physician Decision|0|||
23659101|NCT01177683|66139228|FG002|Study Treatment|Physician Decision|1|||
23659102|NCT01177683|66139226|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
23659103|NCT01177683|66139227|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
23659104|NCT01177683|66139228|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
23481278|NCT02617485|65505107|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
23481279|NCT02617485|65505106|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
23481280|NCT02617485|65505107|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
23481281|NCT02617485|65505106|FG000|Treatment and Observation Period|Physician Decision|0|||
23481282|NCT02617485|65505107|FG001|Treatment and Observation Period|Physician Decision|1|||
23481283|NCT02617485|65505106|FG000|Follow-up Period|Adverse Event|1|||
23481284|NCT02617485|65505107|FG001|Follow-up Period|Adverse Event|0|||
23481285|NCT02617485|65505106|FG000|Follow-up Period|Withdrawal by Subject|1|||
23659105|NCT01177683|66139226|FG000|Study Treatment|Symptomatic Deterioration|0|||
23659106|NCT01177683|66139227|FG001|Study Treatment|Symptomatic Deterioration|0|||
23659107|NCT01177683|66139228|FG002|Study Treatment|Symptomatic Deterioration|1|||
23659108|NCT01177683|66139226|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
23659109|NCT01177683|66139227|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
23659110|NCT01177683|66139228|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
23659111|NCT01177683|66139226|FG000|Follow up|Patient lost to follow up|0|||
23659112|NCT01177683|66139227|FG001|Follow up|Patient lost to follow up|0|||
23659113|NCT01177683|66139228|FG002|Follow up|Patient lost to follow up|2|||
23659114|NCT01177683|66139226|FG000|Follow up|Death|2|||
23364058|NCT01657162|65081093|FG000|Overall Study|Other than Specified|0|||
23659115|NCT01177683|66139227|FG001|Follow up|Death|1|||
23659116|NCT01177683|66139228|FG002|Follow up|Death|7|||
23659117|NCT01177683|66139226|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
23659118|NCT01177683|66139227|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
23659119|NCT01177683|66139228|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
23659120|NCT02243865|66139231|FG000|Overall Study|Protocol Violation|1|||
23659121|NCT02243865|66139232|FG001|Overall Study|Protocol Violation|3|||
23659122|NCT02243865|66139231|FG000|Overall Study|Lost to Follow-up|1|||
23659123|NCT02243865|66139232|FG001|Overall Study|Lost to Follow-up|1|||
23659124|NCT02243865|66139231|FG000|Overall Study|Withdrawal by Subject|1|||
23659125|NCT02243865|66139232|FG001|Overall Study|Withdrawal by Subject|0|||
23659126|NCT02243865|66139231|FG000|Overall Study|Adverse Event|1|||
23659127|NCT02243865|66139232|FG001|Overall Study|Adverse Event|1|||
23659128|NCT00419120|66139235|FG000|Long Term Follow up Period|study ongoing|10|||
23659129|NCT00930722|66139243|FG000|Overall Study|Lost to Follow-up|16|||
23659130|NCT00930722|66139243|FG000|Overall Study|No longer willing to participate|9|||
23659131|NCT00930722|66139243|FG000|Overall Study|Study terminated by sponsor|2|||
23659132|NCT01848353|66139244|FG000|Phase 1|Withdrawal by Subject|3|||
23659133|NCT01848353|66139245|FG001|Phase 1|Withdrawal by Subject|1|||
23659134|NCT01848353|66139246|FG002|Phase 1|Withdrawal by Subject|0|||
23659135|NCT01848353|66139247|FG003|Phase 1|Withdrawal by Subject|0|||
23659136|NCT01848353|66139244|FG000|Phase 2|Withdrawal by Subject|3|||
23659137|NCT01848353|66139245|FG001|Phase 2|Withdrawal by Subject|2|||
23659138|NCT01848353|66139246|FG002|Phase 2|Withdrawal by Subject|0|||
23659139|NCT01848353|66139247|FG003|Phase 2|Withdrawal by Subject|0|||
23659140|NCT01848353|66139244|FG000|Phase 3|Withdrawal by Subject|1|||
23659141|NCT01848353|66139245|FG001|Phase 3|Withdrawal by Subject|1|||
23659142|NCT01848353|66139246|FG002|Phase 3|Withdrawal by Subject|0|||
23659143|NCT01848353|66139247|FG003|Phase 3|Withdrawal by Subject|0|||
23659144|NCT01205438|66139252|FG000|Overall Study|Adverse Event|19|||
23659145|NCT01205438|66139253|FG001|Overall Study|Adverse Event|17|||
23659146|NCT01205438|66139254|FG002|Overall Study|Adverse Event|24|||
23659147|NCT01205438|66139252|FG000|Overall Study|Death|1|||
23659148|NCT01205438|66139253|FG001|Overall Study|Death|1|||
23659149|NCT01205438|66139254|FG002|Overall Study|Death|3|||
23659150|NCT01205438|66139252|FG000|Overall Study|Entry Criteria Not Met|16|||
23659151|NCT01205438|66139253|FG001|Overall Study|Entry Criteria Not Met|15|||
23659152|NCT01205438|66139254|FG002|Overall Study|Entry Criteria Not Met|13|||
23659153|NCT01205438|66139252|FG000|Overall Study|Lack of Efficacy|14|||
23659154|NCT01205438|66139253|FG001|Overall Study|Lack of Efficacy|11|||
23659155|NCT01205438|66139254|FG002|Overall Study|Lack of Efficacy|14|||
23659156|NCT01205438|66139252|FG000|Overall Study|Lost to Follow-up|6|||
23659157|NCT01205438|66139253|FG001|Overall Study|Lost to Follow-up|7|||
23659158|NCT01205438|66139254|FG002|Overall Study|Lost to Follow-up|8|||
23659159|NCT01205438|66139252|FG000|Overall Study|Withdrawal by Subject|19|||
23659160|NCT01205438|66139253|FG001|Overall Study|Withdrawal by Subject|25|||
23659161|NCT01205438|66139254|FG002|Overall Study|Withdrawal by Subject|19|||
23659162|NCT01205438|66139252|FG000|Overall Study|Physician Decision|0|||
23659163|NCT01205438|66139253|FG001|Overall Study|Physician Decision|3|||
23659164|NCT01205438|66139254|FG002|Overall Study|Physician Decision|2|||
23659165|NCT01205438|66139252|FG000|Overall Study|Protocol Violation|2|||
23364059|NCT01657162|65081094|FG001|Overall Study|Other than Specified|2|||
23364060|NCT02829047|65081095|FG000|Overall Study|Withdrawal by Subject|1|||
23364061|NCT02259400|65081096|FG000|Overall Study|Death|0|||
23364062|NCT02259400|65081097|FG001|Overall Study|Death|2|||
23364063|NCT00325819|65081103|FG000|Overall Study|Study product lost in mail|2|||
23364064|NCT00325819|65081104|FG001|Overall Study|Study product lost in mail|1|||
23364065|NCT00325819|65081103|FG000|Overall Study|Did not take a dose of study product|4|||
23364066|NCT00325819|65081104|FG001|Overall Study|Did not take a dose of study product|9|||
23364067|NCT00325819|65081103|FG000|Overall Study|Lost to Follow-up|3|||
23364068|NCT00325819|65081104|FG001|Overall Study|Lost to Follow-up|3|||
23364069|NCT05417412|65081112|FG000|Overall Study|Lost to Follow-up|2|||
23364070|NCT04980014|65081113|FG000|Overall Study|Participants who are Duplicated|1|||
23364071|NCT04980014|65081113|FG000|Overall Study|Follow-up Failure|13|||
23364072|NCT04980014|65081113|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
23364073|NCT04980014|65081113|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
23364074|NCT04980014|65081113|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
23364075|NCT02915159|65081114|FG000|Overall Study|Participant no longer meets criteria|2|||
23364076|NCT02915159|65081115|FG001|Overall Study|Participant no longer meets criteria|0|||
23364077|NCT02915159|65081114|FG000|Overall Study|poor/non-compliance|1|||
23364078|NCT02915159|65081115|FG001|Overall Study|poor/non-compliance|0|||
23364079|NCT02915159|65081114|FG000|Overall Study|Participant withdrew consent|5|||
23364080|NCT02915159|65081115|FG001|Overall Study|Participant withdrew consent|1|||
23364081|NCT02915159|65081114|FG000|Overall Study|Request to discontinue treatment|1|||
23364082|NCT02915159|65081115|FG001|Overall Study|Request to discontinue treatment|2|||
23364083|NCT02915159|65081114|FG000|Overall Study|Adverse Event|2|||
23364084|NCT02915159|65081115|FG001|Overall Study|Adverse Event|2|||
23364085|NCT02915159|65081114|FG000|Overall Study|Lack of Efficacy|0|||
23364086|NCT02915159|65081115|FG001|Overall Study|Lack of Efficacy|3|||
23364087|NCT04030598|65081116|FG000|Overall Study|Voluntary Withdrawal|0|||
23364088|NCT04030598|65081117|FG001|Overall Study|Voluntary Withdrawal|1|||
23364089|NCT04030598|65081118|FG002|Overall Study|Voluntary Withdrawal|0|||
23364090|NCT02175121|65081119|FG000|Overall Study|Lack of Efficacy|1|||
23364091|NCT02175121|65081120|FG001|Overall Study|Lack of Efficacy|0|||
23364092|NCT02175121|65081121|FG002|Overall Study|Lack of Efficacy|0|||
23364093|NCT02175121|65081122|FG003|Overall Study|Lack of Efficacy|0|||
23364094|NCT02175121|65081123|FG004|Overall Study|Lack of Efficacy|0|||
23364095|NCT02175121|65081119|FG000|Overall Study|Lost to Follow-up|0|||
23364096|NCT02175121|65081120|FG001|Overall Study|Lost to Follow-up|1|||
23364097|NCT02175121|65081121|FG002|Overall Study|Lost to Follow-up|0|||
23364098|NCT02175121|65081122|FG003|Overall Study|Lost to Follow-up|1|||
23364099|NCT02175121|65081123|FG004|Overall Study|Lost to Follow-up|0|||
23364100|NCT02175121|65081119|FG000|Overall Study|Personal emergency|0|||
23364101|NCT02175121|65081120|FG001|Overall Study|Personal emergency|0|||
23364102|NCT02175121|65081121|FG002|Overall Study|Personal emergency|0|||
23364103|NCT02175121|65081122|FG003|Overall Study|Personal emergency|0|||
23364104|NCT02175121|65081123|FG004|Overall Study|Personal emergency|1|||
23364105|NCT02175121|65081119|FG000|Overall Study|Schedule conflict|0|||
23364106|NCT02175121|65081120|FG001|Overall Study|Schedule conflict|0|||
23364107|NCT02175121|65081121|FG002|Overall Study|Schedule conflict|1|||
23364108|NCT02175121|65081122|FG003|Overall Study|Schedule conflict|0|||
23364109|NCT02175121|65081123|FG004|Overall Study|Schedule conflict|0|||
23364110|NCT02175121|65081119|FG000|Overall Study|Time issues|0|||
23364111|NCT02175121|65081120|FG001|Overall Study|Time issues|0|||
23364112|NCT02175121|65081121|FG002|Overall Study|Time issues|1|||
23364113|NCT02175121|65081122|FG003|Overall Study|Time issues|0|||
23364114|NCT02175121|65081123|FG004|Overall Study|Time issues|0|||
23364115|NCT01869777|65081128|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
23364116|NCT01324947|65081130|FG000|Overall Study|Adverse Event|7|||
23364117|NCT01324947|65081130|FG000|Overall Study|Death|10|||
23364118|NCT01324947|65081130|FG000|Overall Study|Other|3|||
23364119|NCT01324947|65081130|FG000|Overall Study|Progressive Disease|50|||
23364120|NCT01324947|65081130|FG000|Overall Study|Withdrawal by Subject|3|||
23364121|NCT01324947|65081130|FG000|Overall Study|1 discontinued before starting drug|1|||
23364122|NCT02157519|65081136|FG000|Overall Study|Death|3|||
23364123|NCT02157519|65081137|FG001|Overall Study|Death|1|||
23364124|NCT02157519|65081136|FG000|Overall Study|Withdrawal by Subject|7|||
23364125|NCT02157519|65081137|FG001|Overall Study|Withdrawal by Subject|0|||
23364126|NCT02157519|65081136|FG000|Overall Study|Lost to Follow-up|1|||
23364127|NCT02157519|65081137|FG001|Overall Study|Lost to Follow-up|0|||
23364128|NCT00165503|65081138|FG000|Overall Study|Death|1|||
23364129|NCT00165503|65081138|FG000|Overall Study|Lost to Follow-up|12|||
23364130|NCT00165503|65081138|FG000|Overall Study|Unresectable|3|||
23364131|NCT01619878|65081143|FG000|6 Week Follow-up Phase|Adverse Event|1|||
23364132|NCT01619878|65081143|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
23364133|NCT01619878|65081143|FG000|Follow-up at 12 Months of Age|Death|2|||
23364134|NCT01628848|65081144|FG000|Overall Study|Adverse Event|9|||
23364135|NCT01628848|65081145|FG001|Overall Study|Adverse Event|7|||
23364136|NCT01628848|65081144|FG000|Overall Study|Lack of Efficacy|0|||
23364137|NCT01628848|65081145|FG001|Overall Study|Lack of Efficacy|4|||
23364138|NCT01628848|65081144|FG000|Overall Study|Withdrawal by Subject|0|||
23364139|NCT01628848|65081145|FG001|Overall Study|Withdrawal by Subject|2|||
23364140|NCT01628848|65081144|FG000|Overall Study|Physician Decision|3|||
23364141|NCT01628848|65081145|FG001|Overall Study|Physician Decision|1|||
23364142|NCT01697800|65081147|FG000|Overall Study|Death|0|||
23364143|NCT01697800|65081148|FG001|Overall Study|Death|1|||
23364144|NCT00268983|65081152|FG000|Overall Study|Death|3|||
23364145|NCT00268983|65081153|FG001|Overall Study|Death|0|||
23364146|NCT00493012|65081156|FG000|Overall Study|Lost to Follow-up|18|||
23364147|NCT00493012|65081157|FG001|Overall Study|Lost to Follow-up|17|||
23364148|NCT00249873|65081158|FG000|Overall Study|Not treated|7|||
23364149|NCT00249873|65081159|FG001|Overall Study|Not treated|8|||
23364150|NCT00249873|65081158|FG000|Overall Study|Significant thrombocytopenia|9|||
23364151|NCT00249873|65081159|FG001|Overall Study|Significant thrombocytopenia|8|||
23364152|NCT00249873|65081158|FG000|Overall Study|Severe allergic reaction|8|||
23364153|NCT00249873|65081159|FG001|Overall Study|Severe allergic reaction|1|||
23364154|NCT00249873|65081158|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
23659166|NCT01205438|66139253|FG001|Overall Study|Protocol Violation|7|||
23481286|NCT02617485|65505107|FG001|Follow-up Period|Withdrawal by Subject|0|||
23481287|NCT02617485|65505106|FG000|Follow-up Period|Disease progression|2|||
23481288|NCT02617485|65505107|FG001|Follow-up Period|Disease progression|1|||
23659167|NCT01205438|66139254|FG002|Overall Study|Protocol Violation|4|||
23481289|NCT02617485|65505106|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
23481290|NCT02617485|65505107|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
23481291|NCT02617485|65505106|FG000|Follow-up Period|Patient needed radiotherapy|9|||
23481292|NCT02617485|65505107|FG001|Follow-up Period|Patient needed radiotherapy|5|||
23481293|NCT02617485|65505106|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
23481294|NCT02617485|65505107|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
23481295|NCT02815280|65505110|FG000|Double-Blind Phase|Adverse Event|1|||
23481296|NCT02815280|65505111|FG001|Double-Blind Phase|Adverse Event|1|||
23481297|NCT02815280|65505110|FG000|Double-Blind Phase|Lost to Follow-up|10|||
23481298|NCT02815280|65505111|FG001|Double-Blind Phase|Lost to Follow-up|9|||
23481299|NCT02815280|65505110|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
23601270|NCT00811941|65929900|FG000|All Treated Patients|Withdrawal by Subject|35|||
23601271|NCT00811941|65929901|FG001|All Treated Patients|Withdrawal by Subject|94|||
23601272|NCT00811941|65929900|FG000|All Treated Patients|Lost to Follow-up|3|||
23601273|NCT00811941|65929901|FG001|All Treated Patients|Lost to Follow-up|12|||
23659168|NCT01205438|66139252|FG000|Overall Study|Sponsor Decision|0|||
23659169|NCT01205438|66139253|FG001|Overall Study|Sponsor Decision|1|||
23659170|NCT01205438|66139254|FG002|Overall Study|Sponsor Decision|1|||
23659171|NCT00074581|66139255|FG000|Overall Study|Death|15|||
23659172|NCT00074581|66139256|FG001|Overall Study|Death|16|||
23659173|NCT00074581|66139255|FG000|Overall Study|Withdrawal by Subject|50|||
23659174|NCT00074581|66139256|FG001|Overall Study|Withdrawal by Subject|49|||
23659175|NCT00074581|66139255|FG000|Overall Study|Unable to adhere to visit schedule|13|||
23659176|NCT00074581|66139256|FG001|Overall Study|Unable to adhere to visit schedule|14|||
23659177|NCT00074581|66139255|FG000|Overall Study|Relocated|14|||
23601274|NCT00811941|65929900|FG000|All Treated Patients|Other Reason|4|||
23601275|NCT00811941|65929901|FG001|All Treated Patients|Other Reason|14|||
23601276|NCT00650104|65929902|FG000|Overall Study|Adverse Event|17|||
23601277|NCT00650104|65929902|FG000|Overall Study|Death|2|||
23601278|NCT00650104|65929902|FG000|Overall Study|Withdrawal by Subject|11|||
23601279|NCT00650104|65929902|FG000|Overall Study|Physician Decision|7|||
23601280|NCT00650104|65929902|FG000|Overall Study|Lost to Follow-up|1|||
23659178|NCT00074581|66139256|FG001|Overall Study|Relocated|9|||
23659179|NCT00074581|66139255|FG000|Overall Study|Were withdrawn by investigator|5|||
23481300|NCT02815280|65505111|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
23601281|NCT00650104|65929902|FG000|Overall Study|Non-compliance|2|||
23601282|NCT00650104|65929902|FG000|Overall Study|Sponsor Terminated Dosing|1|||
23601283|NCT03611075|65929903|FG000|Overall Study|Physician Decision|0|||
23659180|NCT00074581|66139256|FG001|Overall Study|Were withdrawn by investigator|2|||
23659181|NCT00074581|66139255|FG000|Overall Study|Lost to Follow-up|16|||
23364155|NCT00249873|65081159|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
23364156|NCT00249873|65081158|FG000|Overall Study|Other Serious Adverse Event|86|||
23364157|NCT00249873|65081159|FG001|Overall Study|Other Serious Adverse Event|97|||
23364158|NCT00249873|65081158|FG000|Overall Study|Qualifying condition not present|20|||
23364159|NCT00249873|65081159|FG001|Overall Study|Qualifying condition not present|23|||
23364160|NCT00249873|65081158|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
23364161|NCT00249873|65081159|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
23364162|NCT00249873|65081158|FG000|Overall Study|Withdrawal by Subject|504|||
23364163|NCT00249873|65081159|FG001|Overall Study|Withdrawal by Subject|466|||
23364164|NCT00249873|65081158|FG000|Overall Study|Lost to Follow-up|4|||
23364165|NCT00249873|65081159|FG001|Overall Study|Lost to Follow-up|7|||
23364166|NCT00249873|65081158|FG000|Overall Study|Minor bleeding|99|||
23364167|NCT00249873|65081159|FG001|Overall Study|Minor bleeding|37|||
23364168|NCT00249873|65081158|FG000|Overall Study|Non-compliance|41|||
23364169|NCT00249873|65081159|FG001|Overall Study|Non-compliance|46|||
23364170|NCT00249873|65081158|FG000|Overall Study|Other non serious Adverse Event|112|||
23481301|NCT02815280|65505110|FG000|Double-Blind Phase|Protocol Violation|2|||
23481302|NCT02815280|65505111|FG001|Double-Blind Phase|Protocol Violation|2|||
23601284|NCT03611075|65929904|FG001|Overall Study|Physician Decision|1|||
23601285|NCT03611075|65929905|FG002|Overall Study|Physician Decision|1|||
23601286|NCT03611075|65929906|FG003|Overall Study|Physician Decision|0|||
23601287|NCT03611075|65929907|FG004|Overall Study|Physician Decision|0|||
23601288|NCT03611075|65929908|FG005|Overall Study|Physician Decision|0|||
23364171|NCT00249873|65081159|FG001|Overall Study|Other non serious Adverse Event|108|||
23601289|NCT03611075|65929909|FG006|Overall Study|Physician Decision|0|||
23601290|NCT03611075|65929910|FG007|Overall Study|Physician Decision|0|||
23601291|NCT03611075|65929911|FG008|Overall Study|Physician Decision|0|||
23601292|NCT03611075|65929903|FG000|Overall Study|Lost to Follow-up|1|||
23601293|NCT03611075|65929904|FG001|Overall Study|Lost to Follow-up|0|||
23601294|NCT03611075|65929905|FG002|Overall Study|Lost to Follow-up|0|||
23601295|NCT03611075|65929906|FG003|Overall Study|Lost to Follow-up|2|||
23601296|NCT03611075|65929907|FG004|Overall Study|Lost to Follow-up|0|||
23364172|NCT00249873|65081158|FG000|Overall Study|Other contraindicated medication|1|||
23364173|NCT00249873|65081159|FG001|Overall Study|Other contraindicated medication|0|||
23659182|NCT00074581|66139256|FG001|Overall Study|Lost to Follow-up|11|||
23364174|NCT00249873|65081158|FG000|Overall Study|Patient not wish to continue after May08|3|||
23601297|NCT03611075|65929908|FG005|Overall Study|Lost to Follow-up|0|||
23601298|NCT03611075|65929909|FG006|Overall Study|Lost to Follow-up|0|||
23601299|NCT03611075|65929910|FG007|Overall Study|Lost to Follow-up|0|||
23364175|NCT00249873|65081159|FG001|Overall Study|Patient not wish to continue after May08|4|||
23364176|NCT00249873|65081158|FG000|Overall Study|Physician withdrew consent|59|||
23364177|NCT00249873|65081159|FG001|Overall Study|Physician withdrew consent|60|||
23364178|NCT00249873|65081158|FG000|Overall Study|Open label clopidogrel required|31|||
23659183|NCT00074581|66139255|FG000|Overall Study|Ended relationship w. index participant|117|||
23659184|NCT00074581|66139256|FG001|Overall Study|Ended relationship w. index participant|106|||
23659185|NCT00074581|66139255|FG000|Overall Study|Other|14|||
23659186|NCT00074581|66139256|FG001|Overall Study|Other|19|||
23659187|NCT04784897|66139257|FG000|Overall Study|Death|4|||
23659188|NCT04784897|66139258|FG001|Overall Study|Death|2|||
23659189|NCT04784897|66139259|FG002|Overall Study|Death|1|||
23659190|NCT04784897|66139257|FG000|Overall Study|Withdrawal by Subject|0|||
23659191|NCT04784897|66139258|FG001|Overall Study|Withdrawal by Subject|0|||
23659192|NCT04784897|66139259|FG002|Overall Study|Withdrawal by Subject|1|||
23659193|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
23659194|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
23659195|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
23659196|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
23659197|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
23364179|NCT00249873|65081159|FG001|Overall Study|Open label clopidogrel required|42|||
23364180|NCT00249873|65081158|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
23364181|NCT00249873|65081159|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
23364182|NCT00249873|65081158|FG000|Overall Study|Oral anticoagulant required|159|||
23659198|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
23659199|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
23364183|NCT00249873|65081159|FG001|Overall Study|Oral anticoagulant required|157|||
23364184|NCT00249873|65081158|FG000|Overall Study|Study drug intolerance|5|||
23364185|NCT00249873|65081159|FG001|Overall Study|Study drug intolerance|0|||
23481303|NCT02815280|65505110|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
23481304|NCT02815280|65505111|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
23481305|NCT02815280|65505110|FG000|Open-Label Phase|Adverse Event|2|||
23481306|NCT02815280|65505111|FG001|Open-Label Phase|Adverse Event|3|||
23481307|NCT02815280|65505110|FG000|Open-Label Phase|Lost to Follow-up|18|||
23481308|NCT02815280|65505111|FG001|Open-Label Phase|Lost to Follow-up|9|||
23481309|NCT02815280|65505110|FG000|Open-Label Phase|Withdrawal by Subject|33|||
23481310|NCT02815280|65505111|FG001|Open-Label Phase|Withdrawal by Subject|18|||
23481311|NCT02815280|65505110|FG000|Open-Label Phase|Protocol Violation|3|||
23364186|NCT00249873|65081158|FG000|Overall Study|Surgery/ procedure|9|||
23364187|NCT00249873|65081159|FG001|Overall Study|Surgery/ procedure|9|||
23364188|NCT00249873|65081158|FG000|Overall Study|Event related to cardiac condition|12|||
23364189|NCT00249873|65081159|FG001|Overall Study|Event related to cardiac condition|21|||
23364190|NCT00249873|65081158|FG000|Overall Study|Thromboembolic/outcome event|82|||
23364191|NCT00249873|65081159|FG001|Overall Study|Thromboembolic/outcome event|122|||
23364192|NCT00103285|65081160|FG000|Induction|Adverse Event|14|||
23364193|NCT00103285|65081161|FG001|Induction|Adverse Event|0|||
23364194|NCT00103285|65081162|FG002|Induction|Adverse Event|0|||
23364195|NCT00103285|65081163|FG003|Induction|Adverse Event|0|||
23364196|NCT00103285|65081164|FG004|Induction|Adverse Event|0|||
23364197|NCT00103285|65081165|FG005|Induction|Adverse Event|0|||
23364198|NCT00103285|65081166|FG006|Induction|Adverse Event|0|||
23364199|NCT00103285|65081167|FG007|Induction|Adverse Event|0|||
23364200|NCT00103285|65081160|FG000|Induction|Death|24|||
23364201|NCT00103285|65081161|FG001|Induction|Death|0|||
23364202|NCT00103285|65081162|FG002|Induction|Death|0|||
23364203|NCT00103285|65081163|FG003|Induction|Death|0|||
23364204|NCT00103285|65081164|FG004|Induction|Death|0|||
23364205|NCT00103285|65081165|FG005|Induction|Death|0|||
23364206|NCT00103285|65081166|FG006|Induction|Death|0|||
23481312|NCT02815280|65505111|FG001|Open-Label Phase|Protocol Violation|0|||
23364207|NCT00103285|65081167|FG007|Induction|Death|0|||
23364208|NCT00103285|65081160|FG000|Induction|Physician Decision|103|||
23364209|NCT00103285|65081161|FG001|Induction|Physician Decision|0|||
23364210|NCT00103285|65081162|FG002|Induction|Physician Decision|0|||
23364211|NCT00103285|65081163|FG003|Induction|Physician Decision|0|||
23659200|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
23659201|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
23364212|NCT00103285|65081164|FG004|Induction|Physician Decision|0|||
23659202|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
23659203|NCT03829241|66139260|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
23659204|NCT03829241|66139261|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
23659205|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
23659206|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
23659207|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
23659208|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
23659209|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
23659210|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
23659211|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
23659212|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
23659213|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
23659214|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
23659215|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
23659216|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
23659217|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
23659218|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
23659219|NCT03829241|66139260|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
23659220|NCT03829241|66139261|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
23659221|NCT01010633|66139262|FG000|Overall Study|Adverse Event|1|||
23659222|NCT01010633|66139263|FG001|Overall Study|Adverse Event|1|||
23659223|NCT01010633|66139262|FG000|Overall Study|Protocol Violation|1|||
23659224|NCT01010633|66139263|FG001|Overall Study|Protocol Violation|2|||
23807370|NCT00974974|66672750|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
23659225|NCT01010633|66139262|FG000|Overall Study|Withdrawal by Subject|2|||
23807371|NCT00974974|66672751|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
23807372|NCT00974974|66672750|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
23807373|NCT00974974|66672751|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
23807374|NCT00974974|66672750|FG000|IR CD-LD Dose Adjustment|Various|0|||
23807375|NCT00974974|66672751|FG001|IR CD-LD Dose Adjustment|Various|9|||
23807376|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Adverse Event|23|||
23807377|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Adverse Event|0|||
23807378|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Death|2|||
23807379|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Death|0|||
23807380|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
23481313|NCT02815280|65505110|FG000|Open-Label Phase|Administrative|26|||
23481314|NCT02815280|65505111|FG001|Open-Label Phase|Administrative|12|||
23659226|NCT01010633|66139263|FG001|Overall Study|Withdrawal by Subject|1|||
23659227|NCT01010633|66139262|FG000|Overall Study|Investigator decision|0|||
23364213|NCT00103285|65081165|FG005|Induction|Physician Decision|0|||
23481315|NCT02815280|65505110|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
23601300|NCT03611075|65929911|FG008|Overall Study|Lost to Follow-up|0|||
23364214|NCT00103285|65081166|FG006|Induction|Physician Decision|0|||
23659228|NCT01010633|66139263|FG001|Overall Study|Investigator decision|1|||
23659229|NCT00894686|66139264|FG000|Overall Study|Withdrawal by Subject|50|||
23659230|NCT00894686|66139264|FG000|Overall Study|Physician Decision|1|||
23659231|NCT00894686|66139264|FG000|Overall Study|Other|5|||
23659232|NCT00239226|66139265|FG000|Overall Study|permAF during stabilization period|0|||
23659233|NCT00239226|66139266|FG001|Overall Study|permAF during stabilization period|0|||
23659234|NCT00239226|66139267|FG002|Overall Study|permAF during stabilization period|0|||
23659235|NCT00239226|66139268|FG003|Overall Study|permAF during stabilization period|3|||
23659236|NCT00239226|66139265|FG000|Overall Study|Lost to Follow-up|1|||
23659237|NCT00239226|66139266|FG001|Overall Study|Lost to Follow-up|0|||
23659238|NCT00239226|66139267|FG002|Overall Study|Lost to Follow-up|1|||
23659239|NCT00239226|66139268|FG003|Overall Study|Lost to Follow-up|0|||
23659240|NCT01287364|66139271|FG000|Overall Study|Adverse Event|0|||
23659241|NCT01287364|66139272|FG001|Overall Study|Adverse Event|3|||
23659242|NCT01287364|66139271|FG000|Overall Study|Protocol Violation|5|||
23659243|NCT01287364|66139272|FG001|Overall Study|Protocol Violation|5|||
23481316|NCT02815280|65505111|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
23481317|NCT01565343|65505117|FG000|Overall Study|Administrative decision/technical issues|1|||
23601301|NCT03611075|65929903|FG000|Overall Study|Withdrawal by Subject|0|||
23601302|NCT03611075|65929904|FG001|Overall Study|Withdrawal by Subject|1|||
23601303|NCT03611075|65929905|FG002|Overall Study|Withdrawal by Subject|1|||
23601304|NCT03611075|65929906|FG003|Overall Study|Withdrawal by Subject|1|||
23601305|NCT03611075|65929907|FG004|Overall Study|Withdrawal by Subject|0|||
23601306|NCT03611075|65929908|FG005|Overall Study|Withdrawal by Subject|0|||
23601307|NCT03611075|65929909|FG006|Overall Study|Withdrawal by Subject|1|||
23601308|NCT03611075|65929910|FG007|Overall Study|Withdrawal by Subject|0|||
23601309|NCT03611075|65929911|FG008|Overall Study|Withdrawal by Subject|0|||
23659244|NCT01287364|66139271|FG000|Overall Study|Other Reason|4|||
23659245|NCT01287364|66139272|FG001|Overall Study|Other Reason|2|||
23601310|NCT03611075|65929903|FG000|Overall Study|Reason unknown|0|||
23659246|NCT03805750|66139273|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
23659247|NCT03805750|66139274|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
23481318|NCT01565343|65505118|FG001|Overall Study|Administrative decision/technical issues|0|||
23481319|NCT01565343|65505119|FG002|Overall Study|Administrative decision/technical issues|0|||
23481320|NCT00555425|65505120|FG000|Overall Study|Missed Medication > 1 wk|34|||
23659248|NCT00332839|66139275|FG000|Core (Months 0 - 12)|Administrative problems|1|||
23659249|NCT00332839|66139276|FG001|Core (Months 0 - 12)|Administrative problems|1|||
23659250|NCT00332839|66139275|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
23659251|NCT00332839|66139276|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
23659252|NCT00332839|66139275|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
23659253|NCT00332839|66139276|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
23659254|NCT00332839|66139275|FG000|Core (Months 0 - 12)|Adverse Event|5|||
23659255|NCT00332839|66139276|FG001|Core (Months 0 - 12)|Adverse Event|15|||
23659256|NCT00332839|66139275|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
23659257|NCT00332839|66139276|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
23659258|NCT00332839|66139275|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
23659259|NCT00332839|66139276|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
23659260|NCT00332839|66139275|FG000|Follow-up (Months 12 - 60)|Death|1|||
23659261|NCT00332839|66139276|FG001|Follow-up (Months 12 - 60)|Death|1|||
23659262|NCT01949155|66139277|FG000|Overall Study|Lost to Follow-up|1|||
23659263|NCT01949155|66139278|FG001|Overall Study|Lost to Follow-up|0|||
23659264|NCT01949155|66139277|FG000|Overall Study|Protocol Violation|1|||
23659265|NCT01949155|66139278|FG001|Overall Study|Protocol Violation|0|||
23659266|NCT02378220|66139279|FG000|Overall Study|Death|6|||
23659267|NCT02378220|66139280|FG001|Overall Study|Death|1|||
23659268|NCT01794520|66139282|FG000|Overall Study|Adverse events- related to progression|0|||
23659269|NCT01794520|66139283|FG001|Overall Study|Adverse events- related to progression|0|||
23659270|NCT01794520|66139284|FG002|Overall Study|Adverse events- related to progression|1|||
23659271|NCT01794520|66139285|FG003|Overall Study|Adverse events- related to progression|2|||
23659272|NCT01794520|66139286|FG004|Overall Study|Adverse events- related to progression|0|||
23659273|NCT01794520|66139287|FG005|Overall Study|Adverse events- related to progression|1|||
23659274|NCT01794520|66139288|FG006|Overall Study|Adverse events- related to progression|0|||
23659275|NCT01794520|66139282|FG000|Overall Study|Adverse event- not related to progression|1|||
23659276|NCT01794520|66139283|FG001|Overall Study|Adverse event- not related to progression|1|||
23659277|NCT01794520|66139284|FG002|Overall Study|Adverse event- not related to progression|0|||
23659278|NCT01794520|66139285|FG003|Overall Study|Adverse event- not related to progression|0|||
23659279|NCT01794520|66139286|FG004|Overall Study|Adverse event- not related to progression|2|||
23659280|NCT01794520|66139287|FG005|Overall Study|Adverse event- not related to progression|0|||
23659281|NCT01794520|66139288|FG006|Overall Study|Adverse event- not related to progression|0|||
23659282|NCT01794520|66139282|FG000|Overall Study|Progressive disease|5|||
23659283|NCT01794520|66139283|FG001|Overall Study|Progressive disease|6|||
23659284|NCT01794520|66139284|FG002|Overall Study|Progressive disease|2|||
23659285|NCT01794520|66139285|FG003|Overall Study|Progressive disease|5|||
23659286|NCT01794520|66139286|FG004|Overall Study|Progressive disease|27|||
23659287|NCT01794520|66139287|FG005|Overall Study|Progressive disease|18|||
23659288|NCT01794520|66139288|FG006|Overall Study|Progressive disease|0|||
23659289|NCT01794520|66139282|FG000|Overall Study|Withdrew consent|0|||
23659290|NCT01794520|66139283|FG001|Overall Study|Withdrew consent|0|||
23659291|NCT01794520|66139284|FG002|Overall Study|Withdrew consent|1|||
23659292|NCT01794520|66139285|FG003|Overall Study|Withdrew consent|1|||
23659293|NCT01794520|66139286|FG004|Overall Study|Withdrew consent|0|||
23659294|NCT01794520|66139287|FG005|Overall Study|Withdrew consent|0|||
23659295|NCT01794520|66139288|FG006|Overall Study|Withdrew consent|0|||
23659296|NCT01794520|66139282|FG000|Overall Study|Lost to Follow-up|0|||
23659297|NCT01794520|66139283|FG001|Overall Study|Lost to Follow-up|0|||
23659298|NCT01794520|66139284|FG002|Overall Study|Lost to Follow-up|0|||
23659299|NCT01794520|66139285|FG003|Overall Study|Lost to Follow-up|0|||
23659300|NCT01794520|66139286|FG004|Overall Study|Lost to Follow-up|1|||
23659301|NCT01794520|66139287|FG005|Overall Study|Lost to Follow-up|0|||
23659302|NCT01794520|66139288|FG006|Overall Study|Lost to Follow-up|0|||
23659303|NCT01794520|66139282|FG000|Overall Study|Toxicity|0|||
23659304|NCT01794520|66139283|FG001|Overall Study|Toxicity|2|||
23659305|NCT01794520|66139284|FG002|Overall Study|Toxicity|0|||
23659306|NCT01794520|66139285|FG003|Overall Study|Toxicity|0|||
23659307|NCT01794520|66139286|FG004|Overall Study|Toxicity|0|||
23659308|NCT01794520|66139287|FG005|Overall Study|Toxicity|0|||
23659309|NCT01794520|66139288|FG006|Overall Study|Toxicity|0|||
23659310|NCT01794520|66139282|FG000|Overall Study|Study terminated by sponsor|0|||
23659311|NCT01794520|66139283|FG001|Overall Study|Study terminated by sponsor|0|||
23659312|NCT01794520|66139284|FG002|Overall Study|Study terminated by sponsor|1|||
23659313|NCT01794520|66139285|FG003|Overall Study|Study terminated by sponsor|0|||
23659314|NCT01794520|66139286|FG004|Overall Study|Study terminated by sponsor|1|||
23659315|NCT01794520|66139287|FG005|Overall Study|Study terminated by sponsor|0|||
23481321|NCT00555425|65505121|FG001|Overall Study|Missed Medication > 1 wk|15|||
23659316|NCT01794520|66139288|FG006|Overall Study|Study terminated by sponsor|7|||
23659317|NCT01794520|66139282|FG000|Overall Study|Death|0|||
23659318|NCT01794520|66139283|FG001|Overall Study|Death|0|||
23659319|NCT01794520|66139284|FG002|Overall Study|Death|0|||
23659320|NCT01794520|66139285|FG003|Overall Study|Death|0|||
23659321|NCT01794520|66139286|FG004|Overall Study|Death|1|||
23659322|NCT01794520|66139287|FG005|Overall Study|Death|0|||
23659323|NCT01794520|66139288|FG006|Overall Study|Death|22|||
23659324|NCT01794520|66139282|FG000|Overall Study|Other, not specified|0|||
23659325|NCT01794520|66139283|FG001|Overall Study|Other, not specified|0|||
23659326|NCT01794520|66139284|FG002|Overall Study|Other, not specified|1|||
23659327|NCT01794520|66139285|FG003|Overall Study|Other, not specified|1|||
23807381|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
23481322|NCT00555425|65505120|FG000|Overall Study|Missed 3 physician management visits|1|||
23481323|NCT00555425|65505121|FG001|Overall Study|Missed 3 physician management visits|0|||
23481324|NCT00555425|65505120|FG000|Overall Study|Met criteria for protective transfer|16|||
23481325|NCT00555425|65505121|FG001|Overall Study|Met criteria for protective transfer|3|||
23481326|NCT00555425|65505120|FG000|Overall Study|Became pregnant and transferred care|0|||
23481327|NCT00555425|65505121|FG001|Overall Study|Became pregnant and transferred care|1|||
23481328|NCT02158364|65505122|FG000|Overall Study|Case report forms uncollected|10|||
23481329|NCT02158364|65505122|FG000|Overall Study|Protocol Deviation|50|||
23481330|NCT02068768|65505123|FG000|Overall Study|Lost to Follow-up|5|||
23481331|NCT02068768|65505123|FG000|Overall Study|Early Termination by Sponsor|2|||
23481332|NCT01653132|65505126|FG000|First Intervention|Protocol Violation|1|||
23481333|NCT01653132|65505127|FG001|First Intervention|Protocol Violation|0|||
23481334|NCT02361580|65505128|FG000|Overall Study|Lost to Follow-up|6|||
23481335|NCT02361580|65505129|FG001|Overall Study|Lost to Follow-up|3|||
23481336|NCT01074047|65505130|FG000|Treatment Phase|Adverse Event|89|||
23601311|NCT03611075|65929904|FG001|Overall Study|Reason unknown|0|||
23601312|NCT03611075|65929905|FG002|Overall Study|Reason unknown|0|||
23601313|NCT03611075|65929906|FG003|Overall Study|Reason unknown|1|||
23601314|NCT03611075|65929907|FG004|Overall Study|Reason unknown|0|||
23601315|NCT03611075|65929908|FG005|Overall Study|Reason unknown|0|||
23601316|NCT03611075|65929909|FG006|Overall Study|Reason unknown|1|||
23601317|NCT03611075|65929910|FG007|Overall Study|Reason unknown|0|||
23601318|NCT03611075|65929911|FG008|Overall Study|Reason unknown|0|||
23601319|NCT03875313|65929912|FG000|Overall Study|Withdrawal by Subject|1|||
23601320|NCT03875313|65929913|FG001|Overall Study|Withdrawal by Subject|3|||
23601321|NCT03875313|65929914|FG002|Overall Study|Withdrawal by Subject|0|||
23601322|NCT03875313|65929915|FG003|Overall Study|Withdrawal by Subject|0|||
23601323|NCT03875313|65929916|FG004|Overall Study|Withdrawal by Subject|0|||
23601324|NCT03875313|65929912|FG000|Overall Study|Death|0|||
23601325|NCT03875313|65929913|FG001|Overall Study|Death|0|||
23601326|NCT03875313|65929914|FG002|Overall Study|Death|0|||
23601327|NCT03875313|65929915|FG003|Overall Study|Death|0|||
23601328|NCT03875313|65929916|FG004|Overall Study|Death|1|||
23601329|NCT03875313|65929912|FG000|Overall Study|Lost to Follow-up|0|||
23601330|NCT03875313|65929913|FG001|Overall Study|Lost to Follow-up|0|||
23601331|NCT03875313|65929914|FG002|Overall Study|Lost to Follow-up|0|||
23601332|NCT03875313|65929915|FG003|Overall Study|Lost to Follow-up|0|||
23601333|NCT03875313|65929916|FG004|Overall Study|Lost to Follow-up|1|||
23601334|NCT03875313|65929912|FG000|Overall Study|Study Termination by Sponsor|0|||
23601335|NCT03875313|65929913|FG001|Overall Study|Study Termination by Sponsor|1|||
23601336|NCT03875313|65929914|FG002|Overall Study|Study Termination by Sponsor|1|||
23601337|NCT03875313|65929915|FG003|Overall Study|Study Termination by Sponsor|0|||
23601338|NCT03875313|65929916|FG004|Overall Study|Study Termination by Sponsor|1|||
23601339|NCT03875313|65929912|FG000|Overall Study|New Anticancer Treatment|0|||
23601340|NCT03875313|65929913|FG001|Overall Study|New Anticancer Treatment|1|||
23601341|NCT03875313|65929914|FG002|Overall Study|New Anticancer Treatment|2|||
23601342|NCT03875313|65929915|FG003|Overall Study|New Anticancer Treatment|1|||
23601343|NCT03875313|65929916|FG004|Overall Study|New Anticancer Treatment|0|||
23601344|NCT03875313|65929912|FG000|Overall Study|Other, Not Specified|2|||
23601345|NCT03875313|65929913|FG001|Overall Study|Other, Not Specified|11|||
23601346|NCT03875313|65929914|FG002|Overall Study|Other, Not Specified|3|||
23601347|NCT03875313|65929915|FG003|Overall Study|Other, Not Specified|3|||
23659328|NCT01794520|66139286|FG004|Overall Study|Other, not specified|4|||
23659329|NCT01794520|66139287|FG005|Overall Study|Other, not specified|1|||
23659330|NCT01794520|66139288|FG006|Overall Study|Other, not specified|2|||
23659331|NCT03794583|66139289|FG000|Overall Study|Death|8|||
23659332|NCT03794583|66139289|FG000|Overall Study|Study Terminated by Sponsor|24|||
23659333|NCT03794583|66139289|FG000|Overall Study|Withdrawal by Subject|9|||
23601348|NCT03875313|65929916|FG004|Overall Study|Other, Not Specified|1|||
23601349|NCT01695954|65929918|FG000|Overall Study|Withdrawal by Subject|4|||
23601350|NCT01695954|65929919|FG001|Overall Study|Withdrawal by Subject|0|||
23601351|NCT01695954|65929918|FG000|Overall Study|Adverse Event|0|||
23601352|NCT01695954|65929919|FG001|Overall Study|Adverse Event|2|||
23601353|NCT00836498|65929920|FG000|Overall Study|Adverse Event|1|||
23659334|NCT00701090|66139290|FG000|Overall Study|Adverse Event|11|||
23481337|NCT01074047|65505131|FG001|Treatment Phase|Adverse Event|66|||
23481338|NCT01074047|65505130|FG000|Treatment Phase|Disease Progression|16|||
23481339|NCT01074047|65505131|FG001|Treatment Phase|Disease Progression|21|||
23481340|NCT01074047|65505130|FG000|Treatment Phase|Withdrawal by Subject|27|||
23481341|NCT01074047|65505131|FG001|Treatment Phase|Withdrawal by Subject|48|||
23601354|NCT00836498|65929921|FG001|Overall Study|Adverse Event|0|||
23601355|NCT00836498|65929920|FG000|Overall Study|Lost to Follow-up|1|||
23481342|NCT01074047|65505130|FG000|Treatment Phase|Death|53|||
23481343|NCT01074047|65505131|FG001|Treatment Phase|Death|58|||
23481344|NCT01074047|65505130|FG000|Treatment Phase|Lost to Follow-up|0|||
23481345|NCT01074047|65505131|FG001|Treatment Phase|Lost to Follow-up|1|||
23481346|NCT01074047|65505130|FG000|Treatment Phase|Protocol Violation|0|||
23481347|NCT01074047|65505131|FG001|Treatment Phase|Protocol Violation|1|||
23481348|NCT01074047|65505130|FG000|Treatment Phase|Miscellaneous|32|||
23481349|NCT01074047|65505131|FG001|Treatment Phase|Miscellaneous|39|||
23481350|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
23481351|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
23481352|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
23481353|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
23481354|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Death|116|||
23481355|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Death|124|||
23481356|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
23481357|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
23481358|NCT01074047|65505130|FG000|Extension Phase|Physician Decision|1|||
23481359|NCT01074047|65505131|FG001|Extension Phase|Physician Decision|0|||
23481360|NCT01074047|65505130|FG000|Extension Phase|Adverse Event|5|||
23481361|NCT01074047|65505131|FG001|Extension Phase|Adverse Event|0|||
23481362|NCT01074047|65505130|FG000|Extension Phase|Disease Progression|9|||
23481363|NCT01074047|65505131|FG001|Extension Phase|Disease Progression|0|||
23481364|NCT01074047|65505130|FG000|Extension Phase|Withdrawal by Subject|2|||
23481365|NCT01074047|65505131|FG001|Extension Phase|Withdrawal by Subject|0|||
23481366|NCT01074047|65505130|FG000|Extension Phase|Death|5|||
23481367|NCT01074047|65505131|FG001|Extension Phase|Death|0|||
23481368|NCT02692651|65505132|FG000|Study Treatment|Death|7|||
23481369|NCT02692651|65505133|FG001|Study Treatment|Death|3|||
23481370|NCT02692651|65505132|FG000|Study Treatment|comfort care|1|||
23481371|NCT02692651|65505133|FG001|Study Treatment|comfort care|1|||
23481372|NCT02692651|65505132|FG000|Study Treatment|Protocol violation per treating team preference|8|||
23481373|NCT02692651|65505133|FG001|Study Treatment|Protocol violation per treating team preference|6|||
23481374|NCT02692651|65505132|FG000|Post Study Treatment Follow-up|Death|4|||
23481375|NCT02692651|65505133|FG001|Post Study Treatment Follow-up|Death|4|||
23481376|NCT03603509|65505136|FG000|Overall Study|Lost to Follow-up|3|||
23481377|NCT03603509|65505137|FG001|Overall Study|Lost to Follow-up|4|||
23481378|NCT00706849|65505138|FG000|Treatment Period|Adverse Event|0|||
23481379|NCT00706849|65505139|FG001|Treatment Period|Adverse Event|9|||
23481380|NCT00706849|65505138|FG000|Treatment Period|Other|0|||
23481381|NCT00706849|65505139|FG001|Treatment Period|Other|1|||
23481382|NCT00706849|65505138|FG000|Follow-up Period|Withdrawal by Subject|0|||
23481383|NCT00706849|65505139|FG001|Follow-up Period|Withdrawal by Subject|2|||
23481384|NCT00706849|65505138|FG000|Follow-up Period|Protocol non-compliance|0|||
23481385|NCT00706849|65505139|FG001|Follow-up Period|Protocol non-compliance|1|||
23481386|NCT03330002|65505140|FG000|Overall Study|Lost to Follow-up|15|||
23481387|NCT03330002|65505140|FG000|Overall Study|Death|7|||
23481388|NCT01998984|65505147|FG000|Overall Study|Adverse Event|0|||
23481389|NCT01998984|65505148|FG001|Overall Study|Adverse Event|0|||
23481390|NCT01998984|65505149|FG002|Overall Study|Adverse Event|0|||
23601356|NCT00836498|65929921|FG001|Overall Study|Lost to Follow-up|0|||
23601357|NCT00836498|65929920|FG000|Overall Study|Withdrawal by Subject|2|||
23601358|NCT00836498|65929921|FG001|Overall Study|Withdrawal by Subject|1|||
23364215|NCT00103285|65081167|FG007|Induction|Physician Decision|0|||
23364216|NCT00103285|65081160|FG000|Induction|Withdrawal by Subject|1|||
23364217|NCT00103285|65081161|FG001|Induction|Withdrawal by Subject|0|||
23481391|NCT01998984|65505150|FG003|Overall Study|Adverse Event|1|||
23481392|NCT01998984|65505147|FG000|Overall Study|Lost to Follow-up|0|||
23481393|NCT01998984|65505148|FG001|Overall Study|Lost to Follow-up|1|||
23481394|NCT01998984|65505149|FG002|Overall Study|Lost to Follow-up|0|||
23364218|NCT00103285|65081162|FG002|Induction|Withdrawal by Subject|0|||
23481395|NCT01998984|65505150|FG003|Overall Study|Lost to Follow-up|1|||
23481396|NCT01998984|65505147|FG000|Overall Study|Withdrawal by Subject|0|||
23481397|NCT01998984|65505148|FG001|Overall Study|Withdrawal by Subject|0|||
23481398|NCT01998984|65505149|FG002|Overall Study|Withdrawal by Subject|1|||
23481399|NCT01998984|65505150|FG003|Overall Study|Withdrawal by Subject|0|||
23481400|NCT01998984|65505147|FG000|Overall Study|Other|0|||
23481401|NCT01998984|65505148|FG001|Overall Study|Other|0|||
23481402|NCT01998984|65505149|FG002|Overall Study|Other|0|||
23481403|NCT01998984|65505150|FG003|Overall Study|Other|1|||
23481404|NCT01073462|65505151|FG000|Overall Study|Death|14|||
23601359|NCT00683800|65929922|FG000|Overall Study|Adverse Event|195|||
23364219|NCT00103285|65081163|FG003|Induction|Withdrawal by Subject|0|||
23364220|NCT00103285|65081164|FG004|Induction|Withdrawal by Subject|0|||
23364221|NCT00103285|65081165|FG005|Induction|Withdrawal by Subject|0|||
23364222|NCT00103285|65081166|FG006|Induction|Withdrawal by Subject|0|||
23481405|NCT01073462|65505151|FG000|Overall Study|Kidney transplant|10|||
23481406|NCT01073462|65505151|FG000|Overall Study|Low parathyroid hormone levels|8|||
23481407|NCT01073462|65505151|FG000|Overall Study|Serious adverse event|2|||
23481408|NCT01073462|65505151|FG000|Overall Study|Lost to Follow-up|7|||
23481409|NCT01238588|65505158|FG000|Overall Study|Withdrawal by Subject|1|||
23481410|NCT01238588|65505158|FG000|Overall Study|Physician Decision|2|||
23481411|NCT03699475|65505159|FG000|Overall Study|Death|1|||
23481412|NCT01077375|65505160|FG000|Overall Study|Adverse Event|2|||
23481413|NCT01077375|65505161|FG001|Overall Study|Adverse Event|15|||
23601360|NCT00683800|65929923|FG001|Overall Study|Adverse Event|102|||
23601361|NCT00683800|65929922|FG000|Overall Study|Death|0|||
23601362|NCT00683800|65929923|FG001|Overall Study|Death|1|||
23601363|NCT00683800|65929922|FG000|Overall Study|Lost to Follow-up|57|||
23601364|NCT00683800|65929923|FG001|Overall Study|Lost to Follow-up|44|||
23601365|NCT00683800|65929922|FG000|Overall Study|Other|5|||
23659335|NCT00701090|66139291|FG001|Overall Study|Adverse Event|2|||
23659336|NCT00701090|66139290|FG000|Overall Study|Death|0|||
23659337|NCT00701090|66139291|FG001|Overall Study|Death|1|||
23659338|NCT00701090|66139290|FG000|Overall Study|Lack of Efficacy|5|||
23659339|NCT00701090|66139291|FG001|Overall Study|Lack of Efficacy|4|||
23659340|NCT00701090|66139290|FG000|Overall Study|Lost to Follow-up|9|||
23659341|NCT00701090|66139291|FG001|Overall Study|Lost to Follow-up|9|||
23659342|NCT00701090|66139290|FG000|Overall Study|Physician Decision|3|||
23659343|NCT00701090|66139291|FG001|Overall Study|Physician Decision|4|||
23659344|NCT00701090|66139290|FG000|Overall Study|Protocol Violation|2|||
23659345|NCT00701090|66139291|FG001|Overall Study|Protocol Violation|3|||
23659346|NCT00701090|66139290|FG000|Overall Study|Withdrawal by Subject|11|||
23659347|NCT00701090|66139291|FG001|Overall Study|Withdrawal by Subject|16|||
23659348|NCT00701090|66139290|FG000|Overall Study|Other|7|||
23659349|NCT00701090|66139291|FG001|Overall Study|Other|12|||
23659350|NCT02689284|66139292|FG000|Overall Study|Adverse Event|1|||
23659351|NCT02689284|66139293|FG001|Overall Study|Adverse Event|8|||
23659352|NCT02689284|66139292|FG000|Overall Study|Death|0|||
23659353|NCT02689284|66139293|FG001|Overall Study|Death|1|||
23659354|NCT02689284|66139292|FG000|Overall Study|Physician Decision|1|||
23659355|NCT02689284|66139293|FG001|Overall Study|Physician Decision|2|||
23659356|NCT02689284|66139292|FG000|Overall Study|Withdrawal by Subject|0|||
23659357|NCT02689284|66139293|FG001|Overall Study|Withdrawal by Subject|1|||
23659358|NCT02689284|66139292|FG000|Overall Study|progression of cancer|1|||
23659359|NCT02689284|66139293|FG001|Overall Study|progression of cancer|72|||
23659360|NCT02689284|66139292|FG000|Overall Study|decreased heart function|0|||
23659361|NCT02689284|66139293|FG001|Overall Study|decreased heart function|1|||
23659362|NCT02689284|66139292|FG000|Overall Study|concern for anemia|0|||
23659363|NCT02689284|66139293|FG001|Overall Study|concern for anemia|1|||
23364223|NCT00103285|65081167|FG007|Induction|Withdrawal by Subject|0|||
23601366|NCT00683800|65929923|FG001|Overall Study|Other|2|||
23601367|NCT00683800|65929922|FG000|Overall Study|Protocol Violation|13|||
23601368|NCT00683800|65929923|FG001|Overall Study|Protocol Violation|16|||
23601369|NCT00683800|65929922|FG000|Overall Study|Withdrawal by Subject|66|||
23601370|NCT00683800|65929923|FG001|Overall Study|Withdrawal by Subject|64|||
23601371|NCT00683800|65929922|FG000|Overall Study|Lack of Efficacy|61|||
23601372|NCT00683800|65929923|FG001|Overall Study|Lack of Efficacy|104|||
23601373|NCT00683800|65929922|FG000|Overall Study|Randomized, not treated|35|||
23601374|NCT00683800|65929923|FG001|Overall Study|Randomized, not treated|33|||
23659364|NCT02689284|66139292|FG000|Overall Study|no measurable cancer for evaluation|0|||
23659365|NCT02689284|66139293|FG001|Overall Study|no measurable cancer for evaluation|1|||
23659366|NCT00733304|66139294|FG000|Overall Study|Adverse Event|3|||
23659367|NCT00733304|66139295|FG001|Overall Study|Adverse Event|0|||
23659368|NCT00733304|66139296|FG002|Overall Study|Adverse Event|0|||
23659369|NCT00733304|66139294|FG000|Overall Study|Lack of Efficacy|0|||
23659370|NCT00733304|66139295|FG001|Overall Study|Lack of Efficacy|0|||
23659371|NCT00733304|66139296|FG002|Overall Study|Lack of Efficacy|2|||
23659372|NCT00733304|66139294|FG000|Overall Study|Lost to Follow-up|0|||
23364224|NCT00103285|65081160|FG000|Induction|Ineligible|43|||
23601375|NCT02789020|65929926|FG000|Overall Study|Withdrawal by Subject|6|||
23601376|NCT02789020|65929927|FG001|Overall Study|Withdrawal by Subject|5|||
23601377|NCT03347396|65929930|FG000|Part A (26 Weeks)|Adverse Event|1|||
23601378|NCT03347396|65929931|FG001|Part A (26 Weeks)|Adverse Event|0|||
23659373|NCT00733304|66139295|FG001|Overall Study|Lost to Follow-up|1|||
23659374|NCT00733304|66139296|FG002|Overall Study|Lost to Follow-up|0|||
23659375|NCT00733304|66139294|FG000|Overall Study|Physician Decision|3|||
23659376|NCT00733304|66139295|FG001|Overall Study|Physician Decision|1|||
23659377|NCT00733304|66139296|FG002|Overall Study|Physician Decision|3|||
23659378|NCT00733304|66139294|FG000|Overall Study|Withdrawal by Subject|1|||
23659379|NCT00733304|66139295|FG001|Overall Study|Withdrawal by Subject|1|||
23659380|NCT00733304|66139296|FG002|Overall Study|Withdrawal by Subject|0|||
23659381|NCT01162239|66139297|FG000|Treatment Phase|Withdrawal by Subject|1|||
23659382|NCT01162239|66139298|FG001|Treatment Phase|Withdrawal by Subject|3|||
23659383|NCT01162239|66139299|FG002|Treatment Phase|Withdrawal by Subject|2|||
23659384|NCT01162239|66139300|FG003|Treatment Phase|Withdrawal by Subject|3|||
23659385|NCT01162239|66139297|FG000|Treatment Phase|Death|0|||
23659386|NCT01162239|66139298|FG001|Treatment Phase|Death|0|||
23659387|NCT01162239|66139299|FG002|Treatment Phase|Death|0|||
23659388|NCT01162239|66139300|FG003|Treatment Phase|Death|1|||
23659389|NCT01162239|66139297|FG000|Treatment Phase|Lost to Follow-up|5|||
23659390|NCT01162239|66139298|FG001|Treatment Phase|Lost to Follow-up|4|||
23364225|NCT00103285|65081161|FG001|Induction|Ineligible|0|||
23659391|NCT01162239|66139299|FG002|Treatment Phase|Lost to Follow-up|2|||
23659392|NCT01162239|66139300|FG003|Treatment Phase|Lost to Follow-up|1|||
23659393|NCT01162239|66139297|FG000|Extended Follow-up|Lost to Follow-up|8|||
23659394|NCT01162239|66139298|FG001|Extended Follow-up|Lost to Follow-up|13|||
23659395|NCT01162239|66139299|FG002|Extended Follow-up|Lost to Follow-up|8|||
23659396|NCT01162239|66139300|FG003|Extended Follow-up|Lost to Follow-up|6|||
23659397|NCT02014740|66139301|FG000|Overall Study|Lost to Follow-up|4|||
23659398|NCT02014740|66139302|FG001|Overall Study|Lost to Follow-up|4|||
23659399|NCT02014740|66139301|FG000|Overall Study|Withdrawal by Subject|2|||
23659400|NCT02014740|66139302|FG001|Overall Study|Withdrawal by Subject|1|||
23659401|NCT00545402|66139305|FG000|Overall Study|Discontinuation of treatment|17|||
23659402|NCT00545402|66139306|FG001|Overall Study|Discontinuation of treatment|9|||
23659403|NCT00545402|66139305|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
23659404|NCT00545402|66139306|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
23659405|NCT00545402|66139305|FG000|Overall Study|Death|5|||
23659406|NCT00545402|66139306|FG001|Overall Study|Death|7|||
23659407|NCT00545402|66139305|FG000|Overall Study|Graft loss|2|||
23659408|NCT00545402|66139306|FG001|Overall Study|Graft loss|4|||
23659409|NCT00545402|66139305|FG000|Overall Study|Withdrawal by Subject|0|||
23659410|NCT00545402|66139306|FG001|Overall Study|Withdrawal by Subject|1|||
23659411|NCT00545402|66139305|FG000|Overall Study|Protocol Violation|1|||
23659412|NCT00545402|66139306|FG001|Overall Study|Protocol Violation|0|||
23659413|NCT00545402|66139305|FG000|Overall Study|Reason not specified|1|||
23659414|NCT00545402|66139306|FG001|Overall Study|Reason not specified|1|||
23659415|NCT04376060|66139307|FG000|Overall Study|Physician Decision|1|||
23659416|NCT00132496|66139310|FG000|Overall Study|Withdrawal by Subject|1|||
23659417|NCT00132496|66139311|FG001|Overall Study|Withdrawal by Subject|2|||
23659418|NCT00132496|66139310|FG000|Overall Study|Physician Decision|1|||
23659419|NCT00132496|66139311|FG001|Overall Study|Physician Decision|0|||
23659420|NCT00922480|66142263|FG000|Main Study|Protocol Violation|3|||
23659421|NCT00922480|66142264|FG001|Main Study|Protocol Violation|6|||
23659422|NCT00922480|66142263|FG000|Main Study|Adverse Event|6|||
23659423|NCT00922480|66142264|FG001|Main Study|Adverse Event|7|||
23659424|NCT00922480|66142263|FG000|Main Study|Lack of Efficacy|3|||
23659425|NCT00922480|66142264|FG001|Main Study|Lack of Efficacy|0|||
23659426|NCT00922480|66142263|FG000|Main Study|Withdrawal by Subject|20|||
23659427|NCT00922480|66142264|FG001|Main Study|Withdrawal by Subject|15|||
23659428|NCT00922480|66142263|FG000|Main Study|Lost to Follow-up|5|||
23659429|NCT00922480|66142264|FG001|Main Study|Lost to Follow-up|0|||
23659430|NCT00922480|66142263|FG000|Main Study|Physician Decision|0|||
23364226|NCT00103285|65081162|FG002|Induction|Ineligible|0|||
23659431|NCT00922480|66142264|FG001|Main Study|Physician Decision|1|||
23659432|NCT00922480|66142263|FG000|Extension Study|Protocol Violation|3|||
23659433|NCT00922480|66142264|FG001|Extension Study|Protocol Violation|0|||
23659434|NCT00922480|66142263|FG000|Extension Study|Adverse Event|1|||
23659435|NCT00922480|66142264|FG001|Extension Study|Adverse Event|1|||
23659436|NCT00922480|66142263|FG000|Extension Study|Withdrawal by Subject|1|||
23659437|NCT00922480|66142264|FG001|Extension Study|Withdrawal by Subject|1|||
23659438|NCT00922480|66142263|FG000|Extension Study|Others|0|||
23659439|NCT00922480|66142264|FG001|Extension Study|Others|1|||
23659440|NCT00718549|66142265|FG000|Induction Phase|Disease Progression|1|||
23659441|NCT00718549|66142266|FG001|Induction Phase|Disease Progression|0|||
23659442|NCT00718549|66142267|FG002|Induction Phase|Disease Progression|0|||
23659443|NCT00718549|66142265|FG000|Induction Phase|Eligibility Criteria Violation|2|||
23659444|NCT00718549|66142266|FG001|Induction Phase|Eligibility Criteria Violation|0|||
23659445|NCT00718549|66142267|FG002|Induction Phase|Eligibility Criteria Violation|0|||
23659446|NCT00718549|66142265|FG000|Induction Phase|Early Termination - No Additional Info|59|||
23659447|NCT00718549|66142266|FG001|Induction Phase|Early Termination - No Additional Info|0|||
23659448|NCT00718549|66142267|FG002|Induction Phase|Early Termination - No Additional Info|0|||
23659449|NCT00718549|66142265|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
23659450|NCT00718549|66142266|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
23659451|NCT00718549|66142267|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
23659452|NCT00718549|66142265|FG000|Maintenance/ Observation Phase|Death|0|||
23659453|NCT00718549|66142266|FG001|Maintenance/ Observation Phase|Death|1|||
23659454|NCT00718549|66142267|FG002|Maintenance/ Observation Phase|Death|2|||
23659455|NCT00718549|66142265|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
23659456|NCT00718549|66142266|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
23659457|NCT00718549|66142267|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
23659458|NCT00718549|66142265|FG000|Maintenance/ Observation Phase|Progression|0|||
23659459|NCT00718549|66142266|FG001|Maintenance/ Observation Phase|Progression|5|||
23659460|NCT00718549|66142267|FG002|Maintenance/ Observation Phase|Progression|14|||
23659461|NCT00718549|66142265|FG000|Maintenance/ Observation Phase|Relapse|0|||
23659462|NCT00718549|66142266|FG001|Maintenance/ Observation Phase|Relapse|3|||
23659463|NCT00718549|66142267|FG002|Maintenance/ Observation Phase|Relapse|2|||
23659464|NCT00590044|66142268|FG000|Overall Study|Withdrawal by Subject|2|||
23659465|NCT00590044|66142269|FG001|Overall Study|Withdrawal by Subject|2|||
23659466|NCT00590044|66142268|FG000|Overall Study|wrong insulin arm assigned|1|||
23659467|NCT00590044|66142269|FG001|Overall Study|wrong insulin arm assigned|0|||
23659468|NCT00590044|66142268|FG000|Overall Study|Protocol Violation|1|||
23659469|NCT00590044|66142269|FG001|Overall Study|Protocol Violation|0|||
23659470|NCT03308942|66142274|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
23659471|NCT03308942|66142275|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
23659472|NCT03308942|66142276|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
23659473|NCT03308942|66142277|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
23659474|NCT03308942|66142278|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
23659475|NCT03308942|66142274|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
23659476|NCT03308942|66142275|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
23659477|NCT03308942|66142276|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
23659478|NCT03308942|66142277|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
23659479|NCT03308942|66142278|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
23659480|NCT03308942|66142274|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23659481|NCT03308942|66142275|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
23659482|NCT03308942|66142276|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23659483|NCT03308942|66142277|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23659484|NCT03308942|66142278|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23659485|NCT03308942|66142274|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
23659486|NCT03308942|66142275|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
23659487|NCT03308942|66142276|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23659488|NCT03308942|66142277|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23659489|NCT03308942|66142278|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23659490|NCT03308942|66142274|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23659491|NCT03308942|66142275|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23659492|NCT03308942|66142276|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23659493|NCT03308942|66142277|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
23659494|NCT03308942|66142278|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23659495|NCT03308942|66142274|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23659496|NCT03308942|66142275|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23659497|NCT03308942|66142276|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23659498|NCT03308942|66142277|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
23659499|NCT03308942|66142278|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23659500|NCT03308942|66142274|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23659501|NCT03308942|66142275|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23659502|NCT03308942|66142276|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23659503|NCT03308942|66142277|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
23659504|NCT03308942|66142278|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23364227|NCT00103285|65081163|FG003|Induction|Ineligible|0|||
23364228|NCT00103285|65081164|FG004|Induction|Ineligible|0|||
23364229|NCT00103285|65081165|FG005|Induction|Ineligible|0|||
23364230|NCT00103285|65081166|FG006|Induction|Ineligible|0|||
23601379|NCT03347396|65929930|FG000|Part A (26 Weeks)|Death|0|||
23601380|NCT03347396|65929931|FG001|Part A (26 Weeks)|Death|1|||
23601381|NCT03347396|65929930|FG000|Part B (149 Weeks)|Adverse Event|1|||
23601382|NCT03347396|65929931|FG001|Part B (149 Weeks)|Adverse Event|1|||
23601383|NCT03347396|65929930|FG000|Part B (149 Weeks)|Death|1|||
23601384|NCT03347396|65929931|FG001|Part B (149 Weeks)|Death|0|||
23601385|NCT01759862|65929932|FG000|Overall Study|Physician Decision|3|||
23601386|NCT01759862|65929933|FG001|Overall Study|Physician Decision|1|||
23601387|NCT01759862|65929932|FG000|Overall Study|Adverse Event|0|||
23601388|NCT01759862|65929933|FG001|Overall Study|Adverse Event|1|||
23601389|NCT01323790|65929936|FG000|Overall Study|Other|3|||
23601390|NCT01323790|65929937|FG001|Overall Study|Other|2|||
23601391|NCT01323790|65929938|FG002|Overall Study|Other|1|||
23364231|NCT00103285|65081167|FG007|Induction|Ineligible|0|||
23364232|NCT00103285|65081160|FG000|Induction|Refusal|906|||
23364233|NCT00103285|65081161|FG001|Induction|Refusal|0|||
23364234|NCT00103285|65081162|FG002|Induction|Refusal|0|||
23364235|NCT00103285|65081163|FG003|Induction|Refusal|0|||
23364236|NCT00103285|65081164|FG004|Induction|Refusal|0|||
23364237|NCT00103285|65081165|FG005|Induction|Refusal|0|||
23364238|NCT00103285|65081166|FG006|Induction|Refusal|0|||
23364239|NCT00103285|65081167|FG007|Induction|Refusal|0|||
23364240|NCT00103285|65081160|FG000|Induction|Other|258|||
23364241|NCT00103285|65081161|FG001|Induction|Other|0|||
23364242|NCT00103285|65081162|FG002|Induction|Other|0|||
23364243|NCT00103285|65081163|FG003|Induction|Other|0|||
23364244|NCT00103285|65081164|FG004|Induction|Other|0|||
23364245|NCT00103285|65081165|FG005|Induction|Other|0|||
23364246|NCT00103285|65081166|FG006|Induction|Other|0|||
23364247|NCT00103285|65081167|FG007|Induction|Other|0|||
23364248|NCT00103285|65081160|FG000|Response Assignment|Adverse Event|0|||
23364249|NCT00103285|65081161|FG001|Response Assignment|Adverse Event|8|||
23364250|NCT00103285|65081162|FG002|Response Assignment|Adverse Event|3|||
23364251|NCT00103285|65081163|FG003|Response Assignment|Adverse Event|2|||
23601392|NCT01323790|65929936|FG000|Overall Study|Lost to Follow-up|11|||
23601393|NCT01323790|65929937|FG001|Overall Study|Lost to Follow-up|9|||
23601394|NCT01323790|65929938|FG002|Overall Study|Lost to Follow-up|9|||
23659505|NCT01378104|66142279|FG000|Overall Study|Adverse Event|8|||
23364252|NCT00103285|65081164|FG004|Response Assignment|Adverse Event|3|||
23364253|NCT00103285|65081165|FG005|Response Assignment|Adverse Event|1|||
23364254|NCT00103285|65081166|FG006|Response Assignment|Adverse Event|1|||
23364255|NCT00103285|65081167|FG007|Response Assignment|Adverse Event|2|||
23364256|NCT00103285|65081160|FG000|Response Assignment|Death|0|||
23364257|NCT00103285|65081161|FG001|Response Assignment|Death|5|||
23601395|NCT01323790|65929936|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23601396|NCT01323790|65929937|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
23601397|NCT01323790|65929938|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
23364258|NCT00103285|65081162|FG002|Response Assignment|Death|2|||
23364259|NCT00103285|65081163|FG003|Response Assignment|Death|2|||
23364260|NCT00103285|65081164|FG004|Response Assignment|Death|3|||
23364261|NCT00103285|65081165|FG005|Response Assignment|Death|1|||
23364262|NCT00103285|65081166|FG006|Response Assignment|Death|0|||
23364263|NCT00103285|65081167|FG007|Response Assignment|Death|8|||
23364264|NCT00103285|65081160|FG000|Response Assignment|Lost to Follow-up|0|||
23364265|NCT00103285|65081161|FG001|Response Assignment|Lost to Follow-up|9|||
23364266|NCT00103285|65081162|FG002|Response Assignment|Lost to Follow-up|5|||
23364267|NCT00103285|65081163|FG003|Response Assignment|Lost to Follow-up|5|||
23364268|NCT00103285|65081164|FG004|Response Assignment|Lost to Follow-up|1|||
23364269|NCT00103285|65081165|FG005|Response Assignment|Lost to Follow-up|2|||
23364270|NCT00103285|65081166|FG006|Response Assignment|Lost to Follow-up|2|||
23364271|NCT00103285|65081167|FG007|Response Assignment|Lost to Follow-up|5|||
23364272|NCT00103285|65081160|FG000|Response Assignment|Physician Decision|0|||
23364273|NCT00103285|65081161|FG001|Response Assignment|Physician Decision|13|||
23364274|NCT00103285|65081162|FG002|Response Assignment|Physician Decision|14|||
23364275|NCT00103285|65081163|FG003|Response Assignment|Physician Decision|9|||
23364276|NCT00103285|65081164|FG004|Response Assignment|Physician Decision|13|||
23364277|NCT00103285|65081165|FG005|Response Assignment|Physician Decision|7|||
23601398|NCT01323790|65929936|FG000|Overall Study|Lack of Efficacy|3|||
23601399|NCT01323790|65929937|FG001|Overall Study|Lack of Efficacy|0|||
23601400|NCT01323790|65929938|FG002|Overall Study|Lack of Efficacy|3|||
23601401|NCT01323790|65929936|FG000|Overall Study|Adverse Event|11|||
23601402|NCT01323790|65929937|FG001|Overall Study|Adverse Event|24|||
23601403|NCT01323790|65929938|FG002|Overall Study|Adverse Event|12|||
23601404|NCT01323790|65929936|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23601405|NCT01323790|65929937|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23364278|NCT00103285|65081166|FG006|Response Assignment|Physician Decision|4|||
23364279|NCT00103285|65081167|FG007|Response Assignment|Physician Decision|35|||
23364280|NCT00103285|65081160|FG000|Response Assignment|Protocol Violation|0|||
23364281|NCT00103285|65081161|FG001|Response Assignment|Protocol Violation|2|||
23364282|NCT00103285|65081162|FG002|Response Assignment|Protocol Violation|0|||
23364283|NCT00103285|65081163|FG003|Response Assignment|Protocol Violation|0|||
23364284|NCT00103285|65081164|FG004|Response Assignment|Protocol Violation|0|||
23364285|NCT00103285|65081165|FG005|Response Assignment|Protocol Violation|0|||
23364286|NCT00103285|65081166|FG006|Response Assignment|Protocol Violation|0|||
23364287|NCT00103285|65081167|FG007|Response Assignment|Protocol Violation|0|||
23364288|NCT00103285|65081160|FG000|Response Assignment|Withdrawal by Subject|0|||
23364289|NCT00103285|65081161|FG001|Response Assignment|Withdrawal by Subject|4|||
23364290|NCT00103285|65081162|FG002|Response Assignment|Withdrawal by Subject|1|||
23364291|NCT00103285|65081163|FG003|Response Assignment|Withdrawal by Subject|1|||
23364292|NCT00103285|65081164|FG004|Response Assignment|Withdrawal by Subject|2|||
23364293|NCT00103285|65081165|FG005|Response Assignment|Withdrawal by Subject|2|||
23364294|NCT00103285|65081166|FG006|Response Assignment|Withdrawal by Subject|0|||
23364295|NCT00103285|65081167|FG007|Response Assignment|Withdrawal by Subject|2|||
23601406|NCT01323790|65929938|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23601407|NCT01323790|65929936|FG000|Overall Study|Withdrawal by Subject|23|||
23601408|NCT01323790|65929937|FG001|Overall Study|Withdrawal by Subject|20|||
23601409|NCT01323790|65929938|FG002|Overall Study|Withdrawal by Subject|13|||
23364296|NCT00103285|65081160|FG000|Response Assignment|Ineligible|0|||
23364297|NCT00103285|65081161|FG001|Response Assignment|Ineligible|8|||
23364298|NCT00103285|65081162|FG002|Response Assignment|Ineligible|6|||
23364299|NCT00103285|65081163|FG003|Response Assignment|Ineligible|2|||
23601410|NCT01323790|65929936|FG000|Overall Study|Did Not Receive Treatment|2|||
23601411|NCT01323790|65929937|FG001|Overall Study|Did Not Receive Treatment|0|||
23659506|NCT01378104|66142280|FG001|Overall Study|Adverse Event|8|||
23364300|NCT00103285|65081164|FG004|Response Assignment|Ineligible|0|||
23364301|NCT00103285|65081165|FG005|Response Assignment|Ineligible|3|||
23364302|NCT00103285|65081166|FG006|Response Assignment|Ineligible|1|||
23364303|NCT00103285|65081167|FG007|Response Assignment|Ineligible|5|||
23481414|NCT01077375|65505160|FG000|Overall Study|Lack of Efficacy|6|||
23481415|NCT01077375|65505161|FG001|Overall Study|Lack of Efficacy|8|||
23481416|NCT01077375|65505160|FG000|Overall Study|Withdrawal by Subject|0|||
23481417|NCT01077375|65505161|FG001|Overall Study|Withdrawal by Subject|6|||
23481418|NCT01077375|65505160|FG000|Overall Study|Lost to Follow-up|2|||
23481419|NCT01077375|65505161|FG001|Overall Study|Lost to Follow-up|5|||
23481420|NCT01077375|65505160|FG000|Overall Study|Other Reason|0|||
23481421|NCT01077375|65505161|FG001|Overall Study|Other Reason|1|||
23481422|NCT02325791|65505170|FG000|Overall Study|Adverse Event|0|||
23481423|NCT02325791|65505171|FG001|Overall Study|Adverse Event|1|||
23481424|NCT02325791|65505172|FG002|Overall Study|Adverse Event|1|||
23481425|NCT02325791|65505173|FG003|Overall Study|Adverse Event|0|||
23481426|NCT02325791|65505170|FG000|Overall Study|Death|0|||
23481427|NCT02325791|65505171|FG001|Overall Study|Death|3|||
23481428|NCT02325791|65505172|FG002|Overall Study|Death|0|||
23481429|NCT02325791|65505173|FG003|Overall Study|Death|1|||
23481430|NCT02325791|65505170|FG000|Overall Study|Lost to Follow-up|0|||
23481431|NCT02325791|65505171|FG001|Overall Study|Lost to Follow-up|15|||
23481432|NCT02325791|65505172|FG002|Overall Study|Lost to Follow-up|14|||
23481433|NCT02325791|65505173|FG003|Overall Study|Lost to Follow-up|9|||
23481434|NCT02325791|65505170|FG000|Overall Study|Physician Decision|0|||
23481435|NCT02325791|65505171|FG001|Overall Study|Physician Decision|1|||
23659507|NCT01378104|66142279|FG000|Overall Study|Lack of Efficacy|7|||
23481436|NCT02325791|65505172|FG002|Overall Study|Physician Decision|1|||
23481437|NCT02325791|65505173|FG003|Overall Study|Physician Decision|0|||
23481438|NCT02325791|65505170|FG000|Overall Study|Protocol Violation|0|||
23481439|NCT02325791|65505171|FG001|Overall Study|Protocol Violation|0|||
23659508|NCT01378104|66142280|FG001|Overall Study|Lack of Efficacy|5|||
23601412|NCT01323790|65929938|FG002|Overall Study|Did Not Receive Treatment|1|||
23364304|NCT00103285|65081160|FG000|Response Assignment|Refusal|0|||
23481440|NCT02325791|65505172|FG002|Overall Study|Protocol Violation|1|||
23481441|NCT02325791|65505173|FG003|Overall Study|Protocol Violation|0|||
23481442|NCT02325791|65505170|FG000|Overall Study|Withdrawal by Subject|0|||
23481443|NCT02325791|65505171|FG001|Overall Study|Withdrawal by Subject|5|||
23481444|NCT02325791|65505172|FG002|Overall Study|Withdrawal by Subject|8|||
23481445|NCT02325791|65505173|FG003|Overall Study|Withdrawal by Subject|16|||
23481446|NCT01185834|65505178|FG000|Overall Study|Lost to Follow-up|2|||
23481447|NCT01185834|65505178|FG000|Overall Study|Discomfort|4|||
23481448|NCT01185834|65505178|FG000|Overall Study|Biomicroscopy|4|||
23481449|NCT01185834|65505178|FG000|Overall Study|Time/Job Conflict|2|||
23481450|NCT01185834|65505178|FG000|Overall Study|Early exit - Site error|2|||
23481451|NCT01289782|65505181|FG000|Overall Study|Lost to Follow-up|14|||
23481452|NCT01289782|65505182|FG001|Overall Study|Lost to Follow-up|7|||
23481453|NCT01289782|65505181|FG000|Overall Study|Protocol Violation|1|||
23481454|NCT01289782|65505182|FG001|Overall Study|Protocol Violation|1|||
23481455|NCT01289782|65505181|FG000|Overall Study|Withdrawal by Subject|8|||
23481456|NCT01289782|65505182|FG001|Overall Study|Withdrawal by Subject|2|||
23481457|NCT01289782|65505181|FG000|Overall Study|Sponsor's Decision|1|||
23481458|NCT01289782|65505182|FG001|Overall Study|Sponsor's Decision|0|||
23481459|NCT01289782|65505181|FG000|Overall Study|Reason not specified|1|||
23481460|NCT01289782|65505182|FG001|Overall Study|Reason not specified|2|||
23481461|NCT00870233|65505183|FG000|Overall Study|Withdrawal by Subject|18|||
23481462|NCT00870233|65505183|FG000|Overall Study|Did not undergo laparotomy|3|||
23481463|NCT00870233|65505183|FG000|Overall Study|Incompatible internet browser|2|||
23481464|NCT00870233|65505183|FG000|Overall Study|Death|1|||
23481465|NCT04966910|65505188|FG000|Baseline|Participant did not complete measure|0|||
23481466|NCT04966910|65505189|FG001|Baseline|Participant did not complete measure|0|||
23481467|NCT04966910|65505190|FG002|Baseline|Participant did not complete measure|1|||
23481468|NCT04966910|65505191|FG003|Baseline|Participant did not complete measure|0|||
23481469|NCT04966910|65505188|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
23481470|NCT04966910|65505189|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
23481471|NCT04966910|65505190|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
23481472|NCT04966910|65505191|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
23481473|NCT04966910|65505188|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
23481474|NCT04966910|65505189|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
23481475|NCT04966910|65505190|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
23481476|NCT04966910|65505191|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
23481477|NCT04966910|65505188|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
23481478|NCT04966910|65505189|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
23481479|NCT04966910|65505190|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
23481480|NCT04966910|65505191|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
23481481|NCT01185301|65505192|FG000|Overall Study|Adverse Event|3|||
23601413|NCT01323790|65929936|FG000|Overall Study|Severe non-compliance with protocol|2|||
23601414|NCT01323790|65929937|FG001|Overall Study|Severe non-compliance with protocol|2|||
23601415|NCT01323790|65929938|FG002|Overall Study|Severe non-compliance with protocol|2|||
23601416|NCT01046136|65929939|FG000|Overall Study|Withdrawal by Subject|0|||
23601417|NCT01046136|65929940|FG001|Overall Study|Withdrawal by Subject|4|||
23601418|NCT01046136|65929939|FG000|Overall Study|Physician Decision|1|||
23601419|NCT01046136|65929940|FG001|Overall Study|Physician Decision|1|||
23601420|NCT01046136|65929939|FG000|Overall Study|Lost to Follow-up|3|||
23601421|NCT01046136|65929940|FG001|Overall Study|Lost to Follow-up|3|||
23601422|NCT00777049|65929941|FG000|Overall Study|Withdrawal by Subject|1|||
23601423|NCT00777049|65929942|FG001|Overall Study|Withdrawal by Subject|0|||
23601424|NCT00777049|65929941|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
23601425|NCT00777049|65929942|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
23601426|NCT02236611|65929943|FG000|Overall Study|Adverse Event|10|||
23601427|NCT02236611|65929944|FG001|Overall Study|Adverse Event|16|||
23601428|NCT02236611|65929943|FG000|Overall Study|Lack of Efficacy|4|||
23601429|NCT02236611|65929944|FG001|Overall Study|Lack of Efficacy|7|||
23659509|NCT01378104|66142279|FG000|Overall Study|Withdrawal by Subject|12|||
23481482|NCT01185301|65505193|FG001|Overall Study|Adverse Event|0|||
23481483|NCT01185301|65505194|FG002|Overall Study|Adverse Event|2|||
23481484|NCT01185301|65505195|FG003|Overall Study|Adverse Event|3|||
23481485|NCT01185301|65505192|FG000|Overall Study|Withdrawal by Subject|7|||
23601430|NCT02236611|65929943|FG000|Overall Study|Lost to Follow-up|0|||
23601431|NCT02236611|65929944|FG001|Overall Study|Lost to Follow-up|2|||
23601432|NCT02236611|65929943|FG000|Overall Study|Protocol deviation|3|||
23481486|NCT01185301|65505193|FG001|Overall Study|Withdrawal by Subject|5|||
23481487|NCT01185301|65505194|FG002|Overall Study|Withdrawal by Subject|2|||
23481488|NCT01185301|65505195|FG003|Overall Study|Withdrawal by Subject|3|||
23481489|NCT01185301|65505192|FG000|Overall Study|Lost to Follow-up|2|||
23481490|NCT01185301|65505193|FG001|Overall Study|Lost to Follow-up|0|||
23481491|NCT01185301|65505194|FG002|Overall Study|Lost to Follow-up|0|||
23481492|NCT01185301|65505195|FG003|Overall Study|Lost to Follow-up|1|||
23481493|NCT01185301|65505192|FG000|Overall Study|Other Reason|3|||
23481494|NCT01185301|65505193|FG001|Overall Study|Other Reason|2|||
23481495|NCT01185301|65505194|FG002|Overall Study|Other Reason|2|||
23481496|NCT01185301|65505195|FG003|Overall Study|Other Reason|2|||
23481497|NCT00089674|65505198|FG000|Overall Study|Physician Decision|4|||
23481498|NCT00089674|65505199|FG001|Overall Study|Physician Decision|2|||
23481499|NCT00089674|65505198|FG000|Overall Study|Adverse Event|23|||
23481500|NCT00089674|65505199|FG001|Overall Study|Adverse Event|29|||
23481501|NCT00089674|65505198|FG000|Overall Study|Withdrawal by Subject|143|||
23481502|NCT00089674|65505199|FG001|Overall Study|Withdrawal by Subject|127|||
23481503|NCT00089674|65505198|FG000|Overall Study|Death|43|||
23481504|NCT00089674|65505199|FG001|Overall Study|Death|43|||
23481505|NCT00089674|65505198|FG000|Overall Study|Disease progression|21|||
23481506|NCT00089674|65505199|FG001|Overall Study|Disease progression|23|||
23481507|NCT00089674|65505198|FG000|Overall Study|Ineligibility determined|8|||
23481508|NCT00089674|65505199|FG001|Overall Study|Ineligibility determined|10|||
23481509|NCT00089674|65505198|FG000|Overall Study|Lost to Follow-up|21|||
23481510|NCT00089674|65505199|FG001|Overall Study|Lost to Follow-up|17|||
23481511|NCT00089674|65505198|FG000|Overall Study|Noncompliance|7|||
23481512|NCT00089674|65505199|FG001|Overall Study|Noncompliance|3|||
23481513|NCT00089674|65505198|FG000|Overall Study|Other|5|||
23481514|NCT00089674|65505199|FG001|Overall Study|Other|9|||
23481515|NCT00089674|65505198|FG000|Overall Study|Requirement for alternative therapy|14|||
23481516|NCT00089674|65505199|FG001|Overall Study|Requirement for alternative therapy|4|||
23481517|NCT01658813|65505204|FG000|Overall Study|Disease progression|3|||
23481518|NCT02213133|65505205|FG000|Overall Study|Participant discontinued study therapy|2|||
23481519|NCT02213133|65505206|FG001|Overall Study|Participant discontinued study therapy|0|||
23481520|NCT02213133|65505207|FG002|Overall Study|Participant discontinued study therapy|0|||
23481521|NCT02213133|65505205|FG000|Overall Study|Participant withdrew informed consent|2|||
23481522|NCT02213133|65505206|FG001|Overall Study|Participant withdrew informed consent|1|||
23481523|NCT02213133|65505207|FG002|Overall Study|Participant withdrew informed consent|2|||
23481524|NCT02213133|65505205|FG000|Overall Study|Disease progression|11|||
23481525|NCT02213133|65505206|FG001|Overall Study|Disease progression|2|||
23601433|NCT02236611|65929944|FG001|Overall Study|Protocol deviation|5|||
23364305|NCT00103285|65081161|FG001|Response Assignment|Refusal|53|||
23481526|NCT02213133|65505207|FG002|Overall Study|Disease progression|0|||
23481527|NCT02213133|65505205|FG000|Overall Study|Adverse Event (AE)|1|||
23481528|NCT02213133|65505206|FG001|Overall Study|Adverse Event (AE)|0|||
23481529|NCT02213133|65505207|FG002|Overall Study|Adverse Event (AE)|0|||
23481530|NCT02213133|65505205|FG000|Overall Study|Death|16|||
23481531|NCT02213133|65505206|FG001|Overall Study|Death|2|||
23601434|NCT02236611|65929943|FG000|Overall Study|Withdrew consent|9|||
23659510|NCT01378104|66142280|FG001|Overall Study|Withdrawal by Subject|13|||
23481532|NCT02213133|65505207|FG002|Overall Study|Death|1|||
23481533|NCT02213133|65505205|FG000|Overall Study|Other|5|||
23481534|NCT02213133|65505206|FG001|Overall Study|Other|0|||
23481535|NCT02213133|65505207|FG002|Overall Study|Other|0|||
23601435|NCT02236611|65929944|FG001|Overall Study|Withdrew consent|4|||
23481536|NCT01027273|65505208|FG000|Overall Study|Lost to Follow-up|57|||
23481537|NCT01027273|65505209|FG001|Overall Study|Lost to Follow-up|31|||
23481538|NCT01027273|65505208|FG000|Overall Study|Death|2|||
23481539|NCT01027273|65505209|FG001|Overall Study|Death|2|||
23481540|NCT02273739|65505210|FG000|Overall Study|Progression of Disease|3|||
23481541|NCT02273739|65505211|FG001|Overall Study|Progression of Disease|4|||
23481542|NCT02273739|65505212|FG002|Overall Study|Progression of Disease|5|||
23481543|NCT02273739|65505213|FG003|Overall Study|Progression of Disease|2|||
23481544|NCT02273739|65505210|FG000|Overall Study|Death|0|||
23481545|NCT02273739|65505211|FG001|Overall Study|Death|0|||
23481546|NCT02273739|65505212|FG002|Overall Study|Death|0|||
23481547|NCT02273739|65505213|FG003|Overall Study|Death|2|||
23481548|NCT02273739|65505210|FG000|Overall Study|Adverse Event|0|||
23481549|NCT02273739|65505211|FG001|Overall Study|Adverse Event|0|||
23481550|NCT02273739|65505212|FG002|Overall Study|Adverse Event|0|||
23481551|NCT02273739|65505213|FG003|Overall Study|Adverse Event|1|||
23481552|NCT02273739|65505210|FG000|Overall Study|Withdrawal by Subject|0|||
23481553|NCT02273739|65505211|FG001|Overall Study|Withdrawal by Subject|0|||
23481554|NCT02273739|65505212|FG002|Overall Study|Withdrawal by Subject|2|||
23481555|NCT02273739|65505213|FG003|Overall Study|Withdrawal by Subject|1|||
23481556|NCT02273739|65505210|FG000|Overall Study|Physician Decision|0|||
23481557|NCT02273739|65505211|FG001|Overall Study|Physician Decision|0|||
23481558|NCT02273739|65505212|FG002|Overall Study|Physician Decision|0|||
23481559|NCT02273739|65505213|FG003|Overall Study|Physician Decision|1|||
23481560|NCT02282345|65505214|FG000|Overall Study|Progression|0|||
23481561|NCT02282345|65505215|FG001|Overall Study|Progression|1|||
23481562|NCT01343823|65505218|FG000|Overall Study|Study Terminated|1|||
23481563|NCT01343823|65505219|FG001|Overall Study|Study Terminated|0|||
23481564|NCT01343823|65505220|FG002|Overall Study|Study Terminated|0|||
23481565|NCT01343823|65505221|FG003|Overall Study|Study Terminated|1|||
23481566|NCT01343823|65505218|FG000|Overall Study|Withdrawal by Subject|1|||
23481567|NCT01343823|65505219|FG001|Overall Study|Withdrawal by Subject|0|||
23481568|NCT01343823|65505220|FG002|Overall Study|Withdrawal by Subject|0|||
23481569|NCT01343823|65505221|FG003|Overall Study|Withdrawal by Subject|0|||
23481570|NCT00545129|65505225|FG000|Overall Study|Lack of Efficacy|2|||
23481571|NCT00545129|65505226|FG001|Overall Study|Lack of Efficacy|5|||
23481572|NCT00545129|65505225|FG000|Overall Study|Death|2|||
23481573|NCT00545129|65505226|FG001|Overall Study|Death|1|||
23481574|NCT00545129|65505225|FG000|Overall Study|Adverse Event|1|||
23481575|NCT00545129|65505226|FG001|Overall Study|Adverse Event|1|||
23481576|NCT00545129|65505225|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
23481577|NCT00545129|65505226|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
23481578|NCT00545129|65505225|FG000|Overall Study|Other|3|||
23481579|NCT00545129|65505226|FG001|Overall Study|Other|3|||
23481580|NCT03309046|65505235|FG000|Overall Study|Withdrawal by Subject|4|||
23481581|NCT03309046|65505236|FG001|Overall Study|Withdrawal by Subject|17|||
23481582|NCT00859638|65505237|FG000|Overall Study|Lost to Follow-up|6|||
23481583|NCT00859638|65505238|FG001|Overall Study|Lost to Follow-up|1|||
23481584|NCT00859638|65505237|FG000|Overall Study|Withdrawal by Subject|3|||
23481585|NCT00859638|65505238|FG001|Overall Study|Withdrawal by Subject|2|||
23481586|NCT00859638|65505237|FG000|Overall Study|Ill health|1|||
23481587|NCT00859638|65505238|FG001|Overall Study|Ill health|1|||
23481588|NCT03390101|65505243|FG000|Weeks 0-12|Withdrawal by Subject|0|||
23481589|NCT03390101|65505244|FG001|Weeks 0-12|Withdrawal by Subject|1|||
23481590|NCT03390101|65505245|FG002|Weeks 0-12|Withdrawal by Subject|1|||
23481591|NCT03390101|65505243|FG000|Weeks 0-12|Lost to Follow-up|0|||
23481592|NCT03390101|65505244|FG001|Weeks 0-12|Lost to Follow-up|1|||
23659511|NCT01484977|66142286|FG000|Overall Study|Adverse Event|8|||
23659512|NCT01484977|66142286|FG000|Overall Study|Lack of Efficacy|4|||
23659513|NCT01484977|66142286|FG000|Overall Study|Protocol Violation|6|||
23659514|NCT01484977|66142286|FG000|Overall Study|Lost to Follow-up|1|||
23481593|NCT03390101|65505245|FG002|Weeks 0-12|Lost to Follow-up|0|||
23481594|NCT03390101|65505243|FG000|Weeks 12-54|Withdrawal by Subject|0|||
23481595|NCT03390101|65505244|FG001|Weeks 12-54|Withdrawal by Subject|3|||
23481596|NCT03390101|65505245|FG002|Weeks 12-54|Withdrawal by Subject|1|||
23481597|NCT03390101|65505243|FG000|Weeks 12-54|Pregnancy|1|||
23481598|NCT03390101|65505244|FG001|Weeks 12-54|Pregnancy|0|||
23481599|NCT03390101|65505245|FG002|Weeks 12-54|Pregnancy|0|||
23481600|NCT03390101|65505243|FG000|Weeks 12-54|Adverse Event|2|||
23481601|NCT03390101|65505244|FG001|Weeks 12-54|Adverse Event|1|||
23601436|NCT01634165|65929947|FG000|Period 2|Adverse Event|0|||
23659515|NCT01484977|66142286|FG000|Overall Study|Withdrawal by Subject|4|||
23481602|NCT03390101|65505245|FG002|Weeks 12-54|Adverse Event|1|||
23481603|NCT01099709|65505246|FG000|Period 1|Withdrawal by Subject|0|||
23481604|NCT01099709|65505247|FG001|Period 1|Withdrawal by Subject|1|||
23481605|NCT01099709|65505246|FG000|Period 1|Positive cotinine test|0|||
23481606|NCT01099709|65505247|FG001|Period 1|Positive cotinine test|1|||
23481607|NCT01099709|65505246|FG000|Period 1|Adverse Event|1|||
23481608|NCT01099709|65505247|FG001|Period 1|Adverse Event|0|||
23481609|NCT00130442|65505248|FG000|Overall Study|Withdrawal by Subject|0|||
23481610|NCT00130442|65505249|FG001|Overall Study|Withdrawal by Subject|1|||
23481611|NCT00130442|65505248|FG000|Overall Study|did not meet criteria|1|||
23659516|NCT01484977|66142286|FG000|Overall Study|Subject Protocol Non-compliant|1|||
23659517|NCT01484977|66142286|FG000|Overall Study|Moving Overseas|1|||
23659518|NCT01484977|66142286|FG000|Overall Study|Low White Blood Cell Count|1|||
23659519|NCT01484977|66142286|FG000|Overall Study|Lack of Compliance|1|||
23659520|NCT04246801|66142287|FG000|Overall Study|Adverse Event|1|||
23659521|NCT04246801|66142288|FG001|Overall Study|Adverse Event|1|||
23659522|NCT04246801|66142287|FG000|Overall Study|Protocol Violation|1|||
23659523|NCT04246801|66142288|FG001|Overall Study|Protocol Violation|1|||
23659524|NCT04246801|66142287|FG000|Overall Study|Lack of Efficacy|0|||
23659525|NCT04246801|66142288|FG001|Overall Study|Lack of Efficacy|2|||
23659526|NCT04246801|66142287|FG000|Overall Study|Lost to Follow-up|1|||
23659527|NCT04246801|66142288|FG001|Overall Study|Lost to Follow-up|1|||
23659528|NCT04246801|66142287|FG000|Overall Study|Withdrawal by Subject|2|||
23659529|NCT04246801|66142288|FG001|Overall Study|Withdrawal by Subject|1|||
23659530|NCT01086410|66142289|FG000|Overall Study|Adverse Event|1|||
23659531|NCT01086410|66142290|FG001|Overall Study|Adverse Event|0|||
23659532|NCT01086410|66142291|FG002|Overall Study|Adverse Event|0|||
23659533|NCT01086410|66142292|FG003|Overall Study|Adverse Event|2|||
23659534|NCT01086410|66142289|FG000|Overall Study|Lack of Efficacy|1|||
23659535|NCT01086410|66142290|FG001|Overall Study|Lack of Efficacy|1|||
23659536|NCT01086410|66142291|FG002|Overall Study|Lack of Efficacy|0|||
23659537|NCT01086410|66142292|FG003|Overall Study|Lack of Efficacy|0|||
23659538|NCT01086410|66142289|FG000|Overall Study|Protocol Violation|1|||
23659539|NCT01086410|66142290|FG001|Overall Study|Protocol Violation|1|||
23659540|NCT01086410|66142291|FG002|Overall Study|Protocol Violation|0|||
23659541|NCT01086410|66142292|FG003|Overall Study|Protocol Violation|0|||
23659542|NCT01086410|66142289|FG000|Overall Study|Lost to Follow-up|0|||
23659543|NCT01086410|66142290|FG001|Overall Study|Lost to Follow-up|0|||
23659544|NCT01086410|66142291|FG002|Overall Study|Lost to Follow-up|1|||
23659545|NCT01086410|66142292|FG003|Overall Study|Lost to Follow-up|0|||
23659546|NCT00454857|66142293|FG000|Overall Study|Withdrawal by Subject|15|||
23659547|NCT00454857|66142293|FG000|Overall Study|Lost to Follow-up|16|||
23659548|NCT00454857|66142293|FG000|Overall Study|Noncompliance|6|||
23659549|NCT00454857|66142293|FG000|Overall Study|Death|5|||
23659550|NCT00454857|66142293|FG000|Overall Study|Other|11|||
23659551|NCT00454857|66142293|FG000|Overall Study|Reason unknown|1|||
23659552|NCT01717287|66142294|FG000|Overall Study|Lost to Follow-up|0|||
23659553|NCT01717287|66142295|FG001|Overall Study|Lost to Follow-up|2|||
23659554|NCT01717287|66142294|FG000|Overall Study|Protocol Violation|0|||
23659555|NCT01717287|66142295|FG001|Overall Study|Protocol Violation|1|||
23364306|NCT00103285|65081162|FG002|Response Assignment|Refusal|5|||
23364307|NCT00103285|65081163|FG003|Response Assignment|Refusal|3|||
23364308|NCT00103285|65081164|FG004|Response Assignment|Refusal|25|||
23364309|NCT00103285|65081165|FG005|Response Assignment|Refusal|15|||
23364310|NCT00103285|65081166|FG006|Response Assignment|Refusal|30|||
23364311|NCT00103285|65081167|FG007|Response Assignment|Refusal|10|||
23364312|NCT00103285|65081160|FG000|Response Assignment|Other|0|||
23364313|NCT00103285|65081161|FG001|Response Assignment|Other|30|||
23481612|NCT00130442|65505249|FG001|Overall Study|did not meet criteria|1|||
23481613|NCT00400153|65505251|FG000|Overall Study|AE due to study disease worsening|14|||
23481614|NCT00400153|65505252|FG001|Overall Study|AE due to study disease worsening|19|||
23481615|NCT00400153|65505253|FG002|Overall Study|AE due to study disease worsening|20|||
23481616|NCT00400153|65505251|FG000|Overall Study|AE due to other disease worsening|2|||
23481617|NCT00400153|65505252|FG001|Overall Study|AE due to other disease worsening|1|||
23481618|NCT00400153|65505253|FG002|Overall Study|AE due to other disease worsening|0|||
23481619|NCT00400153|65505251|FG000|Overall Study|AE due to other condition|3|||
23481620|NCT00400153|65505252|FG001|Overall Study|AE due to other condition|14|||
23481621|NCT00400153|65505253|FG002|Overall Study|AE due to other condition|15|||
23481622|NCT00400153|65505251|FG000|Overall Study|Protocol Violation|7|||
23481623|NCT00400153|65505252|FG001|Overall Study|Protocol Violation|4|||
23481624|NCT00400153|65505253|FG002|Overall Study|Protocol Violation|9|||
23481625|NCT00400153|65505251|FG000|Overall Study|Lost to Follow-up|2|||
23481626|NCT00400153|65505252|FG001|Overall Study|Lost to Follow-up|1|||
23481627|NCT00400153|65505253|FG002|Overall Study|Lost to Follow-up|4|||
23659556|NCT01379573|66142296|FG000|Overall Study|Lost to Follow-up|1|||
23659557|NCT01379573|66142296|FG000|Overall Study|Screen Failure|10|||
23659558|NCT02767323|66142297|FG000|Overall Study|Withdrawal by Subject|17|||
23659559|NCT02767323|66142298|FG001|Overall Study|Withdrawal by Subject|5|||
23659560|NCT02767323|66142299|FG002|Overall Study|Withdrawal by Subject|13|||
23481628|NCT00400153|65505251|FG000|Overall Study|Withdrawal by Subject|12|||
23481629|NCT00400153|65505252|FG001|Overall Study|Withdrawal by Subject|11|||
23659561|NCT02767323|66142300|FG003|Overall Study|Withdrawal by Subject|0|||
23364314|NCT00103285|65081162|FG002|Response Assignment|Other|48|||
23481630|NCT00400153|65505253|FG002|Overall Study|Withdrawal by Subject|10|||
23481631|NCT00400153|65505251|FG000|Overall Study|Other reasons - not mentioned above|8|||
23481632|NCT00400153|65505252|FG001|Overall Study|Other reasons - not mentioned above|5|||
23659562|NCT02767323|66142297|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
23481633|NCT00400153|65505253|FG002|Overall Study|Other reasons - not mentioned above|3|||
23481634|NCT01235598|65505255|FG000|Overall Study|Adverse Event|0|||
23481635|NCT01235598|65505256|FG001|Overall Study|Adverse Event|3|||
23481636|NCT01235598|65505255|FG000|Overall Study|Lack of Efficacy|0|||
23481637|NCT01235598|65505256|FG001|Overall Study|Lack of Efficacy|1|||
23481638|NCT01235598|65505255|FG000|Overall Study|Withdrawal by Subject|1|||
23481639|NCT01235598|65505256|FG001|Overall Study|Withdrawal by Subject|0|||
23481640|NCT02239120|65505257|FG000|Overall Study|Death|56|||
23481641|NCT02239120|65505258|FG001|Overall Study|Death|58|||
23481642|NCT02239120|65505257|FG000|Overall Study|Lost to Follow-up|19|||
23481643|NCT02239120|65505258|FG001|Overall Study|Lost to Follow-up|14|||
23481644|NCT01958827|65505259|FG000|Overall Study|Adverse Event|3|||
23481645|NCT01958827|65505259|FG000|Overall Study|Lack of Efficacy|6|||
23481646|NCT01958827|65505259|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
23481647|NCT02106923|65505260|FG000|Overall Study|Protocol Violation|0|||
23481648|NCT02106923|65505261|FG001|Overall Study|Protocol Violation|0|||
23481649|NCT02106923|65505262|FG002|Overall Study|Protocol Violation|0|||
23481650|NCT02106923|65505263|FG003|Overall Study|Protocol Violation|0|||
23481651|NCT02106923|65505264|FG004|Overall Study|Protocol Violation|0|||
23481652|NCT02106923|65505265|FG005|Overall Study|Protocol Violation|1|||
23481653|NCT01142089|65505266|FG000|Overall Study|Physician Decision|1|||
23481654|NCT01142089|65505267|FG001|Overall Study|Physician Decision|0|||
23481655|NCT01142089|65505266|FG000|Overall Study|Withdrawal by Subject|1|||
23481656|NCT01142089|65505267|FG001|Overall Study|Withdrawal by Subject|2|||
23481657|NCT01142089|65505266|FG000|Overall Study|Use of prohibited medications|0|||
23481658|NCT01142089|65505267|FG001|Overall Study|Use of prohibited medications|1|||
23481659|NCT01142089|65505266|FG000|Overall Study|Noncompliance with study procedures|2|||
23481660|NCT01142089|65505267|FG001|Overall Study|Noncompliance with study procedures|1|||
23481661|NCT01142089|65505266|FG000|Overall Study|Patient required rescue medication|8|||
23481662|NCT01142089|65505267|FG001|Overall Study|Patient required rescue medication|17|||
23481663|NCT02276027|65505268|FG000|Overall Study|Death|1|||
23481664|NCT02276027|65505269|FG001|Overall Study|Death|0|||
23481665|NCT02276027|65505270|FG002|Overall Study|Death|0|||
23481666|NCT02276027|65505271|FG003|Overall Study|Death|2|||
23481667|NCT02276027|65505268|FG000|Overall Study|Physician Decision|0|||
23481668|NCT02276027|65505269|FG001|Overall Study|Physician Decision|0|||
23601437|NCT01634165|65929948|FG001|Period 2|Adverse Event|1|||
23601438|NCT01634165|65929949|FG002|Period 2|Adverse Event|0|||
23601439|NCT01634165|65929950|FG003|Period 2|Adverse Event|0|||
23601440|NCT04250636|65929953|FG000|Overall Study|Lost to Follow-up|2|||
23601441|NCT01532999|65929954|FG000|Overall Study|Lost to Follow-up|14|||
23601442|NCT01532999|65929955|FG001|Overall Study|Lost to Follow-up|8|||
23601443|NCT01532999|65929954|FG000|Overall Study|Physician Decision|1|||
23601444|NCT01532999|65929955|FG001|Overall Study|Physician Decision|2|||
23601445|NCT01532999|65929954|FG000|Overall Study|Withdrawal by Subject|5|||
23601446|NCT01532999|65929955|FG001|Overall Study|Withdrawal by Subject|0|||
23601447|NCT01532999|65929954|FG000|Overall Study|Relocated|2|||
23601448|NCT01532999|65929955|FG001|Overall Study|Relocated|0|||
23601449|NCT01532999|65929954|FG000|Overall Study|should not have been randomized|1|||
23601450|NCT01532999|65929955|FG001|Overall Study|should not have been randomized|0|||
23601451|NCT01532999|65929954|FG000|Overall Study|substantial noncompliance|2|||
23601452|NCT01532999|65929955|FG001|Overall Study|substantial noncompliance|0|||
23601453|NCT01532999|65929954|FG000|Overall Study|no show for week 9 assessments|6|||
23601454|NCT01532999|65929955|FG001|Overall Study|no show for week 9 assessments|4|||
23601455|NCT01532999|65929954|FG000|Overall Study|Adverse Event|0|||
23601456|NCT01532999|65929955|FG001|Overall Study|Adverse Event|1|||
23601457|NCT01532999|65929954|FG000|Overall Study|incarcerated|0|||
23601458|NCT01532999|65929955|FG001|Overall Study|incarcerated|1|||
23601459|NCT01532999|65929954|FG000|Overall Study|New job|0|||
23601460|NCT01532999|65929955|FG001|Overall Study|New job|2|||
23601461|NCT00853580|65929958|FG000|Overall Study|Lost to Follow-up|3|||
23601462|NCT00853580|65929959|FG001|Overall Study|Lost to Follow-up|5|||
23601463|NCT00853580|65929958|FG000|Overall Study|Protocol Violation|2|||
23481669|NCT02276027|65505270|FG002|Overall Study|Physician Decision|0|||
23601464|NCT00853580|65929959|FG001|Overall Study|Protocol Violation|1|||
23601465|NCT00853580|65929958|FG000|Overall Study|Withdrawal by Subject|2|||
23601466|NCT00853580|65929959|FG001|Overall Study|Withdrawal by Subject|8|||
23705648|NCT02402218|66297579|FG002|Overall Study|Withdrawal by Subject|1|||
23481670|NCT02276027|65505271|FG003|Overall Study|Physician Decision|1|||
23481671|NCT02276027|65505268|FG000|Overall Study|Progressive disease|1|||
23481672|NCT02276027|65505269|FG001|Overall Study|Progressive disease|13|||
23481673|NCT02276027|65505270|FG002|Overall Study|Progressive disease|12|||
23481674|NCT02276027|65505271|FG003|Overall Study|Progressive disease|14|||
23481675|NCT02276027|65505268|FG000|Overall Study|Subject/guardian decision|0|||
23601467|NCT00853580|65929958|FG000|Overall Study|Commenced contraindicated therapy|0|||
23601468|NCT00853580|65929959|FG001|Overall Study|Commenced contraindicated therapy|2|||
23601469|NCT03739866|65929960|FG000|Overall Study|Lost to Follow-up|0|||
23601470|NCT03739866|65929961|FG001|Overall Study|Lost to Follow-up|0|||
23481676|NCT02276027|65505269|FG001|Overall Study|Subject/guardian decision|1|||
23481677|NCT02276027|65505270|FG002|Overall Study|Subject/guardian decision|0|||
23481678|NCT02276027|65505271|FG003|Overall Study|Subject/guardian decision|3|||
23481679|NCT02276027|65505268|FG000|Overall Study|Adverse Event|0|||
23481680|NCT02276027|65505269|FG001|Overall Study|Adverse Event|2|||
23481681|NCT02276027|65505270|FG002|Overall Study|Adverse Event|8|||
23481682|NCT02276027|65505271|FG003|Overall Study|Adverse Event|2|||
23481683|NCT00783302|65505273|FG000|Overall Study|Lost to Follow-up|17|||
23481684|NCT00783302|65505273|FG000|Overall Study|Technical Problems|11|||
23481685|NCT00783302|65505273|FG000|Overall Study|Protocol Violation|3|||
23481686|NCT00783302|65505273|FG000|Overall Study|Physician Decision|1|||
23481687|NCT00783302|65505273|FG000|Overall Study|Withdrawal by Subject|3|||
23481688|NCT00906971|65505274|FG000|Overall Study|Withdrawal by Subject|8|||
23481689|NCT00906971|65505275|FG001|Overall Study|Withdrawal by Subject|2|||
23481690|NCT00906971|65505274|FG000|Overall Study|Lost to Follow-up|0|||
23481691|NCT00906971|65505275|FG001|Overall Study|Lost to Follow-up|1|||
23481692|NCT03614975|65505276|FG000|Overall Study|Physician Decision|7|||
23481693|NCT03614975|65505277|FG001|Overall Study|Physician Decision|5|||
23481694|NCT03614975|65505276|FG000|Overall Study|Withdrawal by Subject|2|||
23481695|NCT03614975|65505277|FG001|Overall Study|Withdrawal by Subject|2|||
23481696|NCT03614975|65505276|FG000|Overall Study|Specimens not in lab batch shipment|1|||
23481697|NCT03614975|65505277|FG001|Overall Study|Specimens not in lab batch shipment|1|||
23481698|NCT02290431|65505278|FG000|Overall Study|Adverse Event|20|||
23481699|NCT02290431|65505278|FG000|Overall Study|Progressive disease|4|||
23481700|NCT02290431|65505278|FG000|Overall Study|Study terminated by Sponsor|1|||
23481701|NCT02290431|65505278|FG000|Overall Study|Physician Decision|2|||
23481702|NCT02108262|65505279|FG000|Overall Study|Non-compliance|0|||
23481703|NCT02108262|65505280|FG001|Overall Study|Non-compliance|2|||
23364315|NCT00103285|65081163|FG003|Response Assignment|Other|38|||
23364316|NCT00103285|65081164|FG004|Response Assignment|Other|37|||
23481704|NCT02108262|65505281|FG002|Overall Study|Non-compliance|1|||
23481705|NCT02108262|65505282|FG003|Overall Study|Non-compliance|1|||
23481706|NCT02108262|65505279|FG000|Overall Study|Randomized by error/screen failure|0|||
23481707|NCT02108262|65505280|FG001|Overall Study|Randomized by error/screen failure|0|||
23481708|NCT02108262|65505281|FG002|Overall Study|Randomized by error/screen failure|1|||
23481709|NCT02108262|65505282|FG003|Overall Study|Randomized by error/screen failure|0|||
23481710|NCT02108262|65505279|FG000|Overall Study|Distance to center|0|||
23481711|NCT02108262|65505280|FG001|Overall Study|Distance to center|1|||
23481712|NCT02108262|65505281|FG002|Overall Study|Distance to center|1|||
23481713|NCT02108262|65505282|FG003|Overall Study|Distance to center|0|||
23481714|NCT02108262|65505279|FG000|Overall Study|Adverse Event|0|||
23481715|NCT02108262|65505280|FG001|Overall Study|Adverse Event|11|||
23481716|NCT02108262|65505281|FG002|Overall Study|Adverse Event|6|||
23481717|NCT02108262|65505282|FG003|Overall Study|Adverse Event|12|||
23481718|NCT02108262|65505279|FG000|Overall Study|Death|0|||
23481719|NCT02108262|65505280|FG001|Overall Study|Death|2|||
23481720|NCT02108262|65505281|FG002|Overall Study|Death|2|||
23481721|NCT02108262|65505282|FG003|Overall Study|Death|1|||
23481722|NCT02108262|65505279|FG000|Overall Study|Lost to Follow-up|0|||
23481723|NCT02108262|65505280|FG001|Overall Study|Lost to Follow-up|0|||
23659563|NCT02767323|66142298|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
23659564|NCT02767323|66142299|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
23481724|NCT02108262|65505281|FG002|Overall Study|Lost to Follow-up|1|||
23481725|NCT02108262|65505282|FG003|Overall Study|Lost to Follow-up|0|||
23481726|NCT02108262|65505279|FG000|Overall Study|Physician Decision|0|||
23481727|NCT02108262|65505280|FG001|Overall Study|Physician Decision|0|||
23481728|NCT02108262|65505281|FG002|Overall Study|Physician Decision|2|||
23481729|NCT02108262|65505282|FG003|Overall Study|Physician Decision|0|||
23481730|NCT02108262|65505279|FG000|Overall Study|Withdrawal by Subject|0|||
23481731|NCT02108262|65505280|FG001|Overall Study|Withdrawal by Subject|7|||
23481732|NCT02108262|65505281|FG002|Overall Study|Withdrawal by Subject|3|||
23481733|NCT02108262|65505282|FG003|Overall Study|Withdrawal by Subject|4|||
23481734|NCT02108262|65505279|FG000|Overall Study|Due to key hepatic values|0|||
23481735|NCT02108262|65505280|FG001|Overall Study|Due to key hepatic values|1|||
23481736|NCT02108262|65505281|FG002|Overall Study|Due to key hepatic values|0|||
23481737|NCT02108262|65505282|FG003|Overall Study|Due to key hepatic values|0|||
23481738|NCT02108262|65505279|FG000|Overall Study|Unable to contact patient|0|||
23481739|NCT02108262|65505280|FG001|Overall Study|Unable to contact patient|3|||
23364317|NCT00103285|65081165|FG005|Response Assignment|Other|17|||
23364318|NCT00103285|65081166|FG006|Response Assignment|Other|11|||
23364319|NCT00103285|65081167|FG007|Response Assignment|Other|53|||
23364320|NCT01945944|65081170|FG000|Overall Study|Adverse Event|0|||
23481740|NCT02108262|65505281|FG002|Overall Study|Unable to contact patient|1|||
23481741|NCT02108262|65505282|FG003|Overall Study|Unable to contact patient|2|||
23481742|NCT02108262|65505279|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
23481743|NCT02108262|65505280|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
23481744|NCT02108262|65505281|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
23481745|NCT02108262|65505282|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
23481746|NCT02108262|65505279|FG000|Overall Study|Patient did not want another infusion|0|||
23481747|NCT02108262|65505280|FG001|Overall Study|Patient did not want another infusion|3|||
23481748|NCT02108262|65505281|FG002|Overall Study|Patient did not want another infusion|3|||
23481749|NCT02108262|65505282|FG003|Overall Study|Patient did not want another infusion|2|||
23481750|NCT02108262|65505279|FG000|Overall Study|Vacation|0|||
23481751|NCT02108262|65505280|FG001|Overall Study|Vacation|1|||
23481752|NCT02108262|65505281|FG002|Overall Study|Vacation|0|||
23481753|NCT02108262|65505282|FG003|Overall Study|Vacation|0|||
23481754|NCT02108262|65505279|FG000|Overall Study|Patient decision|0|||
23481755|NCT02108262|65505280|FG001|Overall Study|Patient decision|7|||
23481756|NCT02108262|65505281|FG002|Overall Study|Patient decision|9|||
23481757|NCT02108262|65505282|FG003|Overall Study|Patient decision|14|||
23481758|NCT02108262|65505279|FG000|Overall Study|Missed IV due to pharmacy error|0|||
23481759|NCT02108262|65505280|FG001|Overall Study|Missed IV due to pharmacy error|0|||
23481760|NCT02108262|65505281|FG002|Overall Study|Missed IV due to pharmacy error|1|||
23481761|NCT02108262|65505282|FG003|Overall Study|Missed IV due to pharmacy error|0|||
23481762|NCT02220998|65505285|FG000|Overall Study|Randomized but Never Treated|1|||
23481763|NCT02220998|65505286|FG001|Overall Study|Randomized but Never Treated|2|||
23481764|NCT02220998|65505285|FG000|Overall Study|Death|2|||
23481765|NCT02220998|65505286|FG001|Overall Study|Death|0|||
23481766|NCT02220998|65505285|FG000|Overall Study|Lack of Efficacy|0|||
23481767|NCT02220998|65505286|FG001|Overall Study|Lack of Efficacy|5|||
23481768|NCT02220998|65505285|FG000|Overall Study|Lost to Follow-up|4|||
23481769|NCT02220998|65505286|FG001|Overall Study|Lost to Follow-up|4|||
23481770|NCT01461057|65505294|FG000|Overall Study|Death|10|||
23481771|NCT01461057|65505295|FG001|Overall Study|Death|9|||
23481772|NCT01461057|65505294|FG000|Overall Study|Withdrawal by Subject|2|||
23481773|NCT01461057|65505295|FG001|Overall Study|Withdrawal by Subject|3|||
23481774|NCT01461057|65505294|FG000|Overall Study|Physician Decision|0|||
23481775|NCT01461057|65505295|FG001|Overall Study|Physician Decision|2|||
23481776|NCT01461057|65505294|FG000|Overall Study|Adverse Event|0|||
23481777|NCT01461057|65505295|FG001|Overall Study|Adverse Event|1|||
23481778|NCT01461057|65505294|FG000|Overall Study|Progression of Disease|1|||
23481779|NCT01461057|65505295|FG001|Overall Study|Progression of Disease|0|||
23481780|NCT01461057|65505294|FG000|Overall Study|Study Terminated by Sponsor|2|||
23481781|NCT01461057|65505295|FG001|Overall Study|Study Terminated by Sponsor|0|||
23481782|NCT02483533|65505300|FG000|Overall Study|Lack of Efficacy|50|||
23601471|NCT03739866|65929962|FG002|Overall Study|Lost to Follow-up|0|||
23659565|NCT02767323|66142300|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
23481783|NCT02483533|65505301|FG001|Overall Study|Lack of Efficacy|50|||
23481784|NCT00869778|65505302|FG000|Overall Study|Adverse Event|2|||
23481785|NCT00869778|65505303|FG001|Overall Study|Adverse Event|0|||
23481786|NCT00869778|65505304|FG002|Overall Study|Adverse Event|0|||
23481787|NCT00869778|65505302|FG000|Overall Study|Withdrawal by Subject|3|||
23481788|NCT00869778|65505303|FG001|Overall Study|Withdrawal by Subject|4|||
23481789|NCT00869778|65505304|FG002|Overall Study|Withdrawal by Subject|5|||
23481790|NCT00869778|65505302|FG000|Overall Study|Pregnancy|1|||
23481791|NCT00869778|65505303|FG001|Overall Study|Pregnancy|0|||
23481792|NCT00869778|65505304|FG002|Overall Study|Pregnancy|0|||
23481793|NCT00869778|65505302|FG000|Overall Study|Protocol Violation|5|||
23481794|NCT00869778|65505303|FG001|Overall Study|Protocol Violation|3|||
23481795|NCT00869778|65505304|FG002|Overall Study|Protocol Violation|5|||
23481796|NCT00869778|65505302|FG000|Overall Study|Unblinding|1|||
23481797|NCT00869778|65505303|FG001|Overall Study|Unblinding|0|||
23481798|NCT00869778|65505304|FG002|Overall Study|Unblinding|0|||
23481799|NCT00570232|65505305|FG000|Overall Study|Adverse Event|10|||
23481800|NCT00570232|65505305|FG000|Overall Study|discontinued due to medical condition|3|||
23481801|NCT00570232|65505305|FG000|Overall Study|discontinued due to recurrence|8|||
23481802|NCT00570232|65505305|FG000|Overall Study|discontinued due to noncompliance|2|||
23481803|NCT03709576|65505310|FG000|Overall Study|progression prior to enrollment|1|||
23481804|NCT00816023|65505320|FG000|Overall Study|Lost to Follow-up|1|||
23481805|NCT00816023|65505321|FG001|Overall Study|Lost to Follow-up|1|||
23481806|NCT00816023|65505322|FG002|Overall Study|Lost to Follow-up|0|||
23481807|NCT00816023|65505323|FG003|Overall Study|Lost to Follow-up|0|||
23481808|NCT00816023|65505320|FG000|Overall Study|Withdrawal by Subject|1|||
23481809|NCT00816023|65505321|FG001|Overall Study|Withdrawal by Subject|0|||
23481810|NCT00816023|65505322|FG002|Overall Study|Withdrawal by Subject|0|||
23481811|NCT00816023|65505323|FG003|Overall Study|Withdrawal by Subject|0|||
23481812|NCT00816023|65505320|FG000|Overall Study|Physician Decision|0|||
23481813|NCT00816023|65505321|FG001|Overall Study|Physician Decision|0|||
23481814|NCT00816023|65505322|FG002|Overall Study|Physician Decision|1|||
23481815|NCT00816023|65505323|FG003|Overall Study|Physician Decision|0|||
23481816|NCT00816023|65505320|FG000|Overall Study|assessments complete prior to window|1|||
23481817|NCT00816023|65505321|FG001|Overall Study|assessments complete prior to window|1|||
23481818|NCT00816023|65505322|FG002|Overall Study|assessments complete prior to window|2|||
23481819|NCT00816023|65505323|FG003|Overall Study|assessments complete prior to window|1|||
23481820|NCT00816023|65505320|FG000|Overall Study|Randomized Not Treated|6|||
23601472|NCT03739866|65929963|FG003|Overall Study|Lost to Follow-up|1|||
23659566|NCT03086057|66142301|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
23481821|NCT00816023|65505321|FG001|Overall Study|Randomized Not Treated|4|||
23481822|NCT00816023|65505322|FG002|Overall Study|Randomized Not Treated|6|||
23481823|NCT00816023|65505323|FG003|Overall Study|Randomized Not Treated|11|||
23481824|NCT04590248|65505324|FG000|Overall Study|Lost to Follow-up|1|||
23481825|NCT04590248|65505324|FG000|Overall Study|Withdrawal by Subject|16|||
23481826|NCT04590248|65505324|FG000|Overall Study|Other|2|||
23481827|NCT00424255|65505327|FG000|Overall Study|Death|115|||
23481828|NCT00424255|65505328|FG001|Overall Study|Death|111|||
23481829|NCT00424255|65505327|FG000|Overall Study|Lost to Follow-up|26|||
23481830|NCT00424255|65505328|FG001|Overall Study|Lost to Follow-up|20|||
23481831|NCT00424255|65505327|FG000|Overall Study|Protocol Violation|0|||
23481832|NCT00424255|65505328|FG001|Overall Study|Protocol Violation|1|||
23481833|NCT00424255|65505327|FG000|Overall Study|Withdrawal by Subject|34|||
23481834|NCT00424255|65505328|FG001|Overall Study|Withdrawal by Subject|38|||
23481835|NCT00424255|65505327|FG000|Overall Study|Physician Decision|3|||
23481836|NCT00424255|65505328|FG001|Overall Study|Physician Decision|7|||
23481837|NCT00424255|65505327|FG000|Overall Study|Cognitive Disturbance|1|||
23481838|NCT00424255|65505328|FG001|Overall Study|Cognitive Disturbance|0|||
23481839|NCT00424255|65505327|FG000|Overall Study|Non-compliance by Participants|1|||
23481840|NCT00424255|65505328|FG001|Overall Study|Non-compliance by Participants|0|||
23481841|NCT00424255|65505327|FG000|Overall Study|Fatigue|1|||
23481842|NCT00424255|65505328|FG001|Overall Study|Fatigue|0|||
23481843|NCT00424255|65505327|FG000|Overall Study|Disease Progression|0|||
23481844|NCT00424255|65505328|FG001|Overall Study|Disease Progression|2|||
23481845|NCT00424255|65505327|FG000|Overall Study|Sponsor Terminated Study|161|||
23481846|NCT00424255|65505328|FG001|Overall Study|Sponsor Terminated Study|167|||
23481847|NCT01576159|65505329|FG000|Overall Study|Withdrawal by Subject|0|||
23481848|NCT01576159|65505330|FG001|Overall Study|Withdrawal by Subject|1|||
23481849|NCT01576159|65505331|FG002|Overall Study|Withdrawal by Subject|0|||
23481850|NCT01576159|65505332|FG003|Overall Study|Withdrawal by Subject|0|||
23481851|NCT01576159|65505329|FG000|Overall Study|Physician Decision|0|||
23481852|NCT01576159|65505330|FG001|Overall Study|Physician Decision|0|||
23481853|NCT01576159|65505331|FG002|Overall Study|Physician Decision|1|||
23481854|NCT01576159|65505332|FG003|Overall Study|Physician Decision|0|||
23481855|NCT01576159|65505329|FG000|Overall Study|Lost to Follow-up|0|||
23481856|NCT01576159|65505330|FG001|Overall Study|Lost to Follow-up|0|||
23481857|NCT01576159|65505331|FG002|Overall Study|Lost to Follow-up|0|||
23481858|NCT01576159|65505332|FG003|Overall Study|Lost to Follow-up|1|||
23481859|NCT01576159|65505329|FG000|Overall Study|Protocol Violation|1|||
23481860|NCT01576159|65505330|FG001|Overall Study|Protocol Violation|0|||
23481861|NCT01576159|65505331|FG002|Overall Study|Protocol Violation|0|||
23481862|NCT01576159|65505332|FG003|Overall Study|Protocol Violation|0|||
23481863|NCT04559529|65505337|FG000|First Intervention (1 Day)|Adverse Event|0|||
23481864|NCT04559529|65505338|FG001|First Intervention (1 Day)|Adverse Event|0|||
23481865|NCT04559529|65505339|FG002|First Intervention (1 Day)|Adverse Event|0|||
23481866|NCT04559529|65505340|FG003|First Intervention (1 Day)|Adverse Event|1|||
23481867|NCT04559529|65505337|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481868|NCT04559529|65505338|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481869|NCT04559529|65505339|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
23481870|NCT04559529|65505340|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481871|NCT04559529|65505337|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481872|NCT04559529|65505338|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481873|NCT04559529|65505339|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
23481874|NCT04559529|65505340|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481875|NCT01244490|65505341|FG000|Overall Study|Lack of Efficacy|14|||
23481876|NCT01244490|65505342|FG001|Overall Study|Lack of Efficacy|5|||
23481877|NCT01244490|65505343|FG002|Overall Study|Lack of Efficacy|5|||
23481878|NCT01244490|65505341|FG000|Overall Study|Withdrawal by Subject|4|||
23481879|NCT01244490|65505342|FG001|Overall Study|Withdrawal by Subject|4|||
23481880|NCT01244490|65505343|FG002|Overall Study|Withdrawal by Subject|9|||
23481881|NCT01244490|65505341|FG000|Overall Study|Adverse Event|1|||
23481882|NCT01244490|65505342|FG001|Overall Study|Adverse Event|9|||
23481883|NCT01244490|65505343|FG002|Overall Study|Adverse Event|5|||
23481884|NCT01244490|65505341|FG000|Overall Study|Lost to Follow-up|0|||
23481885|NCT01244490|65505342|FG001|Overall Study|Lost to Follow-up|6|||
23481886|NCT01244490|65505343|FG002|Overall Study|Lost to Follow-up|3|||
23481887|NCT01244490|65505341|FG000|Overall Study|Other|0|||
23481888|NCT01244490|65505342|FG001|Overall Study|Other|0|||
23481889|NCT01244490|65505343|FG002|Overall Study|Other|1|||
23481890|NCT01487577|65505344|FG000|Overall Study|Became ineligible after signing consent|1|||
23481891|NCT02380690|65505345|FG000|Overall Study|Lost to Follow-up|14|||
23481892|NCT02380690|65505346|FG001|Overall Study|Lost to Follow-up|4|||
23481893|NCT02380690|65505345|FG000|Overall Study|Withdrawal by Subject|20|||
23481894|NCT02380690|65505346|FG001|Overall Study|Withdrawal by Subject|8|||
23481895|NCT05463198|65505350|FG000|Overall Study|Withdrawal by Subject|19|||
23481896|NCT05463198|65505350|FG000|Overall Study|Procedure Notes Missing|18|||
23481897|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
23481898|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481899|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481900|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23659567|NCT03086057|66142302|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
23659568|NCT03086057|66142303|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
23659569|NCT03086057|66142304|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
23364321|NCT01945944|65081171|FG001|Overall Study|Adverse Event|2|||
23659570|NCT03086057|66142301|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
23705649|NCT01234402|66297584|FG000|Overall Study|Lost to Follow-up|0|||
23481901|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481902|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481903|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
23481904|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481905|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481906|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481907|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481908|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481909|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23481910|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481911|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481912|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481913|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481914|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481915|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
23481916|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481917|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481918|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481919|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481920|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481921|NCT02946931|65509318|FG000|Overall Study|Did not require collection of CRFs|588|||
23481922|NCT02946931|65509318|FG000|Overall Study|Other than listed|37|||
23481923|NCT02946931|65509318|FG000|Overall Study|Discharge from hospital|118|||
23481924|NCT02946931|65509318|FG000|Overall Study|Adverse Event|81|||
23481925|NCT02946931|65509318|FG000|Overall Study|CRFs not valid|1|||
23481926|NCT02946931|65509318|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
23481927|NCT02915874|65509319|FG000|Overall Study|Lost to Follow-up|5|||
23481928|NCT02915874|65509320|FG001|Overall Study|Lost to Follow-up|4|||
23481929|NCT02915874|65509319|FG000|Overall Study|Withdrawal by Subject|1|||
23481930|NCT02915874|65509320|FG001|Overall Study|Withdrawal by Subject|1|||
23481931|NCT02915874|65509319|FG000|Overall Study|Started New Anxiety Medication|0|||
23481932|NCT02915874|65509320|FG001|Overall Study|Started New Anxiety Medication|1|||
23659571|NCT03086057|66142302|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
23659572|NCT03086057|66142303|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
23659573|NCT03086057|66142304|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
23659574|NCT03086057|66142301|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
23659575|NCT03086057|66142302|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
23659576|NCT03086057|66142303|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
23481939|NCT00251004|65509324|FG000|Overall Study|Withdrawal by Subject|23|||
23481940|NCT00251004|65509325|FG001|Overall Study|Withdrawal by Subject|16|||
23481941|NCT00251004|65509326|FG002|Overall Study|Withdrawal by Subject|14|||
23481942|NCT00251004|65509324|FG000|Overall Study|Death|9|||
23481943|NCT00251004|65509325|FG001|Overall Study|Death|10|||
23481944|NCT00251004|65509326|FG002|Overall Study|Death|8|||
23481945|NCT00251004|65509324|FG000|Overall Study|Lost to Follow-up|1|||
23481946|NCT00251004|65509325|FG001|Overall Study|Lost to Follow-up|2|||
23481947|NCT00251004|65509326|FG002|Overall Study|Lost to Follow-up|1|||
23481948|NCT00251004|65509324|FG000|Overall Study|Graft Loss|12|||
23481949|NCT00251004|65509325|FG001|Overall Study|Graft Loss|13|||
23481950|NCT00251004|65509326|FG002|Overall Study|Graft Loss|8|||
23481951|NCT00924781|65509327|FG000|Overall Study|Study terminated by sponsor|12|||
23481952|NCT00924781|65509328|FG001|Overall Study|Study terminated by sponsor|10|||
23364322|NCT01945944|65081170|FG000|Overall Study|Physician Decision|1|||
23364323|NCT01945944|65081171|FG001|Overall Study|Physician Decision|0|||
23364324|NCT01945944|65081170|FG000|Overall Study|Withdrawal by Subject|0|||
23364325|NCT01945944|65081171|FG001|Overall Study|Withdrawal by Subject|1|||
23364326|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364327|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
23364328|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23364329|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364330|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364331|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364332|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364333|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364334|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364335|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364336|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364337|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364338|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364339|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364340|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364341|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23364342|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
23364343|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364344|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364345|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364346|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364347|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364348|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364349|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364350|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364351|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364352|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364353|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364354|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364355|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364356|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
23364357|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
23364358|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23364359|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364360|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364361|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364362|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364363|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364364|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364365|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364366|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364367|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364368|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364369|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364370|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364371|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364372|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364373|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
23364374|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364375|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364376|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364377|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364378|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364379|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364380|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364381|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364382|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364383|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364384|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364385|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364386|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364387|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364388|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
23364389|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364390|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364391|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364392|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364393|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364394|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364395|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364396|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364397|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364398|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364399|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364400|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364401|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364402|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364403|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
23364404|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364405|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364406|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364407|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364408|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364409|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364410|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364411|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23402810|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
23481953|NCT00674154|65509333|FG000|Overall Study|Withdrawal by Subject|3|||
23601473|NCT03739866|65929964|FG004|Overall Study|Lost to Follow-up|0|||
23601474|NCT03739866|65929965|FG005|Overall Study|Lost to Follow-up|0|||
23601475|NCT03739866|65929966|FG006|Overall Study|Lost to Follow-up|0|||
23601476|NCT03739866|65929967|FG007|Overall Study|Lost to Follow-up|0|||
23659577|NCT03086057|66142304|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
23659578|NCT03086057|66142301|FG000|Stage 1: PrEP Uptake|Death|1|||
23659579|NCT03086057|66142302|FG001|Stage 1: PrEP Uptake|Death|0|||
23659580|NCT03086057|66142303|FG002|Stage 1: PrEP Uptake|Death|0|||
23659581|NCT03086057|66142304|FG003|Stage 1: PrEP Uptake|Death|0|||
23659582|NCT03086057|66142301|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
23659583|NCT03086057|66142302|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
23659584|NCT03086057|66142303|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
23659585|NCT03086057|66142304|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
23364412|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364413|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364414|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23659586|NCT03086057|66142301|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23659587|NCT03086057|66142302|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23659588|NCT03086057|66142303|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
23659589|NCT03086057|66142304|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23659590|NCT03086057|66142301|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
23705650|NCT01234402|66297585|FG001|Overall Study|Lost to Follow-up|1|||
23364415|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364416|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364417|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364418|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
23364419|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364420|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364421|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364422|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364423|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364424|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364425|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364426|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364427|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364428|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364429|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364430|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364431|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364432|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364433|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364434|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364435|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23364436|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
23364437|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
23364438|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23364439|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23364440|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364441|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23659591|NCT03086057|66142302|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
23659592|NCT03086057|66142303|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
23659593|NCT03086057|66142304|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
23659594|NCT00404820|66142314|FG000|Overall Study|Adverse Event|4|||
23364442|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364443|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364444|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364445|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364446|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364447|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364448|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364449|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23659595|NCT00404820|66142315|FG001|Overall Study|Adverse Event|16|||
23659596|NCT00404820|66142314|FG000|Overall Study|Withdrawal by Subject|5|||
23659597|NCT00404820|66142315|FG001|Overall Study|Withdrawal by Subject|3|||
23659598|NCT00404820|66142314|FG000|Overall Study|Lost to Follow-up|7|||
23364450|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364451|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
23364452|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364453|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364454|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364455|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364456|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364457|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364458|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364459|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364460|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364461|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364462|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364463|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364464|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364465|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364466|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23364467|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23659599|NCT00404820|66142315|FG001|Overall Study|Lost to Follow-up|3|||
23659600|NCT00404820|66142314|FG000|Overall Study|Administrative problems|2|||
23659601|NCT00404820|66142315|FG001|Overall Study|Administrative problems|0|||
23364468|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23364469|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364470|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364471|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364472|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364473|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364474|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364475|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364476|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364477|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364478|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364479|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364480|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364481|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
23364482|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364483|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364484|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364485|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364486|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364487|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364488|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364489|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364490|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364491|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364492|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364493|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364494|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364495|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364496|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364497|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364498|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
23364499|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364500|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364501|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364502|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364503|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364504|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364505|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364506|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364507|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364508|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364509|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364510|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364511|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364512|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
23364513|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23481954|NCT00674154|65509334|FG001|Overall Study|Withdrawal by Subject|1|||
23481955|NCT00674154|65509333|FG000|Overall Study|Did not want parathyroidectomy|0|||
23481956|NCT00674154|65509334|FG001|Overall Study|Did not want parathyroidectomy|2|||
23481957|NCT03745820|65509335|FG000|Overall Study|Adverse Event|0|||
23481958|NCT03745820|65509336|FG001|Overall Study|Adverse Event|3|||
23481959|NCT03745820|65509337|FG002|Overall Study|Adverse Event|2|||
23481960|NCT03745820|65509335|FG000|Overall Study|Non-Compliance with Study Drug|4|||
23481961|NCT03745820|65509336|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23481962|NCT03745820|65509337|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23481963|NCT03745820|65509335|FG000|Overall Study|Withdrawal by Subject|4|||
23481964|NCT03745820|65509336|FG001|Overall Study|Withdrawal by Subject|4|||
23481965|NCT03745820|65509337|FG002|Overall Study|Withdrawal by Subject|4|||
23481966|NCT03745820|65509335|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
23481967|NCT03745820|65509336|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
23481968|NCT03745820|65509337|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
23481969|NCT03745820|65509335|FG000|Overall Study|Lost to Follow-up|2|||
23481970|NCT03745820|65509336|FG001|Overall Study|Lost to Follow-up|0|||
23481971|NCT03745820|65509337|FG002|Overall Study|Lost to Follow-up|3|||
23481972|NCT03745820|65509335|FG000|Overall Study|Reason not Specified|2|||
23481973|NCT03745820|65509336|FG001|Overall Study|Reason not Specified|4|||
23481974|NCT03745820|65509337|FG002|Overall Study|Reason not Specified|1|||
23364514|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364515|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364516|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364517|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23659602|NCT00404820|66142314|FG000|Overall Study|Death|1|||
23659603|NCT00404820|66142315|FG001|Overall Study|Death|0|||
23659604|NCT00404820|66142314|FG000|Overall Study|Other|0|||
23659605|NCT00404820|66142315|FG001|Overall Study|Other|2|||
23659606|NCT02790138|66142316|FG000|Overall Study|Adverse Event|5|||
23659607|NCT02790138|66142317|FG001|Overall Study|Adverse Event|2|||
23659608|NCT02790138|66142316|FG000|Overall Study|Significant Protocol Deviation|0|||
23659609|NCT02790138|66142317|FG001|Overall Study|Significant Protocol Deviation|1|||
23659610|NCT02790138|66142316|FG000|Overall Study|Lost to Follow-up|1|||
23659611|NCT02790138|66142317|FG001|Overall Study|Lost to Follow-up|0|||
23659612|NCT02790138|66142316|FG000|Overall Study|Voluntary Withdrawal|8|||
23659613|NCT02790138|66142317|FG001|Overall Study|Voluntary Withdrawal|9|||
23364518|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364519|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364520|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364521|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364522|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364523|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364524|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364525|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364526|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364527|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364528|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364529|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
23364530|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364531|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23481975|NCT02101112|65509342|FG000|Overall Study|Adverse Event|0|||
23481976|NCT02101112|65509343|FG001|Overall Study|Adverse Event|0|||
23659614|NCT02790138|66142316|FG000|Overall Study|Lack of Efficacy|6|||
23364532|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23659615|NCT02790138|66142317|FG001|Overall Study|Lack of Efficacy|7|||
23659616|NCT02790138|66142316|FG000|Overall Study|Reason not Specified|1|||
23659617|NCT02790138|66142317|FG001|Overall Study|Reason not Specified|0|||
23481977|NCT02101112|65509344|FG002|Overall Study|Adverse Event|1|||
23481978|NCT02101112|65509345|FG003|Overall Study|Adverse Event|0|||
23481979|NCT02101112|65509346|FG004|Overall Study|Adverse Event|0|||
23481980|NCT02101112|65509347|FG005|Overall Study|Adverse Event|0|||
23481981|NCT02101112|65509342|FG000|Overall Study|Withdrawal by Subject|0|||
23481982|NCT02101112|65509343|FG001|Overall Study|Withdrawal by Subject|0|||
23481983|NCT02101112|65509344|FG002|Overall Study|Withdrawal by Subject|0|||
23481984|NCT02101112|65509345|FG003|Overall Study|Withdrawal by Subject|0|||
23481985|NCT02101112|65509346|FG004|Overall Study|Withdrawal by Subject|1|||
23481986|NCT02101112|65509347|FG005|Overall Study|Withdrawal by Subject|0|||
23481987|NCT03361176|65509348|FG000|Overall Study|Lost to Follow-up|1|||
23481988|NCT03361176|65509349|FG001|Overall Study|Lost to Follow-up|2|||
23481989|NCT03361176|65509348|FG000|Overall Study|Adverse Event|0|||
23481990|NCT03361176|65509349|FG001|Overall Study|Adverse Event|2|||
23481991|NCT03361176|65509348|FG000|Overall Study|Withdrawal by Subject|0|||
23481992|NCT03361176|65509349|FG001|Overall Study|Withdrawal by Subject|1|||
23481993|NCT03780400|65509350|FG000|Overall Study|Lost to Follow-up|5|||
23481994|NCT03780400|65509350|FG000|Overall Study|Withdrawal by Subject|2|||
23481995|NCT02677324|65509359|FG000|Overall Study|Disease Progression|6|||
23481996|NCT02677324|65509359|FG000|Overall Study|Inability to Swallow pills|1|||
23481997|NCT02677324|65509359|FG000|Overall Study|Non-compliance|1|||
23481998|NCT02677324|65509359|FG000|Overall Study|Lack of Efficacy|1|||
23481999|NCT02677324|65509359|FG000|Overall Study|Medical insurance coverage|1|||
23482000|NCT02677324|65509359|FG000|Overall Study|Adverse Event|1|||
23482001|NCT02677324|65509359|FG000|Overall Study|IgM Myeloma diagnosis|1|||
23482002|NCT01275339|65509360|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
23482003|NCT01275339|65509361|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
23482004|NCT01275339|65509362|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
23482005|NCT01275339|65509363|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
23482006|NCT01275339|65509360|FG000|Overall Study|Withdrawal by Subject|0|||
23482007|NCT01275339|65509361|FG001|Overall Study|Withdrawal by Subject|0|||
23482008|NCT01275339|65509362|FG002|Overall Study|Withdrawal by Subject|1|||
23482009|NCT01275339|65509363|FG003|Overall Study|Withdrawal by Subject|0|||
23482010|NCT02925793|65509364|FG000|Overall Study|Adverse Event|3|||
23482011|NCT02925793|65509365|FG001|Overall Study|Adverse Event|3|||
23482012|NCT02925793|65509366|FG002|Overall Study|Adverse Event|6|||
23482013|NCT02925793|65509364|FG000|Overall Study|Withdrawal by Subject|16|||
23482014|NCT02925793|65509365|FG001|Overall Study|Withdrawal by Subject|15|||
23482015|NCT02925793|65509366|FG002|Overall Study|Withdrawal by Subject|13|||
23482016|NCT02925793|65509364|FG000|Overall Study|Investigator Discretion|0|||
23482017|NCT02925793|65509365|FG001|Overall Study|Investigator Discretion|1|||
23482018|NCT02925793|65509366|FG002|Overall Study|Investigator Discretion|1|||
23482019|NCT02925793|65509364|FG000|Overall Study|Lost to Follow-up|2|||
23482020|NCT02925793|65509365|FG001|Overall Study|Lost to Follow-up|3|||
23482021|NCT02925793|65509366|FG002|Overall Study|Lost to Follow-up|1|||
23482022|NCT02925793|65509364|FG000|Overall Study|Lack of Efficacy|2|||
23482023|NCT02925793|65509365|FG001|Overall Study|Lack of Efficacy|6|||
23482024|NCT02925793|65509366|FG002|Overall Study|Lack of Efficacy|4|||
23482025|NCT02925793|65509364|FG000|Overall Study|Other:|2|||
23482026|NCT02925793|65509365|FG001|Overall Study|Other:|1|||
23482027|NCT02925793|65509366|FG002|Overall Study|Other:|3|||
23482028|NCT04010539|65509367|FG000|Overall Study|Withdrawal by Subject|4|||
23482029|NCT04010539|65509368|FG001|Overall Study|Withdrawal by Subject|1|||
23482030|NCT04010539|65509367|FG000|Overall Study|Physician Decision|0|||
23482031|NCT04010539|65509368|FG001|Overall Study|Physician Decision|2|||
23482032|NCT04010539|65509367|FG000|Overall Study|Lost to Follow-up|10|||
23482033|NCT04010539|65509368|FG001|Overall Study|Lost to Follow-up|14|||
23482034|NCT04010539|65509367|FG000|Overall Study|Adverse Event|3|||
23482035|NCT04010539|65509368|FG001|Overall Study|Adverse Event|0|||
23482036|NCT04010539|65509367|FG000|Overall Study|Participant Did Not Receive IP|0|||
23482037|NCT04010539|65509368|FG001|Overall Study|Participant Did Not Receive IP|1|||
23482038|NCT04010539|65509367|FG000|Overall Study|Protocol Deviation|0|||
23482039|NCT04010539|65509368|FG001|Overall Study|Protocol Deviation|1|||
23482040|NCT04010539|65509367|FG000|Overall Study|Randomized in Error/ Mistake|2|||
23482041|NCT04010539|65509368|FG001|Overall Study|Randomized in Error/ Mistake|0|||
23482042|NCT04010539|65509367|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
23482043|NCT04010539|65509368|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
23482044|NCT03188042|65509374|FG000|Overall Study|Withdrawal by Subject|1|||
23482045|NCT03188042|65509375|FG001|Overall Study|Withdrawal by Subject|1|||
23482046|NCT03729362|65509376|FG000|Overall Study|Withdrawal by Subject|2|||
23482047|NCT03729362|65509377|FG001|Overall Study|Withdrawal by Subject|0|||
23482048|NCT03729362|65509376|FG000|Overall Study|Physician Decision|1|||
23482049|NCT03729362|65509377|FG001|Overall Study|Physician Decision|0|||
23482050|NCT03729362|65509376|FG000|Overall Study|COVID-19 Pandemic|1|||
23482051|NCT03729362|65509377|FG001|Overall Study|COVID-19 Pandemic|0|||
23482052|NCT03729362|65509376|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
23659618|NCT03768505|66142319|FG000|Overall Study|sponsor decision|76|||
23659619|NCT03768505|66142319|FG000|Overall Study|Death|35|||
23659620|NCT03768505|66142319|FG000|Overall Study|Other -Various|30|||
23659621|NCT03768505|66142319|FG000|Overall Study|Withdrawal by Subject|22|||
23659622|NCT03768505|66142319|FG000|Overall Study|Lost to Follow-up|6|||
23659623|NCT03808688|66142320|FG000|Overall Study|Adverse Event|13|||
23659624|NCT03808688|66142321|FG001|Overall Study|Adverse Event|17|||
23659625|NCT03808688|66142320|FG000|Overall Study|Lack of Efficacy|2|||
23659626|NCT03808688|66142321|FG001|Overall Study|Lack of Efficacy|0|||
23659627|NCT03808688|66142320|FG000|Overall Study|Lost to Follow-up|0|||
23659628|NCT03808688|66142321|FG001|Overall Study|Lost to Follow-up|2|||
23659629|NCT03808688|66142320|FG000|Overall Study|Withdrawal by Subject|1|||
23659630|NCT03808688|66142321|FG001|Overall Study|Withdrawal by Subject|0|||
23659631|NCT03808688|66142320|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
23659632|NCT03808688|66142321|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
23659633|NCT03808688|66142320|FG000|Overall Study|IOP Too High|1|||
23659634|NCT03808688|66142321|FG001|Overall Study|IOP Too High|1|||
23659635|NCT03808688|66142320|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
23659636|NCT03808688|66142321|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
23659637|NCT03808688|66142320|FG000|Overall Study|Visit Out of Window|0|||
23659638|NCT03808688|66142321|FG001|Overall Study|Visit Out of Window|1|||
23659639|NCT03808688|66142320|FG000|Overall Study|Medication Non-Compliance|0|||
23364533|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364534|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364535|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364536|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364537|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364538|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364539|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364540|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364541|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
23364542|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
23364543|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
23364544|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
23364545|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364546|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364547|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364548|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364549|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364550|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364551|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364552|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364553|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364554|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364555|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364556|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
23364557|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364558|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364559|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364560|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364561|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364562|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364563|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364564|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364565|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364566|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364567|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364568|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364569|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364570|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364571|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364572|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
23364573|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364574|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364575|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364576|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364577|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364578|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364579|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364580|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364581|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
23364582|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
23364583|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
23364584|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
23364585|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
23364586|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
23364587|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
23364588|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
23364589|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
23364590|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
23364591|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
23364592|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
23364593|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
23364594|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
23364595|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
23364596|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364597|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364598|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364599|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364600|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23482053|NCT03729362|65509377|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
23482054|NCT03729362|65509376|FG000|Overall Study|Adverse Event|0|||
23482055|NCT03729362|65509377|FG001|Overall Study|Adverse Event|1|||
23482056|NCT03729362|65509376|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
23482057|NCT03729362|65509377|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
23482058|NCT01115803|65509378|FG000|Overall Study|Withdrawal by Subject|0|||
23482059|NCT01115803|65509379|FG001|Overall Study|Withdrawal by Subject|0|||
23482060|NCT01115803|65509380|FG002|Overall Study|Withdrawal by Subject|0|||
23482061|NCT01115803|65509381|FG003|Overall Study|Withdrawal by Subject|0|||
23482062|NCT01115803|65509382|FG004|Overall Study|Withdrawal by Subject|0|||
23482063|NCT01115803|65509383|FG005|Overall Study|Withdrawal by Subject|0|||
23482064|NCT01115803|65509384|FG006|Overall Study|Withdrawal by Subject|1|||
23482065|NCT01115803|65509378|FG000|Overall Study|Lost to Follow-up|0|||
23482066|NCT01115803|65509379|FG001|Overall Study|Lost to Follow-up|0|||
23482067|NCT01115803|65509380|FG002|Overall Study|Lost to Follow-up|1|||
23659640|NCT03808688|66142321|FG001|Overall Study|Medication Non-Compliance|1|||
23659641|NCT00290290|66142328|FG000|Overall Study|Death|3|||
23659642|NCT00290290|66142329|FG001|Overall Study|Death|4|||
23659643|NCT00290290|66142328|FG000|Overall Study|Withdrawal by Subject|2|||
23659644|NCT00290290|66142329|FG001|Overall Study|Withdrawal by Subject|2|||
23482068|NCT01115803|65509381|FG003|Overall Study|Lost to Follow-up|0|||
23601477|NCT03739866|65929960|FG000|Overall Study|Enrolled but not treated|0|||
23601478|NCT03739866|65929961|FG001|Overall Study|Enrolled but not treated|0|||
23482069|NCT01115803|65509382|FG004|Overall Study|Lost to Follow-up|0|||
23482070|NCT01115803|65509383|FG005|Overall Study|Lost to Follow-up|0|||
23482071|NCT01115803|65509384|FG006|Overall Study|Lost to Follow-up|0|||
23482072|NCT01115803|65509378|FG000|Overall Study|Progressive Disease during Cycle1|0|||
23482073|NCT01115803|65509379|FG001|Overall Study|Progressive Disease during Cycle1|0|||
23482074|NCT01115803|65509380|FG002|Overall Study|Progressive Disease during Cycle1|0|||
23482075|NCT01115803|65509381|FG003|Overall Study|Progressive Disease during Cycle1|0|||
23482076|NCT01115803|65509382|FG004|Overall Study|Progressive Disease during Cycle1|0|||
23482077|NCT01115803|65509383|FG005|Overall Study|Progressive Disease during Cycle1|0|||
23482078|NCT01115803|65509384|FG006|Overall Study|Progressive Disease during Cycle1|1|||
23482079|NCT01569464|65509385|FG000|Overall Study|Adverse Event|4|||
23482080|NCT01569464|65509386|FG001|Overall Study|Adverse Event|0|||
23482081|NCT01569464|65509385|FG000|Overall Study|Lack of Efficacy|1|||
23482082|NCT01569464|65509386|FG001|Overall Study|Lack of Efficacy|0|||
23482083|NCT01569464|65509385|FG000|Overall Study|Protocol Violation|1|||
23482084|NCT01569464|65509386|FG001|Overall Study|Protocol Violation|0|||
23482085|NCT01569464|65509385|FG000|Overall Study|Lost to Follow-up|2|||
23482086|NCT01569464|65509386|FG001|Overall Study|Lost to Follow-up|3|||
23482087|NCT01569464|65509385|FG000|Overall Study|Withdrawal by Subject|1|||
23482088|NCT01569464|65509386|FG001|Overall Study|Withdrawal by Subject|1|||
23601479|NCT03739866|65929962|FG002|Overall Study|Enrolled but not treated|1|||
23601480|NCT03739866|65929963|FG003|Overall Study|Enrolled but not treated|0|||
23601481|NCT03739866|65929964|FG004|Overall Study|Enrolled but not treated|1|||
23601482|NCT03739866|65929965|FG005|Overall Study|Enrolled but not treated|0|||
23601483|NCT03739866|65929966|FG006|Overall Study|Enrolled but not treated|0|||
23601484|NCT03739866|65929967|FG007|Overall Study|Enrolled but not treated|0|||
23659645|NCT00290290|66142328|FG000|Overall Study|Underwent clean surgical procedure|13|||
23659646|NCT00290290|66142329|FG001|Overall Study|Underwent clean surgical procedure|12|||
23659647|NCT03519867|66142330|FG000|Overall Study|Adverse Event|1|||
23659648|NCT03519867|66142331|FG001|Overall Study|Adverse Event|1|||
23364601|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364602|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364603|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364604|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364605|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364606|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
23364607|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
23364608|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23364609|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364610|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
23364611|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364612|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364613|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364614|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364615|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364616|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364617|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364618|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364619|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364620|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364621|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23364622|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364623|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23364624|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23482089|NCT01569464|65509385|FG000|Overall Study|Other|1|||
23482090|NCT01569464|65509386|FG001|Overall Study|Other|1|||
23482091|NCT00397943|65509387|FG000|Overall Study|Unspecified reasons|12|||
23482092|NCT00397943|65509388|FG001|Overall Study|Unspecified reasons|9|||
23482093|NCT00397943|65509389|FG002|Overall Study|Unspecified reasons|0|||
23482094|NCT00397943|65509390|FG003|Overall Study|Unspecified reasons|0|||
23482095|NCT00397943|65509391|FG004|Overall Study|Unspecified reasons|0|||
23482096|NCT03269552|65509394|FG000|Overall Study|Adverse Event|2|||
23482097|NCT02456103|65509395|FG000|Overall Study|Study Closure|207|||
23482098|NCT02456103|65509395|FG000|Overall Study|Physician Decision|1|||
23482099|NCT02456103|65509395|FG000|Overall Study|Required prohibited medications|5|||
23482100|NCT02456103|65509395|FG000|Overall Study|Protocol Violation|1|||
23482101|NCT02456103|65509395|FG000|Overall Study|Adverse Event|5|||
23482102|NCT02456103|65509395|FG000|Overall Study|Abnormal Laboratory Value|2|||
23482103|NCT02456103|65509395|FG000|Overall Study|Lost to Follow-up|1|||
23482104|NCT02456103|65509395|FG000|Overall Study|Withdrawal by Subject|24|||
23482105|NCT01511055|65509396|FG000|Overall Study|Withdrawal by Subject|6|||
23482106|NCT01006603|65509399|FG000|Overall Study|Withdrawal by Subject|17|||
23482107|NCT01006603|65509400|FG001|Overall Study|Withdrawal by Subject|19|||
23482108|NCT01006603|65509399|FG000|Overall Study|Lost to Follow-up|0|||
23482109|NCT01006603|65509400|FG001|Overall Study|Lost to Follow-up|1|||
23482110|NCT01006603|65509399|FG000|Overall Study|Safety reason|1|||
23482111|NCT01006603|65509400|FG001|Overall Study|Safety reason|1|||
23482112|NCT01006603|65509399|FG000|Overall Study|Protocol Violation|1|||
23482113|NCT01006603|65509400|FG001|Overall Study|Protocol Violation|3|||
23482114|NCT01006603|65509399|FG000|Overall Study|Incorrect enrolment|0|||
23482115|NCT01006603|65509400|FG001|Overall Study|Incorrect enrolment|2|||
23482116|NCT01006603|65509399|FG000|Overall Study|Adverse Event|15|||
23482117|NCT01006603|65509400|FG001|Overall Study|Adverse Event|7|||
23482118|NCT01006603|65509399|FG000|Overall Study|Death|1|||
23482119|NCT01006603|65509400|FG001|Overall Study|Death|1|||
23482120|NCT01006603|65509399|FG000|Overall Study|Study specific discontinuation criteria|33|||
23482121|NCT01006603|65509400|FG001|Overall Study|Study specific discontinuation criteria|34|||
23482122|NCT01006603|65509399|FG000|Overall Study|Other|3|||
23482123|NCT01006603|65509400|FG001|Overall Study|Other|7|||
23482124|NCT05672667|65509401|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
23482125|NCT01095094|65509402|FG000|Overall Study|Withdrawal by Subject|1|||
23482126|NCT01095094|65509402|FG000|Overall Study|Death|1|||
23482127|NCT01095094|65509402|FG000|Overall Study|Physician Decision|1|||
23482128|NCT03490981|65509407|FG000|Overall Study|Lost to Follow-up|1|||
23482129|NCT03490981|65509408|FG001|Overall Study|Lost to Follow-up|2|||
23482130|NCT01445548|65509409|FG000|Overall Study|Adverse Event|1|||
23482131|NCT00669409|65509410|FG000|Part 2|Withdrawal by Subject|0|||
23482132|NCT00669409|65509411|FG001|Part 2|Withdrawal by Subject|0|||
23482133|NCT00669409|65509412|FG002|Part 2|Withdrawal by Subject|0|||
23482134|NCT00669409|65509413|FG003|Part 2|Withdrawal by Subject|0|||
23482135|NCT00669409|65509414|FG004|Part 2|Withdrawal by Subject|0|||
23482136|NCT00669409|65509415|FG005|Part 2|Withdrawal by Subject|0|||
23482137|NCT00669409|65509416|FG006|Part 2|Withdrawal by Subject|0|||
23482138|NCT00669409|65509417|FG007|Part 2|Withdrawal by Subject|0|||
23482139|NCT00669409|65509418|FG008|Part 2|Withdrawal by Subject|0|||
23482140|NCT00669409|65509419|FG009|Part 2|Withdrawal by Subject|1|||
23482141|NCT00669409|65509420|FG010|Part 2|Withdrawal by Subject|0|||
23482142|NCT04439253|65509425|FG000|Overall Study|Adverse Event|1|||
23482143|NCT04439253|65509425|FG000|Overall Study|Disease progression|2|||
23482144|NCT04439253|65509425|FG000|Overall Study|Complicating disease|1|||
23482145|NCT02616601|65509426|FG000|Overall Study|Withdrawal by Subject|4|||
23482146|NCT02616601|65509427|FG001|Overall Study|Withdrawal by Subject|4|||
23482147|NCT02616601|65509428|FG002|Overall Study|Withdrawal by Subject|3|||
23482148|NCT02616601|65509426|FG000|Overall Study|Adverse Event|2|||
23482149|NCT02616601|65509427|FG001|Overall Study|Adverse Event|0|||
23482150|NCT02616601|65509428|FG002|Overall Study|Adverse Event|2|||
23482151|NCT02616601|65509426|FG000|Overall Study|Death|1|||
23482152|NCT02616601|65509427|FG001|Overall Study|Death|0|||
23601485|NCT02260154|65929968|FG000|Overall Study|Screening failure|2|||
23601486|NCT02931396|65929969|FG000|Overall Study|Lost to Follow-up|3|||
23482153|NCT02616601|65509428|FG002|Overall Study|Death|0|||
23482154|NCT02616601|65509426|FG000|Overall Study|Lost to Follow-up|1|||
23482155|NCT02616601|65509427|FG001|Overall Study|Lost to Follow-up|0|||
23482156|NCT02616601|65509428|FG002|Overall Study|Lost to Follow-up|1|||
23482157|NCT02616601|65509426|FG000|Overall Study|Non-Compliance with Test Article|1|||
23482158|NCT02616601|65509427|FG001|Overall Study|Non-Compliance with Test Article|0|||
23601487|NCT02931396|65929970|FG001|Overall Study|Lost to Follow-up|0|||
23482159|NCT02616601|65509428|FG002|Overall Study|Non-Compliance with Test Article|1|||
23482160|NCT00331552|65509430|FG000|Period 3: Phase II|Neurological Symptoms|1|||
23482161|NCT00331552|65509431|FG001|Period 3: Phase II|Neurological Symptoms|0|||
23482162|NCT00331552|65509430|FG000|Period 3: Phase II|Severe Nausea|1|||
23482163|NCT00331552|65509431|FG001|Period 3: Phase II|Severe Nausea|0|||
23482164|NCT01465191|65509434|FG000|Overall Study|Protocol Violation|6|||
23601488|NCT02931396|65929969|FG000|Overall Study|Withdrawal by Subject|2|||
23482165|NCT01465191|65509435|FG001|Overall Study|Protocol Violation|3|||
23482166|NCT01465191|65509436|FG002|Overall Study|Protocol Violation|3|||
23482167|NCT01465191|65509434|FG000|Overall Study|Lost to Follow-up|3|||
23482168|NCT01465191|65509435|FG001|Overall Study|Lost to Follow-up|6|||
23482169|NCT01465191|65509436|FG002|Overall Study|Lost to Follow-up|4|||
23482170|NCT02661178|65509437|FG000|Part 1|Protocol Violation|1|||
23482171|NCT02661178|65509438|FG001|Part 1|Protocol Violation|0|||
23482172|NCT02661178|65509439|FG002|Part 1|Protocol Violation|0|||
23482173|NCT02661178|65509440|FG003|Part 1|Protocol Violation|0|||
23482174|NCT02661178|65509441|FG004|Part 1|Protocol Violation|0|||
23482175|NCT02661178|65509442|FG005|Part 1|Protocol Violation|0|||
23482176|NCT02661178|65509443|FG006|Part 1|Protocol Violation|0|||
23482177|NCT02661178|65509444|FG007|Part 1|Protocol Violation|0|||
23482178|NCT02661178|65509445|FG008|Part 1|Protocol Violation|0|||
23482179|NCT02661178|65509446|FG009|Part 1|Protocol Violation|0|||
23482180|NCT02661178|65509447|FG010|Part 1|Protocol Violation|0|||
23482181|NCT02661178|65509448|FG011|Part 1|Protocol Violation|0|||
23482182|NCT02661178|65509449|FG012|Part 1|Protocol Violation|0|||
23482183|NCT02661178|65509450|FG013|Part 1|Protocol Violation|0|||
23482184|NCT02661178|65509451|FG014|Part 1|Protocol Violation|0|||
23482185|NCT00323869|65509453|FG000|Overall Study|Death|1|||
23482186|NCT02093026|65509454|FG000|Overall Study|Adverse Event|26|||
23482187|NCT02093026|65509454|FG000|Overall Study|Death|10|||
23482188|NCT02093026|65509454|FG000|Overall Study|Other|157|||
23482189|NCT02232880|65509455|FG000|Overall Study|study stopped prior to randomization|1|||
23482190|NCT01625260|65509456|FG000|Overall Study|Adverse Event|3|||
23482191|NCT01625260|65509457|FG001|Overall Study|Adverse Event|0|||
23482192|NCT01625260|65509456|FG000|Overall Study|Study Terminated by Investigator|2|||
23482193|NCT01625260|65509457|FG001|Overall Study|Study Terminated by Investigator|0|||
23482194|NCT01625260|65509456|FG000|Overall Study|Disease Progression|2|||
23482195|NCT01625260|65509457|FG001|Overall Study|Disease Progression|0|||
23482196|NCT01625260|65509456|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
23482197|NCT01625260|65509457|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
23482198|NCT00586664|65509459|FG000|Overall Study|Withdrawal by Subject|3|||
23482199|NCT00586664|65509460|FG001|Overall Study|Withdrawal by Subject|7|||
23482200|NCT00586664|65509461|FG002|Overall Study|Withdrawal by Subject|1|||
23482201|NCT00586664|65509459|FG000|Overall Study|Exclusion criteria met|2|||
23482202|NCT00586664|65509460|FG001|Overall Study|Exclusion criteria met|0|||
23482203|NCT00586664|65509461|FG002|Overall Study|Exclusion criteria met|0|||
23482204|NCT00923364|65509462|FG000|Overall Study|Death|3|||
23482205|NCT00923364|65509463|FG001|Overall Study|Death|0|||
23482206|NCT00923364|65509462|FG000|Overall Study|Did not go to transplant|1|||
23482207|NCT00923364|65509463|FG001|Overall Study|Did not go to transplant|0|||
23482208|NCT01879579|65509464|FG000|Overall Study|Phone incompatible with texting platform|3|||
23482209|NCT01879579|65509465|FG001|Overall Study|Phone incompatible with texting platform|0|||
23482210|NCT01879579|65509464|FG000|Overall Study|Did not enroll in texting platform|1|||
23482211|NCT01879579|65509465|FG001|Overall Study|Did not enroll in texting platform|0|||
23482212|NCT01879579|65509464|FG000|Overall Study|Did not initiate insulin treatment|1|||
23482213|NCT01879579|65509465|FG001|Overall Study|Did not initiate insulin treatment|0|||
23482214|NCT01879579|65509464|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
23482215|NCT01879579|65509465|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
23482216|NCT01879579|65509464|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
23482217|NCT01879579|65509465|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
23482218|NCT00645788|65509468|FG000|Overall Study|Did not receive study drug|1|||
23482219|NCT00645788|65509469|FG001|Overall Study|Did not receive study drug|1|||
23482220|NCT00645788|65509470|FG002|Overall Study|Did not receive study drug|0|||
23482221|NCT00645788|65509471|FG003|Overall Study|Did not receive study drug|0|||
23601489|NCT02931396|65929970|FG001|Overall Study|Withdrawal by Subject|0|||
23601490|NCT01530334|65929972|FG000|Overall Study|Adverse Event|3|||
23601491|NCT01530334|65929972|FG000|Overall Study|unknown reason|1|||
23364625|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23482222|NCT00645788|65509468|FG000|Overall Study|Adverse Event|4|||
23482223|NCT00645788|65509469|FG001|Overall Study|Adverse Event|9|||
23482224|NCT00645788|65509470|FG002|Overall Study|Adverse Event|5|||
23482225|NCT00645788|65509471|FG003|Overall Study|Adverse Event|3|||
23482226|NCT00645788|65509468|FG000|Overall Study|Lost to Follow-up|1|||
23482227|NCT00645788|65509469|FG001|Overall Study|Lost to Follow-up|0|||
23482228|NCT00645788|65509470|FG002|Overall Study|Lost to Follow-up|0|||
23482229|NCT00645788|65509471|FG003|Overall Study|Lost to Follow-up|0|||
23482230|NCT00645788|65509468|FG000|Overall Study|Protocol Violation|1|||
23482231|NCT00645788|65509469|FG001|Overall Study|Protocol Violation|0|||
23482232|NCT00645788|65509470|FG002|Overall Study|Protocol Violation|2|||
23482233|NCT00645788|65509471|FG003|Overall Study|Protocol Violation|0|||
23482234|NCT00645788|65509468|FG000|Overall Study|Withdrawal by Subject|0|||
23482235|NCT00645788|65509469|FG001|Overall Study|Withdrawal by Subject|1|||
23482236|NCT00645788|65509470|FG002|Overall Study|Withdrawal by Subject|0|||
23482237|NCT00645788|65509471|FG003|Overall Study|Withdrawal by Subject|2|||
23659649|NCT03519867|66142332|FG002|Overall Study|Adverse Event|0|||
23364626|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364627|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364628|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364629|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364630|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364631|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364632|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364633|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364634|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364635|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364636|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364637|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
23364638|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364639|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364640|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364641|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364642|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364643|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364644|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364645|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364646|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364647|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364648|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364649|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364650|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364651|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23364652|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364653|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23364654|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364655|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23364656|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364657|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364658|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364659|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364660|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364661|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364662|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23601492|NCT01530334|65929972|FG000|Overall Study|Progressive disease|47|||
23659650|NCT03519867|66142333|FG003|Overall Study|Adverse Event|0|||
23659651|NCT03519867|66142334|FG004|Overall Study|Adverse Event|0|||
23364663|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364664|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364665|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364666|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364667|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
23364668|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364669|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364670|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
23364671|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364672|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364673|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364674|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364675|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364676|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364677|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364678|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364679|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364680|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364681|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364682|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
23364683|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23364684|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364685|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23364686|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364687|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364688|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364689|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364690|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364691|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364692|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364693|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364694|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364695|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364696|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364697|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
23364698|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364699|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364700|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364701|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364702|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364703|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364704|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23601493|NCT01185600|65929973|FG000|Overall Study|Adverse Event|1|||
23601494|NCT01185600|65929974|FG001|Overall Study|Adverse Event|1|||
23601495|NCT01185600|65929973|FG000|Overall Study|Death|0|||
23601496|NCT01185600|65929974|FG001|Overall Study|Death|1|||
23601497|NCT01185600|65929973|FG000|Overall Study|Lost to Follow-up|0|||
23601498|NCT01185600|65929974|FG001|Overall Study|Lost to Follow-up|5|||
23601499|NCT01185600|65929973|FG000|Overall Study|Physician Decision|29|||
23601500|NCT01185600|65929974|FG001|Overall Study|Physician Decision|35|||
23601501|NCT01185600|65929973|FG000|Overall Study|Withdrawal by Subject|1|||
23601502|NCT01185600|65929974|FG001|Overall Study|Withdrawal by Subject|1|||
23601503|NCT01185600|65929973|FG000|Overall Study|Hold by DSMB|1|||
23601504|NCT01185600|65929974|FG001|Overall Study|Hold by DSMB|2|||
23659652|NCT03519867|66142335|FG005|Overall Study|Adverse Event|0|||
23659653|NCT03519867|66142336|FG006|Overall Study|Adverse Event|0|||
23659654|NCT03519867|66142337|FG007|Overall Study|Adverse Event|0|||
23659655|NCT03519867|66142338|FG008|Overall Study|Adverse Event|0|||
23659656|NCT03519867|66142339|FG009|Overall Study|Adverse Event|0|||
23659657|NCT03519867|66142330|FG000|Overall Study|Protocol Violation|0|||
23659658|NCT03519867|66142331|FG001|Overall Study|Protocol Violation|0|||
23659659|NCT03519867|66142332|FG002|Overall Study|Protocol Violation|0|||
23364705|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364706|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364707|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23601505|NCT02538900|65929975|FG000|Overall Study|Death|2|||
23601506|NCT02538900|65929976|FG001|Overall Study|Death|2|||
23601507|NCT02538900|65929977|FG002|Overall Study|Death|2|||
23659660|NCT03519867|66142333|FG003|Overall Study|Protocol Violation|0|||
23659661|NCT03519867|66142334|FG004|Overall Study|Protocol Violation|0|||
23659662|NCT03519867|66142335|FG005|Overall Study|Protocol Violation|1|||
23659663|NCT03519867|66142336|FG006|Overall Study|Protocol Violation|0|||
23659664|NCT03519867|66142337|FG007|Overall Study|Protocol Violation|0|||
23659665|NCT03519867|66142338|FG008|Overall Study|Protocol Violation|0|||
23659666|NCT03519867|66142339|FG009|Overall Study|Protocol Violation|0|||
23659667|NCT03519867|66142330|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659668|NCT03519867|66142331|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659669|NCT03519867|66142332|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659670|NCT03519867|66142333|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659671|NCT03519867|66142334|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659672|NCT03519867|66142335|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659673|NCT03519867|66142336|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
23659674|NCT03519867|66142337|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659675|NCT03519867|66142338|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659676|NCT03519867|66142339|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23659677|NCT03519867|66142330|FG000|Overall Study|Admin. of other reversal agent|1|||
23659678|NCT03519867|66142331|FG001|Overall Study|Admin. of other reversal agent|1|||
23659679|NCT03519867|66142332|FG002|Overall Study|Admin. of other reversal agent|0|||
23659680|NCT03519867|66142333|FG003|Overall Study|Admin. of other reversal agent|0|||
23659681|NCT03519867|66142334|FG004|Overall Study|Admin. of other reversal agent|0|||
23659682|NCT03519867|66142335|FG005|Overall Study|Admin. of other reversal agent|1|||
23659683|NCT03519867|66142336|FG006|Overall Study|Admin. of other reversal agent|0|||
23659684|NCT03519867|66142337|FG007|Overall Study|Admin. of other reversal agent|0|||
23364708|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364709|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364710|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364711|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364712|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364713|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
23659685|NCT03519867|66142338|FG008|Overall Study|Admin. of other reversal agent|0|||
23659686|NCT03519867|66142339|FG009|Overall Study|Admin. of other reversal agent|0|||
23659687|NCT03519867|66142330|FG000|Overall Study|Reason not provided|1|||
23659688|NCT03519867|66142331|FG001|Overall Study|Reason not provided|1|||
23659689|NCT03519867|66142332|FG002|Overall Study|Reason not provided|1|||
23659690|NCT03519867|66142333|FG003|Overall Study|Reason not provided|1|||
23659691|NCT03519867|66142334|FG004|Overall Study|Reason not provided|0|||
23659692|NCT03519867|66142335|FG005|Overall Study|Reason not provided|1|||
23659693|NCT03519867|66142336|FG006|Overall Study|Reason not provided|0|||
23659694|NCT03519867|66142337|FG007|Overall Study|Reason not provided|1|||
23659695|NCT03519867|66142338|FG008|Overall Study|Reason not provided|1|||
23659696|NCT03519867|66142339|FG009|Overall Study|Reason not provided|0|||
23659697|NCT00909181|66142343|FG000|Overall Study|Lost to Follow-up|39|||
23659698|NCT00909181|66142344|FG001|Overall Study|Lost to Follow-up|18|||
23659699|NCT00909181|66142345|FG002|Overall Study|Lost to Follow-up|33|||
23659700|NCT00711425|66142346|FG000|Overall Study|Protocol Violation|1|||
23659701|NCT00711425|66142346|FG000|Overall Study|Death|2|||
23659702|NCT00711425|66142346|FG000|Overall Study|Lost to Follow-up|1|||
23659703|NCT00729378|66142347|FG000|Baseline|Did not complete study measurements|72|||
23659704|NCT00729378|66142348|FG001|Baseline|Did not complete study measurements|33|||
23659705|NCT00729378|66142347|FG000|Baseline|Withdrawal by Subject|66|||
23659706|NCT00729378|66142348|FG001|Baseline|Withdrawal by Subject|59|||
23659707|NCT00729378|66142347|FG000|12-months|Lost to Follow-up|100|||
23659708|NCT00729378|66142348|FG001|12-months|Lost to Follow-up|65|||
23364714|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364715|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364716|NCT00917124|65081200|FG000|Overall Study|Protocol Violation|4|||
23364717|NCT00917124|65081201|FG001|Overall Study|Protocol Violation|6|||
23364718|NCT03101150|65081202|FG000|Overall Study|Lost to Follow-up|2|||
23364719|NCT03101150|65081203|FG001|Overall Study|Lost to Follow-up|4|||
23364720|NCT03101150|65081202|FG000|Overall Study|Miscarriage|3|||
23364721|NCT03101150|65081203|FG001|Overall Study|Miscarriage|6|||
23364722|NCT03589807|65081210|FG000|Overall Study|Lost to Follow-up|0|||
23364723|NCT03589807|65081211|FG001|Overall Study|Lost to Follow-up|2|||
23364724|NCT03589807|65081212|FG002|Overall Study|Lost to Follow-up|2|||
23364725|NCT03589807|65081213|FG003|Overall Study|Lost to Follow-up|3|||
23659709|NCT00729378|66142347|FG000|24-months|Lost to Follow-up|72|||
23659710|NCT00729378|66142348|FG001|24-months|Lost to Follow-up|51|||
23659711|NCT00729378|66142347|FG000|36-months|Lost to Follow-up|15|||
23659712|NCT00729378|66142348|FG001|36-months|Lost to Follow-up|6|||
23659713|NCT01809132|66142349|FG000|Overall Study|Withdrawal by Subject|0|||
23705651|NCT01234402|66297586|FG002|Overall Study|Lost to Follow-up|3|||
23601508|NCT02538900|65929975|FG000|Overall Study|Withdrawal by Subject|18|||
23364726|NCT03589807|65081214|FG004|Overall Study|Lost to Follow-up|1|||
23364727|NCT03589807|65081215|FG005|Overall Study|Lost to Follow-up|1|||
23364728|NCT03589807|65081210|FG000|Overall Study|Withdrawal by Subject|0|||
23659714|NCT01809132|66142350|FG001|Overall Study|Withdrawal by Subject|0|||
23659715|NCT01809132|66142351|FG002|Overall Study|Withdrawal by Subject|1|||
23659716|NCT01873417|66142352|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
23659717|NCT01873417|66142352|FG000|Overall Study|Adverse Event|24|||
23659718|NCT01873417|66142352|FG000|Overall Study|Lost to Follow-up|2|||
23659719|NCT01873417|66142352|FG000|Overall Study|Withdrawal by Subject|2|||
23659720|NCT01873417|66142352|FG000|Overall Study|Physician Decision|3|||
23659721|NCT02873936|66142354|FG000|Overall Study|Withdrew Consent|4|||
23659722|NCT02873936|66142355|FG001|Overall Study|Withdrew Consent|11|||
23659723|NCT02873936|66142356|FG002|Overall Study|Withdrew Consent|20|||
23659724|NCT02873936|66142354|FG000|Overall Study|Investigator's Discretion|3|||
23659725|NCT02873936|66142355|FG001|Overall Study|Investigator's Discretion|5|||
23659726|NCT02873936|66142356|FG002|Overall Study|Investigator's Discretion|4|||
23659727|NCT02873936|66142354|FG000|Overall Study|Adverse Event|3|||
23659728|NCT02873936|66142355|FG001|Overall Study|Adverse Event|5|||
23659729|NCT02873936|66142356|FG002|Overall Study|Adverse Event|3|||
23659730|NCT02873936|66142354|FG000|Overall Study|Protocol Violation|0|||
23659731|NCT02873936|66142355|FG001|Overall Study|Protocol Violation|1|||
23364729|NCT03589807|65081211|FG001|Overall Study|Withdrawal by Subject|5|||
23364730|NCT03589807|65081212|FG002|Overall Study|Withdrawal by Subject|0|||
23364731|NCT03589807|65081213|FG003|Overall Study|Withdrawal by Subject|0|||
23364732|NCT03589807|65081214|FG004|Overall Study|Withdrawal by Subject|0|||
23364733|NCT03589807|65081215|FG005|Overall Study|Withdrawal by Subject|0|||
23364734|NCT03589807|65081210|FG000|Overall Study|Protocol Violation|0|||
23364735|NCT03589807|65081211|FG001|Overall Study|Protocol Violation|0|||
23364736|NCT03589807|65081212|FG002|Overall Study|Protocol Violation|0|||
23364737|NCT03589807|65081213|FG003|Overall Study|Protocol Violation|1|||
23364738|NCT03589807|65081214|FG004|Overall Study|Protocol Violation|0|||
23364739|NCT03589807|65081215|FG005|Overall Study|Protocol Violation|0|||
23364740|NCT03589807|65081210|FG000|Overall Study|Enrolled but treatment not administered|0|||
23364741|NCT03589807|65081211|FG001|Overall Study|Enrolled but treatment not administered|0|||
23364742|NCT03589807|65081212|FG002|Overall Study|Enrolled but treatment not administered|0|||
23601509|NCT02538900|65929976|FG001|Overall Study|Withdrawal by Subject|16|||
23601510|NCT02538900|65929977|FG002|Overall Study|Withdrawal by Subject|15|||
23601511|NCT00380250|65933777|FG000|Overall Study|Withdrawal by Subject|39|||
23601512|NCT00380250|65933778|FG001|Overall Study|Withdrawal by Subject|28|||
23601513|NCT00380250|65933777|FG000|Overall Study|Adverse Event|20|||
23601514|NCT00380250|65933778|FG001|Overall Study|Adverse Event|9|||
23659732|NCT02873936|66142356|FG002|Overall Study|Protocol Violation|3|||
23659733|NCT02873936|66142354|FG000|Overall Study|Lost to Follow-up|1|||
23659734|NCT02873936|66142355|FG001|Overall Study|Lost to Follow-up|1|||
23659735|NCT02873936|66142356|FG002|Overall Study|Lost to Follow-up|1|||
23659736|NCT02873936|66142354|FG000|Overall Study|Non-compliance With Study Drug|1|||
23659737|NCT02873936|66142355|FG001|Overall Study|Non-compliance With Study Drug|0|||
23659738|NCT02873936|66142356|FG002|Overall Study|Non-compliance With Study Drug|1|||
23659739|NCT02873936|66142354|FG000|Overall Study|Randomized but not Dosed|1|||
23659740|NCT02873936|66142355|FG001|Overall Study|Randomized but not Dosed|0|||
23659741|NCT02873936|66142356|FG002|Overall Study|Randomized but not Dosed|0|||
23659742|NCT00362414|66142358|FG000|Overall Study|Death|2|||
23659743|NCT00362414|66142358|FG000|Overall Study|Adverse Event|1|||
23659744|NCT03422172|66142359|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
23659745|NCT03422172|66142359|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
23601515|NCT00380250|65933777|FG000|Overall Study|Lack of Efficacy|10|||
23601516|NCT00380250|65933778|FG001|Overall Study|Lack of Efficacy|8|||
23601517|NCT00380250|65933777|FG000|Overall Study|Protocol Violation|15|||
23659746|NCT03422172|66142359|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
23659747|NCT02462928|66142360|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23659748|NCT02462928|66142361|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23659749|NCT02462928|66142362|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
23659750|NCT02462928|66142360|FG000|Overall Study|Adverse Event|47|||
23659751|NCT02462928|66142361|FG001|Overall Study|Adverse Event|51|||
23364743|NCT03589807|65081213|FG003|Overall Study|Enrolled but treatment not administered|0|||
23601518|NCT00380250|65933778|FG001|Overall Study|Protocol Violation|5|||
23601519|NCT00380250|65933777|FG000|Overall Study|Lost to Follow-up|14|||
23364744|NCT03589807|65081214|FG004|Overall Study|Enrolled but treatment not administered|1|||
23364745|NCT03589807|65081215|FG005|Overall Study|Enrolled but treatment not administered|0|||
23364746|NCT00627497|65081217|FG000|Overall Study|Lost to Follow-up|1|||
23364747|NCT00627497|65081218|FG001|Overall Study|Lost to Follow-up|1|||
23364748|NCT00627497|65081219|FG002|Overall Study|Lost to Follow-up|0|||
23364749|NCT00627497|65081220|FG003|Overall Study|Lost to Follow-up|0|||
23364750|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
23364751|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
23364752|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
23364753|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
23364754|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
23364755|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
23364756|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
23364757|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
23364758|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
23364759|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
23364760|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
23364761|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
23364762|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
23364763|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
23364764|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
23364765|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
23601520|NCT00380250|65933778|FG001|Overall Study|Lost to Follow-up|5|||
23364766|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
23364767|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
23364768|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Other|1|||
23364769|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Other|0|||
23364770|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Other|1|||
23364771|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
23364772|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
23364773|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
23364774|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
23364775|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
23364776|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
23364777|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
23364778|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
23364779|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
23364780|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
23364781|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
23364782|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
23364783|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
23601521|NCT00380250|65933777|FG000|Overall Study|Physician Decision|1|||
23364784|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
23364785|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
23364786|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
23364787|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
23364788|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
23364789|NCT04396626|65081224|FG000|Overall Study|Premature termination of study|975|||
23364790|NCT00689338|65081230|FG000|Overall Study|Death|65|||
23364791|NCT00689338|65081230|FG000|Overall Study|Adverse Event|13|||
23364792|NCT00689338|65081230|FG000|Overall Study|Insufficient Clinical Response|1|||
23364793|NCT00689338|65081230|FG000|Overall Study|Lack of Efficacy|6|||
23364794|NCT00689338|65081230|FG000|Overall Study|Other|8|||
23364795|NCT00689338|65081230|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
23364796|NCT00689338|65081230|FG000|Overall Study|Lost to Follow-up|5|||
23364797|NCT00689338|65081230|FG000|Overall Study|Withdrawal by Subject|3|||
23364798|NCT00689338|65081230|FG000|Overall Study|Protocol Violation|15|||
23364799|NCT03177148|65081231|FG000|Overall Study|Lost to Follow-up|50|||
23364800|NCT03177148|65081232|FG001|Overall Study|Lost to Follow-up|1|||
23364801|NCT03177148|65081231|FG000|Overall Study|Death|1|||
23364802|NCT03177148|65081232|FG001|Overall Study|Death|0|||
23364803|NCT05133323|65081233|FG000|Overall Study|Lack of Efficacy|0|||
23364804|NCT05133323|65081234|FG001|Overall Study|Lack of Efficacy|0|||
23364805|NCT05133323|65081235|FG002|Overall Study|Lack of Efficacy|1|||
23364806|NCT05133323|65081233|FG000|Overall Study|Withdrawal by Subject|2|||
23364807|NCT05133323|65081234|FG001|Overall Study|Withdrawal by Subject|1|||
23364808|NCT05133323|65081235|FG002|Overall Study|Withdrawal by Subject|0|||
23364809|NCT01519817|65081237|FG000|Overall Study|Withdrawal by Subject|1|||
23364810|NCT01519817|65081238|FG001|Overall Study|Withdrawal by Subject|0|||
23364811|NCT01519817|65081239|FG002|Overall Study|Withdrawal by Subject|0|||
23364812|NCT01519817|65081240|FG003|Overall Study|Withdrawal by Subject|0|||
23364813|NCT01519817|65081237|FG000|Overall Study|Off study due to infection|0|||
23364814|NCT01519817|65081238|FG001|Overall Study|Off study due to infection|0|||
23364815|NCT01519817|65081239|FG002|Overall Study|Off study due to infection|0|||
23364816|NCT01519817|65081240|FG003|Overall Study|Off study due to infection|1|||
23364817|NCT00237692|65081241|FG000|Overall Study|Lost to Follow-up|9|||
23364818|NCT00237692|65081242|FG001|Overall Study|Lost to Follow-up|3|||
23364819|NCT00237692|65081243|FG002|Overall Study|Lost to Follow-up|5|||
23364820|NCT00237692|65081244|FG003|Overall Study|Lost to Follow-up|3|||
23364821|NCT00237692|65081241|FG000|Overall Study|Death|1|||
23364822|NCT00237692|65081242|FG001|Overall Study|Death|2|||
23364823|NCT00237692|65081243|FG002|Overall Study|Death|2|||
23364824|NCT00237692|65081244|FG003|Overall Study|Death|3|||
23364825|NCT00237692|65081241|FG000|Overall Study|Excluded - did not meet criteria|4|||
23364826|NCT00237692|65081242|FG001|Overall Study|Excluded - did not meet criteria|3|||
23364827|NCT00237692|65081243|FG002|Overall Study|Excluded - did not meet criteria|5|||
23364828|NCT00237692|65081244|FG003|Overall Study|Excluded - did not meet criteria|9|||
23364829|NCT00237692|65081241|FG000|Overall Study|Withdrawal by Subject|4|||
23364830|NCT00237692|65081242|FG001|Overall Study|Withdrawal by Subject|6|||
23364831|NCT00237692|65081243|FG002|Overall Study|Withdrawal by Subject|10|||
23364832|NCT00237692|65081244|FG003|Overall Study|Withdrawal by Subject|4|||
23364833|NCT02417753|65081250|FG000|Overall Study|Death|1|||
23364834|NCT01819727|65081253|FG000|Overall Study|Adverse Event|8|||
23364835|NCT01819727|65081254|FG001|Overall Study|Adverse Event|9|||
23364836|NCT01819727|65081253|FG000|Overall Study|Death|1|||
23364837|NCT01819727|65081254|FG001|Overall Study|Death|0|||
23364838|NCT01819727|65081253|FG000|Overall Study|Lost to Follow-up|1|||
23364839|NCT01819727|65081254|FG001|Overall Study|Lost to Follow-up|1|||
23364840|NCT01819727|65081253|FG000|Overall Study|Physician Decision|3|||
23364841|NCT01819727|65081254|FG001|Overall Study|Physician Decision|2|||
23364842|NCT01819727|65081253|FG000|Overall Study|Pregnancy|1|||
23364843|NCT01819727|65081254|FG001|Overall Study|Pregnancy|0|||
23364844|NCT01819727|65081253|FG000|Overall Study|Protocol Violation|0|||
23364845|NCT01819727|65081254|FG001|Overall Study|Protocol Violation|2|||
23364846|NCT01819727|65081253|FG000|Overall Study|Study Terminated by Sponsor|0|||
23364847|NCT01819727|65081254|FG001|Overall Study|Study Terminated by Sponsor|1|||
23364848|NCT01819727|65081253|FG000|Overall Study|Withdrawal by Subject|6|||
23482238|NCT00645788|65509468|FG000|Overall Study|Pulmonary exacerbation|13|||
23364849|NCT01819727|65081254|FG001|Overall Study|Withdrawal by Subject|11|||
23482239|NCT00645788|65509469|FG001|Overall Study|Pulmonary exacerbation|16|||
23482240|NCT00645788|65509470|FG002|Overall Study|Pulmonary exacerbation|11|||
23364850|NCT01819727|65081253|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
23364851|NCT01819727|65081254|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
23364852|NCT01819727|65081253|FG000|Overall Study|Quit due to lack of health benifits|0|||
23659752|NCT02462928|66142362|FG002|Overall Study|Adverse Event|25|||
23364853|NCT01819727|65081254|FG001|Overall Study|Quit due to lack of health benifits|1|||
23364854|NCT02782741|65081255|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
23364855|NCT02782741|65081256|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
23364856|NCT02782741|65081257|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
23364857|NCT02782741|65081255|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
23364858|NCT02782741|65081256|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
23364859|NCT02782741|65081257|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
23364860|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
23364861|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
23364862|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
23364863|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
23364864|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
23364865|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
23364866|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
23364867|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
23364868|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
23364869|NCT00970489|65081258|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
23364870|NCT00970489|65081259|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
23482241|NCT00645788|65509471|FG003|Overall Study|Pulmonary exacerbation|9|||
23482242|NCT04054947|65509472|FG000|Overall Study|Withdrawal by Subject|1|||
23482243|NCT04054947|65509473|FG001|Overall Study|Withdrawal by Subject|0|||
23482244|NCT04054947|65509472|FG000|Overall Study|Lost to Follow-up|2|||
23482245|NCT04054947|65509473|FG001|Overall Study|Lost to Follow-up|5|||
23482246|NCT04761627|65509474|FG000|Run-in Period|Death|1|||
23482247|NCT04761627|65509475|FG001|Run-in Period|Death|0|||
23482248|NCT04761627|65509476|FG002|Run-in Period|Death|0|||
23482249|NCT04761627|65509474|FG000|Run-in Period|Required alternative therapy|2|||
23482250|NCT04761627|65509475|FG001|Run-in Period|Required alternative therapy|0|||
23482251|NCT04761627|65509476|FG002|Run-in Period|Required alternative therapy|0|||
23482252|NCT04761627|65509474|FG000|Run-in Period|Lost to Follow-up|2|||
23482253|NCT04761627|65509475|FG001|Run-in Period|Lost to Follow-up|0|||
23482254|NCT04761627|65509476|FG002|Run-in Period|Lost to Follow-up|0|||
23482255|NCT04761627|65509474|FG000|Run-in Period|Protocol Violation|3|||
23482256|NCT04761627|65509475|FG001|Run-in Period|Protocol Violation|0|||
23482257|NCT04761627|65509476|FG002|Run-in Period|Protocol Violation|0|||
23482258|NCT04761627|65509474|FG000|Run-in Period|Abnormal liver function|1|||
23482259|NCT04761627|65509475|FG001|Run-in Period|Abnormal liver function|0|||
23482260|NCT04761627|65509476|FG002|Run-in Period|Abnormal liver function|0|||
23482261|NCT04761627|65509474|FG000|Run-in Period|Adverse Event|6|||
23482262|NCT04761627|65509475|FG001|Run-in Period|Adverse Event|0|||
23482263|NCT04761627|65509476|FG002|Run-in Period|Adverse Event|0|||
23482264|NCT04761627|65509474|FG000|Run-in Period|Withdrawal by Subject|7|||
23482265|NCT04761627|65509475|FG001|Run-in Period|Withdrawal by Subject|0|||
23482266|NCT04761627|65509476|FG002|Run-in Period|Withdrawal by Subject|0|||
23364871|NCT00398216|65081260|FG000|Overall Study|Adverse Event|4|||
23482267|NCT04761627|65509474|FG000|Run-in Period|Did not meet PASI 50|15|||
23482268|NCT04761627|65509475|FG001|Run-in Period|Did not meet PASI 50|0|||
23482269|NCT04761627|65509476|FG002|Run-in Period|Did not meet PASI 50|0|||
23482270|NCT04761627|65509474|FG000|Run-in Period|Study site closure|2|||
23482271|NCT04761627|65509475|FG001|Run-in Period|Study site closure|0|||
23482272|NCT04761627|65509476|FG002|Run-in Period|Study site closure|0|||
23482273|NCT04761627|65509474|FG000|Run-in Period|Pregnancy|2|||
23601522|NCT00380250|65933778|FG001|Overall Study|Physician Decision|0|||
23364872|NCT00398216|65081261|FG001|Overall Study|Adverse Event|2|||
23364873|NCT00398216|65081262|FG002|Overall Study|Adverse Event|5|||
23364874|NCT00398216|65081263|FG003|Overall Study|Adverse Event|7|||
23364875|NCT00398216|65081264|FG004|Overall Study|Adverse Event|2|||
23364876|NCT00398216|65081260|FG000|Overall Study|Protocol Violation|2|||
23364877|NCT00398216|65081261|FG001|Overall Study|Protocol Violation|4|||
23364878|NCT00398216|65081262|FG002|Overall Study|Protocol Violation|5|||
23364879|NCT00398216|65081263|FG003|Overall Study|Protocol Violation|7|||
23364880|NCT00398216|65081264|FG004|Overall Study|Protocol Violation|5|||
23364881|NCT00398216|65081260|FG000|Overall Study|Lost to Follow-up|1|||
23482274|NCT04761627|65509475|FG001|Run-in Period|Pregnancy|0|||
23364882|NCT00398216|65081261|FG001|Overall Study|Lost to Follow-up|6|||
23482275|NCT04761627|65509476|FG002|Run-in Period|Pregnancy|0|||
23482276|NCT04761627|65509474|FG000|Post-randomization Period|Military service|0|||
23364883|NCT00398216|65081262|FG002|Overall Study|Lost to Follow-up|4|||
23364884|NCT00398216|65081263|FG003|Overall Study|Lost to Follow-up|4|||
23482277|NCT04761627|65509475|FG001|Post-randomization Period|Military service|1|||
23364885|NCT00398216|65081264|FG004|Overall Study|Lost to Follow-up|1|||
23364886|NCT00398216|65081260|FG000|Overall Study|Death|0|||
23364887|NCT00398216|65081261|FG001|Overall Study|Death|3|||
23364888|NCT00398216|65081262|FG002|Overall Study|Death|0|||
23364889|NCT00398216|65081263|FG003|Overall Study|Death|0|||
23659753|NCT02462928|66142360|FG000|Overall Study|Lack of Efficacy|3|||
23659754|NCT02462928|66142361|FG001|Overall Study|Lack of Efficacy|8|||
23659755|NCT02462928|66142362|FG002|Overall Study|Lack of Efficacy|3|||
23659756|NCT02462928|66142360|FG000|Overall Study|Lost to Follow-up|4|||
23659757|NCT02462928|66142361|FG001|Overall Study|Lost to Follow-up|4|||
23659758|NCT02462928|66142362|FG002|Overall Study|Lost to Follow-up|1|||
23659759|NCT02462928|66142360|FG000|Overall Study|Withdrawal by Patient|31|||
23659760|NCT02462928|66142361|FG001|Overall Study|Withdrawal by Patient|21|||
23659761|NCT02462928|66142362|FG002|Overall Study|Withdrawal by Patient|21|||
23659762|NCT02462928|66142360|FG000|Overall Study|Protocol Violation|0|||
23659763|NCT02462928|66142361|FG001|Overall Study|Protocol Violation|1|||
23659764|NCT02462928|66142362|FG002|Overall Study|Protocol Violation|0|||
23659765|NCT02462928|66142360|FG000|Overall Study|Reason not Specified|4|||
23659766|NCT02462928|66142361|FG001|Overall Study|Reason not Specified|6|||
23659767|NCT02462928|66142362|FG002|Overall Study|Reason not Specified|5|||
23659768|NCT02448225|66142363|FG000|Overall Study|Withdrawal by Subject|1|||
23659769|NCT02448225|66142363|FG000|Overall Study|Did not get FSPG scan|18|||
23659770|NCT02448225|66142363|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
23659771|NCT03684642|66142370|FG000|Overall Study|Adverse Event|6|||
23659772|NCT03684642|66142371|FG001|Overall Study|Adverse Event|15|||
23659773|NCT03684642|66142372|FG002|Overall Study|Adverse Event|11|||
23659774|NCT03684642|66142370|FG000|Overall Study|Withdrawal by Subject|35|||
23659775|NCT03684642|66142371|FG001|Overall Study|Withdrawal by Subject|53|||
23659776|NCT03684642|66142372|FG002|Overall Study|Withdrawal by Subject|23|||
23659777|NCT03684642|66142370|FG000|Overall Study|Lack of Efficacy|0|||
23659778|NCT03684642|66142371|FG001|Overall Study|Lack of Efficacy|0|||
23659779|NCT03684642|66142372|FG002|Overall Study|Lack of Efficacy|1|||
23659780|NCT03684642|66142370|FG000|Overall Study|Poor compliance to protocol|0|||
23659781|NCT03684642|66142371|FG001|Overall Study|Poor compliance to protocol|4|||
23659782|NCT03684642|66142372|FG002|Overall Study|Poor compliance to protocol|1|||
23659783|NCT03684642|66142370|FG000|Overall Study|Other than specified|62|||
23659784|NCT03684642|66142371|FG001|Overall Study|Other than specified|60|||
23659785|NCT03684642|66142372|FG002|Overall Study|Other than specified|67|||
23659786|NCT03684642|66142370|FG000|Overall Study|Randomized and not treated|0|||
23659787|NCT03684642|66142371|FG001|Overall Study|Randomized and not treated|0|||
23659788|NCT03684642|66142372|FG002|Overall Study|Randomized and not treated|1|||
23659789|NCT03684642|66142370|FG000|Overall Study|Missing completion status but alive at last contact|0|||
23659790|NCT03684642|66142371|FG001|Overall Study|Missing completion status but alive at last contact|1|||
23364890|NCT00398216|65081264|FG004|Overall Study|Death|0|||
23364891|NCT00398216|65081260|FG000|Overall Study|Withdrawal by Subject|1|||
23659791|NCT03684642|66142372|FG002|Overall Study|Missing completion status but alive at last contact|2|||
23364892|NCT00398216|65081261|FG001|Overall Study|Withdrawal by Subject|0|||
23364893|NCT00398216|65081262|FG002|Overall Study|Withdrawal by Subject|3|||
23364894|NCT00398216|65081263|FG003|Overall Study|Withdrawal by Subject|1|||
23364895|NCT00398216|65081264|FG004|Overall Study|Withdrawal by Subject|2|||
23364896|NCT00398216|65081260|FG000|Overall Study|administrative reasons|3|||
23364897|NCT00398216|65081261|FG001|Overall Study|administrative reasons|4|||
23364898|NCT00398216|65081262|FG002|Overall Study|administrative reasons|4|||
23364899|NCT00398216|65081263|FG003|Overall Study|administrative reasons|3|||
23364900|NCT00398216|65081264|FG004|Overall Study|administrative reasons|3|||
23364901|NCT00398216|65081260|FG000|Overall Study|entrance criteria|0|||
23364902|NCT00398216|65081261|FG001|Overall Study|entrance criteria|0|||
23364903|NCT00398216|65081262|FG002|Overall Study|entrance criteria|0|||
23364904|NCT00398216|65081263|FG003|Overall Study|entrance criteria|0|||
23364905|NCT00398216|65081264|FG004|Overall Study|entrance criteria|2|||
23364906|NCT00929994|65081274|FG000|Overall Study|Withdrawal by Subject|1|||
23364907|NCT00929994|65081274|FG000|Overall Study|medical issue unrelated to intervention|4|||
23364908|NCT00929994|65081274|FG000|Overall Study|employment|1|||
23364909|NCT02896569|65081275|FG000|Overall Study|Lost to Follow-up|2|||
23364910|NCT02896569|65081276|FG001|Overall Study|Lost to Follow-up|1|||
23364911|NCT02896569|65081275|FG000|Overall Study|Physician Decision|1|||
23364912|NCT02896569|65081276|FG001|Overall Study|Physician Decision|3|||
23364913|NCT02896569|65081275|FG000|Overall Study|Adverse Event|0|||
23364914|NCT02896569|65081276|FG001|Overall Study|Adverse Event|1|||
23364915|NCT02896569|65081275|FG000|Overall Study|Withdrawal by Subject|1|||
23364916|NCT02896569|65081276|FG001|Overall Study|Withdrawal by Subject|0|||
23364917|NCT00289276|65081279|FG000|Second Part of FAST Study (Expansion)|Death|0|||
23364918|NCT00289276|65081280|FG001|Second Part of FAST Study (Expansion)|Death|2|||
23364919|NCT00289276|65081279|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
23364920|NCT00289276|65081280|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
23364921|NCT00698815|65081283|FG000|Overall Study|Death|1|||
23364922|NCT00698815|65081284|FG001|Overall Study|Death|2|||
23364923|NCT00698815|65081285|FG002|Overall Study|Death|4|||
23364924|NCT00698815|65081283|FG000|Overall Study|Withdrawal by Subject|6|||
23364925|NCT00698815|65081284|FG001|Overall Study|Withdrawal by Subject|3|||
23364926|NCT00698815|65081285|FG002|Overall Study|Withdrawal by Subject|2|||
23364927|NCT00698815|65081283|FG000|Overall Study|MD discretion|2|||
23364928|NCT00698815|65081284|FG001|Overall Study|MD discretion|7|||
23364929|NCT00698815|65081285|FG002|Overall Study|MD discretion|2|||
23364930|NCT00698815|65081283|FG000|Overall Study|Did not receive protocol treatment|1|||
23364931|NCT00698815|65081284|FG001|Overall Study|Did not receive protocol treatment|2|||
23364932|NCT00698815|65081285|FG002|Overall Study|Did not receive protocol treatment|2|||
23364933|NCT03478371|65081288|FG000|Overall Study|non-compliance|1|||
23364934|NCT03478371|65081288|FG000|Overall Study|Lost to Follow-up|4|||
23364935|NCT02419807|65081289|FG000|Overall Study|Withdrawal by Subject|4|||
23364936|NCT02419807|65081289|FG000|Overall Study|Physician Decision|1|||
23364937|NCT02419807|65081289|FG000|Overall Study|Protocol Violation|5|||
23364938|NCT01251952|65081290|FG000|Overall Study|Adverse Event|1|||
23364939|NCT00941304|65081291|FG000|Overall Study|Lost to Follow-up|1|||
23364940|NCT00941304|65081292|FG001|Overall Study|Lost to Follow-up|0|||
23364941|NCT00941304|65081293|FG002|Overall Study|Lost to Follow-up|0|||
23364942|NCT00941304|65081294|FG003|Overall Study|Lost to Follow-up|0|||
23364943|NCT00941304|65081295|FG004|Overall Study|Lost to Follow-up|0|||
23364944|NCT01704755|65081296|FG000|Overall Study|Adverse Event|4|||
23364945|NCT01704755|65081297|FG001|Overall Study|Adverse Event|1|||
23364946|NCT01704755|65081296|FG000|Overall Study|Lost to Follow-up|3|||
23364947|NCT01704755|65081297|FG001|Overall Study|Lost to Follow-up|4|||
23364948|NCT01704755|65081296|FG000|Overall Study|Withdrew consent|1|||
23364949|NCT01704755|65081297|FG001|Overall Study|Withdrew consent|1|||
23364950|NCT01704755|65081296|FG000|Overall Study|Other (not specified)|3|||
23364951|NCT01704755|65081297|FG001|Overall Study|Other (not specified)|1|||
23364952|NCT01704755|65081296|FG000|Overall Study|Withdrew consent and personal issues|1|||
23364953|NCT01704755|65081297|FG001|Overall Study|Withdrew consent and personal issues|0|||
23364954|NCT02155699|65081298|FG000|Overall Study|Withdrawal by Subject|0|||
23364955|NCT02155699|65081299|FG001|Overall Study|Withdrawal by Subject|3|||
23364956|NCT02155699|65081300|FG002|Overall Study|Withdrawal by Subject|6|||
23364957|NCT02155699|65081301|FG003|Overall Study|Withdrawal by Subject|1|||
23364958|NCT02155699|65081298|FG000|Overall Study|Lost to Follow-up|0|||
23364959|NCT02155699|65081299|FG001|Overall Study|Lost to Follow-up|0|||
23364960|NCT02155699|65081300|FG002|Overall Study|Lost to Follow-up|0|||
23364961|NCT02155699|65081301|FG003|Overall Study|Lost to Follow-up|3|||
23659792|NCT02739620|66142388|FG000|Overall Study|Lost to Follow-up|3|||
23364962|NCT02155699|65081298|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
23364963|NCT02155699|65081299|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
23364964|NCT02155699|65081300|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
23364965|NCT02155699|65081301|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
23364966|NCT01839916|65081302|FG000|Overall Study|Death|9|||
23364967|NCT01839916|65081302|FG000|Overall Study|Physician Decision|17|||
23364968|NCT01839916|65081302|FG000|Overall Study|Relapse|12|||
23364969|NCT01839916|65081302|FG000|Overall Study|GVHD|2|||
23364970|NCT01839916|65081302|FG000|Overall Study|Graft Failure|1|||
23364971|NCT00667563|65081303|FG000|Overall Study|Protocol Violation|24|||
23364972|NCT02810418|65081304|FG000|Arm A Dose Escalation|Adverse Event|2|||
23364973|NCT02810418|65081305|FG001|Arm A Dose Escalation|Adverse Event|1|||
23364974|NCT02810418|65081306|FG002|Arm A Dose Escalation|Adverse Event|0|||
23364975|NCT02810418|65081307|FG003|Arm A Dose Escalation|Adverse Event|0|||
23364976|NCT02810418|65081308|FG004|Arm A Dose Escalation|Adverse Event|0|||
23364977|NCT02810418|65081309|FG005|Arm A Dose Escalation|Adverse Event|0|||
23364978|NCT02810418|65081310|FG006|Arm A Dose Escalation|Adverse Event|0|||
23364979|NCT02810418|65081304|FG000|Dose Expansion|Adverse Event|0|||
23364980|NCT02810418|65081305|FG001|Dose Expansion|Adverse Event|1|||
23364981|NCT02810418|65081306|FG002|Dose Expansion|Adverse Event|1|||
23364982|NCT02810418|65081307|FG003|Dose Expansion|Adverse Event|0|||
23364983|NCT02810418|65081308|FG004|Dose Expansion|Adverse Event|0|||
23364984|NCT02810418|65081309|FG005|Dose Expansion|Adverse Event|0|||
23364985|NCT02810418|65081310|FG006|Dose Expansion|Adverse Event|0|||
23364986|NCT02810418|65081304|FG000|Dose Expansion|Physician Decision|0|||
23364987|NCT02810418|65081305|FG001|Dose Expansion|Physician Decision|0|||
23364988|NCT02810418|65081306|FG002|Dose Expansion|Physician Decision|2|||
23364989|NCT02810418|65081307|FG003|Dose Expansion|Physician Decision|0|||
23364990|NCT02810418|65081308|FG004|Dose Expansion|Physician Decision|0|||
23364991|NCT02810418|65081309|FG005|Dose Expansion|Physician Decision|0|||
23364992|NCT02810418|65081310|FG006|Dose Expansion|Physician Decision|0|||
23364993|NCT02810418|65081304|FG000|Arm B Dose Escalation|Adverse Event|0|||
23364994|NCT02810418|65081305|FG001|Arm B Dose Escalation|Adverse Event|0|||
23364995|NCT02810418|65081306|FG002|Arm B Dose Escalation|Adverse Event|0|||
23364996|NCT02810418|65081307|FG003|Arm B Dose Escalation|Adverse Event|0|||
23364997|NCT02810418|65081308|FG004|Arm B Dose Escalation|Adverse Event|1|||
23364998|NCT02810418|65081309|FG005|Arm B Dose Escalation|Adverse Event|2|||
23364999|NCT02810418|65081310|FG006|Arm B Dose Escalation|Adverse Event|0|||
23365000|NCT00919633|65081311|FG000|Overall Study|Adverse Event|1|||
23365001|NCT00919633|65081312|FG001|Overall Study|Adverse Event|9|||
23365002|NCT00919633|65081313|FG002|Overall Study|Adverse Event|12|||
23365003|NCT00919633|65081314|FG003|Overall Study|Adverse Event|10|||
23365004|NCT00919633|65081311|FG000|Overall Study|Death|0|||
23365005|NCT00919633|65081312|FG001|Overall Study|Death|0|||
23365006|NCT00919633|65081313|FG002|Overall Study|Death|2|||
23365007|NCT00919633|65081314|FG003|Overall Study|Death|0|||
23365008|NCT00919633|65081311|FG000|Overall Study|Lack of Efficacy|17|||
23365009|NCT00919633|65081312|FG001|Overall Study|Lack of Efficacy|3|||
23365010|NCT00919633|65081313|FG002|Overall Study|Lack of Efficacy|2|||
23365011|NCT00919633|65081314|FG003|Overall Study|Lack of Efficacy|3|||
23365012|NCT00919633|65081311|FG000|Overall Study|Withdrawal by Subject|1|||
23365013|NCT00919633|65081312|FG001|Overall Study|Withdrawal by Subject|2|||
23365014|NCT00919633|65081313|FG002|Overall Study|Withdrawal by Subject|4|||
23365015|NCT00919633|65081314|FG003|Overall Study|Withdrawal by Subject|3|||
23365016|NCT00919633|65081311|FG000|Overall Study|Lost to Follow-up|3|||
23365017|NCT00919633|65081312|FG001|Overall Study|Lost to Follow-up|1|||
23365018|NCT00919633|65081313|FG002|Overall Study|Lost to Follow-up|0|||
23365019|NCT00919633|65081314|FG003|Overall Study|Lost to Follow-up|2|||
23365020|NCT00919633|65081311|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
23365021|NCT00919633|65081312|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
23365022|NCT00919633|65081313|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
23365023|NCT00919633|65081314|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
23365024|NCT00919633|65081311|FG000|Overall Study|Protocol Violation|0|||
23365025|NCT00919633|65081312|FG001|Overall Study|Protocol Violation|0|||
23365026|NCT00919633|65081313|FG002|Overall Study|Protocol Violation|0|||
23365027|NCT00919633|65081314|FG003|Overall Study|Protocol Violation|1|||
23365028|NCT00919633|65081311|FG000|Overall Study|Physician Decision|0|||
23365029|NCT00919633|65081312|FG001|Overall Study|Physician Decision|0|||
23365030|NCT00919633|65081313|FG002|Overall Study|Physician Decision|0|||
23365031|NCT00919633|65081314|FG003|Overall Study|Physician Decision|1|||
23365032|NCT00919633|65081311|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
23365033|NCT00919633|65081312|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
23365034|NCT00919633|65081313|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
23365035|NCT00919633|65081314|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
23365036|NCT00919633|65081311|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
23365037|NCT00919633|65081312|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
23365038|NCT00919633|65081313|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
23659793|NCT02739620|66142389|FG001|Overall Study|Lost to Follow-up|1|||
23659794|NCT02739620|66142388|FG000|Overall Study|Adverse Event|0|||
23659795|NCT02739620|66142389|FG001|Overall Study|Adverse Event|1|||
23659796|NCT02252536|66142391|FG000|Overall Study|Lost to Follow-up|5|||
23659797|NCT02252536|66142392|FG001|Overall Study|Lost to Follow-up|3|||
23659798|NCT00962390|66142393|FG000|Overall Study|Adverse Event|0|||
23659799|NCT00962390|66142394|FG001|Overall Study|Adverse Event|0|||
23659800|NCT00962390|66142395|FG002|Overall Study|Adverse Event|3|||
23659801|NCT00962390|66142396|FG003|Overall Study|Adverse Event|1|||
23659802|NCT00962390|66142393|FG000|Overall Study|Lost to Follow-up|2|||
23659803|NCT00962390|66142394|FG001|Overall Study|Lost to Follow-up|2|||
23659804|NCT00962390|66142395|FG002|Overall Study|Lost to Follow-up|0|||
23659805|NCT00962390|66142396|FG003|Overall Study|Lost to Follow-up|0|||
23659806|NCT00962390|66142393|FG000|Overall Study|Protocol Violation|1|||
23659807|NCT00962390|66142394|FG001|Overall Study|Protocol Violation|0|||
23659808|NCT00962390|66142395|FG002|Overall Study|Protocol Violation|0|||
23659809|NCT00962390|66142396|FG003|Overall Study|Protocol Violation|0|||
23659810|NCT00962390|66142393|FG000|Overall Study|Withdrawal by Subject|1|||
23659811|NCT00962390|66142394|FG001|Overall Study|Withdrawal by Subject|1|||
23659812|NCT00962390|66142395|FG002|Overall Study|Withdrawal by Subject|1|||
23659813|NCT00962390|66142396|FG003|Overall Study|Withdrawal by Subject|0|||
23659814|NCT03945591|66142397|FG000|Overall Study|Participant not transplanted|1|||
23659815|NCT03945591|66142397|FG000|Overall Study|Change in treatment plan|3|||
23659816|NCT03945591|66142397|FG000|Overall Study|Adverse Event|1|||
23659817|NCT00388505|66142399|FG000|Overall Study|Adverse Event or Death|43|||
23659818|NCT00388505|66142400|FG001|Overall Study|Adverse Event or Death|17|||
23659819|NCT00388505|66142399|FG000|Overall Study|Withdrawal by Subject|24|||
23659820|NCT00388505|66142400|FG001|Overall Study|Withdrawal by Subject|9|||
23659821|NCT00388505|66142399|FG000|Overall Study|Lost to Follow-up|5|||
23365039|NCT00919633|65081314|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
23365040|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365041|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365042|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365043|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365044|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365045|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
23365046|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Refused|0|||
23365047|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Refused|0|||
23365048|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Refused|0|||
23365049|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Refused|0|||
23365050|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Refused|1|||
23482278|NCT04761627|65509476|FG002|Post-randomization Period|Military service|0|||
23482279|NCT04761627|65509474|FG000|Post-randomization Period|Adverse Event|0|||
23482280|NCT04761627|65509475|FG001|Post-randomization Period|Adverse Event|4|||
23659822|NCT00388505|66142400|FG001|Overall Study|Lost to Follow-up|3|||
23659823|NCT00388505|66142399|FG000|Overall Study|Inappropriate Enrollment|0|||
23659824|NCT00388505|66142400|FG001|Overall Study|Inappropriate Enrollment|1|||
23659825|NCT00388505|66142399|FG000|Overall Study|Administrative Reason|1|||
23659826|NCT00388505|66142400|FG001|Overall Study|Administrative Reason|0|||
23659827|NCT00388505|66142399|FG000|Overall Study|Protocol Violation|6|||
23659828|NCT00388505|66142400|FG001|Overall Study|Protocol Violation|5|||
23659829|NCT00388505|66142399|FG000|Overall Study|Unable to classify|4|||
23659830|NCT00388505|66142400|FG001|Overall Study|Unable to classify|3|||
23659831|NCT02090413|66142401|FG000|Overall Study|Adverse Event|11|||
23659832|NCT02090413|66142402|FG001|Overall Study|Adverse Event|15|||
23482281|NCT04761627|65509476|FG002|Post-randomization Period|Adverse Event|2|||
23482282|NCT04761627|65509474|FG000|Post-randomization Period|Lost to Follow-up|0|||
23659833|NCT02090413|66142403|FG002|Overall Study|Adverse Event|20|||
23659834|NCT02090413|66142401|FG000|Overall Study|Flushing event|2|||
23659835|NCT02090413|66142402|FG001|Overall Study|Flushing event|0|||
23365051|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Refused|0|||
23365052|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365053|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
23365054|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365055|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365056|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365057|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365058|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Death|0|||
23365059|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Death|0|||
23365060|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Death|0|||
23365061|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Death|0|||
23365062|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Death|1|||
23365063|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Death|0|||
23365064|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365065|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365066|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365067|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365068|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365069|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
23365070|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365071|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365072|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365073|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365074|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365075|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365076|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
23365077|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365078|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365079|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
23365080|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365081|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
23365082|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
23365083|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365084|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365085|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365086|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365087|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365088|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Death|1|||
23365089|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Death|0|||
23365090|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Death|1|||
23365091|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Death|1|||
23365092|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Death|1|||
23365093|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Death|0|||
23365094|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365095|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365096|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365097|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365098|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365099|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
23365100|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365101|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365102|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365103|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23601523|NCT02455557|65933779|FG000|Overall Study|Withdrawal by Subject|2|||
23601524|NCT01394276|65933780|FG000|Overall Study|Related Adverse event (AEs)|15|||
23601525|NCT01394276|65933780|FG000|Overall Study|Not related AEs|9|||
23601526|NCT01394276|65933780|FG000|Overall Study|Remission of disease|2|||
23365104|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365105|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365106|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
23365107|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
23365108|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365109|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365110|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365111|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365112|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365113|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365114|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365115|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365116|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365117|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365118|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365119|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365120|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365121|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
23365122|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
23365123|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365124|NCT03327324|65081315|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
23365125|NCT03327324|65081316|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365126|NCT03327324|65081317|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23482283|NCT04761627|65509475|FG001|Post-randomization Period|Lost to Follow-up|6|||
23482284|NCT04761627|65509476|FG002|Post-randomization Period|Lost to Follow-up|6|||
23365127|NCT03327324|65081318|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365128|NCT03327324|65081319|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365129|NCT03327324|65081320|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365130|NCT03327324|65081315|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
23365131|NCT03327324|65081316|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365132|NCT03327324|65081317|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365133|NCT03327324|65081318|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365134|NCT03327324|65081319|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365135|NCT03327324|65081320|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365136|NCT04794751|65081321|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
23365137|NCT04794751|65081322|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
23365138|NCT04794751|65081321|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
23365139|NCT04794751|65081322|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
23365140|NCT04794751|65081321|FG000|Period 1|Protocol Violation|0|||
23365141|NCT04794751|65081322|FG001|Period 1|Protocol Violation|2|||
23365142|NCT04794751|65081321|FG000|Period 1|Withdrawal by Subject|0|||
23365143|NCT04794751|65081322|FG001|Period 1|Withdrawal by Subject|1|||
23365144|NCT04794751|65081321|FG000|Period 2|Withdrawal by Subject|0|||
23365145|NCT04794751|65081322|FG001|Period 2|Withdrawal by Subject|1|||
23365146|NCT04794751|65081321|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
23365147|NCT04794751|65081322|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
23365148|NCT04794751|65081321|FG000|Period 2|Protocol Violation|1|||
23365149|NCT04794751|65081322|FG001|Period 2|Protocol Violation|0|||
23365150|NCT00956839|65081324|FG000|Overall Study|Lost to Follow-up|3|||
23365151|NCT00956839|65081325|FG001|Overall Study|Lost to Follow-up|0|||
23365152|NCT00956839|65081326|FG002|Overall Study|Lost to Follow-up|3|||
23365153|NCT00823134|65081327|FG000|Overall Study|Invalid measurement|1|||
23365154|NCT03139552|65081332|FG000|Overall Study|unable to attend tasting due to schedule|3|||
23365155|NCT01222104|65081333|FG000|Overall Study|Lost to Follow-up|37|||
23365156|NCT01222104|65081333|FG000|Overall Study|Death|10|||
23365157|NCT01747499|65084863|FG000|Overall Study|Steroid refractory aGvHD|1|||
23365158|NCT01747499|65084864|FG001|Overall Study|Steroid refractory aGvHD|0|||
23365159|NCT01747499|65084865|FG002|Overall Study|Steroid refractory aGvHD|0|||
23365160|NCT01747499|65084866|FG003|Overall Study|Steroid refractory aGvHD|1|||
23659836|NCT02090413|66142403|FG002|Overall Study|Flushing event|1|||
23659837|NCT02090413|66142401|FG000|Overall Study|Withdrawal by Subject|2|||
23365161|NCT01747499|65084867|FG004|Overall Study|Steroid refractory aGvHD|4|||
23365162|NCT01747499|65084863|FG000|Overall Study|Physician Decision|0|||
23365163|NCT01747499|65084864|FG001|Overall Study|Physician Decision|1|||
23365164|NCT01747499|65084865|FG002|Overall Study|Physician Decision|0|||
23365165|NCT01747499|65084866|FG003|Overall Study|Physician Decision|0|||
23365166|NCT01747499|65084867|FG004|Overall Study|Physician Decision|2|||
23365167|NCT01747499|65084863|FG000|Overall Study|Death|0|||
23365168|NCT01747499|65084864|FG001|Overall Study|Death|0|||
23365169|NCT01747499|65084865|FG002|Overall Study|Death|0|||
23365170|NCT01747499|65084866|FG003|Overall Study|Death|1|||
23365171|NCT01747499|65084867|FG004|Overall Study|Death|1|||
23365172|NCT01747499|65084863|FG000|Overall Study|Withdrawal by Subject|0|||
23365173|NCT01747499|65084864|FG001|Overall Study|Withdrawal by Subject|0|||
23365174|NCT01747499|65084865|FG002|Overall Study|Withdrawal by Subject|0|||
23365175|NCT01747499|65084866|FG003|Overall Study|Withdrawal by Subject|0|||
23365176|NCT01747499|65084867|FG004|Overall Study|Withdrawal by Subject|6|||
23365177|NCT01747499|65084863|FG000|Overall Study|Developed AML and death|0|||
23365178|NCT01747499|65084864|FG001|Overall Study|Developed AML and death|0|||
23365179|NCT01747499|65084865|FG002|Overall Study|Developed AML and death|0|||
23659838|NCT02090413|66142402|FG001|Overall Study|Withdrawal by Subject|2|||
23659839|NCT02090413|66142403|FG002|Overall Study|Withdrawal by Subject|2|||
23659840|NCT02090413|66142401|FG000|Overall Study|Investigator Decision|1|||
23659841|NCT02090413|66142402|FG001|Overall Study|Investigator Decision|1|||
23365180|NCT01747499|65084866|FG003|Overall Study|Developed AML and death|0|||
23365181|NCT01747499|65084867|FG004|Overall Study|Developed AML and death|1|||
23365182|NCT01747499|65084863|FG000|Overall Study|Determined not to be eligible|0|||
23365183|NCT01747499|65084864|FG001|Overall Study|Determined not to be eligible|0|||
23365184|NCT01747499|65084865|FG002|Overall Study|Determined not to be eligible|0|||
23659842|NCT02090413|66142403|FG002|Overall Study|Investigator Decision|0|||
23659843|NCT02090413|66142401|FG000|Overall Study|Other|2|||
23659844|NCT02090413|66142402|FG001|Overall Study|Other|1|||
23659845|NCT02090413|66142403|FG002|Overall Study|Other|0|||
23659846|NCT02090413|66142401|FG000|Overall Study|Lost to Follow-up|1|||
23659847|NCT02090413|66142402|FG001|Overall Study|Lost to Follow-up|1|||
23659848|NCT02090413|66142403|FG002|Overall Study|Lost to Follow-up|0|||
23659849|NCT01007032|66142406|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
23659850|NCT01007032|66142407|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
23659851|NCT01007032|66142408|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
23659852|NCT01007032|66142409|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
23659853|NCT01007032|66142406|FG000|Overall Study|Withdrawal by Subject|0|||
23659854|NCT01007032|66142407|FG001|Overall Study|Withdrawal by Subject|0|||
23659855|NCT01007032|66142408|FG002|Overall Study|Withdrawal by Subject|0|||
23659856|NCT01007032|66142409|FG003|Overall Study|Withdrawal by Subject|1|||
23659857|NCT02321930|66142410|FG000|Overall Study|Lost to Follow-up|1|||
23659858|NCT01506960|66142411|FG000|Overall Study|Did not meet angiographic criteria|47|||
23659859|NCT03520959|66142412|FG000|Overall Study|Study terminated by Sponsor|0|||
23659860|NCT03520959|66142413|FG001|Overall Study|Study terminated by Sponsor|1|||
23659861|NCT02729740|66142414|FG000|Overall Study|Early Termination|130|||
23659862|NCT02729740|66142414|FG000|Overall Study|Other|1|||
23365185|NCT01747499|65084866|FG003|Overall Study|Determined not to be eligible|0|||
23365186|NCT01747499|65084867|FG004|Overall Study|Determined not to be eligible|1|||
23365187|NCT00669318|65084873|FG000|Overall Study|Withdrawal by Subject|2|||
23365188|NCT00828113|65084874|FG000|Overall Study|Withdrawal by Subject|27|||
23365189|NCT00828113|65084875|FG001|Overall Study|Withdrawal by Subject|26|||
23365190|NCT00828113|65084874|FG000|Overall Study|Lost to Follow-up|3|||
23365191|NCT00828113|65084875|FG001|Overall Study|Lost to Follow-up|5|||
23659863|NCT02181816|66142419|FG000|Overall Study|Case Report Forms Uncollected|38|||
23659864|NCT02181816|66142419|FG000|Overall Study|Protocol Deviation|21|||
23659865|NCT00397033|66142420|FG000|Overall Study|Adverse Event|7|||
23659866|NCT00397033|66142421|FG001|Overall Study|Adverse Event|10|||
23659867|NCT00397033|66142422|FG002|Overall Study|Adverse Event|4|||
23659868|NCT00397033|66142420|FG000|Overall Study|Lack of Efficacy|22|||
23659869|NCT00397033|66142421|FG001|Overall Study|Lack of Efficacy|12|||
23659870|NCT00397033|66142422|FG002|Overall Study|Lack of Efficacy|9|||
23365192|NCT01214668|65084882|FG000|Overall Study|Adverse Event|0|||
23659871|NCT00397033|66142420|FG000|Overall Study|Lost to Follow-up|3|||
23659872|NCT00397033|66142421|FG001|Overall Study|Lost to Follow-up|3|||
23365193|NCT01214668|65084883|FG001|Overall Study|Adverse Event|1|||
23365194|NCT01214668|65084884|FG002|Overall Study|Adverse Event|0|||
23365195|NCT01214668|65084885|FG003|Overall Study|Adverse Event|2|||
23365196|NCT01214668|65084886|FG004|Overall Study|Adverse Event|1|||
23365197|NCT01214668|65084887|FG005|Overall Study|Adverse Event|1|||
23365198|NCT01214668|65084882|FG000|Overall Study|Death|0|||
23365199|NCT01214668|65084883|FG001|Overall Study|Death|0|||
23365200|NCT01214668|65084884|FG002|Overall Study|Death|1|||
23365201|NCT01214668|65084885|FG003|Overall Study|Death|0|||
23365202|NCT01214668|65084886|FG004|Overall Study|Death|0|||
23365203|NCT01214668|65084887|FG005|Overall Study|Death|0|||
23365204|NCT01214668|65084882|FG000|Overall Study|Progressive Disease|4|||
23365205|NCT01214668|65084883|FG001|Overall Study|Progressive Disease|2|||
23365206|NCT01214668|65084884|FG002|Overall Study|Progressive Disease|5|||
23365207|NCT01214668|65084885|FG003|Overall Study|Progressive Disease|4|||
23365208|NCT01214668|65084886|FG004|Overall Study|Progressive Disease|4|||
23365209|NCT01214668|65084887|FG005|Overall Study|Progressive Disease|5|||
23365210|NCT01214668|65084882|FG000|Overall Study|Withdrawal by Subject|0|||
23365211|NCT01214668|65084883|FG001|Overall Study|Withdrawal by Subject|0|||
23365212|NCT01214668|65084884|FG002|Overall Study|Withdrawal by Subject|0|||
23365213|NCT01214668|65084885|FG003|Overall Study|Withdrawal by Subject|0|||
23365214|NCT01214668|65084886|FG004|Overall Study|Withdrawal by Subject|1|||
23365215|NCT01214668|65084887|FG005|Overall Study|Withdrawal by Subject|0|||
23365216|NCT00377637|65084888|FG000|Induction Phase|Adverse Event|12|||
23365217|NCT00377637|65084889|FG001|Induction Phase|Adverse Event|21|||
23365218|NCT00377637|65084890|FG002|Induction Phase|Adverse Event|0|||
23659873|NCT00397033|66142422|FG002|Overall Study|Lost to Follow-up|3|||
23365219|NCT00377637|65084891|FG003|Induction Phase|Adverse Event|0|||
23365220|NCT00377637|65084888|FG000|Induction Phase|Deterioration/serum creatinine|2|||
23365221|NCT00377637|65084889|FG001|Induction Phase|Deterioration/serum creatinine|0|||
23365222|NCT00377637|65084890|FG002|Induction Phase|Deterioration/serum creatinine|0|||
23482285|NCT04761627|65509474|FG000|Post-randomization Period|Withdrawal by Subject|0|||
23482286|NCT04761627|65509475|FG001|Post-randomization Period|Withdrawal by Subject|7|||
23482287|NCT04761627|65509476|FG002|Post-randomization Period|Withdrawal by Subject|6|||
23482288|NCT04761627|65509474|FG000|Post-randomization Period|Pregnancy|0|||
23482289|NCT04761627|65509475|FG001|Post-randomization Period|Pregnancy|0|||
23659874|NCT00397033|66142420|FG000|Overall Study|Withdrawal by Subject|12|||
23659875|NCT00397033|66142421|FG001|Overall Study|Withdrawal by Subject|7|||
23659876|NCT00397033|66142422|FG002|Overall Study|Withdrawal by Subject|5|||
23659877|NCT00397033|66142420|FG000|Overall Study|Other|0|||
23659878|NCT00397033|66142421|FG001|Overall Study|Other|5|||
23659879|NCT00397033|66142422|FG002|Overall Study|Other|2|||
23659880|NCT02576444|66142423|FG000|Overall Study|Death|1|||
23659881|NCT02576444|66142424|FG001|Overall Study|Death|1|||
23659882|NCT02576444|66142425|FG002|Overall Study|Death|0|||
23482290|NCT04761627|65509476|FG002|Post-randomization Period|Pregnancy|1|||
23482291|NCT04761627|65509474|FG000|Post-randomization Period|Study site closure|0|||
23482292|NCT04761627|65509475|FG001|Post-randomization Period|Study site closure|0|||
23482293|NCT04761627|65509476|FG002|Post-randomization Period|Study site closure|1|||
23482294|NCT04761627|65509474|FG000|Post-randomization Period|Family planning|0|||
23482295|NCT04761627|65509475|FG001|Post-randomization Period|Family planning|1|||
23482296|NCT04761627|65509476|FG002|Post-randomization Period|Family planning|0|||
23482297|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
23482298|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
23482299|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
23659883|NCT02576444|66142426|FG003|Overall Study|Death|0|||
23659884|NCT02576444|66142423|FG000|Overall Study|Withdrawal by Subject|0|||
23659885|NCT02576444|66142424|FG001|Overall Study|Withdrawal by Subject|0|||
23365223|NCT00377637|65084891|FG003|Induction Phase|Deterioration/serum creatinine|0|||
23365224|NCT00377637|65084888|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365225|NCT00377637|65084889|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
23365226|NCT00377637|65084890|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365227|NCT00377637|65084891|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365228|NCT00377637|65084888|FG000|Induction Phase|Lost to Follow-up|2|||
23365229|NCT00377637|65084889|FG001|Induction Phase|Lost to Follow-up|1|||
23365230|NCT00377637|65084890|FG002|Induction Phase|Lost to Follow-up|0|||
23365231|NCT00377637|65084891|FG003|Induction Phase|Lost to Follow-up|0|||
23365232|NCT00377637|65084888|FG000|Induction Phase|Death|1|||
23659886|NCT02576444|66142425|FG002|Overall Study|Withdrawal by Subject|2|||
23659887|NCT02576444|66142426|FG003|Overall Study|Withdrawal by Subject|0|||
23659888|NCT02576444|66142423|FG000|Overall Study|Adverse Event|0|||
23659889|NCT02576444|66142424|FG001|Overall Study|Adverse Event|0|||
23659890|NCT02576444|66142425|FG002|Overall Study|Adverse Event|1|||
23365233|NCT00377637|65084889|FG001|Induction Phase|Death|3|||
23365234|NCT00377637|65084890|FG002|Induction Phase|Death|0|||
23365235|NCT00377637|65084891|FG003|Induction Phase|Death|0|||
23365236|NCT00377637|65084888|FG000|Induction Phase|Withdrawal by Subject|5|||
23365237|NCT00377637|65084889|FG001|Induction Phase|Withdrawal by Subject|6|||
23482300|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
23482301|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
23482302|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
23482303|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482304|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482305|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
23659891|NCT02576444|66142426|FG003|Overall Study|Adverse Event|0|||
23659892|NCT02576444|66142423|FG000|Overall Study|Physician Decision|0|||
23659893|NCT02576444|66142424|FG001|Overall Study|Physician Decision|0|||
23659894|NCT02576444|66142425|FG002|Overall Study|Physician Decision|1|||
23659895|NCT02576444|66142426|FG003|Overall Study|Physician Decision|0|||
23659896|NCT01353508|66142431|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23659897|NCT01353508|66142432|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23659898|NCT01353508|66142433|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23659899|NCT01353508|66142434|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
23659900|NCT01353508|66142431|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
23659901|NCT01353508|66142432|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23659902|NCT01353508|66142433|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23659903|NCT01353508|66142434|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23659904|NCT03710486|66142436|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
23659905|NCT03710486|66142437|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
23659906|NCT03710486|66142436|FG000|Overall Study|Missing|0|||
23482306|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
23659907|NCT03710486|66142437|FG001|Overall Study|Missing|2|||
23659908|NCT00763971|66142440|FG000|Overall Study|Adverse Event|5|||
23659909|NCT00763971|66142441|FG001|Overall Study|Adverse Event|2|||
23659910|NCT00763971|66142442|FG002|Overall Study|Adverse Event|4|||
23659911|NCT00763971|66142440|FG000|Overall Study|Protocol Violation|3|||
23659912|NCT00763971|66142441|FG001|Overall Study|Protocol Violation|3|||
23659913|NCT00763971|66142442|FG002|Overall Study|Protocol Violation|2|||
23659914|NCT00763971|66142440|FG000|Overall Study|Withdrawal by Subject|4|||
23659915|NCT00763971|66142441|FG001|Overall Study|Withdrawal by Subject|5|||
23659916|NCT00763971|66142442|FG002|Overall Study|Withdrawal by Subject|5|||
23482307|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23659917|NCT00763971|66142440|FG000|Overall Study|Lost to Follow-up|0|||
23659918|NCT00763971|66142441|FG001|Overall Study|Lost to Follow-up|1|||
23365238|NCT00377637|65084890|FG002|Induction Phase|Withdrawal by Subject|0|||
23365239|NCT00377637|65084891|FG003|Induction Phase|Withdrawal by Subject|0|||
23365240|NCT00377637|65084888|FG000|Induction Phase|Physician Decision|3|||
23365241|NCT00377637|65084889|FG001|Induction Phase|Physician Decision|1|||
23365242|NCT00377637|65084890|FG002|Induction Phase|Physician Decision|0|||
23365243|NCT00377637|65084891|FG003|Induction Phase|Physician Decision|0|||
23365244|NCT00377637|65084888|FG000|Induction Phase|Sponsor decision|1|||
23365245|NCT00377637|65084889|FG001|Induction Phase|Sponsor decision|2|||
23365246|NCT00377637|65084890|FG002|Induction Phase|Sponsor decision|0|||
23365247|NCT00377637|65084891|FG003|Induction Phase|Sponsor decision|0|||
23365248|NCT00377637|65084888|FG000|Induction Phase|Non-Compliance|1|||
23365249|NCT00377637|65084889|FG001|Induction Phase|Non-Compliance|0|||
23365250|NCT00377637|65084890|FG002|Induction Phase|Non-Compliance|0|||
23365251|NCT00377637|65084891|FG003|Induction Phase|Non-Compliance|0|||
23365252|NCT00377637|65084888|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
23365253|NCT00377637|65084889|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
23365254|NCT00377637|65084890|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
23365255|NCT00377637|65084891|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
23365256|NCT00377637|65084888|FG000|Maintenance Phase|Adverse Event|0|||
23365257|NCT00377637|65084889|FG001|Maintenance Phase|Adverse Event|0|||
23365258|NCT00377637|65084890|FG002|Maintenance Phase|Adverse Event|29|||
23365259|NCT00377637|65084891|FG003|Maintenance Phase|Adverse Event|43|||
23365260|NCT00377637|65084888|FG000|Maintenance Phase|Physician Decision|0|||
23365261|NCT00377637|65084889|FG001|Maintenance Phase|Physician Decision|0|||
23365262|NCT00377637|65084890|FG002|Maintenance Phase|Physician Decision|5|||
23365263|NCT00377637|65084891|FG003|Maintenance Phase|Physician Decision|4|||
23365264|NCT00377637|65084888|FG000|Maintenance Phase|Lost to Follow-up|0|||
23365265|NCT00377637|65084889|FG001|Maintenance Phase|Lost to Follow-up|0|||
23365266|NCT00377637|65084890|FG002|Maintenance Phase|Lost to Follow-up|3|||
23365267|NCT00377637|65084891|FG003|Maintenance Phase|Lost to Follow-up|1|||
23365268|NCT00377637|65084888|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23365269|NCT00377637|65084889|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23365270|NCT00377637|65084890|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23365271|NCT00377637|65084891|FG003|Maintenance Phase|Withdrawal by Subject|3|||
23365272|NCT00377637|65084888|FG000|Maintenance Phase|Sponsor decision|0|||
23365273|NCT00377637|65084889|FG001|Maintenance Phase|Sponsor decision|0|||
23365274|NCT00377637|65084890|FG002|Maintenance Phase|Sponsor decision|2|||
23365275|NCT00377637|65084891|FG003|Maintenance Phase|Sponsor decision|3|||
23365276|NCT00377637|65084888|FG000|Maintenance Phase|Non-compliance|0|||
23365277|NCT00377637|65084889|FG001|Maintenance Phase|Non-compliance|0|||
23365278|NCT00377637|65084890|FG002|Maintenance Phase|Non-compliance|1|||
23365279|NCT00377637|65084891|FG003|Maintenance Phase|Non-compliance|1|||
23365280|NCT00377637|65084888|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
23365281|NCT00377637|65084889|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
23365282|NCT00377637|65084890|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
23365283|NCT00377637|65084891|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
23482308|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482309|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
23482310|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482311|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482312|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482313|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
23482314|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
23601527|NCT01394276|65933780|FG000|Overall Study|Insufficient therapeutic effect|17|||
23601528|NCT01394276|65933780|FG000|Overall Study|Insufficient compliance|9|||
23601529|NCT01394276|65933780|FG000|Overall Study|Lost to Follow-up|5|||
23601530|NCT01394276|65933780|FG000|Overall Study|Participant moved to another site|1|||
23659919|NCT00763971|66142442|FG002|Overall Study|Lost to Follow-up|0|||
23659920|NCT00763971|66142440|FG000|Overall Study|Lack of Efficacy|11|||
23659921|NCT00763971|66142441|FG001|Overall Study|Lack of Efficacy|22|||
23659922|NCT00763971|66142442|FG002|Overall Study|Lack of Efficacy|54|||
23601531|NCT01394276|65933780|FG000|Overall Study|Pregnancy|1|||
23601532|NCT01394276|65933780|FG000|Overall Study|unavailability of drug at the Hospital|2|||
23601533|NCT01394276|65933780|FG000|Overall Study|Symptoms of concurrent diseases|1|||
23659923|NCT00763971|66142440|FG000|Overall Study|Unable to swallow capsule|2|||
23659924|NCT00763971|66142441|FG001|Overall Study|Unable to swallow capsule|1|||
23365284|NCT00377637|65084888|FG000|Maintenance Phase|Death|0|||
23365285|NCT00377637|65084889|FG001|Maintenance Phase|Death|0|||
23482315|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23601534|NCT02807857|65933781|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
23365286|NCT00377637|65084890|FG002|Maintenance Phase|Death|0|||
23365287|NCT00377637|65084891|FG003|Maintenance Phase|Death|1|||
23365288|NCT02667301|65084894|FG000|Overall Study|Adverse Event|1|||
23365289|NCT02667301|65084894|FG000|Overall Study|Lack of Efficacy|1|||
23365290|NCT00846586|65084895|FG000|Overall Study|Adverse Event|20|||
23365291|NCT00846586|65084896|FG001|Overall Study|Adverse Event|10|||
23365292|NCT00846586|65084895|FG000|Overall Study|Subject withdrew consent|8|||
23365293|NCT00846586|65084896|FG001|Overall Study|Subject withdrew consent|10|||
23365294|NCT00846586|65084895|FG000|Overall Study|Administrative problems|5|||
23365295|NCT00846586|65084896|FG001|Overall Study|Administrative problems|4|||
23365296|NCT00846586|65084895|FG000|Overall Study|Death|2|||
23365297|NCT00846586|65084896|FG001|Overall Study|Death|0|||
23365298|NCT00846586|65084895|FG000|Overall Study|Protocol deviation|2|||
23365299|NCT00846586|65084896|FG001|Overall Study|Protocol deviation|6|||
23365300|NCT00846586|65084895|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23365301|NCT00846586|65084896|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23365302|NCT00846586|65084895|FG000|Overall Study|Lost to Follow-up|1|||
23365303|NCT00846586|65084896|FG001|Overall Study|Lost to Follow-up|4|||
23365304|NCT00846586|65084895|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23365305|NCT00846586|65084896|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23365306|NCT01663402|65084897|FG000|Overall Study|Randomized but not treated|19|||
23365307|NCT01663402|65084898|FG001|Overall Study|Randomized but not treated|11|||
23365308|NCT01663402|65084897|FG000|Overall Study|Adverse Event|347|||
23365309|NCT01663402|65084898|FG001|Overall Study|Adverse Event|362|||
23365310|NCT01663402|65084897|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
23365311|NCT01663402|65084898|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
23365312|NCT01663402|65084897|FG000|Overall Study|Poor compliance to protocol|529|||
23365313|NCT01663402|65084898|FG001|Overall Study|Poor compliance to protocol|454|||
23365314|NCT01663402|65084897|FG000|Overall Study|Physician Decision|77|||
23365315|NCT01663402|65084898|FG001|Overall Study|Physician Decision|62|||
23365316|NCT01663402|65084897|FG000|Overall Study|Site terminated by sponsor|1|||
23365317|NCT01663402|65084898|FG001|Overall Study|Site terminated by sponsor|3|||
23365318|NCT01663402|65084897|FG000|Overall Study|Participant moved|139|||
23365319|NCT01663402|65084898|FG001|Overall Study|Participant moved|104|||
23365320|NCT01663402|65084897|FG000|Overall Study|Withdrawal by Subject|118|||
23365321|NCT01663402|65084898|FG001|Overall Study|Withdrawal by Subject|91|||
23365322|NCT01663402|65084897|FG000|Overall Study|Related to study drug administration|96|||
23365323|NCT01663402|65084898|FG001|Overall Study|Related to study drug administration|105|||
23365324|NCT01663402|65084897|FG000|Overall Study|Lost to Follow-up|17|||
23365325|NCT01663402|65084898|FG001|Overall Study|Lost to Follow-up|15|||
23365326|NCT01663402|65084897|FG000|Overall Study|Other than specified above|172|||
23365327|NCT01663402|65084898|FG001|Overall Study|Other than specified above|147|||
23365328|NCT01316575|65084899|FG000|Overall Study|Withdrawal by Subject|2|||
23365329|NCT01316575|65084900|FG001|Overall Study|Withdrawal by Subject|0|||
23365330|NCT01316575|65084899|FG000|Overall Study|Required alternate treatment|0|||
23365331|NCT01316575|65084900|FG001|Overall Study|Required alternate treatment|1|||
23365332|NCT02619617|65084904|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
23365333|NCT02619617|65084905|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
23365334|NCT02619617|65084904|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
23365335|NCT02619617|65084905|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
23365336|NCT00126594|65084906|FG000|Overall Study|Ineligible|2|||
23365337|NCT00126594|65084907|FG001|Overall Study|Ineligible|0|||
23365338|NCT00126594|65084906|FG000|Overall Study|Withdrawal by Subject|0|||
23365339|NCT00126594|65084907|FG001|Overall Study|Withdrawal by Subject|4|||
23365340|NCT00126594|65084906|FG000|Overall Study|Physician Decision|1|||
23365341|NCT00126594|65084907|FG001|Overall Study|Physician Decision|3|||
23365342|NCT00126594|65084906|FG000|Overall Study|Adverse Event|7|||
23365343|NCT00126594|65084907|FG001|Overall Study|Adverse Event|5|||
23365344|NCT00126594|65084906|FG000|Overall Study|Non-compliance|0|||
23365345|NCT00126594|65084907|FG001|Overall Study|Non-compliance|1|||
23365346|NCT00126594|65084906|FG000|Overall Study|Disease Progression|29|||
23365347|NCT00126594|65084907|FG001|Overall Study|Disease Progression|24|||
23365348|NCT01484951|65084912|FG000|Overall Study|Adverse Event|3|||
23365349|NCT01484951|65084912|FG000|Overall Study|Personal Reasons|1|||
23365350|NCT01484951|65084912|FG000|Overall Study|Non-Compliance|1|||
23365351|NCT04534517|65084918|FG000|Overall Study|Adverse Event|1|||
23365352|NCT04534517|65084918|FG000|Overall Study|Withdrawal by Subject|1|||
23365353|NCT04534517|65084918|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23365354|NCT04534517|65084918|FG000|Overall Study|COVID-19 Related|1|||
23365355|NCT01095835|65084919|FG000|Overall Study|Adverse Event|8|||
23365356|NCT01095835|65084920|FG001|Overall Study|Adverse Event|6|||
23365357|NCT01095835|65084921|FG002|Overall Study|Adverse Event|6|||
23365358|NCT01095835|65084919|FG000|Overall Study|Lack of Efficacy|0|||
23601535|NCT02807857|65933781|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
23601536|NCT02807857|65933781|FG000|Follow-Up Set|Withdrawal by Subject|8|||
23601537|NCT02807857|65933781|FG000|Follow-Up Set|Lost to Follow-up|7|||
23601538|NCT02807857|65933781|FG000|Follow-Up Set|Physician Decision|6|||
23601539|NCT02807857|65933781|FG000|Follow-Up Set|Adverse Event|3|||
23365359|NCT01095835|65084920|FG001|Overall Study|Lack of Efficacy|1|||
23365360|NCT01095835|65084921|FG002|Overall Study|Lack of Efficacy|0|||
23365361|NCT01095835|65084919|FG000|Overall Study|Physician Decision|0|||
23365362|NCT01095835|65084920|FG001|Overall Study|Physician Decision|0|||
23365363|NCT01095835|65084921|FG002|Overall Study|Physician Decision|1|||
23365364|NCT01095835|65084919|FG000|Overall Study|Withdrawal by Subject|1|||
23365365|NCT01095835|65084920|FG001|Overall Study|Withdrawal by Subject|3|||
23365366|NCT01095835|65084921|FG002|Overall Study|Withdrawal by Subject|0|||
23365367|NCT01095835|65084919|FG000|Overall Study|Non study compliance|0|||
23365368|NCT01095835|65084920|FG001|Overall Study|Non study compliance|0|||
23365369|NCT01095835|65084921|FG002|Overall Study|Non study compliance|1|||
23365370|NCT01095835|65084919|FG000|Overall Study|Protocol Violation|1|||
23365371|NCT01095835|65084920|FG001|Overall Study|Protocol Violation|2|||
23365372|NCT01095835|65084921|FG002|Overall Study|Protocol Violation|0|||
23365373|NCT01607593|65084922|FG000|Overall Study|Adverse Event|15|||
23365374|NCT01607593|65084922|FG000|Overall Study|Lack of Efficacy|16|||
23365375|NCT01607593|65084922|FG000|Overall Study|Lost to Follow-up|25|||
23365376|NCT01607593|65084922|FG000|Overall Study|Continuation|33|||
23365377|NCT01607593|65084922|FG000|Overall Study|Other|4|||
23365378|NCT02346708|65084935|FG000|Overall Study|Adverse Event|2|||
23365379|NCT02346708|65084936|FG001|Overall Study|Adverse Event|0|||
23365380|NCT02346708|65084935|FG000|Overall Study|Protocol Violation|0|||
23365381|NCT02346708|65084936|FG001|Overall Study|Protocol Violation|1|||
23365382|NCT01630135|65084937|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
23365383|NCT01630135|65084938|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
23365384|NCT00072410|65084939|FG000|Overall Study|Progressive disease|0|||
23365385|NCT00072410|65084940|FG001|Overall Study|Progressive disease|3|||
23365386|NCT01261390|65084943|FG000|Overall Study|Significant Concurrent Illness|1|||
23365387|NCT01261390|65084944|FG001|Overall Study|Significant Concurrent Illness|0|||
23365388|NCT01261390|65084945|FG002|Overall Study|Significant Concurrent Illness|1|||
23365389|NCT01261390|65084946|FG003|Overall Study|Significant Concurrent Illness|0|||
23365390|NCT01261390|65084943|FG000|Overall Study|Dissatisfaction with Treatment|2|||
23365391|NCT01261390|65084944|FG001|Overall Study|Dissatisfaction with Treatment|1|||
23365392|NCT01261390|65084945|FG002|Overall Study|Dissatisfaction with Treatment|1|||
23365393|NCT01261390|65084946|FG003|Overall Study|Dissatisfaction with Treatment|2|||
23365394|NCT01261390|65084943|FG000|Overall Study|Relocation|0|||
23365395|NCT01261390|65084944|FG001|Overall Study|Relocation|1|||
23365396|NCT01261390|65084945|FG002|Overall Study|Relocation|0|||
23365397|NCT01261390|65084946|FG003|Overall Study|Relocation|0|||
23365398|NCT01261390|65084943|FG000|Overall Study|Loss of Interest in the Study|3|||
23365399|NCT01261390|65084944|FG001|Overall Study|Loss of Interest in the Study|1|||
23365400|NCT01261390|65084945|FG002|Overall Study|Loss of Interest in the Study|0|||
23365401|NCT01261390|65084946|FG003|Overall Study|Loss of Interest in the Study|0|||
23365402|NCT01261390|65084943|FG000|Overall Study|Lost to Follow-up|1|||
23365403|NCT01261390|65084944|FG001|Overall Study|Lost to Follow-up|6|||
23365404|NCT01261390|65084945|FG002|Overall Study|Lost to Follow-up|5|||
23365405|NCT01261390|65084946|FG003|Overall Study|Lost to Follow-up|6|||
23365406|NCT04817332|65084947|FG000|Overall Study|Lost to Follow-up|3|||
23365407|NCT04817332|65084948|FG001|Overall Study|Lost to Follow-up|3|||
23365408|NCT04817332|65084947|FG000|Overall Study|Protocol Violation|2|||
23365409|NCT04817332|65084948|FG001|Overall Study|Protocol Violation|0|||
23365410|NCT00902577|65084953|FG000|Overall Study|Withdrawal by Subject|6|||
23365411|NCT00902577|65084953|FG000|Overall Study|FMISO production failure|2|||
23365412|NCT03492437|65084954|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23365413|NCT03492437|65084955|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23365414|NCT00791999|65084956|FG000|Overall Study|Protocol planed withdrawal|14|||
23365415|NCT00791999|65084957|FG001|Overall Study|Protocol planed withdrawal|11|||
23365416|NCT00791999|65084958|FG002|Overall Study|Protocol planed withdrawal|11|||
23365417|NCT00791999|65084959|FG003|Overall Study|Protocol planed withdrawal|45|||
23365418|NCT00791999|65084956|FG000|Overall Study|Withdrawal by Subject|0|||
23365419|NCT00791999|65084957|FG001|Overall Study|Withdrawal by Subject|1|||
23365420|NCT00791999|65084958|FG002|Overall Study|Withdrawal by Subject|0|||
23365421|NCT00791999|65084959|FG003|Overall Study|Withdrawal by Subject|2|||
23365422|NCT00791999|65084956|FG000|Overall Study|Protocol Violation|3|||
23365423|NCT00791999|65084957|FG001|Overall Study|Protocol Violation|0|||
23365424|NCT00791999|65084958|FG002|Overall Study|Protocol Violation|1|||
23365425|NCT00791999|65084959|FG003|Overall Study|Protocol Violation|0|||
23365426|NCT00791999|65084956|FG000|Overall Study|Adverse Event|3|||
23365427|NCT00791999|65084957|FG001|Overall Study|Adverse Event|3|||
23365428|NCT00791999|65084958|FG002|Overall Study|Adverse Event|7|||
23365429|NCT00791999|65084959|FG003|Overall Study|Adverse Event|3|||
23365430|NCT00791999|65084956|FG000|Overall Study|Lack of Efficacy|0|||
23365431|NCT00791999|65084957|FG001|Overall Study|Lack of Efficacy|1|||
23482316|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
23365432|NCT00791999|65084958|FG002|Overall Study|Lack of Efficacy|0|||
23482317|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23601540|NCT02807857|65933781|FG000|Follow-Up Set|Death|27|||
23365433|NCT00791999|65084959|FG003|Overall Study|Lack of Efficacy|2|||
23365434|NCT00791999|65084956|FG000|Overall Study|Reason other than those above|1|||
23365435|NCT00791999|65084957|FG001|Overall Study|Reason other than those above|0|||
23365436|NCT00791999|65084958|FG002|Overall Study|Reason other than those above|1|||
23365437|NCT00791999|65084959|FG003|Overall Study|Reason other than those above|0|||
23365438|NCT00411450|65084960|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
23365439|NCT01274351|65084961|FG000|Overall Study|Lost to Follow-up|1|||
23365440|NCT01274351|65084961|FG000|Overall Study|patient not compliant with the protocol|1|||
23365441|NCT01274351|65084961|FG000|Overall Study|Pregnancy|1|||
23365442|NCT01274351|65084961|FG000|Overall Study|Death|2|||
23365443|NCT01274351|65084961|FG000|Overall Study|Withdrawal by Subject|3|||
23365444|NCT01274351|65084961|FG000|Overall Study|Adverse Event|8|||
23365445|NCT01274351|65084961|FG000|Overall Study|progression of disease|3|||
23365446|NCT01274351|65084961|FG000|Overall Study|hospitalization|1|||
23365447|NCT03188055|65084962|FG000|Overall Study|Unavailable for training|0|||
23365448|NCT03188055|65084963|FG001|Overall Study|Unavailable for training|0|||
23365449|NCT03188055|65084964|FG002|Overall Study|Unavailable for training|19|||
23365450|NCT03188055|65084965|FG003|Overall Study|Unavailable for training|0|||
23365451|NCT03188055|65084966|FG004|Overall Study|Unavailable for training|0|||
23365452|NCT03188055|65084967|FG005|Overall Study|Unavailable for training|0|||
23365453|NCT03188055|65084962|FG000|Overall Study|Lost to Follow-up|0|||
23365454|NCT03188055|65084963|FG001|Overall Study|Lost to Follow-up|18|||
23365455|NCT03188055|65084964|FG002|Overall Study|Lost to Follow-up|0|||
23365456|NCT03188055|65084965|FG003|Overall Study|Lost to Follow-up|11|||
23365457|NCT03188055|65084966|FG004|Overall Study|Lost to Follow-up|0|||
23365458|NCT03188055|65084967|FG005|Overall Study|Lost to Follow-up|0|||
23365459|NCT03188055|65084962|FG000|Overall Study|Withdrawal by Subject|0|||
23365460|NCT03188055|65084963|FG001|Overall Study|Withdrawal by Subject|1|||
23365461|NCT03188055|65084964|FG002|Overall Study|Withdrawal by Subject|0|||
23365462|NCT03188055|65084965|FG003|Overall Study|Withdrawal by Subject|1|||
23365463|NCT03188055|65084966|FG004|Overall Study|Withdrawal by Subject|0|||
23365464|NCT03188055|65084967|FG005|Overall Study|Withdrawal by Subject|0|||
23365465|NCT02595502|65084968|FG000|Period 1|Adverse Event|0|||
23365466|NCT02595502|65084969|FG001|Period 1|Adverse Event|1|||
23365467|NCT02595502|65084968|FG000|Period 1|Withdrawal by Subject|1|||
23365468|NCT02595502|65084969|FG001|Period 1|Withdrawal by Subject|0|||
23365469|NCT02595502|65084968|FG000|Period 1|Lost to Follow-up|0|||
23365470|NCT02595502|65084969|FG001|Period 1|Lost to Follow-up|1|||
23365471|NCT02595502|65084968|FG000|Period 2|Adverse Event|1|||
23365472|NCT02595502|65084969|FG001|Period 2|Adverse Event|1|||
23365473|NCT02595502|65084968|FG000|Period 2|Received incorrect lens at Period 1|0|||
23365474|NCT02595502|65084969|FG001|Period 2|Received incorrect lens at Period 1|1|||
23365475|NCT02595502|65084968|FG000|Period 3|Protocol Violation|0|||
23365476|NCT02595502|65084969|FG001|Period 3|Protocol Violation|1|||
23365477|NCT02595502|65084968|FG000|Period 3|Lost to Follow-up|1|||
23365478|NCT02595502|65084969|FG001|Period 3|Lost to Follow-up|0|||
23365479|NCT02595502|65084968|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
23365480|NCT02595502|65084969|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
23365481|NCT00577317|65084973|FG000|Overall Study|Study Terminated|0|||
23365482|NCT00577317|65084974|FG001|Overall Study|Study Terminated|2|||
23365483|NCT03498313|65084980|FG000|Experimental Period 1|Adverse Event|1|||
23365484|NCT03498313|65084981|FG001|Experimental Period 1|Adverse Event|0|||
23365485|NCT03498313|65084982|FG002|Experimental Period 1|Adverse Event|0|||
23365486|NCT03498313|65084983|FG003|Experimental Period 1|Adverse Event|1|||
23365487|NCT03498313|65084984|FG004|Experimental Period 1|Adverse Event|0|||
23365488|NCT03498313|65084985|FG005|Experimental Period 1|Adverse Event|0|||
23601541|NCT02807857|65933781|FG000|Follow-Up Set|Relocation|2|||
23659925|NCT00763971|66142442|FG002|Overall Study|Unable to swallow capsule|1|||
23659926|NCT00763971|66142440|FG000|Overall Study|Personal reason|3|||
23659927|NCT00763971|66142441|FG001|Overall Study|Personal reason|0|||
23659928|NCT00763971|66142442|FG002|Overall Study|Personal reason|0|||
23659929|NCT00763971|66142440|FG000|Overall Study|Exclusion criteria met|1|||
23659930|NCT00763971|66142441|FG001|Overall Study|Exclusion criteria met|0|||
23365489|NCT03498313|65084980|FG000|Experimental Period 1|Withdrawal by Subject|0|||
23365490|NCT03498313|65084981|FG001|Experimental Period 1|Withdrawal by Subject|1|||
23365491|NCT03498313|65084982|FG002|Experimental Period 1|Withdrawal by Subject|0|||
23365492|NCT03498313|65084983|FG003|Experimental Period 1|Withdrawal by Subject|0|||
23365493|NCT03498313|65084984|FG004|Experimental Period 1|Withdrawal by Subject|0|||
23365494|NCT03498313|65084985|FG005|Experimental Period 1|Withdrawal by Subject|0|||
23601542|NCT00442104|65933782|FG000|Overall Study|Adverse Event|5|||
23601543|NCT00442104|65933782|FG000|Overall Study|Death|2|||
23601544|NCT00442104|65933782|FG000|Overall Study|Lost to Follow-up|3|||
23601545|NCT00442104|65933782|FG000|Overall Study|Withdrawal by Subject|5|||
23659931|NCT00763971|66142442|FG002|Overall Study|Exclusion criteria met|0|||
23365495|NCT03498313|65084980|FG000|Washout Period 1|Anovulation|1|||
23365496|NCT03498313|65084981|FG001|Washout Period 1|Anovulation|0|||
23365497|NCT03498313|65084982|FG002|Washout Period 1|Anovulation|0|||
23365498|NCT03498313|65084983|FG003|Washout Period 1|Anovulation|0|||
23365499|NCT03498313|65084984|FG004|Washout Period 1|Anovulation|0|||
23365500|NCT03498313|65084985|FG005|Washout Period 1|Anovulation|0|||
23601546|NCT00442104|65933782|FG000|Overall Study|Insufficient Clinical Response|10|||
23659932|NCT00763971|66142440|FG000|Overall Study|Sponsor decision|1|||
23659933|NCT00763971|66142441|FG001|Overall Study|Sponsor decision|0|||
23659934|NCT00763971|66142442|FG002|Overall Study|Sponsor decision|0|||
23659935|NCT00763971|66142440|FG000|Overall Study|Due to holiday season|2|||
23659936|NCT00763971|66142441|FG001|Overall Study|Due to holiday season|0|||
23659937|NCT00763971|66142442|FG002|Overall Study|Due to holiday season|1|||
23659938|NCT00763971|66142440|FG000|Overall Study|Randomization error|0|||
23659939|NCT00763971|66142441|FG001|Overall Study|Randomization error|0|||
23659940|NCT00763971|66142442|FG002|Overall Study|Randomization error|1|||
23659941|NCT00763971|66142440|FG000|Overall Study|Medical monitor decision|0|||
23659942|NCT00763971|66142441|FG001|Overall Study|Medical monitor decision|0|||
23659943|NCT00763971|66142442|FG002|Overall Study|Medical monitor decision|1|||
23659944|NCT00763971|66142440|FG000|Overall Study|Moved to another country|0|||
23659945|NCT00763971|66142441|FG001|Overall Study|Moved to another country|1|||
23659946|NCT00763971|66142442|FG002|Overall Study|Moved to another country|0|||
23482318|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482319|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482320|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482321|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
23482322|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
23482323|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
23482324|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
23482325|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
23482326|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
23482327|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
23482328|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601547|NCT00442104|65933782|FG000|Overall Study|Other|21|||
23601548|NCT00442104|65933782|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
23601549|NCT00526994|65933783|FG000|Overall Study|Lost to Follow-up|98|||
23601550|NCT00526994|65933784|FG001|Overall Study|Lost to Follow-up|108|||
23601551|NCT00526994|65933785|FG002|Overall Study|Lost to Follow-up|96|||
23601552|NCT00526994|65933783|FG000|Overall Study|Death|4|||
23601553|NCT00526994|65933784|FG001|Overall Study|Death|3|||
23601554|NCT00526994|65933785|FG002|Overall Study|Death|3|||
23601555|NCT00526994|65933783|FG000|Overall Study|Withdrawal by Subject|2|||
23601556|NCT00526994|65933784|FG001|Overall Study|Withdrawal by Subject|7|||
23601557|NCT00526994|65933785|FG002|Overall Study|Withdrawal by Subject|5|||
23601558|NCT00526994|65933783|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
23601559|NCT00526994|65933784|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
23601560|NCT00526994|65933785|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
23601561|NCT00491894|65933788|FG000|Overall Study|Adverse Event|14|||
23601562|NCT00491894|65933788|FG000|Overall Study|Withdrawal by Subject|5|||
23601563|NCT00491894|65933788|FG000|Overall Study|Death|3|||
23601564|NCT00491894|65933788|FG000|Overall Study|Lost to Follow-up|3|||
23601565|NCT00491894|65933788|FG000|Overall Study|Lack of Efficacy|2|||
23601566|NCT00491894|65933788|FG000|Overall Study|Other-Failed to meet any criteria|2|||
23601567|NCT00491894|65933788|FG000|Overall Study|Physician Decision|2|||
23601568|NCT00491894|65933788|FG000|Overall Study|Protocol Violation|2|||
23601569|NCT00491894|65933788|FG000|Overall Study|Other-Intake of prohibited medication|1|||
23601570|NCT00371345|65933789|FG000|Overall Study|Disease Progression|21|||
23601571|NCT00371345|65933790|FG001|Overall Study|Disease Progression|35|||
23601572|NCT00371345|65933789|FG000|Overall Study|Study Drug Toxicity|1|||
23601573|NCT00371345|65933790|FG001|Overall Study|Study Drug Toxicity|7|||
23601574|NCT00371345|65933789|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
23601575|NCT00371345|65933790|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
23601576|NCT00371345|65933789|FG000|Overall Study|Participant Request|1|||
23601577|NCT00371345|65933790|FG001|Overall Study|Participant Request|1|||
23601578|NCT00371345|65933789|FG000|Overall Study|Participant Withdrew Consent|0|||
23601579|NCT00371345|65933790|FG001|Overall Study|Participant Withdrew Consent|1|||
23601580|NCT01619410|65933791|FG000|Overall Study|Lost to Follow-up|7|||
23601581|NCT01619410|65933792|FG001|Overall Study|Lost to Follow-up|4|||
23601582|NCT02399449|65933793|FG000|Overall Study|Withdrawal by Subject|3|||
23601583|NCT02399449|65933794|FG001|Overall Study|Withdrawal by Subject|9|||
23601584|NCT02399449|65933793|FG000|Overall Study|Physician Decision|0|||
23601585|NCT02399449|65933794|FG001|Overall Study|Physician Decision|1|||
23601586|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
23601587|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
23601588|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
23601589|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
23601590|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
23601591|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
23601592|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
23601593|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
23601594|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
23601595|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
23601596|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
23601597|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
23659947|NCT00763971|66142440|FG000|Overall Study|Subject wanted dose reduction|0|||
23482329|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
23601598|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
23482330|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601599|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
23601600|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
23601601|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
23601602|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
23659948|NCT00763971|66142441|FG001|Overall Study|Subject wanted dose reduction|1|||
23659949|NCT00763971|66142442|FG002|Overall Study|Subject wanted dose reduction|0|||
23659950|NCT00763971|66142440|FG000|Overall Study|Lack of availability|0|||
23659951|NCT00763971|66142441|FG001|Overall Study|Lack of availability|1|||
23659952|NCT00763971|66142442|FG002|Overall Study|Lack of availability|0|||
23659953|NCT00763971|66142440|FG000|Overall Study|Performed final visit on phone|0|||
23659954|NCT00763971|66142441|FG001|Overall Study|Performed final visit on phone|1|||
23659955|NCT00763971|66142442|FG002|Overall Study|Performed final visit on phone|0|||
23659956|NCT00763971|66142440|FG000|Overall Study|Participation in 489-326 required|1|||
23659957|NCT00763971|66142441|FG001|Overall Study|Participation in 489-326 required|0|||
23659958|NCT00763971|66142442|FG002|Overall Study|Participation in 489-326 required|0|||
23659959|NCT00058552|66142443|FG000|Overall Study|Died prior to receiving treatment|4|||
23659960|NCT00058552|66142444|FG001|Overall Study|Died prior to receiving treatment|2|||
23659961|NCT00058552|66142443|FG000|Overall Study|Disease progression|52|||
23659962|NCT00058552|66142444|FG001|Overall Study|Disease progression|44|||
23659963|NCT00058552|66142443|FG000|Overall Study|Adverse Event|4|||
23659964|NCT00058552|66142444|FG001|Overall Study|Adverse Event|2|||
23659965|NCT00058552|66142443|FG000|Overall Study|Withdrawal by Subject|3|||
23659966|NCT00058552|66142444|FG001|Overall Study|Withdrawal by Subject|5|||
23659967|NCT00058552|66142443|FG000|Overall Study|Physician Decision|2|||
23365501|NCT03498313|65084980|FG000|Washout Period 1|Withdrawal by Subject|0|||
23365502|NCT03498313|65084981|FG001|Washout Period 1|Withdrawal by Subject|3|||
23365503|NCT03498313|65084982|FG002|Washout Period 1|Withdrawal by Subject|0|||
23365504|NCT03498313|65084983|FG003|Washout Period 1|Withdrawal by Subject|1|||
23365505|NCT03498313|65084984|FG004|Washout Period 1|Withdrawal by Subject|0|||
23365506|NCT03498313|65084985|FG005|Washout Period 1|Withdrawal by Subject|1|||
23365507|NCT03498313|65084980|FG000|Experimental Period 2|Adverse Event|0|||
23365508|NCT03498313|65084981|FG001|Experimental Period 2|Adverse Event|0|||
23659968|NCT00058552|66142444|FG001|Overall Study|Physician Decision|5|||
23365509|NCT03498313|65084982|FG002|Experimental Period 2|Adverse Event|0|||
23659969|NCT00058552|66142443|FG000|Overall Study|Clinical disease progression|0|||
23659970|NCT00058552|66142444|FG001|Overall Study|Clinical disease progression|4|||
23659971|NCT01022996|66142449|FG000|Overall Study|Adverse Event|14|||
23365510|NCT03498313|65084983|FG003|Experimental Period 2|Adverse Event|0|||
23365511|NCT03498313|65084984|FG004|Experimental Period 2|Adverse Event|1|||
23365512|NCT03498313|65084985|FG005|Experimental Period 2|Adverse Event|2|||
23365513|NCT03498313|65084980|FG000|Washout Period 2|Physician Decision|1|||
23365514|NCT03498313|65084981|FG001|Washout Period 2|Physician Decision|0|||
23365515|NCT03498313|65084982|FG002|Washout Period 2|Physician Decision|0|||
23365516|NCT03498313|65084983|FG003|Washout Period 2|Physician Decision|1|||
23365517|NCT03498313|65084984|FG004|Washout Period 2|Physician Decision|0|||
23365518|NCT03498313|65084985|FG005|Washout Period 2|Physician Decision|1|||
23365519|NCT03498313|65084980|FG000|Washout Period 2|Withdrawal by Subject|3|||
23365520|NCT03498313|65084981|FG001|Washout Period 2|Withdrawal by Subject|2|||
23365521|NCT03498313|65084982|FG002|Washout Period 2|Withdrawal by Subject|0|||
23365522|NCT03498313|65084983|FG003|Washout Period 2|Withdrawal by Subject|0|||
23365523|NCT03498313|65084984|FG004|Washout Period 2|Withdrawal by Subject|2|||
23365524|NCT03498313|65084985|FG005|Washout Period 2|Withdrawal by Subject|0|||
23365525|NCT03498313|65084980|FG000|Washout Period 2|Anovulation|0|||
23365526|NCT03498313|65084981|FG001|Washout Period 2|Anovulation|0|||
23365527|NCT03498313|65084982|FG002|Washout Period 2|Anovulation|0|||
23365528|NCT03498313|65084983|FG003|Washout Period 2|Anovulation|0|||
23365529|NCT03498313|65084984|FG004|Washout Period 2|Anovulation|0|||
23365530|NCT03498313|65084985|FG005|Washout Period 2|Anovulation|1|||
23365531|NCT01239394|65084986|FG000|Overall Study|Adverse Event|1|||
23365532|NCT01298700|65084987|FG000|Overall Study|Adverse Event|50|||
23365533|NCT01298700|65084988|FG001|Overall Study|Adverse Event|51|||
23365534|NCT01298700|65084987|FG000|Overall Study|Lack of Efficacy|9|||
23365535|NCT01298700|65084988|FG001|Overall Study|Lack of Efficacy|14|||
23365536|NCT01298700|65084987|FG000|Overall Study|Lost to Follow-up|5|||
23365537|NCT01298700|65084988|FG001|Overall Study|Lost to Follow-up|2|||
23365538|NCT01298700|65084987|FG000|Overall Study|Withdrawal by Subject|12|||
23365539|NCT01298700|65084988|FG001|Overall Study|Withdrawal by Subject|9|||
23482331|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23482332|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601603|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
23601604|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
23601605|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
23601606|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
23601607|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
23601608|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
23601609|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
23601610|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
23601611|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
23601612|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
23659972|NCT01022996|66142449|FG000|Overall Study|Withdrawal by Subject|3|||
23659973|NCT01022996|66142449|FG000|Overall Study|Lost to Follow-up|1|||
23659974|NCT01022996|66142449|FG000|Overall Study|Administrative problems|6|||
23659975|NCT01022996|66142449|FG000|Overall Study|Disease Progression|32|||
23482333|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23659976|NCT01022996|66142449|FG000|Overall Study|Protocol Violation|1|||
23659977|NCT02361944|66142450|FG000|Overall Study|surgery cancellation|0|||
23659978|NCT02361944|66142451|FG001|Overall Study|surgery cancellation|1|||
23659979|NCT00578786|66142452|FG000|Overall Study|Adverse Event|27|||
23659980|NCT00578786|66142453|FG001|Overall Study|Adverse Event|37|||
23659981|NCT00578786|66142454|FG002|Overall Study|Adverse Event|17|||
23659982|NCT00578786|66142452|FG000|Overall Study|Lack of Efficacy|2|||
23482334|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482335|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
23482336|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482337|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482338|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482339|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
23482340|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482341|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482342|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482343|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482344|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482345|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
23482346|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482347|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
23482348|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
23482349|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482350|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482351|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
23482352|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482353|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482354|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482355|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482356|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482357|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
23482358|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
23482359|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
23601613|NCT03041233|65933807|FG000|Overall Study|Death|5|||
23601614|NCT03041233|65933807|FG000|Overall Study|Physician Decision|1|||
23601615|NCT03041233|65933807|FG000|Overall Study|Lost to Follow-up|16|||
23601616|NCT03041233|65933807|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
23659983|NCT00578786|66142453|FG001|Overall Study|Lack of Efficacy|5|||
23659984|NCT00578786|66142454|FG002|Overall Study|Lack of Efficacy|2|||
23659985|NCT00578786|66142452|FG000|Overall Study|Early Escape from Prior Study|2|||
23659986|NCT00578786|66142453|FG001|Overall Study|Early Escape from Prior Study|1|||
23659987|NCT00578786|66142454|FG002|Overall Study|Early Escape from Prior Study|2|||
23659988|NCT00578786|66142452|FG000|Overall Study|Withdrawal by Subject|7|||
23659989|NCT00578786|66142453|FG001|Overall Study|Withdrawal by Subject|8|||
23659990|NCT00578786|66142454|FG002|Overall Study|Withdrawal by Subject|5|||
23601617|NCT03041233|65933807|FG000|Overall Study|Sponsor Request|1|||
23601618|NCT03041233|65933807|FG000|Overall Study|Duplicate subject|1|||
23601619|NCT03041233|65933807|FG000|Overall Study|Re-ablation|1|||
23482360|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
23482361|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
23482362|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
23482363|NCT03123185|65509483|FG000|Overall Study|Withdrawal by Subject|0|||
23482364|NCT03123185|65509484|FG001|Overall Study|Withdrawal by Subject|0|||
23482365|NCT03123185|65509485|FG002|Overall Study|Withdrawal by Subject|0|||
23482366|NCT03123185|65509486|FG003|Overall Study|Withdrawal by Subject|0|||
23482367|NCT03123185|65509487|FG004|Overall Study|Withdrawal by Subject|0|||
23482368|NCT03123185|65509488|FG005|Overall Study|Withdrawal by Subject|0|||
23482369|NCT03123185|65509489|FG006|Overall Study|Withdrawal by Subject|0|||
23482370|NCT03123185|65509490|FG007|Overall Study|Withdrawal by Subject|0|||
23482371|NCT03123185|65509491|FG008|Overall Study|Withdrawal by Subject|0|||
23482372|NCT03123185|65509492|FG009|Overall Study|Withdrawal by Subject|0|||
23482373|NCT03123185|65509493|FG010|Overall Study|Withdrawal by Subject|0|||
23482374|NCT03123185|65509494|FG011|Overall Study|Withdrawal by Subject|0|||
23482375|NCT03123185|65509495|FG012|Overall Study|Withdrawal by Subject|1|||
23601620|NCT00609869|65933814|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
23601621|NCT00609869|65933814|FG000|Overall Study|Severe hematologic toxicity|1|||
23601622|NCT00609869|65933814|FG000|Overall Study|Withdrawal by Subject|1|||
23601623|NCT00609869|65933814|FG000|Overall Study|Seizures|1|||
23601624|NCT00609869|65933814|FG000|Overall Study|Severe tumor flare reaction|1|||
23659991|NCT00578786|66142452|FG000|Overall Study|Protocol Violation|0|||
23659992|NCT00578786|66142453|FG001|Overall Study|Protocol Violation|3|||
23659993|NCT00578786|66142454|FG002|Overall Study|Protocol Violation|1|||
23659994|NCT00578786|66142452|FG000|Overall Study|Physician Decision|1|||
23482376|NCT03123185|65509496|FG013|Overall Study|Withdrawal by Subject|0|||
23482377|NCT00409331|65509500|FG000|Overall Study|Physician Decision|1|||
23482378|NCT00791076|65509501|FG000|Overall Study|Study was terminated,PI left institution|8|||
23601625|NCT00609869|65933814|FG000|Overall Study|Hepatitis B infection|1|||
23601626|NCT00609869|65933814|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
23601627|NCT00609869|65933814|FG000|Overall Study|Mantle cell: not evaluable|4|||
23601628|NCT00345046|65933822|FG000|Overall Study|Protocol Violation|1|||
23601629|NCT00345046|65933823|FG001|Overall Study|Protocol Violation|1|||
23601630|NCT00345046|65933824|FG002|Overall Study|Protocol Violation|2|||
23601631|NCT03041090|65933825|FG000|Overall Study|technical error|0|||
23601632|NCT03041090|65933826|FG001|Overall Study|technical error|3|||
23601633|NCT01833455|65933827|FG000|Overall Study|Withdrawal by Subject|1|||
23601634|NCT01833455|65933828|FG001|Overall Study|Withdrawal by Subject|0|||
23601635|NCT03520036|65933832|FG000|Overall Study|Adverse Event|1|||
23601636|NCT03520036|65933833|FG001|Overall Study|Adverse Event|2|||
23601637|NCT03520036|65933834|FG002|Overall Study|Adverse Event|0|||
23601638|NCT03520036|65933832|FG000|Overall Study|Protocol Violation|1|||
23601639|NCT03520036|65933833|FG001|Overall Study|Protocol Violation|0|||
23601640|NCT03520036|65933834|FG002|Overall Study|Protocol Violation|0|||
23601641|NCT03520036|65933832|FG000|Overall Study|Withdrawal by Subject|0|||
23601642|NCT03520036|65933833|FG001|Overall Study|Withdrawal by Subject|1|||
23601643|NCT03520036|65933834|FG002|Overall Study|Withdrawal by Subject|4|||
23601644|NCT03520036|65933832|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
23601645|NCT03520036|65933833|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
23601646|NCT03520036|65933834|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
23601647|NCT01957163|65933835|FG000|Overall Study|Adverse Event|5|||
23601648|NCT01957163|65933836|FG001|Overall Study|Adverse Event|2|||
23601649|NCT01957163|65933837|FG002|Overall Study|Adverse Event|4|||
23601650|NCT01957163|65933835|FG000|Overall Study|Lack of Efficacy|5|||
23601651|NCT01957163|65933836|FG001|Overall Study|Lack of Efficacy|4|||
23601652|NCT01957163|65933837|FG002|Overall Study|Lack of Efficacy|9|||
23601653|NCT01957163|65933835|FG000|Overall Study|Protocol Violation|1|||
23601654|NCT01957163|65933836|FG001|Overall Study|Protocol Violation|2|||
23601655|NCT01957163|65933837|FG002|Overall Study|Protocol Violation|0|||
23601656|NCT01957163|65933835|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
23601657|NCT01957163|65933836|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
23601658|NCT01957163|65933837|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
23601659|NCT01957163|65933835|FG000|Overall Study|Lost to Follow-up|0|||
23601660|NCT01957163|65933836|FG001|Overall Study|Lost to Follow-up|1|||
23601661|NCT01957163|65933837|FG002|Overall Study|Lost to Follow-up|0|||
23601662|NCT01957163|65933835|FG000|Overall Study|Withdrawal by Subject|4|||
23601663|NCT01957163|65933836|FG001|Overall Study|Withdrawal by Subject|2|||
23601664|NCT01957163|65933837|FG002|Overall Study|Withdrawal by Subject|4|||
23482379|NCT00877773|65509504|FG000|Overall Study|Disease Progression|44|||
23482380|NCT04473482|65509505|FG000|Overall Study|Death|0|||
23601665|NCT02235298|65933838|FG000|Overall Study|Lost to Follow-up|6|||
23659995|NCT00578786|66142453|FG001|Overall Study|Physician Decision|0|||
23601666|NCT02235298|65933839|FG001|Overall Study|Lost to Follow-up|5|||
23601667|NCT02235298|65933838|FG000|Overall Study|Adverse Event|2|||
23482381|NCT04473482|65509506|FG001|Overall Study|Death|3|||
23482382|NCT04473482|65509505|FG000|Overall Study|Lost to Follow-up|9|||
23482383|NCT04473482|65509506|FG001|Overall Study|Lost to Follow-up|7|||
23482384|NCT04473482|65509505|FG000|Overall Study|Withdrawal by Subject|2|||
23482385|NCT04473482|65509506|FG001|Overall Study|Withdrawal by Subject|1|||
23482386|NCT03328182|65509509|FG000|Overall Study|Withdrawal by Subject|1|||
23482387|NCT03328182|65509509|FG000|Overall Study|Protocol Violation|2|||
23482388|NCT03328182|65509509|FG000|Overall Study|No Product Evaluated|1|||
23482389|NCT02052414|65509510|FG000|Overall Study|Adverse Event|12|||
23482390|NCT02052414|65509510|FG000|Overall Study|Lack of Efficacy|2|||
23482391|NCT02052414|65509510|FG000|Overall Study|Withdrawal by Subject|3|||
23482392|NCT05498701|65509515|FG000|Period 3|Adverse Event|1|||
23482393|NCT05498701|65509516|FG001|Period 3|Adverse Event|0|||
23482394|NCT01224782|65509517|FG000|Overall Study|Lost to Follow-up|177|||
23482395|NCT01224782|65509517|FG000|Overall Study|Withdrawal by Subject|16|||
23482396|NCT01224782|65509517|FG000|Overall Study|Death|14|||
23482397|NCT01224782|65509517|FG000|Overall Study|Improvement|13|||
23482398|NCT01224782|65509517|FG000|Overall Study|Adverse Event|12|||
23482399|NCT01224782|65509517|FG000|Overall Study|Adverse Reaction|11|||
23482400|NCT01224782|65509517|FG000|Overall Study|Noncompliance|10|||
23482401|NCT01224782|65509517|FG000|Overall Study|Other|4|||
23482402|NCT01224782|65509517|FG000|Overall Study|Start of Dialysis|3|||
23482403|NCT01224782|65509517|FG000|Overall Study|Change of Treatment|1|||
23482404|NCT01224782|65509517|FG000|Overall Study|Financial Reasons|1|||
23482405|NCT01224782|65509517|FG000|Overall Study|Deterioration|1|||
23482406|NCT01224782|65509517|FG000|Overall Study|Transplantation|1|||
23482407|NCT00282464|65509522|FG000|Overall Study|Adverse Event|26|||
23482408|NCT00282464|65509523|FG001|Overall Study|Adverse Event|20|||
23482409|NCT00282464|65509522|FG000|Overall Study|Lack of Efficacy|8|||
23482410|NCT00282464|65509523|FG001|Overall Study|Lack of Efficacy|8|||
23482411|NCT00282464|65509522|FG000|Overall Study|Lost to Follow-up|10|||
23482412|NCT00282464|65509523|FG001|Overall Study|Lost to Follow-up|10|||
23482413|NCT00282464|65509522|FG000|Overall Study|Withdrawal by Subject|24|||
23482414|NCT00282464|65509523|FG001|Overall Study|Withdrawal by Subject|10|||
23482415|NCT00282464|65509522|FG000|Overall Study|laboratory abnormality|1|||
23482416|NCT00282464|65509523|FG001|Overall Study|laboratory abnormality|2|||
23482417|NCT00282464|65509522|FG000|Overall Study|Protocol Violation|0|||
23482418|NCT00282464|65509523|FG001|Overall Study|Protocol Violation|7|||
23482419|NCT00282464|65509522|FG000|Overall Study|Patient moved|1|||
23482420|NCT00282464|65509523|FG001|Overall Study|Patient moved|0|||
23482421|NCT00282464|65509522|FG000|Overall Study|patient non-compliant|3|||
23482422|NCT00282464|65509523|FG001|Overall Study|patient non-compliant|0|||
23482423|NCT00282464|65509522|FG000|Overall Study|patient no show|0|||
23482424|NCT00282464|65509523|FG001|Overall Study|patient no show|1|||
23482425|NCT00282464|65509522|FG000|Overall Study|patient incarcerated|0|||
23482426|NCT00282464|65509523|FG001|Overall Study|patient incarcerated|1|||
23482427|NCT00282464|65509522|FG000|Overall Study|family crisis|0|||
23482428|NCT00282464|65509523|FG001|Overall Study|family crisis|1|||
23482429|NCT00282464|65509522|FG000|Overall Study|dispensed wrong kit|0|||
23482430|NCT00282464|65509523|FG001|Overall Study|dispensed wrong kit|1|||
23482431|NCT00282464|65509522|FG000|Overall Study|dropped due to missed visits|0|||
23482432|NCT00282464|65509523|FG001|Overall Study|dropped due to missed visits|1|||
23482433|NCT02652767|65509525|FG000|Overall Study|Death|2|||
23601668|NCT02235298|65933839|FG001|Overall Study|Adverse Event|2|||
23601669|NCT02235298|65933838|FG000|Overall Study|Withdrawal by Subject|0|||
23601670|NCT02235298|65933839|FG001|Overall Study|Withdrawal by Subject|1|||
23601671|NCT00667017|65933844|FG000|Overall Study|Withdrawal by Subject|1|||
23601672|NCT01779050|65933845|FG000|Overall Study|Withdrawal by Subject|1|||
23601673|NCT01779050|65933846|FG001|Overall Study|Withdrawal by Subject|0|||
23601674|NCT01218009|65933847|FG000|Overall Study|Protocol Violation|2|||
23601675|NCT01218009|65933848|FG001|Overall Study|Protocol Violation|1|||
23601676|NCT01218009|65933847|FG000|Overall Study|Withdrawal by Subject|3|||
23601677|NCT01218009|65933848|FG001|Overall Study|Withdrawal by Subject|1|||
23601678|NCT01218009|65933847|FG000|Overall Study|Sponsor terminated study|161|||
23601679|NCT01218009|65933848|FG001|Overall Study|Sponsor terminated study|163|||
23601680|NCT01856569|65933849|FG000|Overall Study|Other|1|||
23601681|NCT01856569|65933849|FG000|Overall Study|Changed Site/Structure|1|||
23482434|NCT02652767|65509525|FG000|Overall Study|Lost to Follow-up|1|||
23482435|NCT02652767|65509525|FG000|Overall Study|Withdrawal by Subject|1|||
23482436|NCT00814879|65509526|FG000|By Week 24|Cancer Diagnosis|1|||
23482437|NCT00814879|65509527|FG001|By Week 24|Cancer Diagnosis|0|||
23482438|NCT00814879|65509526|FG000|By Week 24|Incarceration|0|||
23482439|NCT00814879|65509527|FG001|By Week 24|Incarceration|1|||
23482440|NCT00814879|65509526|FG000|By Week 48|Lost to Follow-up|2|||
23482441|NCT00814879|65509527|FG001|By Week 48|Lost to Follow-up|2|||
23482442|NCT00814879|65509526|FG000|By Week 48|Death|0|||
23482443|NCT00814879|65509527|FG001|By Week 48|Death|1|||
23482444|NCT00604214|65509528|FG000|Baseline to Day 28|Death|223|||
23601682|NCT01856569|65933849|FG000|Overall Study|Lost to Follow-up|3|||
23482445|NCT00604214|65509529|FG001|Baseline to Day 28|Death|202|||
23482446|NCT00604214|65509528|FG000|Baseline to Day 28|Lost to Follow-up|2|||
23482447|NCT00604214|65509529|FG001|Baseline to Day 28|Lost to Follow-up|4|||
23482448|NCT00604214|65509528|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
23482449|NCT00604214|65509529|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
23482450|NCT00604214|65509528|FG000|Day 29 to Day 90|Death|64|||
23482451|NCT00604214|65509529|FG001|Day 29 to Day 90|Death|67|||
23482452|NCT00604214|65509528|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
23482453|NCT00604214|65509529|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
23482454|NCT00604214|65509528|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
23482455|NCT00604214|65509529|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
23482456|NCT00604214|65509528|FG000|Day 91 to Day 180|Death|19|||
23482457|NCT00604214|65509529|FG001|Day 91 to Day 180|Death|23|||
23482458|NCT00604214|65509528|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
23482459|NCT00604214|65509529|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
23482460|NCT00604214|65509528|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
23482461|NCT00604214|65509529|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
23482462|NCT01752036|65509531|FG000|Overall Study|Death|2|||
23482463|NCT00064298|65509532|FG000|Overall Study|Withdrawal by Subject|2|||
23482464|NCT00064298|65509533|FG001|Overall Study|Withdrawal by Subject|1|||
23482465|NCT00064298|65509532|FG000|Overall Study|Lost to Follow-up|2|||
23482466|NCT00064298|65509533|FG001|Overall Study|Lost to Follow-up|2|||
23482467|NCT00064298|65509532|FG000|Overall Study|Death|0|||
23482468|NCT00064298|65509533|FG001|Overall Study|Death|1|||
23482469|NCT00064298|65509532|FG000|Overall Study|Disease Progression|2|||
23482470|NCT00064298|65509533|FG001|Overall Study|Disease Progression|1|||
23482471|NCT04738318|65509534|FG000|Overall Study|Protocol Violation|1|||
23482472|NCT04738318|65509535|FG001|Overall Study|Protocol Violation|0|||
23482473|NCT02764190|65509536|FG000|Overall Study|Lost to Follow-up|17|||
23482474|NCT02764190|65509537|FG001|Overall Study|Lost to Follow-up|13|||
23482475|NCT00290407|65509539|FG000|Overall Study|Physician Decision|2|||
23482476|NCT03433339|65509541|FG000|Overall Study|Lost to Follow-up|2|||
23482477|NCT03433339|65509542|FG001|Overall Study|Lost to Follow-up|0|||
23482478|NCT03433339|65509541|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
23482479|NCT03433339|65509542|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
23482480|NCT03433339|65509541|FG000|Overall Study|Withdrawal by Subject|0|||
23482481|NCT03433339|65509542|FG001|Overall Study|Withdrawal by Subject|2|||
23482482|NCT01246466|65509544|FG000|Overall Study|Death|1|||
23482483|NCT01246466|65509544|FG000|Overall Study|Withdrawal by Subject|1|||
23482484|NCT01585584|65509547|FG000|Overall Study|Lack of Efficacy|1|||
23482485|NCT01585584|65509547|FG000|Overall Study|Withdrawal by Subject|1|||
23482486|NCT01585584|65509547|FG000|Overall Study|Physician Decision|2|||
23482487|NCT00475423|65509551|FG000|Overall Study|Protocol Violation|5|||
23482488|NCT00475423|65509551|FG000|Overall Study|Adverse Event|4|||
23482489|NCT00475423|65509551|FG000|Overall Study|Withdrawal by Subject|6|||
23482490|NCT00475423|65509551|FG000|Overall Study|Lack of Efficacy|8|||
23482491|NCT00475423|65509551|FG000|Overall Study|Death|1|||
23482492|NCT00475423|65509551|FG000|Overall Study|Reason not specified|1|||
23482493|NCT00475423|65509551|FG000|Overall Study|Lost to Follow-up|7|||
23601683|NCT01856569|65933849|FG000|Overall Study|Did not met inclusion criteria|8|||
23601684|NCT03697603|65933852|FG000|Overall Study|Adverse Event|3|||
23601685|NCT03697603|65933853|FG001|Overall Study|Adverse Event|18|||
23601686|NCT03697603|65933854|FG002|Overall Study|Adverse Event|3|||
23482494|NCT01551420|65509552|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
23482495|NCT01551420|65509553|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
23482496|NCT01551420|65509552|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
23482497|NCT01551420|65509553|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
23482498|NCT01551420|65509552|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
23482499|NCT01551420|65509553|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
23482500|NCT01551420|65509552|FG000|Screened for Part B Eligibility|Declined participation|8|||
23482501|NCT01551420|65509553|FG001|Screened for Part B Eligibility|Declined participation|1|||
23482502|NCT01551420|65509552|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
23482503|NCT01551420|65509553|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
23482504|NCT01551420|65509552|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
23482505|NCT01551420|65509553|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
23482506|NCT01551420|65509552|FG000|Home Use (Part B)|Withdrawal by staff|0|||
23482507|NCT01551420|65509553|FG001|Home Use (Part B)|Withdrawal by staff|1|||
23482508|NCT03860935|65509556|FG000|Overall Study|Withdrawal of Consent|15|||
23482509|NCT03860935|65509557|FG001|Overall Study|Withdrawal of Consent|6|||
23482510|NCT03860935|65509556|FG000|Overall Study|Death|75|||
23482511|NCT03860935|65509557|FG001|Overall Study|Death|51|||
23482512|NCT03025789|65509558|FG000|Overall Study|Lack of Efficacy|6|||
23482513|NCT03025789|65509559|FG001|Overall Study|Lack of Efficacy|1|||
23482514|NCT03025789|65509558|FG000|Overall Study|Death|1|||
23482515|NCT03025789|65509559|FG001|Overall Study|Death|0|||
23482516|NCT03025789|65509558|FG000|Overall Study|Withdrawal by Subject|0|||
23482517|NCT03025789|65509559|FG001|Overall Study|Withdrawal by Subject|2|||
23659996|NCT00578786|66142454|FG002|Overall Study|Physician Decision|1|||
23659997|NCT00578786|66142452|FG000|Overall Study|Sponsor Decision|0|||
23659998|NCT00578786|66142453|FG001|Overall Study|Sponsor Decision|0|||
23659999|NCT00578786|66142454|FG002|Overall Study|Sponsor Decision|1|||
23660000|NCT00578786|66142452|FG000|Overall Study|Lost to Follow-up|0|||
23660001|NCT00578786|66142453|FG001|Overall Study|Lost to Follow-up|4|||
23660002|NCT00578786|66142454|FG002|Overall Study|Lost to Follow-up|0|||
23660003|NCT00578786|66142452|FG000|Overall Study|Pregnancy|0|||
23660004|NCT00578786|66142453|FG001|Overall Study|Pregnancy|1|||
23365540|NCT01298700|65084987|FG000|Overall Study|Protocol Violation|6|||
23601687|NCT03697603|65933852|FG000|Overall Study|Physician Decision|1|||
23601688|NCT03697603|65933853|FG001|Overall Study|Physician Decision|0|||
23601689|NCT03697603|65933854|FG002|Overall Study|Physician Decision|2|||
23601690|NCT03697603|65933852|FG000|Overall Study|Protocol Violation|3|||
23601691|NCT03697603|65933853|FG001|Overall Study|Protocol Violation|8|||
23601692|NCT03697603|65933854|FG002|Overall Study|Protocol Violation|5|||
23601693|NCT03697603|65933852|FG000|Overall Study|Withdrawal by Subject|5|||
23601694|NCT03697603|65933853|FG001|Overall Study|Withdrawal by Subject|1|||
23601695|NCT03697603|65933854|FG002|Overall Study|Withdrawal by Subject|1|||
23601696|NCT03697603|65933852|FG000|Overall Study|Protocol Violation|0|||
23601697|NCT03697603|65933853|FG001|Overall Study|Protocol Violation|0|||
23601698|NCT03697603|65933854|FG002|Overall Study|Protocol Violation|1|||
23601699|NCT03170882|65933855|FG000|Overall Study|Death|17|||
23601700|NCT03170882|65933856|FG001|Overall Study|Death|29|||
23660005|NCT00578786|66142454|FG002|Overall Study|Pregnancy|0|||
23660006|NCT00578786|66142452|FG000|Overall Study|Not Otherwise Specified|0|||
23601701|NCT03170882|65933855|FG000|Overall Study|Lost to Follow-up|0|||
23601702|NCT03170882|65933856|FG001|Overall Study|Lost to Follow-up|1|||
23601703|NCT03170882|65933855|FG000|Overall Study|Withdrawal by Subject|4|||
23601704|NCT03170882|65933856|FG001|Overall Study|Withdrawal by Subject|7|||
23601705|NCT03170882|65933855|FG000|Overall Study|Reason not Specified|28|||
23601706|NCT03170882|65933856|FG001|Overall Study|Reason not Specified|36|||
23601707|NCT00467272|65933857|FG000|Overall Study|Pneumonia|2|||
23601708|NCT00467272|65933857|FG000|Overall Study|Thrombophlebitis|1|||
23601709|NCT02334215|65933870|FG000|Overall Study|Death|1|||
23601710|NCT02334215|65933871|FG001|Overall Study|Death|1|||
23601711|NCT02334215|65933872|FG002|Overall Study|Death|0|||
23601712|NCT02334215|65933870|FG000|Overall Study|Lost to Follow-up|1|||
23601713|NCT02334215|65933871|FG001|Overall Study|Lost to Follow-up|0|||
23601714|NCT02334215|65933872|FG002|Overall Study|Lost to Follow-up|4|||
23601715|NCT02334215|65933870|FG000|Overall Study|Withdrawal by Subject|2|||
23601716|NCT02334215|65933871|FG001|Overall Study|Withdrawal by Subject|2|||
23601717|NCT02334215|65933872|FG002|Overall Study|Withdrawal by Subject|1|||
23601718|NCT02334215|65933870|FG000|Overall Study|Not released from incarceration on time|3|||
23601719|NCT02334215|65933871|FG001|Overall Study|Not released from incarceration on time|3|||
23601720|NCT02334215|65933872|FG002|Overall Study|Not released from incarceration on time|3|||
23601721|NCT02334215|65933870|FG000|Overall Study|Incarcerated|0|||
23601722|NCT02334215|65933871|FG001|Overall Study|Incarcerated|0|||
23601723|NCT02334215|65933872|FG002|Overall Study|Incarcerated|7|||
23601724|NCT02575365|65933878|FG000|Overall Study|Lost to Follow-up|4|||
23660007|NCT00578786|66142453|FG001|Overall Study|Not Otherwise Specified|4|||
23660008|NCT00578786|66142454|FG002|Overall Study|Not Otherwise Specified|1|||
23660009|NCT00578786|66142452|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
23660010|NCT00578786|66142453|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
23660011|NCT00578786|66142454|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
23660012|NCT01293968|66142455|FG000|Overall Study|non-cooperation|3|||
23660013|NCT01293968|66142456|FG001|Overall Study|non-cooperation|3|||
23660014|NCT01721876|66142461|FG000|Overall Study|Not treated|1|||
23660015|NCT01721876|66142462|FG001|Overall Study|Not treated|4|||
23660016|NCT01721876|66142461|FG000|Overall Study|Disease progression / relapse|123|||
23660017|NCT01721876|66142462|FG001|Overall Study|Disease progression / relapse|156|||
23660018|NCT01721876|66142461|FG000|Overall Study|Death|6|||
23660019|NCT01721876|66142462|FG001|Overall Study|Death|13|||
23660020|NCT01721876|66142461|FG000|Overall Study|Adverse Event|41|||
23660021|NCT01721876|66142462|FG001|Overall Study|Adverse Event|165|||
23660022|NCT01721876|66142461|FG000|Overall Study|Protocol Violation|2|||
23660023|NCT01721876|66142462|FG001|Overall Study|Protocol Violation|1|||
23660024|NCT01721876|66142461|FG000|Overall Study|Withdrawal by Subject|15|||
23660025|NCT01721876|66142462|FG001|Overall Study|Withdrawal by Subject|38|||
23660026|NCT01721876|66142461|FG000|Overall Study|Reason not listed|34|||
23660027|NCT01721876|66142462|FG001|Overall Study|Reason not listed|63|||
23660028|NCT01721876|66142461|FG000|Overall Study|Sponsor terminated trial|0|||
23660029|NCT01721876|66142462|FG001|Overall Study|Sponsor terminated trial|4|||
23660030|NCT00073528|66142465|FG000|Overall Study|Death|488|||
23601725|NCT02646618|65933881|FG000|Overall Study|Lost to Follow-up|10|||
23601726|NCT02646618|65933882|FG001|Overall Study|Lost to Follow-up|14|||
23660031|NCT00073528|66142466|FG001|Overall Study|Death|473|||
23660032|NCT00073528|66142465|FG000|Overall Study|Lost to Follow-up|52|||
23660033|NCT00073528|66142466|FG001|Overall Study|Lost to Follow-up|45|||
23660034|NCT00073528|66142465|FG000|Overall Study|Withdrawal by Subject|50|||
23660035|NCT00073528|66142466|FG001|Overall Study|Withdrawal by Subject|45|||
23660036|NCT00073528|66142465|FG000|Overall Study|Study terminated by Sponsor|10|||
23660037|NCT00073528|66142466|FG001|Overall Study|Study terminated by Sponsor|29|||
23660038|NCT00073528|66142465|FG000|Overall Study|Other|18|||
23660039|NCT00073528|66142466|FG001|Overall Study|Other|19|||
23660040|NCT00073528|66142465|FG000|Overall Study|Other|9|||
23660041|NCT00073528|66142466|FG001|Overall Study|Other|12|||
23660042|NCT00073528|66142465|FG000|Overall Study|Protocol Violation|3|||
23660043|NCT00073528|66142466|FG001|Overall Study|Protocol Violation|5|||
23660044|NCT01519765|66142469|FG000|Overall Study|Adverse Event|0|||
23660045|NCT01519765|66142470|FG001|Overall Study|Adverse Event|1|||
23660046|NCT01519765|66142469|FG000|Overall Study|Lack of Efficacy|2|||
23660047|NCT01519765|66142470|FG001|Overall Study|Lack of Efficacy|0|||
23660048|NCT01519765|66142469|FG000|Overall Study|Protocol Violation|1|||
23660049|NCT01519765|66142470|FG001|Overall Study|Protocol Violation|0|||
23660050|NCT01519765|66142469|FG000|Overall Study|Withdrawal by Subject|0|||
23660051|NCT01519765|66142470|FG001|Overall Study|Withdrawal by Subject|1|||
23660052|NCT01490450|66142476|FG000|Period 1|Lack of Efficacy|2|||
23660053|NCT01490450|66142477|FG001|Period 1|Lack of Efficacy|0|||
23660054|NCT01490450|66142478|FG002|Period 1|Lack of Efficacy|3|||
23660055|NCT01490450|66142479|FG003|Period 1|Lack of Efficacy|0|||
23660056|NCT01490450|66142476|FG000|Period 1|Adverse Event|0|||
23660057|NCT01490450|66142477|FG001|Period 1|Adverse Event|0|||
23660058|NCT01490450|66142478|FG002|Period 1|Adverse Event|0|||
23660059|NCT01490450|66142479|FG003|Period 1|Adverse Event|5|||
23660060|NCT01490450|66142476|FG000|Period 1|Request to discontinue treatment|1|||
23660061|NCT01490450|66142477|FG001|Period 1|Request to discontinue treatment|0|||
23660062|NCT01490450|66142478|FG002|Period 1|Request to discontinue treatment|0|||
23660063|NCT01490450|66142479|FG003|Period 1|Request to discontinue treatment|0|||
23660064|NCT01490450|66142476|FG000|Period 1|Withdrawal by Subject|0|||
23660065|NCT01490450|66142477|FG001|Period 1|Withdrawal by Subject|0|||
23660066|NCT01490450|66142478|FG002|Period 1|Withdrawal by Subject|0|||
23660067|NCT01490450|66142479|FG003|Period 1|Withdrawal by Subject|3|||
23660068|NCT01490450|66142476|FG000|Period 1|No longer met study criteria|0|||
23660069|NCT01490450|66142477|FG001|Period 1|No longer met study criteria|1|||
23660070|NCT01490450|66142478|FG002|Period 1|No longer met study criteria|1|||
23660071|NCT01490450|66142479|FG003|Period 1|No longer met study criteria|0|||
23660072|NCT01490450|66142476|FG000|Period 2|Lack of Efficacy|0|||
23660073|NCT01490450|66142477|FG001|Period 2|Lack of Efficacy|0|||
23660074|NCT01490450|66142478|FG002|Period 2|Lack of Efficacy|0|||
23660075|NCT01490450|66142479|FG003|Period 2|Lack of Efficacy|1|||
23660076|NCT01490450|66142476|FG000|Period 2|Adverse Event|1|||
23660077|NCT01490450|66142477|FG001|Period 2|Adverse Event|1|||
23660078|NCT01490450|66142478|FG002|Period 2|Adverse Event|0|||
23660079|NCT01490450|66142479|FG003|Period 2|Adverse Event|1|||
23660080|NCT01490450|66142476|FG000|Period 2|Withdrawal by Subject|1|||
23660081|NCT01490450|66142477|FG001|Period 2|Withdrawal by Subject|0|||
23660082|NCT01490450|66142478|FG002|Period 2|Withdrawal by Subject|0|||
23660083|NCT01490450|66142479|FG003|Period 2|Withdrawal by Subject|0|||
23660084|NCT01490450|66142476|FG000|Period 2|Lost to Follow-up|0|||
23660085|NCT01490450|66142477|FG001|Period 2|Lost to Follow-up|0|||
23660086|NCT01490450|66142478|FG002|Period 2|Lost to Follow-up|0|||
23660087|NCT01490450|66142479|FG003|Period 2|Lost to Follow-up|2|||
23660088|NCT00736034|66142480|FG000|Overall Study|Adverse Event|2|||
23660089|NCT00314249|66142486|FG000|Overall Study|Adverse Event|73|||
23660090|NCT00314249|66142487|FG001|Overall Study|Adverse Event|94|||
23660091|NCT00314249|66142486|FG000|Overall Study|Lack of Efficacy|33|||
23660092|NCT00314249|66142487|FG001|Overall Study|Lack of Efficacy|24|||
23660093|NCT00314249|66142486|FG000|Overall Study|Withdrawal by Subject|21|||
23660094|NCT00314249|66142487|FG001|Overall Study|Withdrawal by Subject|28|||
23660095|NCT00314249|66142486|FG000|Overall Study|Lost to Follow-up|15|||
23660096|NCT00314249|66142487|FG001|Overall Study|Lost to Follow-up|9|||
23660097|NCT00314249|66142486|FG000|Overall Study|Physician Decision|1|||
23660098|NCT00314249|66142487|FG001|Overall Study|Physician Decision|1|||
23660099|NCT00314249|66142486|FG000|Overall Study|Withdrawn for other reasons|4|||
23660100|NCT00314249|66142487|FG001|Overall Study|Withdrawn for other reasons|1|||
23660101|NCT00314249|66142486|FG000|Overall Study|Non-Compliant|5|||
23660102|NCT00314249|66142487|FG001|Overall Study|Non-Compliant|6|||
23660103|NCT00853749|66142492|FG000|Overall Study|Lost to Follow-up|0|||
23660104|NCT00853749|66142493|FG001|Overall Study|Lost to Follow-up|1|||
23365541|NCT01298700|65084988|FG001|Overall Study|Protocol Violation|4|||
23660105|NCT02486653|66142498|FG000|Overall Study|Withdrawal by Subject|1|||
23660106|NCT02486653|66142499|FG001|Overall Study|Withdrawal by Subject|3|||
23660107|NCT02486653|66142498|FG000|Overall Study|Protocol Violation|1|||
23660108|NCT02486653|66142499|FG001|Overall Study|Protocol Violation|0|||
23660109|NCT02486653|66142498|FG000|Overall Study|surgery cancelled|4|||
23660110|NCT02486653|66142499|FG001|Overall Study|surgery cancelled|1|||
23660111|NCT03083847|66142500|FG000|Main|Physician Decision|0|||
23660112|NCT03083847|66142501|FG001|Main|Physician Decision|0|||
23482518|NCT01924429|65509560|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
23660113|NCT03083847|66142502|FG002|Main|Physician Decision|0|||
23365542|NCT01298700|65084987|FG000|Overall Study|Other Miscellaneous Reasons|16|||
23365543|NCT01298700|65084988|FG001|Overall Study|Other Miscellaneous Reasons|15|||
23365544|NCT01298700|65084987|FG000|Overall Study|Did not Receive Study Drug|3|||
23365545|NCT01298700|65084988|FG001|Overall Study|Did not Receive Study Drug|5|||
23365546|NCT04346199|65084991|FG000|Overall Study|Death|8|||
23365547|NCT04346199|65084992|FG001|Overall Study|Death|9|||
23365548|NCT04346199|65084991|FG000|Overall Study|Lost to Follow-up|0|||
23365549|NCT04346199|65084992|FG001|Overall Study|Lost to Follow-up|1|||
23365550|NCT04346199|65084991|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
23365551|NCT04346199|65084992|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
23365552|NCT04346199|65084991|FG000|Overall Study|Withdrawal by Subject|5|||
23365553|NCT04346199|65084992|FG001|Overall Study|Withdrawal by Subject|1|||
23365554|NCT01405898|65084993|FG000|Overall Study|Withdrawal by Subject|2|||
23365555|NCT01405898|65084994|FG001|Overall Study|Withdrawal by Subject|2|||
23365556|NCT03028142|65084995|FG000|Overall Study|Adverse Event|1|||
23365557|NCT03028142|65084996|FG001|Overall Study|Adverse Event|1|||
23365558|NCT03028142|65084997|FG002|Overall Study|Adverse Event|0|||
23365559|NCT03028142|65084998|FG003|Overall Study|Adverse Event|0|||
23365560|NCT03028142|65084999|FG004|Overall Study|Adverse Event|0|||
23365561|NCT03028142|65085000|FG005|Overall Study|Adverse Event|1|||
23365562|NCT03028142|65084995|FG000|Overall Study|Withdrawal by Subject|0|||
23365563|NCT03028142|65084996|FG001|Overall Study|Withdrawal by Subject|0|||
23365564|NCT03028142|65084997|FG002|Overall Study|Withdrawal by Subject|0|||
23365565|NCT03028142|65084998|FG003|Overall Study|Withdrawal by Subject|0|||
23365566|NCT03028142|65084999|FG004|Overall Study|Withdrawal by Subject|1|||
23365567|NCT03028142|65085000|FG005|Overall Study|Withdrawal by Subject|0|||
23365568|NCT01026948|65085001|FG000|Overall Study|Physician Decision|8|||
23365569|NCT03092752|65085005|FG000|Overall Study|Aged <40 years|14209|||
23365570|NCT03092752|65085005|FG000|Overall Study|At least one claim with T2DM|61299|||
23365571|NCT03092752|65085005|FG000|Overall Study|Having no claim of study drugs|29282|||
23365572|NCT03092752|65085005|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
23365573|NCT03092752|65085005|FG000|Overall Study|<6 month history|245900|||
23365574|NCT00606307|65085015|FG000|Overall Study|Adverse Event|2|||
23365575|NCT00606307|65085015|FG000|Overall Study|Withdrawal by Subject|2|||
23365576|NCT00606307|65085015|FG000|Overall Study|Disease progression|6|||
23365577|NCT00606307|65085015|FG000|Overall Study|QTc prolongation|1|||
23365578|NCT01151345|65085016|FG000|First Intervention Period|Protocol Violation|0|||
23365579|NCT01151345|65085017|FG001|First Intervention Period|Protocol Violation|1|||
23365580|NCT00338741|65085022|FG000|Overall Study|Lost to Follow-up|2|||
23365581|NCT00338741|65085023|FG001|Overall Study|Lost to Follow-up|0|||
23365582|NCT03200548|65085026|FG000|Overall Study|Withdrawal by Subject|5|||
23365583|NCT03200548|65085027|FG001|Overall Study|Withdrawal by Subject|11|||
23365584|NCT03200548|65085028|FG002|Overall Study|Withdrawal by Subject|7|||
23365585|NCT03200548|65085029|FG003|Overall Study|Withdrawal by Subject|6|||
23365586|NCT03677869|65085031|FG000|Overall Study|Withdrawal by Subject|1|||
23365587|NCT01051921|65085032|FG000|Overall Study|Physician Decision|9|||
23365588|NCT01051921|65085032|FG000|Overall Study|Adverse Event|8|||
23365589|NCT01051921|65085032|FG000|Overall Study|Withdrawal by Subject|7|||
23365590|NCT01051921|65085032|FG000|Overall Study|Lost to Follow-up|4|||
23365591|NCT01051921|65085032|FG000|Overall Study|virological failure|1|||
23365592|NCT01051921|65085032|FG000|Overall Study|patient moved|1|||
23365593|NCT03489343|65085033|FG000|Overall Study|Documented progressive disease|1|||
23365594|NCT03489343|65085034|FG001|Overall Study|Documented progressive disease|0|||
23365595|NCT03489343|65085035|FG002|Overall Study|Documented progressive disease|3|||
23365596|NCT03489343|65085036|FG003|Overall Study|Documented progressive disease|1|||
23365597|NCT03489343|65085037|FG004|Overall Study|Documented progressive disease|3|||
23365598|NCT03489343|65085038|FG005|Overall Study|Documented progressive disease|5|||
23365599|NCT03489343|65085039|FG006|Overall Study|Documented progressive disease|4|||
23365600|NCT03489343|65085033|FG000|Overall Study|Adverse Event|0|||
23365601|NCT03489343|65085034|FG001|Overall Study|Adverse Event|1|||
23365602|NCT03489343|65085035|FG002|Overall Study|Adverse Event|0|||
23482519|NCT01924429|65509561|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
23482520|NCT01401959|65509562|FG000|Enrolled|Withdrawal by Subject|1|||
23601727|NCT00822900|65933883|FG000|Overall Study|Withdrawal by Subject|14|||
23365603|NCT03489343|65085036|FG003|Overall Study|Adverse Event|0|||
23601728|NCT00822900|65933884|FG001|Overall Study|Withdrawal by Subject|14|||
23601729|NCT00822900|65933883|FG000|Overall Study|Lost to Follow-up|9|||
23601730|NCT00822900|65933884|FG001|Overall Study|Lost to Follow-up|9|||
23601731|NCT00822900|65933883|FG000|Overall Study|Death|83|||
23601732|NCT00822900|65933884|FG001|Overall Study|Death|69|||
23601733|NCT00822900|65933883|FG000|Overall Study|Became a ward of the state|2|||
23601734|NCT00822900|65933884|FG001|Overall Study|Became a ward of the state|1|||
23601735|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
23365604|NCT03489343|65085037|FG004|Overall Study|Adverse Event|0|||
23365605|NCT03489343|65085038|FG005|Overall Study|Adverse Event|1|||
23365606|NCT03489343|65085039|FG006|Overall Study|Adverse Event|0|||
23365607|NCT03489343|65085033|FG000|Overall Study|Withdrawal by Subject|0|||
23482521|NCT01401959|65509563|FG001|Enrolled|Withdrawal by Subject|0|||
23482522|NCT01401959|65509564|FG002|Enrolled|Withdrawal by Subject|0|||
23482523|NCT01401959|65509562|FG000|Treated|Disease Progression|2|||
23482524|NCT01401959|65509563|FG001|Treated|Disease Progression|2|||
23482525|NCT01401959|65509564|FG002|Treated|Disease Progression|1|||
23482526|NCT01401959|65509562|FG000|Treated|Adverse Event|4|||
23482527|NCT01401959|65509563|FG001|Treated|Adverse Event|3|||
23482528|NCT01401959|65509564|FG002|Treated|Adverse Event|2|||
23482529|NCT01401959|65509562|FG000|Treated|Withdrawal by Subject|1|||
23482530|NCT01401959|65509563|FG001|Treated|Withdrawal by Subject|2|||
23482531|NCT01401959|65509564|FG002|Treated|Withdrawal by Subject|2|||
23482532|NCT01401959|65509562|FG000|Treated|Protocol Violation|0|||
23482533|NCT01401959|65509563|FG001|Treated|Protocol Violation|1|||
23482534|NCT01401959|65509564|FG002|Treated|Protocol Violation|0|||
23482535|NCT00636987|65509567|FG000|Overall Study|Death|44|||
23482536|NCT00636987|65509567|FG000|Overall Study|Explanted|13|||
23482537|NCT00636987|65509567|FG000|Overall Study|Lost to Follow-up|63|||
23482538|NCT00636987|65509567|FG000|Overall Study|5 year visit window not complete|69|||
23482539|NCT02478398|65509568|FG000|Overall Study|Adverse Event|20|||
23482540|NCT02478398|65509569|FG001|Overall Study|Adverse Event|5|||
23482541|NCT02478398|65509568|FG000|Overall Study|Lost to Follow-up|5|||
23482542|NCT02478398|65509569|FG001|Overall Study|Lost to Follow-up|4|||
23482543|NCT02478398|65509568|FG000|Overall Study|Non-Compliance With Study Drug|5|||
23482544|NCT02478398|65509569|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23482545|NCT02478398|65509568|FG000|Overall Study|Protocol Violation|3|||
23482546|NCT02478398|65509569|FG001|Overall Study|Protocol Violation|1|||
23482547|NCT02478398|65509568|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
23482548|NCT02478398|65509569|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23482549|NCT02478398|65509568|FG000|Overall Study|Withdrawal By Participant|10|||
23482550|NCT02478398|65509569|FG001|Overall Study|Withdrawal By Participant|4|||
23482551|NCT00219544|65509570|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
23660114|NCT03083847|66142503|FG003|Main|Physician Decision|0|||
23482552|NCT00219544|65509571|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
23482553|NCT00219544|65509570|FG000|Single Blind Treatment Period|Adverse Event|9|||
23482554|NCT00219544|65509571|FG001|Single Blind Treatment Period|Adverse Event|0|||
23482555|NCT00219544|65509570|FG000|Single Blind Treatment Period|Protocol Violation|4|||
23482556|NCT00219544|65509571|FG001|Single Blind Treatment Period|Protocol Violation|0|||
23482557|NCT00219544|65509570|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
23482558|NCT00219544|65509571|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
23482559|NCT00219544|65509570|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
23482560|NCT00219544|65509571|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
23482561|NCT00219544|65509570|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
23482562|NCT00219544|65509571|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
23660115|NCT03083847|66142504|FG004|Main|Physician Decision|0|||
23660116|NCT03083847|66142505|FG005|Main|Physician Decision|1|||
23660117|NCT03083847|66142506|FG006|Main|Physician Decision|0|||
23660118|NCT03083847|66142507|FG007|Main|Physician Decision|0|||
23660119|NCT03083847|66142508|FG008|Main|Physician Decision|0|||
23660120|NCT03083847|66142509|FG009|Main|Physician Decision|0|||
23660121|NCT03083847|66142500|FG000|Main|Pregnancy|0|||
23660122|NCT03083847|66142501|FG001|Main|Pregnancy|0|||
23660123|NCT03083847|66142502|FG002|Main|Pregnancy|0|||
23660124|NCT03083847|66142503|FG003|Main|Pregnancy|0|||
23482563|NCT02882152|65509572|FG000|Overall Study|Lost to Follow-up|1|||
23660125|NCT03083847|66142504|FG004|Main|Pregnancy|0|||
23660126|NCT03083847|66142505|FG005|Main|Pregnancy|0|||
23482564|NCT02882152|65509573|FG001|Overall Study|Lost to Follow-up|0|||
23482565|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
23482566|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
23482567|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
23482568|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
23482569|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
23482570|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
23482571|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
23660127|NCT03083847|66142506|FG006|Main|Pregnancy|0|||
23482572|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
23660128|NCT03083847|66142507|FG007|Main|Pregnancy|1|||
23660129|NCT03083847|66142508|FG008|Main|Pregnancy|0|||
23660130|NCT03083847|66142509|FG009|Main|Pregnancy|0|||
23660131|NCT03083847|66142500|FG000|Main|Adverse Event|0|||
23660132|NCT03083847|66142501|FG001|Main|Adverse Event|0|||
23660133|NCT03083847|66142502|FG002|Main|Adverse Event|0|||
23660134|NCT03083847|66142503|FG003|Main|Adverse Event|0|||
23660135|NCT03083847|66142504|FG004|Main|Adverse Event|0|||
23660136|NCT03083847|66142505|FG005|Main|Adverse Event|0|||
23660137|NCT03083847|66142506|FG006|Main|Adverse Event|0|||
23365608|NCT03489343|65085034|FG001|Overall Study|Withdrawal by Subject|0|||
23365609|NCT03489343|65085035|FG002|Overall Study|Withdrawal by Subject|0|||
23365610|NCT03489343|65085036|FG003|Overall Study|Withdrawal by Subject|1|||
23365611|NCT03489343|65085037|FG004|Overall Study|Withdrawal by Subject|0|||
23365612|NCT03489343|65085038|FG005|Overall Study|Withdrawal by Subject|1|||
23482573|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
23482574|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
23482575|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
23482576|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
23482577|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
23482578|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
23482579|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
23482580|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
23482581|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
23482582|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
23482583|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
23482584|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
23482585|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
23482586|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
23482587|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
23482588|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
23482589|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23482590|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23482591|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
23482592|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23482593|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23482594|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
23482595|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23482596|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23482597|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
23482598|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23482599|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23482600|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
23482601|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23482602|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23482603|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
23482604|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23482605|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23482606|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
23482607|NCT00887744|65509577|FG000|Overall Study|Adverse Event|3|||
23482608|NCT00887744|65509577|FG000|Overall Study|Death|1|||
23482609|NCT00887744|65509577|FG000|Overall Study|Lost to Follow-up|3|||
23482610|NCT00887744|65509577|FG000|Overall Study|Withdrawal by Subject|18|||
23482611|NCT00887744|65509577|FG000|Overall Study|Various reasons|9|||
23482612|NCT02160002|65509580|FG000|Overall Study|Withdrawal by Subject|2|||
23482613|NCT02160002|65509581|FG001|Overall Study|Withdrawal by Subject|1|||
23601736|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
23660138|NCT03083847|66142507|FG007|Main|Adverse Event|2|||
23365613|NCT03489343|65085039|FG006|Overall Study|Withdrawal by Subject|1|||
23365614|NCT03489343|65085033|FG000|Overall Study|Clinical progression|0|||
23365615|NCT03489343|65085034|FG001|Overall Study|Clinical progression|0|||
23365616|NCT03489343|65085035|FG002|Overall Study|Clinical progression|0|||
23482614|NCT03726996|65509582|FG000|Overall Study|Parent's decision|2|||
23482615|NCT03726996|65509582|FG000|Overall Study|Study early termination|2|||
23482616|NCT00829283|65509583|FG000|Overall Study|Lost to Follow-up|7|||
23482617|NCT00829283|65509584|FG001|Overall Study|Lost to Follow-up|25|||
23482618|NCT02536833|65509585|FG000|Overall Study|Discontinued Before Treatment|0|||
23482619|NCT02536833|65509586|FG001|Overall Study|Discontinued Before Treatment|0|||
23482620|NCT02536833|65509587|FG002|Overall Study|Discontinued Before Treatment|1|||
23482621|NCT02536833|65509588|FG003|Overall Study|Discontinued Before Treatment|2|||
23482622|NCT02536833|65509585|FG000|Overall Study|Adverse Event|1|||
23660139|NCT03083847|66142508|FG008|Main|Adverse Event|0|||
23482623|NCT02536833|65509586|FG001|Overall Study|Adverse Event|3|||
23482624|NCT02536833|65509587|FG002|Overall Study|Adverse Event|4|||
23482625|NCT02536833|65509588|FG003|Overall Study|Adverse Event|1|||
23482626|NCT02536833|65509585|FG000|Overall Study|Lost to Follow-up|2|||
23482627|NCT02536833|65509586|FG001|Overall Study|Lost to Follow-up|1|||
23482628|NCT02536833|65509587|FG002|Overall Study|Lost to Follow-up|2|||
23482629|NCT02536833|65509588|FG003|Overall Study|Lost to Follow-up|2|||
23482630|NCT02536833|65509585|FG000|Overall Study|Physician Decision|0|||
23482631|NCT02536833|65509586|FG001|Overall Study|Physician Decision|0|||
23482632|NCT02536833|65509587|FG002|Overall Study|Physician Decision|0|||
23482633|NCT02536833|65509588|FG003|Overall Study|Physician Decision|1|||
23482634|NCT02536833|65509585|FG000|Overall Study|Site Terminated by Sponsor|2|||
23482635|NCT02536833|65509586|FG001|Overall Study|Site Terminated by Sponsor|2|||
23482636|NCT02536833|65509587|FG002|Overall Study|Site Terminated by Sponsor|2|||
23482637|NCT02536833|65509588|FG003|Overall Study|Site Terminated by Sponsor|2|||
23482638|NCT02536833|65509585|FG000|Overall Study|Subject Non-Compliance|0|||
23365617|NCT03489343|65085036|FG003|Overall Study|Clinical progression|1|||
23365618|NCT03489343|65085037|FG004|Overall Study|Clinical progression|0|||
23365619|NCT03489343|65085038|FG005|Overall Study|Clinical progression|0|||
23365620|NCT03489343|65085039|FG006|Overall Study|Clinical progression|1|||
23365621|NCT04435808|65085053|FG000|Overall Study|Study stopped by DSMB|0|||
23365622|NCT04435808|65085054|FG001|Overall Study|Study stopped by DSMB|1|||
23365623|NCT01705080|65085055|FG000|Overall Study|Missed visit|10|||
23482639|NCT02536833|65509586|FG001|Overall Study|Subject Non-Compliance|1|||
23482640|NCT02536833|65509587|FG002|Overall Study|Subject Non-Compliance|1|||
23660140|NCT03083847|66142509|FG009|Main|Adverse Event|0|||
23482641|NCT02536833|65509588|FG003|Overall Study|Subject Non-Compliance|0|||
23482642|NCT02536833|65509585|FG000|Overall Study|Withdrawal by Subject|4|||
23482643|NCT02536833|65509586|FG001|Overall Study|Withdrawal by Subject|3|||
23482644|NCT02536833|65509587|FG002|Overall Study|Withdrawal by Subject|5|||
23482645|NCT02536833|65509588|FG003|Overall Study|Withdrawal by Subject|11|||
23482646|NCT00829933|65509590|FG000|Overall Study|Adverse Event|2|||
23482647|NCT00829933|65509591|FG001|Overall Study|Adverse Event|3|||
23482648|NCT00829933|65509592|FG002|Overall Study|Adverse Event|2|||
23482649|NCT00829933|65509593|FG003|Overall Study|Adverse Event|1|||
23482650|NCT00829933|65509590|FG000|Overall Study|Death|0|||
23482651|NCT00829933|65509591|FG001|Overall Study|Death|0|||
23482652|NCT00829933|65509592|FG002|Overall Study|Death|1|||
23482653|NCT00829933|65509593|FG003|Overall Study|Death|1|||
23482654|NCT00829933|65509590|FG000|Overall Study|Lack of Efficacy|0|||
23482655|NCT00829933|65509591|FG001|Overall Study|Lack of Efficacy|1|||
23482656|NCT00829933|65509592|FG002|Overall Study|Lack of Efficacy|0|||
23482657|NCT00829933|65509593|FG003|Overall Study|Lack of Efficacy|0|||
23482658|NCT00829933|65509590|FG000|Overall Study|Physician Decision|5|||
23482659|NCT00829933|65509591|FG001|Overall Study|Physician Decision|7|||
23482660|NCT00829933|65509592|FG002|Overall Study|Physician Decision|8|||
23482661|NCT00829933|65509593|FG003|Overall Study|Physician Decision|1|||
23482662|NCT00829933|65509590|FG000|Overall Study|Pregnancy|0|||
23482663|NCT00829933|65509591|FG001|Overall Study|Pregnancy|0|||
23482664|NCT00829933|65509592|FG002|Overall Study|Pregnancy|0|||
23482665|NCT00829933|65509593|FG003|Overall Study|Pregnancy|2|||
23482666|NCT00829933|65509590|FG000|Overall Study|Protocol Violation|2|||
23482667|NCT00829933|65509591|FG001|Overall Study|Protocol Violation|1|||
23482668|NCT00829933|65509592|FG002|Overall Study|Protocol Violation|0|||
23482669|NCT00829933|65509593|FG003|Overall Study|Protocol Violation|0|||
23482670|NCT00829933|65509590|FG000|Overall Study|withdrew before treatment started|5|||
23482671|NCT00829933|65509591|FG001|Overall Study|withdrew before treatment started|1|||
23601737|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23660141|NCT03083847|66142500|FG000|Main|Withdrawal by Subject|0|||
23660142|NCT03083847|66142501|FG001|Main|Withdrawal by Subject|0|||
23482672|NCT00829933|65509592|FG002|Overall Study|withdrew before treatment started|2|||
23482673|NCT00829933|65509593|FG003|Overall Study|withdrew before treatment started|9|||
23482674|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
23482675|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
23482676|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
23482677|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
23482678|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
23482679|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
23482680|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
23482681|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
23482682|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
23482683|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23482684|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23660143|NCT03083847|66142502|FG002|Main|Withdrawal by Subject|0|||
23482685|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23482686|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
23482687|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
23482688|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23482689|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
23482690|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
23482691|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
23482692|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Other|4|||
23482693|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Other|9|||
23482694|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Other|4|||
23482695|NCT00591578|65509594|FG000|Open-Label Extension Phase|Adverse Event|3|||
23482696|NCT00591578|65509595|FG001|Open-Label Extension Phase|Adverse Event|5|||
23482697|NCT00591578|65509596|FG002|Open-Label Extension Phase|Adverse Event|0|||
23482698|NCT00591578|65509594|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
23482699|NCT00591578|65509595|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
23482700|NCT00591578|65509596|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23482701|NCT00591578|65509594|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
23482702|NCT00591578|65509595|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
23482703|NCT00591578|65509596|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23482704|NCT00591578|65509594|FG000|Open-Label Extension Phase|Other|1|||
23482705|NCT00591578|65509595|FG001|Open-Label Extension Phase|Other|0|||
23482706|NCT00591578|65509596|FG002|Open-Label Extension Phase|Other|0|||
23482707|NCT03678870|65509599|FG000|Overall Study|prescribed non- protocol medications|10|||
23482708|NCT03678870|65509600|FG001|Overall Study|prescribed non- protocol medications|6|||
23482709|NCT03678870|65509599|FG000|Overall Study|Lost to Follow-up|3|||
23482710|NCT03678870|65509600|FG001|Overall Study|Lost to Follow-up|2|||
23482711|NCT01423604|65509601|FG000|Safety Run-In|Adverse Event|3|||
23482712|NCT01423604|65509602|FG001|Safety Run-In|Adverse Event|0|||
23482713|NCT01423604|65509601|FG000|Safety Run-In|Death|1|||
23482714|NCT01423604|65509602|FG001|Safety Run-In|Death|0|||
23482715|NCT01423604|65509601|FG000|Safety Run-In|Physician Decision|1|||
23482716|NCT01423604|65509602|FG001|Safety Run-In|Physician Decision|0|||
23482717|NCT01423604|65509601|FG000|Safety Run-In|Disease progression|3|||
23482718|NCT01423604|65509602|FG001|Safety Run-In|Disease progression|0|||
23482719|NCT01423604|65509601|FG000|Safety Run-In|Patient decision|1|||
23482720|NCT01423604|65509602|FG001|Safety Run-In|Patient decision|0|||
23482721|NCT01423604|65509601|FG000|Randomized|Adverse Event|4|||
23482722|NCT01423604|65509602|FG001|Randomized|Adverse Event|10|||
23482723|NCT01423604|65509601|FG000|Randomized|Death|1|||
23482724|NCT01423604|65509602|FG001|Randomized|Death|0|||
23482725|NCT01423604|65509601|FG000|Randomized|Physician Decision|16|||
23482726|NCT01423604|65509602|FG001|Randomized|Physician Decision|13|||
23482727|NCT01423604|65509601|FG000|Randomized|Other - unspecified|37|||
23482728|NCT01423604|65509602|FG001|Randomized|Other - unspecified|31|||
23482729|NCT01423604|65509601|FG000|Randomized|Patient decision|5|||
23482730|NCT01423604|65509602|FG001|Randomized|Patient decision|9|||
23482731|NCT02554279|65509603|FG000|Overall Study|Adverse Event|2|||
23365624|NCT01705080|65085056|FG001|Overall Study|Missed visit|4|||
23482732|NCT02554279|65509604|FG001|Overall Study|Adverse Event|5|||
23482733|NCT02554279|65509603|FG000|Overall Study|Lost to Follow-up|3|||
23365625|NCT01705080|65085057|FG002|Overall Study|Missed visit|1|||
23365626|NCT01705080|65085055|FG000|Overall Study|Death|4|||
23365627|NCT01705080|65085056|FG001|Overall Study|Death|4|||
23365628|NCT01705080|65085057|FG002|Overall Study|Death|6|||
23365629|NCT01705080|65085055|FG000|Overall Study|Withdrawal by Subject|61|||
23365630|NCT01705080|65085056|FG001|Overall Study|Withdrawal by Subject|44|||
23365631|NCT01705080|65085057|FG002|Overall Study|Withdrawal by Subject|9|||
23365632|NCT02982863|65085058|FG000|Overall Study|Not eligible patients|809|||
23365633|NCT02982863|65085059|FG001|Overall Study|Not eligible patients|4261|||
23365634|NCT02982863|65085060|FG002|Overall Study|Not eligible patients|1852|||
23660144|NCT03083847|66142503|FG003|Main|Withdrawal by Subject|0|||
23365635|NCT02982863|65085061|FG003|Overall Study|Not eligible patients|1400|||
23365636|NCT02982863|65085062|FG004|Overall Study|Not eligible patients|492|||
23365637|NCT00780975|65085063|FG000|Overall Study|Progressive disease|3|||
23365638|NCT00780975|65085063|FG000|Overall Study|Toxicity|5|||
23365639|NCT01587885|65085065|FG000|Treatment Period 1|Failure to Return|0|||
23660145|NCT03083847|66142504|FG004|Main|Withdrawal by Subject|0|||
23660146|NCT03083847|66142505|FG005|Main|Withdrawal by Subject|0|||
23660147|NCT03083847|66142506|FG006|Main|Withdrawal by Subject|1|||
23660148|NCT03083847|66142507|FG007|Main|Withdrawal by Subject|1|||
23660149|NCT03083847|66142508|FG008|Main|Withdrawal by Subject|0|||
23660150|NCT03083847|66142509|FG009|Main|Withdrawal by Subject|0|||
23660151|NCT00873366|66142511|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
23660152|NCT00873366|66142511|FG000|Overall Study|Off tamoxifen due to side effects|2|||
23660153|NCT00873366|66142511|FG000|Overall Study|Refused to continue DM-BT testing|3|||
23660154|NCT01069120|66142512|FG000|Overall Study|Study prematurely terminated|27|||
23660155|NCT02445755|66142514|FG000|Overall Study|Withdrawal by Subject|2|||
23660156|NCT02445755|66142514|FG000|Overall Study|Protocol Violation|6|||
23660157|NCT02445755|66142514|FG000|Overall Study|Screen Failure|5|||
23660158|NCT04343248|66142522|FG000|Overall Study|Withdrawal by Subject|5|||
23660159|NCT04343248|66142523|FG001|Overall Study|Withdrawal by Subject|6|||
23660160|NCT04343248|66142522|FG000|Overall Study|Death|1|||
23660161|NCT04343248|66142523|FG001|Overall Study|Death|2|||
23660162|NCT04343248|66142522|FG000|Overall Study|Lost to Follow-up|9|||
23660163|NCT04343248|66142523|FG001|Overall Study|Lost to Follow-up|6|||
23660164|NCT04343248|66142522|FG000|Overall Study|Physician Decision|0|||
23660165|NCT04343248|66142523|FG001|Overall Study|Physician Decision|1|||
23660166|NCT04343248|66142522|FG000|Overall Study|Adverse Event|1|||
23660167|NCT04343248|66142523|FG001|Overall Study|Adverse Event|0|||
23660168|NCT01431274|66142524|FG000|Overall Study|Adverse Event|51|||
23660169|NCT01431274|66142525|FG001|Overall Study|Adverse Event|37|||
23660170|NCT01431274|66142526|FG002|Overall Study|Adverse Event|43|||
23660171|NCT01431274|66142527|FG003|Overall Study|Adverse Event|30|||
23660172|NCT01431274|66142528|FG004|Overall Study|Adverse Event|37|||
23660173|NCT01431274|66142524|FG000|Overall Study|Consent withdrawn not due to AE|29|||
23660174|NCT01431274|66142525|FG001|Overall Study|Consent withdrawn not due to AE|20|||
23660175|NCT01431274|66142526|FG002|Overall Study|Consent withdrawn not due to AE|17|||
23660176|NCT01431274|66142527|FG003|Overall Study|Consent withdrawn not due to AE|20|||
23660177|NCT01431274|66142528|FG004|Overall Study|Consent withdrawn not due to AE|11|||
23660178|NCT01431274|66142524|FG000|Overall Study|Non compliant with protocol|5|||
23660179|NCT01431274|66142525|FG001|Overall Study|Non compliant with protocol|8|||
23660180|NCT01431274|66142526|FG002|Overall Study|Non compliant with protocol|4|||
23660181|NCT01431274|66142527|FG003|Overall Study|Non compliant with protocol|4|||
23660182|NCT01431274|66142528|FG004|Overall Study|Non compliant with protocol|4|||
23660183|NCT01431274|66142524|FG000|Overall Study|Lost to Follow-up|6|||
23660184|NCT01431274|66142525|FG001|Overall Study|Lost to Follow-up|7|||
23660185|NCT01431274|66142526|FG002|Overall Study|Lost to Follow-up|1|||
23660186|NCT01431274|66142527|FG003|Overall Study|Lost to Follow-up|4|||
23660187|NCT01431274|66142528|FG004|Overall Study|Lost to Follow-up|0|||
23660188|NCT01431274|66142524|FG000|Overall Study|Other reason not stated above|6|||
23660189|NCT01431274|66142525|FG001|Overall Study|Other reason not stated above|5|||
23660190|NCT01431274|66142526|FG002|Overall Study|Other reason not stated above|7|||
23660191|NCT01431274|66142527|FG003|Overall Study|Other reason not stated above|2|||
23660192|NCT01431274|66142528|FG004|Overall Study|Other reason not stated above|4|||
23660193|NCT03337542|66142529|FG000|Overall Study|Withdrew Consent|17|||
23660194|NCT03337542|66142529|FG000|Overall Study|Allergic Adverse Event|1|||
23660195|NCT03337542|66142529|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
23660196|NCT03337542|66142529|FG000|Overall Study|Lost to Follow-up|1|||
23660197|NCT03337542|66142529|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
23660198|NCT02000427|66142532|FG000|Overall Study|Death|22|||
23660199|NCT01846624|66142535|FG000|Overall Study|Died during induction, no midostaurin|1|||
23660200|NCT00698204|66142536|FG000|Overall Study|Withdrawal by Subject|1|||
23660201|NCT00698204|66142537|FG001|Overall Study|Withdrawal by Subject|0|||
23660202|NCT02146599|66142538|FG000|Overall Study|Failed to meet inclusion criteria|5|||
23365640|NCT01587885|65085066|FG001|Treatment Period 1|Failure to Return|1|||
23365641|NCT01587885|65085065|FG000|Treatment Period 1|Protocol Violation|0|||
23365642|NCT01587885|65085066|FG001|Treatment Period 1|Protocol Violation|2|||
23365643|NCT01157845|65085067|FG000|Overall Study|Lost to Follow-up|5|||
23365644|NCT01157845|65085067|FG000|Overall Study|Withdrawal by Subject|12|||
23365645|NCT01157845|65085067|FG000|Overall Study|Physician Decision|3|||
23365646|NCT01157845|65085067|FG000|Overall Study|Protocol Violation|13|||
23365647|NCT01157845|65085067|FG000|Overall Study|Study was ended|1|||
23365648|NCT01157845|65085067|FG000|Overall Study|Device malfunction|1|||
23365649|NCT03506438|65085068|FG000|Overall Study|Lost to Follow-up|8|||
23365650|NCT03506438|65085069|FG001|Overall Study|Lost to Follow-up|7|||
23365651|NCT03506438|65085070|FG002|Overall Study|Lost to Follow-up|8|||
23660203|NCT00596947|66145490|FG000|Overall Study|study halted due to low enrollment|5|||
23660204|NCT00596947|66145491|FG001|Overall Study|study halted due to low enrollment|3|||
23660205|NCT00596947|66145490|FG000|Overall Study|Lost to Follow-up|1|||
23660206|NCT00596947|66145491|FG001|Overall Study|Lost to Follow-up|0|||
23660207|NCT00785044|66145494|FG000|Overall Study|Dosed at non-participating sites|152|||
23660208|NCT00785044|66145494|FG000|Overall Study|Death|77|||
23660209|NCT00785044|66145494|FG000|Overall Study|Lost to Follow-up|266|||
23660210|NCT00785044|66145494|FG000|Overall Study|Withdrawal by Subject|1|||
23660211|NCT00589420|66145495|FG000|Overall Study|screen failure|1|||
23660212|NCT03418129|66145496|FG000|Overall Study|Lost to Follow-up|11|||
23660213|NCT03418129|66145497|FG001|Overall Study|Lost to Follow-up|20|||
23660214|NCT03418129|66145498|FG002|Overall Study|Lost to Follow-up|15|||
23660215|NCT03418129|66145496|FG000|Overall Study|Withdrawal by Subject|3|||
23660216|NCT03418129|66145497|FG001|Overall Study|Withdrawal by Subject|6|||
23660217|NCT03418129|66145498|FG002|Overall Study|Withdrawal by Subject|4|||
23660218|NCT00054704|66145500|FG000|Overall Study|Lack of Efficacy|2|||
23660219|NCT00054704|66145501|FG001|Overall Study|Lack of Efficacy|3|||
23365652|NCT03506438|65085071|FG003|Overall Study|Lost to Follow-up|7|||
23365653|NCT03506438|65085072|FG004|Overall Study|Lost to Follow-up|0|||
23365654|NCT03506438|65085073|FG005|Overall Study|Lost to Follow-up|0|||
23365655|NCT04010461|65085074|FG000|Overall Study|COVID based withdrawal|5|||
23365656|NCT04010461|65085074|FG000|Overall Study|Withdrawal by Subject|5|||
23365657|NCT04010461|65085074|FG000|Overall Study|Adverse Event|1|||
23365658|NCT04010461|65085074|FG000|Overall Study|No Motor Threshold obtainable|1|||
23365659|NCT04010461|65085074|FG000|Overall Study|Physician Decision|1|||
23365660|NCT00823264|65085076|FG000|Overall Study|Protocol Violation|2|||
23365661|NCT00823264|65085077|FG001|Overall Study|Protocol Violation|0|||
23365662|NCT02168491|65085078|FG000|Overall Study|Withdrawal by Subject|1|||
23365663|NCT02185417|65085079|FG000|Overall Study|Death|448|||
23365664|NCT02185417|65085080|FG001|Overall Study|Death|446|||
23365665|NCT02185417|65085081|FG002|Overall Study|Death|0|||
23365666|NCT02185417|65085079|FG000|Overall Study|Withdrawal by Subject|7|||
23365667|NCT02185417|65085080|FG001|Overall Study|Withdrawal by Subject|12|||
23365668|NCT02185417|65085081|FG002|Overall Study|Withdrawal by Subject|0|||
23365669|NCT03075267|65085082|FG000|Overall Study|Protocol Violation|1|||
23365670|NCT03075267|65085083|FG001|Overall Study|Protocol Violation|0|||
23365671|NCT03075267|65085084|FG002|Overall Study|Protocol Violation|0|||
23365672|NCT01789047|65085089|FG000|Overall Study|Adverse Event|3|||
23365673|NCT01789047|65085090|FG001|Overall Study|Adverse Event|2|||
23365674|NCT01789047|65085089|FG000|Overall Study|Withdrawal by Subject|1|||
23365675|NCT01789047|65085090|FG001|Overall Study|Withdrawal by Subject|2|||
23365676|NCT01687218|65085096|FG000|Overall Study|Withdrawal by Subject|2|||
23365677|NCT01687218|65085097|FG001|Overall Study|Withdrawal by Subject|3|||
23365678|NCT01687218|65085098|FG002|Overall Study|Withdrawal by Subject|0|||
23365679|NCT01687218|65085099|FG003|Overall Study|Withdrawal by Subject|1|||
23365680|NCT01687218|65085100|FG004|Overall Study|Withdrawal by Subject|1|||
23365681|NCT01687218|65085101|FG005|Overall Study|Withdrawal by Subject|0|||
23365682|NCT01687218|65085096|FG000|Overall Study|Relocated, no follow-up planned|1|||
23660220|NCT00054704|66145500|FG000|Overall Study|Adverse Event|3|||
23660221|NCT00054704|66145501|FG001|Overall Study|Adverse Event|1|||
23660222|NCT00054704|66145500|FG000|Overall Study|Lost to Follow-up|0|||
23660223|NCT00054704|66145501|FG001|Overall Study|Lost to Follow-up|1|||
23365683|NCT01687218|65085097|FG001|Overall Study|Relocated, no follow-up planned|0|||
23365684|NCT01687218|65085098|FG002|Overall Study|Relocated, no follow-up planned|1|||
23365685|NCT01687218|65085099|FG003|Overall Study|Relocated, no follow-up planned|1|||
23365686|NCT01687218|65085100|FG004|Overall Study|Relocated, no follow-up planned|0|||
23365687|NCT01687218|65085101|FG005|Overall Study|Relocated, no follow-up planned|0|||
23365688|NCT01061606|65085102|FG000|Overall Study|Adverse Event|1|||
23660224|NCT00770770|66145504|FG000|Overall Study|Lost to Follow-up|1|||
23365689|NCT01061606|65085102|FG000|Overall Study|Death|1|||
23365690|NCT01061606|65085102|FG000|Overall Study|Disease Progression|4|||
23365691|NCT01061606|65085102|FG000|Overall Study|alternative therapy|2|||
23365692|NCT01598610|65085103|FG000|Overall Study|Adverse Event|1|||
23660225|NCT00770770|66145505|FG001|Overall Study|Lost to Follow-up|0|||
23660226|NCT00770770|66145504|FG000|Overall Study|Withdrawal by Subject|1|||
23660227|NCT00770770|66145505|FG001|Overall Study|Withdrawal by Subject|0|||
23660228|NCT00770770|66145504|FG000|Overall Study|Death|0|||
23660229|NCT00770770|66145505|FG001|Overall Study|Death|1|||
23660230|NCT00770770|66145504|FG000|Overall Study|Study Terminated|8|||
23660231|NCT00770770|66145505|FG001|Overall Study|Study Terminated|0|||
23660232|NCT01961349|66145507|FG000|Overall Study|Withdrawal by Subject|1|||
23660233|NCT01961349|66145508|FG001|Overall Study|Withdrawal by Subject|4|||
23660234|NCT01961349|66145509|FG002|Overall Study|Withdrawal by Subject|0|||
23660235|NCT01961349|66145507|FG000|Overall Study|Adverse Event|0|||
23660236|NCT01961349|66145508|FG001|Overall Study|Adverse Event|0|||
23660237|NCT01961349|66145509|FG002|Overall Study|Adverse Event|1|||
23660238|NCT01961349|66145507|FG000|Overall Study|registration error, personal reason etc|2|||
23660239|NCT01961349|66145508|FG001|Overall Study|registration error, personal reason etc|2|||
23660240|NCT01961349|66145509|FG002|Overall Study|registration error, personal reason etc|1|||
23660241|NCT00395863|66145510|FG000|Overall Study|Patients did not complete both exams|2|||
23660242|NCT00395863|66145511|FG001|Overall Study|Patients did not complete both exams|3|||
23660243|NCT03625687|66145512|FG000|Overall Study|Death|1|||
23660244|NCT00555477|66145516|FG000|Overall Study|Adverse Event|0|||
23660245|NCT00555477|66145517|FG001|Overall Study|Adverse Event|9|||
23660246|NCT00555477|66145516|FG000|Overall Study|Withdrawal by Subject|1|||
23660247|NCT00555477|66145517|FG001|Overall Study|Withdrawal by Subject|2|||
23660248|NCT00555477|66145516|FG000|Overall Study|Physician Decision|1|||
23660249|NCT00555477|66145517|FG001|Overall Study|Physician Decision|2|||
23660250|NCT02535715|66145519|FG000|Overall Study|Withdrawal by Subject|0|||
23660251|NCT02535715|66145520|FG001|Overall Study|Withdrawal by Subject|0|||
23660252|NCT02535715|66145521|FG002|Overall Study|Withdrawal by Subject|1|||
23660253|NCT00187096|66145525|FG000|Overall Study|unacceptable toxicity|0|||
23660254|NCT00187096|66145526|FG001|Overall Study|unacceptable toxicity|0|||
23660255|NCT00187096|66145527|FG002|Overall Study|unacceptable toxicity|1|||
23660256|NCT02613884|66145528|FG000|Overall Study|Death|1|||
23660257|NCT02613884|66145528|FG000|Overall Study|Lost to Follow-up|1|||
23660258|NCT01011439|66145531|FG000|Overall Study|Death|37|||
23660259|NCT01011439|66145531|FG000|Overall Study|Lost to Follow-up|4|||
23660260|NCT01011439|66145531|FG000|Overall Study|Withdrawal by Subject|1|||
23660261|NCT01011439|66145531|FG000|Overall Study|Sponsor's decision|15|||
23660262|NCT00601705|66145534|FG000|Overall Study|Withdrawal by Subject|1|||
23660263|NCT03227471|66145535|FG000|Overall Study|Withdrawal by Subject|0|||
23660264|NCT03227471|66145536|FG001|Overall Study|Withdrawal by Subject|0|||
23660265|NCT03227471|66145537|FG002|Overall Study|Withdrawal by Subject|0|||
23660266|NCT03227471|66145538|FG003|Overall Study|Withdrawal by Subject|0|||
23660267|NCT03227471|66145539|FG004|Overall Study|Withdrawal by Subject|1|||
23660268|NCT03227471|66145540|FG005|Overall Study|Withdrawal by Subject|0|||
23660269|NCT03227471|66145541|FG006|Overall Study|Withdrawal by Subject|0|||
23660270|NCT03227471|66145542|FG007|Overall Study|Withdrawal by Subject|0|||
23660271|NCT03227471|66145543|FG008|Overall Study|Withdrawal by Subject|0|||
23660272|NCT03227471|66145544|FG009|Overall Study|Withdrawal by Subject|0|||
23660273|NCT03227471|66145545|FG010|Overall Study|Withdrawal by Subject|0|||
23660274|NCT03227471|66145546|FG011|Overall Study|Withdrawal by Subject|0|||
23660275|NCT03227471|66145547|FG012|Overall Study|Withdrawal by Subject|1|||
23660276|NCT03227471|66145548|FG013|Overall Study|Withdrawal by Subject|0|||
23660277|NCT03227471|66145549|FG014|Overall Study|Withdrawal by Subject|0|||
23660278|NCT03227471|66145535|FG000|Overall Study|Randomized, Never Dosed|0|||
23660279|NCT03227471|66145536|FG001|Overall Study|Randomized, Never Dosed|0|||
23660280|NCT03227471|66145537|FG002|Overall Study|Randomized, Never Dosed|0|||
23660281|NCT03227471|66145538|FG003|Overall Study|Randomized, Never Dosed|0|||
23660282|NCT03227471|66145539|FG004|Overall Study|Randomized, Never Dosed|0|||
23482734|NCT02554279|65509604|FG001|Overall Study|Lost to Follow-up|2|||
23660283|NCT03227471|66145540|FG005|Overall Study|Randomized, Never Dosed|0|||
23660284|NCT03227471|66145541|FG006|Overall Study|Randomized, Never Dosed|0|||
23660285|NCT03227471|66145542|FG007|Overall Study|Randomized, Never Dosed|0|||
23660286|NCT03227471|66145543|FG008|Overall Study|Randomized, Never Dosed|0|||
23660287|NCT03227471|66145544|FG009|Overall Study|Randomized, Never Dosed|0|||
23660288|NCT03227471|66145545|FG010|Overall Study|Randomized, Never Dosed|0|||
23660289|NCT03227471|66145546|FG011|Overall Study|Randomized, Never Dosed|0|||
23660290|NCT03227471|66145547|FG012|Overall Study|Randomized, Never Dosed|0|||
23660291|NCT03227471|66145548|FG013|Overall Study|Randomized, Never Dosed|0|||
23660292|NCT03227471|66145549|FG014|Overall Study|Randomized, Never Dosed|1|||
23660293|NCT04607148|66145553|FG000|Overall Study|Withdrawal by Subject|0|||
23660294|NCT04607148|66145554|FG001|Overall Study|Withdrawal by Subject|4|||
23660295|NCT04607148|66145555|FG002|Overall Study|Withdrawal by Subject|2|||
23660296|NCT04607148|66145556|FG003|Overall Study|Withdrawal by Subject|8|||
23660297|NCT04607148|66145553|FG000|Overall Study|Study Terminated by Sponsor|14|||
23660298|NCT04607148|66145554|FG001|Overall Study|Study Terminated by Sponsor|59|||
23660299|NCT04607148|66145555|FG002|Overall Study|Study Terminated by Sponsor|9|||
23660300|NCT04607148|66145556|FG003|Overall Study|Study Terminated by Sponsor|39|||
23660301|NCT04607148|66145553|FG000|Overall Study|Sponsor Decision|0|||
23660302|NCT04607148|66145554|FG001|Overall Study|Sponsor Decision|0|||
23660303|NCT04607148|66145555|FG002|Overall Study|Sponsor Decision|1|||
23660304|NCT04607148|66145556|FG003|Overall Study|Sponsor Decision|0|||
23660305|NCT04607148|66145553|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23482735|NCT02554279|65509603|FG000|Overall Study|Withdrawal by Subject|6|||
23365693|NCT00610168|65085104|FG000|Overall Study|Withdrawal by Subject|2|||
23365694|NCT00610168|65085105|FG001|Overall Study|Withdrawal by Subject|0|||
23365695|NCT00281697|65085106|FG000|Overall Study|> 60 days since last dose of study drug|4|||
23365696|NCT00281697|65085107|FG001|Overall Study|> 60 days since last dose of study drug|4|||
23365697|NCT00281697|65085106|FG000|Overall Study|Adverse Event|54|||
23365698|NCT00281697|65085107|FG001|Overall Study|Adverse Event|15|||
23365699|NCT00281697|65085106|FG000|Overall Study|Death|8|||
23365700|NCT00281697|65085107|FG001|Overall Study|Death|3|||
23365701|NCT00281697|65085106|FG000|Overall Study|Disease progression|279|||
23365702|NCT00281697|65085107|FG001|Overall Study|Disease progression|149|||
23365703|NCT00281697|65085106|FG000|Overall Study|Other|5|||
23365704|NCT00281697|65085107|FG001|Overall Study|Other|6|||
23365705|NCT00281697|65085106|FG000|Overall Study|Physician's decision to withdraw|15|||
23482736|NCT02554279|65509604|FG001|Overall Study|Withdrawal by Subject|4|||
23482737|NCT02554279|65509603|FG000|Overall Study|Protocol Violation|2|||
23660306|NCT04607148|66145554|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23660307|NCT04607148|66145555|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23660308|NCT04607148|66145556|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23660309|NCT04607148|66145553|FG000|Overall Study|Lost to Follow-up|0|||
23660310|NCT04607148|66145554|FG001|Overall Study|Lost to Follow-up|2|||
23660311|NCT04607148|66145555|FG002|Overall Study|Lost to Follow-up|0|||
23365706|NCT00281697|65085107|FG001|Overall Study|Physician's decision to withdraw|12|||
23365707|NCT00281697|65085106|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
23365708|NCT00281697|65085107|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
23365709|NCT00281697|65085106|FG000|Overall Study|Did not receive study drug|3|||
23660312|NCT04607148|66145556|FG003|Overall Study|Lost to Follow-up|0|||
23365710|NCT00281697|65085107|FG001|Overall Study|Did not receive study drug|2|||
23365711|NCT00732069|65085108|FG000|Washout After First Study Drug|Adverse Event|1|||
23365712|NCT00732069|65085109|FG001|Washout After First Study Drug|Adverse Event|0|||
23365713|NCT00732069|65085110|FG002|Washout After First Study Drug|Adverse Event|0|||
23365714|NCT00732069|65085111|FG003|Washout After First Study Drug|Adverse Event|0|||
23365715|NCT00732069|65085112|FG004|Washout After First Study Drug|Adverse Event|0|||
23365716|NCT00732069|65085113|FG005|Washout After First Study Drug|Adverse Event|0|||
23365717|NCT01534273|65085114|FG000|Period 1|Physician Decision|0|||
23365718|NCT01534273|65085115|FG001|Period 1|Physician Decision|0|||
23365719|NCT01534273|65085116|FG002|Period 1|Physician Decision|0|||
23365720|NCT01534273|65085117|FG003|Period 1|Physician Decision|1|||
23365721|NCT01534273|65085118|FG004|Period 1|Physician Decision|0|||
23365722|NCT01534273|65085119|FG005|Period 1|Physician Decision|0|||
23365723|NCT01534273|65085120|FG006|Period 1|Physician Decision|0|||
23365724|NCT02974868|65085121|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
23365725|NCT02974868|65085122|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
23365726|NCT02974868|65085123|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
23365727|NCT02974868|65085124|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
23365728|NCT02974868|65085121|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
23365729|NCT02974868|65085122|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
23365730|NCT02974868|65085123|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
23365731|NCT02974868|65085124|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
23365732|NCT02974868|65085121|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
23365733|NCT02974868|65085122|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
23365734|NCT02974868|65085123|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
23365735|NCT02974868|65085124|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
23365736|NCT02974868|65085121|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
23365737|NCT02974868|65085122|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
23365738|NCT02974868|65085123|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
23365739|NCT02974868|65085124|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
23365740|NCT03225287|65085125|FG000|Overall Study|Adverse Event|0|||
23365741|NCT03225287|65085126|FG001|Overall Study|Adverse Event|0|||
23365742|NCT03225287|65085127|FG002|Overall Study|Adverse Event|1|||
23365743|NCT03225287|65085125|FG000|Overall Study|Protocol non-compliance|0|||
23365744|NCT03225287|65085126|FG001|Overall Study|Protocol non-compliance|0|||
23365745|NCT03225287|65085127|FG002|Overall Study|Protocol non-compliance|1|||
23365746|NCT03225287|65085125|FG000|Overall Study|Subject withdraws consent|3|||
23365747|NCT03225287|65085126|FG001|Overall Study|Subject withdraws consent|0|||
23365748|NCT03225287|65085127|FG002|Overall Study|Subject withdraws consent|0|||
23365749|NCT03225287|65085125|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
23365750|NCT03225287|65085126|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
23365751|NCT03225287|65085127|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
23365752|NCT03225287|65085125|FG000|Overall Study|Trial drug not effective|0|||
23365753|NCT03225287|65085126|FG001|Overall Study|Trial drug not effective|1|||
23365754|NCT03225287|65085127|FG002|Overall Study|Trial drug not effective|0|||
23365755|NCT03225287|65085125|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
23365756|NCT03225287|65085126|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
23365757|NCT03225287|65085127|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
23365758|NCT03225287|65085125|FG000|Overall Study|Stem cell transplantation|0|||
23365759|NCT03225287|65085126|FG001|Overall Study|Stem cell transplantation|1|||
23365760|NCT03225287|65085127|FG002|Overall Study|Stem cell transplantation|0|||
23365761|NCT02486692|65085128|FG000|Overall Study|did not login for randomization|4|||
23365762|NCT02486692|65085129|FG001|Overall Study|did not login for randomization|7|||
23365763|NCT02329847|65085131|FG000|Overall Study|Death|4|||
23365764|NCT02329847|65085132|FG001|Overall Study|Death|4|||
23365765|NCT02329847|65085133|FG002|Overall Study|Death|22|||
23482738|NCT02554279|65509604|FG001|Overall Study|Protocol Violation|1|||
23482739|NCT02554279|65509603|FG000|Overall Study|Other reason|19|||
23482740|NCT02554279|65509604|FG001|Overall Study|Other reason|6|||
23482741|NCT00169442|65509607|FG000|Overall Study|Withdrawal by Subject|0|||
23482742|NCT00169442|65509608|FG001|Overall Study|Withdrawal by Subject|0|||
23482743|NCT00169442|65509609|FG002|Overall Study|Withdrawal by Subject|1|||
23365766|NCT02329847|65085134|FG003|Overall Study|Death|12|||
23365767|NCT02329847|65085135|FG004|Overall Study|Death|20|||
23365768|NCT02329847|65085136|FG005|Overall Study|Death|13|||
23365769|NCT02329847|65085131|FG000|Overall Study|Lost to Follow-up|0|||
23365770|NCT02329847|65085132|FG001|Overall Study|Lost to Follow-up|0|||
23365771|NCT02329847|65085133|FG002|Overall Study|Lost to Follow-up|2|||
23365772|NCT02329847|65085134|FG003|Overall Study|Lost to Follow-up|3|||
23365773|NCT02329847|65085135|FG004|Overall Study|Lost to Follow-up|0|||
23365774|NCT02329847|65085136|FG005|Overall Study|Lost to Follow-up|1|||
23482744|NCT00169442|65509610|FG003|Overall Study|Withdrawal by Subject|0|||
23482745|NCT00169442|65509611|FG004|Overall Study|Withdrawal by Subject|0|||
23482746|NCT00169442|65509612|FG005|Overall Study|Withdrawal by Subject|0|||
23482747|NCT00169442|65509607|FG000|Overall Study|Migrated/moved from study area|0|||
23482748|NCT00169442|65509608|FG001|Overall Study|Migrated/moved from study area|0|||
23482749|NCT00169442|65509609|FG002|Overall Study|Migrated/moved from study area|0|||
23482750|NCT00169442|65509610|FG003|Overall Study|Migrated/moved from study area|0|||
23482751|NCT00169442|65509611|FG004|Overall Study|Migrated/moved from study area|0|||
23482752|NCT00169442|65509612|FG005|Overall Study|Migrated/moved from study area|2|||
23482753|NCT00169442|65509607|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482754|NCT00169442|65509608|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482755|NCT00169442|65509609|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482756|NCT00169442|65509610|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482757|NCT00169442|65509611|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
23482758|NCT00169442|65509612|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482759|NCT00169442|65509607|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482760|NCT00169442|65509608|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
23482761|NCT00169442|65509609|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482762|NCT00169442|65509610|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482763|NCT00169442|65509611|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482764|NCT00169442|65509612|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482765|NCT03324581|65509613|FG000|Overall Study|Adverse Event|18|||
23482766|NCT03324581|65509614|FG001|Overall Study|Adverse Event|11|||
23482767|NCT03324581|65509615|FG002|Overall Study|Adverse Event|7|||
23482768|NCT03324581|65509613|FG000|Overall Study|Lack of Efficacy|0|||
23482769|NCT03324581|65509614|FG001|Overall Study|Lack of Efficacy|1|||
23482770|NCT03324581|65509615|FG002|Overall Study|Lack of Efficacy|0|||
23482771|NCT03324581|65509613|FG000|Overall Study|Lost to Follow-up|5|||
23482772|NCT03324581|65509614|FG001|Overall Study|Lost to Follow-up|3|||
23482773|NCT03324581|65509615|FG002|Overall Study|Lost to Follow-up|6|||
23482774|NCT03324581|65509613|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
23482775|NCT03324581|65509614|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
23482776|NCT03324581|65509615|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
23482777|NCT03324581|65509613|FG000|Overall Study|Physician Decision|0|||
23482778|NCT03324581|65509614|FG001|Overall Study|Physician Decision|1|||
23482779|NCT03324581|65509615|FG002|Overall Study|Physician Decision|2|||
23482780|NCT03324581|65509613|FG000|Overall Study|Protocol Deviation|8|||
23482781|NCT03324581|65509614|FG001|Overall Study|Protocol Deviation|9|||
23482782|NCT03324581|65509615|FG002|Overall Study|Protocol Deviation|4|||
23482783|NCT03324581|65509613|FG000|Overall Study|Withdrawal by Subject|6|||
23482784|NCT03324581|65509614|FG001|Overall Study|Withdrawal by Subject|8|||
23482785|NCT03324581|65509615|FG002|Overall Study|Withdrawal by Subject|6|||
23482786|NCT03324581|65509613|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
23482787|NCT03324581|65509614|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
23482788|NCT03324581|65509615|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
23482789|NCT00807573|65509616|FG000|Overall Study|Withdrawal by Subject|1|||
23482790|NCT00807573|65509616|FG000|Overall Study|Adverse Event|1|||
23482791|NCT02045303|65509619|FG000|Overall Study|Protocol Violation|2|||
23482792|NCT02045303|65509620|FG001|Overall Study|Protocol Violation|1|||
23482793|NCT02045303|65509621|FG002|Overall Study|Protocol Violation|0|||
23482794|NCT02045303|65509619|FG000|Overall Study|Withdrawal by Subject|0|||
23482795|NCT02045303|65509620|FG001|Overall Study|Withdrawal by Subject|2|||
23482796|NCT02045303|65509621|FG002|Overall Study|Withdrawal by Subject|0|||
23482797|NCT02292784|65509624|FG000|Overall Study|Lost to Follow-up|1|||
23482798|NCT02292784|65509625|FG001|Overall Study|Lost to Follow-up|17|||
23482799|NCT02292784|65509626|FG002|Overall Study|Lost to Follow-up|18|||
23482800|NCT02292784|65509624|FG000|Overall Study|Withdrawal by Subject|0|||
23482801|NCT02292784|65509625|FG001|Overall Study|Withdrawal by Subject|3|||
23482802|NCT02292784|65509626|FG002|Overall Study|Withdrawal by Subject|3|||
23482803|NCT01975831|65509627|FG000|Overall Study|Adverse Event|1|||
23660313|NCT04607148|66145553|FG000|Overall Study|Death|0|||
23482804|NCT01975831|65509628|FG001|Overall Study|Adverse Event|2|||
23482805|NCT01975831|65509629|FG002|Overall Study|Adverse Event|2|||
23482806|NCT01975831|65509630|FG003|Overall Study|Adverse Event|0|||
23482807|NCT01975831|65509631|FG004|Overall Study|Adverse Event|1|||
23482808|NCT01975831|65509632|FG005|Overall Study|Adverse Event|1|||
23482809|NCT01975831|65509633|FG006|Overall Study|Adverse Event|3|||
23482810|NCT01975831|65509634|FG007|Overall Study|Adverse Event|4|||
23482811|NCT01975831|65509635|FG008|Overall Study|Adverse Event|1|||
23482812|NCT01975831|65509627|FG000|Overall Study|Death|1|||
23482813|NCT01975831|65509628|FG001|Overall Study|Death|1|||
23482814|NCT01975831|65509629|FG002|Overall Study|Death|0|||
23482815|NCT01975831|65509630|FG003|Overall Study|Death|0|||
23482816|NCT01975831|65509631|FG004|Overall Study|Death|1|||
23482817|NCT01975831|65509632|FG005|Overall Study|Death|0|||
23482818|NCT01975831|65509633|FG006|Overall Study|Death|1|||
23482819|NCT01975831|65509634|FG007|Overall Study|Death|0|||
23482820|NCT01975831|65509635|FG008|Overall Study|Death|0|||
23482821|NCT01975831|65509627|FG000|Overall Study|Progressive Disease|1|||
23482822|NCT01975831|65509628|FG001|Overall Study|Progressive Disease|3|||
23482823|NCT01975831|65509629|FG002|Overall Study|Progressive Disease|2|||
23482824|NCT01975831|65509630|FG003|Overall Study|Progressive Disease|4|||
23482825|NCT01975831|65509631|FG004|Overall Study|Progressive Disease|13|||
23482826|NCT01975831|65509632|FG005|Overall Study|Progressive Disease|9|||
23482827|NCT01975831|65509633|FG006|Overall Study|Progressive Disease|10|||
23482828|NCT01975831|65509634|FG007|Overall Study|Progressive Disease|8|||
23482829|NCT01975831|65509635|FG008|Overall Study|Progressive Disease|10|||
23482830|NCT01975831|65509627|FG000|Overall Study|Withdrawal by Subject|0|||
23482831|NCT01975831|65509628|FG001|Overall Study|Withdrawal by Subject|3|||
23482832|NCT01975831|65509629|FG002|Overall Study|Withdrawal by Subject|0|||
23482833|NCT01975831|65509630|FG003|Overall Study|Withdrawal by Subject|0|||
23482834|NCT01975831|65509631|FG004|Overall Study|Withdrawal by Subject|3|||
23482835|NCT01975831|65509632|FG005|Overall Study|Withdrawal by Subject|1|||
23482836|NCT01975831|65509633|FG006|Overall Study|Withdrawal by Subject|1|||
23482837|NCT01975831|65509634|FG007|Overall Study|Withdrawal by Subject|0|||
23482838|NCT01975831|65509635|FG008|Overall Study|Withdrawal by Subject|0|||
23482839|NCT01975831|65509627|FG000|Overall Study|Physician Decision|0|||
23482840|NCT01975831|65509628|FG001|Overall Study|Physician Decision|0|||
23482841|NCT01975831|65509629|FG002|Overall Study|Physician Decision|0|||
23482842|NCT01975831|65509630|FG003|Overall Study|Physician Decision|0|||
23482843|NCT01975831|65509631|FG004|Overall Study|Physician Decision|0|||
23482844|NCT01975831|65509632|FG005|Overall Study|Physician Decision|1|||
23482845|NCT01975831|65509633|FG006|Overall Study|Physician Decision|0|||
23482846|NCT01975831|65509634|FG007|Overall Study|Physician Decision|1|||
23482847|NCT01975831|65509635|FG008|Overall Study|Physician Decision|0|||
23482848|NCT01975831|65509627|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
23482849|NCT01975831|65509628|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
23482850|NCT01975831|65509629|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
23482851|NCT01975831|65509630|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
23482852|NCT01975831|65509631|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
23482853|NCT01975831|65509632|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
23482854|NCT01975831|65509633|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
23482855|NCT01975831|65509634|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
23482856|NCT01975831|65509635|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
23482857|NCT01975831|65509627|FG000|Overall Study|Entered Hospice|0|||
23482858|NCT01975831|65509628|FG001|Overall Study|Entered Hospice|0|||
23482859|NCT01975831|65509629|FG002|Overall Study|Entered Hospice|0|||
23482860|NCT01975831|65509630|FG003|Overall Study|Entered Hospice|0|||
23482861|NCT01975831|65509631|FG004|Overall Study|Entered Hospice|0|||
23482862|NCT01975831|65509632|FG005|Overall Study|Entered Hospice|1|||
23482863|NCT01975831|65509633|FG006|Overall Study|Entered Hospice|0|||
23482864|NCT01975831|65509634|FG007|Overall Study|Entered Hospice|0|||
23482865|NCT01975831|65509635|FG008|Overall Study|Entered Hospice|0|||
23482866|NCT01975831|65509627|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482867|NCT01975831|65509628|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482868|NCT01975831|65509629|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482869|NCT01975831|65509630|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482870|NCT01975831|65509631|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482871|NCT01975831|65509632|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482872|NCT01975831|65509633|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
23482873|NCT01975831|65509634|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482874|NCT01975831|65509635|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
23482875|NCT00588952|65509637|FG000|Overall Study|Adverse Event|0|||
23482876|NCT00588952|65509638|FG001|Overall Study|Adverse Event|2|||
23482877|NCT00588952|65509637|FG000|Overall Study|Withdrawal by Subject|3|||
23482878|NCT00588952|65509638|FG001|Overall Study|Withdrawal by Subject|5|||
23482879|NCT01226121|65509642|FG000|Overall Study|Lost to Follow-up|2|||
23482880|NCT01226121|65509643|FG001|Overall Study|Lost to Follow-up|0|||
23482881|NCT01226121|65509644|FG002|Overall Study|Lost to Follow-up|1|||
23482882|NCT00973349|65509647|FG000|Overall Study|Adverse Event|0|||
23482883|NCT00973349|65509648|FG001|Overall Study|Adverse Event|0|||
23482884|NCT00973349|65509649|FG002|Overall Study|Adverse Event|0|||
23482885|NCT00973349|65509650|FG003|Overall Study|Adverse Event|0|||
23482886|NCT00973349|65509651|FG004|Overall Study|Adverse Event|1|||
23482887|NCT00973349|65509652|FG005|Overall Study|Adverse Event|0|||
23482888|NCT00973349|65509653|FG006|Overall Study|Adverse Event|0|||
23482889|NCT00973349|65509654|FG007|Overall Study|Adverse Event|0|||
23482890|NCT00973349|65509655|FG008|Overall Study|Adverse Event|1|||
23482891|NCT00973349|65509656|FG009|Overall Study|Adverse Event|0|||
23482892|NCT00973349|65509657|FG010|Overall Study|Adverse Event|0|||
23482893|NCT00973349|65509658|FG011|Overall Study|Adverse Event|0|||
23482894|NCT00973349|65509659|FG012|Overall Study|Adverse Event|0|||
23482895|NCT00973349|65509660|FG013|Overall Study|Adverse Event|0|||
23482896|NCT00973349|65509661|FG014|Overall Study|Adverse Event|1|||
23482897|NCT00973349|65509662|FG015|Overall Study|Adverse Event|0|||
23482898|NCT00973349|65509647|FG000|Overall Study|Withdrawal by Subject|1|||
23482899|NCT00973349|65509648|FG001|Overall Study|Withdrawal by Subject|2|||
23482900|NCT00973349|65509649|FG002|Overall Study|Withdrawal by Subject|2|||
23482901|NCT00973349|65509650|FG003|Overall Study|Withdrawal by Subject|3|||
23482902|NCT00973349|65509651|FG004|Overall Study|Withdrawal by Subject|2|||
23482903|NCT00973349|65509652|FG005|Overall Study|Withdrawal by Subject|0|||
23482904|NCT00973349|65509653|FG006|Overall Study|Withdrawal by Subject|2|||
23482905|NCT00973349|65509654|FG007|Overall Study|Withdrawal by Subject|2|||
23482906|NCT00973349|65509655|FG008|Overall Study|Withdrawal by Subject|0|||
23482907|NCT00973349|65509656|FG009|Overall Study|Withdrawal by Subject|2|||
23482908|NCT00973349|65509657|FG010|Overall Study|Withdrawal by Subject|0|||
23482909|NCT00973349|65509658|FG011|Overall Study|Withdrawal by Subject|1|||
23482910|NCT00973349|65509659|FG012|Overall Study|Withdrawal by Subject|0|||
23482911|NCT00973349|65509660|FG013|Overall Study|Withdrawal by Subject|0|||
23482912|NCT00973349|65509661|FG014|Overall Study|Withdrawal by Subject|0|||
23482913|NCT00973349|65509662|FG015|Overall Study|Withdrawal by Subject|0|||
23482914|NCT00973349|65509647|FG000|Overall Study|Lost to Follow-up|3|||
23482915|NCT00973349|65509648|FG001|Overall Study|Lost to Follow-up|1|||
23482916|NCT00973349|65509649|FG002|Overall Study|Lost to Follow-up|2|||
23482917|NCT00973349|65509650|FG003|Overall Study|Lost to Follow-up|2|||
23482918|NCT00973349|65509651|FG004|Overall Study|Lost to Follow-up|1|||
23482919|NCT00973349|65509652|FG005|Overall Study|Lost to Follow-up|3|||
23482920|NCT00973349|65509653|FG006|Overall Study|Lost to Follow-up|0|||
23482921|NCT00973349|65509654|FG007|Overall Study|Lost to Follow-up|1|||
23482922|NCT00973349|65509655|FG008|Overall Study|Lost to Follow-up|2|||
23482923|NCT00973349|65509656|FG009|Overall Study|Lost to Follow-up|1|||
23601738|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23601739|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23482924|NCT00973349|65509657|FG010|Overall Study|Lost to Follow-up|0|||
23482925|NCT00973349|65509658|FG011|Overall Study|Lost to Follow-up|1|||
23482926|NCT00973349|65509659|FG012|Overall Study|Lost to Follow-up|0|||
23482927|NCT00973349|65509660|FG013|Overall Study|Lost to Follow-up|0|||
23482928|NCT00973349|65509661|FG014|Overall Study|Lost to Follow-up|0|||
23482929|NCT00973349|65509662|FG015|Overall Study|Lost to Follow-up|1|||
23482930|NCT00973349|65509647|FG000|Overall Study|Inappropriate enrolment|0|||
23482931|NCT00973349|65509648|FG001|Overall Study|Inappropriate enrolment|0|||
23482932|NCT00973349|65509649|FG002|Overall Study|Inappropriate enrolment|1|||
23482933|NCT00973349|65509650|FG003|Overall Study|Inappropriate enrolment|0|||
23482934|NCT00973349|65509651|FG004|Overall Study|Inappropriate enrolment|0|||
23482935|NCT00973349|65509652|FG005|Overall Study|Inappropriate enrolment|0|||
23482936|NCT00973349|65509653|FG006|Overall Study|Inappropriate enrolment|0|||
23482937|NCT00973349|65509654|FG007|Overall Study|Inappropriate enrolment|0|||
23482938|NCT00973349|65509655|FG008|Overall Study|Inappropriate enrolment|0|||
23482939|NCT00973349|65509656|FG009|Overall Study|Inappropriate enrolment|2|||
23482940|NCT00973349|65509657|FG010|Overall Study|Inappropriate enrolment|0|||
23482941|NCT00973349|65509658|FG011|Overall Study|Inappropriate enrolment|0|||
23482942|NCT00973349|65509659|FG012|Overall Study|Inappropriate enrolment|1|||
23482943|NCT00973349|65509660|FG013|Overall Study|Inappropriate enrolment|0|||
23482944|NCT00973349|65509661|FG014|Overall Study|Inappropriate enrolment|1|||
23482945|NCT00973349|65509662|FG015|Overall Study|Inappropriate enrolment|1|||
23482946|NCT00973349|65509647|FG000|Overall Study|Protocol Violation|0|||
23482947|NCT00973349|65509648|FG001|Overall Study|Protocol Violation|0|||
23482948|NCT00973349|65509649|FG002|Overall Study|Protocol Violation|0|||
23482949|NCT00973349|65509650|FG003|Overall Study|Protocol Violation|0|||
23482950|NCT00973349|65509651|FG004|Overall Study|Protocol Violation|0|||
23482951|NCT00973349|65509652|FG005|Overall Study|Protocol Violation|0|||
23482952|NCT00973349|65509653|FG006|Overall Study|Protocol Violation|0|||
23482953|NCT00973349|65509654|FG007|Overall Study|Protocol Violation|0|||
23482954|NCT00973349|65509655|FG008|Overall Study|Protocol Violation|1|||
23482955|NCT00973349|65509656|FG009|Overall Study|Protocol Violation|0|||
23482956|NCT00973349|65509657|FG010|Overall Study|Protocol Violation|0|||
23482957|NCT00973349|65509658|FG011|Overall Study|Protocol Violation|0|||
23482958|NCT00973349|65509659|FG012|Overall Study|Protocol Violation|0|||
23482959|NCT00973349|65509660|FG013|Overall Study|Protocol Violation|0|||
23482960|NCT00973349|65509661|FG014|Overall Study|Protocol Violation|0|||
23482961|NCT00973349|65509662|FG015|Overall Study|Protocol Violation|0|||
23482962|NCT00973349|65509647|FG000|Overall Study|Unable to classify|0|||
23482963|NCT00973349|65509648|FG001|Overall Study|Unable to classify|0|||
23482964|NCT00973349|65509649|FG002|Overall Study|Unable to classify|0|||
23482965|NCT00973349|65509650|FG003|Overall Study|Unable to classify|0|||
23482966|NCT00973349|65509651|FG004|Overall Study|Unable to classify|1|||
23482967|NCT00973349|65509652|FG005|Overall Study|Unable to classify|1|||
23482968|NCT00973349|65509653|FG006|Overall Study|Unable to classify|0|||
23482969|NCT00973349|65509654|FG007|Overall Study|Unable to classify|0|||
23482970|NCT00973349|65509655|FG008|Overall Study|Unable to classify|0|||
23482971|NCT00973349|65509656|FG009|Overall Study|Unable to classify|1|||
23482972|NCT00973349|65509657|FG010|Overall Study|Unable to classify|0|||
23482973|NCT00973349|65509658|FG011|Overall Study|Unable to classify|0|||
23482974|NCT00973349|65509659|FG012|Overall Study|Unable to classify|0|||
23482975|NCT00973349|65509660|FG013|Overall Study|Unable to classify|0|||
23482976|NCT00973349|65509661|FG014|Overall Study|Unable to classify|0|||
23482977|NCT00973349|65509662|FG015|Overall Study|Unable to classify|0|||
23482978|NCT00821509|65509663|FG000|Overall Study|Withdrawal by Subject|12|||
23482979|NCT00821509|65509664|FG001|Overall Study|Withdrawal by Subject|11|||
23482980|NCT00821509|65509665|FG002|Overall Study|Withdrawal by Subject|34|||
23482981|NCT00769483|65509666|FG000|Overall Study|Withdrawal by Subject|0|||
23482982|NCT00769483|65509667|FG001|Overall Study|Withdrawal by Subject|1|||
23482983|NCT00769483|65509668|FG002|Overall Study|Withdrawal by Subject|0|||
23482984|NCT00769483|65509669|FG003|Overall Study|Withdrawal by Subject|0|||
23482985|NCT00769483|65509670|FG004|Overall Study|Withdrawal by Subject|1|||
23482986|NCT00769483|65509671|FG005|Overall Study|Withdrawal by Subject|0|||
23482987|NCT03828370|65512864|FG000|3 Month Follow-up|Lost to Follow-up|4|||
23482988|NCT03828370|65512865|FG001|3 Month Follow-up|Lost to Follow-up|12|||
23482989|NCT03828370|65512864|FG000|9 Month Follow up|Lost to Follow-up|12|||
23482990|NCT03828370|65512865|FG001|9 Month Follow up|Lost to Follow-up|20|||
23482991|NCT01565499|65512869|FG000|Overall Study|Physician Decision|1|||
23482992|NCT01565499|65512869|FG000|Overall Study|Adverse Event|5|||
23482993|NCT01565499|65512869|FG000|Overall Study|Withdrawal by Subject|2|||
23482994|NCT01150474|65512874|FG000|Overall Study|Withdrawal by Subject|5|||
23482995|NCT01150474|65512875|FG001|Overall Study|Withdrawal by Subject|2|||
23482996|NCT01150474|65512874|FG000|Overall Study|Cancer found|1|||
23482997|NCT01150474|65512875|FG001|Overall Study|Cancer found|0|||
23482998|NCT01150474|65512874|FG000|Overall Study|Multiple Studies|0|||
23482999|NCT01150474|65512875|FG001|Overall Study|Multiple Studies|1|||
23601740|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
23483000|NCT01150474|65512874|FG000|Overall Study|Rectotomy|1|||
23483001|NCT01150474|65512875|FG001|Overall Study|Rectotomy|0|||
23483002|NCT01150474|65512874|FG000|Overall Study|Drug did not arrive in time|1|||
23483003|NCT01150474|65512875|FG001|Overall Study|Drug did not arrive in time|0|||
23483004|NCT01150474|65512874|FG000|Overall Study|Drug not administered|1|||
23483005|NCT01150474|65512875|FG001|Overall Study|Drug not administered|0|||
23483006|NCT01150474|65512874|FG000|Overall Study|Surgery Changed|1|||
23601741|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
23483007|NCT01150474|65512875|FG001|Overall Study|Surgery Changed|0|||
23483008|NCT01214174|65512876|FG000|Overall Study|Withdrawal by Subject|0|||
23483009|NCT01214174|65512877|FG001|Overall Study|Withdrawal by Subject|0|||
23483010|NCT01214174|65512878|FG002|Overall Study|Withdrawal by Subject|1|||
23601742|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
23483011|NCT02927067|65512881|FG000|Overall Study|Withdrawn Consent|20|||
23483012|NCT02927067|65512882|FG001|Overall Study|Withdrawn Consent|12|||
23483013|NCT02927067|65512881|FG000|Overall Study|Death|18|||
23483014|NCT02927067|65512882|FG001|Overall Study|Death|31|||
23483015|NCT02927067|65512881|FG000|Overall Study|Adverse Event|13|||
23483016|NCT02927067|65512882|FG001|Overall Study|Adverse Event|10|||
23483017|NCT02927067|65512881|FG000|Overall Study|Noncompliance|5|||
23483018|NCT02927067|65512882|FG001|Overall Study|Noncompliance|2|||
23483019|NCT02927067|65512881|FG000|Overall Study|Reason not Specified|4|||
23483020|NCT02927067|65512882|FG001|Overall Study|Reason not Specified|6|||
23483021|NCT01101191|65512883|FG000|Period 1|Withdrawal by Subject|1|||
23483022|NCT01101191|65512884|FG001|Period 1|Withdrawal by Subject|0|||
23483023|NCT01101191|65512883|FG000|Period 1|Adverse Event|1|||
23483024|NCT01101191|65512884|FG001|Period 1|Adverse Event|2|||
23483025|NCT02195687|65512885|FG000|Overall Study|Personal Reasons|1|||
23483026|NCT02195687|65512886|FG001|Overall Study|Personal Reasons|1|||
23483027|NCT02195687|65512885|FG000|Overall Study|Lost to Follow-up|4|||
23483028|NCT02195687|65512886|FG001|Overall Study|Lost to Follow-up|1|||
23483029|NCT00136604|65512887|FG000|Overall Study|Lost to Follow-up|1|||
23483030|NCT00136604|65512888|FG001|Overall Study|Lost to Follow-up|0|||
23483031|NCT00136604|65512889|FG002|Overall Study|Lost to Follow-up|0|||
23483032|NCT00136604|65512890|FG003|Overall Study|Lost to Follow-up|0|||
23483033|NCT00136604|65512891|FG004|Overall Study|Lost to Follow-up|1|||
23483034|NCT00136604|65512887|FG000|Overall Study|Migrated/moved from study area|0|||
23483035|NCT00136604|65512888|FG001|Overall Study|Migrated/moved from study area|1|||
23483036|NCT00136604|65512889|FG002|Overall Study|Migrated/moved from study area|0|||
23483037|NCT00136604|65512890|FG003|Overall Study|Migrated/moved from study area|0|||
23483038|NCT00136604|65512891|FG004|Overall Study|Migrated/moved from study area|0|||
23483039|NCT01751802|65512896|FG000|Overall Study|Adverse Event|4|||
23483040|NCT01751802|65512897|FG001|Overall Study|Adverse Event|2|||
23483041|NCT01850602|65512898|FG000|Overall Study|Adverse Event|7|||
23483042|NCT01850602|65512899|FG001|Overall Study|Adverse Event|10|||
23483043|NCT01850602|65512898|FG000|Overall Study|Physician Decision|2|||
23483044|NCT01850602|65512899|FG001|Overall Study|Physician Decision|1|||
23483045|NCT01850602|65512898|FG000|Overall Study|Withdrawal by Subject|2|||
23483046|NCT01850602|65512899|FG001|Overall Study|Withdrawal by Subject|4|||
23483047|NCT01850602|65512898|FG000|Overall Study|Decrease in serum calcium|2|||
23483048|NCT01850602|65512899|FG001|Overall Study|Decrease in serum calcium|3|||
23483049|NCT01850602|65512898|FG000|Overall Study|Increase in serum ferritin|1|||
23483050|NCT01850602|65512899|FG001|Overall Study|Increase in serum ferritin|0|||
23483051|NCT02021656|65512900|FG000|Overall Study|Adverse Event|1|||
23483052|NCT02021656|65512900|FG000|Overall Study|Lack of Efficacy|2|||
23483053|NCT02021656|65512900|FG000|Overall Study|Lost to Follow-up|1|||
23483054|NCT02021656|65512900|FG000|Overall Study|Withdrew Consent|2|||
23483055|NCT00719264|65512901|FG000|Overall Study|Adverse Event|41|||
23483056|NCT00719264|65512902|FG001|Overall Study|Adverse Event|49|||
23483057|NCT00719264|65512901|FG000|Overall Study|Death|13|||
23483058|NCT00719264|65512902|FG001|Overall Study|Death|10|||
23483059|NCT00719264|65512901|FG000|Overall Study|Administrative Problems|6|||
23483060|NCT00719264|65512902|FG001|Overall Study|Administrative Problems|4|||
23483061|NCT00719264|65512901|FG000|Overall Study|Lost to Follow-up|1|||
23483062|NCT00719264|65512902|FG001|Overall Study|Lost to Follow-up|1|||
23483063|NCT00719264|65512901|FG000|Overall Study|Withdrawal by Subject|12|||
23483064|NCT00719264|65512902|FG001|Overall Study|Withdrawal by Subject|7|||
23483065|NCT00719264|65512901|FG000|Overall Study|Protocol Deviation|1|||
23483066|NCT00719264|65512902|FG001|Overall Study|Protocol Deviation|3|||
23483067|NCT00719264|65512901|FG000|Overall Study|New Cancer Therapy|4|||
23483068|NCT00719264|65512902|FG001|Overall Study|New Cancer Therapy|2|||
23483069|NCT00719264|65512901|FG000|Overall Study|Disease Progression|104|||
23483070|NCT00719264|65512902|FG001|Overall Study|Disease Progression|107|||
23483071|NCT01894568|65512903|FG000|Overall Study|Adverse Event|2|||
23483072|NCT01894568|65512904|FG001|Overall Study|Adverse Event|3|||
23483073|NCT01894568|65512903|FG000|Overall Study|Protocol required discontinuation|2|||
23483074|NCT01894568|65512904|FG001|Overall Study|Protocol required discontinuation|1|||
23483075|NCT01894568|65512903|FG000|Overall Study|Withdrawal by Subject|5|||
23483076|NCT01894568|65512904|FG001|Overall Study|Withdrawal by Subject|5|||
23483077|NCT01894568|65512903|FG000|Overall Study|Physician Decision|1|||
23483078|NCT01894568|65512904|FG001|Overall Study|Physician Decision|0|||
23483079|NCT01894568|65512903|FG000|Overall Study|Lost to Follow-up|0|||
23483080|NCT01894568|65512904|FG001|Overall Study|Lost to Follow-up|1|||
23483081|NCT01923168|65512906|FG000|Overall Study|Protocol Violation|1|||
23483082|NCT01923168|65512907|FG001|Overall Study|Protocol Violation|1|||
23483083|NCT01923168|65512908|FG002|Overall Study|Protocol Violation|0|||
23483084|NCT01923168|65512906|FG000|Overall Study|Subject/guardian decision|14|||
23483085|NCT01923168|65512907|FG001|Overall Study|Subject/guardian decision|14|||
23483086|NCT01923168|65512908|FG002|Overall Study|Subject/guardian decision|4|||
23483087|NCT01923168|65512906|FG000|Overall Study|Adverse Event|12|||
23483088|NCT01923168|65512907|FG001|Overall Study|Adverse Event|12|||
23483089|NCT01923168|65512908|FG002|Overall Study|Adverse Event|0|||
23483090|NCT01923168|65512906|FG000|Overall Study|Physician Decision|6|||
23483091|NCT01923168|65512907|FG001|Overall Study|Physician Decision|9|||
23483092|NCT01923168|65512908|FG002|Overall Study|Physician Decision|5|||
23483093|NCT01923168|65512906|FG000|Overall Study|Progressive disease|4|||
23483094|NCT01923168|65512907|FG001|Overall Study|Progressive disease|3|||
23483095|NCT01923168|65512908|FG002|Overall Study|Progressive disease|7|||
23483096|NCT01923168|65512906|FG000|Overall Study|Death|0|||
23483097|NCT01923168|65512907|FG001|Overall Study|Death|0|||
23483098|NCT01923168|65512908|FG002|Overall Study|Death|1|||
23483099|NCT01854944|65512909|FG000|Overall Study|Withdrawal by Subject|0|||
23483100|NCT01854944|65512910|FG001|Overall Study|Withdrawal by Subject|0|||
23660314|NCT04607148|66145554|FG001|Overall Study|Death|3|||
23660315|NCT04607148|66145555|FG002|Overall Study|Death|0|||
23483101|NCT01854944|65512911|FG002|Overall Study|Withdrawal by Subject|1|||
23483102|NCT05070546|65512912|FG000|Overall Study|Death|0|||
23483103|NCT05070546|65512913|FG001|Overall Study|Death|0|||
23483104|NCT05070546|65512914|FG002|Overall Study|Death|0|||
23483105|NCT05070546|65512915|FG003|Overall Study|Death|0|||
23483106|NCT05070546|65512916|FG004|Overall Study|Death|0|||
23483107|NCT05070546|65512917|FG005|Overall Study|Death|1|||
23483108|NCT05070546|65512912|FG000|Overall Study|Lost to Follow-up|8|||
23483109|NCT05070546|65512913|FG001|Overall Study|Lost to Follow-up|2|||
23483110|NCT05070546|65512914|FG002|Overall Study|Lost to Follow-up|7|||
23483111|NCT05070546|65512915|FG003|Overall Study|Lost to Follow-up|1|||
23483112|NCT05070546|65512916|FG004|Overall Study|Lost to Follow-up|2|||
23483113|NCT05070546|65512917|FG005|Overall Study|Lost to Follow-up|0|||
23483114|NCT05070546|65512912|FG000|Overall Study|Withdrawal by Subject|1|||
23483115|NCT05070546|65512913|FG001|Overall Study|Withdrawal by Subject|1|||
23483116|NCT05070546|65512914|FG002|Overall Study|Withdrawal by Subject|3|||
23483117|NCT05070546|65512915|FG003|Overall Study|Withdrawal by Subject|0|||
23483118|NCT05070546|65512916|FG004|Overall Study|Withdrawal by Subject|0|||
23601743|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
23601744|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
23601745|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
23601746|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
23601747|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601748|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601749|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601750|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23601751|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
23601752|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23660316|NCT04607148|66145556|FG003|Overall Study|Death|1|||
23483119|NCT05070546|65512917|FG005|Overall Study|Withdrawal by Subject|0|||
23483120|NCT05070546|65512912|FG000|Overall Study|Other|0|||
23483121|NCT05070546|65512913|FG001|Overall Study|Other|0|||
23483122|NCT05070546|65512914|FG002|Overall Study|Other|0|||
23483123|NCT05070546|65512915|FG003|Overall Study|Other|0|||
23483124|NCT05070546|65512916|FG004|Overall Study|Other|3|||
23483125|NCT05070546|65512917|FG005|Overall Study|Other|0|||
23483126|NCT05070546|65512912|FG000|Overall Study|Randomized but not vaccinated|1|||
23483127|NCT05070546|65512913|FG001|Overall Study|Randomized but not vaccinated|0|||
23483128|NCT05070546|65512914|FG002|Overall Study|Randomized but not vaccinated|1|||
23660317|NCT04607148|66145553|FG000|Overall Study|Adverse Event|0|||
23660318|NCT04607148|66145554|FG001|Overall Study|Adverse Event|1|||
23660319|NCT04607148|66145555|FG002|Overall Study|Adverse Event|0|||
23660320|NCT04607148|66145556|FG003|Overall Study|Adverse Event|0|||
23660321|NCT02047253|66145559|FG000|Overall Study|Lost to Follow-up|8|||
23660322|NCT00525044|66145560|FG000|Overall Study|Lost to Follow-up|0|||
23660323|NCT00525044|66145561|FG001|Overall Study|Lost to Follow-up|1|||
23660324|NCT02428855|66145562|FG000|Overall Study|Withdrawal by Subject|2|||
23365775|NCT02329847|65085131|FG000|Overall Study|Physician Decision|0|||
23365776|NCT02329847|65085132|FG001|Overall Study|Physician Decision|0|||
23365777|NCT02329847|65085133|FG002|Overall Study|Physician Decision|0|||
23365778|NCT02329847|65085134|FG003|Overall Study|Physician Decision|0|||
23365779|NCT02329847|65085135|FG004|Overall Study|Physician Decision|1|||
23365780|NCT02329847|65085136|FG005|Overall Study|Physician Decision|0|||
23365781|NCT02329847|65085131|FG000|Overall Study|Withdrawal by Subject|2|||
23365782|NCT02329847|65085132|FG001|Overall Study|Withdrawal by Subject|1|||
23365783|NCT02329847|65085133|FG002|Overall Study|Withdrawal by Subject|5|||
23365784|NCT02329847|65085134|FG003|Overall Study|Withdrawal by Subject|7|||
23365785|NCT02329847|65085135|FG004|Overall Study|Withdrawal by Subject|8|||
23365786|NCT02329847|65085136|FG005|Overall Study|Withdrawal by Subject|3|||
23365787|NCT02329847|65085131|FG000|Overall Study|Other|1|||
23365788|NCT02329847|65085132|FG001|Overall Study|Other|2|||
23365789|NCT02329847|65085133|FG002|Overall Study|Other|6|||
23483129|NCT05070546|65512915|FG003|Overall Study|Randomized but not vaccinated|1|||
23483130|NCT05070546|65512916|FG004|Overall Study|Randomized but not vaccinated|3|||
23483131|NCT05070546|65512917|FG005|Overall Study|Randomized but not vaccinated|0|||
23660325|NCT02495844|66145563|FG000|Overall Study|Lack of Efficacy|1|||
23483132|NCT01307020|65512920|FG000|Overall Study|Lost to Follow-up|0|||
23483133|NCT01307020|65512921|FG001|Overall Study|Lost to Follow-up|0|||
23660326|NCT02495844|66145564|FG001|Overall Study|Lack of Efficacy|2|||
23365790|NCT02329847|65085134|FG003|Overall Study|Other|13|||
23365791|NCT02329847|65085135|FG004|Overall Study|Other|10|||
23365792|NCT02329847|65085136|FG005|Overall Study|Other|3|||
23365793|NCT04155463|65085137|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
23365794|NCT04155463|65085138|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
23365795|NCT01716663|65085143|FG000|Overall Study|Withdrawn prior to procedure|4|||
23365796|NCT01716663|65085143|FG000|Overall Study|Treated with non-study catheter|2|||
23365797|NCT01973218|65085148|FG000|Overall Study|Adverse Event|1|||
23365798|NCT01973218|65085149|FG001|Overall Study|Adverse Event|0|||
23365799|NCT01973218|65085148|FG000|Overall Study|Withdrawal by Subject|1|||
23365800|NCT01973218|65085149|FG001|Overall Study|Withdrawal by Subject|0|||
23365801|NCT00715403|65085150|FG000|Overall Study|Progressive disease|0|||
23365802|NCT00715403|65085151|FG001|Overall Study|Progressive disease|1|||
23365803|NCT00715403|65085152|FG002|Overall Study|Progressive disease|3|||
23365804|NCT00715403|65085153|FG003|Overall Study|Progressive disease|9|||
23365805|NCT00715403|65085154|FG004|Overall Study|Progressive disease|5|||
23365806|NCT00715403|65085155|FG005|Overall Study|Progressive disease|14|||
23365807|NCT00715403|65085156|FG006|Overall Study|Progressive disease|1|||
23365808|NCT00715403|65085150|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365809|NCT00715403|65085151|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365810|NCT00715403|65085152|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365811|NCT00715403|65085153|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365812|NCT00715403|65085154|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365813|NCT00715403|65085155|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
23365814|NCT00715403|65085156|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365815|NCT00715403|65085150|FG000|Overall Study|Other Adverse Event than DLT|1|||
23365816|NCT00715403|65085151|FG001|Overall Study|Other Adverse Event than DLT|0|||
23365817|NCT00715403|65085152|FG002|Overall Study|Other Adverse Event than DLT|0|||
23365818|NCT00715403|65085153|FG003|Overall Study|Other Adverse Event than DLT|0|||
23365819|NCT00715403|65085154|FG004|Overall Study|Other Adverse Event than DLT|0|||
23660327|NCT02495844|66145563|FG000|Overall Study|AE, non-fatal|0|||
23660328|NCT02495844|66145564|FG001|Overall Study|AE, non-fatal|1|||
23660329|NCT02495844|66145563|FG000|Overall Study|Hepatitis Positivity|0|||
23660330|NCT02495844|66145564|FG001|Overall Study|Hepatitis Positivity|1|||
23660331|NCT00804570|66145565|FG000|Overall Study|Adverse Event|14|||
23660332|NCT00804570|66145566|FG001|Overall Study|Adverse Event|7|||
23660333|NCT00804570|66145565|FG000|Overall Study|Lack of Efficacy|0|||
23660334|NCT00804570|66145566|FG001|Overall Study|Lack of Efficacy|1|||
23660335|NCT00804570|66145565|FG000|Overall Study|Lost to Follow-up|18|||
23660336|NCT00804570|66145566|FG001|Overall Study|Lost to Follow-up|21|||
23660337|NCT00804570|66145565|FG000|Overall Study|Entry criteria not met|5|||
23660338|NCT00804570|66145566|FG001|Overall Study|Entry criteria not met|5|||
23660339|NCT00804570|66145565|FG000|Overall Study|Protocol Violation|12|||
23660340|NCT00804570|66145566|FG001|Overall Study|Protocol Violation|16|||
23660341|NCT00804570|66145565|FG000|Overall Study|Physician Decision|1|||
23660342|NCT00804570|66145566|FG001|Overall Study|Physician Decision|2|||
23660343|NCT00804570|66145565|FG000|Overall Study|Sponsor decision|1|||
23660344|NCT00804570|66145566|FG001|Overall Study|Sponsor decision|4|||
23660345|NCT00804570|66145565|FG000|Overall Study|Withdrawal by Subject|21|||
23660346|NCT00804570|66145566|FG001|Overall Study|Withdrawal by Subject|38|||
23660347|NCT01368536|66145567|FG000|Overall Study|Adverse Event|5|||
23660348|NCT01368536|66145568|FG001|Overall Study|Adverse Event|6|||
23660349|NCT01368536|66145569|FG002|Overall Study|Adverse Event|8|||
23365820|NCT00715403|65085155|FG005|Overall Study|Other Adverse Event than DLT|2|||
23365821|NCT00715403|65085156|FG006|Overall Study|Other Adverse Event than DLT|0|||
23365822|NCT00715403|65085150|FG000|Overall Study|Protocol Violation|0|||
23365823|NCT00715403|65085151|FG001|Overall Study|Protocol Violation|0|||
23365824|NCT00715403|65085152|FG002|Overall Study|Protocol Violation|0|||
23365825|NCT00715403|65085153|FG003|Overall Study|Protocol Violation|0|||
23365826|NCT00715403|65085154|FG004|Overall Study|Protocol Violation|0|||
23365827|NCT00715403|65085155|FG005|Overall Study|Protocol Violation|1|||
23660350|NCT01368536|66145567|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23660351|NCT01368536|66145568|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23365828|NCT00715403|65085156|FG006|Overall Study|Protocol Violation|0|||
23365829|NCT00715403|65085150|FG000|Overall Study|Other reason not defined above|0|||
23660352|NCT01368536|66145569|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23365830|NCT00715403|65085151|FG001|Overall Study|Other reason not defined above|0|||
23365831|NCT00715403|65085152|FG002|Overall Study|Other reason not defined above|1|||
23365832|NCT00715403|65085153|FG003|Overall Study|Other reason not defined above|0|||
23365833|NCT00715403|65085154|FG004|Overall Study|Other reason not defined above|1|||
23365834|NCT00715403|65085155|FG005|Overall Study|Other reason not defined above|1|||
23365835|NCT00715403|65085156|FG006|Overall Study|Other reason not defined above|0|||
23365836|NCT03082729|65085157|FG000|Overall Study|Lost to Follow-up|7|||
23365837|NCT03082729|65085157|FG000|Overall Study|Physician Decision|2|||
23365838|NCT03082729|65085157|FG000|Overall Study|Withdrawal by Subject|1|||
23365839|NCT03082729|65085157|FG000|Overall Study|Lack of Efficacy|9|||
23365840|NCT03082729|65085157|FG000|Overall Study|Adverse Event|4|||
23365841|NCT03082729|65085157|FG000|Overall Study|Protocol Violation|6|||
23365842|NCT03082729|65085157|FG000|Overall Study|Fear of study procedure|1|||
23365843|NCT03082729|65085157|FG000|Overall Study|Scheduling conflict|1|||
23365844|NCT00809445|65085163|FG000|1 Month Follow-up|Lost contact|1|||
23365845|NCT00809445|65085164|FG001|1 Month Follow-up|Lost contact|2|||
23365846|NCT00809445|65085165|FG002|1 Month Follow-up|Lost contact|1|||
23365847|NCT00809445|65085163|FG000|1 Month Follow-up|Withdrew consent|1|||
23365848|NCT00809445|65085164|FG001|1 Month Follow-up|Withdrew consent|1|||
23365849|NCT00809445|65085165|FG002|1 Month Follow-up|Withdrew consent|1|||
23365850|NCT00809445|65085163|FG000|1 Month Follow-up|Death|0|||
23365851|NCT00809445|65085164|FG001|1 Month Follow-up|Death|1|||
23365852|NCT00809445|65085165|FG002|1 Month Follow-up|Death|1|||
23365853|NCT00809445|65085163|FG000|1 Month Follow-up|Incarcerated|0|||
23365854|NCT00809445|65085164|FG001|1 Month Follow-up|Incarcerated|0|||
23365855|NCT00809445|65085165|FG002|1 Month Follow-up|Incarcerated|1|||
23365856|NCT00809445|65085163|FG000|6 Month Follow-up|Lost contact|16|||
23483134|NCT01307020|65512922|FG002|Overall Study|Lost to Follow-up|1|||
23483135|NCT01307020|65512923|FG003|Overall Study|Lost to Follow-up|1|||
23483136|NCT01307020|65512924|FG004|Overall Study|Lost to Follow-up|0|||
23365857|NCT00809445|65085164|FG001|6 Month Follow-up|Lost contact|14|||
23365858|NCT00809445|65085165|FG002|6 Month Follow-up|Lost contact|14|||
23365859|NCT00809445|65085163|FG000|6 Month Follow-up|Death|2|||
23365860|NCT00809445|65085164|FG001|6 Month Follow-up|Death|1|||
23483137|NCT01307020|65512925|FG005|Overall Study|Lost to Follow-up|0|||
23483138|NCT01307020|65512926|FG006|Overall Study|Lost to Follow-up|1|||
23365861|NCT00809445|65085165|FG002|6 Month Follow-up|Death|1|||
23365862|NCT00809445|65085163|FG000|6 Month Follow-up|Incarcerated|6|||
23365863|NCT00809445|65085164|FG001|6 Month Follow-up|Incarcerated|8|||
23365864|NCT00809445|65085165|FG002|6 Month Follow-up|Incarcerated|8|||
23365865|NCT00809445|65085163|FG000|6 Month Follow-up|Withdrew consent|0|||
23365866|NCT00809445|65085164|FG001|6 Month Follow-up|Withdrew consent|0|||
23365867|NCT00809445|65085165|FG002|6 Month Follow-up|Withdrew consent|1|||
23365868|NCT02791269|65085166|FG000|Overall Study|Lost to Follow-up|0|||
23365869|NCT02791269|65085167|FG001|Overall Study|Lost to Follow-up|1|||
23365870|NCT00971867|65085168|FG000|Overall Study|Adverse Event|4|||
23365871|NCT00971867|65085168|FG000|Overall Study|Participant Withdrew Consent|1|||
23365872|NCT00971867|65085168|FG000|Overall Study|Disease Progression|6|||
23365873|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365874|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
23365875|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365876|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365877|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365878|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365879|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365880|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365881|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365882|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365883|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365884|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
23365885|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
23365886|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365887|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365888|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365889|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365890|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365891|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365892|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365893|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365894|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365895|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
23365896|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
23365897|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365898|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365899|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365900|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365901|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365902|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365903|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365904|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365905|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365906|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
23365907|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365908|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365909|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365910|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365911|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365912|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365913|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365914|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365915|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365916|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365917|NCT03410992|65085169|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
23365918|NCT03410992|65085170|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
23365919|NCT03410992|65085171|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365920|NCT03410992|65085172|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365921|NCT03410992|65085173|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365922|NCT03410992|65085174|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365923|NCT03410992|65085175|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365924|NCT03410992|65085176|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365925|NCT03410992|65085177|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365926|NCT03410992|65085178|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365927|NCT03410992|65085179|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365928|NCT03410992|65085169|FG000|Week 16 Assessment|Incorrect escapers|0|||
23365929|NCT03410992|65085170|FG001|Week 16 Assessment|Incorrect escapers|6|||
23365930|NCT03410992|65085171|FG002|Week 16 Assessment|Incorrect escapers|0|||
23365931|NCT03410992|65085172|FG003|Week 16 Assessment|Incorrect escapers|0|||
23365932|NCT03410992|65085173|FG004|Week 16 Assessment|Incorrect escapers|0|||
23365933|NCT03410992|65085174|FG005|Week 16 Assessment|Incorrect escapers|0|||
23365934|NCT03410992|65085175|FG006|Week 16 Assessment|Incorrect escapers|0|||
23365935|NCT03410992|65085176|FG007|Week 16 Assessment|Incorrect escapers|0|||
23365936|NCT03410992|65085177|FG008|Week 16 Assessment|Incorrect escapers|0|||
23365937|NCT03410992|65085178|FG009|Week 16 Assessment|Incorrect escapers|0|||
23365938|NCT03410992|65085179|FG010|Week 16 Assessment|Incorrect escapers|0|||
23365939|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365940|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365941|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365942|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
23365943|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
23365944|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365945|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365946|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365947|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365948|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365949|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365950|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365951|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365952|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365953|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
23365954|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
23365955|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
23365956|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365957|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365958|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365959|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365960|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365961|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365962|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365963|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365964|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365965|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365966|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
23365967|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365968|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365969|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365970|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365971|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365972|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365973|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365974|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365975|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
23365976|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
23365977|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
23365978|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365979|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365980|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365981|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365982|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365983|NCT03410992|65085169|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365984|NCT03410992|65085170|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365985|NCT03410992|65085171|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365986|NCT03410992|65085172|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365987|NCT03410992|65085173|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365988|NCT03410992|65085174|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365989|NCT03410992|65085175|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365990|NCT03410992|65085176|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
23365991|NCT03410992|65085177|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365992|NCT03410992|65085178|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365993|NCT03410992|65085179|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365994|NCT03410992|65085169|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365995|NCT03410992|65085170|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365996|NCT03410992|65085171|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365997|NCT03410992|65085172|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365998|NCT03410992|65085173|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365999|NCT03410992|65085174|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366000|NCT03410992|65085175|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366001|NCT03410992|65085176|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366002|NCT03410992|65085177|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
23366003|NCT03410992|65085178|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366004|NCT03410992|65085179|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366005|NCT01468454|65085180|FG000|Overall Study|Did not have surgery after PET|9|||
23366006|NCT00274742|65085188|FG000|Overall Study|Adverse Event|0|||
23366007|NCT00274742|65085189|FG001|Overall Study|Adverse Event|4|||
23366008|NCT00274742|65085190|FG002|Overall Study|Adverse Event|1|||
23366009|NCT00274742|65085191|FG003|Overall Study|Adverse Event|4|||
23366010|NCT00274742|65085192|FG004|Overall Study|Adverse Event|12|||
23366011|NCT00274742|65085193|FG005|Overall Study|Adverse Event|3|||
23366012|NCT00274742|65085188|FG000|Overall Study|Lost to Follow-up|0|||
23366013|NCT00274742|65085189|FG001|Overall Study|Lost to Follow-up|0|||
23366014|NCT00274742|65085190|FG002|Overall Study|Lost to Follow-up|0|||
23366015|NCT00274742|65085191|FG003|Overall Study|Lost to Follow-up|0|||
23366016|NCT00274742|65085192|FG004|Overall Study|Lost to Follow-up|1|||
23366017|NCT00274742|65085193|FG005|Overall Study|Lost to Follow-up|0|||
23366018|NCT00274742|65085188|FG000|Overall Study|End of Study|0|||
23366019|NCT00274742|65085189|FG001|Overall Study|End of Study|0|||
23366020|NCT00274742|65085190|FG002|Overall Study|End of Study|0|||
23366021|NCT00274742|65085191|FG003|Overall Study|End of Study|1|||
23366022|NCT00274742|65085192|FG004|Overall Study|End of Study|0|||
23366023|NCT00274742|65085193|FG005|Overall Study|End of Study|0|||
23366024|NCT00274742|65085188|FG000|Overall Study|Disease Progression|0|||
23366025|NCT00274742|65085189|FG001|Overall Study|Disease Progression|1|||
23366026|NCT00274742|65085190|FG002|Overall Study|Disease Progression|1|||
23366027|NCT00274742|65085191|FG003|Overall Study|Disease Progression|0|||
23366028|NCT00274742|65085192|FG004|Overall Study|Disease Progression|1|||
23366029|NCT00274742|65085193|FG005|Overall Study|Disease Progression|0|||
23366030|NCT00274742|65085188|FG000|Overall Study|Other|0|||
23660353|NCT01368536|66145567|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23660354|NCT01368536|66145568|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23660355|NCT01368536|66145569|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23660356|NCT01368536|66145567|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
23660357|NCT01368536|66145568|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23660358|NCT01368536|66145569|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23660359|NCT01368536|66145567|FG000|Overall Study|No longer required study medication|0|||
23660360|NCT01368536|66145568|FG001|Overall Study|No longer required study medication|0|||
23660361|NCT01368536|66145569|FG002|Overall Study|No longer required study medication|1|||
23660362|NCT01368536|66145567|FG000|Overall Study|Withdrawal by Subject|2|||
23660363|NCT01368536|66145568|FG001|Overall Study|Withdrawal by Subject|5|||
23660364|NCT01368536|66145569|FG002|Overall Study|Withdrawal by Subject|4|||
23660365|NCT01368536|66145567|FG000|Overall Study|Lost to Follow-up|3|||
23660366|NCT01368536|66145568|FG001|Overall Study|Lost to Follow-up|3|||
23660367|NCT01368536|66145569|FG002|Overall Study|Lost to Follow-up|5|||
23660368|NCT01368536|66145567|FG000|Overall Study|Administrative problems|34|||
23660369|NCT01368536|66145568|FG001|Overall Study|Administrative problems|39|||
23660370|NCT01368536|66145569|FG002|Overall Study|Administrative problems|35|||
23660371|NCT01368536|66145567|FG000|Overall Study|Protocol deviation|0|||
23660372|NCT01368536|66145568|FG001|Overall Study|Protocol deviation|3|||
23660373|NCT01368536|66145569|FG002|Overall Study|Protocol deviation|1|||
23660374|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
23660375|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
23660376|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Death|0|||
23660377|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Death|1|||
23660378|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
23660379|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
23660380|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
23660381|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
23660382|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
23660383|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
23660384|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
23660385|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
23660386|NCT00843518|66145570|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
23660387|NCT00843518|66145571|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
23660388|NCT00766090|66145576|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660389|NCT00766090|66145577|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660390|NCT00766090|66145578|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660391|NCT00766090|66145579|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660392|NCT00766090|66145580|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660393|NCT00766090|66145581|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660394|NCT00766090|66145582|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660395|NCT00766090|66145583|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660396|NCT00766090|66145584|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
23483139|NCT01307020|65512927|FG007|Overall Study|Lost to Follow-up|0|||
23483140|NCT01307020|65512928|FG008|Overall Study|Lost to Follow-up|0|||
23483141|NCT01307020|65512929|FG009|Overall Study|Lost to Follow-up|0|||
23660397|NCT00766090|66145585|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660398|NCT00766090|66145586|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23660399|NCT00766090|66145587|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23483142|NCT01307020|65512920|FG000|Overall Study|Electronic data capture failure|0|||
23483143|NCT01307020|65512921|FG001|Overall Study|Electronic data capture failure|1|||
23660400|NCT00766090|66145576|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
23660401|NCT00766090|66145577|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660402|NCT00766090|66145578|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660403|NCT00766090|66145579|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660404|NCT00766090|66145580|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660405|NCT00766090|66145581|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660406|NCT00766090|66145582|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660407|NCT00766090|66145583|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660408|NCT00766090|66145584|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660409|NCT00766090|66145585|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660410|NCT00766090|66145586|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660411|NCT00766090|66145587|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23660412|NCT00766090|66145576|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23660413|NCT00766090|66145577|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660414|NCT00766090|66145578|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660415|NCT00766090|66145579|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23660416|NCT00766090|66145580|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660417|NCT00766090|66145581|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660418|NCT00766090|66145582|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660419|NCT00766090|66145583|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660420|NCT00766090|66145584|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660421|NCT00766090|66145585|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660422|NCT00766090|66145586|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660423|NCT00766090|66145587|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23660424|NCT00766090|66145576|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660425|NCT00766090|66145577|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660426|NCT00766090|66145578|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
23366031|NCT00274742|65085189|FG001|Overall Study|Other|3|||
23366032|NCT00274742|65085190|FG002|Overall Study|Other|0|||
23366033|NCT00274742|65085191|FG003|Overall Study|Other|0|||
23366034|NCT00274742|65085192|FG004|Overall Study|Other|2|||
23601753|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23660427|NCT00766090|66145579|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660428|NCT00766090|66145580|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660429|NCT00766090|66145581|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660430|NCT00766090|66145582|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660431|NCT00766090|66145583|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660432|NCT00766090|66145584|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660433|NCT00766090|66145585|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660434|NCT00766090|66145586|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
23660435|NCT00766090|66145587|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
23366035|NCT00274742|65085193|FG005|Overall Study|Other|0|||
23366036|NCT01096160|65085194|FG000|Overall Study|Adverse Event|0|||
23601754|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23601755|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
23601756|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
23601757|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23601758|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23601759|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23366037|NCT01096160|65085195|FG001|Overall Study|Adverse Event|0|||
23366038|NCT01096160|65085196|FG002|Overall Study|Adverse Event|1|||
23366039|NCT01096160|65085197|FG003|Overall Study|Adverse Event|0|||
23366040|NCT01096160|65085198|FG004|Overall Study|Adverse Event|0|||
23366041|NCT01096160|65085199|FG005|Overall Study|Adverse Event|0|||
23601760|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other|1|||
23601761|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other|0|||
23601762|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other|0|||
23601763|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other|0|||
23601764|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other|0|||
23601765|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
23601766|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
23601767|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601768|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601769|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601770|NCT01372085|65933896|FG000|Washout Period 2|Physician Decision|0|||
23601771|NCT01372085|65933897|FG001|Washout Period 2|Physician Decision|0|||
23601772|NCT01372085|65933898|FG002|Washout Period 2|Physician Decision|0|||
23601773|NCT01372085|65933899|FG003|Washout Period 2|Physician Decision|0|||
23601774|NCT01372085|65933900|FG004|Washout Period 2|Physician Decision|1|||
23601775|NCT01372085|65933901|FG005|Washout Period 2|Physician Decision|0|||
23601776|NCT01372085|65933902|FG006|Washout Period 2|Physician Decision|0|||
23601777|NCT01372085|65933903|FG007|Washout Period 2|Physician Decision|0|||
23601778|NCT01372085|65933904|FG008|Washout Period 2|Physician Decision|0|||
23601779|NCT01372085|65933905|FG009|Washout Period 2|Physician Decision|0|||
23601780|NCT01372085|65933896|FG000|Washout Period 3|Withdrawal by Subject|0|||
23601781|NCT01372085|65933897|FG001|Washout Period 3|Withdrawal by Subject|0|||
23601782|NCT01372085|65933898|FG002|Washout Period 3|Withdrawal by Subject|0|||
23601783|NCT01372085|65933899|FG003|Washout Period 3|Withdrawal by Subject|0|||
23601784|NCT01372085|65933900|FG004|Washout Period 3|Withdrawal by Subject|0|||
23601785|NCT01372085|65933901|FG005|Washout Period 3|Withdrawal by Subject|2|||
23601786|NCT01372085|65933902|FG006|Washout Period 3|Withdrawal by Subject|0|||
23601787|NCT01372085|65933903|FG007|Washout Period 3|Withdrawal by Subject|0|||
23660436|NCT00766090|66145576|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660437|NCT00766090|66145577|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660438|NCT00766090|66145578|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23366042|NCT01096160|65085200|FG006|Overall Study|Adverse Event|0|||
23366043|NCT01096160|65085201|FG007|Overall Study|Adverse Event|0|||
23366044|NCT01096160|65085202|FG008|Overall Study|Adverse Event|0|||
23366045|NCT01096160|65085203|FG009|Overall Study|Adverse Event|1|||
23601788|NCT01372085|65933904|FG008|Washout Period 3|Withdrawal by Subject|0|||
23601789|NCT01372085|65933905|FG009|Washout Period 3|Withdrawal by Subject|0|||
23601790|NCT00366249|65933906|FG000|Overall Study|Adverse Event|53|||
23601791|NCT00366249|65933907|FG001|Overall Study|Adverse Event|28|||
23660439|NCT00766090|66145579|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660440|NCT00766090|66145580|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
23660441|NCT00766090|66145581|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660442|NCT00766090|66145582|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660443|NCT00766090|66145583|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660444|NCT00766090|66145584|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660445|NCT00766090|66145585|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660446|NCT00766090|66145586|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660447|NCT00766090|66145587|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23660448|NCT00766090|66145576|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660449|NCT00766090|66145577|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660450|NCT00766090|66145578|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
23366046|NCT01096160|65085194|FG000|Overall Study|Met stopping criteria per protocol|0|||
23366047|NCT01096160|65085195|FG001|Overall Study|Met stopping criteria per protocol|0|||
23366048|NCT01096160|65085196|FG002|Overall Study|Met stopping criteria per protocol|0|||
23366049|NCT01096160|65085197|FG003|Overall Study|Met stopping criteria per protocol|0|||
23366050|NCT01096160|65085198|FG004|Overall Study|Met stopping criteria per protocol|1|||
23366051|NCT01096160|65085199|FG005|Overall Study|Met stopping criteria per protocol|0|||
23366052|NCT01096160|65085200|FG006|Overall Study|Met stopping criteria per protocol|2|||
23366053|NCT01096160|65085201|FG007|Overall Study|Met stopping criteria per protocol|0|||
23366054|NCT01096160|65085202|FG008|Overall Study|Met stopping criteria per protocol|2|||
23366055|NCT01096160|65085203|FG009|Overall Study|Met stopping criteria per protocol|0|||
23366056|NCT02783170|65088820|FG000|Overall Study|Randomized but not Vaccinated|1|||
23366057|NCT02783170|65088821|FG001|Overall Study|Randomized but not Vaccinated|0|||
23366058|NCT00447772|65088822|FG000|Overall Study|Lack of Efficacy|3|||
23366059|NCT00447772|65088822|FG000|Overall Study|Insufficient compliance|6|||
23366060|NCT00447772|65088822|FG000|Overall Study|Discontinuation of drug therapy|1|||
23366061|NCT00447772|65088822|FG000|Overall Study|Lost to Follow-up|9|||
23366062|NCT00447772|65088822|FG000|Overall Study|Withdrawal by Subject|1|||
23366063|NCT00447772|65088822|FG000|Overall Study|Unable to attend all study visits|2|||
23366064|NCT00447772|65088822|FG000|Overall Study|Adverse Event|1|||
23366065|NCT00447772|65088822|FG000|Overall Study|Patient relocated|1|||
23366066|NCT00447772|65088822|FG000|Overall Study|Incomplete documentation at visit 1|1|||
23366067|NCT00447772|65088822|FG000|Overall Study|Chemotherapy for lung cancer|1|||
23366068|NCT00447772|65088822|FG000|Overall Study|Premature re-injection required|1|||
23366069|NCT01781962|65088826|FG000|Overall Study|Other Miscellaneous Reasons|5|||
23366070|NCT03205150|65088827|FG000|Overall Study|Protocol deviation|1|||
23483144|NCT01307020|65512922|FG002|Overall Study|Electronic data capture failure|0|||
23601792|NCT00366249|65933906|FG000|Overall Study|Death|0|||
23601793|NCT00366249|65933907|FG001|Overall Study|Death|1|||
23601794|NCT00366249|65933906|FG000|Overall Study|Physician Decision|5|||
23601795|NCT00366249|65933907|FG001|Overall Study|Physician Decision|2|||
23601796|NCT00366249|65933906|FG000|Overall Study|Lost to Follow-up|2|||
23601797|NCT00366249|65933907|FG001|Overall Study|Lost to Follow-up|0|||
23601798|NCT00366249|65933906|FG000|Overall Study|Protocol Violation|1|||
23601799|NCT00366249|65933907|FG001|Overall Study|Protocol Violation|2|||
23601800|NCT00366249|65933906|FG000|Overall Study|Withdrawal by Subject|18|||
23601801|NCT00366249|65933907|FG001|Overall Study|Withdrawal by Subject|4|||
23601802|NCT00366249|65933906|FG000|Overall Study|Lack of Efficacy|21|||
23601803|NCT00366249|65933907|FG001|Overall Study|Lack of Efficacy|21|||
23601804|NCT00366249|65933906|FG000|Overall Study|Most due to osteomylitis status|31|||
23660451|NCT00766090|66145579|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23366071|NCT03205150|65088828|FG001|Overall Study|Protocol deviation|3|||
23366072|NCT03205150|65088829|FG002|Overall Study|Protocol deviation|0|||
23366073|NCT03205150|65088827|FG000|Overall Study|Patient/guardian decision|0|||
23366074|NCT03205150|65088828|FG001|Overall Study|Patient/guardian decision|3|||
23483145|NCT01307020|65512923|FG003|Overall Study|Electronic data capture failure|0|||
23601805|NCT00366249|65933907|FG001|Overall Study|Most due to osteomylitis status|20|||
23601806|NCT02605174|65933915|FG000|Overall Study|Adverse Event|0|||
23483146|NCT01307020|65512924|FG004|Overall Study|Electronic data capture failure|0|||
23601807|NCT02605174|65933916|FG001|Overall Study|Adverse Event|0|||
23601808|NCT02605174|65933917|FG002|Overall Study|Adverse Event|1|||
23366075|NCT03205150|65088829|FG002|Overall Study|Patient/guardian decision|0|||
23366076|NCT03205150|65088827|FG000|Overall Study|Adverse Event|1|||
23366077|NCT03205150|65088828|FG001|Overall Study|Adverse Event|1|||
23366078|NCT03205150|65088829|FG002|Overall Study|Adverse Event|1|||
23483147|NCT01307020|65512925|FG005|Overall Study|Electronic data capture failure|0|||
23660452|NCT00766090|66145580|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660453|NCT00766090|66145581|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660454|NCT00766090|66145582|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660455|NCT00766090|66145583|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660456|NCT00766090|66145584|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660457|NCT00766090|66145585|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660458|NCT00766090|66145586|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660459|NCT00766090|66145587|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23660460|NCT00766090|66145576|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
23660461|NCT00766090|66145577|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
23660462|NCT00766090|66145578|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
23660463|NCT00766090|66145579|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
23660464|NCT00766090|66145580|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
23660465|NCT00766090|66145581|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
23660466|NCT00766090|66145582|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
23660467|NCT00766090|66145583|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
23660468|NCT00766090|66145584|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
23660469|NCT00766090|66145585|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
23660470|NCT00766090|66145586|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
23660471|NCT00766090|66145587|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
23660472|NCT00766090|66145576|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660473|NCT00766090|66145577|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660474|NCT00766090|66145578|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660475|NCT00766090|66145579|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660476|NCT00766090|66145580|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660477|NCT00766090|66145581|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
23660478|NCT00766090|66145582|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660479|NCT00766090|66145583|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660480|NCT00766090|66145584|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660481|NCT00766090|66145585|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660482|NCT00766090|66145586|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660483|NCT00766090|66145587|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23660484|NCT00766090|66145576|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660485|NCT00766090|66145577|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23660486|NCT00766090|66145578|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660487|NCT00766090|66145579|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23660488|NCT00766090|66145580|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660489|NCT00766090|66145581|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660490|NCT00766090|66145582|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660491|NCT00766090|66145583|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660492|NCT00766090|66145584|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660493|NCT00766090|66145585|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660494|NCT00766090|66145586|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23660495|NCT00766090|66145587|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23660496|NCT00766090|66145576|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660497|NCT00766090|66145577|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660498|NCT00766090|66145578|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660499|NCT00766090|66145579|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660500|NCT00766090|66145580|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
23660501|NCT00766090|66145581|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660502|NCT00766090|66145582|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660503|NCT00766090|66145583|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23366079|NCT03205150|65088827|FG000|Overall Study|Lost to Follow-up|0|||
23366080|NCT03205150|65088828|FG001|Overall Study|Lost to Follow-up|0|||
23660504|NCT00766090|66145584|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660505|NCT00766090|66145585|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23366081|NCT03205150|65088829|FG002|Overall Study|Lost to Follow-up|1|||
23366082|NCT03110354|65088830|FG000|Overall Study|Death|1|||
23366083|NCT03110354|65088831|FG001|Overall Study|Death|0|||
23366084|NCT03110354|65088832|FG002|Overall Study|Death|0|||
23366085|NCT03110354|65088833|FG003|Overall Study|Death|1|||
23366086|NCT03110354|65088834|FG004|Overall Study|Death|0|||
23366087|NCT03110354|65088830|FG000|Overall Study|Start of new therapy|0|||
23366088|NCT03110354|65088831|FG001|Overall Study|Start of new therapy|0|||
23483148|NCT01307020|65512926|FG006|Overall Study|Electronic data capture failure|0|||
23483149|NCT01307020|65512927|FG007|Overall Study|Electronic data capture failure|0|||
23483150|NCT01307020|65512928|FG008|Overall Study|Electronic data capture failure|0|||
23483151|NCT01307020|65512929|FG009|Overall Study|Electronic data capture failure|0|||
23366089|NCT03110354|65088832|FG002|Overall Study|Start of new therapy|0|||
23366090|NCT03110354|65088833|FG003|Overall Study|Start of new therapy|0|||
23483152|NCT01002820|65512930|FG000|Overall Study|Adverse Event|1|||
23483153|NCT01002820|65512930|FG000|Overall Study|Withdrawal by Subject|2|||
23483154|NCT01002820|65512930|FG000|Overall Study|Lack of Efficacy|1|||
23483155|NCT01209832|65512936|FG000|Period 1|Sponsor Decision and was not dosed|1|||
23483156|NCT01209832|65512936|FG000|Period 2|Sponsor Decision|1|||
23483157|NCT01634178|65512937|FG000|Treatment Period 1|Adverse Event|0|||
23483158|NCT01634178|65512938|FG001|Treatment Period 1|Adverse Event|1|||
23483159|NCT01634178|65512937|FG000|Treatment Period 2|Adverse Event|1|||
23483160|NCT01634178|65512938|FG001|Treatment Period 2|Adverse Event|0|||
23483161|NCT01489111|65512941|FG000|Overall Study|Withdrawal criterion|1|||
23483162|NCT00739596|65512942|FG000|Overall Study|Adverse Event|12|||
23483163|NCT00739596|65512943|FG001|Overall Study|Adverse Event|6|||
23483164|NCT00739596|65512942|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23483165|NCT00739596|65512943|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23483166|NCT00739596|65512942|FG000|Overall Study|Patient Withdrew Consent|8|||
23483167|NCT00739596|65512943|FG001|Overall Study|Patient Withdrew Consent|8|||
23483168|NCT00739596|65512942|FG000|Overall Study|Lost to Follow-up|0|||
23483169|NCT00739596|65512943|FG001|Overall Study|Lost to Follow-up|2|||
23483170|NCT00739596|65512942|FG000|Overall Study|Protocol Deviation|1|||
23483171|NCT00739596|65512943|FG001|Overall Study|Protocol Deviation|1|||
23483172|NCT03021564|65512944|FG000|Overall Study|Death|84|||
23483173|NCT03021564|65512945|FG001|Overall Study|Death|466|||
23483174|NCT03021564|65512944|FG000|Overall Study|Lost to Follow-up|0|||
23483175|NCT03021564|65512945|FG001|Overall Study|Lost to Follow-up|2|||
23483176|NCT00206076|65512946|FG000|Overall Study|Physician Decision|2|||
23483177|NCT00206076|65512947|FG001|Overall Study|Physician Decision|0|||
23483178|NCT00206076|65512946|FG000|Overall Study|Withdrawal by Subject|1|||
23366091|NCT03110354|65088834|FG004|Overall Study|Start of new therapy|1|||
23366092|NCT03110354|65088830|FG000|Overall Study|Failure to achieve response|2|||
23483179|NCT00206076|65512947|FG001|Overall Study|Withdrawal by Subject|1|||
23483180|NCT00708201|65512952|FG000|Overall Study|Adverse Event|4|||
23483181|NCT00708201|65512953|FG001|Overall Study|Adverse Event|4|||
23483182|NCT00708201|65512952|FG000|Overall Study|Withdrawal by Subject|1|||
23483183|NCT00708201|65512953|FG001|Overall Study|Withdrawal by Subject|1|||
23660506|NCT00766090|66145586|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23483184|NCT00708201|65512952|FG000|Overall Study|Lost to Follow-up|2|||
23660507|NCT00766090|66145587|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23660508|NCT01538628|66145591|FG000|Overall Study|Withdrawal by Subject|1|||
23660509|NCT01538628|66145592|FG001|Overall Study|Withdrawal by Subject|1|||
23660510|NCT01538628|66145591|FG000|Overall Study|Lost to Follow-up|0|||
23660511|NCT01538628|66145592|FG001|Overall Study|Lost to Follow-up|1|||
23660512|NCT01735279|66145595|FG000|Overall Study|Lost to Follow-up|11|||
23660513|NCT01735279|66145596|FG001|Overall Study|Lost to Follow-up|8|||
23660514|NCT01187550|66145601|FG000|Overall Study|Protocol Violation|3|||
23660515|NCT01187550|66145602|FG001|Overall Study|Protocol Violation|1|||
23660516|NCT01187550|66145601|FG000|Overall Study|Other|3|||
23660517|NCT01187550|66145602|FG001|Overall Study|Other|0|||
23660518|NCT01187550|66145601|FG000|Overall Study|Randomized but not treated|8|||
23660519|NCT01187550|66145602|FG001|Overall Study|Randomized but not treated|0|||
23660520|NCT01984164|66145603|FG000|Overall Study|Withdrawal by Subject|4|||
23483185|NCT00708201|65512953|FG001|Overall Study|Lost to Follow-up|0|||
23483186|NCT00708201|65512952|FG000|Overall Study|Protocol Violation|0|||
23483187|NCT00708201|65512953|FG001|Overall Study|Protocol Violation|1|||
23483188|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
23483189|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
23483190|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
23483191|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
23483192|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
23483193|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
23483194|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
23483195|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
23483196|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
23483197|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
23483198|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
23483199|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
23483200|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
23483201|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
23483202|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
23483203|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
23483204|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
23483205|NCT02519855|65512957|FG000|Overall Study|Adverse Event|0|||
23483206|NCT02519855|65512958|FG001|Overall Study|Adverse Event|1|||
23483207|NCT02519855|65512957|FG000|Overall Study|Lost to Follow-up|3|||
23483208|NCT02519855|65512958|FG001|Overall Study|Lost to Follow-up|3|||
23483209|NCT00760084|65512964|FG000|Overall Study|Physician Decision|5|||
23660521|NCT01984164|66145604|FG001|Overall Study|Withdrawal by Subject|3|||
23660522|NCT01984164|66145603|FG000|Overall Study|Adverse Event|5|||
23660523|NCT01984164|66145604|FG001|Overall Study|Adverse Event|19|||
23483210|NCT00760084|65512964|FG000|Overall Study|Withdrawal by Subject|2|||
23483211|NCT00760084|65512964|FG000|Overall Study|Progressive Disease|3|||
23660524|NCT01984164|66145603|FG000|Overall Study|Lost to Follow-up|1|||
23366093|NCT03110354|65088831|FG001|Overall Study|Failure to achieve response|3|||
23366094|NCT03110354|65088832|FG002|Overall Study|Failure to achieve response|0|||
23366095|NCT03110354|65088833|FG003|Overall Study|Failure to achieve response|2|||
23366096|NCT03110354|65088834|FG004|Overall Study|Failure to achieve response|1|||
23366097|NCT03110354|65088830|FG000|Overall Study|Progressive disease|1|||
23366098|NCT03110354|65088831|FG001|Overall Study|Progressive disease|1|||
23366099|NCT03110354|65088832|FG002|Overall Study|Progressive disease|3|||
23366100|NCT03110354|65088833|FG003|Overall Study|Progressive disease|4|||
23366101|NCT03110354|65088834|FG004|Overall Study|Progressive disease|2|||
23366102|NCT03110354|65088830|FG000|Overall Study|Adverse Event|0|||
23366103|NCT03110354|65088831|FG001|Overall Study|Adverse Event|0|||
23366104|NCT03110354|65088832|FG002|Overall Study|Adverse Event|0|||
23366105|NCT03110354|65088833|FG003|Overall Study|Adverse Event|2|||
23366106|NCT03110354|65088834|FG004|Overall Study|Adverse Event|2|||
23601809|NCT02605174|65933918|FG003|Overall Study|Adverse Event|0|||
23601810|NCT02605174|65933919|FG004|Overall Study|Adverse Event|4|||
23601811|NCT02605174|65933920|FG005|Overall Study|Adverse Event|0|||
23601812|NCT02605174|65933921|FG006|Overall Study|Adverse Event|0|||
23601813|NCT02605174|65933915|FG000|Overall Study|Lost to Follow-up|20|||
23601814|NCT02605174|65933916|FG001|Overall Study|Lost to Follow-up|7|||
23601815|NCT02605174|65933917|FG002|Overall Study|Lost to Follow-up|27|||
23660525|NCT01984164|66145604|FG001|Overall Study|Lost to Follow-up|3|||
23660526|NCT00594516|66145605|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
23660527|NCT00594516|66145606|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
23660528|NCT00594516|66145607|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
23660529|NCT00594516|66145605|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
23660530|NCT00594516|66145606|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
23660531|NCT00594516|66145607|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
23660532|NCT00594516|66145605|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
23660533|NCT00594516|66145606|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
23660534|NCT00594516|66145607|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
23660535|NCT00594516|66145605|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
23660536|NCT00594516|66145606|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
23660537|NCT00594516|66145607|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
23660538|NCT00594516|66145605|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
23660539|NCT00594516|66145606|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
23660540|NCT00594516|66145607|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
23660541|NCT00594516|66145605|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
23660542|NCT00594516|66145606|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
23660543|NCT00594516|66145607|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
23660544|NCT00594516|66145605|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
23660545|NCT00594516|66145606|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
23660546|NCT00594516|66145607|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
23660547|NCT00594516|66145605|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
23660548|NCT00594516|66145606|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
23660549|NCT00594516|66145607|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
23660550|NCT00594516|66145605|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
23660551|NCT00594516|66145606|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
23660552|NCT00594516|66145607|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
23660553|NCT02349048|66145608|FG000|Overall Study|Withdrawal by Subject|4|||
23660554|NCT02349048|66145609|FG001|Overall Study|Withdrawal by Subject|0|||
23660555|NCT02349048|66145608|FG000|Overall Study|Lost to Follow-up|1|||
23660556|NCT02349048|66145609|FG001|Overall Study|Lost to Follow-up|0|||
23660557|NCT01994382|66145612|FG000|Overall Study|Informed consent withdrawn|0|||
23660558|NCT01994382|66145613|FG001|Overall Study|Informed consent withdrawn|0|||
23660559|NCT01994382|66145614|FG002|Overall Study|Informed consent withdrawn|0|||
23660560|NCT01994382|66145615|FG003|Overall Study|Informed consent withdrawn|0|||
23660561|NCT01994382|66145616|FG004|Overall Study|Informed consent withdrawn|0|||
23660562|NCT01994382|66145617|FG005|Overall Study|Informed consent withdrawn|0|||
23660563|NCT01994382|66145618|FG006|Overall Study|Informed consent withdrawn|1|||
23660564|NCT01994382|66145619|FG007|Overall Study|Informed consent withdrawn|0|||
23660565|NCT01994382|66145620|FG008|Overall Study|Informed consent withdrawn|0|||
23366107|NCT03110354|65088830|FG000|Overall Study|Other|0|||
23601816|NCT02605174|65933918|FG003|Overall Study|Lost to Follow-up|10|||
23601817|NCT02605174|65933919|FG004|Overall Study|Lost to Follow-up|20|||
23660566|NCT01994382|66145621|FG009|Overall Study|Informed consent withdrawn|0|||
23660567|NCT01994382|66145622|FG010|Overall Study|Informed consent withdrawn|0|||
23601818|NCT02605174|65933920|FG005|Overall Study|Lost to Follow-up|10|||
23660568|NCT01994382|66145623|FG011|Overall Study|Informed consent withdrawn|0|||
23660569|NCT01994382|66145624|FG012|Overall Study|Informed consent withdrawn|0|||
23660570|NCT01994382|66145625|FG013|Overall Study|Informed consent withdrawn|0|||
23366108|NCT03110354|65088831|FG001|Overall Study|Other|0|||
23366109|NCT03110354|65088832|FG002|Overall Study|Other|0|||
23366110|NCT03110354|65088833|FG003|Overall Study|Other|1|||
23366111|NCT03110354|65088834|FG004|Overall Study|Other|1|||
23366112|NCT00419757|65088835|FG000|Overall Study|Adverse Event|1|||
23366113|NCT00419757|65088836|FG001|Overall Study|Adverse Event|4|||
23366114|NCT00419757|65088835|FG000|Overall Study|Lost to Follow-up|1|||
23366115|NCT00419757|65088836|FG001|Overall Study|Lost to Follow-up|4|||
23366116|NCT00419757|65088835|FG000|Overall Study|Withdrawal by Subject|7|||
23366117|NCT00419757|65088836|FG001|Overall Study|Withdrawal by Subject|1|||
23366118|NCT00419757|65088835|FG000|Overall Study|Protocol Violation|2|||
23366119|NCT00419757|65088836|FG001|Overall Study|Protocol Violation|3|||
23366120|NCT00419757|65088835|FG000|Overall Study|Study specific discontinuation criteria|4|||
23366121|NCT00419757|65088836|FG001|Overall Study|Study specific discontinuation criteria|8|||
23366122|NCT00419757|65088835|FG000|Overall Study|Multiple reasons|3|||
23366123|NCT00419757|65088836|FG001|Overall Study|Multiple reasons|1|||
23366124|NCT01048541|65088841|FG000|Overall Study|Withdrawal by Subject|1|||
23366125|NCT01048541|65088842|FG001|Overall Study|Withdrawal by Subject|0|||
23366126|NCT01316224|65088845|FG000|Overall Study|Protocol Violation|3|||
23366127|NCT01316224|65088845|FG000|Overall Study|Adverse Event|3|||
23366128|NCT01316224|65088845|FG000|Overall Study|Lack of Efficacy|1|||
23366129|NCT01316224|65088845|FG000|Overall Study|Withdrawal by Subject|1|||
23366130|NCT01316224|65088845|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
23366131|NCT01316224|65088845|FG000|Overall Study|Other|1|||
23366132|NCT02427841|65088849|FG000|Overall Study|Lack of Efficacy|5|||
23366133|NCT02427841|65088849|FG000|Overall Study|Physician Decision|2|||
23366134|NCT02427841|65088849|FG000|Overall Study|Withdrawal by Subject|1|||
23366135|NCT00614874|65088851|FG000|Overall Study|Protocol Violation|1|||
23366136|NCT00614874|65088851|FG000|Overall Study|Withdrawal by Subject|1|||
23366137|NCT04386902|65088852|FG000|Overall Study|Withdrawal by Subject|5|||
23366138|NCT04386902|65088852|FG000|Overall Study|Technical problems in the recording|5|||
23366139|NCT03286218|65088853|FG000|Qualification Phase Period 1|Adverse Event|1|||
23366140|NCT03286218|65088854|FG001|Qualification Phase Period 1|Adverse Event|0|||
23366141|NCT03286218|65088855|FG002|Qualification Phase Period 1|Adverse Event|0|||
23366142|NCT03286218|65088856|FG003|Qualification Phase Period 1|Adverse Event|0|||
23366143|NCT03286218|65088857|FG004|Qualification Phase Period 1|Adverse Event|0|||
23366144|NCT03286218|65088858|FG005|Qualification Phase Period 1|Adverse Event|0|||
23366145|NCT03286218|65088859|FG006|Qualification Phase Period 1|Adverse Event|0|||
23366146|NCT03286218|65088860|FG007|Qualification Phase Period 1|Adverse Event|0|||
23366147|NCT03286218|65088861|FG008|Qualification Phase Period 1|Adverse Event|0|||
23366148|NCT03286218|65088862|FG009|Qualification Phase Period 1|Adverse Event|0|||
23366149|NCT03286218|65088863|FG010|Qualification Phase Period 1|Adverse Event|0|||
23366150|NCT03286218|65088864|FG011|Qualification Phase Period 1|Adverse Event|0|||
23366151|NCT03286218|65088853|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366152|NCT03286218|65088854|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
23366153|NCT03286218|65088855|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366154|NCT03286218|65088856|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366155|NCT03286218|65088857|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366156|NCT03286218|65088858|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366157|NCT03286218|65088859|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366158|NCT03286218|65088860|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366159|NCT03286218|65088861|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366160|NCT03286218|65088862|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366161|NCT03286218|65088863|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366162|NCT03286218|65088864|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366163|NCT03286218|65088853|FG000|Qualification Phase Period 2|Adverse Event|0|||
23366164|NCT03286218|65088854|FG001|Qualification Phase Period 2|Adverse Event|1|||
23366165|NCT03286218|65088855|FG002|Qualification Phase Period 2|Adverse Event|0|||
23366166|NCT03286218|65088856|FG003|Qualification Phase Period 2|Adverse Event|0|||
23366167|NCT03286218|65088857|FG004|Qualification Phase Period 2|Adverse Event|0|||
23366168|NCT03286218|65088858|FG005|Qualification Phase Period 2|Adverse Event|0|||
23366169|NCT03286218|65088859|FG006|Qualification Phase Period 2|Adverse Event|0|||
23366170|NCT03286218|65088860|FG007|Qualification Phase Period 2|Adverse Event|0|||
23366171|NCT03286218|65088861|FG008|Qualification Phase Period 2|Adverse Event|0|||
23366172|NCT03286218|65088862|FG009|Qualification Phase Period 2|Adverse Event|0|||
23366173|NCT03286218|65088863|FG010|Qualification Phase Period 2|Adverse Event|0|||
23366174|NCT03286218|65088864|FG011|Qualification Phase Period 2|Adverse Event|0|||
23483212|NCT00976508|65512970|FG000|Overall Study|Death|7|||
23366175|NCT03286218|65088853|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
23366176|NCT03286218|65088854|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
23366177|NCT03286218|65088855|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366178|NCT03286218|65088856|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366179|NCT03286218|65088857|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23483213|NCT00976508|65512971|FG001|Overall Study|Death|1|||
23366180|NCT03286218|65088858|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366181|NCT03286218|65088859|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366182|NCT03286218|65088860|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366183|NCT03286218|65088861|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366184|NCT03286218|65088862|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366185|NCT03286218|65088863|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366186|NCT03286218|65088864|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366187|NCT03286218|65088853|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
23366188|NCT03286218|65088854|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
23366189|NCT03286218|65088855|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
23366190|NCT03286218|65088856|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
23366191|NCT03286218|65088857|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
23366192|NCT03286218|65088858|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
23366193|NCT03286218|65088859|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
23366194|NCT03286218|65088860|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
23366195|NCT03286218|65088861|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
23366196|NCT03286218|65088862|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
23366197|NCT03286218|65088863|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
23366198|NCT03286218|65088864|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
23366199|NCT03286218|65088853|FG000|Qualification Phase Period 2|Protocol Violation|2|||
23366200|NCT03286218|65088854|FG001|Qualification Phase Period 2|Protocol Violation|0|||
23366201|NCT03286218|65088855|FG002|Qualification Phase Period 2|Protocol Violation|0|||
23366202|NCT03286218|65088856|FG003|Qualification Phase Period 2|Protocol Violation|0|||
23366203|NCT03286218|65088857|FG004|Qualification Phase Period 2|Protocol Violation|0|||
23366204|NCT03286218|65088858|FG005|Qualification Phase Period 2|Protocol Violation|0|||
23366205|NCT03286218|65088859|FG006|Qualification Phase Period 2|Protocol Violation|0|||
23366206|NCT03286218|65088860|FG007|Qualification Phase Period 2|Protocol Violation|0|||
23366207|NCT03286218|65088861|FG008|Qualification Phase Period 2|Protocol Violation|0|||
23366208|NCT03286218|65088862|FG009|Qualification Phase Period 2|Protocol Violation|0|||
23366209|NCT03286218|65088863|FG010|Qualification Phase Period 2|Protocol Violation|0|||
23366210|NCT03286218|65088864|FG011|Qualification Phase Period 2|Protocol Violation|0|||
23366211|NCT03286218|65088853|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
23366212|NCT03286218|65088854|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
23366213|NCT03286218|65088855|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366214|NCT03286218|65088856|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366215|NCT03286218|65088857|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366216|NCT03286218|65088858|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366217|NCT03286218|65088859|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366218|NCT03286218|65088860|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366219|NCT03286218|65088861|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366220|NCT03286218|65088862|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366221|NCT03286218|65088863|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366222|NCT03286218|65088864|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366223|NCT03286218|65088853|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366224|NCT03286218|65088854|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366225|NCT03286218|65088855|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366226|NCT03286218|65088856|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366227|NCT03286218|65088857|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366228|NCT03286218|65088858|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366229|NCT03286218|65088859|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366230|NCT03286218|65088860|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366231|NCT03286218|65088861|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366232|NCT03286218|65088862|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366233|NCT03286218|65088863|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366234|NCT03286218|65088864|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366235|NCT03286218|65088853|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366236|NCT03286218|65088854|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366237|NCT03286218|65088855|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366238|NCT03286218|65088856|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366239|NCT03286218|65088857|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366240|NCT03286218|65088858|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366241|NCT03286218|65088859|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366242|NCT03286218|65088860|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366243|NCT03286218|65088861|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366244|NCT03286218|65088862|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366245|NCT03286218|65088863|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366246|NCT03286218|65088864|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
23366247|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Death|20|||
23601819|NCT02605174|65933921|FG006|Overall Study|Lost to Follow-up|29|||
23601820|NCT02605174|65933915|FG000|Overall Study|Protocol Violation|10|||
23601821|NCT02605174|65933916|FG001|Overall Study|Protocol Violation|4|||
23601822|NCT02605174|65933917|FG002|Overall Study|Protocol Violation|14|||
23366248|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Death|26|||
23601823|NCT02605174|65933918|FG003|Overall Study|Protocol Violation|6|||
23601824|NCT02605174|65933919|FG004|Overall Study|Protocol Violation|7|||
23601825|NCT02605174|65933920|FG005|Overall Study|Protocol Violation|7|||
23601826|NCT02605174|65933921|FG006|Overall Study|Protocol Violation|12|||
23660571|NCT01994382|66145626|FG014|Overall Study|Informed consent withdrawn|0|||
23660572|NCT01994382|66145627|FG015|Overall Study|Informed consent withdrawn|0|||
23660573|NCT01994382|66145628|FG016|Overall Study|Informed consent withdrawn|0|||
23660574|NCT01994382|66145612|FG000|Overall Study|Progressive disease|3|||
23660575|NCT01994382|66145613|FG001|Overall Study|Progressive disease|4|||
23660576|NCT01994382|66145614|FG002|Overall Study|Progressive disease|4|||
23660577|NCT01994382|66145615|FG003|Overall Study|Progressive disease|3|||
23366249|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
23366250|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
23366251|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
23366252|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
23366253|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
23366254|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
23366255|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
23366256|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
23366257|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
23366258|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
23366259|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
23366260|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
23366261|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
23366262|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
23366263|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Other|107|||
23366264|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Other|107|||
23366265|NCT00643201|65088865|FG000|Completed Study Follow Up|Death|28|||
23366266|NCT00643201|65088866|FG001|Completed Study Follow Up|Death|34|||
23366267|NCT00643201|65088865|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
23366268|NCT00643201|65088866|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
23366269|NCT00643201|65088865|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
23366270|NCT00643201|65088866|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
23366271|NCT00643201|65088865|FG000|Completed Study Follow Up|non-specified|1|||
23366272|NCT00643201|65088866|FG001|Completed Study Follow Up|non-specified|0|||
23366273|NCT03372798|65088869|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
23366274|NCT03372798|65088870|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
23366275|NCT03372798|65088869|FG000|Overall Study|Failure of imaging probe|0|||
23366276|NCT03372798|65088870|FG001|Overall Study|Failure of imaging probe|1|||
23366277|NCT02781324|65088871|FG000|Overall Study|Withdrawal by Subject|1|||
23366278|NCT02781324|65088872|FG001|Overall Study|Withdrawal by Subject|0|||
23483214|NCT00976508|65512970|FG000|Overall Study|Lost to Follow-up|1|||
23601827|NCT02605174|65933915|FG000|Overall Study|Pregnancy|1|||
23660578|NCT01994382|66145616|FG004|Overall Study|Progressive disease|2|||
23660579|NCT01994382|66145617|FG005|Overall Study|Progressive disease|3|||
23366279|NCT02781324|65088871|FG000|Overall Study|Physician Decision|1|||
23366280|NCT02781324|65088872|FG001|Overall Study|Physician Decision|2|||
23366281|NCT02254772|65088873|FG000|Overall Study|Ineligible|1|||
23366282|NCT02254772|65088873|FG000|Overall Study|Withdrawal by Subject|1|||
23366283|NCT01610037|65088880|FG000|All Patients|Adverse Event|27|||
23366284|NCT01610037|65088881|FG001|All Patients|Adverse Event|22|||
23366285|NCT01610037|65088882|FG002|All Patients|Adverse Event|26|||
23601828|NCT02605174|65933916|FG001|Overall Study|Pregnancy|0|||
23601829|NCT02605174|65933917|FG002|Overall Study|Pregnancy|0|||
23660580|NCT01994382|66145618|FG006|Overall Study|Progressive disease|3|||
23660581|NCT01994382|66145619|FG007|Overall Study|Progressive disease|6|||
23660582|NCT01994382|66145620|FG008|Overall Study|Progressive disease|2|||
23601830|NCT02605174|65933918|FG003|Overall Study|Pregnancy|2|||
23601831|NCT02605174|65933919|FG004|Overall Study|Pregnancy|0|||
23366286|NCT01610037|65088880|FG000|All Patients|Withdrawal by Subject|12|||
23366287|NCT01610037|65088881|FG001|All Patients|Withdrawal by Subject|10|||
23366288|NCT01610037|65088882|FG002|All Patients|Withdrawal by Subject|20|||
23366289|NCT01610037|65088880|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
23366290|NCT01610037|65088881|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
23660583|NCT01994382|66145621|FG009|Overall Study|Progressive disease|2|||
23660584|NCT01994382|66145622|FG010|Overall Study|Progressive disease|13|||
23366291|NCT01610037|65088882|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
23366292|NCT01610037|65088880|FG000|All Patients|Death|4|||
23366293|NCT01610037|65088881|FG001|All Patients|Death|2|||
23366294|NCT01610037|65088882|FG002|All Patients|Death|1|||
23366295|NCT01610037|65088880|FG000|All Patients|Protocol deviation|4|||
23366296|NCT01610037|65088881|FG001|All Patients|Protocol deviation|3|||
23366297|NCT01610037|65088882|FG002|All Patients|Protocol deviation|3|||
23366298|NCT01610037|65088880|FG000|All Patients|Abnormal laboratory value|1|||
23366299|NCT01610037|65088881|FG001|All Patients|Abnormal laboratory value|1|||
23366300|NCT01610037|65088882|FG002|All Patients|Abnormal laboratory value|0|||
23366301|NCT01610037|65088880|FG000|All Patients|Administrative problems|1|||
23366302|NCT01610037|65088881|FG001|All Patients|Administrative problems|4|||
23366303|NCT01610037|65088882|FG002|All Patients|Administrative problems|4|||
23366304|NCT01610037|65088880|FG000|All Patients|Lost to Follow-up|1|||
23366305|NCT01610037|65088881|FG001|All Patients|Lost to Follow-up|0|||
23366306|NCT01610037|65088882|FG002|All Patients|Lost to Follow-up|0|||
23366307|NCT01610037|65088880|FG000|All Patients|Abnormal test procedure result(s)|0|||
23366308|NCT01610037|65088881|FG001|All Patients|Abnormal test procedure result(s)|1|||
23366309|NCT01610037|65088882|FG002|All Patients|Abnormal test procedure result(s)|3|||
23366310|NCT01610037|65088880|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
23601832|NCT02605174|65933920|FG005|Overall Study|Pregnancy|0|||
23601833|NCT02605174|65933921|FG006|Overall Study|Pregnancy|0|||
23601834|NCT02605174|65933915|FG000|Overall Study|Withdrawal by Subject|9|||
23601835|NCT02605174|65933916|FG001|Overall Study|Withdrawal by Subject|6|||
23601836|NCT02605174|65933917|FG002|Overall Study|Withdrawal by Subject|14|||
23660585|NCT01994382|66145623|FG011|Overall Study|Progressive disease|8|||
23660586|NCT01994382|66145624|FG012|Overall Study|Progressive disease|7|||
23660587|NCT01994382|66145625|FG013|Overall Study|Progressive disease|3|||
23366311|NCT01610037|65088881|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
23366312|NCT01610037|65088882|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
23366313|NCT01610037|65088880|FG000|Treatment and Follow up Period|Death|10|||
23366314|NCT01610037|65088881|FG001|Treatment and Follow up Period|Death|5|||
23366315|NCT01610037|65088882|FG002|Treatment and Follow up Period|Death|4|||
23366316|NCT01610037|65088880|FG000|Treatment and Follow up Period|Administrative problems|1|||
23660588|NCT01994382|66145626|FG014|Overall Study|Progressive disease|6|||
23366317|NCT01610037|65088881|FG001|Treatment and Follow up Period|Administrative problems|3|||
23366318|NCT01610037|65088882|FG002|Treatment and Follow up Period|Administrative problems|2|||
23366319|NCT01610037|65088880|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
23366320|NCT01610037|65088881|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
23366321|NCT01610037|65088882|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
23366322|NCT02762084|65088885|FG000|Overall Study|Withdrawal by Subject|1|||
23366323|NCT02762084|65088886|FG001|Overall Study|Withdrawal by Subject|0|||
23366324|NCT02762084|65088887|FG002|Overall Study|Withdrawal by Subject|0|||
23601837|NCT02605174|65933918|FG003|Overall Study|Withdrawal by Subject|11|||
23601838|NCT02605174|65933919|FG004|Overall Study|Withdrawal by Subject|6|||
23601839|NCT02605174|65933920|FG005|Overall Study|Withdrawal by Subject|4|||
23366325|NCT02762084|65088885|FG000|Overall Study|Adverse Event|0|||
23366326|NCT02762084|65088886|FG001|Overall Study|Adverse Event|0|||
23366327|NCT02762084|65088887|FG002|Overall Study|Adverse Event|1|||
23366328|NCT02446691|65088890|FG000|Overall Study|Withdrawal by Subject|2|||
23366329|NCT02446691|65088890|FG000|Overall Study|Lost to Follow-up|8|||
23366330|NCT02446691|65088890|FG000|Overall Study|Protocol Violation|1|||
23366331|NCT02592447|65088891|FG000|Overall Study|Lost to Follow-up|1|||
23601840|NCT02605174|65933921|FG006|Overall Study|Withdrawal by Subject|15|||
23366332|NCT02592447|65088892|FG001|Overall Study|Lost to Follow-up|0|||
23601841|NCT02605174|65933915|FG000|Overall Study|Physician Decision|2|||
23660589|NCT01994382|66145627|FG015|Overall Study|Progressive disease|44|||
23366333|NCT02592447|65088891|FG000|Overall Study|Ineligible after randomization|1|||
23366334|NCT02592447|65088892|FG001|Overall Study|Ineligible after randomization|0|||
23366335|NCT02592447|65088891|FG000|Overall Study|Withdrawal by Subject|0|||
23366336|NCT02592447|65088892|FG001|Overall Study|Withdrawal by Subject|1|||
23366337|NCT00901342|65088893|FG000|Overall Study|Adverse Event|1|||
23366338|NCT00901342|65088893|FG000|Overall Study|Death|4|||
23366339|NCT00901342|65088893|FG000|Overall Study|Disease progression|1|||
23366340|NCT00901342|65088893|FG000|Overall Study|Withdrawal by Subject|9|||
23366341|NCT02021292|65088900|FG000|Overall Study|Physician Decision|0|||
23366342|NCT02021292|65088901|FG001|Overall Study|Physician Decision|1|||
23366343|NCT02021292|65088900|FG000|Overall Study|Lost to Follow-up|0|||
23366344|NCT02021292|65088901|FG001|Overall Study|Lost to Follow-up|1|||
23366345|NCT02021292|65088900|FG000|Overall Study|Death|0|||
23366346|NCT02021292|65088901|FG001|Overall Study|Death|1|||
23366347|NCT02949947|65088902|FG000|Overall Study|Non Compliance|0|||
23366348|NCT02949947|65088903|FG001|Overall Study|Non Compliance|1|||
23366349|NCT02949947|65088902|FG000|Overall Study|Insurance change|1|||
23366350|NCT02949947|65088903|FG001|Overall Study|Insurance change|0|||
23366351|NCT00737100|65088904|FG000|Overall Study|Adverse Event|6|||
23366352|NCT00737100|65088905|FG001|Overall Study|Adverse Event|5|||
23366353|NCT00737100|65088906|FG002|Overall Study|Adverse Event|3|||
23366354|NCT00737100|65088904|FG000|Overall Study|Lost to Follow-up|0|||
23366355|NCT00737100|65088905|FG001|Overall Study|Lost to Follow-up|1|||
23366356|NCT00737100|65088906|FG002|Overall Study|Lost to Follow-up|0|||
23366357|NCT00737100|65088904|FG000|Overall Study|Withdrawal by Subject|0|||
23366358|NCT00737100|65088905|FG001|Overall Study|Withdrawal by Subject|0|||
23366359|NCT00737100|65088906|FG002|Overall Study|Withdrawal by Subject|3|||
23366360|NCT00737100|65088904|FG000|Overall Study|Reason discontinued not explained above|1|||
23366361|NCT00737100|65088905|FG001|Overall Study|Reason discontinued not explained above|1|||
23366362|NCT00737100|65088906|FG002|Overall Study|Reason discontinued not explained above|1|||
23366363|NCT00471497|65088907|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
23366364|NCT00471497|65088908|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
23366365|NCT00471497|65088909|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
23366366|NCT00471497|65088907|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
23366367|NCT00471497|65088908|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
23366368|NCT00471497|65088909|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
23366369|NCT00471497|65088907|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
23366370|NCT00471497|65088908|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
23366371|NCT00471497|65088909|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
23366372|NCT00471497|65088907|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
23366373|NCT00471497|65088908|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
23483215|NCT00976508|65512971|FG001|Overall Study|Lost to Follow-up|0|||
23483216|NCT00976508|65512970|FG000|Overall Study|Withdrawal by Subject|1|||
23483217|NCT00976508|65512971|FG001|Overall Study|Withdrawal by Subject|0|||
23483218|NCT00976508|65512970|FG000|Overall Study|Disease Progression|4|||
23483219|NCT00976508|65512971|FG001|Overall Study|Disease Progression|4|||
23483220|NCT00976508|65512970|FG000|Overall Study|Subject Enrolled in Hospice|1|||
23483221|NCT00976508|65512971|FG001|Overall Study|Subject Enrolled in Hospice|0|||
23483222|NCT00976508|65512970|FG000|Overall Study|Terminated by the Sponsor|0|||
23483223|NCT00976508|65512971|FG001|Overall Study|Terminated by the Sponsor|1|||
23601842|NCT02605174|65933916|FG001|Overall Study|Physician Decision|0|||
23601843|NCT02605174|65933917|FG002|Overall Study|Physician Decision|0|||
23601844|NCT02605174|65933918|FG003|Overall Study|Physician Decision|0|||
23601845|NCT02605174|65933919|FG004|Overall Study|Physician Decision|0|||
23601846|NCT02605174|65933920|FG005|Overall Study|Physician Decision|0|||
23601847|NCT02605174|65933921|FG006|Overall Study|Physician Decision|3|||
23601848|NCT02605174|65933915|FG000|Overall Study|Randomization Failure|22|||
23366374|NCT00471497|65088909|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
23366375|NCT00471497|65088907|FG000|Core Treatment Phase|Lost to Follow-up|6|||
23483224|NCT02320903|65512972|FG000|Overall Study|Withdrawal by Subject|0|||
23601849|NCT02605174|65933916|FG001|Overall Study|Randomization Failure|6|||
23601850|NCT02605174|65933917|FG002|Overall Study|Randomization Failure|20|||
23601851|NCT02605174|65933918|FG003|Overall Study|Randomization Failure|7|||
23366376|NCT00471497|65088908|FG001|Core Treatment Phase|Lost to Follow-up|6|||
23366377|NCT00471497|65088909|FG002|Core Treatment Phase|Lost to Follow-up|3|||
23366378|NCT00471497|65088907|FG000|Core Treatment Phase|Death|3|||
23366379|NCT00471497|65088908|FG001|Core Treatment Phase|Death|9|||
23366380|NCT00471497|65088909|FG002|Core Treatment Phase|Death|3|||
23483225|NCT02320903|65512973|FG001|Overall Study|Withdrawal by Subject|9|||
23483226|NCT02320903|65512974|FG002|Overall Study|Withdrawal by Subject|9|||
23483227|NCT02320903|65512972|FG000|Overall Study|Exited therapy; no longer eligible|8|||
23483228|NCT02320903|65512973|FG001|Overall Study|Exited therapy; no longer eligible|2|||
23483229|NCT02320903|65512974|FG002|Overall Study|Exited therapy; no longer eligible|2|||
23483230|NCT02320903|65512972|FG000|Overall Study|Lost to Follow-up|0|||
23483231|NCT02320903|65512973|FG001|Overall Study|Lost to Follow-up|5|||
23483232|NCT02320903|65512974|FG002|Overall Study|Lost to Follow-up|5|||
23483233|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
23483234|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
23483235|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
23483236|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
23483237|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
23483238|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
23483239|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
23483240|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
23483241|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
23483242|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
23483243|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
23483244|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
23483245|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
23483246|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
23483247|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
23483248|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
23483249|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
23483250|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
23483251|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
23483252|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
23483253|NCT03312751|65512977|FG000|Overall Study|Death|7|||
23483254|NCT03312751|65512978|FG001|Overall Study|Death|9|||
23483255|NCT03312751|65512977|FG000|Overall Study|Study discontinuation due to other reason|0|||
23483256|NCT03312751|65512978|FG001|Overall Study|Study discontinuation due to other reason|1|||
23483257|NCT03891667|65512979|FG000|Overall Study|Physician Decision|1|||
23483258|NCT03891667|65512980|FG001|Overall Study|Physician Decision|0|||
23483259|NCT03891667|65512979|FG000|Overall Study|COVID related pause|1|||
23483260|NCT03891667|65512980|FG001|Overall Study|COVID related pause|1|||
23483261|NCT03891667|65512979|FG000|Overall Study|Withdrawal by Subject|0|||
23601852|NCT02605174|65933919|FG004|Overall Study|Randomization Failure|16|||
23601853|NCT02605174|65933920|FG005|Overall Study|Randomization Failure|11|||
23601854|NCT02605174|65933921|FG006|Overall Study|Randomization Failure|30|||
23601855|NCT01105975|65933924|FG000|Overall Study|Adverse Event|2|||
23601856|NCT01105975|65933925|FG001|Overall Study|Adverse Event|1|||
23601857|NCT01105975|65933926|FG002|Overall Study|Adverse Event|5|||
23601858|NCT01105975|65933927|FG003|Overall Study|Adverse Event|1|||
23601859|NCT01105975|65933928|FG004|Overall Study|Adverse Event|0|||
23601860|NCT01105975|65933929|FG005|Overall Study|Adverse Event|1|||
23601861|NCT01105975|65933930|FG006|Overall Study|Adverse Event|2|||
23601862|NCT01105975|65933931|FG007|Overall Study|Adverse Event|4|||
23601863|NCT01105975|65933932|FG008|Overall Study|Adverse Event|1|||
23601864|NCT01105975|65933933|FG009|Overall Study|Adverse Event|4|||
23601865|NCT01105975|65933924|FG000|Overall Study|Withdrawal by Subject|2|||
23601866|NCT01105975|65933925|FG001|Overall Study|Withdrawal by Subject|2|||
23601867|NCT01105975|65933926|FG002|Overall Study|Withdrawal by Subject|2|||
23601868|NCT01105975|65933927|FG003|Overall Study|Withdrawal by Subject|0|||
23601869|NCT01105975|65933928|FG004|Overall Study|Withdrawal by Subject|4|||
23601870|NCT01105975|65933929|FG005|Overall Study|Withdrawal by Subject|1|||
23601871|NCT01105975|65933930|FG006|Overall Study|Withdrawal by Subject|2|||
23601872|NCT01105975|65933931|FG007|Overall Study|Withdrawal by Subject|1|||
23601873|NCT01105975|65933932|FG008|Overall Study|Withdrawal by Subject|0|||
23601874|NCT01105975|65933933|FG009|Overall Study|Withdrawal by Subject|3|||
23601875|NCT01105975|65933924|FG000|Overall Study|Lost to Follow-up|1|||
23601876|NCT01105975|65933925|FG001|Overall Study|Lost to Follow-up|0|||
23601877|NCT01105975|65933926|FG002|Overall Study|Lost to Follow-up|0|||
23601878|NCT01105975|65933927|FG003|Overall Study|Lost to Follow-up|1|||
23601879|NCT01105975|65933928|FG004|Overall Study|Lost to Follow-up|1|||
23601880|NCT01105975|65933929|FG005|Overall Study|Lost to Follow-up|0|||
23601881|NCT01105975|65933930|FG006|Overall Study|Lost to Follow-up|0|||
23601882|NCT01105975|65933931|FG007|Overall Study|Lost to Follow-up|0|||
23601883|NCT01105975|65933932|FG008|Overall Study|Lost to Follow-up|1|||
23601884|NCT01105975|65933933|FG009|Overall Study|Lost to Follow-up|0|||
23601885|NCT01105975|65933924|FG000|Overall Study|Physician Decision|0|||
23483262|NCT03891667|65512980|FG001|Overall Study|Withdrawal by Subject|1|||
23483263|NCT03891667|65512979|FG000|Overall Study|Adverse Event|0|||
23483264|NCT03891667|65512980|FG001|Overall Study|Adverse Event|1|||
23483265|NCT03189381|65512983|FG000|Overall Study|Death|1|||
23483266|NCT03189381|65512984|FG001|Overall Study|Death|0|||
23483267|NCT03222492|65512985|FG000|Overall Study|Withdrawal by Subject|0|||
23483268|NCT03222492|65512986|FG001|Overall Study|Withdrawal by Subject|0|||
23483269|NCT03222492|65512987|FG002|Overall Study|Withdrawal by Subject|1|||
23483270|NCT03222492|65512988|FG003|Overall Study|Withdrawal by Subject|0|||
23483271|NCT03222492|65512985|FG000|Overall Study|COVID-19 related|0|||
23483272|NCT03222492|65512986|FG001|Overall Study|COVID-19 related|0|||
23483273|NCT03222492|65512987|FG002|Overall Study|COVID-19 related|1|||
23483274|NCT03222492|65512988|FG003|Overall Study|COVID-19 related|0|||
23483275|NCT03170232|65512992|FG000|Overall Study|Adverse Event|0|||
23660590|NCT01994382|66145628|FG016|Overall Study|Progressive disease|28|||
23660591|NCT01994382|66145612|FG000|Overall Study|Physician Decision|0|||
23660592|NCT01994382|66145613|FG001|Overall Study|Physician Decision|1|||
23660593|NCT01994382|66145614|FG002|Overall Study|Physician Decision|0|||
23483276|NCT03170232|65512993|FG001|Overall Study|Adverse Event|1|||
23483277|NCT03170232|65512992|FG000|Overall Study|Protocol Violation|0|||
23483278|NCT03170232|65512993|FG001|Overall Study|Protocol Violation|1|||
23483279|NCT03170232|65512992|FG000|Overall Study|Lack of Efficacy|0|||
23483280|NCT03170232|65512993|FG001|Overall Study|Lack of Efficacy|1|||
23483281|NCT03170232|65512992|FG000|Overall Study|Study closed/terminated|26|||
23483282|NCT03170232|65512993|FG001|Overall Study|Study closed/terminated|23|||
23483283|NCT03170232|65512992|FG000|Overall Study|Lost to Follow-up|1|||
23483284|NCT03170232|65512993|FG001|Overall Study|Lost to Follow-up|0|||
23483285|NCT03170232|65512992|FG000|Overall Study|Withdrawal by Subject|0|||
23483286|NCT03170232|65512993|FG001|Overall Study|Withdrawal by Subject|1|||
23483287|NCT00278915|65512996|FG000|Overall Study|Disease progression|1|||
23483288|NCT00910247|65512997|FG000|Overall Study|Adverse Event|15|||
23483289|NCT00910247|65512997|FG000|Overall Study|Death|2|||
23483290|NCT00910247|65512997|FG000|Overall Study|Lost to Follow-up|10|||
23483291|NCT00910247|65512997|FG000|Overall Study|Physician Decision|3|||
23483292|NCT00910247|65512997|FG000|Overall Study|Protocol Violation|10|||
23483293|NCT00910247|65512997|FG000|Overall Study|Withdrawal by Subject|25|||
23483294|NCT00910247|65512997|FG000|Overall Study|Not collected|4|||
23483295|NCT02125604|65512998|FG000|Overall Study|Other|4|||
23483296|NCT02125604|65512998|FG000|Overall Study|Investigator Decision|1|||
23483297|NCT02125604|65512998|FG000|Overall Study|Lost to Follow-up|2|||
23483298|NCT02125604|65512998|FG000|Overall Study|Consent Withdrawn|4|||
23483299|NCT02125604|65512998|FG000|Overall Study|Adverse Event|20|||
23483300|NCT03059446|65512999|FG000|Overall Study|Adverse Event|11|||
23483301|NCT03059446|65512999|FG000|Overall Study|Withdrawal of Consent|16|||
23483302|NCT03059446|65512999|FG000|Overall Study|Lost to Follow-up|3|||
23483303|NCT03059446|65512999|FG000|Overall Study|Protocol Violation|1|||
23483304|NCT03059446|65512999|FG000|Overall Study|Study Terminated by Sponsor|131|||
23483305|NCT03059446|65512999|FG000|Overall Study|Reason not Specified|5|||
23483306|NCT01609478|65513002|FG000|Overall Study|Adverse Event|3|||
23483307|NCT01609478|65513003|FG001|Overall Study|Adverse Event|1|||
23483308|NCT01609478|65513004|FG002|Overall Study|Adverse Event|5|||
23483309|NCT01609478|65513002|FG000|Overall Study|Protocol Deviation|0|||
23483310|NCT01609478|65513003|FG001|Overall Study|Protocol Deviation|1|||
23483311|NCT01609478|65513004|FG002|Overall Study|Protocol Deviation|1|||
23483312|NCT01609478|65513002|FG000|Overall Study|Non-Compliance with study treatment|1|||
23483313|NCT01609478|65513003|FG001|Overall Study|Non-Compliance with study treatment|0|||
23483314|NCT01609478|65513004|FG002|Overall Study|Non-Compliance with study treatment|0|||
23483315|NCT01609478|65513002|FG000|Overall Study|Physician Decision|1|||
23483316|NCT01609478|65513003|FG001|Overall Study|Physician Decision|0|||
23660594|NCT01994382|66145615|FG003|Overall Study|Physician Decision|0|||
23483317|NCT01609478|65513004|FG002|Overall Study|Physician Decision|1|||
23483318|NCT01609478|65513002|FG000|Overall Study|Withdrawal by Subject|2|||
23483319|NCT01609478|65513003|FG001|Overall Study|Withdrawal by Subject|0|||
23483320|NCT01609478|65513004|FG002|Overall Study|Withdrawal by Subject|2|||
23483321|NCT01288976|65513005|FG000|Overall Study|Withdrawal by Subject|58|||
23483322|NCT01288976|65513006|FG001|Overall Study|Withdrawal by Subject|12|||
23483323|NCT01288976|65513007|FG002|Overall Study|Withdrawal by Subject|9|||
23483324|NCT01288976|65513005|FG000|Overall Study|Death|98|||
23483325|NCT01288976|65513006|FG001|Overall Study|Death|6|||
23483326|NCT01288976|65513007|FG002|Overall Study|Death|4|||
23483327|NCT01288976|65513005|FG000|Overall Study|Data unavailable|22|||
23483328|NCT01288976|65513006|FG001|Overall Study|Data unavailable|9|||
23483329|NCT01288976|65513007|FG002|Overall Study|Data unavailable|7|||
23483330|NCT00609362|65513008|FG000|Overall Study|Withdrawal by Subject|2|||
23483331|NCT00609362|65513009|FG001|Overall Study|Withdrawal by Subject|1|||
23483332|NCT00609362|65513008|FG000|Overall Study|Adverse Event|1|||
23483333|NCT00609362|65513009|FG001|Overall Study|Adverse Event|0|||
23483334|NCT02230527|65513014|FG000|Overall Study|Withdrawal by Subject|1|||
23483335|NCT02230527|65513015|FG001|Overall Study|Withdrawal by Subject|1|||
23483336|NCT02230527|65513014|FG000|Overall Study|Death|1|||
23660595|NCT01994382|66145616|FG004|Overall Study|Physician Decision|0|||
23660596|NCT01994382|66145617|FG005|Overall Study|Physician Decision|0|||
23660597|NCT01994382|66145618|FG006|Overall Study|Physician Decision|0|||
23660598|NCT01994382|66145619|FG007|Overall Study|Physician Decision|0|||
23660599|NCT01994382|66145620|FG008|Overall Study|Physician Decision|0|||
23660600|NCT01994382|66145621|FG009|Overall Study|Physician Decision|0|||
23660601|NCT01994382|66145622|FG010|Overall Study|Physician Decision|3|||
23660602|NCT01994382|66145623|FG011|Overall Study|Physician Decision|1|||
23660603|NCT01994382|66145624|FG012|Overall Study|Physician Decision|1|||
23660604|NCT01994382|66145625|FG013|Overall Study|Physician Decision|0|||
23660605|NCT01994382|66145626|FG014|Overall Study|Physician Decision|1|||
23660606|NCT01994382|66145627|FG015|Overall Study|Physician Decision|4|||
23660607|NCT01994382|66145628|FG016|Overall Study|Physician Decision|2|||
23660608|NCT01994382|66145612|FG000|Overall Study|Death|0|||
23660609|NCT01994382|66145613|FG001|Overall Study|Death|0|||
23660610|NCT01994382|66145614|FG002|Overall Study|Death|0|||
23660611|NCT01994382|66145615|FG003|Overall Study|Death|0|||
23660612|NCT01994382|66145616|FG004|Overall Study|Death|1|||
23660613|NCT01994382|66145617|FG005|Overall Study|Death|0|||
23660614|NCT01994382|66145618|FG006|Overall Study|Death|0|||
23660615|NCT01994382|66145619|FG007|Overall Study|Death|0|||
23660616|NCT01994382|66145620|FG008|Overall Study|Death|1|||
23660617|NCT01994382|66145621|FG009|Overall Study|Death|1|||
23660618|NCT01994382|66145622|FG010|Overall Study|Death|0|||
23660619|NCT01994382|66145623|FG011|Overall Study|Death|0|||
23366381|NCT00471497|65088907|FG000|Core Treatment Phase|Disease Progression|10|||
23366382|NCT00471497|65088908|FG001|Core Treatment Phase|Disease Progression|2|||
23366383|NCT00471497|65088909|FG002|Core Treatment Phase|Disease Progression|4|||
23660620|NCT01994382|66145624|FG012|Overall Study|Death|0|||
23660621|NCT01994382|66145625|FG013|Overall Study|Death|0|||
23660622|NCT01994382|66145626|FG014|Overall Study|Death|0|||
23483337|NCT02230527|65513015|FG001|Overall Study|Death|0|||
23483338|NCT02230527|65513014|FG000|Overall Study|Lost to Follow-up|2|||
23483339|NCT02230527|65513015|FG001|Overall Study|Lost to Follow-up|1|||
23660623|NCT01994382|66145627|FG015|Overall Study|Death|1|||
23660624|NCT01994382|66145628|FG016|Overall Study|Death|0|||
23660625|NCT01994382|66145612|FG000|Overall Study|Adverse Event|0|||
23483340|NCT02230527|65513014|FG000|Overall Study|Other|1|||
23660626|NCT01994382|66145613|FG001|Overall Study|Adverse Event|1|||
23660627|NCT01994382|66145614|FG002|Overall Study|Adverse Event|2|||
23660628|NCT01994382|66145615|FG003|Overall Study|Adverse Event|0|||
23660629|NCT01994382|66145616|FG004|Overall Study|Adverse Event|0|||
23660630|NCT01994382|66145617|FG005|Overall Study|Adverse Event|0|||
23660631|NCT01994382|66145618|FG006|Overall Study|Adverse Event|0|||
23660632|NCT01994382|66145619|FG007|Overall Study|Adverse Event|0|||
23660633|NCT01994382|66145620|FG008|Overall Study|Adverse Event|0|||
23660634|NCT01994382|66145621|FG009|Overall Study|Adverse Event|0|||
23660635|NCT01994382|66145622|FG010|Overall Study|Adverse Event|15|||
23660636|NCT01994382|66145623|FG011|Overall Study|Adverse Event|2|||
23601886|NCT01105975|65933925|FG001|Overall Study|Physician Decision|0|||
23366384|NCT00471497|65088907|FG000|Core Treatment Phase|Protocol Violation|6|||
23366385|NCT00471497|65088908|FG001|Core Treatment Phase|Protocol Violation|15|||
23366386|NCT00471497|65088909|FG002|Core Treatment Phase|Protocol Violation|11|||
23366387|NCT00471497|65088907|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
23366388|NCT00471497|65088908|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
23366389|NCT00471497|65088909|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
23366390|NCT00471497|65088907|FG000|Core Treatment Phase|Administrative problems|14|||
23366391|NCT00471497|65088908|FG001|Core Treatment Phase|Administrative problems|14|||
23483341|NCT02230527|65513015|FG001|Overall Study|Other|0|||
23483342|NCT03091777|65513020|FG000|Overall Study|Pregnancy|2|||
23483343|NCT03091777|65513021|FG001|Overall Study|Pregnancy|1|||
23483344|NCT03091777|65513022|FG002|Overall Study|Pregnancy|0|||
23483345|NCT03091777|65513020|FG000|Overall Study|Adverse Event|2|||
23366392|NCT00471497|65088909|FG002|Core Treatment Phase|Administrative problems|12|||
23366393|NCT00471497|65088907|FG000|Core Treatment Phase|Adverse Event|43|||
23366394|NCT00471497|65088908|FG001|Core Treatment Phase|Adverse Event|53|||
23366395|NCT00471497|65088909|FG002|Core Treatment Phase|Adverse Event|89|||
23483346|NCT03091777|65513021|FG001|Overall Study|Adverse Event|1|||
23483347|NCT03091777|65513022|FG002|Overall Study|Adverse Event|4|||
23483348|NCT03091777|65513020|FG000|Overall Study|Withdrawal by Subject|4|||
23483349|NCT03091777|65513021|FG001|Overall Study|Withdrawal by Subject|2|||
23483350|NCT03091777|65513022|FG002|Overall Study|Withdrawal by Subject|6|||
23483351|NCT03091777|65513020|FG000|Overall Study|Protocol Violation|2|||
23483352|NCT03091777|65513021|FG001|Overall Study|Protocol Violation|1|||
23483353|NCT03091777|65513022|FG002|Overall Study|Protocol Violation|1|||
23483354|NCT03091777|65513020|FG000|Overall Study|Lost to Follow-up|12|||
23483355|NCT03091777|65513021|FG001|Overall Study|Lost to Follow-up|14|||
23483356|NCT03091777|65513022|FG002|Overall Study|Lost to Follow-up|7|||
23483357|NCT03091777|65513020|FG000|Overall Study|Lack of Efficacy|0|||
23483358|NCT03091777|65513021|FG001|Overall Study|Lack of Efficacy|0|||
23483359|NCT03091777|65513022|FG002|Overall Study|Lack of Efficacy|5|||
23483360|NCT03091777|65513020|FG000|Overall Study|Noncompliance with study drug|2|||
23483361|NCT03091777|65513021|FG001|Overall Study|Noncompliance with study drug|3|||
23483362|NCT03091777|65513022|FG002|Overall Study|Noncompliance with study drug|1|||
23483363|NCT03091777|65513020|FG000|Overall Study|Physician Decision|1|||
23483364|NCT03091777|65513021|FG001|Overall Study|Physician Decision|0|||
23483365|NCT03091777|65513022|FG002|Overall Study|Physician Decision|1|||
23483366|NCT03091777|65513020|FG000|Overall Study|Abnormal Laboratory Value|7|||
23483367|NCT03091777|65513021|FG001|Overall Study|Abnormal Laboratory Value|11|||
23483368|NCT03091777|65513022|FG002|Overall Study|Abnormal Laboratory Value|12|||
23483369|NCT01895361|65513023|FG000|Overall Study|Adverse Event|1|||
23483370|NCT01895361|65513024|FG001|Overall Study|Adverse Event|1|||
23483371|NCT01895361|65513025|FG002|Overall Study|Adverse Event|3|||
23366396|NCT00471497|65088907|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
23366397|NCT00471497|65088908|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
23366398|NCT00471497|65088909|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
23366399|NCT00471497|65088907|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
23366400|NCT00471497|65088908|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
23366401|NCT00471497|65088909|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
23366402|NCT00471497|65088907|FG000|Extension Phase|Adverse Event|9|||
23366403|NCT00471497|65088908|FG001|Extension Phase|Adverse Event|5|||
23483372|NCT01895361|65513023|FG000|Overall Study|Death|2|||
23483373|NCT01895361|65513024|FG001|Overall Study|Death|1|||
23483374|NCT01895361|65513025|FG002|Overall Study|Death|2|||
23483375|NCT01895361|65513023|FG000|Overall Study|Lost to Follow-up|4|||
23483376|NCT01895361|65513024|FG001|Overall Study|Lost to Follow-up|4|||
23483377|NCT01895361|65513025|FG002|Overall Study|Lost to Follow-up|6|||
23483378|NCT01895361|65513023|FG000|Overall Study|Non-compliance with study|1|||
23483379|NCT01895361|65513024|FG001|Overall Study|Non-compliance with study|3|||
23483380|NCT01895361|65513025|FG002|Overall Study|Non-compliance with study|1|||
23483381|NCT01895361|65513023|FG000|Overall Study|Physician Decision|2|||
23483382|NCT01895361|65513024|FG001|Overall Study|Physician Decision|2|||
23483383|NCT01895361|65513025|FG002|Overall Study|Physician Decision|2|||
23601887|NCT01105975|65933926|FG002|Overall Study|Physician Decision|0|||
23601888|NCT01105975|65933927|FG003|Overall Study|Physician Decision|0|||
23483384|NCT01895361|65513023|FG000|Overall Study|Withdrawal by Subject|7|||
23483385|NCT01895361|65513024|FG001|Overall Study|Withdrawal by Subject|6|||
23483386|NCT01895361|65513025|FG002|Overall Study|Withdrawal by Subject|6|||
23483387|NCT01895361|65513023|FG000|Overall Study|Lack of Efficacy|0|||
23483388|NCT01895361|65513024|FG001|Overall Study|Lack of Efficacy|1|||
23483389|NCT01895361|65513025|FG002|Overall Study|Lack of Efficacy|0|||
23483390|NCT01895361|65513023|FG000|Overall Study|Reasons different from categories above|7|||
23483391|NCT01895361|65513024|FG001|Overall Study|Reasons different from categories above|3|||
23483392|NCT01895361|65513025|FG002|Overall Study|Reasons different from categories above|4|||
23483393|NCT03631355|65513026|FG000|Overall Study|Lost to Follow-up|1|||
23483394|NCT03631355|65513027|FG001|Overall Study|Lost to Follow-up|2|||
23483395|NCT00134784|65513030|FG000|Overall Study|Withdrawal by Subject|2|||
23483396|NCT00134784|65513031|FG001|Overall Study|Withdrawal by Subject|2|||
23483397|NCT00134784|65513032|FG002|Overall Study|Withdrawal by Subject|2|||
23483398|NCT00134784|65513033|FG003|Overall Study|Withdrawal by Subject|1|||
23483399|NCT01142128|65513034|FG000|Overall Study|Physician Decision|1|||
23483400|NCT01142128|65513034|FG000|Overall Study|Lost to Follow-up|1|||
23483401|NCT01142128|65513034|FG000|Overall Study|Withdrawal by Subject|2|||
23483402|NCT01653782|65513035|FG000|Overall Study|Withdrawal by Subject|9|||
23483403|NCT01653782|65513036|FG001|Overall Study|Withdrawal by Subject|15|||
23483404|NCT01653782|65513037|FG002|Overall Study|Withdrawal by Subject|4|||
23483405|NCT01653782|65513035|FG000|Overall Study|Lost to Follow-up|7|||
23483406|NCT01653782|65513036|FG001|Overall Study|Lost to Follow-up|3|||
23483407|NCT01653782|65513037|FG002|Overall Study|Lost to Follow-up|2|||
23483408|NCT02937584|65513040|FG000|Period 1|Adverse Event|1|||
23483409|NCT02937584|65513041|FG001|Period 1|Adverse Event|2|||
23483410|NCT02937584|65513040|FG000|Washout|Adverse Event|0|||
23483411|NCT02937584|65513041|FG001|Washout|Adverse Event|1|||
23483412|NCT04369924|65513042|FG000|Overall Study|Lost to Follow-up|302|||
23483413|NCT04369924|65513043|FG001|Overall Study|Lost to Follow-up|339|||
23483414|NCT02312687|65513050|FG000|Overall Study|Other, Not Specified|1|||
23483415|NCT03687970|65513051|FG000|Overall Study|visit scheduling conflicts|2|||
23483416|NCT03687970|65513052|FG001|Overall Study|visit scheduling conflicts|0|||
23483417|NCT00827931|65513053|FG000|Overall Study|Death|3|||
23483418|NCT00827931|65513054|FG001|Overall Study|Death|5|||
23483419|NCT00827931|65513053|FG000|Overall Study|Adverse Event|1|||
23483420|NCT00827931|65513054|FG001|Overall Study|Adverse Event|0|||
23483421|NCT00827931|65513053|FG000|Overall Study|Lost to Follow-up|1|||
23483422|NCT00827931|65513054|FG001|Overall Study|Lost to Follow-up|0|||
23483423|NCT00827931|65513053|FG000|Overall Study|Withdrawal by Subject|0|||
23483424|NCT00827931|65513054|FG001|Overall Study|Withdrawal by Subject|1|||
23483425|NCT00827931|65513053|FG000|Overall Study|Other|1|||
23483426|NCT00827931|65513054|FG001|Overall Study|Other|0|||
23483427|NCT00999921|65513056|FG000|Overall Study|Lost to Follow-up|10|||
23483428|NCT00999921|65513057|FG001|Overall Study|Lost to Follow-up|19|||
23483429|NCT02446743|65513059|FG000|Overall Study|Withdrawal by Subject|1|||
23483430|NCT02446743|65513060|FG001|Overall Study|Withdrawal by Subject|1|||
23483431|NCT02446743|65513059|FG000|Overall Study|Lost to Follow-up|1|||
23483432|NCT02446743|65513060|FG001|Overall Study|Lost to Follow-up|0|||
23483433|NCT02446743|65513059|FG000|Overall Study|Adverse Event|1|||
23483434|NCT02446743|65513060|FG001|Overall Study|Adverse Event|1|||
23483435|NCT02446743|65513059|FG000|Overall Study|Other|2|||
23483436|NCT02446743|65513060|FG001|Overall Study|Other|3|||
23483437|NCT01390220|65513061|FG000|Test Dose Phase|Adverse Event|17|||
23483438|NCT01390220|65513062|FG001|Test Dose Phase|Adverse Event|0|||
23483439|NCT01390220|65513063|FG002|Test Dose Phase|Adverse Event|0|||
23483440|NCT01390220|65513061|FG000|Test Dose Phase|Withdrawal by Subject|8|||
23366404|NCT00471497|65088909|FG002|Extension Phase|Adverse Event|1|||
23366405|NCT00471497|65088907|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
23366406|NCT00471497|65088908|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
23366407|NCT00471497|65088909|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23366408|NCT00471497|65088907|FG000|Extension Phase|Withdrawal by Subject|3|||
23366409|NCT00471497|65088908|FG001|Extension Phase|Withdrawal by Subject|1|||
23366410|NCT00471497|65088909|FG002|Extension Phase|Withdrawal by Subject|0|||
23366411|NCT00471497|65088907|FG000|Extension Phase|Lost to Follow-up|2|||
23366412|NCT00471497|65088908|FG001|Extension Phase|Lost to Follow-up|0|||
23366413|NCT00471497|65088909|FG002|Extension Phase|Lost to Follow-up|0|||
23366414|NCT00471497|65088907|FG000|Extension Phase|Death|1|||
23366415|NCT00471497|65088908|FG001|Extension Phase|Death|0|||
23366416|NCT00471497|65088909|FG002|Extension Phase|Death|0|||
23366417|NCT00471497|65088907|FG000|Extension Phase|Disease progression|2|||
23366418|NCT00471497|65088908|FG001|Extension Phase|Disease progression|0|||
23366419|NCT00471497|65088909|FG002|Extension Phase|Disease progression|0|||
23366420|NCT00471497|65088907|FG000|Extension Phase|Protocol Violation|2|||
23366421|NCT00471497|65088908|FG001|Extension Phase|Protocol Violation|2|||
23366422|NCT00471497|65088909|FG002|Extension Phase|Protocol Violation|0|||
23483441|NCT01390220|65513062|FG001|Test Dose Phase|Withdrawal by Subject|0|||
23366423|NCT00465517|65088915|FG000|Overall Study|Adverse Event|7|||
23483442|NCT01390220|65513063|FG002|Test Dose Phase|Withdrawal by Subject|0|||
23483443|NCT01390220|65513061|FG000|Test Dose Phase|Lost to Follow-up|2|||
23483444|NCT01390220|65513062|FG001|Test Dose Phase|Lost to Follow-up|0|||
23483445|NCT01390220|65513063|FG002|Test Dose Phase|Lost to Follow-up|0|||
23483446|NCT01390220|65513061|FG000|Test Dose Phase|Protocol Violation|8|||
23483447|NCT01390220|65513062|FG001|Test Dose Phase|Protocol Violation|0|||
23483448|NCT01390220|65513063|FG002|Test Dose Phase|Protocol Violation|0|||
23483449|NCT01390220|65513061|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
23483450|NCT01390220|65513062|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
23483451|NCT01390220|65513063|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
23483452|NCT01390220|65513061|FG000|Test Dose Phase|Study/Site closure|6|||
23366424|NCT00465517|65088916|FG001|Overall Study|Adverse Event|3|||
23366425|NCT00465517|65088915|FG000|Overall Study|Lost to Follow-up|1|||
23483453|NCT01390220|65513062|FG001|Test Dose Phase|Study/Site closure|0|||
23483454|NCT01390220|65513063|FG002|Test Dose Phase|Study/Site closure|0|||
23483455|NCT01390220|65513061|FG000|Test Dose Phase|Caregiver no longer available|5|||
23366426|NCT00465517|65088916|FG001|Overall Study|Lost to Follow-up|0|||
23366427|NCT00465517|65088915|FG000|Overall Study|Withdrawal by Subject|4|||
23366428|NCT00465517|65088916|FG001|Overall Study|Withdrawal by Subject|1|||
23366429|NCT02230891|65088917|FG000|Baseline|Did not meet inclusion|0|||
23366430|NCT02230891|65088918|FG001|Baseline|Did not meet inclusion|1|||
23366431|NCT02230891|65088919|FG002|Baseline|Did not meet inclusion|1|||
23366432|NCT02230891|65088917|FG000|2 Week|Withdrawal by Subject|2|||
23366433|NCT02230891|65088918|FG001|2 Week|Withdrawal by Subject|2|||
23366434|NCT02230891|65088919|FG002|2 Week|Withdrawal by Subject|0|||
23366435|NCT02230891|65088917|FG000|2 Week|Consent withdrawn|1|||
23366436|NCT02230891|65088918|FG001|2 Week|Consent withdrawn|0|||
23366437|NCT02230891|65088919|FG002|2 Week|Consent withdrawn|0|||
23366438|NCT02230891|65088917|FG000|6 Month|Withdrawal by Subject|1|||
23366439|NCT02230891|65088918|FG001|6 Month|Withdrawal by Subject|1|||
23366440|NCT02230891|65088919|FG002|6 Month|Withdrawal by Subject|1|||
23366441|NCT02230891|65088917|FG000|6 Month|Physician Decision|0|||
23366442|NCT02230891|65088918|FG001|6 Month|Physician Decision|2|||
23366443|NCT02230891|65088919|FG002|6 Month|Physician Decision|0|||
23366444|NCT02230891|65088917|FG000|12 Month|Death|1|||
23366445|NCT02230891|65088918|FG001|12 Month|Death|0|||
23366446|NCT02230891|65088919|FG002|12 Month|Death|0|||
23366447|NCT02230891|65088917|FG000|12 Month|Lost to Follow-up|0|||
23366448|NCT02230891|65088918|FG001|12 Month|Lost to Follow-up|1|||
23366449|NCT02230891|65088919|FG002|12 Month|Lost to Follow-up|0|||
23366450|NCT02230891|65088917|FG000|12 Month|Withdrawal by Subject|0|||
23366451|NCT02230891|65088918|FG001|12 Month|Withdrawal by Subject|2|||
23366452|NCT02230891|65088919|FG002|12 Month|Withdrawal by Subject|0|||
23366453|NCT02230891|65088917|FG000|18 Month End of Study|Death|0|||
23366454|NCT02230891|65088918|FG001|18 Month End of Study|Death|0|||
23366455|NCT02230891|65088919|FG002|18 Month End of Study|Death|1|||
23366456|NCT02230891|65088917|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
23366457|NCT02230891|65088918|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
23366458|NCT02230891|65088919|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
23366459|NCT01029262|65088927|FG000|Overall Study|Adverse Event|9|||
23366460|NCT01029262|65088928|FG001|Overall Study|Adverse Event|52|||
23366461|NCT01029262|65088927|FG000|Overall Study|Lack of therapeutic effect|57|||
23366462|NCT01029262|65088928|FG001|Overall Study|Lack of therapeutic effect|76|||
23366463|NCT01029262|65088927|FG000|Overall Study|Withdrawal by Subject|10|||
23366464|NCT01029262|65088928|FG001|Overall Study|Withdrawal by Subject|17|||
23366465|NCT01029262|65088927|FG000|Overall Study|Protocol Violation|2|||
23366466|NCT01029262|65088928|FG001|Overall Study|Protocol Violation|3|||
23660637|NCT01994382|66145624|FG012|Overall Study|Adverse Event|7|||
23366467|NCT01029262|65088927|FG000|Overall Study|Miscellaneous|1|||
23366468|NCT01029262|65088928|FG001|Overall Study|Miscellaneous|9|||
23366469|NCT01029262|65088927|FG000|Overall Study|Death|0|||
23366470|NCT01029262|65088928|FG001|Overall Study|Death|3|||
23366471|NCT02869789|65088929|FG000|Overall Study|Disease progression|184|||
23366472|NCT02869789|65088930|FG001|Overall Study|Disease progression|109|||
23366473|NCT02869789|65088931|FG002|Overall Study|Disease progression|260|||
23366474|NCT02869789|65088932|FG003|Overall Study|Disease progression|19|||
23366475|NCT02869789|65088929|FG000|Overall Study|Study drug toxicity|90|||
23366476|NCT02869789|65088930|FG001|Overall Study|Study drug toxicity|32|||
23366477|NCT02869789|65088931|FG002|Overall Study|Study drug toxicity|55|||
23366478|NCT02869789|65088932|FG003|Overall Study|Study drug toxicity|14|||
23366479|NCT02869789|65088929|FG000|Overall Study|Death|7|||
23366480|NCT02869789|65088930|FG001|Overall Study|Death|3|||
23366481|NCT02869789|65088931|FG002|Overall Study|Death|5|||
23366482|NCT02869789|65088932|FG003|Overall Study|Death|1|||
23366483|NCT02869789|65088929|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
23366484|NCT02869789|65088930|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
23366485|NCT02869789|65088931|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
23366486|NCT02869789|65088932|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
23366487|NCT02869789|65088929|FG000|Overall Study|Participant request to discontinue study treatment|10|||
23366488|NCT02869789|65088930|FG001|Overall Study|Participant request to discontinue study treatment|5|||
23366489|NCT02869789|65088931|FG002|Overall Study|Participant request to discontinue study treatment|5|||
23366490|NCT02869789|65088932|FG003|Overall Study|Participant request to discontinue study treatment|3|||
23366491|NCT02869789|65088929|FG000|Overall Study|Withdrawal by Subject|5|||
23366492|NCT02869789|65088930|FG001|Overall Study|Withdrawal by Subject|2|||
23366493|NCT02869789|65088931|FG002|Overall Study|Withdrawal by Subject|7|||
23366494|NCT02869789|65088932|FG003|Overall Study|Withdrawal by Subject|2|||
23660638|NCT01994382|66145625|FG013|Overall Study|Adverse Event|3|||
23660639|NCT01994382|66145626|FG014|Overall Study|Adverse Event|17|||
23660640|NCT01994382|66145627|FG015|Overall Study|Adverse Event|6|||
23660641|NCT01994382|66145628|FG016|Overall Study|Adverse Event|3|||
23660642|NCT01994382|66145612|FG000|Overall Study|Other than specified|0|||
23660643|NCT01994382|66145613|FG001|Overall Study|Other than specified|0|||
23660644|NCT01994382|66145614|FG002|Overall Study|Other than specified|0|||
23660645|NCT01994382|66145615|FG003|Overall Study|Other than specified|0|||
23660646|NCT01994382|66145616|FG004|Overall Study|Other than specified|0|||
23660647|NCT01994382|66145617|FG005|Overall Study|Other than specified|0|||
23660648|NCT01994382|66145618|FG006|Overall Study|Other than specified|0|||
23660649|NCT01994382|66145619|FG007|Overall Study|Other than specified|0|||
23660650|NCT01994382|66145620|FG008|Overall Study|Other than specified|0|||
23660651|NCT01994382|66145621|FG009|Overall Study|Other than specified|0|||
23366495|NCT02869789|65088929|FG000|Overall Study|Lost to Follow-up|0|||
23366496|NCT02869789|65088930|FG001|Overall Study|Lost to Follow-up|0|||
23366497|NCT02869789|65088931|FG002|Overall Study|Lost to Follow-up|2|||
23660652|NCT01994382|66145622|FG010|Overall Study|Other than specified|2|||
23660653|NCT01994382|66145623|FG011|Overall Study|Other than specified|0|||
23660654|NCT01994382|66145624|FG012|Overall Study|Other than specified|2|||
23660655|NCT01994382|66145625|FG013|Overall Study|Other than specified|0|||
23660656|NCT01994382|66145626|FG014|Overall Study|Other than specified|0|||
23660657|NCT01994382|66145627|FG015|Overall Study|Other than specified|4|||
23660658|NCT01994382|66145628|FG016|Overall Study|Other than specified|4|||
23660659|NCT01994382|66145612|FG000|Overall Study|Withdrawal by Subject|0|||
23660660|NCT01994382|66145613|FG001|Overall Study|Withdrawal by Subject|0|||
23660661|NCT01994382|66145614|FG002|Overall Study|Withdrawal by Subject|0|||
23660662|NCT01994382|66145615|FG003|Overall Study|Withdrawal by Subject|0|||
23660663|NCT01994382|66145616|FG004|Overall Study|Withdrawal by Subject|0|||
23660664|NCT01994382|66145617|FG005|Overall Study|Withdrawal by Subject|0|||
23660665|NCT01994382|66145618|FG006|Overall Study|Withdrawal by Subject|0|||
23660666|NCT01994382|66145619|FG007|Overall Study|Withdrawal by Subject|0|||
23660667|NCT01994382|66145620|FG008|Overall Study|Withdrawal by Subject|0|||
23483456|NCT01390220|65513062|FG001|Test Dose Phase|Caregiver no longer available|0|||
23660668|NCT01994382|66145621|FG009|Overall Study|Withdrawal by Subject|0|||
23660669|NCT01994382|66145622|FG010|Overall Study|Withdrawal by Subject|6|||
23366498|NCT02869789|65088932|FG003|Overall Study|Lost to Follow-up|0|||
23366499|NCT02869789|65088929|FG000|Overall Study|Maximum clinical benefit|5|||
23366500|NCT02869789|65088930|FG001|Overall Study|Maximum clinical benefit|2|||
23366501|NCT02869789|65088931|FG002|Overall Study|Maximum clinical benefit|1|||
23366502|NCT02869789|65088932|FG003|Overall Study|Maximum clinical benefit|0|||
23366503|NCT02869789|65088929|FG000|Overall Study|Poor/Non-compliance|0|||
23366504|NCT02869789|65088930|FG001|Overall Study|Poor/Non-compliance|2|||
23366505|NCT02869789|65088931|FG002|Overall Study|Poor/Non-compliance|1|||
23366506|NCT02869789|65088932|FG003|Overall Study|Poor/Non-compliance|0|||
23366507|NCT02869789|65088929|FG000|Overall Study|Participant no longer meets study criteria|0|||
23366508|NCT02869789|65088930|FG001|Overall Study|Participant no longer meets study criteria|1|||
23366509|NCT02869789|65088931|FG002|Overall Study|Participant no longer meets study criteria|1|||
23366510|NCT02869789|65088932|FG003|Overall Study|Participant no longer meets study criteria|0|||
23366511|NCT02869789|65088929|FG000|Overall Study|Administrative reason by sponsor|0|||
23366512|NCT02869789|65088930|FG001|Overall Study|Administrative reason by sponsor|0|||
23366513|NCT02869789|65088931|FG002|Overall Study|Administrative reason by sponsor|1|||
23366514|NCT02869789|65088932|FG003|Overall Study|Administrative reason by sponsor|0|||
23366515|NCT02869789|65088929|FG000|Overall Study|Other reasons|4|||
23366516|NCT02869789|65088930|FG001|Overall Study|Other reasons|8|||
23366517|NCT02869789|65088931|FG002|Overall Study|Other reasons|6|||
23366518|NCT02869789|65088932|FG003|Overall Study|Other reasons|0|||
23366519|NCT02340000|65088933|FG000|Time Period 1|Withdrawal by Subject|6|||
23366520|NCT02340000|65088934|FG001|Time Period 1|Withdrawal by Subject|8|||
23366521|NCT02340000|65088933|FG000|Time Period 1|Lost to Follow-up|6|||
23366522|NCT02340000|65088934|FG001|Time Period 1|Lost to Follow-up|7|||
23366523|NCT02340000|65088933|FG000|Time Period 2|Withdrawal by Subject|9|||
23366524|NCT02340000|65088934|FG001|Time Period 2|Withdrawal by Subject|7|||
23366525|NCT02340000|65088933|FG000|Time Period 2|Lost to Follow-up|10|||
23366526|NCT02340000|65088934|FG001|Time Period 2|Lost to Follow-up|8|||
23366527|NCT01348139|65088935|FG000|Period 1|Adverse Event|1|||
23366528|NCT01348139|65088936|FG001|Period 1|Adverse Event|0|||
23366529|NCT01348139|65088937|FG002|Period 1|Adverse Event|0|||
23366530|NCT01348139|65088938|FG003|Period 1|Adverse Event|0|||
23366531|NCT01348139|65088939|FG004|Period 1|Adverse Event|0|||
23366532|NCT01348139|65088940|FG005|Period 1|Adverse Event|0|||
23366533|NCT00928434|65088946|FG000|Overall Study|Adverse Event|14|||
23366534|NCT00928434|65088947|FG001|Overall Study|Adverse Event|5|||
23366535|NCT00928434|65088948|FG002|Overall Study|Adverse Event|18|||
23366536|NCT00928434|65088946|FG000|Overall Study|Protocol Violation|5|||
23366537|NCT00928434|65088947|FG001|Overall Study|Protocol Violation|0|||
23660670|NCT01994382|66145623|FG011|Overall Study|Withdrawal by Subject|0|||
23660671|NCT01994382|66145624|FG012|Overall Study|Withdrawal by Subject|2|||
23660672|NCT01994382|66145625|FG013|Overall Study|Withdrawal by Subject|0|||
23660673|NCT01994382|66145626|FG014|Overall Study|Withdrawal by Subject|4|||
23660674|NCT01994382|66145627|FG015|Overall Study|Withdrawal by Subject|3|||
23660675|NCT01994382|66145628|FG016|Overall Study|Withdrawal by Subject|0|||
23366538|NCT00928434|65088948|FG002|Overall Study|Protocol Violation|8|||
23366539|NCT00928434|65088946|FG000|Overall Study|Physician Decision|2|||
23366540|NCT00928434|65088947|FG001|Overall Study|Physician Decision|0|||
23366541|NCT00928434|65088948|FG002|Overall Study|Physician Decision|3|||
23366542|NCT00928434|65088946|FG000|Overall Study|Lost to Follow-up|1|||
23366543|NCT00928434|65088947|FG001|Overall Study|Lost to Follow-up|0|||
23660676|NCT01994382|66145612|FG000|Overall Study|Lost to Follow-up|0|||
23366544|NCT00928434|65088948|FG002|Overall Study|Lost to Follow-up|3|||
23366545|NCT00928434|65088946|FG000|Overall Study|Withdrawal by Subject|5|||
23366546|NCT00928434|65088947|FG001|Overall Study|Withdrawal by Subject|3|||
23366547|NCT00928434|65088948|FG002|Overall Study|Withdrawal by Subject|2|||
23366548|NCT00928434|65088946|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
23660677|NCT01994382|66145613|FG001|Overall Study|Lost to Follow-up|0|||
23660678|NCT01994382|66145614|FG002|Overall Study|Lost to Follow-up|0|||
23660679|NCT01994382|66145615|FG003|Overall Study|Lost to Follow-up|0|||
23660680|NCT01994382|66145616|FG004|Overall Study|Lost to Follow-up|0|||
23660681|NCT01994382|66145617|FG005|Overall Study|Lost to Follow-up|0|||
23660682|NCT01994382|66145618|FG006|Overall Study|Lost to Follow-up|0|||
23660683|NCT01994382|66145619|FG007|Overall Study|Lost to Follow-up|0|||
23660684|NCT01994382|66145620|FG008|Overall Study|Lost to Follow-up|0|||
23660685|NCT01994382|66145621|FG009|Overall Study|Lost to Follow-up|0|||
23660686|NCT01994382|66145622|FG010|Overall Study|Lost to Follow-up|1|||
23660687|NCT01994382|66145623|FG011|Overall Study|Lost to Follow-up|0|||
23660688|NCT01994382|66145624|FG012|Overall Study|Lost to Follow-up|0|||
23660689|NCT01994382|66145625|FG013|Overall Study|Lost to Follow-up|0|||
23660690|NCT01994382|66145626|FG014|Overall Study|Lost to Follow-up|0|||
23660691|NCT01994382|66145627|FG015|Overall Study|Lost to Follow-up|0|||
23660692|NCT01994382|66145628|FG016|Overall Study|Lost to Follow-up|0|||
23660693|NCT01994382|66145612|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660694|NCT01994382|66145613|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660695|NCT01994382|66145614|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660696|NCT01994382|66145615|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660697|NCT01994382|66145616|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660698|NCT01994382|66145617|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660699|NCT01994382|66145618|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660700|NCT01994382|66145619|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660701|NCT01994382|66145620|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660702|NCT01994382|66145621|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660703|NCT01994382|66145622|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
23366549|NCT00928434|65088947|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
23366550|NCT00928434|65088948|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
23366551|NCT00928434|65088946|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
23366552|NCT00928434|65088947|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
23366553|NCT00928434|65088948|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
23366554|NCT00928434|65088946|FG000|Overall Study|Other (not meeting above criteria)|5|||
23366555|NCT00928434|65088947|FG001|Overall Study|Other (not meeting above criteria)|1|||
23366556|NCT00928434|65088948|FG002|Overall Study|Other (not meeting above criteria)|2|||
23366557|NCT03299101|65088949|FG000|Overall Study|Lost to Follow-up|1|||
23366558|NCT03299101|65088949|FG000|Overall Study|Withdrawal by Subject|5|||
23366559|NCT03299101|65088949|FG000|Overall Study|Surgery was changed|3|||
23366560|NCT03299101|65088949|FG000|Overall Study|Not enough time to complete prehab|1|||
23366561|NCT01896193|65088950|FG000|Overall Study|Lack of Efficacy|20|||
23366562|NCT01896193|65088951|FG001|Overall Study|Lack of Efficacy|11|||
23366563|NCT01896193|65088950|FG000|Overall Study|Protocol Violation|0|||
23366564|NCT01896193|65088951|FG001|Overall Study|Protocol Violation|1|||
23366565|NCT01896193|65088950|FG000|Overall Study|Withdrew Consent|1|||
23366566|NCT01896193|65088951|FG001|Overall Study|Withdrew Consent|0|||
23366567|NCT00643760|65088952|FG000|Overall Study|Adverse Event|11|||
23366568|NCT00643760|65088953|FG001|Overall Study|Adverse Event|5|||
23366569|NCT00643760|65088954|FG002|Overall Study|Adverse Event|12|||
23366570|NCT00643760|65088955|FG003|Overall Study|Adverse Event|21|||
23366571|NCT00643760|65088956|FG004|Overall Study|Adverse Event|6|||
23366572|NCT00643760|65088952|FG000|Overall Study|Lack of Efficacy|3|||
23366573|NCT00643760|65088953|FG001|Overall Study|Lack of Efficacy|1|||
23366574|NCT00643760|65088954|FG002|Overall Study|Lack of Efficacy|0|||
23366575|NCT00643760|65088955|FG003|Overall Study|Lack of Efficacy|4|||
23366576|NCT00643760|65088956|FG004|Overall Study|Lack of Efficacy|3|||
23366577|NCT00643760|65088952|FG000|Overall Study|Protocol Violation|7|||
23366578|NCT00643760|65088953|FG001|Overall Study|Protocol Violation|6|||
23366579|NCT00643760|65088954|FG002|Overall Study|Protocol Violation|4|||
23366580|NCT00643760|65088955|FG003|Overall Study|Protocol Violation|4|||
23366581|NCT00643760|65088956|FG004|Overall Study|Protocol Violation|6|||
23366582|NCT00643760|65088952|FG000|Overall Study|Lost to Follow-up|6|||
23660704|NCT01994382|66145623|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23660705|NCT01994382|66145624|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
23660706|NCT01994382|66145625|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23366583|NCT00643760|65088953|FG001|Overall Study|Lost to Follow-up|2|||
23366584|NCT00643760|65088954|FG002|Overall Study|Lost to Follow-up|1|||
23366585|NCT00643760|65088955|FG003|Overall Study|Lost to Follow-up|3|||
23366586|NCT00643760|65088956|FG004|Overall Study|Lost to Follow-up|3|||
23366587|NCT00643760|65088952|FG000|Overall Study|Investigator Discretion|0|||
23366588|NCT00643760|65088953|FG001|Overall Study|Investigator Discretion|0|||
23366589|NCT00643760|65088954|FG002|Overall Study|Investigator Discretion|0|||
23366590|NCT00643760|65088955|FG003|Overall Study|Investigator Discretion|2|||
23366591|NCT00643760|65088956|FG004|Overall Study|Investigator Discretion|0|||
23366592|NCT00643760|65088952|FG000|Overall Study|Withdrawal by Subject|3|||
23366593|NCT00643760|65088953|FG001|Overall Study|Withdrawal by Subject|1|||
23483457|NCT01390220|65513063|FG002|Test Dose Phase|Caregiver no longer available|0|||
23660707|NCT01994382|66145626|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23366594|NCT00643760|65088954|FG002|Overall Study|Withdrawal by Subject|2|||
23366595|NCT00643760|65088955|FG003|Overall Study|Withdrawal by Subject|4|||
23366596|NCT00643760|65088956|FG004|Overall Study|Withdrawal by Subject|1|||
23366597|NCT04771013|65088961|FG000|Overall Study|Withdrawal by Subject|2|||
23660708|NCT01994382|66145627|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
23366598|NCT04771013|65088962|FG001|Overall Study|Withdrawal by Subject|0|||
23366599|NCT04771013|65088961|FG000|Overall Study|Death|0|||
23660709|NCT01994382|66145628|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
23660710|NCT01994382|66145612|FG000|Overall Study|Protocol violation/noncompliance|0|||
23660711|NCT01994382|66145613|FG001|Overall Study|Protocol violation/noncompliance|0|||
23366600|NCT04771013|65088962|FG001|Overall Study|Death|5|||
23601889|NCT01105975|65933928|FG004|Overall Study|Physician Decision|0|||
23601890|NCT01105975|65933929|FG005|Overall Study|Physician Decision|0|||
23366601|NCT04771013|65088961|FG000|Overall Study|Referred to another hospital before day 20|0|||
23366602|NCT04771013|65088962|FG001|Overall Study|Referred to another hospital before day 20|1|||
23366603|NCT01939314|65088963|FG000|Overall Study|Withdrawal by Subject|3|||
23366604|NCT01939314|65088964|FG001|Overall Study|Withdrawal by Subject|1|||
23366605|NCT01939314|65088963|FG000|Overall Study|Protocol Violation|1|||
23366606|NCT01939314|65088964|FG001|Overall Study|Protocol Violation|0|||
23366607|NCT01939314|65088963|FG000|Overall Study|Pregnancy|0|||
23366608|NCT01939314|65088964|FG001|Overall Study|Pregnancy|1|||
23366609|NCT01939314|65088963|FG000|Overall Study|Lost to Follow-up|5|||
23366610|NCT01939314|65088964|FG001|Overall Study|Lost to Follow-up|6|||
23366611|NCT00570401|65088965|FG000|Overall Study|Adverse Event|2|||
23366612|NCT01817075|65088968|FG000|Overall Study|Adverse Event|7|||
23366613|NCT01817075|65088969|FG001|Overall Study|Adverse Event|5|||
23366614|NCT01817075|65088968|FG000|Overall Study|Physician Decision|9|||
23366615|NCT01817075|65088969|FG001|Overall Study|Physician Decision|12|||
23366616|NCT01817075|65088968|FG000|Overall Study|Withdrawal by Subject|31|||
23366617|NCT01817075|65088969|FG001|Overall Study|Withdrawal by Subject|15|||
23366618|NCT01817075|65088968|FG000|Overall Study|Received Sorafenib after enrollment|0|||
23366619|NCT01817075|65088969|FG001|Overall Study|Received Sorafenib after enrollment|1|||
23366620|NCT01817075|65088968|FG000|Overall Study|Ineligible|0|||
23366621|NCT01817075|65088969|FG001|Overall Study|Ineligible|2|||
23366622|NCT00315445|65088972|FG000|Overall Study|Adverse Event|7|||
23366623|NCT00315445|65088973|FG001|Overall Study|Adverse Event|12|||
23366624|NCT00315445|65088974|FG002|Overall Study|Adverse Event|15|||
23366625|NCT00315445|65088972|FG000|Overall Study|Lack of Efficacy|16|||
23366626|NCT00315445|65088973|FG001|Overall Study|Lack of Efficacy|1|||
23366627|NCT00315445|65088974|FG002|Overall Study|Lack of Efficacy|7|||
23366628|NCT00315445|65088972|FG000|Overall Study|Lost to Follow-up|1|||
23366629|NCT00315445|65088973|FG001|Overall Study|Lost to Follow-up|0|||
23366630|NCT00315445|65088974|FG002|Overall Study|Lost to Follow-up|1|||
23366631|NCT00315445|65088972|FG000|Overall Study|Protocol Violation|2|||
23366632|NCT00315445|65088973|FG001|Overall Study|Protocol Violation|0|||
23601891|NCT01105975|65933930|FG006|Overall Study|Physician Decision|2|||
23366633|NCT00315445|65088974|FG002|Overall Study|Protocol Violation|1|||
23366634|NCT00315445|65088972|FG000|Overall Study|Other|1|||
23483458|NCT01390220|65513061|FG000|Test Dose Phase|Noncompliance|2|||
23483459|NCT01390220|65513062|FG001|Test Dose Phase|Noncompliance|0|||
23366635|NCT00315445|65088973|FG001|Overall Study|Other|3|||
23366636|NCT00315445|65088974|FG002|Overall Study|Other|0|||
23366637|NCT01499810|65088975|FG000|Overall Study|Lost to Follow-up|10|||
23366638|NCT01499810|65088975|FG000|Overall Study|Protocol Violation|1|||
23366639|NCT01499810|65088975|FG000|Overall Study|Withdrawal by Subject|1|||
23366640|NCT01806168|65088979|FG000|Overall Study|Adverse Event|1|||
23366641|NCT01806168|65088980|FG001|Overall Study|Adverse Event|0|||
23366642|NCT01806168|65088981|FG002|Overall Study|Adverse Event|0|||
23366643|NCT01806168|65088979|FG000|Overall Study|Withdrawal by Subject|0|||
23366644|NCT01806168|65088980|FG001|Overall Study|Withdrawal by Subject|1|||
23366645|NCT01806168|65088981|FG002|Overall Study|Withdrawal by Subject|2|||
23366646|NCT01806168|65088979|FG000|Overall Study|Protocol Violation|0|||
23366647|NCT01806168|65088980|FG001|Overall Study|Protocol Violation|0|||
23366648|NCT01806168|65088981|FG002|Overall Study|Protocol Violation|1|||
23366649|NCT03528551|65088984|FG000|Overall Study|Lost to Follow-up|0|||
23366650|NCT03528551|65088985|FG001|Overall Study|Lost to Follow-up|1|||
23366651|NCT03528551|65088986|FG002|Overall Study|Lost to Follow-up|0|||
23366652|NCT03528551|65088984|FG000|Overall Study|Transferred to other arm/group|2|||
23366653|NCT03528551|65088985|FG001|Overall Study|Transferred to other arm/group|3|||
23366654|NCT03528551|65088986|FG002|Overall Study|Transferred to other arm/group|0|||
23366655|NCT03528551|65088984|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23366656|NCT03528551|65088985|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23366657|NCT03528551|65088986|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23366658|NCT03528551|65088984|FG000|Overall Study|Protocol Violation|0|||
23366659|NCT03528551|65088985|FG001|Overall Study|Protocol Violation|3|||
23366660|NCT03528551|65088986|FG002|Overall Study|Protocol Violation|0|||
23366661|NCT03528551|65088984|FG000|Overall Study|Withdrawal by Subject|0|||
23366662|NCT03528551|65088985|FG001|Overall Study|Withdrawal by Subject|7|||
23366663|NCT03528551|65088986|FG002|Overall Study|Withdrawal by Subject|0|||
23366664|NCT00141518|65088991|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
23366665|NCT00141518|65088992|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
23366666|NCT00141518|65088993|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
23366667|NCT00141518|65088991|FG000|Overall Study|Adverse Event|7|||
23366668|NCT00141518|65088992|FG001|Overall Study|Adverse Event|5|||
23366669|NCT00141518|65088993|FG002|Overall Study|Adverse Event|2|||
23366670|NCT00141518|65088991|FG000|Overall Study|Withdrawal by Subject|2|||
23366671|NCT00141518|65088992|FG001|Overall Study|Withdrawal by Subject|0|||
23366672|NCT00141518|65088993|FG002|Overall Study|Withdrawal by Subject|2|||
23366673|NCT00141518|65088991|FG000|Overall Study|Protocol Violation|1|||
23366674|NCT00141518|65088992|FG001|Overall Study|Protocol Violation|1|||
23366675|NCT00141518|65088993|FG002|Overall Study|Protocol Violation|2|||
23366676|NCT00141518|65088991|FG000|Overall Study|Lack of Efficacy|5|||
23366677|NCT00141518|65088992|FG001|Overall Study|Lack of Efficacy|0|||
23366678|NCT00141518|65088993|FG002|Overall Study|Lack of Efficacy|0|||
23366679|NCT01064479|65088994|FG000|Overall Study|Death|10|||
23366680|NCT01064479|65088995|FG001|Overall Study|Death|11|||
23366681|NCT01064479|65088994|FG000|Overall Study|Withdrawal by Subject|2|||
23366682|NCT01064479|65088995|FG001|Overall Study|Withdrawal by Subject|2|||
23366683|NCT01064479|65088994|FG000|Overall Study|Disease progression|1|||
23366684|NCT01064479|65088995|FG001|Overall Study|Disease progression|1|||
23366685|NCT01064479|65088994|FG000|Overall Study|Toxicity|1|||
23366686|NCT01064479|65088995|FG001|Overall Study|Toxicity|1|||
23366687|NCT01064479|65088994|FG000|Overall Study|Other|1|||
23366688|NCT01064479|65088995|FG001|Overall Study|Other|2|||
23366689|NCT00327340|65088996|FG000|Overall Study|Withdrawal by Subject|1|||
23366690|NCT00327340|65088997|FG001|Overall Study|Withdrawal by Subject|5|||
23366691|NCT00327340|65088996|FG000|Overall Study|Physician Decision|1|||
23366692|NCT00327340|65088997|FG001|Overall Study|Physician Decision|1|||
23366693|NCT00327340|65088996|FG000|Overall Study|Disease Progression|10|||
23366694|NCT00327340|65088997|FG001|Overall Study|Disease Progression|19|||
23366695|NCT00327340|65088996|FG000|Overall Study|Symptomatic Disease|0|||
23366696|NCT00327340|65088997|FG001|Overall Study|Symptomatic Disease|2|||
23366697|NCT00327340|65088996|FG000|Overall Study|Adverse Event|3|||
23366698|NCT00327340|65088997|FG001|Overall Study|Adverse Event|3|||
23366699|NCT03322293|65088998|FG000|Overall Study|Lost to Follow-up|0|||
23366700|NCT03322293|65088999|FG001|Overall Study|Lost to Follow-up|0|||
23366701|NCT03322293|65089000|FG002|Overall Study|Lost to Follow-up|1|||
23366702|NCT03118518|65089001|FG000|Overall Study|Early Exit after treatment|2|||
23366703|NCT03118518|65089002|FG001|Overall Study|Early Exit after treatment|8|||
23366704|NCT03118518|65089001|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
23366705|NCT03118518|65089002|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
23366706|NCT03131167|65089006|FG000|Overall Study|Other (Unspecified)|0|||
23366707|NCT03131167|65089007|FG001|Overall Study|Other (Unspecified)|0|||
23366708|NCT03131167|65089008|FG002|Overall Study|Other (Unspecified)|0|||
23366709|NCT03131167|65089009|FG003|Overall Study|Other (Unspecified)|0|||
23366710|NCT03131167|65089010|FG004|Overall Study|Other (Unspecified)|0|||
23366711|NCT03131167|65089011|FG005|Overall Study|Other (Unspecified)|1|||
23366712|NCT03131167|65089012|FG006|Overall Study|Other (Unspecified)|0|||
23660712|NCT01994382|66145614|FG002|Overall Study|Protocol violation/noncompliance|0|||
23660713|NCT01994382|66145615|FG003|Overall Study|Protocol violation/noncompliance|0|||
23660714|NCT01994382|66145616|FG004|Overall Study|Protocol violation/noncompliance|0|||
23660715|NCT01994382|66145617|FG005|Overall Study|Protocol violation/noncompliance|0|||
23660716|NCT01994382|66145618|FG006|Overall Study|Protocol violation/noncompliance|0|||
23660717|NCT01994382|66145619|FG007|Overall Study|Protocol violation/noncompliance|0|||
23660718|NCT01994382|66145620|FG008|Overall Study|Protocol violation/noncompliance|0|||
23660719|NCT01994382|66145621|FG009|Overall Study|Protocol violation/noncompliance|0|||
23660720|NCT01994382|66145622|FG010|Overall Study|Protocol violation/noncompliance|0|||
23660721|NCT01994382|66145623|FG011|Overall Study|Protocol violation/noncompliance|1|||
23660722|NCT01994382|66145624|FG012|Overall Study|Protocol violation/noncompliance|0|||
23660723|NCT01994382|66145625|FG013|Overall Study|Protocol violation/noncompliance|0|||
23660724|NCT01994382|66145626|FG014|Overall Study|Protocol violation/noncompliance|0|||
23660725|NCT01994382|66145627|FG015|Overall Study|Protocol violation/noncompliance|0|||
23660726|NCT01994382|66145628|FG016|Overall Study|Protocol violation/noncompliance|2|||
23660727|NCT01994382|66145612|FG000|Overall Study|Rolled over to Phase 2a|0|||
23660728|NCT01994382|66145613|FG001|Overall Study|Rolled over to Phase 2a|0|||
23660729|NCT01994382|66145614|FG002|Overall Study|Rolled over to Phase 2a|1|||
23483460|NCT01390220|65513063|FG002|Test Dose Phase|Noncompliance|0|||
23660730|NCT01994382|66145615|FG003|Overall Study|Rolled over to Phase 2a|0|||
23660731|NCT01994382|66145616|FG004|Overall Study|Rolled over to Phase 2a|0|||
23660732|NCT01994382|66145617|FG005|Overall Study|Rolled over to Phase 2a|0|||
23660733|NCT01994382|66145618|FG006|Overall Study|Rolled over to Phase 2a|0|||
23660734|NCT01994382|66145619|FG007|Overall Study|Rolled over to Phase 2a|0|||
23660735|NCT01994382|66145620|FG008|Overall Study|Rolled over to Phase 2a|0|||
23660736|NCT01994382|66145621|FG009|Overall Study|Rolled over to Phase 2a|2|||
23660737|NCT01994382|66145622|FG010|Overall Study|Rolled over to Phase 2a|0|||
23660738|NCT01994382|66145623|FG011|Overall Study|Rolled over to Phase 2a|0|||
23660739|NCT01994382|66145624|FG012|Overall Study|Rolled over to Phase 2a|0|||
23660740|NCT01994382|66145625|FG013|Overall Study|Rolled over to Phase 2a|0|||
23660741|NCT01994382|66145626|FG014|Overall Study|Rolled over to Phase 2a|0|||
23660742|NCT01994382|66145627|FG015|Overall Study|Rolled over to Phase 2a|0|||
23660743|NCT01994382|66145628|FG016|Overall Study|Rolled over to Phase 2a|0|||
23366713|NCT03131167|65089013|FG007|Overall Study|Other (Unspecified)|0|||
23366714|NCT03131167|65089014|FG008|Overall Study|Other (Unspecified)|0|||
23366715|NCT03131167|65089015|FG009|Overall Study|Other (Unspecified)|0|||
23366716|NCT03131167|65089016|FG010|Overall Study|Other (Unspecified)|0|||
23366717|NCT03131167|65089017|FG011|Overall Study|Other (Unspecified)|0|||
23660744|NCT01131520|66145629|FG000|Overall Study|Computer problem|1|||
23660745|NCT01131520|66145630|FG001|Overall Study|Computer problem|0|||
23660746|NCT01131520|66145629|FG000|Overall Study|Counselor not available|0|||
23660747|NCT01131520|66145630|FG001|Overall Study|Counselor not available|3|||
23660748|NCT01131520|66145629|FG000|Overall Study|Subject changed history after enrollment|0|||
23660749|NCT01131520|66145630|FG001|Overall Study|Subject changed history after enrollment|1|||
23660750|NCT04857996|66145631|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
23660751|NCT04857996|66145632|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
23660752|NCT04857996|66145631|FG000|Overall Study|Lost to Follow-up|1|||
23660753|NCT04857996|66145632|FG001|Overall Study|Lost to Follow-up|3|||
23660754|NCT04857996|66145631|FG000|Overall Study|Site Closure|1|||
23660755|NCT04857996|66145632|FG001|Overall Study|Site Closure|0|||
23660756|NCT04857996|66145631|FG000|Overall Study|Withdrawal by Subject|1|||
23660757|NCT04857996|66145632|FG001|Overall Study|Withdrawal by Subject|0|||
23660758|NCT02546765|66145642|FG000|Overall Study|Withdrawal by Subject|0|||
23660759|NCT02546765|66145643|FG001|Overall Study|Withdrawal by Subject|1|||
23660760|NCT02546765|66145644|FG002|Overall Study|Withdrawal by Subject|0|||
23660761|NCT02546765|66145645|FG003|Overall Study|Withdrawal by Subject|0|||
23660762|NCT03275285|66145646|FG000|Overall Study|Ongoing|45|||
23660763|NCT03275285|66145647|FG001|Overall Study|Ongoing|69|||
23660764|NCT00591214|66145648|FG000|Overall Study|Physician Decision|7|||
23660765|NCT00591214|66145648|FG000|Overall Study|Withdrawal by Subject|1|||
23660766|NCT00621751|66145649|FG000|Overall Study|Adverse Event|0|||
23660767|NCT00621751|66145650|FG001|Overall Study|Adverse Event|1|||
23660768|NCT02285920|66145651|FG000|Overall Study|Kidney transplantation|2|||
23660769|NCT02285920|66145652|FG001|Overall Study|Kidney transplantation|2|||
23660770|NCT02285920|66145653|FG002|Overall Study|Kidney transplantation|2|||
23660771|NCT02285920|66145654|FG003|Overall Study|Kidney transplantation|0|||
23366718|NCT03131167|65089018|FG012|Overall Study|Other (Unspecified)|0|||
23366719|NCT01286129|65089022|FG000|Overall Study|Withdrawal by Subject|4|||
23660772|NCT02285920|66145651|FG000|Overall Study|Change to peritoneal dialysis|0|||
23601892|NCT01105975|65933931|FG007|Overall Study|Physician Decision|0|||
23601893|NCT01105975|65933932|FG008|Overall Study|Physician Decision|0|||
23601894|NCT01105975|65933933|FG009|Overall Study|Physician Decision|0|||
23601895|NCT01105975|65933924|FG000|Overall Study|Protocol Violation|0|||
23601896|NCT01105975|65933925|FG001|Overall Study|Protocol Violation|2|||
23601897|NCT01105975|65933926|FG002|Overall Study|Protocol Violation|2|||
23601898|NCT01105975|65933927|FG003|Overall Study|Protocol Violation|0|||
23601899|NCT01105975|65933928|FG004|Overall Study|Protocol Violation|1|||
23601900|NCT01105975|65933929|FG005|Overall Study|Protocol Violation|1|||
23601901|NCT01105975|65933930|FG006|Overall Study|Protocol Violation|1|||
23601902|NCT01105975|65933931|FG007|Overall Study|Protocol Violation|1|||
23601903|NCT01105975|65933932|FG008|Overall Study|Protocol Violation|2|||
23601904|NCT01105975|65933933|FG009|Overall Study|Protocol Violation|2|||
23601905|NCT01105975|65933924|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601906|NCT01105975|65933925|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601907|NCT01105975|65933926|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601908|NCT01105975|65933927|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601909|NCT01105975|65933928|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601910|NCT01105975|65933929|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
23601911|NCT01105975|65933930|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601912|NCT01105975|65933931|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601913|NCT01105975|65933932|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
23601914|NCT01105975|65933933|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601915|NCT03476798|65933939|FG000|Overall Study|Death|1|||
23601916|NCT03476798|65933939|FG000|Overall Study|Withdrawal by Subject|2|||
23601917|NCT03476798|65933939|FG000|Overall Study|Protocol Violation|2|||
23601918|NCT02597920|65933942|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23601919|NCT02597920|65933943|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23601920|NCT02597920|65933944|FG002|Overall Study|Worsening of other pre-existing disease|0|||
23366720|NCT01286129|65089023|FG001|Overall Study|Withdrawal by Subject|1|||
23366721|NCT01286129|65089022|FG000|Overall Study|Could not comply with study requirements|4|||
23366722|NCT01286129|65089023|FG001|Overall Study|Could not comply with study requirements|4|||
23366723|NCT03904420|65089024|FG000|Overall Study|Study terminated|2|||
23366724|NCT03904420|65089025|FG001|Overall Study|Study terminated|2|||
23366725|NCT01545388|65089026|FG000|Overall Study|Adverse Event|2|||
23366726|NCT01545388|65089027|FG001|Overall Study|Adverse Event|4|||
23660773|NCT02285920|66145652|FG001|Overall Study|Change to peritoneal dialysis|0|||
23660774|NCT02285920|66145653|FG002|Overall Study|Change to peritoneal dialysis|1|||
23660775|NCT02285920|66145654|FG003|Overall Study|Change to peritoneal dialysis|0|||
23660776|NCT02285920|66145651|FG000|Overall Study|Transfer to non-participating unit|0|||
23660777|NCT02285920|66145652|FG001|Overall Study|Transfer to non-participating unit|1|||
23660778|NCT02285920|66145653|FG002|Overall Study|Transfer to non-participating unit|0|||
23601921|NCT02597920|65933942|FG000|Overall Study|Other adverse event|20|||
23660779|NCT02285920|66145654|FG003|Overall Study|Transfer to non-participating unit|0|||
23660780|NCT02285920|66145651|FG000|Overall Study|Dialysis discontinuation|0|||
23660781|NCT02285920|66145652|FG001|Overall Study|Dialysis discontinuation|1|||
23366727|NCT01545388|65089028|FG002|Overall Study|Adverse Event|1|||
23366728|NCT01545388|65089026|FG000|Overall Study|Lack of Efficacy|3|||
23601922|NCT02597920|65933943|FG001|Overall Study|Other adverse event|30|||
23601923|NCT02597920|65933944|FG002|Overall Study|Other adverse event|0|||
23601924|NCT02597920|65933942|FG000|Overall Study|Lost to Follow-up|7|||
23601925|NCT02597920|65933943|FG001|Overall Study|Lost to Follow-up|9|||
23601926|NCT02597920|65933944|FG002|Overall Study|Lost to Follow-up|0|||
23601927|NCT02597920|65933942|FG000|Overall Study|Refuse to continue in the study|3|||
23601928|NCT02597920|65933943|FG001|Overall Study|Refuse to continue in the study|13|||
23601929|NCT02597920|65933944|FG002|Overall Study|Refuse to continue in the study|1|||
23601930|NCT02597920|65933942|FG000|Overall Study|Other than specified|10|||
23601931|NCT02597920|65933943|FG001|Overall Study|Other than specified|31|||
23601932|NCT02597920|65933944|FG002|Overall Study|Other than specified|5|||
23601933|NCT02597920|65933942|FG000|Overall Study|Other|1|||
23601934|NCT02597920|65933943|FG001|Overall Study|Other|0|||
23660782|NCT02285920|66145653|FG002|Overall Study|Dialysis discontinuation|0|||
23601935|NCT02597920|65933944|FG002|Overall Study|Other|0|||
23601936|NCT01171976|65933945|FG000|Overall Study|Protocol Violation|0|||
23660783|NCT02285920|66145654|FG003|Overall Study|Dialysis discontinuation|0|||
23660784|NCT02285920|66145651|FG000|Overall Study|Death|2|||
23660785|NCT02285920|66145652|FG001|Overall Study|Death|0|||
23660786|NCT02285920|66145653|FG002|Overall Study|Death|2|||
23660787|NCT02285920|66145654|FG003|Overall Study|Death|1|||
23660788|NCT00445224|66145656|FG000|Specific Exercises|Withdrawal by Subject|3|||
23660789|NCT00445224|66145657|FG001|Specific Exercises|Withdrawal by Subject|3|||
23660790|NCT00445224|66145656|FG000|Specific Exercises|Withdrawal by Subject|1|||
23366729|NCT01545388|65089027|FG001|Overall Study|Lack of Efficacy|2|||
23366730|NCT01545388|65089028|FG002|Overall Study|Lack of Efficacy|5|||
23366731|NCT01545388|65089026|FG000|Overall Study|Participant moved or relocated|1|||
23366732|NCT01545388|65089027|FG001|Overall Study|Participant moved or relocated|0|||
23366733|NCT01545388|65089028|FG002|Overall Study|Participant moved or relocated|0|||
23366734|NCT01545388|65089026|FG000|Overall Study|Withdrawal by Subject|1|||
23366735|NCT01545388|65089027|FG001|Overall Study|Withdrawal by Subject|4|||
23366736|NCT01545388|65089028|FG002|Overall Study|Withdrawal by Subject|2|||
23366737|NCT01545388|65089026|FG000|Overall Study|Other|1|||
23366738|NCT01545388|65089027|FG001|Overall Study|Other|1|||
23366739|NCT01545388|65089028|FG002|Overall Study|Other|0|||
23366740|NCT02515630|65089029|FG000|Overall Study|Withdrawal by Subject|5|||
23660791|NCT00445224|66145657|FG001|Specific Exercises|Withdrawal by Subject|0|||
23660792|NCT01671111|66145659|FG000|Overall Study|Adverse Event|2|||
23366741|NCT02515630|65089029|FG000|Overall Study|Adverse Event|4|||
23366742|NCT02515630|65089029|FG000|Overall Study|Physician Decision|4|||
23366743|NCT02515630|65089029|FG000|Overall Study|Death|2|||
23366744|NCT02515630|65089029|FG000|Overall Study|Disease Progression|1|||
23366745|NCT05117060|65089030|FG000|Overall Study|Adverse Event|3|||
23366746|NCT05117060|65089031|FG001|Overall Study|Adverse Event|5|||
23366747|NCT05117060|65089032|FG002|Overall Study|Adverse Event|6|||
23366748|NCT05117060|65089033|FG003|Overall Study|Adverse Event|1|||
23366749|NCT05117060|65089030|FG000|Overall Study|Lost to Follow-up|0|||
23366750|NCT05117060|65089031|FG001|Overall Study|Lost to Follow-up|0|||
23366751|NCT05117060|65089032|FG002|Overall Study|Lost to Follow-up|0|||
23366752|NCT05117060|65089033|FG003|Overall Study|Lost to Follow-up|1|||
23483461|NCT01390220|65513061|FG000|Test Dose Phase|Logistical|6|||
23483462|NCT01390220|65513062|FG001|Test Dose Phase|Logistical|0|||
23483463|NCT01390220|65513063|FG002|Test Dose Phase|Logistical|0|||
23483464|NCT01390220|65513061|FG000|Comparative Phase|Withdrawal by Subject|0|||
23483465|NCT01390220|65513062|FG001|Comparative Phase|Withdrawal by Subject|1|||
23483466|NCT01390220|65513063|FG002|Comparative Phase|Withdrawal by Subject|0|||
23483467|NCT02793128|65513064|FG000|Overall Study|Death|4|||
23483468|NCT02793128|65513064|FG000|Overall Study|Withdrawal by Subject|2|||
23483469|NCT02793128|65513064|FG000|Overall Study|Physician Decision|1|||
23483470|NCT02793128|65513064|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
23483471|NCT02793128|65513064|FG000|Overall Study|Patient elected nephroureterectomy|1|||
23483472|NCT01916967|65513066|FG000|Overall Study|Adverse Event|0|||
23483473|NCT01916967|65513067|FG001|Overall Study|Adverse Event|0|||
23483474|NCT01916967|65513068|FG002|Overall Study|Adverse Event|2|||
23601937|NCT01171976|65933946|FG001|Overall Study|Protocol Violation|0|||
23601938|NCT01171976|65933947|FG002|Overall Study|Protocol Violation|1|||
23601939|NCT01171976|65933945|FG000|Overall Study|Death|2|||
23601940|NCT01171976|65933946|FG001|Overall Study|Death|4|||
23601941|NCT01171976|65933947|FG002|Overall Study|Death|1|||
23601942|NCT01171976|65933945|FG000|Overall Study|Lost to Follow-up|4|||
23601943|NCT01171976|65933946|FG001|Overall Study|Lost to Follow-up|0|||
23601944|NCT01171976|65933947|FG002|Overall Study|Lost to Follow-up|2|||
23601945|NCT01171976|65933945|FG000|Overall Study|Withdrawal by Subject|1|||
23601946|NCT01171976|65933946|FG001|Overall Study|Withdrawal by Subject|5|||
23601947|NCT01171976|65933947|FG002|Overall Study|Withdrawal by Subject|6|||
23601948|NCT01171976|65933945|FG000|Overall Study|Abnormal test result|1|||
23660793|NCT01671111|66145659|FG000|Overall Study|Lack of Efficacy|1|||
23660794|NCT01671111|66145659|FG000|Overall Study|Withdrawal by Subject|2|||
23660795|NCT01671111|66145659|FG000|Overall Study|Physician Decision|1|||
23660796|NCT01671111|66145659|FG000|Overall Study|Other|24|||
23660797|NCT01830855|66145667|FG000|Overall Study|Other|7|||
23660798|NCT01830855|66145668|FG001|Overall Study|Other|1|||
23660799|NCT01830855|66145669|FG002|Overall Study|Other|4|||
23660800|NCT01830855|66145670|FG003|Overall Study|Other|4|||
23366753|NCT05117060|65089030|FG000|Overall Study|Lack of Efficacy|4|||
23366754|NCT05117060|65089031|FG001|Overall Study|Lack of Efficacy|5|||
23366755|NCT05117060|65089032|FG002|Overall Study|Lack of Efficacy|2|||
23366756|NCT05117060|65089033|FG003|Overall Study|Lack of Efficacy|6|||
23483475|NCT01916967|65513066|FG000|Overall Study|Lack of Efficacy|0|||
23483476|NCT01916967|65513067|FG001|Overall Study|Lack of Efficacy|0|||
23366757|NCT05117060|65089030|FG000|Overall Study|Withdrawal by Subject|8|||
23366758|NCT05117060|65089031|FG001|Overall Study|Withdrawal by Subject|5|||
23483477|NCT01916967|65513068|FG002|Overall Study|Lack of Efficacy|6|||
23601949|NCT01171976|65933946|FG001|Overall Study|Abnormal test result|0|||
23601950|NCT01171976|65933947|FG002|Overall Study|Abnormal test result|0|||
23660801|NCT01830855|66145667|FG000|Overall Study|Medication error without associated AE|1|||
23601951|NCT01171976|65933945|FG000|Overall Study|Adverse Event|6|||
23601952|NCT01171976|65933946|FG001|Overall Study|Adverse Event|2|||
23483478|NCT01916967|65513066|FG000|Overall Study|Physician Decision|0|||
23483479|NCT01916967|65513067|FG001|Overall Study|Physician Decision|0|||
23483480|NCT01916967|65513068|FG002|Overall Study|Physician Decision|1|||
23483481|NCT01916967|65513066|FG000|Overall Study|Protocol Violation|0|||
23483482|NCT01916967|65513067|FG001|Overall Study|Protocol Violation|1|||
23483483|NCT01916967|65513068|FG002|Overall Study|Protocol Violation|0|||
23483484|NCT01606878|65513069|FG000|Overall Study|Adverse Event|1|||
23483485|NCT01606878|65513070|FG001|Overall Study|Adverse Event|1|||
23483486|NCT01606878|65513071|FG002|Overall Study|Adverse Event|0|||
23483487|NCT01606878|65513072|FG003|Overall Study|Adverse Event|0|||
23483488|NCT01606878|65513073|FG004|Overall Study|Adverse Event|0|||
23483489|NCT01606878|65513074|FG005|Overall Study|Adverse Event|0|||
23483490|NCT01606878|65513075|FG006|Overall Study|Adverse Event|1|||
23483491|NCT01606878|65513076|FG007|Overall Study|Adverse Event|0|||
23483492|NCT01606878|65513077|FG008|Overall Study|Adverse Event|1|||
23483493|NCT01606878|65513078|FG009|Overall Study|Adverse Event|3|||
23483494|NCT01606878|65513079|FG010|Overall Study|Adverse Event|0|||
23483495|NCT01606878|65513069|FG000|Overall Study|Lack of Efficacy|1|||
23483496|NCT01606878|65513070|FG001|Overall Study|Lack of Efficacy|1|||
23483497|NCT01606878|65513071|FG002|Overall Study|Lack of Efficacy|1|||
23483498|NCT01606878|65513072|FG003|Overall Study|Lack of Efficacy|2|||
23601953|NCT01171976|65933947|FG002|Overall Study|Adverse Event|5|||
23601954|NCT00512252|65933949|FG000|Overall Study|Lost to Follow-up|0|||
23601955|NCT00512252|65933950|FG001|Overall Study|Lost to Follow-up|0|||
23601956|NCT00512252|65933951|FG002|Overall Study|Lost to Follow-up|1|||
23601957|NCT00512252|65933949|FG000|Overall Study|Protocol Violation|0|||
23601958|NCT00512252|65933950|FG001|Overall Study|Protocol Violation|0|||
23601959|NCT00512252|65933951|FG002|Overall Study|Protocol Violation|1|||
23601960|NCT00512252|65933949|FG000|Overall Study|Death|0|||
23601961|NCT00512252|65933950|FG001|Overall Study|Death|0|||
23601962|NCT00512252|65933951|FG002|Overall Study|Death|1|||
23601963|NCT01359150|65933954|FG000|Overall Study|Lack of Efficacy|1|||
23601964|NCT01359150|65933955|FG001|Overall Study|Lack of Efficacy|1|||
23601965|NCT01359150|65933954|FG000|Overall Study|Withdrawal by Subject|1|||
23601966|NCT01359150|65933955|FG001|Overall Study|Withdrawal by Subject|1|||
23601967|NCT01359150|65933954|FG000|Overall Study|Adverse Event|4|||
23601968|NCT01359150|65933955|FG001|Overall Study|Adverse Event|3|||
23601969|NCT01359150|65933954|FG000|Overall Study|Other|1|||
23601970|NCT01359150|65933955|FG001|Overall Study|Other|0|||
23601971|NCT01091168|65933960|FG000|Overall Study|Progressive disease|250|||
23601972|NCT01091168|65933961|FG001|Overall Study|Progressive disease|234|||
23601973|NCT01091168|65933960|FG000|Overall Study|Adverse Event|21|||
23601974|NCT01091168|65933961|FG001|Overall Study|Adverse Event|24|||
23601975|NCT01091168|65933960|FG000|Overall Study|Lost to Follow-up|0|||
23601976|NCT01091168|65933961|FG001|Overall Study|Lost to Follow-up|1|||
23601977|NCT01091168|65933960|FG000|Overall Study|Physician, patient's decision, other|27|||
23601978|NCT01091168|65933961|FG001|Overall Study|Physician, patient's decision, other|37|||
23601979|NCT03567616|65933964|FG000|Overall Study|Disease progression|4|||
23601980|NCT03567616|65933964|FG000|Overall Study|Withdrawal by Subject|1|||
23601981|NCT03567616|65933964|FG000|Overall Study|Physician Decision|1|||
23601982|NCT03567616|65933964|FG000|Overall Study|Death|1|||
23601983|NCT03567616|65933964|FG000|Overall Study|Adverse Event|1|||
23601984|NCT00895245|65933965|FG000|Overall Study|Lack of Efficacy|6|||
23601985|NCT02988713|65933966|FG000|Overall Study|Withdrawal by Subject|1|||
23601986|NCT02988713|65933966|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
23483499|NCT01606878|65513073|FG004|Overall Study|Lack of Efficacy|1|||
23483500|NCT01606878|65513074|FG005|Overall Study|Lack of Efficacy|2|||
23483501|NCT01606878|65513075|FG006|Overall Study|Lack of Efficacy|1|||
23601987|NCT00582972|65933967|FG000|Overall Study|Protocol Violation|2|||
23601988|NCT02159352|65933969|FG000|Overall Study|Adverse Event|3|||
23601989|NCT02159352|65933970|FG001|Overall Study|Adverse Event|1|||
23601990|NCT02159352|65933969|FG000|Overall Study|Withdrawal by Subject|0|||
23601991|NCT02159352|65933970|FG001|Overall Study|Withdrawal by Subject|1|||
23601992|NCT00989196|65933971|FG000|Treatment Period|Lost to Follow-up|1|||
23483502|NCT01606878|65513076|FG007|Overall Study|Lack of Efficacy|2|||
23483503|NCT01606878|65513077|FG008|Overall Study|Lack of Efficacy|2|||
23483504|NCT01606878|65513078|FG009|Overall Study|Lack of Efficacy|0|||
23483505|NCT01606878|65513079|FG010|Overall Study|Lack of Efficacy|1|||
23483506|NCT01606878|65513069|FG000|Overall Study|Physician Decision|1|||
23483507|NCT01606878|65513070|FG001|Overall Study|Physician Decision|0|||
23483508|NCT01606878|65513071|FG002|Overall Study|Physician Decision|2|||
23483509|NCT01606878|65513072|FG003|Overall Study|Physician Decision|1|||
23483510|NCT01606878|65513073|FG004|Overall Study|Physician Decision|1|||
23483511|NCT01606878|65513074|FG005|Overall Study|Physician Decision|1|||
23483512|NCT01606878|65513075|FG006|Overall Study|Physician Decision|2|||
23483513|NCT01606878|65513076|FG007|Overall Study|Physician Decision|0|||
23483514|NCT01606878|65513077|FG008|Overall Study|Physician Decision|1|||
23483515|NCT01606878|65513078|FG009|Overall Study|Physician Decision|0|||
23483516|NCT01606878|65513079|FG010|Overall Study|Physician Decision|0|||
23483517|NCT01606878|65513069|FG000|Overall Study|Withdrawal by Subject|3|||
23483518|NCT01606878|65513070|FG001|Overall Study|Withdrawal by Subject|2|||
23483519|NCT01606878|65513071|FG002|Overall Study|Withdrawal by Subject|2|||
23483520|NCT01606878|65513072|FG003|Overall Study|Withdrawal by Subject|0|||
23483521|NCT01606878|65513073|FG004|Overall Study|Withdrawal by Subject|1|||
23483522|NCT01606878|65513074|FG005|Overall Study|Withdrawal by Subject|1|||
23483523|NCT01606878|65513075|FG006|Overall Study|Withdrawal by Subject|2|||
23483524|NCT01606878|65513076|FG007|Overall Study|Withdrawal by Subject|1|||
23483525|NCT01606878|65513077|FG008|Overall Study|Withdrawal by Subject|2|||
23483526|NCT01606878|65513078|FG009|Overall Study|Withdrawal by Subject|0|||
23483527|NCT01606878|65513079|FG010|Overall Study|Withdrawal by Subject|2|||
23483528|NCT00924170|65513080|FG000|Overall Study|Refused further treatment|0|||
23483529|NCT00924170|65513081|FG001|Overall Study|Refused further treatment|1|||
23483530|NCT00924170|65513080|FG000|Overall Study|Physician Decision|0|||
23483531|NCT00924170|65513081|FG001|Overall Study|Physician Decision|1|||
23483532|NCT00924170|65513080|FG000|Overall Study|Progressive disease|3|||
23483533|NCT00924170|65513081|FG001|Overall Study|Progressive disease|6|||
23483534|NCT00924170|65513080|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
23483535|NCT00924170|65513081|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
23483536|NCT00924170|65513080|FG000|Overall Study|Death|1|||
23483537|NCT00924170|65513081|FG001|Overall Study|Death|0|||
23483538|NCT03560739|65513087|FG000|Overall Study|Adverse Event|0|||
23483539|NCT03560739|65513088|FG001|Overall Study|Adverse Event|1|||
23483540|NCT03560739|65513089|FG002|Overall Study|Adverse Event|0|||
23483541|NCT03560739|65513090|FG003|Overall Study|Adverse Event|0|||
23483542|NCT01362595|65513093|FG000|Overall Study|Screen failure|10|||
23483543|NCT01362595|65513093|FG000|Overall Study|Withdrawal by Subject|2|||
23601993|NCT00989196|65933972|FG001|Treatment Period|Lost to Follow-up|0|||
23660802|NCT01830855|66145668|FG001|Overall Study|Medication error without associated AE|0|||
23483544|NCT00821327|65513098|FG000|Overall Study|Adverse Event|13|||
23483545|NCT00821327|65513098|FG000|Overall Study|Patient Request|1|||
23483546|NCT00821327|65513098|FG000|Overall Study|Investigator Request|2|||
23483547|NCT00821327|65513098|FG000|Overall Study|Sponsor Request|1|||
23483548|NCT00821327|65513098|FG000|Overall Study|Disease Progression|13|||
23601994|NCT03488719|65933973|FG000|Overall Study|Adverse Event|0|||
23483549|NCT00821327|65513098|FG000|Overall Study|Other/Unknown|5|||
23483550|NCT01736657|65513099|FG000|Overall Study|insufficient vascular access|1|||
23483551|NCT01445886|65513103|FG000|Overall Study|Lost to Follow-up|2|||
23483552|NCT01445886|65513103|FG000|Overall Study|Protocol Violation|3|||
23483553|NCT03442764|65513104|FG000|Overall Study|Adverse Event|1|||
23483554|NCT03442764|65513105|FG001|Overall Study|Adverse Event|0|||
23483555|NCT03442764|65513106|FG002|Overall Study|Adverse Event|0|||
23366759|NCT05117060|65089032|FG002|Overall Study|Withdrawal by Subject|5|||
23366760|NCT05117060|65089033|FG003|Overall Study|Withdrawal by Subject|6|||
23366761|NCT05117060|65089030|FG000|Overall Study|Other|2|||
23366762|NCT05117060|65089031|FG001|Overall Study|Other|1|||
23366763|NCT05117060|65089032|FG002|Overall Study|Other|3|||
23366764|NCT05117060|65089033|FG003|Overall Study|Other|1|||
23366765|NCT00297648|65089034|FG000|Overall Study|Adverse Event|13|||
23366766|NCT00297648|65089034|FG000|Overall Study|Lack of Efficacy|18|||
23366767|NCT00297648|65089034|FG000|Overall Study|Lost to Follow-up|1|||
23366768|NCT00297648|65089034|FG000|Overall Study|Withdrawal by Subject|3|||
23366769|NCT00297648|65089034|FG000|Overall Study|Other: Incompliance|1|||
23366770|NCT02062437|65089039|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
23366771|NCT02062437|65089039|FG000|Overall Study|Patient not available for the 2y visit|18|||
23366772|NCT02062437|65089039|FG000|Overall Study|Death|2|||
23601995|NCT03488719|65933974|FG001|Overall Study|Adverse Event|4|||
23601996|NCT03488719|65933975|FG002|Overall Study|Adverse Event|2|||
23601997|NCT03488719|65933973|FG000|Overall Study|Other|0|||
23601998|NCT03488719|65933974|FG001|Overall Study|Other|0|||
23601999|NCT03488719|65933975|FG002|Overall Study|Other|5|||
23602000|NCT02874534|65933983|FG000|Overall Study|Withdrawal by Subject|5|||
23602001|NCT02874534|65933984|FG001|Overall Study|Withdrawal by Subject|8|||
23602002|NCT02874534|65933983|FG000|Overall Study|Lost to Follow-up|2|||
23366773|NCT02062437|65089039|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
23366774|NCT01656395|65089046|FG000|Overall Study|Adverse Event|1|||
23366775|NCT01656395|65089047|FG001|Overall Study|Adverse Event|14|||
23366776|NCT01656395|65089048|FG002|Overall Study|Adverse Event|5|||
23366777|NCT01656395|65089049|FG003|Overall Study|Adverse Event|4|||
23366778|NCT01656395|65089050|FG004|Overall Study|Adverse Event|5|||
23366779|NCT01656395|65089051|FG005|Overall Study|Adverse Event|7|||
23366780|NCT01656395|65089052|FG006|Overall Study|Adverse Event|0|||
23366781|NCT01656395|65089053|FG007|Overall Study|Adverse Event|0|||
23602003|NCT02874534|65933984|FG001|Overall Study|Lost to Follow-up|2|||
23602004|NCT02874534|65933983|FG000|Overall Study|Ongoing in study|1|||
23602005|NCT02874534|65933984|FG001|Overall Study|Ongoing in study|1|||
23660803|NCT01830855|66145669|FG002|Overall Study|Medication error without associated AE|0|||
23660804|NCT01830855|66145670|FG003|Overall Study|Medication error without associated AE|1|||
23366782|NCT01656395|65089046|FG000|Overall Study|Lack of Efficacy|1|||
23366783|NCT01656395|65089047|FG001|Overall Study|Lack of Efficacy|8|||
23366784|NCT01656395|65089048|FG002|Overall Study|Lack of Efficacy|6|||
23366785|NCT01656395|65089049|FG003|Overall Study|Lack of Efficacy|1|||
23366786|NCT01656395|65089050|FG004|Overall Study|Lack of Efficacy|1|||
23366787|NCT01656395|65089051|FG005|Overall Study|Lack of Efficacy|6|||
23602006|NCT01307800|65933988|FG000|Overall Study|Adverse Event|9|||
23366788|NCT01656395|65089052|FG006|Overall Study|Lack of Efficacy|0|||
23602007|NCT01307800|65933989|FG001|Overall Study|Adverse Event|8|||
23366789|NCT01656395|65089053|FG007|Overall Study|Lack of Efficacy|0|||
23366790|NCT01656395|65089046|FG000|Overall Study|Lost to Follow-up|1|||
23366791|NCT01656395|65089047|FG001|Overall Study|Lost to Follow-up|0|||
23366792|NCT01656395|65089048|FG002|Overall Study|Lost to Follow-up|0|||
23366793|NCT01656395|65089049|FG003|Overall Study|Lost to Follow-up|0|||
23366794|NCT01656395|65089050|FG004|Overall Study|Lost to Follow-up|0|||
23366795|NCT01656395|65089051|FG005|Overall Study|Lost to Follow-up|0|||
23366796|NCT01656395|65089052|FG006|Overall Study|Lost to Follow-up|0|||
23366797|NCT01656395|65089053|FG007|Overall Study|Lost to Follow-up|0|||
23366798|NCT01656395|65089046|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23483556|NCT00366340|65513107|FG000|Infant Series|Protocol Violation|3|||
23483557|NCT00366340|65513108|FG001|Infant Series|Protocol Violation|4|||
23483558|NCT00366340|65513107|FG000|Infant Series|Withdrawal by Subject|3|||
23483559|NCT00366340|65513108|FG001|Infant Series|Withdrawal by Subject|3|||
23602008|NCT01307800|65933990|FG002|Overall Study|Adverse Event|10|||
23602009|NCT01307800|65933991|FG003|Overall Study|Adverse Event|14|||
23602010|NCT01307800|65933988|FG000|Overall Study|Entry Criteria Not Met|0|||
23602011|NCT01307800|65933989|FG001|Overall Study|Entry Criteria Not Met|0|||
23602012|NCT01307800|65933990|FG002|Overall Study|Entry Criteria Not Met|0|||
23602013|NCT01307800|65933991|FG003|Overall Study|Entry Criteria Not Met|2|||
23602014|NCT01307800|65933988|FG000|Overall Study|Lost to Follow-up|5|||
23602015|NCT01307800|65933989|FG001|Overall Study|Lost to Follow-up|6|||
23602016|NCT01307800|65933990|FG002|Overall Study|Lost to Follow-up|2|||
23602017|NCT01307800|65933991|FG003|Overall Study|Lost to Follow-up|8|||
23602018|NCT01307800|65933988|FG000|Overall Study|Perceived Lack of Efficacy|24|||
23602019|NCT01307800|65933989|FG001|Overall Study|Perceived Lack of Efficacy|23|||
23602020|NCT01307800|65933990|FG002|Overall Study|Perceived Lack of Efficacy|20|||
23602021|NCT01307800|65933991|FG003|Overall Study|Perceived Lack of Efficacy|33|||
23602022|NCT01307800|65933988|FG000|Overall Study|Protocol Violation|0|||
23602023|NCT01307800|65933989|FG001|Overall Study|Protocol Violation|3|||
23602024|NCT01307800|65933990|FG002|Overall Study|Protocol Violation|4|||
23602025|NCT01307800|65933991|FG003|Overall Study|Protocol Violation|5|||
23602026|NCT01307800|65933988|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
23602027|NCT01307800|65933989|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
23602028|NCT01307800|65933990|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
23602029|NCT01307800|65933991|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
23602030|NCT01307800|65933988|FG000|Overall Study|Sponsor Decision|6|||
23602031|NCT01307800|65933989|FG001|Overall Study|Sponsor Decision|9|||
23602032|NCT01307800|65933990|FG002|Overall Study|Sponsor Decision|12|||
23602033|NCT01307800|65933991|FG003|Overall Study|Sponsor Decision|28|||
23602034|NCT01307800|65933988|FG000|Overall Study|Withdrawal by Subject|10|||
23602035|NCT01307800|65933989|FG001|Overall Study|Withdrawal by Subject|11|||
23602036|NCT01307800|65933990|FG002|Overall Study|Withdrawal by Subject|8|||
23602037|NCT01307800|65933991|FG003|Overall Study|Withdrawal by Subject|15|||
23602038|NCT01307800|65933988|FG000|Overall Study|Participant Moved|0|||
23602039|NCT01307800|65933989|FG001|Overall Study|Participant Moved|2|||
23660805|NCT01830855|66145667|FG000|Overall Study|Pregnancy|3|||
23660806|NCT01830855|66145668|FG001|Overall Study|Pregnancy|1|||
23602040|NCT01307800|65933990|FG002|Overall Study|Participant Moved|1|||
23602041|NCT01307800|65933991|FG003|Overall Study|Participant Moved|3|||
23660807|NCT01830855|66145669|FG002|Overall Study|Pregnancy|2|||
23366799|NCT01656395|65089047|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23366800|NCT01656395|65089048|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23366801|NCT01656395|65089049|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23483560|NCT00366340|65513107|FG000|Infant Series|Adverse Event|0|||
23602042|NCT01561300|65933992|FG000|Run in on Placebo|Adverse Event|1|||
23602043|NCT01561300|65933993|FG001|Run in on Placebo|Adverse Event|0|||
23602044|NCT00734578|65933994|FG000|Overall Study|Adverse Event|4|||
23660808|NCT01830855|66145670|FG003|Overall Study|Pregnancy|1|||
23366802|NCT01656395|65089050|FG004|Overall Study|Non-Compliance with Study Drug|1|||
23366803|NCT01656395|65089051|FG005|Overall Study|Non-Compliance with Study Drug|1|||
23366804|NCT01656395|65089052|FG006|Overall Study|Non-Compliance with Study Drug|0|||
23366805|NCT01656395|65089053|FG007|Overall Study|Non-Compliance with Study Drug|0|||
23366806|NCT01656395|65089046|FG000|Overall Study|Other|0|||
23366807|NCT01656395|65089047|FG001|Overall Study|Other|0|||
23366808|NCT01656395|65089048|FG002|Overall Study|Other|1|||
23366809|NCT01656395|65089049|FG003|Overall Study|Other|0|||
23366810|NCT01656395|65089050|FG004|Overall Study|Other|0|||
23366811|NCT01656395|65089051|FG005|Overall Study|Other|1|||
23366812|NCT01656395|65089052|FG006|Overall Study|Other|0|||
23366813|NCT01656395|65089053|FG007|Overall Study|Other|0|||
23366814|NCT01656395|65089046|FG000|Overall Study|Physician Decision|2|||
23366815|NCT01656395|65089047|FG001|Overall Study|Physician Decision|3|||
23366816|NCT01656395|65089048|FG002|Overall Study|Physician Decision|3|||
23366817|NCT01656395|65089049|FG003|Overall Study|Physician Decision|2|||
23366818|NCT01656395|65089050|FG004|Overall Study|Physician Decision|3|||
23366819|NCT01656395|65089051|FG005|Overall Study|Physician Decision|3|||
23366820|NCT01656395|65089052|FG006|Overall Study|Physician Decision|0|||
23366821|NCT01656395|65089053|FG007|Overall Study|Physician Decision|0|||
23366822|NCT01656395|65089046|FG000|Overall Study|Pregnancy|0|||
23366823|NCT01656395|65089047|FG001|Overall Study|Pregnancy|0|||
23366824|NCT01656395|65089048|FG002|Overall Study|Pregnancy|1|||
23366825|NCT01656395|65089049|FG003|Overall Study|Pregnancy|0|||
23366826|NCT01656395|65089050|FG004|Overall Study|Pregnancy|0|||
23366827|NCT01656395|65089051|FG005|Overall Study|Pregnancy|0|||
23660809|NCT01830855|66145667|FG000|Overall Study|No longer meets eligibility criteria|11|||
23660810|NCT01830855|66145668|FG001|Overall Study|No longer meets eligibility criteria|2|||
23660811|NCT01830855|66145669|FG002|Overall Study|No longer meets eligibility criteria|3|||
23660812|NCT01830855|66145670|FG003|Overall Study|No longer meets eligibility criteria|5|||
23660813|NCT01830855|66145667|FG000|Overall Study|Adverse Event|11|||
23660814|NCT01830855|66145668|FG001|Overall Study|Adverse Event|5|||
23660815|NCT01830855|66145669|FG002|Overall Study|Adverse Event|6|||
23660816|NCT01830855|66145670|FG003|Overall Study|Adverse Event|3|||
23366828|NCT01656395|65089052|FG006|Overall Study|Pregnancy|0|||
23366829|NCT01656395|65089053|FG007|Overall Study|Pregnancy|0|||
23366830|NCT01656395|65089046|FG000|Overall Study|Progressive Disease|0|||
23366831|NCT01656395|65089047|FG001|Overall Study|Progressive Disease|0|||
23366832|NCT01656395|65089048|FG002|Overall Study|Progressive Disease|0|||
23366833|NCT01656395|65089049|FG003|Overall Study|Progressive Disease|0|||
23366834|NCT01656395|65089050|FG004|Overall Study|Progressive Disease|0|||
23366835|NCT01656395|65089051|FG005|Overall Study|Progressive Disease|1|||
23366836|NCT01656395|65089052|FG006|Overall Study|Progressive Disease|0|||
23366837|NCT01656395|65089053|FG007|Overall Study|Progressive Disease|0|||
23366838|NCT01656395|65089046|FG000|Overall Study|Protocol Violation|6|||
23366839|NCT01656395|65089047|FG001|Overall Study|Protocol Violation|6|||
23366840|NCT01656395|65089048|FG002|Overall Study|Protocol Violation|9|||
23366841|NCT01656395|65089049|FG003|Overall Study|Protocol Violation|2|||
23366842|NCT01656395|65089050|FG004|Overall Study|Protocol Violation|4|||
23366843|NCT01656395|65089051|FG005|Overall Study|Protocol Violation|10|||
23366844|NCT01656395|65089052|FG006|Overall Study|Protocol Violation|0|||
23366845|NCT01656395|65089053|FG007|Overall Study|Protocol Violation|0|||
23366846|NCT01656395|65089046|FG000|Overall Study|Screen Failure|2|||
23366847|NCT01656395|65089047|FG001|Overall Study|Screen Failure|1|||
23366848|NCT01656395|65089048|FG002|Overall Study|Screen Failure|7|||
23366849|NCT01656395|65089049|FG003|Overall Study|Screen Failure|1|||
23366850|NCT01656395|65089050|FG004|Overall Study|Screen Failure|0|||
23366851|NCT01656395|65089051|FG005|Overall Study|Screen Failure|8|||
23366852|NCT01656395|65089052|FG006|Overall Study|Screen Failure|0|||
23366853|NCT01656395|65089053|FG007|Overall Study|Screen Failure|0|||
23366854|NCT01656395|65089046|FG000|Overall Study|Withdrawal by Subject|3|||
23366855|NCT01656395|65089047|FG001|Overall Study|Withdrawal by Subject|1|||
23366856|NCT01656395|65089048|FG002|Overall Study|Withdrawal by Subject|4|||
23366857|NCT01656395|65089049|FG003|Overall Study|Withdrawal by Subject|2|||
23366858|NCT01656395|65089050|FG004|Overall Study|Withdrawal by Subject|0|||
23366859|NCT01656395|65089051|FG005|Overall Study|Withdrawal by Subject|3|||
23366860|NCT01656395|65089052|FG006|Overall Study|Withdrawal by Subject|0|||
23366861|NCT01656395|65089053|FG007|Overall Study|Withdrawal by Subject|0|||
23366862|NCT05222880|65089054|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23366863|NCT05222880|65089054|FG000|Overall Study|Withdrew Consent during Study|1|||
23366864|NCT05222880|65089054|FG000|Overall Study|COVID-19 Related|1|||
23366865|NCT02662569|65089055|FG000|Overall Study|Withdrawal by Subject|6|||
23366866|NCT02662569|65089056|FG001|Overall Study|Withdrawal by Subject|1|||
23366867|NCT02662569|65089057|FG002|Overall Study|Withdrawal by Subject|6|||
23366868|NCT02662569|65089058|FG003|Overall Study|Withdrawal by Subject|4|||
23366869|NCT02662569|65089055|FG000|Overall Study|Lost to Follow-up|1|||
23660817|NCT01830855|66145667|FG000|Overall Study|Protocol deviation|10|||
23660818|NCT01830855|66145668|FG001|Overall Study|Protocol deviation|5|||
23366870|NCT02662569|65089056|FG001|Overall Study|Lost to Follow-up|0|||
23366871|NCT02662569|65089057|FG002|Overall Study|Lost to Follow-up|0|||
23366872|NCT02662569|65089058|FG003|Overall Study|Lost to Follow-up|0|||
23366873|NCT01841970|65089059|FG000|Overall Study|Withdrawal by Subject|1|||
23366874|NCT01841970|65089059|FG000|Overall Study|Physician Decision|2|||
23366875|NCT01841970|65089059|FG000|Overall Study|Lost to Follow-up|8|||
23366876|NCT01526785|65089060|FG000|Overall Study|Study Terminated by Sponsor|8|||
23366877|NCT01526785|65089060|FG000|Overall Study|Death|2|||
23366878|NCT01526785|65089060|FG000|Overall Study|Physician Decision|1|||
23366879|NCT01526785|65089060|FG000|Overall Study|Withdrawal by Subject|2|||
23366880|NCT01093846|65089061|FG000|Overall Study|Adverse Event|0|||
23366881|NCT01093846|65089062|FG001|Overall Study|Adverse Event|0|||
23366882|NCT01093846|65089063|FG002|Overall Study|Adverse Event|1|||
23366883|NCT01093846|65089061|FG000|Overall Study|Lack of Efficacy|0|||
23366884|NCT01093846|65089062|FG001|Overall Study|Lack of Efficacy|0|||
23366885|NCT01093846|65089063|FG002|Overall Study|Lack of Efficacy|4|||
23366886|NCT01093846|65089061|FG000|Overall Study|Condition no longer required study drug|1|||
23366887|NCT01093846|65089062|FG001|Overall Study|Condition no longer required study drug|1|||
23366888|NCT01093846|65089063|FG002|Overall Study|Condition no longer required study drug|1|||
23366889|NCT01093846|65089061|FG000|Overall Study|Administrative Problems|18|||
23366890|NCT01093846|65089062|FG001|Overall Study|Administrative Problems|17|||
23366891|NCT01093846|65089063|FG002|Overall Study|Administrative Problems|15|||
23366892|NCT00095979|65089064|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
23366893|NCT02457195|65089067|FG000|Overall Study|Adverse Event|3|||
23366894|NCT02457195|65089067|FG000|Overall Study|Protocol Violation|2|||
23366895|NCT02457195|65089067|FG000|Overall Study|Withdrawal by Subject|4|||
23366896|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
23366897|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
23366898|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Death|561|||
23366899|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Death|298|||
23366900|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
23366901|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
23366902|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
23366903|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
23366904|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Other|1|||
23366905|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Other|0|||
23366906|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Death|14|||
23366907|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Death|21|||
23366908|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
23366909|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
23366910|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Other|15|||
23366911|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Other|2|||
23366912|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
23602045|NCT00734578|65933995|FG001|Overall Study|Adverse Event|6|||
23602046|NCT00734578|65933996|FG002|Overall Study|Adverse Event|1|||
23602047|NCT00734578|65933994|FG000|Overall Study|Protocol Violation|8|||
23602048|NCT00734578|65933995|FG001|Overall Study|Protocol Violation|6|||
23602049|NCT00734578|65933996|FG002|Overall Study|Protocol Violation|3|||
23660819|NCT01830855|66145669|FG002|Overall Study|Protocol deviation|6|||
23366913|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
23366914|NCT00305227|65089070|FG000|Overall Study|Lost to Follow-up|7|||
23366915|NCT00305227|65089071|FG001|Overall Study|Lost to Follow-up|6|||
23366916|NCT00113295|65089072|FG000|Overall Study|Adverse Event|4|||
23366917|NCT00113295|65089073|FG001|Overall Study|Adverse Event|1|||
23366918|NCT00113295|65089072|FG000|Overall Study|Unrelated Medical Illness|1|||
23366919|NCT00113295|65089073|FG001|Overall Study|Unrelated Medical Illness|0|||
23366920|NCT00230048|65089076|FG000|Overall Study|Lost to Follow-up|13|||
23366921|NCT00230048|65089077|FG001|Overall Study|Lost to Follow-up|18|||
23366922|NCT03713684|65089078|FG000|Overall Study|Adverse Event|1|||
23366923|NCT03713684|65089079|FG001|Overall Study|Adverse Event|3|||
23366924|NCT03713684|65089080|FG002|Overall Study|Adverse Event|1|||
23366925|NCT03713684|65089081|FG003|Overall Study|Adverse Event|0|||
23366926|NCT03713684|65089078|FG000|Overall Study|Poor compliance to protocol|2|||
23366927|NCT03713684|65089079|FG001|Overall Study|Poor compliance to protocol|1|||
23366928|NCT03713684|65089080|FG002|Overall Study|Poor compliance to protocol|0|||
23366929|NCT03713684|65089081|FG003|Overall Study|Poor compliance to protocol|1|||
23366930|NCT03713684|65089078|FG000|Overall Study|Withdrawal by Subject|14|||
23366931|NCT03713684|65089079|FG001|Overall Study|Withdrawal by Subject|6|||
23366932|NCT03713684|65089080|FG002|Overall Study|Withdrawal by Subject|14|||
23366933|NCT03713684|65089081|FG003|Overall Study|Withdrawal by Subject|16|||
23366934|NCT03713684|65089078|FG000|Overall Study|Other than specified|69|||
23366935|NCT03713684|65089079|FG001|Overall Study|Other than specified|77|||
23366936|NCT03713684|65089080|FG002|Overall Study|Other than specified|73|||
23366937|NCT03713684|65089081|FG003|Overall Study|Other than specified|70|||
23366938|NCT00909844|65089086|FG000|Overall Study|Adverse Event|1|||
23366939|NCT00909844|65089086|FG000|Overall Study|Withdrawal by Subject|1|||
23366940|NCT00909844|65089086|FG000|Overall Study|Lost to Follow-up|2|||
23366941|NCT00885118|65089087|FG000|Overall Study|Adverse Event|1|||
23366942|NCT00885118|65089088|FG001|Overall Study|Adverse Event|0|||
23366943|NCT00885118|65089089|FG002|Overall Study|Adverse Event|0|||
23366944|NCT00885118|65089090|FG003|Overall Study|Adverse Event|0|||
23366945|NCT00885118|65089091|FG004|Overall Study|Adverse Event|0|||
23366946|NCT00885118|65089087|FG000|Overall Study|Withdrawal by Subject|0|||
23366947|NCT00885118|65089088|FG001|Overall Study|Withdrawal by Subject|0|||
23366948|NCT00885118|65089089|FG002|Overall Study|Withdrawal by Subject|0|||
23366949|NCT00885118|65089090|FG003|Overall Study|Withdrawal by Subject|0|||
23366950|NCT00885118|65089091|FG004|Overall Study|Withdrawal by Subject|1|||
23366951|NCT00885118|65089087|FG000|Overall Study|Other reason not defined above|0|||
23366952|NCT00885118|65089088|FG001|Overall Study|Other reason not defined above|0|||
23366953|NCT00885118|65089089|FG002|Overall Study|Other reason not defined above|1|||
23366954|NCT00885118|65089090|FG003|Overall Study|Other reason not defined above|0|||
23366955|NCT00885118|65089091|FG004|Overall Study|Other reason not defined above|0|||
23366956|NCT00808067|65089092|FG000|Overall Study|Major/minor bleed|30|||
23366957|NCT00808067|65089093|FG001|Overall Study|Major/minor bleed|44|||
23366958|NCT00808067|65089092|FG000|Overall Study|Outcome event - other|33|||
23366959|NCT00808067|65089093|FG001|Overall Study|Outcome event - other|25|||
23366960|NCT00808067|65089092|FG000|Overall Study|Adverse Event|111|||
23602050|NCT00734578|65933994|FG000|Overall Study|Withdrawal by Subject|7|||
23366961|NCT00808067|65089093|FG001|Overall Study|Adverse Event|121|||
23366962|NCT00808067|65089092|FG000|Overall Study|Hospitalization (not including surgery)|18|||
23366963|NCT00808067|65089093|FG001|Overall Study|Hospitalization (not including surgery)|17|||
23366964|NCT00808067|65089092|FG000|Overall Study|Hospitalization due to surgery|37|||
23602051|NCT00734578|65933995|FG001|Overall Study|Withdrawal by Subject|8|||
23602052|NCT00734578|65933996|FG002|Overall Study|Withdrawal by Subject|11|||
23366965|NCT00808067|65089093|FG001|Overall Study|Hospitalization due to surgery|40|||
23366966|NCT00808067|65089092|FG000|Overall Study|Reduced creatinine clearance|53|||
23366967|NCT00808067|65089093|FG001|Overall Study|Reduced creatinine clearance|55|||
23366968|NCT00808067|65089092|FG000|Overall Study|Elevated LFT results|7|||
23366969|NCT00808067|65089093|FG001|Overall Study|Elevated LFT results|3|||
23366970|NCT00808067|65089092|FG000|Overall Study|Patient refused to take study medication|65|||
23366971|NCT00808067|65089093|FG001|Overall Study|Patient refused to take study medication|76|||
23366972|NCT00808067|65089092|FG000|Overall Study|Missing|1|||
23366973|NCT00808067|65089093|FG001|Overall Study|Missing|0|||
23366974|NCT00808067|65089092|FG000|Overall Study|Death|1|||
23366975|NCT00808067|65089093|FG001|Overall Study|Death|1|||
23366976|NCT00808067|65089092|FG000|Overall Study|Procedure|6|||
23366977|NCT00808067|65089093|FG001|Overall Study|Procedure|7|||
23366978|NCT00808067|65089092|FG000|Overall Study|Withdrawal by Subject|21|||
23366979|NCT00808067|65089093|FG001|Overall Study|Withdrawal by Subject|25|||
23366980|NCT00808067|65089092|FG000|Overall Study|Site closed|4|||
23366981|NCT00808067|65089093|FG001|Overall Study|Site closed|3|||
23366982|NCT00808067|65089092|FG000|Overall Study|Physician Decision|47|||
23366983|NCT00808067|65089093|FG001|Overall Study|Physician Decision|38|||
23366984|NCT00808067|65089092|FG000|Overall Study|Protocol Violation|3|||
23366985|NCT00808067|65089093|FG001|Overall Study|Protocol Violation|11|||
23366986|NCT00808067|65089092|FG000|Overall Study|Patient elected|7|||
23366987|NCT00808067|65089093|FG001|Overall Study|Patient elected|9|||
23366988|NCT00808067|65089092|FG000|Overall Study|Site closed for cause|19|||
23366989|NCT00808067|65089093|FG001|Overall Study|Site closed for cause|19|||
23366990|NCT00808067|65089092|FG000|Overall Study|Other reason not defined above|5|||
23366991|NCT00808067|65089093|FG001|Overall Study|Other reason not defined above|5|||
23366992|NCT00808067|65089092|FG000|Overall Study|Excluded from analysis|13|||
23366993|NCT00808067|65089093|FG001|Overall Study|Excluded from analysis|19|||
23366994|NCT01265498|65089095|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
23366995|NCT01265498|65089096|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
23660820|NCT01830855|66145670|FG003|Overall Study|Protocol deviation|6|||
23660821|NCT01830855|66145667|FG000|Overall Study|Withdrawal by Subject|33|||
23660822|NCT01830855|66145668|FG001|Overall Study|Withdrawal by Subject|14|||
23660823|NCT01830855|66145669|FG002|Overall Study|Withdrawal by Subject|10|||
23660824|NCT01830855|66145670|FG003|Overall Study|Withdrawal by Subject|12|||
23366996|NCT00871234|65089103|FG000|Overall Study|Adverse Event|2|||
23660825|NCT01830855|66145667|FG000|Overall Study|No longer willing to participate|32|||
23660826|NCT01830855|66145668|FG001|Overall Study|No longer willing to participate|13|||
23660827|NCT01830855|66145669|FG002|Overall Study|No longer willing to participate|12|||
23660828|NCT01830855|66145670|FG003|Overall Study|No longer willing to participate|17|||
23660829|NCT01830855|66145667|FG000|Overall Study|Lost to Follow-up|47|||
23660830|NCT01830855|66145668|FG001|Overall Study|Lost to Follow-up|20|||
23660831|NCT01830855|66145669|FG002|Overall Study|Lost to Follow-up|23|||
23660832|NCT01830855|66145670|FG003|Overall Study|Lost to Follow-up|33|||
23660833|NCT01429584|66145671|FG000|Overall Study|Withdrawal by Subject|1|||
23366997|NCT00871234|65089103|FG000|Overall Study|Lost to Follow-up|3|||
23366998|NCT01716806|65089104|FG000|Overall Study|Patient withdrawal of consent|4|||
23660834|NCT01429584|66145672|FG001|Overall Study|Withdrawal by Subject|0|||
23660835|NCT01429584|66145671|FG000|Overall Study|Protocol Violation|0|||
23660836|NCT01429584|66145672|FG001|Overall Study|Protocol Violation|1|||
23602053|NCT00734578|65933994|FG000|Overall Study|Lost to Follow-up|9|||
23602054|NCT00734578|65933995|FG001|Overall Study|Lost to Follow-up|3|||
23602055|NCT00734578|65933996|FG002|Overall Study|Lost to Follow-up|5|||
23602056|NCT00734578|65933994|FG000|Overall Study|Lack of Efficacy|3|||
23602057|NCT00734578|65933995|FG001|Overall Study|Lack of Efficacy|2|||
23602058|NCT00734578|65933996|FG002|Overall Study|Lack of Efficacy|5|||
23602059|NCT00734578|65933994|FG000|Overall Study|Randomized in error|1|||
23602060|NCT00734578|65933995|FG001|Overall Study|Randomized in error|0|||
23602061|NCT00734578|65933996|FG002|Overall Study|Randomized in error|0|||
23602062|NCT00734578|65933994|FG000|Overall Study|Exclusion criteria|1|||
23602063|NCT00734578|65933995|FG001|Overall Study|Exclusion criteria|0|||
23660837|NCT00747643|66145675|FG000|Overall Study|Withdrawal by Subject|36|||
23602064|NCT00734578|65933996|FG002|Overall Study|Exclusion criteria|0|||
23366999|NCT01716806|65089105|FG001|Overall Study|Patient withdrawal of consent|2|||
23367000|NCT01716806|65089106|FG002|Overall Study|Patient withdrawal of consent|4|||
23367001|NCT01716806|65089107|FG003|Overall Study|Patient withdrawal of consent|3|||
23367002|NCT01716806|65089108|FG004|Overall Study|Patient withdrawal of consent|2|||
23367003|NCT01716806|65089109|FG005|Overall Study|Patient withdrawal of consent|0|||
23483561|NCT00366340|65513108|FG001|Infant Series|Adverse Event|2|||
23483562|NCT00366340|65513107|FG000|Infant Series|Lost to Follow-up|1|||
23483563|NCT00366340|65513108|FG001|Infant Series|Lost to Follow-up|1|||
23483564|NCT00366340|65513107|FG000|Infant Series|Failure to return|1|||
23483565|NCT00366340|65513108|FG001|Infant Series|Failure to return|0|||
23483566|NCT00366340|65513107|FG000|After the Infant Series|Parent/legal guardian request|1|||
23483567|NCT00366340|65513108|FG001|After the Infant Series|Parent/legal guardian request|1|||
23483568|NCT00366340|65513107|FG000|After the Infant Series|Failed to return|0|||
23483569|NCT00366340|65513108|FG001|After the Infant Series|Failed to return|1|||
23483570|NCT00366340|65513107|FG000|After the Infant Series|Protocol Violation|2|||
23602065|NCT01766206|65933997|FG000|Overall Study|Withdrawal by Subject|22|||
23367004|NCT01716806|65089104|FG000|Overall Study|Lost to Follow-up|3|||
23367005|NCT01716806|65089105|FG001|Overall Study|Lost to Follow-up|3|||
23367006|NCT01716806|65089106|FG002|Overall Study|Lost to Follow-up|0|||
23367007|NCT01716806|65089107|FG003|Overall Study|Lost to Follow-up|2|||
23367008|NCT01716806|65089108|FG004|Overall Study|Lost to Follow-up|1|||
23367009|NCT01716806|65089109|FG005|Overall Study|Lost to Follow-up|0|||
23367010|NCT01716806|65089104|FG000|Overall Study|Death|13|||
23367011|NCT01716806|65089105|FG001|Overall Study|Death|9|||
23367012|NCT01716806|65089106|FG002|Overall Study|Death|12|||
23367013|NCT01716806|65089107|FG003|Overall Study|Death|4|||
23367014|NCT01716806|65089108|FG004|Overall Study|Death|10|||
23367015|NCT01716806|65089109|FG005|Overall Study|Death|5|||
23367016|NCT01716806|65089104|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367017|NCT01716806|65089105|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367018|NCT01716806|65089106|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367019|NCT01716806|65089107|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367020|NCT01716806|65089108|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
23367021|NCT01716806|65089109|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
23367022|NCT01716806|65089104|FG000|Overall Study|PI decision|0|||
23367023|NCT01716806|65089105|FG001|Overall Study|PI decision|0|||
23367024|NCT01716806|65089106|FG002|Overall Study|PI decision|0|||
23367025|NCT01716806|65089107|FG003|Overall Study|PI decision|0|||
23367026|NCT01716806|65089108|FG004|Overall Study|PI decision|1|||
23367027|NCT01716806|65089109|FG005|Overall Study|PI decision|0|||
23367028|NCT01716806|65089104|FG000|Overall Study|Change in performance status|1|||
23367029|NCT01716806|65089105|FG001|Overall Study|Change in performance status|0|||
23367030|NCT01716806|65089106|FG002|Overall Study|Change in performance status|0|||
23367031|NCT01716806|65089107|FG003|Overall Study|Change in performance status|0|||
23367032|NCT01716806|65089108|FG004|Overall Study|Change in performance status|0|||
23367033|NCT01716806|65089109|FG005|Overall Study|Change in performance status|0|||
23367034|NCT01716806|65089104|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367035|NCT01716806|65089105|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367036|NCT01716806|65089106|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
23367037|NCT01716806|65089107|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367038|NCT01716806|65089108|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367039|NCT01716806|65089109|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367040|NCT01716806|65089104|FG000|Overall Study|Sponsor direction|7|||
23367041|NCT01716806|65089105|FG001|Overall Study|Sponsor direction|8|||
23367042|NCT01716806|65089106|FG002|Overall Study|Sponsor direction|5|||
23367043|NCT01716806|65089107|FG003|Overall Study|Sponsor direction|12|||
23367044|NCT01716806|65089108|FG004|Overall Study|Sponsor direction|16|||
23367045|NCT01716806|65089109|FG005|Overall Study|Sponsor direction|1|||
23367046|NCT03797898|65089111|FG000|Overall Study|Lost to Follow-up|60|||
23367047|NCT03797898|65089112|FG001|Overall Study|Lost to Follow-up|69|||
23367048|NCT03797898|65089111|FG000|Overall Study|Withdrawal by Subject|9|||
23367049|NCT03797898|65089112|FG001|Overall Study|Withdrawal by Subject|7|||
23367050|NCT03797898|65089111|FG000|Overall Study|Became ineligible|5|||
23367051|NCT03797898|65089112|FG001|Overall Study|Became ineligible|2|||
23367052|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
23367053|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
23367054|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
23367055|NCT01676701|65089114|FG000|Overall Study|Protocol Violation|1|||
23367056|NCT01676701|65089115|FG001|Overall Study|Protocol Violation|0|||
23367057|NCT01676701|65089114|FG000|Overall Study|Sponsor Decision|3|||
23367058|NCT01676701|65089115|FG001|Overall Study|Sponsor Decision|4|||
23367059|NCT01783743|65089116|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
23367060|NCT01783743|65089117|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
23367061|NCT01783743|65089116|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
23367062|NCT01783743|65089117|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
23367063|NCT01783743|65089116|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
23367064|NCT01783743|65089117|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
23367065|NCT02100124|65089118|FG000|Overall Study|Lost to Follow-up|5|||
23367066|NCT02100124|65089119|FG001|Overall Study|Lost to Follow-up|11|||
23367067|NCT02100124|65089120|FG002|Overall Study|Lost to Follow-up|3|||
23367068|NCT02100124|65089118|FG000|Overall Study|Withdrawal by Subject|1|||
23367069|NCT02100124|65089119|FG001|Overall Study|Withdrawal by Subject|0|||
23367070|NCT02100124|65089120|FG002|Overall Study|Withdrawal by Subject|0|||
23367071|NCT02532374|65089121|FG000|Overall Study|Withdrawal by Subject|1|||
23660838|NCT00747643|66145676|FG001|Overall Study|Withdrawal by Subject|27|||
23660839|NCT02982590|66145678|FG000|Overall Study|Lost to Follow-up|0|||
23660840|NCT02982590|66145679|FG001|Overall Study|Lost to Follow-up|1|||
23660841|NCT02982590|66145678|FG000|Overall Study|Death|4|||
23660842|NCT02982590|66145679|FG001|Overall Study|Death|0|||
23660843|NCT00482703|66145680|FG000|Overall Study|Poor compliance|1|||
23660844|NCT00482703|66145681|FG001|Overall Study|Poor compliance|0|||
23660845|NCT01045798|66145686|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
23660846|NCT01045798|66145687|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
23660847|NCT01045798|66145686|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
23660848|NCT01045798|66145687|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
23660849|NCT01045798|66145686|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
23660850|NCT01045798|66145687|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
23660851|NCT01045798|66145686|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
23660852|NCT01045798|66145687|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
23660853|NCT00495820|66145688|FG000|Overall Study|Adverse Event|1|||
23660854|NCT00495820|66145689|FG001|Overall Study|Adverse Event|1|||
23660855|NCT01843842|66145692|FG000|Overall Study|Do not meet inclusion criteria|1|||
23660856|NCT01843842|66145693|FG001|Overall Study|Do not meet inclusion criteria|1|||
23660857|NCT00097773|66145694|FG000|Overall Study|Lost to Follow-up|2|||
23660858|NCT00097773|66145695|FG001|Overall Study|Lost to Follow-up|2|||
23660859|NCT00097773|66145696|FG002|Overall Study|Lost to Follow-up|0|||
23660860|NCT00097773|66145697|FG003|Overall Study|Lost to Follow-up|1|||
23660861|NCT00097773|66145694|FG000|Overall Study|Physician Decision|2|||
23660862|NCT00097773|66145695|FG001|Overall Study|Physician Decision|2|||
23660863|NCT00097773|66145696|FG002|Overall Study|Physician Decision|3|||
23660864|NCT00097773|66145697|FG003|Overall Study|Physician Decision|1|||
23660865|NCT00097773|66145694|FG000|Overall Study|Withdrawal by Subject|3|||
23660866|NCT00097773|66145695|FG001|Overall Study|Withdrawal by Subject|3|||
23660867|NCT00097773|66145696|FG002|Overall Study|Withdrawal by Subject|3|||
23660868|NCT00097773|66145697|FG003|Overall Study|Withdrawal by Subject|1|||
23660869|NCT00097773|66145694|FG000|Overall Study|Adverse Event|0|||
23660870|NCT00097773|66145695|FG001|Overall Study|Adverse Event|1|||
23660871|NCT00097773|66145696|FG002|Overall Study|Adverse Event|0|||
23660872|NCT00097773|66145697|FG003|Overall Study|Adverse Event|0|||
23660873|NCT00097773|66145694|FG000|Overall Study|Other|1|||
23660874|NCT00097773|66145695|FG001|Overall Study|Other|0|||
23660875|NCT00097773|66145696|FG002|Overall Study|Other|2|||
23660876|NCT00097773|66145697|FG003|Overall Study|Other|0|||
23660877|NCT00290186|66145700|FG000|Overall Study|Adverse Event|1|||
23660878|NCT00290186|66145701|FG001|Overall Study|Adverse Event|1|||
23660879|NCT00290186|66145700|FG000|Overall Study|Lost to Follow-up|3|||
23660880|NCT00290186|66145701|FG001|Overall Study|Lost to Follow-up|2|||
23660881|NCT00290186|66145700|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
23660882|NCT00290186|66145701|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
23660883|NCT00290186|66145700|FG000|Overall Study|Withdrawal by Subject|0|||
23660884|NCT00290186|66145701|FG001|Overall Study|Withdrawal by Subject|1|||
23660885|NCT02269787|66145703|FG000|Overall Study|Lost to Follow-up|20|||
23660886|NCT02269787|66145704|FG001|Overall Study|Lost to Follow-up|6|||
23660887|NCT02269787|66145703|FG000|Overall Study|Death|2|||
23660888|NCT02269787|66145704|FG001|Overall Study|Death|3|||
23660889|NCT02269787|66145703|FG000|Overall Study|Incapacitated|0|||
23660890|NCT02269787|66145704|FG001|Overall Study|Incapacitated|1|||
23660891|NCT01628107|66145705|FG000|Overall Study|Withdrawal by Subject|17|||
23660892|NCT01628107|66145705|FG000|Overall Study|Lost to Follow-up|4|||
23660893|NCT01628107|66145705|FG000|Overall Study|Adverse Event|33|||
23660894|NCT01628107|66145705|FG000|Overall Study|Physician Decision|2|||
23660895|NCT01628107|66145705|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
23660896|NCT01628107|66145705|FG000|Overall Study|Non-compliant with Study Procedures|10|||
23660897|NCT01628107|66145705|FG000|Overall Study|Not Treated|8|||
23660898|NCT01628107|66145705|FG000|Overall Study|Sponsor Decision|11|||
23660899|NCT01628107|66145705|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
23660900|NCT01628107|66145705|FG000|Overall Study|Relocated|8|||
23367072|NCT02532374|65089121|FG000|Overall Study|Physician Decision|1|||
23367073|NCT03704064|65089122|FG000|Overall Study|Lost to Follow-up|8|||
23367074|NCT03704064|65089123|FG001|Overall Study|Lost to Follow-up|4|||
23367075|NCT03704064|65089122|FG000|Overall Study|Withdrawal by Subject|1|||
23367076|NCT03704064|65089123|FG001|Overall Study|Withdrawal by Subject|1|||
23367077|NCT03704064|65089122|FG000|Overall Study|No longer available for study visits|0|||
23367078|NCT03704064|65089123|FG001|Overall Study|No longer available for study visits|1|||
23367079|NCT03704064|65089122|FG000|Overall Study|Censoring event|1|||
23367080|NCT03704064|65089123|FG001|Overall Study|Censoring event|0|||
23367081|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
23367082|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
23367083|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
23367084|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
23367085|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
23367086|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
23367087|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
23367088|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
23367089|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
23367090|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
23367091|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
23367092|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
23367093|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
23367094|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
23367095|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
23367096|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
23367097|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
23367098|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
23367099|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
23367100|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
23367101|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
23367102|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
23367103|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
23367104|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
23367105|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
23367106|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
23367107|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
23367108|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
23367109|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
23367110|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
23367111|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
23367112|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
23367113|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
23602066|NCT01766206|65933997|FG000|Overall Study|Lost to Follow-up|10|||
23660901|NCT01628107|66145705|FG000|Overall Study|Kidney Transplant|9|||
23660902|NCT01628107|66145705|FG000|Overall Study|Use of Standard of Care|9|||
23660903|NCT01877915|66145706|FG000|Overall Study|Lost to Follow-up|10|||
23660904|NCT01877915|66145707|FG001|Overall Study|Lost to Follow-up|9|||
23660905|NCT01877915|66145706|FG000|Overall Study|Withdrawal by Subject|42|||
23660906|NCT01877915|66145707|FG001|Overall Study|Withdrawal by Subject|55|||
23367114|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
23660907|NCT01877915|66145706|FG000|Overall Study|Other|2|||
23660908|NCT01877915|66145707|FG001|Overall Study|Other|4|||
23660909|NCT00698997|66145708|FG000|Overall Study|Lost to Follow-up|3|||
23367115|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
23367116|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
23367117|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
23367118|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
23660910|NCT00698997|66145709|FG001|Overall Study|Lost to Follow-up|0|||
23660911|NCT00698997|66145708|FG000|Overall Study|Withdrawal by Subject|7|||
23660912|NCT00698997|66145709|FG001|Overall Study|Withdrawal by Subject|27|||
23660913|NCT01641237|66145710|FG000|Period II|Withdrawal by Subject|1|||
23660914|NCT01641237|66145711|FG001|Period II|Withdrawal by Subject|0|||
23660915|NCT01641237|66145712|FG002|Period II|Withdrawal by Subject|0|||
23660916|NCT01641237|66145713|FG003|Period II|Withdrawal by Subject|0|||
23660917|NCT01641237|66145710|FG000|Period III|Lost to Follow-up|1|||
23660918|NCT01641237|66145711|FG001|Period III|Lost to Follow-up|0|||
23660919|NCT01641237|66145712|FG002|Period III|Lost to Follow-up|0|||
23660920|NCT01641237|66145713|FG003|Period III|Lost to Follow-up|0|||
23660921|NCT00290342|66145715|FG000|Overall Study|Other|0|||
23660922|NCT00290342|66145716|FG001|Overall Study|Other|1|||
23660923|NCT00290342|66145715|FG000|Overall Study|Withdrawal by Subject|6|||
23660924|NCT00290342|66145716|FG001|Overall Study|Withdrawal by Subject|4|||
23660925|NCT00290342|66145715|FG000|Overall Study|Lost to Follow-up|1|||
23660926|NCT00290342|66145716|FG001|Overall Study|Lost to Follow-up|0|||
23660927|NCT02632721|66145717|FG000|Overall Study|Adverse Event|0|||
23660928|NCT02632721|66145718|FG001|Overall Study|Adverse Event|0|||
23660929|NCT02632721|66145719|FG002|Overall Study|Adverse Event|2|||
23660930|NCT02632721|66145720|FG003|Overall Study|Adverse Event|5|||
23660931|NCT02632721|66145721|FG004|Overall Study|Adverse Event|3|||
23660932|NCT02632721|66145717|FG000|Overall Study|Dose limiting toxicity|0|||
23660933|NCT02632721|66145718|FG001|Overall Study|Dose limiting toxicity|0|||
23660934|NCT02632721|66145719|FG002|Overall Study|Dose limiting toxicity|0|||
23660935|NCT02632721|66145720|FG003|Overall Study|Dose limiting toxicity|1|||
23660936|NCT02632721|66145721|FG004|Overall Study|Dose limiting toxicity|0|||
23660937|NCT02632721|66145717|FG000|Overall Study|Progressive disease|3|||
23660938|NCT02632721|66145718|FG001|Overall Study|Progressive disease|0|||
23660939|NCT02632721|66145719|FG002|Overall Study|Progressive disease|4|||
23660940|NCT02632721|66145720|FG003|Overall Study|Progressive disease|6|||
23660941|NCT02632721|66145721|FG004|Overall Study|Progressive disease|5|||
23660942|NCT02632721|66145717|FG000|Overall Study|Refused to continue taking trial medication|0|||
23660943|NCT02632721|66145718|FG001|Overall Study|Refused to continue taking trial medication|1|||
23660944|NCT02632721|66145719|FG002|Overall Study|Refused to continue taking trial medication|1|||
23660945|NCT02632721|66145720|FG003|Overall Study|Refused to continue taking trial medication|1|||
23660946|NCT02632721|66145721|FG004|Overall Study|Refused to continue taking trial medication|2|||
23660947|NCT02632721|66145717|FG000|Overall Study|Inadequate clinical condition|0|||
23660948|NCT02632721|66145718|FG001|Overall Study|Inadequate clinical condition|0|||
23660949|NCT02632721|66145719|FG002|Overall Study|Inadequate clinical condition|0|||
23660950|NCT02632721|66145720|FG003|Overall Study|Inadequate clinical condition|0|||
23660951|NCT02632721|66145721|FG004|Overall Study|Inadequate clinical condition|1|||
23660952|NCT02632721|66145717|FG000|Overall Study|No meet eligibility|0|||
23660953|NCT02632721|66145718|FG001|Overall Study|No meet eligibility|0|||
23660954|NCT02632721|66145719|FG002|Overall Study|No meet eligibility|0|||
23660955|NCT02632721|66145720|FG003|Overall Study|No meet eligibility|0|||
23660956|NCT02632721|66145721|FG004|Overall Study|No meet eligibility|1|||
23660957|NCT02632721|66145717|FG000|Overall Study|Allergic reaction|0|||
23660958|NCT02632721|66145718|FG001|Overall Study|Allergic reaction|0|||
23660959|NCT02632721|66145719|FG002|Overall Study|Allergic reaction|0|||
23660960|NCT02632721|66145720|FG003|Overall Study|Allergic reaction|1|||
23660961|NCT02632721|66145721|FG004|Overall Study|Allergic reaction|0|||
23660962|NCT02632721|66145717|FG000|Overall Study|Receiving Decitabine locally|0|||
23660963|NCT02632721|66145718|FG001|Overall Study|Receiving Decitabine locally|0|||
23660964|NCT02632721|66145719|FG002|Overall Study|Receiving Decitabine locally|1|||
23660965|NCT02632721|66145720|FG003|Overall Study|Receiving Decitabine locally|0|||
23660966|NCT02632721|66145721|FG004|Overall Study|Receiving Decitabine locally|0|||
23660967|NCT02632721|66145717|FG000|Overall Study|No benefit from study treatment|1|||
23660968|NCT02632721|66145718|FG001|Overall Study|No benefit from study treatment|1|||
23660969|NCT02632721|66145719|FG002|Overall Study|No benefit from study treatment|0|||
23660970|NCT02632721|66145720|FG003|Overall Study|No benefit from study treatment|0|||
23367119|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
23660971|NCT02632721|66145721|FG004|Overall Study|No benefit from study treatment|1|||
23660972|NCT02632721|66145717|FG000|Overall Study|Patient wish for other treatment|0|||
23660973|NCT02632721|66145718|FG001|Overall Study|Patient wish for other treatment|1|||
23660974|NCT02632721|66145719|FG002|Overall Study|Patient wish for other treatment|0|||
23660975|NCT02632721|66145720|FG003|Overall Study|Patient wish for other treatment|0|||
23660976|NCT02632721|66145721|FG004|Overall Study|Patient wish for other treatment|0|||
23660977|NCT02632721|66145717|FG000|Overall Study|Relapsed Pneumonia|0|||
23660978|NCT02632721|66145718|FG001|Overall Study|Relapsed Pneumonia|0|||
23660979|NCT02632721|66145719|FG002|Overall Study|Relapsed Pneumonia|0|||
23367120|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
23367121|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
23367122|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
23367123|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
23367124|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
23367125|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
23367126|NCT01159574|65089135|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
23367127|NCT01159574|65089135|FG000|Treatment Phase|Adverse Event|3|||
23367128|NCT01159574|65089135|FG000|Treatment Phase|Death|6|||
23367129|NCT01159574|65089135|FG000|Treatment Phase|Physician Decision|2|||
23367130|NCT01159574|65089135|FG000|Treatment Phase|Withdrawal by Subject|7|||
23367131|NCT01159574|65089135|FG000|Treatment Phase|still on treatment|2|||
23367132|NCT01159574|65089135|FG000|Follow Up Phase|Lost to Follow-up|2|||
23367133|NCT01159574|65089135|FG000|Follow Up Phase|still being followed for overall surviva|18|||
23367134|NCT00964028|65089136|FG000|Overall Study|Withdrawal by Subject|0|||
23367135|NCT00964028|65089137|FG001|Overall Study|Withdrawal by Subject|1|||
23367136|NCT04210986|65092332|FG000|Overall Study|Lost to Follow-up|5|||
23367137|NCT04210986|65092333|FG001|Overall Study|Lost to Follow-up|2|||
23367138|NCT04210986|65092332|FG000|Overall Study|Withdrawal by Subject|3|||
23367139|NCT04210986|65092333|FG001|Overall Study|Withdrawal by Subject|1|||
23367140|NCT04210986|65092332|FG000|Overall Study|Protocol Violation|1|||
23367141|NCT04210986|65092333|FG001|Overall Study|Protocol Violation|1|||
23367142|NCT04210986|65092332|FG000|Overall Study|Physician Decision|0|||
23367143|NCT04210986|65092333|FG001|Overall Study|Physician Decision|1|||
23367144|NCT01255904|65092334|FG000|Overall Study|Physician Decision|1|||
23367145|NCT01255904|65092335|FG001|Overall Study|Physician Decision|4|||
23367146|NCT02899065|65092338|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
23367147|NCT02899065|65092339|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
23367148|NCT02899065|65092338|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
23367149|NCT02899065|65092339|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
23367150|NCT02899065|65092338|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
23367151|NCT02899065|65092339|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
23367152|NCT01774591|65092340|FG000|Overall Study|Physician Decision|1|||
23367153|NCT01774591|65092341|FG001|Overall Study|Physician Decision|1|||
23367154|NCT01774591|65092340|FG000|Overall Study|Withdrawal by Subject|0|||
23367155|NCT01774591|65092341|FG001|Overall Study|Withdrawal by Subject|1|||
23367156|NCT01774591|65092340|FG000|Overall Study|Adverse Event|0|||
23367157|NCT01774591|65092341|FG001|Overall Study|Adverse Event|2|||
23367158|NCT02063672|65092342|FG000|Overall Study|Ongoing Follow-up|27|||
23367159|NCT02063672|65092343|FG001|Overall Study|Ongoing Follow-up|14|||
23367160|NCT02063672|65092342|FG000|Overall Study|Death|5|||
23367161|NCT02063672|65092343|FG001|Overall Study|Death|3|||
23367162|NCT02063672|65092342|FG000|Overall Study|Lost to Follow-up|1|||
23367163|NCT02063672|65092343|FG001|Overall Study|Lost to Follow-up|3|||
23367164|NCT02063672|65092342|FG000|Overall Study|Withdrawal by Subject|2|||
23367165|NCT02063672|65092343|FG001|Overall Study|Withdrawal by Subject|2|||
23367166|NCT01566604|65092344|FG000|Overall Study|Patient's inability to use the device|1|||
23367167|NCT01566604|65092345|FG001|Overall Study|Patient's inability to use the device|0|||
23660980|NCT02632721|66145720|FG003|Overall Study|Relapsed Pneumonia|0|||
23367168|NCT01566604|65092344|FG000|Overall Study|Administrative problems|1|||
23660981|NCT02632721|66145721|FG004|Overall Study|Relapsed Pneumonia|1|||
23660982|NCT02632721|66145717|FG000|Overall Study|Therapy refractory AML|0|||
23660983|NCT02632721|66145718|FG001|Overall Study|Therapy refractory AML|0|||
23660984|NCT02632721|66145719|FG002|Overall Study|Therapy refractory AML|0|||
23660985|NCT02632721|66145720|FG003|Overall Study|Therapy refractory AML|0|||
23660986|NCT02632721|66145721|FG004|Overall Study|Therapy refractory AML|1|||
23660987|NCT02632721|66145717|FG000|Overall Study|Increase of white blood cell count|0|||
23660988|NCT02632721|66145718|FG001|Overall Study|Increase of white blood cell count|0|||
23660989|NCT02632721|66145719|FG002|Overall Study|Increase of white blood cell count|0|||
23660990|NCT02632721|66145720|FG003|Overall Study|Increase of white blood cell count|0|||
23660991|NCT02632721|66145721|FG004|Overall Study|Increase of white blood cell count|1|||
23660992|NCT02632721|66145717|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23660993|NCT02632721|66145718|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23660994|NCT02632721|66145719|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
23660995|NCT02632721|66145720|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23660996|NCT02632721|66145721|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23660997|NCT05082376|66145722|FG000|Overall Study|Lost to Follow-up|2|||
23660998|NCT02463071|66145723|FG000|Overall Study|Adverse Event|3|||
23660999|NCT02463071|66145724|FG001|Overall Study|Adverse Event|5|||
23661000|NCT02463071|66145725|FG002|Overall Study|Adverse Event|1|||
23661001|NCT02463071|66145723|FG000|Overall Study|Death|1|||
23367169|NCT01566604|65092345|FG001|Overall Study|Administrative problems|0|||
23367170|NCT01566604|65092344|FG000|Overall Study|Lack of Efficacy|1|||
23367171|NCT01566604|65092345|FG001|Overall Study|Lack of Efficacy|2|||
23367172|NCT01566604|65092344|FG000|Overall Study|Protocol deviation|2|||
23367173|NCT01566604|65092345|FG001|Overall Study|Protocol deviation|0|||
23367174|NCT01566604|65092344|FG000|Overall Study|Abnormal laboratory value|2|||
23367175|NCT01566604|65092345|FG001|Overall Study|Abnormal laboratory value|0|||
23367176|NCT01566604|65092344|FG000|Overall Study|Death|4|||
23367177|NCT01566604|65092345|FG001|Overall Study|Death|1|||
23367178|NCT01566604|65092344|FG000|Overall Study|Adverse Event|4|||
23367179|NCT01566604|65092345|FG001|Overall Study|Adverse Event|2|||
23367180|NCT01566604|65092344|FG000|Overall Study|Withdrawal by Subject|9|||
23367181|NCT01566604|65092345|FG001|Overall Study|Withdrawal by Subject|6|||
23367182|NCT00249834|65092350|FG000|Overall Study|Ovarian stimulation failed|1|||
23367183|NCT00249834|65092351|FG001|Overall Study|Ovarian stimulation failed|0|||
23367184|NCT00249834|65092352|FG002|Overall Study|Ovarian stimulation failed|0|||
23367185|NCT00249834|65092353|FG003|Overall Study|Ovarian stimulation failed|0|||
23367186|NCT00249834|65092354|FG004|Overall Study|Ovarian stimulation failed|0|||
23367187|NCT00249834|65092355|FG005|Overall Study|Ovarian stimulation failed|0|||
23367188|NCT00249834|65092356|FG006|Overall Study|Ovarian stimulation failed|0|||
23367189|NCT00249834|65092357|FG007|Overall Study|Ovarian stimulation failed|0|||
23367190|NCT00249834|65092350|FG000|Overall Study|Failure of down-regulation|0|||
23367191|NCT00249834|65092351|FG001|Overall Study|Failure of down-regulation|0|||
23367192|NCT00249834|65092352|FG002|Overall Study|Failure of down-regulation|0|||
23367193|NCT00249834|65092353|FG003|Overall Study|Failure of down-regulation|0|||
23367194|NCT00249834|65092354|FG004|Overall Study|Failure of down-regulation|0|||
23367195|NCT00249834|65092355|FG005|Overall Study|Failure of down-regulation|0|||
23367196|NCT00249834|65092356|FG006|Overall Study|Failure of down-regulation|1|||
23367197|NCT00249834|65092357|FG007|Overall Study|Failure of down-regulation|0|||
23367198|NCT00249834|65092350|FG000|Overall Study|Protocol Violation|0|||
23367199|NCT00249834|65092351|FG001|Overall Study|Protocol Violation|19|||
23367200|NCT00249834|65092352|FG002|Overall Study|Protocol Violation|14|||
23367201|NCT00249834|65092353|FG003|Overall Study|Protocol Violation|8|||
23367202|NCT00249834|65092354|FG004|Overall Study|Protocol Violation|5|||
23367203|NCT00249834|65092355|FG005|Overall Study|Protocol Violation|2|||
23367204|NCT00249834|65092356|FG006|Overall Study|Protocol Violation|0|||
23367205|NCT00249834|65092357|FG007|Overall Study|Protocol Violation|0|||
23367206|NCT02121210|65092358|FG000|Overall Study|Adverse Event|5|||
23367207|NCT02121210|65092359|FG001|Overall Study|Adverse Event|7|||
23367208|NCT02121210|65092358|FG000|Overall Study|Lack of Efficacy|2|||
23367209|NCT02121210|65092359|FG001|Overall Study|Lack of Efficacy|0|||
23367210|NCT02121210|65092358|FG000|Overall Study|Other than specified above|0|||
23367211|NCT02121210|65092359|FG001|Overall Study|Other than specified above|2|||
23367212|NCT00875563|65092360|FG000|Overall Study|Death|4|||
23367213|NCT00875563|65092360|FG000|Overall Study|Withdrawal by Subject|7|||
23367214|NCT00875563|65092360|FG000|Overall Study|No long-term (3-5 year) consent|6|||
23367215|NCT00875563|65092360|FG000|Overall Study|Still be eligible for follow-up|7|||
23367216|NCT00577772|65092361|FG000|Overall Study|Lost to Follow-up|0|||
23367217|NCT00577772|65092362|FG001|Overall Study|Lost to Follow-up|1|||
23367218|NCT01239797|65092365|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
23367219|NCT01239797|65092366|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
23367220|NCT01239797|65092365|FG000|Randomized Participants|Participant withdrew consent|1|||
23367221|NCT01239797|65092366|FG001|Randomized Participants|Participant withdrew consent|7|||
23367222|NCT01239797|65092365|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
23367223|NCT01239797|65092366|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
23602067|NCT01766206|65933997|FG000|Overall Study|Inappropriate enrollment|18|||
23602068|NCT01766206|65933997|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
23602069|NCT00452452|65934005|FG000|Overall Study|Protocol Violation|0|||
23602070|NCT00452452|65934006|FG001|Overall Study|Protocol Violation|0|||
23602071|NCT00452452|65934007|FG002|Overall Study|Protocol Violation|1|||
23602072|NCT00452452|65934005|FG000|Overall Study|Withdrawal by Subject|1|||
23602073|NCT00452452|65934006|FG001|Overall Study|Withdrawal by Subject|0|||
23602074|NCT00452452|65934007|FG002|Overall Study|Withdrawal by Subject|0|||
23602075|NCT00452452|65934005|FG000|Overall Study|Lost to Follow-up|1|||
23602076|NCT00452452|65934006|FG001|Overall Study|Lost to Follow-up|0|||
23602077|NCT00452452|65934007|FG002|Overall Study|Lost to Follow-up|0|||
23602078|NCT01972776|65934008|FG000|Part 1|Withdrawal by Subject|0|||
23602079|NCT01972776|65934009|FG001|Part 1|Withdrawal by Subject|0|||
23483571|NCT00366340|65513108|FG001|After the Infant Series|Protocol Violation|2|||
23483572|NCT00366340|65513107|FG000|After the Infant Series|Adverse Event|0|||
23483573|NCT00366340|65513108|FG001|After the Infant Series|Adverse Event|1|||
23483574|NCT00366340|65513107|FG000|After the Infant Series|Lost to Follow-up|0|||
23483575|NCT00366340|65513108|FG001|After the Infant Series|Lost to Follow-up|1|||
23483576|NCT00366340|65513107|FG000|Toddler Dose|Failed to return|1|||
23483577|NCT00366340|65513108|FG001|Toddler Dose|Failed to return|0|||
23483578|NCT00366340|65513107|FG000|Toddler Dose|Parent/legal guardian request|0|||
23483579|NCT00366340|65513108|FG001|Toddler Dose|Parent/legal guardian request|1|||
23483580|NCT00367770|65513109|FG000|Overall Study|Adverse Event|1|||
23483581|NCT00367770|65513109|FG000|Overall Study|Withdrawal by Subject|1|||
23483582|NCT03533686|65513110|FG000|Overall Study|Withdrawal by Subject|1|||
23483583|NCT03533686|65513111|FG001|Overall Study|Withdrawal by Subject|0|||
23483584|NCT03533686|65513112|FG002|Overall Study|Withdrawal by Subject|0|||
23483585|NCT03533686|65513113|FG003|Overall Study|Withdrawal by Subject|3|||
23483586|NCT03533686|65513114|FG004|Overall Study|Withdrawal by Subject|5|||
23483587|NCT03533686|65513115|FG005|Overall Study|Withdrawal by Subject|1|||
23483588|NCT03533686|65513110|FG000|Overall Study|Lost to Follow-up|0|||
23483589|NCT03533686|65513111|FG001|Overall Study|Lost to Follow-up|1|||
23483590|NCT03533686|65513112|FG002|Overall Study|Lost to Follow-up|0|||
23483591|NCT03533686|65513113|FG003|Overall Study|Lost to Follow-up|0|||
23483592|NCT03533686|65513114|FG004|Overall Study|Lost to Follow-up|2|||
23483593|NCT03533686|65513115|FG005|Overall Study|Lost to Follow-up|0|||
23483594|NCT03533686|65513110|FG000|Overall Study|Screen Failure|0|||
23483595|NCT03533686|65513111|FG001|Overall Study|Screen Failure|0|||
23483596|NCT03533686|65513112|FG002|Overall Study|Screen Failure|0|||
23483597|NCT03533686|65513113|FG003|Overall Study|Screen Failure|2|||
23483598|NCT03533686|65513114|FG004|Overall Study|Screen Failure|0|||
23483599|NCT03533686|65513115|FG005|Overall Study|Screen Failure|0|||
23602080|NCT01972776|65934010|FG002|Part 1|Withdrawal by Subject|1|||
23602081|NCT01972776|65934011|FG003|Part 1|Withdrawal by Subject|0|||
23602082|NCT01972776|65934012|FG004|Part 1|Withdrawal by Subject|0|||
23602083|NCT01972776|65934013|FG005|Part 1|Withdrawal by Subject|0|||
23602084|NCT01972776|65934008|FG000|Part 1|Adverse Event|0|||
23602085|NCT01972776|65934009|FG001|Part 1|Adverse Event|0|||
23602086|NCT01972776|65934010|FG002|Part 1|Adverse Event|1|||
23602087|NCT01972776|65934011|FG003|Part 1|Adverse Event|1|||
23483600|NCT03036800|65513117|FG000|Overall Study|Protocol Violation|1|||
23483601|NCT03036800|65513118|FG001|Overall Study|Protocol Violation|0|||
23483602|NCT03036800|65513117|FG000|Overall Study|Non-compliance|1|||
23483603|NCT03036800|65513118|FG001|Overall Study|Non-compliance|0|||
23483604|NCT03036800|65513117|FG000|Overall Study|Lost to Follow-up|1|||
23602088|NCT01972776|65934012|FG004|Part 1|Adverse Event|0|||
23483605|NCT03036800|65513118|FG001|Overall Study|Lost to Follow-up|0|||
23602089|NCT01972776|65934013|FG005|Part 1|Adverse Event|0|||
23483606|NCT03036800|65513117|FG000|Overall Study|Death|1|||
23602090|NCT01972776|65934008|FG000|Part 2|Adverse Event|0|||
23602091|NCT01972776|65934009|FG001|Part 2|Adverse Event|0|||
23602092|NCT01972776|65934010|FG002|Part 2|Adverse Event|0|||
23807382|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
23807383|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
23807384|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Various|3|||
23807385|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Various|0|||
23807386|NCT00974974|66672750|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
23807387|NCT00974974|66672751|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
23807388|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
23807389|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
23807390|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
23807391|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
23807392|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
23807393|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
23807394|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
23807395|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
23807396|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
23807397|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
23807398|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
23807399|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
23807400|NCT00974974|66672750|FG000|Maintenance - Double Blind Treatment|Various|4|||
23807401|NCT00974974|66672751|FG001|Maintenance - Double Blind Treatment|Various|0|||
23807402|NCT00262041|66672752|FG000|Overall Study|Withdrawal by Subject|0|||
23807403|NCT00262041|66672753|FG001|Overall Study|Withdrawal by Subject|3|||
23807404|NCT00262041|66672754|FG002|Overall Study|Withdrawal by Subject|1|||
23807405|NCT00262041|66672752|FG000|Overall Study|Lost to Follow-up|1|||
23807406|NCT00262041|66672753|FG001|Overall Study|Lost to Follow-up|1|||
23807407|NCT00262041|66672754|FG002|Overall Study|Lost to Follow-up|5|||
23807408|NCT00262041|66672752|FG000|Overall Study|Unable to classify|1|||
23807409|NCT00262041|66672753|FG001|Overall Study|Unable to classify|0|||
23807410|NCT00262041|66672754|FG002|Overall Study|Unable to classify|0|||
23807411|NCT01197417|66672755|FG000|Overall Study|Physician Decision|3|||
23807412|NCT01197417|66672756|FG001|Overall Study|Physician Decision|2|||
23807413|NCT01197417|66672755|FG000|Overall Study|Withdrawal by Subject|2|||
23807414|NCT01197417|66672756|FG001|Overall Study|Withdrawal by Subject|4|||
23807415|NCT01197417|66672755|FG000|Overall Study|Site miscommunication|0|||
23807416|NCT01197417|66672756|FG001|Overall Study|Site miscommunication|1|||
23807417|NCT01197417|66672755|FG000|Overall Study|Subject transferred to intensive care|0|||
23807418|NCT01197417|66672756|FG001|Overall Study|Subject transferred to intensive care|1|||
23807419|NCT01197417|66672755|FG000|Overall Study|Not consented in time to receive drug|0|||
23807420|NCT01197417|66672756|FG001|Overall Study|Not consented in time to receive drug|1|||
23807421|NCT01197417|66672755|FG000|Overall Study|Hypotension|1|||
23807422|NCT01197417|66672756|FG001|Overall Study|Hypotension|2|||
23807423|NCT01197417|66672755|FG000|Overall Study|Found to be ineligible|2|||
23807424|NCT01197417|66672756|FG001|Overall Study|Found to be ineligible|5|||
23807425|NCT01197417|66672755|FG000|Overall Study|No 25-hour magnesium level|0|||
23807426|NCT01197417|66672756|FG001|Overall Study|No 25-hour magnesium level|2|||
23807427|NCT01698775|66672770|FG000|Phase A|Adverse Event|2|||
23807428|NCT01698775|66672771|FG001|Phase A|Adverse Event|1|||
23807429|NCT01698775|66672770|FG000|Phase A|Death|1|||
23807430|NCT01698775|66672771|FG001|Phase A|Death|1|||
23807431|NCT01698775|66672770|FG000|Phase A|Lack of Efficacy|1|||
23807432|NCT01698775|66672771|FG001|Phase A|Lack of Efficacy|0|||
23807433|NCT01698775|66672770|FG000|Phase A|Lost to Follow-up|1|||
23807434|NCT01698775|66672771|FG001|Phase A|Lost to Follow-up|2|||
23807435|NCT01698775|66672770|FG000|Phase A|Protocol Violation|1|||
23807436|NCT01698775|66672771|FG001|Phase A|Protocol Violation|0|||
23807437|NCT01698775|66672770|FG000|Phase A|Withdrawal by Subject|3|||
23807438|NCT01698775|66672771|FG001|Phase A|Withdrawal by Subject|4|||
23807439|NCT01698775|66672770|FG000|Phase A|Kidney [transplant]|0|||
23807440|NCT01698775|66672771|FG001|Phase A|Kidney [transplant]|1|||
23807441|NCT01698775|66672770|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
23807442|NCT01698775|66672771|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
23602093|NCT01972776|65934011|FG003|Part 2|Adverse Event|0|||
23602094|NCT01972776|65934012|FG004|Part 2|Adverse Event|3|||
23602095|NCT01972776|65934013|FG005|Part 2|Adverse Event|0|||
23367224|NCT01239797|65092365|FG000|Treated Participants|Disease progression|185|||
23367225|NCT01239797|65092366|FG001|Treated Participants|Disease progression|185|||
23367226|NCT01239797|65092365|FG000|Treated Participants|Study drug toxicity|39|||
23367227|NCT01239797|65092366|FG001|Treated Participants|Study drug toxicity|45|||
23367228|NCT01239797|65092365|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
23367229|NCT01239797|65092366|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
23367230|NCT01239797|65092365|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
23367231|NCT01239797|65092366|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
23367232|NCT01239797|65092365|FG000|Treated Participants|Administrative reason by sponsor|13|||
23367233|NCT01239797|65092366|FG001|Treated Participants|Administrative reason by sponsor|4|||
23483607|NCT03036800|65513118|FG001|Overall Study|Death|0|||
23483608|NCT03036800|65513117|FG000|Overall Study|Tolerance|5|||
23483609|NCT03036800|65513118|FG001|Overall Study|Tolerance|0|||
23483610|NCT03036800|65513117|FG000|Overall Study|Unknown/no reason given|50|||
23483611|NCT03036800|65513118|FG001|Overall Study|Unknown/no reason given|39|||
23483612|NCT04449029|65513119|FG000|Overall Study|Adverse Event|0|||
23483613|NCT04449029|65513120|FG001|Overall Study|Adverse Event|1|||
23483614|NCT04449029|65513121|FG002|Overall Study|Adverse Event|1|||
23483615|NCT04449029|65513122|FG003|Overall Study|Adverse Event|0|||
23483616|NCT04449029|65513123|FG004|Overall Study|Adverse Event|1|||
23483617|NCT04449029|65513124|FG005|Overall Study|Adverse Event|0|||
23483618|NCT04449029|65513125|FG006|Overall Study|Adverse Event|1|||
23483619|NCT04449029|65513126|FG007|Overall Study|Adverse Event|0|||
23483620|NCT04449029|65513119|FG000|Overall Study|Lost to Follow-up|0|||
23483621|NCT04449029|65513120|FG001|Overall Study|Lost to Follow-up|1|||
23483622|NCT04449029|65513121|FG002|Overall Study|Lost to Follow-up|0|||
23483623|NCT04449029|65513122|FG003|Overall Study|Lost to Follow-up|0|||
23483624|NCT04449029|65513123|FG004|Overall Study|Lost to Follow-up|0|||
23483625|NCT04449029|65513124|FG005|Overall Study|Lost to Follow-up|0|||
23483626|NCT04449029|65513125|FG006|Overall Study|Lost to Follow-up|0|||
23483627|NCT04449029|65513126|FG007|Overall Study|Lost to Follow-up|0|||
23483628|NCT04449029|65513119|FG000|Overall Study|Protocol Violation|0|||
23483629|NCT04449029|65513120|FG001|Overall Study|Protocol Violation|1|||
23483630|NCT04449029|65513121|FG002|Overall Study|Protocol Violation|0|||
23483631|NCT04449029|65513122|FG003|Overall Study|Protocol Violation|0|||
23483632|NCT04449029|65513123|FG004|Overall Study|Protocol Violation|0|||
23483633|NCT04449029|65513124|FG005|Overall Study|Protocol Violation|0|||
23483634|NCT04449029|65513125|FG006|Overall Study|Protocol Violation|0|||
23483635|NCT04449029|65513126|FG007|Overall Study|Protocol Violation|0|||
23602096|NCT01972776|65934008|FG000|Part 2|Administrative problems|0|||
23602097|NCT01972776|65934009|FG001|Part 2|Administrative problems|0|||
23602098|NCT01972776|65934010|FG002|Part 2|Administrative problems|0|||
23602099|NCT01972776|65934011|FG003|Part 2|Administrative problems|0|||
23602100|NCT01972776|65934012|FG004|Part 2|Administrative problems|10|||
23602101|NCT01972776|65934013|FG005|Part 2|Administrative problems|7|||
23602102|NCT01500200|65934014|FG000|Stage 1|Adverse Event|1|||
23602103|NCT01500200|65934015|FG001|Stage 1|Adverse Event|4|||
23602104|NCT01500200|65934016|FG002|Stage 1|Adverse Event|5|||
23602105|NCT01500200|65934017|FG003|Stage 1|Adverse Event|0|||
23602106|NCT01500200|65934018|FG004|Stage 1|Adverse Event|0|||
23602107|NCT01500200|65934019|FG005|Stage 1|Adverse Event|0|||
23602108|NCT01500200|65934014|FG000|Stage 1|Lost to Follow-up|2|||
23602109|NCT01500200|65934015|FG001|Stage 1|Lost to Follow-up|2|||
23602110|NCT01500200|65934016|FG002|Stage 1|Lost to Follow-up|1|||
23602111|NCT01500200|65934017|FG003|Stage 1|Lost to Follow-up|0|||
23602112|NCT01500200|65934018|FG004|Stage 1|Lost to Follow-up|0|||
23602113|NCT01500200|65934019|FG005|Stage 1|Lost to Follow-up|0|||
23602114|NCT01500200|65934014|FG000|Stage 1|Withdrawal by Subject|3|||
23483636|NCT04449029|65513119|FG000|Overall Study|Physician Decision|0|||
23367234|NCT01239797|65092365|FG000|Treated Participants|Other reasons|14|||
23367235|NCT01239797|65092366|FG001|Treated Participants|Other reasons|14|||
23367236|NCT01239797|65092365|FG000|Treated Participants|Participant withdrew consent|6|||
23367237|NCT01239797|65092366|FG001|Treated Participants|Participant withdrew consent|11|||
23367238|NCT01239797|65092365|FG000|Treated Participants|Death|1|||
23367239|NCT01239797|65092366|FG001|Treated Participants|Death|1|||
23367240|NCT01239797|65092365|FG000|Treated Participants|Participant no longer meets study criteria|1|||
23367241|NCT01239797|65092366|FG001|Treated Participants|Participant no longer meets study criteria|1|||
23367242|NCT01239797|65092365|FG000|Treated Participants|Poor/non-compliance|0|||
23367243|NCT01239797|65092366|FG001|Treated Participants|Poor/non-compliance|1|||
23367244|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
23367245|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367246|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
23367247|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
23367248|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367249|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367250|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367251|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23483637|NCT04449029|65513120|FG001|Overall Study|Physician Decision|0|||
23483638|NCT04449029|65513121|FG002|Overall Study|Physician Decision|0|||
23483639|NCT04449029|65513122|FG003|Overall Study|Physician Decision|0|||
23483640|NCT04449029|65513123|FG004|Overall Study|Physician Decision|0|||
23661002|NCT02463071|66145724|FG001|Overall Study|Death|0|||
23661003|NCT02463071|66145725|FG002|Overall Study|Death|0|||
23661004|NCT02463071|66145723|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23661005|NCT02463071|66145724|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23661006|NCT02463071|66145725|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23661007|NCT02463071|66145723|FG000|Overall Study|Reason not specified|7|||
23661008|NCT02463071|66145724|FG001|Overall Study|Reason not specified|9|||
23661009|NCT02463071|66145725|FG002|Overall Study|Reason not specified|4|||
23661010|NCT02463071|66145723|FG000|Overall Study|Protocol Violation|0|||
23661011|NCT02463071|66145724|FG001|Overall Study|Protocol Violation|2|||
23661012|NCT02463071|66145725|FG002|Overall Study|Protocol Violation|0|||
23661013|NCT02463071|66145723|FG000|Overall Study|Lost to Follow-up|0|||
23661014|NCT02463071|66145724|FG001|Overall Study|Lost to Follow-up|0|||
23661015|NCT02463071|66145725|FG002|Overall Study|Lost to Follow-up|1|||
23661016|NCT03034460|66145726|FG000|Overall Study|Adverse Event|0|||
23661017|NCT03034460|66145727|FG001|Overall Study|Adverse Event|1|||
23661018|NCT03034460|66145726|FG000|Overall Study|Withdrawal by Subject|2|||
23661019|NCT03034460|66145727|FG001|Overall Study|Withdrawal by Subject|2|||
23661020|NCT03034460|66145726|FG000|Overall Study|Personal Reasons|1|||
23661021|NCT03034460|66145727|FG001|Overall Study|Personal Reasons|0|||
23661022|NCT04233164|66145730|FG000|Overall Study|Unable to obtain specimen|0|||
23483641|NCT04449029|65513124|FG005|Overall Study|Physician Decision|1|||
23483642|NCT04449029|65513125|FG006|Overall Study|Physician Decision|0|||
23661023|NCT04233164|66145731|FG001|Overall Study|Unable to obtain specimen|1|||
23661024|NCT01195090|66145736|FG000|Overall Study|Adverse Event|1|||
23661025|NCT01195090|66145737|FG001|Overall Study|Adverse Event|2|||
23661026|NCT01195090|66145736|FG000|Overall Study|Lost to Follow-up|2|||
23661027|NCT01195090|66145737|FG001|Overall Study|Lost to Follow-up|2|||
23661028|NCT01195090|66145736|FG000|Overall Study|Protocol Violation|3|||
23661029|NCT01195090|66145737|FG001|Overall Study|Protocol Violation|4|||
23661030|NCT01621542|66145738|FG000|Overall Study|Adverse Event|0|||
23661031|NCT01621542|66145739|FG001|Overall Study|Adverse Event|0|||
23661032|NCT01621542|66145740|FG002|Overall Study|Adverse Event|1|||
23483643|NCT04449029|65513126|FG007|Overall Study|Physician Decision|0|||
23483644|NCT04449029|65513119|FG000|Overall Study|Withdrawal by Subject|3|||
23483645|NCT04449029|65513120|FG001|Overall Study|Withdrawal by Subject|0|||
23483646|NCT04449029|65513121|FG002|Overall Study|Withdrawal by Subject|1|||
23483647|NCT04449029|65513122|FG003|Overall Study|Withdrawal by Subject|1|||
23483648|NCT04449029|65513123|FG004|Overall Study|Withdrawal by Subject|5|||
23483649|NCT04449029|65513124|FG005|Overall Study|Withdrawal by Subject|1|||
23483650|NCT04449029|65513125|FG006|Overall Study|Withdrawal by Subject|4|||
23483651|NCT04449029|65513126|FG007|Overall Study|Withdrawal by Subject|0|||
23483652|NCT05093790|65513127|FG000|Overall Study|Failure to meet continuation criteria|0|||
23483653|NCT05093790|65513128|FG001|Overall Study|Failure to meet continuation criteria|0|||
23483654|NCT05093790|65513129|FG002|Overall Study|Failure to meet continuation criteria|1|||
23661033|NCT01621542|66145741|FG003|Overall Study|Adverse Event|3|||
23483655|NCT05093790|65513130|FG003|Overall Study|Failure to meet continuation criteria|0|||
23483656|NCT05093790|65513127|FG000|Overall Study|Adverse Event|1|||
23661034|NCT01621542|66145742|FG004|Overall Study|Adverse Event|0|||
23661035|NCT01621542|66145743|FG005|Overall Study|Adverse Event|0|||
23661036|NCT01621542|66145738|FG000|Overall Study|Death|0|||
23661037|NCT01621542|66145739|FG001|Overall Study|Death|1|||
23661038|NCT01621542|66145740|FG002|Overall Study|Death|0|||
23661039|NCT01621542|66145741|FG003|Overall Study|Death|0|||
23367252|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367253|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367254|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367255|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367256|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367257|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367258|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367259|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367260|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367261|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367262|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367263|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
23367264|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
23367265|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
23367266|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
23367267|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367268|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367269|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367270|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367271|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367272|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367273|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367274|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367275|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367276|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367277|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367278|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367279|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367280|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367281|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367282|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367283|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
23367284|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
23367285|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367286|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367287|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367288|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367289|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367290|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367291|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367292|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367293|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367294|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367295|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367296|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367297|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367298|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367299|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367300|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367301|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
23367302|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367303|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367304|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367305|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367306|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367307|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367308|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367309|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367310|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367311|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23661040|NCT01621542|66145742|FG004|Overall Study|Death|0|||
23367312|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23602115|NCT01500200|65934015|FG001|Stage 1|Withdrawal by Subject|0|||
23807443|NCT01698775|66672770|FG000|Phase B|Adverse Event|6|||
23483657|NCT05093790|65513128|FG001|Overall Study|Adverse Event|0|||
23483658|NCT05093790|65513129|FG002|Overall Study|Adverse Event|0|||
23483659|NCT05093790|65513130|FG003|Overall Study|Adverse Event|0|||
23483660|NCT00384111|65513134|FG000|Overall Study|Disease Progression|3|||
23483661|NCT00384111|65513134|FG000|Overall Study|Adverse Event|1|||
23483662|NCT00384111|65513134|FG000|Overall Study|Investigator Decision|3|||
23483663|NCT00384111|65513134|FG000|Overall Study|Study Terminated by the Sponsor|19|||
23483664|NCT01888003|65513135|FG000|Overall Study|Study Terminated|5|||
23483665|NCT01888003|65513136|FG001|Overall Study|Study Terminated|6|||
23483666|NCT01888003|65513137|FG002|Overall Study|Study Terminated|40|||
23483667|NCT01089361|65513138|FG000|Overall Study|Death|1|||
23483668|NCT01089361|65513139|FG001|Overall Study|Death|0|||
23483669|NCT02274038|65513140|FG000|Overall Study|Death|1|||
23483670|NCT03911843|65513141|FG000|Overall Study|Adverse Event|2|||
23483671|NCT03911843|65513142|FG001|Overall Study|Adverse Event|0|||
23483672|NCT03911843|65513141|FG000|Overall Study|Protocol Violation|2|||
23483673|NCT03911843|65513142|FG001|Overall Study|Protocol Violation|0|||
23483674|NCT03911843|65513141|FG000|Overall Study|Lost to Follow-up|0|||
23483675|NCT03911843|65513142|FG001|Overall Study|Lost to Follow-up|1|||
23483676|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
23483677|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
23483678|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Other|2|||
23483679|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Other|2|||
23483680|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Personal reasons|2|||
23602116|NCT01500200|65934016|FG002|Stage 1|Withdrawal by Subject|0|||
23483681|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Personal reasons|2|||
23483682|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
23483683|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
23367313|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367314|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367315|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367316|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367317|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367318|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367319|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367320|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367321|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
23367322|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367323|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367324|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367325|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367326|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367327|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367328|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367329|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367330|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367331|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367332|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367333|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367334|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367335|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367336|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367337|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367338|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367339|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367340|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367341|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367342|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367343|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367344|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
23367345|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367346|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
23367347|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367348|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367349|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367350|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367351|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
23367352|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367353|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367354|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23661041|NCT01621542|66145743|FG005|Overall Study|Death|0|||
23661042|NCT01621542|66145738|FG000|Overall Study|Physician Decision|1|||
23661043|NCT01621542|66145739|FG001|Overall Study|Physician Decision|0|||
23661044|NCT01621542|66145740|FG002|Overall Study|Physician Decision|1|||
23661045|NCT01621542|66145741|FG003|Overall Study|Physician Decision|13|||
23367355|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
23367356|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367357|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367358|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
23367359|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
23367360|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
23367361|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
23367362|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
23367363|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
23367364|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
23367365|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
23367366|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
23661046|NCT01621542|66145742|FG004|Overall Study|Physician Decision|3|||
23661047|NCT01621542|66145743|FG005|Overall Study|Physician Decision|1|||
23661048|NCT01621542|66145738|FG000|Overall Study|Withdrawal by Subject|2|||
23807444|NCT01698775|66672771|FG001|Phase B|Adverse Event|3|||
23807445|NCT01698775|66672770|FG000|Phase B|Death|0|||
23807446|NCT01698775|66672771|FG001|Phase B|Death|1|||
23807447|NCT01698775|66672770|FG000|Phase B|Lack of Efficacy|0|||
23807448|NCT01698775|66672771|FG001|Phase B|Lack of Efficacy|1|||
23807449|NCT01698775|66672770|FG000|Phase B|Lost to Follow-up|0|||
23483684|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
23483685|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
23483686|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
23483687|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
23483688|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
23483689|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
23483690|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
23483691|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
23483692|NCT00667446|65513145|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
23483693|NCT00667446|65513146|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
23483694|NCT01323920|65515802|FG000|Overall Study|Death|5|||
23483695|NCT01323920|65515802|FG000|Overall Study|Withdrawal by Subject|1|||
23483696|NCT02632838|65515805|FG000|Overall Study|Withdrawal by Subject|3|||
23483697|NCT02632838|65515806|FG001|Overall Study|Withdrawal by Subject|0|||
23483698|NCT02632838|65515805|FG000|Overall Study|Lost to Follow-up|0|||
23483699|NCT02632838|65515806|FG001|Overall Study|Lost to Follow-up|2|||
23483700|NCT01227564|65515809|FG000|Overall Study|No Longer Willing to Participate|4|||
23483701|NCT01227564|65515810|FG001|Overall Study|No Longer Willing to Participate|2|||
23483702|NCT01227564|65515811|FG002|Overall Study|No Longer Willing to Participate|5|||
23483703|NCT01227564|65515809|FG000|Overall Study|Participant moved to another town|0|||
23483704|NCT01227564|65515810|FG001|Overall Study|Participant moved to another town|0|||
23483705|NCT01227564|65515811|FG002|Overall Study|Participant moved to another town|1|||
23483706|NCT00466687|65515813|FG000|Overall Study|Adverse Event|1|||
23483707|NCT00466687|65515813|FG000|Overall Study|Other complicating illness|3|||
23483708|NCT00466687|65515813|FG000|Overall Study|Withdrawal by Subject|1|||
23483709|NCT00466687|65515813|FG000|Overall Study|Disease progression|29|||
23483710|NCT01277042|65515817|FG000|Overall Study|Adverse Event|4|||
23483711|NCT01277042|65515818|FG001|Overall Study|Adverse Event|3|||
23483712|NCT01277042|65515817|FG000|Overall Study|Lost to Follow-up|2|||
23483713|NCT01277042|65515818|FG001|Overall Study|Lost to Follow-up|2|||
23483714|NCT01277042|65515817|FG000|Overall Study|Withdrawal by Subject|2|||
23483715|NCT01277042|65515818|FG001|Overall Study|Withdrawal by Subject|0|||
23483716|NCT00256282|65515819|FG000|Overall Study|Disease progression, relapse during acti|12|||
23483717|NCT00256282|65515819|FG000|Overall Study|Adverse Event|3|||
23483718|NCT00256282|65515819|FG000|Overall Study|Physician Decision|1|||
23483719|NCT02360605|65515820|FG000|Overall Study|Withdrawal by Subject|4|||
23602117|NCT01500200|65934017|FG003|Stage 1|Withdrawal by Subject|0|||
23602118|NCT01500200|65934018|FG004|Stage 1|Withdrawal by Subject|0|||
23602119|NCT01500200|65934019|FG005|Stage 1|Withdrawal by Subject|0|||
23602120|NCT01500200|65934014|FG000|Stage 1|Noncompliance with Study Drug|1|||
23602121|NCT01500200|65934015|FG001|Stage 1|Noncompliance with Study Drug|0|||
23602122|NCT01500200|65934016|FG002|Stage 1|Noncompliance with Study Drug|0|||
23602123|NCT01500200|65934017|FG003|Stage 1|Noncompliance with Study Drug|0|||
23602124|NCT01500200|65934018|FG004|Stage 1|Noncompliance with Study Drug|0|||
23602125|NCT01500200|65934019|FG005|Stage 1|Noncompliance with Study Drug|0|||
23602126|NCT01500200|65934014|FG000|Stage 1|Physician Decision|1|||
23602127|NCT01500200|65934015|FG001|Stage 1|Physician Decision|0|||
23661049|NCT01621542|66145739|FG001|Overall Study|Withdrawal by Subject|0|||
23661050|NCT01621542|66145740|FG002|Overall Study|Withdrawal by Subject|1|||
23661051|NCT01621542|66145741|FG003|Overall Study|Withdrawal by Subject|3|||
23661052|NCT01621542|66145742|FG004|Overall Study|Withdrawal by Subject|3|||
23661053|NCT01621542|66145743|FG005|Overall Study|Withdrawal by Subject|3|||
23661054|NCT01621542|66145738|FG000|Overall Study|progression/treatment failure|2|||
23661055|NCT01621542|66145739|FG001|Overall Study|progression/treatment failure|4|||
23661056|NCT01621542|66145740|FG002|Overall Study|progression/treatment failure|3|||
23661057|NCT01621542|66145741|FG003|Overall Study|progression/treatment failure|7|||
23483720|NCT02360605|65515821|FG001|Overall Study|Withdrawal by Subject|9|||
23483721|NCT02360605|65515820|FG000|Overall Study|Lost to Follow-up|7|||
23483722|NCT02360605|65515821|FG001|Overall Study|Lost to Follow-up|8|||
23602128|NCT01500200|65934016|FG002|Stage 1|Physician Decision|0|||
23602129|NCT01500200|65934017|FG003|Stage 1|Physician Decision|0|||
23602130|NCT01500200|65934018|FG004|Stage 1|Physician Decision|0|||
23602131|NCT01500200|65934019|FG005|Stage 1|Physician Decision|0|||
23602132|NCT01500200|65934014|FG000|Stage 2|Adverse Event|0|||
23807450|NCT01698775|66672771|FG001|Phase B|Lost to Follow-up|1|||
23483723|NCT02360605|65515820|FG000|Overall Study|Death|0|||
23602133|NCT01500200|65934015|FG001|Stage 2|Adverse Event|0|||
23483724|NCT02360605|65515821|FG001|Overall Study|Death|1|||
23483725|NCT03418571|65515822|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
23483726|NCT03418571|65515823|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
23483727|NCT02054481|65515824|FG000|Overall Study|Adverse Event|1|||
23483728|NCT02054481|65515825|FG001|Overall Study|Adverse Event|1|||
23483729|NCT02054481|65515826|FG002|Overall Study|Adverse Event|0|||
23483730|NCT02054481|65515827|FG003|Overall Study|Adverse Event|1|||
23483731|NCT02054481|65515824|FG000|Overall Study|Lost to Follow-up|1|||
23483732|NCT02054481|65515825|FG001|Overall Study|Lost to Follow-up|0|||
23483733|NCT02054481|65515826|FG002|Overall Study|Lost to Follow-up|0|||
23483734|NCT02054481|65515827|FG003|Overall Study|Lost to Follow-up|0|||
23483735|NCT02054481|65515824|FG000|Overall Study|Other reason|2|||
23483736|NCT02054481|65515825|FG001|Overall Study|Other reason|1|||
23483737|NCT02054481|65515826|FG002|Overall Study|Other reason|2|||
23483738|NCT02054481|65515827|FG003|Overall Study|Other reason|0|||
23483739|NCT02663687|65515830|FG000|Overall Study|Adverse Event|1|||
23483740|NCT02663687|65515831|FG001|Overall Study|Adverse Event|0|||
23483741|NCT02663687|65515832|FG002|Overall Study|Adverse Event|0|||
23483742|NCT02663687|65515833|FG003|Overall Study|Adverse Event|0|||
23483743|NCT02663687|65515834|FG004|Overall Study|Adverse Event|0|||
23483744|NCT02663687|65515830|FG000|Overall Study|Other|1|||
23483745|NCT02663687|65515831|FG001|Overall Study|Other|0|||
23483746|NCT02663687|65515832|FG002|Overall Study|Other|1|||
23483747|NCT02663687|65515833|FG003|Overall Study|Other|0|||
23483748|NCT02663687|65515834|FG004|Overall Study|Other|0|||
23483749|NCT04285580|65515839|FG000|Overall Study|Protocol Violation|0|||
23483750|NCT04285580|65515840|FG001|Overall Study|Protocol Violation|1|||
23483751|NCT00704522|65515841|FG000|Overall Study|Lack of Efficacy|65|||
23483752|NCT00704522|65515842|FG001|Overall Study|Lack of Efficacy|17|||
23483753|NCT00704522|65515841|FG000|Overall Study|Failure to appear again at hospital|56|||
23483754|NCT00704522|65515842|FG001|Overall Study|Failure to appear again at hospital|10|||
23483755|NCT00704522|65515841|FG000|Overall Study|Withdrawal by Subject|17|||
23483756|NCT00704522|65515842|FG001|Overall Study|Withdrawal by Subject|8|||
23483757|NCT00704522|65515841|FG000|Overall Study|Adverse Event|9|||
23483758|NCT00704522|65515842|FG001|Overall Study|Adverse Event|1|||
23483759|NCT00704522|65515841|FG000|Overall Study|Undefined causes|9|||
23483760|NCT00704522|65515842|FG001|Overall Study|Undefined causes|7|||
23483761|NCT00704522|65515841|FG000|Overall Study|No information on therapy end|27|||
23483762|NCT00704522|65515842|FG001|Overall Study|No information on therapy end|2|||
23483763|NCT00476047|65515843|FG000|Overall Study|Lost to Follow-up|1|||
23483764|NCT00214500|65515844|FG000|Treatment Period|Adverse Event|1|||
23483765|NCT00214500|65515844|FG000|Extension Period|Withdrawal by Subject|2|||
23483766|NCT01117051|65515847|FG000|Overall Study|Withdrawal by Subject|5|||
23483767|NCT01117051|65515848|FG001|Overall Study|Withdrawal by Subject|3|||
23483768|NCT01117051|65515847|FG000|Overall Study|Adverse Event|4|||
23483769|NCT01117051|65515848|FG001|Overall Study|Adverse Event|3|||
23483770|NCT01117051|65515847|FG000|Overall Study|Lost to Follow-up|0|||
23483771|NCT01117051|65515848|FG001|Overall Study|Lost to Follow-up|1|||
23483772|NCT01117051|65515847|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
23483773|NCT01117051|65515848|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
23483774|NCT01117051|65515847|FG000|Overall Study|Sponsor's decision|3|||
23483775|NCT01117051|65515848|FG001|Overall Study|Sponsor's decision|1|||
23483776|NCT01117051|65515847|FG000|Overall Study|Surgical procedure|0|||
23483777|NCT01117051|65515848|FG001|Overall Study|Surgical procedure|1|||
23602134|NCT01500200|65934016|FG002|Stage 2|Adverse Event|0|||
23602135|NCT01500200|65934017|FG003|Stage 2|Adverse Event|0|||
23483778|NCT01117051|65515847|FG000|Overall Study|Randomized by mistake|0|||
23483779|NCT01117051|65515848|FG001|Overall Study|Randomized by mistake|1|||
23483780|NCT01117051|65515847|FG000|Overall Study|Convenience issue|1|||
23483781|NCT01117051|65515848|FG001|Overall Study|Convenience issue|0|||
23483782|NCT00378079|65515849|FG000|Overall Study|Lost to Follow-up|6|||
23483783|NCT00378079|65515850|FG001|Overall Study|Lost to Follow-up|1|||
23483784|NCT00378079|65515851|FG002|Overall Study|Lost to Follow-up|0|||
23483785|NCT00667420|65515856|FG000|Overall Study|Adverse Event|2|||
23483786|NCT00667420|65515856|FG000|Overall Study|Lack of Efficacy|5|||
23483787|NCT00667420|65515856|FG000|Overall Study|Physician Decision|1|||
23483788|NCT00667420|65515856|FG000|Overall Study|Withdrawal by Subject|2|||
23483789|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
23602136|NCT01500200|65934018|FG004|Stage 2|Adverse Event|5|||
23483790|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
23483791|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
23483792|NCT02711345|65515860|FG000|Overall Study|Adverse Event|0|||
23483793|NCT02711345|65515861|FG001|Overall Study|Adverse Event|0|||
23483794|NCT02711345|65515862|FG002|Overall Study|Adverse Event|0|||
23483795|NCT02711345|65515863|FG003|Overall Study|Adverse Event|1|||
23483796|NCT02711345|65515864|FG004|Overall Study|Adverse Event|1|||
23483797|NCT02711345|65515865|FG005|Overall Study|Adverse Event|2|||
23483798|NCT02711345|65515866|FG006|Overall Study|Adverse Event|1|||
23483799|NCT02711345|65515867|FG007|Overall Study|Adverse Event|0|||
23483800|NCT02711345|65515868|FG008|Overall Study|Adverse Event|0|||
23483801|NCT02711345|65515869|FG009|Overall Study|Adverse Event|2|||
23483802|NCT02711345|65515860|FG000|Overall Study|Physician Decision|0|||
23483803|NCT02711345|65515861|FG001|Overall Study|Physician Decision|0|||
23367367|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
23367368|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
23367369|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
23367370|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
23367371|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
23367372|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
23367373|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
23367374|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
23367375|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
23367376|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
23367377|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367378|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367379|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367380|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367381|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
23367382|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
23367383|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
23367384|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367385|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367386|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367387|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367388|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367389|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
23367390|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
23367391|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
23367392|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
23367393|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367394|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367395|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
23367396|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367397|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367398|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367399|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367400|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367401|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367402|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367403|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367404|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367405|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367406|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367407|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
23483804|NCT02711345|65515862|FG002|Overall Study|Physician Decision|1|||
23483805|NCT02711345|65515863|FG003|Overall Study|Physician Decision|0|||
23483806|NCT02711345|65515864|FG004|Overall Study|Physician Decision|0|||
23483807|NCT02711345|65515865|FG005|Overall Study|Physician Decision|0|||
23483808|NCT02711345|65515866|FG006|Overall Study|Physician Decision|0|||
23483809|NCT02711345|65515867|FG007|Overall Study|Physician Decision|0|||
23483810|NCT02711345|65515868|FG008|Overall Study|Physician Decision|1|||
23483811|NCT02711345|65515869|FG009|Overall Study|Physician Decision|0|||
23483812|NCT02711345|65515860|FG000|Overall Study|Progressive disease|1|||
23483813|NCT02711345|65515861|FG001|Overall Study|Progressive disease|3|||
23483814|NCT02711345|65515862|FG002|Overall Study|Progressive disease|5|||
23483815|NCT02711345|65515863|FG003|Overall Study|Progressive disease|3|||
23483816|NCT02711345|65515864|FG004|Overall Study|Progressive disease|7|||
23483817|NCT02711345|65515865|FG005|Overall Study|Progressive disease|2|||
23483818|NCT02711345|65515866|FG006|Overall Study|Progressive disease|8|||
23483819|NCT02711345|65515867|FG007|Overall Study|Progressive disease|4|||
23483820|NCT02711345|65515868|FG008|Overall Study|Progressive disease|5|||
23483821|NCT02711345|65515869|FG009|Overall Study|Progressive disease|6|||
23483822|NCT02711345|65515860|FG000|Overall Study|Subject/guardian decision|0|||
23483823|NCT02711345|65515861|FG001|Overall Study|Subject/guardian decision|0|||
23483824|NCT02711345|65515862|FG002|Overall Study|Subject/guardian decision|0|||
23483825|NCT02711345|65515863|FG003|Overall Study|Subject/guardian decision|0|||
23483826|NCT02711345|65515864|FG004|Overall Study|Subject/guardian decision|0|||
23483827|NCT02711345|65515865|FG005|Overall Study|Subject/guardian decision|2|||
23483828|NCT02711345|65515866|FG006|Overall Study|Subject/guardian decision|3|||
23483829|NCT02711345|65515867|FG007|Overall Study|Subject/guardian decision|1|||
23483830|NCT02711345|65515868|FG008|Overall Study|Subject/guardian decision|0|||
23483831|NCT02711345|65515869|FG009|Overall Study|Subject/guardian decision|4|||
23483832|NCT02711345|65515860|FG000|Overall Study|Death|1|||
23483833|NCT02711345|65515861|FG001|Overall Study|Death|0|||
23483834|NCT02711345|65515862|FG002|Overall Study|Death|0|||
23483835|NCT02711345|65515863|FG003|Overall Study|Death|0|||
23483836|NCT02711345|65515864|FG004|Overall Study|Death|0|||
23483837|NCT02711345|65515865|FG005|Overall Study|Death|0|||
23483838|NCT02711345|65515866|FG006|Overall Study|Death|0|||
23483839|NCT02711345|65515867|FG007|Overall Study|Death|1|||
23483840|NCT02711345|65515868|FG008|Overall Study|Death|0|||
23483841|NCT02711345|65515869|FG009|Overall Study|Death|0|||
23483842|NCT01611454|65515871|FG000|Overall Study|Lack of Efficacy|18|||
23483843|NCT01611454|65515872|FG001|Overall Study|Lack of Efficacy|10|||
23483844|NCT01931670|65515873|FG000|Treatment Period|Exclusionary Medication Received|1|||
23483845|NCT01931670|65515874|FG001|Treatment Period|Exclusionary Medication Received|1|||
23483846|NCT01931670|65515875|FG002|Treatment Period|Exclusionary Medication Received|1|||
23483847|NCT01931670|65515873|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
23483848|NCT01931670|65515874|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
23483849|NCT01931670|65515875|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
23483850|NCT01931670|65515873|FG000|Treatment Period|Subject Noncompliant|4|||
23483851|NCT01931670|65515874|FG001|Treatment Period|Subject Noncompliant|9|||
23483852|NCT01931670|65515875|FG002|Treatment Period|Subject Noncompliant|5|||
23483853|NCT01931670|65515873|FG000|Treatment Period|Adverse Event|19|||
23483854|NCT01931670|65515874|FG001|Treatment Period|Adverse Event|8|||
23483855|NCT01931670|65515875|FG002|Treatment Period|Adverse Event|21|||
23483856|NCT01931670|65515873|FG000|Treatment Period|Lack of Efficacy|11|||
23483857|NCT01931670|65515874|FG001|Treatment Period|Lack of Efficacy|2|||
23483858|NCT01931670|65515875|FG002|Treatment Period|Lack of Efficacy|2|||
23483859|NCT01931670|65515873|FG000|Treatment Period|Pregnancy|7|||
23483860|NCT01931670|65515874|FG001|Treatment Period|Pregnancy|2|||
23483861|NCT01931670|65515875|FG002|Treatment Period|Pregnancy|0|||
23483862|NCT01931670|65515873|FG000|Treatment Period|Other|8|||
23483863|NCT01931670|65515874|FG001|Treatment Period|Other|7|||
23483864|NCT01931670|65515875|FG002|Treatment Period|Other|2|||
23483865|NCT01931670|65515873|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
23483866|NCT01931670|65515874|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
23483867|NCT01931670|65515875|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
23483868|NCT01931670|65515873|FG000|Treatment Period|Lost to Follow-up|19|||
23483869|NCT01931670|65515874|FG001|Treatment Period|Lost to Follow-up|5|||
23483870|NCT01931670|65515875|FG002|Treatment Period|Lost to Follow-up|7|||
23483871|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
23483872|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
23483873|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
23483874|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
23483875|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
23483876|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
23483877|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
23483878|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
23483879|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
23483880|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
23483881|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
23483882|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
23483883|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
23483884|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
23483885|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
23483886|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
23483887|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
23483888|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
23483889|NCT02496676|65515877|FG000|Phase 1 - Period 1|Adverse Event|0|||
23483890|NCT02496676|65515878|FG001|Phase 1 - Period 1|Adverse Event|1|||
23483891|NCT02496676|65515877|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
23483892|NCT02496676|65515878|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
23483893|NCT02025556|65515879|FG000|Overall Study|Adverse Event|0|||
23483894|NCT02025556|65515880|FG001|Overall Study|Adverse Event|4|||
23483895|NCT02025556|65515881|FG002|Overall Study|Adverse Event|2|||
23483896|NCT02025556|65515879|FG000|Overall Study|Lack of Efficacy|2|||
23483897|NCT02025556|65515880|FG001|Overall Study|Lack of Efficacy|1|||
23483898|NCT02025556|65515881|FG002|Overall Study|Lack of Efficacy|0|||
23483899|NCT02025556|65515879|FG000|Overall Study|Protocol Violation|2|||
23483900|NCT02025556|65515880|FG001|Overall Study|Protocol Violation|1|||
23483901|NCT02025556|65515881|FG002|Overall Study|Protocol Violation|0|||
23367408|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367409|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367410|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
23367411|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367412|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367413|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367414|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367415|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
23367416|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
23367417|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
23367418|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
23367419|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
23367420|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
23367421|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
23367422|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
23367423|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
23367424|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
23367425|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
23367426|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
23367427|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
23367428|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
23367429|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
23367430|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
23367431|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
23367432|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
23367433|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
23367434|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367435|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367436|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367437|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367438|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367439|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367440|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
23367441|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367442|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367443|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367444|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367445|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23661058|NCT01621542|66145742|FG004|Overall Study|progression/treatment failure|3|||
23661059|NCT01621542|66145743|FG005|Overall Study|progression/treatment failure|5|||
23661060|NCT01621542|66145738|FG000|Overall Study|Protocol Violation|0|||
23661061|NCT01621542|66145739|FG001|Overall Study|Protocol Violation|0|||
23661062|NCT01621542|66145740|FG002|Overall Study|Protocol Violation|0|||
23661063|NCT01621542|66145741|FG003|Overall Study|Protocol Violation|1|||
23661064|NCT01621542|66145742|FG004|Overall Study|Protocol Violation|0|||
23661065|NCT01621542|66145743|FG005|Overall Study|Protocol Violation|0|||
23661066|NCT01621542|66145738|FG000|Overall Study|study stopped by sponsor|0|||
23367446|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367447|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367448|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367449|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367450|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367451|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23661067|NCT01621542|66145739|FG001|Overall Study|study stopped by sponsor|0|||
23661068|NCT01621542|66145740|FG002|Overall Study|study stopped by sponsor|0|||
23367452|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
23367453|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367454|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367455|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367456|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367457|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
23367458|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
23367459|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367460|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367461|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
23367462|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
23367463|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
23367464|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
23367465|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367466|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
23367467|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
23367468|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
23367469|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
23367470|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
23367471|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
23367472|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367473|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367474|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367475|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367476|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367477|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367478|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367479|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367480|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367481|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
23367482|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
23367483|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367484|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367485|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367486|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
23367487|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367488|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
23367489|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367490|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367491|NCT00676403|65092386|FG000|Overall Study|Adverse Event|1|||
23367492|NCT00676403|65092387|FG001|Overall Study|Adverse Event|2|||
23367493|NCT00676403|65092388|FG002|Overall Study|Adverse Event|0|||
23367494|NCT00676403|65092389|FG003|Overall Study|Adverse Event|5|||
23367495|NCT00676403|65092390|FG004|Overall Study|Adverse Event|1|||
23367496|NCT00676403|65092391|FG005|Overall Study|Adverse Event|2|||
23367497|NCT00676403|65092386|FG000|Overall Study|Lost to Follow-up|0|||
23367498|NCT00676403|65092387|FG001|Overall Study|Lost to Follow-up|0|||
23807451|NCT01698775|66672770|FG000|Phase B|Physician Decision|1|||
23807452|NCT01698775|66672771|FG001|Phase B|Physician Decision|1|||
23807453|NCT01698775|66672770|FG000|Phase B|Protocol Violation|1|||
23807454|NCT01698775|66672771|FG001|Phase B|Protocol Violation|1|||
23807455|NCT01698775|66672770|FG000|Phase B|Withdrawal by Subject|6|||
23807456|NCT01698775|66672771|FG001|Phase B|Withdrawal by Subject|2|||
23807457|NCT02177136|66672776|FG000|DB Phase|Withdrawal by Subject|2|||
23807458|NCT02177136|66672777|FG001|DB Phase|Withdrawal by Subject|0|||
23807459|NCT02177136|66672778|FG002|DB Phase|Withdrawal by Subject|0|||
23807460|NCT02177136|66672779|FG003|DB Phase|Withdrawal by Subject|0|||
23807461|NCT02177136|66672776|FG000|DB Phase|Discontinued Due to Pruritus|1|||
23367499|NCT00676403|65092388|FG002|Overall Study|Lost to Follow-up|0|||
23367500|NCT00676403|65092389|FG003|Overall Study|Lost to Follow-up|0|||
23367501|NCT00676403|65092390|FG004|Overall Study|Lost to Follow-up|0|||
23367502|NCT00676403|65092391|FG005|Overall Study|Lost to Follow-up|1|||
23367503|NCT00676403|65092386|FG000|Overall Study|Reason Unspecified|1|||
23367504|NCT00676403|65092387|FG001|Overall Study|Reason Unspecified|0|||
23367505|NCT00676403|65092388|FG002|Overall Study|Reason Unspecified|1|||
23367506|NCT00676403|65092389|FG003|Overall Study|Reason Unspecified|0|||
23367507|NCT00676403|65092390|FG004|Overall Study|Reason Unspecified|0|||
23483902|NCT02025556|65515879|FG000|Overall Study|Withdrawal by Subject|0|||
23483903|NCT02025556|65515880|FG001|Overall Study|Withdrawal by Subject|3|||
23661069|NCT01621542|66145741|FG003|Overall Study|study stopped by sponsor|1|||
23661070|NCT01621542|66145742|FG004|Overall Study|study stopped by sponsor|0|||
23661071|NCT01621542|66145743|FG005|Overall Study|study stopped by sponsor|0|||
23661072|NCT00359021|66145749|FG000|Overall Study|Adverse Event|26|||
23661073|NCT00359021|66145750|FG001|Overall Study|Adverse Event|8|||
23661074|NCT00359021|66145749|FG000|Overall Study|Subject Non-Compliant|1|||
23661075|NCT00359021|66145750|FG001|Overall Study|Subject Non-Compliant|2|||
23661076|NCT00359021|66145749|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
23661077|NCT00359021|66145750|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
23661078|NCT00359021|66145749|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
23661079|NCT00359021|66145750|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
23661080|NCT00359021|66145749|FG000|Overall Study|Withdrawal by Subject|2|||
23661081|NCT00359021|66145750|FG001|Overall Study|Withdrawal by Subject|9|||
23661082|NCT00359021|66145749|FG000|Overall Study|Lost to Follow-up|1|||
23483904|NCT02025556|65515881|FG002|Overall Study|Withdrawal by Subject|6|||
23483905|NCT02025556|65515879|FG000|Overall Study|Lost to Follow-up|2|||
23483906|NCT02025556|65515880|FG001|Overall Study|Lost to Follow-up|4|||
23483907|NCT02025556|65515881|FG002|Overall Study|Lost to Follow-up|0|||
23483908|NCT02025556|65515879|FG000|Overall Study|Reason not reported|0|||
23483909|NCT02025556|65515880|FG001|Overall Study|Reason not reported|0|||
23483910|NCT02025556|65515881|FG002|Overall Study|Reason not reported|1|||
23483911|NCT03612856|65515885|FG000|Pre-dose Period|Physician Decision|0|||
23483912|NCT03612856|65515886|FG001|Pre-dose Period|Physician Decision|1|||
23602137|NCT01500200|65934019|FG005|Stage 2|Adverse Event|4|||
23602138|NCT03066609|65934020|FG000|INDUCTION|Pregnancy|0|||
23602139|NCT03066609|65934021|FG001|INDUCTION|Pregnancy|0|||
23602140|NCT03066609|65934022|FG002|INDUCTION|Pregnancy|1|||
23602141|NCT03066609|65934023|FG003|INDUCTION|Pregnancy|0|||
23602142|NCT03066609|65934020|FG000|INDUCTION|Lack of Efficacy|0|||
23602143|NCT03066609|65934021|FG001|INDUCTION|Lack of Efficacy|0|||
23602144|NCT03066609|65934022|FG002|INDUCTION|Lack of Efficacy|1|||
23602145|NCT03066609|65934023|FG003|INDUCTION|Lack of Efficacy|0|||
23602146|NCT03066609|65934020|FG000|INDUCTION|Adverse Event|2|||
23602147|NCT03066609|65934021|FG001|INDUCTION|Adverse Event|2|||
23602148|NCT03066609|65934022|FG002|INDUCTION|Adverse Event|0|||
23602149|NCT03066609|65934023|FG003|INDUCTION|Adverse Event|0|||
23602150|NCT03066609|65934020|FG000|MAINTENANCE|Adverse Event|0|||
23602151|NCT03066609|65934021|FG001|MAINTENANCE|Adverse Event|0|||
23602152|NCT03066609|65934022|FG002|MAINTENANCE|Adverse Event|0|||
23602153|NCT03066609|65934023|FG003|MAINTENANCE|Adverse Event|1|||
23602154|NCT03066609|65934020|FG000|MAINTENANCE|Withdrawal by Subject|4|||
23602155|NCT03066609|65934021|FG001|MAINTENANCE|Withdrawal by Subject|2|||
23602156|NCT03066609|65934022|FG002|MAINTENANCE|Withdrawal by Subject|1|||
23602157|NCT03066609|65934023|FG003|MAINTENANCE|Withdrawal by Subject|1|||
23602158|NCT03066609|65934020|FG000|MAINTENANCE|Lost to Follow-up|0|||
23602159|NCT03066609|65934021|FG001|MAINTENANCE|Lost to Follow-up|1|||
23602160|NCT03066609|65934022|FG002|MAINTENANCE|Lost to Follow-up|1|||
23602161|NCT03066609|65934023|FG003|MAINTENANCE|Lost to Follow-up|0|||
23602162|NCT03066609|65934020|FG000|MAINTENANCE|Pregnancy|1|||
23602163|NCT03066609|65934021|FG001|MAINTENANCE|Pregnancy|0|||
23661083|NCT00359021|66145750|FG001|Overall Study|Lost to Follow-up|0|||
23661084|NCT00359021|66145749|FG000|Overall Study|Other|4|||
23661085|NCT00359021|66145750|FG001|Overall Study|Other|1|||
23661086|NCT00359021|66145749|FG000|Overall Study|Pregnancy|1|||
23661087|NCT00359021|66145750|FG001|Overall Study|Pregnancy|0|||
23661088|NCT01092143|66145752|FG000|Overall Study|Adverse Event|10|||
23367508|NCT00676403|65092391|FG005|Overall Study|Reason Unspecified|1|||
23367509|NCT00676403|65092386|FG000|Overall Study|Withdrawal by Subject|0|||
23602164|NCT03066609|65934022|FG002|MAINTENANCE|Pregnancy|0|||
23602165|NCT03066609|65934023|FG003|MAINTENANCE|Pregnancy|0|||
23602166|NCT03066609|65934020|FG000|MAINTENANCE|Lack of Efficacy|2|||
23602167|NCT03066609|65934021|FG001|MAINTENANCE|Lack of Efficacy|1|||
23483913|NCT03612856|65515887|FG002|Pre-dose Period|Physician Decision|1|||
23602168|NCT03066609|65934022|FG002|MAINTENANCE|Lack of Efficacy|0|||
23602169|NCT03066609|65934023|FG003|MAINTENANCE|Lack of Efficacy|1|||
23602170|NCT03066609|65934020|FG000|OVERALL STUDY|Adverse Event|2|||
23602171|NCT03066609|65934021|FG001|OVERALL STUDY|Adverse Event|2|||
23602172|NCT03066609|65934022|FG002|OVERALL STUDY|Adverse Event|0|||
23602173|NCT03066609|65934023|FG003|OVERALL STUDY|Adverse Event|1|||
23602174|NCT03066609|65934020|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
23661089|NCT01092143|66145753|FG001|Overall Study|Adverse Event|5|||
23661090|NCT01092143|66145754|FG002|Overall Study|Adverse Event|1|||
23661091|NCT01092143|66145755|FG003|Overall Study|Adverse Event|4|||
23661092|NCT01092143|66145756|FG004|Overall Study|Adverse Event|3|||
23661093|NCT01092143|66145752|FG000|Overall Study|Lost to Follow-up|1|||
23661094|NCT01092143|66145753|FG001|Overall Study|Lost to Follow-up|0|||
23661095|NCT01092143|66145754|FG002|Overall Study|Lost to Follow-up|1|||
23661096|NCT01092143|66145755|FG003|Overall Study|Lost to Follow-up|0|||
23661097|NCT01092143|66145756|FG004|Overall Study|Lost to Follow-up|0|||
23661098|NCT01092143|66145752|FG000|Overall Study|Consent withdrawn|2|||
23661099|NCT01092143|66145753|FG001|Overall Study|Consent withdrawn|1|||
23483914|NCT03612856|65515885|FG000|Pre-dose Period|Withdrawal by Subject|0|||
23483915|NCT03612856|65515886|FG001|Pre-dose Period|Withdrawal by Subject|1|||
23661100|NCT01092143|66145754|FG002|Overall Study|Consent withdrawn|0|||
23661101|NCT01092143|66145755|FG003|Overall Study|Consent withdrawn|1|||
23661102|NCT01092143|66145756|FG004|Overall Study|Consent withdrawn|3|||
23661103|NCT01092143|66145752|FG000|Overall Study|Not treated|0|||
23661104|NCT01092143|66145753|FG001|Overall Study|Not treated|0|||
23661105|NCT01092143|66145754|FG002|Overall Study|Not treated|1|||
23661106|NCT01092143|66145755|FG003|Overall Study|Not treated|0|||
23661107|NCT01092143|66145756|FG004|Overall Study|Not treated|0|||
23661108|NCT01092143|66145752|FG000|Overall Study|did not reversibility criteria|0|||
23661109|NCT01092143|66145753|FG001|Overall Study|did not reversibility criteria|0|||
23661110|NCT01092143|66145754|FG002|Overall Study|did not reversibility criteria|1|||
23661111|NCT01092143|66145755|FG003|Overall Study|did not reversibility criteria|0|||
23661112|NCT01092143|66145756|FG004|Overall Study|did not reversibility criteria|0|||
23661113|NCT01092143|66145752|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
23661114|NCT01092143|66145753|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
23661115|NCT01092143|66145754|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
23602175|NCT03066609|65934021|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
23602176|NCT03066609|65934022|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
23602177|NCT03066609|65934023|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
23602178|NCT03066609|65934020|FG000|OVERALL STUDY|Lost to Follow-up|1|||
23602179|NCT03066609|65934021|FG001|OVERALL STUDY|Lost to Follow-up|1|||
23602180|NCT03066609|65934022|FG002|OVERALL STUDY|Lost to Follow-up|1|||
23602181|NCT03066609|65934023|FG003|OVERALL STUDY|Lost to Follow-up|1|||
23602182|NCT03066609|65934020|FG000|OVERALL STUDY|Pregnancy|1|||
23602183|NCT03066609|65934021|FG001|OVERALL STUDY|Pregnancy|0|||
23602184|NCT03066609|65934022|FG002|OVERALL STUDY|Pregnancy|1|||
23661116|NCT01092143|66145755|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
23661117|NCT01092143|66145756|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
23661118|NCT01092143|66145752|FG000|Overall Study|Ineligible patient|1|||
23661119|NCT01092143|66145753|FG001|Overall Study|Ineligible patient|0|||
23661120|NCT01092143|66145754|FG002|Overall Study|Ineligible patient|0|||
23661121|NCT01092143|66145755|FG003|Overall Study|Ineligible patient|0|||
23661122|NCT01092143|66145756|FG004|Overall Study|Ineligible patient|0|||
23661123|NCT01092143|66145752|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
23661124|NCT01092143|66145753|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
23661125|NCT01092143|66145754|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
23661126|NCT01092143|66145755|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
23661127|NCT01092143|66145756|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
23661128|NCT01092143|66145752|FG000|Overall Study|Patient travel|0|||
23661129|NCT01092143|66145753|FG001|Overall Study|Patient travel|0|||
23661130|NCT01092143|66145754|FG002|Overall Study|Patient travel|0|||
23661131|NCT01092143|66145755|FG003|Overall Study|Patient travel|0|||
23661132|NCT01092143|66145756|FG004|Overall Study|Patient travel|1|||
23661133|NCT01092143|66145752|FG000|Overall Study|Non compliance with study medication|0|||
23602185|NCT03066609|65934023|FG003|OVERALL STUDY|Pregnancy|0|||
23602186|NCT03066609|65934020|FG000|OVERALL STUDY|Lack of Efficacy|2|||
23661134|NCT01092143|66145753|FG001|Overall Study|Non compliance with study medication|0|||
23661135|NCT01092143|66145754|FG002|Overall Study|Non compliance with study medication|0|||
23661136|NCT01092143|66145755|FG003|Overall Study|Non compliance with study medication|0|||
23661137|NCT01092143|66145756|FG004|Overall Study|Non compliance with study medication|1|||
23661138|NCT01092143|66145752|FG000|Overall Study|Randomized by mistake|0|||
23661139|NCT01092143|66145753|FG001|Overall Study|Randomized by mistake|0|||
23661140|NCT01092143|66145754|FG002|Overall Study|Randomized by mistake|0|||
23661141|NCT01092143|66145755|FG003|Overall Study|Randomized by mistake|1|||
23661142|NCT01092143|66145756|FG004|Overall Study|Randomized by mistake|0|||
23661143|NCT01092143|66145752|FG000|Overall Study|Pregnancy|0|||
23661144|NCT01092143|66145753|FG001|Overall Study|Pregnancy|0|||
23483916|NCT03612856|65515887|FG002|Pre-dose Period|Withdrawal by Subject|0|||
23483917|NCT01251146|65515888|FG000|Overall Study|Lost to Follow-up|3|||
23483918|NCT01251146|65515889|FG001|Overall Study|Lost to Follow-up|10|||
23483919|NCT00058539|65515890|FG000|Overall Study|Disease progression|24|||
23483920|NCT00058539|65515890|FG000|Overall Study|Adverse Event|3|||
23602187|NCT03066609|65934021|FG001|OVERALL STUDY|Lack of Efficacy|1|||
23602188|NCT03066609|65934022|FG002|OVERALL STUDY|Lack of Efficacy|1|||
23602189|NCT03066609|65934023|FG003|OVERALL STUDY|Lack of Efficacy|1|||
23661145|NCT01092143|66145754|FG002|Overall Study|Pregnancy|0|||
23661146|NCT01092143|66145755|FG003|Overall Study|Pregnancy|1|||
23661147|NCT01092143|66145756|FG004|Overall Study|Pregnancy|0|||
23661148|NCT02046096|66145757|FG000|Overall Study|Death|28|||
23661149|NCT02046096|66145758|FG001|Overall Study|Death|45|||
23661150|NCT02046096|66145757|FG000|Overall Study|Lost to Follow-up|9|||
23661151|NCT02046096|66145758|FG001|Overall Study|Lost to Follow-up|20|||
23661152|NCT02046096|66145757|FG000|Overall Study|Withdrawal by Subject|5|||
23661153|NCT02046096|66145758|FG001|Overall Study|Withdrawal by Subject|17|||
23661154|NCT02046096|66145757|FG000|Overall Study|Other endpoint|2|||
23661155|NCT02046096|66145758|FG001|Overall Study|Other endpoint|19|||
23661156|NCT00455013|66145759|FG000|Short Term Period|Adverse Event|2|||
23661157|NCT00455013|66145760|FG001|Short Term Period|Adverse Event|5|||
23661158|NCT00455013|66145761|FG002|Short Term Period|Adverse Event|0|||
23602190|NCT03066609|65934020|FG000|OVERALL STUDY|discontinued follow up|0|||
23602191|NCT03066609|65934021|FG001|OVERALL STUDY|discontinued follow up|2|||
23661159|NCT00455013|66145759|FG000|Short Term Period|Withdrawal by Subject|0|||
23661160|NCT00455013|66145760|FG001|Short Term Period|Withdrawal by Subject|0|||
23661161|NCT00455013|66145761|FG002|Short Term Period|Withdrawal by Subject|1|||
23661162|NCT00455013|66145759|FG000|Short Term Period|Lack of Efficacy|4|||
23661163|NCT00455013|66145760|FG001|Short Term Period|Lack of Efficacy|0|||
23661164|NCT00455013|66145761|FG002|Short Term Period|Lack of Efficacy|0|||
23661165|NCT00455013|66145759|FG000|Short Term Period|Other|0|||
23661166|NCT00455013|66145760|FG001|Short Term Period|Other|0|||
23661167|NCT00455013|66145761|FG002|Short Term Period|Other|1|||
23661168|NCT00455013|66145759|FG000|Long Term Extension (LTE)|Adverse Event|0|||
23807462|NCT02177136|66672777|FG001|DB Phase|Discontinued Due to Pruritus|3|||
23807463|NCT02177136|66672778|FG002|DB Phase|Discontinued Due to Pruritus|0|||
23807464|NCT02177136|66672779|FG003|DB Phase|Discontinued Due to Pruritus|0|||
23807465|NCT02177136|66672776|FG000|DB Phase|Adverse Event|3|||
23807466|NCT02177136|66672777|FG001|DB Phase|Adverse Event|2|||
23807467|NCT02177136|66672778|FG002|DB Phase|Adverse Event|3|||
23807468|NCT02177136|66672779|FG003|DB Phase|Adverse Event|0|||
23807469|NCT02177136|66672776|FG000|DB Phase|Protocol Violation|0|||
23807470|NCT02177136|66672777|FG001|DB Phase|Protocol Violation|0|||
23807471|NCT02177136|66672778|FG002|DB Phase|Protocol Violation|1|||
23602192|NCT03066609|65934022|FG002|OVERALL STUDY|discontinued follow up|0|||
23602193|NCT03066609|65934023|FG003|OVERALL STUDY|discontinued follow up|0|||
23602194|NCT03500549|65934024|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
23602195|NCT03500549|65934025|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
23602196|NCT03500549|65934024|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
23602197|NCT03500549|65934025|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
23602198|NCT00866619|65934026|FG000|Overall Study|Adverse Event|112|||
23602199|NCT00866619|65934027|FG001|Overall Study|Adverse Event|106|||
23602200|NCT00866619|65934028|FG002|Overall Study|Adverse Event|47|||
23661169|NCT00455013|66145760|FG001|Long Term Extension (LTE)|Adverse Event|1|||
23661170|NCT00455013|66145761|FG002|Long Term Extension (LTE)|Adverse Event|1|||
23661171|NCT00455013|66145759|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
23661172|NCT00455013|66145760|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
23661173|NCT00455013|66145761|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
23661174|NCT00455013|66145759|FG000|Long Term Extension (LTE)|Death|1|||
23661175|NCT00455013|66145760|FG001|Long Term Extension (LTE)|Death|1|||
23661176|NCT00455013|66145761|FG002|Long Term Extension (LTE)|Death|0|||
23661177|NCT00455013|66145759|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
23661178|NCT00455013|66145760|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
23661179|NCT00455013|66145761|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
23661180|NCT00455013|66145759|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
23661181|NCT00455013|66145760|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
23661182|NCT00455013|66145761|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
23661183|NCT00455013|66145759|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
23661184|NCT00455013|66145760|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
23661185|NCT00455013|66145761|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
23661186|NCT00455013|66145759|FG000|Long Term Extension (LTE)|non-specified|0|||
23661187|NCT00455013|66145760|FG001|Long Term Extension (LTE)|non-specified|0|||
23661188|NCT00455013|66145761|FG002|Long Term Extension (LTE)|non-specified|1|||
23661189|NCT00955279|66145762|FG000|Overall Study|Other|0|||
23602201|NCT00866619|65934029|FG003|Overall Study|Adverse Event|44|||
23602202|NCT00866619|65934026|FG000|Overall Study|Protocol Violation|2|||
23602203|NCT00866619|65934027|FG001|Overall Study|Protocol Violation|39|||
23661190|NCT00955279|66145763|FG001|Overall Study|Other|0|||
23661191|NCT00955279|66145764|FG002|Overall Study|Other|3|||
23807472|NCT02177136|66672779|FG003|DB Phase|Protocol Violation|0|||
23602204|NCT00866619|65934028|FG002|Overall Study|Protocol Violation|2|||
23661192|NCT00955279|66145762|FG000|Overall Study|Death|1|||
23661193|NCT00955279|66145763|FG001|Overall Study|Death|1|||
23661194|NCT00955279|66145764|FG002|Overall Study|Death|1|||
23661195|NCT00955279|66145762|FG000|Overall Study|Lost to Follow-up|0|||
23661196|NCT00955279|66145763|FG001|Overall Study|Lost to Follow-up|3|||
23661197|NCT00955279|66145764|FG002|Overall Study|Lost to Follow-up|1|||
23661198|NCT00955279|66145762|FG000|Overall Study|Withdrawal by Subject|2|||
23661199|NCT00955279|66145763|FG001|Overall Study|Withdrawal by Subject|0|||
23661200|NCT00955279|66145764|FG002|Overall Study|Withdrawal by Subject|3|||
23661201|NCT00474708|66145769|FG000|Overall Study|Lack of Efficacy|11|||
23661202|NCT00474708|66145770|FG001|Overall Study|Lack of Efficacy|5|||
23661203|NCT00474708|66145769|FG000|Overall Study|Suicide ideation/behavior|0|||
23661204|NCT00474708|66145770|FG001|Overall Study|Suicide ideation/behavior|1|||
23661205|NCT00474708|66145769|FG000|Overall Study|Withdrawal by Subject|7|||
23661206|NCT00474708|66145770|FG001|Overall Study|Withdrawal by Subject|0|||
23661207|NCT00474708|66145769|FG000|Overall Study|Lack of compliance|12|||
23661208|NCT00474708|66145770|FG001|Overall Study|Lack of compliance|4|||
23661209|NCT00474708|66145769|FG000|Overall Study|Lost to Follow-up|18|||
23661210|NCT00474708|66145770|FG001|Overall Study|Lost to Follow-up|9|||
23661211|NCT00474708|66145769|FG000|Overall Study|Physician Decision|9|||
23661212|NCT00474708|66145770|FG001|Overall Study|Physician Decision|6|||
23661213|NCT03155373|66145778|FG000|Overall Study|No longer required surgery|1|||
23661214|NCT03155373|66145778|FG000|Overall Study|Protocol Violation|1|||
23661215|NCT03155373|66145778|FG000|Overall Study|Death|2|||
23661216|NCT03155373|66145778|FG000|Overall Study|Withdrawal by Subject|3|||
23661217|NCT01279850|66145779|FG000|Overall Study|Protocol Violation|50|||
23661218|NCT01279850|66145779|FG000|Overall Study|No Drug Administration Information|7|||
23661219|NCT01279850|66145779|FG000|Overall Study|No Visit After Treatment|34|||
23661220|NCT00295633|66145780|FG000|Overall Study|Lack of Efficacy|19|||
23661221|NCT00295633|66145781|FG001|Overall Study|Lack of Efficacy|7|||
23661222|NCT00295633|66145782|FG002|Overall Study|Lack of Efficacy|16|||
23661223|NCT00295633|66145780|FG000|Overall Study|Withdrawal of consent by subject|16|||
23661224|NCT00295633|66145781|FG001|Overall Study|Withdrawal of consent by subject|16|||
23661225|NCT00295633|66145782|FG002|Overall Study|Withdrawal of consent by subject|26|||
23661226|NCT00295633|66145780|FG000|Overall Study|Adverse Event|9|||
23661227|NCT00295633|66145781|FG001|Overall Study|Adverse Event|17|||
23661228|NCT00295633|66145782|FG002|Overall Study|Adverse Event|9|||
23661229|NCT00295633|66145780|FG000|Overall Study|Lost to Follow-up|6|||
23661230|NCT00295633|66145781|FG001|Overall Study|Lost to Follow-up|11|||
23661231|NCT00295633|66145782|FG002|Overall Study|Lost to Follow-up|7|||
23661232|NCT00295633|66145780|FG000|Overall Study|Physician Decision|9|||
23661233|NCT00295633|66145781|FG001|Overall Study|Physician Decision|10|||
23661234|NCT00295633|66145782|FG002|Overall Study|Physician Decision|8|||
23661235|NCT00295633|66145780|FG000|Overall Study|Poor/Noncompliance|2|||
23661236|NCT00295633|66145781|FG001|Overall Study|Poor/Noncompliance|2|||
23661237|NCT00295633|66145782|FG002|Overall Study|Poor/Noncompliance|6|||
23661238|NCT00295633|66145780|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23661239|NCT00295633|66145781|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
23661240|NCT00295633|66145782|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
23661241|NCT00295633|66145780|FG000|Overall Study|Death|1|||
23661242|NCT00295633|66145781|FG001|Overall Study|Death|1|||
23661243|NCT00295633|66145782|FG002|Overall Study|Death|0|||
23661244|NCT00295633|66145780|FG000|Overall Study|Administrative reason by sponsor|0|||
23661245|NCT00295633|66145781|FG001|Overall Study|Administrative reason by sponsor|0|||
23661246|NCT00295633|66145782|FG002|Overall Study|Administrative reason by sponsor|1|||
23661247|NCT03441334|66145783|FG000|Overall Study|Withdrawal by Subject|1|||
23661248|NCT03441334|66145784|FG001|Overall Study|Withdrawal by Subject|0|||
23661249|NCT00646906|66145789|FG000|Crossover Period 1|Withdrawal by Subject|1|||
23661250|NCT00646906|66145790|FG001|Crossover Period 1|Withdrawal by Subject|0|||
23661251|NCT00646906|66145791|FG002|Crossover Period 1|Withdrawal by Subject|0|||
23661252|NCT00646906|66145792|FG003|Crossover Period 1|Withdrawal by Subject|0|||
23661253|NCT00646906|66145793|FG004|Crossover Period 1|Withdrawal by Subject|0|||
23661254|NCT00646906|66145794|FG005|Crossover Period 1|Withdrawal by Subject|1|||
23661255|NCT00646906|66145795|FG006|Crossover Period 1|Withdrawal by Subject|0|||
23661256|NCT00646906|66145789|FG000|Crossover Period 2|Withdrawal by Subject|0|||
23661257|NCT00646906|66145790|FG001|Crossover Period 2|Withdrawal by Subject|1|||
23661258|NCT00646906|66145791|FG002|Crossover Period 2|Withdrawal by Subject|2|||
23661259|NCT00646906|66145792|FG003|Crossover Period 2|Withdrawal by Subject|1|||
23661260|NCT00646906|66145793|FG004|Crossover Period 2|Withdrawal by Subject|0|||
23661261|NCT00646906|66145794|FG005|Crossover Period 2|Withdrawal by Subject|0|||
23661262|NCT00646906|66145795|FG006|Crossover Period 2|Withdrawal by Subject|0|||
23661263|NCT00646906|66145789|FG000|Crossover Period 2|Physician Decision|0|||
23661264|NCT00646906|66145790|FG001|Crossover Period 2|Physician Decision|0|||
23661265|NCT00646906|66145791|FG002|Crossover Period 2|Physician Decision|0|||
23661266|NCT00646906|66145792|FG003|Crossover Period 2|Physician Decision|0|||
23661267|NCT00646906|66145793|FG004|Crossover Period 2|Physician Decision|0|||
23661268|NCT00646906|66145794|FG005|Crossover Period 2|Physician Decision|0|||
23661269|NCT00646906|66145795|FG006|Crossover Period 2|Physician Decision|1|||
23661270|NCT04163900|66145800|FG000|Overall Study|Radiological disease progression|112|||
23661271|NCT04163900|66145801|FG001|Overall Study|Radiological disease progression|127|||
23661272|NCT04163900|66145800|FG000|Overall Study|Study closure|98|||
23661273|NCT04163900|66145801|FG001|Overall Study|Study closure|133|||
23661274|NCT04163900|66145800|FG000|Overall Study|Adverse Event|78|||
23661275|NCT04163900|66145801|FG001|Overall Study|Adverse Event|32|||
23661276|NCT04163900|66145800|FG000|Overall Study|Withdrawal by Subject|37|||
23661277|NCT04163900|66145801|FG001|Overall Study|Withdrawal by Subject|34|||
23661278|NCT04163900|66145800|FG000|Overall Study|Death|29|||
23661279|NCT04163900|66145801|FG001|Overall Study|Death|16|||
23661280|NCT04163900|66145800|FG000|Overall Study|Physician Decision|17|||
23661281|NCT04163900|66145801|FG001|Overall Study|Physician Decision|25|||
23661282|NCT04163900|66145800|FG000|Overall Study|Clinical disease progression|14|||
23661283|NCT04163900|66145801|FG001|Overall Study|Clinical disease progression|13|||
23661284|NCT04163900|66145800|FG000|Overall Study|Protocol Violation|3|||
23661285|NCT04163900|66145801|FG001|Overall Study|Protocol Violation|4|||
23661286|NCT04163900|66145800|FG000|Overall Study|Lost to Follow-up|0|||
23661287|NCT04163900|66145801|FG001|Overall Study|Lost to Follow-up|1|||
23661288|NCT02285998|66145802|FG000|Overall Study|Adverse Event|9|||
23661289|NCT02285998|66145803|FG001|Overall Study|Adverse Event|8|||
23661290|NCT02285998|66145802|FG000|Overall Study|Physician Decision|1|||
23661291|NCT02285998|66145803|FG001|Overall Study|Physician Decision|2|||
23661292|NCT02285998|66145802|FG000|Overall Study|Lost to Follow-up|176|||
23661293|NCT02285998|66145803|FG001|Overall Study|Lost to Follow-up|172|||
23661294|NCT02285998|66145802|FG000|Overall Study|Withdrawal by Subject|53|||
23661295|NCT02285998|66145803|FG001|Overall Study|Withdrawal by Subject|61|||
23661296|NCT02285998|66145802|FG000|Overall Study|Other Reasons|7|||
23661297|NCT02285998|66145803|FG001|Overall Study|Other Reasons|10|||
23661298|NCT03574753|66145804|FG000|Overall Study|Adverse Event|3|||
23661299|NCT03574753|66145804|FG000|Overall Study|Progression/relapse|19|||
23661300|NCT03574753|66145804|FG000|Overall Study|Death|1|||
23661301|NCT03021499|66145805|FG000|Overall Study|Adverse Event|1|||
23661302|NCT03021499|66145806|FG001|Overall Study|Adverse Event|0|||
23661303|NCT03021499|66145805|FG000|Overall Study|Death|1|||
23661304|NCT03021499|66145806|FG001|Overall Study|Death|5|||
23661305|NCT03021499|66145805|FG000|Overall Study|Lack of Efficacy|0|||
23661306|NCT03021499|66145806|FG001|Overall Study|Lack of Efficacy|1|||
23661307|NCT03021499|66145805|FG000|Overall Study|Lost to Follow-up|1|||
23661308|NCT03021499|66145806|FG001|Overall Study|Lost to Follow-up|3|||
23661309|NCT03021499|66145805|FG000|Overall Study|Physician Decision|2|||
23661310|NCT03021499|66145806|FG001|Overall Study|Physician Decision|3|||
23661311|NCT03021499|66145805|FG000|Overall Study|Pregnancy|1|||
23661312|NCT03021499|66145806|FG001|Overall Study|Pregnancy|0|||
23602205|NCT00866619|65934029|FG003|Overall Study|Protocol Violation|17|||
23661313|NCT03021499|66145805|FG000|Overall Study|Withdrawal by Subject|7|||
23661314|NCT03021499|66145806|FG001|Overall Study|Withdrawal by Subject|14|||
23661315|NCT03021499|66145805|FG000|Overall Study|Prohibited medication required|1|||
23661316|NCT03021499|66145806|FG001|Overall Study|Prohibited medication required|0|||
23661317|NCT03021499|66145805|FG000|Overall Study|Protocol non-compliance|1|||
23661318|NCT03021499|66145806|FG001|Overall Study|Protocol non-compliance|1|||
23661319|NCT03021499|66145805|FG000|Overall Study|None of the above|0|||
23661320|NCT03021499|66145806|FG001|Overall Study|None of the above|4|||
23661321|NCT03021499|66145805|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
23661322|NCT03021499|66145806|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
23661323|NCT00102960|66145807|FG000|Overall Study|Death|23|||
23367510|NCT00676403|65092387|FG001|Overall Study|Withdrawal by Subject|0|||
23367511|NCT00676403|65092388|FG002|Overall Study|Withdrawal by Subject|0|||
23367512|NCT00676403|65092389|FG003|Overall Study|Withdrawal by Subject|0|||
23367513|NCT00676403|65092390|FG004|Overall Study|Withdrawal by Subject|0|||
23602206|NCT00866619|65934026|FG000|Overall Study|Withdrawal by Subject|587|||
23602207|NCT00866619|65934027|FG001|Overall Study|Withdrawal by Subject|295|||
23602208|NCT00866619|65934028|FG002|Overall Study|Withdrawal by Subject|272|||
23602209|NCT00866619|65934029|FG003|Overall Study|Withdrawal by Subject|144|||
23602210|NCT00866619|65934026|FG000|Overall Study|Lost to Follow-up|1145|||
23602211|NCT00866619|65934027|FG001|Overall Study|Lost to Follow-up|830|||
23602212|NCT00866619|65934028|FG002|Overall Study|Lost to Follow-up|568|||
23602213|NCT00866619|65934029|FG003|Overall Study|Lost to Follow-up|425|||
23602214|NCT00562094|65934034|FG000|Overall Study|Lost to Follow-up|62|||
23367514|NCT00676403|65092391|FG005|Overall Study|Withdrawal by Subject|1|||
23367515|NCT03044314|65092396|FG000|Overall Study|Physician Decision|2|||
23367516|NCT03044314|65092396|FG000|Overall Study|Withdrawal by Subject|1|||
23367517|NCT03044314|65092396|FG000|Overall Study|Connector tubing not available|1|||
23367518|NCT02498678|65092397|FG000|Overall Study|interference from the surgical team|0|||
23367519|NCT02498678|65092398|FG001|Overall Study|interference from the surgical team|2|||
23367520|NCT00705757|65092400|FG000|Overall Study|Lack of Efficacy|5|||
23602215|NCT00604669|65934035|FG000|Overall Study|lack of information in chart|7|||
23602216|NCT00857766|65934037|FG000|Overall Study|Adverse Event|13|||
23367521|NCT00705757|65092401|FG001|Overall Study|Lack of Efficacy|1|||
23367522|NCT00705757|65092402|FG002|Overall Study|Lack of Efficacy|3|||
23367523|NCT00705757|65092400|FG000|Overall Study|Lost to Follow-up|7|||
23367524|NCT00705757|65092401|FG001|Overall Study|Lost to Follow-up|6|||
23367525|NCT00705757|65092402|FG002|Overall Study|Lost to Follow-up|6|||
23367526|NCT00705757|65092400|FG000|Overall Study|Withdrawal by Subject|1|||
23367527|NCT00705757|65092401|FG001|Overall Study|Withdrawal by Subject|1|||
23367528|NCT00705757|65092402|FG002|Overall Study|Withdrawal by Subject|2|||
23367529|NCT01228591|65092403|FG000|Baseline|Lack of Efficacy|1|||
23367530|NCT01228591|65092404|FG001|Baseline|Lack of Efficacy|2|||
23367531|NCT01063855|65092408|FG000|Overall Study|Adverse Event|4|||
23367532|NCT01063855|65092409|FG001|Overall Study|Adverse Event|4|||
23367533|NCT01063855|65092408|FG000|Overall Study|Death|0|||
23367534|NCT01063855|65092409|FG001|Overall Study|Death|1|||
23367535|NCT01063855|65092408|FG000|Overall Study|Lost to Follow-up|8|||
23367536|NCT01063855|65092409|FG001|Overall Study|Lost to Follow-up|4|||
23367537|NCT01063855|65092408|FG000|Overall Study|Pregnancy|1|||
23367538|NCT01063855|65092409|FG001|Overall Study|Pregnancy|0|||
23367539|NCT01063855|65092408|FG000|Overall Study|Lack of Efficacy|0|||
23367540|NCT01063855|65092409|FG001|Overall Study|Lack of Efficacy|1|||
23367541|NCT01063855|65092408|FG000|Overall Study|Withdrawal by Subject|11|||
23367542|NCT01063855|65092409|FG001|Overall Study|Withdrawal by Subject|8|||
23367543|NCT01063855|65092408|FG000|Overall Study|Reason not specified|13|||
23367544|NCT01063855|65092409|FG001|Overall Study|Reason not specified|11|||
23367545|NCT03154086|65092410|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367546|NCT03154086|65092411|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367547|NCT03154086|65092412|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367548|NCT03154086|65092413|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
23367549|NCT03154086|65092414|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367550|NCT03154086|65092415|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367551|NCT03154086|65092416|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367552|NCT03154086|65092417|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367553|NCT03154086|65092418|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367554|NCT03154086|65092419|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367555|NCT03154086|65092420|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367556|NCT03154086|65092421|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367557|NCT03154086|65092422|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367558|NCT03154086|65092423|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367559|NCT03154086|65092424|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367560|NCT03154086|65092410|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367561|NCT03154086|65092411|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
23367562|NCT03154086|65092412|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367563|NCT03154086|65092413|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367564|NCT03154086|65092414|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367565|NCT03154086|65092415|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367566|NCT03154086|65092416|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367567|NCT03154086|65092417|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367568|NCT03154086|65092418|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367569|NCT03154086|65092419|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367570|NCT03154086|65092420|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367571|NCT03154086|65092421|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367572|NCT03154086|65092422|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367573|NCT03154086|65092423|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367574|NCT03154086|65092424|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367575|NCT03154086|65092410|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367576|NCT03154086|65092411|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367577|NCT03154086|65092412|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
23367578|NCT03154086|65092413|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367579|NCT03154086|65092414|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367580|NCT03154086|65092415|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367581|NCT03154086|65092416|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23602217|NCT00857766|65934038|FG001|Overall Study|Adverse Event|12|||
23367582|NCT03154086|65092417|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367583|NCT03154086|65092418|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367584|NCT03154086|65092419|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367585|NCT03154086|65092420|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367586|NCT03154086|65092421|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367587|NCT03154086|65092422|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367588|NCT03154086|65092423|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367589|NCT03154086|65092424|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367590|NCT03154086|65092410|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
23367591|NCT03154086|65092411|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367592|NCT03154086|65092412|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367593|NCT03154086|65092413|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367594|NCT03154086|65092414|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367595|NCT03154086|65092415|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367596|NCT03154086|65092416|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367597|NCT03154086|65092417|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367598|NCT03154086|65092418|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23483921|NCT00058539|65515890|FG000|Overall Study|Withdrawal by Subject|5|||
23483922|NCT00058539|65515890|FG000|Overall Study|Physician Decision|9|||
23483923|NCT00058539|65515890|FG000|Overall Study|Death|1|||
23483924|NCT02942576|65515891|FG000|Overall Study|Adverse Event|28|||
23483925|NCT02942576|65515892|FG001|Overall Study|Adverse Event|6|||
23483926|NCT02942576|65515891|FG000|Overall Study|Withdrawal by Subject|7|||
23483927|NCT02942576|65515892|FG001|Overall Study|Withdrawal by Subject|5|||
23483928|NCT02942576|65515891|FG000|Overall Study|Physician Decision|1|||
23483929|NCT02942576|65515892|FG001|Overall Study|Physician Decision|4|||
23483930|NCT02942576|65515891|FG000|Overall Study|Other|10|||
23483931|NCT02942576|65515892|FG001|Overall Study|Other|8|||
23483932|NCT02992132|65515894|FG000|Overall Study|Adverse Event|4|||
23483933|NCT02992132|65515895|FG001|Overall Study|Adverse Event|1|||
23602218|NCT00857766|65934037|FG000|Overall Study|Protocol Violation|11|||
23602219|NCT00857766|65934038|FG001|Overall Study|Protocol Violation|11|||
23602220|NCT00857766|65934037|FG000|Overall Study|Lost to Follow-up|1|||
23602221|NCT00857766|65934038|FG001|Overall Study|Lost to Follow-up|0|||
23602222|NCT00857766|65934037|FG000|Overall Study|Investigator Discretion|2|||
23602223|NCT00857766|65934038|FG001|Overall Study|Investigator Discretion|3|||
23602224|NCT00857766|65934037|FG000|Overall Study|Participant Withdrew Consent|4|||
23602225|NCT00857766|65934038|FG001|Overall Study|Participant Withdrew Consent|4|||
23602226|NCT02760654|65934040|FG000|Overall Study|Lost to Follow-up|3|||
23602227|NCT02760654|65934041|FG001|Overall Study|Lost to Follow-up|3|||
23602228|NCT02760654|65934040|FG000|Overall Study|Withdrawal by Subject|4|||
23602229|NCT02760654|65934041|FG001|Overall Study|Withdrawal by Subject|3|||
23602230|NCT03335488|65934042|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
23602231|NCT03335488|65934043|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
23602232|NCT03335488|65934042|FG000|Safety Extension Period|Adverse Event|1|||
23602233|NCT03335488|65934043|FG001|Safety Extension Period|Adverse Event|0|||
23602234|NCT03335488|65934042|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
23602235|NCT03335488|65934043|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
23602236|NCT00918333|65934044|FG000|Overall Study|Drug not taken per protocol|1|||
23602237|NCT00918333|65934045|FG001|Overall Study|Drug not taken per protocol|0|||
23602238|NCT00918333|65934044|FG000|Overall Study|Inadequate amount of drugs provided|1|||
23602239|NCT00918333|65934045|FG001|Overall Study|Inadequate amount of drugs provided|4|||
23602240|NCT00918333|65934044|FG000|Overall Study|Ineligible|1|||
23602241|NCT00918333|65934045|FG001|Overall Study|Ineligible|0|||
23602242|NCT00918333|65934044|FG000|Overall Study|Withdrawal by Subject|0|||
23602243|NCT00918333|65934045|FG001|Overall Study|Withdrawal by Subject|1|||
23602244|NCT01970007|65934046|FG000|Overall Study|Death|5|||
23602245|NCT01970007|65934046|FG000|Overall Study|Withdrawal by Subject|23|||
23602246|NCT01970007|65934046|FG000|Overall Study|Lost to Follow-up|24|||
23602247|NCT01970007|65934046|FG000|Overall Study|"Other endpoint"|3|||
23602248|NCT01898299|65934047|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
23602249|NCT01898299|65934048|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
23602250|NCT00580866|65934049|FG000|Overall Study|Lost to Follow-up|2|||
23602251|NCT00580866|65934050|FG001|Overall Study|Lost to Follow-up|2|||
23602252|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602253|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
23602254|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602255|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23661324|NCT00102960|66145808|FG001|Overall Study|Death|11|||
23602256|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602257|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602258|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602259|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23661325|NCT00102960|66145809|FG002|Overall Study|Death|11|||
23367599|NCT03154086|65092419|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367600|NCT03154086|65092420|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367601|NCT03154086|65092421|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367602|NCT03154086|65092422|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367603|NCT03154086|65092423|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367604|NCT03154086|65092424|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367605|NCT03154086|65092410|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367606|NCT03154086|65092411|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367607|NCT03154086|65092412|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23661326|NCT00102960|66145807|FG000|Overall Study|Lost to Follow-up|6|||
23661327|NCT00102960|66145808|FG001|Overall Study|Lost to Follow-up|12|||
23661328|NCT00102960|66145809|FG002|Overall Study|Lost to Follow-up|16|||
23661329|NCT00102960|66145807|FG000|Overall Study|Withdrawal by Subject|1|||
23367608|NCT03154086|65092413|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367609|NCT03154086|65092414|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367610|NCT03154086|65092415|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367611|NCT03154086|65092416|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367612|NCT03154086|65092417|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367613|NCT03154086|65092418|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
23367614|NCT03154086|65092419|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367615|NCT03154086|65092420|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367616|NCT03154086|65092421|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367617|NCT03154086|65092422|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367618|NCT03154086|65092423|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23602260|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23367619|NCT03154086|65092424|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23602261|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602262|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602263|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602264|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602265|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602266|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602267|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602268|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602269|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602270|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602271|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602272|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602273|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602274|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602275|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602276|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602277|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602278|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602279|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602280|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602281|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602282|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602283|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602284|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602285|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
23602286|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602287|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602288|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602289|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602290|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602291|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602292|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23661330|NCT00102960|66145808|FG001|Overall Study|Withdrawal by Subject|0|||
23661331|NCT00102960|66145809|FG002|Overall Study|Withdrawal by Subject|1|||
23367620|NCT03154086|65092410|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367621|NCT03154086|65092411|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367622|NCT03154086|65092412|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367623|NCT03154086|65092413|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367624|NCT03154086|65092414|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367625|NCT03154086|65092415|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23661332|NCT04196803|66145810|FG000|Overall Study|Withdrawal by Subject|1|||
23367626|NCT03154086|65092416|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367627|NCT03154086|65092417|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
23367628|NCT03154086|65092418|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367629|NCT03154086|65092419|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367630|NCT03154086|65092420|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367631|NCT03154086|65092421|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367632|NCT03154086|65092422|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367633|NCT03154086|65092423|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367634|NCT03154086|65092424|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367635|NCT03154086|65092410|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
23367636|NCT03154086|65092411|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
23367637|NCT03154086|65092412|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
23367638|NCT03154086|65092413|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
23367639|NCT03154086|65092414|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
23367640|NCT03154086|65092415|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
23367641|NCT03154086|65092416|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
23367642|NCT03154086|65092417|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
23367643|NCT03154086|65092418|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
23367644|NCT03154086|65092419|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
23367645|NCT03154086|65092420|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
23367646|NCT03154086|65092421|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
23367647|NCT03154086|65092422|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
23367648|NCT03154086|65092423|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
23367649|NCT03154086|65092424|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
23367650|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
23367651|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
23367652|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
23367653|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
23367654|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
23367655|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
23367656|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
23367657|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
23367658|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
23367659|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
23367660|NCT01573000|65092427|FG000|Crossover Phase|Lack of Efficacy|0|||
23367661|NCT01573000|65092428|FG001|Crossover Phase|Lack of Efficacy|13|||
23367662|NCT01573000|65092427|FG000|Crossover Phase|Lost to Follow-up|0|||
23367663|NCT01573000|65092428|FG001|Crossover Phase|Lost to Follow-up|2|||
23367664|NCT01573000|65092427|FG000|Crossover Phase|Death|0|||
23367665|NCT01573000|65092428|FG001|Crossover Phase|Death|3|||
23367666|NCT01573000|65092427|FG000|Long-Term Follow-Up|Death|3|||
23602293|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602294|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602295|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602296|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602297|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602298|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602299|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602300|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602301|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602302|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602303|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602304|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602305|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602306|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602307|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602308|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602309|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602310|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602311|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602312|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602313|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602314|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23367667|NCT01573000|65092428|FG001|Long-Term Follow-Up|Death|0|||
23367668|NCT01573000|65092427|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
23367669|NCT01573000|65092428|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
23367670|NCT00749398|65092429|FG000|Overall Study|Lack of Efficacy|7|||
23367671|NCT00749398|65092429|FG000|Overall Study|Adverse Event|4|||
23367672|NCT00749398|65092429|FG000|Overall Study|Serious adverse event|11|||
23602315|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602316|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
23602317|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
23602318|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
23602319|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
23367673|NCT00749398|65092429|FG000|Overall Study|Withdrawal by Subject|17|||
23367674|NCT00749398|65092429|FG000|Overall Study|Lost to Follow-up|11|||
23367675|NCT00749398|65092429|FG000|Overall Study|Reason not specified|2|||
23367676|NCT00749398|65092429|FG000|Overall Study|Unknown reason|1|||
23367677|NCT03118934|65092432|FG000|Overall Study|Adverse Event|0|||
23367678|NCT03118934|65092433|FG001|Overall Study|Adverse Event|0|||
23367679|NCT03118934|65092434|FG002|Overall Study|Adverse Event|0|||
23367680|NCT03118934|65092435|FG003|Overall Study|Adverse Event|0|||
23367681|NCT03118934|65092436|FG004|Overall Study|Adverse Event|0|||
23367682|NCT03118934|65092437|FG005|Overall Study|Adverse Event|1|||
23367683|NCT03118934|65092432|FG000|Overall Study|Physician Decision|0|||
23367684|NCT03118934|65092433|FG001|Overall Study|Physician Decision|0|||
23367685|NCT03118934|65092434|FG002|Overall Study|Physician Decision|0|||
23367686|NCT03118934|65092435|FG003|Overall Study|Physician Decision|0|||
23367687|NCT03118934|65092436|FG004|Overall Study|Physician Decision|0|||
23367688|NCT03118934|65092437|FG005|Overall Study|Physician Decision|1|||
23367689|NCT03118934|65092432|FG000|Overall Study|Discontinued prior to exposure|0|||
23367690|NCT03118934|65092433|FG001|Overall Study|Discontinued prior to exposure|1|||
23367691|NCT03118934|65092434|FG002|Overall Study|Discontinued prior to exposure|1|||
23367692|NCT03118934|65092435|FG003|Overall Study|Discontinued prior to exposure|1|||
23367693|NCT03118934|65092436|FG004|Overall Study|Discontinued prior to exposure|2|||
23367694|NCT03118934|65092437|FG005|Overall Study|Discontinued prior to exposure|0|||
23367695|NCT00511810|65092438|FG000|Overall Study|Lost to Follow-up|1|||
23367696|NCT00511810|65092439|FG001|Overall Study|Lost to Follow-up|2|||
23367697|NCT00511810|65092438|FG000|Overall Study|Lack of Efficacy|0|||
23367698|NCT00511810|65092439|FG001|Overall Study|Lack of Efficacy|2|||
23367699|NCT00511810|65092438|FG000|Overall Study|Refused second scn|0|||
23367700|NCT00511810|65092439|FG001|Overall Study|Refused second scn|1|||
23367701|NCT00010257|65092442|FG000|Overall Study|Withdrawal by Subject|1|||
23367702|NCT00010257|65092443|FG001|Overall Study|Withdrawal by Subject|0|||
23367703|NCT02337491|65092444|FG000|Overall Study|Death|1|||
23367704|NCT02337491|65092445|FG001|Overall Study|Death|1|||
23367705|NCT02337491|65092444|FG000|Overall Study|Adverse Event|0|||
23367706|NCT02337491|65092445|FG001|Overall Study|Adverse Event|1|||
23367707|NCT02337491|65092444|FG000|Overall Study|Withdrawal by Subject|3|||
23367708|NCT02337491|65092445|FG001|Overall Study|Withdrawal by Subject|0|||
23483934|NCT02992132|65515896|FG002|Overall Study|Adverse Event|3|||
23367709|NCT02337491|65092444|FG000|Overall Study|Progressive Disease|44|||
23367710|NCT02337491|65092445|FG001|Overall Study|Progressive Disease|28|||
23367711|NCT02337491|65092444|FG000|Overall Study|On Treatment|2|||
23367712|NCT02337491|65092445|FG001|Overall Study|On Treatment|0|||
23367713|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
23367714|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367715|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367716|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367717|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
23367718|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367719|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367720|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367721|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
23367722|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23367723|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23367724|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23367725|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
23367726|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
23367727|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
23367728|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
23367729|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
23367730|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367731|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367732|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367733|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
23367734|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367735|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367736|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367737|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23483935|NCT02992132|65515894|FG000|Overall Study|Lack of Efficacy|2|||
23483936|NCT02992132|65515895|FG001|Overall Study|Lack of Efficacy|0|||
23483937|NCT02992132|65515896|FG002|Overall Study|Lack of Efficacy|0|||
23483938|NCT02992132|65515894|FG000|Overall Study|Non-compliance with study drug|2|||
23483939|NCT02992132|65515895|FG001|Overall Study|Non-compliance with study drug|0|||
23483940|NCT02992132|65515896|FG002|Overall Study|Non-compliance with study drug|0|||
23483941|NCT02992132|65515894|FG000|Overall Study|Progressive disease|1|||
23483942|NCT02992132|65515895|FG001|Overall Study|Progressive disease|0|||
23483943|NCT02992132|65515896|FG002|Overall Study|Progressive disease|0|||
23367738|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
23367739|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23367740|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23367741|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23483944|NCT02992132|65515894|FG000|Overall Study|Protocol Violation|2|||
23483945|NCT02992132|65515895|FG001|Overall Study|Protocol Violation|2|||
23483946|NCT02992132|65515896|FG002|Overall Study|Protocol Violation|0|||
23483947|NCT02992132|65515894|FG000|Overall Study|Caregiver withdrew consent|2|||
23483948|NCT02992132|65515895|FG001|Overall Study|Caregiver withdrew consent|3|||
23367742|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
23367743|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23367744|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23367745|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
23367746|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
23367747|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
23367748|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
23367749|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367750|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
23367751|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367752|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367753|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367754|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
23367755|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367756|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367757|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
23367758|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
23367759|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
23367760|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
23367761|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367762|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367763|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
23367764|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367765|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
23367766|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
23367767|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
23367768|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
23367769|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
23367770|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
23367771|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
23367772|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
23367773|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
23367774|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
23367775|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
23367776|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
23367777|NCT01462630|65092451|FG000|Overall Study|Did not initiate therapy|3|||
23367778|NCT01462630|65092451|FG000|Overall Study|Death|1|||
23367779|NCT01462630|65092451|FG000|Overall Study|Protocol Violation|2|||
23367780|NCT01462630|65092451|FG000|Overall Study|Adverse Event|1|||
23367781|NCT00496769|65092455|FG000|Double Blind|>=1 reason assigned per patient|558|||
23367782|NCT00496769|65092456|FG001|Double Blind|>=1 reason assigned per patient|649|||
23367783|NCT00496769|65092457|FG002|Double Blind|>=1 reason assigned per patient|0|||
23367784|NCT00496769|65092455|FG000|Open Label|>=1 reason assigned per patient|0|||
23367785|NCT00496769|65092456|FG001|Open Label|>=1 reason assigned per patient|0|||
23367786|NCT00496769|65092457|FG002|Open Label|>=1 reason assigned per patient|1011|||
23367787|NCT01365130|65092458|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
23367788|NCT01181167|65092462|FG000|Overall Study|Adverse Event|11|||
23367789|NCT01181167|65092463|FG001|Overall Study|Adverse Event|21|||
23367790|NCT01181167|65092462|FG000|Overall Study|Lost to Follow-up|1|||
23367791|NCT01181167|65092463|FG001|Overall Study|Lost to Follow-up|0|||
23367792|NCT01181167|65092462|FG000|Overall Study|Physician Decision|2|||
23367793|NCT01181167|65092463|FG001|Overall Study|Physician Decision|3|||
23367794|NCT01181167|65092462|FG000|Overall Study|Protocol Violation|3|||
23367795|NCT01181167|65092463|FG001|Overall Study|Protocol Violation|0|||
23367796|NCT01181167|65092462|FG000|Overall Study|Withdrawal by Subject|6|||
23367797|NCT01181167|65092463|FG001|Overall Study|Withdrawal by Subject|8|||
23367798|NCT01077323|65092468|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
23367799|NCT01077323|65092469|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
23367800|NCT01077323|65092470|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
23367801|NCT01077323|65092468|FG000|Overall Study|Dispensing of drug in baseline period|0|||
23367802|NCT01077323|65092469|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
23483949|NCT02992132|65515896|FG002|Overall Study|Caregiver withdrew consent|2|||
23483950|NCT02992132|65515894|FG000|Overall Study|Withdrawal by Subject|0|||
23661333|NCT04196803|66145811|FG001|Overall Study|Withdrawal by Subject|3|||
23807473|NCT02177136|66672776|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
23483951|NCT02992132|65515895|FG001|Overall Study|Withdrawal by Subject|2|||
23367803|NCT01077323|65092470|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
23367804|NCT01077323|65092468|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
23367805|NCT01077323|65092469|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
23367806|NCT01077323|65092470|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
23367807|NCT01325350|65092473|FG000|Overall Study|Adverse Event|3|||
23367808|NCT01325350|65092474|FG001|Overall Study|Adverse Event|3|||
23367809|NCT01325350|65092475|FG002|Overall Study|Adverse Event|3|||
23367810|NCT01325350|65092476|FG003|Overall Study|Adverse Event|1|||
23367811|NCT01325350|65092477|FG004|Overall Study|Adverse Event|2|||
23367812|NCT01325350|65092473|FG000|Overall Study|Pregnancy|0|||
23367813|NCT01325350|65092474|FG001|Overall Study|Pregnancy|0|||
23367814|NCT01325350|65092475|FG002|Overall Study|Pregnancy|1|||
23367815|NCT01325350|65092476|FG003|Overall Study|Pregnancy|0|||
23367816|NCT01325350|65092477|FG004|Overall Study|Pregnancy|1|||
23367817|NCT01325350|65092473|FG000|Overall Study|Lost to Follow-up|1|||
23367818|NCT01325350|65092474|FG001|Overall Study|Lost to Follow-up|0|||
23367819|NCT01325350|65092475|FG002|Overall Study|Lost to Follow-up|5|||
23367820|NCT01325350|65092476|FG003|Overall Study|Lost to Follow-up|1|||
23367821|NCT01325350|65092477|FG004|Overall Study|Lost to Follow-up|5|||
23367822|NCT01325350|65092473|FG000|Overall Study|Personal Reasons|2|||
23367823|NCT01325350|65092474|FG001|Overall Study|Personal Reasons|1|||
23367824|NCT01325350|65092475|FG002|Overall Study|Personal Reasons|6|||
23367825|NCT01325350|65092476|FG003|Overall Study|Personal Reasons|5|||
23367826|NCT01325350|65092477|FG004|Overall Study|Personal Reasons|3|||
23367827|NCT01325350|65092473|FG000|Overall Study|Protocol Violation|0|||
23367828|NCT01325350|65092474|FG001|Overall Study|Protocol Violation|0|||
23367829|NCT01325350|65092475|FG002|Overall Study|Protocol Violation|0|||
23367830|NCT01325350|65092476|FG003|Overall Study|Protocol Violation|1|||
23367831|NCT01325350|65092477|FG004|Overall Study|Protocol Violation|0|||
23367832|NCT01325350|65092473|FG000|Overall Study|Withdrawal by Subject|0|||
23661334|NCT04196803|66145810|FG000|Overall Study|Adverse Event|4|||
23661335|NCT04196803|66145811|FG001|Overall Study|Adverse Event|2|||
23661336|NCT04196803|66145810|FG000|Overall Study|Lost to Follow-up|0|||
23661337|NCT04196803|66145811|FG001|Overall Study|Lost to Follow-up|1|||
23661338|NCT02217436|66145812|FG000|Overall Study|Protocol Violation|1|||
23661339|NCT02217436|66145813|FG001|Overall Study|Protocol Violation|1|||
23661340|NCT02217436|66145812|FG000|Overall Study|Incomplete data|0|||
23661341|NCT02217436|66145813|FG001|Overall Study|Incomplete data|1|||
23661342|NCT01015768|66145816|FG000|Overall Study|Some subject data unuseable|4|||
23661343|NCT01015768|66145817|FG001|Overall Study|Some subject data unuseable|4|||
23661344|NCT00117507|66145818|FG000|Overall Study|Adverse Event|4|||
23661345|NCT00117507|66145818|FG000|Overall Study|Abnormal laboratory values|3|||
23661346|NCT00117507|66145818|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23661347|NCT00117507|66145818|FG000|Overall Study|Patient withdrew consent|4|||
23661348|NCT00117507|66145818|FG000|Overall Study|Death|3|||
23661349|NCT02953639|66145819|FG000|Overall Study|Adverse Event|2|||
23661350|NCT02953639|66145820|FG001|Overall Study|Adverse Event|0|||
23661351|NCT02953639|66145821|FG002|Overall Study|Adverse Event|1|||
23661352|NCT02953639|66145819|FG000|Overall Study|Lost to Follow-up|8|||
23661353|NCT02953639|66145820|FG001|Overall Study|Lost to Follow-up|4|||
23661354|NCT02953639|66145821|FG002|Overall Study|Lost to Follow-up|3|||
23661355|NCT02953639|66145819|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23661356|NCT02953639|66145820|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23661357|NCT02953639|66145821|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23661358|NCT02953639|66145819|FG000|Overall Study|Multiple Reasons|1|||
23661359|NCT02953639|66145820|FG001|Overall Study|Multiple Reasons|0|||
23661360|NCT02953639|66145821|FG002|Overall Study|Multiple Reasons|1|||
23661361|NCT02953639|66145819|FG000|Overall Study|Physician Decision|1|||
23661362|NCT02953639|66145820|FG001|Overall Study|Physician Decision|0|||
23661363|NCT02953639|66145821|FG002|Overall Study|Physician Decision|0|||
23661364|NCT02953639|66145819|FG000|Overall Study|Withdrawal by Subject|7|||
23367833|NCT01325350|65092474|FG001|Overall Study|Withdrawal by Subject|0|||
23367834|NCT01325350|65092475|FG002|Overall Study|Withdrawal by Subject|1|||
23661365|NCT02953639|66145820|FG001|Overall Study|Withdrawal by Subject|8|||
23661366|NCT02953639|66145821|FG002|Overall Study|Withdrawal by Subject|10|||
23661367|NCT02953639|66145819|FG000|Overall Study|Completed or Discontinued information is missing|1|||
23367835|NCT01325350|65092476|FG003|Overall Study|Withdrawal by Subject|1|||
23367836|NCT01325350|65092477|FG004|Overall Study|Withdrawal by Subject|0|||
23367837|NCT01325350|65092473|FG000|Overall Study|Did Not Receive Treatment|0|||
23367838|NCT01325350|65092474|FG001|Overall Study|Did Not Receive Treatment|1|||
23367839|NCT01325350|65092475|FG002|Overall Study|Did Not Receive Treatment|1|||
23367840|NCT01325350|65092476|FG003|Overall Study|Did Not Receive Treatment|0|||
23367841|NCT01325350|65092477|FG004|Overall Study|Did Not Receive Treatment|1|||
23367842|NCT01765296|65092479|FG000|Overall Study|Protocol Violation|0|||
23483952|NCT02992132|65515896|FG002|Overall Study|Withdrawal by Subject|1|||
23483953|NCT02992132|65515894|FG000|Overall Study|Physician Decision|0|||
23483954|NCT02992132|65515895|FG001|Overall Study|Physician Decision|0|||
23483955|NCT02992132|65515896|FG002|Overall Study|Physician Decision|1|||
23483956|NCT02353143|65515898|FG000|Overall Study|Withdrawal by Subject|1|||
23483957|NCT02353143|65515899|FG001|Overall Study|Withdrawal by Subject|0|||
23483958|NCT02353143|65515900|FG002|Overall Study|Withdrawal by Subject|0|||
23483959|NCT02353143|65515901|FG003|Overall Study|Withdrawal by Subject|0|||
23483960|NCT02353143|65515902|FG004|Overall Study|Withdrawal by Subject|1|||
23483961|NCT02353143|65515903|FG005|Overall Study|Withdrawal by Subject|0|||
23483962|NCT02353143|65515904|FG006|Overall Study|Withdrawal by Subject|0|||
23483963|NCT02353143|65515905|FG007|Overall Study|Withdrawal by Subject|1|||
23483964|NCT02353143|65515906|FG008|Overall Study|Withdrawal by Subject|1|||
23483965|NCT02353143|65515898|FG000|Overall Study|Lack of Efficacy|2|||
23483966|NCT02353143|65515899|FG001|Overall Study|Lack of Efficacy|1|||
23483967|NCT02353143|65515900|FG002|Overall Study|Lack of Efficacy|2|||
23483968|NCT02353143|65515901|FG003|Overall Study|Lack of Efficacy|4|||
23483969|NCT02353143|65515902|FG004|Overall Study|Lack of Efficacy|13|||
23483970|NCT02353143|65515903|FG005|Overall Study|Lack of Efficacy|2|||
23483971|NCT02353143|65515904|FG006|Overall Study|Lack of Efficacy|2|||
23483972|NCT02353143|65515905|FG007|Overall Study|Lack of Efficacy|2|||
23483973|NCT02353143|65515906|FG008|Overall Study|Lack of Efficacy|1|||
23483974|NCT02353143|65515898|FG000|Overall Study|reason not specified|1|||
23483975|NCT02353143|65515899|FG001|Overall Study|reason not specified|2|||
23483976|NCT02353143|65515900|FG002|Overall Study|reason not specified|0|||
23483977|NCT02353143|65515901|FG003|Overall Study|reason not specified|0|||
23483978|NCT02353143|65515902|FG004|Overall Study|reason not specified|6|||
23483979|NCT02353143|65515903|FG005|Overall Study|reason not specified|1|||
23483980|NCT02353143|65515904|FG006|Overall Study|reason not specified|0|||
23483981|NCT02353143|65515905|FG007|Overall Study|reason not specified|3|||
23483982|NCT02353143|65515906|FG008|Overall Study|reason not specified|1|||
23483983|NCT02353143|65515898|FG000|Overall Study|Physician Decision|0|||
23483984|NCT02353143|65515899|FG001|Overall Study|Physician Decision|4|||
23483985|NCT02353143|65515900|FG002|Overall Study|Physician Decision|2|||
23483986|NCT02353143|65515901|FG003|Overall Study|Physician Decision|3|||
23483987|NCT02353143|65515902|FG004|Overall Study|Physician Decision|4|||
23483988|NCT02353143|65515903|FG005|Overall Study|Physician Decision|0|||
23483989|NCT02353143|65515904|FG006|Overall Study|Physician Decision|1|||
23483990|NCT02353143|65515905|FG007|Overall Study|Physician Decision|2|||
23483991|NCT02353143|65515906|FG008|Overall Study|Physician Decision|0|||
23483992|NCT02353143|65515898|FG000|Overall Study|Adverse Event|0|||
23483993|NCT02353143|65515899|FG001|Overall Study|Adverse Event|0|||
23483994|NCT02353143|65515900|FG002|Overall Study|Adverse Event|1|||
23483995|NCT02353143|65515901|FG003|Overall Study|Adverse Event|0|||
23483996|NCT02353143|65515902|FG004|Overall Study|Adverse Event|1|||
23602320|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
23602321|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
23367843|NCT01765296|65092480|FG001|Overall Study|Protocol Violation|5|||
23483997|NCT02353143|65515903|FG005|Overall Study|Adverse Event|1|||
23483998|NCT02353143|65515904|FG006|Overall Study|Adverse Event|0|||
23483999|NCT02353143|65515905|FG007|Overall Study|Adverse Event|0|||
23484000|NCT02353143|65515906|FG008|Overall Study|Adverse Event|0|||
23484001|NCT02353143|65515898|FG000|Overall Study|patient receiving other treatment for AML|0|||
23484002|NCT02353143|65515899|FG001|Overall Study|patient receiving other treatment for AML|0|||
23602322|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
23484003|NCT02353143|65515900|FG002|Overall Study|patient receiving other treatment for AML|1|||
23484004|NCT02353143|65515901|FG003|Overall Study|patient receiving other treatment for AML|0|||
23602323|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
23484005|NCT02353143|65515902|FG004|Overall Study|patient receiving other treatment for AML|0|||
23484006|NCT02353143|65515903|FG005|Overall Study|patient receiving other treatment for AML|0|||
23484007|NCT02353143|65515904|FG006|Overall Study|patient receiving other treatment for AML|0|||
23484008|NCT02353143|65515905|FG007|Overall Study|patient receiving other treatment for AML|0|||
23484009|NCT02353143|65515906|FG008|Overall Study|patient receiving other treatment for AML|0|||
23484010|NCT02353143|65515898|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
23484011|NCT02353143|65515899|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
23484012|NCT02353143|65515900|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
23484013|NCT02353143|65515901|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
23484014|NCT02353143|65515902|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
23484015|NCT02353143|65515903|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
23484016|NCT02353143|65515904|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
23484017|NCT02353143|65515905|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
23484018|NCT02353143|65515906|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
23484019|NCT00880165|65515908|FG000|Overall Study|Withdrawal by Subject|27|||
23484020|NCT00880165|65515909|FG001|Overall Study|Withdrawal by Subject|23|||
23484021|NCT00880165|65515908|FG000|Overall Study|Not diagnosed with OSA|14|||
23484022|NCT00880165|65515909|FG001|Overall Study|Not diagnosed with OSA|8|||
23484023|NCT00880165|65515908|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
23484024|NCT00880165|65515909|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
23484025|NCT00880165|65515908|FG000|Overall Study|Lost to follow|9|||
23484026|NCT00880165|65515909|FG001|Overall Study|Lost to follow|15|||
23484027|NCT00969280|65515910|FG000|Overall Study|Protocol Violation|2|||
23484028|NCT00969280|65515911|FG001|Overall Study|Protocol Violation|1|||
23484029|NCT00969280|65515910|FG000|Overall Study|Withdrawal by Subject|0|||
23484030|NCT00969280|65515911|FG001|Overall Study|Withdrawal by Subject|1|||
23484031|NCT00969280|65515910|FG000|Overall Study|infection of influenza A(H1N1)|0|||
23484032|NCT00969280|65515911|FG001|Overall Study|infection of influenza A(H1N1)|1|||
23484033|NCT02628769|65515912|FG000|First Intervention|Adverse Event|1|||
23484034|NCT02628769|65515913|FG001|First Intervention|Adverse Event|0|||
23484035|NCT02628769|65515912|FG000|First Intervention|Withdrawal by Subject|0|||
23484036|NCT02628769|65515913|FG001|First Intervention|Withdrawal by Subject|1|||
23484037|NCT02628769|65515912|FG000|Second Intervention|Adverse Event|2|||
23484038|NCT02628769|65515913|FG001|Second Intervention|Adverse Event|0|||
23484039|NCT02628769|65515912|FG000|Second Intervention|Physician Decision|0|||
23484040|NCT02628769|65515913|FG001|Second Intervention|Physician Decision|1|||
23484041|NCT01082640|65515914|FG000|Overall Study|Adverse Event|9|||
23484042|NCT01082640|65515915|FG001|Overall Study|Adverse Event|5|||
23484043|NCT01082640|65515916|FG002|Overall Study|Adverse Event|3|||
23484044|NCT01082640|65515914|FG000|Overall Study|Withdrawal by Subject|3|||
23484045|NCT01082640|65515915|FG001|Overall Study|Withdrawal by Subject|3|||
23484046|NCT01082640|65515916|FG002|Overall Study|Withdrawal by Subject|2|||
23484047|NCT01082640|65515914|FG000|Overall Study|Major protocol deviation|3|||
23484048|NCT01082640|65515915|FG001|Overall Study|Major protocol deviation|3|||
23484049|NCT01082640|65515916|FG002|Overall Study|Major protocol deviation|0|||
23484050|NCT01082640|65515914|FG000|Overall Study|Lost to Follow-up|0|||
23484051|NCT01082640|65515915|FG001|Overall Study|Lost to Follow-up|3|||
23484052|NCT01082640|65515916|FG002|Overall Study|Lost to Follow-up|0|||
23484053|NCT01082640|65515914|FG000|Overall Study|Other|2|||
23484054|NCT01082640|65515915|FG001|Overall Study|Other|1|||
23484055|NCT01082640|65515916|FG002|Overall Study|Other|3|||
23484056|NCT02486627|65515917|FG000|Overall Study|Death|1|||
23484057|NCT02486627|65515918|FG001|Overall Study|Death|0|||
23484058|NCT02486627|65515917|FG000|Overall Study|Other Unspecified|0|||
23484059|NCT02486627|65515918|FG001|Overall Study|Other Unspecified|2|||
23484060|NCT02486627|65515917|FG000|Overall Study|Consent Withdrawn by Participant|4|||
23484061|NCT02486627|65515918|FG001|Overall Study|Consent Withdrawn by Participant|3|||
23484062|NCT02486627|65515917|FG000|Overall Study|Significant Participant Noncompliance|1|||
23484063|NCT02486627|65515918|FG001|Overall Study|Significant Participant Noncompliance|1|||
23484064|NCT02486627|65515917|FG000|Overall Study|Lost to Follow-up|1|||
23484065|NCT02486627|65515918|FG001|Overall Study|Lost to Follow-up|3|||
23484066|NCT03783702|65515919|FG000|Overall Study|Lost to Follow-up|6|||
23484067|NCT03783702|65515920|FG001|Overall Study|Lost to Follow-up|8|||
23484068|NCT03783702|65515919|FG000|Overall Study|Protocol Violation|1|||
23484069|NCT03783702|65515920|FG001|Overall Study|Protocol Violation|3|||
23484070|NCT02582255|65515925|FG000|Overall Study|Protocol Violation|0|||
23484071|NCT02582255|65515926|FG001|Overall Study|Protocol Violation|3|||
23367844|NCT01765296|65092481|FG002|Overall Study|Protocol Violation|4|||
23484072|NCT01155479|65515929|FG000|Part I|Adverse Event|13|||
23484073|NCT01155479|65515930|FG001|Part I|Adverse Event|8|||
23484074|NCT01155479|65515931|FG002|Part I|Adverse Event|18|||
23602324|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
23602325|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
23484075|NCT01155479|65515932|FG003|Part I|Adverse Event|7|||
23484076|NCT01155479|65515933|FG004|Part I|Adverse Event|6|||
23484077|NCT01155479|65515929|FG000|Part I|Administrative|2|||
23484078|NCT01155479|65515930|FG001|Part I|Administrative|2|||
23484079|NCT01155479|65515931|FG002|Part I|Administrative|2|||
23367845|NCT01765296|65092479|FG000|Overall Study|Withdrawal by Subject|4|||
23484080|NCT01155479|65515932|FG003|Part I|Administrative|0|||
23484081|NCT01155479|65515933|FG004|Part I|Administrative|0|||
23484082|NCT01155479|65515929|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
23484083|NCT01155479|65515930|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
23484084|NCT01155479|65515931|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
23484085|NCT01155479|65515932|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
23484086|NCT01155479|65515933|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
23484087|NCT01155479|65515929|FG000|Part I|Withdrawal by Subject|11|||
23484088|NCT01155479|65515930|FG001|Part I|Withdrawal by Subject|13|||
23484089|NCT01155479|65515931|FG002|Part I|Withdrawal by Subject|8|||
23484090|NCT01155479|65515932|FG003|Part I|Withdrawal by Subject|8|||
23484091|NCT01155479|65515933|FG004|Part I|Withdrawal by Subject|9|||
23484092|NCT01155479|65515929|FG000|Part I|Lost to Follow-up|0|||
23484093|NCT01155479|65515930|FG001|Part I|Lost to Follow-up|0|||
23484094|NCT01155479|65515931|FG002|Part I|Lost to Follow-up|1|||
23484095|NCT01155479|65515932|FG003|Part I|Lost to Follow-up|1|||
23484096|NCT01155479|65515933|FG004|Part I|Lost to Follow-up|0|||
23484097|NCT01155479|65515929|FG000|Part I|Treatment Failure|3|||
23484098|NCT01155479|65515930|FG001|Part I|Treatment Failure|0|||
23484099|NCT01155479|65515931|FG002|Part I|Treatment Failure|3|||
23661368|NCT02953639|66145820|FG001|Overall Study|Completed or Discontinued information is missing|0|||
23807474|NCT02177136|66672777|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
23807475|NCT02177136|66672778|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
23484100|NCT01155479|65515932|FG003|Part I|Treatment Failure|1|||
23484101|NCT01155479|65515933|FG004|Part I|Treatment Failure|2|||
23484102|NCT01155479|65515929|FG000|Part I|Did Not Receive Treatment|4|||
23484103|NCT01155479|65515930|FG001|Part I|Did Not Receive Treatment|2|||
23484104|NCT01155479|65515931|FG002|Part I|Did Not Receive Treatment|2|||
23484105|NCT01155479|65515932|FG003|Part I|Did Not Receive Treatment|6|||
23484106|NCT01155479|65515933|FG004|Part I|Did Not Receive Treatment|1|||
23484107|NCT01155479|65515929|FG000|Part I|Non-Compliance with Protocol|2|||
23484108|NCT01155479|65515930|FG001|Part I|Non-Compliance with Protocol|1|||
23484109|NCT01155479|65515931|FG002|Part I|Non-Compliance with Protocol|3|||
23484110|NCT01155479|65515932|FG003|Part I|Non-Compliance with Protocol|3|||
23484111|NCT01155479|65515933|FG004|Part I|Non-Compliance with Protocol|2|||
23484112|NCT01155479|65515929|FG000|Part II|Adverse Event|7|||
23484113|NCT01155479|65515930|FG001|Part II|Adverse Event|6|||
23484114|NCT01155479|65515931|FG002|Part II|Adverse Event|8|||
23484115|NCT01155479|65515932|FG003|Part II|Adverse Event|3|||
23484116|NCT01155479|65515933|FG004|Part II|Adverse Event|4|||
23484117|NCT01155479|65515929|FG000|Part II|Administrative|43|||
23484118|NCT01155479|65515930|FG001|Part II|Administrative|49|||
23484119|NCT01155479|65515931|FG002|Part II|Administrative|36|||
23484120|NCT01155479|65515932|FG003|Part II|Administrative|38|||
23602326|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
23602327|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
23484121|NCT01155479|65515933|FG004|Part II|Administrative|46|||
23484122|NCT01155479|65515929|FG000|Part II|Withdrawal by Subject|8|||
23484123|NCT01155479|65515930|FG001|Part II|Withdrawal by Subject|4|||
23484124|NCT01155479|65515931|FG002|Part II|Withdrawal by Subject|12|||
23602328|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
23602329|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
23602330|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
23602331|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
23602332|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
23661369|NCT02953639|66145821|FG002|Overall Study|Completed or Discontinued information is missing|0|||
23661370|NCT03677596|66145822|FG000|Overall Study|Adverse Event|0|||
23661371|NCT03677596|66145823|FG001|Overall Study|Adverse Event|1|||
23661372|NCT03677596|66145822|FG000|Overall Study|Death|10|||
23661373|NCT03677596|66145823|FG001|Overall Study|Death|6|||
23661374|NCT03677596|66145822|FG000|Overall Study|Lost to Follow-up|0|||
23661375|NCT03677596|66145823|FG001|Overall Study|Lost to Follow-up|1|||
23661376|NCT03677596|66145822|FG000|Overall Study|Progressive Disease|8|||
23661377|NCT03677596|66145823|FG001|Overall Study|Progressive Disease|8|||
23661378|NCT03677596|66145822|FG000|Overall Study|Withdrawal by Subject|3|||
23661379|NCT03677596|66145823|FG001|Overall Study|Withdrawal by Subject|0|||
23661380|NCT03677596|66145822|FG000|Overall Study|Disease Relapse|2|||
23661381|NCT03677596|66145823|FG001|Overall Study|Disease Relapse|2|||
23661382|NCT03677596|66145822|FG000|Overall Study|Other|0|||
23661383|NCT03677596|66145823|FG001|Overall Study|Other|1|||
23661384|NCT05038020|66145826|FG000|Overall Study|Early Termination|3|||
23661385|NCT05038020|66145827|FG001|Overall Study|Early Termination|0|||
23661386|NCT03349099|66145828|FG000|Overall Study|Physician Decision|3|||
23661387|NCT03349099|66145829|FG001|Overall Study|Physician Decision|4|||
23661388|NCT03349099|66145828|FG000|Overall Study|Stone migrated from the kidney|1|||
23661389|NCT03349099|66145829|FG001|Overall Study|Stone migrated from the kidney|0|||
23661390|NCT03838198|66145830|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23661391|NCT03838198|66145831|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23661392|NCT03838198|66145832|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
23661393|NCT03838198|66145833|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23661394|NCT03838198|66145830|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
23661395|NCT03838198|66145831|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
23661396|NCT03838198|66145832|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
23661397|NCT03838198|66145833|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
23661398|NCT00228566|66148807|FG000|Overall Study|Adverse Event|31|||
23661399|NCT00228566|66148807|FG000|Overall Study|Lack of Efficacy|14|||
23661400|NCT00228566|66148807|FG000|Overall Study|Lost to Follow-up|16|||
23661401|NCT00228566|66148807|FG000|Overall Study|Physician Decision|5|||
23661402|NCT00228566|66148807|FG000|Overall Study|Withdrawal by Subject|4|||
23661403|NCT00228566|66148807|FG000|Overall Study|Miscellaneous|1|||
23661404|NCT00754793|66148811|FG000|Overall Study|voluntary withdrawn from study|0|||
23661405|NCT00754793|66148812|FG001|Overall Study|voluntary withdrawn from study|1|||
23661406|NCT01816061|66148813|FG000|Overall Study|Lost to Follow-up|13|||
23661407|NCT01816061|66148814|FG001|Overall Study|Lost to Follow-up|24|||
23661408|NCT04251910|66148819|FG000|Overall Study|Covid 19 lockdown|0|||
23661409|NCT04251910|66148820|FG001|Overall Study|Covid 19 lockdown|5|||
23661410|NCT04251910|66148821|FG002|Overall Study|Covid 19 lockdown|0|||
23661411|NCT04251910|66148822|FG003|Overall Study|Covid 19 lockdown|4|||
23661412|NCT04251910|66148823|FG004|Overall Study|Covid 19 lockdown|0|||
23661413|NCT04251910|66148824|FG005|Overall Study|Covid 19 lockdown|0|||
23661414|NCT04251910|66148819|FG000|Overall Study|Assisted living facility was closed|0|||
23661415|NCT04251910|66148820|FG001|Overall Study|Assisted living facility was closed|0|||
23661416|NCT04251910|66148821|FG002|Overall Study|Assisted living facility was closed|0|||
23661417|NCT04251910|66148822|FG003|Overall Study|Assisted living facility was closed|0|||
23661418|NCT04251910|66148823|FG004|Overall Study|Assisted living facility was closed|1|||
23661419|NCT04251910|66148824|FG005|Overall Study|Assisted living facility was closed|0|||
23484125|NCT01155479|65515932|FG003|Part II|Withdrawal by Subject|7|||
23484126|NCT01155479|65515933|FG004|Part II|Withdrawal by Subject|3|||
23484127|NCT01155479|65515929|FG000|Part II|Lost to Follow-up|1|||
23484128|NCT01155479|65515930|FG001|Part II|Lost to Follow-up|0|||
23484129|NCT01155479|65515931|FG002|Part II|Lost to Follow-up|0|||
23484130|NCT01155479|65515932|FG003|Part II|Lost to Follow-up|0|||
23484131|NCT01155479|65515933|FG004|Part II|Lost to Follow-up|1|||
23484132|NCT01155479|65515929|FG000|Part II|Treatment Failure|0|||
23484133|NCT01155479|65515930|FG001|Part II|Treatment Failure|1|||
23484134|NCT01155479|65515931|FG002|Part II|Treatment Failure|2|||
23484135|NCT01155479|65515932|FG003|Part II|Treatment Failure|0|||
23484136|NCT01155479|65515933|FG004|Part II|Treatment Failure|1|||
23484137|NCT01155479|65515929|FG000|Part II|Non-Compliance with Protocol|0|||
23484138|NCT01155479|65515930|FG001|Part II|Non-Compliance with Protocol|1|||
23484139|NCT01155479|65515931|FG002|Part II|Non-Compliance with Protocol|0|||
23484140|NCT01155479|65515932|FG003|Part II|Non-Compliance with Protocol|2|||
23484141|NCT01155479|65515933|FG004|Part II|Non-Compliance with Protocol|0|||
23484142|NCT02017171|65515936|FG000|Overall Study|Death|10|||
23484143|NCT02017171|65515937|FG001|Overall Study|Death|4|||
23484144|NCT02017171|65515936|FG000|Overall Study|Withdrawal by Subject|23|||
23484145|NCT02017171|65515937|FG001|Overall Study|Withdrawal by Subject|17|||
23484146|NCT02017171|65515936|FG000|Overall Study|Lost to Follow-up|21|||
23484147|NCT02017171|65515937|FG001|Overall Study|Lost to Follow-up|20|||
23484148|NCT02017171|65515936|FG000|Overall Study|ESKD|6|||
23484149|NCT02017171|65515937|FG001|Overall Study|ESKD|2|||
23484150|NCT02017171|65515936|FG000|Overall Study|Miscellaneous|2|||
23484151|NCT02017171|65515937|FG001|Overall Study|Miscellaneous|3|||
23484152|NCT02119676|65515941|FG000|Overall Study|Adverse Event|9|||
23484153|NCT02119676|65515942|FG001|Overall Study|Adverse Event|17|||
23484154|NCT02119676|65515943|FG002|Overall Study|Adverse Event|10|||
23484155|NCT02119676|65515944|FG003|Overall Study|Adverse Event|10|||
23484156|NCT02119676|65515941|FG000|Overall Study|Disease progression|53|||
23484157|NCT02119676|65515942|FG001|Overall Study|Disease progression|55|||
23484158|NCT02119676|65515943|FG002|Overall Study|Disease progression|68|||
23484159|NCT02119676|65515944|FG003|Overall Study|Disease progression|73|||
23484160|NCT02119676|65515941|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
23602333|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
23602334|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
23602335|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
23602336|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
23602337|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
23602338|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
23602339|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
23602340|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
23602341|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
23602342|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
23602343|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
23602344|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
23602345|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
23602346|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
23602347|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
23602348|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Other|1|||
23602349|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Other|0|||
23602350|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Other|0|||
23602351|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Other|0|||
23602352|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Other|0|||
23602353|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Other|0|||
23602354|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Other|0|||
23602355|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Other|0|||
23602356|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Other|0|||
23602357|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Other|0|||
23602358|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Other|0|||
23484161|NCT02119676|65515942|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
23484162|NCT02119676|65515943|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
23484163|NCT02119676|65515944|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
23484164|NCT02119676|65515941|FG000|Overall Study|Physician Decision|4|||
23602359|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Other|0|||
23602360|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Other|0|||
23602361|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Other|0|||
23602362|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Other|0|||
23484165|NCT02119676|65515942|FG001|Overall Study|Physician Decision|2|||
23484166|NCT02119676|65515943|FG002|Overall Study|Physician Decision|3|||
23484167|NCT02119676|65515944|FG003|Overall Study|Physician Decision|2|||
23484168|NCT02119676|65515941|FG000|Overall Study|Death|9|||
23484169|NCT02119676|65515942|FG001|Overall Study|Death|3|||
23602363|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Other|0|||
23602364|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Other|0|||
23484170|NCT02119676|65515943|FG002|Overall Study|Death|2|||
23602365|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Other|0|||
23602366|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Other|0|||
23602367|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Other|0|||
23661420|NCT01553188|66148828|FG000|Overall Study|Patient choice|1|||
23661421|NCT01553188|66148829|FG001|Overall Study|Patient choice|0|||
23661422|NCT01553188|66148830|FG002|Overall Study|Patient choice|0|||
23661423|NCT01553188|66148831|FG003|Overall Study|Patient choice|0|||
23661424|NCT01553188|66148828|FG000|Overall Study|Intercurrent illness and adverse event|0|||
23661425|NCT01553188|66148829|FG001|Overall Study|Intercurrent illness and adverse event|1|||
23661426|NCT01553188|66148830|FG002|Overall Study|Intercurrent illness and adverse event|2|||
23661427|NCT01553188|66148831|FG003|Overall Study|Intercurrent illness and adverse event|0|||
23661428|NCT00003702|66148832|FG000|Overall Study|Ineligible cell types|2|||
23661429|NCT00003702|66148833|FG001|Overall Study|Ineligible cell types|2|||
23661430|NCT00003702|66148832|FG000|Overall Study|Did not meet criteria for persistence|8|||
23661431|NCT00003702|66148833|FG001|Overall Study|Did not meet criteria for persistence|5|||
23661432|NCT00003702|66148832|FG000|Overall Study|WHO score > 6|2|||
23661433|NCT00003702|66148833|FG001|Overall Study|WHO score > 6|1|||
23661434|NCT00003702|66148832|FG000|Overall Study|Inadequate documentation of disease|1|||
23661435|NCT00003702|66148833|FG001|Overall Study|Inadequate documentation of disease|3|||
23661436|NCT00652366|66148843|FG000|Overall Study|Adverse Event|8|||
23661437|NCT00652366|66148844|FG001|Overall Study|Adverse Event|4|||
23661438|NCT00652366|66148845|FG002|Overall Study|Adverse Event|7|||
23661439|NCT00652366|66148846|FG003|Overall Study|Adverse Event|17|||
23661440|NCT00652366|66148847|FG004|Overall Study|Adverse Event|13|||
23661441|NCT00652366|66148843|FG000|Overall Study|Death|5|||
23661442|NCT00652366|66148844|FG001|Overall Study|Death|4|||
23661443|NCT00652366|66148845|FG002|Overall Study|Death|1|||
23661444|NCT00652366|66148846|FG003|Overall Study|Death|8|||
23661445|NCT00652366|66148847|FG004|Overall Study|Death|5|||
23661446|NCT00652366|66148843|FG000|Overall Study|Lack of Efficacy|84|||
23661447|NCT00652366|66148844|FG001|Overall Study|Lack of Efficacy|58|||
23661448|NCT00652366|66148845|FG002|Overall Study|Lack of Efficacy|53|||
23661449|NCT00652366|66148846|FG003|Overall Study|Lack of Efficacy|133|||
23661450|NCT00652366|66148847|FG004|Overall Study|Lack of Efficacy|13|||
23661451|NCT00652366|66148843|FG000|Overall Study|Violation of Selection Criteria|0|||
23661452|NCT00652366|66148844|FG001|Overall Study|Violation of Selection Criteria|0|||
23661453|NCT00652366|66148845|FG002|Overall Study|Violation of Selection Criteria|1|||
23661454|NCT00652366|66148846|FG003|Overall Study|Violation of Selection Criteria|0|||
23661455|NCT00652366|66148847|FG004|Overall Study|Violation of Selection Criteria|0|||
23661456|NCT00652366|66148843|FG000|Overall Study|Protocol Violation|1|||
23661457|NCT00652366|66148844|FG001|Overall Study|Protocol Violation|0|||
23661458|NCT00652366|66148845|FG002|Overall Study|Protocol Violation|0|||
23661459|NCT00652366|66148846|FG003|Overall Study|Protocol Violation|0|||
23661460|NCT00652366|66148847|FG004|Overall Study|Protocol Violation|0|||
23661461|NCT00652366|66148843|FG000|Overall Study|Refused treatment|3|||
23661462|NCT00652366|66148844|FG001|Overall Study|Refused treatment|7|||
23661463|NCT00652366|66148845|FG002|Overall Study|Refused treatment|6|||
23661464|NCT00652366|66148846|FG003|Overall Study|Refused treatment|17|||
23661465|NCT00652366|66148847|FG004|Overall Study|Refused treatment|5|||
23661466|NCT00652366|66148843|FG000|Overall Study|Other|5|||
23661467|NCT00652366|66148844|FG001|Overall Study|Other|2|||
23661468|NCT00652366|66148845|FG002|Overall Study|Other|3|||
23661469|NCT00652366|66148846|FG003|Overall Study|Other|4|||
23661470|NCT00652366|66148847|FG004|Overall Study|Other|0|||
23661471|NCT02375724|66148848|FG000|Overall Study|Lack of Efficacy|1|||
23661472|NCT02375724|66148849|FG001|Overall Study|Lack of Efficacy|1|||
23661473|NCT02375724|66148848|FG000|Overall Study|Withdrawal by Subject|1|||
23661474|NCT02375724|66148849|FG001|Overall Study|Withdrawal by Subject|1|||
23661475|NCT02375724|66148848|FG000|Overall Study|Lost to Follow-up|1|||
23661476|NCT02375724|66148849|FG001|Overall Study|Lost to Follow-up|0|||
23661477|NCT02375724|66148848|FG000|Overall Study|Protocol Violation|1|||
23661478|NCT02375724|66148849|FG001|Overall Study|Protocol Violation|0|||
23661479|NCT02375724|66148848|FG000|Overall Study|Adverse Event|2|||
23661480|NCT02375724|66148849|FG001|Overall Study|Adverse Event|4|||
23661481|NCT01721057|66148850|FG000|Treatment Period|Withdrawal by Subject|11|||
23661482|NCT01721057|66148851|FG001|Treatment Period|Withdrawal by Subject|5|||
23661483|NCT01721057|66148852|FG002|Treatment Period|Withdrawal by Subject|8|||
23661484|NCT01721057|66148853|FG003|Treatment Period|Withdrawal by Subject|0|||
23661485|NCT01721057|66148854|FG004|Treatment Period|Withdrawal by Subject|0|||
23661486|NCT01721057|66148855|FG005|Treatment Period|Withdrawal by Subject|0|||
23661487|NCT01721057|66148856|FG006|Treatment Period|Withdrawal by Subject|0|||
23661488|NCT01721057|66148850|FG000|Treatment Period|Adverse Event|7|||
23484171|NCT02119676|65515944|FG003|Overall Study|Death|1|||
23661489|NCT01721057|66148851|FG001|Treatment Period|Adverse Event|10|||
23661490|NCT01721057|66148852|FG002|Treatment Period|Adverse Event|12|||
23661491|NCT01721057|66148853|FG003|Treatment Period|Adverse Event|0|||
23661492|NCT01721057|66148854|FG004|Treatment Period|Adverse Event|0|||
23661493|NCT01721057|66148855|FG005|Treatment Period|Adverse Event|0|||
23661494|NCT01721057|66148856|FG006|Treatment Period|Adverse Event|0|||
23661495|NCT01721057|66148850|FG000|Treatment Period|Lack of Efficacy|7|||
23661496|NCT01721057|66148851|FG001|Treatment Period|Lack of Efficacy|3|||
23661497|NCT01721057|66148852|FG002|Treatment Period|Lack of Efficacy|0|||
23661498|NCT01721057|66148853|FG003|Treatment Period|Lack of Efficacy|0|||
23661499|NCT01721057|66148854|FG004|Treatment Period|Lack of Efficacy|0|||
23661500|NCT01721057|66148855|FG005|Treatment Period|Lack of Efficacy|0|||
23661501|NCT01721057|66148856|FG006|Treatment Period|Lack of Efficacy|0|||
23602368|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Other|0|||
23602369|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Other|0|||
23602370|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Other|0|||
23602371|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Other|0|||
23602372|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Other|0|||
23602373|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Other|0|||
23602374|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Other|0|||
23602375|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Other|0|||
23602376|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Other|0|||
23602377|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Other|0|||
23602378|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Other|0|||
23602379|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Other|0|||
23602380|NCT01998958|65934053|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
23602381|NCT01998958|65934054|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
23602382|NCT01998958|65934055|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
23602383|NCT01998958|65934056|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
23602384|NCT01998958|65934057|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
23602385|NCT01998958|65934058|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
23602386|NCT01998958|65934059|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
23602387|NCT01998958|65934060|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
23602388|NCT01998958|65934061|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
23602389|NCT01998958|65934062|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
23602390|NCT01998958|65934063|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
23602391|NCT01998958|65934064|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
23602392|NCT01998958|65934065|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
23602393|NCT01998958|65934066|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
23602394|NCT01998958|65934067|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
23661502|NCT01721057|66148850|FG000|Treatment Period|Lost to Follow-up|1|||
23661503|NCT01721057|66148851|FG001|Treatment Period|Lost to Follow-up|0|||
23661504|NCT01721057|66148852|FG002|Treatment Period|Lost to Follow-up|0|||
23661505|NCT01721057|66148853|FG003|Treatment Period|Lost to Follow-up|0|||
23367846|NCT01765296|65092480|FG001|Overall Study|Withdrawal by Subject|2|||
23602395|NCT01998958|65934068|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
23602396|NCT01998958|65934069|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
23602397|NCT01998958|65934070|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
23602398|NCT01998958|65934071|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
23602399|NCT01998958|65934072|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
23602400|NCT01998958|65934073|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
23661506|NCT01721057|66148854|FG004|Treatment Period|Lost to Follow-up|0|||
23661507|NCT01721057|66148855|FG005|Treatment Period|Lost to Follow-up|0|||
23661508|NCT01721057|66148856|FG006|Treatment Period|Lost to Follow-up|0|||
23661509|NCT01721057|66148850|FG000|Treatment Period|Physician Decision|0|||
23661510|NCT01721057|66148851|FG001|Treatment Period|Physician Decision|1|||
23602401|NCT01998958|65934074|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
23602402|NCT01998958|65934075|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
23602403|NCT01998958|65934076|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
23602404|NCT01998958|65934077|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
23602405|NCT01998958|65934078|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
23602406|NCT01998958|65934079|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
23602407|NCT01998958|65934080|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
23661511|NCT01721057|66148852|FG002|Treatment Period|Physician Decision|3|||
23661512|NCT01721057|66148853|FG003|Treatment Period|Physician Decision|0|||
23661513|NCT01721057|66148854|FG004|Treatment Period|Physician Decision|0|||
23661514|NCT01721057|66148855|FG005|Treatment Period|Physician Decision|0|||
23661515|NCT01721057|66148856|FG006|Treatment Period|Physician Decision|0|||
23661516|NCT01721057|66148850|FG000|Treatment Period|Death|2|||
23367847|NCT01765296|65092481|FG002|Overall Study|Withdrawal by Subject|2|||
23367848|NCT01765296|65092479|FG000|Overall Study|Adverse Event|1|||
23367849|NCT01765296|65092480|FG001|Overall Study|Adverse Event|13|||
23367850|NCT01765296|65092481|FG002|Overall Study|Adverse Event|5|||
23367851|NCT01765296|65092479|FG000|Overall Study|Lack of Efficacy|0|||
23367852|NCT01765296|65092480|FG001|Overall Study|Lack of Efficacy|0|||
23367853|NCT01765296|65092481|FG002|Overall Study|Lack of Efficacy|2|||
23367854|NCT01065818|65092483|FG000|Overall Study|Withdrawal by Subject|1|||
23367855|NCT01065818|65092483|FG000|Overall Study|Not a candidate for surgery|1|||
23367856|NCT01776554|65092486|FG000|Overall Study|Adverse Event|1|||
23367857|NCT01776554|65092487|FG001|Overall Study|Adverse Event|0|||
23367858|NCT01776554|65092486|FG000|Overall Study|Withdrawal by Subject|3|||
23367859|NCT01776554|65092487|FG001|Overall Study|Withdrawal by Subject|8|||
23367860|NCT01776554|65092486|FG000|Overall Study|Lost to Follow-up|6|||
23367861|NCT01776554|65092487|FG001|Overall Study|Lost to Follow-up|9|||
23367862|NCT01776554|65092486|FG000|Overall Study|Administrative Reason|2|||
23367863|NCT01776554|65092487|FG001|Overall Study|Administrative Reason|5|||
23367864|NCT01776554|65092486|FG000|Overall Study|Protocol Violation|1|||
23367865|NCT01776554|65092487|FG001|Overall Study|Protocol Violation|0|||
23367866|NCT01776554|65092486|FG000|Overall Study|Unclassified|4|||
23367867|NCT01776554|65092487|FG001|Overall Study|Unclassified|1|||
23367868|NCT00452439|65092497|FG000|Overall Study|Lost to Follow-up|1|||
23367869|NCT00452439|65092498|FG001|Overall Study|Lost to Follow-up|1|||
23367870|NCT00452439|65092497|FG000|Overall Study|Refused Treatment|4|||
23367871|NCT00452439|65092498|FG001|Overall Study|Refused Treatment|3|||
23367872|NCT00452439|65092497|FG000|Overall Study|Death|3|||
23367873|NCT00452439|65092498|FG001|Overall Study|Death|1|||
23367874|NCT00452439|65092497|FG000|Overall Study|Bone Marrow Transplant|0|||
23367875|NCT00452439|65092498|FG001|Overall Study|Bone Marrow Transplant|1|||
23367876|NCT00452439|65092497|FG000|Overall Study|Too Ill to Continue|0|||
23367877|NCT00452439|65092498|FG001|Overall Study|Too Ill to Continue|1|||
23367878|NCT00452439|65092497|FG000|Overall Study|Failed to achieve complete response|2|||
23367879|NCT00452439|65092498|FG001|Overall Study|Failed to achieve complete response|0|||
23367880|NCT00452439|65092497|FG000|Overall Study|Relapse|3|||
23367881|NCT00452439|65092498|FG001|Overall Study|Relapse|0|||
23367882|NCT00452439|65092497|FG000|Overall Study|Fracture|1|||
23367883|NCT00452439|65092498|FG001|Overall Study|Fracture|0|||
23367884|NCT04085601|65092499|FG000|Overall Study|Lost to Follow-up|1|||
23367885|NCT04085601|65092500|FG001|Overall Study|Lost to Follow-up|0|||
23602408|NCT01998958|65934081|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
23602409|NCT01998958|65934082|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
23602410|NCT01998958|65934083|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
23602411|NCT01998958|65934084|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
23602412|NCT01998958|65934053|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602413|NCT01998958|65934054|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602414|NCT01998958|65934055|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602415|NCT01998958|65934056|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23661517|NCT01721057|66148851|FG001|Treatment Period|Death|0|||
23367886|NCT04085601|65092499|FG000|Overall Study|Death|1|||
23367887|NCT04085601|65092500|FG001|Overall Study|Death|1|||
23367888|NCT05556148|65092501|FG000|Overall Study|Early Termination|29|||
23367889|NCT05556148|65092501|FG000|Overall Study|Baseline Tasks Expired|4|||
23367890|NCT05556148|65092501|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
23602416|NCT01998958|65934057|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23661518|NCT01721057|66148852|FG002|Treatment Period|Death|0|||
23661519|NCT01721057|66148853|FG003|Treatment Period|Death|0|||
23661520|NCT01721057|66148854|FG004|Treatment Period|Death|0|||
23367891|NCT05556148|65092501|FG000|Overall Study|No Longer Wished to Participate|1|||
23367892|NCT05556148|65092501|FG000|Overall Study|Bacterial Conjunctivitis|1|||
23367893|NCT02812186|65092502|FG000|Period 1|Post randomization screen failure|5|||
23367894|NCT02812186|65092503|FG001|Period 1|Post randomization screen failure|9|||
23367895|NCT02812186|65092502|FG000|Period 1|nonevaluable data sets|6|||
23367896|NCT02812186|65092503|FG001|Period 1|nonevaluable data sets|6|||
23367897|NCT04644029|65092504|FG000|Overall Study|Death|1|||
23367898|NCT04644029|65092505|FG001|Overall Study|Death|0|||
23367899|NCT04644029|65092504|FG000|Overall Study|Physician Decision|1|||
23367900|NCT04644029|65092505|FG001|Overall Study|Physician Decision|2|||
23367901|NCT04644029|65092504|FG000|Overall Study|Withdrawal by Subject|21|||
23367902|NCT04644029|65092505|FG001|Overall Study|Withdrawal by Subject|19|||
23367903|NCT04644029|65092504|FG000|Overall Study|Lost to Follow-up|31|||
23367904|NCT04644029|65092505|FG001|Overall Study|Lost to Follow-up|34|||
23367905|NCT04644029|65092504|FG000|Overall Study|Study Terminated by Sponsor|305|||
23367906|NCT04644029|65092505|FG001|Overall Study|Study Terminated by Sponsor|301|||
23367907|NCT04644029|65092504|FG000|Overall Study|Status Not Recorded|3|||
23367908|NCT04644029|65092505|FG001|Overall Study|Status Not Recorded|8|||
23367909|NCT04644029|65092504|FG000|Overall Study|Randomized in Error|2|||
23367910|NCT04644029|65092505|FG001|Overall Study|Randomized in Error|1|||
23367911|NCT04644029|65092504|FG000|Overall Study|Other|0|||
23367912|NCT04644029|65092505|FG001|Overall Study|Other|1|||
23367913|NCT01418339|65092506|FG000|Overall Study|Adverse Event|5|||
23367914|NCT01418339|65092507|FG001|Overall Study|Adverse Event|2|||
23367915|NCT01418339|65092506|FG000|Overall Study|Subject Withdrew Consent|1|||
23367916|NCT01418339|65092507|FG001|Overall Study|Subject Withdrew Consent|2|||
23367917|NCT01418339|65092506|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
23367918|NCT01418339|65092507|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
23367919|NCT00161213|65092510|FG000|Overall Study|Withdrawal by Subject|1|||
23367920|NCT00161213|65092510|FG000|Overall Study|Evaluable for toxicity but not response|1|||
23367921|NCT01919164|65092511|FG000|Overall Study|Adverse Event|6|||
23367922|NCT01919164|65092512|FG001|Overall Study|Adverse Event|4|||
23367923|NCT01919164|65092513|FG002|Overall Study|Adverse Event|9|||
23367924|NCT01919164|65092514|FG003|Overall Study|Adverse Event|3|||
23367925|NCT01919164|65092515|FG004|Overall Study|Adverse Event|2|||
23367926|NCT01919164|65092511|FG000|Overall Study|Lost to Follow-up|2|||
23367927|NCT01919164|65092512|FG001|Overall Study|Lost to Follow-up|2|||
23367928|NCT01919164|65092513|FG002|Overall Study|Lost to Follow-up|2|||
23367929|NCT01919164|65092514|FG003|Overall Study|Lost to Follow-up|0|||
23367930|NCT01919164|65092515|FG004|Overall Study|Lost to Follow-up|4|||
23367931|NCT01919164|65092511|FG000|Overall Study|Death|1|||
23367932|NCT01919164|65092512|FG001|Overall Study|Death|0|||
23367933|NCT01919164|65092513|FG002|Overall Study|Death|0|||
23367934|NCT01919164|65092514|FG003|Overall Study|Death|0|||
23367935|NCT01919164|65092515|FG004|Overall Study|Death|0|||
23367936|NCT01919164|65092511|FG000|Overall Study|Protocol Violation|6|||
23367937|NCT01919164|65092512|FG001|Overall Study|Protocol Violation|0|||
23367938|NCT01919164|65092513|FG002|Overall Study|Protocol Violation|3|||
23367939|NCT01919164|65092514|FG003|Overall Study|Protocol Violation|2|||
23367940|NCT01919164|65092515|FG004|Overall Study|Protocol Violation|2|||
23367941|NCT01919164|65092511|FG000|Overall Study|Disease progression|2|||
23367942|NCT01919164|65092512|FG001|Overall Study|Disease progression|2|||
23367943|NCT01919164|65092513|FG002|Overall Study|Disease progression|1|||
23367944|NCT01919164|65092514|FG003|Overall Study|Disease progression|2|||
23367945|NCT01919164|65092515|FG004|Overall Study|Disease progression|1|||
23367946|NCT01919164|65092511|FG000|Overall Study|Withdrew consent|13|||
23367947|NCT01919164|65092512|FG001|Overall Study|Withdrew consent|13|||
23367948|NCT01919164|65092513|FG002|Overall Study|Withdrew consent|14|||
23367949|NCT01919164|65092514|FG003|Overall Study|Withdrew consent|14|||
23367950|NCT01919164|65092515|FG004|Overall Study|Withdrew consent|9|||
23367951|NCT01919164|65092511|FG000|Overall Study|Other Un-specified|13|||
23367952|NCT01919164|65092512|FG001|Overall Study|Other Un-specified|9|||
23367953|NCT01919164|65092513|FG002|Overall Study|Other Un-specified|8|||
23367954|NCT01919164|65092514|FG003|Overall Study|Other Un-specified|7|||
23367955|NCT01919164|65092515|FG004|Overall Study|Other Un-specified|15|||
23367956|NCT02723188|65092519|FG000|Overall Study|Withdrawal by Subject|1|||
23367957|NCT02723188|65092520|FG001|Overall Study|Withdrawal by Subject|0|||
23367958|NCT02723188|65092521|FG002|Overall Study|Withdrawal by Subject|0|||
23367959|NCT03718429|65092522|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
23367960|NCT03718429|65092523|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
23367961|NCT03718429|65092524|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
23367962|NCT03718429|65092525|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
23367963|NCT04805671|65092526|FG000|Overall Study|Death|2|||
23661521|NCT01721057|66148855|FG005|Treatment Period|Death|0|||
23661522|NCT01721057|66148856|FG006|Treatment Period|Death|0|||
23661523|NCT01721057|66148850|FG000|Rescue Period|Adverse Event|0|||
23661524|NCT01721057|66148851|FG001|Rescue Period|Adverse Event|0|||
23661525|NCT01721057|66148852|FG002|Rescue Period|Adverse Event|0|||
23661526|NCT01721057|66148853|FG003|Rescue Period|Adverse Event|1|||
23661527|NCT01721057|66148854|FG004|Rescue Period|Adverse Event|0|||
23661528|NCT01721057|66148855|FG005|Rescue Period|Adverse Event|0|||
23661529|NCT01721057|66148856|FG006|Rescue Period|Adverse Event|0|||
23661530|NCT01721057|66148850|FG000|Rescue Period|Lack of Efficacy|0|||
23661531|NCT01721057|66148851|FG001|Rescue Period|Lack of Efficacy|0|||
23661532|NCT01721057|66148852|FG002|Rescue Period|Lack of Efficacy|0|||
23367964|NCT04805671|65092527|FG001|Overall Study|Death|7|||
23367965|NCT04805671|65092526|FG000|Overall Study|Lost to Follow-up|1|||
23367966|NCT04805671|65092527|FG001|Overall Study|Lost to Follow-up|0|||
23367967|NCT04805671|65092526|FG000|Overall Study|Withdrawal by Subject|9|||
23367968|NCT04805671|65092527|FG001|Overall Study|Withdrawal by Subject|7|||
23367969|NCT04805671|65092526|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
23367970|NCT04805671|65092527|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
23367971|NCT02976519|65092528|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367972|NCT02976519|65092529|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
23367973|NCT02976519|65092530|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367974|NCT02976519|65092531|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367975|NCT02976519|65092532|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367976|NCT02976519|65092533|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367977|NCT02976519|65092534|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367978|NCT02976519|65092528|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367979|NCT02976519|65092529|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367980|NCT02976519|65092530|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367981|NCT02976519|65092531|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
23367982|NCT02976519|65092532|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367983|NCT02976519|65092533|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367984|NCT02976519|65092534|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367985|NCT02976519|65092528|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367986|NCT02976519|65092529|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367987|NCT02976519|65092530|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367988|NCT02976519|65092531|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367989|NCT02976519|65092532|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367990|NCT02976519|65092533|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367991|NCT02976519|65092534|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
23367992|NCT02976519|65092528|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367993|NCT02976519|65092529|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367994|NCT02976519|65092530|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367995|NCT02976519|65092531|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367996|NCT02976519|65092532|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367997|NCT02976519|65092533|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367998|NCT02976519|65092534|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
23367999|NCT02976519|65092528|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368000|NCT02976519|65092529|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368001|NCT02976519|65092530|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23602417|NCT01998958|65934058|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602418|NCT01998958|65934059|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602419|NCT01998958|65934060|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602420|NCT01998958|65934061|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602421|NCT01998958|65934062|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602422|NCT01998958|65934063|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602423|NCT01998958|65934064|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602424|NCT01998958|65934065|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602425|NCT01998958|65934066|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602426|NCT01998958|65934067|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
23602427|NCT01998958|65934068|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602428|NCT01998958|65934069|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602429|NCT01998958|65934070|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602430|NCT01998958|65934071|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
23661533|NCT01721057|66148853|FG003|Rescue Period|Lack of Efficacy|2|||
23661534|NCT01721057|66148854|FG004|Rescue Period|Lack of Efficacy|0|||
23661535|NCT01721057|66148855|FG005|Rescue Period|Lack of Efficacy|0|||
23661536|NCT01721057|66148856|FG006|Rescue Period|Lack of Efficacy|0|||
23661537|NCT01732796|66148862|FG000|Overall Study|Adverse Event|16|||
23661538|NCT01732796|66148863|FG001|Overall Study|Adverse Event|16|||
23661539|NCT01732796|66148864|FG002|Overall Study|Adverse Event|4|||
23661540|NCT01732796|66148862|FG000|Overall Study|Lack of Efficacy|21|||
23661541|NCT01732796|66148863|FG001|Overall Study|Lack of Efficacy|18|||
23661542|NCT01732796|66148864|FG002|Overall Study|Lack of Efficacy|5|||
23661543|NCT01732796|66148862|FG000|Overall Study|Lost to Follow-up|2|||
23661544|NCT01732796|66148863|FG001|Overall Study|Lost to Follow-up|0|||
23661545|NCT01732796|66148864|FG002|Overall Study|Lost to Follow-up|0|||
23661546|NCT01732796|66148862|FG000|Overall Study|Withdrawal by Subject|6|||
23661547|NCT01732796|66148863|FG001|Overall Study|Withdrawal by Subject|8|||
23661548|NCT01732796|66148864|FG002|Overall Study|Withdrawal by Subject|2|||
23661549|NCT01732796|66148862|FG000|Overall Study|Other reason not defined above|1|||
23661550|NCT01732796|66148863|FG001|Overall Study|Other reason not defined above|0|||
23661551|NCT01732796|66148864|FG002|Overall Study|Other reason not defined above|2|||
23661552|NCT03281668|66148869|FG000|Overall Study|Physician Decision|1|||
23661553|NCT03281668|66148869|FG000|Overall Study|scheduling conflict, family circumstance|2|||
23368002|NCT02976519|65092531|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23661554|NCT03281668|66148869|FG000|Overall Study|Withdrawal by Subject|4|||
23661555|NCT03281668|66148869|FG000|Overall Study|Lost to Follow-up|1|||
23661556|NCT01147744|66148870|FG000|Overall Study|Protocol Violation|1|||
23661557|NCT01147744|66148871|FG001|Overall Study|Protocol Violation|0|||
23661558|NCT01147744|66148872|FG002|Overall Study|Protocol Violation|1|||
23661559|NCT01147744|66148873|FG003|Overall Study|Protocol Violation|0|||
23661560|NCT01147744|66148874|FG004|Overall Study|Protocol Violation|1|||
23661561|NCT01147744|66148875|FG005|Overall Study|Protocol Violation|3|||
23661562|NCT01147744|66148876|FG006|Overall Study|Protocol Violation|1|||
23661563|NCT01147744|66148870|FG000|Overall Study|Physician Decision|0|||
23661564|NCT01147744|66148871|FG001|Overall Study|Physician Decision|1|||
23661565|NCT01147744|66148872|FG002|Overall Study|Physician Decision|1|||
23661566|NCT01147744|66148873|FG003|Overall Study|Physician Decision|0|||
23661567|NCT01147744|66148874|FG004|Overall Study|Physician Decision|0|||
23661568|NCT01147744|66148875|FG005|Overall Study|Physician Decision|0|||
23661569|NCT01147744|66148876|FG006|Overall Study|Physician Decision|1|||
23661570|NCT01147744|66148870|FG000|Overall Study|Lack of Efficacy|11|||
23661571|NCT01147744|66148871|FG001|Overall Study|Lack of Efficacy|11|||
23661572|NCT01147744|66148872|FG002|Overall Study|Lack of Efficacy|9|||
23661573|NCT01147744|66148873|FG003|Overall Study|Lack of Efficacy|11|||
23661574|NCT01147744|66148874|FG004|Overall Study|Lack of Efficacy|13|||
23807476|NCT02177136|66672779|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
23807477|NCT02177136|66672776|FG000|LTSE Phase|Withdrawal by Subject|0|||
23807478|NCT02177136|66672777|FG001|LTSE Phase|Withdrawal by Subject|0|||
23807479|NCT02177136|66672778|FG002|LTSE Phase|Withdrawal by Subject|0|||
23807480|NCT02177136|66672779|FG003|LTSE Phase|Withdrawal by Subject|6|||
23807481|NCT02177136|66672776|FG000|LTSE Phase|Adverse Event|0|||
23807482|NCT02177136|66672777|FG001|LTSE Phase|Adverse Event|0|||
23807483|NCT02177136|66672778|FG002|LTSE Phase|Adverse Event|0|||
23807484|NCT02177136|66672779|FG003|LTSE Phase|Adverse Event|10|||
23807485|NCT02177136|66672776|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
23807486|NCT02177136|66672777|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
23807487|NCT02177136|66672778|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
23807488|NCT02177136|66672779|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
23807489|NCT02177136|66672776|FG000|LTSE Phase|Physician Decision|0|||
23807490|NCT02177136|66672777|FG001|LTSE Phase|Physician Decision|0|||
23807491|NCT02177136|66672778|FG002|LTSE Phase|Physician Decision|0|||
23807492|NCT02177136|66672779|FG003|LTSE Phase|Physician Decision|2|||
23807493|NCT02177136|66672776|FG000|LTSE Phase|Lost to Follow-up|0|||
23807494|NCT02177136|66672777|FG001|LTSE Phase|Lost to Follow-up|0|||
23807495|NCT02177136|66672778|FG002|LTSE Phase|Lost to Follow-up|0|||
23807496|NCT02177136|66672779|FG003|LTSE Phase|Lost to Follow-up|1|||
23807497|NCT02177136|66672776|FG000|LTSE Phase|Participant Moved|0|||
23807498|NCT02177136|66672777|FG001|LTSE Phase|Participant Moved|0|||
23807499|NCT02177136|66672778|FG002|LTSE Phase|Participant Moved|0|||
23807500|NCT02177136|66672779|FG003|LTSE Phase|Participant Moved|1|||
23807501|NCT02566993|66672782|FG000|Overall Study|Randomized but not treated|5|||
23807502|NCT02566993|66672783|FG001|Overall Study|Randomized but not treated|16|||
23807503|NCT02566993|66672782|FG000|Overall Study|Progressive disease|213|||
23807504|NCT02566993|66672783|FG001|Overall Study|Progressive disease|152|||
23807505|NCT02566993|66672782|FG000|Overall Study|Withdrawal by Subject|12|||
23807506|NCT02566993|66672783|FG001|Overall Study|Withdrawal by Subject|28|||
23807507|NCT02566993|66672782|FG000|Overall Study|Death|17|||
23807508|NCT02566993|66672783|FG001|Overall Study|Death|23|||
23807509|NCT02566993|66672782|FG000|Overall Study|Physician Decision|10|||
23807510|NCT02566993|66672783|FG001|Overall Study|Physician Decision|17|||
23807511|NCT02566993|66672782|FG000|Overall Study|Study drug-related adverse event|20|||
23807512|NCT02566993|66672783|FG001|Overall Study|Study drug-related adverse event|41|||
23807513|NCT02566993|66672782|FG000|Overall Study|Non study drug-related adverse event|9|||
23807514|NCT02566993|66672783|FG001|Overall Study|Non study drug-related adverse event|9|||
23807515|NCT02566993|66672782|FG000|Overall Study|Symptomatic deterioration|9|||
23807516|NCT02566993|66672783|FG001|Overall Study|Symptomatic deterioration|16|||
23661575|NCT01147744|66148875|FG005|Overall Study|Lack of Efficacy|8|||
23661576|NCT01147744|66148876|FG006|Overall Study|Lack of Efficacy|7|||
23661577|NCT01147744|66148870|FG000|Overall Study|Adverse Event|1|||
23661578|NCT01147744|66148871|FG001|Overall Study|Adverse Event|2|||
23661579|NCT01147744|66148872|FG002|Overall Study|Adverse Event|3|||
23661580|NCT01147744|66148873|FG003|Overall Study|Adverse Event|0|||
23368003|NCT02976519|65092532|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368004|NCT02976519|65092533|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368005|NCT02976519|65092534|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
23368006|NCT03102762|65092537|FG000|Overall Study|Lost to Follow-up|1|||
23368007|NCT03102762|65092538|FG001|Overall Study|Lost to Follow-up|0|||
23368008|NCT00875810|65092539|FG000|Overall Study|Withdrawal by Subject|1|||
23368009|NCT00875810|65092539|FG000|Overall Study|Physician Decision|3|||
23368010|NCT00875810|65092539|FG000|Overall Study|Lost to Follow-up|39|||
23368011|NCT00875810|65092539|FG000|Overall Study|Patient enroled but not implanted|2|||
23368012|NCT00875810|65092539|FG000|Overall Study|Device explanted|1|||
23368013|NCT01296412|65092542|FG000|Overall Study|Adverse Event|8|||
23368014|NCT01296412|65092543|FG001|Overall Study|Adverse Event|29|||
23368015|NCT01296412|65092542|FG000|Overall Study|Lack of Efficacy|1|||
23368016|NCT01296412|65092543|FG001|Overall Study|Lack of Efficacy|0|||
23368017|NCT01296412|65092542|FG000|Overall Study|Lost to Follow-up|10|||
23368018|NCT01296412|65092543|FG001|Overall Study|Lost to Follow-up|7|||
23368019|NCT01296412|65092542|FG000|Overall Study|Non-compliance with study drug|1|||
23368020|NCT01296412|65092543|FG001|Overall Study|Non-compliance with study drug|2|||
23368021|NCT01296412|65092542|FG000|Overall Study|Other reason not specified|20|||
23368022|NCT01296412|65092543|FG001|Overall Study|Other reason not specified|15|||
23368023|NCT01296412|65092542|FG000|Overall Study|Physician Decision|1|||
23368024|NCT01296412|65092543|FG001|Overall Study|Physician Decision|3|||
23368025|NCT01296412|65092542|FG000|Overall Study|Pregnancy|0|||
23368026|NCT01296412|65092543|FG001|Overall Study|Pregnancy|1|||
23368027|NCT01296412|65092542|FG000|Overall Study|Withdrawal by Subject|10|||
23368028|NCT01296412|65092543|FG001|Overall Study|Withdrawal by Subject|13|||
23368029|NCT03342001|65092544|FG000|Overall Study|Adverse Event|1|||
23484172|NCT02119676|65515941|FG000|Overall Study|Noncompliance|0|||
23484173|NCT02119676|65515942|FG001|Overall Study|Noncompliance|1|||
23484174|NCT02119676|65515943|FG002|Overall Study|Noncompliance|0|||
23484175|NCT02119676|65515944|FG003|Overall Study|Noncompliance|0|||
23484176|NCT02119676|65515941|FG000|Overall Study|Lost to Follow-up|0|||
23484177|NCT02119676|65515942|FG001|Overall Study|Lost to Follow-up|0|||
23484178|NCT02119676|65515943|FG002|Overall Study|Lost to Follow-up|1|||
23484179|NCT02119676|65515944|FG003|Overall Study|Lost to Follow-up|0|||
23484180|NCT02119676|65515941|FG000|Overall Study|Protocol deviation|0|||
23484181|NCT02119676|65515942|FG001|Overall Study|Protocol deviation|0|||
23661581|NCT01147744|66148874|FG004|Overall Study|Adverse Event|2|||
23661582|NCT01147744|66148875|FG005|Overall Study|Adverse Event|1|||
23661583|NCT01147744|66148876|FG006|Overall Study|Adverse Event|2|||
23661584|NCT01147744|66148870|FG000|Overall Study|Withdrawal by Subject|8|||
23661585|NCT01147744|66148871|FG001|Overall Study|Withdrawal by Subject|4|||
23661586|NCT01147744|66148872|FG002|Overall Study|Withdrawal by Subject|2|||
23661587|NCT01147744|66148873|FG003|Overall Study|Withdrawal by Subject|2|||
23661588|NCT01147744|66148874|FG004|Overall Study|Withdrawal by Subject|2|||
23661589|NCT01147744|66148875|FG005|Overall Study|Withdrawal by Subject|5|||
23661590|NCT01147744|66148876|FG006|Overall Study|Withdrawal by Subject|2|||
23661591|NCT01147744|66148870|FG000|Overall Study|Lost to Follow-up|0|||
23661592|NCT01147744|66148871|FG001|Overall Study|Lost to Follow-up|1|||
23484182|NCT02119676|65515943|FG002|Overall Study|Protocol deviation|1|||
23484183|NCT02119676|65515944|FG003|Overall Study|Protocol deviation|0|||
23661593|NCT01147744|66148872|FG002|Overall Study|Lost to Follow-up|0|||
23368030|NCT03342001|65092544|FG000|Overall Study|Lost to Follow-up|1|||
23368031|NCT03902613|65092550|FG000|Overall Study|Physician Decision|1|||
23484184|NCT02119676|65515941|FG000|Overall Study|Other, unspecified|2|||
23368032|NCT00102596|65092551|FG000|Part A|Screen failures|6|||
23368033|NCT00102596|65092552|FG001|Part A|Screen failures|0|||
23368034|NCT00102596|65092551|FG000|Part A|Adverse Event|1|||
23368035|NCT00102596|65092552|FG001|Part A|Adverse Event|0|||
23368036|NCT02557295|65092556|FG000|Overall Study|Withdrawal by Subject|9|||
23368037|NCT02557295|65092557|FG001|Overall Study|Withdrawal by Subject|2|||
23368038|NCT02557295|65092558|FG002|Overall Study|Withdrawal by Subject|4|||
23368039|NCT02557295|65092559|FG003|Overall Study|Withdrawal by Subject|0|||
23368040|NCT02557295|65092560|FG004|Overall Study|Withdrawal by Subject|0|||
23368041|NCT02557295|65092561|FG005|Overall Study|Withdrawal by Subject|0|||
23368042|NCT02557295|65092562|FG006|Overall Study|Withdrawal by Subject|15|||
23368043|NCT02557295|65092563|FG007|Overall Study|Withdrawal by Subject|1|||
23368044|NCT02557295|65092564|FG008|Overall Study|Withdrawal by Subject|3|||
23368045|NCT02557295|65092556|FG000|Overall Study|Disease Progression|0|||
23368046|NCT02557295|65092557|FG001|Overall Study|Disease Progression|0|||
23368047|NCT02557295|65092558|FG002|Overall Study|Disease Progression|0|||
23368048|NCT02557295|65092559|FG003|Overall Study|Disease Progression|0|||
23368049|NCT02557295|65092560|FG004|Overall Study|Disease Progression|0|||
23368050|NCT02557295|65092561|FG005|Overall Study|Disease Progression|0|||
23602431|NCT01998958|65934072|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602432|NCT01998958|65934073|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602433|NCT01998958|65934074|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602434|NCT01998958|65934075|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23368051|NCT02557295|65092562|FG006|Overall Study|Disease Progression|1|||
23602435|NCT01998958|65934076|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23368052|NCT02557295|65092563|FG007|Overall Study|Disease Progression|0|||
23368053|NCT02557295|65092564|FG008|Overall Study|Disease Progression|0|||
23368054|NCT02557295|65092556|FG000|Overall Study|Lack of Efficacy|24|||
23368055|NCT02557295|65092557|FG001|Overall Study|Lack of Efficacy|1|||
23661594|NCT01147744|66148873|FG003|Overall Study|Lost to Follow-up|0|||
23661595|NCT01147744|66148874|FG004|Overall Study|Lost to Follow-up|0|||
23661596|NCT01147744|66148875|FG005|Overall Study|Lost to Follow-up|0|||
23661597|NCT01147744|66148876|FG006|Overall Study|Lost to Follow-up|0|||
23484185|NCT02119676|65515942|FG001|Overall Study|Other, unspecified|1|||
23484186|NCT02119676|65515943|FG002|Overall Study|Other, unspecified|3|||
23661598|NCT01147744|66148870|FG000|Overall Study|Sponsor decision to amend protocol|7|||
23661599|NCT01147744|66148871|FG001|Overall Study|Sponsor decision to amend protocol|4|||
23661600|NCT01147744|66148872|FG002|Overall Study|Sponsor decision to amend protocol|2|||
23484187|NCT02119676|65515944|FG003|Overall Study|Other, unspecified|4|||
23661601|NCT01147744|66148873|FG003|Overall Study|Sponsor decision to amend protocol|5|||
23661602|NCT01147744|66148874|FG004|Overall Study|Sponsor decision to amend protocol|7|||
23661603|NCT01147744|66148875|FG005|Overall Study|Sponsor decision to amend protocol|2|||
23661604|NCT01147744|66148876|FG006|Overall Study|Sponsor decision to amend protocol|6|||
23661605|NCT01147744|66148870|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23661606|NCT01147744|66148871|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23661607|NCT01147744|66148872|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23661608|NCT01147744|66148873|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23661609|NCT01147744|66148874|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23661610|NCT01147744|66148875|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23661611|NCT01147744|66148876|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23661612|NCT02163187|66148878|FG000|Overall Study|Device removed|1|||
23661613|NCT02163187|66148879|FG001|Overall Study|Device removed|0|||
23661614|NCT02163187|66148878|FG000|Overall Study|Progressive disease|1|||
23661615|NCT02163187|66148879|FG001|Overall Study|Progressive disease|0|||
23661616|NCT02830776|66148882|FG000|Overall Study|Lost to Follow-up|1|||
23661617|NCT03007979|66148883|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
23661618|NCT01553136|66148884|FG000|Overall Study|Adverse Event|3|||
23661619|NCT01553136|66148885|FG001|Overall Study|Adverse Event|2|||
23661620|NCT01553136|66148884|FG000|Overall Study|Withdrawal by Subject|2|||
23661621|NCT01553136|66148885|FG001|Overall Study|Withdrawal by Subject|3|||
23661622|NCT01553136|66148884|FG000|Overall Study|Lost to Follow-up|4|||
23661623|NCT01553136|66148885|FG001|Overall Study|Lost to Follow-up|10|||
23661624|NCT01553136|66148884|FG000|Overall Study|Physician Decision|2|||
23661625|NCT01553136|66148885|FG001|Overall Study|Physician Decision|3|||
23661626|NCT01553136|66148884|FG000|Overall Study|Scheduling Difficulties|5|||
23661627|NCT01553136|66148885|FG001|Overall Study|Scheduling Difficulties|4|||
23661628|NCT01667081|66148889|FG000|Overall Study|Death|43|||
23661629|NCT01667081|66148890|FG001|Overall Study|Death|3|||
23661630|NCT01667081|66148889|FG000|Overall Study|Lost to Follow-up|99|||
23661631|NCT01667081|66148890|FG001|Overall Study|Lost to Follow-up|48|||
23661632|NCT01667081|66148889|FG000|Overall Study|Physician Decision|16|||
23661633|NCT01667081|66148890|FG001|Overall Study|Physician Decision|2|||
23661634|NCT01667081|66148889|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
23661635|NCT01667081|66148890|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
23661636|NCT01667081|66148889|FG000|Overall Study|Withdrawal by Subject|90|||
23661637|NCT01667081|66148890|FG001|Overall Study|Withdrawal by Subject|35|||
23661638|NCT02568475|66148891|FG000|Overall Study|Lost to Follow-up|40|||
23661639|NCT02568475|66148892|FG001|Overall Study|Lost to Follow-up|39|||
23661640|NCT02568475|66148891|FG000|Overall Study|Withdrawal by Subject|2|||
23661641|NCT02568475|66148892|FG001|Overall Study|Withdrawal by Subject|0|||
23661642|NCT02568475|66148891|FG000|Overall Study|Discharged home|4|||
23661643|NCT02568475|66148892|FG001|Overall Study|Discharged home|4|||
23661644|NCT02568475|66148891|FG000|Overall Study|Short-term: Discharge location unknown|4|||
23661645|NCT02568475|66148892|FG001|Overall Study|Short-term: Discharge location unknown|0|||
23661646|NCT02568475|66148891|FG000|Overall Study|Transferred to another facility|1|||
23661647|NCT02568475|66148892|FG001|Overall Study|Transferred to another facility|0|||
23661648|NCT02064920|66148893|FG000|Overall Study|Adverse Event|0|||
23661649|NCT02064920|66148894|FG001|Overall Study|Adverse Event|4|||
23661650|NCT02064920|66148893|FG000|Overall Study|Physician Decision|0|||
23661651|NCT02064920|66148894|FG001|Overall Study|Physician Decision|1|||
23661652|NCT02064920|66148893|FG000|Overall Study|Technical Problems|0|||
23661653|NCT02064920|66148894|FG001|Overall Study|Technical Problems|1|||
23661654|NCT02064920|66148893|FG000|Overall Study|Withdrawal by Subject|1|||
23661655|NCT02064920|66148894|FG001|Overall Study|Withdrawal by Subject|3|||
23661656|NCT01161043|66148895|FG000|Overall Study|Withdrawal by Subject|3|||
23661657|NCT03807349|66148898|FG000|Overall Study|Early Study Termination|9|||
23661658|NCT02294682|66148899|FG000|Overall Study|Could not swallow pills|1|||
23368056|NCT02557295|65092558|FG002|Overall Study|Lack of Efficacy|3|||
23368057|NCT02557295|65092559|FG003|Overall Study|Lack of Efficacy|0|||
23368058|NCT02557295|65092560|FG004|Overall Study|Lack of Efficacy|0|||
23368059|NCT02557295|65092561|FG005|Overall Study|Lack of Efficacy|0|||
23368060|NCT02557295|65092562|FG006|Overall Study|Lack of Efficacy|12|||
23368061|NCT02557295|65092563|FG007|Overall Study|Lack of Efficacy|1|||
23368062|NCT02557295|65092564|FG008|Overall Study|Lack of Efficacy|0|||
23368063|NCT02557295|65092556|FG000|Overall Study|Adverse Event|16|||
23368064|NCT02557295|65092557|FG001|Overall Study|Adverse Event|2|||
23368065|NCT02557295|65092558|FG002|Overall Study|Adverse Event|3|||
23368066|NCT02557295|65092559|FG003|Overall Study|Adverse Event|0|||
23368067|NCT02557295|65092560|FG004|Overall Study|Adverse Event|0|||
23368068|NCT02557295|65092561|FG005|Overall Study|Adverse Event|0|||
23661659|NCT02294682|66148900|FG001|Overall Study|Could not swallow pills|0|||
23661660|NCT03329196|66148901|FG000|Overall Study|Adverse Event|10|||
23368069|NCT02557295|65092562|FG006|Overall Study|Adverse Event|2|||
23368070|NCT02557295|65092563|FG007|Overall Study|Adverse Event|1|||
23368071|NCT02557295|65092564|FG008|Overall Study|Adverse Event|1|||
23368072|NCT02557295|65092556|FG000|Overall Study|Lost to Follow-up|4|||
23368073|NCT02557295|65092557|FG001|Overall Study|Lost to Follow-up|0|||
23368074|NCT02557295|65092558|FG002|Overall Study|Lost to Follow-up|0|||
23368075|NCT02557295|65092559|FG003|Overall Study|Lost to Follow-up|0|||
23661661|NCT03329196|66148902|FG001|Overall Study|Adverse Event|5|||
23661662|NCT03329196|66148901|FG000|Overall Study|Physician Decision|2|||
23661663|NCT03329196|66148902|FG001|Overall Study|Physician Decision|2|||
23661664|NCT03329196|66148901|FG000|Overall Study|Withdrawal by Subject|11|||
23661665|NCT03329196|66148902|FG001|Overall Study|Withdrawal by Subject|3|||
23661666|NCT03329196|66148901|FG000|Overall Study|Hepatic function abnormalities|0|||
23661667|NCT03329196|66148902|FG001|Overall Study|Hepatic function abnormalities|1|||
23661668|NCT03329196|66148901|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
23661669|NCT03329196|66148902|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
23661670|NCT03329196|66148901|FG000|Overall Study|Difficult to control Hb|2|||
23661671|NCT03329196|66148902|FG001|Overall Study|Difficult to control Hb|3|||
23661672|NCT03329196|66148901|FG000|Overall Study|Dialysis or renal transplant|13|||
23661673|NCT03329196|66148902|FG001|Overall Study|Dialysis or renal transplant|15|||
23368076|NCT02557295|65092560|FG004|Overall Study|Lost to Follow-up|0|||
23368077|NCT02557295|65092561|FG005|Overall Study|Lost to Follow-up|0|||
23368078|NCT02557295|65092562|FG006|Overall Study|Lost to Follow-up|9|||
23368079|NCT02557295|65092563|FG007|Overall Study|Lost to Follow-up|0|||
23368080|NCT02557295|65092564|FG008|Overall Study|Lost to Follow-up|0|||
23368081|NCT02557295|65092556|FG000|Overall Study|Study Close|54|||
23368082|NCT02557295|65092557|FG001|Overall Study|Study Close|3|||
23368083|NCT02557295|65092558|FG002|Overall Study|Study Close|5|||
23368084|NCT02557295|65092559|FG003|Overall Study|Study Close|3|||
23368085|NCT02557295|65092560|FG004|Overall Study|Study Close|0|||
23368086|NCT02557295|65092561|FG005|Overall Study|Study Close|0|||
23368087|NCT02557295|65092562|FG006|Overall Study|Study Close|37|||
23484188|NCT02119676|65515941|FG000|Overall Study|Did not receive study med|2|||
23484189|NCT02119676|65515942|FG001|Overall Study|Did not receive study med|2|||
23484190|NCT02119676|65515943|FG002|Overall Study|Did not receive study med|4|||
23484191|NCT02119676|65515944|FG003|Overall Study|Did not receive study med|5|||
23484192|NCT01017575|65515949|FG000|Overall Study|Lack of Efficacy|0|||
23484193|NCT01017575|65515950|FG001|Overall Study|Lack of Efficacy|1|||
23484194|NCT01017575|65515951|FG002|Overall Study|Lack of Efficacy|0|||
23484195|NCT01017575|65515952|FG003|Overall Study|Lack of Efficacy|1|||
23484196|NCT01017575|65515953|FG004|Overall Study|Lack of Efficacy|1|||
23484197|NCT01017575|65515949|FG000|Overall Study|Adverse Event|0|||
23368088|NCT02557295|65092563|FG007|Overall Study|Study Close|3|||
23368089|NCT02557295|65092564|FG008|Overall Study|Study Close|19|||
23484198|NCT01017575|65515950|FG001|Overall Study|Adverse Event|1|||
23484199|NCT01017575|65515951|FG002|Overall Study|Adverse Event|0|||
23484200|NCT01017575|65515952|FG003|Overall Study|Adverse Event|0|||
23661674|NCT01131351|66148905|FG000|Overall Study|Adverse Event|0|||
23661675|NCT01131351|66148906|FG001|Overall Study|Adverse Event|2|||
23368090|NCT02557295|65092556|FG000|Overall Study|except for study close|4|||
23661676|NCT01131351|66148905|FG000|Overall Study|Protocol Deviation|0|||
23661677|NCT01131351|66148906|FG001|Overall Study|Protocol Deviation|1|||
23661678|NCT00382720|66148912|FG000|Overall Study|Adverse Event|21|||
23661679|NCT00382720|66148913|FG001|Overall Study|Adverse Event|23|||
23661680|NCT00382720|66148914|FG002|Overall Study|Adverse Event|15|||
23661681|NCT00382720|66148912|FG000|Overall Study|Protocol Violation|2|||
23484201|NCT01017575|65515953|FG004|Overall Study|Adverse Event|2|||
23484202|NCT01017575|65515949|FG000|Overall Study|Withdrawal by Subject|1|||
23484203|NCT01017575|65515950|FG001|Overall Study|Withdrawal by Subject|0|||
23484204|NCT01017575|65515951|FG002|Overall Study|Withdrawal by Subject|0|||
23484205|NCT01017575|65515952|FG003|Overall Study|Withdrawal by Subject|0|||
23484206|NCT01017575|65515953|FG004|Overall Study|Withdrawal by Subject|0|||
23484207|NCT01992159|65515954|FG000|Overall Study|Withdrawal by Subject|4|||
23484208|NCT01992159|65515955|FG001|Overall Study|Withdrawal by Subject|7|||
23484209|NCT01992159|65515956|FG002|Overall Study|Withdrawal by Subject|0|||
23484210|NCT01992159|65515957|FG003|Overall Study|Withdrawal by Subject|3|||
23484211|NCT01992159|65515954|FG000|Overall Study|Adverse Event|0|||
23484212|NCT01992159|65515955|FG001|Overall Study|Adverse Event|1|||
23484213|NCT01992159|65515956|FG002|Overall Study|Adverse Event|0|||
23484214|NCT01992159|65515957|FG003|Overall Study|Adverse Event|1|||
23484215|NCT01992159|65515954|FG000|Overall Study|Death|0|||
23484216|NCT01992159|65515955|FG001|Overall Study|Death|0|||
23484217|NCT01992159|65515956|FG002|Overall Study|Death|1|||
23484218|NCT01992159|65515957|FG003|Overall Study|Death|0|||
23484219|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
23484220|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
23484221|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
23484222|NCT02862600|65515958|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
23484223|NCT00895011|65515962|FG000|Overall Study|Withdrawal by Subject|14|||
23484224|NCT00895011|65515963|FG001|Overall Study|Withdrawal by Subject|7|||
23484225|NCT00895011|65515964|FG002|Overall Study|Withdrawal by Subject|2|||
23484226|NCT00895011|65515962|FG000|Overall Study|Lost to Follow-up|5|||
23484227|NCT00895011|65515963|FG001|Overall Study|Lost to Follow-up|4|||
23484228|NCT00895011|65515964|FG002|Overall Study|Lost to Follow-up|1|||
23484229|NCT00895011|65515962|FG000|Overall Study|Protocol Violation|3|||
23484230|NCT00895011|65515963|FG001|Overall Study|Protocol Violation|1|||
23484231|NCT00895011|65515964|FG002|Overall Study|Protocol Violation|3|||
23484232|NCT00895011|65515962|FG000|Overall Study|Adverse Event|1|||
23484233|NCT00895011|65515963|FG001|Overall Study|Adverse Event|2|||
23484234|NCT00895011|65515964|FG002|Overall Study|Adverse Event|2|||
23484235|NCT00895011|65515962|FG000|Overall Study|schedule conflict|1|||
23484236|NCT00895011|65515963|FG001|Overall Study|schedule conflict|0|||
23484237|NCT00895011|65515964|FG002|Overall Study|schedule conflict|0|||
23484238|NCT03355664|65515965|FG000|Overall Study|Adverse Event|1|||
23484239|NCT03355664|65515966|FG001|Overall Study|Adverse Event|2|||
23484240|NCT03355664|65515965|FG000|Overall Study|Lost to Follow-up|11|||
23484241|NCT03355664|65515966|FG001|Overall Study|Lost to Follow-up|7|||
23484242|NCT03355664|65515965|FG000|Overall Study|Protocol Violation|1|||
23484243|NCT03355664|65515966|FG001|Overall Study|Protocol Violation|2|||
23484244|NCT03355664|65515965|FG000|Overall Study|Withdrawal by Subject|2|||
23484245|NCT03355664|65515966|FG001|Overall Study|Withdrawal by Subject|1|||
23484246|NCT01475071|65515967|FG000|Overall Study|Physician Decision|1|||
23484247|NCT01475071|65515967|FG000|Overall Study|Withdrawal by Subject|6|||
23484248|NCT01475071|65515967|FG000|Overall Study|Lost to Follow-up|1|||
23484249|NCT00548405|65515969|FG000|Overall Study|Adverse Event|6|||
23484250|NCT00548405|65515970|FG001|Overall Study|Adverse Event|2|||
23484251|NCT00548405|65515971|FG002|Overall Study|Adverse Event|0|||
23484252|NCT00548405|65515969|FG000|Overall Study|Lack of Efficacy|6|||
23484253|NCT00548405|65515970|FG001|Overall Study|Lack of Efficacy|0|||
23661682|NCT00382720|66148913|FG001|Overall Study|Protocol Violation|5|||
23661683|NCT00382720|66148914|FG002|Overall Study|Protocol Violation|1|||
23661684|NCT00382720|66148912|FG000|Overall Study|Death|0|||
23661685|NCT00382720|66148913|FG001|Overall Study|Death|1|||
23484254|NCT00548405|65515971|FG002|Overall Study|Lack of Efficacy|0|||
23484255|NCT00548405|65515969|FG000|Overall Study|Physician Decision|3|||
23484256|NCT00548405|65515970|FG001|Overall Study|Physician Decision|4|||
23484257|NCT00548405|65515971|FG002|Overall Study|Physician Decision|1|||
23484258|NCT00548405|65515969|FG000|Overall Study|Pregnancy|1|||
23484259|NCT00548405|65515970|FG001|Overall Study|Pregnancy|0|||
23484260|NCT00548405|65515971|FG002|Overall Study|Pregnancy|0|||
23484261|NCT00548405|65515969|FG000|Overall Study|Protocol Violation|1|||
23661686|NCT00382720|66148914|FG002|Overall Study|Death|2|||
23368091|NCT02557295|65092557|FG001|Overall Study|except for study close|0|||
23368092|NCT02557295|65092558|FG002|Overall Study|except for study close|0|||
23368093|NCT02557295|65092559|FG003|Overall Study|except for study close|0|||
23368094|NCT02557295|65092560|FG004|Overall Study|except for study close|0|||
23368095|NCT02557295|65092561|FG005|Overall Study|except for study close|0|||
23368096|NCT02557295|65092562|FG006|Overall Study|except for study close|5|||
23368097|NCT02557295|65092563|FG007|Overall Study|except for study close|1|||
23368098|NCT02557295|65092564|FG008|Overall Study|except for study close|0|||
23368099|NCT02692586|65092565|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
23368100|NCT02692586|65092565|FG000|Overall Study|Received adjunctive thrombolytics|2|||
23661687|NCT00382720|66148912|FG000|Overall Study|Progressive disease|37|||
23661688|NCT00382720|66148913|FG001|Overall Study|Progressive disease|28|||
23661689|NCT00382720|66148914|FG002|Overall Study|Progressive disease|38|||
23661690|NCT00382720|66148912|FG000|Overall Study|Withdrew consent|1|||
23661691|NCT00382720|66148913|FG001|Overall Study|Withdrew consent|1|||
23661692|NCT00382720|66148914|FG002|Overall Study|Withdrew consent|2|||
23661693|NCT00382720|66148912|FG000|Overall Study|Withdrawal by Subject|11|||
23661694|NCT00382720|66148913|FG001|Overall Study|Withdrawal by Subject|20|||
23661695|NCT00382720|66148914|FG002|Overall Study|Withdrawal by Subject|12|||
23661696|NCT00382720|66148912|FG000|Overall Study|Surgery|1|||
23661697|NCT00382720|66148913|FG001|Overall Study|Surgery|1|||
23661698|NCT00382720|66148914|FG002|Overall Study|Surgery|4|||
23661699|NCT00382720|66148912|FG000|Overall Study|Patient did not receive study medication|1|||
23661700|NCT00382720|66148913|FG001|Overall Study|Patient did not receive study medication|1|||
23661701|NCT00382720|66148914|FG002|Overall Study|Patient did not receive study medication|4|||
23661702|NCT00382720|66148912|FG000|Overall Study|Clinically progressive disease|0|||
23661703|NCT00382720|66148913|FG001|Overall Study|Clinically progressive disease|1|||
23661704|NCT00382720|66148914|FG002|Overall Study|Clinically progressive disease|0|||
23661705|NCT00382720|66148912|FG000|Overall Study|Good prognosis|0|||
23661706|NCT00382720|66148913|FG001|Overall Study|Good prognosis|1|||
23661707|NCT00382720|66148914|FG002|Overall Study|Good prognosis|0|||
23661708|NCT00382720|66148912|FG000|Overall Study|Investigator/Clinical decision|5|||
23661709|NCT00382720|66148913|FG001|Overall Study|Investigator/Clinical decision|6|||
23661710|NCT00382720|66148914|FG002|Overall Study|Investigator/Clinical decision|6|||
23661711|NCT00382720|66148912|FG000|Overall Study|Discontinued at end of study|0|||
23661712|NCT00382720|66148913|FG001|Overall Study|Discontinued at end of study|1|||
23661713|NCT00382720|66148914|FG002|Overall Study|Discontinued at end of study|2|||
23661714|NCT03891264|66148915|FG000|Overall Study|Adverse Event|1|||
23661715|NCT03891264|66148915|FG000|Overall Study|Withdrawal by Subject|2|||
23661716|NCT03891264|66148915|FG000|Overall Study|Physician Decision|2|||
23661717|NCT00932360|66148919|FG000|Washout (One Week)|Withdrawal by Subject|0|||
23661718|NCT00932360|66148920|FG001|Washout (One Week)|Withdrawal by Subject|0|||
23661719|NCT00932360|66148921|FG002|Washout (One Week)|Withdrawal by Subject|0|||
23661720|NCT00932360|66148922|FG003|Washout (One Week)|Withdrawal by Subject|0|||
23661721|NCT00932360|66148923|FG004|Washout (One Week)|Withdrawal by Subject|2|||
23661722|NCT00932360|66148924|FG005|Washout (One Week)|Withdrawal by Subject|0|||
23661723|NCT01444742|66148925|FG000|Overall Study|Death|1|||
23661724|NCT01168973|66148929|FG000|Overall Study|Progressive Disease|341|||
23661725|NCT01168973|66148930|FG001|Overall Study|Progressive Disease|429|||
23661726|NCT01168973|66148929|FG000|Overall Study|Adverse Event|94|||
23661727|NCT01168973|66148930|FG001|Overall Study|Adverse Event|55|||
23661728|NCT01168973|66148929|FG000|Overall Study|Withdrawal by Subject|90|||
23661729|NCT01168973|66148930|FG001|Overall Study|Withdrawal by Subject|53|||
23661730|NCT01168973|66148929|FG000|Overall Study|Death|42|||
23661731|NCT01168973|66148930|FG001|Overall Study|Death|45|||
23661732|NCT01168973|66148929|FG000|Overall Study|Physician Decision|37|||
23661733|NCT01168973|66148930|FG001|Overall Study|Physician Decision|19|||
23661734|NCT01168973|66148929|FG000|Overall Study|Sponsor Decision|2|||
23661735|NCT01168973|66148930|FG001|Overall Study|Sponsor Decision|1|||
23661736|NCT01168973|66148929|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
23661737|NCT01168973|66148930|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
23661738|NCT03370120|66148931|FG000|Overall Study|Adverse event, non-fatal|24|||
23661739|NCT03370120|66148931|FG000|Overall Study|Withdrawal by Subject|6|||
23661740|NCT03370120|66148931|FG000|Overall Study|Lost to Follow-up|1|||
23661741|NCT03370120|66148931|FG000|Overall Study|Lack of Efficacy|37|||
23661742|NCT03370120|66148931|FG000|Overall Study|Per sponsor's instructions|1|||
23661743|NCT03370120|66148931|FG000|Overall Study|Study was terminated by parent company UCB|2|||
23661744|NCT03370120|66148931|FG000|Overall Study|The study was ended by the promoter|3|||
23661745|NCT03370120|66148931|FG000|Overall Study|Discontinuation of drug development|3|||
23661746|NCT03370120|66148931|FG000|Overall Study|End of project|2|||
23661747|NCT03370120|66148931|FG000|Overall Study|Premature study closure|2|||
23661748|NCT03370120|66148931|FG000|Overall Study|Premature program termination|1|||
23661749|NCT03370120|66148931|FG000|Overall Study|Premature study termination|7|||
23661750|NCT03370120|66148931|FG000|Overall Study|Trial terminated by sponsor|2|||
23661751|NCT03370120|66148931|FG000|Overall Study|Trial discontinued by sponsor|2|||
23661752|NCT03370120|66148931|FG000|Overall Study|Study ended|15|||
23661753|NCT03370120|66148931|FG000|Overall Study|Clinical trial has been cancelled|1|||
23661754|NCT03370120|66148931|FG000|Overall Study|End of study per sponsor decision|2|||
23661755|NCT03370120|66148931|FG000|Overall Study|Promoter's decision|2|||
23661756|NCT03370120|66148931|FG000|Overall Study|The trial has been suspended|3|||
23661757|NCT03370120|66148931|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
23661758|NCT03370120|66148931|FG000|Overall Study|Early termination by order of sponsor|2|||
23661759|NCT03370120|66148931|FG000|Overall Study|Discontinuation of the study|5|||
23661760|NCT03370120|66148931|FG000|Overall Study|End of clinical trial discontinuation|1|||
23661761|NCT03370120|66148931|FG000|Overall Study|Because the clinical trial ended halfway|4|||
23484262|NCT00548405|65515970|FG001|Overall Study|Protocol Violation|0|||
23368101|NCT00735007|65092566|FG000|Overall Study|Adverse Event|4|||
23368102|NCT00735007|65092566|FG000|Overall Study|Protocol Violation|1|||
23484263|NCT00548405|65515971|FG002|Overall Study|Protocol Violation|0|||
23368103|NCT00468585|65092567|FG000|Overall Study|Patient not treated|1|||
23484264|NCT00548405|65515969|FG000|Overall Study|Withdrawal by Subject|36|||
23661762|NCT03370120|66148931|FG000|Overall Study|Development discontinued|5|||
23661763|NCT03370120|66148931|FG000|Overall Study|Padsenovil program closed|3|||
23661764|NCT03370120|66148931|FG000|Overall Study|End of project|2|||
23661765|NCT03370120|66148931|FG000|Overall Study|Termination of project|1|||
23661766|NCT03370120|66148931|FG000|Overall Study|The study was interrupted by sponsor|4|||
23661767|NCT03370120|66148931|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
23661768|NCT03370120|66148931|FG000|Overall Study|End of sponsor decision|1|||
23661769|NCT03370120|66148931|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
23661770|NCT03370120|66148931|FG000|Overall Study|Early termination of studies|5|||
23661771|NCT03370120|66148931|FG000|Overall Study|This study is ended early|1|||
23661772|NCT03370120|66148931|FG000|Overall Study|End of padsevonil program|2|||
23661773|NCT03370120|66148931|FG000|Overall Study|Decision of sponsor|6|||
23661774|NCT03370120|66148931|FG000|Overall Study|Asked by the sponsor|3|||
23661775|NCT03370120|66148931|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
23661776|NCT03370120|66148931|FG000|Overall Study|PI decision poor compliance from participant|1|||
23661777|NCT03370120|66148931|FG000|Overall Study|Promoter ended the study|3|||
23661778|NCT03370120|66148931|FG000|Overall Study|Premature study close by sponsor's decision|4|||
23661779|NCT03370120|66148931|FG000|Overall Study|Study terminated by sponsor|33|||
23368104|NCT00468585|65092568|FG001|Overall Study|Patient not treated|0|||
23368105|NCT00468585|65092569|FG002|Overall Study|Patient not treated|1|||
23368106|NCT00468585|65092570|FG003|Overall Study|Patient not treated|0|||
23602436|NCT01998958|65934077|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602437|NCT01998958|65934078|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602438|NCT01998958|65934079|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602439|NCT01998958|65934080|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602440|NCT01998958|65934081|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602441|NCT01998958|65934082|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602442|NCT01998958|65934083|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602443|NCT01998958|65934084|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602444|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Adverse Event|0|||
23602445|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Adverse Event|0|||
23602446|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Adverse Event|0|||
23602447|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Adverse Event|0|||
23602448|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Adverse Event|0|||
23602449|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Adverse Event|0|||
23602450|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Adverse Event|0|||
23602451|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Adverse Event|0|||
23602452|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Adverse Event|0|||
23602453|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Adverse Event|0|||
23602454|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Adverse Event|0|||
23602455|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Adverse Event|0|||
23602456|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Adverse Event|0|||
23602457|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Adverse Event|0|||
23368107|NCT00468585|65092567|FG000|Overall Study|Patient found to be ineligible|0|||
23602458|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Adverse Event|0|||
23602459|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Adverse Event|0|||
23368108|NCT00468585|65092568|FG001|Overall Study|Patient found to be ineligible|0|||
23368109|NCT00468585|65092569|FG002|Overall Study|Patient found to be ineligible|1|||
23368110|NCT00468585|65092570|FG003|Overall Study|Patient found to be ineligible|0|||
23368111|NCT00468585|65092567|FG000|Overall Study|Adverse Event|0|||
23368112|NCT00468585|65092568|FG001|Overall Study|Adverse Event|0|||
23368113|NCT00468585|65092569|FG002|Overall Study|Adverse Event|1|||
23368114|NCT00468585|65092570|FG003|Overall Study|Adverse Event|0|||
23368115|NCT00468585|65092567|FG000|Overall Study|Withdrawal by Subject|0|||
23368116|NCT00468585|65092568|FG001|Overall Study|Withdrawal by Subject|0|||
23368117|NCT00468585|65092569|FG002|Overall Study|Withdrawal by Subject|2|||
23368118|NCT00468585|65092570|FG003|Overall Study|Withdrawal by Subject|1|||
23368119|NCT00116688|65092571|FG000|Overall Study|Protocol deviation|1|||
23368120|NCT00116688|65092572|FG001|Overall Study|Protocol deviation|0|||
23368121|NCT00116688|65092571|FG000|Overall Study|Noncompliance|3|||
23368122|NCT00116688|65092572|FG001|Overall Study|Noncompliance|1|||
23368123|NCT00116688|65092571|FG000|Overall Study|Adverse Event|11|||
23368124|NCT00116688|65092572|FG001|Overall Study|Adverse Event|0|||
23484265|NCT00548405|65515970|FG001|Overall Study|Withdrawal by Subject|12|||
23484266|NCT00548405|65515971|FG002|Overall Study|Withdrawal by Subject|5|||
23484267|NCT00548405|65515969|FG000|Overall Study|Lost to Follow-up|1|||
23484268|NCT00548405|65515970|FG001|Overall Study|Lost to Follow-up|1|||
23484269|NCT00548405|65515971|FG002|Overall Study|Lost to Follow-up|2|||
23484270|NCT00548405|65515969|FG000|Overall Study|Death|0|||
23484271|NCT00548405|65515970|FG001|Overall Study|Death|1|||
23661780|NCT03370120|66148931|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
23661781|NCT03370120|66148931|FG000|Overall Study|Sponsor decision to terminate study|63|||
23368125|NCT00116688|65092571|FG000|Overall Study|Withdrawal by Subject|26|||
23484272|NCT00548405|65515971|FG002|Overall Study|Death|1|||
23484273|NCT00548405|65515969|FG000|Overall Study|Sponsor decision|1|||
23484274|NCT00548405|65515970|FG001|Overall Study|Sponsor decision|0|||
23484275|NCT00548405|65515971|FG002|Overall Study|Sponsor decision|0|||
23484276|NCT00548405|65515969|FG000|Overall Study|Randomized but not treated|1|||
23484277|NCT00548405|65515970|FG001|Overall Study|Randomized but not treated|0|||
23484278|NCT00548405|65515971|FG002|Overall Study|Randomized but not treated|0|||
23484279|NCT01758289|65515973|FG000|Overall Study|Premature Study Termination|44|||
23484280|NCT01758289|65515973|FG000|Overall Study|Adverse Event|9|||
23484281|NCT04461600|65515977|FG000|Overall Study|Death|6|||
23484282|NCT04461600|65515978|FG001|Overall Study|Death|5|||
23484283|NCT04461600|65515977|FG000|Overall Study|Withdrawal by Subject|0|||
23484284|NCT04461600|65515978|FG001|Overall Study|Withdrawal by Subject|1|||
23484285|NCT03194490|65515979|FG000|Overall Study|Lost to Follow-up|1|||
23484286|NCT03194490|65515980|FG001|Overall Study|Lost to Follow-up|3|||
23484287|NCT03194490|65515979|FG000|Overall Study|participant developed specific neck pain|1|||
23484288|NCT03194490|65515980|FG001|Overall Study|participant developed specific neck pain|0|||
23602460|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Adverse Event|0|||
23602461|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Adverse Event|0|||
23602462|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Adverse Event|0|||
23602463|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Adverse Event|0|||
23602464|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Adverse Event|0|||
23602465|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Adverse Event|0|||
23602466|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Adverse Event|0|||
23602467|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Adverse Event|1|||
23602468|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Adverse Event|0|||
23602469|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Adverse Event|0|||
23602470|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Adverse Event|0|||
23602471|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Adverse Event|0|||
23602472|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Adverse Event|0|||
23602473|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Adverse Event|0|||
23602474|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Adverse Event|0|||
23602475|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Adverse Event|0|||
23602476|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Other|0|||
23602477|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Other|0|||
23602478|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Other|0|||
23602479|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Other|0|||
23602480|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Other|0|||
23602481|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Other|0|||
23661782|NCT03370120|66148931|FG000|Overall Study|Program closure|3|||
23661783|NCT03370120|66148931|FG000|Overall Study|Study ended prematurely|1|||
23368126|NCT00116688|65092572|FG001|Overall Study|Withdrawal by Subject|2|||
23368127|NCT00116688|65092571|FG000|Overall Study|Requirement for alternative therapy|11|||
23484289|NCT04085367|65515983|FG000|Overall Study|Adverse Event|1|||
23484290|NCT04085367|65515984|FG001|Overall Study|Adverse Event|1|||
23484291|NCT04085367|65515983|FG000|Overall Study|Withdrawal by Subject|13|||
23484292|NCT04085367|65515984|FG001|Overall Study|Withdrawal by Subject|4|||
23484293|NCT04085367|65515983|FG000|Overall Study|Lost to Follow-up|3|||
23484294|NCT04085367|65515984|FG001|Overall Study|Lost to Follow-up|1|||
23484295|NCT04085367|65515983|FG000|Overall Study|Other unspecified|2|||
23484296|NCT04085367|65515984|FG001|Overall Study|Other unspecified|1|||
23602482|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Other|0|||
23484297|NCT04085367|65515983|FG000|Overall Study|Status Unknown|1|||
23661784|NCT03370120|66148931|FG000|Overall Study|Study stopped by sponsor|2|||
23661785|NCT03370120|66148931|FG000|Overall Study|Program termination|55|||
23661786|NCT03370120|66148931|FG000|Overall Study|Sponsor decision|62|||
23661787|NCT03370120|66148931|FG000|Overall Study|Sponsor study closure|10|||
23661788|NCT01423851|66148934|FG000|Whole Study|Disease progression|2|||
23661789|NCT01423851|66148935|FG001|Whole Study|Disease progression|1|||
23661790|NCT01423851|66148936|FG002|Whole Study|Disease progression|1|||
23661791|NCT01423851|66148937|FG003|Whole Study|Disease progression|4|||
23661792|NCT01423851|66148938|FG004|Whole Study|Disease progression|1|||
23661793|NCT01423851|66148939|FG005|Whole Study|Disease progression|3|||
23661794|NCT01423851|66148940|FG006|Whole Study|Disease progression|1|||
23661795|NCT01423851|66148941|FG007|Whole Study|Disease progression|4|||
23661796|NCT01423851|66148942|FG008|Whole Study|Disease progression|0|||
23661797|NCT01423851|66148943|FG009|Whole Study|Disease progression|2|||
23484298|NCT04085367|65515984|FG001|Overall Study|Status Unknown|1|||
23661798|NCT01423851|66148944|FG010|Whole Study|Disease progression|10|||
23661799|NCT01423851|66148934|FG000|Whole Study|Physician Decision|0|||
23661800|NCT01423851|66148935|FG001|Whole Study|Physician Decision|1|||
23661801|NCT01423851|66148936|FG002|Whole Study|Physician Decision|2|||
23661802|NCT01423851|66148937|FG003|Whole Study|Physician Decision|0|||
23661803|NCT01423851|66148938|FG004|Whole Study|Physician Decision|2|||
23661804|NCT01423851|66148939|FG005|Whole Study|Physician Decision|0|||
23661805|NCT01423851|66148940|FG006|Whole Study|Physician Decision|2|||
23661806|NCT01423851|66148941|FG007|Whole Study|Physician Decision|1|||
23661807|NCT01423851|66148942|FG008|Whole Study|Physician Decision|3|||
23661808|NCT01423851|66148943|FG009|Whole Study|Physician Decision|4|||
23661809|NCT01423851|66148944|FG010|Whole Study|Physician Decision|12|||
23368128|NCT00116688|65092572|FG001|Overall Study|Requirement for alternative therapy|1|||
23368129|NCT00116688|65092571|FG000|Overall Study|Physician Decision|7|||
23368130|NCT00116688|65092572|FG001|Overall Study|Physician Decision|0|||
23368131|NCT00116688|65092571|FG000|Overall Study|Lost to Follow-up|3|||
23368132|NCT00116688|65092572|FG001|Overall Study|Lost to Follow-up|0|||
23368133|NCT00116688|65092571|FG000|Overall Study|Death|15|||
23368134|NCT00116688|65092572|FG001|Overall Study|Death|0|||
23368135|NCT00116688|65092571|FG000|Overall Study|Protocol-specified criteria|3|||
23368136|NCT00116688|65092572|FG001|Overall Study|Protocol-specified criteria|0|||
23368137|NCT00116688|65092571|FG000|Overall Study|Pregnancy|1|||
23368138|NCT00116688|65092572|FG001|Overall Study|Pregnancy|0|||
23368139|NCT00116688|65092571|FG000|Overall Study|Other|11|||
23368140|NCT00116688|65092572|FG001|Overall Study|Other|0|||
23368141|NCT02287038|65092575|FG000|Overall Study|Stopped attending appointments|3|||
23368142|NCT02287038|65092576|FG001|Overall Study|Stopped attending appointments|2|||
23368143|NCT02287038|65092575|FG000|Overall Study|Anxiety after starting medication|0|||
23368144|NCT02287038|65092576|FG001|Overall Study|Anxiety after starting medication|1|||
23368145|NCT02287038|65092575|FG000|Overall Study|Nausea after starting medication|1|||
23368146|NCT02287038|65092576|FG001|Overall Study|Nausea after starting medication|0|||
23368147|NCT02287038|65092575|FG000|Overall Study|Abnormal ECG after starting medication|1|||
23368148|NCT02287038|65092576|FG001|Overall Study|Abnormal ECG after starting medication|0|||
23368149|NCT00467519|65092577|FG000|Overall Study|Protocol Violation|8|||
23368150|NCT00467519|65092578|FG001|Overall Study|Protocol Violation|4|||
23368151|NCT00467519|65092577|FG000|Overall Study|Lost to Follow-up|2|||
23368152|NCT00467519|65092578|FG001|Overall Study|Lost to Follow-up|9|||
23368153|NCT00467519|65092577|FG000|Overall Study|Withdrawal by Subject|4|||
23368154|NCT00467519|65092578|FG001|Overall Study|Withdrawal by Subject|10|||
23368155|NCT01447407|65092579|FG000|Overall Study|Withdrawal by Subject|2|||
23368156|NCT01447407|65092580|FG001|Overall Study|Withdrawal by Subject|0|||
23368157|NCT01447407|65092581|FG002|Overall Study|Withdrawal by Subject|0|||
23368158|NCT01447407|65092582|FG003|Overall Study|Withdrawal by Subject|1|||
23368159|NCT01447407|65092579|FG000|Overall Study|Physician Decision|0|||
23368160|NCT01447407|65092580|FG001|Overall Study|Physician Decision|0|||
23368161|NCT01447407|65092581|FG002|Overall Study|Physician Decision|1|||
23368162|NCT01447407|65092582|FG003|Overall Study|Physician Decision|1|||
23368163|NCT02567188|65092584|FG000|Overall Study|Death|10|||
23368164|NCT02567188|65092584|FG000|Overall Study|Terminated Mircera Treatment|9|||
23368165|NCT02567188|65092584|FG000|Overall Study|Lost to Follow-up|5|||
23368166|NCT02567188|65092584|FG000|Overall Study|Adverse Event|1|||
23368167|NCT02567188|65092584|FG000|Overall Study|Withdrawal by Subject|1|||
23368168|NCT02567188|65092584|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
23368169|NCT02567188|65092584|FG000|Overall Study|Moved and Changed Clinic|1|||
23368170|NCT02567188|65092584|FG000|Overall Study|Started Hemodialysis|2|||
23368171|NCT02567188|65092584|FG000|Overall Study|Protocol Violation|5|||
23368172|NCT01714544|65092586|FG000|Overall Study|Lost to Follow-up|1|||
23368173|NCT01714544|65092586|FG000|Overall Study|Physician Decision|1|||
23368174|NCT01714544|65092586|FG000|Overall Study|Withdrawal by Subject|1|||
23368175|NCT00297167|65092587|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
23368176|NCT00297167|65092588|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
23368177|NCT00297167|65092589|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
23368178|NCT00297167|65092587|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
23368179|NCT00297167|65092588|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
23368180|NCT00297167|65092589|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
23368181|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
23368182|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
23368183|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Adverse Event|57|||
23368184|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Adverse Event|49|||
23368185|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
23368186|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
23368187|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Site closure|3|||
23368188|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Site closure|2|||
23484299|NCT04389970|65515985|FG000|Overall Study|Lost to Follow-up|1|||
23368189|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
23368190|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
23368191|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Physician Decision|48|||
23368192|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Physician Decision|38|||
23368193|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
23368194|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
23368195|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
23368196|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
23368197|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
23368198|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
23368199|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
23368200|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
23368201|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
23368202|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
23368203|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
23368204|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
23368205|NCT00528424|65092594|FG000|Overall Study|Lost to Follow-up|13|||
23368206|NCT00528424|65092594|FG000|Overall Study|Withdrew consent|2|||
23368207|NCT00528424|65092594|FG000|Overall Study|Administrative reason|2|||
23368208|NCT00528424|65092594|FG000|Overall Study|Other|12|||
23368209|NCT01190813|65092597|FG000|Overall Study|Lost to Follow-up|1|||
23368210|NCT01190813|65092598|FG001|Overall Study|Lost to Follow-up|2|||
23368211|NCT01190813|65092597|FG000|Overall Study|Withdrawal by Subject|2|||
23368212|NCT01190813|65092598|FG001|Overall Study|Withdrawal by Subject|1|||
23368213|NCT01190813|65092597|FG000|Overall Study|Refused study treatment after randomized|1|||
23368214|NCT01190813|65092598|FG001|Overall Study|Refused study treatment after randomized|0|||
23368215|NCT01190813|65092597|FG000|Overall Study|Adverse Event|0|||
23368216|NCT01190813|65092598|FG001|Overall Study|Adverse Event|1|||
23368217|NCT01053741|65092599|FG000|2nd Study Intervention|Physician Decision|0|||
23368218|NCT01053741|65092600|FG001|2nd Study Intervention|Physician Decision|1|||
23368219|NCT03804268|65092603|FG000|Overall Study|Adverse Event|2|||
23368220|NCT03804268|65092604|FG001|Overall Study|Adverse Event|2|||
23368221|NCT03804268|65092603|FG000|Overall Study|Withdrawal by Subject|2|||
23368222|NCT03804268|65092604|FG001|Overall Study|Withdrawal by Subject|0|||
23368223|NCT03804268|65092603|FG000|Overall Study|Lost to Follow-up|1|||
23368224|NCT03804268|65092604|FG001|Overall Study|Lost to Follow-up|0|||
23368225|NCT03804268|65092603|FG000|Overall Study|Physician Decision|2|||
23368226|NCT03804268|65092604|FG001|Overall Study|Physician Decision|0|||
23368227|NCT02089347|65092605|FG000|Overall Study|Protocol Violation|1|||
23368228|NCT02089347|65092606|FG001|Overall Study|Protocol Violation|0|||
23368229|NCT03874013|65092607|FG000|Overall Study|Adverse Event|0|||
23368230|NCT03874013|65092608|FG001|Overall Study|Adverse Event|1|||
23368231|NCT02074514|65092609|FG000|Overall Study|Lack of Efficacy|3|||
23368232|NCT02074514|65092610|FG001|Overall Study|Lack of Efficacy|2|||
23368233|NCT02074514|65092609|FG000|Overall Study|Lost to Follow-up|0|||
23368234|NCT02074514|65092610|FG001|Overall Study|Lost to Follow-up|1|||
23368235|NCT02074514|65092609|FG000|Overall Study|Withdrew Consent|0|||
23368236|NCT02074514|65092610|FG001|Overall Study|Withdrew Consent|1|||
23368237|NCT02456727|65092615|FG000|Overall Study|Lost to Follow-up|63|||
23368238|NCT02456727|65092616|FG001|Overall Study|Lost to Follow-up|65|||
23368239|NCT02456727|65092615|FG000|Overall Study|Death|2|||
23368240|NCT02456727|65092616|FG001|Overall Study|Death|1|||
23368241|NCT02456727|65092615|FG000|Overall Study|Withdrawal by Subject|1|||
23368242|NCT02456727|65092616|FG001|Overall Study|Withdrawal by Subject|10|||
23368243|NCT02456727|65092615|FG000|Overall Study|Never Initiated Treatment|43|||
23368244|NCT02456727|65092616|FG001|Overall Study|Never Initiated Treatment|30|||
23368245|NCT05002972|65092617|FG000|Overall Study|Withdrawal by Subject|2|||
23368246|NCT01232790|65092621|FG000|Randomization|Withdrawal by Subject|2|||
23368247|NCT01232790|65092622|FG001|Randomization|Withdrawal by Subject|0|||
23368248|NCT01232790|65092621|FG000|Randomization|Protocol Violation|0|||
23368249|NCT01232790|65092622|FG001|Randomization|Protocol Violation|1|||
23368250|NCT01232790|65092621|FG000|Randomization|Physician Decision|0|||
23368251|NCT01232790|65092622|FG001|Randomization|Physician Decision|1|||
23368252|NCT01232790|65092621|FG000|Initial Assessment|Withdrawal by Subject|0|||
23368253|NCT01232790|65092622|FG001|Initial Assessment|Withdrawal by Subject|1|||
23368254|NCT01232790|65092621|FG000|First Crossover|Withdrawal by Subject|1|||
23368255|NCT01232790|65092622|FG001|First Crossover|Withdrawal by Subject|0|||
23368256|NCT01232790|65092621|FG000|Second Crossover|Withdrawal by Subject|1|||
23368257|NCT01232790|65092622|FG001|Second Crossover|Withdrawal by Subject|2|||
23368258|NCT03217591|65092624|FG000|Overall Study|Adverse Event|1|||
23368259|NCT03217591|65092625|FG001|Overall Study|Adverse Event|2|||
23368260|NCT03217591|65092626|FG002|Overall Study|Adverse Event|6|||
23368261|NCT03217591|65092624|FG000|Overall Study|Withdrawal by Subject|0|||
23368262|NCT03217591|65092625|FG001|Overall Study|Withdrawal by Subject|1|||
23368263|NCT03217591|65092626|FG002|Overall Study|Withdrawal by Subject|3|||
23368264|NCT03217591|65092624|FG000|Overall Study|Lost to Follow-up|1|||
23368265|NCT03217591|65092625|FG001|Overall Study|Lost to Follow-up|0|||
23368266|NCT03217591|65092626|FG002|Overall Study|Lost to Follow-up|0|||
23368267|NCT03217591|65092624|FG000|Overall Study|Protocol Violation|1|||
23368268|NCT03217591|65092625|FG001|Overall Study|Protocol Violation|0|||
23368269|NCT03217591|65092626|FG002|Overall Study|Protocol Violation|1|||
23368270|NCT01307787|65092629|FG000|Overall Study|Withdrawal by Subject|2|||
23368271|NCT01307787|65092630|FG001|Overall Study|Withdrawal by Subject|0|||
23368272|NCT00661089|65092631|FG000|Overall Study|1 subject withdrawal|0|||
23368273|NCT00661089|65092632|FG001|Overall Study|1 subject withdrawal|1|||
23368274|NCT00661089|65092631|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
23368275|NCT00661089|65092632|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
23368276|NCT03016169|65092633|FG000|Overall Study|Lost to Follow-up|4|||
23368277|NCT03016169|65092633|FG000|Overall Study|Death|54|||
23368278|NCT03016169|65092633|FG000|Overall Study|Device Explant|11|||
23368279|NCT03016169|65092633|FG000|Overall Study|Withdrawal by Subject|19|||
23368280|NCT03016169|65092633|FG000|Overall Study|Other Reasons|1|||
23368281|NCT01190891|65092634|FG000|Overall Study|Protocol Violation|1|||
23368282|NCT01190891|65092635|FG001|Overall Study|Protocol Violation|0|||
23368283|NCT01190891|65092634|FG000|Overall Study|Withdrawal by Subject|5|||
23368284|NCT01190891|65092635|FG001|Overall Study|Withdrawal by Subject|0|||
23368285|NCT01001429|65092636|FG000|Overall Study|surgery cancelled|0|||
23368286|NCT01001429|65092637|FG001|Overall Study|surgery cancelled|1|||
23368287|NCT01618968|65092642|FG000|Overall Study|Adverse Event|1|||
23368288|NCT01618968|65092643|FG001|Overall Study|Adverse Event|0|||
23368289|NCT01618968|65092644|FG002|Overall Study|Adverse Event|0|||
23368290|NCT01618968|65092645|FG003|Overall Study|Adverse Event|0|||
23368291|NCT01618968|65092642|FG000|Overall Study|Death|0|||
23368292|NCT01618968|65092643|FG001|Overall Study|Death|0|||
23368293|NCT01618968|65092644|FG002|Overall Study|Death|0|||
23368294|NCT01618968|65092645|FG003|Overall Study|Death|1|||
23368295|NCT01396083|65095984|FG000|Overall Study|Adverse Event|2|||
23602483|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Other|0|||
23602484|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Other|0|||
23602485|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Other|0|||
23602486|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Other|0|||
23602487|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Other|0|||
23602488|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Other|0|||
23602489|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Other|0|||
23602490|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Other|0|||
23368296|NCT01396083|65095985|FG001|Overall Study|Adverse Event|28|||
23368297|NCT01396083|65095984|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23602491|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Other|0|||
23602492|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Other|0|||
23602493|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Other|0|||
23368298|NCT01396083|65095985|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23484300|NCT00622739|65515988|FG000|Overall Study|Physician Decision|1|||
23484301|NCT00622739|65515989|FG001|Overall Study|Physician Decision|0|||
23484302|NCT00622739|65515988|FG000|Overall Study|Adverse Event|1|||
23484303|NCT00622739|65515989|FG001|Overall Study|Adverse Event|2|||
23484304|NCT00622739|65515988|FG000|Overall Study|Lack of Efficacy|0|||
23602494|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Other|0|||
23368299|NCT01396083|65095984|FG000|Overall Study|Consent withdrawn|4|||
23368300|NCT01396083|65095985|FG001|Overall Study|Consent withdrawn|5|||
23368301|NCT01396083|65095984|FG000|Overall Study|Protocol deviation(s)|0|||
23368302|NCT01396083|65095985|FG001|Overall Study|Protocol deviation(s)|1|||
23602495|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Other|0|||
23602496|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Other|0|||
23484305|NCT00622739|65515989|FG001|Overall Study|Lack of Efficacy|2|||
23602497|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Other|0|||
23602498|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Other|5|||
23484306|NCT00622739|65515988|FG000|Overall Study|Withdrawal by Subject|0|||
23484307|NCT00622739|65515989|FG001|Overall Study|Withdrawal by Subject|1|||
23368303|NCT01396083|65095984|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23602499|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Other|1|||
23484308|NCT00622739|65515988|FG000|Overall Study|Lost to Follow-up|0|||
23484309|NCT00622739|65515989|FG001|Overall Study|Lost to Follow-up|1|||
23661810|NCT01423851|66148934|FG000|Whole Study|Withdrawal by Subject|1|||
23661811|NCT01423851|66148935|FG001|Whole Study|Withdrawal by Subject|1|||
23661812|NCT01423851|66148936|FG002|Whole Study|Withdrawal by Subject|0|||
23661813|NCT01423851|66148937|FG003|Whole Study|Withdrawal by Subject|0|||
23661814|NCT01423851|66148938|FG004|Whole Study|Withdrawal by Subject|0|||
23661815|NCT01423851|66148939|FG005|Whole Study|Withdrawal by Subject|0|||
23661816|NCT01423851|66148940|FG006|Whole Study|Withdrawal by Subject|0|||
23661817|NCT01423851|66148941|FG007|Whole Study|Withdrawal by Subject|0|||
23661818|NCT01423851|66148942|FG008|Whole Study|Withdrawal by Subject|2|||
23661819|NCT01423851|66148943|FG009|Whole Study|Withdrawal by Subject|0|||
23661820|NCT01423851|66148944|FG010|Whole Study|Withdrawal by Subject|4|||
23661821|NCT01423851|66148934|FG000|Whole Study|Adverse Event|0|||
23661822|NCT01423851|66148935|FG001|Whole Study|Adverse Event|0|||
23661823|NCT01423851|66148936|FG002|Whole Study|Adverse Event|0|||
23661824|NCT01423851|66148937|FG003|Whole Study|Adverse Event|2|||
23661825|NCT01423851|66148938|FG004|Whole Study|Adverse Event|0|||
23661826|NCT01423851|66148939|FG005|Whole Study|Adverse Event|0|||
23661827|NCT01423851|66148940|FG006|Whole Study|Adverse Event|0|||
23661828|NCT01423851|66148941|FG007|Whole Study|Adverse Event|3|||
23661829|NCT01423851|66148942|FG008|Whole Study|Adverse Event|3|||
23661830|NCT01423851|66148943|FG009|Whole Study|Adverse Event|2|||
23661831|NCT01423851|66148944|FG010|Whole Study|Adverse Event|3|||
23661832|NCT01186796|66148947|FG000|Overall Study|Adverse Event|3|||
23661833|NCT01186796|66148948|FG001|Overall Study|Adverse Event|0|||
23661834|NCT01186796|66148947|FG000|Overall Study|Withdrawal by Subject|1|||
23661835|NCT01186796|66148948|FG001|Overall Study|Withdrawal by Subject|1|||
23602500|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Other|0|||
23602501|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Other|0|||
23602502|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Other|0|||
23602503|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Other|0|||
23602504|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Other|0|||
23602505|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Other|0|||
23602506|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Other|0|||
23602507|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Other|0|||
23602508|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602509|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602510|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602511|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602512|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602513|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602514|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602515|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602516|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602517|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
23661836|NCT01186796|66148947|FG000|Overall Study|Protocol Violation|0|||
23661837|NCT01186796|66148948|FG001|Overall Study|Protocol Violation|1|||
23661838|NCT04667377|66148950|FG000|Dose Escalation Period|Other not specified below|3|||
23661839|NCT04667377|66148951|FG001|Dose Escalation Period|Other not specified below|3|||
23661840|NCT04667377|66148952|FG002|Dose Escalation Period|Other not specified below|2|||
23602518|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602519|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602520|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602521|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
23661841|NCT04667377|66148953|FG003|Dose Escalation Period|Other not specified below|1|||
23661842|NCT04667377|66148954|FG004|Dose Escalation Period|Other not specified below|3|||
23484310|NCT03112590|65515990|FG000|Overall Study|Adverse Event|0|||
23484311|NCT03112590|65515991|FG001|Overall Study|Adverse Event|1|||
23484312|NCT03112590|65515992|FG002|Overall Study|Adverse Event|0|||
23484313|NCT03505710|65515997|FG000|Overall Study|Progressive Disease|22|||
23484314|NCT03505710|65515998|FG001|Overall Study|Progressive Disease|9|||
23484315|NCT03505710|65515999|FG002|Overall Study|Progressive Disease|34|||
23484316|NCT03505710|65515997|FG000|Overall Study|Clinical Progression|6|||
23484317|NCT03505710|65515998|FG001|Overall Study|Clinical Progression|6|||
23484318|NCT03505710|65515999|FG002|Overall Study|Clinical Progression|3|||
23484319|NCT03505710|65515997|FG000|Overall Study|Adverse Event|12|||
23484320|NCT03505710|65515998|FG001|Overall Study|Adverse Event|5|||
23484321|NCT03505710|65515999|FG002|Overall Study|Adverse Event|27|||
23484322|NCT03505710|65515997|FG000|Overall Study|Withdrawal by Subject|1|||
23484323|NCT03505710|65515998|FG001|Overall Study|Withdrawal by Subject|3|||
23484324|NCT03505710|65515999|FG002|Overall Study|Withdrawal by Subject|3|||
23484325|NCT03505710|65515997|FG000|Overall Study|Physician Decision|1|||
23484326|NCT03505710|65515998|FG001|Overall Study|Physician Decision|0|||
23484327|NCT03505710|65515999|FG002|Overall Study|Physician Decision|2|||
23484328|NCT03505710|65515997|FG000|Overall Study|Death|4|||
23484329|NCT03505710|65515998|FG001|Overall Study|Death|3|||
23484330|NCT03505710|65515999|FG002|Overall Study|Death|6|||
23484331|NCT03505710|65515997|FG000|Overall Study|Other Reasons|1|||
23484332|NCT03505710|65515998|FG001|Overall Study|Other Reasons|1|||
23484333|NCT03505710|65515999|FG002|Overall Study|Other Reasons|1|||
23484334|NCT02376829|65516000|FG000|Overall Study|Withdrawal by Subject|27|||
23484335|NCT02376829|65516001|FG001|Overall Study|Withdrawal by Subject|44|||
23484336|NCT00521001|65516002|FG000|Overall Study|Ineligible|1|||
23484337|NCT01309893|65516005|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
23484338|NCT01309893|65516006|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
23484339|NCT01309893|65516005|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
23484340|NCT01309893|65516006|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
23484341|NCT01466595|65516007|FG000|Overall Study|Withdrawal by Subject|0|||
23484342|NCT01466595|65516008|FG001|Overall Study|Withdrawal by Subject|1|||
23484343|NCT02718300|65516010|FG000|Overall Study|Death|4|||
23484344|NCT02718300|65516011|FG001|Overall Study|Death|5|||
23484345|NCT02718300|65516012|FG002|Overall Study|Death|17|||
23484346|NCT02718300|65516010|FG000|Overall Study|Lost to Follow-up|1|||
23484347|NCT02718300|65516011|FG001|Overall Study|Lost to Follow-up|0|||
23484348|NCT02718300|65516012|FG002|Overall Study|Lost to Follow-up|2|||
23484349|NCT02718300|65516010|FG000|Overall Study|Physician Decision|1|||
23484350|NCT02718300|65516011|FG001|Overall Study|Physician Decision|0|||
23484351|NCT02718300|65516012|FG002|Overall Study|Physician Decision|2|||
23484352|NCT02718300|65516010|FG000|Overall Study|Study Terminated by Sponsor|6|||
23484353|NCT02718300|65516011|FG001|Overall Study|Study Terminated by Sponsor|3|||
23484354|NCT02718300|65516012|FG002|Overall Study|Study Terminated by Sponsor|4|||
23484355|NCT02718300|65516010|FG000|Overall Study|Withdrawal by Subject|0|||
23484356|NCT02718300|65516011|FG001|Overall Study|Withdrawal by Subject|4|||
23484357|NCT02718300|65516012|FG002|Overall Study|Withdrawal by Subject|3|||
23484358|NCT02718300|65516010|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
23484359|NCT02718300|65516011|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
23484360|NCT02718300|65516012|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
23484361|NCT01925989|65516013|FG000|Period 1|Sponsor Decision|1|||
23484362|NCT01925989|65516014|FG001|Period 1|Sponsor Decision|1|||
23484363|NCT01925989|65516015|FG002|Period 1|Sponsor Decision|0|||
23484364|NCT01925989|65516013|FG000|Period 1|Withdrawal by Subject|0|||
23484365|NCT01925989|65516014|FG001|Period 1|Withdrawal by Subject|1|||
23484366|NCT01925989|65516015|FG002|Period 1|Withdrawal by Subject|0|||
23484367|NCT01426789|65516018|FG000|Part 1|Protocol deviation|0|||
23484368|NCT01426789|65516019|FG001|Part 1|Protocol deviation|1|||
23484369|NCT01426789|65516020|FG002|Part 1|Protocol deviation|0|||
23484370|NCT01426789|65516021|FG003|Part 1|Protocol deviation|0|||
23484371|NCT01426789|65516022|FG004|Part 1|Protocol deviation|0|||
23484372|NCT01426789|65516023|FG005|Part 1|Protocol deviation|0|||
23484373|NCT01426789|65516018|FG000|Part 1|Lost to Follow-up|1|||
23484374|NCT01426789|65516019|FG001|Part 1|Lost to Follow-up|2|||
23484375|NCT01426789|65516020|FG002|Part 1|Lost to Follow-up|0|||
23484376|NCT01426789|65516021|FG003|Part 1|Lost to Follow-up|0|||
23484377|NCT01426789|65516022|FG004|Part 1|Lost to Follow-up|0|||
23484378|NCT01426789|65516023|FG005|Part 1|Lost to Follow-up|0|||
23484379|NCT01426789|65516018|FG000|Part 1|Lack of Efficacy|2|||
23484380|NCT01426789|65516019|FG001|Part 1|Lack of Efficacy|1|||
23484381|NCT01426789|65516020|FG002|Part 1|Lack of Efficacy|0|||
23484382|NCT01426789|65516021|FG003|Part 1|Lack of Efficacy|0|||
23484383|NCT01426789|65516022|FG004|Part 1|Lack of Efficacy|0|||
23484384|NCT01426789|65516023|FG005|Part 1|Lack of Efficacy|0|||
23484385|NCT01426789|65516018|FG000|Part 1|Adverse Event|3|||
23484386|NCT01426789|65516019|FG001|Part 1|Adverse Event|0|||
23484387|NCT01426789|65516020|FG002|Part 1|Adverse Event|0|||
23484388|NCT01426789|65516021|FG003|Part 1|Adverse Event|0|||
23484389|NCT01426789|65516022|FG004|Part 1|Adverse Event|0|||
23484390|NCT01426789|65516023|FG005|Part 1|Adverse Event|0|||
23484391|NCT01426789|65516018|FG000|Part 2|Protocol deviation|0|||
23484392|NCT01426789|65516019|FG001|Part 2|Protocol deviation|0|||
23484393|NCT01426789|65516020|FG002|Part 2|Protocol deviation|1|||
23484394|NCT01426789|65516021|FG003|Part 2|Protocol deviation|0|||
23484395|NCT01426789|65516022|FG004|Part 2|Protocol deviation|0|||
23484396|NCT01426789|65516023|FG005|Part 2|Protocol deviation|0|||
23484397|NCT01426789|65516018|FG000|Part 2|Death|0|||
23484398|NCT01426789|65516019|FG001|Part 2|Death|0|||
23484399|NCT01426789|65516020|FG002|Part 2|Death|1|||
23484400|NCT01426789|65516021|FG003|Part 2|Death|0|||
23484401|NCT01426789|65516022|FG004|Part 2|Death|1|||
23484402|NCT01426789|65516023|FG005|Part 2|Death|0|||
23484403|NCT01426789|65516018|FG000|Part 2|Administrative problems|0|||
23484404|NCT01426789|65516019|FG001|Part 2|Administrative problems|0|||
23484405|NCT01426789|65516020|FG002|Part 2|Administrative problems|2|||
23484406|NCT01426789|65516021|FG003|Part 2|Administrative problems|0|||
23484407|NCT01426789|65516022|FG004|Part 2|Administrative problems|1|||
23484408|NCT01426789|65516023|FG005|Part 2|Administrative problems|0|||
23484409|NCT01426789|65516018|FG000|Part 2|Lost to Follow-up|0|||
23484410|NCT01426789|65516019|FG001|Part 2|Lost to Follow-up|0|||
23484411|NCT01426789|65516020|FG002|Part 2|Lost to Follow-up|4|||
23484412|NCT01426789|65516021|FG003|Part 2|Lost to Follow-up|0|||
23368304|NCT01396083|65095985|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23368305|NCT01396083|65095984|FG000|Overall Study|Administrative problems|1|||
23484413|NCT01426789|65516022|FG004|Part 2|Lost to Follow-up|1|||
23484414|NCT01426789|65516023|FG005|Part 2|Lost to Follow-up|0|||
23484415|NCT01426789|65516018|FG000|Part 2|Withdrawal by Subject|0|||
23484416|NCT01426789|65516019|FG001|Part 2|Withdrawal by Subject|0|||
23484417|NCT01426789|65516020|FG002|Part 2|Withdrawal by Subject|0|||
23484418|NCT01426789|65516021|FG003|Part 2|Withdrawal by Subject|1|||
23484419|NCT01426789|65516022|FG004|Part 2|Withdrawal by Subject|2|||
23484420|NCT01426789|65516023|FG005|Part 2|Withdrawal by Subject|0|||
23484421|NCT01426789|65516018|FG000|Part 2|Lack of Efficacy|0|||
23484422|NCT01426789|65516019|FG001|Part 2|Lack of Efficacy|0|||
23484423|NCT01426789|65516020|FG002|Part 2|Lack of Efficacy|5|||
23484424|NCT01426789|65516021|FG003|Part 2|Lack of Efficacy|0|||
23484425|NCT01426789|65516022|FG004|Part 2|Lack of Efficacy|2|||
23484426|NCT01426789|65516023|FG005|Part 2|Lack of Efficacy|0|||
23661843|NCT04667377|66148950|FG000|Dose Escalation Period|Protocol Violation|2|||
23661844|NCT04667377|66148951|FG001|Dose Escalation Period|Protocol Violation|2|||
23661845|NCT04667377|66148952|FG002|Dose Escalation Period|Protocol Violation|0|||
23661846|NCT04667377|66148953|FG003|Dose Escalation Period|Protocol Violation|2|||
23661847|NCT04667377|66148954|FG004|Dose Escalation Period|Protocol Violation|1|||
23661848|NCT04667377|66148950|FG000|Dose Escalation Period|Burden of study procedures|2|||
23661849|NCT04667377|66148951|FG001|Dose Escalation Period|Burden of study procedures|1|||
23661850|NCT04667377|66148952|FG002|Dose Escalation Period|Burden of study procedures|1|||
23661851|NCT04667377|66148953|FG003|Dose Escalation Period|Burden of study procedures|1|||
23661852|NCT04667377|66148954|FG004|Dose Escalation Period|Burden of study procedures|5|||
23661853|NCT04667377|66148950|FG000|Dose Escalation Period|Change of residence|0|||
23661854|NCT04667377|66148951|FG001|Dose Escalation Period|Change of residence|0|||
23661855|NCT04667377|66148952|FG002|Dose Escalation Period|Change of residence|1|||
23661856|NCT04667377|66148953|FG003|Dose Escalation Period|Change of residence|0|||
23661857|NCT04667377|66148954|FG004|Dose Escalation Period|Change of residence|0|||
23661858|NCT04667377|66148950|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
23661859|NCT04667377|66148951|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
23661860|NCT04667377|66148952|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
23661861|NCT04667377|66148953|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
23661862|NCT04667377|66148954|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
23661863|NCT04667377|66148950|FG000|Dose Escalation Period|Adverse Event|9|||
23661864|NCT04667377|66148951|FG001|Dose Escalation Period|Adverse Event|10|||
23661865|NCT04667377|66148952|FG002|Dose Escalation Period|Adverse Event|12|||
23368306|NCT01396083|65095985|FG001|Overall Study|Administrative problems|0|||
23368307|NCT01396083|65095984|FG000|Overall Study|Lost to Follow-up|1|||
23661866|NCT04667377|66148953|FG003|Dose Escalation Period|Adverse Event|17|||
23661867|NCT04667377|66148954|FG004|Dose Escalation Period|Adverse Event|3|||
23661868|NCT04667377|66148950|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
23661869|NCT04667377|66148951|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
23602522|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602523|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602524|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602525|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602526|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602527|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
23368308|NCT01396083|65095985|FG001|Overall Study|Lost to Follow-up|0|||
23368309|NCT00960193|65095986|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
23368310|NCT04609514|65095987|FG000|Overall Study|Lost to Follow-up|5|||
23368311|NCT04609514|65095988|FG001|Overall Study|Lost to Follow-up|4|||
23368312|NCT04609514|65095987|FG000|Overall Study|Withdrawal by PI|0|||
23368313|NCT04609514|65095988|FG001|Overall Study|Withdrawal by PI|2|||
23368314|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Early discharge|5|||
23368315|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Early discharge|5|||
23368316|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
23368317|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
23368318|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
23368319|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
23368320|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
23368321|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
23368322|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
23368323|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
23484427|NCT01426789|65516018|FG000|Part 2|Adverse Event|0|||
23484428|NCT01426789|65516019|FG001|Part 2|Adverse Event|0|||
23484429|NCT01426789|65516020|FG002|Part 2|Adverse Event|2|||
23484430|NCT01426789|65516021|FG003|Part 2|Adverse Event|0|||
23484431|NCT01426789|65516022|FG004|Part 2|Adverse Event|1|||
23484432|NCT01426789|65516023|FG005|Part 2|Adverse Event|0|||
23484433|NCT00938964|65516024|FG000|Overall Study|Death|3|||
23484434|NCT00938964|65516025|FG001|Overall Study|Death|3|||
23484435|NCT00938964|65516024|FG000|Overall Study|Lost to Follow-up|2|||
23484436|NCT00938964|65516025|FG001|Overall Study|Lost to Follow-up|3|||
23484437|NCT00938964|65516024|FG000|Overall Study|Withdrawal by Subject|22|||
23484438|NCT00938964|65516025|FG001|Overall Study|Withdrawal by Subject|18|||
23484439|NCT00938964|65516024|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
23484440|NCT00938964|65516025|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
23484441|NCT00817479|65516026|FG000|Overall Study|Physician Decision|1|||
23484442|NCT00817479|65516027|FG001|Overall Study|Physician Decision|1|||
23484443|NCT03119701|65516030|FG000|6-day Dosing|Death|4|||
23484444|NCT03119701|65516031|FG001|6-day Dosing|Death|1|||
23484445|NCT03119701|65516030|FG000|6-day Dosing|Adverse Event|3|||
23484446|NCT03119701|65516031|FG001|6-day Dosing|Adverse Event|0|||
23484447|NCT03119701|65516030|FG000|6-day Dosing|Physician Decision|0|||
23484448|NCT03119701|65516031|FG001|6-day Dosing|Physician Decision|1|||
23484449|NCT03119701|65516030|FG000|6-day Dosing|Withdrawal by Subject|0|||
23484450|NCT03119701|65516031|FG001|6-day Dosing|Withdrawal by Subject|1|||
23484451|NCT03119701|65516030|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
23484452|NCT03119701|65516031|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
23484453|NCT00761150|65516032|FG000|Open-label Period|Adverse Event|36|||
23484454|NCT00761150|65516033|FG001|Open-label Period|Adverse Event|0|||
23484455|NCT00761150|65516034|FG002|Open-label Period|Adverse Event|0|||
23484456|NCT00761150|65516032|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
23484457|NCT00761150|65516033|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
23484458|NCT00761150|65516034|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
23484459|NCT00761150|65516032|FG000|Open-label Period|Lost to Follow-up|7|||
23484460|NCT00761150|65516033|FG001|Open-label Period|Lost to Follow-up|0|||
23484461|NCT00761150|65516034|FG002|Open-label Period|Lost to Follow-up|0|||
23484462|NCT00761150|65516032|FG000|Open-label Period|Lack of Efficacy|4|||
23484463|NCT00761150|65516033|FG001|Open-label Period|Lack of Efficacy|0|||
23484464|NCT00761150|65516034|FG002|Open-label Period|Lack of Efficacy|0|||
23368324|NCT04460326|65095995|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
23368325|NCT04460326|65095996|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
23661870|NCT04667377|66148952|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
23661871|NCT04667377|66148953|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
23368326|NCT00789321|65095997|FG000|Overall Study|Adverse Event|0|||
23368327|NCT00789321|65095998|FG001|Overall Study|Adverse Event|1|||
23368328|NCT02224625|65095999|FG000|Irritation|Adverse Event|6|||
23368329|NCT02224625|65095999|FG000|Sensitization|Adverse Event|55|||
23368330|NCT03006562|65096000|FG000|Overall Study|Lost to Follow-up|0|||
23368331|NCT03006562|65096001|FG001|Overall Study|Lost to Follow-up|1|||
23368332|NCT03074695|65096003|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
23368333|NCT03074695|65096004|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
23368334|NCT03074695|65096003|FG000|Overall Study|Research staff not available|1|||
23368335|NCT03074695|65096004|FG001|Overall Study|Research staff not available|2|||
23368336|NCT03074695|65096003|FG000|Overall Study|Did not receive neuraxial block|2|||
23368337|NCT03074695|65096004|FG001|Overall Study|Did not receive neuraxial block|2|||
23368338|NCT02163395|65096005|FG000|Overall Study|Withdrawal by Subject|1|||
23368339|NCT02163395|65096005|FG000|Overall Study|Lost to Follow-up|3|||
23368340|NCT02163395|65096005|FG000|Overall Study|Adverse Event|1|||
23368341|NCT03426345|65096006|FG000|Overall Study|Adverse Event|4|||
23368342|NCT03426345|65096007|FG001|Overall Study|Adverse Event|4|||
23368343|NCT03426345|65096006|FG000|Overall Study|Lack of Efficacy|1|||
23368344|NCT03426345|65096007|FG001|Overall Study|Lack of Efficacy|0|||
23368345|NCT03426345|65096006|FG000|Overall Study|Withdrawal by Subject|5|||
23368346|NCT03426345|65096007|FG001|Overall Study|Withdrawal by Subject|6|||
23368347|NCT03426345|65096006|FG000|Overall Study|Lost to Follow-up|3|||
23368348|NCT03426345|65096007|FG001|Overall Study|Lost to Follow-up|1|||
23368349|NCT03426345|65096006|FG000|Overall Study|Protocol Deviation|3|||
23368350|NCT03426345|65096007|FG001|Overall Study|Protocol Deviation|4|||
23368351|NCT03426345|65096006|FG000|Overall Study|Reason Not Specified|1|||
23368352|NCT03426345|65096007|FG001|Overall Study|Reason Not Specified|2|||
23368353|NCT03426345|65096006|FG000|Overall Study|Missing Completion Status|1|||
23368354|NCT03426345|65096007|FG001|Overall Study|Missing Completion Status|0|||
23368355|NCT02900352|65096008|FG000|Overall Study|Lost to Follow-up|28|||
23368356|NCT02900352|65096009|FG001|Overall Study|Lost to Follow-up|17|||
23368357|NCT04356937|65096010|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
23368358|NCT04356937|65096011|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
23368359|NCT03885908|65096012|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
23368360|NCT03885908|65096013|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
23368361|NCT03885908|65096012|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
23368362|NCT03885908|65096013|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
23368363|NCT03885908|65096012|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
23368364|NCT03885908|65096013|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
23402811|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
23368365|NCT03885908|65096012|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
23368366|NCT03885908|65096013|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
23368367|NCT00617357|65096018|FG000|Overall Study|Lost to Follow-up|7|||
23368368|NCT00617357|65096018|FG000|Overall Study|Death|5|||
23368369|NCT00617357|65096018|FG000|Overall Study|insurance concerns|2|||
23368370|NCT00617357|65096018|FG000|Overall Study|Withdrawal by Subject|1|||
23368371|NCT00617357|65096018|FG000|Overall Study|Physician Decision|1|||
23368372|NCT01791985|65096020|FG000|Overall Study|Adverse Event|7|||
23368373|NCT01791985|65096020|FG000|Overall Study|Withdrawal by Subject|1|||
23368374|NCT04006145|65096021|FG000|Overall Study|Lost to Follow-up|0|||
23368375|NCT04006145|65096022|FG001|Overall Study|Lost to Follow-up|1|||
23368376|NCT04006145|65096021|FG000|Overall Study|Other|1|||
23368377|NCT04006145|65096022|FG001|Overall Study|Other|2|||
23368378|NCT00483652|65096023|FG000|Double-blind Treatment Period|Protocol Violation|2|||
23368379|NCT00483652|65096024|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23368380|NCT00483652|65096023|FG000|Double-blind Treatment Period|Adverse Event|3|||
23368381|NCT00483652|65096024|FG001|Double-blind Treatment Period|Adverse Event|4|||
23368382|NCT00483652|65096023|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
23368383|NCT00483652|65096024|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
23368384|NCT00483652|65096023|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
23368385|NCT00483652|65096024|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
23368386|NCT01619865|65096025|FG000|Overall Study|Adverse Event|1|||
23368387|NCT01619865|65096025|FG000|Overall Study|Death|2|||
23368388|NCT01619865|65096025|FG000|Overall Study|subject not able to comply|1|||
23368389|NCT02700048|65096026|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
23368390|NCT02700048|65096027|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
23368391|NCT00739648|65096028|FG000|Overall Study|Adverse Event|3|||
23661872|NCT04667377|66148954|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
23661873|NCT04667377|66148950|FG000|Dose Escalation Period|Not treated|1|||
23661874|NCT04667377|66148951|FG001|Dose Escalation Period|Not treated|0|||
23661875|NCT04667377|66148952|FG002|Dose Escalation Period|Not treated|0|||
23661876|NCT04667377|66148953|FG003|Dose Escalation Period|Not treated|0|||
23661877|NCT04667377|66148954|FG004|Dose Escalation Period|Not treated|0|||
23661878|NCT04667377|66148950|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
23661879|NCT04667377|66148951|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
23661880|NCT04667377|66148952|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
23661881|NCT04667377|66148953|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
23661882|NCT04667377|66148954|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
23661883|NCT04667377|66148950|FG000|Dose Escalation Period|Lost to Follow-up|0|||
23661884|NCT04667377|66148951|FG001|Dose Escalation Period|Lost to Follow-up|1|||
23661885|NCT04667377|66148952|FG002|Dose Escalation Period|Lost to Follow-up|0|||
23661886|NCT04667377|66148953|FG003|Dose Escalation Period|Lost to Follow-up|0|||
23661887|NCT04667377|66148954|FG004|Dose Escalation Period|Lost to Follow-up|0|||
23661888|NCT04667377|66148950|FG000|Maintenance Period|Perceived lack of efficacy|0|||
23661889|NCT04667377|66148951|FG001|Maintenance Period|Perceived lack of efficacy|2|||
23661890|NCT04667377|66148952|FG002|Maintenance Period|Perceived lack of efficacy|1|||
23661891|NCT04667377|66148953|FG003|Maintenance Period|Perceived lack of efficacy|0|||
23661892|NCT04667377|66148954|FG004|Maintenance Period|Perceived lack of efficacy|1|||
23661893|NCT04667377|66148950|FG000|Maintenance Period|Adverse Event|2|||
23661894|NCT04667377|66148951|FG001|Maintenance Period|Adverse Event|8|||
23661895|NCT04667377|66148952|FG002|Maintenance Period|Adverse Event|5|||
23661896|NCT04667377|66148953|FG003|Maintenance Period|Adverse Event|4|||
23661897|NCT04667377|66148954|FG004|Maintenance Period|Adverse Event|1|||
23661898|NCT04667377|66148950|FG000|Maintenance Period|Adverse event: COVID infection|0|||
23661899|NCT04667377|66148951|FG001|Maintenance Period|Adverse event: COVID infection|1|||
23661900|NCT04667377|66148952|FG002|Maintenance Period|Adverse event: COVID infection|0|||
23661901|NCT04667377|66148953|FG003|Maintenance Period|Adverse event: COVID infection|0|||
23661902|NCT04667377|66148954|FG004|Maintenance Period|Adverse event: COVID infection|0|||
23661903|NCT04667377|66148950|FG000|Maintenance Period|COVID-related|0|||
23661904|NCT04667377|66148951|FG001|Maintenance Period|COVID-related|0|||
23661905|NCT04667377|66148952|FG002|Maintenance Period|COVID-related|1|||
23661906|NCT04667377|66148953|FG003|Maintenance Period|COVID-related|1|||
23368392|NCT00739648|65096029|FG001|Overall Study|Adverse Event|15|||
23368393|NCT00739648|65096028|FG000|Overall Study|Withdrawal by Subject|13|||
23661907|NCT04667377|66148954|FG004|Maintenance Period|COVID-related|0|||
23661908|NCT04667377|66148950|FG000|Maintenance Period|Protocol Violation|1|||
23661909|NCT04667377|66148951|FG001|Maintenance Period|Protocol Violation|0|||
23368394|NCT00739648|65096029|FG001|Overall Study|Withdrawal by Subject|25|||
23368395|NCT00739648|65096028|FG000|Overall Study|Lost to Follow-up|4|||
23661910|NCT04667377|66148952|FG002|Maintenance Period|Protocol Violation|0|||
23661911|NCT04667377|66148953|FG003|Maintenance Period|Protocol Violation|0|||
23661912|NCT04667377|66148954|FG004|Maintenance Period|Protocol Violation|1|||
23661913|NCT04667377|66148950|FG000|Maintenance Period|Burden of study procedures|1|||
23368396|NCT00739648|65096029|FG001|Overall Study|Lost to Follow-up|7|||
23368397|NCT00739648|65096028|FG000|Overall Study|Death|2|||
23368398|NCT00739648|65096029|FG001|Overall Study|Death|0|||
23368399|NCT00739648|65096028|FG000|Overall Study|Do not know|4|||
23368400|NCT00739648|65096029|FG001|Overall Study|Do not know|6|||
23368401|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
23368402|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
23661914|NCT04667377|66148951|FG001|Maintenance Period|Burden of study procedures|2|||
23661915|NCT04667377|66148952|FG002|Maintenance Period|Burden of study procedures|0|||
23661916|NCT04667377|66148953|FG003|Maintenance Period|Burden of study procedures|1|||
23661917|NCT04667377|66148954|FG004|Maintenance Period|Burden of study procedures|0|||
23661918|NCT04667377|66148950|FG000|Maintenance Period|Change of residence|0|||
23661919|NCT04667377|66148951|FG001|Maintenance Period|Change of residence|1|||
23661920|NCT04667377|66148952|FG002|Maintenance Period|Change of residence|0|||
23661921|NCT04667377|66148953|FG003|Maintenance Period|Change of residence|0|||
23368403|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368404|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368405|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368406|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
23368407|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
23368408|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368409|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368410|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368411|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
23368412|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
23368413|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368414|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368415|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368416|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
23368417|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
23368418|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368419|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368420|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368421|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
23368422|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
23368423|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368424|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368425|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368426|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
23368427|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
23368428|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368429|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368430|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368431|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
23368432|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
23368433|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368434|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368435|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368436|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
23368437|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
23368438|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368439|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368440|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368441|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
23368442|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23661922|NCT04667377|66148954|FG004|Maintenance Period|Change of residence|1|||
23661923|NCT04667377|66148950|FG000|Maintenance Period|Missing|1|||
23661924|NCT04667377|66148951|FG001|Maintenance Period|Missing|0|||
23661925|NCT04667377|66148952|FG002|Maintenance Period|Missing|0|||
23368443|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368444|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368445|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368446|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
23602528|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
23661926|NCT04667377|66148953|FG003|Maintenance Period|Missing|0|||
23661927|NCT04667377|66148954|FG004|Maintenance Period|Missing|0|||
23602529|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
23661928|NCT04667377|66148950|FG000|Maintenance Period|Other than listed above|2|||
23661929|NCT04667377|66148951|FG001|Maintenance Period|Other than listed above|0|||
23661930|NCT04667377|66148952|FG002|Maintenance Period|Other than listed above|3|||
23661931|NCT04667377|66148953|FG003|Maintenance Period|Other than listed above|2|||
23661932|NCT04667377|66148954|FG004|Maintenance Period|Other than listed above|6|||
23661933|NCT04667377|66148950|FG000|Maintenance Period|Withdrawal by Subject|0|||
23661934|NCT04667377|66148951|FG001|Maintenance Period|Withdrawal by Subject|1|||
23661935|NCT04667377|66148952|FG002|Maintenance Period|Withdrawal by Subject|0|||
23661936|NCT04667377|66148953|FG003|Maintenance Period|Withdrawal by Subject|0|||
23661937|NCT04667377|66148954|FG004|Maintenance Period|Withdrawal by Subject|0|||
23661938|NCT04667377|66148950|FG000|Maintenance Period|Lost to Follow-up|1|||
23661939|NCT04667377|66148951|FG001|Maintenance Period|Lost to Follow-up|0|||
23661940|NCT04667377|66148952|FG002|Maintenance Period|Lost to Follow-up|1|||
23661941|NCT04667377|66148953|FG003|Maintenance Period|Lost to Follow-up|0|||
23661942|NCT04667377|66148954|FG004|Maintenance Period|Lost to Follow-up|1|||
23661943|NCT01786603|66148962|FG000|Overall Study|Death|5|||
23661944|NCT01786603|66148963|FG001|Overall Study|Death|1|||
23661945|NCT01786603|66148962|FG000|Overall Study|Adverse Event|6|||
23661946|NCT01786603|66148963|FG001|Overall Study|Adverse Event|2|||
23602530|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
23602531|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602532|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602533|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602534|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602535|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602536|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602537|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602538|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602539|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602540|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602541|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602542|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602543|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602544|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602545|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
23661947|NCT01786603|66148962|FG000|Overall Study|Physician decision to withdraw|6|||
23661948|NCT01786603|66148963|FG001|Overall Study|Physician decision to withdraw|7|||
23661949|NCT01786603|66148962|FG000|Overall Study|Lost to Follow-up|1|||
23661950|NCT01786603|66148963|FG001|Overall Study|Lost to Follow-up|2|||
23368447|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
23368448|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
23368449|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
23368450|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
23368451|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
23368452|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
23368453|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
23368454|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
23368455|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
23368456|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
23368457|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368458|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368459|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368460|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368461|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
23661951|NCT00618410|66148976|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
23661952|NCT00618410|66148977|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
23368462|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368463|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368464|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368465|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368466|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368467|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
23368468|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368469|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368470|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368471|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
23368472|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
23368473|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368474|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368475|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368476|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368477|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
23368478|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368479|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368480|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368481|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
23368482|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368483|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368484|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368485|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368486|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368487|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
23368488|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368489|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368490|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368491|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
23368492|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368493|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368494|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368495|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368496|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368497|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
23368498|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368499|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368500|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368501|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
23368502|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368503|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368504|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368505|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368506|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
23368507|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23368508|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23661953|NCT00006392|66148978|FG000|Overall Study|Ineligible|11|||
23368509|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23484465|NCT00761150|65516032|FG000|Open-label Period|Withdrawal by Subject|5|||
23661954|NCT00006392|66148979|FG001|Overall Study|Ineligible|3|||
23368510|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23368511|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
23368512|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
23368513|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
23368514|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
23368515|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
23368516|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
23368517|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
23368518|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
23368519|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
23368520|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
23368521|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
23368522|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
23368523|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
23368524|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
23368525|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
23368526|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23368527|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23368528|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
23368529|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23368530|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
23661955|NCT00006392|66148980|FG002|Overall Study|Ineligible|5|||
23368531|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23368532|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23368533|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
23368534|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
23368535|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
23368536|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368537|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368538|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368539|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
23368540|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
23368541|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368542|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368543|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
23368544|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368545|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368546|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368547|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368548|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368549|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
23484466|NCT00761150|65516033|FG001|Open-label Period|Withdrawal by Subject|0|||
23484467|NCT00761150|65516034|FG002|Open-label Period|Withdrawal by Subject|0|||
23368550|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
23368551|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368552|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368553|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368554|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
23368555|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
23368556|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368557|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368558|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368559|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368560|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
23368561|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368562|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368563|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368564|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
23368565|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
23368566|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368567|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368568|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368569|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368570|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
23368571|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368572|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368573|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
23368574|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368575|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368576|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368577|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368578|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368579|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
23368580|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
23368581|NCT00264147|65096035|FG000|Treatment I Period|Adverse Event|3|||
23368582|NCT00264147|65096036|FG001|Treatment I Period|Adverse Event|6|||
23368583|NCT00264147|65096037|FG002|Treatment I Period|Adverse Event|3|||
23602546|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
23661956|NCT00006392|66148981|FG003|Overall Study|Ineligible|5|||
23661957|NCT00006392|66148978|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
23661958|NCT00006392|66148979|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23661959|NCT00006392|66148980|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23661960|NCT00006392|66148981|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23661961|NCT00698932|66148982|FG000|Overall Study|Adverse Event|0|||
23661962|NCT00698932|66148983|FG001|Overall Study|Adverse Event|2|||
23661963|NCT00698932|66148982|FG000|Overall Study|Incorrect enrollment|0|||
23661964|NCT00698932|66148983|FG001|Overall Study|Incorrect enrollment|2|||
23602547|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602548|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602549|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602550|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602551|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602552|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
23661965|NCT00698932|66148982|FG000|Overall Study|Study specific discontinuation criteria|3|||
23661966|NCT00698932|66148983|FG001|Overall Study|Study specific discontinuation criteria|4|||
23661967|NCT00698932|66148982|FG000|Overall Study|Withdrawal by Subject|11|||
23661968|NCT00698932|66148983|FG001|Overall Study|Withdrawal by Subject|23|||
23368584|NCT00264147|65096038|FG003|Treatment I Period|Adverse Event|5|||
23368585|NCT00264147|65096039|FG004|Treatment I Period|Adverse Event|7|||
23368586|NCT00264147|65096040|FG005|Treatment I Period|Adverse Event|0|||
23368587|NCT00264147|65096035|FG000|Treatment I Period|Laboratory Adverse Event|0|||
23368588|NCT00264147|65096036|FG001|Treatment I Period|Laboratory Adverse Event|0|||
23368589|NCT00264147|65096037|FG002|Treatment I Period|Laboratory Adverse Event|0|||
23368590|NCT00264147|65096038|FG003|Treatment I Period|Laboratory Adverse Event|1|||
23368591|NCT00264147|65096039|FG004|Treatment I Period|Laboratory Adverse Event|0|||
23368592|NCT00264147|65096040|FG005|Treatment I Period|Laboratory Adverse Event|0|||
23368593|NCT00264147|65096035|FG000|Treatment I Period|Lack of Efficacy|6|||
23368594|NCT00264147|65096036|FG001|Treatment I Period|Lack of Efficacy|2|||
23368595|NCT00264147|65096037|FG002|Treatment I Period|Lack of Efficacy|8|||
23368596|NCT00264147|65096038|FG003|Treatment I Period|Lack of Efficacy|0|||
23368597|NCT00264147|65096039|FG004|Treatment I Period|Lack of Efficacy|1|||
23368598|NCT00264147|65096040|FG005|Treatment I Period|Lack of Efficacy|0|||
23368599|NCT00264147|65096035|FG000|Treatment I Period|Lost to Follow-up|1|||
23368600|NCT00264147|65096036|FG001|Treatment I Period|Lost to Follow-up|0|||
23368601|NCT00264147|65096037|FG002|Treatment I Period|Lost to Follow-up|0|||
23368602|NCT00264147|65096038|FG003|Treatment I Period|Lost to Follow-up|1|||
23368603|NCT00264147|65096039|FG004|Treatment I Period|Lost to Follow-up|1|||
23368604|NCT00264147|65096040|FG005|Treatment I Period|Lost to Follow-up|0|||
23368605|NCT00264147|65096035|FG000|Treatment I Period|Protocol Violation|2|||
23368606|NCT00264147|65096036|FG001|Treatment I Period|Protocol Violation|2|||
23368607|NCT00264147|65096037|FG002|Treatment I Period|Protocol Violation|0|||
23368608|NCT00264147|65096038|FG003|Treatment I Period|Protocol Violation|0|||
23368609|NCT00264147|65096039|FG004|Treatment I Period|Protocol Violation|0|||
23368610|NCT00264147|65096040|FG005|Treatment I Period|Protocol Violation|0|||
23368611|NCT00264147|65096035|FG000|Treatment I Period|Withdrawal by Subject|2|||
23368612|NCT00264147|65096036|FG001|Treatment I Period|Withdrawal by Subject|0|||
23368613|NCT00264147|65096037|FG002|Treatment I Period|Withdrawal by Subject|0|||
23368614|NCT00264147|65096038|FG003|Treatment I Period|Withdrawal by Subject|2|||
23368615|NCT00264147|65096039|FG004|Treatment I Period|Withdrawal by Subject|2|||
23368616|NCT00264147|65096040|FG005|Treatment I Period|Withdrawal by Subject|0|||
23368617|NCT00264147|65096035|FG000|Treatment I Period|Patient out of town for an extended time|0|||
23368618|NCT00264147|65096036|FG001|Treatment I Period|Patient out of town for an extended time|1|||
23368619|NCT00264147|65096037|FG002|Treatment I Period|Patient out of town for an extended time|0|||
23368620|NCT00264147|65096038|FG003|Treatment I Period|Patient out of town for an extended time|0|||
23368621|NCT00264147|65096039|FG004|Treatment I Period|Patient out of town for an extended time|0|||
23484468|NCT00761150|65516032|FG000|Open-label Period|Noncompliance|2|||
23661969|NCT00698932|66148982|FG000|Overall Study|Lost to Follow-up|6|||
23368622|NCT00264147|65096040|FG005|Treatment I Period|Patient out of town for an extended time|0|||
23368623|NCT00264147|65096035|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368624|NCT00264147|65096036|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368625|NCT00264147|65096037|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
23368626|NCT00264147|65096038|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23484469|NCT00761150|65516033|FG001|Open-label Period|Noncompliance|0|||
23484470|NCT00761150|65516034|FG002|Open-label Period|Noncompliance|0|||
23484471|NCT00761150|65516032|FG000|Open-label Period|Other|5|||
23484472|NCT00761150|65516033|FG001|Open-label Period|Other|0|||
23484473|NCT00761150|65516034|FG002|Open-label Period|Other|0|||
23484474|NCT00761150|65516032|FG000|Double-blind Period|Lack of Efficacy|0|||
23484475|NCT00761150|65516033|FG001|Double-blind Period|Lack of Efficacy|2|||
23484476|NCT00761150|65516034|FG002|Double-blind Period|Lack of Efficacy|19|||
23484477|NCT00761150|65516032|FG000|Double-blind Period|Adverse Event|0|||
23484478|NCT00761150|65516033|FG001|Double-blind Period|Adverse Event|3|||
23484479|NCT00761150|65516034|FG002|Double-blind Period|Adverse Event|3|||
23484480|NCT00761150|65516032|FG000|Double-blind Period|Withdrawal by Subject|0|||
23484481|NCT00761150|65516033|FG001|Double-blind Period|Withdrawal by Subject|3|||
23484482|NCT00761150|65516034|FG002|Double-blind Period|Withdrawal by Subject|2|||
23484483|NCT00761150|65516032|FG000|Double-blind Period|Lost to Follow-up|0|||
23484484|NCT00761150|65516033|FG001|Double-blind Period|Lost to Follow-up|2|||
23484485|NCT00761150|65516034|FG002|Double-blind Period|Lost to Follow-up|1|||
23484486|NCT00761150|65516032|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
23484487|NCT00761150|65516033|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
23484488|NCT00761150|65516034|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
23484489|NCT00761150|65516032|FG000|Double-blind Period|Noncompliance|0|||
23484490|NCT00761150|65516033|FG001|Double-blind Period|Noncompliance|1|||
23484491|NCT00761150|65516034|FG002|Double-blind Period|Noncompliance|0|||
23484492|NCT00761150|65516032|FG000|Double-blind Period|Other|0|||
23484493|NCT00761150|65516033|FG001|Double-blind Period|Other|3|||
23484494|NCT00761150|65516034|FG002|Double-blind Period|Other|3|||
23484495|NCT00993044|65516038|FG000|Irinotecan 50 mg|Physician Decision|1|||
23484496|NCT00920907|65516039|FG000|Induction Period|Adverse Event|0|||
23484497|NCT00920907|65516040|FG001|Induction Period|Adverse Event|2|||
23484498|NCT00920907|65516039|FG000|Induction Period|Death|1|||
23484499|NCT00920907|65516040|FG001|Induction Period|Death|1|||
23484500|NCT00920907|65516039|FG000|Induction Period|Disease Progression|12|||
23484501|NCT00920907|65516040|FG001|Induction Period|Disease Progression|11|||
23484502|NCT00920907|65516039|FG000|Induction Period|Study Drug Toxicity|8|||
23484503|NCT00920907|65516040|FG001|Induction Period|Study Drug Toxicity|6|||
23484504|NCT00920907|65516039|FG000|Induction Period|No longer meets study criteria|0|||
23484505|NCT00920907|65516040|FG001|Induction Period|No longer meets study criteria|1|||
23484506|NCT00920907|65516039|FG000|Induction Period|Withdrawal by Subject|1|||
23484507|NCT00920907|65516040|FG001|Induction Period|Withdrawal by Subject|1|||
23484508|NCT00920907|65516039|FG000|Maintenance Period|Disease Progression|3|||
23484509|NCT00920907|65516040|FG001|Maintenance Period|Disease Progression|7|||
23484510|NCT00920907|65516039|FG000|Maintenance Period|Administrative (study closure)|7|||
23484511|NCT00920907|65516040|FG001|Maintenance Period|Administrative (study closure)|2|||
23484512|NCT00920907|65516039|FG000|Maintenance Period|Study Drug Toxicity|0|||
23484513|NCT00920907|65516040|FG001|Maintenance Period|Study Drug Toxicity|2|||
23484514|NCT00920907|65516039|FG000|Maintenance Period|Death|1|||
23484515|NCT00920907|65516040|FG001|Maintenance Period|Death|1|||
23484516|NCT00920907|65516039|FG000|Maintenance Period|Withdrawal by Subject|1|||
23484517|NCT00920907|65516040|FG001|Maintenance Period|Withdrawal by Subject|0|||
23484518|NCT00920907|65516039|FG000|Maintenance Period|Adverse Event|0|||
23484519|NCT00920907|65516040|FG001|Maintenance Period|Adverse Event|1|||
23484520|NCT00459979|65516041|FG000|Overall Study|Withdrawal by Subject|1|||
23484521|NCT00459979|65516041|FG000|Overall Study|Protocol Violation|1|||
23484522|NCT01117792|65518593|FG000|Overall Study|Death|1|||
23484523|NCT01117792|65518593|FG000|Overall Study|Adverse Event|3|||
23484524|NCT00504582|65518594|FG000|Overall Study|Lost to Follow-up|1|||
23484525|NCT00504582|65518595|FG001|Overall Study|Lost to Follow-up|0|||
23484526|NCT00504582|65518596|FG002|Overall Study|Lost to Follow-up|0|||
23484527|NCT04050371|65518600|FG000|Overall Study|Withdrawal by Subject|1|||
23484528|NCT04050371|65518601|FG001|Overall Study|Withdrawal by Subject|0|||
23484529|NCT04854642|65518602|FG000|Overall Study|Adverse Event|1|||
23484530|NCT04854642|65518603|FG001|Overall Study|Adverse Event|2|||
23484531|NCT04854642|65518602|FG000|Overall Study|Withdrawal by Subject|0|||
23484532|NCT04854642|65518603|FG001|Overall Study|Withdrawal by Subject|1|||
23484533|NCT02233946|65518604|FG000|Baseline|Withdrawal by Subject|2|||
23484534|NCT02233946|65518605|FG001|Baseline|Withdrawal by Subject|0|||
23484535|NCT02233946|65518604|FG000|3-months Follow-up|Lost to Follow-up|53|||
23484536|NCT02233946|65518605|FG001|3-months Follow-up|Lost to Follow-up|29|||
23484537|NCT02233946|65518604|FG000|6-months Follow-up|Lost to Follow-up|21|||
23484538|NCT02233946|65518605|FG001|6-months Follow-up|Lost to Follow-up|2|||
23484539|NCT02233946|65518604|FG000|9-month Follow-up|Lost to Follow-up|20|||
23484540|NCT02233946|65518605|FG001|9-month Follow-up|Lost to Follow-up|11|||
23484541|NCT02233946|65518604|FG000|12-month Follow-up|Lost to Follow-up|28|||
23484542|NCT02233946|65518605|FG001|12-month Follow-up|Lost to Follow-up|11|||
23484543|NCT01856023|65518606|FG000|Overall Study|Death|1|||
23484544|NCT01856023|65518607|FG001|Overall Study|Death|2|||
23484545|NCT01856023|65518606|FG000|Overall Study|Adverse Event|2|||
23484546|NCT01856023|65518607|FG001|Overall Study|Adverse Event|1|||
23484547|NCT01856023|65518606|FG000|Overall Study|Lack of Efficacy|5|||
23484548|NCT01856023|65518607|FG001|Overall Study|Lack of Efficacy|5|||
23484549|NCT01856023|65518606|FG000|Overall Study|non compliance, study closure|1|||
23484550|NCT01856023|65518607|FG001|Overall Study|non compliance, study closure|3|||
23484551|NCT01856023|65518606|FG000|Overall Study|Withdrawal by Subject|1|||
23484552|NCT01856023|65518607|FG001|Overall Study|Withdrawal by Subject|1|||
23484553|NCT01727700|65518609|FG000|Overall Study|Adverse Event|0|||
23484554|NCT01727700|65518610|FG001|Overall Study|Adverse Event|7|||
23484555|NCT01727700|65518611|FG002|Overall Study|Adverse Event|1|||
23484556|NCT01727700|65518609|FG000|Overall Study|Particpant withdrew consent|0|||
23484557|NCT01727700|65518610|FG001|Overall Study|Particpant withdrew consent|3|||
23484558|NCT01727700|65518611|FG002|Overall Study|Particpant withdrew consent|1|||
23484559|NCT01727700|65518609|FG000|Overall Study|Protocol Violation|2|||
23484560|NCT01727700|65518610|FG001|Overall Study|Protocol Violation|0|||
23484561|NCT01727700|65518611|FG002|Overall Study|Protocol Violation|0|||
23484562|NCT02469038|65518615|FG000|Overall Study|Physician Decision|4|||
23484563|NCT02469038|65518616|FG001|Overall Study|Physician Decision|5|||
23484564|NCT00510952|65518632|FG000|Overall Study|Adverse Event|1|||
23484565|NCT00510952|65518633|FG001|Overall Study|Adverse Event|0|||
23484566|NCT00510952|65518632|FG000|Overall Study|Entry Criteria Not Met|3|||
23484567|NCT00510952|65518633|FG001|Overall Study|Entry Criteria Not Met|1|||
23484568|NCT00510952|65518632|FG000|Overall Study|Lost to Follow-up|5|||
23484569|NCT00510952|65518633|FG001|Overall Study|Lost to Follow-up|3|||
23484570|NCT00510952|65518632|FG000|Overall Study|Physician Decision|1|||
23484571|NCT00510952|65518633|FG001|Overall Study|Physician Decision|1|||
23484572|NCT00510952|65518632|FG000|Overall Study|Protocol Violation|7|||
23484573|NCT00510952|65518633|FG001|Overall Study|Protocol Violation|4|||
23484574|NCT00510952|65518632|FG000|Overall Study|Sponsor Decision|1|||
23484575|NCT00510952|65518633|FG001|Overall Study|Sponsor Decision|0|||
23484576|NCT00510952|65518632|FG000|Overall Study|Withdrawal by Subject|6|||
23602553|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602554|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602555|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602556|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602557|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602558|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602559|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
23484577|NCT00510952|65518633|FG001|Overall Study|Withdrawal by Subject|7|||
23484578|NCT00510952|65518632|FG000|Overall Study|Did Not Receive Study Drug|2|||
23602560|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602561|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
23602562|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
23602563|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
23484579|NCT00510952|65518633|FG001|Overall Study|Did Not Receive Study Drug|0|||
23484580|NCT01347580|65518634|FG000|Overall Study|Withdrawal by Subject|13|||
23484581|NCT01347580|65518635|FG001|Overall Study|Withdrawal by Subject|23|||
23484582|NCT01347580|65518634|FG000|Overall Study|Death|30|||
23602564|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602565|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
23484583|NCT01347580|65518635|FG001|Overall Study|Death|19|||
23484584|NCT01347580|65518634|FG000|Overall Study|Protocol Violation|10|||
23484585|NCT01347580|65518635|FG001|Overall Study|Protocol Violation|7|||
23602566|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
23368627|NCT00264147|65096039|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368628|NCT00264147|65096040|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368629|NCT00264147|65096035|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
23368630|NCT00264147|65096036|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
23368631|NCT00264147|65096037|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
23807517|NCT02566993|66672782|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
23807518|NCT02566993|66672783|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
23807519|NCT02566993|66672782|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
23807520|NCT02566993|66672783|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
23807521|NCT02566993|66672782|FG000|Overall Study|Screening failure|2|||
23807522|NCT02566993|66672783|FG001|Overall Study|Screening failure|0|||
23807523|NCT02566993|66672782|FG000|Overall Study|Lost to Follow-up|0|||
23807524|NCT02566993|66672783|FG001|Overall Study|Lost to Follow-up|1|||
23807525|NCT02566993|66672782|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
23807526|NCT02566993|66672783|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
23807527|NCT03212521|66672784|FG000|Overall Study|Adverse Event|1|||
23807528|NCT03212521|66672784|FG000|Overall Study|Lost to Follow-up|4|||
23807529|NCT03212521|66672784|FG000|Overall Study|Withdrawal by Subject|1|||
23807530|NCT03212521|66672784|FG000|Overall Study|Other|1|||
23807531|NCT01524913|66672785|FG000|Overall Study|Lost to Follow-up|4|||
23807532|NCT01524913|66672786|FG001|Overall Study|Lost to Follow-up|0|||
23807533|NCT01524913|66672787|FG002|Overall Study|Lost to Follow-up|0|||
23807534|NCT01641133|66672792|FG000|Overall Study|Protocol Violation|0|||
23807535|NCT01641133|66672793|FG001|Overall Study|Protocol Violation|1|||
23807536|NCT01641133|66672794|FG002|Overall Study|Protocol Violation|1|||
23661970|NCT00698932|66148983|FG001|Overall Study|Lost to Follow-up|1|||
23661971|NCT00698932|66148982|FG000|Overall Study|Severe non-compliance to protocol|1|||
23368632|NCT00264147|65096038|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
23807537|NCT01641133|66672792|FG000|Overall Study|Migrated/moved from study area|5|||
23807538|NCT01641133|66672793|FG001|Overall Study|Migrated/moved from study area|3|||
23807539|NCT01641133|66672794|FG002|Overall Study|Migrated/moved from study area|1|||
23807540|NCT01641133|66672792|FG000|Overall Study|Adverse Event|0|||
23807541|NCT01641133|66672793|FG001|Overall Study|Adverse Event|0|||
23807542|NCT01641133|66672794|FG002|Overall Study|Adverse Event|1|||
23807543|NCT01641133|66672792|FG000|Overall Study|Withdrawal by Subject|5|||
23807544|NCT01641133|66672793|FG001|Overall Study|Withdrawal by Subject|3|||
23602567|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602568|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602569|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602570|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
23368633|NCT00264147|65096039|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
23368634|NCT00264147|65096040|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
23368635|NCT00264147|65096035|FG000|Treatment II Period|Adverse Event|0|||
23368636|NCT00264147|65096036|FG001|Treatment II Period|Adverse Event|0|||
23368637|NCT00264147|65096037|FG002|Treatment II Period|Adverse Event|0|||
23368638|NCT00264147|65096038|FG003|Treatment II Period|Adverse Event|0|||
23368639|NCT00264147|65096039|FG004|Treatment II Period|Adverse Event|9|||
23368640|NCT00264147|65096040|FG005|Treatment II Period|Adverse Event|9|||
23368641|NCT00264147|65096035|FG000|Treatment II Period|Laboratory Adverse Event|0|||
23368642|NCT00264147|65096036|FG001|Treatment II Period|Laboratory Adverse Event|0|||
23368643|NCT00264147|65096037|FG002|Treatment II Period|Laboratory Adverse Event|0|||
23368644|NCT00264147|65096038|FG003|Treatment II Period|Laboratory Adverse Event|0|||
23368645|NCT00264147|65096039|FG004|Treatment II Period|Laboratory Adverse Event|0|||
23368646|NCT00264147|65096040|FG005|Treatment II Period|Laboratory Adverse Event|1|||
23368647|NCT00264147|65096035|FG000|Treatment II Period|Lack of Efficacy|0|||
23368648|NCT00264147|65096036|FG001|Treatment II Period|Lack of Efficacy|0|||
23368649|NCT00264147|65096037|FG002|Treatment II Period|Lack of Efficacy|0|||
23368650|NCT00264147|65096038|FG003|Treatment II Period|Lack of Efficacy|0|||
23368651|NCT00264147|65096039|FG004|Treatment II Period|Lack of Efficacy|20|||
23368652|NCT00264147|65096040|FG005|Treatment II Period|Lack of Efficacy|19|||
23368653|NCT00264147|65096035|FG000|Treatment II Period|Lost to Follow-up|0|||
23368654|NCT00264147|65096036|FG001|Treatment II Period|Lost to Follow-up|0|||
23368655|NCT00264147|65096037|FG002|Treatment II Period|Lost to Follow-up|0|||
23368656|NCT00264147|65096038|FG003|Treatment II Period|Lost to Follow-up|0|||
23368657|NCT00264147|65096039|FG004|Treatment II Period|Lost to Follow-up|1|||
23368658|NCT00264147|65096040|FG005|Treatment II Period|Lost to Follow-up|1|||
23661972|NCT00698932|66148983|FG001|Overall Study|Severe non-compliance to protocol|2|||
23368659|NCT00264147|65096035|FG000|Treatment II Period|Withdrawal by Subject|0|||
23368660|NCT00264147|65096036|FG001|Treatment II Period|Withdrawal by Subject|0|||
23368661|NCT00264147|65096037|FG002|Treatment II Period|Withdrawal by Subject|0|||
23368662|NCT00264147|65096038|FG003|Treatment II Period|Withdrawal by Subject|0|||
23368663|NCT00264147|65096039|FG004|Treatment II Period|Withdrawal by Subject|3|||
23368664|NCT00264147|65096040|FG005|Treatment II Period|Withdrawal by Subject|2|||
23368665|NCT00264147|65096035|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368666|NCT00264147|65096036|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368667|NCT00264147|65096037|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368668|NCT00264147|65096038|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368669|NCT00264147|65096039|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368670|NCT00264147|65096040|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
23368671|NCT00269152|65096041|FG000|Overall Study|Adverse Event|9|||
23368672|NCT00269152|65096042|FG001|Overall Study|Adverse Event|3|||
23368673|NCT00269152|65096041|FG000|Overall Study|Withdrawal by Subject|7|||
23368674|NCT00269152|65096042|FG001|Overall Study|Withdrawal by Subject|3|||
23368675|NCT00269152|65096041|FG000|Overall Study|Physician Decision|2|||
23368676|NCT00269152|65096042|FG001|Overall Study|Physician Decision|3|||
23368677|NCT00269152|65096041|FG000|Overall Study|Protocol Violation|0|||
23368678|NCT00269152|65096042|FG001|Overall Study|Protocol Violation|1|||
23368679|NCT00863707|65096043|FG000|Overall Study|Randomized, but drug not received|4|||
23368680|NCT00863707|65096044|FG001|Overall Study|Randomized, but drug not received|3|||
23368681|NCT00735709|65096047|FG000|Overall Study|Adverse Event|2|||
23368682|NCT00735709|65096048|FG001|Overall Study|Adverse Event|3|||
23661973|NCT00698932|66148982|FG000|Overall Study|Safety reasons|0|||
23368683|NCT00735709|65096049|FG002|Overall Study|Adverse Event|1|||
23484586|NCT01347580|65518634|FG000|Overall Study|Lost to Follow-up|3|||
23602571|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602572|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602573|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602574|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602575|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602576|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602577|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602578|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602579|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23661974|NCT00698932|66148983|FG001|Overall Study|Safety reasons|2|||
23368684|NCT00735709|65096050|FG003|Overall Study|Adverse Event|5|||
23368685|NCT00735709|65096047|FG000|Overall Study|Lack of Efficacy|8|||
23602580|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602581|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602582|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602583|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602584|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368686|NCT00735709|65096048|FG001|Overall Study|Lack of Efficacy|4|||
23368687|NCT00735709|65096049|FG002|Overall Study|Lack of Efficacy|2|||
23368688|NCT00735709|65096050|FG003|Overall Study|Lack of Efficacy|3|||
23368689|NCT00735709|65096047|FG000|Overall Study|Noncompliance|0|||
23368690|NCT00735709|65096048|FG001|Overall Study|Noncompliance|0|||
23368691|NCT00735709|65096049|FG002|Overall Study|Noncompliance|1|||
23368692|NCT00735709|65096050|FG003|Overall Study|Noncompliance|0|||
23368693|NCT00735709|65096047|FG000|Overall Study|Protocol deviations|1|||
23368694|NCT00735709|65096048|FG001|Overall Study|Protocol deviations|2|||
23602585|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23661975|NCT00698932|66148982|FG000|Overall Study|Death|1|||
23661976|NCT00698932|66148983|FG001|Overall Study|Death|0|||
23661977|NCT02319668|66148989|FG000|Overall Study|Other (Not specified)|0|||
23661978|NCT02319668|66148990|FG001|Overall Study|Other (Not specified)|2|||
23661979|NCT02844920|66148991|FG000|Overall Study|Lost to Follow-up|2|||
23661980|NCT00682448|66148992|FG000|Overall Study|Adverse Event|1|||
23661981|NCT00682448|66148993|FG001|Overall Study|Adverse Event|2|||
23661982|NCT00682448|66148992|FG000|Overall Study|Lack of Efficacy|1|||
23661983|NCT00682448|66148993|FG001|Overall Study|Lack of Efficacy|0|||
23661984|NCT00682448|66148992|FG000|Overall Study|Lost to Follow-up|1|||
23661985|NCT00682448|66148993|FG001|Overall Study|Lost to Follow-up|3|||
23661986|NCT00682448|66148992|FG000|Overall Study|Pregnancy|0|||
23661987|NCT00682448|66148993|FG001|Overall Study|Pregnancy|1|||
23661988|NCT00682448|66148992|FG000|Overall Study|Withdrawal by Subject|2|||
23661989|NCT00682448|66148993|FG001|Overall Study|Withdrawal by Subject|0|||
23661990|NCT02023242|66148994|FG000|Overall Study|Lost to Follow-up|3|||
23661991|NCT02023242|66148995|FG001|Overall Study|Lost to Follow-up|1|||
23661992|NCT02023242|66148994|FG000|Overall Study|Death|0|||
23661993|NCT02023242|66148995|FG001|Overall Study|Death|1|||
23661994|NCT00310804|66148996|FG000|Overall Study|Lost to Follow-up|2|||
23661995|NCT00310804|66148997|FG001|Overall Study|Lost to Follow-up|0|||
23661996|NCT00310804|66148996|FG000|Overall Study|Withdrawal by Subject|3|||
23661997|NCT00310804|66148997|FG001|Overall Study|Withdrawal by Subject|0|||
23661998|NCT03104075|66149000|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
23661999|NCT03104075|66149001|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
23662000|NCT03184077|66149004|FG000|Overall Study|Lost to Follow-up|21|||
23662001|NCT03184077|66149005|FG001|Overall Study|Lost to Follow-up|21|||
23662002|NCT02819635|66149006|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
23662003|NCT02819635|66149007|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
23662004|NCT02819635|66149008|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
23662005|NCT02819635|66149009|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
23662006|NCT02819635|66149010|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
23662007|NCT02819635|66149011|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
23662008|NCT02819635|66149012|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
23368695|NCT00735709|65096049|FG002|Overall Study|Protocol deviations|1|||
23368696|NCT00735709|65096050|FG003|Overall Study|Protocol deviations|1|||
23368697|NCT00735709|65096047|FG000|Overall Study|Voluntary Withdrawal|1|||
23368698|NCT00735709|65096048|FG001|Overall Study|Voluntary Withdrawal|3|||
23368699|NCT00735709|65096049|FG002|Overall Study|Voluntary Withdrawal|5|||
23368700|NCT00735709|65096050|FG003|Overall Study|Voluntary Withdrawal|7|||
23368701|NCT00735709|65096047|FG000|Overall Study|Lost to Follow-up|0|||
23368702|NCT00735709|65096048|FG001|Overall Study|Lost to Follow-up|1|||
23368703|NCT00735709|65096049|FG002|Overall Study|Lost to Follow-up|1|||
23368704|NCT00735709|65096050|FG003|Overall Study|Lost to Follow-up|1|||
23368705|NCT00735709|65096047|FG000|Overall Study|Excluded medication|1|||
23368706|NCT00735709|65096048|FG001|Overall Study|Excluded medication|0|||
23368707|NCT00735709|65096049|FG002|Overall Study|Excluded medication|0|||
23368708|NCT00735709|65096050|FG003|Overall Study|Excluded medication|1|||
23368709|NCT01924533|65096053|FG000|Overall Study|Death|181|||
23368710|NCT01924533|65096054|FG001|Overall Study|Death|200|||
23368711|NCT01924533|65096053|FG000|Overall Study|Lost to Follow-up|0|||
23368712|NCT01924533|65096054|FG001|Overall Study|Lost to Follow-up|1|||
23368713|NCT01924533|65096053|FG000|Overall Study|Withdrawal by Subject|7|||
23368714|NCT01924533|65096054|FG001|Overall Study|Withdrawal by Subject|3|||
23368715|NCT01924533|65096053|FG000|Overall Study|Other Eligibility criteria|1|||
23368716|NCT01924533|65096054|FG001|Overall Study|Other Eligibility criteria|1|||
23368717|NCT01386606|65096057|FG000|Overall Study|Adverse Event|0|||
23368718|NCT01386606|65096058|FG001|Overall Study|Adverse Event|1|||
23368719|NCT01386606|65096059|FG002|Overall Study|Adverse Event|0|||
23368720|NCT01386606|65096060|FG003|Overall Study|Adverse Event|0|||
23368721|NCT01386606|65096057|FG000|Overall Study|Withdrawal by Subject|0|||
23368722|NCT01386606|65096058|FG001|Overall Study|Withdrawal by Subject|1|||
23368723|NCT01386606|65096059|FG002|Overall Study|Withdrawal by Subject|1|||
23368724|NCT01386606|65096060|FG003|Overall Study|Withdrawal by Subject|0|||
23368725|NCT01386606|65096057|FG000|Overall Study|Protocol Violation|1|||
23368726|NCT01386606|65096058|FG001|Overall Study|Protocol Violation|0|||
23368727|NCT01386606|65096059|FG002|Overall Study|Protocol Violation|1|||
23368728|NCT01386606|65096060|FG003|Overall Study|Protocol Violation|1|||
23368729|NCT01386606|65096057|FG000|Overall Study|Lost to Follow-up|2|||
23368730|NCT01386606|65096058|FG001|Overall Study|Lost to Follow-up|0|||
23368731|NCT01386606|65096059|FG002|Overall Study|Lost to Follow-up|0|||
23368732|NCT01386606|65096060|FG003|Overall Study|Lost to Follow-up|0|||
23368733|NCT01386606|65096057|FG000|Overall Study|Subject incarcerated|0|||
23368734|NCT01386606|65096058|FG001|Overall Study|Subject incarcerated|1|||
23368735|NCT01386606|65096059|FG002|Overall Study|Subject incarcerated|0|||
23368736|NCT01386606|65096060|FG003|Overall Study|Subject incarcerated|0|||
23368737|NCT01386606|65096057|FG000|Overall Study|Unable to draw PK|1|||
23368738|NCT01386606|65096058|FG001|Overall Study|Unable to draw PK|0|||
23368739|NCT01386606|65096059|FG002|Overall Study|Unable to draw PK|0|||
23368740|NCT01386606|65096060|FG003|Overall Study|Unable to draw PK|0|||
23368741|NCT01386606|65096057|FG000|Overall Study|T levels too high|0|||
23368742|NCT01386606|65096058|FG001|Overall Study|T levels too high|1|||
23368743|NCT01386606|65096059|FG002|Overall Study|T levels too high|1|||
23368744|NCT01386606|65096060|FG003|Overall Study|T levels too high|0|||
23368745|NCT00830765|65096061|FG000|Overall Study|Protocol Violation|3|||
23368746|NCT00830765|65096062|FG001|Overall Study|Protocol Violation|2|||
23368747|NCT03903172|65096064|FG000|Overall Study|screen fail|4|||
23368748|NCT03903172|65096065|FG001|Overall Study|screen fail|1|||
23368749|NCT00838097|65096066|FG000|Overall Study|Ineligibility determined|6|||
23368750|NCT00838097|65096066|FG000|Overall Study|Adverse Event|2|||
23368751|NCT00838097|65096066|FG000|Overall Study|Withdrawal by Subject|3|||
23368752|NCT00838097|65096066|FG000|Overall Study|Requirement for alternative therapy|2|||
23368753|NCT00838097|65096066|FG000|Overall Study|Physician Decision|4|||
23368754|NCT00838097|65096066|FG000|Overall Study|Lost to Follow-up|11|||
23368755|NCT00838097|65096066|FG000|Overall Study|Death|6|||
23368756|NCT00838097|65096066|FG000|Overall Study|Protocol-specified criteria|142|||
23368757|NCT03644017|65096067|FG000|Overall Study|Access Abandonment|5|||
23368758|NCT03644017|65096067|FG000|Overall Study|Kidney Transplant|2|||
23368759|NCT03316586|65096070|FG000|Overall Study|Adverse Event|2|||
23484587|NCT01347580|65518635|FG001|Overall Study|Lost to Follow-up|1|||
23484588|NCT01347580|65518634|FG000|Overall Study|Had other reason|9|||
23484589|NCT01347580|65518635|FG001|Overall Study|Had other reason|6|||
23484590|NCT02889562|65518638|FG000|Overall Study|Physician Decision|0|||
23484591|NCT02889562|65518639|FG001|Overall Study|Physician Decision|1|||
23484592|NCT02889562|65518638|FG000|Overall Study|Withdrawal by Subject|0|||
23484593|NCT02889562|65518639|FG001|Overall Study|Withdrawal by Subject|1|||
23484594|NCT02829944|65518645|FG000|Overall Study|Physician Decision|0|||
23484595|NCT02829944|65518646|FG001|Overall Study|Physician Decision|1|||
23484596|NCT02829944|65518645|FG000|Overall Study|Screen Failure|2|||
23484597|NCT02829944|65518646|FG001|Overall Study|Screen Failure|2|||
23484598|NCT02829944|65518645|FG000|Overall Study|Inadequate Neuraxial Block|1|||
23484599|NCT02829944|65518646|FG001|Overall Study|Inadequate Neuraxial Block|1|||
23484600|NCT02829944|65518645|FG000|Overall Study|Withdrawal by Subject|2|||
23484601|NCT02829944|65518646|FG001|Overall Study|Withdrawal by Subject|1|||
23602586|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368760|NCT03316586|65096070|FG000|Overall Study|Physician Decision|3|||
23368761|NCT03316586|65096070|FG000|Overall Study|Lack of Efficacy|10|||
23368762|NCT03316586|65096070|FG000|Overall Study|still on treatment|1|||
23368763|NCT03316586|65096070|FG000|Overall Study|Patient needed radiation therapy|1|||
23484602|NCT02829944|65518645|FG000|Overall Study|Catheter Displacement|1|||
23368764|NCT03316586|65096070|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
23368765|NCT03234465|65096071|FG000|Overall Study|Adverse Event|4|||
23368766|NCT03234465|65096072|FG001|Overall Study|Adverse Event|2|||
23368767|NCT03234465|65096071|FG000|Overall Study|Death|0|||
23368768|NCT03234465|65096072|FG001|Overall Study|Death|1|||
23368769|NCT03234465|65096071|FG000|Overall Study|Lost to Follow-up|1|||
23368770|NCT03234465|65096072|FG001|Overall Study|Lost to Follow-up|1|||
23368771|NCT03234465|65096071|FG000|Overall Study|Withdrawal by Subject|12|||
23368772|NCT03234465|65096072|FG001|Overall Study|Withdrawal by Subject|27|||
23368773|NCT03234465|65096071|FG000|Overall Study|Symptomatic deterioration|0|||
23368774|NCT03234465|65096072|FG001|Overall Study|Symptomatic deterioration|1|||
23368775|NCT03234465|65096071|FG000|Overall Study|Non-compliance|2|||
23368776|NCT03234465|65096072|FG001|Overall Study|Non-compliance|0|||
23368777|NCT03234465|65096071|FG000|Overall Study|Other|14|||
23368778|NCT03234465|65096072|FG001|Overall Study|Other|8|||
23368779|NCT01775670|65096075|FG000|Overall Study|Lost to Follow-up|1|||
23368780|NCT01775670|65096076|FG001|Overall Study|Lost to Follow-up|1|||
23368781|NCT03498521|65096077|FG000|Overall Study|Death|191|||
23368782|NCT03498521|65096078|FG001|Overall Study|Death|64|||
23368783|NCT03498521|65096079|FG002|Overall Study|Death|72|||
23368784|NCT03498521|65096077|FG000|Overall Study|Exclusion criteria|1|||
23368785|NCT03498521|65096078|FG001|Overall Study|Exclusion criteria|0|||
23368786|NCT03498521|65096079|FG002|Overall Study|Exclusion criteria|0|||
23368787|NCT03498521|65096077|FG000|Overall Study|Lost to Follow-up|3|||
23662009|NCT02819635|66149013|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23662010|NCT02819635|66149014|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23484603|NCT02829944|65518646|FG001|Overall Study|Catheter Displacement|0|||
23484604|NCT02829944|65518645|FG000|Overall Study|Catheter broke|0|||
23484605|NCT02829944|65518646|FG001|Overall Study|Catheter broke|1|||
23484606|NCT02829944|65518645|FG000|Overall Study|Staff unavailable|0|||
23484607|NCT02829944|65518646|FG001|Overall Study|Staff unavailable|1|||
23484608|NCT00371761|65518647|FG000|Overall Study|Adverse Event|1|||
23484609|NCT00371761|65518648|FG001|Overall Study|Adverse Event|1|||
23484610|NCT00371761|65518647|FG000|Overall Study|Withdrawal by Subject|1|||
23484611|NCT00371761|65518648|FG001|Overall Study|Withdrawal by Subject|3|||
23484612|NCT00371761|65518647|FG000|Overall Study|Investigator Judgment|2|||
23484613|NCT00371761|65518648|FG001|Overall Study|Investigator Judgment|3|||
23484614|NCT00371761|65518647|FG000|Overall Study|Study termination|4|||
23484615|NCT00371761|65518648|FG001|Overall Study|Study termination|3|||
23484616|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
23484617|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
23484618|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
23484619|NCT01298193|65518649|FG000|Efficacy Phase (Second Cycle)|Death|1|||
23484620|NCT01028378|65518650|FG000|Overall Study|Lost to Follow-up|12|||
23484621|NCT01028378|65518650|FG000|Overall Study|Withdrawal by Subject|1|||
23484622|NCT01028378|65518650|FG000|Overall Study|Adminstrative Reasons|4|||
23484623|NCT00249288|65518655|FG000|Overall Study|Lost to Follow-up|3|||
23484624|NCT00249288|65518656|FG001|Overall Study|Lost to Follow-up|3|||
23484625|NCT00249288|65518655|FG000|Overall Study|Withdrawal by Subject|2|||
23602587|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602588|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602589|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602590|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602591|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602592|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602593|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
23602594|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
23602595|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
23602596|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602597|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602598|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602599|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602600|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602601|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23807545|NCT01641133|66672794|FG002|Overall Study|Withdrawal by Subject|3|||
23807546|NCT01641133|66672792|FG000|Overall Study|Lost to Follow-up|0|||
23484626|NCT00249288|65518656|FG001|Overall Study|Withdrawal by Subject|2|||
23602602|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368788|NCT03498521|65096078|FG001|Overall Study|Lost to Follow-up|3|||
23368789|NCT03498521|65096079|FG002|Overall Study|Lost to Follow-up|3|||
23368790|NCT03498521|65096077|FG000|Overall Study|No profile due to technical failure|1|||
23368791|NCT03498521|65096078|FG001|Overall Study|No profile due to technical failure|0|||
23368792|NCT03498521|65096079|FG002|Overall Study|No profile due to technical failure|0|||
23484627|NCT01439347|65518659|FG000|Overall Study|Death|10|||
23602603|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602604|NCT00890591|65934085|FG000|Overall Study|Lack of Efficacy|20|||
23662011|NCT02819635|66149015|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23662012|NCT02819635|66149016|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23662013|NCT02819635|66149017|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23662014|NCT02819635|66149006|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662015|NCT02819635|66149007|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662016|NCT02819635|66149008|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662017|NCT02819635|66149009|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662018|NCT02819635|66149010|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
23662019|NCT02819635|66149011|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
23662020|NCT02819635|66149012|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
23662021|NCT02819635|66149013|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662022|NCT02819635|66149014|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662023|NCT02819635|66149015|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662024|NCT02819635|66149016|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662025|NCT02819635|66149017|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23662026|NCT02819635|66149006|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662027|NCT02819635|66149007|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662028|NCT02819635|66149008|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662029|NCT02819635|66149009|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662030|NCT02819635|66149010|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662031|NCT02819635|66149011|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
23662032|NCT02819635|66149012|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
23662033|NCT02819635|66149013|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662034|NCT02819635|66149014|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662035|NCT02819635|66149015|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662036|NCT02819635|66149016|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662037|NCT02819635|66149017|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23662038|NCT02819635|66149006|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662039|NCT02819635|66149007|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662040|NCT02819635|66149008|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662041|NCT02819635|66149009|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662042|NCT02819635|66149010|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662043|NCT02819635|66149011|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662044|NCT02819635|66149012|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
23662045|NCT02819635|66149013|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662046|NCT02819635|66149014|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662047|NCT02819635|66149015|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662048|NCT02819635|66149016|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662049|NCT02819635|66149017|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23662050|NCT02819635|66149006|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
23662051|NCT02819635|66149007|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
23662052|NCT02819635|66149008|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
23662053|NCT02819635|66149009|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
23662054|NCT02819635|66149010|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
23662055|NCT02819635|66149011|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
23662056|NCT02819635|66149012|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
23662057|NCT02819635|66149013|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23662058|NCT02819635|66149014|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23662059|NCT02819635|66149015|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23662060|NCT02819635|66149016|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23662061|NCT02819635|66149017|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23602605|NCT04009291|65934086|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602606|NCT04009291|65934087|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602607|NCT04009291|65934088|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602608|NCT04009291|65934089|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602609|NCT04009291|65934090|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
23602610|NCT04009291|65934086|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23602611|NCT04009291|65934087|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23602612|NCT04009291|65934088|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23602613|NCT04009291|65934089|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23662062|NCT02819635|66149006|FG000|Substudy 2, Part 2|Adverse Event|0|||
23662063|NCT02819635|66149007|FG001|Substudy 2, Part 2|Adverse Event|0|||
23662064|NCT02819635|66149008|FG002|Substudy 2, Part 2|Adverse Event|0|||
23662065|NCT02819635|66149009|FG003|Substudy 2, Part 2|Adverse Event|0|||
23662066|NCT02819635|66149010|FG004|Substudy 2, Part 2|Adverse Event|0|||
23662067|NCT02819635|66149011|FG005|Substudy 2, Part 2|Adverse Event|4|||
23662068|NCT02819635|66149012|FG006|Substudy 2, Part 2|Adverse Event|0|||
23662069|NCT02819635|66149013|FG007|Substudy 2, Part 2|Adverse Event|0|||
23662070|NCT02819635|66149014|FG008|Substudy 2, Part 2|Adverse Event|0|||
23662071|NCT02819635|66149015|FG009|Substudy 2, Part 2|Adverse Event|0|||
23662072|NCT02819635|66149016|FG010|Substudy 2, Part 2|Adverse Event|0|||
23662073|NCT02819635|66149017|FG011|Substudy 2, Part 2|Adverse Event|0|||
23662074|NCT02819635|66149006|FG000|Substudy 2, Part 2|Withdrew consent|0|||
23662075|NCT02819635|66149007|FG001|Substudy 2, Part 2|Withdrew consent|0|||
23368793|NCT03498521|65096077|FG000|Overall Study|Physician Decision|0|||
23368794|NCT03498521|65096078|FG001|Overall Study|Physician Decision|1|||
23368795|NCT03498521|65096079|FG002|Overall Study|Physician Decision|0|||
23368796|NCT03498521|65096077|FG000|Overall Study|Withdrawal by Subject|9|||
23368797|NCT03498521|65096078|FG001|Overall Study|Withdrawal by Subject|6|||
23368798|NCT03498521|65096079|FG002|Overall Study|Withdrawal by Subject|2|||
23368799|NCT03498521|65096077|FG000|Overall Study|Study ongoing|121|||
23368800|NCT03498521|65096078|FG001|Overall Study|Study ongoing|36|||
23368801|NCT03498521|65096079|FG002|Overall Study|Study ongoing|15|||
23368802|NCT03575702|65096084|FG000|Overall Study|Withdrawal by Subject|1|||
23368803|NCT03575702|65096085|FG001|Overall Study|Withdrawal by Subject|1|||
23368804|NCT03575702|65096084|FG000|Overall Study|Lost to Follow-up|1|||
23602614|NCT04009291|65934090|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
23602615|NCT04060212|65934092|FG000|Overall Study|Withdrawal by Subject|7|||
23602616|NCT03035942|65934095|FG000|Overall Study|Adverse Event|8|||
23602617|NCT03035942|65934096|FG001|Overall Study|Adverse Event|4|||
23602618|NCT03035942|65934097|FG002|Overall Study|Adverse Event|5|||
23602619|NCT02347332|65934100|FG000|Overall Study|Not treated|5|||
23602620|NCT02347332|65934101|FG001|Overall Study|Not treated|2|||
23602621|NCT02347332|65934100|FG000|Overall Study|Progressive disease|141|||
23602622|NCT02347332|65934101|FG001|Overall Study|Progressive disease|159|||
23602623|NCT02347332|65934100|FG000|Overall Study|Adverse Event|50|||
23602624|NCT02347332|65934101|FG001|Overall Study|Adverse Event|41|||
23602625|NCT02347332|65934100|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
23602626|NCT02347332|65934101|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
23602627|NCT02347332|65934100|FG000|Overall Study|Protocol Violation|1|||
23602628|NCT02347332|65934101|FG001|Overall Study|Protocol Violation|1|||
23602629|NCT02347332|65934100|FG000|Overall Study|Lost to Follow-up|2|||
23602630|NCT02347332|65934101|FG001|Overall Study|Lost to Follow-up|1|||
23602631|NCT02347332|65934100|FG000|Overall Study|Physician Decision|4|||
23602632|NCT02347332|65934101|FG001|Overall Study|Physician Decision|3|||
23602633|NCT02347332|65934100|FG000|Overall Study|Withdrawal by Subject|20|||
23602634|NCT02347332|65934101|FG001|Overall Study|Withdrawal by Subject|14|||
23602635|NCT02347332|65934100|FG000|Overall Study|Protocol requirement|1|||
23602636|NCT02347332|65934101|FG001|Overall Study|Protocol requirement|1|||
23602637|NCT02347332|65934100|FG000|Overall Study|Switch Post-Trial program|0|||
23602638|NCT02347332|65934101|FG001|Overall Study|Switch Post-Trial program|1|||
23602639|NCT00686595|65934104|FG000|Overall Study|Adverse Event|3|||
23602640|NCT00686595|65934104|FG000|Overall Study|Protocol Violation|1|||
23602641|NCT00686595|65934104|FG000|Overall Study|Lost to Follow-up|1|||
23602642|NCT00686595|65934104|FG000|Overall Study|Lack of Efficacy|1|||
23602643|NCT00686595|65934104|FG000|Overall Study|Poor Compliance|1|||
23602644|NCT03184987|65934105|FG000|Overall Study|Withdrawal by Subject|0|||
23602645|NCT03184987|65934106|FG001|Overall Study|Withdrawal by Subject|1|||
23602646|NCT03184987|65934107|FG002|Overall Study|Withdrawal by Subject|2|||
23602647|NCT03184987|65934105|FG000|Overall Study|Physician Decision|0|||
23602648|NCT03184987|65934106|FG001|Overall Study|Physician Decision|0|||
23602649|NCT03184987|65934107|FG002|Overall Study|Physician Decision|1|||
23602650|NCT03184987|65934105|FG000|Overall Study|Adverse Event|1|||
23602651|NCT03184987|65934106|FG001|Overall Study|Adverse Event|0|||
23602652|NCT03184987|65934107|FG002|Overall Study|Adverse Event|1|||
23602653|NCT00372775|65934108|FG000|Overall Study|Adverse Event|8|||
23602654|NCT00372775|65934108|FG000|Overall Study|Death|15|||
23602655|NCT00372775|65934108|FG000|Overall Study|Objective progression or relapse|30|||
23662076|NCT02819635|66149008|FG002|Substudy 2, Part 2|Withdrew consent|0|||
23368805|NCT03575702|65096085|FG001|Overall Study|Lost to Follow-up|2|||
23602656|NCT00372775|65934108|FG000|Overall Study|Global deterioration of health status|6|||
23602657|NCT00372775|65934108|FG000|Overall Study|Withdrawal by Subject|1|||
23602658|NCT00372775|65934108|FG000|Overall Study|Other|1|||
23602659|NCT00372775|65934108|FG000|Overall Study|Not Treated|2|||
23602660|NCT00655499|65934109|FG000|Overall Study|not eligible|4|||
23602661|NCT00722046|65934110|FG000|Overall Study|Adverse Event|0|||
23602662|NCT00722046|65934111|FG001|Overall Study|Adverse Event|1|||
23602663|NCT00722046|65934112|FG002|Overall Study|Adverse Event|2|||
23602664|NCT00722046|65934113|FG003|Overall Study|Adverse Event|1|||
23662077|NCT02819635|66149009|FG003|Substudy 2, Part 2|Withdrew consent|0|||
23662078|NCT02819635|66149010|FG004|Substudy 2, Part 2|Withdrew consent|0|||
23662079|NCT02819635|66149011|FG005|Substudy 2, Part 2|Withdrew consent|3|||
23662080|NCT02819635|66149012|FG006|Substudy 2, Part 2|Withdrew consent|1|||
23662081|NCT02819635|66149013|FG007|Substudy 2, Part 2|Withdrew consent|0|||
23602665|NCT00722046|65934114|FG004|Overall Study|Adverse Event|2|||
23602666|NCT00722046|65934115|FG005|Overall Study|Adverse Event|1|||
23602667|NCT00722046|65934116|FG006|Overall Study|Adverse Event|0|||
23602668|NCT00722046|65934110|FG000|Overall Study|Death|0|||
23602669|NCT00722046|65934111|FG001|Overall Study|Death|1|||
23602670|NCT00722046|65934112|FG002|Overall Study|Death|0|||
23602671|NCT00722046|65934113|FG003|Overall Study|Death|0|||
23602672|NCT00722046|65934114|FG004|Overall Study|Death|0|||
23602673|NCT00722046|65934115|FG005|Overall Study|Death|0|||
23602674|NCT00722046|65934116|FG006|Overall Study|Death|2|||
23602675|NCT00722046|65934110|FG000|Overall Study|Protocol Violation|1|||
23602676|NCT00722046|65934111|FG001|Overall Study|Protocol Violation|0|||
23602677|NCT00722046|65934112|FG002|Overall Study|Protocol Violation|0|||
23602678|NCT00722046|65934113|FG003|Overall Study|Protocol Violation|0|||
23602679|NCT00722046|65934114|FG004|Overall Study|Protocol Violation|0|||
23602680|NCT00722046|65934115|FG005|Overall Study|Protocol Violation|1|||
23602681|NCT00722046|65934116|FG006|Overall Study|Protocol Violation|0|||
23602682|NCT00722046|65934110|FG000|Overall Study|Withdrawal by Subject|3|||
23602683|NCT00722046|65934111|FG001|Overall Study|Withdrawal by Subject|3|||
23602684|NCT00722046|65934112|FG002|Overall Study|Withdrawal by Subject|4|||
23602685|NCT00722046|65934113|FG003|Overall Study|Withdrawal by Subject|4|||
23662082|NCT02819635|66149014|FG008|Substudy 2, Part 2|Withdrew consent|0|||
23662083|NCT02819635|66149015|FG009|Substudy 2, Part 2|Withdrew consent|0|||
23662084|NCT02819635|66149016|FG010|Substudy 2, Part 2|Withdrew consent|0|||
23662085|NCT02819635|66149017|FG011|Substudy 2, Part 2|Withdrew consent|0|||
23662086|NCT02819635|66149006|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
23662087|NCT02819635|66149007|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
23662088|NCT02819635|66149008|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
23368806|NCT03575702|65096084|FG000|Overall Study|Protocol Violation|0|||
23602686|NCT00722046|65934114|FG004|Overall Study|Withdrawal by Subject|4|||
23602687|NCT00722046|65934115|FG005|Overall Study|Withdrawal by Subject|7|||
23602688|NCT00722046|65934116|FG006|Overall Study|Withdrawal by Subject|3|||
23602689|NCT00722046|65934110|FG000|Overall Study|Randomized, but not treated|1|||
23602690|NCT00722046|65934111|FG001|Overall Study|Randomized, but not treated|1|||
23602691|NCT00722046|65934112|FG002|Overall Study|Randomized, but not treated|0|||
23602692|NCT00722046|65934113|FG003|Overall Study|Randomized, but not treated|2|||
23602693|NCT00722046|65934114|FG004|Overall Study|Randomized, but not treated|0|||
23602694|NCT00722046|65934115|FG005|Overall Study|Randomized, but not treated|0|||
23602695|NCT00722046|65934116|FG006|Overall Study|Randomized, but not treated|0|||
23602696|NCT00722046|65934110|FG000|Overall Study|Other|0|||
23602697|NCT00722046|65934111|FG001|Overall Study|Other|0|||
23602698|NCT00722046|65934112|FG002|Overall Study|Other|1|||
23602699|NCT00722046|65934113|FG003|Overall Study|Other|1|||
23602700|NCT00722046|65934114|FG004|Overall Study|Other|3|||
23602701|NCT00722046|65934115|FG005|Overall Study|Other|2|||
23602702|NCT00722046|65934116|FG006|Overall Study|Other|1|||
23602703|NCT00309166|65934117|FG000|Overall Study|Adverse event, non-fatal|1|||
23602704|NCT00309166|65934118|FG001|Overall Study|Adverse event, non-fatal|0|||
23662089|NCT02819635|66149009|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
23662090|NCT02819635|66149010|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
23368807|NCT03575702|65096085|FG001|Overall Study|Protocol Violation|1|||
23368808|NCT03575702|65096084|FG000|Overall Study|Patient non compliance|4|||
23662091|NCT02819635|66149011|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
23368809|NCT03575702|65096085|FG001|Overall Study|Patient non compliance|0|||
23368810|NCT02154139|65096087|FG000|Overall Study|Injection not administered|2|||
23602705|NCT00309166|65934117|FG000|Overall Study|Withdrawal by Subject|4|||
23602706|NCT00309166|65934118|FG001|Overall Study|Withdrawal by Subject|3|||
23602707|NCT02310581|65934119|FG000|Overall Study|Adverse Event|1|||
23602708|NCT02310581|65934120|FG001|Overall Study|Adverse Event|1|||
23602709|NCT02310581|65934121|FG002|Overall Study|Adverse Event|1|||
23602710|NCT02310581|65934122|FG003|Overall Study|Adverse Event|0|||
23602711|NCT02310581|65934119|FG000|Overall Study|Withdrawal by Subject|2|||
23602712|NCT02310581|65934120|FG001|Overall Study|Withdrawal by Subject|1|||
23602713|NCT02310581|65934121|FG002|Overall Study|Withdrawal by Subject|0|||
23484628|NCT01439347|65518660|FG001|Overall Study|Death|9|||
23484629|NCT01439347|65518659|FG000|Overall Study|Withdrawal by Subject|0|||
23484630|NCT01439347|65518660|FG001|Overall Study|Withdrawal by Subject|1|||
23484631|NCT01439347|65518659|FG000|Overall Study|Physician Decision|1|||
23484632|NCT01439347|65518660|FG001|Overall Study|Physician Decision|0|||
23484633|NCT01439347|65518659|FG000|Overall Study|Sponsor Terminated Study|2|||
23484634|NCT01439347|65518660|FG001|Overall Study|Sponsor Terminated Study|3|||
23484635|NCT01858636|65518661|FG000|Overall Study|No Device Deployment Attempted|24|||
23484636|NCT01858636|65518661|FG000|Overall Study|Physician Decision|1|||
23484637|NCT01858636|65518661|FG000|Overall Study|Death|1|||
23484638|NCT01858636|65518661|FG000|Overall Study|Lost to Follow-up|1|||
23484639|NCT01858636|65518661|FG000|Overall Study|Withdrawal by Subject|1|||
23484640|NCT01268683|65518666|FG000|Overall Study|Lost to Follow-up|1|||
23484641|NCT01268683|65518666|FG000|Overall Study|Death|1|||
23484642|NCT03945175|65518667|FG000|Overall Study|Did not meet inclusion criteria|31|||
23484643|NCT03945175|65518667|FG000|Overall Study|Withdrew consent|2|||
23484644|NCT03945175|65518667|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
23484645|NCT03945175|65518667|FG000|Overall Study|Early termination during Mydayis treatment|1|||
23484646|NCT02730208|65518668|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23484647|NCT02730208|65518669|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
23484648|NCT05342532|65518670|FG000|Overall Study|Adverse Event|5|||
23484649|NCT05342532|65518671|FG001|Overall Study|Adverse Event|20|||
23484650|NCT05342532|65518670|FG000|Overall Study|Lost to Follow-up|10|||
23484651|NCT05342532|65518671|FG001|Overall Study|Lost to Follow-up|15|||
23484652|NCT00740051|65518672|FG000|Overall Study|Lack of Efficacy|2|||
23484653|NCT00740051|65518673|FG001|Overall Study|Lack of Efficacy|5|||
23484654|NCT00740051|65518672|FG000|Overall Study|Adverse Event|1|||
23484655|NCT00740051|65518673|FG001|Overall Study|Adverse Event|4|||
23484656|NCT00740051|65518672|FG000|Overall Study|Protocol Violation|2|||
23484657|NCT00740051|65518673|FG001|Overall Study|Protocol Violation|6|||
23484658|NCT00740051|65518672|FG000|Overall Study|Lost to Follow-up|3|||
23484659|NCT00740051|65518673|FG001|Overall Study|Lost to Follow-up|8|||
23484660|NCT00740051|65518672|FG000|Overall Study|Withdrawal by Subject|6|||
23484661|NCT00740051|65518673|FG001|Overall Study|Withdrawal by Subject|8|||
23484662|NCT00740051|65518672|FG000|Overall Study|Other reason (not specified)|4|||
23484663|NCT00740051|65518673|FG001|Overall Study|Other reason (not specified)|1|||
23484664|NCT00772070|65518674|FG000|Overall Study|Lost to Follow-up|0|||
23484665|NCT00772070|65518675|FG001|Overall Study|Lost to Follow-up|8|||
23484666|NCT00772070|65518674|FG000|Overall Study|Withdrawal by Subject|0|||
23484667|NCT00772070|65518675|FG001|Overall Study|Withdrawal by Subject|2|||
23484668|NCT00772070|65518674|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
23484669|NCT00772070|65518675|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
23484670|NCT00245583|65518677|FG000|Overall Study|Lost to Follow-up|1|||
23484671|NCT00245583|65518678|FG001|Overall Study|Lost to Follow-up|5|||
23484672|NCT00245583|65518677|FG000|Overall Study|Adverse Event|2|||
23484673|NCT00245583|65518678|FG001|Overall Study|Adverse Event|1|||
23484674|NCT00245583|65518677|FG000|Overall Study|Lack of Efficacy|1|||
23368811|NCT02154139|65096087|FG000|Overall Study|Other|2|||
23368812|NCT02154139|65096087|FG000|Overall Study|Investigator transferred|3|||
23484675|NCT00245583|65518678|FG001|Overall Study|Lack of Efficacy|0|||
23484676|NCT00245583|65518677|FG000|Overall Study|Withdrawal by Subject|2|||
23484677|NCT00245583|65518678|FG001|Overall Study|Withdrawal by Subject|3|||
23484678|NCT02775903|65518679|FG000|Overall Study|Death|7|||
23484679|NCT02775903|65518680|FG001|Overall Study|Death|11|||
23484680|NCT02775903|65518681|FG002|Overall Study|Death|12|||
23484681|NCT02775903|65518682|FG003|Overall Study|Death|11|||
23484682|NCT02775903|65518679|FG000|Overall Study|Adverse Event|0|||
23484683|NCT02775903|65518680|FG001|Overall Study|Adverse Event|1|||
23484684|NCT02775903|65518681|FG002|Overall Study|Adverse Event|12|||
23484685|NCT02775903|65518682|FG003|Overall Study|Adverse Event|3|||
23484686|NCT02775903|65518679|FG000|Overall Study|Progressive disease|15|||
23484687|NCT02775903|65518680|FG001|Overall Study|Progressive disease|14|||
23484688|NCT02775903|65518681|FG002|Overall Study|Progressive disease|30|||
23484689|NCT02775903|65518682|FG003|Overall Study|Progressive disease|20|||
23484690|NCT02775903|65518679|FG000|Overall Study|Lack of Efficacy|2|||
23484691|NCT02775903|65518680|FG001|Overall Study|Lack of Efficacy|2|||
23484692|NCT02775903|65518681|FG002|Overall Study|Lack of Efficacy|2|||
23484693|NCT02775903|65518682|FG003|Overall Study|Lack of Efficacy|6|||
23484694|NCT02775903|65518679|FG000|Overall Study|Withdrawal by Subject|7|||
23484695|NCT02775903|65518680|FG001|Overall Study|Withdrawal by Subject|5|||
23484696|NCT02775903|65518681|FG002|Overall Study|Withdrawal by Subject|5|||
23484697|NCT02775903|65518682|FG003|Overall Study|Withdrawal by Subject|8|||
23484698|NCT02775903|65518679|FG000|Overall Study|Other reasons|7|||
23484699|NCT02775903|65518680|FG001|Overall Study|Other reasons|8|||
23484700|NCT02775903|65518681|FG002|Overall Study|Other reasons|2|||
23484701|NCT02775903|65518682|FG003|Overall Study|Other reasons|12|||
23484702|NCT02314143|65518683|FG000|Overall Study|Adverse Event|0|||
23484703|NCT02314143|65518684|FG001|Overall Study|Adverse Event|6|||
23484704|NCT02314143|65518685|FG002|Overall Study|Adverse Event|4|||
23484705|NCT02314143|65518683|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
23484706|NCT02314143|65518684|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
23484707|NCT02314143|65518685|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
23484708|NCT02314143|65518683|FG000|Overall Study|Physician Decision|2|||
23484709|NCT02314143|65518684|FG001|Overall Study|Physician Decision|1|||
23484710|NCT02314143|65518685|FG002|Overall Study|Physician Decision|0|||
23484711|NCT02314143|65518683|FG000|Overall Study|Withdrawal by Subject|1|||
23484712|NCT02314143|65518684|FG001|Overall Study|Withdrawal by Subject|0|||
23602714|NCT02310581|65934122|FG003|Overall Study|Withdrawal by Subject|1|||
23602715|NCT00571649|65934123|FG000|Treatment Period|Adverse Event|438|||
23484713|NCT02314143|65518685|FG002|Overall Study|Withdrawal by Subject|1|||
23484714|NCT01484938|65518686|FG000|Overall Study|Adverse Event|2|||
23484715|NCT01484938|65518686|FG000|Overall Study|Lost to Follow-up|1|||
23484716|NCT01484938|65518686|FG000|Overall Study|Noncompliance|1|||
23484717|NCT01574079|65518687|FG000|Overall Study|Physician Decision|0|||
23484718|NCT01574079|65518688|FG001|Overall Study|Physician Decision|2|||
23602716|NCT00571649|65934124|FG001|Treatment Period|Adverse Event|385|||
23484719|NCT01574079|65518687|FG000|Overall Study|Lost to Follow-up|1|||
23484720|NCT01574079|65518688|FG001|Overall Study|Lost to Follow-up|0|||
23484721|NCT03718299|65518689|FG000|Overall Study|Adverse Event|1|||
23484722|NCT03718299|65518689|FG000|Overall Study|Withdrawal by Subject|6|||
23484723|NCT03718299|65518689|FG000|Overall Study|Physician Decision|2|||
23484724|NCT03718299|65518689|FG000|Overall Study|Lost to Follow-up|1|||
23484725|NCT04352127|65518697|FG000|Overall Study|Unable to obtain readings|4|||
23484726|NCT04352127|65518698|FG001|Overall Study|Unable to obtain readings|1|||
23484727|NCT01011478|65518701|FG000|Overall Study|No follow up data|12|||
23484728|NCT01011478|65518702|FG001|Overall Study|No follow up data|7|||
23484729|NCT02011893|65518704|FG000|Enrollment to Randomization|Adverse Event|2|||
23484730|NCT02011893|65518705|FG001|Enrollment to Randomization|Adverse Event|0|||
23484731|NCT02011893|65518706|FG002|Enrollment to Randomization|Adverse Event|0|||
23484732|NCT02011893|65518704|FG000|Enrollment to Randomization|Physician Decision|10|||
23484733|NCT02011893|65518705|FG001|Enrollment to Randomization|Physician Decision|0|||
23484734|NCT02011893|65518706|FG002|Enrollment to Randomization|Physician Decision|0|||
23484735|NCT02011893|65518704|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
23484736|NCT02011893|65518705|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
23484737|NCT02011893|65518706|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
23484738|NCT02011893|65518704|FG000|Enrollment to Randomization|Screening Failure|29|||
23484739|NCT02011893|65518705|FG001|Enrollment to Randomization|Screening Failure|0|||
23484740|NCT02011893|65518706|FG002|Enrollment to Randomization|Screening Failure|0|||
23484741|NCT02011893|65518704|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
23484742|NCT02011893|65518705|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
23484743|NCT02011893|65518706|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
23484744|NCT02011893|65518704|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
23484745|NCT02011893|65518705|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
23484746|NCT02011893|65518706|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
23484747|NCT02011893|65518704|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
23484748|NCT02011893|65518705|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
23484749|NCT02011893|65518706|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
23484750|NCT02011893|65518704|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
23484751|NCT02011893|65518705|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
23484752|NCT02011893|65518706|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
23484753|NCT02011893|65518704|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
23484754|NCT02011893|65518705|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
23484755|NCT02011893|65518706|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
23484756|NCT04271280|65518707|FG000|Overall Study|Lost to Follow-up|300|||
23484757|NCT04271280|65518707|FG000|Overall Study|Death|153|||
23484758|NCT04271280|65518707|FG000|Overall Study|Withdrawal of consent by patient|59|||
23484759|NCT04271280|65518707|FG000|Overall Study|Other|51|||
23484760|NCT04271280|65518707|FG000|Overall Study|No end of study information|42|||
23484761|NCT00171054|65518709|FG000|Overall Study|Protocol Violation|1|||
23484762|NCT00171054|65518710|FG001|Overall Study|Protocol Violation|2|||
23484763|NCT00171054|65518709|FG000|Overall Study|Patient withdrew consent|1|||
23484764|NCT00171054|65518710|FG001|Overall Study|Patient withdrew consent|0|||
23484765|NCT00171054|65518709|FG000|Overall Study|Lost to Follow-up|0|||
23484766|NCT00171054|65518710|FG001|Overall Study|Lost to Follow-up|1|||
23484767|NCT00171054|65518709|FG000|Overall Study|Adverse Event|8|||
23484768|NCT00171054|65518710|FG001|Overall Study|Adverse Event|8|||
23484769|NCT00171054|65518709|FG000|Overall Study|Condition no longer required study drug|0|||
23484770|NCT00171054|65518710|FG001|Overall Study|Condition no longer required study drug|1|||
23484771|NCT02117414|65518711|FG000|Overall Study|Death|5|||
23484772|NCT02117414|65518712|FG001|Overall Study|Death|2|||
23484773|NCT02117414|65518711|FG000|Overall Study|Withdrawal by Subject|10|||
23484774|NCT02117414|65518712|FG001|Overall Study|Withdrawal by Subject|4|||
23484775|NCT00908011|65518713|FG000|Overall Study|Withdrawal by Subject|2|||
23484776|NCT00908011|65518714|FG001|Overall Study|Withdrawal by Subject|2|||
23484777|NCT01056380|65518717|FG000|Overall Study|Lost to Follow-up|2|||
23484778|NCT01056380|65518718|FG001|Overall Study|Lost to Follow-up|3|||
23484779|NCT02448680|65518719|FG000|Overall Study|Physician Decision|1|||
23484780|NCT02448680|65518720|FG001|Overall Study|Physician Decision|1|||
23484781|NCT02448680|65518719|FG000|Overall Study|Withdrawal by Subject|0|||
23484782|NCT02448680|65518720|FG001|Overall Study|Withdrawal by Subject|2|||
23484783|NCT01525901|65518721|FG000|Period 2: 12 Weeks|Adverse Event|0|||
23484784|NCT01525901|65518722|FG001|Period 2: 12 Weeks|Adverse Event|1|||
23484785|NCT01525901|65518723|FG002|Period 2: 12 Weeks|Adverse Event|0|||
23484786|NCT01525901|65518724|FG003|Period 2: 12 Weeks|Adverse Event|0|||
23484787|NCT01172275|65518728|FG000|Overall Study|Lost to Follow-up|1|||
23484788|NCT01172275|65518729|FG001|Overall Study|Lost to Follow-up|0|||
23484789|NCT01172275|65518728|FG000|Overall Study|Protocol Violation|1|||
23484790|NCT01172275|65518729|FG001|Overall Study|Protocol Violation|0|||
23484791|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
23484792|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
23484793|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
23484794|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
23484795|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
23484796|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
23484797|NCT01505647|65518734|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
23484798|NCT01505647|65518735|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
23484799|NCT01505647|65518734|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
23484800|NCT01505647|65518735|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
23484801|NCT00321893|65518737|FG000|Overall Study|Non-Compliance/Refusal|16|||
23484802|NCT00321893|65518738|FG001|Overall Study|Non-Compliance/Refusal|10|||
23484803|NCT00321893|65518737|FG000|Overall Study|Lost to Follow-up|2|||
23484804|NCT00321893|65518738|FG001|Overall Study|Lost to Follow-up|1|||
23484805|NCT00321893|65518737|FG000|Overall Study|Adverse Event|6|||
23484806|NCT00321893|65518738|FG001|Overall Study|Adverse Event|3|||
23484807|NCT01629706|65518739|FG000|Phase 1 PureVision|Screen Failure|4|||
23484808|NCT01629706|65518739|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
23484809|NCT01629706|65518739|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
23484810|NCT01629706|65518739|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
23484811|NCT01629706|65518739|FG000|Phase 2 Habitual|Screen Failure|6|||
23484812|NCT01629706|65518739|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
23484813|NCT01629706|65518739|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
23484814|NCT01629706|65518739|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
23484815|NCT01629706|65518739|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
23484816|NCT00686998|65518745|FG000|Overall Study|Adverse Event|3|||
23484817|NCT00686998|65518746|FG001|Overall Study|Adverse Event|2|||
23484818|NCT00686998|65518747|FG002|Overall Study|Adverse Event|1|||
23484819|NCT00686998|65518745|FG000|Overall Study|Withdrawal by Subject|2|||
23484820|NCT00686998|65518746|FG001|Overall Study|Withdrawal by Subject|1|||
23484821|NCT00686998|65518747|FG002|Overall Study|Withdrawal by Subject|2|||
23484822|NCT00686998|65518745|FG000|Overall Study|Lack of Efficacy|7|||
23484823|NCT00686998|65518746|FG001|Overall Study|Lack of Efficacy|5|||
23484824|NCT00686998|65518747|FG002|Overall Study|Lack of Efficacy|0|||
23484825|NCT00686998|65518745|FG000|Overall Study|Other|0|||
23484826|NCT00686998|65518746|FG001|Overall Study|Other|0|||
23484827|NCT00686998|65518747|FG002|Overall Study|Other|1|||
23484828|NCT00686998|65518745|FG000|Overall Study|Safety Reasons|1|||
23484829|NCT00686998|65518746|FG001|Overall Study|Safety Reasons|0|||
23484830|NCT00686998|65518747|FG002|Overall Study|Safety Reasons|0|||
23484831|NCT01205581|65518748|FG000|Overall Study|Withdrawal by Subject|1|||
23484832|NCT01205581|65518749|FG001|Overall Study|Withdrawal by Subject|0|||
23484833|NCT01205581|65518750|FG002|Overall Study|Withdrawal by Subject|0|||
23484834|NCT01205581|65518751|FG003|Overall Study|Withdrawal by Subject|0|||
23484835|NCT01205581|65518752|FG004|Overall Study|Withdrawal by Subject|0|||
23484836|NCT01205581|65518753|FG005|Overall Study|Withdrawal by Subject|0|||
23484837|NCT00812487|65518754|FG000|Overall Study|Lost to Follow-up|2|||
23484838|NCT00812487|65518755|FG001|Overall Study|Lost to Follow-up|0|||
23602717|NCT00571649|65934123|FG000|Treatment Period|Clinical endpoint reached|50|||
23602718|NCT00571649|65934124|FG001|Treatment Period|Clinical endpoint reached|56|||
23602719|NCT00571649|65934123|FG000|Treatment Period|Withdrawal by Subject|285|||
23602720|NCT00571649|65934124|FG001|Treatment Period|Withdrawal by Subject|255|||
23602721|NCT00571649|65934123|FG000|Treatment Period|Death|76|||
23602722|NCT00571649|65934124|FG001|Treatment Period|Death|59|||
23602723|NCT00571649|65934123|FG000|Treatment Period|Physician Decision|8|||
23602724|NCT00571649|65934124|FG001|Treatment Period|Physician Decision|9|||
23602725|NCT00571649|65934123|FG000|Treatment Period|Lost to Follow-up|43|||
23602726|NCT00571649|65934124|FG001|Treatment Period|Lost to Follow-up|41|||
23484839|NCT00812487|65518754|FG000|Overall Study|Withdrawal by Subject|3|||
23484840|NCT00812487|65518755|FG001|Overall Study|Withdrawal by Subject|2|||
23484841|NCT00812487|65518754|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
23484842|NCT00812487|65518755|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
23484843|NCT00812487|65518754|FG000|Overall Study|Protocol Violation|0|||
23602727|NCT00571649|65934123|FG000|Treatment Period|Non-compliant with study medication|88|||
23602728|NCT00571649|65934124|FG001|Treatment Period|Non-compliant with study medication|89|||
23484844|NCT00812487|65518755|FG001|Overall Study|Protocol Violation|1|||
23484845|NCT02117427|65518756|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
23484846|NCT02117427|65518757|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
23484847|NCT02117427|65518758|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
23484848|NCT02117427|65518756|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
23484849|NCT02117427|65518757|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
23484850|NCT02117427|65518758|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
23484851|NCT02117427|65518756|FG000|Overall Study|Physician Decision|0|||
23484852|NCT02117427|65518757|FG001|Overall Study|Physician Decision|2|||
23484853|NCT02117427|65518758|FG002|Overall Study|Physician Decision|0|||
23484854|NCT02117427|65518756|FG000|Overall Study|No longer meets inclusion criteria|0|||
23484855|NCT02117427|65518757|FG001|Overall Study|No longer meets inclusion criteria|1|||
23602729|NCT00571649|65934123|FG000|Treatment Period|Patient convenience|11|||
23602730|NCT00571649|65934124|FG001|Treatment Period|Patient convenience|13|||
23602731|NCT00571649|65934123|FG000|Treatment Period|Protocol Violation|90|||
23602732|NCT00571649|65934124|FG001|Treatment Period|Protocol Violation|92|||
23602733|NCT00571649|65934123|FG000|Treatment Period|Technical problems|3|||
23602734|NCT00571649|65934124|FG001|Treatment Period|Technical problems|5|||
23602735|NCT00571649|65934123|FG000|Follow-up Period|Adverse Event|46|||
23602736|NCT00571649|65934124|FG001|Follow-up Period|Adverse Event|40|||
23602737|NCT00571649|65934123|FG000|Follow-up Period|Clinical endpoint reached|5|||
23602738|NCT00571649|65934124|FG001|Follow-up Period|Clinical endpoint reached|2|||
23602739|NCT00571649|65934123|FG000|Follow-up Period|Withdrawal by Subject|119|||
23602740|NCT00571649|65934124|FG001|Follow-up Period|Withdrawal by Subject|115|||
23602741|NCT00571649|65934123|FG000|Follow-up Period|Death|132|||
23602742|NCT00571649|65934124|FG001|Follow-up Period|Death|133|||
23602743|NCT00571649|65934123|FG000|Follow-up Period|Physician Decision|7|||
23602744|NCT00571649|65934124|FG001|Follow-up Period|Physician Decision|13|||
23602745|NCT00571649|65934123|FG000|Follow-up Period|Lost to Follow-up|95|||
23602746|NCT00571649|65934124|FG001|Follow-up Period|Lost to Follow-up|92|||
23602747|NCT00571649|65934123|FG000|Follow-up Period|Patient convenience|136|||
23602748|NCT00571649|65934124|FG001|Follow-up Period|Patient convenience|121|||
23602749|NCT00571649|65934123|FG000|Follow-up Period|Protocol Violation|5|||
23602750|NCT00571649|65934124|FG001|Follow-up Period|Protocol Violation|12|||
23602751|NCT00273052|65934125|FG000|Overall Study|Withdrawal by Subject|16|||
23368813|NCT03608826|65096088|FG000|Overall Study|Death|3|||
23602752|NCT00273052|65934126|FG001|Overall Study|Withdrawal by Subject|19|||
23602753|NCT00273052|65934125|FG000|Overall Study|Adverse Event|21|||
23602754|NCT00273052|65934126|FG001|Overall Study|Adverse Event|19|||
23602755|NCT00273052|65934125|FG000|Overall Study|Protocol Violation|14|||
23602756|NCT00273052|65934126|FG001|Overall Study|Protocol Violation|18|||
23602757|NCT00273052|65934125|FG000|Overall Study|Lost to Follow-up|7|||
23602758|NCT00273052|65934126|FG001|Overall Study|Lost to Follow-up|25|||
23602759|NCT00273052|65934125|FG000|Overall Study|Lack of Efficacy|6|||
23602760|NCT00273052|65934126|FG001|Overall Study|Lack of Efficacy|4|||
23602761|NCT00273052|65934125|FG000|Overall Study|Non-Compliance|3|||
23602762|NCT00273052|65934126|FG001|Overall Study|Non-Compliance|1|||
23602763|NCT00273052|65934125|FG000|Overall Study|Other|2|||
23602764|NCT00273052|65934126|FG001|Overall Study|Other|0|||
23602765|NCT00273052|65934125|FG000|Overall Study|Worsening serum lipid levels|0|||
23602766|NCT00273052|65934126|FG001|Overall Study|Worsening serum lipid levels|2|||
23662092|NCT02819635|66149012|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
23662093|NCT02819635|66149013|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
23662094|NCT02819635|66149014|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
23662095|NCT02819635|66149015|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
23368814|NCT03608826|65096088|FG000|Overall Study|Heart Transplant|3|||
23368815|NCT03608826|65096088|FG000|Overall Study|Physician Decision|4|||
23662096|NCT02819635|66149016|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
23662097|NCT02819635|66149017|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
23662098|NCT02819635|66149006|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662099|NCT02819635|66149007|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23602767|NCT01880736|65937143|FG000|Overall Study|Adverse Event|0|||
23602768|NCT01880736|65937144|FG001|Overall Study|Adverse Event|0|||
23602769|NCT01880736|65937145|FG002|Overall Study|Adverse Event|0|||
23602770|NCT01880736|65937146|FG003|Overall Study|Adverse Event|1|||
23602771|NCT01880736|65937143|FG000|Overall Study|Withdrawal Criteria|1|||
23602772|NCT01880736|65937144|FG001|Overall Study|Withdrawal Criteria|2|||
23602773|NCT01880736|65937145|FG002|Overall Study|Withdrawal Criteria|1|||
23368816|NCT01883895|65096089|FG000|Overall Study|Lost to Follow-up|2|||
23368817|NCT00232557|65096090|FG000|Overall Study|Lost to Follow-up|3|||
23368818|NCT00232557|65096091|FG001|Overall Study|Lost to Follow-up|5|||
23368819|NCT01089127|65096092|FG000|Overall Study|Adverse Event|5|||
23368820|NCT01089127|65096093|FG001|Overall Study|Adverse Event|1|||
23368821|NCT01089127|65096094|FG002|Overall Study|Adverse Event|1|||
23368822|NCT01089127|65096095|FG003|Overall Study|Adverse Event|0|||
23368823|NCT01089127|65096096|FG004|Overall Study|Adverse Event|0|||
23368824|NCT01089127|65096097|FG005|Overall Study|Adverse Event|1|||
23368825|NCT01089127|65096092|FG000|Overall Study|Subject withdrew consent|0|||
23368826|NCT01089127|65096093|FG001|Overall Study|Subject withdrew consent|1|||
23368827|NCT01089127|65096094|FG002|Overall Study|Subject withdrew consent|1|||
23368828|NCT01089127|65096095|FG003|Overall Study|Subject withdrew consent|1|||
23368829|NCT01089127|65096096|FG004|Overall Study|Subject withdrew consent|0|||
23368830|NCT01089127|65096097|FG005|Overall Study|Subject withdrew consent|2|||
23368831|NCT01089127|65096092|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23368832|NCT01089127|65096093|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23368833|NCT01089127|65096094|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23368834|NCT01089127|65096095|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23368835|NCT01089127|65096096|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23368836|NCT01089127|65096097|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23368837|NCT01089127|65096092|FG000|Overall Study|Lost to Follow-up|1|||
23368838|NCT01089127|65096093|FG001|Overall Study|Lost to Follow-up|1|||
23368839|NCT01089127|65096094|FG002|Overall Study|Lost to Follow-up|0|||
23368840|NCT01089127|65096095|FG003|Overall Study|Lost to Follow-up|0|||
23368841|NCT01089127|65096096|FG004|Overall Study|Lost to Follow-up|1|||
23368842|NCT01089127|65096097|FG005|Overall Study|Lost to Follow-up|0|||
23368843|NCT01089127|65096092|FG000|Overall Study|Protocol deviation|0|||
23368844|NCT01089127|65096093|FG001|Overall Study|Protocol deviation|1|||
23368845|NCT01089127|65096094|FG002|Overall Study|Protocol deviation|0|||
23368846|NCT01089127|65096095|FG003|Overall Study|Protocol deviation|0|||
23368847|NCT01089127|65096096|FG004|Overall Study|Protocol deviation|1|||
23368848|NCT01089127|65096097|FG005|Overall Study|Protocol deviation|0|||
23368849|NCT01278342|65096098|FG000|Overall Study|Physician Decision|0|||
23368850|NCT01278342|65096099|FG001|Overall Study|Physician Decision|1|||
23368851|NCT01278342|65096100|FG002|Overall Study|Physician Decision|0|||
23368852|NCT01278342|65096098|FG000|Overall Study|Lost to Follow-up|1|||
23368853|NCT01278342|65096099|FG001|Overall Study|Lost to Follow-up|0|||
23368854|NCT01278342|65096100|FG002|Overall Study|Lost to Follow-up|0|||
23368855|NCT01278342|65096098|FG000|Overall Study|Administrative problems|2|||
23368856|NCT01278342|65096099|FG001|Overall Study|Administrative problems|0|||
23662100|NCT02819635|66149008|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23368857|NCT01278342|65096100|FG002|Overall Study|Administrative problems|0|||
23602774|NCT01880736|65937146|FG003|Overall Study|Withdrawal Criteria|5|||
23602775|NCT00933270|65937148|FG000|Overall Study|Withdrawal by Subject|26|||
23484856|NCT02117427|65518758|FG002|Overall Study|No longer meets inclusion criteria|0|||
23484857|NCT02117427|65518756|FG000|Overall Study|Death|0|||
23484858|NCT02117427|65518757|FG001|Overall Study|Death|1|||
23484859|NCT02117427|65518758|FG002|Overall Study|Death|0|||
23484860|NCT02414139|65518759|FG000|Treatment Period|Adverse Event|11|||
23484861|NCT02414139|65518760|FG001|Treatment Period|Adverse Event|6|||
23484862|NCT02414139|65518761|FG002|Treatment Period|Adverse Event|8|||
23484863|NCT02414139|65518762|FG003|Treatment Period|Adverse Event|5|||
23484864|NCT02414139|65518763|FG004|Treatment Period|Adverse Event|14|||
23484865|NCT02414139|65518764|FG005|Treatment Period|Adverse Event|3|||
23484866|NCT02414139|65518765|FG006|Treatment Period|Adverse Event|6|||
23484867|NCT02414139|65518766|FG007|Treatment Period|Adverse Event|1|||
23484868|NCT02414139|65518767|FG008|Treatment Period|Adverse Event|6|||
23484869|NCT02414139|65518768|FG009|Treatment Period|Adverse Event|8|||
23484870|NCT02414139|65518759|FG000|Treatment Period|Death|0|||
23484871|NCT02414139|65518760|FG001|Treatment Period|Death|0|||
23484872|NCT02414139|65518761|FG002|Treatment Period|Death|1|||
23484873|NCT02414139|65518762|FG003|Treatment Period|Death|1|||
23484874|NCT02414139|65518763|FG004|Treatment Period|Death|0|||
23484875|NCT02414139|65518764|FG005|Treatment Period|Death|0|||
23484876|NCT02414139|65518765|FG006|Treatment Period|Death|0|||
23484877|NCT02414139|65518766|FG007|Treatment Period|Death|0|||
23484878|NCT02414139|65518767|FG008|Treatment Period|Death|0|||
23484879|NCT02414139|65518768|FG009|Treatment Period|Death|1|||
23484880|NCT02414139|65518759|FG000|Treatment Period|Physician Decision|5|||
23484881|NCT02414139|65518760|FG001|Treatment Period|Physician Decision|4|||
23484882|NCT02414139|65518761|FG002|Treatment Period|Physician Decision|6|||
23484883|NCT02414139|65518762|FG003|Treatment Period|Physician Decision|1|||
23484884|NCT02414139|65518763|FG004|Treatment Period|Physician Decision|4|||
23484885|NCT02414139|65518764|FG005|Treatment Period|Physician Decision|0|||
23484886|NCT02414139|65518765|FG006|Treatment Period|Physician Decision|2|||
23602776|NCT00933270|65937148|FG000|Overall Study|Insufficient Follow-up|10|||
23602777|NCT00933270|65937148|FG000|Overall Study|Lost to Follow-up|14|||
23602778|NCT00933270|65937148|FG000|Overall Study|Adverse Event|1|||
23602779|NCT00933270|65937148|FG000|Overall Study|Missed Visit|2|||
23602780|NCT00933270|65937148|FG000|Overall Study|Death|24|||
23602781|NCT00933270|65937148|FG000|Overall Study|Moved or would not return|10|||
23602782|NCT01218659|65937151|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
23602783|NCT01218659|65937152|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
23602784|NCT01218659|65937153|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
23602785|NCT01218659|65937151|FG000|18-Month Randomized Period|Did not receive study drug|0|||
23602786|NCT01218659|65937152|FG001|18-Month Randomized Period|Did not receive study drug|3|||
23602787|NCT01218659|65937153|FG002|18-Month Randomized Period|Did not receive study drug|0|||
23602788|NCT01218659|65937151|FG000|12-Month OLE|Withdrawal by Subject|0|||
23602789|NCT01218659|65937152|FG001|12-Month OLE|Withdrawal by Subject|0|||
23602790|NCT01218659|65937153|FG002|12-Month OLE|Withdrawal by Subject|2|||
23602791|NCT01218659|65937151|FG000|12-Month OLE|Physician Decision|0|||
23602792|NCT01218659|65937152|FG001|12-Month OLE|Physician Decision|0|||
23602793|NCT01218659|65937153|FG002|12-Month OLE|Physician Decision|1|||
23484887|NCT02414139|65518766|FG007|Treatment Period|Physician Decision|0|||
23484888|NCT02414139|65518767|FG008|Treatment Period|Physician Decision|1|||
23484889|NCT02414139|65518768|FG009|Treatment Period|Physician Decision|4|||
23484890|NCT02414139|65518759|FG000|Treatment Period|Progressive disease|48|||
23484891|NCT02414139|65518760|FG001|Treatment Period|Progressive disease|31|||
23484892|NCT02414139|65518761|FG002|Treatment Period|Progressive disease|37|||
23484893|NCT02414139|65518762|FG003|Treatment Period|Progressive disease|21|||
23484894|NCT02414139|65518763|FG004|Treatment Period|Progressive disease|43|||
23602794|NCT01218659|65937151|FG000|12-Month OLE|Lost to Follow-up|0|||
23484895|NCT02414139|65518764|FG005|Treatment Period|Progressive disease|12|||
23484896|NCT02414139|65518765|FG006|Treatment Period|Progressive disease|16|||
23602795|NCT01218659|65937152|FG001|12-Month OLE|Lost to Follow-up|0|||
23602796|NCT01218659|65937153|FG002|12-Month OLE|Lost to Follow-up|1|||
23368858|NCT01278342|65096098|FG000|Overall Study|Other|1|||
23368859|NCT01278342|65096099|FG001|Overall Study|Other|0|||
23368860|NCT01278342|65096100|FG002|Overall Study|Other|0|||
23368861|NCT00671788|65096101|FG000|Overall Study|Adverse Event|8|||
23368862|NCT00671788|65096101|FG000|Overall Study|Refused further treatment|3|||
23368863|NCT00671788|65096101|FG000|Overall Study|Ineligible|1|||
23368864|NCT00671788|65096101|FG000|Overall Study|MD Decision|1|||
23368865|NCT00671788|65096101|FG000|Overall Study|Other|1|||
23368866|NCT02438280|65096102|FG000|Overall Study|Physician Decision|1|||
23368867|NCT02438280|65096103|FG001|Overall Study|Physician Decision|0|||
23368868|NCT02460289|65096119|FG000|Overall Study|Adverse Event|1|||
23368869|NCT02460289|65096119|FG000|Overall Study|Withdrawal by Subject|8|||
23368870|NCT02460289|65096119|FG000|Overall Study|Lost to Follow-up|1|||
23368871|NCT02121795|65096122|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
23368872|NCT02121795|65096123|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
23368873|NCT02121795|65096122|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
23368874|NCT02121795|65096123|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
23368875|NCT02121795|65096122|FG000|Double-Blind Phase|Lost to Follow-up|7|||
23368876|NCT02121795|65096123|FG001|Double-Blind Phase|Lost to Follow-up|4|||
23368877|NCT02121795|65096122|FG000|Double-Blind Phase|Physician Decision|2|||
23368878|NCT02121795|65096123|FG001|Double-Blind Phase|Physician Decision|5|||
23662101|NCT02819635|66149009|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662102|NCT02819635|66149010|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662103|NCT02819635|66149011|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662104|NCT02819635|66149012|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
23662105|NCT02819635|66149013|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662106|NCT02819635|66149014|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662107|NCT02819635|66149015|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662108|NCT02819635|66149016|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23368879|NCT02121795|65096122|FG000|Double-Blind Phase|Adverse Event|5|||
23368880|NCT02121795|65096123|FG001|Double-Blind Phase|Adverse Event|0|||
23602797|NCT01218659|65937151|FG000|12-Month OLE|Pregnancy|0|||
23602798|NCT01218659|65937152|FG001|12-Month OLE|Pregnancy|0|||
23602799|NCT01218659|65937153|FG002|12-Month OLE|Pregnancy|1|||
23602800|NCT01218659|65937151|FG000|12-Month OLE|Lack of Efficacy|0|||
23602801|NCT01218659|65937152|FG001|12-Month OLE|Lack of Efficacy|0|||
23602802|NCT01218659|65937153|FG002|12-Month OLE|Lack of Efficacy|1|||
23602803|NCT01218659|65937151|FG000|12-Month OLE|Declined to participate in the OLE|0|||
23602804|NCT01218659|65937152|FG001|12-Month OLE|Declined to participate in the OLE|0|||
23602805|NCT01218659|65937153|FG002|12-Month OLE|Declined to participate in the OLE|4|||
23602806|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
23602807|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
23602808|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
23602809|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
23602810|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
23602811|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
23602812|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
23602813|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
23368881|NCT02121795|65096122|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23368882|NCT02121795|65096123|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23368883|NCT02121795|65096122|FG000|Double-Blind Phase|Protocol Violation|0|||
23368884|NCT02121795|65096123|FG001|Double-Blind Phase|Protocol Violation|3|||
23368885|NCT02121795|65096122|FG000|Double-Blind Phase|Death|1|||
23368886|NCT02121795|65096123|FG001|Double-Blind Phase|Death|1|||
23368887|NCT02121795|65096122|FG000|Open-Label Phase|Physician Decision|8|||
23368888|NCT02121795|65096123|FG001|Open-Label Phase|Physician Decision|8|||
23368889|NCT02121795|65096122|FG000|Open-Label Phase|Withdrawal by Subject|3|||
23368890|NCT02121795|65096123|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23602814|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
23602815|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
23602816|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
23602817|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
23368891|NCT02121795|65096122|FG000|Open-Label Phase|Lost to Follow-up|1|||
23602818|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
23602819|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
23602820|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Death|1|||
23602821|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Death|0|||
23602822|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
23602823|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
23602824|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
23602825|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
23602826|NCT00605306|65937156|FG000|Overall Study|Adverse Event|0|||
23602827|NCT00605306|65937157|FG001|Overall Study|Adverse Event|1|||
23602828|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Adverse Event|1|||
23602829|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23602830|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23602831|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23602832|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Physician Decision|1|||
23602833|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Physician Decision|0|||
23662109|NCT02819635|66149017|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23662110|NCT02819635|66149006|FG000|Substudy 2, Part 2|Other, not specified|0|||
23662111|NCT02819635|66149007|FG001|Substudy 2, Part 2|Other, not specified|0|||
23662112|NCT02819635|66149008|FG002|Substudy 2, Part 2|Other, not specified|0|||
23662113|NCT02819635|66149009|FG003|Substudy 2, Part 2|Other, not specified|0|||
23662114|NCT02819635|66149010|FG004|Substudy 2, Part 2|Other, not specified|0|||
23662115|NCT02819635|66149011|FG005|Substudy 2, Part 2|Other, not specified|4|||
23662116|NCT02819635|66149012|FG006|Substudy 2, Part 2|Other, not specified|8|||
23662117|NCT02819635|66149013|FG007|Substudy 2, Part 2|Other, not specified|0|||
23662118|NCT02819635|66149014|FG008|Substudy 2, Part 2|Other, not specified|0|||
23602834|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Physician Decision|0|||
23602835|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23602836|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
23602837|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
23662119|NCT02819635|66149015|FG009|Substudy 2, Part 2|Other, not specified|0|||
23662120|NCT02819635|66149016|FG010|Substudy 2, Part 2|Other, not specified|0|||
23662121|NCT02819635|66149017|FG011|Substudy 2, Part 2|Other, not specified|0|||
23662122|NCT02819635|66149006|FG000|Substudy 3|Adverse Event|0|||
23662123|NCT02819635|66149007|FG001|Substudy 3|Adverse Event|0|||
23662124|NCT02819635|66149008|FG002|Substudy 3|Adverse Event|0|||
23368892|NCT02121795|65096123|FG001|Open-Label Phase|Lost to Follow-up|0|||
23368893|NCT02260817|65096127|FG000|Overall Study|Lost to Follow-up|0|||
23368894|NCT02260817|65096128|FG001|Overall Study|Lost to Follow-up|14|||
23602838|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
23602839|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
23602840|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
23662125|NCT02819635|66149009|FG003|Substudy 3|Adverse Event|0|||
23662126|NCT02819635|66149010|FG004|Substudy 3|Adverse Event|0|||
23368895|NCT02260817|65096127|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
23368896|NCT02260817|65096128|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
23368897|NCT02260817|65096127|FG000|Overall Study|Observation, no biopsy|0|||
23368898|NCT02260817|65096128|FG001|Overall Study|Observation, no biopsy|1|||
23368899|NCT02260817|65096127|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
23602841|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
23662127|NCT02819635|66149011|FG005|Substudy 3|Adverse Event|0|||
23662128|NCT02819635|66149012|FG006|Substudy 3|Adverse Event|0|||
23662129|NCT02819635|66149013|FG007|Substudy 3|Adverse Event|0|||
23662130|NCT02819635|66149014|FG008|Substudy 3|Adverse Event|32|||
23602842|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
23602843|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
23602844|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602845|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602846|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602847|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
23602848|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602849|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602850|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602851|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
23602852|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602853|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602854|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602855|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
23602856|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602857|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602858|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602859|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
23602860|NCT01177670|65937166|FG000|Overall Study|Study Terminated|115|||
23602861|NCT01177670|65937166|FG000|Overall Study|Physician Decision|50|||
23602862|NCT01177670|65937166|FG000|Overall Study|Withdrawal by Subject|4|||
23602863|NCT03883828|65937170|FG000|Overall Study|Did not start radiotherapy|1|||
23602864|NCT03883828|65937171|FG001|Overall Study|Did not start radiotherapy|2|||
23602865|NCT01256359|65937172|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
23602866|NCT01256359|65937173|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
23602867|NCT01256359|65937172|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
23602868|NCT01256359|65937173|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
23602869|NCT01773993|65937179|FG000|Overall Study|No Visit After Treatment|35|||
23602870|NCT02167451|65937181|FG000|Overall Study|Withdrawal by Subject|1|||
23602871|NCT01604824|65937184|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602872|NCT01604824|65937185|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602873|NCT01604824|65937186|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602874|NCT01604824|65937187|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602875|NCT01604824|65937188|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
23662131|NCT02819635|66149015|FG009|Substudy 3|Adverse Event|3|||
23662132|NCT02819635|66149016|FG010|Substudy 3|Adverse Event|12|||
23662133|NCT02819635|66149017|FG011|Substudy 3|Adverse Event|18|||
23662134|NCT02819635|66149006|FG000|Substudy 3|Withdrew consent|0|||
23662135|NCT02819635|66149007|FG001|Substudy 3|Withdrew consent|0|||
23662136|NCT02819635|66149008|FG002|Substudy 3|Withdrew consent|0|||
23662137|NCT02819635|66149009|FG003|Substudy 3|Withdrew consent|0|||
23662138|NCT02819635|66149010|FG004|Substudy 3|Withdrew consent|0|||
23662139|NCT02819635|66149011|FG005|Substudy 3|Withdrew consent|0|||
23662140|NCT02819635|66149012|FG006|Substudy 3|Withdrew consent|0|||
23662141|NCT02819635|66149013|FG007|Substudy 3|Withdrew consent|0|||
23662142|NCT02819635|66149014|FG008|Substudy 3|Withdrew consent|11|||
23662143|NCT02819635|66149015|FG009|Substudy 3|Withdrew consent|1|||
23662144|NCT02819635|66149016|FG010|Substudy 3|Withdrew consent|4|||
23662145|NCT02819635|66149017|FG011|Substudy 3|Withdrew consent|9|||
23662146|NCT02819635|66149006|FG000|Substudy 3|Lost to Follow-up|0|||
23662147|NCT02819635|66149007|FG001|Substudy 3|Lost to Follow-up|0|||
23662148|NCT02819635|66149008|FG002|Substudy 3|Lost to Follow-up|0|||
23662149|NCT02819635|66149009|FG003|Substudy 3|Lost to Follow-up|0|||
23662150|NCT02819635|66149010|FG004|Substudy 3|Lost to Follow-up|0|||
23662151|NCT02819635|66149011|FG005|Substudy 3|Lost to Follow-up|0|||
23662152|NCT02819635|66149012|FG006|Substudy 3|Lost to Follow-up|0|||
23662153|NCT02819635|66149013|FG007|Substudy 3|Lost to Follow-up|0|||
23662154|NCT02819635|66149014|FG008|Substudy 3|Lost to Follow-up|1|||
23662155|NCT02819635|66149015|FG009|Substudy 3|Lost to Follow-up|0|||
23662156|NCT02819635|66149016|FG010|Substudy 3|Lost to Follow-up|1|||
23662157|NCT02819635|66149017|FG011|Substudy 3|Lost to Follow-up|1|||
23662158|NCT02819635|66149006|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662159|NCT02819635|66149007|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662160|NCT02819635|66149008|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662161|NCT02819635|66149009|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
23807547|NCT01641133|66672793|FG001|Overall Study|Lost to Follow-up|2|||
23662162|NCT02819635|66149010|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662163|NCT02819635|66149011|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662164|NCT02819635|66149012|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
23368900|NCT02260817|65096128|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
23368901|NCT02260817|65096127|FG000|Overall Study|Protocol Violation|0|||
23368902|NCT02260817|65096128|FG001|Overall Study|Protocol Violation|14|||
23368903|NCT00969228|65096130|FG000|Overall Study|Adverse Event|1|||
23368904|NCT00969228|65096131|FG001|Overall Study|Adverse Event|0|||
23368905|NCT00969228|65096130|FG000|Overall Study|Withdrawal by Subject|4|||
23368906|NCT00969228|65096131|FG001|Overall Study|Withdrawal by Subject|0|||
23368907|NCT00969228|65096130|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
23368908|NCT00969228|65096131|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
23368909|NCT00994110|65096134|FG000|Overall Study|Withdrawal by Subject|9|||
23368910|NCT00994110|65096135|FG001|Overall Study|Withdrawal by Subject|9|||
23368911|NCT00994110|65096134|FG000|Overall Study|Not Treated|4|||
23368912|NCT00994110|65096135|FG001|Overall Study|Not Treated|8|||
23368913|NCT00994110|65096134|FG000|Overall Study|Adverse Event|1|||
23368914|NCT00994110|65096135|FG001|Overall Study|Adverse Event|0|||
23368915|NCT00994110|65096134|FG000|Overall Study|Patient not resected|41|||
23368916|NCT00994110|65096135|FG001|Overall Study|Patient not resected|52|||
23368917|NCT00994110|65096134|FG000|Overall Study|Pt not eligible|10|||
23368918|NCT00994110|65096135|FG001|Overall Study|Pt not eligible|5|||
23368919|NCT02364388|65096137|FG000|Overall Study|Protocol Violation|1|||
23368920|NCT02364388|65096137|FG000|Overall Study|Technical Failure|3|||
23368921|NCT02364388|65096137|FG000|Overall Study|No OA/US data|2|||
23368922|NCT02364388|65096137|FG000|Overall Study|No Biopsy|2|||
23368923|NCT04161391|65096138|FG000|Overall Study|Adverse Event|0|||
23368924|NCT04161391|65096139|FG001|Overall Study|Adverse Event|1|||
23368925|NCT04161391|65096140|FG002|Overall Study|Adverse Event|0|||
23368926|NCT04161391|65096141|FG003|Overall Study|Adverse Event|1|||
23368927|NCT04161391|65096142|FG004|Overall Study|Adverse Event|0|||
23368928|NCT04161391|65096143|FG005|Overall Study|Adverse Event|0|||
23368929|NCT04161391|65096144|FG006|Overall Study|Adverse Event|0|||
23368930|NCT04161391|65096145|FG007|Overall Study|Adverse Event|3|||
23368931|NCT04161391|65096146|FG008|Overall Study|Adverse Event|0|||
23368932|NCT04161391|65096138|FG000|Overall Study|Death|0|||
23368933|NCT04161391|65096139|FG001|Overall Study|Death|0|||
23368934|NCT04161391|65096140|FG002|Overall Study|Death|0|||
23368935|NCT04161391|65096141|FG003|Overall Study|Death|0|||
23368936|NCT04161391|65096142|FG004|Overall Study|Death|0|||
23368937|NCT04161391|65096143|FG005|Overall Study|Death|0|||
23368938|NCT04161391|65096144|FG006|Overall Study|Death|0|||
23368939|NCT04161391|65096145|FG007|Overall Study|Death|1|||
23368940|NCT04161391|65096146|FG008|Overall Study|Death|0|||
23368941|NCT04161391|65096138|FG000|Overall Study|Physician Decision|0|||
23368942|NCT04161391|65096139|FG001|Overall Study|Physician Decision|0|||
23368943|NCT04161391|65096140|FG002|Overall Study|Physician Decision|1|||
23368944|NCT04161391|65096141|FG003|Overall Study|Physician Decision|2|||
23368945|NCT04161391|65096142|FG004|Overall Study|Physician Decision|0|||
23368946|NCT04161391|65096143|FG005|Overall Study|Physician Decision|0|||
23368947|NCT04161391|65096144|FG006|Overall Study|Physician Decision|2|||
23368948|NCT04161391|65096145|FG007|Overall Study|Physician Decision|0|||
23368949|NCT04161391|65096146|FG008|Overall Study|Physician Decision|0|||
23368950|NCT04161391|65096138|FG000|Overall Study|Progressive Disease|4|||
23368951|NCT04161391|65096139|FG001|Overall Study|Progressive Disease|3|||
23368952|NCT04161391|65096140|FG002|Overall Study|Progressive Disease|3|||
23368953|NCT04161391|65096141|FG003|Overall Study|Progressive Disease|5|||
23368954|NCT04161391|65096142|FG004|Overall Study|Progressive Disease|3|||
23484897|NCT02414139|65518766|FG007|Treatment Period|Progressive disease|2|||
23484898|NCT02414139|65518767|FG008|Treatment Period|Progressive disease|20|||
23484899|NCT02414139|65518768|FG009|Treatment Period|Progressive disease|14|||
23662165|NCT02819635|66149013|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
23368955|NCT04161391|65096143|FG005|Overall Study|Progressive Disease|3|||
23368956|NCT04161391|65096144|FG006|Overall Study|Progressive Disease|5|||
23368957|NCT04161391|65096145|FG007|Overall Study|Progressive Disease|2|||
23368958|NCT04161391|65096146|FG008|Overall Study|Progressive Disease|2|||
23368959|NCT01719380|65096154|FG000|Overall Study|Adverse Event|0|||
23368960|NCT01719380|65096155|FG001|Overall Study|Adverse Event|0|||
23368961|NCT01719380|65096156|FG002|Overall Study|Adverse Event|1|||
23368962|NCT01719380|65096157|FG003|Overall Study|Adverse Event|2|||
23368963|NCT01719380|65096158|FG004|Overall Study|Adverse Event|0|||
23368964|NCT01719380|65096159|FG005|Overall Study|Adverse Event|1|||
23368965|NCT01719380|65096160|FG006|Overall Study|Adverse Event|0|||
23368966|NCT01719380|65096161|FG007|Overall Study|Adverse Event|1|||
23368967|NCT01719380|65096162|FG008|Overall Study|Adverse Event|4|||
23368968|NCT01719380|65096163|FG009|Overall Study|Adverse Event|3|||
23368969|NCT01719380|65096154|FG000|Overall Study|Death|0|||
23368970|NCT01719380|65096155|FG001|Overall Study|Death|1|||
23368971|NCT01719380|65096156|FG002|Overall Study|Death|0|||
23368972|NCT01719380|65096157|FG003|Overall Study|Death|0|||
23662166|NCT02819635|66149014|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662167|NCT02819635|66149015|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662168|NCT02819635|66149016|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
23662169|NCT02819635|66149017|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
23662170|NCT02819635|66149006|FG000|Substudy 3|Other, not specified|0|||
23662171|NCT02819635|66149007|FG001|Substudy 3|Other, not specified|0|||
23368973|NCT01719380|65096158|FG004|Overall Study|Death|0|||
23368974|NCT01719380|65096159|FG005|Overall Study|Death|0|||
23368975|NCT01719380|65096160|FG006|Overall Study|Death|0|||
23484900|NCT02414139|65518759|FG000|Treatment Period|Protocol deviation|0|||
23368976|NCT01719380|65096161|FG007|Overall Study|Death|0|||
23368977|NCT01719380|65096162|FG008|Overall Study|Death|3|||
23368978|NCT01719380|65096163|FG009|Overall Study|Death|3|||
23368979|NCT01719380|65096154|FG000|Overall Study|Participant/Guardian Decision|0|||
23368980|NCT01719380|65096155|FG001|Overall Study|Participant/Guardian Decision|0|||
23368981|NCT01719380|65096156|FG002|Overall Study|Participant/Guardian Decision|1|||
23368982|NCT01719380|65096157|FG003|Overall Study|Participant/Guardian Decision|0|||
23368983|NCT01719380|65096158|FG004|Overall Study|Participant/Guardian Decision|0|||
23368984|NCT01719380|65096159|FG005|Overall Study|Participant/Guardian Decision|0|||
23368985|NCT01719380|65096160|FG006|Overall Study|Participant/Guardian Decision|0|||
23368986|NCT01719380|65096161|FG007|Overall Study|Participant/Guardian Decision|0|||
23368987|NCT01719380|65096162|FG008|Overall Study|Participant/Guardian Decision|2|||
23368988|NCT01719380|65096163|FG009|Overall Study|Participant/Guardian Decision|2|||
23368989|NCT01719380|65096154|FG000|Overall Study|Physician Decision|0|||
23368990|NCT01719380|65096155|FG001|Overall Study|Physician Decision|0|||
23368991|NCT01719380|65096156|FG002|Overall Study|Physician Decision|2|||
23368992|NCT01719380|65096157|FG003|Overall Study|Physician Decision|0|||
23368993|NCT01719380|65096158|FG004|Overall Study|Physician Decision|0|||
23368994|NCT01719380|65096159|FG005|Overall Study|Physician Decision|0|||
23368995|NCT01719380|65096160|FG006|Overall Study|Physician Decision|0|||
23368996|NCT01719380|65096161|FG007|Overall Study|Physician Decision|0|||
23368997|NCT01719380|65096162|FG008|Overall Study|Physician Decision|1|||
23368998|NCT01719380|65096163|FG009|Overall Study|Physician Decision|1|||
23368999|NCT01719380|65096154|FG000|Overall Study|Lack of Efficacy|2|||
23369000|NCT01719380|65096155|FG001|Overall Study|Lack of Efficacy|6|||
23484901|NCT02414139|65518760|FG001|Treatment Period|Protocol deviation|0|||
23484902|NCT02414139|65518761|FG002|Treatment Period|Protocol deviation|1|||
23484903|NCT02414139|65518762|FG003|Treatment Period|Protocol deviation|0|||
23484904|NCT02414139|65518763|FG004|Treatment Period|Protocol deviation|0|||
23484905|NCT02414139|65518764|FG005|Treatment Period|Protocol deviation|0|||
23484906|NCT02414139|65518765|FG006|Treatment Period|Protocol deviation|0|||
23484907|NCT02414139|65518766|FG007|Treatment Period|Protocol deviation|0|||
23484908|NCT02414139|65518767|FG008|Treatment Period|Protocol deviation|0|||
23484909|NCT02414139|65518768|FG009|Treatment Period|Protocol deviation|0|||
23662172|NCT02819635|66149008|FG002|Substudy 3|Other, not specified|0|||
23662173|NCT02819635|66149009|FG003|Substudy 3|Other, not specified|0|||
23662174|NCT02819635|66149010|FG004|Substudy 3|Other, not specified|0|||
23369001|NCT01719380|65096156|FG002|Overall Study|Lack of Efficacy|5|||
23662175|NCT02819635|66149011|FG005|Substudy 3|Other, not specified|0|||
23662176|NCT02819635|66149012|FG006|Substudy 3|Other, not specified|0|||
23369002|NCT01719380|65096157|FG003|Overall Study|Lack of Efficacy|6|||
23369003|NCT01719380|65096158|FG004|Overall Study|Lack of Efficacy|3|||
23369004|NCT01719380|65096159|FG005|Overall Study|Lack of Efficacy|7|||
23369005|NCT01719380|65096160|FG006|Overall Study|Lack of Efficacy|10|||
23369006|NCT01719380|65096161|FG007|Overall Study|Lack of Efficacy|6|||
23369007|NCT01719380|65096162|FG008|Overall Study|Lack of Efficacy|39|||
23369008|NCT01719380|65096163|FG009|Overall Study|Lack of Efficacy|42|||
23369009|NCT01719380|65096154|FG000|Overall Study|Progressive Disease|0|||
23602876|NCT01604824|65937189|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602877|NCT01604824|65937184|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602878|NCT01604824|65937185|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602879|NCT01604824|65937186|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602880|NCT01604824|65937187|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602881|NCT01604824|65937188|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
23602882|NCT01604824|65937189|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602883|NCT01593020|65937190|FG000|Overall Study|Adverse Event|1|||
23602884|NCT01593020|65937191|FG001|Overall Study|Adverse Event|1|||
23602885|NCT01593020|65937190|FG000|Overall Study|Death|0|||
23602886|NCT01593020|65937191|FG001|Overall Study|Death|1|||
23602887|NCT01593020|65937190|FG000|Overall Study|Ineligible|1|||
23602888|NCT01593020|65937191|FG001|Overall Study|Ineligible|0|||
23602889|NCT01961609|65937193|FG000|Initiation|Missing|3|||
23602890|NCT01961609|65937194|FG001|Initiation|Missing|2|||
23602891|NCT01961609|65937195|FG002|Initiation|Missing|0|||
23602892|NCT01961609|65937196|FG003|Initiation|Missing|0|||
23662177|NCT02819635|66149013|FG007|Substudy 3|Other, not specified|0|||
23662178|NCT02819635|66149014|FG008|Substudy 3|Other, not specified|202|||
23662179|NCT02819635|66149015|FG009|Substudy 3|Other, not specified|5|||
23662180|NCT02819635|66149016|FG010|Substudy 3|Other, not specified|89|||
23662181|NCT02819635|66149017|FG011|Substudy 3|Other, not specified|39|||
23662182|NCT03996876|66149022|FG000|Overall Study|Incomplete Data|2|||
23662183|NCT03996876|66149023|FG001|Overall Study|Incomplete Data|4|||
23662184|NCT03901079|66149026|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
23662185|NCT01202279|66149027|FG000|Overall Study|Adverse Event|8|||
23662186|NCT01202279|66149028|FG001|Overall Study|Adverse Event|6|||
23662187|NCT01202279|66149027|FG000|Overall Study|Withdrawal by Subject|13|||
23662188|NCT01202279|66149028|FG001|Overall Study|Withdrawal by Subject|10|||
23662189|NCT01202279|66149027|FG000|Overall Study|Physician Decision|0|||
23662190|NCT01202279|66149028|FG001|Overall Study|Physician Decision|1|||
23662191|NCT01202279|66149027|FG000|Overall Study|Lost to Follow-up|10|||
23662192|NCT01202279|66149028|FG001|Overall Study|Lost to Follow-up|7|||
23662193|NCT01202279|66149027|FG000|Overall Study|Protocol Violation|1|||
23662194|NCT01202279|66149028|FG001|Overall Study|Protocol Violation|1|||
23662195|NCT01202279|66149027|FG000|Overall Study|study compliance|5|||
23662196|NCT01202279|66149028|FG001|Overall Study|study compliance|2|||
23662197|NCT01056510|66149029|FG000|Overall Study|Dropout Before Start of Treatment|1|||
23662198|NCT01056510|66149030|FG001|Overall Study|Dropout Before Start of Treatment|1|||
23662199|NCT01056510|66149029|FG000|Overall Study|Withdrawal by Subject|4|||
23662200|NCT01056510|66149030|FG001|Overall Study|Withdrawal by Subject|2|||
23662201|NCT01056510|66149029|FG000|Overall Study|Death|29|||
23662202|NCT01056510|66149030|FG001|Overall Study|Death|34|||
23662203|NCT01056510|66149029|FG000|Overall Study|Noncompliance|1|||
23662204|NCT01056510|66149030|FG001|Overall Study|Noncompliance|3|||
23662205|NCT01056510|66149029|FG000|Overall Study|Physician Decision|4|||
23662206|NCT01056510|66149030|FG001|Overall Study|Physician Decision|5|||
23662207|NCT01056510|66149029|FG000|Overall Study|Lost to Follow-up|5|||
23662208|NCT01056510|66149030|FG001|Overall Study|Lost to Follow-up|6|||
23662209|NCT01056510|66149029|FG000|Overall Study|Other|10|||
23662210|NCT01056510|66149030|FG001|Overall Study|Other|12|||
23662211|NCT01056510|66149029|FG000|Overall Study|Missing|0|||
23662212|NCT01056510|66149030|FG001|Overall Study|Missing|1|||
23662213|NCT04353284|66149031|FG000|Overall Study|Adverse Event|1|||
23369010|NCT01719380|65096155|FG001|Overall Study|Progressive Disease|0|||
23602893|NCT01961609|65937193|FG000|Initiation|Protocol deviation|1|||
23662214|NCT04353284|66149032|FG001|Overall Study|Adverse Event|1|||
23662215|NCT04353284|66149031|FG000|Overall Study|Lost to Follow-up|1|||
23602894|NCT01961609|65937194|FG001|Initiation|Protocol deviation|0|||
23662216|NCT04353284|66149032|FG001|Overall Study|Lost to Follow-up|0|||
23662217|NCT00433914|66149033|FG000|Overall Study|Withdrawal by Subject|0|||
23662218|NCT00433914|66149034|FG001|Overall Study|Withdrawal by Subject|2|||
23662219|NCT00433914|66149033|FG000|Overall Study|Lost to Follow-up|0|||
23662220|NCT00433914|66149034|FG001|Overall Study|Lost to Follow-up|1|||
23662221|NCT02865018|66149035|FG000|Overall Study|Withdrawal by Subject|1|||
23662222|NCT00427349|66149036|FG000|Overall Study|Lack of Efficacy|23|||
23662223|NCT00427349|66149036|FG000|Overall Study|Adverse Event|14|||
23662224|NCT00427349|66149036|FG000|Overall Study|Death|1|||
23662225|NCT00427349|66149036|FG000|Overall Study|Withdrawal by Subject|3|||
23662226|NCT00427349|66149036|FG000|Overall Study|Alternative therapy|1|||
23662227|NCT00427349|66149036|FG000|Overall Study|Other|2|||
23662228|NCT00427349|66149036|FG000|Overall Study|Ineligible|1|||
23662229|NCT00427349|66149036|FG000|Overall Study|Never started therapy|1|||
23662230|NCT02228720|66149039|FG000|Open Label - Day 30|Lost to Follow-up|1|||
23662231|NCT01490814|66149041|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
23662232|NCT01490814|66149042|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
23662233|NCT01490814|66149041|FG000|Overall Study|Physician Decision|1|||
23662234|NCT01490814|66149042|FG001|Overall Study|Physician Decision|0|||
23662235|NCT01490814|66149041|FG000|Overall Study|Withdrawal by Subject|0|||
23662236|NCT01490814|66149042|FG001|Overall Study|Withdrawal by Subject|5|||
23662237|NCT00253643|66149043|FG000|Overall Study|Withdrawal by Subject|0|||
23662238|NCT00253643|66149044|FG001|Overall Study|Withdrawal by Subject|0|||
23662239|NCT00253643|66149045|FG002|Overall Study|Withdrawal by Subject|1|||
23662240|NCT00253643|66149046|FG003|Overall Study|Withdrawal by Subject|1|||
23662241|NCT00253643|66149043|FG000|Overall Study|Non-Compliance|0|||
23662242|NCT00253643|66149044|FG001|Overall Study|Non-Compliance|0|||
23602895|NCT01961609|65937195|FG002|Initiation|Protocol deviation|0|||
23602896|NCT01961609|65937196|FG003|Initiation|Protocol deviation|0|||
23602897|NCT01961609|65937193|FG000|Initiation|Death|0|||
23602898|NCT01961609|65937194|FG001|Initiation|Death|1|||
23602899|NCT01961609|65937195|FG002|Initiation|Death|0|||
23602900|NCT01961609|65937196|FG003|Initiation|Death|0|||
23602901|NCT01961609|65937193|FG000|Initiation|Administrative problems|1|||
23602902|NCT01961609|65937194|FG001|Initiation|Administrative problems|0|||
23602903|NCT01961609|65937195|FG002|Initiation|Administrative problems|0|||
23602904|NCT01961609|65937196|FG003|Initiation|Administrative problems|0|||
23602905|NCT01961609|65937193|FG000|Initiation|Withdrawal by Subject|1|||
23602906|NCT01961609|65937194|FG001|Initiation|Withdrawal by Subject|2|||
23602907|NCT01961609|65937195|FG002|Initiation|Withdrawal by Subject|0|||
23602908|NCT01961609|65937196|FG003|Initiation|Withdrawal by Subject|0|||
23602909|NCT01961609|65937193|FG000|Initiation|Lack of Efficacy|2|||
23602910|NCT01961609|65937194|FG001|Initiation|Lack of Efficacy|1|||
23602911|NCT01961609|65937195|FG002|Initiation|Lack of Efficacy|0|||
23602912|NCT01961609|65937196|FG003|Initiation|Lack of Efficacy|0|||
23602913|NCT01961609|65937193|FG000|Initiation|Abnormal lab values|0|||
23602914|NCT01961609|65937194|FG001|Initiation|Abnormal lab values|1|||
23602915|NCT01961609|65937195|FG002|Initiation|Abnormal lab values|0|||
23602916|NCT01961609|65937196|FG003|Initiation|Abnormal lab values|0|||
23602917|NCT01961609|65937193|FG000|Initiation|Adverse Event|3|||
23602918|NCT01961609|65937194|FG001|Initiation|Adverse Event|5|||
23602919|NCT01961609|65937195|FG002|Initiation|Adverse Event|0|||
23602920|NCT01961609|65937196|FG003|Initiation|Adverse Event|0|||
23602921|NCT01961609|65937193|FG000|Initiation|Randomized but not treated|1|||
23602922|NCT01961609|65937194|FG001|Initiation|Randomized but not treated|1|||
23602923|NCT01961609|65937195|FG002|Initiation|Randomized but not treated|0|||
23602924|NCT01961609|65937196|FG003|Initiation|Randomized but not treated|0|||
23602925|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
23602926|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
23602927|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
23602928|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
23602929|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
23602930|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
23602931|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
23602932|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
23602933|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
23602934|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
23602935|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
23602936|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
23602937|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
23602938|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
23602939|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
23369011|NCT01719380|65096156|FG002|Overall Study|Progressive Disease|0|||
23602940|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
23602941|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
23602942|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
23602943|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
23662243|NCT00253643|66149045|FG002|Overall Study|Non-Compliance|0|||
23662244|NCT00253643|66149046|FG003|Overall Study|Non-Compliance|2|||
23662245|NCT00424749|66149049|FG000|Overall Study|Withdrawal by Subject|1|||
23662246|NCT00516048|66149050|FG000|Overall Study|Death|0|||
23602944|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
23602945|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602946|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602947|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
23602948|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602949|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
23602950|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
23602951|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
23602952|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
23369012|NCT01719380|65096157|FG003|Overall Study|Progressive Disease|0|||
23369013|NCT01719380|65096158|FG004|Overall Study|Progressive Disease|0|||
23369014|NCT01719380|65096159|FG005|Overall Study|Progressive Disease|0|||
23369015|NCT01719380|65096160|FG006|Overall Study|Progressive Disease|0|||
23369016|NCT01719380|65096161|FG007|Overall Study|Progressive Disease|0|||
23369017|NCT01719380|65096162|FG008|Overall Study|Progressive Disease|1|||
23369018|NCT01719380|65096163|FG009|Overall Study|Progressive Disease|0|||
23369019|NCT00192114|65096164|FG000|Overall Study|Objective Tumor Progression|19|||
23602953|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602954|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602955|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
23602956|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602957|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
23602958|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602959|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602960|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602961|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602962|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
23602963|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602964|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602965|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
23602966|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
23602967|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
23602968|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
23602969|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
23602970|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
23602971|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
23602972|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
23602973|NCT01728324|65937198|FG000|Termination of DBV|Adverse Event|14|||
23602974|NCT01728324|65937199|FG001|Termination of DBV|Adverse Event|13|||
23369020|NCT00192114|65096164|FG000|Overall Study|Adverse Event|2|||
23602975|NCT01728324|65937200|FG002|Termination of DBV|Adverse Event|4|||
23602976|NCT01728324|65937198|FG000|Termination of DBV|Lack of Efficacy|14|||
23602977|NCT01728324|65937199|FG001|Termination of DBV|Lack of Efficacy|12|||
23602978|NCT01728324|65937200|FG002|Termination of DBV|Lack of Efficacy|8|||
23602979|NCT01728324|65937198|FG000|Termination of DBV|Withdrawal by Subject|9|||
23602980|NCT01728324|65937199|FG001|Termination of DBV|Withdrawal by Subject|6|||
23602981|NCT01728324|65937200|FG002|Termination of DBV|Withdrawal by Subject|2|||
23602982|NCT01728324|65937198|FG000|Termination of DBV|Other than stated|1|||
23602983|NCT01728324|65937199|FG001|Termination of DBV|Other than stated|3|||
23602984|NCT01728324|65937200|FG002|Termination of DBV|Other than stated|0|||
23602985|NCT01728324|65937198|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
23602986|NCT01728324|65937199|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
23602987|NCT01728324|65937200|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
23602988|NCT01728324|65937198|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
23369021|NCT00192114|65096164|FG000|Overall Study|Clinical Progression|2|||
23369022|NCT00192114|65096164|FG000|Overall Study|Death|1|||
23369023|NCT01204671|65096165|FG000|Overall Study|Adverse Event|4|||
23369024|NCT01204671|65096166|FG001|Overall Study|Adverse Event|3|||
23369025|NCT01204671|65096167|FG002|Overall Study|Adverse Event|3|||
23369026|NCT01204671|65096168|FG003|Overall Study|Adverse Event|3|||
23369027|NCT01204671|65096169|FG004|Overall Study|Adverse Event|1|||
23369028|NCT01204671|65096165|FG000|Overall Study|Withdrawal by Subject|2|||
23369029|NCT01204671|65096166|FG001|Overall Study|Withdrawal by Subject|3|||
23369030|NCT01204671|65096167|FG002|Overall Study|Withdrawal by Subject|4|||
23369031|NCT01204671|65096168|FG003|Overall Study|Withdrawal by Subject|5|||
23369032|NCT01204671|65096169|FG004|Overall Study|Withdrawal by Subject|3|||
23369033|NCT01204671|65096165|FG000|Overall Study|Lost to Follow-up|7|||
23662247|NCT00516048|66149051|FG001|Overall Study|Death|0|||
23662248|NCT00516048|66149052|FG002|Overall Study|Death|1|||
23807548|NCT01641133|66672794|FG002|Overall Study|Lost to Follow-up|2|||
23369034|NCT01204671|65096166|FG001|Overall Study|Lost to Follow-up|8|||
23369035|NCT01204671|65096167|FG002|Overall Study|Lost to Follow-up|6|||
23369036|NCT01204671|65096168|FG003|Overall Study|Lost to Follow-up|4|||
23602989|NCT01728324|65937199|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
23602990|NCT01728324|65937200|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
23602991|NCT01728324|65937198|FG000|Termination of FDV|Adverse Event|14|||
23602992|NCT01728324|65937199|FG001|Termination of FDV|Adverse Event|13|||
23602993|NCT01728324|65937200|FG002|Termination of FDV|Adverse Event|4|||
23602994|NCT01728324|65937198|FG000|Termination of FDV|Lack of Efficacy|14|||
23602995|NCT01728324|65937199|FG001|Termination of FDV|Lack of Efficacy|12|||
23602996|NCT01728324|65937200|FG002|Termination of FDV|Lack of Efficacy|8|||
23602997|NCT01728324|65937198|FG000|Termination of FDV|Withdrawal by Subject|9|||
23602998|NCT01728324|65937199|FG001|Termination of FDV|Withdrawal by Subject|6|||
23602999|NCT01728324|65937200|FG002|Termination of FDV|Withdrawal by Subject|2|||
23603000|NCT01728324|65937198|FG000|Termination of FDV|Other than stated|1|||
23603001|NCT01728324|65937199|FG001|Termination of FDV|Other than stated|3|||
23603002|NCT01728324|65937200|FG002|Termination of FDV|Other than stated|0|||
23603003|NCT01728324|65937198|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
23603004|NCT01728324|65937199|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
23603005|NCT01728324|65937200|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
23603006|NCT01728324|65937198|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
23603007|NCT01728324|65937199|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
23603008|NCT01728324|65937200|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
23603009|NCT01728324|65937198|FG000|Termination of RBV|Adverse Event|15|||
23603010|NCT01728324|65937199|FG001|Termination of RBV|Adverse Event|16|||
23662249|NCT00516048|66149050|FG000|Overall Study|Subject Decision|0|||
23662250|NCT00516048|66149051|FG001|Overall Study|Subject Decision|2|||
23662251|NCT00516048|66149052|FG002|Overall Study|Subject Decision|0|||
23662252|NCT02596620|66149054|FG000|Overall Study|Lost to Follow-up|1|||
23662253|NCT02596620|66149055|FG001|Overall Study|Lost to Follow-up|1|||
23662254|NCT01342484|66149058|FG000|Overall Study|Other Reasons|1|||
23662255|NCT01342484|66149059|FG001|Overall Study|Other Reasons|0|||
23662256|NCT01342484|66149060|FG002|Overall Study|Other Reasons|0|||
23662257|NCT01342484|66149058|FG000|Overall Study|Protocol Violation|0|||
23662258|NCT01342484|66149059|FG001|Overall Study|Protocol Violation|0|||
23662259|NCT01342484|66149060|FG002|Overall Study|Protocol Violation|1|||
23662260|NCT01342484|66149058|FG000|Overall Study|Withdrawal by Subject|1|||
23662261|NCT01342484|66149059|FG001|Overall Study|Withdrawal by Subject|0|||
23662262|NCT01342484|66149060|FG002|Overall Study|Withdrawal by Subject|0|||
23662263|NCT01543828|66149063|FG000|Treatment 2|Lost to Follow-up|1|||
23662264|NCT01543828|66149064|FG001|Treatment 2|Lost to Follow-up|0|||
23662265|NCT01392677|66149065|FG000|Overall Study|Adverse Event|3|||
23369037|NCT01204671|65096169|FG004|Overall Study|Lost to Follow-up|0|||
23369038|NCT01204671|65096165|FG000|Overall Study|Unknown Completion Status|1|||
23369039|NCT01204671|65096166|FG001|Overall Study|Unknown Completion Status|1|||
23369040|NCT01204671|65096167|FG002|Overall Study|Unknown Completion Status|0|||
23369041|NCT01204671|65096168|FG003|Overall Study|Unknown Completion Status|0|||
23369042|NCT01204671|65096169|FG004|Overall Study|Unknown Completion Status|0|||
23369043|NCT01204671|65096165|FG000|Overall Study|Physician Decision|0|||
23369044|NCT01204671|65096166|FG001|Overall Study|Physician Decision|0|||
23369045|NCT01204671|65096167|FG002|Overall Study|Physician Decision|0|||
23369046|NCT01204671|65096168|FG003|Overall Study|Physician Decision|1|||
23369047|NCT01204671|65096169|FG004|Overall Study|Physician Decision|0|||
23369048|NCT05081388|65096172|FG000|Overall Study|Adverse Event|1|||
23369049|NCT05081388|65096173|FG001|Overall Study|Adverse Event|0|||
23369050|NCT05081388|65096174|FG002|Overall Study|Adverse Event|0|||
23369051|NCT05081388|65096175|FG003|Overall Study|Adverse Event|0|||
23369052|NCT05081388|65096176|FG004|Overall Study|Adverse Event|0|||
23369053|NCT05081388|65096172|FG000|Overall Study|Lost to Follow-up|0|||
23369054|NCT05081388|65096173|FG001|Overall Study|Lost to Follow-up|1|||
23369055|NCT05081388|65096174|FG002|Overall Study|Lost to Follow-up|0|||
23369056|NCT05081388|65096175|FG003|Overall Study|Lost to Follow-up|0|||
23369057|NCT05081388|65096176|FG004|Overall Study|Lost to Follow-up|0|||
23369058|NCT05081388|65096172|FG000|Overall Study|Subject decision|0|||
23369059|NCT05081388|65096173|FG001|Overall Study|Subject decision|0|||
23369060|NCT05081388|65096174|FG002|Overall Study|Subject decision|0|||
23662266|NCT01392677|66149066|FG001|Overall Study|Adverse Event|1|||
23369061|NCT05081388|65096175|FG003|Overall Study|Subject decision|1|||
23369062|NCT05081388|65096176|FG004|Overall Study|Subject decision|0|||
23369063|NCT00492297|65096177|FG000|Treatment|Death|2|||
23369064|NCT00492297|65096177|FG000|Treatment|Study terminated by sponsor|3|||
23369065|NCT00492297|65096177|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
23369066|NCT00492297|65096177|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
23369067|NCT00492297|65096177|FG000|Survival Only Follow-up|Death|46|||
23603011|NCT01728324|65937200|FG002|Termination of RBV|Adverse Event|5|||
23662267|NCT01392677|66149065|FG000|Overall Study|Withdrawal by Subject|0|||
23662268|NCT01392677|66149066|FG001|Overall Study|Withdrawal by Subject|2|||
23662269|NCT01392677|66149065|FG000|Overall Study|Incorrect enrollment|2|||
23662270|NCT01392677|66149066|FG001|Overall Study|Incorrect enrollment|3|||
23662271|NCT01392677|66149065|FG000|Overall Study|Other reason|3|||
23369068|NCT00492297|65096177|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
23369069|NCT00492297|65096177|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
23369070|NCT01001910|65096192|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
23369071|NCT03234036|65096193|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
23369072|NCT03234036|65096194|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
23369073|NCT03234036|65096195|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
23369074|NCT03234036|65096196|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
23369075|NCT00785356|65096197|FG000|Overall Study|Study prematurely terminated|8|||
23369076|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
23369077|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
23369078|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
23369079|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
23369080|NCT00716456|65096201|FG000|Overall Study|Adverse Event|0|||
23369081|NCT00716456|65096202|FG001|Overall Study|Adverse Event|2|||
23369082|NCT00716456|65096203|FG002|Overall Study|Adverse Event|0|||
23484910|NCT02414139|65518759|FG000|Treatment Period|Subject/Guardian decision|5|||
23369083|NCT00072384|65096204|FG000|Overall Study|Physician Decision|1|||
23369084|NCT00072384|65096204|FG000|Overall Study|Ineligible|8|||
23369085|NCT03150082|65096205|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
23369086|NCT03150082|65096206|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
23369087|NCT00243919|65096216|FG000|Overall Study|Death|3|||
23369088|NCT00243919|65096217|FG001|Overall Study|Death|4|||
23369089|NCT00243919|65096218|FG002|Overall Study|Death|6|||
23369090|NCT00243919|65096216|FG000|Overall Study|Withdrawal by Subject|6|||
23369091|NCT00243919|65096217|FG001|Overall Study|Withdrawal by Subject|6|||
23369092|NCT00243919|65096218|FG002|Overall Study|Withdrawal by Subject|2|||
23369093|NCT00243919|65096216|FG000|Overall Study|Lost to Follow-up|6|||
23369094|NCT00243919|65096217|FG001|Overall Study|Lost to Follow-up|7|||
23369095|NCT00243919|65096218|FG002|Overall Study|Lost to Follow-up|3|||
23369096|NCT00243919|65096216|FG000|Overall Study|Administrative Error|1|||
23369097|NCT00243919|65096217|FG001|Overall Study|Administrative Error|0|||
23369098|NCT00243919|65096218|FG002|Overall Study|Administrative Error|0|||
23369099|NCT00243919|65096216|FG000|Overall Study|Physician Decision|1|||
23369100|NCT00243919|65096217|FG001|Overall Study|Physician Decision|1|||
23369101|NCT00243919|65096218|FG002|Overall Study|Physician Decision|0|||
23369102|NCT01128296|65096219|FG000|Overall Study|Physician Decision|0|||
23369103|NCT01128296|65096220|FG001|Overall Study|Physician Decision|0|||
23369104|NCT01128296|65096221|FG002|Overall Study|Physician Decision|0|||
23369105|NCT01128296|65096222|FG003|Overall Study|Physician Decision|0|||
23369106|NCT01128296|65096223|FG004|Overall Study|Physician Decision|0|||
23369107|NCT01128296|65096224|FG005|Overall Study|Physician Decision|3|||
23484911|NCT02414139|65518760|FG001|Treatment Period|Subject/Guardian decision|1|||
23369108|NCT01128296|65096219|FG000|Overall Study|Withdrawal by Subject|0|||
23369109|NCT01128296|65096220|FG001|Overall Study|Withdrawal by Subject|0|||
23369110|NCT01128296|65096221|FG002|Overall Study|Withdrawal by Subject|0|||
23369111|NCT01128296|65096222|FG003|Overall Study|Withdrawal by Subject|0|||
23369112|NCT01128296|65096223|FG004|Overall Study|Withdrawal by Subject|0|||
23603012|NCT01728324|65937198|FG000|Termination of RBV|Lack of Efficacy|14|||
23603013|NCT01728324|65937199|FG001|Termination of RBV|Lack of Efficacy|11|||
23603014|NCT01728324|65937200|FG002|Termination of RBV|Lack of Efficacy|7|||
23484912|NCT02414139|65518761|FG002|Treatment Period|Subject/Guardian decision|1|||
23484913|NCT02414139|65518762|FG003|Treatment Period|Subject/Guardian decision|2|||
23484914|NCT02414139|65518763|FG004|Treatment Period|Subject/Guardian decision|5|||
23484915|NCT02414139|65518764|FG005|Treatment Period|Subject/Guardian decision|0|||
23484916|NCT02414139|65518765|FG006|Treatment Period|Subject/Guardian decision|2|||
23484917|NCT02414139|65518766|FG007|Treatment Period|Subject/Guardian decision|0|||
23484918|NCT02414139|65518767|FG008|Treatment Period|Subject/Guardian decision|1|||
23484919|NCT02414139|65518768|FG009|Treatment Period|Subject/Guardian decision|1|||
23484920|NCT02414139|65518759|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484921|NCT02414139|65518760|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484922|NCT02414139|65518761|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484923|NCT02414139|65518762|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484924|NCT02414139|65518763|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
23484925|NCT02414139|65518764|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484926|NCT02414139|65518765|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
23484927|NCT02414139|65518766|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484928|NCT02414139|65518767|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
23484929|NCT02414139|65518768|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
23484930|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
23484931|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484932|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484933|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484934|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
23484935|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484936|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484937|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484938|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484939|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484940|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23484941|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23484942|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Death|0|||
23484943|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Death|0|||
23484944|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Death|1|||
23662272|NCT01392677|66149066|FG001|Overall Study|Other reason|2|||
23662273|NCT01376778|66149067|FG000|Overall Study|Lost to Follow-up|3|||
23662274|NCT01376778|66149068|FG001|Overall Study|Lost to Follow-up|2|||
23662275|NCT00199836|66149069|FG000|Overall Study|Progressive Disease|5|||
23662276|NCT00199836|66149069|FG000|Overall Study|Death|1|||
23662277|NCT01087775|66149070|FG000|Overall Study|failed inclusion criteria|2|||
23807549|NCT04135196|66672797|FG000|Overall Study|Lost to Follow-up|8|||
23484945|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Death|0|||
23484946|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Death|0|||
23484947|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Death|0|||
23484948|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Death|0|||
23484949|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Death|1|||
23484950|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
23484951|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23807550|NCT04135196|66672798|FG001|Overall Study|Lost to Follow-up|7|||
23662278|NCT02101021|66149073|FG000|Overall Study|Death|4|||
23807551|NCT04135196|66672799|FG002|Overall Study|Lost to Follow-up|8|||
23662279|NCT02101021|66149074|FG001|Overall Study|Death|3|||
23807552|NCT04135196|66672800|FG003|Overall Study|Lost to Follow-up|9|||
23807553|NCT04135196|66672801|FG004|Overall Study|Lost to Follow-up|1|||
23807554|NCT04135196|66672797|FG000|Overall Study|Pregnancy|0|||
23807555|NCT04135196|66672798|FG001|Overall Study|Pregnancy|0|||
23484952|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484953|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484954|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484955|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484956|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484957|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484958|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484959|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484960|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484961|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23484962|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484963|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23484964|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484965|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23484966|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23484967|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23662280|NCT02101021|66149075|FG002|Overall Study|Death|6|||
23484968|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23484969|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23484970|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23484971|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484972|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
23484973|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484974|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
23484975|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
23662281|NCT02101021|66149076|FG003|Overall Study|Death|0|||
23662282|NCT02101021|66149077|FG004|Overall Study|Death|3|||
23662283|NCT02101021|66149073|FG000|Overall Study|Withdrew Consent from study|1|||
23662284|NCT02101021|66149074|FG001|Overall Study|Withdrew Consent from study|1|||
23662285|NCT02101021|66149075|FG002|Overall Study|Withdrew Consent from study|0|||
23662286|NCT02101021|66149076|FG003|Overall Study|Withdrew Consent from study|2|||
23662287|NCT02101021|66149077|FG004|Overall Study|Withdrew Consent from study|0|||
23662288|NCT02101021|66149073|FG000|Overall Study|Lost to Follow-up|1|||
23662289|NCT02101021|66149074|FG001|Overall Study|Lost to Follow-up|0|||
23662290|NCT02101021|66149075|FG002|Overall Study|Lost to Follow-up|0|||
23662291|NCT02101021|66149076|FG003|Overall Study|Lost to Follow-up|0|||
23662292|NCT02101021|66149077|FG004|Overall Study|Lost to Follow-up|0|||
23662293|NCT02101021|66149073|FG000|Overall Study|Study Terminated by Sponsor|1|||
23662294|NCT02101021|66149074|FG001|Overall Study|Study Terminated by Sponsor|0|||
23662295|NCT02101021|66149075|FG002|Overall Study|Study Terminated by Sponsor|1|||
23662296|NCT02101021|66149076|FG003|Overall Study|Study Terminated by Sponsor|1|||
23662297|NCT02101021|66149077|FG004|Overall Study|Study Terminated by Sponsor|1|||
23662298|NCT00475722|66149081|FG000|Overall Study|Withdrawal by Subject|12|||
23662299|NCT00475722|66149082|FG001|Overall Study|Withdrawal by Subject|12|||
23662300|NCT00475722|66149081|FG000|Overall Study|Protocol Violation|3|||
23662301|NCT00475722|66149082|FG001|Overall Study|Protocol Violation|0|||
23662302|NCT01624259|66149083|FG000|Overall Study|Adverse Event|18|||
23662303|NCT01624259|66149084|FG001|Overall Study|Adverse Event|18|||
23662304|NCT01624259|66149083|FG000|Overall Study|Protocol Violation|1|||
23662305|NCT01624259|66149084|FG001|Overall Study|Protocol Violation|2|||
23662306|NCT01624259|66149083|FG000|Overall Study|Withdrawal by Subject|5|||
23662307|NCT01624259|66149084|FG001|Overall Study|Withdrawal by Subject|7|||
23662308|NCT01624259|66149083|FG000|Overall Study|Physician Decision|1|||
23662309|NCT01624259|66149084|FG001|Overall Study|Physician Decision|1|||
23662310|NCT01624259|66149083|FG000|Overall Study|Lost to Follow-up|2|||
23662311|NCT01624259|66149084|FG001|Overall Study|Lost to Follow-up|3|||
23662312|NCT01624259|66149083|FG000|Overall Study|Abnormal laboratory measure|3|||
23662313|NCT01624259|66149084|FG001|Overall Study|Abnormal laboratory measure|0|||
23662314|NCT00789880|66149085|FG000|Overall Study|Adverse Event|0|||
23662315|NCT00789880|66149086|FG001|Overall Study|Adverse Event|0|||
23662316|NCT00789880|66149087|FG002|Overall Study|Adverse Event|0|||
23662317|NCT00789880|66149088|FG003|Overall Study|Adverse Event|0|||
23662318|NCT00789880|66149089|FG004|Overall Study|Adverse Event|1|||
23662319|NCT00789880|66149090|FG005|Overall Study|Adverse Event|0|||
23662320|NCT00789880|66149085|FG000|Overall Study|Protocol Violation|0|||
23807556|NCT04135196|66672799|FG002|Overall Study|Pregnancy|1|||
23662321|NCT00789880|66149086|FG001|Overall Study|Protocol Violation|1|||
23662322|NCT00789880|66149087|FG002|Overall Study|Protocol Violation|0|||
23662323|NCT00789880|66149088|FG003|Overall Study|Protocol Violation|1|||
23662324|NCT00789880|66149089|FG004|Overall Study|Protocol Violation|0|||
23662325|NCT00789880|66149090|FG005|Overall Study|Protocol Violation|0|||
23662326|NCT00789880|66149085|FG000|Overall Study|Withdrawal by Subject|1|||
23662327|NCT00789880|66149086|FG001|Overall Study|Withdrawal by Subject|0|||
23662328|NCT00789880|66149087|FG002|Overall Study|Withdrawal by Subject|0|||
23484976|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484977|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
23484978|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23484979|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23484980|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484981|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
23484982|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484983|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484984|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484985|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484986|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484987|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484988|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484989|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
23484990|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
23484991|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23484992|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
23484993|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484994|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484995|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484996|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484997|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484998|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484999|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23485000|NCT02961218|65518771|FG000|Overall Study|Lost to Follow-up|0|||
23485001|NCT02961218|65518772|FG001|Overall Study|Lost to Follow-up|2|||
23662329|NCT00789880|66149088|FG003|Overall Study|Withdrawal by Subject|0|||
23662330|NCT00789880|66149089|FG004|Overall Study|Withdrawal by Subject|2|||
23662331|NCT00789880|66149090|FG005|Overall Study|Withdrawal by Subject|0|||
23662332|NCT01572675|66149095|FG000|Overall Study|End of prescribed treatment|140|||
23662333|NCT01572675|66149096|FG001|Overall Study|End of prescribed treatment|118|||
23662334|NCT01572675|66149095|FG000|Overall Study|Recovery|16|||
23662335|NCT01572675|66149096|FG001|Overall Study|Recovery|23|||
23662336|NCT01572675|66149095|FG000|Overall Study|Lack of Efficacy|31|||
23662337|NCT01572675|66149096|FG001|Overall Study|Lack of Efficacy|31|||
23662338|NCT01572675|66149095|FG000|Overall Study|Intolerance|6|||
23662339|NCT01572675|66149096|FG001|Overall Study|Intolerance|5|||
23485002|NCT02961218|65518771|FG000|Overall Study|Physician Decision|0|||
23485003|NCT02961218|65518772|FG001|Overall Study|Physician Decision|2|||
23485004|NCT02961218|65518771|FG000|Overall Study|Subject/Guardian Decision|3|||
23485005|NCT02961218|65518772|FG001|Overall Study|Subject/Guardian Decision|1|||
23662340|NCT01572675|66149095|FG000|Overall Study|Improved symptoms|8|||
23662341|NCT01572675|66149096|FG001|Overall Study|Improved symptoms|2|||
23807557|NCT04135196|66672800|FG003|Overall Study|Pregnancy|0|||
23369113|NCT01128296|65096224|FG005|Overall Study|Withdrawal by Subject|2|||
23369114|NCT02666222|65096229|FG000|Overall Study|Death|2|||
23369115|NCT01079780|65096230|FG000|Overall Study|Disease progression|43|||
23369116|NCT01079780|65096231|FG001|Overall Study|Disease progression|7|||
23369117|NCT01079780|65096232|FG002|Overall Study|Disease progression|31|||
23369118|NCT01079780|65096230|FG000|Overall Study|Adverse Event|13|||
23369119|NCT01079780|65096231|FG001|Overall Study|Adverse Event|5|||
23369120|NCT01079780|65096232|FG002|Overall Study|Adverse Event|7|||
23369121|NCT01079780|65096230|FG000|Overall Study|Death|2|||
23485006|NCT02140775|65518774|FG000|Overall Study|Withdrawal by Subject|30|||
23662342|NCT01572675|66149095|FG000|Overall Study|Surgical intervention|3|||
23662343|NCT01572675|66149096|FG001|Overall Study|Surgical intervention|6|||
23662344|NCT01572675|66149095|FG000|Overall Study|Withdrawal by Subject|5|||
23662345|NCT01572675|66149096|FG001|Overall Study|Withdrawal by Subject|1|||
23662346|NCT01572675|66149095|FG000|Overall Study|Physician Decision|2|||
23662347|NCT01572675|66149096|FG001|Overall Study|Physician Decision|2|||
23662348|NCT01572675|66149095|FG000|Overall Study|Death unrelated to coxibs|1|||
23662349|NCT01572675|66149096|FG001|Overall Study|Death unrelated to coxibs|1|||
23662350|NCT01572675|66149095|FG000|Overall Study|Other disease detected|1|||
23662351|NCT01572675|66149096|FG001|Overall Study|Other disease detected|1|||
23662352|NCT01572675|66149095|FG000|Overall Study|Unknown reason|1|||
23662353|NCT01572675|66149096|FG001|Overall Study|Unknown reason|1|||
23662354|NCT01572675|66149095|FG000|Overall Study|Rheumatologist new evaluation|0|||
23662355|NCT01572675|66149096|FG001|Overall Study|Rheumatologist new evaluation|1|||
23662356|NCT01572675|66149095|FG000|Overall Study|Missing data|1|||
23662357|NCT01572675|66149096|FG001|Overall Study|Missing data|4|||
23662358|NCT01572675|66149095|FG000|Overall Study|Lost to Follow-up|22|||
23662359|NCT01572675|66149096|FG001|Overall Study|Lost to Follow-up|27|||
23662360|NCT00449670|66149097|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
23662361|NCT00449670|66149098|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
23662362|NCT00449670|66149097|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
23662363|NCT00449670|66149098|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
23662364|NCT00449670|66149097|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
23662365|NCT00449670|66149098|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
23662366|NCT00449670|66149097|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
23662367|NCT00449670|66149098|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
23662368|NCT00449670|66149097|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
23662369|NCT00449670|66149098|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
23662370|NCT00449670|66149097|FG000|Booster Phase (Study no.109873)|Other|0|||
23485007|NCT02140775|65518775|FG001|Overall Study|Withdrawal by Subject|7|||
23369122|NCT01079780|65096231|FG001|Overall Study|Death|0|||
23369123|NCT01079780|65096232|FG002|Overall Study|Death|2|||
23662371|NCT00449670|66149098|FG001|Booster Phase (Study no.109873)|Other|2|||
23662372|NCT04344301|66149099|FG000|Overall Study|Withdrawal by Subject|1|||
23369124|NCT01079780|65096230|FG000|Overall Study|Withdrawal by Subject|6|||
23369125|NCT01079780|65096231|FG001|Overall Study|Withdrawal by Subject|4|||
23369126|NCT01079780|65096232|FG002|Overall Study|Withdrawal by Subject|4|||
23369127|NCT01079780|65096230|FG000|Overall Study|Alternative therapy|2|||
23369128|NCT01079780|65096231|FG001|Overall Study|Alternative therapy|0|||
23369129|NCT01079780|65096232|FG002|Overall Study|Alternative therapy|2|||
23369130|NCT01079780|65096230|FG000|Overall Study|Physician Decision|1|||
23369131|NCT01079780|65096231|FG001|Overall Study|Physician Decision|0|||
23369132|NCT01079780|65096232|FG002|Overall Study|Physician Decision|1|||
23369133|NCT01079780|65096230|FG000|Overall Study|Error made in lesion measurement|1|||
23369134|NCT01079780|65096231|FG001|Overall Study|Error made in lesion measurement|0|||
23369135|NCT01079780|65096232|FG002|Overall Study|Error made in lesion measurement|0|||
23369136|NCT01079780|65096230|FG000|Overall Study|Patient had surgery|1|||
23369137|NCT01079780|65096231|FG001|Overall Study|Patient had surgery|0|||
23369138|NCT01079780|65096232|FG002|Overall Study|Patient had surgery|0|||
23603015|NCT01728324|65937198|FG000|Termination of RBV|Withdrawal by Subject|9|||
23603016|NCT01728324|65937199|FG001|Termination of RBV|Withdrawal by Subject|5|||
23603017|NCT01728324|65937200|FG002|Termination of RBV|Withdrawal by Subject|2|||
23662373|NCT04344301|66149100|FG001|Overall Study|Withdrawal by Subject|0|||
23662374|NCT04344301|66149099|FG000|Overall Study|Death|0|||
23662375|NCT04344301|66149100|FG001|Overall Study|Death|1|||
23662376|NCT00470054|66149101|FG000|Overall Study|Ineligible|1|||
23662377|NCT00121108|66149108|FG000|Overall Study|Lost to Follow-up|10|||
23662378|NCT00121108|66149109|FG001|Overall Study|Lost to Follow-up|22|||
23662379|NCT00121108|66149108|FG000|Overall Study|Withdrawal by Subject|106|||
23662380|NCT00121108|66149109|FG001|Overall Study|Withdrawal by Subject|195|||
23662381|NCT00121108|66149108|FG000|Overall Study|Death|5|||
23662382|NCT00121108|66149109|FG001|Overall Study|Death|8|||
23662383|NCT02716675|66149110|FG000|Overall Study|Death|2|||
23662384|NCT02716675|66149111|FG001|Overall Study|Death|3|||
23662385|NCT02716675|66149112|FG002|Overall Study|Death|0|||
23662386|NCT02716675|66149110|FG000|Overall Study|Physician Decision|2|||
23662387|NCT02716675|66149111|FG001|Overall Study|Physician Decision|1|||
23662388|NCT02716675|66149112|FG002|Overall Study|Physician Decision|1|||
23662389|NCT02716675|66149110|FG000|Overall Study|Lost to Follow-up|100|||
23662390|NCT02716675|66149111|FG001|Overall Study|Lost to Follow-up|87|||
23662391|NCT02716675|66149112|FG002|Overall Study|Lost to Follow-up|99|||
23662392|NCT02716675|66149110|FG000|Overall Study|Withdrawal by Subject|22|||
23662393|NCT02716675|66149111|FG001|Overall Study|Withdrawal by Subject|25|||
23662394|NCT02716675|66149112|FG002|Overall Study|Withdrawal by Subject|20|||
23662395|NCT02716675|66149110|FG000|Overall Study|Protocol Violation|0|||
23662396|NCT02716675|66149111|FG001|Overall Study|Protocol Violation|3|||
23662397|NCT02716675|66149112|FG002|Overall Study|Protocol Violation|1|||
23662398|NCT02716675|66149110|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
23603018|NCT01728324|65937198|FG000|Termination of RBV|Other than stated|1|||
23603019|NCT01728324|65937199|FG001|Termination of RBV|Other than stated|3|||
23603020|NCT01728324|65937200|FG002|Termination of RBV|Other than stated|1|||
23603021|NCT01728324|65937198|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
23603022|NCT01728324|65937199|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
23603023|NCT01728324|65937200|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
23603024|NCT01728324|65937198|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
23603025|NCT01728324|65937199|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
23603026|NCT01728324|65937200|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
23603027|NCT00705406|65937205|FG000|Overall Study|Lost to Follow-up|3|||
23603028|NCT00705406|65937206|FG001|Overall Study|Lost to Follow-up|3|||
23603029|NCT00705406|65937205|FG000|Overall Study|Did not receive study drug|1|||
23603030|NCT00705406|65937206|FG001|Overall Study|Did not receive study drug|2|||
23603031|NCT00403494|65937211|FG000|Overall Study|Adverse Event|10|||
23662399|NCT02716675|66149111|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
23603032|NCT00403494|65937212|FG001|Overall Study|Adverse Event|8|||
23603033|NCT00403494|65937211|FG000|Overall Study|Withdrew Consent|3|||
23603034|NCT00403494|65937212|FG001|Overall Study|Withdrew Consent|2|||
23603035|NCT00403494|65937211|FG000|Overall Study|Inappropriately enrolled|0|||
23603036|NCT00403494|65937212|FG001|Overall Study|Inappropriately enrolled|1|||
23603037|NCT00403494|65937211|FG000|Overall Study|Lost to Follow-up|0|||
23662400|NCT02716675|66149112|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
23662401|NCT02716675|66149110|FG000|Overall Study|Other|38|||
23369139|NCT01079780|65096230|FG000|Overall Study|Treatment cycle delay|0|||
23369140|NCT01079780|65096231|FG001|Overall Study|Treatment cycle delay|0|||
23369141|NCT01079780|65096232|FG002|Overall Study|Treatment cycle delay|1|||
23369142|NCT01079780|65096230|FG000|Overall Study|Never started treatment|1|||
23369143|NCT01079780|65096231|FG001|Overall Study|Never started treatment|0|||
23369144|NCT01079780|65096232|FG002|Overall Study|Never started treatment|2|||
23603038|NCT00403494|65937212|FG001|Overall Study|Lost to Follow-up|2|||
23603039|NCT00403494|65937211|FG000|Overall Study|Protocol noncompliance|0|||
23662402|NCT02716675|66149111|FG001|Overall Study|Other|47|||
23662403|NCT02716675|66149112|FG002|Overall Study|Other|48|||
23603040|NCT00403494|65937212|FG001|Overall Study|Protocol noncompliance|1|||
23603041|NCT00403494|65937211|FG000|Overall Study|Death|1|||
23603042|NCT00403494|65937212|FG001|Overall Study|Death|0|||
23603043|NCT00403494|65937211|FG000|Overall Study|Sponsor Request|1|||
23603044|NCT00403494|65937212|FG001|Overall Study|Sponsor Request|0|||
23603045|NCT02797132|65937213|FG000|Part A (15 Days)|Adverse Event|1|||
23603046|NCT02797132|65937213|FG000|Part B (24 Weeks)|Adverse Event|3|||
23603047|NCT03259568|65937214|FG000|Overall Study|Participant performance was low|3|||
23603048|NCT03589768|65937215|FG000|Overall Study|Death|1|||
23603049|NCT03589768|65937216|FG001|Overall Study|Death|0|||
23603050|NCT03589768|65937217|FG002|Overall Study|Death|8|||
23603051|NCT03589768|65937218|FG003|Overall Study|Death|3|||
23603052|NCT03589768|65937215|FG000|Overall Study|Withdrawal by Subject|2|||
23603053|NCT03589768|65937216|FG001|Overall Study|Withdrawal by Subject|0|||
23603054|NCT03589768|65937217|FG002|Overall Study|Withdrawal by Subject|0|||
23603055|NCT03589768|65937218|FG003|Overall Study|Withdrawal by Subject|0|||
23603056|NCT03589768|65937215|FG000|Overall Study|Protocol Violation|1|||
23603057|NCT03589768|65937216|FG001|Overall Study|Protocol Violation|0|||
23603058|NCT03589768|65937217|FG002|Overall Study|Protocol Violation|0|||
23603059|NCT03589768|65937218|FG003|Overall Study|Protocol Violation|0|||
23603060|NCT02923349|65937222|FG000|Overall Study|Other|1|||
23603061|NCT02923349|65937223|FG001|Overall Study|Other|2|||
23662404|NCT01128361|66149114|FG000|Overall Study|Lost to Follow-up|0|||
23662405|NCT01128361|66149115|FG001|Overall Study|Lost to Follow-up|1|||
23662406|NCT01128361|66149114|FG000|Overall Study|Withdrawal by Subject|5|||
23662407|NCT01128361|66149115|FG001|Overall Study|Withdrawal by Subject|2|||
23662408|NCT04416555|66149116|FG000|Overall Study|Withdrawal by Subject|0|||
23662409|NCT04416555|66149117|FG001|Overall Study|Withdrawal by Subject|3|||
23662410|NCT01301950|66149118|FG000|Overall Study|Surgery was cancelled by patient|0|||
23662411|NCT01301950|66149119|FG001|Overall Study|Surgery was cancelled by patient|1|||
23662412|NCT00915772|66149120|FG000|Overall Study|Adverse Event|12|||
23662413|NCT00915772|66149121|FG001|Overall Study|Adverse Event|13|||
23662414|NCT00915772|66149122|FG002|Overall Study|Adverse Event|11|||
23662415|NCT00915772|66149120|FG000|Overall Study|Protocol Violation|4|||
23662416|NCT00915772|66149121|FG001|Overall Study|Protocol Violation|1|||
23662417|NCT00915772|66149122|FG002|Overall Study|Protocol Violation|2|||
23662418|NCT00915772|66149120|FG000|Overall Study|Lost to Follow-up|1|||
23662419|NCT00915772|66149121|FG001|Overall Study|Lost to Follow-up|2|||
23662420|NCT00915772|66149122|FG002|Overall Study|Lost to Follow-up|2|||
23662421|NCT00915772|66149120|FG000|Overall Study|Lack of Efficacy|9|||
23662422|NCT00915772|66149121|FG001|Overall Study|Lack of Efficacy|15|||
23662423|NCT00915772|66149122|FG002|Overall Study|Lack of Efficacy|3|||
23662424|NCT00915772|66149120|FG000|Overall Study|Refused to continue trial medication|6|||
23662425|NCT00915772|66149121|FG001|Overall Study|Refused to continue trial medication|8|||
23662426|NCT00915772|66149122|FG002|Overall Study|Refused to continue trial medication|4|||
23662427|NCT00915772|66149120|FG000|Overall Study|Any other reason|4|||
23662428|NCT00915772|66149121|FG001|Overall Study|Any other reason|7|||
23662429|NCT00915772|66149122|FG002|Overall Study|Any other reason|7|||
23662430|NCT00307333|66149123|FG000|Overall Study|Lost to Follow-up|11|||
23662431|NCT00307333|66149124|FG001|Overall Study|Lost to Follow-up|3|||
23662432|NCT02354222|66149125|FG000|Overall Study|Adverse Event|0|||
23662433|NCT02354222|66149126|FG001|Overall Study|Adverse Event|3|||
23662434|NCT02354222|66149125|FG000|Overall Study|Physician Decision|1|||
23662435|NCT02354222|66149126|FG001|Overall Study|Physician Decision|1|||
23603062|NCT02923349|65937224|FG002|Overall Study|Other|4|||
23662436|NCT02354222|66149125|FG000|Overall Study|Pregnancy|1|||
23662437|NCT02354222|66149126|FG001|Overall Study|Pregnancy|0|||
23662438|NCT02354222|66149125|FG000|Overall Study|Withdrawal by Subject|2|||
23603063|NCT02923349|65937225|FG003|Overall Study|Other|1|||
23662439|NCT02354222|66149126|FG001|Overall Study|Withdrawal by Subject|3|||
23603064|NCT02923349|65937226|FG004|Overall Study|Other|3|||
23662440|NCT02354222|66149125|FG000|Overall Study|Conflict with the stopping criteria|0|||
23662441|NCT02354222|66149126|FG001|Overall Study|Conflict with the stopping criteria|4|||
23603065|NCT02923349|65937227|FG005|Overall Study|Other|0|||
23603066|NCT02923349|65937228|FG006|Overall Study|Other|1|||
23603067|NCT02923349|65937222|FG000|Overall Study|Withdrawal by Subject|2|||
23603068|NCT02923349|65937223|FG001|Overall Study|Withdrawal by Subject|2|||
23662442|NCT00750698|66149127|FG000|Overall Study|Withdrawal by Subject|1|||
23662443|NCT00750698|66149128|FG001|Overall Study|Withdrawal by Subject|0|||
23662444|NCT00750698|66149127|FG000|Overall Study|Progressive disease|5|||
23662445|NCT00750698|66149128|FG001|Overall Study|Progressive disease|2|||
23662446|NCT01368042|66149129|FG000|Overall Study|Death|14|||
23662447|NCT01368042|66149129|FG000|Overall Study|Protocol Violation|11|||
23662448|NCT01368042|66149129|FG000|Overall Study|Lost to Follow-up|4|||
23662449|NCT01368042|66149129|FG000|Overall Study|Transplanted|1|||
23662450|NCT01942148|66149130|FG000|Overall Study|Adverse Event|4|||
23662451|NCT01942148|66149130|FG000|Overall Study|Lack of Efficacy|2|||
23662452|NCT01942148|66149130|FG000|Overall Study|Physician Decision|11|||
23662453|NCT01942148|66149130|FG000|Overall Study|Protocol Violation|1|||
23662454|NCT01942148|66149130|FG000|Overall Study|Withdrawal by Subject|8|||
23662455|NCT01942148|66149130|FG000|Overall Study|Use of the prohibition medicine|1|||
23662456|NCT02230254|66149131|FG000|Overall Study|Lost to Follow-up|3|||
23662457|NCT03302975|66149132|FG000|Overall Study|Lost to Follow-up|4|||
23662458|NCT01245387|66149133|FG000|Overall Study|Lost to Follow-up|106|||
23662459|NCT01245387|66149133|FG000|Overall Study|Lack of Efficacy|195|||
23662460|NCT01245387|66149133|FG000|Overall Study|Adverse Event|9|||
23662461|NCT01245387|66149133|FG000|Overall Study|Death|3|||
23662462|NCT01245387|66149133|FG000|Overall Study|Other|131|||
23662463|NCT01245387|66149133|FG000|Overall Study|Missing discontinuation status|369|||
23662464|NCT03700320|66149134|FG000|Overall Study|Adverse Event|5|||
23662465|NCT03700320|66149135|FG001|Overall Study|Adverse Event|31|||
23662466|NCT03700320|66149134|FG000|Overall Study|Lack of Efficacy|2|||
23807558|NCT04135196|66672801|FG004|Overall Study|Pregnancy|0|||
23807559|NCT04135196|66672797|FG000|Overall Study|Withdrawal by Subject|0|||
23807560|NCT04135196|66672798|FG001|Overall Study|Withdrawal by Subject|0|||
23807561|NCT04135196|66672799|FG002|Overall Study|Withdrawal by Subject|0|||
23807562|NCT04135196|66672800|FG003|Overall Study|Withdrawal by Subject|0|||
23807563|NCT04135196|66672801|FG004|Overall Study|Withdrawal by Subject|1|||
23807564|NCT00073021|66672805|FG000|Overall Study|Protocol Violation|2|||
23807565|NCT00073021|66672806|FG001|Overall Study|Protocol Violation|1|||
23807566|NCT00073021|66672805|FG000|Overall Study|Adverse Event|4|||
23807567|NCT00073021|66672806|FG001|Overall Study|Adverse Event|4|||
23807568|NCT00073021|66672805|FG000|Overall Study|Withdrawal by Subject|6|||
23807569|NCT00073021|66672806|FG001|Overall Study|Withdrawal by Subject|5|||
23807570|NCT00073021|66672805|FG000|Overall Study|Physician Decision|3|||
23807571|NCT00073021|66672806|FG001|Overall Study|Physician Decision|1|||
23807572|NCT00073021|66672805|FG000|Overall Study|Lack of Efficacy|11|||
23807573|NCT00073021|66672806|FG001|Overall Study|Lack of Efficacy|5|||
23807574|NCT03476343|66672807|FG000|Overall Study|Clinical exam moved to another scanner|7|||
23807575|NCT03476343|66672807|FG000|Overall Study|Clinical order cancelled|4|||
23807576|NCT03476343|66672807|FG000|Overall Study|Neonate did not settle down for the scan|1|||
23807577|NCT01753336|66672808|FG000|Overall Study|Patient decision|12|||
23807578|NCT01753336|66672808|FG000|Overall Study|Lost to Follow-up|3|||
23807579|NCT01753336|66672808|FG000|Overall Study|Physician Decision|2|||
23807580|NCT01753336|66672808|FG000|Overall Study|Sponsor's decision|2|||
23807581|NCT01753336|66672808|FG000|Overall Study|Withdrawal by Subject|1|||
23807582|NCT00914459|66672809|FG000|Overall Study|Protocol Violation|0|||
23807583|NCT00914459|66672810|FG001|Overall Study|Protocol Violation|1|||
23807584|NCT00914459|66672809|FG000|Overall Study|Parent/Legal guardian request|1|||
23807585|NCT00914459|66672810|FG001|Overall Study|Parent/Legal guardian request|0|||
23807586|NCT01449279|66672811|FG000|Overall Study|Lack of Efficacy|5|||
23807587|NCT01449279|66672811|FG000|Overall Study|Toxicity|2|||
23807588|NCT00499174|66672813|FG000|Overall Study|Physician Decision|78|||
23662467|NCT03700320|66149135|FG001|Overall Study|Lack of Efficacy|5|||
23662468|NCT03700320|66149134|FG000|Overall Study|Withdrawal by Subject|29|||
23662469|NCT03700320|66149135|FG001|Overall Study|Withdrawal by Subject|75|||
23662470|NCT03700320|66149134|FG000|Overall Study|Lost to Follow-up|16|||
23662471|NCT03700320|66149135|FG001|Overall Study|Lost to Follow-up|23|||
23662472|NCT03700320|66149134|FG000|Overall Study|Pregnancy|2|||
23662473|NCT03700320|66149135|FG001|Overall Study|Pregnancy|4|||
23662474|NCT03700320|66149134|FG000|Overall Study|Protocol Deviation|7|||
23662475|NCT03700320|66149135|FG001|Overall Study|Protocol Deviation|31|||
23662476|NCT03700320|66149134|FG000|Overall Study|Non-compliance with Study Drug|1|||
23662477|NCT03700320|66149135|FG001|Overall Study|Non-compliance with Study Drug|3|||
23662478|NCT03700320|66149134|FG000|Overall Study|Reason not Specified|0|||
23662479|NCT03700320|66149135|FG001|Overall Study|Reason not Specified|1|||
23662480|NCT04534491|66149136|FG000|Overall Study|Not completed end-of-study interview|24|||
23662481|NCT04534491|66149136|FG000|Overall Study|Non-users|70|||
23369145|NCT01746862|65096235|FG000|Overall Study|Withdrawal by Subject|1|||
23662482|NCT04534491|66149136|FG000|Overall Study|Non-verifiable users|58|||
23662483|NCT02066311|66149137|FG000|Overall Study|Adverse Event|4|||
23662484|NCT02066311|66149137|FG000|Overall Study|Withdrawal by Subject|1|||
23662485|NCT02257372|66152219|FG000|Overall Study|Adverse Event|3|||
23662486|NCT02257372|66152220|FG001|Overall Study|Adverse Event|7|||
23662487|NCT02257372|66152219|FG000|Overall Study|Lack of Efficacy|2|||
23369146|NCT01746862|65096236|FG001|Overall Study|Withdrawal by Subject|1|||
23369147|NCT01746862|65096235|FG000|Overall Study|Protocol Violation|1|||
23369148|NCT01746862|65096236|FG001|Overall Study|Protocol Violation|0|||
23369149|NCT01746862|65096235|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
23369150|NCT01746862|65096236|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
23369151|NCT01746862|65096235|FG000|Overall Study|Entered puberty during the study|1|||
23369152|NCT01746862|65096236|FG001|Overall Study|Entered puberty during the study|0|||
23369153|NCT00617279|65096237|FG000|Overall Study|Study terminated by Sponsor|10|||
23369154|NCT00617279|65096238|FG001|Overall Study|Study terminated by Sponsor|15|||
23369155|NCT00617279|65096237|FG000|Overall Study|Graft abandonment|2|||
23369156|NCT00617279|65096238|FG001|Overall Study|Graft abandonment|0|||
23369157|NCT00617279|65096237|FG000|Overall Study|Lost to Follow-up|1|||
23369158|NCT00617279|65096238|FG001|Overall Study|Lost to Follow-up|0|||
23369159|NCT00617279|65096237|FG000|Overall Study|Death|1|||
23369160|NCT00617279|65096238|FG001|Overall Study|Death|2|||
23369161|NCT02801331|65096239|FG000|Overall Study|Transferred to another hospital|8|||
23369162|NCT02801331|65096240|FG001|Overall Study|Transferred to another hospital|7|||
23662488|NCT02257372|66152220|FG001|Overall Study|Lack of Efficacy|1|||
23662489|NCT02257372|66152219|FG000|Overall Study|Protocol Violation|1|||
23662490|NCT02257372|66152220|FG001|Overall Study|Protocol Violation|1|||
23662491|NCT02257372|66152219|FG000|Overall Study|Lost to Follow-up|0|||
23662492|NCT02257372|66152220|FG001|Overall Study|Lost to Follow-up|1|||
23369163|NCT02801331|65096239|FG000|Overall Study|Withdrawal by Subject|0|||
23662493|NCT02257372|66152219|FG000|Overall Study|Withdrew consent|1|||
23662494|NCT02257372|66152220|FG001|Overall Study|Withdrew consent|0|||
23662495|NCT04869345|66152221|FG000|Overall Study|Lost to Follow-up|8|||
23369164|NCT02801331|65096240|FG001|Overall Study|Withdrawal by Subject|4|||
23369165|NCT02801331|65096239|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
23369166|NCT02801331|65096240|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
23369167|NCT00728494|65096247|FG000|Overall Study|Adverse Event|7|||
23369168|NCT00728494|65096248|FG001|Overall Study|Adverse Event|0|||
23369169|NCT00728494|65096247|FG000|Overall Study|Withdrawal by Subject|0|||
23369170|NCT00728494|65096248|FG001|Overall Study|Withdrawal by Subject|2|||
23369171|NCT00728494|65096247|FG000|Overall Study|Lack of Efficacy|2|||
23369172|NCT00728494|65096248|FG001|Overall Study|Lack of Efficacy|4|||
23369173|NCT00728494|65096247|FG000|Overall Study|No data available|0|||
23369174|NCT00728494|65096248|FG001|Overall Study|No data available|1|||
23369175|NCT01494818|65096249|FG000|Overall Study|Relocation|1|||
23369176|NCT01494818|65096250|FG001|Overall Study|Relocation|2|||
23369177|NCT01494818|65096249|FG000|Overall Study|Lost to Follow-up|1|||
23369178|NCT01494818|65096250|FG001|Overall Study|Lost to Follow-up|0|||
23369179|NCT03769649|65096251|FG000|Overall Study|Lost to Follow-up|4|||
23369180|NCT01305564|65096252|FG000|Overall Study|Death|21|||
23369181|NCT01305564|65096252|FG000|Overall Study|Lost to Follow-up|12|||
23369182|NCT01305564|65096252|FG000|Overall Study|Withdrawal by Subject|1|||
23369183|NCT01305564|65096252|FG000|Overall Study|Physician Decision|3|||
23369184|NCT02087774|65096253|FG000|Overall Study|Were absent day of data collection|8|||
23369185|NCT02087774|65096254|FG001|Overall Study|Were absent day of data collection|20|||
23369186|NCT02100839|65096255|FG000|Multiple Ascending Dose|Adverse Event|2|||
23369187|NCT02100839|65096256|FG001|Multiple Ascending Dose|Adverse Event|0|||
23369188|NCT02100839|65096255|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
23369189|NCT02100839|65096256|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
23369190|NCT01825200|65096257|FG000|Overall Study|Lost to Follow-up|5|||
23369191|NCT01825200|65096258|FG001|Overall Study|Lost to Follow-up|6|||
23369192|NCT01825200|65096257|FG000|Overall Study|Withdrawal by Subject|0|||
23369193|NCT01825200|65096258|FG001|Overall Study|Withdrawal by Subject|1|||
23369194|NCT03163446|65096261|FG000|Overall Study|Unable to return for Day 180 visit|2|||
23369195|NCT03163446|65096262|FG001|Overall Study|Unable to return for Day 180 visit|0|||
23369196|NCT03163446|65096261|FG000|Overall Study|Withdrawal by Subject|2|||
23369197|NCT03163446|65096262|FG001|Overall Study|Withdrawal by Subject|6|||
23369198|NCT03163446|65096261|FG000|Overall Study|Death|16|||
23369199|NCT03163446|65096262|FG001|Overall Study|Death|5|||
23369200|NCT03163446|65096261|FG000|Overall Study|Lost to Follow-up|6|||
23807589|NCT00499174|66672814|FG001|Overall Study|Physician Decision|9|||
23807590|NCT02192164|66672820|FG000|Overall Study|Other|8|||
23807591|NCT02192164|66672820|FG000|Overall Study|Withdrawal by Subject|1|||
23807592|NCT02192164|66672820|FG000|Overall Study|Physician Decision|4|||
23807593|NCT02192164|66672820|FG000|Overall Study|Did not meet the exclusion criteria|1|||
23807594|NCT00855803|66672821|FG000|Overall Study|Death|2|||
23807595|NCT00855803|66672821|FG000|Overall Study|Lost to Follow-up|2|||
23369201|NCT03163446|65096262|FG001|Overall Study|Lost to Follow-up|5|||
23369202|NCT03163446|65096261|FG000|Overall Study|Physician Decision|1|||
23369203|NCT03163446|65096262|FG001|Overall Study|Physician Decision|1|||
23369204|NCT03163446|65096261|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
23369205|NCT03163446|65096262|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
23369206|NCT03191799|65096267|FG000|Overall Study|Withdrawal by Subject|4|||
23369207|NCT03191799|65096267|FG000|Overall Study|Physician Decision|2|||
23369208|NCT03191799|65096267|FG000|Overall Study|Lost to Follow-up|1|||
23369209|NCT03191799|65096267|FG000|Overall Study|Death|2|||
23369210|NCT00111761|65096268|FG000|Part 1|Physician Decision|0|||
23369211|NCT00111761|65096269|FG001|Part 1|Physician Decision|1|||
23369212|NCT00111761|65096268|FG000|Part 1|Death|0|||
23369213|NCT00111761|65096269|FG001|Part 1|Death|2|||
23369214|NCT00111761|65096268|FG000|Part 1|Other|0|||
23369215|NCT00111761|65096269|FG001|Part 1|Other|1|||
23369216|NCT00111761|65096268|FG000|Part 1|Withdrawal by Subject|0|||
23369217|NCT00111761|65096269|FG001|Part 1|Withdrawal by Subject|1|||
23369218|NCT00111761|65096268|FG000|Part 2|Adverse Event|1|||
23369219|NCT00111761|65096269|FG001|Part 2|Adverse Event|0|||
23369220|NCT00111761|65096268|FG000|Part 2|Physician Decision|1|||
23369221|NCT00111761|65096269|FG001|Part 2|Physician Decision|0|||
23369222|NCT00111761|65096268|FG000|Part 2|Death|1|||
23369223|NCT00111761|65096269|FG001|Part 2|Death|0|||
23369224|NCT00111761|65096268|FG000|Part 2|Disease progression|3|||
23369225|NCT00111761|65096269|FG001|Part 2|Disease progression|0|||
23369226|NCT00111761|65096268|FG000|Part 2|Protocol-specified criteria|1|||
23369227|NCT00111761|65096269|FG001|Part 2|Protocol-specified criteria|0|||
23369228|NCT00111761|65096268|FG000|Part 2|Other|1|||
23369229|NCT00111761|65096269|FG001|Part 2|Other|0|||
23369230|NCT01614470|65096270|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
23369231|NCT01614470|65096271|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23369232|NCT01614470|65096272|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23369233|NCT01614470|65096270|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
23369234|NCT01614470|65096271|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
23369235|NCT01614470|65096272|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
23369236|NCT00073918|65096273|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
23369237|NCT00073918|65096273|FG000|Overall Study|Rapid disease progression|2|||
23369238|NCT00073918|65096273|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
23369239|NCT03321721|65096275|FG000|Overall Study|Lost to Follow-up|4|||
23369240|NCT03321721|65096276|FG001|Overall Study|Lost to Follow-up|8|||
23369241|NCT03321721|65096277|FG002|Overall Study|Lost to Follow-up|11|||
23369242|NCT01483118|65096278|FG000|Overall Study|Lost to Follow-up|12|||
23603069|NCT02923349|65937224|FG002|Overall Study|Withdrawal by Subject|8|||
23603070|NCT02923349|65937225|FG003|Overall Study|Withdrawal by Subject|10|||
23603071|NCT02923349|65937226|FG004|Overall Study|Withdrawal by Subject|12|||
23603072|NCT02923349|65937227|FG005|Overall Study|Withdrawal by Subject|3|||
23603073|NCT02923349|65937228|FG006|Overall Study|Withdrawal by Subject|0|||
23603074|NCT02923349|65937222|FG000|Overall Study|Physician Decision|0|||
23603075|NCT02923349|65937223|FG001|Overall Study|Physician Decision|0|||
23369243|NCT01483118|65096279|FG001|Overall Study|Lost to Follow-up|16|||
23369244|NCT00641056|65096280|FG000|Overall Study|Adverse Event|12|||
23369245|NCT00641056|65096281|FG001|Overall Study|Adverse Event|2|||
23369246|NCT00641056|65096280|FG000|Overall Study|Lost to Follow-up|2|||
23603076|NCT02923349|65937224|FG002|Overall Study|Physician Decision|0|||
23369247|NCT00641056|65096281|FG001|Overall Study|Lost to Follow-up|1|||
23369248|NCT00641056|65096280|FG000|Overall Study|Physician Decision|3|||
23369249|NCT00641056|65096281|FG001|Overall Study|Physician Decision|1|||
23369250|NCT00641056|65096280|FG000|Overall Study|Protocol Violation|2|||
23369251|NCT00641056|65096281|FG001|Overall Study|Protocol Violation|0|||
23603077|NCT02923349|65937225|FG003|Overall Study|Physician Decision|1|||
23369252|NCT00641056|65096280|FG000|Overall Study|Entry Criteria Not Met|3|||
23369253|NCT00641056|65096281|FG001|Overall Study|Entry Criteria Not Met|0|||
23369254|NCT00641056|65096280|FG000|Overall Study|Subject Decision|6|||
23369255|NCT00641056|65096281|FG001|Overall Study|Subject Decision|19|||
23369256|NCT00641056|65096280|FG000|Overall Study|Sponsor Decision|1|||
23369257|NCT00641056|65096281|FG001|Overall Study|Sponsor Decision|2|||
23369258|NCT00492726|65096282|FG000|Overall Study|Adverse Event|10|||
23369259|NCT00492726|65096283|FG001|Overall Study|Adverse Event|6|||
23369260|NCT00492726|65096282|FG000|Overall Study|Death|7|||
23369261|NCT00492726|65096283|FG001|Overall Study|Death|2|||
23369262|NCT00492726|65096282|FG000|Overall Study|Lack of Efficacy|0|||
23369263|NCT00492726|65096283|FG001|Overall Study|Lack of Efficacy|2|||
23369264|NCT00492726|65096282|FG000|Overall Study|Lost to Follow-up|27|||
23369265|NCT00492726|65096283|FG001|Overall Study|Lost to Follow-up|19|||
23369266|NCT00492726|65096282|FG000|Overall Study|Physician Decision|0|||
23369267|NCT00492726|65096283|FG001|Overall Study|Physician Decision|1|||
23369268|NCT00492726|65096282|FG000|Overall Study|Withdrawal by Subject|6|||
23369269|NCT00492726|65096283|FG001|Overall Study|Withdrawal by Subject|3|||
23369270|NCT00492726|65096282|FG000|Overall Study|Non compliant with study medication|0|||
23369271|NCT00492726|65096283|FG001|Overall Study|Non compliant with study medication|3|||
23369272|NCT00619827|65096284|FG000|Overall Study|Adverse Event|1|||
23369273|NCT00619827|65096285|FG001|Overall Study|Adverse Event|2|||
23369274|NCT00619827|65096284|FG000|Overall Study|Withdrawal by Subject|2|||
23369275|NCT00619827|65096285|FG001|Overall Study|Withdrawal by Subject|2|||
23369276|NCT02048722|65096286|FG000|2 Cycles of Treatment|Adverse Event|2|||
23369277|NCT02048722|65096286|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
23369278|NCT02048722|65096286|FG000|2 Cycles of Treatment|Progressive Disease|2|||
23369279|NCT02048722|65096286|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
23369280|NCT02048722|65096286|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
23369281|NCT02048722|65096286|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
23369282|NCT02033759|65096289|FG000|Overall Study|Withdrawal by Subject|2|||
23369283|NCT02033759|65096290|FG001|Overall Study|Withdrawal by Subject|1|||
23369284|NCT02033759|65096289|FG000|Overall Study|Protocol Violation|1|||
23369285|NCT02033759|65096290|FG001|Overall Study|Protocol Violation|1|||
23485008|NCT00718081|65518776|FG000|Overall Study|Adverse Event|0|||
23485009|NCT00718081|65518777|FG001|Overall Study|Adverse Event|1|||
23485010|NCT00718081|65518778|FG002|Overall Study|Adverse Event|0|||
23369286|NCT01245101|65096294|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
23603078|NCT02923349|65937226|FG004|Overall Study|Physician Decision|1|||
23603079|NCT02923349|65937227|FG005|Overall Study|Physician Decision|0|||
23603080|NCT02923349|65937228|FG006|Overall Study|Physician Decision|2|||
23603081|NCT02923349|65937222|FG000|Overall Study|Lost to Follow-up|0|||
23662496|NCT04869345|66152222|FG001|Overall Study|Lost to Follow-up|3|||
23662497|NCT01365039|66152223|FG000|Overall Study|Study related symptoms and complaints|1|||
23662498|NCT01365039|66152224|FG001|Overall Study|Study related symptoms and complaints|0|||
23662499|NCT04353596|66152227|FG000|Overall Study|Protocol Violation|4|||
23603082|NCT02923349|65937223|FG001|Overall Study|Lost to Follow-up|0|||
23662500|NCT04353596|66152228|FG001|Overall Study|Protocol Violation|4|||
23369287|NCT01245101|65096295|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
23369288|NCT01245101|65096294|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
23369289|NCT01245101|65096295|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
23369290|NCT01245101|65096294|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
23369291|NCT01245101|65096295|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
23369292|NCT01928771|65096296|FG000|Overall Study|Adverse Event|6|||
23369293|NCT01928771|65096297|FG001|Overall Study|Adverse Event|5|||
23369294|NCT01928771|65096298|FG002|Overall Study|Adverse Event|1|||
23662501|NCT04353596|66152227|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
23662502|NCT04353596|66152228|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
23662503|NCT00820950|66152236|FG000|Overall Study|Scheduling Conflict|0|||
23662504|NCT00820950|66152237|FG001|Overall Study|Scheduling Conflict|0|||
23662505|NCT00820950|66152238|FG002|Overall Study|Scheduling Conflict|0|||
23662506|NCT00820950|66152239|FG003|Overall Study|Scheduling Conflict|0|||
23662507|NCT00820950|66152240|FG004|Overall Study|Scheduling Conflict|0|||
23662508|NCT00820950|66152241|FG005|Overall Study|Scheduling Conflict|0|||
23662509|NCT00820950|66152242|FG006|Overall Study|Scheduling Conflict|1|||
23662510|NCT00820950|66152243|FG007|Overall Study|Scheduling Conflict|1|||
23662511|NCT00820950|66152244|FG008|Overall Study|Scheduling Conflict|0|||
23662512|NCT00820950|66152245|FG009|Overall Study|Scheduling Conflict|0|||
23662513|NCT00820950|66152236|FG000|Overall Study|Protocol Violation|1|||
23662514|NCT00820950|66152237|FG001|Overall Study|Protocol Violation|1|||
23662515|NCT00820950|66152238|FG002|Overall Study|Protocol Violation|0|||
23369295|NCT01928771|65096296|FG000|Overall Study|Death|2|||
23369296|NCT01928771|65096297|FG001|Overall Study|Death|2|||
23662516|NCT00820950|66152239|FG003|Overall Study|Protocol Violation|0|||
23662517|NCT00820950|66152240|FG004|Overall Study|Protocol Violation|0|||
23662518|NCT00820950|66152241|FG005|Overall Study|Protocol Violation|0|||
23662519|NCT00820950|66152242|FG006|Overall Study|Protocol Violation|0|||
23662520|NCT00820950|66152243|FG007|Overall Study|Protocol Violation|0|||
23369297|NCT01928771|65096298|FG002|Overall Study|Death|2|||
23369298|NCT01928771|65096296|FG000|Overall Study|Lost to Follow-up|5|||
23369299|NCT01928771|65096297|FG001|Overall Study|Lost to Follow-up|6|||
23369300|NCT01928771|65096298|FG002|Overall Study|Lost to Follow-up|3|||
23369301|NCT01928771|65096296|FG000|Overall Study|Withdrawal by Subject|20|||
23369302|NCT01928771|65096297|FG001|Overall Study|Withdrawal by Subject|15|||
23369303|NCT01928771|65096298|FG002|Overall Study|Withdrawal by Subject|17|||
23369304|NCT01928771|65096296|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23369305|NCT01928771|65096297|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23369306|NCT01928771|65096298|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
23369307|NCT01928771|65096296|FG000|Overall Study|Other Reasons|9|||
23369308|NCT01928771|65096297|FG001|Overall Study|Other Reasons|9|||
23369309|NCT01928771|65096298|FG002|Overall Study|Other Reasons|14|||
23369310|NCT01928771|65096296|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23369311|NCT01928771|65096297|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23369312|NCT01928771|65096298|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
23369313|NCT03638128|65096302|FG000|Overall Study|Withdrawal by Subject|1|||
23662521|NCT00820950|66152244|FG008|Overall Study|Protocol Violation|0|||
23662522|NCT00820950|66152245|FG009|Overall Study|Protocol Violation|0|||
23662523|NCT03511053|66152246|FG000|Overall Study|Withdrawal by Subject|1|||
23662524|NCT00282295|66152247|FG000|Overall Study|Adverse Event|0|||
23662525|NCT00282295|66152248|FG001|Overall Study|Adverse Event|1|||
23662526|NCT00282295|66152249|FG002|Overall Study|Adverse Event|0|||
23662527|NCT00282295|66152247|FG000|Overall Study|Serious Adverse Events|0|||
23369314|NCT03638128|65096303|FG001|Overall Study|Withdrawal by Subject|7|||
23369315|NCT03638128|65096304|FG002|Overall Study|Withdrawal by Subject|6|||
23369316|NCT03638128|65096302|FG000|Overall Study|Sponsor Decision|15|||
23369317|NCT03638128|65096303|FG001|Overall Study|Sponsor Decision|12|||
23369318|NCT03638128|65096304|FG002|Overall Study|Sponsor Decision|19|||
23369319|NCT03638128|65096302|FG000|Overall Study|Lost to Follow-up|0|||
23369320|NCT03638128|65096303|FG001|Overall Study|Lost to Follow-up|0|||
23369321|NCT03638128|65096304|FG002|Overall Study|Lost to Follow-up|1|||
23369322|NCT01309386|65099051|FG000|Overall Study|Other|2|||
23369323|NCT01309386|65099052|FG001|Overall Study|Other|0|||
23369324|NCT01309386|65099051|FG000|Overall Study|Withdrawal by Subject|2|||
23369325|NCT01309386|65099052|FG001|Overall Study|Withdrawal by Subject|0|||
23369326|NCT01309386|65099051|FG000|Overall Study|Progressive disease|9|||
23369327|NCT01309386|65099052|FG001|Overall Study|Progressive disease|11|||
23369328|NCT01309386|65099051|FG000|Overall Study|Physician Decision|1|||
23369329|NCT01309386|65099052|FG001|Overall Study|Physician Decision|1|||
23369330|NCT01309386|65099051|FG000|Overall Study|Lack of Efficacy|3|||
23369331|NCT01309386|65099052|FG001|Overall Study|Lack of Efficacy|1|||
23369332|NCT01309386|65099051|FG000|Overall Study|Adverse Event|5|||
23662528|NCT00282295|66152248|FG001|Overall Study|Serious Adverse Events|0|||
23369333|NCT01309386|65099052|FG001|Overall Study|Adverse Event|8|||
23369334|NCT03642990|65099055|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
23369335|NCT03642990|65099055|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
23369336|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
23369337|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
23369338|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
23369339|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
23369340|NCT00104052|65099064|FG000|Overall Study|Adverse Event|1|||
23369341|NCT00104052|65099064|FG000|Overall Study|Lack of Efficacy|26|||
23369342|NCT00104052|65099064|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
23369343|NCT01118052|65099068|FG000|Overall Study|Never treated|2|||
23369344|NCT02187783|65099069|FG000|Overall Study|Adverse Event|8|||
23369345|NCT02187783|65099069|FG000|Overall Study|Death|3|||
23369346|NCT02187783|65099069|FG000|Overall Study|Progressive disease|80|||
23369347|NCT02187783|65099069|FG000|Overall Study|Protocol Violation|3|||
23369348|NCT02187783|65099069|FG000|Overall Study|Physician Decision|2|||
23662529|NCT00282295|66152249|FG002|Overall Study|Serious Adverse Events|1|||
23662530|NCT00282295|66152247|FG000|Overall Study|Protocol Violation|0|||
23369349|NCT02187783|65099069|FG000|Overall Study|Withdrawal by Subject|9|||
23369350|NCT02187783|65099069|FG000|Overall Study|Study terminated by sponsor|1|||
23369351|NCT02175225|65099070|FG000|Overall Study|Withdrawal by Subject|1|||
23369352|NCT02175225|65099071|FG001|Overall Study|Withdrawal by Subject|2|||
23369353|NCT02175225|65099070|FG000|Overall Study|Lost to Follow-up|6|||
23369354|NCT02175225|65099071|FG001|Overall Study|Lost to Follow-up|7|||
23369355|NCT02175225|65099070|FG000|Overall Study|Study drug not administered|1|||
23369356|NCT02175225|65099071|FG001|Overall Study|Study drug not administered|2|||
23369357|NCT02849587|65099072|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
23369358|NCT02849587|65099073|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
23369359|NCT02849587|65099074|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
23369360|NCT02849587|65099072|FG000|Overall Study|Withdrawal by Subject|0|||
23369361|NCT02849587|65099073|FG001|Overall Study|Withdrawal by Subject|1|||
23369362|NCT02849587|65099074|FG002|Overall Study|Withdrawal by Subject|0|||
23369363|NCT00666237|65099087|FG000|Overall Study|Death|5|||
23369364|NCT00666237|65099088|FG001|Overall Study|Death|5|||
23369365|NCT00666237|65099087|FG000|Overall Study|Lost to Follow-up|29|||
23369366|NCT00666237|65099088|FG001|Overall Study|Lost to Follow-up|25|||
23369367|NCT02027025|65099089|FG000|Overall Study|Adverse Event|0|||
23369368|NCT02027025|65099090|FG001|Overall Study|Adverse Event|1|||
23369369|NCT02027025|65099091|FG002|Overall Study|Adverse Event|1|||
23369370|NCT02027025|65099089|FG000|Overall Study|Protocol Violation|1|||
23369371|NCT02027025|65099090|FG001|Overall Study|Protocol Violation|0|||
23369372|NCT02027025|65099091|FG002|Overall Study|Protocol Violation|0|||
23369373|NCT02027025|65099089|FG000|Overall Study|Lost to Follow-up|0|||
23369374|NCT02027025|65099090|FG001|Overall Study|Lost to Follow-up|2|||
23369375|NCT02027025|65099091|FG002|Overall Study|Lost to Follow-up|0|||
23369376|NCT02027025|65099089|FG000|Overall Study|Withdrawal by Subject|0|||
23369377|NCT02027025|65099090|FG001|Overall Study|Withdrawal by Subject|1|||
23369378|NCT02027025|65099091|FG002|Overall Study|Withdrawal by Subject|0|||
23369379|NCT02027025|65099089|FG000|Overall Study|Sponsor's decision|0|||
23369380|NCT02027025|65099090|FG001|Overall Study|Sponsor's decision|1|||
23603083|NCT02923349|65937224|FG002|Overall Study|Lost to Follow-up|3|||
23603084|NCT02923349|65937225|FG003|Overall Study|Lost to Follow-up|0|||
23603085|NCT02923349|65937226|FG004|Overall Study|Lost to Follow-up|1|||
23603086|NCT02923349|65937227|FG005|Overall Study|Lost to Follow-up|1|||
23603087|NCT02923349|65937228|FG006|Overall Study|Lost to Follow-up|0|||
23603088|NCT02923349|65937222|FG000|Overall Study|Death|1|||
23603089|NCT02923349|65937223|FG001|Overall Study|Death|0|||
23603090|NCT02923349|65937224|FG002|Overall Study|Death|2|||
23603091|NCT02923349|65937225|FG003|Overall Study|Death|4|||
23603092|NCT02923349|65937226|FG004|Overall Study|Death|2|||
23603093|NCT02923349|65937227|FG005|Overall Study|Death|3|||
23603094|NCT02923349|65937228|FG006|Overall Study|Death|0|||
23603095|NCT00738400|65937229|FG000|Overall Study|Adverse Event|3|||
23603096|NCT00738400|65937230|FG001|Overall Study|Adverse Event|1|||
23603097|NCT00738400|65937229|FG000|Overall Study|Withdrawal by Subject|0|||
23603098|NCT00738400|65937230|FG001|Overall Study|Withdrawal by Subject|1|||
23603099|NCT00738400|65937229|FG000|Overall Study|Lack of Efficacy|0|||
23603100|NCT00738400|65937230|FG001|Overall Study|Lack of Efficacy|1|||
23603101|NCT00738400|65937229|FG000|Overall Study|Lost to Follow-up|0|||
23603102|NCT00738400|65937230|FG001|Overall Study|Lost to Follow-up|3|||
23662531|NCT00282295|66152248|FG001|Overall Study|Protocol Violation|2|||
23662532|NCT00282295|66152249|FG002|Overall Study|Protocol Violation|1|||
23369381|NCT02027025|65099091|FG002|Overall Study|Sponsor's decision|0|||
23369382|NCT01814007|65099092|FG000|Overall Study|Withdrawal by Subject|1|||
23369383|NCT00975416|65099093|FG000|Overall Study|early discharge from tx|3|||
23369384|NCT00975416|65099094|FG001|Overall Study|early discharge from tx|5|||
23369385|NCT00879658|65099099|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23369386|NCT00879658|65099100|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23369387|NCT00879658|65099101|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23369388|NCT00879658|65099102|FG003|Overall Study|Abnormal laboratory value(s)|1|||
23369389|NCT00879658|65099103|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23369390|NCT00879658|65099104|FG005|Overall Study|Abnormal laboratory value(s)|0|||
23369391|NCT00879658|65099105|FG006|Overall Study|Abnormal laboratory value(s)|0|||
23369392|NCT00879658|65099099|FG000|Overall Study|Administrative problems|2|||
23369393|NCT00879658|65099100|FG001|Overall Study|Administrative problems|1|||
23369394|NCT00879658|65099101|FG002|Overall Study|Administrative problems|0|||
23369395|NCT00879658|65099102|FG003|Overall Study|Administrative problems|1|||
23369396|NCT00879658|65099103|FG004|Overall Study|Administrative problems|0|||
23369397|NCT00879658|65099104|FG005|Overall Study|Administrative problems|0|||
23369398|NCT00879658|65099105|FG006|Overall Study|Administrative problems|0|||
23369399|NCT00879658|65099099|FG000|Overall Study|Adverse Event|6|||
23369400|NCT00879658|65099100|FG001|Overall Study|Adverse Event|4|||
23369401|NCT00879658|65099101|FG002|Overall Study|Adverse Event|3|||
23369402|NCT00879658|65099102|FG003|Overall Study|Adverse Event|1|||
23369403|NCT00879658|65099103|FG004|Overall Study|Adverse Event|2|||
23369404|NCT00879658|65099104|FG005|Overall Study|Adverse Event|0|||
23369405|NCT00879658|65099105|FG006|Overall Study|Adverse Event|0|||
23369406|NCT00879658|65099099|FG000|Overall Study|Protocol Violation|1|||
23369407|NCT00879658|65099100|FG001|Overall Study|Protocol Violation|0|||
23369408|NCT00879658|65099101|FG002|Overall Study|Protocol Violation|0|||
23369409|NCT00879658|65099102|FG003|Overall Study|Protocol Violation|0|||
23369410|NCT00879658|65099103|FG004|Overall Study|Protocol Violation|0|||
23369411|NCT00879658|65099104|FG005|Overall Study|Protocol Violation|0|||
23369412|NCT00879658|65099105|FG006|Overall Study|Protocol Violation|0|||
23369413|NCT00879658|65099099|FG000|Overall Study|Withdrawal by Subject|3|||
23369414|NCT00879658|65099100|FG001|Overall Study|Withdrawal by Subject|0|||
23369415|NCT00879658|65099101|FG002|Overall Study|Withdrawal by Subject|2|||
23369416|NCT00879658|65099102|FG003|Overall Study|Withdrawal by Subject|0|||
23369417|NCT00879658|65099103|FG004|Overall Study|Withdrawal by Subject|0|||
23369418|NCT00879658|65099104|FG005|Overall Study|Withdrawal by Subject|1|||
23369419|NCT00879658|65099105|FG006|Overall Study|Withdrawal by Subject|0|||
23369420|NCT00879658|65099099|FG000|Overall Study|Lack of Efficacy|0|||
23369421|NCT00879658|65099100|FG001|Overall Study|Lack of Efficacy|0|||
23369422|NCT00879658|65099101|FG002|Overall Study|Lack of Efficacy|2|||
23369423|NCT00879658|65099102|FG003|Overall Study|Lack of Efficacy|0|||
23662533|NCT00282295|66152247|FG000|Overall Study|Withdrawal by Subject|2|||
23662534|NCT00282295|66152248|FG001|Overall Study|Withdrawal by Subject|6|||
23369424|NCT00879658|65099103|FG004|Overall Study|Lack of Efficacy|0|||
23369425|NCT00879658|65099104|FG005|Overall Study|Lack of Efficacy|0|||
23369426|NCT00879658|65099105|FG006|Overall Study|Lack of Efficacy|0|||
23369427|NCT00879658|65099099|FG000|Overall Study|misrandomized (never received study med)|0|||
23369428|NCT00879658|65099100|FG001|Overall Study|misrandomized (never received study med)|0|||
23662535|NCT00282295|66152249|FG002|Overall Study|Withdrawal by Subject|4|||
23662536|NCT00282295|66152247|FG000|Overall Study|Lost to Follow-up|1|||
23662537|NCT00282295|66152248|FG001|Overall Study|Lost to Follow-up|7|||
23662538|NCT00282295|66152249|FG002|Overall Study|Lost to Follow-up|2|||
23662539|NCT00282295|66152247|FG000|Overall Study|Other|0|||
23662540|NCT00282295|66152248|FG001|Overall Study|Other|1|||
23662541|NCT00282295|66152249|FG002|Overall Study|Other|0|||
23662542|NCT03349775|66152250|FG000|Overall Study|Side Effects|1|||
23662543|NCT03349775|66152251|FG001|Overall Study|Side Effects|2|||
23662544|NCT03349775|66152250|FG000|Overall Study|Withdrawal by Subject|1|||
23662545|NCT03349775|66152251|FG001|Overall Study|Withdrawal by Subject|1|||
23662546|NCT03349775|66152250|FG000|Overall Study|No primary outcome measurements|0|||
23662547|NCT03349775|66152251|FG001|Overall Study|No primary outcome measurements|1|||
23662548|NCT05092919|66152253|FG000|Overall Study|Lost to Follow-up|7|||
23662549|NCT05092919|66152253|FG000|Overall Study|Withdrawal by Subject|2|||
23662550|NCT02109562|66152257|FG000|Overall Study|Insufficient clinical response|2|||
23662551|NCT02109562|66152258|FG001|Overall Study|Insufficient clinical response|0|||
23662552|NCT02109562|66152259|FG002|Overall Study|Insufficient clinical response|4|||
23662553|NCT02109562|66152257|FG000|Overall Study|Adverse Event|0|||
23662554|NCT02109562|66152258|FG001|Overall Study|Adverse Event|2|||
23662555|NCT02109562|66152259|FG002|Overall Study|Adverse Event|3|||
23662556|NCT02109562|66152257|FG000|Overall Study|Lost to Follow-up|1|||
23662557|NCT02109562|66152258|FG001|Overall Study|Lost to Follow-up|0|||
23662558|NCT02109562|66152259|FG002|Overall Study|Lost to Follow-up|1|||
23662559|NCT02109562|66152257|FG000|Overall Study|Protocol Violation|0|||
23662560|NCT02109562|66152258|FG001|Overall Study|Protocol Violation|3|||
23662561|NCT02109562|66152259|FG002|Overall Study|Protocol Violation|1|||
23662562|NCT02109562|66152257|FG000|Overall Study|Withdrawal by Subject|20|||
23369429|NCT00879658|65099101|FG002|Overall Study|misrandomized (never received study med)|0|||
23662563|NCT02109562|66152258|FG001|Overall Study|Withdrawal by Subject|25|||
23662564|NCT02109562|66152259|FG002|Overall Study|Withdrawal by Subject|21|||
23662565|NCT02109562|66152257|FG000|Overall Study|Physician Decision|3|||
23662566|NCT02109562|66152258|FG001|Overall Study|Physician Decision|4|||
23662567|NCT02109562|66152259|FG002|Overall Study|Physician Decision|5|||
23662568|NCT02490475|66152265|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
23485011|NCT00718081|65518776|FG000|Overall Study|Lack of Efficacy|7|||
23662569|NCT02490475|66152266|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
23369430|NCT00879658|65099102|FG003|Overall Study|misrandomized (never received study med)|1|||
23369431|NCT00879658|65099103|FG004|Overall Study|misrandomized (never received study med)|0|||
23485012|NCT00718081|65518777|FG001|Overall Study|Lack of Efficacy|3|||
23485013|NCT00718081|65518778|FG002|Overall Study|Lack of Efficacy|21|||
23485014|NCT00322153|65518779|FG000|Overall Study|Adverse Event|21|||
23485015|NCT00322153|65518780|FG001|Overall Study|Adverse Event|34|||
23662570|NCT02490475|66152267|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
23662571|NCT02490475|66152268|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
23662572|NCT02490475|66152265|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23662573|NCT02490475|66152266|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
23662574|NCT02490475|66152267|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23662575|NCT02490475|66152268|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23662576|NCT02490475|66152265|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
23662577|NCT02490475|66152266|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
23662578|NCT02490475|66152267|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
23662579|NCT02490475|66152268|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
23662580|NCT02490475|66152265|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
23662581|NCT02490475|66152266|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
23662582|NCT02490475|66152267|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
23662583|NCT02490475|66152268|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
23662584|NCT02490475|66152265|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
23662585|NCT02490475|66152266|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
23662586|NCT02490475|66152267|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
23662587|NCT02490475|66152268|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
23662588|NCT02490475|66152265|FG000|Period 2: Extension Phase|Refused Treatment|0|||
23662589|NCT02490475|66152266|FG001|Period 2: Extension Phase|Refused Treatment|0|||
23662590|NCT02490475|66152267|FG002|Period 2: Extension Phase|Refused Treatment|0|||
23662591|NCT02490475|66152268|FG003|Period 2: Extension Phase|Refused Treatment|1|||
23662592|NCT02490475|66152265|FG000|Period 2: Extension Phase|Adverse Event|0|||
23662593|NCT02490475|66152266|FG001|Period 2: Extension Phase|Adverse Event|0|||
23662594|NCT02490475|66152267|FG002|Period 2: Extension Phase|Adverse Event|1|||
23662595|NCT02490475|66152268|FG003|Period 2: Extension Phase|Adverse Event|0|||
23662596|NCT00766038|66152269|FG000|Overall Study|Lost to Follow-up|15|||
23662597|NCT00766038|66152270|FG001|Overall Study|Lost to Follow-up|14|||
23662598|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Adverse Event|2|||
23662599|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Adverse Event|2|||
23662600|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Adverse Event|4|||
23662601|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Adverse Event|0|||
23662602|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Adverse Event|0|||
23662603|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Progressive disease|0|||
23662604|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Progressive disease|0|||
23662605|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Progressive disease|1|||
23662606|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Progressive disease|0|||
23662607|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Progressive disease|0|||
23662608|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
23662609|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
23662610|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
23662611|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
23662612|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
23662613|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
23662614|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23662615|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23662616|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23603103|NCT00738400|65937229|FG000|Overall Study|Protocol Violation|1|||
23603104|NCT00738400|65937230|FG001|Overall Study|Protocol Violation|0|||
23603105|NCT00738400|65937229|FG000|Overall Study|Non-compliant with study medication|0|||
23603106|NCT00738400|65937230|FG001|Overall Study|Non-compliant with study medication|1|||
23603107|NCT00569166|65937231|FG000|Overall Study|Withdrawal by Subject|7|||
23603108|NCT00569166|65937232|FG001|Overall Study|Withdrawal by Subject|5|||
23603109|NCT00569166|65937233|FG002|Overall Study|Withdrawal by Subject|3|||
23603110|NCT00569166|65937231|FG000|Overall Study|Lost to Follow-up|2|||
23603111|NCT00569166|65937232|FG001|Overall Study|Lost to Follow-up|1|||
23603112|NCT00569166|65937233|FG002|Overall Study|Lost to Follow-up|1|||
23603113|NCT01719172|65937234|FG000|Overall Study|Lost to Follow-up|1|||
23603114|NCT01719172|65937234|FG000|Overall Study|Death|1|||
23603115|NCT01583166|65937235|FG000|Overall Study|Withdrawal by Subject|4|||
23603116|NCT01583166|65937236|FG001|Overall Study|Withdrawal by Subject|6|||
23603117|NCT01523392|65937237|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23603118|NCT01523392|65937238|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23603119|NCT01523392|65937237|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
23603120|NCT01523392|65937238|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
23603121|NCT01523392|65937237|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
23603122|NCT01523392|65937238|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
23603123|NCT00523419|65937239|FG000|Overall Study|Adverse Event|1|||
23603124|NCT00523419|65937239|FG000|Overall Study|Withdrawal by Subject|1|||
23662617|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23662618|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
23662619|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
23662620|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
23662621|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
23662622|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
23662623|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
23662624|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
23662625|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
23662626|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
23662627|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
23662628|NCT03523728|66152271|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
23662629|NCT03523728|66152272|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
23603125|NCT00523419|65937239|FG000|Overall Study|Physician Decision|2|||
23662630|NCT03523728|66152273|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
23662631|NCT03523728|66152274|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
23662632|NCT03523728|66152275|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
23603126|NCT00523419|65937239|FG000|Overall Study|Progressive Disease|22|||
23662633|NCT03523728|66152271|FG000|Stage 2 (24 Months)|Adverse Event|0|||
23662634|NCT03523728|66152272|FG001|Stage 2 (24 Months)|Adverse Event|0|||
23662635|NCT03523728|66152273|FG002|Stage 2 (24 Months)|Adverse Event|0|||
23662636|NCT03523728|66152274|FG003|Stage 2 (24 Months)|Adverse Event|1|||
23662637|NCT03523728|66152275|FG004|Stage 2 (24 Months)|Adverse Event|2|||
23662638|NCT03523728|66152271|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23603127|NCT00523419|65937239|FG000|Overall Study|Death due to Study Disease|4|||
23369432|NCT00879658|65099104|FG005|Overall Study|misrandomized (never received study med)|0|||
23369433|NCT00879658|65099105|FG006|Overall Study|misrandomized (never received study med)|0|||
23369434|NCT01811732|65099106|FG000|Overall Study|Lost to Follow-up|24|||
23369435|NCT01811732|65099107|FG001|Overall Study|Lost to Follow-up|30|||
23369436|NCT01811732|65099106|FG000|Overall Study|Withdrawal by Subject|16|||
23369437|NCT01811732|65099107|FG001|Overall Study|Withdrawal by Subject|10|||
23369438|NCT01811732|65099106|FG000|Overall Study|Adverse Event|3|||
23369439|NCT01811732|65099107|FG001|Overall Study|Adverse Event|9|||
23369440|NCT01811732|65099106|FG000|Overall Study|Lack of Efficacy|3|||
23369441|NCT01811732|65099107|FG001|Overall Study|Lack of Efficacy|1|||
23369442|NCT01811732|65099106|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
23369443|NCT01811732|65099107|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
23369444|NCT01811732|65099106|FG000|Overall Study|Physician Decision|2|||
23369445|NCT01811732|65099107|FG001|Overall Study|Physician Decision|0|||
23369446|NCT01811732|65099106|FG000|Overall Study|Death|1|||
23369447|NCT01811732|65099107|FG001|Overall Study|Death|1|||
23369448|NCT01811732|65099106|FG000|Overall Study|Insufficient venous access|0|||
23369449|NCT01811732|65099107|FG001|Overall Study|Insufficient venous access|1|||
23369450|NCT01811732|65099106|FG000|Overall Study|Protocol Violation|0|||
23369451|NCT01811732|65099107|FG001|Overall Study|Protocol Violation|1|||
23369452|NCT01811732|65099106|FG000|Overall Study|Subject incarcerated|1|||
23603128|NCT00523419|65937239|FG000|Overall Study|Death due to Adverse Event|2|||
23603129|NCT02095678|65937242|FG000|Overall Study|Withdrawal by Subject|0|||
23603130|NCT02095678|65937243|FG001|Overall Study|Withdrawal by Subject|1|||
23603131|NCT02095678|65937242|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
23603132|NCT02095678|65937243|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
23603133|NCT02095678|65937242|FG000|Overall Study|lesion impacted by previous treatment|1|||
23603134|NCT02095678|65937243|FG001|Overall Study|lesion impacted by previous treatment|1|||
23603135|NCT02095678|65937242|FG000|Overall Study|No Confirmed Diagnosis|0|||
23603136|NCT02095678|65937243|FG001|Overall Study|No Confirmed Diagnosis|3|||
23603137|NCT02095678|65937242|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
23603138|NCT02095678|65937243|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
23603139|NCT02095678|65937242|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
23603140|NCT02095678|65937243|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
23603141|NCT01313663|65937248|FG000|Overall Study|Study Closed/Terminated|2|||
23603142|NCT01313663|65937249|FG001|Overall Study|Study Closed/Terminated|4|||
23603143|NCT01313663|65937248|FG000|Overall Study|Lost to Follow-up|0|||
23603144|NCT01313663|65937249|FG001|Overall Study|Lost to Follow-up|1|||
23603145|NCT01313663|65937248|FG000|Overall Study|Physician Decision|0|||
23603146|NCT01313663|65937249|FG001|Overall Study|Physician Decision|2|||
23603147|NCT01313663|65937248|FG000|Overall Study|Withdrawal by Subject|2|||
23603148|NCT01313663|65937249|FG001|Overall Study|Withdrawal by Subject|1|||
23603149|NCT00747006|65937256|FG000|Overall Study|Adverse Event|1|||
23603150|NCT00747006|65937257|FG001|Overall Study|Adverse Event|0|||
23603151|NCT00747006|65937258|FG002|Overall Study|Adverse Event|0|||
23603152|NCT00747006|65937256|FG000|Overall Study|Lost to Follow-up|0|||
23603153|NCT00747006|65937257|FG001|Overall Study|Lost to Follow-up|1|||
23603154|NCT00747006|65937258|FG002|Overall Study|Lost to Follow-up|0|||
23603155|NCT00747006|65937256|FG000|Overall Study|Physician Decision|2|||
23603156|NCT00747006|65937257|FG001|Overall Study|Physician Decision|0|||
23603157|NCT00747006|65937258|FG002|Overall Study|Physician Decision|1|||
23662639|NCT03523728|66152272|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23369453|NCT01811732|65099107|FG001|Overall Study|Subject incarcerated|2|||
23369454|NCT01811732|65099106|FG000|Overall Study|Admitted to another facility|1|||
23603158|NCT01812759|65937259|FG000|Overall Study|Physician Decision|0|||
23485016|NCT00322153|65518779|FG000|Overall Study|Protocol Violation|6|||
23603159|NCT01812759|65937260|FG001|Overall Study|Physician Decision|0|||
23603160|NCT01812759|65937261|FG002|Overall Study|Physician Decision|1|||
23662640|NCT03523728|66152273|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23662641|NCT03523728|66152274|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23662642|NCT03523728|66152275|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
23662643|NCT03523728|66152271|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23662644|NCT03523728|66152272|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23662645|NCT03523728|66152273|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23662646|NCT03523728|66152274|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
23603161|NCT01092416|65937262|FG000|Enrollment|Atherectomy device not inserted|3|||
23603162|NCT01092416|65937262|FG000|30-Day Follow-up|Death|2|||
23603163|NCT01092416|65937262|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
23603164|NCT01092416|65937262|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
23369455|NCT01811732|65099107|FG001|Overall Study|Admitted to another facility|0|||
23369456|NCT01811732|65099106|FG000|Overall Study|Correct study drug not available on site|1|||
23369457|NCT01811732|65099107|FG001|Overall Study|Correct study drug not available on site|0|||
23369458|NCT00296244|65099110|FG000|Overall Study|Underwent retransplant|0|||
23369459|NCT00296244|65099111|FG001|Overall Study|Underwent retransplant|1|||
23369460|NCT00848497|65099112|FG000|Overall Study|Screen failure|2|||
23369461|NCT00848497|65099113|FG001|Overall Study|Screen failure|0|||
23369462|NCT00848497|65099112|FG000|Overall Study|Withdrawal by Subject|0|||
23369463|NCT00848497|65099113|FG001|Overall Study|Withdrawal by Subject|1|||
23369464|NCT01123655|65099114|FG000|Overall Study|Medication for RA had to be changed|1|||
23369465|NCT01123655|65099115|FG001|Overall Study|Medication for RA had to be changed|0|||
23369466|NCT01123655|65099116|FG002|Overall Study|Medication for RA had to be changed|0|||
23369467|NCT01123655|65099114|FG000|Overall Study|new illness|0|||
23485017|NCT00322153|65518780|FG001|Overall Study|Protocol Violation|14|||
23485018|NCT00322153|65518779|FG000|Overall Study|Withdrawal by Subject|18|||
23485019|NCT00322153|65518780|FG001|Overall Study|Withdrawal by Subject|10|||
23603165|NCT01092416|65937262|FG000|12-Month Follow-up|Death|16|||
23485020|NCT00322153|65518779|FG000|Overall Study|Lack of Efficacy|8|||
23485021|NCT00322153|65518780|FG001|Overall Study|Lack of Efficacy|3|||
23485022|NCT00322153|65518779|FG000|Overall Study|Lost to Follow-up|5|||
23485023|NCT00322153|65518780|FG001|Overall Study|Lost to Follow-up|4|||
23485024|NCT00322153|65518779|FG000|Overall Study|Withdrawn for other reasons|5|||
23485025|NCT00322153|65518780|FG001|Overall Study|Withdrawn for other reasons|4|||
23485026|NCT00442468|65518781|FG000|Overall Study|Adverse Event|4|||
23485027|NCT00442468|65518781|FG000|Overall Study|Withdrawal by Subject|91|||
23485028|NCT00442468|65518781|FG000|Overall Study|Did not complete all study procedures|88|||
23485029|NCT00194675|65518783|FG000|Overall Study|Lost to Follow-up|1|||
23485030|NCT00194675|65518784|FG001|Overall Study|Lost to Follow-up|1|||
23485031|NCT00194675|65518783|FG000|Overall Study|lack of interest|1|||
23485032|NCT00194675|65518784|FG001|Overall Study|lack of interest|1|||
23485033|NCT00194675|65518783|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
23485034|NCT00194675|65518784|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
23485035|NCT00194675|65518783|FG000|Overall Study|Protocol Violation|1|||
23485036|NCT00194675|65518784|FG001|Overall Study|Protocol Violation|0|||
23485037|NCT00194675|65518783|FG000|Overall Study|Death|1|||
23485038|NCT00194675|65518784|FG001|Overall Study|Death|0|||
23485039|NCT01673282|65518785|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
23485040|NCT01673282|65518786|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
23485041|NCT01673282|65518785|FG000|Overall Study|Lack of Efficacy|9|||
23485042|NCT01673282|65518786|FG001|Overall Study|Lack of Efficacy|2|||
23485043|NCT01673282|65518785|FG000|Overall Study|Lost to Follow-up|11|||
23485044|NCT01673282|65518786|FG001|Overall Study|Lost to Follow-up|10|||
23485045|NCT01673282|65518785|FG000|Overall Study|Withdrawal by Subject|3|||
23485046|NCT01673282|65518786|FG001|Overall Study|Withdrawal by Subject|3|||
23485047|NCT01673282|65518785|FG000|Overall Study|Other|1|||
23485048|NCT01673282|65518786|FG001|Overall Study|Other|6|||
23485049|NCT03475875|65518787|FG000|Period 1|Lost to Follow-up|1|||
23485050|NCT03475875|65518788|FG001|Period 1|Lost to Follow-up|0|||
23485051|NCT03475875|65518787|FG000|Period 1|Adverse Event|2|||
23485052|NCT03475875|65518788|FG001|Period 1|Adverse Event|1|||
23485053|NCT03475875|65518787|FG000|Period 2|Adverse Event|3|||
23485054|NCT03475875|65518788|FG001|Period 2|Adverse Event|0|||
23603166|NCT01092416|65937262|FG000|12-Month Follow-up|Lost to Follow-up|4|||
23603167|NCT01092416|65937262|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
23603168|NCT01092416|65937262|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
23603169|NCT01092416|65937262|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
23662647|NCT03523728|66152275|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
23662648|NCT03523728|66152271|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
23369468|NCT01123655|65099115|FG001|Overall Study|new illness|1|||
23485055|NCT03475875|65518787|FG000|Period 2|Protocol Violation|0|||
23485056|NCT03475875|65518788|FG001|Period 2|Protocol Violation|1|||
23369469|NCT01123655|65099116|FG002|Overall Study|new illness|0|||
23485057|NCT01479985|65518792|FG000|Overall Study|Tablet malfunction, no data saved|1|||
23485058|NCT01479985|65518793|FG001|Overall Study|Tablet malfunction, no data saved|1|||
23485059|NCT01479985|65518792|FG000|Overall Study|No decisional conflict scale responses|0|||
23603170|NCT01074242|65937265|FG000|Overall Study|Case report before date of contract|40|||
23603171|NCT01074242|65937265|FG000|Overall Study|Lost to Follow-up|1|||
23603172|NCT01074242|65937265|FG000|Overall Study|Case report unclear|6|||
23603173|NCT01074242|65937265|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
23603174|NCT01074242|65937265|FG000|Overall Study|Duplicate Case Report Form|5|||
23603175|NCT04867382|65937267|FG000|Overall Study|Did not complete the survey|2|||
23603176|NCT04867382|65937268|FG001|Overall Study|Did not complete the survey|1|||
23603177|NCT00845520|65937269|FG000|Overall Study|Death|1|||
23603178|NCT00845520|65937270|FG001|Overall Study|Death|2|||
23603179|NCT00845520|65937271|FG002|Overall Study|Death|0|||
23603180|NCT00845520|65937269|FG000|Overall Study|Lost to Follow-up|1|||
23603181|NCT00845520|65937270|FG001|Overall Study|Lost to Follow-up|0|||
23603182|NCT00845520|65937271|FG002|Overall Study|Lost to Follow-up|0|||
23485060|NCT01479985|65518793|FG001|Overall Study|No decisional conflict scale responses|2|||
23603183|NCT00845520|65937269|FG000|Overall Study|Adverse Event|0|||
23662649|NCT03523728|66152272|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
23662650|NCT03523728|66152273|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
23485061|NCT01479985|65518792|FG000|Overall Study|No post-visit survey|5|||
23485062|NCT01479985|65518793|FG001|Overall Study|No post-visit survey|3|||
23485063|NCT04099251|65518794|FG000|Pre-Treatment|Other reasons|1|||
23485064|NCT04099251|65518795|FG001|Pre-Treatment|Other reasons|0|||
23485065|NCT04099251|65518794|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
23485066|NCT04099251|65518795|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
23485067|NCT04099251|65518794|FG000|Blinded Treatment Phase|Other reasons|16|||
23485068|NCT04099251|65518795|FG001|Blinded Treatment Phase|Other reasons|7|||
23485069|NCT04099251|65518794|FG000|Blinded Treatment Phase|Disease recurrence|26|||
23485070|NCT04099251|65518795|FG001|Blinded Treatment Phase|Disease recurrence|41|||
23485071|NCT04099251|65518794|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
23485072|NCT04099251|65518795|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
23485073|NCT04099251|65518794|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
23603184|NCT00845520|65937270|FG001|Overall Study|Adverse Event|0|||
23603185|NCT00845520|65937271|FG002|Overall Study|Adverse Event|1|||
23662651|NCT03523728|66152274|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
23603186|NCT01450007|65937279|FG000|Overall Study|Late exclusion before treatment|2|||
23603187|NCT01450007|65937280|FG001|Overall Study|Late exclusion before treatment|3|||
23485074|NCT04099251|65518795|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
23603188|NCT01450007|65937281|FG002|Overall Study|Late exclusion before treatment|2|||
23603189|NCT01450007|65937279|FG000|Overall Study|Protocol Violation|0|||
23603190|NCT01450007|65937280|FG001|Overall Study|Protocol Violation|1|||
23603191|NCT01450007|65937281|FG002|Overall Study|Protocol Violation|1|||
23603192|NCT01450007|65937279|FG000|Overall Study|Adverse Event|0|||
23603193|NCT01450007|65937280|FG001|Overall Study|Adverse Event|1|||
23603194|NCT01450007|65937281|FG002|Overall Study|Adverse Event|0|||
23603195|NCT01436175|65937282|FG000|Overall Study|Adverse Event|111|||
23603196|NCT01436175|65937282|FG000|Overall Study|Protocol Violation|49|||
23603197|NCT01436175|65937282|FG000|Overall Study|Withdrawal by Subject|108|||
23603198|NCT01436175|65937282|FG000|Overall Study|Lost to Follow-up|89|||
23603199|NCT01436175|65937282|FG000|Overall Study|Lack of Efficacy|24|||
23603200|NCT01436175|65937282|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
23662652|NCT03523728|66152275|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
23662653|NCT03523728|66152271|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
23662654|NCT03523728|66152272|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
23662655|NCT03523728|66152273|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
23662656|NCT03523728|66152274|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
23662657|NCT03523728|66152275|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
23662658|NCT03029143|66152284|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
23662659|NCT03029143|66152285|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
23662660|NCT03029143|66152286|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
23662661|NCT03029143|66152284|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
23662662|NCT03029143|66152285|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
23662663|NCT03029143|66152286|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
23662664|NCT03029143|66152284|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
23662665|NCT03029143|66152285|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
23662666|NCT03029143|66152286|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
23662667|NCT03029143|66152284|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
23662668|NCT03029143|66152285|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
23662669|NCT03029143|66152286|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
23662670|NCT03029143|66152284|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
23662671|NCT03029143|66152285|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
23662672|NCT03029143|66152286|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
23662673|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
23662674|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
23662675|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
23662676|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
23662677|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
23662678|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
23662679|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23662680|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23662681|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
23662682|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
23662683|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
23662684|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
23662685|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23662686|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
23662687|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
23662688|NCT03029143|66152284|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
23662689|NCT03029143|66152285|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
23662690|NCT03029143|66152286|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
23662691|NCT04425720|66152287|FG000|Overall Study|Withdrawal by Subject|0|||
23662692|NCT04425720|66152288|FG001|Overall Study|Withdrawal by Subject|20|||
23662693|NCT05418673|66152289|FG000|Overall Study|Study Terminated by Sponsor|2|||
23662694|NCT05418673|66152290|FG001|Overall Study|Study Terminated by Sponsor|4|||
23662695|NCT05418673|66152289|FG000|Overall Study|Lost to Follow-up|1|||
23662696|NCT05418673|66152290|FG001|Overall Study|Lost to Follow-up|0|||
23662697|NCT02248259|66152291|FG000|Treatment Period 1|Adverse Event|0|||
23603201|NCT01436175|65937282|FG000|Overall Study|Other|826|||
23662698|NCT02248259|66152292|FG001|Treatment Period 1|Adverse Event|0|||
23662699|NCT02248259|66152293|FG002|Treatment Period 1|Adverse Event|1|||
23662700|NCT02248259|66152294|FG003|Treatment Period 1|Adverse Event|0|||
23662701|NCT03631784|66152295|FG000|Overall Study|Death|48|||
23662702|NCT03631784|66152296|FG001|Overall Study|Death|28|||
23662703|NCT03631784|66152295|FG000|Overall Study|Lost to Follow-up|1|||
23662704|NCT03631784|66152296|FG001|Overall Study|Lost to Follow-up|0|||
23603202|NCT03987074|65937287|FG000|Overall Study|Withdrew Consent|1|||
23603203|NCT03987074|65937288|FG001|Overall Study|Withdrew Consent|1|||
23662705|NCT03631784|66152295|FG000|Overall Study|Withdrawal by Subject|0|||
23662706|NCT03631784|66152296|FG001|Overall Study|Withdrawal by Subject|3|||
23662707|NCT03631784|66152295|FG000|Overall Study|Participants Ongoing|63|||
23662708|NCT03631784|66152296|FG001|Overall Study|Participants Ongoing|71|||
23662709|NCT03061175|66152297|FG000|Baseline|Participant was deemed ineligible|1|||
23662710|NCT03061175|66152298|FG001|Baseline|Participant was deemed ineligible|0|||
23662711|NCT03061175|66152297|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
23662712|NCT03061175|66152298|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
23662713|NCT03061175|66152297|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
23662714|NCT03061175|66152298|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
23662715|NCT03061175|66152297|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
23662716|NCT03061175|66152298|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
23662717|NCT00243386|66152299|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
23662718|NCT00243386|66152300|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
23662719|NCT00243386|66152301|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
23662720|NCT00243386|66152299|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
23662721|NCT00243386|66152300|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
23662722|NCT00243386|66152301|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
23662723|NCT00243386|66152299|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
23662724|NCT00243386|66152300|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
23662725|NCT00243386|66152301|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
23662726|NCT00243386|66152299|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
23662727|NCT00243386|66152300|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
23662728|NCT00243386|66152301|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
23662729|NCT00243386|66152299|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
23662730|NCT00243386|66152300|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
23662731|NCT00243386|66152301|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
23662732|NCT00243386|66152299|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
23662733|NCT00243386|66152300|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
23662734|NCT00243386|66152301|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
23662735|NCT00243386|66152299|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
23662736|NCT00243386|66152300|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
23662737|NCT00243386|66152301|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
23662738|NCT00243386|66152299|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
23662739|NCT00243386|66152300|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
23662740|NCT00243386|66152301|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
23662741|NCT03823404|66152302|FG000|Overall Study|Lost to Follow-up|1|||
23662742|NCT03823404|66152303|FG001|Overall Study|Lost to Follow-up|2|||
23662743|NCT03823404|66152304|FG002|Overall Study|Lost to Follow-up|3|||
23662744|NCT03823404|66152302|FG000|Overall Study|Protocol Violation|2|||
23662745|NCT03823404|66152303|FG001|Overall Study|Protocol Violation|0|||
23662746|NCT03823404|66152304|FG002|Overall Study|Protocol Violation|2|||
23662747|NCT03823404|66152302|FG000|Overall Study|Adverse Event|35|||
23662748|NCT03823404|66152303|FG001|Overall Study|Adverse Event|38|||
23662749|NCT03823404|66152304|FG002|Overall Study|Adverse Event|8|||
23662750|NCT03823404|66152302|FG000|Overall Study|Withdrawal by Subject|38|||
23662751|NCT03823404|66152303|FG001|Overall Study|Withdrawal by Subject|40|||
23662752|NCT03823404|66152304|FG002|Overall Study|Withdrawal by Subject|35|||
23662753|NCT03823404|66152302|FG000|Overall Study|Death|4|||
23662754|NCT03823404|66152303|FG001|Overall Study|Death|0|||
23662755|NCT03823404|66152304|FG002|Overall Study|Death|0|||
23662756|NCT03823404|66152302|FG000|Overall Study|Other: Various reasons provided|5|||
23662757|NCT03823404|66152303|FG001|Overall Study|Other: Various reasons provided|5|||
23662758|NCT03823404|66152304|FG002|Overall Study|Other: Various reasons provided|6|||
23662759|NCT01469182|66152313|FG000|Overall Study|Adverse Event|21|||
23662760|NCT01469182|66152314|FG001|Overall Study|Adverse Event|3|||
23662761|NCT01469182|66152313|FG000|Overall Study|Lost to Follow-up|3|||
23662762|NCT01469182|66152314|FG001|Overall Study|Lost to Follow-up|0|||
23662763|NCT01469182|66152313|FG000|Overall Study|Withdrawal by Subject|4|||
23662764|NCT01469182|66152314|FG001|Overall Study|Withdrawal by Subject|1|||
23662765|NCT01469182|66152313|FG000|Overall Study|Protocol Violation|4|||
23662766|NCT01469182|66152314|FG001|Overall Study|Protocol Violation|2|||
23662767|NCT01469182|66152313|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
23662768|NCT01469182|66152314|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
23662769|NCT00432042|66152315|FG000|Overall Study|Protocol Violation|2|||
23662770|NCT00432042|66152316|FG001|Overall Study|Protocol Violation|0|||
23662771|NCT00432042|66152317|FG002|Overall Study|Protocol Violation|0|||
23662772|NCT00432042|66152315|FG000|Overall Study|Withdrawal by Subject|0|||
23662773|NCT00432042|66152316|FG001|Overall Study|Withdrawal by Subject|0|||
23662774|NCT00432042|66152317|FG002|Overall Study|Withdrawal by Subject|2|||
23662775|NCT00432042|66152315|FG000|Overall Study|Lost to Follow-up|5|||
23662776|NCT00432042|66152316|FG001|Overall Study|Lost to Follow-up|1|||
23662777|NCT00432042|66152317|FG002|Overall Study|Lost to Follow-up|0|||
23662778|NCT01205230|66152320|FG000|Overall Study|Adverse Event|4|||
23662779|NCT01205230|66152321|FG001|Overall Study|Adverse Event|0|||
23662780|NCT01205230|66152320|FG000|Overall Study|Physician Decision|1|||
23662781|NCT01205230|66152321|FG001|Overall Study|Physician Decision|0|||
23662782|NCT03975920|66152323|FG000|Overall Study|Lost to Follow-up|1|||
23662783|NCT03975920|66152324|FG001|Overall Study|Lost to Follow-up|2|||
23662784|NCT03975920|66152323|FG000|Overall Study|Protocol Violation|1|||
23662785|NCT03975920|66152324|FG001|Overall Study|Protocol Violation|1|||
23369470|NCT01123655|65099114|FG000|Overall Study|began prohibitive drug|0|||
23369471|NCT01123655|65099115|FG001|Overall Study|began prohibitive drug|0|||
23369472|NCT01123655|65099116|FG002|Overall Study|began prohibitive drug|1|||
23369473|NCT03191552|65099120|FG000|Overall Study|Lost to Follow-up|1|||
23369474|NCT03191552|65099121|FG001|Overall Study|Lost to Follow-up|0|||
23369475|NCT03191552|65099122|FG002|Overall Study|Lost to Follow-up|0|||
23369476|NCT03191552|65099120|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
23369477|NCT03191552|65099121|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
23369478|NCT03191552|65099122|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
23369479|NCT01100502|65099123|FG000|Overall Study|Withdrawal by Subject|18|||
23369480|NCT01100502|65099124|FG001|Overall Study|Withdrawal by Subject|25|||
23369481|NCT01100502|65099123|FG000|Overall Study|Lost to Follow-up|13|||
23369482|NCT01100502|65099124|FG001|Overall Study|Lost to Follow-up|28|||
23369483|NCT01100502|65099123|FG000|Overall Study|Site request to end participation in study|0|||
23369484|NCT01100502|65099124|FG001|Overall Study|Site request to end participation in study|1|||
23369485|NCT01100502|65099123|FG000|Overall Study|Death|45|||
23369486|NCT01100502|65099124|FG001|Overall Study|Death|40|||
23369487|NCT00828711|65099125|FG000|Overall Study|Lost to Follow-up|1|||
23369488|NCT00828711|65099126|FG001|Overall Study|Lost to Follow-up|0|||
23369489|NCT00828711|65099127|FG002|Overall Study|Lost to Follow-up|0|||
23369490|NCT03087058|65099128|FG000|Overall Study|Withdrawal by Subject|2|||
23369491|NCT03087058|65099129|FG001|Overall Study|Withdrawal by Subject|0|||
23662786|NCT03975920|66152323|FG000|Overall Study|Did not complete survey|2|||
23662787|NCT03975920|66152324|FG001|Overall Study|Did not complete survey|1|||
23662788|NCT01471015|66152332|FG000|Overall Study|Death|0|||
23662789|NCT01471015|66152333|FG001|Overall Study|Death|1|||
23662790|NCT01471015|66152334|FG002|Overall Study|Death|1|||
23662791|NCT03069352|66152335|FG000|Overall Study|Ongoing|12|||
23662792|NCT03069352|66152336|FG001|Overall Study|Ongoing|40|||
23662793|NCT01924182|66152339|FG000|Overall Study|Withdrawal by Subject|1|||
23662794|NCT01924182|66152340|FG001|Overall Study|Withdrawal by Subject|0|||
23662795|NCT01380379|66152341|FG000|Overall Study|Pregnancy|1|||
23369492|NCT03087058|65099130|FG002|Overall Study|Withdrawal by Subject|0|||
23369493|NCT02563899|65099131|FG000|Overall Study|Protocol Violation|1|||
23369494|NCT02563899|65099132|FG001|Overall Study|Protocol Violation|0|||
23369495|NCT02563899|65099133|FG002|Overall Study|Protocol Violation|0|||
23369496|NCT02563899|65099134|FG003|Overall Study|Protocol Violation|0|||
23603204|NCT03987074|65937289|FG002|Overall Study|Withdrew Consent|0|||
23603205|NCT03987074|65937290|FG003|Overall Study|Withdrew Consent|2|||
23603206|NCT03987074|65937291|FG004|Overall Study|Withdrew Consent|1|||
23603207|NCT03987074|65937287|FG000|Overall Study|Adverse Event|2|||
23603208|NCT03987074|65937288|FG001|Overall Study|Adverse Event|1|||
23603209|NCT03987074|65937289|FG002|Overall Study|Adverse Event|0|||
23603210|NCT03987074|65937290|FG003|Overall Study|Adverse Event|0|||
23603211|NCT03987074|65937291|FG004|Overall Study|Adverse Event|1|||
23603212|NCT03987074|65937287|FG000|Overall Study|Lost to Follow-up|0|||
23369497|NCT02563899|65099131|FG000|Overall Study|Withdrawal by Subject|0|||
23369498|NCT02563899|65099132|FG001|Overall Study|Withdrawal by Subject|0|||
23485075|NCT04099251|65518794|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
23603213|NCT03987074|65937288|FG001|Overall Study|Lost to Follow-up|0|||
23603214|NCT03987074|65937289|FG002|Overall Study|Lost to Follow-up|1|||
23369499|NCT02563899|65099133|FG002|Overall Study|Withdrawal by Subject|1|||
23369500|NCT02563899|65099134|FG003|Overall Study|Withdrawal by Subject|0|||
23369501|NCT02247466|65099143|FG000|Overall Study|Procedure changed to open surgery|0|||
23369502|NCT02247466|65099144|FG001|Overall Study|Procedure changed to open surgery|3|||
23369503|NCT01294423|65099145|FG000|Overall Study|Adverse Event|1|||
23369504|NCT01294423|65099146|FG001|Overall Study|Adverse Event|2|||
23369505|NCT01294423|65099147|FG002|Overall Study|Adverse Event|3|||
23369506|NCT01294423|65099145|FG000|Overall Study|Withdrawal by Subject|1|||
23369507|NCT01294423|65099146|FG001|Overall Study|Withdrawal by Subject|2|||
23369508|NCT01294423|65099147|FG002|Overall Study|Withdrawal by Subject|2|||
23369509|NCT01294423|65099145|FG000|Overall Study|subject no longer meets study criteria|2|||
23369510|NCT01294423|65099146|FG001|Overall Study|subject no longer meets study criteria|5|||
23369511|NCT01294423|65099147|FG002|Overall Study|subject no longer meets study criteria|2|||
23369512|NCT01294423|65099145|FG000|Overall Study|poor/non-compliance|1|||
23369513|NCT01294423|65099146|FG001|Overall Study|poor/non-compliance|0|||
23603215|NCT03987074|65937290|FG003|Overall Study|Lost to Follow-up|1|||
23603216|NCT03987074|65937291|FG004|Overall Study|Lost to Follow-up|0|||
23603217|NCT03987074|65937287|FG000|Overall Study|Investigator's Discretion|0|||
23603218|NCT03987074|65937288|FG001|Overall Study|Investigator's Discretion|0|||
23603219|NCT03987074|65937289|FG002|Overall Study|Investigator's Discretion|0|||
23603220|NCT03987074|65937290|FG003|Overall Study|Investigator's Discretion|1|||
23603221|NCT03987074|65937291|FG004|Overall Study|Investigator's Discretion|0|||
23662796|NCT04641299|66152345|FG000|Overall Study|Adverse Event|0|||
23662797|NCT04641299|66152346|FG001|Overall Study|Adverse Event|0|||
23662798|NCT04641299|66152347|FG002|Overall Study|Adverse Event|2|||
23662799|NCT04641299|66152348|FG003|Overall Study|Adverse Event|0|||
23603222|NCT01128595|65937292|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23603223|NCT01128595|65937293|FG001|Treatment Period 3|Withdrawal by Subject|1|||
23662800|NCT04641299|66152345|FG000|Overall Study|Lost to Follow-up|0|||
23662801|NCT04641299|66152346|FG001|Overall Study|Lost to Follow-up|1|||
23662802|NCT04641299|66152347|FG002|Overall Study|Lost to Follow-up|0|||
23662803|NCT04641299|66152348|FG003|Overall Study|Lost to Follow-up|0|||
23369514|NCT01294423|65099147|FG002|Overall Study|poor/non-compliance|1|||
23603224|NCT01128595|65937294|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23603225|NCT01128595|65937295|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23603226|NCT00391170|65937296|FG000|Overall Study|Withdrawal by Subject|1|||
23603227|NCT00391170|65937297|FG001|Overall Study|Withdrawal by Subject|0|||
23603228|NCT00391170|65937296|FG000|Overall Study|Adverse Event|3|||
23603229|NCT00391170|65937297|FG001|Overall Study|Adverse Event|2|||
23603230|NCT00391170|65937296|FG000|Overall Study|Physician Decision|2|||
23603231|NCT00391170|65937297|FG001|Overall Study|Physician Decision|2|||
23603232|NCT01989689|65937300|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
23603233|NCT01989689|65937301|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
23603234|NCT01989689|65937300|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
23603235|NCT01989689|65937301|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
23603236|NCT00312208|65937302|FG000|Overall Study|Adverse Event|97|||
23603237|NCT00312208|65937303|FG001|Overall Study|Adverse Event|61|||
23662804|NCT04641299|66152345|FG000|Overall Study|Withdrawal by Subject|1|||
23369515|NCT00909870|65099149|FG000|Overall Study|Adverse Event|13|||
23603238|NCT00312208|65937302|FG000|Overall Study|Protocol Violation|5|||
23603239|NCT00312208|65937303|FG001|Overall Study|Protocol Violation|3|||
23603240|NCT00312208|65937302|FG000|Overall Study|Death|2|||
23369516|NCT00909870|65099150|FG001|Overall Study|Adverse Event|7|||
23662805|NCT04641299|66152346|FG001|Overall Study|Withdrawal by Subject|0|||
23662806|NCT04641299|66152347|FG002|Overall Study|Withdrawal by Subject|0|||
23662807|NCT04641299|66152348|FG003|Overall Study|Withdrawal by Subject|0|||
23662808|NCT04641299|66152345|FG000|Overall Study|Reason not given|1|||
23662809|NCT04641299|66152346|FG001|Overall Study|Reason not given|0|||
23662810|NCT04641299|66152347|FG002|Overall Study|Reason not given|0|||
23662811|NCT04641299|66152348|FG003|Overall Study|Reason not given|0|||
23662812|NCT03179891|66152349|FG000|First Intervention|Withdrawal by Subject|1|||
23662813|NCT03179891|66152350|FG001|First Intervention|Withdrawal by Subject|1|||
23662814|NCT03179891|66152349|FG000|First Intervention|Unspecified reason|1|||
23662815|NCT03179891|66152350|FG001|First Intervention|Unspecified reason|0|||
23662816|NCT03179891|66152349|FG000|First Intervention|Protocol Violation|0|||
23662817|NCT03179891|66152350|FG001|First Intervention|Protocol Violation|1|||
23662818|NCT00733954|66152352|FG000|Overall Study|Lost to Follow-up|5|||
23662819|NCT00733954|66152353|FG001|Overall Study|Lost to Follow-up|2|||
23662820|NCT00733954|66152352|FG000|Overall Study|Protocol Violation|1|||
23662821|NCT00733954|66152353|FG001|Overall Study|Protocol Violation|0|||
23662822|NCT00733954|66152352|FG000|Overall Study|Withdrawal by Subject|2|||
23662823|NCT00733954|66152353|FG001|Overall Study|Withdrawal by Subject|0|||
23662824|NCT01473563|66152354|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
23603241|NCT00312208|65937303|FG001|Overall Study|Death|1|||
23662825|NCT00806195|66152355|FG000|Overall Study|Death|6|||
23662826|NCT00806195|66152356|FG001|Overall Study|Death|0|||
23662827|NCT00806195|66152357|FG002|Overall Study|Death|1|||
23662828|NCT00806195|66152358|FG003|Overall Study|Death|0|||
23662829|NCT00806195|66152355|FG000|Overall Study|Adverse Event|25|||
23662830|NCT00806195|66152356|FG001|Overall Study|Adverse Event|5|||
23662831|NCT00806195|66152357|FG002|Overall Study|Adverse Event|11|||
23662832|NCT00806195|66152358|FG003|Overall Study|Adverse Event|2|||
23662833|NCT00806195|66152355|FG000|Overall Study|Withdrawal by Subject|119|||
23662834|NCT00806195|66152356|FG001|Overall Study|Withdrawal by Subject|31|||
23662835|NCT00806195|66152357|FG002|Overall Study|Withdrawal by Subject|76|||
23662836|NCT00806195|66152358|FG003|Overall Study|Withdrawal by Subject|35|||
23662837|NCT00806195|66152355|FG000|Overall Study|Lost to Follow-up|217|||
23662838|NCT00806195|66152356|FG001|Overall Study|Lost to Follow-up|66|||
23662839|NCT00806195|66152357|FG002|Overall Study|Lost to Follow-up|90|||
23662840|NCT00806195|66152358|FG003|Overall Study|Lost to Follow-up|34|||
23662841|NCT00806195|66152355|FG000|Overall Study|Inappropriate Enrollment|0|||
23662842|NCT00806195|66152356|FG001|Overall Study|Inappropriate Enrollment|1|||
23662843|NCT00806195|66152357|FG002|Overall Study|Inappropriate Enrollment|0|||
23662844|NCT00806195|66152358|FG003|Overall Study|Inappropriate Enrollment|0|||
23662845|NCT00806195|66152355|FG000|Overall Study|Administrative Reason|113|||
23662846|NCT00806195|66152356|FG001|Overall Study|Administrative Reason|35|||
23662847|NCT00806195|66152357|FG002|Overall Study|Administrative Reason|66|||
23662848|NCT00806195|66152358|FG003|Overall Study|Administrative Reason|26|||
23662849|NCT00806195|66152355|FG000|Overall Study|Protocol Violation|34|||
23662850|NCT00806195|66152356|FG001|Overall Study|Protocol Violation|24|||
23662851|NCT00806195|66152357|FG002|Overall Study|Protocol Violation|26|||
23662852|NCT00806195|66152358|FG003|Overall Study|Protocol Violation|9|||
23662853|NCT00382018|66152359|FG000|Overall Study|Progression|0|||
23662854|NCT00382018|66152360|FG001|Overall Study|Progression|136|||
23662855|NCT00382018|66152361|FG002|Overall Study|Progression|51|||
23662856|NCT00382018|66152362|FG003|Overall Study|Progression|43|||
23662857|NCT00382018|66152359|FG000|Overall Study|Death|0|||
23662858|NCT00382018|66152360|FG001|Overall Study|Death|9|||
23662859|NCT00382018|66152361|FG002|Overall Study|Death|7|||
23662860|NCT00382018|66152362|FG003|Overall Study|Death|11|||
23662861|NCT00382018|66152359|FG000|Overall Study|Withdrawal by Subject|0|||
23662862|NCT00382018|66152360|FG001|Overall Study|Withdrawal by Subject|4|||
23662863|NCT00382018|66152361|FG002|Overall Study|Withdrawal by Subject|3|||
23662864|NCT00382018|66152362|FG003|Overall Study|Withdrawal by Subject|4|||
23662865|NCT00382018|66152359|FG000|Overall Study|Other, not protocol specified|0|||
23662866|NCT00382018|66152360|FG001|Overall Study|Other, not protocol specified|16|||
23662867|NCT00382018|66152361|FG002|Overall Study|Other, not protocol specified|3|||
23662868|NCT00382018|66152362|FG003|Overall Study|Other, not protocol specified|1|||
23662869|NCT04202679|66152365|FG000|Overall Study|Adverse Event|2|||
23662870|NCT04202679|66152366|FG001|Overall Study|Adverse Event|0|||
23662871|NCT04202679|66152365|FG000|Overall Study|Poor compliance to protocol|1|||
23662872|NCT04202679|66152366|FG001|Overall Study|Poor compliance to protocol|0|||
23662873|NCT04202679|66152365|FG000|Overall Study|Withdrawal by Subject|23|||
23662874|NCT04202679|66152366|FG001|Overall Study|Withdrawal by Subject|6|||
23662875|NCT00827606|66152378|FG000|Overall Study|Protocol Violation|4|||
23662876|NCT00827606|66152379|FG001|Overall Study|Protocol Violation|3|||
23662877|NCT00827606|66152378|FG000|Overall Study|Lost to Follow-up|3|||
23662878|NCT00827606|66152379|FG001|Overall Study|Lost to Follow-up|1|||
23662879|NCT00827606|66152378|FG000|Overall Study|Withdrawal by Subject|7|||
23662880|NCT00827606|66152379|FG001|Overall Study|Withdrawal by Subject|6|||
23662881|NCT00827606|66152378|FG000|Overall Study|Pregnancy|0|||
23662882|NCT00827606|66152379|FG001|Overall Study|Pregnancy|1|||
23662883|NCT00827606|66152378|FG000|Overall Study|Other|5|||
23662884|NCT00827606|66152379|FG001|Overall Study|Other|13|||
23662885|NCT00827606|66152378|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
23662886|NCT00827606|66152379|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
23662887|NCT00827606|66152378|FG000|Overall Study|Adverse Event|4|||
23662888|NCT00827606|66152379|FG001|Overall Study|Adverse Event|2|||
23662889|NCT01054144|66152380|FG000|Overall Study|Death|2|||
23662890|NCT02625233|66152381|FG000|Overall Study|Adverse Event|2|||
23662891|NCT02625233|66152382|FG001|Overall Study|Adverse Event|0|||
23662892|NCT00467779|66152383|FG000|Stage 1|Adverse Event|1|||
23662893|NCT00467779|66152384|FG001|Stage 1|Adverse Event|0|||
23662894|NCT00467779|66152385|FG002|Stage 1|Adverse Event|0|||
23662895|NCT00467779|66152386|FG003|Stage 1|Adverse Event|0|||
23662896|NCT00467779|66152387|FG004|Stage 1|Adverse Event|0|||
23662897|NCT00467779|66152388|FG005|Stage 1|Adverse Event|1|||
23662898|NCT00467779|66152389|FG006|Stage 1|Adverse Event|2|||
23662899|NCT00467779|66152390|FG007|Stage 1|Adverse Event|1|||
23662900|NCT00467779|66152391|FG008|Stage 1|Adverse Event|0|||
23662901|NCT00467779|66152392|FG009|Stage 1|Adverse Event|0|||
23662902|NCT00467779|66152393|FG010|Stage 1|Adverse Event|0|||
23662903|NCT00467779|66152394|FG011|Stage 1|Adverse Event|0|||
23662904|NCT00467779|66152395|FG012|Stage 1|Adverse Event|0|||
23662905|NCT00467779|66152396|FG013|Stage 1|Adverse Event|0|||
23662906|NCT00467779|66152397|FG014|Stage 1|Adverse Event|0|||
23662907|NCT00467779|66152383|FG000|Stage 1|Disease Progression|2|||
23662908|NCT00467779|66152384|FG001|Stage 1|Disease Progression|2|||
23662909|NCT00467779|66152385|FG002|Stage 1|Disease Progression|2|||
23662910|NCT00467779|66152386|FG003|Stage 1|Disease Progression|3|||
23662911|NCT00467779|66152387|FG004|Stage 1|Disease Progression|2|||
23662912|NCT00467779|66152388|FG005|Stage 1|Disease Progression|2|||
23662913|NCT00467779|66152389|FG006|Stage 1|Disease Progression|4|||
23662914|NCT00467779|66152390|FG007|Stage 1|Disease Progression|5|||
23662915|NCT00467779|66152391|FG008|Stage 1|Disease Progression|0|||
23662916|NCT00467779|66152392|FG009|Stage 1|Disease Progression|0|||
23662917|NCT00467779|66152393|FG010|Stage 1|Disease Progression|0|||
23662918|NCT00467779|66152394|FG011|Stage 1|Disease Progression|0|||
23662919|NCT00467779|66152395|FG012|Stage 1|Disease Progression|0|||
23662920|NCT00467779|66152396|FG013|Stage 1|Disease Progression|0|||
23662921|NCT00467779|66152397|FG014|Stage 1|Disease Progression|0|||
23662922|NCT00467779|66152383|FG000|Stage 1|Unspecified Reason|1|||
23662923|NCT00467779|66152384|FG001|Stage 1|Unspecified Reason|0|||
23662924|NCT00467779|66152385|FG002|Stage 1|Unspecified Reason|1|||
23662925|NCT00467779|66152386|FG003|Stage 1|Unspecified Reason|0|||
23662926|NCT00467779|66152387|FG004|Stage 1|Unspecified Reason|1|||
23603242|NCT00312208|65937302|FG000|Overall Study|Lack of Efficacy|7|||
23603243|NCT00312208|65937303|FG001|Overall Study|Lack of Efficacy|4|||
23603244|NCT00312208|65937302|FG000|Overall Study|Lost to Follow-up|3|||
23603245|NCT00312208|65937303|FG001|Overall Study|Lost to Follow-up|5|||
23603246|NCT00312208|65937302|FG000|Overall Study|Withdrawal by Subject|53|||
23603247|NCT00312208|65937303|FG001|Overall Study|Withdrawal by Subject|42|||
23603248|NCT00312208|65937302|FG000|Overall Study|Other|5|||
23603249|NCT00312208|65937303|FG001|Overall Study|Other|7|||
23603250|NCT00360269|65937304|FG000|Overall Study|Lost to Follow-up|7|||
23603251|NCT00360269|65937305|FG001|Overall Study|Lost to Follow-up|9|||
23603252|NCT00360269|65937304|FG000|Overall Study|Physician Decision|1|||
23603253|NCT00360269|65937305|FG001|Overall Study|Physician Decision|2|||
23603254|NCT00360269|65937304|FG000|Overall Study|Adverse Event|1|||
23603255|NCT00360269|65937305|FG001|Overall Study|Adverse Event|0|||
23603256|NCT00360269|65937304|FG000|Overall Study|Withdrawal by Subject|1|||
23603257|NCT00360269|65937305|FG001|Overall Study|Withdrawal by Subject|1|||
23603258|NCT00776009|65937309|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
23603259|NCT00776009|65937310|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
23603260|NCT00776009|65937311|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
23603261|NCT00776009|65937312|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
23603262|NCT00776009|65937313|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
23603263|NCT00776009|65937314|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
23603264|NCT00776009|65937309|FG000|Period 1: First Intervention|Protocol Violation|0|||
23603265|NCT00776009|65937310|FG001|Period 1: First Intervention|Protocol Violation|1|||
23603266|NCT00776009|65937311|FG002|Period 1: First Intervention|Protocol Violation|0|||
23603267|NCT00776009|65937312|FG003|Period 1: First Intervention|Protocol Violation|0|||
23603268|NCT00776009|65937313|FG004|Period 1: First Intervention|Protocol Violation|1|||
23603269|NCT00776009|65937314|FG005|Period 1: First Intervention|Protocol Violation|0|||
23603270|NCT00776009|65937309|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603271|NCT00776009|65937310|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603272|NCT00776009|65937311|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603273|NCT00776009|65937312|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603274|NCT00776009|65937313|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603275|NCT00776009|65937314|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
23603276|NCT00776009|65937309|FG000|Period 2: Second Intervention|Protocol Violation|1|||
23603277|NCT00776009|65937310|FG001|Period 2: Second Intervention|Protocol Violation|0|||
23662927|NCT00467779|66152388|FG005|Stage 1|Unspecified Reason|2|||
23662928|NCT00467779|66152389|FG006|Stage 1|Unspecified Reason|0|||
23662929|NCT00467779|66152390|FG007|Stage 1|Unspecified Reason|0|||
23662930|NCT00467779|66152391|FG008|Stage 1|Unspecified Reason|0|||
23662931|NCT00467779|66152392|FG009|Stage 1|Unspecified Reason|0|||
23662932|NCT00467779|66152393|FG010|Stage 1|Unspecified Reason|0|||
23662933|NCT00467779|66152394|FG011|Stage 1|Unspecified Reason|0|||
23662934|NCT00467779|66152395|FG012|Stage 1|Unspecified Reason|0|||
23662935|NCT00467779|66152396|FG013|Stage 1|Unspecified Reason|0|||
23662936|NCT00467779|66152397|FG014|Stage 1|Unspecified Reason|0|||
23662937|NCT00467779|66152383|FG000|Stage 1|Physician Decision|0|||
23662938|NCT00467779|66152384|FG001|Stage 1|Physician Decision|1|||
23662939|NCT00467779|66152385|FG002|Stage 1|Physician Decision|0|||
23662940|NCT00467779|66152386|FG003|Stage 1|Physician Decision|0|||
23662941|NCT00467779|66152387|FG004|Stage 1|Physician Decision|0|||
23662942|NCT00467779|66152388|FG005|Stage 1|Physician Decision|0|||
23662943|NCT00467779|66152389|FG006|Stage 1|Physician Decision|0|||
23603278|NCT00776009|65937311|FG002|Period 2: Second Intervention|Protocol Violation|1|||
23603279|NCT00776009|65937312|FG003|Period 2: Second Intervention|Protocol Violation|0|||
23603280|NCT00776009|65937313|FG004|Period 2: Second Intervention|Protocol Violation|0|||
23603281|NCT00776009|65937314|FG005|Period 2: Second Intervention|Protocol Violation|0|||
23603282|NCT00776009|65937309|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
23603283|NCT00776009|65937310|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
23369517|NCT00909870|65099149|FG000|Overall Study|Protocol Violation|1|||
23369518|NCT00909870|65099150|FG001|Overall Study|Protocol Violation|2|||
23369519|NCT00909870|65099149|FG000|Overall Study|Withdrawal by Subject|5|||
23369520|NCT00909870|65099150|FG001|Overall Study|Withdrawal by Subject|8|||
23369521|NCT00909870|65099149|FG000|Overall Study|Lost to Follow-up|3|||
23369522|NCT00909870|65099150|FG001|Overall Study|Lost to Follow-up|3|||
23369523|NCT00909870|65099149|FG000|Overall Study|Physician Decision|0|||
23369524|NCT00909870|65099150|FG001|Overall Study|Physician Decision|2|||
23369525|NCT00909870|65099149|FG000|Overall Study|Other|1|||
23369526|NCT00909870|65099150|FG001|Overall Study|Other|5|||
23369527|NCT01075048|65099151|FG000|Overall Study|Death|4|||
23369528|NCT01075048|65099152|FG001|Overall Study|Death|17|||
23369529|NCT01075048|65099153|FG002|Overall Study|Death|12|||
23369530|NCT01075048|65099151|FG000|Overall Study|Start of other or new therapy|4|||
23369531|NCT01075048|65099152|FG001|Overall Study|Start of other or new therapy|36|||
23369532|NCT01075048|65099153|FG002|Overall Study|Start of other or new therapy|46|||
23369533|NCT01075048|65099151|FG000|Overall Study|Withdrawal by Subject|1|||
23369534|NCT01075048|65099152|FG001|Overall Study|Withdrawal by Subject|6|||
23369535|NCT01075048|65099153|FG002|Overall Study|Withdrawal by Subject|3|||
23369536|NCT01075048|65099151|FG000|Overall Study|Lost to Follow-up|0|||
23369537|NCT01075048|65099152|FG001|Overall Study|Lost to Follow-up|1|||
23369538|NCT01075048|65099153|FG002|Overall Study|Lost to Follow-up|1|||
23369539|NCT01324102|65099154|FG000|Overall Study|illness|1|||
23369540|NCT01324102|65099155|FG001|Overall Study|illness|6|||
23369541|NCT01926028|65099164|FG000|Overall Study|Lost to Follow-up|7|||
23369542|NCT01926028|65099165|FG001|Overall Study|Lost to Follow-up|6|||
23603284|NCT00776009|65937311|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603285|NCT00776009|65937312|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603286|NCT00776009|65937313|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603287|NCT00776009|65937314|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603288|NCT02628626|65937315|FG000|Overall Study|Withdrawal by Subject|2|||
23603289|NCT02628626|65937316|FG001|Overall Study|Withdrawal by Subject|2|||
23603290|NCT00724126|65937320|FG000|Overall Study|Adverse Event|2|||
23603291|NCT00724126|65937321|FG001|Overall Study|Adverse Event|0|||
23603292|NCT00724126|65937320|FG000|Overall Study|Withdrawal by Subject|8|||
23603293|NCT00724126|65937321|FG001|Overall Study|Withdrawal by Subject|6|||
23603294|NCT00724126|65937320|FG000|Overall Study|Lost to Follow-up|6|||
23603295|NCT00724126|65937321|FG001|Overall Study|Lost to Follow-up|6|||
23603296|NCT00724126|65937320|FG000|Overall Study|Noncompliance|2|||
23603297|NCT00724126|65937321|FG001|Overall Study|Noncompliance|1|||
23603298|NCT00724126|65937320|FG000|Overall Study|Subject randomized although ineligible|1|||
23603299|NCT00724126|65937321|FG001|Overall Study|Subject randomized although ineligible|1|||
23603300|NCT00724126|65937320|FG000|Overall Study|Subject had to leave vicinity of site|0|||
23603301|NCT00724126|65937321|FG001|Overall Study|Subject had to leave vicinity of site|1|||
23603302|NCT01227421|65937324|FG000|Overall Study|Lost to Follow-up|6|||
23603303|NCT01227421|65937325|FG001|Overall Study|Lost to Follow-up|7|||
23603304|NCT01227421|65937326|FG002|Overall Study|Lost to Follow-up|5|||
23603305|NCT01227421|65937324|FG000|Overall Study|Adverse Event|2|||
23603306|NCT01227421|65937325|FG001|Overall Study|Adverse Event|7|||
23603307|NCT01227421|65937326|FG002|Overall Study|Adverse Event|2|||
23603308|NCT01227421|65937324|FG000|Overall Study|Withdrawal by Subject|1|||
23662944|NCT00467779|66152390|FG007|Stage 1|Physician Decision|0|||
23369543|NCT01926028|65099166|FG002|Overall Study|Lost to Follow-up|0|||
23369544|NCT01926028|65099164|FG000|Overall Study|Physician Decision|1|||
23369545|NCT01926028|65099165|FG001|Overall Study|Physician Decision|5|||
23369546|NCT01926028|65099166|FG002|Overall Study|Physician Decision|0|||
23603309|NCT01227421|65937325|FG001|Overall Study|Withdrawal by Subject|2|||
23662945|NCT00467779|66152391|FG008|Stage 1|Physician Decision|0|||
23662946|NCT00467779|66152392|FG009|Stage 1|Physician Decision|0|||
23662947|NCT00467779|66152393|FG010|Stage 1|Physician Decision|0|||
23662948|NCT00467779|66152394|FG011|Stage 1|Physician Decision|0|||
23662949|NCT00467779|66152395|FG012|Stage 1|Physician Decision|0|||
23662950|NCT00467779|66152396|FG013|Stage 1|Physician Decision|0|||
23662951|NCT00467779|66152397|FG014|Stage 1|Physician Decision|0|||
23662952|NCT00467779|66152383|FG000|Stage 1|Withdrawal by Subject|0|||
23662953|NCT00467779|66152384|FG001|Stage 1|Withdrawal by Subject|0|||
23662954|NCT00467779|66152385|FG002|Stage 1|Withdrawal by Subject|0|||
23662955|NCT00467779|66152386|FG003|Stage 1|Withdrawal by Subject|0|||
23662956|NCT00467779|66152387|FG004|Stage 1|Withdrawal by Subject|0|||
23662957|NCT00467779|66152388|FG005|Stage 1|Withdrawal by Subject|0|||
23662958|NCT00467779|66152389|FG006|Stage 1|Withdrawal by Subject|1|||
23662959|NCT00467779|66152390|FG007|Stage 1|Withdrawal by Subject|1|||
23662960|NCT00467779|66152391|FG008|Stage 1|Withdrawal by Subject|0|||
23662961|NCT00467779|66152392|FG009|Stage 1|Withdrawal by Subject|0|||
23662962|NCT00467779|66152393|FG010|Stage 1|Withdrawal by Subject|0|||
23662963|NCT00467779|66152394|FG011|Stage 1|Withdrawal by Subject|0|||
23662964|NCT00467779|66152395|FG012|Stage 1|Withdrawal by Subject|0|||
23662965|NCT00467779|66152396|FG013|Stage 1|Withdrawal by Subject|0|||
23662966|NCT00467779|66152397|FG014|Stage 1|Withdrawal by Subject|0|||
23662967|NCT00467779|66152383|FG000|Stage 1A|Adverse Event|0|||
23662968|NCT00467779|66152384|FG001|Stage 1A|Adverse Event|0|||
23662969|NCT00467779|66152385|FG002|Stage 1A|Adverse Event|0|||
23662970|NCT00467779|66152386|FG003|Stage 1A|Adverse Event|0|||
23662971|NCT00467779|66152387|FG004|Stage 1A|Adverse Event|0|||
23662972|NCT00467779|66152388|FG005|Stage 1A|Adverse Event|0|||
23662973|NCT00467779|66152389|FG006|Stage 1A|Adverse Event|0|||
23662974|NCT00467779|66152390|FG007|Stage 1A|Adverse Event|0|||
23662975|NCT00467779|66152391|FG008|Stage 1A|Adverse Event|0|||
23662976|NCT00467779|66152392|FG009|Stage 1A|Adverse Event|0|||
23662977|NCT00467779|66152393|FG010|Stage 1A|Adverse Event|0|||
23662978|NCT00467779|66152394|FG011|Stage 1A|Adverse Event|0|||
23662979|NCT00467779|66152395|FG012|Stage 1A|Adverse Event|1|||
23662980|NCT00467779|66152396|FG013|Stage 1A|Adverse Event|0|||
23662981|NCT00467779|66152397|FG014|Stage 1A|Adverse Event|0|||
23662982|NCT00467779|66152383|FG000|Stage 1A|Death|0|||
23662983|NCT00467779|66152384|FG001|Stage 1A|Death|0|||
23662984|NCT00467779|66152385|FG002|Stage 1A|Death|0|||
23662985|NCT00467779|66152386|FG003|Stage 1A|Death|0|||
23662986|NCT00467779|66152387|FG004|Stage 1A|Death|0|||
23662987|NCT00467779|66152388|FG005|Stage 1A|Death|0|||
23662988|NCT00467779|66152389|FG006|Stage 1A|Death|0|||
23662989|NCT00467779|66152390|FG007|Stage 1A|Death|0|||
23662990|NCT00467779|66152391|FG008|Stage 1A|Death|0|||
23662991|NCT00467779|66152392|FG009|Stage 1A|Death|0|||
23662992|NCT00467779|66152393|FG010|Stage 1A|Death|0|||
23662993|NCT00467779|66152394|FG011|Stage 1A|Death|1|||
23662994|NCT00467779|66152395|FG012|Stage 1A|Death|1|||
23662995|NCT00467779|66152396|FG013|Stage 1A|Death|0|||
23369547|NCT01926028|65099164|FG000|Overall Study|Withdrawal by Subject|9|||
23662996|NCT00467779|66152397|FG014|Stage 1A|Death|0|||
23662997|NCT00467779|66152383|FG000|Stage 1A|Disease Progression|0|||
23662998|NCT00467779|66152384|FG001|Stage 1A|Disease Progression|0|||
23662999|NCT00467779|66152385|FG002|Stage 1A|Disease Progression|0|||
23663000|NCT00467779|66152386|FG003|Stage 1A|Disease Progression|0|||
23663001|NCT00467779|66152387|FG004|Stage 1A|Disease Progression|0|||
23663002|NCT00467779|66152388|FG005|Stage 1A|Disease Progression|0|||
23663003|NCT00467779|66152389|FG006|Stage 1A|Disease Progression|0|||
23663004|NCT00467779|66152390|FG007|Stage 1A|Disease Progression|0|||
23663005|NCT00467779|66152391|FG008|Stage 1A|Disease Progression|0|||
23663006|NCT00467779|66152392|FG009|Stage 1A|Disease Progression|2|||
23663007|NCT00467779|66152393|FG010|Stage 1A|Disease Progression|2|||
23663008|NCT00467779|66152394|FG011|Stage 1A|Disease Progression|5|||
23663009|NCT00467779|66152395|FG012|Stage 1A|Disease Progression|2|||
23663010|NCT00467779|66152396|FG013|Stage 1A|Disease Progression|0|||
23663011|NCT00467779|66152397|FG014|Stage 1A|Disease Progression|0|||
23663012|NCT00467779|66152383|FG000|Stage 1A|Physician Decision|0|||
23663013|NCT00467779|66152384|FG001|Stage 1A|Physician Decision|0|||
23663014|NCT00467779|66152385|FG002|Stage 1A|Physician Decision|0|||
23663015|NCT00467779|66152386|FG003|Stage 1A|Physician Decision|0|||
23663016|NCT00467779|66152387|FG004|Stage 1A|Physician Decision|0|||
23663017|NCT00467779|66152388|FG005|Stage 1A|Physician Decision|0|||
23663018|NCT00467779|66152389|FG006|Stage 1A|Physician Decision|0|||
23663019|NCT00467779|66152390|FG007|Stage 1A|Physician Decision|0|||
23663020|NCT00467779|66152391|FG008|Stage 1A|Physician Decision|0|||
23663021|NCT00467779|66152392|FG009|Stage 1A|Physician Decision|1|||
23663022|NCT00467779|66152393|FG010|Stage 1A|Physician Decision|0|||
23663023|NCT00467779|66152394|FG011|Stage 1A|Physician Decision|0|||
23663024|NCT00467779|66152395|FG012|Stage 1A|Physician Decision|0|||
23663025|NCT00467779|66152396|FG013|Stage 1A|Physician Decision|0|||
23663026|NCT00467779|66152397|FG014|Stage 1A|Physician Decision|0|||
23663027|NCT00467779|66152383|FG000|Stage 1A|Withdrawal by Subject|0|||
23663028|NCT00467779|66152384|FG001|Stage 1A|Withdrawal by Subject|0|||
23663029|NCT00467779|66152385|FG002|Stage 1A|Withdrawal by Subject|0|||
23663030|NCT00467779|66152386|FG003|Stage 1A|Withdrawal by Subject|0|||
23663031|NCT00467779|66152387|FG004|Stage 1A|Withdrawal by Subject|0|||
23663032|NCT00467779|66152388|FG005|Stage 1A|Withdrawal by Subject|0|||
23663033|NCT00467779|66152389|FG006|Stage 1A|Withdrawal by Subject|0|||
23663034|NCT00467779|66152390|FG007|Stage 1A|Withdrawal by Subject|0|||
23663035|NCT00467779|66152391|FG008|Stage 1A|Withdrawal by Subject|0|||
23663036|NCT00467779|66152392|FG009|Stage 1A|Withdrawal by Subject|0|||
23663037|NCT00467779|66152393|FG010|Stage 1A|Withdrawal by Subject|1|||
23663038|NCT00467779|66152394|FG011|Stage 1A|Withdrawal by Subject|1|||
23663039|NCT00467779|66152395|FG012|Stage 1A|Withdrawal by Subject|1|||
23663040|NCT00467779|66152396|FG013|Stage 1A|Withdrawal by Subject|0|||
23663041|NCT00467779|66152397|FG014|Stage 1A|Withdrawal by Subject|0|||
23663042|NCT00467779|66152383|FG000|Stage 1A|Unspecified Reason|0|||
23663043|NCT00467779|66152384|FG001|Stage 1A|Unspecified Reason|0|||
23663044|NCT00467779|66152385|FG002|Stage 1A|Unspecified Reason|0|||
23663045|NCT00467779|66152386|FG003|Stage 1A|Unspecified Reason|0|||
23663046|NCT00467779|66152387|FG004|Stage 1A|Unspecified Reason|0|||
23663047|NCT00467779|66152388|FG005|Stage 1A|Unspecified Reason|0|||
23663048|NCT00467779|66152389|FG006|Stage 1A|Unspecified Reason|0|||
23663049|NCT00467779|66152390|FG007|Stage 1A|Unspecified Reason|0|||
23663050|NCT00467779|66152391|FG008|Stage 1A|Unspecified Reason|0|||
23663051|NCT00467779|66152392|FG009|Stage 1A|Unspecified Reason|0|||
23663052|NCT00467779|66152393|FG010|Stage 1A|Unspecified Reason|0|||
23663053|NCT00467779|66152394|FG011|Stage 1A|Unspecified Reason|1|||
23663054|NCT00467779|66152395|FG012|Stage 1A|Unspecified Reason|1|||
23369548|NCT01926028|65099165|FG001|Overall Study|Withdrawal by Subject|9|||
23663055|NCT00467779|66152396|FG013|Stage 1A|Unspecified Reason|0|||
23663056|NCT00467779|66152397|FG014|Stage 1A|Unspecified Reason|0|||
23663057|NCT00467779|66152383|FG000|Stage 2|Adverse Event|0|||
23663058|NCT00467779|66152384|FG001|Stage 2|Adverse Event|0|||
23663059|NCT00467779|66152385|FG002|Stage 2|Adverse Event|0|||
23663060|NCT00467779|66152386|FG003|Stage 2|Adverse Event|0|||
23663061|NCT00467779|66152387|FG004|Stage 2|Adverse Event|0|||
23663062|NCT00467779|66152388|FG005|Stage 2|Adverse Event|0|||
23663063|NCT00467779|66152389|FG006|Stage 2|Adverse Event|0|||
23663064|NCT00467779|66152390|FG007|Stage 2|Adverse Event|0|||
23663065|NCT00467779|66152391|FG008|Stage 2|Adverse Event|1|||
23663066|NCT00467779|66152392|FG009|Stage 2|Adverse Event|0|||
23663067|NCT00467779|66152393|FG010|Stage 2|Adverse Event|0|||
23663068|NCT00467779|66152394|FG011|Stage 2|Adverse Event|0|||
23663069|NCT00467779|66152395|FG012|Stage 2|Adverse Event|0|||
23369549|NCT01926028|65099166|FG002|Overall Study|Withdrawal by Subject|2|||
23369550|NCT01926028|65099164|FG000|Overall Study|Non compliance or other reasons|4|||
23369551|NCT01926028|65099165|FG001|Overall Study|Non compliance or other reasons|2|||
23369552|NCT01926028|65099166|FG002|Overall Study|Non compliance or other reasons|0|||
23369553|NCT00087178|65099167|FG000|Overall Study|No follow up data|5|||
23369554|NCT00087178|65099168|FG001|Overall Study|No follow up data|15|||
23369555|NCT00087178|65099167|FG000|Overall Study|No clinical assessment|1|||
23369556|NCT00087178|65099168|FG001|Overall Study|No clinical assessment|2|||
23369557|NCT00087178|65099167|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
23369558|NCT00087178|65099168|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
23369559|NCT00977197|65099169|FG000|Overall Study|Withdrawal by Subject|3|||
23369560|NCT00977197|65099170|FG001|Overall Study|Withdrawal by Subject|4|||
23369561|NCT00977197|65099169|FG000|Overall Study|Adverse Event|3|||
23369562|NCT00977197|65099170|FG001|Overall Study|Adverse Event|1|||
23369563|NCT00977197|65099169|FG000|Overall Study|Lack of Efficacy|1|||
23369564|NCT00977197|65099170|FG001|Overall Study|Lack of Efficacy|0|||
23369565|NCT00977197|65099169|FG000|Overall Study|Lost to Follow-up|1|||
23369566|NCT00977197|65099170|FG001|Overall Study|Lost to Follow-up|3|||
23369567|NCT00977197|65099169|FG000|Overall Study|Nonadherence|1|||
23369568|NCT00977197|65099170|FG001|Overall Study|Nonadherence|1|||
23369569|NCT00746551|65099171|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
23369570|NCT00746551|65099172|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
23369571|NCT00746551|65099171|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
23369572|NCT00746551|65099172|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
23369573|NCT00746551|65099171|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
23369574|NCT00746551|65099172|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
23369575|NCT01774981|65099173|FG000|Overall Study|Adverse Event|0|||
23369576|NCT01774981|65099174|FG001|Overall Study|Adverse Event|0|||
23369577|NCT01774981|65099175|FG002|Overall Study|Adverse Event|0|||
23369578|NCT01774981|65099176|FG003|Overall Study|Adverse Event|0|||
23369579|NCT01774981|65099177|FG004|Overall Study|Adverse Event|0|||
23369580|NCT01774981|65099178|FG005|Overall Study|Adverse Event|1|||
23369581|NCT01774981|65099179|FG006|Overall Study|Adverse Event|0|||
23369582|NCT01774981|65099180|FG007|Overall Study|Adverse Event|0|||
23369583|NCT01774981|65099173|FG000|Overall Study|Withdrawal by Subject|0|||
23369584|NCT01774981|65099174|FG001|Overall Study|Withdrawal by Subject|0|||
23369585|NCT01774981|65099175|FG002|Overall Study|Withdrawal by Subject|0|||
23369586|NCT01774981|65099176|FG003|Overall Study|Withdrawal by Subject|0|||
23369587|NCT01774981|65099177|FG004|Overall Study|Withdrawal by Subject|0|||
23369588|NCT01774981|65099178|FG005|Overall Study|Withdrawal by Subject|0|||
23369589|NCT01774981|65099179|FG006|Overall Study|Withdrawal by Subject|0|||
23369590|NCT01774981|65099180|FG007|Overall Study|Withdrawal by Subject|1|||
23369591|NCT01774981|65099173|FG000|Overall Study|Death|0|||
23369592|NCT01774981|65099174|FG001|Overall Study|Death|0|||
23369593|NCT01774981|65099175|FG002|Overall Study|Death|0|||
23369594|NCT01774981|65099176|FG003|Overall Study|Death|0|||
23369595|NCT01774981|65099177|FG004|Overall Study|Death|1|||
23369596|NCT01774981|65099178|FG005|Overall Study|Death|0|||
23369597|NCT01774981|65099179|FG006|Overall Study|Death|0|||
23369598|NCT01774981|65099180|FG007|Overall Study|Death|0|||
23369599|NCT01268267|65099181|FG000|Overall Study|Protocol Violation|1|||
23369600|NCT01965327|65099182|FG000|Overall Study|Physician Decision|2|||
23369601|NCT01172873|65099183|FG000|Overall Study|Withdrawal by Subject|3|||
23369602|NCT01172873|65099184|FG001|Overall Study|Withdrawal by Subject|2|||
23369603|NCT00368251|65099185|FG000|Overall Study|SAE, non-fatal|1|||
23369604|NCT00368251|65099186|FG001|Overall Study|SAE, non-fatal|0|||
23369605|NCT00368251|65099187|FG002|Overall Study|SAE, non-fatal|0|||
23369606|NCT00368251|65099185|FG000|Overall Study|AE, non-serious non-fatal|0|||
23369607|NCT00368251|65099186|FG001|Overall Study|AE, non-serious non-fatal|0|||
23369608|NCT00368251|65099187|FG002|Overall Study|AE, non-serious non-fatal|1|||
23369609|NCT00113607|65099188|FG000|Overall Study|Adverse Event|40|||
23369610|NCT00113607|65099189|FG001|Overall Study|Adverse Event|71|||
23369611|NCT00113607|65099188|FG000|Overall Study|Death|8|||
23369612|NCT00113607|65099189|FG001|Overall Study|Death|8|||
23369613|NCT00113607|65099188|FG000|Overall Study|Withdrawal by Subject|50|||
23369614|NCT00113607|65099189|FG001|Overall Study|Withdrawal by Subject|58|||
23369615|NCT00113607|65099188|FG000|Overall Study|Lost to Follow-up|0|||
23369616|NCT00113607|65099189|FG001|Overall Study|Lost to Follow-up|2|||
23369617|NCT00113607|65099188|FG000|Overall Study|Disease Progression|180|||
23369618|NCT00113607|65099189|FG001|Overall Study|Disease Progression|142|||
23369619|NCT00113607|65099188|FG000|Overall Study|Complete Response (Confirmed)|14|||
23485076|NCT04099251|65518795|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
23603310|NCT01227421|65937326|FG002|Overall Study|Withdrawal by Subject|1|||
23369620|NCT00113607|65099189|FG001|Overall Study|Complete Response (Confirmed)|24|||
23603311|NCT01227421|65937324|FG000|Overall Study|Protocol Violation|1|||
23369621|NCT00113607|65099188|FG000|Overall Study|Other|43|||
23369622|NCT00113607|65099189|FG001|Overall Study|Other|32|||
23369623|NCT01022203|65099190|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
23369624|NCT01022203|65099191|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
23369625|NCT01022203|65099190|FG000|Post Treatment Assessment|Physician Decision|2|||
23369626|NCT01022203|65099191|FG001|Post Treatment Assessment|Physician Decision|0|||
23369627|NCT01022203|65099190|FG000|Post Treatment Assessment|Adverse Event|0|||
23369628|NCT01022203|65099191|FG001|Post Treatment Assessment|Adverse Event|2|||
23369629|NCT01022203|65099190|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
23369630|NCT01022203|65099191|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
23369631|NCT00521365|65099192|FG000|Overall Study|Adverse Event|3|||
23369632|NCT00521365|65099192|FG000|Overall Study|Lost to Follow-up|6|||
23369633|NCT00521365|65099192|FG000|Overall Study|Protocol deviation|2|||
23369634|NCT00521365|65099192|FG000|Overall Study|Drug compliance|3|||
23369635|NCT00521365|65099192|FG000|Overall Study|Usage of not allowed drugs|6|||
23369636|NCT01041859|65099193|FG000|Open-Label Titration|Adverse Event|69|||
23369637|NCT01041859|65099194|FG001|Open-Label Titration|Adverse Event|0|||
23369638|NCT01041859|65099195|FG002|Open-Label Titration|Adverse Event|0|||
23369639|NCT01041859|65099193|FG000|Open-Label Titration|Lack of Efficacy|3|||
23369640|NCT01041859|65099194|FG001|Open-Label Titration|Lack of Efficacy|0|||
23369641|NCT01041859|65099195|FG002|Open-Label Titration|Lack of Efficacy|0|||
23369642|NCT01041859|65099193|FG000|Open-Label Titration|Lost to Follow-up|1|||
23369643|NCT01041859|65099194|FG001|Open-Label Titration|Lost to Follow-up|0|||
23369644|NCT01041859|65099195|FG002|Open-Label Titration|Lost to Follow-up|0|||
23369645|NCT01041859|65099193|FG000|Open-Label Titration|Physician Decision|1|||
23369646|NCT01041859|65099194|FG001|Open-Label Titration|Physician Decision|0|||
23369647|NCT01041859|65099195|FG002|Open-Label Titration|Physician Decision|0|||
23369648|NCT01041859|65099193|FG000|Open-Label Titration|Protocol Violation|1|||
23369649|NCT01041859|65099194|FG001|Open-Label Titration|Protocol Violation|0|||
23369650|NCT01041859|65099195|FG002|Open-Label Titration|Protocol Violation|0|||
23369651|NCT01041859|65099193|FG000|Open-Label Titration|Other|7|||
23369652|NCT01041859|65099194|FG001|Open-Label Titration|Other|0|||
23369653|NCT01041859|65099195|FG002|Open-Label Titration|Other|0|||
23369654|NCT01041859|65099193|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
23369655|NCT01041859|65099194|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
23369656|NCT01041859|65099195|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
23369657|NCT01041859|65099193|FG000|Open-Label Titration|Withdrawal by Subject|11|||
23369658|NCT01041859|65099194|FG001|Open-Label Titration|Withdrawal by Subject|0|||
23369659|NCT01041859|65099195|FG002|Open-Label Titration|Withdrawal by Subject|0|||
23369660|NCT01041859|65099193|FG000|Double-Blind Maintenance|Adverse Event|0|||
23369661|NCT01041859|65099194|FG001|Double-Blind Maintenance|Adverse Event|23|||
23369662|NCT01041859|65099195|FG002|Double-Blind Maintenance|Adverse Event|13|||
23369663|NCT01041859|65099193|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
23369664|NCT01041859|65099194|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
23369665|NCT01041859|65099195|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
23369666|NCT01041859|65099193|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
23369667|NCT01041859|65099194|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
23369668|NCT01041859|65099195|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
23369669|NCT01041859|65099193|FG000|Double-Blind Maintenance|Physician Decision|0|||
23369670|NCT01041859|65099194|FG001|Double-Blind Maintenance|Physician Decision|2|||
23369671|NCT01041859|65099195|FG002|Double-Blind Maintenance|Physician Decision|1|||
23369672|NCT01041859|65099193|FG000|Double-Blind Maintenance|Protocol Violation|0|||
23369673|NCT01041859|65099194|FG001|Double-Blind Maintenance|Protocol Violation|1|||
23369674|NCT01041859|65099195|FG002|Double-Blind Maintenance|Protocol Violation|3|||
23369675|NCT01041859|65099193|FG000|Double-Blind Maintenance|Other|0|||
23369676|NCT01041859|65099194|FG001|Double-Blind Maintenance|Other|6|||
23369677|NCT01041859|65099195|FG002|Double-Blind Maintenance|Other|2|||
23369678|NCT01041859|65099193|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
23369679|NCT01041859|65099194|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
23369680|NCT01041859|65099195|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
23369681|NCT01041859|65099193|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
23369682|NCT01041859|65099194|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
23369683|NCT01041859|65099195|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
23485077|NCT04099251|65518794|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
23485078|NCT04099251|65518795|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
23485079|NCT04099251|65518794|FG000|Blinded Treatment Phase|Death|6|||
23369684|NCT01604785|65099196|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
23369685|NCT01604785|65099197|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
23369686|NCT01603277|65099198|FG000|Overall Study|Adverse Event|1|||
23369687|NCT01603277|65099199|FG001|Overall Study|Adverse Event|2|||
23369688|NCT01603277|65099198|FG000|Overall Study|Physician Decision|0|||
23369689|NCT01603277|65099199|FG001|Overall Study|Physician Decision|1|||
23369690|NCT01603277|65099198|FG000|Overall Study|Protocol Violation|6|||
23369691|NCT01603277|65099199|FG001|Overall Study|Protocol Violation|10|||
23485080|NCT04099251|65518795|FG001|Blinded Treatment Phase|Death|2|||
23485081|NCT04099251|65518794|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
23369692|NCT01603277|65099198|FG000|Overall Study|Withdrawal by Subject|5|||
23369693|NCT01603277|65099199|FG001|Overall Study|Withdrawal by Subject|4|||
23369694|NCT01603277|65099198|FG000|Overall Study|Non-Compliance|2|||
23369695|NCT01603277|65099199|FG001|Overall Study|Non-Compliance|1|||
23369696|NCT00449163|65099200|FG000|Overall Study|Physician Decision|3|||
23369697|NCT03722576|65099201|FG000|Overall Study|Withdrawal by Subject|3|||
23369698|NCT03722576|65099201|FG000|Overall Study|Adverse Event|2|||
23369699|NCT03722576|65099201|FG000|Overall Study|Physician Decision|1|||
23369700|NCT03722576|65099201|FG000|Overall Study|Lost to Follow-up|1|||
23369701|NCT02806713|65099204|FG000|Overall Study|Urethral injury during procedure|1|||
23369702|NCT02806713|65099205|FG001|Overall Study|Urethral injury during procedure|0|||
23369703|NCT02806713|65099204|FG000|Overall Study|cancelled surgery|1|||
23369704|NCT02806713|65099205|FG001|Overall Study|cancelled surgery|2|||
23485082|NCT04099251|65518795|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
23485083|NCT04099251|65518794|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
23485084|NCT04099251|65518795|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
23485085|NCT04099251|65518794|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
23485086|NCT04099251|65518795|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
23485087|NCT04099251|65518794|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
23485088|NCT04099251|65518795|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
23485089|NCT04099251|65518794|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
23485090|NCT04099251|65518795|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
23485091|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
23485092|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
23485093|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
23485094|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
23603312|NCT01227421|65937325|FG001|Overall Study|Protocol Violation|1|||
23603313|NCT01227421|65937326|FG002|Overall Study|Protocol Violation|2|||
23663070|NCT00467779|66152396|FG013|Stage 2|Adverse Event|0|||
23663071|NCT00467779|66152397|FG014|Stage 2|Adverse Event|0|||
23663072|NCT00467779|66152383|FG000|Stage 2|Death|0|||
23663073|NCT00467779|66152384|FG001|Stage 2|Death|0|||
23663074|NCT00467779|66152385|FG002|Stage 2|Death|0|||
23663075|NCT00467779|66152386|FG003|Stage 2|Death|0|||
23663076|NCT00467779|66152387|FG004|Stage 2|Death|0|||
23663077|NCT00467779|66152388|FG005|Stage 2|Death|0|||
23663078|NCT00467779|66152389|FG006|Stage 2|Death|0|||
23663079|NCT00467779|66152390|FG007|Stage 2|Death|0|||
23663080|NCT00467779|66152391|FG008|Stage 2|Death|1|||
23663081|NCT00467779|66152392|FG009|Stage 2|Death|0|||
23663082|NCT00467779|66152393|FG010|Stage 2|Death|0|||
23663083|NCT00467779|66152394|FG011|Stage 2|Death|0|||
23663084|NCT00467779|66152395|FG012|Stage 2|Death|0|||
23663085|NCT00467779|66152396|FG013|Stage 2|Death|0|||
23663086|NCT00467779|66152397|FG014|Stage 2|Death|0|||
23663087|NCT00467779|66152383|FG000|Stage 2|Disease Progression|0|||
23663088|NCT00467779|66152384|FG001|Stage 2|Disease Progression|0|||
23663089|NCT00467779|66152385|FG002|Stage 2|Disease Progression|0|||
23663090|NCT00467779|66152386|FG003|Stage 2|Disease Progression|0|||
23663091|NCT00467779|66152387|FG004|Stage 2|Disease Progression|0|||
23663092|NCT00467779|66152388|FG005|Stage 2|Disease Progression|0|||
23663093|NCT00467779|66152389|FG006|Stage 2|Disease Progression|0|||
23369705|NCT01401322|65099206|FG000|Overall Study|Withdrawal by Subject|1|||
23603314|NCT01227421|65937324|FG000|Overall Study|Randomized in error|1|||
23603315|NCT01227421|65937325|FG001|Overall Study|Randomized in error|1|||
23603316|NCT01227421|65937326|FG002|Overall Study|Randomized in error|0|||
23603317|NCT01128959|65937327|FG000|Lead in Period|Adverse Event|3|||
23603318|NCT01128959|65937327|FG000|Treatment Period|Adverse Event|3|||
23603319|NCT01128959|65937327|FG000|Treatment Period|Withdrawal by Subject|1|||
23603320|NCT01822756|65937328|FG000|Overall Study|Adverse Event|0|||
23603321|NCT01822756|65937329|FG001|Overall Study|Adverse Event|0|||
23603322|NCT01822756|65937330|FG002|Overall Study|Adverse Event|0|||
23603323|NCT01822756|65937331|FG003|Overall Study|Adverse Event|2|||
23603324|NCT01822756|65937332|FG004|Overall Study|Adverse Event|0|||
23663094|NCT00467779|66152390|FG007|Stage 2|Disease Progression|0|||
23663095|NCT00467779|66152391|FG008|Stage 2|Disease Progression|16|||
23663096|NCT00467779|66152392|FG009|Stage 2|Disease Progression|0|||
23663097|NCT00467779|66152393|FG010|Stage 2|Disease Progression|0|||
23663098|NCT00467779|66152394|FG011|Stage 2|Disease Progression|0|||
23663099|NCT00467779|66152395|FG012|Stage 2|Disease Progression|0|||
23369706|NCT01401322|65099206|FG000|Overall Study|Physician Decision|1|||
23369707|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
23369708|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23663100|NCT00467779|66152396|FG013|Stage 2|Disease Progression|0|||
23663101|NCT00467779|66152397|FG014|Stage 2|Disease Progression|0|||
23663102|NCT00467779|66152383|FG000|Stage 2|Unspecified Reason|0|||
23663103|NCT00467779|66152384|FG001|Stage 2|Unspecified Reason|0|||
23663104|NCT00467779|66152385|FG002|Stage 2|Unspecified Reason|0|||
23663105|NCT00467779|66152386|FG003|Stage 2|Unspecified Reason|0|||
23663106|NCT00467779|66152387|FG004|Stage 2|Unspecified Reason|0|||
23663107|NCT00467779|66152388|FG005|Stage 2|Unspecified Reason|0|||
23663108|NCT00467779|66152389|FG006|Stage 2|Unspecified Reason|0|||
23663109|NCT00467779|66152390|FG007|Stage 2|Unspecified Reason|0|||
23663110|NCT00467779|66152391|FG008|Stage 2|Unspecified Reason|3|||
23663111|NCT00467779|66152392|FG009|Stage 2|Unspecified Reason|0|||
23369709|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369710|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369711|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369712|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369713|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369714|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
23369715|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369716|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369717|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369718|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369719|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369720|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369721|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369722|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
23369723|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369724|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369725|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369726|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369727|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369728|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369729|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369730|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
23369731|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369732|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369733|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369734|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369735|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369736|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369737|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
23369738|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369739|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369740|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369741|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369742|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369743|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369744|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
23369745|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369746|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369747|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369748|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369749|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369750|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369751|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369752|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
23369753|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369754|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369755|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369756|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369757|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369758|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369759|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
23369760|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369761|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369762|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23663112|NCT00467779|66152393|FG010|Stage 2|Unspecified Reason|0|||
23663113|NCT00467779|66152394|FG011|Stage 2|Unspecified Reason|0|||
23663114|NCT00467779|66152395|FG012|Stage 2|Unspecified Reason|0|||
23663115|NCT00467779|66152396|FG013|Stage 2|Unspecified Reason|0|||
23663116|NCT00467779|66152397|FG014|Stage 2|Unspecified Reason|0|||
23485095|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
23485096|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
23485097|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
23485098|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
23603325|NCT01822756|65937328|FG000|Overall Study|Disease progression|11|||
23603326|NCT01822756|65937329|FG001|Overall Study|Disease progression|1|||
23603327|NCT01822756|65937330|FG002|Overall Study|Disease progression|7|||
23603328|NCT01822756|65937331|FG003|Overall Study|Disease progression|2|||
23603329|NCT01822756|65937332|FG004|Overall Study|Disease progression|6|||
23603330|NCT01822756|65937328|FG000|Overall Study|Death|2|||
23603331|NCT01822756|65937329|FG001|Overall Study|Death|2|||
23369763|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369764|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369765|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369766|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369767|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
23369768|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369769|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369770|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369771|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369772|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369773|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369774|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
23369775|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369776|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369777|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369778|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369779|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369780|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369781|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
23369782|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369783|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369784|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369785|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369786|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369787|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369788|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
23369789|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369790|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23603332|NCT01822756|65937330|FG002|Overall Study|Death|1|||
23603333|NCT01822756|65937331|FG003|Overall Study|Death|0|||
23603334|NCT01822756|65937332|FG004|Overall Study|Death|0|||
23603335|NCT01822756|65937328|FG000|Overall Study|Lost to Follow-up|1|||
23603336|NCT01822756|65937329|FG001|Overall Study|Lost to Follow-up|0|||
23603337|NCT01822756|65937330|FG002|Overall Study|Lost to Follow-up|1|||
23603338|NCT01822756|65937331|FG003|Overall Study|Lost to Follow-up|0|||
23603339|NCT01822756|65937332|FG004|Overall Study|Lost to Follow-up|1|||
23603340|NCT01822756|65937328|FG000|Overall Study|Physician Decision|0|||
23603341|NCT01822756|65937329|FG001|Overall Study|Physician Decision|1|||
23603342|NCT01822756|65937330|FG002|Overall Study|Physician Decision|0|||
23603343|NCT01822756|65937331|FG003|Overall Study|Physician Decision|0|||
23603344|NCT01822756|65937332|FG004|Overall Study|Physician Decision|0|||
23663117|NCT00467779|66152383|FG000|Stage 2A|Adverse Event|0|||
23663118|NCT00467779|66152384|FG001|Stage 2A|Adverse Event|0|||
23485099|NCT00768469|65518798|FG000|Overall Study|Adverse Event|0|||
23485100|NCT00768469|65518799|FG001|Overall Study|Adverse Event|2|||
23485101|NCT00768469|65518798|FG000|Overall Study|Disease Progression|3|||
23485102|NCT00768469|65518799|FG001|Overall Study|Disease Progression|4|||
23485103|NCT00768469|65518798|FG000|Overall Study|Withdrawal by Subject|0|||
23485104|NCT00768469|65518799|FG001|Overall Study|Withdrawal by Subject|1|||
23485105|NCT01739400|65518800|FG000|Overall Study|Physician Decision|3|||
23485106|NCT01739400|65518801|FG001|Overall Study|Physician Decision|0|||
23485107|NCT01739400|65518800|FG000|Overall Study|Lost to Follow-up|2|||
23485108|NCT01739400|65518801|FG001|Overall Study|Lost to Follow-up|0|||
23485109|NCT01739400|65518800|FG000|Overall Study|Death|5|||
23485110|NCT01739400|65518801|FG001|Overall Study|Death|2|||
23485111|NCT01739400|65518800|FG000|Overall Study|Withdrawal by Subject|7|||
23485112|NCT01739400|65518801|FG001|Overall Study|Withdrawal by Subject|7|||
23485113|NCT00815516|65518805|FG000|Overall Study|Death|3|||
23485114|NCT00815516|65518806|FG001|Overall Study|Death|1|||
23485115|NCT00815516|65518805|FG000|Overall Study|Physician Decision|1|||
23485116|NCT00815516|65518806|FG001|Overall Study|Physician Decision|0|||
23485117|NCT02497976|65518807|FG000|Overall Study|Withdrawal by Subject|2|||
23485118|NCT02497976|65518808|FG001|Overall Study|Withdrawal by Subject|0|||
23485119|NCT02497976|65518807|FG000|Overall Study|Moved out of area|0|||
23485120|NCT02497976|65518808|FG001|Overall Study|Moved out of area|1|||
23485121|NCT01860846|65518809|FG000|Overall Study|Lost to Follow-up|33|||
23485122|NCT02537574|65518811|FG000|Overall Study|Adverse Event|1|||
23485123|NCT02537574|65518812|FG001|Overall Study|Adverse Event|3|||
23485124|NCT02537574|65518813|FG002|Overall Study|Adverse Event|2|||
23485125|NCT02537574|65518811|FG000|Overall Study|Lost to Follow-up|40|||
23485126|NCT02537574|65518812|FG001|Overall Study|Lost to Follow-up|51|||
23485127|NCT02537574|65518813|FG002|Overall Study|Lost to Follow-up|55|||
23485128|NCT02537574|65518811|FG000|Overall Study|Noncompliance with study drug|0|||
23485129|NCT02537574|65518812|FG001|Overall Study|Noncompliance with study drug|1|||
23485130|NCT02537574|65518813|FG002|Overall Study|Noncompliance with study drug|1|||
23485131|NCT02537574|65518811|FG000|Overall Study|Physician Decision|2|||
23485132|NCT02537574|65518812|FG001|Overall Study|Physician Decision|0|||
23485133|NCT02537574|65518813|FG002|Overall Study|Physician Decision|0|||
23485134|NCT02537574|65518811|FG000|Overall Study|Protocol Violation|4|||
23485135|NCT02537574|65518812|FG001|Overall Study|Protocol Violation|2|||
23485136|NCT02537574|65518813|FG002|Overall Study|Protocol Violation|3|||
23485137|NCT02537574|65518811|FG000|Overall Study|Withdrawal by Subject|37|||
23485138|NCT02537574|65518812|FG001|Overall Study|Withdrawal by Subject|27|||
23485139|NCT02537574|65518813|FG002|Overall Study|Withdrawal by Subject|29|||
23485140|NCT02537574|65518811|FG000|Overall Study|Lack of Efficacy|14|||
23485141|NCT02537574|65518812|FG001|Overall Study|Lack of Efficacy|16|||
23485142|NCT02537574|65518813|FG002|Overall Study|Lack of Efficacy|15|||
23485143|NCT02537574|65518811|FG000|Overall Study|Duplicate Patient|1|||
23485144|NCT02537574|65518812|FG001|Overall Study|Duplicate Patient|0|||
23485145|NCT02537574|65518813|FG002|Overall Study|Duplicate Patient|0|||
23485146|NCT02537574|65518811|FG000|Overall Study|Patient not Stable|0|||
23485147|NCT02537574|65518812|FG001|Overall Study|Patient not Stable|1|||
23485148|NCT02537574|65518813|FG002|Overall Study|Patient not Stable|0|||
23485149|NCT02537574|65518811|FG000|Overall Study|Incarceration|0|||
23485150|NCT02537574|65518812|FG001|Overall Study|Incarceration|1|||
23485151|NCT02537574|65518813|FG002|Overall Study|Incarceration|0|||
23485152|NCT02537574|65518811|FG000|Overall Study|Failed Naloxone Challenge|0|||
23485153|NCT02537574|65518812|FG001|Overall Study|Failed Naloxone Challenge|1|||
23485154|NCT02537574|65518813|FG002|Overall Study|Failed Naloxone Challenge|0|||
23485155|NCT02537574|65518811|FG000|Overall Study|Transportation Issues|0|||
23485156|NCT02537574|65518812|FG001|Overall Study|Transportation Issues|0|||
23485157|NCT02537574|65518813|FG002|Overall Study|Transportation Issues|1|||
23485158|NCT02537574|65518811|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
23485159|NCT02537574|65518812|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
23485160|NCT02537574|65518813|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
23485161|NCT02537574|65518811|FG000|Overall Study|Noncompliance with Protocol|0|||
23485162|NCT02537574|65518812|FG001|Overall Study|Noncompliance with Protocol|0|||
23485163|NCT02537574|65518813|FG002|Overall Study|Noncompliance with Protocol|1|||
23663119|NCT00467779|66152385|FG002|Stage 2A|Adverse Event|0|||
23663120|NCT00467779|66152386|FG003|Stage 2A|Adverse Event|0|||
23485164|NCT00510874|65518815|FG000|Overall Study|Withdrawal by Subject|1|||
23485165|NCT00510874|65518816|FG001|Overall Study|Withdrawal by Subject|1|||
23485166|NCT00510874|65518817|FG002|Overall Study|Withdrawal by Subject|0|||
23485167|NCT00510874|65518818|FG003|Overall Study|Withdrawal by Subject|0|||
23485168|NCT00510874|65518819|FG004|Overall Study|Withdrawal by Subject|3|||
23485169|NCT00510874|65518820|FG005|Overall Study|Withdrawal by Subject|0|||
23485170|NCT00510874|65518821|FG006|Overall Study|Withdrawal by Subject|0|||
23485171|NCT00510874|65518815|FG000|Overall Study|Lost to Follow-up|2|||
23485172|NCT00510874|65518816|FG001|Overall Study|Lost to Follow-up|3|||
23485173|NCT00510874|65518817|FG002|Overall Study|Lost to Follow-up|1|||
23485174|NCT00510874|65518818|FG003|Overall Study|Lost to Follow-up|3|||
23663121|NCT00467779|66152387|FG004|Stage 2A|Adverse Event|0|||
23369791|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369792|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369793|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369794|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369795|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369796|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
23369797|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369798|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369799|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369800|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369801|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369802|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369803|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
23369804|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369805|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369806|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369807|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369808|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369809|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369810|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369811|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
23369812|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369813|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369814|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369815|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369816|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369817|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369818|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
23369819|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369820|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369821|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369822|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369823|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369824|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369825|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
23369826|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369827|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369828|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369829|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369830|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369831|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369832|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
23369833|NCT03558516|65099230|FG000|Overall Study|Protocol Violation|2|||
23369834|NCT03558516|65099231|FG001|Overall Study|Protocol Violation|2|||
23369835|NCT02314728|65099232|FG000|Overall Study|Protocol Violation|1|||
23369836|NCT02314728|65099233|FG001|Overall Study|Protocol Violation|0|||
23369837|NCT02314728|65099232|FG000|Overall Study|Lost to Follow-up|0|||
23369838|NCT02314728|65099233|FG001|Overall Study|Lost to Follow-up|1|||
23369839|NCT03964207|65099235|FG000|First Treatment|Withdrawal by Subject|1|||
23369840|NCT03964207|65099236|FG001|First Treatment|Withdrawal by Subject|2|||
23369841|NCT03964207|65099235|FG000|First Treatment|Protocol Violation|1|||
23369842|NCT03964207|65099236|FG001|First Treatment|Protocol Violation|0|||
23369843|NCT03964207|65099235|FG000|First Treatment|Lost to Follow-up|1|||
23369844|NCT03964207|65099236|FG001|First Treatment|Lost to Follow-up|0|||
23369845|NCT03964207|65099235|FG000|Second Treatment|Lost to Follow-up|0|||
23369846|NCT03964207|65099236|FG001|Second Treatment|Lost to Follow-up|1|||
23369847|NCT03964207|65099235|FG000|Second Treatment|Adverse Event|1|||
23369848|NCT03964207|65099236|FG001|Second Treatment|Adverse Event|2|||
23369849|NCT01710020|65099237|FG000|Period 1|Protocol Violation|1|||
23369850|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
23485175|NCT00510874|65518819|FG004|Overall Study|Lost to Follow-up|4|||
23485176|NCT00510874|65518820|FG005|Overall Study|Lost to Follow-up|0|||
23369851|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
23369852|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369853|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369854|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369855|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369856|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369857|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369858|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369859|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369860|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
23369861|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
23663122|NCT00467779|66152388|FG005|Stage 2A|Adverse Event|0|||
23369862|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369863|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369864|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369865|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369866|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369867|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369868|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369869|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369870|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
23369871|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369872|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369873|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369874|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369875|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369876|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369877|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369878|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369879|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369880|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
23663123|NCT00467779|66152389|FG006|Stage 2A|Adverse Event|0|||
23369881|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
23369882|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369883|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369884|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369885|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23603345|NCT01822756|65937328|FG000|Overall Study|disease progression & patient preference|2|||
23603346|NCT01822756|65937329|FG001|Overall Study|disease progression & patient preference|0|||
23603347|NCT01822756|65937330|FG002|Overall Study|disease progression & patient preference|1|||
23603348|NCT01822756|65937331|FG003|Overall Study|disease progression & patient preference|0|||
23603349|NCT01822756|65937332|FG004|Overall Study|disease progression & patient preference|0|||
23603350|NCT01409837|65937334|FG000|Overall Study|Withdrawal by Subject|2|||
23603351|NCT01409837|65937335|FG001|Overall Study|Withdrawal by Subject|1|||
23603352|NCT01409837|65937334|FG000|Overall Study|Lost to Follow-up|1|||
23603353|NCT01409837|65937335|FG001|Overall Study|Lost to Follow-up|0|||
23603354|NCT01409837|65937334|FG000|Overall Study|Physician Decision|0|||
23603355|NCT01409837|65937335|FG001|Overall Study|Physician Decision|1|||
23663124|NCT00467779|66152390|FG007|Stage 2A|Adverse Event|0|||
23663125|NCT00467779|66152391|FG008|Stage 2A|Adverse Event|0|||
23369886|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369887|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369888|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369889|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369890|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
23369891|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
23369892|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369893|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369894|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369895|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369896|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369897|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369898|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369899|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369900|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
23369901|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
23369902|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369903|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369904|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369905|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369906|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369907|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369908|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369909|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369910|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
23369911|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
23369912|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369913|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369914|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369915|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369916|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369917|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369918|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369919|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369920|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23603356|NCT00960206|65937338|FG000|Overall Study|Death|7|||
23603357|NCT00960206|65937339|FG001|Overall Study|Death|4|||
23603358|NCT00960206|65937340|FG002|Overall Study|Death|1|||
23603359|NCT00960206|65937338|FG000|Overall Study|Unwilling/Unable to return|1|||
23603360|NCT00960206|65937339|FG001|Overall Study|Unwilling/Unable to return|2|||
23603361|NCT00960206|65937340|FG002|Overall Study|Unwilling/Unable to return|0|||
23603362|NCT00960206|65937338|FG000|Overall Study|Lost to Follow-up|8|||
23603363|NCT00960206|65937339|FG001|Overall Study|Lost to Follow-up|14|||
23603364|NCT00960206|65937340|FG002|Overall Study|Lost to Follow-up|8|||
23603365|NCT00960206|65937338|FG000|Overall Study|Withdrawal by Subject|2|||
23603366|NCT00960206|65937339|FG001|Overall Study|Withdrawal by Subject|4|||
23603367|NCT00960206|65937340|FG002|Overall Study|Withdrawal by Subject|0|||
23603368|NCT00960206|65937338|FG000|Overall Study|Revision of study component|2|||
23603369|NCT00960206|65937339|FG001|Overall Study|Revision of study component|2|||
23603370|NCT00960206|65937340|FG002|Overall Study|Revision of study component|2|||
23603371|NCT00960206|65937338|FG000|Overall Study|Missing 10 year data|20|||
23603372|NCT00960206|65937339|FG001|Overall Study|Missing 10 year data|1|||
23603373|NCT00960206|65937340|FG002|Overall Study|Missing 10 year data|1|||
23603374|NCT00491400|65937341|FG000|Overall Study|Withdrawal by Subject|5|||
23603375|NCT00491400|65937342|FG001|Overall Study|Withdrawal by Subject|4|||
23603376|NCT01399099|65937345|FG000|Overall Study|Lost to Follow-up|11|||
23603377|NCT01399099|65937345|FG000|Overall Study|Physician Decision|1|||
23603378|NCT01399099|65937345|FG000|Overall Study|Protocol Violation|1|||
23603379|NCT01399099|65937345|FG000|Overall Study|Skin Irritation|13|||
23603380|NCT01399099|65937345|FG000|Overall Study|Infection|1|||
23603381|NCT01399099|65937345|FG000|Overall Study|Miscellaneous|4|||
23603382|NCT00337610|65937346|FG000|Overall Study|Adverse Event|2|||
23603383|NCT00337610|65937347|FG001|Overall Study|Adverse Event|2|||
23603384|NCT00337610|65937346|FG000|Overall Study|Death|0|||
23603385|NCT00337610|65937347|FG001|Overall Study|Death|1|||
23485177|NCT00510874|65518821|FG006|Overall Study|Lost to Follow-up|1|||
23603386|NCT00337610|65937346|FG000|Overall Study|Lack of Efficacy|6|||
23603387|NCT00337610|65937347|FG001|Overall Study|Lack of Efficacy|3|||
23603388|NCT00337610|65937346|FG000|Overall Study|Lost to Follow-up|3|||
23603389|NCT00337610|65937347|FG001|Overall Study|Lost to Follow-up|3|||
23603390|NCT00337610|65937346|FG000|Overall Study|Withdrawal by Subject|6|||
23603391|NCT00337610|65937347|FG001|Overall Study|Withdrawal by Subject|5|||
23663126|NCT00467779|66152392|FG009|Stage 2A|Adverse Event|0|||
23663127|NCT00467779|66152393|FG010|Stage 2A|Adverse Event|0|||
23663128|NCT00467779|66152394|FG011|Stage 2A|Adverse Event|0|||
23663129|NCT00467779|66152395|FG012|Stage 2A|Adverse Event|0|||
23663130|NCT00467779|66152396|FG013|Stage 2A|Adverse Event|2|||
23663131|NCT00467779|66152397|FG014|Stage 2A|Adverse Event|0|||
23663132|NCT00467779|66152383|FG000|Stage 2A|Death|0|||
23663133|NCT00467779|66152384|FG001|Stage 2A|Death|0|||
23663134|NCT00467779|66152385|FG002|Stage 2A|Death|0|||
23663135|NCT00467779|66152386|FG003|Stage 2A|Death|0|||
23663136|NCT00467779|66152387|FG004|Stage 2A|Death|0|||
23663137|NCT00467779|66152388|FG005|Stage 2A|Death|0|||
23663138|NCT00467779|66152389|FG006|Stage 2A|Death|0|||
23663139|NCT00467779|66152390|FG007|Stage 2A|Death|0|||
23663140|NCT00467779|66152391|FG008|Stage 2A|Death|0|||
23663141|NCT00467779|66152392|FG009|Stage 2A|Death|0|||
23663142|NCT00467779|66152393|FG010|Stage 2A|Death|0|||
23663143|NCT00467779|66152394|FG011|Stage 2A|Death|0|||
23663144|NCT00467779|66152395|FG012|Stage 2A|Death|0|||
23663145|NCT00467779|66152396|FG013|Stage 2A|Death|1|||
23663146|NCT00467779|66152397|FG014|Stage 2A|Death|0|||
23663147|NCT00467779|66152383|FG000|Stage 2A|Disease Progression|0|||
23663148|NCT00467779|66152384|FG001|Stage 2A|Disease Progression|0|||
23663149|NCT00467779|66152385|FG002|Stage 2A|Disease Progression|0|||
23663150|NCT00467779|66152386|FG003|Stage 2A|Disease Progression|0|||
23663151|NCT00467779|66152387|FG004|Stage 2A|Disease Progression|0|||
23663152|NCT00467779|66152388|FG005|Stage 2A|Disease Progression|0|||
23663153|NCT00467779|66152389|FG006|Stage 2A|Disease Progression|0|||
23663154|NCT00467779|66152390|FG007|Stage 2A|Disease Progression|0|||
23663155|NCT00467779|66152391|FG008|Stage 2A|Disease Progression|0|||
23663156|NCT00467779|66152392|FG009|Stage 2A|Disease Progression|0|||
23663157|NCT00467779|66152393|FG010|Stage 2A|Disease Progression|0|||
23603392|NCT02091752|65937350|FG000|Overall Study|Study terminated by Sponsor|2|||
23603393|NCT02091752|65937350|FG000|Overall Study|Adverse Event|1|||
23663158|NCT00467779|66152394|FG011|Stage 2A|Disease Progression|0|||
23663159|NCT00467779|66152395|FG012|Stage 2A|Disease Progression|0|||
23663160|NCT00467779|66152396|FG013|Stage 2A|Disease Progression|10|||
23663161|NCT00467779|66152397|FG014|Stage 2A|Disease Progression|0|||
23663162|NCT00467779|66152383|FG000|Stage 2A|Unspecified Reason|0|||
23369921|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369922|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
23369923|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
23369924|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369925|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369926|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369927|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369928|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369929|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369930|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23663163|NCT00467779|66152384|FG001|Stage 2A|Unspecified Reason|0|||
23663164|NCT00467779|66152385|FG002|Stage 2A|Unspecified Reason|0|||
23663165|NCT00467779|66152386|FG003|Stage 2A|Unspecified Reason|0|||
23663166|NCT00467779|66152387|FG004|Stage 2A|Unspecified Reason|0|||
23663167|NCT00467779|66152388|FG005|Stage 2A|Unspecified Reason|0|||
23369931|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369932|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
23369933|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
23369934|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369935|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369936|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369937|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369938|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369939|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369940|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369941|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369942|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
23369943|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369944|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369945|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369946|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369947|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369948|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369949|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369950|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369951|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369952|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
23369953|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
23369954|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369955|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369956|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369957|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369958|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369959|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369960|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369961|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369962|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
23369963|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
23369964|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369965|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369966|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369967|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369968|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369969|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369970|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
23369971|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
23369972|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
23603394|NCT01263496|65937351|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
23663168|NCT00467779|66152389|FG006|Stage 2A|Unspecified Reason|0|||
23369973|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
23369974|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
23369975|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
23369976|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
23369977|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
23369978|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
23369979|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
23369980|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369981|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369982|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369983|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369984|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
23369985|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
23603395|NCT01263496|65937352|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23369986|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369987|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
23369988|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369989|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369990|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369991|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369992|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369993|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369994|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
23369995|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369996|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
23369997|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
23369998|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369999|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23370000|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370001|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370002|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370003|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370004|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370005|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370006|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370007|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
23370008|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370009|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370010|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370011|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370012|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370013|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370014|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
23370015|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370016|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370017|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370018|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370019|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370020|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370021|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370022|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370023|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370024|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
23370025|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23485178|NCT01222403|65518824|FG000|Overall Study|Inappropriate enrollment|0|||
23485179|NCT01222403|65518825|FG001|Overall Study|Inappropriate enrollment|2|||
23485180|NCT04535167|65518826|FG000|Treatment|Adverse Event|0|||
23485181|NCT04535167|65518827|FG001|Treatment|Adverse Event|0|||
23370026|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
23370027|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
23485182|NCT04535167|65518828|FG002|Treatment|Adverse Event|0|||
23370028|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370029|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370030|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370031|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23663169|NCT00467779|66152390|FG007|Stage 2A|Unspecified Reason|0|||
23663170|NCT00467779|66152391|FG008|Stage 2A|Unspecified Reason|0|||
23663171|NCT00467779|66152392|FG009|Stage 2A|Unspecified Reason|0|||
23663172|NCT00467779|66152393|FG010|Stage 2A|Unspecified Reason|0|||
23663173|NCT00467779|66152394|FG011|Stage 2A|Unspecified Reason|0|||
23663174|NCT00467779|66152395|FG012|Stage 2A|Unspecified Reason|0|||
23663175|NCT00467779|66152396|FG013|Stage 2A|Unspecified Reason|7|||
23663176|NCT00467779|66152397|FG014|Stage 2A|Unspecified Reason|0|||
23663177|NCT00467779|66152383|FG000|Stage 2A|Withdrawal by Subject|0|||
23663178|NCT00467779|66152384|FG001|Stage 2A|Withdrawal by Subject|0|||
23663179|NCT00467779|66152385|FG002|Stage 2A|Withdrawal by Subject|0|||
23663180|NCT00467779|66152386|FG003|Stage 2A|Withdrawal by Subject|0|||
23663181|NCT00467779|66152387|FG004|Stage 2A|Withdrawal by Subject|0|||
23663182|NCT00467779|66152388|FG005|Stage 2A|Withdrawal by Subject|0|||
23663183|NCT00467779|66152389|FG006|Stage 2A|Withdrawal by Subject|0|||
23663184|NCT00467779|66152390|FG007|Stage 2A|Withdrawal by Subject|0|||
23663185|NCT00467779|66152391|FG008|Stage 2A|Withdrawal by Subject|0|||
23663186|NCT00467779|66152392|FG009|Stage 2A|Withdrawal by Subject|0|||
23663187|NCT00467779|66152393|FG010|Stage 2A|Withdrawal by Subject|0|||
23663188|NCT00467779|66152394|FG011|Stage 2A|Withdrawal by Subject|0|||
23663189|NCT00467779|66152395|FG012|Stage 2A|Withdrawal by Subject|0|||
23663190|NCT00467779|66152396|FG013|Stage 2A|Withdrawal by Subject|1|||
23663191|NCT00467779|66152397|FG014|Stage 2A|Withdrawal by Subject|0|||
23663192|NCT00467779|66152383|FG000|Stage 3|Adverse Event|0|||
23663193|NCT00467779|66152384|FG001|Stage 3|Adverse Event|0|||
23663194|NCT00467779|66152385|FG002|Stage 3|Adverse Event|0|||
23663195|NCT00467779|66152386|FG003|Stage 3|Adverse Event|0|||
23663196|NCT00467779|66152387|FG004|Stage 3|Adverse Event|0|||
23663197|NCT00467779|66152388|FG005|Stage 3|Adverse Event|0|||
23663198|NCT00467779|66152389|FG006|Stage 3|Adverse Event|0|||
23663199|NCT00467779|66152390|FG007|Stage 3|Adverse Event|0|||
23663200|NCT00467779|66152391|FG008|Stage 3|Adverse Event|0|||
23663201|NCT00467779|66152392|FG009|Stage 3|Adverse Event|0|||
23663202|NCT00467779|66152393|FG010|Stage 3|Adverse Event|0|||
23663203|NCT00467779|66152394|FG011|Stage 3|Adverse Event|0|||
23663204|NCT00467779|66152395|FG012|Stage 3|Adverse Event|0|||
23663205|NCT00467779|66152396|FG013|Stage 3|Adverse Event|0|||
23663206|NCT00467779|66152397|FG014|Stage 3|Adverse Event|2|||
23663207|NCT00467779|66152383|FG000|Stage 3|Death|0|||
23663208|NCT00467779|66152384|FG001|Stage 3|Death|0|||
23663209|NCT00467779|66152385|FG002|Stage 3|Death|0|||
23663210|NCT00467779|66152386|FG003|Stage 3|Death|0|||
23663211|NCT00467779|66152387|FG004|Stage 3|Death|0|||
23663212|NCT00467779|66152388|FG005|Stage 3|Death|0|||
23663213|NCT00467779|66152389|FG006|Stage 3|Death|0|||
23663214|NCT00467779|66152390|FG007|Stage 3|Death|0|||
23663215|NCT00467779|66152391|FG008|Stage 3|Death|0|||
23663216|NCT00467779|66152392|FG009|Stage 3|Death|0|||
23663217|NCT00467779|66152393|FG010|Stage 3|Death|0|||
23663218|NCT00467779|66152394|FG011|Stage 3|Death|0|||
23663219|NCT00467779|66152395|FG012|Stage 3|Death|0|||
23663220|NCT00467779|66152396|FG013|Stage 3|Death|0|||
23663221|NCT00467779|66152397|FG014|Stage 3|Death|1|||
23663222|NCT00467779|66152383|FG000|Stage 3|Disease Progression|0|||
23663223|NCT00467779|66152384|FG001|Stage 3|Disease Progression|0|||
23663224|NCT00467779|66152385|FG002|Stage 3|Disease Progression|0|||
23663225|NCT00467779|66152386|FG003|Stage 3|Disease Progression|0|||
23663226|NCT00467779|66152387|FG004|Stage 3|Disease Progression|0|||
23663227|NCT00467779|66152388|FG005|Stage 3|Disease Progression|0|||
23663228|NCT00467779|66152389|FG006|Stage 3|Disease Progression|0|||
23663229|NCT00467779|66152390|FG007|Stage 3|Disease Progression|0|||
23663230|NCT00467779|66152391|FG008|Stage 3|Disease Progression|0|||
23485183|NCT04535167|65518829|FG003|Treatment|Adverse Event|0|||
23485184|NCT04535167|65518830|FG004|Treatment|Adverse Event|0|||
23485185|NCT04535167|65518831|FG005|Treatment|Adverse Event|0|||
23485186|NCT04535167|65518832|FG006|Treatment|Adverse Event|1|||
23485187|NCT04535167|65518826|FG000|Follow-Up|Death|0|||
23485188|NCT04535167|65518827|FG001|Follow-Up|Death|0|||
23485189|NCT04535167|65518828|FG002|Follow-Up|Death|0|||
23485190|NCT04535167|65518829|FG003|Follow-Up|Death|0|||
23485191|NCT04535167|65518830|FG004|Follow-Up|Death|0|||
23485192|NCT04535167|65518831|FG005|Follow-Up|Death|0|||
23485193|NCT04535167|65518832|FG006|Follow-Up|Death|1|||
23485194|NCT04535167|65518826|FG000|Follow-Up|Lost to Follow-up|0|||
23485195|NCT04535167|65518827|FG001|Follow-Up|Lost to Follow-up|0|||
23485196|NCT04535167|65518828|FG002|Follow-Up|Lost to Follow-up|0|||
23485197|NCT04535167|65518829|FG003|Follow-Up|Lost to Follow-up|1|||
23485198|NCT04535167|65518830|FG004|Follow-Up|Lost to Follow-up|0|||
23485199|NCT04535167|65518831|FG005|Follow-Up|Lost to Follow-up|0|||
23603396|NCT01263496|65937353|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603397|NCT01263496|65937354|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23485200|NCT04535167|65518832|FG006|Follow-Up|Lost to Follow-up|0|||
23485201|NCT00773383|65518840|FG000|Overall Study|Adverse Event|4|||
23485202|NCT00773383|65518840|FG000|Overall Study|Death|1|||
23603398|NCT01263496|65937355|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23485203|NCT00773383|65518840|FG000|Overall Study|Progression of Disease|23|||
23663231|NCT00467779|66152392|FG009|Stage 3|Disease Progression|0|||
23663232|NCT00467779|66152393|FG010|Stage 3|Disease Progression|0|||
23663233|NCT00467779|66152394|FG011|Stage 3|Disease Progression|0|||
23663234|NCT00467779|66152395|FG012|Stage 3|Disease Progression|0|||
23663235|NCT00467779|66152396|FG013|Stage 3|Disease Progression|0|||
23663236|NCT00467779|66152397|FG014|Stage 3|Disease Progression|9|||
23663237|NCT00467779|66152383|FG000|Stage 3|Unspecified Reason|0|||
23663238|NCT00467779|66152384|FG001|Stage 3|Unspecified Reason|0|||
23663239|NCT00467779|66152385|FG002|Stage 3|Unspecified Reason|0|||
23663240|NCT00467779|66152386|FG003|Stage 3|Unspecified Reason|0|||
23485204|NCT00773383|65518840|FG000|Overall Study|Other|2|||
23485205|NCT00773383|65518840|FG000|Overall Study|No study dose received|1|||
23485206|NCT01306877|65518841|FG000|Overall Study|Lost to Follow-up|3|||
23485207|NCT01306877|65518842|FG001|Overall Study|Lost to Follow-up|3|||
23485208|NCT01306877|65518841|FG000|Overall Study|Physician Decision|0|||
23370032|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23485209|NCT01306877|65518842|FG001|Overall Study|Physician Decision|1|||
23485210|NCT04571515|65518843|FG000|Overall Study|Physician Decision|0|||
23485211|NCT04571515|65518844|FG001|Overall Study|Physician Decision|0|||
23663241|NCT00467779|66152387|FG004|Stage 3|Unspecified Reason|0|||
23663242|NCT00467779|66152388|FG005|Stage 3|Unspecified Reason|0|||
23370033|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23663243|NCT00467779|66152389|FG006|Stage 3|Unspecified Reason|0|||
23663244|NCT00467779|66152390|FG007|Stage 3|Unspecified Reason|0|||
23663245|NCT00467779|66152391|FG008|Stage 3|Unspecified Reason|0|||
23663246|NCT00467779|66152392|FG009|Stage 3|Unspecified Reason|0|||
23663247|NCT00467779|66152393|FG010|Stage 3|Unspecified Reason|0|||
23663248|NCT00467779|66152394|FG011|Stage 3|Unspecified Reason|0|||
23663249|NCT00467779|66152395|FG012|Stage 3|Unspecified Reason|0|||
23663250|NCT00467779|66152396|FG013|Stage 3|Unspecified Reason|0|||
23663251|NCT00467779|66152397|FG014|Stage 3|Unspecified Reason|5|||
23663252|NCT00710879|66152405|FG000|Overall Study|Lost to Follow-up|2|||
23663253|NCT00710879|66152406|FG001|Overall Study|Lost to Follow-up|1|||
23663254|NCT00710879|66152405|FG000|Overall Study|Protocol Violation|0|||
23663255|NCT00710879|66152406|FG001|Overall Study|Protocol Violation|3|||
23663256|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
23663257|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
23663258|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
23663259|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
23663260|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
23663261|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
23663262|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23663263|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23663264|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23663265|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23663266|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
23663267|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
23663268|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
23485212|NCT04571515|65518845|FG002|Overall Study|Physician Decision|0|||
23485213|NCT04571515|65518846|FG003|Overall Study|Physician Decision|0|||
23663269|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
23663270|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
23663271|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
23663272|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
23663273|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
23663274|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
23663275|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
23663276|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
23663277|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
23663278|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
23663279|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
23663280|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
23663281|NCT03829657|66152407|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
23663282|NCT03829657|66152408|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
23663283|NCT03829657|66152409|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
23663284|NCT03829657|66152410|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
23663285|NCT03829657|66152411|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
23663286|NCT03829657|66152407|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23663287|NCT03829657|66152408|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23663288|NCT03829657|66152409|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23663289|NCT03829657|66152410|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23485214|NCT04571515|65518847|FG004|Overall Study|Physician Decision|1|||
23663290|NCT03829657|66152411|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
23663291|NCT03829657|66152407|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23663292|NCT03829657|66152408|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23663293|NCT03829657|66152409|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23663294|NCT03829657|66152410|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
23663295|NCT03829657|66152411|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
23663296|NCT03829657|66152407|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23663297|NCT03829657|66152408|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23663298|NCT03829657|66152409|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23663299|NCT03829657|66152410|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
23663300|NCT03829657|66152411|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
23663301|NCT03829657|66152407|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23663302|NCT03829657|66152408|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23663303|NCT03829657|66152409|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23663304|NCT03829657|66152410|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23807596|NCT00855803|66672821|FG000|Overall Study|Technical inability to undergo procedure|2|||
23807597|NCT00855803|66672821|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
23807598|NCT00855803|66672821|FG000|Overall Study|Withdrawal by Subject|3|||
23807599|NCT00855803|66672821|FG000|Overall Study|Physician Decision|3|||
23370034|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370035|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370036|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370037|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
23370038|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370039|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370040|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370041|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370042|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370043|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370044|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370045|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
23370046|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370047|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370048|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370049|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370050|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370051|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370052|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370053|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370054|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370055|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23485215|NCT04571515|65518843|FG000|Overall Study|Withdrawal by Subject|0|||
23370056|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370057|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370058|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
23370059|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
23370060|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370061|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370062|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370063|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370064|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370065|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370066|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370067|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370068|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
23370069|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
23370070|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23485216|NCT04571515|65518844|FG001|Overall Study|Withdrawal by Subject|0|||
23485217|NCT04571515|65518845|FG002|Overall Study|Withdrawal by Subject|0|||
23370071|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370072|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370073|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370074|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370075|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370076|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370077|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370078|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
23370079|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
23370080|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370081|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370082|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370083|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370084|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370085|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370086|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370087|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370088|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
23370089|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
23663305|NCT03829657|66152411|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
23663306|NCT03610724|66152417|FG000|Overall Study|Death|17|||
23663307|NCT03610724|66152417|FG000|Overall Study|Lost to Follow-up|1|||
23663308|NCT03610724|66152417|FG000|Overall Study|Physician Decision|1|||
23663309|NCT03610724|66152417|FG000|Overall Study|Died prior to infusion|1|||
23663310|NCT01274715|66152418|FG000|Overall Study|Lost to Follow-up|1|||
23663311|NCT01274715|66152418|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23663312|NCT01274715|66152418|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23663313|NCT01274715|66152418|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23663314|NCT01876251|66152419|FG000|Overall Study|Clinical progression|1|||
23663315|NCT01876251|66152420|FG001|Overall Study|Clinical progression|0|||
23663316|NCT01876251|66152421|FG002|Overall Study|Clinical progression|0|||
23663317|NCT01876251|66152419|FG000|Overall Study|Death|2|||
23663318|NCT01876251|66152420|FG001|Overall Study|Death|0|||
23663319|NCT01876251|66152421|FG002|Overall Study|Death|1|||
23663320|NCT01876251|66152419|FG000|Overall Study|Participant started new treatment|1|||
23663321|NCT01876251|66152420|FG001|Overall Study|Participant started new treatment|0|||
23663322|NCT01876251|66152421|FG002|Overall Study|Participant started new treatment|1|||
23663323|NCT01876251|66152419|FG000|Overall Study|Participant refused further follow-up|0|||
23663324|NCT01876251|66152420|FG001|Overall Study|Participant refused further follow-up|0|||
23370090|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370091|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23663325|NCT01876251|66152421|FG002|Overall Study|Participant refused further follow-up|1|||
23663326|NCT01876251|66152419|FG000|Overall Study|Study terminated|1|||
23663327|NCT01876251|66152420|FG001|Overall Study|Study terminated|0|||
23370092|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370093|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370094|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370095|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370096|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370097|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370098|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
23370099|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
23370100|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370101|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370102|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370103|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370104|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370105|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370106|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370107|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370108|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
23370109|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370110|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370111|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370112|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370113|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370114|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370115|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370116|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370117|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370118|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
23370119|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370120|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370121|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370122|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370123|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370124|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370125|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370126|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23663328|NCT01876251|66152421|FG002|Overall Study|Study terminated|0|||
23663329|NCT01876251|66152419|FG000|Overall Study|Objective progression or relapse|10|||
23663330|NCT01876251|66152420|FG001|Overall Study|Objective progression or relapse|3|||
23663331|NCT01876251|66152421|FG002|Overall Study|Objective progression or relapse|8|||
23663332|NCT03668600|66152424|FG000|Overall Study|Study Terminated by the Sponsor|157|||
23663333|NCT03668600|66152424|FG000|Overall Study|Protocol Violation|1|||
23663334|NCT03668600|66152424|FG000|Overall Study|Pregnancy|1|||
23663335|NCT03668600|66152424|FG000|Overall Study|Lost to Follow-up|7|||
23663336|NCT03668600|66152424|FG000|Overall Study|Withdrawal by Subject|56|||
23663337|NCT03668600|66152424|FG000|Overall Study|Lack of Efficacy|7|||
23663338|NCT03668600|66152424|FG000|Overall Study|Adverse Event|1|||
23663339|NCT02536313|66152425|FG000|Overall Study|Lack of Efficacy|0|||
23663340|NCT02536313|66152426|FG001|Overall Study|Lack of Efficacy|1|||
23370127|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23663341|NCT02554903|66152434|FG000|Overall Study|Death|1|||
23807600|NCT00704730|66672822|FG000|Overall Study|Adverse Event|35|||
23663342|NCT02554903|66152435|FG001|Overall Study|Death|1|||
23663343|NCT02554903|66152434|FG000|Overall Study|Physician Decision|2|||
23370128|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
23370129|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
23370130|NCT02823470|65099248|FG000|Overall Study|Adverse Event|1|||
23370131|NCT02823470|65099249|FG001|Overall Study|Adverse Event|0|||
23370132|NCT02823470|65099248|FG000|Overall Study|Study terminated by sponsor|8|||
23370133|NCT02823470|65099249|FG001|Overall Study|Study terminated by sponsor|15|||
23370134|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
23370135|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370136|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370137|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370138|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370139|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
23370140|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370141|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370142|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370143|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370144|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
23370145|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370146|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370147|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370148|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370149|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
23370150|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370151|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370152|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370153|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370154|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
23370155|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370156|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370157|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370158|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370159|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
23370160|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23370161|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23603399|NCT01263496|65937356|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23663344|NCT02554903|66152435|FG001|Overall Study|Physician Decision|2|||
23370162|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23370163|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23370164|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
23370165|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370166|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370167|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370168|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370169|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370170|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370171|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370172|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23370173|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370174|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370175|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370176|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
23370177|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370178|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370179|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23370180|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
23370181|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23370182|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
23370183|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23603400|NCT01263496|65937357|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603401|NCT01263496|65937358|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603402|NCT01263496|65937359|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603403|NCT01263496|65937351|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603404|NCT01263496|65937352|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603405|NCT01263496|65937353|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603406|NCT01263496|65937354|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23603407|NCT01263496|65937355|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
23603408|NCT01263496|65937356|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603409|NCT01263496|65937357|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603410|NCT01263496|65937358|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603411|NCT01263496|65937359|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603412|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
23603413|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
23603414|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
23370184|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370185|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370186|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370187|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
23370188|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370189|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370190|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370191|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370192|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370193|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
23370194|NCT02668640|65099258|FG000|Overall Study|Lost to Follow-up|13|||
23370195|NCT02668640|65099258|FG000|Overall Study|Other, not specified|1|||
23370196|NCT02771275|65099259|FG000|Overall Study|Reoperation|3|||
23370197|NCT02771275|65099259|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
23370198|NCT01100853|65099260|FG000|Overall Study|Lost to Follow-up|11|||
23370199|NCT01100853|65099261|FG001|Overall Study|Lost to Follow-up|6|||
23370200|NCT01100853|65099260|FG000|Overall Study|Received <4 study injections|10|||
23370201|NCT01100853|65099261|FG001|Overall Study|Received <4 study injections|13|||
23603415|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
23603416|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
23603417|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
23603418|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
23603419|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
23603420|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
23603421|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603422|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
23603423|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23663345|NCT02554903|66152434|FG000|Overall Study|Heart Transplant|1|||
23663346|NCT02554903|66152435|FG001|Overall Study|Heart Transplant|2|||
23663347|NCT02161575|66152436|FG000|Overall Study|Protocol Violation|8|||
23663348|NCT02161575|66152436|FG000|Overall Study|Lack of Efficacy|1|||
23663349|NCT02161575|66152436|FG000|Overall Study|Adverse Event|2|||
23663350|NCT01401842|66152439|FG000|Overall Study|Withdrawal by Subject|3|||
23663351|NCT01401842|66152440|FG001|Overall Study|Withdrawal by Subject|2|||
23663352|NCT01401842|66152439|FG000|Overall Study|academic reason|4|||
23663353|NCT01401842|66152440|FG001|Overall Study|academic reason|1|||
23663354|NCT01401842|66152439|FG000|Overall Study|changed companies|20|||
23603424|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603425|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603426|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603427|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603428|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603429|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603430|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603431|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23603432|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23663355|NCT01401842|66152440|FG001|Overall Study|changed companies|34|||
23663356|NCT01401842|66152439|FG000|Overall Study|discharged from US Army|3|||
23663357|NCT01401842|66152440|FG001|Overall Study|discharged from US Army|4|||
23807601|NCT00704730|66672823|FG001|Overall Study|Adverse Event|9|||
23807602|NCT00704730|66672822|FG000|Overall Study|Death|11|||
23807603|NCT00704730|66672823|FG001|Overall Study|Death|5|||
23807604|NCT00704730|66672822|FG000|Overall Study|Physician Decision|2|||
23807605|NCT00704730|66672823|FG001|Overall Study|Physician Decision|0|||
23807606|NCT00704730|66672822|FG000|Overall Study|Did not receive drug|5|||
23807607|NCT00704730|66672823|FG001|Overall Study|Did not receive drug|2|||
23807608|NCT00704730|66672822|FG000|Overall Study|Disease progression per PI|58|||
23807609|NCT00704730|66672823|FG001|Overall Study|Disease progression per PI|67|||
23807610|NCT00704730|66672822|FG000|Overall Study|data unavailable|1|||
23807611|NCT00704730|66672823|FG001|Overall Study|data unavailable|0|||
23807612|NCT00704730|66672822|FG000|Overall Study|Withdrawal by Subject|9|||
23807613|NCT00704730|66672823|FG001|Overall Study|Withdrawal by Subject|13|||
23807614|NCT00891839|66672824|FG000|Overall Study|Adverse Event|2|||
23807615|NCT00891839|66672824|FG000|Overall Study|Withdrawal by Subject|2|||
23807616|NCT00891839|66672824|FG000|Overall Study|Disease progression|3|||
23485218|NCT04571515|65518846|FG003|Overall Study|Withdrawal by Subject|0|||
23485219|NCT04571515|65518847|FG004|Overall Study|Withdrawal by Subject|1|||
23485220|NCT04571515|65518843|FG000|Overall Study|insufficient pain|1|||
23485221|NCT04571515|65518844|FG001|Overall Study|insufficient pain|0|||
23485222|NCT04571515|65518845|FG002|Overall Study|insufficient pain|0|||
23485223|NCT04571515|65518846|FG003|Overall Study|insufficient pain|0|||
23485224|NCT04571515|65518847|FG004|Overall Study|insufficient pain|1|||
23485225|NCT00761748|65518848|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
23485226|NCT00761748|65518849|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
23485227|NCT00761748|65518848|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
23485228|NCT00761748|65518849|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
23485229|NCT01058265|65518852|FG000|Overall Study|Lost to Follow-up|11|||
23485230|NCT01058265|65518853|FG001|Overall Study|Lost to Follow-up|12|||
23485231|NCT04706416|65518854|FG000|Overall Study|Lost to Follow-up|2|||
23485232|NCT04706416|65518855|FG001|Overall Study|Lost to Follow-up|0|||
23485233|NCT01315236|65521681|FG000|Double-blind Phase|Death|1|||
23485234|NCT01315236|65521682|FG001|Double-blind Phase|Death|0|||
23485235|NCT01315236|65521681|FG000|Double-blind Phase|Adverse Event|1|||
23485236|NCT01315236|65521682|FG001|Double-blind Phase|Adverse Event|0|||
23485237|NCT01315236|65521681|FG000|Double-blind Phase|Withdrawal of Consent|1|||
23485238|NCT01315236|65521682|FG001|Double-blind Phase|Withdrawal of Consent|0|||
23485239|NCT01315236|65521681|FG000|Double-blind Phase|Lost to Follow-up|1|||
23485240|NCT01315236|65521682|FG001|Double-blind Phase|Lost to Follow-up|0|||
23485241|NCT01315236|65521681|FG000|Open-label Phase|Death|1|||
23485242|NCT01315236|65521682|FG001|Open-label Phase|Death|0|||
23485243|NCT01315236|65521681|FG000|Open-label Phase|Adverse Event|0|||
23485244|NCT01315236|65521682|FG001|Open-label Phase|Adverse Event|1|||
23485245|NCT01315236|65521681|FG000|Open-label Phase|Other|0|||
23485246|NCT01315236|65521682|FG001|Open-label Phase|Other|1|||
23485247|NCT01315236|65521681|FG000|12-Month Follow-up Period|Death|0|||
23485248|NCT01315236|65521682|FG001|12-Month Follow-up Period|Death|1|||
23485249|NCT01315236|65521681|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
23485250|NCT01315236|65521682|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
23485251|NCT01255787|65521683|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
23485252|NCT01255787|65521684|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
23485253|NCT01255787|65521685|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
23485254|NCT01255787|65521686|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
23485255|NCT01255787|65521683|FG000|Overall Study|Major Protocol Deviation|1|||
23485256|NCT01255787|65521684|FG001|Overall Study|Major Protocol Deviation|1|||
23485257|NCT01255787|65521685|FG002|Overall Study|Major Protocol Deviation|0|||
23485258|NCT01255787|65521686|FG003|Overall Study|Major Protocol Deviation|4|||
23485259|NCT01255787|65521683|FG000|Overall Study|Lost to Follow-up|1|||
23485260|NCT01255787|65521684|FG001|Overall Study|Lost to Follow-up|2|||
23485261|NCT01255787|65521685|FG002|Overall Study|Lost to Follow-up|4|||
23485262|NCT01255787|65521686|FG003|Overall Study|Lost to Follow-up|2|||
23485263|NCT01255787|65521683|FG000|Overall Study|Withdrawal of Consent|3|||
23485264|NCT01255787|65521684|FG001|Overall Study|Withdrawal of Consent|9|||
23485265|NCT01255787|65521685|FG002|Overall Study|Withdrawal of Consent|3|||
23485266|NCT01255787|65521686|FG003|Overall Study|Withdrawal of Consent|4|||
23485267|NCT01255787|65521683|FG000|Overall Study|Pregnancy|0|||
23485268|NCT01255787|65521684|FG001|Overall Study|Pregnancy|0|||
23485269|NCT01255787|65521685|FG002|Overall Study|Pregnancy|0|||
23485270|NCT01255787|65521686|FG003|Overall Study|Pregnancy|1|||
23485271|NCT01255787|65521683|FG000|Overall Study|Lack of Efficacy|2|||
23485272|NCT01255787|65521684|FG001|Overall Study|Lack of Efficacy|2|||
23663358|NCT01401842|66152439|FG000|Overall Study|invalid follow-up strength data|1|||
23663359|NCT01401842|66152440|FG001|Overall Study|invalid follow-up strength data|4|||
23663360|NCT01401842|66152439|FG000|Overall Study|on profile|9|||
23663361|NCT01401842|66152440|FG001|Overall Study|on profile|5|||
23663362|NCT01401842|66152439|FG000|Overall Study|other/unknown|28|||
23663363|NCT01401842|66152440|FG001|Overall Study|other/unknown|17|||
23663364|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
23663365|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
23663366|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
23663367|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
23663368|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
23807617|NCT03347422|66672825|FG000|Part A (26 Weeks)|Adverse Event|3|||
23370202|NCT01100853|65099260|FG000|Overall Study|Withdrawal by Subject|6|||
23370203|NCT01100853|65099261|FG001|Overall Study|Withdrawal by Subject|4|||
23370204|NCT01317940|65099264|FG000|Overall Study|Death|1|||
23370205|NCT01317940|65099265|FG001|Overall Study|Death|0|||
23370206|NCT01317940|65099266|FG002|Overall Study|Death|1|||
23370207|NCT01317940|65099267|FG003|Overall Study|Death|0|||
23370208|NCT01317940|65099268|FG004|Overall Study|Death|0|||
23370209|NCT01317940|65099269|FG005|Overall Study|Death|0|||
23370210|NCT01317940|65099264|FG000|Overall Study|Lost to Follow-up|0|||
23370211|NCT01317940|65099265|FG001|Overall Study|Lost to Follow-up|0|||
23370212|NCT01317940|65099266|FG002|Overall Study|Lost to Follow-up|1|||
23370213|NCT01317940|65099267|FG003|Overall Study|Lost to Follow-up|1|||
23370214|NCT01317940|65099268|FG004|Overall Study|Lost to Follow-up|1|||
23370215|NCT01317940|65099269|FG005|Overall Study|Lost to Follow-up|0|||
23370216|NCT01317940|65099264|FG000|Overall Study|Change in therapy plan|0|||
23370217|NCT01317940|65099265|FG001|Overall Study|Change in therapy plan|0|||
23370218|NCT01317940|65099266|FG002|Overall Study|Change in therapy plan|3|||
23370219|NCT01317940|65099267|FG003|Overall Study|Change in therapy plan|0|||
23663369|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
23663370|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
23663371|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
23663372|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
23663373|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
23807618|NCT03347422|66672826|FG001|Part A (26 Weeks)|Adverse Event|0|||
23370220|NCT01317940|65099268|FG004|Overall Study|Change in therapy plan|0|||
23370221|NCT01317940|65099269|FG005|Overall Study|Change in therapy plan|0|||
23370222|NCT02308046|65099270|FG000|Overall Study|Negative yeast culture at Baseline|32|||
23485273|NCT01255787|65521685|FG002|Overall Study|Lack of Efficacy|2|||
23370223|NCT02308046|65099271|FG001|Overall Study|Negative yeast culture at Baseline|33|||
23370224|NCT02308046|65099270|FG000|Overall Study|Positive for STD at Baseline|1|||
23370225|NCT02308046|65099271|FG001|Overall Study|Positive for STD at Baseline|2|||
23370226|NCT02308046|65099270|FG000|Overall Study|Lost to Follow-up|1|||
23370227|NCT02308046|65099271|FG001|Overall Study|Lost to Follow-up|3|||
23370228|NCT03669588|65099281|FG000|Overall Study|Adverse Event|1|||
23370229|NCT03669588|65099282|FG001|Overall Study|Adverse Event|0|||
23370230|NCT03669588|65099281|FG000|Overall Study|Physician Decision|0|||
23370231|NCT03669588|65099282|FG001|Overall Study|Physician Decision|1|||
23370232|NCT03669588|65099281|FG000|Overall Study|Protocol Violation|1|||
23370233|NCT03669588|65099282|FG001|Overall Study|Protocol Violation|0|||
23370234|NCT03669588|65099281|FG000|Overall Study|Sponsor Decision|1|||
23370235|NCT03669588|65099282|FG001|Overall Study|Sponsor Decision|1|||
23370236|NCT03669588|65099281|FG000|Overall Study|Withdrawal by Subject|1|||
23370237|NCT03669588|65099282|FG001|Overall Study|Withdrawal by Subject|4|||
23370238|NCT03669588|65099281|FG000|Overall Study|Rescue Therapy Needed|0|||
23370239|NCT03669588|65099282|FG001|Overall Study|Rescue Therapy Needed|1|||
23370240|NCT02914834|65099285|FG000|Overall Study|Study halted due to COVID|1|||
23370241|NCT02914834|65099286|FG001|Overall Study|Study halted due to COVID|1|||
23370242|NCT02914834|65099285|FG000|Overall Study|1 subject withdrew|0|||
23370243|NCT02914834|65099286|FG001|Overall Study|1 subject withdrew|1|||
23370244|NCT02736617|65099295|FG000|Treatment|Adverse Event|1|||
23370245|NCT02736617|65099295|FG000|Treatment|Lack of Efficacy|1|||
23370246|NCT02736617|65099295|FG000|Treatment|Withdrawal by Subject|1|||
23370247|NCT02736617|65099295|FG000|Maintenance|Lack of Efficacy|4|||
23370248|NCT02736617|65099295|FG000|Maintenance|Physician Decision|1|||
23370249|NCT00379834|65099297|FG000|Overall Study|Time constraints|2|||
23370250|NCT02792504|65099298|FG000|Overall Study|Lost to Follow-up|24|||
23370251|NCT02792504|65099298|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
23370252|NCT02999789|65099299|FG000|Overall Study|Withdrawal by Subject|0|||
23370253|NCT02999789|65099300|FG001|Overall Study|Withdrawal by Subject|1|||
23370254|NCT02999789|65099299|FG000|Overall Study|Became ineligible|1|||
23370255|NCT02999789|65099300|FG001|Overall Study|Became ineligible|2|||
23370256|NCT01619852|65099301|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
23370257|NCT01619852|65099302|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
23370258|NCT01619852|65099301|FG000|3 Month Follow up|Lost to Follow-up|31|||
23370259|NCT01619852|65099302|FG001|3 Month Follow up|Lost to Follow-up|34|||
23370260|NCT00983372|65099303|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
23370261|NCT00983372|65099303|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
23370262|NCT00983372|65099303|FG000|Diltiazem ER Alone|Adverse Event|1|||
23370263|NCT04350827|65099306|FG000|Overall Study|Lost to Follow-up|1|||
23370264|NCT04350827|65099307|FG001|Overall Study|Lost to Follow-up|2|||
23370265|NCT04494646|65099308|FG000|Overall Study|Adverse Event|0|||
23370266|NCT04494646|65099309|FG001|Overall Study|Adverse Event|1|||
23370267|NCT04494646|65099308|FG000|Overall Study|Withdrawal by Subject|0|||
23370268|NCT04494646|65099309|FG001|Overall Study|Withdrawal by Subject|1|||
23370269|NCT03555149|65099313|FG000|Overall Study|Death|18|||
23370270|NCT03555149|65099314|FG001|Overall Study|Death|15|||
23370271|NCT03555149|65099315|FG002|Overall Study|Death|15|||
23370272|NCT03555149|65099316|FG003|Overall Study|Death|4|||
23370273|NCT03555149|65099317|FG004|Overall Study|Death|4|||
23370274|NCT03555149|65099318|FG005|Overall Study|Death|11|||
23370275|NCT03555149|65099319|FG006|Overall Study|Death|12|||
23370276|NCT03555149|65099320|FG007|Overall Study|Death|1|||
23370277|NCT03555149|65099313|FG000|Overall Study|Lost to Follow-up|1|||
23370278|NCT03555149|65099314|FG001|Overall Study|Lost to Follow-up|0|||
23370279|NCT03555149|65099315|FG002|Overall Study|Lost to Follow-up|0|||
23370280|NCT03555149|65099316|FG003|Overall Study|Lost to Follow-up|0|||
23370281|NCT03555149|65099317|FG004|Overall Study|Lost to Follow-up|0|||
23370282|NCT03555149|65099318|FG005|Overall Study|Lost to Follow-up|1|||
23370283|NCT03555149|65099319|FG006|Overall Study|Lost to Follow-up|0|||
23485274|NCT01255787|65521686|FG003|Overall Study|Lack of Efficacy|2|||
23485275|NCT01255787|65521683|FG000|Overall Study|Noncompliance with Study Drug|3|||
23370284|NCT03555149|65099320|FG007|Overall Study|Lost to Follow-up|0|||
23370285|NCT03555149|65099313|FG000|Overall Study|Physician Decision|1|||
23370286|NCT03555149|65099314|FG001|Overall Study|Physician Decision|0|||
23370287|NCT03555149|65099315|FG002|Overall Study|Physician Decision|0|||
23370288|NCT03555149|65099316|FG003|Overall Study|Physician Decision|0|||
23370289|NCT03555149|65099317|FG004|Overall Study|Physician Decision|0|||
23370290|NCT03555149|65099318|FG005|Overall Study|Physician Decision|0|||
23485276|NCT01255787|65521684|FG001|Overall Study|Noncompliance with Study Drug|1|||
23370291|NCT03555149|65099319|FG006|Overall Study|Physician Decision|0|||
23370292|NCT03555149|65099320|FG007|Overall Study|Physician Decision|0|||
23370293|NCT03555149|65099313|FG000|Overall Study|Study Terminated By Sponsor|1|||
23370294|NCT03555149|65099314|FG001|Overall Study|Study Terminated By Sponsor|0|||
23370295|NCT03555149|65099315|FG002|Overall Study|Study Terminated By Sponsor|0|||
23807619|NCT03347422|66672825|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
23370296|NCT03555149|65099316|FG003|Overall Study|Study Terminated By Sponsor|0|||
23370297|NCT03555149|65099317|FG004|Overall Study|Study Terminated By Sponsor|0|||
23370298|NCT03555149|65099318|FG005|Overall Study|Study Terminated By Sponsor|2|||
23370299|NCT03555149|65099319|FG006|Overall Study|Study Terminated By Sponsor|3|||
23370300|NCT03555149|65099320|FG007|Overall Study|Study Terminated By Sponsor|1|||
23370301|NCT03555149|65099313|FG000|Overall Study|Withdrawal by Subject|3|||
23370302|NCT03555149|65099314|FG001|Overall Study|Withdrawal by Subject|0|||
23603433|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23603434|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
23603435|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603436|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603437|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23663374|NCT01299376|66152441|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
23663375|NCT01299376|66152442|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
23603438|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603439|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
23603440|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23603441|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23663376|NCT01299376|66152441|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
23663377|NCT01299376|66152442|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
23663378|NCT01299376|66152441|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
23663379|NCT01299376|66152442|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
23663380|NCT01299376|66152441|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
23663381|NCT01299376|66152442|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
23663382|NCT01299376|66152441|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
23663383|NCT01299376|66152442|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
23663384|NCT01299376|66152441|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
23663385|NCT01299376|66152442|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
23663386|NCT04206020|66152448|FG000|Overall Study|Adverse Event|1|||
23663387|NCT04206020|66152449|FG001|Overall Study|Adverse Event|4|||
23663388|NCT04206020|66152448|FG000|Overall Study|Protocol Violation|2|||
23603442|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23603443|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
23603444|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603445|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603446|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603447|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23370303|NCT03555149|65099315|FG002|Overall Study|Withdrawal by Subject|0|||
23370304|NCT03555149|65099316|FG003|Overall Study|Withdrawal by Subject|2|||
23370305|NCT03555149|65099317|FG004|Overall Study|Withdrawal by Subject|0|||
23663389|NCT04206020|66152449|FG001|Overall Study|Protocol Violation|0|||
23370306|NCT03555149|65099318|FG005|Overall Study|Withdrawal by Subject|1|||
23370307|NCT03555149|65099319|FG006|Overall Study|Withdrawal by Subject|0|||
23370308|NCT03555149|65099320|FG007|Overall Study|Withdrawal by Subject|0|||
23370309|NCT03713281|65099321|FG000|Overall Study|Lens handling difficuluties|2|||
23370310|NCT03713281|65099321|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
23370311|NCT01285518|65099322|FG000|Overall Study|Lost to Follow-up|0|||
23370312|NCT01285518|65099323|FG001|Overall Study|Lost to Follow-up|0|||
23370313|NCT01285518|65099324|FG002|Overall Study|Lost to Follow-up|0|||
23370314|NCT01285518|65099325|FG003|Overall Study|Lost to Follow-up|0|||
23370315|NCT01285518|65099326|FG004|Overall Study|Lost to Follow-up|0|||
23370316|NCT01285518|65099327|FG005|Overall Study|Lost to Follow-up|1|||
23370317|NCT01285518|65099328|FG006|Overall Study|Lost to Follow-up|0|||
23370318|NCT01285518|65099329|FG007|Overall Study|Lost to Follow-up|0|||
23370319|NCT01165307|65099330|FG000|Overall Study|Lost to Follow-up|11|||
23370320|NCT01165307|65099331|FG001|Overall Study|Lost to Follow-up|3|||
23370321|NCT01165307|65099330|FG000|Overall Study|Withdrawal by Subject|2|||
23370322|NCT01165307|65099331|FG001|Overall Study|Withdrawal by Subject|0|||
23370323|NCT01165307|65099330|FG000|Overall Study|Subject not available for contact|1|||
23370324|NCT01165307|65099331|FG001|Overall Study|Subject not available for contact|0|||
23370325|NCT01178294|65099338|FG000|Overall Study|Adverse Event|4|||
23370326|NCT01178294|65099338|FG000|Overall Study|Lost to Follow-up|2|||
23370327|NCT01178294|65099338|FG000|Overall Study|Lack of Efficacy|1|||
23370328|NCT01178294|65099338|FG000|Overall Study|Death|1|||
23370329|NCT01178294|65099338|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
23370330|NCT01178294|65099338|FG000|Overall Study|Subject status is terminal|1|||
23370331|NCT01178294|65099338|FG000|Overall Study|Completion status could not be verified|1|||
23370332|NCT01433159|65099339|FG000|Overall Study|Adverse Event|1|||
23370333|NCT01433159|65099340|FG001|Overall Study|Adverse Event|0|||
23370334|NCT01433159|65099339|FG000|Overall Study|Physician Decision|1|||
23370335|NCT01433159|65099340|FG001|Overall Study|Physician Decision|0|||
23370336|NCT01433159|65099339|FG000|Overall Study|Protocol Violation|0|||
23370337|NCT01433159|65099340|FG001|Overall Study|Protocol Violation|1|||
23370338|NCT01107925|65099345|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
23370339|NCT01107925|65099346|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370340|NCT01107925|65099347|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370341|NCT01107925|65099348|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370342|NCT01107925|65099349|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
23370343|NCT01107925|65099350|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370344|NCT01107925|65099345|FG000|Period 2|Withdrawal by Subject|0|||
23370345|NCT01107925|65099346|FG001|Period 2|Withdrawal by Subject|1|||
23370346|NCT01107925|65099347|FG002|Period 2|Withdrawal by Subject|0|||
23370347|NCT01107925|65099348|FG003|Period 2|Withdrawal by Subject|0|||
23370348|NCT01107925|65099349|FG004|Period 2|Withdrawal by Subject|0|||
23370349|NCT01107925|65099350|FG005|Period 2|Withdrawal by Subject|1|||
23370350|NCT01884597|65099351|FG000|Overall Study|Adverse Event|0|||
23370351|NCT01884597|65099352|FG001|Overall Study|Adverse Event|0|||
23370352|NCT01884597|65099353|FG002|Overall Study|Adverse Event|1|||
23370353|NCT01884597|65099351|FG000|Overall Study|Lack of Efficacy|1|||
23370354|NCT01884597|65099352|FG001|Overall Study|Lack of Efficacy|0|||
23663390|NCT04206020|66152448|FG000|Overall Study|Withdrawal by Subject|2|||
23663391|NCT04206020|66152449|FG001|Overall Study|Withdrawal by Subject|0|||
23663392|NCT04206020|66152448|FG000|Overall Study|Lost to Follow-up|2|||
23663393|NCT04206020|66152449|FG001|Overall Study|Lost to Follow-up|0|||
23370355|NCT01884597|65099353|FG002|Overall Study|Lack of Efficacy|0|||
23370356|NCT01884597|65099351|FG000|Overall Study|Death|0|||
23370357|NCT01884597|65099352|FG001|Overall Study|Death|1|||
23370358|NCT01884597|65099353|FG002|Overall Study|Death|0|||
23370359|NCT02000921|65099360|FG000|Overall Study|Withdrawal by Subject|3|||
23370360|NCT02000921|65099361|FG001|Overall Study|Withdrawal by Subject|10|||
23370361|NCT02000921|65099362|FG002|Overall Study|Withdrawal by Subject|5|||
23370362|NCT02000921|65099360|FG000|Overall Study|Lost to Follow-up|2|||
23370363|NCT02000921|65099361|FG001|Overall Study|Lost to Follow-up|4|||
23663394|NCT04206020|66152448|FG000|Overall Study|Pregnancy|0|||
23370364|NCT02000921|65099362|FG002|Overall Study|Lost to Follow-up|5|||
23370365|NCT02000921|65099360|FG000|Overall Study|Physician Decision|0|||
23370366|NCT02000921|65099361|FG001|Overall Study|Physician Decision|2|||
23370367|NCT02000921|65099362|FG002|Overall Study|Physician Decision|0|||
23370368|NCT03106077|65099363|FG000|Overall Study|Screen Failure|94|||
23370369|NCT03106077|65099364|FG001|Overall Study|Screen Failure|0|||
23370370|NCT01274533|65102660|FG000|Overall Study|Withdrawal by Subject|1|||
23370371|NCT01274533|65102660|FG000|Overall Study|Non-compliance|1|||
23370372|NCT01274533|65102660|FG000|Overall Study|Disease progression|2|||
23370373|NCT03533751|65102665|FG000|Overall Study|Withdrawal by Subject|12|||
23370374|NCT03533751|65102666|FG001|Overall Study|Withdrawal by Subject|6|||
23370375|NCT03533751|65102667|FG002|Overall Study|Withdrawal by Subject|11|||
23370376|NCT03533751|65102668|FG003|Overall Study|Withdrawal by Subject|9|||
23370377|NCT03533751|65102669|FG004|Overall Study|Withdrawal by Subject|10|||
23370378|NCT03533751|65102665|FG000|Overall Study|Adverse Event|4|||
23370379|NCT03533751|65102666|FG001|Overall Study|Adverse Event|7|||
23370380|NCT03533751|65102667|FG002|Overall Study|Adverse Event|2|||
23370381|NCT03533751|65102668|FG003|Overall Study|Adverse Event|4|||
23370382|NCT03533751|65102669|FG004|Overall Study|Adverse Event|5|||
23370383|NCT03533751|65102665|FG000|Overall Study|Physician Decision|0|||
23370384|NCT03533751|65102666|FG001|Overall Study|Physician Decision|2|||
23370385|NCT03533751|65102667|FG002|Overall Study|Physician Decision|1|||
23370386|NCT03533751|65102668|FG003|Overall Study|Physician Decision|2|||
23370387|NCT03533751|65102669|FG004|Overall Study|Physician Decision|1|||
23370388|NCT03533751|65102665|FG000|Overall Study|Sponsor Decision|0|||
23370389|NCT03533751|65102666|FG001|Overall Study|Sponsor Decision|0|||
23370390|NCT03533751|65102667|FG002|Overall Study|Sponsor Decision|1|||
23370391|NCT03533751|65102668|FG003|Overall Study|Sponsor Decision|1|||
23370392|NCT03533751|65102669|FG004|Overall Study|Sponsor Decision|0|||
23370393|NCT03533751|65102665|FG000|Overall Study|Lost to Follow-up|3|||
23370394|NCT03533751|65102666|FG001|Overall Study|Lost to Follow-up|7|||
23370395|NCT03533751|65102667|FG002|Overall Study|Lost to Follow-up|6|||
23370396|NCT03533751|65102668|FG003|Overall Study|Lost to Follow-up|4|||
23370397|NCT03533751|65102669|FG004|Overall Study|Lost to Follow-up|3|||
23370398|NCT03533751|65102665|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
23370399|NCT03533751|65102666|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
23370400|NCT03533751|65102667|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
23370401|NCT03533751|65102668|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
23370402|NCT03533751|65102669|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
23370403|NCT03533751|65102665|FG000|Overall Study|Other|0|||
23370404|NCT03533751|65102666|FG001|Overall Study|Other|2|||
23370405|NCT03533751|65102667|FG002|Overall Study|Other|1|||
23370406|NCT03533751|65102668|FG003|Overall Study|Other|0|||
23370407|NCT03533751|65102669|FG004|Overall Study|Other|3|||
23370408|NCT03934216|65102670|FG000|Overall Study|Other Reasons|5|||
23370409|NCT03934216|65102671|FG001|Overall Study|Other Reasons|5|||
23370410|NCT03934216|65102670|FG000|Overall Study|Adverse Event|22|||
23370411|NCT03934216|65102671|FG001|Overall Study|Adverse Event|11|||
23370412|NCT03934216|65102670|FG000|Overall Study|Lack of Efficacy|8|||
23370413|NCT03934216|65102671|FG001|Overall Study|Lack of Efficacy|7|||
23370414|NCT03934216|65102670|FG000|Overall Study|Lost to Follow-up|2|||
23370415|NCT03934216|65102671|FG001|Overall Study|Lost to Follow-up|0|||
23370416|NCT03934216|65102670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23370417|NCT03934216|65102671|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23370418|NCT03934216|65102670|FG000|Overall Study|Pregnancy|1|||
23370419|NCT03934216|65102671|FG001|Overall Study|Pregnancy|0|||
23370420|NCT03934216|65102670|FG000|Overall Study|Withdrawal by Subject|18|||
23370421|NCT03934216|65102671|FG001|Overall Study|Withdrawal by Subject|6|||
23370422|NCT03934216|65102670|FG000|Overall Study|Randomized but not treated|1|||
23370423|NCT03934216|65102671|FG001|Overall Study|Randomized but not treated|1|||
23370424|NCT00385840|65102672|FG000|Overall Study|Adverse Event|1|||
23370425|NCT00385840|65102673|FG001|Overall Study|Adverse Event|1|||
23370426|NCT00385840|65102672|FG000|Overall Study|Lost to Follow-up|3|||
23370427|NCT00385840|65102673|FG001|Overall Study|Lost to Follow-up|13|||
23370428|NCT02765035|65102674|FG000|First Intervention (90 Days)|Adverse Event|1|||
23663395|NCT04206020|66152449|FG001|Overall Study|Pregnancy|1|||
23663396|NCT04206020|66152448|FG000|Overall Study|Unable to attend visits|1|||
23370429|NCT02765035|65102675|FG001|First Intervention (90 Days)|Adverse Event|1|||
23370430|NCT02765035|65102674|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
23370431|NCT02765035|65102675|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
23370432|NCT02273167|65102676|FG000|Overall Study|Adverse Event|1|||
23370433|NCT02273167|65102677|FG001|Overall Study|Adverse Event|0|||
23370434|NCT02273167|65102678|FG002|Overall Study|Adverse Event|0|||
23370435|NCT02273167|65102676|FG000|Overall Study|Protocol Violation|3|||
23370436|NCT02273167|65102677|FG001|Overall Study|Protocol Violation|1|||
23370437|NCT02273167|65102678|FG002|Overall Study|Protocol Violation|1|||
23370438|NCT02273167|65102676|FG000|Overall Study|Lost to Follow-up|0|||
23370439|NCT02273167|65102677|FG001|Overall Study|Lost to Follow-up|1|||
23370440|NCT02273167|65102678|FG002|Overall Study|Lost to Follow-up|1|||
23370441|NCT02273167|65102676|FG000|Overall Study|Withdrawal by Subject|10|||
23370442|NCT02273167|65102677|FG001|Overall Study|Withdrawal by Subject|12|||
23370443|NCT02273167|65102678|FG002|Overall Study|Withdrawal by Subject|11|||
23370444|NCT02273167|65102676|FG000|Overall Study|Various|10|||
23370445|NCT02273167|65102677|FG001|Overall Study|Various|9|||
23370446|NCT02273167|65102678|FG002|Overall Study|Various|8|||
23370447|NCT01900444|65102679|FG000|Overall Study|Protocol Violation|2|||
23370448|NCT01900444|65102679|FG000|Overall Study|Lost to Follow-up|1|||
23370449|NCT02351934|65102680|FG000|Allocation|POD weight<pre-op weight|3|||
23663397|NCT04206020|66152449|FG001|Overall Study|Unable to attend visits|2|||
23663398|NCT00257166|66152450|FG000|Overall Study|Adverse Event|18|||
23663399|NCT00257166|66152451|FG001|Overall Study|Adverse Event|13|||
23370450|NCT02351934|65102681|FG001|Allocation|POD weight<pre-op weight|0|||
23370451|NCT02351934|65102680|FG000|Allocation|Hypotension preventing administration|2|||
23370452|NCT02351934|65102681|FG001|Allocation|Hypotension preventing administration|0|||
23370453|NCT02351934|65102680|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
23370454|NCT02351934|65102681|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
23370455|NCT02351934|65102680|FG000|Follow-Up|POD weight<pre-op weight|3|||
23370456|NCT02351934|65102681|FG001|Follow-Up|POD weight<pre-op weight|0|||
23370457|NCT02351934|65102680|FG000|Follow-Up|Acute Kidney Injury|1|||
23370458|NCT02351934|65102681|FG001|Follow-Up|Acute Kidney Injury|0|||
23370459|NCT02351934|65102680|FG000|Follow-Up|Early dismissal|3|||
23370460|NCT02351934|65102681|FG001|Follow-Up|Early dismissal|0|||
23370461|NCT02351934|65102680|FG000|Follow-Up|Hypotension|3|||
23370462|NCT02351934|65102681|FG001|Follow-Up|Hypotension|0|||
23370463|NCT02351934|65102680|FG000|Follow-Up|No documentation|2|||
23370464|NCT02351934|65102681|FG001|Follow-Up|No documentation|0|||
23370465|NCT02351934|65102680|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
23370466|NCT02351934|65102681|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
23370467|NCT02351934|65102680|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
23370468|NCT02351934|65102681|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
23370469|NCT02378662|65102682|FG000|Overall Study|Early Discontinuation|2|||
23370470|NCT02378662|65102683|FG001|Overall Study|Early Discontinuation|0|||
23370471|NCT03652818|65102686|FG000|Overall Study|Adverse Event|1|||
23370472|NCT03652818|65102687|FG001|Overall Study|Adverse Event|0|||
23370473|NCT03652818|65102688|FG002|Overall Study|Adverse Event|0|||
23370474|NCT03652818|65102689|FG003|Overall Study|Adverse Event|0|||
23370475|NCT03652818|65102690|FG004|Overall Study|Adverse Event|0|||
23370476|NCT03652818|65102686|FG000|Overall Study|Physician Decision|1|||
23370477|NCT03652818|65102687|FG001|Overall Study|Physician Decision|0|||
23370478|NCT03652818|65102688|FG002|Overall Study|Physician Decision|0|||
23370479|NCT03652818|65102689|FG003|Overall Study|Physician Decision|0|||
23370480|NCT03652818|65102690|FG004|Overall Study|Physician Decision|0|||
23370481|NCT03652818|65102686|FG000|Overall Study|Lost to Follow-up|0|||
23485277|NCT01255787|65521685|FG002|Overall Study|Noncompliance with Study Drug|0|||
23663400|NCT00257166|66152450|FG000|Overall Study|Laboratory abnormality|1|||
23663401|NCT00257166|66152451|FG001|Overall Study|Laboratory abnormality|0|||
23663402|NCT00257166|66152450|FG000|Overall Study|Lost to Follow-up|8|||
23370482|NCT03652818|65102687|FG001|Overall Study|Lost to Follow-up|1|||
23370483|NCT03652818|65102688|FG002|Overall Study|Lost to Follow-up|2|||
23370484|NCT03652818|65102689|FG003|Overall Study|Lost to Follow-up|1|||
23370485|NCT03652818|65102690|FG004|Overall Study|Lost to Follow-up|1|||
23370486|NCT01855958|65102693|FG000|Overall Study|Withdrawal by Subject|1|||
23370487|NCT01855958|65102694|FG001|Overall Study|Withdrawal by Subject|0|||
23370488|NCT02814526|65102696|FG000|Overall Study|Adverse Event|4|||
23370489|NCT02814526|65102697|FG001|Overall Study|Adverse Event|3|||
23370490|NCT02814526|65102696|FG000|Overall Study|Death|1|||
23370491|NCT02814526|65102697|FG001|Overall Study|Death|1|||
23370492|NCT02814526|65102696|FG000|Overall Study|Lost to Follow-up|3|||
23370493|NCT02814526|65102697|FG001|Overall Study|Lost to Follow-up|4|||
23370494|NCT02814526|65102696|FG000|Overall Study|non site physician decision|1|||
23370495|NCT02814526|65102697|FG001|Overall Study|non site physician decision|0|||
23370496|NCT02814526|65102696|FG000|Overall Study|participant noncompliance|1|||
23663403|NCT00257166|66152451|FG001|Overall Study|Lost to Follow-up|1|||
23663404|NCT00257166|66152450|FG000|Overall Study|Withdrawal by Subject|9|||
23663405|NCT00257166|66152451|FG001|Overall Study|Withdrawal by Subject|2|||
23663406|NCT00257166|66152450|FG000|Overall Study|Other|16|||
23663407|NCT00257166|66152451|FG001|Overall Study|Other|21|||
23663408|NCT00257166|66152450|FG000|Overall Study|Randomized, but not treated|1|||
23663409|NCT00257166|66152451|FG001|Overall Study|Randomized, but not treated|0|||
23663410|NCT01648790|66152452|FG000|Treatment 3|Withdrawal by Subject|0|||
23663411|NCT01648790|66152453|FG001|Treatment 3|Withdrawal by Subject|0|||
23370497|NCT02814526|65102697|FG001|Overall Study|participant noncompliance|1|||
23370498|NCT02814526|65102696|FG000|Overall Study|Withdrawal by Subject|20|||
23370499|NCT02814526|65102697|FG001|Overall Study|Withdrawal by Subject|14|||
23370500|NCT02814526|65102696|FG000|Overall Study|safety risk|2|||
23370501|NCT02814526|65102697|FG001|Overall Study|safety risk|1|||
23370502|NCT02814526|65102696|FG000|Overall Study|early termination-study terminated|1|||
23370503|NCT02814526|65102697|FG001|Overall Study|early termination-study terminated|2|||
23370504|NCT02814526|65102696|FG000|Overall Study|Other|0|||
23370505|NCT02814526|65102697|FG001|Overall Study|Other|4|||
23370506|NCT02008526|65102701|FG000|Overall Study|Death|0|||
23370507|NCT02008526|65102702|FG001|Overall Study|Death|2|||
23370508|NCT02008526|65102703|FG002|Overall Study|Death|1|||
23370509|NCT02008526|65102701|FG000|Overall Study|Withdrawal by Subject|3|||
23370510|NCT02008526|65102702|FG001|Overall Study|Withdrawal by Subject|3|||
23370511|NCT02008526|65102703|FG002|Overall Study|Withdrawal by Subject|2|||
23370512|NCT02008526|65102701|FG000|Overall Study|Lost to Follow-up|5|||
23370513|NCT02008526|65102702|FG001|Overall Study|Lost to Follow-up|9|||
23370514|NCT02008526|65102703|FG002|Overall Study|Lost to Follow-up|6|||
23370515|NCT02410629|65102705|FG000|Overall Study|Family cannot commit to the study|2|||
23370516|NCT02410629|65102706|FG001|Overall Study|Family cannot commit to the study|1|||
23370517|NCT02410629|65102705|FG000|Overall Study|Subject returned to work|1|||
23370518|NCT02410629|65102706|FG001|Overall Study|Subject returned to work|0|||
23370519|NCT02410629|65102705|FG000|Overall Study|Subject moved back to home country|0|||
23370520|NCT02410629|65102706|FG001|Overall Study|Subject moved back to home country|1|||
23370521|NCT02410629|65102705|FG000|Overall Study|Subject underwent heart surgery|0|||
23370522|NCT02410629|65102706|FG001|Overall Study|Subject underwent heart surgery|1|||
23370523|NCT00720499|65102712|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
23370524|NCT00720499|65102713|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23370525|NCT00720499|65102712|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
23370526|NCT00720499|65102713|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
23370527|NCT00720499|65102712|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
23370528|NCT00720499|65102713|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
23370529|NCT04275336|65102714|FG000|Overall Study|First venipuncture failed|4|||
23370530|NCT04275336|65102715|FG001|Overall Study|First venipuncture failed|6|||
23370531|NCT04275336|65102716|FG002|Overall Study|First venipuncture failed|5|||
23485278|NCT01255787|65521686|FG003|Overall Study|Noncompliance with Study Drug|0|||
23603448|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603449|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603450|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603451|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603452|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603453|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603454|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603455|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23603456|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603457|NCT01613417|65937364|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
23603458|NCT01613417|65937365|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
23603459|NCT01641900|65937366|FG000|Overall Study|Withdrawal by Subject|2|||
23603460|NCT01641900|65937367|FG001|Overall Study|Withdrawal by Subject|2|||
23603461|NCT01160354|65937370|FG000|Overall Study|Death|0|||
23603462|NCT01160354|65937371|FG001|Overall Study|Death|1|||
23603463|NCT01160354|65937372|FG002|Overall Study|Death|1|||
23663412|NCT01648790|66152454|FG002|Treatment 3|Withdrawal by Subject|0|||
23663413|NCT01648790|66152455|FG003|Treatment 3|Withdrawal by Subject|1|||
23663414|NCT01648790|66152456|FG004|Treatment 3|Withdrawal by Subject|0|||
23370532|NCT04275336|65102714|FG000|Overall Study|Unscheduled venipuncture|9|||
23370533|NCT04275336|65102715|FG001|Overall Study|Unscheduled venipuncture|13|||
23370534|NCT04275336|65102716|FG002|Overall Study|Unscheduled venipuncture|7|||
23370535|NCT04275336|65102714|FG000|Overall Study|Failed specimen of saliva|4|||
23370536|NCT04275336|65102715|FG001|Overall Study|Failed specimen of saliva|3|||
23370537|NCT04275336|65102716|FG002|Overall Study|Failed specimen of saliva|4|||
23370538|NCT01384877|65102717|FG000|Treatment 2|Lost to Follow-up|2|||
23370539|NCT01384877|65102718|FG001|Treatment 2|Lost to Follow-up|2|||
23370540|NCT02984982|65102719|FG000|Overall Study|Adverse Event|2|||
23370541|NCT02984982|65102720|FG001|Overall Study|Adverse Event|5|||
23370542|NCT02984982|65102719|FG000|Overall Study|Poor Compliance to Protocol|4|||
23370543|NCT02984982|65102720|FG001|Overall Study|Poor Compliance to Protocol|4|||
23663415|NCT01226459|66152460|FG000|Overall Study|Adverse Event|2|||
23663416|NCT01226459|66152461|FG001|Overall Study|Adverse Event|8|||
23663417|NCT01226459|66152460|FG000|Overall Study|Protocol Violation|4|||
23663418|NCT01226459|66152461|FG001|Overall Study|Protocol Violation|3|||
23663419|NCT01226459|66152460|FG000|Overall Study|Withdrawal by Subject|10|||
23663420|NCT01226459|66152461|FG001|Overall Study|Withdrawal by Subject|13|||
23663421|NCT01226459|66152460|FG000|Overall Study|Lost to Follow-up|4|||
23663422|NCT01226459|66152461|FG001|Overall Study|Lost to Follow-up|8|||
23663423|NCT01226459|66152460|FG000|Overall Study|Pregnancy|1|||
23663424|NCT01226459|66152461|FG001|Overall Study|Pregnancy|0|||
23663425|NCT00577642|66152462|FG000|Overall Study|Clinical Disease Progression|1|||
23663426|NCT03198520|66152463|FG000|Overall Study|Physician Decision|2|||
23663427|NCT03198520|66152463|FG000|Overall Study|Protocol Violation|2|||
23663428|NCT03198520|66152463|FG000|Overall Study|Withdrawal by Subject|1|||
23370544|NCT02984982|65102719|FG000|Overall Study|Withdrawal by Subject|2|||
23370545|NCT02984982|65102720|FG001|Overall Study|Withdrawal by Subject|0|||
23370546|NCT02984982|65102719|FG000|Overall Study|Randomized but not treated|0|||
23370547|NCT02984982|65102720|FG001|Overall Study|Randomized but not treated|1|||
23370548|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
23663429|NCT03198520|66152463|FG000|Overall Study|Study Ended|1|||
23663430|NCT02737852|66152465|FG000|Overall Study|Withdrawal by Subject|2|||
23663431|NCT04126083|66152466|FG000|Overall Study|Withdrawal by Subject|1|||
23663432|NCT02187172|66152467|FG000|Overall Study|Lost to Follow-up|1|||
23663433|NCT02187172|66152468|FG001|Overall Study|Lost to Follow-up|2|||
23663434|NCT02187172|66152467|FG000|Overall Study|Lack of Efficacy|1|||
23663435|NCT02187172|66152468|FG001|Overall Study|Lack of Efficacy|2|||
23663436|NCT02187172|66152467|FG000|Overall Study|Adverse Event|0|||
23663437|NCT02187172|66152468|FG001|Overall Study|Adverse Event|1|||
23663438|NCT02187172|66152467|FG000|Overall Study|Physician Decision|1|||
23663439|NCT02187172|66152468|FG001|Overall Study|Physician Decision|1|||
23663440|NCT02437864|66152474|FG000|Overall Study|Protocol Violation|4|||
23370549|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
23485279|NCT04041700|65521687|FG000|Overall Study|Pregnancy|1|||
23663441|NCT02437864|66152475|FG001|Overall Study|Protocol Violation|0|||
23663442|NCT01436084|66152476|FG000|Overall Study|Disease Progression|2|||
23663443|NCT01436084|66152476|FG000|Overall Study|Withdrawal by Subject|1|||
23663444|NCT01436084|66152476|FG000|Overall Study|Early Closure of Study|1|||
23663445|NCT03000179|66152477|FG000|Overall Study|Lost to Follow-up|2|||
23663446|NCT04206605|66152478|FG000|Overall Study|Adverse Event|0|||
23663447|NCT04206605|66152479|FG001|Overall Study|Adverse Event|1|||
23663448|NCT04206605|66152478|FG000|Overall Study|Withdrawal by Subject|1|||
23663449|NCT04206605|66152479|FG001|Overall Study|Withdrawal by Subject|0|||
23370550|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
23370551|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
23370552|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
23370553|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370554|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
23370555|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370556|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370557|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370558|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
23370559|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
23370560|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
23370561|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23370562|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23370563|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370564|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370565|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
23370566|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370567|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370568|NCT03176771|65102721|FG000|Double-Blind Extension Period|Adverse Event|0|||
23370569|NCT03176771|65102722|FG001|Double-Blind Extension Period|Adverse Event|0|||
23370570|NCT03176771|65102723|FG002|Double-Blind Extension Period|Adverse Event|0|||
23370571|NCT03176771|65102724|FG003|Double-Blind Extension Period|Adverse Event|15|||
23370572|NCT03176771|65102725|FG004|Double-Blind Extension Period|Adverse Event|18|||
23370573|NCT03176771|65102721|FG000|Double-Blind Extension Period|Death|0|||
23370574|NCT03176771|65102722|FG001|Double-Blind Extension Period|Death|0|||
23370575|NCT03176771|65102723|FG002|Double-Blind Extension Period|Death|0|||
23370576|NCT03176771|65102724|FG003|Double-Blind Extension Period|Death|3|||
23370577|NCT03176771|65102725|FG004|Double-Blind Extension Period|Death|4|||
23370578|NCT03176771|65102721|FG000|Double-Blind Extension Period|Physician Decision|0|||
23370579|NCT03176771|65102722|FG001|Double-Blind Extension Period|Physician Decision|0|||
23370580|NCT03176771|65102723|FG002|Double-Blind Extension Period|Physician Decision|0|||
23370581|NCT03176771|65102724|FG003|Double-Blind Extension Period|Physician Decision|3|||
23370582|NCT03176771|65102725|FG004|Double-Blind Extension Period|Physician Decision|1|||
23370583|NCT03176771|65102721|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370584|NCT03176771|65102722|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370585|NCT03176771|65102723|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370586|NCT03176771|65102724|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
23370587|NCT03176771|65102725|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
23370588|NCT03353792|65102726|FG000|Overall Study|Lost to Follow-up|1|||
23370589|NCT03353792|65102727|FG001|Overall Study|Lost to Follow-up|0|||
23370590|NCT03353792|65102726|FG000|Overall Study|Participant Unable to Manage Device|1|||
23370591|NCT03353792|65102727|FG001|Overall Study|Participant Unable to Manage Device|0|||
23370592|NCT01718483|65102728|FG000|Overall Study|Withdrawal by Subject|14|||
23370593|NCT01718483|65102729|FG001|Overall Study|Withdrawal by Subject|12|||
23370594|NCT01718483|65102728|FG000|Overall Study|Adverse Event|5|||
23370595|NCT01718483|65102729|FG001|Overall Study|Adverse Event|12|||
23370596|NCT01718483|65102728|FG000|Overall Study|Lost to Follow-up|8|||
23370597|NCT01718483|65102729|FG001|Overall Study|Lost to Follow-up|3|||
23370598|NCT01718483|65102728|FG000|Overall Study|Protocol Violation|4|||
23370599|NCT01718483|65102729|FG001|Overall Study|Protocol Violation|2|||
23370600|NCT01718483|65102728|FG000|Overall Study|Other|1|||
23370601|NCT01718483|65102729|FG001|Overall Study|Other|4|||
23370602|NCT01718483|65102728|FG000|Overall Study|Pregnancy|1|||
23370603|NCT01718483|65102729|FG001|Overall Study|Pregnancy|1|||
23370604|NCT01718483|65102728|FG000|Overall Study|Lack of Efficacy|1|||
23370605|NCT01718483|65102729|FG001|Overall Study|Lack of Efficacy|0|||
23370606|NCT03248037|65102730|FG000|Overall Study|Withdrawal by Subject|6|||
23370607|NCT03248037|65102731|FG001|Overall Study|Withdrawal by Subject|9|||
23370608|NCT03248037|65102730|FG000|Overall Study|Adverse Event|15|||
23370609|NCT03248037|65102731|FG001|Overall Study|Adverse Event|0|||
23370610|NCT01863771|65102732|FG000|Induction Phase|Adverse Event|9|||
23370611|NCT01863771|65102733|FG001|Induction Phase|Adverse Event|0|||
23370612|NCT01863771|65102734|FG002|Induction Phase|Adverse Event|0|||
23370613|NCT01863771|65102735|FG003|Induction Phase|Adverse Event|0|||
23370614|NCT01863771|65102732|FG000|Induction Phase|Lack of Efficacy|10|||
23370615|NCT01863771|65102733|FG001|Induction Phase|Lack of Efficacy|0|||
23370616|NCT01863771|65102734|FG002|Induction Phase|Lack of Efficacy|0|||
23370617|NCT01863771|65102735|FG003|Induction Phase|Lack of Efficacy|0|||
23370618|NCT01863771|65102732|FG000|Induction Phase|Withdrawal by Subject|2|||
23370619|NCT01863771|65102733|FG001|Induction Phase|Withdrawal by Subject|0|||
23370620|NCT01863771|65102734|FG002|Induction Phase|Withdrawal by Subject|0|||
23603464|NCT01787032|65937373|FG000|Overall Study|Protocol Violation|0|||
23370621|NCT01863771|65102735|FG003|Induction Phase|Withdrawal by Subject|0|||
23370622|NCT01863771|65102732|FG000|Maintenance Phase|Adverse Event|0|||
23370623|NCT01863771|65102733|FG001|Maintenance Phase|Adverse Event|0|||
23370624|NCT01863771|65102734|FG002|Maintenance Phase|Adverse Event|1|||
23370625|NCT01863771|65102735|FG003|Maintenance Phase|Adverse Event|1|||
23370626|NCT01863771|65102732|FG000|Maintenance Phase|Lack of Efficacy|0|||
23370627|NCT01863771|65102733|FG001|Maintenance Phase|Lack of Efficacy|3|||
23370628|NCT01863771|65102734|FG002|Maintenance Phase|Lack of Efficacy|7|||
23370629|NCT01863771|65102735|FG003|Maintenance Phase|Lack of Efficacy|38|||
23370630|NCT01863771|65102732|FG000|Maintenance Phase|Physician Decision|0|||
23370631|NCT01863771|65102733|FG001|Maintenance Phase|Physician Decision|0|||
23370632|NCT01863771|65102734|FG002|Maintenance Phase|Physician Decision|2|||
23370633|NCT01863771|65102735|FG003|Maintenance Phase|Physician Decision|1|||
23370634|NCT01863771|65102732|FG000|Maintenance Phase|Pregnancy|0|||
23370635|NCT01863771|65102733|FG001|Maintenance Phase|Pregnancy|1|||
23370636|NCT01863771|65102734|FG002|Maintenance Phase|Pregnancy|0|||
23370637|NCT01863771|65102735|FG003|Maintenance Phase|Pregnancy|0|||
23370638|NCT01863771|65102732|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23370639|NCT01863771|65102733|FG001|Maintenance Phase|Withdrawal by Subject|1|||
23370640|NCT01863771|65102734|FG002|Maintenance Phase|Withdrawal by Subject|2|||
23370641|NCT01863771|65102735|FG003|Maintenance Phase|Withdrawal by Subject|3|||
23370642|NCT01241279|65102742|FG000|Overall Study|Lost to Follow-up|0|||
23370643|NCT01241279|65102743|FG001|Overall Study|Lost to Follow-up|1|||
23370644|NCT00313846|65102744|FG000|Overall Study|Withdrawal by Subject|2|||
23370645|NCT00313846|65102745|FG001|Overall Study|Withdrawal by Subject|0|||
23370646|NCT00313846|65102744|FG000|Overall Study|Adverse Event|1|||
23370647|NCT00313846|65102745|FG001|Overall Study|Adverse Event|8|||
23370648|NCT00313846|65102744|FG000|Overall Study|Administrative|2|||
23370649|NCT00313846|65102745|FG001|Overall Study|Administrative|3|||
23370650|NCT00062166|65102748|FG000|Overall Study|Withdrawal by Subject|6|||
23370651|NCT03439137|65102758|FG000|Overall Study|Adverse Event|16|||
23370652|NCT03439137|65102759|FG001|Overall Study|Adverse Event|12|||
23370653|NCT03439137|65102758|FG000|Overall Study|Physician Decision|0|||
23370654|NCT03439137|65102759|FG001|Overall Study|Physician Decision|5|||
23370655|NCT03439137|65102758|FG000|Overall Study|Withdrawal by Subject|14|||
23370656|NCT03439137|65102759|FG001|Overall Study|Withdrawal by Subject|4|||
23370657|NCT03439137|65102758|FG000|Overall Study|Conducting rescue therapy|2|||
23370658|NCT03439137|65102759|FG001|Overall Study|Conducting rescue therapy|1|||
23370659|NCT03439137|65102758|FG000|Overall Study|Difficult to control Hb|10|||
23370660|NCT03439137|65102759|FG001|Overall Study|Difficult to control Hb|2|||
23370661|NCT03439137|65102758|FG000|Overall Study|Initiation of a renal transplant|0|||
23370662|NCT03439137|65102759|FG001|Overall Study|Initiation of a renal transplant|2|||
23370663|NCT01420536|65102760|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
23370664|NCT01420536|65102761|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
23370665|NCT00086190|65102762|FG000|Overall Study|Adverse Event|6|||
23370666|NCT00086190|65102763|FG001|Overall Study|Adverse Event|2|||
23370667|NCT00086190|65102764|FG002|Overall Study|Adverse Event|2|||
23370668|NCT00086190|65102762|FG000|Overall Study|Withdrawal by Subject|0|||
23370669|NCT00086190|65102763|FG001|Overall Study|Withdrawal by Subject|2|||
23370670|NCT00086190|65102764|FG002|Overall Study|Withdrawal by Subject|2|||
23370671|NCT00086190|65102762|FG000|Overall Study|Protocol Violation|1|||
23370672|NCT00086190|65102763|FG001|Overall Study|Protocol Violation|0|||
23370673|NCT00086190|65102764|FG002|Overall Study|Protocol Violation|0|||
23370674|NCT00086190|65102762|FG000|Overall Study|Moved|1|||
23370675|NCT00086190|65102763|FG001|Overall Study|Moved|0|||
23370676|NCT00086190|65102764|FG002|Overall Study|Moved|0|||
23370677|NCT00086190|65102762|FG000|Overall Study|Worsening depression|0|||
23370678|NCT00086190|65102763|FG001|Overall Study|Worsening depression|0|||
23370679|NCT00086190|65102764|FG002|Overall Study|Worsening depression|2|||
23370680|NCT02051296|65102765|FG000|Overall Study|Lost to Follow-up|1|||
23370681|NCT02051296|65102766|FG001|Overall Study|Lost to Follow-up|2|||
23370682|NCT02051296|65102765|FG000|Overall Study|withdraw prior to treatment|7|||
23370683|NCT02051296|65102766|FG001|Overall Study|withdraw prior to treatment|7|||
23370684|NCT00794664|65102768|FG000|Treatment Period|Withdrawal by Subject|0|||
23370685|NCT00794664|65102769|FG001|Treatment Period|Withdrawal by Subject|2|||
23370686|NCT00794664|65102768|FG000|Treatment Period|Protocol non-compliance|0|||
23603465|NCT01787032|65937374|FG001|Overall Study|Protocol Violation|0|||
23370687|NCT00794664|65102769|FG001|Treatment Period|Protocol non-compliance|1|||
23370688|NCT00794664|65102768|FG000|Treatment Period|Other|0|||
23370689|NCT00794664|65102769|FG001|Treatment Period|Other|1|||
23603466|NCT01787032|65937375|FG002|Overall Study|Protocol Violation|0|||
23603467|NCT01787032|65937376|FG003|Overall Study|Protocol Violation|0|||
23370690|NCT00794664|65102768|FG000|Treatment Period|Adverse Event|1|||
23370691|NCT00794664|65102769|FG001|Treatment Period|Adverse Event|8|||
23370692|NCT00794664|65102768|FG000|Follow-up Period|Other|1|||
23370693|NCT00794664|65102769|FG001|Follow-up Period|Other|2|||
23370694|NCT00794664|65102768|FG000|Follow-up Period|Withdrawal by Subject|0|||
23370695|NCT00794664|65102769|FG001|Follow-up Period|Withdrawal by Subject|2|||
23370696|NCT00794664|65102768|FG000|Follow-up Period|Protocol non-compliance|0|||
23370697|NCT00794664|65102769|FG001|Follow-up Period|Protocol non-compliance|1|||
23370698|NCT01677741|65102770|FG000|Overall Study|Death|0|||
23370699|NCT01677741|65102771|FG001|Overall Study|Death|0|||
23370700|NCT01677741|65102772|FG002|Overall Study|Death|0|||
23370701|NCT01677741|65102773|FG003|Overall Study|Death|1|||
23370702|NCT01677741|65102774|FG004|Overall Study|Death|0|||
23370703|NCT01677741|65102775|FG005|Overall Study|Death|1|||
23370704|NCT01677741|65102776|FG006|Overall Study|Death|0|||
23370705|NCT01677741|65102777|FG007|Overall Study|Death|0|||
23370706|NCT01677741|65102770|FG000|Overall Study|Withdrawal by Subject|2|||
23370707|NCT01677741|65102771|FG001|Overall Study|Withdrawal by Subject|7|||
23370708|NCT01677741|65102772|FG002|Overall Study|Withdrawal by Subject|5|||
23370709|NCT01677741|65102773|FG003|Overall Study|Withdrawal by Subject|4|||
23370710|NCT01677741|65102774|FG004|Overall Study|Withdrawal by Subject|11|||
23370711|NCT01677741|65102775|FG005|Overall Study|Withdrawal by Subject|20|||
23370712|NCT01677741|65102776|FG006|Overall Study|Withdrawal by Subject|4|||
23370713|NCT01677741|65102777|FG007|Overall Study|Withdrawal by Subject|2|||
23370714|NCT01677741|65102770|FG000|Overall Study|Enrolled in a rollover study|0|||
23370715|NCT01677741|65102771|FG001|Overall Study|Enrolled in a rollover study|3|||
23370716|NCT01677741|65102772|FG002|Overall Study|Enrolled in a rollover study|2|||
23370717|NCT01677741|65102773|FG003|Overall Study|Enrolled in a rollover study|1|||
23370718|NCT01677741|65102774|FG004|Overall Study|Enrolled in a rollover study|6|||
23370719|NCT01677741|65102775|FG005|Overall Study|Enrolled in a rollover study|6|||
23370720|NCT01677741|65102776|FG006|Overall Study|Enrolled in a rollover study|7|||
23370721|NCT01677741|65102777|FG007|Overall Study|Enrolled in a rollover study|0|||
23370722|NCT01677741|65102770|FG000|Overall Study|Progressive disease|1|||
23370723|NCT01677741|65102771|FG001|Overall Study|Progressive disease|0|||
23370724|NCT01677741|65102772|FG002|Overall Study|Progressive disease|1|||
23370725|NCT01677741|65102773|FG003|Overall Study|Progressive disease|0|||
23370726|NCT01677741|65102774|FG004|Overall Study|Progressive disease|0|||
23370727|NCT01677741|65102775|FG005|Overall Study|Progressive disease|1|||
23370728|NCT01677741|65102776|FG006|Overall Study|Progressive disease|0|||
23370729|NCT01677741|65102777|FG007|Overall Study|Progressive disease|0|||
23370730|NCT00262119|65102784|FG000|Overall Study|Lost to Follow-up|38|||
23370731|NCT00262119|65102785|FG001|Overall Study|Lost to Follow-up|51|||
23370732|NCT00262119|65102786|FG002|Overall Study|Lost to Follow-up|42|||
23370733|NCT00262119|65102784|FG000|Overall Study|Death|20|||
23370734|NCT00262119|65102785|FG001|Overall Study|Death|19|||
23370735|NCT00262119|65102786|FG002|Overall Study|Death|16|||
23370736|NCT02997163|65102787|FG000|Overall Study|Adverse Event|1|||
23370737|NCT02997163|65102788|FG001|Overall Study|Adverse Event|0|||
23370738|NCT02997163|65102789|FG002|Overall Study|Adverse Event|0|||
23370739|NCT02997163|65102790|FG003|Overall Study|Adverse Event|1|||
23370740|NCT03506477|65102803|FG000|Overall Study|Withdrawal by Subject|1|||
23370741|NCT03506477|65102804|FG001|Overall Study|Withdrawal by Subject|0|||
23370742|NCT01867008|65102805|FG000|Overall Study|Withdrawal by Subject|1|||
23370743|NCT00288912|65102807|FG000|Overall Study|Developed exclusion criterion|4|||
23370744|NCT00288912|65102808|FG001|Overall Study|Developed exclusion criterion|6|||
23370745|NCT00288912|65102809|FG002|Overall Study|Developed exclusion criterion|7|||
23370746|NCT00288912|65102807|FG000|Overall Study|Lost to Follow-up|9|||
23370747|NCT00288912|65102808|FG001|Overall Study|Lost to Follow-up|6|||
23370748|NCT00288912|65102809|FG002|Overall Study|Lost to Follow-up|9|||
23370749|NCT00288912|65102807|FG000|Overall Study|Withdrawal by Subject|4|||
23370750|NCT00288912|65102808|FG001|Overall Study|Withdrawal by Subject|5|||
23370751|NCT00288912|65102809|FG002|Overall Study|Withdrawal by Subject|12|||
23370752|NCT01764841|65102814|FG000|Overall Study|Logistical Difficulties|0|||
23370753|NCT01764841|65102815|FG001|Overall Study|Logistical Difficulties|1|||
23370754|NCT01764841|65102816|FG002|Overall Study|Logistical Difficulties|0|||
23370755|NCT01764841|65102817|FG003|Overall Study|Logistical Difficulties|0|||
23370756|NCT01764841|65102814|FG000|Overall Study|Death|3|||
23370757|NCT01764841|65102815|FG001|Overall Study|Death|0|||
23485280|NCT04041700|65521687|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
23485281|NCT02734433|65521688|FG000|Overall Study|Disease progression|1|||
23603468|NCT01787032|65937377|FG004|Overall Study|Protocol Violation|1|||
23370758|NCT01764841|65102816|FG002|Overall Study|Death|1|||
23370759|NCT01764841|65102817|FG003|Overall Study|Death|4|||
23370760|NCT01764841|65102814|FG000|Overall Study|No Follow Up|1|||
23370761|NCT01764841|65102815|FG001|Overall Study|No Follow Up|0|||
23370762|NCT01764841|65102816|FG002|Overall Study|No Follow Up|1|||
23370763|NCT01764841|65102817|FG003|Overall Study|No Follow Up|0|||
23370764|NCT01764841|65102814|FG000|Overall Study|Protocol Violation|0|||
23370765|NCT01764841|65102815|FG001|Overall Study|Protocol Violation|1|||
23370766|NCT01764841|65102816|FG002|Overall Study|Protocol Violation|0|||
23370767|NCT01764841|65102817|FG003|Overall Study|Protocol Violation|0|||
23370768|NCT01764841|65102814|FG000|Overall Study|Withdrawal by Subject|16|||
23370769|NCT01764841|65102815|FG001|Overall Study|Withdrawal by Subject|24|||
23370770|NCT01764841|65102816|FG002|Overall Study|Withdrawal by Subject|11|||
23370771|NCT01764841|65102817|FG003|Overall Study|Withdrawal by Subject|15|||
23370772|NCT01764841|65102814|FG000|Overall Study|Lost to Follow-up|3|||
23370773|NCT01764841|65102815|FG001|Overall Study|Lost to Follow-up|0|||
23370774|NCT01764841|65102816|FG002|Overall Study|Lost to Follow-up|1|||
23370775|NCT01764841|65102817|FG003|Overall Study|Lost to Follow-up|0|||
23370776|NCT03074500|65102818|FG000|Overall Study|Lost to Follow-up|1|||
23370777|NCT03074500|65102819|FG001|Overall Study|Lost to Follow-up|0|||
23370778|NCT03074500|65102820|FG002|Overall Study|Lost to Follow-up|0|||
23370779|NCT03074500|65102818|FG000|Overall Study|Lack of Efficacy|0|||
23370780|NCT03074500|65102819|FG001|Overall Study|Lack of Efficacy|1|||
23370781|NCT03074500|65102820|FG002|Overall Study|Lack of Efficacy|0|||
23370782|NCT03074500|65102818|FG000|Overall Study|Adverse Event|0|||
23370783|NCT03074500|65102819|FG001|Overall Study|Adverse Event|0|||
23370784|NCT03074500|65102820|FG002|Overall Study|Adverse Event|1|||
23370785|NCT00402831|65102821|FG000|Overall Study|Lost to Follow-up|1|||
23370786|NCT00402831|65102822|FG001|Overall Study|Lost to Follow-up|2|||
23370787|NCT00402831|65102821|FG000|Overall Study|Non-compliance with protocol|0|||
23370788|NCT00402831|65102822|FG001|Overall Study|Non-compliance with protocol|1|||
23370789|NCT02696616|65102823|FG000|Overall Study|Adverse Event|0|||
23370790|NCT02696616|65102824|FG001|Overall Study|Adverse Event|1|||
23370791|NCT02696616|65102825|FG002|Overall Study|Adverse Event|0|||
23370792|NCT02696616|65102826|FG003|Overall Study|Adverse Event|0|||
23370793|NCT02696616|65102827|FG004|Overall Study|Adverse Event|0|||
23370794|NCT02696616|65102828|FG005|Overall Study|Adverse Event|0|||
23370795|NCT02696616|65102829|FG006|Overall Study|Adverse Event|0|||
23370796|NCT03435055|65102830|FG000|Screening|Physician Decision|2|||
23370797|NCT03435055|65102830|FG000|Received Intervention|Did not complete nitrous administration|3|||
23370798|NCT01103323|65102831|FG000|Without/Before Drug Switch|Adverse Event|50|||
23370799|NCT01103323|65102832|FG001|Without/Before Drug Switch|Adverse Event|7|||
23370800|NCT01103323|65102831|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
23370801|NCT01103323|65102832|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
23370802|NCT01103323|65102831|FG000|Without/Before Drug Switch|Protocol Violation|2|||
23370803|NCT01103323|65102832|FG001|Without/Before Drug Switch|Protocol Violation|0|||
23370804|NCT01103323|65102831|FG000|Without/Before Drug Switch|Physician Decision|2|||
23370805|NCT01103323|65102832|FG001|Without/Before Drug Switch|Physician Decision|0|||
23370806|NCT01103323|65102831|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
23370807|NCT01103323|65102832|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
23370808|NCT01103323|65102831|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
23370809|NCT01103323|65102832|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
23370810|NCT01103323|65102831|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
23370811|NCT01103323|65102832|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
23370812|NCT00726609|65102841|FG000|Overall Study|Adverse Event|10|||
23370813|NCT00726609|65102841|FG000|Overall Study|Withdrawal by Subject|2|||
23370814|NCT00726609|65102841|FG000|Overall Study|Lack of Efficacy|25|||
23370815|NCT00726609|65102841|FG000|Overall Study|Other|16|||
23370816|NCT00726609|65102841|FG000|Overall Study|Missing|42|||
23370817|NCT00726609|65102841|FG000|Overall Study|Other|3|||
23370818|NCT03933449|65102842|FG000|Overall Study|Adverse Event|6|||
23370819|NCT03933449|65102843|FG001|Overall Study|Adverse Event|4|||
23370820|NCT03933449|65102842|FG000|Overall Study|Death|55|||
23370821|NCT03933449|65102843|FG001|Overall Study|Death|57|||
23370822|NCT03933449|65102842|FG000|Overall Study|Sponsor Decision|1|||
23370823|NCT03933449|65102843|FG001|Overall Study|Sponsor Decision|0|||
23370824|NCT03054428|65102844|FG000|Overall Study|Physician Decision|0|||
23370825|NCT03054428|65102845|FG001|Overall Study|Physician Decision|1|||
23370826|NCT03054428|65102846|FG002|Overall Study|Physician Decision|1|||
23370827|NCT03054428|65102844|FG000|Overall Study|Lack of Efficacy|3|||
23370828|NCT03054428|65102845|FG001|Overall Study|Lack of Efficacy|1|||
23370829|NCT03054428|65102846|FG002|Overall Study|Lack of Efficacy|0|||
23370830|NCT03054428|65102844|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
23370831|NCT03054428|65102845|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
23370832|NCT03054428|65102846|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
23370833|NCT03054428|65102844|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
23370834|NCT03054428|65102845|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
23370835|NCT03054428|65102846|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
23370836|NCT03054428|65102844|FG000|Overall Study|Transitioned to OLE study|76|||
23370837|NCT03054428|65102845|FG001|Overall Study|Transitioned to OLE study|76|||
23370838|NCT03054428|65102846|FG002|Overall Study|Transitioned to OLE study|73|||
23370839|NCT03054428|65102844|FG000|Overall Study|Withdrawal by Subject|3|||
23370840|NCT03054428|65102845|FG001|Overall Study|Withdrawal by Subject|2|||
23370841|NCT03054428|65102846|FG002|Overall Study|Withdrawal by Subject|3|||
23370842|NCT03054428|65102844|FG000|Overall Study|Lost to Follow-up|0|||
23370843|NCT03054428|65102845|FG001|Overall Study|Lost to Follow-up|0|||
23370844|NCT03054428|65102846|FG002|Overall Study|Lost to Follow-up|1|||
23370845|NCT03573297|65102847|FG000|Open Label Treatment Period|Adverse Event|67|||
23370846|NCT03573297|65102848|FG001|Open Label Treatment Period|Adverse Event|0|||
23370847|NCT03573297|65102849|FG002|Open Label Treatment Period|Adverse Event|0|||
23370848|NCT03573297|65102850|FG003|Open Label Treatment Period|Adverse Event|0|||
23370849|NCT03573297|65102847|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
23370850|NCT03573297|65102848|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
23370851|NCT03573297|65102849|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
23370852|NCT03573297|65102850|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
23485282|NCT02734433|65521689|FG001|Overall Study|Disease progression|5|||
23485283|NCT02734433|65521688|FG000|Overall Study|Clinical progression|0|||
23485284|NCT02734433|65521689|FG001|Overall Study|Clinical progression|1|||
23485285|NCT02734433|65521688|FG000|Overall Study|Withdrawal by Subject|1|||
23485286|NCT02734433|65521689|FG001|Overall Study|Withdrawal by Subject|2|||
23485287|NCT03055858|65521693|FG000|Overall Study|Death|9|||
23485288|NCT03055858|65521693|FG000|Overall Study|Withdrawal by Subject|11|||
23485289|NCT03055858|65521693|FG000|Overall Study|Lost to Follow-up|6|||
23485290|NCT03055858|65521693|FG000|Overall Study|Missed Follow-Up Visits|18|||
23485291|NCT00589784|65521694|FG000|Overall Study|Withdrawal by Subject|0|||
23485292|NCT00589784|65521695|FG001|Overall Study|Withdrawal by Subject|6|||
23485293|NCT00589784|65521694|FG000|Overall Study|Patient inevaluable|1|||
23485294|NCT00589784|65521695|FG001|Overall Study|Patient inevaluable|0|||
23485295|NCT00589784|65521694|FG000|Overall Study|Adverse Event|0|||
23485296|NCT00589784|65521695|FG001|Overall Study|Adverse Event|4|||
23485297|NCT01920555|65521698|FG000|Overall Study|Physician Decision|1|||
23485298|NCT01920555|65521699|FG001|Overall Study|Physician Decision|2|||
23485299|NCT01920555|65521700|FG002|Overall Study|Physician Decision|1|||
23485300|NCT01920555|65521701|FG003|Overall Study|Physician Decision|2|||
23485301|NCT01920555|65521702|FG004|Overall Study|Physician Decision|0|||
23485302|NCT01920555|65521698|FG000|Overall Study|Lack of Efficacy|2|||
23485303|NCT01920555|65521699|FG001|Overall Study|Lack of Efficacy|0|||
23485304|NCT01920555|65521700|FG002|Overall Study|Lack of Efficacy|0|||
23370853|NCT03573297|65102847|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
23485305|NCT01920555|65521701|FG003|Overall Study|Lack of Efficacy|0|||
23485306|NCT01920555|65521702|FG004|Overall Study|Lack of Efficacy|0|||
23485307|NCT01920555|65521698|FG000|Overall Study|Travel Difficulties|1|||
23485308|NCT01920555|65521699|FG001|Overall Study|Travel Difficulties|1|||
23485309|NCT01920555|65521700|FG002|Overall Study|Travel Difficulties|0|||
23485310|NCT01920555|65521701|FG003|Overall Study|Travel Difficulties|0|||
23370854|NCT03573297|65102848|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
23370855|NCT03573297|65102849|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
23370856|NCT03573297|65102850|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
23370857|NCT03573297|65102847|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
23370858|NCT03573297|65102848|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
23370859|NCT03573297|65102849|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
23370860|NCT03573297|65102850|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
23370861|NCT03573297|65102847|FG000|Open Label Treatment Period|Pregnancy|1|||
23370862|NCT03573297|65102848|FG001|Open Label Treatment Period|Pregnancy|0|||
23370863|NCT03573297|65102849|FG002|Open Label Treatment Period|Pregnancy|0|||
23370864|NCT03573297|65102850|FG003|Open Label Treatment Period|Pregnancy|0|||
23370865|NCT03573297|65102847|FG000|Open Label Treatment Period|Protocol Violation|17|||
23370866|NCT03573297|65102848|FG001|Open Label Treatment Period|Protocol Violation|0|||
23370867|NCT03573297|65102849|FG002|Open Label Treatment Period|Protocol Violation|0|||
23370868|NCT03573297|65102850|FG003|Open Label Treatment Period|Protocol Violation|0|||
23370869|NCT03573297|65102847|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
23370870|NCT03573297|65102848|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370871|NCT03573297|65102849|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370872|NCT03573297|65102850|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370873|NCT03573297|65102847|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
23370874|NCT03573297|65102848|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370875|NCT03573297|65102849|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370876|NCT03573297|65102850|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370877|NCT03573297|65102847|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
23370878|NCT03573297|65102848|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370879|NCT03573297|65102849|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370880|NCT03573297|65102850|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370881|NCT03573297|65102847|FG000|Open Label Treatment Period|Other, Not Specified|7|||
23370882|NCT03573297|65102848|FG001|Open Label Treatment Period|Other, Not Specified|0|||
23370883|NCT03573297|65102849|FG002|Open Label Treatment Period|Other, Not Specified|0|||
23370884|NCT03573297|65102850|FG003|Open Label Treatment Period|Other, Not Specified|0|||
23370885|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
23370886|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
23370887|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
23370888|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
23370889|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23370890|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23370891|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Adverse Event|5|||
23370892|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Adverse Event|1|||
23370893|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370894|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23370895|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370896|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370897|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23370898|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
23370899|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
23370900|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
23370901|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23370902|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
23370903|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
23370904|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
23370905|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23370906|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
23370907|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
23370908|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
23370909|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
23370910|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
23370911|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
23370912|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
23370913|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
23370914|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
23370915|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
23370916|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
23370917|NCT01405560|65102856|FG000|Overall Study|Physician Decision|1|||
23370918|NCT00266708|65102857|FG000|Overall Study|No renal function|1|||
23370919|NCT00266708|65102858|FG001|Overall Study|No renal function|1|||
23370920|NCT00266708|65102857|FG000|Overall Study|Refused biopsy|3|||
23663450|NCT02663453|66152481|FG000|Overall Study|Death|4|||
23663451|NCT02663453|66152482|FG001|Overall Study|Death|4|||
23663452|NCT02663453|66152481|FG000|Overall Study|Withdrawal by Subject|1|||
23663453|NCT02663453|66152482|FG001|Overall Study|Withdrawal by Subject|0|||
23663454|NCT00800436|66152483|FG000|Overall Study|Withdrawal by Subject|0|||
23663455|NCT00800436|66152484|FG001|Overall Study|Withdrawal by Subject|0|||
23663456|NCT00800436|66152485|FG002|Overall Study|Withdrawal by Subject|1|||
23663457|NCT00800436|66152486|FG003|Overall Study|Withdrawal by Subject|1|||
23663458|NCT00800436|66152487|FG004|Overall Study|Withdrawal by Subject|0|||
23663459|NCT00800436|66152488|FG005|Overall Study|Withdrawal by Subject|0|||
23663460|NCT00800436|66152489|FG006|Overall Study|Withdrawal by Subject|0|||
23663461|NCT03593850|66152490|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
23663462|NCT03593850|66152491|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
23370921|NCT00266708|65102858|FG001|Overall Study|Refused biopsy|6|||
23603469|NCT01787032|65937378|FG005|Overall Study|Protocol Violation|1|||
23663463|NCT01977820|66152495|FG000|Overall Study|Sponsor terminated the study|1|||
23663464|NCT01977820|66152496|FG001|Overall Study|Sponsor terminated the study|1|||
23663465|NCT01668719|66152499|FG000|Phase I|On treatment|1|||
23370922|NCT00266708|65102857|FG000|Overall Study|Asthma|0|||
23370923|NCT00266708|65102858|FG001|Overall Study|Asthma|2|||
23370924|NCT01408706|65102859|FG000|Overall Study|Physician Decision|1|||
23370925|NCT01408706|65102860|FG001|Overall Study|Physician Decision|0|||
23370926|NCT01387269|65102861|FG000|Overall Study|Death|38|||
23370927|NCT01387269|65102862|FG001|Overall Study|Death|20|||
23370928|NCT01387269|65102861|FG000|Overall Study|Other|8|||
23370929|NCT01387269|65102862|FG001|Overall Study|Other|7|||
23370930|NCT01387269|65102861|FG000|Overall Study|Unrelated AE|12|||
23370931|NCT01387269|65102862|FG001|Overall Study|Unrelated AE|3|||
23370932|NCT01387269|65102861|FG000|Overall Study|Withdrawal by patient|32|||
23370933|NCT01387269|65102862|FG001|Overall Study|Withdrawal by patient|10|||
23370934|NCT01387269|65102861|FG000|Overall Study|Study drug-related AE|1|||
23370935|NCT01387269|65102862|FG001|Overall Study|Study drug-related AE|0|||
23370936|NCT01387269|65102861|FG000|Overall Study|Lost to Follow-up|1|||
23370937|NCT01387269|65102862|FG001|Overall Study|Lost to Follow-up|0|||
23370938|NCT03122171|65102863|FG000|Overall Study|Withdrawal by Subject|1|||
23370939|NCT04076917|65102864|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
23370940|NCT04076917|65102864|FG000|Overall Study|Study closure|13|||
23370941|NCT04076917|65102864|FG000|Overall Study|Physician Decision|3|||
23370942|NCT04076917|65102864|FG000|Overall Study|Death|1|||
23370943|NCT04076917|65102864|FG000|Overall Study|Lost to Follow-up|1|||
23370944|NCT04076917|65102864|FG000|Overall Study|Withdrawal by Subject|1|||
23370945|NCT04076917|65102864|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
23370946|NCT00183430|65102865|FG000|Overall Study|Adverse Event|1|||
23370947|NCT00183430|65102866|FG001|Overall Study|Adverse Event|0|||
23370948|NCT00183430|65102865|FG000|Overall Study|Lost to Follow-up|3|||
23370949|NCT00183430|65102866|FG001|Overall Study|Lost to Follow-up|0|||
23370950|NCT00183430|65102865|FG000|Overall Study|did not meet inclusion criteria|1|||
23370951|NCT00183430|65102866|FG001|Overall Study|did not meet inclusion criteria|0|||
23370952|NCT00183430|65102865|FG000|Overall Study|Withdrawal by Subject|1|||
23370953|NCT00183430|65102866|FG001|Overall Study|Withdrawal by Subject|0|||
23370954|NCT01302899|65102869|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
23370955|NCT01302899|65102870|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
23370956|NCT01302899|65102869|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
23370957|NCT01302899|65102870|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
23370958|NCT00830128|65102871|FG000|Overall Study|Adverse Event|5|||
23370959|NCT00830128|65102871|FG000|Overall Study|Lack of Efficacy|7|||
23370960|NCT00830128|65102871|FG000|Overall Study|Protocol Violation|1|||
23370961|NCT00830128|65102871|FG000|Overall Study|Withdrawal by Subject|2|||
23370962|NCT00830128|65102871|FG000|Overall Study|Family obligation|1|||
23370963|NCT00830128|65102871|FG000|Overall Study|Relocation|1|||
23370964|NCT00830128|65102871|FG000|Overall Study|Work obligation|1|||
23370965|NCT00830128|65102871|FG000|Overall Study|Operating a vehicle|1|||
23370966|NCT03257436|65102872|FG000|Overall Study|Withdrawal by Subject|76|||
23370967|NCT03257436|65102872|FG000|Overall Study|Death|19|||
23370968|NCT02204917|65102873|FG000|Overall Study|Protocol Violation|1|||
23370969|NCT00721799|65102874|FG000|Overall Study|Withdrawal by Subject|7|||
23370970|NCT00721799|65102874|FG000|Overall Study|withdraw by subject after scan 1|1|||
23370971|NCT01914393|65102875|FG000|Overall Study|Protocol Violation|11|||
23370972|NCT01914393|65102876|FG001|Overall Study|Protocol Violation|3|||
23370973|NCT01914393|65102877|FG002|Overall Study|Protocol Violation|19|||
23370974|NCT01914393|65102875|FG000|Overall Study|Lack of Efficacy|11|||
23370975|NCT01914393|65102876|FG001|Overall Study|Lack of Efficacy|16|||
23370976|NCT01914393|65102877|FG002|Overall Study|Lack of Efficacy|5|||
23370977|NCT01914393|65102875|FG000|Overall Study|no reason given|14|||
23370978|NCT01914393|65102876|FG001|Overall Study|no reason given|8|||
23370979|NCT01914393|65102877|FG002|Overall Study|no reason given|16|||
23370980|NCT01914393|65102875|FG000|Overall Study|Adverse Event|29|||
23370981|NCT01914393|65102876|FG001|Overall Study|Adverse Event|18|||
23370982|NCT01914393|65102877|FG002|Overall Study|Adverse Event|31|||
23370983|NCT01914393|65102875|FG000|Overall Study|Withdrawal by Subject|38|||
23370984|NCT01914393|65102876|FG001|Overall Study|Withdrawal by Subject|20|||
23370985|NCT01914393|65102877|FG002|Overall Study|Withdrawal by Subject|47|||
23370986|NCT01914393|65102875|FG000|Overall Study|Lost to Follow-up|12|||
23370987|NCT01914393|65102876|FG001|Overall Study|Lost to Follow-up|6|||
23370988|NCT01914393|65102877|FG002|Overall Study|Lost to Follow-up|19|||
23370989|NCT01914393|65102875|FG000|Overall Study|subject never dosed|0|||
23370990|NCT01914393|65102876|FG001|Overall Study|subject never dosed|0|||
23370991|NCT01914393|65102877|FG002|Overall Study|subject never dosed|1|||
23370992|NCT01287936|65102878|FG000|Overall Study|Lost to Follow-up|0|||
23370993|NCT01287936|65102879|FG001|Overall Study|Lost to Follow-up|1|||
23370994|NCT01287936|65102880|FG002|Overall Study|Lost to Follow-up|1|||
23370995|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
23370996|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370997|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370998|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370999|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23371000|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
23371001|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371002|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371003|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371004|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371005|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
23371006|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371007|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371008|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371009|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371010|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
23371011|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371012|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371013|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371014|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371015|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
23371016|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371017|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371018|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371019|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371020|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
23371021|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371022|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371023|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371024|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371025|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
23371026|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371027|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371028|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23485311|NCT01920555|65521702|FG004|Overall Study|Travel Difficulties|1|||
23485312|NCT01920555|65521698|FG000|Overall Study|Lost to Follow-up|0|||
23485313|NCT01920555|65521699|FG001|Overall Study|Lost to Follow-up|1|||
23485314|NCT01920555|65521700|FG002|Overall Study|Lost to Follow-up|0|||
23485315|NCT01920555|65521701|FG003|Overall Study|Lost to Follow-up|1|||
23485316|NCT01920555|65521702|FG004|Overall Study|Lost to Follow-up|0|||
23485317|NCT00900601|65521706|FG000|Overall Study|Physician Decision|1|||
23485318|NCT03350984|65521707|FG000|Overall Study|Death|1|||
23485319|NCT03350984|65521708|FG001|Overall Study|Death|0|||
23485320|NCT03350984|65521707|FG000|Overall Study|Lost to Follow-up|5|||
23485321|NCT03350984|65521708|FG001|Overall Study|Lost to Follow-up|6|||
23485322|NCT03350984|65521707|FG000|Overall Study|Protocol Violation|1|||
23485323|NCT03350984|65521708|FG001|Overall Study|Protocol Violation|2|||
23485324|NCT03350984|65521707|FG000|Overall Study|Physician Decision|1|||
23485325|NCT03350984|65521708|FG001|Overall Study|Physician Decision|0|||
23485326|NCT00381381|65521711|FG000|Overall Study|Adverse Event|3|||
23485327|NCT00381381|65521711|FG000|Overall Study|Lost to Follow-up|52|||
23603470|NCT00071799|65937379|FG000|Overall Study|Adverse Event|19|||
23603471|NCT00071799|65937380|FG001|Overall Study|Adverse Event|10|||
23603472|NCT00071799|65937379|FG000|Overall Study|Protocol Violation|1|||
23603473|NCT00071799|65937380|FG001|Overall Study|Protocol Violation|7|||
23603474|NCT00071799|65937379|FG000|Overall Study|Lost to Follow-up|1|||
23485328|NCT00381381|65521711|FG000|Overall Study|Withdrawal by Subject|9|||
23603475|NCT00071799|65937380|FG001|Overall Study|Lost to Follow-up|1|||
23603476|NCT00071799|65937379|FG000|Overall Study|Withdrawal by Subject|15|||
23663466|NCT01668719|66152500|FG001|Phase I|On treatment|0|||
23663467|NCT01668719|66152501|FG002|Phase I|On treatment|0|||
23663468|NCT01668719|66152499|FG000|Phase I|Adverse Event|2|||
23663469|NCT01668719|66152500|FG001|Phase I|Adverse Event|0|||
23663470|NCT01668719|66152501|FG002|Phase I|Adverse Event|0|||
23663471|NCT01668719|66152499|FG000|Phase I|Progression/relapse|1|||
23663472|NCT01668719|66152500|FG001|Phase I|Progression/relapse|0|||
23663473|NCT01668719|66152501|FG002|Phase I|Progression/relapse|0|||
23663474|NCT01668719|66152499|FG000|Phase I|not protocol specified|2|||
23663475|NCT01668719|66152500|FG001|Phase I|not protocol specified|0|||
23663476|NCT01668719|66152501|FG002|Phase I|not protocol specified|0|||
23663477|NCT01668719|66152499|FG000|Phase II|On treatment|0|||
23663478|NCT01668719|66152500|FG001|Phase II|On treatment|4|||
23663479|NCT01668719|66152501|FG002|Phase II|On treatment|3|||
23663480|NCT01668719|66152499|FG000|Phase II|Adverse Event|0|||
23663481|NCT01668719|66152500|FG001|Phase II|Adverse Event|18|||
23663482|NCT01668719|66152501|FG002|Phase II|Adverse Event|18|||
23663483|NCT01668719|66152499|FG000|Phase II|Refusal unrelated to adverse event|0|||
23663484|NCT01668719|66152500|FG001|Phase II|Refusal unrelated to adverse event|4|||
23663485|NCT01668719|66152501|FG002|Phase II|Refusal unrelated to adverse event|1|||
23663486|NCT01668719|66152499|FG000|Phase II|Progression/relapse|0|||
23663487|NCT01668719|66152500|FG001|Phase II|Progression/relapse|13|||
23663488|NCT01668719|66152501|FG002|Phase II|Progression/relapse|17|||
23663489|NCT01668719|66152499|FG000|Phase II|Death|0|||
23663490|NCT01668719|66152500|FG001|Phase II|Death|0|||
23663491|NCT01668719|66152501|FG002|Phase II|Death|2|||
23663492|NCT01668719|66152499|FG000|Phase II|not protocol specified|0|||
23663493|NCT01668719|66152500|FG001|Phase II|not protocol specified|13|||
23663494|NCT01668719|66152501|FG002|Phase II|not protocol specified|7|||
23663495|NCT00906087|66152506|FG000|Initial Washout|Withdrawal by Subject|1|||
23663496|NCT00906087|66152506|FG000|Initial Washout|Physician Decision|1|||
23663497|NCT00383084|66152508|FG000|Overall Study|Withdrawal by Subject|12|||
23663498|NCT00383084|66152509|FG001|Overall Study|Withdrawal by Subject|10|||
23663499|NCT00829179|66152510|FG000|Overall Study|Withdrawal by Subject|1|||
23663500|NCT03199040|66152511|FG000|Overall Study|Lack of Efficacy|2|||
23663501|NCT03199040|66152512|FG001|Overall Study|Lack of Efficacy|0|||
23663502|NCT03199040|66152511|FG000|Overall Study|Withdrawal by Subject|2|||
23663503|NCT03199040|66152512|FG001|Overall Study|Withdrawal by Subject|0|||
23663504|NCT03199040|66152511|FG000|Overall Study|Adverse Event|0|||
23663505|NCT03199040|66152512|FG001|Overall Study|Adverse Event|1|||
23663506|NCT03199040|66152511|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
23663507|NCT03199040|66152512|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
23663508|NCT01793142|66152513|FG000|Overall Study|Randomized not treated|7|||
23663509|NCT02634151|66155268|FG000|Overall Study|Withdrawal by Subject|1|||
23371029|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371030|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
23371031|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23485329|NCT02180724|65521712|FG000|Overall Study|Death|26|||
23485330|NCT02180724|65521713|FG001|Overall Study|Death|1|||
23371032|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23371033|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23371034|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23603477|NCT00071799|65937380|FG001|Overall Study|Withdrawal by Subject|37|||
23603478|NCT00071799|65937379|FG000|Overall Study|Physician Decision|0|||
23603479|NCT00071799|65937380|FG001|Overall Study|Physician Decision|2|||
23603480|NCT00071799|65937379|FG000|Overall Study|Lack of Efficacy|11|||
23603481|NCT00071799|65937380|FG001|Overall Study|Lack of Efficacy|18|||
23603482|NCT00071799|65937379|FG000|Overall Study|Disease Progression|23|||
23603483|NCT00071799|65937380|FG001|Overall Study|Disease Progression|20|||
23603484|NCT00071799|65937379|FG000|Overall Study|Different Central+Local Pathology Review|0|||
23603485|NCT00071799|65937380|FG001|Overall Study|Different Central+Local Pathology Review|1|||
23603486|NCT00071799|65937379|FG000|Overall Study|Not Documented|0|||
23603487|NCT00071799|65937380|FG001|Overall Study|Not Documented|2|||
23603488|NCT03244800|65937381|FG000|Overall Study|Adverse Event|0|||
23603489|NCT03244800|65937382|FG001|Overall Study|Adverse Event|1|||
23603490|NCT03244800|65937383|FG002|Overall Study|Adverse Event|0|||
23603491|NCT03244800|65937384|FG003|Overall Study|Adverse Event|1|||
23603492|NCT03244800|65937381|FG000|Overall Study|Withdrew treatment|0|||
23603493|NCT03244800|65937382|FG001|Overall Study|Withdrew treatment|0|||
23603494|NCT03244800|65937383|FG002|Overall Study|Withdrew treatment|0|||
23603495|NCT03244800|65937384|FG003|Overall Study|Withdrew treatment|1|||
23663510|NCT02634151|66155269|FG001|Overall Study|Withdrawal by Subject|0|||
23663511|NCT02634151|66155268|FG000|Overall Study|Non-Compliance|0|||
23663512|NCT02634151|66155269|FG001|Overall Study|Non-Compliance|1|||
23663513|NCT02634151|66155268|FG000|Overall Study|Other|0|||
23663514|NCT02634151|66155269|FG001|Overall Study|Other|1|||
23663515|NCT01505634|66155274|FG000|Overall Study|Withdrawal by Subject|2|||
23663516|NCT01505634|66155275|FG001|Overall Study|Withdrawal by Subject|5|||
23663517|NCT01505634|66155276|FG002|Overall Study|Withdrawal by Subject|1|||
23485331|NCT02180724|65521712|FG000|Overall Study|Lost to Follow-up|3|||
23485332|NCT02180724|65521713|FG001|Overall Study|Lost to Follow-up|1|||
23485333|NCT02180724|65521712|FG000|Overall Study|Withdrawal by Subject|4|||
23485334|NCT02180724|65521713|FG001|Overall Study|Withdrawal by Subject|2|||
23485335|NCT02180724|65521712|FG000|Overall Study|PI Decision|5|||
23485336|NCT02180724|65521713|FG001|Overall Study|PI Decision|2|||
23485337|NCT02180724|65521712|FG000|Overall Study|Study terminated by sponsor|54|||
23485338|NCT02180724|65521713|FG001|Overall Study|Study terminated by sponsor|8|||
23485339|NCT03026088|65521714|FG000|Overall Study|Study termination|20|||
23485340|NCT01280955|65521715|FG000|Overall Study|Death|2|||
23371035|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
23371036|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371037|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371038|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371039|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371040|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23371041|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
23371042|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23371043|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23485341|NCT01280955|65521715|FG000|Overall Study|Withdrawal by Subject|1|||
23485342|NCT02480712|65521718|FG000|Overall Study|Enrolled but Never Treated|1|||
23485343|NCT02480712|65521718|FG000|Overall Study|Lost to Follow-up|5|||
23485344|NCT02480712|65521718|FG000|Overall Study|Withdrew Consent|3|||
23485345|NCT02480712|65521718|FG000|Overall Study|Death|1|||
23485346|NCT02480712|65521718|FG000|Overall Study|Lack of Efficacy|1|||
23485347|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
23485348|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
23485349|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485350|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
23485351|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485352|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485353|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485354|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
23485355|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485356|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485357|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485358|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485359|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
23603496|NCT02255474|65937385|FG000|Overall Study|Lost to Follow-up|1|||
23663518|NCT01505634|66155274|FG000|Overall Study|Physician Decision|1|||
23663519|NCT01505634|66155275|FG001|Overall Study|Physician Decision|1|||
23663520|NCT01505634|66155276|FG002|Overall Study|Physician Decision|0|||
23663521|NCT01505634|66155274|FG000|Overall Study|Adverse Event|1|||
23371044|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
23371045|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
23485360|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
23485361|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
23485362|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
23485363|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
23485364|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
23485365|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485366|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
23485367|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485368|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485369|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485370|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23603497|NCT02255474|65937386|FG001|Overall Study|Lost to Follow-up|1|||
23603498|NCT02255474|65937387|FG002|Overall Study|Lost to Follow-up|3|||
23485371|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485372|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
23485373|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485374|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485375|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485376|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485377|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485378|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485379|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485380|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485381|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
23485382|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
23485383|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485384|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485385|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485386|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485387|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
23485388|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
23485389|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485390|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485391|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485392|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485393|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
23485394|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
23485395|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485396|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485397|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485398|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485399|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
23485400|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
23485401|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485402|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485403|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485404|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485405|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
23485406|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
23485407|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485408|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485409|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485410|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485411|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
23485412|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
23485413|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485414|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485415|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485416|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485417|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485418|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
23485419|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485420|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485421|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485422|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485423|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485424|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
23485425|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23485426|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23485427|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23371046|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
23485428|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23485429|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
23485430|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
23485431|NCT02581943|65521740|FG000|Overall Study|Death|5|||
23485432|NCT02581943|65521741|FG001|Overall Study|Death|2|||
23485433|NCT02581943|65521740|FG000|Overall Study|Disease Progression|12|||
23485434|NCT02581943|65521741|FG001|Overall Study|Disease Progression|15|||
23485435|NCT02581943|65521740|FG000|Overall Study|Withdrawal by Subject|1|||
23485436|NCT02581943|65521741|FG001|Overall Study|Withdrawal by Subject|2|||
23485437|NCT02605837|65521742|FG000|Overall Study|Adverse Event|3|||
23485438|NCT02605837|65521743|FG001|Overall Study|Adverse Event|1|||
23485439|NCT02605837|65521742|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23485440|NCT02605837|65521743|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23485441|NCT02605837|65521742|FG000|Overall Study|Withdrawal by Subject|8|||
23485442|NCT02605837|65521743|FG001|Overall Study|Withdrawal by Subject|8|||
23485443|NCT02605837|65521742|FG000|Overall Study|Physician Decision|0|||
23485444|NCT02605837|65521743|FG001|Overall Study|Physician Decision|1|||
23485445|NCT05867342|65521746|FG000|Overall Study|Investigator Decision|3|||
23485446|NCT05867342|65521747|FG001|Overall Study|Investigator Decision|3|||
23485447|NCT00450112|65521748|FG000|Overall Study|Other Treatment Required|5|||
23485448|NCT00450112|65521749|FG001|Overall Study|Other Treatment Required|1|||
23485449|NCT00450112|65521748|FG000|Overall Study|Withdrawal by Subject|4|||
23485450|NCT00450112|65521749|FG001|Overall Study|Withdrawal by Subject|1|||
23485451|NCT00450112|65521748|FG000|Overall Study|Lost to Follow-up|2|||
23485452|NCT00450112|65521749|FG001|Overall Study|Lost to Follow-up|1|||
23485453|NCT00450112|65521748|FG000|Overall Study|Others|2|||
23485454|NCT00450112|65521749|FG001|Overall Study|Others|3|||
23485455|NCT01076075|65521750|FG000|Overall Study|Adverse Event|3|||
23485456|NCT01076075|65521751|FG001|Overall Study|Adverse Event|9|||
23485457|NCT01076075|65521750|FG000|Overall Study|Lack of Efficacy|5|||
23485458|NCT01076075|65521751|FG001|Overall Study|Lack of Efficacy|4|||
23485459|NCT01076075|65521750|FG000|Overall Study|Lost to Follow-up|6|||
23485460|NCT01076075|65521751|FG001|Overall Study|Lost to Follow-up|5|||
23485461|NCT01076075|65521750|FG000|Overall Study|other|19|||
23485462|NCT01076075|65521751|FG001|Overall Study|other|9|||
23485463|NCT01076075|65521750|FG000|Overall Study|Protocol Violation|0|||
23485464|NCT01076075|65521751|FG001|Overall Study|Protocol Violation|1|||
23485465|NCT01076075|65521750|FG000|Overall Study|Withdrawal by Subject|8|||
23485466|NCT01076075|65521751|FG001|Overall Study|Withdrawal by Subject|19|||
23485467|NCT04618770|65521752|FG000|Overall Study|Censored from Analysis|12|||
23485468|NCT04618770|65521752|FG000|Overall Study|Early Termination|25|||
23485469|NCT01721577|65521758|FG000|Overall Study|Lack of Efficacy|1|||
23485470|NCT01721577|65521759|FG001|Overall Study|Lack of Efficacy|0|||
23485471|NCT01721577|65521758|FG000|Overall Study|Death|1|||
23485472|NCT01721577|65521759|FG001|Overall Study|Death|0|||
23485473|NCT01721577|65521758|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
23485474|NCT01721577|65521759|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
23485475|NCT01721577|65521758|FG000|Overall Study|Adverse Event|0|||
23485476|NCT01721577|65521759|FG001|Overall Study|Adverse Event|2|||
23485477|NCT00608543|65521760|FG000|Overall Study|Adverse Event|4|||
23485478|NCT01007253|65521765|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
23485479|NCT01007253|65521766|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485480|NCT01007253|65521767|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485481|NCT01007253|65521768|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485482|NCT00117286|65521776|FG000|Overall Study|Adverse Event|12|||
23485483|NCT00117286|65521777|FG001|Overall Study|Adverse Event|6|||
23485484|NCT00117286|65521776|FG000|Overall Study|Lost to Follow-up|2|||
23485485|NCT00117286|65521777|FG001|Overall Study|Lost to Follow-up|0|||
23485486|NCT00117286|65521776|FG000|Overall Study|Protocol Violation|3|||
23485487|NCT00117286|65521777|FG001|Overall Study|Protocol Violation|3|||
23485488|NCT00117286|65521776|FG000|Overall Study|Withdrawal by Subject|6|||
23485489|NCT00117286|65521777|FG001|Overall Study|Withdrawal by Subject|2|||
23663522|NCT01505634|66155275|FG001|Overall Study|Adverse Event|0|||
23485490|NCT00117286|65521776|FG000|Overall Study|Physician Decision|3|||
23485491|NCT00117286|65521777|FG001|Overall Study|Physician Decision|7|||
23485492|NCT00117286|65521776|FG000|Overall Study|Lack of Efficacy|2|||
23485493|NCT00117286|65521777|FG001|Overall Study|Lack of Efficacy|1|||
23485494|NCT00117286|65521776|FG000|Overall Study|Research site closing|0|||
23485495|NCT00117286|65521777|FG001|Overall Study|Research site closing|2|||
23485496|NCT03823378|65521780|FG000|Overall Study|Adverse Event|2|||
23485497|NCT03823378|65521781|FG001|Overall Study|Adverse Event|2|||
23485498|NCT03823378|65521782|FG002|Overall Study|Adverse Event|0|||
23485499|NCT03823378|65521783|FG003|Overall Study|Adverse Event|0|||
23603499|NCT02255474|65937385|FG000|Overall Study|Withdrawal by Subject|1|||
23485500|NCT03823378|65521784|FG004|Overall Study|Adverse Event|0|||
23485501|NCT03823378|65521785|FG005|Overall Study|Adverse Event|0|||
23485502|NCT03823378|65521780|FG000|Overall Study|Lost to Follow-up|0|||
23485503|NCT03823378|65521781|FG001|Overall Study|Lost to Follow-up|1|||
23485504|NCT03823378|65521782|FG002|Overall Study|Lost to Follow-up|0|||
23485505|NCT03823378|65521783|FG003|Overall Study|Lost to Follow-up|0|||
23485506|NCT03823378|65521784|FG004|Overall Study|Lost to Follow-up|1|||
23485507|NCT03823378|65521785|FG005|Overall Study|Lost to Follow-up|0|||
23485508|NCT03823378|65521780|FG000|Overall Study|Withdrawal by Subject|0|||
23485509|NCT03823378|65521781|FG001|Overall Study|Withdrawal by Subject|1|||
23485510|NCT03823378|65521782|FG002|Overall Study|Withdrawal by Subject|4|||
23485511|NCT03823378|65521783|FG003|Overall Study|Withdrawal by Subject|2|||
23485512|NCT03823378|65521784|FG004|Overall Study|Withdrawal by Subject|0|||
23485513|NCT03823378|65521785|FG005|Overall Study|Withdrawal by Subject|1|||
23485514|NCT03823378|65521780|FG000|Overall Study|Other, not specified|19|||
23485515|NCT03823378|65521781|FG001|Overall Study|Other, not specified|12|||
23485516|NCT03823378|65521782|FG002|Overall Study|Other, not specified|6|||
23485517|NCT03823378|65521783|FG003|Overall Study|Other, not specified|8|||
23485518|NCT03823378|65521784|FG004|Overall Study|Other, not specified|17|||
23485519|NCT03823378|65521785|FG005|Overall Study|Other, not specified|7|||
23485520|NCT03370289|65521786|FG000|Overall Study|Screen Failure|1|||
23485521|NCT03370289|65521786|FG000|Overall Study|Sample Size Sufficient|4|||
23485522|NCT00843726|65521801|FG000|Overall Study|Death|1|||
23485523|NCT00843726|65521802|FG001|Overall Study|Death|0|||
23485524|NCT00843726|65521801|FG000|Overall Study|Withdrawal by Subject|0|||
23485525|NCT00843726|65521802|FG001|Overall Study|Withdrawal by Subject|1|||
23485526|NCT01249118|65521807|FG000|First Washout Period|Physician Decision|0|||
23485527|NCT01249118|65521808|FG001|First Washout Period|Physician Decision|1|||
23485528|NCT01249118|65521809|FG002|First Washout Period|Physician Decision|0|||
23485529|NCT01055496|65521813|FG000|Overall Study|Withdrawal by Subject|2|||
23485530|NCT01055496|65521814|FG001|Overall Study|Withdrawal by Subject|4|||
23485531|NCT01055496|65521813|FG000|Overall Study|Death|13|||
23485532|NCT01055496|65521814|FG001|Overall Study|Death|23|||
23485533|NCT01055496|65521813|FG000|Overall Study|Lost to Follow-up|0|||
23485534|NCT01055496|65521814|FG001|Overall Study|Lost to Follow-up|2|||
23485535|NCT01055496|65521813|FG000|Overall Study|Other - Unspecified|0|||
23485536|NCT01055496|65521814|FG001|Overall Study|Other - Unspecified|1|||
23485537|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Adverse Event|1|||
23485538|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Adverse Event|0|||
23485539|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Adverse Event|0|||
23485540|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Adverse Event|0|||
23485541|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Adverse Event|0|||
23485542|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485543|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
23485544|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485545|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485546|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485547|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
23485548|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
23485549|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
23485550|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
23485551|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
23485552|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485553|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
23485554|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485555|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485556|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485557|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Reason not specified|0|||
23485558|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Reason not specified|1|||
23485559|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Reason not specified|0|||
23485560|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Reason not specified|0|||
23485561|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Reason not specified|0|||
23485562|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Adverse Event|0|||
23485563|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Adverse Event|0|||
23485564|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Adverse Event|0|||
23485565|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Adverse Event|0|||
23485566|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Adverse Event|3|||
23485567|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Death|0|||
23485568|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Death|0|||
23485569|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Death|0|||
23485570|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Death|0|||
23485571|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Death|1|||
23485572|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
23485573|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
23485574|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
23485575|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
23485576|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
23485577|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Reason not specified|0|||
23485578|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Reason not specified|0|||
23485579|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Reason not specified|0|||
23485580|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Reason not specified|0|||
23485581|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Reason not specified|3|||
23485582|NCT01857310|65521820|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
23485583|NCT01857310|65521821|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
23485584|NCT01514370|65521823|FG000|Overall Study|Protocol Violation|2|||
23485585|NCT01514370|65521824|FG001|Overall Study|Protocol Violation|3|||
23485586|NCT01514370|65521823|FG000|Overall Study|Lost to Follow-up|0|||
23485587|NCT01514370|65521824|FG001|Overall Study|Lost to Follow-up|2|||
23485588|NCT01514370|65521823|FG000|Overall Study|Withdrawal by Subject|2|||
23485589|NCT01514370|65521824|FG001|Overall Study|Withdrawal by Subject|1|||
23485590|NCT01514370|65521823|FG000|Overall Study|Adverse Event|1|||
23485591|NCT01514370|65521824|FG001|Overall Study|Adverse Event|3|||
23485592|NCT01514370|65521823|FG000|Overall Study|Other|6|||
23485593|NCT01514370|65521824|FG001|Overall Study|Other|7|||
23485594|NCT02398227|65521825|FG000|Overall Study|Lost to Follow-up|21|||
23485595|NCT02398227|65521826|FG001|Overall Study|Lost to Follow-up|12|||
23485596|NCT02398227|65521825|FG000|Overall Study|Withdrawal by Subject|5|||
23485597|NCT02398227|65521826|FG001|Overall Study|Withdrawal by Subject|6|||
23485598|NCT02398227|65521825|FG000|Overall Study|Removed from treatment and dropped out|1|||
23485599|NCT02398227|65521826|FG001|Overall Study|Removed from treatment and dropped out|0|||
23485600|NCT02425644|65521827|FG000|Overall Study|Lost to Follow-up|2|||
23485601|NCT02425644|65521828|FG001|Overall Study|Lost to Follow-up|3|||
23485602|NCT02425644|65521827|FG000|Overall Study|Withdrawal by Subject|41|||
23485603|NCT02425644|65521828|FG001|Overall Study|Withdrawal by Subject|36|||
23485604|NCT02425644|65521827|FG000|Overall Study|Lack of Efficacy|3|||
23485605|NCT02425644|65521828|FG001|Overall Study|Lack of Efficacy|10|||
23485606|NCT02425644|65521827|FG000|Overall Study|Adverse Event|13|||
23485607|NCT02425644|65521828|FG001|Overall Study|Adverse Event|3|||
23485608|NCT02425644|65521827|FG000|Overall Study|Death|0|||
23485609|NCT02425644|65521828|FG001|Overall Study|Death|2|||
23485610|NCT02425644|65521827|FG000|Overall Study|Other|18|||
23485611|NCT02425644|65521828|FG001|Overall Study|Other|17|||
23485612|NCT01757691|65521833|FG000|Overall Study|Administrative problems|2|||
23485613|NCT01757691|65521834|FG001|Overall Study|Administrative problems|0|||
23485614|NCT00873860|65521835|FG000|Overall Study|Lost to Follow-up|1|||
23485615|NCT00873860|65521836|FG001|Overall Study|Lost to Follow-up|0|||
23485616|NCT00873860|65521837|FG002|Overall Study|Lost to Follow-up|0|||
23485617|NCT00873860|65521838|FG003|Overall Study|Lost to Follow-up|1|||
23485618|NCT00873860|65521835|FG000|Overall Study|Withdrawal by Subject|1|||
23485619|NCT00873860|65521836|FG001|Overall Study|Withdrawal by Subject|0|||
23485620|NCT00873860|65521837|FG002|Overall Study|Withdrawal by Subject|2|||
23485621|NCT00873860|65521838|FG003|Overall Study|Withdrawal by Subject|0|||
23485622|NCT00873860|65521835|FG000|Overall Study|Death|1|||
23485623|NCT00873860|65521836|FG001|Overall Study|Death|0|||
23485624|NCT00873860|65521837|FG002|Overall Study|Death|0|||
23485625|NCT00873860|65521838|FG003|Overall Study|Death|0|||
23485626|NCT00873860|65521835|FG000|Overall Study|Other|1|||
23485627|NCT00873860|65521836|FG001|Overall Study|Other|0|||
23485628|NCT00873860|65521837|FG002|Overall Study|Other|1|||
23485629|NCT00873860|65521838|FG003|Overall Study|Other|0|||
23485630|NCT04179890|65521839|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
23485631|NCT04179890|65521840|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
23485632|NCT04179890|65521839|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
23485633|NCT04179890|65521840|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
23485634|NCT04179890|65521839|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
23485635|NCT04179890|65521840|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
23485636|NCT04179890|65521839|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
23485637|NCT04179890|65521840|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
23485638|NCT04179890|65521839|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
23485639|NCT04179890|65521840|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
23485640|NCT04179890|65521839|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
23485641|NCT04179890|65521840|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
23485642|NCT04179890|65521839|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
23485643|NCT04179890|65521840|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
23485644|NCT04179890|65521839|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
23485645|NCT04179890|65521840|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
23485646|NCT04179890|65521839|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
23485647|NCT04179890|65521840|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
23485648|NCT03435640|65521841|FG000|Overall Study|Withdrawal by Subject|0|||
23603500|NCT02255474|65937386|FG001|Overall Study|Withdrawal by Subject|1|||
23603501|NCT02255474|65937387|FG002|Overall Study|Withdrawal by Subject|0|||
23603502|NCT05270460|65937388|FG000|Overall Study|Adverse Event|0|||
23603503|NCT05270460|65937389|FG001|Overall Study|Adverse Event|1|||
23603504|NCT05270460|65937390|FG002|Overall Study|Adverse Event|0|||
23603505|NCT05270460|65937388|FG000|Overall Study|Early Termination|0|||
23603506|NCT05270460|65937389|FG001|Overall Study|Early Termination|1|||
23603507|NCT05270460|65937390|FG002|Overall Study|Early Termination|0|||
23371047|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
23371048|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
23485649|NCT03435640|65521842|FG001|Overall Study|Withdrawal by Subject|1|||
23485650|NCT03435640|65521843|FG002|Overall Study|Withdrawal by Subject|0|||
23603508|NCT01976507|65937391|FG000|Overall Study|Adverse Event|6|||
23485651|NCT03435640|65521844|FG003|Overall Study|Withdrawal by Subject|2|||
23485652|NCT03435640|65521845|FG004|Overall Study|Withdrawal by Subject|0|||
23485653|NCT03435640|65521846|FG005|Overall Study|Withdrawal by Subject|0|||
23485654|NCT03435640|65521847|FG006|Overall Study|Withdrawal by Subject|3|||
23485655|NCT03435640|65521848|FG007|Overall Study|Withdrawal by Subject|0|||
23485656|NCT03435640|65521849|FG008|Overall Study|Withdrawal by Subject|0|||
23485657|NCT03435640|65521850|FG009|Overall Study|Withdrawal by Subject|2|||
23485658|NCT03435640|65521851|FG010|Overall Study|Withdrawal by Subject|3|||
23485659|NCT03435640|65521841|FG000|Overall Study|Lost to Follow-up|0|||
23485660|NCT03435640|65521842|FG001|Overall Study|Lost to Follow-up|0|||
23485661|NCT03435640|65521843|FG002|Overall Study|Lost to Follow-up|1|||
23485662|NCT03435640|65521844|FG003|Overall Study|Lost to Follow-up|0|||
23663523|NCT01505634|66155276|FG002|Overall Study|Adverse Event|0|||
23663524|NCT01505634|66155274|FG000|Overall Study|Insufficient supply of drug at site|1|||
23663525|NCT01505634|66155275|FG001|Overall Study|Insufficient supply of drug at site|0|||
23663526|NCT01505634|66155276|FG002|Overall Study|Insufficient supply of drug at site|0|||
23663527|NCT01505634|66155274|FG000|Overall Study|Protocol Violation|2|||
23663528|NCT01505634|66155275|FG001|Overall Study|Protocol Violation|0|||
23663529|NCT01505634|66155276|FG002|Overall Study|Protocol Violation|0|||
23663530|NCT01505634|66155274|FG000|Overall Study|Lost to Follow-up|1|||
23663531|NCT01505634|66155275|FG001|Overall Study|Lost to Follow-up|4|||
23663532|NCT01505634|66155276|FG002|Overall Study|Lost to Follow-up|4|||
23663533|NCT01505634|66155274|FG000|Overall Study|Death|1|||
23663534|NCT01505634|66155275|FG001|Overall Study|Death|0|||
23663535|NCT01505634|66155276|FG002|Overall Study|Death|0|||
23663536|NCT01505634|66155274|FG000|Overall Study|In a conflict zone|0|||
23663537|NCT01505634|66155275|FG001|Overall Study|In a conflict zone|0|||
23663538|NCT01505634|66155276|FG002|Overall Study|In a conflict zone|1|||
23663539|NCT02663271|66155282|FG000|Overall Study|Withdrawal by Subject|5|||
23663540|NCT02663271|66155282|FG000|Overall Study|Lack of Efficacy|1|||
23663541|NCT05162027|66155283|FG000|Overall Study|Adverse Event|1|||
23663542|NCT05162027|66155284|FG001|Overall Study|Adverse Event|0|||
23663543|NCT01430455|66155285|FG000|Overall Study|Withdrawal by Subject|1|||
23663544|NCT01430455|66155285|FG000|Overall Study|Switched to follow-up phase|1|||
23663545|NCT03215771|66155290|FG000|Overall Study|Withdrawal by Subject|2|||
23663546|NCT03215771|66155290|FG000|Overall Study|Physician Decision|1|||
23663547|NCT01543152|66155296|FG000|Overall Study|Withdrawal by Subject|0|||
23663548|NCT01543152|66155297|FG001|Overall Study|Withdrawal by Subject|2|||
23663549|NCT01543152|66155298|FG002|Overall Study|Withdrawal by Subject|0|||
23663550|NCT01543152|66155299|FG003|Overall Study|Withdrawal by Subject|0|||
23663551|NCT01543152|66155300|FG004|Overall Study|Withdrawal by Subject|0|||
23663552|NCT04854434|66155306|FG000|Overall Study|Death|1|||
23663553|NCT04854434|66155307|FG001|Overall Study|Death|3|||
23663554|NCT04854434|66155308|FG002|Overall Study|Death|4|||
23663555|NCT04854434|66155306|FG000|Overall Study|Study Terminated by Sponsor|2|||
23663556|NCT04854434|66155307|FG001|Overall Study|Study Terminated by Sponsor|0|||
23663557|NCT04854434|66155308|FG002|Overall Study|Study Terminated by Sponsor|0|||
23663558|NCT04854434|66155306|FG000|Overall Study|Other|1|||
23663559|NCT04854434|66155307|FG001|Overall Study|Other|1|||
23663560|NCT04854434|66155308|FG002|Overall Study|Other|0|||
23663561|NCT00636675|66155309|FG000|Overall Study|Lost to Follow-up|121|||
23663562|NCT00636675|66155310|FG001|Overall Study|Lost to Follow-up|31|||
23663563|NCT00636675|66155309|FG000|Overall Study|Withdrawal by Subject|19|||
23663564|NCT00636675|66155310|FG001|Overall Study|Withdrawal by Subject|10|||
23663565|NCT00687440|66155311|FG000|Overall Study|Adverse Event|3|||
23663566|NCT00687440|66155311|FG000|Overall Study|Lost to Follow-up|3|||
23663567|NCT00687440|66155311|FG000|Overall Study|Lack of Efficacy|2|||
23663568|NCT00687440|66155311|FG000|Overall Study|Death|2|||
23663569|NCT00687440|66155311|FG000|Overall Study|Other|1|||
23663570|NCT00687440|66155311|FG000|Overall Study|Missing|1|||
23663571|NCT02592551|66155312|FG000|Overall Study|Not evaluable|1|||
23485663|NCT03435640|65521845|FG004|Overall Study|Lost to Follow-up|0|||
23663572|NCT02592551|66155313|FG001|Overall Study|Not evaluable|3|||
23663573|NCT02592551|66155314|FG002|Overall Study|Not evaluable|0|||
23663574|NCT00113074|66155334|FG000|Overall Study|Lost to Follow-up|10|||
23663575|NCT00113074|66155335|FG001|Overall Study|Lost to Follow-up|10|||
23663576|NCT00113074|66155336|FG002|Overall Study|Lost to Follow-up|14|||
23663577|NCT00942175|66155337|FG000|Overall Study|Adverse Event|2|||
23485664|NCT03435640|65521846|FG005|Overall Study|Lost to Follow-up|0|||
23485665|NCT03435640|65521847|FG006|Overall Study|Lost to Follow-up|0|||
23485666|NCT03435640|65521848|FG007|Overall Study|Lost to Follow-up|0|||
23603509|NCT01976507|65937391|FG000|Overall Study|ablation not done, drug not given|1|||
23663578|NCT00942175|66155338|FG001|Overall Study|Adverse Event|1|||
23663579|NCT00942175|66155339|FG002|Overall Study|Adverse Event|0|||
23663580|NCT00942175|66155340|FG003|Overall Study|Adverse Event|0|||
23663581|NCT00942175|66155337|FG000|Overall Study|Protocol Violation|0|||
23663582|NCT00942175|66155338|FG001|Overall Study|Protocol Violation|1|||
23663583|NCT00942175|66155339|FG002|Overall Study|Protocol Violation|2|||
23663584|NCT00942175|66155340|FG003|Overall Study|Protocol Violation|0|||
23663585|NCT00942175|66155337|FG000|Overall Study|Pregnancy|0|||
23485667|NCT03435640|65521849|FG008|Overall Study|Lost to Follow-up|0|||
23485668|NCT03435640|65521850|FG009|Overall Study|Lost to Follow-up|0|||
23485669|NCT03435640|65521851|FG010|Overall Study|Lost to Follow-up|0|||
23485670|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485671|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485672|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485673|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485674|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
23485675|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485676|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485677|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485678|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485679|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
23485680|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485681|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485682|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485683|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485684|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
23485685|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485686|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485687|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485688|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485689|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
23485690|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485691|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485692|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485693|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485694|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
23485695|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485696|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485697|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485698|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485699|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
23485700|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485701|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485702|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485703|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485704|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
23485705|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485706|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485707|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485708|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485709|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
23485710|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485711|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485712|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
23485713|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
23485714|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485715|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485716|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485717|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
23485718|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
23485719|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485720|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
23485721|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
23485722|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
23485723|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
23485724|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
23485725|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485726|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
23485727|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485728|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485729|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485730|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485731|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485732|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
23485733|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485734|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485735|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
23371049|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
23371050|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
23603510|NCT03802994|65937392|FG000|Overall Study|Lost to Follow-up|0|||
23603511|NCT03802994|65937393|FG001|Overall Study|Lost to Follow-up|2|||
23603512|NCT03802994|65937394|FG002|Overall Study|Lost to Follow-up|3|||
23371051|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
23371052|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
23371053|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
23371054|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
23371055|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
23371056|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
23371057|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
23371058|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
23371059|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
23371060|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
23371061|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
23371062|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
23485736|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
23485737|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
23485738|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
23485739|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
23485740|NCT02278471|65521860|FG000|Overall Study|Lost to Follow-up|6|||
23485741|NCT02278471|65521861|FG001|Overall Study|Lost to Follow-up|15|||
23485742|NCT02278471|65521860|FG000|Overall Study|Death|2|||
23485743|NCT02278471|65521861|FG001|Overall Study|Death|2|||
23485744|NCT02278471|65521860|FG000|Overall Study|Withdrawal by Subject|0|||
23485745|NCT02278471|65521861|FG001|Overall Study|Withdrawal by Subject|3|||
23485746|NCT00076024|65521862|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
23485747|NCT00076024|65521863|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
23485748|NCT00076024|65521864|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
23485749|NCT00076024|65521865|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
23485750|NCT00076024|65521862|FG000|Phase 1, Lead-in|Adverse Event|1|||
23485751|NCT00076024|65521863|FG001|Phase 1, Lead-in|Adverse Event|0|||
23485752|NCT00076024|65521864|FG002|Phase 1, Lead-in|Adverse Event|0|||
23485753|NCT00076024|65521865|FG003|Phase 1, Lead-in|Adverse Event|0|||
23485754|NCT00076024|65521862|FG000|Phase 1, Lead-in|Clinical progression|1|||
23485755|NCT00076024|65521863|FG001|Phase 1, Lead-in|Clinical progression|0|||
23485756|NCT00076024|65521864|FG002|Phase 1, Lead-in|Clinical progression|0|||
23485757|NCT00076024|65521865|FG003|Phase 1, Lead-in|Clinical progression|0|||
23485758|NCT00076024|65521862|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
23485759|NCT00076024|65521863|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
23485760|NCT00076024|65521864|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
23485761|NCT00076024|65521865|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
23485762|NCT00076024|65521862|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
23485763|NCT00076024|65521863|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
23485764|NCT00076024|65521864|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
23603513|NCT03802994|65937395|FG003|Overall Study|Lost to Follow-up|2|||
23603514|NCT03802994|65937396|FG004|Overall Study|Lost to Follow-up|2|||
23663586|NCT00942175|66155338|FG001|Overall Study|Pregnancy|0|||
23485765|NCT00076024|65521865|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
23485766|NCT00076024|65521862|FG000|Phase 2, Double-blind|Adverse Event|0|||
23485767|NCT00076024|65521863|FG001|Phase 2, Double-blind|Adverse Event|25|||
23485768|NCT00076024|65521864|FG002|Phase 2, Double-blind|Adverse Event|6|||
23485769|NCT00076024|65521865|FG003|Phase 2, Double-blind|Adverse Event|0|||
23485770|NCT00076024|65521862|FG000|Phase 2, Double-blind|Un-specified|0|||
23485771|NCT00076024|65521863|FG001|Phase 2, Double-blind|Un-specified|14|||
23485772|NCT00076024|65521864|FG002|Phase 2, Double-blind|Un-specified|6|||
23603515|NCT00266656|65937397|FG000|Overall Study|Death|1|||
23371063|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
23371064|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
23371065|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
23371066|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371067|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371068|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371069|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
23371070|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371071|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371072|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
23371073|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371074|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371075|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
23371076|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
23371077|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
23371078|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
23663587|NCT00942175|66155339|FG002|Overall Study|Pregnancy|0|||
23663588|NCT00942175|66155340|FG003|Overall Study|Pregnancy|1|||
23663589|NCT00942175|66155337|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
23663590|NCT00942175|66155338|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
23663591|NCT00942175|66155339|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
23663592|NCT00942175|66155340|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
23663593|NCT00942175|66155337|FG000|Overall Study|Low Platelet Count|0|||
23663594|NCT00942175|66155338|FG001|Overall Study|Low Platelet Count|2|||
23663595|NCT00942175|66155339|FG002|Overall Study|Low Platelet Count|0|||
23663596|NCT00942175|66155340|FG003|Overall Study|Low Platelet Count|0|||
23663597|NCT02953340|66155348|FG000|Overall Study|Death|0|||
23663598|NCT02953340|66155349|FG001|Overall Study|Death|1|||
23663599|NCT02953340|66155348|FG000|Overall Study|Investigator Decision|3|||
23663600|NCT02953340|66155349|FG001|Overall Study|Investigator Decision|3|||
23663601|NCT02953340|66155348|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
23663602|NCT02953340|66155349|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
23663603|NCT02953340|66155348|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
23663604|NCT02953340|66155349|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
23663605|NCT02953340|66155348|FG000|Overall Study|Withdrawal by Subject|9|||
23663606|NCT02953340|66155349|FG001|Overall Study|Withdrawal by Subject|9|||
23663607|NCT02953340|66155348|FG000|Overall Study|Sponsor decision|0|||
23371079|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
23371080|NCT00427908|65102886|FG000|Primary Phase|Lost to Follow-up|4|||
23371081|NCT00427908|65102887|FG001|Primary Phase|Lost to Follow-up|0|||
23371082|NCT00427908|65102888|FG002|Primary Phase|Lost to Follow-up|2|||
23371083|NCT00427908|65102889|FG003|Primary Phase|Lost to Follow-up|0|||
23371084|NCT00427908|65102886|FG000|Primary Phase|Withdrawal by Subject|1|||
23371085|NCT00427908|65102887|FG001|Primary Phase|Withdrawal by Subject|2|||
23371086|NCT00427908|65102888|FG002|Primary Phase|Withdrawal by Subject|1|||
23371087|NCT00427908|65102889|FG003|Primary Phase|Withdrawal by Subject|0|||
23371088|NCT00427908|65102886|FG000|Primary Phase|Adverse Event|0|||
23371089|NCT00427908|65102887|FG001|Primary Phase|Adverse Event|1|||
23371090|NCT00427908|65102888|FG002|Primary Phase|Adverse Event|0|||
23371091|NCT00427908|65102889|FG003|Primary Phase|Adverse Event|0|||
23371092|NCT00473655|65102890|FG000|Overall Study|Lost to Follow-up|9|||
23371093|NCT00473655|65102891|FG001|Overall Study|Lost to Follow-up|5|||
23371094|NCT00473655|65102892|FG002|Overall Study|Lost to Follow-up|8|||
23371095|NCT01147822|65102893|FG000|Overall Study|Death|66|||
23371096|NCT01147822|65102894|FG001|Overall Study|Death|59|||
23371097|NCT01147822|65102893|FG000|Overall Study|Protocol Violation|0|||
23371098|NCT01147822|65102894|FG001|Overall Study|Protocol Violation|1|||
23371099|NCT01147822|65102893|FG000|Overall Study|Lost to Follow-up|3|||
23371100|NCT01147822|65102894|FG001|Overall Study|Lost to Follow-up|2|||
23371101|NCT01147822|65102893|FG000|Overall Study|Physician Decision|0|||
23371102|NCT01147822|65102894|FG001|Overall Study|Physician Decision|2|||
23371103|NCT01147822|65102893|FG000|Overall Study|Withdrawal by Subject|8|||
23371104|NCT01147822|65102894|FG001|Overall Study|Withdrawal by Subject|13|||
23371105|NCT01147822|65102893|FG000|Overall Study|Not Completed/Ongoing|111|||
23371106|NCT01147822|65102894|FG001|Overall Study|Not Completed/Ongoing|102|||
23371107|NCT00551369|65102895|FG000|Overall Study|Protocol Violation|5|||
23371108|NCT00551369|65102895|FG000|Overall Study|Withdrawal by Subject|1|||
23371109|NCT00551369|65102895|FG000|Overall Study|Not treated per protocol and re|1|||
23371110|NCT03353220|65102896|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
23663608|NCT02953340|66155349|FG001|Overall Study|Sponsor decision|2|||
23663609|NCT02953340|66155348|FG000|Overall Study|Lost to Follow-up|3|||
23663610|NCT02953340|66155349|FG001|Overall Study|Lost to Follow-up|2|||
23663611|NCT02953340|66155348|FG000|Overall Study|Reason not specified|2|||
23371111|NCT03353220|65102897|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
23371112|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
23371113|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
23371114|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
23371115|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Death|0|||
23371116|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Death|1|||
23371117|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Death|0|||
23371118|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
23371119|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
23371120|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
23371121|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
23371122|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
23371123|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
23371124|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23371125|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23371126|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23371127|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Other|4|||
23371128|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Other|7|||
23371129|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Other|2|||
23371130|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23371131|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23371132|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23371133|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Death|0|||
23371134|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Death|1|||
23371135|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23371136|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23371137|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23371138|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23371139|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23371140|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23371141|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23371142|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23371143|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23371144|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23371145|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
23371146|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23371147|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23371148|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371149|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371150|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371151|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Other|5|||
23371152|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Other|2|||
23371153|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Other|1|||
23371154|NCT01035138|65102901|FG000|Overall Study|Adverse Event|4|||
23371155|NCT01035138|65102902|FG001|Overall Study|Adverse Event|0|||
23371156|NCT01035138|65102903|FG002|Overall Study|Adverse Event|2|||
23371157|NCT01035138|65102901|FG000|Overall Study|Caregiver Decision|2|||
23371158|NCT01035138|65102902|FG001|Overall Study|Caregiver Decision|0|||
23371159|NCT01035138|65102903|FG002|Overall Study|Caregiver Decision|1|||
23371160|NCT01035138|65102901|FG000|Overall Study|Withdrawal by Subject|1|||
23371161|NCT01035138|65102902|FG001|Overall Study|Withdrawal by Subject|0|||
23371162|NCT01035138|65102903|FG002|Overall Study|Withdrawal by Subject|0|||
23371163|NCT01035138|65102901|FG000|Overall Study|Physician Decision|0|||
23371164|NCT01035138|65102902|FG001|Overall Study|Physician Decision|0|||
23371165|NCT01035138|65102903|FG002|Overall Study|Physician Decision|1|||
23371166|NCT01035138|65102901|FG000|Overall Study|Sponsor Decision|66|||
23371167|NCT01035138|65102902|FG001|Overall Study|Sponsor Decision|60|||
23371168|NCT01035138|65102903|FG002|Overall Study|Sponsor Decision|42|||
23371169|NCT01035138|65102901|FG000|Overall Study|Lost to Follow-up|0|||
23371170|NCT01035138|65102902|FG001|Overall Study|Lost to Follow-up|0|||
23371171|NCT01035138|65102903|FG002|Overall Study|Lost to Follow-up|1|||
23371172|NCT01317641|65102906|FG000|Overall Study|Not treated|0|||
23371173|NCT01317641|65102907|FG001|Overall Study|Not treated|0|||
23371174|NCT01317641|65102908|FG002|Overall Study|Not treated|0|||
23371175|NCT01317641|65102909|FG003|Overall Study|Not treated|0|||
23371176|NCT01317641|65102910|FG004|Overall Study|Not treated|0|||
23371177|NCT01317641|65102911|FG005|Overall Study|Not treated|0|||
23371178|NCT01317641|65102912|FG006|Overall Study|Not treated|0|||
23371179|NCT01317641|65102913|FG007|Overall Study|Not treated|1|||
23371180|NCT01317641|65102914|FG008|Overall Study|Not treated|1|||
23371181|NCT01317641|65102906|FG000|Overall Study|Adverse Event|0|||
23371182|NCT01317641|65102907|FG001|Overall Study|Adverse Event|1|||
23371183|NCT01317641|65102908|FG002|Overall Study|Adverse Event|0|||
23371184|NCT01317641|65102909|FG003|Overall Study|Adverse Event|1|||
23371185|NCT01317641|65102910|FG004|Overall Study|Adverse Event|0|||
23371186|NCT01317641|65102911|FG005|Overall Study|Adverse Event|0|||
23371187|NCT01317641|65102912|FG006|Overall Study|Adverse Event|2|||
23371188|NCT01317641|65102913|FG007|Overall Study|Adverse Event|1|||
23371189|NCT01317641|65102914|FG008|Overall Study|Adverse Event|0|||
23371190|NCT01317641|65102906|FG000|Overall Study|Protocol Violation|1|||
23371191|NCT01317641|65102907|FG001|Overall Study|Protocol Violation|0|||
23371192|NCT01317641|65102908|FG002|Overall Study|Protocol Violation|0|||
23371193|NCT01317641|65102909|FG003|Overall Study|Protocol Violation|0|||
23371194|NCT01317641|65102910|FG004|Overall Study|Protocol Violation|0|||
23371195|NCT01317641|65102911|FG005|Overall Study|Protocol Violation|0|||
23371196|NCT01317641|65102912|FG006|Overall Study|Protocol Violation|0|||
23371197|NCT01317641|65102913|FG007|Overall Study|Protocol Violation|0|||
23371198|NCT01317641|65102914|FG008|Overall Study|Protocol Violation|0|||
23371199|NCT01317641|65102906|FG000|Overall Study|Disease progression|0|||
23371200|NCT01317641|65102907|FG001|Overall Study|Disease progression|0|||
23371201|NCT01317641|65102908|FG002|Overall Study|Disease progression|0|||
23371202|NCT01317641|65102909|FG003|Overall Study|Disease progression|0|||
23371203|NCT01317641|65102910|FG004|Overall Study|Disease progression|0|||
23371204|NCT01317641|65102911|FG005|Overall Study|Disease progression|0|||
23371205|NCT01317641|65102912|FG006|Overall Study|Disease progression|0|||
23371206|NCT01317641|65102913|FG007|Overall Study|Disease progression|3|||
23371207|NCT01317641|65102914|FG008|Overall Study|Disease progression|4|||
23371208|NCT01317641|65102906|FG000|Overall Study|Withdrawal by Subject|0|||
23371209|NCT01317641|65102907|FG001|Overall Study|Withdrawal by Subject|0|||
23371210|NCT01317641|65102908|FG002|Overall Study|Withdrawal by Subject|0|||
23371211|NCT01317641|65102909|FG003|Overall Study|Withdrawal by Subject|0|||
23371212|NCT01317641|65102910|FG004|Overall Study|Withdrawal by Subject|0|||
23371213|NCT01317641|65102911|FG005|Overall Study|Withdrawal by Subject|0|||
23485773|NCT00076024|65521865|FG003|Phase 2, Double-blind|Un-specified|0|||
23485774|NCT00076024|65521862|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
23485775|NCT00076024|65521863|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
23485776|NCT00076024|65521864|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
23485777|NCT00076024|65521865|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
23485778|NCT00076024|65521862|FG000|Phase 2, Open-label|Adverse Event|0|||
23485779|NCT00076024|65521863|FG001|Phase 2, Open-label|Adverse Event|0|||
23485780|NCT00076024|65521864|FG002|Phase 2, Open-label|Adverse Event|0|||
23485781|NCT00076024|65521865|FG003|Phase 2, Open-label|Adverse Event|2|||
23603516|NCT00266656|65937398|FG001|Overall Study|Death|0|||
23371214|NCT01317641|65102912|FG006|Overall Study|Withdrawal by Subject|1|||
23371215|NCT01317641|65102913|FG007|Overall Study|Withdrawal by Subject|0|||
23371216|NCT01317641|65102914|FG008|Overall Study|Withdrawal by Subject|0|||
23371217|NCT03103503|65102915|FG000|Overall Study|Death|64|||
23371218|NCT03103503|65102915|FG000|Overall Study|Physician Decision|57|||
23485782|NCT00076024|65521862|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
23485783|NCT00076024|65521863|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
23485784|NCT00076024|65521864|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
23485785|NCT00076024|65521865|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
23603517|NCT00266656|65937397|FG000|Overall Study|Lost to Follow-up|4|||
23371219|NCT03103503|65102915|FG000|Overall Study|Withdrawal by Subject|10|||
23371220|NCT03103503|65102915|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
23371221|NCT03103503|65102915|FG000|Overall Study|Lost to Follow-up|3|||
23371222|NCT03103503|65102915|FG000|Overall Study|Study Closure|757|||
23371223|NCT02481050|65102918|FG000|Overall Study|Adverse Event|1|||
23371224|NCT02481050|65102918|FG000|Overall Study|Disease Progression|47|||
23371225|NCT02481050|65102918|FG000|Overall Study|Withdrawal by Subject|7|||
23371226|NCT02481050|65102918|FG000|Overall Study|Other|3|||
23371227|NCT00372424|65102919|FG000|Overall Study|Adverse Event|2|||
23371228|NCT00372424|65102919|FG000|Overall Study|Withdrawal by Subject|1|||
23371229|NCT00372424|65102919|FG000|Overall Study|Death|1|||
23663612|NCT02953340|66155349|FG001|Overall Study|Reason not specified|2|||
23371230|NCT00372424|65102919|FG000|Overall Study|Objective Progression or Relapse|14|||
23371231|NCT00372424|65102919|FG000|Overall Study|Other|7|||
23371232|NCT00372424|65102919|FG000|Overall Study|Enrolled, Not Treated|1|||
23371233|NCT01200329|65102920|FG000|Overall Study|Lack of financial coverage|2|||
23371234|NCT01200329|65102920|FG000|Overall Study|Progressive disease|1|||
23371235|NCT01692119|65102921|FG000|Overall Study|Protocol Violation|3|||
23371236|NCT01692119|65102922|FG001|Overall Study|Protocol Violation|1|||
23371237|NCT01692119|65102921|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
23371238|NCT01692119|65102922|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
23371239|NCT00386334|65102929|FG000|Double Blind Period|Adverse Event|9|||
23371240|NCT00386334|65102930|FG001|Double Blind Period|Adverse Event|14|||
23371241|NCT00386334|65102929|FG000|Double Blind Period|Protocol Violation|1|||
23371242|NCT00386334|65102930|FG001|Double Blind Period|Protocol Violation|1|||
23371243|NCT00386334|65102929|FG000|Double Blind Period|Withdrawal by Subject|9|||
23371244|NCT00386334|65102930|FG001|Double Blind Period|Withdrawal by Subject|13|||
23371245|NCT00386334|65102929|FG000|Double Blind Period|Lack of Efficacy|20|||
23371246|NCT00386334|65102930|FG001|Double Blind Period|Lack of Efficacy|11|||
23603518|NCT00266656|65937398|FG001|Overall Study|Lost to Follow-up|1|||
23663613|NCT02230384|66155350|FG000|Phase 1|Lost to Follow-up|1|||
23371247|NCT00386334|65102929|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
23371248|NCT00386334|65102930|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
23371249|NCT00386334|65102929|FG000|Double Blind Period|Other|3|||
23371250|NCT00386334|65102930|FG001|Double Blind Period|Other|3|||
23371251|NCT00386334|65102929|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
23371252|NCT00386334|65102930|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
23371253|NCT00869960|65102932|FG000|Overall Study|Lost to Follow-up|2|||
23371254|NCT01981616|65102933|FG000|Overall Study|Adverse Event|0|||
23371255|NCT01981616|65102934|FG001|Overall Study|Adverse Event|1|||
23371256|NCT01981616|65102933|FG000|Overall Study|Protocol Violation|1|||
23371257|NCT01981616|65102934|FG001|Overall Study|Protocol Violation|0|||
23371258|NCT04919317|65102936|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
23371259|NCT04919317|65102937|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
23371260|NCT04919317|65102936|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
23371261|NCT04919317|65102937|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
23371262|NCT03886272|65102942|FG000|Period 1|Withdrawal by Subject|0|||
23371263|NCT03886272|65102943|FG001|Period 1|Withdrawal by Subject|0|||
23371264|NCT03886272|65102944|FG002|Period 1|Withdrawal by Subject|0|||
23371265|NCT03886272|65102945|FG003|Period 1|Withdrawal by Subject|0|||
23371266|NCT03886272|65102946|FG004|Period 1|Withdrawal by Subject|0|||
23371267|NCT03886272|65102947|FG005|Period 1|Withdrawal by Subject|1|||
23371268|NCT03886272|65102948|FG006|Period 1|Withdrawal by Subject|0|||
23371269|NCT00748241|65102949|FG000|Overall Study|Implant failure|1|||
23663614|NCT02230384|66155351|FG001|Phase 1|Lost to Follow-up|0|||
23663615|NCT02230384|66155350|FG000|Phase 1|Physician Decision|0|||
23663616|NCT02230384|66155351|FG001|Phase 1|Physician Decision|1|||
23663617|NCT02230384|66155350|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
23663618|NCT02230384|66155351|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
23663619|NCT02230384|66155350|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
23663620|NCT02230384|66155351|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
23663621|NCT02230384|66155350|FG000|Phase 2 - Switch|Adverse Event|2|||
23663622|NCT02230384|66155351|FG001|Phase 2 - Switch|Adverse Event|0|||
23663623|NCT01230242|66155352|FG000|Overall Study|Physician Decision|2|||
23663624|NCT01230242|66155352|FG000|Overall Study|Withdrawal by Subject|1|||
23663625|NCT02700412|66155353|FG000|Overall Study|Adverse Event|6|||
23663626|NCT02700412|66155353|FG000|Overall Study|Death|1|||
23663627|NCT02700412|66155353|FG000|Overall Study|Lack of Efficacy|19|||
23663628|NCT02700412|66155353|FG000|Overall Study|Protocol Violation|5|||
23663629|NCT02700412|66155353|FG000|Overall Study|Withdrawal by Subject|2|||
23663630|NCT01967628|66155354|FG000|Overall Study|Withdrawal by Subject|2|||
23663631|NCT01967628|66155355|FG001|Overall Study|Withdrawal by Subject|0|||
23663632|NCT01967628|66155354|FG000|Overall Study|Unable to complete bronchoscopy|4|||
23663633|NCT01967628|66155355|FG001|Overall Study|Unable to complete bronchoscopy|6|||
23663634|NCT01967628|66155354|FG000|Overall Study|Lost to Follow-up|1|||
23663635|NCT01967628|66155355|FG001|Overall Study|Lost to Follow-up|0|||
23371270|NCT00748241|65102949|FG000|Overall Study|Lost to Follow-up|5|||
23371271|NCT00748241|65102949|FG000|Overall Study|Death|2|||
23371272|NCT04584788|65102950|FG000|Overall Study|Physician Decision|8|||
23371273|NCT04584788|65102950|FG000|Overall Study|Withdrawal by Subject|1|||
23371274|NCT04584788|65102950|FG000|Overall Study|Adverse Event|3|||
23371275|NCT02611882|65106077|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
23663636|NCT01967628|66155354|FG000|Overall Study|Low protein concentration in sample|20|||
23663637|NCT01967628|66155355|FG001|Overall Study|Low protein concentration in sample|25|||
23663638|NCT03654976|66155356|FG000|Overall Study|Withdrawal by Subject|12|||
23663639|NCT03654976|66155357|FG001|Overall Study|Withdrawal by Subject|11|||
23663640|NCT03654976|66155356|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
23663641|NCT03654976|66155357|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
23663642|NCT03654976|66155356|FG000|Overall Study|Adverse Event|5|||
23485786|NCT00076024|65521862|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
23485787|NCT00076024|65521863|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
23485788|NCT00076024|65521864|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
23485789|NCT00076024|65521865|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
23485790|NCT00076024|65521862|FG000|Phase 2, Open-label|Other|0|||
23485791|NCT00076024|65521863|FG001|Phase 2, Open-label|Other|0|||
23485792|NCT00076024|65521864|FG002|Phase 2, Open-label|Other|0|||
23485793|NCT00076024|65521865|FG003|Phase 2, Open-label|Other|2|||
23485794|NCT01709578|65521866|FG000|Overall Study|Rescued and entered in long term safety|63|||
23485795|NCT01709578|65521867|FG001|Overall Study|Rescued and entered in long term safety|25|||
23663643|NCT03654976|66155357|FG001|Overall Study|Adverse Event|0|||
23663644|NCT03654976|66155356|FG000|Overall Study|Lost to Follow-up|2|||
23663645|NCT03654976|66155357|FG001|Overall Study|Lost to Follow-up|0|||
23663646|NCT03654976|66155356|FG000|Overall Study|Lack of Efficacy|0|||
23663647|NCT03654976|66155357|FG001|Overall Study|Lack of Efficacy|1|||
23663648|NCT02664272|66155359|FG000|Overall Study|Fluoroscopic images not made available|2|||
23663649|NCT01225731|66155360|FG000|Part 1|Did not meet eligibility criteria|1|||
23663650|NCT01225731|66155361|FG001|Part 1|Did not meet eligibility criteria|0|||
23663651|NCT01225731|66155362|FG002|Part 1|Did not meet eligibility criteria|0|||
23663652|NCT01225731|66155363|FG003|Part 1|Did not meet eligibility criteria|0|||
23663653|NCT01225731|66155364|FG004|Part 1|Did not meet eligibility criteria|1|||
23663654|NCT01225731|66155365|FG005|Part 1|Did not meet eligibility criteria|0|||
23663655|NCT01225731|66155366|FG006|Part 1|Did not meet eligibility criteria|0|||
23663656|NCT01225731|66155367|FG007|Part 1|Did not meet eligibility criteria|0|||
23663657|NCT01225731|66155368|FG008|Part 1|Did not meet eligibility criteria|0|||
23663658|NCT01225731|66155369|FG009|Part 1|Did not meet eligibility criteria|0|||
23663659|NCT01225731|66155370|FG010|Part 1|Did not meet eligibility criteria|0|||
23663660|NCT01225731|66155371|FG011|Part 1|Did not meet eligibility criteria|0|||
23663661|NCT01225731|66155372|FG012|Part 1|Did not meet eligibility criteria|0|||
23663662|NCT01225731|66155360|FG000|Part 1|Adverse Event|1|||
23663663|NCT01225731|66155361|FG001|Part 1|Adverse Event|2|||
23663664|NCT01225731|66155362|FG002|Part 1|Adverse Event|1|||
23663665|NCT01225731|66155363|FG003|Part 1|Adverse Event|1|||
23663666|NCT01225731|66155364|FG004|Part 1|Adverse Event|1|||
23663667|NCT01225731|66155365|FG005|Part 1|Adverse Event|0|||
23663668|NCT01225731|66155366|FG006|Part 1|Adverse Event|0|||
23663669|NCT01225731|66155367|FG007|Part 1|Adverse Event|0|||
23663670|NCT01225731|66155368|FG008|Part 1|Adverse Event|0|||
23663671|NCT01225731|66155369|FG009|Part 1|Adverse Event|0|||
23663672|NCT01225731|66155370|FG010|Part 1|Adverse Event|0|||
23663673|NCT01225731|66155371|FG011|Part 1|Adverse Event|0|||
23663674|NCT01225731|66155372|FG012|Part 1|Adverse Event|0|||
23663675|NCT01225731|66155360|FG000|Part 1|Withdrawal by Subject|0|||
23663676|NCT01225731|66155361|FG001|Part 1|Withdrawal by Subject|3|||
23663677|NCT01225731|66155362|FG002|Part 1|Withdrawal by Subject|0|||
23485796|NCT01709578|65521868|FG002|Overall Study|Rescued and entered in long term safety|26|||
23663678|NCT01225731|66155363|FG003|Part 1|Withdrawal by Subject|0|||
23663679|NCT01225731|66155364|FG004|Part 1|Withdrawal by Subject|4|||
23663680|NCT01225731|66155365|FG005|Part 1|Withdrawal by Subject|0|||
23663681|NCT01225731|66155366|FG006|Part 1|Withdrawal by Subject|0|||
23663682|NCT01225731|66155367|FG007|Part 1|Withdrawal by Subject|0|||
23663683|NCT01225731|66155368|FG008|Part 1|Withdrawal by Subject|0|||
23663684|NCT01225731|66155369|FG009|Part 1|Withdrawal by Subject|0|||
23485797|NCT01709578|65521866|FG000|Overall Study|Adverse Event|9|||
23485798|NCT01709578|65521867|FG001|Overall Study|Adverse Event|18|||
23485799|NCT01709578|65521868|FG002|Overall Study|Adverse Event|17|||
23485800|NCT01709578|65521866|FG000|Overall Study|Lack of Efficacy|5|||
23485801|NCT01709578|65521867|FG001|Overall Study|Lack of Efficacy|4|||
23485802|NCT01709578|65521868|FG002|Overall Study|Lack of Efficacy|2|||
23485803|NCT01709578|65521866|FG000|Overall Study|Poor compliance to protocol|1|||
23485804|NCT01709578|65521867|FG001|Overall Study|Poor compliance to protocol|2|||
23485805|NCT01709578|65521868|FG002|Overall Study|Poor compliance to protocol|1|||
23485806|NCT01709578|65521866|FG000|Overall Study|Other, not related to safety or efficacy|2|||
23485807|NCT01709578|65521867|FG001|Overall Study|Other, not related to safety or efficacy|7|||
23485808|NCT01709578|65521868|FG002|Overall Study|Other, not related to safety or efficacy|5|||
23663685|NCT01225731|66155370|FG010|Part 1|Withdrawal by Subject|0|||
23485809|NCT01562873|65521869|FG000|Overall Study|Disease Progression per RECIST|10|||
23485810|NCT01562873|65521870|FG001|Overall Study|Disease Progression per RECIST|0|||
23485811|NCT01562873|65521869|FG000|Overall Study|Adverse Event|1|||
23485812|NCT01562873|65521870|FG001|Overall Study|Adverse Event|0|||
23485813|NCT01562873|65521869|FG000|Overall Study|Clinical Disease Progression|9|||
23485814|NCT01562873|65521870|FG001|Overall Study|Clinical Disease Progression|0|||
23485815|NCT01562873|65521869|FG000|Overall Study|Clinical PD and adverse event|1|||
23485816|NCT01562873|65521870|FG001|Overall Study|Clinical PD and adverse event|0|||
23485817|NCT03463031|65521871|FG000|Overall Study|Withdrawal by Subject|4|||
23485818|NCT03463031|65521872|FG001|Overall Study|Withdrawal by Subject|2|||
23485819|NCT03463031|65521871|FG000|Overall Study|Investigator/Sponsor Decision|0|||
23485820|NCT03463031|65521872|FG001|Overall Study|Investigator/Sponsor Decision|1|||
23485821|NCT03463031|65521871|FG000|Overall Study|Lost to Follow-up|1|||
23485822|NCT03463031|65521872|FG001|Overall Study|Lost to Follow-up|1|||
23485823|NCT03463031|65521871|FG000|Overall Study|Adverse Event|4|||
23485824|NCT03463031|65521872|FG001|Overall Study|Adverse Event|1|||
23485825|NCT03463031|65521871|FG000|Overall Study|Use of prohibited medication by subject|1|||
23485826|NCT03463031|65521872|FG001|Overall Study|Use of prohibited medication by subject|0|||
23485827|NCT01624870|65521880|FG000|Overall Study|Death|19|||
23485828|NCT01624870|65521880|FG000|Overall Study|Withdrawal by Subject|1|||
23485829|NCT01624870|65521880|FG000|Overall Study|CoreValve not implanted|6|||
23485830|NCT01624870|65521880|FG000|Overall Study|Lost to follow up|1|||
23485831|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
23485832|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
23485833|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
23485834|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
23663686|NCT01225731|66155371|FG011|Part 1|Withdrawal by Subject|0|||
23663687|NCT01225731|66155372|FG012|Part 1|Withdrawal by Subject|0|||
23663688|NCT01225731|66155360|FG000|Part 1|Protocol Violation|0|||
23371276|NCT02611882|65106078|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
23485835|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
23485836|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
23485837|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
23485838|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
23485839|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
23485840|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Death|1|||
23485841|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Death|0|||
23485842|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Death|0|||
23485843|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
23485844|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
23485845|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
23485846|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
23485847|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
23485848|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
23485849|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
23485850|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
23485851|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
23485852|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Death|1|||
23485853|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Death|1|||
23485854|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Death|0|||
23485855|NCT00640835|65521892|FG000|Overall Study|Adverse Event|5|||
23485856|NCT00640835|65521893|FG001|Overall Study|Adverse Event|3|||
23485857|NCT00640835|65521892|FG000|Overall Study|Withdrawal by Subject|12|||
23485858|NCT00640835|65521893|FG001|Overall Study|Withdrawal by Subject|14|||
23485859|NCT00640835|65521892|FG000|Overall Study|Physician Decision|10|||
23485860|NCT00640835|65521893|FG001|Overall Study|Physician Decision|14|||
23485861|NCT00640835|65521892|FG000|Overall Study|Sponsor's Decision|11|||
23485862|NCT00640835|65521893|FG001|Overall Study|Sponsor's Decision|7|||
23485863|NCT00640835|65521892|FG000|Overall Study|Protocol Violation|2|||
23485864|NCT00640835|65521893|FG001|Overall Study|Protocol Violation|2|||
23485865|NCT00640835|65521892|FG000|Overall Study|Lost to Follow-up|17|||
23485866|NCT00640835|65521893|FG001|Overall Study|Lost to Follow-up|13|||
23485867|NCT00640835|65521892|FG000|Overall Study|Other Reason|19|||
23485868|NCT00640835|65521893|FG001|Overall Study|Other Reason|4|||
23485869|NCT02284178|65521895|FG000|Overall Study|Met exclusion criteria|49|||
23485870|NCT02284178|65521896|FG001|Overall Study|Met exclusion criteria|54|||
23485871|NCT00814801|65521899|FG000|Overall Study|Adverse Event|15|||
23485872|NCT00814801|65521900|FG001|Overall Study|Adverse Event|16|||
23485873|NCT00814801|65521901|FG002|Overall Study|Adverse Event|19|||
23485874|NCT00814801|65521899|FG000|Overall Study|Withdrawal by Subject|9|||
23485875|NCT00814801|65521900|FG001|Overall Study|Withdrawal by Subject|11|||
23485876|NCT00814801|65521901|FG002|Overall Study|Withdrawal by Subject|14|||
23485877|NCT00814801|65521899|FG000|Overall Study|Inappropriate as a subject|1|||
23485878|NCT00814801|65521900|FG001|Overall Study|Inappropriate as a subject|1|||
23485879|NCT00814801|65521901|FG002|Overall Study|Inappropriate as a subject|1|||
23485880|NCT00814801|65521899|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
23485881|NCT00814801|65521900|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
23485882|NCT00814801|65521901|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
23485883|NCT00814801|65521899|FG000|Overall Study|Missing or change of caregiver|6|||
23485884|NCT00814801|65521900|FG001|Overall Study|Missing or change of caregiver|2|||
23485885|NCT00814801|65521901|FG002|Overall Study|Missing or change of caregiver|4|||
23485886|NCT00814801|65521899|FG000|Overall Study|Non-compliance|0|||
23485887|NCT00814801|65521900|FG001|Overall Study|Non-compliance|1|||
23485888|NCT00814801|65521901|FG002|Overall Study|Non-compliance|1|||
23485889|NCT00814801|65521899|FG000|Overall Study|Other|2|||
23485890|NCT00814801|65521900|FG001|Overall Study|Other|6|||
23485891|NCT00814801|65521901|FG002|Overall Study|Other|4|||
23485892|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
23485893|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
23485894|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
23485895|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
23485896|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
23485897|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
23485898|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
23485899|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
23485900|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
23485901|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
23485902|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
23485903|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
23485904|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
23485905|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
23603519|NCT00266656|65937397|FG000|Overall Study|Withdrawal by Subject|4|||
23603520|NCT00266656|65937398|FG001|Overall Study|Withdrawal by Subject|2|||
23603521|NCT00266656|65937397|FG000|Overall Study|Did Not Reach Final Height|4|||
23603522|NCT00266656|65937398|FG001|Overall Study|Did Not Reach Final Height|8|||
23603523|NCT00266656|65937397|FG000|Overall Study|Parent/Caregiver Decision|1|||
23603524|NCT00266656|65937398|FG001|Overall Study|Parent/Caregiver Decision|2|||
23603525|NCT00999596|65937399|FG000|Overall Study|Statistical population not required|101|||
23603526|NCT00800176|65937402|FG000|Overall Study|Adverse Event|2|||
23603527|NCT00800176|65937403|FG001|Overall Study|Adverse Event|1|||
23603528|NCT00800176|65937404|FG002|Overall Study|Adverse Event|0|||
23603529|NCT00800176|65937405|FG003|Overall Study|Adverse Event|2|||
23371277|NCT02611882|65106079|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
23485906|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
23485907|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
23485908|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
23485909|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
23485910|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
23603530|NCT00800176|65937406|FG004|Overall Study|Adverse Event|1|||
23371278|NCT00499122|65106080|FG000|Overall Study|Withdrawal by Subject|2|||
23371279|NCT01674725|65106081|FG000|Overall Study|Adverse Event|1|||
23663689|NCT01225731|66155361|FG001|Part 1|Protocol Violation|0|||
23663690|NCT01225731|66155362|FG002|Part 1|Protocol Violation|0|||
23371280|NCT01674725|65106082|FG001|Overall Study|Adverse Event|0|||
23371281|NCT01674725|65106081|FG000|Overall Study|Did not receive study drug|1|||
23371282|NCT01674725|65106082|FG001|Overall Study|Did not receive study drug|0|||
23603531|NCT00800176|65937407|FG005|Overall Study|Adverse Event|1|||
23603532|NCT00800176|65937402|FG000|Overall Study|Refused treatment|3|||
23603533|NCT00800176|65937403|FG001|Overall Study|Refused treatment|2|||
23371283|NCT01674725|65106081|FG000|Overall Study|Withdrawal by Subject|1|||
23371284|NCT01674725|65106082|FG001|Overall Study|Withdrawal by Subject|0|||
23371285|NCT01674725|65106081|FG000|Overall Study|Lost to Follow-up|0|||
23371286|NCT01674725|65106082|FG001|Overall Study|Lost to Follow-up|1|||
23371287|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371288|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371289|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
23371290|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371291|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371292|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
23371293|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
23371294|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371295|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371296|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371297|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
23371298|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
23371299|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371300|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371301|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371302|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Adverse Event|0|||
23371303|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Adverse Event|0|||
23371304|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Adverse Event|0|||
23371305|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Adverse Event|0|||
23371306|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Adverse Event|9|||
23371307|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Death|0|||
23371308|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Death|0|||
23371309|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Death|0|||
23371310|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Death|0|||
23371311|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Death|2|||
23371312|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Physician Decision|0|||
23371313|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Physician Decision|0|||
23371314|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Physician Decision|0|||
23371315|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Physician Decision|0|||
23371316|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Physician Decision|1|||
23371317|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23485911|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
23485912|NCT03345342|65521906|FG000|Open-Label Phase|Adverse Event|30|||
23485913|NCT03345342|65521907|FG001|Open-Label Phase|Adverse Event|0|||
23603534|NCT00800176|65937404|FG002|Overall Study|Refused treatment|0|||
23603535|NCT00800176|65937405|FG003|Overall Study|Refused treatment|0|||
23603536|NCT00800176|65937406|FG004|Overall Study|Refused treatment|1|||
23603537|NCT00800176|65937407|FG005|Overall Study|Refused treatment|4|||
23603538|NCT00800176|65937402|FG000|Overall Study|Failure to return|3|||
23603539|NCT00800176|65937403|FG001|Overall Study|Failure to return|3|||
23603540|NCT00800176|65937404|FG002|Overall Study|Failure to return|0|||
23603541|NCT00800176|65937405|FG003|Overall Study|Failure to return|2|||
23603542|NCT00800176|65937406|FG004|Overall Study|Failure to return|0|||
23603543|NCT00800176|65937407|FG005|Overall Study|Failure to return|0|||
23603544|NCT00800176|65937402|FG000|Overall Study|Other|1|||
23603545|NCT00800176|65937403|FG001|Overall Study|Other|0|||
23603546|NCT00800176|65937404|FG002|Overall Study|Other|0|||
23603547|NCT00800176|65937405|FG003|Overall Study|Other|0|||
23603548|NCT00800176|65937406|FG004|Overall Study|Other|2|||
23603549|NCT00800176|65937407|FG005|Overall Study|Other|0|||
23603550|NCT02824198|65937409|FG000|Overall Study|Non-compliance with the protocol|5|||
23603551|NCT02824198|65937410|FG001|Overall Study|Non-compliance with the protocol|1|||
23603552|NCT02824198|65937409|FG000|Overall Study|Lost to Follow-up|5|||
23603553|NCT02824198|65937410|FG001|Overall Study|Lost to Follow-up|2|||
23663691|NCT01225731|66155363|FG003|Part 1|Protocol Violation|1|||
23663692|NCT01225731|66155364|FG004|Part 1|Protocol Violation|0|||
23371318|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371319|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371320|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371321|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
23603554|NCT02824198|65937409|FG000|Overall Study|Withdrawal by Subject|5|||
23603555|NCT02824198|65937410|FG001|Overall Study|Withdrawal by Subject|0|||
23663693|NCT01225731|66155365|FG005|Part 1|Protocol Violation|0|||
23371322|NCT00408499|65106084|FG000|Phase II- MTD Expansion|treatment delay|0|||
23371323|NCT00408499|65106085|FG001|Phase II- MTD Expansion|treatment delay|0|||
23371324|NCT00408499|65106086|FG002|Phase II- MTD Expansion|treatment delay|0|||
23371325|NCT00408499|65106087|FG003|Phase II- MTD Expansion|treatment delay|0|||
23371326|NCT00408499|65106088|FG004|Phase II- MTD Expansion|treatment delay|3|||
23371327|NCT03409744|65106089|FG000|Overall Study|Death|2|||
23371328|NCT03409744|65106089|FG000|Overall Study|Physician Decision|5|||
23371329|NCT03409744|65106089|FG000|Overall Study|Pregnancy|1|||
23371330|NCT03409744|65106089|FG000|Overall Study|Lost to Follow-up|1|||
23371331|NCT03409744|65106089|FG000|Overall Study|Protocol Violation|1|||
23371332|NCT01186770|65106090|FG000|Overall Study|Ineligibility|0|||
23371333|NCT01186770|65106091|FG001|Overall Study|Ineligibility|0|||
23371334|NCT01186770|65106092|FG002|Overall Study|Ineligibility|2|||
23371335|NCT01186770|65106093|FG003|Overall Study|Ineligibility|0|||
23371336|NCT01186770|65106090|FG000|Overall Study|Protocol Violation|7|||
23371337|NCT01186770|65106091|FG001|Overall Study|Protocol Violation|9|||
23371338|NCT01186770|65106092|FG002|Overall Study|Protocol Violation|12|||
23371339|NCT01186770|65106093|FG003|Overall Study|Protocol Violation|14|||
23371340|NCT01186770|65106090|FG000|Overall Study|Adverse Event|2|||
23371341|NCT01186770|65106091|FG001|Overall Study|Adverse Event|9|||
23371342|NCT01186770|65106092|FG002|Overall Study|Adverse Event|7|||
23371343|NCT01186770|65106093|FG003|Overall Study|Adverse Event|9|||
23371344|NCT01186770|65106090|FG000|Overall Study|Withdrawal by Subject|15|||
23371345|NCT01186770|65106091|FG001|Overall Study|Withdrawal by Subject|13|||
23371346|NCT01186770|65106092|FG002|Overall Study|Withdrawal by Subject|11|||
23371347|NCT01186770|65106093|FG003|Overall Study|Withdrawal by Subject|17|||
23371348|NCT01186770|65106090|FG000|Overall Study|Lost to Follow-up|10|||
23371349|NCT01186770|65106091|FG001|Overall Study|Lost to Follow-up|6|||
23371350|NCT01186770|65106092|FG002|Overall Study|Lost to Follow-up|14|||
23371351|NCT01186770|65106093|FG003|Overall Study|Lost to Follow-up|9|||
23371352|NCT01186770|65106090|FG000|Overall Study|Insufficient response to treatment|7|||
23371353|NCT01186770|65106091|FG001|Overall Study|Insufficient response to treatment|8|||
23371354|NCT01186770|65106092|FG002|Overall Study|Insufficient response to treatment|5|||
23371355|NCT01186770|65106093|FG003|Overall Study|Insufficient response to treatment|7|||
23371356|NCT01186770|65106090|FG000|Overall Study|Other than specified|0|||
23371357|NCT01186770|65106091|FG001|Overall Study|Other than specified|1|||
23371358|NCT01186770|65106092|FG002|Overall Study|Other than specified|1|||
23371359|NCT01186770|65106093|FG003|Overall Study|Other than specified|2|||
23371360|NCT02160626|65106094|FG000|Overall Study|Adverse Event|1|||
23371361|NCT02160626|65106095|FG001|Overall Study|Adverse Event|0|||
23371362|NCT02160626|65106096|FG002|Overall Study|Adverse Event|0|||
23371363|NCT02160626|65106094|FG000|Overall Study|Schedule not conducive to study visits|0|||
23371364|NCT02160626|65106095|FG001|Overall Study|Schedule not conducive to study visits|0|||
23371365|NCT02160626|65106096|FG002|Overall Study|Schedule not conducive to study visits|1|||
23371366|NCT02160626|65106094|FG000|Overall Study|Withdrawal by Subject|0|||
23371367|NCT02160626|65106095|FG001|Overall Study|Withdrawal by Subject|1|||
23371368|NCT02160626|65106096|FG002|Overall Study|Withdrawal by Subject|0|||
23371369|NCT00094445|65106097|FG000|Overall Study|Withdrawal by Subject|3|||
23371370|NCT00094445|65106097|FG000|Overall Study|Lost to Follow-up|1|||
23371371|NCT00094445|65106097|FG000|Overall Study|Progressive Disease|2|||
23371372|NCT03817528|65106098|FG000|Overall Study|Withdrawal by Subject|1|||
23371373|NCT03817528|65106098|FG000|Overall Study|Adverse Event|2|||
23371374|NCT02295644|65106104|FG000|Overall Study|Did not meet inclusion criterion|0|||
23371375|NCT02295644|65106105|FG001|Overall Study|Did not meet inclusion criterion|0|||
23371376|NCT02295644|65106106|FG002|Overall Study|Did not meet inclusion criterion|1|||
23371377|NCT02295644|65106107|FG003|Overall Study|Did not meet inclusion criterion|2|||
23371378|NCT01026493|65106108|FG000|Overall Study|Protocol Violation|0|||
23371379|NCT01026493|65106109|FG001|Overall Study|Protocol Violation|1|||
23371380|NCT01026493|65106110|FG002|Overall Study|Protocol Violation|0|||
23371381|NCT01026493|65106111|FG003|Overall Study|Protocol Violation|0|||
23371382|NCT01026493|65106112|FG004|Overall Study|Protocol Violation|2|||
23371383|NCT01026493|65106113|FG005|Overall Study|Protocol Violation|3|||
23371384|NCT01026493|65106114|FG006|Overall Study|Protocol Violation|4|||
23485914|NCT03345342|65521908|FG002|Open-Label Phase|Adverse Event|0|||
23603556|NCT00597376|65937416|FG000|Overall Study|Withdrawal by Subject|4|||
23371385|NCT01026493|65106115|FG007|Overall Study|Protocol Violation|1|||
23371386|NCT01586195|65106116|FG000|Overall Study|Death|11|||
23371387|NCT01586195|65106116|FG000|Overall Study|Withdrawal of Consent|5|||
23371388|NCT01586195|65106116|FG000|Overall Study|Started new anti-melanoma therapy|1|||
23371389|NCT01586195|65106116|FG000|Overall Study|Reason not specified|9|||
23371390|NCT01701245|65106117|FG000|Overall Study|Protocol Violation|1|||
23371391|NCT01701245|65106118|FG001|Overall Study|Protocol Violation|3|||
23371392|NCT01701245|65106117|FG000|Overall Study|Did not complete the open label period|11|||
23371393|NCT01701245|65106118|FG001|Overall Study|Did not complete the open label period|12|||
23371394|NCT02897349|65106119|FG000|Overall Study|Lost to Follow-up|2|||
23371395|NCT02897349|65106120|FG001|Overall Study|Lost to Follow-up|2|||
23371396|NCT02897349|65106119|FG000|Overall Study|Adverse Event|3|||
23371397|NCT02897349|65106120|FG001|Overall Study|Adverse Event|3|||
23371398|NCT02897349|65106119|FG000|Overall Study|Other than listed above|0|||
23371399|NCT02897349|65106120|FG001|Overall Study|Other than listed above|1|||
23371400|NCT00472420|65106121|FG000|Induction Treatment Period|Physician Decision|9|||
23371401|NCT00472420|65106121|FG000|Induction Treatment Period|Adverse Event|3|||
23371402|NCT00472420|65106121|FG000|Induction Treatment Period|Non-compliance|1|||
23371403|NCT00472420|65106121|FG000|Induction Treatment Period|Death|3|||
23371404|NCT00472420|65106121|FG000|Follow-up Period|Death|5|||
23371405|NCT00472420|65106121|FG000|Follow-up Period|Physician Decision|9|||
23371406|NCT00472420|65106121|FG000|Follow-up Period|Lost to Follow-up|2|||
23371407|NCT00472420|65106121|FG000|Follow-up Period|Protocol Violation|1|||
23371408|NCT01631214|65106125|FG000|Overall Study|Withdrawal by Subject|276|||
23371409|NCT01631214|65106126|FG001|Overall Study|Withdrawal by Subject|290|||
23371410|NCT01631214|65106125|FG000|Overall Study|Death|113|||
23371411|NCT01631214|65106126|FG001|Overall Study|Death|106|||
23371412|NCT01631214|65106125|FG000|Overall Study|Lost to Follow-up|54|||
23371413|NCT01631214|65106126|FG001|Overall Study|Lost to Follow-up|40|||
23371414|NCT01631214|65106125|FG000|Overall Study|Adverse Event|45|||
23371415|NCT01631214|65106126|FG001|Overall Study|Adverse Event|45|||
23371416|NCT01631214|65106125|FG000|Overall Study|Other|22|||
23371417|NCT01631214|65106126|FG001|Overall Study|Other|19|||
23371418|NCT01631214|65106125|FG000|Overall Study|Noncompliance|16|||
23371419|NCT01631214|65106126|FG001|Overall Study|Noncompliance|15|||
23371420|NCT01631214|65106125|FG000|Overall Study|Requirement for Alternative Therapy|8|||
23371421|NCT01631214|65106126|FG001|Overall Study|Requirement for Alternative Therapy|3|||
23371422|NCT01631214|65106125|FG000|Overall Study|Protocol Deviation|4|||
23371423|NCT01631214|65106126|FG001|Overall Study|Protocol Deviation|3|||
23371424|NCT01631214|65106125|FG000|Overall Study|Ineligibility determined|5|||
23371425|NCT01631214|65106126|FG001|Overall Study|Ineligibility determined|2|||
23371426|NCT01631214|65106125|FG000|Overall Study|Administrative Decision|1|||
23371427|NCT01631214|65106126|FG001|Overall Study|Administrative Decision|0|||
23371428|NCT01225549|65106134|FG000|Period 4 - Washout|Disallowed medication|0|||
23371429|NCT01225549|65106135|FG001|Period 4 - Washout|Disallowed medication|1|||
23371430|NCT01225549|65106136|FG002|Period 4 - Washout|Disallowed medication|0|||
23371431|NCT01225549|65106137|FG003|Period 4 - Washout|Disallowed medication|0|||
23371432|NCT01225549|65106138|FG004|Period 4 - Washout|Disallowed medication|0|||
23371433|NCT01225549|65106139|FG005|Period 4 - Washout|Disallowed medication|0|||
23371434|NCT01225549|65106140|FG006|Period 4 - Washout|Disallowed medication|0|||
23371435|NCT01225549|65106141|FG007|Period 4 - Washout|Disallowed medication|0|||
23371436|NCT01225549|65106142|FG008|Period 4 - Washout|Disallowed medication|0|||
23371437|NCT01225549|65106143|FG009|Period 4 - Washout|Disallowed medication|0|||
23371438|NCT01225549|65106134|FG000|Period 6 - Washout|Disallowed medication|0|||
23371439|NCT01225549|65106135|FG001|Period 6 - Washout|Disallowed medication|0|||
23371440|NCT01225549|65106136|FG002|Period 6 - Washout|Disallowed medication|0|||
23371441|NCT01225549|65106137|FG003|Period 6 - Washout|Disallowed medication|1|||
23371442|NCT01225549|65106138|FG004|Period 6 - Washout|Disallowed medication|0|||
23371443|NCT01225549|65106139|FG005|Period 6 - Washout|Disallowed medication|0|||
23371444|NCT01225549|65106140|FG006|Period 6 - Washout|Disallowed medication|0|||
23371445|NCT01225549|65106141|FG007|Period 6 - Washout|Disallowed medication|0|||
23371446|NCT01225549|65106142|FG008|Period 6 - Washout|Disallowed medication|0|||
23371447|NCT01225549|65106143|FG009|Period 6 - Washout|Disallowed medication|0|||
23371448|NCT00336544|65106144|FG000|Overall Study|Lack of Efficacy|8|||
23371449|NCT00336544|65106145|FG001|Overall Study|Lack of Efficacy|5|||
23371450|NCT00336544|65106144|FG000|Overall Study|Adverse Event|4|||
23371451|NCT00336544|65106145|FG001|Overall Study|Adverse Event|9|||
23371452|NCT00336544|65106144|FG000|Overall Study|Withdrawal by Subject|4|||
23371453|NCT00336544|65106145|FG001|Overall Study|Withdrawal by Subject|3|||
23371454|NCT00336544|65106144|FG000|Overall Study|Other|3|||
23371455|NCT00336544|65106145|FG001|Overall Study|Other|5|||
23371456|NCT02674516|65106149|FG000|Overall Study|Lost to Follow-up|3|||
23371457|NCT02674516|65106150|FG001|Overall Study|Lost to Follow-up|0|||
23371458|NCT02674516|65106149|FG000|Overall Study|Protocol Violation|0|||
23371459|NCT02674516|65106150|FG001|Overall Study|Protocol Violation|4|||
23371460|NCT02674516|65106149|FG000|Overall Study|Knowledge of study hypothesis|1|||
23371461|NCT02674516|65106150|FG001|Overall Study|Knowledge of study hypothesis|0|||
23371462|NCT00001566|65106159|FG000|Overall Study|patients' choice to discontinue protocol|3|||
23371463|NCT00001566|65106159|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
23371464|NCT00001566|65106159|FG000|Overall Study|Death|13|||
23371465|NCT00001566|65106159|FG000|Overall Study|Lost to Follow-up|1|||
23371466|NCT00001566|65106159|FG000|Overall Study|unable to complete initial apheresis|1|||
23371467|NCT02579629|65106161|FG000|Overall Study|Withdrawal by Subject|0|||
23371468|NCT02579629|65106162|FG001|Overall Study|Withdrawal by Subject|1|||
23371469|NCT02579629|65106163|FG002|Overall Study|Withdrawal by Subject|0|||
23371470|NCT02579629|65106161|FG000|Overall Study|Screen Failure|2|||
23371471|NCT02579629|65106162|FG001|Overall Study|Screen Failure|0|||
23371472|NCT02579629|65106163|FG002|Overall Study|Screen Failure|2|||
23371473|NCT00731822|65106166|FG000|Overall Study|Adverse Event|2|||
23371474|NCT00731822|65106167|FG001|Overall Study|Adverse Event|1|||
23371475|NCT00731822|65106166|FG000|Overall Study|Protocol Violation|1|||
23371476|NCT00731822|65106167|FG001|Overall Study|Protocol Violation|0|||
23371477|NCT00731822|65106166|FG000|Overall Study|Lost to Follow-up|1|||
23371478|NCT00731822|65106167|FG001|Overall Study|Lost to Follow-up|0|||
23371479|NCT03627832|65106168|FG000|Overall Study|Withdrawal by Subject|10|||
23371480|NCT03627832|65106169|FG001|Overall Study|Withdrawal by Subject|1|||
23371481|NCT01529606|65106170|FG000|Overall Study|Lost to Follow-up|21|||
23371482|NCT01529606|65106171|FG001|Overall Study|Lost to Follow-up|18|||
23371483|NCT00611806|65106172|FG000|Overall Study|Withdrawal by Subject|8|||
23371484|NCT00611806|65106173|FG001|Overall Study|Withdrawal by Subject|2|||
23371485|NCT00611806|65106172|FG000|Overall Study|Adverse Event|2|||
23371486|NCT00611806|65106173|FG001|Overall Study|Adverse Event|1|||
23371487|NCT00611806|65106172|FG000|Overall Study|Lost to Follow-up|6|||
23371488|NCT00611806|65106173|FG001|Overall Study|Lost to Follow-up|0|||
23371489|NCT00630916|65106174|FG000|Overall Study|Death|110|||
23371490|NCT00630916|65106174|FG000|Overall Study|Explant|8|||
23371491|NCT00630916|65106174|FG000|Overall Study|Lost to Follow-up|5|||
23371492|NCT00630916|65106174|FG000|Overall Study|Withdrawal by Subject|30|||
23371493|NCT00630916|65106174|FG000|Overall Study|Protocol Violation|7|||
23371494|NCT00630916|65106174|FG000|Overall Study|Physician Decision|47|||
23371495|NCT00630916|65106174|FG000|Overall Study|Lack of Efficacy|3|||
23371496|NCT01712178|65106191|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
23371497|NCT01712178|65106192|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
23371498|NCT01712178|65106191|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
23371499|NCT01712178|65106192|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
23371500|NCT01712178|65106191|FG000|Overall Study|Lost to Follow-up|0|||
23371501|NCT01712178|65106192|FG001|Overall Study|Lost to Follow-up|1|||
23371502|NCT01832766|65106202|FG000|Washout|Lost to Follow-up|0|||
23371503|NCT01832766|65106203|FG001|Washout|Lost to Follow-up|1|||
23371504|NCT01443858|65106205|FG000|Overall Study|Withdrawal by Subject|9|||
23371505|NCT01443858|65106206|FG001|Overall Study|Withdrawal by Subject|8|||
23371506|NCT01443858|65106207|FG002|Overall Study|Withdrawal by Subject|5|||
23371507|NCT01443858|65106205|FG000|Overall Study|Lack of Efficacy|1|||
23371508|NCT01443858|65106206|FG001|Overall Study|Lack of Efficacy|0|||
23371509|NCT01443858|65106207|FG002|Overall Study|Lack of Efficacy|0|||
23371510|NCT01443858|65106205|FG000|Overall Study|Lost to Follow-up|5|||
23371511|NCT01443858|65106206|FG001|Overall Study|Lost to Follow-up|5|||
23371512|NCT01443858|65106207|FG002|Overall Study|Lost to Follow-up|2|||
23371513|NCT01004614|65106210|FG000|Washout|Withdrawal by Subject|0|||
23371514|NCT01004614|65106211|FG001|Washout|Withdrawal by Subject|1|||
23371515|NCT01004614|65106212|FG002|Washout|Withdrawal by Subject|0|||
23371516|NCT01004614|65106213|FG003|Washout|Withdrawal by Subject|0|||
23371517|NCT01715831|65106214|FG000|Overall Study|Adverse Event|1|||
23371518|NCT01474486|65106217|FG000|Overall Study|Death|2|||
23371519|NCT01474486|65106217|FG000|Overall Study|Withdrawal by Subject|4|||
23371520|NCT01474486|65106217|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
23371521|NCT02111083|65106229|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
23371522|NCT02111083|65106230|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
23371523|NCT01290718|65106231|FG000|Overall Study|Early termination of the study|4|||
23371524|NCT03167242|65106234|FG000|Overall Study|Patient/Guardian Decision|0|||
23371525|NCT03167242|65106235|FG001|Overall Study|Patient/Guardian Decision|1|||
23371526|NCT03167242|65106236|FG002|Overall Study|Patient/Guardian Decision|2|||
23371527|NCT03167242|65106237|FG003|Overall Study|Patient/Guardian Decision|1|||
23371528|NCT03167242|65106238|FG004|Overall Study|Patient/Guardian Decision|1|||
23371529|NCT03167242|65106239|FG005|Overall Study|Patient/Guardian Decision|1|||
23371530|NCT03167242|65106240|FG006|Overall Study|Patient/Guardian Decision|0|||
23371531|NCT03167242|65106241|FG007|Overall Study|Patient/Guardian Decision|0|||
23371532|NCT03167242|65106242|FG008|Overall Study|Patient/Guardian Decision|0|||
23371533|NCT03167242|65106243|FG009|Overall Study|Patient/Guardian Decision|0|||
23371534|NCT03167242|65106244|FG010|Overall Study|Patient/Guardian Decision|1|||
23371535|NCT03167242|65106245|FG011|Overall Study|Patient/Guardian Decision|0|||
23371536|NCT03167242|65106234|FG000|Overall Study|Lost to Follow-up|0|||
23371537|NCT03167242|65106235|FG001|Overall Study|Lost to Follow-up|0|||
23371538|NCT03167242|65106236|FG002|Overall Study|Lost to Follow-up|1|||
23371539|NCT03167242|65106237|FG003|Overall Study|Lost to Follow-up|0|||
23371540|NCT03167242|65106238|FG004|Overall Study|Lost to Follow-up|0|||
23371541|NCT03167242|65106239|FG005|Overall Study|Lost to Follow-up|1|||
23485915|NCT03345342|65521909|FG003|Open-Label Phase|Adverse Event|0|||
23371542|NCT03167242|65106240|FG006|Overall Study|Lost to Follow-up|2|||
23485916|NCT03345342|65521910|FG004|Open-Label Phase|Adverse Event|0|||
23485917|NCT03345342|65521906|FG000|Open-Label Phase|Death|1|||
23485918|NCT03345342|65521907|FG001|Open-Label Phase|Death|0|||
23371543|NCT03167242|65106241|FG007|Overall Study|Lost to Follow-up|1|||
23371544|NCT03167242|65106242|FG008|Overall Study|Lost to Follow-up|0|||
23371545|NCT03167242|65106243|FG009|Overall Study|Lost to Follow-up|0|||
23371546|NCT03167242|65106244|FG010|Overall Study|Lost to Follow-up|1|||
23371547|NCT03167242|65106245|FG011|Overall Study|Lost to Follow-up|1|||
23371548|NCT03167242|65106234|FG000|Overall Study|Reason not provided|0|||
23663694|NCT01225731|66155366|FG006|Part 1|Protocol Violation|0|||
23371549|NCT03167242|65106235|FG001|Overall Study|Reason not provided|0|||
23371550|NCT03167242|65106236|FG002|Overall Study|Reason not provided|0|||
23371551|NCT03167242|65106237|FG003|Overall Study|Reason not provided|0|||
23371552|NCT03167242|65106238|FG004|Overall Study|Reason not provided|0|||
23371553|NCT03167242|65106239|FG005|Overall Study|Reason not provided|0|||
23371554|NCT03167242|65106240|FG006|Overall Study|Reason not provided|0|||
23371555|NCT03167242|65106241|FG007|Overall Study|Reason not provided|0|||
23371556|NCT03167242|65106242|FG008|Overall Study|Reason not provided|1|||
23371557|NCT03167242|65106243|FG009|Overall Study|Reason not provided|0|||
23371558|NCT03167242|65106244|FG010|Overall Study|Reason not provided|0|||
23371559|NCT03167242|65106245|FG011|Overall Study|Reason not provided|0|||
23371560|NCT02683109|65106246|FG000|Overall Study|Adverse Event|1|||
23371561|NCT02683109|65106247|FG001|Overall Study|Adverse Event|0|||
23371562|NCT01673386|65106250|FG000|Overall Study|Study terminated by sponsor|16|||
23371563|NCT01673386|65106251|FG001|Overall Study|Study terminated by sponsor|22|||
23371564|NCT01673386|65106250|FG000|Overall Study|Adverse Event|5|||
23371565|NCT01673386|65106251|FG001|Overall Study|Adverse Event|2|||
23371566|NCT01673386|65106250|FG000|Overall Study|Progressive disease|4|||
23371567|NCT01673386|65106251|FG001|Overall Study|Progressive disease|1|||
23371568|NCT01673386|65106250|FG000|Overall Study|Withdrawal by Subject|0|||
23371569|NCT01673386|65106251|FG001|Overall Study|Withdrawal by Subject|2|||
23371570|NCT01922934|65106254|FG000|Eligible Patients|Death|0|||
23371571|NCT01922934|65106255|FG001|Eligible Patients|Death|7|||
23371572|NCT01922934|65106254|FG000|Eligible Patients|Physician Decision|17|||
23371573|NCT01922934|65106255|FG001|Eligible Patients|Physician Decision|0|||
23371574|NCT01922934|65106254|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
23371575|NCT01922934|65106255|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
23371576|NCT01922934|65106254|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
23371577|NCT01922934|65106255|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
23371578|NCT01922934|65106254|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
23371579|NCT01922934|65106255|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
23371580|NCT01922934|65106254|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
23371581|NCT01922934|65106255|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
23371582|NCT01145482|65106266|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23371583|NCT01145482|65106267|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23371584|NCT02659943|65106268|FG000|Overall Study|Switched to alternative treatment|1|||
23371585|NCT02659943|65106269|FG001|Overall Study|Switched to alternative treatment|1|||
23371586|NCT02659943|65106270|FG002|Overall Study|Switched to alternative treatment|0|||
23371587|NCT02659943|65106271|FG003|Overall Study|Switched to alternative treatment|2|||
23371588|NCT02659943|65106272|FG004|Overall Study|Switched to alternative treatment|1|||
23371589|NCT02659943|65106273|FG005|Overall Study|Switched to alternative treatment|0|||
23371590|NCT02659943|65106274|FG006|Overall Study|Switched to alternative treatment|1|||
23371591|NCT02659943|65106268|FG000|Overall Study|Disease progression on study|0|||
23485919|NCT03345342|65521908|FG002|Open-Label Phase|Death|0|||
23485920|NCT03345342|65521909|FG003|Open-Label Phase|Death|0|||
23485921|NCT03345342|65521910|FG004|Open-Label Phase|Death|0|||
23485922|NCT03345342|65521906|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
23485923|NCT03345342|65521907|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
23485924|NCT03345342|65521908|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
23485925|NCT03345342|65521909|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
23485926|NCT03345342|65521910|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
23485927|NCT03345342|65521906|FG000|Open-Label Phase|Lack of Efficacy|6|||
23485928|NCT03345342|65521907|FG001|Open-Label Phase|Lack of Efficacy|0|||
23485929|NCT03345342|65521908|FG002|Open-Label Phase|Lack of Efficacy|0|||
23485930|NCT03345342|65521909|FG003|Open-Label Phase|Lack of Efficacy|0|||
23485931|NCT03345342|65521910|FG004|Open-Label Phase|Lack of Efficacy|0|||
23485932|NCT03345342|65521906|FG000|Open-Label Phase|Lost to Follow-up|9|||
23485933|NCT03345342|65521907|FG001|Open-Label Phase|Lost to Follow-up|0|||
23485934|NCT03345342|65521908|FG002|Open-Label Phase|Lost to Follow-up|0|||
23485935|NCT03345342|65521909|FG003|Open-Label Phase|Lost to Follow-up|0|||
23485936|NCT03345342|65521910|FG004|Open-Label Phase|Lost to Follow-up|0|||
23485937|NCT03345342|65521906|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
23485938|NCT03345342|65521907|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485939|NCT03345342|65521908|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485940|NCT03345342|65521909|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485941|NCT03345342|65521910|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485942|NCT03345342|65521906|FG000|Open-Label Phase|Physician Decision|4|||
23485943|NCT03345342|65521907|FG001|Open-Label Phase|Physician Decision|0|||
23485944|NCT03345342|65521908|FG002|Open-Label Phase|Physician Decision|0|||
23485945|NCT03345342|65521909|FG003|Open-Label Phase|Physician Decision|0|||
23485946|NCT03345342|65521910|FG004|Open-Label Phase|Physician Decision|0|||
23485947|NCT03345342|65521906|FG000|Open-Label Phase|Protocol Violation|8|||
23485948|NCT03345342|65521907|FG001|Open-Label Phase|Protocol Violation|0|||
23485949|NCT03345342|65521908|FG002|Open-Label Phase|Protocol Violation|0|||
23485950|NCT03345342|65521909|FG003|Open-Label Phase|Protocol Violation|0|||
23603557|NCT00597376|65937417|FG001|Overall Study|Withdrawal by Subject|3|||
23371592|NCT02659943|65106269|FG001|Overall Study|Disease progression on study|1|||
23371593|NCT02659943|65106270|FG002|Overall Study|Disease progression on study|1|||
23371594|NCT02659943|65106271|FG003|Overall Study|Disease progression on study|1|||
23371595|NCT02659943|65106272|FG004|Overall Study|Disease progression on study|1|||
23371596|NCT02659943|65106273|FG005|Overall Study|Disease progression on study|4|||
23371597|NCT02659943|65106274|FG006|Overall Study|Disease progression on study|0|||
23371598|NCT02659943|65106268|FG000|Overall Study|Patient's condition per principal investigator|0|||
23371599|NCT02659943|65106269|FG001|Overall Study|Patient's condition per principal investigator|0|||
23371600|NCT02659943|65106270|FG002|Overall Study|Patient's condition per principal investigator|0|||
23371601|NCT02659943|65106271|FG003|Overall Study|Patient's condition per principal investigator|0|||
23371602|NCT02659943|65106272|FG004|Overall Study|Patient's condition per principal investigator|0|||
23485951|NCT03345342|65521910|FG004|Open-Label Phase|Protocol Violation|0|||
23485952|NCT03345342|65521906|FG000|Open-Label Phase|Withdrawal by Subject|57|||
23603558|NCT00597376|65937416|FG000|Overall Study|Adverse Event|4|||
23663695|NCT01225731|66155367|FG007|Part 1|Protocol Violation|0|||
23663696|NCT01225731|66155368|FG008|Part 1|Protocol Violation|0|||
23663697|NCT01225731|66155369|FG009|Part 1|Protocol Violation|0|||
23663698|NCT01225731|66155370|FG010|Part 1|Protocol Violation|0|||
23663699|NCT01225731|66155371|FG011|Part 1|Protocol Violation|0|||
23663700|NCT01225731|66155372|FG012|Part 1|Protocol Violation|0|||
23663701|NCT01225731|66155360|FG000|Part 2|Protocol Violation|0|||
23371603|NCT02659943|65106273|FG005|Overall Study|Patient's condition per principal investigator|1|||
23371604|NCT02659943|65106274|FG006|Overall Study|Patient's condition per principal investigator|0|||
23371605|NCT02659943|65106268|FG000|Overall Study|Ineligible|0|||
23371606|NCT02659943|65106269|FG001|Overall Study|Ineligible|0|||
23371607|NCT02659943|65106270|FG002|Overall Study|Ineligible|0|||
23371608|NCT02659943|65106271|FG003|Overall Study|Ineligible|0|||
23371609|NCT02659943|65106272|FG004|Overall Study|Ineligible|0|||
23371610|NCT02659943|65106273|FG005|Overall Study|Ineligible|0|||
23371611|NCT02659943|65106274|FG006|Overall Study|Ineligible|1|||
23371612|NCT02659943|65106268|FG000|Overall Study|No longer meets eligibility|0|||
23371613|NCT02659943|65106269|FG001|Overall Study|No longer meets eligibility|0|||
23371614|NCT02659943|65106270|FG002|Overall Study|No longer meets eligibility|0|||
23371615|NCT02659943|65106271|FG003|Overall Study|No longer meets eligibility|0|||
23371616|NCT02659943|65106272|FG004|Overall Study|No longer meets eligibility|0|||
23371617|NCT02659943|65106273|FG005|Overall Study|No longer meets eligibility|0|||
23371618|NCT02659943|65106274|FG006|Overall Study|No longer meets eligibility|1|||
23371619|NCT02659943|65106268|FG000|Overall Study|No treatment, per protocol|0|||
23371620|NCT02659943|65106269|FG001|Overall Study|No treatment, per protocol|0|||
23371621|NCT02659943|65106270|FG002|Overall Study|No treatment, per protocol|0|||
23371622|NCT02659943|65106271|FG003|Overall Study|No treatment, per protocol|0|||
23371623|NCT02659943|65106272|FG004|Overall Study|No treatment, per protocol|0|||
23371624|NCT02659943|65106273|FG005|Overall Study|No treatment, per protocol|0|||
23371625|NCT02659943|65106274|FG006|Overall Study|No treatment, per protocol|3|||
23371626|NCT03712280|65106275|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
23371627|NCT03712280|65106276|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
23371628|NCT03712280|65106277|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
23371629|NCT03712280|65106278|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
23371630|NCT03712280|65106275|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
23371631|NCT03712280|65106276|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371632|NCT03712280|65106277|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371633|NCT03712280|65106278|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371634|NCT03712280|65106275|FG000|Overall Study|Adverse Event|0|||
23371635|NCT03712280|65106276|FG001|Overall Study|Adverse Event|0|||
23371636|NCT03712280|65106277|FG002|Overall Study|Adverse Event|1|||
23371637|NCT03712280|65106278|FG003|Overall Study|Adverse Event|0|||
23371638|NCT02497469|65106279|FG000|Overall Study|Randomized but not Treated|0|||
23371639|NCT02497469|65106280|FG001|Overall Study|Randomized but not Treated|2|||
23371640|NCT02497469|65106279|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
23371641|NCT02497469|65106280|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
23371642|NCT02497469|65106279|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
23371643|NCT02497469|65106280|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
23371644|NCT02497469|65106279|FG000|Overall Study|Significant Protocol Deviation|4|||
23371645|NCT02497469|65106280|FG001|Overall Study|Significant Protocol Deviation|5|||
23371646|NCT02497469|65106279|FG000|Overall Study|Lost to Follow-up|14|||
23663702|NCT01225731|66155361|FG001|Part 2|Protocol Violation|0|||
23485953|NCT03345342|65521907|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23485954|NCT03345342|65521908|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23485955|NCT03345342|65521909|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23485956|NCT03345342|65521910|FG004|Open-Label Phase|Withdrawal by Subject|0|||
23485957|NCT03345342|65521906|FG000|Open-Label Phase|Other|15|||
23485958|NCT03345342|65521907|FG001|Open-Label Phase|Other|0|||
23485959|NCT03345342|65521908|FG002|Open-Label Phase|Other|0|||
23485960|NCT03345342|65521909|FG003|Open-Label Phase|Other|0|||
23485961|NCT03345342|65521910|FG004|Open-Label Phase|Other|0|||
23485962|NCT03345342|65521906|FG000|Double-Blind Phase|Adverse Event|0|||
23485963|NCT03345342|65521907|FG001|Double-Blind Phase|Adverse Event|1|||
23485964|NCT03345342|65521908|FG002|Double-Blind Phase|Adverse Event|6|||
23485965|NCT03345342|65521909|FG003|Double-Blind Phase|Adverse Event|0|||
23485966|NCT03345342|65521910|FG004|Double-Blind Phase|Adverse Event|0|||
23485967|NCT03345342|65521906|FG000|Double-Blind Phase|Death|0|||
23485968|NCT03345342|65521907|FG001|Double-Blind Phase|Death|2|||
23485969|NCT03345342|65521908|FG002|Double-Blind Phase|Death|1|||
23485970|NCT03345342|65521909|FG003|Double-Blind Phase|Death|0|||
23485971|NCT03345342|65521910|FG004|Double-Blind Phase|Death|0|||
23485972|NCT03345342|65521906|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485973|NCT03345342|65521907|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485974|NCT03345342|65521908|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
23485975|NCT03345342|65521909|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485976|NCT03345342|65521910|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485977|NCT03345342|65521906|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23485978|NCT03345342|65521907|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23485979|NCT03345342|65521908|FG002|Double-Blind Phase|Lost to Follow-up|7|||
23485980|NCT03345342|65521909|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23485981|NCT03345342|65521910|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23485982|NCT03345342|65521906|FG000|Double-Blind Phase|Physician Decision|0|||
23485983|NCT03345342|65521907|FG001|Double-Blind Phase|Physician Decision|1|||
23485984|NCT03345342|65521908|FG002|Double-Blind Phase|Physician Decision|4|||
23485985|NCT03345342|65521909|FG003|Double-Blind Phase|Physician Decision|0|||
23485986|NCT03345342|65521910|FG004|Double-Blind Phase|Physician Decision|0|||
23485987|NCT03345342|65521906|FG000|Double-Blind Phase|Protocol Violation|0|||
23485988|NCT03345342|65521907|FG001|Double-Blind Phase|Protocol Violation|0|||
23485989|NCT03345342|65521908|FG002|Double-Blind Phase|Protocol Violation|1|||
23485990|NCT03345342|65521909|FG003|Double-Blind Phase|Protocol Violation|0|||
23485991|NCT03345342|65521910|FG004|Double-Blind Phase|Protocol Violation|0|||
23485992|NCT03345342|65521906|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23485993|NCT03345342|65521907|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
23485994|NCT03345342|65521908|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
23485995|NCT03345342|65521909|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23485996|NCT03345342|65521910|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23485997|NCT03345342|65521906|FG000|Double-Blind Phase|Other|0|||
23485998|NCT03345342|65521907|FG001|Double-Blind Phase|Other|1|||
23485999|NCT03345342|65521908|FG002|Double-Blind Phase|Other|3|||
23486000|NCT03345342|65521909|FG003|Double-Blind Phase|Other|0|||
23486001|NCT03345342|65521910|FG004|Double-Blind Phase|Other|0|||
23486002|NCT03345342|65521906|FG000|Follow-Up Phase|Adverse Event|0|||
23486003|NCT03345342|65521907|FG001|Follow-Up Phase|Adverse Event|0|||
23486004|NCT03345342|65521908|FG002|Follow-Up Phase|Adverse Event|0|||
23486005|NCT03345342|65521909|FG003|Follow-Up Phase|Adverse Event|0|||
23486006|NCT03345342|65521910|FG004|Follow-Up Phase|Adverse Event|4|||
23486007|NCT03345342|65521906|FG000|Follow-Up Phase|Lost to Follow-up|0|||
23486008|NCT03345342|65521907|FG001|Follow-Up Phase|Lost to Follow-up|0|||
23486009|NCT03345342|65521908|FG002|Follow-Up Phase|Lost to Follow-up|0|||
23486010|NCT03345342|65521909|FG003|Follow-Up Phase|Lost to Follow-up|0|||
23486011|NCT03345342|65521910|FG004|Follow-Up Phase|Lost to Follow-up|6|||
23486012|NCT03345342|65521906|FG000|Follow-Up Phase|Physician Decision|0|||
23486013|NCT03345342|65521907|FG001|Follow-Up Phase|Physician Decision|0|||
23486014|NCT03345342|65521908|FG002|Follow-Up Phase|Physician Decision|0|||
23486015|NCT03345342|65521909|FG003|Follow-Up Phase|Physician Decision|0|||
23486016|NCT03345342|65521910|FG004|Follow-Up Phase|Physician Decision|5|||
23486017|NCT03345342|65521906|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23486018|NCT03345342|65521907|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23486019|NCT03345342|65521908|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
23486020|NCT03345342|65521909|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
23486021|NCT03345342|65521910|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
23486022|NCT03345342|65521906|FG000|Follow-Up Phase|Other|0|||
23486023|NCT03345342|65521907|FG001|Follow-Up Phase|Other|0|||
23486024|NCT03345342|65521908|FG002|Follow-Up Phase|Other|0|||
23486025|NCT03345342|65521909|FG003|Follow-Up Phase|Other|3|||
23486026|NCT03345342|65521910|FG004|Follow-Up Phase|Other|1|||
23486027|NCT03455764|65521915|FG000|Overall Study|Adverse Event|1|||
23486028|NCT03455764|65521916|FG001|Overall Study|Adverse Event|0|||
23486029|NCT03455764|65521917|FG002|Overall Study|Adverse Event|0|||
23486030|NCT03455764|65521918|FG003|Overall Study|Adverse Event|0|||
23486031|NCT03455764|65521919|FG004|Overall Study|Adverse Event|0|||
23486032|NCT03455764|65521915|FG000|Overall Study|Disease Progression|4|||
23486033|NCT03455764|65521916|FG001|Overall Study|Disease Progression|0|||
23486034|NCT03455764|65521917|FG002|Overall Study|Disease Progression|0|||
23486035|NCT03455764|65521918|FG003|Overall Study|Disease Progression|0|||
23486036|NCT03455764|65521919|FG004|Overall Study|Disease Progression|0|||
23486037|NCT03455764|65521915|FG000|Overall Study|On Treatment|1|||
23486038|NCT03455764|65521916|FG001|Overall Study|On Treatment|0|||
23486039|NCT03455764|65521917|FG002|Overall Study|On Treatment|0|||
23486040|NCT03455764|65521918|FG003|Overall Study|On Treatment|0|||
23486041|NCT03455764|65521919|FG004|Overall Study|On Treatment|0|||
23486042|NCT00543855|65521928|FG000|Overall Study|Adverse Event|3|||
23486043|NCT00543855|65521929|FG001|Overall Study|Adverse Event|1|||
23486044|NCT00543855|65521930|FG002|Overall Study|Adverse Event|3|||
23486045|NCT00543855|65521931|FG003|Overall Study|Adverse Event|4|||
23486046|NCT00543855|65521928|FG000|Overall Study|Lost to Follow-up|0|||
23663703|NCT01225731|66155362|FG002|Part 2|Protocol Violation|0|||
23663704|NCT01225731|66155363|FG003|Part 2|Protocol Violation|0|||
23663705|NCT01225731|66155364|FG004|Part 2|Protocol Violation|0|||
23663706|NCT01225731|66155365|FG005|Part 2|Protocol Violation|1|||
23663707|NCT01225731|66155366|FG006|Part 2|Protocol Violation|0|||
23663708|NCT01225731|66155367|FG007|Part 2|Protocol Violation|0|||
23663709|NCT01225731|66155368|FG008|Part 2|Protocol Violation|1|||
23486047|NCT00543855|65521929|FG001|Overall Study|Lost to Follow-up|0|||
23486048|NCT00543855|65521930|FG002|Overall Study|Lost to Follow-up|1|||
23486049|NCT00543855|65521931|FG003|Overall Study|Lost to Follow-up|0|||
23486050|NCT00543855|65521928|FG000|Overall Study|Withdrawal by Subject|0|||
23486051|NCT00543855|65521929|FG001|Overall Study|Withdrawal by Subject|1|||
23486052|NCT00543855|65521930|FG002|Overall Study|Withdrawal by Subject|2|||
23486053|NCT00543855|65521931|FG003|Overall Study|Withdrawal by Subject|0|||
23486054|NCT00543855|65521928|FG000|Overall Study|Protocol Violation|1|||
23663710|NCT01225731|66155369|FG009|Part 2|Protocol Violation|0|||
23663711|NCT01225731|66155370|FG010|Part 2|Protocol Violation|0|||
23603559|NCT00597376|65937417|FG001|Overall Study|Adverse Event|1|||
23486055|NCT00543855|65521929|FG001|Overall Study|Protocol Violation|0|||
23603560|NCT00326183|65937418|FG000|Overall Study|Lost to Follow-up|104|||
23603561|NCT00326183|65937419|FG001|Overall Study|Lost to Follow-up|56|||
23603562|NCT00326183|65937418|FG000|Overall Study|Protocol Violation|6|||
23603563|NCT00326183|65937419|FG001|Overall Study|Protocol Violation|3|||
23486056|NCT00543855|65521930|FG002|Overall Study|Protocol Violation|0|||
23603564|NCT00326183|65937418|FG000|Overall Study|Withdrawal by Subject|35|||
23486057|NCT00543855|65521931|FG003|Overall Study|Protocol Violation|0|||
23486058|NCT02716896|65521932|FG000|Overall Study|Physician Decision|0|||
23486059|NCT02716896|65521933|FG001|Overall Study|Physician Decision|1|||
23486060|NCT00730028|65521934|FG000|Overall Study|Adverse Event|23|||
23486061|NCT00730028|65521935|FG001|Overall Study|Adverse Event|26|||
23486062|NCT00730028|65521936|FG002|Overall Study|Adverse Event|16|||
23486063|NCT00730028|65521937|FG003|Overall Study|Adverse Event|20|||
23486064|NCT00730028|65521938|FG004|Overall Study|Adverse Event|43|||
23486065|NCT00730028|65521934|FG000|Overall Study|Lost to Follow-up|13|||
23486066|NCT00730028|65521935|FG001|Overall Study|Lost to Follow-up|26|||
23486067|NCT00730028|65521936|FG002|Overall Study|Lost to Follow-up|22|||
23663712|NCT01225731|66155371|FG011|Part 2|Protocol Violation|0|||
23663713|NCT01225731|66155372|FG012|Part 2|Protocol Violation|0|||
23663714|NCT01225731|66155360|FG000|Part 2|Adverse Event|0|||
23663715|NCT01225731|66155361|FG001|Part 2|Adverse Event|0|||
23663716|NCT01225731|66155362|FG002|Part 2|Adverse Event|0|||
23663717|NCT01225731|66155363|FG003|Part 2|Adverse Event|0|||
23663718|NCT01225731|66155364|FG004|Part 2|Adverse Event|0|||
23663719|NCT01225731|66155365|FG005|Part 2|Adverse Event|0|||
23663720|NCT01225731|66155366|FG006|Part 2|Adverse Event|4|||
23663721|NCT01225731|66155367|FG007|Part 2|Adverse Event|4|||
23663722|NCT01225731|66155368|FG008|Part 2|Adverse Event|2|||
23663723|NCT01225731|66155369|FG009|Part 2|Adverse Event|0|||
23663724|NCT01225731|66155370|FG010|Part 2|Adverse Event|0|||
23663725|NCT01225731|66155371|FG011|Part 2|Adverse Event|0|||
23603565|NCT00326183|65937419|FG001|Overall Study|Withdrawal by Subject|7|||
23603566|NCT00326183|65937418|FG000|Overall Study|Subject Moved|7|||
23603567|NCT00326183|65937419|FG001|Overall Study|Subject Moved|4|||
23603568|NCT00326183|65937418|FG000|Overall Study|Other|47|||
23603569|NCT00326183|65937419|FG001|Overall Study|Other|13|||
23603570|NCT00326183|65937418|FG000|Overall Study|Adverse Event|1|||
23603571|NCT00326183|65937419|FG001|Overall Study|Adverse Event|0|||
23603572|NCT03392194|65937420|FG000|Overall Study|Withdrawal by Subject|1|||
23603573|NCT03392194|65937421|FG001|Overall Study|Withdrawal by Subject|2|||
23603574|NCT03392194|65937420|FG000|Overall Study|Conflicts with personal schedule|1|||
23603575|NCT03392194|65937421|FG001|Overall Study|Conflicts with personal schedule|0|||
23603576|NCT02892019|65937422|FG000|Overall Study|randomized but not treated|0|||
23663726|NCT01225731|66155372|FG012|Part 2|Adverse Event|0|||
23371647|NCT02497469|65106280|FG001|Overall Study|Lost to Follow-up|4|||
23663727|NCT01225731|66155360|FG000|Part 2|Lack of Efficacy|0|||
23663728|NCT01225731|66155361|FG001|Part 2|Lack of Efficacy|0|||
23371648|NCT02497469|65106279|FG000|Overall Study|Voluntary Withdrawal|39|||
23371649|NCT02497469|65106280|FG001|Overall Study|Voluntary Withdrawal|41|||
23371650|NCT02497469|65106279|FG000|Overall Study|Pregnancy|1|||
23371651|NCT02497469|65106280|FG001|Overall Study|Pregnancy|1|||
23486068|NCT00730028|65521937|FG003|Overall Study|Lost to Follow-up|26|||
23486069|NCT00730028|65521938|FG004|Overall Study|Lost to Follow-up|25|||
23486070|NCT00730028|65521934|FG000|Overall Study|Protocol Violation|6|||
23603577|NCT02892019|65937423|FG001|Overall Study|randomized but not treated|1|||
23663729|NCT01225731|66155362|FG002|Part 2|Lack of Efficacy|0|||
23663730|NCT01225731|66155363|FG003|Part 2|Lack of Efficacy|0|||
23663731|NCT01225731|66155364|FG004|Part 2|Lack of Efficacy|0|||
23663732|NCT01225731|66155365|FG005|Part 2|Lack of Efficacy|1|||
23663733|NCT01225731|66155366|FG006|Part 2|Lack of Efficacy|0|||
23371652|NCT02497469|65106279|FG000|Overall Study|Lack of Efficacy|86|||
23371653|NCT02497469|65106280|FG001|Overall Study|Lack of Efficacy|40|||
23371654|NCT02497469|65106279|FG000|Overall Study|Reason not Specified|6|||
23371655|NCT02497469|65106280|FG001|Overall Study|Reason not Specified|6|||
23371656|NCT03641508|65106285|FG000|First Injection|Lost to Follow-up|2|||
23371657|NCT03641508|65106286|FG001|First Injection|Lost to Follow-up|0|||
23371658|NCT01576575|65106291|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
23371659|NCT01576575|65106291|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
23371660|NCT01576575|65106291|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
23371661|NCT01930539|65106292|FG000|Overall Study|Withdrawal by Subject|2|||
23371662|NCT01930539|65106293|FG001|Overall Study|Withdrawal by Subject|2|||
23371663|NCT03363906|65106294|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
23371664|NCT03363906|65106295|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
23371665|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
23371666|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
23371667|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
23371668|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
23371669|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
23371670|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
23371671|NCT02592824|65106296|FG000|Overall Study|Protocol Violation|5|||
23371672|NCT02592824|65106297|FG001|Overall Study|Protocol Violation|3|||
23371673|NCT02592824|65106296|FG000|Overall Study|Lost to Follow-up|2|||
23371674|NCT02592824|65106297|FG001|Overall Study|Lost to Follow-up|1|||
23371675|NCT02701634|65106298|FG000|Overall Study|Adverse Event|2|||
23371676|NCT02701634|65106299|FG001|Overall Study|Adverse Event|3|||
23371677|NCT02701634|65106298|FG000|Overall Study|Death|1|||
23371678|NCT02701634|65106299|FG001|Overall Study|Death|0|||
23371679|NCT02701634|65106298|FG000|Overall Study|Investigator's Discretion|7|||
23371680|NCT02701634|65106299|FG001|Overall Study|Investigator's Discretion|4|||
23371681|NCT02701634|65106298|FG000|Overall Study|Study terminated by Sponsor|15|||
23371682|NCT02701634|65106299|FG001|Overall Study|Study terminated by Sponsor|17|||
23371683|NCT02701634|65106298|FG000|Overall Study|Withdrew Consent|6|||
23371684|NCT02701634|65106299|FG001|Overall Study|Withdrew Consent|7|||
23371685|NCT02701634|65106298|FG000|Overall Study|Randomized but not treated|1|||
23371686|NCT02701634|65106299|FG001|Overall Study|Randomized but not treated|0|||
23371687|NCT02737358|65106300|FG000|Overall Study|Withdrawal by Subject|7|||
23371688|NCT02737358|65106301|FG001|Overall Study|Withdrawal by Subject|12|||
23663734|NCT01225731|66155367|FG007|Part 2|Lack of Efficacy|12|||
23663735|NCT01225731|66155368|FG008|Part 2|Lack of Efficacy|3|||
23663736|NCT01225731|66155369|FG009|Part 2|Lack of Efficacy|0|||
23663737|NCT01225731|66155370|FG010|Part 2|Lack of Efficacy|0|||
23371689|NCT02737358|65106300|FG000|Overall Study|Lost to Follow-up|2|||
23371690|NCT02737358|65106301|FG001|Overall Study|Lost to Follow-up|3|||
23371691|NCT00703534|65106302|FG000|Overall Study|Adverse Event|14|||
23371692|NCT00703534|65106303|FG001|Overall Study|Adverse Event|3|||
23371693|NCT00703534|65106302|FG000|Overall Study|Withdrawal by Subject|8|||
23371694|NCT00703534|65106303|FG001|Overall Study|Withdrawal by Subject|7|||
23371695|NCT00703534|65106302|FG000|Overall Study|Incorrect Enrollment|6|||
23371696|NCT00703534|65106303|FG001|Overall Study|Incorrect Enrollment|6|||
23371697|NCT00703534|65106302|FG000|Overall Study|Lost to Follow-up|1|||
23371698|NCT00703534|65106303|FG001|Overall Study|Lost to Follow-up|4|||
23371699|NCT00703534|65106302|FG000|Overall Study|Severe Non Compliance|1|||
23371700|NCT00703534|65106303|FG001|Overall Study|Severe Non Compliance|5|||
23371701|NCT02127658|65106312|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
23371702|NCT02127658|65106313|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
23371703|NCT02127658|65106312|FG000|Overall Study|Withdrawal by Subject|0|||
23371704|NCT02127658|65106313|FG001|Overall Study|Withdrawal by Subject|2|||
23371705|NCT02127658|65106312|FG000|Overall Study|Physician Decision|0|||
23371706|NCT02127658|65106313|FG001|Overall Study|Physician Decision|1|||
23371707|NCT01033136|65106314|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
23371708|NCT01033136|65106315|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
23371709|NCT04239924|65106316|FG000|Overall Study|Lost to Follow-up|2|||
23663738|NCT01225731|66155371|FG011|Part 2|Lack of Efficacy|0|||
23371710|NCT00706004|65106320|FG000|Overall Study|Did not meet eligibility criteria|2|||
23371711|NCT01255163|65106321|FG000|Overall Study|Withdrawal by Subject|1|||
23371712|NCT01255163|65106322|FG001|Overall Study|Withdrawal by Subject|0|||
23486071|NCT00730028|65521935|FG001|Overall Study|Protocol Violation|1|||
23486072|NCT00730028|65521936|FG002|Overall Study|Protocol Violation|1|||
23371713|NCT01255163|65106321|FG000|Overall Study|Lost to Follow-up|2|||
23371714|NCT01255163|65106322|FG001|Overall Study|Lost to Follow-up|0|||
23371715|NCT01255163|65106321|FG000|Overall Study|Adverse Event|0|||
23371716|NCT01255163|65106322|FG001|Overall Study|Adverse Event|2|||
23371717|NCT01255163|65106321|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
23371718|NCT01255163|65106322|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
23486073|NCT00730028|65521937|FG003|Overall Study|Protocol Violation|2|||
23663739|NCT01225731|66155372|FG012|Part 2|Lack of Efficacy|0|||
23663740|NCT01225731|66155360|FG000|Part 2|Pregnancy|0|||
23486074|NCT00730028|65521938|FG004|Overall Study|Protocol Violation|0|||
23486075|NCT00730028|65521934|FG000|Overall Study|Withdrawal by Subject|9|||
23486076|NCT00730028|65521935|FG001|Overall Study|Withdrawal by Subject|5|||
23486077|NCT00730028|65521936|FG002|Overall Study|Withdrawal by Subject|4|||
23486078|NCT00730028|65521937|FG003|Overall Study|Withdrawal by Subject|5|||
23486079|NCT00730028|65521938|FG004|Overall Study|Withdrawal by Subject|9|||
23486080|NCT00730028|65521934|FG000|Overall Study|Physician Decision|3|||
23486081|NCT00730028|65521935|FG001|Overall Study|Physician Decision|3|||
23486082|NCT00730028|65521936|FG002|Overall Study|Physician Decision|2|||
23486083|NCT00730028|65521937|FG003|Overall Study|Physician Decision|3|||
23486084|NCT00730028|65521938|FG004|Overall Study|Physician Decision|2|||
23486085|NCT00730028|65521934|FG000|Overall Study|Treatment Failure|5|||
23486086|NCT00730028|65521935|FG001|Overall Study|Treatment Failure|5|||
23486087|NCT00730028|65521936|FG002|Overall Study|Treatment Failure|0|||
23486088|NCT00730028|65521937|FG003|Overall Study|Treatment Failure|0|||
23486089|NCT00730028|65521938|FG004|Overall Study|Treatment Failure|1|||
23486090|NCT00730028|65521934|FG000|Overall Study|Randomization Error|1|||
23486091|NCT00730028|65521935|FG001|Overall Study|Randomization Error|0|||
23663741|NCT01225731|66155361|FG001|Part 2|Pregnancy|0|||
23807620|NCT03347422|66672826|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
23807621|NCT03347422|66672825|FG000|Part B (149 Weeks)|Adverse Event|0|||
23807622|NCT03347422|66672826|FG001|Part B (149 Weeks)|Adverse Event|1|||
23486092|NCT00730028|65521936|FG002|Overall Study|Randomization Error|0|||
23486093|NCT00730028|65521937|FG003|Overall Study|Randomization Error|0|||
23663742|NCT01225731|66155362|FG002|Part 2|Pregnancy|0|||
23807623|NCT03347422|66672825|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
23807624|NCT03347422|66672826|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
23807625|NCT03347422|66672825|FG000|Part B (149 Weeks)|Other|1|||
23807626|NCT03347422|66672826|FG001|Part B (149 Weeks)|Other|0|||
23807627|NCT00325195|66672827|FG000|Randomized|Not dosed|5|||
23807628|NCT00325195|66672828|FG001|Randomized|Not dosed|5|||
23807629|NCT00325195|66672829|FG002|Randomized|Not dosed|3|||
23807630|NCT00325195|66672827|FG000|Received Intervention: ITT Population|Adverse Event|15|||
23807631|NCT00325195|66672828|FG001|Received Intervention: ITT Population|Adverse Event|17|||
23807632|NCT00325195|66672829|FG002|Received Intervention: ITT Population|Adverse Event|1|||
23807633|NCT00325195|66672827|FG000|Received Intervention: ITT Population|Death|3|||
23807634|NCT00325195|66672828|FG001|Received Intervention: ITT Population|Death|1|||
23807635|NCT00325195|66672829|FG002|Received Intervention: ITT Population|Death|0|||
23807636|NCT00325195|66672827|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
23807637|NCT00325195|66672828|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
23807638|NCT00325195|66672829|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
23807639|NCT00325195|66672827|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
23807640|NCT00325195|66672828|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
23807641|NCT00325195|66672829|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
23807642|NCT00325195|66672827|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
23371719|NCT01162343|65106323|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
23371720|NCT01162343|65106323|FG000|Overall Study|Refused psychiatrist assessment|12|||
23371721|NCT00427934|65106324|FG000|Overall Study|Adverse Event|1|||
23371722|NCT00427934|65106325|FG001|Overall Study|Adverse Event|0|||
23371723|NCT00427934|65106326|FG002|Overall Study|Adverse Event|5|||
23371724|NCT00427934|65106327|FG003|Overall Study|Adverse Event|4|||
23371725|NCT00427934|65106324|FG000|Overall Study|Lack of Efficacy|0|||
23371726|NCT00427934|65106325|FG001|Overall Study|Lack of Efficacy|0|||
23371727|NCT00427934|65106326|FG002|Overall Study|Lack of Efficacy|5|||
23371728|NCT00427934|65106327|FG003|Overall Study|Lack of Efficacy|2|||
23371729|NCT00427934|65106324|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
23371730|NCT00427934|65106325|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
23371731|NCT00427934|65106326|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
23371732|NCT00427934|65106327|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
23371733|NCT00427934|65106324|FG000|Overall Study|Other|0|||
23371734|NCT00427934|65106325|FG001|Overall Study|Other|0|||
23371735|NCT00427934|65106326|FG002|Overall Study|Other|11|||
23371736|NCT00427934|65106327|FG003|Overall Study|Other|5|||
23371737|NCT00427934|65106324|FG000|Overall Study|Withdrawal by Subject|0|||
23807643|NCT00325195|66672828|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
23807644|NCT00325195|66672829|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
23486094|NCT00730028|65521938|FG004|Overall Study|Randomization Error|2|||
23486095|NCT03116347|65521939|FG000|Overall Study|Withdrawal by Subject|1|||
23486096|NCT03116347|65521940|FG001|Overall Study|Withdrawal by Subject|2|||
23486097|NCT00542451|65521941|FG000|Overall Study|Adverse Event|31|||
23486098|NCT00542451|65521941|FG000|Overall Study|Withdrawal by Subject|30|||
23486099|NCT00542451|65521941|FG000|Overall Study|Physician Decision|4|||
23486100|NCT00542451|65521941|FG000|Overall Study|Recurrent disease|1|||
23486101|NCT00542451|65521941|FG000|Overall Study|unknown reason|1|||
23486102|NCT00542451|65521941|FG000|Overall Study|Death|2|||
23486103|NCT00542451|65521941|FG000|Overall Study|Lost to Follow-up|10|||
23486104|NCT00568685|65521942|FG000|Overall Study|Adverse Event|2|||
23486105|NCT00568685|65521943|FG001|Overall Study|Adverse Event|3|||
23486106|NCT00568685|65521944|FG002|Overall Study|Adverse Event|3|||
23486107|NCT00568685|65521942|FG000|Overall Study|Withdrawal by Subject|7|||
23486108|NCT00568685|65521943|FG001|Overall Study|Withdrawal by Subject|2|||
23486109|NCT00568685|65521944|FG002|Overall Study|Withdrawal by Subject|2|||
23486110|NCT00568685|65521942|FG000|Overall Study|Protocol Violation|1|||
23486111|NCT00568685|65521943|FG001|Overall Study|Protocol Violation|0|||
23486112|NCT00568685|65521944|FG002|Overall Study|Protocol Violation|0|||
23486113|NCT03523000|65521945|FG000|Overall Study|Withdrawal by Subject|3|||
23486114|NCT03523000|65521946|FG001|Overall Study|Withdrawal by Subject|0|||
23486115|NCT03523000|65521945|FG000|Overall Study|Unsuccessful trial|2|||
23371738|NCT00427934|65106325|FG001|Overall Study|Withdrawal by Subject|0|||
23371739|NCT00427934|65106326|FG002|Overall Study|Withdrawal by Subject|1|||
23371740|NCT00427934|65106327|FG003|Overall Study|Withdrawal by Subject|3|||
23486116|NCT03523000|65521946|FG001|Overall Study|Unsuccessful trial|0|||
23371741|NCT05379920|65106328|FG000|Overall Study|Lost to Follow-up|0|||
23371742|NCT05379920|65106329|FG001|Overall Study|Lost to Follow-up|5|||
23371743|NCT05379920|65106330|FG002|Overall Study|Lost to Follow-up|0|||
23371744|NCT05379920|65106331|FG003|Overall Study|Lost to Follow-up|0|||
23371745|NCT01114724|65106333|FG000|Overall Study|Death|8|||
23371746|NCT01114724|65106333|FG000|Overall Study|Lost to Follow-up|1|||
23371747|NCT01114724|65106333|FG000|Overall Study|Withdrawal by Subject|1|||
23371748|NCT03292016|65106334|FG000|Second Washout|Adverse Event|0|||
23371749|NCT03292016|65106335|FG001|Second Washout|Adverse Event|1|||
23371750|NCT03292016|65106336|FG002|Second Washout|Adverse Event|0|||
23371751|NCT03292016|65106337|FG003|Second Washout|Adverse Event|0|||
23371752|NCT03292016|65106338|FG004|Second Washout|Adverse Event|0|||
23371753|NCT03292016|65106339|FG005|Second Washout|Adverse Event|0|||
23371754|NCT01299909|65106340|FG000|Overall Study|Lost to Follow-up|22|||
23371755|NCT01299909|65106341|FG001|Overall Study|Lost to Follow-up|18|||
23371756|NCT01299909|65106342|FG002|Overall Study|Lost to Follow-up|17|||
23371757|NCT00744939|65106343|FG000|Overall Study|Withdrawal by Subject|9|||
23371758|NCT00744939|65106343|FG000|Overall Study|Protocol Violation|13|||
23371759|NCT00744939|65106343|FG000|Overall Study|Death|24|||
23371760|NCT00744939|65106343|FG000|Overall Study|distance|4|||
23371761|NCT00744939|65106343|FG000|Overall Study|Lost to Follow-up|12|||
23371762|NCT00744939|65106343|FG000|Overall Study|Medical history exclusionary|1|||
23371763|NCT00744939|65106343|FG000|Overall Study|Did not receive Magnevist|7|||
23371764|NCT00744939|65106343|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
23371765|NCT00744939|65106343|FG000|Overall Study|coma|1|||
23371766|NCT00744939|65106343|FG000|Overall Study|incorrect race|1|||
23371767|NCT02466399|65106344|FG000|Overall Study|Adverse Event|1|||
23371768|NCT02466399|65106345|FG001|Overall Study|Adverse Event|0|||
23486117|NCT03481660|65521948|FG000|Overall Study|Adverse Event|5|||
23486118|NCT03481660|65521949|FG001|Overall Study|Adverse Event|4|||
23486119|NCT03481660|65521948|FG000|Overall Study|Death|13|||
23486120|NCT03481660|65521949|FG001|Overall Study|Death|9|||
23486121|NCT03481660|65521948|FG000|Overall Study|Lost to Follow-up|2|||
23486122|NCT03481660|65521949|FG001|Overall Study|Lost to Follow-up|2|||
23486123|NCT03481660|65521948|FG000|Overall Study|Physician Decision|2|||
23486124|NCT03481660|65521949|FG001|Overall Study|Physician Decision|3|||
23486125|NCT03481660|65521948|FG000|Overall Study|Withdrawal by Subject|14|||
23486126|NCT03481660|65521949|FG001|Overall Study|Withdrawal by Subject|7|||
23486127|NCT00107952|65524197|FG000|Overall Study|Death|75|||
23486128|NCT00107952|65524198|FG001|Overall Study|Death|61|||
23486129|NCT00107952|65524197|FG000|Overall Study|Lost to Follow-up|0|||
23486130|NCT00107952|65524198|FG001|Overall Study|Lost to Follow-up|3|||
23486131|NCT00107952|65524197|FG000|Overall Study|Withdrawal by Subject|9|||
23486132|NCT00107952|65524198|FG001|Overall Study|Withdrawal by Subject|6|||
23486133|NCT00107952|65524197|FG000|Overall Study|Other|2|||
23486134|NCT00107952|65524198|FG001|Overall Study|Other|5|||
23486135|NCT00107952|65524197|FG000|Overall Study|Never received study treatment|9|||
23486136|NCT00107952|65524198|FG001|Overall Study|Never received study treatment|6|||
23486137|NCT02038452|65524205|FG000|Overall Study|Withdrawal by Subject|7|||
23486138|NCT02038452|65524206|FG001|Overall Study|Withdrawal by Subject|9|||
23486139|NCT02038452|65524205|FG000|Overall Study|Lost to Follow-up|31|||
23486140|NCT02038452|65524206|FG001|Overall Study|Lost to Follow-up|28|||
23486141|NCT01314911|65524209|FG000|Overall Study|Lost to Follow-up|3|||
23486142|NCT01314911|65524210|FG001|Overall Study|Lost to Follow-up|2|||
23486143|NCT01314911|65524209|FG000|Overall Study|Withdrawal by Subject|1|||
23486144|NCT01314911|65524210|FG001|Overall Study|Withdrawal by Subject|3|||
23486145|NCT01314911|65524209|FG000|Overall Study|Received Non-randomized Study Drug|0|||
23486146|NCT01314911|65524210|FG001|Overall Study|Received Non-randomized Study Drug|1|||
23486147|NCT01314911|65524209|FG000|Overall Study|Never Started Treatment|1|||
23486148|NCT01314911|65524210|FG001|Overall Study|Never Started Treatment|0|||
23486149|NCT02567552|65524212|FG000|Overall Study|Adverse Event|0|||
23486150|NCT02567552|65524213|FG001|Overall Study|Adverse Event|1|||
23486151|NCT01285960|65524214|FG000|Overall Study|Withdrawal by Subject|2|||
23486152|NCT01285960|65524214|FG000|Overall Study|Lost to Follow-up|2|||
23371769|NCT02466399|65106344|FG000|Overall Study|Early exit due to family emergency|1|||
23371770|NCT02466399|65106345|FG001|Overall Study|Early exit due to family emergency|0|||
23371771|NCT02858401|65106352|FG000|Overall Study|Withdrew Consent|0|||
23371772|NCT02858401|65106353|FG001|Overall Study|Withdrew Consent|0|||
23371773|NCT02858401|65106354|FG002|Overall Study|Withdrew Consent|0|||
23371774|NCT02858401|65106355|FG003|Overall Study|Withdrew Consent|0|||
23371775|NCT02858401|65106356|FG004|Overall Study|Withdrew Consent|0|||
23371776|NCT02858401|65106357|FG005|Overall Study|Withdrew Consent|1|||
23371777|NCT02858401|65106358|FG006|Overall Study|Withdrew Consent|0|||
23371778|NCT02858401|65106352|FG000|Overall Study|Lost to Follow-up|0|||
23486153|NCT01285960|65524214|FG000|Overall Study|2 subjects received less 10 sonications|2|||
23486154|NCT01933789|65524224|FG000|Overall Study|Death|0|||
23486155|NCT01933789|65524225|FG001|Overall Study|Death|0|||
23486156|NCT01933789|65524226|FG002|Overall Study|Death|0|||
23486157|NCT01933789|65524227|FG003|Overall Study|Death|0|||
23486158|NCT01933789|65524228|FG004|Overall Study|Death|21|||
23486159|NCT01933789|65524229|FG005|Overall Study|Death|32|||
23486160|NCT01933789|65524230|FG006|Overall Study|Death|0|||
23663743|NCT01225731|66155363|FG003|Part 2|Pregnancy|0|||
23371779|NCT02858401|65106353|FG001|Overall Study|Lost to Follow-up|1|||
23371780|NCT02858401|65106354|FG002|Overall Study|Lost to Follow-up|0|||
23371781|NCT02858401|65106355|FG003|Overall Study|Lost to Follow-up|0|||
23371782|NCT02858401|65106356|FG004|Overall Study|Lost to Follow-up|0|||
23371783|NCT02858401|65106357|FG005|Overall Study|Lost to Follow-up|0|||
23371784|NCT02858401|65106358|FG006|Overall Study|Lost to Follow-up|0|||
23486161|NCT01933789|65524231|FG007|Overall Study|Death|0|||
23486162|NCT01933789|65524232|FG008|Overall Study|Death|0|||
23486163|NCT01933789|65524224|FG000|Overall Study|Lost to Follow-up|0|||
23486164|NCT01933789|65524225|FG001|Overall Study|Lost to Follow-up|0|||
23486165|NCT01933789|65524226|FG002|Overall Study|Lost to Follow-up|0|||
23486166|NCT01933789|65524227|FG003|Overall Study|Lost to Follow-up|1|||
23486167|NCT01933789|65524228|FG004|Overall Study|Lost to Follow-up|8|||
23486168|NCT01933789|65524229|FG005|Overall Study|Lost to Follow-up|9|||
23486169|NCT01933789|65524230|FG006|Overall Study|Lost to Follow-up|1|||
23486170|NCT01933789|65524231|FG007|Overall Study|Lost to Follow-up|4|||
23486171|NCT01933789|65524232|FG008|Overall Study|Lost to Follow-up|0|||
23486172|NCT01933789|65524224|FG000|Overall Study|Withdrawal by Subject|2|||
23486173|NCT01933789|65524225|FG001|Overall Study|Withdrawal by Subject|1|||
23486174|NCT01933789|65524226|FG002|Overall Study|Withdrawal by Subject|0|||
23486175|NCT01933789|65524227|FG003|Overall Study|Withdrawal by Subject|0|||
23486176|NCT01933789|65524228|FG004|Overall Study|Withdrawal by Subject|17|||
23486177|NCT01933789|65524229|FG005|Overall Study|Withdrawal by Subject|16|||
23486178|NCT01933789|65524230|FG006|Overall Study|Withdrawal by Subject|1|||
23486179|NCT01933789|65524231|FG007|Overall Study|Withdrawal by Subject|4|||
23486180|NCT01933789|65524232|FG008|Overall Study|Withdrawal by Subject|0|||
23486181|NCT01933789|65524224|FG000|Overall Study|Became Ineligible|4|||
23486182|NCT01933789|65524225|FG001|Overall Study|Became Ineligible|0|||
23486183|NCT01933789|65524226|FG002|Overall Study|Became Ineligible|0|||
23486184|NCT01933789|65524227|FG003|Overall Study|Became Ineligible|0|||
23486185|NCT01933789|65524228|FG004|Overall Study|Became Ineligible|13|||
23486186|NCT01933789|65524229|FG005|Overall Study|Became Ineligible|10|||
23486187|NCT01933789|65524230|FG006|Overall Study|Became Ineligible|13|||
23486188|NCT01933789|65524231|FG007|Overall Study|Became Ineligible|6|||
23486189|NCT01933789|65524232|FG008|Overall Study|Became Ineligible|0|||
23486190|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
23486191|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
23486192|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
23486193|NCT02460458|65524236|FG000|First Prospective Phase|Lost to Follow-up|16|||
23486194|NCT02460458|65524236|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
23486195|NCT03882008|65524237|FG000|Overall Study|Withdrawal by Subject|1|||
23486196|NCT03882008|65524237|FG000|Overall Study|Lost to Follow-up|1|||
23486197|NCT00426231|65524241|FG000|Overall Study|Withdrawal by Subject|9|||
23486198|NCT00426231|65524242|FG001|Overall Study|Withdrawal by Subject|12|||
23486199|NCT00470184|65524243|FG000|Overall Study|Not Treated(became ineligible)|4|||
23486200|NCT00470184|65524243|FG000|Overall Study|Not treated (other)|1|||
23486201|NCT00470184|65524243|FG000|Overall Study|disease Progression|4|||
23486202|NCT00470184|65524243|FG000|Overall Study|Adverse Event|3|||
23486203|NCT00470184|65524243|FG000|Overall Study|Withdrawal by Subject|4|||
23486204|NCT00470184|65524243|FG000|Overall Study|other|5|||
23486205|NCT00470184|65524243|FG000|Overall Study|recurrence|1|||
23486206|NCT02750943|65524245|FG000|Overall Study|Lost to Follow-up|1|||
23486207|NCT02750943|65524246|FG001|Overall Study|Lost to Follow-up|2|||
23486208|NCT02750943|65524245|FG000|Overall Study|Withdrawal by Subject|5|||
23486209|NCT02750943|65524246|FG001|Overall Study|Withdrawal by Subject|7|||
23486210|NCT00046891|65524247|FG000|Overall Study|Cancels|5|||
23371785|NCT02404545|65106365|FG000|Overall Study|Sponsor Termination|6|||
23371786|NCT02404545|65106366|FG001|Overall Study|Sponsor Termination|6|||
23371787|NCT01670292|65106367|FG000|Overall Study|Lost to Follow-up|14|||
23371788|NCT01787552|65106368|FG000|Overall Study|Withdrawal by Subject|2|||
23486211|NCT00046891|65524248|FG001|Overall Study|Cancels|9|||
23486212|NCT00046891|65524247|FG000|Overall Study|Ineligible|1|||
23486213|NCT00046891|65524248|FG001|Overall Study|Ineligible|1|||
23486214|NCT00046891|65524247|FG000|Overall Study|Withdrawal by Subject|18|||
23486215|NCT00046891|65524248|FG001|Overall Study|Withdrawal by Subject|15|||
23486216|NCT00046891|65524247|FG000|Overall Study|Adverse Event|5|||
23486217|NCT00046891|65524248|FG001|Overall Study|Adverse Event|5|||
23486218|NCT03023046|65524249|FG000|Overall Study|Withdrawal by Subject|1|||
23486219|NCT02359851|65524253|FG000|Overall Study|Death|1|||
23486220|NCT02359851|65524253|FG000|Overall Study|Disease progression|1|||
23663744|NCT01225731|66155364|FG004|Part 2|Pregnancy|0|||
23663745|NCT01225731|66155365|FG005|Part 2|Pregnancy|0|||
23663746|NCT01225731|66155366|FG006|Part 2|Pregnancy|1|||
23663747|NCT01225731|66155367|FG007|Part 2|Pregnancy|0|||
23663748|NCT01225731|66155368|FG008|Part 2|Pregnancy|1|||
23663749|NCT01225731|66155369|FG009|Part 2|Pregnancy|0|||
23663750|NCT01225731|66155370|FG010|Part 2|Pregnancy|0|||
23663751|NCT01225731|66155371|FG011|Part 2|Pregnancy|0|||
23663752|NCT01225731|66155372|FG012|Part 2|Pregnancy|0|||
23663753|NCT01225731|66155360|FG000|Part 2|Lost to Follow-up|0|||
23663754|NCT01225731|66155361|FG001|Part 2|Lost to Follow-up|0|||
23663755|NCT01225731|66155362|FG002|Part 2|Lost to Follow-up|0|||
23663756|NCT01225731|66155363|FG003|Part 2|Lost to Follow-up|0|||
23663757|NCT01225731|66155364|FG004|Part 2|Lost to Follow-up|0|||
23663758|NCT01225731|66155365|FG005|Part 2|Lost to Follow-up|0|||
23663759|NCT01225731|66155366|FG006|Part 2|Lost to Follow-up|0|||
23663760|NCT01225731|66155367|FG007|Part 2|Lost to Follow-up|3|||
23663761|NCT01225731|66155368|FG008|Part 2|Lost to Follow-up|1|||
23663762|NCT01225731|66155369|FG009|Part 2|Lost to Follow-up|0|||
23371789|NCT01787552|65106369|FG001|Overall Study|Withdrawal by Subject|0|||
23663763|NCT01225731|66155370|FG010|Part 2|Lost to Follow-up|0|||
23663764|NCT01225731|66155371|FG011|Part 2|Lost to Follow-up|0|||
23663765|NCT01225731|66155372|FG012|Part 2|Lost to Follow-up|0|||
23663766|NCT01225731|66155360|FG000|Part 2|Physician Decision|0|||
23663767|NCT01225731|66155361|FG001|Part 2|Physician Decision|0|||
23663768|NCT01225731|66155362|FG002|Part 2|Physician Decision|0|||
23663769|NCT01225731|66155363|FG003|Part 2|Physician Decision|0|||
23663770|NCT01225731|66155364|FG004|Part 2|Physician Decision|0|||
23663771|NCT01225731|66155365|FG005|Part 2|Physician Decision|0|||
23663772|NCT01225731|66155366|FG006|Part 2|Physician Decision|0|||
23663773|NCT01225731|66155367|FG007|Part 2|Physician Decision|2|||
23486221|NCT00976573|65524254|FG000|Overall Study|Ineligible|0|||
23663774|NCT01225731|66155368|FG008|Part 2|Physician Decision|2|||
23663775|NCT01225731|66155369|FG009|Part 2|Physician Decision|0|||
23663776|NCT01225731|66155370|FG010|Part 2|Physician Decision|0|||
23663777|NCT01225731|66155371|FG011|Part 2|Physician Decision|0|||
23663778|NCT01225731|66155372|FG012|Part 2|Physician Decision|0|||
23663779|NCT01225731|66155360|FG000|Part 2|Withdrawal by Subject|0|||
23663780|NCT01225731|66155361|FG001|Part 2|Withdrawal by Subject|0|||
23663781|NCT01225731|66155362|FG002|Part 2|Withdrawal by Subject|0|||
23663782|NCT01225731|66155363|FG003|Part 2|Withdrawal by Subject|0|||
23663783|NCT01225731|66155364|FG004|Part 2|Withdrawal by Subject|0|||
23663784|NCT01225731|66155365|FG005|Part 2|Withdrawal by Subject|1|||
23663785|NCT01225731|66155366|FG006|Part 2|Withdrawal by Subject|3|||
23663786|NCT01225731|66155367|FG007|Part 2|Withdrawal by Subject|4|||
23663787|NCT01225731|66155368|FG008|Part 2|Withdrawal by Subject|1|||
23663788|NCT01225731|66155369|FG009|Part 2|Withdrawal by Subject|0|||
23663789|NCT01225731|66155370|FG010|Part 2|Withdrawal by Subject|0|||
23371790|NCT01787552|65106370|FG002|Overall Study|Withdrawal by Subject|0|||
23371791|NCT01787552|65106371|FG003|Overall Study|Withdrawal by Subject|4|||
23371792|NCT01787552|65106368|FG000|Overall Study|Physician Decision|2|||
23371793|NCT01787552|65106369|FG001|Overall Study|Physician Decision|2|||
23371794|NCT01787552|65106370|FG002|Overall Study|Physician Decision|1|||
23371795|NCT01787552|65106371|FG003|Overall Study|Physician Decision|2|||
23371796|NCT01787552|65106368|FG000|Overall Study|Death|0|||
23371797|NCT01787552|65106369|FG001|Overall Study|Death|0|||
23663790|NCT01225731|66155371|FG011|Part 2|Withdrawal by Subject|0|||
23371798|NCT01787552|65106370|FG002|Overall Study|Death|0|||
23371799|NCT01787552|65106371|FG003|Overall Study|Death|1|||
23663791|NCT01225731|66155372|FG012|Part 2|Withdrawal by Subject|0|||
23663792|NCT01225731|66155360|FG000|Part 3|Adverse Event|0|||
23663793|NCT01225731|66155361|FG001|Part 3|Adverse Event|0|||
23663794|NCT01225731|66155362|FG002|Part 3|Adverse Event|0|||
23663795|NCT01225731|66155363|FG003|Part 3|Adverse Event|0|||
23371800|NCT01787552|65106368|FG000|Overall Study|Adverse Event|2|||
23371801|NCT01787552|65106369|FG001|Overall Study|Adverse Event|5|||
23371802|NCT01787552|65106370|FG002|Overall Study|Adverse Event|2|||
23371803|NCT01787552|65106371|FG003|Overall Study|Adverse Event|16|||
23371804|NCT01787552|65106368|FG000|Overall Study|Study terminated by Sponsor|0|||
23371805|NCT01787552|65106369|FG001|Overall Study|Study terminated by Sponsor|0|||
23371806|NCT01787552|65106370|FG002|Overall Study|Study terminated by Sponsor|1|||
23371807|NCT01787552|65106371|FG003|Overall Study|Study terminated by Sponsor|3|||
23371808|NCT01787552|65106368|FG000|Overall Study|Progressive Disease|2|||
23371809|NCT01787552|65106369|FG001|Overall Study|Progressive Disease|2|||
23371810|NCT01787552|65106370|FG002|Overall Study|Progressive Disease|1|||
23371811|NCT01787552|65106371|FG003|Overall Study|Progressive Disease|1|||
23371812|NCT02765165|65106375|FG000|Treatment Period|Progressive disease|3|||
23371813|NCT02765165|65106376|FG001|Treatment Period|Progressive disease|2|||
23371814|NCT02765165|65106377|FG002|Treatment Period|Progressive disease|3|||
23371815|NCT02765165|65106378|FG003|Treatment Period|Progressive disease|3|||
23371816|NCT02765165|65106379|FG004|Treatment Period|Progressive disease|4|||
23663796|NCT01225731|66155364|FG004|Part 3|Adverse Event|0|||
23663797|NCT01225731|66155365|FG005|Part 3|Adverse Event|0|||
23663798|NCT01225731|66155366|FG006|Part 3|Adverse Event|0|||
23663799|NCT01225731|66155367|FG007|Part 3|Adverse Event|0|||
23663800|NCT01225731|66155368|FG008|Part 3|Adverse Event|0|||
23663801|NCT01225731|66155369|FG009|Part 3|Adverse Event|0|||
23663802|NCT01225731|66155370|FG010|Part 3|Adverse Event|1|||
23663803|NCT01225731|66155371|FG011|Part 3|Adverse Event|1|||
23663804|NCT01225731|66155372|FG012|Part 3|Adverse Event|0|||
23663805|NCT01225731|66155360|FG000|Part 3|Lost to Follow-up|0|||
23663806|NCT01225731|66155361|FG001|Part 3|Lost to Follow-up|0|||
23663807|NCT01225731|66155362|FG002|Part 3|Lost to Follow-up|0|||
23663808|NCT01225731|66155363|FG003|Part 3|Lost to Follow-up|0|||
23663809|NCT01225731|66155364|FG004|Part 3|Lost to Follow-up|0|||
23663810|NCT01225731|66155365|FG005|Part 3|Lost to Follow-up|0|||
23663811|NCT01225731|66155366|FG006|Part 3|Lost to Follow-up|0|||
23663812|NCT01225731|66155367|FG007|Part 3|Lost to Follow-up|0|||
23663813|NCT01225731|66155368|FG008|Part 3|Lost to Follow-up|0|||
23663814|NCT01225731|66155369|FG009|Part 3|Lost to Follow-up|0|||
23371817|NCT02765165|65106380|FG005|Treatment Period|Progressive disease|2|||
23371818|NCT02765165|65106381|FG006|Treatment Period|Progressive disease|2|||
23371819|NCT02765165|65106375|FG000|Treatment Period|Physician Decision|0|||
23371820|NCT02765165|65106376|FG001|Treatment Period|Physician Decision|1|||
23371821|NCT02765165|65106377|FG002|Treatment Period|Physician Decision|0|||
23371822|NCT02765165|65106378|FG003|Treatment Period|Physician Decision|0|||
23371823|NCT02765165|65106379|FG004|Treatment Period|Physician Decision|0|||
23371824|NCT02765165|65106380|FG005|Treatment Period|Physician Decision|0|||
23371825|NCT02765165|65106381|FG006|Treatment Period|Physician Decision|0|||
23371826|NCT02765165|65106375|FG000|Treatment Period|Adverse Event|0|||
23371827|NCT02765165|65106376|FG001|Treatment Period|Adverse Event|1|||
23371828|NCT02765165|65106377|FG002|Treatment Period|Adverse Event|0|||
23371829|NCT02765165|65106378|FG003|Treatment Period|Adverse Event|0|||
23371830|NCT02765165|65106379|FG004|Treatment Period|Adverse Event|0|||
23371831|NCT02765165|65106380|FG005|Treatment Period|Adverse Event|0|||
23371832|NCT02765165|65106381|FG006|Treatment Period|Adverse Event|0|||
23371833|NCT02765165|65106375|FG000|Treatment Period|Withdrawal by Subject|0|||
23371834|NCT02765165|65106376|FG001|Treatment Period|Withdrawal by Subject|0|||
23371835|NCT02765165|65106377|FG002|Treatment Period|Withdrawal by Subject|0|||
23371836|NCT02765165|65106378|FG003|Treatment Period|Withdrawal by Subject|0|||
23371837|NCT02765165|65106379|FG004|Treatment Period|Withdrawal by Subject|2|||
23371838|NCT02765165|65106380|FG005|Treatment Period|Withdrawal by Subject|0|||
23371839|NCT02765165|65106381|FG006|Treatment Period|Withdrawal by Subject|0|||
23371840|NCT02765165|65106375|FG000|Treatment Period|Study terminated|0|||
23371841|NCT02765165|65106376|FG001|Treatment Period|Study terminated|0|||
23371842|NCT02765165|65106377|FG002|Treatment Period|Study terminated|0|||
23371843|NCT02765165|65106378|FG003|Treatment Period|Study terminated|0|||
23486222|NCT00976573|65524255|FG001|Overall Study|Ineligible|1|||
23371844|NCT02765165|65106379|FG004|Treatment Period|Study terminated|0|||
23371845|NCT02765165|65106380|FG005|Treatment Period|Study terminated|1|||
23371846|NCT02765165|65106381|FG006|Treatment Period|Study terminated|2|||
23371847|NCT02765165|65106375|FG000|Post-treatment Follow-up|Death|1|||
23486223|NCT00976573|65524254|FG000|Overall Study|Cancel prior to receiving treatment|4|||
23371848|NCT02765165|65106376|FG001|Post-treatment Follow-up|Death|2|||
23371849|NCT02765165|65106377|FG002|Post-treatment Follow-up|Death|1|||
23371850|NCT02765165|65106378|FG003|Post-treatment Follow-up|Death|1|||
23486224|NCT00976573|65524255|FG001|Overall Study|Cancel prior to receiving treatment|2|||
23663815|NCT01225731|66155370|FG010|Part 3|Lost to Follow-up|1|||
23663816|NCT01225731|66155371|FG011|Part 3|Lost to Follow-up|2|||
23663817|NCT01225731|66155372|FG012|Part 3|Lost to Follow-up|1|||
23663818|NCT01225731|66155360|FG000|Part 3|Physician Decision|0|||
23663819|NCT01225731|66155361|FG001|Part 3|Physician Decision|0|||
23663820|NCT01225731|66155362|FG002|Part 3|Physician Decision|0|||
23663821|NCT01225731|66155363|FG003|Part 3|Physician Decision|0|||
23371851|NCT02765165|65106379|FG004|Post-treatment Follow-up|Death|1|||
23371852|NCT02765165|65106380|FG005|Post-treatment Follow-up|Death|1|||
23371853|NCT02765165|65106381|FG006|Post-treatment Follow-up|Death|0|||
23371854|NCT02765165|65106375|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
23371855|NCT02765165|65106376|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
23371856|NCT02765165|65106377|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
23371857|NCT02765165|65106378|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
23371858|NCT02765165|65106379|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
23371859|NCT02765165|65106380|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
23371860|NCT02765165|65106381|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
23371861|NCT02765165|65106375|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371862|NCT02765165|65106376|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371863|NCT02765165|65106377|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
23371864|NCT02765165|65106378|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371865|NCT02765165|65106379|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371866|NCT02765165|65106380|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371867|NCT02765165|65106381|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371868|NCT02765165|65106375|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371869|NCT02765165|65106376|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371870|NCT02765165|65106377|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
23371871|NCT02765165|65106378|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
23371872|NCT02765165|65106379|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371873|NCT02765165|65106380|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371874|NCT02765165|65106381|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371875|NCT02765165|65106375|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
23486225|NCT00145600|65524256|FG000|Overall Study|Death|1|||
23486226|NCT00145600|65524257|FG001|Overall Study|Death|2|||
23486227|NCT00145600|65524258|FG002|Overall Study|Death|2|||
23486228|NCT00145600|65524259|FG003|Overall Study|Death|6|||
23486229|NCT00145600|65524256|FG000|Overall Study|Ineligible|3|||
23486230|NCT00145600|65524257|FG001|Overall Study|Ineligible|0|||
23486231|NCT00145600|65524258|FG002|Overall Study|Ineligible|1|||
23486232|NCT00145600|65524259|FG003|Overall Study|Ineligible|5|||
23371876|NCT02765165|65106376|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
23371877|NCT02765165|65106377|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371878|NCT02765165|65106378|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371879|NCT02765165|65106379|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371880|NCT02765165|65106380|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371881|NCT02765165|65106381|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371882|NCT02765165|65106375|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371883|NCT02765165|65106376|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371884|NCT02765165|65106377|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371885|NCT02765165|65106378|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371886|NCT02765165|65106379|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
23371887|NCT02765165|65106380|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
23371888|NCT02765165|65106381|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
23371889|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371890|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371891|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371892|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371893|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
23371894|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371895|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
23371896|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371897|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371898|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371899|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371900|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371901|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371902|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371903|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
23371904|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
23371905|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371906|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
23371907|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371908|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371909|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
23371910|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
23371911|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371912|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
23371913|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371914|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371915|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371916|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
23371917|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371918|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371919|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371920|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371921|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371922|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
23371923|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371924|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371925|NCT00843492|65106389|FG000|Overall Study|Adverse Event|0|||
23371926|NCT00843492|65106390|FG001|Overall Study|Adverse Event|3|||
23371927|NCT00843492|65106389|FG000|Overall Study|Lost to Follow-up|4|||
23371928|NCT00843492|65106390|FG001|Overall Study|Lost to Follow-up|4|||
23371929|NCT00843492|65106389|FG000|Overall Study|Withdrawal by Subject|0|||
23371930|NCT00843492|65106390|FG001|Overall Study|Withdrawal by Subject|4|||
23371931|NCT00843492|65106389|FG000|Overall Study|Immobilization Stopped|1|||
23371932|NCT00843492|65106390|FG001|Overall Study|Immobilization Stopped|0|||
23371933|NCT00843492|65106389|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
23371934|NCT00843492|65106390|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
23371935|NCT00843492|65106389|FG000|Overall Study|Orthopedic Surgery|0|||
23371936|NCT00843492|65106390|FG001|Overall Study|Orthopedic Surgery|2|||
23371937|NCT00843492|65106389|FG000|Overall Study|Visit Not Performed|1|||
23486233|NCT00145600|65524256|FG000|Overall Study|Lost to Follow-up|2|||
23371938|NCT00843492|65106390|FG001|Overall Study|Visit Not Performed|0|||
23371939|NCT00843492|65106389|FG000|Overall Study|Deep-vein Thrombosis|1|||
23371940|NCT00843492|65106390|FG001|Overall Study|Deep-vein Thrombosis|0|||
23371941|NCT00888654|65106391|FG000|Overall Study|Problems swallowing oral meds.|1|||
23371942|NCT00888654|65106391|FG000|Overall Study|Not enough oral meds before surgery|3|||
23486234|NCT00145600|65524257|FG001|Overall Study|Lost to Follow-up|6|||
23371943|NCT00888654|65106391|FG000|Overall Study|Surgery aborted|2|||
23371944|NCT00888654|65106391|FG000|Overall Study|Withdrawal by Subject|1|||
23371945|NCT00888654|65106391|FG000|Overall Study|Inelig. due to contraindication of med|1|||
23371946|NCT00888654|65106391|FG000|Overall Study|Change in surg date|1|||
23371947|NCT00888654|65106391|FG000|Overall Study|Stopped meds due to headaches|1|||
23371948|NCT02631941|65106392|FG000|Overall Study|Physician Decision|0|||
23371949|NCT02631941|65106393|FG001|Overall Study|Physician Decision|1|||
23371950|NCT02631941|65106394|FG002|Overall Study|Physician Decision|0|||
23371951|NCT02631941|65106395|FG003|Overall Study|Physician Decision|0|||
23371952|NCT02631941|65106396|FG004|Overall Study|Physician Decision|0|||
23371953|NCT02631941|65106397|FG005|Overall Study|Physician Decision|0|||
23371954|NCT02631941|65106398|FG006|Overall Study|Physician Decision|0|||
23371955|NCT02631941|65106399|FG007|Overall Study|Physician Decision|0|||
23371956|NCT02631941|65106400|FG008|Overall Study|Physician Decision|0|||
23371957|NCT02631941|65106401|FG009|Overall Study|Physician Decision|0|||
23371958|NCT02631941|65106392|FG000|Overall Study|Adverse Event|0|||
23371959|NCT02631941|65106393|FG001|Overall Study|Adverse Event|1|||
23371960|NCT02631941|65106394|FG002|Overall Study|Adverse Event|0|||
23371961|NCT02631941|65106395|FG003|Overall Study|Adverse Event|0|||
23371962|NCT02631941|65106396|FG004|Overall Study|Adverse Event|0|||
23371963|NCT02631941|65106397|FG005|Overall Study|Adverse Event|0|||
23371964|NCT02631941|65106398|FG006|Overall Study|Adverse Event|0|||
23371965|NCT02631941|65106399|FG007|Overall Study|Adverse Event|0|||
23371966|NCT02631941|65106400|FG008|Overall Study|Adverse Event|0|||
23371967|NCT02631941|65106401|FG009|Overall Study|Adverse Event|0|||
23371968|NCT02631941|65106392|FG000|Overall Study|Withdrawal by Subject|0|||
23371969|NCT02631941|65106393|FG001|Overall Study|Withdrawal by Subject|0|||
23371970|NCT02631941|65106394|FG002|Overall Study|Withdrawal by Subject|0|||
23371971|NCT02631941|65106395|FG003|Overall Study|Withdrawal by Subject|0|||
23371972|NCT02631941|65106396|FG004|Overall Study|Withdrawal by Subject|1|||
23371973|NCT02631941|65106397|FG005|Overall Study|Withdrawal by Subject|0|||
23371974|NCT02631941|65106398|FG006|Overall Study|Withdrawal by Subject|0|||
23371975|NCT02631941|65106399|FG007|Overall Study|Withdrawal by Subject|1|||
23371976|NCT02631941|65106400|FG008|Overall Study|Withdrawal by Subject|0|||
23371977|NCT02631941|65106401|FG009|Overall Study|Withdrawal by Subject|0|||
23371978|NCT02631941|65106392|FG000|Overall Study|Lost to Follow-up|0|||
23371979|NCT02631941|65106393|FG001|Overall Study|Lost to Follow-up|0|||
23371980|NCT02631941|65106394|FG002|Overall Study|Lost to Follow-up|0|||
23371981|NCT02631941|65106395|FG003|Overall Study|Lost to Follow-up|0|||
23371982|NCT02631941|65106396|FG004|Overall Study|Lost to Follow-up|0|||
23371983|NCT02631941|65106397|FG005|Overall Study|Lost to Follow-up|0|||
23371984|NCT02631941|65106398|FG006|Overall Study|Lost to Follow-up|0|||
23371985|NCT02631941|65106399|FG007|Overall Study|Lost to Follow-up|0|||
23371986|NCT02631941|65106400|FG008|Overall Study|Lost to Follow-up|1|||
23371987|NCT02631941|65106401|FG009|Overall Study|Lost to Follow-up|0|||
23371988|NCT01155570|65106404|FG000|Overall Study|Adverse Event|39|||
23371989|NCT01155570|65106404|FG000|Overall Study|Lack of Efficacy|46|||
23371990|NCT01155570|65106404|FG000|Overall Study|Participant's Economic Reasons|17|||
23371991|NCT01155570|65106404|FG000|Overall Study|No Hospital Visits|7|||
23371992|NCT01155570|65106404|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
23371993|NCT01155570|65106404|FG000|Overall Study|Adverse Event + Other Reasons|7|||
23371994|NCT01155570|65106404|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
23371995|NCT01155570|65106404|FG000|Overall Study|Other Reasons|23|||
23371996|NCT00486044|65106407|FG000|Overall Study|Withdrawal by Subject|2|||
23371997|NCT00486044|65106408|FG001|Overall Study|Withdrawal by Subject|1|||
23371998|NCT00486044|65106407|FG000|Overall Study|Adverse Event|0|||
23371999|NCT00486044|65106408|FG001|Overall Study|Adverse Event|1|||
23372000|NCT00486044|65106407|FG000|Overall Study|Lost to Follow-up|0|||
23372001|NCT00486044|65106408|FG001|Overall Study|Lost to Follow-up|1|||
23372002|NCT03470922|65106413|FG000|Overall Study|Death|107|||
23372003|NCT03470922|65106414|FG001|Overall Study|Death|118|||
23372004|NCT03470922|65106413|FG000|Overall Study|Lost to Follow-up|5|||
23372005|NCT03470922|65106414|FG001|Overall Study|Lost to Follow-up|5|||
23372006|NCT03470922|65106413|FG000|Overall Study|Participant Withdrew Consent|4|||
23372007|NCT03470922|65106414|FG001|Overall Study|Participant Withdrew Consent|9|||
23372008|NCT03470922|65106413|FG000|Overall Study|Other reasons|1|||
23372009|NCT03470922|65106414|FG001|Overall Study|Other reasons|0|||
23372010|NCT03470922|65106413|FG000|Overall Study|Not reported|1|||
23372011|NCT03470922|65106414|FG001|Overall Study|Not reported|0|||
23372012|NCT01977846|65109732|FG000|Total Study - Prospective|Death|0|||
23372013|NCT01977846|65109733|FG001|Total Study - Prospective|Death|1|||
23372014|NCT01977846|65109732|FG000|Total Study - Prospective|Lost to Follow-up|0|||
23372015|NCT01977846|65109733|FG001|Total Study - Prospective|Lost to Follow-up|8|||
23372016|NCT01977846|65109732|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
23372017|NCT01977846|65109733|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
23372018|NCT01977846|65109732|FG000|Total Study - Prospective|Not available at time of visit|0|||
23372019|NCT01977846|65109733|FG001|Total Study - Prospective|Not available at time of visit|5|||
23372020|NCT01977846|65109732|FG000|Total Study - Prospective|No show|0|||
23372021|NCT01977846|65109733|FG001|Total Study - Prospective|No show|1|||
23372022|NCT01977846|65109732|FG000|Total Study - Prospective|Protocol Violation|0|||
23372023|NCT01977846|65109733|FG001|Total Study - Prospective|Protocol Violation|1|||
23372024|NCT03585270|65109734|FG000|Overall Study|Withdrawal by Subject|2|||
23372025|NCT03585270|65109735|FG001|Overall Study|Withdrawal by Subject|6|||
23372026|NCT03585270|65109734|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
23372027|NCT03585270|65109735|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
23372028|NCT03585270|65109734|FG000|Overall Study|Adverse Event|5|||
23372029|NCT03585270|65109735|FG001|Overall Study|Adverse Event|2|||
23486235|NCT00145600|65524258|FG002|Overall Study|Lost to Follow-up|2|||
23663822|NCT01225731|66155364|FG004|Part 3|Physician Decision|0|||
23663823|NCT01225731|66155365|FG005|Part 3|Physician Decision|0|||
23663824|NCT01225731|66155366|FG006|Part 3|Physician Decision|0|||
23663825|NCT01225731|66155367|FG007|Part 3|Physician Decision|0|||
23663826|NCT01225731|66155368|FG008|Part 3|Physician Decision|0|||
23663827|NCT01225731|66155369|FG009|Part 3|Physician Decision|0|||
23663828|NCT01225731|66155370|FG010|Part 3|Physician Decision|0|||
23663829|NCT01225731|66155371|FG011|Part 3|Physician Decision|1|||
23663830|NCT01225731|66155372|FG012|Part 3|Physician Decision|2|||
23663831|NCT01225731|66155360|FG000|Part 3|Withdrawal by Subject|0|||
23663832|NCT01225731|66155361|FG001|Part 3|Withdrawal by Subject|0|||
23663833|NCT01225731|66155362|FG002|Part 3|Withdrawal by Subject|0|||
23663834|NCT01225731|66155363|FG003|Part 3|Withdrawal by Subject|0|||
23663835|NCT01225731|66155364|FG004|Part 3|Withdrawal by Subject|0|||
23663836|NCT01225731|66155365|FG005|Part 3|Withdrawal by Subject|0|||
23663837|NCT01225731|66155366|FG006|Part 3|Withdrawal by Subject|0|||
23663838|NCT01225731|66155367|FG007|Part 3|Withdrawal by Subject|0|||
23663839|NCT01225731|66155368|FG008|Part 3|Withdrawal by Subject|0|||
23663840|NCT01225731|66155369|FG009|Part 3|Withdrawal by Subject|0|||
23663841|NCT01225731|66155370|FG010|Part 3|Withdrawal by Subject|4|||
23663842|NCT01225731|66155371|FG011|Part 3|Withdrawal by Subject|6|||
23663843|NCT01225731|66155372|FG012|Part 3|Withdrawal by Subject|4|||
23663844|NCT01003210|66155375|FG000|Overall Study|Lost to Follow-up|1|||
23663845|NCT01003210|66155376|FG001|Overall Study|Lost to Follow-up|3|||
23663846|NCT00993265|66155377|FG000|Overall Study|Adverse Event|1|||
23663847|NCT00993265|66155378|FG001|Overall Study|Adverse Event|0|||
23663848|NCT00993265|66155377|FG000|Overall Study|Changed dose of concomitant drug|2|||
23663849|NCT00993265|66155378|FG001|Overall Study|Changed dose of concomitant drug|0|||
23663850|NCT00993265|66155377|FG000|Overall Study|Non-compliant with study medication|1|||
23663851|NCT00993265|66155378|FG001|Overall Study|Non-compliant with study medication|0|||
23663852|NCT02234284|66155385|FG000|Overall Study|Death|4|||
23663853|NCT02234284|66155386|FG001|Overall Study|Death|2|||
23663854|NCT02234284|66155385|FG000|Overall Study|Withdrawal by Subject|1|||
23663855|NCT02234284|66155386|FG001|Overall Study|Withdrawal by Subject|0|||
23663856|NCT02234284|66155385|FG000|Overall Study|Lost to Follow-up|20|||
23663857|NCT02234284|66155386|FG001|Overall Study|Lost to Follow-up|7|||
23663858|NCT01485627|66155388|FG000|Overall Study|Patient withdrew|6|||
23486236|NCT00145600|65524259|FG003|Overall Study|Lost to Follow-up|4|||
23663859|NCT01485627|66155389|FG001|Overall Study|Patient withdrew|5|||
23663860|NCT01485627|66155388|FG000|Overall Study|Patient died|3|||
23663861|NCT01485627|66155389|FG001|Overall Study|Patient died|1|||
23663862|NCT01485627|66155388|FG000|Overall Study|Patient lost to followup|0|||
23663863|NCT01485627|66155389|FG001|Overall Study|Patient lost to followup|1|||
23372030|NCT03585270|65109734|FG000|Overall Study|Lost to Follow-up|1|||
23372031|NCT03585270|65109735|FG001|Overall Study|Lost to Follow-up|4|||
23372032|NCT03585270|65109734|FG000|Overall Study|Death|5|||
23372033|NCT03585270|65109735|FG001|Overall Study|Death|3|||
23372034|NCT03585270|65109734|FG000|Overall Study|Other reasons|2|||
23372035|NCT03585270|65109735|FG001|Overall Study|Other reasons|2|||
23372036|NCT03980223|65109736|FG000|Overall Study|Lost to Follow-up|3|||
23372037|NCT03980223|65109737|FG001|Overall Study|Lost to Follow-up|7|||
23372038|NCT03980223|65109738|FG002|Overall Study|Lost to Follow-up|10|||
23372039|NCT03980223|65109739|FG003|Overall Study|Lost to Follow-up|8|||
23372040|NCT03980223|65109736|FG000|Overall Study|Withdrawal by Subject|0|||
23372041|NCT03980223|65109737|FG001|Overall Study|Withdrawal by Subject|0|||
23372042|NCT03980223|65109738|FG002|Overall Study|Withdrawal by Subject|1|||
23372043|NCT03980223|65109739|FG003|Overall Study|Withdrawal by Subject|2|||
23372044|NCT03980223|65109736|FG000|Overall Study|Physician Decision|0|||
23372045|NCT03980223|65109737|FG001|Overall Study|Physician Decision|0|||
23372046|NCT03980223|65109738|FG002|Overall Study|Physician Decision|1|||
23372047|NCT03980223|65109739|FG003|Overall Study|Physician Decision|0|||
23372048|NCT03980223|65109736|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
23372049|NCT03980223|65109737|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
23372050|NCT03980223|65109738|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
23372051|NCT03980223|65109739|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
23372052|NCT00301834|65109743|FG000|Overall Study|Death|1|||
23372053|NCT03834350|65109750|FG000|Overall Study|Withdrawal by Subject|1|||
23372054|NCT00737048|65109751|FG000|Overall Study|Physician Decision|0|||
23372055|NCT00737048|65109752|FG001|Overall Study|Physician Decision|0|||
23372056|NCT00737048|65109753|FG002|Overall Study|Physician Decision|1|||
23372057|NCT00737048|65109751|FG000|Overall Study|Adverse Event|0|||
23372058|NCT00737048|65109752|FG001|Overall Study|Adverse Event|1|||
23372059|NCT00737048|65109753|FG002|Overall Study|Adverse Event|0|||
23372060|NCT00737048|65109751|FG000|Overall Study|Worsening of the symptoms|3|||
23372061|NCT00737048|65109752|FG001|Overall Study|Worsening of the symptoms|5|||
23372062|NCT00737048|65109753|FG002|Overall Study|Worsening of the symptoms|3|||
23372063|NCT02732639|65109760|FG000|Overall Study|Lost to Follow-up|1|||
23372064|NCT04456686|65109761|FG000|Overall Study|Adverse Event|2|||
23372065|NCT04456686|65109762|FG001|Overall Study|Adverse Event|1|||
23372066|NCT04456686|65109761|FG000|Overall Study|Lack of Efficacy|3|||
23486237|NCT00145600|65524256|FG000|Overall Study|Noncompliance|1|||
23486238|NCT00145600|65524257|FG001|Overall Study|Noncompliance|0|||
23486239|NCT00145600|65524258|FG002|Overall Study|Noncompliance|0|||
23486240|NCT00145600|65524259|FG003|Overall Study|Noncompliance|0|||
23486241|NCT00145600|65524256|FG000|Overall Study|Withdrawal by Subject|1|||
23486242|NCT00145600|65524257|FG001|Overall Study|Withdrawal by Subject|2|||
23486243|NCT00145600|65524258|FG002|Overall Study|Withdrawal by Subject|0|||
23486244|NCT00145600|65524259|FG003|Overall Study|Withdrawal by Subject|1|||
23486245|NCT00723203|65524260|FG000|Overall Study|Withdrawal by Subject|3|||
23486246|NCT02435069|65524266|FG000|Dose Response - First Intervention|Adverse Event|0|||
23486247|NCT02435069|65524267|FG001|Dose Response - First Intervention|Adverse Event|1|||
23486248|NCT02435069|65524268|FG002|Dose Response - First Intervention|Adverse Event|1|||
23486249|NCT02435069|65524269|FG003|Dose Response - First Intervention|Adverse Event|0|||
23486250|NCT02435069|65524270|FG004|Dose Response - First Intervention|Adverse Event|0|||
23486251|NCT02435069|65524266|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486252|NCT02435069|65524267|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486253|NCT02435069|65524268|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486254|NCT02435069|65524269|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486255|NCT02435069|65524270|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
23486256|NCT00095628|65524271|FG000|Overall Study|Disease progression prior to treatment|1|||
23603578|NCT02892019|65937422|FG000|Overall Study|Withdrawal by Subject|0|||
23603579|NCT02892019|65937423|FG001|Overall Study|Withdrawal by Subject|1|||
23372067|NCT04456686|65109762|FG001|Overall Study|Lack of Efficacy|1|||
23603580|NCT02892019|65937422|FG000|Overall Study|Adverse Event|1|||
23603581|NCT02892019|65937423|FG001|Overall Study|Adverse Event|1|||
23372068|NCT04456686|65109761|FG000|Overall Study|Withdrew consent|3|||
23372069|NCT04456686|65109762|FG001|Overall Study|Withdrew consent|1|||
23603582|NCT01005914|65937428|FG000|Overall Study|Adverse Event|4|||
23603583|NCT01005914|65937428|FG000|Overall Study|Death|4|||
23603584|NCT01005914|65937428|FG000|Overall Study|Lack of Efficacy|1|||
23372070|NCT04456686|65109761|FG000|Overall Study|Physician Decision|2|||
23372071|NCT04456686|65109762|FG001|Overall Study|Physician Decision|2|||
23372072|NCT04456686|65109761|FG000|Overall Study|Withdrawal by Subject|5|||
23372073|NCT04456686|65109762|FG001|Overall Study|Withdrawal by Subject|1|||
23372074|NCT04456686|65109761|FG000|Overall Study|Protocol Violation|0|||
23372075|NCT04456686|65109762|FG001|Overall Study|Protocol Violation|1|||
23486257|NCT01467583|65524279|FG000|Overall Study|Death|1|||
23486258|NCT01467583|65524280|FG001|Overall Study|Death|1|||
23663864|NCT01485627|66155388|FG000|Overall Study|Caregiver withdrew|3|||
23372076|NCT02452047|65109765|FG000|Overall Study|Adverse Event|0|||
23372077|NCT02452047|65109766|FG001|Overall Study|Adverse Event|1|||
23372078|NCT02452047|65109767|FG002|Overall Study|Adverse Event|1|||
23372079|NCT02452047|65109765|FG000|Overall Study|Death|1|||
23372080|NCT02452047|65109766|FG001|Overall Study|Death|3|||
23372081|NCT02452047|65109767|FG002|Overall Study|Death|1|||
23372082|NCT02452047|65109765|FG000|Overall Study|Physician Decision|1|||
23372083|NCT02452047|65109766|FG001|Overall Study|Physician Decision|0|||
23486259|NCT01467583|65524281|FG002|Overall Study|Death|0|||
23486260|NCT01467583|65524279|FG000|Overall Study|Withdrawal by Subject|1|||
23603585|NCT01005914|65937428|FG000|Overall Study|Withdrawal by Subject|1|||
23486261|NCT01467583|65524280|FG001|Overall Study|Withdrawal by Subject|0|||
23372084|NCT02452047|65109767|FG002|Overall Study|Physician Decision|0|||
23603586|NCT03340961|65937431|FG000|Overall Study|Adverse Event|1|||
23603587|NCT03340961|65937432|FG001|Overall Study|Adverse Event|3|||
23372085|NCT02452047|65109765|FG000|Overall Study|Lost to Follow-up|1|||
23372086|NCT02452047|65109766|FG001|Overall Study|Lost to Follow-up|1|||
23372087|NCT02452047|65109767|FG002|Overall Study|Lost to Follow-up|0|||
23372088|NCT02452047|65109765|FG000|Overall Study|Withdrawal by Subject|1|||
23372089|NCT02452047|65109766|FG001|Overall Study|Withdrawal by Subject|0|||
23372090|NCT02452047|65109767|FG002|Overall Study|Withdrawal by Subject|0|||
23372091|NCT01802385|65109782|FG000|Overall Study|Death|106|||
23372092|NCT01802385|65109783|FG001|Overall Study|Death|120|||
23372093|NCT01192178|65109784|FG000|Overall Study|Withdrawal by Subject|6|||
23372094|NCT01192178|65109785|FG001|Overall Study|Withdrawal by Subject|10|||
23372095|NCT01192178|65109784|FG000|Overall Study|Protocol Violation|10|||
23372096|NCT01192178|65109785|FG001|Overall Study|Protocol Violation|3|||
23372097|NCT01192178|65109784|FG000|Overall Study|Physician Decision|2|||
23372098|NCT01192178|65109785|FG001|Overall Study|Physician Decision|4|||
23372099|NCT01192178|65109784|FG000|Overall Study|Lost to Follow-up|3|||
23372100|NCT01192178|65109785|FG001|Overall Study|Lost to Follow-up|3|||
23372101|NCT01192178|65109784|FG000|Overall Study|Adverse Event|2|||
23372102|NCT01192178|65109785|FG001|Overall Study|Adverse Event|1|||
23372103|NCT01192178|65109784|FG000|Overall Study|Lack of Efficacy|1|||
23603588|NCT03340961|65937433|FG002|Overall Study|Adverse Event|2|||
23603589|NCT03340961|65937434|FG003|Overall Study|Adverse Event|4|||
23603590|NCT03340961|65937431|FG000|Overall Study|Lost to Follow-up|0|||
23603591|NCT03340961|65937432|FG001|Overall Study|Lost to Follow-up|1|||
23603592|NCT03340961|65937433|FG002|Overall Study|Lost to Follow-up|0|||
23603593|NCT03340961|65937434|FG003|Overall Study|Lost to Follow-up|1|||
23603594|NCT03340961|65937431|FG000|Overall Study|Withdrawal by Subject|3|||
23603595|NCT03340961|65937432|FG001|Overall Study|Withdrawal by Subject|2|||
23603596|NCT03340961|65937433|FG002|Overall Study|Withdrawal by Subject|4|||
23603597|NCT03340961|65937434|FG003|Overall Study|Withdrawal by Subject|7|||
23603598|NCT03340961|65937431|FG000|Overall Study|Use of prohibited treatment|0|||
23603599|NCT03340961|65937432|FG001|Overall Study|Use of prohibited treatment|3|||
23603600|NCT03340961|65937433|FG002|Overall Study|Use of prohibited treatment|2|||
23603601|NCT03340961|65937434|FG003|Overall Study|Use of prohibited treatment|4|||
23603602|NCT03340961|65937431|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
23603603|NCT03340961|65937432|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
23603604|NCT03340961|65937433|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
23603605|NCT03340961|65937434|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
23603606|NCT03340961|65937431|FG000|Overall Study|Subject developed an exclusion criterion|0|||
23603607|NCT03340961|65937432|FG001|Overall Study|Subject developed an exclusion criterion|1|||
23603608|NCT03340961|65937433|FG002|Overall Study|Subject developed an exclusion criterion|0|||
23603609|NCT03340961|65937434|FG003|Overall Study|Subject developed an exclusion criterion|0|||
23603610|NCT03340961|65937431|FG000|Overall Study|Protocol Violation|1|||
23603611|NCT03340961|65937432|FG001|Overall Study|Protocol Violation|0|||
23603612|NCT03340961|65937433|FG002|Overall Study|Protocol Violation|1|||
23603613|NCT03340961|65937434|FG003|Overall Study|Protocol Violation|0|||
23603614|NCT03340961|65937431|FG000|Overall Study|Adverse Event|1|||
23603615|NCT03340961|65937432|FG001|Overall Study|Adverse Event|1|||
23603616|NCT03340961|65937433|FG002|Overall Study|Adverse Event|0|||
23603617|NCT03340961|65937434|FG003|Overall Study|Adverse Event|0|||
23603618|NCT03340961|65937431|FG000|Overall Study|Lack of Efficacy|0|||
23603619|NCT03340961|65937432|FG001|Overall Study|Lack of Efficacy|0|||
23603620|NCT03340961|65937433|FG002|Overall Study|Lack of Efficacy|0|||
23603621|NCT03340961|65937434|FG003|Overall Study|Lack of Efficacy|1|||
23603622|NCT02470806|65937435|FG000|Overall Study|Lost to Follow-up|1|||
23603623|NCT02470806|65937436|FG001|Overall Study|Lost to Follow-up|1|||
23603624|NCT02470806|65937435|FG000|Overall Study|Adverse Event|5|||
23603625|NCT02470806|65937436|FG001|Overall Study|Adverse Event|2|||
23603626|NCT02470806|65937435|FG000|Overall Study|Protocol Violation|4|||
23603627|NCT02470806|65937436|FG001|Overall Study|Protocol Violation|11|||
23663865|NCT01485627|66155389|FG001|Overall Study|Caregiver withdrew|3|||
23372104|NCT01192178|65109785|FG001|Overall Study|Lack of Efficacy|2|||
23372105|NCT03630393|65109786|FG000|Overall Study|Death|1|||
23372106|NCT03630393|65109787|FG001|Overall Study|Death|0|||
23372107|NCT02147626|65109789|FG000|Overall Study|Lost to Follow-up|4|||
23372108|NCT02147626|65109790|FG001|Overall Study|Lost to Follow-up|4|||
23372109|NCT02147626|65109789|FG000|Overall Study|Pregnancy|1|||
23372110|NCT02147626|65109790|FG001|Overall Study|Pregnancy|2|||
23372111|NCT02147626|65109789|FG000|Overall Study|Withdrawal by Subject|0|||
23372112|NCT02147626|65109790|FG001|Overall Study|Withdrawal by Subject|1|||
23372113|NCT01411852|65109792|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
23372114|NCT01411852|65109793|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
23372115|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
23372116|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
23372117|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Found to be under age|0|||
23372118|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Found to be under age|1|||
23372119|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
23372120|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
23372121|NCT01411852|65109792|FG000|Hospital Intervention Phase|Severe head injury|5|||
23372122|NCT01411852|65109793|FG001|Hospital Intervention Phase|Severe head injury|4|||
23372123|NCT01411852|65109792|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
23372124|NCT01411852|65109793|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
23372125|NCT01411852|65109792|FG000|Hospital Intervention Phase|Miscommunication error|1|||
23372126|NCT01411852|65109793|FG001|Hospital Intervention Phase|Miscommunication error|2|||
23372127|NCT01411852|65109792|FG000|Hospital Intervention Phase|CPR administered|3|||
23372128|NCT01411852|65109793|FG001|Hospital Intervention Phase|CPR administered|1|||
23372129|NCT01411852|65109792|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
23372130|NCT01411852|65109793|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
23372131|NCT01411852|65109792|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
23372132|NCT01411852|65109793|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
23372133|NCT01411852|65109792|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
23372134|NCT01411852|65109793|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
23372135|NCT01411852|65109792|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
23372136|NCT01411852|65109793|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
23372137|NCT01411852|65109792|FG000|Hospital Intervention Phase|Other ineligible|2|||
23372138|NCT01411852|65109793|FG001|Hospital Intervention Phase|Other ineligible|2|||
23372139|NCT01411852|65109792|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
23372140|NCT01411852|65109793|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
23372141|NCT01411852|65109792|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
23372142|NCT01411852|65109793|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
23372143|NCT01411852|65109792|FG000|Hospital Intervention Phase|Vascular access failed|1|||
23372144|NCT01411852|65109793|FG001|Hospital Intervention Phase|Vascular access failed|0|||
23372145|NCT02078817|65109794|FG000|Overall Study|Withdrawal by Subject|1|||
23486262|NCT01467583|65524281|FG002|Overall Study|Withdrawal by Subject|0|||
23486263|NCT01467583|65524279|FG000|Overall Study|Protocol Violation|0|||
23486264|NCT01467583|65524280|FG001|Overall Study|Protocol Violation|0|||
23663866|NCT01485627|66155388|FG000|Overall Study|Caregiver lost to follow up|11|||
23663867|NCT01485627|66155389|FG001|Overall Study|Caregiver lost to follow up|12|||
23663868|NCT01485627|66155388|FG000|Overall Study|Caregiver died|1|||
23663869|NCT01485627|66155389|FG001|Overall Study|Caregiver died|0|||
23663870|NCT01485627|66155388|FG000|Overall Study|caregiver was not bereaved|42|||
23663871|NCT01485627|66155389|FG001|Overall Study|caregiver was not bereaved|35|||
23663872|NCT01378858|66155390|FG000|Overall Study|Withdrawal by Subject|4|||
23486265|NCT01467583|65524281|FG002|Overall Study|Protocol Violation|2|||
23486266|NCT00995865|65524282|FG000|Overall Study|Protocol Violation|2|||
23663873|NCT01378858|66155391|FG001|Overall Study|Withdrawal by Subject|4|||
23663874|NCT02053168|66155392|FG000|Overall Study|Withdrawal by Subject|1|||
23663875|NCT02053168|66155392|FG000|Overall Study|Physician Decision|1|||
23663876|NCT02053168|66155392|FG000|Overall Study|Lost to Follow-up|1|||
23663877|NCT00677820|66155393|FG000|Overall Study|Lost to Follow-up|1|||
23663878|NCT00677820|66155394|FG001|Overall Study|Lost to Follow-up|0|||
23486267|NCT00995865|65524283|FG001|Overall Study|Protocol Violation|0|||
23486268|NCT00995865|65524284|FG002|Overall Study|Protocol Violation|0|||
23486269|NCT00995865|65524282|FG000|Overall Study|Lost to Follow-up|0|||
23486270|NCT00995865|65524283|FG001|Overall Study|Lost to Follow-up|0|||
23486271|NCT00995865|65524284|FG002|Overall Study|Lost to Follow-up|1|||
23486272|NCT01236118|65524285|FG000|Overall Study|Adverse Event|2|||
23486273|NCT01236118|65524286|FG001|Overall Study|Adverse Event|0|||
23486274|NCT01236118|65524287|FG002|Overall Study|Adverse Event|2|||
23486275|NCT01236118|65524285|FG000|Overall Study|Physician Decision|0|||
23486276|NCT01236118|65524286|FG001|Overall Study|Physician Decision|1|||
23663879|NCT00923130|66155396|FG000|Overall Study|Stopped treatment due to progression|17|||
23663880|NCT00923130|66155396|FG000|Overall Study|Death|1|||
23663881|NCT00923130|66155396|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
23663882|NCT00923130|66155396|FG000|Overall Study|Switched to alternative treatment|2|||
23663883|NCT00923130|66155396|FG000|Overall Study|Refused further treatment|2|||
23663884|NCT00003895|66155397|FG000|Overall Study|Adverse Event|4|||
23663885|NCT00003895|66155398|FG001|Overall Study|Adverse Event|0|||
23663886|NCT00003895|66155397|FG000|Overall Study|Lack of Efficacy|1|||
23663887|NCT00003895|66155398|FG001|Overall Study|Lack of Efficacy|1|||
23663888|NCT00003895|66155397|FG000|Overall Study|Patient Vacation|2|||
23663889|NCT00003895|66155398|FG001|Overall Study|Patient Vacation|0|||
23663890|NCT00003895|66155397|FG000|Overall Study|Withdrawal by Subject|0|||
23663891|NCT00003895|66155398|FG001|Overall Study|Withdrawal by Subject|3|||
23663892|NCT03703102|66155399|FG000|Overall Study|Adverse Event|4|||
23663893|NCT03703102|66155400|FG001|Overall Study|Adverse Event|3|||
23663894|NCT03703102|66155401|FG002|Overall Study|Adverse Event|7|||
23663895|NCT03703102|66155402|FG003|Overall Study|Adverse Event|3|||
23486277|NCT01236118|65524287|FG002|Overall Study|Physician Decision|0|||
23486278|NCT01236118|65524285|FG000|Overall Study|Withdrawal by Subject|0|||
23486279|NCT01236118|65524286|FG001|Overall Study|Withdrawal by Subject|0|||
23486280|NCT01236118|65524287|FG002|Overall Study|Withdrawal by Subject|1|||
23372146|NCT00505921|65109796|FG000|Overall Study|Ineligible|1|||
23372147|NCT00505921|65109796|FG000|Overall Study|Failed to Mobilize|8|||
23372148|NCT01704261|65109799|FG000|Overall Study|Withdrawal by Subject|12|||
23372149|NCT01704261|65109800|FG001|Overall Study|Withdrawal by Subject|15|||
23372150|NCT01704261|65109799|FG000|Overall Study|Lost to Follow-up|1|||
23372151|NCT01704261|65109800|FG001|Overall Study|Lost to Follow-up|0|||
23372152|NCT03080935|65109818|FG000|Overall Study|Death|34|||
23372153|NCT03080935|65109819|FG001|Overall Study|Death|50|||
23372154|NCT03080935|65109818|FG000|Overall Study|Lost to Follow-up|5|||
23372155|NCT03080935|65109819|FG001|Overall Study|Lost to Follow-up|4|||
23372156|NCT03080935|65109818|FG000|Overall Study|Withdrawal by Subject|11|||
23372157|NCT03080935|65109819|FG001|Overall Study|Withdrawal by Subject|15|||
23372158|NCT02737722|65109820|FG000|Overall Study|Physician Decision|0|||
23663896|NCT03703102|66155403|FG004|Overall Study|Adverse Event|13|||
23486281|NCT01230710|65524288|FG000|Overall Study|Disease Progression|41|||
23486282|NCT01230710|65524288|FG000|Overall Study|Lost to Follow-up|3|||
23486283|NCT01230710|65524288|FG000|Overall Study|Death|4|||
23486284|NCT01230710|65524288|FG000|Overall Study|Withdrawal of Consent|1|||
23486285|NCT03468543|65524291|FG000|Overall Study|Protocol stopping rules met|3|||
23486286|NCT00084838|65524292|FG000|Overall Study|Death|1|||
23486287|NCT00084838|65524292|FG000|Overall Study|Adverse Event|2|||
23486288|NCT00084838|65524292|FG000|Overall Study|Withdrawal by Subject|1|||
23486289|NCT00084838|65524292|FG000|Overall Study|Progressive Disease|4|||
23486290|NCT00084838|65524292|FG000|Overall Study|Pt Non-Compliance|1|||
23486291|NCT00084838|65524292|FG000|Overall Study|Ineligible|4|||
23486292|NCT02514473|65524293|FG000|Overall Study|Adverse Event|0|||
23486293|NCT02514473|65524294|FG001|Overall Study|Adverse Event|2|||
23486294|NCT02514473|65524293|FG000|Overall Study|Withdrawal by Subject|2|||
23486295|NCT02514473|65524294|FG001|Overall Study|Withdrawal by Subject|1|||
23486296|NCT02514473|65524293|FG000|Overall Study|Lost to Follow-up|0|||
23486297|NCT02514473|65524294|FG001|Overall Study|Lost to Follow-up|1|||
23486298|NCT02514473|65524293|FG000|Overall Study|Other|1|||
23486299|NCT02514473|65524294|FG001|Overall Study|Other|1|||
23486300|NCT02280473|65524295|FG000|Overall Study|Adverse Event|1|||
23486301|NCT02280473|65524296|FG001|Overall Study|Adverse Event|1|||
23486302|NCT02280473|65524295|FG000|Overall Study|Lack of Efficacy|0|||
23486303|NCT02280473|65524296|FG001|Overall Study|Lack of Efficacy|1|||
23486304|NCT02280473|65524295|FG000|Overall Study|Lost to Follow-up|0|||
23486305|NCT02280473|65524296|FG001|Overall Study|Lost to Follow-up|1|||
23486306|NCT02821910|65524299|FG000|Overall Study|Withdrawal by Subject|0|||
23486307|NCT02821910|65524300|FG001|Overall Study|Withdrawal by Subject|0|||
23486308|NCT02821910|65524301|FG002|Overall Study|Withdrawal by Subject|1|||
23486309|NCT02821910|65524302|FG003|Overall Study|Withdrawal by Subject|0|||
23486310|NCT02821910|65524303|FG004|Overall Study|Withdrawal by Subject|0|||
23486311|NCT02821910|65524304|FG005|Overall Study|Withdrawal by Subject|1|||
23486312|NCT02821910|65524299|FG000|Overall Study|Other than specified|1|||
23486313|NCT02821910|65524300|FG001|Overall Study|Other than specified|0|||
23486314|NCT02821910|65524301|FG002|Overall Study|Other than specified|1|||
23486315|NCT02821910|65524302|FG003|Overall Study|Other than specified|0|||
23486316|NCT02821910|65524303|FG004|Overall Study|Other than specified|0|||
23486317|NCT02821910|65524304|FG005|Overall Study|Other than specified|0|||
23486318|NCT01151098|65524305|FG000|Overall Study|Adverse Event|82|||
23486319|NCT01151098|65524305|FG000|Overall Study|Lost to Follow-up|6|||
23486320|NCT01151098|65524305|FG000|Overall Study|Lack of Efficacy|15|||
23486321|NCT01151098|65524305|FG000|Overall Study|Protocol Violation|1|||
23486322|NCT01151098|65524305|FG000|Overall Study|Miscellaneous|13|||
23486323|NCT03150485|65524306|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23486324|NCT03150485|65524307|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23372159|NCT02737722|65109821|FG001|Overall Study|Physician Decision|0|||
23372160|NCT02737722|65109822|FG002|Overall Study|Physician Decision|1|||
23372161|NCT02737722|65109823|FG003|Overall Study|Physician Decision|0|||
23372162|NCT03499795|65109825|FG000|Overall Study|Adverse Event|1|||
23372163|NCT03499795|65109825|FG000|Overall Study|Lost to Follow-up|1|||
23372164|NCT01723072|65109826|FG000|Overall Study|Withdrawal by Subject|7|||
23486325|NCT03150485|65524308|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
23486326|NCT03150485|65524309|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
23486327|NCT03150485|65524310|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
23486328|NCT03150485|65524311|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
23486329|NCT00777205|65524312|FG000|Overall Study|Lost to Follow-up|25|||
23486330|NCT00777205|65524313|FG001|Overall Study|Lost to Follow-up|9|||
23486331|NCT00777205|65524312|FG000|Overall Study|Withdrawal by Subject|6|||
23486332|NCT00777205|65524313|FG001|Overall Study|Withdrawal by Subject|4|||
23486333|NCT00777205|65524312|FG000|Overall Study|Death|0|||
23486334|NCT00777205|65524313|FG001|Overall Study|Death|2|||
23486335|NCT00777205|65524312|FG000|Overall Study|Protocol Violation|0|||
23372165|NCT01723072|65109827|FG001|Overall Study|Withdrawal by Subject|13|||
23372166|NCT01723072|65109826|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
23486336|NCT00777205|65524313|FG001|Overall Study|Protocol Violation|56|||
23486337|NCT03282565|65524318|FG000|Overall Study|COVID-19 Research Shutdown|0|||
23486338|NCT03282565|65524319|FG001|Overall Study|COVID-19 Research Shutdown|2|||
23486339|NCT03282565|65524320|FG002|Overall Study|COVID-19 Research Shutdown|2|||
23486340|NCT00920829|65524324|FG000|Allocation|No post randomization data|3|||
23486341|NCT00920829|65524325|FG001|Allocation|No post randomization data|1|||
23486342|NCT00920829|65524326|FG002|Allocation|No post randomization data|0|||
23486343|NCT00920829|65524327|FG003|Allocation|No post randomization data|2|||
23486344|NCT00920829|65524324|FG000|Available for Analysis|Withdrawal by Subject|6|||
23486345|NCT00920829|65524325|FG001|Available for Analysis|Withdrawal by Subject|6|||
23486346|NCT00920829|65524326|FG002|Available for Analysis|Withdrawal by Subject|6|||
23486347|NCT00920829|65524327|FG003|Available for Analysis|Withdrawal by Subject|10|||
23486348|NCT00920829|65524324|FG000|Available for Analysis|Required Medical Treatment|0|||
23486349|NCT00920829|65524325|FG001|Available for Analysis|Required Medical Treatment|1|||
23486350|NCT00920829|65524326|FG002|Available for Analysis|Required Medical Treatment|2|||
23486351|NCT00920829|65524327|FG003|Available for Analysis|Required Medical Treatment|0|||
23486352|NCT00920829|65524324|FG000|Available for Analysis|Adverse Event|1|||
23486353|NCT00920829|65524325|FG001|Available for Analysis|Adverse Event|2|||
23663897|NCT03703102|66155399|FG000|Overall Study|Lack of Efficacy|4|||
23663898|NCT03703102|66155400|FG001|Overall Study|Lack of Efficacy|0|||
23663899|NCT03703102|66155401|FG002|Overall Study|Lack of Efficacy|1|||
23663900|NCT03703102|66155402|FG003|Overall Study|Lack of Efficacy|4|||
23663901|NCT03703102|66155403|FG004|Overall Study|Lack of Efficacy|1|||
23663902|NCT03703102|66155399|FG000|Overall Study|Lost to Follow-up|0|||
23663903|NCT03703102|66155400|FG001|Overall Study|Lost to Follow-up|0|||
23663904|NCT03703102|66155401|FG002|Overall Study|Lost to Follow-up|1|||
23663905|NCT03703102|66155402|FG003|Overall Study|Lost to Follow-up|2|||
23663906|NCT03703102|66155403|FG004|Overall Study|Lost to Follow-up|2|||
23663907|NCT03703102|66155399|FG000|Overall Study|Physician Decision|2|||
23663908|NCT03703102|66155400|FG001|Overall Study|Physician Decision|2|||
23663909|NCT03703102|66155401|FG002|Overall Study|Physician Decision|2|||
23663910|NCT03703102|66155402|FG003|Overall Study|Physician Decision|2|||
23663911|NCT03703102|66155403|FG004|Overall Study|Physician Decision|4|||
23486354|NCT00920829|65524326|FG002|Available for Analysis|Adverse Event|1|||
23663912|NCT03703102|66155399|FG000|Overall Study|Withdrawal by Subject|7|||
23663913|NCT03703102|66155400|FG001|Overall Study|Withdrawal by Subject|5|||
23663914|NCT03703102|66155401|FG002|Overall Study|Withdrawal by Subject|5|||
23663915|NCT03703102|66155402|FG003|Overall Study|Withdrawal by Subject|5|||
23663916|NCT03703102|66155403|FG004|Overall Study|Withdrawal by Subject|9|||
23663917|NCT03703102|66155399|FG000|Overall Study|Ineligibility|0|||
23663918|NCT03703102|66155400|FG001|Overall Study|Ineligibility|0|||
23486355|NCT00920829|65524327|FG003|Available for Analysis|Adverse Event|0|||
23486356|NCT00920829|65524324|FG000|Available for Analysis|Death|1|||
23486357|NCT00920829|65524325|FG001|Available for Analysis|Death|0|||
23372167|NCT01723072|65109827|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
23372168|NCT01723072|65109826|FG000|Overall Study|Other|4|||
23372169|NCT01723072|65109827|FG001|Overall Study|Other|3|||
23372170|NCT02251275|65109835|FG000|Overall Study|Adverse Event|23|||
23372171|NCT02251275|65109836|FG001|Overall Study|Adverse Event|60|||
23372172|NCT02251275|65109837|FG002|Overall Study|Adverse Event|28|||
23372173|NCT02251275|65109838|FG003|Overall Study|Adverse Event|0|||
23372174|NCT02251275|65109839|FG004|Overall Study|Adverse Event|0|||
23372175|NCT02251275|65109835|FG000|Overall Study|Lost to Follow-up|5|||
23372176|NCT02251275|65109836|FG001|Overall Study|Lost to Follow-up|6|||
23372177|NCT02251275|65109837|FG002|Overall Study|Lost to Follow-up|4|||
23372178|NCT02251275|65109838|FG003|Overall Study|Lost to Follow-up|0|||
23372179|NCT02251275|65109839|FG004|Overall Study|Lost to Follow-up|0|||
23372180|NCT02251275|65109835|FG000|Overall Study|Physician Decision|19|||
23372181|NCT02251275|65109836|FG001|Overall Study|Physician Decision|30|||
23372182|NCT02251275|65109837|FG002|Overall Study|Physician Decision|26|||
23372183|NCT02251275|65109838|FG003|Overall Study|Physician Decision|0|||
23372184|NCT02251275|65109839|FG004|Overall Study|Physician Decision|1|||
23372185|NCT02251275|65109835|FG000|Overall Study|Protocol Deviation|0|||
23372186|NCT02251275|65109836|FG001|Overall Study|Protocol Deviation|0|||
23372187|NCT02251275|65109837|FG002|Overall Study|Protocol Deviation|1|||
23372188|NCT02251275|65109838|FG003|Overall Study|Protocol Deviation|0|||
23372189|NCT02251275|65109839|FG004|Overall Study|Protocol Deviation|0|||
23372190|NCT02251275|65109835|FG000|Overall Study|Withdrawal by Subject|25|||
23372191|NCT02251275|65109836|FG001|Overall Study|Withdrawal by Subject|51|||
23372192|NCT02251275|65109837|FG002|Overall Study|Withdrawal by Subject|35|||
23372193|NCT02251275|65109838|FG003|Overall Study|Withdrawal by Subject|1|||
23372194|NCT02251275|65109839|FG004|Overall Study|Withdrawal by Subject|0|||
23372195|NCT01101178|65109840|FG000|Period 1|Withdrawal by Subject|1|||
23372196|NCT01101178|65109841|FG001|Period 1|Withdrawal by Subject|2|||
23372197|NCT01101178|65109840|FG000|Period 1|Positive drug screen|1|||
23372198|NCT01101178|65109841|FG001|Period 1|Positive drug screen|1|||
23372199|NCT01101178|65109840|FG000|Period 1|Adverse Event|2|||
23372200|NCT01101178|65109841|FG001|Period 1|Adverse Event|1|||
23372201|NCT01101178|65109840|FG000|Period 2|Withdrawal by Subject|0|||
23372202|NCT01101178|65109841|FG001|Period 2|Withdrawal by Subject|1|||
23372203|NCT00656617|65109857|FG000|Overall Study|Adverse Event|1|||
23372204|NCT00656617|65109857|FG000|Overall Study|Death|2|||
23663919|NCT03703102|66155401|FG002|Overall Study|Ineligibility|1|||
23663920|NCT03703102|66155402|FG003|Overall Study|Ineligibility|0|||
23663921|NCT03703102|66155403|FG004|Overall Study|Ineligibility|0|||
23663922|NCT03703102|66155399|FG000|Overall Study|Protocol Deviation|4|||
23663923|NCT03703102|66155400|FG001|Overall Study|Protocol Deviation|4|||
23663924|NCT03703102|66155401|FG002|Overall Study|Protocol Deviation|3|||
23663925|NCT03703102|66155402|FG003|Overall Study|Protocol Deviation|0|||
23663926|NCT03703102|66155403|FG004|Overall Study|Protocol Deviation|0|||
23663927|NCT03703102|66155399|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23663928|NCT03703102|66155400|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23663929|NCT03703102|66155401|FG002|Overall Study|Non-Compliance with Study Drug|2|||
23663930|NCT03703102|66155402|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23663931|NCT03703102|66155403|FG004|Overall Study|Non-Compliance with Study Drug|4|||
23663932|NCT04912245|66155404|FG000|Overall Study|Withdrawal by Subject|21|||
23663933|NCT04912245|66155405|FG001|Overall Study|Withdrawal by Subject|4|||
23663934|NCT04912245|66155404|FG000|Overall Study|Lost to Follow-up|5|||
23663935|NCT04912245|66155405|FG001|Overall Study|Lost to Follow-up|11|||
23663936|NCT00530894|66155406|FG000|Overall Study|Death|84|||
23663937|NCT00530894|66155407|FG001|Overall Study|Death|89|||
23663938|NCT00530894|66155408|FG002|Overall Study|Death|55|||
23663939|NCT00530894|66155409|FG003|Overall Study|Death|89|||
23663940|NCT00530894|66155406|FG000|Overall Study|Lost to Follow-up|1|||
23663941|NCT00530894|66155407|FG001|Overall Study|Lost to Follow-up|3|||
23663942|NCT00530894|66155408|FG002|Overall Study|Lost to Follow-up|0|||
23663943|NCT00530894|66155409|FG003|Overall Study|Lost to Follow-up|0|||
23663944|NCT00530894|66155406|FG000|Overall Study|Withdrawal by Subject|1|||
23663945|NCT00530894|66155407|FG001|Overall Study|Withdrawal by Subject|23|||
23663946|NCT00530894|66155408|FG002|Overall Study|Withdrawal by Subject|0|||
23663947|NCT00530894|66155409|FG003|Overall Study|Withdrawal by Subject|5|||
23663948|NCT00530894|66155406|FG000|Overall Study|Alive and censored prior to 1 year|2|||
23663949|NCT00530894|66155407|FG001|Overall Study|Alive and censored prior to 1 year|0|||
23663950|NCT00530894|66155408|FG002|Overall Study|Alive and censored prior to 1 year|0|||
23663951|NCT00530894|66155409|FG003|Overall Study|Alive and censored prior to 1 year|0|||
23663952|NCT04037748|66155413|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23663953|NCT04037748|66155414|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23663954|NCT04037748|66155413|FG000|Treatment Period 1|Adverse Event|1|||
23663955|NCT04037748|66155414|FG001|Treatment Period 1|Adverse Event|1|||
23663956|NCT04037748|66155413|FG000|Treatment Period 1|Protocol Violation|4|||
23663957|NCT04037748|66155414|FG001|Treatment Period 1|Protocol Violation|5|||
23663958|NCT04037748|66155413|FG000|Treatment Period 2|Adverse Event|0|||
23663959|NCT04037748|66155414|FG001|Treatment Period 2|Adverse Event|1|||
23663960|NCT04037748|66155413|FG000|Treatment Period 2|Protocol Violation|2|||
23663961|NCT04037748|66155414|FG001|Treatment Period 2|Protocol Violation|0|||
23663962|NCT00268437|66155415|FG000|Overall Study|Ineligible|1|||
23663963|NCT03335163|66155418|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
23663964|NCT03335163|66155418|FG000|Overall Study|Withdrawal by Subject|18|||
23663965|NCT02665052|66155419|FG000|Overall Study|Lost to Follow-up|1|||
23663966|NCT02665052|66155420|FG001|Overall Study|Lost to Follow-up|0|||
23663967|NCT02665052|66155421|FG002|Overall Study|Lost to Follow-up|0|||
23663968|NCT02665052|66155422|FG003|Overall Study|Lost to Follow-up|0|||
23663969|NCT02665052|66155419|FG000|Overall Study|Withdrawal by Subject|1|||
23663970|NCT02665052|66155420|FG001|Overall Study|Withdrawal by Subject|1|||
23663971|NCT02665052|66155421|FG002|Overall Study|Withdrawal by Subject|0|||
23663972|NCT02665052|66155422|FG003|Overall Study|Withdrawal by Subject|5|||
23663973|NCT02665052|66155419|FG000|Overall Study|Adverse Event|1|||
23486358|NCT00920829|65524326|FG002|Available for Analysis|Death|0|||
23486359|NCT00920829|65524327|FG003|Available for Analysis|Death|0|||
23486360|NCT00920829|65524324|FG000|Available for Analysis|Protocol Violation|0|||
23486361|NCT00920829|65524325|FG001|Available for Analysis|Protocol Violation|0|||
23486362|NCT00920829|65524326|FG002|Available for Analysis|Protocol Violation|1|||
23486363|NCT00920829|65524327|FG003|Available for Analysis|Protocol Violation|0|||
23486364|NCT00920829|65524324|FG000|Available for Analysis|Required more treatment|0|||
23486365|NCT00920829|65524325|FG001|Available for Analysis|Required more treatment|2|||
23486366|NCT00920829|65524326|FG002|Available for Analysis|Required more treatment|0|||
23486367|NCT00920829|65524327|FG003|Available for Analysis|Required more treatment|1|||
23486368|NCT01163032|65524328|FG000|Randomization Phase|Withdrawal by Subject|2|||
23486369|NCT01163032|65524329|FG001|Randomization Phase|Withdrawal by Subject|3|||
23486370|NCT01163032|65524330|FG002|Randomization Phase|Withdrawal by Subject|0|||
23486371|NCT01163032|65524328|FG000|Randomization Phase|Adverse Event|3|||
23486372|NCT01163032|65524329|FG001|Randomization Phase|Adverse Event|3|||
23486373|NCT01163032|65524330|FG002|Randomization Phase|Adverse Event|0|||
23486374|NCT01163032|65524328|FG000|Randomization Phase|Protocol Violation|0|||
23486375|NCT01163032|65524329|FG001|Randomization Phase|Protocol Violation|1|||
23486376|NCT01163032|65524330|FG002|Randomization Phase|Protocol Violation|0|||
23486377|NCT01163032|65524328|FG000|Randomization Phase|Various*|5|||
23486378|NCT01163032|65524329|FG001|Randomization Phase|Various*|4|||
23486379|NCT01163032|65524330|FG002|Randomization Phase|Various*|0|||
23486380|NCT01163032|65524328|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
23486381|NCT01163032|65524329|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
23486382|NCT01163032|65524330|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
23486383|NCT01163032|65524328|FG000|Open Label Extension Phase|Adverse Event|0|||
23486384|NCT01163032|65524329|FG001|Open Label Extension Phase|Adverse Event|0|||
23486385|NCT01163032|65524330|FG002|Open Label Extension Phase|Adverse Event|3|||
23486386|NCT01163032|65524328|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
23486387|NCT01163032|65524329|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
23486388|NCT01163032|65524330|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
23486389|NCT01163032|65524328|FG000|Open Label Extension Phase|Protocol Violation|0|||
23486390|NCT01163032|65524329|FG001|Open Label Extension Phase|Protocol Violation|0|||
23486391|NCT01163032|65524330|FG002|Open Label Extension Phase|Protocol Violation|1|||
23486392|NCT01163032|65524328|FG000|Open Label Extension Phase|Study Termination|0|||
23486393|NCT01163032|65524329|FG001|Open Label Extension Phase|Study Termination|0|||
23486394|NCT01163032|65524330|FG002|Open Label Extension Phase|Study Termination|7|||
23486395|NCT01163032|65524328|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
23486396|NCT01163032|65524329|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
23486397|NCT01163032|65524330|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
23486398|NCT00287079|65524331|FG000|Overall Study|Qualifying relapse|12|||
23486399|NCT00287079|65524332|FG001|Overall Study|Qualifying relapse|1|||
23486400|NCT00287079|65524331|FG000|Overall Study|Non-qualifying relapse|1|||
23486401|NCT00287079|65524332|FG001|Overall Study|Non-qualifying relapse|0|||
23486402|NCT00287079|65524331|FG000|Overall Study|Adverse Event|5|||
23486403|NCT00287079|65524332|FG001|Overall Study|Adverse Event|0|||
23486404|NCT00287079|65524331|FG000|Overall Study|Protocol Violation|1|||
23486405|NCT00287079|65524332|FG001|Overall Study|Protocol Violation|0|||
23486406|NCT00287079|65524331|FG000|Overall Study|Other|3|||
23486407|NCT00287079|65524332|FG001|Overall Study|Other|0|||
23486408|NCT00006389|65524336|FG000|Overall Study|Adverse Event|1|||
23486409|NCT00122278|65524348|FG000|Overall Study|Lost to Follow-up|2|||
23486410|NCT00122278|65524349|FG001|Overall Study|Lost to Follow-up|0|||
23486411|NCT02301988|65524350|FG000|Overall Study|Withdrawal by Subject|2|||
23486412|NCT02301988|65524351|FG001|Overall Study|Withdrawal by Subject|1|||
23486413|NCT02301988|65524350|FG000|Overall Study|Physician Decision|2|||
23486414|NCT02301988|65524351|FG001|Overall Study|Physician Decision|2|||
23486415|NCT02301988|65524350|FG000|Overall Study|Unknown Reason|1|||
23486416|NCT02301988|65524351|FG001|Overall Study|Unknown Reason|3|||
23486417|NCT02301988|65524350|FG000|Overall Study|Lack of Efficacy|3|||
23486418|NCT02301988|65524351|FG001|Overall Study|Lack of Efficacy|2|||
23486419|NCT02301988|65524350|FG000|Overall Study|Death|1|||
23486420|NCT02301988|65524351|FG001|Overall Study|Death|0|||
23486421|NCT02301988|65524350|FG000|Overall Study|Adverse Event|1|||
23486422|NCT02301988|65524351|FG001|Overall Study|Adverse Event|1|||
23663974|NCT02665052|66155420|FG001|Overall Study|Adverse Event|1|||
23486423|NCT02283177|65524352|FG000|Overall Study|Withdrawal by Subject|1|||
23486424|NCT02283177|65524353|FG001|Overall Study|Withdrawal by Subject|1|||
23486425|NCT00470158|65524354|FG000|Overall Study|Death|0|||
23486426|NCT00470158|65524355|FG001|Overall Study|Death|0|||
23486427|NCT00470158|65524356|FG002|Overall Study|Death|0|||
23486428|NCT00470158|65524357|FG003|Overall Study|Death|0|||
23486429|NCT00470158|65524358|FG004|Overall Study|Death|2|||
23486430|NCT00470158|65524354|FG000|Overall Study|Lost to Follow-up|7|||
23486431|NCT00470158|65524355|FG001|Overall Study|Lost to Follow-up|8|||
23486432|NCT00470158|65524356|FG002|Overall Study|Lost to Follow-up|8|||
23486433|NCT00470158|65524357|FG003|Overall Study|Lost to Follow-up|5|||
23663975|NCT02665052|66155421|FG002|Overall Study|Adverse Event|0|||
23663976|NCT02665052|66155422|FG003|Overall Study|Adverse Event|0|||
23663977|NCT01892163|66155426|FG000|Overall Study|Death|1|||
23663978|NCT01892163|66155427|FG001|Overall Study|Death|1|||
23372205|NCT00656617|65109857|FG000|Overall Study|Insurance Issues|2|||
23372206|NCT00656617|65109857|FG000|Overall Study|Move to different clinical trial|2|||
23372207|NCT02119299|65109863|FG000|Overall Study|Withdrawal by Subject|7|||
23372208|NCT02119299|65109863|FG000|Overall Study|Lack of Efficacy|1|||
23372209|NCT02119299|65109863|FG000|Overall Study|Pregnancy|1|||
23372210|NCT03427411|65109864|FG000|Overall Study|Screen failure - platelets too low|0|||
23372211|NCT03427411|65109865|FG001|Overall Study|Screen failure - platelets too low|1|||
23372212|NCT00997334|65109866|FG000|Overall Study|still on therapy|12|||
23372213|NCT00997334|65109866|FG000|Overall Study|Adverse Event|3|||
23372214|NCT00997334|65109866|FG000|Overall Study|Patient non-compliance|1|||
23372215|NCT00997334|65109866|FG000|Overall Study|Withdrawal by Subject|3|||
23372216|NCT00997334|65109866|FG000|Overall Study|Death|2|||
23372217|NCT00997334|65109866|FG000|Overall Study|Urgent Palliative Care|2|||
23372218|NCT00997334|65109866|FG000|Overall Study|No lesion amenable|1|||
23372219|NCT00997334|65109866|FG000|Overall Study|Ineligible|1|||
23372220|NCT03538041|65109868|FG000|12-Week Treatment Period|Adverse Event|1|||
23372221|NCT03538041|65109869|FG001|12-Week Treatment Period|Adverse Event|1|||
23372222|NCT03538041|65109868|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
23372223|NCT03538041|65109869|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
23372224|NCT03538041|65109868|FG000|Treatment Extension Period|Adverse Event|4|||
23663979|NCT01892163|66155426|FG000|Overall Study|Lost to Follow-up|1|||
23663980|NCT01892163|66155427|FG001|Overall Study|Lost to Follow-up|0|||
23663981|NCT02113436|66155428|FG000|Period 1: 8 Weeks|Adverse Event|1|||
23663982|NCT02113436|66155429|FG001|Period 1: 8 Weeks|Adverse Event|0|||
23663983|NCT02113436|66155430|FG002|Period 1: 8 Weeks|Adverse Event|0|||
23663984|NCT02113436|66155431|FG003|Period 1: 8 Weeks|Adverse Event|0|||
23663985|NCT02113436|66155428|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
23663986|NCT02113436|66155429|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
23663987|NCT02113436|66155430|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
23663988|NCT02113436|66155431|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
23663989|NCT02113436|66155428|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
23663990|NCT02113436|66155429|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
23663991|NCT02113436|66155430|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
23663992|NCT02113436|66155431|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
23663993|NCT02113436|66155428|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
23663994|NCT02113436|66155429|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23663995|NCT02113436|66155430|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23663996|NCT02113436|66155431|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23663997|NCT02113436|66155428|FG000|Period 2: 16 Weeks|Adverse Event|0|||
23663998|NCT02113436|66155429|FG001|Period 2: 16 Weeks|Adverse Event|0|||
23663999|NCT02113436|66155430|FG002|Period 2: 16 Weeks|Adverse Event|4|||
23664000|NCT02113436|66155431|FG003|Period 2: 16 Weeks|Adverse Event|5|||
23664001|NCT02113436|66155428|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
23664002|NCT02113436|66155429|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
23664003|NCT02113436|66155430|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
23664004|NCT02113436|66155431|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
23664005|NCT02113436|66155428|FG000|Period 2: 16 Weeks|Physician Decision|0|||
23664006|NCT02113436|66155429|FG001|Period 2: 16 Weeks|Physician Decision|0|||
23664007|NCT02113436|66155430|FG002|Period 2: 16 Weeks|Physician Decision|2|||
23372225|NCT03538041|65109869|FG001|Treatment Extension Period|Adverse Event|0|||
23372226|NCT03538041|65109868|FG000|Treatment Extension Period|Physician Decision|1|||
23372227|NCT03538041|65109869|FG001|Treatment Extension Period|Physician Decision|0|||
23372228|NCT03538041|65109868|FG000|Treatment Extension Period|Lack of Efficacy|1|||
23372229|NCT03538041|65109869|FG001|Treatment Extension Period|Lack of Efficacy|3|||
23372230|NCT03538041|65109868|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
23372231|NCT03538041|65109869|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
23372232|NCT02870868|65109871|FG000|Overall Study|Withdrawal by Subject|2|||
23486434|NCT00470158|65524358|FG004|Overall Study|Lost to Follow-up|4|||
23486435|NCT00470158|65524354|FG000|Overall Study|Protocol Violation|1|||
23486436|NCT00470158|65524355|FG001|Overall Study|Protocol Violation|0|||
23372233|NCT02870868|65109872|FG001|Overall Study|Withdrawal by Subject|1|||
23372234|NCT01850641|65109873|FG000|Overall Study|Physician Decision|1|||
23664008|NCT02113436|66155431|FG003|Period 2: 16 Weeks|Physician Decision|0|||
23664009|NCT02113436|66155428|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
23664010|NCT02113436|66155429|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
23664011|NCT02113436|66155430|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
23372235|NCT01850641|65109873|FG000|Overall Study|Decrease in serum phosphorus|1|||
23372236|NCT01850641|65109873|FG000|Overall Study|Decrease in serum calcium|2|||
23372237|NCT01850641|65109873|FG000|Overall Study|Increase in serum ferritin|1|||
23372238|NCT02785939|65109883|FG000|Overall Study|Progression|25|||
23486437|NCT00470158|65524356|FG002|Overall Study|Protocol Violation|0|||
23372239|NCT02785939|65109884|FG001|Overall Study|Progression|8|||
23372240|NCT02785939|65109883|FG000|Overall Study|Adverse Event|3|||
23372241|NCT02785939|65109884|FG001|Overall Study|Adverse Event|1|||
23372242|NCT02785939|65109883|FG000|Overall Study|Death|1|||
23372243|NCT02785939|65109884|FG001|Overall Study|Death|0|||
23372244|NCT02785939|65109883|FG000|Overall Study|Refusal|1|||
23372245|NCT02785939|65109884|FG001|Overall Study|Refusal|0|||
23372246|NCT02785939|65109883|FG000|Overall Study|Deteriorating health|1|||
23372247|NCT02785939|65109884|FG001|Overall Study|Deteriorating health|0|||
23372248|NCT02785939|65109883|FG000|Overall Study|Not protocol specified|0|||
23372249|NCT02785939|65109884|FG001|Overall Study|Not protocol specified|1|||
23372250|NCT00368108|65109886|FG000|Overall Study|Adverse Event|38|||
23372251|NCT00368108|65109887|FG001|Overall Study|Adverse Event|26|||
23372252|NCT00368108|65109888|FG002|Overall Study|Adverse Event|44|||
23372253|NCT00368108|65109886|FG000|Overall Study|Abnormal Laboratory Value|0|||
23372254|NCT00368108|65109887|FG001|Overall Study|Abnormal Laboratory Value|0|||
23372255|NCT00368108|65109888|FG002|Overall Study|Abnormal Laboratory Value|3|||
23372256|NCT00368108|65109886|FG000|Overall Study|Protocol Violation|5|||
23372257|NCT00368108|65109887|FG001|Overall Study|Protocol Violation|9|||
23372258|NCT00368108|65109888|FG002|Overall Study|Protocol Violation|9|||
23372259|NCT00368108|65109886|FG000|Overall Study|Withdrawal by Subject|9|||
23372260|NCT00368108|65109887|FG001|Overall Study|Withdrawal by Subject|3|||
23372261|NCT00368108|65109888|FG002|Overall Study|Withdrawal by Subject|5|||
23372262|NCT00368108|65109886|FG000|Overall Study|Lack of Efficacy|7|||
23372263|NCT00368108|65109887|FG001|Overall Study|Lack of Efficacy|8|||
23372264|NCT00368108|65109888|FG002|Overall Study|Lack of Efficacy|5|||
23372265|NCT00368108|65109886|FG000|Overall Study|Physician Decision|2|||
23372266|NCT00368108|65109887|FG001|Overall Study|Physician Decision|0|||
23372267|NCT00368108|65109888|FG002|Overall Study|Physician Decision|1|||
23372268|NCT00368108|65109886|FG000|Overall Study|Other|3|||
23372269|NCT00368108|65109887|FG001|Overall Study|Other|7|||
23372270|NCT00368108|65109888|FG002|Overall Study|Other|1|||
23372271|NCT00827567|65109893|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
23372272|NCT00856180|65109898|FG000|Overall Study|Adverse Event|4|||
23372273|NCT00856180|65109898|FG000|Overall Study|Progressive Disease|16|||
23372274|NCT00834041|65109900|FG000|Overall Study|Withdrawal by Subject|1|||
23372275|NCT00834041|65109901|FG001|Overall Study|Withdrawal by Subject|0|||
23372276|NCT00834041|65109900|FG000|Overall Study|Lost to Follow-up|0|||
23372277|NCT00834041|65109901|FG001|Overall Study|Lost to Follow-up|1|||
23372278|NCT02265510|65109902|FG000|Overall Study|Withdrawal by Subject|1|||
23372279|NCT02265510|65109903|FG001|Overall Study|Withdrawal by Subject|1|||
23372280|NCT02265510|65109904|FG002|Overall Study|Withdrawal by Subject|2|||
23372281|NCT02265510|65109905|FG003|Overall Study|Withdrawal by Subject|1|||
23372282|NCT02265510|65109906|FG004|Overall Study|Withdrawal by Subject|0|||
23372283|NCT02265510|65109907|FG005|Overall Study|Withdrawal by Subject|2|||
23372284|NCT02265510|65109908|FG006|Overall Study|Withdrawal by Subject|0|||
23372285|NCT02265510|65109909|FG007|Overall Study|Withdrawal by Subject|2|||
23372286|NCT02265510|65109910|FG008|Overall Study|Withdrawal by Subject|0|||
23372287|NCT02265510|65109911|FG009|Overall Study|Withdrawal by Subject|0|||
23372288|NCT02265510|65109912|FG010|Overall Study|Withdrawal by Subject|0|||
23372289|NCT02265510|65109913|FG011|Overall Study|Withdrawal by Subject|0|||
23372290|NCT02265510|65109914|FG012|Overall Study|Withdrawal by Subject|1|||
23372291|NCT02265510|65109915|FG013|Overall Study|Withdrawal by Subject|0|||
23372292|NCT02265510|65109902|FG000|Overall Study|Disease Progression|0|||
23372293|NCT02265510|65109903|FG001|Overall Study|Disease Progression|1|||
23372294|NCT02265510|65109904|FG002|Overall Study|Disease Progression|2|||
23372295|NCT02265510|65109905|FG003|Overall Study|Disease Progression|1|||
23372296|NCT02265510|65109906|FG004|Overall Study|Disease Progression|1|||
23372297|NCT02265510|65109907|FG005|Overall Study|Disease Progression|0|||
23603628|NCT02470806|65937435|FG000|Overall Study|Physician Decision|0|||
23372298|NCT02265510|65109908|FG006|Overall Study|Disease Progression|0|||
23603629|NCT02470806|65937436|FG001|Overall Study|Physician Decision|3|||
23603630|NCT02470806|65937435|FG000|Overall Study|Withdrawal by Subject|3|||
23603631|NCT02470806|65937436|FG001|Overall Study|Withdrawal by Subject|10|||
23603632|NCT02470806|65937435|FG000|Overall Study|Lack of Efficacy|5|||
23372299|NCT02265510|65109909|FG007|Overall Study|Disease Progression|0|||
23372300|NCT02265510|65109910|FG008|Overall Study|Disease Progression|0|||
23372301|NCT02265510|65109911|FG009|Overall Study|Disease Progression|0|||
23372302|NCT02265510|65109912|FG010|Overall Study|Disease Progression|0|||
23372303|NCT02265510|65109913|FG011|Overall Study|Disease Progression|0|||
23372304|NCT02265510|65109914|FG012|Overall Study|Disease Progression|0|||
23372305|NCT02265510|65109915|FG013|Overall Study|Disease Progression|0|||
23372306|NCT02265510|65109902|FG000|Overall Study|Death|2|||
23372307|NCT02265510|65109903|FG001|Overall Study|Death|0|||
23372308|NCT02265510|65109904|FG002|Overall Study|Death|2|||
23372309|NCT02265510|65109905|FG003|Overall Study|Death|2|||
23372310|NCT02265510|65109906|FG004|Overall Study|Death|1|||
23372311|NCT02265510|65109907|FG005|Overall Study|Death|3|||
23372312|NCT02265510|65109908|FG006|Overall Study|Death|2|||
23372313|NCT02265510|65109909|FG007|Overall Study|Death|1|||
23372314|NCT02265510|65109910|FG008|Overall Study|Death|3|||
23372315|NCT02265510|65109911|FG009|Overall Study|Death|3|||
23372316|NCT02265510|65109912|FG010|Overall Study|Death|4|||
23372317|NCT02265510|65109913|FG011|Overall Study|Death|12|||
23372318|NCT02265510|65109914|FG012|Overall Study|Death|7|||
23372319|NCT02265510|65109915|FG013|Overall Study|Death|6|||
23372320|NCT02265510|65109902|FG000|Overall Study|Lost to Follow-up|0|||
23372321|NCT02265510|65109903|FG001|Overall Study|Lost to Follow-up|0|||
23372322|NCT02265510|65109904|FG002|Overall Study|Lost to Follow-up|0|||
23372323|NCT02265510|65109905|FG003|Overall Study|Lost to Follow-up|0|||
23372324|NCT02265510|65109906|FG004|Overall Study|Lost to Follow-up|1|||
23372325|NCT02265510|65109907|FG005|Overall Study|Lost to Follow-up|0|||
23372326|NCT02265510|65109908|FG006|Overall Study|Lost to Follow-up|0|||
23372327|NCT02265510|65109909|FG007|Overall Study|Lost to Follow-up|0|||
23372328|NCT02265510|65109910|FG008|Overall Study|Lost to Follow-up|0|||
23372329|NCT02265510|65109911|FG009|Overall Study|Lost to Follow-up|2|||
23372330|NCT02265510|65109912|FG010|Overall Study|Lost to Follow-up|0|||
23372331|NCT02265510|65109913|FG011|Overall Study|Lost to Follow-up|0|||
23372332|NCT02265510|65109914|FG012|Overall Study|Lost to Follow-up|0|||
23372333|NCT02265510|65109915|FG013|Overall Study|Lost to Follow-up|2|||
23372334|NCT02265510|65109902|FG000|Overall Study|Other|0|||
23372335|NCT02265510|65109903|FG001|Overall Study|Other|1|||
23372336|NCT02265510|65109904|FG002|Overall Study|Other|0|||
23372337|NCT02265510|65109905|FG003|Overall Study|Other|0|||
23664012|NCT02113436|66155431|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
23664013|NCT00928889|66155432|FG000|Overall Study|Lost to Follow-up|3|||
23664014|NCT00928889|66155433|FG001|Overall Study|Lost to Follow-up|1|||
23664015|NCT00928889|66155432|FG000|Overall Study|Protocol Violation|0|||
23664016|NCT00928889|66155433|FG001|Overall Study|Protocol Violation|1|||
23372338|NCT02265510|65109906|FG004|Overall Study|Other|0|||
23372339|NCT02265510|65109907|FG005|Overall Study|Other|0|||
23372340|NCT02265510|65109908|FG006|Overall Study|Other|0|||
23372341|NCT02265510|65109909|FG007|Overall Study|Other|0|||
23372342|NCT02265510|65109910|FG008|Overall Study|Other|0|||
23372343|NCT02265510|65109911|FG009|Overall Study|Other|0|||
23603633|NCT02470806|65937436|FG001|Overall Study|Lack of Efficacy|15|||
23603634|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
23603635|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
23603636|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
23603637|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
23603638|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
23603639|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
23603640|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Adverse Event|6|||
23603641|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Adverse Event|4|||
23603642|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Adverse Event|8|||
23603643|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
23603644|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
23603645|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
23603646|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603647|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603648|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603649|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
23603650|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
23603651|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
23603652|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
23603653|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
23664017|NCT00928889|66155432|FG000|Overall Study|Adverse Event|1|||
23372344|NCT02265510|65109912|FG010|Overall Study|Other|0|||
23372345|NCT02265510|65109913|FG011|Overall Study|Other|0|||
23372346|NCT02265510|65109914|FG012|Overall Study|Other|0|||
23603654|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
23372347|NCT02265510|65109915|FG013|Overall Study|Other|0|||
23372348|NCT02265510|65109902|FG000|Overall Study|Study Terminated by Sponsor|0|||
23372349|NCT02265510|65109903|FG001|Overall Study|Study Terminated by Sponsor|0|||
23372350|NCT02265510|65109904|FG002|Overall Study|Study Terminated by Sponsor|0|||
23372351|NCT02265510|65109905|FG003|Overall Study|Study Terminated by Sponsor|0|||
23372352|NCT02265510|65109906|FG004|Overall Study|Study Terminated by Sponsor|0|||
23372353|NCT02265510|65109907|FG005|Overall Study|Study Terminated by Sponsor|1|||
23372354|NCT02265510|65109908|FG006|Overall Study|Study Terminated by Sponsor|1|||
23372355|NCT02265510|65109909|FG007|Overall Study|Study Terminated by Sponsor|1|||
23372356|NCT02265510|65109910|FG008|Overall Study|Study Terminated by Sponsor|1|||
23372357|NCT02265510|65109911|FG009|Overall Study|Study Terminated by Sponsor|2|||
23372358|NCT02265510|65109912|FG010|Overall Study|Study Terminated by Sponsor|1|||
23372359|NCT02265510|65109913|FG011|Overall Study|Study Terminated by Sponsor|4|||
23372360|NCT02265510|65109914|FG012|Overall Study|Study Terminated by Sponsor|1|||
23372361|NCT02265510|65109915|FG013|Overall Study|Study Terminated by Sponsor|2|||
23372362|NCT00741611|65109916|FG000|Overall Study|Death|0|||
23372363|NCT00741611|65109917|FG001|Overall Study|Death|0|||
23372364|NCT00741611|65109918|FG002|Overall Study|Death|1|||
23372365|NCT00741611|65109916|FG000|Overall Study|Withdrawal by Subject|0|||
23372366|NCT00741611|65109917|FG001|Overall Study|Withdrawal by Subject|2|||
23372367|NCT00741611|65109918|FG002|Overall Study|Withdrawal by Subject|2|||
23372368|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
23372369|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
23372370|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
23372371|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
23372372|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
23372373|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
23372374|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
23372375|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
23372376|NCT00325416|65109919|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
23372377|NCT00325416|65109920|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
23372378|NCT00325416|65109919|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
23372379|NCT00325416|65109920|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
23372380|NCT02669849|65109921|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23372381|NCT02669849|65109922|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23372382|NCT02669849|65109923|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23372383|NCT02669849|65109921|FG000|Overall Study|Lost to Follow-up|1|||
23372384|NCT02669849|65109922|FG001|Overall Study|Lost to Follow-up|0|||
23372385|NCT02669849|65109923|FG002|Overall Study|Lost to Follow-up|3|||
23372386|NCT02669849|65109921|FG000|Overall Study|Death|1|||
23372387|NCT02669849|65109922|FG001|Overall Study|Death|1|||
23372388|NCT02669849|65109923|FG002|Overall Study|Death|2|||
23372389|NCT02669849|65109921|FG000|Overall Study|Study terminated by sponsor|16|||
23372390|NCT02669849|65109922|FG001|Overall Study|Study terminated by sponsor|1|||
23372391|NCT02669849|65109923|FG002|Overall Study|Study terminated by sponsor|14|||
23372392|NCT02669849|65109921|FG000|Overall Study|Other|0|||
23372393|NCT02669849|65109922|FG001|Overall Study|Other|0|||
23372394|NCT02669849|65109923|FG002|Overall Study|Other|2|||
23372395|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
23372396|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
23372397|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
23372398|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
23372399|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
23372400|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
23372401|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
23372402|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
23372403|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
23372404|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
23372405|NCT02495389|65109931|FG000|Overall Study|Withdrawal by Subject|40|||
23372406|NCT00323063|65109932|FG000|Overall Study|Adverse Event|1|||
23372407|NCT00323063|65109933|FG001|Overall Study|Adverse Event|0|||
23372408|NCT00323063|65109932|FG000|Overall Study|brain mets discovered prior to treatment|1|||
23372409|NCT00323063|65109933|FG001|Overall Study|brain mets discovered prior to treatment|0|||
23372410|NCT00947544|65109934|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
23372411|NCT00947544|65109935|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
23372412|NCT00296517|65109936|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
23372413|NCT00296517|65109937|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
23372414|NCT00296517|65109936|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
23372415|NCT00296517|65109937|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
23372416|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
23372417|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
23372418|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
23372419|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
23372420|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
23372421|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
23372422|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
23372423|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
23372424|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
23372425|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
23372426|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
23372427|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
23372428|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
23372429|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
23372430|NCT03502798|65109938|FG000|Overall Study|equipment failure|0|||
23372431|NCT03502798|65109939|FG001|Overall Study|equipment failure|7|||
23372432|NCT01829347|65109940|FG000|VTI-210|Death|5|||
23372433|NCT01829347|65109941|FG001|VTI-210|Death|3|||
23372434|NCT01829347|65109940|FG000|VTI-210|Withdrawal by Subject|1|||
23372435|NCT01829347|65109941|FG001|VTI-210|Withdrawal by Subject|0|||
23372436|NCT01829347|65109940|FG000|VTI-210E|Death|2|||
23372437|NCT01829347|65109941|FG001|VTI-210E|Death|1|||
23372438|NCT01829347|65109940|FG000|VTI-210E|Study terminated prematurely|1|||
23372439|NCT01829347|65109941|FG001|VTI-210E|Study terminated prematurely|5|||
23372440|NCT00106002|65109942|FG000|Overall Study|Did not take any study drug|1|||
23372441|NCT00106002|65109942|FG000|Overall Study|Ineligible after Registration|1|||
23372442|NCT00529035|65109943|FG000|Overall Study|Withdrawal by Subject|1|||
23372443|NCT01663623|65109944|FG000|Overall Study|Adverse Event|3|||
23372444|NCT01663623|65109945|FG001|Overall Study|Adverse Event|7|||
23372445|NCT01663623|65109944|FG000|Overall Study|Lack of Efficacy|5|||
23372446|NCT01663623|65109945|FG001|Overall Study|Lack of Efficacy|6|||
23372447|NCT01663623|65109944|FG000|Overall Study|Protocol Violation|0|||
23372448|NCT01663623|65109945|FG001|Overall Study|Protocol Violation|1|||
23372449|NCT01663623|65109944|FG000|Overall Study|Other-Study closed/terminated|1|||
23372450|NCT01663623|65109945|FG001|Overall Study|Other-Study closed/terminated|1|||
23486438|NCT00470158|65524357|FG003|Overall Study|Protocol Violation|0|||
23486439|NCT00470158|65524358|FG004|Overall Study|Protocol Violation|0|||
23372451|NCT01663623|65109944|FG000|Overall Study|Physician Decision|1|||
23372452|NCT01663623|65109945|FG001|Overall Study|Physician Decision|4|||
23372453|NCT01663623|65109944|FG000|Overall Study|Withdrawal by Subject|2|||
23372454|NCT01663623|65109945|FG001|Overall Study|Withdrawal by Subject|1|||
23486440|NCT00596362|65524359|FG000|Overall Study|Progressive Disease|1|||
23372455|NCT03805841|65109948|FG000|Overall Study|Clinical Progression|2|||
23372456|NCT03805841|65109949|FG001|Overall Study|Clinical Progression|0|||
23372457|NCT03805841|65109950|FG002|Overall Study|Clinical Progression|0|||
23372458|NCT03805841|65109948|FG000|Overall Study|Death|0|||
23372459|NCT03805841|65109949|FG001|Overall Study|Death|3|||
23603655|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
23372460|NCT03805841|65109950|FG002|Overall Study|Death|1|||
23372461|NCT03805841|65109948|FG000|Overall Study|Lost to Follow-up|0|||
23372462|NCT03805841|65109949|FG001|Overall Study|Lost to Follow-up|0|||
23372463|NCT03805841|65109950|FG002|Overall Study|Lost to Follow-up|1|||
23372464|NCT03805841|65109948|FG000|Overall Study|Withdrawal by Subject|2|||
23372465|NCT03805841|65109949|FG001|Overall Study|Withdrawal by Subject|3|||
23372466|NCT03805841|65109950|FG002|Overall Study|Withdrawal by Subject|0|||
23372467|NCT03805841|65109948|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
23372468|NCT03805841|65109949|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
23372469|NCT03805841|65109950|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
23372470|NCT00984867|65109957|FG000|Overall Study|Adverse Event|3|||
23372471|NCT00984867|65109958|FG001|Overall Study|Adverse Event|7|||
23372472|NCT00984867|65109957|FG000|Overall Study|Death|1|||
23372473|NCT00984867|65109958|FG001|Overall Study|Death|0|||
23372474|NCT00984867|65109957|FG000|Overall Study|Withdrawal by Subject|13|||
23372475|NCT00984867|65109958|FG001|Overall Study|Withdrawal by Subject|4|||
23372476|NCT00984867|65109957|FG000|Overall Study|Lost to Follow-up|3|||
23372477|NCT00984867|65109958|FG001|Overall Study|Lost to Follow-up|4|||
23372478|NCT00984867|65109957|FG000|Overall Study|Poor/non-compliance|0|||
23372479|NCT00984867|65109958|FG001|Overall Study|Poor/non-compliance|1|||
23372480|NCT00984867|65109957|FG000|Overall Study|Subject no longer meets study criteria|1|||
23372481|NCT00984867|65109958|FG001|Overall Study|Subject no longer meets study criteria|1|||
23372482|NCT00984867|65109957|FG000|Overall Study|site closing|1|||
23372483|NCT00984867|65109958|FG001|Overall Study|site closing|0|||
23372484|NCT00984867|65109957|FG000|Overall Study|lack of efficacy and subject compliance|1|||
23372485|NCT00984867|65109958|FG001|Overall Study|lack of efficacy and subject compliance|0|||
23372486|NCT00846365|65109959|FG000|Overall Study|Adverse Event|20|||
23372487|NCT00846365|65109960|FG001|Overall Study|Adverse Event|30|||
23372488|NCT00846365|65109961|FG002|Overall Study|Adverse Event|11|||
23372489|NCT00846365|65109959|FG000|Overall Study|Protocol Violation|5|||
23372490|NCT00846365|65109960|FG001|Overall Study|Protocol Violation|4|||
23372491|NCT00846365|65109961|FG002|Overall Study|Protocol Violation|0|||
23372492|NCT00846365|65109959|FG000|Overall Study|Lost to Follow-up|8|||
23372493|NCT00846365|65109960|FG001|Overall Study|Lost to Follow-up|2|||
23372494|NCT00846365|65109961|FG002|Overall Study|Lost to Follow-up|5|||
23372495|NCT00846365|65109959|FG000|Overall Study|Withdrawal by Subject|11|||
23372496|NCT00846365|65109960|FG001|Overall Study|Withdrawal by Subject|11|||
23372497|NCT00846365|65109961|FG002|Overall Study|Withdrawal by Subject|9|||
23372498|NCT00846365|65109959|FG000|Overall Study|Pregnancy|1|||
23372499|NCT00846365|65109960|FG001|Overall Study|Pregnancy|0|||
23372500|NCT00846365|65109961|FG002|Overall Study|Pregnancy|0|||
23372501|NCT00846365|65109959|FG000|Overall Study|Lack of Efficacy|1|||
23372502|NCT00846365|65109960|FG001|Overall Study|Lack of Efficacy|1|||
23372503|NCT00846365|65109961|FG002|Overall Study|Lack of Efficacy|2|||
23372504|NCT00846365|65109959|FG000|Overall Study|Other|9|||
23372505|NCT00846365|65109960|FG001|Overall Study|Other|1|||
23372506|NCT00846365|65109961|FG002|Overall Study|Other|6|||
23372507|NCT00239720|65109962|FG000|Overall Study|Adverse Event|1|||
23372508|NCT00239720|65109963|FG001|Overall Study|Adverse Event|0|||
23372509|NCT00239720|65109962|FG000|Overall Study|Lost to Follow-up|0|||
23372510|NCT00239720|65109963|FG001|Overall Study|Lost to Follow-up|1|||
23372511|NCT01094288|65109964|FG000|Overall Study|Adverse Event|0|||
23372512|NCT01094288|65109965|FG001|Overall Study|Adverse Event|3|||
23372513|NCT01094288|65109966|FG002|Overall Study|Adverse Event|1|||
23372514|NCT01094288|65109967|FG003|Overall Study|Adverse Event|1|||
23372515|NCT01094288|65109968|FG004|Overall Study|Adverse Event|0|||
23372516|NCT01094288|65109969|FG005|Overall Study|Adverse Event|0|||
23372517|NCT01094288|65109970|FG006|Overall Study|Adverse Event|0|||
23486441|NCT02445391|65524360|FG000|Overall Study|No active protocol treatment|3|||
23486442|NCT02445391|65524361|FG001|Overall Study|No active protocol treatment|0|||
23603656|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
23372518|NCT01094288|65109971|FG007|Overall Study|Adverse Event|0|||
23372519|NCT01094288|65109964|FG000|Overall Study|Withdrawal by Subject|0|||
23372520|NCT01094288|65109965|FG001|Overall Study|Withdrawal by Subject|1|||
23372521|NCT01094288|65109966|FG002|Overall Study|Withdrawal by Subject|2|||
23372522|NCT01094288|65109967|FG003|Overall Study|Withdrawal by Subject|0|||
23372523|NCT01094288|65109968|FG004|Overall Study|Withdrawal by Subject|0|||
23372524|NCT01094288|65109969|FG005|Overall Study|Withdrawal by Subject|0|||
23372525|NCT01094288|65109970|FG006|Overall Study|Withdrawal by Subject|0|||
23372526|NCT01094288|65109971|FG007|Overall Study|Withdrawal by Subject|2|||
23372527|NCT01094288|65109964|FG000|Overall Study|Initiation of Alternative Therapy|0|||
23372528|NCT01094288|65109965|FG001|Overall Study|Initiation of Alternative Therapy|0|||
23372529|NCT01094288|65109966|FG002|Overall Study|Initiation of Alternative Therapy|1|||
23372530|NCT01094288|65109967|FG003|Overall Study|Initiation of Alternative Therapy|0|||
23372531|NCT01094288|65109968|FG004|Overall Study|Initiation of Alternative Therapy|0|||
23372532|NCT01094288|65109969|FG005|Overall Study|Initiation of Alternative Therapy|0|||
23486443|NCT02445391|65524362|FG002|Overall Study|No active protocol treatment|0|||
23486444|NCT02445391|65524360|FG000|Overall Study|Adverse Event|0|||
23486445|NCT02445391|65524361|FG001|Overall Study|Adverse Event|21|||
23486446|NCT02445391|65524362|FG002|Overall Study|Adverse Event|12|||
23486447|NCT02445391|65524360|FG000|Overall Study|Alternative therapy|0|||
23486448|NCT02445391|65524361|FG001|Overall Study|Alternative therapy|0|||
23486449|NCT02445391|65524362|FG002|Overall Study|Alternative therapy|1|||
23486450|NCT02445391|65524360|FG000|Overall Study|Disease progression|0|||
23486451|NCT02445391|65524361|FG001|Overall Study|Disease progression|7|||
23486452|NCT02445391|65524362|FG002|Overall Study|Disease progression|22|||
23486453|NCT02445391|65524360|FG000|Overall Study|Complicating disease|0|||
23486454|NCT02445391|65524361|FG001|Overall Study|Complicating disease|2|||
23486455|NCT02445391|65524362|FG002|Overall Study|Complicating disease|1|||
23486456|NCT02445391|65524360|FG000|Overall Study|Withdrawal by Subject|0|||
23486457|NCT02445391|65524361|FG001|Overall Study|Withdrawal by Subject|4|||
23486458|NCT02445391|65524362|FG002|Overall Study|Withdrawal by Subject|9|||
23486459|NCT02445391|65524360|FG000|Overall Study|Financial issue|0|||
23486460|NCT02445391|65524361|FG001|Overall Study|Financial issue|0|||
23486461|NCT02445391|65524362|FG002|Overall Study|Financial issue|2|||
23486462|NCT02445391|65524360|FG000|Overall Study|Still on treatment|0|||
23486463|NCT02445391|65524361|FG001|Overall Study|Still on treatment|7|||
23486464|NCT02445391|65524362|FG002|Overall Study|Still on treatment|16|||
23486465|NCT02445391|65524360|FG000|Overall Study|Not start protocol therapy|0|||
23486466|NCT02445391|65524361|FG001|Overall Study|Not start protocol therapy|12|||
23486467|NCT02445391|65524362|FG002|Overall Study|Not start protocol therapy|9|||
23486468|NCT02923427|65524364|FG000|Overall Study|convert to laparatomy|2|||
23486469|NCT02923427|65524365|FG001|Overall Study|convert to laparatomy|2|||
23486470|NCT02923427|65524364|FG000|Overall Study|destaturation|1|||
23486471|NCT02923427|65524365|FG001|Overall Study|destaturation|0|||
23486472|NCT02923427|65524364|FG000|Overall Study|can not replace LMA|1|||
23486473|NCT02923427|65524365|FG001|Overall Study|can not replace LMA|0|||
23486474|NCT00301821|65524366|FG000|Overall Study|Ineligible|25|||
23486475|NCT00301821|65524366|FG000|Overall Study|Cancel|1|||
23486476|NCT00989573|65524367|FG000|Overall Study|Adverse Event|8|||
23486477|NCT00989573|65524368|FG001|Overall Study|Adverse Event|12|||
23486478|NCT00989573|65524369|FG002|Overall Study|Adverse Event|4|||
23486479|NCT00989573|65524367|FG000|Overall Study|Physician Decision|0|||
23486480|NCT00989573|65524368|FG001|Overall Study|Physician Decision|2|||
23486481|NCT00989573|65524369|FG002|Overall Study|Physician Decision|0|||
23486482|NCT00989573|65524367|FG000|Overall Study|Protocol Violation|1|||
23486483|NCT00989573|65524368|FG001|Overall Study|Protocol Violation|1|||
23486484|NCT00989573|65524369|FG002|Overall Study|Protocol Violation|1|||
23486485|NCT00989573|65524367|FG000|Overall Study|Withdrawal by Subject|4|||
23486486|NCT00989573|65524368|FG001|Overall Study|Withdrawal by Subject|7|||
23486487|NCT00989573|65524369|FG002|Overall Study|Withdrawal by Subject|3|||
23486488|NCT04250714|65524377|FG000|Overall Study|Treatment - withdrawal by subject|14|||
23486489|NCT04250714|65524377|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
23486490|NCT04250714|65524377|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
23486491|NCT04250714|65524377|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
23486492|NCT04250714|65524377|FG000|Overall Study|Treatment - Death|1|||
23486493|NCT04250714|65524377|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
23486494|NCT04250714|65524377|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
23486495|NCT04250714|65524377|FG000|Overall Study|Attempt|2|||
23486496|NCT04250714|65524377|FG000|Overall Study|Intent|7|||
23486497|NCT02898116|65524379|FG000|Overall Study|Adverse Event|1|||
23486498|NCT02898116|65524379|FG000|Overall Study|Progressive disease|1|||
23486499|NCT02131532|65524380|FG000|Overall Study|Withdrawal by Subject|1|||
23486500|NCT02131532|65524380|FG000|Overall Study|Physician Decision|1|||
23486501|NCT02131532|65524380|FG000|Overall Study|Other health conditions|2|||
23486502|NCT00679055|65524388|FG000|Overall Study|Adverse Event|0|||
23486503|NCT00679055|65524389|FG001|Overall Study|Adverse Event|1|||
23486504|NCT00679055|65524388|FG000|Overall Study|Other|0|||
23486505|NCT00679055|65524389|FG001|Overall Study|Other|3|||
23486506|NCT00679055|65524388|FG000|Overall Study|Study Terminated|2|||
23486507|NCT00679055|65524389|FG001|Overall Study|Study Terminated|1|||
23486508|NCT01002482|65524393|FG000|Overall Study|Withdrawal by Subject|14|||
23486509|NCT01002482|65524394|FG001|Overall Study|Withdrawal by Subject|21|||
23486510|NCT01002482|65524393|FG000|Overall Study|Included twice|1|||
23486511|NCT01002482|65524394|FG001|Overall Study|Included twice|0|||
23486512|NCT00566501|65524395|FG000|Overall Study|Adverse Event|68|||
23486513|NCT00566501|65524396|FG001|Overall Study|Adverse Event|59|||
23486514|NCT00566501|65524395|FG000|Overall Study|Medication Non-compliance|5|||
23486515|NCT00566501|65524396|FG001|Overall Study|Medication Non-compliance|0|||
23486516|NCT00566501|65524395|FG000|Overall Study|Protocol Violation|2|||
23486517|NCT00566501|65524396|FG001|Overall Study|Protocol Violation|2|||
23486518|NCT00566501|65524395|FG000|Overall Study|Request of Investigator or Sponsor|6|||
23486519|NCT00566501|65524396|FG001|Overall Study|Request of Investigator or Sponsor|7|||
23486520|NCT00566501|65524395|FG000|Overall Study|Withdrawal by Subject|33|||
23486521|NCT00566501|65524396|FG001|Overall Study|Withdrawal by Subject|30|||
23486522|NCT00566501|65524395|FG000|Overall Study|Lack of Efficacy|8|||
23486523|NCT00566501|65524396|FG001|Overall Study|Lack of Efficacy|3|||
23486524|NCT00566501|65524395|FG000|Overall Study|Other|25|||
23486525|NCT00566501|65524396|FG001|Overall Study|Other|21|||
23486526|NCT01912963|65524397|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
23486527|NCT01912963|65524398|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
23486528|NCT01912963|65524399|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
23486529|NCT01912963|65524397|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
23486530|NCT01912963|65524398|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
23486531|NCT01912963|65524399|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
23486532|NCT01912963|65524397|FG000|Overall Study|Adverse Event|0|||
23486533|NCT01912963|65524398|FG001|Overall Study|Adverse Event|1|||
23486534|NCT01912963|65524399|FG002|Overall Study|Adverse Event|1|||
23486535|NCT01912963|65524397|FG000|Overall Study|Withdrawal by Subject|0|||
23486536|NCT01912963|65524398|FG001|Overall Study|Withdrawal by Subject|1|||
23486537|NCT01912963|65524399|FG002|Overall Study|Withdrawal by Subject|0|||
23486538|NCT01912963|65524397|FG000|Overall Study|Sought treatment locally|0|||
23486539|NCT01912963|65524398|FG001|Overall Study|Sought treatment locally|1|||
23486540|NCT01912963|65524399|FG002|Overall Study|Sought treatment locally|0|||
23486541|NCT04123665|65524400|FG000|Overall Study|Withdrawal by Subject|7|||
23486542|NCT04123665|65524401|FG001|Overall Study|Withdrawal by Subject|0|||
23486543|NCT04123665|65524400|FG000|Overall Study|Lost to Follow-up|1|||
23486544|NCT04123665|65524401|FG001|Overall Study|Lost to Follow-up|0|||
23486545|NCT03489551|65524402|FG000|Overall Study|Withdrawal by Subject|2|||
23486546|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Adverse Event|10|||
23486547|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Adverse Event|0|||
23486548|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
23486549|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
23486550|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
23486551|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
23486552|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
23486553|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
23486554|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
23486555|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
23486556|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Other than specified|3|||
23486557|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Other than specified|1|||
23486558|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
23486559|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
23486560|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
23486561|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
23486562|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
23486563|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
23486564|NCT01009281|65524410|FG000|Overall Study|Administrative problems|7|||
23486565|NCT01610271|65527198|FG000|Overall Study|Surgery not complete|0|||
23486566|NCT01610271|65527199|FG001|Overall Study|Surgery not complete|1|||
23486567|NCT01610271|65527198|FG000|Overall Study|Prosthesis not implanted|2|||
23486568|NCT01610271|65527199|FG001|Overall Study|Prosthesis not implanted|3|||
23486569|NCT03611010|65527200|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
23486570|NCT03611010|65527201|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486571|NCT03611010|65527202|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486572|NCT03611010|65527203|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486573|NCT03488927|65527204|FG000|Overall Study|Withdrawal by Subject|44|||
23486574|NCT03488927|65527205|FG001|Overall Study|Withdrawal by Subject|118|||
23486575|NCT03488927|65527206|FG002|Overall Study|Withdrawal by Subject|217|||
23486576|NCT01725308|65527213|FG000|Treatment Period I|Did Not Receive Drug|1|||
23486577|NCT01725308|65527214|FG001|Treatment Period I|Did Not Receive Drug|0|||
23486578|NCT01725308|65527215|FG002|Treatment Period I|Did Not Receive Drug|0|||
23486579|NCT01725308|65527213|FG000|Treatment Period I|Adverse Event|5|||
23486580|NCT01725308|65527214|FG001|Treatment Period I|Adverse Event|4|||
23486581|NCT01725308|65527215|FG002|Treatment Period I|Adverse Event|21|||
23486582|NCT01725308|65527213|FG000|Treatment Period I|Insufficient Response|7|||
23486583|NCT01725308|65527214|FG001|Treatment Period I|Insufficient Response|0|||
23486584|NCT01725308|65527215|FG002|Treatment Period I|Insufficient Response|5|||
23486585|NCT01725308|65527213|FG000|Treatment Period I|Worsening of the Target Disease|8|||
23486586|NCT01725308|65527214|FG001|Treatment Period I|Worsening of the Target Disease|0|||
23603657|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
23486587|NCT01725308|65527215|FG002|Treatment Period I|Worsening of the Target Disease|2|||
23486588|NCT01725308|65527213|FG000|Treatment Period I|Changes in the Episodes|3|||
23486589|NCT01725308|65527214|FG001|Treatment Period I|Changes in the Episodes|0|||
23486590|NCT01725308|65527215|FG002|Treatment Period I|Changes in the Episodes|2|||
23486591|NCT01725308|65527213|FG000|Treatment Period I|Withdrawal of Consent|12|||
23486592|NCT01725308|65527214|FG001|Treatment Period I|Withdrawal of Consent|7|||
23486593|NCT01725308|65527215|FG002|Treatment Period I|Withdrawal of Consent|5|||
23486594|NCT01725308|65527213|FG000|Treatment Period I|Lost to Follow-up|3|||
23664018|NCT00928889|66155433|FG001|Overall Study|Adverse Event|0|||
23664019|NCT00928889|66155432|FG000|Overall Study|Other|1|||
23664020|NCT00928889|66155433|FG001|Overall Study|Other|0|||
23664021|NCT02716987|66155434|FG000|Overall Study|Ligand synthesis failure|0|||
23664022|NCT02716987|66155435|FG001|Overall Study|Ligand synthesis failure|0|||
23664023|NCT02716987|66155436|FG002|Overall Study|Ligand synthesis failure|1|||
23664024|NCT02716987|66155437|FG003|Overall Study|Ligand synthesis failure|0|||
23664025|NCT02716987|66155438|FG004|Overall Study|Ligand synthesis failure|0|||
23664026|NCT02716987|66155439|FG005|Overall Study|Ligand synthesis failure|0|||
23664027|NCT02716987|66155434|FG000|Overall Study|Withdrawal by Subject|0|||
23664028|NCT02716987|66155435|FG001|Overall Study|Withdrawal by Subject|0|||
23664029|NCT02716987|66155436|FG002|Overall Study|Withdrawal by Subject|0|||
23664030|NCT02716987|66155437|FG003|Overall Study|Withdrawal by Subject|0|||
23664031|NCT02716987|66155438|FG004|Overall Study|Withdrawal by Subject|1|||
23664032|NCT02716987|66155439|FG005|Overall Study|Withdrawal by Subject|1|||
23664033|NCT01210807|66155440|FG000|Overall Study|Lost to Follow-up|1|||
23664034|NCT01210807|66155441|FG001|Overall Study|Lost to Follow-up|2|||
23664035|NCT01210807|66155440|FG000|Overall Study|Not implanted bilaterally|2|||
23664036|NCT01210807|66155441|FG001|Overall Study|Not implanted bilaterally|1|||
23664037|NCT00916279|66155442|FG000|Overall Study|Death|2|||
23664038|NCT00916279|66155442|FG000|Overall Study|Lost to Follow-up|2|||
23664039|NCT00917150|66155444|FG000|Overall Study|Adverse Event|12|||
23664040|NCT00917150|66155445|FG001|Overall Study|Adverse Event|7|||
23664041|NCT00917150|66155446|FG002|Overall Study|Adverse Event|12|||
23664042|NCT00917150|66155447|FG003|Overall Study|Adverse Event|11|||
23664043|NCT00917150|66155444|FG000|Overall Study|Death|1|||
23664044|NCT00917150|66155445|FG001|Overall Study|Death|4|||
23664045|NCT00917150|66155446|FG002|Overall Study|Death|3|||
23664046|NCT00917150|66155447|FG003|Overall Study|Death|2|||
23664047|NCT00917150|66155444|FG000|Overall Study|Lost to Follow-up|1|||
23664048|NCT00917150|66155445|FG001|Overall Study|Lost to Follow-up|0|||
23664049|NCT00917150|66155446|FG002|Overall Study|Lost to Follow-up|4|||
23664050|NCT00917150|66155447|FG003|Overall Study|Lost to Follow-up|2|||
23664051|NCT00917150|66155444|FG000|Overall Study|Physician Decision|0|||
23664052|NCT00917150|66155445|FG001|Overall Study|Physician Decision|2|||
23664053|NCT00917150|66155446|FG002|Overall Study|Physician Decision|0|||
23664054|NCT00917150|66155447|FG003|Overall Study|Physician Decision|1|||
23664055|NCT00917150|66155444|FG000|Overall Study|Protocol Violation|5|||
23664056|NCT00917150|66155445|FG001|Overall Study|Protocol Violation|5|||
23664057|NCT00917150|66155446|FG002|Overall Study|Protocol Violation|3|||
23664058|NCT00917150|66155447|FG003|Overall Study|Protocol Violation|5|||
23486595|NCT01725308|65527214|FG001|Treatment Period I|Lost to Follow-up|2|||
23486596|NCT01725308|65527215|FG002|Treatment Period I|Lost to Follow-up|2|||
23486597|NCT01725308|65527213|FG000|Treatment Period I|Protocol Deviations|3|||
23486598|NCT01725308|65527214|FG001|Treatment Period I|Protocol Deviations|1|||
23486599|NCT01725308|65527215|FG002|Treatment Period I|Protocol Deviations|1|||
23486600|NCT01725308|65527213|FG000|Treatment Period I|Miscellaneous|2|||
23486601|NCT01725308|65527214|FG001|Treatment Period I|Miscellaneous|0|||
23486602|NCT01725308|65527215|FG002|Treatment Period I|Miscellaneous|3|||
23486603|NCT01725308|65527213|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
23486604|NCT01725308|65527214|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
23664059|NCT00917150|66155444|FG000|Overall Study|Withdrawal by Subject|15|||
23664060|NCT00917150|66155445|FG001|Overall Study|Withdrawal by Subject|16|||
23664061|NCT00917150|66155446|FG002|Overall Study|Withdrawal by Subject|18|||
23664062|NCT00917150|66155447|FG003|Overall Study|Withdrawal by Subject|11|||
23486605|NCT01725308|65527215|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
23486606|NCT01725308|65527213|FG000|Treatment Period II|Did Not Receive Drug|4|||
23486607|NCT01725308|65527214|FG001|Treatment Period II|Did Not Receive Drug|0|||
23664063|NCT00917150|66155444|FG000|Overall Study|Other than specified|3|||
23664064|NCT00917150|66155445|FG001|Overall Study|Other than specified|3|||
23664065|NCT00917150|66155446|FG002|Overall Study|Other than specified|2|||
23664066|NCT00917150|66155447|FG003|Overall Study|Other than specified|2|||
23664067|NCT01349465|66155448|FG000|Overall Study|Adverse Event|1|||
23664068|NCT01349465|66155449|FG001|Overall Study|Adverse Event|0|||
23486608|NCT01725308|65527215|FG002|Treatment Period II|Did Not Receive Drug|0|||
23486609|NCT01725308|65527213|FG000|Treatment Period II|Adverse Event|13|||
23486610|NCT01725308|65527214|FG001|Treatment Period II|Adverse Event|8|||
23486611|NCT01725308|65527215|FG002|Treatment Period II|Adverse Event|20|||
23486612|NCT01725308|65527213|FG000|Treatment Period II|Insufficient Response|2|||
23486613|NCT01725308|65527214|FG001|Treatment Period II|Insufficient Response|4|||
23486614|NCT01725308|65527215|FG002|Treatment Period II|Insufficient Response|6|||
23486615|NCT01725308|65527213|FG000|Treatment Period II|Worsening of the Target Disease|1|||
23486616|NCT01725308|65527214|FG001|Treatment Period II|Worsening of the Target Disease|4|||
23486617|NCT01725308|65527215|FG002|Treatment Period II|Worsening of the Target Disease|2|||
23486618|NCT01725308|65527213|FG000|Treatment Period II|Changes in the Episodes|1|||
23486619|NCT01725308|65527214|FG001|Treatment Period II|Changes in the Episodes|0|||
23486620|NCT01725308|65527215|FG002|Treatment Period II|Changes in the Episodes|5|||
23486621|NCT01725308|65527213|FG000|Treatment Period II|Withdrawal of Consent|28|||
23486622|NCT01725308|65527214|FG001|Treatment Period II|Withdrawal of Consent|2|||
23486623|NCT01725308|65527215|FG002|Treatment Period II|Withdrawal of Consent|16|||
23486624|NCT01725308|65527213|FG000|Treatment Period II|Lost to Follow-up|1|||
23486625|NCT01725308|65527214|FG001|Treatment Period II|Lost to Follow-up|5|||
23486626|NCT01725308|65527215|FG002|Treatment Period II|Lost to Follow-up|3|||
23486627|NCT01725308|65527213|FG000|Treatment Period II|Protocol Deviations|0|||
23486628|NCT01725308|65527214|FG001|Treatment Period II|Protocol Deviations|0|||
23486629|NCT01725308|65527215|FG002|Treatment Period II|Protocol Deviations|1|||
23486630|NCT01725308|65527213|FG000|Treatment Period II|Miscellaneous|5|||
23486631|NCT01725308|65527214|FG001|Treatment Period II|Miscellaneous|3|||
23486632|NCT01725308|65527215|FG002|Treatment Period II|Miscellaneous|7|||
23486633|NCT00744471|65527220|FG000|Overall Study|Randomized but not treated|1|||
23486634|NCT00744471|65527221|FG001|Overall Study|Randomized but not treated|1|||
23486635|NCT00744471|65527222|FG002|Overall Study|Randomized but not treated|4|||
23486636|NCT00744471|65527223|FG003|Overall Study|Randomized but not treated|0|||
23486637|NCT00744471|65527220|FG000|Overall Study|Death|0|||
23486638|NCT00744471|65527221|FG001|Overall Study|Death|0|||
23486639|NCT00744471|65527222|FG002|Overall Study|Death|0|||
23486640|NCT00744471|65527223|FG003|Overall Study|Death|1|||
23486641|NCT00744471|65527220|FG000|Overall Study|Adverse Event|6|||
23486642|NCT00744471|65527221|FG001|Overall Study|Adverse Event|7|||
23486643|NCT00744471|65527222|FG002|Overall Study|Adverse Event|5|||
23486644|NCT00744471|65527223|FG003|Overall Study|Adverse Event|9|||
23486645|NCT00744471|65527220|FG000|Overall Study|Withdrawal by Subject|9|||
23486646|NCT00744471|65527221|FG001|Overall Study|Withdrawal by Subject|9|||
23486647|NCT00744471|65527222|FG002|Overall Study|Withdrawal by Subject|15|||
23486648|NCT00744471|65527223|FG003|Overall Study|Withdrawal by Subject|12|||
23486649|NCT00744471|65527220|FG000|Overall Study|Protocol Violation|1|||
23486650|NCT00744471|65527221|FG001|Overall Study|Protocol Violation|4|||
23486651|NCT00744471|65527222|FG002|Overall Study|Protocol Violation|1|||
23486652|NCT00744471|65527223|FG003|Overall Study|Protocol Violation|2|||
23486653|NCT00744471|65527220|FG000|Overall Study|Entered extension study|41|||
23486654|NCT00744471|65527221|FG001|Overall Study|Entered extension study|84|||
23486655|NCT00744471|65527222|FG002|Overall Study|Entered extension study|100|||
23486656|NCT00744471|65527223|FG003|Overall Study|Entered extension study|91|||
23486657|NCT00744471|65527220|FG000|Overall Study|Other|2|||
23486658|NCT00744471|65527221|FG001|Overall Study|Other|3|||
23372533|NCT01094288|65109970|FG006|Overall Study|Initiation of Alternative Therapy|0|||
23372534|NCT01094288|65109971|FG007|Overall Study|Initiation of Alternative Therapy|0|||
23372535|NCT01094288|65109964|FG000|Overall Study|Reason not Specified|2|||
23372536|NCT01094288|65109965|FG001|Overall Study|Reason not Specified|3|||
23372537|NCT01094288|65109966|FG002|Overall Study|Reason not Specified|0|||
23372538|NCT01094288|65109967|FG003|Overall Study|Reason not Specified|1|||
23372539|NCT01094288|65109968|FG004|Overall Study|Reason not Specified|0|||
23372540|NCT01094288|65109969|FG005|Overall Study|Reason not Specified|0|||
23372541|NCT01094288|65109970|FG006|Overall Study|Reason not Specified|0|||
23372542|NCT01094288|65109971|FG007|Overall Study|Reason not Specified|0|||
23372543|NCT01094288|65109964|FG000|Overall Study|Ongoing Participants|0|||
23372544|NCT01094288|65109965|FG001|Overall Study|Ongoing Participants|3|||
23372545|NCT01094288|65109966|FG002|Overall Study|Ongoing Participants|0|||
23372546|NCT01094288|65109967|FG003|Overall Study|Ongoing Participants|0|||
23372547|NCT01094288|65109968|FG004|Overall Study|Ongoing Participants|0|||
23372548|NCT01094288|65109969|FG005|Overall Study|Ongoing Participants|0|||
23372549|NCT01094288|65109970|FG006|Overall Study|Ongoing Participants|0|||
23372550|NCT01094288|65109971|FG007|Overall Study|Ongoing Participants|0|||
23372551|NCT00003537|65109979|FG000|Overall Study|Not evalauable|1|||
23372552|NCT03093181|65109980|FG000|Overall Study|Withdrawal by Subject|2|||
23486659|NCT00744471|65527222|FG002|Overall Study|Other|6|||
23486660|NCT00744471|65527223|FG003|Overall Study|Other|2|||
23486661|NCT00744471|65527220|FG000|Overall Study|Lack of Efficacy|83|||
23486662|NCT00744471|65527221|FG001|Overall Study|Lack of Efficacy|37|||
23486663|NCT00744471|65527222|FG002|Overall Study|Lack of Efficacy|19|||
23486664|NCT00744471|65527223|FG003|Overall Study|Lack of Efficacy|31|||
23664069|NCT01349465|66155448|FG000|Overall Study|Death|3|||
23664070|NCT01349465|66155449|FG001|Overall Study|Death|0|||
23664071|NCT01349465|66155448|FG000|Overall Study|Lost to Follow-up|10|||
23664072|NCT01349465|66155449|FG001|Overall Study|Lost to Follow-up|1|||
23664073|NCT01349465|66155448|FG000|Overall Study|Withdrawal by Subject|4|||
23664074|NCT01349465|66155449|FG001|Overall Study|Withdrawal by Subject|2|||
23664075|NCT01349465|66155448|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
23664076|NCT01349465|66155449|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
23664077|NCT02246582|66155450|FG000|Overall Study|Withdrawal by Subject|3|||
23664078|NCT02246582|66155451|FG001|Overall Study|Withdrawal by Subject|4|||
23664079|NCT03451084|66155452|FG000|Overall Study|Withdrawal by Subject|2|||
23486665|NCT00744471|65527220|FG000|Overall Study|Lost to Follow-up|0|||
23664080|NCT03451084|66155453|FG001|Overall Study|Withdrawal by Subject|1|||
23664081|NCT03451084|66155454|FG002|Overall Study|Withdrawal by Subject|2|||
23664082|NCT03451084|66155455|FG003|Overall Study|Withdrawal by Subject|1|||
23486666|NCT00744471|65527221|FG001|Overall Study|Lost to Follow-up|0|||
23486667|NCT00744471|65527222|FG002|Overall Study|Lost to Follow-up|2|||
23486668|NCT00744471|65527223|FG003|Overall Study|Lost to Follow-up|0|||
23486669|NCT04597918|65527224|FG000|Overall Study|Withdrawal by Subject|6|||
23486670|NCT04597918|65527224|FG000|Overall Study|Lost to Follow-up|3|||
23486671|NCT04597918|65527224|FG000|Overall Study|Death|1|||
23486672|NCT04073368|65527225|FG000|Overall Study|Adverse Event|2|||
23486673|NCT04073368|65527226|FG001|Overall Study|Adverse Event|0|||
23486674|NCT04073368|65527227|FG002|Overall Study|Adverse Event|1|||
23486675|NCT04073368|65527228|FG003|Overall Study|Adverse Event|1|||
23486676|NCT04073368|65527225|FG000|Overall Study|Withdrawal by Subject|2|||
23486677|NCT04073368|65527226|FG001|Overall Study|Withdrawal by Subject|2|||
23486678|NCT04073368|65527227|FG002|Overall Study|Withdrawal by Subject|1|||
23486679|NCT04073368|65527228|FG003|Overall Study|Withdrawal by Subject|1|||
23486680|NCT04073368|65527225|FG000|Overall Study|Lost to Follow-up|1|||
23486681|NCT04073368|65527226|FG001|Overall Study|Lost to Follow-up|1|||
23486682|NCT04073368|65527227|FG002|Overall Study|Lost to Follow-up|1|||
23486683|NCT04073368|65527228|FG003|Overall Study|Lost to Follow-up|0|||
23486684|NCT04073368|65527225|FG000|Overall Study|Protocol Violation|0|||
23486685|NCT04073368|65527226|FG001|Overall Study|Protocol Violation|1|||
23486686|NCT04073368|65527227|FG002|Overall Study|Protocol Violation|0|||
23486687|NCT04073368|65527228|FG003|Overall Study|Protocol Violation|0|||
23486688|NCT04073368|65527225|FG000|Overall Study|Subject noncompliance|7|||
23486689|NCT04073368|65527226|FG001|Overall Study|Subject noncompliance|4|||
23486690|NCT04073368|65527227|FG002|Overall Study|Subject noncompliance|0|||
23486691|NCT04073368|65527228|FG003|Overall Study|Subject noncompliance|0|||
23486692|NCT00761579|65527229|FG000|Overall Study|Adverse Event|10|||
23486693|NCT00761579|65527229|FG000|Overall Study|Death|2|||
23486694|NCT00761579|65527229|FG000|Overall Study|Lack of Efficacy|21|||
23486695|NCT00761579|65527229|FG000|Overall Study|Lost to Follow-up|16|||
23486696|NCT00761579|65527229|FG000|Overall Study|Pregnancy|1|||
23486697|NCT00761579|65527229|FG000|Overall Study|Withdrawal by Subject|34|||
23486698|NCT00761579|65527229|FG000|Overall Study|Lack of compliance|2|||
23486699|NCT00761579|65527229|FG000|Overall Study|Protocol deviation|1|||
23486700|NCT00761579|65527229|FG000|Overall Study|Drug overdose|1|||
23486701|NCT00761579|65527229|FG000|Overall Study|Aggravation of depression|1|||
23486702|NCT00761579|65527229|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
23486703|NCT00761579|65527229|FG000|Overall Study|Lost survey form|1|||
23486704|NCT00761579|65527229|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
23486705|NCT00072176|65527230|FG000|Overall Study|Withdrawal by Subject|1|||
23486706|NCT00072176|65527231|FG001|Overall Study|Withdrawal by Subject|0|||
23486707|NCT00072176|65527230|FG000|Overall Study|Protocol Violation|0|||
23486708|NCT00072176|65527231|FG001|Overall Study|Protocol Violation|1|||
23486709|NCT01711879|65527232|FG000|Overall Study|Death|1|||
23486710|NCT01711879|65527233|FG001|Overall Study|Death|0|||
23486711|NCT02294773|65527235|FG000|Overall Study|Withdrawal by Subject|0|||
23486712|NCT02294773|65527236|FG001|Overall Study|Withdrawal by Subject|2|||
23603658|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
23486713|NCT02059005|65527238|FG000|Overall Study|Death|1|||
23486714|NCT02059005|65527239|FG001|Overall Study|Death|3|||
23486715|NCT02059005|65527238|FG000|Overall Study|Lost to Follow-up|19|||
23486716|NCT02059005|65527239|FG001|Overall Study|Lost to Follow-up|19|||
23486717|NCT02059005|65527238|FG000|Overall Study|Incarceration|0|||
23486718|NCT02059005|65527239|FG001|Overall Study|Incarceration|1|||
23486719|NCT02059005|65527238|FG000|Overall Study|Inpatient|0|||
23486720|NCT02059005|65527239|FG001|Overall Study|Inpatient|1|||
23486721|NCT00427960|65527240|FG000|Overall Study|Adverse Event|2|||
23486722|NCT00427960|65527241|FG001|Overall Study|Adverse Event|0|||
23486723|NCT00427960|65527240|FG000|Overall Study|Withdrawal by Subject|0|||
23372553|NCT03093181|65109981|FG001|Overall Study|Withdrawal by Subject|1|||
23372554|NCT03093181|65109982|FG002|Overall Study|Withdrawal by Subject|2|||
23372555|NCT03093181|65109980|FG000|Overall Study|Other (Not specified)|1|||
23486724|NCT00427960|65527241|FG001|Overall Study|Withdrawal by Subject|3|||
23372556|NCT03093181|65109981|FG001|Overall Study|Other (Not specified)|0|||
23372557|NCT03093181|65109982|FG002|Overall Study|Other (Not specified)|0|||
23603659|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
23486725|NCT00427960|65527240|FG000|Overall Study|Other|0|||
23486726|NCT00427960|65527241|FG001|Overall Study|Other|1|||
23486727|NCT04163718|65527242|FG000|Overall Study|Study terminated|12|||
23486728|NCT00174291|65527249|FG000|Overall Study|Lost to Follow-up|1|||
23486729|NCT00174291|65527250|FG001|Overall Study|Lost to Follow-up|1|||
23486730|NCT00174291|65527249|FG000|Overall Study|Protocol Violation|0|||
23486731|NCT00174291|65527250|FG001|Overall Study|Protocol Violation|2|||
23486732|NCT00174291|65527249|FG000|Overall Study|Study terminated by sponsor|1|||
23486733|NCT00174291|65527250|FG001|Overall Study|Study terminated by sponsor|0|||
23486734|NCT00174291|65527249|FG000|Overall Study|Withdrawal by Subject|3|||
23486735|NCT00174291|65527250|FG001|Overall Study|Withdrawal by Subject|3|||
23486736|NCT00751621|65527251|FG000|Overall Study|Adverse Event|1|||
23486737|NCT00751621|65527251|FG000|Overall Study|Withdrawal by Subject|1|||
23486738|NCT00751621|65527251|FG000|Overall Study|Subject moved to another country|1|||
23486739|NCT00751621|65527251|FG000|Overall Study|Poor adherence to asthma treatment|1|||
23486740|NCT00433654|65527252|FG000|Overall Study|Death|4|||
23486741|NCT00433654|65527253|FG001|Overall Study|Death|0|||
23664083|NCT03451084|66155452|FG000|Overall Study|Disease recurrence|0|||
23664084|NCT03451084|66155453|FG001|Overall Study|Disease recurrence|2|||
23664085|NCT03451084|66155454|FG002|Overall Study|Disease recurrence|0|||
23664086|NCT03451084|66155455|FG003|Overall Study|Disease recurrence|0|||
23664087|NCT03451084|66155452|FG000|Overall Study|Lack of Efficacy|0|||
23664088|NCT03451084|66155453|FG001|Overall Study|Lack of Efficacy|3|||
23664089|NCT03451084|66155454|FG002|Overall Study|Lack of Efficacy|0|||
23664090|NCT03451084|66155455|FG003|Overall Study|Lack of Efficacy|1|||
23664091|NCT03451084|66155452|FG000|Overall Study|Death|1|||
23664092|NCT03451084|66155453|FG001|Overall Study|Death|0|||
23664093|NCT03451084|66155454|FG002|Overall Study|Death|2|||
23486742|NCT00433654|65527252|FG000|Overall Study|Missed visit|6|||
23486743|NCT00433654|65527253|FG001|Overall Study|Missed visit|3|||
23486744|NCT00433654|65527252|FG000|Overall Study|Subject not yet due for visit|4|||
23486745|NCT00433654|65527253|FG001|Overall Study|Subject not yet due for visit|0|||
23486746|NCT00433654|65527252|FG000|Overall Study|Withdrawal by Subject|1|||
23486747|NCT00433654|65527253|FG001|Overall Study|Withdrawal by Subject|2|||
23486748|NCT01903525|65527255|FG000|Overall Study|Lost to Follow-up|5|||
23486749|NCT01903525|65527256|FG001|Overall Study|Lost to Follow-up|9|||
23486750|NCT01903525|65527255|FG000|Overall Study|Adverse Event|0|||
23486751|NCT01903525|65527256|FG001|Overall Study|Adverse Event|1|||
23486752|NCT03224546|65527259|FG000|Overall Study|Lost to Follow-up|9|||
23486753|NCT03224546|65527260|FG001|Overall Study|Lost to Follow-up|8|||
23486754|NCT03224546|65527261|FG002|Overall Study|Lost to Follow-up|3|||
23486755|NCT03224546|65527259|FG000|Overall Study|Withdrawal by Subject|7|||
23486756|NCT03224546|65527260|FG001|Overall Study|Withdrawal by Subject|14|||
23486757|NCT03224546|65527261|FG002|Overall Study|Withdrawal by Subject|12|||
23664094|NCT03451084|66155455|FG003|Overall Study|Death|0|||
23664095|NCT03451084|66155452|FG000|Overall Study|Physician Decision|0|||
23664096|NCT03451084|66155453|FG001|Overall Study|Physician Decision|0|||
23486758|NCT01931202|65527262|FG000|Overall Study|Withdrawal by Subject|0|||
23486759|NCT01931202|65527263|FG001|Overall Study|Withdrawal by Subject|0|||
23486760|NCT01931202|65527264|FG002|Overall Study|Withdrawal by Subject|2|||
23486761|NCT01931202|65527262|FG000|Overall Study|Lost to Follow-up|0|||
23486762|NCT01931202|65527263|FG001|Overall Study|Lost to Follow-up|5|||
23664097|NCT03451084|66155454|FG002|Overall Study|Physician Decision|2|||
23486763|NCT01931202|65527264|FG002|Overall Study|Lost to Follow-up|2|||
23486764|NCT00997438|65527265|FG000|Overall Study|Blood draw difficulty|2|||
23664098|NCT03451084|66155455|FG003|Overall Study|Physician Decision|2|||
23372558|NCT03093181|65109980|FG000|Overall Study|Adverse Event|0|||
23372559|NCT03093181|65109981|FG001|Overall Study|Adverse Event|1|||
23372560|NCT03093181|65109982|FG002|Overall Study|Adverse Event|0|||
23372561|NCT03093181|65109980|FG000|Overall Study|Other (Protocol violation)|0|||
23372562|NCT03093181|65109981|FG001|Overall Study|Other (Protocol violation)|0|||
23372563|NCT03093181|65109982|FG002|Overall Study|Other (Protocol violation)|1|||
23372564|NCT01787838|65109983|FG000|Overall Study|refused|1413|||
23372565|NCT02229084|65109984|FG000|Overall Study|Adverse Event|1|||
23372566|NCT02229084|65109985|FG001|Overall Study|Adverse Event|0|||
23486765|NCT00997438|65527266|FG001|Overall Study|Blood draw difficulty|0|||
23486766|NCT00997438|65527267|FG002|Overall Study|Blood draw difficulty|1|||
23486767|NCT00997438|65527265|FG000|Overall Study|Withdrawal by Subject|1|||
23486768|NCT00997438|65527266|FG001|Overall Study|Withdrawal by Subject|1|||
23486769|NCT00997438|65527267|FG002|Overall Study|Withdrawal by Subject|0|||
23486770|NCT00997438|65527265|FG000|Overall Study|Exclusion criteria at visit 1|2|||
23372567|NCT02229084|65109986|FG002|Overall Study|Adverse Event|0|||
23372568|NCT02229084|65109987|FG003|Overall Study|Adverse Event|0|||
23372569|NCT02229084|65109988|FG004|Overall Study|Adverse Event|0|||
23372570|NCT02229084|65109989|FG005|Overall Study|Adverse Event|0|||
23372571|NCT02229084|65109990|FG006|Overall Study|Adverse Event|0|||
23372572|NCT02229084|65109984|FG000|Overall Study|Lost to Follow-up|0|||
23372573|NCT02229084|65109985|FG001|Overall Study|Lost to Follow-up|0|||
23372574|NCT02229084|65109986|FG002|Overall Study|Lost to Follow-up|1|||
23372575|NCT02229084|65109987|FG003|Overall Study|Lost to Follow-up|1|||
23372576|NCT02229084|65109988|FG004|Overall Study|Lost to Follow-up|0|||
23372577|NCT02229084|65109989|FG005|Overall Study|Lost to Follow-up|0|||
23372578|NCT02229084|65109990|FG006|Overall Study|Lost to Follow-up|1|||
23372579|NCT02229084|65109984|FG000|Overall Study|Physician Decision|0|||
23372580|NCT02229084|65109985|FG001|Overall Study|Physician Decision|0|||
23372581|NCT02229084|65109986|FG002|Overall Study|Physician Decision|0|||
23372582|NCT02229084|65109987|FG003|Overall Study|Physician Decision|1|||
23372583|NCT02229084|65109988|FG004|Overall Study|Physician Decision|3|||
23372584|NCT02229084|65109989|FG005|Overall Study|Physician Decision|0|||
23372585|NCT02229084|65109990|FG006|Overall Study|Physician Decision|1|||
23486771|NCT00997438|65527266|FG001|Overall Study|Exclusion criteria at visit 1|2|||
23664099|NCT03451084|66155452|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
23372586|NCT02229084|65109984|FG000|Overall Study|Withdrawal by Subject|0|||
23372587|NCT02229084|65109985|FG001|Overall Study|Withdrawal by Subject|0|||
23372588|NCT02229084|65109986|FG002|Overall Study|Withdrawal by Subject|1|||
23372589|NCT02229084|65109987|FG003|Overall Study|Withdrawal by Subject|0|||
23372590|NCT02229084|65109988|FG004|Overall Study|Withdrawal by Subject|1|||
23372591|NCT02229084|65109989|FG005|Overall Study|Withdrawal by Subject|1|||
23372592|NCT02229084|65109990|FG006|Overall Study|Withdrawal by Subject|1|||
23372593|NCT02229084|65109984|FG000|Overall Study|Death|0|||
23372594|NCT02229084|65109985|FG001|Overall Study|Death|0|||
23372595|NCT02229084|65109986|FG002|Overall Study|Death|0|||
23372596|NCT02229084|65109987|FG003|Overall Study|Death|0|||
23372597|NCT02229084|65109988|FG004|Overall Study|Death|0|||
23372598|NCT02229084|65109989|FG005|Overall Study|Death|0|||
23372599|NCT02229084|65109990|FG006|Overall Study|Death|1|||
23372600|NCT02340949|65109991|FG000|Overall Study|Adverse Event|4|||
23372601|NCT02340949|65109992|FG001|Overall Study|Adverse Event|2|||
23372602|NCT02340949|65109991|FG000|Overall Study|Withdrawal by Subject|2|||
23372603|NCT02340949|65109992|FG001|Overall Study|Withdrawal by Subject|0|||
23372604|NCT02340949|65109991|FG000|Overall Study|Progression disease|6|||
23372605|NCT02340949|65109992|FG001|Overall Study|Progression disease|2|||
23372606|NCT02340949|65109991|FG000|Overall Study|Death|3|||
23372607|NCT02340949|65109992|FG001|Overall Study|Death|0|||
23372608|NCT02340949|65109991|FG000|Overall Study|Physician Decision|1|||
23372609|NCT02340949|65109992|FG001|Overall Study|Physician Decision|0|||
23372610|NCT01122173|65109993|FG000|Overall Study|Lost to Follow-up|3|||
23372611|NCT01122173|65109993|FG000|Overall Study|Withdrawal by Subject|3|||
23372612|NCT01122173|65109993|FG000|Overall Study|Left study for other reasons|3|||
23372613|NCT04556760|65109996|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372614|NCT04556760|65109997|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
23372615|NCT04556760|65109998|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372616|NCT04556760|65109999|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372617|NCT04556760|65110000|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372618|NCT04556760|65110001|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372619|NCT04556760|65109996|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372620|NCT04556760|65109997|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372621|NCT04556760|65109998|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372622|NCT04556760|65109999|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
23372623|NCT04556760|65110000|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372624|NCT04556760|65110001|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372625|NCT00853762|65110009|FG000|Overall Study|Premature Termination|16|||
23372626|NCT00853762|65110010|FG001|Overall Study|Premature Termination|15|||
23372627|NCT00853762|65110011|FG002|Overall Study|Premature Termination|14|||
23372628|NCT00853762|65110012|FG003|Overall Study|Premature Termination|21|||
23372629|NCT00853762|65110009|FG000|Overall Study|Protocol Violation|0|||
23372630|NCT00853762|65110010|FG001|Overall Study|Protocol Violation|0|||
23372631|NCT00853762|65110011|FG002|Overall Study|Protocol Violation|0|||
23372632|NCT00853762|65110012|FG003|Overall Study|Protocol Violation|1|||
23372633|NCT00853762|65110009|FG000|Overall Study|Withdrawal by Subject|0|||
23372634|NCT00853762|65110010|FG001|Overall Study|Withdrawal by Subject|0|||
23372635|NCT00853762|65110011|FG002|Overall Study|Withdrawal by Subject|1|||
23372636|NCT00853762|65110012|FG003|Overall Study|Withdrawal by Subject|0|||
23372637|NCT00853762|65110009|FG000|Overall Study|Other|0|||
23372638|NCT00853762|65110010|FG001|Overall Study|Other|2|||
23372639|NCT00853762|65110011|FG002|Overall Study|Other|0|||
23372640|NCT00853762|65110012|FG003|Overall Study|Other|0|||
23486772|NCT00997438|65527267|FG002|Overall Study|Exclusion criteria at visit 1|3|||
23372641|NCT00853762|65110009|FG000|Overall Study|Randomised but not Treated|0|||
23372642|NCT00853762|65110010|FG001|Overall Study|Randomised but not Treated|2|||
23372643|NCT00853762|65110011|FG002|Overall Study|Randomised but not Treated|2|||
23372644|NCT00853762|65110012|FG003|Overall Study|Randomised but not Treated|0|||
23372645|NCT02988661|65110013|FG000|Overall Study|Death|2|||
23372646|NCT02988661|65110014|FG001|Overall Study|Death|18|||
23372647|NCT02988661|65110013|FG000|Overall Study|Lost to Follow-up|0|||
23372648|NCT02988661|65110014|FG001|Overall Study|Lost to Follow-up|33|||
23372649|NCT02988661|65110013|FG000|Overall Study|Withdrawal by Subject|0|||
23372650|NCT02988661|65110014|FG001|Overall Study|Withdrawal by Subject|6|||
23372651|NCT02988661|65110013|FG000|Overall Study|Unable to complete the 18-month survey|1|||
23372652|NCT02988661|65110014|FG001|Overall Study|Unable to complete the 18-month survey|27|||
23372653|NCT02643693|65110021|FG000|Overall Study|Physician Decision|0|||
23372654|NCT02643693|65110022|FG001|Overall Study|Physician Decision|1|||
23372655|NCT02643693|65110023|FG002|Overall Study|Physician Decision|0|||
23372656|NCT02643693|65110024|FG003|Overall Study|Physician Decision|0|||
23372657|NCT02643693|65110025|FG004|Overall Study|Physician Decision|0|||
23372658|NCT02643693|65110026|FG005|Overall Study|Physician Decision|0|||
23372659|NCT02643693|65110021|FG000|Overall Study|Withdrawal by Subject|0|||
23372660|NCT02643693|65110022|FG001|Overall Study|Withdrawal by Subject|1|||
23372661|NCT02643693|65110023|FG002|Overall Study|Withdrawal by Subject|0|||
23372662|NCT02643693|65110024|FG003|Overall Study|Withdrawal by Subject|0|||
23372663|NCT02643693|65110025|FG004|Overall Study|Withdrawal by Subject|0|||
23372664|NCT02643693|65110026|FG005|Overall Study|Withdrawal by Subject|0|||
23372665|NCT02643693|65110021|FG000|Overall Study|Protocol Adherence Issues|2|||
23372666|NCT02643693|65110022|FG001|Overall Study|Protocol Adherence Issues|0|||
23372667|NCT02643693|65110023|FG002|Overall Study|Protocol Adherence Issues|1|||
23372668|NCT02643693|65110024|FG003|Overall Study|Protocol Adherence Issues|0|||
23372669|NCT02643693|65110025|FG004|Overall Study|Protocol Adherence Issues|0|||
23372670|NCT02643693|65110026|FG005|Overall Study|Protocol Adherence Issues|1|||
23372671|NCT01020123|65110027|FG000|Main Period|Withdrawal by Subject|6|||
23372672|NCT01020123|65110028|FG001|Main Period|Withdrawal by Subject|5|||
23372673|NCT01020123|65110029|FG002|Main Period|Withdrawal by Subject|3|||
23372674|NCT01020123|65110030|FG003|Main Period|Withdrawal by Subject|1|||
23372675|NCT01020123|65110031|FG004|Main Period|Withdrawal by Subject|6|||
23372676|NCT01020123|65110032|FG005|Main Period|Withdrawal by Subject|3|||
23372677|NCT01020123|65110033|FG006|Main Period|Withdrawal by Subject|2|||
23372678|NCT01020123|65110027|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
23372679|NCT01020123|65110028|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
23372680|NCT01020123|65110029|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
23372681|NCT01020123|65110030|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
23372682|NCT01020123|65110031|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
23372683|NCT01020123|65110032|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
23372684|NCT01020123|65110033|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
23372685|NCT01020123|65110027|FG000|Main Period|Adverse Event|5|||
23372686|NCT01020123|65110028|FG001|Main Period|Adverse Event|2|||
23372687|NCT01020123|65110029|FG002|Main Period|Adverse Event|2|||
23372688|NCT01020123|65110030|FG003|Main Period|Adverse Event|1|||
23372689|NCT01020123|65110031|FG004|Main Period|Adverse Event|1|||
23372690|NCT01020123|65110032|FG005|Main Period|Adverse Event|2|||
23372691|NCT01020123|65110033|FG006|Main Period|Adverse Event|1|||
23372692|NCT01020123|65110027|FG000|Main Period|Protocol Violation|4|||
23372693|NCT01020123|65110028|FG001|Main Period|Protocol Violation|4|||
23372694|NCT01020123|65110029|FG002|Main Period|Protocol Violation|2|||
23372695|NCT01020123|65110030|FG003|Main Period|Protocol Violation|5|||
23372696|NCT01020123|65110031|FG004|Main Period|Protocol Violation|2|||
23372697|NCT01020123|65110032|FG005|Main Period|Protocol Violation|3|||
23372698|NCT01020123|65110033|FG006|Main Period|Protocol Violation|2|||
23372699|NCT01020123|65110027|FG000|Main Period|Lost to Follow-up|0|||
23372700|NCT01020123|65110028|FG001|Main Period|Lost to Follow-up|2|||
23372701|NCT01020123|65110029|FG002|Main Period|Lost to Follow-up|0|||
23372702|NCT01020123|65110030|FG003|Main Period|Lost to Follow-up|0|||
23372703|NCT01020123|65110031|FG004|Main Period|Lost to Follow-up|0|||
23372704|NCT01020123|65110032|FG005|Main Period|Lost to Follow-up|0|||
23372705|NCT01020123|65110033|FG006|Main Period|Lost to Follow-up|0|||
23372706|NCT01020123|65110027|FG000|Main Period|Unclasified|2|||
23372707|NCT01020123|65110028|FG001|Main Period|Unclasified|0|||
23372708|NCT01020123|65110029|FG002|Main Period|Unclasified|1|||
23372709|NCT01020123|65110030|FG003|Main Period|Unclasified|0|||
23372710|NCT01020123|65110031|FG004|Main Period|Unclasified|1|||
23372711|NCT01020123|65110032|FG005|Main Period|Unclasified|3|||
23372712|NCT01020123|65110033|FG006|Main Period|Unclasified|6|||
23372713|NCT01020123|65110027|FG000|Extention Period|Withdrawal by Subject|2|||
23372714|NCT01020123|65110028|FG001|Extention Period|Withdrawal by Subject|1|||
23372715|NCT01020123|65110029|FG002|Extention Period|Withdrawal by Subject|1|||
23372716|NCT01020123|65110030|FG003|Extention Period|Withdrawal by Subject|0|||
23372717|NCT01020123|65110031|FG004|Extention Period|Withdrawal by Subject|0|||
23372718|NCT01020123|65110032|FG005|Extention Period|Withdrawal by Subject|0|||
23372719|NCT01020123|65110033|FG006|Extention Period|Withdrawal by Subject|0|||
23372720|NCT01020123|65110027|FG000|Extention Period|Adverse Event|0|||
23372721|NCT01020123|65110028|FG001|Extention Period|Adverse Event|0|||
23372722|NCT01020123|65110029|FG002|Extention Period|Adverse Event|0|||
23372723|NCT01020123|65110030|FG003|Extention Period|Adverse Event|1|||
23372724|NCT01020123|65110031|FG004|Extention Period|Adverse Event|0|||
23372725|NCT01020123|65110032|FG005|Extention Period|Adverse Event|0|||
23372726|NCT01020123|65110033|FG006|Extention Period|Adverse Event|0|||
23372727|NCT01020123|65110027|FG000|Extention Period|Protocol Violation|1|||
23372728|NCT01020123|65110028|FG001|Extention Period|Protocol Violation|1|||
23372729|NCT01020123|65110029|FG002|Extention Period|Protocol Violation|1|||
23372730|NCT01020123|65110030|FG003|Extention Period|Protocol Violation|0|||
23372731|NCT01020123|65110031|FG004|Extention Period|Protocol Violation|0|||
23372732|NCT01020123|65110032|FG005|Extention Period|Protocol Violation|0|||
23486773|NCT00625742|65527270|FG000|Overall Study|Disease Progression|2|||
23372733|NCT01020123|65110033|FG006|Extention Period|Protocol Violation|1|||
23372734|NCT01020123|65110027|FG000|Extention Period|Lost to Follow-up|0|||
23372735|NCT01020123|65110028|FG001|Extention Period|Lost to Follow-up|0|||
23372736|NCT01020123|65110029|FG002|Extention Period|Lost to Follow-up|0|||
23372737|NCT01020123|65110030|FG003|Extention Period|Lost to Follow-up|0|||
23372738|NCT01020123|65110031|FG004|Extention Period|Lost to Follow-up|0|||
23372739|NCT01020123|65110032|FG005|Extention Period|Lost to Follow-up|2|||
23372740|NCT01020123|65110033|FG006|Extention Period|Lost to Follow-up|0|||
23372741|NCT00764790|65110034|FG000|Overall Study|Protocol Violation|0|||
23372742|NCT00764790|65110035|FG001|Overall Study|Protocol Violation|0|||
23372743|NCT00764790|65110036|FG002|Overall Study|Protocol Violation|1|||
23372744|NCT00764790|65110034|FG000|Overall Study|Withdrawal by Subject|10|||
23372745|NCT00764790|65110035|FG001|Overall Study|Withdrawal by Subject|12|||
23372746|NCT00764790|65110036|FG002|Overall Study|Withdrawal by Subject|6|||
23372747|NCT00764790|65110034|FG000|Overall Study|Lost to Follow-up|28|||
23372748|NCT00764790|65110035|FG001|Overall Study|Lost to Follow-up|29|||
23372749|NCT00764790|65110036|FG002|Overall Study|Lost to Follow-up|23|||
23372750|NCT04889040|65110037|FG000|Overall Study|Withdrawal by Subject|3|||
23372751|NCT04889040|65110038|FG001|Overall Study|Withdrawal by Subject|3|||
23372752|NCT04889040|65110037|FG000|Overall Study|Lost to Follow-up|0|||
23372753|NCT04889040|65110038|FG001|Overall Study|Lost to Follow-up|1|||
23372754|NCT04889040|65110037|FG000|Overall Study|Adverse Event|2|||
23372755|NCT04889040|65110038|FG001|Overall Study|Adverse Event|1|||
23372756|NCT02513550|65110039|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
23372757|NCT02513550|65110040|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
23372758|NCT02513550|65110041|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
23372759|NCT02513550|65110042|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372760|NCT02513550|65110043|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372761|NCT02513550|65110044|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372762|NCT02513550|65110039|FG000|Double Blind Treatment Period|Adverse Event|5|||
23372763|NCT02513550|65110040|FG001|Double Blind Treatment Period|Adverse Event|13|||
23372764|NCT02513550|65110041|FG002|Double Blind Treatment Period|Adverse Event|17|||
23372765|NCT02513550|65110042|FG003|Double Blind Treatment Period|Adverse Event|0|||
23372766|NCT02513550|65110043|FG004|Double Blind Treatment Period|Adverse Event|1|||
23372767|NCT02513550|65110044|FG005|Double Blind Treatment Period|Adverse Event|0|||
23372768|NCT02513550|65110039|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
23372769|NCT02513550|65110040|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
23372770|NCT02513550|65110041|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
23372771|NCT02513550|65110042|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
23372772|NCT02513550|65110043|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
23372773|NCT02513550|65110044|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
23372774|NCT02513550|65110039|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
23372775|NCT02513550|65110040|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
23372776|NCT02513550|65110041|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
23372777|NCT02513550|65110042|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23372778|NCT02513550|65110043|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23372779|NCT02513550|65110044|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
23372780|NCT02513550|65110039|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23372781|NCT02513550|65110040|FG001|Double Blind Treatment Period|Protocol Violation|1|||
23372782|NCT02513550|65110041|FG002|Double Blind Treatment Period|Protocol Violation|4|||
23372783|NCT02513550|65110042|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23372784|NCT02513550|65110043|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23372785|NCT02513550|65110044|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23372786|NCT02513550|65110039|FG000|Double Blind Treatment Period|Physician Decision|2|||
23372787|NCT02513550|65110040|FG001|Double Blind Treatment Period|Physician Decision|0|||
23372788|NCT02513550|65110041|FG002|Double Blind Treatment Period|Physician Decision|4|||
23372789|NCT02513550|65110042|FG003|Double Blind Treatment Period|Physician Decision|0|||
23372790|NCT02513550|65110043|FG004|Double Blind Treatment Period|Physician Decision|0|||
23372791|NCT02513550|65110044|FG005|Double Blind Treatment Period|Physician Decision|0|||
23372792|NCT02513550|65110039|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
23372793|NCT02513550|65110040|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
23372794|NCT02513550|65110041|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
23372795|NCT02513550|65110042|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372796|NCT02513550|65110043|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372797|NCT02513550|65110044|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372798|NCT02513550|65110039|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372799|NCT02513550|65110040|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372800|NCT02513550|65110041|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
23372801|NCT02513550|65110042|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372802|NCT02513550|65110043|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23486774|NCT00625742|65527270|FG000|Overall Study|Withdrawal by Subject|1|||
23486775|NCT00625742|65527270|FG000|Overall Study|Adverse Event|4|||
23664100|NCT03451084|66155453|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
23664101|NCT03451084|66155454|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
23664102|NCT03451084|66155455|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
23664103|NCT01372150|66155458|FG000|Overall Study|Lack of Efficacy|3|||
23664104|NCT01372150|66155459|FG001|Overall Study|Lack of Efficacy|0|||
23664105|NCT01372150|66155460|FG002|Overall Study|Lack of Efficacy|1|||
23664106|NCT01372150|66155458|FG000|Overall Study|Lost to Follow-up|4|||
23486776|NCT00625742|65527270|FG000|Overall Study|Lost to Follow-up|4|||
23486777|NCT00625742|65527270|FG000|Overall Study|Ineligible|1|||
23486778|NCT00749580|65527272|FG000|Overall Study|Lost to Follow-up|4|||
23486779|NCT00749580|65527273|FG001|Overall Study|Lost to Follow-up|8|||
23486780|NCT00749580|65527272|FG000|Overall Study|Adverse Event|0|||
23372803|NCT02513550|65110044|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372804|NCT02513550|65110039|FG000|Double Blind Treatment Period|Due to personal business|2|||
23372805|NCT02513550|65110040|FG001|Double Blind Treatment Period|Due to personal business|0|||
23372806|NCT02513550|65110041|FG002|Double Blind Treatment Period|Due to personal business|1|||
23372807|NCT02513550|65110042|FG003|Double Blind Treatment Period|Due to personal business|0|||
23372808|NCT02513550|65110043|FG004|Double Blind Treatment Period|Due to personal business|0|||
23372809|NCT02513550|65110044|FG005|Double Blind Treatment Period|Due to personal business|0|||
23372810|NCT02513550|65110039|FG000|Double Blind Treatment Period|Death|1|||
23372811|NCT02513550|65110040|FG001|Double Blind Treatment Period|Death|0|||
23372812|NCT02513550|65110041|FG002|Double Blind Treatment Period|Death|2|||
23372813|NCT02513550|65110042|FG003|Double Blind Treatment Period|Death|0|||
23372814|NCT02513550|65110043|FG004|Double Blind Treatment Period|Death|0|||
23372815|NCT02513550|65110044|FG005|Double Blind Treatment Period|Death|0|||
23372816|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
23372817|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
23372818|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
23372819|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372820|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372821|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372822|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
23372823|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
23372824|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
23372825|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372826|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372827|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372828|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
23372829|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
23372830|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
23372831|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372832|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372833|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372834|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
23372835|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
23372836|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
23372837|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
23372838|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
23372839|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
23372840|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
23372841|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
23372842|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
23372843|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
23372844|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
23372845|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
23372846|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Death|0|||
23372847|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Death|0|||
23372848|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Death|1|||
23372849|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Death|0|||
23372850|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Death|0|||
23372851|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Death|0|||
23372852|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372853|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372854|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
23372855|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372856|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372857|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372858|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372859|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372860|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
23372861|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372862|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372863|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372864|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372865|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
23486781|NCT00749580|65527273|FG001|Overall Study|Adverse Event|1|||
23486782|NCT03911154|65527274|FG000|Overall Study|Withdrawal by Subject|1|||
23664107|NCT01372150|66155459|FG001|Overall Study|Lost to Follow-up|5|||
23486783|NCT02788474|65527278|FG000|Double Blind Treatment Period|Not treated|1|||
23372866|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
23372867|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372868|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372869|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372870|NCT00091819|65110048|FG000|Overall Study|Adverse Event|1|||
23372871|NCT00091819|65110049|FG001|Overall Study|Adverse Event|1|||
23372872|NCT00091819|65110048|FG000|Overall Study|Death|4|||
23372873|NCT00091819|65110049|FG001|Overall Study|Death|5|||
23372874|NCT00091819|65110048|FG000|Overall Study|Lost to Follow-up|26|||
23372875|NCT00091819|65110049|FG001|Overall Study|Lost to Follow-up|23|||
23372876|NCT00091819|65110048|FG000|Overall Study|Withdrawal by Subject|5|||
23372877|NCT00091819|65110049|FG001|Overall Study|Withdrawal by Subject|8|||
23372878|NCT00091819|65110048|FG000|Overall Study|Protocol Violation|1|||
23372879|NCT00091819|65110049|FG001|Overall Study|Protocol Violation|2|||
23372880|NCT00091819|65110048|FG000|Overall Study|Other|2|||
23372881|NCT00091819|65110049|FG001|Overall Study|Other|3|||
23372882|NCT00091819|65110048|FG000|Overall Study|Never received study treatment|3|||
23372883|NCT00091819|65110049|FG001|Overall Study|Never received study treatment|4|||
23372884|NCT01699750|65110050|FG000|Overall Study|Withdrew Consent|0|||
23372885|NCT01699750|65110051|FG001|Overall Study|Withdrew Consent|1|||
23372886|NCT01699750|65110050|FG000|Overall Study|Other|0|||
23372887|NCT01699750|65110051|FG001|Overall Study|Other|2|||
23372888|NCT00321763|65110052|FG000|Overall Study|Adverse Event|1|||
23372889|NCT00321763|65110053|FG001|Overall Study|Adverse Event|1|||
23372890|NCT00321763|65110054|FG002|Overall Study|Adverse Event|0|||
23372891|NCT00321763|65110055|FG003|Overall Study|Adverse Event|1|||
23372892|NCT00321763|65110052|FG000|Overall Study|Withdrawal by Subject|2|||
23372893|NCT00321763|65110053|FG001|Overall Study|Withdrawal by Subject|0|||
23372894|NCT00321763|65110054|FG002|Overall Study|Withdrawal by Subject|1|||
23372895|NCT00321763|65110055|FG003|Overall Study|Withdrawal by Subject|0|||
23372896|NCT00321763|65110052|FG000|Overall Study|Lost to Follow-up|3|||
23372897|NCT00321763|65110053|FG001|Overall Study|Lost to Follow-up|1|||
23372898|NCT00321763|65110054|FG002|Overall Study|Lost to Follow-up|5|||
23372899|NCT00321763|65110055|FG003|Overall Study|Lost to Follow-up|4|||
23372900|NCT03444584|65110056|FG000|Overall Study|Withdrawal by Subject|0|||
23372901|NCT03444584|65110057|FG001|Overall Study|Withdrawal by Subject|1|||
23372902|NCT03444584|65110056|FG000|Overall Study|Other|0|||
23372903|NCT03444584|65110057|FG001|Overall Study|Other|1|||
23372904|NCT03863353|65110058|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
23372905|NCT03863353|65110059|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
23372906|NCT03034967|65110060|FG000|Overall Study|Withdrawal by Subject|9|||
23372907|NCT03034967|65110061|FG001|Overall Study|Withdrawal by Subject|2|||
23372908|NCT03034967|65110062|FG002|Overall Study|Withdrawal by Subject|6|||
23372909|NCT03034967|65110063|FG003|Overall Study|Withdrawal by Subject|6|||
23372910|NCT03034967|65110064|FG004|Overall Study|Withdrawal by Subject|9|||
23372911|NCT03034967|65110065|FG005|Overall Study|Withdrawal by Subject|2|||
23372912|NCT03034967|65110060|FG000|Overall Study|Physician Decision|1|||
23372913|NCT03034967|65110061|FG001|Overall Study|Physician Decision|0|||
23372914|NCT03034967|65110062|FG002|Overall Study|Physician Decision|1|||
23372915|NCT03034967|65110063|FG003|Overall Study|Physician Decision|1|||
23372916|NCT03034967|65110064|FG004|Overall Study|Physician Decision|1|||
23372917|NCT03034967|65110065|FG005|Overall Study|Physician Decision|0|||
23372918|NCT03034967|65110060|FG000|Overall Study|Lost to Follow-up|0|||
23372919|NCT03034967|65110061|FG001|Overall Study|Lost to Follow-up|0|||
23372920|NCT03034967|65110062|FG002|Overall Study|Lost to Follow-up|0|||
23372921|NCT03034967|65110063|FG003|Overall Study|Lost to Follow-up|1|||
23372922|NCT03034967|65110064|FG004|Overall Study|Lost to Follow-up|0|||
23372923|NCT03034967|65110065|FG005|Overall Study|Lost to Follow-up|2|||
23372924|NCT03034967|65110060|FG000|Overall Study|Liver function test abnormality|0|||
23372925|NCT03034967|65110061|FG001|Overall Study|Liver function test abnormality|0|||
23372926|NCT03034967|65110062|FG002|Overall Study|Liver function test abnormality|1|||
23486784|NCT02788474|65527279|FG001|Double Blind Treatment Period|Not treated|0|||
23372927|NCT03034967|65110063|FG003|Overall Study|Liver function test abnormality|0|||
23372928|NCT03034967|65110064|FG004|Overall Study|Liver function test abnormality|0|||
23372929|NCT03034967|65110065|FG005|Overall Study|Liver function test abnormality|0|||
23372930|NCT03034967|65110060|FG000|Overall Study|Protocol Violation|1|||
23372931|NCT03034967|65110061|FG001|Overall Study|Protocol Violation|0|||
23372932|NCT03034967|65110062|FG002|Overall Study|Protocol Violation|0|||
23372933|NCT03034967|65110063|FG003|Overall Study|Protocol Violation|0|||
23372934|NCT03034967|65110064|FG004|Overall Study|Protocol Violation|0|||
23372935|NCT03034967|65110065|FG005|Overall Study|Protocol Violation|2|||
23372936|NCT03034967|65110060|FG000|Overall Study|Lack of Efficacy|0|||
23372937|NCT03034967|65110061|FG001|Overall Study|Lack of Efficacy|1|||
23372938|NCT03034967|65110062|FG002|Overall Study|Lack of Efficacy|2|||
23372939|NCT03034967|65110063|FG003|Overall Study|Lack of Efficacy|1|||
23372940|NCT03034967|65110064|FG004|Overall Study|Lack of Efficacy|1|||
23372941|NCT03034967|65110065|FG005|Overall Study|Lack of Efficacy|0|||
23486785|NCT02788474|65527278|FG000|Double Blind Treatment Period|Patient's refusal|3|||
23664108|NCT01372150|66155460|FG002|Overall Study|Lost to Follow-up|6|||
23664109|NCT01372150|66155458|FG000|Overall Study|Protocol Violation|1|||
23664110|NCT01372150|66155459|FG001|Overall Study|Protocol Violation|0|||
23664111|NCT01372150|66155460|FG002|Overall Study|Protocol Violation|3|||
23664112|NCT01372150|66155458|FG000|Overall Study|Withdrawal by Subject|2|||
23664113|NCT01372150|66155459|FG001|Overall Study|Withdrawal by Subject|7|||
23664114|NCT01372150|66155460|FG002|Overall Study|Withdrawal by Subject|2|||
23664115|NCT01372150|66155458|FG000|Overall Study|Other|1|||
23664116|NCT01372150|66155459|FG001|Overall Study|Other|0|||
23664117|NCT01372150|66155460|FG002|Overall Study|Other|2|||
23664118|NCT01372150|66155458|FG000|Overall Study|Adverse Event|2|||
23664119|NCT01372150|66155459|FG001|Overall Study|Adverse Event|1|||
23664120|NCT01372150|66155460|FG002|Overall Study|Adverse Event|2|||
23664121|NCT01372150|66155458|FG000|Overall Study|Randomized but not treated|0|||
23664122|NCT01372150|66155459|FG001|Overall Study|Randomized but not treated|1|||
23664123|NCT01372150|66155460|FG002|Overall Study|Randomized but not treated|0|||
23664124|NCT03016325|66155461|FG000|Treatment Period|Participant withdrew consent|0|||
23664125|NCT03016325|66155462|FG001|Treatment Period|Participant withdrew consent|1|||
23664126|NCT03016325|66155463|FG002|Treatment Period|Participant withdrew consent|0|||
23664127|NCT03016325|66155464|FG003|Treatment Period|Participant withdrew consent|0|||
23664128|NCT03016325|66155465|FG004|Treatment Period|Participant withdrew consent|0|||
23664129|NCT03016325|66155466|FG005|Treatment Period|Participant withdrew consent|0|||
23664130|NCT03016325|66155467|FG006|Treatment Period|Participant withdrew consent|0|||
23664131|NCT03016325|66155468|FG007|Treatment Period|Participant withdrew consent|0|||
23664132|NCT03016325|66155461|FG000|Treatment Period|Death|0|||
23664133|NCT03016325|66155462|FG001|Treatment Period|Death|0|||
23664134|NCT03016325|66155463|FG002|Treatment Period|Death|0|||
23664135|NCT03016325|66155464|FG003|Treatment Period|Death|0|||
23664136|NCT03016325|66155465|FG004|Treatment Period|Death|2|||
23664137|NCT03016325|66155466|FG005|Treatment Period|Death|0|||
23664138|NCT03016325|66155467|FG006|Treatment Period|Death|0|||
23664139|NCT03016325|66155468|FG007|Treatment Period|Death|0|||
23664140|NCT03016325|66155461|FG000|Treatment Period|Participant refuses assessments|0|||
23664141|NCT03016325|66155462|FG001|Treatment Period|Participant refuses assessments|0|||
23664142|NCT03016325|66155463|FG002|Treatment Period|Participant refuses assessments|1|||
23664143|NCT03016325|66155464|FG003|Treatment Period|Participant refuses assessments|0|||
23664144|NCT03016325|66155465|FG004|Treatment Period|Participant refuses assessments|0|||
23664145|NCT03016325|66155466|FG005|Treatment Period|Participant refuses assessments|0|||
23664146|NCT03016325|66155467|FG006|Treatment Period|Participant refuses assessments|0|||
23664147|NCT03016325|66155468|FG007|Treatment Period|Participant refuses assessments|0|||
23664148|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Death|2|||
23664149|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Death|0|||
23664150|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Death|5|||
23664151|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Death|6|||
23664152|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Death|3|||
23664153|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Death|0|||
23664154|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Death|0|||
23372942|NCT03034967|65110060|FG000|Overall Study|Adverse Event, non-fatal|3|||
23372943|NCT03034967|65110061|FG001|Overall Study|Adverse Event, non-fatal|1|||
23372944|NCT03034967|65110062|FG002|Overall Study|Adverse Event, non-fatal|2|||
23372945|NCT03034967|65110063|FG003|Overall Study|Adverse Event, non-fatal|0|||
23372946|NCT03034967|65110064|FG004|Overall Study|Adverse Event, non-fatal|2|||
23372947|NCT03034967|65110065|FG005|Overall Study|Adverse Event, non-fatal|8|||
23372948|NCT03034967|65110060|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
23372949|NCT03034967|65110061|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
23372950|NCT03034967|65110062|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
23372951|NCT03034967|65110063|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
23372952|NCT03034967|65110064|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
23372953|NCT03034967|65110065|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
23372954|NCT03257267|65112520|FG000|Overall Study|Adverse Event|17|||
23372955|NCT03257267|65112521|FG001|Overall Study|Adverse Event|7|||
23372956|NCT03257267|65112520|FG000|Overall Study|Death|96|||
23372957|NCT03257267|65112521|FG001|Overall Study|Death|98|||
23372958|NCT03257267|65112520|FG000|Overall Study|Lost to Follow-up|2|||
23372959|NCT03257267|65112521|FG001|Overall Study|Lost to Follow-up|2|||
23372960|NCT03257267|65112520|FG000|Overall Study|Non-compliance with Study Drug|0|||
23372961|NCT03257267|65112521|FG001|Overall Study|Non-compliance with Study Drug|2|||
23372962|NCT03257267|65112520|FG000|Overall Study|Participant Decision|35|||
23372963|NCT03257267|65112521|FG001|Overall Study|Participant Decision|43|||
23372964|NCT03257267|65112520|FG000|Overall Study|Sponsor Decision|1|||
23372965|NCT03257267|65112521|FG001|Overall Study|Sponsor Decision|0|||
23372966|NCT03257267|65112520|FG000|Overall Study|Physician Decision|1|||
23372967|NCT03257267|65112521|FG001|Overall Study|Physician Decision|3|||
23372968|NCT03257267|65112520|FG000|Overall Study|Disease Progression|109|||
23372969|NCT03257267|65112521|FG001|Overall Study|Disease Progression|121|||
23372970|NCT03257267|65112520|FG000|Overall Study|Withdrawal by Subject|8|||
23372971|NCT03257267|65112521|FG001|Overall Study|Withdrawal by Subject|26|||
23372972|NCT03257267|65112520|FG000|Overall Study|Other|0|||
23372973|NCT03257267|65112521|FG001|Overall Study|Other|2|||
23372974|NCT01721798|65112528|FG000|Overall Study|Death|0|||
23372975|NCT01721798|65112529|FG001|Overall Study|Death|0|||
23372976|NCT01721798|65112530|FG002|Overall Study|Death|1|||
23372977|NCT01721798|65112531|FG003|Overall Study|Death|1|||
23372978|NCT01721798|65112528|FG000|Overall Study|Lost to Follow-up|2|||
23372979|NCT01721798|65112529|FG001|Overall Study|Lost to Follow-up|2|||
23372980|NCT01721798|65112530|FG002|Overall Study|Lost to Follow-up|9|||
23372981|NCT01721798|65112531|FG003|Overall Study|Lost to Follow-up|9|||
23372982|NCT01721798|65112528|FG000|Overall Study|Pregnancy|0|||
23372983|NCT01721798|65112529|FG001|Overall Study|Pregnancy|0|||
23372984|NCT01721798|65112530|FG002|Overall Study|Pregnancy|1|||
23372985|NCT01721798|65112531|FG003|Overall Study|Pregnancy|1|||
23372986|NCT01721798|65112528|FG000|Overall Study|Withdrawal by Subject|1|||
23372987|NCT01721798|65112529|FG001|Overall Study|Withdrawal by Subject|0|||
23372988|NCT01721798|65112530|FG002|Overall Study|Withdrawal by Subject|2|||
23372989|NCT01721798|65112531|FG003|Overall Study|Withdrawal by Subject|1|||
23372990|NCT01721798|65112528|FG000|Overall Study|Not eligible for 24 month visit|1|||
23372991|NCT01721798|65112529|FG001|Overall Study|Not eligible for 24 month visit|0|||
23372992|NCT01721798|65112530|FG002|Overall Study|Not eligible for 24 month visit|8|||
23372993|NCT01721798|65112531|FG003|Overall Study|Not eligible for 24 month visit|7|||
23372994|NCT01030900|65112536|FG000|Overall Study|Not treated due to congestive heart failure|1|||
23372995|NCT01030900|65112536|FG000|Overall Study|Not treated due to rapid disease|1|||
23372996|NCT01569022|65112541|FG000|First Intervention|Lost to Follow-up|2|||
23372997|NCT01569022|65112542|FG001|First Intervention|Lost to Follow-up|1|||
23372998|NCT01569022|65112541|FG000|Second Intervention|Lost to Follow-up|2|||
23372999|NCT01569022|65112542|FG001|Second Intervention|Lost to Follow-up|2|||
23373000|NCT00537277|65112543|FG000|Overall Study|Adverse Event|1|||
23373001|NCT00537277|65112543|FG000|Overall Study|Lack of Efficacy|2|||
23373002|NCT00537277|65112543|FG000|Overall Study|Lost to Follow-up|12|||
23373003|NCT00537277|65112543|FG000|Overall Study|Protocol Violation|11|||
23373004|NCT00537277|65112543|FG000|Overall Study|Unclassified|4|||
23373005|NCT00537277|65112543|FG000|Overall Study|Inability to tolerate trial medication|4|||
23373006|NCT00537277|65112543|FG000|Overall Study|Non-compliance with trial procedures|15|||
23373007|NCT00171249|65112551|FG000|Overall Study|Withdrawal by Subject|2|||
23373008|NCT00171249|65112552|FG001|Overall Study|Withdrawal by Subject|0|||
23373009|NCT00171249|65112553|FG002|Overall Study|Withdrawal by Subject|0|||
23373010|NCT00171249|65112554|FG003|Overall Study|Withdrawal by Subject|6|||
23373011|NCT00171249|65112555|FG004|Overall Study|Withdrawal by Subject|0|||
23373012|NCT00171249|65112556|FG005|Overall Study|Withdrawal by Subject|0|||
23373013|NCT00171249|65112557|FG006|Overall Study|Withdrawal by Subject|0|||
23373014|NCT00171249|65112551|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
23373015|NCT00171249|65112552|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23373016|NCT00171249|65112553|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
23373017|NCT00171249|65112554|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
23373018|NCT00171249|65112555|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23373019|NCT00171249|65112556|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
23373020|NCT00171249|65112557|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23373021|NCT00171249|65112551|FG000|Overall Study|Death|7|||
23373022|NCT00171249|65112552|FG001|Overall Study|Death|1|||
23373023|NCT00171249|65112553|FG002|Overall Study|Death|0|||
23373024|NCT00171249|65112554|FG003|Overall Study|Death|4|||
23373025|NCT00171249|65112555|FG004|Overall Study|Death|0|||
23373026|NCT00171249|65112556|FG005|Overall Study|Death|3|||
23373027|NCT00171249|65112557|FG006|Overall Study|Death|1|||
23373028|NCT00171249|65112551|FG000|Overall Study|Other|10|||
23373029|NCT00171249|65112552|FG001|Overall Study|Other|0|||
23373030|NCT00171249|65112553|FG002|Overall Study|Other|0|||
23373031|NCT00171249|65112554|FG003|Overall Study|Other|43|||
23373032|NCT00171249|65112555|FG004|Overall Study|Other|0|||
23373033|NCT00171249|65112556|FG005|Overall Study|Other|2|||
23373034|NCT00171249|65112557|FG006|Overall Study|Other|0|||
23373035|NCT00171249|65112551|FG000|Overall Study|No Longer Requires Study Drug|4|||
23373036|NCT00171249|65112552|FG001|Overall Study|No Longer Requires Study Drug|0|||
23373037|NCT00171249|65112553|FG002|Overall Study|No Longer Requires Study Drug|0|||
23373038|NCT00171249|65112554|FG003|Overall Study|No Longer Requires Study Drug|3|||
23373039|NCT00171249|65112555|FG004|Overall Study|No Longer Requires Study Drug|0|||
23373040|NCT00171249|65112556|FG005|Overall Study|No Longer Requires Study Drug|5|||
23373041|NCT00171249|65112557|FG006|Overall Study|No Longer Requires Study Drug|0|||
23373042|NCT00171249|65112551|FG000|Overall Study|Administrative Problems|1|||
23373043|NCT00171249|65112552|FG001|Overall Study|Administrative Problems|0|||
23373044|NCT00171249|65112553|FG002|Overall Study|Administrative Problems|0|||
23373045|NCT00171249|65112554|FG003|Overall Study|Administrative Problems|2|||
23373046|NCT00171249|65112555|FG004|Overall Study|Administrative Problems|0|||
23373047|NCT00171249|65112556|FG005|Overall Study|Administrative Problems|0|||
23373048|NCT00171249|65112557|FG006|Overall Study|Administrative Problems|0|||
23373049|NCT00171249|65112551|FG000|Overall Study|Adverse Event|3|||
23373050|NCT00171249|65112552|FG001|Overall Study|Adverse Event|1|||
23373051|NCT00171249|65112553|FG002|Overall Study|Adverse Event|0|||
23373052|NCT00171249|65112554|FG003|Overall Study|Adverse Event|15|||
23373053|NCT00171249|65112555|FG004|Overall Study|Adverse Event|0|||
23373054|NCT00171249|65112556|FG005|Overall Study|Adverse Event|2|||
23373055|NCT00171249|65112557|FG006|Overall Study|Adverse Event|0|||
23373056|NCT00171249|65112551|FG000|Overall Study|Lost to Follow-up|5|||
23373057|NCT00171249|65112552|FG001|Overall Study|Lost to Follow-up|0|||
23373058|NCT00171249|65112553|FG002|Overall Study|Lost to Follow-up|0|||
23373059|NCT00171249|65112554|FG003|Overall Study|Lost to Follow-up|9|||
23373060|NCT00171249|65112555|FG004|Overall Study|Lost to Follow-up|0|||
23373061|NCT00171249|65112556|FG005|Overall Study|Lost to Follow-up|0|||
23373062|NCT00171249|65112557|FG006|Overall Study|Lost to Follow-up|0|||
23373063|NCT01868646|65112558|FG000|Overall Study|Do not meet inclusion criteria|3|||
23373064|NCT01868646|65112559|FG001|Overall Study|Do not meet inclusion criteria|5|||
23373065|NCT00719901|65112563|FG000|Overall Study|Adverse Event|5|||
23373066|NCT00719901|65112563|FG000|Overall Study|Withdrawal by Subject|1|||
23373067|NCT00719901|65112563|FG000|Overall Study|Alternate Treatment|1|||
23373068|NCT00719901|65112563|FG000|Overall Study|Disease Progression|3|||
23486786|NCT02788474|65527279|FG001|Double Blind Treatment Period|Patient's refusal|0|||
23373069|NCT00719901|65112563|FG000|Overall Study|Availability of Study Drug|1|||
23373070|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
23373071|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373072|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373073|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373074|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
23373075|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373076|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373077|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373078|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
23373079|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
23373080|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
23373081|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
23373082|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
23373083|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373084|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373085|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373086|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
23373087|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
23373088|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
23373089|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
23373090|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
23373091|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373092|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373093|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373094|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
23373095|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373096|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373097|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373098|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
23373099|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373100|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373101|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373102|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373103|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
23373104|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373105|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373106|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373107|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
23373108|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373109|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373110|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
23373111|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
23373112|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
23373113|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
23373114|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23664155|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Death|0|||
23373115|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
23373116|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23373117|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23373118|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373119|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
23373120|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373121|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373122|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373123|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
23373124|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373125|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373126|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373127|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
23373128|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373129|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373130|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373131|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
23373132|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373133|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373134|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
23373135|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
23373136|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
23373137|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
23373138|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
23373139|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
23373140|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
23373141|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
23373142|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
23373143|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
23373144|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
23373145|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
23373146|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
23373147|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
23373148|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
23373149|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
23373150|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373151|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373152|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
23373153|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373154|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
23373155|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
23373156|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
23373157|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
23373158|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
23373159|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
23373160|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
23373161|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
23373162|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
23373163|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
23373164|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
23373165|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
23373166|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
23373167|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
23373168|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
23373169|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
23373170|NCT01349595|65112568|FG000|Overall Study|Lack of funding|2|||
23373171|NCT01349595|65112569|FG001|Overall Study|Lack of funding|2|||
23373172|NCT00069264|65112570|FG000|Overall Study|Adverse Event|3|||
23373173|NCT00069264|65112570|FG000|Overall Study|Progressive Disease|23|||
23373174|NCT00069264|65112570|FG000|Overall Study|Withdrawal by Subject|3|||
23373175|NCT00069264|65112570|FG000|Overall Study|Discon Therapy|3|||
23373176|NCT05412134|65112579|FG000|Overall Study|Lost to Follow-up|2|||
23373177|NCT05412134|65112580|FG001|Overall Study|Lost to Follow-up|0|||
23373178|NCT00487188|65112581|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
23373179|NCT00487188|65112582|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
23373180|NCT00487188|65112583|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
23373181|NCT00487188|65112581|FG000|Induction Phase|Adverse Event|5|||
23373182|NCT00487188|65112582|FG001|Induction Phase|Adverse Event|0|||
23373183|NCT00487188|65112583|FG002|Induction Phase|Adverse Event|0|||
23373184|NCT00487188|65112581|FG000|Induction Phase|Lack of Efficacy|0|||
23373185|NCT00487188|65112582|FG001|Induction Phase|Lack of Efficacy|1|||
23373186|NCT00487188|65112583|FG002|Induction Phase|Lack of Efficacy|0|||
23373187|NCT00487188|65112581|FG000|Induction Phase|Protocol Violation|1|||
23373188|NCT00487188|65112582|FG001|Induction Phase|Protocol Violation|0|||
23373189|NCT00487188|65112583|FG002|Induction Phase|Protocol Violation|0|||
23373190|NCT00487188|65112581|FG000|Induction Phase|Refused Treatment|1|||
23373191|NCT00487188|65112582|FG001|Induction Phase|Refused Treatment|2|||
23373192|NCT00487188|65112583|FG002|Induction Phase|Refused Treatment|0|||
23373193|NCT00487188|65112581|FG000|Induction Phase|Lost to Follow-up|2|||
23373194|NCT00487188|65112582|FG001|Induction Phase|Lost to Follow-up|2|||
23373195|NCT00487188|65112583|FG002|Induction Phase|Lost to Follow-up|0|||
23373196|NCT00487188|65112581|FG000|Induction Phase|Administrative|0|||
23373197|NCT00487188|65112582|FG001|Induction Phase|Administrative|1|||
23373198|NCT00487188|65112583|FG002|Induction Phase|Administrative|0|||
23373199|NCT00487188|65112581|FG000|Maintenance Phase|Adverse Event|1|||
23373200|NCT00487188|65112582|FG001|Maintenance Phase|Adverse Event|0|||
23373201|NCT00487188|65112583|FG002|Maintenance Phase|Adverse Event|0|||
23373202|NCT00487188|65112581|FG000|Maintenance Phase|Death|1|||
23373203|NCT00487188|65112582|FG001|Maintenance Phase|Death|0|||
23373204|NCT00487188|65112583|FG002|Maintenance Phase|Death|0|||
23373205|NCT00487188|65112581|FG000|Maintenance Phase|Lost to Follow-up|1|||
23373206|NCT00487188|65112582|FG001|Maintenance Phase|Lost to Follow-up|0|||
23373207|NCT00487188|65112583|FG002|Maintenance Phase|Lost to Follow-up|0|||
23373208|NCT00487188|65112581|FG000|Maintenance Phase|Administrative|0|||
23373209|NCT00487188|65112582|FG001|Maintenance Phase|Administrative|0|||
23373210|NCT00487188|65112583|FG002|Maintenance Phase|Administrative|1|||
23373211|NCT02164916|65112584|FG000|Overall Study|Adverse Event|3|||
23373212|NCT02164916|65112585|FG001|Overall Study|Adverse Event|8|||
23373213|NCT02164916|65112584|FG000|Overall Study|Death|1|||
23373214|NCT02164916|65112585|FG001|Overall Study|Death|1|||
23373215|NCT02164916|65112584|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23373216|NCT02164916|65112585|FG001|Overall Study|Refusal unrelated to adverse event|7|||
23373217|NCT02164916|65112584|FG000|Overall Study|Progression|37|||
23373218|NCT02164916|65112585|FG001|Overall Study|Progression|26|||
23373219|NCT02164916|65112584|FG000|Overall Study|Not protocol specified|5|||
23373220|NCT02164916|65112585|FG001|Overall Study|Not protocol specified|1|||
23373221|NCT02164916|65112584|FG000|Overall Study|Reason under review|1|||
23373222|NCT02164916|65112585|FG001|Overall Study|Reason under review|6|||
23373223|NCT02164916|65112584|FG000|Overall Study|Not eligible|2|||
23373224|NCT02164916|65112585|FG001|Overall Study|Not eligible|5|||
23373225|NCT01799889|65112586|FG000|Overall Study|Adverse Event|4|||
23373226|NCT01799889|65112587|FG001|Overall Study|Adverse Event|4|||
23373227|NCT01799889|65112588|FG002|Overall Study|Adverse Event|5|||
23373228|NCT01799889|65112589|FG003|Overall Study|Adverse Event|1|||
23373229|NCT01799889|65112590|FG004|Overall Study|Adverse Event|11|||
23373230|NCT01799889|65112591|FG005|Overall Study|Adverse Event|1|||
23373231|NCT01799889|65112592|FG006|Overall Study|Adverse Event|5|||
23373232|NCT01799889|65112593|FG007|Overall Study|Adverse Event|2|||
23373233|NCT01799889|65112594|FG008|Overall Study|Adverse Event|3|||
23373234|NCT01799889|65112595|FG009|Overall Study|Adverse Event|1|||
23373235|NCT01799889|65112596|FG010|Overall Study|Adverse Event|1|||
23373236|NCT01799889|65112597|FG011|Overall Study|Adverse Event|0|||
23373237|NCT01799889|65112586|FG000|Overall Study|Death|1|||
23373238|NCT01799889|65112587|FG001|Overall Study|Death|0|||
23373239|NCT01799889|65112588|FG002|Overall Study|Death|5|||
23373240|NCT01799889|65112589|FG003|Overall Study|Death|3|||
23373241|NCT01799889|65112590|FG004|Overall Study|Death|1|||
23373242|NCT01799889|65112591|FG005|Overall Study|Death|0|||
23373243|NCT01799889|65112592|FG006|Overall Study|Death|0|||
23373244|NCT01799889|65112593|FG007|Overall Study|Death|0|||
23373245|NCT01799889|65112594|FG008|Overall Study|Death|1|||
23373246|NCT01799889|65112595|FG009|Overall Study|Death|0|||
23373247|NCT01799889|65112596|FG010|Overall Study|Death|1|||
23373248|NCT01799889|65112597|FG011|Overall Study|Death|0|||
23373249|NCT01799889|65112586|FG000|Overall Study|Lack of Efficacy|1|||
23373250|NCT01799889|65112587|FG001|Overall Study|Lack of Efficacy|1|||
23373251|NCT01799889|65112588|FG002|Overall Study|Lack of Efficacy|0|||
23603660|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
23664156|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
23373252|NCT01799889|65112589|FG003|Overall Study|Lack of Efficacy|1|||
23373253|NCT01799889|65112590|FG004|Overall Study|Lack of Efficacy|2|||
23373254|NCT01799889|65112591|FG005|Overall Study|Lack of Efficacy|2|||
23373255|NCT01799889|65112592|FG006|Overall Study|Lack of Efficacy|0|||
23373256|NCT01799889|65112593|FG007|Overall Study|Lack of Efficacy|0|||
23373257|NCT01799889|65112594|FG008|Overall Study|Lack of Efficacy|2|||
23373258|NCT01799889|65112595|FG009|Overall Study|Lack of Efficacy|0|||
23373259|NCT01799889|65112596|FG010|Overall Study|Lack of Efficacy|1|||
23373260|NCT01799889|65112597|FG011|Overall Study|Lack of Efficacy|0|||
23373261|NCT01799889|65112586|FG000|Overall Study|Lost to Follow-up|0|||
23373262|NCT01799889|65112587|FG001|Overall Study|Lost to Follow-up|1|||
23373263|NCT01799889|65112588|FG002|Overall Study|Lost to Follow-up|0|||
23373264|NCT01799889|65112589|FG003|Overall Study|Lost to Follow-up|0|||
23373265|NCT01799889|65112590|FG004|Overall Study|Lost to Follow-up|0|||
23373266|NCT01799889|65112591|FG005|Overall Study|Lost to Follow-up|0|||
23373267|NCT01799889|65112592|FG006|Overall Study|Lost to Follow-up|0|||
23373268|NCT01799889|65112593|FG007|Overall Study|Lost to Follow-up|0|||
23373269|NCT01799889|65112594|FG008|Overall Study|Lost to Follow-up|0|||
23373270|NCT01799889|65112595|FG009|Overall Study|Lost to Follow-up|0|||
23373271|NCT01799889|65112596|FG010|Overall Study|Lost to Follow-up|0|||
23373272|NCT01799889|65112597|FG011|Overall Study|Lost to Follow-up|0|||
23373273|NCT01799889|65112586|FG000|Overall Study|Physician Decision|3|||
23603661|NCT02158806|65937443|FG000|Overall Study|Death|2|||
23603662|NCT02158806|65937444|FG001|Overall Study|Death|0|||
23603663|NCT02158806|65937443|FG000|Overall Study|Withdrawal by Subject|2|||
23603664|NCT02158806|65937444|FG001|Overall Study|Withdrawal by Subject|0|||
23664157|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
23664158|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
23373274|NCT01799889|65112587|FG001|Overall Study|Physician Decision|2|||
23373275|NCT01799889|65112588|FG002|Overall Study|Physician Decision|4|||
23373276|NCT01799889|65112589|FG003|Overall Study|Physician Decision|4|||
23373277|NCT01799889|65112590|FG004|Overall Study|Physician Decision|5|||
23373278|NCT01799889|65112591|FG005|Overall Study|Physician Decision|5|||
23373279|NCT01799889|65112592|FG006|Overall Study|Physician Decision|5|||
23373280|NCT01799889|65112593|FG007|Overall Study|Physician Decision|2|||
23373281|NCT01799889|65112594|FG008|Overall Study|Physician Decision|6|||
23373282|NCT01799889|65112595|FG009|Overall Study|Physician Decision|0|||
23373283|NCT01799889|65112596|FG010|Overall Study|Physician Decision|0|||
23373284|NCT01799889|65112597|FG011|Overall Study|Physician Decision|1|||
23373285|NCT01799889|65112586|FG000|Overall Study|Progressive Disease|30|||
23373286|NCT01799889|65112587|FG001|Overall Study|Progressive Disease|26|||
23373287|NCT01799889|65112588|FG002|Overall Study|Progressive Disease|25|||
23373288|NCT01799889|65112589|FG003|Overall Study|Progressive Disease|30|||
23373289|NCT01799889|65112590|FG004|Overall Study|Progressive Disease|23|||
23373290|NCT01799889|65112591|FG005|Overall Study|Progressive Disease|9|||
23373291|NCT01799889|65112592|FG006|Overall Study|Progressive Disease|8|||
23373292|NCT01799889|65112593|FG007|Overall Study|Progressive Disease|13|||
23373293|NCT01799889|65112594|FG008|Overall Study|Progressive Disease|18|||
23373294|NCT01799889|65112595|FG009|Overall Study|Progressive Disease|5|||
23373295|NCT01799889|65112596|FG010|Overall Study|Progressive Disease|3|||
23373296|NCT01799889|65112597|FG011|Overall Study|Progressive Disease|1|||
23373297|NCT01799889|65112586|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
23373298|NCT01799889|65112587|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
23373299|NCT01799889|65112588|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
23373300|NCT01799889|65112589|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
23373301|NCT01799889|65112590|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
23373302|NCT01799889|65112591|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
23373303|NCT01799889|65112592|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
23373304|NCT01799889|65112593|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
23373305|NCT01799889|65112594|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
23373306|NCT01799889|65112595|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
23373307|NCT01799889|65112596|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
23373308|NCT01799889|65112597|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
23373309|NCT01799889|65112586|FG000|Overall Study|Study Terminated By Sponsor|1|||
23373310|NCT01799889|65112587|FG001|Overall Study|Study Terminated By Sponsor|0|||
23373311|NCT01799889|65112588|FG002|Overall Study|Study Terminated By Sponsor|0|||
23373312|NCT01799889|65112589|FG003|Overall Study|Study Terminated By Sponsor|0|||
23373313|NCT01799889|65112590|FG004|Overall Study|Study Terminated By Sponsor|2|||
23373314|NCT01799889|65112591|FG005|Overall Study|Study Terminated By Sponsor|1|||
23373315|NCT01799889|65112592|FG006|Overall Study|Study Terminated By Sponsor|0|||
23373316|NCT01799889|65112593|FG007|Overall Study|Study Terminated By Sponsor|2|||
23373317|NCT01799889|65112594|FG008|Overall Study|Study Terminated By Sponsor|1|||
23373318|NCT01799889|65112595|FG009|Overall Study|Study Terminated By Sponsor|1|||
23373319|NCT01799889|65112596|FG010|Overall Study|Study Terminated By Sponsor|0|||
23373320|NCT01799889|65112597|FG011|Overall Study|Study Terminated By Sponsor|0|||
23373321|NCT01799889|65112586|FG000|Overall Study|Withdrawal by Subject|1|||
23373322|NCT01799889|65112587|FG001|Overall Study|Withdrawal by Subject|6|||
23373323|NCT01799889|65112588|FG002|Overall Study|Withdrawal by Subject|4|||
23373324|NCT01799889|65112589|FG003|Overall Study|Withdrawal by Subject|0|||
23486787|NCT02788474|65527278|FG000|Double Blind Treatment Period|Adverse Event|6|||
23486788|NCT02788474|65527279|FG001|Double Blind Treatment Period|Adverse Event|4|||
23486789|NCT02788474|65527278|FG000|Open Label Treatment Period|Adverse Event|29|||
23486790|NCT02788474|65527279|FG001|Open Label Treatment Period|Adverse Event|9|||
23486791|NCT02788474|65527278|FG000|Open Label Treatment Period|Other than reason specified|1|||
23486792|NCT02788474|65527279|FG001|Open Label Treatment Period|Other than reason specified|0|||
23486793|NCT02788474|65527278|FG000|Open Label Treatment Period|Patient's refusal|1|||
23486794|NCT02788474|65527279|FG001|Open Label Treatment Period|Patient's refusal|3|||
23486795|NCT02788474|65527278|FG000|Open Label Treatment Period|Non-compliance|1|||
23486796|NCT02788474|65527279|FG001|Open Label Treatment Period|Non-compliance|0|||
23486797|NCT00267189|65527280|FG000|Overall Study|Patient withdrew consent|1|||
23486798|NCT00267189|65527281|FG001|Overall Study|Patient withdrew consent|1|||
23486799|NCT00267189|65527280|FG000|Overall Study|Death|1|||
23486800|NCT00267189|65527281|FG001|Overall Study|Death|0|||
23486801|NCT00267189|65527280|FG000|Overall Study|Missing|3|||
23486802|NCT00267189|65527281|FG001|Overall Study|Missing|0|||
23486803|NCT01309308|65527290|FG000|Overall Study|Lost to Follow-up|6|||
23603665|NCT02158806|65937443|FG000|Overall Study|Lost to Follow-up|0|||
23603666|NCT02158806|65937444|FG001|Overall Study|Lost to Follow-up|3|||
23373325|NCT01799889|65112590|FG004|Overall Study|Withdrawal by Subject|5|||
23373326|NCT01799889|65112591|FG005|Overall Study|Withdrawal by Subject|1|||
23373327|NCT01799889|65112592|FG006|Overall Study|Withdrawal by Subject|3|||
23373328|NCT01799889|65112593|FG007|Overall Study|Withdrawal by Subject|1|||
23373329|NCT01799889|65112594|FG008|Overall Study|Withdrawal by Subject|2|||
23373330|NCT01799889|65112595|FG009|Overall Study|Withdrawal by Subject|1|||
23373331|NCT01799889|65112596|FG010|Overall Study|Withdrawal by Subject|1|||
23373332|NCT01799889|65112597|FG011|Overall Study|Withdrawal by Subject|1|||
23373333|NCT01799889|65112586|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23373334|NCT01799889|65112587|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23603667|NCT02158806|65937443|FG000|Overall Study|Moved out of area|0|||
23603668|NCT02158806|65937444|FG001|Overall Study|Moved out of area|1|||
23603669|NCT02158806|65937443|FG000|Overall Study|Transferred to palliative care|0|||
23373335|NCT01799889|65112588|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23603670|NCT02158806|65937444|FG001|Overall Study|Transferred to palliative care|1|||
23373336|NCT01799889|65112589|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23373337|NCT01799889|65112590|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23373338|NCT01799889|65112591|FG005|Overall Study|Non-Compliance With Study Drug|1|||
23373339|NCT01799889|65112592|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23373340|NCT01799889|65112593|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23373341|NCT01799889|65112594|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23373342|NCT01799889|65112595|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23373343|NCT01799889|65112596|FG010|Overall Study|Non-Compliance With Study Drug|0|||
23373344|NCT01799889|65112597|FG011|Overall Study|Non-Compliance With Study Drug|0|||
23373345|NCT01249131|65112598|FG000|Washout Period of 10 Days|Adverse Event|0|||
23373346|NCT01249131|65112599|FG001|Washout Period of 10 Days|Adverse Event|0|||
23373347|NCT01249131|65112600|FG002|Washout Period of 10 Days|Adverse Event|0|||
23373348|NCT01249131|65112601|FG003|Washout Period of 10 Days|Adverse Event|0|||
23373349|NCT01249131|65112602|FG004|Washout Period of 10 Days|Adverse Event|1|||
23373350|NCT01249131|65112603|FG005|Washout Period of 10 Days|Adverse Event|0|||
23373351|NCT01548404|65112604|FG000|Overall Study|Adverse Event|3|||
23373352|NCT01548404|65112605|FG001|Overall Study|Adverse Event|1|||
23373353|NCT01548404|65112604|FG000|Overall Study|Physician Decision|2|||
23373354|NCT01548404|65112605|FG001|Overall Study|Physician Decision|1|||
23373355|NCT01548404|65112604|FG000|Overall Study|Inadequate response to study treatment|23|||
23373356|NCT01548404|65112605|FG001|Overall Study|Inadequate response to study treatment|7|||
23373357|NCT01548404|65112604|FG000|Overall Study|Lost to Follow-up|2|||
23373358|NCT01548404|65112605|FG001|Overall Study|Lost to Follow-up|0|||
23373359|NCT01548404|65112604|FG000|Overall Study|Withdrawal by Subject|0|||
23373360|NCT01548404|65112605|FG001|Overall Study|Withdrawal by Subject|3|||
23373361|NCT01548404|65112604|FG000|Overall Study|Other than specified above|0|||
23373362|NCT01548404|65112605|FG001|Overall Study|Other than specified above|2|||
23373363|NCT03238417|65112606|FG000|Overall|non-response|955|||
23373364|NCT03238417|65112607|FG001|Overall|non-response|1920|||
23373365|NCT03238417|65112606|FG000|Overall|partial completion|48|||
23373366|NCT03238417|65112607|FG001|Overall|partial completion|68|||
23373367|NCT03238417|65112606|FG000|Baseline|Partial completion|17|||
23373368|NCT03238417|65112607|FG001|Baseline|Partial completion|48|||
23373369|NCT03238417|65112606|FG000|Baseline|non-response|372|||
23603671|NCT03403036|65937445|FG000|Overall Study|Lack of Efficacy|5|||
23603672|NCT00949117|65937446|FG000|Overall Study|Lack of Efficacy|2|||
23603673|NCT00949117|65937447|FG001|Overall Study|Lack of Efficacy|3|||
23373370|NCT03238417|65112607|FG001|Baseline|non-response|669|||
23373371|NCT03238417|65112606|FG000|12-month|non-response|296|||
23373372|NCT03238417|65112607|FG001|12-month|non-response|669|||
23486804|NCT01309308|65527291|FG001|Overall Study|Lost to Follow-up|4|||
23486805|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23486806|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23486807|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23486808|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23486809|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
23486810|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
23486811|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
23486812|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23486813|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
23486814|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
23486815|NCT00925990|65527294|FG000|Overall Study|Adverse Event|1|||
23486816|NCT00925990|65527295|FG001|Overall Study|Adverse Event|3|||
23486817|NCT00925990|65527294|FG000|Overall Study|Withdrawal by Subject|2|||
23486818|NCT00925990|65527295|FG001|Overall Study|Withdrawal by Subject|2|||
23486819|NCT00925990|65527294|FG000|Overall Study|Lost to Follow-up|1|||
23486820|NCT00925990|65527295|FG001|Overall Study|Lost to Follow-up|3|||
23486821|NCT00925990|65527294|FG000|Overall Study|Physician Decision|1|||
23486822|NCT00925990|65527295|FG001|Overall Study|Physician Decision|1|||
23486823|NCT00925990|65527294|FG000|Overall Study|moved out of state, missed medication|0|||
23486824|NCT00925990|65527295|FG001|Overall Study|moved out of state, missed medication|2|||
23486825|NCT00586846|65527296|FG000|Overall Study|Physician Decision|1|||
23486826|NCT00586846|65527296|FG000|Overall Study|Death|1|||
23486827|NCT00586846|65527296|FG000|Overall Study|Evaluable for Toxicity Only|4|||
23486828|NCT01178073|65527297|FG000|Overall Study|Adverse Event|34|||
23486829|NCT01178073|65527298|FG001|Overall Study|Adverse Event|27|||
23486830|NCT01178073|65527299|FG002|Overall Study|Adverse Event|24|||
23486831|NCT01178073|65527297|FG000|Overall Study|Protocol Violation|1|||
23486832|NCT01178073|65527298|FG001|Overall Study|Protocol Violation|1|||
23486833|NCT01178073|65527299|FG002|Overall Study|Protocol Violation|1|||
23486834|NCT01178073|65527297|FG000|Overall Study|Lost to Follow-up|2|||
23486835|NCT01178073|65527298|FG001|Overall Study|Lost to Follow-up|0|||
23486836|NCT01178073|65527299|FG002|Overall Study|Lost to Follow-up|3|||
23486837|NCT01178073|65527297|FG000|Overall Study|Physician Decision|14|||
23486838|NCT01178073|65527298|FG001|Overall Study|Physician Decision|10|||
23486839|NCT01178073|65527299|FG002|Overall Study|Physician Decision|10|||
23486840|NCT01178073|65527297|FG000|Overall Study|Withdrawal by Subject|10|||
23486841|NCT01178073|65527298|FG001|Overall Study|Withdrawal by Subject|6|||
23486842|NCT01178073|65527299|FG002|Overall Study|Withdrawal by Subject|8|||
23486843|NCT01178073|65527297|FG000|Overall Study|Missing Completion Status|1|||
23486844|NCT01178073|65527298|FG001|Overall Study|Missing Completion Status|0|||
23486845|NCT01178073|65527299|FG002|Overall Study|Missing Completion Status|0|||
23486846|NCT00930982|65527305|FG000|Overall Study|Adverse Event|19|||
23486847|NCT00930982|65527306|FG001|Overall Study|Adverse Event|23|||
23486848|NCT00930982|65527305|FG000|Overall Study|Protocol Violation|1|||
23486849|NCT00930982|65527306|FG001|Overall Study|Protocol Violation|5|||
23486850|NCT00930982|65527305|FG000|Overall Study|Withdrawal by Subject|1|||
23486851|NCT00930982|65527306|FG001|Overall Study|Withdrawal by Subject|1|||
23486852|NCT01741012|65527307|FG000|Overall Study|Lost to Follow-up|1|||
23486853|NCT01741012|65527307|FG000|Overall Study|Withdrawal by Subject|2|||
23486854|NCT01570868|65527309|FG000|Overall Study|Adverse Event|8|||
23486855|NCT01570868|65527310|FG001|Overall Study|Adverse Event|1|||
23486856|NCT01570868|65527309|FG000|Overall Study|FDA Recommendation|23|||
23486857|NCT01570868|65527310|FG001|Overall Study|FDA Recommendation|3|||
23486858|NCT01570868|65527309|FG000|Overall Study|Physician Decision|10|||
23486859|NCT01570868|65527310|FG001|Overall Study|Physician Decision|4|||
23486860|NCT01570868|65527309|FG000|Overall Study|Lost to Follow-up|1|||
23486861|NCT01570868|65527310|FG001|Overall Study|Lost to Follow-up|0|||
23486862|NCT01570868|65527309|FG000|Overall Study|Withdrawal by Subject|1|||
23486863|NCT01570868|65527310|FG001|Overall Study|Withdrawal by Subject|0|||
23486864|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
23486865|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
23486866|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
23486867|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
23486868|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
23486869|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
23373373|NCT03238417|65112606|FG000|12-month|partial completion|23|||
23486870|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
23486871|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
23486872|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
23486873|NCT03183778|65527322|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
23486874|NCT01484132|65527325|FG000|Overall Study|Lost to Follow-up|8|||
23486875|NCT01484132|65527325|FG000|Overall Study|Difficulty with time commitment|2|||
23486876|NCT01484132|65527325|FG000|Overall Study|Ineligible|1|||
23486877|NCT01484132|65527325|FG000|Overall Study|No pre-treatment urine sample collected|1|||
23486878|NCT01484132|65527325|FG000|Overall Study|No post-treatment urine sample collected|10|||
23486879|NCT02676466|65527326|FG000|Overall Study|Death|0|||
23486880|NCT02676466|65527327|FG001|Overall Study|Death|2|||
23486881|NCT02676466|65527328|FG002|Overall Study|Death|1|||
23486882|NCT02676466|65527329|FG003|Overall Study|Death|0|||
23486883|NCT02676466|65527330|FG004|Overall Study|Death|0|||
23603674|NCT00949117|65937446|FG000|Overall Study|Protocol Violation|1|||
23603675|NCT00949117|65937447|FG001|Overall Study|Protocol Violation|1|||
23603676|NCT00949117|65937446|FG000|Overall Study|Adverse Event|0|||
23603677|NCT00949117|65937447|FG001|Overall Study|Adverse Event|1|||
23603678|NCT00595959|65937448|FG000|Overall Study|Withdrawal by Subject|1|||
23603679|NCT00595959|65937448|FG000|Overall Study|Lost to Follow-up|1|||
23486884|NCT02676466|65527331|FG005|Overall Study|Death|0|||
23486885|NCT02676466|65527332|FG006|Overall Study|Death|0|||
23486886|NCT02676466|65527333|FG007|Overall Study|Death|0|||
23486887|NCT02676466|65527326|FG000|Overall Study|Withdrawal by Subject|4|||
23486888|NCT02676466|65527327|FG001|Overall Study|Withdrawal by Subject|3|||
23486889|NCT02676466|65527328|FG002|Overall Study|Withdrawal by Subject|1|||
23486890|NCT02676466|65527329|FG003|Overall Study|Withdrawal by Subject|0|||
23486891|NCT02676466|65527330|FG004|Overall Study|Withdrawal by Subject|3|||
23486892|NCT02676466|65527331|FG005|Overall Study|Withdrawal by Subject|1|||
23486893|NCT02676466|65527332|FG006|Overall Study|Withdrawal by Subject|1|||
23486894|NCT02676466|65527333|FG007|Overall Study|Withdrawal by Subject|1|||
23486895|NCT00764491|65527336|FG000|Overall Study|Lost to Follow-up|35|||
23486896|NCT00764491|65527337|FG001|Overall Study|Lost to Follow-up|17|||
23486897|NCT03711266|65527344|FG000|Overall Study|Lost to Follow-up|10|||
23486898|NCT01476644|65527346|FG000|Overall Study|Death|5|||
23486899|NCT01476644|65527346|FG000|Overall Study|moved to another state|2|||
23486900|NCT01476644|65527346|FG000|Overall Study|Lost to Follow-up|19|||
23486901|NCT01476644|65527346|FG000|Overall Study|Withdrawal by Subject|13|||
23486902|NCT05128773|65527347|FG000|Overall Study|Sponsor decision to terminate study|3|||
23486903|NCT00048061|65527348|FG000|Overall Study|Adverse Event|41|||
23603680|NCT01353274|65937449|FG000|Overall Study|No case report form (CRF) collected|28|||
23373374|NCT03238417|65112607|FG001|12-month|partial completion|37|||
23373375|NCT03238417|65112606|FG000|24-month|non-response|287|||
23486904|NCT00048061|65527349|FG001|Overall Study|Adverse Event|32|||
23486905|NCT00048061|65527350|FG002|Overall Study|Adverse Event|44|||
23486906|NCT00048061|65527351|FG003|Overall Study|Adverse Event|37|||
23486907|NCT00048061|65527348|FG000|Overall Study|Lost to Follow-up|3|||
23486908|NCT00048061|65527349|FG001|Overall Study|Lost to Follow-up|2|||
23486909|NCT00048061|65527350|FG002|Overall Study|Lost to Follow-up|4|||
23486910|NCT00048061|65527351|FG003|Overall Study|Lost to Follow-up|5|||
23373376|NCT03238417|65112607|FG001|24-month|non-response|594|||
23373377|NCT03238417|65112606|FG000|24-month|partial completion|8|||
23373378|NCT03238417|65112607|FG001|24-month|partial completion|31|||
23373379|NCT01326871|65112608|FG000|Overall Study|Major surgery|0|||
23373380|NCT01326871|65112609|FG001|Overall Study|Major surgery|1|||
23373381|NCT01326871|65112610|FG002|Overall Study|Major surgery|0|||
23373382|NCT01326871|65112608|FG000|Overall Study|SAE and death|0|||
23373383|NCT01326871|65112609|FG001|Overall Study|SAE and death|2|||
23373384|NCT01326871|65112610|FG002|Overall Study|SAE and death|0|||
23373385|NCT01326871|65112608|FG000|Overall Study|Physician decision and decreased performance status|0|||
23486911|NCT00048061|65527348|FG000|Overall Study|Withdrawal by Subject|20|||
23486912|NCT00048061|65527349|FG001|Overall Study|Withdrawal by Subject|29|||
23486913|NCT00048061|65527350|FG002|Overall Study|Withdrawal by Subject|29|||
23486914|NCT00048061|65527351|FG003|Overall Study|Withdrawal by Subject|32|||
23486915|NCT00048061|65527348|FG000|Overall Study|Did not follow-up|5|||
23486916|NCT00048061|65527349|FG001|Overall Study|Did not follow-up|5|||
23486917|NCT00048061|65527350|FG002|Overall Study|Did not follow-up|4|||
23486918|NCT00048061|65527351|FG003|Overall Study|Did not follow-up|5|||
23486919|NCT00048061|65527348|FG000|Overall Study|Early improvement|6|||
23486920|NCT00048061|65527349|FG001|Overall Study|Early improvement|5|||
23486921|NCT00048061|65527350|FG002|Overall Study|Early improvement|3|||
23486922|NCT00048061|65527351|FG003|Overall Study|Early improvement|0|||
23486923|NCT01631812|65527352|FG000|Overall Study|Adverse Event|25|||
23486924|NCT01631812|65527352|FG000|Overall Study|Lack of Efficacy|5|||
23486925|NCT01631812|65527352|FG000|Overall Study|Withdrawal by Subject|4|||
23486926|NCT01631812|65527352|FG000|Overall Study|Physician Decision|3|||
23486927|NCT02987660|65527357|FG000|Overall Study|Study terminated by sponsor|10|||
23486928|NCT02987660|65527358|FG001|Overall Study|Study terminated by sponsor|10|||
23486929|NCT03960554|65527359|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
23486930|NCT03960554|65527360|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
23486931|NCT01229397|65527365|FG000|Overall Study|Withdrawal by Subject|3|||
23486932|NCT01229397|65527366|FG001|Overall Study|Withdrawal by Subject|3|||
23486933|NCT01229397|65527365|FG000|Overall Study|Lost to Follow-up|7|||
23486934|NCT01229397|65527366|FG001|Overall Study|Lost to Follow-up|6|||
23486935|NCT01229397|65527365|FG000|Overall Study|Migrated/moved from study area|1|||
23486936|NCT01229397|65527366|FG001|Overall Study|Migrated/moved from study area|0|||
23486937|NCT04738734|65527367|FG000|Overall Study|Withdrawal by Subject|2|||
23486938|NCT04738734|65527368|FG001|Overall Study|Withdrawal by Subject|4|||
23486939|NCT04738734|65527367|FG000|Overall Study|Lost to Follow-up|5|||
23486940|NCT04738734|65527368|FG001|Overall Study|Lost to Follow-up|2|||
23486941|NCT04738734|65527367|FG000|Overall Study|Physician Decision|0|||
23486942|NCT04738734|65527368|FG001|Overall Study|Physician Decision|1|||
23486943|NCT04738734|65527367|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
23486944|NCT04738734|65527368|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
23486945|NCT03500679|65527369|FG000|Overall Study|Lost to Follow-up|6|||
23486946|NCT03500679|65527370|FG001|Overall Study|Lost to Follow-up|3|||
23486947|NCT03500679|65527369|FG000|Overall Study|Withdrawal by Subject|3|||
23486948|NCT03500679|65527370|FG001|Overall Study|Withdrawal by Subject|0|||
23486949|NCT00495131|65527373|FG000|Overall Study|Adverse Event|6|||
23486950|NCT00495131|65527374|FG001|Overall Study|Adverse Event|2|||
23486951|NCT00495131|65527373|FG000|Overall Study|Lack of Efficacy|0|||
23486952|NCT00495131|65527374|FG001|Overall Study|Lack of Efficacy|2|||
23486953|NCT00495131|65527373|FG000|Overall Study|Lost to Follow-up|0|||
23486954|NCT00495131|65527374|FG001|Overall Study|Lost to Follow-up|2|||
23373386|NCT01326871|65112609|FG001|Overall Study|Physician decision and decreased performance status|1|||
23373387|NCT01326871|65112610|FG002|Overall Study|Physician decision and decreased performance status|0|||
23486955|NCT00495131|65527373|FG000|Overall Study|Withdrawal by Subject|1|||
23486956|NCT00495131|65527374|FG001|Overall Study|Withdrawal by Subject|0|||
23373388|NCT01326871|65112608|FG000|Overall Study|Disease progression|0|||
23486957|NCT00945555|65527375|FG000|Overall Study|Referred to another hospital|5|||
23486958|NCT00945555|65527375|FG000|Overall Study|Worsening condition, intensive care unit|1|||
23486959|NCT00945555|65527375|FG000|Overall Study|Withdrawal by Subject|2|||
23486960|NCT00945555|65527375|FG000|Overall Study|Participant continued treatment at home|1|||
23486961|NCT00945555|65527375|FG000|Overall Study|Death|18|||
23486962|NCT00945555|65527375|FG000|Overall Study|Other|1|||
23486963|NCT01325623|65527380|FG000|Overall Study|Withdrawal by Subject|3|||
23603681|NCT03100370|65937450|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603682|NCT03100370|65937451|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603683|NCT03100370|65937452|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603684|NCT03100370|65937453|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23603685|NCT03100370|65937454|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603686|NCT03100370|65937455|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603687|NCT01034306|65937456|FG000|Overall Study|Adverse Event|1|||
23603688|NCT01034306|65937457|FG001|Overall Study|Adverse Event|0|||
23603689|NCT01034306|65937456|FG000|Overall Study|Lost to Follow-up|0|||
23603690|NCT01034306|65937457|FG001|Overall Study|Lost to Follow-up|1|||
23603691|NCT01034306|65937456|FG000|Overall Study|Withdrawal by Subject|2|||
23603692|NCT01034306|65937457|FG001|Overall Study|Withdrawal by Subject|2|||
23603693|NCT01034306|65937456|FG000|Overall Study|hospitalized and decided to stop|1|||
23603694|NCT01034306|65937457|FG001|Overall Study|hospitalized and decided to stop|0|||
23664159|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
23664160|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
23664161|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
23664162|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
23664163|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
23664164|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
23664165|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
23664166|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
23664167|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
23664168|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
23664169|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
23373389|NCT01326871|65112609|FG001|Overall Study|Disease progression|11|||
23664170|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
23664171|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
23664172|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
23664173|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
23664174|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
23664175|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
23664176|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
23664177|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
23664178|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
23664179|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
23373390|NCT01326871|65112610|FG002|Overall Study|Disease progression|5|||
23664180|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
23664181|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
23664182|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
23664183|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
23373391|NCT01326871|65112608|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
23373392|NCT01326871|65112609|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
23373393|NCT01326871|65112610|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
23373394|NCT01326871|65112608|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
23373395|NCT01326871|65112609|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
23373396|NCT01326871|65112610|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
23373397|NCT01326871|65112608|FG000|Overall Study|Withdrawal by Subject|0|||
23373398|NCT01326871|65112609|FG001|Overall Study|Withdrawal by Subject|1|||
23373399|NCT01326871|65112610|FG002|Overall Study|Withdrawal by Subject|0|||
23373400|NCT01326871|65112608|FG000|Overall Study|DLT|0|||
23373401|NCT01326871|65112609|FG001|Overall Study|DLT|2|||
23373402|NCT01326871|65112610|FG002|Overall Study|DLT|0|||
23373403|NCT01326871|65112608|FG000|Overall Study|SAE, disease progression and subject decision|0|||
23373404|NCT01326871|65112609|FG001|Overall Study|SAE, disease progression and subject decision|1|||
23373405|NCT01326871|65112610|FG002|Overall Study|SAE, disease progression and subject decision|0|||
23373406|NCT01326871|65112608|FG000|Overall Study|Death|0|||
23373407|NCT01326871|65112609|FG001|Overall Study|Death|1|||
23373408|NCT01326871|65112610|FG002|Overall Study|Death|0|||
23373409|NCT01326871|65112608|FG000|Overall Study|Other|0|||
23373410|NCT01326871|65112609|FG001|Overall Study|Other|3|||
23373411|NCT01326871|65112610|FG002|Overall Study|Other|0|||
23373412|NCT01326871|65112608|FG000|Overall Study|SAE and disease progression|0|||
23373413|NCT01326871|65112609|FG001|Overall Study|SAE and disease progression|0|||
23373414|NCT01326871|65112610|FG002|Overall Study|SAE and disease progression|1|||
23373415|NCT01326871|65112608|FG000|Overall Study|SAE and physician decision|0|||
23373416|NCT01326871|65112609|FG001|Overall Study|SAE and physician decision|0|||
23373417|NCT01326871|65112610|FG002|Overall Study|SAE and physician decision|1|||
23373418|NCT01326871|65112608|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
23373419|NCT01326871|65112609|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
23373420|NCT01326871|65112610|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
23373421|NCT01326871|65112608|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
23373422|NCT01326871|65112609|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
23373423|NCT01326871|65112610|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
23373424|NCT01326871|65112608|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
23373425|NCT01326871|65112609|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
23373426|NCT01326871|65112610|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
23373427|NCT01326871|65112608|FG000|Overall Study|Physician Decision|0|||
23373428|NCT01326871|65112609|FG001|Overall Study|Physician Decision|0|||
23373429|NCT01326871|65112610|FG002|Overall Study|Physician Decision|1|||
23373430|NCT01326871|65112608|FG000|Overall Study|SAE|0|||
23373431|NCT01326871|65112609|FG001|Overall Study|SAE|0|||
23373432|NCT01326871|65112610|FG002|Overall Study|SAE|1|||
23373433|NCT01326871|65112608|FG000|Overall Study|Disease progression and death|0|||
23373434|NCT01326871|65112609|FG001|Overall Study|Disease progression and death|0|||
23373435|NCT01326871|65112610|FG002|Overall Study|Disease progression and death|1|||
23373436|NCT01326871|65112608|FG000|Overall Study|Subject decision|0|||
23373437|NCT01326871|65112609|FG001|Overall Study|Subject decision|0|||
23373438|NCT01326871|65112610|FG002|Overall Study|Subject decision|1|||
23373439|NCT01648764|65112615|FG000|Overall Study|Progressive Disease|0|||
23373440|NCT01648764|65112616|FG001|Overall Study|Progressive Disease|1|||
23373441|NCT01648764|65112617|FG002|Overall Study|Progressive Disease|0|||
23373442|NCT01648764|65112618|FG003|Overall Study|Progressive Disease|0|||
23373443|NCT01648764|65112619|FG004|Overall Study|Progressive Disease|0|||
23373444|NCT01648764|65112620|FG005|Overall Study|Progressive Disease|1|||
23373445|NCT01648764|65112621|FG006|Overall Study|Progressive Disease|1|||
23373446|NCT01648764|65112622|FG007|Overall Study|Progressive Disease|0|||
23373447|NCT01648764|65112623|FG008|Overall Study|Progressive Disease|0|||
23373448|NCT01648764|65112624|FG009|Overall Study|Progressive Disease|2|||
23373449|NCT01648764|65112625|FG010|Overall Study|Progressive Disease|0|||
23373450|NCT01648764|65112626|FG011|Overall Study|Progressive Disease|1|||
23373451|NCT01648764|65112627|FG012|Overall Study|Progressive Disease|2|||
23373452|NCT01648764|65112628|FG013|Overall Study|Progressive Disease|1|||
23373453|NCT01648764|65112615|FG000|Overall Study|Adverse Event|0|||
23373454|NCT01648764|65112616|FG001|Overall Study|Adverse Event|0|||
23373455|NCT01648764|65112617|FG002|Overall Study|Adverse Event|0|||
23373456|NCT01648764|65112618|FG003|Overall Study|Adverse Event|0|||
23373457|NCT01648764|65112619|FG004|Overall Study|Adverse Event|0|||
23373458|NCT01648764|65112620|FG005|Overall Study|Adverse Event|1|||
23373459|NCT01648764|65112621|FG006|Overall Study|Adverse Event|0|||
23373460|NCT01648764|65112622|FG007|Overall Study|Adverse Event|0|||
23373461|NCT01648764|65112623|FG008|Overall Study|Adverse Event|0|||
23373462|NCT01648764|65112624|FG009|Overall Study|Adverse Event|1|||
23373463|NCT01648764|65112625|FG010|Overall Study|Adverse Event|0|||
23373464|NCT01648764|65112626|FG011|Overall Study|Adverse Event|3|||
23373465|NCT01648764|65112627|FG012|Overall Study|Adverse Event|1|||
23373466|NCT01648764|65112628|FG013|Overall Study|Adverse Event|1|||
23373467|NCT01648764|65112615|FG000|Overall Study|Death|0|||
23373468|NCT01648764|65112616|FG001|Overall Study|Death|0|||
23373469|NCT01648764|65112617|FG002|Overall Study|Death|0|||
23373470|NCT01648764|65112618|FG003|Overall Study|Death|0|||
23373471|NCT01648764|65112619|FG004|Overall Study|Death|0|||
23373472|NCT01648764|65112620|FG005|Overall Study|Death|0|||
23373473|NCT01648764|65112621|FG006|Overall Study|Death|1|||
23373474|NCT01648764|65112622|FG007|Overall Study|Death|0|||
23373475|NCT01648764|65112623|FG008|Overall Study|Death|0|||
23373476|NCT01648764|65112624|FG009|Overall Study|Death|0|||
23373477|NCT01648764|65112625|FG010|Overall Study|Death|0|||
23373478|NCT01648764|65112626|FG011|Overall Study|Death|0|||
23373479|NCT01648764|65112627|FG012|Overall Study|Death|0|||
23373480|NCT01648764|65112628|FG013|Overall Study|Death|1|||
23373481|NCT01648764|65112615|FG000|Overall Study|Withdrawal by Subject|0|||
23373482|NCT01648764|65112616|FG001|Overall Study|Withdrawal by Subject|0|||
23373483|NCT01648764|65112617|FG002|Overall Study|Withdrawal by Subject|0|||
23373484|NCT01648764|65112618|FG003|Overall Study|Withdrawal by Subject|0|||
23373485|NCT01648764|65112619|FG004|Overall Study|Withdrawal by Subject|0|||
23373486|NCT01648764|65112620|FG005|Overall Study|Withdrawal by Subject|0|||
23373487|NCT01648764|65112621|FG006|Overall Study|Withdrawal by Subject|2|||
23373488|NCT01648764|65112622|FG007|Overall Study|Withdrawal by Subject|0|||
23373489|NCT01648764|65112623|FG008|Overall Study|Withdrawal by Subject|0|||
23373490|NCT01648764|65112624|FG009|Overall Study|Withdrawal by Subject|0|||
23373491|NCT01648764|65112625|FG010|Overall Study|Withdrawal by Subject|0|||
23373492|NCT01648764|65112626|FG011|Overall Study|Withdrawal by Subject|0|||
23373493|NCT01648764|65112627|FG012|Overall Study|Withdrawal by Subject|1|||
23373494|NCT01648764|65112628|FG013|Overall Study|Withdrawal by Subject|0|||
23373495|NCT01648764|65112615|FG000|Overall Study|Investigator Decision|0|||
23373496|NCT01648764|65112616|FG001|Overall Study|Investigator Decision|0|||
23373497|NCT01648764|65112617|FG002|Overall Study|Investigator Decision|0|||
23373498|NCT01648764|65112618|FG003|Overall Study|Investigator Decision|0|||
23373499|NCT01648764|65112619|FG004|Overall Study|Investigator Decision|0|||
23373500|NCT01648764|65112620|FG005|Overall Study|Investigator Decision|0|||
23373501|NCT01648764|65112621|FG006|Overall Study|Investigator Decision|1|||
23373502|NCT01648764|65112622|FG007|Overall Study|Investigator Decision|0|||
23373503|NCT01648764|65112623|FG008|Overall Study|Investigator Decision|0|||
23373504|NCT01648764|65112624|FG009|Overall Study|Investigator Decision|0|||
23373505|NCT01648764|65112625|FG010|Overall Study|Investigator Decision|0|||
23373506|NCT01648764|65112626|FG011|Overall Study|Investigator Decision|1|||
23373507|NCT01648764|65112627|FG012|Overall Study|Investigator Decision|0|||
23373508|NCT01648764|65112628|FG013|Overall Study|Investigator Decision|0|||
23373509|NCT00626639|65112641|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
23373510|NCT00626639|65112642|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
23373511|NCT04018066|65112643|FG000|Overall Study|participants started taking medications during the study period|3|||
23373512|NCT04018066|65112643|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
23373513|NCT02020941|65112644|FG000|Overall Study|Adverse Event|1|||
23373514|NCT02020941|65112644|FG000|Overall Study|Physician Decision|2|||
23373515|NCT02020941|65112644|FG000|Overall Study|Withdrawal by Subject|1|||
23373516|NCT02020941|65112644|FG000|Overall Study|Disease Progression|4|||
23373517|NCT00465179|65112659|FG000|Overall Study|Adverse Event|4|||
23373518|NCT00465179|65112659|FG000|Overall Study|Withdrawal by Subject|2|||
23373519|NCT00465179|65112659|FG000|Overall Study|Progression of Disease|47|||
23373520|NCT03183908|65112665|FG000|Overall Study|Missing Symptom Diary Data|0|||
23373521|NCT03183908|65112666|FG001|Overall Study|Missing Symptom Diary Data|2|||
23373522|NCT04465422|65112667|FG000|Overall Study|Lost to Follow-up|0|||
23373523|NCT04465422|65112668|FG001|Overall Study|Lost to Follow-up|2|||
23373524|NCT00972478|65112669|FG000|Overall Study|Adverse Event|3|||
23373525|NCT00972478|65112670|FG001|Overall Study|Adverse Event|16|||
23373526|NCT00972478|65112669|FG000|Overall Study|Withdrawal by Subject|1|||
23373527|NCT00972478|65112670|FG001|Overall Study|Withdrawal by Subject|8|||
23373528|NCT00972478|65112669|FG000|Overall Study|Progression/Relapse|0|||
23373529|NCT00972478|65112670|FG001|Overall Study|Progression/Relapse|2|||
23373530|NCT00972478|65112669|FG000|Overall Study|Death|0|||
23373531|NCT00972478|65112670|FG001|Overall Study|Death|2|||
23373532|NCT00972478|65112669|FG000|Overall Study|Not protocol specified|1|||
23373533|NCT00972478|65112670|FG001|Overall Study|Not protocol specified|1|||
23373534|NCT00972478|65112669|FG000|Overall Study|Ineligible|1|||
23373535|NCT00972478|65112670|FG001|Overall Study|Ineligible|7|||
23373536|NCT00972478|65112669|FG000|Overall Study|Not start protocol treatment|1|||
23373537|NCT00972478|65112670|FG001|Overall Study|Not start protocol treatment|2|||
23373538|NCT02382939|65112671|FG000|Overall Study|Adverse Event|1|||
23373539|NCT02382939|65112672|FG001|Overall Study|Adverse Event|1|||
23373540|NCT02382939|65112671|FG000|Overall Study|Withdrawal by Subject|2|||
23373541|NCT02382939|65112672|FG001|Overall Study|Withdrawal by Subject|2|||
23373542|NCT00284856|65112676|FG000|Overall Study|Adverse Event|3|||
23373543|NCT00284856|65112677|FG001|Overall Study|Adverse Event|3|||
23373544|NCT00284856|65112678|FG002|Overall Study|Adverse Event|3|||
23373545|NCT00284856|65112676|FG000|Overall Study|Lack of Efficacy|2|||
23373546|NCT00284856|65112677|FG001|Overall Study|Lack of Efficacy|1|||
23373547|NCT00284856|65112678|FG002|Overall Study|Lack of Efficacy|8|||
23373548|NCT00284856|65112676|FG000|Overall Study|Lost to Follow-up|25|||
23373549|NCT00284856|65112677|FG001|Overall Study|Lost to Follow-up|21|||
23373550|NCT00284856|65112678|FG002|Overall Study|Lost to Follow-up|22|||
23373551|NCT00284856|65112676|FG000|Overall Study|Protocol Violation|5|||
23373552|NCT00284856|65112677|FG001|Overall Study|Protocol Violation|4|||
23373553|NCT00284856|65112678|FG002|Overall Study|Protocol Violation|5|||
23373554|NCT00284856|65112676|FG000|Overall Study|Withdrawal by Subject|12|||
23373555|NCT00284856|65112677|FG001|Overall Study|Withdrawal by Subject|16|||
23373556|NCT00284856|65112678|FG002|Overall Study|Withdrawal by Subject|18|||
23373557|NCT00284856|65112676|FG000|Overall Study|Other|4|||
23373558|NCT00284856|65112677|FG001|Overall Study|Other|5|||
23373559|NCT00284856|65112678|FG002|Overall Study|Other|4|||
23373560|NCT03810183|65112679|FG000|Overall Study|Study terminated by Sponsor|2|||
23373561|NCT03810183|65112680|FG001|Overall Study|Study terminated by Sponsor|1|||
23373562|NCT03440320|65112683|FG000|Overall Study|Withdrawal by Subject|0|||
23373563|NCT03440320|65112684|FG001|Overall Study|Withdrawal by Subject|1|||
23373564|NCT02873689|65112686|FG000|Overall Study|Lack of Efficacy|1|||
23373565|NCT02873689|65112687|FG001|Overall Study|Lack of Efficacy|0|||
23373566|NCT02873689|65112686|FG000|Overall Study|Withdrawal by Subject|2|||
23373567|NCT02873689|65112687|FG001|Overall Study|Withdrawal by Subject|2|||
23373568|NCT02873689|65112686|FG000|Overall Study|Protocol Violation|1|||
23373569|NCT02873689|65112687|FG001|Overall Study|Protocol Violation|0|||
23373570|NCT02873689|65112686|FG000|Overall Study|Adverse Event|2|||
23373571|NCT02873689|65112687|FG001|Overall Study|Adverse Event|2|||
23664184|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
23664185|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
23664186|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
23664187|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
23664188|NCT03016325|66155461|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664189|NCT03016325|66155462|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664190|NCT03016325|66155463|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
23373572|NCT02873689|65112686|FG000|Overall Study|Randomized but not Treated|1|||
23373573|NCT02873689|65112687|FG001|Overall Study|Randomized but not Treated|1|||
23373574|NCT01027949|65112688|FG000|Overall Study|Death|174|||
23373575|NCT01027949|65112688|FG000|Overall Study|Progressive Disease|163|||
23373576|NCT01027949|65112688|FG000|Overall Study|Adverse Event|172|||
23373577|NCT01027949|65112688|FG000|Overall Study|Withdrawal by Subject|113|||
23486964|NCT00336583|65527381|FG000|Overall Study|Lost to Follow-up|1|||
23486965|NCT00336583|65527381|FG000|Overall Study|Death|1|||
23664191|NCT03016325|66155464|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664192|NCT03016325|66155465|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664193|NCT03016325|66155466|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664194|NCT03016325|66155467|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664195|NCT03016325|66155468|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23664196|NCT03016325|66155461|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23664197|NCT03016325|66155462|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
23664198|NCT03016325|66155463|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23373578|NCT01027949|65112688|FG000|Overall Study|Lost to Follow-up|17|||
23486966|NCT04263454|65527384|FG000|Overall Study|Adverse Event|0|||
23664199|NCT03016325|66155464|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23373579|NCT01027949|65112688|FG000|Overall Study|Protocol Violation|13|||
23373580|NCT01027949|65112688|FG000|Overall Study|PI Decision|8|||
23373581|NCT01027949|65112688|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
23373582|NCT01027949|65112688|FG000|Overall Study|Non-compliance with Study Procedures|7|||
23373583|NCT01027949|65112688|FG000|Overall Study|Lung Transplant|5|||
23373584|NCT01027949|65112688|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
23373585|NCT01027949|65112688|FG000|Overall Study|Use of Excluded Medication|2|||
23373586|NCT01027949|65112688|FG000|Overall Study|Patient Self-discontinuation|1|||
23373587|NCT01027949|65112688|FG000|Overall Study|Pregnancy|1|||
23373588|NCT01027949|65112688|FG000|Overall Study|Surgery|1|||
23373589|NCT03311555|65112691|FG000|Overall Study|Adverse Event|1|||
23373590|NCT00896493|65112696|FG000|Overall Study|Early disease relapse|3|||
23373591|NCT02472353|65112697|FG000|Overall Study|Lost to Follow-up|1|||
23373592|NCT02472353|65112698|FG001|Overall Study|Lost to Follow-up|1|||
23373593|NCT02472353|65112697|FG000|Overall Study|Withdrawal by Subject|2|||
23373594|NCT02472353|65112698|FG001|Overall Study|Withdrawal by Subject|1|||
23373595|NCT02472353|65112697|FG000|Overall Study|Study Termination|1|||
23373596|NCT02472353|65112698|FG001|Overall Study|Study Termination|4|||
23373597|NCT01582451|65112700|FG000|Overall Study|Adverse Event|1|||
23373598|NCT01582451|65112701|FG001|Overall Study|Adverse Event|3|||
23486967|NCT04263454|65527385|FG001|Overall Study|Adverse Event|2|||
23486968|NCT04263454|65527384|FG000|Overall Study|Physician Decision|3|||
23486969|NCT04263454|65527385|FG001|Overall Study|Physician Decision|5|||
23486970|NCT04263454|65527384|FG000|Overall Study|Poor Data Quality|0|||
23486971|NCT04263454|65527385|FG001|Overall Study|Poor Data Quality|1|||
23486972|NCT01155219|65527386|FG000|Overall Study|Adverse Event|3|||
23486973|NCT01155219|65527387|FG001|Overall Study|Adverse Event|1|||
23486974|NCT01155219|65527386|FG000|Overall Study|non-medical reason|1|||
23486975|NCT01155219|65527387|FG001|Overall Study|non-medical reason|2|||
23486976|NCT00395538|65527390|FG000|Overall Study|Did not re-consent to revised protocol|1|||
23486977|NCT00395538|65527391|FG001|Overall Study|Did not re-consent to revised protocol|10|||
23486978|NCT00395538|65527392|FG002|Overall Study|Did not re-consent to revised protocol|0|||
23486979|NCT00395538|65527390|FG000|Overall Study|FDA partial hold on PTH|0|||
23486980|NCT00395538|65527391|FG001|Overall Study|FDA partial hold on PTH|0|||
23486981|NCT00395538|65527392|FG002|Overall Study|FDA partial hold on PTH|11|||
23486982|NCT00395538|65527390|FG000|Overall Study|Failed screening|0|||
23486983|NCT00395538|65527391|FG001|Overall Study|Failed screening|0|||
23486984|NCT00395538|65527392|FG002|Overall Study|Failed screening|4|||
23486985|NCT00395538|65527390|FG000|Overall Study|Switch to Natpara|0|||
23486986|NCT00395538|65527391|FG001|Overall Study|Switch to Natpara|0|||
23486987|NCT00395538|65527392|FG002|Overall Study|Switch to Natpara|3|||
23486988|NCT00395538|65527390|FG000|Overall Study|Adverse Event|1|||
23486989|NCT00395538|65527391|FG001|Overall Study|Adverse Event|0|||
23486990|NCT00395538|65527392|FG002|Overall Study|Adverse Event|2|||
23486991|NCT00395538|65527390|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
23486992|NCT00395538|65527391|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
23486993|NCT00395538|65527392|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
23486994|NCT00395538|65527390|FG000|Overall Study|Non-compliance with study protocol|0|||
23486995|NCT00395538|65527391|FG001|Overall Study|Non-compliance with study protocol|1|||
23486996|NCT00395538|65527392|FG002|Overall Study|Non-compliance with study protocol|0|||
23486997|NCT00395538|65527390|FG000|Overall Study|PTH resistance|0|||
23486998|NCT00395538|65527391|FG001|Overall Study|PTH resistance|0|||
23486999|NCT00395538|65527392|FG002|Overall Study|PTH resistance|1|||
23487000|NCT00395538|65527390|FG000|Overall Study|Pregnancy|1|||
23487001|NCT00395538|65527391|FG001|Overall Study|Pregnancy|0|||
23487002|NCT00395538|65527392|FG002|Overall Study|Pregnancy|0|||
23487003|NCT00395538|65527390|FG000|Overall Study|Partial recovery of parathyroid function|0|||
23487004|NCT00395538|65527391|FG001|Overall Study|Partial recovery of parathyroid function|0|||
23487005|NCT00395538|65527392|FG002|Overall Study|Partial recovery of parathyroid function|1|||
23487006|NCT00395538|65527390|FG000|Overall Study|Participant elected to discontinue|0|||
23487007|NCT00395538|65527391|FG001|Overall Study|Participant elected to discontinue|0|||
23487008|NCT00395538|65527392|FG002|Overall Study|Participant elected to discontinue|1|||
23487009|NCT01467427|65527399|FG000|Overall Study|Withdrawal by Subject|1|||
23487010|NCT01467427|65527400|FG001|Overall Study|Withdrawal by Subject|0|||
23487011|NCT01467427|65527399|FG000|Overall Study|Entered extension phase|11|||
23373599|NCT01582451|65112700|FG000|Overall Study|Death|3|||
23373600|NCT01582451|65112701|FG001|Overall Study|Death|3|||
23373601|NCT01582451|65112700|FG000|Overall Study|Lost to Follow-up|0|||
23373602|NCT01582451|65112701|FG001|Overall Study|Lost to Follow-up|2|||
23373603|NCT01582451|65112700|FG000|Overall Study|Protocol Violation|11|||
23373604|NCT01582451|65112701|FG001|Overall Study|Protocol Violation|3|||
23373605|NCT01582451|65112700|FG000|Overall Study|Withdrawal by Subject|13|||
23373606|NCT01582451|65112701|FG001|Overall Study|Withdrawal by Subject|9|||
23373607|NCT01582451|65112700|FG000|Overall Study|Physician Decision|3|||
23487012|NCT01467427|65527400|FG001|Overall Study|Entered extension phase|11|||
23487013|NCT01467427|65527399|FG000|Overall Study|Not continuing in extension phase|0|||
23487014|NCT01467427|65527400|FG001|Overall Study|Not continuing in extension phase|2|||
23373608|NCT01582451|65112701|FG001|Overall Study|Physician Decision|0|||
23373609|NCT01582451|65112700|FG000|Overall Study|Sponsor Decision|1|||
23373610|NCT01582451|65112701|FG001|Overall Study|Sponsor Decision|0|||
23487015|NCT01539317|65527401|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
23487016|NCT01539317|65527402|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
23487017|NCT00116428|65527403|FG000|Overall Study|Withdrawal by Subject|2|||
23487018|NCT00116428|65527404|FG001|Overall Study|Withdrawal by Subject|5|||
23373611|NCT02774889|65112704|FG000|Overall Study|Lost to Follow-up|2|||
23373612|NCT02774889|65112705|FG001|Overall Study|Lost to Follow-up|1|||
23487019|NCT00116428|65527403|FG000|Overall Study|Did not meet inclusion criteria|1|||
23487020|NCT00116428|65527404|FG001|Overall Study|Did not meet inclusion criteria|0|||
23487021|NCT00478881|65527405|FG000|Overall Study|Adverse Event|31|||
23487022|NCT00478881|65527406|FG001|Overall Study|Adverse Event|12|||
23487023|NCT00478881|65527405|FG000|Overall Study|Lack of Efficacy|0|||
23487024|NCT00478881|65527406|FG001|Overall Study|Lack of Efficacy|3|||
23487025|NCT00478881|65527405|FG000|Overall Study|Lost to Follow-up|0|||
23487026|NCT00478881|65527406|FG001|Overall Study|Lost to Follow-up|1|||
23487027|NCT00478881|65527405|FG000|Overall Study|Protocol Violation|2|||
23487028|NCT00478881|65527406|FG001|Overall Study|Protocol Violation|2|||
23487029|NCT00478881|65527405|FG000|Overall Study|Withdrawal by Subject|6|||
23487030|NCT00478881|65527406|FG001|Overall Study|Withdrawal by Subject|2|||
23487031|NCT00478881|65527405|FG000|Overall Study|Non-Compliance with Study Medication|0|||
23664200|NCT03016325|66155465|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23664201|NCT03016325|66155466|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23664202|NCT03016325|66155467|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23664203|NCT03016325|66155468|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23664204|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Death|3|||
23664205|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Death|3|||
23664206|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Death|11|||
23664207|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Death|12|||
23664208|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Death|9|||
23373613|NCT00830219|65112706|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23373614|NCT00830219|65112707|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23373615|NCT02153918|65112709|FG000|Overall Study|Refused further treatment|1|||
23373616|NCT03256578|65112710|FG000|Overall Study|Excluded Post Randomization|66|||
23373617|NCT03256578|65112711|FG001|Overall Study|Excluded Post Randomization|56|||
23373618|NCT01811238|65112714|FG000|Overall Study|Withdrawal by Subject|42|||
23373619|NCT01811238|65112714|FG000|Overall Study|Adverse Event|25|||
23373620|NCT01811238|65112714|FG000|Overall Study|Protocol Violation|4|||
23373621|NCT01811238|65112714|FG000|Overall Study|Lack of Efficacy|4|||
23373622|NCT01811238|65112714|FG000|Overall Study|subject refused study medication|6|||
23373623|NCT02783066|65112715|FG000|Overall Study|Withdrawal by Subject|13|||
23373624|NCT00473083|65112719|FG000|Overall Study|Adverse Event|1|||
23373625|NCT00473083|65112720|FG001|Overall Study|Adverse Event|0|||
23373626|NCT00473083|65112721|FG002|Overall Study|Adverse Event|0|||
23373627|NCT01369433|65112722|FG000|Overall Study|Adverse Event|31|||
23373628|NCT01369433|65112723|FG001|Overall Study|Adverse Event|1|||
23373629|NCT01369433|65112722|FG000|Overall Study|Required significant surgical procedure|1|||
23373630|NCT01369433|65112723|FG001|Overall Study|Required significant surgical procedure|0|||
23487032|NCT00478881|65527406|FG001|Overall Study|Non-Compliance with Study Medication|2|||
23664209|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Death|0|||
23664210|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Death|0|||
23664211|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Death|1|||
23664212|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
23664213|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664214|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664215|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664216|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664217|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664218|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664219|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23664220|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664221|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664222|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664223|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664224|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
23664225|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664226|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
23664227|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
23664228|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664229|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664230|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664231|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664232|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
23373631|NCT01369433|65112722|FG000|Overall Study|Non-compliance|1|||
23373632|NCT01369433|65112723|FG001|Overall Study|Non-compliance|0|||
23373633|NCT01369433|65112722|FG000|Overall Study|Withdrawal by Subject|5|||
23373634|NCT01369433|65112723|FG001|Overall Study|Withdrawal by Subject|2|||
23487033|NCT01278160|65527407|FG000|Overall Study|Adverse Event|1|||
23487034|NCT01278160|65527408|FG001|Overall Study|Adverse Event|1|||
23487035|NCT01278160|65527407|FG000|Overall Study|Lost to Follow-up|0|||
23487036|NCT01278160|65527408|FG001|Overall Study|Lost to Follow-up|1|||
23664233|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664234|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664235|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23664236|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664237|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664238|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664239|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664240|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
23603695|NCT01034306|65937456|FG000|Overall Study|Noncomplience|1|||
23603696|NCT01034306|65937457|FG001|Overall Study|Noncomplience|0|||
23603697|NCT03138499|65940154|FG000|Overall Study|Lost to Follow-up|1|||
23603698|NCT03138499|65940155|FG001|Overall Study|Lost to Follow-up|0|||
23603699|NCT03138499|65940154|FG000|Overall Study|Participants withdrew consent|1|||
23603700|NCT03138499|65940155|FG001|Overall Study|Participants withdrew consent|0|||
23664241|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664242|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
23664243|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
23603701|NCT03138499|65940154|FG000|Overall Study|Participant discontinued study before treatment|0|||
23603702|NCT03138499|65940155|FG001|Overall Study|Participant discontinued study before treatment|1|||
23603703|NCT03138499|65940154|FG000|Overall Study|Disease Progression|2|||
23603704|NCT03138499|65940155|FG001|Overall Study|Disease Progression|6|||
23487037|NCT01278160|65527407|FG000|Overall Study|Withdrawal by Subject|3|||
23487038|NCT01278160|65527408|FG001|Overall Study|Withdrawal by Subject|2|||
23373635|NCT01369433|65112722|FG000|Overall Study|Study terminated by Sponsor|67|||
23373636|NCT01369433|65112723|FG001|Overall Study|Study terminated by Sponsor|0|||
23373637|NCT01369433|65112722|FG000|Overall Study|Lost to Follow-up|1|||
23373638|NCT01369433|65112723|FG001|Overall Study|Lost to Follow-up|0|||
23373639|NCT01369433|65112722|FG000|Overall Study|Death|5|||
23373640|NCT01369433|65112723|FG001|Overall Study|Death|0|||
23373641|NCT01369433|65112722|FG000|Overall Study|Investigator discretion|6|||
23373642|NCT01369433|65112723|FG001|Overall Study|Investigator discretion|1|||
23373643|NCT01369433|65112722|FG000|Overall Study|Progressive Disease|92|||
23373644|NCT01369433|65112723|FG001|Overall Study|Progressive Disease|12|||
23373645|NCT00964782|65112726|FG000|Overall Study|Lost to Follow-up|1|||
23373646|NCT00964782|65112727|FG001|Overall Study|Lost to Follow-up|0|||
23373647|NCT00921024|65112731|FG000|Overall Study|Lost to Follow-up|2|||
23373648|NCT00921024|65112732|FG001|Overall Study|Lost to Follow-up|0|||
23373649|NCT00921024|65112731|FG000|Overall Study|Received concomittant therapy|2|||
23373650|NCT00921024|65112732|FG001|Overall Study|Received concomittant therapy|0|||
23373651|NCT00921024|65112731|FG000|Overall Study|Withdrawal by Subject|0|||
23373652|NCT00921024|65112732|FG001|Overall Study|Withdrawal by Subject|3|||
23373653|NCT03427892|65112735|FG000|Overall Study|Lost to Follow-up|2|||
23373654|NCT00314145|65112738|FG000|Overall Study|Withdrawal by Subject|8|||
23373655|NCT00314145|65112739|FG001|Overall Study|Withdrawal by Subject|10|||
23373656|NCT00314145|65112738|FG000|Overall Study|Lost to Follow-up|5|||
23373657|NCT00314145|65112739|FG001|Overall Study|Lost to Follow-up|12|||
23373658|NCT00314145|65112738|FG000|Overall Study|Physician Decision|3|||
23373659|NCT00314145|65112739|FG001|Overall Study|Physician Decision|4|||
23373660|NCT00314145|65112738|FG000|Overall Study|Adverse Event|0|||
23373661|NCT00314145|65112739|FG001|Overall Study|Adverse Event|3|||
23373662|NCT00314145|65112738|FG000|Overall Study|Protocol Violation|3|||
23373663|NCT00314145|65112739|FG001|Overall Study|Protocol Violation|0|||
23373664|NCT00314145|65112738|FG000|Overall Study|Sponsor Decision|2|||
23373665|NCT00314145|65112739|FG001|Overall Study|Sponsor Decision|0|||
23373666|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
23373667|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
23373668|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
23373669|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
23373670|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
23373671|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
23373672|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
23373673|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
23373674|NCT00891813|65112741|FG000|Overall Study|Adverse Event|3|||
23373675|NCT00891813|65112741|FG000|Overall Study|Withdrawal by Subject|1|||
23373676|NCT00891813|65112741|FG000|Overall Study|Patient Noncompliance|6|||
23373677|NCT00891813|65112741|FG000|Overall Study|Protocol Violation|2|||
23373678|NCT01649765|65112742|FG000|Overall Study|Adverse Event|5|||
23373679|NCT01649765|65112743|FG001|Overall Study|Adverse Event|3|||
23373680|NCT01649765|65112742|FG000|Overall Study|Lack of Efficacy|1|||
23373681|NCT01649765|65112743|FG001|Overall Study|Lack of Efficacy|1|||
23373682|NCT01649765|65112742|FG000|Overall Study|Physician Decision|0|||
23373683|NCT01649765|65112743|FG001|Overall Study|Physician Decision|3|||
23373684|NCT01649765|65112742|FG000|Overall Study|Protocol Violation|1|||
23373685|NCT01649765|65112743|FG001|Overall Study|Protocol Violation|0|||
23373686|NCT01649765|65112742|FG000|Overall Study|Withdrawal by Subject|2|||
23373687|NCT01649765|65112743|FG001|Overall Study|Withdrawal by Subject|1|||
23373688|NCT00572832|65112747|FG000|Overall Study|Lost to Follow-up|0|||
23373689|NCT00572832|65112748|FG001|Overall Study|Lost to Follow-up|11|||
23373690|NCT00572832|65112747|FG000|Overall Study|Pregnancy|0|||
23373691|NCT00572832|65112748|FG001|Overall Study|Pregnancy|1|||
23373692|NCT01925417|65112750|FG000|Overall Study|Withdrawal by Subject|2|||
23373693|NCT01925417|65112750|FG000|Overall Study|Death|1|||
23664244|NCT03016325|66155461|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664245|NCT03016325|66155462|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664246|NCT03016325|66155463|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664247|NCT03016325|66155464|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
23664248|NCT03016325|66155465|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664249|NCT03016325|66155466|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664250|NCT03016325|66155467|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664251|NCT03016325|66155468|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23664252|NCT03016325|66155461|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664253|NCT03016325|66155462|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
23664254|NCT03016325|66155463|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664255|NCT03016325|66155464|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664256|NCT03016325|66155465|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664257|NCT03016325|66155466|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664258|NCT03016325|66155467|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664259|NCT03016325|66155468|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23664260|NCT03016325|66155461|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23664261|NCT03016325|66155462|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23664262|NCT03016325|66155463|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23664263|NCT03016325|66155464|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23664264|NCT03016325|66155465|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23664265|NCT03016325|66155466|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
23664266|NCT03016325|66155467|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
23664267|NCT03016325|66155468|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
23664268|NCT00841568|66155469|FG000|Overall Study|Adverse Event|1|||
23664269|NCT00841568|66155469|FG000|Overall Study|Death|1|||
23664270|NCT00841568|66155469|FG000|Overall Study|Withdrawal by Subject|2|||
23664271|NCT00841568|66155469|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
23664272|NCT00912028|66155478|FG000|Overall Study|Lost to Follow-up|2|||
23664273|NCT00912028|66155479|FG001|Overall Study|Lost to Follow-up|3|||
23664274|NCT00912028|66155480|FG002|Overall Study|Lost to Follow-up|0|||
23664275|NCT00912028|66155481|FG003|Overall Study|Lost to Follow-up|1|||
23664276|NCT00912028|66155482|FG004|Overall Study|Lost to Follow-up|3|||
23664277|NCT00912028|66155478|FG000|Overall Study|Withdrawal by Subject|3|||
23664278|NCT00912028|66155479|FG001|Overall Study|Withdrawal by Subject|0|||
23373694|NCT00753519|65112751|FG000|Overall Study|Withdrawal by Subject|0|||
23373695|NCT00753519|65112752|FG001|Overall Study|Withdrawal by Subject|2|||
23373696|NCT01553851|65112753|FG000|Overall Study|Adverse Event|2|||
23373697|NCT01553851|65112753|FG000|Overall Study|constipation|1|||
23373698|NCT01277861|65112754|FG000|Overall Study|Physician Decision|2|||
23373699|NCT01277861|65112755|FG001|Overall Study|Physician Decision|2|||
23373700|NCT00407511|65112758|FG000|Overall Study|Adverse Event|9|||
23373701|NCT00407511|65112758|FG000|Overall Study|Lost to Follow-up|4|||
23373702|NCT00407511|65112758|FG000|Overall Study|Other|5|||
23373703|NCT00407511|65112758|FG000|Overall Study|Withdrawal by Subject|4|||
23373704|NCT01933594|65112761|FG000|Overall Study|Lost to Follow-up|1|||
23373705|NCT01933594|65112762|FG001|Overall Study|Lost to Follow-up|0|||
23373706|NCT01933594|65112763|FG002|Overall Study|Lost to Follow-up|0|||
23373707|NCT01933594|65112764|FG003|Overall Study|Lost to Follow-up|0|||
23373708|NCT01933594|65112765|FG004|Overall Study|Lost to Follow-up|1|||
23373709|NCT01933594|65112766|FG005|Overall Study|Lost to Follow-up|0|||
23373710|NCT01933594|65112761|FG000|Overall Study|Ineligible for subsequent study step|0|||
23373711|NCT01933594|65112762|FG001|Overall Study|Ineligible for subsequent study step|0|||
23373712|NCT01933594|65112763|FG002|Overall Study|Ineligible for subsequent study step|0|||
23487039|NCT01278160|65527407|FG000|Overall Study|Unclassified|1|||
23487040|NCT01278160|65527408|FG001|Overall Study|Unclassified|2|||
23487041|NCT01107418|65527414|FG000|Overall Study|Disease Progression|45|||
23487042|NCT01107418|65527414|FG000|Overall Study|Adverse Event|3|||
23487043|NCT01107418|65527414|FG000|Overall Study|Withdrawal by Subject|1|||
23487044|NCT01107418|65527414|FG000|Overall Study|Study Closing|1|||
23487045|NCT01107418|65527414|FG000|Overall Study|Started Other Therapy|1|||
23487046|NCT01107418|65527414|FG000|Overall Study|Entered Extension Study|1|||
23487047|NCT01606254|65527417|FG000|Overall Study|Withdrawal by Subject|1|||
23487048|NCT01606254|65527418|FG001|Overall Study|Withdrawal by Subject|3|||
23487049|NCT01606254|65527419|FG002|Overall Study|Withdrawal by Subject|0|||
23487050|NCT01606254|65527420|FG003|Overall Study|Withdrawal by Subject|2|||
23487051|NCT01606254|65527417|FG000|Overall Study|Adverse Event|1|||
23487052|NCT01606254|65527418|FG001|Overall Study|Adverse Event|1|||
23487053|NCT01606254|65527419|FG002|Overall Study|Adverse Event|0|||
23487054|NCT01606254|65527420|FG003|Overall Study|Adverse Event|1|||
23487055|NCT03766685|65527421|FG000|Overall Study|Lost to Follow-up|1|||
23487056|NCT03766685|65527422|FG001|Overall Study|Lost to Follow-up|1|||
23487057|NCT03766685|65527423|FG002|Overall Study|Lost to Follow-up|0|||
23487058|NCT03766685|65527424|FG003|Overall Study|Lost to Follow-up|0|||
23487059|NCT03766685|65527421|FG000|Overall Study|Adverse Event, not fatal|0|||
23487060|NCT03766685|65527422|FG001|Overall Study|Adverse Event, not fatal|1|||
23487061|NCT03766685|65527423|FG002|Overall Study|Adverse Event, not fatal|0|||
23487062|NCT03766685|65527424|FG003|Overall Study|Adverse Event, not fatal|1|||
23487063|NCT03766685|65527421|FG000|Overall Study|Withdrawal by Subject|0|||
23487064|NCT03766685|65527422|FG001|Overall Study|Withdrawal by Subject|2|||
23487065|NCT03766685|65527423|FG002|Overall Study|Withdrawal by Subject|0|||
23664279|NCT00912028|66155480|FG002|Overall Study|Withdrawal by Subject|0|||
23664280|NCT00912028|66155481|FG003|Overall Study|Withdrawal by Subject|0|||
23664281|NCT00912028|66155482|FG004|Overall Study|Withdrawal by Subject|0|||
23664282|NCT00545298|66155483|FG000|Overall Study|Issues with Standard of Care|2|||
23664283|NCT00545298|66155484|FG001|Overall Study|Issues with Standard of Care|0|||
23664284|NCT00545298|66155485|FG002|Overall Study|Issues with Standard of Care|1|||
23664285|NCT01979536|66155486|FG000|Overall Study|Physician Decision|2|||
23664286|NCT01979536|66155487|FG001|Overall Study|Physician Decision|3|||
23487066|NCT03766685|65527424|FG003|Overall Study|Withdrawal by Subject|0|||
23664287|NCT01979536|66155486|FG000|Overall Study|Withdrawal by Subject|0|||
23664288|NCT01979536|66155487|FG001|Overall Study|Withdrawal by Subject|1|||
23487067|NCT03766685|65527421|FG000|Overall Study|Protocol Violation|0|||
23487068|NCT03766685|65527422|FG001|Overall Study|Protocol Violation|1|||
23487069|NCT03766685|65527423|FG002|Overall Study|Protocol Violation|0|||
23487070|NCT03766685|65527424|FG003|Overall Study|Protocol Violation|0|||
23487071|NCT03766685|65527421|FG000|Overall Study|Non-compliance|0|||
23487072|NCT03766685|65527422|FG001|Overall Study|Non-compliance|2|||
23487073|NCT03766685|65527423|FG002|Overall Study|Non-compliance|0|||
23487074|NCT03766685|65527424|FG003|Overall Study|Non-compliance|0|||
23487075|NCT01859143|65527425|FG000|Overall Study|Lost to Follow-up|2|||
23487076|NCT01859143|65527426|FG001|Overall Study|Lost to Follow-up|0|||
23487077|NCT00237185|65527427|FG000|Core|Adverse Event|3|||
23487078|NCT00237185|65527428|FG001|Core|Adverse Event|4|||
23487079|NCT00237185|65527427|FG000|Core|Abnormal laboratory value|0|||
23487080|NCT00237185|65527428|FG001|Core|Abnormal laboratory value|4|||
23487081|NCT00237185|65527427|FG000|Core|Abnormal test procedure results|1|||
23487082|NCT00237185|65527428|FG001|Core|Abnormal test procedure results|0|||
23487083|NCT00237185|65527427|FG000|Core|Lack of Efficacy|30|||
23487084|NCT00237185|65527428|FG001|Core|Lack of Efficacy|23|||
23487085|NCT00237185|65527427|FG000|Core|Protocol Violation|1|||
23487086|NCT00237185|65527428|FG001|Core|Protocol Violation|1|||
23487087|NCT00237185|65527427|FG000|Core|Withdrawal by Subject|4|||
23487088|NCT00237185|65527428|FG001|Core|Withdrawal by Subject|4|||
23487089|NCT00237185|65527427|FG000|Core|Administrative problems|0|||
23487090|NCT00237185|65527428|FG001|Core|Administrative problems|1|||
23487091|NCT00237185|65527427|FG000|Core|Death|4|||
23487092|NCT00237185|65527428|FG001|Core|Death|0|||
23487093|NCT00237185|65527427|FG000|Core|Determined ineligible post randomization|1|||
23487094|NCT00237185|65527428|FG001|Core|Determined ineligible post randomization|0|||
23487095|NCT00237185|65527427|FG000|Extension|Adverse Event|1|||
23487096|NCT00237185|65527428|FG001|Extension|Adverse Event|0|||
23487097|NCT00237185|65527427|FG000|Extension|Abnormal laboratory value|0|||
23487098|NCT00237185|65527428|FG001|Extension|Abnormal laboratory value|1|||
23487099|NCT00237185|65527427|FG000|Extension|Lack of Efficacy|9|||
23487100|NCT00237185|65527428|FG001|Extension|Lack of Efficacy|14|||
23487101|NCT00237185|65527427|FG000|Extension|Condition no longer required study drug|0|||
23487102|NCT00237185|65527428|FG001|Extension|Condition no longer required study drug|1|||
23487103|NCT00237185|65527427|FG000|Extension|Withdrawal by Subject|3|||
23487104|NCT00237185|65527428|FG001|Extension|Withdrawal by Subject|2|||
23487105|NCT00237185|65527427|FG000|Extension|Lost to Follow-up|1|||
23487106|NCT00237185|65527428|FG001|Extension|Lost to Follow-up|0|||
23487107|NCT00237185|65527427|FG000|Extension|Administrative problems|1|||
23487108|NCT00237185|65527428|FG001|Extension|Administrative problems|0|||
23487109|NCT00237185|65527427|FG000|Extension|Death|1|||
23487110|NCT00237185|65527428|FG001|Extension|Death|1|||
23487111|NCT02962765|65527429|FG000|Overall Study|Protocol Violation|9|||
23487112|NCT02962765|65527429|FG000|Overall Study|Withdrawal by Subject|3|||
23487113|NCT02962765|65527429|FG000|Overall Study|Lost to Follow-up|1|||
23487114|NCT02962765|65527429|FG000|Overall Study|Death|1|||
23487115|NCT02962765|65527429|FG000|Overall Study|Limited access to study medication|3|||
23487116|NCT02203071|65527430|FG000|Overall Study|Lost to Follow-up|3|||
23487117|NCT02203071|65527431|FG001|Overall Study|Lost to Follow-up|1|||
23487118|NCT01367119|65527432|FG000|Overall Study|Adverse Event|1|||
23487119|NCT01367119|65527433|FG001|Overall Study|Adverse Event|0|||
23487120|NCT01367119|65527432|FG000|Overall Study|Withdrawal by Subject|1|||
23487121|NCT01367119|65527433|FG001|Overall Study|Withdrawal by Subject|1|||
23487122|NCT03977454|65527434|FG000|Overall Study|immediate postoperative revision|2|||
23487123|NCT03977454|65527435|FG001|Overall Study|immediate postoperative revision|2|||
23487124|NCT01272661|65527438|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
23487125|NCT01272661|65527439|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
23487126|NCT01272661|65527440|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
23664289|NCT01979536|66155486|FG000|Overall Study|Refusal|0|||
23373713|NCT01933594|65112764|FG003|Overall Study|Ineligible for subsequent study step|0|||
23487127|NCT03505671|65527441|FG000|Overall Study|Withdrawal by Subject|2|||
23603705|NCT03138499|65940154|FG000|Overall Study|Study drug toxicity|2|||
23664290|NCT01979536|66155487|FG001|Overall Study|Refusal|1|||
23487128|NCT03505671|65527442|FG001|Overall Study|Withdrawal by Subject|1|||
23487129|NCT03505671|65527441|FG000|Overall Study|Lost to Follow-up|1|||
23487130|NCT03505671|65527442|FG001|Overall Study|Lost to Follow-up|0|||
23487131|NCT01336569|65527443|FG000|Overall Study|Lost to Follow-up|4|||
23487132|NCT02579928|65527444|FG000|Overall Study|Withdrawal by Subject|1|||
23487133|NCT02579928|65527445|FG001|Overall Study|Withdrawal by Subject|0|||
23487134|NCT01962922|65527448|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
23487135|NCT01962922|65527449|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
23487136|NCT01962922|65527448|FG000|PK Portion Day 7|non-compliance|1|||
23487137|NCT01962922|65527449|FG001|PK Portion Day 7|non-compliance|0|||
23487138|NCT01962922|65527448|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
23487139|NCT01962922|65527449|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
23487140|NCT01962922|65527448|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
23487141|NCT01962922|65527449|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
23487142|NCT03206073|65527452|FG000|Overall Study|Participant Noncompliance|0|||
23487143|NCT03206073|65527453|FG001|Overall Study|Participant Noncompliance|1|||
23487144|NCT03206073|65527454|FG002|Overall Study|Participant Noncompliance|0|||
23487145|NCT03206073|65527455|FG003|Overall Study|Participant Noncompliance|0|||
23487146|NCT03206073|65527452|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
23487147|NCT03206073|65527453|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487148|NCT03206073|65527454|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487149|NCT03206073|65527455|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487150|NCT03206073|65527452|FG000|Overall Study|Death|0|||
23487151|NCT03206073|65527453|FG001|Overall Study|Death|0|||
23487152|NCT03206073|65527454|FG002|Overall Study|Death|1|||
23487153|NCT03206073|65527455|FG003|Overall Study|Death|0|||
23487154|NCT03206073|65527452|FG000|Overall Study|Taken off active treatment|0|||
23487155|NCT03206073|65527453|FG001|Overall Study|Taken off active treatment|0|||
23487156|NCT03206073|65527454|FG002|Overall Study|Taken off active treatment|3|||
23487157|NCT03206073|65527455|FG003|Overall Study|Taken off active treatment|0|||
23487158|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
23487159|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
23487160|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
23487161|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
23487162|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23487163|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
23487164|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23487165|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
23487166|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
23487167|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
23487168|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
23487169|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
23487170|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487171|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
23487172|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487173|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487174|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Program Termination|3|||
23487175|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Program Termination|0|||
23487176|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Program Termination|1|||
23487177|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Program Termination|1|||
23487178|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
23487179|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487180|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487181|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487182|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
23487183|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
23487184|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
23487185|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
23487186|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
23487187|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
23487188|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
23487189|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
23487190|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487191|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
23487192|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487193|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487194|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487195|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
23487196|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487197|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487198|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487199|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
23487200|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487201|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487202|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
23487203|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
23487204|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
23487205|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
23487206|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487207|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487208|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
23487209|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487210|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487211|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487212|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
23487213|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487214|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487215|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487216|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487217|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
23487218|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487219|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487220|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487221|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
23487222|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487223|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487224|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487225|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
23487226|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
23487227|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487228|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487229|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487230|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487231|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487232|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487233|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
23487234|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
23487235|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487236|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487237|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487238|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487239|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
23487240|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487241|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487242|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487243|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
23487244|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487245|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487246|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487247|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487248|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
23487249|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487250|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487251|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487252|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
23487253|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487254|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487255|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487256|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
23487257|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487258|NCT01756300|65527461|FG000|Overall Study|Death|1|||
23487259|NCT01756300|65527461|FG000|Overall Study|Withdrawal by Subject|1|||
23487260|NCT00560885|65527462|FG000|Overall Study|Death|7|||
23487261|NCT00560885|65527462|FG000|Overall Study|Withdrawal by Subject|1|||
23487262|NCT00292318|65527465|FG000|Overall Study|Study terminated by officials|2|||
23487263|NCT00292318|65527466|FG001|Overall Study|Study terminated by officials|1|||
23487264|NCT01721070|65527467|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
23487265|NCT04365257|65527470|FG000|Overall Study|Physician Decision|1|||
23487266|NCT04365257|65527471|FG001|Overall Study|Physician Decision|0|||
23487267|NCT04365257|65527470|FG000|Overall Study|Patient Noncompliance|1|||
23487268|NCT04365257|65527471|FG001|Overall Study|Patient Noncompliance|0|||
23487269|NCT04365257|65527470|FG000|Overall Study|Withdrawal by Subject|0|||
23487270|NCT04365257|65527471|FG001|Overall Study|Withdrawal by Subject|1|||
23487271|NCT00364130|65527472|FG000|Intervention Period|Lost to Follow-up|4|||
23487272|NCT00364130|65527473|FG001|Intervention Period|Lost to Follow-up|3|||
23487273|NCT00364130|65527472|FG000|Intervention Period|Pregnancy|1|||
23487274|NCT00364130|65527473|FG001|Intervention Period|Pregnancy|0|||
23487275|NCT00364130|65527472|FG000|Intervention Period|Withdrawal by Subject|4|||
23487276|NCT00364130|65527473|FG001|Intervention Period|Withdrawal by Subject|5|||
23487277|NCT00364130|65527472|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
23487278|NCT00364130|65527473|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
23487279|NCT02028871|65527474|FG000|Overall Study|Positive urine drug screen|1|||
23487280|NCT02028871|65527475|FG001|Overall Study|Positive urine drug screen|1|||
23487281|NCT02028871|65527474|FG000|Overall Study|Withdrawal by Subject|1|||
23487282|NCT02028871|65527475|FG001|Overall Study|Withdrawal by Subject|2|||
23487283|NCT02028871|65527474|FG000|Overall Study|IV placement difficulty|1|||
23487284|NCT02028871|65527475|FG001|Overall Study|IV placement difficulty|0|||
23487285|NCT02028871|65527474|FG000|Overall Study|Current Illness|1|||
23487286|NCT02028871|65527475|FG001|Overall Study|Current Illness|0|||
23487287|NCT01672736|65527476|FG000|Overall Study|Available drug expired on 31 May 16|3|||
23487288|NCT00597701|65527479|FG000|Overall Study|Withdrawal by Subject|5|||
23487289|NCT00597701|65527480|FG001|Overall Study|Withdrawal by Subject|5|||
23487290|NCT00597701|65527479|FG000|Overall Study|Death|0|||
23487291|NCT00597701|65527480|FG001|Overall Study|Death|1|||
23487292|NCT00597701|65527479|FG000|Overall Study|Physician Decision|2|||
23487293|NCT00597701|65527480|FG001|Overall Study|Physician Decision|0|||
23487294|NCT00597701|65527479|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
23487295|NCT00597701|65527480|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
23487296|NCT03693170|65527481|FG000|Overall Study|Disease Progression|48|||
23487297|NCT03693170|65527481|FG000|Overall Study|Adverse Event|16|||
23487298|NCT03693170|65527481|FG000|Overall Study|Physician Decision|6|||
23487299|NCT03693170|65527481|FG000|Overall Study|Protocol Violation|2|||
23487300|NCT03693170|65527481|FG000|Overall Study|Death|1|||
23487301|NCT03693170|65527481|FG000|Overall Study|Non compliance with study drug|1|||
23487302|NCT03693170|65527481|FG000|Overall Study|Withdrawal by Subject|1|||
23487303|NCT00700570|65527482|FG000|Overall Study|Adverse Event|2|||
23487304|NCT00700570|65527483|FG001|Overall Study|Adverse Event|6|||
23487305|NCT00700570|65527482|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
23487306|NCT00700570|65527483|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
23487307|NCT00700570|65527482|FG000|Overall Study|Disease Progression|8|||
23487308|NCT00700570|65527483|FG001|Overall Study|Disease Progression|11|||
23487309|NCT00700570|65527482|FG000|Overall Study|Withdrawal by Subject|1|||
23487310|NCT00700570|65527483|FG001|Overall Study|Withdrawal by Subject|6|||
23487311|NCT02393690|65527485|FG000|Overall Study|Ineligible|0|||
23487312|NCT02393690|65527486|FG001|Overall Study|Ineligible|1|||
23487313|NCT02038829|65530307|FG000|Washout Period 1|Death|0|||
23487314|NCT02038829|65530308|FG001|Washout Period 1|Death|0|||
23487315|NCT02038829|65530309|FG002|Washout Period 1|Death|0|||
23487316|NCT02038829|65530310|FG003|Washout Period 1|Death|0|||
23487317|NCT02038829|65530311|FG004|Washout Period 1|Death|1|||
23487318|NCT02038829|65530312|FG005|Washout Period 1|Death|0|||
23487319|NCT02038829|65530313|FG006|Washout Period 1|Death|0|||
23487320|NCT02038829|65530314|FG007|Washout Period 1|Death|0|||
23487321|NCT02038829|65530315|FG008|Washout Period 1|Death|0|||
23487322|NCT02038829|65530316|FG009|Washout Period 1|Death|0|||
23487323|NCT02038829|65530317|FG010|Washout Period 1|Death|0|||
23487324|NCT02038829|65530318|FG011|Washout Period 1|Death|0|||
23487325|NCT02038829|65530307|FG000|Treatment Period 2|Adverse Event|0|||
23487326|NCT02038829|65530308|FG001|Treatment Period 2|Adverse Event|0|||
23487327|NCT02038829|65530309|FG002|Treatment Period 2|Adverse Event|0|||
23487328|NCT02038829|65530310|FG003|Treatment Period 2|Adverse Event|0|||
23487329|NCT02038829|65530311|FG004|Treatment Period 2|Adverse Event|0|||
23487330|NCT02038829|65530312|FG005|Treatment Period 2|Adverse Event|0|||
23487331|NCT02038829|65530313|FG006|Treatment Period 2|Adverse Event|0|||
23487332|NCT02038829|65530314|FG007|Treatment Period 2|Adverse Event|0|||
23487333|NCT02038829|65530315|FG008|Treatment Period 2|Adverse Event|0|||
23487334|NCT02038829|65530316|FG009|Treatment Period 2|Adverse Event|0|||
23487335|NCT02038829|65530317|FG010|Treatment Period 2|Adverse Event|1|||
23487336|NCT02038829|65530318|FG011|Treatment Period 2|Adverse Event|0|||
23487337|NCT02038829|65530307|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23487338|NCT02038829|65530308|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23487339|NCT02038829|65530309|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23487340|NCT02038829|65530310|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23487341|NCT02038829|65530311|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23487342|NCT02038829|65530312|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23487343|NCT02038829|65530313|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23487344|NCT02038829|65530314|FG007|Treatment Period 2|Withdrawal by Subject|0|||
23487345|NCT02038829|65530315|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23487346|NCT02038829|65530316|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23487347|NCT02038829|65530317|FG010|Treatment Period 2|Withdrawal by Subject|0|||
23487348|NCT02038829|65530318|FG011|Treatment Period 2|Withdrawal by Subject|0|||
23487349|NCT02038829|65530307|FG000|Washout Period 2|Adverse Event|0|||
23487350|NCT02038829|65530308|FG001|Washout Period 2|Adverse Event|0|||
23487351|NCT02038829|65530309|FG002|Washout Period 2|Adverse Event|0|||
23487352|NCT02038829|65530310|FG003|Washout Period 2|Adverse Event|0|||
23487353|NCT02038829|65530311|FG004|Washout Period 2|Adverse Event|0|||
23487354|NCT02038829|65530312|FG005|Washout Period 2|Adverse Event|0|||
23487355|NCT02038829|65530313|FG006|Washout Period 2|Adverse Event|0|||
23487356|NCT02038829|65530314|FG007|Washout Period 2|Adverse Event|0|||
23487357|NCT02038829|65530315|FG008|Washout Period 2|Adverse Event|1|||
23487358|NCT02038829|65530316|FG009|Washout Period 2|Adverse Event|0|||
23487359|NCT02038829|65530317|FG010|Washout Period 2|Adverse Event|0|||
23487360|NCT02038829|65530318|FG011|Washout Period 2|Adverse Event|0|||
23487361|NCT02038829|65530307|FG000|Washout Period 2|Withdrawal by Subject|0|||
23487362|NCT02038829|65530308|FG001|Washout Period 2|Withdrawal by Subject|0|||
23487363|NCT02038829|65530309|FG002|Washout Period 2|Withdrawal by Subject|0|||
23487364|NCT02038829|65530310|FG003|Washout Period 2|Withdrawal by Subject|0|||
23603706|NCT03138499|65940155|FG001|Overall Study|Study drug toxicity|2|||
23487365|NCT02038829|65530311|FG004|Washout Period 2|Withdrawal by Subject|0|||
23487366|NCT02038829|65530312|FG005|Washout Period 2|Withdrawal by Subject|1|||
23664291|NCT01979536|66155486|FG000|Overall Study|Relapse|0|||
23664292|NCT01979536|66155487|FG001|Overall Study|Relapse|1|||
23664293|NCT01979536|66155486|FG000|Overall Study|Study terminated by Sponsor|0|||
23664294|NCT01979536|66155487|FG001|Overall Study|Study terminated by Sponsor|1|||
23664295|NCT01979536|66155486|FG000|Overall Study|Did not start treatment|0|||
23664296|NCT01979536|66155487|FG001|Overall Study|Did not start treatment|1|||
23664297|NCT00814892|66155488|FG000|Overall Study|Disease Progression|1|||
23664298|NCT00814892|66155488|FG000|Overall Study|Study Termination|1|||
23664299|NCT00645593|66155489|FG000|Overall Study|Later found to be ineligible|1|||
23664300|NCT00645593|66155490|FG001|Overall Study|Later found to be ineligible|0|||
23664301|NCT02263079|66155491|FG000|Overall Study|Physician Decision|1|||
23664302|NCT02263079|66155492|FG001|Overall Study|Physician Decision|0|||
23664303|NCT02263079|66155493|FG002|Overall Study|Physician Decision|0|||
23664304|NCT02263079|66155491|FG000|Overall Study|Withdrawal by Subject|2|||
23664305|NCT02263079|66155492|FG001|Overall Study|Withdrawal by Subject|8|||
23373714|NCT01933594|65112765|FG004|Overall Study|Ineligible for subsequent study step|1|||
23373715|NCT01933594|65112766|FG005|Overall Study|Ineligible for subsequent study step|0|||
23373716|NCT00717886|65112767|FG000|Overall Study|Withdrawal by Subject|3|||
23373717|NCT00717886|65112767|FG000|Overall Study|Treatment Failure|1|||
23373718|NCT03055936|65112768|FG000|Overall Study|Adverse Event|0|||
23373719|NCT03055936|65112769|FG001|Overall Study|Adverse Event|1|||
23373720|NCT03055936|65112770|FG002|Overall Study|Adverse Event|1|||
23373721|NCT03055936|65112771|FG003|Overall Study|Adverse Event|1|||
23373722|NCT03055936|65112768|FG000|Overall Study|Personal reason|2|||
23373723|NCT03055936|65112769|FG001|Overall Study|Personal reason|0|||
23373724|NCT03055936|65112770|FG002|Overall Study|Personal reason|1|||
23373725|NCT03055936|65112771|FG003|Overall Study|Personal reason|0|||
23373726|NCT02475369|65112772|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
23373727|NCT02475369|65112773|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
23373728|NCT01516216|65112774|FG000|Overall Study|Adverse Event|2|||
23373729|NCT01516216|65112775|FG001|Overall Study|Adverse Event|4|||
23373730|NCT01516216|65112774|FG000|Overall Study|Disease Progression|38|||
23373731|NCT01516216|65112775|FG001|Overall Study|Disease Progression|34|||
23373732|NCT01516216|65112774|FG000|Overall Study|Withdrawal by Subject|9|||
23373733|NCT01516216|65112775|FG001|Overall Study|Withdrawal by Subject|11|||
23373734|NCT01516216|65112774|FG000|Overall Study|Potentially Curative Resection|6|||
23373735|NCT01516216|65112775|FG001|Overall Study|Potentially Curative Resection|12|||
23373736|NCT01516216|65112774|FG000|Overall Study|Nonadherence|2|||
23373737|NCT01516216|65112775|FG001|Overall Study|Nonadherence|3|||
23373738|NCT01516216|65112774|FG000|Overall Study|Physician Decision|6|||
23373739|NCT01516216|65112775|FG001|Overall Study|Physician Decision|3|||
23373740|NCT01516216|65112774|FG000|Overall Study|Prolonged Treatment Delay|5|||
23373741|NCT01516216|65112775|FG001|Overall Study|Prolonged Treatment Delay|1|||
23373742|NCT01516216|65112774|FG000|Overall Study|Intercurrent Illness|1|||
23373743|NCT01516216|65112775|FG001|Overall Study|Intercurrent Illness|0|||
23373744|NCT01516216|65112774|FG000|Overall Study|Death|1|||
23603707|NCT03138499|65940154|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23603708|NCT03138499|65940155|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23603709|NCT03138499|65940154|FG000|Overall Study|Other reasons|2|||
23603710|NCT03138499|65940155|FG001|Overall Study|Other reasons|0|||
23603711|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
23603712|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
23603713|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
23603714|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
23603715|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
23603716|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
23603717|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
23603718|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603719|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603720|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603721|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
23603722|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603723|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603724|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603725|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
23603726|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
23603727|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
23603728|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
23603729|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
23603730|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
23603731|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
23603732|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
23603733|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
23603734|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
23603735|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
23603736|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
23603737|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
23603738|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
23603739|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
23603740|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
23373745|NCT01516216|65112775|FG001|Overall Study|Death|1|||
23373746|NCT03736967|65112776|FG000|Overall Study|Withdrawal by Subject|26|||
23373747|NCT03736967|65112777|FG001|Overall Study|Withdrawal by Subject|25|||
23373748|NCT03736967|65112778|FG002|Overall Study|Withdrawal by Subject|23|||
23373749|NCT03736967|65112779|FG003|Overall Study|Withdrawal by Subject|26|||
23373750|NCT03736967|65112776|FG000|Overall Study|Lost to Follow-up|3|||
23373751|NCT03736967|65112777|FG001|Overall Study|Lost to Follow-up|2|||
23373752|NCT03736967|65112778|FG002|Overall Study|Lost to Follow-up|1|||
23603741|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603742|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603743|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
23373753|NCT03736967|65112779|FG003|Overall Study|Lost to Follow-up|1|||
23373754|NCT03736967|65112776|FG000|Overall Study|Physician Decision|1|||
23373755|NCT03736967|65112777|FG001|Overall Study|Physician Decision|0|||
23373756|NCT03736967|65112778|FG002|Overall Study|Physician Decision|0|||
23373757|NCT03736967|65112779|FG003|Overall Study|Physician Decision|1|||
23373758|NCT03736967|65112776|FG000|Overall Study|Adverse Event|0|||
23373759|NCT03736967|65112777|FG001|Overall Study|Adverse Event|1|||
23373760|NCT03736967|65112778|FG002|Overall Study|Adverse Event|0|||
23373761|NCT03736967|65112779|FG003|Overall Study|Adverse Event|1|||
23373762|NCT03736967|65112776|FG000|Overall Study|Death|0|||
23373763|NCT03736967|65112777|FG001|Overall Study|Death|0|||
23373764|NCT03736967|65112778|FG002|Overall Study|Death|0|||
23373765|NCT03736967|65112779|FG003|Overall Study|Death|1|||
23373766|NCT03736967|65112776|FG000|Overall Study|Randomized but never treated|1|||
23373767|NCT03736967|65112777|FG001|Overall Study|Randomized but never treated|0|||
23373768|NCT03736967|65112778|FG002|Overall Study|Randomized but never treated|0|||
23373769|NCT03736967|65112779|FG003|Overall Study|Randomized but never treated|0|||
23373770|NCT00761319|65112786|FG000|Overall Study|Protocol Violation|21|||
23373771|NCT00761319|65112787|FG001|Overall Study|Protocol Violation|14|||
23373772|NCT00761319|65112786|FG000|Overall Study|Adverse Event|11|||
23373773|NCT00761319|65112787|FG001|Overall Study|Adverse Event|7|||
23373774|NCT00761319|65112786|FG000|Overall Study|Withdrawal by Subject|8|||
23373775|NCT00761319|65112787|FG001|Overall Study|Withdrawal by Subject|7|||
23373776|NCT00761319|65112786|FG000|Overall Study|Noncompliance|4|||
23373777|NCT00761319|65112787|FG001|Overall Study|Noncompliance|3|||
23373778|NCT00761319|65112786|FG000|Overall Study|Lost to Follow-up|1|||
23373779|NCT00761319|65112787|FG001|Overall Study|Lost to Follow-up|1|||
23373780|NCT00761319|65112786|FG000|Overall Study|Nonspecified|2|||
23373781|NCT00761319|65112787|FG001|Overall Study|Nonspecified|2|||
23373782|NCT00761319|65112786|FG000|Overall Study|Missing|1|||
23373783|NCT00761319|65112787|FG001|Overall Study|Missing|0|||
23373784|NCT04635839|65112788|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
23373785|NCT04635839|65112789|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
23373786|NCT01963611|65112790|FG000|Overall Study|Adverse Event|1|||
23373787|NCT01963611|65112791|FG001|Overall Study|Adverse Event|1|||
23373788|NCT01963611|65112792|FG002|Overall Study|Adverse Event|3|||
23373789|NCT01963611|65112793|FG003|Overall Study|Adverse Event|4|||
23373790|NCT01963611|65112794|FG004|Overall Study|Adverse Event|3|||
23373791|NCT01963611|65112790|FG000|Overall Study|Protocol Violation|0|||
23373792|NCT01963611|65112791|FG001|Overall Study|Protocol Violation|0|||
23373793|NCT01963611|65112792|FG002|Overall Study|Protocol Violation|0|||
23373794|NCT01963611|65112793|FG003|Overall Study|Protocol Violation|1|||
23373795|NCT01963611|65112794|FG004|Overall Study|Protocol Violation|0|||
23373796|NCT01963611|65112790|FG000|Overall Study|Lack of Efficacy|0|||
23373797|NCT01963611|65112791|FG001|Overall Study|Lack of Efficacy|0|||
23373798|NCT01963611|65112792|FG002|Overall Study|Lack of Efficacy|0|||
23373799|NCT01963611|65112793|FG003|Overall Study|Lack of Efficacy|1|||
23373800|NCT01963611|65112794|FG004|Overall Study|Lack of Efficacy|0|||
23373801|NCT01963611|65112790|FG000|Overall Study|Withdrawal by Subject|3|||
23373802|NCT01963611|65112791|FG001|Overall Study|Withdrawal by Subject|2|||
23373803|NCT01963611|65112792|FG002|Overall Study|Withdrawal by Subject|1|||
23373804|NCT01963611|65112793|FG003|Overall Study|Withdrawal by Subject|1|||
23373805|NCT01963611|65112794|FG004|Overall Study|Withdrawal by Subject|3|||
23373806|NCT01963611|65112790|FG000|Overall Study|Other|47|||
23373807|NCT01963611|65112791|FG001|Overall Study|Other|46|||
23373808|NCT01963611|65112792|FG002|Overall Study|Other|48|||
23373809|NCT01963611|65112793|FG003|Overall Study|Other|45|||
23373810|NCT01963611|65112794|FG004|Overall Study|Other|45|||
23373811|NCT01160614|65115832|FG000|Overall Study|Withdrawal by Subject|0|||
23373812|NCT01160614|65115833|FG001|Overall Study|Withdrawal by Subject|2|||
23373813|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
23373814|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
23373815|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
23373816|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
23373817|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
23373818|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
23373819|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
23373820|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
23373821|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
23373822|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
23373823|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
23373824|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
23373825|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
23373826|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
23373827|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
23373828|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
23373829|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
23373830|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
23373831|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
23373832|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
23373833|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
23373834|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
23373835|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
23373836|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
23373837|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
23373838|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
23373839|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
23373840|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
23373841|NCT04181788|65115840|FG000|TREATMENT|Adverse Event|0|||
23373842|NCT04181788|65115841|FG001|TREATMENT|Adverse Event|2|||
23373843|NCT04181788|65115842|FG002|TREATMENT|Adverse Event|1|||
23373844|NCT04181788|65115843|FG003|TREATMENT|Adverse Event|0|||
23373845|NCT04181788|65115844|FG004|TREATMENT|Adverse Event|1|||
23373846|NCT04181788|65115845|FG005|TREATMENT|Adverse Event|3|||
23373847|NCT04181788|65115840|FG000|TREATMENT|Death|0|||
23373848|NCT04181788|65115841|FG001|TREATMENT|Death|0|||
23373849|NCT04181788|65115842|FG002|TREATMENT|Death|0|||
23373850|NCT04181788|65115843|FG003|TREATMENT|Death|0|||
23373851|NCT04181788|65115844|FG004|TREATMENT|Death|8|||
23373852|NCT04181788|65115845|FG005|TREATMENT|Death|8|||
23373853|NCT04181788|65115840|FG000|TREATMENT|Physician Decision|0|||
23373854|NCT04181788|65115841|FG001|TREATMENT|Physician Decision|0|||
23373855|NCT04181788|65115842|FG002|TREATMENT|Physician Decision|0|||
23373856|NCT04181788|65115843|FG003|TREATMENT|Physician Decision|0|||
23373857|NCT04181788|65115844|FG004|TREATMENT|Physician Decision|0|||
23373858|NCT04181788|65115845|FG005|TREATMENT|Physician Decision|1|||
23373859|NCT04181788|65115840|FG000|TREATMENT|Progressive disease|3|||
23373860|NCT04181788|65115841|FG001|TREATMENT|Progressive disease|3|||
23373861|NCT04181788|65115842|FG002|TREATMENT|Progressive disease|5|||
23373862|NCT04181788|65115843|FG003|TREATMENT|Progressive disease|7|||
23373863|NCT04181788|65115844|FG004|TREATMENT|Progressive disease|20|||
23373864|NCT04181788|65115845|FG005|TREATMENT|Progressive disease|38|||
23373865|NCT04181788|65115840|FG000|TREATMENT|Global deterioration of health status|0|||
23373866|NCT04181788|65115841|FG001|TREATMENT|Global deterioration of health status|2|||
23373867|NCT04181788|65115842|FG002|TREATMENT|Global deterioration of health status|0|||
23373868|NCT04181788|65115843|FG003|TREATMENT|Global deterioration of health status|0|||
23373869|NCT04181788|65115844|FG004|TREATMENT|Global deterioration of health status|2|||
23373870|NCT04181788|65115845|FG005|TREATMENT|Global deterioration of health status|8|||
23373871|NCT04181788|65115840|FG000|TREATMENT|Withdrawal by Subject|1|||
23373872|NCT04181788|65115841|FG001|TREATMENT|Withdrawal by Subject|2|||
23373873|NCT04181788|65115842|FG002|TREATMENT|Withdrawal by Subject|0|||
23373874|NCT04181788|65115843|FG003|TREATMENT|Withdrawal by Subject|0|||
23373875|NCT04181788|65115844|FG004|TREATMENT|Withdrawal by Subject|3|||
23373876|NCT04181788|65115845|FG005|TREATMENT|Withdrawal by Subject|5|||
23373877|NCT04181788|65115840|FG000|TREATMENT|Other unspecified|0|||
23373878|NCT04181788|65115841|FG001|TREATMENT|Other unspecified|0|||
23373879|NCT04181788|65115842|FG002|TREATMENT|Other unspecified|0|||
23373880|NCT04181788|65115843|FG003|TREATMENT|Other unspecified|0|||
23373881|NCT04181788|65115844|FG004|TREATMENT|Other unspecified|0|||
23373882|NCT04181788|65115845|FG005|TREATMENT|Other unspecified|2|||
23373883|NCT04181788|65115840|FG000|TREATMENT|Ongoing|0|||
23373884|NCT04181788|65115841|FG001|TREATMENT|Ongoing|3|||
23373885|NCT04181788|65115842|FG002|TREATMENT|Ongoing|0|||
23373886|NCT04181788|65115843|FG003|TREATMENT|Ongoing|5|||
23373887|NCT04181788|65115844|FG004|TREATMENT|Ongoing|7|||
23373888|NCT04181788|65115845|FG005|TREATMENT|Ongoing|15|||
23373889|NCT04181788|65115840|FG000|FOLLOW-UP|Death|0|||
23373890|NCT04181788|65115841|FG001|FOLLOW-UP|Death|0|||
23664306|NCT02263079|66155493|FG002|Overall Study|Withdrawal by Subject|0|||
23373891|NCT04181788|65115842|FG002|FOLLOW-UP|Death|1|||
23373892|NCT04181788|65115843|FG003|FOLLOW-UP|Death|2|||
23373893|NCT04181788|65115844|FG004|FOLLOW-UP|Death|8|||
23373894|NCT04181788|65115845|FG005|FOLLOW-UP|Death|20|||
23373895|NCT04181788|65115840|FG000|FOLLOW-UP|Lost to Follow-up|0|||
23373896|NCT04181788|65115841|FG001|FOLLOW-UP|Lost to Follow-up|0|||
23373897|NCT04181788|65115842|FG002|FOLLOW-UP|Lost to Follow-up|0|||
23373898|NCT04181788|65115843|FG003|FOLLOW-UP|Lost to Follow-up|0|||
23373899|NCT04181788|65115844|FG004|FOLLOW-UP|Lost to Follow-up|0|||
23373900|NCT04181788|65115845|FG005|FOLLOW-UP|Lost to Follow-up|2|||
23373901|NCT04181788|65115840|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
23373902|NCT04181788|65115841|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
23373903|NCT04181788|65115842|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
23373904|NCT04181788|65115843|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
23373905|NCT04181788|65115844|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
23373906|NCT04181788|65115845|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
23373907|NCT04181788|65115840|FG000|FOLLOW-UP|Other unspecified|0|||
23373908|NCT04181788|65115841|FG001|FOLLOW-UP|Other unspecified|1|||
23373909|NCT04181788|65115842|FG002|FOLLOW-UP|Other unspecified|0|||
23373910|NCT04181788|65115843|FG003|FOLLOW-UP|Other unspecified|0|||
23373911|NCT04181788|65115844|FG004|FOLLOW-UP|Other unspecified|0|||
23373912|NCT04181788|65115845|FG005|FOLLOW-UP|Other unspecified|3|||
23373913|NCT04181788|65115840|FG000|FOLLOW-UP|Ongoing|0|||
23373914|NCT04181788|65115841|FG001|FOLLOW-UP|Ongoing|0|||
23373915|NCT04181788|65115842|FG002|FOLLOW-UP|Ongoing|1|||
23373916|NCT04181788|65115843|FG003|FOLLOW-UP|Ongoing|3|||
23487367|NCT02038829|65530313|FG006|Washout Period 2|Withdrawal by Subject|0|||
23487368|NCT02038829|65530314|FG007|Washout Period 2|Withdrawal by Subject|0|||
23487369|NCT02038829|65530315|FG008|Washout Period 2|Withdrawal by Subject|0|||
23487370|NCT02038829|65530316|FG009|Washout Period 2|Withdrawal by Subject|0|||
23373917|NCT04181788|65115844|FG004|FOLLOW-UP|Ongoing|2|||
23487371|NCT02038829|65530317|FG010|Washout Period 2|Withdrawal by Subject|0|||
23373918|NCT04181788|65115845|FG005|FOLLOW-UP|Ongoing|2|||
23373919|NCT00959751|65115848|FG000|Overall Study|Lost to Follow-up|2|||
23373920|NCT00959751|65115849|FG001|Overall Study|Lost to Follow-up|3|||
23664307|NCT00880399|66155504|FG000|Overall Study|Adverse Event|4|||
23664308|NCT00880399|66155505|FG001|Overall Study|Adverse Event|6|||
23664309|NCT00880399|66155506|FG002|Overall Study|Adverse Event|5|||
23664310|NCT00880399|66155504|FG000|Overall Study|Lack of Efficacy|1|||
23664311|NCT00880399|66155505|FG001|Overall Study|Lack of Efficacy|4|||
23664312|NCT00880399|66155506|FG002|Overall Study|Lack of Efficacy|2|||
23664313|NCT00880399|66155504|FG000|Overall Study|Protocol Violation|4|||
23664314|NCT00880399|66155505|FG001|Overall Study|Protocol Violation|4|||
23664315|NCT00880399|66155506|FG002|Overall Study|Protocol Violation|6|||
23664316|NCT00880399|66155504|FG000|Overall Study|Study closed/terminated|3|||
23664317|NCT00880399|66155505|FG001|Overall Study|Study closed/terminated|7|||
23664318|NCT00880399|66155506|FG002|Overall Study|Study closed/terminated|4|||
23664319|NCT00880399|66155504|FG000|Overall Study|Lost to Follow-up|8|||
23664320|NCT00880399|66155505|FG001|Overall Study|Lost to Follow-up|5|||
23664321|NCT00880399|66155506|FG002|Overall Study|Lost to Follow-up|3|||
23664322|NCT00880399|66155504|FG000|Overall Study|Physician Decision|5|||
23664323|NCT00880399|66155505|FG001|Overall Study|Physician Decision|0|||
23664324|NCT00880399|66155506|FG002|Overall Study|Physician Decision|3|||
23664325|NCT00880399|66155504|FG000|Overall Study|Withdrawal by Subject|6|||
23664326|NCT00880399|66155505|FG001|Overall Study|Withdrawal by Subject|3|||
23664327|NCT00880399|66155506|FG002|Overall Study|Withdrawal by Subject|3|||
23664328|NCT02616614|66155507|FG000|Overall Study|Withdrawal by Subject|10|||
23664329|NCT02616614|66155508|FG001|Overall Study|Withdrawal by Subject|5|||
23664330|NCT02616614|66155509|FG002|Overall Study|Withdrawal by Subject|6|||
23664331|NCT02616614|66155507|FG000|Overall Study|Physician Decision|2|||
23664332|NCT02616614|66155508|FG001|Overall Study|Physician Decision|1|||
23664333|NCT02616614|66155509|FG002|Overall Study|Physician Decision|0|||
23664334|NCT02616614|66155507|FG000|Overall Study|Adverse Event|1|||
23664335|NCT02616614|66155508|FG001|Overall Study|Adverse Event|4|||
23664336|NCT02616614|66155509|FG002|Overall Study|Adverse Event|1|||
23603744|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603745|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603746|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603747|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603748|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603749|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603750|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23603751|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23603752|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
23603753|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603754|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603755|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603756|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603757|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603758|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
23603759|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603760|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603761|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603762|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603763|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
23603764|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603765|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603766|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603767|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
23603768|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
23603769|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
23603770|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
23603771|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
23603772|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
23603773|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
23603774|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23664337|NCT02616614|66155507|FG000|Overall Study|Protocol Violation|0|||
23664338|NCT02616614|66155508|FG001|Overall Study|Protocol Violation|3|||
23664339|NCT02616614|66155509|FG002|Overall Study|Protocol Violation|1|||
23664340|NCT02616614|66155507|FG000|Overall Study|Prohibited Medication|12|||
23664341|NCT02616614|66155508|FG001|Overall Study|Prohibited Medication|9|||
23664342|NCT02616614|66155509|FG002|Overall Study|Prohibited Medication|5|||
23664343|NCT02616614|66155507|FG000|Overall Study|More than 3 applications missed|6|||
23664344|NCT02616614|66155508|FG001|Overall Study|More than 3 applications missed|8|||
23664345|NCT02616614|66155509|FG002|Overall Study|More than 3 applications missed|1|||
23664346|NCT02616614|66155507|FG000|Overall Study|Lost to Follow-up|31|||
23603775|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23603776|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
23603777|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
23603778|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
23603779|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
23603780|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23603781|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603782|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
23603783|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603784|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603785|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603786|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603787|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603788|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603789|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603790|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603791|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603792|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603793|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603794|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603795|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
23603796|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
23603797|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603798|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603799|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
23603800|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603801|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603802|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
23603803|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
23603804|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
23603805|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
23603806|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
23603807|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
23603808|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
23603809|NCT00667732|65940163|FG000|Run -In (8 Weeks)|Adverse Event|4|||
23603810|NCT00667732|65940164|FG001|Run -In (8 Weeks)|Adverse Event|0|||
23603811|NCT00667732|65940165|FG002|Run -In (8 Weeks)|Adverse Event|0|||
23603812|NCT00667732|65940163|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
23603813|NCT00667732|65940164|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
23603814|NCT00667732|65940165|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
23603815|NCT00667732|65940163|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
23603816|NCT00667732|65940164|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
23603817|NCT00667732|65940165|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
23603818|NCT02038049|65940170|FG000|Overall Study|Lost to Follow-up|1|||
23603819|NCT02038049|65940171|FG001|Overall Study|Lost to Follow-up|0|||
23603820|NCT03418545|65940174|FG000|Overall Study|Withdrawal by Participant|2|||
23664347|NCT02616614|66155508|FG001|Overall Study|Lost to Follow-up|28|||
23664348|NCT02616614|66155509|FG002|Overall Study|Lost to Follow-up|13|||
23664349|NCT02616614|66155507|FG000|Overall Study|Pregnancy|2|||
23664350|NCT02616614|66155508|FG001|Overall Study|Pregnancy|0|||
23664351|NCT02616614|66155509|FG002|Overall Study|Pregnancy|1|||
23664352|NCT02616614|66155507|FG000|Overall Study|Other|1|||
23664353|NCT02616614|66155508|FG001|Overall Study|Other|2|||
23664354|NCT02616614|66155509|FG002|Overall Study|Other|1|||
23664355|NCT02369848|66155510|FG000|Overall Study|Death|1|||
23664356|NCT02369848|66155510|FG000|Overall Study|Withdrawal by Subject|2|||
23664357|NCT02369848|66155510|FG000|Overall Study|Lost to Follow-up|1|||
23664358|NCT00312221|66155511|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
23664359|NCT00312221|66155512|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23664360|NCT00312221|66155513|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23664361|NCT00312221|66155514|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
23373921|NCT00959751|65115848|FG000|Overall Study|Consent Withdrawn|0|||
23373922|NCT00959751|65115849|FG001|Overall Study|Consent Withdrawn|1|||
23373923|NCT00959751|65115848|FG000|Overall Study|Non-compliance to Study Procedures|0|||
23373924|NCT00959751|65115849|FG001|Overall Study|Non-compliance to Study Procedures|1|||
23373925|NCT00959751|65115848|FG000|Overall Study|No migraine headache without aura|7|||
23373926|NCT00959751|65115849|FG001|Overall Study|No migraine headache without aura|7|||
23487372|NCT02038829|65530318|FG011|Washout Period 2|Withdrawal by Subject|0|||
23487373|NCT02038829|65530307|FG000|Treatment Period 4|Adverse Event|0|||
23487374|NCT02038829|65530308|FG001|Treatment Period 4|Adverse Event|1|||
23487375|NCT02038829|65530309|FG002|Treatment Period 4|Adverse Event|0|||
23487376|NCT02038829|65530310|FG003|Treatment Period 4|Adverse Event|0|||
23487377|NCT02038829|65530311|FG004|Treatment Period 4|Adverse Event|0|||
23487378|NCT02038829|65530312|FG005|Treatment Period 4|Adverse Event|0|||
23487379|NCT02038829|65530313|FG006|Treatment Period 4|Adverse Event|0|||
23487380|NCT02038829|65530314|FG007|Treatment Period 4|Adverse Event|0|||
23487381|NCT02038829|65530315|FG008|Treatment Period 4|Adverse Event|0|||
23487382|NCT02038829|65530316|FG009|Treatment Period 4|Adverse Event|0|||
23487383|NCT02038829|65530317|FG010|Treatment Period 4|Adverse Event|0|||
23487384|NCT02038829|65530318|FG011|Treatment Period 4|Adverse Event|0|||
23487385|NCT02038829|65530307|FG000|Washout Period 4|Adverse Event|0|||
23487386|NCT02038829|65530308|FG001|Washout Period 4|Adverse Event|0|||
23487387|NCT02038829|65530309|FG002|Washout Period 4|Adverse Event|0|||
23487388|NCT02038829|65530310|FG003|Washout Period 4|Adverse Event|0|||
23487389|NCT02038829|65530311|FG004|Washout Period 4|Adverse Event|0|||
23487390|NCT02038829|65530312|FG005|Washout Period 4|Adverse Event|0|||
23487391|NCT02038829|65530313|FG006|Washout Period 4|Adverse Event|1|||
23487392|NCT02038829|65530314|FG007|Washout Period 4|Adverse Event|0|||
23487393|NCT02038829|65530315|FG008|Washout Period 4|Adverse Event|0|||
23487394|NCT02038829|65530316|FG009|Washout Period 4|Adverse Event|0|||
23487395|NCT02038829|65530317|FG010|Washout Period 4|Adverse Event|0|||
23487396|NCT02038829|65530318|FG011|Washout Period 4|Adverse Event|0|||
23487397|NCT02038829|65530307|FG000|Treatment Period 6|Adverse Event|0|||
23487398|NCT02038829|65530308|FG001|Treatment Period 6|Adverse Event|0|||
23487399|NCT02038829|65530309|FG002|Treatment Period 6|Adverse Event|1|||
23487400|NCT02038829|65530310|FG003|Treatment Period 6|Adverse Event|0|||
23487401|NCT02038829|65530311|FG004|Treatment Period 6|Adverse Event|0|||
23487402|NCT02038829|65530312|FG005|Treatment Period 6|Adverse Event|0|||
23487403|NCT02038829|65530313|FG006|Treatment Period 6|Adverse Event|0|||
23487404|NCT02038829|65530314|FG007|Treatment Period 6|Adverse Event|0|||
23487405|NCT02038829|65530315|FG008|Treatment Period 6|Adverse Event|0|||
23487406|NCT02038829|65530316|FG009|Treatment Period 6|Adverse Event|0|||
23487407|NCT02038829|65530317|FG010|Treatment Period 6|Adverse Event|0|||
23487408|NCT02038829|65530318|FG011|Treatment Period 6|Adverse Event|0|||
23487409|NCT01143207|65530319|FG000|Overall Study|Lost to Follow-up|2|||
23487410|NCT05442775|65530333|FG000|Overall Study|Trial terminated|61|||
23487411|NCT05442775|65530333|FG000|Overall Study|Lack of Efficacy|4|||
23487412|NCT05442775|65530333|FG000|Overall Study|Withdrawal by Subject|4|||
23487413|NCT05442775|65530333|FG000|Overall Study|Death|1|||
23487414|NCT05442775|65530333|FG000|Overall Study|Participant removed at Sponsor request|1|||
23487415|NCT00096954|65530334|FG000|Overall Study|Adverse Event|3|||
23487416|NCT00096954|65530335|FG001|Overall Study|Adverse Event|1|||
23487417|NCT00096954|65530334|FG000|Overall Study|Withdrawal by Subject|9|||
23487418|NCT00096954|65530335|FG001|Overall Study|Withdrawal by Subject|8|||
23487419|NCT00096954|65530334|FG000|Overall Study|Physician Decision|1|||
23603821|NCT03418545|65940175|FG001|Overall Study|Withdrawal by Participant|4|||
23603822|NCT03418545|65940174|FG000|Overall Study|Lost to Follow-up|3|||
23603823|NCT03418545|65940175|FG001|Overall Study|Lost to Follow-up|5|||
23373927|NCT00547339|65115850|FG000|Overall Study|Physician Decision|0|||
23373928|NCT00547339|65115851|FG001|Overall Study|Physician Decision|0|||
23373929|NCT00547339|65115852|FG002|Overall Study|Physician Decision|1|||
23373930|NCT00547339|65115853|FG003|Overall Study|Physician Decision|0|||
23373931|NCT00433836|65115854|FG000|Overall Study|Adverse Event|7|||
23373932|NCT00433836|65115855|FG001|Overall Study|Adverse Event|0|||
23487420|NCT00096954|65530335|FG001|Overall Study|Physician Decision|1|||
23487421|NCT00096954|65530334|FG000|Overall Study|Sponsors Decision|1|||
23487422|NCT00096954|65530335|FG001|Overall Study|Sponsors Decision|1|||
23487423|NCT00096954|65530334|FG000|Overall Study|Pregnancy|1|||
23487424|NCT00096954|65530335|FG001|Overall Study|Pregnancy|1|||
23487425|NCT00096954|65530334|FG000|Overall Study|Initiation of immunotherapy|1|||
23487426|NCT00096954|65530335|FG001|Overall Study|Initiation of immunotherapy|0|||
23487427|NCT00096954|65530334|FG000|Overall Study|Non-compliance|0|||
23487428|NCT00096954|65530335|FG001|Overall Study|Non-compliance|3|||
23487429|NCT00096954|65530334|FG000|Overall Study|Lost to Follow-up|8|||
23487430|NCT00096954|65530335|FG001|Overall Study|Lost to Follow-up|5|||
23487431|NCT02634710|65530337|FG000|Overall Study|Death|4|||
23487432|NCT04533880|65530338|FG000|Overall Study|Lost to Follow-up|0|||
23373933|NCT00433836|65115854|FG000|Overall Study|Lost to Follow-up|3|||
23373934|NCT00433836|65115855|FG001|Overall Study|Lost to Follow-up|0|||
23487433|NCT04533880|65530339|FG001|Overall Study|Lost to Follow-up|1|||
23487434|NCT04533880|65530340|FG002|Overall Study|Lost to Follow-up|1|||
23487435|NCT01982331|65530341|FG000|Received Vaccination 2|Adverse Event|1|||
23487436|NCT01982331|65530342|FG001|Received Vaccination 2|Adverse Event|2|||
23487437|NCT01982331|65530341|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23487438|NCT01982331|65530342|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
23487439|NCT01982331|65530341|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
23487440|NCT01982331|65530342|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
23487441|NCT05036369|65530343|FG000|Overall Study|Run In non compliance|1|||
23487442|NCT05036369|65530344|FG001|Overall Study|Run In non compliance|2|||
23487443|NCT05036369|65530343|FG000|Overall Study|Change in eligibility criteria|0|||
23487444|NCT05036369|65530344|FG001|Overall Study|Change in eligibility criteria|1|||
23487445|NCT03956056|65530345|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
23487446|NCT03956056|65530345|FG000|Overall Study|Lack of Efficacy|1|||
23487447|NCT00518973|65530346|FG000|Overall Study|Withdrawal by Subject|3|||
23487448|NCT00518973|65530347|FG001|Overall Study|Withdrawal by Subject|2|||
23487449|NCT01163266|65530354|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
23487450|NCT01163266|65530355|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
23487451|NCT01163266|65530356|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
23487452|NCT01163266|65530354|FG000|Overall Study|Lack of Efficacy|1|||
23487453|NCT01163266|65530355|FG001|Overall Study|Lack of Efficacy|3|||
23487454|NCT01163266|65530356|FG002|Overall Study|Lack of Efficacy|1|||
23487455|NCT01163266|65530354|FG000|Overall Study|Noncompliance with Study Drug|0|||
23487456|NCT01163266|65530355|FG001|Overall Study|Noncompliance with Study Drug|2|||
23487457|NCT01163266|65530356|FG002|Overall Study|Noncompliance with Study Drug|0|||
23487458|NCT01163266|65530354|FG000|Overall Study|Protocol Deviations|2|||
23487459|NCT01163266|65530355|FG001|Overall Study|Protocol Deviations|2|||
23487460|NCT01163266|65530356|FG002|Overall Study|Protocol Deviations|5|||
23487461|NCT01163266|65530354|FG000|Overall Study|Withdrawal of Consent|5|||
23487462|NCT01163266|65530355|FG001|Overall Study|Withdrawal of Consent|7|||
23487463|NCT01163266|65530356|FG002|Overall Study|Withdrawal of Consent|3|||
23487464|NCT01163266|65530354|FG000|Overall Study|Lost to Follow-up|7|||
23487465|NCT01163266|65530355|FG001|Overall Study|Lost to Follow-up|7|||
23487466|NCT01163266|65530356|FG002|Overall Study|Lost to Follow-up|10|||
23487467|NCT01163266|65530354|FG000|Overall Study|Other|1|||
23487468|NCT01163266|65530355|FG001|Overall Study|Other|1|||
23487469|NCT01163266|65530356|FG002|Overall Study|Other|2|||
23487470|NCT03875118|65530364|FG000|Overall Study|Withdrawal by Subject|4|||
23487471|NCT03875118|65530365|FG001|Overall Study|Withdrawal by Subject|4|||
23487472|NCT01675427|65530368|FG000|Overall Study|Withdrawal by Subject|7|||
23487473|NCT01675427|65530368|FG000|Overall Study|Participant Refused Sample Collection|18|||
23487474|NCT01675427|65530368|FG000|Overall Study|Sample not Collected by Mistake|2|||
23487475|NCT01675427|65530368|FG000|Overall Study|Lost to Follow-up|5|||
23487476|NCT01675427|65530368|FG000|Overall Study|Other|2|||
23487477|NCT03901456|65530370|FG000|Overall Study|Withdrawal by Subject|0|||
23487478|NCT03901456|65530371|FG001|Overall Study|Withdrawal by Subject|0|||
23487479|NCT03901456|65530372|FG002|Overall Study|Withdrawal by Subject|1|||
23487480|NCT03901456|65530370|FG000|Overall Study|Lost to Follow-up|0|||
23487481|NCT03901456|65530371|FG001|Overall Study|Lost to Follow-up|1|||
23487482|NCT03901456|65530372|FG002|Overall Study|Lost to Follow-up|0|||
23487483|NCT03332771|65530375|FG000|Overall Study|Adverse Event|6|||
23487484|NCT03332771|65530376|FG001|Overall Study|Adverse Event|4|||
23487485|NCT03332771|65530377|FG002|Overall Study|Adverse Event|1|||
23487486|NCT03332771|65530378|FG003|Overall Study|Adverse Event|3|||
23487487|NCT03332771|65530375|FG000|Overall Study|Poor Compliance to Protocol|0|||
23487488|NCT03332771|65530376|FG001|Overall Study|Poor Compliance to Protocol|1|||
23487489|NCT03332771|65530377|FG002|Overall Study|Poor Compliance to Protocol|0|||
23487490|NCT03332771|65530378|FG003|Overall Study|Poor Compliance to Protocol|1|||
23487491|NCT03332771|65530375|FG000|Overall Study|Lost to Follow-up|2|||
23487492|NCT03332771|65530376|FG001|Overall Study|Lost to Follow-up|2|||
23487493|NCT03332771|65530377|FG002|Overall Study|Lost to Follow-up|1|||
23487494|NCT03332771|65530378|FG003|Overall Study|Lost to Follow-up|2|||
23487495|NCT03332771|65530375|FG000|Overall Study|At the Participant's own request|20|||
23487496|NCT03332771|65530376|FG001|Overall Study|At the Participant's own request|26|||
23487497|NCT03332771|65530377|FG002|Overall Study|At the Participant's own request|14|||
23487498|NCT03332771|65530378|FG003|Overall Study|At the Participant's own request|23|||
23487499|NCT03332771|65530375|FG000|Overall Study|Reason Not Specified|6|||
23487500|NCT03332771|65530376|FG001|Overall Study|Reason Not Specified|18|||
23487501|NCT03332771|65530377|FG002|Overall Study|Reason Not Specified|16|||
23487502|NCT03332771|65530378|FG003|Overall Study|Reason Not Specified|19|||
23487503|NCT00116168|65530379|FG000|Overall Study|Lost to Follow-up|6|||
23487504|NCT00116168|65530380|FG001|Overall Study|Lost to Follow-up|5|||
23487505|NCT00116168|65530381|FG002|Overall Study|Lost to Follow-up|0|||
23487506|NCT00116168|65530382|FG003|Overall Study|Lost to Follow-up|0|||
23487507|NCT02939079|65530383|FG000|Overall Study|Adverse Event|2|||
23487508|NCT02939079|65530384|FG001|Overall Study|Adverse Event|1|||
23487509|NCT02939079|65530383|FG000|Overall Study|Lost to Follow-up|0|||
23487510|NCT02939079|65530384|FG001|Overall Study|Lost to Follow-up|2|||
23487511|NCT02939079|65530383|FG000|Overall Study|Protocol Violation|1|||
23603824|NCT03418545|65940174|FG000|Overall Study|Reason Not Specified|0|||
23603825|NCT03418545|65940175|FG001|Overall Study|Reason Not Specified|1|||
23487512|NCT02939079|65530384|FG001|Overall Study|Protocol Violation|0|||
23487513|NCT02939079|65530383|FG000|Overall Study|Withdrawal by Subject|0|||
23487514|NCT02939079|65530384|FG001|Overall Study|Withdrawal by Subject|1|||
23603826|NCT03418545|65940174|FG000|Overall Study|Missing Completion Status|0|||
23603827|NCT03418545|65940175|FG001|Overall Study|Missing Completion Status|1|||
23603828|NCT01549951|65940178|FG000|Overall Study|Adverse Event|15|||
23603829|NCT01549951|65940178|FG000|Overall Study|Withdrawal by Subject|2|||
23603830|NCT01549951|65940178|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23603831|NCT01549951|65940178|FG000|Overall Study|Progressive disease|29|||
23603832|NCT01549951|65940178|FG000|Overall Study|Symptomatic deterioration|1|||
23603833|NCT01549951|65940178|FG000|Overall Study|Other|2|||
23603834|NCT01670526|65940181|FG000|Overall Study|Withdrawal by Subject|3|||
23664362|NCT00312221|66155511|FG000|Open-label Run-in Period|Adverse Event|74|||
23487515|NCT02939079|65530383|FG000|Overall Study|relapse during the study|1|||
23487516|NCT02939079|65530384|FG001|Overall Study|relapse during the study|1|||
23487517|NCT01954342|65530385|FG000|Overall Study|Missing data from 13-16week study visit|0|||
23487518|NCT01954342|65530386|FG001|Overall Study|Missing data from 13-16week study visit|0|||
23487519|NCT01954342|65530387|FG002|Overall Study|Missing data from 13-16week study visit|0|||
23487520|NCT01954342|65530388|FG003|Overall Study|Missing data from 13-16week study visit|1|||
23487521|NCT01954342|65530385|FG000|Overall Study|Miscarriage|0|||
23487522|NCT01954342|65530386|FG001|Overall Study|Miscarriage|0|||
23487523|NCT01954342|65530387|FG002|Overall Study|Miscarriage|0|||
23487524|NCT01954342|65530388|FG003|Overall Study|Miscarriage|3|||
23487525|NCT01954342|65530385|FG000|Overall Study|Lost to Follow-up|0|||
23487526|NCT01954342|65530386|FG001|Overall Study|Lost to Follow-up|0|||
23487527|NCT01954342|65530387|FG002|Overall Study|Lost to Follow-up|0|||
23487528|NCT01954342|65530388|FG003|Overall Study|Lost to Follow-up|5|||
23487529|NCT01954342|65530385|FG000|Overall Study|Preterm delivery|0|||
23487530|NCT01954342|65530386|FG001|Overall Study|Preterm delivery|0|||
23487531|NCT01954342|65530387|FG002|Overall Study|Preterm delivery|0|||
23487532|NCT01954342|65530388|FG003|Overall Study|Preterm delivery|3|||
23487533|NCT01954342|65530385|FG000|Overall Study|Pre-eclampsia|0|||
23487534|NCT01954342|65530386|FG001|Overall Study|Pre-eclampsia|0|||
23487535|NCT01954342|65530387|FG002|Overall Study|Pre-eclampsia|0|||
23487536|NCT01954342|65530388|FG003|Overall Study|Pre-eclampsia|4|||
23487537|NCT01954342|65530385|FG000|Overall Study|Unreliable Data|0|||
23487538|NCT01954342|65530386|FG001|Overall Study|Unreliable Data|0|||
23487539|NCT01954342|65530387|FG002|Overall Study|Unreliable Data|0|||
23487540|NCT01954342|65530388|FG003|Overall Study|Unreliable Data|2|||
23487541|NCT03953183|65530389|FG000|Overall Study|Physician Decision|0|||
23487542|NCT03953183|65530390|FG001|Overall Study|Physician Decision|1|||
23487543|NCT03953183|65530389|FG000|Overall Study|Withdrawal by Subject|0|||
23487544|NCT03953183|65530390|FG001|Overall Study|Withdrawal by Subject|1|||
23487545|NCT02963831|65530391|FG000|Overall Study|Progressive Disease|3|||
23487546|NCT02963831|65530392|FG001|Overall Study|Progressive Disease|3|||
23487547|NCT02963831|65530393|FG002|Overall Study|Progressive Disease|16|||
23487548|NCT02963831|65530394|FG003|Overall Study|Progressive Disease|27|||
23487549|NCT02963831|65530391|FG000|Overall Study|Withdrawal by Subject|1|||
23487550|NCT02963831|65530392|FG001|Overall Study|Withdrawal by Subject|0|||
23487551|NCT02963831|65530393|FG002|Overall Study|Withdrawal by Subject|2|||
23487552|NCT02963831|65530394|FG003|Overall Study|Withdrawal by Subject|4|||
23487553|NCT02963831|65530391|FG000|Overall Study|Adverse Event|0|||
23373935|NCT00433836|65115854|FG000|Overall Study|Withdrawal by Subject|2|||
23373936|NCT00433836|65115855|FG001|Overall Study|Withdrawal by Subject|1|||
23664363|NCT00312221|66155512|FG001|Open-label Run-in Period|Adverse Event|0|||
23373937|NCT00433836|65115854|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23373938|NCT00433836|65115855|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23373939|NCT00433836|65115854|FG000|Overall Study|Protocol Violation|0|||
23373940|NCT00433836|65115855|FG001|Overall Study|Protocol Violation|2|||
23373941|NCT00433836|65115854|FG000|Overall Study|Condition no longer requires study drug|0|||
23373942|NCT00433836|65115855|FG001|Overall Study|Condition no longer requires study drug|1|||
23373943|NCT00433836|65115854|FG000|Overall Study|Abnormal laboratory values|0|||
23373944|NCT00433836|65115855|FG001|Overall Study|Abnormal laboratory values|1|||
23373945|NCT03408899|65115856|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
23373946|NCT03329989|65115861|FG000|Overall Study|Withdrawal by Subject|9|||
23373947|NCT03329989|65115861|FG000|Overall Study|Lost to Follow-up|8|||
23373948|NCT03329989|65115861|FG000|Overall Study|Adverse Event|5|||
23373949|NCT03329989|65115861|FG000|Overall Study|Protocol Violation|1|||
23373950|NCT03312738|65115862|FG000|Overall Study|Progressive disease|58|||
23373951|NCT03312738|65115863|FG001|Overall Study|Progressive disease|67|||
23373952|NCT03312738|65115862|FG000|Overall Study|Patient/guardian decision|13|||
23373953|NCT03312738|65115863|FG001|Overall Study|Patient/guardian decision|5|||
23373954|NCT03312738|65115862|FG000|Overall Study|Adverse Event|5|||
23373955|NCT03312738|65115863|FG001|Overall Study|Adverse Event|3|||
23373956|NCT03312738|65115862|FG000|Overall Study|Protocol deviation|2|||
23373957|NCT03312738|65115863|FG001|Overall Study|Protocol deviation|0|||
23373958|NCT03312738|65115862|FG000|Overall Study|Technical problems|0|||
23373959|NCT03312738|65115863|FG001|Overall Study|Technical problems|1|||
23373960|NCT03312738|65115862|FG000|Overall Study|Physician Decision|2|||
23373961|NCT03312738|65115863|FG001|Overall Study|Physician Decision|3|||
23373962|NCT02145390|65115865|FG000|Overall Study|Withdrawal by Subject|1|||
23373963|NCT02915835|65115868|FG000|Overall Study|Physician Decision|1|||
23373964|NCT02915835|65115869|FG001|Overall Study|Physician Decision|0|||
23373965|NCT02915835|65115868|FG000|Overall Study|Withdrawal by Subject|0|||
23373966|NCT02915835|65115869|FG001|Overall Study|Withdrawal by Subject|1|||
23373967|NCT04796415|65115875|FG000|Overall Study|not interested|12|||
23373968|NCT04796415|65115875|FG000|Overall Study|health issue|8|||
23373969|NCT04796415|65115875|FG000|Overall Study|Other|4|||
23373970|NCT04796415|65115875|FG000|Overall Study|discharged from home health service|3|||
23373971|NCT04796415|65115875|FG000|Overall Study|re-hospitalization|2|||
23373972|NCT04796415|65115875|FG000|Overall Study|moving to nursing home|1|||
23373973|NCT04796415|65115875|FG000|Overall Study|lost contact|1|||
23373974|NCT02059239|65115876|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
23373975|NCT02059239|65115877|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
23373976|NCT02059239|65115876|FG000|Overall Study|Physician Decision|1|||
23373977|NCT02059239|65115877|FG001|Overall Study|Physician Decision|0|||
23373978|NCT01142336|65115878|FG000|Overall Study|Adverse Event|1|||
23373979|NCT01142336|65115879|FG001|Overall Study|Adverse Event|1|||
23373980|NCT01142336|65115878|FG000|Overall Study|Lost to Follow-up|0|||
23373981|NCT01142336|65115879|FG001|Overall Study|Lost to Follow-up|1|||
23373982|NCT00374868|65115882|FG000|Overall Study|Adverse Event|12|||
23664364|NCT00312221|66155513|FG002|Open-label Run-in Period|Adverse Event|0|||
23664365|NCT00312221|66155514|FG003|Open-label Run-in Period|Adverse Event|0|||
23664366|NCT00312221|66155511|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
23373983|NCT00374868|65115882|FG000|Overall Study|Progressive Disease|7|||
23373984|NCT00374868|65115882|FG000|Overall Study|Physician Decision|13|||
23373985|NCT00374868|65115882|FG000|Overall Study|Lost to Follow-up|1|||
23664367|NCT00312221|66155512|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23373986|NCT00374868|65115882|FG000|Overall Study|Death|2|||
23373987|NCT00374868|65115882|FG000|Overall Study|Other - Not Specified|1|||
23373988|NCT00423046|65115883|FG000|Overall Study|Other|340|||
23664368|NCT00312221|66155513|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23664369|NCT00312221|66155514|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
23664370|NCT00312221|66155511|FG000|Open-label Run-in Period|Administrative|42|||
23373989|NCT00423046|65115884|FG001|Overall Study|Other|345|||
23373990|NCT00116142|65115888|FG000|Overall Study|Adverse Event|8|||
23373991|NCT00116142|65115889|FG001|Overall Study|Adverse Event|7|||
23373992|NCT00116142|65115888|FG000|Overall Study|Protocol Violation|2|||
23373993|NCT00116142|65115889|FG001|Overall Study|Protocol Violation|1|||
23373994|NCT00116142|65115888|FG000|Overall Study|Withdrawal by Subject|5|||
23373995|NCT00116142|65115889|FG001|Overall Study|Withdrawal by Subject|5|||
23373996|NCT00116142|65115888|FG000|Overall Study|Physician Decision|3|||
23373997|NCT00116142|65115889|FG001|Overall Study|Physician Decision|1|||
23664371|NCT00312221|66155512|FG001|Open-label Run-in Period|Administrative|0|||
23664372|NCT00312221|66155513|FG002|Open-label Run-in Period|Administrative|0|||
23664373|NCT00312221|66155514|FG003|Open-label Run-in Period|Administrative|0|||
23664374|NCT00312221|66155511|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
23664375|NCT00312221|66155512|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23664376|NCT00312221|66155513|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23664377|NCT00312221|66155514|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
23664378|NCT00312221|66155511|FG000|Open-label Run-in Period|Did not qualify|5|||
23664379|NCT00312221|66155512|FG001|Open-label Run-in Period|Did not qualify|0|||
23664380|NCT00312221|66155513|FG002|Open-label Run-in Period|Did not qualify|0|||
23664381|NCT00312221|66155514|FG003|Open-label Run-in Period|Did not qualify|0|||
23664382|NCT00312221|66155511|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23664383|NCT00312221|66155512|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23664384|NCT00312221|66155513|FG002|Double-blind Phase|Withdrawal by Subject|8|||
23664385|NCT00312221|66155514|FG003|Double-blind Phase|Withdrawal by Subject|7|||
23373998|NCT00116142|65115888|FG000|Overall Study|Delayed Radiation Therapy|1|||
23373999|NCT00116142|65115889|FG001|Overall Study|Delayed Radiation Therapy|0|||
23374000|NCT00116142|65115888|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
23374001|NCT00116142|65115889|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
23374002|NCT00116142|65115888|FG000|Overall Study|Patient stopped due to depression|0|||
23374003|NCT00116142|65115889|FG001|Overall Study|Patient stopped due to depression|1|||
23374004|NCT00116142|65115888|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
23374005|NCT00116142|65115889|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
23374006|NCT00116142|65115888|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
23374007|NCT00116142|65115889|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
23374008|NCT00116142|65115888|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
23374009|NCT00116142|65115889|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
23374010|NCT04219189|65115890|FG000|Overall Study|Withdrawal by Subject|1|||
23374011|NCT04219189|65115891|FG001|Overall Study|Withdrawal by Subject|2|||
23374012|NCT04219189|65115890|FG000|Overall Study|Protocol Violation|0|||
23374013|NCT04219189|65115891|FG001|Overall Study|Protocol Violation|1|||
23374014|NCT04219189|65115890|FG000|Overall Study|Lost to Follow-up|0|||
23374015|NCT04219189|65115891|FG001|Overall Study|Lost to Follow-up|1|||
23374016|NCT04219189|65115890|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
23374017|NCT04219189|65115891|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
23374018|NCT04539275|65115892|FG000|Overall Study|Death|2|||
23374019|NCT04539275|65115893|FG001|Overall Study|Death|4|||
23664386|NCT00312221|66155511|FG000|Double-blind Phase|Adverse Event|0|||
23664387|NCT00312221|66155512|FG001|Double-blind Phase|Adverse Event|10|||
23664388|NCT00312221|66155513|FG002|Double-blind Phase|Adverse Event|19|||
23664389|NCT00312221|66155514|FG003|Double-blind Phase|Adverse Event|18|||
23664390|NCT00312221|66155511|FG000|Double-blind Phase|Lost to Follow-up|0|||
23664391|NCT00312221|66155512|FG001|Double-blind Phase|Lost to Follow-up|0|||
23664392|NCT00312221|66155513|FG002|Double-blind Phase|Lost to Follow-up|2|||
23664393|NCT00312221|66155514|FG003|Double-blind Phase|Lost to Follow-up|2|||
23664394|NCT00312221|66155511|FG000|Double-blind Phase|Administrative|0|||
23664395|NCT00312221|66155512|FG001|Double-blind Phase|Administrative|26|||
23374020|NCT04539275|65115892|FG000|Overall Study|Lost to Follow-up|1|||
23374021|NCT04539275|65115893|FG001|Overall Study|Lost to Follow-up|1|||
23374022|NCT04539275|65115892|FG000|Overall Study|Withdrawal by Subject|3|||
23374023|NCT04539275|65115893|FG001|Overall Study|Withdrawal by Subject|0|||
23374024|NCT03307174|65115894|FG000|Overall Study|Unplanned ICU Administrion|5|||
23374025|NCT03307174|65115895|FG001|Overall Study|Unplanned ICU Administrion|3|||
23374026|NCT03307174|65115894|FG000|Overall Study|Aborted Surgery|1|||
23603835|NCT01670526|65940182|FG001|Overall Study|Withdrawal by Subject|1|||
23603836|NCT01670526|65940181|FG000|Overall Study|Lost to Follow-up|9|||
23603837|NCT01670526|65940182|FG001|Overall Study|Lost to Follow-up|5|||
23603838|NCT02392507|65940183|FG000|Induction Regimen|Death|3|||
23603839|NCT02392507|65940183|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
23603840|NCT02392507|65940183|FG000|Induction Regimen|Physician Decision|1|||
23603841|NCT02392507|65940183|FG000|Induction Regimen|Withdrawal by Subject|2|||
23603842|NCT02392507|65940183|FG000|Maintenance Regimen|Death|1|||
23664396|NCT00312221|66155513|FG002|Double-blind Phase|Administrative|37|||
23664397|NCT00312221|66155514|FG003|Double-blind Phase|Administrative|33|||
23664398|NCT00312221|66155511|FG000|Double-blind Phase|Lack of Efficacy|0|||
23664399|NCT00312221|66155512|FG001|Double-blind Phase|Lack of Efficacy|17|||
23664400|NCT00312221|66155513|FG002|Double-blind Phase|Lack of Efficacy|6|||
23664401|NCT00312221|66155514|FG003|Double-blind Phase|Lack of Efficacy|10|||
23664402|NCT00632099|66155515|FG000|Overall Study|Lost to Follow-up|3|||
23664403|NCT00632099|66155516|FG001|Overall Study|Lost to Follow-up|3|||
23664404|NCT01537198|66155527|FG000|Overall Study|RSV infection|2|||
23664405|NCT01537198|66155527|FG000|Overall Study|Adverse Event|4|||
23664406|NCT01537198|66155527|FG000|Overall Study|No Further Visits to the Clinic|37|||
23664407|NCT01537198|66155527|FG000|Overall Study|Other|111|||
23664408|NCT02311153|66155538|FG000|Overall Study|Lost to Follow-up|5|||
23664409|NCT02311153|66155539|FG001|Overall Study|Lost to Follow-up|7|||
23664410|NCT00544648|66155541|FG000|Overall Study|Withdrawal by Subject|1|||
23664411|NCT00544648|66155542|FG001|Overall Study|Withdrawal by Subject|0|||
23664412|NCT00544648|66155541|FG000|Overall Study|Adverse Event|1|||
23664413|NCT00544648|66155542|FG001|Overall Study|Adverse Event|1|||
23664414|NCT00544648|66155541|FG000|Overall Study|progression of disease|1|||
23664415|NCT00544648|66155542|FG001|Overall Study|progression of disease|0|||
23664416|NCT01380730|66158455|FG000|Overall Study|Death|0|||
23664417|NCT01380730|66158456|FG001|Overall Study|Death|0|||
23664418|NCT01380730|66158457|FG002|Overall Study|Death|0|||
23664419|NCT01380730|66158458|FG003|Overall Study|Death|0|||
23664420|NCT01380730|66158459|FG004|Overall Study|Death|1|||
23664421|NCT01380730|66158460|FG005|Overall Study|Death|0|||
23664422|NCT01380730|66158461|FG006|Overall Study|Death|0|||
23664423|NCT01380730|66158462|FG007|Overall Study|Death|0|||
23664424|NCT02039375|66158463|FG000|Overall Study|Lost to Follow-up|2|||
23664425|NCT03861936|66158470|FG000|Overall Study|Withdrawal by Subject|4|||
23664426|NCT03861936|66158471|FG001|Overall Study|Withdrawal by Subject|1|||
23664427|NCT03861936|66158472|FG002|Overall Study|Withdrawal by Subject|3|||
23664428|NCT03861936|66158470|FG000|Overall Study|Lost to Follow-up|5|||
23664429|NCT03861936|66158471|FG001|Overall Study|Lost to Follow-up|3|||
23664430|NCT03861936|66158472|FG002|Overall Study|Lost to Follow-up|3|||
23664431|NCT03861936|66158470|FG000|Overall Study|Physician Decision|0|||
23664432|NCT03861936|66158471|FG001|Overall Study|Physician Decision|1|||
23664433|NCT03861936|66158472|FG002|Overall Study|Physician Decision|0|||
23664434|NCT03861936|66158470|FG000|Overall Study|Protocol Deviation|0|||
23664435|NCT03861936|66158471|FG001|Overall Study|Protocol Deviation|0|||
23664436|NCT03861936|66158472|FG002|Overall Study|Protocol Deviation|1|||
23664437|NCT03861936|66158470|FG000|Overall Study|Reason not Specified|5|||
23664438|NCT03861936|66158471|FG001|Overall Study|Reason not Specified|5|||
23664439|NCT03861936|66158472|FG002|Overall Study|Reason not Specified|3|||
23664440|NCT02322125|66158473|FG000|Overall Study|Withdrawal by Subject|2|||
23664441|NCT04305275|66158476|FG000|Overall Study|Adverse Event|4|||
23664442|NCT04305275|66158477|FG001|Overall Study|Adverse Event|0|||
23664443|NCT04305275|66158476|FG000|Overall Study|Lost to Follow-up|1|||
23664444|NCT04305275|66158477|FG001|Overall Study|Lost to Follow-up|1|||
23664445|NCT04305275|66158476|FG000|Overall Study|Withdrawal by Participant|8|||
23664446|NCT04305275|66158477|FG001|Overall Study|Withdrawal by Participant|1|||
23664447|NCT01627899|66158478|FG000|Overall Study|Study terminated early by sponsor.|5|||
23664448|NCT00607386|66158479|FG000|Overall Study|Physician Decision|1|||
23664449|NCT00133991|66158480|FG000|Overall Study|Death|4|||
23664450|NCT02943564|66158481|FG000|Overall Study|Miscellaneous Reasons|0|||
23664451|NCT02943564|66158482|FG001|Overall Study|Miscellaneous Reasons|0|||
23664452|NCT02943564|66158483|FG002|Overall Study|Miscellaneous Reasons|3|||
23664453|NCT02943564|66158481|FG000|Overall Study|Site terminated by sponsor|0|||
23374027|NCT03307174|65115895|FG001|Overall Study|Aborted Surgery|2|||
23374028|NCT03307174|65115894|FG000|Overall Study|Hypotension|6|||
23664454|NCT02943564|66158482|FG001|Overall Study|Site terminated by sponsor|1|||
23664455|NCT02943564|66158483|FG002|Overall Study|Site terminated by sponsor|0|||
23664456|NCT02943564|66158481|FG000|Overall Study|Non-compliance with study drug|0|||
23664457|NCT02943564|66158482|FG001|Overall Study|Non-compliance with study drug|1|||
23664458|NCT02943564|66158483|FG002|Overall Study|Non-compliance with study drug|0|||
23664459|NCT02943564|66158481|FG000|Overall Study|Pregnancy|0|||
23603843|NCT02392507|65940183|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
23664460|NCT02943564|66158482|FG001|Overall Study|Pregnancy|1|||
23664461|NCT02943564|66158483|FG002|Overall Study|Pregnancy|1|||
23664462|NCT02943564|66158481|FG000|Overall Study|Protocol Violation|2|||
23374029|NCT03307174|65115895|FG001|Overall Study|Hypotension|0|||
23374030|NCT03307174|65115894|FG000|Overall Study|Nonfunctional epidural|1|||
23487554|NCT02963831|65530392|FG001|Overall Study|Adverse Event|1|||
23487555|NCT02963831|65530393|FG002|Overall Study|Adverse Event|1|||
23487556|NCT02963831|65530394|FG003|Overall Study|Adverse Event|2|||
23487557|NCT02963831|65530391|FG000|Overall Study|Death|0|||
23487558|NCT02963831|65530392|FG001|Overall Study|Death|0|||
23487559|NCT02963831|65530393|FG002|Overall Study|Death|0|||
23487560|NCT02963831|65530394|FG003|Overall Study|Death|2|||
23487561|NCT01994590|65530395|FG000|Overall Study|Adverse Event|1|||
23487562|NCT01994590|65530395|FG000|Overall Study|Trial Terminated|1|||
23487563|NCT01484054|65530396|FG000|Period 1|Withdrawal by Subject|0|||
23487564|NCT01484054|65530397|FG001|Period 1|Withdrawal by Subject|1|||
23487565|NCT01869725|65530398|FG000|Overall Study|ineligible after registration|1|||
23487566|NCT01869725|65530398|FG000|Overall Study|Death|1|||
23487567|NCT01869725|65530398|FG000|Overall Study|Lost to Follow-up|2|||
23487568|NCT01638819|65530399|FG000|Overall Study|Lost to Follow-up|1|||
23487569|NCT01638819|65530400|FG001|Overall Study|Lost to Follow-up|0|||
23487570|NCT02160782|65530407|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
23487571|NCT02160782|65530408|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
23487572|NCT02160782|65530409|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
23487573|NCT02160782|65530410|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
23487574|NCT02160782|65530411|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
23487575|NCT02160782|65530407|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487576|NCT02160782|65530408|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487577|NCT02160782|65530409|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487578|NCT02160782|65530410|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
23487579|NCT02160782|65530411|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487580|NCT02160782|65530407|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487581|NCT02160782|65530408|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487582|NCT02160782|65530409|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487583|NCT02160782|65530410|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
23487584|NCT02160782|65530411|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487585|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487586|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487587|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487588|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487589|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
23487590|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487591|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487592|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487593|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487594|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
23487595|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487596|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487597|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487598|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487599|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
23487600|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487601|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487602|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487603|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487604|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
23487605|NCT00736879|65530412|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23487606|NCT00736879|65530413|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23487607|NCT00736879|65530414|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23487608|NCT00736879|65530415|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23487609|NCT00736879|65530412|FG000|Double Blind Treatment Period|Adverse Event|0|||
23487610|NCT00736879|65530413|FG001|Double Blind Treatment Period|Adverse Event|1|||
23487611|NCT00736879|65530414|FG002|Double Blind Treatment Period|Adverse Event|1|||
23487612|NCT00736879|65530415|FG003|Double Blind Treatment Period|Adverse Event|0|||
23487613|NCT00736879|65530412|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
23487614|NCT00736879|65530413|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23487615|NCT00736879|65530414|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
23487616|NCT00736879|65530415|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
23487617|NCT00736879|65530412|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
23603844|NCT00824408|65940190|FG000|Run-in Phase|Progressive disease|4|||
23374031|NCT03307174|65115895|FG001|Overall Study|Nonfunctional epidural|1|||
23374032|NCT03307174|65115894|FG000|Overall Study|Planned epidural removal|1|||
23374033|NCT03307174|65115895|FG001|Overall Study|Planned epidural removal|0|||
23374034|NCT03307174|65115894|FG000|Overall Study|Intrathecal catheter placement|0|||
23374035|NCT03307174|65115895|FG001|Overall Study|Intrathecal catheter placement|1|||
23374036|NCT00317369|65115896|FG000|Overall Study|Adverse Event|2|||
23374037|NCT00317369|65115897|FG001|Overall Study|Adverse Event|1|||
23374038|NCT00317369|65115898|FG002|Overall Study|Adverse Event|0|||
23374039|NCT00317369|65115896|FG000|Overall Study|Lack of Efficacy|0|||
23374040|NCT00317369|65115897|FG001|Overall Study|Lack of Efficacy|1|||
23374041|NCT00317369|65115898|FG002|Overall Study|Lack of Efficacy|1|||
23374042|NCT00317369|65115896|FG000|Overall Study|Withdrawal by Subject|0|||
23374043|NCT00317369|65115897|FG001|Overall Study|Withdrawal by Subject|0|||
23374044|NCT00317369|65115898|FG002|Overall Study|Withdrawal by Subject|1|||
23374045|NCT01901185|65115900|FG000|Overall Study|Withdrawal by Subject|2|||
23374046|NCT01496456|65115902|FG000|Overall Study|Protocol Violation|1|||
23374047|NCT01496456|65115902|FG000|Overall Study|Lost to Follow-up|7|||
23374048|NCT04009837|65115909|FG000|Overall Study|Withdrawal by Subject|5|||
23374049|NCT04009837|65115910|FG001|Overall Study|Withdrawal by Subject|4|||
23374050|NCT04009837|65115909|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
23374051|NCT04009837|65115910|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
23374052|NCT03738696|65115916|FG000|Overall Study|Withdrawal by Subject|0|||
23374053|NCT03738696|65115917|FG001|Overall Study|Withdrawal by Subject|1|||
23374054|NCT03738696|65115916|FG000|Overall Study|Lost to Follow-up|8|||
23374055|NCT03738696|65115917|FG001|Overall Study|Lost to Follow-up|14|||
23374056|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
23374057|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
23374058|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
23374059|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
23374060|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
23374061|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
23374062|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
23374063|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
23374064|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374065|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374066|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
23374067|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374068|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374069|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374070|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
23374071|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374072|NCT02349386|65115918|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
23374073|NCT02349386|65115919|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
23374074|NCT02349386|65115920|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
23374075|NCT02349386|65115921|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
23374076|NCT02349386|65115918|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374077|NCT02349386|65115919|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374078|NCT02349386|65115920|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
23374079|NCT02349386|65115921|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374080|NCT00701363|65115924|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
23374081|NCT00701363|65115925|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374082|NCT00701363|65115926|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374083|NCT00701363|65115927|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374084|NCT00701363|65115924|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
23603845|NCT00824408|65940191|FG001|Run-in Phase|Progressive disease|4|||
23603846|NCT00824408|65940192|FG002|Run-in Phase|Progressive disease|0|||
23603847|NCT00824408|65940193|FG003|Run-in Phase|Progressive disease|0|||
23603848|NCT00824408|65940194|FG004|Run-in Phase|Progressive disease|0|||
23603849|NCT00824408|65940190|FG000|Run-in Phase|Adverse Event|1|||
23603850|NCT00824408|65940191|FG001|Run-in Phase|Adverse Event|1|||
23603851|NCT00824408|65940192|FG002|Run-in Phase|Adverse Event|0|||
23603852|NCT00824408|65940193|FG003|Run-in Phase|Adverse Event|0|||
23603853|NCT00824408|65940194|FG004|Run-in Phase|Adverse Event|0|||
23374085|NCT00701363|65115925|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
23664463|NCT02943564|66158482|FG001|Overall Study|Protocol Violation|2|||
23374086|NCT00701363|65115926|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
23374087|NCT00701363|65115927|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
23603854|NCT00824408|65940190|FG000|Run-in Phase|Refused to continue medication|1|||
23603855|NCT00824408|65940191|FG001|Run-in Phase|Refused to continue medication|0|||
23664464|NCT02943564|66158483|FG002|Overall Study|Protocol Violation|2|||
23664465|NCT02943564|66158481|FG000|Overall Study|Lost to Follow-up|1|||
23664466|NCT02943564|66158482|FG001|Overall Study|Lost to Follow-up|0|||
23664467|NCT02943564|66158483|FG002|Overall Study|Lost to Follow-up|0|||
23664468|NCT02943564|66158481|FG000|Overall Study|Withdrawal by Subject|6|||
23664469|NCT02943564|66158482|FG001|Overall Study|Withdrawal by Subject|5|||
23664470|NCT02943564|66158483|FG002|Overall Study|Withdrawal by Subject|2|||
23664471|NCT02943564|66158481|FG000|Overall Study|Adverse Event|1|||
23664472|NCT02943564|66158482|FG001|Overall Study|Adverse Event|2|||
23664473|NCT02943564|66158483|FG002|Overall Study|Adverse Event|1|||
23664474|NCT02943564|66158481|FG000|Overall Study|Lack of Efficacy|0|||
23374088|NCT00701363|65115924|FG000|Treatment Phase 1|Adverse Event|7|||
23374089|NCT00701363|65115925|FG001|Treatment Phase 1|Adverse Event|0|||
23374090|NCT00701363|65115926|FG002|Treatment Phase 1|Adverse Event|0|||
23374091|NCT00701363|65115927|FG003|Treatment Phase 1|Adverse Event|0|||
23374092|NCT00701363|65115924|FG000|Treatment Phase 1|Protocol Violation|1|||
23374093|NCT00701363|65115925|FG001|Treatment Phase 1|Protocol Violation|0|||
23374094|NCT00701363|65115926|FG002|Treatment Phase 1|Protocol Violation|0|||
23374095|NCT00701363|65115927|FG003|Treatment Phase 1|Protocol Violation|0|||
23374096|NCT00701363|65115924|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
23374097|NCT00701363|65115925|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
23374098|NCT00701363|65115926|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
23374099|NCT00701363|65115927|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
23374100|NCT00701363|65115924|FG000|Treatment Phase 1|Lack of Efficacy|1|||
23374101|NCT00701363|65115925|FG001|Treatment Phase 1|Lack of Efficacy|0|||
23374102|NCT00701363|65115926|FG002|Treatment Phase 1|Lack of Efficacy|0|||
23374103|NCT00701363|65115927|FG003|Treatment Phase 1|Lack of Efficacy|0|||
23374104|NCT00701363|65115924|FG000|Treatment Phase 2|Adverse Event|0|||
23374105|NCT00701363|65115925|FG001|Treatment Phase 2|Adverse Event|0|||
23374106|NCT00701363|65115926|FG002|Treatment Phase 2|Adverse Event|1|||
23374107|NCT00701363|65115927|FG003|Treatment Phase 2|Adverse Event|0|||
23374108|NCT00701363|65115924|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
23374109|NCT00701363|65115925|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
23374110|NCT00701363|65115926|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
23664475|NCT02943564|66158482|FG001|Overall Study|Lack of Efficacy|1|||
23374111|NCT00701363|65115927|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
23374112|NCT01294046|65115938|FG000|Overall Study|Infection and surgical explant|1|||
23374113|NCT01294046|65115938|FG000|Overall Study|Eligibility criteria expanded|1|||
23374114|NCT01294046|65115938|FG000|Overall Study|Stimulation response inadqequate|1|||
23374115|NCT04124965|65115939|FG000|Overall Study|Adverse event, non-fatal|3|||
23374116|NCT04124965|65115940|FG001|Overall Study|Adverse event, non-fatal|1|||
23664476|NCT02943564|66158483|FG002|Overall Study|Lack of Efficacy|0|||
23664477|NCT01617070|66158486|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
23487618|NCT00736879|65530413|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23487619|NCT00736879|65530414|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
23487620|NCT00736879|65530415|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
23487621|NCT00736879|65530412|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
23487622|NCT00736879|65530413|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
23487623|NCT00736879|65530414|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
23487624|NCT00736879|65530415|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
23487625|NCT00736879|65530412|FG000|Double Blind Treatment Period|No longer met criteria|0|||
23487626|NCT00736879|65530413|FG001|Double Blind Treatment Period|No longer met criteria|1|||
23487627|NCT00736879|65530414|FG002|Double Blind Treatment Period|No longer met criteria|0|||
23487628|NCT00736879|65530415|FG003|Double Blind Treatment Period|No longer met criteria|0|||
23603856|NCT00824408|65940192|FG002|Run-in Phase|Refused to continue medication|0|||
23603857|NCT00824408|65940193|FG003|Run-in Phase|Refused to continue medication|0|||
23603858|NCT00824408|65940194|FG004|Run-in Phase|Refused to continue medication|0|||
23603859|NCT00824408|65940190|FG000|Run-in Phase|Other reason not defined above|0|||
23603860|NCT00824408|65940191|FG001|Run-in Phase|Other reason not defined above|1|||
23603861|NCT00824408|65940192|FG002|Run-in Phase|Other reason not defined above|0|||
23603862|NCT00824408|65940193|FG003|Run-in Phase|Other reason not defined above|0|||
23603863|NCT00824408|65940194|FG004|Run-in Phase|Other reason not defined above|0|||
23603864|NCT00824408|65940190|FG000|Randomized Phase|Not treated|0|||
23664478|NCT03200366|66158487|FG000|Patient Navigation Intervention Given|Death|0|||
23487629|NCT00736879|65530412|FG000|Double Blind Treatment Period|non-specified|0|||
23603865|NCT00824408|65940191|FG001|Randomized Phase|Not treated|0|||
23664479|NCT03200366|66158488|FG001|Patient Navigation Intervention Given|Death|2|||
23487630|NCT00736879|65530413|FG001|Double Blind Treatment Period|non-specified|1|||
23487631|NCT00736879|65530414|FG002|Double Blind Treatment Period|non-specified|0|||
23487632|NCT00736879|65530415|FG003|Double Blind Treatment Period|non-specified|0|||
23487633|NCT00736879|65530412|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487634|NCT00736879|65530413|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
23487635|NCT00736879|65530414|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487636|NCT00736879|65530415|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487637|NCT00736879|65530412|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
23487638|NCT00736879|65530413|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
23487639|NCT00736879|65530414|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
23487640|NCT00736879|65530415|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
23487641|NCT00978432|65530416|FG000|Overall Study|Withdrawal by Subject|0|||
23487642|NCT00978432|65530417|FG001|Overall Study|Withdrawal by Subject|0|||
23487643|NCT00978432|65530418|FG002|Overall Study|Withdrawal by Subject|1|||
23487644|NCT00978432|65530416|FG000|Overall Study|Lack of Efficacy|1|||
23487645|NCT00978432|65530417|FG001|Overall Study|Lack of Efficacy|1|||
23487646|NCT00978432|65530418|FG002|Overall Study|Lack of Efficacy|3|||
23487647|NCT00978432|65530416|FG000|Overall Study|Adverse Event|2|||
23487648|NCT00978432|65530417|FG001|Overall Study|Adverse Event|0|||
23487649|NCT00978432|65530418|FG002|Overall Study|Adverse Event|1|||
23487650|NCT00471146|65530424|FG000|Overall Study|Adverse Event|32|||
23487651|NCT00471146|65530425|FG001|Overall Study|Adverse Event|33|||
23487652|NCT00471146|65530424|FG000|Overall Study|Withdrawal by Subject|14|||
23487653|NCT00471146|65530425|FG001|Overall Study|Withdrawal by Subject|11|||
23487654|NCT00471146|65530424|FG000|Overall Study|Death|11|||
23487655|NCT00471146|65530425|FG001|Overall Study|Death|12|||
23487656|NCT00471146|65530424|FG000|Overall Study|Lost to Follow-up|4|||
23487657|NCT00471146|65530425|FG001|Overall Study|Lost to Follow-up|2|||
23487658|NCT00471146|65530424|FG000|Overall Study|Protocol Violation|2|||
23487659|NCT00471146|65530425|FG001|Overall Study|Protocol Violation|2|||
23487660|NCT00471146|65530424|FG000|Overall Study|Objective progression or relapse|84|||
23487661|NCT00471146|65530425|FG001|Overall Study|Objective progression or relapse|87|||
23487662|NCT00471146|65530424|FG000|Overall Study|Global deterioration of health status|12|||
23487663|NCT00471146|65530425|FG001|Overall Study|Global deterioration of health status|14|||
23487664|NCT00471146|65530424|FG000|Overall Study|Randomized but not treated|9|||
23487665|NCT00471146|65530425|FG001|Overall Study|Randomized but not treated|8|||
23487666|NCT00471146|65530424|FG000|Overall Study|Other|4|||
23487667|NCT00471146|65530425|FG001|Overall Study|Other|5|||
23487668|NCT03416374|65530426|FG000|Between Treatment Period I and II|Other|0|||
23487669|NCT03416374|65530427|FG001|Between Treatment Period I and II|Other|9|||
23487670|NCT03416374|65530426|FG000|Treatment Period II|Lack of Efficacy|3|||
23487671|NCT03416374|65530427|FG001|Treatment Period II|Lack of Efficacy|11|||
23487672|NCT03416374|65530426|FG000|Treatment Period II|Adverse Event|1|||
23487673|NCT03416374|65530427|FG001|Treatment Period II|Adverse Event|4|||
23487674|NCT03416374|65530426|FG000|Treatment Period II|Death|0|||
23487675|NCT03416374|65530427|FG001|Treatment Period II|Death|1|||
23487676|NCT03416374|65530426|FG000|Treatment Period II|Other|0|||
23487677|NCT03416374|65530427|FG001|Treatment Period II|Other|2|||
23487678|NCT00923936|65530428|FG000|Overall Study|progressive disease on study|2|||
23487679|NCT00923936|65530429|FG001|Overall Study|progressive disease on study|1|||
23487680|NCT00923936|65530428|FG000|Overall Study|Adverse Event|2|||
23487681|NCT00923936|65530429|FG001|Overall Study|Adverse Event|1|||
23487682|NCT00923936|65530428|FG000|Overall Study|Lost to follow up|2|||
23487683|NCT00923936|65530429|FG001|Overall Study|Lost to follow up|0|||
23487684|NCT00923936|65530428|FG000|Overall Study|Continuing in follow up period|2|||
23487685|NCT00923936|65530429|FG001|Overall Study|Continuing in follow up period|1|||
23487686|NCT00932737|65530430|FG000|Overall Study|Not treated in second episode|1|||
23487687|NCT00932737|65530431|FG001|Overall Study|Not treated in second episode|0|||
23487688|NCT00932737|65530430|FG000|Overall Study|Adverse Event|0|||
23487689|NCT00932737|65530431|FG001|Overall Study|Adverse Event|1|||
23487690|NCT03538431|65530432|FG000|Overall Study|Physician Decision|0|||
23487691|NCT03538431|65530433|FG001|Overall Study|Physician Decision|1|||
23487692|NCT03538431|65530432|FG000|Overall Study|Withdrawal by Subject|1|||
23487693|NCT03538431|65530433|FG001|Overall Study|Withdrawal by Subject|0|||
23487694|NCT03161093|65530434|FG000|Overall Study|Protocol Violation|11|||
23487695|NCT03161093|65530435|FG001|Overall Study|Protocol Violation|14|||
23487696|NCT03161093|65530436|FG002|Overall Study|Protocol Violation|6|||
23487697|NCT03161093|65530437|FG003|Overall Study|Protocol Violation|13|||
23487698|NCT03161093|65530438|FG004|Overall Study|Protocol Violation|1|||
23487699|NCT03161093|65530439|FG005|Overall Study|Protocol Violation|0|||
23487700|NCT03161093|65530434|FG000|Overall Study|Adverse Event|5|||
23487701|NCT03161093|65530435|FG001|Overall Study|Adverse Event|21|||
23487702|NCT03161093|65530436|FG002|Overall Study|Adverse Event|16|||
23487703|NCT03161093|65530437|FG003|Overall Study|Adverse Event|35|||
23487704|NCT03161093|65530438|FG004|Overall Study|Adverse Event|2|||
23487705|NCT03161093|65530439|FG005|Overall Study|Adverse Event|1|||
23487706|NCT03161093|65530434|FG000|Overall Study|Lack of Efficacy|9|||
23487707|NCT03161093|65530435|FG001|Overall Study|Lack of Efficacy|13|||
23487708|NCT03161093|65530436|FG002|Overall Study|Lack of Efficacy|9|||
23487709|NCT03161093|65530437|FG003|Overall Study|Lack of Efficacy|24|||
23487710|NCT03161093|65530438|FG004|Overall Study|Lack of Efficacy|4|||
23487711|NCT03161093|65530439|FG005|Overall Study|Lack of Efficacy|1|||
23487712|NCT03161093|65530434|FG000|Overall Study|Physician Decision|0|||
23487713|NCT03161093|65530435|FG001|Overall Study|Physician Decision|1|||
23487714|NCT03161093|65530436|FG002|Overall Study|Physician Decision|0|||
23487715|NCT03161093|65530437|FG003|Overall Study|Physician Decision|2|||
23487716|NCT03161093|65530438|FG004|Overall Study|Physician Decision|17|||
23487717|NCT03161093|65530439|FG005|Overall Study|Physician Decision|15|||
23487718|NCT03161093|65530434|FG000|Overall Study|Withdrawal by Subject|24|||
23487719|NCT03161093|65530435|FG001|Overall Study|Withdrawal by Subject|73|||
23487720|NCT03161093|65530436|FG002|Overall Study|Withdrawal by Subject|44|||
23487721|NCT03161093|65530437|FG003|Overall Study|Withdrawal by Subject|97|||
23487722|NCT03161093|65530438|FG004|Overall Study|Withdrawal by Subject|11|||
23487723|NCT03161093|65530439|FG005|Overall Study|Withdrawal by Subject|10|||
23487724|NCT03161093|65530434|FG000|Overall Study|Lost to Follow-up|3|||
23487725|NCT03161093|65530435|FG001|Overall Study|Lost to Follow-up|12|||
23487726|NCT03161093|65530436|FG002|Overall Study|Lost to Follow-up|4|||
23487727|NCT03161093|65530437|FG003|Overall Study|Lost to Follow-up|7|||
23487728|NCT03161093|65530438|FG004|Overall Study|Lost to Follow-up|8|||
23487729|NCT03161093|65530439|FG005|Overall Study|Lost to Follow-up|13|||
23487730|NCT03161093|65530434|FG000|Overall Study|Death|3|||
23487731|NCT03161093|65530435|FG001|Overall Study|Death|9|||
23487732|NCT03161093|65530436|FG002|Overall Study|Death|7|||
23487733|NCT03161093|65530437|FG003|Overall Study|Death|9|||
23487734|NCT03161093|65530438|FG004|Overall Study|Death|0|||
23487735|NCT03161093|65530439|FG005|Overall Study|Death|0|||
23487736|NCT03161093|65530434|FG000|Overall Study|Unknown - Not reported|0|||
23487737|NCT03161093|65530435|FG001|Overall Study|Unknown - Not reported|1|||
23487738|NCT03161093|65530436|FG002|Overall Study|Unknown - Not reported|0|||
23487739|NCT03161093|65530437|FG003|Overall Study|Unknown - Not reported|0|||
23487740|NCT03161093|65530438|FG004|Overall Study|Unknown - Not reported|0|||
23487741|NCT03161093|65530439|FG005|Overall Study|Unknown - Not reported|1|||
23487742|NCT01439568|65530440|FG000|Overall Study|Lost to Follow-up|1|||
23487743|NCT01439568|65530441|FG001|Overall Study|Lost to Follow-up|0|||
23487744|NCT01439568|65530440|FG000|Overall Study|Withdrawal by Subject|2|||
23487745|NCT01439568|65530441|FG001|Overall Study|Withdrawal by Subject|2|||
23487746|NCT00704808|65530442|FG000|Overall Study|Discontinued prior to starting treatment|14|||
23487747|NCT00704808|65530442|FG000|Overall Study|Death|7|||
23487748|NCT00704808|65530442|FG000|Overall Study|Tumor progression|80|||
23487749|NCT00704808|65530442|FG000|Overall Study|Patient's decision|11|||
23487750|NCT00704808|65530442|FG000|Overall Study|Early therapy discontinuation|16|||
23487751|NCT00704808|65530442|FG000|Overall Study|Adverse Event|1|||
23487752|NCT00704808|65530442|FG000|Overall Study|Lost to Follow-up|1|||
23487753|NCT00704808|65530442|FG000|Overall Study|Treatment change|1|||
23487754|NCT00764504|65530446|FG000|Overall Study|Death|12|||
23487755|NCT00764504|65530447|FG001|Overall Study|Death|6|||
23487756|NCT00764504|65530448|FG002|Overall Study|Death|13|||
23487757|NCT00764504|65530446|FG000|Overall Study|Revision of Device|12|||
23487758|NCT00764504|65530447|FG001|Overall Study|Revision of Device|23|||
23487759|NCT00764504|65530448|FG002|Overall Study|Revision of Device|14|||
23487760|NCT00764504|65530446|FG000|Overall Study|Physician Decision|1|||
23487761|NCT00764504|65530447|FG001|Overall Study|Physician Decision|0|||
23487762|NCT00764504|65530448|FG002|Overall Study|Physician Decision|0|||
23487763|NCT00764504|65530446|FG000|Overall Study|Withdrawal by Subject|1|||
23487764|NCT00764504|65530447|FG001|Overall Study|Withdrawal by Subject|7|||
23487765|NCT00764504|65530448|FG002|Overall Study|Withdrawal by Subject|4|||
23487766|NCT00764504|65530446|FG000|Overall Study|Lost to Follow-up|40|||
23487767|NCT00764504|65530447|FG001|Overall Study|Lost to Follow-up|34|||
23487768|NCT00764504|65530448|FG002|Overall Study|Lost to Follow-up|72|||
23487769|NCT04072575|65530453|FG000|Overall Study|Physician Decision|1|||
23487770|NCT04072575|65530453|FG000|Overall Study|Adverse Event|7|||
23487771|NCT04072575|65530453|FG000|Overall Study|Withdrawal by Subject|14|||
23487772|NCT04072575|65530453|FG000|Overall Study|Other|2|||
23487773|NCT01483690|65530454|FG000|Overall Study|Adverse Event|1|||
23487774|NCT01483690|65530455|FG001|Overall Study|Adverse Event|2|||
23487775|NCT01483690|65530454|FG000|Overall Study|clinical deterioration|1|||
23487776|NCT01483690|65530455|FG001|Overall Study|clinical deterioration|0|||
23487777|NCT01483690|65530454|FG000|Overall Study|Physician Decision|0|||
23487778|NCT01483690|65530455|FG001|Overall Study|Physician Decision|2|||
23487779|NCT01483690|65530454|FG000|Overall Study|exclusionary procedure|0|||
23487780|NCT01483690|65530455|FG001|Overall Study|exclusionary procedure|1|||
23487781|NCT00423670|65530459|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
23487782|NCT00423670|65530460|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487783|NCT00423670|65530461|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487784|NCT00423670|65530462|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487785|NCT00423670|65530463|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487786|NCT00423670|65530464|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487787|NCT00423670|65530465|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487788|NCT00423670|65530466|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487789|NCT00423670|65530459|FG000|Treatment Period|Adverse Event|8|||
23487790|NCT00423670|65530460|FG001|Treatment Period|Adverse Event|12|||
23487791|NCT00423670|65530461|FG002|Treatment Period|Adverse Event|15|||
23487792|NCT00423670|65530462|FG003|Treatment Period|Adverse Event|20|||
23487793|NCT00423670|65530463|FG004|Treatment Period|Adverse Event|9|||
23487794|NCT00423670|65530464|FG005|Treatment Period|Adverse Event|4|||
23487795|NCT00423670|65530465|FG006|Treatment Period|Adverse Event|7|||
23487796|NCT00423670|65530466|FG007|Treatment Period|Adverse Event|2|||
23487797|NCT00423670|65530459|FG000|Treatment Period|Protocol-defined clinical event|0|||
23487798|NCT00423670|65530460|FG001|Treatment Period|Protocol-defined clinical event|7|||
23487799|NCT00423670|65530461|FG002|Treatment Period|Protocol-defined clinical event|4|||
23487800|NCT00423670|65530462|FG003|Treatment Period|Protocol-defined clinical event|12|||
23487801|NCT00423670|65530463|FG004|Treatment Period|Protocol-defined clinical event|5|||
23487802|NCT00423670|65530464|FG005|Treatment Period|Protocol-defined clinical event|4|||
23487803|NCT00423670|65530465|FG006|Treatment Period|Protocol-defined clinical event|16|||
23487804|NCT00423670|65530466|FG007|Treatment Period|Protocol-defined clinical event|15|||
23487805|NCT00423670|65530459|FG000|Treatment Period|Lost to Follow-up|2|||
23487806|NCT00423670|65530460|FG001|Treatment Period|Lost to Follow-up|1|||
23487807|NCT00423670|65530461|FG002|Treatment Period|Lost to Follow-up|3|||
23487808|NCT00423670|65530462|FG003|Treatment Period|Lost to Follow-up|1|||
23487809|NCT00423670|65530463|FG004|Treatment Period|Lost to Follow-up|6|||
23487810|NCT00423670|65530464|FG005|Treatment Period|Lost to Follow-up|0|||
23487811|NCT00423670|65530465|FG006|Treatment Period|Lost to Follow-up|3|||
23487812|NCT00423670|65530466|FG007|Treatment Period|Lost to Follow-up|1|||
23487813|NCT00423670|65530459|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
23487814|NCT00423670|65530460|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
23487815|NCT00423670|65530461|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
23487816|NCT00423670|65530462|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
23487817|NCT00423670|65530463|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
23487818|NCT00423670|65530464|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
23603866|NCT00824408|65940192|FG002|Randomized Phase|Not treated|1|||
23603867|NCT00824408|65940193|FG003|Randomized Phase|Not treated|1|||
23603868|NCT00824408|65940194|FG004|Randomized Phase|Not treated|1|||
23487819|NCT00423670|65530465|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
23487820|NCT00423670|65530466|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
23487821|NCT00423670|65530459|FG000|Treatment Period|Investigator decision|0|||
23487822|NCT00423670|65530460|FG001|Treatment Period|Investigator decision|0|||
23487823|NCT00423670|65530461|FG002|Treatment Period|Investigator decision|0|||
23487824|NCT00423670|65530462|FG003|Treatment Period|Investigator decision|0|||
23487825|NCT00423670|65530463|FG004|Treatment Period|Investigator decision|0|||
23487826|NCT00423670|65530464|FG005|Treatment Period|Investigator decision|0|||
23487827|NCT00423670|65530465|FG006|Treatment Period|Investigator decision|0|||
23487828|NCT00423670|65530466|FG007|Treatment Period|Investigator decision|1|||
23603869|NCT00824408|65940190|FG000|Randomized Phase|Progressive disease|0|||
23487829|NCT00423670|65530459|FG000|Treatment Period|Non-compliance with protocol|3|||
23487830|NCT00423670|65530460|FG001|Treatment Period|Non-compliance with protocol|1|||
23487831|NCT00423670|65530461|FG002|Treatment Period|Non-compliance with protocol|1|||
23487832|NCT00423670|65530462|FG003|Treatment Period|Non-compliance with protocol|3|||
23487833|NCT00423670|65530463|FG004|Treatment Period|Non-compliance with protocol|2|||
23487834|NCT00423670|65530464|FG005|Treatment Period|Non-compliance with protocol|0|||
23487835|NCT00423670|65530465|FG006|Treatment Period|Non-compliance with protocol|2|||
23487836|NCT00423670|65530466|FG007|Treatment Period|Non-compliance with protocol|2|||
23603870|NCT00824408|65940191|FG001|Randomized Phase|Progressive disease|0|||
23603871|NCT00824408|65940192|FG002|Randomized Phase|Progressive disease|25|||
23374117|NCT04124965|65115939|FG000|Overall Study|Withdrawal by Subject|1|||
23374118|NCT04124965|65115940|FG001|Overall Study|Withdrawal by Subject|1|||
23374119|NCT04124965|65115939|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
23374120|NCT04124965|65115940|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
23374121|NCT04124965|65115939|FG000|Overall Study|Pregnancy|1|||
23374122|NCT04124965|65115940|FG001|Overall Study|Pregnancy|0|||
23374123|NCT04124965|65115939|FG000|Overall Study|Sponsor and participant decision|0|||
23374124|NCT04124965|65115940|FG001|Overall Study|Sponsor and participant decision|1|||
23374125|NCT04124965|65115939|FG000|Overall Study|Personal surgery|0|||
23374126|NCT04124965|65115940|FG001|Overall Study|Personal surgery|1|||
23374127|NCT04124965|65115939|FG000|Overall Study|Physician Decision|0|||
23374128|NCT04124965|65115940|FG001|Overall Study|Physician Decision|1|||
23374129|NCT01218802|65115943|FG000|Overall Study|Lost to Follow-up|5|||
23374130|NCT01218802|65115944|FG001|Overall Study|Lost to Follow-up|6|||
23374131|NCT01218802|65115943|FG000|Overall Study|Withdrawal by Subject|3|||
23374132|NCT01218802|65115944|FG001|Overall Study|Withdrawal by Subject|10|||
23374133|NCT01218802|65115943|FG000|Overall Study|Adverse Event|0|||
23374134|NCT01218802|65115944|FG001|Overall Study|Adverse Event|2|||
23374135|NCT01218802|65115943|FG000|Overall Study|Incarcerated|2|||
23374136|NCT01218802|65115944|FG001|Overall Study|Incarcerated|0|||
23374137|NCT01206764|65115945|FG000|Overall Study|Adverse Event|20|||
23374138|NCT01206764|65115945|FG000|Overall Study|Abnormal laboratory value|2|||
23374139|NCT01206764|65115945|FG000|Overall Study|Abnormal test procedure result|1|||
23374140|NCT01206764|65115945|FG000|Overall Study|Patient withdrew consent|5|||
23374141|NCT01206764|65115945|FG000|Overall Study|Lost to Follow-up|6|||
23374142|NCT01206764|65115945|FG000|Overall Study|Death|11|||
23374143|NCT01206764|65115945|FG000|Overall Study|New cancer therapy|2|||
23374144|NCT01206764|65115945|FG000|Overall Study|Disease progression|88|||
23374145|NCT01206764|65115945|FG000|Overall Study|Protocol deviation|3|||
23374146|NCT01140906|65115947|FG000|Overall Study|Adverse Event|7|||
23374147|NCT01140906|65115948|FG001|Overall Study|Adverse Event|10|||
23374148|NCT01140906|65115949|FG002|Overall Study|Adverse Event|17|||
23374149|NCT01140906|65115950|FG003|Overall Study|Adverse Event|7|||
23374150|NCT01140906|65115947|FG000|Overall Study|Lack of Efficacy|6|||
23374151|NCT01140906|65115948|FG001|Overall Study|Lack of Efficacy|8|||
23374152|NCT01140906|65115949|FG002|Overall Study|Lack of Efficacy|2|||
23374153|NCT01140906|65115950|FG003|Overall Study|Lack of Efficacy|1|||
23374154|NCT01140906|65115947|FG000|Overall Study|Non-compliance|0|||
23374155|NCT01140906|65115948|FG001|Overall Study|Non-compliance|1|||
23374156|NCT01140906|65115949|FG002|Overall Study|Non-compliance|0|||
23374157|NCT01140906|65115950|FG003|Overall Study|Non-compliance|1|||
23374158|NCT01140906|65115947|FG000|Overall Study|Protocol Violation|5|||
23374159|NCT01140906|65115948|FG001|Overall Study|Protocol Violation|3|||
23374160|NCT01140906|65115949|FG002|Overall Study|Protocol Violation|2|||
23374161|NCT01140906|65115950|FG003|Overall Study|Protocol Violation|1|||
23374162|NCT01140906|65115947|FG000|Overall Study|Withdrawal of consent|6|||
23374163|NCT01140906|65115948|FG001|Overall Study|Withdrawal of consent|6|||
23374164|NCT01140906|65115949|FG002|Overall Study|Withdrawal of consent|2|||
23374165|NCT01140906|65115950|FG003|Overall Study|Withdrawal of consent|2|||
23374166|NCT01140906|65115947|FG000|Overall Study|Lost to Follow-up|1|||
23374167|NCT01140906|65115948|FG001|Overall Study|Lost to Follow-up|1|||
23487837|NCT00423670|65530459|FG000|Follow-up Period|Lost to Follow-up|0|||
23487838|NCT00423670|65530460|FG001|Follow-up Period|Lost to Follow-up|12|||
23487839|NCT00423670|65530461|FG002|Follow-up Period|Lost to Follow-up|8|||
23487840|NCT00423670|65530462|FG003|Follow-up Period|Lost to Follow-up|3|||
23374168|NCT01140906|65115949|FG002|Overall Study|Lost to Follow-up|0|||
23374169|NCT01140906|65115950|FG003|Overall Study|Lost to Follow-up|2|||
23374170|NCT01140906|65115947|FG000|Overall Study|Administrative or other reason|0|||
23374171|NCT01140906|65115948|FG001|Overall Study|Administrative or other reason|5|||
23374172|NCT01140906|65115949|FG002|Overall Study|Administrative or other reason|3|||
23374173|NCT01140906|65115950|FG003|Overall Study|Administrative or other reason|2|||
23374174|NCT00076570|65115951|FG000|Overall Study|Drug intolerance|8|||
23374175|NCT00076570|65115952|FG001|Overall Study|Drug intolerance|8|||
23374176|NCT02834975|65115953|FG000|Overall Study|Physician Decision|2|||
23374177|NCT02834975|65115953|FG000|Overall Study|Adverse Event|1|||
23374178|NCT02834975|65115953|FG000|Overall Study|Withdrawal by Subject|1|||
23374179|NCT02834975|65115953|FG000|Overall Study|Lack of Efficacy|1|||
23487841|NCT00423670|65530463|FG004|Follow-up Period|Lost to Follow-up|1|||
23487842|NCT00423670|65530464|FG005|Follow-up Period|Lost to Follow-up|0|||
23487843|NCT00423670|65530465|FG006|Follow-up Period|Lost to Follow-up|5|||
23487844|NCT00423670|65530466|FG007|Follow-up Period|Lost to Follow-up|0|||
23487845|NCT00423670|65530459|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487846|NCT00423670|65530460|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
23487847|NCT00423670|65530461|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
23487848|NCT00423670|65530462|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487849|NCT00423670|65530463|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487850|NCT00423670|65530464|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
23487851|NCT00423670|65530465|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487852|NCT00423670|65530466|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487853|NCT00423670|65530459|FG000|Follow-up Period|Non-compliance with protocol|2|||
23487854|NCT00423670|65530460|FG001|Follow-up Period|Non-compliance with protocol|0|||
23487855|NCT00423670|65530461|FG002|Follow-up Period|Non-compliance with protocol|1|||
23487856|NCT00423670|65530462|FG003|Follow-up Period|Non-compliance with protocol|1|||
23487857|NCT00423670|65530463|FG004|Follow-up Period|Non-compliance with protocol|0|||
23487858|NCT00423670|65530464|FG005|Follow-up Period|Non-compliance with protocol|0|||
23487859|NCT00423670|65530465|FG006|Follow-up Period|Non-compliance with protocol|3|||
23487860|NCT00423670|65530466|FG007|Follow-up Period|Non-compliance with protocol|2|||
23487861|NCT01070043|65530469|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
23487862|NCT01070043|65530470|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
23487863|NCT01070043|65530471|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
23487864|NCT01070043|65530469|FG000|Double-Blind Treatment|Adverse Event|0|||
23487865|NCT01070043|65530470|FG001|Double-Blind Treatment|Adverse Event|0|||
23487866|NCT01070043|65530471|FG002|Double-Blind Treatment|Adverse Event|2|||
23487867|NCT00737464|65530472|FG000|Overall Study|Adverse Event|1|||
23487868|NCT00737464|65530472|FG000|Overall Study|Death|6|||
23487869|NCT00737464|65530472|FG000|Overall Study|Other - Failure to Return|1|||
23487870|NCT00737464|65530472|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
23603872|NCT00824408|65940193|FG003|Randomized Phase|Progressive disease|36|||
23603873|NCT00824408|65940194|FG004|Randomized Phase|Progressive disease|34|||
23603874|NCT00824408|65940190|FG000|Randomized Phase|Adverse Event|0|||
23603875|NCT00824408|65940191|FG001|Randomized Phase|Adverse Event|0|||
23603876|NCT00824408|65940192|FG002|Randomized Phase|Adverse Event|4|||
23603877|NCT00824408|65940193|FG003|Randomized Phase|Adverse Event|5|||
23603878|NCT00824408|65940194|FG004|Randomized Phase|Adverse Event|5|||
23603879|NCT00824408|65940190|FG000|Randomized Phase|Refused to continue medication|0|||
23603880|NCT00824408|65940191|FG001|Randomized Phase|Refused to continue medication|0|||
23603881|NCT00824408|65940192|FG002|Randomized Phase|Refused to continue medication|2|||
23487871|NCT00737464|65530472|FG000|Overall Study|Other reasons|4|||
23603882|NCT00824408|65940193|FG003|Randomized Phase|Refused to continue medication|2|||
23603883|NCT00824408|65940194|FG004|Randomized Phase|Refused to continue medication|2|||
23603884|NCT00824408|65940190|FG000|Randomized Phase|Other reason not defined above|0|||
23603885|NCT00824408|65940191|FG001|Randomized Phase|Other reason not defined above|0|||
23603886|NCT00824408|65940192|FG002|Randomized Phase|Other reason not defined above|4|||
23603887|NCT00824408|65940193|FG003|Randomized Phase|Other reason not defined above|2|||
23603888|NCT00824408|65940194|FG004|Randomized Phase|Other reason not defined above|4|||
23603889|NCT02384382|65940195|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
23603890|NCT02384382|65940195|FG000|Overall Study|Death|1|||
23603891|NCT02384382|65940195|FG000|Overall Study|Adverse Event|1|||
23603892|NCT02384382|65940195|FG000|Overall Study|Disease progression|16|||
23603893|NCT00655824|65940196|FG000|Overall Study|Adverse Event|3|||
23603894|NCT00655824|65940196|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
23603895|NCT00655824|65940196|FG000|Overall Study|Protocol Violation|1|||
23603896|NCT00655824|65940196|FG000|Overall Study|Withdrawal by Subject|4|||
23603897|NCT00655824|65940196|FG000|Overall Study|Deterioration of Trial Disease|2|||
23603898|NCT02000752|65940197|FG000|Overall Study|Dystocic delivery|19|||
23603899|NCT02000752|65940198|FG001|Overall Study|Dystocic delivery|8|||
23603900|NCT02000752|65940197|FG000|Overall Study|Shift Changes|12|||
23487872|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
23487873|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487874|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
23487875|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23603901|NCT02000752|65940198|FG001|Overall Study|Shift Changes|5|||
23603902|NCT02542943|65940205|FG000|Overall Study|Lost to Follow-up|1|||
23603903|NCT02542943|65940206|FG001|Overall Study|Lost to Follow-up|0|||
23603904|NCT02542943|65940207|FG002|Overall Study|Lost to Follow-up|0|||
23603905|NCT02542943|65940205|FG000|Overall Study|Withdrawal by Subject|0|||
23603906|NCT02542943|65940206|FG001|Overall Study|Withdrawal by Subject|1|||
23487876|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487877|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487878|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487879|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487880|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487881|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487882|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
23487883|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487884|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487885|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487886|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487887|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487888|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487889|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
23487890|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487891|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487892|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487893|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487894|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487895|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487896|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Adverse Event|1|||
23487897|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Adverse Event|0|||
23487898|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Adverse Event|0|||
23487899|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Adverse Event|1|||
23487900|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Adverse Event|1|||
23487901|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Adverse Event|0|||
23487902|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Adverse Event|2|||
23487903|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Adverse Event|1|||
23487904|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Death|0|||
23487905|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Death|0|||
23487906|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Death|0|||
23487907|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Death|1|||
23487908|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Death|0|||
23664480|NCT03200366|66158489|FG002|Patient Navigation Intervention Given|Death|0|||
23664481|NCT03200366|66158487|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
23664482|NCT03200366|66158488|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
23664483|NCT03200366|66158489|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
23664484|NCT03200366|66158487|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
23664485|NCT03200366|66158488|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
23664486|NCT03200366|66158489|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
23664487|NCT03200366|66158487|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
23374180|NCT00634504|65115956|FG000|Overall Study|Protocol Violation|1|||
23664488|NCT03200366|66158488|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
23664489|NCT03200366|66158489|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
23664490|NCT03200366|66158487|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
23374181|NCT00634504|65115957|FG001|Overall Study|Protocol Violation|0|||
23374182|NCT05259917|65115958|FG000|Overall Study|Protocol Violation|0|||
23374183|NCT05259917|65115959|FG001|Overall Study|Protocol Violation|0|||
23374184|NCT05259917|65115960|FG002|Overall Study|Protocol Violation|1|||
23374185|NCT05259917|65115961|FG003|Overall Study|Protocol Violation|0|||
23374186|NCT05259917|65115962|FG004|Overall Study|Protocol Violation|0|||
23374187|NCT05259917|65115963|FG005|Overall Study|Protocol Violation|0|||
23374188|NCT05259917|65115958|FG000|Overall Study|Lost to Follow-up|0|||
23374189|NCT05259917|65115959|FG001|Overall Study|Lost to Follow-up|0|||
23374190|NCT05259917|65115960|FG002|Overall Study|Lost to Follow-up|1|||
23374191|NCT05259917|65115961|FG003|Overall Study|Lost to Follow-up|0|||
23487909|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Death|1|||
23487910|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Death|0|||
23603907|NCT02542943|65940207|FG002|Overall Study|Withdrawal by Subject|0|||
23603908|NCT00047385|65940208|FG000|Overall Study|Death before any screening|2|||
23603909|NCT00047385|65940209|FG001|Overall Study|Death before any screening|5|||
23603910|NCT00047385|65940208|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
23603911|NCT00047385|65940209|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
23664491|NCT03200366|66158488|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
23664492|NCT03200366|66158489|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
23374192|NCT05259917|65115962|FG004|Overall Study|Lost to Follow-up|0|||
23374193|NCT05259917|65115963|FG005|Overall Study|Lost to Follow-up|1|||
23374194|NCT05259917|65115958|FG000|Overall Study|Physician Decision|0|||
23374195|NCT05259917|65115959|FG001|Overall Study|Physician Decision|1|||
23487911|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Death|3|||
23487912|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487913|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487914|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487915|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
23487916|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487917|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487918|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487919|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487920|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
23487921|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
23487922|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
23487923|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
23664493|NCT03200366|66158487|FG000|6 Month Post-Baseline Interview|Death|1|||
23664494|NCT03200366|66158488|FG001|6 Month Post-Baseline Interview|Death|1|||
23664495|NCT03200366|66158489|FG002|6 Month Post-Baseline Interview|Death|1|||
23664496|NCT03200366|66158487|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
23664497|NCT03200366|66158488|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
23664498|NCT03200366|66158489|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
23664499|NCT03200366|66158487|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
23664500|NCT03200366|66158488|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
23664501|NCT03200366|66158489|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
23664502|NCT03200366|66158487|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
23664503|NCT03200366|66158488|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
23664504|NCT03200366|66158489|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
23664505|NCT03200366|66158487|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
23664506|NCT03200366|66158488|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
23664507|NCT03200366|66158489|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
23664508|NCT03200366|66158487|FG000|9 Month Post-Baseline Interview|Death|1|||
23664509|NCT03200366|66158488|FG001|9 Month Post-Baseline Interview|Death|1|||
23664510|NCT03200366|66158489|FG002|9 Month Post-Baseline Interview|Death|1|||
23664511|NCT03200366|66158487|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
23664512|NCT03200366|66158488|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
23374196|NCT05259917|65115960|FG002|Overall Study|Physician Decision|0|||
23487924|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
23603912|NCT00047385|65940208|FG000|Overall Study|Eligible for screening but had no screen|260|||
23664513|NCT03200366|66158489|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
23664514|NCT03200366|66158487|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
23664515|NCT03200366|66158488|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
23664516|NCT03200366|66158489|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
23374197|NCT05259917|65115961|FG003|Overall Study|Physician Decision|0|||
23374198|NCT05259917|65115962|FG004|Overall Study|Physician Decision|0|||
23664517|NCT03200366|66158487|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
23664518|NCT03200366|66158488|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
23664519|NCT03200366|66158489|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
23664520|NCT02713542|66158490|FG000|Overall Study|Use of prohibited medication|14|||
23664521|NCT02713542|66158491|FG001|Overall Study|Use of prohibited medication|5|||
23664522|NCT02713542|66158490|FG000|Overall Study|Withdrawal by Subject|4|||
23664523|NCT02713542|66158491|FG001|Overall Study|Withdrawal by Subject|1|||
23664524|NCT01439555|66158499|FG000|Overall Study|Protocol Violation|1|||
23664525|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
23664526|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
23664527|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
23664528|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23664529|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23664530|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23664531|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Death|2|||
23664532|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Death|0|||
23664533|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
23664534|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
23664535|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
23664536|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23664537|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
23664538|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23664539|NCT02603120|66158500|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
23664540|NCT02603120|66158501|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
23664541|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
23664542|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
23664543|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
23664544|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
23664545|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
23664546|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
23664547|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
23664548|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
23664549|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
23664550|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
23664551|NCT02603120|66158500|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
23374199|NCT05259917|65115963|FG005|Overall Study|Physician Decision|0|||
23664552|NCT02603120|66158501|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
23664553|NCT01999465|66158505|FG000|Overall Study|Lost to Follow-up|0|||
23664554|NCT01999465|66158506|FG001|Overall Study|Lost to Follow-up|2|||
23664555|NCT01999465|66158505|FG000|Overall Study|Protocol Violation|0|||
23664556|NCT01999465|66158506|FG001|Overall Study|Protocol Violation|1|||
23664557|NCT01877187|66158508|FG000|Overall Study|Death|2|||
23664558|NCT01877187|66158508|FG000|Overall Study|Withdrawal by Subject|4|||
23664559|NCT01877187|66158508|FG000|Overall Study|Lost to Follow-up|3|||
23664560|NCT01877187|66158508|FG000|Overall Study|Declining clinical status|11|||
23664561|NCT01877187|66158508|FG000|Overall Study|Liver transplant|2|||
23664562|NCT01462435|66158511|FG000|Overall Study|Lack of Efficacy|1|||
23664563|NCT01462435|66158512|FG001|Overall Study|Lack of Efficacy|0|||
23664564|NCT01462435|66158513|FG002|Overall Study|Lack of Efficacy|0|||
23664565|NCT01462435|66158514|FG003|Overall Study|Lack of Efficacy|3|||
23374200|NCT05259917|65115958|FG000|Overall Study|Withdrawal by Subject|0|||
23374201|NCT05259917|65115959|FG001|Overall Study|Withdrawal by Subject|1|||
23487925|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
23664566|NCT01462435|66158511|FG000|Overall Study|Physician Decision|0|||
23664567|NCT01462435|66158512|FG001|Overall Study|Physician Decision|0|||
23664568|NCT01462435|66158513|FG002|Overall Study|Physician Decision|1|||
23664569|NCT01462435|66158514|FG003|Overall Study|Physician Decision|0|||
23664570|NCT01462435|66158511|FG000|Overall Study|Withdrawal by Subject|0|||
23664571|NCT01462435|66158512|FG001|Overall Study|Withdrawal by Subject|0|||
23664572|NCT01462435|66158513|FG002|Overall Study|Withdrawal by Subject|0|||
23664573|NCT01462435|66158514|FG003|Overall Study|Withdrawal by Subject|1|||
23374202|NCT05259917|65115960|FG002|Overall Study|Withdrawal by Subject|0|||
23374203|NCT05259917|65115961|FG003|Overall Study|Withdrawal by Subject|0|||
23374204|NCT05259917|65115962|FG004|Overall Study|Withdrawal by Subject|1|||
23374205|NCT05259917|65115963|FG005|Overall Study|Withdrawal by Subject|1|||
23374206|NCT05259917|65115958|FG000|Overall Study|Trial Termination by Sponsor|7|||
23374207|NCT05259917|65115959|FG001|Overall Study|Trial Termination by Sponsor|2|||
23374208|NCT05259917|65115960|FG002|Overall Study|Trial Termination by Sponsor|3|||
23374209|NCT05259917|65115961|FG003|Overall Study|Trial Termination by Sponsor|5|||
23374210|NCT05259917|65115962|FG004|Overall Study|Trial Termination by Sponsor|11|||
23374211|NCT05259917|65115963|FG005|Overall Study|Trial Termination by Sponsor|4|||
23374212|NCT05259917|65115958|FG000|Overall Study|Other|1|||
23374213|NCT05259917|65115959|FG001|Overall Study|Other|0|||
23374214|NCT05259917|65115960|FG002|Overall Study|Other|2|||
23374215|NCT05259917|65115961|FG003|Overall Study|Other|0|||
23374216|NCT05259917|65115962|FG004|Overall Study|Other|0|||
23374217|NCT05259917|65115963|FG005|Overall Study|Other|0|||
23374218|NCT03451045|65115966|FG000|Overall Study|Lack of Efficacy|3|||
23374219|NCT03451045|65115967|FG001|Overall Study|Lack of Efficacy|2|||
23664574|NCT01462435|66158511|FG000|Overall Study|Lost to Follow-up|0|||
23664575|NCT01462435|66158512|FG001|Overall Study|Lost to Follow-up|0|||
23664576|NCT01462435|66158513|FG002|Overall Study|Lost to Follow-up|0|||
23374220|NCT03451045|65115968|FG002|Overall Study|Lack of Efficacy|2|||
23374221|NCT03451045|65115966|FG000|Overall Study|Physician Decision|1|||
23374222|NCT03451045|65115967|FG001|Overall Study|Physician Decision|1|||
23374223|NCT03451045|65115968|FG002|Overall Study|Physician Decision|1|||
23374224|NCT03451045|65115966|FG000|Overall Study|Withdrawal by Subject|4|||
23374225|NCT03451045|65115967|FG001|Overall Study|Withdrawal by Subject|0|||
23374226|NCT03451045|65115968|FG002|Overall Study|Withdrawal by Subject|5|||
23374227|NCT03451045|65115966|FG000|Overall Study|Pregnancy|0|||
23374228|NCT03451045|65115967|FG001|Overall Study|Pregnancy|0|||
23374229|NCT03451045|65115968|FG002|Overall Study|Pregnancy|2|||
23374230|NCT03451045|65115966|FG000|Overall Study|Adverse Event|7|||
23374231|NCT03451045|65115967|FG001|Overall Study|Adverse Event|1|||
23374232|NCT03451045|65115968|FG002|Overall Study|Adverse Event|3|||
23374233|NCT03451045|65115966|FG000|Overall Study|Non-compliance with study|2|||
23374234|NCT03451045|65115967|FG001|Overall Study|Non-compliance with study|0|||
23374235|NCT03451045|65115968|FG002|Overall Study|Non-compliance with study|1|||
23374236|NCT03451045|65115966|FG000|Overall Study|any other reason|10|||
23374237|NCT03451045|65115967|FG001|Overall Study|any other reason|2|||
23374238|NCT03451045|65115968|FG002|Overall Study|any other reason|13|||
23487926|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
23487927|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
23664577|NCT01462435|66158514|FG003|Overall Study|Lost to Follow-up|1|||
23664578|NCT00823823|66158516|FG000|Overall Study|Lost to Follow-up|3|||
23664579|NCT00823823|66158517|FG001|Overall Study|Lost to Follow-up|1|||
23664580|NCT00823823|66158516|FG000|Overall Study|Protocol Violation|5|||
23664581|NCT00823823|66158517|FG001|Overall Study|Protocol Violation|5|||
23664582|NCT03697720|66158518|FG000|Overall Study|Lost to Follow-up|7|||
23374239|NCT02026141|65115969|FG000|Overall Study|Protocol Violation|0|||
23374240|NCT02026141|65115970|FG001|Overall Study|Protocol Violation|1|||
23374241|NCT01189266|65115971|FG000|Overall Study|Adverse Event|1|||
23374242|NCT01189266|65115972|FG001|Overall Study|Adverse Event|0|||
23374243|NCT01189266|65115973|FG002|Overall Study|Adverse Event|5|||
23374244|NCT01189266|65115971|FG000|Overall Study|Death|0|||
23374245|NCT01189266|65115972|FG001|Overall Study|Death|0|||
23374246|NCT01189266|65115973|FG002|Overall Study|Death|5|||
23374247|NCT01189266|65115971|FG000|Overall Study|Lack of Efficacy|4|||
23374248|NCT01189266|65115972|FG001|Overall Study|Lack of Efficacy|5|||
23664583|NCT01422915|66158520|FG000|Overall Study|Adverse Event|1|||
23374249|NCT01189266|65115973|FG002|Overall Study|Lack of Efficacy|44|||
23374250|NCT01189266|65115971|FG000|Overall Study|Physician Decision|0|||
23374251|NCT01189266|65115972|FG001|Overall Study|Physician Decision|0|||
23374252|NCT01189266|65115973|FG002|Overall Study|Physician Decision|1|||
23374253|NCT01189266|65115971|FG000|Overall Study|Protocol Violation|0|||
23374254|NCT01189266|65115972|FG001|Overall Study|Protocol Violation|1|||
23374255|NCT01189266|65115973|FG002|Overall Study|Protocol Violation|1|||
23374256|NCT01189266|65115971|FG000|Overall Study|Withdrawal by Subject|0|||
23374257|NCT01189266|65115972|FG001|Overall Study|Withdrawal by Subject|0|||
23374258|NCT01189266|65115973|FG002|Overall Study|Withdrawal by Subject|1|||
23374259|NCT01189266|65115971|FG000|Overall Study|Patient refuses further therapy|1|||
23374260|NCT01189266|65115972|FG001|Overall Study|Patient refuses further therapy|0|||
23374261|NCT01189266|65115973|FG002|Overall Study|Patient refuses further therapy|7|||
23374262|NCT01189266|65115971|FG000|Overall Study|No treatment|0|||
23374263|NCT01189266|65115972|FG001|Overall Study|No treatment|0|||
23374264|NCT01189266|65115973|FG002|Overall Study|No treatment|1|||
23374265|NCT01299584|65115974|FG000|Overall Study|Protocol Violation|9|||
23374266|NCT02722967|65115983|FG000|Overall Study|Adverse Event|1|||
23374267|NCT02722967|65115984|FG001|Overall Study|Adverse Event|0|||
23374268|NCT02722967|65115985|FG002|Overall Study|Adverse Event|0|||
23374269|NCT02722967|65115983|FG000|Overall Study|Lost to Follow-up|0|||
23374270|NCT02722967|65115984|FG001|Overall Study|Lost to Follow-up|1|||
23374271|NCT02722967|65115985|FG002|Overall Study|Lost to Follow-up|0|||
23374272|NCT02722967|65115983|FG000|Overall Study|Non-compliance with patch wearing|2|||
23374273|NCT02722967|65115984|FG001|Overall Study|Non-compliance with patch wearing|1|||
23374274|NCT02722967|65115985|FG002|Overall Study|Non-compliance with patch wearing|1|||
23374275|NCT02722967|65115983|FG000|Overall Study|Withdrawal by Subject|1|||
23374276|NCT02722967|65115984|FG001|Overall Study|Withdrawal by Subject|0|||
23603913|NCT00047385|65940209|FG001|Overall Study|Eligible for screening but had no screen|492|||
23603914|NCT03939897|65940210|FG000|Overall Study|Still receiving active treatment|0|||
23603915|NCT03939897|65940211|FG001|Overall Study|Still receiving active treatment|0|||
23603916|NCT03939897|65940212|FG002|Overall Study|Still receiving active treatment|1|||
23603917|NCT03939897|65940213|FG003|Overall Study|Still receiving active treatment|0|||
23603918|NCT03939897|65940214|FG004|Overall Study|Still receiving active treatment|0|||
23603919|NCT03939897|65940215|FG005|Overall Study|Still receiving active treatment|0|||
23603920|NCT01286311|65940216|FG000|Overall Study|Physician did not want outreach sent|14|||
23603921|NCT01286311|65940217|FG001|Overall Study|Physician did not want outreach sent|0|||
23603922|NCT00875706|65940221|FG000|Overall Study|Withdrawal by Subject|1|||
23603923|NCT00875706|65940222|FG001|Overall Study|Withdrawal by Subject|0|||
23603924|NCT00875706|65940223|FG002|Overall Study|Withdrawal by Subject|0|||
23603925|NCT00390884|65940224|FG000|Overall Study|Withdrawal by Subject|2|||
23603926|NCT00390884|65940225|FG001|Overall Study|Withdrawal by Subject|2|||
23603927|NCT01332266|65940228|FG000|Phase 1b|Death|3|||
23603928|NCT01332266|65940229|FG001|Phase 1b|Death|3|||
23603929|NCT01332266|65940230|FG002|Phase 1b|Death|2|||
23603930|NCT01332266|65940231|FG003|Phase 1b|Death|0|||
23603931|NCT01332266|65940232|FG004|Phase 1b|Death|0|||
23603932|NCT01332266|65940228|FG000|Phase 1b|Lost to Follow-up|0|||
23603933|NCT01332266|65940229|FG001|Phase 1b|Lost to Follow-up|1|||
23603934|NCT01332266|65940230|FG002|Phase 1b|Lost to Follow-up|0|||
23603935|NCT01332266|65940231|FG003|Phase 1b|Lost to Follow-up|0|||
23603936|NCT01332266|65940232|FG004|Phase 1b|Lost to Follow-up|0|||
23374277|NCT02722967|65115985|FG002|Overall Study|Withdrawal by Subject|1|||
23603937|NCT01332266|65940228|FG000|Phase 1b|Withdrawal by Subject|1|||
23603938|NCT01332266|65940229|FG001|Phase 1b|Withdrawal by Subject|1|||
23603939|NCT01332266|65940230|FG002|Phase 1b|Withdrawal by Subject|1|||
23603940|NCT01332266|65940231|FG003|Phase 1b|Withdrawal by Subject|0|||
23603941|NCT01332266|65940232|FG004|Phase 1b|Withdrawal by Subject|0|||
23374278|NCT02722967|65115983|FG000|Overall Study|Physician Decision|1|||
23603942|NCT01332266|65940228|FG000|Phase 2|Death|0|||
23374279|NCT02722967|65115984|FG001|Overall Study|Physician Decision|0|||
23374280|NCT02722967|65115985|FG002|Overall Study|Physician Decision|0|||
23374281|NCT02722967|65115983|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
23374282|NCT02722967|65115984|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
23374283|NCT02722967|65115985|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
23374284|NCT02471339|65115986|FG000|Overall Study|Did not provide follow-up data|2|||
23374285|NCT02471339|65115987|FG001|Overall Study|Did not provide follow-up data|0|||
23487928|NCT04228783|65530491|FG000|Overall Study|Adverse Event|1|||
23487929|NCT04228783|65530492|FG001|Overall Study|Adverse Event|0|||
23487930|NCT04228783|65530493|FG002|Overall Study|Adverse Event|2|||
23487931|NCT04228783|65530494|FG003|Overall Study|Adverse Event|0|||
23487932|NCT04228783|65530495|FG004|Overall Study|Adverse Event|0|||
23487933|NCT04228783|65530496|FG005|Overall Study|Adverse Event|1|||
23487934|NCT04228783|65530491|FG000|Overall Study|Death|0|||
23487935|NCT04228783|65530492|FG001|Overall Study|Death|0|||
23487936|NCT04228783|65530493|FG002|Overall Study|Death|0|||
23487937|NCT04228783|65530494|FG003|Overall Study|Death|0|||
23487938|NCT04228783|65530495|FG004|Overall Study|Death|1|||
23487939|NCT04228783|65530496|FG005|Overall Study|Death|0|||
23487940|NCT04228783|65530491|FG000|Overall Study|Lost to Follow-up|36|||
23487941|NCT04228783|65530492|FG001|Overall Study|Lost to Follow-up|36|||
23487942|NCT04228783|65530493|FG002|Overall Study|Lost to Follow-up|28|||
23487943|NCT04228783|65530494|FG003|Overall Study|Lost to Follow-up|6|||
23487944|NCT04228783|65530495|FG004|Overall Study|Lost to Follow-up|14|||
23487945|NCT04228783|65530496|FG005|Overall Study|Lost to Follow-up|3|||
23664584|NCT03357731|66158521|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
23664585|NCT03357731|66158522|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
23664586|NCT03357731|66158523|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
23664587|NCT03357731|66158524|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
23664588|NCT03357731|66158525|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
23664589|NCT03357731|66158526|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
23374286|NCT02371616|65115988|FG000|Overall Study|Protocol Violation|2|||
23374287|NCT02371616|65115989|FG001|Overall Study|Protocol Violation|1|||
23374288|NCT02371616|65115988|FG000|Overall Study|Adverse Event|0|||
23374289|NCT02371616|65115989|FG001|Overall Study|Adverse Event|1|||
23664590|NCT03357731|66158521|FG000|Overall Study|Acute bradycardia and hypotension|0|||
23374290|NCT02371616|65115988|FG000|Overall Study|Withdrawal of Consent|1|||
23374291|NCT02371616|65115989|FG001|Overall Study|Withdrawal of Consent|0|||
23487946|NCT04228783|65530491|FG000|Overall Study|Physician Decision|1|||
23487947|NCT04228783|65530492|FG001|Overall Study|Physician Decision|2|||
23487948|NCT04228783|65530493|FG002|Overall Study|Physician Decision|0|||
23487949|NCT04228783|65530494|FG003|Overall Study|Physician Decision|0|||
23487950|NCT04228783|65530495|FG004|Overall Study|Physician Decision|0|||
23487951|NCT04228783|65530496|FG005|Overall Study|Physician Decision|0|||
23374292|NCT02371616|65115988|FG000|Overall Study|Other (Not specified)|1|||
23374293|NCT02371616|65115989|FG001|Overall Study|Other (Not specified)|5|||
23374294|NCT01572792|65115990|FG000|Lead-in Study|Lost to Follow-up|5|||
23374295|NCT01572792|65115991|FG001|Lead-in Study|Lost to Follow-up|9|||
23374296|NCT01572792|65115992|FG002|Lead-in Study|Lost to Follow-up|4|||
23374297|NCT01572792|65115993|FG003|Lead-in Study|Lost to Follow-up|2|||
23374298|NCT01572792|65115994|FG004|Lead-in Study|Lost to Follow-up|4|||
23374299|NCT01572792|65115990|FG000|Lead-in Study|Withdrawal by Subject|22|||
23374300|NCT01572792|65115991|FG001|Lead-in Study|Withdrawal by Subject|11|||
23374301|NCT01572792|65115992|FG002|Lead-in Study|Withdrawal by Subject|12|||
23374302|NCT01572792|65115993|FG003|Lead-in Study|Withdrawal by Subject|24|||
23374303|NCT01572792|65115994|FG004|Lead-in Study|Withdrawal by Subject|11|||
23374304|NCT01572792|65115990|FG000|Lead-in Study|Protocol Violation|19|||
23374305|NCT01572792|65115991|FG001|Lead-in Study|Protocol Violation|10|||
23374306|NCT01572792|65115992|FG002|Lead-in Study|Protocol Violation|12|||
23374307|NCT01572792|65115993|FG003|Lead-in Study|Protocol Violation|13|||
23374308|NCT01572792|65115994|FG004|Lead-in Study|Protocol Violation|21|||
23374309|NCT01572792|65115990|FG000|Lead-in Study|Lack of Efficacy|20|||
23374310|NCT01572792|65115991|FG001|Lead-in Study|Lack of Efficacy|5|||
23374311|NCT01572792|65115992|FG002|Lead-in Study|Lack of Efficacy|4|||
23374312|NCT01572792|65115993|FG003|Lead-in Study|Lack of Efficacy|8|||
23374313|NCT01572792|65115994|FG004|Lead-in Study|Lack of Efficacy|10|||
23374314|NCT01572792|65115990|FG000|Lead-in Study|Adverse Event|21|||
23374315|NCT01572792|65115991|FG001|Lead-in Study|Adverse Event|21|||
23374316|NCT01572792|65115992|FG002|Lead-in Study|Adverse Event|22|||
23374317|NCT01572792|65115993|FG003|Lead-in Study|Adverse Event|16|||
23374318|NCT01572792|65115994|FG004|Lead-in Study|Adverse Event|14|||
23374319|NCT01572792|65115990|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
23374320|NCT01572792|65115991|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
23374321|NCT01572792|65115992|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
23374322|NCT01572792|65115993|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
23374323|NCT01572792|65115994|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
23374324|NCT01572792|65115990|FG000|Extension Study|Lost to Follow-up|6|||
23374325|NCT01572792|65115991|FG001|Extension Study|Lost to Follow-up|2|||
23374326|NCT01572792|65115992|FG002|Extension Study|Lost to Follow-up|0|||
23374327|NCT01572792|65115993|FG003|Extension Study|Lost to Follow-up|3|||
23374328|NCT01572792|65115994|FG004|Extension Study|Lost to Follow-up|3|||
23374329|NCT01572792|65115990|FG000|Extension Study|Withdrawal by Subject|7|||
23374330|NCT01572792|65115991|FG001|Extension Study|Withdrawal by Subject|6|||
23374331|NCT01572792|65115992|FG002|Extension Study|Withdrawal by Subject|11|||
23374332|NCT01572792|65115993|FG003|Extension Study|Withdrawal by Subject|8|||
23374333|NCT01572792|65115994|FG004|Extension Study|Withdrawal by Subject|14|||
23374334|NCT01572792|65115990|FG000|Extension Study|Protocol Violation|0|||
23374335|NCT01572792|65115991|FG001|Extension Study|Protocol Violation|4|||
23374336|NCT01572792|65115992|FG002|Extension Study|Protocol Violation|3|||
23374337|NCT01572792|65115993|FG003|Extension Study|Protocol Violation|4|||
23374338|NCT01572792|65115994|FG004|Extension Study|Protocol Violation|3|||
23374339|NCT01572792|65115990|FG000|Extension Study|Lack of Efficacy|2|||
23374340|NCT01572792|65115991|FG001|Extension Study|Lack of Efficacy|3|||
23374341|NCT01572792|65115992|FG002|Extension Study|Lack of Efficacy|3|||
23374342|NCT01572792|65115993|FG003|Extension Study|Lack of Efficacy|2|||
23374343|NCT01572792|65115994|FG004|Extension Study|Lack of Efficacy|2|||
23374344|NCT01572792|65115990|FG000|Extension Study|Adverse Event|7|||
23374345|NCT01572792|65115991|FG001|Extension Study|Adverse Event|6|||
23374346|NCT01572792|65115992|FG002|Extension Study|Adverse Event|5|||
23374347|NCT01572792|65115993|FG003|Extension Study|Adverse Event|6|||
23374348|NCT01572792|65115994|FG004|Extension Study|Adverse Event|4|||
23374349|NCT01572792|65115990|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
23374350|NCT01572792|65115991|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
23487952|NCT04228783|65530491|FG000|Overall Study|Protocol Violation|0|||
23487953|NCT04228783|65530492|FG001|Overall Study|Protocol Violation|0|||
23487954|NCT04228783|65530493|FG002|Overall Study|Protocol Violation|0|||
23487955|NCT04228783|65530494|FG003|Overall Study|Protocol Violation|1|||
23487956|NCT04228783|65530495|FG004|Overall Study|Protocol Violation|0|||
23487957|NCT04228783|65530496|FG005|Overall Study|Protocol Violation|0|||
23487958|NCT04228783|65530491|FG000|Overall Study|Withdrawal by Subject|6|||
23487959|NCT04228783|65530492|FG001|Overall Study|Withdrawal by Subject|10|||
23487960|NCT04228783|65530493|FG002|Overall Study|Withdrawal by Subject|19|||
23664591|NCT03357731|66158522|FG001|Overall Study|Acute bradycardia and hypotension|0|||
23487961|NCT04228783|65530494|FG003|Overall Study|Withdrawal by Subject|1|||
23487962|NCT04228783|65530495|FG004|Overall Study|Withdrawal by Subject|2|||
23487963|NCT04228783|65530496|FG005|Overall Study|Withdrawal by Subject|0|||
23374351|NCT01572792|65115992|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
23374352|NCT01572792|65115993|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
23374353|NCT01572792|65115994|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
23374354|NCT00490035|65115998|FG000|Overall Study|AE, non-serious non-fatal|3|||
23487964|NCT04228783|65530491|FG000|Overall Study|Other|4|||
23487965|NCT04228783|65530492|FG001|Overall Study|Other|3|||
23487966|NCT04228783|65530493|FG002|Overall Study|Other|2|||
23487967|NCT04228783|65530494|FG003|Overall Study|Other|1|||
23487968|NCT04228783|65530495|FG004|Overall Study|Other|0|||
23487969|NCT04228783|65530496|FG005|Overall Study|Other|0|||
23487970|NCT01243671|65530497|FG000|Overall Study|Adverse Event|3|||
23487971|NCT01243671|65530497|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
23487972|NCT01243671|65530497|FG000|Overall Study|Other|1|||
23487973|NCT02237911|65530498|FG000|Overall Study|Withdrawal by Subject|4|||
23487974|NCT02237911|65530499|FG001|Overall Study|Withdrawal by Subject|7|||
23487975|NCT02237911|65530500|FG002|Overall Study|Withdrawal by Subject|2|||
23487976|NCT02237911|65530498|FG000|Overall Study|Lost to Follow-up|3|||
23487977|NCT02237911|65530499|FG001|Overall Study|Lost to Follow-up|1|||
23487978|NCT02237911|65530500|FG002|Overall Study|Lost to Follow-up|1|||
23487979|NCT00901927|65530506|FG000|Overall Study|Lack of Efficacy|1|||
23487980|NCT00901927|65530506|FG000|Overall Study|Protocol Violation|3|||
23487981|NCT00901927|65530506|FG000|Overall Study|Withdrawal by Subject|2|||
23487982|NCT01086423|65530512|FG000|Overall Study|Protocol Violation|0|||
23487983|NCT01086423|65530513|FG001|Overall Study|Protocol Violation|0|||
23487984|NCT01086423|65530514|FG002|Overall Study|Protocol Violation|1|||
23487985|NCT01086423|65530512|FG000|Overall Study|Migrated/moved from study area|2|||
23487986|NCT01086423|65530513|FG001|Overall Study|Migrated/moved from study area|0|||
23487987|NCT01086423|65530514|FG002|Overall Study|Migrated/moved from study area|4|||
23487988|NCT01086423|65530512|FG000|Overall Study|Adverse event, fatal|1|||
23487989|NCT01086423|65530513|FG001|Overall Study|Adverse event, fatal|1|||
23487990|NCT01086423|65530514|FG002|Overall Study|Adverse event, fatal|0|||
23487991|NCT01086423|65530512|FG000|Overall Study|Adverse event, non-fatal|2|||
23487992|NCT01086423|65530513|FG001|Overall Study|Adverse event, non-fatal|1|||
23487993|NCT01086423|65530514|FG002|Overall Study|Adverse event, non-fatal|0|||
23487994|NCT01086423|65530512|FG000|Overall Study|Withdrawal by Subject|5|||
23487995|NCT01086423|65530513|FG001|Overall Study|Withdrawal by Subject|1|||
23487996|NCT01086423|65530514|FG002|Overall Study|Withdrawal by Subject|3|||
23487997|NCT01086423|65530512|FG000|Overall Study|Lost to Follow-up|0|||
23487998|NCT01086423|65530513|FG001|Overall Study|Lost to Follow-up|0|||
23487999|NCT01086423|65530514|FG002|Overall Study|Lost to Follow-up|1|||
23488000|NCT00144027|65530515|FG000|Overall Study|Lost to Follow-up|1|||
23488001|NCT00144027|65530516|FG001|Overall Study|Lost to Follow-up|3|||
23488002|NCT00144027|65530515|FG000|Overall Study|Withdrawal by Subject|2|||
23488003|NCT00144027|65530516|FG001|Overall Study|Withdrawal by Subject|2|||
23488004|NCT00144027|65530515|FG000|Overall Study|did not complete baseline assessment|0|||
23488005|NCT00144027|65530516|FG001|Overall Study|did not complete baseline assessment|6|||
23488006|NCT03053271|65530517|FG000|Overall Study|Did not meet randomization criteria|3|||
23488007|NCT03053271|65530517|FG000|Overall Study|Withdrawal by Subject|1|||
23488008|NCT02595970|65530518|FG000|Overall Study|Withdrawal by Subject|2|||
23488009|NCT02595970|65530518|FG000|Overall Study|Physician Decision|2|||
23488010|NCT02595970|65530518|FG000|Overall Study|Protocol Violation|4|||
23488011|NCT02595970|65530518|FG000|Overall Study|Adverse Event|5|||
23488012|NCT02595970|65530518|FG000|Overall Study|Lack of Efficacy|7|||
23488013|NCT02305888|65530520|FG000|Overall Study|Lost to Follow-up|0|||
23488014|NCT02305888|65530521|FG001|Overall Study|Lost to Follow-up|0|||
23488015|NCT02305888|65530522|FG002|Overall Study|Lost to Follow-up|1|||
23488016|NCT02305888|65530520|FG000|Overall Study|Adverse Event|0|||
23488017|NCT02305888|65530521|FG001|Overall Study|Adverse Event|1|||
23488018|NCT02305888|65530522|FG002|Overall Study|Adverse Event|0|||
23488019|NCT02966873|65530523|FG000|Overall Study|Lost to Follow-up|16|||
23488020|NCT02966873|65530524|FG001|Overall Study|Lost to Follow-up|15|||
23488021|NCT01282203|65530525|FG000|Overall Study|Adverse Event|1|||
23488022|NCT03238196|65530532|FG000|Overall Study|Adverse Event|3|||
23488023|NCT03238196|65530533|FG001|Overall Study|Adverse Event|0|||
23488024|NCT03238196|65530534|FG002|Overall Study|Adverse Event|2|||
23488025|NCT03238196|65530535|FG003|Overall Study|Adverse Event|2|||
23488026|NCT03238196|65530532|FG000|Overall Study|Withdrawal by Subject|4|||
23488027|NCT03238196|65530533|FG001|Overall Study|Withdrawal by Subject|1|||
23488028|NCT03238196|65530534|FG002|Overall Study|Withdrawal by Subject|1|||
23488029|NCT03238196|65530535|FG003|Overall Study|Withdrawal by Subject|0|||
23488030|NCT03238196|65530532|FG000|Overall Study|Disease progression|14|||
23488031|NCT03238196|65530533|FG001|Overall Study|Disease progression|2|||
23488032|NCT03238196|65530534|FG002|Overall Study|Disease progression|3|||
23488033|NCT03238196|65530535|FG003|Overall Study|Disease progression|2|||
23488034|NCT03238196|65530532|FG000|Overall Study|Still on treatment|1|||
23488035|NCT03238196|65530533|FG001|Overall Study|Still on treatment|0|||
23488036|NCT03238196|65530534|FG002|Overall Study|Still on treatment|0|||
23488037|NCT03238196|65530535|FG003|Overall Study|Still on treatment|0|||
23488038|NCT03384693|65530536|FG000|Overall Study|Adverse Event|3|||
23488039|NCT01400815|65530537|FG000|Overall Study|Adverse Event|3|||
23488040|NCT01400815|65530538|FG001|Overall Study|Adverse Event|0|||
23488041|NCT01400815|65530537|FG000|Overall Study|Death|0|||
23488042|NCT01400815|65530538|FG001|Overall Study|Death|1|||
23488043|NCT01400815|65530537|FG000|Overall Study|Lost to Follow-up|18|||
23488044|NCT01400815|65530538|FG001|Overall Study|Lost to Follow-up|11|||
23488045|NCT01400815|65530537|FG000|Overall Study|Protocol Violation|0|||
23488046|NCT01400815|65530538|FG001|Overall Study|Protocol Violation|1|||
23488047|NCT01400815|65530537|FG000|Overall Study|Physician Decision|1|||
23488048|NCT01400815|65530538|FG001|Overall Study|Physician Decision|0|||
23488049|NCT01400815|65530537|FG000|Overall Study|Withdrawal by Subject|15|||
23488050|NCT01400815|65530538|FG001|Overall Study|Withdrawal by Subject|8|||
23488051|NCT01400815|65530537|FG000|Overall Study|Subject in jail|1|||
23488052|NCT01400815|65530538|FG001|Overall Study|Subject in jail|0|||
23488053|NCT01394718|65530539|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
23488054|NCT01394718|65530540|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
23488055|NCT05274165|65530542|FG000|Overall Study|Withdrawal by Subject|3|||
23488056|NCT05274165|65530543|FG001|Overall Study|Withdrawal by Subject|3|||
23488057|NCT01067976|65530546|FG000|Overall Study|Study drug never administered|20|||
23488058|NCT01067976|65530546|FG000|Overall Study|Study prematurely discontinued|2|||
23488059|NCT01369615|65530558|FG000|Overall Study|Withdrawal by Subject|0|||
23488060|NCT01369615|65530559|FG001|Overall Study|Withdrawal by Subject|1|||
23488061|NCT01369615|65530558|FG000|Overall Study|Lost to Follow-up|0|||
23488062|NCT01369615|65530559|FG001|Overall Study|Lost to Follow-up|1|||
23488063|NCT03799211|65530561|FG000|Overall Study|Lost to Follow-up|2|||
23488064|NCT03799211|65530562|FG001|Overall Study|Lost to Follow-up|13|||
23488065|NCT03799211|65530561|FG000|Overall Study|Withdrawal by Subject|2|||
23488066|NCT03799211|65530562|FG001|Overall Study|Withdrawal by Subject|0|||
23488067|NCT00089284|65530563|FG000|Overall Study|Adverse event before starting treatment|0|||
23488068|NCT00089284|65530564|FG001|Overall Study|Adverse event before starting treatment|0|||
23488069|NCT00089284|65530565|FG002|Overall Study|Adverse event before starting treatment|0|||
23488070|NCT00089284|65530566|FG003|Overall Study|Adverse event before starting treatment|0|||
23488071|NCT00089284|65530567|FG004|Overall Study|Adverse event before starting treatment|0|||
23488072|NCT00089284|65530568|FG005|Overall Study|Adverse event before starting treatment|0|||
23488073|NCT00089284|65530569|FG006|Overall Study|Adverse event before starting treatment|1|||
23488074|NCT05080660|65530570|FG000|Overall Study|Adverse Event|4|||
23488075|NCT05080660|65530571|FG001|Overall Study|Adverse Event|0|||
23488076|NCT05080660|65530570|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
23488077|NCT05080660|65530571|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
23488078|NCT05080660|65530570|FG000|Overall Study|Physician Decision|1|||
23488079|NCT05080660|65530571|FG001|Overall Study|Physician Decision|0|||
23488080|NCT05080660|65530570|FG000|Overall Study|Protocol Deviation|2|||
23488081|NCT05080660|65530571|FG001|Overall Study|Protocol Deviation|0|||
23488082|NCT05080660|65530570|FG000|Overall Study|Withdrawal by Subject|5|||
23488083|NCT05080660|65530571|FG001|Overall Study|Withdrawal by Subject|2|||
23488084|NCT01437878|65530572|FG000|Overall Study|Withdrawal by Subject|1|||
23488085|NCT01437878|65530573|FG001|Overall Study|Withdrawal by Subject|0|||
23488086|NCT01462227|65530574|FG000|Second Assignment|Lost to Follow-up|1|||
23488087|NCT01462227|65530575|FG001|Second Assignment|Lost to Follow-up|0|||
23488088|NCT01462227|65530576|FG002|Second Assignment|Lost to Follow-up|0|||
23488089|NCT01462227|65530577|FG003|Second Assignment|Lost to Follow-up|0|||
23488090|NCT01462227|65530574|FG000|Second Assignment|Protocol Violation|0|||
23488091|NCT01462227|65530575|FG001|Second Assignment|Protocol Violation|1|||
23488092|NCT01462227|65530576|FG002|Second Assignment|Protocol Violation|1|||
23488093|NCT01462227|65530577|FG003|Second Assignment|Protocol Violation|0|||
23488094|NCT03131453|65530580|FG000|Overall Study|Study terminated by Sponsor|424|||
23488095|NCT03131453|65530581|FG001|Overall Study|Study terminated by Sponsor|222|||
23488096|NCT03131453|65530582|FG002|Overall Study|Study terminated by Sponsor|438|||
23488097|NCT03131453|65530580|FG000|Overall Study|Withdrawal by Subject|18|||
23488098|NCT03131453|65530581|FG001|Overall Study|Withdrawal by Subject|7|||
23488099|NCT03131453|65530582|FG002|Overall Study|Withdrawal by Subject|13|||
23488100|NCT03131453|65530580|FG000|Overall Study|Adverse Event|10|||
23488101|NCT03131453|65530581|FG001|Overall Study|Adverse Event|3|||
23488102|NCT03131453|65530582|FG002|Overall Study|Adverse Event|3|||
23488103|NCT03131453|65530580|FG000|Overall Study|Lost to Follow-up|1|||
23488104|NCT03131453|65530581|FG001|Overall Study|Lost to Follow-up|0|||
23488105|NCT03131453|65530582|FG002|Overall Study|Lost to Follow-up|1|||
23488106|NCT03131453|65530580|FG000|Overall Study|Physician Decision|1|||
23488107|NCT03131453|65530581|FG001|Overall Study|Physician Decision|0|||
23488108|NCT03131453|65530582|FG002|Overall Study|Physician Decision|1|||
23488109|NCT03131453|65530580|FG000|Overall Study|Non-compliance with study treatment|1|||
23488110|NCT03131453|65530581|FG001|Overall Study|Non-compliance with study treatment|0|||
23488111|NCT03131453|65530582|FG002|Overall Study|Non-compliance with study treatment|0|||
23488112|NCT03131453|65530580|FG000|Overall Study|Technical problems|1|||
23488113|NCT03131453|65530581|FG001|Overall Study|Technical problems|0|||
23488114|NCT03131453|65530582|FG002|Overall Study|Technical problems|0|||
23488115|NCT03131453|65530580|FG000|Overall Study|Protocol deviation|0|||
23488116|NCT03131453|65530581|FG001|Overall Study|Protocol deviation|1|||
23488117|NCT03131453|65530582|FG002|Overall Study|Protocol deviation|0|||
23488118|NCT03114488|65530585|FG000|Time Period 2|Withdrawal by Subject|1|||
23488119|NCT03114488|65530586|FG001|Time Period 2|Withdrawal by Subject|3|||
23488120|NCT00467610|65533735|FG000|Overall Study|Withdrawal by Subject|1|||
23488121|NCT02149875|65533738|FG000|Overall Study|Lost to Follow-up|3|||
23488122|NCT02149875|65533739|FG001|Overall Study|Lost to Follow-up|4|||
23488123|NCT02149875|65533740|FG002|Overall Study|Lost to Follow-up|5|||
23488124|NCT02149875|65533738|FG000|Overall Study|Withdrawal by Subject|3|||
23488125|NCT02149875|65533739|FG001|Overall Study|Withdrawal by Subject|2|||
23488126|NCT02149875|65533740|FG002|Overall Study|Withdrawal by Subject|2|||
23488127|NCT02149875|65533738|FG000|Overall Study|Physician Decision|1|||
23488128|NCT02149875|65533739|FG001|Overall Study|Physician Decision|2|||
23488129|NCT02149875|65533740|FG002|Overall Study|Physician Decision|2|||
23488130|NCT04223232|65533756|FG000|Overall Study|Withdrawal by Subject|1|||
23488131|NCT00567593|65533757|FG000|Overall Study|Adverse Event|1|||
23488132|NCT00567593|65533757|FG000|Overall Study|Physician Decision|1|||
23488133|NCT02063880|65533760|FG000|Overall Study|Death|21|||
23488134|NCT02063880|65533761|FG001|Overall Study|Death|18|||
23488135|NCT02063880|65533760|FG000|Overall Study|Lost to Follow-up|7|||
23488136|NCT02063880|65533761|FG001|Overall Study|Lost to Follow-up|7|||
23488137|NCT02063880|65533760|FG000|Overall Study|Ineligible|0|||
23488138|NCT02063880|65533761|FG001|Overall Study|Ineligible|2|||
23488139|NCT02806973|65533762|FG000|Period 1|Withdrawal by Subject|0|||
23488140|NCT02806973|65533763|FG001|Period 1|Withdrawal by Subject|2|||
23488141|NCT02806973|65533764|FG002|Period 1|Withdrawal by Subject|1|||
23488142|NCT02806973|65533765|FG003|Period 1|Withdrawal by Subject|1|||
23488143|NCT02806973|65533762|FG000|Period 1|Adverse Event|0|||
23488144|NCT02806973|65533763|FG001|Period 1|Adverse Event|0|||
23488145|NCT02806973|65533764|FG002|Period 1|Adverse Event|0|||
23488146|NCT02806973|65533765|FG003|Period 1|Adverse Event|1|||
23488147|NCT02806973|65533762|FG000|Period 3|Withdrawal by Subject|0|||
23488148|NCT02806973|65533763|FG001|Period 3|Withdrawal by Subject|0|||
23488149|NCT02806973|65533764|FG002|Period 3|Withdrawal by Subject|0|||
23488150|NCT02806973|65533765|FG003|Period 3|Withdrawal by Subject|3|||
23488151|NCT02806973|65533762|FG000|Period 3|Adverse Event|0|||
23488152|NCT02806973|65533763|FG001|Period 3|Adverse Event|0|||
23374355|NCT00490035|65115999|FG001|Overall Study|AE, non-serious non-fatal|4|||
23488153|NCT02806973|65533764|FG002|Period 3|Adverse Event|1|||
23488154|NCT02806973|65533765|FG003|Period 3|Adverse Event|0|||
23603943|NCT01332266|65940229|FG001|Phase 2|Death|0|||
23603944|NCT01332266|65940230|FG002|Phase 2|Death|0|||
23603945|NCT01332266|65940231|FG003|Phase 2|Death|33|||
23603946|NCT01332266|65940232|FG004|Phase 2|Death|36|||
23374356|NCT00490035|65116000|FG002|Overall Study|AE, non-serious non-fatal|4|||
23603947|NCT01332266|65940228|FG000|Phase 2|Lost to Follow-up|0|||
23603948|NCT01332266|65940229|FG001|Phase 2|Lost to Follow-up|0|||
23603949|NCT01332266|65940230|FG002|Phase 2|Lost to Follow-up|0|||
23603950|NCT01332266|65940231|FG003|Phase 2|Lost to Follow-up|2|||
23603951|NCT01332266|65940232|FG004|Phase 2|Lost to Follow-up|0|||
23603952|NCT01332266|65940228|FG000|Phase 2|Physician Decision|0|||
23603953|NCT01332266|65940229|FG001|Phase 2|Physician Decision|0|||
23603954|NCT01332266|65940230|FG002|Phase 2|Physician Decision|0|||
23603955|NCT01332266|65940231|FG003|Phase 2|Physician Decision|3|||
23374357|NCT00490035|65116001|FG003|Overall Study|AE, non-serious non-fatal|5|||
23488155|NCT03179761|65533766|FG000|Overall Study|Death|2|||
23488156|NCT03179761|65533767|FG001|Overall Study|Death|5|||
23488157|NCT03179761|65533766|FG000|Overall Study|Lost to Follow-up|2|||
23488158|NCT03179761|65533767|FG001|Overall Study|Lost to Follow-up|2|||
23488159|NCT03179761|65533766|FG000|Overall Study|Protocol Violation|1|||
23488160|NCT03179761|65533767|FG001|Overall Study|Protocol Violation|0|||
23488161|NCT03179761|65533766|FG000|Overall Study|Withdrawal by Subject|1|||
23488162|NCT03179761|65533767|FG001|Overall Study|Withdrawal by Subject|4|||
23603956|NCT01332266|65940232|FG004|Phase 2|Physician Decision|1|||
23603957|NCT01332266|65940228|FG000|Phase 2|Symptomatic deterioration|0|||
23603958|NCT01332266|65940229|FG001|Phase 2|Symptomatic deterioration|0|||
23603959|NCT01332266|65940230|FG002|Phase 2|Symptomatic deterioration|0|||
23374358|NCT00490035|65115998|FG000|Overall Study|Lost to Follow-up|2|||
23374359|NCT00490035|65115999|FG001|Overall Study|Lost to Follow-up|0|||
23374360|NCT00490035|65116000|FG002|Overall Study|Lost to Follow-up|1|||
23374361|NCT00490035|65116001|FG003|Overall Study|Lost to Follow-up|0|||
23374362|NCT00490035|65115998|FG000|Overall Study|Withdrawal by Subject|2|||
23374363|NCT00490035|65115999|FG001|Overall Study|Withdrawal by Subject|1|||
23374364|NCT00490035|65116000|FG002|Overall Study|Withdrawal by Subject|1|||
23374365|NCT00490035|65116001|FG003|Overall Study|Withdrawal by Subject|0|||
23374366|NCT00490035|65115998|FG000|Overall Study|Other reason|0|||
23374367|NCT00490035|65115999|FG001|Overall Study|Other reason|1|||
23374368|NCT00490035|65116000|FG002|Overall Study|Other reason|3|||
23374369|NCT00490035|65116001|FG003|Overall Study|Other reason|1|||
23374370|NCT00490035|65115998|FG000|Overall Study|AE, serious fatal|1|||
23374371|NCT00490035|65115999|FG001|Overall Study|AE, serious fatal|0|||
23374372|NCT00490035|65116000|FG002|Overall Study|AE, serious fatal|0|||
23374373|NCT00490035|65116001|FG003|Overall Study|AE, serious fatal|0|||
23374374|NCT00490035|65115998|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374375|NCT00490035|65115999|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374376|NCT00490035|65116000|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
23374377|NCT00490035|65116001|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374378|NCT00490035|65115998|FG000|Overall Study|AE of unknown type|0|||
23374379|NCT00490035|65115999|FG001|Overall Study|AE of unknown type|0|||
23374380|NCT00490035|65116000|FG002|Overall Study|AE of unknown type|2|||
23374381|NCT00490035|65116001|FG003|Overall Study|AE of unknown type|0|||
23374382|NCT00375752|65116002|FG000|Overall Study|Lack of Efficacy|4|||
23374383|NCT00375752|65116003|FG001|Overall Study|Lack of Efficacy|4|||
23374384|NCT00375752|65116002|FG000|Overall Study|Adverse Event|1|||
23374385|NCT00375752|65116003|FG001|Overall Study|Adverse Event|6|||
23374386|NCT00375752|65116002|FG000|Overall Study|Withdrawal by Subject|6|||
23374387|NCT00375752|65116003|FG001|Overall Study|Withdrawal by Subject|1|||
23374388|NCT00375752|65116002|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23374389|NCT00375752|65116003|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23374390|NCT00375752|65116002|FG000|Overall Study|Protocol Violation|0|||
23374391|NCT00375752|65116003|FG001|Overall Study|Protocol Violation|2|||
23374392|NCT00375752|65116002|FG000|Overall Study|Administrative Problems|0|||
23374393|NCT00375752|65116003|FG001|Overall Study|Administrative Problems|1|||
23603960|NCT01332266|65940231|FG003|Phase 2|Symptomatic deterioration|0|||
23603961|NCT01332266|65940232|FG004|Phase 2|Symptomatic deterioration|1|||
23603962|NCT01332266|65940228|FG000|Phase 2|Progression Disease|0|||
23603963|NCT01332266|65940229|FG001|Phase 2|Progression Disease|0|||
23603964|NCT01332266|65940230|FG002|Phase 2|Progression Disease|0|||
23664592|NCT03357731|66158523|FG002|Overall Study|Acute bradycardia and hypotension|0|||
23664593|NCT03357731|66158524|FG003|Overall Study|Acute bradycardia and hypotension|1|||
23664594|NCT03357731|66158525|FG004|Overall Study|Acute bradycardia and hypotension|0|||
23664595|NCT03357731|66158526|FG005|Overall Study|Acute bradycardia and hypotension|0|||
23664596|NCT03357731|66158521|FG000|Overall Study|Adverse Event|0|||
23664597|NCT03357731|66158522|FG001|Overall Study|Adverse Event|0|||
23603965|NCT01332266|65940231|FG003|Phase 2|Progression Disease|2|||
23603966|NCT01332266|65940232|FG004|Phase 2|Progression Disease|1|||
23603967|NCT01332266|65940228|FG000|Phase 2|Withdrawal by Subject|0|||
23603968|NCT01332266|65940229|FG001|Phase 2|Withdrawal by Subject|0|||
23603969|NCT01332266|65940230|FG002|Phase 2|Withdrawal by Subject|0|||
23603970|NCT01332266|65940231|FG003|Phase 2|Withdrawal by Subject|2|||
23374394|NCT03839641|65116010|FG000|Overall Study|Withdrawal by Subject|1|||
23374395|NCT03839641|65116011|FG001|Overall Study|Withdrawal by Subject|1|||
23374396|NCT00424008|65116012|FG000|Overall Study|Adverse Event|8|||
23374397|NCT00424008|65116013|FG001|Overall Study|Adverse Event|6|||
23374398|NCT00424008|65116012|FG000|Overall Study|Lack of Efficacy|40|||
23374399|NCT00424008|65116013|FG001|Overall Study|Lack of Efficacy|34|||
23374400|NCT00424008|65116012|FG000|Overall Study|Lost to Follow-up|1|||
23374401|NCT00424008|65116013|FG001|Overall Study|Lost to Follow-up|2|||
23374402|NCT00424008|65116012|FG000|Overall Study|Withdrawal by Subject|5|||
23603971|NCT01332266|65940232|FG004|Phase 2|Withdrawal by Subject|2|||
23603972|NCT04248868|65940235|FG000|Overall Study|Death|1|||
23664598|NCT03357731|66158523|FG002|Overall Study|Adverse Event|0|||
23664599|NCT03357731|66158524|FG003|Overall Study|Adverse Event|0|||
23664600|NCT03357731|66158525|FG004|Overall Study|Adverse Event|0|||
23664601|NCT03357731|66158526|FG005|Overall Study|Adverse Event|1|||
23664602|NCT03357731|66158521|FG000|Overall Study|Hypotension|0|||
23374403|NCT00424008|65116013|FG001|Overall Study|Withdrawal by Subject|8|||
23374404|NCT00424008|65116012|FG000|Overall Study|Noncompliance with protocol|13|||
23374405|NCT00424008|65116013|FG001|Overall Study|Noncompliance with protocol|7|||
23374406|NCT00424008|65116012|FG000|Overall Study|Did not meet protocol eligibility|16|||
23664603|NCT03357731|66158522|FG001|Overall Study|Hypotension|0|||
23664604|NCT03357731|66158523|FG002|Overall Study|Hypotension|1|||
23664605|NCT03357731|66158524|FG003|Overall Study|Hypotension|1|||
23664606|NCT03357731|66158525|FG004|Overall Study|Hypotension|0|||
23374407|NCT00424008|65116013|FG001|Overall Study|Did not meet protocol eligibility|21|||
23664607|NCT03357731|66158526|FG005|Overall Study|Hypotension|0|||
23374408|NCT00424008|65116012|FG000|Overall Study|Administrative|266|||
23374409|NCT00424008|65116013|FG001|Overall Study|Administrative|257|||
23374410|NCT01294514|65116014|FG000|Overall Study|Excluded due to Arrhythmia|1|||
23374411|NCT01218308|65116015|FG000|Overall Study|Adverse Event|1|||
23374412|NCT01218308|65116016|FG001|Overall Study|Adverse Event|2|||
23374413|NCT01218308|65116015|FG000|Overall Study|Protocol Violation|0|||
23374414|NCT01218308|65116016|FG001|Overall Study|Protocol Violation|2|||
23374415|NCT01218308|65116015|FG000|Overall Study|Withdrawal by Subject|61|||
23374416|NCT01218308|65116016|FG001|Overall Study|Withdrawal by Subject|64|||
23374417|NCT01218308|65116015|FG000|Overall Study|Lost to Follow-up|27|||
23374418|NCT01218308|65116016|FG001|Overall Study|Lost to Follow-up|31|||
23374419|NCT01218308|65116015|FG000|Overall Study|Other|14|||
23374420|NCT01218308|65116016|FG001|Overall Study|Other|21|||
23374421|NCT02017717|65116020|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374422|NCT02017717|65116021|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374423|NCT02017717|65116022|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374424|NCT02017717|65116023|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
23374425|NCT02017717|65116024|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374426|NCT02017717|65116025|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374427|NCT02017717|65116026|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374428|NCT02017717|65116027|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374429|NCT02017717|65116028|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374430|NCT02017717|65116020|FG000|Before Treatment Period|Participant request to stop therapy|0|||
23374431|NCT02017717|65116021|FG001|Before Treatment Period|Participant request to stop therapy|0|||
23374432|NCT02017717|65116022|FG002|Before Treatment Period|Participant request to stop therapy|0|||
23374433|NCT02017717|65116023|FG003|Before Treatment Period|Participant request to stop therapy|0|||
23664608|NCT03357731|66158521|FG000|Overall Study|Lost to Follow-up|0|||
23374434|NCT02017717|65116024|FG004|Before Treatment Period|Participant request to stop therapy|5|||
23374435|NCT02017717|65116025|FG005|Before Treatment Period|Participant request to stop therapy|0|||
23374436|NCT02017717|65116026|FG006|Before Treatment Period|Participant request to stop therapy|0|||
23374437|NCT02017717|65116027|FG007|Before Treatment Period|Participant request to stop therapy|0|||
23374438|NCT02017717|65116028|FG008|Before Treatment Period|Participant request to stop therapy|0|||
23374439|NCT02017717|65116020|FG000|Before Treatment Period|Participant withdrew consent|0|||
23488163|NCT03179761|65533766|FG000|Overall Study|Investigator Request|0|||
23488164|NCT03179761|65533767|FG001|Overall Study|Investigator Request|2|||
23488165|NCT01147172|65533768|FG000|Overall Study|Withdrawal by Subject|2|||
23488166|NCT01147172|65533768|FG000|Overall Study|Lost to Follow-up|2|||
23488167|NCT03698331|65533769|FG000|Overall Study|Adverse Event|2|||
23488168|NCT03698331|65533770|FG001|Overall Study|Adverse Event|3|||
23488169|NCT03698331|65533769|FG000|Overall Study|Withdrawal by Subject|1|||
23488170|NCT03698331|65533770|FG001|Overall Study|Withdrawal by Subject|1|||
23488171|NCT03698331|65533769|FG000|Overall Study|Lost to Follow-up|0|||
23488172|NCT03698331|65533770|FG001|Overall Study|Lost to Follow-up|2|||
23488173|NCT03698331|65533769|FG000|Overall Study|Non-compliance with study drug|1|||
23664609|NCT03357731|66158522|FG001|Overall Study|Lost to Follow-up|0|||
23664610|NCT03357731|66158523|FG002|Overall Study|Lost to Follow-up|0|||
23664611|NCT03357731|66158524|FG003|Overall Study|Lost to Follow-up|1|||
23664612|NCT03357731|66158525|FG004|Overall Study|Lost to Follow-up|0|||
23664613|NCT03357731|66158526|FG005|Overall Study|Lost to Follow-up|0|||
23374440|NCT02017717|65116021|FG001|Before Treatment Period|Participant withdrew consent|0|||
23374441|NCT02017717|65116022|FG002|Before Treatment Period|Participant withdrew consent|0|||
23374442|NCT02017717|65116023|FG003|Before Treatment Period|Participant withdrew consent|0|||
23374443|NCT02017717|65116024|FG004|Before Treatment Period|Participant withdrew consent|11|||
23374444|NCT02017717|65116025|FG005|Before Treatment Period|Participant withdrew consent|0|||
23488174|NCT03698331|65533770|FG001|Overall Study|Non-compliance with study drug|0|||
23488175|NCT01614600|65533771|FG000|Overall Study|Unacceptable fit|1|||
23603973|NCT04248868|65940235|FG000|Overall Study|Lost to Follow-up|3|||
23664614|NCT01357655|66158529|FG000|Overall Study|Administrative Reason by Sponsor|45|||
23374445|NCT02017717|65116026|FG006|Before Treatment Period|Participant withdrew consent|0|||
23374446|NCT02017717|65116027|FG007|Before Treatment Period|Participant withdrew consent|0|||
23374447|NCT02017717|65116028|FG008|Before Treatment Period|Participant withdrew consent|2|||
23374448|NCT02017717|65116020|FG000|Before Treatment Period|Lost to Follow-up|0|||
23374449|NCT02017717|65116021|FG001|Before Treatment Period|Lost to Follow-up|0|||
23374450|NCT02017717|65116022|FG002|Before Treatment Period|Lost to Follow-up|0|||
23374451|NCT02017717|65116023|FG003|Before Treatment Period|Lost to Follow-up|0|||
23374452|NCT02017717|65116024|FG004|Before Treatment Period|Lost to Follow-up|1|||
23374453|NCT02017717|65116025|FG005|Before Treatment Period|Lost to Follow-up|0|||
23374454|NCT02017717|65116026|FG006|Before Treatment Period|Lost to Follow-up|0|||
23374455|NCT02017717|65116027|FG007|Before Treatment Period|Lost to Follow-up|0|||
23374456|NCT02017717|65116028|FG008|Before Treatment Period|Lost to Follow-up|0|||
23374457|NCT02017717|65116020|FG000|Before Treatment Period|Participant no longer met criteria|0|||
23374458|NCT02017717|65116021|FG001|Before Treatment Period|Participant no longer met criteria|0|||
23374459|NCT02017717|65116022|FG002|Before Treatment Period|Participant no longer met criteria|0|||
23374460|NCT02017717|65116023|FG003|Before Treatment Period|Participant no longer met criteria|1|||
23374461|NCT02017717|65116024|FG004|Before Treatment Period|Participant no longer met criteria|2|||
23374462|NCT02017717|65116025|FG005|Before Treatment Period|Participant no longer met criteria|0|||
23374463|NCT02017717|65116026|FG006|Before Treatment Period|Participant no longer met criteria|0|||
23374464|NCT02017717|65116027|FG007|Before Treatment Period|Participant no longer met criteria|1|||
23374465|NCT02017717|65116028|FG008|Before Treatment Period|Participant no longer met criteria|0|||
23374466|NCT02017717|65116020|FG000|Before Treatment Period|other reason|0|||
23374467|NCT02017717|65116021|FG001|Before Treatment Period|other reason|0|||
23374468|NCT02017717|65116022|FG002|Before Treatment Period|other reason|0|||
23374469|NCT02017717|65116023|FG003|Before Treatment Period|other reason|0|||
23374470|NCT02017717|65116024|FG004|Before Treatment Period|other reason|1|||
23374471|NCT02017717|65116025|FG005|Before Treatment Period|other reason|0|||
23374472|NCT02017717|65116026|FG006|Before Treatment Period|other reason|0|||
23374473|NCT02017717|65116027|FG007|Before Treatment Period|other reason|0|||
23374474|NCT02017717|65116028|FG008|Before Treatment Period|other reason|0|||
23374475|NCT02017717|65116020|FG000|Treatment Period|Disease progression|7|||
23374476|NCT02017717|65116021|FG001|Treatment Period|Disease progression|9|||
23374477|NCT02017717|65116022|FG002|Treatment Period|Disease progression|12|||
23374478|NCT02017717|65116023|FG003|Treatment Period|Disease progression|165|||
23374479|NCT02017717|65116024|FG004|Treatment Period|Disease progression|134|||
23374480|NCT02017717|65116025|FG005|Treatment Period|Disease progression|20|||
23374481|NCT02017717|65116026|FG006|Treatment Period|Disease progression|26|||
23374482|NCT02017717|65116027|FG007|Treatment Period|Disease progression|17|||
23374483|NCT02017717|65116028|FG008|Treatment Period|Disease progression|22|||
23374484|NCT02017717|65116020|FG000|Treatment Period|Study drug toxicity|3|||
23374485|NCT02017717|65116021|FG001|Treatment Period|Study drug toxicity|0|||
23374486|NCT02017717|65116022|FG002|Treatment Period|Study drug toxicity|1|||
23374487|NCT02017717|65116023|FG003|Treatment Period|Study drug toxicity|7|||
23374488|NCT02017717|65116024|FG004|Treatment Period|Study drug toxicity|11|||
23374489|NCT02017717|65116025|FG005|Treatment Period|Study drug toxicity|4|||
23374490|NCT02017717|65116026|FG006|Treatment Period|Study drug toxicity|4|||
23374491|NCT02017717|65116027|FG007|Treatment Period|Study drug toxicity|5|||
23374492|NCT02017717|65116028|FG008|Treatment Period|Study drug toxicity|3|||
23374493|NCT02017717|65116020|FG000|Treatment Period|Death|0|||
23374494|NCT02017717|65116021|FG001|Treatment Period|Death|0|||
23374495|NCT02017717|65116022|FG002|Treatment Period|Death|1|||
23374496|NCT02017717|65116023|FG003|Treatment Period|Death|0|||
23374497|NCT02017717|65116024|FG004|Treatment Period|Death|0|||
23374498|NCT02017717|65116025|FG005|Treatment Period|Death|0|||
23374499|NCT02017717|65116026|FG006|Treatment Period|Death|0|||
23374500|NCT02017717|65116027|FG007|Treatment Period|Death|1|||
23374501|NCT02017717|65116028|FG008|Treatment Period|Death|0|||
23374502|NCT02017717|65116020|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
23374503|NCT02017717|65116021|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
23374504|NCT02017717|65116022|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
23374505|NCT02017717|65116023|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
23374506|NCT02017717|65116024|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
23664615|NCT01357655|66158530|FG001|Overall Study|Administrative Reason by Sponsor|0|||
23374507|NCT02017717|65116025|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
23374508|NCT02017717|65116026|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
23374509|NCT02017717|65116027|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
23374510|NCT02017717|65116028|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
23374511|NCT02017717|65116020|FG000|Treatment Period|Participant request to stop therapy|0|||
23374512|NCT02017717|65116021|FG001|Treatment Period|Participant request to stop therapy|0|||
23374513|NCT02017717|65116022|FG002|Treatment Period|Participant request to stop therapy|3|||
23374514|NCT02017717|65116023|FG003|Treatment Period|Participant request to stop therapy|4|||
23603974|NCT04248868|65940235|FG000|Overall Study|Protocol Violation|2|||
23374515|NCT02017717|65116024|FG004|Treatment Period|Participant request to stop therapy|7|||
23374516|NCT02017717|65116025|FG005|Treatment Period|Participant request to stop therapy|5|||
23374517|NCT02017717|65116026|FG006|Treatment Period|Participant request to stop therapy|0|||
23374518|NCT02017717|65116027|FG007|Treatment Period|Participant request to stop therapy|2|||
23374519|NCT02017717|65116028|FG008|Treatment Period|Participant request to stop therapy|1|||
23374520|NCT02017717|65116020|FG000|Treatment Period|Participant withdrew consent|0|||
23374521|NCT02017717|65116021|FG001|Treatment Period|Participant withdrew consent|0|||
23374522|NCT02017717|65116022|FG002|Treatment Period|Participant withdrew consent|1|||
23374523|NCT02017717|65116023|FG003|Treatment Period|Participant withdrew consent|1|||
23374524|NCT02017717|65116024|FG004|Treatment Period|Participant withdrew consent|4|||
23374525|NCT02017717|65116025|FG005|Treatment Period|Participant withdrew consent|0|||
23374526|NCT02017717|65116026|FG006|Treatment Period|Participant withdrew consent|0|||
23488176|NCT01614600|65533771|FG000|Overall Study|Discomfort|1|||
23374527|NCT02017717|65116027|FG007|Treatment Period|Participant withdrew consent|2|||
23374528|NCT02017717|65116028|FG008|Treatment Period|Participant withdrew consent|0|||
23374529|NCT02017717|65116020|FG000|Treatment Period|Participant no longer met criteria|0|||
23374530|NCT02017717|65116021|FG001|Treatment Period|Participant no longer met criteria|0|||
23374531|NCT02017717|65116022|FG002|Treatment Period|Participant no longer met criteria|0|||
23374532|NCT02017717|65116023|FG003|Treatment Period|Participant no longer met criteria|0|||
23374533|NCT02017717|65116024|FG004|Treatment Period|Participant no longer met criteria|1|||
23374534|NCT02017717|65116025|FG005|Treatment Period|Participant no longer met criteria|0|||
23374535|NCT02017717|65116026|FG006|Treatment Period|Participant no longer met criteria|0|||
23374536|NCT02017717|65116027|FG007|Treatment Period|Participant no longer met criteria|0|||
23374537|NCT02017717|65116028|FG008|Treatment Period|Participant no longer met criteria|0|||
23374538|NCT02017717|65116020|FG000|Treatment Period|other reasons|0|||
23374539|NCT02017717|65116021|FG001|Treatment Period|other reasons|0|||
23374540|NCT02017717|65116022|FG002|Treatment Period|other reasons|0|||
23374541|NCT02017717|65116023|FG003|Treatment Period|other reasons|0|||
23374542|NCT02017717|65116024|FG004|Treatment Period|other reasons|1|||
23374543|NCT02017717|65116025|FG005|Treatment Period|other reasons|0|||
23374544|NCT02017717|65116026|FG006|Treatment Period|other reasons|0|||
23374545|NCT02017717|65116027|FG007|Treatment Period|other reasons|1|||
23374546|NCT02017717|65116028|FG008|Treatment Period|other reasons|1|||
23374547|NCT02017717|65116020|FG000|Treatment Period|Maximum clinical benefit|0|||
23374548|NCT02017717|65116021|FG001|Treatment Period|Maximum clinical benefit|0|||
23374549|NCT02017717|65116022|FG002|Treatment Period|Maximum clinical benefit|0|||
23374550|NCT02017717|65116023|FG003|Treatment Period|Maximum clinical benefit|0|||
23374551|NCT02017717|65116024|FG004|Treatment Period|Maximum clinical benefit|1|||
23374552|NCT02017717|65116025|FG005|Treatment Period|Maximum clinical benefit|0|||
23374553|NCT02017717|65116026|FG006|Treatment Period|Maximum clinical benefit|0|||
23374554|NCT02017717|65116027|FG007|Treatment Period|Maximum clinical benefit|0|||
23374555|NCT02017717|65116028|FG008|Treatment Period|Maximum clinical benefit|0|||
23374556|NCT00715208|65116029|FG000|Overall Study|Withdrawal by Subject|1|||
23374557|NCT00715208|65116030|FG001|Overall Study|Withdrawal by Subject|1|||
23374558|NCT00715208|65116029|FG000|Overall Study|Adverse Event|0|||
23374559|NCT00715208|65116030|FG001|Overall Study|Adverse Event|6|||
23374560|NCT00715208|65116029|FG000|Overall Study|Lack of Efficacy|0|||
23374561|NCT00715208|65116030|FG001|Overall Study|Lack of Efficacy|2|||
23374562|NCT00251758|65116033|FG000|Overall Study|Adverse Event|7|||
23374563|NCT00251758|65116034|FG001|Overall Study|Adverse Event|9|||
23374564|NCT00251758|65116035|FG002|Overall Study|Adverse Event|11|||
23374565|NCT00251758|65116033|FG000|Overall Study|Lost to Follow-up|4|||
23374566|NCT00251758|65116034|FG001|Overall Study|Lost to Follow-up|2|||
23374567|NCT00251758|65116035|FG002|Overall Study|Lost to Follow-up|5|||
23374568|NCT00251758|65116033|FG000|Overall Study|Withdrawal by Subject|13|||
23374569|NCT00251758|65116034|FG001|Overall Study|Withdrawal by Subject|7|||
23374570|NCT00251758|65116035|FG002|Overall Study|Withdrawal by Subject|3|||
23374571|NCT00251758|65116033|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23374572|NCT00251758|65116034|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
23374573|NCT00251758|65116035|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23374574|NCT00251758|65116033|FG000|Overall Study|Lack of Efficacy|3|||
23374575|NCT00251758|65116034|FG001|Overall Study|Lack of Efficacy|0|||
23374576|NCT00251758|65116035|FG002|Overall Study|Lack of Efficacy|0|||
23374577|NCT00251758|65116033|FG000|Overall Study|Noncompliant|0|||
23374578|NCT00251758|65116034|FG001|Overall Study|Noncompliant|2|||
23374579|NCT00251758|65116035|FG002|Overall Study|Noncompliant|2|||
23374580|NCT00251758|65116033|FG000|Overall Study|Pregnancy|0|||
23374581|NCT00251758|65116034|FG001|Overall Study|Pregnancy|1|||
23374582|NCT00251758|65116035|FG002|Overall Study|Pregnancy|0|||
23374583|NCT00251758|65116033|FG000|Overall Study|Per Subject Request|0|||
23374584|NCT00251758|65116034|FG001|Overall Study|Per Subject Request|0|||
23374585|NCT00251758|65116035|FG002|Overall Study|Per Subject Request|1|||
23374586|NCT00251758|65116033|FG000|Overall Study|Per Investigator Request|1|||
23374587|NCT00251758|65116034|FG001|Overall Study|Per Investigator Request|0|||
23374588|NCT00251758|65116035|FG002|Overall Study|Per Investigator Request|0|||
23374589|NCT00797563|65116036|FG000|Overall Study|Adverse Event|1|||
23374590|NCT01184872|65116037|FG000|Overall Study|Adverse Event|3|||
23374591|NCT01184872|65116038|FG001|Overall Study|Adverse Event|4|||
23374592|NCT01184872|65116037|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23374593|NCT01184872|65116038|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23374594|NCT01184872|65116037|FG000|Overall Study|Withdrawal by Subject|2|||
23374595|NCT01184872|65116038|FG001|Overall Study|Withdrawal by Subject|0|||
23374596|NCT01184872|65116037|FG000|Overall Study|Lost to Follow-up|0|||
23374597|NCT01184872|65116038|FG001|Overall Study|Lost to Follow-up|1|||
23374598|NCT01184872|65116037|FG000|Overall Study|Administrative problems|1|||
23374599|NCT01184872|65116038|FG001|Overall Study|Administrative problems|1|||
23374600|NCT01184872|65116037|FG000|Overall Study|Protocol deviation|1|||
23374601|NCT01184872|65116038|FG001|Overall Study|Protocol deviation|0|||
23374602|NCT00855218|65116040|FG000|Overall Study|Adverse Event|43|||
23374603|NCT00855218|65116041|FG001|Overall Study|Adverse Event|27|||
23374604|NCT00855218|65116040|FG000|Overall Study|Withdrawal by Subject|10|||
23374605|NCT00855218|65116041|FG001|Overall Study|Withdrawal by Subject|6|||
23374606|NCT00855218|65116040|FG000|Overall Study|Physician Decision|18|||
23374607|NCT00855218|65116041|FG001|Overall Study|Physician Decision|11|||
23374608|NCT00855218|65116040|FG000|Overall Study|Lost to Follow-up|0|||
23374609|NCT00855218|65116041|FG001|Overall Study|Lost to Follow-up|1|||
23374610|NCT00855218|65116040|FG000|Overall Study|Protocol Violation|5|||
23374611|NCT00855218|65116041|FG001|Overall Study|Protocol Violation|9|||
23374612|NCT00855218|65116040|FG000|Overall Study|non-compliant with study drug|3|||
23374613|NCT00855218|65116041|FG001|Overall Study|non-compliant with study drug|1|||
23374614|NCT00855218|65116040|FG000|Overall Study|patient convenience|2|||
23374615|NCT00855218|65116041|FG001|Overall Study|patient convenience|0|||
23374616|NCT00855218|65116040|FG000|Overall Study|technical problems|2|||
23374617|NCT00855218|65116041|FG001|Overall Study|technical problems|1|||
23374618|NCT00855218|65116040|FG000|Overall Study|Still treated with study medication|0|||
23374619|NCT00855218|65116041|FG001|Overall Study|Still treated with study medication|1|||
23374620|NCT00855218|65116040|FG000|Overall Study|Untreatable disease progression|54|||
23374621|NCT00855218|65116041|FG001|Overall Study|Untreatable disease progression|67|||
23374622|NCT00855218|65116040|FG000|Overall Study|Second malignancy|0|||
23374623|NCT00855218|65116041|FG001|Overall Study|Second malignancy|1|||
23374624|NCT00855218|65116040|FG000|Overall Study|Progression measurement proven|7|||
23374625|NCT00855218|65116041|FG001|Overall Study|Progression measurement proven|15|||
23374626|NCT00855218|65116040|FG000|Overall Study|Clinical endpoint reached|10|||
23374627|NCT00855218|65116041|FG001|Overall Study|Clinical endpoint reached|13|||
23374628|NCT00903968|65116042|FG000|Overall Study|Adverse Event|0|||
23374629|NCT00903968|65116043|FG001|Overall Study|Adverse Event|0|||
23374630|NCT00903968|65116044|FG002|Overall Study|Adverse Event|0|||
23374631|NCT00903968|65116045|FG003|Overall Study|Adverse Event|0|||
23374632|NCT00903968|65116046|FG004|Overall Study|Adverse Event|0|||
23374633|NCT00903968|65116047|FG005|Overall Study|Adverse Event|0|||
23374634|NCT00903968|65116048|FG006|Overall Study|Adverse Event|1|||
23374635|NCT00903968|65116049|FG007|Overall Study|Adverse Event|8|||
23374636|NCT00903968|65116042|FG000|Overall Study|DLT|0|||
23374637|NCT00903968|65116043|FG001|Overall Study|DLT|0|||
23374638|NCT00903968|65116044|FG002|Overall Study|DLT|0|||
23374639|NCT00903968|65116045|FG003|Overall Study|DLT|0|||
23374640|NCT00903968|65116046|FG004|Overall Study|DLT|0|||
23374641|NCT00903968|65116047|FG005|Overall Study|DLT|0|||
23374642|NCT00903968|65116048|FG006|Overall Study|DLT|2|||
23374643|NCT00903968|65116049|FG007|Overall Study|DLT|0|||
23374644|NCT00903968|65116042|FG000|Overall Study|Withdrawal by Subject|1|||
23374645|NCT00903968|65116043|FG001|Overall Study|Withdrawal by Subject|0|||
23374646|NCT00903968|65116044|FG002|Overall Study|Withdrawal by Subject|1|||
23374647|NCT00903968|65116045|FG003|Overall Study|Withdrawal by Subject|0|||
23374648|NCT00903968|65116046|FG004|Overall Study|Withdrawal by Subject|1|||
23374649|NCT00903968|65116047|FG005|Overall Study|Withdrawal by Subject|1|||
23374650|NCT00903968|65116048|FG006|Overall Study|Withdrawal by Subject|0|||
23374651|NCT00903968|65116049|FG007|Overall Study|Withdrawal by Subject|4|||
23374652|NCT00903968|65116042|FG000|Overall Study|Non-Compliance|0|||
23374653|NCT00903968|65116043|FG001|Overall Study|Non-Compliance|0|||
23374654|NCT00903968|65116044|FG002|Overall Study|Non-Compliance|0|||
23374655|NCT00903968|65116045|FG003|Overall Study|Non-Compliance|0|||
23374656|NCT00903968|65116046|FG004|Overall Study|Non-Compliance|0|||
23374657|NCT00903968|65116047|FG005|Overall Study|Non-Compliance|1|||
23374658|NCT00903968|65116048|FG006|Overall Study|Non-Compliance|0|||
23374659|NCT00903968|65116049|FG007|Overall Study|Non-Compliance|0|||
23374660|NCT00903968|65116042|FG000|Overall Study|Physician Decision|0|||
23374661|NCT00903968|65116043|FG001|Overall Study|Physician Decision|0|||
23374662|NCT00903968|65116044|FG002|Overall Study|Physician Decision|0|||
23374663|NCT00903968|65116045|FG003|Overall Study|Physician Decision|0|||
23374664|NCT00903968|65116046|FG004|Overall Study|Physician Decision|0|||
23374665|NCT00903968|65116047|FG005|Overall Study|Physician Decision|1|||
23374666|NCT00903968|65116048|FG006|Overall Study|Physician Decision|0|||
23374667|NCT00903968|65116049|FG007|Overall Study|Physician Decision|0|||
23374668|NCT00903968|65116042|FG000|Overall Study|Progressive Disease|2|||
23374669|NCT00903968|65116043|FG001|Overall Study|Progressive Disease|3|||
23374670|NCT00903968|65116044|FG002|Overall Study|Progressive Disease|2|||
23374671|NCT00903968|65116045|FG003|Overall Study|Progressive Disease|3|||
23374672|NCT00903968|65116046|FG004|Overall Study|Progressive Disease|3|||
23374673|NCT00903968|65116047|FG005|Overall Study|Progressive Disease|3|||
23374674|NCT00903968|65116048|FG006|Overall Study|Progressive Disease|0|||
23374675|NCT00903968|65116049|FG007|Overall Study|Progressive Disease|18|||
23374676|NCT00903968|65116042|FG000|Overall Study|Lack of Efficacy|0|||
23374677|NCT00903968|65116043|FG001|Overall Study|Lack of Efficacy|0|||
23374678|NCT00903968|65116044|FG002|Overall Study|Lack of Efficacy|0|||
23374679|NCT00903968|65116045|FG003|Overall Study|Lack of Efficacy|0|||
23374680|NCT00903968|65116046|FG004|Overall Study|Lack of Efficacy|0|||
23374681|NCT00903968|65116047|FG005|Overall Study|Lack of Efficacy|0|||
23374682|NCT00903968|65116048|FG006|Overall Study|Lack of Efficacy|0|||
23374683|NCT00903968|65116049|FG007|Overall Study|Lack of Efficacy|3|||
23374684|NCT01316614|65116052|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
23374685|NCT01316614|65116052|FG000|Overall Study|Cytology slides not available for review|4|||
23374686|NCT01316614|65116052|FG000|Overall Study|Cystic lesion|5|||
23374687|NCT01316614|65116052|FG000|Overall Study|Inadequate number of passes|2|||
23374688|NCT01316614|65116052|FG000|Overall Study|Medically unstable|1|||
23374689|NCT02990000|65116053|FG000|Overall Study|Failed to provide data beyond baseline|36|||
23374690|NCT02990000|65116054|FG001|Overall Study|Failed to provide data beyond baseline|34|||
23374691|NCT02014272|65116057|FG000|Intervention Period 1|Withdrawal by Subject|1|||
23374692|NCT02014272|65116058|FG001|Intervention Period 1|Withdrawal by Subject|0|||
23374693|NCT02014272|65116057|FG000|Intervention Period 1|Adverse Event|0|||
23374694|NCT02014272|65116058|FG001|Intervention Period 1|Adverse Event|1|||
23374695|NCT03883386|65116062|FG000|First Assignment|Lost to Follow-up|1|||
23374696|NCT03883386|65116063|FG001|First Assignment|Lost to Follow-up|0|||
23374697|NCT03883386|65116062|FG000|First Assignment|Withdrawal by Subject|1|||
23374698|NCT03883386|65116063|FG001|First Assignment|Withdrawal by Subject|1|||
23374699|NCT04745351|65116064|FG000|Overall Study|Death|51|||
23374700|NCT04745351|65116065|FG001|Overall Study|Death|25|||
23374701|NCT04745351|65116064|FG000|Overall Study|Lost to Follow-up|9|||
23374702|NCT04745351|65116065|FG001|Overall Study|Lost to Follow-up|3|||
23374703|NCT04745351|65116064|FG000|Overall Study|Randomized but Never Treated|3|||
23374704|NCT04745351|65116065|FG001|Overall Study|Randomized but Never Treated|3|||
23374705|NCT04745351|65116064|FG000|Overall Study|Adverse Event|4|||
23374706|NCT04745351|65116065|FG001|Overall Study|Adverse Event|0|||
23374707|NCT04745351|65116064|FG000|Overall Study|Withdrew Consent|1|||
23374708|NCT04745351|65116065|FG001|Overall Study|Withdrew Consent|2|||
23374709|NCT04745351|65116064|FG000|Overall Study|Investigator's Discretion|2|||
23374710|NCT04745351|65116065|FG001|Overall Study|Investigator's Discretion|0|||
23374711|NCT04745351|65116064|FG000|Overall Study|Protocol Violation|1|||
23374712|NCT04745351|65116065|FG001|Overall Study|Protocol Violation|0|||
23374713|NCT02391337|65116066|FG000|6 Months Follow-up|Death|5|||
23374714|NCT02391337|65116067|FG001|6 Months Follow-up|Death|4|||
23374715|NCT02391337|65116066|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
23374716|NCT02391337|65116067|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
23374717|NCT02391337|65116066|FG000|12 Months Follow-up|Death|2|||
23374718|NCT02391337|65116067|FG001|12 Months Follow-up|Death|0|||
23374719|NCT02391337|65116066|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
23374720|NCT02391337|65116067|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
23374721|NCT02391337|65116066|FG000|12 Months Follow-up|Lost to Follow-up|0|||
23374722|NCT02391337|65116067|FG001|12 Months Follow-up|Lost to Follow-up|2|||
23374723|NCT01130272|65116068|FG000|Overall Study|Adverse Event|2|||
23374724|NCT01130272|65116069|FG001|Overall Study|Adverse Event|5|||
23374725|NCT01130272|65116070|FG002|Overall Study|Adverse Event|6|||
23374726|NCT01130272|65116071|FG003|Overall Study|Adverse Event|22|||
23374727|NCT01130272|65116072|FG004|Overall Study|Adverse Event|7|||
23374728|NCT01130272|65116068|FG000|Overall Study|IVRS-confirmed constipation|0|||
23374729|NCT01130272|65116069|FG001|Overall Study|IVRS-confirmed constipation|1|||
23374730|NCT01130272|65116070|FG002|Overall Study|IVRS-confirmed constipation|1|||
23374731|NCT01130272|65116071|FG003|Overall Study|IVRS-confirmed constipation|2|||
23374732|NCT01130272|65116072|FG004|Overall Study|IVRS-confirmed constipation|0|||
23374733|NCT01130272|65116068|FG000|Overall Study|Rescue medications due to diarrhea|3|||
23374734|NCT01130272|65116069|FG001|Overall Study|Rescue medications due to diarrhea|5|||
23374735|NCT01130272|65116070|FG002|Overall Study|Rescue medications due to diarrhea|8|||
23374736|NCT01130272|65116071|FG003|Overall Study|Rescue medications due to diarrhea|8|||
23374737|NCT01130272|65116072|FG004|Overall Study|Rescue medications due to diarrhea|6|||
23603975|NCT03735849|65940236|FG000|Overall Study|Lost to Follow-up|1|||
23374738|NCT01130272|65116068|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
23374739|NCT01130272|65116069|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
23374740|NCT01130272|65116070|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
23603976|NCT03735849|65940237|FG001|Overall Study|Lost to Follow-up|0|||
23374741|NCT01130272|65116071|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
23603977|NCT03735849|65940238|FG002|Overall Study|Lost to Follow-up|0|||
23374742|NCT01130272|65116072|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
23374743|NCT01130272|65116068|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374744|NCT01130272|65116069|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374745|NCT01130272|65116070|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374746|NCT01130272|65116071|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
23374747|NCT01130272|65116072|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374748|NCT01130272|65116068|FG000|Overall Study|Protocol Violation|0|||
23374749|NCT01130272|65116069|FG001|Overall Study|Protocol Violation|0|||
23374750|NCT01130272|65116070|FG002|Overall Study|Protocol Violation|3|||
23374751|NCT01130272|65116071|FG003|Overall Study|Protocol Violation|5|||
23374752|NCT01130272|65116072|FG004|Overall Study|Protocol Violation|5|||
23374753|NCT01130272|65116068|FG000|Overall Study|Lost to Follow-up|4|||
23374754|NCT01130272|65116069|FG001|Overall Study|Lost to Follow-up|3|||
23374755|NCT01130272|65116070|FG002|Overall Study|Lost to Follow-up|4|||
23374756|NCT01130272|65116071|FG003|Overall Study|Lost to Follow-up|7|||
23374757|NCT01130272|65116072|FG004|Overall Study|Lost to Follow-up|6|||
23374758|NCT01130272|65116068|FG000|Overall Study|Withdrawal by Subject|4|||
23374759|NCT01130272|65116069|FG001|Overall Study|Withdrawal by Subject|11|||
23374760|NCT01130272|65116070|FG002|Overall Study|Withdrawal by Subject|10|||
23374761|NCT01130272|65116071|FG003|Overall Study|Withdrawal by Subject|9|||
23374762|NCT01130272|65116072|FG004|Overall Study|Withdrawal by Subject|8|||
23374763|NCT01130272|65116068|FG000|Overall Study|Physician Decision|1|||
23374764|NCT01130272|65116069|FG001|Overall Study|Physician Decision|1|||
23374765|NCT01130272|65116070|FG002|Overall Study|Physician Decision|0|||
23374766|NCT01130272|65116071|FG003|Overall Study|Physician Decision|1|||
23374767|NCT01130272|65116072|FG004|Overall Study|Physician Decision|2|||
23374768|NCT01130272|65116068|FG000|Overall Study|Sponsor decision|6|||
23374769|NCT01130272|65116069|FG001|Overall Study|Sponsor decision|15|||
23374770|NCT01130272|65116070|FG002|Overall Study|Sponsor decision|16|||
23374771|NCT01130272|65116071|FG003|Overall Study|Sponsor decision|13|||
23374772|NCT01130272|65116072|FG004|Overall Study|Sponsor decision|16|||
23374773|NCT01130272|65116068|FG000|Overall Study|Study arm discontinued|38|||
23374774|NCT01130272|65116069|FG001|Overall Study|Study arm discontinued|0|||
23664616|NCT01357655|66158529|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23664617|NCT01357655|66158530|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23664618|NCT01357655|66158529|FG000|Overall Study|Disease Progression|1|||
23664619|NCT01357655|66158530|FG001|Overall Study|Disease Progression|0|||
23664620|NCT01357655|66158529|FG000|Overall Study|Lost to Follow-up|2|||
23664621|NCT01357655|66158530|FG001|Overall Study|Lost to Follow-up|0|||
23664622|NCT01357655|66158529|FG000|Overall Study|Maximum Clinical Benefit|2|||
23664623|NCT01357655|66158530|FG001|Overall Study|Maximum Clinical Benefit|0|||
23664624|NCT01357655|66158529|FG000|Overall Study|Reason Unspecified|1|||
23664625|NCT01357655|66158530|FG001|Overall Study|Reason Unspecified|0|||
23664626|NCT01357655|66158529|FG000|Overall Study|Study Drug Toxicity|11|||
23664627|NCT01357655|66158530|FG001|Overall Study|Study Drug Toxicity|0|||
23664628|NCT01357655|66158529|FG000|Overall Study|Subject Withdrew Consent|1|||
23664629|NCT01357655|66158530|FG001|Overall Study|Subject Withdrew Consent|0|||
23664630|NCT01379274|66158531|FG000|Overall Study|funding withdrawn|1|||
23664631|NCT01858532|66158532|FG000|Overall Study|Adverse Event|58|||
23664632|NCT01858532|66158533|FG001|Overall Study|Adverse Event|50|||
23664633|NCT01858532|66158534|FG002|Overall Study|Adverse Event|23|||
23664634|NCT01858532|66158535|FG003|Overall Study|Adverse Event|28|||
23664635|NCT01858532|66158532|FG000|Overall Study|Withdrew consent|71|||
23664636|NCT01858532|66158533|FG001|Overall Study|Withdrew consent|93|||
23664637|NCT01858532|66158534|FG002|Overall Study|Withdrew consent|46|||
23664638|NCT01858532|66158535|FG003|Overall Study|Withdrew consent|27|||
23374775|NCT01130272|65116070|FG002|Overall Study|Study arm discontinued|0|||
23374776|NCT01130272|65116071|FG003|Overall Study|Study arm discontinued|0|||
23374777|NCT01130272|65116072|FG004|Overall Study|Study arm discontinued|0|||
23374778|NCT02029417|65116073|FG000|Overall Study|Death|1|||
23374779|NCT02029417|65116073|FG000|Overall Study|Adverse Event|1|||
23374780|NCT00142415|65116074|FG000|Overall Study|Physician Decision|0|||
23374781|NCT00142415|65116075|FG001|Overall Study|Physician Decision|0|||
23664639|NCT01858532|66158532|FG000|Overall Study|Lost to Follow-up|17|||
23664640|NCT01858532|66158533|FG001|Overall Study|Lost to Follow-up|26|||
23664641|NCT01858532|66158534|FG002|Overall Study|Lost to Follow-up|11|||
23664642|NCT01858532|66158535|FG003|Overall Study|Lost to Follow-up|14|||
23664643|NCT01858532|66158532|FG000|Overall Study|Deterioration of medical status|3|||
23374782|NCT00142415|65116076|FG002|Overall Study|Physician Decision|0|||
23374783|NCT00142415|65116077|FG003|Overall Study|Physician Decision|0|||
23374784|NCT00142415|65116078|FG004|Overall Study|Physician Decision|1|||
23374785|NCT00142415|65116079|FG005|Overall Study|Physician Decision|2|||
23374786|NCT01240746|65116080|FG000|Overall Study|Adverse Event|2|||
23374787|NCT01240746|65116081|FG001|Overall Study|Adverse Event|0|||
23374788|NCT01240746|65116082|FG002|Overall Study|Adverse Event|10|||
23374789|NCT01240746|65116080|FG000|Overall Study|Lost to Follow-up|23|||
23374790|NCT01240746|65116081|FG001|Overall Study|Lost to Follow-up|20|||
23374791|NCT01240746|65116082|FG002|Overall Study|Lost to Follow-up|102|||
23374792|NCT01240746|65116080|FG000|Overall Study|Protocol Violation|24|||
23374793|NCT01240746|65116081|FG001|Overall Study|Protocol Violation|15|||
23374794|NCT01240746|65116082|FG002|Overall Study|Protocol Violation|72|||
23374795|NCT01240746|65116080|FG000|Overall Study|Withdrawal by Subject|10|||
23374796|NCT01240746|65116081|FG001|Overall Study|Withdrawal by Subject|13|||
23374797|NCT01240746|65116082|FG002|Overall Study|Withdrawal by Subject|59|||
23374798|NCT04748718|65116088|FG000|Overall Study|Lost to Follow-up|50|||
23374799|NCT01408641|65116090|FG000|Overall Study|Physician Decision|1|||
23488177|NCT01614600|65533771|FG000|Overall Study|Unable to remove lens at the end of day|1|||
23488178|NCT01614600|65533771|FG000|Overall Study|Protocol deviation|1|||
23488179|NCT03923738|65533774|FG000|Period 1|Adverse Event|1|||
23488180|NCT03923738|65533774|FG000|Period 1|Withdrawal by Subject|1|||
23374800|NCT01408641|65116091|FG001|Overall Study|Physician Decision|0|||
23374801|NCT02152007|65116094|FG000|Overall Study|Withdrawal by Subject|1|||
23374802|NCT02394756|65116105|FG000|Period 1|Lens Discomfort|0|||
23374803|NCT02394756|65116106|FG001|Period 1|Lens Discomfort|0|||
23374804|NCT02394756|65116107|FG002|Period 1|Lens Discomfort|0|||
23374805|NCT02394756|65116108|FG003|Period 1|Lens Discomfort|0|||
23374806|NCT02394756|65116109|FG004|Period 1|Lens Discomfort|0|||
23374807|NCT02394756|65116110|FG005|Period 1|Lens Discomfort|1|||
23664644|NCT01858532|66158533|FG001|Overall Study|Deterioration of medical status|4|||
23664645|NCT01858532|66158534|FG002|Overall Study|Deterioration of medical status|3|||
23664646|NCT01858532|66158535|FG003|Overall Study|Deterioration of medical status|7|||
23664647|NCT01858532|66158532|FG000|Overall Study|Investigator request|3|||
23374808|NCT02394756|65116105|FG000|Period 1|Withdrawal by Subject|0|||
23374809|NCT02394756|65116106|FG001|Period 1|Withdrawal by Subject|1|||
23374810|NCT02394756|65116107|FG002|Period 1|Withdrawal by Subject|1|||
23374811|NCT02394756|65116108|FG003|Period 1|Withdrawal by Subject|1|||
23374812|NCT02394756|65116109|FG004|Period 1|Withdrawal by Subject|0|||
23374813|NCT02394756|65116110|FG005|Period 1|Withdrawal by Subject|0|||
23488181|NCT00880685|65533776|FG000|Memantine 10mg|Lost to Follow-up|2|||
23488182|NCT00880685|65533776|FG000|Memantine 20mg|Withdrawal by Subject|1|||
23488183|NCT02169284|65533782|FG000|Overall Study|Physician Decision|0|||
23488184|NCT02169284|65533783|FG001|Overall Study|Physician Decision|1|||
23488185|NCT01130103|65533784|FG000|Randomized Treatment|Adverse Event|1|||
23664648|NCT01858532|66158533|FG001|Overall Study|Investigator request|4|||
23664649|NCT01858532|66158534|FG002|Overall Study|Investigator request|2|||
23664650|NCT01858532|66158535|FG003|Overall Study|Investigator request|6|||
23664651|NCT01858532|66158532|FG000|Overall Study|Other, not specified|29|||
23664652|NCT01858532|66158533|FG001|Overall Study|Other, not specified|15|||
23664653|NCT01858532|66158534|FG002|Overall Study|Other, not specified|13|||
23664654|NCT01858532|66158535|FG003|Overall Study|Other, not specified|11|||
23664655|NCT03719690|66158536|FG000|Overall Study|Withdrawal by Subject|5|||
23664656|NCT03719690|66158537|FG001|Overall Study|Withdrawal by Subject|10|||
23664657|NCT03719690|66158536|FG000|Overall Study|Death|40|||
23664658|NCT03719690|66158537|FG001|Overall Study|Death|149|||
23664659|NCT03719690|66158536|FG000|Overall Study|Miscellaneous|12|||
23664660|NCT03719690|66158537|FG001|Overall Study|Miscellaneous|56|||
23664661|NCT03719690|66158536|FG000|Overall Study|Lost to Follow-up|2|||
23664662|NCT03719690|66158537|FG001|Overall Study|Lost to Follow-up|18|||
23664663|NCT03719690|66158536|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
23664664|NCT03719690|66158537|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
23664665|NCT01075412|66158556|FG000|Overall Study|Withdrawal by Subject|0|||
23664666|NCT01075412|66158557|FG001|Overall Study|Withdrawal by Subject|1|||
23664667|NCT02054897|66158558|FG000|Overall Study|Withdrawal by Subject|2|||
23374814|NCT02394756|65116105|FG000|Period 2|Unsatisfactory Visual Response|0|||
23374815|NCT02394756|65116106|FG001|Period 2|Unsatisfactory Visual Response|0|||
23374816|NCT02394756|65116107|FG002|Period 2|Unsatisfactory Visual Response|0|||
23374817|NCT02394756|65116108|FG003|Period 2|Unsatisfactory Visual Response|0|||
23374818|NCT02394756|65116109|FG004|Period 2|Unsatisfactory Visual Response|1|||
23374819|NCT02394756|65116110|FG005|Period 2|Unsatisfactory Visual Response|0|||
23488186|NCT01130103|65533785|FG001|Randomized Treatment|Adverse Event|1|||
23488187|NCT01130103|65533784|FG000|Randomized Treatment|Lost to Follow-up|1|||
23374820|NCT00817063|65116112|FG000|Overall Study|Adverse Event|32|||
23488188|NCT01130103|65533785|FG001|Randomized Treatment|Lost to Follow-up|0|||
23488189|NCT01130103|65533784|FG000|Randomized Treatment|Protocol Violation|3|||
23488190|NCT01130103|65533785|FG001|Randomized Treatment|Protocol Violation|2|||
23488191|NCT01130103|65533784|FG000|Randomized Treatment|Withdrawal by Subject|1|||
23488192|NCT01130103|65533785|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23488193|NCT01130103|65533784|FG000|Maintenance Treatment|Lack of Efficacy|0|||
23488194|NCT01130103|65533785|FG001|Maintenance Treatment|Lack of Efficacy|1|||
23488195|NCT01130103|65533784|FG000|Maintenance Treatment|Lost to Follow-up|1|||
23488196|NCT01130103|65533785|FG001|Maintenance Treatment|Lost to Follow-up|1|||
23488197|NCT01130103|65533784|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
23488198|NCT01130103|65533785|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
23488199|NCT01736124|65533788|FG000|Post-intervention Assessment|Death|2|||
23488200|NCT01736124|65533789|FG001|Post-intervention Assessment|Death|2|||
23488201|NCT01736124|65533788|FG000|Post-intervention Assessment|lost computer access|1|||
23488202|NCT01736124|65533789|FG001|Post-intervention Assessment|lost computer access|1|||
23488203|NCT01736124|65533788|FG000|Post-intervention Assessment|Moved away|3|||
23488204|NCT01736124|65533789|FG001|Post-intervention Assessment|Moved away|1|||
23488205|NCT01736124|65533788|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
23488206|NCT01736124|65533789|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
23488207|NCT01736124|65533788|FG000|Post-intervention Assessment|Illness|3|||
23488208|NCT01736124|65533789|FG001|Post-intervention Assessment|Illness|2|||
23488209|NCT01736124|65533788|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
23488210|NCT01736124|65533789|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
23488211|NCT01736124|65533788|FG000|Post-intervention Assessment|Temporarily away|3|||
23488212|NCT01736124|65533789|FG001|Post-intervention Assessment|Temporarily away|1|||
23488213|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
23488214|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
23488215|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
23488216|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
23488217|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
23488218|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
23488219|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
23488220|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
23488221|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
23488222|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
23488223|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
23488224|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
23488225|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
23488226|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
23488227|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
23488228|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
23488229|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
23488230|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
23488231|NCT01674634|65533790|FG000|Overall Study|Withdrawal by Subject|3|||
23488232|NCT01674634|65533790|FG000|Overall Study|Lost to Follow-up|3|||
23488233|NCT01466179|65533793|FG000|Overall Study|Ongoing in core study|2|||
23488234|NCT01466179|65533793|FG000|Overall Study|Physician Decision|46|||
23488235|NCT01466179|65533793|FG000|Overall Study|Progressive disease|43|||
23488236|NCT01466179|65533793|FG000|Overall Study|Adverse Event|32|||
23488237|NCT01466179|65533793|FG000|Overall Study|Disease relapse|23|||
23488238|NCT01466179|65533793|FG000|Overall Study|Lack of Efficacy|14|||
23488239|NCT01466179|65533793|FG000|Overall Study|Death|7|||
23603978|NCT03735849|65940236|FG000|Overall Study|Participant unable to adhere to visit|1|||
23603979|NCT03735849|65940237|FG001|Overall Study|Participant unable to adhere to visit|0|||
23603980|NCT03735849|65940238|FG002|Overall Study|Participant unable to adhere to visit|0|||
23603981|NCT03735849|65940236|FG000|Overall Study|Not Randomized|0|||
23603982|NCT03735849|65940237|FG001|Overall Study|Not Randomized|0|||
23603983|NCT03735849|65940238|FG002|Overall Study|Not Randomized|4|||
23603984|NCT03009344|65940239|FG000|Overall Study|Lack of Efficacy|5|||
23603985|NCT03009344|65940239|FG000|Overall Study|Withdrawal by Subject|1|||
23603986|NCT03009344|65940239|FG000|Overall Study|Adverse Event|1|||
23603987|NCT02067663|65940241|FG000|Overall Study|Lost to Follow-up|13|||
23603988|NCT02067663|65940242|FG001|Overall Study|Lost to Follow-up|14|||
23488240|NCT01466179|65533793|FG000|Overall Study|Withdrawal by Subject|7|||
23488241|NCT01466179|65533793|FG000|Overall Study|Protocol Violation|2|||
23488242|NCT01466179|65533793|FG000|Overall Study|Other|3|||
23488243|NCT01104155|65533794|FG000|Overall Study|Adverse Event|15|||
23488244|NCT01104155|65533795|FG001|Overall Study|Adverse Event|8|||
23488245|NCT01104155|65533794|FG000|Overall Study|Participant choice|6|||
23488246|NCT01104155|65533795|FG001|Overall Study|Participant choice|5|||
23603989|NCT00019604|65940251|FG000|Overall Study|Death|1|||
23603990|NCT00019604|65940251|FG000|Overall Study|Progressive disease|23|||
23603991|NCT00019604|65940251|FG000|Overall Study|Refused treatment|1|||
23488247|NCT01104155|65533794|FG000|Overall Study|Withdrawal of consent|1|||
23488248|NCT01104155|65533795|FG001|Overall Study|Withdrawal of consent|1|||
23488249|NCT01104155|65533794|FG000|Overall Study|Other|3|||
23488250|NCT01104155|65533795|FG001|Overall Study|Other|4|||
23488251|NCT04399837|65533796|FG000|Overall Study|Other than listed|0|||
23488252|NCT04399837|65533797|FG001|Overall Study|Other than listed|2|||
23488253|NCT04399837|65533798|FG002|Overall Study|Other than listed|2|||
23374821|NCT00817063|65116113|FG001|Overall Study|Adverse Event|13|||
23374822|NCT00817063|65116112|FG000|Overall Study|Death|1|||
23374823|NCT00817063|65116113|FG001|Overall Study|Death|1|||
23374824|NCT00817063|65116112|FG000|Overall Study|Lack of Efficacy|33|||
23374825|NCT00817063|65116113|FG001|Overall Study|Lack of Efficacy|86|||
23374826|NCT00817063|65116112|FG000|Overall Study|Failure to Return|13|||
23374827|NCT00817063|65116113|FG001|Overall Study|Failure to Return|12|||
23374828|NCT00817063|65116112|FG000|Overall Study|Violation of Selection at Entry|7|||
23374829|NCT00817063|65116113|FG001|Overall Study|Violation of Selection at Entry|4|||
23374830|NCT00817063|65116112|FG000|Overall Study|Protocol Violation|3|||
23374831|NCT00817063|65116113|FG001|Overall Study|Protocol Violation|8|||
23374832|NCT00817063|65116112|FG000|Overall Study|Withdrawal by Subject|17|||
23374833|NCT00817063|65116113|FG001|Overall Study|Withdrawal by Subject|37|||
23374834|NCT00817063|65116112|FG000|Overall Study|Early Improvement|19|||
23374835|NCT00817063|65116113|FG001|Overall Study|Early Improvement|4|||
23374836|NCT00817063|65116112|FG000|Overall Study|Administrative|10|||
23374837|NCT00817063|65116113|FG001|Overall Study|Administrative|4|||
23374838|NCT00817063|65116112|FG000|Overall Study|Abnormality of Laboratory Test|2|||
23374839|NCT00817063|65116113|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23488254|NCT04399837|65533799|FG003|Overall Study|Other than listed|3|||
23488255|NCT04399837|65533796|FG000|Overall Study|Withdrawal by Subject|1|||
23488256|NCT04399837|65533797|FG001|Overall Study|Withdrawal by Subject|2|||
23374840|NCT05172570|65116114|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
23374841|NCT05172570|65116115|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
23374842|NCT05172570|65116116|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
23374843|NCT05172570|65116114|FG000|Overall Study|PI Decision due to equipment shortages|0|||
23374844|NCT05172570|65116115|FG001|Overall Study|PI Decision due to equipment shortages|0|||
23488257|NCT04399837|65533798|FG002|Overall Study|Withdrawal by Subject|1|||
23488258|NCT04399837|65533799|FG003|Overall Study|Withdrawal by Subject|1|||
23488259|NCT04068610|65533800|FG000|Overall Study|Death|4|||
23488260|NCT04068610|65533801|FG001|Overall Study|Death|8|||
23488261|NCT04068610|65533802|FG002|Overall Study|Death|13|||
23488262|NCT04068610|65533800|FG000|Overall Study|Lost to Follow-up|0|||
23488263|NCT04068610|65533801|FG001|Overall Study|Lost to Follow-up|2|||
23488264|NCT04068610|65533802|FG002|Overall Study|Lost to Follow-up|0|||
23488265|NCT04068610|65533800|FG000|Overall Study|Withdrawal by Subject|0|||
23488266|NCT04068610|65533801|FG001|Overall Study|Withdrawal by Subject|4|||
23488267|NCT04068610|65533802|FG002|Overall Study|Withdrawal by Subject|2|||
23488268|NCT04068610|65533800|FG000|Overall Study|Other|3|||
23488269|NCT04068610|65533801|FG001|Overall Study|Other|12|||
23488270|NCT04068610|65533802|FG002|Overall Study|Other|11|||
23488271|NCT01134731|65533803|FG000|Overall Study|Adverse Event|3|||
23488272|NCT01134731|65533804|FG001|Overall Study|Adverse Event|2|||
23488273|NCT01134731|65533805|FG002|Overall Study|Adverse Event|1|||
23488274|NCT01134731|65533803|FG000|Overall Study|Physician Decision|2|||
23603992|NCT00019604|65940251|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
23603993|NCT00019604|65940251|FG000|Overall Study|Going to have liver transplant|1|||
23603994|NCT00019604|65940251|FG000|Overall Study|Move to a different study|1|||
23603995|NCT00019604|65940251|FG000|Overall Study|Non compliant on systemic CH|1|||
23603996|NCT00019604|65940251|FG000|Overall Study|Non compliant|1|||
23603997|NCT00019604|65940251|FG000|Overall Study|Resectable disease|1|||
23603998|NCT00019604|65940251|FG000|Overall Study|Started new chemo regimen|1|||
23603999|NCT00019604|65940251|FG000|Overall Study|Pt going to immunotherapy study|1|||
23604000|NCT00019604|65940251|FG000|Overall Study|Too much disease|1|||
23604001|NCT00019604|65940251|FG000|Overall Study|Unable to evaluate|1|||
23604002|NCT00019604|65940251|FG000|Overall Study|Details for other not available|4|||
23604003|NCT02454959|65940253|FG000|Overall Study|Protocol-Specified Criteria|3|||
23604004|NCT02454959|65940253|FG000|Overall Study|Physician Decision|1|||
23604005|NCT02454959|65940253|FG000|Overall Study|Withdrawal by Subject|3|||
23488275|NCT01134731|65533804|FG001|Overall Study|Physician Decision|2|||
23604006|NCT02454959|65940253|FG000|Overall Study|Adverse Event|2|||
23488276|NCT01134731|65533805|FG002|Overall Study|Physician Decision|2|||
23488277|NCT01134731|65533803|FG000|Overall Study|Lack of Efficacy|0|||
23604007|NCT00761267|65940257|FG000|Overall Study|Death|1|||
23604008|NCT00761267|65940258|FG001|Overall Study|Death|2|||
23374845|NCT05172570|65116116|FG002|Overall Study|PI Decision due to equipment shortages|1|||
23374846|NCT01739335|65116117|FG000|Overall Study|Lost to Follow-up|7|||
23488278|NCT01134731|65533804|FG001|Overall Study|Lack of Efficacy|0|||
23488279|NCT01134731|65533805|FG002|Overall Study|Lack of Efficacy|1|||
23488280|NCT01134731|65533803|FG000|Overall Study|Withdrawal by Subject|3|||
23488281|NCT01134731|65533804|FG001|Overall Study|Withdrawal by Subject|3|||
23488282|NCT01134731|65533805|FG002|Overall Study|Withdrawal by Subject|1|||
23488283|NCT01134731|65533803|FG000|Overall Study|Lost to Follow-up|5|||
23488284|NCT01134731|65533804|FG001|Overall Study|Lost to Follow-up|4|||
23488285|NCT01134731|65533805|FG002|Overall Study|Lost to Follow-up|3|||
23488286|NCT03078907|65533806|FG000|Overall Study|Adverse Event|2|||
23488287|NCT03078907|65533807|FG001|Overall Study|Adverse Event|0|||
23488288|NCT03078907|65533806|FG000|Overall Study|Other|1|||
23488289|NCT03078907|65533807|FG001|Overall Study|Other|0|||
23488290|NCT03078907|65533806|FG000|Overall Study|Protocol Violation|0|||
23488291|NCT03078907|65533807|FG001|Overall Study|Protocol Violation|1|||
23488292|NCT01539642|65533809|FG000|Overall Study|Lack of Efficacy|20|||
23488293|NCT01539642|65533810|FG001|Overall Study|Lack of Efficacy|18|||
23488294|NCT01539642|65533809|FG000|Overall Study|Patient ready for early discharge|8|||
23488295|NCT01539642|65533810|FG001|Overall Study|Patient ready for early discharge|7|||
23488296|NCT01539642|65533809|FG000|Overall Study|Adverse Event|6|||
23488297|NCT01539642|65533810|FG001|Overall Study|Adverse Event|4|||
23488298|NCT01539642|65533809|FG000|Overall Study|Withdrawal by Subject|2|||
23488299|NCT01539642|65533810|FG001|Overall Study|Withdrawal by Subject|2|||
23488300|NCT02787005|65533814|FG000|Overall Study|Adverse Event|24|||
23488301|NCT02787005|65533815|FG001|Overall Study|Adverse Event|9|||
23488302|NCT02787005|65533816|FG002|Overall Study|Adverse Event|9|||
23488303|NCT02787005|65533817|FG003|Overall Study|Adverse Event|7|||
23488304|NCT02787005|65533818|FG004|Overall Study|Adverse Event|2|||
23488305|NCT02787005|65533814|FG000|Overall Study|Death|100|||
23488306|NCT02787005|65533815|FG001|Overall Study|Death|53|||
23488307|NCT02787005|65533816|FG002|Overall Study|Death|48|||
23488308|NCT02787005|65533817|FG003|Overall Study|Death|69|||
23488309|NCT02787005|65533818|FG004|Overall Study|Death|38|||
23488310|NCT02787005|65533814|FG000|Overall Study|Sponsor Decision|7|||
23604009|NCT00761267|65940259|FG002|Overall Study|Death|5|||
23604010|NCT00761267|65940257|FG000|Overall Study|Lost to Follow-up|0|||
23604011|NCT00761267|65940258|FG001|Overall Study|Lost to Follow-up|0|||
23604012|NCT00761267|65940259|FG002|Overall Study|Lost to Follow-up|1|||
23488311|NCT02787005|65533815|FG001|Overall Study|Sponsor Decision|4|||
23488312|NCT02787005|65533816|FG002|Overall Study|Sponsor Decision|0|||
23488313|NCT02787005|65533817|FG003|Overall Study|Sponsor Decision|4|||
23488314|NCT02787005|65533818|FG004|Overall Study|Sponsor Decision|5|||
23488315|NCT02787005|65533814|FG000|Overall Study|Withdrawal by Subject|2|||
23488316|NCT02787005|65533815|FG001|Overall Study|Withdrawal by Subject|1|||
23488317|NCT02787005|65533816|FG002|Overall Study|Withdrawal by Subject|1|||
23488318|NCT02787005|65533817|FG003|Overall Study|Withdrawal by Subject|0|||
23488319|NCT02787005|65533818|FG004|Overall Study|Withdrawal by Subject|1|||
23488320|NCT02787005|65533814|FG000|Overall Study|Screen Failure|0|||
23488321|NCT02787005|65533815|FG001|Overall Study|Screen Failure|2|||
23488322|NCT02787005|65533816|FG002|Overall Study|Screen Failure|0|||
23488323|NCT02787005|65533817|FG003|Overall Study|Screen Failure|0|||
23488324|NCT02787005|65533818|FG004|Overall Study|Screen Failure|1|||
23488325|NCT02787005|65533814|FG000|Overall Study|Lost to Follow-up|0|||
23488326|NCT02787005|65533815|FG001|Overall Study|Lost to Follow-up|0|||
23488327|NCT02787005|65533816|FG002|Overall Study|Lost to Follow-up|0|||
23488328|NCT02787005|65533817|FG003|Overall Study|Lost to Follow-up|1|||
23488329|NCT02787005|65533818|FG004|Overall Study|Lost to Follow-up|0|||
23488330|NCT01083173|65533824|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
23488331|NCT01083173|65533825|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
23488332|NCT01083173|65533824|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
23488333|NCT01083173|65533825|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
23488334|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
23488335|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
23488336|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
23488337|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
23488338|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
23488339|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
23488340|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
23488341|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
23488342|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
23488343|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
23488344|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
23488345|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
23488346|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
23488347|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
23488348|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
23488349|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
23488350|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
23488351|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
23488352|NCT00857415|65533828|FG000|Overall Study|Image acquisition failure|2|||
23488353|NCT00857415|65533829|FG001|Overall Study|Image acquisition failure|0|||
23488354|NCT00857415|65533828|FG000|Overall Study|Invalid image or not imaged|3|||
23488355|NCT00857415|65533829|FG001|Overall Study|Invalid image or not imaged|0|||
23488356|NCT00857415|65533828|FG000|Overall Study|Subject still living at end of study|110|||
23488357|NCT00857415|65533829|FG001|Overall Study|Subject still living at end of study|0|||
23604013|NCT00761267|65940257|FG000|Overall Study|Randomized but not treated|1|||
23604014|NCT00761267|65940258|FG001|Overall Study|Randomized but not treated|1|||
23488358|NCT00857415|65533828|FG000|Overall Study|Deceased with no autopsy|2|||
23488359|NCT00857415|65533829|FG001|Overall Study|Deceased with no autopsy|0|||
23488360|NCT00591266|65533830|FG000|Overall Study|Adverse Event|2|||
23488361|NCT00591266|65533831|FG001|Overall Study|Adverse Event|2|||
23488362|NCT00591266|65533832|FG002|Overall Study|Adverse Event|3|||
23488363|NCT00591266|65533830|FG000|Overall Study|Lost to Follow-up|0|||
23488364|NCT00591266|65533831|FG001|Overall Study|Lost to Follow-up|1|||
23488365|NCT00591266|65533832|FG002|Overall Study|Lost to Follow-up|0|||
23488366|NCT00591266|65533830|FG000|Overall Study|Protocol Violation|0|||
23488367|NCT00591266|65533831|FG001|Overall Study|Protocol Violation|0|||
23488368|NCT00591266|65533832|FG002|Overall Study|Protocol Violation|1|||
23488369|NCT00591266|65533830|FG000|Overall Study|Withdrawal by Subject|6|||
23488370|NCT00591266|65533831|FG001|Overall Study|Withdrawal by Subject|2|||
23488371|NCT00591266|65533832|FG002|Overall Study|Withdrawal by Subject|5|||
23488372|NCT00591266|65533830|FG000|Overall Study|Lack of Efficacy|0|||
23488373|NCT00591266|65533831|FG001|Overall Study|Lack of Efficacy|2|||
23488374|NCT00591266|65533832|FG002|Overall Study|Lack of Efficacy|0|||
23488375|NCT00591266|65533830|FG000|Overall Study|Other|1|||
23488376|NCT00591266|65533831|FG001|Overall Study|Other|4|||
23488377|NCT00591266|65533832|FG002|Overall Study|Other|5|||
23488378|NCT01442038|65533833|FG000|Overall Study|Death|35|||
23488379|NCT01442038|65533834|FG001|Overall Study|Death|29|||
23488380|NCT01442038|65533833|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
23488381|NCT01442038|65533834|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
23488382|NCT01442038|65533833|FG000|Overall Study|Participant Withdrew Consent|137|||
23488383|NCT01442038|65533834|FG001|Overall Study|Participant Withdrew Consent|102|||
23488384|NCT01442038|65533833|FG000|Overall Study|Lost to Follow-up|37|||
23488385|NCT01442038|65533834|FG001|Overall Study|Lost to Follow-up|51|||
23488386|NCT01442038|65533833|FG000|Overall Study|Adverse Event|26|||
23488387|NCT01442038|65533834|FG001|Overall Study|Adverse Event|15|||
23488388|NCT01442038|65533833|FG000|Overall Study|Protocol Deviation|9|||
23488389|NCT01442038|65533834|FG001|Overall Study|Protocol Deviation|20|||
23488390|NCT01442038|65533833|FG000|Overall Study|Investigator's Discretion|13|||
23488391|NCT01442038|65533834|FG001|Overall Study|Investigator's Discretion|16|||
23488392|NCT01442038|65533833|FG000|Overall Study|Study Terminated By Sponsor|2|||
23488393|NCT01442038|65533834|FG001|Overall Study|Study Terminated By Sponsor|3|||
23488394|NCT00620464|65533835|FG000|Overall Study|Adverse Event|15|||
23488395|NCT00620464|65533836|FG001|Overall Study|Adverse Event|17|||
23488396|NCT00620464|65533835|FG000|Overall Study|Lost to Follow-up|1|||
23664668|NCT02054897|66158559|FG001|Overall Study|Withdrawal by Subject|0|||
23664669|NCT02054897|66158560|FG002|Overall Study|Withdrawal by Subject|2|||
23664670|NCT02054897|66158558|FG000|Overall Study|Missing follow-up information|3|||
23664671|NCT02054897|66158559|FG001|Overall Study|Missing follow-up information|5|||
23664672|NCT02054897|66158560|FG002|Overall Study|Missing follow-up information|3|||
23664673|NCT02054897|66158558|FG000|Overall Study|Lost to Follow-up|4|||
23664674|NCT02054897|66158559|FG001|Overall Study|Lost to Follow-up|2|||
23664675|NCT02054897|66158560|FG002|Overall Study|Lost to Follow-up|7|||
23664676|NCT02054897|66158558|FG000|Overall Study|Randomized but not exposed|1|||
23664677|NCT02054897|66158559|FG001|Overall Study|Randomized but not exposed|0|||
23664678|NCT02054897|66158560|FG002|Overall Study|Randomized but not exposed|0|||
23664679|NCT01911442|66158564|FG000|Overall Study|Adverse Event|2|||
23664680|NCT01911442|66158565|FG001|Overall Study|Adverse Event|2|||
23488397|NCT00620464|65533836|FG001|Overall Study|Lost to Follow-up|1|||
23488398|NCT00620464|65533835|FG000|Overall Study|Planning Pregnancy|1|||
23488399|NCT00620464|65533836|FG001|Overall Study|Planning Pregnancy|4|||
23488400|NCT00620464|65533835|FG000|Overall Study|Personal|2|||
23488401|NCT00620464|65533836|FG001|Overall Study|Personal|2|||
23604015|NCT00761267|65940259|FG002|Overall Study|Randomized but not treated|0|||
23604016|NCT00761267|65940257|FG000|Overall Study|Withdrawal by Subject|0|||
23604017|NCT00761267|65940258|FG001|Overall Study|Withdrawal by Subject|1|||
23604018|NCT00761267|65940259|FG002|Overall Study|Withdrawal by Subject|0|||
23604019|NCT01328496|65940272|FG000|Overall Study|Significant Change in Health Status|1|||
23604020|NCT01328496|65940273|FG001|Overall Study|Significant Change in Health Status|0|||
23604021|NCT00645411|65940280|FG000|Overall Study|Adverse Event|0|||
23604022|NCT00645411|65940281|FG001|Overall Study|Adverse Event|0|||
23604023|NCT00645411|65940282|FG002|Overall Study|Adverse Event|0|||
23604024|NCT00645411|65940283|FG003|Overall Study|Adverse Event|2|||
23664681|NCT01911442|66158566|FG002|Overall Study|Adverse Event|4|||
23488402|NCT00620464|65533835|FG000|Overall Study|Used prohibited medication|1|||
23488403|NCT00620464|65533836|FG001|Overall Study|Used prohibited medication|0|||
23488404|NCT02130024|65533845|FG000|Overall Study|Adverse Event|10|||
23488405|NCT02130024|65533846|FG001|Overall Study|Adverse Event|11|||
23488406|NCT02130024|65533845|FG000|Overall Study|Death|2|||
23488407|NCT02130024|65533846|FG001|Overall Study|Death|2|||
23604025|NCT00645411|65940280|FG000|Overall Study|Withdrawal by Subject|2|||
23664682|NCT01911442|66158564|FG000|Overall Study|Lack of Efficacy|1|||
23488408|NCT02130024|65533845|FG000|Overall Study|Lost to Follow-up|1|||
23488409|NCT02130024|65533846|FG001|Overall Study|Lost to Follow-up|1|||
23604026|NCT00645411|65940281|FG001|Overall Study|Withdrawal by Subject|1|||
23488410|NCT02130024|65533845|FG000|Overall Study|Physician Decision|1|||
23488411|NCT02130024|65533846|FG001|Overall Study|Physician Decision|3|||
23488412|NCT02130024|65533845|FG000|Overall Study|Protocol Deviation|4|||
23664683|NCT01911442|66158565|FG001|Overall Study|Lack of Efficacy|1|||
23374847|NCT01739335|65116118|FG001|Overall Study|Lost to Follow-up|4|||
23374848|NCT01739335|65116117|FG000|Overall Study|Ineligible patient randomized|0|||
23374849|NCT01739335|65116118|FG001|Overall Study|Ineligible patient randomized|1|||
23374850|NCT03504917|65116119|FG000|Blinded Treatment Period|Protocol Violation|1|||
23374851|NCT03504917|65116120|FG001|Blinded Treatment Period|Protocol Violation|0|||
23374852|NCT03504917|65116119|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
23374853|NCT03504917|65116120|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
23374854|NCT03504917|65116119|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
23374855|NCT03504917|65116120|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
23374856|NCT03504917|65116119|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
23374857|NCT03504917|65116120|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
23374858|NCT03504917|65116119|FG000|Blinded Treatment Period|Adverse Event|4|||
23374859|NCT03504917|65116120|FG001|Blinded Treatment Period|Adverse Event|4|||
23374860|NCT03504917|65116119|FG000|Blinded Treatment Period|Physician Decision|1|||
23374861|NCT03504917|65116120|FG001|Blinded Treatment Period|Physician Decision|0|||
23374862|NCT03504917|65116119|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
23374863|NCT03504917|65116120|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
23374864|NCT03504917|65116119|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
23488413|NCT02130024|65533846|FG001|Overall Study|Protocol Deviation|0|||
23488414|NCT02130024|65533845|FG000|Overall Study|Site Administration Problems|1|||
23488415|NCT02130024|65533846|FG001|Overall Study|Site Administration Problems|0|||
23488416|NCT02130024|65533845|FG000|Overall Study|Subject Withdrew Consent|6|||
23488417|NCT02130024|65533846|FG001|Overall Study|Subject Withdrew Consent|14|||
23664684|NCT01911442|66158566|FG002|Overall Study|Lack of Efficacy|1|||
23664685|NCT01911442|66158564|FG000|Overall Study|Lost to Follow-up|2|||
23664686|NCT01911442|66158565|FG001|Overall Study|Lost to Follow-up|0|||
23664687|NCT01911442|66158566|FG002|Overall Study|Lost to Follow-up|1|||
23664688|NCT01911442|66158564|FG000|Overall Study|Withdrawal by Subject|1|||
23664689|NCT01911442|66158565|FG001|Overall Study|Withdrawal by Subject|0|||
23664690|NCT01911442|66158566|FG002|Overall Study|Withdrawal by Subject|6|||
23664691|NCT01911442|66158564|FG000|Overall Study|Mother's Work Schedule|0|||
23664692|NCT01911442|66158565|FG001|Overall Study|Mother's Work Schedule|1|||
23664693|NCT01911442|66158566|FG002|Overall Study|Mother's Work Schedule|0|||
23664694|NCT02025907|66158567|FG000|Overall Study|Lack of Efficacy|1|||
23664695|NCT02025907|66158568|FG001|Overall Study|Lack of Efficacy|0|||
23664696|NCT02025907|66158567|FG000|Overall Study|Withdrawal by Subject|15|||
23664697|NCT02025907|66158568|FG001|Overall Study|Withdrawal by Subject|8|||
23664698|NCT02025907|66158567|FG000|Overall Study|Protocol Violation|2|||
23664699|NCT02025907|66158568|FG001|Overall Study|Protocol Violation|0|||
23664700|NCT02025907|66158567|FG000|Overall Study|Physician Decision|2|||
23664701|NCT02025907|66158568|FG001|Overall Study|Physician Decision|0|||
23664702|NCT02025907|66158567|FG000|Overall Study|Lost to Follow-up|2|||
23664703|NCT02025907|66158568|FG001|Overall Study|Lost to Follow-up|2|||
23664704|NCT02025907|66158567|FG000|Overall Study|Adverse Event|3|||
23664705|NCT02025907|66158568|FG001|Overall Study|Adverse Event|1|||
23664706|NCT02025907|66158567|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
23664707|NCT02025907|66158568|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
23664708|NCT04143009|66158569|FG000|Pilot Trial|Lost to Follow-up|0|||
23664709|NCT04143009|66158570|FG001|Pilot Trial|Lost to Follow-up|1|||
23664710|NCT04143009|66158571|FG002|Pilot Trial|Lost to Follow-up|1|||
23664711|NCT02316340|66158576|FG000|First Progression|Clinical progression|2|||
23664712|NCT02316340|66158577|FG001|First Progression|Clinical progression|1|||
23664713|NCT02316340|66158576|FG000|First Progression|Withdrawal by Subject|1|||
23664714|NCT02316340|66158577|FG001|First Progression|Withdrawal by Subject|0|||
23664715|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
23664716|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
23664717|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
23664718|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
23664719|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
23664720|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
23664721|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
23664722|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
23664723|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
23664724|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
23664725|NCT00219284|66158582|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
23664726|NCT00219284|66158583|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
23488418|NCT01368432|65533850|FG000|Overall Study|Lost to Follow-up|0|||
23488419|NCT01368432|65533851|FG001|Overall Study|Lost to Follow-up|1|||
23664727|NCT00219284|66158582|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
23664728|NCT00219284|66158583|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
23664729|NCT00219284|66158582|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
23664730|NCT00219284|66158583|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
23374865|NCT03504917|65116120|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
23374866|NCT03504917|65116119|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
23374867|NCT03504917|65116120|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
23374868|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
23374869|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
23374870|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
23664731|NCT00219284|66158582|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
23664732|NCT00219284|66158583|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
23664733|NCT01236573|66158584|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23374871|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
23374872|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
23374873|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
23374874|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
23374875|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
23374876|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
23374877|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
23374878|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
23374879|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
23374880|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
23664734|NCT01236573|66158585|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23374881|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
23374882|NCT00350545|65116121|FG000|Overall Study|Withdrawal by Subject|2|||
23374883|NCT00720759|65116122|FG000|Overall Study|Lost to Follow-up|0|||
23374884|NCT00720759|65116123|FG001|Overall Study|Lost to Follow-up|1|||
23374885|NCT00720759|65116124|FG002|Overall Study|Lost to Follow-up|1|||
23374886|NCT00720759|65116125|FG003|Overall Study|Lost to Follow-up|0|||
23374887|NCT00141817|65116126|FG000|Overall Study|Protocol Violation|0|||
23374888|NCT00141817|65116127|FG001|Overall Study|Protocol Violation|0|||
23374889|NCT00141817|65116128|FG002|Overall Study|Protocol Violation|1|||
23374890|NCT00141817|65116129|FG003|Overall Study|Protocol Violation|0|||
23664735|NCT01236573|66158586|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664736|NCT01236573|66158587|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664737|NCT01236573|66158588|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664738|NCT01236573|66158589|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664739|NCT01236573|66158590|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23664740|NCT01236573|66158591|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664741|NCT01236573|66158592|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23664742|NCT01236573|66158593|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23664743|NCT01236573|66158594|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23664744|NCT01236573|66158584|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664745|NCT01236573|66158585|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664746|NCT01236573|66158586|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664747|NCT01236573|66158587|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664748|NCT01236573|66158588|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664749|NCT01236573|66158589|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664750|NCT01236573|66158590|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23374891|NCT00141817|65116126|FG000|Overall Study|Parent request|1|||
23664751|NCT01236573|66158591|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664752|NCT01236573|66158592|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
23664753|NCT01236573|66158593|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664754|NCT01236573|66158594|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23664755|NCT01236573|66158584|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664756|NCT01236573|66158585|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664757|NCT01236573|66158586|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664758|NCT01236573|66158587|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664759|NCT01236573|66158588|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664760|NCT01236573|66158589|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664761|NCT01236573|66158590|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664762|NCT01236573|66158591|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664763|NCT01236573|66158592|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664764|NCT01236573|66158593|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23664765|NCT01236573|66158594|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
23664766|NCT00688155|66158595|FG000|Overall Study|Withdrawal by Subject|2|||
23664767|NCT00688155|66158596|FG001|Overall Study|Withdrawal by Subject|2|||
23664768|NCT00688155|66158597|FG002|Overall Study|Withdrawal by Subject|1|||
23664769|NCT00688155|66158598|FG003|Overall Study|Withdrawal by Subject|1|||
23664770|NCT02285777|66158602|FG000|Overall Study|Withdrawal by Subject|1|||
23664771|NCT02285777|66158603|FG001|Overall Study|Withdrawal by Subject|1|||
23664772|NCT02285777|66158602|FG000|Overall Study|Lost to Follow-up|4|||
23664773|NCT02285777|66158603|FG001|Overall Study|Lost to Follow-up|2|||
23664774|NCT00552175|66158604|FG000|Overall Study|Lack of Efficacy|2|||
23664775|NCT00552175|66158605|FG001|Overall Study|Lack of Efficacy|0|||
23664776|NCT00552175|66158606|FG002|Overall Study|Lack of Efficacy|1|||
23664777|NCT00552175|66158604|FG000|Overall Study|Adverse Event|9|||
23664778|NCT00552175|66158605|FG001|Overall Study|Adverse Event|9|||
23664779|NCT00552175|66158606|FG002|Overall Study|Adverse Event|10|||
23664780|NCT00552175|66158604|FG000|Overall Study|Withdrawal by Subject|2|||
23664781|NCT00552175|66158605|FG001|Overall Study|Withdrawal by Subject|2|||
23664782|NCT00552175|66158606|FG002|Overall Study|Withdrawal by Subject|1|||
23374892|NCT00141817|65116127|FG001|Overall Study|Parent request|0|||
23664783|NCT00552175|66158604|FG000|Overall Study|Lost to Follow-up|0|||
23664784|NCT00552175|66158605|FG001|Overall Study|Lost to Follow-up|0|||
23664785|NCT00552175|66158606|FG002|Overall Study|Lost to Follow-up|1|||
23664786|NCT00552175|66158604|FG000|Overall Study|Entry Criteria Not Met|1|||
23488420|NCT04502979|65533864|FG000|Overall Study|Lost to Follow-up|1|||
23488421|NCT04502979|65533865|FG001|Overall Study|Lost to Follow-up|3|||
23488422|NCT04502979|65533864|FG000|Overall Study|Withdrawal by Subject|2|||
23488423|NCT04502979|65533865|FG001|Overall Study|Withdrawal by Subject|1|||
23488424|NCT00057876|65533867|FG000|Overall Study|Adverse Event|8|||
23488425|NCT00057876|65533868|FG001|Overall Study|Adverse Event|8|||
23488426|NCT00057876|65533867|FG000|Overall Study|Death|2|||
23488427|NCT00057876|65533868|FG001|Overall Study|Death|1|||
23488428|NCT00057876|65533867|FG000|Overall Study|Withdrawal by Subject|5|||
23488429|NCT00057876|65533868|FG001|Overall Study|Withdrawal by Subject|6|||
23488430|NCT00057876|65533867|FG000|Overall Study|Lack of Efficacy|10|||
23488431|NCT00057876|65533868|FG001|Overall Study|Lack of Efficacy|8|||
23488432|NCT00057876|65533867|FG000|Overall Study|Ineligible|1|||
23488433|NCT00057876|65533868|FG001|Overall Study|Ineligible|2|||
23488434|NCT00057876|65533867|FG000|Overall Study|other reason|2|||
23488435|NCT00057876|65533868|FG001|Overall Study|other reason|2|||
23488436|NCT00057876|65533867|FG000|Overall Study|other complicating disease|1|||
23488437|NCT00057876|65533868|FG001|Overall Study|other complicating disease|0|||
23488438|NCT00943124|65533869|FG000|Period 1|Withdrawal by Subject|1|||
23488439|NCT00943124|65533870|FG001|Period 1|Withdrawal by Subject|1|||
23488440|NCT00943124|65533869|FG000|Period 1|Did Not Follow Study Procedures|1|||
23488441|NCT00943124|65533870|FG001|Period 1|Did Not Follow Study Procedures|0|||
23488442|NCT00943124|65533869|FG000|Period 1|Personal Reasons|0|||
23488443|NCT00943124|65533870|FG001|Period 1|Personal Reasons|1|||
23488444|NCT00950911|65533875|FG000|Overall Study|Adverse Event|0|||
23488445|NCT00950911|65533876|FG001|Overall Study|Adverse Event|2|||
23488446|NCT00950911|65533875|FG000|Overall Study|Death|4|||
23488447|NCT00950911|65533876|FG001|Overall Study|Death|6|||
23488448|NCT00950911|65533875|FG000|Overall Study|Disease progression|2|||
23488449|NCT00950911|65533876|FG001|Overall Study|Disease progression|2|||
23488450|NCT00950911|65533875|FG000|Overall Study|Consent withdrawn|1|||
23488451|NCT00950911|65533876|FG001|Overall Study|Consent withdrawn|3|||
23488452|NCT00950911|65533875|FG000|Overall Study|Administrative decision|3|||
23488453|NCT00950911|65533876|FG001|Overall Study|Administrative decision|1|||
23488454|NCT00950911|65533875|FG000|Overall Study|Ineligibility determined|1|||
23488455|NCT00950911|65533876|FG001|Overall Study|Ineligibility determined|0|||
23488456|NCT00950911|65533875|FG000|Overall Study|Noncompliance|1|||
23488457|NCT00950911|65533876|FG001|Overall Study|Noncompliance|0|||
23488458|NCT00950911|65533875|FG000|Overall Study|Poor performance status|0|||
23488459|NCT00950911|65533876|FG001|Overall Study|Poor performance status|1|||
23488460|NCT02057393|65533877|FG000|Overall Study|Withdrawal by Subject|1|||
23488461|NCT02057393|65533877|FG000|Overall Study|Patient did not meet criteria|1|||
23488462|NCT00532155|65533878|FG000|Overall Study|Adverse Event|66|||
23488463|NCT00532155|65533879|FG001|Overall Study|Adverse Event|123|||
23488464|NCT00532155|65533878|FG000|Overall Study|Lack of Efficacy|332|||
23488465|NCT00532155|65533879|FG001|Overall Study|Lack of Efficacy|255|||
23488466|NCT00532155|65533878|FG000|Overall Study|Protocol Violation|1|||
23488467|NCT00532155|65533879|FG001|Overall Study|Protocol Violation|3|||
23488468|NCT00532155|65533878|FG000|Overall Study|Lost to Follow-up|2|||
23488469|NCT00532155|65533879|FG001|Overall Study|Lost to Follow-up|0|||
23488470|NCT00532155|65533878|FG000|Overall Study|Physician Decision|16|||
23488471|NCT00532155|65533879|FG001|Overall Study|Physician Decision|15|||
23488472|NCT00532155|65533878|FG000|Overall Study|Withdrawal by Subject|23|||
23488473|NCT00532155|65533879|FG001|Overall Study|Withdrawal by Subject|44|||
23488474|NCT00532155|65533878|FG000|Overall Study|Consent withdrawn|5|||
23488475|NCT00532155|65533879|FG001|Overall Study|Consent withdrawn|7|||
23488476|NCT00532155|65533878|FG000|Overall Study|Moved|1|||
23488477|NCT00532155|65533879|FG001|Overall Study|Moved|0|||
23488478|NCT00532155|65533878|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
23488479|NCT00532155|65533879|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
23374893|NCT00141817|65116128|FG002|Overall Study|Parent request|0|||
23488480|NCT00532155|65533878|FG000|Overall Study|Occurence of a second cancer|0|||
23488481|NCT00532155|65533879|FG001|Overall Study|Occurence of a second cancer|1|||
23488482|NCT00532155|65533878|FG000|Overall Study|Occurence of a secondary cancer|0|||
23488483|NCT00532155|65533879|FG001|Overall Study|Occurence of a secondary cancer|1|||
23488484|NCT00532155|65533878|FG000|Overall Study|Promotor ended study|1|||
23664787|NCT00552175|66158605|FG001|Overall Study|Entry Criteria Not Met|1|||
23664788|NCT00552175|66158606|FG002|Overall Study|Entry Criteria Not Met|0|||
23664789|NCT00552175|66158604|FG000|Overall Study|Reason Not Specified|3|||
23664790|NCT00552175|66158605|FG001|Overall Study|Reason Not Specified|1|||
23664791|NCT00552175|66158606|FG002|Overall Study|Reason Not Specified|1|||
23664792|NCT00761306|66158608|FG000|Overall Study|Adverse Event|5|||
23664793|NCT00761306|66158608|FG000|Overall Study|Lack of Efficacy|4|||
23664794|NCT00761306|66158608|FG000|Overall Study|Protocol Violation|2|||
23664795|NCT00761306|66158608|FG000|Overall Study|Withdrawal of Consent|3|||
23664796|NCT00761306|66158608|FG000|Overall Study|Lost to Follow-up|1|||
23664797|NCT00761306|66158608|FG000|Overall Study|Administrative or Other Reasons|5|||
23664798|NCT00549939|66158609|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
23664799|NCT00549939|66158610|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
23664800|NCT00549939|66158611|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
23664801|NCT00549939|66158609|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
23664802|NCT00549939|66158610|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
23664803|NCT00549939|66158611|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
23664804|NCT00549939|66158609|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
23374894|NCT00141817|65116129|FG003|Overall Study|Parent request|0|||
23374895|NCT03415178|65116134|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
23374896|NCT03415178|65116135|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
23374897|NCT03415178|65116134|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
23374898|NCT03415178|65116135|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
23402812|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
23402813|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
23402814|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
23402815|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
23402816|NCT04872569|65220015|FG000|Overall Study|Withdrawal by Subject|2|||
23402817|NCT02185534|65220017|FG000|First Period|Withdrawal by Subject|0|||
23402818|NCT02185534|65220018|FG001|First Period|Withdrawal by Subject|0|||
23402819|NCT02185534|65220019|FG002|First Period|Withdrawal by Subject|0|||
23402820|NCT02185534|65220020|FG003|First Period|Withdrawal by Subject|1|||
23402821|NCT02185534|65220021|FG004|First Period|Withdrawal by Subject|0|||
23402822|NCT02185534|65220022|FG005|First Period|Withdrawal by Subject|0|||
23402823|NCT02185534|65220017|FG000|First Washout Period|Withdrawal by Subject|1|||
23402824|NCT02185534|65220018|FG001|First Washout Period|Withdrawal by Subject|0|||
23402825|NCT02185534|65220019|FG002|First Washout Period|Withdrawal by Subject|0|||
23402826|NCT02185534|65220020|FG003|First Washout Period|Withdrawal by Subject|0|||
23402827|NCT02185534|65220021|FG004|First Washout Period|Withdrawal by Subject|1|||
23664805|NCT00549939|66158610|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
23664806|NCT00549939|66158611|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
23488485|NCT00532155|65533879|FG001|Overall Study|Promotor ended study|0|||
23488486|NCT00532155|65533878|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
23488487|NCT00532155|65533879|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
23488488|NCT00532155|65533878|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
23488489|NCT00532155|65533879|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
23488490|NCT00532155|65533878|FG000|Overall Study|Study stopped|1|||
23488491|NCT00532155|65533879|FG001|Overall Study|Study stopped|0|||
23488492|NCT00532155|65533878|FG000|Overall Study|Study terminated by sponsor|1|||
23488493|NCT00532155|65533879|FG001|Overall Study|Study terminated by sponsor|0|||
23488494|NCT00532155|65533878|FG000|Overall Study|Study termination stop further treatment|4|||
23488495|NCT00532155|65533879|FG001|Overall Study|Study termination stop further treatment|0|||
23488496|NCT00532155|65533878|FG000|Overall Study|Did not receive study medication|2|||
23488497|NCT00532155|65533879|FG001|Overall Study|Did not receive study medication|6|||
23488498|NCT00591344|65533880|FG000|Overall Study|Transportation issues|1|||
23488499|NCT00591344|65533881|FG001|Overall Study|Transportation issues|0|||
23488500|NCT00591344|65533880|FG000|Overall Study|Moved out of state|1|||
23488501|NCT00591344|65533881|FG001|Overall Study|Moved out of state|0|||
23488502|NCT00591344|65533880|FG000|Overall Study|Medical complications|1|||
23488503|NCT00591344|65533881|FG001|Overall Study|Medical complications|3|||
23488504|NCT00591344|65533880|FG000|Overall Study|Underwent DBS|2|||
23488505|NCT00591344|65533881|FG001|Overall Study|Underwent DBS|2|||
23488506|NCT00591344|65533880|FG000|Overall Study|Death|0|||
23488507|NCT00591344|65533881|FG001|Overall Study|Death|1|||
23488508|NCT00591344|65533880|FG000|Overall Study|Lost to Follow-up|0|||
23488509|NCT00591344|65533881|FG001|Overall Study|Lost to Follow-up|1|||
23488510|NCT00591344|65533880|FG000|Overall Study|Did not want to come off medication|0|||
23488511|NCT00591344|65533881|FG001|Overall Study|Did not want to come off medication|1|||
23488512|NCT01904058|65533882|FG000|Overall Study|Adverse Event|2|||
23488513|NCT01904058|65533883|FG001|Overall Study|Adverse Event|0|||
23488514|NCT01904058|65533884|FG002|Overall Study|Adverse Event|0|||
23488515|NCT01904058|65533885|FG003|Overall Study|Adverse Event|0|||
23488516|NCT01904058|65533882|FG000|Overall Study|Withdrawal by Subject|1|||
23488517|NCT01904058|65533883|FG001|Overall Study|Withdrawal by Subject|0|||
23488518|NCT01904058|65533884|FG002|Overall Study|Withdrawal by Subject|1|||
23488519|NCT01904058|65533885|FG003|Overall Study|Withdrawal by Subject|0|||
23488520|NCT01904058|65533882|FG000|Overall Study|Pregnancy|0|||
23488521|NCT01904058|65533883|FG001|Overall Study|Pregnancy|0|||
23488522|NCT01904058|65533884|FG002|Overall Study|Pregnancy|0|||
23488523|NCT01904058|65533885|FG003|Overall Study|Pregnancy|1|||
23488524|NCT01795638|65533889|FG000|Overall Study|Death|0|||
23488525|NCT01795638|65533890|FG001|Overall Study|Death|3|||
23488526|NCT01795638|65533889|FG000|Overall Study|transferred to quaternary hospital|2|||
23488527|NCT01795638|65533890|FG001|Overall Study|transferred to quaternary hospital|3|||
23488528|NCT01795638|65533889|FG000|Overall Study|Protocol Violation|3|||
23488529|NCT01795638|65533890|FG001|Overall Study|Protocol Violation|0|||
23488530|NCT01795638|65533889|FG000|Overall Study|discharged from hospital|7|||
23488531|NCT01795638|65533890|FG001|Overall Study|discharged from hospital|5|||
23488532|NCT01795638|65533889|FG000|Overall Study|Withdrawal by Subject|1|||
23488533|NCT01795638|65533890|FG001|Overall Study|Withdrawal by Subject|0|||
23488534|NCT01977937|65533891|FG000|Overall Study|Withdrawal by Subject|2|||
23488535|NCT01977937|65533892|FG001|Overall Study|Withdrawal by Subject|1|||
23488536|NCT01977937|65533891|FG000|Overall Study|Adverse Event|1|||
23488537|NCT01977937|65533892|FG001|Overall Study|Adverse Event|0|||
23488538|NCT01977937|65533891|FG000|Overall Study|Physician Decision|0|||
23488539|NCT01977937|65533892|FG001|Overall Study|Physician Decision|1|||
23488540|NCT03187756|65533893|FG000|Overall Study|Termination of study|4|||
23488541|NCT00598702|65533896|FG000|Overall Study|Other|0|||
23488542|NCT00598702|65533897|FG001|Overall Study|Other|2|||
23604027|NCT00645411|65940282|FG002|Overall Study|Withdrawal by Subject|19|||
23604028|NCT00645411|65940283|FG003|Overall Study|Withdrawal by Subject|21|||
23488543|NCT00598702|65533898|FG002|Overall Study|Other|0|||
23664807|NCT00549939|66158609|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
23488544|NCT00598702|65533899|FG003|Overall Study|Other|0|||
23488545|NCT00598702|65533900|FG004|Overall Study|Other|0|||
23488546|NCT00598702|65533901|FG005|Overall Study|Other|1|||
23488547|NCT00598702|65533902|FG006|Overall Study|Other|0|||
23488548|NCT00598702|65533903|FG007|Overall Study|Other|0|||
23488549|NCT00598702|65533896|FG000|Overall Study|Early discharge from hospital|0|||
23488550|NCT00598702|65533897|FG001|Overall Study|Early discharge from hospital|0|||
23604029|NCT00645411|65940280|FG000|Overall Study|Lost to Follow-up|10|||
23488551|NCT00598702|65533898|FG002|Overall Study|Early discharge from hospital|2|||
23488552|NCT00598702|65533899|FG003|Overall Study|Early discharge from hospital|5|||
23488553|NCT00598702|65533900|FG004|Overall Study|Early discharge from hospital|0|||
23488554|NCT00598702|65533901|FG005|Overall Study|Early discharge from hospital|10|||
23488555|NCT00598702|65533902|FG006|Overall Study|Early discharge from hospital|1|||
23488556|NCT00598702|65533903|FG007|Overall Study|Early discharge from hospital|0|||
23488557|NCT00598702|65533896|FG000|Overall Study|Adverse Event|0|||
23488558|NCT00598702|65533897|FG001|Overall Study|Adverse Event|0|||
23488559|NCT00598702|65533898|FG002|Overall Study|Adverse Event|0|||
23488560|NCT00598702|65533899|FG003|Overall Study|Adverse Event|1|||
23488561|NCT00598702|65533900|FG004|Overall Study|Adverse Event|0|||
23488562|NCT00598702|65533901|FG005|Overall Study|Adverse Event|0|||
23488563|NCT00598702|65533902|FG006|Overall Study|Adverse Event|0|||
23488564|NCT00598702|65533903|FG007|Overall Study|Adverse Event|0|||
23488565|NCT00598702|65533896|FG000|Overall Study|Withdrawal by Subject|0|||
23488566|NCT00598702|65533897|FG001|Overall Study|Withdrawal by Subject|0|||
23488567|NCT00598702|65533898|FG002|Overall Study|Withdrawal by Subject|0|||
23488568|NCT00598702|65533899|FG003|Overall Study|Withdrawal by Subject|1|||
23488569|NCT00598702|65533900|FG004|Overall Study|Withdrawal by Subject|1|||
23488570|NCT00598702|65533901|FG005|Overall Study|Withdrawal by Subject|0|||
23488571|NCT00598702|65533902|FG006|Overall Study|Withdrawal by Subject|0|||
23488572|NCT00598702|65533903|FG007|Overall Study|Withdrawal by Subject|0|||
23488573|NCT00598702|65533896|FG000|Overall Study|Physician Decision|0|||
23488574|NCT00598702|65533897|FG001|Overall Study|Physician Decision|0|||
23488575|NCT00598702|65533898|FG002|Overall Study|Physician Decision|0|||
23488576|NCT00598702|65533899|FG003|Overall Study|Physician Decision|0|||
23488577|NCT00598702|65533900|FG004|Overall Study|Physician Decision|1|||
23488578|NCT00598702|65533901|FG005|Overall Study|Physician Decision|0|||
23488579|NCT00598702|65533902|FG006|Overall Study|Physician Decision|0|||
23488580|NCT00598702|65533903|FG007|Overall Study|Physician Decision|0|||
23488581|NCT00598702|65533896|FG000|Overall Study|Dose limiting toxicity|0|||
23488582|NCT00598702|65533897|FG001|Overall Study|Dose limiting toxicity|0|||
23664808|NCT00549939|66158610|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
23664809|NCT00549939|66158611|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
23488583|NCT00598702|65533898|FG002|Overall Study|Dose limiting toxicity|0|||
23488584|NCT00598702|65533899|FG003|Overall Study|Dose limiting toxicity|1|||
23488585|NCT00598702|65533900|FG004|Overall Study|Dose limiting toxicity|1|||
23488586|NCT00598702|65533901|FG005|Overall Study|Dose limiting toxicity|1|||
23488587|NCT00598702|65533902|FG006|Overall Study|Dose limiting toxicity|0|||
23488588|NCT00598702|65533903|FG007|Overall Study|Dose limiting toxicity|0|||
23374899|NCT01047319|65119301|FG000|Overall Study|Teva requested participant withdrawal|3|||
23374900|NCT01047319|65119302|FG001|Overall Study|Teva requested participant withdrawal|0|||
23374901|NCT01047319|65119303|FG002|Overall Study|Teva requested participant withdrawal|1|||
23374902|NCT01047319|65119301|FG000|Overall Study|Protocol Violation|3|||
23374903|NCT01047319|65119302|FG001|Overall Study|Protocol Violation|2|||
23374904|NCT01047319|65119303|FG002|Overall Study|Protocol Violation|4|||
23374905|NCT01047319|65119301|FG000|Overall Study|Lack of Efficacy|4|||
23374906|NCT01047319|65119302|FG001|Overall Study|Lack of Efficacy|3|||
23374907|NCT01047319|65119303|FG002|Overall Study|Lack of Efficacy|3|||
23374908|NCT01047319|65119301|FG000|Overall Study|Death|5|||
23374909|NCT01047319|65119302|FG001|Overall Study|Death|1|||
23374910|NCT01047319|65119303|FG002|Overall Study|Death|5|||
23374911|NCT01047319|65119301|FG000|Overall Study|Pregnancy|13|||
23374912|NCT01047319|65119302|FG001|Overall Study|Pregnancy|8|||
23488589|NCT02435147|65533908|FG000|Overall Study|non-evaluable DXA scan|11|||
23374913|NCT01047319|65119303|FG002|Overall Study|Pregnancy|8|||
23374914|NCT01047319|65119301|FG000|Overall Study|Physician Decision|12|||
23374915|NCT01047319|65119302|FG001|Overall Study|Physician Decision|9|||
23374916|NCT01047319|65119303|FG002|Overall Study|Physician Decision|10|||
23374917|NCT01047319|65119301|FG000|Overall Study|Lost to Follow-up|14|||
23374918|NCT01047319|65119302|FG001|Overall Study|Lost to Follow-up|10|||
23374919|NCT01047319|65119303|FG002|Overall Study|Lost to Follow-up|10|||
23374920|NCT01047319|65119301|FG000|Overall Study|Adverse Event|16|||
23374921|NCT01047319|65119302|FG001|Overall Study|Adverse Event|27|||
23374922|NCT01047319|65119303|FG002|Overall Study|Adverse Event|21|||
23374923|NCT01047319|65119301|FG000|Overall Study|Withdrawal by Subject|77|||
23374924|NCT01047319|65119302|FG001|Overall Study|Withdrawal by Subject|75|||
23374925|NCT01047319|65119303|FG002|Overall Study|Withdrawal by Subject|87|||
23374926|NCT01047319|65119301|FG000|Overall Study|Study terminated by Sponsor|198|||
23374927|NCT01047319|65119302|FG001|Overall Study|Study terminated by Sponsor|215|||
23374928|NCT01047319|65119303|FG002|Overall Study|Study terminated by Sponsor|203|||
23374929|NCT03095287|65119304|FG000|Overall Study|Treatment Failure|1|||
23374930|NCT03095287|65119304|FG000|Overall Study|Adverse Event|1|||
23374931|NCT01056536|65119311|FG000|Overall Study|Lost to Follow-up|202|||
23374932|NCT01056536|65119312|FG001|Overall Study|Lost to Follow-up|116|||
23374933|NCT01056536|65119313|FG002|Overall Study|Lost to Follow-up|248|||
23374934|NCT04919161|65119314|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
23374935|NCT04919161|65119315|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
23374936|NCT04919161|65119314|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
23374937|NCT04919161|65119315|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
23374938|NCT04919161|65119314|FG000|Overall Study|Acute ankle sprain after session 1|0|||
23374939|NCT04919161|65119315|FG001|Overall Study|Acute ankle sprain after session 1|1|||
23374940|NCT00658528|65119316|FG000|Overall Study|Adverse Event|5|||
23374941|NCT00658528|65119317|FG001|Overall Study|Adverse Event|7|||
23374942|NCT00658528|65119316|FG000|Overall Study|Lost to Follow-up|14|||
23374943|NCT00658528|65119317|FG001|Overall Study|Lost to Follow-up|22|||
23374944|NCT00658528|65119316|FG000|Overall Study|Withdrawal by Subject|8|||
23374945|NCT00658528|65119317|FG001|Overall Study|Withdrawal by Subject|6|||
23374946|NCT00658528|65119316|FG000|Overall Study|Withdrawal of consent|5|||
23374947|NCT00658528|65119317|FG001|Overall Study|Withdrawal of consent|6|||
23374948|NCT00658528|65119316|FG000|Overall Study|Other|8|||
23374949|NCT00658528|65119317|FG001|Overall Study|Other|4|||
23374950|NCT00423605|65119318|FG000|Overall Study|Adverse Event|129|||
23374951|NCT00423605|65119318|FG000|Overall Study|Withdrawal by Subject|36|||
23374952|NCT00423605|65119318|FG000|Overall Study|Lost to Follow-up|15|||
23374953|NCT00423605|65119318|FG000|Overall Study|Lack of Efficacy|38|||
23374954|NCT00423605|65119318|FG000|Overall Study|Sponsor Decision|3|||
23374955|NCT00423605|65119318|FG000|Overall Study|Physician Decision|8|||
23374956|NCT00423605|65119318|FG000|Overall Study|Protocol Violation|7|||
23374957|NCT00423605|65119318|FG000|Overall Study|Not one of the pre-specified options|5|||
23374958|NCT02369653|65119319|FG000|Overall Study|Lost to Follow-up|0|||
23374959|NCT02369653|65119320|FG001|Overall Study|Lost to Follow-up|1|||
23374960|NCT02369653|65119319|FG000|Overall Study|Administrative reason by sponsor|0|||
23374961|NCT02369653|65119320|FG001|Overall Study|Administrative reason by sponsor|1|||
23374962|NCT02369653|65119319|FG000|Overall Study|Death|1|||
23374963|NCT02369653|65119320|FG001|Overall Study|Death|2|||
23374964|NCT02369653|65119319|FG000|Overall Study|Participant withdrew consent|13|||
23374965|NCT02369653|65119320|FG001|Overall Study|Participant withdrew consent|3|||
23488590|NCT03190369|65533909|FG000|Overall Study|Poor compliance to protocol|0|||
23488591|NCT03190369|65533910|FG001|Overall Study|Poor compliance to protocol|1|||
23374966|NCT01799941|65119321|FG000|Overall Study|Adverse Event|34|||
23374967|NCT01799941|65119321|FG000|Overall Study|Withdrawal by Subject|21|||
23374968|NCT01799941|65119321|FG000|Overall Study|Death|2|||
23374969|NCT01799941|65119321|FG000|Overall Study|Investigator Decision|4|||
23374970|NCT01799941|65119321|FG000|Overall Study|Lack of Efficacy|3|||
23374971|NCT01799941|65119321|FG000|Overall Study|Lost to Follow-up|17|||
23374972|NCT01799941|65119321|FG000|Overall Study|Other|15|||
23374973|NCT03861039|65119324|FG000|Overall Study|Adverse Event|2|||
23374974|NCT03861039|65119325|FG001|Overall Study|Adverse Event|5|||
23374975|NCT03861039|65119326|FG002|Overall Study|Adverse Event|11|||
23374976|NCT03861039|65119324|FG000|Overall Study|Withdrawal by Subject|1|||
23374977|NCT03861039|65119325|FG001|Overall Study|Withdrawal by Subject|3|||
23374978|NCT03861039|65119326|FG002|Overall Study|Withdrawal by Subject|4|||
23374979|NCT04400318|65119327|FG000|Overall Study|Adverse Event|1|||
23374980|NCT04400318|65119328|FG001|Overall Study|Adverse Event|0|||
23374981|NCT04400318|65119327|FG000|Overall Study|Withdrawal by Subject|1|||
23374982|NCT04400318|65119328|FG001|Overall Study|Withdrawal by Subject|1|||
23374983|NCT04400318|65119327|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
23374984|NCT04400318|65119328|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
23374985|NCT02034006|65119335|FG000|Overall Study|Withdrawal by Subject|7|||
23374986|NCT02034006|65119335|FG000|Overall Study|Lost to Follow-up|5|||
23374987|NCT02034006|65119335|FG000|Overall Study|Death|1|||
23374988|NCT02034006|65119335|FG000|Overall Study|Pregnancy|1|||
23374989|NCT01461551|65119336|FG000|Overall Study|Physician Decision|2|||
23374990|NCT01461551|65119337|FG001|Overall Study|Physician Decision|1|||
23374991|NCT01461551|65119338|FG002|Overall Study|Physician Decision|2|||
23374992|NCT02577029|65119343|FG000|Overall Study|Adverse Event|1|||
23374993|NCT02577029|65119344|FG001|Overall Study|Adverse Event|0|||
23374994|NCT02577029|65119345|FG002|Overall Study|Adverse Event|2|||
23374995|NCT02577029|65119346|FG003|Overall Study|Adverse Event|0|||
23374996|NCT02577029|65119347|FG004|Overall Study|Adverse Event|1|||
23374997|NCT02577029|65119348|FG005|Overall Study|Adverse Event|0|||
23374998|NCT02577029|65119349|FG006|Overall Study|Adverse Event|0|||
23374999|NCT02577029|65119350|FG007|Overall Study|Adverse Event|0|||
23375000|NCT02577029|65119343|FG000|Overall Study|Withdrawal by Subject|0|||
23375001|NCT02577029|65119344|FG001|Overall Study|Withdrawal by Subject|0|||
23375002|NCT02577029|65119345|FG002|Overall Study|Withdrawal by Subject|0|||
23375003|NCT02577029|65119346|FG003|Overall Study|Withdrawal by Subject|0|||
23375004|NCT02577029|65119347|FG004|Overall Study|Withdrawal by Subject|0|||
23375005|NCT02577029|65119348|FG005|Overall Study|Withdrawal by Subject|1|||
23375006|NCT02577029|65119349|FG006|Overall Study|Withdrawal by Subject|0|||
23375007|NCT02577029|65119350|FG007|Overall Study|Withdrawal by Subject|0|||
23375008|NCT02577029|65119343|FG000|Overall Study|Sponsor Termination of the Study|9|||
23375009|NCT02577029|65119344|FG001|Overall Study|Sponsor Termination of the Study|2|||
23375010|NCT02577029|65119345|FG002|Overall Study|Sponsor Termination of the Study|5|||
23375011|NCT02577029|65119346|FG003|Overall Study|Sponsor Termination of the Study|12|||
23375012|NCT02577029|65119347|FG004|Overall Study|Sponsor Termination of the Study|10|||
23375013|NCT02577029|65119348|FG005|Overall Study|Sponsor Termination of the Study|12|||
23375014|NCT02577029|65119349|FG006|Overall Study|Sponsor Termination of the Study|12|||
23375015|NCT02577029|65119350|FG007|Overall Study|Sponsor Termination of the Study|12|||
23375016|NCT02357459|65119351|FG000|Overall Study|Adverse Event|0|||
23375017|NCT02357459|65119352|FG001|Overall Study|Adverse Event|1|||
23375018|NCT02357459|65119353|FG002|Overall Study|Adverse Event|1|||
23375019|NCT02357459|65119351|FG000|Overall Study|Withdrawal by Subject|5|||
23375020|NCT02357459|65119352|FG001|Overall Study|Withdrawal by Subject|3|||
23375021|NCT02357459|65119353|FG002|Overall Study|Withdrawal by Subject|3|||
23375022|NCT02357459|65119351|FG000|Overall Study|Physician Decision|0|||
23375023|NCT02357459|65119352|FG001|Overall Study|Physician Decision|2|||
23375024|NCT02357459|65119353|FG002|Overall Study|Physician Decision|0|||
23375025|NCT02357459|65119351|FG000|Overall Study|Protocol Violation|1|||
23375026|NCT02357459|65119352|FG001|Overall Study|Protocol Violation|1|||
23375027|NCT02357459|65119353|FG002|Overall Study|Protocol Violation|0|||
23375028|NCT02357459|65119351|FG000|Overall Study|Lost to Follow-up|1|||
23375029|NCT02357459|65119352|FG001|Overall Study|Lost to Follow-up|3|||
23375030|NCT02357459|65119353|FG002|Overall Study|Lost to Follow-up|0|||
23375031|NCT02357459|65119351|FG000|Overall Study|Lack of Efficacy|7|||
23375032|NCT02357459|65119352|FG001|Overall Study|Lack of Efficacy|4|||
23375033|NCT02357459|65119353|FG002|Overall Study|Lack of Efficacy|4|||
23375034|NCT02357459|65119351|FG000|Overall Study|Patient Relocated|2|||
23375035|NCT02357459|65119352|FG001|Overall Study|Patient Relocated|0|||
23375036|NCT02357459|65119353|FG002|Overall Study|Patient Relocated|0|||
23375037|NCT02357459|65119351|FG000|Overall Study|Instruction from PCP|1|||
23375038|NCT02357459|65119352|FG001|Overall Study|Instruction from PCP|0|||
23375039|NCT02357459|65119353|FG002|Overall Study|Instruction from PCP|0|||
23375040|NCT02357459|65119351|FG000|Overall Study|Incarceration|0|||
23375041|NCT02357459|65119352|FG001|Overall Study|Incarceration|0|||
23375042|NCT02357459|65119353|FG002|Overall Study|Incarceration|1|||
23375043|NCT02357459|65119351|FG000|Overall Study|Pre-planned Knee surgery|0|||
23488592|NCT03190369|65533909|FG000|Overall Study|Withdraw before treatment|1|||
23375044|NCT02357459|65119352|FG001|Overall Study|Pre-planned Knee surgery|0|||
23375045|NCT02357459|65119353|FG002|Overall Study|Pre-planned Knee surgery|2|||
23375046|NCT02357459|65119351|FG000|Overall Study|Job Commitments|0|||
23375047|NCT02357459|65119352|FG001|Overall Study|Job Commitments|0|||
23375048|NCT02357459|65119353|FG002|Overall Study|Job Commitments|1|||
23375049|NCT03091439|65119354|FG000|Overall Study|Study Terminated by the Sponsor|1|||
23375050|NCT03091439|65119355|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23488593|NCT03190369|65533910|FG001|Overall Study|Withdraw before treatment|5|||
23375051|NCT00700635|65119356|FG000|Overall Study|Adverse Event|1|||
23375052|NCT00700635|65119357|FG001|Overall Study|Adverse Event|0|||
23375053|NCT00700635|65119358|FG002|Overall Study|Adverse Event|0|||
23375054|NCT00700635|65119356|FG000|Overall Study|Lost to Follow-up|1|||
23375055|NCT00700635|65119357|FG001|Overall Study|Lost to Follow-up|3|||
23375056|NCT00700635|65119358|FG002|Overall Study|Lost to Follow-up|0|||
23375057|NCT00700635|65119356|FG000|Overall Study|Protocol Violation|2|||
23375058|NCT00700635|65119357|FG001|Overall Study|Protocol Violation|2|||
23375059|NCT00700635|65119358|FG002|Overall Study|Protocol Violation|0|||
23375060|NCT00700635|65119356|FG000|Overall Study|Withdrawal by Subject|7|||
23375061|NCT00700635|65119357|FG001|Overall Study|Withdrawal by Subject|3|||
23375062|NCT00700635|65119358|FG002|Overall Study|Withdrawal by Subject|1|||
23375063|NCT02337764|65119359|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
23375064|NCT02337764|65119359|FG000|Overall Study|Voluntary Withdrawal|12|||
23375065|NCT02337764|65119359|FG000|Overall Study|Lack of Efficacy|2|||
23375066|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
23604030|NCT00645411|65940281|FG001|Overall Study|Lost to Follow-up|5|||
23375067|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
23375068|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
23375069|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
23375070|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
23375071|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
23375072|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
23375073|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
23375074|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
23375075|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
23375076|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
23375077|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
23375078|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
23375079|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
23375080|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
23375081|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
23375082|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23375083|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
23375084|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23375085|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
23375086|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
23375087|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
23375088|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
23375089|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
23375090|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
23375091|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
23375092|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23375093|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23375094|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
23375095|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
23375096|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
23375097|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
23375098|NCT03329885|65119362|FG000|Overall Study|Sponsor discontinued the study early|0|||
23375099|NCT03329885|65119363|FG001|Overall Study|Sponsor discontinued the study early|0|||
23375100|NCT03329885|65119364|FG002|Overall Study|Sponsor discontinued the study early|0|||
23375101|NCT03329885|65119365|FG003|Overall Study|Sponsor discontinued the study early|0|||
23375102|NCT03329885|65119366|FG004|Overall Study|Sponsor discontinued the study early|0|||
23375103|NCT03329885|65119367|FG005|Overall Study|Sponsor discontinued the study early|0|||
23375104|NCT03329885|65119368|FG006|Overall Study|Sponsor discontinued the study early|1|||
23375105|NCT03329885|65119369|FG007|Overall Study|Sponsor discontinued the study early|1|||
23375106|NCT03329885|65119370|FG008|Overall Study|Sponsor discontinued the study early|0|||
23375107|NCT00695019|65119373|FG000|Overall Study|Withdrawal by Subject|8|||
23375108|NCT00695019|65119374|FG001|Overall Study|Withdrawal by Subject|6|||
23375109|NCT00695019|65119375|FG002|Overall Study|Withdrawal by Subject|4|||
23375110|NCT00695019|65119373|FG000|Overall Study|Protocol Violation|1|||
23375111|NCT00695019|65119374|FG001|Overall Study|Protocol Violation|3|||
23375112|NCT00695019|65119375|FG002|Overall Study|Protocol Violation|1|||
23375113|NCT00695019|65119373|FG000|Overall Study|Lack of Efficacy|0|||
23375114|NCT00695019|65119374|FG001|Overall Study|Lack of Efficacy|0|||
23375115|NCT00695019|65119375|FG002|Overall Study|Lack of Efficacy|1|||
23375116|NCT00695019|65119373|FG000|Overall Study|Various|4|||
23375117|NCT00695019|65119374|FG001|Overall Study|Various|5|||
23375118|NCT00695019|65119375|FG002|Overall Study|Various|4|||
23375119|NCT02783911|65119376|FG000|Overall Study|Lost to Follow-up|3|||
23375120|NCT02783911|65119377|FG001|Overall Study|Lost to Follow-up|32|||
23375121|NCT00157755|65119378|FG000|Overall Study|Death|2|||
23375122|NCT00157755|65119379|FG001|Overall Study|Death|3|||
23488594|NCT03190369|65533909|FG000|Overall Study|Randomized but not treated|0|||
23488595|NCT03190369|65533910|FG001|Overall Study|Randomized but not treated|2|||
23488596|NCT01180647|65533911|FG000|Overall Study|Lost to Follow-up|5|||
23488597|NCT01180647|65533912|FG001|Overall Study|Lost to Follow-up|6|||
23488598|NCT01528215|65533913|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
23488599|NCT01528215|65533914|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
23488600|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
23488601|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
23488602|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
23375123|NCT00157755|65119380|FG002|Overall Study|Death|3|||
23488603|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
23375124|NCT00157755|65119381|FG003|Overall Study|Death|2|||
23375125|NCT00157755|65119382|FG004|Overall Study|Death|0|||
23604031|NCT00645411|65940282|FG002|Overall Study|Lost to Follow-up|124|||
23604032|NCT00645411|65940283|FG003|Overall Study|Lost to Follow-up|75|||
23375126|NCT00157755|65119383|FG005|Overall Study|Death|0|||
23488604|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
23488605|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
23488606|NCT02853344|65533915|FG000|Overall Study|Lost to Follow-up|1|||
23488607|NCT02853344|65533916|FG001|Overall Study|Lost to Follow-up|1|||
23488608|NCT02853344|65533915|FG000|Overall Study|Withdrawal by Subject|2|||
23488609|NCT02853344|65533916|FG001|Overall Study|Withdrawal by Subject|4|||
23488610|NCT02853344|65533915|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
23488611|NCT02853344|65533916|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
23488612|NCT02853344|65533915|FG000|Overall Study|Death|70|||
23488613|NCT02853344|65533916|FG001|Overall Study|Death|112|||
23488614|NCT02106910|65533917|FG000|Overall Study|Lost to Follow-up|1|||
23488615|NCT02106910|65533918|FG001|Overall Study|Lost to Follow-up|1|||
23488616|NCT02507973|65533919|FG000|Overall Study|Adverse Event|1|||
23488617|NCT02204007|65533924|FG000|Overall Study|Surgery Canceled|1|||
23488618|NCT02204007|65533925|FG001|Overall Study|Surgery Canceled|1|||
23488619|NCT01865084|65533926|FG000|Double Blind Period (DB)|Adverse Event|2|||
23488620|NCT01865084|65533927|FG001|Double Blind Period (DB)|Adverse Event|2|||
23488621|NCT01865084|65533928|FG002|Double Blind Period (DB)|Adverse Event|1|||
23488622|NCT01865084|65533926|FG000|Double Blind Period (DB)|Protocol Violation|0|||
23488623|NCT01865084|65533927|FG001|Double Blind Period (DB)|Protocol Violation|0|||
23488624|NCT01865084|65533928|FG002|Double Blind Period (DB)|Protocol Violation|1|||
23488625|NCT01865084|65533926|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
23488626|NCT01865084|65533927|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
23488627|NCT01865084|65533928|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
23488628|NCT01865084|65533926|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
23488629|NCT01865084|65533927|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
23488630|NCT01865084|65533928|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
23488631|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
23488632|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
23488633|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
23488634|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
23488635|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
23488636|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
23488637|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
23488638|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
23488639|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
23488640|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
23488641|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
23488642|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
23488643|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
23488644|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
23488645|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
23488646|NCT04447755|65533930|FG000|Overall Study|Death|8|||
23488647|NCT04447755|65533931|FG001|Overall Study|Death|14|||
23488648|NCT04447755|65533932|FG002|Overall Study|Death|8|||
23488649|NCT04447755|65533933|FG003|Overall Study|Death|9|||
23488650|NCT04447755|65533934|FG004|Overall Study|Death|7|||
23488651|NCT04447755|65533935|FG005|Overall Study|Death|7|||
23488652|NCT04447755|65533936|FG006|Overall Study|Death|40|||
23488653|NCT04447755|65533930|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23488654|NCT04447755|65533931|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23488655|NCT04447755|65533932|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23488656|NCT04447755|65533933|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23488657|NCT04447755|65533934|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23375127|NCT00157755|65119378|FG000|Overall Study|Lost to Follow-up|0|||
23375128|NCT00157755|65119379|FG001|Overall Study|Lost to Follow-up|0|||
23375129|NCT00157755|65119380|FG002|Overall Study|Lost to Follow-up|1|||
23375130|NCT00157755|65119381|FG003|Overall Study|Lost to Follow-up|0|||
23375131|NCT00157755|65119382|FG004|Overall Study|Lost to Follow-up|0|||
23375132|NCT00157755|65119383|FG005|Overall Study|Lost to Follow-up|0|||
23375133|NCT00157755|65119378|FG000|Overall Study|Withdrawal by Subject|0|||
23375134|NCT00157755|65119379|FG001|Overall Study|Withdrawal by Subject|0|||
23375135|NCT00157755|65119380|FG002|Overall Study|Withdrawal by Subject|1|||
23375136|NCT00157755|65119381|FG003|Overall Study|Withdrawal by Subject|1|||
23375137|NCT00157755|65119382|FG004|Overall Study|Withdrawal by Subject|1|||
23375138|NCT00157755|65119383|FG005|Overall Study|Withdrawal by Subject|2|||
23375139|NCT00157755|65119378|FG000|Overall Study|Explant due to infection|0|||
23375140|NCT00157755|65119379|FG001|Overall Study|Explant due to infection|0|||
23375141|NCT00157755|65119380|FG002|Overall Study|Explant due to infection|1|||
23375142|NCT00157755|65119381|FG003|Overall Study|Explant due to infection|0|||
23375143|NCT00157755|65119382|FG004|Overall Study|Explant due to infection|0|||
23375144|NCT00157755|65119383|FG005|Overall Study|Explant due to infection|0|||
23375145|NCT00157755|65119378|FG000|Overall Study|Medical reason|0|||
23375146|NCT00157755|65119379|FG001|Overall Study|Medical reason|0|||
23375147|NCT00157755|65119380|FG002|Overall Study|Medical reason|1|||
23375148|NCT00157755|65119381|FG003|Overall Study|Medical reason|1|||
23375149|NCT00157755|65119382|FG004|Overall Study|Medical reason|0|||
23375150|NCT00157755|65119383|FG005|Overall Study|Medical reason|0|||
23375151|NCT00157755|65119378|FG000|Overall Study|Study site closure|0|||
23375152|NCT00157755|65119379|FG001|Overall Study|Study site closure|1|||
23375153|NCT00157755|65119380|FG002|Overall Study|Study site closure|0|||
23375154|NCT00157755|65119381|FG003|Overall Study|Study site closure|0|||
23375155|NCT00157755|65119382|FG004|Overall Study|Study site closure|0|||
23375156|NCT00157755|65119383|FG005|Overall Study|Study site closure|0|||
23375157|NCT00157755|65119378|FG000|Overall Study|Subject non-compliance|0|||
23375158|NCT00157755|65119379|FG001|Overall Study|Subject non-compliance|0|||
23375159|NCT00157755|65119380|FG002|Overall Study|Subject non-compliance|0|||
23375160|NCT00157755|65119381|FG003|Overall Study|Subject non-compliance|0|||
23375161|NCT00157755|65119382|FG004|Overall Study|Subject non-compliance|0|||
23375162|NCT00157755|65119383|FG005|Overall Study|Subject non-compliance|1|||
23375163|NCT00157755|65119378|FG000|Overall Study|Study completion|0|||
23375164|NCT00157755|65119379|FG001|Overall Study|Study completion|0|||
23375165|NCT00157755|65119380|FG002|Overall Study|Study completion|0|||
23375166|NCT00157755|65119381|FG003|Overall Study|Study completion|0|||
23375167|NCT00157755|65119382|FG004|Overall Study|Study completion|1|||
23375168|NCT00157755|65119383|FG005|Overall Study|Study completion|2|||
23375169|NCT01125930|65119384|FG000|Overall Study|Adverse Event|0|||
23375170|NCT01125930|65119385|FG001|Overall Study|Adverse Event|1|||
23375171|NCT01125930|65119384|FG000|Overall Study|Withdrawal by Subject|1|||
23375172|NCT01125930|65119385|FG001|Overall Study|Withdrawal by Subject|6|||
23375173|NCT01125930|65119384|FG000|Overall Study|Protocol Violation|0|||
23375174|NCT01125930|65119385|FG001|Overall Study|Protocol Violation|1|||
23375175|NCT01125930|65119384|FG000|Overall Study|Lost to Follow-up|0|||
23375176|NCT01125930|65119385|FG001|Overall Study|Lost to Follow-up|2|||
23375177|NCT00109343|65119386|FG000|Overall Study|Adverse Event|1|||
23375178|NCT00109343|65119387|FG001|Overall Study|Adverse Event|0|||
23375179|NCT00109343|65119388|FG002|Overall Study|Adverse Event|2|||
23375180|NCT00109343|65119386|FG000|Overall Study|Lack of Efficacy|1|||
23375181|NCT00109343|65119387|FG001|Overall Study|Lack of Efficacy|0|||
23375182|NCT00109343|65119388|FG002|Overall Study|Lack of Efficacy|0|||
23375183|NCT00109343|65119386|FG000|Overall Study|Lost to Follow-up|35|||
23375184|NCT00109343|65119387|FG001|Overall Study|Lost to Follow-up|20|||
23375185|NCT00109343|65119388|FG002|Overall Study|Lost to Follow-up|14|||
23375186|NCT00109343|65119386|FG000|Overall Study|Protocol Violation|1|||
23375187|NCT00109343|65119387|FG001|Overall Study|Protocol Violation|2|||
23375188|NCT00109343|65119388|FG002|Overall Study|Protocol Violation|2|||
23375189|NCT00109343|65119386|FG000|Overall Study|Withdrawal by Subject|15|||
23375190|NCT00109343|65119387|FG001|Overall Study|Withdrawal by Subject|11|||
23375191|NCT00109343|65119388|FG002|Overall Study|Withdrawal by Subject|10|||
23375192|NCT00109343|65119386|FG000|Overall Study|Subject Moved|6|||
23375193|NCT00109343|65119387|FG001|Overall Study|Subject Moved|2|||
23375194|NCT00109343|65119388|FG002|Overall Study|Subject Moved|1|||
23375195|NCT00109343|65119386|FG000|Overall Study|Other|5|||
23375196|NCT00109343|65119387|FG001|Overall Study|Other|2|||
23375197|NCT00109343|65119388|FG002|Overall Study|Other|1|||
23488658|NCT04447755|65533935|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23488659|NCT04447755|65533936|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
23488660|NCT04447755|65533930|FG000|Overall Study|Ongoing in Study|1|||
23375198|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
23375199|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
23375200|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
23375201|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
23375202|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
23375203|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
23375204|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
23375205|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
23375206|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
23375207|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
23375208|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
23375209|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
23375210|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
23375211|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
23375212|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
23375213|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
23375214|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
23375215|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
23375216|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
23375217|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
23375218|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
23375219|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
23375220|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
23375221|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
23375222|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
23375223|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
23375224|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
23375225|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
23375226|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
23375227|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
23375228|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
23375229|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
23375230|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
23375231|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
23488661|NCT04447755|65533931|FG001|Overall Study|Ongoing in Study|2|||
23488662|NCT04447755|65533932|FG002|Overall Study|Ongoing in Study|0|||
23488663|NCT04447755|65533933|FG003|Overall Study|Ongoing in Study|0|||
23488664|NCT04447755|65533934|FG004|Overall Study|Ongoing in Study|2|||
23488665|NCT04447755|65533935|FG005|Overall Study|Ongoing in Study|2|||
23488666|NCT04447755|65533936|FG006|Overall Study|Ongoing in Study|26|||
23488667|NCT00910988|65533938|FG000|Overall Study|Lost to Follow-up|2|||
23488668|NCT00910988|65533939|FG001|Overall Study|Lost to Follow-up|4|||
23488669|NCT00910988|65533940|FG002|Overall Study|Lost to Follow-up|3|||
23488670|NCT00910988|65533941|FG003|Overall Study|Lost to Follow-up|0|||
23488671|NCT00642473|65533942|FG000|Overall Study|Withdrawal by Subject|0|||
23375232|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
23375233|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
23375234|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
23375235|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
23375236|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
23375237|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
23375238|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
23375239|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
23375240|NCT00862992|65119398|FG000|Overall Study|Adverse Event|2|||
23375241|NCT00862992|65119399|FG001|Overall Study|Adverse Event|1|||
23375242|NCT00862992|65119400|FG002|Overall Study|Adverse Event|1|||
23375243|NCT00862992|65119398|FG000|Overall Study|Physician Decision|1|||
23375244|NCT00862992|65119399|FG001|Overall Study|Physician Decision|0|||
23375245|NCT00862992|65119400|FG002|Overall Study|Physician Decision|0|||
23375246|NCT00862992|65119398|FG000|Overall Study|Withdrawal by Subject|0|||
23375247|NCT00862992|65119399|FG001|Overall Study|Withdrawal by Subject|0|||
23375248|NCT00862992|65119400|FG002|Overall Study|Withdrawal by Subject|2|||
23375249|NCT03617588|65119401|FG000|Overall Study|Withdrawal by Subject|1|||
23375250|NCT03617588|65119402|FG001|Overall Study|Withdrawal by Subject|0|||
23375251|NCT03937778|65119403|FG000|Overall Study|Withdrawal by Subject|1|||
23488672|NCT00642473|65533943|FG001|Overall Study|Withdrawal by Subject|5|||
23375252|NCT03937778|65119403|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
23375253|NCT01860989|65119404|FG000|Overall Study|Unsatisfactory therapeutic|5|||
23375254|NCT02566005|65119405|FG000|Overall Study|vaginal bleeding|0|||
23375255|NCT02566005|65119406|FG001|Overall Study|vaginal bleeding|1|||
23488673|NCT00642473|65533942|FG000|Overall Study|Progression or death|2|||
23488674|NCT00642473|65533943|FG001|Overall Study|Progression or death|4|||
23375256|NCT02566005|65119405|FG000|Overall Study|received foley|8|||
23375257|NCT02566005|65119406|FG001|Overall Study|received foley|0|||
23488675|NCT00642473|65533942|FG000|Overall Study|Other|2|||
23488676|NCT00642473|65533943|FG001|Overall Study|Other|2|||
23488677|NCT02360111|65533944|FG000|Overall Study|Death|2|||
23488678|NCT01066000|65533949|FG000|Overall Study|Protocol Violation|4|||
23488679|NCT01066000|65533949|FG000|Overall Study|Death|3|||
23488680|NCT01066000|65533949|FG000|Overall Study|Withdrawal by Subject|1|||
23488681|NCT01066000|65533949|FG000|Overall Study|Adverse Event|1|||
23488682|NCT01069627|65533950|FG000|Overall Study|Disease progression|7|||
23488683|NCT01069627|65533950|FG000|Overall Study|Adverse Event|12|||
23488684|NCT01069627|65533950|FG000|Overall Study|Protocol Violation|1|||
23488685|NCT02810340|65533952|FG000|Overall Study|Withdrawal by Subject|1|||
23488686|NCT02810340|65533953|FG001|Overall Study|Withdrawal by Subject|0|||
23488687|NCT02810340|65533954|FG002|Overall Study|Withdrawal by Subject|0|||
23488688|NCT02810340|65533952|FG000|Overall Study|Incarceration|0|||
23488689|NCT02810340|65533953|FG001|Overall Study|Incarceration|1|||
23488690|NCT02810340|65533954|FG002|Overall Study|Incarceration|0|||
23488691|NCT02810340|65533952|FG000|Overall Study|Lost to Follow-up|0|||
23488692|NCT02810340|65533953|FG001|Overall Study|Lost to Follow-up|0|||
23488693|NCT02810340|65533954|FG002|Overall Study|Lost to Follow-up|1|||
23488694|NCT02452697|65533955|FG000|Overall Study|Physician Decision|4|||
23488695|NCT02452697|65533956|FG001|Overall Study|Physician Decision|4|||
23488696|NCT02452697|65533957|FG002|Overall Study|Physician Decision|3|||
23488697|NCT02452697|65533958|FG003|Overall Study|Physician Decision|2|||
23488698|NCT02452697|65533955|FG000|Overall Study|Withdrawal by Subject|1|||
23488699|NCT02452697|65533956|FG001|Overall Study|Withdrawal by Subject|0|||
23488700|NCT02452697|65533957|FG002|Overall Study|Withdrawal by Subject|0|||
23488701|NCT02452697|65533958|FG003|Overall Study|Withdrawal by Subject|0|||
23375258|NCT02566005|65119405|FG000|Overall Study|did not receive foley|0|||
23375259|NCT02566005|65119406|FG001|Overall Study|did not receive foley|1|||
23375260|NCT02566005|65119405|FG000|Overall Study|labor after randomization|0|||
23488702|NCT02452697|65533955|FG000|Overall Study|still in follow-up|2|||
23488703|NCT02452697|65533956|FG001|Overall Study|still in follow-up|2|||
23488704|NCT02452697|65533957|FG002|Overall Study|still in follow-up|1|||
23488705|NCT02452697|65533958|FG003|Overall Study|still in follow-up|3|||
23488706|NCT00589290|65533959|FG000|Overall Study|Withdrawal by Subject|1|||
23488707|NCT01927341|65533962|FG000|Phase 1b|Lost to Follow-up|1|||
23375261|NCT02566005|65119406|FG001|Overall Study|labor after randomization|4|||
23375262|NCT00143507|65119407|FG000|Overall Study|Death|572|||
23375263|NCT00143507|65119408|FG001|Overall Study|Death|547|||
23375264|NCT00143507|65119407|FG000|Overall Study|Withdrawal by Subject|114|||
23375265|NCT00143507|65119408|FG001|Overall Study|Withdrawal by Subject|102|||
23375266|NCT00143507|65119407|FG000|Overall Study|Lost to Follow-up|1|||
23375267|NCT00143507|65119408|FG001|Overall Study|Lost to Follow-up|0|||
23375268|NCT00143507|65119407|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
23375269|NCT00143507|65119408|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
23375270|NCT03620162|65119409|FG000|Overall Study|Physician Decision|4|||
23375271|NCT03620162|65119410|FG001|Overall Study|Physician Decision|0|||
23375272|NCT03620162|65119411|FG002|Overall Study|Physician Decision|1|||
23375273|NCT03620162|65119412|FG003|Overall Study|Physician Decision|0|||
23375274|NCT03620162|65119413|FG004|Overall Study|Physician Decision|2|||
23375275|NCT03620162|65119409|FG000|Overall Study|Lost to Follow-up|2|||
23375276|NCT03620162|65119410|FG001|Overall Study|Lost to Follow-up|6|||
23375277|NCT03620162|65119411|FG002|Overall Study|Lost to Follow-up|7|||
23375278|NCT03620162|65119412|FG003|Overall Study|Lost to Follow-up|3|||
23375279|NCT03620162|65119413|FG004|Overall Study|Lost to Follow-up|2|||
23375280|NCT03620162|65119409|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
23604033|NCT00645411|65940280|FG000|Overall Study|Protocol Violation|1|||
23604034|NCT00645411|65940281|FG001|Overall Study|Protocol Violation|0|||
23604035|NCT00645411|65940282|FG002|Overall Study|Protocol Violation|1|||
23604036|NCT00645411|65940283|FG003|Overall Study|Protocol Violation|0|||
23604037|NCT00645411|65940280|FG000|Overall Study|Inappropriate enrollment|0|||
23604038|NCT00645411|65940281|FG001|Overall Study|Inappropriate enrollment|0|||
23375281|NCT03620162|65119410|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
23375282|NCT03620162|65119411|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
23375283|NCT03620162|65119412|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
23375284|NCT03620162|65119413|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
23375285|NCT01655901|65119420|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23604039|NCT00645411|65940282|FG002|Overall Study|Inappropriate enrollment|4|||
23604040|NCT00645411|65940283|FG003|Overall Study|Inappropriate enrollment|1|||
23604041|NCT00645411|65940280|FG000|Overall Study|Unable to classify|0|||
23604042|NCT00645411|65940281|FG001|Overall Study|Unable to classify|0|||
23604043|NCT00645411|65940282|FG002|Overall Study|Unable to classify|3|||
23604044|NCT00645411|65940283|FG003|Overall Study|Unable to classify|4|||
23604045|NCT00689351|65940284|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
23375286|NCT01655901|65119421|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375287|NCT01655901|65119422|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375288|NCT01655901|65119423|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
23375289|NCT01655901|65119424|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375290|NCT01655901|65119425|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
23375291|NCT00655889|65119426|FG000|Overall Study|Inadequate cell growth|1|||
23375292|NCT00655889|65119426|FG000|Overall Study|Protocol Violation|1|||
23375293|NCT03479905|65119427|FG000|Overall Study|Other airway method used|4|||
23375294|NCT03479905|65119428|FG001|Overall Study|Other airway method used|5|||
23375295|NCT03479905|65119429|FG002|Overall Study|Other airway method used|5|||
23375296|NCT05166876|65119433|FG000|Overall Study|Withdrawal by Subject|1|||
23375297|NCT05166876|65119434|FG001|Overall Study|Withdrawal by Subject|0|||
23375298|NCT05166876|65119435|FG002|Overall Study|Withdrawal by Subject|0|||
23375299|NCT00207740|65119436|FG000|Overall Study|Adverse Event|4|||
23375300|NCT00207740|65119437|FG001|Overall Study|Adverse Event|14|||
23375301|NCT00207740|65119438|FG002|Overall Study|Adverse Event|14|||
23375302|NCT00207740|65119439|FG003|Overall Study|Adverse Event|11|||
23488708|NCT01927341|65533963|FG001|Phase 1b|Lost to Follow-up|0|||
23488709|NCT01927341|65533964|FG002|Phase 1b|Lost to Follow-up|0|||
23488710|NCT01927341|65533965|FG003|Phase 1b|Lost to Follow-up|0|||
23375303|NCT00207740|65119436|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23664810|NCT00549939|66158609|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
23664811|NCT00549939|66158610|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
23604046|NCT00689351|65940285|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
23604047|NCT00689351|65940284|FG000|Infant Series of Dosing|Adverse Event|1|||
23604048|NCT00689351|65940285|FG001|Infant Series of Dosing|Adverse Event|0|||
23604049|NCT00689351|65940284|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
23604050|NCT00689351|65940285|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
23604051|NCT00689351|65940284|FG000|After Infant Series|Parent/legal guardian request|1|||
23604052|NCT00689351|65940285|FG001|After Infant Series|Parent/legal guardian request|0|||
23375304|NCT00207740|65119437|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23375305|NCT00207740|65119438|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23375306|NCT00207740|65119439|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
23375307|NCT00207740|65119436|FG000|Overall Study|Lost to Follow-up|0|||
23375308|NCT00207740|65119437|FG001|Overall Study|Lost to Follow-up|2|||
23375309|NCT00207740|65119438|FG002|Overall Study|Lost to Follow-up|1|||
23375310|NCT00207740|65119439|FG003|Overall Study|Lost to Follow-up|1|||
23375311|NCT00207740|65119436|FG000|Overall Study|Death|0|||
23375312|NCT00207740|65119437|FG001|Overall Study|Death|0|||
23375313|NCT00207740|65119438|FG002|Overall Study|Death|0|||
23375314|NCT00207740|65119439|FG003|Overall Study|Death|1|||
23375315|NCT00207740|65119436|FG000|Overall Study|Sponsor Directive|22|||
23375316|NCT00207740|65119437|FG001|Overall Study|Sponsor Directive|15|||
23375317|NCT00207740|65119438|FG002|Overall Study|Sponsor Directive|16|||
23375318|NCT00207740|65119439|FG003|Overall Study|Sponsor Directive|21|||
23375319|NCT00207740|65119436|FG000|Overall Study|Other|2|||
23375320|NCT00207740|65119437|FG001|Overall Study|Other|10|||
23375321|NCT00207740|65119438|FG002|Overall Study|Other|7|||
23375322|NCT00207740|65119439|FG003|Overall Study|Other|5|||
23375323|NCT02313155|65119440|FG000|Overall Study|Lost to Follow-up|0|||
23664812|NCT00549939|66158611|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
23664813|NCT00549939|66158609|FG000|40-week Open Label Treatment Period|Other|0|||
23664814|NCT00549939|66158610|FG001|40-week Open Label Treatment Period|Other|1|||
23664815|NCT00549939|66158611|FG002|40-week Open Label Treatment Period|Other|4|||
23664816|NCT02687542|66158616|FG000|Overall Study|Medication error without associated AEs|0|||
23664817|NCT02687542|66158617|FG001|Overall Study|Medication error without associated AEs|0|||
23664818|NCT02687542|66158618|FG002|Overall Study|Medication error without associated AEs|0|||
23664819|NCT02687542|66158619|FG003|Overall Study|Medication error without associated AEs|0|||
23664820|NCT02687542|66158620|FG004|Overall Study|Medication error without associated AEs|1|||
23664821|NCT02687542|66158616|FG000|Overall Study|Lost to Follow-up|0|||
23664822|NCT02687542|66158617|FG001|Overall Study|Lost to Follow-up|0|||
23664823|NCT02687542|66158618|FG002|Overall Study|Lost to Follow-up|0|||
23375324|NCT02313155|65119441|FG001|Overall Study|Lost to Follow-up|1|||
23375325|NCT01548599|65119445|FG000|Overall Study|Lost to Follow-up|0|||
23375326|NCT01548599|65119446|FG001|Overall Study|Lost to Follow-up|1|||
23375327|NCT01548599|65119445|FG000|Overall Study|Withdrawal by Subject|4|||
23375328|NCT01548599|65119446|FG001|Overall Study|Withdrawal by Subject|0|||
23375329|NCT01548599|65119445|FG000|Overall Study|Death|2|||
23375330|NCT01548599|65119446|FG001|Overall Study|Death|1|||
23375331|NCT03587636|65119447|FG000|Overall Study|Lost to Follow-up|2|||
23375332|NCT03587636|65119448|FG001|Overall Study|Lost to Follow-up|5|||
23375333|NCT02550795|65119451|FG000|Overall Study|Physician Decision|0|||
23375334|NCT02550795|65119452|FG001|Overall Study|Physician Decision|1|||
23375335|NCT02550795|65119453|FG002|Overall Study|Physician Decision|0|||
23375336|NCT01652690|65119454|FG000|Overall Study|Withdrawal by Subject|16|||
23375337|NCT01652690|65119455|FG001|Overall Study|Withdrawal by Subject|4|||
23375338|NCT01652690|65119454|FG000|Overall Study|Other|8|||
23375339|NCT01652690|65119455|FG001|Overall Study|Other|9|||
23375340|NCT01652690|65119454|FG000|Overall Study|Lost to Follow-up|6|||
23375341|NCT01652690|65119455|FG001|Overall Study|Lost to Follow-up|6|||
23375342|NCT01652690|65119454|FG000|Overall Study|Death|5|||
23375343|NCT01652690|65119455|FG001|Overall Study|Death|2|||
23375344|NCT01654276|65119456|FG000|Overall Study|Lack of Efficacy|1|||
23375345|NCT01654276|65119456|FG000|Overall Study|Lost to Follow-up|4|||
23375346|NCT01654276|65119456|FG000|Overall Study|Withdrawal by Subject|1|||
23375347|NCT03010501|65119457|FG000|Study Week 1|Withdrawal by Subject|2|||
23375348|NCT03010501|65119458|FG001|Study Week 1|Withdrawal by Subject|1|||
23375349|NCT03010501|65119459|FG002|Study Week 1|Withdrawal by Subject|0|||
23375350|NCT03010501|65119460|FG003|Study Week 1|Withdrawal by Subject|2|||
23375351|NCT03010501|65119461|FG004|Study Week 1|Withdrawal by Subject|0|||
23375352|NCT03010501|65119462|FG005|Study Week 1|Withdrawal by Subject|0|||
23375353|NCT03010501|65119457|FG000|Study Week 3|Withdrawal by Subject|0|||
23375354|NCT03010501|65119458|FG001|Study Week 3|Withdrawal by Subject|0|||
23375355|NCT03010501|65119459|FG002|Study Week 3|Withdrawal by Subject|0|||
23375356|NCT03010501|65119460|FG003|Study Week 3|Withdrawal by Subject|1|||
23375357|NCT03010501|65119461|FG004|Study Week 3|Withdrawal by Subject|0|||
23375358|NCT03010501|65119462|FG005|Study Week 3|Withdrawal by Subject|0|||
23375359|NCT00607893|65119465|FG000|Overall Study|Lost to Follow-up|4|||
23375360|NCT00607893|65119466|FG001|Overall Study|Lost to Follow-up|0|||
23375361|NCT00607893|65119465|FG000|Overall Study|withdrew due to loss of interest|0|||
23375362|NCT00607893|65119466|FG001|Overall Study|withdrew due to loss of interest|1|||
23375363|NCT00607893|65119465|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
23375364|NCT00607893|65119466|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
23375365|NCT00607893|65119465|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
23375366|NCT00607893|65119466|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
23375367|NCT00607893|65119465|FG000|Overall Study|Declined to be treated|1|||
23375368|NCT00607893|65119466|FG001|Overall Study|Declined to be treated|0|||
23375369|NCT00607893|65119465|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
23375370|NCT00607893|65119466|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
23375371|NCT04040439|65119467|FG000|Overall Study|Invalid registration|11|||
23375372|NCT04040439|65119467|FG000|Overall Study|No IC* on publication of study results|2|||
23375373|NCT00686972|65119471|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
23375374|NCT03334175|65119472|FG000|Overall Study|Lost to Follow-up|0|||
23375375|NCT03334175|65119473|FG001|Overall Study|Lost to Follow-up|1|||
23375376|NCT03407482|65119474|FG000|Overall Study|Adverse Event|12|||
23375377|NCT03407482|65119474|FG000|Overall Study|Disease Relapse|1|||
23375378|NCT03407482|65119474|FG000|Overall Study|Lost to Follow-up|1|||
23375379|NCT03407482|65119474|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23375380|NCT03407482|65119474|FG000|Overall Study|Pregnancy|2|||
23375381|NCT03407482|65119474|FG000|Overall Study|Protocol Violation|1|||
23375382|NCT03407482|65119474|FG000|Overall Study|Study Terminated By Sponsor|106|||
23375383|NCT03407482|65119474|FG000|Overall Study|Withdrawal by Subject|6|||
23375384|NCT03407482|65119474|FG000|Overall Study|Data Entry Error|1|||
23375385|NCT02911116|65119487|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23375386|NCT02911116|65119488|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23375387|NCT02911116|65119487|FG000|Overall Study|Lost to Follow-up|0|||
23375388|NCT02911116|65119488|FG001|Overall Study|Lost to Follow-up|1|||
23375389|NCT00352118|65119491|FG000|Overall Study|Physician Decision|4|||
23375390|NCT01937299|65119492|FG000|Overall Study|Adverse Event|13|||
23375391|NCT01937299|65119493|FG001|Overall Study|Adverse Event|0|||
23375392|NCT01937299|65119492|FG000|Overall Study|Lack of Efficacy|0|||
23375393|NCT01937299|65119493|FG001|Overall Study|Lack of Efficacy|4|||
23375394|NCT01937299|65119492|FG000|Overall Study|Withdrawal by Subject|1|||
23375395|NCT01937299|65119493|FG001|Overall Study|Withdrawal by Subject|0|||
23375396|NCT00644059|65119494|FG000|Overall Study|Lost to Follow-up|37|||
23375397|NCT00644059|65119495|FG001|Overall Study|Lost to Follow-up|34|||
23375398|NCT00644059|65119496|FG002|Overall Study|Lost to Follow-up|16|||
23488711|NCT01927341|65533966|FG004|Phase 1b|Lost to Follow-up|0|||
23664824|NCT02687542|66158619|FG003|Overall Study|Lost to Follow-up|0|||
23488712|NCT01927341|65533962|FG000|Phase 1b|Death|2|||
23488713|NCT01927341|65533963|FG001|Phase 1b|Death|0|||
23375399|NCT00644059|65119494|FG000|Overall Study|Withdrawal by Subject|52|||
23375400|NCT00644059|65119495|FG001|Overall Study|Withdrawal by Subject|60|||
23375401|NCT00644059|65119496|FG002|Overall Study|Withdrawal by Subject|30|||
23375402|NCT00644059|65119494|FG000|Overall Study|Adverse Event|8|||
23375403|NCT00644059|65119495|FG001|Overall Study|Adverse Event|5|||
23375404|NCT00644059|65119496|FG002|Overall Study|Adverse Event|1|||
23375405|NCT00644059|65119494|FG000|Overall Study|Inappropriate Enrollment|1|||
23375406|NCT00644059|65119495|FG001|Overall Study|Inappropriate Enrollment|3|||
23375407|NCT00644059|65119496|FG002|Overall Study|Inappropriate Enrollment|0|||
23375408|NCT00644059|65119494|FG000|Overall Study|Protocol Deviation/violation|20|||
23375409|NCT00644059|65119495|FG001|Overall Study|Protocol Deviation/violation|19|||
23375410|NCT00644059|65119496|FG002|Overall Study|Protocol Deviation/violation|15|||
23375411|NCT00644059|65119494|FG000|Overall Study|Unable to classify|6|||
23375412|NCT00644059|65119495|FG001|Overall Study|Unable to classify|2|||
23375413|NCT00644059|65119496|FG002|Overall Study|Unable to classify|3|||
23375414|NCT01248455|65119497|FG000|Overall Study|switched to alternate treatment|1|||
23375415|NCT02530385|65119498|FG000|Overall Study|Withdrawal by Subject|0|||
23375416|NCT02530385|65119499|FG001|Overall Study|Withdrawal by Subject|1|||
23375417|NCT00833755|65119500|FG000|Overall Study|Physician Decision|4|||
23375418|NCT00833755|65119501|FG001|Overall Study|Physician Decision|4|||
23375419|NCT00833755|65119502|FG002|Overall Study|Physician Decision|2|||
23375420|NCT00833755|65119503|FG003|Overall Study|Physician Decision|6|||
23375421|NCT00833755|65119500|FG000|Overall Study|Subject had scheduling issues|0|||
23375422|NCT00833755|65119501|FG001|Overall Study|Subject had scheduling issues|1|||
23375423|NCT00833755|65119502|FG002|Overall Study|Subject had scheduling issues|0|||
23375424|NCT00833755|65119503|FG003|Overall Study|Subject had scheduling issues|0|||
23375425|NCT00606008|65119504|FG000|Overall Study|Adverse Event|1|||
23375426|NCT00606008|65119504|FG000|Overall Study|Withdrawal by Subject|4|||
23375427|NCT00420745|65119505|FG000|Overall Study|Adverse Event|2|||
23375428|NCT00420745|65119506|FG001|Overall Study|Adverse Event|2|||
23375429|NCT00420745|65119505|FG000|Overall Study|Lost to Follow-up|10|||
23375430|NCT00420745|65119506|FG001|Overall Study|Lost to Follow-up|2|||
23375431|NCT00420745|65119505|FG000|Overall Study|Protocol Violation|1|||
23375432|NCT00420745|65119506|FG001|Overall Study|Protocol Violation|0|||
23375433|NCT00420745|65119505|FG000|Overall Study|Physician Decision|1|||
23375434|NCT00420745|65119506|FG001|Overall Study|Physician Decision|1|||
23375435|NCT00420745|65119505|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
23375436|NCT00420745|65119506|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
23375437|NCT00420745|65119505|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
23375438|NCT00420745|65119506|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
23375439|NCT04424901|65119507|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
23375440|NCT04424901|65119508|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
23375441|NCT02030600|65119518|FG000|Treatment Period 1|Adverse Event|5|||
23375442|NCT02030600|65119519|FG001|Treatment Period 1|Adverse Event|7|||
23375443|NCT02030600|65119518|FG000|Treatment Period 1|Lack of Efficacy|0|||
23375444|NCT02030600|65119519|FG001|Treatment Period 1|Lack of Efficacy|1|||
23375445|NCT02030600|65119518|FG000|Treatment Period 1|Lost to Follow-up|11|||
23375446|NCT02030600|65119519|FG001|Treatment Period 1|Lost to Follow-up|3|||
23375447|NCT02030600|65119518|FG000|Treatment Period 1|Protocol Violation|22|||
23375448|NCT02030600|65119519|FG001|Treatment Period 1|Protocol Violation|17|||
23375449|NCT02030600|65119518|FG000|Treatment Period 1|Withdrawal by Subject|13|||
23375450|NCT02030600|65119519|FG001|Treatment Period 1|Withdrawal by Subject|17|||
23375451|NCT02030600|65119518|FG000|Treatment Period 1|Casebook Unsigned|1|||
23375452|NCT02030600|65119519|FG001|Treatment Period 1|Casebook Unsigned|0|||
23375453|NCT02030600|65119518|FG000|Treatment Period 1|Unclassified|1|||
23375454|NCT02030600|65119519|FG001|Treatment Period 1|Unclassified|0|||
23375455|NCT02030600|65119518|FG000|Treatment Period 2|Adverse Event|4|||
23375456|NCT02030600|65119519|FG001|Treatment Period 2|Adverse Event|4|||
23375457|NCT02030600|65119518|FG000|Treatment Period 2|Lack of Efficacy|2|||
23375458|NCT02030600|65119519|FG001|Treatment Period 2|Lack of Efficacy|1|||
23375459|NCT02030600|65119518|FG000|Treatment Period 2|Lost to Follow-up|4|||
23375460|NCT02030600|65119519|FG001|Treatment Period 2|Lost to Follow-up|2|||
23375461|NCT02030600|65119518|FG000|Treatment Period 2|Protocol Violation|1|||
23375462|NCT02030600|65119519|FG001|Treatment Period 2|Protocol Violation|2|||
23375463|NCT02030600|65119518|FG000|Treatment Period 2|Withdrawal by Subject|13|||
23375464|NCT02030600|65119519|FG001|Treatment Period 2|Withdrawal by Subject|9|||
23375465|NCT02030600|65119518|FG000|Treatment Period 2|Unclassified|1|||
23375466|NCT02030600|65119519|FG001|Treatment Period 2|Unclassified|0|||
23375467|NCT01452347|65119520|FG000|Overall Study|Adverse Event|2|||
23375468|NCT01452347|65119521|FG001|Overall Study|Adverse Event|1|||
23375469|NCT01452347|65119520|FG000|Overall Study|Non compliance protocol|2|||
23375470|NCT01452347|65119521|FG001|Overall Study|Non compliance protocol|0|||
23375471|NCT01452347|65119520|FG000|Overall Study|Lost to Follow-up|2|||
23375472|NCT01452347|65119521|FG001|Overall Study|Lost to Follow-up|0|||
23375473|NCT01452347|65119520|FG000|Overall Study|Withdrawal by Subject|3|||
23375474|NCT01452347|65119521|FG001|Overall Study|Withdrawal by Subject|3|||
23375475|NCT01452347|65119520|FG000|Overall Study|Not treated|6|||
23664825|NCT02687542|66158620|FG004|Overall Study|Lost to Follow-up|1|||
23375476|NCT01452347|65119521|FG001|Overall Study|Not treated|3|||
23375477|NCT01452347|65119520|FG000|Overall Study|Other reason not defined above|2|||
23375478|NCT01452347|65119521|FG001|Overall Study|Other reason not defined above|0|||
23375479|NCT00549055|65119522|FG000|Overall Study|Adverse Event|4|||
23375480|NCT00549055|65119522|FG000|Overall Study|Lack of Efficacy|18|||
23375481|NCT00549055|65119522|FG000|Overall Study|Stabilization|5|||
23664826|NCT02687542|66158616|FG000|Overall Study|Protocol Violation|0|||
23664827|NCT02687542|66158617|FG001|Overall Study|Protocol Violation|1|||
23664828|NCT02687542|66158618|FG002|Overall Study|Protocol Violation|0|||
23664829|NCT02687542|66158619|FG003|Overall Study|Protocol Violation|0|||
23664830|NCT02687542|66158620|FG004|Overall Study|Protocol Violation|0|||
23664831|NCT02687542|66158616|FG000|Overall Study|Other|5|||
23664832|NCT02687542|66158617|FG001|Overall Study|Other|9|||
23664833|NCT02687542|66158618|FG002|Overall Study|Other|10|||
23664834|NCT02687542|66158619|FG003|Overall Study|Other|6|||
23664835|NCT02687542|66158620|FG004|Overall Study|Other|5|||
23664836|NCT02687542|66158616|FG000|Overall Study|Adverse Event|3|||
23664837|NCT02687542|66158617|FG001|Overall Study|Adverse Event|1|||
23664838|NCT02687542|66158618|FG002|Overall Study|Adverse Event|3|||
23664839|NCT02687542|66158619|FG003|Overall Study|Adverse Event|2|||
23664840|NCT02687542|66158620|FG004|Overall Study|Adverse Event|9|||
23604053|NCT03132636|65940286|FG000|Overall Study|Adverse Event|1|||
23604054|NCT03132636|65940287|FG001|Overall Study|Adverse Event|2|||
23604055|NCT03132636|65940286|FG000|Overall Study|Death|4|||
23604056|NCT03132636|65940287|FG001|Overall Study|Death|7|||
23604057|NCT03132636|65940286|FG000|Overall Study|Lost to Follow-up|3|||
23604058|NCT03132636|65940287|FG001|Overall Study|Lost to Follow-up|2|||
23604059|NCT03132636|65940286|FG000|Overall Study|Non compliance with protocol by participant|1|||
23604060|NCT03132636|65940287|FG001|Overall Study|Non compliance with protocol by participant|1|||
23604061|NCT03132636|65940286|FG000|Overall Study|Subject decision|1|||
23604062|NCT03132636|65940287|FG001|Overall Study|Subject decision|9|||
23604063|NCT03132636|65940286|FG000|Overall Study|Sponsor decision|0|||
23604064|NCT03132636|65940287|FG001|Overall Study|Sponsor decision|1|||
23604065|NCT03132636|65940286|FG000|Overall Study|Physician Decision|1|||
23604066|NCT03132636|65940287|FG001|Overall Study|Physician Decision|0|||
23604067|NCT03132636|65940286|FG000|Overall Study|Progressive disease|33|||
23604068|NCT03132636|65940287|FG001|Overall Study|Progressive disease|36|||
23604069|NCT03132636|65940286|FG000|Overall Study|Withdrawal of consent|2|||
23604070|NCT03132636|65940287|FG001|Overall Study|Withdrawal of consent|5|||
23604071|NCT03132636|65940286|FG000|Overall Study|Did not re-consent|1|||
23604072|NCT03132636|65940287|FG001|Overall Study|Did not re-consent|0|||
23604073|NCT03132636|65940286|FG000|Overall Study|Lost insurance coverage|1|||
23604074|NCT03132636|65940287|FG001|Overall Study|Lost insurance coverage|0|||
23604075|NCT03132636|65940286|FG000|Overall Study|Related to radiological outcomes|0|||
23604076|NCT03132636|65940287|FG001|Overall Study|Related to radiological outcomes|1|||
23604077|NCT03132636|65940286|FG000|Overall Study|Unable to come to site for continued visits|0|||
23604078|NCT03132636|65940287|FG001|Overall Study|Unable to come to site for continued visits|1|||
23604079|NCT01218594|65940296|FG000|Overall Study|Death|1|||
23604080|NCT01218594|65940296|FG000|Overall Study|Withdrawal by Subject|3|||
23604081|NCT01218594|65940296|FG000|Overall Study|Adverse Event|2|||
23604082|NCT01218594|65940296|FG000|Overall Study|Physician Decision|6|||
23604083|NCT02502526|65940301|FG000|Overall Study|Lost to Follow-up|2|||
23604084|NCT02502526|65940302|FG001|Overall Study|Lost to Follow-up|2|||
23604085|NCT02502526|65940303|FG002|Overall Study|Lost to Follow-up|3|||
23604086|NCT02502526|65940301|FG000|Overall Study|Withdrawal by Subject|0|||
23604087|NCT02502526|65940302|FG001|Overall Study|Withdrawal by Subject|1|||
23604088|NCT02502526|65940303|FG002|Overall Study|Withdrawal by Subject|1|||
23604089|NCT02502526|65940301|FG000|Overall Study|Disqualified due to cataract grading|0|||
23604090|NCT02502526|65940302|FG001|Overall Study|Disqualified due to cataract grading|0|||
23604091|NCT02502526|65940303|FG002|Overall Study|Disqualified due to cataract grading|1|||
23604092|NCT02502526|65940301|FG000|Overall Study|Enrollment suspension|4|||
23604093|NCT02502526|65940302|FG001|Overall Study|Enrollment suspension|1|||
23604094|NCT02502526|65940303|FG002|Overall Study|Enrollment suspension|1|||
23604095|NCT03547154|65940305|FG000|Overall Study|Disease Progression/Recurrence|6|||
23604096|NCT03547154|65940306|FG001|Overall Study|Disease Progression/Recurrence|14|||
23604097|NCT03547154|65940305|FG000|Overall Study|Adverse Event|26|||
23604098|NCT03547154|65940306|FG001|Overall Study|Adverse Event|31|||
23604099|NCT03547154|65940305|FG000|Overall Study|Protocol Violation|6|||
23604100|NCT03547154|65940306|FG001|Overall Study|Protocol Violation|1|||
23604101|NCT03547154|65940305|FG000|Overall Study|Physician Decision|4|||
23664841|NCT02687542|66158616|FG000|Overall Study|Withdrawal by Subject|0|||
23664842|NCT02687542|66158617|FG001|Overall Study|Withdrawal by Subject|1|||
23664843|NCT02687542|66158618|FG002|Overall Study|Withdrawal by Subject|1|||
23664844|NCT02687542|66158619|FG003|Overall Study|Withdrawal by Subject|2|||
23664845|NCT02687542|66158620|FG004|Overall Study|Withdrawal by Subject|4|||
23664846|NCT00176605|66158621|FG000|Overall Study|Withdrawal by Subject|2|||
23664847|NCT02142738|66158622|FG000|Overall Study|Adverse Event|13|||
23664848|NCT02142738|66158623|FG001|Overall Study|Adverse Event|9|||
23664849|NCT02142738|66158622|FG000|Overall Study|Death|92|||
23664850|NCT02142738|66158623|FG001|Overall Study|Death|112|||
23664851|NCT02142738|66158622|FG000|Overall Study|Lost to Follow-up|0|||
23664852|NCT02142738|66158623|FG001|Overall Study|Lost to Follow-up|3|||
23664853|NCT02142738|66158622|FG000|Overall Study|Withdrawal by Subject|6|||
23604102|NCT03547154|65940306|FG001|Overall Study|Physician Decision|3|||
23604103|NCT03547154|65940305|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23604104|NCT03547154|65940306|FG001|Overall Study|Insufficient Therapeutic Response|10|||
23604105|NCT03547154|65940305|FG000|Overall Study|Withdrawal by Subject|10|||
23604106|NCT03547154|65940306|FG001|Overall Study|Withdrawal by Subject|6|||
23604107|NCT03547154|65940305|FG000|Overall Study|Not Selected|0|||
23604108|NCT03547154|65940306|FG001|Overall Study|Not Selected|1|||
23604109|NCT03547154|65940305|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
23604110|NCT03547154|65940306|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
23604111|NCT03352713|65940308|FG000|Overall Study|Lost to Follow-up|8|||
23604112|NCT03352713|65940308|FG000|Overall Study|Withdrawn by investigator|5|||
23604113|NCT03352713|65940308|FG000|Overall Study|Completed 0 EMAs|8|||
23604114|NCT03352713|65940308|FG000|Overall Study|Device incompatible/stolen|5|||
23604115|NCT00705159|65940309|FG000|Overall Study|Withdrawal by Subject|0|||
23604116|NCT00705159|65940310|FG001|Overall Study|Withdrawal by Subject|1|||
23604117|NCT00705159|65940311|FG002|Overall Study|Withdrawal by Subject|1|||
23604118|NCT00705159|65940312|FG003|Overall Study|Withdrawal by Subject|1|||
23604119|NCT00705159|65940309|FG000|Overall Study|Protocol Violation|0|||
23604120|NCT00705159|65940310|FG001|Overall Study|Protocol Violation|1|||
23604121|NCT00705159|65940311|FG002|Overall Study|Protocol Violation|0|||
23604122|NCT00705159|65940312|FG003|Overall Study|Protocol Violation|0|||
23604123|NCT00705159|65940309|FG000|Overall Study|Adverse Event|0|||
23604124|NCT00705159|65940310|FG001|Overall Study|Adverse Event|0|||
23664854|NCT02142738|66158623|FG001|Overall Study|Withdrawal by Subject|7|||
23664855|NCT02142738|66158622|FG000|Overall Study|Follow up ended by sponsor|43|||
23664856|NCT02142738|66158623|FG001|Overall Study|Follow up ended by sponsor|20|||
23375482|NCT00549055|65119522|FG000|Overall Study|Progression to fibrosis|2|||
23375483|NCT00549055|65119522|FG000|Overall Study|Decrease of size|1|||
23375484|NCT00549055|65119522|FG000|Overall Study|Active choroidal neovascula increased|1|||
23375485|NCT00549055|65119522|FG000|Overall Study|Vitreous hemorrhage|1|||
23375486|NCT00549055|65119522|FG000|Overall Study|Growth choroidal neovascularisation|1|||
23375487|NCT00549055|65119522|FG000|Overall Study|Choroidal neovascularization|1|||
23375488|NCT00549055|65119522|FG000|Overall Study|Very low visual acuity (VA)|1|||
23375489|NCT03451071|65119523|FG000|First Vaccine|Withdrawal by Subject|1|||
23375490|NCT03451071|65119523|FG000|Second Vaccine|Lost to Follow-up|19|||
23375491|NCT03451071|65119523|FG000|Third Vaccine|Lost to Follow-up|22|||
23375492|NCT03451071|65119523|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
23375493|NCT02426684|65119526|FG000|Overall Study|Physician Decision|1|||
23375494|NCT00997893|65119527|FG000|Overall Study|Adverse Event|1|||
23375495|NCT00997893|65119528|FG001|Overall Study|Adverse Event|0|||
23375496|NCT00997893|65119529|FG002|Overall Study|Adverse Event|0|||
23375497|NCT00997893|65119527|FG000|Overall Study|Unable to meet study timelines|1|||
23664857|NCT04770389|66158624|FG000|Overall Study|Adverse Event|1|||
23664858|NCT04770389|66158625|FG001|Overall Study|Adverse Event|2|||
23664859|NCT04770389|66158626|FG002|Overall Study|Adverse Event|0|||
23375498|NCT00997893|65119528|FG001|Overall Study|Unable to meet study timelines|0|||
23488714|NCT01927341|65533964|FG002|Phase 1b|Death|0|||
23488715|NCT01927341|65533965|FG003|Phase 1b|Death|0|||
23488716|NCT01927341|65533966|FG004|Phase 1b|Death|0|||
23488717|NCT01927341|65533962|FG000|Phase 1b|Follow-up completed|7|||
23488718|NCT01927341|65533963|FG001|Phase 1b|Follow-up completed|0|||
23488719|NCT01927341|65533964|FG002|Phase 1b|Follow-up completed|0|||
23488720|NCT01927341|65533965|FG003|Phase 1b|Follow-up completed|0|||
23488721|NCT01927341|65533966|FG004|Phase 1b|Follow-up completed|0|||
23488722|NCT01927341|65533962|FG000|Phase 2|Lost to Follow-up|0|||
23488723|NCT01927341|65533963|FG001|Phase 2|Lost to Follow-up|1|||
23488724|NCT01927341|65533964|FG002|Phase 2|Lost to Follow-up|0|||
23488725|NCT01927341|65533965|FG003|Phase 2|Lost to Follow-up|0|||
23488726|NCT01927341|65533966|FG004|Phase 2|Lost to Follow-up|0|||
23488727|NCT01927341|65533962|FG000|Phase 2|Participant withdrew consent|0|||
23488728|NCT01927341|65533963|FG001|Phase 2|Participant withdrew consent|2|||
23488729|NCT01927341|65533964|FG002|Phase 2|Participant withdrew consent|1|||
23488730|NCT01927341|65533965|FG003|Phase 2|Participant withdrew consent|2|||
23488731|NCT01927341|65533966|FG004|Phase 2|Participant withdrew consent|3|||
23488732|NCT01927341|65533962|FG000|Phase 2|Death|0|||
23488733|NCT01927341|65533963|FG001|Phase 2|Death|4|||
23488734|NCT01927341|65533964|FG002|Phase 2|Death|0|||
23488735|NCT01927341|65533965|FG003|Phase 2|Death|3|||
23488736|NCT01927341|65533966|FG004|Phase 2|Death|2|||
23488737|NCT01927341|65533962|FG000|Phase 2|New cancer therapy|0|||
23488738|NCT01927341|65533963|FG001|Phase 2|New cancer therapy|1|||
23488739|NCT01927341|65533964|FG002|Phase 2|New cancer therapy|0|||
23488740|NCT01927341|65533965|FG003|Phase 2|New cancer therapy|4|||
23488741|NCT01927341|65533966|FG004|Phase 2|New cancer therapy|1|||
23604125|NCT00705159|65940311|FG002|Overall Study|Adverse Event|1|||
23604126|NCT00705159|65940312|FG003|Overall Study|Adverse Event|0|||
23488742|NCT01927341|65533962|FG000|Phase 2|Disease progression|0|||
23604127|NCT00705159|65940309|FG000|Overall Study|Lost to Follow-up|0|||
23604128|NCT00705159|65940310|FG001|Overall Study|Lost to Follow-up|0|||
23604129|NCT00705159|65940311|FG002|Overall Study|Lost to Follow-up|3|||
23375499|NCT00997893|65119529|FG002|Overall Study|Unable to meet study timelines|0|||
23375500|NCT00997893|65119527|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
23375501|NCT00997893|65119528|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
23375502|NCT00997893|65119529|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
23488743|NCT01927341|65533963|FG001|Phase 2|Disease progression|1|||
23488744|NCT01927341|65533964|FG002|Phase 2|Disease progression|1|||
23488745|NCT01927341|65533965|FG003|Phase 2|Disease progression|1|||
23488746|NCT01927341|65533966|FG004|Phase 2|Disease progression|0|||
23488747|NCT01927341|65533962|FG000|Phase 2|Follow-up completed|0|||
23488748|NCT01927341|65533963|FG001|Phase 2|Follow-up completed|6|||
23604130|NCT00705159|65940312|FG003|Overall Study|Lost to Follow-up|2|||
23604131|NCT00705159|65940309|FG000|Overall Study|Screen Failure|0|||
23488749|NCT01927341|65533964|FG002|Phase 2|Follow-up completed|3|||
23488750|NCT01927341|65533965|FG003|Phase 2|Follow-up completed|5|||
23488751|NCT01927341|65533966|FG004|Phase 2|Follow-up completed|2|||
23488752|NCT01977651|65533967|FG000|4 Month Treatment Period|Adverse Event|34|||
23488753|NCT01977651|65533967|FG000|4 Month Treatment Period|Death|3|||
23488754|NCT01977651|65533967|FG000|4 Month Treatment Period|Progressive Disease|43|||
23488755|NCT01977651|65533967|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
23488756|NCT01977651|65533967|FG000|4 Month Treatment Period|Physician Decision|4|||
23488757|NCT01977651|65533967|FG000|1 Year Extension Period|Adverse Event|14|||
23488758|NCT01977651|65533967|FG000|1 Year Extension Period|Death|10|||
23488759|NCT01977651|65533967|FG000|1 Year Extension Period|Lost to Follow-up|2|||
23488760|NCT01977651|65533967|FG000|1 Year Extension Period|Progressive Disease|86|||
23488761|NCT01977651|65533967|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
23488762|NCT01977651|65533967|FG000|1 Year Extension Period|Physician Decision|6|||
23488763|NCT01977651|65533967|FG000|1 Year Extension Period|Miscellaneous|1|||
23488764|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Adverse Event|5|||
23488765|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Death|13|||
23488766|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
23488767|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
23488768|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Physician Decision|4|||
23488769|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
23488770|NCT00054717|65533968|FG000|Overall Study|Randomized but not treated|2|||
23488771|NCT00054717|65533969|FG001|Overall Study|Randomized but not treated|8|||
23488772|NCT00054717|65533968|FG000|Overall Study|Adverse Event|70|||
23488773|NCT00054717|65533969|FG001|Overall Study|Adverse Event|22|||
23488774|NCT00054717|65533968|FG000|Overall Study|Protocol Violation|18|||
23488775|NCT00054717|65533969|FG001|Overall Study|Protocol Violation|19|||
23488776|NCT00054717|65533968|FG000|Overall Study|Lost to Follow-up|23|||
23488777|NCT00054717|65533969|FG001|Overall Study|Lost to Follow-up|13|||
23488778|NCT00054717|65533968|FG000|Overall Study|Withdrawal by Subject|32|||
23488779|NCT00054717|65533969|FG001|Overall Study|Withdrawal by Subject|20|||
23488780|NCT00054717|65533968|FG000|Overall Study|Other reason not defined above|117|||
23488781|NCT00054717|65533969|FG001|Overall Study|Other reason not defined above|217|||
23488782|NCT00760214|65533972|FG000|Overall Study|Adverse Event|8|||
23488783|NCT00760214|65533973|FG001|Overall Study|Adverse Event|9|||
23488784|NCT00760214|65533974|FG002|Overall Study|Adverse Event|12|||
23488785|NCT00760214|65533972|FG000|Overall Study|Protocol Violation|3|||
23488786|NCT00760214|65533973|FG001|Overall Study|Protocol Violation|0|||
23488787|NCT00760214|65533974|FG002|Overall Study|Protocol Violation|3|||
23488788|NCT00760214|65533972|FG000|Overall Study|Lost to Follow-up|0|||
23488789|NCT00760214|65533973|FG001|Overall Study|Lost to Follow-up|0|||
23488790|NCT00760214|65533974|FG002|Overall Study|Lost to Follow-up|1|||
23488791|NCT00760214|65533972|FG000|Overall Study|Withdrawal by Subject|12|||
23488792|NCT00760214|65533973|FG001|Overall Study|Withdrawal by Subject|14|||
23488793|NCT00760214|65533974|FG002|Overall Study|Withdrawal by Subject|13|||
23488794|NCT00760214|65533972|FG000|Overall Study|Lack of Efficacy|3|||
23488795|NCT00760214|65533973|FG001|Overall Study|Lack of Efficacy|2|||
23488796|NCT00760214|65533974|FG002|Overall Study|Lack of Efficacy|4|||
23488797|NCT00760214|65533972|FG000|Overall Study|Pregnancy|0|||
23488798|NCT00760214|65533973|FG001|Overall Study|Pregnancy|0|||
23488799|NCT00760214|65533974|FG002|Overall Study|Pregnancy|1|||
23488800|NCT00760214|65533972|FG000|Overall Study|Physician Decision|1|||
23488801|NCT00760214|65533973|FG001|Overall Study|Physician Decision|1|||
23488802|NCT00760214|65533974|FG002|Overall Study|Physician Decision|1|||
23488803|NCT00760214|65533972|FG000|Overall Study|Other|3|||
23488804|NCT00760214|65533973|FG001|Overall Study|Other|4|||
23604132|NCT00705159|65940310|FG001|Overall Study|Screen Failure|0|||
23488805|NCT00760214|65533974|FG002|Overall Study|Other|6|||
23488806|NCT00053365|65533975|FG000|Overall Study|Incorrect cell type|1|||
23488807|NCT00053365|65533975|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
23488808|NCT00053365|65533975|FG000|Overall Study|Never treated|4|||
23488809|NCT02694523|65533978|FG000|Part A|Adverse Event|7|||
23488810|NCT02694523|65533979|FG001|Part A|Adverse Event|3|||
23488811|NCT02694523|65533980|FG002|Part A|Adverse Event|0|||
23488812|NCT02694523|65533981|FG003|Part A|Adverse Event|0|||
23604133|NCT00705159|65940311|FG002|Overall Study|Screen Failure|0|||
23488813|NCT02694523|65533982|FG004|Part A|Adverse Event|0|||
23488814|NCT02694523|65533983|FG005|Part A|Adverse Event|0|||
23488815|NCT02694523|65533984|FG006|Part A|Adverse Event|0|||
23488816|NCT02694523|65533978|FG000|Part A|Protocol Violation|1|||
23488817|NCT02694523|65533979|FG001|Part A|Protocol Violation|0|||
23488818|NCT02694523|65533980|FG002|Part A|Protocol Violation|0|||
23488819|NCT02694523|65533981|FG003|Part A|Protocol Violation|0|||
23488820|NCT02694523|65533982|FG004|Part A|Protocol Violation|0|||
23488821|NCT02694523|65533983|FG005|Part A|Protocol Violation|0|||
23488822|NCT02694523|65533984|FG006|Part A|Protocol Violation|0|||
23488823|NCT02694523|65533978|FG000|Part A|Lost to Follow-up|1|||
23488824|NCT02694523|65533979|FG001|Part A|Lost to Follow-up|2|||
23488825|NCT02694523|65533980|FG002|Part A|Lost to Follow-up|0|||
23488826|NCT02694523|65533981|FG003|Part A|Lost to Follow-up|0|||
23488827|NCT02694523|65533982|FG004|Part A|Lost to Follow-up|0|||
23488828|NCT02694523|65533983|FG005|Part A|Lost to Follow-up|0|||
23488829|NCT02694523|65533984|FG006|Part A|Lost to Follow-up|0|||
23488830|NCT02694523|65533978|FG000|Part A|Withdrawal by Subject|3|||
23664860|NCT04770389|66158627|FG003|Overall Study|Adverse Event|1|||
23664861|NCT04770389|66158624|FG000|Overall Study|Withdrawal by Subject|0|||
23664862|NCT04770389|66158625|FG001|Overall Study|Withdrawal by Subject|2|||
23664863|NCT04770389|66158626|FG002|Overall Study|Withdrawal by Subject|1|||
23664864|NCT04770389|66158627|FG003|Overall Study|Withdrawal by Subject|0|||
23664865|NCT04770389|66158624|FG000|Overall Study|Failed attempt to draw blood|1|||
23488831|NCT02694523|65533979|FG001|Part A|Withdrawal by Subject|1|||
23488832|NCT02694523|65533980|FG002|Part A|Withdrawal by Subject|0|||
23488833|NCT02694523|65533981|FG003|Part A|Withdrawal by Subject|0|||
23488834|NCT02694523|65533982|FG004|Part A|Withdrawal by Subject|0|||
23488835|NCT02694523|65533983|FG005|Part A|Withdrawal by Subject|0|||
23488836|NCT02694523|65533984|FG006|Part A|Withdrawal by Subject|0|||
23488837|NCT02694523|65533978|FG000|Part A|Other|1|||
23488838|NCT02694523|65533979|FG001|Part A|Other|1|||
23488839|NCT02694523|65533980|FG002|Part A|Other|0|||
23488840|NCT02694523|65533981|FG003|Part A|Other|0|||
23488841|NCT02694523|65533982|FG004|Part A|Other|0|||
23488842|NCT02694523|65533983|FG005|Part A|Other|0|||
23488843|NCT02694523|65533984|FG006|Part A|Other|0|||
23488844|NCT02694523|65533978|FG000|Part B|Adverse Event|0|||
23488845|NCT02694523|65533979|FG001|Part B|Adverse Event|0|||
23488846|NCT02694523|65533980|FG002|Part B|Adverse Event|7|||
23488847|NCT02694523|65533981|FG003|Part B|Adverse Event|1|||
23488848|NCT02694523|65533982|FG004|Part B|Adverse Event|1|||
23488849|NCT02694523|65533983|FG005|Part B|Adverse Event|2|||
23488850|NCT02694523|65533984|FG006|Part B|Adverse Event|0|||
23488851|NCT02694523|65533978|FG000|Part B|Protocol Violation|0|||
23488852|NCT02694523|65533979|FG001|Part B|Protocol Violation|0|||
23488853|NCT02694523|65533980|FG002|Part B|Protocol Violation|1|||
23488854|NCT02694523|65533981|FG003|Part B|Protocol Violation|0|||
23488855|NCT02694523|65533982|FG004|Part B|Protocol Violation|0|||
23488856|NCT02694523|65533983|FG005|Part B|Protocol Violation|0|||
23488857|NCT02694523|65533984|FG006|Part B|Protocol Violation|0|||
23488858|NCT02694523|65533978|FG000|Part B|Lost to Follow-up|0|||
23488859|NCT02694523|65533979|FG001|Part B|Lost to Follow-up|0|||
23488860|NCT02694523|65533980|FG002|Part B|Lost to Follow-up|2|||
23488861|NCT02694523|65533981|FG003|Part B|Lost to Follow-up|3|||
23488862|NCT02694523|65533982|FG004|Part B|Lost to Follow-up|2|||
23488863|NCT02694523|65533983|FG005|Part B|Lost to Follow-up|0|||
23488864|NCT02694523|65533984|FG006|Part B|Lost to Follow-up|1|||
23488865|NCT02694523|65533978|FG000|Part B|Withdrawal by Subject|0|||
23488866|NCT02694523|65533979|FG001|Part B|Withdrawal by Subject|0|||
23488867|NCT02694523|65533980|FG002|Part B|Withdrawal by Subject|9|||
23488868|NCT02694523|65533981|FG003|Part B|Withdrawal by Subject|0|||
23488869|NCT02694523|65533982|FG004|Part B|Withdrawal by Subject|1|||
23488870|NCT02694523|65533983|FG005|Part B|Withdrawal by Subject|3|||
23488871|NCT02694523|65533984|FG006|Part B|Withdrawal by Subject|0|||
23664866|NCT04770389|66158625|FG001|Overall Study|Failed attempt to draw blood|0|||
23488872|NCT02694523|65533978|FG000|Part B|Other|0|||
23488873|NCT02694523|65533979|FG001|Part B|Other|0|||
23488874|NCT02694523|65533980|FG002|Part B|Other|1|||
23488875|NCT02694523|65533981|FG003|Part B|Other|0|||
23488876|NCT02694523|65533982|FG004|Part B|Other|0|||
23488877|NCT02694523|65533983|FG005|Part B|Other|0|||
23488878|NCT02694523|65533984|FG006|Part B|Other|1|||
23488879|NCT02027376|65533985|FG000|Overall Study|Death|1|||
23664867|NCT04770389|66158626|FG002|Overall Study|Failed attempt to draw blood|0|||
23488880|NCT02027376|65533986|FG001|Overall Study|Death|0|||
23488881|NCT02027376|65533987|FG002|Overall Study|Death|0|||
23488882|NCT04543409|65533991|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23488883|NCT04543409|65533992|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23488884|NCT04543409|65533991|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
23488885|NCT04543409|65533992|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
23488886|NCT04543409|65533991|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
23488887|NCT04543409|65533992|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23488888|NCT04543409|65533991|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
23488889|NCT04543409|65533992|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
23488890|NCT04543409|65533991|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
23488891|NCT04543409|65533992|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
23488892|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
23488893|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
23488894|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
23488895|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
23488896|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
23488897|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
23488898|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
23488899|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
23488900|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
23488901|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
23488902|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
23488903|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
23488904|NCT00562627|65533997|FG000|Overall Study|Protocol Violation|1|||
23488905|NCT00562627|65533998|FG001|Overall Study|Protocol Violation|1|||
23488906|NCT00562627|65533999|FG002|Overall Study|Protocol Violation|1|||
23488907|NCT03387150|65534000|FG000|Overall Study|Withdrawal by Subject|3|||
23488908|NCT03387150|65534001|FG001|Overall Study|Withdrawal by Subject|0|||
23488909|NCT03387150|65534002|FG002|Overall Study|Withdrawal by Subject|3|||
23488910|NCT03387150|65534003|FG003|Overall Study|Withdrawal by Subject|4|||
23488911|NCT03387150|65534004|FG004|Overall Study|Withdrawal by Subject|1|||
23488912|NCT03387150|65534005|FG005|Overall Study|Withdrawal by Subject|2|||
23488913|NCT03387150|65534006|FG006|Overall Study|Withdrawal by Subject|0|||
23488914|NCT03387150|65534000|FG000|Overall Study|Lost to Follow-up|3|||
23488915|NCT03387150|65534001|FG001|Overall Study|Lost to Follow-up|2|||
23488916|NCT03387150|65534002|FG002|Overall Study|Lost to Follow-up|2|||
23488917|NCT03387150|65534003|FG003|Overall Study|Lost to Follow-up|3|||
23488918|NCT03387150|65534004|FG004|Overall Study|Lost to Follow-up|3|||
23488919|NCT03387150|65534005|FG005|Overall Study|Lost to Follow-up|3|||
23488920|NCT03387150|65534006|FG006|Overall Study|Lost to Follow-up|0|||
23488921|NCT03387150|65534000|FG000|Overall Study|Participant unable to adhere to visit|0|||
23488922|NCT03387150|65534001|FG001|Overall Study|Participant unable to adhere to visit|1|||
23488923|NCT03387150|65534002|FG002|Overall Study|Participant unable to adhere to visit|0|||
23488924|NCT03387150|65534003|FG003|Overall Study|Participant unable to adhere to visit|0|||
23488925|NCT03387150|65534004|FG004|Overall Study|Participant unable to adhere to visit|2|||
23488926|NCT03387150|65534005|FG005|Overall Study|Participant unable to adhere to visit|2|||
23488927|NCT03387150|65534006|FG006|Overall Study|Participant unable to adhere to visit|0|||
23488928|NCT01251744|65534007|FG000|Overall Study|Lost to Follow-up|1|||
23604134|NCT00705159|65940312|FG003|Overall Study|Screen Failure|1|||
23375503|NCT04079790|65119535|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
23375504|NCT04079790|65119536|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23375505|NCT04079790|65119537|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23375506|NCT04079790|65119538|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23488929|NCT01251744|65534008|FG001|Overall Study|Lost to Follow-up|0|||
23488930|NCT02484690|65534009|FG000|Overall Study|Adverse Event|1|||
23604135|NCT03683576|65940315|FG000|Overall Study|Withdrawal by Subject|2|||
23604136|NCT03683576|65940316|FG001|Overall Study|Withdrawal by Subject|0|||
23604137|NCT03683576|65940317|FG002|Overall Study|Withdrawal by Subject|8|||
23604138|NCT03683576|65940318|FG003|Overall Study|Withdrawal by Subject|3|||
23604139|NCT03683576|65940315|FG000|Overall Study|Adverse Event|3|||
23604140|NCT03683576|65940316|FG001|Overall Study|Adverse Event|0|||
23604141|NCT03683576|65940317|FG002|Overall Study|Adverse Event|0|||
23604142|NCT03683576|65940318|FG003|Overall Study|Adverse Event|4|||
23604143|NCT03683576|65940315|FG000|Overall Study|Lack of Efficacy|1|||
23604144|NCT03683576|65940316|FG001|Overall Study|Lack of Efficacy|0|||
23604145|NCT03683576|65940317|FG002|Overall Study|Lack of Efficacy|1|||
23604146|NCT03683576|65940318|FG003|Overall Study|Lack of Efficacy|1|||
23604147|NCT03683576|65940315|FG000|Overall Study|Lost to Follow-up|0|||
23604148|NCT03683576|65940316|FG001|Overall Study|Lost to Follow-up|1|||
23604149|NCT03683576|65940317|FG002|Overall Study|Lost to Follow-up|2|||
23604150|NCT03683576|65940318|FG003|Overall Study|Lost to Follow-up|0|||
23604151|NCT03683576|65940315|FG000|Overall Study|Other, Not Specified|0|||
23604152|NCT03683576|65940316|FG001|Overall Study|Other, Not Specified|2|||
23604153|NCT03683576|65940317|FG002|Overall Study|Other, Not Specified|0|||
23375507|NCT04079790|65119535|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23375508|NCT04079790|65119536|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23375509|NCT04079790|65119537|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
23375510|NCT04079790|65119538|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23664868|NCT04770389|66158627|FG003|Overall Study|Failed attempt to draw blood|0|||
23664869|NCT04770389|66158624|FG000|Overall Study|Left the country|0|||
23664870|NCT04770389|66158625|FG001|Overall Study|Left the country|0|||
23664871|NCT04770389|66158626|FG002|Overall Study|Left the country|1|||
23664872|NCT04770389|66158627|FG003|Overall Study|Left the country|2|||
23664873|NCT04770389|66158624|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
23664874|NCT04770389|66158625|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
23664875|NCT04770389|66158626|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
23664876|NCT04770389|66158627|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
23664877|NCT04770389|66158624|FG000|Overall Study|Lost to Follow-up|0|||
23664878|NCT04770389|66158625|FG001|Overall Study|Lost to Follow-up|0|||
23664879|NCT04770389|66158626|FG002|Overall Study|Lost to Follow-up|0|||
23664880|NCT04770389|66158627|FG003|Overall Study|Lost to Follow-up|1|||
23664881|NCT04770389|66158624|FG000|Overall Study|Moved away from study site|0|||
23664882|NCT04770389|66158625|FG001|Overall Study|Moved away from study site|1|||
23664883|NCT04770389|66158626|FG002|Overall Study|Moved away from study site|0|||
23664884|NCT04770389|66158627|FG003|Overall Study|Moved away from study site|0|||
23664885|NCT03150862|66158628|FG000|Overall Study|Death|2|||
23664886|NCT03150862|66158629|FG001|Overall Study|Death|7|||
23664887|NCT03150862|66158630|FG002|Overall Study|Death|8|||
23664888|NCT03150862|66158631|FG003|Overall Study|Death|27|||
23664889|NCT03150862|66158632|FG004|Overall Study|Death|4|||
23664890|NCT03150862|66158633|FG005|Overall Study|Death|8|||
23664891|NCT03150862|66158634|FG006|Overall Study|Death|6|||
23664892|NCT03150862|66158635|FG007|Overall Study|Death|21|||
23664893|NCT03150862|66158628|FG000|Overall Study|Withdrawal by Subject|1|||
23664894|NCT03150862|66158629|FG001|Overall Study|Withdrawal by Subject|1|||
23664895|NCT03150862|66158630|FG002|Overall Study|Withdrawal by Subject|0|||
23664896|NCT03150862|66158631|FG003|Overall Study|Withdrawal by Subject|3|||
23664897|NCT03150862|66158632|FG004|Overall Study|Withdrawal by Subject|1|||
23375511|NCT04079790|65119535|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375512|NCT04079790|65119536|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375513|NCT04079790|65119537|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
23375514|NCT04079790|65119538|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375515|NCT02133508|65119539|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
23375516|NCT02133508|65119539|FG000|Overall Study|Death|12|||
23375517|NCT02133508|65119539|FG000|Overall Study|Lost to Follow-up|2|||
23375518|NCT02948400|65119542|FG000|Overall Study|Withdrawal by Subject|17|||
23375519|NCT02948400|65119543|FG001|Overall Study|Withdrawal by Subject|10|||
23375520|NCT02948400|65119542|FG000|Overall Study|failed to attend appointments|47|||
23375521|NCT02948400|65119543|FG001|Overall Study|failed to attend appointments|34|||
23375522|NCT02948400|65119542|FG000|Overall Study|COVID-related closure|6|||
23375523|NCT02948400|65119543|FG001|Overall Study|COVID-related closure|2|||
23375524|NCT02948400|65119542|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
23375525|NCT02948400|65119543|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
23375526|NCT02948400|65119542|FG000|Overall Study|motion sickness in virtual reality|2|||
23664898|NCT03150862|66158633|FG005|Overall Study|Withdrawal by Subject|1|||
23664899|NCT03150862|66158634|FG006|Overall Study|Withdrawal by Subject|1|||
23664900|NCT03150862|66158635|FG007|Overall Study|Withdrawal by Subject|3|||
23664901|NCT03150862|66158628|FG000|Overall Study|Lost to Follow-up|0|||
23664902|NCT03150862|66158629|FG001|Overall Study|Lost to Follow-up|0|||
23664903|NCT03150862|66158630|FG002|Overall Study|Lost to Follow-up|1|||
23488931|NCT02484690|65534010|FG001|Overall Study|Adverse Event|3|||
23664904|NCT03150862|66158631|FG003|Overall Study|Lost to Follow-up|0|||
23664905|NCT03150862|66158632|FG004|Overall Study|Lost to Follow-up|0|||
23664906|NCT03150862|66158633|FG005|Overall Study|Lost to Follow-up|0|||
23664907|NCT03150862|66158634|FG006|Overall Study|Lost to Follow-up|0|||
23664908|NCT03150862|66158635|FG007|Overall Study|Lost to Follow-up|2|||
23664909|NCT03150862|66158628|FG000|Overall Study|Sponsor's decision|0|||
23664910|NCT03150862|66158629|FG001|Overall Study|Sponsor's decision|0|||
23664911|NCT03150862|66158630|FG002|Overall Study|Sponsor's decision|0|||
23664912|NCT03150862|66158631|FG003|Overall Study|Sponsor's decision|10|||
23664913|NCT03150862|66158632|FG004|Overall Study|Sponsor's decision|3|||
23664914|NCT03150862|66158633|FG005|Overall Study|Sponsor's decision|0|||
23664915|NCT03150862|66158634|FG006|Overall Study|Sponsor's decision|1|||
23664916|NCT03150862|66158635|FG007|Overall Study|Sponsor's decision|1|||
23664917|NCT03150862|66158628|FG000|Overall Study|Change in Methylation status|0|||
23664918|NCT03150862|66158629|FG001|Overall Study|Change in Methylation status|0|||
23664919|NCT03150862|66158630|FG002|Overall Study|Change in Methylation status|0|||
23664920|NCT03150862|66158631|FG003|Overall Study|Change in Methylation status|0|||
23664921|NCT03150862|66158632|FG004|Overall Study|Change in Methylation status|1|||
23664922|NCT03150862|66158633|FG005|Overall Study|Change in Methylation status|0|||
23664923|NCT03150862|66158634|FG006|Overall Study|Change in Methylation status|0|||
23664924|NCT03150862|66158635|FG007|Overall Study|Change in Methylation status|0|||
23664925|NCT03150862|66158628|FG000|Overall Study|Roll over in to Long Term Extension|0|||
23664926|NCT03150862|66158629|FG001|Overall Study|Roll over in to Long Term Extension|0|||
23488932|NCT02484690|65534011|FG002|Overall Study|Adverse Event|0|||
23664927|NCT03150862|66158630|FG002|Overall Study|Roll over in to Long Term Extension|0|||
23664928|NCT03150862|66158631|FG003|Overall Study|Roll over in to Long Term Extension|0|||
23664929|NCT03150862|66158632|FG004|Overall Study|Roll over in to Long Term Extension|0|||
23664930|NCT03150862|66158633|FG005|Overall Study|Roll over in to Long Term Extension|0|||
23664931|NCT03150862|66158634|FG006|Overall Study|Roll over in to Long Term Extension|0|||
23664932|NCT03150862|66158635|FG007|Overall Study|Roll over in to Long Term Extension|1|||
23664933|NCT03150862|66158628|FG000|Overall Study|Progressive Disease|0|||
23664934|NCT03150862|66158629|FG001|Overall Study|Progressive Disease|0|||
23664935|NCT03150862|66158630|FG002|Overall Study|Progressive Disease|0|||
23664936|NCT03150862|66158631|FG003|Overall Study|Progressive Disease|0|||
23664937|NCT03150862|66158632|FG004|Overall Study|Progressive Disease|0|||
23664938|NCT03150862|66158633|FG005|Overall Study|Progressive Disease|0|||
23664939|NCT03150862|66158634|FG006|Overall Study|Progressive Disease|0|||
23664940|NCT03150862|66158635|FG007|Overall Study|Progressive Disease|2|||
23664941|NCT01670539|66158636|FG000|Overall Study|Death|3|||
23664942|NCT01670539|66158637|FG001|Overall Study|Death|5|||
23664943|NCT01670539|66158636|FG000|Overall Study|Withdrawal by Subject|3|||
23664944|NCT01670539|66158637|FG001|Overall Study|Withdrawal by Subject|0|||
23664945|NCT01835015|66158638|FG000|Overall Study|Adverse Event|0|||
23664946|NCT01835015|66158639|FG001|Overall Study|Adverse Event|0|||
23664947|NCT01835015|66158640|FG002|Overall Study|Adverse Event|1|||
23664948|NCT01835015|66158641|FG003|Overall Study|Adverse Event|0|||
23664949|NCT01835015|66158642|FG004|Overall Study|Adverse Event|0|||
23664950|NCT02347098|66158643|FG000|Overall Study|Death|1|||
23664951|NCT02347098|66158644|FG001|Overall Study|Death|0|||
23664952|NCT02347098|66158643|FG000|Overall Study|Withdrawal by Subject|1|||
23664953|NCT02347098|66158644|FG001|Overall Study|Withdrawal by Subject|0|||
23664954|NCT02347098|66158643|FG000|Overall Study|Lost to Follow-up|2|||
23664955|NCT02347098|66158644|FG001|Overall Study|Lost to Follow-up|2|||
23664956|NCT02347098|66158643|FG000|Overall Study|Refuse Follow-up Visit|1|||
23664957|NCT02347098|66158644|FG001|Overall Study|Refuse Follow-up Visit|5|||
23664958|NCT02347098|66158643|FG000|Overall Study|no visit due to illness|2|||
23664959|NCT02347098|66158644|FG001|Overall Study|no visit due to illness|1|||
23664960|NCT01033825|66158645|FG000|Overall Study|Withdrawal by Subject|2|||
23664961|NCT01033825|66158646|FG001|Overall Study|Withdrawal by Subject|3|||
23664962|NCT01033825|66158647|FG002|Overall Study|Withdrawal by Subject|2|||
23488933|NCT02484690|65534012|FG003|Overall Study|Adverse Event|0|||
23664963|NCT01033825|66158648|FG003|Overall Study|Withdrawal by Subject|1|||
23664964|NCT01033825|66158649|FG004|Overall Study|Withdrawal by Subject|1|||
23664965|NCT01033825|66158650|FG005|Overall Study|Withdrawal by Subject|0|||
23664966|NCT01033825|66158651|FG006|Overall Study|Withdrawal by Subject|0|||
23664967|NCT01033825|66158645|FG000|Overall Study|Adverse Event|0|||
23488934|NCT02484690|65534013|FG004|Overall Study|Adverse Event|5|||
23664968|NCT01033825|66158646|FG001|Overall Study|Adverse Event|0|||
23664969|NCT01033825|66158647|FG002|Overall Study|Adverse Event|0|||
23664970|NCT01033825|66158648|FG003|Overall Study|Adverse Event|1|||
23664971|NCT01033825|66158649|FG004|Overall Study|Adverse Event|0|||
23664972|NCT01033825|66158650|FG005|Overall Study|Adverse Event|0|||
23664973|NCT01033825|66158651|FG006|Overall Study|Adverse Event|0|||
23664974|NCT01033825|66158645|FG000|Overall Study|Protocol Violation|1|||
23664975|NCT01033825|66158646|FG001|Overall Study|Protocol Violation|0|||
23664976|NCT01033825|66158647|FG002|Overall Study|Protocol Violation|0|||
23664977|NCT01033825|66158648|FG003|Overall Study|Protocol Violation|0|||
23664978|NCT01033825|66158649|FG004|Overall Study|Protocol Violation|0|||
23664979|NCT01033825|66158650|FG005|Overall Study|Protocol Violation|0|||
23664980|NCT01033825|66158651|FG006|Overall Study|Protocol Violation|0|||
23664981|NCT01033825|66158645|FG000|Overall Study|Other|0|||
23664982|NCT01033825|66158646|FG001|Overall Study|Other|0|||
23664983|NCT01033825|66158647|FG002|Overall Study|Other|0|||
23664984|NCT01033825|66158648|FG003|Overall Study|Other|0|||
23664985|NCT01033825|66158649|FG004|Overall Study|Other|1|||
23664986|NCT01033825|66158650|FG005|Overall Study|Other|0|||
23664987|NCT01033825|66158651|FG006|Overall Study|Other|0|||
23664988|NCT03680911|66158659|FG000|At Home Treatment|Study Termination|3|||
23664989|NCT03680911|66158660|FG001|At Home Treatment|Study Termination|0|||
23664990|NCT03680911|66158659|FG000|At Home Treatment|Lost to Follow-up|0|||
23664991|NCT03680911|66158660|FG001|At Home Treatment|Lost to Follow-up|1|||
23664992|NCT03680911|66158659|FG000|At Home Treatment|Withdrawal by Subject|0|||
23664993|NCT03680911|66158660|FG001|At Home Treatment|Withdrawal by Subject|2|||
23664994|NCT03680911|66158659|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
23664995|NCT03680911|66158660|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
23664996|NCT00528021|66158662|FG000|Overall Study|Lack of Efficacy|17|||
23664997|NCT00528021|66158663|FG001|Overall Study|Lack of Efficacy|13|||
23664998|NCT00528021|66158664|FG002|Overall Study|Lack of Efficacy|7|||
23664999|NCT00528021|66158665|FG003|Overall Study|Lack of Efficacy|9|||
23665000|NCT00974675|66158667|FG000|Overall Study|Adverse Event|2|||
23665001|NCT00974675|66158668|FG001|Overall Study|Adverse Event|1|||
23665002|NCT00974675|66158669|FG002|Overall Study|Adverse Event|1|||
23665003|NCT00974675|66158670|FG003|Overall Study|Adverse Event|1|||
23665004|NCT00974675|66158667|FG000|Overall Study|Physician Decision|0|||
23665005|NCT00974675|66158668|FG001|Overall Study|Physician Decision|0|||
23665006|NCT00974675|66158669|FG002|Overall Study|Physician Decision|1|||
23665007|NCT00974675|66158670|FG003|Overall Study|Physician Decision|0|||
23665008|NCT00974675|66158667|FG000|Overall Study|Participant on holiday; unable to attend|0|||
23665009|NCT00974675|66158668|FG001|Overall Study|Participant on holiday; unable to attend|0|||
23665010|NCT00974675|66158669|FG002|Overall Study|Participant on holiday; unable to attend|0|||
23375527|NCT02948400|65119543|FG001|Overall Study|motion sickness in virtual reality|0|||
23604154|NCT03683576|65940318|FG003|Overall Study|Other, Not Specified|0|||
23604155|NCT03683576|65940315|FG000|Overall Study|Protocol Violation|0|||
23604156|NCT03683576|65940316|FG001|Overall Study|Protocol Violation|1|||
23604157|NCT03683576|65940317|FG002|Overall Study|Protocol Violation|1|||
23604158|NCT03683576|65940318|FG003|Overall Study|Protocol Violation|0|||
23604159|NCT01228734|65940320|FG000|Overall Study|Randomized, but not treated|0|||
23604160|NCT01228734|65940321|FG001|Overall Study|Randomized, but not treated|4|||
23604161|NCT03451422|65940322|FG000|Overall Study|Lost to Follow-up|0|||
23604162|NCT03451422|65940323|FG001|Overall Study|Lost to Follow-up|0|||
23604163|NCT03451422|65940324|FG002|Overall Study|Lost to Follow-up|0|||
23604164|NCT03451422|65940325|FG003|Overall Study|Lost to Follow-up|0|||
23665011|NCT00974675|66158670|FG003|Overall Study|Participant on holiday; unable to attend|1|||
23665012|NCT01549275|66158671|FG000|Overall Study|Lost to Follow-up|1|||
23665013|NCT01549275|66158672|FG001|Overall Study|Lost to Follow-up|0|||
23665014|NCT04439175|66158673|FG000|Overall Study|Never started treatment|4|||
23604165|NCT03451422|65940326|FG004|Overall Study|Lost to Follow-up|0|||
23665015|NCT04439175|66158673|FG000|Overall Study|Ineligible|5|||
23665016|NCT04439175|66158673|FG000|Overall Study|Adverse Event|6|||
23665017|NCT04439175|66158673|FG000|Overall Study|Death|4|||
23665018|NCT04439175|66158673|FG000|Overall Study|Disease progression|44|||
23665019|NCT04439175|66158673|FG000|Overall Study|Withdrawal by Subject|4|||
23665020|NCT04439175|66158673|FG000|Overall Study|Alternative Therapy|1|||
23665021|NCT04439175|66158673|FG000|Overall Study|Other|2|||
23665022|NCT00365456|66158674|FG000|Trial Period I (12 Months)|Adverse Event|84|||
23665023|NCT00365456|66158675|FG001|Trial Period I (12 Months)|Adverse Event|0|||
23665024|NCT00365456|66158674|FG000|Trial Period I (12 Months)|Non-compliance|3|||
23665025|NCT00365456|66158675|FG001|Trial Period I (12 Months)|Non-compliance|0|||
23665026|NCT00365456|66158674|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
23665027|NCT00365456|66158675|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
23665028|NCT00365456|66158674|FG000|Trial Period I (12 Months)|Other|11|||
23665029|NCT00365456|66158675|FG001|Trial Period I (12 Months)|Other|0|||
23604166|NCT03451422|65940327|FG005|Overall Study|Lost to Follow-up|1|||
23604167|NCT03451422|65940322|FG000|Overall Study|Decision by sponsor|1|||
23604168|NCT03451422|65940323|FG001|Overall Study|Decision by sponsor|0|||
23604169|NCT03451422|65940324|FG002|Overall Study|Decision by sponsor|1|||
23604170|NCT03451422|65940325|FG003|Overall Study|Decision by sponsor|0|||
23604171|NCT03451422|65940326|FG004|Overall Study|Decision by sponsor|0|||
23604172|NCT03451422|65940327|FG005|Overall Study|Decision by sponsor|0|||
23604173|NCT03451422|65940322|FG000|Overall Study|Withdrawal by Subject|0|||
23604174|NCT03451422|65940323|FG001|Overall Study|Withdrawal by Subject|0|||
23604175|NCT03451422|65940324|FG002|Overall Study|Withdrawal by Subject|2|||
23604176|NCT03451422|65940325|FG003|Overall Study|Withdrawal by Subject|3|||
23604177|NCT03451422|65940326|FG004|Overall Study|Withdrawal by Subject|2|||
23604178|NCT03451422|65940327|FG005|Overall Study|Withdrawal by Subject|1|||
23604179|NCT00745875|65940328|FG000|Overall Study|Continuing study treatment|4|||
23604180|NCT00745875|65940329|FG001|Overall Study|Continuing study treatment|4|||
23604181|NCT00022672|65940332|FG000|Main Phase: 24 Months|Adverse Event|6|||
23604182|NCT00022672|65940333|FG001|Main Phase: 24 Months|Adverse Event|0|||
23604183|NCT00022672|65940332|FG000|Main Phase: 24 Months|Death|0|||
23665030|NCT00365456|66158674|FG000|Trial Period II (12 Months)|Adverse Event|0|||
23665031|NCT00365456|66158675|FG001|Trial Period II (12 Months)|Adverse Event|6|||
23665032|NCT00365456|66158674|FG000|Trial Period II (12 Months)|Non-compliance|0|||
23604184|NCT00022672|65940333|FG001|Main Phase: 24 Months|Death|3|||
23604185|NCT00022672|65940332|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
23604186|NCT00022672|65940333|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
23604187|NCT00022672|65940332|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
23604188|NCT00022672|65940333|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
23604189|NCT00022672|65940332|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
23604190|NCT00022672|65940333|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
23604191|NCT00022672|65940332|FG000|Main Phase: 24 Months|Refused Treatment|3|||
23665033|NCT00365456|66158675|FG001|Trial Period II (12 Months)|Non-compliance|2|||
23665034|NCT00365456|66158674|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
23604192|NCT00022672|65940333|FG001|Main Phase: 24 Months|Refused Treatment|4|||
23604193|NCT00022672|65940332|FG000|Main Phase: 24 Months|Failure to Return|1|||
23604194|NCT00022672|65940333|FG001|Main Phase: 24 Months|Failure to Return|1|||
23604195|NCT00022672|65940332|FG000|Main Phase: 24 Months|Other|1|||
23604196|NCT00022672|65940333|FG001|Main Phase: 24 Months|Other|0|||
23604197|NCT00022672|65940332|FG000|Extension Phase|Adverse Event|1|||
23604198|NCT00022672|65940333|FG001|Extension Phase|Adverse Event|3|||
23604199|NCT00022672|65940332|FG000|Extension Phase|Death|0|||
23604200|NCT00022672|65940333|FG001|Extension Phase|Death|1|||
23604201|NCT00022672|65940332|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
23604202|NCT00022672|65940333|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
23604203|NCT00022672|65940332|FG000|Extension Phase|Refused Treatment|0|||
23604204|NCT00022672|65940333|FG001|Extension Phase|Refused Treatment|2|||
23604205|NCT00022672|65940332|FG000|Extension Phase|Other|1|||
23665035|NCT00365456|66158675|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
23665036|NCT00365456|66158674|FG000|Trial Period II (12 Months)|Other|0|||
23665037|NCT00365456|66158675|FG001|Trial Period II (12 Months)|Other|1|||
23665038|NCT00365456|66158674|FG000|Trial Period III (12 Months)|Adverse Event|13|||
23665039|NCT00365456|66158675|FG001|Trial Period III (12 Months)|Adverse Event|3|||
23604206|NCT00022672|65940333|FG001|Extension Phase|Other|1|||
23604207|NCT02722434|65940338|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
23604208|NCT02722434|65940339|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
23604209|NCT02722434|65940338|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
23665040|NCT00365456|66158674|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
23665041|NCT00365456|66158675|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
23665042|NCT00365456|66158674|FG000|Trial Period III (12 Months)|Other|1|||
23604210|NCT02722434|65940339|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
23604211|NCT01278030|65940340|FG000|Overall Study|Withdrawal by Subject|8|||
23604212|NCT01278030|65940341|FG001|Overall Study|Withdrawal by Subject|4|||
23665043|NCT00365456|66158675|FG001|Trial Period III (12 Months)|Other|1|||
23375528|NCT01259245|65119544|FG000|Overall Study|Withdrawal by Subject|27|||
23375529|NCT01259245|65119545|FG001|Overall Study|Withdrawal by Subject|24|||
23375530|NCT01259245|65119544|FG000|Overall Study|Death|1|||
23604213|NCT01079806|65940344|FG000|Day 1 to Week 96|Adverse Event|0|||
23375531|NCT01259245|65119545|FG001|Overall Study|Death|2|||
23375532|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
23375533|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
23375534|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
23375535|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
23375536|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
23375537|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
23375538|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
23375539|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
23375540|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
23375541|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
23375542|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
23375543|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
23375544|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
23375545|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
23375546|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
23375547|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
23375548|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
23375549|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
23375550|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
23375551|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
23375552|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
23375553|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
23375554|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
23375555|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
23375556|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
23375557|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
23375558|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
23375559|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
23375560|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
23375561|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
23375562|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
23375563|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
23375564|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
23375565|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
23375566|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
23375567|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
23375568|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
23375569|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
23375570|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
23375571|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
23604214|NCT01079806|65940345|FG001|Day 1 to Week 96|Adverse Event|3|||
23604215|NCT01079806|65940344|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
23604216|NCT01079806|65940345|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
23604217|NCT01079806|65940344|FG000|Day 1 to Week 96|Pregnancy|0|||
23604218|NCT01079806|65940345|FG001|Day 1 to Week 96|Pregnancy|1|||
23604219|NCT01079806|65940344|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
23604220|NCT01079806|65940345|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
23604221|NCT01079806|65940344|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
23604222|NCT01079806|65940345|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
23375572|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
23375573|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
23375574|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
23375575|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
23375576|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
23375577|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
23375578|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
23375579|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
23375580|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
23375581|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
23375582|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
23375583|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
23375584|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
23375585|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
23375586|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
23375587|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
23375588|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
23375589|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
23375590|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
23375591|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
23375592|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
23375593|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
23375594|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
23375595|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
23375596|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
23375597|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
23375598|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
23375599|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
23375600|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
23375601|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
23375602|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
23375603|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
23375604|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
23375605|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
23375606|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
23375607|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
23375608|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
23375609|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
23375610|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
23375611|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
23375612|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
23375613|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
23375614|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
23375615|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
23375616|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
23375617|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
23375618|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
23375619|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
23375620|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
23375621|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
23375622|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
23375623|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
23375624|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
23375625|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
23375626|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
23375627|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
23375628|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
23375629|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
23375630|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
23375631|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
23375632|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
23375633|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
23375634|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
23665044|NCT01834274|66158676|FG000|Overall Study|Study Termination|41|||
23665045|NCT01834274|66158677|FG001|Overall Study|Study Termination|38|||
23665046|NCT01834274|66158676|FG000|Overall Study|Withdrawal by Subject|1|||
23665047|NCT01834274|66158677|FG001|Overall Study|Withdrawal by Subject|1|||
23665048|NCT01834274|66158676|FG000|Overall Study|Lost to Follow-up|3|||
23665049|NCT01834274|66158677|FG001|Overall Study|Lost to Follow-up|1|||
23665050|NCT01834274|66158676|FG000|Overall Study|Other|2|||
23665051|NCT01834274|66158677|FG001|Overall Study|Other|1|||
23665052|NCT05289570|66158678|FG000|Overall Study|Physician Decision|1|||
23665053|NCT02374099|66158682|FG000|Overall Study|Adverse Event|1|||
23665054|NCT02374099|66158683|FG001|Overall Study|Adverse Event|0|||
23665055|NCT02374099|66158682|FG000|Overall Study|Progressive Disease|35|||
23665056|NCT02374099|66158683|FG001|Overall Study|Progressive Disease|40|||
23665057|NCT02374099|66158682|FG000|Overall Study|Withdrawal by Subject|5|||
23665058|NCT02374099|66158683|FG001|Overall Study|Withdrawal by Subject|1|||
23665059|NCT02374099|66158682|FG000|Overall Study|Miscellaneous|2|||
23665060|NCT02374099|66158683|FG001|Overall Study|Miscellaneous|3|||
23665061|NCT02374099|66158682|FG000|Overall Study|Randomized, but not treated|2|||
23665062|NCT02374099|66158683|FG001|Overall Study|Randomized, but not treated|1|||
23665063|NCT02374099|66158682|FG000|Overall Study|Study Terminated by Sponsor|3|||
23665064|NCT02374099|66158683|FG001|Overall Study|Study Terminated by Sponsor|4|||
23665065|NCT01230307|66158684|FG000|Overall Study|LVAD Placement|0|||
23665066|NCT01230307|66158685|FG001|Overall Study|LVAD Placement|2|||
23665067|NCT01517893|66158687|FG000|Overall Study|Withdrawal by Subject|3|||
23665068|NCT01517893|66158688|FG001|Overall Study|Withdrawal by Subject|0|||
23665069|NCT04518462|66158690|FG000|Overall Study|Withdrawal by Subject|0|||
23665070|NCT04518462|66158691|FG001|Overall Study|Withdrawal by Subject|0|||
23665071|NCT04518462|66158692|FG002|Overall Study|Withdrawal by Subject|1|||
23665072|NCT04518462|66158690|FG000|Overall Study|Physician Decision|1|||
23604223|NCT01079806|65940344|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
23604224|NCT01079806|65940345|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
23604225|NCT01079806|65940344|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
23604226|NCT01079806|65940345|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
23604227|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
23604228|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
23604229|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
23604230|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
23604231|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
23604232|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
23604233|NCT00536120|65940346|FG000|Overall Study|Lost to Follow-up|1|||
23604234|NCT00536120|65940347|FG001|Overall Study|Lost to Follow-up|0|||
23604235|NCT00536120|65940346|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
23604236|NCT00536120|65940347|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
23604237|NCT00536120|65940346|FG000|Overall Study|Non-compliance|1|||
23604238|NCT00536120|65940347|FG001|Overall Study|Non-compliance|0|||
23604239|NCT00536120|65940346|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
23604240|NCT00536120|65940347|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
23604241|NCT00536120|65940346|FG000|Overall Study|Steroid Use|0|||
23604242|NCT00536120|65940347|FG001|Overall Study|Steroid Use|2|||
23604243|NCT00536120|65940346|FG000|Overall Study|Missed Study Visit|0|||
23604244|NCT00536120|65940347|FG001|Overall Study|Missed Study Visit|1|||
23604245|NCT01478594|65940348|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
23604246|NCT01478594|65940349|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
23604247|NCT01478594|65940348|FG000|Overall Study|Death|45|||
23604248|NCT01478594|65940349|FG001|Overall Study|Death|18|||
23604249|NCT01478594|65940348|FG000|Overall Study|Lost to Follow-up|3|||
23604250|NCT01478594|65940349|FG001|Overall Study|Lost to Follow-up|1|||
23604251|NCT01478594|65940348|FG000|Overall Study|Withdrawal by Subject|9|||
23604252|NCT01478594|65940349|FG001|Overall Study|Withdrawal by Subject|3|||
23604253|NCT01478594|65940348|FG000|Overall Study|Study Closed by Sponsor|8|||
23604254|NCT01478594|65940349|FG001|Overall Study|Study Closed by Sponsor|5|||
23604255|NCT00070317|65940350|FG000|Overall Study|Inevaluable (Never Treated)|1|||
23604256|NCT00070317|65940350|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
23604257|NCT00070317|65940350|FG000|Overall Study|Ineligible required test not done|1|||
23604258|NCT00070317|65940350|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
23604259|NCT00070317|65940350|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
23604260|NCT02630186|65940359|FG000|Overall Study|Withdrawal by Subject|1|||
23604261|NCT01529632|65940360|FG000|Overall Study|Administrative problem|2|||
23604262|NCT01529632|65940361|FG001|Overall Study|Administrative problem|1|||
23665073|NCT04518462|66158691|FG001|Overall Study|Physician Decision|1|||
23665074|NCT04518462|66158692|FG002|Overall Study|Physician Decision|0|||
23665075|NCT00282334|66158693|FG000|Overall Study|Withdrawal by Subject|8|||
23604263|NCT01529632|65940360|FG000|Overall Study|Protocol Violation|0|||
23604264|NCT01529632|65940361|FG001|Overall Study|Protocol Violation|1|||
23665076|NCT00282334|66158694|FG001|Overall Study|Withdrawal by Subject|5|||
23375635|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
23375636|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
23375637|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
23375638|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
23375639|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
23375640|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
23375641|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
23375642|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
23375643|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
23375644|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
23375645|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
23604265|NCT01529632|65940360|FG000|Overall Study|Adverse Event|1|||
23604266|NCT01529632|65940361|FG001|Overall Study|Adverse Event|1|||
23604267|NCT05405244|65940362|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
23604268|NCT05405244|65940363|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
23604269|NCT05405244|65940362|FG000|Washout (2 Weeks)|Adverse Event|2|||
23604270|NCT05405244|65940363|FG001|Washout (2 Weeks)|Adverse Event|0|||
23665077|NCT01199042|66158700|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
23375646|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
23375647|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
23375648|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
23375649|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
23375650|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
23375651|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
23375652|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
23375653|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
23375654|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
23665078|NCT01199042|66158700|FG000|At Home (3 Months)|Lost to Follow-up|1|||
23375655|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
23375656|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
23375657|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
23375658|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
23375659|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
23375660|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
23375661|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
23375662|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
23375663|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
23375664|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
23375665|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
23604271|NCT05405244|65940362|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
23604272|NCT05405244|65940363|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23604273|NCT00263757|65940368|FG000|Overall Study|Withdrawal by Subject|5|||
23604274|NCT00263757|65940369|FG001|Overall Study|Withdrawal by Subject|4|||
23604275|NCT00263757|65940368|FG000|Overall Study|Screen failure|0|||
23604276|NCT00263757|65940369|FG001|Overall Study|Screen failure|1|||
23604277|NCT00263757|65940368|FG000|Overall Study|Adverse Event|3|||
23604278|NCT00263757|65940369|FG001|Overall Study|Adverse Event|3|||
23604279|NCT01567852|65940370|FG000|Overall Study|Withdrawal by Subject|3|||
23604280|NCT01567852|65940371|FG001|Overall Study|Withdrawal by Subject|6|||
23604281|NCT01567852|65940370|FG000|Overall Study|ECT discontinued|1|||
23665079|NCT01081912|66158701|FG000|Conversion/Titration|Adverse Event|47|||
23665080|NCT01081912|66158702|FG001|Conversion/Titration|Adverse Event|0|||
23665081|NCT01081912|66158703|FG002|Conversion/Titration|Adverse Event|0|||
23665082|NCT01081912|66158701|FG000|Conversion/Titration|Lack of Efficacy|17|||
23665083|NCT01081912|66158702|FG001|Conversion/Titration|Lack of Efficacy|0|||
23665084|NCT01081912|66158703|FG002|Conversion/Titration|Lack of Efficacy|0|||
23665085|NCT01081912|66158701|FG000|Conversion/Titration|Lost to Follow-up|5|||
23665086|NCT01081912|66158702|FG001|Conversion/Titration|Lost to Follow-up|0|||
23665087|NCT01081912|66158703|FG002|Conversion/Titration|Lost to Follow-up|0|||
23665088|NCT01081912|66158701|FG000|Conversion/Titration|Physician Decision|2|||
23665089|NCT01081912|66158702|FG001|Conversion/Titration|Physician Decision|0|||
23665090|NCT01081912|66158703|FG002|Conversion/Titration|Physician Decision|0|||
23665091|NCT01081912|66158701|FG000|Conversion/Titration|Protocol Violation|67|||
23604282|NCT01567852|65940371|FG001|Overall Study|ECT discontinued|1|||
23375666|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
23604283|NCT00713596|65940374|FG000|Overall Study|Study was terminated|2|||
23604284|NCT00713596|65940375|FG001|Overall Study|Study was terminated|3|||
23604285|NCT00713596|65940376|FG002|Overall Study|Study was terminated|2|||
23604286|NCT00518206|65940381|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
23604287|NCT00518206|65940382|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
23604288|NCT00518206|65940381|FG000|Overall Study|Withdrawal by Subject|2|||
23604289|NCT00518206|65940382|FG001|Overall Study|Withdrawal by Subject|0|||
23375667|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
23375668|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
23375669|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
23375670|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
23375671|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
23375672|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
23375673|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Death|1|||
23375674|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Death|0|||
23375675|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Death|1|||
23375676|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
23375677|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
23375678|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
23375679|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
23375680|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
23375681|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
23375682|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
23375683|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
23375684|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
23375685|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
23375686|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
23375687|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
23375688|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
23375689|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
23375690|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
23375691|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
23375692|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
23375693|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
23375694|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
23375695|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
23375696|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
23375697|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Depression|0|||
23375698|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Depression|1|||
23375699|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Depression|0|||
23375700|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
23375701|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
23375702|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
23375703|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Jailed|0|||
23375704|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Jailed|1|||
23375705|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Jailed|0|||
23375706|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Other|0|||
23375707|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Other|1|||
23375708|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Other|0|||
23375709|NCT01260948|65119553|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23375710|NCT01260948|65119554|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
23375711|NCT01260948|65119553|FG000|Second Intervention|Emesis|0|||
23375712|NCT01260948|65119554|FG001|Second Intervention|Emesis|1|||
23375713|NCT00750269|65119555|FG000|Overall Study|Protocol Violation|0|||
23375714|NCT00750269|65119556|FG001|Overall Study|Protocol Violation|1|||
23375715|NCT00750269|65119557|FG002|Overall Study|Protocol Violation|1|||
23375716|NCT00750269|65119558|FG003|Overall Study|Protocol Violation|2|||
23375717|NCT00750269|65119559|FG004|Overall Study|Protocol Violation|4|||
23375718|NCT00750269|65119555|FG000|Overall Study|Withdrawal by Subject|0|||
23375719|NCT00750269|65119556|FG001|Overall Study|Withdrawal by Subject|0|||
23375720|NCT00750269|65119557|FG002|Overall Study|Withdrawal by Subject|2|||
23375721|NCT00750269|65119558|FG003|Overall Study|Withdrawal by Subject|2|||
23375722|NCT00750269|65119559|FG004|Overall Study|Withdrawal by Subject|2|||
23375723|NCT00750269|65119555|FG000|Overall Study|Physician Decision|0|||
23375724|NCT00750269|65119556|FG001|Overall Study|Physician Decision|0|||
23375725|NCT00750269|65119557|FG002|Overall Study|Physician Decision|0|||
23375726|NCT00750269|65119558|FG003|Overall Study|Physician Decision|0|||
23375727|NCT00750269|65119559|FG004|Overall Study|Physician Decision|2|||
23375728|NCT00750269|65119555|FG000|Overall Study|Patient too large for positioning|0|||
23375729|NCT00750269|65119556|FG001|Overall Study|Patient too large for positioning|0|||
23375730|NCT00750269|65119557|FG002|Overall Study|Patient too large for positioning|1|||
23375731|NCT00750269|65119558|FG003|Overall Study|Patient too large for positioning|0|||
23375732|NCT00750269|65119559|FG004|Overall Study|Patient too large for positioning|0|||
23375733|NCT00750269|65119555|FG000|Overall Study|Site error|0|||
23375734|NCT00750269|65119556|FG001|Overall Study|Site error|0|||
23375735|NCT00750269|65119557|FG002|Overall Study|Site error|0|||
23375736|NCT00750269|65119558|FG003|Overall Study|Site error|1|||
23375737|NCT00750269|65119559|FG004|Overall Study|Site error|0|||
23375738|NCT00750269|65119555|FG000|Overall Study|SBRT plan could not be drawn|0|||
23375739|NCT00750269|65119556|FG001|Overall Study|SBRT plan could not be drawn|0|||
23375740|NCT00750269|65119557|FG002|Overall Study|SBRT plan could not be drawn|0|||
23375741|NCT00750269|65119558|FG003|Overall Study|SBRT plan could not be drawn|0|||
23375742|NCT00750269|65119559|FG004|Overall Study|SBRT plan could not be drawn|1|||
23375743|NCT00750269|65119555|FG000|Overall Study|Fiducials could not be placed|0|||
23375744|NCT00750269|65119556|FG001|Overall Study|Fiducials could not be placed|0|||
23375745|NCT00750269|65119557|FG002|Overall Study|Fiducials could not be placed|0|||
23375746|NCT00750269|65119558|FG003|Overall Study|Fiducials could not be placed|0|||
23375747|NCT00750269|65119559|FG004|Overall Study|Fiducials could not be placed|1|||
23375748|NCT00754741|65119560|FG000|Overall Study|Died or disenrolled|57|||
23375749|NCT00754741|65119561|FG001|Overall Study|Died or disenrolled|69|||
23375750|NCT00754741|65119562|FG002|Overall Study|Died or disenrolled|54|||
23375751|NCT01117870|65119564|FG000|Overall Study|Inability to place needle|1|||
23375752|NCT01117870|65119565|FG001|Overall Study|Inability to place needle|0|||
23375753|NCT01685437|65119566|FG000|Overall Study|Withdrawal by Subject|22|||
23375754|NCT01685437|65119566|FG000|Overall Study|Lost to Follow-up|3|||
23375755|NCT01685437|65119566|FG000|Overall Study|Adverse Event|1|||
23375756|NCT01685437|65119566|FG000|Overall Study|Protocol Violation|4|||
23375757|NCT01685437|65119566|FG000|Overall Study|Unable to make visits due to work|1|||
23375758|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
23375759|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
23375760|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
23375761|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Death|0|||
23375762|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Death|0|||
23375763|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Death|1|||
23375764|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
23375765|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
23375766|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
23375767|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
23375768|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
23375769|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
23375770|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
23375771|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
23375772|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
23375773|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
23375774|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
23375775|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
23375776|NCT02696798|65119567|FG000|Extended Treatment Period|Adverse Event|1|||
23375777|NCT02696798|65119568|FG001|Extended Treatment Period|Adverse Event|4|||
23604290|NCT00518206|65940381|FG000|Overall Study|Drug Supply Issue|1|||
23375778|NCT02696798|65119569|FG002|Extended Treatment Period|Adverse Event|5|||
23375779|NCT02696798|65119567|FG000|Extended Treatment Period|Lack of Efficacy|7|||
23375780|NCT02696798|65119568|FG001|Extended Treatment Period|Lack of Efficacy|2|||
23375781|NCT02696798|65119569|FG002|Extended Treatment Period|Lack of Efficacy|2|||
23375782|NCT02696798|65119567|FG000|Extended Treatment Period|Lost to Follow-up|1|||
23375783|NCT02696798|65119568|FG001|Extended Treatment Period|Lost to Follow-up|0|||
23375784|NCT02696798|65119569|FG002|Extended Treatment Period|Lost to Follow-up|0|||
23375785|NCT02696798|65119567|FG000|Extended Treatment Period|Physician Decision|0|||
23375786|NCT02696798|65119568|FG001|Extended Treatment Period|Physician Decision|1|||
23375787|NCT02696798|65119569|FG002|Extended Treatment Period|Physician Decision|0|||
23375788|NCT02696798|65119567|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
23375789|NCT02696798|65119568|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
23375790|NCT02696798|65119569|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
23375791|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
23375792|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
23488935|NCT02484690|65534009|FG000|Overall Study|Death|0|||
23488936|NCT02484690|65534010|FG001|Overall Study|Death|0|||
23488937|NCT02484690|65534011|FG002|Overall Study|Death|0|||
23488938|NCT02484690|65534012|FG003|Overall Study|Death|0|||
23488939|NCT02484690|65534013|FG004|Overall Study|Death|1|||
23488940|NCT02484690|65534009|FG000|Overall Study|Withdrawal by Subject|1|||
23488941|NCT02484690|65534010|FG001|Overall Study|Withdrawal by Subject|3|||
23488942|NCT02484690|65534011|FG002|Overall Study|Withdrawal by Subject|1|||
23488943|NCT02484690|65534012|FG003|Overall Study|Withdrawal by Subject|2|||
23488944|NCT02484690|65534013|FG004|Overall Study|Withdrawal by Subject|0|||
23488945|NCT02484690|65534009|FG000|Overall Study|Physician Decision|2|||
23488946|NCT02484690|65534010|FG001|Overall Study|Physician Decision|0|||
23488947|NCT02484690|65534011|FG002|Overall Study|Physician Decision|1|||
23375793|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
23375794|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
23375795|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
23375796|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
23375797|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
23375798|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
23375799|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
23375800|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
23375801|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
23375802|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
23375803|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
23375804|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
23375805|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
23375806|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
23665092|NCT01081912|66158702|FG001|Conversion/Titration|Protocol Violation|0|||
23665093|NCT01081912|66158703|FG002|Conversion/Titration|Protocol Violation|0|||
23665094|NCT01081912|66158701|FG000|Conversion/Titration|Withdrawal by Subject|23|||
23665095|NCT01081912|66158702|FG001|Conversion/Titration|Withdrawal by Subject|0|||
23665096|NCT01081912|66158703|FG002|Conversion/Titration|Withdrawal by Subject|0|||
23665097|NCT01081912|66158701|FG000|Conversion/Titration|Non-Compliance|47|||
23375807|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
23488948|NCT02484690|65534012|FG003|Overall Study|Physician Decision|0|||
23488949|NCT02484690|65534013|FG004|Overall Study|Physician Decision|0|||
23665098|NCT01081912|66158702|FG001|Conversion/Titration|Non-Compliance|0|||
23665099|NCT01081912|66158703|FG002|Conversion/Titration|Non-Compliance|0|||
23375808|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
23375809|NCT00671060|65119571|FG000|Overall Study|Protocol Violation|1|||
23488950|NCT02484690|65534009|FG000|Overall Study|Lost to Follow-up|0|||
23604291|NCT00518206|65940382|FG001|Overall Study|Drug Supply Issue|0|||
23604292|NCT00518206|65940381|FG000|Overall Study|Reason Unknown|1|||
23604293|NCT00518206|65940382|FG001|Overall Study|Reason Unknown|0|||
23604294|NCT00518206|65940381|FG000|Overall Study|Completion Status Unknown|1|||
23604295|NCT00518206|65940382|FG001|Overall Study|Completion Status Unknown|0|||
23604296|NCT02202317|65940383|FG000|Overall Study|Lost to Follow-up|1|||
23604297|NCT01240590|65940385|FG000|Phase I|Refused further treatment|0|||
23604298|NCT01240590|65940386|FG001|Phase I|Refused further treatment|0|||
23604299|NCT01240590|65940387|FG002|Phase I|Refused further treatment|3|||
23604300|NCT01240590|65940388|FG003|Phase I|Refused further treatment|0|||
23604301|NCT01240590|65940389|FG004|Phase I|Refused further treatment|0|||
23604302|NCT01240590|65940385|FG000|Phase II|Refused further treatment|0|||
23604303|NCT01240590|65940386|FG001|Phase II|Refused further treatment|0|||
23604304|NCT01240590|65940387|FG002|Phase II|Refused further treatment|0|||
23604305|NCT01240590|65940388|FG003|Phase II|Refused further treatment|2|||
23604306|NCT01240590|65940389|FG004|Phase II|Refused further treatment|1|||
23604307|NCT01779700|65940390|FG000|Overall Study|Adverse Event|4|||
23604308|NCT01779700|65940391|FG001|Overall Study|Adverse Event|3|||
23604309|NCT01779700|65940390|FG000|Overall Study|Withdrawal by Subject|0|||
23604310|NCT01779700|65940391|FG001|Overall Study|Withdrawal by Subject|2|||
23604311|NCT00666705|65940395|FG000|Overall Study|Withdrawal by Subject|1|||
23604312|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
23604313|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
23604314|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
23604315|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
23604316|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
23604317|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
23604318|NCT01147471|65940396|FG000|3 Month Follow Up|Lost to Follow-up|1|||
23604319|NCT01147471|65940397|FG001|3 Month Follow Up|Lost to Follow-up|1|||
23604320|NCT01147471|65940396|FG000|3 Month Follow Up|Physician Decision|0|||
23604321|NCT01147471|65940397|FG001|3 Month Follow Up|Physician Decision|1|||
23604322|NCT01147471|65940396|FG000|6 Month Follow Up|Lost to Follow-up|4|||
23604323|NCT01147471|65940397|FG001|6 Month Follow Up|Lost to Follow-up|2|||
23604324|NCT01429285|65940398|FG000|Overall Study|Protocol Violation|9|||
23604325|NCT01429285|65940399|FG001|Overall Study|Protocol Violation|4|||
23604326|NCT01429285|65940398|FG000|Overall Study|Missing Data|5|||
23604327|NCT01429285|65940399|FG001|Overall Study|Missing Data|3|||
23604328|NCT01429285|65940398|FG000|Overall Study|Erroneously Enrolled Twice|8|||
23604329|NCT01429285|65940399|FG001|Overall Study|Erroneously Enrolled Twice|2|||
23604330|NCT03909100|65940400|FG000|Overall Study|Protocol Deviation|2|||
23604331|NCT03909100|65940400|FG000|Overall Study|Technical Problems|4|||
23604332|NCT03909100|65940400|FG000|Overall Study|Withdrawal by Subject|4|||
23604333|NCT03909100|65940400|FG000|Overall Study|Lost to Follow-up|1|||
23604334|NCT03909100|65940400|FG000|Overall Study|Reason not Specified|4|||
23604335|NCT03960645|65940401|FG000|Overall Study|Protocol Violation|1|||
23665100|NCT01081912|66158701|FG000|Maintenance Treatment|Adverse Event|0|||
23665101|NCT01081912|66158702|FG001|Maintenance Treatment|Adverse Event|2|||
23665102|NCT01081912|66158703|FG002|Maintenance Treatment|Adverse Event|12|||
23665103|NCT01081912|66158701|FG000|Maintenance Treatment|Lack of Efficacy|0|||
23665104|NCT01081912|66158702|FG001|Maintenance Treatment|Lack of Efficacy|14|||
23665105|NCT01081912|66158703|FG002|Maintenance Treatment|Lack of Efficacy|64|||
23665106|NCT01081912|66158701|FG000|Maintenance Treatment|Lost to Follow-up|0|||
23665107|NCT01081912|66158702|FG001|Maintenance Treatment|Lost to Follow-up|1|||
23665108|NCT01081912|66158703|FG002|Maintenance Treatment|Lost to Follow-up|0|||
23665109|NCT01081912|66158701|FG000|Maintenance Treatment|Physician Decision|0|||
23665110|NCT01081912|66158702|FG001|Maintenance Treatment|Physician Decision|0|||
23665111|NCT01081912|66158703|FG002|Maintenance Treatment|Physician Decision|1|||
23665112|NCT01081912|66158701|FG000|Maintenance Treatment|Protocol Violation|0|||
23665113|NCT01081912|66158702|FG001|Maintenance Treatment|Protocol Violation|1|||
23665114|NCT01081912|66158703|FG002|Maintenance Treatment|Protocol Violation|2|||
23665115|NCT01081912|66158701|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
23665116|NCT01081912|66158702|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
23665117|NCT01081912|66158703|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
23665118|NCT01081912|66158701|FG000|Maintenance Treatment|Non-Compliance|0|||
23665119|NCT01081912|66158702|FG001|Maintenance Treatment|Non-Compliance|4|||
23665120|NCT01081912|66158703|FG002|Maintenance Treatment|Non-Compliance|7|||
23665121|NCT01081912|66158701|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
23665122|NCT01081912|66158702|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
23665123|NCT01081912|66158703|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
23665124|NCT00894556|66158704|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
23665125|NCT00894556|66158705|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
23665126|NCT00894556|66158706|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
23665127|NCT00894556|66158707|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
23665128|NCT00894556|66158704|FG000|Treatment Phase|Lost to Follow-up|2|||
23665129|NCT00894556|66158705|FG001|Treatment Phase|Lost to Follow-up|3|||
23665130|NCT00894556|66158706|FG002|Treatment Phase|Lost to Follow-up|1|||
23665131|NCT00894556|66158707|FG003|Treatment Phase|Lost to Follow-up|0|||
23375810|NCT00671060|65119572|FG001|Overall Study|Protocol Violation|0|||
23375811|NCT00671060|65119571|FG000|Overall Study|Physician Decision|0|||
23375812|NCT00671060|65119572|FG001|Overall Study|Physician Decision|1|||
23375813|NCT04113694|65119573|FG000|Overall Study|Adverse Event|2|||
23375814|NCT04113694|65119573|FG000|Overall Study|Lost to Follow-up|2|||
23375815|NCT04113694|65119573|FG000|Overall Study|Withdrawal by Subject|6|||
23375816|NCT04113694|65119573|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
23375817|NCT01525589|65119574|FG000|Overall Study|Non-treatment-related AE|1|||
23375818|NCT01525589|65119575|FG001|Overall Study|Non-treatment-related AE|0|||
23375819|NCT01525589|65119576|FG002|Overall Study|Non-treatment-related AE|0|||
23375820|NCT01525589|65119574|FG000|Overall Study|Progressive disease|48|||
23375821|NCT01525589|65119575|FG001|Overall Study|Progressive disease|15|||
23375822|NCT01525589|65119576|FG002|Overall Study|Progressive disease|29|||
23375823|NCT01525589|65119574|FG000|Overall Study|Never treated|2|||
23375824|NCT01525589|65119575|FG001|Overall Study|Never treated|0|||
23375825|NCT01525589|65119576|FG002|Overall Study|Never treated|0|||
23375826|NCT01525589|65119574|FG000|Overall Study|Physician Decision|4|||
23375827|NCT01525589|65119575|FG001|Overall Study|Physician Decision|2|||
23604336|NCT03960645|65940402|FG001|Overall Study|Protocol Violation|0|||
23665132|NCT00894556|66158704|FG000|Treatment Phase|Lack of Qualifying Event|2|||
23665133|NCT00894556|66158705|FG001|Treatment Phase|Lack of Qualifying Event|1|||
23665134|NCT00894556|66158706|FG002|Treatment Phase|Lack of Qualifying Event|0|||
23665135|NCT00894556|66158707|FG003|Treatment Phase|Lack of Qualifying Event|0|||
23665136|NCT00609986|66158708|FG000|Overall Study|Did not receive transplant or treatment|8|||
23665137|NCT00609986|66158709|FG001|Overall Study|Did not receive transplant or treatment|3|||
23375828|NCT01525589|65119576|FG002|Overall Study|Physician Decision|2|||
23375829|NCT01525589|65119574|FG000|Overall Study|Death|0|||
23375830|NCT01525589|65119575|FG001|Overall Study|Death|0|||
23375831|NCT01525589|65119576|FG002|Overall Study|Death|2|||
23604337|NCT00089791|65940403|FG000|Overall Study|Physician Decision|6|||
23604338|NCT00089791|65940404|FG001|Overall Study|Physician Decision|3|||
23604339|NCT00089791|65940403|FG000|Overall Study|Adverse Event|81|||
23375832|NCT01525589|65119574|FG000|Overall Study|Treatment-related AE|1|||
23375833|NCT01525589|65119575|FG001|Overall Study|Treatment-related AE|1|||
23375834|NCT01525589|65119576|FG002|Overall Study|Treatment-related AE|2|||
23375835|NCT01525589|65119574|FG000|Overall Study|Other reasons|0|||
23375836|NCT01525589|65119575|FG001|Overall Study|Other reasons|1|||
23375837|NCT01525589|65119576|FG002|Overall Study|Other reasons|0|||
23375838|NCT01525589|65119574|FG000|Overall Study|Withdrawal by Subject|0|||
23375839|NCT01525589|65119575|FG001|Overall Study|Withdrawal by Subject|1|||
23375840|NCT01525589|65119576|FG002|Overall Study|Withdrawal by Subject|0|||
23375841|NCT00819039|65119577|FG000|Overall Study|Physician Decision|1|||
23375842|NCT00819039|65119578|FG001|Overall Study|Physician Decision|0|||
23375843|NCT00819039|65119579|FG002|Overall Study|Physician Decision|1|||
23375844|NCT00819039|65119577|FG000|Overall Study|Protocol Violation|1|||
23375845|NCT00819039|65119578|FG001|Overall Study|Protocol Violation|0|||
23375846|NCT00819039|65119579|FG002|Overall Study|Protocol Violation|0|||
23375847|NCT01373164|65122942|FG000|Overall Study|Lost to Follow-up|0|||
23375848|NCT01373164|65122943|FG001|Overall Study|Lost to Follow-up|0|||
23375849|NCT01373164|65122944|FG002|Overall Study|Lost to Follow-up|1|||
23375850|NCT01373164|65122945|FG003|Overall Study|Lost to Follow-up|2|||
23665138|NCT00631020|66158710|FG000|Overall Study|Lost to Follow-up|7|||
23665139|NCT00631020|66158710|FG000|Overall Study|Incarcerated|1|||
23665140|NCT01516970|66158711|FG000|Overall Study|Lost to Follow-up|7|||
23665141|NCT01516970|66158712|FG001|Overall Study|Lost to Follow-up|8|||
23665142|NCT01516970|66158711|FG000|Overall Study|Adverse Event|1|||
23665143|NCT01516970|66158712|FG001|Overall Study|Adverse Event|5|||
23375851|NCT01373164|65122946|FG004|Overall Study|Lost to Follow-up|0|||
23375852|NCT01373164|65122942|FG000|Overall Study|Withdrawal by Subject|0|||
23375853|NCT01373164|65122943|FG001|Overall Study|Withdrawal by Subject|1|||
23665144|NCT01516970|66158711|FG000|Overall Study|Withdrawal by Subject|1|||
23375854|NCT01373164|65122944|FG002|Overall Study|Withdrawal by Subject|0|||
23665145|NCT01516970|66158712|FG001|Overall Study|Withdrawal by Subject|1|||
23665146|NCT01516970|66158711|FG000|Overall Study|Other|9|||
23375855|NCT01373164|65122945|FG003|Overall Study|Withdrawal by Subject|10|||
23375856|NCT01373164|65122946|FG004|Overall Study|Withdrawal by Subject|2|||
23375857|NCT02349412|65122947|FG000|Overall Study|Withdrawal by Subject|7|||
23375858|NCT02349412|65122948|FG001|Overall Study|Withdrawal by Subject|7|||
23375859|NCT02207608|65122949|FG000|Overall Study|Adverse Event|1|||
23375860|NCT02207608|65122950|FG001|Overall Study|Adverse Event|0|||
23665147|NCT01516970|66158712|FG001|Overall Study|Other|7|||
23665148|NCT02829138|66158716|FG000|Overall Study|Withdrawal by Subject|1|||
23665149|NCT02829138|66158717|FG001|Overall Study|Withdrawal by Subject|0|||
23665150|NCT04544475|66158718|FG000|Overall Study|Withdrawal by Subject|1|||
23665151|NCT04544475|66158719|FG001|Overall Study|Withdrawal by Subject|3|||
23665152|NCT00175877|66158723|FG000|Overall Study|Adverse Event|136|||
23665153|NCT00175877|66158723|FG000|Overall Study|Withdrawal by Subject|141|||
23665154|NCT00175877|66158723|FG000|Overall Study|Lost to Follow-up|9|||
23665155|NCT00175877|66158723|FG000|Overall Study|Lack of Efficacy|26|||
23665156|NCT00175877|66158723|FG000|Overall Study|Protocol Violation|15|||
23665157|NCT00175877|66158723|FG000|Overall Study|Other Reason|20|||
23665158|NCT00175877|66158723|FG000|Overall Study|AE & Other|1|||
23604340|NCT00089791|65940404|FG001|Overall Study|Adverse Event|93|||
23604341|NCT00089791|65940403|FG000|Overall Study|Withdrawal by Subject|403|||
23604342|NCT00089791|65940404|FG001|Overall Study|Withdrawal by Subject|344|||
23604343|NCT00089791|65940403|FG000|Overall Study|Death|78|||
23604344|NCT00089791|65940404|FG001|Overall Study|Death|62|||
23665159|NCT00175877|66158723|FG000|Overall Study|Withdrawal by subject & Other|1|||
23665160|NCT01197521|66158727|FG000|Overall Study|Not reported|24|||
23665161|NCT01197521|66158728|FG001|Overall Study|Not reported|25|||
23665162|NCT01197521|66158729|FG002|Overall Study|Not reported|21|||
23665163|NCT01197521|66158727|FG000|Overall Study|Enrolment in long term extension|42|||
23375861|NCT00089648|65122953|FG000|Overall Study|Adverse Event|7|||
23375862|NCT00089648|65122953|FG000|Overall Study|Withdrawal by Subject|1|||
23375863|NCT00089648|65122953|FG000|Overall Study|Lack of Efficacy|33|||
23375864|NCT01697579|65122954|FG000|Base Study-Cycle 1|Adverse Event|1|||
23375865|NCT01697579|65122955|FG001|Base Study-Cycle 1|Adverse Event|0|||
23375866|NCT01697579|65122956|FG002|Base Study-Cycle 1|Adverse Event|0|||
23375867|NCT01697579|65122957|FG003|Base Study-Cycle 1|Adverse Event|0|||
23375868|NCT01697579|65122958|FG004|Base Study-Cycle 1|Adverse Event|0|||
23375869|NCT01697579|65122959|FG005|Base Study-Cycle 1|Adverse Event|0|||
23375870|NCT01697579|65122960|FG006|Base Study-Cycle 1|Adverse Event|0|||
23375871|NCT01697579|65122954|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
23375872|NCT01697579|65122955|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375873|NCT01697579|65122956|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375874|NCT01697579|65122957|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375875|NCT01697579|65122958|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375876|NCT01697579|65122959|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375877|NCT01697579|65122960|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375878|NCT01697579|65122954|FG000|Base Study-Cycle 1|Protocol Violation|0|||
23375879|NCT01697579|65122955|FG001|Base Study-Cycle 1|Protocol Violation|0|||
23375880|NCT01697579|65122956|FG002|Base Study-Cycle 1|Protocol Violation|0|||
23375881|NCT01697579|65122957|FG003|Base Study-Cycle 1|Protocol Violation|0|||
23375882|NCT01697579|65122958|FG004|Base Study-Cycle 1|Protocol Violation|3|||
23375883|NCT01697579|65122959|FG005|Base Study-Cycle 1|Protocol Violation|0|||
23375884|NCT01697579|65122960|FG006|Base Study-Cycle 1|Protocol Violation|0|||
23375885|NCT01697579|65122954|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375886|NCT01697579|65122955|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
23375887|NCT01697579|65122956|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375888|NCT01697579|65122957|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375889|NCT01697579|65122958|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375890|NCT01697579|65122959|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375891|NCT01697579|65122960|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375892|NCT01697579|65122954|FG000|Base Study-Cycle 1|Technical Problems|0|||
23375893|NCT01697579|65122955|FG001|Base Study-Cycle 1|Technical Problems|0|||
23375894|NCT01697579|65122956|FG002|Base Study-Cycle 1|Technical Problems|1|||
23375895|NCT01697579|65122957|FG003|Base Study-Cycle 1|Technical Problems|1|||
23375896|NCT01697579|65122958|FG004|Base Study-Cycle 1|Technical Problems|0|||
23375897|NCT01697579|65122959|FG005|Base Study-Cycle 1|Technical Problems|0|||
23375898|NCT01697579|65122960|FG006|Base Study-Cycle 1|Technical Problems|0|||
23375899|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Death|0|||
23375900|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Death|0|||
23375901|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Death|0|||
23375902|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Death|0|||
23375903|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Death|0|||
23375904|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Death|0|||
23375905|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Death|2|||
23375906|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375907|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375908|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375909|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375910|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375911|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
23375912|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
23604345|NCT00089791|65940403|FG000|Overall Study|Disease progression|7|||
23604346|NCT00089791|65940404|FG001|Overall Study|Disease progression|3|||
23604347|NCT00089791|65940403|FG000|Overall Study|Ineligibility determined|12|||
23604348|NCT00089791|65940404|FG001|Overall Study|Ineligibility determined|9|||
23604349|NCT00089791|65940403|FG000|Overall Study|Lost to Follow-up|57|||
23604350|NCT00089791|65940404|FG001|Overall Study|Lost to Follow-up|57|||
23604351|NCT00089791|65940403|FG000|Overall Study|Noncompliance|17|||
23604352|NCT00089791|65940404|FG001|Overall Study|Noncompliance|13|||
23604353|NCT00089791|65940403|FG000|Overall Study|Other|20|||
23604354|NCT00089791|65940404|FG001|Overall Study|Other|32|||
23604355|NCT00089791|65940403|FG000|Overall Study|Protocol deviation|12|||
23604356|NCT00089791|65940404|FG001|Overall Study|Protocol deviation|10|||
23375913|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
23604357|NCT00089791|65940403|FG000|Overall Study|Requirement for alternative therapy|7|||
23604358|NCT00089791|65940404|FG001|Overall Study|Requirement for alternative therapy|4|||
23604359|NCT00739934|65940405|FG000|Voriconazole IV|Adverse Event|6|||
23375914|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375915|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375916|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375917|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
23488951|NCT02484690|65534010|FG001|Overall Study|Lost to Follow-up|0|||
23375918|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
23665164|NCT01197521|66158728|FG001|Overall Study|Enrolment in long term extension|36|||
23665165|NCT01197521|66158729|FG002|Overall Study|Enrolment in long term extension|87|||
23665166|NCT01197521|66158727|FG000|Overall Study|Severe non-compliance to protocol|1|||
23665167|NCT01197521|66158728|FG001|Overall Study|Severe non-compliance to protocol|3|||
23665168|NCT01197521|66158729|FG002|Overall Study|Severe non-compliance to protocol|3|||
23665169|NCT01197521|66158727|FG000|Overall Study|Lack of therapeutic response|2|||
23665170|NCT01197521|66158728|FG001|Overall Study|Lack of therapeutic response|3|||
23665171|NCT01197521|66158729|FG002|Overall Study|Lack of therapeutic response|4|||
23665172|NCT01197521|66158727|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
23665173|NCT01197521|66158728|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
23665174|NCT01197521|66158729|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
23665175|NCT01197521|66158727|FG000|Overall Study|Lost to Follow-up|3|||
23665176|NCT01197521|66158728|FG001|Overall Study|Lost to Follow-up|2|||
23665177|NCT01197521|66158729|FG002|Overall Study|Lost to Follow-up|2|||
23665178|NCT01197521|66158727|FG000|Overall Study|Adverse Event|25|||
23665179|NCT01197521|66158728|FG001|Overall Study|Adverse Event|28|||
23665180|NCT01197521|66158729|FG002|Overall Study|Adverse Event|24|||
23665181|NCT00715026|66158732|FG000|Overall Study|Withdrawal by Subject|5|||
23665182|NCT00715026|66158732|FG000|Overall Study|Lost to Follow-up|3|||
23665183|NCT00715026|66158732|FG000|Overall Study|Protocol Violation|1|||
23665184|NCT00715026|66158732|FG000|Overall Study|Surgery done on non-study consented hip|1|||
23665185|NCT00736255|66158733|FG000|Overall Study|Adverse Event|1|||
23665186|NCT00736255|66158734|FG001|Overall Study|Adverse Event|0|||
23665187|NCT00736255|66158733|FG000|Overall Study|Physician Decision|1|||
23665188|NCT00736255|66158734|FG001|Overall Study|Physician Decision|0|||
23665189|NCT00736255|66158733|FG000|Overall Study|Non-compliance|1|||
23665190|NCT00736255|66158734|FG001|Overall Study|Non-compliance|1|||
23665191|NCT02004262|66158735|FG000|Overall Study|Death|67|||
23665192|NCT02004262|66158736|FG001|Overall Study|Death|64|||
23665193|NCT02004262|66158737|FG002|Overall Study|Death|66|||
23665194|NCT02004262|66158738|FG003|Overall Study|Death|28|||
23665195|NCT02004262|66158739|FG004|Overall Study|Death|29|||
23665196|NCT02004262|66158740|FG005|Overall Study|Death|22|||
23665197|NCT02004262|66158735|FG000|Overall Study|Withdrawal by Subject|1|||
23375919|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
23488952|NCT02484690|65534011|FG002|Overall Study|Lost to Follow-up|1|||
23604360|NCT00739934|65940405|FG000|Voriconazole Oral|Other|3|||
23604361|NCT00513071|65940406|FG000|Overall Study|Adverse Event|1|||
23604362|NCT00513071|65940406|FG000|Overall Study|Withdrawal by Subject|1|||
23604363|NCT00513071|65940406|FG000|Overall Study|Physician Decision|3|||
23604364|NCT00786188|65940407|FG000|Overall Study|Adverse Event|3|||
23604365|NCT00786188|65940408|FG001|Overall Study|Adverse Event|1|||
23604366|NCT00786188|65940407|FG000|Overall Study|Withdrawal by Subject|2|||
23604367|NCT00786188|65940408|FG001|Overall Study|Withdrawal by Subject|0|||
23604368|NCT02165202|65940409|FG000|Oral Phase|Refused further participation|5|||
23604369|NCT02165202|65940410|FG001|Oral Phase|Refused further participation|1|||
23604370|NCT02165202|65940409|FG000|Oral Phase|Study product Related Toxicity|1|||
23604371|NCT02165202|65940410|FG001|Oral Phase|Study product Related Toxicity|0|||
23604372|NCT02165202|65940409|FG000|Oral Phase|Unable to contact Participant|1|||
23604373|NCT02165202|65940410|FG001|Oral Phase|Unable to contact Participant|1|||
23604374|NCT02165202|65940409|FG000|Oral Phase|Clinical reasons|1|||
23604375|NCT02165202|65940410|FG001|Oral Phase|Clinical reasons|0|||
23604376|NCT02165202|65940409|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
23604377|NCT02165202|65940410|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
23604378|NCT02165202|65940409|FG000|Oral Phase|CMC advised termination|1|||
23604379|NCT02165202|65940410|FG001|Oral Phase|CMC advised termination|0|||
23604380|NCT02165202|65940409|FG000|Oral Phase|Relocated, no follow-up planned|1|||
23604381|NCT02165202|65940410|FG001|Oral Phase|Relocated, no follow-up planned|0|||
23604382|NCT02165202|65940409|FG000|Oral Phase|Abnormal EKG|0|||
23604383|NCT02165202|65940410|FG001|Oral Phase|Abnormal EKG|1|||
23604384|NCT02165202|65940409|FG000|Injection Phase|Abnormal Lab Value|5|||
23604385|NCT02165202|65940410|FG001|Injection Phase|Abnormal Lab Value|1|||
23604386|NCT02165202|65940409|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
23604387|NCT02165202|65940410|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
23604388|NCT02165202|65940409|FG000|Injection Phase|Unable to attend within Visit Window|1|||
23604389|NCT02165202|65940410|FG001|Injection Phase|Unable to attend within Visit Window|0|||
23665198|NCT02004262|66158736|FG001|Overall Study|Withdrawal by Subject|0|||
23665199|NCT02004262|66158737|FG002|Overall Study|Withdrawal by Subject|4|||
23665200|NCT02004262|66158738|FG003|Overall Study|Withdrawal by Subject|0|||
23665201|NCT02004262|66158739|FG004|Overall Study|Withdrawal by Subject|1|||
23665202|NCT02004262|66158740|FG005|Overall Study|Withdrawal by Subject|3|||
23665203|NCT02004262|66158735|FG000|Overall Study|Lost to Follow-up|1|||
23375920|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23665204|NCT02004262|66158736|FG001|Overall Study|Lost to Follow-up|1|||
23665205|NCT02004262|66158737|FG002|Overall Study|Lost to Follow-up|0|||
23375921|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375922|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375923|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375924|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375925|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375926|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
23375927|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375928|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375929|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375930|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375931|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375932|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
23375933|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
23375934|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375935|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375936|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375937|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375938|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375939|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
23375940|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375941|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375942|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375943|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375944|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375945|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375946|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
23375947|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
23375948|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375949|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375950|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375951|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375952|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375953|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
23375954|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
23375955|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375956|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375957|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375958|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375959|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23488953|NCT02484690|65534012|FG003|Overall Study|Lost to Follow-up|0|||
23488954|NCT02484690|65534013|FG004|Overall Study|Lost to Follow-up|0|||
23488955|NCT02239224|65534016|FG000|Overall Study|Administrative|0|||
23488956|NCT02239224|65534017|FG001|Overall Study|Administrative|0|||
23488957|NCT02239224|65534018|FG002|Overall Study|Administrative|3|||
23488958|NCT02239224|65534019|FG003|Overall Study|Administrative|1|||
23488959|NCT00191646|65534022|FG000|Overall Study|Toxicity|26|||
23488960|NCT00191646|65534023|FG001|Overall Study|Toxicity|37|||
23488961|NCT00191646|65534022|FG000|Overall Study|Disease Progression|5|||
23488962|NCT00191646|65534023|FG001|Overall Study|Disease Progression|6|||
23488963|NCT00191646|65534022|FG000|Overall Study|Physician Decision|20|||
23488964|NCT00191646|65534023|FG001|Overall Study|Physician Decision|11|||
23488965|NCT00191646|65534022|FG000|Overall Study|Withdrawal by Subject|58|||
23488966|NCT00191646|65534023|FG001|Overall Study|Withdrawal by Subject|39|||
23488967|NCT00191646|65534022|FG000|Overall Study|Protocol Violation|5|||
23488968|NCT00191646|65534023|FG001|Overall Study|Protocol Violation|7|||
23488969|NCT00191646|65534022|FG000|Overall Study|Death|6|||
23488970|NCT00191646|65534023|FG001|Overall Study|Death|8|||
23488971|NCT00191646|65534022|FG000|Overall Study|Other|33|||
23488972|NCT00191646|65534023|FG001|Overall Study|Other|34|||
23488973|NCT00191646|65534022|FG000|Overall Study|Missing Data|18|||
23665206|NCT02004262|66158738|FG003|Overall Study|Lost to Follow-up|0|||
23375960|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375961|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
23375962|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
23488974|NCT00191646|65534023|FG001|Overall Study|Missing Data|11|||
23488975|NCT04043728|65534027|FG000|Overall Study|Lost to Follow-up|1|||
23488976|NCT04043728|65534028|FG001|Overall Study|Lost to Follow-up|2|||
23488977|NCT04043728|65534029|FG002|Overall Study|Lost to Follow-up|0|||
23488978|NCT01702571|65534035|FG000|Overall Study|Death|1067|||
23375963|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375964|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375965|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375966|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375967|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375968|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
23375969|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375970|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375971|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375972|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375973|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375974|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375975|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
23375976|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375977|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375978|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375979|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375980|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375981|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
23375982|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
23375983|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375984|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375985|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375986|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375987|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375988|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375989|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
23375990|NCT03636256|65122963|FG000|Overall Study|Lost to Follow-up|3|||
23375991|NCT03636256|65122964|FG001|Overall Study|Lost to Follow-up|0|||
23375992|NCT03636256|65122965|FG002|Overall Study|Lost to Follow-up|2|||
23375993|NCT03636256|65122966|FG003|Overall Study|Lost to Follow-up|1|||
23375994|NCT03636256|65122967|FG004|Overall Study|Lost to Follow-up|0|||
23375995|NCT03636256|65122968|FG005|Overall Study|Lost to Follow-up|4|||
23375996|NCT03636256|65122969|FG006|Overall Study|Lost to Follow-up|2|||
23375997|NCT03636256|65122970|FG007|Overall Study|Lost to Follow-up|0|||
23375998|NCT03636256|65122971|FG008|Overall Study|Lost to Follow-up|4|||
23375999|NCT03636256|65122963|FG000|Overall Study|Withdrawal by Subject|0|||
23376000|NCT03636256|65122964|FG001|Overall Study|Withdrawal by Subject|0|||
23376001|NCT03636256|65122965|FG002|Overall Study|Withdrawal by Subject|0|||
23376002|NCT03636256|65122966|FG003|Overall Study|Withdrawal by Subject|0|||
23376003|NCT03636256|65122967|FG004|Overall Study|Withdrawal by Subject|0|||
23376004|NCT03636256|65122968|FG005|Overall Study|Withdrawal by Subject|0|||
23376005|NCT03636256|65122969|FG006|Overall Study|Withdrawal by Subject|0|||
23376006|NCT03636256|65122970|FG007|Overall Study|Withdrawal by Subject|0|||
23376007|NCT03636256|65122971|FG008|Overall Study|Withdrawal by Subject|1|||
23376008|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376009|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
23376010|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376011|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376012|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376013|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376014|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376015|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376016|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376017|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
23376018|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376019|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376020|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376021|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23665207|NCT02004262|66158739|FG004|Overall Study|Lost to Follow-up|0|||
23376022|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376023|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376024|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376025|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376026|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
23376027|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376028|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23604390|NCT02165202|65940409|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
23604391|NCT02165202|65940410|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
23604392|NCT02165202|65940409|FG000|Injection Phase|End of Study|2|||
23604393|NCT02165202|65940410|FG001|Injection Phase|End of Study|1|||
23604394|NCT02165202|65940409|FG000|Injection Phase|Study Product related Toxicity|1|||
23604395|NCT02165202|65940410|FG001|Injection Phase|Study Product related Toxicity|0|||
23604396|NCT02165202|65940409|FG000|Injection Phase|No longer interested|0|||
23604397|NCT02165202|65940410|FG001|Injection Phase|No longer interested|1|||
23604398|NCT02165202|65940409|FG000|Injection Phase|Participant unwilling to comply|1|||
23604399|NCT02165202|65940410|FG001|Injection Phase|Participant unwilling to comply|0|||
23604400|NCT03601715|65940411|FG000|Second Intervention|Lost to Follow-up|1|||
23604401|NCT03601715|65940412|FG001|Second Intervention|Lost to Follow-up|1|||
23604402|NCT03601715|65940413|FG002|Second Intervention|Lost to Follow-up|0|||
23604403|NCT02022670|65940414|FG000|Overall Study|Adverse Event|1|||
23604404|NCT02022670|65940415|FG001|Overall Study|Adverse Event|0|||
23604405|NCT02022670|65940416|FG002|Overall Study|Adverse Event|1|||
23604406|NCT04895085|65940417|FG000|Overall Study|Death|1|||
23604407|NCT04895085|65940417|FG000|Overall Study|Withdrawal by Subject|1|||
23604408|NCT04895085|65940417|FG000|Overall Study|No longer eligible: Moved from area|1|||
23604409|NCT00622700|65940418|FG000|Core Treatment Period|Randomized but Not Treated|0|||
23604410|NCT00622700|65940419|FG001|Core Treatment Period|Randomized but Not Treated|2|||
23604411|NCT00622700|65940420|FG002|Core Treatment Period|Randomized but Not Treated|2|||
23604412|NCT00622700|65940421|FG003|Core Treatment Period|Randomized but Not Treated|0|||
23604413|NCT00622700|65940422|FG004|Core Treatment Period|Randomized but Not Treated|0|||
23604414|NCT00622700|65940423|FG005|Core Treatment Period|Randomized but Not Treated|0|||
23604415|NCT00622700|65940424|FG006|Core Treatment Period|Randomized but Not Treated|0|||
23604416|NCT00622700|65940418|FG000|Core Treatment Period|Adverse Event|18|||
23604417|NCT00622700|65940419|FG001|Core Treatment Period|Adverse Event|25|||
23604418|NCT00622700|65940420|FG002|Core Treatment Period|Adverse Event|18|||
23604419|NCT00622700|65940421|FG003|Core Treatment Period|Adverse Event|0|||
23604420|NCT00622700|65940422|FG004|Core Treatment Period|Adverse Event|0|||
23604421|NCT00622700|65940423|FG005|Core Treatment Period|Adverse Event|0|||
23604422|NCT00622700|65940424|FG006|Core Treatment Period|Adverse Event|0|||
23604423|NCT00622700|65940418|FG000|Core Treatment Period|Lack of Efficacy|19|||
23604424|NCT00622700|65940419|FG001|Core Treatment Period|Lack of Efficacy|6|||
23604425|NCT00622700|65940420|FG002|Core Treatment Period|Lack of Efficacy|12|||
23604426|NCT00622700|65940421|FG003|Core Treatment Period|Lack of Efficacy|0|||
23604427|NCT00622700|65940422|FG004|Core Treatment Period|Lack of Efficacy|0|||
23604428|NCT00622700|65940423|FG005|Core Treatment Period|Lack of Efficacy|0|||
23604429|NCT00622700|65940424|FG006|Core Treatment Period|Lack of Efficacy|0|||
23604430|NCT00622700|65940418|FG000|Core Treatment Period|Lost to Follow-up|1|||
23604431|NCT00622700|65940419|FG001|Core Treatment Period|Lost to Follow-up|1|||
23604432|NCT00622700|65940420|FG002|Core Treatment Period|Lost to Follow-up|1|||
23604433|NCT00622700|65940421|FG003|Core Treatment Period|Lost to Follow-up|0|||
23604434|NCT00622700|65940422|FG004|Core Treatment Period|Lost to Follow-up|0|||
23604435|NCT00622700|65940423|FG005|Core Treatment Period|Lost to Follow-up|0|||
23604436|NCT00622700|65940424|FG006|Core Treatment Period|Lost to Follow-up|0|||
23604437|NCT00622700|65940418|FG000|Core Treatment Period|Death|1|||
23488979|NCT01702571|65534036|FG001|Overall Study|Death|76|||
23604438|NCT00622700|65940419|FG001|Core Treatment Period|Death|0|||
23604439|NCT00622700|65940420|FG002|Core Treatment Period|Death|0|||
23604440|NCT00622700|65940421|FG003|Core Treatment Period|Death|0|||
23604441|NCT00622700|65940422|FG004|Core Treatment Period|Death|0|||
23665208|NCT02004262|66158740|FG005|Overall Study|Lost to Follow-up|0|||
23665209|NCT02004262|66158735|FG000|Overall Study|Study Terminated by Sponsor|4|||
23665210|NCT02004262|66158736|FG001|Overall Study|Study Terminated by Sponsor|3|||
23665211|NCT02004262|66158737|FG002|Overall Study|Study Terminated by Sponsor|2|||
23665212|NCT02004262|66158738|FG003|Overall Study|Study Terminated by Sponsor|1|||
23665213|NCT02004262|66158739|FG004|Overall Study|Study Terminated by Sponsor|1|||
23665214|NCT02004262|66158740|FG005|Overall Study|Study Terminated by Sponsor|5|||
23665215|NCT04640272|66158742|FG000|Overall Study|Subject moved out of area|1|||
23665216|NCT01476475|66158743|FG000|Overall Study|Adverse Event|6|||
23665217|NCT01476475|66158744|FG001|Overall Study|Adverse Event|0|||
23604442|NCT00622700|65940423|FG005|Core Treatment Period|Death|0|||
23604443|NCT00622700|65940424|FG006|Core Treatment Period|Death|0|||
23604444|NCT00622700|65940418|FG000|Core Treatment Period|Progressive Disease|3|||
23604445|NCT00622700|65940419|FG001|Core Treatment Period|Progressive Disease|1|||
23604446|NCT00622700|65940420|FG002|Core Treatment Period|Progressive Disease|0|||
23604447|NCT00622700|65940421|FG003|Core Treatment Period|Progressive Disease|0|||
23604448|NCT00622700|65940422|FG004|Core Treatment Period|Progressive Disease|0|||
23604449|NCT00622700|65940423|FG005|Core Treatment Period|Progressive Disease|0|||
23604450|NCT00622700|65940424|FG006|Core Treatment Period|Progressive Disease|0|||
23376029|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376030|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376031|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376032|NCT00729586|65122980|FG000|Overall Study|Ineligible|0|||
23376033|NCT00729586|65122981|FG001|Overall Study|Ineligible|1|||
23376034|NCT00729586|65122980|FG000|Overall Study|never treated|1|||
23376035|NCT00729586|65122981|FG001|Overall Study|never treated|0|||
23376036|NCT01240694|65122982|FG000|Overall Study|Adverse Event|9|||
23376037|NCT01240694|65122982|FG000|Overall Study|Lack of Efficacy|6|||
23376038|NCT01240694|65122982|FG000|Overall Study|Withdrawal by Subject|6|||
23376039|NCT01240694|65122982|FG000|Overall Study|Protocol Violation|2|||
23376040|NCT01240694|65122982|FG000|Overall Study|Lost to Follow-up|2|||
23376041|NCT01240694|65122982|FG000|Overall Study|Other than specified|3|||
23376042|NCT01240694|65122982|FG000|Overall Study|Withdrawn due to early study termination|107|||
23376043|NCT01155141|65122983|FG000|Overall Study|Withdrawal by Subject|1|||
23376044|NCT01155141|65122983|FG000|Overall Study|Screen Failure|1|||
23376045|NCT01192815|65122986|FG000|Overall Study|Withdrawal by Subject|1|||
23376046|NCT01192815|65122986|FG000|Overall Study|Lack of Efficacy|1|||
23376047|NCT02787304|65122987|FG000|Overall Study|Adverse Event|9|||
23376048|NCT02787304|65122988|FG001|Overall Study|Adverse Event|3|||
23376049|NCT02787304|65122989|FG002|Overall Study|Adverse Event|8|||
23376050|NCT02787304|65122990|FG003|Overall Study|Adverse Event|1|||
23376051|NCT02787304|65122987|FG000|Overall Study|Withdrawal by Subject|1|||
23376052|NCT02787304|65122988|FG001|Overall Study|Withdrawal by Subject|4|||
23376053|NCT02787304|65122989|FG002|Overall Study|Withdrawal by Subject|0|||
23376054|NCT02787304|65122990|FG003|Overall Study|Withdrawal by Subject|0|||
23376055|NCT02787304|65122987|FG000|Overall Study|Lost to Follow-up|1|||
23488980|NCT01702571|65534035|FG000|Overall Study|Lost to Follow-up|144|||
23488981|NCT01702571|65534036|FG001|Overall Study|Lost to Follow-up|10|||
23488982|NCT01702571|65534035|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
23488983|NCT01702571|65534036|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
23488984|NCT01702571|65534035|FG000|Overall Study|Investigator Decision|5|||
23488985|NCT01702571|65534036|FG001|Overall Study|Investigator Decision|0|||
23488986|NCT01702571|65534035|FG000|Overall Study|Not Classifiable|1|||
23488987|NCT01702571|65534036|FG001|Overall Study|Not Classifiable|0|||
23488988|NCT01702571|65534035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
23488989|NCT01702571|65534036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
23488990|NCT01702571|65534035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
23376056|NCT02787304|65122988|FG001|Overall Study|Lost to Follow-up|0|||
23376057|NCT02787304|65122989|FG002|Overall Study|Lost to Follow-up|0|||
23488991|NCT01702571|65534036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
23488992|NCT01702571|65534035|FG000|Overall Study|Progressive Disease|3|||
23488993|NCT01702571|65534036|FG001|Overall Study|Progressive Disease|0|||
23488994|NCT01702571|65534035|FG000|Overall Study|Protocol Violation|2|||
23488995|NCT01702571|65534036|FG001|Overall Study|Protocol Violation|0|||
23488996|NCT01702571|65534035|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
23488997|NCT01702571|65534036|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
23488998|NCT01702571|65534035|FG000|Overall Study|Termination By Sponsor|4|||
23488999|NCT01702571|65534036|FG001|Overall Study|Termination By Sponsor|0|||
23376058|NCT02787304|65122990|FG003|Overall Study|Lost to Follow-up|1|||
23376059|NCT02787304|65122987|FG000|Overall Study|Noncompliance with study drug|0|||
23376060|NCT02787304|65122988|FG001|Overall Study|Noncompliance with study drug|0|||
23376061|NCT02787304|65122989|FG002|Overall Study|Noncompliance with study drug|1|||
23376062|NCT02787304|65122990|FG003|Overall Study|Noncompliance with study drug|0|||
23376063|NCT02787304|65122987|FG000|Overall Study|Physician Decision|0|||
23376064|NCT02787304|65122988|FG001|Overall Study|Physician Decision|0|||
23376065|NCT02787304|65122989|FG002|Overall Study|Physician Decision|1|||
23376066|NCT02787304|65122990|FG003|Overall Study|Physician Decision|0|||
23376067|NCT02787304|65122987|FG000|Overall Study|Study terminated by sponsor|25|||
23376068|NCT02787304|65122988|FG001|Overall Study|Study terminated by sponsor|31|||
23376069|NCT02787304|65122989|FG002|Overall Study|Study terminated by sponsor|31|||
23376070|NCT02787304|65122990|FG003|Overall Study|Study terminated by sponsor|32|||
23376071|NCT00390013|65122993|FG000|Phase 1|tired|0|||
23376072|NCT00390013|65122994|FG001|Phase 1|tired|0|||
23376073|NCT00390013|65122995|FG002|Phase 1|tired|0|||
23376074|NCT00390013|65122996|FG003|Phase 1|tired|1|||
23376075|NCT00390013|65122993|FG000|Phase 2 First Treatment|tired|1|||
23376076|NCT00390013|65122994|FG001|Phase 2 First Treatment|tired|0|||
23376077|NCT00390013|65122995|FG002|Phase 2 First Treatment|tired|0|||
23376078|NCT00390013|65122996|FG003|Phase 2 First Treatment|tired|0|||
23376079|NCT00390013|65122993|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
23376080|NCT00390013|65122994|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
23489000|NCT01702571|65534035|FG000|Overall Study|Withdrawal by Subject|177|||
23489001|NCT01702571|65534036|FG001|Overall Study|Withdrawal by Subject|29|||
23489002|NCT03666624|65536941|FG000|Overall Study|participant grieving over recent death of parent|1|||
23489003|NCT03666624|65536942|FG001|Overall Study|participant grieving over recent death of parent|0|||
23489004|NCT01199731|65536943|FG000|Overall Study|Adverse Event|0|||
23489005|NCT01199731|65536944|FG001|Overall Study|Adverse Event|1|||
23489006|NCT01199731|65536945|FG002|Overall Study|Adverse Event|0|||
23489007|NCT01199731|65536943|FG000|Overall Study|Study closed/terminated|7|||
23489008|NCT01199731|65536944|FG001|Overall Study|Study closed/terminated|9|||
23489009|NCT01199731|65536945|FG002|Overall Study|Study closed/terminated|7|||
23489010|NCT01199731|65536943|FG000|Overall Study|Lost to Follow-up|0|||
23489011|NCT01199731|65536944|FG001|Overall Study|Lost to Follow-up|0|||
23489012|NCT01199731|65536945|FG002|Overall Study|Lost to Follow-up|2|||
23489013|NCT01199731|65536943|FG000|Overall Study|Physician Decision|0|||
23489014|NCT01199731|65536944|FG001|Overall Study|Physician Decision|1|||
23489015|NCT01199731|65536945|FG002|Overall Study|Physician Decision|1|||
23489016|NCT01199731|65536943|FG000|Overall Study|Withdrawal by Subject|2|||
23489017|NCT01199731|65536944|FG001|Overall Study|Withdrawal by Subject|0|||
23489018|NCT01199731|65536945|FG002|Overall Study|Withdrawal by Subject|0|||
23489019|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489020|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
23489021|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489022|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489023|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489024|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
23489025|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
23489026|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
23489027|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23489028|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23489029|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
23489030|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
23489031|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
23489032|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
23489033|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
23489034|NCT03971071|65536946|FG000|Open-label Treatment Period|Sponsor decision|0|||
23489035|NCT03971071|65536947|FG001|Open-label Treatment Period|Sponsor decision|0|||
23489036|NCT03971071|65536948|FG002|Open-label Treatment Period|Sponsor decision|0|||
23489037|NCT03971071|65536949|FG003|Open-label Treatment Period|Sponsor decision|0|||
23489038|NCT03971071|65536950|FG004|Open-label Treatment Period|Sponsor decision|1|||
23489039|NCT03971071|65536946|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23489040|NCT03971071|65536947|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23489041|NCT03971071|65536948|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23489042|NCT03971071|65536949|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
23489043|NCT03971071|65536950|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
23489044|NCT03971071|65536946|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23489045|NCT03971071|65536947|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23489046|NCT03971071|65536948|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23489047|NCT03971071|65536949|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23489048|NCT03971071|65536950|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
23489049|NCT00747812|65536951|FG000|Overall Study|Research Site Staff Relocation|5|||
23489050|NCT00747812|65536952|FG001|Overall Study|Research Site Staff Relocation|3|||
23489051|NCT00750880|65536953|FG000|Overall Study|Adverse Event|76|||
23489052|NCT00750880|65536953|FG000|Overall Study|Death|4|||
23489053|NCT00750880|65536953|FG000|Overall Study|Lack of Efficacy|46|||
23489054|NCT00750880|65536953|FG000|Overall Study|Lost to Follow-up|10|||
23489055|NCT00750880|65536953|FG000|Overall Study|Protocol Violation|15|||
23489056|NCT00750880|65536953|FG000|Overall Study|Withdrawal by Subject|33|||
23489057|NCT00750880|65536953|FG000|Overall Study|Physician Decision|20|||
23489058|NCT00750880|65536953|FG000|Overall Study|Administrative|11|||
23489059|NCT04209348|65536954|FG000|Overall Study|Lost to Follow-up|1|||
23489060|NCT04209348|65536955|FG001|Overall Study|Lost to Follow-up|0|||
23489061|NCT00915356|65536956|FG000|Overall Study|Withdrawal by Subject|1|||
23489062|NCT00915356|65536957|FG001|Overall Study|Withdrawal by Subject|0|||
23489063|NCT00915356|65536958|FG002|Overall Study|Withdrawal by Subject|0|||
23489064|NCT00915356|65536959|FG003|Overall Study|Withdrawal by Subject|0|||
23489065|NCT00915356|65536960|FG004|Overall Study|Withdrawal by Subject|0|||
23489066|NCT04478123|65536961|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
23489067|NCT04478123|65536961|FG000|Overall Study|NE|1|||
23489068|NCT00697073|65536963|FG000|Overall Study|Withdrawal by Subject|2|||
23489069|NCT00697073|65536963|FG000|Overall Study|Pregnancy|1|||
23489070|NCT00697073|65536963|FG000|Overall Study|non compliance and other|6|||
23489071|NCT03181893|65536965|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489072|NCT03181893|65536966|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
23489073|NCT03181893|65536967|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489074|NCT03181893|65536968|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489075|NCT03181893|65536969|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489076|NCT03181893|65536970|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489077|NCT03181893|65536971|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489078|NCT03181893|65536972|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489079|NCT03181893|65536973|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489080|NCT03181893|65536974|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489081|NCT03181893|65536975|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489082|NCT03181893|65536965|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
23489083|NCT03181893|65536966|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
23489084|NCT03181893|65536967|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489085|NCT03181893|65536968|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489086|NCT03181893|65536969|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489087|NCT03181893|65536970|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489088|NCT03181893|65536971|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489089|NCT03181893|65536972|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489090|NCT03181893|65536973|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489091|NCT03181893|65536974|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489092|NCT03181893|65536975|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489093|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23604451|NCT00622700|65940418|FG000|Core Treatment Period|Withdrawal by Subject|12|||
23604452|NCT00622700|65940419|FG001|Core Treatment Period|Withdrawal by Subject|18|||
23604453|NCT00622700|65940420|FG002|Core Treatment Period|Withdrawal by Subject|15|||
23604454|NCT00622700|65940421|FG003|Core Treatment Period|Withdrawal by Subject|0|||
23604455|NCT00622700|65940422|FG004|Core Treatment Period|Withdrawal by Subject|0|||
23604456|NCT00622700|65940423|FG005|Core Treatment Period|Withdrawal by Subject|0|||
23604457|NCT00622700|65940424|FG006|Core Treatment Period|Withdrawal by Subject|0|||
23604458|NCT00622700|65940418|FG000|Core Treatment Period|Other than specified above|2|||
23604459|NCT00622700|65940419|FG001|Core Treatment Period|Other than specified above|2|||
23604460|NCT00622700|65940420|FG002|Core Treatment Period|Other than specified above|5|||
23604461|NCT00622700|65940421|FG003|Core Treatment Period|Other than specified above|0|||
23604462|NCT00622700|65940422|FG004|Core Treatment Period|Other than specified above|0|||
23604463|NCT00622700|65940423|FG005|Core Treatment Period|Other than specified above|0|||
23604464|NCT00622700|65940424|FG006|Core Treatment Period|Other than specified above|0|||
23604465|NCT00622700|65940418|FG000|Extension Treatment Period|Adverse Event|0|||
23604466|NCT00622700|65940419|FG001|Extension Treatment Period|Adverse Event|0|||
23604467|NCT00622700|65940420|FG002|Extension Treatment Period|Adverse Event|0|||
23604468|NCT00622700|65940421|FG003|Extension Treatment Period|Adverse Event|5|||
23604469|NCT00622700|65940422|FG004|Extension Treatment Period|Adverse Event|9|||
23604470|NCT00622700|65940423|FG005|Extension Treatment Period|Adverse Event|6|||
23604471|NCT00622700|65940424|FG006|Extension Treatment Period|Adverse Event|8|||
23604472|NCT00622700|65940418|FG000|Extension Treatment Period|Lack of Efficacy|0|||
23604473|NCT00622700|65940419|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23604474|NCT00622700|65940420|FG002|Extension Treatment Period|Lack of Efficacy|0|||
23604475|NCT00622700|65940421|FG003|Extension Treatment Period|Lack of Efficacy|2|||
23604476|NCT00622700|65940422|FG004|Extension Treatment Period|Lack of Efficacy|8|||
23604477|NCT00622700|65940423|FG005|Extension Treatment Period|Lack of Efficacy|1|||
23604478|NCT00622700|65940424|FG006|Extension Treatment Period|Lack of Efficacy|9|||
23604479|NCT00622700|65940418|FG000|Extension Treatment Period|Protocol Violation|0|||
23604480|NCT00622700|65940419|FG001|Extension Treatment Period|Protocol Violation|0|||
23604481|NCT00622700|65940420|FG002|Extension Treatment Period|Protocol Violation|0|||
23604482|NCT00622700|65940421|FG003|Extension Treatment Period|Protocol Violation|0|||
23604483|NCT00622700|65940422|FG004|Extension Treatment Period|Protocol Violation|0|||
23604484|NCT00622700|65940423|FG005|Extension Treatment Period|Protocol Violation|2|||
23489094|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489095|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489096|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23604485|NCT00622700|65940424|FG006|Extension Treatment Period|Protocol Violation|0|||
23604486|NCT00622700|65940418|FG000|Extension Treatment Period|Lost to Follow-up|0|||
23489097|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489098|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489099|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489100|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
23489101|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
23489102|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489103|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489104|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489105|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489106|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489107|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489108|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489109|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489110|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489111|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489112|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489113|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
23489114|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489115|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489116|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489117|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489118|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489119|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489120|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489121|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489122|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489123|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489124|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489125|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
23489126|NCT00674973|65536976|FG000|Overall Study|Insufficient Therapeutic Response|77|||
23489127|NCT00674973|65536977|FG001|Overall Study|Insufficient Therapeutic Response|72|||
23489128|NCT00674973|65536976|FG000|Overall Study|Refused Treatment|1|||
23489129|NCT00674973|65536977|FG001|Overall Study|Refused Treatment|5|||
23489130|NCT00674973|65536976|FG000|Overall Study|Failure to Return|1|||
23489131|NCT00674973|65536977|FG001|Overall Study|Failure to Return|0|||
23489132|NCT00674973|65536976|FG000|Overall Study|Adverse Event|2|||
23489133|NCT00674973|65536977|FG001|Overall Study|Adverse Event|9|||
23489134|NCT00674973|65536976|FG000|Overall Study|Death|19|||
23489135|NCT00674973|65536977|FG001|Overall Study|Death|15|||
23489136|NCT00674973|65536976|FG000|Overall Study|Protocol Violation|0|||
23489137|NCT00674973|65536977|FG001|Overall Study|Protocol Violation|1|||
23489138|NCT02913612|65536978|FG000|Overall Study|Lost to Follow-up|6|||
23489139|NCT02913612|65536979|FG001|Overall Study|Lost to Follow-up|5|||
23489140|NCT02913612|65536980|FG002|Overall Study|Lost to Follow-up|2|||
23489141|NCT02913612|65536981|FG003|Overall Study|Lost to Follow-up|0|||
23489142|NCT02913612|65536978|FG000|Overall Study|Physician Decision|1|||
23489143|NCT02913612|65536979|FG001|Overall Study|Physician Decision|4|||
23489144|NCT02913612|65536980|FG002|Overall Study|Physician Decision|1|||
23489145|NCT02913612|65536981|FG003|Overall Study|Physician Decision|0|||
23489146|NCT02913612|65536978|FG000|Overall Study|Withdrawal by Subject|2|||
23489147|NCT02913612|65536979|FG001|Overall Study|Withdrawal by Subject|4|||
23489148|NCT02913612|65536980|FG002|Overall Study|Withdrawal by Subject|0|||
23489149|NCT02913612|65536981|FG003|Overall Study|Withdrawal by Subject|0|||
23489150|NCT02913612|65536978|FG000|Overall Study|Hemangioma resolved|1|||
23489151|NCT02913612|65536979|FG001|Overall Study|Hemangioma resolved|0|||
23489152|NCT02913612|65536980|FG002|Overall Study|Hemangioma resolved|0|||
23489153|NCT02913612|65536981|FG003|Overall Study|Hemangioma resolved|0|||
23489154|NCT02913612|65536978|FG000|Overall Study|Local IRB decision|1|||
23489155|NCT02913612|65536979|FG001|Overall Study|Local IRB decision|0|||
23489156|NCT02913612|65536980|FG002|Overall Study|Local IRB decision|0|||
23489157|NCT02913612|65536981|FG003|Overall Study|Local IRB decision|0|||
23489158|NCT02913612|65536978|FG000|Overall Study|Study drug non-compliance|1|||
23489159|NCT02913612|65536979|FG001|Overall Study|Study drug non-compliance|1|||
23489160|NCT02913612|65536980|FG002|Overall Study|Study drug non-compliance|0|||
23376081|NCT00390013|65122995|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
23489161|NCT02913612|65536981|FG003|Overall Study|Study drug non-compliance|0|||
23489162|NCT02913612|65536978|FG000|Overall Study|Insurance issues|0|||
23489163|NCT02913612|65536979|FG001|Overall Study|Insurance issues|1|||
23489164|NCT02913612|65536980|FG002|Overall Study|Insurance issues|0|||
23376082|NCT00390013|65122996|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
23489165|NCT02913612|65536981|FG003|Overall Study|Insurance issues|0|||
23489166|NCT02913612|65536978|FG000|Overall Study|Needed to treat second hemangioma|0|||
23489167|NCT02913612|65536979|FG001|Overall Study|Needed to treat second hemangioma|1|||
23489168|NCT02913612|65536980|FG002|Overall Study|Needed to treat second hemangioma|0|||
23489169|NCT02913612|65536981|FG003|Overall Study|Needed to treat second hemangioma|0|||
23489170|NCT02913612|65536978|FG000|Overall Study|Study completion criteria not met|0|||
23489171|NCT02913612|65536979|FG001|Overall Study|Study completion criteria not met|1|||
23489172|NCT02913612|65536980|FG002|Overall Study|Study completion criteria not met|0|||
23489173|NCT02913612|65536981|FG003|Overall Study|Study completion criteria not met|0|||
23489174|NCT02913612|65536978|FG000|Overall Study|Ineligible|0|||
23489175|NCT02913612|65536979|FG001|Overall Study|Ineligible|1|||
23489176|NCT02913612|65536980|FG002|Overall Study|Ineligible|0|||
23489177|NCT02913612|65536981|FG003|Overall Study|Ineligible|0|||
23489178|NCT02600351|65536984|FG000|Overall Study|Lack of Efficacy|3|||
23489179|NCT02600351|65536985|FG001|Overall Study|Lack of Efficacy|0|||
23489180|NCT02600351|65536986|FG002|Overall Study|Lack of Efficacy|5|||
23489181|NCT02600351|65536987|FG003|Overall Study|Lack of Efficacy|2|||
23489182|NCT02600351|65536984|FG000|Overall Study|Lost to Follow-up|1|||
23489183|NCT02600351|65536985|FG001|Overall Study|Lost to Follow-up|0|||
23489184|NCT02600351|65536986|FG002|Overall Study|Lost to Follow-up|0|||
23489185|NCT02600351|65536987|FG003|Overall Study|Lost to Follow-up|0|||
23489186|NCT02600351|65536984|FG000|Overall Study|Randomized but Not Treated|1|||
23489187|NCT02600351|65536985|FG001|Overall Study|Randomized but Not Treated|0|||
23489188|NCT02600351|65536986|FG002|Overall Study|Randomized but Not Treated|1|||
23489189|NCT02600351|65536987|FG003|Overall Study|Randomized but Not Treated|3|||
23489190|NCT03626168|65536988|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23489191|NCT03626168|65536989|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23489192|NCT03626168|65536988|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
23489193|NCT03626168|65536989|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
23489194|NCT03626168|65536988|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23489195|NCT03626168|65536989|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
23489196|NCT01229371|65536990|FG000|Overall Study|Withdrawal by Subject|0|||
23489197|NCT01229371|65536991|FG001|Overall Study|Withdrawal by Subject|1|||
23489198|NCT01229371|65536992|FG002|Overall Study|Withdrawal by Subject|0|||
23489199|NCT01229371|65536993|FG003|Overall Study|Withdrawal by Subject|0|||
23489200|NCT04889222|65536994|FG000|Overall Study|Did not meet eligibility criteria|8|||
23489201|NCT04889222|65536994|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
23489202|NCT04889222|65536994|FG000|Overall Study|Did not proceed due to time constraints|5|||
23489203|NCT02517866|65536996|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23489204|NCT02517866|65536997|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23489205|NCT02517866|65536998|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23489206|NCT02517866|65536996|FG000|Overall Study|Significant Protocol Deviation|4|||
23489207|NCT02517866|65536997|FG001|Overall Study|Significant Protocol Deviation|1|||
23489208|NCT02517866|65536998|FG002|Overall Study|Significant Protocol Deviation|0|||
23489209|NCT02517866|65536996|FG000|Overall Study|Lost to Follow-up|1|||
23489210|NCT02517866|65536997|FG001|Overall Study|Lost to Follow-up|0|||
23489211|NCT02517866|65536998|FG002|Overall Study|Lost to Follow-up|0|||
23489212|NCT02517866|65536996|FG000|Overall Study|Voluntary Withdrawal|2|||
23489213|NCT02517866|65536997|FG001|Overall Study|Voluntary Withdrawal|2|||
23489214|NCT02517866|65536998|FG002|Overall Study|Voluntary Withdrawal|0|||
23489215|NCT02517866|65536996|FG000|Overall Study|Investigator Decision|2|||
23489216|NCT02517866|65536997|FG001|Overall Study|Investigator Decision|1|||
23489217|NCT02517866|65536998|FG002|Overall Study|Investigator Decision|0|||
23489218|NCT02517866|65536996|FG000|Overall Study|Reason not specified|2|||
23489219|NCT02517866|65536997|FG001|Overall Study|Reason not specified|0|||
23489220|NCT02517866|65536998|FG002|Overall Study|Reason not specified|0|||
23489221|NCT03139279|65536999|FG000|Overall Study|Physician Decision|2|||
23489222|NCT03139279|65537000|FG001|Overall Study|Physician Decision|0|||
23489223|NCT03139279|65536999|FG000|Overall Study|Protocol Violation|5|||
23489224|NCT03139279|65537000|FG001|Overall Study|Protocol Violation|4|||
23489225|NCT03139279|65536999|FG000|Overall Study|Withdrawal by Subject|0|||
23489226|NCT03139279|65537000|FG001|Overall Study|Withdrawal by Subject|2|||
23489227|NCT00678080|65537001|FG000|Overall Study|Physician Decision|2|||
23489228|NCT00678080|65537002|FG001|Overall Study|Physician Decision|0|||
23489229|NCT00678080|65537001|FG000|Overall Study|Lost to Follow-up|1|||
23489230|NCT00678080|65537002|FG001|Overall Study|Lost to Follow-up|0|||
23489231|NCT00678080|65537001|FG000|Overall Study|Withdrawal by Subject|0|||
23489232|NCT00678080|65537002|FG001|Overall Study|Withdrawal by Subject|1|||
23489233|NCT01886716|65537003|FG000|Week 1|Lost to Follow-up|0|||
23489234|NCT01886716|65537004|FG001|Week 1|Lost to Follow-up|0|||
23376083|NCT00769561|65122997|FG000|Overall Study|Withdrawal by Subject|2|||
23376084|NCT00769561|65122998|FG001|Overall Study|Withdrawal by Subject|2|||
23376085|NCT00769561|65122997|FG000|Overall Study|Lost to Follow-up|1|||
23376086|NCT00769561|65122998|FG001|Overall Study|Lost to Follow-up|3|||
23376087|NCT01991314|65122999|FG000|Overall Study|Adverse Event|5|||
23376088|NCT01991314|65123000|FG001|Overall Study|Adverse Event|1|||
23376089|NCT01991314|65122999|FG000|Overall Study|Lost to Follow-up|6|||
23376090|NCT01991314|65123000|FG001|Overall Study|Lost to Follow-up|10|||
23376091|NCT02747927|65123001|FG000|Overall Study|Adverse Event|5|||
23376092|NCT02747927|65123002|FG001|Overall Study|Adverse Event|14|||
23376093|NCT02747927|65123001|FG000|Overall Study|Lost to Follow-up|22|||
23376094|NCT02747927|65123002|FG001|Overall Study|Lost to Follow-up|43|||
23489235|NCT01886716|65537005|FG002|Week 1|Lost to Follow-up|2|||
23489236|NCT01886716|65537006|FG003|Week 1|Lost to Follow-up|2|||
23489237|NCT01886716|65537003|FG000|Week 2|Lost to Follow-up|3|||
23376095|NCT02747927|65123001|FG000|Overall Study|Pregnancy|34|||
23376096|NCT02747927|65123002|FG001|Overall Study|Pregnancy|66|||
23489238|NCT01886716|65537004|FG001|Week 2|Lost to Follow-up|2|||
23604487|NCT00622700|65940419|FG001|Extension Treatment Period|Lost to Follow-up|0|||
23604488|NCT00622700|65940420|FG002|Extension Treatment Period|Lost to Follow-up|0|||
23604489|NCT00622700|65940421|FG003|Extension Treatment Period|Lost to Follow-up|0|||
23604490|NCT00622700|65940422|FG004|Extension Treatment Period|Lost to Follow-up|1|||
23604491|NCT00622700|65940423|FG005|Extension Treatment Period|Lost to Follow-up|0|||
23604492|NCT00622700|65940424|FG006|Extension Treatment Period|Lost to Follow-up|0|||
23604493|NCT00622700|65940418|FG000|Extension Treatment Period|Progressive Disease|0|||
23604494|NCT00622700|65940419|FG001|Extension Treatment Period|Progressive Disease|0|||
23604495|NCT00622700|65940420|FG002|Extension Treatment Period|Progressive Disease|0|||
23604496|NCT00622700|65940421|FG003|Extension Treatment Period|Progressive Disease|1|||
23604497|NCT00622700|65940422|FG004|Extension Treatment Period|Progressive Disease|2|||
23604498|NCT00622700|65940423|FG005|Extension Treatment Period|Progressive Disease|0|||
23604499|NCT00622700|65940424|FG006|Extension Treatment Period|Progressive Disease|2|||
23604500|NCT00622700|65940418|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23604501|NCT00622700|65940419|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23604502|NCT00622700|65940420|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23604503|NCT00622700|65940421|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
23665218|NCT01476475|66158743|FG000|Overall Study|Poor compliance to protocol|1|||
23665219|NCT01476475|66158744|FG001|Overall Study|Poor compliance to protocol|1|||
23665220|NCT01476475|66158743|FG000|Overall Study|Other reasons|4|||
23665221|NCT01476475|66158744|FG001|Overall Study|Other reasons|2|||
23665222|NCT03077685|66158749|FG000|Overall Study|Lost to Follow-up|0|||
23665223|NCT03077685|66158750|FG001|Overall Study|Lost to Follow-up|0|||
23665224|NCT03077685|66158751|FG002|Overall Study|Lost to Follow-up|0|||
23665225|NCT03077685|66158752|FG003|Overall Study|Lost to Follow-up|0|||
23665226|NCT03077685|66158753|FG004|Overall Study|Lost to Follow-up|1|||
23665227|NCT03077685|66158749|FG000|Overall Study|Death|0|||
23665228|NCT03077685|66158750|FG001|Overall Study|Death|0|||
23665229|NCT03077685|66158751|FG002|Overall Study|Death|1|||
23665230|NCT03077685|66158752|FG003|Overall Study|Death|1|||
23665231|NCT03077685|66158753|FG004|Overall Study|Death|3|||
23665232|NCT03077685|66158749|FG000|Overall Study|Withdrawal by Subject|0|||
23665233|NCT03077685|66158750|FG001|Overall Study|Withdrawal by Subject|0|||
23665234|NCT03077685|66158751|FG002|Overall Study|Withdrawal by Subject|0|||
23665235|NCT03077685|66158752|FG003|Overall Study|Withdrawal by Subject|2|||
23665236|NCT03077685|66158753|FG004|Overall Study|Withdrawal by Subject|1|||
23665237|NCT03077685|66158749|FG000|Overall Study|Physician Decision|0|||
23665238|NCT03077685|66158750|FG001|Overall Study|Physician Decision|0|||
23665239|NCT03077685|66158751|FG002|Overall Study|Physician Decision|1|||
23665240|NCT03077685|66158752|FG003|Overall Study|Physician Decision|0|||
23665241|NCT03077685|66158753|FG004|Overall Study|Physician Decision|3|||
23665242|NCT03077685|66158749|FG000|Overall Study|Disease Progression|1|||
23665243|NCT03077685|66158750|FG001|Overall Study|Disease Progression|0|||
23665244|NCT03077685|66158751|FG002|Overall Study|Disease Progression|0|||
23665245|NCT03077685|66158752|FG003|Overall Study|Disease Progression|2|||
23665246|NCT03077685|66158753|FG004|Overall Study|Disease Progression|1|||
23665247|NCT03077685|66158749|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
23665248|NCT03077685|66158750|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
23665249|NCT03077685|66158751|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
23665250|NCT03077685|66158752|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
23376097|NCT02747927|65123001|FG000|Overall Study|Protocol Violation|2|||
23489239|NCT01886716|65537005|FG002|Week 2|Lost to Follow-up|1|||
23489240|NCT01886716|65537006|FG003|Week 2|Lost to Follow-up|3|||
23489241|NCT01886716|65537003|FG000|Week 3|Lost to Follow-up|1|||
23489242|NCT01886716|65537004|FG001|Week 3|Lost to Follow-up|1|||
23489243|NCT01886716|65537005|FG002|Week 3|Lost to Follow-up|0|||
23489244|NCT01886716|65537006|FG003|Week 3|Lost to Follow-up|1|||
23604504|NCT00622700|65940422|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
23665251|NCT03077685|66158753|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
23665252|NCT03077685|66158749|FG000|Overall Study|Subject entered hospice care|0|||
23665253|NCT03077685|66158750|FG001|Overall Study|Subject entered hospice care|0|||
23489245|NCT03422627|65537007|FG000|Overall Study|Protocol-specified Criteria|1|||
23489246|NCT03422627|65537008|FG001|Overall Study|Protocol-specified Criteria|1|||
23489247|NCT03422627|65537009|FG002|Overall Study|Protocol-specified Criteria|0|||
23489248|NCT03422627|65537010|FG003|Overall Study|Protocol-specified Criteria|0|||
23489249|NCT03422627|65537011|FG004|Overall Study|Protocol-specified Criteria|2|||
23489250|NCT03422627|65537007|FG000|Overall Study|Requirement for Alternative Therapy|1|||
23604505|NCT00622700|65940423|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
23604506|NCT00622700|65940424|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
23604507|NCT00622700|65940418|FG000|Extension Treatment Period|Missing|0|||
23604508|NCT00622700|65940419|FG001|Extension Treatment Period|Missing|0|||
23604509|NCT00622700|65940420|FG002|Extension Treatment Period|Missing|0|||
23604510|NCT00622700|65940421|FG003|Extension Treatment Period|Missing|2|||
23604511|NCT00622700|65940422|FG004|Extension Treatment Period|Missing|3|||
23604512|NCT00622700|65940423|FG005|Extension Treatment Period|Missing|1|||
23665254|NCT03077685|66158751|FG002|Overall Study|Subject entered hospice care|0|||
23489251|NCT03422627|65537008|FG001|Overall Study|Requirement for Alternative Therapy|1|||
23489252|NCT03422627|65537009|FG002|Overall Study|Requirement for Alternative Therapy|2|||
23604513|NCT00622700|65940424|FG006|Extension Treatment Period|Missing|0|||
23604514|NCT00622700|65940418|FG000|Extension Treatment Period|Other than specified above|0|||
23604515|NCT00622700|65940419|FG001|Extension Treatment Period|Other than specified above|0|||
23604516|NCT00622700|65940420|FG002|Extension Treatment Period|Other than specified above|0|||
23604517|NCT00622700|65940421|FG003|Extension Treatment Period|Other than specified above|0|||
23604518|NCT00622700|65940422|FG004|Extension Treatment Period|Other than specified above|0|||
23489253|NCT03422627|65537010|FG003|Overall Study|Requirement for Alternative Therapy|0|||
23489254|NCT03422627|65537011|FG004|Overall Study|Requirement for Alternative Therapy|0|||
23489255|NCT03422627|65537007|FG000|Overall Study|Disease Progression|1|||
23489256|NCT03422627|65537008|FG001|Overall Study|Disease Progression|0|||
23489257|NCT03422627|65537009|FG002|Overall Study|Disease Progression|1|||
23489258|NCT03422627|65537010|FG003|Overall Study|Disease Progression|2|||
23489259|NCT03422627|65537011|FG004|Overall Study|Disease Progression|0|||
23489260|NCT03422627|65537007|FG000|Overall Study|Adverse Event|2|||
23376098|NCT02747927|65123002|FG001|Overall Study|Protocol Violation|4|||
23376099|NCT02747927|65123001|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
23376100|NCT02747927|65123002|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
23376101|NCT02747927|65123001|FG000|Overall Study|Reason not Specified|11|||
23376102|NCT02747927|65123002|FG001|Overall Study|Reason not Specified|27|||
23376103|NCT00639509|65123003|FG000|Overall Study|Death|1|||
23376104|NCT00587457|65123004|FG000|Overall Study|Adverse Event|1|||
23376105|NCT00587457|65123005|FG001|Overall Study|Adverse Event|2|||
23376106|NCT00587457|65123006|FG002|Overall Study|Adverse Event|1|||
23376107|NCT00587457|65123004|FG000|Overall Study|Disease progression|2|||
23376108|NCT00587457|65123005|FG001|Overall Study|Disease progression|0|||
23376109|NCT00587457|65123006|FG002|Overall Study|Disease progression|2|||
23376110|NCT00587457|65123004|FG000|Overall Study|Initiation of alternative therapy|0|||
23376111|NCT00587457|65123005|FG001|Overall Study|Initiation of alternative therapy|1|||
23376112|NCT00587457|65123006|FG002|Overall Study|Initiation of alternative therapy|0|||
23376113|NCT00587457|65123004|FG000|Overall Study|Undefined|0|||
23376114|NCT00587457|65123005|FG001|Overall Study|Undefined|0|||
23376115|NCT00587457|65123006|FG002|Overall Study|Undefined|1|||
23376116|NCT00587457|65123004|FG000|Overall Study|Development of neutralizing Abs|0|||
23376117|NCT00587457|65123005|FG001|Overall Study|Development of neutralizing Abs|0|||
23376118|NCT00587457|65123006|FG002|Overall Study|Development of neutralizing Abs|1|||
23376119|NCT00900562|65123007|FG000|Overall Study|Progressive disease|9|||
23376120|NCT00900562|65123008|FG001|Overall Study|Progressive disease|5|||
23376121|NCT00900562|65123007|FG000|Overall Study|Toxicity|1|||
23376122|NCT00900562|65123008|FG001|Overall Study|Toxicity|0|||
23376123|NCT00900562|65123007|FG000|Overall Study|Death|1|||
23376124|NCT00900562|65123008|FG001|Overall Study|Death|1|||
23376125|NCT00900562|65123007|FG000|Overall Study|Withdrawal by Subject|0|||
23376126|NCT00900562|65123008|FG001|Overall Study|Withdrawal by Subject|1|||
23376127|NCT00900562|65123007|FG000|Overall Study|Unrelated adverse event|1|||
23376128|NCT00900562|65123008|FG001|Overall Study|Unrelated adverse event|0|||
23376129|NCT00851591|65123012|FG000|Overall Study|Withdrawal by Subject|2|||
23376130|NCT00851591|65123013|FG001|Overall Study|Withdrawal by Subject|0|||
23376131|NCT01603602|65123017|FG000|Overall Study|Adverse Event|1|||
23376132|NCT01603602|65123018|FG001|Overall Study|Adverse Event|0|||
23376133|NCT01603602|65123019|FG002|Overall Study|Adverse Event|0|||
23376134|NCT01603602|65123017|FG000|Overall Study|Personal Reasons|1|||
23376135|NCT01603602|65123018|FG001|Overall Study|Personal Reasons|0|||
23376136|NCT01603602|65123019|FG002|Overall Study|Personal Reasons|1|||
23376137|NCT02101294|65123020|FG000|Overall Study|Withdrawal by Subject|5|||
23376138|NCT02101294|65123020|FG000|Overall Study|Lost to Follow-up|6|||
23489261|NCT03422627|65537008|FG001|Overall Study|Adverse Event|1|||
23604519|NCT00622700|65940423|FG005|Extension Treatment Period|Other than specified above|1|||
23604520|NCT00622700|65940424|FG006|Extension Treatment Period|Other than specified above|1|||
23376139|NCT03188822|65123027|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
23376140|NCT03188822|65123027|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
23376141|NCT00961415|65123028|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
23376142|NCT00961415|65123029|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
23489262|NCT03422627|65537009|FG002|Overall Study|Adverse Event|0|||
23489263|NCT03422627|65537010|FG003|Overall Study|Adverse Event|0|||
23376143|NCT00961415|65123030|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
23376144|NCT00961415|65123028|FG000|Induction Treatment Phase|Death|77|||
23376145|NCT00961415|65123029|FG001|Induction Treatment Phase|Death|0|||
23376146|NCT00961415|65123030|FG002|Induction Treatment Phase|Death|0|||
23376147|NCT00961415|65123028|FG000|Induction Treatment Phase|Protocol Violation|1|||
23376148|NCT00961415|65123029|FG001|Induction Treatment Phase|Protocol Violation|0|||
23376149|NCT00961415|65123030|FG002|Induction Treatment Phase|Protocol Violation|0|||
23376150|NCT00961415|65123028|FG000|Induction Treatment Phase|Physician Decision|2|||
23376151|NCT00961415|65123029|FG001|Induction Treatment Phase|Physician Decision|0|||
23376152|NCT00961415|65123030|FG002|Induction Treatment Phase|Physician Decision|0|||
23376153|NCT00961415|65123028|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
23376154|NCT00961415|65123029|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
23376155|NCT00961415|65123030|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
23376156|NCT00961415|65123028|FG000|Induction Treatment Phase|Other Reason|5|||
23376157|NCT00961415|65123029|FG001|Induction Treatment Phase|Other Reason|0|||
23376158|NCT00961415|65123030|FG002|Induction Treatment Phase|Other Reason|0|||
23376159|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Death|0|||
23376160|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Death|42|||
23376161|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Death|34|||
23376162|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Investigators decision|0|||
23376163|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Investigators decision|2|||
23376164|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Investigators decision|0|||
23376165|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23376166|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
23489264|NCT03422627|65537011|FG004|Overall Study|Adverse Event|2|||
23489265|NCT03422627|65537007|FG000|Overall Study|Ineligibility Determined|0|||
23489266|NCT03422627|65537008|FG001|Overall Study|Ineligibility Determined|1|||
23489267|NCT03422627|65537009|FG002|Overall Study|Ineligibility Determined|0|||
23489268|NCT03422627|65537010|FG003|Overall Study|Ineligibility Determined|0|||
23489269|NCT03422627|65537011|FG004|Overall Study|Ineligibility Determined|0|||
23489270|NCT03422627|65537007|FG000|Overall Study|Death|0|||
23376167|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
23376168|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Other reason|0|||
23376169|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Other reason|1|||
23376170|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Other reason|3|||
23376171|NCT00916578|65123031|FG000|Overall Study|Physician Decision|2|||
23604521|NCT01860079|65940425|FG000|Overall Study|Physician Decision|14|||
23604522|NCT01860079|65940426|FG001|Overall Study|Physician Decision|22|||
23604523|NCT01662505|65940429|FG000|Overall Study|Progressive disease|6|||
23604524|NCT01662505|65940430|FG001|Overall Study|Progressive disease|1|||
23604525|NCT01662505|65940431|FG002|Overall Study|Progressive disease|5|||
23604526|NCT01662505|65940429|FG000|Overall Study|Refused cont. medication|0|||
23604527|NCT01662505|65940430|FG001|Overall Study|Refused cont. medication|0|||
23604528|NCT01662505|65940431|FG002|Overall Study|Refused cont. medication|1|||
23604529|NCT01662505|65940429|FG000|Overall Study|Not specified above|1|||
23604530|NCT01662505|65940430|FG001|Overall Study|Not specified above|3|||
23604531|NCT01662505|65940431|FG002|Overall Study|Not specified above|2|||
23604532|NCT03775213|65940435|FG000|Overall Study|Withdrawal by Subject|51|||
23604533|NCT03775213|65940436|FG001|Overall Study|Withdrawal by Subject|53|||
23604534|NCT03775213|65940435|FG000|Overall Study|Incomplete Survey|7|||
23376172|NCT00916578|65123031|FG000|Overall Study|Withdrawal by Subject|3|||
23376173|NCT00916578|65123031|FG000|Overall Study|Insurance Denial|2|||
23376174|NCT01126424|65123032|FG000|Overall Study|Adverse Event|0|||
23489271|NCT03422627|65537008|FG001|Overall Study|Death|1|||
23489272|NCT03422627|65537009|FG002|Overall Study|Death|1|||
23489273|NCT03422627|65537010|FG003|Overall Study|Death|0|||
23604535|NCT03775213|65940436|FG001|Overall Study|Incomplete Survey|7|||
23604536|NCT02157948|65940437|FG000|Overall Study|Withdrawal by Subject|4|||
23604537|NCT02157948|65940438|FG001|Overall Study|Withdrawal by Subject|5|||
23604538|NCT02157948|65940437|FG000|Overall Study|Lost to Follow-up|3|||
23604539|NCT02157948|65940438|FG001|Overall Study|Lost to Follow-up|2|||
23376175|NCT01126424|65123033|FG001|Overall Study|Adverse Event|0|||
23376176|NCT01126424|65123034|FG002|Overall Study|Adverse Event|0|||
23376177|NCT01126424|65123035|FG003|Overall Study|Adverse Event|0|||
23604540|NCT02157948|65940437|FG000|Overall Study|Protocol Specified Criteria|2|||
23604541|NCT02157948|65940438|FG001|Overall Study|Protocol Specified Criteria|1|||
23604542|NCT02157948|65940437|FG000|Overall Study|Decision by Sponsor|0|||
23604543|NCT02157948|65940438|FG001|Overall Study|Decision by Sponsor|1|||
23604544|NCT03345095|65940443|FG000|Overall Study|Lack of Efficacy|184|||
23604545|NCT03345095|65940444|FG001|Overall Study|Lack of Efficacy|156|||
23604546|NCT03345095|65940443|FG000|Overall Study|Adverse Event|36|||
23604547|NCT03345095|65940444|FG001|Overall Study|Adverse Event|118|||
23604548|NCT03345095|65940443|FG000|Overall Study|Withdrawal by Subject|22|||
23604549|NCT03345095|65940444|FG001|Overall Study|Withdrawal by Subject|59|||
23604550|NCT03345095|65940443|FG000|Overall Study|Physician Decision|3|||
23604551|NCT03345095|65940444|FG001|Overall Study|Physician Decision|18|||
23604552|NCT03345095|65940443|FG000|Overall Study|Death|2|||
23604553|NCT03345095|65940444|FG001|Overall Study|Death|4|||
23604554|NCT03345095|65940443|FG000|Overall Study|Other reasons|2|||
23604555|NCT03345095|65940444|FG001|Overall Study|Other reasons|11|||
23604556|NCT03345095|65940443|FG000|Overall Study|Protocol Violation|0|||
23604557|NCT03345095|65940444|FG001|Overall Study|Protocol Violation|1|||
23604558|NCT04652869|65940447|FG000|Overall Study|Withdrawal by Subject|0|||
23604559|NCT04652869|65940448|FG001|Overall Study|Withdrawal by Subject|2|||
23604560|NCT04652869|65940449|FG002|Overall Study|Withdrawal by Subject|0|||
23604561|NCT02644122|65940450|FG000|Overall Study|Withdrawal by Subject|1|||
23604562|NCT00487240|65943441|FG000|Overall Study|Withdrawal by Subject|12|||
23604563|NCT00487240|65943442|FG001|Overall Study|Withdrawal by Subject|6|||
23604564|NCT00487240|65943441|FG000|Overall Study|Lost to Follow-up|7|||
23604565|NCT00487240|65943442|FG001|Overall Study|Lost to Follow-up|6|||
23604566|NCT00487240|65943441|FG000|Overall Study|Adverse Event|0|||
23604567|NCT00487240|65943442|FG001|Overall Study|Adverse Event|4|||
23604568|NCT00487240|65943441|FG000|Overall Study|Protocol Violation|5|||
23604569|NCT00487240|65943442|FG001|Overall Study|Protocol Violation|5|||
23604570|NCT00487240|65943441|FG000|Overall Study|Entry Criteria Not Met|3|||
23604571|NCT00487240|65943442|FG001|Overall Study|Entry Criteria Not Met|4|||
23604572|NCT00487240|65943441|FG000|Overall Study|Sponsor Decision|2|||
23604573|NCT00487240|65943442|FG001|Overall Study|Sponsor Decision|1|||
23376178|NCT01126424|65123036|FG004|Overall Study|Adverse Event|1|||
23604574|NCT00487240|65943441|FG000|Overall Study|Physician Decision|2|||
23604575|NCT00487240|65943442|FG001|Overall Study|Physician Decision|0|||
23665255|NCT03077685|66158752|FG003|Overall Study|Subject entered hospice care|0|||
23665256|NCT03077685|66158753|FG004|Overall Study|Subject entered hospice care|1|||
23665257|NCT03462576|66158754|FG000|Overall Study|Protocol Violation|5|||
23665258|NCT03462576|66158755|FG001|Overall Study|Protocol Violation|11|||
23665259|NCT03462576|66158756|FG002|Overall Study|Protocol Violation|7|||
23376179|NCT01126424|65123037|FG005|Overall Study|Adverse Event|0|||
23376180|NCT01126424|65123032|FG000|Overall Study|Withdrawal by Subject|0|||
23376181|NCT01126424|65123033|FG001|Overall Study|Withdrawal by Subject|0|||
23376182|NCT01126424|65123034|FG002|Overall Study|Withdrawal by Subject|1|||
23376183|NCT01126424|65123035|FG003|Overall Study|Withdrawal by Subject|3|||
23376184|NCT01126424|65123036|FG004|Overall Study|Withdrawal by Subject|1|||
23376185|NCT01126424|65123037|FG005|Overall Study|Withdrawal by Subject|0|||
23376186|NCT00883181|65123038|FG000|Overall Study|Hematological Adverse Event|26|||
23376187|NCT00883181|65123038|FG000|Overall Study|Non-hematological Adverse Event|55|||
23376188|NCT00883181|65123038|FG000|Overall Study|Disease Progression|94|||
23489274|NCT03422627|65537011|FG004|Overall Study|Death|0|||
23489275|NCT03422627|65537007|FG000|Overall Study|Withdrawal by Subject|0|||
23489276|NCT03422627|65537008|FG001|Overall Study|Withdrawal by Subject|0|||
23489277|NCT03422627|65537009|FG002|Overall Study|Withdrawal by Subject|0|||
23489278|NCT03422627|65537010|FG003|Overall Study|Withdrawal by Subject|1|||
23376189|NCT00883181|65123038|FG000|Overall Study|Administrative Reason|24|||
23376190|NCT00883181|65123038|FG000|Overall Study|Withdrawal by Subject|4|||
23376191|NCT00883181|65123038|FG000|Overall Study|Death|31|||
23376192|NCT00883181|65123038|FG000|Overall Study|Other|38|||
23376193|NCT00883181|65123038|FG000|Overall Study|Protocol Deviation|3|||
23604576|NCT01579318|65943444|FG000|Overall Study|Disease Progression|1|||
23604577|NCT00148122|65943445|FG000|Overall Study|Withdrawal by Subject|2|||
23604578|NCT01686152|65943446|FG000|Overall Study|Withdrawal by Subject|11|||
23604579|NCT01686152|65943447|FG001|Overall Study|Withdrawal by Subject|11|||
23604580|NCT01686152|65943448|FG002|Overall Study|Withdrawal by Subject|3|||
23604581|NCT01686152|65943446|FG000|Overall Study|Drug Code Unblinded|0|||
23604582|NCT01686152|65943447|FG001|Overall Study|Drug Code Unblinded|1|||
23604583|NCT01686152|65943448|FG002|Overall Study|Drug Code Unblinded|0|||
23604584|NCT01686152|65943446|FG000|Overall Study|Protocol Violation|6|||
23604585|NCT01686152|65943447|FG001|Overall Study|Protocol Violation|1|||
23604586|NCT01686152|65943448|FG002|Overall Study|Protocol Violation|0|||
23604587|NCT01686152|65943446|FG000|Overall Study|Adverse Event|12|||
23604588|NCT01686152|65943447|FG001|Overall Study|Adverse Event|11|||
23604589|NCT01686152|65943448|FG002|Overall Study|Adverse Event|0|||
23604590|NCT01686152|65943446|FG000|Overall Study|Lack of Efficacy|0|||
23604591|NCT01686152|65943447|FG001|Overall Study|Lack of Efficacy|0|||
23604592|NCT01686152|65943448|FG002|Overall Study|Lack of Efficacy|1|||
23604593|NCT01686152|65943446|FG000|Overall Study|IP Non-compliance|5|||
23604594|NCT01686152|65943447|FG001|Overall Study|IP Non-compliance|5|||
23604595|NCT01686152|65943448|FG002|Overall Study|IP Non-compliance|0|||
23604596|NCT01686152|65943446|FG000|Overall Study|Lost to Follow-up|7|||
23604597|NCT01686152|65943447|FG001|Overall Study|Lost to Follow-up|6|||
23604598|NCT01686152|65943448|FG002|Overall Study|Lost to Follow-up|5|||
23604599|NCT04183491|65943449|FG000|Overall Study|Withdrawal by Subject|0|||
23604600|NCT04183491|65943450|FG001|Overall Study|Withdrawal by Subject|0|||
23604601|NCT04183491|65943451|FG002|Overall Study|Withdrawal by Subject|1|||
23665260|NCT03462576|66158754|FG000|Overall Study|Device Malfunction|0|||
23376194|NCT00883181|65123038|FG000|Overall Study|Noncompliance|3|||
23489279|NCT03422627|65537011|FG004|Overall Study|Withdrawal by Subject|0|||
23489280|NCT02808650|65537012|FG000|Overall Study|Death|0|||
23604602|NCT04183491|65943452|FG003|Overall Study|Withdrawal by Subject|0|||
23604603|NCT04183491|65943453|FG004|Overall Study|Withdrawal by Subject|0|||
23604604|NCT04183491|65943454|FG005|Overall Study|Withdrawal by Subject|1|||
23376195|NCT02555878|65123039|FG000|Overall Study|Lost to Follow-up|2|||
23376196|NCT02555878|65123040|FG001|Overall Study|Lost to Follow-up|3|||
23376197|NCT02555878|65123039|FG000|Overall Study|Withdrawal by Subject|48|||
23376198|NCT02555878|65123040|FG001|Overall Study|Withdrawal by Subject|48|||
23376199|NCT02555878|65123039|FG000|Overall Study|Adverse Event|12|||
23376200|NCT02555878|65123040|FG001|Overall Study|Adverse Event|8|||
23489281|NCT02808650|65537013|FG001|Overall Study|Death|0|||
23376201|NCT02555878|65123039|FG000|Overall Study|Death|74|||
23489282|NCT02808650|65537014|FG002|Overall Study|Death|0|||
23489283|NCT02808650|65537015|FG003|Overall Study|Death|0|||
23489284|NCT02808650|65537016|FG004|Overall Study|Death|1|||
23489285|NCT02808650|65537012|FG000|Overall Study|Lack of Efficacy|5|||
23489286|NCT02808650|65537013|FG001|Overall Study|Lack of Efficacy|5|||
23489287|NCT02808650|65537014|FG002|Overall Study|Lack of Efficacy|6|||
23489288|NCT02808650|65537015|FG003|Overall Study|Lack of Efficacy|5|||
23489289|NCT02808650|65537016|FG004|Overall Study|Lack of Efficacy|4|||
23489290|NCT02808650|65537012|FG000|Overall Study|Physician Decision|1|||
23489291|NCT02808650|65537013|FG001|Overall Study|Physician Decision|1|||
23489292|NCT02808650|65537014|FG002|Overall Study|Physician Decision|0|||
23489293|NCT02808650|65537015|FG003|Overall Study|Physician Decision|0|||
23489294|NCT02808650|65537016|FG004|Overall Study|Physician Decision|0|||
23489295|NCT02808650|65537012|FG000|Overall Study|Withdrawal by Subject|0|||
23489296|NCT02808650|65537013|FG001|Overall Study|Withdrawal by Subject|0|||
23489297|NCT02808650|65537014|FG002|Overall Study|Withdrawal by Subject|0|||
23489298|NCT02808650|65537015|FG003|Overall Study|Withdrawal by Subject|1|||
23489299|NCT02808650|65537016|FG004|Overall Study|Withdrawal by Subject|1|||
23489300|NCT02319837|65537020|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
23489301|NCT02319837|65537021|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
23489302|NCT02319837|65537022|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
23489303|NCT02319837|65537020|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
23376202|NCT02555878|65123040|FG001|Overall Study|Death|59|||
23376203|NCT02555878|65123039|FG000|Overall Study|Protocol Violation|1|||
23376204|NCT02555878|65123040|FG001|Overall Study|Protocol Violation|2|||
23376205|NCT02555878|65123039|FG000|Overall Study|Physician Decision|12|||
23376206|NCT02555878|65123040|FG001|Overall Study|Physician Decision|13|||
23376207|NCT02555878|65123039|FG000|Overall Study|Other|17|||
23376208|NCT02555878|65123040|FG001|Overall Study|Other|17|||
23376209|NCT03370302|65123041|FG000|Dose Escalation Phase|Other|0|||
23376210|NCT03370302|65123042|FG001|Dose Escalation Phase|Other|1|||
23489304|NCT02319837|65537021|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
23489305|NCT02319837|65537022|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
23489306|NCT02319837|65537020|FG000|Study Treatment Phase|Adverse Event|73|||
23489307|NCT02319837|65537021|FG001|Study Treatment Phase|Adverse Event|36|||
23489308|NCT02319837|65537022|FG002|Study Treatment Phase|Adverse Event|63|||
23665261|NCT03462576|66158755|FG001|Overall Study|Device Malfunction|0|||
23376211|NCT03370302|65123043|FG002|Dose Escalation Phase|Other|1|||
23376212|NCT03370302|65123044|FG003|Dose Escalation Phase|Other|0|||
23376213|NCT03370302|65123045|FG004|Dose Escalation Phase|Other|0|||
23376214|NCT03370302|65123046|FG005|Dose Escalation Phase|Other|0|||
23376215|NCT03370302|65123041|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23376216|NCT03370302|65123042|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
23376217|NCT03370302|65123043|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
23665262|NCT03462576|66158756|FG002|Overall Study|Device Malfunction|1|||
23376218|NCT03370302|65123044|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23376219|NCT03370302|65123045|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23376220|NCT03370302|65123046|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
23376221|NCT03370302|65123041|FG000|Dose Escalation Phase|Adverse Event|1|||
23665263|NCT01486927|66162404|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
23665264|NCT01486927|66162404|FG000|Overall Study|Physician Decision|1|||
23665265|NCT01486927|66162404|FG000|Overall Study|50 Exposure days not reached|2|||
23665266|NCT01486927|66162404|FG000|Overall Study|Withdrawal by Subject|8|||
23665267|NCT01486927|66162404|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
23665268|NCT03127384|66162405|FG000|Overall Study|Lost to Follow-up|4|||
23665269|NCT03127384|66162405|FG000|Overall Study|Subject request|2|||
23665270|NCT00496730|66162406|FG000|Overall Study|Lost to Follow-up|4|||
23665271|NCT00496730|66162407|FG001|Overall Study|Lost to Follow-up|3|||
23665272|NCT00496730|66162406|FG000|Overall Study|Withdrawal by Subject|2|||
23665273|NCT00496730|66162407|FG001|Overall Study|Withdrawal by Subject|2|||
23665274|NCT02055820|66162417|FG000|Phase I: Dose-Finding|Death|1|||
23665275|NCT02055820|66162418|FG001|Phase I: Dose-Finding|Death|0|||
23665276|NCT02055820|66162419|FG002|Phase I: Dose-Finding|Death|1|||
23665277|NCT02055820|66162420|FG003|Phase I: Dose-Finding|Death|2|||
23665278|NCT02055820|66162421|FG004|Phase I: Dose-Finding|Death|0|||
23665279|NCT02055820|66162422|FG005|Phase I: Dose-Finding|Death|1|||
23665280|NCT02055820|66162423|FG006|Phase I: Dose-Finding|Death|1|||
23376222|NCT03370302|65123042|FG001|Dose Escalation Phase|Adverse Event|0|||
23376223|NCT03370302|65123043|FG002|Dose Escalation Phase|Adverse Event|2|||
23376224|NCT03370302|65123044|FG003|Dose Escalation Phase|Adverse Event|0|||
23376225|NCT03370302|65123045|FG004|Dose Escalation Phase|Adverse Event|0|||
23376226|NCT03370302|65123046|FG005|Dose Escalation Phase|Adverse Event|0|||
23376227|NCT03370302|65123041|FG000|Dose Escalation Phase|Progressive Disease|2|||
23376228|NCT03370302|65123042|FG001|Dose Escalation Phase|Progressive Disease|4|||
23376229|NCT03370302|65123043|FG002|Dose Escalation Phase|Progressive Disease|2|||
23376230|NCT03370302|65123044|FG003|Dose Escalation Phase|Progressive Disease|0|||
23376231|NCT03370302|65123045|FG004|Dose Escalation Phase|Progressive Disease|3|||
23376232|NCT03370302|65123046|FG005|Dose Escalation Phase|Progressive Disease|1|||
23376233|NCT03370302|65123041|FG000|Dose Expansion Phase|Progressive Disease|0|||
23376234|NCT03370302|65123042|FG001|Dose Expansion Phase|Progressive Disease|0|||
23376235|NCT03370302|65123043|FG002|Dose Expansion Phase|Progressive Disease|0|||
23489309|NCT02319837|65537020|FG000|Study Treatment Phase|Development of castration resistance|0|||
23604605|NCT04183491|65943455|FG006|Overall Study|Withdrawal by Subject|0|||
23604606|NCT00357994|65943456|FG000|Overall Study|Adverse Event|1|||
23604607|NCT00357994|65943457|FG001|Overall Study|Adverse Event|2|||
23604608|NCT00357994|65943456|FG000|Overall Study|Lack of Efficacy|0|||
23604609|NCT00357994|65943457|FG001|Overall Study|Lack of Efficacy|1|||
23604610|NCT00357994|65943456|FG000|Overall Study|Protocol Violation|1|||
23604611|NCT00357994|65943457|FG001|Overall Study|Protocol Violation|0|||
23604612|NCT02309294|65943458|FG000|Overall Study|Withdrawal by Subject|2|||
23604613|NCT01670877|65943459|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604614|NCT01670877|65943460|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
23604615|NCT01670877|65943461|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604616|NCT01670877|65943462|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604617|NCT01670877|65943463|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23665281|NCT02055820|66162424|FG007|Phase I: Dose-Finding|Death|0|||
23665282|NCT02055820|66162425|FG008|Phase I: Dose-Finding|Death|0|||
23665283|NCT02055820|66162426|FG009|Phase I: Dose-Finding|Death|0|||
23665284|NCT02055820|66162417|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665285|NCT02055820|66162418|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665286|NCT02055820|66162419|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665287|NCT02055820|66162420|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23376236|NCT03370302|65123044|FG003|Dose Expansion Phase|Progressive Disease|6|||
23376237|NCT03370302|65123045|FG004|Dose Expansion Phase|Progressive Disease|0|||
23376238|NCT03370302|65123046|FG005|Dose Expansion Phase|Progressive Disease|0|||
23376239|NCT01838876|65123049|FG000|Overall Study|Adverse Event|49|||
23376240|NCT01838876|65123049|FG000|Overall Study|Insufficient Therapeutic Response|10|||
23376241|NCT01838876|65123049|FG000|Overall Study|Protocol Violation|34|||
23376242|NCT01838876|65123049|FG000|Overall Study|Withdrawal of Consent|33|||
23376243|NCT01838876|65123049|FG000|Overall Study|Lost to Follow-up|21|||
23376244|NCT01838876|65123049|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
23376245|NCT01838876|65123049|FG000|Overall Study|Reason not Specified|7|||
23376246|NCT01838876|65123049|FG000|Overall Study|Did not meet eligibility criteria|78|||
23376247|NCT00630292|65123050|FG000|Overall Study|Withdrawal by Subject|1|||
23376248|NCT00300053|65123051|FG000|Overall Study|Patient/Caregiver Preference|2|||
23376249|NCT00300053|65123052|FG001|Overall Study|Patient/Caregiver Preference|2|||
23376250|NCT00300053|65123053|FG002|Overall Study|Patient/Caregiver Preference|3|||
23376251|NCT00300053|65123051|FG000|Overall Study|Death|0|||
23376252|NCT00300053|65123052|FG001|Overall Study|Death|0|||
23376253|NCT00300053|65123053|FG002|Overall Study|Death|3|||
23376254|NCT00300053|65123051|FG000|Overall Study|Lost to Follow-up|0|||
23489310|NCT02319837|65537021|FG001|Study Treatment Phase|Development of castration resistance|2|||
23489311|NCT02319837|65537022|FG002|Study Treatment Phase|Development of castration resistance|0|||
23604618|NCT01670877|65943464|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604619|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604620|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604621|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
23604622|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604623|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604624|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604625|NCT01670877|65943459|FG000|Part I and Part 2|Grade 2 vomiting|0|||
23604626|NCT01670877|65943460|FG001|Part I and Part 2|Grade 2 vomiting|0|||
23604627|NCT01670877|65943461|FG002|Part I and Part 2|Grade 2 vomiting|0|||
23604628|NCT01670877|65943462|FG003|Part I and Part 2|Grade 2 vomiting|1|||
23604629|NCT01670877|65943463|FG004|Part I and Part 2|Grade 2 vomiting|0|||
23604630|NCT01670877|65943464|FG005|Part I and Part 2|Grade 2 vomiting|0|||
23604631|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604632|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604633|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604634|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
23604635|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604636|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604637|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604638|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604639|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604640|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
23604641|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604642|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604643|NCT01706159|65943465|FG000|Overall Study|Withdrawal Criteria|2|||
23604644|NCT01706159|65943466|FG001|Overall Study|Withdrawal Criteria|1|||
23604645|NCT01706159|65943465|FG000|Overall Study|Unclassified|6|||
23604646|NCT01706159|65943466|FG001|Overall Study|Unclassified|1|||
23604647|NCT02744066|65943469|FG000|Overall Study|Withdrawal by parent|0|||
23604648|NCT02744066|65943470|FG001|Overall Study|Withdrawal by parent|1|||
23604649|NCT02744066|65943469|FG000|Overall Study|Discharged from NICU prior to completion|0|||
23604650|NCT02744066|65943470|FG001|Overall Study|Discharged from NICU prior to completion|4|||
23604651|NCT03015220|65943472|FG000|Overall Study|Withdrawal by Subject|3|||
23376255|NCT00300053|65123052|FG001|Overall Study|Lost to Follow-up|1|||
23376256|NCT00300053|65123053|FG002|Overall Study|Lost to Follow-up|0|||
23376257|NCT02058095|65123056|FG000|Overall Study|Adverse Event|1|||
23376258|NCT02058095|65123057|FG001|Overall Study|Adverse Event|0|||
23376259|NCT02324153|65123060|FG000|Overall Study|Withdrawal by Subject|4|||
23376260|NCT02324153|65123061|FG001|Overall Study|Withdrawal by Subject|1|||
23376261|NCT02324153|65123060|FG000|Overall Study|Surgery postponed after randomization|3|||
23376262|NCT02324153|65123061|FG001|Overall Study|Surgery postponed after randomization|0|||
23376263|NCT02324153|65123060|FG000|Overall Study|Developed delirium preoperatively|1|||
23376264|NCT02324153|65123061|FG001|Overall Study|Developed delirium preoperatively|0|||
23376265|NCT00479232|65123070|FG000|Overall Study|Adverse Event|0|||
23376266|NCT00479232|65123071|FG001|Overall Study|Adverse Event|0|||
23376267|NCT00479232|65123072|FG002|Overall Study|Adverse Event|5|||
23376268|NCT00479232|65123073|FG003|Overall Study|Adverse Event|0|||
23376269|NCT00479232|65123074|FG004|Overall Study|Adverse Event|0|||
23376270|NCT00479232|65123075|FG005|Overall Study|Adverse Event|10|||
23376271|NCT00479232|65123070|FG000|Overall Study|Deviation from Protocol|0|||
23376272|NCT00479232|65123071|FG001|Overall Study|Deviation from Protocol|0|||
23376273|NCT00479232|65123072|FG002|Overall Study|Deviation from Protocol|1|||
23376274|NCT00479232|65123073|FG003|Overall Study|Deviation from Protocol|0|||
23376275|NCT00479232|65123074|FG004|Overall Study|Deviation from Protocol|0|||
23376276|NCT00479232|65123075|FG005|Overall Study|Deviation from Protocol|0|||
23376277|NCT00479232|65123070|FG000|Overall Study|Lack of Efficacy|0|||
23376278|NCT00479232|65123071|FG001|Overall Study|Lack of Efficacy|0|||
23376279|NCT00479232|65123072|FG002|Overall Study|Lack of Efficacy|2|||
23376280|NCT00479232|65123073|FG003|Overall Study|Lack of Efficacy|0|||
23376281|NCT00479232|65123074|FG004|Overall Study|Lack of Efficacy|0|||
23376282|NCT00479232|65123075|FG005|Overall Study|Lack of Efficacy|4|||
23376283|NCT00479232|65123070|FG000|Overall Study|Physician Decision|0|||
23376284|NCT00479232|65123071|FG001|Overall Study|Physician Decision|0|||
23376285|NCT00479232|65123072|FG002|Overall Study|Physician Decision|2|||
23376286|NCT00479232|65123073|FG003|Overall Study|Physician Decision|0|||
23376287|NCT00479232|65123074|FG004|Overall Study|Physician Decision|0|||
23376288|NCT00479232|65123075|FG005|Overall Study|Physician Decision|1|||
23376289|NCT00479232|65123070|FG000|Overall Study|Progressive Disease|3|||
23376290|NCT00479232|65123071|FG001|Overall Study|Progressive Disease|1|||
23376291|NCT00479232|65123072|FG002|Overall Study|Progressive Disease|12|||
23376292|NCT00479232|65123073|FG003|Overall Study|Progressive Disease|3|||
23376293|NCT00479232|65123074|FG004|Overall Study|Progressive Disease|3|||
23376294|NCT00479232|65123075|FG005|Overall Study|Progressive Disease|12|||
23376295|NCT00479232|65123070|FG000|Overall Study|Withdrew Consent|0|||
23376296|NCT00479232|65123071|FG001|Overall Study|Withdrew Consent|2|||
23376297|NCT00479232|65123072|FG002|Overall Study|Withdrew Consent|6|||
23376298|NCT00479232|65123073|FG003|Overall Study|Withdrew Consent|0|||
23376299|NCT00479232|65123074|FG004|Overall Study|Withdrew Consent|1|||
23376300|NCT00479232|65123075|FG005|Overall Study|Withdrew Consent|3|||
23376301|NCT05001620|65123076|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
23376302|NCT05001620|65123077|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
23376303|NCT04739709|65123078|FG000|Overall Study|Physician Decision|1|||
23376304|NCT04739709|65123079|FG001|Overall Study|Physician Decision|0|||
23376305|NCT01416571|65123083|FG000|Overall Study|Lost to Follow-up|2|||
23376306|NCT02515227|65123088|FG000|Overall Study|Adverse Event|0|||
23376307|NCT02515227|65123089|FG001|Overall Study|Adverse Event|2|||
23376308|NCT02515227|65123088|FG000|Overall Study|Progressive disease|2|||
23376309|NCT02515227|65123089|FG001|Overall Study|Progressive disease|9|||
23376310|NCT00303186|65123090|FG000|Overall Study|Other|52|||
23376311|NCT02362451|65123108|FG000|Overall Study|Withdrawal by Subject|0|||
23376312|NCT02362451|65123109|FG001|Overall Study|Withdrawal by Subject|1|||
23376313|NCT02362451|65123108|FG000|Overall Study|Lack of Efficacy|2|||
23376314|NCT02362451|65123109|FG001|Overall Study|Lack of Efficacy|0|||
23376315|NCT02362451|65123108|FG000|Overall Study|Progression|1|||
23376316|NCT02362451|65123109|FG001|Overall Study|Progression|0|||
23376317|NCT02362451|65123108|FG000|Overall Study|Participant chose other therapy.|1|||
23376318|NCT02362451|65123109|FG001|Overall Study|Participant chose other therapy.|0|||
23376319|NCT03846479|65123111|FG000|Overall Study|Death|8|||
23376320|NCT03846479|65123111|FG000|Overall Study|Lost to Follow-up|1|||
23376321|NCT00596635|65123113|FG000|Overall Study|Lost to Follow-up|0|||
23376322|NCT00596635|65123114|FG001|Overall Study|Lost to Follow-up|2|||
23376323|NCT00596635|65123115|FG002|Overall Study|Lost to Follow-up|0|||
23376324|NCT00596635|65123113|FG000|Overall Study|Treatment for symptomatic UTI|4|||
23376325|NCT00596635|65123114|FG001|Overall Study|Treatment for symptomatic UTI|6|||
23376326|NCT00596635|65123115|FG002|Overall Study|Treatment for symptomatic UTI|3|||
23376327|NCT00596635|65123113|FG000|Overall Study|Hip fracture|2|||
23376328|NCT00596635|65123114|FG001|Overall Study|Hip fracture|3|||
23376329|NCT00596635|65123115|FG002|Overall Study|Hip fracture|3|||
23376330|NCT00596635|65123113|FG000|Overall Study|Could not provide urine specimen|1|||
23376331|NCT00596635|65123114|FG001|Overall Study|Could not provide urine specimen|2|||
23376332|NCT00596635|65123115|FG002|Overall Study|Could not provide urine specimen|2|||
23376333|NCT02593864|65123119|FG000|Overall Study|Withdrawal by Subject|3|||
23376334|NCT02593864|65123119|FG000|Overall Study|Lost to Follow-up|3|||
23376335|NCT02194465|65123123|FG000|Overall Study|Adverse Event|6|||
23376336|NCT02194465|65123124|FG001|Overall Study|Adverse Event|1|||
23376337|NCT02194465|65123125|FG002|Overall Study|Adverse Event|4|||
23376338|NCT02194465|65123126|FG003|Overall Study|Adverse Event|4|||
23376339|NCT02194465|65123127|FG004|Overall Study|Adverse Event|4|||
23376340|NCT02194465|65123128|FG005|Overall Study|Adverse Event|2|||
23376341|NCT02194465|65123129|FG006|Overall Study|Adverse Event|0|||
23376342|NCT02194465|65123123|FG000|Overall Study|Lost to Follow-up|0|||
23376343|NCT02194465|65123124|FG001|Overall Study|Lost to Follow-up|0|||
23376344|NCT02194465|65123125|FG002|Overall Study|Lost to Follow-up|0|||
23376345|NCT02194465|65123126|FG003|Overall Study|Lost to Follow-up|1|||
23376346|NCT02194465|65123127|FG004|Overall Study|Lost to Follow-up|0|||
23376347|NCT02194465|65123128|FG005|Overall Study|Lost to Follow-up|1|||
23376348|NCT02194465|65123129|FG006|Overall Study|Lost to Follow-up|0|||
23376349|NCT02194465|65123123|FG000|Overall Study|Physician Decision|1|||
23376350|NCT02194465|65123124|FG001|Overall Study|Physician Decision|0|||
23376351|NCT02194465|65123125|FG002|Overall Study|Physician Decision|0|||
23376352|NCT02194465|65123126|FG003|Overall Study|Physician Decision|0|||
23376353|NCT02194465|65123127|FG004|Overall Study|Physician Decision|0|||
23376354|NCT02194465|65123128|FG005|Overall Study|Physician Decision|0|||
23376355|NCT02194465|65123129|FG006|Overall Study|Physician Decision|0|||
23376356|NCT02194465|65123123|FG000|Overall Study|Protocol Violation|1|||
23376357|NCT02194465|65123124|FG001|Overall Study|Protocol Violation|1|||
23376358|NCT02194465|65123125|FG002|Overall Study|Protocol Violation|2|||
23376359|NCT02194465|65123126|FG003|Overall Study|Protocol Violation|1|||
23376360|NCT02194465|65123127|FG004|Overall Study|Protocol Violation|1|||
23376361|NCT02194465|65123128|FG005|Overall Study|Protocol Violation|0|||
23376362|NCT02194465|65123129|FG006|Overall Study|Protocol Violation|0|||
23376363|NCT02194465|65123123|FG000|Overall Study|Withdrawal by Subject|1|||
23376364|NCT02194465|65123124|FG001|Overall Study|Withdrawal by Subject|3|||
23376365|NCT02194465|65123125|FG002|Overall Study|Withdrawal by Subject|1|||
23376366|NCT02194465|65123126|FG003|Overall Study|Withdrawal by Subject|2|||
23376367|NCT02194465|65123127|FG004|Overall Study|Withdrawal by Subject|2|||
23376368|NCT02194465|65123128|FG005|Overall Study|Withdrawal by Subject|1|||
23376369|NCT02194465|65123129|FG006|Overall Study|Withdrawal by Subject|2|||
23376370|NCT02194465|65123123|FG000|Overall Study|Discontinued follow-up period|0|||
23376371|NCT02194465|65123124|FG001|Overall Study|Discontinued follow-up period|2|||
23376372|NCT02194465|65123125|FG002|Overall Study|Discontinued follow-up period|1|||
23376373|NCT02194465|65123126|FG003|Overall Study|Discontinued follow-up period|0|||
23376374|NCT02194465|65123127|FG004|Overall Study|Discontinued follow-up period|2|||
23376375|NCT02194465|65123128|FG005|Overall Study|Discontinued follow-up period|0|||
23376376|NCT02194465|65123129|FG006|Overall Study|Discontinued follow-up period|0|||
23376377|NCT02969018|65123133|FG000|Overall Study|Adverse Event|2|||
23376378|NCT02969018|65123134|FG001|Overall Study|Adverse Event|4|||
23376379|NCT02969018|65123135|FG002|Overall Study|Adverse Event|1|||
23376380|NCT02969018|65123136|FG003|Overall Study|Adverse Event|2|||
23376381|NCT02969018|65123137|FG004|Overall Study|Adverse Event|0|||
23376382|NCT02969018|65123138|FG005|Overall Study|Adverse Event|1|||
23376383|NCT02969018|65123139|FG006|Overall Study|Adverse Event|2|||
23376384|NCT02969018|65123140|FG007|Overall Study|Adverse Event|0|||
23376385|NCT02969018|65123133|FG000|Overall Study|Lack of Efficacy|0|||
23376386|NCT02969018|65123134|FG001|Overall Study|Lack of Efficacy|1|||
23376387|NCT02969018|65123135|FG002|Overall Study|Lack of Efficacy|0|||
23376388|NCT02969018|65123136|FG003|Overall Study|Lack of Efficacy|0|||
23376389|NCT02969018|65123137|FG004|Overall Study|Lack of Efficacy|1|||
23376390|NCT02969018|65123138|FG005|Overall Study|Lack of Efficacy|1|||
23376391|NCT02969018|65123139|FG006|Overall Study|Lack of Efficacy|1|||
23376392|NCT02969018|65123140|FG007|Overall Study|Lack of Efficacy|1|||
23376393|NCT02969018|65123133|FG000|Overall Study|Lost to Follow-up|1|||
23376394|NCT02969018|65123134|FG001|Overall Study|Lost to Follow-up|2|||
23489312|NCT02319837|65537020|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
23489313|NCT02319837|65537021|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
23376395|NCT02969018|65123135|FG002|Overall Study|Lost to Follow-up|2|||
23376396|NCT02969018|65123136|FG003|Overall Study|Lost to Follow-up|0|||
23376397|NCT02969018|65123137|FG004|Overall Study|Lost to Follow-up|1|||
23376398|NCT02969018|65123138|FG005|Overall Study|Lost to Follow-up|1|||
23376399|NCT02969018|65123139|FG006|Overall Study|Lost to Follow-up|0|||
23376400|NCT02969018|65123140|FG007|Overall Study|Lost to Follow-up|1|||
23376401|NCT02969018|65123133|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376402|NCT02969018|65123134|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376403|NCT02969018|65123135|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376404|NCT02969018|65123136|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376405|NCT02969018|65123137|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23489314|NCT02319837|65537022|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
23376406|NCT02969018|65123138|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376407|NCT02969018|65123139|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
23376408|NCT02969018|65123140|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376409|NCT02969018|65123133|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23376410|NCT02969018|65123134|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23376411|NCT02969018|65123135|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23376412|NCT02969018|65123136|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23376413|NCT02969018|65123137|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23376414|NCT02969018|65123138|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23376415|NCT02969018|65123139|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23376416|NCT02969018|65123140|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23376417|NCT02969018|65123133|FG000|Overall Study|Other|0|||
23376418|NCT02969018|65123134|FG001|Overall Study|Other|0|||
23376419|NCT02969018|65123135|FG002|Overall Study|Other|0|||
23376420|NCT02969018|65123136|FG003|Overall Study|Other|1|||
23376421|NCT02969018|65123137|FG004|Overall Study|Other|0|||
23376422|NCT02969018|65123138|FG005|Overall Study|Other|0|||
23376423|NCT02969018|65123139|FG006|Overall Study|Other|0|||
23376424|NCT02969018|65123140|FG007|Overall Study|Other|2|||
23376425|NCT02969018|65123133|FG000|Overall Study|Pregnancy|0|||
23376426|NCT02969018|65123134|FG001|Overall Study|Pregnancy|0|||
23376427|NCT02969018|65123135|FG002|Overall Study|Pregnancy|0|||
23376428|NCT02969018|65123136|FG003|Overall Study|Pregnancy|0|||
23376429|NCT02969018|65123137|FG004|Overall Study|Pregnancy|0|||
23376430|NCT02969018|65123138|FG005|Overall Study|Pregnancy|1|||
23376431|NCT02969018|65123139|FG006|Overall Study|Pregnancy|0|||
23376432|NCT02969018|65123140|FG007|Overall Study|Pregnancy|0|||
23376433|NCT02969018|65123133|FG000|Overall Study|Protocol Violation|0|||
23376434|NCT02969018|65123134|FG001|Overall Study|Protocol Violation|0|||
23376435|NCT02969018|65123135|FG002|Overall Study|Protocol Violation|1|||
23376436|NCT02969018|65123136|FG003|Overall Study|Protocol Violation|1|||
23376437|NCT02969018|65123137|FG004|Overall Study|Protocol Violation|0|||
23604652|NCT03015220|65943473|FG001|Overall Study|Withdrawal by Subject|2|||
23665288|NCT02055820|66162421|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665289|NCT02055820|66162422|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
23665290|NCT02055820|66162423|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665291|NCT02055820|66162424|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665292|NCT02055820|66162425|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23665293|NCT02055820|66162426|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23376438|NCT02969018|65123138|FG005|Overall Study|Protocol Violation|0|||
23376439|NCT02969018|65123139|FG006|Overall Study|Protocol Violation|0|||
23604653|NCT03015220|65943474|FG002|Overall Study|Withdrawal by Subject|2|||
23376440|NCT02969018|65123140|FG007|Overall Study|Protocol Violation|0|||
23604654|NCT03015220|65943475|FG003|Overall Study|Withdrawal by Subject|2|||
23376441|NCT02969018|65123133|FG000|Overall Study|Withdrawal by Subject|0|||
23376442|NCT02969018|65123134|FG001|Overall Study|Withdrawal by Subject|1|||
23376443|NCT02969018|65123135|FG002|Overall Study|Withdrawal by Subject|2|||
23376444|NCT02969018|65123136|FG003|Overall Study|Withdrawal by Subject|1|||
23376445|NCT02969018|65123137|FG004|Overall Study|Withdrawal by Subject|0|||
23376446|NCT02969018|65123138|FG005|Overall Study|Withdrawal by Subject|4|||
23489315|NCT02319837|65537020|FG000|Study Treatment Phase|Protocol Violation|2|||
23489316|NCT02319837|65537021|FG001|Study Treatment Phase|Protocol Violation|2|||
23489317|NCT02319837|65537022|FG002|Study Treatment Phase|Protocol Violation|1|||
23489318|NCT02319837|65537020|FG000|Study Treatment Phase|Lost to Follow-up|0|||
23489319|NCT02319837|65537021|FG001|Study Treatment Phase|Lost to Follow-up|1|||
23489320|NCT02319837|65537022|FG002|Study Treatment Phase|Lost to Follow-up|0|||
23489321|NCT02319837|65537020|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
23489322|NCT02319837|65537021|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
23489323|NCT02319837|65537022|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
23489324|NCT02319837|65537020|FG000|Study Treatment Phase|Other|0|||
23604655|NCT03015220|65943472|FG000|Overall Study|Lost to Follow-up|0|||
23376447|NCT02969018|65123139|FG006|Overall Study|Withdrawal by Subject|4|||
23376448|NCT02969018|65123140|FG007|Overall Study|Withdrawal by Subject|3|||
23376449|NCT03250273|65123148|FG000|Overall Study|Disease Progression|2|||
23376450|NCT03250273|65123149|FG001|Overall Study|Disease Progression|11|||
23376451|NCT03250273|65123148|FG000|Overall Study|Death|0|||
23376452|NCT03250273|65123149|FG001|Overall Study|Death|1|||
23376453|NCT01715298|65123152|FG000|Overall Study|Lost to Follow-up|0|||
23376454|NCT01715298|65123153|FG001|Overall Study|Lost to Follow-up|2|||
23376455|NCT01715298|65123152|FG000|Overall Study|Patient/guardian decision|7|||
23376456|NCT01715298|65123153|FG001|Overall Study|Patient/guardian decision|9|||
23376457|NCT01664091|65123158|FG000|Overall Study|Death|1|||
23376458|NCT01664091|65123158|FG000|Overall Study|Disease Progression|2|||
23376459|NCT01664091|65123158|FG000|Overall Study|Lost to Follow-up|2|||
23376460|NCT01664091|65123158|FG000|Overall Study|Withdrawal by Subject|1|||
23376461|NCT03530696|65123159|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
23376462|NCT03530696|65123160|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
23376463|NCT00975923|65123161|FG000|Overall Study|Withdrawal by Subject|0|||
23376464|NCT00975923|65123162|FG001|Overall Study|Withdrawal by Subject|1|||
23376465|NCT00924898|65123163|FG000|Overall Study|Withdrawal by Subject|2|||
23604656|NCT03015220|65943473|FG001|Overall Study|Lost to Follow-up|0|||
23376466|NCT00922636|65123169|FG000|Overall Study|Adverse Event|3|||
23665294|NCT02055820|66162417|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665295|NCT02055820|66162418|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665296|NCT02055820|66162419|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665297|NCT02055820|66162420|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
23665298|NCT02055820|66162421|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665299|NCT02055820|66162422|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665300|NCT02055820|66162423|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
23665301|NCT02055820|66162424|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665302|NCT02055820|66162425|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665303|NCT02055820|66162426|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
23665304|NCT02055820|66162417|FG000|Phase II: Expansion|Death|0|||
23665305|NCT02055820|66162418|FG001|Phase II: Expansion|Death|0|||
23665306|NCT02055820|66162419|FG002|Phase II: Expansion|Death|0|||
23376467|NCT00922636|65123170|FG001|Overall Study|Adverse Event|3|||
23376468|NCT00922636|65123171|FG002|Overall Study|Adverse Event|2|||
23376469|NCT00922636|65123172|FG003|Overall Study|Adverse Event|3|||
23376470|NCT00922636|65123173|FG004|Overall Study|Adverse Event|2|||
23376471|NCT00922636|65123169|FG000|Overall Study|Lack of Efficacy|1|||
23376472|NCT00922636|65123170|FG001|Overall Study|Lack of Efficacy|7|||
23376473|NCT00922636|65123171|FG002|Overall Study|Lack of Efficacy|3|||
23376474|NCT00922636|65123172|FG003|Overall Study|Lack of Efficacy|2|||
23376475|NCT00922636|65123173|FG004|Overall Study|Lack of Efficacy|4|||
23376476|NCT00922636|65123169|FG000|Overall Study|Sponsor Decision|0|||
23376477|NCT00922636|65123170|FG001|Overall Study|Sponsor Decision|0|||
23376478|NCT00922636|65123171|FG002|Overall Study|Sponsor Decision|2|||
23489325|NCT02319837|65537021|FG001|Study Treatment Phase|Other|1|||
23489326|NCT02319837|65537022|FG002|Study Treatment Phase|Other|0|||
23489327|NCT02319837|65537020|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
23489328|NCT02319837|65537021|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
23489329|NCT02319837|65537022|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
23489330|NCT02319837|65537020|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
23489331|NCT02319837|65537021|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
23489332|NCT02319837|65537022|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
23489333|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
23489334|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
23489335|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
23489336|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
23489337|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
23489338|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
23489339|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
23489340|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
23489341|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
23489342|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
23489343|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
23489344|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
23489345|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Death|33|||
23489346|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Death|54|||
23489347|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Death|42|||
23489348|NCT04093414|65537023|FG000|3 Month Follow up|Physician Decision|0|||
23489349|NCT04093414|65537024|FG001|3 Month Follow up|Physician Decision|1|||
23489350|NCT04093414|65537023|FG000|6month Follow up|Physician Decision|1|||
23489351|NCT04093414|65537024|FG001|6month Follow up|Physician Decision|3|||
23489352|NCT01646073|65537035|FG000|Period A (12 Weeks)|Adverse Event|0|||
23489353|NCT01646073|65537036|FG001|Period A (12 Weeks)|Adverse Event|2|||
23489354|NCT01646073|65537035|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
23489355|NCT01646073|65537036|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
23376479|NCT00922636|65123172|FG003|Overall Study|Sponsor Decision|0|||
23376480|NCT00922636|65123173|FG004|Overall Study|Sponsor Decision|0|||
23376481|NCT00922636|65123169|FG000|Overall Study|Withdrawal by Subject|0|||
23376482|NCT00922636|65123170|FG001|Overall Study|Withdrawal by Subject|0|||
23376483|NCT00922636|65123171|FG002|Overall Study|Withdrawal by Subject|5|||
23376484|NCT00922636|65123172|FG003|Overall Study|Withdrawal by Subject|2|||
23376485|NCT00922636|65123173|FG004|Overall Study|Withdrawal by Subject|4|||
23376486|NCT00922636|65123169|FG000|Overall Study|Protocol Violation|0|||
23376487|NCT00922636|65123170|FG001|Overall Study|Protocol Violation|0|||
23376488|NCT00922636|65123171|FG002|Overall Study|Protocol Violation|2|||
23376489|NCT00922636|65123172|FG003|Overall Study|Protocol Violation|2|||
23376490|NCT00922636|65123173|FG004|Overall Study|Protocol Violation|0|||
23376491|NCT00922636|65123169|FG000|Overall Study|Entry Criteria Not Met|0|||
23376492|NCT00922636|65123170|FG001|Overall Study|Entry Criteria Not Met|0|||
23376493|NCT00922636|65123171|FG002|Overall Study|Entry Criteria Not Met|1|||
23376494|NCT00922636|65123172|FG003|Overall Study|Entry Criteria Not Met|1|||
23376495|NCT00922636|65123173|FG004|Overall Study|Entry Criteria Not Met|0|||
23376496|NCT00922636|65123169|FG000|Overall Study|Parent/Caregiver Decision|2|||
23376497|NCT00922636|65123170|FG001|Overall Study|Parent/Caregiver Decision|4|||
23376498|NCT00922636|65123171|FG002|Overall Study|Parent/Caregiver Decision|3|||
23376499|NCT00922636|65123172|FG003|Overall Study|Parent/Caregiver Decision|5|||
23376500|NCT00922636|65123173|FG004|Overall Study|Parent/Caregiver Decision|2|||
23376501|NCT00922636|65123169|FG000|Overall Study|Lost to Follow-up|1|||
23376502|NCT00922636|65123170|FG001|Overall Study|Lost to Follow-up|2|||
23376503|NCT00922636|65123171|FG002|Overall Study|Lost to Follow-up|2|||
23376504|NCT00922636|65123172|FG003|Overall Study|Lost to Follow-up|2|||
23376505|NCT00922636|65123173|FG004|Overall Study|Lost to Follow-up|4|||
23376506|NCT01240382|65123174|FG000|Overall Study|Adverse Event|2|||
23376507|NCT01240382|65123175|FG001|Overall Study|Adverse Event|1|||
23376508|NCT01240382|65123174|FG000|Overall Study|Lack of Efficacy|0|||
23376509|NCT01240382|65123175|FG001|Overall Study|Lack of Efficacy|2|||
23376510|NCT01240382|65123174|FG000|Overall Study|Fear of adverse events|0|||
23376511|NCT01240382|65123175|FG001|Overall Study|Fear of adverse events|1|||
23376512|NCT04969289|65123177|FG000|Overall Study|Lost to Follow-up|13|||
23376513|NCT04969289|65123178|FG001|Overall Study|Lost to Follow-up|9|||
23376514|NCT00294658|65123179|FG000|Overall Study|Death|0|||
23376515|NCT00294658|65123180|FG001|Overall Study|Death|1|||
23376516|NCT00294658|65123179|FG000|Overall Study|Lost to Follow-up|4|||
23376517|NCT00294658|65123180|FG001|Overall Study|Lost to Follow-up|0|||
23376518|NCT00294658|65123179|FG000|Overall Study|Physician Decision|1|||
23376519|NCT00294658|65123180|FG001|Overall Study|Physician Decision|2|||
23376520|NCT00294658|65123179|FG000|Overall Study|Pregnancy|0|||
23376521|NCT00294658|65123180|FG001|Overall Study|Pregnancy|1|||
23376522|NCT00294658|65123179|FG000|Overall Study|Withdrawal by Subject|0|||
23376523|NCT00294658|65123180|FG001|Overall Study|Withdrawal by Subject|4|||
23376524|NCT00294658|65123179|FG000|Overall Study|Found to have invasive thymoma|1|||
23376525|NCT00294658|65123180|FG001|Overall Study|Found to have invasive thymoma|0|||
23376526|NCT00294658|65123179|FG000|Overall Study|Patient and family were not satisfied|0|||
23376527|NCT00294658|65123180|FG001|Overall Study|Patient and family were not satisfied|1|||
23376528|NCT00481676|65123182|FG000|Overall Study|Adverse Event|0|||
23376529|NCT00481676|65123183|FG001|Overall Study|Adverse Event|1|||
23376530|NCT00481676|65123182|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23376531|NCT00481676|65123183|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23376532|NCT00481676|65123182|FG000|Overall Study|Administrative problem|1|||
23376533|NCT00481676|65123183|FG001|Overall Study|Administrative problem|0|||
23376534|NCT03473197|65123188|FG000|Overall Study|Adverse Event|4|||
23376535|NCT03473197|65123188|FG000|Overall Study|Lost to Follow-up|1|||
23376536|NCT03473197|65123188|FG000|Overall Study|Withdrawal by Subject|5|||
23376537|NCT00112957|65123191|FG000|Overall Study|Progressive disease|18|||
23489356|NCT01646073|65537035|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
23376538|NCT00112957|65123191|FG000|Overall Study|Physician Decision|1|||
23376539|NCT02802228|65123192|FG000|Overall Study|Withdrawal by Subject|2|||
23376540|NCT02802228|65123193|FG001|Overall Study|Withdrawal by Subject|0|||
23376541|NCT02802228|65123192|FG000|Overall Study|Lost to Follow-up|1|||
23376542|NCT02802228|65123193|FG001|Overall Study|Lost to Follow-up|0|||
23376543|NCT02802228|65123192|FG000|Overall Study|Adverse Event|1|||
23489357|NCT01646073|65537036|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
23489358|NCT01646073|65537035|FG000|Period A (12 Weeks)|Protocol Violation|0|||
23489359|NCT01646073|65537036|FG001|Period A (12 Weeks)|Protocol Violation|1|||
23489360|NCT01646073|65537035|FG000|Period A (12 Weeks)|Other|0|||
23489361|NCT01646073|65537036|FG001|Period A (12 Weeks)|Other|1|||
23489362|NCT01646073|65537035|FG000|Period B (12 Weeks)|Adverse Event|0|||
23489363|NCT01646073|65537036|FG001|Period B (12 Weeks)|Adverse Event|7|||
23376544|NCT02802228|65123193|FG001|Overall Study|Adverse Event|0|||
23376545|NCT02802228|65123192|FG000|Overall Study|Physician Decision|1|||
23376546|NCT02802228|65123193|FG001|Overall Study|Physician Decision|0|||
23376547|NCT02225587|65123194|FG000|Overall Study|Adverse Event|5|||
23376548|NCT02225587|65123195|FG001|Overall Study|Adverse Event|5|||
23376549|NCT02225587|65123194|FG000|Overall Study|Lost to Follow-up|5|||
23376550|NCT02225587|65123195|FG001|Overall Study|Lost to Follow-up|5|||
23376551|NCT02225587|65123194|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23376552|NCT02225587|65123195|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23376553|NCT02225587|65123194|FG000|Overall Study|Physician Decision|2|||
23376554|NCT02225587|65123195|FG001|Overall Study|Physician Decision|0|||
23376555|NCT02225587|65123194|FG000|Overall Study|Protocol Violation|1|||
23376556|NCT02225587|65123195|FG001|Overall Study|Protocol Violation|0|||
23376557|NCT02225587|65123194|FG000|Overall Study|Participant Moved|1|||
23376558|NCT02225587|65123195|FG001|Overall Study|Participant Moved|0|||
23489364|NCT01646073|65537035|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
23489365|NCT01646073|65537036|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
23489366|NCT01646073|65537035|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
23489367|NCT01646073|65537036|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
23489368|NCT02337738|65537039|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
23489369|NCT02337738|65537040|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
23489370|NCT02337738|65537041|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
23489371|NCT02337738|65537039|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23489372|NCT02337738|65537040|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
23376559|NCT02225587|65123194|FG000|Overall Study|Withdrawal by Subject|13|||
23376560|NCT02225587|65123195|FG001|Overall Study|Withdrawal by Subject|28|||
23376561|NCT00706797|65123198|FG000|Overall Study|Lack of Efficacy|3|||
23376562|NCT00706797|65123199|FG001|Overall Study|Lack of Efficacy|0|||
23376563|NCT00706797|65123198|FG000|Overall Study|Adverse Event|0|||
23376564|NCT00706797|65123199|FG001|Overall Study|Adverse Event|3|||
23376565|NCT00706797|65123198|FG000|Overall Study|Withdrawal by Subject|8|||
23376566|NCT00706797|65123199|FG001|Overall Study|Withdrawal by Subject|1|||
23376567|NCT00706797|65123198|FG000|Overall Study|Death|1|||
23376568|NCT00706797|65123199|FG001|Overall Study|Death|0|||
23376569|NCT00706797|65123198|FG000|Overall Study|Discontinuation of study by sponsor|52|||
23376570|NCT00706797|65123199|FG001|Overall Study|Discontinuation of study by sponsor|63|||
23376571|NCT00706797|65123198|FG000|Overall Study|Protocol Violation|3|||
23376572|NCT00706797|65123199|FG001|Overall Study|Protocol Violation|2|||
23376573|NCT00706797|65123198|FG000|Overall Study|Lost to Follow-up|1|||
23376574|NCT00706797|65123199|FG001|Overall Study|Lost to Follow-up|2|||
23376575|NCT00706797|65123198|FG000|Overall Study|Other|1|||
23376576|NCT00706797|65123199|FG001|Overall Study|Other|0|||
23376577|NCT01513590|65123202|FG000|Overall Study|Adverse Event|2|||
23376578|NCT01513590|65123203|FG001|Overall Study|Adverse Event|3|||
23376579|NCT01513590|65123202|FG000|Overall Study|Withdrawal Criteria|3|||
23376580|NCT01513590|65123203|FG001|Overall Study|Withdrawal Criteria|0|||
23376581|NCT01513590|65123202|FG000|Overall Study|Unclassified|5|||
23376582|NCT01513590|65123203|FG001|Overall Study|Unclassified|10|||
23376583|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23376584|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
23376585|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23376586|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
23489373|NCT02337738|65537041|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
23489374|NCT02337738|65537039|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
23489375|NCT02337738|65537040|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
23604657|NCT03015220|65943474|FG002|Overall Study|Lost to Follow-up|1|||
23665307|NCT02055820|66162420|FG003|Phase II: Expansion|Death|0|||
23376587|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
23376588|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23376589|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
23376590|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
23376591|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
23376592|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
23376593|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
23376594|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
23376595|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
23376596|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23376597|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23376598|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23376599|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23376600|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
23376601|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
23376602|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
23376603|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
23376604|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
23376605|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
23376606|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
23376607|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
23376608|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
23376609|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
23376610|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
23376611|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
23376612|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
23376613|NCT00963235|65123208|FG000|Overall Study|Withdrawal by Subject|22|||
23376614|NCT00963235|65123208|FG000|Overall Study|Lost to Follow-up|14|||
23376615|NCT00963235|65123208|FG000|Overall Study|Failed to return|9|||
23376616|NCT00963235|65123208|FG000|Overall Study|Protocol Violation|7|||
23376617|NCT00963235|65123208|FG000|Overall Study|Adverse Event|5|||
23376618|NCT00963235|65123208|FG000|Overall Study|Physician Decision|2|||
23376619|NCT00963235|65123208|FG000|Overall Study|Other|1|||
23376620|NCT02335944|65123209|FG000|Treatment Phase|Progressive Disease|2|||
23376621|NCT02335944|65123210|FG001|Treatment Phase|Progressive Disease|5|||
23376622|NCT02335944|65123211|FG002|Treatment Phase|Progressive Disease|2|||
23376623|NCT02335944|65123212|FG003|Treatment Phase|Progressive Disease|11|||
23376624|NCT02335944|65123213|FG004|Treatment Phase|Progressive Disease|4|||
23376625|NCT02335944|65123214|FG005|Treatment Phase|Progressive Disease|25|||
23376626|NCT02335944|65123215|FG006|Treatment Phase|Progressive Disease|2|||
23376627|NCT02335944|65123216|FG007|Treatment Phase|Progressive Disease|30|||
23376628|NCT02335944|65123217|FG008|Treatment Phase|Progressive Disease|27|||
23376629|NCT02335944|65123218|FG009|Treatment Phase|Progressive Disease|0|||
23376630|NCT02335944|65123209|FG000|Treatment Phase|Adverse Event|2|||
23376631|NCT02335944|65123210|FG001|Treatment Phase|Adverse Event|0|||
23376632|NCT02335944|65123211|FG002|Treatment Phase|Adverse Event|0|||
23376633|NCT02335944|65123212|FG003|Treatment Phase|Adverse Event|2|||
23376634|NCT02335944|65123213|FG004|Treatment Phase|Adverse Event|1|||
23376635|NCT02335944|65123214|FG005|Treatment Phase|Adverse Event|15|||
23376636|NCT02335944|65123215|FG006|Treatment Phase|Adverse Event|0|||
23376637|NCT02335944|65123216|FG007|Treatment Phase|Adverse Event|5|||
23376638|NCT02335944|65123217|FG008|Treatment Phase|Adverse Event|7|||
23376639|NCT02335944|65123218|FG009|Treatment Phase|Adverse Event|0|||
23376640|NCT02335944|65123209|FG000|Treatment Phase|Physician Decision|0|||
23376641|NCT02335944|65123210|FG001|Treatment Phase|Physician Decision|0|||
23376642|NCT02335944|65123211|FG002|Treatment Phase|Physician Decision|0|||
23376643|NCT02335944|65123212|FG003|Treatment Phase|Physician Decision|1|||
23376644|NCT02335944|65123213|FG004|Treatment Phase|Physician Decision|0|||
23376645|NCT02335944|65123214|FG005|Treatment Phase|Physician Decision|6|||
23376646|NCT02335944|65123215|FG006|Treatment Phase|Physician Decision|1|||
23376647|NCT02335944|65123216|FG007|Treatment Phase|Physician Decision|2|||
23376648|NCT02335944|65123217|FG008|Treatment Phase|Physician Decision|1|||
23376649|NCT02335944|65123218|FG009|Treatment Phase|Physician Decision|0|||
23376650|NCT02335944|65123209|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
23376651|NCT02335944|65123210|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
23376652|NCT02335944|65123211|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
23376653|NCT02335944|65123212|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
23376654|NCT02335944|65123213|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
23376655|NCT02335944|65123214|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
23376656|NCT02335944|65123215|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
23376657|NCT02335944|65123216|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
23376658|NCT02335944|65123217|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
23376659|NCT02335944|65123218|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
23376660|NCT02335944|65123209|FG000|Treatment Phase|Subject/Guardian Decision|0|||
23376661|NCT02335944|65123210|FG001|Treatment Phase|Subject/Guardian Decision|0|||
23376662|NCT02335944|65123211|FG002|Treatment Phase|Subject/Guardian Decision|1|||
23376663|NCT02335944|65123212|FG003|Treatment Phase|Subject/Guardian Decision|0|||
23376664|NCT02335944|65123213|FG004|Treatment Phase|Subject/Guardian Decision|0|||
23376665|NCT02335944|65123214|FG005|Treatment Phase|Subject/Guardian Decision|1|||
23376666|NCT02335944|65123215|FG006|Treatment Phase|Subject/Guardian Decision|0|||
23376667|NCT02335944|65123216|FG007|Treatment Phase|Subject/Guardian Decision|4|||
23376668|NCT02335944|65123217|FG008|Treatment Phase|Subject/Guardian Decision|0|||
23376669|NCT02335944|65123218|FG009|Treatment Phase|Subject/Guardian Decision|0|||
23376670|NCT02335944|65123209|FG000|Post-treatment Follow-up|Progressive Disease|0|||
23376671|NCT02335944|65123210|FG001|Post-treatment Follow-up|Progressive Disease|0|||
23376672|NCT02335944|65123211|FG002|Post-treatment Follow-up|Progressive Disease|0|||
23376673|NCT02335944|65123212|FG003|Post-treatment Follow-up|Progressive Disease|1|||
23376674|NCT02335944|65123213|FG004|Post-treatment Follow-up|Progressive Disease|0|||
23376675|NCT02335944|65123214|FG005|Post-treatment Follow-up|Progressive Disease|9|||
23376676|NCT02335944|65123215|FG006|Post-treatment Follow-up|Progressive Disease|0|||
23376677|NCT02335944|65123216|FG007|Post-treatment Follow-up|Progressive Disease|2|||
23376678|NCT02335944|65123217|FG008|Post-treatment Follow-up|Progressive Disease|3|||
23376679|NCT02335944|65123218|FG009|Post-treatment Follow-up|Progressive Disease|0|||
23376680|NCT02335944|65123209|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376681|NCT02335944|65123210|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376682|NCT02335944|65123211|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376683|NCT02335944|65123212|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376684|NCT02335944|65123213|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376685|NCT02335944|65123214|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
23376686|NCT02335944|65123215|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376687|NCT02335944|65123216|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376688|NCT02335944|65123217|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376689|NCT02335944|65123218|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376690|NCT02335944|65123209|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376691|NCT02335944|65123210|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376692|NCT02335944|65123211|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376693|NCT02335944|65123212|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376694|NCT02335944|65123213|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376695|NCT02335944|65123214|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376696|NCT02335944|65123215|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376697|NCT02335944|65123216|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
23376698|NCT02335944|65123217|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376699|NCT02335944|65123218|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376700|NCT02335944|65123209|FG000|Post-treatment Follow-up|Adverse Event|0|||
23376701|NCT02335944|65123210|FG001|Post-treatment Follow-up|Adverse Event|0|||
23376702|NCT02335944|65123211|FG002|Post-treatment Follow-up|Adverse Event|0|||
23376703|NCT02335944|65123212|FG003|Post-treatment Follow-up|Adverse Event|0|||
23376704|NCT02335944|65123213|FG004|Post-treatment Follow-up|Adverse Event|0|||
23376705|NCT02335944|65123214|FG005|Post-treatment Follow-up|Adverse Event|1|||
23376706|NCT02335944|65123215|FG006|Post-treatment Follow-up|Adverse Event|0|||
23376707|NCT02335944|65123216|FG007|Post-treatment Follow-up|Adverse Event|0|||
23376708|NCT02335944|65123217|FG008|Post-treatment Follow-up|Adverse Event|0|||
23376709|NCT02335944|65123218|FG009|Post-treatment Follow-up|Adverse Event|0|||
23376710|NCT02335944|65123209|FG000|Post-treatment Follow-up|Death|0|||
23376711|NCT02335944|65123210|FG001|Post-treatment Follow-up|Death|0|||
23376712|NCT02335944|65123211|FG002|Post-treatment Follow-up|Death|0|||
23376713|NCT02335944|65123212|FG003|Post-treatment Follow-up|Death|1|||
23376714|NCT02335944|65123213|FG004|Post-treatment Follow-up|Death|0|||
23376715|NCT02335944|65123214|FG005|Post-treatment Follow-up|Death|1|||
23376716|NCT02335944|65123215|FG006|Post-treatment Follow-up|Death|0|||
23376717|NCT02335944|65123216|FG007|Post-treatment Follow-up|Death|0|||
23376718|NCT02335944|65123217|FG008|Post-treatment Follow-up|Death|0|||
23376719|NCT02335944|65123218|FG009|Post-treatment Follow-up|Death|0|||
23376720|NCT02335944|65123209|FG000|Post-treatment Follow-up|Physician Decision|1|||
23376721|NCT02335944|65123210|FG001|Post-treatment Follow-up|Physician Decision|0|||
23376722|NCT02335944|65123211|FG002|Post-treatment Follow-up|Physician Decision|0|||
23376723|NCT02335944|65123212|FG003|Post-treatment Follow-up|Physician Decision|0|||
23376724|NCT02335944|65123213|FG004|Post-treatment Follow-up|Physician Decision|0|||
23376725|NCT02335944|65123214|FG005|Post-treatment Follow-up|Physician Decision|0|||
23376726|NCT02335944|65123215|FG006|Post-treatment Follow-up|Physician Decision|0|||
23376727|NCT02335944|65123216|FG007|Post-treatment Follow-up|Physician Decision|1|||
23376728|NCT02335944|65123217|FG008|Post-treatment Follow-up|Physician Decision|0|||
23376729|NCT02335944|65123218|FG009|Post-treatment Follow-up|Physician Decision|0|||
23376730|NCT01529268|65123219|FG000|Overall Study|Lost to Follow-up|9|||
23376731|NCT01529268|65123220|FG001|Overall Study|Lost to Follow-up|3|||
23376732|NCT01529268|65123219|FG000|Overall Study|Moved|3|||
23376733|NCT01529268|65123220|FG001|Overall Study|Moved|0|||
23376734|NCT02807259|65123221|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
23376735|NCT02807259|65123222|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
23376736|NCT02807259|65123221|FG000|Midline (3 Months)|migration, refusal, not available|30|||
23376737|NCT02807259|65123222|FG001|Midline (3 Months)|migration, refusal, not available|34|||
23376738|NCT02807259|65123221|FG000|Endline (3 Months)|migration, refusal, not available|35|||
23376739|NCT02807259|65123222|FG001|Endline (3 Months)|migration, refusal, not available|87|||
23376740|NCT03086343|65123227|FG000|Period 1|Adverse Event|7|||
23376741|NCT03086343|65123228|FG001|Period 1|Adverse Event|7|||
23376742|NCT03086343|65123229|FG002|Period 1|Adverse Event|0|||
23376743|NCT03086343|65123230|FG003|Period 1|Adverse Event|1|||
23376744|NCT03086343|65123227|FG000|Period 1|Withdrawal by Subject|6|||
23376745|NCT03086343|65123228|FG001|Period 1|Withdrawal by Subject|10|||
23376746|NCT03086343|65123229|FG002|Period 1|Withdrawal by Subject|0|||
23376747|NCT03086343|65123230|FG003|Period 1|Withdrawal by Subject|0|||
23376748|NCT03086343|65123227|FG000|Period 1|Lost to Follow-up|1|||
23604658|NCT03015220|65943475|FG003|Overall Study|Lost to Follow-up|0|||
23604659|NCT04559698|65943476|FG000|Overall Study|Lost to Follow-up|14|||
23604660|NCT04559698|65943477|FG001|Overall Study|Lost to Follow-up|15|||
23376749|NCT03086343|65123228|FG001|Period 1|Lost to Follow-up|3|||
23376750|NCT03086343|65123229|FG002|Period 1|Lost to Follow-up|1|||
23376751|NCT03086343|65123230|FG003|Period 1|Lost to Follow-up|0|||
23376752|NCT03086343|65123227|FG000|Period 1|Other, Not Specified|10|||
23376753|NCT03086343|65123228|FG001|Period 1|Other, Not Specified|12|||
23376754|NCT03086343|65123229|FG002|Period 1|Other, Not Specified|2|||
23376755|NCT03086343|65123230|FG003|Period 1|Other, Not Specified|1|||
23376756|NCT03086343|65123227|FG000|Period 1|Missing|1|||
23376757|NCT03086343|65123228|FG001|Period 1|Missing|0|||
23604661|NCT04559698|65943476|FG000|Overall Study|Withdrawal by Subject|0|||
23604662|NCT04559698|65943477|FG001|Overall Study|Withdrawal by Subject|1|||
23665308|NCT02055820|66162421|FG004|Phase II: Expansion|Death|33|||
23376758|NCT03086343|65123229|FG002|Period 1|Missing|0|||
23376759|NCT03086343|65123230|FG003|Period 1|Missing|0|||
23665309|NCT02055820|66162422|FG005|Phase II: Expansion|Death|0|||
23665310|NCT02055820|66162423|FG006|Phase II: Expansion|Death|0|||
23376760|NCT03086343|65123227|FG000|Period 2|Adverse Event|20|||
23376761|NCT03086343|65123228|FG001|Period 2|Adverse Event|11|||
23376762|NCT03086343|65123229|FG002|Period 2|Adverse Event|1|||
23376763|NCT03086343|65123230|FG003|Period 2|Adverse Event|2|||
23376764|NCT03086343|65123227|FG000|Period 2|Withdrawal by Subject|15|||
23376765|NCT03086343|65123228|FG001|Period 2|Withdrawal by Subject|25|||
23376766|NCT03086343|65123229|FG002|Period 2|Withdrawal by Subject|2|||
23376767|NCT03086343|65123230|FG003|Period 2|Withdrawal by Subject|2|||
23376768|NCT03086343|65123227|FG000|Period 2|Lost to Follow-up|6|||
23376769|NCT03086343|65123228|FG001|Period 2|Lost to Follow-up|11|||
23376770|NCT03086343|65123229|FG002|Period 2|Lost to Follow-up|1|||
23376771|NCT03086343|65123230|FG003|Period 2|Lost to Follow-up|0|||
23376772|NCT03086343|65123227|FG000|Period 2|COVID-19 Infection|5|||
23376773|NCT03086343|65123228|FG001|Period 2|COVID-19 Infection|0|||
23376774|NCT03086343|65123229|FG002|Period 2|COVID-19 Infection|0|||
23376775|NCT03086343|65123230|FG003|Period 2|COVID-19 Infection|0|||
23376776|NCT03086343|65123227|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
23376777|NCT03086343|65123228|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
23376778|NCT03086343|65123229|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
23376779|NCT03086343|65123230|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
23376780|NCT03086343|65123227|FG000|Period 2|Other, Not Specified|23|||
23376781|NCT03086343|65123228|FG001|Period 2|Other, Not Specified|22|||
23376782|NCT03086343|65123229|FG002|Period 2|Other, Not Specified|2|||
23376783|NCT03086343|65123230|FG003|Period 2|Other, Not Specified|4|||
23376784|NCT00941928|65123234|FG000|Overall Study|Withdrawal by Subject|1|||
23376785|NCT00941928|65123234|FG000|Overall Study|Disease Progression|1|||
23376786|NCT01458587|65123238|FG000|Overall Study|Withdrawal by Subject|1|||
23376787|NCT01458587|65123239|FG001|Overall Study|Withdrawal by Subject|0|||
23376788|NCT00689936|65123240|FG000|Active Treatment Phase|Adverse Event|68|||
23376789|NCT00689936|65123241|FG001|Active Treatment Phase|Adverse Event|71|||
23376790|NCT00689936|65123242|FG002|Active Treatment Phase|Adverse Event|76|||
23376791|NCT00689936|65123240|FG000|Active Treatment Phase|Disease Progression|273|||
23376792|NCT00689936|65123241|FG001|Active Treatment Phase|Disease Progression|362|||
23376793|NCT00689936|65123242|FG002|Active Treatment Phase|Disease Progression|339|||
23376794|NCT00689936|65123240|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
23376795|NCT00689936|65123241|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
23376796|NCT00689936|65123242|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
23376797|NCT00689936|65123240|FG000|Active Treatment Phase|Death|60|||
23376798|NCT00689936|65123241|FG001|Active Treatment Phase|Death|28|||
23376799|NCT00689936|65123242|FG002|Active Treatment Phase|Death|37|||
23376800|NCT00689936|65123240|FG000|Active Treatment Phase|Lost to Follow-up|0|||
23376801|NCT00689936|65123241|FG001|Active Treatment Phase|Lost to Follow-up|2|||
23376802|NCT00689936|65123242|FG002|Active Treatment Phase|Lost to Follow-up|2|||
23376803|NCT00689936|65123240|FG000|Active Treatment Phase|Protocol Violation|2|||
23376804|NCT00689936|65123241|FG001|Active Treatment Phase|Protocol Violation|2|||
23376805|NCT00689936|65123242|FG002|Active Treatment Phase|Protocol Violation|4|||
23489376|NCT02337738|65537041|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
23665311|NCT02055820|66162424|FG007|Phase II: Expansion|Death|0|||
23376806|NCT00689936|65123240|FG000|Active Treatment Phase|Study Close Out|64|||
23376807|NCT00689936|65123241|FG001|Active Treatment Phase|Study Close Out|26|||
23376808|NCT00689936|65123242|FG002|Active Treatment Phase|Study Close Out|21|||
23376809|NCT00689936|65123240|FG000|Active Treatment Phase|Miscellaneous|52|||
23376810|NCT00689936|65123241|FG001|Active Treatment Phase|Miscellaneous|34|||
23376811|NCT00689936|65123242|FG002|Active Treatment Phase|Miscellaneous|47|||
23604663|NCT04809623|65943478|FG000|Overall Study|Study Terminated by Sponsor|1|||
23604664|NCT04809623|65943479|FG001|Overall Study|Study Terminated by Sponsor|0|||
23376812|NCT00689936|65123240|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
23376813|NCT00689936|65123241|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
23376814|NCT00689936|65123242|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
23376815|NCT03482024|65123247|FG000|Overall Study|Physician Decision|1|||
23376816|NCT03482024|65123248|FG001|Overall Study|Physician Decision|0|||
23376817|NCT03482024|65123249|FG002|Overall Study|Physician Decision|0|||
23376818|NCT03482024|65123250|FG003|Overall Study|Physician Decision|0|||
23376819|NCT03482024|65123251|FG004|Overall Study|Physician Decision|0|||
23376820|NCT02832037|65123252|FG000|Overall Study|Administrative reasons|0|||
23376821|NCT02832037|65123253|FG001|Overall Study|Administrative reasons|0|||
23604665|NCT00786864|65943480|FG000|Overall Study|Lost to Follow-up|0|||
23604666|NCT00786864|65943481|FG001|Overall Study|Lost to Follow-up|1|||
23604667|NCT00786864|65943480|FG000|Overall Study|Sustained serious back injury|1|||
23604668|NCT00786864|65943481|FG001|Overall Study|Sustained serious back injury|0|||
23604669|NCT01021748|65943482|FG000|Overall Study|Adverse Event|2|||
23604670|NCT01021748|65943483|FG001|Overall Study|Adverse Event|1|||
23604671|NCT01021748|65943484|FG002|Overall Study|Adverse Event|2|||
23665312|NCT02055820|66162425|FG008|Phase II: Expansion|Death|0|||
23665313|NCT02055820|66162426|FG009|Phase II: Expansion|Death|0|||
23665314|NCT02055820|66162417|FG000|Phase II: Expansion|Lost to Follow-up|0|||
23665315|NCT02055820|66162418|FG001|Phase II: Expansion|Lost to Follow-up|0|||
23665316|NCT02055820|66162419|FG002|Phase II: Expansion|Lost to Follow-up|0|||
23665317|NCT02055820|66162420|FG003|Phase II: Expansion|Lost to Follow-up|0|||
23665318|NCT02055820|66162421|FG004|Phase II: Expansion|Lost to Follow-up|4|||
23604672|NCT01021748|65943485|FG003|Overall Study|Adverse Event|0|||
23604673|NCT01021748|65943486|FG004|Overall Study|Adverse Event|2|||
23604674|NCT01021748|65943487|FG005|Overall Study|Adverse Event|0|||
23376822|NCT02832037|65123254|FG002|Overall Study|Administrative reasons|1|||
23604675|NCT01021748|65943488|FG006|Overall Study|Adverse Event|1|||
23665319|NCT02055820|66162422|FG005|Phase II: Expansion|Lost to Follow-up|0|||
23604676|NCT01021748|65943489|FG007|Overall Study|Adverse Event|0|||
23376823|NCT02832037|65123255|FG003|Overall Study|Administrative reasons|0|||
23665320|NCT02055820|66162423|FG006|Phase II: Expansion|Lost to Follow-up|0|||
23665321|NCT02055820|66162424|FG007|Phase II: Expansion|Lost to Follow-up|0|||
23665322|NCT02055820|66162425|FG008|Phase II: Expansion|Lost to Follow-up|0|||
23665323|NCT02055820|66162426|FG009|Phase II: Expansion|Lost to Follow-up|0|||
23665324|NCT02055820|66162417|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
23665325|NCT02055820|66162418|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
23665326|NCT02055820|66162419|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
23665327|NCT02055820|66162420|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
23665328|NCT02055820|66162421|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
23665329|NCT02055820|66162422|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
23665330|NCT02055820|66162423|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
23665331|NCT02055820|66162424|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
23665332|NCT02055820|66162425|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
23665333|NCT02055820|66162426|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
23665334|NCT00388973|66162427|FG000|Overall Study|Adverse Event|16|||
23376824|NCT02832037|65123256|FG004|Overall Study|Administrative reasons|0|||
23665335|NCT00388973|66162428|FG001|Overall Study|Adverse Event|6|||
23665336|NCT00388973|66162427|FG000|Overall Study|Lack of Efficacy|1|||
23376825|NCT02832037|65123252|FG000|Overall Study|Protocol Violation|3|||
23376826|NCT02832037|65123253|FG001|Overall Study|Protocol Violation|0|||
23489377|NCT02337738|65537039|FG000|Overall Study|Voluntary Withdrawal|10|||
23489378|NCT02337738|65537040|FG001|Overall Study|Voluntary Withdrawal|5|||
23489379|NCT02337738|65537041|FG002|Overall Study|Voluntary Withdrawal|2|||
23489380|NCT02337738|65537039|FG000|Overall Study|Lack of Efficacy|2|||
23489381|NCT02337738|65537040|FG001|Overall Study|Lack of Efficacy|4|||
23489382|NCT02337738|65537041|FG002|Overall Study|Lack of Efficacy|0|||
23489383|NCT02337738|65537039|FG000|Overall Study|Investigator's Judgment|1|||
23489384|NCT02337738|65537040|FG001|Overall Study|Investigator's Judgment|1|||
23489385|NCT02337738|65537041|FG002|Overall Study|Investigator's Judgment|3|||
23489386|NCT01676727|65537042|FG000|Overall Study|Death|18|||
23489387|NCT01676727|65537042|FG000|Overall Study|Withdrawal by Subject|6|||
23489388|NCT01676727|65537042|FG000|Overall Study|Screening failure|5|||
23489389|NCT01676727|65537042|FG000|Overall Study|Not willing to attend 1-year visit|2|||
23489390|NCT01676727|65537042|FG000|Overall Study|Valve explanted|1|||
23489391|NCT00753766|65537046|FG000|Overall Study|Physician Decision|1|||
23489392|NCT00753766|65537047|FG001|Overall Study|Physician Decision|0|||
23489393|NCT01925274|65537048|FG000|Overall Study|Death|1|||
23489394|NCT01925274|65537049|FG001|Overall Study|Death|0|||
23489395|NCT01925274|65537050|FG002|Overall Study|Death|0|||
23489396|NCT01925274|65537048|FG000|Overall Study|Lost to Follow-up|0|||
23489397|NCT01925274|65537049|FG001|Overall Study|Lost to Follow-up|1|||
23489398|NCT01925274|65537050|FG002|Overall Study|Lost to Follow-up|0|||
23489399|NCT01925274|65537048|FG000|Overall Study|Withdrawal by Subject|1|||
23489400|NCT01925274|65537049|FG001|Overall Study|Withdrawal by Subject|2|||
23489401|NCT01925274|65537050|FG002|Overall Study|Withdrawal by Subject|0|||
23489402|NCT01925274|65537048|FG000|Overall Study|Study terminated by sponsor|4|||
23489403|NCT01925274|65537049|FG001|Overall Study|Study terminated by sponsor|0|||
23489404|NCT01925274|65537050|FG002|Overall Study|Study terminated by sponsor|0|||
23489405|NCT01925274|65537048|FG000|Overall Study|Protocol amendment|1|||
23489406|NCT01925274|65537049|FG001|Overall Study|Protocol amendment|3|||
23489407|NCT01925274|65537050|FG002|Overall Study|Protocol amendment|6|||
23489408|NCT04545554|65537051|FG000|Overall Study|Withdrawal by Subject|0|||
23489409|NCT04545554|65537052|FG001|Overall Study|Withdrawal by Subject|0|||
23489410|NCT04545554|65537053|FG002|Overall Study|Withdrawal by Subject|0|||
23489411|NCT04545554|65537054|FG003|Overall Study|Withdrawal by Subject|1|||
23489412|NCT04545554|65537055|FG004|Overall Study|Withdrawal by Subject|0|||
23489413|NCT04545554|65537056|FG005|Overall Study|Withdrawal by Subject|0|||
23489414|NCT03270644|65537057|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
23489415|NCT03270644|65537057|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
23489416|NCT02478372|65537058|FG000|Overall Study|Protocol Violation|12|||
23489417|NCT02478372|65537059|FG001|Overall Study|Protocol Violation|8|||
23489418|NCT02478372|65537058|FG000|Overall Study|Lost to Follow-up|1|||
23489419|NCT02478372|65537059|FG001|Overall Study|Lost to Follow-up|4|||
23489420|NCT02478372|65537058|FG000|Overall Study|Death|0|||
23489421|NCT02478372|65537059|FG001|Overall Study|Death|2|||
23489422|NCT03387683|65537060|FG000|Overall Study|In receipt of disallowed medication|1|||
23489423|NCT03387683|65537061|FG001|Overall Study|In receipt of disallowed medication|0|||
23489424|NCT03387683|65537060|FG000|Overall Study|Did not receive treatment|1|||
23489425|NCT03387683|65537061|FG001|Overall Study|Did not receive treatment|0|||
23489426|NCT01241240|65537065|FG000|Overall Study|Adverse Event|5|||
23376827|NCT02832037|65123254|FG002|Overall Study|Protocol Violation|4|||
23489427|NCT01241240|65537066|FG001|Overall Study|Adverse Event|4|||
23489428|NCT01241240|65537065|FG000|Overall Study|Lost to Follow-up|2|||
23489429|NCT01241240|65537066|FG001|Overall Study|Lost to Follow-up|4|||
23489430|NCT01241240|65537065|FG000|Overall Study|Personal Reasons|1|||
23489431|NCT01241240|65537066|FG001|Overall Study|Personal Reasons|1|||
23489432|NCT01031706|65537067|FG000|Overall Study|Adverse Event|1|||
23489433|NCT01031706|65537068|FG001|Overall Study|Adverse Event|0|||
23489434|NCT01031706|65537067|FG000|Overall Study|Withdrawal by Subject|1|||
23489435|NCT01031706|65537068|FG001|Overall Study|Withdrawal by Subject|1|||
23489436|NCT01193660|65537069|FG000|Overall Study|Withdrawal by Subject|2|||
23489437|NCT01193660|65537070|FG001|Overall Study|Withdrawal by Subject|3|||
23489438|NCT01193660|65537071|FG002|Overall Study|Withdrawal by Subject|1|||
23489439|NCT01193660|65537069|FG000|Overall Study|Death|1|||
23489440|NCT01193660|65537070|FG001|Overall Study|Death|0|||
23489441|NCT01193660|65537071|FG002|Overall Study|Death|0|||
23489442|NCT01193660|65537069|FG000|Overall Study|Physician Decision|1|||
23489443|NCT01193660|65537070|FG001|Overall Study|Physician Decision|0|||
23489444|NCT01193660|65537071|FG002|Overall Study|Physician Decision|1|||
23489445|NCT02413372|65537072|FG000|Treatment|Lost to Follow-up|0|||
23489446|NCT02413372|65537073|FG001|Treatment|Lost to Follow-up|2|||
23489447|NCT02413372|65537074|FG002|Treatment|Lost to Follow-up|1|||
23489448|NCT02413372|65537072|FG000|Treatment|Withdrawal by Subject|1|||
23489449|NCT02413372|65537073|FG001|Treatment|Withdrawal by Subject|0|||
23489450|NCT02413372|65537074|FG002|Treatment|Withdrawal by Subject|0|||
23489451|NCT02413372|65537072|FG000|Follow-up|Lost to Follow-up|1|||
23489452|NCT02413372|65537073|FG001|Follow-up|Lost to Follow-up|1|||
23489453|NCT02413372|65537074|FG002|Follow-up|Lost to Follow-up|0|||
23489454|NCT02413372|65537072|FG000|Follow-up|Subject Withdrew Consent|1|||
23489455|NCT02413372|65537073|FG001|Follow-up|Subject Withdrew Consent|0|||
23489456|NCT02413372|65537074|FG002|Follow-up|Subject Withdrew Consent|1|||
23489457|NCT02413372|65537072|FG000|Follow-up|Subject unable to return for visit|0|||
23489458|NCT02413372|65537073|FG001|Follow-up|Subject unable to return for visit|0|||
23489459|NCT02413372|65537074|FG002|Follow-up|Subject unable to return for visit|1|||
23489460|NCT00586066|65537075|FG000|Overall Study|Lost to Follow-up|6|||
23489461|NCT00586066|65537076|FG001|Overall Study|Lost to Follow-up|3|||
23489462|NCT00586066|65537075|FG000|Overall Study|Lack of Efficacy|5|||
23489463|NCT00586066|65537076|FG001|Overall Study|Lack of Efficacy|3|||
23489464|NCT00586066|65537075|FG000|Overall Study|Adverse Event|2|||
23489465|NCT00586066|65537076|FG001|Overall Study|Adverse Event|2|||
23489466|NCT00586066|65537075|FG000|Overall Study|Physician Decision|1|||
23489467|NCT00586066|65537076|FG001|Overall Study|Physician Decision|0|||
23489468|NCT00586066|65537075|FG000|Overall Study|Withdrawal of consent|4|||
23489469|NCT00586066|65537076|FG001|Overall Study|Withdrawal of consent|2|||
23489470|NCT04795622|65537077|FG000|Overall Study|Adverse Event|1|||
23489471|NCT04795622|65537078|FG001|Overall Study|Adverse Event|0|||
23489472|NCT04795622|65537077|FG000|Overall Study|Withdrawal by Subject|3|||
23489473|NCT04795622|65537078|FG001|Overall Study|Withdrawal by Subject|3|||
23489474|NCT04795622|65537077|FG000|Overall Study|Protocol Violation|0|||
23489475|NCT04795622|65537078|FG001|Overall Study|Protocol Violation|2|||
23489476|NCT04795622|65537077|FG000|Overall Study|Lost to Follow-up|2|||
23489477|NCT04795622|65537078|FG001|Overall Study|Lost to Follow-up|3|||
23489478|NCT04795622|65537077|FG000|Overall Study|Other|7|||
23489479|NCT04795622|65537078|FG001|Overall Study|Other|8|||
23489480|NCT01231347|65537080|FG000|Overall Study|Full Consent withdrawn|19|||
23489481|NCT01231347|65537081|FG001|Overall Study|Full Consent withdrawn|19|||
23489482|NCT01231347|65537082|FG002|Overall Study|Full Consent withdrawn|11|||
23489483|NCT01231347|65537080|FG000|Overall Study|Lost to Follow-up|4|||
23489484|NCT01231347|65537081|FG001|Overall Study|Lost to Follow-up|2|||
23489485|NCT01231347|65537082|FG002|Overall Study|Lost to Follow-up|2|||
23489486|NCT01231347|65537080|FG000|Overall Study|Death|202|||
23489487|NCT01231347|65537081|FG001|Overall Study|Death|210|||
23489488|NCT01231347|65537082|FG002|Overall Study|Death|101|||
23489489|NCT01231347|65537080|FG000|Overall Study|other event|7|||
23489490|NCT01231347|65537081|FG001|Overall Study|other event|9|||
23489491|NCT01231347|65537082|FG002|Overall Study|other event|3|||
23489492|NCT00667602|65537083|FG000|Overall Study|Withdrawal by Subject|4|||
23489493|NCT00667602|65537084|FG001|Overall Study|Withdrawal by Subject|9|||
23489494|NCT00667602|65537085|FG002|Overall Study|Withdrawal by Subject|10|||
23489495|NCT00667602|65537083|FG000|Overall Study|Lost to Follow-up|4|||
23489496|NCT00667602|65537084|FG001|Overall Study|Lost to Follow-up|5|||
23489497|NCT00667602|65537085|FG002|Overall Study|Lost to Follow-up|6|||
23489498|NCT00667602|65537083|FG000|Overall Study|Administrative reason|0|||
23489499|NCT00667602|65537084|FG001|Overall Study|Administrative reason|0|||
23489500|NCT00667602|65537085|FG002|Overall Study|Administrative reason|2|||
23489501|NCT00667602|65537083|FG000|Overall Study|Protocol Violation|0|||
23489502|NCT00667602|65537084|FG001|Overall Study|Protocol Violation|1|||
23489503|NCT00667602|65537085|FG002|Overall Study|Protocol Violation|0|||
23489504|NCT03257371|65537088|FG000|Overall Study|Lost to Follow-up|1|||
23489505|NCT01180634|65537095|FG000|Overall Study|Adverse Event|4|||
23489506|NCT01180634|65537096|FG001|Overall Study|Adverse Event|1|||
23489507|NCT01180634|65537095|FG000|Overall Study|Miscellaneous|2|||
23489508|NCT01180634|65537096|FG001|Overall Study|Miscellaneous|0|||
23489509|NCT01180634|65537095|FG000|Overall Study|Withdrawal by Subject|4|||
23489510|NCT01180634|65537096|FG001|Overall Study|Withdrawal by Subject|0|||
23489511|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
23489512|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
23489513|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
23489514|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
23489515|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
23489516|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
23489517|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
23489518|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
23489519|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
23489520|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
23489521|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
23489522|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
23489523|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
23489524|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
23489525|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
23489526|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
23489527|NCT04251273|65537099|FG000|Overall Study|Lost to Follow-up|331|||
23489528|NCT04251273|65537100|FG001|Overall Study|Lost to Follow-up|290|||
23489529|NCT04447417|65537101|FG000|Overall Study|Withdrawal by Subject|1|||
23489530|NCT04447417|65537102|FG001|Overall Study|Withdrawal by Subject|0|||
23489531|NCT04447417|65537101|FG000|Overall Study|Failure to meet inclusion criteria|1|||
23489532|NCT04447417|65537102|FG001|Overall Study|Failure to meet inclusion criteria|0|||
23489533|NCT04447417|65537101|FG000|Overall Study|Lost to Follow-up|1|||
23489534|NCT04447417|65537102|FG001|Overall Study|Lost to Follow-up|0|||
23489535|NCT01986140|65537103|FG000|Overall Study|Withdrawal by Subject|31|||
23489536|NCT01986140|65537104|FG001|Overall Study|Withdrawal by Subject|25|||
23489537|NCT01986140|65537103|FG000|Overall Study|alternative treatment|1|||
23665337|NCT00388973|66162428|FG001|Overall Study|Lack of Efficacy|12|||
23665338|NCT00388973|66162427|FG000|Overall Study|Protocol Violation|3|||
23376828|NCT02832037|65123255|FG003|Overall Study|Protocol Violation|1|||
23376829|NCT02832037|65123256|FG004|Overall Study|Protocol Violation|2|||
23376830|NCT02832037|65123252|FG000|Overall Study|Lost to Follow-up|2|||
23376831|NCT02832037|65123253|FG001|Overall Study|Lost to Follow-up|0|||
23376832|NCT02832037|65123254|FG002|Overall Study|Lost to Follow-up|3|||
23376833|NCT02832037|65123255|FG003|Overall Study|Lost to Follow-up|0|||
23376834|NCT02832037|65123256|FG004|Overall Study|Lost to Follow-up|5|||
23376835|NCT02832037|65123252|FG000|Overall Study|Withdrawal by Subject|9|||
23376836|NCT02832037|65123253|FG001|Overall Study|Withdrawal by Subject|8|||
23376837|NCT02832037|65123254|FG002|Overall Study|Withdrawal by Subject|0|||
23376838|NCT02832037|65123255|FG003|Overall Study|Withdrawal by Subject|4|||
23376839|NCT02832037|65123256|FG004|Overall Study|Withdrawal by Subject|8|||
23376840|NCT02832037|65123252|FG000|Overall Study|Adverse Event|5|||
23376841|NCT02832037|65123253|FG001|Overall Study|Adverse Event|4|||
23376842|NCT02832037|65123254|FG002|Overall Study|Adverse Event|0|||
23376843|NCT02832037|65123255|FG003|Overall Study|Adverse Event|2|||
23376844|NCT02832037|65123256|FG004|Overall Study|Adverse Event|4|||
23376845|NCT00392223|65123263|FG000|Overall Study|Adverse Event|5|||
23376846|NCT00392223|65123264|FG001|Overall Study|Adverse Event|4|||
23376847|NCT00392223|65123263|FG000|Overall Study|Lost to Follow-up|1|||
23376848|NCT00392223|65123264|FG001|Overall Study|Lost to Follow-up|4|||
23376849|NCT00392223|65123263|FG000|Overall Study|Protocol Violation|0|||
23376850|NCT00392223|65123264|FG001|Overall Study|Protocol Violation|3|||
23376851|NCT00392223|65123263|FG000|Overall Study|Withdrawal by Subject|3|||
23376852|NCT00392223|65123264|FG001|Overall Study|Withdrawal by Subject|2|||
23376853|NCT00726453|65123265|FG000|Primary Enrollment Group|Death|18|||
23376854|NCT00726453|65123266|FG001|Primary Enrollment Group|Death|0|||
23376855|NCT00726453|65123265|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
23376856|NCT00726453|65123266|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
23376857|NCT00726453|65123265|FG000|38 mm Length Group|Death|0|||
23376858|NCT00726453|65123266|FG001|38 mm Length Group|Death|3|||
23376859|NCT00329108|65126433|FG000|Overall Study|Adverse Event|2|||
23376860|NCT00329108|65126434|FG001|Overall Study|Adverse Event|2|||
23376861|NCT00329108|65126433|FG000|Overall Study|Lack of Efficacy|3|||
23489538|NCT01986140|65537104|FG001|Overall Study|alternative treatment|1|||
23489539|NCT01986140|65537103|FG000|Overall Study|found not eligible|3|||
23376862|NCT00329108|65126434|FG001|Overall Study|Lack of Efficacy|3|||
23376863|NCT00329108|65126433|FG000|Overall Study|Withdrawal by Subject|0|||
23376864|NCT00329108|65126434|FG001|Overall Study|Withdrawal by Subject|2|||
23376865|NCT00329108|65126433|FG000|Overall Study|symptomatic deterioration|1|||
23376866|NCT00329108|65126434|FG001|Overall Study|symptomatic deterioration|1|||
23376867|NCT00329108|65126433|FG000|Overall Study|Subject no longer willing to participate|2|||
23376868|NCT00329108|65126434|FG001|Overall Study|Subject no longer willing to participate|2|||
23665339|NCT00388973|66162428|FG001|Overall Study|Protocol Violation|0|||
23665340|NCT00388973|66162427|FG000|Overall Study|Withdrawal by Subject|14|||
23665341|NCT00388973|66162428|FG001|Overall Study|Withdrawal by Subject|17|||
23604677|NCT01021748|65943490|FG008|Overall Study|Adverse Event|7|||
23604678|NCT01021748|65943482|FG000|Overall Study|Physician Decision|1|||
23604679|NCT01021748|65943483|FG001|Overall Study|Physician Decision|0|||
23604680|NCT01021748|65943484|FG002|Overall Study|Physician Decision|1|||
23604681|NCT01021748|65943485|FG003|Overall Study|Physician Decision|1|||
23604682|NCT01021748|65943486|FG004|Overall Study|Physician Decision|0|||
23604683|NCT01021748|65943487|FG005|Overall Study|Physician Decision|0|||
23604684|NCT01021748|65943488|FG006|Overall Study|Physician Decision|1|||
23604685|NCT01021748|65943489|FG007|Overall Study|Physician Decision|1|||
23604686|NCT01021748|65943490|FG008|Overall Study|Physician Decision|2|||
23604687|NCT01021748|65943482|FG000|Overall Study|Progressive Disease|3|||
23604688|NCT01021748|65943483|FG001|Overall Study|Progressive Disease|3|||
23604689|NCT01021748|65943484|FG002|Overall Study|Progressive Disease|4|||
23604690|NCT01021748|65943485|FG003|Overall Study|Progressive Disease|6|||
23604691|NCT01021748|65943486|FG004|Overall Study|Progressive Disease|7|||
23604692|NCT01021748|65943487|FG005|Overall Study|Progressive Disease|3|||
23604693|NCT01021748|65943488|FG006|Overall Study|Progressive Disease|0|||
23604694|NCT01021748|65943489|FG007|Overall Study|Progressive Disease|5|||
23604695|NCT01021748|65943490|FG008|Overall Study|Progressive Disease|6|||
23604696|NCT01021748|65943482|FG000|Overall Study|Withdrawal by Subject|0|||
23604697|NCT01021748|65943483|FG001|Overall Study|Withdrawal by Subject|0|||
23604698|NCT01021748|65943484|FG002|Overall Study|Withdrawal by Subject|0|||
23604699|NCT01021748|65943485|FG003|Overall Study|Withdrawal by Subject|0|||
23604700|NCT01021748|65943486|FG004|Overall Study|Withdrawal by Subject|0|||
23604701|NCT01021748|65943487|FG005|Overall Study|Withdrawal by Subject|0|||
23604702|NCT01021748|65943488|FG006|Overall Study|Withdrawal by Subject|1|||
23604703|NCT01021748|65943489|FG007|Overall Study|Withdrawal by Subject|0|||
23604704|NCT01021748|65943490|FG008|Overall Study|Withdrawal by Subject|1|||
23604705|NCT01021748|65943482|FG000|Overall Study|Not Treated|0|||
23604706|NCT01021748|65943483|FG001|Overall Study|Not Treated|1|||
23604707|NCT01021748|65943484|FG002|Overall Study|Not Treated|0|||
23604708|NCT01021748|65943485|FG003|Overall Study|Not Treated|0|||
23604709|NCT01021748|65943486|FG004|Overall Study|Not Treated|0|||
23604710|NCT01021748|65943487|FG005|Overall Study|Not Treated|0|||
23604711|NCT01021748|65943488|FG006|Overall Study|Not Treated|0|||
23604712|NCT01021748|65943489|FG007|Overall Study|Not Treated|0|||
23604713|NCT01021748|65943490|FG008|Overall Study|Not Treated|0|||
23604714|NCT03200574|65943491|FG000|Overall Study|Death|4|||
23604715|NCT03200574|65943491|FG000|Overall Study|Withdrawal by Subject|8|||
23604716|NCT03200574|65943491|FG000|Overall Study|Long-Term need for anticoagulation|1|||
23604717|NCT03200574|65943491|FG000|Overall Study|Relocation|2|||
23604718|NCT03200574|65943491|FG000|Overall Study|Lost to Follow-up|2|||
23604719|NCT03737110|65943496|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
23604720|NCT03737110|65943497|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
23604721|NCT03737110|65943498|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
23604722|NCT03737110|65943499|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
23604723|NCT03737110|65943500|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
23604724|NCT03737110|65943501|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
23604725|NCT03737110|65943496|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
23604726|NCT03737110|65943497|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604727|NCT03737110|65943498|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604728|NCT03737110|65943499|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604729|NCT03737110|65943500|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604730|NCT03737110|65943501|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604731|NCT03737110|65943496|FG000|Run-in (RI) Period|Adverse Event|4|||
23604732|NCT03737110|65943497|FG001|Run-in (RI) Period|Adverse Event|0|||
23604733|NCT03737110|65943498|FG002|Run-in (RI) Period|Adverse Event|0|||
23604734|NCT03737110|65943499|FG003|Run-in (RI) Period|Adverse Event|0|||
23604735|NCT03737110|65943500|FG004|Run-in (RI) Period|Adverse Event|0|||
23604736|NCT03737110|65943501|FG005|Run-in (RI) Period|Adverse Event|0|||
23604737|NCT03737110|65943496|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604738|NCT03737110|65943497|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
23604739|NCT03737110|65943498|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604740|NCT03737110|65943499|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604741|NCT03737110|65943500|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604742|NCT03737110|65943501|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604743|NCT03737110|65943496|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604744|NCT03737110|65943497|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604745|NCT03737110|65943498|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
23604746|NCT03737110|65943499|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604747|NCT03737110|65943500|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604748|NCT03737110|65943501|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23665342|NCT00388973|66162427|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
23665343|NCT00388973|66162428|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
23665344|NCT00388973|66162427|FG000|Overall Study|Did not complete 61 days of treatment|5|||
23665345|NCT00388973|66162428|FG001|Overall Study|Did not complete 61 days of treatment|4|||
23665346|NCT00388973|66162427|FG000|Overall Study|Left region|0|||
23665347|NCT00388973|66162428|FG001|Overall Study|Left region|1|||
23665348|NCT00388973|66162427|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
23665349|NCT00388973|66162428|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
23665350|NCT03159091|66162429|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
23665351|NCT03159091|66162430|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
23665352|NCT03159091|66162429|FG000|Overall Study|Patient has taken no dose of study drug|0|||
23665353|NCT03159091|66162430|FG001|Overall Study|Patient has taken no dose of study drug|1|||
23489540|NCT01986140|65537104|FG001|Overall Study|found not eligible|0|||
23489541|NCT01986140|65537103|FG000|Overall Study|Adverse Event|0|||
23489542|NCT01986140|65537104|FG001|Overall Study|Adverse Event|1|||
23489543|NCT01986140|65537103|FG000|Overall Study|progression disease|0|||
23489544|NCT01986140|65537104|FG001|Overall Study|progression disease|1|||
23489545|NCT05064735|65537107|FG000|Overall Study|Withdrawal by Subject|7|||
23489546|NCT05064735|65537108|FG001|Overall Study|Withdrawal by Subject|8|||
23489547|NCT05064735|65537107|FG000|Overall Study|Lost to Follow-up|7|||
23489548|NCT05064735|65537108|FG001|Overall Study|Lost to Follow-up|2|||
23489549|NCT05064735|65537107|FG000|Overall Study|Physician Decision|2|||
23489550|NCT05064735|65537108|FG001|Overall Study|Physician Decision|1|||
23489551|NCT05064735|65537107|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
23489552|NCT05064735|65537108|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
23489553|NCT05064735|65537107|FG000|Overall Study|Site Closure|7|||
23489554|NCT05064735|65537108|FG001|Overall Study|Site Closure|2|||
23665354|NCT03882970|66162433|FG000|Overall Study|Adverse Event|5|||
23665355|NCT03882970|66162434|FG001|Overall Study|Adverse Event|7|||
23665356|NCT03882970|66162435|FG002|Overall Study|Adverse Event|3|||
23665357|NCT03882970|66162436|FG003|Overall Study|Adverse Event|1|||
23665358|NCT03882970|66162433|FG000|Overall Study|Death|1|||
23665359|NCT03882970|66162434|FG001|Overall Study|Death|2|||
23665360|NCT03882970|66162435|FG002|Overall Study|Death|1|||
23665361|NCT03882970|66162436|FG003|Overall Study|Death|1|||
23665362|NCT03882970|66162433|FG000|Overall Study|Lost to Follow-up|8|||
23665363|NCT03882970|66162434|FG001|Overall Study|Lost to Follow-up|9|||
23665364|NCT03882970|66162435|FG002|Overall Study|Lost to Follow-up|5|||
23665365|NCT03882970|66162436|FG003|Overall Study|Lost to Follow-up|5|||
23665366|NCT03882970|66162433|FG000|Overall Study|Physician Decision|0|||
23665367|NCT03882970|66162434|FG001|Overall Study|Physician Decision|2|||
23665368|NCT03882970|66162435|FG002|Overall Study|Physician Decision|2|||
23665369|NCT03882970|66162436|FG003|Overall Study|Physician Decision|2|||
23665370|NCT03882970|66162433|FG000|Overall Study|Protocol Violation|2|||
23665371|NCT03882970|66162434|FG001|Overall Study|Protocol Violation|0|||
23665372|NCT03882970|66162435|FG002|Overall Study|Protocol Violation|0|||
23665373|NCT03882970|66162436|FG003|Overall Study|Protocol Violation|0|||
23665374|NCT03882970|66162433|FG000|Overall Study|Withdrawal by Subject|8|||
23665375|NCT03882970|66162434|FG001|Overall Study|Withdrawal by Subject|17|||
23665376|NCT03882970|66162435|FG002|Overall Study|Withdrawal by Subject|7|||
23665377|NCT03882970|66162436|FG003|Overall Study|Withdrawal by Subject|22|||
23665378|NCT03882970|66162433|FG000|Overall Study|Personal Reason|2|||
23665379|NCT03882970|66162434|FG001|Overall Study|Personal Reason|3|||
23665380|NCT03882970|66162435|FG002|Overall Study|Personal Reason|1|||
23665381|NCT03882970|66162436|FG003|Overall Study|Personal Reason|3|||
23665382|NCT04649255|66162437|FG000|Overall Study|Death|9|||
23665383|NCT04649255|66162437|FG000|Overall Study|Withdrawal by Subject|1|||
23665384|NCT04194528|66162438|FG000|Overall Study|Adverse Event|1|||
23665385|NCT02164929|66162439|FG000|Overall Study|Converted to open procedure|1|||
23665386|NCT02164929|66162440|FG001|Overall Study|Converted to open procedure|0|||
23665387|NCT02164929|66162441|FG002|Overall Study|Converted to open procedure|0|||
23376869|NCT00329108|65126433|FG000|Overall Study|study terminated by sponsor|1|||
23376870|NCT00329108|65126434|FG001|Overall Study|study terminated by sponsor|0|||
23665388|NCT02164929|66162442|FG003|Overall Study|Converted to open procedure|2|||
23665389|NCT02164929|66162439|FG000|Overall Study|Failed regional block|0|||
23665390|NCT02164929|66162440|FG001|Overall Study|Failed regional block|0|||
23376871|NCT00329108|65126433|FG000|Overall Study|withdrew patient after SAE resolved|1|||
23376872|NCT00329108|65126434|FG001|Overall Study|withdrew patient after SAE resolved|0|||
23376873|NCT00329108|65126433|FG000|Overall Study|Protocol Violation|0|||
23489555|NCT01090973|65537112|FG000|Overall Study|Disease progression|1|||
23489556|NCT02367131|65537113|FG000|Overall Study|Adverse Event|64|||
23489557|NCT02367131|65537113|FG000|Overall Study|No visit since the first visit|3|||
23489558|NCT02367131|65537113|FG000|Overall Study|Request by patient|53|||
23665391|NCT02164929|66162441|FG002|Overall Study|Failed regional block|1|||
23665392|NCT02164929|66162442|FG003|Overall Study|Failed regional block|0|||
23665393|NCT03921424|66162443|FG000|Overall Study|Lost to Follow-up|0|||
23489559|NCT02367131|65537113|FG000|Overall Study|Improvement/remission|2|||
23489560|NCT02367131|65537113|FG000|Overall Study|No change/progressive disease|78|||
23489561|NCT02367131|65537113|FG000|Overall Study|Other than stated above|20|||
23489562|NCT02367131|65537113|FG000|Overall Study|Not treated|2|||
23489563|NCT00386607|65537114|FG000|Core|Adverse Event|40|||
23489564|NCT00386607|65537115|FG001|Core|Adverse Event|0|||
23489565|NCT00386607|65537114|FG000|Core|Abnormal laboratory value(s)|3|||
23489566|NCT00386607|65537115|FG001|Core|Abnormal laboratory value(s)|0|||
23489567|NCT00386607|65537114|FG000|Core|Unsatisfactory therapeutic effect|23|||
23489568|NCT00386607|65537115|FG001|Core|Unsatisfactory therapeutic effect|0|||
23489569|NCT00386607|65537114|FG000|Core|Condition no longer requires study drug|4|||
23489570|NCT00386607|65537115|FG001|Core|Condition no longer requires study drug|0|||
23489571|NCT00386607|65537114|FG000|Core|Patient withdrew consent|15|||
23489572|NCT00386607|65537115|FG001|Core|Patient withdrew consent|0|||
23489573|NCT00386607|65537114|FG000|Core|Lost to Follow-up|23|||
23489574|NCT00386607|65537115|FG001|Core|Lost to Follow-up|0|||
23489575|NCT00386607|65537114|FG000|Core|Administrative problems|1|||
23489576|NCT00386607|65537115|FG001|Core|Administrative problems|0|||
23489577|NCT00386607|65537114|FG000|Core|Protocol Deviation|6|||
23489578|NCT00386607|65537115|FG001|Core|Protocol Deviation|0|||
23489579|NCT00386607|65537114|FG000|Extension|Adverse Event|0|||
23489580|NCT00386607|65537115|FG001|Extension|Adverse Event|6|||
23489581|NCT00386607|65537114|FG000|Extension|Abnormal laboratory value(s)|0|||
23489582|NCT00386607|65537115|FG001|Extension|Abnormal laboratory value(s)|1|||
23489583|NCT00386607|65537114|FG000|Extension|Administrative problems|0|||
23489584|NCT00386607|65537115|FG001|Extension|Administrative problems|1|||
23489585|NCT00386607|65537114|FG000|Extension|Lost to Follow-up|0|||
23489586|NCT00386607|65537115|FG001|Extension|Lost to Follow-up|3|||
23665394|NCT03921424|66162444|FG001|Overall Study|Lost to Follow-up|1|||
23665395|NCT03921424|66162443|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23665396|NCT03921424|66162444|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23665397|NCT02159729|66162448|FG000|Overall Study|Adverse Event|0|||
23665398|NCT02159729|66162449|FG001|Overall Study|Adverse Event|1|||
23665399|NCT02159729|66162448|FG000|Overall Study|Subject's Request|13|||
23665400|NCT02159729|66162449|FG001|Overall Study|Subject's Request|10|||
23665401|NCT02159729|66162448|FG000|Overall Study|Lost to Follow-up|24|||
23665402|NCT02159729|66162449|FG001|Overall Study|Lost to Follow-up|9|||
23665403|NCT02159729|66162448|FG000|Overall Study|Non compliance|2|||
23665404|NCT02159729|66162449|FG001|Overall Study|Non compliance|0|||
23665405|NCT02159729|66162448|FG000|Overall Study|Other Unspecified|3|||
23665406|NCT02159729|66162449|FG001|Overall Study|Other Unspecified|1|||
23665407|NCT02573870|66162450|FG000|Overall Study|Adverse Event|0|||
23665408|NCT02573870|66162451|FG001|Overall Study|Adverse Event|2|||
23665409|NCT02573870|66162450|FG000|Overall Study|Lack of Efficacy|0|||
23665410|NCT02573870|66162451|FG001|Overall Study|Lack of Efficacy|1|||
23665411|NCT02573870|66162450|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
23665412|NCT02573870|66162451|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
23665413|NCT02573870|66162450|FG000|Overall Study|Lost to Follow-up|0|||
23665414|NCT02573870|66162451|FG001|Overall Study|Lost to Follow-up|1|||
23665415|NCT02573870|66162450|FG000|Overall Study|Other: Fail to Meet Visit|0|||
23665416|NCT02573870|66162451|FG001|Overall Study|Other: Fail to Meet Visit|2|||
23665417|NCT02289742|66162452|FG000|First Wear Period|Adverse event prior to treatment|0|||
23665418|NCT02289742|66162453|FG001|First Wear Period|Adverse event prior to treatment|1|||
23665419|NCT02289742|66162454|FG002|First Wear Period|Adverse event prior to treatment|0|||
23665420|NCT02289742|66162455|FG003|First Wear Period|Adverse event prior to treatment|0|||
23665421|NCT02289742|66162452|FG000|First Wear Period|Adverse Event|0|||
23665422|NCT02289742|66162453|FG001|First Wear Period|Adverse Event|0|||
23665423|NCT02289742|66162454|FG002|First Wear Period|Adverse Event|1|||
23665424|NCT02289742|66162455|FG003|First Wear Period|Adverse Event|0|||
23665425|NCT02289742|66162452|FG000|First Wear Period|Other prior to treatment|0|||
23665426|NCT02289742|66162453|FG001|First Wear Period|Other prior to treatment|0|||
23665427|NCT02289742|66162454|FG002|First Wear Period|Other prior to treatment|0|||
23665428|NCT02289742|66162455|FG003|First Wear Period|Other prior to treatment|1|||
23665429|NCT02289742|66162452|FG000|Third Wear Period|Adverse Event|0|||
23665430|NCT02289742|66162453|FG001|Third Wear Period|Adverse Event|1|||
23665431|NCT02289742|66162454|FG002|Third Wear Period|Adverse Event|0|||
23665432|NCT02289742|66162455|FG003|Third Wear Period|Adverse Event|0|||
23665433|NCT02289742|66162452|FG000|Third Wear Period|Reason not given|0|||
23665434|NCT02289742|66162453|FG001|Third Wear Period|Reason not given|0|||
23665435|NCT02289742|66162454|FG002|Third Wear Period|Reason not given|0|||
23665436|NCT02289742|66162455|FG003|Third Wear Period|Reason not given|1|||
23665437|NCT03803059|66162459|FG000|Overall Study|Protocol Violation|2|||
23665438|NCT03803059|66162459|FG000|Overall Study|Lost to Follow-up|1|||
23665439|NCT01508702|66162467|FG000|Overall Study|Adverse Event|7|||
23665440|NCT01508702|66162468|FG001|Overall Study|Adverse Event|3|||
23665441|NCT01508702|66162467|FG000|Overall Study|Gout flare|2|||
23665442|NCT01508702|66162468|FG001|Overall Study|Gout flare|0|||
23665443|NCT01508702|66162467|FG000|Overall Study|Protocol Violation|2|||
23665444|NCT01508702|66162468|FG001|Overall Study|Protocol Violation|1|||
23665445|NCT01508702|66162467|FG000|Overall Study|Lost to Follow-up|1|||
23665446|NCT01508702|66162468|FG001|Overall Study|Lost to Follow-up|2|||
23665447|NCT01508702|66162467|FG000|Overall Study|Withdrawal by Subject|11|||
23665448|NCT01508702|66162468|FG001|Overall Study|Withdrawal by Subject|7|||
23665449|NCT00808236|66162469|FG000|Overall Study|Was not resuscitated|50|||
23665450|NCT00808236|66162470|FG001|Overall Study|Was not resuscitated|56|||
23665451|NCT00808236|66162469|FG000|Overall Study|Pre-defined exclusion|13|||
23665452|NCT00808236|66162470|FG001|Overall Study|Pre-defined exclusion|3|||
23665453|NCT00808236|66162469|FG000|Overall Study|Lost to Follow-up|1|||
23665454|NCT00808236|66162470|FG001|Overall Study|Lost to Follow-up|1|||
23665455|NCT00808236|66162469|FG000|Overall Study|Physician Decision|0|||
23665456|NCT00808236|66162470|FG001|Overall Study|Physician Decision|1|||
23665457|NCT00808236|66162469|FG000|Overall Study|Death|18|||
23665458|NCT00808236|66162470|FG001|Overall Study|Death|30|||
23665459|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
23665460|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
23665461|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23376874|NCT00329108|65126434|FG001|Overall Study|Protocol Violation|2|||
23376875|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
23665462|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23665463|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
23665464|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23665465|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
23665466|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23376876|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
23376877|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Death|28|||
23376878|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Death|29|||
23376879|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
23376880|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
23376881|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Other|30|||
23376882|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Other|20|||
23376883|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
23376884|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
23376885|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
23376886|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
23376887|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
23376888|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
23376889|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
23376890|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
23376891|NCT02115386|65126441|FG000|Overall Study|Protocol Violation|1|||
23376892|NCT02115386|65126441|FG000|Overall Study|Administrative - trial was terminated|6|||
23376893|NCT01847209|65126445|FG000|Overall Study|Withdrawal by Subject|1|||
23376894|NCT01847209|65126445|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
23376895|NCT00676143|65126448|FG000|Overall Study|Adverse Event|34|||
23376896|NCT00676143|65126449|FG001|Overall Study|Adverse Event|60|||
23376897|NCT00676143|65126448|FG000|Overall Study|Death|4|||
23376898|NCT00676143|65126449|FG001|Overall Study|Death|4|||
23376899|NCT00676143|65126448|FG000|Overall Study|Lack of Efficacy|0|||
23376900|NCT00676143|65126449|FG001|Overall Study|Lack of Efficacy|6|||
23376901|NCT00676143|65126448|FG000|Overall Study|Lost to Follow-up|0|||
23376902|NCT00676143|65126449|FG001|Overall Study|Lost to Follow-up|13|||
23376903|NCT00676143|65126448|FG000|Overall Study|Physician Decision|5|||
23376904|NCT00676143|65126449|FG001|Overall Study|Physician Decision|8|||
23376905|NCT00676143|65126448|FG000|Overall Study|Protocol Violation|4|||
23376906|NCT00676143|65126449|FG001|Overall Study|Protocol Violation|8|||
23376907|NCT00676143|65126448|FG000|Overall Study|Withdrawal by Subject|24|||
23376908|NCT00676143|65126449|FG001|Overall Study|Withdrawal by Subject|42|||
23376909|NCT00676143|65126448|FG000|Overall Study|Discontinuation of study by sponsor|65|||
23376910|NCT00676143|65126449|FG001|Overall Study|Discontinuation of study by sponsor|88|||
23376911|NCT00676143|65126448|FG000|Overall Study|Failed to return|2|||
23376912|NCT00676143|65126449|FG001|Overall Study|Failed to return|1|||
23376913|NCT00676143|65126448|FG000|Overall Study|Loss of caregiver|5|||
23376914|NCT00676143|65126449|FG001|Overall Study|Loss of caregiver|3|||
23376915|NCT00676143|65126448|FG000|Overall Study|Other|11|||
23376916|NCT00676143|65126449|FG001|Overall Study|Other|20|||
23376917|NCT00676143|65126448|FG000|Overall Study|Participant participation unknown|1|||
23376918|NCT00676143|65126449|FG001|Overall Study|Participant participation unknown|4|||
23376919|NCT00676143|65126448|FG000|Overall Study|Vasogenic edema recurrence|1|||
23376920|NCT00676143|65126449|FG001|Overall Study|Vasogenic edema recurrence|3|||
23489587|NCT00386607|65537114|FG000|Extension|Patient withdrew consent|0|||
23489588|NCT00386607|65537115|FG001|Extension|Patient withdrew consent|5|||
23489589|NCT00386607|65537114|FG000|Extension|Unsatisfactory therapeutic effect|0|||
23489590|NCT00386607|65537115|FG001|Extension|Unsatisfactory therapeutic effect|1|||
23489591|NCT00937391|65537116|FG000|Stage 2|Withdrawal by Subject|1|||
23489592|NCT01822496|65537119|FG000|Overall Study|Protocol Violation|2|||
23489593|NCT01822496|65537120|FG001|Overall Study|Protocol Violation|2|||
23489594|NCT01822496|65537121|FG002|Overall Study|Protocol Violation|0|||
23489595|NCT01822496|65537122|FG003|Overall Study|Protocol Violation|1|||
23489596|NCT01822496|65537119|FG000|Overall Study|Withdrawal by Subject|0|||
23489597|NCT01822496|65537120|FG001|Overall Study|Withdrawal by Subject|0|||
23489598|NCT01822496|65537121|FG002|Overall Study|Withdrawal by Subject|0|||
23489599|NCT01822496|65537122|FG003|Overall Study|Withdrawal by Subject|3|||
23489600|NCT01710046|65537124|FG000|Overall Study|Lost to Follow-up|1|||
23489601|NCT01710046|65537125|FG001|Overall Study|Lost to Follow-up|0|||
23489602|NCT00464269|65537135|FG000|Overall Study|Lack of Efficacy|1|||
23489603|NCT00464269|65537136|FG001|Overall Study|Lack of Efficacy|0|||
23489604|NCT00464269|65537137|FG002|Overall Study|Lack of Efficacy|0|||
23489605|NCT00464269|65537138|FG003|Overall Study|Lack of Efficacy|0|||
23489606|NCT00464269|65537135|FG000|Overall Study|Lost to Follow-up|0|||
23489607|NCT00464269|65537136|FG001|Overall Study|Lost to Follow-up|4|||
23489608|NCT00464269|65537137|FG002|Overall Study|Lost to Follow-up|0|||
23489609|NCT00464269|65537138|FG003|Overall Study|Lost to Follow-up|1|||
23489610|NCT00464269|65537135|FG000|Overall Study|Withdrawal by Subject|0|||
23489611|NCT00464269|65537136|FG001|Overall Study|Withdrawal by Subject|2|||
23489612|NCT00464269|65537137|FG002|Overall Study|Withdrawal by Subject|1|||
23489613|NCT00464269|65537138|FG003|Overall Study|Withdrawal by Subject|1|||
23489614|NCT00464269|65537135|FG000|Overall Study|Other reason|3|||
23489615|NCT00464269|65537136|FG001|Overall Study|Other reason|3|||
23489616|NCT00464269|65537137|FG002|Overall Study|Other reason|1|||
23489617|NCT00464269|65537138|FG003|Overall Study|Other reason|1|||
23489618|NCT00464269|65537135|FG000|Overall Study|AE, serious fatal|0|||
23489619|NCT00464269|65537136|FG001|Overall Study|AE, serious fatal|0|||
23489620|NCT00464269|65537137|FG002|Overall Study|AE, serious fatal|1|||
23489621|NCT00464269|65537138|FG003|Overall Study|AE, serious fatal|1|||
23489622|NCT00464269|65537135|FG000|Overall Study|SAE, non-fatal|0|||
23489623|NCT00464269|65537136|FG001|Overall Study|SAE, non-fatal|0|||
23489624|NCT00464269|65537137|FG002|Overall Study|SAE, non-fatal|0|||
23489625|NCT00464269|65537138|FG003|Overall Study|SAE, non-fatal|1|||
23489626|NCT00464269|65537135|FG000|Overall Study|AE, non-serious non-fatal|2|||
23489627|NCT00464269|65537136|FG001|Overall Study|AE, non-serious non-fatal|8|||
23489628|NCT00464269|65537137|FG002|Overall Study|AE, non-serious non-fatal|3|||
23489629|NCT00464269|65537138|FG003|Overall Study|AE, non-serious non-fatal|4|||
23489630|NCT00464269|65537135|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489631|NCT00464269|65537136|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489632|NCT00464269|65537137|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23489633|NCT00464269|65537138|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489634|NCT00771316|65537139|FG000|Overall Study|Adverse Event|0|||
23489635|NCT00771316|65537140|FG001|Overall Study|Adverse Event|1|||
23489636|NCT00771316|65537139|FG000|Overall Study|Patient withdrew consent|1|||
23489637|NCT00771316|65537140|FG001|Overall Study|Patient withdrew consent|0|||
23489638|NCT00771316|65537139|FG000|Overall Study|Discontinued due to early termination|1|||
23376921|NCT00548327|65126450|FG000|Overall Study|Adverse Event|0|||
23489639|NCT00771316|65537140|FG001|Overall Study|Discontinued due to early termination|0|||
23489640|NCT03911713|65537149|FG000|Overall Study|Lost to Follow-up|0|||
23489641|NCT03911713|65537150|FG001|Overall Study|Lost to Follow-up|2|||
23489642|NCT03911713|65537151|FG002|Overall Study|Lost to Follow-up|0|||
23489643|NCT03911713|65537152|FG003|Overall Study|Lost to Follow-up|0|||
23489644|NCT03911713|65537153|FG004|Overall Study|Lost to Follow-up|0|||
23489645|NCT03911713|65537149|FG000|Overall Study|Other|0|||
23489646|NCT03911713|65537150|FG001|Overall Study|Other|0|||
23489647|NCT03911713|65537151|FG002|Overall Study|Other|0|||
23489648|NCT03911713|65537152|FG003|Overall Study|Other|1|||
23489649|NCT03911713|65537153|FG004|Overall Study|Other|0|||
23489650|NCT03911713|65537149|FG000|Overall Study|Randomized, Never Dosed|1|||
23489651|NCT03911713|65537150|FG001|Overall Study|Randomized, Never Dosed|0|||
23489652|NCT03911713|65537151|FG002|Overall Study|Randomized, Never Dosed|0|||
23489653|NCT03911713|65537152|FG003|Overall Study|Randomized, Never Dosed|1|||
23489654|NCT03911713|65537153|FG004|Overall Study|Randomized, Never Dosed|0|||
23489655|NCT01461980|65537154|FG000|Overall Study|Other|9|||
23489656|NCT01461980|65537155|FG001|Overall Study|Other|8|||
23489657|NCT01461980|65537156|FG002|Overall Study|Other|6|||
23604749|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23376922|NCT00548327|65126451|FG001|Overall Study|Adverse Event|1|||
23376923|NCT01750346|65126454|FG000|Overall Study|Adverse Event|1|||
23376924|NCT01750346|65126455|FG001|Overall Study|Adverse Event|0|||
23376925|NCT01750346|65126456|FG002|Overall Study|Adverse Event|0|||
23376926|NCT02364557|65126457|FG000|Overall Study|Protocol Violation|3|||
23376927|NCT02364557|65126458|FG001|Overall Study|Protocol Violation|1|||
23376928|NCT00557466|65126459|FG000|Overall Study|Adverse Event|3|||
23376929|NCT00557466|65126460|FG001|Overall Study|Adverse Event|1|||
23376930|NCT00557466|65126461|FG002|Overall Study|Adverse Event|4|||
23376931|NCT00557466|65126462|FG003|Overall Study|Adverse Event|1|||
23376932|NCT00557466|65126463|FG004|Overall Study|Adverse Event|2|||
23376933|NCT00557466|65126464|FG005|Overall Study|Adverse Event|4|||
23376934|NCT00557466|65126459|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23376935|NCT00557466|65126460|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23376936|NCT00557466|65126461|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23376937|NCT00557466|65126462|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23376938|NCT00557466|65126463|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23376939|NCT00557466|65126464|FG005|Overall Study|Abnormal laboratory value(s)|0|||
23376940|NCT00557466|65126459|FG000|Overall Study|Protocol deviation|0|||
23376941|NCT00557466|65126460|FG001|Overall Study|Protocol deviation|1|||
23376942|NCT00557466|65126461|FG002|Overall Study|Protocol deviation|0|||
23376943|NCT00557466|65126462|FG003|Overall Study|Protocol deviation|2|||
23376944|NCT00557466|65126463|FG004|Overall Study|Protocol deviation|0|||
23376945|NCT00557466|65126464|FG005|Overall Study|Protocol deviation|0|||
23376946|NCT00557466|65126459|FG000|Overall Study|Subject withdrew consent|0|||
23376947|NCT00557466|65126460|FG001|Overall Study|Subject withdrew consent|0|||
23376948|NCT00557466|65126461|FG002|Overall Study|Subject withdrew consent|0|||
23376949|NCT00557466|65126462|FG003|Overall Study|Subject withdrew consent|0|||
23376950|NCT00557466|65126463|FG004|Overall Study|Subject withdrew consent|1|||
23376951|NCT00557466|65126464|FG005|Overall Study|Subject withdrew consent|2|||
23376952|NCT00557466|65126459|FG000|Overall Study|Administrative problems|0|||
23376953|NCT00557466|65126460|FG001|Overall Study|Administrative problems|1|||
23604750|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23665467|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
23376954|NCT00557466|65126461|FG002|Overall Study|Administrative problems|1|||
23376955|NCT00557466|65126462|FG003|Overall Study|Administrative problems|0|||
23376956|NCT00557466|65126463|FG004|Overall Study|Administrative problems|0|||
23665468|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23376957|NCT00557466|65126464|FG005|Overall Study|Administrative problems|0|||
23376958|NCT00557466|65126459|FG000|Overall Study|Abnormal test procedure results|0|||
23376959|NCT00557466|65126460|FG001|Overall Study|Abnormal test procedure results|0|||
23489658|NCT01461980|65537154|FG000|Overall Study|Medication error|7|||
23489659|NCT01461980|65537155|FG001|Overall Study|Medication error|5|||
23489660|NCT01461980|65537156|FG002|Overall Study|Medication error|6|||
23489661|NCT01461980|65537154|FG000|Overall Study|Adverse Event|12|||
23489662|NCT01461980|65537155|FG001|Overall Study|Adverse Event|5|||
23489663|NCT01461980|65537156|FG002|Overall Study|Adverse Event|6|||
23489664|NCT01461980|65537154|FG000|Overall Study|Protocol Violation|12|||
23489665|NCT01461980|65537155|FG001|Overall Study|Protocol Violation|19|||
23489666|NCT01461980|65537156|FG002|Overall Study|Protocol Violation|16|||
23489667|NCT01461980|65537154|FG000|Overall Study|No longer meets eligibility criteria|18|||
23489668|NCT01461980|65537155|FG001|Overall Study|No longer meets eligibility criteria|9|||
23489669|NCT01461980|65537156|FG002|Overall Study|No longer meets eligibility criteria|19|||
23489670|NCT01461980|65537154|FG000|Overall Study|Lost to Follow-up|52|||
23489671|NCT01461980|65537155|FG001|Overall Study|Lost to Follow-up|53|||
23489672|NCT01461980|65537156|FG002|Overall Study|Lost to Follow-up|51|||
23489673|NCT01461980|65537154|FG000|Overall Study|No longer willing to participate|52|||
23604751|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23604752|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
23604753|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23604754|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23604755|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604756|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604757|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604758|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
23604759|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604760|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
23604761|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604762|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604763|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604764|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604765|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
23604766|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604767|NCT02052440|65943502|FG000|Overall Study|Withdrawal by Subject|0|||
23604768|NCT02052440|65943503|FG001|Overall Study|Withdrawal by Subject|1|||
23604769|NCT01159600|65943504|FG000|Overall Study|Not treated|0|||
23604770|NCT01159600|65943505|FG001|Overall Study|Not treated|0|||
23376960|NCT00557466|65126461|FG002|Overall Study|Abnormal test procedure results|1|||
23376961|NCT00557466|65126462|FG003|Overall Study|Abnormal test procedure results|0|||
23376962|NCT00557466|65126463|FG004|Overall Study|Abnormal test procedure results|0|||
23376963|NCT00557466|65126464|FG005|Overall Study|Abnormal test procedure results|0|||
23376964|NCT00557466|65126459|FG000|Overall Study|Lost to Follow-up|0|||
23376965|NCT00557466|65126460|FG001|Overall Study|Lost to Follow-up|0|||
23376966|NCT00557466|65126461|FG002|Overall Study|Lost to Follow-up|0|||
23376967|NCT00557466|65126462|FG003|Overall Study|Lost to Follow-up|1|||
23376968|NCT00557466|65126463|FG004|Overall Study|Lost to Follow-up|0|||
23376969|NCT00557466|65126464|FG005|Overall Study|Lost to Follow-up|0|||
23376970|NCT00845182|65126465|FG000|Overall Study|Lost to Follow-up|3|||
23376971|NCT00845182|65126466|FG001|Overall Study|Lost to Follow-up|3|||
23376972|NCT00845182|65126467|FG002|Overall Study|Lost to Follow-up|4|||
23376973|NCT00845182|65126465|FG000|Overall Study|Adverse Event|0|||
23376974|NCT00845182|65126466|FG001|Overall Study|Adverse Event|1|||
23376975|NCT00845182|65126467|FG002|Overall Study|Adverse Event|1|||
23376976|NCT00845182|65126465|FG000|Overall Study|Physician Decision|0|||
23376977|NCT00845182|65126466|FG001|Overall Study|Physician Decision|0|||
23376978|NCT00845182|65126467|FG002|Overall Study|Physician Decision|1|||
23376979|NCT01177410|65126469|FG000|Overall Study|Adverse Event|0|||
23376980|NCT01177410|65126470|FG001|Overall Study|Adverse Event|2|||
23376981|NCT01177410|65126471|FG002|Overall Study|Adverse Event|2|||
23376982|NCT01177410|65126469|FG000|Overall Study|Withdrawal by Subject|1|||
23376983|NCT01177410|65126470|FG001|Overall Study|Withdrawal by Subject|4|||
23376984|NCT01177410|65126471|FG002|Overall Study|Withdrawal by Subject|3|||
23376985|NCT01177410|65126469|FG000|Overall Study|Lost to Follow-up|0|||
23376986|NCT01177410|65126470|FG001|Overall Study|Lost to Follow-up|1|||
23376987|NCT01177410|65126471|FG002|Overall Study|Lost to Follow-up|0|||
23376988|NCT00945243|65126472|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
23376989|NCT00712920|65126473|FG000|Overall Study|Adverse Event|3|||
23376990|NCT00712920|65126474|FG001|Overall Study|Adverse Event|4|||
23376991|NCT00712920|65126475|FG002|Overall Study|Adverse Event|7|||
23376992|NCT00712920|65126473|FG000|Overall Study|Withdrawal by Subject|4|||
23376993|NCT00712920|65126474|FG001|Overall Study|Withdrawal by Subject|2|||
23376994|NCT00712920|65126475|FG002|Overall Study|Withdrawal by Subject|1|||
23376995|NCT00712920|65126473|FG000|Overall Study|Lost to Follow-up|1|||
23376996|NCT00712920|65126474|FG001|Overall Study|Lost to Follow-up|4|||
23376997|NCT00712920|65126475|FG002|Overall Study|Lost to Follow-up|0|||
23376998|NCT00712920|65126473|FG000|Overall Study|Lack of Efficacy|1|||
23376999|NCT00712920|65126474|FG001|Overall Study|Lack of Efficacy|0|||
23377000|NCT00712920|65126475|FG002|Overall Study|Lack of Efficacy|1|||
23377001|NCT00712920|65126473|FG000|Overall Study|Other|5|||
23377002|NCT00712920|65126474|FG001|Overall Study|Other|7|||
23377003|NCT00712920|65126475|FG002|Overall Study|Other|3|||
23377004|NCT00712920|65126473|FG000|Overall Study|Non-compliance|3|||
23377005|NCT00712920|65126474|FG001|Overall Study|Non-compliance|0|||
23377006|NCT00712920|65126475|FG002|Overall Study|Non-compliance|0|||
23377007|NCT00434252|65126476|FG000|Overall Study|Lack of Efficacy|50|||
23377008|NCT00434252|65126477|FG001|Overall Study|Lack of Efficacy|100|||
23377009|NCT00434252|65126476|FG000|Overall Study|Adverse Event|6|||
23377010|NCT00434252|65126477|FG001|Overall Study|Adverse Event|13|||
23377011|NCT00434252|65126476|FG000|Overall Study|Death|1|||
23377012|NCT00434252|65126477|FG001|Overall Study|Death|2|||
23377013|NCT00434252|65126476|FG000|Overall Study|Lost to Follow-up|0|||
23377014|NCT00434252|65126477|FG001|Overall Study|Lost to Follow-up|1|||
23377015|NCT00434252|65126476|FG000|Overall Study|Physician Decision|4|||
23377016|NCT00434252|65126477|FG001|Overall Study|Physician Decision|8|||
23377017|NCT00434252|65126476|FG000|Overall Study|Withdrawal by Subject|3|||
23377018|NCT00434252|65126477|FG001|Overall Study|Withdrawal by Subject|7|||
23377019|NCT00671749|65126478|FG000|Overall Study|Adverse Event|2|||
23377020|NCT00671749|65126478|FG000|Overall Study|Withdrawal by Subject|4|||
23377021|NCT00671749|65126478|FG000|Overall Study|Protocol Violation|1|||
23377022|NCT00671749|65126478|FG000|Overall Study|Lost to Follow-up|1|||
23377023|NCT03255187|65126479|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
23377024|NCT03255187|65126480|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
23377025|NCT03255187|65126479|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
23377026|NCT03255187|65126480|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
23377027|NCT02469857|65126481|FG000|Overall Study|Death|24|||
23377028|NCT02469857|65126482|FG001|Overall Study|Death|29|||
23377029|NCT02469857|65126481|FG000|Overall Study|Discontinuation|1|||
23377030|NCT02469857|65126482|FG001|Overall Study|Discontinuation|3|||
23377031|NCT03880565|65126483|FG000|Overall Study|Withdrawal by Subject|1|||
23377032|NCT03880565|65126484|FG001|Overall Study|Withdrawal by Subject|0|||
23377033|NCT04459338|65126489|FG000|Overall Study|Loss of IV during study|1|||
23377034|NCT04459338|65126490|FG001|Overall Study|Loss of IV during study|0|||
23377035|NCT01202591|65126495|FG000|Overall Study|Adverse Event|2|||
23377036|NCT01202591|65126496|FG001|Overall Study|Adverse Event|1|||
23377037|NCT01202591|65126497|FG002|Overall Study|Adverse Event|4|||
23604771|NCT01159600|65943506|FG002|Overall Study|Not treated|1|||
23377038|NCT01202591|65126498|FG003|Overall Study|Adverse Event|4|||
23377039|NCT01202591|65126499|FG004|Overall Study|Adverse Event|0|||
23377040|NCT01202591|65126500|FG005|Overall Study|Adverse Event|0|||
23377041|NCT01202591|65126495|FG000|Overall Study|Other reason as per investigator|3|||
23665469|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23665470|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
23665471|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
23665472|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
23665473|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
23665474|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
23665475|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
23665476|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
23665477|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
23665478|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
23665479|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
23665480|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
23665481|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
23665482|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
23665483|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
23665484|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23665485|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23665486|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
23377042|NCT01202591|65126496|FG001|Overall Study|Other reason as per investigator|4|||
23604772|NCT01159600|65943507|FG003|Overall Study|Not treated|0|||
23377043|NCT01202591|65126497|FG002|Overall Study|Other reason as per investigator|7|||
23604773|NCT01159600|65943508|FG004|Overall Study|Not treated|0|||
23604774|NCT01159600|65943509|FG005|Overall Study|Not treated|1|||
23604775|NCT01159600|65943510|FG006|Overall Study|Not treated|2|||
23604776|NCT01159600|65943511|FG007|Overall Study|Not treated|2|||
23604777|NCT01159600|65943504|FG000|Overall Study|Adverse Event|7|||
23604778|NCT01159600|65943505|FG001|Overall Study|Adverse Event|2|||
23604779|NCT01159600|65943506|FG002|Overall Study|Adverse Event|5|||
23604780|NCT01159600|65943507|FG003|Overall Study|Adverse Event|1|||
23604781|NCT01159600|65943508|FG004|Overall Study|Adverse Event|8|||
23377044|NCT01202591|65126498|FG003|Overall Study|Other reason as per investigator|3|||
23377045|NCT01202591|65126499|FG004|Overall Study|Other reason as per investigator|1|||
23377046|NCT01202591|65126500|FG005|Overall Study|Other reason as per investigator|3|||
23377047|NCT01202591|65126495|FG000|Overall Study|Withdrawal by Subject|0|||
23377048|NCT01202591|65126496|FG001|Overall Study|Withdrawal by Subject|0|||
23377049|NCT01202591|65126497|FG002|Overall Study|Withdrawal by Subject|0|||
23377050|NCT01202591|65126498|FG003|Overall Study|Withdrawal by Subject|0|||
23377051|NCT01202591|65126499|FG004|Overall Study|Withdrawal by Subject|2|||
23377052|NCT01202591|65126500|FG005|Overall Study|Withdrawal by Subject|1|||
23377053|NCT01202591|65126495|FG000|Overall Study|Objective Disease Progression|0|||
23377054|NCT01202591|65126496|FG001|Overall Study|Objective Disease Progression|0|||
23377055|NCT01202591|65126497|FG002|Overall Study|Objective Disease Progression|0|||
23377056|NCT01202591|65126498|FG003|Overall Study|Objective Disease Progression|0|||
23377057|NCT01202591|65126499|FG004|Overall Study|Objective Disease Progression|2|||
23377058|NCT01202591|65126500|FG005|Overall Study|Objective Disease Progression|0|||
23377059|NCT00262925|65126501|FG000|Overall Study|Lack of Efficacy|3|||
23377060|NCT00262925|65126501|FG000|Overall Study|Adverse Event|4|||
23377061|NCT00262925|65126501|FG000|Overall Study|Death|2|||
23604782|NCT01159600|65943509|FG005|Overall Study|Adverse Event|6|||
23604783|NCT01159600|65943510|FG006|Overall Study|Adverse Event|7|||
23377062|NCT00262925|65126501|FG000|Overall Study|alternative therapy|1|||
23377063|NCT00262925|65126501|FG000|Overall Study|Other|1|||
23377064|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
23665487|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23377065|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
23604784|NCT01159600|65943511|FG007|Overall Study|Adverse Event|5|||
23604785|NCT01159600|65943504|FG000|Overall Study|Lack of Efficacy|0|||
23489674|NCT01461980|65537155|FG001|Overall Study|No longer willing to participate|38|||
23489675|NCT01461980|65537156|FG002|Overall Study|No longer willing to participate|54|||
23489676|NCT01461980|65537154|FG000|Overall Study|Randomized but not vaccinated|4|||
23377066|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
23377067|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
23377068|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
23377069|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
23377070|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
23377071|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
23377072|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
23377073|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
23377074|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
23377075|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
23377076|NCT03979313|65126502|FG000|All Subjects|Any Other Reason|16|||
23377077|NCT03979313|65126503|FG001|All Subjects|Any Other Reason|23|||
23377078|NCT03979313|65126502|FG000|All Subjects|Covid-19|1|||
23377079|NCT03979313|65126503|FG001|All Subjects|Covid-19|3|||
23377080|NCT03979313|65126502|FG000|All Subjects|Withdrawal by Subject|35|||
23377081|NCT03979313|65126503|FG001|All Subjects|Withdrawal by Subject|44|||
23377082|NCT03979313|65126502|FG000|All Subjects|Death|0|||
23377083|NCT03979313|65126503|FG001|All Subjects|Death|5|||
23377084|NCT03979313|65126502|FG000|All Subjects|Lost to Follow-up|28|||
23377085|NCT03979313|65126503|FG001|All Subjects|Lost to Follow-up|61|||
23377086|NCT02318940|65126505|FG000|Overall Study|lost the record|1|||
23377087|NCT02318940|65126506|FG001|Overall Study|lost the record|0|||
23377088|NCT02394275|65126507|FG000|Overall Study|Adverse Event|22|||
23377089|NCT02394275|65126507|FG000|Overall Study|Lost to Follow-up|7|||
23377090|NCT00593814|65126510|FG000|Overall Study|Death|7|||
23377091|NCT00593814|65126511|FG001|Overall Study|Death|0|||
23377092|NCT00593814|65126510|FG000|Overall Study|Withdrawal by Subject|7|||
23377093|NCT00593814|65126511|FG001|Overall Study|Withdrawal by Subject|0|||
23377094|NCT00593814|65126510|FG000|Overall Study|Lost to Follow-up|7|||
23377095|NCT00593814|65126511|FG001|Overall Study|Lost to Follow-up|0|||
23377096|NCT00593814|65126510|FG000|Overall Study|Physician Decision|3|||
23377097|NCT00593814|65126511|FG001|Overall Study|Physician Decision|0|||
23377098|NCT00134719|65126512|FG000|Primary Vaccination Phase|Adverse Event|4|||
23377099|NCT00134719|65126513|FG001|Primary Vaccination Phase|Adverse Event|0|||
23377100|NCT00134719|65126514|FG002|Primary Vaccination Phase|Adverse Event|0|||
23377101|NCT00134719|65126512|FG000|Primary Vaccination Phase|Protocol Violation|1|||
23377102|NCT00134719|65126513|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23377103|NCT00134719|65126514|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23377104|NCT00134719|65126512|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
23377105|NCT00134719|65126513|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
23377106|NCT00134719|65126514|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
23377107|NCT00134719|65126512|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
23377108|NCT00134719|65126513|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
23377109|NCT00134719|65126514|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
23665488|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23665489|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665490|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23665491|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23665492|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23665493|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665494|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23665495|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23665496|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23665497|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23665498|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23665499|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23665500|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23665501|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
23665502|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
23665503|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23665504|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23377110|NCT00134719|65126512|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
23377111|NCT00134719|65126513|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
23377112|NCT00134719|65126514|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
23377113|NCT00134719|65126512|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
23377114|NCT00134719|65126513|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
23377115|NCT00134719|65126514|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
23377116|NCT00071981|65126515|FG000|Overall Study|Lack of Efficacy|37|||
23377117|NCT00071981|65126516|FG001|Overall Study|Lack of Efficacy|29|||
23377118|NCT00071981|65126517|FG002|Overall Study|Lack of Efficacy|30|||
23665505|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23665506|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23665507|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
23665508|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23665509|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23665510|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23665511|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23665512|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23665513|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23665514|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
23665515|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23665516|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23665517|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23665518|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23665519|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23665520|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
23665521|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23665522|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23665523|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23665524|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23665525|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23665526|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
23665527|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23377119|NCT00071981|65126518|FG003|Overall Study|Lack of Efficacy|43|||
23377120|NCT00071981|65126515|FG000|Overall Study|Adverse Event|4|||
23377121|NCT00071981|65126516|FG001|Overall Study|Adverse Event|4|||
23377122|NCT00071981|65126517|FG002|Overall Study|Adverse Event|3|||
23377123|NCT00071981|65126518|FG003|Overall Study|Adverse Event|1|||
23377124|NCT00071981|65126515|FG000|Overall Study|Death|0|||
23377125|NCT00071981|65126516|FG001|Overall Study|Death|0|||
23377126|NCT00071981|65126517|FG002|Overall Study|Death|1|||
23377127|NCT00071981|65126518|FG003|Overall Study|Death|1|||
23377128|NCT00071981|65126515|FG000|Overall Study|Withdrawal by Subject|3|||
23377129|NCT00071981|65126516|FG001|Overall Study|Withdrawal by Subject|1|||
23377130|NCT00071981|65126517|FG002|Overall Study|Withdrawal by Subject|0|||
23377131|NCT00071981|65126518|FG003|Overall Study|Withdrawal by Subject|0|||
23377132|NCT00071981|65126515|FG000|Overall Study|No protocol therapy|2|||
23377133|NCT00071981|65126516|FG001|Overall Study|No protocol therapy|5|||
23377134|NCT00071981|65126517|FG002|Overall Study|No protocol therapy|1|||
23377135|NCT00071981|65126518|FG003|Overall Study|No protocol therapy|0|||
23665528|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23665529|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23665530|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23665531|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23665532|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
23665533|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23665534|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23665535|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23665536|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23665537|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23665538|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23665539|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23665540|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
23665541|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23665542|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23665543|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23665544|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23665545|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23665546|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
23665547|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23665548|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23665549|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23665550|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23665551|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23665552|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23665553|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
23665554|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23665555|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23665556|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23665557|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23665558|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23665559|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
23665560|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23665561|NCT00111800|66162473|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23665562|NCT00111800|66162474|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23665563|NCT00111800|66162475|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23665564|NCT00111800|66162476|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23665565|NCT00111800|66162477|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23665566|NCT00111800|66162478|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
23665567|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23665568|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
23665569|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
23665570|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
23665571|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23665572|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23665573|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23665574|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
23665575|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
23377136|NCT00071981|65126515|FG000|Overall Study|others (not specified in the study)|0|||
23665576|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23665577|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23665578|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23665579|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23665580|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
23665581|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
23665582|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23665583|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
23665584|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23665585|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23377137|NCT00071981|65126516|FG001|Overall Study|others (not specified in the study)|2|||
23489677|NCT01461980|65537155|FG001|Overall Study|Randomized but not vaccinated|8|||
23377138|NCT00071981|65126517|FG002|Overall Study|others (not specified in the study)|2|||
23665586|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
23665587|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23665588|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23665589|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
23665590|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23665591|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665592|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665593|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23665594|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665595|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665596|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23665597|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23377139|NCT00071981|65126518|FG003|Overall Study|others (not specified in the study)|0|||
23377140|NCT00118287|65126525|FG000|Overall Study|Intracranial haemorrhage|1|||
23377141|NCT00118287|65126525|FG000|Overall Study|Muscle pain|1|||
23377142|NCT01541748|65126526|FG000|Overall Study|Lost to Follow-up|17|||
23377143|NCT01541748|65126526|FG000|Overall Study|Moved out of state|1|||
23377144|NCT01541748|65126526|FG000|Overall Study|Withdrawal by Subject|7|||
23377145|NCT01541748|65126526|FG000|Overall Study|Screen failure|5|||
23377146|NCT01541748|65126526|FG000|Overall Study|Did not receive study device|1|||
23377147|NCT01147458|65126527|FG000|First Intervention|Study terminated by sponsor|8|||
23377148|NCT01147458|65126528|FG001|First Intervention|Study terminated by sponsor|8|||
23377149|NCT01147458|65126529|FG002|First Intervention|Study terminated by sponsor|7|||
23377150|NCT01147458|65126530|FG003|First Intervention|Study terminated by sponsor|8|||
23377151|NCT01147458|65126527|FG000|First Intervention|Protocol Violation|2|||
23377152|NCT01147458|65126528|FG001|First Intervention|Protocol Violation|3|||
23377153|NCT01147458|65126529|FG002|First Intervention|Protocol Violation|2|||
23377154|NCT01147458|65126530|FG003|First Intervention|Protocol Violation|3|||
23377155|NCT01147458|65126527|FG000|First Intervention|Withdrawal by Subject|3|||
23377156|NCT01147458|65126528|FG001|First Intervention|Withdrawal by Subject|0|||
23377157|NCT01147458|65126529|FG002|First Intervention|Withdrawal by Subject|1|||
23377158|NCT01147458|65126530|FG003|First Intervention|Withdrawal by Subject|0|||
23377159|NCT01147458|65126527|FG000|First Intervention|Adverse Event|0|||
23377160|NCT01147458|65126528|FG001|First Intervention|Adverse Event|3|||
23377161|NCT01147458|65126529|FG002|First Intervention|Adverse Event|2|||
23377162|NCT01147458|65126530|FG003|First Intervention|Adverse Event|3|||
23377163|NCT01147458|65126527|FG000|First Intervention|Other|1|||
23377164|NCT01147458|65126528|FG001|First Intervention|Other|2|||
23377165|NCT01147458|65126529|FG002|First Intervention|Other|0|||
23377166|NCT01147458|65126530|FG003|First Intervention|Other|0|||
23377167|NCT01147458|65126527|FG000|Second Intervention|Study terminated by sponsor|7|||
23377168|NCT01147458|65126528|FG001|Second Intervention|Study terminated by sponsor|5|||
23377169|NCT01147458|65126529|FG002|Second Intervention|Study terminated by sponsor|5|||
23377170|NCT01147458|65126530|FG003|Second Intervention|Study terminated by sponsor|3|||
23377171|NCT01147458|65126527|FG000|Second Intervention|Protocol Violation|0|||
23377172|NCT01147458|65126528|FG001|Second Intervention|Protocol Violation|1|||
23377173|NCT01147458|65126529|FG002|Second Intervention|Protocol Violation|1|||
23377174|NCT01147458|65126530|FG003|Second Intervention|Protocol Violation|0|||
23377175|NCT01147458|65126527|FG000|Second Intervention|Withdrawal by Subject|0|||
23377176|NCT01147458|65126528|FG001|Second Intervention|Withdrawal by Subject|1|||
23377177|NCT01147458|65126529|FG002|Second Intervention|Withdrawal by Subject|0|||
23377178|NCT01147458|65126530|FG003|Second Intervention|Withdrawal by Subject|0|||
23377179|NCT01147458|65126527|FG000|Second Intervention|Adverse Event|2|||
23665598|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
23665599|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23665600|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23665601|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23665602|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23377180|NCT01147458|65126528|FG001|Second Intervention|Adverse Event|0|||
23377181|NCT01147458|65126529|FG002|Second Intervention|Adverse Event|1|||
23377182|NCT01147458|65126530|FG003|Second Intervention|Adverse Event|1|||
23377183|NCT01147458|65126527|FG000|Second Intervention|Other|0|||
23377184|NCT01147458|65126528|FG001|Second Intervention|Other|0|||
23377185|NCT01147458|65126529|FG002|Second Intervention|Other|1|||
23377186|NCT01147458|65126530|FG003|Second Intervention|Other|0|||
23377187|NCT02188160|65126533|FG000|Overall Study|Adverse Event|1|||
23377188|NCT02188160|65126534|FG001|Overall Study|Adverse Event|0|||
23377189|NCT02188160|65126533|FG000|Overall Study|Use of an excluded medication|0|||
23377190|NCT02188160|65126534|FG001|Overall Study|Use of an excluded medication|1|||
23377191|NCT00005047|65126535|FG000|Overall Study|Withdrawal by Subject|12|||
23377192|NCT00005047|65126536|FG001|Overall Study|Withdrawal by Subject|0|||
23377193|NCT00005047|65126537|FG002|Overall Study|Withdrawal by Subject|0|||
23377194|NCT00005047|65126538|FG003|Overall Study|Withdrawal by Subject|0|||
23377195|NCT00005047|65126535|FG000|Overall Study|Adverse Event|5|||
23377196|NCT00005047|65126536|FG001|Overall Study|Adverse Event|0|||
23377197|NCT00005047|65126537|FG002|Overall Study|Adverse Event|0|||
23377198|NCT00005047|65126538|FG003|Overall Study|Adverse Event|0|||
23377199|NCT00005047|65126535|FG000|Overall Study|Lost to Follow-up|1|||
23377200|NCT00005047|65126536|FG001|Overall Study|Lost to Follow-up|0|||
23377201|NCT00005047|65126537|FG002|Overall Study|Lost to Follow-up|0|||
23377202|NCT00005047|65126538|FG003|Overall Study|Lost to Follow-up|0|||
23377203|NCT00005047|65126535|FG000|Overall Study|Lack of Efficacy|1|||
23377204|NCT00005047|65126536|FG001|Overall Study|Lack of Efficacy|0|||
23377205|NCT00005047|65126537|FG002|Overall Study|Lack of Efficacy|0|||
23377206|NCT00005047|65126538|FG003|Overall Study|Lack of Efficacy|0|||
23377207|NCT02326883|65126540|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
23377208|NCT02326883|65126541|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
23377209|NCT02326883|65126542|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
23377210|NCT00324155|65126543|FG000|Enrolled and Randomized|No longer met study criteria|3|||
23377211|NCT00324155|65126544|FG001|Enrolled and Randomized|No longer met study criteria|0|||
23377212|NCT00324155|65126543|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
23377213|NCT00324155|65126544|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
23377214|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
23377215|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
23377216|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
23377217|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
23377218|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Death|8|||
23377219|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Death|15|||
23377220|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
23377221|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
23377222|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
23377223|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
23377224|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
23377225|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
23377226|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
23377227|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
23377228|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
23377229|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
23377230|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
23377231|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
23377232|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
23377233|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
23377234|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
23377235|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
23377236|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
23377237|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
23377238|NCT00324155|65126543|FG000|Follow-up Phase|On-going participants still on drug|11|||
23377239|NCT00324155|65126544|FG001|Follow-up Phase|On-going participants still on drug|6|||
23377240|NCT01118299|65126545|FG000|Overall Study|Death|7|||
23377241|NCT01118299|65126546|FG001|Overall Study|Death|5|||
23377242|NCT01118299|65126545|FG000|Overall Study|Withdrawal by Subject|8|||
23377243|NCT01118299|65126546|FG001|Overall Study|Withdrawal by Subject|8|||
23377244|NCT01118299|65126545|FG000|Overall Study|Lost to Follow-up|2|||
23377245|NCT01118299|65126546|FG001|Overall Study|Lost to Follow-up|1|||
23377246|NCT01118299|65126545|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
23377247|NCT01118299|65126546|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
23377248|NCT02921789|65126551|FG000|Overall Study|Adverse Event|0|||
23377249|NCT02921789|65126552|FG001|Overall Study|Adverse Event|1|||
23377250|NCT02921789|65126551|FG000|Overall Study|Lost to Follow-up|1|||
23377251|NCT02921789|65126552|FG001|Overall Study|Lost to Follow-up|0|||
23377252|NCT02921789|65126551|FG000|Overall Study|Protocol Deviation|2|||
23377253|NCT02921789|65126552|FG001|Overall Study|Protocol Deviation|0|||
23377254|NCT02921789|65126551|FG000|Overall Study|Withdrawal by Subject|2|||
23377255|NCT02921789|65126552|FG001|Overall Study|Withdrawal by Subject|1|||
23377256|NCT02921789|65126551|FG000|Overall Study|Miscellaneous|3|||
23377257|NCT02921789|65126552|FG001|Overall Study|Miscellaneous|2|||
23377258|NCT04591015|65126553|FG000|Overall Study|Death|6|||
23377259|NCT04591015|65126554|FG001|Overall Study|Death|4|||
23377260|NCT04591015|65126553|FG000|Overall Study|Withdrawal by Subject|6|||
23377261|NCT04591015|65126554|FG001|Overall Study|Withdrawal by Subject|3|||
23377262|NCT04591015|65126553|FG000|Overall Study|Lost to Follow-up|16|||
23377263|NCT04591015|65126554|FG001|Overall Study|Lost to Follow-up|11|||
23377264|NCT00426270|65126555|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
23377265|NCT00426270|65126555|FG000|Overall Study|Adverse Event|5|||
23377266|NCT01881425|65126556|FG000|Overall Study|Death|5|||
23377267|NCT01881425|65126557|FG001|Overall Study|Death|1|||
23377268|NCT01881425|65126556|FG000|Overall Study|Withdrawal by Subject|8|||
23377269|NCT01881425|65126557|FG001|Overall Study|Withdrawal by Subject|3|||
23377270|NCT01881425|65126556|FG000|Overall Study|Physician Decision|2|||
23377271|NCT01881425|65126557|FG001|Overall Study|Physician Decision|1|||
23377272|NCT01881425|65126556|FG000|Overall Study|Adverse Event|3|||
23489678|NCT01461980|65537156|FG002|Overall Study|Randomized but not vaccinated|7|||
23377273|NCT01881425|65126557|FG001|Overall Study|Adverse Event|0|||
23377274|NCT01881425|65126556|FG000|Overall Study|General Anesthesia panic attack|0|||
23489679|NCT01134315|65537157|FG000|Overall Study|Adverse Event|1|||
23489680|NCT01134315|65537158|FG001|Overall Study|Adverse Event|2|||
23489681|NCT01134315|65537157|FG000|Overall Study|Other Reason|8|||
23489682|NCT01134315|65537158|FG001|Overall Study|Other Reason|17|||
23489683|NCT00629772|65537159|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
23489684|NCT00629772|65537160|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
23489685|NCT00629772|65537159|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
23489686|NCT00629772|65537160|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
23489687|NCT00958789|65537161|FG000|Overall Study|Death|5|||
23489688|NCT00958789|65537161|FG000|Overall Study|Lost to Follow-up|14|||
23665603|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23665604|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23665605|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
23665606|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23665607|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23489689|NCT00958789|65537161|FG000|Overall Study|Withdrawal by Subject|17|||
23489690|NCT00958789|65537161|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
23665608|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23665609|NCT00111800|66162473|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23665610|NCT00111800|66162474|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23665611|NCT00111800|66162475|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
23705652|NCT01234402|66297584|FG000|Overall Study|Withdrawal by Subject|1|||
23377275|NCT01881425|65126557|FG001|Overall Study|General Anesthesia panic attack|1|||
23377276|NCT01881425|65126556|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
23377277|NCT01881425|65126557|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
23377278|NCT01881425|65126556|FG000|Overall Study|Lost to Follow-up|7|||
23665612|NCT00111800|66162476|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23665613|NCT00111800|66162477|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23377279|NCT01881425|65126557|FG001|Overall Study|Lost to Follow-up|2|||
23377280|NCT01499511|65126561|FG000|Overall Study|Death|1|||
23377281|NCT01499511|65126562|FG001|Overall Study|Death|0|||
23665614|NCT00111800|66162478|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23665615|NCT01066585|66162479|FG000|Overall Study|Protocol Violation|1|||
23665616|NCT01066585|66162480|FG001|Overall Study|Protocol Violation|0|||
23665617|NCT01066585|66162479|FG000|Overall Study|Withdrawal by Subject|0|||
23665618|NCT01066585|66162480|FG001|Overall Study|Withdrawal by Subject|3|||
23665619|NCT04419610|66162481|FG000|Overall Study|Withdrawal by Subject|3|||
23665620|NCT04419610|66162482|FG001|Overall Study|Withdrawal by Subject|1|||
23665621|NCT04419610|66162481|FG000|Overall Study|Adverse Event|1|||
23665622|NCT04419610|66162482|FG001|Overall Study|Adverse Event|0|||
23665623|NCT04419610|66162481|FG000|Overall Study|discharged early|1|||
23665624|NCT04419610|66162482|FG001|Overall Study|discharged early|1|||
23665625|NCT00531752|66162487|FG000|First Double-blind Intervention Period|Adverse Event|2|||
23665626|NCT00531752|66162488|FG001|First Double-blind Intervention Period|Adverse Event|0|||
23665627|NCT00531752|66162489|FG002|First Double-blind Intervention Period|Adverse Event|1|||
23377282|NCT00250588|65126563|FG000|Overall Study|Withdrawal by Subject|3|||
23377283|NCT00250588|65126564|FG001|Overall Study|Withdrawal by Subject|6|||
23377284|NCT00250588|65126565|FG002|Overall Study|Withdrawal by Subject|0|||
23377285|NCT00250588|65126563|FG000|Overall Study|Lost to Follow-up|6|||
23377286|NCT00250588|65126564|FG001|Overall Study|Lost to Follow-up|13|||
23377287|NCT00250588|65126565|FG002|Overall Study|Lost to Follow-up|13|||
23377288|NCT03098979|65126566|FG000|Overall Study|Adverse Event|1|||
23377289|NCT03098979|65126567|FG001|Overall Study|Adverse Event|0|||
23377290|NCT03098979|65126568|FG002|Overall Study|Adverse Event|1|||
23377291|NCT03098979|65126569|FG003|Overall Study|Adverse Event|4|||
23377292|NCT03098979|65126570|FG004|Overall Study|Adverse Event|6|||
23377293|NCT03098979|65126571|FG005|Overall Study|Adverse Event|1|||
23377294|NCT03098979|65126566|FG000|Overall Study|Withdrawal by Subject|2|||
23665628|NCT00531752|66162490|FG003|First Double-blind Intervention Period|Adverse Event|1|||
23665629|NCT00531752|66162487|FG000|First Double-blind Intervention Period|Other|1|||
23665630|NCT00531752|66162488|FG001|First Double-blind Intervention Period|Other|4|||
23489691|NCT00958789|65537161|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
23489692|NCT00958789|65537161|FG000|Overall Study|Subject terminated|2|||
23489693|NCT00958789|65537161|FG000|Overall Study|Revision|7|||
23489694|NCT01147640|65537162|FG000|Overall Study|Adverse Event|2|||
23489695|NCT01147640|65537163|FG001|Overall Study|Adverse Event|0|||
23489696|NCT01147640|65537162|FG000|Overall Study|Physician Decision|1|||
23489697|NCT01147640|65537163|FG001|Overall Study|Physician Decision|0|||
23489698|NCT01147640|65537162|FG000|Overall Study|Withdrawal by Subject|1|||
23489699|NCT01147640|65537163|FG001|Overall Study|Withdrawal by Subject|0|||
23489700|NCT01147640|65537162|FG000|Overall Study|Lost to Follow-up|0|||
23489701|NCT01147640|65537163|FG001|Overall Study|Lost to Follow-up|1|||
23489702|NCT01147640|65537162|FG000|Overall Study|Didn't meet eligibility criteria|1|||
23377295|NCT03098979|65126567|FG001|Overall Study|Withdrawal by Subject|1|||
23489703|NCT01147640|65537163|FG001|Overall Study|Didn't meet eligibility criteria|0|||
23489704|NCT01008150|65537164|FG000|Overall Study|did not receive study drug|1|||
23489705|NCT01008150|65537165|FG001|Overall Study|did not receive study drug|1|||
23489706|NCT01008150|65537166|FG002|Overall Study|did not receive study drug|1|||
23489707|NCT01008150|65537167|FG003|Overall Study|did not receive study drug|0|||
23489708|NCT01907100|65537168|FG000|Overall Study|PD based on modified RECIST criteria|31|||
23489709|NCT01907100|65537169|FG001|Overall Study|PD based on modified RECIST criteria|32|||
23489710|NCT01907100|65537170|FG002|Overall Study|PD based on modified RECIST criteria|95|||
23489711|NCT01907100|65537171|FG003|Overall Study|PD based on modified RECIST criteria|92|||
23489712|NCT01907100|65537168|FG000|Overall Study|Withdrawal by Subject|2|||
23489713|NCT01907100|65537169|FG001|Overall Study|Withdrawal by Subject|5|||
23489714|NCT01907100|65537170|FG002|Overall Study|Withdrawal by Subject|10|||
23489715|NCT01907100|65537171|FG003|Overall Study|Withdrawal by Subject|13|||
23489716|NCT01907100|65537168|FG000|Overall Study|Protocol Violation|0|||
23489717|NCT01907100|65537169|FG001|Overall Study|Protocol Violation|0|||
23489718|NCT01907100|65537170|FG002|Overall Study|Protocol Violation|1|||
23489719|NCT01907100|65537171|FG003|Overall Study|Protocol Violation|1|||
23489720|NCT01907100|65537168|FG000|Overall Study|Lost to Follow-up|0|||
23489721|NCT01907100|65537169|FG001|Overall Study|Lost to Follow-up|0|||
23489722|NCT01907100|65537170|FG002|Overall Study|Lost to Follow-up|0|||
23489723|NCT01907100|65537171|FG003|Overall Study|Lost to Follow-up|1|||
23489724|NCT01907100|65537168|FG000|Overall Study|Not treated|2|||
23489725|NCT01907100|65537169|FG001|Overall Study|Not treated|0|||
23489726|NCT01907100|65537170|FG002|Overall Study|Not treated|1|||
23489727|NCT01907100|65537171|FG003|Overall Study|Not treated|2|||
23489728|NCT01907100|65537168|FG000|Overall Study|Other than reasons specified|1|||
23489729|NCT01907100|65537169|FG001|Overall Study|Other than reasons specified|0|||
23489730|NCT01907100|65537170|FG002|Overall Study|Other than reasons specified|10|||
23489731|NCT01907100|65537171|FG003|Overall Study|Other than reasons specified|6|||
23489732|NCT01907100|65537168|FG000|Overall Study|Adverse event (AE)|6|||
23489733|NCT01907100|65537169|FG001|Overall Study|Adverse event (AE)|3|||
23489734|NCT01907100|65537170|FG002|Overall Study|Adverse event (AE)|22|||
23489735|NCT01907100|65537171|FG003|Overall Study|Adverse event (AE)|23|||
23489736|NCT01907100|65537168|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
23489737|NCT01907100|65537169|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
23489738|NCT01907100|65537170|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
23377296|NCT03098979|65126568|FG002|Overall Study|Withdrawal by Subject|1|||
23489739|NCT01907100|65537171|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
23489740|NCT00580970|65537173|FG000|Pre-treatment|Non-compliance|1|||
23489741|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Non-compliance|6|||
23489742|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
23489743|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Physician Decision|4|||
23489744|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
23489745|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Death|1|||
23489746|NCT02770170|65537179|FG000|Overall Study|Withdrawal by Subject|0|||
23489747|NCT02770170|65537180|FG001|Overall Study|Withdrawal by Subject|0|||
23665631|NCT00531752|66162489|FG002|First Double-blind Intervention Period|Other|4|||
23665632|NCT00531752|66162490|FG003|First Double-blind Intervention Period|Other|0|||
23665633|NCT00531752|66162487|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
23665634|NCT00531752|66162488|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
23377297|NCT03098979|65126569|FG003|Overall Study|Withdrawal by Subject|1|||
23377298|NCT03098979|65126570|FG004|Overall Study|Withdrawal by Subject|2|||
23377299|NCT03098979|65126571|FG005|Overall Study|Withdrawal by Subject|1|||
23377300|NCT03098979|65126566|FG000|Overall Study|Death|1|||
23377301|NCT03098979|65126567|FG001|Overall Study|Death|0|||
23377302|NCT03098979|65126568|FG002|Overall Study|Death|2|||
23377303|NCT03098979|65126569|FG003|Overall Study|Death|0|||
23377304|NCT03098979|65126570|FG004|Overall Study|Death|1|||
23377305|NCT03098979|65126571|FG005|Overall Study|Death|0|||
23377306|NCT03098979|65126566|FG000|Overall Study|Physician Decision|2|||
23377307|NCT03098979|65126567|FG001|Overall Study|Physician Decision|1|||
23377308|NCT03098979|65126568|FG002|Overall Study|Physician Decision|0|||
23377309|NCT03098979|65126569|FG003|Overall Study|Physician Decision|0|||
23665635|NCT00531752|66162489|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
23665636|NCT00531752|66162490|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
23665637|NCT00531752|66162487|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
23665638|NCT00531752|66162488|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
23665639|NCT00531752|66162489|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
23665640|NCT00531752|66162490|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
23665641|NCT00531752|66162487|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
23665642|NCT00531752|66162488|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
23665643|NCT00531752|66162489|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
23665644|NCT00531752|66162490|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
23665645|NCT00531752|66162487|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
23665646|NCT00531752|66162488|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
23665647|NCT00531752|66162489|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
23665648|NCT00531752|66162490|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
23665649|NCT00531752|66162487|FG000|Second Double-blind Intervention Period|Other|1|||
23665650|NCT00531752|66162488|FG001|Second Double-blind Intervention Period|Other|1|||
23665651|NCT00531752|66162489|FG002|Second Double-blind Intervention Period|Other|0|||
23665652|NCT00531752|66162490|FG003|Second Double-blind Intervention Period|Other|0|||
23377310|NCT03098979|65126570|FG004|Overall Study|Physician Decision|0|||
23665653|NCT00531752|66162487|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23665654|NCT00531752|66162488|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23665655|NCT00531752|66162489|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23377311|NCT03098979|65126571|FG005|Overall Study|Physician Decision|0|||
23377312|NCT03098979|65126566|FG000|Overall Study|Non-compliance|0|||
23377313|NCT03098979|65126567|FG001|Overall Study|Non-compliance|0|||
23377314|NCT03098979|65126568|FG002|Overall Study|Non-compliance|0|||
23377315|NCT03098979|65126569|FG003|Overall Study|Non-compliance|0|||
23377316|NCT03098979|65126570|FG004|Overall Study|Non-compliance|0|||
23377317|NCT03098979|65126571|FG005|Overall Study|Non-compliance|1|||
23377318|NCT03098979|65126566|FG000|Overall Study|Protocol Violation|0|||
23377319|NCT03098979|65126567|FG001|Overall Study|Protocol Violation|0|||
23377320|NCT03098979|65126568|FG002|Overall Study|Protocol Violation|0|||
23377321|NCT03098979|65126569|FG003|Overall Study|Protocol Violation|0|||
23377322|NCT03098979|65126570|FG004|Overall Study|Protocol Violation|0|||
23377323|NCT03098979|65126571|FG005|Overall Study|Protocol Violation|1|||
23489748|NCT02770170|65537181|FG002|Overall Study|Withdrawal by Subject|0|||
23489749|NCT02770170|65537182|FG003|Overall Study|Withdrawal by Subject|2|||
23604786|NCT01159600|65943505|FG001|Overall Study|Lack of Efficacy|0|||
23377324|NCT02583269|65126573|FG000|Overall Study|Patient hospitalized prior to start|1|||
23489750|NCT02770170|65537179|FG000|Overall Study|due to pregnancy|1|||
23377325|NCT02583269|65126574|FG001|Overall Study|Patient hospitalized prior to start|0|||
23377326|NCT02583269|65126575|FG002|Overall Study|Patient hospitalized prior to start|0|||
23377327|NCT02583269|65126576|FG003|Overall Study|Patient hospitalized prior to start|0|||
23377328|NCT02583269|65126577|FG004|Overall Study|Patient hospitalized prior to start|0|||
23377329|NCT00226655|65126578|FG000|Overall Study|Death|13|||
23377330|NCT00226655|65126578|FG000|Overall Study|Withdrawal by Subject|15|||
23377331|NCT00226655|65126578|FG000|Overall Study|Adverse Event|35|||
23377332|NCT00226655|65126578|FG000|Overall Study|Physician Decision|6|||
23377333|NCT00226655|65126578|FG000|Overall Study|Clinical deterioration|10|||
23377334|NCT01983930|65126582|FG000|Overall Study|Withdrawal by Subject|9|||
23665656|NCT00531752|66162490|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
23665657|NCT00531752|66162487|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23665658|NCT00531752|66162488|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23665659|NCT00531752|66162489|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23665660|NCT00531752|66162490|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
23665661|NCT04096274|66162491|FG000|Phase I|Lost to Follow-up|5|||
23665662|NCT04096274|66162492|FG001|Phase I|Lost to Follow-up|5|||
23377335|NCT01983930|65126583|FG001|Overall Study|Withdrawal by Subject|8|||
23377336|NCT01983930|65126582|FG000|Overall Study|Adverse Event|0|||
23377337|NCT01983930|65126583|FG001|Overall Study|Adverse Event|1|||
23377338|NCT01288430|65126584|FG000|Part 1|Progressive disease|2|||
23377339|NCT01288430|65126585|FG001|Part 1|Progressive disease|1|||
23377340|NCT01288430|65126586|FG002|Part 1|Progressive disease|1|||
23377341|NCT01288430|65126587|FG003|Part 1|Progressive disease|6|||
23377342|NCT01288430|65126588|FG004|Part 1|Progressive disease|2|||
23377343|NCT01288430|65126589|FG005|Part 1|Progressive disease|4|||
23377344|NCT01288430|65126590|FG006|Part 1|Progressive disease|2|||
23377345|NCT01288430|65126591|FG007|Part 1|Progressive disease|0|||
23377346|NCT01288430|65126592|FG008|Part 1|Progressive disease|0|||
23377347|NCT01288430|65126593|FG009|Part 1|Progressive disease|0|||
23377348|NCT01288430|65126584|FG000|Part 1|Clinical disease progression|0|||
23377349|NCT01288430|65126585|FG001|Part 1|Clinical disease progression|0|||
23377350|NCT01288430|65126586|FG002|Part 1|Clinical disease progression|1|||
23377351|NCT01288430|65126587|FG003|Part 1|Clinical disease progression|0|||
23377352|NCT01288430|65126588|FG004|Part 1|Clinical disease progression|0|||
23377353|NCT01288430|65126589|FG005|Part 1|Clinical disease progression|2|||
23377354|NCT01288430|65126590|FG006|Part 1|Clinical disease progression|2|||
23377355|NCT01288430|65126591|FG007|Part 1|Clinical disease progression|0|||
23377356|NCT01288430|65126592|FG008|Part 1|Clinical disease progression|0|||
23377357|NCT01288430|65126593|FG009|Part 1|Clinical disease progression|0|||
23377358|NCT01288430|65126584|FG000|Part 1|Death due to disease progression|0|||
23377359|NCT01288430|65126585|FG001|Part 1|Death due to disease progression|0|||
23377360|NCT01288430|65126586|FG002|Part 1|Death due to disease progression|0|||
23665663|NCT04096274|66162491|FG000|Phase II|Lost to Follow-up|11|||
23665664|NCT04096274|66162492|FG001|Phase II|Lost to Follow-up|11|||
23665665|NCT03693625|66162496|FG000|Overall Study|Adverse Event|2|||
23665666|NCT03693625|66162497|FG001|Overall Study|Adverse Event|0|||
23665667|NCT03693625|66162496|FG000|Overall Study|Study Terminated By Sponsor|20|||
23665668|NCT03693625|66162497|FG001|Overall Study|Study Terminated By Sponsor|7|||
23665669|NCT03693625|66162496|FG000|Overall Study|Withdrawal by Subject|1|||
23665670|NCT03693625|66162497|FG001|Overall Study|Withdrawal by Subject|1|||
23665671|NCT02114268|66162498|FG000|Overall Study|Lost to Follow-up|4|||
23665672|NCT02114268|66162499|FG001|Overall Study|Lost to Follow-up|1|||
23665673|NCT02114268|66162500|FG002|Overall Study|Lost to Follow-up|1|||
23665674|NCT02114268|66162501|FG003|Overall Study|Lost to Follow-up|0|||
23665675|NCT02114268|66162502|FG004|Overall Study|Lost to Follow-up|0|||
23665676|NCT02114268|66162503|FG005|Overall Study|Lost to Follow-up|2|||
23665677|NCT02114268|66162498|FG000|Overall Study|Withdrawal by Subject|1|||
23665678|NCT02114268|66162499|FG001|Overall Study|Withdrawal by Subject|0|||
23665679|NCT02114268|66162500|FG002|Overall Study|Withdrawal by Subject|0|||
23665680|NCT02114268|66162501|FG003|Overall Study|Withdrawal by Subject|0|||
23665681|NCT02114268|66162502|FG004|Overall Study|Withdrawal by Subject|0|||
23665682|NCT02114268|66162503|FG005|Overall Study|Withdrawal by Subject|1|||
23377361|NCT01288430|65126587|FG003|Part 1|Death due to disease progression|0|||
23377362|NCT01288430|65126588|FG004|Part 1|Death due to disease progression|1|||
23377363|NCT01288430|65126589|FG005|Part 1|Death due to disease progression|0|||
23489751|NCT02770170|65537180|FG001|Overall Study|due to pregnancy|0|||
23489752|NCT02770170|65537181|FG002|Overall Study|due to pregnancy|0|||
23489753|NCT02770170|65537182|FG003|Overall Study|due to pregnancy|0|||
23489754|NCT02770170|65537179|FG000|Overall Study|Lack of Efficacy|2|||
23665683|NCT02114268|66162498|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
23665684|NCT02114268|66162499|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
23665685|NCT02114268|66162500|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
23665686|NCT02114268|66162501|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
23665687|NCT02114268|66162502|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
23665688|NCT02114268|66162503|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
23377364|NCT01288430|65126590|FG006|Part 1|Death due to disease progression|0|||
23377365|NCT01288430|65126591|FG007|Part 1|Death due to disease progression|0|||
23377366|NCT01288430|65126592|FG008|Part 1|Death due to disease progression|0|||
23377367|NCT01288430|65126593|FG009|Part 1|Death due to disease progression|0|||
23377368|NCT01288430|65126584|FG000|Part 1|Adverse Event|0|||
23377369|NCT01288430|65126585|FG001|Part 1|Adverse Event|0|||
23377370|NCT01288430|65126586|FG002|Part 1|Adverse Event|3|||
23377371|NCT01288430|65126587|FG003|Part 1|Adverse Event|1|||
23377372|NCT01288430|65126588|FG004|Part 1|Adverse Event|0|||
23377373|NCT01288430|65126589|FG005|Part 1|Adverse Event|0|||
23377374|NCT01288430|65126590|FG006|Part 1|Adverse Event|2|||
23377375|NCT01288430|65126591|FG007|Part 1|Adverse Event|0|||
23377376|NCT01288430|65126592|FG008|Part 1|Adverse Event|0|||
23377377|NCT01288430|65126593|FG009|Part 1|Adverse Event|0|||
23377378|NCT01288430|65126584|FG000|Part 1|Other|0|||
23377379|NCT01288430|65126585|FG001|Part 1|Other|2|||
23377380|NCT01288430|65126586|FG002|Part 1|Other|0|||
23377381|NCT01288430|65126587|FG003|Part 1|Other|0|||
23377382|NCT01288430|65126588|FG004|Part 1|Other|0|||
23377383|NCT01288430|65126589|FG005|Part 1|Other|0|||
23377384|NCT01288430|65126590|FG006|Part 1|Other|1|||
23377385|NCT01288430|65126591|FG007|Part 1|Other|0|||
23377386|NCT01288430|65126592|FG008|Part 1|Other|0|||
23377387|NCT01288430|65126593|FG009|Part 1|Other|0|||
23377388|NCT01288430|65126584|FG000|Part 2|Progressive disease|0|||
23377389|NCT01288430|65126585|FG001|Part 2|Progressive disease|0|||
23377390|NCT01288430|65126586|FG002|Part 2|Progressive disease|0|||
23377391|NCT01288430|65126587|FG003|Part 2|Progressive disease|0|||
23377392|NCT01288430|65126588|FG004|Part 2|Progressive disease|0|||
23377393|NCT01288430|65126589|FG005|Part 2|Progressive disease|0|||
23377394|NCT01288430|65126590|FG006|Part 2|Progressive disease|0|||
23377395|NCT01288430|65126591|FG007|Part 2|Progressive disease|8|||
23377396|NCT01288430|65126592|FG008|Part 2|Progressive disease|7|||
23377397|NCT01288430|65126593|FG009|Part 2|Progressive disease|2|||
23377398|NCT01288430|65126584|FG000|Part 2|Clinical disease progression|0|||
23377399|NCT01288430|65126585|FG001|Part 2|Clinical disease progression|0|||
23377400|NCT01288430|65126586|FG002|Part 2|Clinical disease progression|0|||
23377401|NCT01288430|65126587|FG003|Part 2|Clinical disease progression|0|||
23377402|NCT01288430|65126588|FG004|Part 2|Clinical disease progression|0|||
23377403|NCT01288430|65126589|FG005|Part 2|Clinical disease progression|0|||
23377404|NCT01288430|65126590|FG006|Part 2|Clinical disease progression|0|||
23377405|NCT01288430|65126591|FG007|Part 2|Clinical disease progression|2|||
23665689|NCT00766532|66162504|FG000|Overall Study|Protocol Violation|2|||
23665690|NCT04995055|66162505|FG000|Period 1|COVID-19 Related|1|||
23665691|NCT04995055|66162506|FG001|Period 1|COVID-19 Related|0|||
23665692|NCT04995055|66162505|FG000|Period 1|Withdrawal by Subject|0|||
23665693|NCT04995055|66162506|FG001|Period 1|Withdrawal by Subject|1|||
23665694|NCT04995055|66162505|FG000|Period 1|Subject discontinued due to timing|4|||
23665695|NCT04995055|66162506|FG001|Period 1|Subject discontinued due to timing|4|||
23665696|NCT00794677|66162509|FG000|First Intervention|Withdrawal by Subject|2|||
23665697|NCT00794677|66162510|FG001|First Intervention|Withdrawal by Subject|0|||
23665698|NCT00530270|66162511|FG000|Overall Study|Protocol Violation|1|||
23665699|NCT00530270|66162512|FG001|Overall Study|Protocol Violation|0|||
23665700|NCT00876187|66162513|FG000|Overall Study|Adverse Event|14|||
23665701|NCT00876187|66162514|FG001|Overall Study|Adverse Event|12|||
23665702|NCT00876187|66162515|FG002|Overall Study|Adverse Event|19|||
23665703|NCT00876187|66162516|FG003|Overall Study|Adverse Event|29|||
23665704|NCT00876187|66162517|FG004|Overall Study|Adverse Event|10|||
23665705|NCT00876187|66162513|FG000|Overall Study|Lack of Efficacy|59|||
23665706|NCT00876187|66162514|FG001|Overall Study|Lack of Efficacy|34|||
23665707|NCT00876187|66162515|FG002|Overall Study|Lack of Efficacy|45|||
23665708|NCT00876187|66162516|FG003|Overall Study|Lack of Efficacy|34|||
23377406|NCT01288430|65126592|FG008|Part 2|Clinical disease progression|0|||
23377407|NCT01288430|65126593|FG009|Part 2|Clinical disease progression|0|||
23377408|NCT01288430|65126584|FG000|Part 2|Withdrawal by Subject|0|||
23377409|NCT01288430|65126585|FG001|Part 2|Withdrawal by Subject|0|||
23377410|NCT01288430|65126586|FG002|Part 2|Withdrawal by Subject|0|||
23377411|NCT01288430|65126587|FG003|Part 2|Withdrawal by Subject|0|||
23665709|NCT00876187|66162517|FG004|Overall Study|Lack of Efficacy|59|||
23377412|NCT01288430|65126588|FG004|Part 2|Withdrawal by Subject|0|||
23377413|NCT01288430|65126589|FG005|Part 2|Withdrawal by Subject|0|||
23377414|NCT01288430|65126590|FG006|Part 2|Withdrawal by Subject|0|||
23377415|NCT01288430|65126591|FG007|Part 2|Withdrawal by Subject|1|||
23377416|NCT01288430|65126592|FG008|Part 2|Withdrawal by Subject|4|||
23665710|NCT00876187|66162513|FG000|Overall Study|Lost to Follow-up|9|||
23377417|NCT01288430|65126593|FG009|Part 2|Withdrawal by Subject|0|||
23377418|NCT01288430|65126584|FG000|Part 2|Adverse Event|0|||
23377419|NCT01288430|65126585|FG001|Part 2|Adverse Event|0|||
23377420|NCT01288430|65126586|FG002|Part 2|Adverse Event|0|||
23665711|NCT00876187|66162514|FG001|Overall Study|Lost to Follow-up|10|||
23665712|NCT00876187|66162515|FG002|Overall Study|Lost to Follow-up|8|||
23665713|NCT00876187|66162516|FG003|Overall Study|Lost to Follow-up|8|||
23665714|NCT00876187|66162517|FG004|Overall Study|Lost to Follow-up|11|||
23665715|NCT00876187|66162513|FG000|Overall Study|Protocol Violation|6|||
23665716|NCT00876187|66162514|FG001|Overall Study|Protocol Violation|7|||
23665717|NCT00876187|66162515|FG002|Overall Study|Protocol Violation|7|||
23665718|NCT00876187|66162516|FG003|Overall Study|Protocol Violation|6|||
23665719|NCT00876187|66162517|FG004|Overall Study|Protocol Violation|3|||
23665720|NCT00876187|66162513|FG000|Overall Study|Withdrawal by Subject|16|||
23665721|NCT00876187|66162514|FG001|Overall Study|Withdrawal by Subject|26|||
23665722|NCT00876187|66162515|FG002|Overall Study|Withdrawal by Subject|32|||
23665723|NCT00876187|66162516|FG003|Overall Study|Withdrawal by Subject|38|||
23665724|NCT00876187|66162517|FG004|Overall Study|Withdrawal by Subject|37|||
23665725|NCT00876187|66162513|FG000|Overall Study|Entered extension study|101|||
23665726|NCT00876187|66162514|FG001|Overall Study|Entered extension study|120|||
23665727|NCT00876187|66162515|FG002|Overall Study|Entered extension study|156|||
23665728|NCT00876187|66162516|FG003|Overall Study|Entered extension study|151|||
23665729|NCT00876187|66162517|FG004|Overall Study|Entered extension study|144|||
23665730|NCT00876187|66162513|FG000|Overall Study|Randomized but not treated|3|||
23377421|NCT01288430|65126587|FG003|Part 2|Adverse Event|0|||
23377422|NCT01288430|65126588|FG004|Part 2|Adverse Event|0|||
23377423|NCT01288430|65126589|FG005|Part 2|Adverse Event|0|||
23377424|NCT01288430|65126590|FG006|Part 2|Adverse Event|0|||
23377425|NCT01288430|65126591|FG007|Part 2|Adverse Event|1|||
23377426|NCT01288430|65126592|FG008|Part 2|Adverse Event|1|||
23377427|NCT01288430|65126593|FG009|Part 2|Adverse Event|0|||
23377428|NCT01288430|65126584|FG000|Part 2|Other|0|||
23377429|NCT01288430|65126585|FG001|Part 2|Other|0|||
23377430|NCT01288430|65126586|FG002|Part 2|Other|0|||
23377431|NCT01288430|65126587|FG003|Part 2|Other|0|||
23377432|NCT01288430|65126588|FG004|Part 2|Other|0|||
23377433|NCT01288430|65126589|FG005|Part 2|Other|0|||
23377434|NCT01288430|65126590|FG006|Part 2|Other|0|||
23377435|NCT01288430|65126591|FG007|Part 2|Other|0|||
23377436|NCT01288430|65126592|FG008|Part 2|Other|0|||
23377437|NCT01288430|65126593|FG009|Part 2|Other|1|||
23377438|NCT01431976|65126594|FG000|Overall Study|Adverse Event|6|||
23377439|NCT01431976|65126594|FG000|Overall Study|Lack of Efficacy|2|||
23377440|NCT01431976|65126594|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23489755|NCT02770170|65537180|FG001|Overall Study|Lack of Efficacy|0|||
23489756|NCT02770170|65537181|FG002|Overall Study|Lack of Efficacy|0|||
23489757|NCT02770170|65537182|FG003|Overall Study|Lack of Efficacy|1|||
23489758|NCT02770170|65537179|FG000|Overall Study|Adverse Event|4|||
23489759|NCT02770170|65537180|FG001|Overall Study|Adverse Event|3|||
23489760|NCT02770170|65537181|FG002|Overall Study|Adverse Event|5|||
23489761|NCT02770170|65537182|FG003|Overall Study|Adverse Event|3|||
23489762|NCT02770170|65537179|FG000|Overall Study|due to disease worsening|0|||
23489763|NCT02770170|65537180|FG001|Overall Study|due to disease worsening|0|||
23489764|NCT02770170|65537181|FG002|Overall Study|due to disease worsening|0|||
23489765|NCT02770170|65537182|FG003|Overall Study|due to disease worsening|1|||
23489766|NCT01200524|65537185|FG000|Overall Study|Withdrawal by Subject|1|||
23665731|NCT00876187|66162514|FG001|Overall Study|Randomized but not treated|1|||
23665732|NCT00876187|66162515|FG002|Overall Study|Randomized but not treated|3|||
23377441|NCT01431976|65126594|FG000|Overall Study|Physician Decision|1|||
23377442|NCT01431976|65126594|FG000|Overall Study|Withdrawal by Subject|1|||
23377443|NCT00127803|65126595|FG000|Overall Study|Adverse Event|2|||
23377444|NCT00127803|65126596|FG001|Overall Study|Adverse Event|0|||
23489767|NCT01200524|65537186|FG001|Overall Study|Withdrawal by Subject|1|||
23377445|NCT00127803|65126597|FG002|Overall Study|Adverse Event|0|||
23377446|NCT00127803|65126598|FG003|Overall Study|Adverse Event|0|||
23377447|NCT00127803|65126595|FG000|Overall Study|Withdrawal by Subject|1|||
23377448|NCT00127803|65126596|FG001|Overall Study|Withdrawal by Subject|0|||
23377449|NCT00127803|65126597|FG002|Overall Study|Withdrawal by Subject|0|||
23377450|NCT00127803|65126598|FG003|Overall Study|Withdrawal by Subject|0|||
23377451|NCT00127803|65126595|FG000|Overall Study|Lost to Follow-up|0|||
23377452|NCT00127803|65126596|FG001|Overall Study|Lost to Follow-up|0|||
23377453|NCT00127803|65126597|FG002|Overall Study|Lost to Follow-up|0|||
23377454|NCT00127803|65126598|FG003|Overall Study|Lost to Follow-up|1|||
23377455|NCT02278354|65126600|FG000|Overall Study|Lost to Follow-up|2|||
23377456|NCT02278354|65126601|FG001|Overall Study|Lost to Follow-up|2|||
23377457|NCT02278354|65126600|FG000|Overall Study|Withdrawal by Subject|0|||
23377458|NCT02278354|65126601|FG001|Overall Study|Withdrawal by Subject|1|||
23377459|NCT02278354|65126600|FG000|Overall Study|<10 professional fights|2|||
23377460|NCT02278354|65126601|FG001|Overall Study|<10 professional fights|0|||
23377461|NCT04900272|65126606|FG000|Overall Study|Lost to Follow-up|2|||
23377462|NCT04900272|65126606|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
23377463|NCT04900272|65126606|FG000|Overall Study|Withdrawal by Subject|1|||
23377464|NCT01860404|65126608|FG000|Overall Study|Lost to Follow-up|3|||
23377465|NCT01860404|65126609|FG001|Overall Study|Lost to Follow-up|4|||
23377466|NCT01860404|65126610|FG002|Overall Study|Lost to Follow-up|1|||
23377467|NCT01860404|65126611|FG003|Overall Study|Lost to Follow-up|6|||
23377468|NCT01860404|65126612|FG004|Overall Study|Lost to Follow-up|4|||
23377469|NCT01860404|65126608|FG000|Overall Study|Withdrawal by Subject|0|||
23377470|NCT01860404|65126609|FG001|Overall Study|Withdrawal by Subject|0|||
23377471|NCT01860404|65126610|FG002|Overall Study|Withdrawal by Subject|4|||
23377472|NCT01860404|65126611|FG003|Overall Study|Withdrawal by Subject|0|||
23377473|NCT01860404|65126612|FG004|Overall Study|Withdrawal by Subject|0|||
23377474|NCT00484159|65126613|FG000|Overall Study|Lost to Follow-up|1|||
23377475|NCT00484159|65126614|FG001|Overall Study|Lost to Follow-up|1|||
23377476|NCT00484159|65126615|FG002|Overall Study|Lost to Follow-up|0|||
23377477|NCT01631188|65126617|FG000|Overall Study|Physician Decision|75|||
23377478|NCT00724945|65126628|FG000|Period 1|non-compliance|1|||
23377479|NCT00724945|65126629|FG001|Period 1|non-compliance|0|||
23377480|NCT00724945|65126628|FG000|Period 1|Adverse Event|1|||
23377481|NCT00724945|65126629|FG001|Period 1|Adverse Event|1|||
23377482|NCT00724945|65126628|FG000|Period 1|Lost to Follow-up|1|||
23377483|NCT00724945|65126629|FG001|Period 1|Lost to Follow-up|0|||
23377484|NCT00724945|65126628|FG000|Period 2|lens comfort issue|3|||
23377485|NCT00724945|65126629|FG001|Period 2|lens comfort issue|0|||
23377486|NCT00724945|65126628|FG000|Period 2|lens physiology issue|1|||
23377487|NCT00724945|65126629|FG001|Period 2|lens physiology issue|0|||
23377488|NCT01113749|65126630|FG000|Overall Study|Lost to Follow-up|1|||
23377489|NCT01113749|65126631|FG001|Overall Study|Lost to Follow-up|2|||
23377490|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
23377491|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
23377492|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
23377493|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
23377494|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
23377495|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
23377496|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
23377497|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
23377498|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
23377499|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
23377500|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
23377501|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
23377502|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
23377503|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
23377504|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
23377505|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
23377506|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
23377507|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
23377508|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Removal|1|||
23377509|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Removal|0|||
23377510|NCT00316004|65126636|FG000|Overall Study|Subject was not given study fluid.|14|||
23377511|NCT00316004|65126637|FG001|Overall Study|Subject was not given study fluid.|14|||
23377512|NCT00316004|65126638|FG002|Overall Study|Subject was not given study fluid.|21|||
23377513|NCT02714153|65126641|FG000|Overall Study|Death|1|||
23377514|NCT03915067|65126642|FG000|Overall Study|Adverse Event|0|||
23377515|NCT03915067|65126643|FG001|Overall Study|Adverse Event|0|||
23489768|NCT01200524|65537187|FG002|Overall Study|Withdrawal by Subject|3|||
23489769|NCT01200524|65537185|FG000|Overall Study|Adverse Event|1|||
23377516|NCT03915067|65126644|FG002|Overall Study|Adverse Event|1|||
23377517|NCT03915067|65126642|FG000|Overall Study|Withdrawal by Subject|4|||
23377518|NCT03915067|65126643|FG001|Overall Study|Withdrawal by Subject|3|||
23377519|NCT03915067|65126644|FG002|Overall Study|Withdrawal by Subject|0|||
23377520|NCT03915067|65126642|FG000|Overall Study|Lost to Follow-up|3|||
23377521|NCT03915067|65126643|FG001|Overall Study|Lost to Follow-up|2|||
23377522|NCT03915067|65126644|FG002|Overall Study|Lost to Follow-up|0|||
23377523|NCT03915067|65126642|FG000|Overall Study|Protocol Deviation|0|||
23377524|NCT03915067|65126643|FG001|Overall Study|Protocol Deviation|0|||
23377525|NCT03915067|65126644|FG002|Overall Study|Protocol Deviation|1|||
23377526|NCT03915067|65126642|FG000|Overall Study|Covid-19 Related Issues|2|||
23377527|NCT03915067|65126643|FG001|Overall Study|Covid-19 Related Issues|4|||
23377528|NCT03915067|65126644|FG002|Overall Study|Covid-19 Related Issues|4|||
23377529|NCT03915067|65126642|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
23377530|NCT03915067|65126643|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
23665733|NCT00876187|66162516|FG003|Overall Study|Randomized but not treated|2|||
23665734|NCT00876187|66162517|FG004|Overall Study|Randomized but not treated|3|||
23665735|NCT00876187|66162513|FG000|Overall Study|Other|2|||
23665736|NCT00876187|66162514|FG001|Overall Study|Other|5|||
23665737|NCT00876187|66162515|FG002|Overall Study|Other|9|||
23665738|NCT00876187|66162516|FG003|Overall Study|Other|7|||
23665739|NCT00876187|66162517|FG004|Overall Study|Other|4|||
23665740|NCT00117598|66162518|FG000|Prior to Treatment Cross Over|Death|40|||
23665741|NCT00117598|66162519|FG001|Prior to Treatment Cross Over|Death|41|||
23665742|NCT00117598|66162520|FG002|Prior to Treatment Cross Over|Death|37|||
23665743|NCT00117598|66162521|FG003|Prior to Treatment Cross Over|Death|0|||
23377531|NCT03915067|65126644|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
23377532|NCT04682301|65126645|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
23377533|NCT04682301|65126645|FG000|Overall Study|Death|2|||
23377534|NCT02572167|65126650|FG000|Overall Study|Withdrawal by Subject|0|||
23377535|NCT02572167|65126651|FG001|Overall Study|Withdrawal by Subject|3|||
23377536|NCT02572167|65126652|FG002|Overall Study|Withdrawal by Subject|0|||
23377537|NCT02572167|65126650|FG000|Overall Study|Lost to Follow-up|2|||
23377538|NCT02572167|65126651|FG001|Overall Study|Lost to Follow-up|5|||
23377539|NCT02572167|65126652|FG002|Overall Study|Lost to Follow-up|3|||
23377540|NCT02572167|65126650|FG000|Overall Study|Death|0|||
23604787|NCT01159600|65943506|FG002|Overall Study|Lack of Efficacy|0|||
23604788|NCT01159600|65943507|FG003|Overall Study|Lack of Efficacy|0|||
23604789|NCT01159600|65943508|FG004|Overall Study|Lack of Efficacy|2|||
23604790|NCT01159600|65943509|FG005|Overall Study|Lack of Efficacy|0|||
23604791|NCT01159600|65943510|FG006|Overall Study|Lack of Efficacy|0|||
23604792|NCT01159600|65943511|FG007|Overall Study|Lack of Efficacy|1|||
23604793|NCT01159600|65943504|FG000|Overall Study|Non compliant with protocol|2|||
23604794|NCT01159600|65943505|FG001|Overall Study|Non compliant with protocol|1|||
23604795|NCT01159600|65943506|FG002|Overall Study|Non compliant with protocol|0|||
23604796|NCT01159600|65943507|FG003|Overall Study|Non compliant with protocol|0|||
23604797|NCT01159600|65943508|FG004|Overall Study|Non compliant with protocol|2|||
23665744|NCT00117598|66162522|FG004|Prior to Treatment Cross Over|Death|0|||
23665745|NCT00117598|66162518|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23665746|NCT00117598|66162519|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
23665747|NCT00117598|66162520|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
23665748|NCT00117598|66162521|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23665749|NCT00117598|66162522|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23665750|NCT00117598|66162518|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
23665751|NCT00117598|66162519|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
23665752|NCT00117598|66162520|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
23665753|NCT00117598|66162521|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
23665754|NCT00117598|66162522|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
23665755|NCT00117598|66162518|FG000|Prior to Treatment Cross Over|Other|15|||
23665756|NCT00117598|66162519|FG001|Prior to Treatment Cross Over|Other|9|||
23665757|NCT00117598|66162520|FG002|Prior to Treatment Cross Over|Other|9|||
23665758|NCT00117598|66162521|FG003|Prior to Treatment Cross Over|Other|0|||
23665759|NCT00117598|66162522|FG004|Prior to Treatment Cross Over|Other|0|||
23665760|NCT00117598|66162518|FG000|After Treament Cross Over|Death|0|||
23665761|NCT00117598|66162519|FG001|After Treament Cross Over|Death|0|||
23665762|NCT00117598|66162520|FG002|After Treament Cross Over|Death|0|||
23665763|NCT00117598|66162521|FG003|After Treament Cross Over|Death|1|||
23665764|NCT00117598|66162522|FG004|After Treament Cross Over|Death|2|||
23377541|NCT02572167|65126651|FG001|Overall Study|Death|8|||
23377542|NCT02572167|65126652|FG002|Overall Study|Death|3|||
23377543|NCT02572167|65126650|FG000|Overall Study|Did not meet inclusion criteria|0|||
23377544|NCT02572167|65126651|FG001|Overall Study|Did not meet inclusion criteria|0|||
23377545|NCT02572167|65126652|FG002|Overall Study|Did not meet inclusion criteria|1|||
23377546|NCT02572167|65126650|FG000|Overall Study|Study closure by Sponsor|4|||
23377547|NCT02572167|65126651|FG001|Overall Study|Study closure by Sponsor|40|||
23377548|NCT02572167|65126652|FG002|Overall Study|Study closure by Sponsor|24|||
23377549|NCT03530293|65126653|FG000|Pre-randomization|Adverse Event|12|||
23377550|NCT03530293|65126654|FG001|Pre-randomization|Adverse Event|0|||
23665765|NCT00117598|66162518|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
23665766|NCT00117598|66162519|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
23665767|NCT00117598|66162520|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
23665768|NCT00117598|66162521|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
23665769|NCT00117598|66162522|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
23377551|NCT03530293|65126655|FG002|Pre-randomization|Adverse Event|0|||
23377552|NCT03530293|65126653|FG000|Pre-randomization|Protocol Violation|2|||
23377553|NCT03530293|65126654|FG001|Pre-randomization|Protocol Violation|0|||
23377554|NCT03530293|65126655|FG002|Pre-randomization|Protocol Violation|0|||
23665770|NCT00117598|66162518|FG000|After Treament Cross Over|Other|0|||
23665771|NCT00117598|66162519|FG001|After Treament Cross Over|Other|0|||
23665772|NCT00117598|66162520|FG002|After Treament Cross Over|Other|0|||
23665773|NCT00117598|66162521|FG003|After Treament Cross Over|Other|1|||
23665774|NCT00117598|66162522|FG004|After Treament Cross Over|Other|2|||
23665775|NCT02231164|66162523|FG000|Overall Study|Adverse Event|1|||
23665776|NCT02231164|66162524|FG001|Overall Study|Adverse Event|1|||
23665777|NCT02231164|66162523|FG000|Overall Study|Lack of Efficacy|4|||
23377555|NCT03530293|65126653|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
23377556|NCT03530293|65126654|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
23489770|NCT01200524|65537186|FG001|Overall Study|Adverse Event|0|||
23489771|NCT01200524|65537187|FG002|Overall Study|Adverse Event|0|||
23489772|NCT01200524|65537185|FG000|Overall Study|Non availability of study nurse|0|||
23489773|NCT01200524|65537186|FG001|Overall Study|Non availability of study nurse|0|||
23489774|NCT01200524|65537187|FG002|Overall Study|Non availability of study nurse|1|||
23489775|NCT02963935|65537188|FG000|Overall Study|Adverse Event|12|||
23489776|NCT02963935|65537189|FG001|Overall Study|Adverse Event|6|||
23489777|NCT02963935|65537188|FG000|Overall Study|Protocol Violation|2|||
23489778|NCT02963935|65537189|FG001|Overall Study|Protocol Violation|1|||
23489779|NCT02963935|65537188|FG000|Overall Study|Lack of Efficacy|0|||
23489780|NCT02963935|65537189|FG001|Overall Study|Lack of Efficacy|2|||
23489781|NCT02963935|65537188|FG000|Overall Study|Lost to Follow-up|1|||
23489782|NCT02963935|65537189|FG001|Overall Study|Lost to Follow-up|6|||
23489783|NCT02963935|65537188|FG000|Overall Study|Unclassified|13|||
23489784|NCT02963935|65537189|FG001|Overall Study|Unclassified|22|||
23489785|NCT01565642|65537190|FG000|Overall Study|Withdrawal by Subject|2|||
23489786|NCT01565642|65537191|FG001|Overall Study|Withdrawal by Subject|1|||
23489787|NCT00839852|65537194|FG000|Overall Study|Adverse Event|10|||
23489788|NCT00839852|65537194|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23489789|NCT00839852|65537194|FG000|Overall Study|Protocol Violation|9|||
23489790|NCT00839852|65537194|FG000|Overall Study|Withdrawal of Consent|16|||
23489791|NCT00839852|65537194|FG000|Overall Study|Lost to Follow-up|7|||
23489792|NCT00839852|65537194|FG000|Overall Study|Lack of Compliance While in Jail|1|||
23489793|NCT00839852|65537194|FG000|Overall Study|Pregnancy|1|||
23489794|NCT01555983|65537197|FG000|Overall Study|Withdrawal by Subject|1|||
23489795|NCT01555983|65537198|FG001|Overall Study|Withdrawal by Subject|0|||
23489796|NCT01555983|65537199|FG002|Overall Study|Withdrawal by Subject|0|||
23489797|NCT01555983|65537200|FG003|Overall Study|Withdrawal by Subject|0|||
23489798|NCT01555983|65537201|FG004|Overall Study|Withdrawal by Subject|1|||
23489799|NCT01555983|65537202|FG005|Overall Study|Withdrawal by Subject|1|||
23489800|NCT03039192|65537203|FG000|Overall Study|Lost to Follow-up|4|||
23489801|NCT03039192|65537204|FG001|Overall Study|Lost to Follow-up|4|||
23489802|NCT03039192|65537203|FG000|Overall Study|Adverse event, serious fatal|0|||
23489803|NCT03039192|65537204|FG001|Overall Study|Adverse event, serious fatal|1|||
23489804|NCT03039192|65537203|FG000|Overall Study|Adverse event, non-fatal|0|||
23489805|NCT03039192|65537204|FG001|Overall Study|Adverse event, non-fatal|2|||
23489806|NCT03039192|65537203|FG000|Overall Study|Withdrawal by Subject|6|||
23489807|NCT03039192|65537204|FG001|Overall Study|Withdrawal by Subject|9|||
23489808|NCT03039192|65537203|FG000|Overall Study|Discontinued from treatment phase|19|||
23489809|NCT03039192|65537204|FG001|Overall Study|Discontinued from treatment phase|12|||
23489810|NCT03039192|65537203|FG000|Overall Study|Other|3|||
23489811|NCT03039192|65537204|FG001|Overall Study|Other|2|||
23489812|NCT02428608|65537206|FG000|Overall Study|Pregnancy|2|||
23489813|NCT02428608|65537206|FG000|Overall Study|Lost to Follow-up|37|||
23489814|NCT02428608|65537206|FG000|Overall Study|Withdrawal by Subject|2|||
23489815|NCT02428608|65537206|FG000|Overall Study|scheduling conflicts|15|||
23489816|NCT02428608|65537206|FG000|Overall Study|moved away|10|||
23489817|NCT02428608|65537206|FG000|Overall Study|Death|1|||
23489818|NCT02428608|65537206|FG000|Overall Study|various|16|||
23489819|NCT04137224|65537207|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
23489820|NCT04137224|65537208|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
23489821|NCT04137224|65537207|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
23489822|NCT04137224|65537208|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
23489823|NCT04137224|65537207|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
23489824|NCT04137224|65537208|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
23489825|NCT02024529|65537221|FG000|Overall Study|Withdrawal by Subject|11|||
23489826|NCT02024529|65537222|FG001|Overall Study|Withdrawal by Subject|21|||
23489827|NCT02024529|65537221|FG000|Overall Study|Lost to Follow-up|2|||
23489828|NCT02024529|65537222|FG001|Overall Study|Lost to Follow-up|4|||
23489829|NCT02035475|65537223|FG000|Overall Study|Withdrawal by Subject|4|||
23489830|NCT02035475|65537223|FG000|Overall Study|Physician Decision|1|||
23489831|NCT02035475|65537223|FG000|Overall Study|Equipment Error|1|||
23489832|NCT00986479|65537224|FG000|Period 1|Improved mood|1|||
23489833|NCT00986479|65537225|FG001|Period 1|Improved mood|0|||
23489834|NCT00986479|65537224|FG000|Period 1|Administrative reasons|1|||
23489835|NCT00986479|65537225|FG001|Period 1|Administrative reasons|0|||
23489836|NCT02545075|65537226|FG000|Randomization|Lost to Follow-up|0|||
23489837|NCT02545075|65537227|FG001|Randomization|Lost to Follow-up|1|||
23489838|NCT02545075|65537226|FG000|Randomization|Withdrawal by Subject|0|||
23489839|NCT02545075|65537227|FG001|Randomization|Withdrawal by Subject|6|||
23489840|NCT02545075|65537226|FG000|Treatment|Disease progression|71|||
23489841|NCT02545075|65537227|FG001|Treatment|Disease progression|32|||
23489842|NCT02545075|65537226|FG000|Treatment|Participant dicontinued study treatment|7|||
23489843|NCT02545075|65537227|FG001|Treatment|Participant dicontinued study treatment|9|||
23489844|NCT02545075|65537226|FG000|Treatment|Withdrawal by Subject|1|||
23489845|NCT02545075|65537227|FG001|Treatment|Withdrawal by Subject|0|||
23489846|NCT02545075|65537226|FG000|Treatment|Adverse event not related to study drug|1|||
23665778|NCT02231164|66162524|FG001|Overall Study|Lack of Efficacy|3|||
23665779|NCT02231164|66162523|FG000|Overall Study|Withdrawal by Subject|1|||
23665780|NCT02231164|66162524|FG001|Overall Study|Withdrawal by Subject|2|||
23665781|NCT02343159|66162525|FG000|Overall Study|Early Study Termination|16|||
23665782|NCT02343159|66162526|FG001|Overall Study|Early Study Termination|19|||
23665783|NCT02343159|66162527|FG002|Overall Study|Early Study Termination|23|||
23665784|NCT02343159|66162525|FG000|Overall Study|Physician Decision|2|||
23665785|NCT02343159|66162526|FG001|Overall Study|Physician Decision|0|||
23665786|NCT02343159|66162527|FG002|Overall Study|Physician Decision|1|||
23665787|NCT02343159|66162525|FG000|Overall Study|Withdrawal by Subject|3|||
23665788|NCT02343159|66162526|FG001|Overall Study|Withdrawal by Subject|0|||
23665789|NCT02343159|66162527|FG002|Overall Study|Withdrawal by Subject|2|||
23665790|NCT02343159|66162525|FG000|Overall Study|Lost to Follow-up|0|||
23665791|NCT02343159|66162526|FG001|Overall Study|Lost to Follow-up|2|||
23665792|NCT02343159|66162527|FG002|Overall Study|Lost to Follow-up|2|||
23665793|NCT02343159|66162525|FG000|Overall Study|Adverse Event|4|||
23665794|NCT02343159|66162526|FG001|Overall Study|Adverse Event|4|||
23665795|NCT02343159|66162527|FG002|Overall Study|Adverse Event|2|||
23665796|NCT02343159|66162525|FG000|Overall Study|Sponsor Decision|0|||
23665797|NCT02343159|66162526|FG001|Overall Study|Sponsor Decision|1|||
23665798|NCT02343159|66162527|FG002|Overall Study|Sponsor Decision|0|||
23665799|NCT02343159|66162525|FG000|Overall Study|Enrollment Error|1|||
23665800|NCT02343159|66162526|FG001|Overall Study|Enrollment Error|0|||
23665801|NCT02343159|66162527|FG002|Overall Study|Enrollment Error|0|||
23665802|NCT05376215|66162528|FG000|Overall Study|Withdrawal by Subject|2|||
23665803|NCT05376215|66162529|FG001|Overall Study|Withdrawal by Subject|1|||
23665804|NCT05376215|66162528|FG000|Overall Study|Lost to Follow-up|0|||
23665805|NCT05376215|66162529|FG001|Overall Study|Lost to Follow-up|1|||
23665806|NCT02256540|66162530|FG000|Overall Study|Withdrawal by Subject|0|||
23665807|NCT02256540|66162531|FG001|Overall Study|Withdrawal by Subject|1|||
23665808|NCT02256540|66162532|FG002|Overall Study|Withdrawal by Subject|1|||
23665809|NCT02256540|66162530|FG000|Overall Study|Back pain preventing exercise|0|||
23665810|NCT02256540|66162531|FG001|Overall Study|Back pain preventing exercise|0|||
23665811|NCT02256540|66162532|FG002|Overall Study|Back pain preventing exercise|1|||
23665812|NCT01744665|66162539|FG000|Monitoring Phase|Adverse Event|4|||
23665813|NCT01744665|66162539|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
23665814|NCT01744665|66162539|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
23665815|NCT01744665|66162539|FG000|Monitoring Phase|Withdrawal by Subject|5|||
23665816|NCT01744665|66162539|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
23665817|NCT01744665|66162539|FG000|Consolidation Phase|Adverse Event|2|||
23665818|NCT01744665|66162539|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
23665819|NCT01744665|66162539|FG000|Consolidation Phase|Withdrawal by Subject|4|||
23665820|NCT01744665|66162539|FG000|Consolidation Phase|Administrative problems|9|||
23665821|NCT01744665|66162539|FG000|Re-initiation Phase|Administrative problems|10|||
23665822|NCT01744665|66162539|FG000|Re-initiation Phase|Adverse Event|1|||
23665823|NCT01744665|66162539|FG000|Re-initiation Phase|No longer required treatment|1|||
23665824|NCT01744665|66162539|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
23665825|NCT01838616|66162540|FG000|Titration Period|Adverse Event|18|||
23665826|NCT01838616|66162541|FG001|Titration Period|Adverse Event|48|||
23665827|NCT01838616|66162540|FG000|Titration Period|Lack of Efficacy|5|||
23665828|NCT01838616|66162541|FG001|Titration Period|Lack of Efficacy|12|||
23665829|NCT01838616|66162540|FG000|Titration Period|Withdrawal by Subject|5|||
23665830|NCT01838616|66162541|FG001|Titration Period|Withdrawal by Subject|5|||
23665831|NCT01838616|66162540|FG000|Titration Period|Technical problems|1|||
23665832|NCT01838616|66162541|FG001|Titration Period|Technical problems|0|||
23665833|NCT01838616|66162540|FG000|Titration Period|Other|1|||
23665834|NCT01838616|66162541|FG001|Titration Period|Other|0|||
23489847|NCT02545075|65537227|FG001|Treatment|Adverse event not related to study drug|0|||
23489848|NCT02545075|65537226|FG000|Treatment|Death|1|||
23489849|NCT02545075|65537227|FG001|Treatment|Death|0|||
23489850|NCT02545075|65537226|FG000|Treatment|Participant drug toxicity|1|||
23665835|NCT01838616|66162540|FG000|Titration Period|Protocol Violation|0|||
23665836|NCT01838616|66162541|FG001|Titration Period|Protocol Violation|1|||
23665837|NCT01838616|66162540|FG000|Continuation Period|Lack of Efficacy|3|||
23665838|NCT01838616|66162541|FG001|Continuation Period|Lack of Efficacy|5|||
23377557|NCT03530293|65126655|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
23377558|NCT03530293|65126653|FG000|Pre-randomization|Withdrawal by Subject|5|||
23377559|NCT03530293|65126654|FG001|Pre-randomization|Withdrawal by Subject|0|||
23377560|NCT03530293|65126655|FG002|Pre-randomization|Withdrawal by Subject|0|||
23377561|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
23377562|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
23377563|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
23377564|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
23377565|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
23377566|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
23377567|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
23377568|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
23377569|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
23377570|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
23377571|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
23377572|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
23377573|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
23377574|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
23377575|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
23377576|NCT04711005|65126656|FG000|Overall Study|Withdrawal by Subject|0|||
23377577|NCT04711005|65126657|FG001|Overall Study|Withdrawal by Subject|0|||
23377578|NCT04711005|65126658|FG002|Overall Study|Withdrawal by Subject|0|||
23377579|NCT04711005|65126659|FG003|Overall Study|Withdrawal by Subject|0|||
23377580|NCT04711005|65126660|FG004|Overall Study|Withdrawal by Subject|0|||
23377581|NCT04711005|65126661|FG005|Overall Study|Withdrawal by Subject|0|||
23377582|NCT04711005|65126662|FG006|Overall Study|Withdrawal by Subject|0|||
23377583|NCT04711005|65126663|FG007|Overall Study|Withdrawal by Subject|1|||
23377584|NCT04711005|65126664|FG008|Overall Study|Withdrawal by Subject|0|||
23377585|NCT04711005|65126665|FG009|Overall Study|Withdrawal by Subject|0|||
23377586|NCT04711005|65126656|FG000|Overall Study|Physician Decision|0|||
23377587|NCT04711005|65126657|FG001|Overall Study|Physician Decision|0|||
23377588|NCT04711005|65126658|FG002|Overall Study|Physician Decision|0|||
23377589|NCT04711005|65126659|FG003|Overall Study|Physician Decision|0|||
23377590|NCT04711005|65126660|FG004|Overall Study|Physician Decision|0|||
23377591|NCT04711005|65126661|FG005|Overall Study|Physician Decision|0|||
23377592|NCT04711005|65126662|FG006|Overall Study|Physician Decision|0|||
23377593|NCT04711005|65126663|FG007|Overall Study|Physician Decision|2|||
23377594|NCT04711005|65126664|FG008|Overall Study|Physician Decision|1|||
23377595|NCT04711005|65126665|FG009|Overall Study|Physician Decision|0|||
23377596|NCT01006629|65126670|FG000|Overall Study|Adverse Event|1|||
23377597|NCT01006629|65126670|FG000|Overall Study|Parent refused to continue participation|1|||
23377598|NCT01006629|65126670|FG000|Overall Study|Parent unable to perform site visit|4|||
23377599|NCT03069989|65126671|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
23377600|NCT03069989|65126672|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
23377601|NCT02472405|65126673|FG000|Overall Study|Lost to Follow-up|9|||
23377602|NCT02472405|65126673|FG000|Overall Study|Adverse Event|1|||
23377603|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
23377604|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
23377605|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
23377606|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Death|1|||
23377607|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Death|0|||
23377608|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Death|0|||
23377609|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
23377610|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
23377611|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
23377612|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
23377613|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
23604798|NCT01159600|65943509|FG005|Overall Study|Non compliant with protocol|0|||
23489851|NCT02545075|65537227|FG001|Treatment|Participant drug toxicity|0|||
23489852|NCT02545075|65537226|FG000|Treatment|Completed treatment|40|||
23489853|NCT02545075|65537227|FG001|Treatment|Completed treatment|12|||
23489854|NCT01759511|65537228|FG000|Overall Study|Adverse Event|4|||
23489855|NCT01759511|65537228|FG000|Overall Study|Death|2|||
23489856|NCT01759511|65537228|FG000|Overall Study|Lack of Efficacy|2|||
23489857|NCT01759511|65537228|FG000|Overall Study|Physician Decision|1|||
23489858|NCT01759511|65537228|FG000|Overall Study|Progressive Disease|5|||
23489859|NCT01759511|65537228|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
23489860|NCT01759511|65537228|FG000|Overall Study|Study Terminated by Sponsor|13|||
23489861|NCT01759511|65537228|FG000|Overall Study|Withdrawal by Subject|3|||
23665839|NCT01838616|66162540|FG000|Continuation Period|Adverse Event|8|||
23665840|NCT01838616|66162541|FG001|Continuation Period|Adverse Event|4|||
23665841|NCT01838616|66162540|FG000|Continuation Period|Protocol Violation|2|||
23665842|NCT01838616|66162541|FG001|Continuation Period|Protocol Violation|0|||
23665843|NCT01838616|66162540|FG000|Continuation Period|Lost to Follow-up|1|||
23665844|NCT01838616|66162541|FG001|Continuation Period|Lost to Follow-up|0|||
23665845|NCT01838616|66162540|FG000|Continuation Period|Withdrawal by Subject|0|||
23665846|NCT01838616|66162541|FG001|Continuation Period|Withdrawal by Subject|4|||
23665847|NCT01838616|66162540|FG000|Continuation Period|Technical problems|0|||
23665848|NCT01838616|66162541|FG001|Continuation Period|Technical problems|1|||
23377614|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
23377615|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
23377616|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
23489862|NCT01845818|65537231|FG000|Overall Study|Withdrawal by Subject|0|||
23665849|NCT01838616|66162540|FG000|Pick-up Arm|Lack of Efficacy|4|||
23665850|NCT01838616|66162541|FG001|Pick-up Arm|Lack of Efficacy|0|||
23665851|NCT01838616|66162540|FG000|Pick-up Arm|Adverse Event|9|||
23665852|NCT01838616|66162541|FG001|Pick-up Arm|Adverse Event|0|||
23489863|NCT01845818|65537232|FG001|Overall Study|Withdrawal by Subject|1|||
23489864|NCT01845818|65537231|FG000|Overall Study|Lost to Follow-up|7|||
23489865|NCT01845818|65537232|FG001|Overall Study|Lost to Follow-up|5|||
23489866|NCT01845818|65537231|FG000|Overall Study|Administrative Reasons|3|||
23489867|NCT01845818|65537232|FG001|Overall Study|Administrative Reasons|1|||
23665853|NCT01838616|66162540|FG000|Pick-up Arm|Withdrawal by Subject|1|||
23665854|NCT01838616|66162541|FG001|Pick-up Arm|Withdrawal by Subject|0|||
23665855|NCT01838616|66162540|FG000|Pick-up Arm|Technical problems|1|||
23489868|NCT01845818|65537231|FG000|Overall Study|Serious Adverse Event|1|||
23489869|NCT01845818|65537232|FG001|Overall Study|Serious Adverse Event|1|||
23489870|NCT01845818|65537231|FG000|Overall Study|Other|25|||
23489871|NCT01845818|65537232|FG001|Overall Study|Other|8|||
23489872|NCT01845818|65537231|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
23489873|NCT01845818|65537232|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
23489874|NCT01845818|65537231|FG000|Overall Study|No Follow-Up Data Available|4|||
23489875|NCT01845818|65537232|FG001|Overall Study|No Follow-Up Data Available|1|||
23489876|NCT02869438|65537233|FG000|Overall Study|Lost to Follow-up|1|||
23489877|NCT02869438|65537234|FG001|Overall Study|Lost to Follow-up|0|||
23489878|NCT02869438|65537233|FG000|Overall Study|Adverse Event|1|||
23489879|NCT02869438|65537234|FG001|Overall Study|Adverse Event|0|||
23489880|NCT02869438|65537233|FG000|Overall Study|Withdrawal by Subject|1|||
23489881|NCT02869438|65537234|FG001|Overall Study|Withdrawal by Subject|2|||
23489882|NCT02943460|65537235|FG000|Blinded Study Phase|Adverse Event|3|||
23489883|NCT02943460|65537236|FG001|Blinded Study Phase|Adverse Event|0|||
23489884|NCT02943460|65537237|FG002|Blinded Study Phase|Adverse Event|0|||
23489885|NCT02943460|65537235|FG000|Blinded Study Phase|Withdrew Consent|0|||
23489886|NCT02943460|65537236|FG001|Blinded Study Phase|Withdrew Consent|1|||
23489887|NCT02943460|65537237|FG002|Blinded Study Phase|Withdrew Consent|0|||
23489888|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
23489889|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
23489890|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
23489891|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
23489892|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
23489893|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
23489894|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
23489895|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
23489896|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
23489897|NCT00853073|65537240|FG000|Overall Study|Withdrawal by Subject|3|||
23489898|NCT00853073|65537241|FG001|Overall Study|Withdrawal by Subject|2|||
23489899|NCT03360747|65537242|FG000|Overall Study|Voluntary Withdrawal|1|||
23489900|NCT05061966|65541231|FG000|Overall Study|Lost to Follow-up|13|||
23489901|NCT05061966|65541232|FG001|Overall Study|Lost to Follow-up|13|||
23489902|NCT01104701|65541233|FG000|Overall Study|Withdrawal by Subject|0|||
23489903|NCT01104701|65541234|FG001|Overall Study|Withdrawal by Subject|1|||
23489904|NCT01104701|65541235|FG002|Overall Study|Withdrawal by Subject|2|||
23489905|NCT01104701|65541236|FG003|Overall Study|Withdrawal by Subject|1|||
23489906|NCT01104701|65541233|FG000|Overall Study|Adverse Event|0|||
23489907|NCT01104701|65541234|FG001|Overall Study|Adverse Event|0|||
23489908|NCT01104701|65541235|FG002|Overall Study|Adverse Event|0|||
23604799|NCT01159600|65943510|FG006|Overall Study|Non compliant with protocol|2|||
23604800|NCT01159600|65943511|FG007|Overall Study|Non compliant with protocol|0|||
23604801|NCT01159600|65943504|FG000|Overall Study|Lost to Follow-up|2|||
23604802|NCT01159600|65943505|FG001|Overall Study|Lost to Follow-up|3|||
23604803|NCT01159600|65943506|FG002|Overall Study|Lost to Follow-up|4|||
23604804|NCT01159600|65943507|FG003|Overall Study|Lost to Follow-up|3|||
23604805|NCT01159600|65943508|FG004|Overall Study|Lost to Follow-up|3|||
23604806|NCT01159600|65943509|FG005|Overall Study|Lost to Follow-up|0|||
23604807|NCT01159600|65943510|FG006|Overall Study|Lost to Follow-up|3|||
23604808|NCT01159600|65943511|FG007|Overall Study|Lost to Follow-up|2|||
23604809|NCT01159600|65943504|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
23604810|NCT01159600|65943505|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
23604811|NCT01159600|65943506|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
23604812|NCT01159600|65943507|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
23604813|NCT01159600|65943508|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
23604814|NCT01159600|65943509|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
23604815|NCT01159600|65943510|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
23604816|NCT01159600|65943511|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
23604817|NCT01159600|65943504|FG000|Overall Study|Other reason not defined above|3|||
23604818|NCT01159600|65943505|FG001|Overall Study|Other reason not defined above|0|||
23604819|NCT01159600|65943506|FG002|Overall Study|Other reason not defined above|4|||
23604820|NCT01159600|65943507|FG003|Overall Study|Other reason not defined above|2|||
23604821|NCT01159600|65943508|FG004|Overall Study|Other reason not defined above|5|||
23604822|NCT01159600|65943509|FG005|Overall Study|Other reason not defined above|7|||
23489909|NCT01104701|65541236|FG003|Overall Study|Adverse Event|1|||
23489910|NCT01104701|65541233|FG000|Overall Study|Physician Decision|0|||
23604823|NCT01159600|65943510|FG006|Overall Study|Other reason not defined above|3|||
23604824|NCT01159600|65943511|FG007|Overall Study|Other reason not defined above|3|||
23604825|NCT01566890|65943512|FG000|Overall Study|Adverse Event|1|||
23489911|NCT01104701|65541234|FG001|Overall Study|Physician Decision|2|||
23489912|NCT01104701|65541235|FG002|Overall Study|Physician Decision|0|||
23489913|NCT01104701|65541236|FG003|Overall Study|Physician Decision|0|||
23489914|NCT02047227|65541238|FG000|Overall Study|Adverse Event|2|||
23377617|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
23377618|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
23377619|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
23377620|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
23377621|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
23377622|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
23377623|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
23377624|NCT05073315|65126674|FG000|Period 2|Adverse Event|0|||
23377625|NCT05073315|65126675|FG001|Period 2|Adverse Event|3|||
23377626|NCT05073315|65126676|FG002|Period 2|Adverse Event|6|||
23377627|NCT05073315|65126674|FG000|Period 2|Lost to Follow-up|0|||
23377628|NCT05073315|65126675|FG001|Period 2|Lost to Follow-up|5|||
23377629|NCT05073315|65126676|FG002|Period 2|Lost to Follow-up|5|||
23377630|NCT05073315|65126674|FG000|Period 2|Withdrawal by Subject|0|||
23377631|NCT05073315|65126675|FG001|Period 2|Withdrawal by Subject|4|||
23377632|NCT05073315|65126676|FG002|Period 2|Withdrawal by Subject|9|||
23377633|NCT05073315|65126674|FG000|Period 2|Protocol Violation|0|||
23377634|NCT05073315|65126675|FG001|Period 2|Protocol Violation|0|||
23377635|NCT05073315|65126676|FG002|Period 2|Protocol Violation|1|||
23377636|NCT02107898|65126680|FG000|Overall Study|Adverse Event|4|||
23377637|NCT02107898|65126681|FG001|Overall Study|Adverse Event|7|||
23377638|NCT02107898|65126680|FG000|Overall Study|Poor compliance to protocol|0|||
23377639|NCT02107898|65126681|FG001|Overall Study|Poor compliance to protocol|1|||
23377640|NCT02107898|65126680|FG000|Overall Study|Participant moved|0|||
23377641|NCT02107898|65126681|FG001|Overall Study|Participant moved|2|||
23377642|NCT02107898|65126680|FG000|Overall Study|Consent withdrawn by participant|2|||
23377643|NCT02107898|65126681|FG001|Overall Study|Consent withdrawn by participant|1|||
23377644|NCT02107898|65126680|FG000|Overall Study|Randomized but not treated|0|||
23377645|NCT02107898|65126681|FG001|Overall Study|Randomized but not treated|1|||
23377646|NCT00998946|65126682|FG000|Overall Study|Lost to Follow-up|1|||
23377647|NCT00998946|65126682|FG000|Overall Study|Withdrawal by Subject|1|||
23377648|NCT00998946|65126682|FG000|Overall Study|Death|2|||
23377649|NCT00998946|65126682|FG000|Overall Study|Reason Unspecified|3|||
23377650|NCT00998946|65126682|FG000|Overall Study|Enrolled but not Dosed|2|||
23377651|NCT03101020|65126683|FG000|Overall Study|Lack of time to participate|1|||
23377652|NCT03101020|65126684|FG001|Overall Study|Lack of time to participate|0|||
23377653|NCT03101020|65126683|FG000|Overall Study|Ran over by a car|0|||
23377654|NCT03101020|65126684|FG001|Overall Study|Ran over by a car|1|||
23377655|NCT03101020|65126683|FG000|Overall Study|Withdrawal by Subject|0|||
23377656|NCT03101020|65126684|FG001|Overall Study|Withdrawal by Subject|2|||
23489915|NCT02047227|65541239|FG001|Overall Study|Adverse Event|4|||
23489916|NCT02047227|65541238|FG000|Overall Study|Lost to Follow-up|0|||
23489917|NCT02047227|65541239|FG001|Overall Study|Lost to Follow-up|3|||
23489918|NCT02047227|65541238|FG000|Overall Study|Protocol Violation|1|||
23604826|NCT01566890|65943513|FG001|Overall Study|Adverse Event|0|||
23604827|NCT01566890|65943514|FG002|Overall Study|Adverse Event|0|||
23604828|NCT01566890|65943515|FG003|Overall Study|Adverse Event|0|||
23604829|NCT01566890|65943516|FG004|Overall Study|Adverse Event|0|||
23604830|NCT01566890|65943512|FG000|Overall Study|Withdrawal by Subject|3|||
23604831|NCT01566890|65943513|FG001|Overall Study|Withdrawal by Subject|1|||
23604832|NCT01566890|65943514|FG002|Overall Study|Withdrawal by Subject|1|||
23377657|NCT00858988|65126685|FG000|Analysis|Lactulose unable to be detected in urine|2|||
23377658|NCT00858988|65126686|FG001|Analysis|Lactulose unable to be detected in urine|1|||
23489919|NCT02047227|65541239|FG001|Overall Study|Protocol Violation|0|||
23604833|NCT01566890|65943515|FG003|Overall Study|Withdrawal by Subject|1|||
23377659|NCT01405911|65126689|FG000|Overall Study|Pre-treatment lab AE|0|||
23377660|NCT01405911|65126690|FG001|Overall Study|Pre-treatment lab AE|1|||
23377661|NCT01405911|65126691|FG002|Overall Study|Pre-treatment lab AE|0|||
23377662|NCT01405911|65126689|FG000|Overall Study|Lost to Follow-up|0|||
23377663|NCT01405911|65126690|FG001|Overall Study|Lost to Follow-up|1|||
23377664|NCT01405911|65126691|FG002|Overall Study|Lost to Follow-up|0|||
23377665|NCT01405911|65126689|FG000|Overall Study|Protocol Violation|1|||
23377666|NCT01405911|65126690|FG001|Overall Study|Protocol Violation|0|||
23377667|NCT01405911|65126691|FG002|Overall Study|Protocol Violation|0|||
23377668|NCT01405911|65126689|FG000|Overall Study|Withdrawal by Subject|3|||
23377669|NCT01405911|65126690|FG001|Overall Study|Withdrawal by Subject|1|||
23377670|NCT01405911|65126691|FG002|Overall Study|Withdrawal by Subject|1|||
23377671|NCT00662259|65126700|FG000|Overall Study|Adverse Event|2|||
23377672|NCT00662259|65126701|FG001|Overall Study|Adverse Event|0|||
23377673|NCT02780388|65126702|FG000|Overall Study|Lost to Follow-up|0|||
23377674|NCT02780388|65126703|FG001|Overall Study|Lost to Follow-up|1|||
23377675|NCT02780388|65126704|FG002|Overall Study|Lost to Follow-up|0|||
23377676|NCT02780388|65126705|FG003|Overall Study|Lost to Follow-up|0|||
23377677|NCT02780388|65126706|FG004|Overall Study|Lost to Follow-up|0|||
23377678|NCT02780388|65126702|FG000|Overall Study|Withdrawal by Subject|1|||
23377679|NCT02780388|65126703|FG001|Overall Study|Withdrawal by Subject|1|||
23377680|NCT02780388|65126704|FG002|Overall Study|Withdrawal by Subject|0|||
23377681|NCT02780388|65126705|FG003|Overall Study|Withdrawal by Subject|0|||
23377682|NCT02780388|65126706|FG004|Overall Study|Withdrawal by Subject|0|||
23377683|NCT00576758|65126709|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
23377684|NCT00576758|65126710|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
23377685|NCT00576758|65126709|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
23377686|NCT00576758|65126710|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
23377687|NCT00576758|65126709|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
23377688|NCT00576758|65126710|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
23377689|NCT00576758|65126709|FG000|Induction Treatment Period|Death|1|||
23377690|NCT00576758|65126710|FG001|Induction Treatment Period|Death|0|||
23377691|NCT00576758|65126709|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
23377692|NCT00576758|65126710|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
23377693|NCT00576758|65126709|FG000|Induction Treatment Period|Withdrew consent|1|||
23377694|NCT00576758|65126710|FG001|Induction Treatment Period|Withdrew consent|0|||
23377695|NCT00576758|65126709|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
23377696|NCT00576758|65126710|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
23377697|NCT00576758|65126709|FG000|Extension Treatment Period|Death|1|||
23377698|NCT00576758|65126710|FG001|Extension Treatment Period|Death|1|||
23377699|NCT00576758|65126709|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
23377700|NCT00576758|65126710|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
23377701|NCT00576758|65126709|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
23377702|NCT00576758|65126710|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
23377703|NCT00576758|65126709|FG000|Extension Treatment Period|Administrative/Other|3|||
23377704|NCT00576758|65126710|FG001|Extension Treatment Period|Administrative/Other|1|||
23377705|NCT00576758|65126709|FG000|Follow-up Period|Administrative/Other|6|||
23377706|NCT00576758|65126710|FG001|Follow-up Period|Administrative/Other|8|||
23377707|NCT00576758|65126709|FG000|Follow-up Period|Death|3|||
23377708|NCT00576758|65126710|FG001|Follow-up Period|Death|3|||
23377709|NCT00576758|65126709|FG000|Follow-up Period|Insufficient therapeutic response|16|||
23377710|NCT00576758|65126710|FG001|Follow-up Period|Insufficient therapeutic response|5|||
23377711|NCT00576758|65126709|FG000|Follow-up Period|Withdrew consent|2|||
23377712|NCT00576758|65126710|FG001|Follow-up Period|Withdrew consent|1|||
23377713|NCT03416179|65126711|FG000|Overall Study|Death|90|||
23377714|NCT03416179|65126712|FG001|Overall Study|Death|87|||
23377715|NCT03416179|65126713|FG002|Overall Study|Death|117|||
23377716|NCT03416179|65126714|FG003|Overall Study|Death|113|||
23377717|NCT03416179|65126711|FG000|Overall Study|Withdrawal by Subject|15|||
23377718|NCT03416179|65126712|FG001|Overall Study|Withdrawal by Subject|20|||
23377719|NCT03416179|65126713|FG002|Overall Study|Withdrawal by Subject|6|||
23377720|NCT03416179|65126714|FG003|Overall Study|Withdrawal by Subject|9|||
23377721|NCT03416179|65126711|FG000|Overall Study|Lost to Follow-up|1|||
23377722|NCT03416179|65126712|FG001|Overall Study|Lost to Follow-up|1|||
23377723|NCT03416179|65126713|FG002|Overall Study|Lost to Follow-up|0|||
23377724|NCT03416179|65126714|FG003|Overall Study|Lost to Follow-up|3|||
23377725|NCT03416179|65126711|FG000|Overall Study|Study participation terminated by Sponsor|93|||
23377726|NCT03416179|65126712|FG001|Overall Study|Study participation terminated by Sponsor|91|||
23377727|NCT03416179|65126713|FG002|Overall Study|Study participation terminated by Sponsor|26|||
23377728|NCT03416179|65126714|FG003|Overall Study|Study participation terminated by Sponsor|31|||
23665856|NCT01838616|66162541|FG001|Pick-up Arm|Technical problems|0|||
23665857|NCT01358864|66162542|FG000|Overall Study|Adverse Event|0|||
23665858|NCT01358864|66162543|FG001|Overall Study|Adverse Event|6|||
23665859|NCT01358864|66162544|FG002|Overall Study|Adverse Event|9|||
23665860|NCT01358864|66162545|FG003|Overall Study|Adverse Event|0|||
23377729|NCT03416179|65126711|FG000|Overall Study|Other|2|||
23604834|NCT01566890|65943516|FG004|Overall Study|Withdrawal by Subject|0|||
23604835|NCT01566890|65943512|FG000|Overall Study|Screen failure|6|||
23604836|NCT01566890|65943513|FG001|Overall Study|Screen failure|0|||
23604837|NCT01566890|65943514|FG002|Overall Study|Screen failure|1|||
23604838|NCT01566890|65943515|FG003|Overall Study|Screen failure|1|||
23604839|NCT01566890|65943516|FG004|Overall Study|Screen failure|0|||
23604840|NCT01566890|65943512|FG000|Overall Study|Incomplete CEU data|1|||
23604841|NCT01566890|65943513|FG001|Overall Study|Incomplete CEU data|3|||
23604842|NCT01566890|65943514|FG002|Overall Study|Incomplete CEU data|5|||
23604843|NCT01566890|65943515|FG003|Overall Study|Incomplete CEU data|8|||
23604844|NCT01566890|65943516|FG004|Overall Study|Incomplete CEU data|0|||
23604845|NCT01566890|65943512|FG000|Overall Study|Lost to Follow-up|0|||
23604846|NCT01566890|65943513|FG001|Overall Study|Lost to Follow-up|0|||
23604847|NCT01566890|65943514|FG002|Overall Study|Lost to Follow-up|4|||
23604848|NCT01566890|65943515|FG003|Overall Study|Lost to Follow-up|4|||
23604849|NCT01566890|65943516|FG004|Overall Study|Lost to Follow-up|0|||
23604850|NCT01566890|65943512|FG000|Overall Study|Other|0|||
23604851|NCT01566890|65943513|FG001|Overall Study|Other|0|||
23604852|NCT01566890|65943514|FG002|Overall Study|Other|0|||
23377730|NCT03416179|65126712|FG001|Overall Study|Other|3|||
23377731|NCT03416179|65126713|FG002|Overall Study|Other|1|||
23377732|NCT03416179|65126714|FG003|Overall Study|Other|0|||
23377733|NCT01253161|65126717|FG000|Overall Study|Adverse Event|1|||
23377734|NCT00929669|65126726|FG000|Overall Study|elevated glucose levels|1|||
23604853|NCT01566890|65943515|FG003|Overall Study|Other|0|||
23665861|NCT01358864|66162546|FG004|Overall Study|Adverse Event|4|||
23665862|NCT01358864|66162547|FG005|Overall Study|Adverse Event|8|||
23665863|NCT01358864|66162548|FG006|Overall Study|Adverse Event|12|||
23665864|NCT01358864|66162549|FG007|Overall Study|Adverse Event|7|||
23665865|NCT01358864|66162542|FG000|Overall Study|Lack of Efficacy|26|||
23665866|NCT01358864|66162543|FG001|Overall Study|Lack of Efficacy|3|||
23665867|NCT01358864|66162544|FG002|Overall Study|Lack of Efficacy|4|||
23665868|NCT01358864|66162545|FG003|Overall Study|Lack of Efficacy|19|||
23665869|NCT01358864|66162546|FG004|Overall Study|Lack of Efficacy|7|||
23665870|NCT01358864|66162547|FG005|Overall Study|Lack of Efficacy|4|||
23665871|NCT01358864|66162548|FG006|Overall Study|Lack of Efficacy|49|||
23665872|NCT01358864|66162549|FG007|Overall Study|Lack of Efficacy|44|||
23665873|NCT01358864|66162542|FG000|Overall Study|Lost to Follow-up|0|||
23665874|NCT01358864|66162543|FG001|Overall Study|Lost to Follow-up|0|||
23665875|NCT01358864|66162544|FG002|Overall Study|Lost to Follow-up|1|||
23665876|NCT01358864|66162545|FG003|Overall Study|Lost to Follow-up|0|||
23665877|NCT01358864|66162546|FG004|Overall Study|Lost to Follow-up|0|||
23665878|NCT01358864|66162547|FG005|Overall Study|Lost to Follow-up|0|||
23665879|NCT01358864|66162548|FG006|Overall Study|Lost to Follow-up|0|||
23665880|NCT01358864|66162549|FG007|Overall Study|Lost to Follow-up|1|||
23665881|NCT01358864|66162542|FG000|Overall Study|Withdrawal by Subject|3|||
23665882|NCT01358864|66162543|FG001|Overall Study|Withdrawal by Subject|4|||
23665883|NCT01358864|66162544|FG002|Overall Study|Withdrawal by Subject|2|||
23604854|NCT01566890|65943516|FG004|Overall Study|Other|7|||
23604855|NCT00068107|65943519|FG000|Overall Study|end-stage renal disease|6|||
23604856|NCT00068107|65943519|FG000|Overall Study|Death|2|||
23604857|NCT00068107|65943519|FG000|Overall Study|Withdrawal by Subject|1|||
23604858|NCT04660799|65943520|FG000|Overall Study|Progressive Disease|1|||
23604859|NCT04660799|65943521|FG001|Overall Study|Progressive Disease|1|||
23604860|NCT04660799|65943520|FG000|Overall Study|Death|2|||
23604861|NCT04660799|65943521|FG001|Overall Study|Death|1|||
23604862|NCT04660799|65943520|FG000|Overall Study|Adverse Event|2|||
23604863|NCT04660799|65943521|FG001|Overall Study|Adverse Event|1|||
23604864|NCT04660799|65943520|FG000|Overall Study|Withdrawal by Subject|2|||
23604865|NCT04660799|65943521|FG001|Overall Study|Withdrawal by Subject|5|||
23604866|NCT00065182|65943529|FG000|Overall Study|Adverse Event|24|||
23604867|NCT00065182|65943530|FG001|Overall Study|Adverse Event|17|||
23604868|NCT00065182|65943529|FG000|Overall Study|Lost to Follow-up|0|||
23604869|NCT00065182|65943530|FG001|Overall Study|Lost to Follow-up|4|||
23604870|NCT00065182|65943529|FG000|Overall Study|Protocol Violation|3|||
23604871|NCT00065182|65943530|FG001|Overall Study|Protocol Violation|4|||
23604872|NCT00065182|65943529|FG000|Overall Study|Serious adverse events (SAE)|1|||
23489920|NCT02047227|65541238|FG000|Overall Study|Spontaneous pregnancy|1|||
23489921|NCT02047227|65541239|FG001|Overall Study|Spontaneous pregnancy|0|||
23604873|NCT00065182|65943530|FG001|Overall Study|Serious adverse events (SAE)|0|||
23604874|NCT00065182|65943529|FG000|Overall Study|Sponsor Decision|11|||
23604875|NCT00065182|65943530|FG001|Overall Study|Sponsor Decision|7|||
23665884|NCT01358864|66162545|FG003|Overall Study|Withdrawal by Subject|0|||
23665885|NCT01358864|66162546|FG004|Overall Study|Withdrawal by Subject|0|||
23665886|NCT01358864|66162547|FG005|Overall Study|Withdrawal by Subject|1|||
23665887|NCT01358864|66162548|FG006|Overall Study|Withdrawal by Subject|1|||
23604876|NCT00065182|65943529|FG000|Overall Study|Withdrawal by Subject|8|||
23665888|NCT01358864|66162549|FG007|Overall Study|Withdrawal by Subject|3|||
23665889|NCT01358864|66162542|FG000|Overall Study|Other reason not defined above|2|||
23604877|NCT00065182|65943530|FG001|Overall Study|Withdrawal by Subject|3|||
23604878|NCT00065182|65943529|FG000|Overall Study|No clinical benefit|1|||
23604879|NCT00065182|65943530|FG001|Overall Study|No clinical benefit|0|||
23604880|NCT00065182|65943529|FG000|Overall Study|Death|0|||
23604881|NCT00065182|65943530|FG001|Overall Study|Death|1|||
23604882|NCT00065182|65943529|FG000|Overall Study|Decline in Status|0|||
23604883|NCT00065182|65943530|FG001|Overall Study|Decline in Status|1|||
23604884|NCT00570505|65943531|FG000|Overall Study|Adverse Event|7|||
23604885|NCT00570505|65943531|FG000|Overall Study|Withdrawal by Subject|7|||
23604886|NCT00570505|65943531|FG000|Overall Study|Lost to Follow-up|23|||
23604887|NCT00570505|65943531|FG000|Overall Study|Other loss to follow-up|4|||
23604888|NCT03490032|65943532|FG000|Overall Study|family issue (child custody)|1|||
23604889|NCT03490032|65943533|FG001|Overall Study|family issue (child custody)|0|||
23604890|NCT03490032|65943534|FG002|Overall Study|family issue (child custody)|0|||
23604891|NCT00553332|65943535|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
23489922|NCT02047227|65541238|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
23489923|NCT02047227|65541239|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
23489924|NCT02047227|65541238|FG000|Overall Study|No oocytes retrieved|21|||
23489925|NCT02047227|65541239|FG001|Overall Study|No oocytes retrieved|20|||
23489926|NCT02047227|65541238|FG000|Overall Study|No fertilization|61|||
23489927|NCT02047227|65541239|FG001|Overall Study|No fertilization|51|||
23489928|NCT02047227|65541238|FG000|Overall Study|Intention to freeze all embryos|1|||
23489929|NCT02047227|65541239|FG001|Overall Study|Intention to freeze all embryos|0|||
23489930|NCT02047227|65541238|FG000|Overall Study|All embryos discarded|12|||
23489931|NCT02047227|65541239|FG001|Overall Study|All embryos discarded|11|||
23489932|NCT02047227|65541238|FG000|Overall Study|Other|10|||
23489933|NCT02047227|65541239|FG001|Overall Study|Other|9|||
23489934|NCT01051466|65541242|FG000|Overall Study|Adverse Event|1|||
23489935|NCT01051466|65541243|FG001|Overall Study|Adverse Event|0|||
23489936|NCT01051466|65541242|FG000|Overall Study|Lost to Follow-up|1|||
23489937|NCT01051466|65541243|FG001|Overall Study|Lost to Follow-up|1|||
23489938|NCT01051466|65541242|FG000|Overall Study|Withdrawal by Subject|5|||
23489939|NCT01051466|65541243|FG001|Overall Study|Withdrawal by Subject|1|||
23489940|NCT01051466|65541242|FG000|Overall Study|Entry Criteria Not Met|0|||
23489941|NCT01051466|65541243|FG001|Overall Study|Entry Criteria Not Met|3|||
23489942|NCT01051466|65541242|FG000|Overall Study|Physician Decision|1|||
23489943|NCT01051466|65541243|FG001|Overall Study|Physician Decision|0|||
23489944|NCT00470847|65541244|FG000|Overall Study|Pt still receiving treatment|1|||
23489945|NCT01609231|65541245|FG000|Overall Study|Adverse Event|1|||
23489946|NCT01609231|65541246|FG001|Overall Study|Adverse Event|3|||
23489947|NCT01609231|65541245|FG000|Overall Study|Physician Decision|1|||
23489948|NCT01609231|65541246|FG001|Overall Study|Physician Decision|0|||
23489949|NCT01609231|65541245|FG000|Overall Study|Withdrawal by Subject|1|||
23489950|NCT01609231|65541246|FG001|Overall Study|Withdrawal by Subject|0|||
23489951|NCT01858376|65541249|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
23604892|NCT03418922|65943536|FG000|Overall Study|Withdrawal by Subject|0|||
23489952|NCT01068652|65541252|FG000|Overall Study|Adverse Event|4|||
23489953|NCT01068652|65541253|FG001|Overall Study|Adverse Event|0|||
23489954|NCT01068652|65541252|FG000|Overall Study|Lack of Efficacy|0|||
23489955|NCT01068652|65541253|FG001|Overall Study|Lack of Efficacy|2|||
23489956|NCT01068652|65541252|FG000|Overall Study|Lost to Follow-up|2|||
23489957|NCT01068652|65541253|FG001|Overall Study|Lost to Follow-up|1|||
23489958|NCT01068652|65541252|FG000|Overall Study|Protocol Violation|3|||
23489959|NCT01068652|65541253|FG001|Overall Study|Protocol Violation|6|||
23489960|NCT01068652|65541252|FG000|Overall Study|Withdrawal criteria|1|||
23489961|NCT01068652|65541253|FG001|Overall Study|Withdrawal criteria|2|||
23489962|NCT01068652|65541252|FG000|Overall Study|Patient was not eligible|1|||
23489963|NCT01068652|65541253|FG001|Overall Study|Patient was not eligible|0|||
23604893|NCT03418922|65943537|FG001|Overall Study|Withdrawal by Subject|2|||
23489964|NCT01068652|65541252|FG000|Overall Study|Unclassified|7|||
23489965|NCT01068652|65541253|FG001|Overall Study|Unclassified|4|||
23604894|NCT03418922|65943536|FG000|Overall Study|Adverse Event|2|||
23604895|NCT03418922|65943537|FG001|Overall Study|Adverse Event|2|||
23604896|NCT03418922|65943536|FG000|Overall Study|Death|0|||
23604897|NCT03418922|65943537|FG001|Overall Study|Death|1|||
23604898|NCT03418922|65943536|FG000|Overall Study|Physician Decision|0|||
23604899|NCT03418922|65943537|FG001|Overall Study|Physician Decision|1|||
23604900|NCT04820491|65943538|FG000|Overall Study|Withdrawal by Subject|1|||
23604901|NCT04820491|65943539|FG001|Overall Study|Withdrawal by Subject|0|||
23604902|NCT02338999|65943541|FG000|First Intervention|Withdrawal by Subject|3|||
23604903|NCT02338999|65943542|FG001|First Intervention|Withdrawal by Subject|1|||
23604904|NCT02338999|65943541|FG000|Washout Period|Withdrawal by Subject|0|||
23604905|NCT02338999|65943542|FG001|Washout Period|Withdrawal by Subject|2|||
23604906|NCT02338999|65943541|FG000|Second Intervention|Withdrawal by Subject|0|||
23604907|NCT02338999|65943542|FG001|Second Intervention|Withdrawal by Subject|2|||
23604908|NCT03938272|65943552|FG000|Overall Study|Withdrawal by Subject|1|||
23604909|NCT03938272|65943553|FG001|Overall Study|Withdrawal by Subject|0|||
23604910|NCT03938272|65943552|FG000|Overall Study|Physician Decision|0|||
23604911|NCT03938272|65943553|FG001|Overall Study|Physician Decision|2|||
23604912|NCT03938272|65943552|FG000|Overall Study|Study termination by sponsor|10|||
23604913|NCT03938272|65943553|FG001|Overall Study|Study termination by sponsor|8|||
23604914|NCT02410278|65943556|FG000|Run-in Period|Adverse Event|5|||
23604915|NCT02410278|65943557|FG001|Run-in Period|Adverse Event|0|||
23604916|NCT02410278|65943558|FG002|Run-in Period|Adverse Event|0|||
23604917|NCT02410278|65943556|FG000|Run-in Period|GSRS Threshold Not Met|30|||
23377735|NCT01125748|65126727|FG000|Overall Study|Adverse Event|0|||
23377736|NCT01125748|65126728|FG001|Overall Study|Adverse Event|2|||
23377737|NCT01125748|65126727|FG000|Overall Study|Lost to Follow-up|0|||
23377738|NCT01125748|65126728|FG001|Overall Study|Lost to Follow-up|1|||
23377739|NCT01125748|65126727|FG000|Overall Study|Physician Decision|8|||
23377740|NCT01125748|65126728|FG001|Overall Study|Physician Decision|7|||
23377741|NCT01125748|65126727|FG000|Overall Study|Patient Decision to Withdraw|2|||
23377742|NCT01125748|65126728|FG001|Overall Study|Patient Decision to Withdraw|4|||
23377743|NCT03122106|65126729|FG000|Overall Study|Not enough tissue|1|||
23377744|NCT03122106|65126729|FG000|Overall Study|Disease progression during screening|2|||
23377745|NCT03122106|65126729|FG000|Overall Study|Poor RNA quality for vaccine|1|||
23377746|NCT00857389|65126730|FG000|Overall Study|Did not proceed to transplant|2|||
23377747|NCT00832975|65126731|FG000|Overall Study|Lost to Follow-up|7|||
23377748|NCT00832975|65126731|FG000|Overall Study|Protocol Violation|6|||
23377749|NCT00832975|65126731|FG000|Overall Study|Death|5|||
23377750|NCT00832975|65126731|FG000|Overall Study|Physician Decision|4|||
23377751|NCT00832975|65126731|FG000|Overall Study|Withdrawal by Subject|3|||
23377752|NCT00832975|65126731|FG000|Overall Study|Other reasons|14|||
23377753|NCT02114684|65126734|FG000|Overall Study|Death|6|||
23377754|NCT02114684|65126735|FG001|Overall Study|Death|4|||
23377755|NCT02114684|65126734|FG000|Overall Study|Lost to Follow-up|1|||
23377756|NCT02114684|65126735|FG001|Overall Study|Lost to Follow-up|2|||
23377757|NCT02114684|65126734|FG000|Overall Study|Withdrawal by Subject|1|||
23377758|NCT02114684|65126735|FG001|Overall Study|Withdrawal by Subject|2|||
23377759|NCT02114684|65126734|FG000|Overall Study|Relocation|3|||
23377760|NCT02114684|65126735|FG001|Overall Study|Relocation|1|||
23377761|NCT02114684|65126734|FG000|Overall Study|Rifampicin resistant on culture|0|||
23377762|NCT02114684|65126735|FG001|Overall Study|Rifampicin resistant on culture|1|||
23377763|NCT02114684|65126734|FG000|Overall Study|Patient Incarcerated|1|||
23377764|NCT02114684|65126735|FG001|Overall Study|Patient Incarcerated|0|||
23377765|NCT01039675|65126739|FG000|Overall Study|Adverse Event|0|||
23377766|NCT01039675|65126740|FG001|Overall Study|Adverse Event|2|||
23377767|NCT01039675|65126739|FG000|Overall Study|Lack of Efficacy|0|||
23377768|NCT01039675|65126740|FG001|Overall Study|Lack of Efficacy|2|||
23377769|NCT01039675|65126739|FG000|Overall Study|Withdrawal by Subject|0|||
23377770|NCT01039675|65126740|FG001|Overall Study|Withdrawal by Subject|1|||
23377771|NCT01039675|65126739|FG000|Overall Study|Lost to Follow-up|0|||
23377772|NCT01039675|65126740|FG001|Overall Study|Lost to Follow-up|1|||
23377773|NCT01039675|65126739|FG000|Overall Study|Physician Decision|0|||
23604918|NCT02410278|65943557|FG001|Run-in Period|GSRS Threshold Not Met|0|||
23604919|NCT02410278|65943558|FG002|Run-in Period|GSRS Threshold Not Met|0|||
23604920|NCT02410278|65943556|FG000|Run-in Period|Lost to Follow-up|1|||
23604921|NCT02410278|65943557|FG001|Run-in Period|Lost to Follow-up|0|||
23604922|NCT02410278|65943558|FG002|Run-in Period|Lost to Follow-up|0|||
23604923|NCT02410278|65943556|FG000|Run-in Period|Withdrawal by Subject|1|||
23377774|NCT01039675|65126740|FG001|Overall Study|Physician Decision|1|||
23377775|NCT02690727|65126743|FG000|Overall Study|Adverse Event|2|||
23377776|NCT02690727|65126744|FG001|Overall Study|Adverse Event|2|||
23377777|NCT05630196|65126748|FG000|Overall Study|Adverse Event|2|||
23377778|NCT05630196|65126749|FG001|Overall Study|Adverse Event|1|||
23377779|NCT05630196|65126748|FG000|Overall Study|Lost to Follow-up|1|||
23377780|NCT05630196|65126749|FG001|Overall Study|Lost to Follow-up|1|||
23377781|NCT05630196|65126748|FG000|Overall Study|Protocol Violation|2|||
23377782|NCT05630196|65126749|FG001|Overall Study|Protocol Violation|3|||
23604924|NCT02410278|65943557|FG001|Run-in Period|Withdrawal by Subject|0|||
23377783|NCT05630196|65126748|FG000|Overall Study|Physician Decision|1|||
23377784|NCT05630196|65126749|FG001|Overall Study|Physician Decision|0|||
23377785|NCT05630196|65126748|FG000|Overall Study|Withdrawal by Subject|3|||
23377786|NCT05630196|65126749|FG001|Overall Study|Withdrawal by Subject|4|||
23377787|NCT03157089|65126750|FG000|Overall Study|Treated only with pembrolizumab|1|||
23377788|NCT03157089|65126751|FG001|Overall Study|Treated only with pembrolizumab|0|||
23377789|NCT03157089|65126750|FG000|Overall Study|Adverse Event|5|||
23377790|NCT03157089|65126751|FG001|Overall Study|Adverse Event|4|||
23377791|NCT03157089|65126750|FG000|Overall Study|Progressive disease|6|||
23377792|NCT03157089|65126751|FG001|Overall Study|Progressive disease|8|||
23377793|NCT00390689|65126752|FG000|Overall Study|Adverse Event|2|||
23377794|NCT00390689|65126753|FG001|Overall Study|Adverse Event|5|||
23377795|NCT00390689|65126754|FG002|Overall Study|Adverse Event|2|||
23377796|NCT00390689|65126752|FG000|Overall Study|Lack of Efficacy|0|||
23377797|NCT00390689|65126753|FG001|Overall Study|Lack of Efficacy|0|||
23377798|NCT00390689|65126754|FG002|Overall Study|Lack of Efficacy|1|||
23377799|NCT00390689|65126752|FG000|Overall Study|Protocol Violation|1|||
23377800|NCT00390689|65126753|FG001|Overall Study|Protocol Violation|0|||
23377801|NCT00390689|65126754|FG002|Overall Study|Protocol Violation|0|||
23377802|NCT00390689|65126752|FG000|Overall Study|Investigator's judgement|2|||
23377803|NCT00390689|65126753|FG001|Overall Study|Investigator's judgement|0|||
23377804|NCT00390689|65126754|FG002|Overall Study|Investigator's judgement|0|||
23377805|NCT00903201|65126755|FG000|Overall Study|Adverse Event|1|||
23377806|NCT00903201|65126756|FG001|Overall Study|Adverse Event|4|||
23377807|NCT00903201|65126757|FG002|Overall Study|Adverse Event|0|||
23377808|NCT00903201|65126755|FG000|Overall Study|Protocol Violation|2|||
23377809|NCT00903201|65126756|FG001|Overall Study|Protocol Violation|1|||
23377810|NCT00903201|65126757|FG002|Overall Study|Protocol Violation|0|||
23377811|NCT00903201|65126755|FG000|Overall Study|Lost to Follow-up|0|||
23377812|NCT00903201|65126756|FG001|Overall Study|Lost to Follow-up|1|||
23377813|NCT00903201|65126757|FG002|Overall Study|Lost to Follow-up|0|||
23377814|NCT00903201|65126755|FG000|Overall Study|Physician Decision|1|||
23377815|NCT00903201|65126756|FG001|Overall Study|Physician Decision|0|||
23377816|NCT00903201|65126757|FG002|Overall Study|Physician Decision|1|||
23377817|NCT00903201|65126755|FG000|Overall Study|Withdrawal by Subject|1|||
23377818|NCT00903201|65126756|FG001|Overall Study|Withdrawal by Subject|0|||
23377819|NCT00903201|65126757|FG002|Overall Study|Withdrawal by Subject|1|||
23377820|NCT02811159|65126760|FG000|Treatment Course 1|Lost to Follow-up|1|||
23377821|NCT03188705|65126761|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
23377822|NCT03188705|65126761|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
23377823|NCT01706328|65126762|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
23377824|NCT01706328|65126763|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23377825|NCT01706328|65126764|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23377826|NCT01706328|65126762|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
23377827|NCT01706328|65126763|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23377828|NCT01706328|65126764|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23377829|NCT01706328|65126762|FG000|2-week Run-in Period|Physician Decision|4|||
23377830|NCT01706328|65126763|FG001|2-week Run-in Period|Physician Decision|0|||
23377831|NCT01706328|65126764|FG002|2-week Run-in Period|Physician Decision|0|||
23377832|NCT01706328|65126762|FG000|2-week Run-in Period|Adverse Event|4|||
23377833|NCT01706328|65126763|FG001|2-week Run-in Period|Adverse Event|0|||
23377834|NCT01706328|65126764|FG002|2-week Run-in Period|Adverse Event|0|||
23377835|NCT01706328|65126762|FG000|2-week Run-in Period|Lost to Follow-up|2|||
23377836|NCT01706328|65126763|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23377837|NCT01706328|65126764|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23377838|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
23377839|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
23377840|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
23377841|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
23377842|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
23377843|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
23377844|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
23377845|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
23489966|NCT02758171|65541254|FG000|Wash-out|Withdrawal by Subject|1|||
23377846|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
23377847|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
23489967|NCT02758171|65541255|FG001|Wash-out|Withdrawal by Subject|0|||
23377848|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
23377849|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
23377850|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
23377851|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
23377852|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
23377853|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
23377854|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
23377855|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
23377856|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23377857|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
23377858|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
23377859|NCT02246777|65126765|FG000|Overall Study|Adverse Event|2|||
23377860|NCT02246777|65126765|FG000|Overall Study|Change of residence|1|||
23377861|NCT00937950|65126766|FG000|Overall Study|Withdrawal by Subject|23|||
23377862|NCT00937950|65126766|FG000|Overall Study|Migrated/moved from study area|27|||
23377863|NCT00937950|65126766|FG000|Overall Study|Lost to Follow-up|144|||
23377864|NCT00937950|65126766|FG000|Overall Study|Missing confirmed|4|||
23377865|NCT00937950|65126766|FG000|Overall Study|Other|18|||
23377866|NCT02934178|65126767|FG000|Received Vaccination 2|Death|0|||
23377867|NCT02934178|65126768|FG001|Received Vaccination 2|Death|1|||
23377868|NCT02934178|65126767|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
23377869|NCT02934178|65126768|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
23377870|NCT01925794|65130321|FG000|180 Days|Death|2|||
23377871|NCT01925794|65130321|FG000|180 Days|Withdrawal by Subject|2|||
23377872|NCT01925794|65130321|FG000|270 Days|Death|2|||
23377873|NCT01925794|65130321|FG000|270 Days|Protocol Violation|3|||
23377874|NCT01462942|65130324|FG000|Overall Study|Adverse Event|7|||
23377875|NCT01462942|65130325|FG001|Overall Study|Adverse Event|12|||
23377876|NCT01462942|65130326|FG002|Overall Study|Adverse Event|10|||
23377877|NCT01462942|65130327|FG003|Overall Study|Adverse Event|11|||
23377878|NCT01462942|65130328|FG004|Overall Study|Adverse Event|11|||
23377879|NCT01462942|65130324|FG000|Overall Study|Other, including COPD exacerbation|3|||
23377880|NCT01462942|65130325|FG001|Overall Study|Other, including COPD exacerbation|5|||
23377881|NCT01462942|65130326|FG002|Overall Study|Other, including COPD exacerbation|2|||
23377882|NCT01462942|65130327|FG003|Overall Study|Other, including COPD exacerbation|8|||
23377883|NCT01462942|65130328|FG004|Overall Study|Other, including COPD exacerbation|5|||
23377884|NCT01462942|65130324|FG000|Overall Study|Withdrawal by Subject|14|||
23377885|NCT01462942|65130325|FG001|Overall Study|Withdrawal by Subject|10|||
23377886|NCT01462942|65130326|FG002|Overall Study|Withdrawal by Subject|14|||
23377887|NCT01462942|65130327|FG003|Overall Study|Withdrawal by Subject|16|||
23377888|NCT01462942|65130328|FG004|Overall Study|Withdrawal by Subject|19|||
23377889|NCT01462942|65130324|FG000|Overall Study|Lack of Efficacy|6|||
23377890|NCT01462942|65130325|FG001|Overall Study|Lack of Efficacy|0|||
23377891|NCT01462942|65130326|FG002|Overall Study|Lack of Efficacy|4|||
23377892|NCT01462942|65130327|FG003|Overall Study|Lack of Efficacy|5|||
23377893|NCT01462942|65130328|FG004|Overall Study|Lack of Efficacy|3|||
23377894|NCT01462942|65130324|FG000|Overall Study|Lost to Follow-up|0|||
23377895|NCT01462942|65130325|FG001|Overall Study|Lost to Follow-up|1|||
23377896|NCT01462942|65130326|FG002|Overall Study|Lost to Follow-up|1|||
23377897|NCT01462942|65130327|FG003|Overall Study|Lost to Follow-up|1|||
23604925|NCT02410278|65943558|FG002|Run-in Period|Withdrawal by Subject|0|||
23604926|NCT02410278|65943556|FG000|Run-in Period|Pregnancy|1|||
23604927|NCT02410278|65943557|FG001|Run-in Period|Pregnancy|0|||
23604928|NCT02410278|65943558|FG002|Run-in Period|Pregnancy|0|||
23604929|NCT02410278|65943556|FG000|Study Treatment Period|Adverse Event|0|||
23604930|NCT02410278|65943557|FG001|Study Treatment Period|Adverse Event|6|||
23604931|NCT02410278|65943558|FG002|Study Treatment Period|Adverse Event|3|||
23604932|NCT02410278|65943556|FG000|Study Treatment Period|Physician Decision|0|||
23604933|NCT02410278|65943557|FG001|Study Treatment Period|Physician Decision|0|||
23604934|NCT02410278|65943558|FG002|Study Treatment Period|Physician Decision|1|||
23604935|NCT02410278|65943556|FG000|Study Treatment Period|Withdrawal by Subject|0|||
23604936|NCT02410278|65943557|FG001|Study Treatment Period|Withdrawal by Subject|1|||
23604937|NCT02410278|65943558|FG002|Study Treatment Period|Withdrawal by Subject|0|||
23604938|NCT02410278|65943556|FG000|Study Treatment Period|Other|0|||
23604939|NCT02410278|65943557|FG001|Study Treatment Period|Other|3|||
23604940|NCT02410278|65943558|FG002|Study Treatment Period|Other|0|||
23604941|NCT02410278|65943556|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
23604942|NCT02410278|65943557|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
23604943|NCT02410278|65943558|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
23604944|NCT03140670|65943559|FG000|Overall Study|Withdrawal by Subject|2|||
23604945|NCT03140670|65943559|FG000|Overall Study|Lost to Follow-up|1|||
23604946|NCT03140670|65943559|FG000|Overall Study|Physician Decision|1|||
23604947|NCT04705051|65943560|FG000|Overall Study|Enrolled but not treated|1|||
23665890|NCT01358864|66162543|FG001|Overall Study|Other reason not defined above|0|||
23665891|NCT01358864|66162544|FG002|Overall Study|Other reason not defined above|0|||
23377898|NCT01462942|65130328|FG004|Overall Study|Lost to Follow-up|1|||
23377899|NCT01462942|65130324|FG000|Overall Study|Protocol Violation|4|||
23377900|NCT01462942|65130325|FG001|Overall Study|Protocol Violation|6|||
23377901|NCT01462942|65130326|FG002|Overall Study|Protocol Violation|9|||
23377902|NCT01462942|65130327|FG003|Overall Study|Protocol Violation|9|||
23377903|NCT01462942|65130328|FG004|Overall Study|Protocol Violation|6|||
23377904|NCT01682031|65130329|FG000|Overall Study|Withdrawal by Subject|0|||
23377905|NCT01682031|65130330|FG001|Overall Study|Withdrawal by Subject|1|||
23604948|NCT04705051|65943560|FG000|Overall Study|Study terminated by sponsor|23|||
23604949|NCT03865732|65943561|FG000|Overall Study|Adverse Event|0|||
23604950|NCT03865732|65943562|FG001|Overall Study|Adverse Event|1|||
23604951|NCT02372799|65943563|FG000|Treatment Period|Adverse Event|3|||
23604952|NCT02372799|65943564|FG001|Treatment Period|Adverse Event|10|||
23604953|NCT02372799|65943565|FG002|Treatment Period|Adverse Event|6|||
23604954|NCT02372799|65943563|FG000|Treatment Period|Insufficient therapeutic response|2|||
23604955|NCT02372799|65943564|FG001|Treatment Period|Insufficient therapeutic response|2|||
23604956|NCT02372799|65943565|FG002|Treatment Period|Insufficient therapeutic response|0|||
23665892|NCT01358864|66162545|FG003|Overall Study|Other reason not defined above|0|||
23665893|NCT01358864|66162546|FG004|Overall Study|Other reason not defined above|0|||
23665894|NCT01358864|66162547|FG005|Overall Study|Other reason not defined above|0|||
23665895|NCT01358864|66162548|FG006|Overall Study|Other reason not defined above|2|||
23665896|NCT01358864|66162549|FG007|Overall Study|Other reason not defined above|0|||
23665897|NCT01358864|66162542|FG000|Overall Study|Not treated|0|||
23665898|NCT01358864|66162543|FG001|Overall Study|Not treated|0|||
23665899|NCT01358864|66162544|FG002|Overall Study|Not treated|0|||
23665900|NCT01358864|66162545|FG003|Overall Study|Not treated|0|||
23665901|NCT01358864|66162546|FG004|Overall Study|Not treated|0|||
23665902|NCT01358864|66162547|FG005|Overall Study|Not treated|0|||
23604957|NCT02372799|65943563|FG000|Treatment Period|Withdrawal by Subject|10|||
23665903|NCT01358864|66162548|FG006|Overall Study|Not treated|1|||
23665904|NCT01358864|66162549|FG007|Overall Study|Not treated|0|||
23665905|NCT03044249|66162553|FG000|Overall Study|Adverse Event|4|||
23665906|NCT03044249|66162554|FG001|Overall Study|Adverse Event|9|||
23377906|NCT01682031|65130329|FG000|Overall Study|Adverse Event|0|||
23665907|NCT03044249|66162553|FG000|Overall Study|Lost to Follow-up|1|||
23665908|NCT03044249|66162554|FG001|Overall Study|Lost to Follow-up|0|||
23489968|NCT02758171|65541254|FG000|Wash-out|Other reason|1|||
23489969|NCT02758171|65541255|FG001|Wash-out|Other reason|0|||
23489970|NCT03439657|65541256|FG000|Overall Study|Adverse Event|2|||
23489971|NCT03439657|65541257|FG001|Overall Study|Adverse Event|3|||
23377907|NCT01682031|65130330|FG001|Overall Study|Adverse Event|2|||
23377908|NCT01682031|65130329|FG000|Overall Study|MRI results indicate increased nodul|0|||
23377909|NCT01682031|65130330|FG001|Overall Study|MRI results indicate increased nodul|1|||
23377910|NCT01682031|65130329|FG000|Overall Study|Patient could not swallow tablets|1|||
23377911|NCT01682031|65130330|FG001|Overall Study|Patient could not swallow tablets|0|||
23377912|NCT01682031|65130329|FG000|Overall Study|Patient stopped selenium on his own|0|||
23377913|NCT01682031|65130330|FG001|Overall Study|Patient stopped selenium on his own|1|||
23377914|NCT03439839|65130332|FG000|Overall Study|Death|3|||
23377915|NCT03439839|65130333|FG001|Overall Study|Death|0|||
23377916|NCT00286455|65130334|FG000|Overall Study|Hyperglycemia rescue|19|||
23377917|NCT00286455|65130335|FG001|Overall Study|Hyperglycemia rescue|13|||
23377918|NCT00286455|65130336|FG002|Overall Study|Hyperglycemia rescue|10|||
23377919|NCT00286455|65130334|FG000|Overall Study|Adverse Event|1|||
23377920|NCT00286455|65130335|FG001|Overall Study|Adverse Event|3|||
23377921|NCT00286455|65130336|FG002|Overall Study|Adverse Event|2|||
23377922|NCT00286455|65130334|FG000|Overall Study|Lost to Follow-up|0|||
23377923|NCT00286455|65130335|FG001|Overall Study|Lost to Follow-up|3|||
23377924|NCT00286455|65130336|FG002|Overall Study|Lost to Follow-up|3|||
23377925|NCT00286455|65130334|FG000|Overall Study|Physician Decision|3|||
23377926|NCT00286455|65130335|FG001|Overall Study|Physician Decision|0|||
23377927|NCT00286455|65130336|FG002|Overall Study|Physician Decision|2|||
23377928|NCT00286455|65130334|FG000|Overall Study|Protocol Violation|1|||
23377929|NCT00286455|65130335|FG001|Overall Study|Protocol Violation|1|||
23377930|NCT00286455|65130336|FG002|Overall Study|Protocol Violation|0|||
23377931|NCT00286455|65130334|FG000|Overall Study|Participant Non-compliance|1|||
23377932|NCT00286455|65130335|FG001|Overall Study|Participant Non-compliance|0|||
23377933|NCT00286455|65130336|FG002|Overall Study|Participant Non-compliance|0|||
23377934|NCT00286455|65130334|FG000|Overall Study|Withdrawal by Subject|0|||
23377935|NCT00286455|65130335|FG001|Overall Study|Withdrawal by Subject|8|||
23377936|NCT00286455|65130336|FG002|Overall Study|Withdrawal by Subject|7|||
23489972|NCT03439657|65541256|FG000|Overall Study|Lost to Follow-up|1|||
23489973|NCT03439657|65541257|FG001|Overall Study|Lost to Follow-up|0|||
23377937|NCT01980888|65130342|FG000|Overall Study|Study Terminated by Sponsor|116|||
23377938|NCT01980888|65130343|FG001|Overall Study|Study Terminated by Sponsor|122|||
23377939|NCT01980888|65130342|FG000|Overall Study|Withdrew Consent|17|||
23377940|NCT01980888|65130343|FG001|Overall Study|Withdrew Consent|6|||
23377941|NCT01980888|65130342|FG000|Overall Study|Investigator's Discretion|8|||
23377942|NCT01980888|65130343|FG001|Overall Study|Investigator's Discretion|3|||
23489974|NCT03439657|65541256|FG000|Overall Study|Protocol Violation|1|||
23489975|NCT03439657|65541257|FG001|Overall Study|Protocol Violation|1|||
23489976|NCT03439657|65541256|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
23489977|NCT03439657|65541257|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
23489978|NCT00569270|65541260|FG000|Period: First Intervention|Protocol Violation|0|||
23489979|NCT00569270|65541261|FG001|Period: First Intervention|Protocol Violation|1|||
23489980|NCT01856907|65541262|FG000|Overall Study|Pregnancy|0|||
23489981|NCT01856907|65541263|FG001|Overall Study|Pregnancy|1|||
23489982|NCT01856907|65541264|FG002|Overall Study|Pregnancy|0|||
23489983|NCT01856907|65541262|FG000|Overall Study|Pregnancy|0|||
23489984|NCT01856907|65541263|FG001|Overall Study|Pregnancy|1|||
23489985|NCT01856907|65541264|FG002|Overall Study|Pregnancy|0|||
23489986|NCT01856907|65541262|FG000|Overall Study|Withdrawal by Subject|0|||
23489987|NCT01856907|65541263|FG001|Overall Study|Withdrawal by Subject|1|||
23489988|NCT01856907|65541264|FG002|Overall Study|Withdrawal by Subject|0|||
23489989|NCT01810432|65541265|FG000|Washout|Protocol Violation|0|||
23489990|NCT01810432|65541266|FG001|Washout|Protocol Violation|1|||
23489991|NCT01810432|65541265|FG000|Washout|Adverse Event|1|||
23489992|NCT01810432|65541266|FG001|Washout|Adverse Event|0|||
23489993|NCT01810432|65541265|FG000|Period 2|Withdrawal by Subject|2|||
23489994|NCT01810432|65541266|FG001|Period 2|Withdrawal by Subject|1|||
23489995|NCT01810432|65541265|FG000|Period 2|Physician Decision|1|||
23489996|NCT01810432|65541266|FG001|Period 2|Physician Decision|0|||
23489997|NCT01810432|65541265|FG000|Period 2|Lost to Follow-up|1|||
23489998|NCT01810432|65541266|FG001|Period 2|Lost to Follow-up|1|||
23489999|NCT00747461|65541267|FG000|Overall Study|study terminated by sponsor|5|||
23490000|NCT03589469|65541270|FG000|Overall Study|Withdrawal by Subject|8|||
23490001|NCT03589469|65541270|FG000|Overall Study|Physician Decision|20|||
23490002|NCT03589469|65541270|FG000|Overall Study|Death|97|||
23490003|NCT03589469|65541270|FG000|Overall Study|Lost to Follow-up|8|||
23490004|NCT03589469|65541270|FG000|Overall Study|Miscellaneous|1|||
23490005|NCT02231918|65541271|FG000|Overall Study|Withdrawal by Subject|0|||
23490006|NCT02231918|65541272|FG001|Overall Study|Withdrawal by Subject|1|||
23490007|NCT02231918|65541273|FG002|Overall Study|Withdrawal by Subject|0|||
23490008|NCT02231918|65541271|FG000|Overall Study|Adverse Event|0|||
23490009|NCT02231918|65541272|FG001|Overall Study|Adverse Event|0|||
23490010|NCT02231918|65541273|FG002|Overall Study|Adverse Event|1|||
23490011|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23490012|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
23490013|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23490014|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23490015|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23490016|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23490017|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
23490018|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
23490019|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
23490020|NCT03452228|65541274|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23490021|NCT03452228|65541275|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23490022|NCT03452228|65541276|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23665909|NCT03044249|66162553|FG000|Overall Study|Non-compliance with Study Drug|1|||
23490023|NCT00333801|65541277|FG000|Overall Study|Moved to another state|5|||
23490024|NCT00333801|65541278|FG001|Overall Study|Moved to another state|3|||
23490025|NCT00333801|65541277|FG000|Overall Study|Lost to Follow-up|2|||
23490026|NCT00333801|65541278|FG001|Overall Study|Lost to Follow-up|0|||
23490027|NCT00333801|65541277|FG000|Overall Study|Incarcerated|1|||
23490028|NCT00333801|65541278|FG001|Overall Study|Incarcerated|2|||
23490029|NCT00333801|65541277|FG000|Overall Study|Withdrawal by Subject|0|||
23490030|NCT00333801|65541278|FG001|Overall Study|Withdrawal by Subject|1|||
23490031|NCT03917459|65541279|FG000|Overall Study|Adverse Event|1|||
23490032|NCT03917459|65541280|FG001|Overall Study|Adverse Event|0|||
23490033|NCT03917459|65541279|FG000|Overall Study|Withdrawal by Subject|0|||
23490034|NCT03917459|65541280|FG001|Overall Study|Withdrawal by Subject|1|||
23490035|NCT03906461|65541281|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
23490036|NCT03906461|65541281|FG000|Completed 12-month Follow-up|Missed Visit|6|||
23490037|NCT00702689|65541290|FG000|Overall Study|Withdrawal by Subject|4|||
23490038|NCT00702689|65541290|FG000|Overall Study|Recurrent malignancy|1|||
23490039|NCT00702689|65541290|FG000|Overall Study|Adverse Event|1|||
23490040|NCT01011738|65541291|FG000|Overall Study|Death|12|||
23490041|NCT01011738|65541292|FG001|Overall Study|Death|3|||
23490042|NCT01011738|65541293|FG002|Overall Study|Death|0|||
23490043|NCT01011738|65541291|FG000|Overall Study|Unknown reasons|312|||
23490044|NCT01011738|65541292|FG001|Overall Study|Unknown reasons|291|||
23490045|NCT01011738|65541293|FG002|Overall Study|Unknown reasons|17|||
23490046|NCT00410202|65541294|FG000|On-Treatment|Continuing treatment|69|||
23490047|NCT00410202|65541295|FG001|On-Treatment|Continuing treatment|71|||
23490048|NCT00410202|65541296|FG002|On-Treatment|Continuing treatment|66|||
23490049|NCT00410202|65541294|FG000|On-Treatment|Adverse Event|1|||
23490050|NCT00410202|65541295|FG001|On-Treatment|Adverse Event|3|||
23490051|NCT00410202|65541296|FG002|On-Treatment|Adverse Event|2|||
23490052|NCT00410202|65541294|FG000|On-Treatment|Death|1|||
23490053|NCT00410202|65541295|FG001|On-Treatment|Death|0|||
23490054|NCT00410202|65541296|FG002|On-Treatment|Death|0|||
23490055|NCT00410202|65541294|FG000|On-Treatment|Lost to Follow-up|1|||
23490056|NCT00410202|65541295|FG001|On-Treatment|Lost to Follow-up|0|||
23490057|NCT00410202|65541296|FG002|On-Treatment|Lost to Follow-up|1|||
23490058|NCT00410202|65541294|FG000|On-Treatment|Lack of Efficacy|1|||
23490059|NCT00410202|65541295|FG001|On-Treatment|Lack of Efficacy|4|||
23490060|NCT00410202|65541296|FG002|On-Treatment|Lack of Efficacy|0|||
23490061|NCT00410202|65541294|FG000|On-Treatment|Withdrawal by Subject|2|||
23490062|NCT00410202|65541295|FG001|On-Treatment|Withdrawal by Subject|1|||
23490063|NCT00410202|65541296|FG002|On-Treatment|Withdrawal by Subject|1|||
23490064|NCT00410202|65541294|FG000|On-Treatment|Other Reason|0|||
23490065|NCT00410202|65541295|FG001|On-Treatment|Other Reason|0|||
23490066|NCT00410202|65541296|FG002|On-Treatment|Other Reason|1|||
23490067|NCT00410202|65541294|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
23490068|NCT00410202|65541295|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
23490069|NCT00410202|65541296|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
23490070|NCT00410202|65541294|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
23490071|NCT00410202|65541295|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
23490072|NCT00410202|65541296|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
23490073|NCT00410202|65541294|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
23490074|NCT00410202|65541295|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
23490075|NCT00410202|65541296|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
23490076|NCT02777333|65541297|FG000|Overall Study|Withdrawal by Subject|0|||
23490077|NCT02777333|65541298|FG001|Overall Study|Withdrawal by Subject|1|||
23490078|NCT02777333|65541297|FG000|Overall Study|Lost to Follow-up|0|||
23490079|NCT02777333|65541298|FG001|Overall Study|Lost to Follow-up|1|||
23490080|NCT00828854|65541301|FG000|Overall Study|Disease Progression|17|||
23490081|NCT00828854|65541301|FG000|Overall Study|Adverse Event|9|||
23490082|NCT00828854|65541301|FG000|Overall Study|Reason not Specified|1|||
23490083|NCT02497612|65541302|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
23490084|NCT02497612|65541303|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
23490085|NCT02497612|65541304|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
23490086|NCT02497612|65541305|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
23490087|NCT02497612|65541302|FG000|Overall Study|Participant's request|2|||
23490088|NCT02497612|65541303|FG001|Overall Study|Participant's request|3|||
23490089|NCT02497612|65541304|FG002|Overall Study|Participant's request|4|||
23490090|NCT02497612|65541305|FG003|Overall Study|Participant's request|1|||
23490091|NCT02497612|65541302|FG000|Overall Study|Investigator's judgement|1|||
23604958|NCT02372799|65943564|FG001|Treatment Period|Withdrawal by Subject|10|||
23490092|NCT02497612|65541303|FG001|Overall Study|Investigator's judgement|0|||
23490093|NCT02497612|65541304|FG002|Overall Study|Investigator's judgement|0|||
23377943|NCT01980888|65130342|FG000|Overall Study|Non-Compliance with Study Drug|3|||
23377944|NCT01980888|65130343|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23377945|NCT01922011|65130344|FG000|Overall Study|Protocol Violation|0|||
23377946|NCT01922011|65130345|FG001|Overall Study|Protocol Violation|1|||
23490094|NCT02497612|65541305|FG003|Overall Study|Investigator's judgement|2|||
23490095|NCT02497612|65541302|FG000|Overall Study|Adverse Event|3|||
23377947|NCT01922011|65130344|FG000|Overall Study|Physician Decision|0|||
23490096|NCT02497612|65541303|FG001|Overall Study|Adverse Event|1|||
23665910|NCT03044249|66162554|FG001|Overall Study|Non-compliance with Study Drug|0|||
23665911|NCT03044249|66162553|FG000|Overall Study|Study Terminated by Sponsor|2|||
23665912|NCT03044249|66162554|FG001|Overall Study|Study Terminated by Sponsor|0|||
23665913|NCT03044249|66162553|FG000|Overall Study|Withdrawal by Subject|2|||
23665914|NCT03044249|66162554|FG001|Overall Study|Withdrawal by Subject|5|||
23665915|NCT02667275|66162559|FG000|Overall Study|Protocol Violation|11|||
23665916|NCT02667275|66162560|FG001|Overall Study|Protocol Violation|7|||
23665917|NCT02667275|66162559|FG000|Overall Study|Lost to Follow-up|0|||
23665918|NCT02667275|66162560|FG001|Overall Study|Lost to Follow-up|2|||
23665919|NCT02667275|66162559|FG000|Overall Study|Withdrawal by Subject|0|||
23665920|NCT02667275|66162560|FG001|Overall Study|Withdrawal by Subject|5|||
23665921|NCT02667275|66162559|FG000|Overall Study|Discontinued early without completing|0|||
23665922|NCT02667275|66162560|FG001|Overall Study|Discontinued early without completing|1|||
23665923|NCT01524198|66162561|FG000|Overall Study|Protocol Violation|8|||
23665924|NCT01524198|66162562|FG001|Overall Study|Protocol Violation|6|||
23665925|NCT01524198|66162561|FG000|Overall Study|Withdrawal by Subject|15|||
23377948|NCT01922011|65130345|FG001|Overall Study|Physician Decision|1|||
23377949|NCT01922011|65130344|FG000|Overall Study|Parent/Guardian Decision|3|||
23377950|NCT01922011|65130345|FG001|Overall Study|Parent/Guardian Decision|0|||
23377951|NCT01922011|65130344|FG000|Overall Study|Lost to Follow-up|0|||
23377952|NCT01922011|65130345|FG001|Overall Study|Lost to Follow-up|1|||
23377953|NCT01922011|65130344|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
23377954|NCT01922011|65130345|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
23377955|NCT01922011|65130344|FG000|Overall Study|Not Treated|1|||
23377956|NCT01922011|65130345|FG001|Overall Study|Not Treated|0|||
23377957|NCT01922011|65130344|FG000|Overall Study|Lack of willing home health agency|1|||
23377958|NCT01922011|65130345|FG001|Overall Study|Lack of willing home health agency|0|||
23490097|NCT02497612|65541304|FG002|Overall Study|Adverse Event|4|||
23490098|NCT02497612|65541305|FG003|Overall Study|Adverse Event|1|||
23490099|NCT02497612|65541302|FG000|Overall Study|Lost to Follow-up|1|||
23490100|NCT02497612|65541303|FG001|Overall Study|Lost to Follow-up|1|||
23490101|NCT02497612|65541304|FG002|Overall Study|Lost to Follow-up|0|||
23490102|NCT02497612|65541305|FG003|Overall Study|Lost to Follow-up|1|||
23490103|NCT02497612|65541302|FG000|Overall Study|Other unspecified|1|||
23490104|NCT02497612|65541303|FG001|Overall Study|Other unspecified|1|||
23490105|NCT02497612|65541304|FG002|Overall Study|Other unspecified|2|||
23490106|NCT02497612|65541305|FG003|Overall Study|Other unspecified|0|||
23490107|NCT02497612|65541302|FG000|Overall Study|Not eligible|1|||
23490108|NCT02497612|65541303|FG001|Overall Study|Not eligible|0|||
23490109|NCT02497612|65541304|FG002|Overall Study|Not eligible|0|||
23490110|NCT02497612|65541305|FG003|Overall Study|Not eligible|1|||
23490111|NCT03583164|65541306|FG000|Overall Study|Death in Main Phase|35|||
23490112|NCT03583164|65541306|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
23665926|NCT01524198|66162562|FG001|Overall Study|Withdrawal by Subject|10|||
23665927|NCT00562354|66162565|FG000|Overall Study|Physician Decision|0|||
23665928|NCT00562354|66162566|FG001|Overall Study|Physician Decision|1|||
23665929|NCT00562354|66162565|FG000|Overall Study|Lost to Follow-up|0|||
23377959|NCT01922011|65130344|FG000|Overall Study|Randomized in error|1|||
23377960|NCT01922011|65130345|FG001|Overall Study|Randomized in error|0|||
23490113|NCT03583164|65541306|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
23490114|NCT03583164|65541306|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
23490115|NCT03583164|65541306|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
23665930|NCT00562354|66162566|FG001|Overall Study|Lost to Follow-up|1|||
23377961|NCT01732783|65130347|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
23377962|NCT01732783|65130348|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
23377963|NCT01732783|65130349|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
23377964|NCT01732783|65130347|FG000|Overall Study|Death|13|||
23377965|NCT01732783|65130348|FG001|Overall Study|Death|4|||
23377966|NCT01732783|65130349|FG002|Overall Study|Death|1|||
23377967|NCT01732783|65130347|FG000|Overall Study|Lost to Follow-up|7|||
23377968|NCT01732783|65130348|FG001|Overall Study|Lost to Follow-up|1|||
23377969|NCT01732783|65130349|FG002|Overall Study|Lost to Follow-up|1|||
23377970|NCT01732783|65130347|FG000|Overall Study|Administrative Decision|8|||
23377971|NCT01732783|65130348|FG001|Overall Study|Administrative Decision|2|||
23377972|NCT01732783|65130349|FG002|Overall Study|Administrative Decision|1|||
23377973|NCT01732783|65130347|FG000|Overall Study|Withdrawal by Subject|1|||
23377974|NCT01732783|65130348|FG001|Overall Study|Withdrawal by Subject|0|||
23377975|NCT01732783|65130349|FG002|Overall Study|Withdrawal by Subject|0|||
23377976|NCT02724644|65130350|FG000|Overall Study|Adverse Event|7|||
23377977|NCT02724644|65130351|FG001|Overall Study|Adverse Event|1|||
23377978|NCT02724644|65130350|FG000|Overall Study|Lost to Follow-up|6|||
23377979|NCT02724644|65130351|FG001|Overall Study|Lost to Follow-up|2|||
23377980|NCT02724644|65130350|FG000|Overall Study|Withdrawal by Subject|7|||
23604959|NCT02372799|65943565|FG002|Treatment Period|Withdrawal by Subject|2|||
23604960|NCT02372799|65943563|FG000|Treatment Period|Lost to Follow-up|11|||
23604961|NCT02372799|65943564|FG001|Treatment Period|Lost to Follow-up|5|||
23604962|NCT02372799|65943565|FG002|Treatment Period|Lost to Follow-up|3|||
23604963|NCT02372799|65943563|FG000|Treatment Period|Protocol Violation|3|||
23604964|NCT02372799|65943564|FG001|Treatment Period|Protocol Violation|0|||
23604965|NCT02372799|65943565|FG002|Treatment Period|Protocol Violation|0|||
23604966|NCT02372799|65943563|FG000|Treatment Period|Non-compliance with study drug|4|||
23604967|NCT02372799|65943564|FG001|Treatment Period|Non-compliance with study drug|4|||
23604968|NCT02372799|65943565|FG002|Treatment Period|Non-compliance with study drug|4|||
23604969|NCT02372799|65943563|FG000|Treatment Period|Miscellaneous Reasons|1|||
23604970|NCT02372799|65943564|FG001|Treatment Period|Miscellaneous Reasons|1|||
23604971|NCT02372799|65943565|FG002|Treatment Period|Miscellaneous Reasons|0|||
23604972|NCT02372799|65943563|FG000|Down-taper Period|Lost to Follow-up|1|||
23604973|NCT02372799|65943564|FG001|Down-taper Period|Lost to Follow-up|2|||
23604974|NCT02372799|65943565|FG002|Down-taper Period|Lost to Follow-up|2|||
23604975|NCT03205488|65943566|FG000|Overall Study|Adverse Event|1|||
23604976|NCT03205488|65943567|FG001|Overall Study|Adverse Event|2|||
23604977|NCT03205488|65943568|FG002|Overall Study|Adverse Event|4|||
23377981|NCT02724644|65130351|FG001|Overall Study|Withdrawal by Subject|1|||
23604978|NCT03205488|65943566|FG000|Overall Study|Protocol Violation|0|||
23604979|NCT03205488|65943567|FG001|Overall Study|Protocol Violation|0|||
23604980|NCT03205488|65943568|FG002|Overall Study|Protocol Violation|1|||
23604981|NCT00736502|65943570|FG000|Overall Study|Adverse Event|22|||
23377982|NCT02724644|65130350|FG000|Overall Study|Administrative|1|||
23377983|NCT02724644|65130351|FG001|Overall Study|Administrative|0|||
23377984|NCT01301092|65130352|FG000|Overall Study|Lost to Follow-up|0|||
23377985|NCT01301092|65130353|FG001|Overall Study|Lost to Follow-up|0|||
23604982|NCT00736502|65943570|FG000|Overall Study|Lack of Efficacy|16|||
23377986|NCT01301092|65130354|FG002|Overall Study|Lost to Follow-up|1|||
23377987|NCT00165698|65130364|FG000|Overall Study|Adverse Event|2|||
23377988|NCT00165698|65130365|FG001|Overall Study|Adverse Event|10|||
23377989|NCT00165698|65130364|FG000|Overall Study|Lost to Follow-up|2|||
23377990|NCT00165698|65130365|FG001|Overall Study|Lost to Follow-up|2|||
23377991|NCT00165698|65130364|FG000|Overall Study|Withdrawal by Subject|2|||
23377992|NCT00165698|65130365|FG001|Overall Study|Withdrawal by Subject|1|||
23377993|NCT00165698|65130364|FG000|Overall Study|Protocol Violation|1|||
23377994|NCT00165698|65130365|FG001|Overall Study|Protocol Violation|0|||
23377995|NCT00165698|65130364|FG000|Overall Study|Not Taken/Lost the medicine|1|||
23377996|NCT00165698|65130365|FG001|Overall Study|Not Taken/Lost the medicine|2|||
23377997|NCT03670628|65130368|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
23377998|NCT03670628|65130369|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
23377999|NCT03670628|65130368|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
23378000|NCT03670628|65130369|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
23378001|NCT01551173|65130370|FG000|Overall Study|Withdrawal by Subject|11|||
23378002|NCT01551173|65130371|FG001|Overall Study|Withdrawal by Subject|16|||
23378003|NCT01551173|65130370|FG000|Overall Study|Adverse Event|7|||
23378004|NCT01551173|65130371|FG001|Overall Study|Adverse Event|6|||
23378005|NCT01551173|65130370|FG000|Overall Study|Lost to Follow-up|5|||
23378006|NCT01551173|65130371|FG001|Overall Study|Lost to Follow-up|7|||
23378007|NCT01551173|65130370|FG000|Overall Study|Other|5|||
23378008|NCT01551173|65130371|FG001|Overall Study|Other|3|||
23378009|NCT02332707|65130381|FG000|Overall Study|Adverse Event|0|||
23378010|NCT02332707|65130382|FG001|Overall Study|Adverse Event|0|||
23378011|NCT02332707|65130383|FG002|Overall Study|Adverse Event|0|||
23378012|NCT02332707|65130384|FG003|Overall Study|Adverse Event|0|||
23378013|NCT02332707|65130385|FG004|Overall Study|Adverse Event|0|||
23378014|NCT02332707|65130386|FG005|Overall Study|Adverse Event|0|||
23378015|NCT02332707|65130387|FG006|Overall Study|Adverse Event|0|||
23378016|NCT02332707|65130388|FG007|Overall Study|Adverse Event|0|||
23378017|NCT02332707|65130389|FG008|Overall Study|Adverse Event|0|||
23378018|NCT02332707|65130390|FG009|Overall Study|Adverse Event|0|||
23378019|NCT02332707|65130391|FG010|Overall Study|Adverse Event|0|||
23378020|NCT02332707|65130392|FG011|Overall Study|Adverse Event|0|||
23378021|NCT02332707|65130393|FG012|Overall Study|Adverse Event|1|||
23378022|NCT02332707|65130394|FG013|Overall Study|Adverse Event|0|||
23378023|NCT02332707|65130395|FG014|Overall Study|Adverse Event|0|||
23378024|NCT02332707|65130396|FG015|Overall Study|Adverse Event|0|||
23378025|NCT02332707|65130397|FG016|Overall Study|Adverse Event|0|||
23378026|NCT02332707|65130398|FG017|Overall Study|Adverse Event|0|||
23378027|NCT02332707|65130381|FG000|Overall Study|Lost to Follow-up|0|||
23378028|NCT02332707|65130382|FG001|Overall Study|Lost to Follow-up|0|||
23378029|NCT02332707|65130383|FG002|Overall Study|Lost to Follow-up|0|||
23378030|NCT02332707|65130384|FG003|Overall Study|Lost to Follow-up|0|||
23378031|NCT02332707|65130385|FG004|Overall Study|Lost to Follow-up|0|||
23378032|NCT02332707|65130386|FG005|Overall Study|Lost to Follow-up|1|||
23378033|NCT02332707|65130387|FG006|Overall Study|Lost to Follow-up|0|||
23378034|NCT02332707|65130388|FG007|Overall Study|Lost to Follow-up|0|||
23378035|NCT02332707|65130389|FG008|Overall Study|Lost to Follow-up|0|||
23378036|NCT02332707|65130390|FG009|Overall Study|Lost to Follow-up|0|||
23378037|NCT02332707|65130391|FG010|Overall Study|Lost to Follow-up|2|||
23378038|NCT02332707|65130392|FG011|Overall Study|Lost to Follow-up|0|||
23490116|NCT03583164|65541306|FG000|Overall Study|Physician decision in Main Phase|1|||
23490117|NCT03583164|65541306|FG000|Overall Study|Physician decision in Extended Phase|2|||
23490118|NCT03583164|65541306|FG000|Overall Study|Death in Extended Phase|13|||
23490119|NCT03583164|65541306|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
23490120|NCT03583164|65541306|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
23490121|NCT03583164|65541306|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
23490122|NCT03583164|65541306|FG000|Overall Study|Treatment failure in Main Phase|2|||
23490123|NCT03583164|65541306|FG000|Overall Study|Treatment failure in Extended Phase|4|||
23490124|NCT03583164|65541306|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
23490125|NCT03583164|65541306|FG000|Overall Study|Other not specified reason in Main Phase|2|||
23604983|NCT00736502|65943570|FG000|Overall Study|Lost to Follow-up|27|||
23378039|NCT02332707|65130393|FG012|Overall Study|Lost to Follow-up|3|||
23378040|NCT02332707|65130394|FG013|Overall Study|Lost to Follow-up|0|||
23378041|NCT02332707|65130395|FG014|Overall Study|Lost to Follow-up|0|||
23378042|NCT02332707|65130396|FG015|Overall Study|Lost to Follow-up|0|||
23378043|NCT02332707|65130397|FG016|Overall Study|Lost to Follow-up|0|||
23378044|NCT02332707|65130398|FG017|Overall Study|Lost to Follow-up|0|||
23378045|NCT02332707|65130381|FG000|Overall Study|Physician Decision|0|||
23378046|NCT02332707|65130382|FG001|Overall Study|Physician Decision|0|||
23378047|NCT02332707|65130383|FG002|Overall Study|Physician Decision|0|||
23378048|NCT02332707|65130384|FG003|Overall Study|Physician Decision|1|||
23378049|NCT02332707|65130385|FG004|Overall Study|Physician Decision|0|||
23378050|NCT02332707|65130386|FG005|Overall Study|Physician Decision|0|||
23378051|NCT02332707|65130387|FG006|Overall Study|Physician Decision|0|||
23378052|NCT02332707|65130388|FG007|Overall Study|Physician Decision|0|||
23378053|NCT02332707|65130389|FG008|Overall Study|Physician Decision|0|||
23378054|NCT02332707|65130390|FG009|Overall Study|Physician Decision|0|||
23378055|NCT02332707|65130391|FG010|Overall Study|Physician Decision|0|||
23378056|NCT02332707|65130392|FG011|Overall Study|Physician Decision|0|||
23378057|NCT02332707|65130393|FG012|Overall Study|Physician Decision|1|||
23378058|NCT02332707|65130394|FG013|Overall Study|Physician Decision|0|||
23378059|NCT02332707|65130395|FG014|Overall Study|Physician Decision|0|||
23490126|NCT03265665|65541307|FG000|24-week Data Collection|Withdrawal by Subject|2|||
23490127|NCT03265665|65541308|FG001|24-week Data Collection|Withdrawal by Subject|2|||
23604984|NCT02102724|65943571|FG000|Overall Study|Lost to Follow-up|1|||
23604985|NCT02102724|65943572|FG001|Overall Study|Lost to Follow-up|0|||
23604986|NCT02102724|65943571|FG000|Overall Study|surgery for brain aneurysm|1|||
23604987|NCT02102724|65943572|FG001|Overall Study|surgery for brain aneurysm|1|||
23490128|NCT03265665|65541307|FG000|24-week Data Collection|Lost to Follow-up|4|||
23490129|NCT03265665|65541308|FG001|24-week Data Collection|Lost to Follow-up|5|||
23490130|NCT03265665|65541307|FG000|36-week Data Collection|Lost to Follow-up|6|||
23490131|NCT03265665|65541308|FG001|36-week Data Collection|Lost to Follow-up|8|||
23490132|NCT01933217|65541309|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
23490133|NCT01933217|65541310|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
23490134|NCT01933217|65541309|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
23490135|NCT01933217|65541310|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
23490136|NCT01691898|65541311|FG000|Overall Study|Death|34|||
23490137|NCT01691898|65541312|FG001|Overall Study|Death|32|||
23490138|NCT01691898|65541313|FG002|Overall Study|Death|6|||
23604988|NCT00701415|65943573|FG000|Overall Study|Adverse Event|0|||
23604989|NCT00701415|65943574|FG001|Overall Study|Adverse Event|1|||
23604990|NCT00701415|65943573|FG000|Overall Study|Social/family issues and needle phobia|1|||
23604991|NCT00701415|65943574|FG001|Overall Study|Social/family issues and needle phobia|0|||
23604992|NCT00756574|65943578|FG000|Overall Study|Withdrawal by Subject|9|||
23604993|NCT00756574|65943579|FG001|Overall Study|Withdrawal by Subject|7|||
23604994|NCT00756574|65943578|FG000|Overall Study|Lost to Follow-up|4|||
23604995|NCT00756574|65943579|FG001|Overall Study|Lost to Follow-up|4|||
23604996|NCT03026166|65943584|FG000|Overall Study|Death|22|||
23604997|NCT03026166|65943585|FG001|Overall Study|Death|7|||
23604998|NCT03026166|65943584|FG000|Overall Study|Physician Decision|2|||
23604999|NCT03026166|65943585|FG001|Overall Study|Physician Decision|0|||
23605000|NCT03026166|65943584|FG000|Overall Study|Withdrawal by Subject|1|||
23605001|NCT03026166|65943585|FG001|Overall Study|Withdrawal by Subject|2|||
23605002|NCT03026166|65943584|FG000|Overall Study|Lost to Follow-up|1|||
23605003|NCT03026166|65943585|FG001|Overall Study|Lost to Follow-up|0|||
23605004|NCT03026166|65943584|FG000|Overall Study|Study Terminated by Sponsor|3|||
23605005|NCT03026166|65943585|FG001|Overall Study|Study Terminated by Sponsor|3|||
23605006|NCT03026166|65943584|FG000|Overall Study|Other|1|||
23605007|NCT03026166|65943585|FG001|Overall Study|Other|0|||
23605008|NCT02066636|65943589|FG000|Overall Study|Disease progression|51|||
23605009|NCT02066636|65943590|FG001|Overall Study|Disease progression|60|||
23605010|NCT02066636|65943591|FG002|Overall Study|Disease progression|700|||
23605011|NCT02066636|65943589|FG000|Overall Study|Study drug toxicity|13|||
23605012|NCT02066636|65943590|FG001|Overall Study|Study drug toxicity|2|||
23605013|NCT02066636|65943591|FG002|Overall Study|Study drug toxicity|58|||
23605014|NCT02066636|65943589|FG000|Overall Study|Death|4|||
23605015|NCT02066636|65943590|FG001|Overall Study|Death|2|||
23605016|NCT02066636|65943591|FG002|Overall Study|Death|158|||
23605017|NCT02066636|65943589|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23605018|NCT02066636|65943590|FG001|Overall Study|Adverse event unrelated to study drug|4|||
23605019|NCT02066636|65943591|FG002|Overall Study|Adverse event unrelated to study drug|45|||
23605020|NCT02066636|65943589|FG000|Overall Study|Participant request to discontinue treatment|12|||
23605021|NCT02066636|65943590|FG001|Overall Study|Participant request to discontinue treatment|12|||
23605022|NCT02066636|65943591|FG002|Overall Study|Participant request to discontinue treatment|70|||
23605023|NCT02066636|65943589|FG000|Overall Study|Participant withdrew consent|10|||
23605024|NCT02066636|65943590|FG001|Overall Study|Participant withdrew consent|18|||
23605025|NCT02066636|65943591|FG002|Overall Study|Participant withdrew consent|61|||
23605026|NCT02066636|65943589|FG000|Overall Study|Lost to Follow-up|0|||
23605027|NCT02066636|65943590|FG001|Overall Study|Lost to Follow-up|2|||
23605028|NCT02066636|65943591|FG002|Overall Study|Lost to Follow-up|2|||
23605029|NCT02066636|65943589|FG000|Overall Study|Maximum clinical benefit|2|||
23605030|NCT02066636|65943590|FG001|Overall Study|Maximum clinical benefit|2|||
23605031|NCT02066636|65943591|FG002|Overall Study|Maximum clinical benefit|3|||
23605032|NCT02066636|65943589|FG000|Overall Study|Poor/non-compliance|2|||
23605033|NCT02066636|65943590|FG001|Overall Study|Poor/non-compliance|1|||
23605034|NCT02066636|65943591|FG002|Overall Study|Poor/non-compliance|1|||
23378060|NCT02332707|65130396|FG015|Overall Study|Physician Decision|0|||
23378061|NCT02332707|65130397|FG016|Overall Study|Physician Decision|0|||
23378062|NCT02332707|65130398|FG017|Overall Study|Physician Decision|0|||
23378063|NCT02332707|65130381|FG000|Overall Study|Withdrawal by Subject|0|||
23378064|NCT02332707|65130382|FG001|Overall Study|Withdrawal by Subject|0|||
23378065|NCT02332707|65130383|FG002|Overall Study|Withdrawal by Subject|1|||
23378066|NCT02332707|65130384|FG003|Overall Study|Withdrawal by Subject|0|||
23378067|NCT02332707|65130385|FG004|Overall Study|Withdrawal by Subject|0|||
23490139|NCT01691898|65541314|FG003|Overall Study|Death|3|||
23490140|NCT01691898|65541315|FG004|Overall Study|Death|8|||
23605035|NCT02066636|65943589|FG000|Overall Study|Participant no loner meets study criteria|3|||
23605036|NCT02066636|65943590|FG001|Overall Study|Participant no loner meets study criteria|2|||
23605037|NCT02066636|65943591|FG002|Overall Study|Participant no loner meets study criteria|28|||
23605038|NCT02066636|65943589|FG000|Overall Study|Administrative reasons by sponsor|8|||
23605039|NCT02066636|65943590|FG001|Overall Study|Administrative reasons by sponsor|5|||
23605040|NCT02066636|65943591|FG002|Overall Study|Administrative reasons by sponsor|0|||
23605041|NCT02066636|65943589|FG000|Overall Study|Other reasons|16|||
23605042|NCT02066636|65943590|FG001|Overall Study|Other reasons|15|||
23605043|NCT02066636|65943591|FG002|Overall Study|Other reasons|50|||
23605044|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
23605045|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
23605046|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
23605047|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Death|0|||
23605048|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Death|2|||
23605049|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Death|1|||
23605050|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
23605051|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
23605052|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
23605053|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
23605054|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
23605055|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
23605056|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
23605057|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
23605058|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
23605059|NCT00790569|65943592|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
23605060|NCT00790569|65943593|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
23605061|NCT00790569|65943594|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
23605062|NCT03292406|65943595|FG000|Overall Study|Progressive Disease|6|||
23605063|NCT03292406|65943596|FG001|Overall Study|Progressive Disease|3|||
23605064|NCT03292406|65943597|FG002|Overall Study|Progressive Disease|4|||
23605065|NCT03292406|65943595|FG000|Overall Study|Adverse Event|7|||
23605066|NCT03292406|65943596|FG001|Overall Study|Adverse Event|1|||
23605067|NCT03292406|65943597|FG002|Overall Study|Adverse Event|4|||
23605068|NCT03292406|65943595|FG000|Overall Study|Withdrawal by Subject|0|||
23605069|NCT03292406|65943596|FG001|Overall Study|Withdrawal by Subject|7|||
23605070|NCT03292406|65943597|FG002|Overall Study|Withdrawal by Subject|2|||
23605071|NCT03292406|65943595|FG000|Overall Study|Protocol Violation|0|||
23605072|NCT03292406|65943596|FG001|Overall Study|Protocol Violation|1|||
23605073|NCT03292406|65943597|FG002|Overall Study|Protocol Violation|1|||
23605074|NCT03292406|65943595|FG000|Overall Study|Other|0|||
23605075|NCT03292406|65943596|FG001|Overall Study|Other|1|||
23490141|NCT01691898|65541316|FG005|Overall Study|Death|31|||
23605076|NCT03292406|65943597|FG002|Overall Study|Other|2|||
23665931|NCT00441974|66162567|FG000|Overall Study|Adverse Event|6|||
23490142|NCT01691898|65541311|FG000|Overall Study|Adverse Event|0|||
23665932|NCT00441974|66162567|FG000|Overall Study|Consent Withdrawn|35|||
23665933|NCT00441974|66162567|FG000|Overall Study|Lost to Follow-up|80|||
23665934|NCT00441974|66162567|FG000|Overall Study|Protocol Violation|7|||
23665935|NCT00434421|66162570|FG000|Overall Study|Withdrawal by Subject|1|||
23665936|NCT00434421|66162570|FG000|Overall Study|Non-compliance with study treatment|1|||
23665937|NCT03134599|66162571|FG000|Week 1|Lost to Follow-up|0|||
23665938|NCT03134599|66162572|FG001|Week 1|Lost to Follow-up|0|||
23665939|NCT03134599|66162573|FG002|Week 1|Lost to Follow-up|0|||
23665940|NCT03134599|66162574|FG003|Week 1|Lost to Follow-up|0|||
23665941|NCT03134599|66162575|FG004|Week 1|Lost to Follow-up|1|||
23665942|NCT03134599|66162576|FG005|Week 1|Lost to Follow-up|0|||
23665943|NCT03134599|66162571|FG000|Week 2|Lost to Follow-up|1|||
23665944|NCT03134599|66162572|FG001|Week 2|Lost to Follow-up|0|||
23665945|NCT03134599|66162573|FG002|Week 2|Lost to Follow-up|0|||
23378068|NCT02332707|65130386|FG005|Overall Study|Withdrawal by Subject|0|||
23378069|NCT02332707|65130387|FG006|Overall Study|Withdrawal by Subject|0|||
23378070|NCT02332707|65130388|FG007|Overall Study|Withdrawal by Subject|0|||
23378071|NCT02332707|65130389|FG008|Overall Study|Withdrawal by Subject|0|||
23378072|NCT02332707|65130390|FG009|Overall Study|Withdrawal by Subject|3|||
23378073|NCT02332707|65130391|FG010|Overall Study|Withdrawal by Subject|0|||
23378074|NCT02332707|65130392|FG011|Overall Study|Withdrawal by Subject|0|||
23378075|NCT02332707|65130393|FG012|Overall Study|Withdrawal by Subject|0|||
23378076|NCT02332707|65130394|FG013|Overall Study|Withdrawal by Subject|0|||
23378077|NCT02332707|65130395|FG014|Overall Study|Withdrawal by Subject|0|||
23378078|NCT02332707|65130396|FG015|Overall Study|Withdrawal by Subject|0|||
23378079|NCT02332707|65130397|FG016|Overall Study|Withdrawal by Subject|0|||
23378080|NCT02332707|65130398|FG017|Overall Study|Withdrawal by Subject|0|||
23378081|NCT01712516|65130399|FG000|Overall Study|Technical problems|0|||
23378082|NCT01712516|65130400|FG001|Overall Study|Technical problems|0|||
23378083|NCT01712516|65130401|FG002|Overall Study|Technical problems|0|||
23378084|NCT01712516|65130402|FG003|Overall Study|Technical problems|2|||
23378085|NCT01712516|65130399|FG000|Overall Study|Lost to Follow-up|0|||
23378086|NCT01712516|65130400|FG001|Overall Study|Lost to Follow-up|0|||
23378087|NCT01712516|65130401|FG002|Overall Study|Lost to Follow-up|2|||
23378088|NCT01712516|65130402|FG003|Overall Study|Lost to Follow-up|1|||
23378089|NCT01712516|65130399|FG000|Overall Study|Death|0|||
23378090|NCT01712516|65130400|FG001|Overall Study|Death|1|||
23378091|NCT01712516|65130401|FG002|Overall Study|Death|0|||
23378092|NCT01712516|65130402|FG003|Overall Study|Death|0|||
23378093|NCT01712516|65130399|FG000|Overall Study|Protocol deviation|1|||
23378094|NCT01712516|65130400|FG001|Overall Study|Protocol deviation|0|||
23378095|NCT01712516|65130401|FG002|Overall Study|Protocol deviation|1|||
23378096|NCT01712516|65130402|FG003|Overall Study|Protocol deviation|0|||
23605077|NCT02224755|65943598|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
23605078|NCT02224755|65943599|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
23605079|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Death|103|||
23605080|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Death|98|||
23605081|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
23605082|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
23605083|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
23605084|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
23605085|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
23605086|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
23605087|NCT02630966|65943600|FG000|Overall Study|Adverse Event|1|||
23605088|NCT02630966|65943601|FG001|Overall Study|Adverse Event|3|||
23605089|NCT02630966|65943600|FG000|Overall Study|Significant Protocol Deviation|0|||
23605090|NCT02630966|65943601|FG001|Overall Study|Significant Protocol Deviation|2|||
23605091|NCT02630966|65943600|FG000|Overall Study|Voluntary Withdrawal|1|||
23605092|NCT02630966|65943601|FG001|Overall Study|Voluntary Withdrawal|1|||
23605093|NCT02630966|65943600|FG000|Overall Study|Lack of Efficacy|0|||
23605094|NCT02630966|65943601|FG001|Overall Study|Lack of Efficacy|2|||
23605095|NCT00590759|65943604|FG000|Overall Study|Death|52|||
23605096|NCT00590759|65943604|FG000|Overall Study|Lost to Follow-up|28|||
23665946|NCT03134599|66162574|FG003|Week 2|Lost to Follow-up|1|||
23665947|NCT03134599|66162575|FG004|Week 2|Lost to Follow-up|1|||
23665948|NCT03134599|66162576|FG005|Week 2|Lost to Follow-up|0|||
23665949|NCT03134599|66162571|FG000|Week 3|Lost to Follow-up|0|||
23665950|NCT03134599|66162572|FG001|Week 3|Lost to Follow-up|0|||
23665951|NCT03134599|66162573|FG002|Week 3|Lost to Follow-up|0|||
23665952|NCT03134599|66162574|FG003|Week 3|Lost to Follow-up|1|||
23665953|NCT03134599|66162575|FG004|Week 3|Lost to Follow-up|0|||
23378097|NCT01712516|65130399|FG000|Overall Study|Physician Decision|2|||
23378098|NCT01712516|65130400|FG001|Overall Study|Physician Decision|0|||
23378099|NCT01712516|65130401|FG002|Overall Study|Physician Decision|0|||
23378100|NCT01712516|65130402|FG003|Overall Study|Physician Decision|1|||
23378101|NCT01712516|65130399|FG000|Overall Study|Withdrawal by Subject|3|||
23378102|NCT01712516|65130400|FG001|Overall Study|Withdrawal by Subject|9|||
23378103|NCT01712516|65130401|FG002|Overall Study|Withdrawal by Subject|3|||
23665954|NCT03134599|66162576|FG005|Week 3|Lost to Follow-up|1|||
23605097|NCT04108858|65943605|FG000|Overall Study|Adverse Event|1|||
23605098|NCT01915914|65943606|FG000|Acute Phase|Withdrawal by Subject|4|||
23605099|NCT01915914|65943607|FG001|Acute Phase|Withdrawal by Subject|0|||
23605100|NCT01915914|65943608|FG002|Acute Phase|Withdrawal by Subject|0|||
23605101|NCT01915914|65943609|FG003|Acute Phase|Withdrawal by Subject|0|||
23605102|NCT01915914|65943606|FG000|Acute Phase|Lost to Follow-up|4|||
23605103|NCT01915914|65943607|FG001|Acute Phase|Lost to Follow-up|0|||
23605104|NCT01915914|65943608|FG002|Acute Phase|Lost to Follow-up|0|||
23605105|NCT01915914|65943609|FG003|Acute Phase|Lost to Follow-up|0|||
23605106|NCT01915914|65943606|FG000|Acute Phase|Physician Decision|1|||
23605107|NCT01915914|65943607|FG001|Acute Phase|Physician Decision|0|||
23605108|NCT01915914|65943608|FG002|Acute Phase|Physician Decision|0|||
23605109|NCT01915914|65943609|FG003|Acute Phase|Physician Decision|0|||
23605110|NCT01915914|65943606|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
23605111|NCT01915914|65943607|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
23605112|NCT01915914|65943608|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
23665955|NCT00143312|66162577|FG000|Overall Study|Death|11|||
23665956|NCT00143312|66162577|FG000|Overall Study|Adverse Event|2|||
23665957|NCT00143312|66162577|FG000|Overall Study|Lost to Follow-up|1|||
23665958|NCT00143312|66162577|FG000|Overall Study|Other|1|||
23665959|NCT00143312|66162577|FG000|Overall Study|Withdrawal by Subject|1|||
23665960|NCT04329702|66162578|FG000|Overall Study|illness|3|||
23665961|NCT04329702|66162579|FG001|Overall Study|illness|4|||
23605113|NCT01915914|65943609|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
23605114|NCT01915914|65943606|FG000|Acute Phase|"Not Achieved treatment success"|1|||
23605115|NCT01915914|65943607|FG001|Acute Phase|"Not Achieved treatment success"|0|||
23605116|NCT01915914|65943608|FG002|Acute Phase|"Not Achieved treatment success"|0|||
23605117|NCT01915914|65943609|FG003|Acute Phase|"Not Achieved treatment success"|0|||
23605118|NCT01915914|65943606|FG000|Acute Phase|Missing|1|||
23605119|NCT01915914|65943607|FG001|Acute Phase|Missing|0|||
23605120|NCT01915914|65943608|FG002|Acute Phase|Missing|0|||
23605121|NCT01915914|65943609|FG003|Acute Phase|Missing|0|||
23605122|NCT01915914|65943606|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23605123|NCT01915914|65943607|FG001|Maintenance Phase|Withdrawal by Subject|1|||
23605124|NCT01915914|65943608|FG002|Maintenance Phase|Withdrawal by Subject|1|||
23605125|NCT01915914|65943609|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23605126|NCT01915914|65943606|FG000|Maintenance Phase|Lost to Follow-up|0|||
23605127|NCT01915914|65943607|FG001|Maintenance Phase|Lost to Follow-up|4|||
23605128|NCT01915914|65943608|FG002|Maintenance Phase|Lost to Follow-up|1|||
23605129|NCT01915914|65943609|FG003|Maintenance Phase|Lost to Follow-up|0|||
23605130|NCT01915914|65943606|FG000|Maintenance Phase|Missing|0|||
23605131|NCT01915914|65943607|FG001|Maintenance Phase|Missing|1|||
23605132|NCT01915914|65943608|FG002|Maintenance Phase|Missing|0|||
23605133|NCT01915914|65943609|FG003|Maintenance Phase|Missing|0|||
23605134|NCT01915914|65943606|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23605135|NCT01915914|65943607|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23665962|NCT04329702|66162580|FG002|Overall Study|illness|0|||
23665963|NCT04329702|66162578|FG000|Overall Study|Lost to Follow-up|0|||
23605136|NCT01915914|65943608|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23605137|NCT01915914|65943609|FG003|Follow-up Phase|Withdrawal by Subject|1|||
23605138|NCT01915914|65943606|FG000|Follow-up Phase|Physician Decision|0|||
23605139|NCT01915914|65943607|FG001|Follow-up Phase|Physician Decision|0|||
23605140|NCT01915914|65943608|FG002|Follow-up Phase|Physician Decision|0|||
23605141|NCT01915914|65943609|FG003|Follow-up Phase|Physician Decision|1|||
23665964|NCT04329702|66162579|FG001|Overall Study|Lost to Follow-up|0|||
23665965|NCT04329702|66162580|FG002|Overall Study|Lost to Follow-up|2|||
23665966|NCT04329702|66162578|FG000|Overall Study|Death|0|||
23605142|NCT03032198|65943610|FG000|Overall Study|Screen Fail|1|||
23665967|NCT04329702|66162579|FG001|Overall Study|Death|2|||
23665968|NCT04329702|66162580|FG002|Overall Study|Death|0|||
23378104|NCT01712516|65130402|FG003|Overall Study|Withdrawal by Subject|9|||
23378105|NCT02471183|65130403|FG000|Main Treatment Period|Adverse Event|1|||
23378106|NCT02471183|65130403|FG000|Main Treatment Period|Withdrawal by Subject|1|||
23378107|NCT02471183|65130403|FG000|Extended Treatment Period|Lack of Efficacy|1|||
23378108|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
23378109|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
23378110|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
23378111|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Physician Decision|2|||
23378112|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Physician Decision|4|||
23378113|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Physician Decision|0|||
23378114|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
23378115|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
23378116|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
23378117|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
23378118|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
23378119|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
23378120|NCT01245062|65130406|FG000|Cross-over Phase|Lost to Follow-up|0|||
23378121|NCT01245062|65130407|FG001|Cross-over Phase|Lost to Follow-up|0|||
23378122|NCT01245062|65130408|FG002|Cross-over Phase|Lost to Follow-up|1|||
23378123|NCT01245062|65130406|FG000|Cross-over Phase|Physician Decision|0|||
23378124|NCT01245062|65130407|FG001|Cross-over Phase|Physician Decision|0|||
23378125|NCT01245062|65130408|FG002|Cross-over Phase|Physician Decision|1|||
23378126|NCT01245062|65130406|FG000|Cross-over Phase|Withdrew Consent|0|||
23378127|NCT01245062|65130407|FG001|Cross-over Phase|Withdrew Consent|0|||
23378128|NCT01245062|65130408|FG002|Cross-over Phase|Withdrew Consent|4|||
23378129|NCT01245062|65130406|FG000|Cross-over Phase|Study closed/ terminated|0|||
23378130|NCT01245062|65130407|FG001|Cross-over Phase|Study closed/ terminated|0|||
23378131|NCT01245062|65130408|FG002|Cross-over Phase|Study closed/ terminated|11|||
23378132|NCT02202616|65130409|FG000|Overall Study|Screen failed|24|||
23378133|NCT02202616|65130409|FG000|Overall Study|Adverse Event|32|||
23378134|NCT02202616|65130409|FG000|Overall Study|Protocol deviation|18|||
23378135|NCT02202616|65130409|FG000|Overall Study|Patient withdrew consent|12|||
23378136|NCT02202616|65130409|FG000|Overall Study|Lost to Follow-up|6|||
23378137|NCT02202616|65130409|FG000|Overall Study|Administrative problems|6|||
23378138|NCT02202616|65130409|FG000|Overall Study|Abnormal test procedure result|1|||
23378139|NCT02202616|65130409|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23378140|NCT04000724|65130426|FG000|Overall Study|Withdrawal by Subject|5|||
23378141|NCT04000724|65130427|FG001|Overall Study|Withdrawal by Subject|3|||
23378142|NCT04000724|65130428|FG002|Overall Study|Withdrawal by Subject|4|||
23378143|NCT04000724|65130426|FG000|Overall Study|Lost to Follow-up|11|||
23378144|NCT04000724|65130427|FG001|Overall Study|Lost to Follow-up|7|||
23378145|NCT04000724|65130428|FG002|Overall Study|Lost to Follow-up|13|||
23378146|NCT00640289|65130429|FG000|Overall Study|Death|3|||
23378147|NCT00640289|65130429|FG000|Overall Study|Withdrawal by Subject|1|||
23378148|NCT00640289|65130429|FG000|Overall Study|Lost to Follow-up|1|||
23378149|NCT00640289|65130429|FG000|Overall Study|Data collected under different amendment|2|||
23378150|NCT00640289|65130429|FG000|Overall Study|Transferred to another center|1|||
23378151|NCT00640289|65130429|FG000|Overall Study|Missing status|5|||
23378152|NCT01695772|65130430|FG000|Overall Study|Withdrawal by Subject|18|||
23378153|NCT01695772|65130430|FG000|Overall Study|Progressive Disease|8|||
23378154|NCT01695772|65130430|FG000|Overall Study|Investigator Decision|5|||
23378155|NCT01695772|65130430|FG000|Overall Study|Lost to Follow-up|4|||
23378156|NCT01695772|65130430|FG000|Overall Study|Protocol Violation|2|||
23378157|NCT01695772|65130430|FG000|Overall Study|Unspecified Reason|1|||
23378158|NCT02836769|65130432|FG000|Overall Study|Lost to Follow-up|10|||
23378159|NCT02836769|65130432|FG000|Overall Study|Medical withdrawal|2|||
23378160|NCT02836769|65130432|FG000|Overall Study|Withdrawal by Subject|3|||
23378161|NCT00724893|65130433|FG000|Overall Study|Adverse Event|76|||
23378162|NCT00724893|65130434|FG001|Overall Study|Adverse Event|142|||
23378163|NCT00724893|65130433|FG000|Overall Study|Withdrawal by Subject|0|||
23378164|NCT00724893|65130434|FG001|Overall Study|Withdrawal by Subject|1|||
23378165|NCT00724893|65130433|FG000|Overall Study|Lack of virologic response|94|||
23378166|NCT00724893|65130434|FG001|Overall Study|Lack of virologic response|202|||
23605143|NCT04070105|65943611|FG000|Overall Study|Lost to Follow-up|0|||
23605144|NCT04070105|65943612|FG001|Overall Study|Lost to Follow-up|0|||
23605145|NCT04070105|65943613|FG002|Overall Study|Lost to Follow-up|0|||
23378167|NCT00724893|65130433|FG000|Overall Study|Reason not specified|193|||
23378168|NCT00724893|65130434|FG001|Overall Study|Reason not specified|7|||
23378169|NCT00724893|65130433|FG000|Overall Study|Patient choice|0|||
23378170|NCT00724893|65130434|FG001|Overall Study|Patient choice|26|||
23378171|NCT00724893|65130433|FG000|Overall Study|Geographic reasons|0|||
23378172|NCT00724893|65130434|FG001|Overall Study|Geographic reasons|11|||
23378173|NCT00724893|65130433|FG000|Overall Study|Incarceration|0|||
23378174|NCT00724893|65130434|FG001|Overall Study|Incarceration|9|||
23378175|NCT00724893|65130433|FG000|Overall Study|Substance abuse|0|||
23490143|NCT01691898|65541312|FG001|Overall Study|Adverse Event|1|||
23490144|NCT01691898|65541313|FG002|Overall Study|Adverse Event|0|||
23490145|NCT01691898|65541314|FG003|Overall Study|Adverse Event|1|||
23490146|NCT01691898|65541315|FG004|Overall Study|Adverse Event|1|||
23490147|NCT01691898|65541316|FG005|Overall Study|Adverse Event|0|||
23490148|NCT01691898|65541311|FG000|Overall Study|Progression of Disease|1|||
23490149|NCT01691898|65541312|FG001|Overall Study|Progression of Disease|2|||
23490150|NCT01691898|65541313|FG002|Overall Study|Progression of Disease|1|||
23490151|NCT01691898|65541314|FG003|Overall Study|Progression of Disease|0|||
23490152|NCT01691898|65541315|FG004|Overall Study|Progression of Disease|0|||
23490153|NCT01691898|65541316|FG005|Overall Study|Progression of Disease|1|||
23490154|NCT01691898|65541311|FG000|Overall Study|Lost to Follow-up|3|||
23490155|NCT01691898|65541312|FG001|Overall Study|Lost to Follow-up|1|||
23490156|NCT01691898|65541313|FG002|Overall Study|Lost to Follow-up|0|||
23490157|NCT01691898|65541314|FG003|Overall Study|Lost to Follow-up|0|||
23490158|NCT01691898|65541315|FG004|Overall Study|Lost to Follow-up|1|||
23490159|NCT01691898|65541316|FG005|Overall Study|Lost to Follow-up|0|||
23490160|NCT01691898|65541311|FG000|Overall Study|Withdrawal by Subject|9|||
23490161|NCT01691898|65541312|FG001|Overall Study|Withdrawal by Subject|8|||
23490162|NCT01691898|65541313|FG002|Overall Study|Withdrawal by Subject|2|||
23490163|NCT01691898|65541314|FG003|Overall Study|Withdrawal by Subject|1|||
23490164|NCT01691898|65541315|FG004|Overall Study|Withdrawal by Subject|3|||
23490165|NCT01691898|65541316|FG005|Overall Study|Withdrawal by Subject|3|||
23490166|NCT01691898|65541311|FG000|Overall Study|Non-Compliance|0|||
23490167|NCT01691898|65541312|FG001|Overall Study|Non-Compliance|0|||
23490168|NCT01691898|65541313|FG002|Overall Study|Non-Compliance|0|||
23490169|NCT01691898|65541314|FG003|Overall Study|Non-Compliance|0|||
23490170|NCT01691898|65541315|FG004|Overall Study|Non-Compliance|1|||
23490171|NCT01691898|65541316|FG005|Overall Study|Non-Compliance|0|||
23490172|NCT00884377|65541324|FG000|Overall Study|Withdrawal by Subject|1|||
23490173|NCT00884377|65541325|FG001|Overall Study|Withdrawal by Subject|0|||
23490174|NCT00884377|65541324|FG000|Overall Study|Could not confirm diagnosis|1|||
23490175|NCT00884377|65541325|FG001|Overall Study|Could not confirm diagnosis|0|||
23490176|NCT00884377|65541324|FG000|Overall Study|Physician Decision|0|||
23490177|NCT00884377|65541325|FG001|Overall Study|Physician Decision|1|||
23490178|NCT02611960|65541333|FG000|Overall Study|Adverse Event|7|||
23490179|NCT02611960|65541334|FG001|Overall Study|Adverse Event|8|||
23490180|NCT02611960|65541333|FG000|Overall Study|Death|98|||
23490181|NCT02611960|65541334|FG001|Overall Study|Death|92|||
23490182|NCT02611960|65541333|FG000|Overall Study|Withdrawal by Subject|1|||
23490183|NCT02611960|65541334|FG001|Overall Study|Withdrawal by Subject|5|||
23490184|NCT02611960|65541333|FG000|Overall Study|Sponsor Decision|11|||
23490185|NCT02611960|65541334|FG001|Overall Study|Sponsor Decision|11|||
23490186|NCT01225887|65541335|FG000|Overall Study|Ineligible:required test not done|2|||
23490187|NCT01225887|65541335|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
23490188|NCT01225887|65541335|FG000|Overall Study|Ineligible:inadequate pathology|2|||
23490189|NCT00617851|65541339|FG000|Overall Study|Death|0|||
23490190|NCT00617851|65541340|FG001|Overall Study|Death|0|||
23490191|NCT00617851|65541341|FG002|Overall Study|Death|0|||
23490192|NCT00617851|65541342|FG003|Overall Study|Death|1|||
23490193|NCT00617851|65541339|FG000|Overall Study|Withdrawal by Subject|14|||
23490194|NCT00617851|65541340|FG001|Overall Study|Withdrawal by Subject|7|||
23490195|NCT00617851|65541341|FG002|Overall Study|Withdrawal by Subject|12|||
23490196|NCT00617851|65541342|FG003|Overall Study|Withdrawal by Subject|4|||
23490197|NCT00617851|65541339|FG000|Overall Study|Lost to Follow-up|27|||
23490198|NCT00617851|65541340|FG001|Overall Study|Lost to Follow-up|29|||
23490199|NCT00617851|65541341|FG002|Overall Study|Lost to Follow-up|31|||
23490200|NCT00617851|65541342|FG003|Overall Study|Lost to Follow-up|19|||
23490201|NCT00617851|65541339|FG000|Overall Study|Inappropriate Enrollment|5|||
23490202|NCT00617851|65541340|FG001|Overall Study|Inappropriate Enrollment|4|||
23490203|NCT00617851|65541341|FG002|Overall Study|Inappropriate Enrollment|1|||
23490204|NCT00617851|65541342|FG003|Overall Study|Inappropriate Enrollment|1|||
23490205|NCT00617851|65541339|FG000|Overall Study|Unable to classify|1|||
23490206|NCT00617851|65541340|FG001|Overall Study|Unable to classify|0|||
23490207|NCT00617851|65541341|FG002|Overall Study|Unable to classify|1|||
23490208|NCT00617851|65541342|FG003|Overall Study|Unable to classify|0|||
23490209|NCT01052844|65541343|FG000|Overall Study|Adverse Event|0|||
23490210|NCT01052844|65541344|FG001|Overall Study|Adverse Event|1|||
23490211|NCT02395016|65541345|FG000|Overall Study|Adverse Event|4|||
23490212|NCT02395016|65541346|FG001|Overall Study|Adverse Event|3|||
23490213|NCT02395016|65541345|FG000|Overall Study|Withdrawal by Subject|9|||
23490214|NCT02395016|65541346|FG001|Overall Study|Withdrawal by Subject|6|||
23490215|NCT02395016|65541345|FG000|Overall Study|Protocol Violation|2|||
23490216|NCT02395016|65541346|FG001|Overall Study|Protocol Violation|3|||
23490217|NCT04521777|65541347|FG000|Overall Study|Death|2|||
23490218|NCT04521777|65541347|FG000|Overall Study|Withdrawal by Subject|2|||
23490219|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
23490220|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
23490221|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
23490222|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
23490223|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490224|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
23490225|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490226|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490227|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
23490228|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490229|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490230|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490231|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490232|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
23490233|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490234|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490235|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490236|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
23490237|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490238|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490239|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
23490240|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
23490241|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
23490242|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
23490243|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Adverse Event|0|||
23490244|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Adverse Event|0|||
23665969|NCT02270242|66162581|FG000|Overall Study|Withdrawal by Subject|18|||
23665970|NCT02270242|66162582|FG001|Overall Study|Withdrawal by Subject|25|||
23665971|NCT02270242|66162581|FG000|Overall Study|Lost to Follow-up|41|||
23490245|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Adverse Event|1|||
23490246|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Adverse Event|1|||
23490247|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
23490248|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
23490249|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
23490250|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
23490251|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
23490252|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
23490253|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
23490254|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
23665972|NCT02270242|66162582|FG001|Overall Study|Lost to Follow-up|27|||
23490255|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
23490256|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
23490257|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
23490258|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
23490259|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Physician Decision|0|||
23490260|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Physician Decision|0|||
23490261|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Physician Decision|3|||
23490262|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Physician Decision|2|||
23490263|NCT01226043|65541349|FG000|6-week Re-randomization Phase|completed in error|0|||
23490264|NCT01226043|65541350|FG001|6-week Re-randomization Phase|completed in error|0|||
23490265|NCT01226043|65541351|FG002|6-week Re-randomization Phase|completed in error|0|||
23490266|NCT01226043|65541352|FG003|6-week Re-randomization Phase|completed in error|1|||
23490267|NCT01226043|65541349|FG000|30-week Observational Phase|Adverse Event|0|||
23490268|NCT01226043|65541350|FG001|30-week Observational Phase|Adverse Event|0|||
23490269|NCT01226043|65541351|FG002|30-week Observational Phase|Adverse Event|1|||
23605146|NCT04070105|65943614|FG003|Overall Study|Lost to Follow-up|0|||
23605147|NCT04070105|65943615|FG004|Overall Study|Lost to Follow-up|0|||
23605148|NCT04070105|65943616|FG005|Overall Study|Lost to Follow-up|1|||
23665973|NCT02270242|66162581|FG000|Overall Study|Physician Decision|0|||
23665974|NCT02270242|66162582|FG001|Overall Study|Physician Decision|1|||
23605149|NCT01229176|65943617|FG000|Overall Study|Withdrawal by Subject|0|||
23605150|NCT01229176|65943618|FG001|Overall Study|Withdrawal by Subject|0|||
23605151|NCT01229176|65943619|FG002|Overall Study|Withdrawal by Subject|0|||
23605152|NCT01229176|65943620|FG003|Overall Study|Withdrawal by Subject|1|||
23605153|NCT01229176|65943621|FG004|Overall Study|Withdrawal by Subject|1|||
23605154|NCT01229176|65943622|FG005|Overall Study|Withdrawal by Subject|1|||
23605155|NCT01229176|65943623|FG006|Overall Study|Withdrawal by Subject|0|||
23605156|NCT01229176|65943624|FG007|Overall Study|Withdrawal by Subject|1|||
23605157|NCT01229176|65943617|FG000|Overall Study|Lost to Follow-up|0|||
23605158|NCT01229176|65943618|FG001|Overall Study|Lost to Follow-up|3|||
23665975|NCT01923285|66162585|FG000|Overall Study|Withdrawal by Subject|7|||
23665976|NCT01923285|66162586|FG001|Overall Study|Withdrawal by Subject|6|||
23490270|NCT01226043|65541352|FG003|30-week Observational Phase|Adverse Event|1|||
23490271|NCT01226043|65541349|FG000|30-week Observational Phase|Protocol Violation|0|||
23490272|NCT01226043|65541350|FG001|30-week Observational Phase|Protocol Violation|0|||
23490273|NCT01226043|65541351|FG002|30-week Observational Phase|Protocol Violation|0|||
23490274|NCT01226043|65541352|FG003|30-week Observational Phase|Protocol Violation|1|||
23490275|NCT01226043|65541349|FG000|30-week Observational Phase|Lost to Follow-up|0|||
23490276|NCT01226043|65541350|FG001|30-week Observational Phase|Lost to Follow-up|0|||
23490277|NCT01226043|65541351|FG002|30-week Observational Phase|Lost to Follow-up|2|||
23490278|NCT01226043|65541352|FG003|30-week Observational Phase|Lost to Follow-up|2|||
23490279|NCT01226043|65541349|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
23490280|NCT01226043|65541350|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
23490281|NCT01226043|65541351|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
23490282|NCT01226043|65541352|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
23490283|NCT01226043|65541349|FG000|30-week Observational Phase|Physician Decision|0|||
23490284|NCT01226043|65541350|FG001|30-week Observational Phase|Physician Decision|0|||
23490285|NCT01226043|65541351|FG002|30-week Observational Phase|Physician Decision|2|||
23490286|NCT01226043|65541352|FG003|30-week Observational Phase|Physician Decision|2|||
23490287|NCT01346969|65541353|FG000|Overall Study|Withdrawal by Subject|0|||
23490288|NCT01346969|65541354|FG001|Overall Study|Withdrawal by Subject|0|||
23490289|NCT01346969|65541355|FG002|Overall Study|Withdrawal by Subject|1|||
23490290|NCT01346969|65541356|FG003|Overall Study|Withdrawal by Subject|0|||
23490291|NCT01346969|65541353|FG000|Overall Study|Lost to Follow-up|1|||
23490292|NCT01346969|65541354|FG001|Overall Study|Lost to Follow-up|0|||
23490293|NCT01346969|65541355|FG002|Overall Study|Lost to Follow-up|2|||
23490294|NCT01346969|65541356|FG003|Overall Study|Lost to Follow-up|0|||
23490295|NCT01346969|65541353|FG000|Overall Study|Physician Decision|0|||
23490296|NCT01346969|65541354|FG001|Overall Study|Physician Decision|0|||
23490297|NCT01346969|65541355|FG002|Overall Study|Physician Decision|0|||
23490298|NCT01346969|65541356|FG003|Overall Study|Physician Decision|1|||
23490299|NCT01346969|65541353|FG000|Overall Study|Randomized but not treated|1|||
23490300|NCT01346969|65541354|FG001|Overall Study|Randomized but not treated|0|||
23490301|NCT01346969|65541355|FG002|Overall Study|Randomized but not treated|0|||
23490302|NCT01346969|65541356|FG003|Overall Study|Randomized but not treated|0|||
23490303|NCT01193842|65541357|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23665977|NCT02807480|66162587|FG000|Overall Study|Withdrawal by Subject|14|||
23665978|NCT02807480|66162588|FG001|Overall Study|Withdrawal by Subject|10|||
23665979|NCT02703311|66162589|FG000|Overall Study|Death|5|||
23665980|NCT02703311|66162589|FG000|Overall Study|Withdrawal by Subject|3|||
23665981|NCT01471782|66162590|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
23378176|NCT00724893|65130434|FG001|Overall Study|Substance abuse|3|||
23490304|NCT01193842|65541358|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
23490305|NCT01193842|65541359|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490306|NCT01193842|65541360|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490307|NCT01193842|65541361|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490308|NCT01193842|65541357|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
23490309|NCT01193842|65541358|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490310|NCT01193842|65541359|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490311|NCT01193842|65541360|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490312|NCT01193842|65541361|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490313|NCT01193842|65541357|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490314|NCT01193842|65541358|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490315|NCT01193842|65541359|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
23490316|NCT01193842|65541360|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490317|NCT01193842|65541361|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490318|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Death|0|||
23490319|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Death|0|||
23490320|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Death|0|||
23490321|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Death|1|||
23490322|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Death|1|||
23490323|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Adverse Event|0|||
23490324|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Adverse Event|0|||
23490325|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Adverse Event|0|||
23490326|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Adverse Event|5|||
23490327|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Adverse Event|3|||
23490328|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490329|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490330|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490331|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
23490332|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
23490333|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Ineligible|0|||
23490334|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Ineligible|0|||
23490335|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Ineligible|0|||
23490336|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Ineligible|0|||
23490337|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Ineligible|1|||
23490338|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490339|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490340|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490341|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
23490342|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
23490343|NCT02556203|65541370|FG000|Overall Study|Withdrawal by Subject|21|||
23490344|NCT02556203|65541371|FG001|Overall Study|Withdrawal by Subject|21|||
23490345|NCT02556203|65541370|FG000|Overall Study|Lost to Follow-up|5|||
23490346|NCT02556203|65541371|FG001|Overall Study|Lost to Follow-up|5|||
23490347|NCT02556203|65541370|FG000|Overall Study|Adverse Event|1|||
23490348|NCT02556203|65541371|FG001|Overall Study|Adverse Event|0|||
23490349|NCT02979197|65541373|FG000|Overall Study|Adverse Event|4|||
23490350|NCT02979197|65541374|FG001|Overall Study|Adverse Event|2|||
23490351|NCT02979197|65541375|FG002|Overall Study|Adverse Event|0|||
23490352|NCT02979197|65541373|FG000|Overall Study|Protocol Violation|0|||
23490353|NCT02979197|65541374|FG001|Overall Study|Protocol Violation|1|||
23490354|NCT02979197|65541375|FG002|Overall Study|Protocol Violation|0|||
23490355|NCT02979197|65541373|FG000|Overall Study|Subject unable to commit to study dates|0|||
23490356|NCT02979197|65541374|FG001|Overall Study|Subject unable to commit to study dates|1|||
23490357|NCT02979197|65541375|FG002|Overall Study|Subject unable to commit to study dates|0|||
23490358|NCT00195273|65541376|FG000|Overall Study|Adverse Event|9|||
23490359|NCT00195273|65541377|FG001|Overall Study|Adverse Event|9|||
23490360|NCT00195273|65541376|FG000|Overall Study|Protocol deviation|0|||
23490361|NCT00195273|65541377|FG001|Overall Study|Protocol deviation|1|||
23490362|NCT00195273|65541376|FG000|Overall Study|Lack of Efficacy|3|||
23490363|NCT00195273|65541377|FG001|Overall Study|Lack of Efficacy|1|||
23490364|NCT00195273|65541376|FG000|Overall Study|Procedural complications|9|||
23490365|NCT00195273|65541377|FG001|Overall Study|Procedural complications|3|||
23490366|NCT00107783|65541378|FG000|Overall Study|Adverse Event|0|||
23490367|NCT00107783|65541379|FG001|Overall Study|Adverse Event|2|||
23490368|NCT00107783|65541378|FG000|Overall Study|Death|0|||
23490369|NCT00107783|65541379|FG001|Overall Study|Death|1|||
23490370|NCT00107783|65541378|FG000|Overall Study|Withdrawal by Subject|2|||
23490371|NCT00107783|65541379|FG001|Overall Study|Withdrawal by Subject|0|||
23490372|NCT00107783|65541378|FG000|Overall Study|Second hip replacement|1|||
23490373|NCT00107783|65541379|FG001|Overall Study|Second hip replacement|1|||
23490374|NCT05095454|65541380|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
23490375|NCT05095454|65541381|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
23490376|NCT01281137|65541384|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
23490377|NCT01281137|65541385|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
23490378|NCT01281137|65541384|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
23490379|NCT01281137|65541385|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
23490380|NCT01281137|65541384|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
23490381|NCT01281137|65541385|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
23490382|NCT01281137|65541384|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
23490383|NCT01281137|65541385|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
23490384|NCT01281137|65541384|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
23490385|NCT01281137|65541385|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
23490386|NCT04676412|65541386|FG000|Overall Study|Death|17|||
23490387|NCT04676412|65541387|FG001|Overall Study|Death|23|||
23490388|NCT04676412|65541386|FG000|Overall Study|Withdrawal by Subject|0|||
23490389|NCT04676412|65541387|FG001|Overall Study|Withdrawal by Subject|2|||
23490390|NCT04676412|65541386|FG000|Overall Study|Participants ongoing|32|||
23665982|NCT01471782|66162591|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
23665983|NCT01471782|66162592|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
23378177|NCT00724893|65130433|FG000|Overall Study|Financial reasons|0|||
23378178|NCT00724893|65130434|FG001|Overall Study|Financial reasons|2|||
23378179|NCT00724893|65130433|FG000|Overall Study|Assigned shorter treatment|0|||
23378180|NCT00724893|65130434|FG001|Overall Study|Assigned shorter treatment|2|||
23378181|NCT00724893|65130433|FG000|Overall Study|Lost to Follow-up|0|||
23378182|NCT00724893|65130434|FG001|Overall Study|Lost to Follow-up|52|||
23378183|NCT00724893|65130433|FG000|Overall Study|Unknown, missing data|1|||
23378184|NCT00724893|65130434|FG001|Overall Study|Unknown, missing data|1|||
23378185|NCT01104766|65130435|FG000|Overall Study|Did not meet inc/exc criteria|1|||
23378186|NCT01104766|65130436|FG001|Overall Study|Did not meet inc/exc criteria|0|||
23378187|NCT01104766|65130437|FG002|Overall Study|Did not meet inc/exc criteria|0|||
23378188|NCT01104766|65130438|FG003|Overall Study|Did not meet inc/exc criteria|0|||
23378189|NCT01104766|65130435|FG000|Overall Study|Adverse Event|17|||
23378190|NCT01104766|65130436|FG001|Overall Study|Adverse Event|15|||
23378191|NCT01104766|65130437|FG002|Overall Study|Adverse Event|20|||
23378192|NCT01104766|65130438|FG003|Overall Study|Adverse Event|14|||
23378193|NCT01104766|65130435|FG000|Overall Study|Lack of Efficacy|20|||
23378194|NCT01104766|65130436|FG001|Overall Study|Lack of Efficacy|15|||
23378195|NCT01104766|65130437|FG002|Overall Study|Lack of Efficacy|14|||
23378196|NCT01104766|65130438|FG003|Overall Study|Lack of Efficacy|8|||
23378197|NCT01104766|65130435|FG000|Overall Study|Protocol Violation|2|||
23378198|NCT01104766|65130436|FG001|Overall Study|Protocol Violation|0|||
23378199|NCT01104766|65130437|FG002|Overall Study|Protocol Violation|0|||
23378200|NCT01104766|65130438|FG003|Overall Study|Protocol Violation|0|||
23378201|NCT01104766|65130435|FG000|Overall Study|Withdrawal by Subject|17|||
23378202|NCT01104766|65130436|FG001|Overall Study|Withdrawal by Subject|19|||
23378203|NCT01104766|65130437|FG002|Overall Study|Withdrawal by Subject|25|||
23378204|NCT01104766|65130438|FG003|Overall Study|Withdrawal by Subject|15|||
23378205|NCT01104766|65130435|FG000|Overall Study|Lost to Follow-up|1|||
23378206|NCT01104766|65130436|FG001|Overall Study|Lost to Follow-up|2|||
23378207|NCT01104766|65130437|FG002|Overall Study|Lost to Follow-up|1|||
23378208|NCT01104766|65130438|FG003|Overall Study|Lost to Follow-up|1|||
23378209|NCT03387046|65130441|FG000|Overall Study|Adverse Event|1|||
23378210|NCT03387046|65130442|FG001|Overall Study|Adverse Event|1|||
23378211|NCT02693418|65130443|FG000|Overall Study|Lost to Follow-up|1|||
23378212|NCT02693418|65130444|FG001|Overall Study|Lost to Follow-up|2|||
23378213|NCT02693418|65130445|FG002|Overall Study|Lost to Follow-up|0|||
23378214|NCT02693418|65130446|FG003|Overall Study|Lost to Follow-up|0|||
23378215|NCT02693418|65130447|FG004|Overall Study|Lost to Follow-up|0|||
23378216|NCT02693418|65130443|FG000|Overall Study|Menses during study period|0|||
23378217|NCT02693418|65130444|FG001|Overall Study|Menses during study period|0|||
23378218|NCT02693418|65130445|FG002|Overall Study|Menses during study period|2|||
23378219|NCT02693418|65130446|FG003|Overall Study|Menses during study period|0|||
23378220|NCT02693418|65130447|FG004|Overall Study|Menses during study period|0|||
23490391|NCT04676412|65541387|FG001|Overall Study|Participants ongoing|33|||
23490392|NCT02003365|65541388|FG000|Overall Study|Lost to Follow-up|0|||
23490393|NCT02003365|65541389|FG001|Overall Study|Lost to Follow-up|0|||
23490394|NCT02003365|65541390|FG002|Overall Study|Lost to Follow-up|1|||
23490395|NCT00131508|65541391|FG000|Overall Study|Disease progression|0|||
23490396|NCT00131508|65541392|FG001|Overall Study|Disease progression|2|||
23490397|NCT00131508|65541391|FG000|Overall Study|Non-Compliance|2|||
23490398|NCT00131508|65541392|FG001|Overall Study|Non-Compliance|4|||
23490399|NCT00131508|65541391|FG000|Overall Study|Withdrawal by Subject|1|||
23490400|NCT00131508|65541392|FG001|Overall Study|Withdrawal by Subject|2|||
23490401|NCT00737438|65541393|FG000|Overall Study|Withdrawal by Subject|2|||
23490402|NCT00737438|65541393|FG000|Overall Study|Patient ineligible|1|||
23490403|NCT04697056|65541396|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
23490404|NCT04697056|65541397|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
23490405|NCT02520661|65541400|FG000|Overall Study|Lost to Follow-up|7|||
23490406|NCT02520661|65541401|FG001|Overall Study|Lost to Follow-up|3|||
23490407|NCT02520661|65541400|FG000|Overall Study|Admitted from ED|49|||
23490408|NCT02520661|65541401|FG001|Overall Study|Admitted from ED|48|||
23490409|NCT02520661|65541400|FG000|Overall Study|ED greater than 24 hours|29|||
23490410|NCT02520661|65541401|FG001|Overall Study|ED greater than 24 hours|38|||
23490411|NCT02520661|65541400|FG000|Overall Study|other ineligibility|14|||
23490412|NCT02520661|65541401|FG001|Overall Study|other ineligibility|22|||
23490413|NCT02520661|65541400|FG000|Overall Study|Withdrawal by Subject|7|||
23490414|NCT02520661|65541401|FG001|Overall Study|Withdrawal by Subject|16|||
23490415|NCT03898960|65541402|FG000|Overall Study|Death|10|||
23490416|NCT02448810|65541403|FG000|Overall Study|Adverse Event|0|||
23490417|NCT02448810|65541404|FG001|Overall Study|Adverse Event|0|||
23490418|NCT02448810|65541405|FG002|Overall Study|Adverse Event|1|||
23490419|NCT02448810|65541406|FG003|Overall Study|Adverse Event|0|||
23378221|NCT01179399|65130448|FG000|Overall Study|Adverse Event|1|||
23378222|NCT01179399|65130448|FG000|Overall Study|Lack of Efficacy|30|||
23378223|NCT01179399|65130448|FG000|Overall Study|Withdrawal by Subject|1|||
23378224|NCT01018979|65130449|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
23378225|NCT01018979|65130450|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
23378226|NCT01018979|65130449|FG000|Overall Study|Not received at least one dose|0|||
23378227|NCT01018979|65130450|FG001|Overall Study|Not received at least one dose|1|||
23378228|NCT00970944|65130456|FG000|Overall Study|Death|1|||
23378229|NCT00970944|65130457|FG001|Overall Study|Death|0|||
23490420|NCT02448810|65541407|FG004|Overall Study|Adverse Event|0|||
23490421|NCT02448810|65541408|FG005|Overall Study|Adverse Event|0|||
23490422|NCT02448810|65541409|FG006|Overall Study|Adverse Event|0|||
23605159|NCT01229176|65943619|FG002|Overall Study|Lost to Follow-up|0|||
23490423|NCT02448810|65541410|FG007|Overall Study|Adverse Event|0|||
23490424|NCT02448810|65541403|FG000|Overall Study|Withdrawal by Subject|0|||
23490425|NCT02448810|65541404|FG001|Overall Study|Withdrawal by Subject|0|||
23490426|NCT02448810|65541405|FG002|Overall Study|Withdrawal by Subject|1|||
23378230|NCT00970944|65130456|FG000|Overall Study|Physician Decision|0|||
23378231|NCT00970944|65130457|FG001|Overall Study|Physician Decision|2|||
23378232|NCT01913353|65130458|FG000|Overall Study|Adverse Event|2|||
23378233|NCT01913353|65130459|FG001|Overall Study|Adverse Event|0|||
23378234|NCT01913353|65130458|FG000|Overall Study|Physician Decision|0|||
23378235|NCT01913353|65130459|FG001|Overall Study|Physician Decision|2|||
23605160|NCT01229176|65943620|FG003|Overall Study|Lost to Follow-up|0|||
23605161|NCT01229176|65943621|FG004|Overall Study|Lost to Follow-up|1|||
23605162|NCT01229176|65943622|FG005|Overall Study|Lost to Follow-up|1|||
23605163|NCT01229176|65943623|FG006|Overall Study|Lost to Follow-up|0|||
23605164|NCT01229176|65943624|FG007|Overall Study|Lost to Follow-up|2|||
23605165|NCT01989104|65943627|FG000|Overall Study|Withdrawal by Subject|3|||
23605166|NCT01989104|65943628|FG001|Overall Study|Withdrawal by Subject|0|||
23605167|NCT01989104|65943629|FG002|Overall Study|Withdrawal by Subject|0|||
23605168|NCT01989104|65943630|FG003|Overall Study|Withdrawal by Subject|0|||
23605169|NCT01989104|65943631|FG004|Overall Study|Withdrawal by Subject|0|||
23605170|NCT02188459|65943633|FG000|Overall Study|Lost to Follow-up|3|||
23605171|NCT02188459|65943634|FG001|Overall Study|Lost to Follow-up|4|||
23605172|NCT02188459|65943633|FG000|Overall Study|Early Termination|0|||
23605173|NCT02188459|65943634|FG001|Overall Study|Early Termination|3|||
23605174|NCT01794299|65943635|FG000|Overall Study|ATIR manufacturing not possible|1|||
23605175|NCT01794299|65943635|FG000|Overall Study|Death|14|||
23605176|NCT01794299|65943635|FG000|Overall Study|Graft failure|1|||
23605177|NCT01794299|65943635|FG000|Overall Study|ATIR batch rejected|2|||
23378236|NCT01913353|65130458|FG000|Overall Study|Withdrawal by Subject|20|||
23605178|NCT01794299|65943635|FG000|Overall Study|Relapse|2|||
23378237|NCT01913353|65130459|FG001|Overall Study|Withdrawal by Subject|6|||
23378238|NCT01913353|65130458|FG000|Overall Study|multiple reasons|10|||
23378239|NCT01913353|65130459|FG001|Overall Study|multiple reasons|7|||
23378240|NCT00303953|65130466|FG000|Overall Study|Ineligible|1|||
23378241|NCT00303953|65130466|FG000|Overall Study|Death|1|||
23378242|NCT00303953|65130466|FG000|Overall Study|Adverse Event|4|||
23378243|NCT00303953|65130466|FG000|Overall Study|Lack of Efficacy|12|||
23378244|NCT00303953|65130466|FG000|Overall Study|Physician Decision|1|||
23378245|NCT02875080|65130473|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
23378246|NCT02875080|65130474|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
23378247|NCT02875080|65130475|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
23378248|NCT03704688|65130480|FG000|Overall Study|Adverse Event|0|||
23378249|NCT03704688|65130481|FG001|Overall Study|Adverse Event|0|||
23378250|NCT03704688|65130482|FG002|Overall Study|Adverse Event|0|||
23378251|NCT03704688|65130483|FG003|Overall Study|Adverse Event|4|||
23378252|NCT03704688|65130484|FG004|Overall Study|Adverse Event|1|||
23378253|NCT03704688|65130485|FG005|Overall Study|Adverse Event|0|||
23378254|NCT03704688|65130480|FG000|Overall Study|Disease Progression|0|||
23378255|NCT03704688|65130481|FG001|Overall Study|Disease Progression|0|||
23378256|NCT03704688|65130482|FG002|Overall Study|Disease Progression|0|||
23378257|NCT03704688|65130483|FG003|Overall Study|Disease Progression|3|||
23378258|NCT03704688|65130484|FG004|Overall Study|Disease Progression|1|||
23378259|NCT03704688|65130485|FG005|Overall Study|Disease Progression|0|||
23378260|NCT03704688|65130480|FG000|Overall Study|Death|0|||
23378261|NCT03704688|65130481|FG001|Overall Study|Death|0|||
23378262|NCT03704688|65130482|FG002|Overall Study|Death|0|||
23378263|NCT03704688|65130483|FG003|Overall Study|Death|0|||
23378264|NCT03704688|65130484|FG004|Overall Study|Death|3|||
23378265|NCT03704688|65130485|FG005|Overall Study|Death|0|||
23378266|NCT01389232|65130486|FG000|Overall Study|Had scaffold removed|15|||
23378267|NCT01389232|65130486|FG000|Overall Study|Personal reasons|2|||
23378268|NCT01389232|65130486|FG000|Overall Study|Adverse Event|1|||
23378269|NCT01389232|65130486|FG000|Overall Study|Death|1|||
23378270|NCT00177671|65130487|FG000|Overall Study|Withdrawal by Subject|5|||
23378271|NCT00177671|65130488|FG001|Overall Study|Withdrawal by Subject|6|||
23378272|NCT00177671|65130487|FG000|Overall Study|medical complications|2|||
23378273|NCT00177671|65130488|FG001|Overall Study|medical complications|0|||
23378274|NCT00177671|65130487|FG000|Overall Study|Adverse Event|6|||
23378275|NCT00177671|65130488|FG001|Overall Study|Adverse Event|0|||
23378276|NCT00177671|65130487|FG000|Overall Study|Physician Decision|12|||
23378277|NCT00177671|65130488|FG001|Overall Study|Physician Decision|8|||
23378278|NCT01898078|65130489|FG000|Overall Study|Progressive Disease|1|||
23378279|NCT01898078|65130490|FG001|Overall Study|Progressive Disease|5|||
23378280|NCT01898078|65130489|FG000|Overall Study|Adverse Event|2|||
23378281|NCT01898078|65130490|FG001|Overall Study|Adverse Event|1|||
23378282|NCT01898078|65130489|FG000|Overall Study|Withdrawal by Subject|1|||
23378283|NCT01898078|65130490|FG001|Overall Study|Withdrawal by Subject|1|||
23378284|NCT01898078|65130489|FG000|Overall Study|Symptomatic Deterioration|2|||
23378285|NCT01898078|65130490|FG001|Overall Study|Symptomatic Deterioration|0|||
23378286|NCT01898078|65130489|FG000|Overall Study|Reason not Specified|0|||
23378287|NCT01898078|65130490|FG001|Overall Study|Reason not Specified|1|||
23378288|NCT00768053|65130493|FG000|Overall Study|Adverse Event|10|||
23378289|NCT00768053|65130493|FG000|Overall Study|Lost to Follow-up|1|||
23378290|NCT02184156|65130494|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
23378291|NCT02184156|65130495|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
23378292|NCT02184156|65130494|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
23378293|NCT02184156|65130495|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
23378294|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
23378295|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
23378296|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23378297|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23605179|NCT01794299|65943635|FG000|Overall Study|Discontinued from active follow-up|1|||
23605180|NCT01794299|65943635|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
23605181|NCT02241785|65943637|FG000|Overall Study|Sponsor Termination|43|||
23605182|NCT02241785|65943637|FG000|Overall Study|Withdrawal by Subject|1|||
23378298|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
23378299|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
23378300|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
23378301|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
23378302|NCT02965833|65130496|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
23378303|NCT02965833|65130497|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
23378304|NCT01137812|65130498|FG000|Overall Study|Adverse Event|21|||
23378305|NCT01137812|65130499|FG001|Overall Study|Adverse Event|14|||
23378306|NCT01137812|65130498|FG000|Overall Study|Lost to Follow-up|6|||
23378307|NCT01137812|65130499|FG001|Overall Study|Lost to Follow-up|8|||
23378308|NCT01137812|65130498|FG000|Overall Study|Physician Decision|25|||
23378309|NCT01137812|65130499|FG001|Overall Study|Physician Decision|17|||
23378310|NCT01137812|65130498|FG000|Overall Study|Protocol Violation|5|||
23378311|NCT01137812|65130499|FG001|Overall Study|Protocol Violation|4|||
23378312|NCT01137812|65130498|FG000|Overall Study|Withdrawal by Subject|5|||
23378313|NCT01137812|65130499|FG001|Overall Study|Withdrawal by Subject|13|||
23378314|NCT01137812|65130498|FG000|Overall Study|Death|2|||
23378315|NCT01137812|65130499|FG001|Overall Study|Death|0|||
23378316|NCT01137812|65130498|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
23378317|NCT01137812|65130499|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
23378318|NCT01137812|65130498|FG000|Overall Study|Other|19|||
23378319|NCT01137812|65130499|FG001|Overall Study|Other|27|||
23378320|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
23378321|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
23378322|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
23378323|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
23378324|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378325|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378326|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378327|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
23378328|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378329|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
23378330|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378331|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378332|NCT01022580|65130504|FG000|Overall Study|Death|18|||
23378333|NCT01022580|65130505|FG001|Overall Study|Death|22|||
23378334|NCT04790201|65130506|FG000|Overall Study|Lost to Follow-up|0|||
23378335|NCT04790201|65130507|FG001|Overall Study|Lost to Follow-up|0|||
23378336|NCT04790201|65130508|FG002|Overall Study|Lost to Follow-up|2|||
23378337|NCT04790201|65130506|FG000|Overall Study|Death|0|||
23378338|NCT04790201|65130507|FG001|Overall Study|Death|1|||
23378339|NCT04790201|65130508|FG002|Overall Study|Death|0|||
23378340|NCT04790201|65130506|FG000|Overall Study|Protocol Violation|1|||
23378341|NCT04790201|65130507|FG001|Overall Study|Protocol Violation|0|||
23378342|NCT04790201|65130508|FG002|Overall Study|Protocol Violation|1|||
23378343|NCT03462680|65130511|FG000|Overall Study|Withdrawal by Subject|3|||
23378344|NCT03462680|65130512|FG001|Overall Study|Withdrawal by Subject|5|||
23378345|NCT03881371|65130515|FG000|Overall Study|Adverse Event|8|||
23378346|NCT03881371|65130516|FG001|Overall Study|Adverse Event|9|||
23378347|NCT03881371|65130515|FG000|Overall Study|Death|1|||
23378348|NCT03881371|65130516|FG001|Overall Study|Death|0|||
23378349|NCT03881371|65130515|FG000|Overall Study|Lost to Follow-up|1|||
23378350|NCT03881371|65130516|FG001|Overall Study|Lost to Follow-up|0|||
23378351|NCT03881371|65130515|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23378352|NCT03881371|65130516|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23378353|NCT03881371|65130515|FG000|Overall Study|Physician Decision|3|||
23378354|NCT03881371|65130516|FG001|Overall Study|Physician Decision|3|||
23378355|NCT03881371|65130515|FG000|Overall Study|Withdrawal by Subject|2|||
23378356|NCT03881371|65130516|FG001|Overall Study|Withdrawal by Subject|10|||
23378357|NCT03881371|65130515|FG000|Overall Study|Discontinuation from Study|1|||
23378358|NCT03881371|65130516|FG001|Overall Study|Discontinuation from Study|0|||
23378359|NCT02908347|65130520|FG000|Overall Study|Adverse Event|0|||
23378360|NCT02908347|65130521|FG001|Overall Study|Adverse Event|1|||
23378361|NCT02908347|65130520|FG000|Overall Study|Lost to Follow-up|1|||
23378362|NCT02908347|65130521|FG001|Overall Study|Lost to Follow-up|0|||
23378363|NCT00770367|65130522|FG000|First Intervention|Withdrawal by Subject|0|||
23378364|NCT00770367|65130523|FG001|First Intervention|Withdrawal by Subject|2|||
23378365|NCT00770367|65130522|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
23665984|NCT01471782|66162593|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
23665985|NCT01471782|66162594|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
23665986|NCT01471782|66162595|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
23665987|NCT01471782|66162590|FG000|Overall Study|Lack of Efficacy|1|||
23665988|NCT01471782|66162591|FG001|Overall Study|Lack of Efficacy|2|||
23665989|NCT01471782|66162592|FG002|Overall Study|Lack of Efficacy|1|||
23665990|NCT01471782|66162593|FG003|Overall Study|Lack of Efficacy|1|||
23665991|NCT01471782|66162594|FG004|Overall Study|Lack of Efficacy|5|||
23665992|NCT01471782|66162595|FG005|Overall Study|Lack of Efficacy|18|||
23665993|NCT01471782|66162590|FG000|Overall Study|Adverse Event|1|||
23665994|NCT01471782|66162591|FG001|Overall Study|Adverse Event|1|||
23605183|NCT02241785|65943637|FG000|Overall Study|Lost to Follow-up|2|||
23605184|NCT02241785|65943637|FG000|Overall Study|Adverse Event|1|||
23665995|NCT01471782|66162592|FG002|Overall Study|Adverse Event|2|||
23665996|NCT01471782|66162593|FG003|Overall Study|Adverse Event|2|||
23665997|NCT01471782|66162594|FG004|Overall Study|Adverse Event|3|||
23665998|NCT01471782|66162595|FG005|Overall Study|Adverse Event|1|||
23665999|NCT01471782|66162590|FG000|Overall Study|Other|0|||
23666000|NCT01471782|66162591|FG001|Overall Study|Other|0|||
23666001|NCT01471782|66162592|FG002|Overall Study|Other|1|||
23666002|NCT01471782|66162593|FG003|Overall Study|Other|1|||
23666003|NCT01471782|66162594|FG004|Overall Study|Other|6|||
23666004|NCT01471782|66162595|FG005|Overall Study|Other|5|||
23666005|NCT01471782|66162590|FG000|Overall Study|Change of Chemotherapy|1|||
23666006|NCT01471782|66162591|FG001|Overall Study|Change of Chemotherapy|1|||
23666007|NCT01471782|66162592|FG002|Overall Study|Change of Chemotherapy|0|||
23666008|NCT01471782|66162593|FG003|Overall Study|Change of Chemotherapy|0|||
23605185|NCT01852045|65943638|FG000|Overall Study|Adverse Event|1|||
23605186|NCT01852045|65943639|FG001|Overall Study|Adverse Event|0|||
23605187|NCT01852045|65943640|FG002|Overall Study|Adverse Event|0|||
23605188|NCT01852045|65943638|FG000|Overall Study|Lack of Efficacy|3|||
23605189|NCT01852045|65943639|FG001|Overall Study|Lack of Efficacy|0|||
23605190|NCT01852045|65943640|FG002|Overall Study|Lack of Efficacy|0|||
23605191|NCT01852045|65943638|FG000|Overall Study|Lost to Follow-up|0|||
23605192|NCT01852045|65943639|FG001|Overall Study|Lost to Follow-up|1|||
23605193|NCT01852045|65943640|FG002|Overall Study|Lost to Follow-up|1|||
23605194|NCT01852045|65943638|FG000|Overall Study|Withdrawal by Subject|1|||
23605195|NCT01852045|65943639|FG001|Overall Study|Withdrawal by Subject|0|||
23605196|NCT01852045|65943640|FG002|Overall Study|Withdrawal by Subject|1|||
23605197|NCT01852045|65943638|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23605198|NCT01852045|65943639|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23605199|NCT01852045|65943640|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23605200|NCT02114515|65943644|FG000|Overall Study|Lost to Follow-up|52|||
23605201|NCT02114515|65943645|FG001|Overall Study|Lost to Follow-up|55|||
23605202|NCT02114515|65943644|FG000|Overall Study|Death|12|||
23605203|NCT02114515|65943645|FG001|Overall Study|Death|12|||
23605204|NCT02114515|65943644|FG000|Overall Study|Withdrawal by Subject|4|||
23605205|NCT02114515|65943645|FG001|Overall Study|Withdrawal by Subject|22|||
23605206|NCT02114515|65943644|FG000|Overall Study|Other|65|||
23605207|NCT02114515|65943645|FG001|Overall Study|Other|61|||
23605208|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
23605209|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605210|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605211|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605212|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
23605213|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23605214|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23605215|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23666009|NCT01471782|66162594|FG004|Overall Study|Change of Chemotherapy|1|||
23666010|NCT01471782|66162595|FG005|Overall Study|Change of Chemotherapy|4|||
23605216|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
23605217|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23605218|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23605219|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23666011|NCT01471782|66162590|FG000|Overall Study|Disease Relapse|0|||
23605220|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
23605221|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23605222|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23605223|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23666012|NCT01471782|66162591|FG001|Overall Study|Disease Relapse|0|||
23666013|NCT01471782|66162592|FG002|Overall Study|Disease Relapse|0|||
23666014|NCT01471782|66162593|FG003|Overall Study|Disease Relapse|1|||
23666015|NCT01471782|66162594|FG004|Overall Study|Disease Relapse|2|||
23666016|NCT01471782|66162595|FG005|Overall Study|Disease Relapse|1|||
23666017|NCT01471782|66162590|FG000|Overall Study|Physician Decision|0|||
23666018|NCT01471782|66162591|FG001|Overall Study|Physician Decision|0|||
23666019|NCT01471782|66162592|FG002|Overall Study|Physician Decision|0|||
23666020|NCT01471782|66162593|FG003|Overall Study|Physician Decision|0|||
23666021|NCT01471782|66162594|FG004|Overall Study|Physician Decision|3|||
23666022|NCT01471782|66162595|FG005|Overall Study|Physician Decision|8|||
23666023|NCT01471782|66162590|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23666024|NCT01471782|66162591|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23666025|NCT01471782|66162592|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23666026|NCT01471782|66162593|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23666027|NCT01471782|66162594|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
23666028|NCT01471782|66162595|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23666029|NCT01471782|66162590|FG000|Overall Study|Death|0|||
23378366|NCT00770367|65130523|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
23378367|NCT00770367|65130522|FG000|Second Intervention|Lost to Follow-up|2|||
23378368|NCT00770367|65130523|FG001|Second Intervention|Lost to Follow-up|0|||
23378369|NCT01695746|65130526|FG000|Overall Study|Adverse Event|1|||
23378370|NCT01695746|65130526|FG000|Overall Study|Non-compliance by the participant|3|||
23378371|NCT01695746|65130526|FG000|Overall Study|Protocol Violation|5|||
23378372|NCT01695746|65130526|FG000|Overall Study|Participant not willing to participate|3|||
23378373|NCT03261401|65130527|FG000|Overall Study|Withdrawal by Subject|0|||
23378374|NCT03261401|65130528|FG001|Overall Study|Withdrawal by Subject|0|||
23378375|NCT03261401|65130529|FG002|Overall Study|Withdrawal by Subject|0|||
23378376|NCT03261401|65130530|FG003|Overall Study|Withdrawal by Subject|0|||
23378377|NCT03261401|65130531|FG004|Overall Study|Withdrawal by Subject|0|||
23378378|NCT03261401|65130532|FG005|Overall Study|Withdrawal by Subject|1|||
23378379|NCT03261401|65130533|FG006|Overall Study|Withdrawal by Subject|0|||
23378380|NCT03261401|65130534|FG007|Overall Study|Withdrawal by Subject|0|||
23378381|NCT03261401|65130535|FG008|Overall Study|Withdrawal by Subject|0|||
23378382|NCT03261401|65130536|FG009|Overall Study|Withdrawal by Subject|0|||
23378383|NCT03261401|65130537|FG010|Overall Study|Withdrawal by Subject|0|||
23378384|NCT03261401|65130538|FG011|Overall Study|Withdrawal by Subject|0|||
23378385|NCT03261401|65130539|FG012|Overall Study|Withdrawal by Subject|0|||
23378386|NCT03261401|65130527|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
23378387|NCT03261401|65130528|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
23378388|NCT03261401|65130529|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
23378389|NCT03261401|65130530|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
23378390|NCT03261401|65130531|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
23378391|NCT03261401|65130532|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
23378392|NCT03261401|65130533|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
23378393|NCT03261401|65130534|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
23378394|NCT03261401|65130535|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
23378395|NCT03261401|65130536|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
23378396|NCT03261401|65130537|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
23378397|NCT03261401|65130538|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
23378398|NCT03261401|65130539|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
23378399|NCT03801252|65130540|FG000|Overall Study|Protocol Violation|1|||
23378400|NCT03801252|65130541|FG001|Overall Study|Protocol Violation|2|||
23378401|NCT01033942|65130552|FG000|Overall Study|Withdrawal by Subject|1|||
23378402|NCT01033942|65130553|FG001|Overall Study|Withdrawal by Subject|1|||
23378403|NCT01033942|65130554|FG002|Overall Study|Withdrawal by Subject|1|||
23378404|NCT01033942|65130552|FG000|Overall Study|Lost to Follow-up|1|||
23378405|NCT01033942|65130553|FG001|Overall Study|Lost to Follow-up|0|||
23378406|NCT01033942|65130554|FG002|Overall Study|Lost to Follow-up|0|||
23605224|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
23605225|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605226|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605227|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605228|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
23605229|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23605230|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23605231|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23666030|NCT01471782|66162591|FG001|Overall Study|Death|0|||
23666031|NCT01471782|66162592|FG002|Overall Study|Death|0|||
23666032|NCT01471782|66162593|FG003|Overall Study|Death|0|||
23666033|NCT01471782|66162594|FG004|Overall Study|Death|0|||
23666034|NCT01471782|66162595|FG005|Overall Study|Death|1|||
23666035|NCT00402649|66162599|FG000|Overall Study|Lost to Follow-up|1|||
23378407|NCT01033942|65130552|FG000|Overall Study|Enrolled in Extension Study|0|||
23378408|NCT01033942|65130553|FG001|Overall Study|Enrolled in Extension Study|3|||
23378409|NCT01033942|65130554|FG002|Overall Study|Enrolled in Extension Study|0|||
23378410|NCT05417113|65130555|FG000|Overall Study|Lost to Follow-up|2|||
23378411|NCT05417113|65130556|FG001|Overall Study|Lost to Follow-up|2|||
23378412|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
23378413|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
23378414|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Death|1|||
23378415|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Death|3|||
23378416|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
23378417|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
23378418|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
23378419|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
23378420|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
23378421|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
23378422|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
23378423|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
23378424|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
23378425|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
23378426|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
23378427|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
23378428|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
23378429|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
23378430|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
23378431|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
23378432|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
23378433|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
23378434|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
23378435|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
23378436|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
23378437|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
23378438|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
23378439|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
23378440|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
23378441|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
23378442|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
23378443|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
23378444|NCT01134042|65130563|FG000|Overall Study|Adverse Event|3|||
23378445|NCT01134042|65130564|FG001|Overall Study|Adverse Event|7|||
23378446|NCT01134042|65130565|FG002|Overall Study|Adverse Event|2|||
23378447|NCT01134042|65130563|FG000|Overall Study|Lack of Efficacy|21|||
23378448|NCT01134042|65130564|FG001|Overall Study|Lack of Efficacy|6|||
23378449|NCT01134042|65130565|FG002|Overall Study|Lack of Efficacy|18|||
23378450|NCT01134042|65130563|FG000|Overall Study|Protocol Violation|5|||
23378451|NCT01134042|65130564|FG001|Overall Study|Protocol Violation|3|||
23666036|NCT00402649|66162599|FG000|Overall Study|Withdrawal by Subject|1|||
23666037|NCT00777101|66162604|FG000|Overall Study|Death|48|||
23378452|NCT01134042|65130565|FG002|Overall Study|Protocol Violation|5|||
23378453|NCT01134042|65130563|FG000|Overall Study|Lost to Follow-up|2|||
23378454|NCT01134042|65130564|FG001|Overall Study|Lost to Follow-up|0|||
23378455|NCT01134042|65130565|FG002|Overall Study|Lost to Follow-up|1|||
23378456|NCT01134042|65130563|FG000|Overall Study|Physician Decision|4|||
23378457|NCT01134042|65130564|FG001|Overall Study|Physician Decision|8|||
23666038|NCT00777101|66162605|FG001|Overall Study|Death|43|||
23666039|NCT00777101|66162604|FG000|Overall Study|Withdrawal by Subject|11|||
23666040|NCT00777101|66162605|FG001|Overall Study|Withdrawal by Subject|6|||
23666041|NCT00777101|66162604|FG000|Overall Study|Lost to Follow-up|2|||
23666042|NCT00777101|66162605|FG001|Overall Study|Lost to Follow-up|1|||
23666043|NCT00777101|66162604|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23666044|NCT00777101|66162605|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23666045|NCT00777101|66162604|FG000|Overall Study|Failed to Return|0|||
23666046|NCT00777101|66162605|FG001|Overall Study|Failed to Return|1|||
23605232|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
23605233|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23605234|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23605235|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23378458|NCT01134042|65130565|FG002|Overall Study|Physician Decision|1|||
23378459|NCT01134042|65130563|FG000|Overall Study|Withdrawal by Subject|13|||
23378460|NCT01134042|65130564|FG001|Overall Study|Withdrawal by Subject|4|||
23605236|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
23605237|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
23605238|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
23605239|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
23605240|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
23605241|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
23605242|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
23605243|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
23605244|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
23605245|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
23605246|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
23605247|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
23605248|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605249|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605250|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605251|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
23605252|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
23605253|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
23605254|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
23666047|NCT00096785|66162606|FG000|Overall Study|Lost to Follow-up|1|||
23666048|NCT00096785|66162607|FG001|Overall Study|Lost to Follow-up|0|||
23666049|NCT00096785|66162606|FG000|Overall Study|Withdrawal by Subject|0|||
23666050|NCT00096785|66162607|FG001|Overall Study|Withdrawal by Subject|1|||
23666051|NCT00096785|66162606|FG000|Overall Study|Relocated|1|||
23666052|NCT00096785|66162607|FG001|Overall Study|Relocated|0|||
23666053|NCT02300298|66162608|FG000|Disposition for Nintedanib|Progressive disease|10|||
23666054|NCT02300298|66162609|FG001|Disposition for Nintedanib|Progressive disease|0|||
23666055|NCT02300298|66162608|FG000|Disposition for Docetaxel|Progressive disease|0|||
23666056|NCT02300298|66162609|FG001|Disposition for Docetaxel|Progressive disease|6|||
23666057|NCT02300298|66162608|FG000|Disposition for Docetaxel|other adverse event|0|||
23666058|NCT02300298|66162609|FG001|Disposition for Docetaxel|other adverse event|4|||
23378461|NCT01134042|65130565|FG002|Overall Study|Withdrawal by Subject|7|||
23378462|NCT01047501|65130566|FG000|Overall Study|Adverse Event|7|||
23378463|NCT01047501|65130567|FG001|Overall Study|Adverse Event|8|||
23378464|NCT01047501|65130568|FG002|Overall Study|Adverse Event|5|||
23378465|NCT01047501|65130566|FG000|Overall Study|Withdrew Consent|6|||
23378466|NCT01047501|65130567|FG001|Overall Study|Withdrew Consent|2|||
23378467|NCT01047501|65130568|FG002|Overall Study|Withdrew Consent|4|||
23378468|NCT01047501|65130566|FG000|Overall Study|Lost to Follow-up|0|||
23378469|NCT01047501|65130567|FG001|Overall Study|Lost to Follow-up|1|||
23378470|NCT01047501|65130568|FG002|Overall Study|Lost to Follow-up|1|||
23378471|NCT01047501|65130566|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
23378472|NCT01047501|65130567|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
23378473|NCT01047501|65130568|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
23378474|NCT01047501|65130566|FG000|Overall Study|Death|1|||
23605255|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
23490427|NCT02448810|65541406|FG003|Overall Study|Withdrawal by Subject|0|||
23490428|NCT02448810|65541407|FG004|Overall Study|Withdrawal by Subject|3|||
23605256|NCT01970878|65943650|FG000|Overall Study|Withdrawal by Subject|11|||
23605257|NCT01970878|65943651|FG001|Overall Study|Withdrawal by Subject|10|||
23666059|NCT02898259|66162610|FG000|Overall Study|Adverse Event|0|||
23666060|NCT02898259|66162611|FG001|Overall Study|Adverse Event|0|||
23666061|NCT02898259|66162612|FG002|Overall Study|Adverse Event|1|||
23666062|NCT02898259|66162613|FG003|Overall Study|Adverse Event|0|||
23666063|NCT02898259|66162614|FG004|Overall Study|Adverse Event|0|||
23378475|NCT01047501|65130567|FG001|Overall Study|Death|0|||
23605258|NCT01970878|65943652|FG002|Overall Study|Withdrawal by Subject|14|||
23605259|NCT01970878|65943653|FG003|Overall Study|Withdrawal by Subject|7|||
23605260|NCT01970878|65943650|FG000|Overall Study|Lost to Follow-up|1|||
23605261|NCT01970878|65943651|FG001|Overall Study|Lost to Follow-up|3|||
23605262|NCT01970878|65943652|FG002|Overall Study|Lost to Follow-up|2|||
23605263|NCT01970878|65943653|FG003|Overall Study|Lost to Follow-up|4|||
23605264|NCT01970878|65943650|FG000|Overall Study|Administrative Reasons|1|||
23605265|NCT01970878|65943651|FG001|Overall Study|Administrative Reasons|0|||
23605266|NCT01970878|65943652|FG002|Overall Study|Administrative Reasons|0|||
23605267|NCT01970878|65943653|FG003|Overall Study|Administrative Reasons|4|||
23605268|NCT01970878|65943650|FG000|Overall Study|Lack of Efficacy|2|||
23605269|NCT01970878|65943651|FG001|Overall Study|Lack of Efficacy|1|||
23605270|NCT01970878|65943652|FG002|Overall Study|Lack of Efficacy|2|||
23605271|NCT01970878|65943653|FG003|Overall Study|Lack of Efficacy|0|||
23605272|NCT01970878|65943650|FG000|Overall Study|Adverse Event|12|||
23605273|NCT01970878|65943651|FG001|Overall Study|Adverse Event|7|||
23605274|NCT01970878|65943652|FG002|Overall Study|Adverse Event|4|||
23605275|NCT01970878|65943653|FG003|Overall Study|Adverse Event|3|||
23605276|NCT01970878|65943650|FG000|Overall Study|Protocol Specified Criteria|10|||
23605277|NCT01970878|65943651|FG001|Overall Study|Protocol Specified Criteria|4|||
23605278|NCT01970878|65943652|FG002|Overall Study|Protocol Specified Criteria|3|||
23605279|NCT01970878|65943653|FG003|Overall Study|Protocol Specified Criteria|6|||
23605280|NCT01970878|65943650|FG000|Overall Study|Physician Decision|0|||
23378476|NCT01047501|65130568|FG002|Overall Study|Death|0|||
23378477|NCT01047501|65130566|FG000|Overall Study|Other discontinuation|1|||
23378478|NCT01047501|65130567|FG001|Overall Study|Other discontinuation|0|||
23378479|NCT01047501|65130568|FG002|Overall Study|Other discontinuation|1|||
23378480|NCT01047501|65130566|FG000|Overall Study|Investigator judgement|0|||
23378481|NCT01047501|65130567|FG001|Overall Study|Investigator judgement|0|||
23378482|NCT01047501|65130568|FG002|Overall Study|Investigator judgement|1|||
23378483|NCT01500096|65130569|FG000|Overall Study|Lost to Follow-up|1|||
23378484|NCT01500096|65130570|FG001|Overall Study|Lost to Follow-up|0|||
23378485|NCT01500096|65130571|FG002|Overall Study|Lost to Follow-up|0|||
23378486|NCT01500096|65130572|FG003|Overall Study|Lost to Follow-up|2|||
23378487|NCT00831844|65130573|FG000|Overall Study|Adverse Event|2|||
23378488|NCT00831844|65130574|FG001|Overall Study|Adverse Event|0|||
23378489|NCT00831844|65130575|FG002|Overall Study|Adverse Event|0|||
23378490|NCT00831844|65130576|FG003|Overall Study|Adverse Event|0|||
23378491|NCT00831844|65130577|FG004|Overall Study|Adverse Event|1|||
23378492|NCT00831844|65130578|FG005|Overall Study|Adverse Event|1|||
23378493|NCT00831844|65130579|FG006|Overall Study|Adverse Event|2|||
23378494|NCT00831844|65130580|FG007|Overall Study|Adverse Event|0|||
23378495|NCT00831844|65130581|FG008|Overall Study|Adverse Event|0|||
23378496|NCT00831844|65130582|FG009|Overall Study|Adverse Event|0|||
23378497|NCT00831844|65130573|FG000|Overall Study|Death|0|||
23378498|NCT00831844|65130574|FG001|Overall Study|Death|0|||
23378499|NCT00831844|65130575|FG002|Overall Study|Death|0|||
23378500|NCT00831844|65130576|FG003|Overall Study|Death|1|||
23378501|NCT00831844|65130577|FG004|Overall Study|Death|0|||
23378502|NCT00831844|65130578|FG005|Overall Study|Death|0|||
23605281|NCT01970878|65943651|FG001|Overall Study|Physician Decision|1|||
23605282|NCT01970878|65943652|FG002|Overall Study|Physician Decision|1|||
23605283|NCT01970878|65943653|FG003|Overall Study|Physician Decision|0|||
23605284|NCT01970878|65943650|FG000|Overall Study|No Completion Status|0|||
23378503|NCT00831844|65130579|FG006|Overall Study|Death|0|||
23378504|NCT00831844|65130580|FG007|Overall Study|Death|0|||
23378505|NCT00831844|65130581|FG008|Overall Study|Death|0|||
23378506|NCT00831844|65130582|FG009|Overall Study|Death|0|||
23605285|NCT01970878|65943651|FG001|Overall Study|No Completion Status|1|||
23605286|NCT01970878|65943652|FG002|Overall Study|No Completion Status|0|||
23605287|NCT01970878|65943653|FG003|Overall Study|No Completion Status|0|||
23378507|NCT00831844|65130573|FG000|Overall Study|Lack of Efficacy|8|||
23378508|NCT00831844|65130574|FG001|Overall Study|Lack of Efficacy|10|||
23378509|NCT00831844|65130575|FG002|Overall Study|Lack of Efficacy|15|||
23378510|NCT00831844|65130576|FG003|Overall Study|Lack of Efficacy|8|||
23378511|NCT00831844|65130577|FG004|Overall Study|Lack of Efficacy|11|||
23378512|NCT00831844|65130578|FG005|Overall Study|Lack of Efficacy|17|||
23490429|NCT02448810|65541408|FG005|Overall Study|Withdrawal by Subject|5|||
23490430|NCT02448810|65541409|FG006|Overall Study|Withdrawal by Subject|0|||
23490431|NCT02448810|65541410|FG007|Overall Study|Withdrawal by Subject|2|||
23490432|NCT02448810|65541403|FG000|Overall Study|Other (study terminated by sponsor)|0|||
23490433|NCT02448810|65541404|FG001|Overall Study|Other (study terminated by sponsor)|0|||
23490434|NCT02448810|65541405|FG002|Overall Study|Other (study terminated by sponsor)|0|||
23378513|NCT00831844|65130579|FG006|Overall Study|Lack of Efficacy|8|||
23378514|NCT00831844|65130580|FG007|Overall Study|Lack of Efficacy|9|||
23378515|NCT00831844|65130581|FG008|Overall Study|Lack of Efficacy|7|||
23378516|NCT00831844|65130582|FG009|Overall Study|Lack of Efficacy|0|||
23378517|NCT00831844|65130573|FG000|Overall Study|Physician Decision|0|||
23378518|NCT00831844|65130574|FG001|Overall Study|Physician Decision|1|||
23378519|NCT00831844|65130575|FG002|Overall Study|Physician Decision|3|||
23378520|NCT00831844|65130576|FG003|Overall Study|Physician Decision|1|||
23378521|NCT00831844|65130577|FG004|Overall Study|Physician Decision|1|||
23378522|NCT00831844|65130578|FG005|Overall Study|Physician Decision|1|||
23378523|NCT00831844|65130579|FG006|Overall Study|Physician Decision|0|||
23378524|NCT00831844|65130580|FG007|Overall Study|Physician Decision|0|||
23378525|NCT00831844|65130581|FG008|Overall Study|Physician Decision|1|||
23378526|NCT00831844|65130582|FG009|Overall Study|Physician Decision|0|||
23378527|NCT00831844|65130573|FG000|Overall Study|Withdrawal by Subject|0|||
23378528|NCT00831844|65130574|FG001|Overall Study|Withdrawal by Subject|0|||
23378529|NCT00831844|65130575|FG002|Overall Study|Withdrawal by Subject|1|||
23378530|NCT00831844|65130576|FG003|Overall Study|Withdrawal by Subject|0|||
23378531|NCT00831844|65130577|FG004|Overall Study|Withdrawal by Subject|0|||
23378532|NCT00831844|65130578|FG005|Overall Study|Withdrawal by Subject|0|||
23490435|NCT02448810|65541406|FG003|Overall Study|Other (study terminated by sponsor)|0|||
23490436|NCT02448810|65541407|FG004|Overall Study|Other (study terminated by sponsor)|4|||
23490437|NCT02448810|65541408|FG005|Overall Study|Other (study terminated by sponsor)|2|||
23378533|NCT00831844|65130579|FG006|Overall Study|Withdrawal by Subject|0|||
23378534|NCT00831844|65130580|FG007|Overall Study|Withdrawal by Subject|1|||
23378535|NCT00831844|65130581|FG008|Overall Study|Withdrawal by Subject|1|||
23378536|NCT00831844|65130582|FG009|Overall Study|Withdrawal by Subject|0|||
23378537|NCT00831844|65130573|FG000|Overall Study|Ineligible|0|||
23490438|NCT02448810|65541409|FG006|Overall Study|Other (study terminated by sponsor)|2|||
23490439|NCT02448810|65541410|FG007|Overall Study|Other (study terminated by sponsor)|1|||
23490440|NCT02448810|65541403|FG000|Overall Study|Death|1|||
23666064|NCT02898259|66162610|FG000|Overall Study|Lack of Efficacy|1|||
23666065|NCT02898259|66162611|FG001|Overall Study|Lack of Efficacy|1|||
23666066|NCT02898259|66162612|FG002|Overall Study|Lack of Efficacy|3|||
23666067|NCT02898259|66162613|FG003|Overall Study|Lack of Efficacy|0|||
23666068|NCT02898259|66162614|FG004|Overall Study|Lack of Efficacy|0|||
23666069|NCT02898259|66162610|FG000|Overall Study|Lost to Follow-up|0|||
23666070|NCT02898259|66162611|FG001|Overall Study|Lost to Follow-up|0|||
23666071|NCT02898259|66162612|FG002|Overall Study|Lost to Follow-up|1|||
23666072|NCT02898259|66162613|FG003|Overall Study|Lost to Follow-up|0|||
23666073|NCT02898259|66162614|FG004|Overall Study|Lost to Follow-up|0|||
23666074|NCT02898259|66162610|FG000|Overall Study|Transformation before study began|0|||
23666075|NCT02898259|66162611|FG001|Overall Study|Transformation before study began|0|||
23666076|NCT02898259|66162612|FG002|Overall Study|Transformation before study began|0|||
23666077|NCT02898259|66162613|FG003|Overall Study|Transformation before study began|1|||
23666078|NCT02898259|66162614|FG004|Overall Study|Transformation before study began|0|||
23666079|NCT00271817|66162619|FG000|Part 1|Adverse Event|68|||
23490441|NCT02448810|65541404|FG001|Overall Study|Death|0|||
23490442|NCT02448810|65541405|FG002|Overall Study|Death|1|||
23490443|NCT02448810|65541406|FG003|Overall Study|Death|0|||
23490444|NCT02448810|65541407|FG004|Overall Study|Death|1|||
23490445|NCT02448810|65541408|FG005|Overall Study|Death|0|||
23490446|NCT02448810|65541409|FG006|Overall Study|Death|0|||
23490447|NCT02448810|65541410|FG007|Overall Study|Death|0|||
23490448|NCT02448810|65541403|FG000|Overall Study|Other (Progressive disease)|2|||
23490449|NCT02448810|65541404|FG001|Overall Study|Other (Progressive disease)|2|||
23490450|NCT02448810|65541405|FG002|Overall Study|Other (Progressive disease)|0|||
23490451|NCT02448810|65541406|FG003|Overall Study|Other (Progressive disease)|3|||
23490452|NCT02448810|65541407|FG004|Overall Study|Other (Progressive disease)|23|||
23490453|NCT02448810|65541408|FG005|Overall Study|Other (Progressive disease)|9|||
23490454|NCT02448810|65541409|FG006|Overall Study|Other (Progressive disease)|14|||
23490455|NCT02448810|65541410|FG007|Overall Study|Other (Progressive disease)|5|||
23490456|NCT02448810|65541403|FG000|Overall Study|Lost to Follow-up|0|||
23490457|NCT02448810|65541404|FG001|Overall Study|Lost to Follow-up|1|||
23490458|NCT02448810|65541405|FG002|Overall Study|Lost to Follow-up|0|||
23490459|NCT02448810|65541406|FG003|Overall Study|Lost to Follow-up|0|||
23490460|NCT02448810|65541407|FG004|Overall Study|Lost to Follow-up|0|||
23490461|NCT02448810|65541408|FG005|Overall Study|Lost to Follow-up|0|||
23490462|NCT02448810|65541409|FG006|Overall Study|Lost to Follow-up|0|||
23490463|NCT02448810|65541410|FG007|Overall Study|Lost to Follow-up|0|||
23490464|NCT02448810|65541403|FG000|Overall Study|Other (unspecified)|0|||
23490465|NCT02448810|65541404|FG001|Overall Study|Other (unspecified)|0|||
23490466|NCT02448810|65541405|FG002|Overall Study|Other (unspecified)|0|||
23490467|NCT02448810|65541406|FG003|Overall Study|Other (unspecified)|0|||
23490468|NCT02448810|65541407|FG004|Overall Study|Other (unspecified)|0|||
23490469|NCT02448810|65541408|FG005|Overall Study|Other (unspecified)|0|||
23490470|NCT02448810|65541409|FG006|Overall Study|Other (unspecified)|2|||
23490471|NCT02448810|65541410|FG007|Overall Study|Other (unspecified)|0|||
23490472|NCT02633501|65541411|FG000|Overall Study|Adverse Event|0|||
23666080|NCT00271817|66162620|FG001|Part 1|Adverse Event|25|||
23666081|NCT00271817|66162621|FG002|Part 1|Adverse Event|156|||
23666082|NCT00271817|66162619|FG000|Part 1|Lost to Follow-up|6|||
23666083|NCT00271817|66162620|FG001|Part 1|Lost to Follow-up|8|||
23666084|NCT00271817|66162621|FG002|Part 1|Lost to Follow-up|24|||
23666085|NCT00271817|66162619|FG000|Part 1|Protocol Violation|5|||
23666086|NCT00271817|66162620|FG001|Part 1|Protocol Violation|4|||
23666087|NCT00271817|66162621|FG002|Part 1|Protocol Violation|7|||
23666088|NCT00271817|66162619|FG000|Part 1|Patient Moved|3|||
23666089|NCT00271817|66162620|FG001|Part 1|Patient Moved|1|||
23490473|NCT02633501|65541412|FG001|Overall Study|Adverse Event|0|||
23490474|NCT02633501|65541413|FG002|Overall Study|Adverse Event|1|||
23666090|NCT00271817|66162621|FG002|Part 1|Patient Moved|5|||
23666091|NCT00271817|66162619|FG000|Part 1|Withdrawal by Subject|23|||
23666092|NCT00271817|66162620|FG001|Part 1|Withdrawal by Subject|17|||
23378538|NCT00831844|65130574|FG001|Overall Study|Ineligible|1|||
23666093|NCT00271817|66162621|FG002|Part 1|Withdrawal by Subject|45|||
23666094|NCT00271817|66162619|FG000|Part 1|LDL < 50 mg/dL|1|||
23666095|NCT00271817|66162620|FG001|Part 1|LDL < 50 mg/dL|4|||
23666096|NCT00271817|66162621|FG002|Part 1|LDL < 50 mg/dL|48|||
23490475|NCT02633501|65541414|FG003|Overall Study|Adverse Event|0|||
23490476|NCT02633501|65541415|FG004|Overall Study|Adverse Event|1|||
23490477|NCT02633501|65541416|FG005|Overall Study|Adverse Event|1|||
23490478|NCT02633501|65541411|FG000|Overall Study|Withdrawal by Subject|2|||
23490479|NCT02633501|65541412|FG001|Overall Study|Withdrawal by Subject|1|||
23490480|NCT02633501|65541413|FG002|Overall Study|Withdrawal by Subject|2|||
23490481|NCT02633501|65541414|FG003|Overall Study|Withdrawal by Subject|2|||
23490482|NCT02633501|65541415|FG004|Overall Study|Withdrawal by Subject|1|||
23666097|NCT00271817|66162619|FG000|Part 2|Adverse Event|0|||
23666098|NCT00271817|66162620|FG001|Part 2|Adverse Event|17|||
23378539|NCT00831844|65130575|FG002|Overall Study|Ineligible|1|||
23490483|NCT02633501|65541416|FG005|Overall Study|Withdrawal by Subject|3|||
23490484|NCT02633501|65541411|FG000|Overall Study|Various other reasons|0|||
23490485|NCT02633501|65541412|FG001|Overall Study|Various other reasons|2|||
23490486|NCT02633501|65541413|FG002|Overall Study|Various other reasons|4|||
23490487|NCT02633501|65541414|FG003|Overall Study|Various other reasons|1|||
23490488|NCT02633501|65541415|FG004|Overall Study|Various other reasons|7|||
23490489|NCT02633501|65541416|FG005|Overall Study|Various other reasons|11|||
23490490|NCT02633501|65541411|FG000|Overall Study|Lost to Follow-up|0|||
23490491|NCT02633501|65541412|FG001|Overall Study|Lost to Follow-up|0|||
23490492|NCT02633501|65541413|FG002|Overall Study|Lost to Follow-up|0|||
23490493|NCT02633501|65541414|FG003|Overall Study|Lost to Follow-up|1|||
23490494|NCT02633501|65541415|FG004|Overall Study|Lost to Follow-up|2|||
23490495|NCT02633501|65541416|FG005|Overall Study|Lost to Follow-up|0|||
23490496|NCT04128371|65541417|FG000|Overall Study|Lack of Efficacy|1|||
23490497|NCT01123850|65541418|FG000|Overall Study|Slow enrollment|45|||
23490498|NCT01262573|65541420|FG000|Overall Study|Withdrawal by Subject|0|||
23490499|NCT01262573|65541421|FG001|Overall Study|Withdrawal by Subject|1|||
23490500|NCT00902668|65541424|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
23490501|NCT00976677|65541427|FG000|Overall Study|Adverse Event|1|||
23490502|NCT00976677|65541428|FG001|Overall Study|Adverse Event|0|||
23605288|NCT02040870|65943654|FG000|Overall Study|Completed treatment phase|6|||
23605289|NCT02040870|65943654|FG000|Overall Study|Adverse Event|7|||
23605290|NCT02040870|65943654|FG000|Overall Study|Progressive disease|58|||
23605291|NCT02040870|65943654|FG000|Overall Study|Physician Decision|6|||
23605292|NCT02040870|65943654|FG000|Overall Study|Subject/guardian decision|10|||
23605293|NCT02040870|65943654|FG000|Overall Study|Lost to Follow-up|3|||
23666099|NCT00271817|66162621|FG002|Part 2|Adverse Event|33|||
23666100|NCT00271817|66162619|FG000|Part 2|Lack of Efficacy|0|||
23666101|NCT00271817|66162620|FG001|Part 2|Lack of Efficacy|1|||
23666102|NCT00271817|66162621|FG002|Part 2|Lack of Efficacy|6|||
23666103|NCT00271817|66162619|FG000|Part 2|Lost to Follow-up|0|||
23605294|NCT02040870|65943654|FG000|Overall Study|Death|13|||
23605295|NCT01930188|65943655|FG000|Overall Study|unclassified|4|||
23605296|NCT01930188|65943656|FG001|Overall Study|unclassified|5|||
23605297|NCT01930188|65943657|FG002|Overall Study|unclassified|3|||
23605298|NCT01930188|65943655|FG000|Overall Study|Missing follow-up information|2|||
23605299|NCT01930188|65943656|FG001|Overall Study|Missing follow-up information|2|||
23605300|NCT01930188|65943657|FG002|Overall Study|Missing follow-up information|3|||
23605301|NCT01930188|65943655|FG000|Overall Study|Lost to Follow-up|5|||
23605302|NCT01930188|65943656|FG001|Overall Study|Lost to Follow-up|2|||
23605303|NCT01930188|65943657|FG002|Overall Study|Lost to Follow-up|2|||
23605304|NCT01930188|65943655|FG000|Overall Study|Death|2|||
23605305|NCT01930188|65943656|FG001|Overall Study|Death|1|||
23605306|NCT01930188|65943657|FG002|Overall Study|Death|3|||
23605307|NCT01930188|65943655|FG000|Overall Study|Withdrawal by Subject|9|||
23605308|NCT01930188|65943656|FG001|Overall Study|Withdrawal by Subject|11|||
23605309|NCT01930188|65943657|FG002|Overall Study|Withdrawal by Subject|8|||
23605310|NCT02326220|65943658|FG000|Double-blind Treatment Period|Adverse Event|1|||
23605311|NCT02326220|65943659|FG001|Double-blind Treatment Period|Adverse Event|2|||
23605312|NCT02326220|65943660|FG002|Double-blind Treatment Period|Adverse Event|0|||
23605313|NCT02326220|65943658|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23605314|NCT02326220|65943659|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23605315|NCT02326220|65943660|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23605316|NCT02326220|65943658|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23605317|NCT02326220|65943659|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23605318|NCT02326220|65943660|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23605319|NCT02326220|65943658|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23666104|NCT00271817|66162620|FG001|Part 2|Lost to Follow-up|6|||
23666105|NCT00271817|66162621|FG002|Part 2|Lost to Follow-up|18|||
23666106|NCT00271817|66162619|FG000|Part 2|Protocol Violation|0|||
23666107|NCT00271817|66162620|FG001|Part 2|Protocol Violation|3|||
23378540|NCT00831844|65130576|FG003|Overall Study|Ineligible|0|||
23490503|NCT00976677|65541427|FG000|Overall Study|Withdrawal by Subject|0|||
23490504|NCT00976677|65541428|FG001|Overall Study|Withdrawal by Subject|2|||
23378541|NCT00831844|65130577|FG004|Overall Study|Ineligible|1|||
23605320|NCT02326220|65943659|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23605321|NCT02326220|65943660|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
23605322|NCT02326220|65943658|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23605323|NCT02326220|65943659|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23605324|NCT02326220|65943660|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
23605325|NCT01918033|65943672|FG000|Overall Study|Adverse Event|1|||
23605326|NCT01918033|65943673|FG001|Overall Study|Adverse Event|0|||
23666108|NCT00271817|66162621|FG002|Part 2|Protocol Violation|5|||
23490505|NCT00976677|65541427|FG000|Overall Study|Disease progression|1|||
23490506|NCT00976677|65541428|FG001|Overall Study|Disease progression|1|||
23490507|NCT00976677|65541427|FG000|Overall Study|Trial unblinded|2|||
23490508|NCT00976677|65541428|FG001|Overall Study|Trial unblinded|2|||
23490509|NCT00976677|65541427|FG000|Overall Study|Unknown/Missing|1|||
23490510|NCT00976677|65541428|FG001|Overall Study|Unknown/Missing|0|||
23490511|NCT00302107|65541429|FG000|Overall Study|Lost to Follow-up|6|||
23490512|NCT00302107|65541430|FG001|Overall Study|Lost to Follow-up|5|||
23490513|NCT00302107|65541429|FG000|Overall Study|Protocol Violation|1|||
23490514|NCT00302107|65541430|FG001|Overall Study|Protocol Violation|0|||
23490515|NCT00302107|65541429|FG000|Overall Study|Relocation|0|||
23490516|NCT00302107|65541430|FG001|Overall Study|Relocation|1|||
23490517|NCT00302107|65541429|FG000|Overall Study|Withdrawal by Subject|0|||
23490518|NCT00302107|65541430|FG001|Overall Study|Withdrawal by Subject|3|||
23490519|NCT00302107|65541429|FG000|Overall Study|Adverse Event|1|||
23490520|NCT00302107|65541430|FG001|Overall Study|Adverse Event|0|||
23490521|NCT00543543|65541431|FG000|Base Study|Adverse Event|1|||
23490522|NCT00543543|65541432|FG001|Base Study|Adverse Event|11|||
23490523|NCT00543543|65541433|FG002|Base Study|Adverse Event|0|||
23490524|NCT00543543|65541434|FG003|Base Study|Adverse Event|5|||
23490525|NCT00543543|65541431|FG000|Base Study|Lost to Follow-up|12|||
23490526|NCT00543543|65541432|FG001|Base Study|Lost to Follow-up|749|||
23490527|NCT00543543|65541433|FG002|Base Study|Lost to Follow-up|9|||
23490528|NCT00543543|65541434|FG003|Base Study|Lost to Follow-up|701|||
23490529|NCT00543543|65541431|FG000|Base Study|Physician Decision|0|||
23490530|NCT00543543|65541432|FG001|Base Study|Physician Decision|4|||
23490531|NCT00543543|65541433|FG002|Base Study|Physician Decision|0|||
23490532|NCT00543543|65541434|FG003|Base Study|Physician Decision|7|||
23490533|NCT00543543|65541431|FG000|Base Study|Protocol Violation|0|||
23490534|NCT00543543|65541432|FG001|Base Study|Protocol Violation|6|||
23490535|NCT00543543|65541433|FG002|Base Study|Protocol Violation|0|||
23490536|NCT00543543|65541434|FG003|Base Study|Protocol Violation|6|||
23490537|NCT00543543|65541431|FG000|Base Study|Withdrawal by Subject|7|||
23490538|NCT00543543|65541432|FG001|Base Study|Withdrawal by Subject|482|||
23490539|NCT00543543|65541433|FG002|Base Study|Withdrawal by Subject|5|||
23490540|NCT00543543|65541434|FG003|Base Study|Withdrawal by Subject|503|||
23490541|NCT00543543|65541431|FG000|Extension Study|Adverse Event|0|||
23490542|NCT00543543|65541432|FG001|Extension Study|Adverse Event|0|||
23490543|NCT00543543|65541433|FG002|Extension Study|Adverse Event|0|||
23490544|NCT00543543|65541434|FG003|Extension Study|Adverse Event|5|||
23490545|NCT00543543|65541431|FG000|Extension Study|Lost to Follow-up|0|||
23490546|NCT00543543|65541432|FG001|Extension Study|Lost to Follow-up|0|||
23490547|NCT00543543|65541433|FG002|Extension Study|Lost to Follow-up|0|||
23490548|NCT00543543|65541434|FG003|Extension Study|Lost to Follow-up|77|||
23490549|NCT00543543|65541431|FG000|Extension Study|Physician Decision|0|||
23490550|NCT00543543|65541432|FG001|Extension Study|Physician Decision|0|||
23605327|NCT01918033|65943674|FG002|Overall Study|Adverse Event|2|||
23605328|NCT01918033|65943672|FG000|Overall Study|Lost to Follow-up|0|||
23490551|NCT00543543|65541433|FG002|Extension Study|Physician Decision|0|||
23490552|NCT00543543|65541434|FG003|Extension Study|Physician Decision|7|||
23490553|NCT00543543|65541431|FG000|Extension Study|Pregnancy|0|||
23490554|NCT00543543|65541432|FG001|Extension Study|Pregnancy|0|||
23490555|NCT00543543|65541433|FG002|Extension Study|Pregnancy|0|||
23490556|NCT00543543|65541434|FG003|Extension Study|Pregnancy|6|||
23605329|NCT01918033|65943673|FG001|Overall Study|Lost to Follow-up|1|||
23490557|NCT00543543|65541431|FG000|Extension Study|Protocol Violation|0|||
23490558|NCT00543543|65541432|FG001|Extension Study|Protocol Violation|0|||
23490559|NCT00543543|65541433|FG002|Extension Study|Protocol Violation|0|||
23490560|NCT00543543|65541434|FG003|Extension Study|Protocol Violation|11|||
23605330|NCT01918033|65943674|FG002|Overall Study|Lost to Follow-up|0|||
23605331|NCT01918033|65943672|FG000|Overall Study|Protocol Violation|2|||
23490561|NCT00543543|65541431|FG000|Extension Study|Withdrawal by Subject|0|||
23490562|NCT00543543|65541432|FG001|Extension Study|Withdrawal by Subject|0|||
23490563|NCT00543543|65541433|FG002|Extension Study|Withdrawal by Subject|0|||
23490564|NCT00543543|65541434|FG003|Extension Study|Withdrawal by Subject|120|||
23490565|NCT03021304|65541438|FG000|Overall Study|Lack of Efficacy|1|||
23490566|NCT00559754|65541441|FG000|Overall Study|Disease progression|1|||
23490567|NCT00559754|65541441|FG000|Overall Study|Adverse Event|5|||
23605332|NCT01918033|65943673|FG001|Overall Study|Protocol Violation|0|||
23605333|NCT01918033|65943674|FG002|Overall Study|Protocol Violation|1|||
23605334|NCT01918033|65943672|FG000|Overall Study|Withdrawal by Subject|2|||
23605335|NCT01918033|65943673|FG001|Overall Study|Withdrawal by Subject|1|||
23605336|NCT01918033|65943674|FG002|Overall Study|Withdrawal by Subject|0|||
23605337|NCT02203799|65943680|FG000|Overall Study|Withdrawal by Subject|3|||
23605338|NCT01885559|65943681|FG000|Overall Study|Lost to Follow-up|15|||
23605339|NCT01885559|65943682|FG001|Overall Study|Lost to Follow-up|16|||
23605340|NCT01885559|65943681|FG000|Overall Study|Less than full participation|9|||
23605341|NCT01885559|65943682|FG001|Overall Study|Less than full participation|19|||
23605342|NCT01885559|65943681|FG000|Overall Study|Protocol Violation|0|||
23605343|NCT01885559|65943682|FG001|Overall Study|Protocol Violation|1|||
23605344|NCT03288506|65943684|FG000|Overall Study|Withdrawal by Subject|52|||
23605345|NCT04803734|65943685|FG000|Overall Study|Withdrawal by Subject|0|||
23605346|NCT04803734|65943686|FG001|Overall Study|Withdrawal by Subject|1|||
23605347|NCT04803734|65943685|FG000|Overall Study|Protocol Violation|0|||
23666109|NCT00271817|66162619|FG000|Part 2|Patient Moved|0|||
23666110|NCT00271817|66162620|FG001|Part 2|Patient Moved|0|||
23666111|NCT00271817|66162621|FG002|Part 2|Patient Moved|5|||
23666112|NCT00271817|66162619|FG000|Part 2|Withdrawal by Subject|0|||
23666113|NCT00271817|66162620|FG001|Part 2|Withdrawal by Subject|2|||
23666114|NCT00271817|66162621|FG002|Part 2|Withdrawal by Subject|13|||
23666115|NCT00271817|66162619|FG000|Part 2|LDL < 50 mg/dL|0|||
23666116|NCT00271817|66162620|FG001|Part 2|LDL < 50 mg/dL|3|||
23666117|NCT00271817|66162621|FG002|Part 2|LDL < 50 mg/dL|4|||
23666118|NCT00960843|66162622|FG000|Overall Study|Lost to Follow-up|2|||
23666119|NCT00960843|66162623|FG001|Overall Study|Lost to Follow-up|0|||
23666120|NCT00960843|66162622|FG000|Overall Study|Protocol Violation|0|||
23666121|NCT00960843|66162623|FG001|Overall Study|Protocol Violation|4|||
23666122|NCT00960843|66162622|FG000|Overall Study|Repeated needle dislodgment|0|||
23666123|NCT00960843|66162623|FG001|Overall Study|Repeated needle dislodgment|1|||
23666124|NCT01231659|66162628|FG000|Overall Study|Adverse Event|9|||
23605348|NCT04803734|65943686|FG001|Overall Study|Protocol Violation|1|||
23605349|NCT00805441|65943689|FG000|Overall Study|Adverse Event|5|||
23490568|NCT00559754|65541441|FG000|Overall Study|Protocol Violation|1|||
23490569|NCT00559754|65541441|FG000|Overall Study|Investigator criteria|2|||
23490570|NCT00559754|65541441|FG000|Overall Study|Withdrawal by Subject|2|||
23605350|NCT00805441|65943690|FG001|Overall Study|Adverse Event|2|||
23605351|NCT00805441|65943689|FG000|Overall Study|Lack of Efficacy|0|||
23605352|NCT00805441|65943690|FG001|Overall Study|Lack of Efficacy|2|||
23666125|NCT01231659|66162628|FG000|Overall Study|Disease Progression|48|||
23666126|NCT01231659|66162628|FG000|Overall Study|Death|2|||
23666127|NCT01231659|66162628|FG000|Overall Study|Patient refused to complete study visit|1|||
23666128|NCT01231659|66162628|FG000|Overall Study|Other protocol defined criteria|12|||
23666129|NCT00405067|66162629|FG000|Overall Study|Adverse Event|4|||
23490571|NCT01309165|65541442|FG000|Overall Study|Lost to Follow-up|4|||
23666130|NCT00405067|66162630|FG001|Overall Study|Adverse Event|9|||
23666131|NCT00405067|66162631|FG002|Overall Study|Adverse Event|4|||
23378542|NCT00831844|65130578|FG005|Overall Study|Ineligible|0|||
23490572|NCT01309165|65541443|FG001|Overall Study|Lost to Follow-up|3|||
23605353|NCT00805441|65943689|FG000|Overall Study|Protocol Violation|4|||
23605354|NCT00805441|65943690|FG001|Overall Study|Protocol Violation|8|||
23378543|NCT00831844|65130579|FG006|Overall Study|Ineligible|0|||
23378544|NCT00831844|65130580|FG007|Overall Study|Ineligible|0|||
23378545|NCT00831844|65130581|FG008|Overall Study|Ineligible|0|||
23378546|NCT00831844|65130582|FG009|Overall Study|Ineligible|0|||
23378547|NCT05399771|65130585|FG000|Overall Study|Physician Decision|3|||
23378548|NCT05399771|65130585|FG000|Overall Study|Adverse Event|1|||
23378549|NCT02774278|65130588|FG000|Overall Study|Lack of Efficacy|199|||
23378550|NCT02774278|65130588|FG000|Overall Study|Death|29|||
23378551|NCT02774278|65130588|FG000|Overall Study|Adverse event/intercurrent illness|16|||
23378552|NCT02774278|65130588|FG000|Overall Study|Refused treatment/did not cooperate|9|||
23378553|NCT02774278|65130588|FG000|Overall Study|Administrative reasons|6|||
23378554|NCT02774278|65130588|FG000|Overall Study|Withdrawal by Subject|3|||
23378555|NCT02774278|65130588|FG000|Overall Study|Protocol Violation|2|||
23378556|NCT02595749|65130601|FG000|Overall Study|Withdrawal by Subject|12|||
23378557|NCT02595749|65130602|FG001|Overall Study|Withdrawal by Subject|7|||
23378558|NCT01500083|65130603|FG000|Overall Study|Adverse Event|4|||
23378559|NCT01500083|65130604|FG001|Overall Study|Adverse Event|17|||
23378560|NCT01500083|65130603|FG000|Overall Study|Death|0|||
23378561|NCT01500083|65130604|FG001|Overall Study|Death|2|||
23378562|NCT01500083|65130603|FG000|Overall Study|Lost to Follow-up|1|||
23378563|NCT01500083|65130604|FG001|Overall Study|Lost to Follow-up|0|||
23378564|NCT01500083|65130603|FG000|Overall Study|Withdrawal of Consent|0|||
23378565|NCT01500083|65130604|FG001|Overall Study|Withdrawal of Consent|1|||
23378566|NCT01500083|65130603|FG000|Overall Study|Disease Progression|2|||
23378567|NCT01500083|65130604|FG001|Overall Study|Disease Progression|10|||
23378568|NCT01500083|65130603|FG000|Overall Study|Investigator Discretion|3|||
23378569|NCT01500083|65130604|FG001|Overall Study|Investigator Discretion|8|||
23378570|NCT01500083|65130603|FG000|Overall Study|Other Reasons|2|||
23378571|NCT01500083|65130604|FG001|Overall Study|Other Reasons|5|||
23490573|NCT01309165|65541442|FG000|Overall Study|Return to work|1|||
23490574|NCT01309165|65541443|FG001|Overall Study|Return to work|2|||
23490575|NCT01309165|65541442|FG000|Overall Study|Left country|0|||
23490576|NCT01309165|65541443|FG001|Overall Study|Left country|1|||
23490577|NCT01309165|65541442|FG000|Overall Study|No transportation|0|||
23490578|NCT01309165|65541443|FG001|Overall Study|No transportation|1|||
23490579|NCT01309165|65541442|FG000|Overall Study|Admitted to hospital for second stroke|1|||
23490580|NCT01309165|65541443|FG001|Overall Study|Admitted to hospital for second stroke|0|||
23490581|NCT02437513|65541444|FG000|Overall Study|Withdrawal by Subject|2|||
23605355|NCT00805441|65943689|FG000|Overall Study|Lost to Follow-up|10|||
23605356|NCT00805441|65943690|FG001|Overall Study|Lost to Follow-up|13|||
23666132|NCT00405067|66162629|FG000|Overall Study|Lost to Follow-up|0|||
23378572|NCT01947933|65130605|FG000|Overall Study|Withdrawal by Subject|0|||
23378573|NCT01947933|65130606|FG001|Overall Study|Withdrawal by Subject|0|||
23378574|NCT01947933|65130607|FG002|Overall Study|Withdrawal by Subject|1|||
23666133|NCT00405067|66162630|FG001|Overall Study|Lost to Follow-up|0|||
23378575|NCT01947933|65130608|FG003|Overall Study|Withdrawal by Subject|0|||
23378576|NCT01947933|65130609|FG004|Overall Study|Withdrawal by Subject|0|||
23490582|NCT00467857|65541445|FG000|Overall Study|Adverse Event|1|||
23490583|NCT00467857|65541446|FG001|Overall Study|Adverse Event|0|||
23378577|NCT01947933|65130610|FG005|Overall Study|Withdrawal by Subject|0|||
23378578|NCT01947933|65130611|FG006|Overall Study|Withdrawal by Subject|0|||
23378579|NCT01947933|65130612|FG007|Overall Study|Withdrawal by Subject|0|||
23378580|NCT01947933|65130613|FG008|Overall Study|Withdrawal by Subject|0|||
23378581|NCT01947933|65130605|FG000|Overall Study|Lost to Follow-up|0|||
23378582|NCT01947933|65130606|FG001|Overall Study|Lost to Follow-up|0|||
23378583|NCT01947933|65130607|FG002|Overall Study|Lost to Follow-up|0|||
23378584|NCT01947933|65130608|FG003|Overall Study|Lost to Follow-up|0|||
23378585|NCT01947933|65130609|FG004|Overall Study|Lost to Follow-up|0|||
23378586|NCT01947933|65130610|FG005|Overall Study|Lost to Follow-up|0|||
23378587|NCT01947933|65130611|FG006|Overall Study|Lost to Follow-up|0|||
23378588|NCT01947933|65130612|FG007|Overall Study|Lost to Follow-up|0|||
23378589|NCT01947933|65130613|FG008|Overall Study|Lost to Follow-up|1|||
23378590|NCT01179516|65130617|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23378591|NCT01179516|65130618|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
23378592|NCT01179516|65130619|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
23378593|NCT01179516|65130617|FG000|Overall Study|Lack of Efficacy|4|||
23378594|NCT01179516|65130618|FG001|Overall Study|Lack of Efficacy|2|||
23378595|NCT01179516|65130619|FG002|Overall Study|Lack of Efficacy|0|||
23378596|NCT01179516|65130617|FG000|Overall Study|Noncompliance with Study Drug|2|||
23378597|NCT01179516|65130618|FG001|Overall Study|Noncompliance with Study Drug|0|||
23378598|NCT01179516|65130619|FG002|Overall Study|Noncompliance with Study Drug|1|||
23378599|NCT01179516|65130617|FG000|Overall Study|Protocol Deviations|4|||
23378600|NCT01179516|65130618|FG001|Overall Study|Protocol Deviations|3|||
23378601|NCT01179516|65130619|FG002|Overall Study|Protocol Deviations|3|||
23378602|NCT01179516|65130617|FG000|Overall Study|Withdrawal of Consent|2|||
23378603|NCT01179516|65130618|FG001|Overall Study|Withdrawal of Consent|6|||
23378604|NCT01179516|65130619|FG002|Overall Study|Withdrawal of Consent|10|||
23378605|NCT01179516|65130617|FG000|Overall Study|Lost to Follow-up|7|||
23378606|NCT01179516|65130618|FG001|Overall Study|Lost to Follow-up|7|||
23378607|NCT01179516|65130619|FG002|Overall Study|Lost to Follow-up|3|||
23378608|NCT01179516|65130617|FG000|Overall Study|Other|2|||
23378609|NCT01179516|65130618|FG001|Overall Study|Other|0|||
23378610|NCT01179516|65130619|FG002|Overall Study|Other|2|||
23378611|NCT00147238|65130620|FG000|Overall Study|Inevaluable|8|||
23378612|NCT01991795|65130625|FG000|Overall Study|Lost to Follow-up|6|||
23378613|NCT01991795|65130626|FG001|Overall Study|Lost to Follow-up|4|||
23378614|NCT01991795|65130625|FG000|Overall Study|Withdrawal by Subject|117|||
23378615|NCT01991795|65130626|FG001|Overall Study|Withdrawal by Subject|94|||
23378616|NCT01991795|65130625|FG000|Overall Study|Site prematurely closed by sponsor|26|||
23378617|NCT01991795|65130626|FG001|Overall Study|Site prematurely closed by sponsor|25|||
23378618|NCT02691572|65130627|FG000|Overall Study|Withdrawal by Subject|1|||
23378619|NCT02691572|65130628|FG001|Overall Study|Withdrawal by Subject|0|||
23378620|NCT02691572|65130627|FG000|Overall Study|Protocol Violation|0|||
23378621|NCT02691572|65130628|FG001|Overall Study|Protocol Violation|1|||
23378622|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
23378623|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
23378624|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
23378625|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
23378626|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
23378627|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
23378628|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
23378629|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
23378630|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
23378631|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
23378632|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Death|3|||
23378633|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Death|1|||
23378634|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
23378635|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
23378636|NCT01056276|65130631|FG000|Maintenance Therapy|Toxicity|0|||
23378637|NCT01056276|65130632|FG001|Maintenance Therapy|Toxicity|2|||
23378638|NCT01056276|65130631|FG000|Maintenance Therapy|Progressive Disease|0|||
23378639|NCT01056276|65130632|FG001|Maintenance Therapy|Progressive Disease|9|||
23378640|NCT01056276|65130631|FG000|Maintenance Therapy|Physician Decision|0|||
23378641|NCT01056276|65130632|FG001|Maintenance Therapy|Physician Decision|1|||
23378642|NCT01056276|65130631|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
23378643|NCT01056276|65130632|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
23378644|NCT01056276|65130631|FG000|Maintenance Therapy|Intercurrent Illness|0|||
23378645|NCT01056276|65130632|FG001|Maintenance Therapy|Intercurrent Illness|1|||
23378646|NCT01056276|65130631|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
23378647|NCT01056276|65130632|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
23378648|NCT00853385|65133995|FG000|Overall Study|Death|0|||
23378649|NCT00853385|65133996|FG001|Overall Study|Death|0|||
23378650|NCT00853385|65133997|FG002|Overall Study|Death|0|||
23378651|NCT00853385|65133998|FG003|Overall Study|Death|0|||
23378652|NCT00853385|65133999|FG004|Overall Study|Death|1|||
23378653|NCT00853385|65133995|FG000|Overall Study|Adverse Event|24|||
23378654|NCT00853385|65133996|FG001|Overall Study|Adverse Event|24|||
23378655|NCT00853385|65133997|FG002|Overall Study|Adverse Event|2|||
23378656|NCT00853385|65133998|FG003|Overall Study|Adverse Event|5|||
23378657|NCT00853385|65133999|FG004|Overall Study|Adverse Event|22|||
23378658|NCT00853385|65133995|FG000|Overall Study|Lack of Efficacy|6|||
23378659|NCT00853385|65133996|FG001|Overall Study|Lack of Efficacy|7|||
23378660|NCT00853385|65133997|FG002|Overall Study|Lack of Efficacy|3|||
23378661|NCT00853385|65133998|FG003|Overall Study|Lack of Efficacy|3|||
23378662|NCT00853385|65133999|FG004|Overall Study|Lack of Efficacy|6|||
23378663|NCT00853385|65133995|FG000|Overall Study|Lost to Follow-up|2|||
23378664|NCT00853385|65133996|FG001|Overall Study|Lost to Follow-up|1|||
23378665|NCT00853385|65133997|FG002|Overall Study|Lost to Follow-up|0|||
23378666|NCT00853385|65133998|FG003|Overall Study|Lost to Follow-up|0|||
23378667|NCT00853385|65133999|FG004|Overall Study|Lost to Follow-up|0|||
23378668|NCT00853385|65133995|FG000|Overall Study|Withdrawal by Subject|4|||
23378669|NCT00853385|65133996|FG001|Overall Study|Withdrawal by Subject|2|||
23378670|NCT00853385|65133997|FG002|Overall Study|Withdrawal by Subject|0|||
23378671|NCT00853385|65133998|FG003|Overall Study|Withdrawal by Subject|1|||
23378672|NCT00853385|65133999|FG004|Overall Study|Withdrawal by Subject|1|||
23378673|NCT00853385|65133995|FG000|Overall Study|Other|18|||
23378674|NCT00853385|65133996|FG001|Overall Study|Other|9|||
23378675|NCT00853385|65133997|FG002|Overall Study|Other|4|||
23378676|NCT00853385|65133998|FG003|Overall Study|Other|4|||
23378677|NCT00853385|65133999|FG004|Overall Study|Other|12|||
23378678|NCT02233413|65134000|FG000|Overall Study|Lost to Follow-up|7|||
23378679|NCT02233413|65134001|FG001|Overall Study|Lost to Follow-up|9|||
23378680|NCT02233413|65134000|FG000|Overall Study|Withdrawal by Subject|4|||
23378681|NCT02233413|65134001|FG001|Overall Study|Withdrawal by Subject|5|||
23378682|NCT03572218|65134003|FG000|Overall Study|Lost to Follow-up|3|||
23605357|NCT00805441|65943689|FG000|Overall Study|Withdrawal by Subject|15|||
23605358|NCT00805441|65943690|FG001|Overall Study|Withdrawal by Subject|9|||
23605359|NCT00805441|65943689|FG000|Overall Study|Physician Decision|0|||
23605360|NCT00805441|65943690|FG001|Overall Study|Physician Decision|1|||
23605361|NCT00805441|65943689|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
23605362|NCT00805441|65943690|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
23605363|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
23605364|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
23605365|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
23666134|NCT00405067|66162631|FG002|Overall Study|Lost to Follow-up|1|||
23666135|NCT00550680|66162632|FG000|Overall Study|Administrative Reasons|1|||
23666136|NCT00550680|66162632|FG000|Overall Study|Adverse Event|5|||
23378683|NCT03572218|65134004|FG001|Overall Study|Lost to Follow-up|2|||
23378684|NCT03572218|65134003|FG000|Overall Study|No longer available for study visits|2|||
23605366|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
23666137|NCT00550680|66162632|FG000|Overall Study|Death|3|||
23666138|NCT00550680|66162632|FG000|Overall Study|Early Improvement|1|||
23666139|NCT00550680|66162632|FG000|Overall Study|Lost to Follow-up|3|||
23666140|NCT00550680|66162632|FG000|Overall Study|Lack of Efficacy|1|||
23666141|NCT00550680|66162632|FG000|Overall Study|Other|10|||
23666142|NCT00550680|66162632|FG000|Overall Study|Protocol Violation|7|||
23666143|NCT00550680|66162632|FG000|Overall Study|Refused Treatment|19|||
23666144|NCT00550680|66162632|FG000|Overall Study|Screen Failure|6|||
23666145|NCT00847145|66162633|FG000|Overall Study|AE or Death|0|||
23666146|NCT00847145|66162634|FG001|Overall Study|AE or Death|1|||
23666147|NCT00847145|66162635|FG002|Overall Study|AE or Death|1|||
23666148|NCT00847145|66162636|FG003|Overall Study|AE or Death|0|||
23666149|NCT00847145|66162637|FG004|Overall Study|AE or Death|0|||
23378685|NCT03572218|65134004|FG001|Overall Study|No longer available for study visits|1|||
23378686|NCT03572218|65134003|FG000|Overall Study|No longer interested|1|||
23378687|NCT03572218|65134004|FG001|Overall Study|No longer interested|2|||
23666150|NCT00847145|66162638|FG005|Overall Study|AE or Death|0|||
23666151|NCT00847145|66162639|FG006|Overall Study|AE or Death|0|||
23666152|NCT00847145|66162640|FG007|Overall Study|AE or Death|0|||
23666153|NCT00847145|66162633|FG000|Overall Study|Withdrawal by Subject|3|||
23666154|NCT00847145|66162634|FG001|Overall Study|Withdrawal by Subject|4|||
23666155|NCT00847145|66162635|FG002|Overall Study|Withdrawal by Subject|6|||
23378688|NCT01373229|65134005|FG000|Overall Study|Death|3|||
23666156|NCT00847145|66162636|FG003|Overall Study|Withdrawal by Subject|1|||
23666157|NCT00847145|66162637|FG004|Overall Study|Withdrawal by Subject|0|||
23666158|NCT00847145|66162638|FG005|Overall Study|Withdrawal by Subject|0|||
23666159|NCT00847145|66162639|FG006|Overall Study|Withdrawal by Subject|1|||
23666160|NCT00847145|66162640|FG007|Overall Study|Withdrawal by Subject|1|||
23666161|NCT00847145|66162633|FG000|Overall Study|Lost to Follow-up|3|||
23666162|NCT00847145|66162634|FG001|Overall Study|Lost to Follow-up|1|||
23666163|NCT00847145|66162635|FG002|Overall Study|Lost to Follow-up|1|||
23666164|NCT00847145|66162636|FG003|Overall Study|Lost to Follow-up|0|||
23666165|NCT00847145|66162637|FG004|Overall Study|Lost to Follow-up|4|||
23666166|NCT00847145|66162638|FG005|Overall Study|Lost to Follow-up|4|||
23666167|NCT00847145|66162639|FG006|Overall Study|Lost to Follow-up|8|||
23666168|NCT00847145|66162640|FG007|Overall Study|Lost to Follow-up|2|||
23666169|NCT00847145|66162633|FG000|Overall Study|Inappropriate enrollment|0|||
23666170|NCT00847145|66162634|FG001|Overall Study|Inappropriate enrollment|0|||
23666171|NCT00847145|66162635|FG002|Overall Study|Inappropriate enrollment|0|||
23605367|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
23605368|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
23605369|NCT03851094|65943693|FG000|Overall Study|Withdrawal by Subject|0|||
23605370|NCT03851094|65943694|FG001|Overall Study|Withdrawal by Subject|1|||
23605371|NCT03851094|65943693|FG000|Overall Study|Participant lost device|0|||
23666172|NCT00847145|66162636|FG003|Overall Study|Inappropriate enrollment|0|||
23666173|NCT00847145|66162637|FG004|Overall Study|Inappropriate enrollment|1|||
23666174|NCT00847145|66162638|FG005|Overall Study|Inappropriate enrollment|0|||
23666175|NCT00847145|66162639|FG006|Overall Study|Inappropriate enrollment|0|||
23666176|NCT00847145|66162640|FG007|Overall Study|Inappropriate enrollment|0|||
23666177|NCT00847145|66162633|FG000|Overall Study|Protocol Violation|0|||
23666178|NCT00847145|66162634|FG001|Overall Study|Protocol Violation|0|||
23666179|NCT00847145|66162635|FG002|Overall Study|Protocol Violation|3|||
23666180|NCT00847145|66162636|FG003|Overall Study|Protocol Violation|0|||
23666181|NCT00847145|66162637|FG004|Overall Study|Protocol Violation|1|||
23378689|NCT01373229|65134005|FG000|Overall Study|Physician Decision|3|||
23378690|NCT01303419|65134006|FG000|Overall Study|Discontinuation of study|60|||
23378691|NCT01303419|65134006|FG000|Overall Study|Did not complete both imaging methods|5|||
23378692|NCT01303419|65134006|FG000|Overall Study|Did not meet all I/E after screening|31|||
23378693|NCT04666298|65134016|FG000|Overall Study|Subject decision|1|||
23378694|NCT04666298|65134017|FG001|Overall Study|Subject decision|0|||
23378695|NCT04666298|65134018|FG002|Overall Study|Subject decision|0|||
23378696|NCT04666298|65134019|FG003|Overall Study|Subject decision|2|||
23378697|NCT04666298|65134016|FG000|Overall Study|Death|1|||
23378698|NCT04666298|65134017|FG001|Overall Study|Death|0|||
23378699|NCT04666298|65134018|FG002|Overall Study|Death|0|||
23378700|NCT04666298|65134019|FG003|Overall Study|Death|0|||
23378701|NCT04666298|65134016|FG000|Overall Study|Lost to Follow-up|0|||
23605372|NCT03851094|65943694|FG001|Overall Study|Participant lost device|1|||
23605373|NCT03851094|65943693|FG000|Overall Study|Participant returned device|0|||
23605374|NCT03851094|65943694|FG001|Overall Study|Participant returned device|2|||
23605375|NCT04017611|65943695|FG000|Overall Study|Withdrawn prior to completion|1|||
23605376|NCT03890484|65943696|FG000|Overall Study|Lost to Follow-up|1|||
23605377|NCT03890484|65943697|FG001|Overall Study|Lost to Follow-up|1|||
23605378|NCT01052272|65943700|FG000|Overall Study|Death|0|||
23605379|NCT01052272|65943701|FG001|Overall Study|Death|0|||
23605380|NCT01052272|65943702|FG002|Overall Study|Death|1|||
23605381|NCT01052272|65943703|FG003|Overall Study|Death|1|||
23605382|NCT01052272|65943700|FG000|Overall Study|Physician Decision|0|||
23605383|NCT01052272|65943701|FG001|Overall Study|Physician Decision|1|||
23605384|NCT01052272|65943702|FG002|Overall Study|Physician Decision|0|||
23605385|NCT01052272|65943703|FG003|Overall Study|Physician Decision|0|||
23605386|NCT01052272|65943700|FG000|Overall Study|patient refuses follow-up|5|||
23605387|NCT01052272|65943701|FG001|Overall Study|patient refuses follow-up|4|||
23605388|NCT01052272|65943702|FG002|Overall Study|patient refuses follow-up|2|||
23605389|NCT01052272|65943703|FG003|Overall Study|patient refuses follow-up|4|||
23605390|NCT01052272|65943700|FG000|Overall Study|Withdrawal by Subject|0|||
23605391|NCT01052272|65943701|FG001|Overall Study|Withdrawal by Subject|2|||
23605392|NCT01052272|65943702|FG002|Overall Study|Withdrawal by Subject|3|||
23605393|NCT01052272|65943703|FG003|Overall Study|Withdrawal by Subject|2|||
23666182|NCT00847145|66162638|FG005|Overall Study|Protocol Violation|0|||
23666183|NCT00847145|66162639|FG006|Overall Study|Protocol Violation|0|||
23666184|NCT00847145|66162640|FG007|Overall Study|Protocol Violation|1|||
23666185|NCT02116777|66162645|FG000|Overall Study|Adverse Event|0|||
23666186|NCT02116777|66162646|FG001|Overall Study|Adverse Event|0|||
23666187|NCT02116777|66162647|FG002|Overall Study|Adverse Event|0|||
23666188|NCT02116777|66162648|FG003|Overall Study|Adverse Event|0|||
23666189|NCT02116777|66162649|FG004|Overall Study|Adverse Event|2|||
23666190|NCT02116777|66162650|FG005|Overall Study|Adverse Event|2|||
23666191|NCT02116777|66162651|FG006|Overall Study|Adverse Event|0|||
23666192|NCT02116777|66162645|FG000|Overall Study|Death|0|||
23378702|NCT04666298|65134017|FG001|Overall Study|Lost to Follow-up|0|||
23378703|NCT04666298|65134018|FG002|Overall Study|Lost to Follow-up|0|||
23666193|NCT02116777|66162646|FG001|Overall Study|Death|0|||
23666194|NCT02116777|66162647|FG002|Overall Study|Death|0|||
23378704|NCT04666298|65134019|FG003|Overall Study|Lost to Follow-up|1|||
23378705|NCT04666298|65134016|FG000|Overall Study|Physician Decision|0|||
23378706|NCT04666298|65134017|FG001|Overall Study|Physician Decision|0|||
23378707|NCT04666298|65134018|FG002|Overall Study|Physician Decision|0|||
23378708|NCT04666298|65134019|FG003|Overall Study|Physician Decision|1|||
23378709|NCT04666298|65134016|FG000|Overall Study|Protocol deviation|0|||
23378710|NCT04666298|65134017|FG001|Overall Study|Protocol deviation|0|||
23378711|NCT04666298|65134018|FG002|Overall Study|Protocol deviation|1|||
23378712|NCT04666298|65134019|FG003|Overall Study|Protocol deviation|0|||
23378713|NCT02711137|65134020|FG000|Overall Study|Death|1|||
23378714|NCT02711137|65134021|FG001|Overall Study|Death|4|||
23378715|NCT02711137|65134022|FG002|Overall Study|Death|5|||
23378716|NCT02711137|65134023|FG003|Overall Study|Death|5|||
23378717|NCT02711137|65134024|FG004|Overall Study|Death|3|||
23378718|NCT02711137|65134025|FG005|Overall Study|Death|1|||
23378719|NCT02711137|65134026|FG006|Overall Study|Death|61|||
23378720|NCT02711137|65134027|FG007|Overall Study|Death|3|||
23378721|NCT02711137|65134028|FG008|Overall Study|Death|0|||
23378722|NCT02711137|65134029|FG009|Overall Study|Death|1|||
23378723|NCT02711137|65134030|FG010|Overall Study|Death|1|||
23378724|NCT02711137|65134031|FG011|Overall Study|Death|1|||
23378725|NCT02711137|65134032|FG012|Overall Study|Death|0|||
23378726|NCT02711137|65134033|FG013|Overall Study|Death|0|||
23378727|NCT02711137|65134034|FG014|Overall Study|Death|0|||
23378728|NCT02711137|65134020|FG000|Overall Study|Study Terminated by Sponsor|0|||
23378729|NCT02711137|65134021|FG001|Overall Study|Study Terminated by Sponsor|0|||
23378730|NCT02711137|65134022|FG002|Overall Study|Study Terminated by Sponsor|1|||
23378731|NCT02711137|65134023|FG003|Overall Study|Study Terminated by Sponsor|0|||
23378732|NCT02711137|65134024|FG004|Overall Study|Study Terminated by Sponsor|0|||
23378733|NCT02711137|65134025|FG005|Overall Study|Study Terminated by Sponsor|0|||
23378734|NCT02711137|65134026|FG006|Overall Study|Study Terminated by Sponsor|1|||
23378735|NCT02711137|65134027|FG007|Overall Study|Study Terminated by Sponsor|0|||
23378736|NCT02711137|65134028|FG008|Overall Study|Study Terminated by Sponsor|0|||
23378737|NCT02711137|65134029|FG009|Overall Study|Study Terminated by Sponsor|0|||
23378738|NCT02711137|65134030|FG010|Overall Study|Study Terminated by Sponsor|0|||
23378739|NCT02711137|65134031|FG011|Overall Study|Study Terminated by Sponsor|0|||
23378740|NCT02711137|65134032|FG012|Overall Study|Study Terminated by Sponsor|0|||
23378741|NCT02711137|65134033|FG013|Overall Study|Study Terminated by Sponsor|0|||
23666195|NCT02116777|66162648|FG003|Overall Study|Death|1|||
23666196|NCT02116777|66162649|FG004|Overall Study|Death|0|||
23666197|NCT02116777|66162650|FG005|Overall Study|Death|0|||
23666198|NCT02116777|66162651|FG006|Overall Study|Death|0|||
23666199|NCT02116777|66162645|FG000|Overall Study|Lack of Efficacy|3|||
23666200|NCT02116777|66162646|FG001|Overall Study|Lack of Efficacy|3|||
23666201|NCT02116777|66162647|FG002|Overall Study|Lack of Efficacy|3|||
23666202|NCT02116777|66162648|FG003|Overall Study|Lack of Efficacy|8|||
23666203|NCT02116777|66162649|FG004|Overall Study|Lack of Efficacy|4|||
23666204|NCT02116777|66162650|FG005|Overall Study|Lack of Efficacy|1|||
23666205|NCT02116777|66162651|FG006|Overall Study|Lack of Efficacy|9|||
23666206|NCT02116777|66162645|FG000|Overall Study|Physician Decision|0|||
23666207|NCT02116777|66162646|FG001|Overall Study|Physician Decision|0|||
23666208|NCT02116777|66162647|FG002|Overall Study|Physician Decision|0|||
23378742|NCT02711137|65134034|FG014|Overall Study|Study Terminated by Sponsor|0|||
23378743|NCT02711137|65134020|FG000|Overall Study|Physician Decision|1|||
23378744|NCT02711137|65134021|FG001|Overall Study|Physician Decision|0|||
23378745|NCT02711137|65134022|FG002|Overall Study|Physician Decision|2|||
23378746|NCT02711137|65134023|FG003|Overall Study|Physician Decision|1|||
23378747|NCT02711137|65134024|FG004|Overall Study|Physician Decision|1|||
23378748|NCT02711137|65134025|FG005|Overall Study|Physician Decision|0|||
23378749|NCT02711137|65134026|FG006|Overall Study|Physician Decision|12|||
23378750|NCT02711137|65134027|FG007|Overall Study|Physician Decision|2|||
23378751|NCT02711137|65134028|FG008|Overall Study|Physician Decision|1|||
23666209|NCT02116777|66162648|FG003|Overall Study|Physician Decision|2|||
23666210|NCT02116777|66162649|FG004|Overall Study|Physician Decision|0|||
23666211|NCT02116777|66162650|FG005|Overall Study|Physician Decision|0|||
23666212|NCT02116777|66162651|FG006|Overall Study|Physician Decision|0|||
23666213|NCT02116777|66162645|FG000|Overall Study|Protocol Violation|0|||
23666214|NCT02116777|66162646|FG001|Overall Study|Protocol Violation|0|||
23666215|NCT02116777|66162647|FG002|Overall Study|Protocol Violation|0|||
23666216|NCT02116777|66162648|FG003|Overall Study|Protocol Violation|1|||
23666217|NCT02116777|66162649|FG004|Overall Study|Protocol Violation|0|||
23666218|NCT02116777|66162650|FG005|Overall Study|Protocol Violation|0|||
23666219|NCT02116777|66162651|FG006|Overall Study|Protocol Violation|0|||
23666220|NCT02116777|66162645|FG000|Overall Study|Withdrawal by Subject|0|||
23666221|NCT02116777|66162646|FG001|Overall Study|Withdrawal by Subject|0|||
23666222|NCT02116777|66162647|FG002|Overall Study|Withdrawal by Subject|0|||
23666223|NCT02116777|66162648|FG003|Overall Study|Withdrawal by Subject|1|||
23666224|NCT02116777|66162649|FG004|Overall Study|Withdrawal by Subject|0|||
23666225|NCT02116777|66162650|FG005|Overall Study|Withdrawal by Subject|0|||
23666226|NCT02116777|66162651|FG006|Overall Study|Withdrawal by Subject|0|||
23666227|NCT01438489|66162654|FG000|Overall Study|Lost to Follow-up|4|||
23666228|NCT01438489|66162655|FG001|Overall Study|Lost to Follow-up|2|||
23666229|NCT01438489|66162656|FG002|Overall Study|Lost to Follow-up|2|||
23666230|NCT01438489|66162654|FG000|Overall Study|Withdrawal by Subject|11|||
23666231|NCT01438489|66162655|FG001|Overall Study|Withdrawal by Subject|3|||
23666232|NCT01438489|66162656|FG002|Overall Study|Withdrawal by Subject|8|||
23666233|NCT01438489|66162654|FG000|Overall Study|Death|0|||
23666234|NCT01438489|66162655|FG001|Overall Study|Death|0|||
23666235|NCT01438489|66162656|FG002|Overall Study|Death|1|||
23666236|NCT01438489|66162654|FG000|Overall Study|Sponsor decision|4|||
23666237|NCT01438489|66162655|FG001|Overall Study|Sponsor decision|1|||
23666238|NCT01438489|66162656|FG002|Overall Study|Sponsor decision|4|||
23666239|NCT01438489|66162654|FG000|Overall Study|Subject choice/Subject moved|2|||
23666240|NCT01438489|66162655|FG001|Overall Study|Subject choice/Subject moved|1|||
23666241|NCT01438489|66162656|FG002|Overall Study|Subject choice/Subject moved|1|||
23666242|NCT01438489|66162654|FG000|Overall Study|Investigator decision|0|||
23666243|NCT01438489|66162655|FG001|Overall Study|Investigator decision|1|||
23666244|NCT01438489|66162656|FG002|Overall Study|Investigator decision|0|||
23378752|NCT02711137|65134029|FG009|Overall Study|Physician Decision|1|||
23378753|NCT02711137|65134030|FG010|Overall Study|Physician Decision|3|||
23378754|NCT02711137|65134031|FG011|Overall Study|Physician Decision|2|||
23378755|NCT02711137|65134032|FG012|Overall Study|Physician Decision|1|||
23378756|NCT02711137|65134033|FG013|Overall Study|Physician Decision|1|||
23378757|NCT02711137|65134034|FG014|Overall Study|Physician Decision|2|||
23378758|NCT02711137|65134020|FG000|Overall Study|Other|0|||
23378759|NCT02711137|65134021|FG001|Overall Study|Other|1|||
23378760|NCT02711137|65134022|FG002|Overall Study|Other|0|||
23378761|NCT02711137|65134023|FG003|Overall Study|Other|0|||
23378762|NCT02711137|65134024|FG004|Overall Study|Other|0|||
23378763|NCT02711137|65134025|FG005|Overall Study|Other|0|||
23378764|NCT02711137|65134026|FG006|Overall Study|Other|3|||
23378765|NCT02711137|65134027|FG007|Overall Study|Other|0|||
23378766|NCT02711137|65134028|FG008|Overall Study|Other|0|||
23378767|NCT02711137|65134029|FG009|Overall Study|Other|0|||
23378768|NCT02711137|65134030|FG010|Overall Study|Other|0|||
23605394|NCT01052272|65943700|FG000|Overall Study|placed in long-term care|0|||
23605395|NCT01052272|65943701|FG001|Overall Study|placed in long-term care|0|||
23605396|NCT01052272|65943702|FG002|Overall Study|placed in long-term care|1|||
23605397|NCT01052272|65943703|FG003|Overall Study|placed in long-term care|0|||
23605398|NCT01052272|65943700|FG000|Overall Study|decline in health|0|||
23605399|NCT01052272|65943701|FG001|Overall Study|decline in health|0|||
23605400|NCT01052272|65943702|FG002|Overall Study|decline in health|1|||
23605401|NCT01052272|65943703|FG003|Overall Study|decline in health|0|||
23605402|NCT03964974|65943704|FG000|Overall Study|Lost to Follow-up|3|||
23605403|NCT03964974|65943705|FG001|Overall Study|Lost to Follow-up|2|||
23605404|NCT03964974|65943704|FG000|Overall Study|Withdrawal by Subject|0|||
23605405|NCT03964974|65943705|FG001|Overall Study|Withdrawal by Subject|3|||
23605406|NCT02208843|65943706|FG000|Overall Study|Clinical symptoms of progression|2|||
23666245|NCT01438489|66162654|FG000|Overall Study|AE/SAEs|2|||
23666246|NCT01438489|66162655|FG001|Overall Study|AE/SAEs|1|||
23666247|NCT01438489|66162656|FG002|Overall Study|AE/SAEs|1|||
23666248|NCT01438489|66162654|FG000|Overall Study|Received prohibited medication|1|||
23666249|NCT01438489|66162655|FG001|Overall Study|Received prohibited medication|0|||
23666250|NCT01438489|66162656|FG002|Overall Study|Received prohibited medication|0|||
23666251|NCT01438489|66162654|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
23666252|NCT01438489|66162655|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
23378769|NCT02711137|65134031|FG011|Overall Study|Other|0|||
23378770|NCT02711137|65134032|FG012|Overall Study|Other|0|||
23605407|NCT02208843|65943706|FG000|Overall Study|Progression disease according to RECIST|24|||
23605408|NCT02208843|65943706|FG000|Overall Study|Adverse Event|12|||
23605409|NCT02208843|65943706|FG000|Overall Study|Protocol Violation|1|||
23605410|NCT02208843|65943706|FG000|Overall Study|Withdrawal by Subject|1|||
23605411|NCT02208843|65943706|FG000|Overall Study|Switched to commercial afatinib|20|||
23605412|NCT02659540|65943719|FG000|Overall Study|Adverse Event|3|||
23666253|NCT01438489|66162656|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
23666254|NCT01438489|66162654|FG000|Overall Study|Inadequate venous access|0|||
23666255|NCT01438489|66162655|FG001|Overall Study|Inadequate venous access|2|||
23666256|NCT01438489|66162656|FG002|Overall Study|Inadequate venous access|0|||
23666257|NCT01449461|66162657|FG000|Overall Study|Adverse Event|0|||
23666258|NCT01449461|66162658|FG001|Overall Study|Adverse Event|3|||
23666259|NCT01449461|66162659|FG002|Overall Study|Adverse Event|2|||
23666260|NCT01449461|66162660|FG003|Overall Study|Adverse Event|3|||
23666261|NCT01449461|66162661|FG004|Overall Study|Adverse Event|4|||
23666262|NCT01449461|66162662|FG005|Overall Study|Adverse Event|4|||
23666263|NCT01449461|66162657|FG000|Overall Study|Death|0|||
23666264|NCT01449461|66162658|FG001|Overall Study|Death|2|||
23378771|NCT02711137|65134033|FG013|Overall Study|Other|0|||
23378772|NCT02711137|65134034|FG014|Overall Study|Other|1|||
23378773|NCT02711137|65134020|FG000|Overall Study|Withdrawal by Subject|1|||
23378774|NCT02711137|65134021|FG001|Overall Study|Withdrawal by Subject|0|||
23378775|NCT02711137|65134022|FG002|Overall Study|Withdrawal by Subject|0|||
23378776|NCT02711137|65134023|FG003|Overall Study|Withdrawal by Subject|1|||
23378777|NCT02711137|65134024|FG004|Overall Study|Withdrawal by Subject|1|||
23378778|NCT02711137|65134025|FG005|Overall Study|Withdrawal by Subject|0|||
23378779|NCT02711137|65134026|FG006|Overall Study|Withdrawal by Subject|7|||
23378780|NCT02711137|65134027|FG007|Overall Study|Withdrawal by Subject|0|||
23378781|NCT02711137|65134028|FG008|Overall Study|Withdrawal by Subject|0|||
23378782|NCT02711137|65134029|FG009|Overall Study|Withdrawal by Subject|0|||
23378783|NCT02711137|65134030|FG010|Overall Study|Withdrawal by Subject|0|||
23378784|NCT02711137|65134031|FG011|Overall Study|Withdrawal by Subject|0|||
23378785|NCT02711137|65134032|FG012|Overall Study|Withdrawal by Subject|0|||
23378786|NCT02711137|65134033|FG013|Overall Study|Withdrawal by Subject|1|||
23378787|NCT02711137|65134034|FG014|Overall Study|Withdrawal by Subject|0|||
23378788|NCT02711137|65134020|FG000|Overall Study|Lost to Follow-up|1|||
23378789|NCT02711137|65134021|FG001|Overall Study|Lost to Follow-up|0|||
23378790|NCT02711137|65134022|FG002|Overall Study|Lost to Follow-up|0|||
23378791|NCT02711137|65134023|FG003|Overall Study|Lost to Follow-up|0|||
23378792|NCT02711137|65134024|FG004|Overall Study|Lost to Follow-up|0|||
23378793|NCT02711137|65134025|FG005|Overall Study|Lost to Follow-up|0|||
23378794|NCT02711137|65134026|FG006|Overall Study|Lost to Follow-up|2|||
23378795|NCT02711137|65134027|FG007|Overall Study|Lost to Follow-up|0|||
23378796|NCT02711137|65134028|FG008|Overall Study|Lost to Follow-up|0|||
23378797|NCT02711137|65134029|FG009|Overall Study|Lost to Follow-up|0|||
23378798|NCT02711137|65134030|FG010|Overall Study|Lost to Follow-up|0|||
23378799|NCT02711137|65134031|FG011|Overall Study|Lost to Follow-up|0|||
23378800|NCT02711137|65134032|FG012|Overall Study|Lost to Follow-up|0|||
23378801|NCT02711137|65134033|FG013|Overall Study|Lost to Follow-up|0|||
23378802|NCT02711137|65134034|FG014|Overall Study|Lost to Follow-up|0|||
23378803|NCT00421993|65134035|FG000|Overall Study|Withdrawal by Subject|22|||
23378804|NCT00421993|65134036|FG001|Overall Study|Withdrawal by Subject|23|||
23378805|NCT00421993|65134037|FG002|Overall Study|Withdrawal by Subject|23|||
23378806|NCT00421993|65134038|FG003|Overall Study|Withdrawal by Subject|24|||
23378807|NCT00421993|65134035|FG000|Overall Study|Lost to Follow-up|18|||
23378808|NCT00421993|65134036|FG001|Overall Study|Lost to Follow-up|19|||
23378809|NCT00421993|65134037|FG002|Overall Study|Lost to Follow-up|22|||
23490584|NCT00467857|65541445|FG000|Overall Study|Withdrew consent|2|||
23490585|NCT00467857|65541446|FG001|Overall Study|Withdrew consent|0|||
23490586|NCT00467857|65541445|FG000|Overall Study|Death|0|||
23490587|NCT00467857|65541446|FG001|Overall Study|Death|1|||
23490588|NCT00467857|65541445|FG000|Overall Study|Discharged from court service|0|||
23490589|NCT00467857|65541446|FG001|Overall Study|Discharged from court service|1|||
23490590|NCT00467857|65541445|FG000|Overall Study|Emergency care required|0|||
23490591|NCT00467857|65541446|FG001|Overall Study|Emergency care required|1|||
23490592|NCT00467857|65541445|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
23490593|NCT00467857|65541446|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
23490594|NCT00467857|65541445|FG000|Overall Study|Discontinuation reason missing|0|||
23490595|NCT00467857|65541446|FG001|Overall Study|Discontinuation reason missing|3|||
23490596|NCT01024231|65541447|FG000|Overall Study|Other Reasons|1|||
23490597|NCT01024231|65541448|FG001|Overall Study|Other Reasons|2|||
23378810|NCT00421993|65134038|FG003|Overall Study|Lost to Follow-up|20|||
23378811|NCT00421993|65134035|FG000|Overall Study|Adverse Event|11|||
23378812|NCT00421993|65134036|FG001|Overall Study|Adverse Event|1|||
23378813|NCT00421993|65134037|FG002|Overall Study|Adverse Event|6|||
23378814|NCT00421993|65134038|FG003|Overall Study|Adverse Event|4|||
23378815|NCT00421993|65134035|FG000|Overall Study|Protocol Violation|2|||
23378816|NCT00421993|65134036|FG001|Overall Study|Protocol Violation|2|||
23666265|NCT01449461|66162659|FG002|Overall Study|Death|0|||
23666266|NCT01449461|66162660|FG003|Overall Study|Death|0|||
23666267|NCT01449461|66162661|FG004|Overall Study|Death|7|||
23378817|NCT00421993|65134037|FG002|Overall Study|Protocol Violation|0|||
23490598|NCT01024231|65541449|FG002|Overall Study|Other Reasons|0|||
23490599|NCT01024231|65541450|FG003|Overall Study|Other Reasons|0|||
23666268|NCT01449461|66162662|FG005|Overall Study|Death|1|||
23666269|NCT01449461|66162657|FG000|Overall Study|Physician Decision|0|||
23666270|NCT01449461|66162658|FG001|Overall Study|Physician Decision|1|||
23666271|NCT01449461|66162659|FG002|Overall Study|Physician Decision|0|||
23666272|NCT01449461|66162660|FG003|Overall Study|Physician Decision|4|||
23666273|NCT01449461|66162661|FG004|Overall Study|Physician Decision|1|||
23666274|NCT01449461|66162662|FG005|Overall Study|Physician Decision|0|||
23666275|NCT01449461|66162657|FG000|Overall Study|Documented Progressive Disease|4|||
23666276|NCT01449461|66162658|FG001|Overall Study|Documented Progressive Disease|7|||
23666277|NCT01449461|66162659|FG002|Overall Study|Documented Progressive Disease|14|||
23605413|NCT02659540|65943720|FG001|Overall Study|Adverse Event|2|||
23605414|NCT02659540|65943719|FG000|Overall Study|Death|1|||
23605415|NCT02659540|65943720|FG001|Overall Study|Death|0|||
23605416|NCT02659540|65943719|FG000|Overall Study|Progressive disease|2|||
23605417|NCT02659540|65943720|FG001|Overall Study|Progressive disease|6|||
23605418|NCT05376397|65943724|FG000|Overall Study|Lost to Follow-up|1|||
23605419|NCT02161458|65943725|FG000|Overall Study|Withdrawal by Subject|0|||
23605420|NCT02161458|65943726|FG001|Overall Study|Withdrawal by Subject|4|||
23605421|NCT02161458|65943727|FG002|Overall Study|Withdrawal by Subject|4|||
23605422|NCT02161458|65943728|FG003|Overall Study|Withdrawal by Subject|0|||
23605423|NCT02161458|65943725|FG000|Overall Study|Lost to Follow-up|0|||
23605424|NCT02161458|65943726|FG001|Overall Study|Lost to Follow-up|2|||
23605425|NCT02161458|65943727|FG002|Overall Study|Lost to Follow-up|1|||
23605426|NCT02161458|65943728|FG003|Overall Study|Lost to Follow-up|0|||
23605427|NCT00428714|65943736|FG000|Overall Study|Progressive Disease|28|||
23605428|NCT00428714|65943737|FG001|Overall Study|Progressive Disease|36|||
23605429|NCT00428714|65943736|FG000|Overall Study|Withdrawal by Subject|0|||
23605430|NCT00428714|65943737|FG001|Overall Study|Withdrawal by Subject|3|||
23605431|NCT00428714|65943736|FG000|Overall Study|Adverse Event|0|||
23605432|NCT00428714|65943737|FG001|Overall Study|Adverse Event|2|||
23605433|NCT00428714|65943736|FG000|Overall Study|Physician Decision|1|||
23605434|NCT00428714|65943737|FG001|Overall Study|Physician Decision|1|||
23605435|NCT00428714|65943736|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
23605436|NCT00428714|65943737|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
23605437|NCT00428714|65943736|FG000|Overall Study|Death due to other then PD|1|||
23605438|NCT00428714|65943737|FG001|Overall Study|Death due to other then PD|0|||
23605439|NCT01828021|65943738|FG000|Overall Study|Adverse Event|5|||
23605440|NCT01828021|65943738|FG000|Overall Study|Lack of Efficacy|17|||
23605441|NCT01828021|65943738|FG000|Overall Study|Withdrawal by Subject|2|||
23605442|NCT01828021|65943738|FG000|Overall Study|Ileal obstruction, unrelated|1|||
23605443|NCT00853593|65943739|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
23605444|NCT00853593|65943739|FG000|Overall Study|Model 4396 lead not attempted|29|||
23605445|NCT00853593|65943739|FG000|Overall Study|Implant not attempted|4|||
23666278|NCT01449461|66162660|FG003|Overall Study|Documented Progressive Disease|15|||
23605446|NCT02991118|65943742|FG000|Overall Study|Death|3|||
23605447|NCT02991118|65943743|FG001|Overall Study|Death|8|||
23605448|NCT02991118|65943742|FG000|Overall Study|Protocol Violation|0|||
23378818|NCT00421993|65134038|FG003|Overall Study|Protocol Violation|1|||
23378819|NCT00421993|65134035|FG000|Overall Study|Lack of Efficacy|0|||
23378820|NCT00421993|65134036|FG001|Overall Study|Lack of Efficacy|3|||
23378821|NCT00421993|65134037|FG002|Overall Study|Lack of Efficacy|0|||
23378822|NCT00421993|65134038|FG003|Overall Study|Lack of Efficacy|5|||
23378823|NCT00421993|65134035|FG000|Overall Study|Pregnancy|0|||
23378824|NCT00421993|65134036|FG001|Overall Study|Pregnancy|1|||
23378825|NCT00421993|65134037|FG002|Overall Study|Pregnancy|1|||
23666279|NCT01449461|66162661|FG004|Overall Study|Documented Progressive Disease|24|||
23666280|NCT01449461|66162662|FG005|Overall Study|Documented Progressive Disease|5|||
23666281|NCT01449461|66162657|FG000|Overall Study|Clinical Progressive Disease|2|||
23666282|NCT01449461|66162658|FG001|Overall Study|Clinical Progressive Disease|2|||
23666283|NCT01449461|66162659|FG002|Overall Study|Clinical Progressive Disease|0|||
23666284|NCT01449461|66162660|FG003|Overall Study|Clinical Progressive Disease|3|||
23666285|NCT01449461|66162661|FG004|Overall Study|Clinical Progressive Disease|4|||
23666286|NCT01449461|66162662|FG005|Overall Study|Clinical Progressive Disease|2|||
23666287|NCT01449461|66162657|FG000|Overall Study|Protocol Violation|0|||
23666288|NCT01449461|66162658|FG001|Overall Study|Protocol Violation|0|||
23666289|NCT01449461|66162659|FG002|Overall Study|Protocol Violation|0|||
23378826|NCT00421993|65134038|FG003|Overall Study|Pregnancy|2|||
23378827|NCT00421993|65134035|FG000|Overall Study|Subject transportation issues|0|||
23378828|NCT00421993|65134036|FG001|Overall Study|Subject transportation issues|0|||
23378829|NCT00421993|65134037|FG002|Overall Study|Subject transportation issues|0|||
23378830|NCT00421993|65134038|FG003|Overall Study|Subject transportation issues|1|||
23378831|NCT01001104|65134046|FG000|Overall Study|Adverse Event|2|||
23378832|NCT01001104|65134047|FG001|Overall Study|Adverse Event|1|||
23378833|NCT01001104|65134048|FG002|Overall Study|Adverse Event|0|||
23378834|NCT01001104|65134049|FG003|Overall Study|Adverse Event|0|||
23378835|NCT01001104|65134046|FG000|Overall Study|Lost to Follow-up|0|||
23378836|NCT01001104|65134047|FG001|Overall Study|Lost to Follow-up|0|||
23378837|NCT01001104|65134048|FG002|Overall Study|Lost to Follow-up|1|||
23378838|NCT01001104|65134049|FG003|Overall Study|Lost to Follow-up|0|||
23378839|NCT01001104|65134046|FG000|Overall Study|Entry Criteria Not Met|0|||
23490600|NCT01024231|65541451|FG004|Overall Study|Other Reasons|2|||
23605449|NCT02991118|65943743|FG001|Overall Study|Protocol Violation|3|||
23378840|NCT01001104|65134047|FG001|Overall Study|Entry Criteria Not Met|0|||
23378841|NCT01001104|65134048|FG002|Overall Study|Entry Criteria Not Met|0|||
23605450|NCT02991118|65943742|FG000|Overall Study|Physician Decision|0|||
23378842|NCT01001104|65134049|FG003|Overall Study|Entry Criteria Not Met|1|||
23378843|NCT01001104|65134046|FG000|Overall Study|Withdrawal by Subject|0|||
23378844|NCT01001104|65134047|FG001|Overall Study|Withdrawal by Subject|0|||
23490601|NCT01024231|65541452|FG005|Overall Study|Other Reasons|0|||
23666290|NCT01449461|66162660|FG003|Overall Study|Protocol Violation|1|||
23666291|NCT01449461|66162661|FG004|Overall Study|Protocol Violation|0|||
23378845|NCT01001104|65134048|FG002|Overall Study|Withdrawal by Subject|0|||
23378846|NCT01001104|65134049|FG003|Overall Study|Withdrawal by Subject|2|||
23378847|NCT01995201|65134054|FG000|From Baseline Until Week 24|Adverse Event|4|||
23378848|NCT01995201|65134055|FG001|From Baseline Until Week 24|Adverse Event|15|||
23378849|NCT01995201|65134056|FG002|From Baseline Until Week 24|Adverse Event|0|||
23378850|NCT01995201|65134057|FG003|From Baseline Until Week 24|Adverse Event|0|||
23378851|NCT01995201|65134058|FG004|From Baseline Until Week 24|Adverse Event|0|||
23378852|NCT01995201|65134059|FG005|From Baseline Until Week 24|Adverse Event|0|||
23378853|NCT01995201|65134060|FG006|From Baseline Until Week 24|Adverse Event|0|||
23378854|NCT01995201|65134054|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378855|NCT01995201|65134055|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
23378856|NCT01995201|65134056|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378857|NCT01995201|65134057|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378858|NCT01995201|65134058|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378859|NCT01995201|65134059|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378860|NCT01995201|65134060|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378861|NCT01995201|65134054|FG000|From Baseline Until Week 24|Death|0|||
23378862|NCT01995201|65134055|FG001|From Baseline Until Week 24|Death|1|||
23378863|NCT01995201|65134056|FG002|From Baseline Until Week 24|Death|0|||
23378864|NCT01995201|65134057|FG003|From Baseline Until Week 24|Death|0|||
23378865|NCT01995201|65134058|FG004|From Baseline Until Week 24|Death|0|||
23378866|NCT01995201|65134059|FG005|From Baseline Until Week 24|Death|0|||
23378867|NCT01995201|65134060|FG006|From Baseline Until Week 24|Death|0|||
23378868|NCT01995201|65134054|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
23378869|NCT01995201|65134055|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
23378870|NCT01995201|65134056|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
23378871|NCT01995201|65134057|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
23378872|NCT01995201|65134058|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
23490602|NCT01024231|65541453|FG006|Overall Study|Other Reasons|1|||
23490603|NCT01024231|65541447|FG000|Overall Study|Maximum Clinical Benefit|1|||
23490604|NCT01024231|65541448|FG001|Overall Study|Maximum Clinical Benefit|2|||
23490605|NCT01024231|65541449|FG002|Overall Study|Maximum Clinical Benefit|0|||
23490606|NCT01024231|65541450|FG003|Overall Study|Maximum Clinical Benefit|1|||
23490607|NCT01024231|65541451|FG004|Overall Study|Maximum Clinical Benefit|1|||
23378873|NCT01995201|65134059|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
23378874|NCT01995201|65134060|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
23378875|NCT01995201|65134054|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
23378876|NCT01995201|65134055|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
23378877|NCT01995201|65134056|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
23378878|NCT01995201|65134057|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
23378879|NCT01995201|65134058|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
23378880|NCT01995201|65134059|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
23378881|NCT01995201|65134060|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
23378882|NCT01995201|65134054|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
23378883|NCT01995201|65134055|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
23378884|NCT01995201|65134056|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378885|NCT01995201|65134057|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378886|NCT01995201|65134058|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378887|NCT01995201|65134059|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378888|NCT01995201|65134060|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378889|NCT01995201|65134054|FG000|From Baseline Until Week 24|Physician Decision|0|||
23378890|NCT01995201|65134055|FG001|From Baseline Until Week 24|Physician Decision|2|||
23378891|NCT01995201|65134056|FG002|From Baseline Until Week 24|Physician Decision|0|||
23378892|NCT01995201|65134057|FG003|From Baseline Until Week 24|Physician Decision|0|||
23378893|NCT01995201|65134058|FG004|From Baseline Until Week 24|Physician Decision|0|||
23378894|NCT01995201|65134059|FG005|From Baseline Until Week 24|Physician Decision|0|||
23378895|NCT01995201|65134060|FG006|From Baseline Until Week 24|Physician Decision|0|||
23378896|NCT01995201|65134054|FG000|From Baseline Until Week 24|Protocol Violation|0|||
23378897|NCT01995201|65134055|FG001|From Baseline Until Week 24|Protocol Violation|9|||
23378898|NCT01995201|65134056|FG002|From Baseline Until Week 24|Protocol Violation|0|||
23378899|NCT01995201|65134057|FG003|From Baseline Until Week 24|Protocol Violation|0|||
23378900|NCT01995201|65134058|FG004|From Baseline Until Week 24|Protocol Violation|0|||
23378901|NCT01995201|65134059|FG005|From Baseline Until Week 24|Protocol Violation|0|||
23378902|NCT01995201|65134060|FG006|From Baseline Until Week 24|Protocol Violation|0|||
23378903|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Adverse Event|0|||
23378904|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Adverse Event|0|||
23378905|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Adverse Event|2|||
23378906|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Adverse Event|1|||
23378907|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Adverse Event|1|||
23378908|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Adverse Event|3|||
23378909|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Adverse Event|1|||
23378910|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Death|0|||
23378911|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Death|0|||
23378912|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Death|0|||
23378913|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Death|0|||
23378914|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Death|0|||
23666292|NCT01449461|66162662|FG005|Overall Study|Protocol Violation|0|||
23490608|NCT01024231|65541452|FG005|Overall Study|Maximum Clinical Benefit|0|||
23490609|NCT01024231|65541453|FG006|Overall Study|Maximum Clinical Benefit|0|||
23490610|NCT01024231|65541447|FG000|Overall Study|Disease Progression|3|||
23490611|NCT01024231|65541448|FG001|Overall Study|Disease Progression|1|||
23490612|NCT01024231|65541449|FG002|Overall Study|Disease Progression|3|||
23490613|NCT01024231|65541450|FG003|Overall Study|Disease Progression|0|||
23490614|NCT01024231|65541451|FG004|Overall Study|Disease Progression|4|||
23490615|NCT01024231|65541452|FG005|Overall Study|Disease Progression|11|||
23490616|NCT01024231|65541453|FG006|Overall Study|Disease Progression|6|||
23490617|NCT01024231|65541447|FG000|Overall Study|AE unrelated to Study Drug|0|||
23490618|NCT01024231|65541448|FG001|Overall Study|AE unrelated to Study Drug|1|||
23490619|NCT01024231|65541449|FG002|Overall Study|AE unrelated to Study Drug|0|||
23490620|NCT01024231|65541450|FG003|Overall Study|AE unrelated to Study Drug|0|||
23490621|NCT01024231|65541451|FG004|Overall Study|AE unrelated to Study Drug|0|||
23490622|NCT01024231|65541452|FG005|Overall Study|AE unrelated to Study Drug|0|||
23490623|NCT01024231|65541453|FG006|Overall Study|AE unrelated to Study Drug|0|||
23490624|NCT01024231|65541447|FG000|Overall Study|No longer meets criteria|0|||
23490625|NCT01024231|65541448|FG001|Overall Study|No longer meets criteria|0|||
23490626|NCT01024231|65541449|FG002|Overall Study|No longer meets criteria|0|||
23666293|NCT01449461|66162657|FG000|Overall Study|Site Terminated by Sponsor|0|||
23490627|NCT01024231|65541450|FG003|Overall Study|No longer meets criteria|0|||
23666294|NCT01449461|66162658|FG001|Overall Study|Site Terminated by Sponsor|1|||
23666295|NCT01449461|66162659|FG002|Overall Study|Site Terminated by Sponsor|2|||
23666296|NCT01449461|66162660|FG003|Overall Study|Site Terminated by Sponsor|3|||
23666297|NCT01449461|66162661|FG004|Overall Study|Site Terminated by Sponsor|4|||
23490628|NCT01024231|65541451|FG004|Overall Study|No longer meets criteria|1|||
23490629|NCT01024231|65541452|FG005|Overall Study|No longer meets criteria|0|||
23490630|NCT01024231|65541453|FG006|Overall Study|No longer meets criteria|1|||
23490631|NCT01024231|65541447|FG000|Overall Study|Study Drug Toxicity|1|||
23490632|NCT01024231|65541448|FG001|Overall Study|Study Drug Toxicity|6|||
23490633|NCT01024231|65541449|FG002|Overall Study|Study Drug Toxicity|6|||
23490634|NCT01024231|65541450|FG003|Overall Study|Study Drug Toxicity|4|||
23490635|NCT01024231|65541451|FG004|Overall Study|Study Drug Toxicity|2|||
23490636|NCT01024231|65541452|FG005|Overall Study|Study Drug Toxicity|0|||
23490637|NCT01024231|65541453|FG006|Overall Study|Study Drug Toxicity|7|||
23490638|NCT01024231|65541447|FG000|Overall Study|Death|6|||
23490639|NCT01024231|65541448|FG001|Overall Study|Death|2|||
23490640|NCT01024231|65541449|FG002|Overall Study|Death|1|||
23490641|NCT01024231|65541450|FG003|Overall Study|Death|0|||
23490642|NCT01024231|65541451|FG004|Overall Study|Death|4|||
23490643|NCT01024231|65541452|FG005|Overall Study|Death|3|||
23490644|NCT01024231|65541453|FG006|Overall Study|Death|5|||
23490645|NCT01024231|65541447|FG000|Overall Study|Lost to Follow-up|0|||
23490646|NCT01024231|65541448|FG001|Overall Study|Lost to Follow-up|0|||
23490647|NCT01024231|65541449|FG002|Overall Study|Lost to Follow-up|0|||
23490648|NCT01024231|65541450|FG003|Overall Study|Lost to Follow-up|0|||
23490649|NCT01024231|65541451|FG004|Overall Study|Lost to Follow-up|0|||
23666298|NCT01449461|66162662|FG005|Overall Study|Site Terminated by Sponsor|1|||
23666299|NCT01449461|66162657|FG000|Overall Study|Withdrawal by Subject|0|||
23666300|NCT01449461|66162658|FG001|Overall Study|Withdrawal by Subject|1|||
23490650|NCT01024231|65541452|FG005|Overall Study|Lost to Follow-up|0|||
23490651|NCT01024231|65541453|FG006|Overall Study|Lost to Follow-up|1|||
23490652|NCT01024231|65541447|FG000|Overall Study|Withdrew Consent|0|||
23490653|NCT01024231|65541448|FG001|Overall Study|Withdrew Consent|1|||
23490654|NCT01024231|65541449|FG002|Overall Study|Withdrew Consent|0|||
23490655|NCT01024231|65541450|FG003|Overall Study|Withdrew Consent|0|||
23490656|NCT01024231|65541451|FG004|Overall Study|Withdrew Consent|0|||
23490657|NCT01024231|65541452|FG005|Overall Study|Withdrew Consent|0|||
23490658|NCT01024231|65541453|FG006|Overall Study|Withdrew Consent|0|||
23490659|NCT01024231|65541447|FG000|Overall Study|Continuing on Treatment|0|||
23490660|NCT01024231|65541448|FG001|Overall Study|Continuing on Treatment|0|||
23490661|NCT01024231|65541449|FG002|Overall Study|Continuing on Treatment|0|||
23490662|NCT01024231|65541450|FG003|Overall Study|Continuing on Treatment|0|||
23666301|NCT01449461|66162659|FG002|Overall Study|Withdrawal by Subject|0|||
23666302|NCT01449461|66162660|FG003|Overall Study|Withdrawal by Subject|0|||
23490663|NCT01024231|65541451|FG004|Overall Study|Continuing on Treatment|3|||
23490664|NCT01024231|65541452|FG005|Overall Study|Continuing on Treatment|2|||
23490665|NCT01024231|65541453|FG006|Overall Study|Continuing on Treatment|0|||
23490666|NCT00611533|65541454|FG000|First Intervention (6 Weeks)|Never started study|0|||
23490667|NCT00611533|65541455|FG001|First Intervention (6 Weeks)|Never started study|1|||
23490668|NCT00611533|65541454|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
23666303|NCT01449461|66162661|FG004|Overall Study|Withdrawal by Subject|2|||
23490669|NCT00611533|65541455|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23490670|NCT00611533|65541454|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23490671|NCT00611533|65541455|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
23666304|NCT01449461|66162662|FG005|Overall Study|Withdrawal by Subject|1|||
23490672|NCT00694707|65541456|FG000|Overall Study|Did Not Receive Treatment|0|||
23490673|NCT00694707|65541457|FG001|Overall Study|Did Not Receive Treatment|0|||
23490674|NCT00694707|65541458|FG002|Overall Study|Did Not Receive Treatment|1|||
23490675|NCT00694707|65541459|FG003|Overall Study|Did Not Receive Treatment|1|||
23490676|NCT00694707|65541460|FG004|Overall Study|Did Not Receive Treatment|1|||
23490677|NCT00694707|65541456|FG000|Overall Study|Adverse Event|22|||
23490678|NCT00694707|65541457|FG001|Overall Study|Adverse Event|14|||
23490679|NCT00694707|65541458|FG002|Overall Study|Adverse Event|8|||
23490680|NCT00694707|65541459|FG003|Overall Study|Adverse Event|12|||
23490681|NCT00694707|65541460|FG004|Overall Study|Adverse Event|13|||
23490682|NCT00694707|65541456|FG000|Overall Study|Insufficient Therapeutic Response|33|||
23490683|NCT00694707|65541457|FG001|Overall Study|Insufficient Therapeutic Response|18|||
23490684|NCT00694707|65541458|FG002|Overall Study|Insufficient Therapeutic Response|17|||
23490685|NCT00694707|65541459|FG003|Overall Study|Insufficient Therapeutic Response|15|||
23490686|NCT00694707|65541460|FG004|Overall Study|Insufficient Therapeutic Response|10|||
23490687|NCT00694707|65541456|FG000|Overall Study|Protocol Violation|1|||
23490688|NCT00694707|65541457|FG001|Overall Study|Protocol Violation|2|||
23490689|NCT00694707|65541458|FG002|Overall Study|Protocol Violation|1|||
23490690|NCT00694707|65541459|FG003|Overall Study|Protocol Violation|3|||
23490691|NCT00694707|65541460|FG004|Overall Study|Protocol Violation|1|||
23490692|NCT00694707|65541456|FG000|Overall Study|Withdrawal of Consent|14|||
23490693|NCT00694707|65541457|FG001|Overall Study|Withdrawal of Consent|18|||
23490694|NCT00694707|65541458|FG002|Overall Study|Withdrawal of Consent|22|||
23490695|NCT00694707|65541459|FG003|Overall Study|Withdrawal of Consent|16|||
23490696|NCT00694707|65541460|FG004|Overall Study|Withdrawal of Consent|15|||
23490697|NCT00694707|65541456|FG000|Overall Study|Lost to Follow-up|0|||
23490698|NCT00694707|65541457|FG001|Overall Study|Lost to Follow-up|1|||
23490699|NCT00694707|65541458|FG002|Overall Study|Lost to Follow-up|2|||
23490700|NCT00694707|65541459|FG003|Overall Study|Lost to Follow-up|0|||
23490701|NCT00694707|65541460|FG004|Overall Study|Lost to Follow-up|0|||
23490702|NCT00694707|65541456|FG000|Overall Study|Jeopardizing Parole Status|1|||
23490703|NCT00694707|65541457|FG001|Overall Study|Jeopardizing Parole Status|0|||
23490704|NCT00694707|65541458|FG002|Overall Study|Jeopardizing Parole Status|0|||
23490705|NCT00694707|65541459|FG003|Overall Study|Jeopardizing Parole Status|0|||
23490706|NCT00694707|65541460|FG004|Overall Study|Jeopardizing Parole Status|0|||
23490707|NCT00694707|65541456|FG000|Overall Study|Death in the Family|1|||
23490708|NCT00694707|65541457|FG001|Overall Study|Death in the Family|0|||
23490709|NCT00694707|65541458|FG002|Overall Study|Death in the Family|0|||
23490710|NCT00694707|65541459|FG003|Overall Study|Death in the Family|0|||
23490711|NCT00694707|65541460|FG004|Overall Study|Death in the Family|0|||
23490712|NCT00694707|65541456|FG000|Overall Study|Arrest by Police|0|||
23490713|NCT00694707|65541457|FG001|Overall Study|Arrest by Police|1|||
23490714|NCT00694707|65541458|FG002|Overall Study|Arrest by Police|0|||
23490715|NCT00694707|65541459|FG003|Overall Study|Arrest by Police|0|||
23490716|NCT00694707|65541460|FG004|Overall Study|Arrest by Police|0|||
23490717|NCT00694707|65541456|FG000|Overall Study|Administrative Reasons|0|||
23490718|NCT00694707|65541457|FG001|Overall Study|Administrative Reasons|1|||
23490719|NCT00694707|65541458|FG002|Overall Study|Administrative Reasons|0|||
23490720|NCT00694707|65541459|FG003|Overall Study|Administrative Reasons|2|||
23490721|NCT00694707|65541460|FG004|Overall Study|Administrative Reasons|0|||
23490722|NCT00694707|65541456|FG000|Overall Study|Notification of Past Head Injury|0|||
23490723|NCT00694707|65541457|FG001|Overall Study|Notification of Past Head Injury|0|||
23490724|NCT00694707|65541458|FG002|Overall Study|Notification of Past Head Injury|0|||
23666305|NCT01449461|66162657|FG000|Overall Study|Reason not Specified|0|||
23378915|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Death|2|||
23378916|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Death|0|||
23666306|NCT01449461|66162658|FG001|Overall Study|Reason not Specified|1|||
23666307|NCT01449461|66162659|FG002|Overall Study|Reason not Specified|0|||
23666308|NCT01449461|66162660|FG003|Overall Study|Reason not Specified|3|||
23666309|NCT01449461|66162661|FG004|Overall Study|Reason not Specified|2|||
23666310|NCT01449461|66162662|FG005|Overall Study|Reason not Specified|1|||
23666311|NCT02969187|66162665|FG000|Overall Study|Physician Decision|12|||
23666312|NCT02969187|66162666|FG001|Overall Study|Physician Decision|13|||
23666313|NCT00262522|66162669|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
23378917|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378918|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378919|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
23378920|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378921|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378922|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
23378923|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
23378924|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378925|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378926|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378927|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378928|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
23378929|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
23378930|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378931|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378932|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378933|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
23378934|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378935|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
23378936|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378937|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378938|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Physician Decision|0|||
23378939|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Physician Decision|0|||
23378940|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Physician Decision|0|||
23378941|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Physician Decision|0|||
23378942|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Physician Decision|1|||
23378943|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Physician Decision|0|||
23378944|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Physician Decision|0|||
23378945|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
23378946|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
23378947|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
23378948|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
23378949|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
23378950|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
23378951|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
23378952|NCT00958074|65134061|FG000|Overall Study|Withdrawal by Subject|0|||
23378953|NCT00958074|65134062|FG001|Overall Study|Withdrawal by Subject|1|||
23378954|NCT01454284|65134063|FG000|Overall Study|Adverse Event|20|||
23378955|NCT01454284|65134064|FG001|Overall Study|Adverse Event|7|||
23378956|NCT01454284|65134063|FG000|Overall Study|Death|0|||
23378957|NCT01454284|65134064|FG001|Overall Study|Death|3|||
23378958|NCT01454284|65134063|FG000|Overall Study|Lost to Follow-up|13|||
23490725|NCT00694707|65541459|FG003|Overall Study|Notification of Past Head Injury|1|||
23378959|NCT01454284|65134064|FG001|Overall Study|Lost to Follow-up|8|||
23378960|NCT01454284|65134063|FG000|Overall Study|Protocol Violation|9|||
23490726|NCT00694707|65541460|FG004|Overall Study|Notification of Past Head Injury|0|||
23666314|NCT00262522|66162670|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
23666315|NCT00262522|66162671|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
23490727|NCT01187433|65541461|FG000|Overall Study|Protocol Violation|6|||
23490728|NCT01187433|65541462|FG001|Overall Study|Protocol Violation|2|||
23490729|NCT01187433|65541461|FG000|Overall Study|Withdrawal by Subject|5|||
23490730|NCT01187433|65541462|FG001|Overall Study|Withdrawal by Subject|2|||
23490731|NCT01385371|65541463|FG000|Overall Study|Adverse Event|54|||
23490732|NCT01385371|65541464|FG001|Overall Study|Adverse Event|19|||
23490733|NCT01385371|65541463|FG000|Overall Study|Lost to Follow-up|16|||
23490734|NCT01385371|65541464|FG001|Overall Study|Lost to Follow-up|16|||
23490735|NCT01385371|65541463|FG000|Overall Study|Withdrawal by Subject|52|||
23490736|NCT01385371|65541464|FG001|Overall Study|Withdrawal by Subject|39|||
23490737|NCT01385371|65541463|FG000|Overall Study|Protocol Violation|25|||
23490738|NCT01385371|65541464|FG001|Overall Study|Protocol Violation|21|||
23490739|NCT01385371|65541463|FG000|Overall Study|Administrative|2|||
23490740|NCT01385371|65541464|FG001|Overall Study|Administrative|2|||
23490741|NCT02805972|65541465|FG000|Washout Period|Lost to Follow-up|3|||
23490742|NCT02805972|65541466|FG001|Washout Period|Lost to Follow-up|0|||
23490743|NCT03063203|65541467|FG000|Overall Study|Chose alternative therapy|3|||
23490744|NCT03063203|65541467|FG000|Overall Study|Death|2|||
23490745|NCT03063203|65541467|FG000|Overall Study|Disease progression|4|||
23490746|NCT03063203|65541467|FG000|Overall Study|Physician Decision|5|||
23490747|NCT04122534|65541468|FG000|Overall Study|Lost to Follow-up|4|||
23490748|NCT01986907|65541471|FG000|Overall Study|Adverse Event|11|||
23490749|NCT01986907|65541471|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
23490750|NCT01986907|65541471|FG000|Overall Study|Protocol Violation|4|||
23490751|NCT01986907|65541471|FG000|Overall Study|Withdrawal by Subject|76|||
23490752|NCT01986907|65541471|FG000|Overall Study|Lost to Follow-up|38|||
23490753|NCT01986907|65541471|FG000|Overall Study|Death|9|||
23490754|NCT00447005|65541472|FG000|Overall Study|Adverse Event|1|||
23490755|NCT00447005|65541472|FG000|Overall Study|Lack of Efficacy|11|||
23490756|NCT00437320|65541478|FG000|Overall Study|Participant request|2|||
23490757|NCT00437320|65541479|FG001|Overall Study|Participant request|1|||
23490758|NCT00437320|65541480|FG002|Overall Study|Participant request|4|||
23490759|NCT01264016|65541483|FG000|Overall Study|Withdrawal by Subject|1|||
23490760|NCT01264016|65541483|FG000|Overall Study|Felt faint at sight of blood|1|||
23490761|NCT01460368|65541484|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490762|NCT01460368|65541485|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490763|NCT01460368|65541486|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490764|NCT01460368|65541487|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490765|NCT01460368|65541488|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
23490766|NCT01460368|65541489|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490767|NCT01460368|65541490|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490768|NCT01460368|65541484|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490769|NCT01460368|65541485|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
23490770|NCT01460368|65541486|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490771|NCT01460368|65541487|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490772|NCT01460368|65541488|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490773|NCT01460368|65541489|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490774|NCT01460368|65541490|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
23490775|NCT01460368|65541484|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490776|NCT01460368|65541485|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
23490777|NCT01460368|65541486|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490778|NCT01460368|65541487|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490779|NCT01460368|65541488|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23666316|NCT00262522|66162672|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
23666317|NCT00262522|66162669|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
23666318|NCT00262522|66162670|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
23666319|NCT00262522|66162671|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
23666320|NCT00262522|66162672|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
23666321|NCT00262522|66162669|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
23666322|NCT00262522|66162670|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
23666323|NCT00262522|66162671|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
23378961|NCT01454284|65134064|FG001|Overall Study|Protocol Violation|6|||
23490780|NCT01460368|65541489|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490781|NCT01460368|65541490|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490782|NCT01460368|65541484|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490783|NCT01460368|65541485|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490784|NCT01460368|65541486|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
23490785|NCT01460368|65541487|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23666324|NCT00262522|66162672|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
23666325|NCT00262522|66162669|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
23378962|NCT01454284|65134063|FG000|Overall Study|Withdrawal by Subject|58|||
23378963|NCT01454284|65134064|FG001|Overall Study|Withdrawal by Subject|36|||
23490786|NCT01460368|65541488|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490787|NCT01460368|65541489|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490788|NCT01460368|65541490|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490789|NCT01460368|65541484|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490790|NCT01460368|65541485|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490791|NCT01460368|65541486|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490792|NCT01460368|65541487|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490793|NCT01460368|65541488|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490794|NCT01460368|65541489|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490795|NCT01460368|65541490|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23378964|NCT01454284|65134063|FG000|Overall Study|Physician Decision|16|||
23378965|NCT01454284|65134064|FG001|Overall Study|Physician Decision|11|||
23378966|NCT01454284|65134063|FG000|Overall Study|Sponsor Decision|0|||
23378967|NCT01454284|65134064|FG001|Overall Study|Sponsor Decision|2|||
23378968|NCT02239328|65134065|FG000|Overall Study|Benign disease noted at time of surgery|6|||
23378969|NCT02239328|65134065|FG000|Overall Study|Equipment or website malfunction|2|||
23378970|NCT00972738|65134066|FG000|Overall Study|Adverse Event|7|||
23378971|NCT00972738|65134067|FG001|Overall Study|Adverse Event|1|||
23378972|NCT00972738|65134068|FG002|Overall Study|Adverse Event|8|||
23378973|NCT00972738|65134066|FG000|Overall Study|Protocol Violation|2|||
23378974|NCT00972738|65134067|FG001|Overall Study|Protocol Violation|1|||
23378975|NCT00972738|65134068|FG002|Overall Study|Protocol Violation|3|||
23378976|NCT00972738|65134066|FG000|Overall Study|Lost to Follow-up|1|||
23378977|NCT00972738|65134067|FG001|Overall Study|Lost to Follow-up|0|||
23378978|NCT00972738|65134068|FG002|Overall Study|Lost to Follow-up|1|||
23378979|NCT00972738|65134066|FG000|Overall Study|Lack of Efficacy|5|||
23378980|NCT00972738|65134067|FG001|Overall Study|Lack of Efficacy|1|||
23378981|NCT00972738|65134068|FG002|Overall Study|Lack of Efficacy|11|||
23378982|NCT00972738|65134066|FG000|Overall Study|Withdrawal by Subject|5|||
23378983|NCT00972738|65134067|FG001|Overall Study|Withdrawal by Subject|1|||
23378984|NCT00972738|65134068|FG002|Overall Study|Withdrawal by Subject|4|||
23378985|NCT00972738|65134066|FG000|Overall Study|Moved|0|||
23378986|NCT00972738|65134067|FG001|Overall Study|Moved|0|||
23378987|NCT00972738|65134068|FG002|Overall Study|Moved|1|||
23378988|NCT00972738|65134066|FG000|Overall Study|Other|1|||
23378989|NCT00972738|65134067|FG001|Overall Study|Other|2|||
23378990|NCT00972738|65134068|FG002|Overall Study|Other|1|||
23378991|NCT00393367|65134069|FG000|Overall Study|Protocol Violation|2|||
23378992|NCT00393367|65134070|FG001|Overall Study|Protocol Violation|5|||
23378993|NCT00393367|65134069|FG000|Overall Study|Withdrawal by Subject|0|||
23378994|NCT00393367|65134070|FG001|Overall Study|Withdrawal by Subject|2|||
23378995|NCT00876395|65134075|FG000|Overall Study|Untreated|8|||
23378996|NCT00876395|65134076|FG001|Overall Study|Untreated|1|||
23378997|NCT00876395|65134075|FG000|Overall Study|Adverse Event|63|||
23378998|NCT00876395|65134076|FG001|Overall Study|Adverse Event|11|||
23378999|NCT00876395|65134075|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23379000|NCT00876395|65134076|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23379001|NCT00876395|65134075|FG000|Overall Study|Disease progression|259|||
23379002|NCT00876395|65134076|FG001|Overall Study|Disease progression|162|||
23379003|NCT00876395|65134075|FG000|Overall Study|New cancer therapy|25|||
23379004|NCT00876395|65134076|FG001|Overall Study|New cancer therapy|7|||
23379005|NCT00876395|65134075|FG000|Overall Study|Protocol Violation|5|||
23379006|NCT00876395|65134076|FG001|Overall Study|Protocol Violation|2|||
23379007|NCT00876395|65134075|FG000|Overall Study|Withdrawal by Subject|66|||
23379008|NCT00876395|65134076|FG001|Overall Study|Withdrawal by Subject|33|||
23379009|NCT00876395|65134075|FG000|Overall Study|Lost to Follow-up|2|||
23379010|NCT00876395|65134076|FG001|Overall Study|Lost to Follow-up|0|||
23379011|NCT00876395|65134075|FG000|Overall Study|Administrative problems|39|||
23379012|NCT00876395|65134076|FG001|Overall Study|Administrative problems|23|||
23379013|NCT00876395|65134075|FG000|Overall Study|Death|12|||
23379014|NCT00876395|65134076|FG001|Overall Study|Death|0|||
23379015|NCT02421510|65134079|FG000|Overall Study|Other|4|||
23379016|NCT02421510|65134080|FG001|Overall Study|Other|2|||
23379017|NCT02421510|65134081|FG002|Overall Study|Other|3|||
23379018|NCT02421510|65134079|FG000|Overall Study|Protocol Violation|1|||
23379019|NCT02421510|65134080|FG001|Overall Study|Protocol Violation|2|||
23379020|NCT02421510|65134081|FG002|Overall Study|Protocol Violation|0|||
23379021|NCT02421510|65134079|FG000|Overall Study|Death|1|||
23379022|NCT02421510|65134080|FG001|Overall Study|Death|0|||
23379023|NCT02421510|65134081|FG002|Overall Study|Death|0|||
23379024|NCT02421510|65134079|FG000|Overall Study|Noncompliance with study drug|1|||
23379025|NCT02421510|65134080|FG001|Overall Study|Noncompliance with study drug|0|||
23379026|NCT02421510|65134081|FG002|Overall Study|Noncompliance with study drug|0|||
23379027|NCT02421510|65134079|FG000|Overall Study|Physician Decision|1|||
23379028|NCT02421510|65134080|FG001|Overall Study|Physician Decision|1|||
23379029|NCT02421510|65134081|FG002|Overall Study|Physician Decision|3|||
23379030|NCT02421510|65134079|FG000|Overall Study|Adverse Event|9|||
23379031|NCT02421510|65134080|FG001|Overall Study|Adverse Event|10|||
23379032|NCT02421510|65134081|FG002|Overall Study|Adverse Event|18|||
23379033|NCT02421510|65134079|FG000|Overall Study|Pregnancy|1|||
23379034|NCT02421510|65134080|FG001|Overall Study|Pregnancy|1|||
23379035|NCT02421510|65134081|FG002|Overall Study|Pregnancy|0|||
23666326|NCT00262522|66162670|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
23666327|NCT00262522|66162671|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
23666328|NCT00262522|66162672|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
23666329|NCT00262522|66162669|FG000|Study Start Through 8 Weeks|Death|1|||
23666330|NCT00262522|66162670|FG001|Study Start Through 8 Weeks|Death|0|||
23666331|NCT00262522|66162671|FG002|Study Start Through 8 Weeks|Death|0|||
23666332|NCT00262522|66162672|FG003|Study Start Through 8 Weeks|Death|0|||
23666333|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
23666334|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
23666335|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
23666336|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
23666337|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
23666338|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
23666339|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
23666340|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
23666341|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
23379036|NCT02421510|65134079|FG000|Overall Study|Withdrawal by Subject|14|||
23379037|NCT02421510|65134080|FG001|Overall Study|Withdrawal by Subject|18|||
23379038|NCT02421510|65134081|FG002|Overall Study|Withdrawal by Subject|12|||
23379039|NCT02421510|65134079|FG000|Overall Study|Lost to Follow-up|1|||
23379040|NCT02421510|65134080|FG001|Overall Study|Lost to Follow-up|1|||
23490796|NCT03509467|65541491|FG000|Overall Study|Withdrawal by Subject|5|||
23379041|NCT02421510|65134081|FG002|Overall Study|Lost to Follow-up|0|||
23379042|NCT04470427|65134082|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
23379043|NCT04470427|65134083|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
23490797|NCT03509467|65541492|FG001|Overall Study|Withdrawal by Subject|1|||
23379044|NCT04470427|65134084|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
23379045|NCT04470427|65134085|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
23379046|NCT04470427|65134086|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
23666342|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
23666343|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
23666344|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
23666345|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
23666346|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
23666347|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
23666348|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
23666349|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Death|2|||
23666350|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Death|0|||
23666351|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Death|1|||
23666352|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Death|0|||
23666353|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
23666354|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
23666355|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
23666356|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
23666357|NCT00262522|66162669|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
23666358|NCT00262522|66162670|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
23666359|NCT00262522|66162671|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
23666360|NCT00262522|66162672|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
23666361|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
23666362|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
23490798|NCT03509467|65541493|FG002|Overall Study|Withdrawal by Subject|6|||
23666363|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
23666364|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
23605451|NCT02991118|65943743|FG001|Overall Study|Physician Decision|1|||
23666365|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
23666366|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
23666367|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
23666368|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
23666369|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
23666370|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
23666371|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
23666372|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
23666373|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
23666374|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
23666375|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
23666376|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
23666377|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Death|2|||
23666378|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Death|0|||
23666379|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Death|2|||
23666380|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Death|0|||
23666381|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
23666382|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
23666383|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
23666384|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
23666385|NCT00262522|66162669|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
23666386|NCT00262522|66162670|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
23666387|NCT00262522|66162671|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
23666388|NCT00262522|66162672|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
23666389|NCT05003622|66162673|FG000|Overall Study|Progressive disease|2|||
23666390|NCT05003622|66162673|FG000|Overall Study|Withdrawal by Subject|1|||
23666391|NCT04053868|66162674|FG000|Overall Study|Withdrawal by Subject|1|||
23666392|NCT04053868|66162675|FG001|Overall Study|Withdrawal by Subject|0|||
23666393|NCT02839265|66162676|FG000|Overall Study|Screen Failure|2|||
23666394|NCT02839265|66162676|FG000|Overall Study|Death|1|||
23666395|NCT02839265|66162676|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
23666396|NCT04050670|66162677|FG000|Period 3|Physician Decision|0|||
23666397|NCT04050670|66162678|FG001|Period 3|Physician Decision|1|||
23666398|NCT04050670|66162679|FG002|Period 3|Physician Decision|0|||
23666399|NCT01986920|66162680|FG000|A- 101 25%|Withdrawal by Subject|1|||
23666400|NCT01986920|66162681|FG001|A- 101 25%|Withdrawal by Subject|0|||
23666401|NCT01986920|66162682|FG002|A- 101 25%|Withdrawal by Subject|0|||
23666402|NCT01986920|66162683|FG003|A- 101 25%|Withdrawal by Subject|0|||
23666403|NCT01986920|66162680|FG000|A-101 32.5%|Withdrawal by Subject|0|||
23666404|NCT01986920|66162681|FG001|A-101 32.5%|Withdrawal by Subject|1|||
23666405|NCT01986920|66162682|FG002|A-101 32.5%|Withdrawal by Subject|0|||
23666406|NCT01986920|66162683|FG003|A-101 32.5%|Withdrawal by Subject|0|||
23666407|NCT01986920|66162680|FG000|A-101 40%|Withdrawal by Subject|0|||
23666408|NCT01986920|66162681|FG001|A-101 40%|Withdrawal by Subject|0|||
23666409|NCT01986920|66162682|FG002|A-101 40%|Withdrawal by Subject|1|||
23666410|NCT01986920|66162683|FG003|A-101 40%|Withdrawal by Subject|0|||
23666411|NCT01986920|66162680|FG000|Placebo|Withdrawal by Subject|0|||
23666412|NCT01986920|66162681|FG001|Placebo|Withdrawal by Subject|0|||
23666413|NCT01986920|66162682|FG002|Placebo|Withdrawal by Subject|0|||
23666414|NCT01986920|66162683|FG003|Placebo|Withdrawal by Subject|1|||
23666415|NCT00440947|66162684|FG000|36-Week Induction Phase|Adverse Event|16|||
23666416|NCT00440947|66162685|FG001|36-Week Induction Phase|Adverse Event|0|||
23666417|NCT00440947|66162686|FG002|36-Week Induction Phase|Adverse Event|0|||
23666418|NCT00440947|66162687|FG003|36-Week Induction Phase|Adverse Event|0|||
23666419|NCT00440947|66162688|FG004|36-Week Induction Phase|Adverse Event|0|||
23666420|NCT00440947|66162684|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
23666421|NCT00440947|66162685|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23666422|NCT00440947|66162686|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23666423|NCT00440947|66162687|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23666424|NCT00440947|66162688|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23666425|NCT00440947|66162684|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
23666426|NCT00440947|66162685|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23666427|NCT00440947|66162686|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23666428|NCT00440947|66162687|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23666429|NCT00440947|66162688|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23666430|NCT00440947|66162684|FG000|36-Week Induction Phase|Non-compliance|10|||
23666431|NCT00440947|66162685|FG001|36-Week Induction Phase|Non-compliance|0|||
23666432|NCT00440947|66162686|FG002|36-Week Induction Phase|Non-compliance|0|||
23666433|NCT00440947|66162687|FG003|36-Week Induction Phase|Non-compliance|0|||
23666434|NCT00440947|66162688|FG004|36-Week Induction Phase|Non-compliance|0|||
23666435|NCT00440947|66162684|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
23666436|NCT00440947|66162685|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
23666437|NCT00440947|66162686|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
23605452|NCT02991118|65943742|FG000|Overall Study|Moved out of the country|0|||
23605453|NCT02991118|65943743|FG001|Overall Study|Moved out of the country|1|||
23605454|NCT02991118|65943742|FG000|Overall Study|Adverse Event|2|||
23605455|NCT02991118|65943743|FG001|Overall Study|Adverse Event|2|||
23605456|NCT02991118|65943742|FG000|Overall Study|Withdrawal by Subject|1|||
23605457|NCT02991118|65943743|FG001|Overall Study|Withdrawal by Subject|7|||
23605458|NCT02991118|65943742|FG000|Overall Study|Could not attend study visits|0|||
23605459|NCT02991118|65943743|FG001|Overall Study|Could not attend study visits|1|||
23605460|NCT02991118|65943742|FG000|Overall Study|Lost to Follow-up|1|||
23605461|NCT02991118|65943743|FG001|Overall Study|Lost to Follow-up|9|||
23605462|NCT02538094|65943744|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
23605463|NCT02538094|65943745|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
23666438|NCT00440947|66162687|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
23666439|NCT00440947|66162688|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
23666440|NCT00440947|66162684|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
23666441|NCT00440947|66162685|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
23666442|NCT00440947|66162686|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
23666443|NCT00440947|66162687|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
23666444|NCT00440947|66162688|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
23666445|NCT00440947|66162684|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
23666446|NCT00440947|66162685|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23666447|NCT00440947|66162686|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23666448|NCT00440947|66162687|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23666449|NCT00440947|66162688|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23666450|NCT00440947|66162684|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
23666451|NCT00440947|66162685|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
23666452|NCT00440947|66162686|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
23666453|NCT00440947|66162687|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
23666454|NCT00440947|66162688|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
23666455|NCT00440947|66162684|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
23605464|NCT02538094|65943744|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
23379047|NCT04470427|65134087|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
23379048|NCT04470427|65134082|FG000|Part B :Open-label|Other than specified|0|||
23379049|NCT04470427|65134083|FG001|Part B :Open-label|Other than specified|0|||
23379050|NCT04470427|65134084|FG002|Part B :Open-label|Other than specified|788|||
23379051|NCT04470427|65134085|FG003|Part B :Open-label|Other than specified|0|||
23379052|NCT04470427|65134086|FG004|Part B :Open-label|Other than specified|523|||
23379053|NCT04470427|65134087|FG005|Part B :Open-label|Other than specified|0|||
23379054|NCT04470427|65134082|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
23379055|NCT04470427|65134083|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
23379056|NCT04470427|65134084|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
23379057|NCT04470427|65134085|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
23605465|NCT02538094|65943745|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
23605466|NCT02707952|65943746|FG000|Overall Study|Adverse Event|1|||
23605467|NCT02707952|65943747|FG001|Overall Study|Adverse Event|0|||
23605468|NCT02707952|65943748|FG002|Overall Study|Adverse Event|0|||
23605469|NCT02707952|65943749|FG003|Overall Study|Adverse Event|0|||
23666456|NCT00440947|66162685|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23379058|NCT04470427|65134086|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
23379059|NCT04470427|65134087|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
23605470|NCT02707952|65943746|FG000|Overall Study|Lost to Follow-up|1|||
23379060|NCT04470427|65134082|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
23605471|NCT02707952|65943747|FG001|Overall Study|Lost to Follow-up|0|||
23605472|NCT02707952|65943748|FG002|Overall Study|Lost to Follow-up|0|||
23605473|NCT02707952|65943749|FG003|Overall Study|Lost to Follow-up|0|||
23605474|NCT02707952|65943746|FG000|Overall Study|Withdrawal by Subject|0|||
23605475|NCT02707952|65943747|FG001|Overall Study|Withdrawal by Subject|1|||
23605476|NCT02707952|65943748|FG002|Overall Study|Withdrawal by Subject|2|||
23490799|NCT03509467|65541494|FG003|Overall Study|Withdrawal by Subject|7|||
23490800|NCT03509467|65541495|FG004|Overall Study|Withdrawal by Subject|10|||
23490801|NCT03509467|65541496|FG005|Overall Study|Withdrawal by Subject|10|||
23490802|NCT03509467|65541497|FG006|Overall Study|Withdrawal by Subject|10|||
23490803|NCT03509467|65541498|FG007|Overall Study|Withdrawal by Subject|10|||
23490804|NCT03509467|65541491|FG000|Overall Study|Death|0|||
23490805|NCT03509467|65541492|FG001|Overall Study|Death|0|||
23490806|NCT03509467|65541493|FG002|Overall Study|Death|2|||
23490807|NCT03509467|65541494|FG003|Overall Study|Death|2|||
23490808|NCT03509467|65541495|FG004|Overall Study|Death|1|||
23490809|NCT03509467|65541496|FG005|Overall Study|Death|0|||
23605477|NCT02707952|65943749|FG003|Overall Study|Withdrawal by Subject|0|||
23605478|NCT03055988|65943750|FG000|Period 1|Adverse Event|0|||
23605479|NCT03055988|65943751|FG001|Period 1|Adverse Event|1|||
23605480|NCT03055988|65943750|FG000|Period 1|Lost to Follow-up|1|||
23605481|NCT03055988|65943751|FG001|Period 1|Lost to Follow-up|0|||
23605482|NCT03055988|65943750|FG000|Period 1|Withdrawal by Subject|0|||
23605483|NCT03055988|65943751|FG001|Period 1|Withdrawal by Subject|4|||
23605484|NCT03055988|65943750|FG000|Period 2|Adverse Event|0|||
23605485|NCT03055988|65943751|FG001|Period 2|Adverse Event|1|||
23605486|NCT03055988|65943750|FG000|Period 2|Other than listed|1|||
23605487|NCT03055988|65943751|FG001|Period 2|Other than listed|1|||
23605488|NCT02634307|65943752|FG000|Overall Study|Adverse Event|50|||
23605489|NCT02634307|65943753|FG001|Overall Study|Adverse Event|24|||
23605490|NCT02634307|65943754|FG002|Overall Study|Adverse Event|14|||
23605491|NCT02634307|65943752|FG000|Overall Study|Lost to Follow-up|21|||
23605492|NCT02634307|65943753|FG001|Overall Study|Lost to Follow-up|5|||
23605493|NCT02634307|65943754|FG002|Overall Study|Lost to Follow-up|6|||
23605494|NCT02634307|65943752|FG000|Overall Study|Pregnancy|5|||
23605495|NCT02634307|65943753|FG001|Overall Study|Pregnancy|1|||
23605496|NCT02634307|65943754|FG002|Overall Study|Pregnancy|3|||
23605497|NCT02634307|65943752|FG000|Overall Study|Withdrawal by Subject|38|||
23666457|NCT00440947|66162686|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23666458|NCT00440947|66162687|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23605498|NCT02634307|65943753|FG001|Overall Study|Withdrawal by Subject|24|||
23605499|NCT02634307|65943754|FG002|Overall Study|Withdrawal by Subject|18|||
23605500|NCT02634307|65943752|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23666459|NCT00440947|66162688|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23490810|NCT03509467|65541497|FG006|Overall Study|Death|1|||
23490811|NCT03509467|65541498|FG007|Overall Study|Death|0|||
23490812|NCT03509467|65541491|FG000|Overall Study|Proxy Withdrawal|0|||
23490813|NCT03509467|65541492|FG001|Overall Study|Proxy Withdrawal|0|||
23605501|NCT02634307|65943753|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23605502|NCT02634307|65943754|FG002|Overall Study|Non-Compliance with Study Drug|2|||
23605503|NCT02634307|65943752|FG000|Overall Study|Lack of Efficacy|1|||
23379061|NCT04470427|65134083|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
23379062|NCT04470427|65134084|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
23379063|NCT04470427|65134085|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
23379064|NCT04470427|65134086|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
23666460|NCT00440947|66162684|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
23666461|NCT00440947|66162685|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23666462|NCT00440947|66162686|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23666463|NCT00440947|66162687|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23666464|NCT00440947|66162688|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23666465|NCT00440947|66162684|FG000|36-Week Induction Phase|Incarceration|3|||
23666466|NCT00440947|66162685|FG001|36-Week Induction Phase|Incarceration|0|||
23666467|NCT00440947|66162686|FG002|36-Week Induction Phase|Incarceration|0|||
23666468|NCT00440947|66162687|FG003|36-Week Induction Phase|Incarceration|0|||
23666469|NCT00440947|66162688|FG004|36-Week Induction Phase|Incarceration|0|||
23666470|NCT00440947|66162684|FG000|36-Week Induction Phase|Pregnancy|1|||
23666471|NCT00440947|66162685|FG001|36-Week Induction Phase|Pregnancy|0|||
23666472|NCT00440947|66162686|FG002|36-Week Induction Phase|Pregnancy|0|||
23666473|NCT00440947|66162687|FG003|36-Week Induction Phase|Pregnancy|0|||
23666474|NCT00440947|66162688|FG004|36-Week Induction Phase|Pregnancy|0|||
23666475|NCT00440947|66162684|FG000|48-Week Randomization Phase|Adverse Event|0|||
23666476|NCT00440947|66162685|FG001|48-Week Randomization Phase|Adverse Event|2|||
23666477|NCT00440947|66162686|FG002|48-Week Randomization Phase|Adverse Event|5|||
23666478|NCT00440947|66162687|FG003|48-Week Randomization Phase|Adverse Event|0|||
23666479|NCT00440947|66162688|FG004|48-Week Randomization Phase|Adverse Event|0|||
23666480|NCT00440947|66162684|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23666481|NCT00440947|66162685|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
23666482|NCT00440947|66162686|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
23666483|NCT00440947|66162687|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23666484|NCT00440947|66162688|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23666485|NCT00440947|66162684|FG000|48-Week Randomization Phase|Non-compliance|0|||
23666486|NCT00440947|66162685|FG001|48-Week Randomization Phase|Non-compliance|3|||
23666487|NCT00440947|66162686|FG002|48-Week Randomization Phase|Non-compliance|4|||
23666488|NCT00440947|66162687|FG003|48-Week Randomization Phase|Non-compliance|0|||
23666489|NCT00440947|66162688|FG004|48-Week Randomization Phase|Non-compliance|0|||
23379065|NCT04470427|65134087|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
23379066|NCT02452190|65134088|FG000|Overall Study|Withdrawal by Sponsor|1|||
23379067|NCT02452190|65134089|FG001|Overall Study|Withdrawal by Sponsor|3|||
23379068|NCT02452190|65134088|FG000|Overall Study|Pregnancy|1|||
23379069|NCT02452190|65134089|FG001|Overall Study|Pregnancy|0|||
23379070|NCT02452190|65134088|FG000|Overall Study|Investigator's Decision|2|||
23379071|NCT02452190|65134089|FG001|Overall Study|Investigator's Decision|0|||
23379072|NCT02452190|65134088|FG000|Overall Study|Lack of Efficacy|3|||
23379073|NCT02452190|65134089|FG001|Overall Study|Lack of Efficacy|1|||
23379074|NCT02452190|65134088|FG000|Overall Study|Lost to Follow-up|4|||
23379075|NCT02452190|65134089|FG001|Overall Study|Lost to Follow-up|3|||
23379076|NCT02452190|65134088|FG000|Overall Study|Adverse Event|2|||
23379077|NCT02452190|65134089|FG001|Overall Study|Adverse Event|5|||
23666490|NCT00440947|66162684|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
23666491|NCT00440947|66162685|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
23666492|NCT00440947|66162686|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
23666493|NCT00440947|66162687|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
23379078|NCT02452190|65134088|FG000|Overall Study|Withdrawal by Subject|20|||
23379079|NCT02452190|65134089|FG001|Overall Study|Withdrawal by Subject|11|||
23379080|NCT02452190|65134088|FG000|Overall Study|Noncompliance with study drug|1|||
23379081|NCT02452190|65134089|FG001|Overall Study|Noncompliance with study drug|0|||
23379082|NCT02452190|65134088|FG000|Overall Study|Participant traveled abroad|1|||
23379083|NCT02452190|65134089|FG001|Overall Study|Participant traveled abroad|0|||
23379084|NCT02452190|65134088|FG000|Overall Study|Death|0|||
23379085|NCT02452190|65134089|FG001|Overall Study|Death|1|||
23379086|NCT01341470|65134090|FG000|Overall Study|Sponsor decision|0|||
23379087|NCT01341470|65134091|FG001|Overall Study|Sponsor decision|0|||
23379088|NCT01341470|65134092|FG002|Overall Study|Sponsor decision|1|||
23379089|NCT01341470|65134093|FG003|Overall Study|Sponsor decision|1|||
23379090|NCT01341470|65134094|FG004|Overall Study|Sponsor decision|0|||
23379091|NCT01341470|65134095|FG005|Overall Study|Sponsor decision|1|||
23666494|NCT00440947|66162688|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
23666495|NCT00440947|66162684|FG000|48-Week Randomization Phase|Protocol Violation|0|||
23666496|NCT00440947|66162685|FG001|48-Week Randomization Phase|Protocol Violation|0|||
23666497|NCT00440947|66162686|FG002|48-Week Randomization Phase|Protocol Violation|1|||
23666498|NCT00440947|66162687|FG003|48-Week Randomization Phase|Protocol Violation|0|||
23666499|NCT00440947|66162688|FG004|48-Week Randomization Phase|Protocol Violation|0|||
23666500|NCT00440947|66162684|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
23666501|NCT00440947|66162685|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
23666502|NCT00440947|66162686|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
23666503|NCT00440947|66162687|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
23666504|NCT00440947|66162688|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
23666505|NCT00440947|66162684|FG000|48-Week Randomization Phase|Pregnancy|0|||
23666506|NCT00440947|66162685|FG001|48-Week Randomization Phase|Pregnancy|0|||
23666507|NCT00440947|66162686|FG002|48-Week Randomization Phase|Pregnancy|1|||
23666508|NCT00440947|66162687|FG003|48-Week Randomization Phase|Pregnancy|0|||
23666509|NCT00440947|66162688|FG004|48-Week Randomization Phase|Pregnancy|0|||
23666510|NCT00440947|66162684|FG000|48-Week Randomization Phase|Incarceration|0|||
23666511|NCT00440947|66162685|FG001|48-Week Randomization Phase|Incarceration|3|||
23666512|NCT00440947|66162686|FG002|48-Week Randomization Phase|Incarceration|0|||
23666513|NCT00440947|66162687|FG003|48-Week Randomization Phase|Incarceration|0|||
23666514|NCT00440947|66162688|FG004|48-Week Randomization Phase|Incarceration|0|||
23666515|NCT00440947|66162684|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23666516|NCT00440947|66162685|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
23666517|NCT00440947|66162686|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23666518|NCT00440947|66162687|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23666519|NCT00440947|66162688|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23666520|NCT00440947|66162684|FG000|48-Week Randomization Phase|Physician Decision|0|||
23666521|NCT00440947|66162685|FG001|48-Week Randomization Phase|Physician Decision|2|||
23666522|NCT00440947|66162686|FG002|48-Week Randomization Phase|Physician Decision|0|||
23666523|NCT00440947|66162687|FG003|48-Week Randomization Phase|Physician Decision|0|||
23666524|NCT00440947|66162688|FG004|48-Week Randomization Phase|Physician Decision|0|||
23666525|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
23666526|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
23666527|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
23666528|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
23666529|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
23666530|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23666531|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23666532|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23666533|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
23666534|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
23666535|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23379092|NCT02323880|65134096|FG000|Overall Study|Adverse Event|2|||
23379093|NCT02323880|65134097|FG001|Overall Study|Adverse Event|0|||
23379094|NCT02323880|65134098|FG002|Overall Study|Adverse Event|1|||
23379095|NCT02323880|65134099|FG003|Overall Study|Adverse Event|1|||
23379096|NCT02323880|65134100|FG004|Overall Study|Adverse Event|1|||
23379097|NCT02323880|65134101|FG005|Overall Study|Adverse Event|0|||
23666536|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23666537|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23605504|NCT02634307|65943753|FG001|Overall Study|Lack of Efficacy|5|||
23605505|NCT02634307|65943754|FG002|Overall Study|Lack of Efficacy|3|||
23605506|NCT02634307|65943752|FG000|Overall Study|Physician Decision|7|||
23379098|NCT02323880|65134102|FG006|Overall Study|Adverse Event|1|||
23379099|NCT02323880|65134103|FG007|Overall Study|Adverse Event|0|||
23379100|NCT02323880|65134096|FG000|Overall Study|Death|0|||
23379101|NCT02323880|65134097|FG001|Overall Study|Death|0|||
23379102|NCT02323880|65134098|FG002|Overall Study|Death|0|||
23379103|NCT02323880|65134099|FG003|Overall Study|Death|0|||
23379104|NCT02323880|65134100|FG004|Overall Study|Death|0|||
23379105|NCT02323880|65134101|FG005|Overall Study|Death|1|||
23379106|NCT02323880|65134102|FG006|Overall Study|Death|0|||
23379107|NCT02323880|65134103|FG007|Overall Study|Death|0|||
23379108|NCT02323880|65134096|FG000|Overall Study|Lack of Efficacy|4|||
23379109|NCT02323880|65134097|FG001|Overall Study|Lack of Efficacy|11|||
23379110|NCT02323880|65134098|FG002|Overall Study|Lack of Efficacy|5|||
23379111|NCT02323880|65134099|FG003|Overall Study|Lack of Efficacy|5|||
23379112|NCT02323880|65134100|FG004|Overall Study|Lack of Efficacy|4|||
23379113|NCT02323880|65134101|FG005|Overall Study|Lack of Efficacy|8|||
23379114|NCT02323880|65134102|FG006|Overall Study|Lack of Efficacy|4|||
23379115|NCT02323880|65134103|FG007|Overall Study|Lack of Efficacy|6|||
23379116|NCT02323880|65134096|FG000|Overall Study|Physician Decision|0|||
23379117|NCT02323880|65134097|FG001|Overall Study|Physician Decision|0|||
23379118|NCT02323880|65134098|FG002|Overall Study|Physician Decision|0|||
23379119|NCT02323880|65134099|FG003|Overall Study|Physician Decision|0|||
23379120|NCT02323880|65134100|FG004|Overall Study|Physician Decision|1|||
23379121|NCT02323880|65134101|FG005|Overall Study|Physician Decision|1|||
23379122|NCT02323880|65134102|FG006|Overall Study|Physician Decision|1|||
23379123|NCT02323880|65134103|FG007|Overall Study|Physician Decision|0|||
23605507|NCT02634307|65943753|FG001|Overall Study|Physician Decision|5|||
23605508|NCT02634307|65943754|FG002|Overall Study|Physician Decision|5|||
23605509|NCT02634307|65943752|FG000|Overall Study|Reason not Specified|3|||
23605510|NCT02634307|65943753|FG001|Overall Study|Reason not Specified|5|||
23605511|NCT02634307|65943754|FG002|Overall Study|Reason not Specified|10|||
23605512|NCT02915783|65943755|FG000|Overall Study|Death|21|||
23605513|NCT02915783|65943755|FG000|Overall Study|Lost to Follow-up|1|||
23605514|NCT02915783|65943755|FG000|Overall Study|Withdrawal by Subject|2|||
23605515|NCT01584648|65946957|FG000|Overall Study|Death|136|||
23605516|NCT01584648|65946958|FG001|Overall Study|Death|146|||
23605517|NCT01584648|65946957|FG000|Overall Study|Lost to Follow-up|9|||
23605518|NCT01584648|65946958|FG001|Overall Study|Lost to Follow-up|9|||
23605519|NCT01584648|65946957|FG000|Overall Study|Investigator discretion|3|||
23605520|NCT01584648|65946958|FG001|Overall Study|Investigator discretion|2|||
23379124|NCT02323880|65134096|FG000|Overall Study|Withdrawal by Subject|0|||
23379125|NCT02323880|65134097|FG001|Overall Study|Withdrawal by Subject|2|||
23379126|NCT02323880|65134098|FG002|Overall Study|Withdrawal by Subject|0|||
23605521|NCT01584648|65946957|FG000|Overall Study|Withdrew consent|13|||
23379127|NCT02323880|65134099|FG003|Overall Study|Withdrawal by Subject|0|||
23605522|NCT01584648|65946958|FG001|Overall Study|Withdrew consent|4|||
23605523|NCT01584648|65946957|FG000|Overall Study|Study closed/terminated|50|||
23379128|NCT02323880|65134100|FG004|Overall Study|Withdrawal by Subject|0|||
23379129|NCT02323880|65134101|FG005|Overall Study|Withdrawal by Subject|0|||
23379130|NCT02323880|65134102|FG006|Overall Study|Withdrawal by Subject|0|||
23379131|NCT02323880|65134103|FG007|Overall Study|Withdrawal by Subject|0|||
23379132|NCT02008370|65134104|FG000|Overall Study|Lost to Follow-up|7|||
23379133|NCT02181738|65134105|FG000|Overall Study|Participant Withdrew Consent|2|||
23379134|NCT02181738|65134106|FG001|Overall Study|Participant Withdrew Consent|1|||
23379135|NCT02181738|65134107|FG002|Overall Study|Participant Withdrew Consent|1|||
23379136|NCT02181738|65134108|FG003|Overall Study|Participant Withdrew Consent|1|||
23379137|NCT02181738|65134105|FG000|Overall Study|Lost to Follow-up|1|||
23379138|NCT02181738|65134106|FG001|Overall Study|Lost to Follow-up|2|||
23379139|NCT02181738|65134107|FG002|Overall Study|Lost to Follow-up|1|||
23379140|NCT02181738|65134108|FG003|Overall Study|Lost to Follow-up|1|||
23379141|NCT02181738|65134105|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379142|NCT02181738|65134106|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379143|NCT02181738|65134107|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379144|NCT02181738|65134108|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
23379145|NCT02181738|65134105|FG000|Overall Study|Poor/Non-Compliance|1|||
23379146|NCT02181738|65134106|FG001|Overall Study|Poor/Non-Compliance|0|||
23379147|NCT02181738|65134107|FG002|Overall Study|Poor/Non-Compliance|2|||
23379148|NCT02181738|65134108|FG003|Overall Study|Poor/Non-Compliance|1|||
23379149|NCT02181738|65134105|FG000|Overall Study|Disease Progression|28|||
23379150|NCT02181738|65134106|FG001|Overall Study|Disease Progression|35|||
23379151|NCT02181738|65134107|FG002|Overall Study|Disease Progression|40|||
23379152|NCT02181738|65134108|FG003|Overall Study|Disease Progression|0|||
23379153|NCT02181738|65134105|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
23379154|NCT02181738|65134106|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
23379155|NCT02181738|65134107|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
23379156|NCT02181738|65134108|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
23379157|NCT02181738|65134105|FG000|Overall Study|Study Drug Toxicity|6|||
23379158|NCT02181738|65134106|FG001|Overall Study|Study Drug Toxicity|11|||
23379159|NCT02181738|65134107|FG002|Overall Study|Study Drug Toxicity|8|||
23379160|NCT02181738|65134108|FG003|Overall Study|Study Drug Toxicity|1|||
23379161|NCT02181738|65134105|FG000|Overall Study|Other Reasons|14|||
23379162|NCT02181738|65134106|FG001|Overall Study|Other Reasons|16|||
23379163|NCT02181738|65134107|FG002|Overall Study|Other Reasons|28|||
23379164|NCT02181738|65134108|FG003|Overall Study|Other Reasons|0|||
23379165|NCT02181738|65134105|FG000|Overall Study|Maximum Clinical Benefit|3|||
23379166|NCT02181738|65134106|FG001|Overall Study|Maximum Clinical Benefit|0|||
23379167|NCT02181738|65134107|FG002|Overall Study|Maximum Clinical Benefit|1|||
23379168|NCT02181738|65134108|FG003|Overall Study|Maximum Clinical Benefit|0|||
23379169|NCT02181738|65134105|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23379170|NCT02181738|65134106|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23490814|NCT03509467|65541493|FG002|Overall Study|Proxy Withdrawal|0|||
23379171|NCT02181738|65134107|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23379172|NCT02181738|65134108|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23379173|NCT02187055|65134111|FG000|Overall Study|Lack of Efficacy|10|||
23379174|NCT02187055|65134112|FG001|Overall Study|Lack of Efficacy|3|||
23379175|NCT02187055|65134113|FG002|Overall Study|Lack of Efficacy|7|||
23605524|NCT01584648|65946958|FG001|Overall Study|Study closed/terminated|23|||
23605525|NCT01584648|65946957|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
23666538|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
23666539|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
23666540|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
23666541|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
23666542|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
23666543|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
23666544|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
23666545|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23666546|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23666547|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23605526|NCT01584648|65946958|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
23605527|NCT00310037|65946960|FG000|Overall Study|Adverse Event|7|||
23605528|NCT00310037|65946961|FG001|Overall Study|Adverse Event|14|||
23605529|NCT00310037|65946960|FG000|Overall Study|Withdrawal by Subject|4|||
23605530|NCT00310037|65946961|FG001|Overall Study|Withdrawal by Subject|3|||
23605531|NCT00310037|65946960|FG000|Overall Study|Progression|6|||
23605532|NCT00310037|65946961|FG001|Overall Study|Progression|0|||
23605533|NCT00310037|65946960|FG000|Overall Study|Non-protocol treatment|1|||
23605534|NCT00310037|65946961|FG001|Overall Study|Non-protocol treatment|0|||
23605535|NCT03128099|65946962|FG000|Overall Study|High dose task was too long|0|||
23605536|NCT03128099|65946963|FG001|Overall Study|High dose task was too long|4|||
23605537|NCT03128099|65946964|FG002|Overall Study|High dose task was too long|0|||
23605538|NCT03128099|65946962|FG000|Overall Study|Participant got a full time job.|1|||
23605539|NCT03128099|65946963|FG001|Overall Study|Participant got a full time job.|0|||
23605540|NCT03128099|65946964|FG002|Overall Study|Participant got a full time job.|0|||
23379176|NCT02187055|65134111|FG000|Overall Study|Lost to Follow-up|2|||
23605541|NCT03128099|65946962|FG000|Overall Study|Became homeless and lost contact|1|||
23605542|NCT03128099|65946963|FG001|Overall Study|Became homeless and lost contact|0|||
23666548|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
23666549|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
23490815|NCT03509467|65541494|FG003|Overall Study|Proxy Withdrawal|0|||
23490816|NCT03509467|65541495|FG004|Overall Study|Proxy Withdrawal|0|||
23490817|NCT03509467|65541496|FG005|Overall Study|Proxy Withdrawal|0|||
23490818|NCT03509467|65541497|FG006|Overall Study|Proxy Withdrawal|0|||
23490819|NCT03509467|65541498|FG007|Overall Study|Proxy Withdrawal|1|||
23490820|NCT00071396|65541499|FG000|Overall Study|Withdrawal by Subject|1|||
23490821|NCT00071396|65541499|FG000|Overall Study|Physician Decision|2|||
23490822|NCT01303861|65541500|FG000|Overall Study|Lost to Follow-up|34|||
23490823|NCT01303861|65541501|FG001|Overall Study|Lost to Follow-up|14|||
23490824|NCT01303861|65541502|FG002|Overall Study|Lost to Follow-up|27|||
23490825|NCT01303861|65541503|FG003|Overall Study|Lost to Follow-up|31|||
23490826|NCT01303861|65541500|FG000|Overall Study|Lack of Efficacy|3|||
23490827|NCT01303861|65541501|FG001|Overall Study|Lack of Efficacy|2|||
23490828|NCT01303861|65541502|FG002|Overall Study|Lack of Efficacy|1|||
23490829|NCT01303861|65541503|FG003|Overall Study|Lack of Efficacy|0|||
23490830|NCT01303861|65541500|FG000|Overall Study|Withdrawal by Subject|16|||
23490831|NCT01303861|65541501|FG001|Overall Study|Withdrawal by Subject|8|||
23490832|NCT01303861|65541502|FG002|Overall Study|Withdrawal by Subject|8|||
23490833|NCT01303861|65541503|FG003|Overall Study|Withdrawal by Subject|23|||
23490834|NCT01303861|65541500|FG000|Overall Study|Adverse Event|4|||
23490835|NCT01303861|65541501|FG001|Overall Study|Adverse Event|1|||
23490836|NCT01303861|65541502|FG002|Overall Study|Adverse Event|0|||
23490837|NCT01303861|65541503|FG003|Overall Study|Adverse Event|5|||
23490838|NCT01303861|65541500|FG000|Overall Study|Pregnancy|1|||
23605543|NCT03128099|65946964|FG002|Overall Study|Became homeless and lost contact|0|||
23605544|NCT03128099|65946962|FG000|Overall Study|Did not complete all the assessments|0|||
23605545|NCT03128099|65946963|FG001|Overall Study|Did not complete all the assessments|0|||
23605546|NCT03128099|65946964|FG002|Overall Study|Did not complete all the assessments|1|||
23605547|NCT03615404|65946965|FG000|Overall Study|Death|1|||
23605548|NCT03615404|65946965|FG000|Overall Study|vaccine did not pass quality assurance|1|||
23605549|NCT02039401|65946967|FG000|Overall Study|Adverse Event|0|||
23605550|NCT02039401|65946968|FG001|Overall Study|Adverse Event|1|||
23605551|NCT00983294|65946969|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
23605552|NCT00983294|65946969|FG000|Colchicine With Azithromycin|Adverse Event|1|||
23605553|NCT01801007|65946970|FG000|Overall Study|Adverse Event|2|||
23605554|NCT01801007|65946970|FG000|Overall Study|Lost to Follow-up|4|||
23605555|NCT01801007|65946970|FG000|Overall Study|Withdrawal by Subject|5|||
23605556|NCT02736188|65946974|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
23605557|NCT02736188|65946974|FG000|Overall Study|Adverse Event|1|||
23605558|NCT02736188|65946974|FG000|Overall Study|Withdrawal by Subject|1|||
23605559|NCT02736188|65946974|FG000|Overall Study|Other|6|||
23605560|NCT00929526|65946978|FG000|Overall Study|Withdrawal by Subject|1|||
23605561|NCT00929526|65946979|FG001|Overall Study|Withdrawal by Subject|11|||
23605562|NCT00929526|65946978|FG000|Overall Study|Lost to Follow-up|8|||
23605563|NCT00929526|65946979|FG001|Overall Study|Lost to Follow-up|12|||
23605564|NCT00929526|65946978|FG000|Overall Study|Other|8|||
23605565|NCT00929526|65946979|FG001|Overall Study|Other|6|||
23605566|NCT03137784|65946983|FG000|Overall Study|Adverse Event|1|||
23605567|NCT03137784|65946984|FG001|Overall Study|Adverse Event|1|||
23605568|NCT03137784|65946985|FG002|Overall Study|Adverse Event|0|||
23605569|NCT03137784|65946986|FG003|Overall Study|Adverse Event|0|||
23605570|NCT03137784|65946987|FG004|Overall Study|Adverse Event|0|||
23605571|NCT03137784|65946988|FG005|Overall Study|Adverse Event|0|||
23605572|NCT03137784|65946983|FG000|Overall Study|Subject/guardian decision|1|||
23605573|NCT03137784|65946984|FG001|Overall Study|Subject/guardian decision|0|||
23605574|NCT03137784|65946985|FG002|Overall Study|Subject/guardian decision|0|||
23605575|NCT03137784|65946986|FG003|Overall Study|Subject/guardian decision|0|||
23605576|NCT03137784|65946987|FG004|Overall Study|Subject/guardian decision|0|||
23605577|NCT03137784|65946988|FG005|Overall Study|Subject/guardian decision|0|||
23605578|NCT03137784|65946983|FG000|Overall Study|Non-compliance with study treatment|0|||
23605579|NCT03137784|65946984|FG001|Overall Study|Non-compliance with study treatment|0|||
23605580|NCT03137784|65946985|FG002|Overall Study|Non-compliance with study treatment|0|||
23605581|NCT03137784|65946986|FG003|Overall Study|Non-compliance with study treatment|0|||
23605582|NCT03137784|65946987|FG004|Overall Study|Non-compliance with study treatment|1|||
23490839|NCT01303861|65541501|FG001|Overall Study|Pregnancy|0|||
23490840|NCT01303861|65541502|FG002|Overall Study|Pregnancy|0|||
23490841|NCT01303861|65541503|FG003|Overall Study|Pregnancy|0|||
23490842|NCT03438383|65541504|FG000|Overall Study|Protocol Violation|9|||
23605583|NCT03137784|65946988|FG005|Overall Study|Non-compliance with study treatment|0|||
23605584|NCT00681109|65946989|FG000|Overall Study|Lost to Follow-up|2|||
23605585|NCT00681109|65946990|FG001|Overall Study|Lost to Follow-up|6|||
23605586|NCT00681109|65946991|FG002|Overall Study|Lost to Follow-up|0|||
23605587|NCT03345979|65946992|FG000|Overall Study|Withdrawal by Subject|20|||
23605588|NCT03345979|65946993|FG001|Overall Study|Withdrawal by Subject|31|||
23605589|NCT03345979|65946992|FG000|Overall Study|Adverse Event|10|||
23490843|NCT03438383|65541505|FG001|Overall Study|Protocol Violation|3|||
23490844|NCT00338104|65541506|FG000|Overall Study|Protocol Violation|2|||
23490845|NCT00338104|65541507|FG001|Overall Study|Protocol Violation|1|||
23490846|NCT00338104|65541508|FG002|Overall Study|Protocol Violation|3|||
23490847|NCT04761822|65541513|FG000|Overall Study|Adverse Event|3|||
23490848|NCT04761822|65541514|FG001|Overall Study|Adverse Event|1|||
23490849|NCT04761822|65541515|FG002|Overall Study|Adverse Event|1|||
23490850|NCT04761822|65541516|FG003|Overall Study|Adverse Event|3|||
23490851|NCT04761822|65541513|FG000|Overall Study|Lost to Follow-up|1|||
23490852|NCT04761822|65541514|FG001|Overall Study|Lost to Follow-up|0|||
23490853|NCT04761822|65541515|FG002|Overall Study|Lost to Follow-up|2|||
23490854|NCT04761822|65541516|FG003|Overall Study|Lost to Follow-up|3|||
23490855|NCT04761822|65541513|FG000|Overall Study|Physician Decision|0|||
23490856|NCT04761822|65541514|FG001|Overall Study|Physician Decision|1|||
23666550|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
23666551|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
23490857|NCT04761822|65541515|FG002|Overall Study|Physician Decision|0|||
23490858|NCT04761822|65541516|FG003|Overall Study|Physician Decision|0|||
23490859|NCT04761822|65541513|FG000|Overall Study|Withdrawal by Subject|3|||
23490860|NCT04761822|65541514|FG001|Overall Study|Withdrawal by Subject|8|||
23490861|NCT04761822|65541515|FG002|Overall Study|Withdrawal by Subject|1|||
23490862|NCT04761822|65541516|FG003|Overall Study|Withdrawal by Subject|11|||
23490863|NCT04761822|65541513|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
23490864|NCT04761822|65541514|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490865|NCT04761822|65541515|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490866|NCT04761822|65541516|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490867|NCT04761822|65541513|FG000|Overall Study|Participant requested unblinding|0|||
23490868|NCT04761822|65541514|FG001|Overall Study|Participant requested unblinding|0|||
23490869|NCT04761822|65541515|FG002|Overall Study|Participant requested unblinding|0|||
23490870|NCT04761822|65541516|FG003|Overall Study|Participant requested unblinding|1|||
23490871|NCT03605212|65541518|FG000|Treatment Period|Adverse Event|1|||
23490872|NCT03605212|65541519|FG001|Treatment Period|Adverse Event|0|||
23490873|NCT03605212|65541520|FG002|Treatment Period|Adverse Event|0|||
23490874|NCT03605212|65541521|FG003|Treatment Period|Adverse Event|0|||
23490875|NCT03605212|65541522|FG004|Treatment Period|Adverse Event|0|||
23490876|NCT03605212|65541518|FG000|Treatment Period|Physician Decision|0|||
23490877|NCT03605212|65541519|FG001|Treatment Period|Physician Decision|0|||
23490878|NCT03605212|65541520|FG002|Treatment Period|Physician Decision|0|||
23490879|NCT03605212|65541521|FG003|Treatment Period|Physician Decision|0|||
23490880|NCT03605212|65541522|FG004|Treatment Period|Physician Decision|1|||
23490881|NCT02322021|65541527|FG000|Core Phase|Adverse Event|1|||
23490882|NCT02322021|65541528|FG001|Core Phase|Adverse Event|3|||
23605590|NCT03345979|65946993|FG001|Overall Study|Adverse Event|11|||
23605591|NCT03345979|65946992|FG000|Overall Study|Lost to Follow-up|8|||
23605592|NCT03345979|65946993|FG001|Overall Study|Lost to Follow-up|9|||
23605593|NCT03345979|65946992|FG000|Overall Study|Lack of Efficacy|4|||
23605594|NCT03345979|65946993|FG001|Overall Study|Lack of Efficacy|2|||
23666552|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
23605595|NCT03345979|65946992|FG000|Overall Study|Protocol Violation|1|||
23605596|NCT03345979|65946993|FG001|Overall Study|Protocol Violation|3|||
23605597|NCT03345979|65946992|FG000|Overall Study|Physician Decision|0|||
23605598|NCT03345979|65946993|FG001|Overall Study|Physician Decision|2|||
23605599|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605600|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605601|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
23605602|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605603|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605604|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
23605605|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
23605606|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
23605607|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
23605608|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
23605609|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23605610|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
23605611|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23605612|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23490883|NCT02322021|65541529|FG002|Core Phase|Adverse Event|4|||
23490884|NCT02322021|65541530|FG003|Core Phase|Adverse Event|2|||
23490885|NCT02322021|65541531|FG004|Core Phase|Adverse Event|0|||
23490886|NCT02322021|65541527|FG000|Core Phase|Participant Choice|4|||
23490887|NCT02322021|65541528|FG001|Core Phase|Participant Choice|5|||
23605613|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23490888|NCT02322021|65541529|FG002|Core Phase|Participant Choice|4|||
23490889|NCT02322021|65541530|FG003|Core Phase|Participant Choice|2|||
23490890|NCT02322021|65541531|FG004|Core Phase|Participant Choice|0|||
23490891|NCT02322021|65541527|FG000|Core Phase|Lost to Follow-up|0|||
23605614|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23605615|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23490892|NCT02322021|65541528|FG001|Core Phase|Lost to Follow-up|0|||
23490893|NCT02322021|65541529|FG002|Core Phase|Lost to Follow-up|0|||
23490894|NCT02322021|65541530|FG003|Core Phase|Lost to Follow-up|1|||
23490895|NCT02322021|65541531|FG004|Core Phase|Lost to Follow-up|0|||
23490896|NCT02322021|65541527|FG000|Core Phase|Other|0|||
23490897|NCT02322021|65541528|FG001|Core Phase|Other|0|||
23490898|NCT02322021|65541529|FG002|Core Phase|Other|1|||
23490899|NCT02322021|65541530|FG003|Core Phase|Other|0|||
23490900|NCT02322021|65541531|FG004|Core Phase|Other|0|||
23490901|NCT02322021|65541527|FG000|Extension Phase|Adverse Event|0|||
23490902|NCT02322021|65541528|FG001|Extension Phase|Adverse Event|0|||
23490903|NCT02322021|65541529|FG002|Extension Phase|Adverse Event|0|||
23490904|NCT02322021|65541530|FG003|Extension Phase|Adverse Event|0|||
23490905|NCT02322021|65541531|FG004|Extension Phase|Adverse Event|3|||
23490906|NCT02322021|65541527|FG000|Extension Phase|Participant Choice|0|||
23490907|NCT02322021|65541528|FG001|Extension Phase|Participant Choice|0|||
23490908|NCT02322021|65541529|FG002|Extension Phase|Participant Choice|0|||
23490909|NCT02322021|65541530|FG003|Extension Phase|Participant Choice|0|||
23490910|NCT02322021|65541531|FG004|Extension Phase|Participant Choice|6|||
23490911|NCT02322021|65541527|FG000|Extension Phase|Other|0|||
23490912|NCT02322021|65541528|FG001|Extension Phase|Other|0|||
23490913|NCT02322021|65541529|FG002|Extension Phase|Other|0|||
23490914|NCT02322021|65541530|FG003|Extension Phase|Other|0|||
23490915|NCT02322021|65541531|FG004|Extension Phase|Other|3|||
23490916|NCT02322021|65541527|FG000|Extension Phase|Lost to Follow-up|0|||
23490917|NCT02322021|65541528|FG001|Extension Phase|Lost to Follow-up|0|||
23490918|NCT02322021|65541529|FG002|Extension Phase|Lost to Follow-up|0|||
23490919|NCT02322021|65541530|FG003|Extension Phase|Lost to Follow-up|0|||
23490920|NCT02322021|65541531|FG004|Extension Phase|Lost to Follow-up|1|||
23490921|NCT02322021|65541527|FG000|Extension Phase|Study terminated by sponsor|0|||
23490922|NCT02322021|65541528|FG001|Extension Phase|Study terminated by sponsor|0|||
23490923|NCT02322021|65541529|FG002|Extension Phase|Study terminated by sponsor|0|||
23490924|NCT02322021|65541530|FG003|Extension Phase|Study terminated by sponsor|0|||
23490925|NCT02322021|65541531|FG004|Extension Phase|Study terminated by sponsor|28|||
23490926|NCT03516812|65541535|FG000|Overall Study|Adverse Event|4|||
23490927|NCT03516812|65541535|FG000|Overall Study|Lack of Efficacy|2|||
23490928|NCT00147251|65541536|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
23490929|NCT00147251|65541537|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
23490930|NCT03894046|65541538|FG000|Overall Study|Protocol Violation|1|||
23490931|NCT03894046|65541539|FG001|Overall Study|Protocol Violation|0|||
23490932|NCT03894046|65541540|FG002|Overall Study|Protocol Violation|0|||
23490933|NCT03894046|65541538|FG000|Overall Study|Adverse Event|0|||
23490934|NCT03894046|65541539|FG001|Overall Study|Adverse Event|1|||
23490935|NCT03894046|65541540|FG002|Overall Study|Adverse Event|0|||
23490936|NCT03894046|65541538|FG000|Overall Study|Withdrawal by Subject|2|||
23490937|NCT03894046|65541539|FG001|Overall Study|Withdrawal by Subject|3|||
23490938|NCT03894046|65541540|FG002|Overall Study|Withdrawal by Subject|1|||
23490939|NCT03894046|65541538|FG000|Overall Study|Death|15|||
23490940|NCT03894046|65541539|FG001|Overall Study|Death|21|||
23490941|NCT03894046|65541540|FG002|Overall Study|Death|4|||
23490942|NCT03894046|65541538|FG000|Overall Study|No growth of ABC|2|||
23490943|NCT03894046|65541539|FG001|Overall Study|No growth of ABC|1|||
23490944|NCT03894046|65541540|FG002|Overall Study|No growth of ABC|0|||
23490945|NCT03894046|65541538|FG000|Overall Study|Physician Decision|1|||
23490946|NCT03894046|65541539|FG001|Overall Study|Physician Decision|1|||
23490947|NCT03894046|65541540|FG002|Overall Study|Physician Decision|1|||
23490948|NCT03894046|65541538|FG000|Overall Study|Prohibited concomitant medication|1|||
23490949|NCT03894046|65541539|FG001|Overall Study|Prohibited concomitant medication|0|||
23490950|NCT03894046|65541540|FG002|Overall Study|Prohibited concomitant medication|0|||
23490951|NCT03894046|65541538|FG000|Overall Study|Transferred to other arm/group|1|||
23490952|NCT03894046|65541539|FG001|Overall Study|Transferred to other arm/group|1|||
23490953|NCT03894046|65541540|FG002|Overall Study|Transferred to other arm/group|0|||
23490954|NCT00573248|65541541|FG000|Overall Study|scheduling conflicts|15|||
23490955|NCT00573248|65541542|FG001|Overall Study|scheduling conflicts|11|||
23490956|NCT02155881|65541543|FG000|Overall Study|Withdrawal by Subject|0|||
23490957|NCT02155881|65541544|FG001|Overall Study|Withdrawal by Subject|2|||
23490958|NCT02155881|65541543|FG000|Overall Study|Inappropriately randomized|2|||
23490959|NCT02155881|65541544|FG001|Overall Study|Inappropriately randomized|2|||
23490960|NCT01601132|65541545|FG000|Overall Study|Patient withdrew consent|1|||
23490961|NCT01601132|65541545|FG000|Overall Study|Protocol deviation|1|||
23490962|NCT01397201|65541546|FG000|Overall Study|Not treated|0|||
23490963|NCT01397201|65541547|FG001|Overall Study|Not treated|0|||
23490964|NCT01397201|65541548|FG002|Overall Study|Not treated|1|||
23490965|NCT01397201|65541549|FG003|Overall Study|Not treated|0|||
23490966|NCT01397201|65541550|FG004|Overall Study|Not treated|0|||
23490967|NCT01397201|65541546|FG000|Overall Study|Not yet defined|3|||
23490968|NCT01397201|65541547|FG001|Overall Study|Not yet defined|6|||
23490969|NCT01397201|65541548|FG002|Overall Study|Not yet defined|5|||
23490970|NCT01397201|65541549|FG003|Overall Study|Not yet defined|5|||
23490971|NCT01397201|65541550|FG004|Overall Study|Not yet defined|4|||
23490972|NCT01397201|65541546|FG000|Overall Study|Adverse Event|2|||
23490973|NCT01397201|65541547|FG001|Overall Study|Adverse Event|0|||
23490974|NCT01397201|65541548|FG002|Overall Study|Adverse Event|0|||
23605616|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23379177|NCT02187055|65134112|FG001|Overall Study|Lost to Follow-up|7|||
23379178|NCT02187055|65134113|FG002|Overall Study|Lost to Follow-up|3|||
23379179|NCT02187055|65134111|FG000|Overall Study|No longer meets eligibility criteria|0|||
23379180|NCT02187055|65134112|FG001|Overall Study|No longer meets eligibility criteria|2|||
23379181|NCT02187055|65134113|FG002|Overall Study|No longer meets eligibility criteria|0|||
23379182|NCT02187055|65134111|FG000|Overall Study|No longer willing to participate|6|||
23379183|NCT02187055|65134112|FG001|Overall Study|No longer willing to participate|8|||
23379184|NCT02187055|65134113|FG002|Overall Study|No longer willing to participate|10|||
23379185|NCT02187055|65134111|FG000|Overall Study|Other|5|||
23379186|NCT02187055|65134112|FG001|Overall Study|Other|6|||
23379187|NCT02187055|65134113|FG002|Overall Study|Other|3|||
23379188|NCT02187055|65134111|FG000|Overall Study|Protocol Violation|9|||
23379189|NCT02187055|65134112|FG001|Overall Study|Protocol Violation|9|||
23379190|NCT02187055|65134113|FG002|Overall Study|Protocol Violation|4|||
23379191|NCT02187055|65134111|FG000|Overall Study|Pregnancy|3|||
23379192|NCT02187055|65134112|FG001|Overall Study|Pregnancy|1|||
23379193|NCT02187055|65134113|FG002|Overall Study|Pregnancy|0|||
23379194|NCT02187055|65134111|FG000|Overall Study|Withdrawal by Subject|11|||
23379195|NCT02187055|65134112|FG001|Overall Study|Withdrawal by Subject|11|||
23379196|NCT02187055|65134113|FG002|Overall Study|Withdrawal by Subject|11|||
23379197|NCT02187055|65134111|FG000|Overall Study|Adverse Event|21|||
23379198|NCT02187055|65134112|FG001|Overall Study|Adverse Event|26|||
23379199|NCT02187055|65134113|FG002|Overall Study|Adverse Event|36|||
23379200|NCT02187055|65134111|FG000|Overall Study|Death|2|||
23379201|NCT02187055|65134112|FG001|Overall Study|Death|0|||
23379202|NCT02187055|65134113|FG002|Overall Study|Death|0|||
23379203|NCT01078545|65134117|FG000|Overall Study|Lost to Follow-up|13|||
23379204|NCT01078545|65134117|FG000|Overall Study|Physician Decision|6|||
23379205|NCT01078545|65134117|FG000|Overall Study|Withdrawal by Subject|3|||
23379206|NCT01078545|65134117|FG000|Overall Study|Death|3|||
23379207|NCT01078545|65134117|FG000|Overall Study|Participant moved to another physician|1|||
23379208|NCT01407367|65134118|FG000|Overall Study|Death|24|||
23379209|NCT01407367|65134119|FG001|Overall Study|Death|32|||
23379210|NCT01407367|65134118|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
23379211|NCT01407367|65134119|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
23379212|NCT01407367|65134118|FG000|Overall Study|Withdrawal by Subject|4|||
23379213|NCT01407367|65134119|FG001|Overall Study|Withdrawal by Subject|15|||
23379214|NCT01407367|65134118|FG000|Overall Study|Lost to Follow-up|0|||
23379215|NCT01407367|65134119|FG001|Overall Study|Lost to Follow-up|2|||
23379216|NCT00976027|65134120|FG000|Overall Study|Serious Adverse Event|36|||
23379217|NCT00976027|65134121|FG001|Overall Study|Serious Adverse Event|17|||
23379218|NCT00976027|65134120|FG000|Overall Study|Adverse Event|0|||
23379219|NCT00976027|65134121|FG001|Overall Study|Adverse Event|2|||
23379220|NCT00976027|65134120|FG000|Overall Study|Protocol Violation|60|||
23379221|NCT00976027|65134121|FG001|Overall Study|Protocol Violation|27|||
23379222|NCT00976027|65134120|FG000|Overall Study|Lost to Follow-up|208|||
23379223|NCT00976027|65134121|FG001|Overall Study|Lost to Follow-up|103|||
23379224|NCT00976027|65134120|FG000|Overall Study|Withdrawal by Subject|107|||
23379225|NCT00976027|65134121|FG001|Overall Study|Withdrawal by Subject|66|||
23379226|NCT02100631|65134127|FG000|Overall Study|Withdrawal by Subject|1|||
23379227|NCT02100631|65134128|FG001|Overall Study|Withdrawal by Subject|0|||
23379228|NCT02100631|65134129|FG002|Overall Study|Withdrawal by Subject|0|||
23379229|NCT02100631|65134127|FG000|Overall Study|Lost to Follow-up|3|||
23379230|NCT02100631|65134128|FG001|Overall Study|Lost to Follow-up|4|||
23379231|NCT02100631|65134129|FG002|Overall Study|Lost to Follow-up|0|||
23379232|NCT02100631|65134127|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
23379233|NCT02100631|65134128|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
23490975|NCT01397201|65541549|FG003|Overall Study|Adverse Event|0|||
23490976|NCT01397201|65541550|FG004|Overall Study|Adverse Event|0|||
23379234|NCT02100631|65134129|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
23379235|NCT01143324|65134134|FG000|Overall Study|Lost to Follow-up|11|||
23379236|NCT01143324|65134134|FG000|Overall Study|Withdrawal by Subject|4|||
23379237|NCT01143324|65134134|FG000|Overall Study|Explant of the device|4|||
23379238|NCT01164475|65134135|FG000|Overall Study|Lack of Efficacy|1|||
23379239|NCT01164475|65134136|FG001|Overall Study|Lack of Efficacy|0|||
23379240|NCT01164475|65134135|FG000|Overall Study|Other|0|||
23379241|NCT01164475|65134136|FG001|Overall Study|Other|1|||
23379242|NCT01164475|65134135|FG000|Overall Study|Progressive disease|0|||
23379243|NCT01164475|65134136|FG001|Overall Study|Progressive disease|1|||
23379244|NCT01164475|65134135|FG000|Overall Study|Protocol Violation|1|||
23379245|NCT01164475|65134136|FG001|Overall Study|Protocol Violation|0|||
23379246|NCT00614393|65134137|FG000|Overall Study|Adverse Event|20|||
23379247|NCT00614393|65134138|FG001|Overall Study|Adverse Event|2|||
23379248|NCT00614393|65134139|FG002|Overall Study|Adverse Event|3|||
23379249|NCT00614393|65134140|FG003|Overall Study|Adverse Event|13|||
23379250|NCT00614393|65134141|FG004|Overall Study|Adverse Event|21|||
23379251|NCT00614393|65134137|FG000|Overall Study|Lost to Follow-up|0|||
23379252|NCT00614393|65134138|FG001|Overall Study|Lost to Follow-up|0|||
23379253|NCT00614393|65134139|FG002|Overall Study|Lost to Follow-up|0|||
23379254|NCT00614393|65134140|FG003|Overall Study|Lost to Follow-up|1|||
23379255|NCT00614393|65134141|FG004|Overall Study|Lost to Follow-up|2|||
23379256|NCT00614393|65134137|FG000|Overall Study|Physician Decision|17|||
23379257|NCT00614393|65134138|FG001|Overall Study|Physician Decision|0|||
23379258|NCT00614393|65134139|FG002|Overall Study|Physician Decision|1|||
23379259|NCT00614393|65134140|FG003|Overall Study|Physician Decision|8|||
23379260|NCT00614393|65134141|FG004|Overall Study|Physician Decision|9|||
23379261|NCT00614393|65134137|FG000|Overall Study|Progressive Disease|118|||
23379262|NCT00614393|65134138|FG001|Overall Study|Progressive Disease|5|||
23379263|NCT00614393|65134139|FG002|Overall Study|Progressive Disease|5|||
23379264|NCT00614393|65134140|FG003|Overall Study|Progressive Disease|138|||
23379265|NCT00614393|65134141|FG004|Overall Study|Progressive Disease|130|||
23379266|NCT00614393|65134137|FG000|Overall Study|Protocol Violation|1|||
23379267|NCT00614393|65134138|FG001|Overall Study|Protocol Violation|0|||
23379268|NCT00614393|65134139|FG002|Overall Study|Protocol Violation|0|||
23379269|NCT00614393|65134140|FG003|Overall Study|Protocol Violation|0|||
23379270|NCT00614393|65134141|FG004|Overall Study|Protocol Violation|0|||
23379271|NCT00614393|65134137|FG000|Overall Study|Terminated by Sponsor|0|||
23379272|NCT00614393|65134138|FG001|Overall Study|Terminated by Sponsor|0|||
23379273|NCT00614393|65134139|FG002|Overall Study|Terminated by Sponsor|0|||
23379274|NCT00614393|65134140|FG003|Overall Study|Terminated by Sponsor|0|||
23379275|NCT00614393|65134141|FG004|Overall Study|Terminated by Sponsor|1|||
23379276|NCT00614393|65134137|FG000|Overall Study|Withdrawal by Subject|20|||
23379277|NCT00614393|65134138|FG001|Overall Study|Withdrawal by Subject|1|||
23379278|NCT00614393|65134139|FG002|Overall Study|Withdrawal by Subject|1|||
23379279|NCT00614393|65134140|FG003|Overall Study|Withdrawal by Subject|16|||
23379280|NCT00614393|65134141|FG004|Overall Study|Withdrawal by Subject|13|||
23379281|NCT00614393|65134137|FG000|Overall Study|Other|4|||
23379282|NCT00614393|65134138|FG001|Overall Study|Other|0|||
23379283|NCT00614393|65134139|FG002|Overall Study|Other|0|||
23379284|NCT00614393|65134140|FG003|Overall Study|Other|4|||
23379285|NCT00614393|65134141|FG004|Overall Study|Other|2|||
23379286|NCT00614393|65134137|FG000|Overall Study|Not Treated|0|||
23379287|NCT00614393|65134138|FG001|Overall Study|Not Treated|0|||
23379288|NCT00614393|65134139|FG002|Overall Study|Not Treated|0|||
23379289|NCT00614393|65134140|FG003|Overall Study|Not Treated|0|||
23379290|NCT00614393|65134141|FG004|Overall Study|Not Treated|2|||
23379291|NCT01482221|65134142|FG000|Overall Study|Lack of Efficacy|1|||
23379292|NCT01482221|65134143|FG001|Overall Study|Lack of Efficacy|0|||
23379293|NCT01482221|65134144|FG002|Overall Study|Lack of Efficacy|1|||
23379294|NCT01482221|65134142|FG000|Overall Study|Lost to Follow-up|3|||
23379295|NCT01482221|65134143|FG001|Overall Study|Lost to Follow-up|2|||
23490977|NCT01323946|65541555|FG000|Overall Study|Lost to Follow-up|0|||
23490978|NCT01323946|65541556|FG001|Overall Study|Lost to Follow-up|1|||
23379296|NCT01482221|65134144|FG002|Overall Study|Lost to Follow-up|1|||
23379297|NCT01482221|65134142|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
23379298|NCT01482221|65134143|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
23379299|NCT01482221|65134144|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
23379300|NCT01482221|65134142|FG000|Overall Study|Condition under Investigation Worsened|3|||
23379301|NCT01482221|65134143|FG001|Overall Study|Condition under Investigation Worsened|2|||
23379302|NCT01482221|65134144|FG002|Overall Study|Condition under Investigation Worsened|4|||
23379303|NCT01482221|65134142|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23379304|NCT01482221|65134143|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
23490979|NCT01323946|65541557|FG002|Overall Study|Lost to Follow-up|0|||
23379305|NCT01482221|65134144|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23379306|NCT01482221|65134142|FG000|Overall Study|Adverse Event|1|||
23379307|NCT01482221|65134143|FG001|Overall Study|Adverse Event|7|||
23379308|NCT01482221|65134144|FG002|Overall Study|Adverse Event|3|||
23379309|NCT01482221|65134142|FG000|Overall Study|Withdrawal by Subject|10|||
23379310|NCT01482221|65134143|FG001|Overall Study|Withdrawal by Subject|7|||
23379311|NCT01482221|65134144|FG002|Overall Study|Withdrawal by Subject|12|||
23379312|NCT01482221|65134142|FG000|Overall Study|Incorrect randomization|0|||
23379313|NCT01482221|65134143|FG001|Overall Study|Incorrect randomization|1|||
23379314|NCT01482221|65134144|FG002|Overall Study|Incorrect randomization|0|||
23379315|NCT01482221|65134142|FG000|Overall Study|Physician Decision|0|||
23379316|NCT01482221|65134143|FG001|Overall Study|Physician Decision|1|||
23379317|NCT01482221|65134144|FG002|Overall Study|Physician Decision|0|||
23379318|NCT04871113|65134145|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379319|NCT04871113|65134146|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379320|NCT04871113|65134147|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379321|NCT04871113|65134148|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379322|NCT04871113|65134149|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379323|NCT04871113|65134150|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
23379324|NCT04871113|65134151|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379325|NCT04871113|65134152|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379326|NCT04871113|65134153|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379327|NCT04871113|65134154|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379328|NCT04871113|65134145|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379329|NCT04871113|65134146|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379330|NCT04871113|65134147|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379331|NCT04871113|65134148|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379332|NCT04871113|65134149|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379333|NCT04871113|65134150|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379334|NCT04871113|65134151|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
23379335|NCT04871113|65134152|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
23379336|NCT04871113|65134153|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379337|NCT04871113|65134154|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379338|NCT05177094|65134160|FG000|Overall Study|Adverse Event|5|||
23379339|NCT05177094|65134161|FG001|Overall Study|Adverse Event|5|||
23379340|NCT05177094|65134160|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
23379341|NCT05177094|65134161|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
23379342|NCT05177094|65134160|FG000|Overall Study|Protocol Deviation|3|||
23379343|NCT05177094|65134161|FG001|Overall Study|Protocol Deviation|0|||
23379344|NCT05177094|65134160|FG000|Overall Study|Withdrawal by Subject|6|||
23379345|NCT05177094|65134161|FG001|Overall Study|Withdrawal by Subject|3|||
23379346|NCT05177094|65134160|FG000|Overall Study|Participant could not tolerate long study visits|1|||
23379347|NCT05177094|65134161|FG001|Overall Study|Participant could not tolerate long study visits|0|||
23379348|NCT00580840|65134164|FG000|Run-in|Adverse Event|17|||
23379349|NCT00580840|65134165|FG001|Run-in|Adverse Event|0|||
23379350|NCT00580840|65134166|FG002|Run-in|Adverse Event|0|||
23379351|NCT00580840|65134167|FG003|Run-in|Adverse Event|0|||
23379352|NCT00580840|65134164|FG000|Run-in|Lack of Efficacy|93|||
23379353|NCT00580840|65134165|FG001|Run-in|Lack of Efficacy|0|||
23379354|NCT00580840|65134166|FG002|Run-in|Lack of Efficacy|0|||
23379355|NCT00580840|65134167|FG003|Run-in|Lack of Efficacy|0|||
23379356|NCT00580840|65134164|FG000|Run-in|Loss of Efficacy|1|||
23379357|NCT00580840|65134165|FG001|Run-in|Loss of Efficacy|0|||
23379358|NCT00580840|65134166|FG002|Run-in|Loss of Efficacy|0|||
23379359|NCT00580840|65134167|FG003|Run-in|Loss of Efficacy|0|||
23379360|NCT00580840|65134164|FG000|Run-in|Lost to Follow-up|4|||
23379361|NCT00580840|65134165|FG001|Run-in|Lost to Follow-up|0|||
23379362|NCT00580840|65134166|FG002|Run-in|Lost to Follow-up|0|||
23379363|NCT00580840|65134167|FG003|Run-in|Lost to Follow-up|0|||
23379364|NCT00580840|65134164|FG000|Run-in|Withdrawal by Subject|5|||
23379365|NCT00580840|65134165|FG001|Run-in|Withdrawal by Subject|0|||
23379366|NCT00580840|65134166|FG002|Run-in|Withdrawal by Subject|0|||
23490980|NCT01323946|65541555|FG000|Overall Study|Parents refused the last blood draw|1|||
23490981|NCT01323946|65541556|FG001|Overall Study|Parents refused the last blood draw|0|||
23490982|NCT01323946|65541557|FG002|Overall Study|Parents refused the last blood draw|0|||
23490983|NCT01323946|65541555|FG000|Overall Study|Withdrawal by Subject|2|||
23490984|NCT01323946|65541556|FG001|Overall Study|Withdrawal by Subject|2|||
23490985|NCT01323946|65541557|FG002|Overall Study|Withdrawal by Subject|0|||
23490986|NCT00537238|65541558|FG000|Overall Study|Death|1|||
23490987|NCT00537238|65541559|FG001|Overall Study|Death|2|||
23490988|NCT00537238|65541558|FG000|Overall Study|Adverse Event|31|||
23490989|NCT00537238|65541559|FG001|Overall Study|Adverse Event|22|||
23490990|NCT00537238|65541558|FG000|Overall Study|Lack of Efficacy|20|||
23490991|NCT00537238|65541559|FG001|Overall Study|Lack of Efficacy|21|||
23379367|NCT00580840|65134167|FG003|Run-in|Withdrawal by Subject|0|||
23379368|NCT00580840|65134164|FG000|Run-in|Other: Per Sponsor Request|2|||
23379369|NCT00580840|65134165|FG001|Run-in|Other: Per Sponsor Request|0|||
23379370|NCT00580840|65134166|FG002|Run-in|Other: Per Sponsor Request|0|||
23379371|NCT00580840|65134167|FG003|Run-in|Other: Per Sponsor Request|0|||
23666553|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
23666554|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
23666555|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23666556|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23605617|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
23605618|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
23605619|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23666557|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23605620|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605621|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
23605622|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605623|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605624|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
23605625|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605626|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605627|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
23605628|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605629|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
23605630|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605631|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605632|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605633|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
23605634|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
23605635|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605636|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605637|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605638|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605639|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
23605640|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
23605641|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
23605642|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
23666558|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
23605643|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
23605644|NCT01683409|65947000|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605645|NCT01683409|65947001|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605646|NCT01683409|65947002|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23666559|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
23666560|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
23666561|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
23666562|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
23666563|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
23666564|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
23666565|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
23666566|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
23666567|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
23666568|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
23666569|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
23666570|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
23666571|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
23666572|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
23666573|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
23605647|NCT01683409|65947003|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605648|NCT01683409|65947004|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
23605649|NCT01683409|65947000|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605650|NCT01683409|65947001|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605651|NCT01683409|65947002|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
23605652|NCT01683409|65947003|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605653|NCT01683409|65947004|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605654|NCT00620854|65947007|FG000|Washout 1|Withdrawal by Subject|0|||
23605655|NCT00620854|65947008|FG001|Washout 1|Withdrawal by Subject|0|||
23605656|NCT00620854|65947009|FG002|Washout 1|Withdrawal by Subject|1|||
23666574|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
23666575|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23666576|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23666577|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23666578|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
23666579|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
23666580|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Other|0|||
23666581|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Other|0|||
23666582|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Other|0|||
23666583|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Other|1|||
23666584|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Other|0|||
23666585|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
23666586|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
23666587|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
23666588|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
23666589|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
23666590|NCT00440947|66162684|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23666591|NCT00440947|66162685|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23666592|NCT00440947|66162686|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23605657|NCT00620854|65947010|FG003|Washout 1|Withdrawal by Subject|1|||
23605658|NCT00620854|65947011|FG004|Washout 1|Withdrawal by Subject|0|||
23605659|NCT00620854|65947012|FG005|Washout 1|Withdrawal by Subject|0|||
23605660|NCT01240785|65947016|FG000|Overall Study|Lost to Follow-up|1|||
23605661|NCT01240785|65947017|FG001|Overall Study|Lost to Follow-up|0|||
23605662|NCT01240785|65947016|FG000|Overall Study|Protocol Violation|0|||
23605663|NCT01240785|65947017|FG001|Overall Study|Protocol Violation|3|||
23605664|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
23605665|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
23605666|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23666593|NCT00440947|66162687|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23666594|NCT00440947|66162688|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
23666595|NCT00361270|66162689|FG000|Overall Study|Death|0|||
23666596|NCT00361270|66162690|FG001|Overall Study|Death|0|||
23666597|NCT00361270|66162691|FG002|Overall Study|Death|0|||
23666598|NCT00361270|66162692|FG003|Overall Study|Death|2|||
23666599|NCT00361270|66162689|FG000|Overall Study|Lost to Follow-up|4|||
23666600|NCT00361270|66162690|FG001|Overall Study|Lost to Follow-up|1|||
23666601|NCT00361270|66162691|FG002|Overall Study|Lost to Follow-up|0|||
23666602|NCT00361270|66162692|FG003|Overall Study|Lost to Follow-up|0|||
23666603|NCT00361270|66162689|FG000|Overall Study|Physician Decision|0|||
23666604|NCT00361270|66162690|FG001|Overall Study|Physician Decision|0|||
23666605|NCT00361270|66162691|FG002|Overall Study|Physician Decision|1|||
23666606|NCT00361270|66162692|FG003|Overall Study|Physician Decision|0|||
23666607|NCT00361270|66162689|FG000|Overall Study|Protocol Violation|9|||
23666608|NCT00361270|66162690|FG001|Overall Study|Protocol Violation|4|||
23666609|NCT00361270|66162691|FG002|Overall Study|Protocol Violation|5|||
23666610|NCT00361270|66162692|FG003|Overall Study|Protocol Violation|4|||
23666611|NCT00361270|66162689|FG000|Overall Study|Withdrawal by Subject|6|||
23666612|NCT00361270|66162690|FG001|Overall Study|Withdrawal by Subject|6|||
23666613|NCT00361270|66162691|FG002|Overall Study|Withdrawal by Subject|3|||
23666614|NCT00361270|66162692|FG003|Overall Study|Withdrawal by Subject|7|||
23666615|NCT00361270|66162689|FG000|Overall Study|Afraid of Hypnosis|1|||
23666616|NCT00361270|66162690|FG001|Overall Study|Afraid of Hypnosis|2|||
23666617|NCT00361270|66162691|FG002|Overall Study|Afraid of Hypnosis|0|||
23666618|NCT00361270|66162692|FG003|Overall Study|Afraid of Hypnosis|0|||
23666619|NCT00361270|66162689|FG000|Overall Study|Problems with Transportation|4|||
23666620|NCT00361270|66162690|FG001|Overall Study|Problems with Transportation|0|||
23666621|NCT00361270|66162691|FG002|Overall Study|Problems with Transportation|0|||
23666622|NCT00361270|66162692|FG003|Overall Study|Problems with Transportation|0|||
23666623|NCT00361270|66162689|FG000|Overall Study|Adverse Event|0|||
23666624|NCT00361270|66162690|FG001|Overall Study|Adverse Event|1|||
23666625|NCT00361270|66162691|FG002|Overall Study|Adverse Event|1|||
23666626|NCT00361270|66162692|FG003|Overall Study|Adverse Event|0|||
23666627|NCT02121262|66162693|FG000|Overall Study|Adverse Event|6|||
23666628|NCT02121262|66162694|FG001|Overall Study|Adverse Event|3|||
23666629|NCT02121262|66162693|FG000|Overall Study|Lack of Efficacy|3|||
23666630|NCT02121262|66162694|FG001|Overall Study|Lack of Efficacy|0|||
23666631|NCT02121262|66162693|FG000|Overall Study|Personal Reasons|19|||
23666632|NCT02121262|66162694|FG001|Overall Study|Personal Reasons|5|||
23666633|NCT02121262|66162693|FG000|Overall Study|Protocol Violation|1|||
23666634|NCT02121262|66162694|FG001|Overall Study|Protocol Violation|1|||
23666635|NCT02121262|66162693|FG000|Overall Study|Participant Dropped-out|0|||
23666636|NCT02121262|66162694|FG001|Overall Study|Participant Dropped-out|1|||
23666637|NCT02121262|66162693|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
23666638|NCT02121262|66162694|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
23666639|NCT02121262|66162693|FG000|Overall Study|Consent Withdrawn|1|||
23666640|NCT02121262|66162694|FG001|Overall Study|Consent Withdrawn|0|||
23379372|NCT00580840|65134164|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
23379373|NCT00580840|65134165|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23379374|NCT00580840|65134166|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23379375|NCT00580840|65134167|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23666641|NCT00957528|66162698|FG000|Overall Study|Protocol Violation|0|||
23379376|NCT00580840|65134164|FG000|Run-in|Other: Exclusionary Lab Value|1|||
23666642|NCT00957528|66162699|FG001|Overall Study|Protocol Violation|1|||
23666643|NCT00957528|66162700|FG002|Overall Study|Protocol Violation|0|||
23666644|NCT00957528|66162698|FG000|Overall Study|Withdrawal by Subject|0|||
23666645|NCT00957528|66162699|FG001|Overall Study|Withdrawal by Subject|0|||
23490992|NCT00537238|65541558|FG000|Overall Study|Lost to Follow-up|12|||
23666646|NCT00957528|66162700|FG002|Overall Study|Withdrawal by Subject|1|||
23666647|NCT00950664|66162702|FG000|First Intervention|Lost to Follow-up|1|||
23666648|NCT00950664|66162703|FG001|First Intervention|Lost to Follow-up|3|||
23379377|NCT00580840|65134165|FG001|Run-in|Other: Exclusionary Lab Value|0|||
23379378|NCT00580840|65134166|FG002|Run-in|Other: Exclusionary Lab Value|0|||
23379379|NCT00580840|65134167|FG003|Run-in|Other: Exclusionary Lab Value|0|||
23379380|NCT00580840|65134164|FG000|Double-Blind|Adverse Event|0|||
23379381|NCT00580840|65134165|FG001|Double-Blind|Adverse Event|3|||
23379382|NCT00580840|65134166|FG002|Double-Blind|Adverse Event|4|||
23379383|NCT00580840|65134167|FG003|Double-Blind|Adverse Event|1|||
23379384|NCT00580840|65134164|FG000|Double-Blind|Loss of Efficacy|0|||
23379385|NCT00580840|65134165|FG001|Double-Blind|Loss of Efficacy|1|||
23379386|NCT00580840|65134166|FG002|Double-Blind|Loss of Efficacy|2|||
23379387|NCT00580840|65134167|FG003|Double-Blind|Loss of Efficacy|10|||
23379388|NCT00580840|65134164|FG000|Double-Blind|Lost to Follow-up|0|||
23379389|NCT00580840|65134165|FG001|Double-Blind|Lost to Follow-up|1|||
23379390|NCT00580840|65134166|FG002|Double-Blind|Lost to Follow-up|0|||
23379391|NCT00580840|65134167|FG003|Double-Blind|Lost to Follow-up|2|||
23490993|NCT00537238|65541559|FG001|Overall Study|Lost to Follow-up|8|||
23490994|NCT00537238|65541558|FG000|Overall Study|Withdrawal by Subject|51|||
23490995|NCT00537238|65541559|FG001|Overall Study|Withdrawal by Subject|47|||
23490996|NCT00537238|65541558|FG000|Overall Study|Protocol Violation|15|||
23490997|NCT00537238|65541559|FG001|Overall Study|Protocol Violation|19|||
23490998|NCT00537238|65541558|FG000|Overall Study|Does not meet entrance criteria|0|||
23490999|NCT00537238|65541559|FG001|Overall Study|Does not meet entrance criteria|2|||
23491000|NCT00537238|65541558|FG000|Overall Study|Other|44|||
23491001|NCT00537238|65541559|FG001|Overall Study|Other|52|||
23491002|NCT02128932|65541560|FG000|Overall Study|Withdrawal by Subject|11|||
23491003|NCT02128932|65541561|FG001|Overall Study|Withdrawal by Subject|7|||
23491004|NCT02128932|65541562|FG002|Overall Study|Withdrawal by Subject|8|||
23491005|NCT02128932|65541560|FG000|Overall Study|Death|2|||
23491006|NCT02128932|65541561|FG001|Overall Study|Death|0|||
23491007|NCT02128932|65541562|FG002|Overall Study|Death|2|||
23491008|NCT02128932|65541560|FG000|Overall Study|Lost to Follow-up|2|||
23491009|NCT02128932|65541561|FG001|Overall Study|Lost to Follow-up|1|||
23491010|NCT02128932|65541562|FG002|Overall Study|Lost to Follow-up|1|||
23491011|NCT02128932|65541560|FG000|Overall Study|No reason for withdrawal|12|||
23491012|NCT02128932|65541561|FG001|Overall Study|No reason for withdrawal|11|||
23491013|NCT02128932|65541562|FG002|Overall Study|No reason for withdrawal|7|||
23491014|NCT02395666|65541565|FG000|Overall Study|Physician Decision|3|||
23491015|NCT02395666|65541566|FG001|Overall Study|Physician Decision|0|||
23491016|NCT02395666|65541565|FG000|Overall Study|Lost to Follow-up|1|||
23491017|NCT02395666|65541566|FG001|Overall Study|Lost to Follow-up|0|||
23491018|NCT02395666|65541565|FG000|Overall Study|Withdrawal by Subject|2|||
23491019|NCT02395666|65541566|FG001|Overall Study|Withdrawal by Subject|1|||
23491020|NCT01347307|65541567|FG000|Overall Study|Death|0|||
23491021|NCT01347307|65541568|FG001|Overall Study|Death|4|||
23491022|NCT01347307|65541567|FG000|Overall Study|Physician Decision|0|||
23491023|NCT01347307|65541568|FG001|Overall Study|Physician Decision|1|||
23491024|NCT03511664|65541569|FG000|Overall Study|Treatment ongoing|49|||
23491025|NCT03511664|65541570|FG001|Overall Study|Treatment ongoing|5|||
23491026|NCT03511664|65541569|FG000|Overall Study|Entered long-term follow-up|140|||
23491027|NCT03511664|65541570|FG001|Overall Study|Entered long-term follow-up|50|||
23491028|NCT03511664|65541569|FG000|Overall Study|Withdrawal by Subject|29|||
23491029|NCT03511664|65541570|FG001|Overall Study|Withdrawal by Subject|53|||
23491030|NCT03511664|65541569|FG000|Overall Study|Lost to Follow-up|4|||
23491031|NCT03511664|65541570|FG001|Overall Study|Lost to Follow-up|4|||
23491032|NCT03511664|65541569|FG000|Overall Study|Physician Decision|0|||
23491033|NCT03511664|65541570|FG001|Overall Study|Physician Decision|1|||
23491034|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
23491035|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491036|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491037|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23666649|NCT00950664|66162702|FG000|First Intervention|Withdrawal by Subject|2|||
23666650|NCT00950664|66162703|FG001|First Intervention|Withdrawal by Subject|2|||
23379392|NCT00580840|65134164|FG000|Double-Blind|Withdrawal by Subject|0|||
23379393|NCT00580840|65134165|FG001|Double-Blind|Withdrawal by Subject|1|||
23379394|NCT00580840|65134166|FG002|Double-Blind|Withdrawal by Subject|2|||
23379395|NCT00580840|65134167|FG003|Double-Blind|Withdrawal by Subject|2|||
23491038|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23666651|NCT01073267|66162704|FG000|Overall Study|Disease Progression|3|||
23491039|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491040|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491041|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
23379396|NCT00580840|65134164|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
23379397|NCT00580840|65134165|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
23379398|NCT00580840|65134166|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
23379399|NCT00580840|65134167|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
23379400|NCT00580840|65134164|FG000|Double-Blind|Other: Forbidden Medication|0|||
23379401|NCT00580840|65134165|FG001|Double-Blind|Other: Forbidden Medication|0|||
23379402|NCT00580840|65134166|FG002|Double-Blind|Other: Forbidden Medication|1|||
23379403|NCT00580840|65134167|FG003|Double-Blind|Other: Forbidden Medication|0|||
23379404|NCT00283959|65134168|FG000|Extension Period|Low Compliance|1|||
23379405|NCT03677401|65134169|FG000|Overall Study|Adverse Event|4|||
23379406|NCT03677401|65134170|FG001|Overall Study|Adverse Event|14|||
23379407|NCT03677401|65134169|FG000|Overall Study|Lack of Efficacy|3|||
23379408|NCT03677401|65134170|FG001|Overall Study|Lack of Efficacy|1|||
23379409|NCT03677401|65134169|FG000|Overall Study|Withdrawal by Subject|2|||
23379410|NCT03677401|65134170|FG001|Overall Study|Withdrawal by Subject|2|||
23379411|NCT03677401|65134169|FG000|Overall Study|Sponsor decision|0|||
23379412|NCT03677401|65134170|FG001|Overall Study|Sponsor decision|1|||
23379413|NCT03677401|65134169|FG000|Overall Study|Reason Unspecified|1|||
23379414|NCT03677401|65134170|FG001|Overall Study|Reason Unspecified|0|||
23379415|NCT02065557|65134171|FG000|Induction Period|Withdrawal by Subject|2|||
23379416|NCT02065557|65134172|FG001|Induction Period|Withdrawal by Subject|1|||
23379417|NCT02065557|65134173|FG002|Induction Period|Withdrawal by Subject|0|||
23379418|NCT02065557|65134174|FG003|Induction Period|Withdrawal by Subject|0|||
23379419|NCT02065557|65134175|FG004|Induction Period|Withdrawal by Subject|0|||
23379420|NCT02065557|65134176|FG005|Induction Period|Withdrawal by Subject|0|||
23379421|NCT02065557|65134171|FG000|Induction Period|Lack of Efficacy|2|||
23379422|NCT02065557|65134172|FG001|Induction Period|Lack of Efficacy|1|||
23379423|NCT02065557|65134173|FG002|Induction Period|Lack of Efficacy|1|||
23379424|NCT02065557|65134174|FG003|Induction Period|Lack of Efficacy|0|||
23379425|NCT02065557|65134175|FG004|Induction Period|Lack of Efficacy|0|||
23379426|NCT02065557|65134176|FG005|Induction Period|Lack of Efficacy|0|||
23379427|NCT02065557|65134171|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379428|NCT02065557|65134172|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379429|NCT02065557|65134173|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379430|NCT02065557|65134174|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379431|NCT02065557|65134175|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379432|NCT02065557|65134176|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379433|NCT02065557|65134171|FG000|Induction Period|Non-Responder at Week 8|4|||
23379434|NCT02065557|65134172|FG001|Induction Period|Non-Responder at Week 8|4|||
23379435|NCT02065557|65134173|FG002|Induction Period|Non-Responder at Week 8|0|||
23379436|NCT02065557|65134174|FG003|Induction Period|Non-Responder at Week 8|0|||
23379437|NCT02065557|65134175|FG004|Induction Period|Non-Responder at Week 8|0|||
23379438|NCT02065557|65134176|FG005|Induction Period|Non-Responder at Week 8|0|||
23379439|NCT02065557|65134171|FG000|Induction Period|Adverse Event|1|||
23379440|NCT02065557|65134172|FG001|Induction Period|Adverse Event|1|||
23379441|NCT02065557|65134173|FG002|Induction Period|Adverse Event|0|||
23379442|NCT02065557|65134174|FG003|Induction Period|Adverse Event|0|||
23379443|NCT02065557|65134175|FG004|Induction Period|Adverse Event|0|||
23379444|NCT02065557|65134176|FG005|Induction Period|Adverse Event|0|||
23379445|NCT02065557|65134171|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379446|NCT02065557|65134172|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379447|NCT02065557|65134173|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379448|NCT02065557|65134174|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
23379449|NCT02065557|65134175|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
23379450|NCT02065557|65134176|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379451|NCT02065557|65134171|FG000|Maintenance Period|Withdrawal by Subject|0|||
23379452|NCT02065557|65134172|FG001|Maintenance Period|Withdrawal by Subject|0|||
23379453|NCT02065557|65134173|FG002|Maintenance Period|Withdrawal by Subject|0|||
23379454|NCT02065557|65134174|FG003|Maintenance Period|Withdrawal by Subject|0|||
23379455|NCT02065557|65134175|FG004|Maintenance Period|Withdrawal by Subject|2|||
23379456|NCT02065557|65134176|FG005|Maintenance Period|Withdrawal by Subject|1|||
23379457|NCT02065557|65134171|FG000|Maintenance Period|Lack of Efficacy|0|||
23379458|NCT02065557|65134172|FG001|Maintenance Period|Lack of Efficacy|0|||
23379459|NCT02065557|65134173|FG002|Maintenance Period|Lack of Efficacy|0|||
23379460|NCT02065557|65134174|FG003|Maintenance Period|Lack of Efficacy|0|||
23379461|NCT02065557|65134175|FG004|Maintenance Period|Lack of Efficacy|5|||
23379462|NCT02065557|65134176|FG005|Maintenance Period|Lack of Efficacy|2|||
23379463|NCT02065557|65134171|FG000|Maintenance Period|Subject Non-Compliance|0|||
23379464|NCT02065557|65134172|FG001|Maintenance Period|Subject Non-Compliance|0|||
23379465|NCT02065557|65134173|FG002|Maintenance Period|Subject Non-Compliance|0|||
23379466|NCT02065557|65134174|FG003|Maintenance Period|Subject Non-Compliance|0|||
23379467|NCT02065557|65134175|FG004|Maintenance Period|Subject Non-Compliance|0|||
23379468|NCT02065557|65134176|FG005|Maintenance Period|Subject Non-Compliance|1|||
23379469|NCT01771913|65134177|FG000|Overall Study|Withdrawal by Subject|1|||
23379470|NCT01771913|65134178|FG001|Overall Study|Withdrawal by Subject|0|||
23379471|NCT02842866|65134179|FG000|Overall Study|Serious Adverse Event|0|||
23379472|NCT02842866|65134180|FG001|Overall Study|Serious Adverse Event|1|||
23379473|NCT02842866|65134179|FG000|Overall Study|Protocol Violation|4|||
23379474|NCT02842866|65134180|FG001|Overall Study|Protocol Violation|2|||
23379475|NCT02842866|65134179|FG000|Overall Study|Lost to Follow-up|2|||
23379476|NCT02842866|65134180|FG001|Overall Study|Lost to Follow-up|0|||
23379477|NCT02842866|65134179|FG000|Overall Study|Withdrawal by Subject|1|||
23379478|NCT02842866|65134180|FG001|Overall Study|Withdrawal by Subject|0|||
23379479|NCT02453048|65134181|FG000|Overall Study|Only part of initial 6 mo. study|0|||
23379480|NCT02453048|65134182|FG001|Overall Study|Only part of initial 6 mo. study|0|||
23379481|NCT02453048|65134183|FG002|Overall Study|Only part of initial 6 mo. study|0|||
23379482|NCT02453048|65134184|FG003|Overall Study|Only part of initial 6 mo. study|0|||
23379483|NCT02453048|65134185|FG004|Overall Study|Only part of initial 6 mo. study|6|||
23379484|NCT02453048|65134181|FG000|Overall Study|Lost to Follow-up|0|||
23379485|NCT02453048|65134182|FG001|Overall Study|Lost to Follow-up|1|||
23379486|NCT02453048|65134183|FG002|Overall Study|Lost to Follow-up|2|||
23379487|NCT02453048|65134184|FG003|Overall Study|Lost to Follow-up|0|||
23379488|NCT02453048|65134185|FG004|Overall Study|Lost to Follow-up|0|||
23379489|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
23379490|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
23379491|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
23379492|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
23379493|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
23379494|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
23379495|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379496|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379497|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
23379498|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
23379499|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
23379500|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
23379501|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
23379502|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
23379503|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
23379504|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
23379505|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379506|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
23379507|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379508|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379509|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379510|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
23379511|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379512|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379513|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
23379514|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
23379515|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
23379516|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
23379517|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
23379518|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
23379519|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
23379520|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
23379521|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
23379522|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
23379523|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
23379524|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
23379525|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
23379526|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
23491042|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491043|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491044|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491045|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491046|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491047|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491048|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491049|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491050|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
23491051|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491052|NCT02642029|65541577|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
23491053|NCT02642029|65541578|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
23491054|NCT02642029|65541579|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
23491055|NCT02642029|65541580|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
23491056|NCT02642029|65541581|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
23491057|NCT02642029|65541582|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
23666652|NCT02184195|66162705|FG000|Overall Study|Patient decision|5|||
23666653|NCT02184195|66162706|FG001|Overall Study|Patient decision|2|||
23666654|NCT02184195|66162705|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23491058|NCT02642029|65541577|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
23491059|NCT02642029|65541578|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491060|NCT02642029|65541579|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491061|NCT02642029|65541580|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491062|NCT02642029|65541581|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491063|NCT02642029|65541582|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491064|NCT02642029|65541577|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
23491065|NCT02642029|65541578|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491066|NCT02642029|65541579|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491067|NCT02642029|65541580|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491068|NCT02642029|65541581|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491069|NCT02642029|65541582|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491070|NCT03575897|65541583|FG000|Overall Study|Lost to Follow-up|12|||
23491071|NCT03575897|65541584|FG001|Overall Study|Lost to Follow-up|13|||
23491072|NCT02635776|65541590|FG000|Overall Study|Physician Decision|1|||
23491073|NCT02635776|65541591|FG001|Overall Study|Physician Decision|0|||
23491074|NCT02635776|65541590|FG000|Overall Study|Adverse Event|51|||
23491075|NCT02635776|65541591|FG001|Overall Study|Adverse Event|3|||
23491076|NCT02635776|65541590|FG000|Overall Study|Withdrawal by Subject|41|||
23491077|NCT02635776|65541591|FG001|Overall Study|Withdrawal by Subject|7|||
23491078|NCT02635776|65541590|FG000|Overall Study|Lost to Follow-up|4|||
23491079|NCT02635776|65541591|FG001|Overall Study|Lost to Follow-up|0|||
23491080|NCT02635776|65541590|FG000|Overall Study|Other reasons|5|||
23491081|NCT02635776|65541591|FG001|Overall Study|Other reasons|1|||
23491082|NCT02436681|65541604|FG000|Overall Study|Lost to Follow-up|10|||
23491083|NCT02436681|65541604|FG000|Overall Study|Withdrawal by Subject|2|||
23491084|NCT02436681|65541604|FG000|Overall Study|Death|2|||
23491085|NCT04850313|65541605|FG000|Overall Study|Withdrawal by Subject|0|||
23491086|NCT04850313|65541606|FG001|Overall Study|Withdrawal by Subject|1|||
23491087|NCT02639546|65544873|FG000|Overall Study|Death|2|||
23491088|NCT02639546|65544874|FG001|Overall Study|Death|2|||
23491089|NCT02639546|65544875|FG002|Overall Study|Death|1|||
23491090|NCT02639546|65544876|FG003|Overall Study|Death|2|||
23491091|NCT02639546|65544877|FG004|Overall Study|Death|2|||
23491092|NCT02639546|65544878|FG005|Overall Study|Death|2|||
23491093|NCT02639546|65544879|FG006|Overall Study|Death|0|||
23491094|NCT02639546|65544880|FG007|Overall Study|Death|0|||
23491095|NCT02639546|65544873|FG000|Overall Study|Lost to Follow-up|0|||
23666655|NCT02184195|66162706|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23491096|NCT02639546|65544874|FG001|Overall Study|Lost to Follow-up|0|||
23491097|NCT02639546|65544875|FG002|Overall Study|Lost to Follow-up|1|||
23491098|NCT02639546|65544876|FG003|Overall Study|Lost to Follow-up|0|||
23491099|NCT02639546|65544877|FG004|Overall Study|Lost to Follow-up|1|||
23491100|NCT02639546|65544878|FG005|Overall Study|Lost to Follow-up|1|||
23491101|NCT02639546|65544879|FG006|Overall Study|Lost to Follow-up|0|||
23491102|NCT02639546|65544880|FG007|Overall Study|Lost to Follow-up|1|||
23491103|NCT02639546|65544873|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
23491104|NCT02639546|65544874|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
23491105|NCT02639546|65544875|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
23491106|NCT02639546|65544876|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
23491107|NCT02639546|65544877|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
23491108|NCT02639546|65544878|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
23491109|NCT02639546|65544879|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
23491110|NCT02639546|65544880|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
23491111|NCT02639546|65544873|FG000|Overall Study|Study Terminated By Sponsor|0|||
23491112|NCT02639546|65544874|FG001|Overall Study|Study Terminated By Sponsor|2|||
23491113|NCT02639546|65544875|FG002|Overall Study|Study Terminated By Sponsor|3|||
23491114|NCT02639546|65544876|FG003|Overall Study|Study Terminated By Sponsor|4|||
23491115|NCT02639546|65544877|FG004|Overall Study|Study Terminated By Sponsor|4|||
23491116|NCT02639546|65544878|FG005|Overall Study|Study Terminated By Sponsor|3|||
23491117|NCT02639546|65544879|FG006|Overall Study|Study Terminated By Sponsor|3|||
23491118|NCT02639546|65544880|FG007|Overall Study|Study Terminated By Sponsor|9|||
23491119|NCT02639546|65544873|FG000|Overall Study|Withdrawal by Subject|2|||
23491120|NCT02639546|65544874|FG001|Overall Study|Withdrawal by Subject|2|||
23491121|NCT02639546|65544875|FG002|Overall Study|Withdrawal by Subject|1|||
23491122|NCT02639546|65544876|FG003|Overall Study|Withdrawal by Subject|0|||
23491123|NCT02639546|65544877|FG004|Overall Study|Withdrawal by Subject|0|||
23491124|NCT02639546|65544878|FG005|Overall Study|Withdrawal by Subject|1|||
23605667|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605668|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605669|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23666656|NCT02184195|66162705|FG000|Overall Study|Death|67|||
23666657|NCT02184195|66162706|FG001|Overall Study|Death|44|||
23605670|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605671|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
23605672|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
23605673|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23379527|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
23379528|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
23491125|NCT02639546|65544879|FG006|Overall Study|Withdrawal by Subject|2|||
23491126|NCT02639546|65544880|FG007|Overall Study|Withdrawal by Subject|1|||
23491127|NCT05021081|65544885|FG000|Phase 2|Subject enrolled in error|1|||
23491128|NCT05021081|65544886|FG001|Phase 2|Subject enrolled in error|1|||
23491129|NCT05021081|65544887|FG002|Phase 2|Subject enrolled in error|0|||
23491130|NCT00891462|65544888|FG000|Overall Study|Withdrawal by Subject|9|||
23605674|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605675|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605676|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605677|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605678|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
23605679|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
23605680|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23605681|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23666658|NCT02184195|66162705|FG000|Overall Study|Lost to Follow-up|1|||
23666659|NCT02184195|66162706|FG001|Overall Study|Lost to Follow-up|5|||
23666660|NCT02184195|66162705|FG000|Overall Study|Other|0|||
23666661|NCT02184195|66162706|FG001|Overall Study|Other|3|||
23491131|NCT00891462|65544889|FG001|Overall Study|Withdrawal by Subject|6|||
23491132|NCT00891462|65544890|FG002|Overall Study|Withdrawal by Subject|7|||
23491133|NCT00891462|65544888|FG000|Overall Study|Adverse Event|7|||
23491134|NCT00891462|65544889|FG001|Overall Study|Adverse Event|8|||
23491135|NCT00891462|65544890|FG002|Overall Study|Adverse Event|7|||
23491136|NCT00891462|65544888|FG000|Overall Study|Lack of Efficacy|10|||
23491137|NCT00891462|65544889|FG001|Overall Study|Lack of Efficacy|5|||
23491138|NCT00891462|65544890|FG002|Overall Study|Lack of Efficacy|1|||
23491139|NCT00891462|65544888|FG000|Overall Study|COPD exacerbation|7|||
23491140|NCT00891462|65544889|FG001|Overall Study|COPD exacerbation|4|||
23491141|NCT00891462|65544890|FG002|Overall Study|COPD exacerbation|1|||
23491142|NCT00891462|65544888|FG000|Overall Study|Other Reason|2|||
23491143|NCT00891462|65544889|FG001|Overall Study|Other Reason|5|||
23491144|NCT00891462|65544890|FG002|Overall Study|Other Reason|3|||
23491145|NCT00891462|65544888|FG000|Overall Study|Protocol Violation|2|||
23491146|NCT00891462|65544889|FG001|Overall Study|Protocol Violation|1|||
23491147|NCT00891462|65544890|FG002|Overall Study|Protocol Violation|3|||
23491148|NCT00891462|65544888|FG000|Overall Study|Inclusion/exclusion criteria|0|||
23379529|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
23379530|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
23379531|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
23379532|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
23379533|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
23379534|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
23379535|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
23379536|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
23379537|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
23379538|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
23379539|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
23379540|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
23379541|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
23379542|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
23379543|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
23379544|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
23379545|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
23379546|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
23379547|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
23379548|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
23379549|NCT01033071|65134192|FG000|Overall Study|Adverse Event|28|||
23379550|NCT01033071|65134193|FG001|Overall Study|Adverse Event|51|||
23379551|NCT01033071|65134194|FG002|Overall Study|Adverse Event|26|||
23379552|NCT01033071|65134192|FG000|Overall Study|Protocol Violation|0|||
23379553|NCT01033071|65134193|FG001|Overall Study|Protocol Violation|2|||
23379554|NCT01033071|65134194|FG002|Overall Study|Protocol Violation|1|||
23379555|NCT01033071|65134192|FG000|Overall Study|Lost to Follow-up|4|||
23379556|NCT01033071|65134193|FG001|Overall Study|Lost to Follow-up|5|||
23379557|NCT01033071|65134194|FG002|Overall Study|Lost to Follow-up|5|||
23379558|NCT01033071|65134192|FG000|Overall Study|Withdrawal by Subject|17|||
23379559|NCT01033071|65134193|FG001|Overall Study|Withdrawal by Subject|14|||
23379560|NCT01033071|65134194|FG002|Overall Study|Withdrawal by Subject|11|||
23379561|NCT01033071|65134192|FG000|Overall Study|Lack of Efficacy|0|||
23379562|NCT01033071|65134193|FG001|Overall Study|Lack of Efficacy|1|||
23379563|NCT01033071|65134194|FG002|Overall Study|Lack of Efficacy|1|||
23491149|NCT00891462|65544889|FG001|Overall Study|Inclusion/exclusion criteria|2|||
23491150|NCT00891462|65544890|FG002|Overall Study|Inclusion/exclusion criteria|2|||
23491151|NCT00891462|65544888|FG000|Overall Study|Lost to Follow-up|0|||
23491152|NCT00891462|65544889|FG001|Overall Study|Lost to Follow-up|2|||
23491153|NCT00891462|65544890|FG002|Overall Study|Lost to Follow-up|0|||
23379564|NCT01033071|65134192|FG000|Overall Study|Other|6|||
23379565|NCT01033071|65134193|FG001|Overall Study|Other|4|||
23379566|NCT01033071|65134194|FG002|Overall Study|Other|3|||
23379567|NCT01875237|65134197|FG000|Overall Study|GVDH before DLI|1|||
23379568|NCT01875237|65134198|FG001|Overall Study|GVDH before DLI|0|||
23379569|NCT01875237|65134197|FG000|Overall Study|DLI cells could not be produced|1|||
23379570|NCT01875237|65134198|FG001|Overall Study|DLI cells could not be produced|0|||
23379571|NCT00954538|65134199|FG000|Part III|Withdrawal by Subject|0|||
23379572|NCT00954538|65134200|FG001|Part III|Withdrawal by Subject|0|||
23379573|NCT00954538|65134201|FG002|Part III|Withdrawal by Subject|0|||
23379574|NCT00954538|65134202|FG003|Part III|Withdrawal by Subject|0|||
23379575|NCT00954538|65134203|FG004|Part III|Withdrawal by Subject|1|||
23379576|NCT00954538|65134204|FG005|Part III|Withdrawal by Subject|0|||
23379577|NCT02612155|65134207|FG000|Overall Study|Death|1|||
23379578|NCT02612155|65134208|FG001|Overall Study|Death|1|||
23379579|NCT02612155|65134207|FG000|Overall Study|Lost to Follow-up|2|||
23379580|NCT02612155|65134208|FG001|Overall Study|Lost to Follow-up|2|||
23379581|NCT00782067|65134209|FG000|Overall Study|Adverse Event|35|||
23379582|NCT00782067|65134209|FG000|Overall Study|Subject withdrew consent|11|||
23379583|NCT00782067|65134209|FG000|Overall Study|Lost to Follow-up|2|||
23379584|NCT00782067|65134209|FG000|Overall Study|Administrative problems|14|||
23379585|NCT00782067|65134209|FG000|Overall Study|Death|9|||
23379586|NCT00782067|65134209|FG000|Overall Study|Disease progression|43|||
23379587|NCT00782067|65134209|FG000|Overall Study|Protocol deviation|2|||
23379588|NCT00002874|65134210|FG000|Overall Study|Withdrawal by Subject|1|||
23379589|NCT00002874|65134211|FG001|Overall Study|Withdrawal by Subject|1|||
23379590|NCT00002874|65134210|FG000|Overall Study|Protocol Violation|44|||
23379591|NCT00002874|65134211|FG001|Overall Study|Protocol Violation|34|||
23379592|NCT00800540|65134212|FG000|Period One: 6 Weeks|Noncompliance|1|||
23379593|NCT00800540|65134213|FG001|Period One: 6 Weeks|Noncompliance|0|||
23379594|NCT00800540|65134212|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
23379595|NCT00800540|65134213|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
23379596|NCT00800540|65134212|FG000|Period 2: 6 Weeks|Adverse Event|0|||
23379597|NCT00800540|65134213|FG001|Period 2: 6 Weeks|Adverse Event|1|||
23379598|NCT02347787|65134216|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
23379599|NCT02347787|65134217|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
23379600|NCT02347787|65134216|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
23379601|NCT02347787|65134217|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
23379602|NCT02347787|65134216|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
23379603|NCT02347787|65134217|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
23379604|NCT02347787|65134216|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
23379605|NCT02347787|65134217|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
23379606|NCT00632359|65134218|FG000|Overall Study|Withdrawal by Subject|2|||
23379607|NCT01800058|65134220|FG000|Overall Study|Lost to Follow-up|1|||
23379608|NCT03807843|65134226|FG000|Overall Study|Lost to Follow-up|1|||
23379609|NCT03807843|65134227|FG001|Overall Study|Lost to Follow-up|0|||
23379610|NCT02260986|65134228|FG000|Overall Study|Adverse Event|24|||
23379611|NCT02260986|65134229|FG001|Overall Study|Adverse Event|0|||
23379612|NCT02260986|65134230|FG002|Overall Study|Adverse Event|11|||
23379613|NCT02260986|65134228|FG000|Overall Study|Lack of Efficacy|27|||
23379614|NCT02260986|65134229|FG001|Overall Study|Lack of Efficacy|3|||
23379615|NCT02260986|65134230|FG002|Overall Study|Lack of Efficacy|0|||
23379616|NCT02260986|65134228|FG000|Overall Study|Protocol Violation|14|||
23379617|NCT02260986|65134229|FG001|Overall Study|Protocol Violation|5|||
23379618|NCT02260986|65134230|FG002|Overall Study|Protocol Violation|16|||
23379619|NCT02260986|65134228|FG000|Overall Study|Car accident|0|||
23379620|NCT02260986|65134229|FG001|Overall Study|Car accident|0|||
23379621|NCT02260986|65134230|FG002|Overall Study|Car accident|1|||
23379622|NCT02260986|65134228|FG000|Overall Study|Withdrawal by Subject|17|||
23379623|NCT02260986|65134229|FG001|Overall Study|Withdrawal by Subject|4|||
23379624|NCT02260986|65134230|FG002|Overall Study|Withdrawal by Subject|9|||
23379625|NCT02260986|65134228|FG000|Overall Study|Incorrect randomization|0|||
23379626|NCT02260986|65134229|FG001|Overall Study|Incorrect randomization|1|||
23379627|NCT02260986|65134230|FG002|Overall Study|Incorrect randomization|0|||
23379628|NCT02260986|65134228|FG000|Overall Study|Lack of investigation product supply|2|||
23379629|NCT02260986|65134229|FG001|Overall Study|Lack of investigation product supply|0|||
23379630|NCT02260986|65134230|FG002|Overall Study|Lack of investigation product supply|1|||
23491154|NCT03437512|65544891|FG000|Randomized|Withdrawal by Subject|0|||
23379631|NCT02260986|65134228|FG000|Overall Study|Lost to Follow-up|4|||
23379632|NCT02260986|65134229|FG001|Overall Study|Lost to Follow-up|0|||
23379633|NCT02260986|65134230|FG002|Overall Study|Lost to Follow-up|3|||
23379634|NCT02260986|65134228|FG000|Overall Study|Pregnancy|2|||
23379635|NCT02260986|65134229|FG001|Overall Study|Pregnancy|0|||
23379636|NCT02260986|65134230|FG002|Overall Study|Pregnancy|0|||
23379637|NCT04327271|65134231|FG000|Overall Study|Death|1|||
23379638|NCT04327271|65134232|FG001|Overall Study|Death|0|||
23379639|NCT04327271|65134231|FG000|Overall Study|Withdrawal by Subject|1|||
23379640|NCT04327271|65134232|FG001|Overall Study|Withdrawal by Subject|0|||
23491155|NCT03437512|65544892|FG001|Randomized|Withdrawal by Subject|2|||
23379641|NCT04327271|65134231|FG000|Overall Study|randomization error (data capture)|4|||
23379642|NCT04327271|65134232|FG001|Overall Study|randomization error (data capture)|3|||
23379643|NCT02665117|65134233|FG000|Overall Study|Physician Decision|1|||
23379644|NCT02665117|65134234|FG001|Overall Study|Physician Decision|0|||
23379645|NCT01279200|65134235|FG000|Overall Study|Withdrawal by Subject|1|||
23379646|NCT01279200|65134236|FG001|Overall Study|Withdrawal by Subject|3|||
23379647|NCT01279200|65134235|FG000|Overall Study|Patient withdrawal due to high cost|0|||
23379648|NCT01279200|65134236|FG001|Overall Study|Patient withdrawal due to high cost|1|||
23379649|NCT01279200|65134235|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
23379650|NCT01279200|65134236|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
23379651|NCT01279200|65134235|FG000|Overall Study|ultrasound screening failure|0|||
23379652|NCT01279200|65134236|FG001|Overall Study|ultrasound screening failure|1|||
23379653|NCT01279200|65134235|FG000|Overall Study|Lost to Follow-up|0|||
23379654|NCT01279200|65134236|FG001|Overall Study|Lost to Follow-up|1|||
23379655|NCT01279200|65134235|FG000|Overall Study|Adverse Event|1|||
23379656|NCT01279200|65134236|FG001|Overall Study|Adverse Event|0|||
23379657|NCT02006654|65134237|FG000|Overall Study|Withdrawal before treatment|4|||
23379658|NCT02006654|65134238|FG001|Overall Study|Withdrawal before treatment|2|||
23379659|NCT02006654|65134237|FG000|Overall Study|Adverse Event|16|||
23379660|NCT02006654|65134238|FG001|Overall Study|Adverse Event|17|||
23379661|NCT02006654|65134237|FG000|Overall Study|Death|1|||
23379662|NCT02006654|65134238|FG001|Overall Study|Death|0|||
23379663|NCT02006654|65134237|FG000|Overall Study|Withdrawal by Subject|14|||
23379664|NCT02006654|65134238|FG001|Overall Study|Withdrawal by Subject|12|||
23379665|NCT02006654|65134237|FG000|Overall Study|Protocol Violation|5|||
23379666|NCT02006654|65134238|FG001|Overall Study|Protocol Violation|8|||
23379667|NCT02006654|65134237|FG000|Overall Study|Lost to Follow-up|1|||
23379668|NCT02006654|65134238|FG001|Overall Study|Lost to Follow-up|0|||
23379669|NCT02006654|65134237|FG000|Overall Study|patient's will|2|||
23379670|NCT02006654|65134238|FG001|Overall Study|patient's will|1|||
23379671|NCT02006654|65134237|FG000|Overall Study|insufficient compliance|1|||
23379672|NCT02006654|65134238|FG001|Overall Study|insufficient compliance|0|||
23379673|NCT02006654|65134237|FG000|Overall Study|worsening cognitive condition|0|||
23379674|NCT02006654|65134238|FG001|Overall Study|worsening cognitive condition|1|||
23379675|NCT02006654|65134237|FG000|Overall Study|faecal incontinence|0|||
23379676|NCT02006654|65134238|FG001|Overall Study|faecal incontinence|1|||
23379677|NCT02006654|65134237|FG000|Overall Study|mood disorder|0|||
23379678|NCT02006654|65134238|FG001|Overall Study|mood disorder|1|||
23379679|NCT02006654|65134237|FG000|Overall Study|disallowed medication|1|||
23379680|NCT02006654|65134238|FG001|Overall Study|disallowed medication|0|||
23379681|NCT02006654|65134237|FG000|Overall Study|moving out of state|0|||
23379682|NCT02006654|65134238|FG001|Overall Study|moving out of state|1|||
23379683|NCT01136954|65134243|FG000|Overall Study|Adverse Event|3|||
23379684|NCT01136954|65134244|FG001|Overall Study|Adverse Event|2|||
23379685|NCT01136954|65134243|FG000|Overall Study|Withdrawal by Subject|6|||
23379686|NCT01136954|65134244|FG001|Overall Study|Withdrawal by Subject|2|||
23379687|NCT01136954|65134243|FG000|Overall Study|Lack of Efficacy|14|||
23379688|NCT01136954|65134244|FG001|Overall Study|Lack of Efficacy|13|||
23379689|NCT01136954|65134243|FG000|Overall Study|Physician Decision|0|||
23379690|NCT01136954|65134244|FG001|Overall Study|Physician Decision|1|||
23379691|NCT01136954|65134243|FG000|Overall Study|Other|1|||
23379692|NCT01136954|65134244|FG001|Overall Study|Other|3|||
23379693|NCT00274456|65134245|FG000|Overall Study|Still on treatment|2|||
23379694|NCT00274456|65134246|FG001|Overall Study|Still on treatment|3|||
23379695|NCT00274456|65134247|FG002|Overall Study|Still on treatment|5|||
23379696|NCT00274456|65134248|FG003|Overall Study|Still on treatment|1|||
23379697|NCT00274456|65134245|FG000|Overall Study|Unacceptable toxicity|10|||
23379698|NCT00274456|65134246|FG001|Overall Study|Unacceptable toxicity|5|||
23379699|NCT00274456|65134247|FG002|Overall Study|Unacceptable toxicity|12|||
23379700|NCT00274456|65134248|FG003|Overall Study|Unacceptable toxicity|16|||
23379701|NCT00274456|65134245|FG000|Overall Study|Adverse Event|0|||
23379702|NCT00274456|65134246|FG001|Overall Study|Adverse Event|1|||
23379703|NCT00274456|65134247|FG002|Overall Study|Adverse Event|2|||
23379704|NCT00274456|65134248|FG003|Overall Study|Adverse Event|2|||
23605682|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23379705|NCT00274456|65134245|FG000|Overall Study|Physician Decision|7|||
23379706|NCT00274456|65134246|FG001|Overall Study|Physician Decision|5|||
23379707|NCT00274456|65134247|FG002|Overall Study|Physician Decision|6|||
23379708|NCT00274456|65134248|FG003|Overall Study|Physician Decision|13|||
23379709|NCT00274456|65134245|FG000|Overall Study|Lost to Follow-up|0|||
23379710|NCT00274456|65134246|FG001|Overall Study|Lost to Follow-up|0|||
23379711|NCT00274456|65134247|FG002|Overall Study|Lost to Follow-up|1|||
23379712|NCT00274456|65134248|FG003|Overall Study|Lost to Follow-up|0|||
23379713|NCT00274456|65134245|FG000|Overall Study|Withdrawal by Subject|18|||
23379714|NCT00274456|65134246|FG001|Overall Study|Withdrawal by Subject|13|||
23379715|NCT00274456|65134247|FG002|Overall Study|Withdrawal by Subject|9|||
23379716|NCT00274456|65134248|FG003|Overall Study|Withdrawal by Subject|13|||
23379717|NCT03003468|65134249|FG000|Overall Study|Withdrawal by Subject|0|||
23379718|NCT03003468|65134250|FG001|Overall Study|Withdrawal by Subject|0|||
23379719|NCT03003468|65134251|FG002|Overall Study|Withdrawal by Subject|1|||
23379720|NCT03003468|65134249|FG000|Overall Study|No measurable lesions|0|||
23379721|NCT03003468|65134250|FG001|Overall Study|No measurable lesions|0|||
23379722|NCT03003468|65134251|FG002|Overall Study|No measurable lesions|1|||
23379723|NCT01044498|65134252|FG000|Overall Study|Withdrew consent|1|||
23379724|NCT01044498|65134253|FG001|Overall Study|Withdrew consent|1|||
23379725|NCT01044498|65134252|FG000|Overall Study|Adverse Event|1|||
23379726|NCT01044498|65134253|FG001|Overall Study|Adverse Event|1|||
23379727|NCT01044498|65134252|FG000|Overall Study|Other|1|||
23379728|NCT01044498|65134253|FG001|Overall Study|Other|0|||
23379729|NCT00915525|65134258|FG000|Overall Study|Protocol Violation|9|||
23379730|NCT00915525|65134259|FG001|Overall Study|Protocol Violation|4|||
23379731|NCT00915525|65134258|FG000|Overall Study|Withdrawal by Subject|59|||
23379732|NCT00915525|65134259|FG001|Overall Study|Withdrawal by Subject|21|||
23379733|NCT00915525|65134258|FG000|Overall Study|Lost to Follow-up|27|||
23379734|NCT00915525|65134259|FG001|Overall Study|Lost to Follow-up|16|||
23379735|NCT00915525|65134258|FG000|Overall Study|Pregnancy|2|||
23379736|NCT00915525|65134259|FG001|Overall Study|Pregnancy|0|||
23379737|NCT00915525|65134258|FG000|Overall Study|Lack of Efficacy|15|||
23379738|NCT00915525|65134259|FG001|Overall Study|Lack of Efficacy|32|||
23379739|NCT00915525|65134258|FG000|Overall Study|Adverse Event|29|||
23379740|NCT00915525|65134259|FG001|Overall Study|Adverse Event|13|||
23379741|NCT00915525|65134258|FG000|Overall Study|Missing|12|||
23379742|NCT00915525|65134259|FG001|Overall Study|Missing|1|||
23379743|NCT00915525|65134258|FG000|Overall Study|Other Reason|35|||
23379744|NCT00915525|65134259|FG001|Overall Study|Other Reason|12|||
23379745|NCT00915525|65134258|FG000|Overall Study|Site Closed|27|||
23379746|NCT00915525|65134259|FG001|Overall Study|Site Closed|9|||
23379747|NCT00915525|65134258|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
23379748|NCT00915525|65134259|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
23379749|NCT00915525|65134258|FG000|Overall Study|Study Burden|28|||
23379750|NCT00915525|65134259|FG001|Overall Study|Study Burden|12|||
23379751|NCT00915525|65134258|FG000|Overall Study|Non-Compliance|3|||
23379752|NCT00915525|65134259|FG001|Overall Study|Non-Compliance|1|||
23379753|NCT00915525|65134258|FG000|Overall Study|Patient Moved|15|||
23379754|NCT00915525|65134259|FG001|Overall Study|Patient Moved|9|||
23379755|NCT03720847|65134260|FG000|Washout|Physician Decision|1|||
23379756|NCT03720847|65134261|FG001|Washout|Physician Decision|2|||
23379757|NCT01432951|65134262|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
23379758|NCT00844519|65134266|FG000|Overall Study|Withdrawal by Subject|1|||
23379759|NCT00844519|65134267|FG001|Overall Study|Withdrawal by Subject|1|||
23379760|NCT00844519|65134266|FG000|Overall Study|Adverse Event|1|||
23379761|NCT00844519|65134267|FG001|Overall Study|Adverse Event|0|||
23379762|NCT02916927|65134268|FG000|Overall Study|Discharged prior to study drug receipt|0|||
23379763|NCT02916927|65134269|FG001|Overall Study|Discharged prior to study drug receipt|2|||
23379764|NCT02916927|65134268|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
23379765|NCT02916927|65134269|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
23379766|NCT02916927|65134268|FG000|Overall Study|Withdrawal before first time point|1|||
23379767|NCT02916927|65134269|FG001|Overall Study|Withdrawal before first time point|0|||
23379768|NCT01625182|65134272|FG000|Overall Study|Administrative problems|1|||
23379769|NCT01625182|65134273|FG001|Overall Study|Administrative problems|0|||
23379770|NCT01625182|65134272|FG000|Overall Study|Protocol deviation|0|||
23379771|NCT01625182|65134273|FG001|Overall Study|Protocol deviation|2|||
23379772|NCT01625182|65134272|FG000|Overall Study|Adverse Event|2|||
23379773|NCT01625182|65134273|FG001|Overall Study|Adverse Event|0|||
23379774|NCT01625182|65134272|FG000|Overall Study|Withdrawal by Subject|5|||
23379775|NCT01625182|65134273|FG001|Overall Study|Withdrawal by Subject|1|||
23379776|NCT01625182|65134272|FG000|Overall Study|Lack of Efficacy|12|||
23379777|NCT01625182|65134273|FG001|Overall Study|Lack of Efficacy|8|||
23379778|NCT00764517|65134274|FG000|Overall Study|Adverse Event|9|||
23379779|NCT00764517|65134275|FG001|Overall Study|Adverse Event|3|||
23379780|NCT00764517|65134274|FG000|Overall Study|Death|3|||
23379781|NCT00764517|65134275|FG001|Overall Study|Death|11|||
23379782|NCT00764517|65134274|FG000|Overall Study|Physician Decision|3|||
23666662|NCT01251653|66162707|FG000|Overall Study|Progressive Disease|1|||
23666663|NCT01251653|66162708|FG001|Overall Study|Progressive Disease|7|||
23666664|NCT01251653|66162709|FG002|Overall Study|Progressive Disease|16|||
23379783|NCT00764517|65134275|FG001|Overall Study|Physician Decision|0|||
23379784|NCT04115059|65134276|FG000|Overall Study|Withdrawal by Subject|1|||
23379785|NCT04115059|65134276|FG000|Overall Study|Lack of Efficacy|2|||
23379786|NCT01910441|65134281|FG000|Overall Study|Sponsor decision|0|||
23379787|NCT01910441|65134282|FG001|Overall Study|Sponsor decision|2|||
23379788|NCT01910441|65134281|FG000|Overall Study|Lost to Follow-up|6|||
23605683|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23605684|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23605685|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605686|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
23605687|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605688|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605689|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605690|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605691|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605692|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
23605693|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
23605694|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605695|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605696|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605697|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605698|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605699|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605700|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605701|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605702|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
23605703|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
23605704|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605705|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
23605706|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605707|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605708|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
23605709|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605710|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605711|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605712|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605713|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605714|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605715|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
23605716|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605717|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605718|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605719|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605720|NCT03146845|65947025|FG000|Overall Study|Reference ulcer healed|1|||
23605721|NCT03146845|65947026|FG001|Overall Study|Reference ulcer healed|0|||
23605722|NCT03146845|65947025|FG000|Overall Study|Physician Decision|1|||
23605723|NCT03146845|65947026|FG001|Overall Study|Physician Decision|0|||
23605724|NCT03146845|65947025|FG000|Overall Study|Adverse Event|1|||
23605725|NCT03146845|65947026|FG001|Overall Study|Adverse Event|0|||
23605726|NCT03146845|65947025|FG000|Overall Study|Withdrawal by Subject|2|||
23605727|NCT03146845|65947026|FG001|Overall Study|Withdrawal by Subject|0|||
23605728|NCT03146845|65947025|FG000|Overall Study|Noncompliance|0|||
23605729|NCT03146845|65947026|FG001|Overall Study|Noncompliance|1|||
23605730|NCT03146845|65947025|FG000|Overall Study|Protocol Violation|0|||
23605731|NCT03146845|65947026|FG001|Overall Study|Protocol Violation|2|||
23605732|NCT03146845|65947025|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
23605733|NCT03146845|65947026|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
23605734|NCT00599196|65947029|FG000|Overall Study|Lack of Efficacy|22|||
23605735|NCT00599196|65947029|FG000|Overall Study|Adverse Event|93|||
23605736|NCT00599196|65947029|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
23605737|NCT00599196|65947029|FG000|Overall Study|Subject withdrew consent|43|||
23605738|NCT00599196|65947029|FG000|Overall Study|Study ended per sponsor|197|||
23666665|NCT01251653|66162710|FG003|Overall Study|Progressive Disease|4|||
23379789|NCT01910441|65134282|FG001|Overall Study|Lost to Follow-up|5|||
23379790|NCT01910441|65134281|FG000|Overall Study|Withdrawal by Subject|0|||
23379791|NCT01910441|65134282|FG001|Overall Study|Withdrawal by Subject|1|||
23379792|NCT01910441|65134281|FG000|Overall Study|Non-compliance|0|||
23379793|NCT01910441|65134282|FG001|Overall Study|Non-compliance|1|||
23379794|NCT01910441|65134281|FG000|Overall Study|Adverse Event|1|||
23379795|NCT01910441|65134282|FG001|Overall Study|Adverse Event|0|||
23379796|NCT01910441|65134281|FG000|Overall Study|Physician Decision|0|||
23379797|NCT01910441|65134282|FG001|Overall Study|Physician Decision|1|||
23491156|NCT03437512|65544891|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
23491157|NCT03437512|65544892|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
23605739|NCT00599196|65947029|FG000|Overall Study|Lost to Follow-up|17|||
23605740|NCT00599196|65947029|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
23605741|NCT00599196|65947029|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
23605742|NCT00599196|65947029|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
23605743|NCT00599196|65947029|FG000|Overall Study|Other: Pt Moved To Australia|1|||
23605744|NCT00599196|65947029|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
23605745|NCT00599196|65947029|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
23605746|NCT03131713|65947030|FG000|Overall Study|Lost to Follow-up|5|||
23605747|NCT03131713|65947031|FG001|Overall Study|Lost to Follow-up|0|||
23605748|NCT01536704|65947032|FG000|Washout Period 1|Withdrawal by Subject|1|||
23605749|NCT01536704|65947033|FG001|Washout Period 1|Withdrawal by Subject|2|||
23491158|NCT05246397|65544896|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
23491159|NCT04087213|65544897|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
23491160|NCT04087213|65544897|FG000|In-Facility Introduction|Adverse Event|1|||
23491161|NCT04087213|65544897|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
23491162|NCT04087213|65544897|FG000|Assisted Evaluable Period|Personal reasons|3|||
23491163|NCT04087213|65544897|FG000|Transition Period B|Renal Transplantation|1|||
23491164|NCT00494299|65544898|FG000|Overall Study|Adverse Event|93|||
23491165|NCT00494299|65544899|FG001|Overall Study|Adverse Event|13|||
23491166|NCT00494299|65544898|FG000|Overall Study|Lost to Follow-up|1|||
23491167|NCT00494299|65544899|FG001|Overall Study|Lost to Follow-up|0|||
23491168|NCT00494299|65544898|FG000|Overall Study|Physician Decision|0|||
23491169|NCT00494299|65544899|FG001|Overall Study|Physician Decision|2|||
23491170|NCT00494299|65544898|FG000|Overall Study|Protocol Violation|1|||
23491171|NCT00494299|65544899|FG001|Overall Study|Protocol Violation|2|||
23491172|NCT00494299|65544898|FG000|Overall Study|Withdrawal by Subject|8|||
23491173|NCT00494299|65544899|FG001|Overall Study|Withdrawal by Subject|3|||
23491174|NCT00494299|65544898|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
23491175|NCT00494299|65544899|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
23491176|NCT00494299|65544898|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
23491177|NCT00494299|65544899|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
23491178|NCT00494299|65544898|FG000|Overall Study|Site Closed by Sponsor|6|||
23491179|NCT00494299|65544899|FG001|Overall Study|Site Closed by Sponsor|0|||
23491180|NCT00494299|65544898|FG000|Overall Study|Protocol Driven Decision Point|11|||
23491181|NCT00494299|65544899|FG001|Overall Study|Protocol Driven Decision Point|22|||
23491182|NCT02761733|65544900|FG000|Overall Study|Death|3|||
23491183|NCT02761733|65544901|FG001|Overall Study|Death|5|||
23491184|NCT02761733|65544902|FG002|Overall Study|Death|1|||
23491185|NCT02761733|65544903|FG003|Overall Study|Death|1|||
23491186|NCT02761733|65544900|FG000|Overall Study|Lost to Follow-up|6|||
23491187|NCT02761733|65544901|FG001|Overall Study|Lost to Follow-up|7|||
23491188|NCT02761733|65544902|FG002|Overall Study|Lost to Follow-up|0|||
23491189|NCT02761733|65544903|FG003|Overall Study|Lost to Follow-up|3|||
23491190|NCT02761733|65544900|FG000|Overall Study|Physician Decision|4|||
23491191|NCT02761733|65544901|FG001|Overall Study|Physician Decision|0|||
23491192|NCT02761733|65544902|FG002|Overall Study|Physician Decision|0|||
23491193|NCT02761733|65544903|FG003|Overall Study|Physician Decision|0|||
23491194|NCT02761733|65544900|FG000|Overall Study|Withdrawal by Subject|2|||
23491195|NCT02761733|65544901|FG001|Overall Study|Withdrawal by Subject|0|||
23491196|NCT02761733|65544902|FG002|Overall Study|Withdrawal by Subject|0|||
23491197|NCT02761733|65544903|FG003|Overall Study|Withdrawal by Subject|0|||
23491198|NCT02761733|65544900|FG000|Overall Study|Discharged from Study Site|10|||
23491199|NCT02761733|65544901|FG001|Overall Study|Discharged from Study Site|9|||
23491200|NCT02761733|65544902|FG002|Overall Study|Discharged from Study Site|25|||
23491201|NCT02761733|65544903|FG003|Overall Study|Discharged from Study Site|11|||
23491202|NCT02761733|65544900|FG000|Overall Study|Cognitive Impairment|5|||
23491203|NCT02761733|65544901|FG001|Overall Study|Cognitive Impairment|0|||
23491204|NCT02761733|65544902|FG002|Overall Study|Cognitive Impairment|1|||
23491205|NCT02761733|65544903|FG003|Overall Study|Cognitive Impairment|0|||
23491206|NCT04806503|65544904|FG000|Overall Study|Lost to Follow-up|0|||
23491207|NCT04806503|65544905|FG001|Overall Study|Lost to Follow-up|0|||
23491208|NCT04806503|65544906|FG002|Overall Study|Lost to Follow-up|1|||
23491209|NCT04806503|65544907|FG003|Overall Study|Lost to Follow-up|0|||
23491210|NCT04806503|65544908|FG004|Overall Study|Lost to Follow-up|0|||
23491211|NCT04806503|65544904|FG000|Overall Study|Withdrawal by Subject|1|||
23491212|NCT04806503|65544905|FG001|Overall Study|Withdrawal by Subject|0|||
23491213|NCT04806503|65544906|FG002|Overall Study|Withdrawal by Subject|1|||
23491214|NCT04806503|65544907|FG003|Overall Study|Withdrawal by Subject|1|||
23491215|NCT04806503|65544908|FG004|Overall Study|Withdrawal by Subject|1|||
23491216|NCT04806503|65544904|FG000|Overall Study|Adverse Event|1|||
23491217|NCT04806503|65544905|FG001|Overall Study|Adverse Event|1|||
23491218|NCT04806503|65544906|FG002|Overall Study|Adverse Event|0|||
23491219|NCT04806503|65544907|FG003|Overall Study|Adverse Event|1|||
23491220|NCT04806503|65544908|FG004|Overall Study|Adverse Event|0|||
23491221|NCT02589405|65544909|FG000|Overall Study|Adverse Event|3|||
23605750|NCT01536704|65947034|FG002|Washout Period 1|Withdrawal by Subject|0|||
23491222|NCT02589405|65544909|FG000|Overall Study|Withdrawal by Subject|1|||
23491223|NCT03061097|65544911|FG000|Overall Study|Withdrawal by Subject|0|||
23491224|NCT03061097|65544912|FG001|Overall Study|Withdrawal by Subject|3|||
23491225|NCT04810481|65544913|FG000|Overall Study|Disqualified data sets|10|||
23491226|NCT04810481|65544914|FG001|Overall Study|Disqualified data sets|28|||
23605751|NCT01536704|65947035|FG003|Washout Period 1|Withdrawal by Subject|0|||
23491227|NCT00973674|65544921|FG000|Overall Study|Protocol Violation|2|||
23491228|NCT00973674|65544922|FG001|Overall Study|Protocol Violation|0|||
23491229|NCT01436396|65544923|FG000|Overall Study|Protocol Violation|7|||
23491230|NCT01436396|65544924|FG001|Overall Study|Protocol Violation|5|||
23491231|NCT01436396|65544923|FG000|Overall Study|Adverse Event|1|||
23491232|NCT01436396|65544924|FG001|Overall Study|Adverse Event|2|||
23379798|NCT00462462|65134288|FG000|Overall Study|Physician Decision|0|||
23379799|NCT00462462|65134289|FG001|Overall Study|Physician Decision|1|||
23379800|NCT04167670|65134290|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
23379801|NCT04167670|65134291|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
23379802|NCT04167670|65134292|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
23379803|NCT04167670|65134290|FG000|Overall Study|Significant protocol deviation|3|||
23379804|NCT04167670|65134291|FG001|Overall Study|Significant protocol deviation|1|||
23379805|NCT04167670|65134292|FG002|Overall Study|Significant protocol deviation|0|||
23379806|NCT04167670|65134290|FG000|Overall Study|Lost to Follow-up|0|||
23379807|NCT04167670|65134291|FG001|Overall Study|Lost to Follow-up|3|||
23379808|NCT04167670|65134292|FG002|Overall Study|Lost to Follow-up|3|||
23379809|NCT04167670|65134290|FG000|Overall Study|Voluntary Withdrawal|0|||
23379810|NCT04167670|65134291|FG001|Overall Study|Voluntary Withdrawal|1|||
23379811|NCT04167670|65134292|FG002|Overall Study|Voluntary Withdrawal|1|||
23379812|NCT04167670|65134290|FG000|Overall Study|Withdrawal of Consent|4|||
23379813|NCT04167670|65134291|FG001|Overall Study|Withdrawal of Consent|1|||
23379814|NCT04167670|65134292|FG002|Overall Study|Withdrawal of Consent|3|||
23379815|NCT04167670|65134290|FG000|Overall Study|Miscellaneous|7|||
23379816|NCT04167670|65134291|FG001|Overall Study|Miscellaneous|5|||
23379817|NCT04167670|65134292|FG002|Overall Study|Miscellaneous|3|||
23379818|NCT03301714|65137135|FG000|Overall Study|Lost to Follow-up|10|||
23379819|NCT03301714|65137136|FG001|Overall Study|Lost to Follow-up|4|||
23379820|NCT03301714|65137137|FG002|Overall Study|Lost to Follow-up|4|||
23379821|NCT03301714|65137135|FG000|Overall Study|Did not receive allocated intervention|0|||
23491233|NCT01436396|65544923|FG000|Overall Study|Withdrawal by Subject|19|||
23491234|NCT01436396|65544924|FG001|Overall Study|Withdrawal by Subject|29|||
23491235|NCT01436396|65544923|FG000|Overall Study|Serious adverse event|2|||
23491236|NCT01436396|65544924|FG001|Overall Study|Serious adverse event|3|||
23491237|NCT01436396|65544923|FG000|Overall Study|Lost to Follow-up|3|||
23491238|NCT01436396|65544924|FG001|Overall Study|Lost to Follow-up|3|||
23491239|NCT03643159|65544929|FG000|Overall Study|Adverse Event|1|||
23491240|NCT03643159|65544929|FG000|Overall Study|Withdrawal by Subject|1|||
23491241|NCT01863953|65544930|FG000|Overall Study|Adverse Event|0|||
23491242|NCT01863953|65544931|FG001|Overall Study|Adverse Event|0|||
23491243|NCT01863953|65544932|FG002|Overall Study|Adverse Event|1|||
23491244|NCT00299182|65544937|FG000|Overall Study|Withdrawal by Subject|0|||
23491245|NCT00299182|65544938|FG001|Overall Study|Withdrawal by Subject|0|||
23491246|NCT00299182|65544939|FG002|Overall Study|Withdrawal by Subject|1|||
23491247|NCT00299182|65544940|FG003|Overall Study|Withdrawal by Subject|0|||
23491248|NCT00299182|65544941|FG004|Overall Study|Withdrawal by Subject|1|||
23491249|NCT00299182|65544942|FG005|Overall Study|Withdrawal by Subject|2|||
23491250|NCT00299182|65544943|FG006|Overall Study|Withdrawal by Subject|0|||
23491251|NCT00299182|65544937|FG000|Overall Study|Chemotherapy Changed|0|||
23491252|NCT00299182|65544938|FG001|Overall Study|Chemotherapy Changed|0|||
23491253|NCT00299182|65544939|FG002|Overall Study|Chemotherapy Changed|1|||
23491254|NCT00299182|65544940|FG003|Overall Study|Chemotherapy Changed|0|||
23491255|NCT00299182|65544941|FG004|Overall Study|Chemotherapy Changed|1|||
23491256|NCT00299182|65544942|FG005|Overall Study|Chemotherapy Changed|0|||
23491257|NCT00299182|65544943|FG006|Overall Study|Chemotherapy Changed|1|||
23491258|NCT00299182|65544937|FG000|Overall Study|Adverse Event|0|||
23491259|NCT00299182|65544938|FG001|Overall Study|Adverse Event|0|||
23666666|NCT01251653|66162711|FG004|Overall Study|Progressive Disease|0|||
23666667|NCT01251653|66162712|FG005|Overall Study|Progressive Disease|17|||
23666668|NCT01251653|66162713|FG006|Overall Study|Progressive Disease|14|||
23666669|NCT01251653|66162714|FG007|Overall Study|Progressive Disease|7|||
23666670|NCT01251653|66162715|FG008|Overall Study|Progressive Disease|5|||
23666671|NCT01251653|66162707|FG000|Overall Study|Dose-limiting toxicity|0|||
23666672|NCT01251653|66162708|FG001|Overall Study|Dose-limiting toxicity|1|||
23666673|NCT01251653|66162709|FG002|Overall Study|Dose-limiting toxicity|1|||
23666674|NCT01251653|66162710|FG003|Overall Study|Dose-limiting toxicity|1|||
23666675|NCT01251653|66162711|FG004|Overall Study|Dose-limiting toxicity|0|||
23666676|NCT01251653|66162712|FG005|Overall Study|Dose-limiting toxicity|0|||
23666677|NCT01251653|66162713|FG006|Overall Study|Dose-limiting toxicity|2|||
23666678|NCT01251653|66162714|FG007|Overall Study|Dose-limiting toxicity|0|||
23666679|NCT01251653|66162715|FG008|Overall Study|Dose-limiting toxicity|0|||
23666680|NCT01251653|66162707|FG000|Overall Study|Adverse Event|1|||
23666681|NCT01251653|66162708|FG001|Overall Study|Adverse Event|0|||
23379822|NCT03301714|65137136|FG001|Overall Study|Did not receive allocated intervention|2|||
23379823|NCT03301714|65137137|FG002|Overall Study|Did not receive allocated intervention|3|||
23379824|NCT01363076|65137138|FG000|Overall Study|Withdrawal by Subject|0|||
23379825|NCT01363076|65137139|FG001|Overall Study|Withdrawal by Subject|1|||
23379826|NCT01348698|65137140|FG000|Overall Study|Does not meet lesion size criteria|1|||
23379827|NCT01348698|65137140|FG000|Overall Study|Death|3|||
23379828|NCT01348698|65137140|FG000|Overall Study|PI decision to close study|68|||
23379829|NCT00765076|65137143|FG000|Overall Study|Adverse Event|1|||
23379830|NCT00765076|65137144|FG001|Overall Study|Adverse Event|0|||
23379831|NCT00765076|65137145|FG002|Overall Study|Adverse Event|0|||
23379832|NCT00765076|65137143|FG000|Overall Study|Withdrawal by Subject|0|||
23379833|NCT00765076|65137144|FG001|Overall Study|Withdrawal by Subject|0|||
23379834|NCT00765076|65137145|FG002|Overall Study|Withdrawal by Subject|1|||
23379835|NCT03595748|65137149|FG000|Overall Study|Death|11|||
23379836|NCT03595748|65137150|FG001|Overall Study|Death|12|||
23666682|NCT01251653|66162709|FG002|Overall Study|Adverse Event|2|||
23666683|NCT01251653|66162710|FG003|Overall Study|Adverse Event|1|||
23666684|NCT01251653|66162711|FG004|Overall Study|Adverse Event|1|||
23666685|NCT01251653|66162712|FG005|Overall Study|Adverse Event|0|||
23379837|NCT03595748|65137149|FG000|Overall Study|Withdrawal by Subject|28|||
23666686|NCT01251653|66162713|FG006|Overall Study|Adverse Event|2|||
23666687|NCT01251653|66162714|FG007|Overall Study|Adverse Event|2|||
23666688|NCT01251653|66162715|FG008|Overall Study|Adverse Event|1|||
23379838|NCT03595748|65137150|FG001|Overall Study|Withdrawal by Subject|29|||
23379839|NCT03595748|65137149|FG000|Overall Study|Protocol Violation|0|||
23379840|NCT03595748|65137150|FG001|Overall Study|Protocol Violation|1|||
23379841|NCT01145222|65137151|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379842|NCT01145222|65137152|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379843|NCT01145222|65137153|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
23379844|NCT01145222|65137154|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379845|NCT01145222|65137151|FG000|Overall Study|Poor bowel preparation|0|||
23379846|NCT01145222|65137152|FG001|Overall Study|Poor bowel preparation|0|||
23605752|NCT01536704|65947032|FG000|Washout Period 2|Adverse Event|1|||
23666689|NCT01251653|66162707|FG000|Overall Study|Withdrawal by Subject|1|||
23666690|NCT01251653|66162708|FG001|Overall Study|Withdrawal by Subject|0|||
23666691|NCT01251653|66162709|FG002|Overall Study|Withdrawal by Subject|1|||
23666692|NCT01251653|66162710|FG003|Overall Study|Withdrawal by Subject|0|||
23666693|NCT01251653|66162711|FG004|Overall Study|Withdrawal by Subject|1|||
23666694|NCT01251653|66162712|FG005|Overall Study|Withdrawal by Subject|1|||
23666695|NCT01251653|66162713|FG006|Overall Study|Withdrawal by Subject|0|||
23666696|NCT01251653|66162714|FG007|Overall Study|Withdrawal by Subject|1|||
23666697|NCT01251653|66162715|FG008|Overall Study|Withdrawal by Subject|0|||
23666698|NCT01251653|66162707|FG000|Overall Study|Other reason not mentioned above|0|||
23666699|NCT01251653|66162708|FG001|Overall Study|Other reason not mentioned above|0|||
23666700|NCT01251653|66162709|FG002|Overall Study|Other reason not mentioned above|0|||
23666701|NCT01251653|66162710|FG003|Overall Study|Other reason not mentioned above|0|||
23666702|NCT01251653|66162711|FG004|Overall Study|Other reason not mentioned above|0|||
23666703|NCT01251653|66162712|FG005|Overall Study|Other reason not mentioned above|0|||
23666704|NCT01251653|66162713|FG006|Overall Study|Other reason not mentioned above|0|||
23666705|NCT01251653|66162714|FG007|Overall Study|Other reason not mentioned above|2|||
23666706|NCT01251653|66162715|FG008|Overall Study|Other reason not mentioned above|0|||
23379847|NCT01145222|65137153|FG002|Overall Study|Poor bowel preparation|0|||
23379848|NCT01145222|65137154|FG003|Overall Study|Poor bowel preparation|1|||
23605753|NCT01536704|65947033|FG001|Washout Period 2|Adverse Event|0|||
23605754|NCT01536704|65947034|FG002|Washout Period 2|Adverse Event|0|||
23605755|NCT01536704|65947035|FG003|Washout Period 2|Adverse Event|0|||
23605756|NCT01536704|65947032|FG000|Washout Period 2|Withdrawal by Subject|0|||
23605757|NCT01536704|65947033|FG001|Washout Period 2|Withdrawal by Subject|0|||
23605758|NCT01536704|65947034|FG002|Washout Period 2|Withdrawal by Subject|0|||
23605759|NCT01536704|65947035|FG003|Washout Period 2|Withdrawal by Subject|1|||
23605760|NCT01536704|65947032|FG000|Period 3|Adverse Event|0|||
23605761|NCT01536704|65947033|FG001|Period 3|Adverse Event|0|||
23605762|NCT01536704|65947034|FG002|Period 3|Adverse Event|0|||
23379849|NCT00294398|65137155|FG000|Overall Study|Lost to Follow-up|21|||
23379850|NCT00294398|65137156|FG001|Overall Study|Lost to Follow-up|26|||
23379851|NCT00441896|65137160|FG000|Overall Study|Withdrawal by Subject|0|||
23379852|NCT00441896|65137161|FG001|Overall Study|Withdrawal by Subject|0|||
23379853|NCT00441896|65137162|FG002|Overall Study|Withdrawal by Subject|0|||
23379854|NCT00441896|65137163|FG003|Overall Study|Withdrawal by Subject|1|||
23379855|NCT00441896|65137164|FG004|Overall Study|Withdrawal by Subject|0|||
23379856|NCT00441896|65137165|FG005|Overall Study|Withdrawal by Subject|0|||
23379857|NCT00441896|65137166|FG006|Overall Study|Withdrawal by Subject|0|||
23379858|NCT00441896|65137167|FG007|Overall Study|Withdrawal by Subject|0|||
23379859|NCT00441896|65137168|FG008|Overall Study|Withdrawal by Subject|0|||
23379860|NCT00441896|65137169|FG009|Overall Study|Withdrawal by Subject|0|||
23666707|NCT00807742|66162717|FG000|Overall Study|Death|9|||
23666708|NCT00807742|66162718|FG001|Overall Study|Death|2|||
23666709|NCT00807742|66162717|FG000|Overall Study|Withdrawal by Subject|2|||
23666710|NCT00807742|66162718|FG001|Overall Study|Withdrawal by Subject|1|||
23666711|NCT00807742|66162717|FG000|Overall Study|Lost to Follow-up|35|||
23666712|NCT00807742|66162718|FG001|Overall Study|Lost to Follow-up|51|||
23666713|NCT00254501|66162721|FG000|Overall Study|Lost to Follow-up|1|||
23666714|NCT00254501|66162722|FG001|Overall Study|Lost to Follow-up|1|||
23666715|NCT03028870|66162725|FG000|Overall Study|Adverse Event|7|||
23666716|NCT03028870|66162726|FG001|Overall Study|Adverse Event|4|||
23666717|NCT03028870|66162727|FG002|Overall Study|Adverse Event|3|||
23379861|NCT00441896|65137160|FG000|Overall Study|Other|0|||
23379862|NCT00441896|65137161|FG001|Overall Study|Other|0|||
23605763|NCT01536704|65947035|FG003|Period 3|Adverse Event|1|||
23605764|NCT01536704|65947032|FG000|Washout Period 3|Adverse Event|0|||
23605765|NCT01536704|65947033|FG001|Washout Period 3|Adverse Event|0|||
23605766|NCT01536704|65947034|FG002|Washout Period 3|Adverse Event|1|||
23605767|NCT01536704|65947035|FG003|Washout Period 3|Adverse Event|0|||
23605768|NCT02542696|65947036|FG000|Overall Study|Adverse Event|167|||
23605769|NCT02542696|65947036|FG000|Overall Study|Lack of Efficacy|26|||
23605770|NCT02542696|65947036|FG000|Overall Study|Lost to Follow-up|6|||
23605771|NCT02542696|65947036|FG000|Overall Study|Withdrawal by Subject|104|||
23605772|NCT02542696|65947036|FG000|Overall Study|Protocol Violation|5|||
23605773|NCT02542696|65947036|FG000|Overall Study|Death|8|||
23605774|NCT02542696|65947036|FG000|Overall Study|DECREASED OFF TIME|1|||
23605775|NCT02542696|65947036|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
23605776|NCT02542696|65947036|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
23605777|NCT02542696|65947036|FG000|Overall Study|MEDICAL HISTORY|1|||
23605778|NCT02542696|65947036|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
23605779|NCT02542696|65947036|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
23605780|NCT02542696|65947036|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
23605781|NCT02542696|65947036|FG000|Overall Study|SPONSOR DECISION|3|||
23605782|NCT02542696|65947036|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
23605783|NCT02542696|65947036|FG000|Overall Study|SUBJECT DECISION|2|||
23605784|NCT03652610|65947039|FG000|Overall Study|Lost to Follow-up|1|||
23666718|NCT03028870|66162728|FG003|Overall Study|Adverse Event|3|||
23666719|NCT03028870|66162725|FG000|Overall Study|Withdrawal by Subject|1|||
23666720|NCT03028870|66162726|FG001|Overall Study|Withdrawal by Subject|1|||
23666721|NCT03028870|66162727|FG002|Overall Study|Withdrawal by Subject|1|||
23666722|NCT03028870|66162728|FG003|Overall Study|Withdrawal by Subject|2|||
23379863|NCT00441896|65137162|FG002|Overall Study|Other|0|||
23379864|NCT00441896|65137163|FG003|Overall Study|Other|0|||
23605785|NCT03652610|65947040|FG001|Overall Study|Lost to Follow-up|0|||
23605786|NCT03652610|65947039|FG000|Overall Study|Withdrawal by Subject|3|||
23605787|NCT03652610|65947040|FG001|Overall Study|Withdrawal by Subject|5|||
23605788|NCT02077374|65947041|FG000|Overall Study|Withdrawal by Subject|0|||
23605789|NCT02077374|65947042|FG001|Overall Study|Withdrawal by Subject|1|||
23666723|NCT03028870|66162725|FG000|Overall Study|Lost to Follow-up|1|||
23666724|NCT03028870|66162726|FG001|Overall Study|Lost to Follow-up|0|||
23666725|NCT03028870|66162727|FG002|Overall Study|Lost to Follow-up|0|||
23666726|NCT03028870|66162728|FG003|Overall Study|Lost to Follow-up|0|||
23666727|NCT03028870|66162725|FG000|Overall Study|Lack of Efficacy|3|||
23666728|NCT03028870|66162726|FG001|Overall Study|Lack of Efficacy|0|||
23666729|NCT03028870|66162727|FG002|Overall Study|Lack of Efficacy|0|||
23666730|NCT03028870|66162728|FG003|Overall Study|Lack of Efficacy|0|||
23666731|NCT03028870|66162725|FG000|Overall Study|Administrative|5|||
23666732|NCT03028870|66162726|FG001|Overall Study|Administrative|5|||
23666733|NCT03028870|66162727|FG002|Overall Study|Administrative|12|||
23666734|NCT03028870|66162728|FG003|Overall Study|Administrative|4|||
23379865|NCT00441896|65137164|FG004|Overall Study|Other|1|||
23379866|NCT00441896|65137165|FG005|Overall Study|Other|0|||
23379867|NCT00441896|65137166|FG006|Overall Study|Other|0|||
23379868|NCT00441896|65137167|FG007|Overall Study|Other|0|||
23379869|NCT00441896|65137168|FG008|Overall Study|Other|0|||
23379870|NCT00441896|65137169|FG009|Overall Study|Other|0|||
23379871|NCT02178956|65137170|FG000|Overall Study|Lost to Follow-up|4|||
23379872|NCT02178956|65137171|FG001|Overall Study|Lost to Follow-up|4|||
23605790|NCT02077374|65947041|FG000|Overall Study|Protocol Violation|0|||
23605791|NCT02077374|65947042|FG001|Overall Study|Protocol Violation|1|||
23605792|NCT03075878|65947043|FG000|Overall Study|Physician Decision|1|||
23605793|NCT04658784|65947046|FG000|6-month Follow-up|Lost to Follow-up|2|||
23605794|NCT04658784|65947047|FG001|6-month Follow-up|Lost to Follow-up|5|||
23605795|NCT01951703|65947057|FG000|First Intervention|Withdrawal by Subject|1|||
23605796|NCT01951703|65947058|FG001|First Intervention|Withdrawal by Subject|0|||
23605797|NCT01951703|65947057|FG000|First Intervention|Subject was not compliant|1|||
23605798|NCT01951703|65947058|FG001|First Intervention|Subject was not compliant|1|||
23605799|NCT01951703|65947057|FG000|First Intervention|Physician Decision|1|||
23666735|NCT03962738|66162733|FG000|Overall Study|Protocol Deviation|3|||
23666736|NCT03962738|66162734|FG001|Overall Study|Protocol Deviation|0|||
23666737|NCT03962738|66162735|FG002|Overall Study|Protocol Deviation|1|||
23666738|NCT03962738|66162736|FG003|Overall Study|Protocol Deviation|1|||
23666739|NCT03962738|66162733|FG000|Overall Study|Withdrawal by Subject|4|||
23666740|NCT03962738|66162734|FG001|Overall Study|Withdrawal by Subject|0|||
23666741|NCT03962738|66162735|FG002|Overall Study|Withdrawal by Subject|0|||
23666742|NCT03962738|66162736|FG003|Overall Study|Withdrawal by Subject|0|||
23666743|NCT03962738|66162733|FG000|Overall Study|Lost to Follow-up|0|||
23666744|NCT03962738|66162734|FG001|Overall Study|Lost to Follow-up|0|||
23666745|NCT03962738|66162735|FG002|Overall Study|Lost to Follow-up|1|||
23666746|NCT03962738|66162736|FG003|Overall Study|Lost to Follow-up|0|||
23666747|NCT01840579|66162745|FG000|Overall Study|Status not recorded|0|||
23666748|NCT01840579|66162746|FG001|Overall Study|Status not recorded|0|||
23666749|NCT01840579|66162747|FG002|Overall Study|Status not recorded|2|||
23666750|NCT01840579|66162748|FG003|Overall Study|Status not recorded|3|||
23666751|NCT01840579|66162749|FG004|Overall Study|Status not recorded|4|||
23666752|NCT01840579|66162750|FG005|Overall Study|Status not recorded|3|||
23666753|NCT01840579|66162751|FG006|Overall Study|Status not recorded|0|||
23666754|NCT01840579|66162752|FG007|Overall Study|Status not recorded|3|||
23666755|NCT01840579|66162753|FG008|Overall Study|Status not recorded|3|||
23666756|NCT01840579|66162754|FG009|Overall Study|Status not recorded|3|||
23666757|NCT01840579|66162745|FG000|Overall Study|Progressive disease|3|||
23666758|NCT01840579|66162746|FG001|Overall Study|Progressive disease|5|||
23666759|NCT01840579|66162747|FG002|Overall Study|Progressive disease|0|||
23666760|NCT01840579|66162748|FG003|Overall Study|Progressive disease|0|||
23666761|NCT01840579|66162749|FG004|Overall Study|Progressive disease|0|||
23379873|NCT02178956|65137170|FG000|Overall Study|Sponsor terminated study|49|||
23379874|NCT02178956|65137171|FG001|Overall Study|Sponsor terminated study|58|||
23666762|NCT01840579|66162750|FG005|Overall Study|Progressive disease|0|||
23666763|NCT01840579|66162751|FG006|Overall Study|Progressive disease|0|||
23379875|NCT02178956|65137170|FG000|Overall Study|Withdrawal by Subject|15|||
23379876|NCT02178956|65137171|FG001|Overall Study|Withdrawal by Subject|11|||
23379877|NCT02178956|65137170|FG000|Overall Study|Various Reasons|3|||
23379878|NCT02178956|65137171|FG001|Overall Study|Various Reasons|5|||
23379879|NCT03188185|65137172|FG000|Stage 1|Adverse Event|4|||
23379880|NCT03188185|65137173|FG001|Stage 1|Adverse Event|12|||
23379881|NCT03188185|65137174|FG002|Stage 1|Adverse Event|0|||
23379882|NCT03188185|65137175|FG003|Stage 1|Adverse Event|0|||
23379883|NCT03188185|65137172|FG000|Stage 1|Lack of Efficacy|0|||
23379884|NCT03188185|65137173|FG001|Stage 1|Lack of Efficacy|2|||
23379885|NCT03188185|65137174|FG002|Stage 1|Lack of Efficacy|0|||
23379886|NCT03188185|65137175|FG003|Stage 1|Lack of Efficacy|0|||
23379887|NCT03188185|65137172|FG000|Stage 1|Lost to Follow-up|6|||
23379888|NCT03188185|65137173|FG001|Stage 1|Lost to Follow-up|1|||
23379889|NCT03188185|65137174|FG002|Stage 1|Lost to Follow-up|0|||
23379890|NCT03188185|65137175|FG003|Stage 1|Lost to Follow-up|0|||
23379891|NCT03188185|65137172|FG000|Stage 1|Withdrawal by Subject|9|||
23379892|NCT03188185|65137173|FG001|Stage 1|Withdrawal by Subject|0|||
23379893|NCT03188185|65137174|FG002|Stage 1|Withdrawal by Subject|0|||
23379894|NCT03188185|65137175|FG003|Stage 1|Withdrawal by Subject|0|||
23379895|NCT03188185|65137172|FG000|Stage 1|Identified as a professional patient|0|||
23379896|NCT03188185|65137173|FG001|Stage 1|Identified as a professional patient|1|||
23379897|NCT03188185|65137174|FG002|Stage 1|Identified as a professional patient|0|||
23379898|NCT03188185|65137175|FG003|Stage 1|Identified as a professional patient|0|||
23379899|NCT03188185|65137172|FG000|Stage 2|Adverse Event|0|||
23379900|NCT03188185|65137173|FG001|Stage 2|Adverse Event|0|||
23379901|NCT03188185|65137174|FG002|Stage 2|Adverse Event|2|||
23379902|NCT03188185|65137175|FG003|Stage 2|Adverse Event|4|||
23379903|NCT03188185|65137172|FG000|Stage 2|Lack of Efficacy|0|||
23379904|NCT03188185|65137173|FG001|Stage 2|Lack of Efficacy|0|||
23379905|NCT03188185|65137174|FG002|Stage 2|Lack of Efficacy|3|||
23379906|NCT03188185|65137175|FG003|Stage 2|Lack of Efficacy|0|||
23379907|NCT03188185|65137172|FG000|Stage 2|Lost to Follow-up|0|||
23379908|NCT03188185|65137173|FG001|Stage 2|Lost to Follow-up|0|||
23379909|NCT03188185|65137174|FG002|Stage 2|Lost to Follow-up|1|||
23379910|NCT03188185|65137175|FG003|Stage 2|Lost to Follow-up|0|||
23379911|NCT03188185|65137172|FG000|Stage 2|Physician Decision|0|||
23379912|NCT03188185|65137173|FG001|Stage 2|Physician Decision|0|||
23379913|NCT03188185|65137174|FG002|Stage 2|Physician Decision|0|||
23379914|NCT03188185|65137175|FG003|Stage 2|Physician Decision|1|||
23379915|NCT03188185|65137172|FG000|Stage 2|Withdrawal by Subject|0|||
23379916|NCT03188185|65137173|FG001|Stage 2|Withdrawal by Subject|0|||
23379917|NCT03188185|65137174|FG002|Stage 2|Withdrawal by Subject|3|||
23379918|NCT03188185|65137175|FG003|Stage 2|Withdrawal by Subject|1|||
23379919|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379920|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
23379921|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
23379922|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379923|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379924|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379925|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379926|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
23379927|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379928|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
23379929|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379930|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379931|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379932|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379933|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379934|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379935|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
23379936|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379937|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379938|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379939|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379940|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
23379941|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379942|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379943|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379944|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379945|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379946|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379947|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379948|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379949|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
23379950|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379951|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379952|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379953|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23666764|NCT01840579|66162752|FG007|Overall Study|Progressive disease|0|||
23666765|NCT01840579|66162753|FG008|Overall Study|Progressive disease|0|||
23666766|NCT01840579|66162754|FG009|Overall Study|Progressive disease|0|||
23666767|NCT01840579|66162745|FG000|Overall Study|Ongoing in study|0|||
23666768|NCT01840579|66162746|FG001|Overall Study|Ongoing in study|1|||
23666769|NCT01840579|66162747|FG002|Overall Study|Ongoing in study|0|||
23666770|NCT01840579|66162748|FG003|Overall Study|Ongoing in study|0|||
23666771|NCT01840579|66162749|FG004|Overall Study|Ongoing in study|0|||
23666772|NCT01840579|66162750|FG005|Overall Study|Ongoing in study|0|||
23666773|NCT01840579|66162751|FG006|Overall Study|Ongoing in study|0|||
23666774|NCT01840579|66162752|FG007|Overall Study|Ongoing in study|0|||
23666775|NCT01840579|66162753|FG008|Overall Study|Ongoing in study|0|||
23666776|NCT01840579|66162754|FG009|Overall Study|Ongoing in study|0|||
23666777|NCT01840579|66162745|FG000|Overall Study|Death|0|||
23666778|NCT01840579|66162746|FG001|Overall Study|Death|0|||
23666779|NCT01840579|66162747|FG002|Overall Study|Death|0|||
23666780|NCT01840579|66162748|FG003|Overall Study|Death|0|||
23666781|NCT01840579|66162749|FG004|Overall Study|Death|0|||
23666782|NCT01840579|66162750|FG005|Overall Study|Death|1|||
23666783|NCT01840579|66162751|FG006|Overall Study|Death|0|||
23666784|NCT01840579|66162752|FG007|Overall Study|Death|0|||
23666785|NCT01840579|66162753|FG008|Overall Study|Death|0|||
23666786|NCT01840579|66162754|FG009|Overall Study|Death|0|||
23666787|NCT01840579|66162745|FG000|Overall Study|Adverse Event|0|||
23666788|NCT01840579|66162746|FG001|Overall Study|Adverse Event|1|||
23666789|NCT01840579|66162747|FG002|Overall Study|Adverse Event|0|||
23666790|NCT01840579|66162748|FG003|Overall Study|Adverse Event|0|||
23666791|NCT01840579|66162749|FG004|Overall Study|Adverse Event|0|||
23666792|NCT01840579|66162750|FG005|Overall Study|Adverse Event|0|||
23666793|NCT01840579|66162751|FG006|Overall Study|Adverse Event|0|||
23666794|NCT01840579|66162752|FG007|Overall Study|Adverse Event|0|||
23666795|NCT01840579|66162753|FG008|Overall Study|Adverse Event|0|||
23666796|NCT01840579|66162754|FG009|Overall Study|Adverse Event|0|||
23379954|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
23666797|NCT01840579|66162745|FG000|Overall Study|Follow-up ended by Sponsor|0|||
23666798|NCT01840579|66162746|FG001|Overall Study|Follow-up ended by Sponsor|0|||
23666799|NCT01840579|66162747|FG002|Overall Study|Follow-up ended by Sponsor|0|||
23666800|NCT01840579|66162748|FG003|Overall Study|Follow-up ended by Sponsor|0|||
23666801|NCT01840579|66162749|FG004|Overall Study|Follow-up ended by Sponsor|0|||
23666802|NCT01840579|66162750|FG005|Overall Study|Follow-up ended by Sponsor|0|||
23666803|NCT01840579|66162751|FG006|Overall Study|Follow-up ended by Sponsor|2|||
23666804|NCT01840579|66162752|FG007|Overall Study|Follow-up ended by Sponsor|0|||
23666805|NCT01840579|66162753|FG008|Overall Study|Follow-up ended by Sponsor|0|||
23379955|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23666806|NCT01840579|66162754|FG009|Overall Study|Follow-up ended by Sponsor|0|||
23379956|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379957|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379958|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379959|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379960|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379961|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
23379962|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
23666807|NCT01549002|66165253|FG000|Overall Study|Excessive pain|0|||
23666808|NCT01549002|66165254|FG001|Overall Study|Excessive pain|2|||
23666809|NCT01549002|66165253|FG000|Overall Study|Moderate sedation required|0|||
23666810|NCT01549002|66165254|FG001|Overall Study|Moderate sedation required|2|||
23666811|NCT00769184|66165255|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
23666812|NCT00769184|66165256|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
23666813|NCT00769184|66165255|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
23666814|NCT00769184|66165256|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
23666815|NCT00769184|66165255|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
23666816|NCT00769184|66165256|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
23666817|NCT02581202|66165257|FG000|Overall Study|Lack of Efficacy|2|||
23666818|NCT02581202|66165257|FG000|Overall Study|Withdrawal by Subject|4|||
23666819|NCT02581202|66165257|FG000|Overall Study|Lost to Follow-up|5|||
23666820|NCT02581202|66165257|FG000|Overall Study|Pregnancy|3|||
23666821|NCT02289950|66165271|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
23666822|NCT02289950|66165272|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
23666823|NCT02289950|66165271|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
23666824|NCT02289950|66165272|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
23666825|NCT02289950|66165271|FG000|Overall Study|Lost to Follow-up|1|||
23666826|NCT02289950|66165272|FG001|Overall Study|Lost to Follow-up|0|||
23666827|NCT02289950|66165271|FG000|Overall Study|Physician Decision|9|||
23666828|NCT02289950|66165272|FG001|Overall Study|Physician Decision|3|||
23666829|NCT02289950|66165271|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
23666830|NCT02289950|66165272|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
23666831|NCT02289950|66165271|FG000|Overall Study|Withdrawal by Subject|1|||
23666832|NCT02289950|66165272|FG001|Overall Study|Withdrawal by Subject|3|||
23666833|NCT02289950|66165271|FG000|Overall Study|Test article held for greater than 28 days|0|||
23666834|NCT02289950|66165272|FG001|Overall Study|Test article held for greater than 28 days|1|||
23666835|NCT02289950|66165271|FG000|Overall Study|Adverse Event|11|||
23666836|NCT02289950|66165272|FG001|Overall Study|Adverse Event|3|||
23666837|NCT02289950|66165271|FG000|Overall Study|Death|1|||
23379963|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379964|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379965|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
23379966|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379967|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379968|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379969|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379970|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379971|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
23379972|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379973|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379974|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379975|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
23379976|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23666838|NCT02289950|66165272|FG001|Overall Study|Death|1|||
23666839|NCT02289950|66165271|FG000|Overall Study|Other|5|||
23666840|NCT02289950|66165272|FG001|Overall Study|Other|2|||
23666841|NCT02289950|66165271|FG000|Overall Study|Not Treated|2|||
23666842|NCT02289950|66165272|FG001|Overall Study|Not Treated|1|||
23666843|NCT01250379|66165273|FG000|Overall Study|Death|141|||
23666844|NCT01250379|66165274|FG001|Overall Study|Death|148|||
23666845|NCT01250379|66165273|FG000|Overall Study|Withdrawal by Subject|32|||
23666846|NCT01250379|66165274|FG001|Overall Study|Withdrawal by Subject|20|||
23666847|NCT01250379|66165273|FG000|Overall Study|Physician Decision|11|||
23379977|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379978|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23491260|NCT00299182|65544939|FG002|Overall Study|Adverse Event|0|||
23491261|NCT00299182|65544940|FG003|Overall Study|Adverse Event|0|||
23491262|NCT00299182|65544941|FG004|Overall Study|Adverse Event|0|||
23491263|NCT00299182|65544942|FG005|Overall Study|Adverse Event|1|||
23491264|NCT00299182|65544943|FG006|Overall Study|Adverse Event|0|||
23491265|NCT00299182|65544937|FG000|Overall Study|Not Eligible|0|||
23491266|NCT00299182|65544938|FG001|Overall Study|Not Eligible|0|||
23491267|NCT00299182|65544939|FG002|Overall Study|Not Eligible|0|||
23491268|NCT00299182|65544940|FG003|Overall Study|Not Eligible|0|||
23491269|NCT00299182|65544941|FG004|Overall Study|Not Eligible|1|||
23491270|NCT00299182|65544942|FG005|Overall Study|Not Eligible|0|||
23491271|NCT00299182|65544943|FG006|Overall Study|Not Eligible|0|||
23491272|NCT01297920|65544944|FG000|Overall Study|Adverse Event|42|||
23491273|NCT01297920|65544945|FG001|Overall Study|Adverse Event|10|||
23491274|NCT01297920|65544946|FG002|Overall Study|Adverse Event|38|||
23491275|NCT01297920|65544944|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
23491276|NCT01297920|65544945|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
23491277|NCT01297920|65544946|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
23491278|NCT01297920|65544944|FG000|Overall Study|Noncompliance|1|||
23491279|NCT01297920|65544945|FG001|Overall Study|Noncompliance|0|||
23491280|NCT01297920|65544946|FG002|Overall Study|Noncompliance|0|||
23491281|NCT01297920|65544944|FG000|Overall Study|Protocol Violation|1|||
23491282|NCT01297920|65544945|FG001|Overall Study|Protocol Violation|3|||
23491283|NCT01297920|65544946|FG002|Overall Study|Protocol Violation|0|||
23491284|NCT01297920|65544944|FG000|Overall Study|Inadequate Control of IOP|7|||
23491285|NCT01297920|65544945|FG001|Overall Study|Inadequate Control of IOP|9|||
23491286|NCT01297920|65544946|FG002|Overall Study|Inadequate Control of IOP|17|||
23491287|NCT01297920|65544944|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
23491288|NCT01297920|65544945|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
23491289|NCT01297920|65544946|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
23491290|NCT01642407|65544947|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
23491291|NCT01642407|65544947|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
23491292|NCT01642407|65544947|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
23491293|NCT02764697|65544952|FG000|Overall Study|Lack of Efficacy|3|||
23491294|NCT00057954|65544953|FG000|Overall Study|Death|1|||
23491295|NCT00057954|65544953|FG000|Overall Study|Disease progression|1|||
23491296|NCT00736957|65544957|FG000|Overall Study|Adverse Event|43|||
23491297|NCT00736957|65544957|FG000|Overall Study|Withdrawal by Subject|49|||
23491298|NCT00736957|65544957|FG000|Overall Study|violation of eligibility criteria|2|||
23491299|NCT00736957|65544957|FG000|Overall Study|did not attend hospital appointments|1|||
23491300|NCT00736957|65544957|FG000|Overall Study|not eligible for Treatment Period I|22|||
23491301|NCT00736957|65544957|FG000|Overall Study|Physician Decision|5|||
23491302|NCT05055128|65544958|FG000|Overall Study|Adverse Event|0|||
23491303|NCT05055128|65544959|FG001|Overall Study|Adverse Event|0|||
23491304|NCT05055128|65544960|FG002|Overall Study|Adverse Event|0|||
23491305|NCT05055128|65544961|FG003|Overall Study|Adverse Event|1|||
23491306|NCT05055128|65544962|FG004|Overall Study|Adverse Event|1|||
23491307|NCT05055128|65544958|FG000|Overall Study|Protocol Violation|0|||
23491308|NCT05055128|65544959|FG001|Overall Study|Protocol Violation|0|||
23379979|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379980|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379981|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23491309|NCT05055128|65544960|FG002|Overall Study|Protocol Violation|0|||
23491310|NCT05055128|65544961|FG003|Overall Study|Protocol Violation|1|||
23491311|NCT05055128|65544962|FG004|Overall Study|Protocol Violation|0|||
23491312|NCT05055128|65544958|FG000|Overall Study|Withdrawal by Subject|5|||
23491313|NCT05055128|65544959|FG001|Overall Study|Withdrawal by Subject|2|||
23666848|NCT01250379|66165274|FG001|Overall Study|Physician Decision|3|||
23491314|NCT05055128|65544960|FG002|Overall Study|Withdrawal by Subject|2|||
23491315|NCT05055128|65544961|FG003|Overall Study|Withdrawal by Subject|4|||
23491316|NCT05055128|65544962|FG004|Overall Study|Withdrawal by Subject|2|||
23491317|NCT05055128|65544958|FG000|Overall Study|Randomized By Mistake|0|||
23491318|NCT05055128|65544959|FG001|Overall Study|Randomized By Mistake|1|||
23491319|NCT05055128|65544960|FG002|Overall Study|Randomized By Mistake|0|||
23491320|NCT05055128|65544961|FG003|Overall Study|Randomized By Mistake|0|||
23491321|NCT05055128|65544962|FG004|Overall Study|Randomized By Mistake|0|||
23491322|NCT05055128|65544958|FG000|Overall Study|Other|1|||
23491323|NCT05055128|65544959|FG001|Overall Study|Other|0|||
23491324|NCT05055128|65544960|FG002|Overall Study|Other|0|||
23491325|NCT05055128|65544961|FG003|Overall Study|Other|0|||
23491326|NCT05055128|65544962|FG004|Overall Study|Other|0|||
23491327|NCT02572388|65544963|FG000|Overall Study|Withdrawal by Subject|1|||
23491328|NCT02572388|65544964|FG001|Overall Study|Withdrawal by Subject|1|||
23491329|NCT02572388|65544965|FG002|Overall Study|Withdrawal by Subject|2|||
23491330|NCT02572388|65544966|FG003|Overall Study|Withdrawal by Subject|2|||
23491331|NCT03570697|65544987|FG000|Overall Study|Lost to Follow-up|0|||
23491332|NCT03570697|65544988|FG001|Overall Study|Lost to Follow-up|1|||
23491333|NCT03570697|65544987|FG000|Overall Study|Death|2|||
23491334|NCT03570697|65544988|FG001|Overall Study|Death|0|||
23491335|NCT03570697|65544987|FG000|Overall Study|Withdrawal by Subject|4|||
23491336|NCT03570697|65544988|FG001|Overall Study|Withdrawal by Subject|2|||
23491337|NCT01013350|65544989|FG000|Overall Study|Lost to Follow-up|15|||
23491338|NCT01013350|65544990|FG001|Overall Study|Lost to Follow-up|95|||
23491339|NCT01013350|65544989|FG000|Overall Study|Adverse Event|0|||
23491340|NCT01013350|65544990|FG001|Overall Study|Adverse Event|1|||
23491341|NCT01013350|65544989|FG000|Overall Study|Physician Decision|4|||
23491342|NCT01013350|65544990|FG001|Overall Study|Physician Decision|20|||
23491343|NCT01013350|65544989|FG000|Overall Study|Withdrawal by Subject|15|||
23491344|NCT01013350|65544990|FG001|Overall Study|Withdrawal by Subject|38|||
23491345|NCT01013350|65544989|FG000|Overall Study|Death|3|||
23491346|NCT01013350|65544990|FG001|Overall Study|Death|5|||
23491347|NCT01013350|65544989|FG000|Overall Study|Participant entered interventional study|0|||
23491348|NCT01013350|65544990|FG001|Overall Study|Participant entered interventional study|8|||
23491349|NCT01013350|65544989|FG000|Overall Study|Other|1|||
23491350|NCT01013350|65544990|FG001|Overall Study|Other|25|||
23491351|NCT01497275|65544993|FG000|Overall Study|Death|1|||
23491352|NCT01497275|65544993|FG000|Overall Study|Adverse Event|1|||
23491353|NCT01254630|65544994|FG000|Overall Study|Adverse Event|36|||
23491354|NCT01254630|65544995|FG001|Overall Study|Adverse Event|15|||
23491355|NCT01254630|65544996|FG002|Overall Study|Adverse Event|40|||
23491356|NCT01254630|65544997|FG003|Overall Study|Adverse Event|8|||
23491357|NCT01254630|65544994|FG000|Overall Study|Death|461|||
23491358|NCT01254630|65544995|FG001|Overall Study|Death|151|||
23491359|NCT01254630|65544996|FG002|Overall Study|Death|478|||
23491360|NCT01254630|65544997|FG003|Overall Study|Death|139|||
23491361|NCT01254630|65544994|FG000|Overall Study|Lost to Follow-up|80|||
23491362|NCT01254630|65544995|FG001|Overall Study|Lost to Follow-up|26|||
23491363|NCT01254630|65544996|FG002|Overall Study|Lost to Follow-up|89|||
23491364|NCT01254630|65544997|FG003|Overall Study|Lost to Follow-up|32|||
23491365|NCT01254630|65544994|FG000|Overall Study|Physician Decision|24|||
23491366|NCT01254630|65544995|FG001|Overall Study|Physician Decision|8|||
23491367|NCT01254630|65544996|FG002|Overall Study|Physician Decision|16|||
23491368|NCT01254630|65544997|FG003|Overall Study|Physician Decision|7|||
23491369|NCT01254630|65544994|FG000|Overall Study|Withdrawal by Subject|201|||
23491370|NCT01254630|65544995|FG001|Overall Study|Withdrawal by Subject|94|||
23491371|NCT01254630|65544996|FG002|Overall Study|Withdrawal by Subject|188|||
23491372|NCT01254630|65544997|FG003|Overall Study|Withdrawal by Subject|89|||
23491373|NCT01254630|65544994|FG000|Overall Study|Study terminated by sponsor|0|||
23491374|NCT01254630|65544995|FG001|Overall Study|Study terminated by sponsor|994|||
23491375|NCT01254630|65544996|FG002|Overall Study|Study terminated by sponsor|0|||
23491376|NCT01254630|65544997|FG003|Overall Study|Study terminated by sponsor|1010|||
23491377|NCT01254630|65544994|FG000|Overall Study|Status not recorded|0|||
23491378|NCT01254630|65544995|FG001|Overall Study|Status not recorded|0|||
23491379|NCT01254630|65544996|FG002|Overall Study|Status not recorded|1|||
23491380|NCT01254630|65544997|FG003|Overall Study|Status not recorded|0|||
23491381|NCT00122109|65544998|FG000|Overall Study|Did not meet criteria|6|||
23491382|NCT00122109|65544999|FG001|Overall Study|Did not meet criteria|7|||
23491383|NCT02001181|65545002|FG000|Overall Study|Adverse Event|0|||
23491384|NCT02001181|65545003|FG001|Overall Study|Adverse Event|2|||
23491385|NCT02001181|65545002|FG000|Overall Study|Lost to Follow-up|1|||
23491386|NCT02001181|65545003|FG001|Overall Study|Lost to Follow-up|0|||
23491387|NCT02001181|65545002|FG000|Overall Study|Withdrawal by Subject|0|||
23666849|NCT01250379|66165273|FG000|Overall Study|Protocol Violation|2|||
23666850|NCT01250379|66165274|FG001|Overall Study|Protocol Violation|8|||
23491388|NCT02001181|65545003|FG001|Overall Study|Withdrawal by Subject|1|||
23491389|NCT02186873|65545004|FG000|Overall Study|Adverse Event|1|||
23491390|NCT02186873|65545005|FG001|Overall Study|Adverse Event|3|||
23491391|NCT02186873|65545004|FG000|Overall Study|Lack of Efficacy|0|||
23491392|NCT02186873|65545005|FG001|Overall Study|Lack of Efficacy|1|||
23491393|NCT02186873|65545004|FG000|Overall Study|Lost to Follow-up|1|||
23491394|NCT02186873|65545005|FG001|Overall Study|Lost to Follow-up|2|||
23491395|NCT02186873|65545004|FG000|Overall Study|Withdrawal by Subject|7|||
23491396|NCT02186873|65545005|FG001|Overall Study|Withdrawal by Subject|2|||
23491397|NCT00333840|65545006|FG000|First-line Treatment Period|Adverse Event|38|||
23491398|NCT00333840|65545007|FG001|First-line Treatment Period|Adverse Event|37|||
23491399|NCT00333840|65545008|FG002|First-line Treatment Period|Adverse Event|0|||
23491400|NCT00333840|65545009|FG003|First-line Treatment Period|Adverse Event|0|||
23491401|NCT00333840|65545006|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
23491402|NCT00333840|65545007|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
23491403|NCT00333840|65545008|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
23491404|NCT00333840|65545009|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
23491405|NCT00333840|65545006|FG000|First-line Treatment Period|Abnormal procedure|2|||
23491406|NCT00333840|65545007|FG001|First-line Treatment Period|Abnormal procedure|0|||
23491407|NCT00333840|65545008|FG002|First-line Treatment Period|Abnormal procedure|0|||
23491408|NCT00333840|65545009|FG003|First-line Treatment Period|Abnormal procedure|0|||
23491409|NCT00333840|65545006|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
23491410|NCT00333840|65545007|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
23491411|NCT00333840|65545008|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491412|NCT00333840|65545009|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491413|NCT00333840|65545006|FG000|First-line Treatment Period|No longer required study drug|21|||
23491414|NCT00333840|65545007|FG001|First-line Treatment Period|No longer required study drug|8|||
23491415|NCT00333840|65545008|FG002|First-line Treatment Period|No longer required study drug|0|||
23491416|NCT00333840|65545009|FG003|First-line Treatment Period|No longer required study drug|0|||
23491417|NCT00333840|65545006|FG000|First-line Treatment Period|Protocol Violation|17|||
23491418|NCT00333840|65545007|FG001|First-line Treatment Period|Protocol Violation|17|||
23491419|NCT00333840|65545008|FG002|First-line Treatment Period|Protocol Violation|0|||
23491420|NCT00333840|65545009|FG003|First-line Treatment Period|Protocol Violation|0|||
23491421|NCT00333840|65545006|FG000|First-line Treatment Period|Subject withdrew consent|57|||
23491422|NCT00333840|65545007|FG001|First-line Treatment Period|Subject withdrew consent|77|||
23491423|NCT00333840|65545008|FG002|First-line Treatment Period|Subject withdrew consent|0|||
23491424|NCT00333840|65545009|FG003|First-line Treatment Period|Subject withdrew consent|0|||
23491425|NCT00333840|65545006|FG000|First-line Treatment Period|Lost to Follow-up|15|||
23491426|NCT00333840|65545007|FG001|First-line Treatment Period|Lost to Follow-up|6|||
23491427|NCT00333840|65545008|FG002|First-line Treatment Period|Lost to Follow-up|0|||
23491428|NCT00333840|65545009|FG003|First-line Treatment Period|Lost to Follow-up|0|||
23491429|NCT00333840|65545006|FG000|First-line Treatment Period|Administrative problems|12|||
23491430|NCT00333840|65545007|FG001|First-line Treatment Period|Administrative problems|6|||
23491431|NCT00333840|65545008|FG002|First-line Treatment Period|Administrative problems|0|||
23491432|NCT00333840|65545009|FG003|First-line Treatment Period|Administrative problems|0|||
23491433|NCT00333840|65545006|FG000|First-line Treatment Period|Death|19|||
23491434|NCT00333840|65545007|FG001|First-line Treatment Period|Death|2|||
23491435|NCT00333840|65545008|FG002|First-line Treatment Period|Death|0|||
23491436|NCT00333840|65545009|FG003|First-line Treatment Period|Death|0|||
23491437|NCT00333840|65545006|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
23491438|NCT00333840|65545007|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
23491439|NCT00333840|65545008|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
23491440|NCT00333840|65545009|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
23491441|NCT00333840|65545006|FG000|Second-line Treatment Period|Adverse Event|0|||
23491442|NCT00333840|65545007|FG001|Second-line Treatment Period|Adverse Event|0|||
23491443|NCT00333840|65545008|FG002|Second-line Treatment Period|Adverse Event|3|||
23491444|NCT00333840|65545009|FG003|Second-line Treatment Period|Adverse Event|34|||
23491445|NCT00333840|65545006|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491446|NCT00333840|65545007|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491447|NCT00333840|65545008|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491448|NCT00333840|65545009|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
23491449|NCT00333840|65545006|FG000|Second-line Treatment Period|Abnormal procedure|0|||
23491450|NCT00333840|65545007|FG001|Second-line Treatment Period|Abnormal procedure|0|||
23379982|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379983|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
23379984|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379985|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379986|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379987|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379988|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379989|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
23379990|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379991|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379992|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
23491451|NCT00333840|65545008|FG002|Second-line Treatment Period|Abnormal procedure|0|||
23666851|NCT01250379|66165273|FG000|Overall Study|Lost to Follow-up|9|||
23491452|NCT00333840|65545009|FG003|Second-line Treatment Period|Abnormal procedure|1|||
23379993|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379994|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379995|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379996|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
23379997|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
23379998|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23379999|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380000|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
23380001|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380002|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380003|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380004|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380005|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380006|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380007|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380008|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380009|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380010|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
23380011|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
23380012|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380013|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
23380014|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
23380015|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380016|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380017|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380018|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380019|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380020|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380021|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380022|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
23380023|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380024|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380025|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380026|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380027|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380028|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380029|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
23380030|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380031|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380032|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380033|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380034|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380035|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380036|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
23380037|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
23380038|NCT00337194|65137189|FG000|Overall Study|Adverse Event|5|||
23380039|NCT00337194|65137190|FG001|Overall Study|Adverse Event|1|||
23380040|NCT00337194|65137189|FG000|Overall Study|Death|2|||
23380041|NCT00337194|65137190|FG001|Overall Study|Death|0|||
23380042|NCT00337194|65137189|FG000|Overall Study|Withdrawal by Subject|1|||
23380043|NCT00337194|65137190|FG001|Overall Study|Withdrawal by Subject|0|||
23380044|NCT00337194|65137189|FG000|Overall Study|Disease progression|1|||
23380045|NCT00337194|65137190|FG001|Overall Study|Disease progression|2|||
23380046|NCT00337194|65137189|FG000|Overall Study|Subsequent non-protocol therapy|3|||
23380047|NCT00337194|65137190|FG001|Overall Study|Subsequent non-protocol therapy|1|||
23380048|NCT01327703|65137193|FG000|Second Treatment Period|Adverse Event|1|||
23380049|NCT01327703|65137194|FG001|Second Treatment Period|Adverse Event|1|||
23380050|NCT01327703|65137193|FG000|Second Treatment Period|Protocol Violation|0|||
23380051|NCT01327703|65137194|FG001|Second Treatment Period|Protocol Violation|1|||
23380052|NCT00088153|65137198|FG000|Overall Study|Physician Decision|3|||
23380053|NCT00088153|65137199|FG001|Overall Study|Physician Decision|3|||
23380054|NCT00088153|65137198|FG000|Overall Study|Withdrawal by Subject|10|||
23380055|NCT00088153|65137199|FG001|Overall Study|Withdrawal by Subject|10|||
23380056|NCT00088153|65137198|FG000|Overall Study|Lost to Follow-up|11|||
23380057|NCT00088153|65137199|FG001|Overall Study|Lost to Follow-up|12|||
23380058|NCT00976898|65137202|FG000|Overall Study|Protocol Violation|1|||
23380059|NCT00976898|65137202|FG000|Overall Study|Adverse Event|1|||
23380060|NCT00976898|65137202|FG000|Overall Study|Physician Decision|1|||
23380061|NCT00976898|65137202|FG000|Overall Study|Liver Transplant|1|||
23380062|NCT00976898|65137202|FG000|Overall Study|Progressive Disease|1|||
23380063|NCT04333498|65137204|FG000|Overall Study|Lost to Follow-up|1|||
23380064|NCT04333498|65137205|FG001|Overall Study|Lost to Follow-up|0|||
23380065|NCT04333498|65137204|FG000|Overall Study|Lost to Follow-up|0|||
23380066|NCT04333498|65137205|FG001|Overall Study|Lost to Follow-up|1|||
23380067|NCT02447029|65137210|FG000|Overall Study|Withdrawal by Subject|3|||
23380068|NCT02447029|65137211|FG001|Overall Study|Withdrawal by Subject|2|||
23380069|NCT00313170|65137212|FG000|Overall Study|Death|2|||
23380070|NCT00313170|65137213|FG001|Overall Study|Death|4|||
23380071|NCT00313170|65137214|FG002|Overall Study|Death|2|||
23380072|NCT00313170|65137212|FG000|Overall Study|Adverse Event|1|||
23380073|NCT00313170|65137213|FG001|Overall Study|Adverse Event|2|||
23380074|NCT00313170|65137214|FG002|Overall Study|Adverse Event|0|||
23380075|NCT00313170|65137212|FG000|Overall Study|Disease progression|31|||
23380076|NCT00313170|65137213|FG001|Overall Study|Disease progression|26|||
23380077|NCT00313170|65137214|FG002|Overall Study|Disease progression|27|||
23380078|NCT00313170|65137212|FG000|Overall Study|Withdrawal by Subject|1|||
23491453|NCT00333840|65545006|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491454|NCT00333840|65545007|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491455|NCT00333840|65545008|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
23491456|NCT00333840|65545009|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
23491457|NCT00333840|65545006|FG000|Second-line Treatment Period|No longer required study drug|0|||
23491458|NCT00333840|65545007|FG001|Second-line Treatment Period|No longer required study drug|0|||
23491459|NCT00333840|65545008|FG002|Second-line Treatment Period|No longer required study drug|1|||
23491460|NCT00333840|65545009|FG003|Second-line Treatment Period|No longer required study drug|14|||
23491461|NCT00333840|65545006|FG000|Second-line Treatment Period|Protocol Violation|0|||
23491462|NCT00333840|65545007|FG001|Second-line Treatment Period|Protocol Violation|0|||
23491463|NCT00333840|65545008|FG002|Second-line Treatment Period|Protocol Violation|1|||
23491464|NCT00333840|65545009|FG003|Second-line Treatment Period|Protocol Violation|10|||
23491465|NCT00333840|65545006|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
23491466|NCT00333840|65545007|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
23491467|NCT00333840|65545008|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
23491468|NCT00333840|65545009|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
23491469|NCT00333840|65545006|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
23666852|NCT01250379|66165274|FG001|Overall Study|Lost to Follow-up|6|||
23666853|NCT01250379|66165273|FG000|Overall Study|Adverse Event|5|||
23666854|NCT01250379|66165274|FG001|Overall Study|Adverse Event|4|||
23380079|NCT00313170|65137213|FG001|Overall Study|Withdrawal by Subject|0|||
23380080|NCT00313170|65137214|FG002|Overall Study|Withdrawal by Subject|1|||
23380081|NCT00313170|65137212|FG000|Overall Study|Incorrect enrollment|0|||
23380082|NCT00313170|65137213|FG001|Overall Study|Incorrect enrollment|2|||
23380083|NCT00313170|65137214|FG002|Overall Study|Incorrect enrollment|1|||
23380084|NCT00313170|65137212|FG000|Overall Study|Lost to Follow-up|0|||
23380085|NCT00313170|65137213|FG001|Overall Study|Lost to Follow-up|0|||
23380086|NCT00313170|65137214|FG002|Overall Study|Lost to Follow-up|1|||
23491470|NCT00333840|65545007|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
23491471|NCT00333840|65545008|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
23491472|NCT00333840|65545009|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
23491473|NCT00333840|65545006|FG000|Second-line Treatment Period|Administrative problems|0|||
23491474|NCT00333840|65545007|FG001|Second-line Treatment Period|Administrative problems|0|||
23491475|NCT00333840|65545008|FG002|Second-line Treatment Period|Administrative problems|0|||
23491476|NCT00333840|65545009|FG003|Second-line Treatment Period|Administrative problems|7|||
23491477|NCT00333840|65545006|FG000|Second-line Treatment Period|Death|0|||
23491478|NCT00333840|65545007|FG001|Second-line Treatment Period|Death|0|||
23491479|NCT00333840|65545008|FG002|Second-line Treatment Period|Death|0|||
23491480|NCT00333840|65545009|FG003|Second-line Treatment Period|Death|9|||
23666855|NCT01250379|66165273|FG000|Overall Study|Other|0|||
23491481|NCT01823146|65545010|FG000|Overall Study|Withdrawal by Subject|0|||
23666856|NCT01250379|66165274|FG001|Overall Study|Other|4|||
23666857|NCT01250379|66165273|FG000|Overall Study|Participant noncompliance|2|||
23491482|NCT01823146|65545011|FG001|Overall Study|Withdrawal by Subject|1|||
23491483|NCT01823146|65545010|FG000|Overall Study|Lost to Follow-up|2|||
23666858|NCT01250379|66165274|FG001|Overall Study|Participant noncompliance|0|||
23666859|NCT01827670|66165276|FG000|Overall Study|Withdrawal of Consent|3|||
23666860|NCT01827670|66165277|FG001|Overall Study|Withdrawal of Consent|2|||
23666861|NCT01827670|66165276|FG000|Overall Study|Lost to Follow-up|0|||
23666862|NCT01827670|66165277|FG001|Overall Study|Lost to Follow-up|1|||
23666863|NCT02411539|66165282|FG000|Overall Study|Lost to Follow-up|2|||
23666864|NCT02411539|66165283|FG001|Overall Study|Lost to Follow-up|0|||
23666865|NCT02411539|66165282|FG000|Overall Study|Confounding medical condition|0|||
23666866|NCT02411539|66165283|FG001|Overall Study|Confounding medical condition|1|||
23666867|NCT01181011|66165284|FG000|Overall Study|Adverse Event|2|||
23666868|NCT01181011|66165284|FG000|Overall Study|Lost to Follow-up|1|||
23666869|NCT03962101|66165285|FG000|Overall Study|Adverse Event|1|||
23666870|NCT03962101|66165285|FG000|Overall Study|Physician Decision|2|||
23666871|NCT03962101|66165285|FG000|Overall Study|Not related to medical events|1|||
23666872|NCT04050982|66165286|FG000|Overall Study|Did not meet eligibility criteria|0|||
23666873|NCT04050982|66165287|FG001|Overall Study|Did not meet eligibility criteria|1|||
23666874|NCT04050982|66165288|FG002|Overall Study|Did not meet eligibility criteria|0|||
23666875|NCT04050982|66165286|FG000|Overall Study|Withdrawal by Subject|1|||
23666876|NCT04050982|66165287|FG001|Overall Study|Withdrawal by Subject|0|||
23666877|NCT04050982|66165288|FG002|Overall Study|Withdrawal by Subject|0|||
23666878|NCT04050982|66165286|FG000|Overall Study|Unable to enroll on platform|1|||
23666879|NCT04050982|66165287|FG001|Overall Study|Unable to enroll on platform|0|||
23666880|NCT04050982|66165288|FG002|Overall Study|Unable to enroll on platform|0|||
23666881|NCT01097746|66165291|FG000|Overall Study|Adverse Event|4|||
23666882|NCT01097746|66165291|FG000|Overall Study|taken off study before any treatment given|1|||
23666883|NCT00971178|66165300|FG000|Overall Study|Lost to Follow-up|2|||
23666884|NCT00971178|66165301|FG001|Overall Study|Lost to Follow-up|2|||
23666885|NCT00971178|66165302|FG002|Overall Study|Lost to Follow-up|2|||
23666886|NCT01502709|66165309|FG000|Overall Study|Lost to Follow-up|4|||
23666887|NCT01502709|66165310|FG001|Overall Study|Lost to Follow-up|0|||
23666888|NCT01146873|66165314|FG000|Overall Study|Transfer out|0|||
23666889|NCT01146873|66165315|FG001|Overall Study|Transfer out|6|||
23666890|NCT00492752|66165316|FG000|Double Blind Treatment|Death|13|||
23666891|NCT00492752|66165317|FG001|Double Blind Treatment|Death|0|||
23666892|NCT00492752|66165318|FG002|Double Blind Treatment|Death|2|||
23666893|NCT00492752|66165319|FG003|Double Blind Treatment|Death|0|||
23666894|NCT00492752|66165316|FG000|Double Blind Treatment|Adverse Event|1|||
23666895|NCT00492752|66165317|FG001|Double Blind Treatment|Adverse Event|0|||
23666896|NCT00492752|66165318|FG002|Double Blind Treatment|Adverse Event|0|||
23666897|NCT00492752|66165319|FG003|Double Blind Treatment|Adverse Event|0|||
23666898|NCT00492752|66165316|FG000|Double Blind Treatment|Protocol Violation|0|||
23666899|NCT00492752|66165317|FG001|Double Blind Treatment|Protocol Violation|0|||
23491484|NCT01823146|65545011|FG001|Overall Study|Lost to Follow-up|1|||
23491485|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
23491486|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
23491487|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
23491488|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
23491489|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Death|2|||
23491490|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Death|2|||
23491491|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
23491492|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
23666900|NCT00492752|66165318|FG002|Double Blind Treatment|Protocol Violation|1|||
23666901|NCT00492752|66165319|FG003|Double Blind Treatment|Protocol Violation|0|||
23666902|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
23666903|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
23666904|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
23666905|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
23666906|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
23666907|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
23666908|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
23666909|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
23666910|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
23666911|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
23666912|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
23666913|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
23666914|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
23666915|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
23666916|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
23666917|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
23666918|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
23666919|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
23666920|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
23666921|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
23666922|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23666923|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23666924|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23666925|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
23666926|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23666927|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
23666928|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23666929|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23666930|NCT00492752|66165316|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
23666931|NCT00492752|66165317|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23605800|NCT01951703|65947058|FG001|First Intervention|Physician Decision|0|||
23605801|NCT01951703|65947057|FG000|Second Intervention|Protocol Violation|0|||
23605802|NCT01951703|65947058|FG001|Second Intervention|Protocol Violation|1|||
23605803|NCT01951703|65947057|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
23605804|NCT01951703|65947058|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
23605805|NCT01947491|65947059|FG000|Overall Study|Lost to Follow-up|5|||
23605806|NCT01947491|65947060|FG001|Overall Study|Lost to Follow-up|3|||
23605807|NCT01947491|65947061|FG002|Overall Study|Lost to Follow-up|1|||
23605808|NCT01947491|65947062|FG003|Overall Study|Lost to Follow-up|2|||
23605809|NCT01947491|65947059|FG000|Overall Study|Lack of Efficacy|1|||
23605810|NCT01947491|65947060|FG001|Overall Study|Lack of Efficacy|0|||
23605811|NCT01947491|65947061|FG002|Overall Study|Lack of Efficacy|0|||
23605812|NCT01947491|65947062|FG003|Overall Study|Lack of Efficacy|1|||
23605813|NCT01947491|65947059|FG000|Overall Study|Protocol Violation|1|||
23605814|NCT01947491|65947060|FG001|Overall Study|Protocol Violation|0|||
23605815|NCT01947491|65947061|FG002|Overall Study|Protocol Violation|0|||
23605816|NCT01947491|65947062|FG003|Overall Study|Protocol Violation|0|||
23605817|NCT01947491|65947059|FG000|Overall Study|Withdrawal by Subject|1|||
23605818|NCT01947491|65947060|FG001|Overall Study|Withdrawal by Subject|1|||
23605819|NCT01947491|65947061|FG002|Overall Study|Withdrawal by Subject|1|||
23605820|NCT01947491|65947062|FG003|Overall Study|Withdrawal by Subject|0|||
23605821|NCT01947491|65947059|FG000|Overall Study|Worsening of condition|0|||
23605822|NCT01947491|65947060|FG001|Overall Study|Worsening of condition|1|||
23605823|NCT01947491|65947061|FG002|Overall Study|Worsening of condition|0|||
23605824|NCT01947491|65947062|FG003|Overall Study|Worsening of condition|0|||
23605825|NCT01947491|65947059|FG000|Overall Study|Adverse Event|0|||
23605826|NCT01947491|65947060|FG001|Overall Study|Adverse Event|1|||
23605827|NCT01947491|65947061|FG002|Overall Study|Adverse Event|0|||
23605828|NCT01947491|65947062|FG003|Overall Study|Adverse Event|2|||
23605829|NCT00600353|65947065|FG000|Overall Study|history of malignancy within 5 years|1|||
23605830|NCT00600353|65947066|FG001|Overall Study|history of malignancy within 5 years|0|||
23380087|NCT00313170|65137212|FG000|Overall Study|Progression (investigators opinion)|1|||
23380088|NCT00313170|65137213|FG001|Overall Study|Progression (investigators opinion)|0|||
23380089|NCT00313170|65137214|FG002|Overall Study|Progression (investigators opinion)|0|||
23380090|NCT02018887|65137215|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
23380091|NCT02018887|65137216|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380092|NCT02018887|65137217|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380093|NCT02018887|65137218|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380094|NCT02018887|65137219|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380095|NCT02018887|65137220|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380096|NCT02018887|65137221|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380097|NCT02018887|65137222|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380098|NCT02018887|65137223|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380099|NCT02018887|65137224|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380100|NCT02018887|65137225|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380101|NCT02018887|65137215|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380102|NCT02018887|65137216|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380103|NCT02018887|65137217|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380104|NCT02018887|65137218|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380105|NCT02018887|65137219|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
23380106|NCT02018887|65137220|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380107|NCT02018887|65137221|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
23380108|NCT02018887|65137222|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
23380109|NCT02018887|65137223|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380110|NCT02018887|65137224|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380111|NCT02018887|65137225|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380112|NCT02018887|65137215|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
23380113|NCT02018887|65137216|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
23380114|NCT02018887|65137217|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
23380115|NCT02018887|65137218|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
23380116|NCT02018887|65137219|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
23380117|NCT02018887|65137220|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
23666932|NCT00492752|66165318|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23666933|NCT00492752|66165319|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23666934|NCT01111851|66165320|FG000|Overall Study|All planned PET scans were not obtained.|2|||
23666935|NCT01111851|66165321|FG001|Overall Study|All planned PET scans were not obtained.|0|||
23666936|NCT02431702|66165323|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
23666937|NCT02431702|66165324|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23666938|NCT02431702|66165325|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23380118|NCT02018887|65137221|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
23380119|NCT02018887|65137222|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
23380120|NCT02018887|65137223|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
23380121|NCT02018887|65137224|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
23380122|NCT02018887|65137225|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
23666939|NCT02431702|66165326|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23666940|NCT02431702|66165327|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23666941|NCT02431702|66165328|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23666942|NCT02431702|66165329|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23666943|NCT02431702|66165323|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
23666944|NCT02431702|66165324|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23666945|NCT02431702|66165325|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23666946|NCT02431702|66165326|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23666947|NCT02431702|66165327|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23666948|NCT02431702|66165328|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23666949|NCT02431702|66165329|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
23666950|NCT02431702|66165323|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
23666951|NCT02431702|66165324|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23666952|NCT02431702|66165325|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23666953|NCT02431702|66165326|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23666954|NCT02431702|66165327|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23666955|NCT02431702|66165328|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23666956|NCT02431702|66165329|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
23666957|NCT02431702|66165323|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
23666958|NCT02431702|66165324|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23666959|NCT02431702|66165325|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23666960|NCT02431702|66165326|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23666961|NCT02431702|66165327|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23666962|NCT02431702|66165328|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23666963|NCT02431702|66165329|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
23666964|NCT02431702|66165323|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
23666965|NCT02431702|66165324|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666966|NCT02431702|66165325|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666967|NCT02431702|66165326|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666968|NCT02431702|66165327|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666969|NCT02431702|66165328|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666970|NCT02431702|66165329|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23666971|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23666972|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
23666973|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
23666974|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23666975|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23666976|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23666977|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23666978|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23380123|NCT02018887|65137215|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
23380124|NCT02018887|65137216|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
23380125|NCT02018887|65137217|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
23666979|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
23666980|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
23666981|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23666982|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23666983|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23666984|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23666985|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23666986|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
23666987|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
23666988|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23666989|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23666990|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23666991|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23666992|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23666993|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
23666994|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23666995|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23605831|NCT00600353|65947065|FG000|Overall Study|History of prepartive regimen|0|||
23605832|NCT00600353|65947066|FG001|Overall Study|History of prepartive regimen|1|||
23605833|NCT01313884|65947069|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
23605834|NCT03072862|65947070|FG000|Overall Study|Withdrawal by Subject|4|||
23605835|NCT03072862|65947070|FG000|Overall Study|Lost to Follow-up|6|||
23605836|NCT03072862|65947070|FG000|Overall Study|Protocol Violation|4|||
23605837|NCT03072862|65947070|FG000|Overall Study|Physician Decision|2|||
23605838|NCT03072862|65947070|FG000|Overall Study|Death|1|||
23605839|NCT03072862|65947070|FG000|Overall Study|Adverse Event|1|||
23605840|NCT02827201|65947071|FG000|Overall Study|Death|1|||
23605841|NCT02827201|65947072|FG001|Overall Study|Death|2|||
23605842|NCT02827201|65947071|FG000|Overall Study|Patients not treated|1|||
23605843|NCT02827201|65947072|FG001|Overall Study|Patients not treated|1|||
23605844|NCT02169414|65947073|FG000|Overall Study|Withdrawal by Subject|1|||
23605845|NCT02169414|65947074|FG001|Overall Study|Withdrawal by Subject|0|||
23605846|NCT02169414|65947075|FG002|Overall Study|Withdrawal by Subject|0|||
23605847|NCT02169414|65947076|FG003|Overall Study|Withdrawal by Subject|0|||
23605848|NCT02169414|65947073|FG000|Overall Study|Adverse Event|0|||
23666996|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23666997|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23666998|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23666999|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
23667000|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
23667001|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
23667002|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
23667003|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
23667004|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
23667005|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
23667006|NCT02431702|66165323|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23667007|NCT02431702|66165324|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23605849|NCT02169414|65947074|FG001|Overall Study|Adverse Event|1|||
23605850|NCT02169414|65947075|FG002|Overall Study|Adverse Event|0|||
23605851|NCT02169414|65947076|FG003|Overall Study|Adverse Event|0|||
23605852|NCT01138657|65947078|FG000|Overall Study|Adverse Event|3|||
23667008|NCT02431702|66165325|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
23667009|NCT02431702|66165326|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23667010|NCT02431702|66165327|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23667011|NCT02431702|66165328|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23667012|NCT02431702|66165329|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23667013|NCT02431702|66165323|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23667014|NCT02431702|66165324|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23667015|NCT02431702|66165325|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23667016|NCT02431702|66165326|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
23667017|NCT02431702|66165327|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
23667018|NCT02431702|66165328|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23667019|NCT02431702|66165329|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23667020|NCT02431702|66165323|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23667021|NCT02431702|66165324|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23667022|NCT02431702|66165325|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23667023|NCT02431702|66165326|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
23605853|NCT01138657|65947079|FG001|Overall Study|Adverse Event|10|||
23667024|NCT02431702|66165327|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23667025|NCT02431702|66165328|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
23667026|NCT02431702|66165329|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23667027|NCT02431702|66165323|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23667028|NCT02431702|66165324|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23667029|NCT02431702|66165325|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23667030|NCT02431702|66165326|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
23667031|NCT02431702|66165327|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
23667032|NCT02431702|66165328|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
23667033|NCT02431702|66165329|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23667034|NCT02431702|66165323|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
23667035|NCT02431702|66165324|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
23667036|NCT02431702|66165325|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
23667037|NCT02431702|66165326|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
23667038|NCT02431702|66165327|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
23667039|NCT02431702|66165328|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
23667040|NCT02431702|66165329|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
23667041|NCT01394627|66165335|FG000|First Intervention (1 Day)|poor intravenous access|0|||
23667042|NCT01394627|66165336|FG001|First Intervention (1 Day)|poor intravenous access|1|||
23667043|NCT01394627|66165335|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
23667044|NCT01394627|66165336|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
23667045|NCT01785160|66165337|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
23667046|NCT01785160|66165337|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
23667047|NCT03765138|66165338|FG000|Overall Study|Lost to Follow-up|1|||
23667048|NCT02614859|66165340|FG000|Overall Study|Physician Decision|0|||
23667049|NCT02614859|66165341|FG001|Overall Study|Physician Decision|1|||
23667050|NCT02016820|66165342|FG000|Overall Study|Lost to Follow-up|2|||
23667051|NCT02016820|66165343|FG001|Overall Study|Lost to Follow-up|4|||
23380126|NCT02018887|65137218|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
23380127|NCT02018887|65137219|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
23380128|NCT02018887|65137220|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
23380129|NCT02018887|65137221|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
23380130|NCT02018887|65137222|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
23667052|NCT02234479|66165344|FG000|Overall Study|Withdrawal by Subject|1|||
23667053|NCT02234479|66165345|FG001|Overall Study|Withdrawal by Subject|3|||
23380131|NCT02018887|65137223|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
23380132|NCT02018887|65137224|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
23380133|NCT02018887|65137225|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
23380134|NCT00690898|65137226|FG000|SCREENING|Screen failure|18|||
23380135|NCT00690898|65137226|FG000|TREATMENT|Adverse Event|3|||
23380136|NCT00690898|65137226|FG000|TREATMENT|Lack of Efficacy|18|||
23667054|NCT00889265|66165346|FG000|Overall Study|Adverse Event|1|||
23667055|NCT00889265|66165346|FG000|Overall Study|Lost to Follow-up|5|||
23667056|NCT00889265|66165346|FG000|Overall Study|Protocol Violation|1|||
23667057|NCT01347554|66165349|FG000|Overall Study|Lack of Efficacy|7|||
23667058|NCT01347554|66165350|FG001|Overall Study|Lack of Efficacy|11|||
23667059|NCT00562588|66165351|FG000|Overall Study|Adverse Event|40|||
23667060|NCT00562588|66165352|FG001|Overall Study|Adverse Event|58|||
23667061|NCT00562588|66165351|FG000|Overall Study|Protocol Violation|30|||
23667062|NCT00562588|66165352|FG001|Overall Study|Protocol Violation|26|||
23667063|NCT00562588|66165351|FG000|Overall Study|Lost to Follow-up|12|||
23667064|NCT00562588|66165352|FG001|Overall Study|Lost to Follow-up|4|||
23667065|NCT00562588|66165351|FG000|Overall Study|Withdrawal by Subject|10|||
23667066|NCT00562588|66165352|FG001|Overall Study|Withdrawal by Subject|9|||
23667067|NCT00562588|66165351|FG000|Overall Study|Other|0|||
23667068|NCT00562588|66165352|FG001|Overall Study|Other|2|||
23667069|NCT03440814|66165354|FG000|Overall Study|Adverse Event|2|||
23380137|NCT00690898|65137226|FG000|TREATMENT|Withdrawal by Subject|4|||
23380138|NCT00690898|65137226|FG000|TREATMENT|Other (not otherwise specified)|1|||
23380139|NCT00933933|65137228|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
23380140|NCT00933933|65137229|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
23380141|NCT00933933|65137230|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
23380142|NCT00933933|65137228|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
23380143|NCT00933933|65137229|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
23380144|NCT00933933|65137230|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
23380145|NCT02265744|65137231|FG000|Overall Study|Poor/Non-compliance|1|||
23380146|NCT02265744|65137232|FG001|Overall Study|Poor/Non-compliance|1|||
23491493|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
23491494|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
23491495|NCT01528033|65545012|FG000|Follow Up|No data available|46|||
23491496|NCT01528033|65545013|FG001|Follow Up|No data available|44|||
23491497|NCT01033851|65545014|FG000|Overall Study|Withdrawal by Subject|3|||
23491498|NCT01033851|65545015|FG001|Overall Study|Withdrawal by Subject|7|||
23491499|NCT03001882|65545018|FG000|Overall Study|Death|1|||
23491500|NCT03001882|65545019|FG001|Overall Study|Death|0|||
23491501|NCT03001882|65545020|FG002|Overall Study|Death|0|||
23491502|NCT03001882|65545021|FG003|Overall Study|Death|3|||
23491503|NCT03001882|65545018|FG000|Overall Study|Participant withdrew consent|0|||
23491504|NCT03001882|65545019|FG001|Overall Study|Participant withdrew consent|1|||
23491505|NCT03001882|65545020|FG002|Overall Study|Participant withdrew consent|0|||
23491506|NCT03001882|65545021|FG003|Overall Study|Participant withdrew consent|5|||
23491507|NCT03001882|65545018|FG000|Overall Study|Other reasons|1|||
23491508|NCT03001882|65545019|FG001|Overall Study|Other reasons|2|||
23491509|NCT03001882|65545020|FG002|Overall Study|Other reasons|0|||
23667070|NCT03440814|66165355|FG001|Overall Study|Adverse Event|1|||
23667071|NCT03440814|66165354|FG000|Overall Study|Lost to Follow-up|2|||
23667072|NCT03440814|66165355|FG001|Overall Study|Lost to Follow-up|0|||
23667073|NCT03440814|66165354|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
23667074|NCT03440814|66165355|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
23667075|NCT03785925|66165356|FG000|Overall Study|Withdrawal by Subject|15|||
23667076|NCT03785925|66165356|FG000|Overall Study|Lost to Follow-up|1|||
23667077|NCT03317795|66165357|FG000|Overall Study|IUD Expulsion|1|||
23667078|NCT03317795|66165358|FG001|Overall Study|IUD Expulsion|0|||
23380147|NCT02265744|65137233|FG002|Overall Study|Poor/Non-compliance|0|||
23380148|NCT02265744|65137234|FG003|Overall Study|Poor/Non-compliance|0|||
23380149|NCT02265744|65137235|FG004|Overall Study|Poor/Non-compliance|2|||
23380150|NCT02265744|65137231|FG000|Overall Study|Lost to Follow-up|0|||
23380151|NCT02265744|65137232|FG001|Overall Study|Lost to Follow-up|0|||
23380152|NCT02265744|65137233|FG002|Overall Study|Lost to Follow-up|0|||
23380153|NCT02265744|65137234|FG003|Overall Study|Lost to Follow-up|1|||
23380154|NCT02265744|65137235|FG004|Overall Study|Lost to Follow-up|0|||
23380155|NCT02265744|65137231|FG000|Overall Study|Death|0|||
23380156|NCT02265744|65137232|FG001|Overall Study|Death|0|||
23380157|NCT02265744|65137233|FG002|Overall Study|Death|0|||
23380158|NCT02265744|65137234|FG003|Overall Study|Death|2|||
23380159|NCT02265744|65137235|FG004|Overall Study|Death|0|||
23380160|NCT02265744|65137231|FG000|Overall Study|Withdrawal by Subject|2|||
23380161|NCT02265744|65137232|FG001|Overall Study|Withdrawal by Subject|0|||
23380162|NCT02265744|65137233|FG002|Overall Study|Withdrawal by Subject|0|||
23380163|NCT02265744|65137234|FG003|Overall Study|Withdrawal by Subject|2|||
23380164|NCT02265744|65137235|FG004|Overall Study|Withdrawal by Subject|0|||
23380165|NCT02265744|65137231|FG000|Overall Study|Participant request to discontinue|2|||
23380166|NCT02265744|65137232|FG001|Overall Study|Participant request to discontinue|2|||
23380167|NCT02265744|65137233|FG002|Overall Study|Participant request to discontinue|2|||
23380168|NCT02265744|65137234|FG003|Overall Study|Participant request to discontinue|0|||
23380169|NCT02265744|65137235|FG004|Overall Study|Participant request to discontinue|0|||
23380170|NCT02265744|65137231|FG000|Overall Study|Adverse Event|8|||
23491510|NCT03001882|65545021|FG003|Overall Study|Other reasons|5|||
23667079|NCT03317795|66165357|FG000|Overall Study|Lost to Follow-up|1|||
23667080|NCT03317795|66165358|FG001|Overall Study|Lost to Follow-up|3|||
23667081|NCT03317795|66165357|FG000|Overall Study|Treatment change|0|||
23667082|NCT03317795|66165358|FG001|Overall Study|Treatment change|3|||
23667083|NCT03317795|66165357|FG000|Overall Study|Intolerance of medication|0|||
23667084|NCT03317795|66165358|FG001|Overall Study|Intolerance of medication|1|||
23667085|NCT03332498|66165360|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
23667086|NCT03332498|66165361|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
23380171|NCT02265744|65137232|FG001|Overall Study|Adverse Event|4|||
23380172|NCT02265744|65137233|FG002|Overall Study|Adverse Event|9|||
23380173|NCT02265744|65137234|FG003|Overall Study|Adverse Event|8|||
23380174|NCT02265744|65137235|FG004|Overall Study|Adverse Event|2|||
23380175|NCT02265744|65137231|FG000|Overall Study|Lack of Efficacy|2|||
23667087|NCT03332498|66165362|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
23667088|NCT02232802|66165385|FG000|Period 1|Sponsor request|1|||
23667089|NCT02232802|66165386|FG001|Period 1|Sponsor request|0|||
23667090|NCT02232802|66165385|FG000|Period 1|Adverse Event|1|||
23667091|NCT02232802|66165386|FG001|Period 1|Adverse Event|1|||
23667092|NCT00343889|66165390|FG000|Overall Study|Lost to Follow-up|2|||
23667093|NCT00343889|66165391|FG001|Overall Study|Lost to Follow-up|0|||
23667094|NCT00343889|66165390|FG000|Overall Study|Withdrawal by Subject|0|||
23667095|NCT00343889|66165391|FG001|Overall Study|Withdrawal by Subject|1|||
23667096|NCT00343889|66165390|FG000|Overall Study|Protocol Violation|1|||
23667097|NCT00343889|66165391|FG001|Overall Study|Protocol Violation|0|||
23667098|NCT00573430|66165392|FG000|Overall Study|Incorrect enrollment of randomization|0|||
23380176|NCT02265744|65137232|FG001|Overall Study|Lack of Efficacy|4|||
23667099|NCT00573430|66165393|FG001|Overall Study|Incorrect enrollment of randomization|4|||
23667100|NCT00573430|66165394|FG002|Overall Study|Incorrect enrollment of randomization|3|||
23667101|NCT00573430|66165392|FG000|Overall Study|Adverse Event|0|||
23667102|NCT00573430|66165393|FG001|Overall Study|Adverse Event|0|||
23667103|NCT00573430|66165394|FG002|Overall Study|Adverse Event|2|||
23667104|NCT00573430|66165392|FG000|Overall Study|Withdrawal by Subject|1|||
23667105|NCT00573430|66165393|FG001|Overall Study|Withdrawal by Subject|0|||
23667106|NCT00573430|66165394|FG002|Overall Study|Withdrawal by Subject|1|||
23667107|NCT00573430|66165392|FG000|Overall Study|Protocol Violation|0|||
23667108|NCT00573430|66165393|FG001|Overall Study|Protocol Violation|1|||
23667109|NCT00573430|66165394|FG002|Overall Study|Protocol Violation|1|||
23667110|NCT00573430|66165392|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23667111|NCT00573430|66165393|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23380177|NCT02265744|65137233|FG002|Overall Study|Lack of Efficacy|3|||
23380178|NCT02265744|65137234|FG003|Overall Study|Lack of Efficacy|4|||
23380179|NCT02265744|65137235|FG004|Overall Study|Lack of Efficacy|5|||
23380180|NCT02265744|65137231|FG000|Overall Study|Reason not provided by Investigator|1|||
23380181|NCT02265744|65137232|FG001|Overall Study|Reason not provided by Investigator|0|||
23380182|NCT02265744|65137233|FG002|Overall Study|Reason not provided by Investigator|0|||
23380183|NCT02265744|65137234|FG003|Overall Study|Reason not provided by Investigator|2|||
23380184|NCT02265744|65137235|FG004|Overall Study|Reason not provided by Investigator|0|||
23380185|NCT02265744|65137231|FG000|Overall Study|Administrative reason by sponsor|3|||
23380186|NCT02265744|65137232|FG001|Overall Study|Administrative reason by sponsor|2|||
23380187|NCT02265744|65137233|FG002|Overall Study|Administrative reason by sponsor|2|||
23380188|NCT02265744|65137234|FG003|Overall Study|Administrative reason by sponsor|3|||
23380189|NCT02265744|65137235|FG004|Overall Study|Administrative reason by sponsor|3|||
23380190|NCT02265744|65137231|FG000|Overall Study|Subject no longer meets study criteria|0|||
23380191|NCT02265744|65137232|FG001|Overall Study|Subject no longer meets study criteria|0|||
23380192|NCT02265744|65137233|FG002|Overall Study|Subject no longer meets study criteria|0|||
23380193|NCT02265744|65137234|FG003|Overall Study|Subject no longer meets study criteria|0|||
23380194|NCT02265744|65137235|FG004|Overall Study|Subject no longer meets study criteria|1|||
23380195|NCT02265744|65137231|FG000|Overall Study|Pregnancy|1|||
23380196|NCT02265744|65137232|FG001|Overall Study|Pregnancy|2|||
23380197|NCT02265744|65137233|FG002|Overall Study|Pregnancy|1|||
23380198|NCT02265744|65137234|FG003|Overall Study|Pregnancy|1|||
23380199|NCT02265744|65137235|FG004|Overall Study|Pregnancy|0|||
23380200|NCT01588509|65137236|FG000|Overall Study|Lost to Follow-up|1|||
23380201|NCT01588509|65137237|FG001|Overall Study|Lost to Follow-up|0|||
23380202|NCT02110693|65137241|FG000|Overall Study|Withdrawal by Subject|6|||
23380203|NCT02110693|65137242|FG001|Overall Study|Withdrawal by Subject|7|||
23380204|NCT02110693|65137241|FG000|Overall Study|skipped assessment|15|||
23380205|NCT02110693|65137242|FG001|Overall Study|skipped assessment|18|||
23380206|NCT02110693|65137241|FG000|Overall Study|technical difficulties|6|||
23380207|NCT02110693|65137242|FG001|Overall Study|technical difficulties|4|||
23380208|NCT02110693|65137241|FG000|Overall Study|Other|1|||
23380209|NCT02110693|65137242|FG001|Overall Study|Other|0|||
23380210|NCT01239680|65137243|FG000|Overall Study|Withdrawal by Subject|2|||
23380211|NCT01239680|65137244|FG001|Overall Study|Withdrawal by Subject|0|||
23380212|NCT01257542|65137245|FG000|Overall Study|Protocol Violation|3|||
23380213|NCT01257542|65137246|FG001|Overall Study|Protocol Violation|5|||
23380214|NCT01257542|65137245|FG000|Overall Study|Withdrawal by Subject|0|||
23380215|NCT01257542|65137246|FG001|Overall Study|Withdrawal by Subject|2|||
23667112|NCT00573430|66165394|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
23667113|NCT01918007|66165395|FG000|Overall Study|Baseline oximetry not acceptable|11|||
23380216|NCT03822416|65137251|FG000|Overall Study|Lost to Follow-up|1|||
23380217|NCT03822416|65137252|FG001|Overall Study|Lost to Follow-up|0|||
23380218|NCT03822416|65137251|FG000|Overall Study|Withdrawal by Subject|0|||
23380219|NCT03822416|65137252|FG001|Overall Study|Withdrawal by Subject|1|||
23380220|NCT02782104|65137255|FG000|Overall Study|Other|215|||
23380221|NCT02782104|65137255|FG000|Overall Study|Induction Day 28 Non Responder|9|||
23380222|NCT02782104|65137255|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23380223|NCT02782104|65137255|FG000|Overall Study|Death|8|||
23380224|NCT02782104|65137255|FG000|Overall Study|Pregnancy|6|||
23667114|NCT01918007|66165396|FG001|Overall Study|Baseline oximetry not acceptable|7|||
23380225|NCT02782104|65137255|FG000|Overall Study|Withdrawal by Subject|63|||
23380226|NCT02782104|65137255|FG000|Overall Study|Protocol Violation|7|||
23380227|NCT02782104|65137255|FG000|Overall Study|Lack of Efficacy|61|||
23380228|NCT02782104|65137255|FG000|Overall Study|Lost to Follow-up|23|||
23380229|NCT02782104|65137255|FG000|Overall Study|Adverse Event|74|||
23380230|NCT03329001|65137256|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380231|NCT03329001|65137257|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380232|NCT03329001|65137258|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
23380233|NCT03329001|65137259|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
23380234|NCT03329001|65137260|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380235|NCT03329001|65137261|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380236|NCT03329001|65137262|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380237|NCT03329001|65137263|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380238|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380239|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380240|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380241|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
23380242|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380243|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380244|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380245|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380246|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380247|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23667115|NCT01918007|66165395|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
23667116|NCT01918007|66165396|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
23667117|NCT01918007|66165395|FG000|Overall Study|Lost to Follow-up|4|||
23667118|NCT01918007|66165396|FG001|Overall Study|Lost to Follow-up|7|||
23667119|NCT01294579|66165397|FG000|Overall Study|Disease progression|12|||
23667120|NCT01294579|66165397|FG000|Overall Study|Adverse Event|11|||
23667121|NCT01294579|66165397|FG000|Overall Study|Study closed/terminated|3|||
23380248|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380249|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
23380250|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380251|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380252|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380253|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380254|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380255|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380256|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380257|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
23380258|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380259|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380260|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380261|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380262|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23402828|NCT02185534|65220022|FG005|First Washout Period|Withdrawal by Subject|0|||
23667122|NCT01294579|66165397|FG000|Overall Study|Lost to Follow-up|1|||
23380263|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380264|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
23380265|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380266|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380267|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380268|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23667123|NCT01294579|66165397|FG000|Overall Study|Physician Decision|3|||
23667124|NCT01294579|66165397|FG000|Overall Study|Withdrawal by Subject|5|||
23667125|NCT01014689|66165398|FG000|Overall Study|Lack of Efficacy|0|||
23667126|NCT01014689|66165399|FG001|Overall Study|Lack of Efficacy|1|||
23667127|NCT01014689|66165398|FG000|Overall Study|Adverse Event|3|||
23667128|NCT01014689|66165399|FG001|Overall Study|Adverse Event|0|||
23380269|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380270|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380271|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380272|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
23380273|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380274|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380275|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380276|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380277|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380278|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380279|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380280|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
23380281|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380282|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23491511|NCT03001882|65545018|FG000|Overall Study|Administrative reason by sponsor|0|||
23667129|NCT01014689|66165398|FG000|Overall Study|Withdrawal by Subject|5|||
23667130|NCT01014689|66165399|FG001|Overall Study|Withdrawal by Subject|4|||
23667131|NCT01014689|66165398|FG000|Overall Study|Protocol Violation|1|||
23667132|NCT01014689|66165399|FG001|Overall Study|Protocol Violation|1|||
23380283|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380284|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380285|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380286|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380287|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380288|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
23380289|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380290|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380291|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380292|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380293|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380294|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380295|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380296|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
23380297|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
23380298|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380299|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380300|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23402829|NCT02185534|65220017|FG000|First Washout Period|Protocol Violation|0|||
23667133|NCT01014689|66165398|FG000|Overall Study|Lost to Follow-up|3|||
23667134|NCT01014689|66165399|FG001|Overall Study|Lost to Follow-up|7|||
23667135|NCT01014689|66165398|FG000|Overall Study|Pregnancy|1|||
23667136|NCT01014689|66165399|FG001|Overall Study|Pregnancy|0|||
23667137|NCT01040351|66165400|FG000|Overall Study|poor ovarian response|1|||
23667138|NCT01040351|66165401|FG001|Overall Study|poor ovarian response|2|||
23667139|NCT00781911|66165402|FG000|Overall Study|Adverse Event|4|||
23667140|NCT00781911|66165403|FG001|Overall Study|Adverse Event|4|||
23667141|NCT00781911|66165402|FG000|Overall Study|Withdrawal by Subject|1|||
23667142|NCT00781911|66165403|FG001|Overall Study|Withdrawal by Subject|2|||
23667143|NCT00781911|66165402|FG000|Overall Study|Physician Decision|0|||
23667144|NCT00781911|66165403|FG001|Overall Study|Physician Decision|2|||
23667145|NCT00781911|66165402|FG000|Overall Study|Sponsor Decision|1|||
23667146|NCT00781911|66165403|FG001|Overall Study|Sponsor Decision|0|||
23667147|NCT01417195|66165414|FG000|Overall Study|Stimulation failure|1|||
23667148|NCT01417195|66165415|FG001|Overall Study|Stimulation failure|0|||
23667149|NCT01417195|66165414|FG000|Overall Study|No embryos for transfer|0|||
23667150|NCT01417195|66165415|FG001|Overall Study|No embryos for transfer|1|||
23667151|NCT01417195|66165414|FG000|Overall Study|No transfer due to risk of OHSS|1|||
23667152|NCT01417195|66165415|FG001|Overall Study|No transfer due to risk of OHSS|0|||
23667153|NCT01417195|66165414|FG000|Overall Study|No transfer due to elevated progesterone|1|||
23667154|NCT01417195|66165415|FG001|Overall Study|No transfer due to elevated progesterone|0|||
23667155|NCT01692275|66165418|FG000|Overall Study|Lost to Follow-up|57|||
23667156|NCT01692275|66165419|FG001|Overall Study|Lost to Follow-up|48|||
23667157|NCT01692275|66165418|FG000|Overall Study|Withdrawal by Subject|9|||
23667158|NCT01692275|66165419|FG001|Overall Study|Withdrawal by Subject|11|||
23667159|NCT02463409|66165421|FG000|Overall Study|Withdrawal by Subject|1|||
23667160|NCT02463409|66165421|FG000|Overall Study|Screen failure|1|||
23667161|NCT04744207|66165422|FG000|Treatment|Withdrawal by Subject|2|||
23667162|NCT04744207|66165423|FG001|Treatment|Withdrawal by Subject|0|||
23667163|NCT04744207|66165422|FG000|Treatment|Adverse Event|1|||
23667164|NCT04744207|66165423|FG001|Treatment|Adverse Event|2|||
23667165|NCT02287623|66165424|FG000|Overall Study|Protocol Violation|0|||
23667166|NCT02287623|66165425|FG001|Overall Study|Protocol Violation|1|||
23667167|NCT03221751|66165426|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
23667168|NCT03221751|66165427|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
23667169|NCT04013529|66165428|FG000|Overall Study|Withdrawal by Subject|1|||
23667170|NCT04013529|66165429|FG001|Overall Study|Withdrawal by Subject|1|||
23667171|NCT00257725|66165430|FG000|Overall Study|Adverse Event|3|||
23667172|NCT00574288|66165431|FG000|Overall Study|Adverse Event|2|||
23667173|NCT00574288|66165432|FG001|Overall Study|Adverse Event|0|||
23667174|NCT00574288|66165433|FG002|Overall Study|Adverse Event|0|||
23491512|NCT03001882|65545019|FG001|Overall Study|Administrative reason by sponsor|0|||
23491513|NCT03001882|65545020|FG002|Overall Study|Administrative reason by sponsor|0|||
23491514|NCT03001882|65545021|FG003|Overall Study|Administrative reason by sponsor|1|||
23491515|NCT03001882|65545018|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
23491516|NCT03001882|65545019|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
23491517|NCT03001882|65545020|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
23491518|NCT03001882|65545021|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
23491519|NCT03001882|65545018|FG000|Overall Study|Not reported|0|||
23491520|NCT03001882|65545019|FG001|Overall Study|Not reported|0|||
23491521|NCT03001882|65545020|FG002|Overall Study|Not reported|0|||
23491522|NCT03001882|65545021|FG003|Overall Study|Not reported|6|||
23491523|NCT03001882|65545018|FG000|Overall Study|Maximum clinical benefit|2|||
23491524|NCT03001882|65545019|FG001|Overall Study|Maximum clinical benefit|3|||
23491525|NCT03001882|65545020|FG002|Overall Study|Maximum clinical benefit|0|||
23491526|NCT03001882|65545021|FG003|Overall Study|Maximum clinical benefit|10|||
23491527|NCT03001882|65545018|FG000|Overall Study|AE unrelated to study drug|3|||
23491528|NCT03001882|65545019|FG001|Overall Study|AE unrelated to study drug|3|||
23491529|NCT03001882|65545020|FG002|Overall Study|AE unrelated to study drug|0|||
23491530|NCT03001882|65545021|FG003|Overall Study|AE unrelated to study drug|11|||
23491531|NCT03001882|65545018|FG000|Overall Study|Study Drug Toxicity|8|||
23491532|NCT03001882|65545019|FG001|Overall Study|Study Drug Toxicity|5|||
23491533|NCT03001882|65545020|FG002|Overall Study|Study Drug Toxicity|0|||
23491534|NCT03001882|65545021|FG003|Overall Study|Study Drug Toxicity|37|||
23491535|NCT03001882|65545018|FG000|Overall Study|Disease progression|16|||
23491536|NCT03001882|65545019|FG001|Overall Study|Disease progression|14|||
23491537|NCT03001882|65545020|FG002|Overall Study|Disease progression|1|||
23491538|NCT03001882|65545021|FG003|Overall Study|Disease progression|90|||
23491539|NCT03800173|65545022|FG000|Overall Study|Lost to Follow-up|0|||
23491540|NCT03800173|65545023|FG001|Overall Study|Lost to Follow-up|0|||
23667175|NCT00574288|66165434|FG003|Overall Study|Adverse Event|0|||
23605854|NCT01138657|65947078|FG000|Overall Study|Lack of Efficacy|2|||
23605855|NCT01138657|65947079|FG001|Overall Study|Lack of Efficacy|1|||
23605856|NCT01138657|65947078|FG000|Overall Study|Lost to Follow-up|0|||
23605857|NCT01138657|65947079|FG001|Overall Study|Lost to Follow-up|3|||
23605858|NCT01138657|65947078|FG000|Overall Study|Miscellaneous Reasons|3|||
23605859|NCT01138657|65947079|FG001|Overall Study|Miscellaneous Reasons|4|||
23605860|NCT02196259|65947080|FG000|Overall Study|Researcher choice|0|||
23605861|NCT02196259|65947081|FG001|Overall Study|Researcher choice|0|||
23605862|NCT02196259|65947082|FG002|Overall Study|Researcher choice|1|||
23605863|NCT02196259|65947080|FG000|Overall Study|Partial data analysis|0|||
23605864|NCT02196259|65947081|FG001|Overall Study|Partial data analysis|3|||
23491541|NCT03800173|65545024|FG002|Overall Study|Lost to Follow-up|0|||
23491542|NCT03800173|65545025|FG003|Overall Study|Lost to Follow-up|0|||
23667176|NCT00574288|66165435|FG004|Overall Study|Adverse Event|1|||
23667177|NCT00574288|66165436|FG005|Overall Study|Adverse Event|0|||
23491543|NCT03800173|65545026|FG004|Overall Study|Lost to Follow-up|1|||
23491544|NCT03228420|65545027|FG000|Overall Study|Lost to Follow-up|5|||
23491545|NCT03228420|65545028|FG001|Overall Study|Lost to Follow-up|3|||
23491546|NCT03228420|65545027|FG000|Overall Study|Withdrawal by Subject|10|||
23491547|NCT03228420|65545028|FG001|Overall Study|Withdrawal by Subject|0|||
23491548|NCT03228420|65545027|FG000|Overall Study|Adverse Event|5|||
23491549|NCT03228420|65545028|FG001|Overall Study|Adverse Event|2|||
23491550|NCT02905149|65545029|FG000|Overall Study|Lost to Follow-up|2|||
23491551|NCT02905149|65545030|FG001|Overall Study|Lost to Follow-up|0|||
23491552|NCT03004443|65545031|FG000|Overall Study|Pregnancy|0|||
23491553|NCT03004443|65545032|FG001|Overall Study|Pregnancy|1|||
23491554|NCT01298531|65545033|FG000|Overall Study|Lack of Efficacy|0|||
23491555|NCT01298531|65545034|FG001|Overall Study|Lack of Efficacy|1|||
23491556|NCT01298531|65545033|FG000|Overall Study|Lost to Follow-up|2|||
23491557|NCT01298531|65545034|FG001|Overall Study|Lost to Follow-up|0|||
23491558|NCT01298531|65545033|FG000|Overall Study|Protocol Violation|1|||
23491559|NCT01298531|65545034|FG001|Overall Study|Protocol Violation|1|||
23491560|NCT01298531|65545033|FG000|Overall Study|Adverse Event|4|||
23491561|NCT01298531|65545034|FG001|Overall Study|Adverse Event|3|||
23491562|NCT01298531|65545033|FG000|Overall Study|Does not meet entrance criteria|0|||
23491563|NCT01298531|65545034|FG001|Overall Study|Does not meet entrance criteria|1|||
23491564|NCT01298531|65545033|FG000|Overall Study|Other|2|||
23491565|NCT01298531|65545034|FG001|Overall Study|Other|1|||
23491566|NCT01927627|65545035|FG000|Overall Study|Adverse Event|3|||
23491567|NCT01927627|65545035|FG000|Overall Study|Lack of Efficacy|1|||
23491568|NCT01927627|65545035|FG000|Overall Study|Financial Concerns|1|||
23491569|NCT03633617|65545036|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
23491570|NCT03633617|65545037|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
23491571|NCT03633617|65545038|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491572|NCT03633617|65545039|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491573|NCT03633617|65545040|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491574|NCT03633617|65545041|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491575|NCT03633617|65545042|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491576|NCT03633617|65545043|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491577|NCT03633617|65545044|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491578|NCT03633617|65545045|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491579|NCT03633617|65545046|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491580|NCT03633617|65545036|FG000|Part A|Unconfirmed early termination visit|1|||
23491581|NCT03633617|65545037|FG001|Part A|Unconfirmed early termination visit|0|||
23491582|NCT03633617|65545038|FG002|Part A|Unconfirmed early termination visit|0|||
23491583|NCT03633617|65545039|FG003|Part A|Unconfirmed early termination visit|0|||
23491584|NCT03633617|65545040|FG004|Part A|Unconfirmed early termination visit|0|||
23491585|NCT03633617|65545041|FG005|Part A|Unconfirmed early termination visit|0|||
23491586|NCT03633617|65545042|FG006|Part A|Unconfirmed early termination visit|0|||
23491587|NCT03633617|65545043|FG007|Part A|Unconfirmed early termination visit|0|||
23491588|NCT03633617|65545044|FG008|Part A|Unconfirmed early termination visit|0|||
23491589|NCT03633617|65545045|FG009|Part A|Unconfirmed early termination visit|0|||
23491590|NCT03633617|65545046|FG010|Part A|Unconfirmed early termination visit|0|||
23491591|NCT03633617|65545036|FG000|Part A|Adverse Event|0|||
23491592|NCT03633617|65545037|FG001|Part A|Adverse Event|1|||
23605865|NCT02196259|65947082|FG002|Overall Study|Partial data analysis|0|||
23605866|NCT00871715|65947083|FG000|Overall Study|Withdrawal by Subject|6|||
23605867|NCT00871715|65947084|FG001|Overall Study|Withdrawal by Subject|10|||
23605868|NCT00871715|65947085|FG002|Overall Study|Withdrawal by Subject|15|||
23605869|NCT00871715|65947083|FG000|Overall Study|Physician Decision|6|||
23605870|NCT00871715|65947084|FG001|Overall Study|Physician Decision|0|||
23605871|NCT00871715|65947085|FG002|Overall Study|Physician Decision|2|||
23605872|NCT00871715|65947083|FG000|Overall Study|Lost to Follow-up|3|||
23605873|NCT00871715|65947084|FG001|Overall Study|Lost to Follow-up|6|||
23605874|NCT00871715|65947085|FG002|Overall Study|Lost to Follow-up|9|||
23605875|NCT02309515|65947086|FG000|Overall Study|Withdrawal by Subject|0|||
23605876|NCT02309515|65947087|FG001|Overall Study|Withdrawal by Subject|1|||
23605877|NCT01855399|65947090|FG000|6 Month|Lost to Follow-up|12|||
23605878|NCT01855399|65947091|FG001|6 Month|Lost to Follow-up|9|||
23605879|NCT01855399|65947090|FG000|6 Month|Withdrawal by Subject|8|||
23605880|NCT01855399|65947091|FG001|6 Month|Withdrawal by Subject|6|||
23605881|NCT01855399|65947090|FG000|12 Month|Lost to Follow-up|7|||
23605882|NCT01855399|65947091|FG001|12 Month|Lost to Follow-up|11|||
23605883|NCT01109979|65947092|FG000|Overall Study|Physician Decision|2|||
23605884|NCT01109979|65947093|FG001|Overall Study|Physician Decision|0|||
23605885|NCT01109979|65947092|FG000|Overall Study|Withdrawal by Subject|0|||
23491593|NCT03633617|65545038|FG002|Part A|Adverse Event|0|||
23491594|NCT03633617|65545039|FG003|Part A|Adverse Event|0|||
23491595|NCT03633617|65545040|FG004|Part A|Adverse Event|0|||
23491596|NCT03633617|65545041|FG005|Part A|Adverse Event|0|||
23491597|NCT03633617|65545042|FG006|Part A|Adverse Event|0|||
23491598|NCT03633617|65545043|FG007|Part A|Adverse Event|0|||
23605886|NCT01109979|65947093|FG001|Overall Study|Withdrawal by Subject|1|||
23667178|NCT00574288|66165437|FG006|Overall Study|Adverse Event|0|||
23667179|NCT00574288|66165431|FG000|Overall Study|Death|0|||
23667180|NCT00574288|66165432|FG001|Overall Study|Death|0|||
23667181|NCT00574288|66165433|FG002|Overall Study|Death|0|||
23667182|NCT00574288|66165434|FG003|Overall Study|Death|0|||
23667183|NCT00574288|66165435|FG004|Overall Study|Death|0|||
23667184|NCT00574288|66165436|FG005|Overall Study|Death|25|||
23667185|NCT00574288|66165437|FG006|Overall Study|Death|21|||
23667186|NCT00574288|66165431|FG000|Overall Study|Lost to Follow-up|0|||
23667187|NCT00574288|66165432|FG001|Overall Study|Lost to Follow-up|0|||
23667188|NCT00574288|66165433|FG002|Overall Study|Lost to Follow-up|0|||
23667189|NCT00574288|66165434|FG003|Overall Study|Lost to Follow-up|0|||
23667190|NCT00574288|66165435|FG004|Overall Study|Lost to Follow-up|0|||
23667191|NCT00574288|66165436|FG005|Overall Study|Lost to Follow-up|1|||
23667192|NCT00574288|66165437|FG006|Overall Study|Lost to Follow-up|2|||
23667193|NCT00574288|66165431|FG000|Overall Study|Study Terminated By Sponsor|0|||
23667194|NCT00574288|66165432|FG001|Overall Study|Study Terminated By Sponsor|0|||
23667195|NCT00574288|66165433|FG002|Overall Study|Study Terminated By Sponsor|0|||
23667196|NCT00574288|66165434|FG003|Overall Study|Study Terminated By Sponsor|0|||
23667197|NCT00574288|66165435|FG004|Overall Study|Study Terminated By Sponsor|0|||
23667198|NCT00574288|66165436|FG005|Overall Study|Study Terminated By Sponsor|0|||
23667199|NCT00574288|66165437|FG006|Overall Study|Study Terminated By Sponsor|5|||
23667200|NCT00574288|66165431|FG000|Overall Study|Progressive Disease|17|||
23667201|NCT00574288|66165432|FG001|Overall Study|Progressive Disease|2|||
23667202|NCT00574288|66165433|FG002|Overall Study|Progressive Disease|3|||
23667203|NCT00574288|66165434|FG003|Overall Study|Progressive Disease|2|||
23667204|NCT00574288|66165435|FG004|Overall Study|Progressive Disease|1|||
23667205|NCT00574288|66165436|FG005|Overall Study|Progressive Disease|0|||
23667206|NCT00574288|66165437|FG006|Overall Study|Progressive Disease|0|||
23667207|NCT00574288|66165431|FG000|Overall Study|Other|1|||
23667208|NCT00574288|66165432|FG001|Overall Study|Other|1|||
23667209|NCT00574288|66165433|FG002|Overall Study|Other|0|||
23667210|NCT00574288|66165434|FG003|Overall Study|Other|0|||
23667211|NCT00574288|66165435|FG004|Overall Study|Other|0|||
23667212|NCT00574288|66165436|FG005|Overall Study|Other|0|||
23667213|NCT00574288|66165437|FG006|Overall Study|Other|0|||
23667214|NCT00714285|66165439|FG000|Overall Study|Lost to Follow-up|0|||
23667215|NCT00714285|66165440|FG001|Overall Study|Lost to Follow-up|2|||
23667216|NCT00714285|66165441|FG002|Overall Study|Lost to Follow-up|0|||
23667217|NCT00714285|66165442|FG003|Overall Study|Lost to Follow-up|1|||
23667218|NCT00714285|66165439|FG000|Overall Study|Migrated/moved from study area|0|||
23667219|NCT00714285|66165440|FG001|Overall Study|Migrated/moved from study area|1|||
23667220|NCT00714285|66165441|FG002|Overall Study|Migrated/moved from study area|0|||
23667221|NCT00714285|66165442|FG003|Overall Study|Migrated/moved from study area|0|||
23667222|NCT00139776|66165445|FG000|Period I|Did not enter Period II|575|||
23667223|NCT00139776|66165446|FG001|Period I|Did not enter Period II|0|||
23667224|NCT00139776|66165447|FG002|Period I|Did not enter Period II|0|||
23667225|NCT00139776|66165448|FG003|Period I|Did not enter Period II|0|||
23667226|NCT00139776|66165445|FG000|Period II|Not Randomized into Period III|0|||
23667227|NCT00139776|66165446|FG001|Period II|Not Randomized into Period III|322|||
23667228|NCT00139776|66165447|FG002|Period II|Not Randomized into Period III|0|||
23667229|NCT00139776|66165448|FG003|Period II|Not Randomized into Period III|0|||
23667230|NCT00139776|66165445|FG000|Period III|Adverse Event|0|||
23380301|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380302|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380303|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380304|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
23380305|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380306|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380307|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380308|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380309|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380310|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380311|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380312|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
23380313|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
23380314|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380315|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380316|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380317|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380318|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380319|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380320|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
23380321|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
23380322|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380323|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380324|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380325|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380326|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380327|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380328|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
23380329|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
23380330|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380331|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380332|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380333|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380334|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23491599|NCT03633617|65545044|FG008|Part A|Adverse Event|0|||
23667231|NCT00139776|66165446|FG001|Period III|Adverse Event|0|||
23667232|NCT00139776|66165447|FG002|Period III|Adverse Event|22|||
23667233|NCT00139776|66165448|FG003|Period III|Adverse Event|23|||
23667234|NCT00139776|66165445|FG000|Period III|Other|0|||
23667235|NCT00139776|66165446|FG001|Period III|Other|0|||
23667236|NCT00139776|66165447|FG002|Period III|Other|23|||
23667237|NCT00139776|66165448|FG003|Period III|Other|34|||
23667238|NCT00139776|66165445|FG000|Period III|Lack of Efficacy|0|||
23667239|NCT00139776|66165446|FG001|Period III|Lack of Efficacy|0|||
23667240|NCT00139776|66165447|FG002|Period III|Lack of Efficacy|10|||
23667241|NCT00139776|66165448|FG003|Period III|Lack of Efficacy|24|||
23667242|NCT00139776|66165445|FG000|Period III|Lost to Follow-up|0|||
23667243|NCT00139776|66165446|FG001|Period III|Lost to Follow-up|0|||
23667244|NCT00139776|66165447|FG002|Period III|Lost to Follow-up|5|||
23667245|NCT00139776|66165448|FG003|Period III|Lost to Follow-up|4|||
23667246|NCT00139776|66165445|FG000|Period III|Withdrawal by Subject|0|||
23667247|NCT00139776|66165446|FG001|Period III|Withdrawal by Subject|0|||
23667248|NCT00139776|66165447|FG002|Period III|Withdrawal by Subject|16|||
23491600|NCT03633617|65545045|FG009|Part A|Adverse Event|0|||
23605887|NCT00807599|65947094|FG000|Overall Study|Not treated on protocol study|0|||
23605888|NCT00807599|65947095|FG001|Overall Study|Not treated on protocol study|0|||
23605889|NCT00807599|65947096|FG002|Overall Study|Not treated on protocol study|2|||
23605890|NCT00807599|65947094|FG000|Overall Study|Adverse Event|0|||
23605891|NCT00807599|65947095|FG001|Overall Study|Adverse Event|0|||
23605892|NCT00807599|65947096|FG002|Overall Study|Adverse Event|5|||
23605893|NCT00807599|65947094|FG000|Overall Study|Inadequate response to induction|0|||
23605894|NCT00807599|65947095|FG001|Overall Study|Inadequate response to induction|0|||
23605895|NCT00807599|65947096|FG002|Overall Study|Inadequate response to induction|9|||
23605896|NCT00807599|65947094|FG000|Overall Study|Withdrawal by Subject|0|||
23605897|NCT00807599|65947095|FG001|Overall Study|Withdrawal by Subject|0|||
23605898|NCT00807599|65947096|FG002|Overall Study|Withdrawal by Subject|1|||
23667249|NCT00139776|66165448|FG003|Period III|Withdrawal by Subject|21|||
23667250|NCT02250274|66165451|FG000|Overall Study|Insufficient blood draw amount|7|||
23667251|NCT02250274|66165452|FG001|Overall Study|Insufficient blood draw amount|6|||
23667252|NCT02915523|66165453|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
23667253|NCT02915523|66165454|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
23667254|NCT02915523|66165455|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
23605899|NCT02340806|65947097|FG000|Overall Study|Protocol Violation|2|||
23605900|NCT02340806|65947098|FG001|Overall Study|Protocol Violation|0|||
23605901|NCT02340806|65947097|FG000|Overall Study|epidural catheter replaced|2|||
23605902|NCT02340806|65947098|FG001|Overall Study|epidural catheter replaced|1|||
23605903|NCT02340806|65947097|FG000|Overall Study|history of chronic pain medication|1|||
23605904|NCT02340806|65947098|FG001|Overall Study|history of chronic pain medication|0|||
23605905|NCT02340806|65947097|FG000|Overall Study|re-dose < 90 min of CSE|1|||
23605906|NCT02340806|65947098|FG001|Overall Study|re-dose < 90 min of CSE|3|||
23605907|NCT01640951|65947101|FG000|Overall Study|Adverse Event|8|||
23605908|NCT01640951|65947102|FG001|Overall Study|Adverse Event|3|||
23605909|NCT01640951|65947103|FG002|Overall Study|Adverse Event|10|||
23605910|NCT01640951|65947104|FG003|Overall Study|Adverse Event|6|||
23605911|NCT01640951|65947105|FG004|Overall Study|Adverse Event|1|||
23605912|NCT01640951|65947106|FG005|Overall Study|Adverse Event|11|||
23667255|NCT02915523|66165456|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
23667256|NCT02915523|66165453|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
23667257|NCT02915523|66165454|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
23667258|NCT02915523|66165455|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
23667259|NCT02915523|66165456|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
23667260|NCT02915523|66165453|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23667261|NCT02915523|66165454|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
23667262|NCT02915523|66165455|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23667263|NCT02915523|66165456|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23667264|NCT02915523|66165453|FG000|Expansion Phase (Phase 2)|Death|0|||
23667265|NCT02915523|66165454|FG001|Expansion Phase (Phase 2)|Death|0|||
23667266|NCT02915523|66165455|FG002|Expansion Phase (Phase 2)|Death|26|||
23667267|NCT02915523|66165456|FG003|Expansion Phase (Phase 2)|Death|53|||
23667268|NCT02915523|66165453|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
23667269|NCT02915523|66165454|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
23667270|NCT02915523|66165455|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
23667271|NCT02915523|66165456|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
23667272|NCT02915523|66165453|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
23667273|NCT02915523|66165454|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
23667274|NCT02915523|66165455|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
23667275|NCT02915523|66165456|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
23667276|NCT02915523|66165453|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23667277|NCT02915523|66165454|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23667278|NCT02915523|66165455|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23667279|NCT02915523|66165456|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
23667280|NCT02577146|66165461|FG000|Overall Study|Lost to Follow-up|8|||
23667281|NCT02577146|66165461|FG000|Overall Study|Physician Decision|3|||
23667282|NCT02577146|66165461|FG000|Overall Study|Screen Failure|17|||
23667283|NCT00003535|66165462|FG000|Overall Study|Not evaluable|5|||
23667284|NCT02553265|66165463|FG000|Enrollment|Death|0|||
23667285|NCT02553265|66165464|FG001|Enrollment|Death|0|||
23667286|NCT02553265|66165465|FG002|Enrollment|Death|1|||
23667287|NCT02553265|66165463|FG000|First Intervention (28 Days)|Adverse Event|1|||
23667288|NCT02553265|66165464|FG001|First Intervention (28 Days)|Adverse Event|0|||
23667289|NCT02553265|66165465|FG002|First Intervention (28 Days)|Adverse Event|0|||
23667290|NCT02553265|66165463|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
23667291|NCT02553265|66165464|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
23667292|NCT02553265|66165465|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
23667293|NCT02553265|66165463|FG000|Second Intervention (28 Days)|Adverse Event|1|||
23667294|NCT02553265|66165464|FG001|Second Intervention (28 Days)|Adverse Event|0|||
23667295|NCT02553265|66165465|FG002|Second Intervention (28 Days)|Adverse Event|0|||
23667296|NCT02553265|66165463|FG000|Third Intervention (28 Days)|Adverse Event|1|||
23667297|NCT02553265|66165464|FG001|Third Intervention (28 Days)|Adverse Event|0|||
23667298|NCT02553265|66165465|FG002|Third Intervention (28 Days)|Adverse Event|0|||
23667299|NCT02553265|66165463|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
23605913|NCT01640951|65947107|FG006|Overall Study|Adverse Event|1|||
23667300|NCT02553265|66165464|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
23667301|NCT02553265|66165465|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
23667302|NCT01265797|66165466|FG000|Run-in Month|Withdrawal by Subject|0|||
23667303|NCT01265797|66165467|FG001|Run-in Month|Withdrawal by Subject|4|||
23667304|NCT01265797|66165466|FG000|Run-in Month|1st seizure during run-in month|0|||
23667305|NCT01265797|66165467|FG001|Run-in Month|1st seizure during run-in month|1|||
23667306|NCT01265797|66165466|FG000|Blinded Month|Lack of Efficacy|5|||
23667307|NCT01265797|66165467|FG001|Blinded Month|Lack of Efficacy|0|||
23667308|NCT01265797|66165466|FG000|Blinded Month|Lost to Follow-up|1|||
23667309|NCT01265797|66165467|FG001|Blinded Month|Lost to Follow-up|0|||
23667310|NCT01265797|66165466|FG000|Blinded Month|Protocol Violation|2|||
23667311|NCT01265797|66165467|FG001|Blinded Month|Protocol Violation|1|||
23667312|NCT01265797|66165466|FG000|Blinded Month|Adverse Event|2|||
23667313|NCT01265797|66165467|FG001|Blinded Month|Adverse Event|0|||
23667314|NCT01265797|66165466|FG000|Blinded Month|Diary data incomplete|0|||
23667315|NCT01265797|66165467|FG001|Blinded Month|Diary data incomplete|1|||
23667316|NCT01265797|66165466|FG000|Open Label Month|Lost to Follow-up|0|||
23667317|NCT01265797|66165467|FG001|Open Label Month|Lost to Follow-up|1|||
23667318|NCT00840086|66165468|FG000|Overall Study|Adverse Event|1|||
23667319|NCT00840086|66165468|FG000|Overall Study|Protocol Violation|2|||
23667320|NCT00840086|66165468|FG000|Overall Study|Lost to Follow-up|1|||
23667321|NCT00833053|66165469|FG000|Overall Study|Adverse Event|4|||
23667322|NCT00833053|66165470|FG001|Overall Study|Adverse Event|0|||
23667323|NCT00833053|66165469|FG000|Overall Study|Treatment Failure|3|||
23667324|NCT00833053|66165470|FG001|Overall Study|Treatment Failure|1|||
23667325|NCT00833053|66165469|FG000|Overall Study|Withdrawal by Subject|0|||
23667326|NCT00833053|66165470|FG001|Overall Study|Withdrawal by Subject|1|||
23667327|NCT00833053|66165469|FG000|Overall Study|Protocol Violation|2|||
23667328|NCT00833053|66165470|FG001|Overall Study|Protocol Violation|1|||
23667329|NCT00066703|66165474|FG000|Overall Study|Adverse Event|80|||
23667330|NCT00066703|66165475|FG001|Overall Study|Adverse Event|111|||
23667331|NCT00066703|66165474|FG000|Overall Study|Death|3|||
23667332|NCT00066703|66165475|FG001|Overall Study|Death|0|||
23667333|NCT00066703|66165474|FG000|Overall Study|Lack of Efficacy|114|||
23667334|NCT00066703|66165475|FG001|Overall Study|Lack of Efficacy|69|||
23667335|NCT00066703|66165474|FG000|Overall Study|Lost to Follow-up|31|||
23667336|NCT00066703|66165475|FG001|Overall Study|Lost to Follow-up|28|||
23667337|NCT00066703|66165474|FG000|Overall Study|Withdrawal by Subject|38|||
23667338|NCT00066703|66165475|FG001|Overall Study|Withdrawal by Subject|63|||
23667339|NCT00066703|66165474|FG000|Overall Study|Treatment ongoing|346|||
23667340|NCT00066703|66165475|FG001|Overall Study|Treatment ongoing|311|||
23667341|NCT02255409|66165481|FG000|Overall Study|Administrative Reason|3|||
23667342|NCT02255409|66165482|FG001|Overall Study|Administrative Reason|7|||
23667343|NCT02255409|66165481|FG000|Overall Study|Withdrawal by Subject|1|||
23667344|NCT02255409|66165482|FG001|Overall Study|Withdrawal by Subject|5|||
23667345|NCT02255409|66165481|FG000|Overall Study|Lost to Follow-up|10|||
23667346|NCT02255409|66165482|FG001|Overall Study|Lost to Follow-up|19|||
23667347|NCT00514514|66165483|FG000|Pre-phase|Death|10|||
23667348|NCT00514514|66165484|FG001|Pre-phase|Death|0|||
23667349|NCT00514514|66165485|FG002|Pre-phase|Death|0|||
23667350|NCT00514514|66165483|FG000|Pre-phase|administrative problems|2|||
23667351|NCT00514514|66165484|FG001|Pre-phase|administrative problems|0|||
23667352|NCT00514514|66165485|FG002|Pre-phase|administrative problems|0|||
23667353|NCT00514514|66165483|FG000|Pre-phase|Protocol Violation|6|||
23667354|NCT00514514|66165484|FG001|Pre-phase|Protocol Violation|0|||
23667355|NCT00514514|66165485|FG002|Pre-phase|Protocol Violation|0|||
23667356|NCT00514514|66165483|FG000|Pre-phase|condition no longer requires study drug|7|||
23667357|NCT00514514|66165484|FG001|Pre-phase|condition no longer requires study drug|0|||
23667358|NCT00514514|66165485|FG002|Pre-phase|condition no longer requires study drug|0|||
23667359|NCT00514514|66165483|FG000|Pre-phase|abnormal test procedure results|15|||
23667360|NCT00514514|66165484|FG001|Pre-phase|abnormal test procedure results|0|||
23667361|NCT00514514|66165485|FG002|Pre-phase|abnormal test procedure results|0|||
23667362|NCT00514514|66165483|FG000|Pre-phase|Lost to Follow-up|2|||
23667363|NCT00514514|66165484|FG001|Pre-phase|Lost to Follow-up|0|||
23667364|NCT00514514|66165485|FG002|Pre-phase|Lost to Follow-up|0|||
23667365|NCT00514514|66165483|FG000|Pre-phase|abnormal lab values|23|||
23667366|NCT00514514|66165484|FG001|Pre-phase|abnormal lab values|0|||
23667367|NCT00514514|66165485|FG002|Pre-phase|abnormal lab values|0|||
23667368|NCT00514514|66165483|FG000|Pre-phase|Lack of Efficacy|35|||
23667369|NCT00514514|66165484|FG001|Pre-phase|Lack of Efficacy|0|||
23667370|NCT00514514|66165485|FG002|Pre-phase|Lack of Efficacy|0|||
23667371|NCT00514514|66165483|FG000|Pre-phase|Adverse Event|137|||
23667372|NCT00514514|66165484|FG001|Pre-phase|Adverse Event|0|||
23667373|NCT00514514|66165485|FG002|Pre-phase|Adverse Event|0|||
23667374|NCT00514514|66165483|FG000|Pre-phase|Withdrawal by Subject|66|||
23667375|NCT00514514|66165484|FG001|Pre-phase|Withdrawal by Subject|0|||
23667376|NCT00514514|66165485|FG002|Pre-phase|Withdrawal by Subject|0|||
23667377|NCT00514514|66165483|FG000|Randomized - 9 Month|Death|3|||
23667378|NCT00514514|66165484|FG001|Randomized - 9 Month|Death|2|||
23667379|NCT00514514|66165485|FG002|Randomized - 9 Month|Death|2|||
23667380|NCT00514514|66165483|FG000|Randomized - 9 Month|Administrative problems|1|||
23667381|NCT00514514|66165484|FG001|Randomized - 9 Month|Administrative problems|1|||
23667382|NCT00514514|66165485|FG002|Randomized - 9 Month|Administrative problems|2|||
23667383|NCT00514514|66165483|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
23667384|NCT00514514|66165484|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
23667385|NCT00514514|66165485|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
23667386|NCT00514514|66165483|FG000|Randomized - 9 Month|Protocol Violation|1|||
23667387|NCT00514514|66165484|FG001|Randomized - 9 Month|Protocol Violation|1|||
23667388|NCT00514514|66165485|FG002|Randomized - 9 Month|Protocol Violation|0|||
23667389|NCT00514514|66165483|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
23667390|NCT00514514|66165484|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
23667391|NCT00514514|66165485|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
23667392|NCT00514514|66165483|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
23667393|NCT00514514|66165484|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
23667394|NCT00514514|66165485|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
23667395|NCT00514514|66165483|FG000|Randomized - 9 Month|Adverse Event|25|||
23667396|NCT00514514|66165484|FG001|Randomized - 9 Month|Adverse Event|44|||
23667397|NCT00514514|66165485|FG002|Randomized - 9 Month|Adverse Event|27|||
23667398|NCT00514514|66165483|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
23667399|NCT00514514|66165484|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
23667400|NCT00514514|66165485|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
23667401|NCT00514514|66165483|FG000|Extension - 4 Years|Lost to Follow-up|12|||
23667402|NCT00514514|66165484|FG001|Extension - 4 Years|Lost to Follow-up|10|||
23667403|NCT00514514|66165485|FG002|Extension - 4 Years|Lost to Follow-up|9|||
23667404|NCT00514514|66165483|FG000|Extension - 4 Years|Administrative problems|3|||
23667405|NCT00514514|66165484|FG001|Extension - 4 Years|Administrative problems|1|||
23667406|NCT00514514|66165485|FG002|Extension - 4 Years|Administrative problems|1|||
23667407|NCT00514514|66165483|FG000|Extension - 4 Years|Death|8|||
23667408|NCT00514514|66165484|FG001|Extension - 4 Years|Death|3|||
23667409|NCT00514514|66165485|FG002|Extension - 4 Years|Death|6|||
23667410|NCT00514514|66165483|FG000|Extension - 4 Years|Adverse Event|9|||
23667411|NCT00514514|66165484|FG001|Extension - 4 Years|Adverse Event|6|||
23667412|NCT00514514|66165485|FG002|Extension - 4 Years|Adverse Event|3|||
23667413|NCT00129766|66165493|FG000|Overall Study|Death|3|||
23667414|NCT00129766|66165494|FG001|Overall Study|Death|8|||
23667415|NCT00129766|66165493|FG000|Overall Study|Withdrawal of consent|31|||
23667416|NCT00129766|66165494|FG001|Overall Study|Withdrawal of consent|30|||
23667417|NCT00129766|66165493|FG000|Overall Study|Lost to Follow-up|26|||
23667418|NCT00129766|66165494|FG001|Overall Study|Lost to Follow-up|21|||
23667419|NCT01970501|66165498|FG000|Overall Study|Discontinuation of study by sponsor|16|||
23667420|NCT01970501|66165499|FG001|Overall Study|Discontinuation of study by sponsor|14|||
23667421|NCT01970501|66165498|FG000|Overall Study|Withdrawal by Subject|6|||
23667422|NCT01970501|66165499|FG001|Overall Study|Withdrawal by Subject|7|||
23667423|NCT01970501|66165498|FG000|Overall Study|Adverse Event|2|||
23667424|NCT01970501|66165499|FG001|Overall Study|Adverse Event|4|||
23667425|NCT01970501|66165498|FG000|Overall Study|Death|1|||
23667426|NCT01970501|66165499|FG001|Overall Study|Death|3|||
23667427|NCT01970501|66165498|FG000|Overall Study|Physician Decision|2|||
23667428|NCT01970501|66165499|FG001|Overall Study|Physician Decision|0|||
23667429|NCT01585272|66165502|FG000|Overall Study|Adverse Event|22|||
23667430|NCT01585272|66165502|FG000|Overall Study|Protocol Violation|7|||
23667431|NCT01585272|66165502|FG000|Overall Study|Withdrawal by Subject|10|||
23667432|NCT00961220|66165503|FG000|Overall Study|Adverse Event|3|||
23667433|NCT00961220|66165503|FG000|Overall Study|Lack of Efficacy|1|||
23667434|NCT00961220|66165503|FG000|Overall Study|No IV access for O6BG|1|||
23667435|NCT00961220|66165503|FG000|Overall Study|O6BG no longer supplied|1|||
23667436|NCT00961220|66165503|FG000|Overall Study|Complete Response prior to 12 courses|1|||
23667437|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
23667438|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
23667439|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
23667440|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
23667441|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
23667442|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
23491601|NCT03633617|65545046|FG010|Part A|Adverse Event|0|||
23667443|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23667444|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23667445|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
23667446|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
23667447|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23667448|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23667449|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
23667450|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
23667451|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
23667452|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
23667453|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
23667454|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
23667455|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
23667456|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
23667457|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
23667458|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
23667459|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23667460|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
23667461|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Death|2|||
23667462|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Death|1|||
23667463|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Death|0|||
23667464|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Death|0|||
23667465|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23667466|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23667467|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23667468|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23667469|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
23667470|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
23667471|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
23667472|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
23667473|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23667474|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23667475|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23667476|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23380335|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380336|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380337|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
23380338|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380339|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380340|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380341|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380342|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380343|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380344|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380345|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
23380346|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380347|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380348|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380349|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380350|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380351|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380352|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
23380353|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23667477|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
23667478|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23667479|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23667480|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23667481|NCT01940471|66165506|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
23667482|NCT01940471|66165507|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
23667483|NCT01940471|66165508|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
23380354|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380355|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380356|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23667484|NCT01940471|66165509|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
23667485|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23667486|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23667487|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
23667488|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
23667489|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23667490|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23667491|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
23667492|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
23667493|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23667494|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23667495|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
23667496|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
23667497|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
23667498|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
23667499|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
23667500|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
23667501|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23667502|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23667503|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
23667504|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
23667505|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23667506|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23667507|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
23667508|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
23667509|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23667510|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23667511|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
23667512|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23667513|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23667514|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23667515|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
23667516|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23667517|NCT01940471|66165506|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23667518|NCT01940471|66165507|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23667519|NCT01940471|66165508|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
23380357|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380358|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380359|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380360|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
23380361|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
23380362|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380363|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380364|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380365|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380366|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380367|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380368|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
23380369|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380370|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380371|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380372|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380373|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380374|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380375|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380376|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
23380377|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380378|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380379|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380380|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23402830|NCT02185534|65220018|FG001|First Washout Period|Protocol Violation|0|||
23667520|NCT01940471|66165509|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23667521|NCT01439282|66165518|FG000|Overall Study|Adverse Event|5|||
23667522|NCT01439282|66165519|FG001|Overall Study|Adverse Event|0|||
23667523|NCT01439282|66165518|FG000|Overall Study|Withdrawal by Subject|2|||
23667524|NCT01439282|66165519|FG001|Overall Study|Withdrawal by Subject|0|||
23667525|NCT01439282|66165518|FG000|Overall Study|Other|1|||
23667526|NCT01439282|66165519|FG001|Overall Study|Other|1|||
23667527|NCT03688880|66165520|FG000|Overall Study|Withdrawal by Subject|0|||
23667528|NCT03688880|66165521|FG001|Overall Study|Withdrawal by Subject|2|||
23667529|NCT03688880|66165520|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
23667530|NCT03688880|66165521|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
23667531|NCT03688880|66165520|FG000|Overall Study|Lost to Follow-up|4|||
23667532|NCT03688880|66165521|FG001|Overall Study|Lost to Follow-up|7|||
23667533|NCT03688880|66165520|FG000|Overall Study|Adverse Event|0|||
23667534|NCT03688880|66165521|FG001|Overall Study|Adverse Event|2|||
23667535|NCT03688880|66165520|FG000|Overall Study|Device deficiencies|0|||
23667536|NCT03688880|66165521|FG001|Overall Study|Device deficiencies|2|||
23667537|NCT03688880|66165520|FG000|Overall Study|Other|10|||
23667538|NCT03688880|66165521|FG001|Overall Study|Other|16|||
23667539|NCT00939783|66165522|FG000|Overall Study|Death|6|||
23667540|NCT00939783|66165522|FG000|Overall Study|Adverse Event|39|||
23667541|NCT00939783|66165522|FG000|Overall Study|Study Terminated by Sponsor|498|||
23667542|NCT00939783|66165522|FG000|Overall Study|Withdrawal by Subject|78|||
23667543|NCT00939783|66165522|FG000|Overall Study|Other|16|||
23667544|NCT00939783|66165522|FG000|Overall Study|Lost to Follow-up|8|||
23667545|NCT00939783|66165522|FG000|Overall Study|Protocol Violation|3|||
23667546|NCT00939783|66165522|FG000|Overall Study|Enrolled but not treated|1|||
23667547|NCT00708123|66165523|FG000|Period 1|Protocol Violation|0|||
23667548|NCT00708123|66165524|FG001|Period 1|Protocol Violation|1|||
23667549|NCT00708123|66165525|FG002|Period 1|Protocol Violation|0|||
23667550|NCT00708123|66165526|FG003|Period 1|Protocol Violation|1|||
23667551|NCT00708123|66165527|FG004|Period 1|Protocol Violation|0|||
23667552|NCT00708123|66165523|FG000|Period 1|Adverse Event|0|||
23667553|NCT00708123|66165524|FG001|Period 1|Adverse Event|0|||
23667554|NCT00708123|66165525|FG002|Period 1|Adverse Event|1|||
23667555|NCT00708123|66165526|FG003|Period 1|Adverse Event|0|||
23667556|NCT00708123|66165527|FG004|Period 1|Adverse Event|0|||
23667557|NCT00708123|66165523|FG000|Period 2|Protocol Violation|0|||
23667558|NCT00708123|66165524|FG001|Period 2|Protocol Violation|0|||
23667559|NCT00708123|66165525|FG002|Period 2|Protocol Violation|0|||
23667560|NCT00708123|66165526|FG003|Period 2|Protocol Violation|1|||
23667561|NCT00708123|66165527|FG004|Period 2|Protocol Violation|0|||
23667562|NCT00708123|66165523|FG000|Period 2|Other Reason|1|||
23667563|NCT00708123|66165524|FG001|Period 2|Other Reason|0|||
23667564|NCT00708123|66165525|FG002|Period 2|Other Reason|0|||
23667565|NCT00708123|66165526|FG003|Period 2|Other Reason|0|||
23667566|NCT00708123|66165527|FG004|Period 2|Other Reason|0|||
23667567|NCT00708123|66165523|FG000|Period 3|Lost to Follow-up|0|||
23667568|NCT00708123|66165524|FG001|Period 3|Lost to Follow-up|0|||
23667569|NCT00708123|66165525|FG002|Period 3|Lost to Follow-up|1|||
23667570|NCT00708123|66165526|FG003|Period 3|Lost to Follow-up|1|||
23667571|NCT00708123|66165527|FG004|Period 3|Lost to Follow-up|0|||
23667572|NCT00708123|66165523|FG000|Period 4|Protocol Violation|0|||
23667573|NCT00708123|66165524|FG001|Period 4|Protocol Violation|1|||
23667574|NCT00708123|66165525|FG002|Period 4|Protocol Violation|0|||
23667575|NCT00708123|66165526|FG003|Period 4|Protocol Violation|0|||
23667576|NCT00708123|66165527|FG004|Period 4|Protocol Violation|0|||
23667577|NCT02255422|66165532|FG000|Overall Study|Withdrawal by Subject|0|||
23667578|NCT02255422|66165533|FG001|Overall Study|Withdrawal by Subject|0|||
23667579|NCT02255422|66165534|FG002|Overall Study|Withdrawal by Subject|0|||
23667580|NCT02255422|66165535|FG003|Overall Study|Withdrawal by Subject|0|||
23667581|NCT02255422|66165536|FG004|Overall Study|Withdrawal by Subject|0|||
23667582|NCT02255422|66165537|FG005|Overall Study|Withdrawal by Subject|0|||
23667583|NCT02255422|66165538|FG006|Overall Study|Withdrawal by Subject|2|||
23667584|NCT02255422|66165532|FG000|Overall Study|Lost to Follow-up|0|||
23667585|NCT02255422|66165533|FG001|Overall Study|Lost to Follow-up|0|||
23667586|NCT02255422|66165534|FG002|Overall Study|Lost to Follow-up|1|||
23667587|NCT02255422|66165535|FG003|Overall Study|Lost to Follow-up|0|||
23667588|NCT02255422|66165536|FG004|Overall Study|Lost to Follow-up|0|||
23667589|NCT02255422|66165537|FG005|Overall Study|Lost to Follow-up|0|||
23667590|NCT02255422|66165538|FG006|Overall Study|Lost to Follow-up|0|||
23667591|NCT03681119|66165539|FG000|Overall Study|No specific reason|4|||
23667592|NCT03681119|66165540|FG001|Overall Study|No specific reason|0|||
23667593|NCT03681119|66165539|FG000|Overall Study|Sickness|2|||
23667594|NCT03681119|66165540|FG001|Overall Study|Sickness|0|||
23667595|NCT01399788|66165544|FG000|First Intervention Period|Adverse Event|1|||
23667596|NCT01399788|66165545|FG001|First Intervention Period|Adverse Event|0|||
23667597|NCT04179734|66168608|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
23667598|NCT04179734|66168609|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
23667599|NCT04179734|66168608|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
23667600|NCT04179734|66168609|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
23667601|NCT00317109|66168610|FG000|Overall Study|Withdrawal by Subject|2|||
23667602|NCT00317109|66168611|FG001|Overall Study|Withdrawal by Subject|0|||
23667603|NCT00317109|66168610|FG000|Overall Study|Migated/moved from study area|1|||
23667604|NCT00317109|66168611|FG001|Overall Study|Migated/moved from study area|0|||
23667605|NCT00706134|66168612|FG000|Overall Study|Adverse Event|8|||
23667606|NCT00706134|66168613|FG001|Overall Study|Adverse Event|7|||
23667607|NCT00706134|66168614|FG002|Overall Study|Adverse Event|2|||
23667608|NCT00706134|66168615|FG003|Overall Study|Adverse Event|3|||
23667609|NCT00706134|66168612|FG000|Overall Study|Lost to Follow-up|0|||
23667610|NCT00706134|66168613|FG001|Overall Study|Lost to Follow-up|1|||
23667611|NCT00706134|66168614|FG002|Overall Study|Lost to Follow-up|0|||
23667612|NCT00706134|66168615|FG003|Overall Study|Lost to Follow-up|0|||
23667613|NCT00706134|66168612|FG000|Overall Study|Protocol Violation|0|||
23667614|NCT00706134|66168613|FG001|Overall Study|Protocol Violation|6|||
23667615|NCT00706134|66168614|FG002|Overall Study|Protocol Violation|0|||
23667616|NCT00706134|66168615|FG003|Overall Study|Protocol Violation|3|||
23667617|NCT00706134|66168612|FG000|Overall Study|Withdrawal by Subject|1|||
23667618|NCT00706134|66168613|FG001|Overall Study|Withdrawal by Subject|2|||
23667619|NCT00706134|66168614|FG002|Overall Study|Withdrawal by Subject|1|||
23667620|NCT00706134|66168615|FG003|Overall Study|Withdrawal by Subject|0|||
23667621|NCT00706134|66168612|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23667622|NCT00706134|66168613|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23667623|NCT00706134|66168614|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23667624|NCT00706134|66168615|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
23667625|NCT00706134|66168612|FG000|Overall Study|Did not meet study criteria|2|||
23667626|NCT00706134|66168613|FG001|Overall Study|Did not meet study criteria|0|||
23667627|NCT00706134|66168614|FG002|Overall Study|Did not meet study criteria|0|||
23667628|NCT00706134|66168615|FG003|Overall Study|Did not meet study criteria|0|||
23667629|NCT00488982|66168616|FG000|Course 1|Physician Decision|0|||
23667630|NCT00488982|66168617|FG001|Course 1|Physician Decision|2|||
23667631|NCT00488982|66168618|FG002|Course 1|Physician Decision|4|||
23667632|NCT00488982|66168616|FG000|Course 1|Withdrawal by Subject|0|||
23667633|NCT00488982|66168617|FG001|Course 1|Withdrawal by Subject|8|||
23667634|NCT00488982|66168618|FG002|Course 1|Withdrawal by Subject|2|||
23380381|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380382|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380383|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380384|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380385|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
23380386|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380387|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380388|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380389|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380390|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380391|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380392|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380393|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380394|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380395|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
23380396|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380397|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380398|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380399|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380400|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380401|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380402|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
23380403|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380404|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380405|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380406|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380407|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380408|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380409|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380410|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
23380411|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
23380412|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380413|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380414|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380415|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380416|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380417|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380418|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
23380419|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380420|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23491602|NCT03633617|65545036|FG000|Part A|Pregnancy|1|||
23491603|NCT03633617|65545037|FG001|Part A|Pregnancy|0|||
23491604|NCT03633617|65545038|FG002|Part A|Pregnancy|0|||
23491605|NCT03633617|65545039|FG003|Part A|Pregnancy|0|||
23491606|NCT03633617|65545040|FG004|Part A|Pregnancy|0|||
23491607|NCT03633617|65545041|FG005|Part A|Pregnancy|0|||
23491608|NCT03633617|65545042|FG006|Part A|Pregnancy|0|||
23491609|NCT03633617|65545043|FG007|Part A|Pregnancy|0|||
23491610|NCT03633617|65545044|FG008|Part A|Pregnancy|0|||
23380421|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23491611|NCT03633617|65545045|FG009|Part A|Pregnancy|0|||
23491612|NCT03633617|65545046|FG010|Part A|Pregnancy|0|||
23491613|NCT03633617|65545036|FG000|Part A|Withdrawal by Subject|0|||
23491614|NCT03633617|65545037|FG001|Part A|Withdrawal by Subject|1|||
23491615|NCT03633617|65545038|FG002|Part A|Withdrawal by Subject|0|||
23491616|NCT03633617|65545039|FG003|Part A|Withdrawal by Subject|0|||
23491617|NCT03633617|65545040|FG004|Part A|Withdrawal by Subject|0|||
23491618|NCT03633617|65545041|FG005|Part A|Withdrawal by Subject|0|||
23491619|NCT03633617|65545042|FG006|Part A|Withdrawal by Subject|0|||
23491620|NCT03633617|65545043|FG007|Part A|Withdrawal by Subject|0|||
23491621|NCT03633617|65545044|FG008|Part A|Withdrawal by Subject|0|||
23491622|NCT03633617|65545045|FG009|Part A|Withdrawal by Subject|0|||
23491623|NCT03633617|65545046|FG010|Part A|Withdrawal by Subject|0|||
23491624|NCT03633617|65545036|FG000|Part B|Adverse Event|0|||
23491625|NCT03633617|65545037|FG001|Part B|Adverse Event|0|||
23491626|NCT03633617|65545038|FG002|Part B|Adverse Event|2|||
23491627|NCT03633617|65545039|FG003|Part B|Adverse Event|2|||
23491628|NCT03633617|65545040|FG004|Part B|Adverse Event|1|||
23491629|NCT03633617|65545041|FG005|Part B|Adverse Event|0|||
23491630|NCT03633617|65545042|FG006|Part B|Adverse Event|0|||
23491631|NCT03633617|65545043|FG007|Part B|Adverse Event|0|||
23491632|NCT03633617|65545044|FG008|Part B|Adverse Event|0|||
23491633|NCT03633617|65545045|FG009|Part B|Adverse Event|0|||
23491634|NCT03633617|65545046|FG010|Part B|Adverse Event|0|||
23491635|NCT03633617|65545036|FG000|Part B|Withdrawal by Subject|0|||
23491636|NCT03633617|65545037|FG001|Part B|Withdrawal by Subject|0|||
23491637|NCT03633617|65545038|FG002|Part B|Withdrawal by Subject|1|||
23491638|NCT03633617|65545039|FG003|Part B|Withdrawal by Subject|0|||
23491639|NCT03633617|65545040|FG004|Part B|Withdrawal by Subject|2|||
23491640|NCT03633617|65545041|FG005|Part B|Withdrawal by Subject|0|||
23491641|NCT03633617|65545042|FG006|Part B|Withdrawal by Subject|0|||
23491642|NCT03633617|65545043|FG007|Part B|Withdrawal by Subject|0|||
23491643|NCT03633617|65545044|FG008|Part B|Withdrawal by Subject|0|||
23491644|NCT03633617|65545045|FG009|Part B|Withdrawal by Subject|0|||
23491645|NCT03633617|65545046|FG010|Part B|Withdrawal by Subject|0|||
23491646|NCT03633617|65545036|FG000|Part B|Lost to Follow-up|0|||
23491647|NCT03633617|65545037|FG001|Part B|Lost to Follow-up|0|||
23491648|NCT03633617|65545038|FG002|Part B|Lost to Follow-up|0|||
23491649|NCT03633617|65545039|FG003|Part B|Lost to Follow-up|0|||
23491650|NCT03633617|65545040|FG004|Part B|Lost to Follow-up|1|||
23491651|NCT03633617|65545041|FG005|Part B|Lost to Follow-up|0|||
23380422|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380423|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380424|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380425|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380426|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
23380427|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
23380428|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380429|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380430|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380431|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380432|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380433|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380434|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380435|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380436|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
23380437|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
23380438|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380439|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380440|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380441|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380442|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380443|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380444|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
23380445|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380446|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23667635|NCT00488982|66168616|FG000|Course 1|nonprotocol therapy|0|||
23667636|NCT00488982|66168617|FG001|Course 1|nonprotocol therapy|2|||
23667637|NCT00488982|66168618|FG002|Course 1|nonprotocol therapy|2|||
23667638|NCT00488982|66168616|FG000|Course 1|Adverse Event|0|||
23667639|NCT00488982|66168617|FG001|Course 1|Adverse Event|0|||
23380447|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380448|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380449|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380450|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380451|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380452|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
23380453|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
23380454|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380455|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380456|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380457|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23667640|NCT00488982|66168618|FG002|Course 1|Adverse Event|6|||
23491652|NCT03633617|65545042|FG006|Part B|Lost to Follow-up|0|||
23667641|NCT04066491|66168619|FG000|Overall Study|Randomized, not treated|0|||
23667642|NCT04066491|66168620|FG001|Overall Study|Randomized, not treated|0|||
23491653|NCT03633617|65545043|FG007|Part B|Lost to Follow-up|0|||
23380458|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380459|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380460|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
23380461|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
23380462|NCT02328105|65137264|FG000|Overall Study|Death|6|||
23380463|NCT02328105|65137264|FG000|Overall Study|Withdrawal by Subject|1|||
23380464|NCT02328105|65137264|FG000|Overall Study|Still On Study in Follow-Up|4|||
23380465|NCT00485303|65137265|FG000|Overall Study|Adverse Event|5|||
23380466|NCT00485303|65137265|FG000|Overall Study|Progressive Disease|44|||
23380467|NCT00485303|65137265|FG000|Overall Study|Other|3|||
23380468|NCT00485303|65137265|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
23380469|NCT00485303|65137265|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
23380470|NCT02737618|65137267|FG000|Overall Study|Withdrawal by Subject|9|||
23380471|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Death|0|||
23491654|NCT03633617|65545044|FG008|Part B|Lost to Follow-up|0|||
23491655|NCT03633617|65545045|FG009|Part B|Lost to Follow-up|0|||
23491656|NCT03633617|65545046|FG010|Part B|Lost to Follow-up|0|||
23491657|NCT03633617|65545036|FG000|Part B|Physician Decision|0|||
23491658|NCT03633617|65545037|FG001|Part B|Physician Decision|0|||
23491659|NCT03633617|65545038|FG002|Part B|Physician Decision|0|||
23491660|NCT03633617|65545039|FG003|Part B|Physician Decision|0|||
23491661|NCT03633617|65545040|FG004|Part B|Physician Decision|1|||
23491662|NCT03633617|65545041|FG005|Part B|Physician Decision|0|||
23491663|NCT03633617|65545042|FG006|Part B|Physician Decision|0|||
23491664|NCT03633617|65545043|FG007|Part B|Physician Decision|0|||
23491665|NCT03633617|65545044|FG008|Part B|Physician Decision|0|||
23491666|NCT03633617|65545045|FG009|Part B|Physician Decision|0|||
23491667|NCT03633617|65545046|FG010|Part B|Physician Decision|0|||
23491668|NCT03633617|65545036|FG000|Part B|COVID-19 Restrictions|0|||
23667643|NCT04066491|66168621|FG002|Overall Study|Randomized, not treated|2|||
23667644|NCT02325219|66168623|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
23491669|NCT03633617|65545037|FG001|Part B|COVID-19 Restrictions|0|||
23491670|NCT03633617|65545038|FG002|Part B|COVID-19 Restrictions|1|||
23491671|NCT03633617|65545039|FG003|Part B|COVID-19 Restrictions|0|||
23491672|NCT03633617|65545040|FG004|Part B|COVID-19 Restrictions|0|||
23491673|NCT03633617|65545041|FG005|Part B|COVID-19 Restrictions|0|||
23491674|NCT03633617|65545042|FG006|Part B|COVID-19 Restrictions|0|||
23491675|NCT03633617|65545043|FG007|Part B|COVID-19 Restrictions|0|||
23491676|NCT03633617|65545044|FG008|Part B|COVID-19 Restrictions|0|||
23491677|NCT03633617|65545045|FG009|Part B|COVID-19 Restrictions|0|||
23491678|NCT03633617|65545046|FG010|Part B|COVID-19 Restrictions|0|||
23491679|NCT03633617|65545036|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491680|NCT03633617|65545037|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491681|NCT03633617|65545038|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
23491682|NCT03633617|65545039|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491683|NCT03633617|65545040|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491684|NCT03633617|65545041|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23605914|NCT01640951|65947108|FG007|Overall Study|Adverse Event|3|||
23667645|NCT02325219|66168624|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
23667646|NCT02325219|66168625|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23667647|NCT02325219|66168626|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23667648|NCT02325219|66168627|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23667649|NCT02325219|66168623|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
23605915|NCT01640951|65947101|FG000|Overall Study|Lack of Efficacy|20|||
23380472|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Death|2|||
23491685|NCT03633617|65545042|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491686|NCT03633617|65545043|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23605916|NCT01640951|65947102|FG001|Overall Study|Lack of Efficacy|1|||
23605917|NCT01640951|65947103|FG002|Overall Study|Lack of Efficacy|7|||
23605918|NCT01640951|65947104|FG003|Overall Study|Lack of Efficacy|14|||
23605919|NCT01640951|65947105|FG004|Overall Study|Lack of Efficacy|0|||
23605920|NCT01640951|65947106|FG005|Overall Study|Lack of Efficacy|6|||
23380473|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Death|2|||
23380474|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Death|0|||
23380475|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
23380476|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
23380477|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
23380478|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
23380479|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
23380480|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
23380481|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
23380482|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
23380483|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
23380484|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
23380485|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
23380486|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
23380487|NCT04913675|65137270|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380488|NCT04913675|65137271|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380489|NCT04913675|65137272|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380490|NCT04913675|65137273|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
23380491|NCT00083915|65137276|FG000|Overall Study|Death|6|||
23380492|NCT00083915|65137277|FG001|Overall Study|Death|3|||
23380493|NCT00083915|65137276|FG000|Overall Study|Physician Decision|11|||
23380494|NCT00083915|65137277|FG001|Overall Study|Physician Decision|6|||
23380495|NCT00083915|65137276|FG000|Overall Study|Withdrawal by Subject|8|||
23380496|NCT00083915|65137277|FG001|Overall Study|Withdrawal by Subject|3|||
23380497|NCT00083915|65137276|FG000|Overall Study|disease progression|18|||
23380498|NCT00083915|65137277|FG001|Overall Study|disease progression|23|||
23380499|NCT00083915|65137276|FG000|Overall Study|Failure to collect|3|||
23380500|NCT00083915|65137277|FG001|Overall Study|Failure to collect|0|||
23380501|NCT00083915|65137276|FG000|Overall Study|No response|3|||
23380502|NCT00083915|65137277|FG001|Overall Study|No response|1|||
23380503|NCT00083915|65137276|FG000|Overall Study|Insurance issues|1|||
23380504|NCT00083915|65137277|FG001|Overall Study|Insurance issues|1|||
23380505|NCT02378181|65137280|FG000|Overall Study|Lost to Follow-up|2|||
23380506|NCT02378181|65137281|FG001|Overall Study|Lost to Follow-up|5|||
23380507|NCT02378181|65137280|FG000|Overall Study|Withdrawal by Subject|1|||
23380508|NCT02378181|65137281|FG001|Overall Study|Withdrawal by Subject|1|||
23380509|NCT02378181|65137280|FG000|Overall Study|Incarcerated|0|||
23380510|NCT02378181|65137281|FG001|Overall Study|Incarcerated|1|||
23380511|NCT01510756|65137282|FG000|Overall Study|Death|1|||
23380512|NCT01510756|65137282|FG000|Overall Study|Lack of Efficacy|2|||
23380513|NCT01510756|65137282|FG000|Overall Study|Physician Decision|1|||
23380514|NCT01027845|65137291|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
23380515|NCT01027845|65137292|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
23380516|NCT01027845|65137293|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
23380517|NCT01027845|65137294|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
23380518|NCT01027845|65137291|FG000|Primary Vaccination Phase|Adverse Event|1|||
23380519|NCT01027845|65137292|FG001|Primary Vaccination Phase|Adverse Event|0|||
23380520|NCT01027845|65137293|FG002|Primary Vaccination Phase|Adverse Event|0|||
23380521|NCT01027845|65137294|FG003|Primary Vaccination Phase|Adverse Event|0|||
23380522|NCT01027845|65137291|FG000|Primary Vaccination Phase|Protocol Violation|1|||
23380523|NCT01027845|65137292|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23380524|NCT01027845|65137293|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23380525|NCT01027845|65137294|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23380526|NCT01027845|65137291|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380527|NCT01027845|65137292|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
23380528|NCT01027845|65137293|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380529|NCT01027845|65137294|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380530|NCT01027845|65137291|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
23380531|NCT01027845|65137292|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380532|NCT01027845|65137293|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380533|NCT01027845|65137294|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380534|NCT01027845|65137291|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
23380535|NCT01027845|65137292|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380536|NCT01027845|65137293|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380537|NCT01027845|65137294|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380538|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
23380539|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
23380540|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
23380541|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
23605921|NCT01640951|65947107|FG006|Overall Study|Lack of Efficacy|5|||
23667650|NCT02325219|66168624|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
23667651|NCT02325219|66168625|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23380542|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
23380543|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
23380544|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
23380545|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
23380546|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
23380547|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
23380548|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
23380549|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
23380550|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
23380551|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
23380552|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
23380553|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Other|3|||
23380554|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Other|0|||
23667652|NCT02325219|66168626|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23667653|NCT02325219|66168627|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23667654|NCT02325219|66168623|FG000|Controlled Period (Week 0 - 16)|Other|0|||
23667655|NCT02325219|66168624|FG001|Controlled Period (Week 0 - 16)|Other|0|||
23667656|NCT02325219|66168625|FG002|Controlled Period (Week 0 - 16)|Other|1|||
23667657|NCT02325219|66168626|FG003|Controlled Period (Week 0 - 16)|Other|0|||
23667658|NCT02325219|66168627|FG004|Controlled Period (Week 0 - 16)|Other|0|||
23667659|NCT02325219|66168623|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23667660|NCT02325219|66168624|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23667661|NCT02325219|66168625|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23667662|NCT02325219|66168626|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23667663|NCT02325219|66168627|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23667664|NCT02325219|66168623|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23667665|NCT02325219|66168624|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
23667666|NCT02325219|66168625|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23667667|NCT02325219|66168626|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23667668|NCT02325219|66168627|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23667669|NCT02325219|66168623|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23667670|NCT02325219|66168624|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23667671|NCT02325219|66168625|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23667672|NCT02325219|66168626|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23667673|NCT02325219|66168627|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23667674|NCT01652885|66168636|FG000|Overall Study|Adverse Event|1|||
23667675|NCT02941627|66168637|FG000|Overall Study|Death|1|||
23667676|NCT02941627|66168637|FG000|Overall Study|Surgical failure|1|||
23667677|NCT02941627|66168637|FG000|Overall Study|cholesteatoma prevented implantation|1|||
23380555|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Other|0|||
23667678|NCT01326546|66168638|FG000|Overall Study|Lost to Follow-up|8|||
23667679|NCT01326546|66168639|FG001|Overall Study|Lost to Follow-up|7|||
23667680|NCT01326546|66168638|FG000|Overall Study|Protocol Violation|3|||
23667681|NCT01326546|66168639|FG001|Overall Study|Protocol Violation|4|||
23667682|NCT01326546|66168638|FG000|Overall Study|Pregnancy|0|||
23605922|NCT01640951|65947108|FG007|Overall Study|Lack of Efficacy|6|||
23667683|NCT01326546|66168639|FG001|Overall Study|Pregnancy|1|||
23667684|NCT01326546|66168638|FG000|Overall Study|Adverse Event|1|||
23667685|NCT01326546|66168639|FG001|Overall Study|Adverse Event|0|||
23667686|NCT01326546|66168638|FG000|Overall Study|Withdrawal by Subject|5|||
23667687|NCT01326546|66168639|FG001|Overall Study|Withdrawal by Subject|1|||
23667688|NCT04169373|66168640|FG000|Week 1 to Week 14|Adverse Event|1|||
23667689|NCT04169373|66168641|FG001|Week 1 to Week 14|Adverse Event|0|||
23667690|NCT04169373|66168642|FG002|Week 1 to Week 14|Adverse Event|1|||
23667691|NCT04169373|66168643|FG003|Week 1 to Week 14|Adverse Event|2|||
23667692|NCT04169373|66168640|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
23667693|NCT04169373|66168641|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
23667694|NCT04169373|66168642|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
23667695|NCT04169373|66168643|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
23667696|NCT04169373|66168640|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
23667697|NCT04169373|66168641|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
23667698|NCT04169373|66168642|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
23667699|NCT04169373|66168643|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
23667700|NCT04169373|66168640|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23667701|NCT04169373|66168641|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
23667702|NCT04169373|66168642|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23667703|NCT04169373|66168643|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23667704|NCT04169373|66168640|FG000|Week 1 to Week 14|Other|1|||
23667705|NCT04169373|66168641|FG001|Week 1 to Week 14|Other|3|||
23667706|NCT04169373|66168642|FG002|Week 1 to Week 14|Other|3|||
23667707|NCT04169373|66168643|FG003|Week 1 to Week 14|Other|5|||
23667708|NCT04169373|66168640|FG000|Week 14 to Week 52|Adverse Event|1|||
23667709|NCT04169373|66168641|FG001|Week 14 to Week 52|Adverse Event|0|||
23667710|NCT04169373|66168642|FG002|Week 14 to Week 52|Adverse Event|0|||
23667711|NCT04169373|66168643|FG003|Week 14 to Week 52|Adverse Event|1|||
23667712|NCT04169373|66168640|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
23667713|NCT04169373|66168641|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
23667714|NCT04169373|66168642|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
23667715|NCT04169373|66168643|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
23667716|NCT04169373|66168640|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
23667717|NCT04169373|66168641|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
23667718|NCT04169373|66168642|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
23667719|NCT04169373|66168643|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
23667720|NCT04169373|66168640|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
23667721|NCT04169373|66168641|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23667722|NCT04169373|66168642|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23667723|NCT04169373|66168643|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23667724|NCT04169373|66168640|FG000|Week 14 to Week 52|Other|4|||
23667725|NCT04169373|66168641|FG001|Week 14 to Week 52|Other|5|||
23667726|NCT04169373|66168642|FG002|Week 14 to Week 52|Other|4|||
23667727|NCT04169373|66168643|FG003|Week 14 to Week 52|Other|5|||
23667728|NCT04169373|66168640|FG000|Week 14 to Week 52|Ongoing|0|||
23667729|NCT04169373|66168641|FG001|Week 14 to Week 52|Ongoing|1|||
23667730|NCT04169373|66168642|FG002|Week 14 to Week 52|Ongoing|0|||
23667731|NCT04169373|66168643|FG003|Week 14 to Week 52|Ongoing|0|||
23667732|NCT00294060|66168644|FG000|Overall Study|Death|225|||
23667733|NCT00294060|66168644|FG000|Overall Study|Other|59|||
23667734|NCT00294060|66168644|FG000|Overall Study|Lost to Follow-up|55|||
23667735|NCT00294060|66168644|FG000|Overall Study|Withdrawal by Subject|11|||
23667736|NCT00294060|66168644|FG000|Overall Study|Physician Decision|797|||
23667737|NCT00294060|66168644|FG000|Overall Study|Medical condition|3|||
23667738|NCT00294060|66168644|FG000|Overall Study|Device explanted/not replaced|23|||
23667739|NCT03374189|66168646|FG000|Overall Study|Lost to Follow-up|1|||
23667740|NCT03374189|66168647|FG001|Overall Study|Lost to Follow-up|0|||
23667741|NCT01246583|66168651|FG000|Overall Study|Lost to Follow-up|0|||
23667742|NCT01246583|66168652|FG001|Overall Study|Lost to Follow-up|0|||
23667743|NCT01246583|66168653|FG002|Overall Study|Lost to Follow-up|0|||
23667744|NCT01246583|66168654|FG003|Overall Study|Lost to Follow-up|1|||
23667745|NCT01246583|66168651|FG000|Overall Study|Protocol Violation|0|||
23667746|NCT01246583|66168652|FG001|Overall Study|Protocol Violation|0|||
23667747|NCT01246583|66168653|FG002|Overall Study|Protocol Violation|1|||
23667748|NCT01246583|66168654|FG003|Overall Study|Protocol Violation|0|||
23667749|NCT01246583|66168651|FG000|Overall Study|Withdrawal by Subject|1|||
23605923|NCT01640951|65947101|FG000|Overall Study|Lost to Follow-up|1|||
23380556|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
23380557|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
23380558|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
23380559|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
23380560|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
23380561|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
23380562|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
23380563|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
23380564|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
23380565|NCT01002105|65137298|FG000|Overall Study|Lost to Follow-up|10|||
23380566|NCT01002105|65137299|FG001|Overall Study|Lost to Follow-up|16|||
23380567|NCT01002105|65137298|FG000|Overall Study|non compliance|5|||
23380568|NCT01002105|65137299|FG001|Overall Study|non compliance|3|||
23380569|NCT01002105|65137298|FG000|Overall Study|condition worsened|4|||
23380570|NCT01002105|65137299|FG001|Overall Study|condition worsened|2|||
23380571|NCT00081458|65137301|FG000|Overall Study|Adverse Event|1|||
23380572|NCT00081458|65137302|FG001|Overall Study|Adverse Event|5|||
23380573|NCT00081458|65137303|FG002|Overall Study|Adverse Event|2|||
23380574|NCT00081458|65137301|FG000|Overall Study|Withdrawal by Subject|0|||
23380575|NCT00081458|65137302|FG001|Overall Study|Withdrawal by Subject|3|||
23380576|NCT00081458|65137303|FG002|Overall Study|Withdrawal by Subject|1|||
23380577|NCT00081458|65137301|FG000|Overall Study|Randomized but not dosed|0|||
23380578|NCT00081458|65137302|FG001|Overall Study|Randomized but not dosed|0|||
23380579|NCT00081458|65137303|FG002|Overall Study|Randomized but not dosed|1|||
23380580|NCT02232698|65137306|FG000|Overall Study|Pregnancy|1|||
23380581|NCT02232698|65137307|FG001|Overall Study|Pregnancy|1|||
23380582|NCT02232698|65137306|FG000|Overall Study|Met exclusion criteria|1|||
23380583|NCT02232698|65137307|FG001|Overall Study|Met exclusion criteria|1|||
23380584|NCT02232698|65137306|FG000|Overall Study|Had device-associated symptoms|7|||
23380585|NCT02232698|65137307|FG001|Overall Study|Had device-associated symptoms|0|||
23380586|NCT02232698|65137306|FG000|Overall Study|Non-compliance with study device|1|||
23380587|NCT02232698|65137307|FG001|Overall Study|Non-compliance with study device|4|||
23380588|NCT02232698|65137306|FG000|Overall Study|Allocated to control group|0|||
23380589|NCT02232698|65137307|FG001|Overall Study|Allocated to control group|3|||
23380590|NCT02232698|65137306|FG000|Overall Study|Withdrawal by Subject|0|||
23380591|NCT02232698|65137307|FG001|Overall Study|Withdrawal by Subject|11|||
23380592|NCT01562444|65137309|FG000|Overall Study|Did not meet entry criteria|2|||
23380593|NCT01562444|65137310|FG001|Overall Study|Did not meet entry criteria|0|||
23380594|NCT01562444|65137311|FG002|Overall Study|Did not meet entry criteria|3|||
23380595|NCT01562444|65137309|FG000|Overall Study|Did not comply with blood draw schedule|1|||
23380596|NCT01562444|65137310|FG001|Overall Study|Did not comply with blood draw schedule|0|||
23380597|NCT01562444|65137311|FG002|Overall Study|Did not comply with blood draw schedule|1|||
23380598|NCT01562444|65137309|FG000|Overall Study|Unavailable serological results|0|||
23380599|NCT01562444|65137310|FG001|Overall Study|Unavailable serological results|2|||
23380600|NCT01562444|65137311|FG002|Overall Study|Unavailable serological results|2|||
23667750|NCT01246583|66168652|FG001|Overall Study|Withdrawal by Subject|0|||
23667751|NCT01246583|66168653|FG002|Overall Study|Withdrawal by Subject|0|||
23667752|NCT01246583|66168654|FG003|Overall Study|Withdrawal by Subject|0|||
23667753|NCT04839380|66168655|FG000|Overall Study|Withdrawal by Subject|2|||
23667754|NCT04839380|66168655|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
23667755|NCT01187953|66168661|FG000|Overall Study|Death|11|||
23667756|NCT01187953|66168662|FG001|Overall Study|Death|13|||
23667757|NCT01187953|66168661|FG000|Overall Study|Adverse Event|1|||
23667758|NCT01187953|66168662|FG001|Overall Study|Adverse Event|2|||
23667759|NCT01187953|66168661|FG000|Overall Study|Lost to Follow-up|0|||
23667760|NCT01187953|66168662|FG001|Overall Study|Lost to Follow-up|3|||
23667761|NCT01187953|66168661|FG000|Overall Study|Withdrawal by Subject|3|||
23667762|NCT01187953|66168662|FG001|Overall Study|Withdrawal by Subject|3|||
23667763|NCT00644787|66168665|FG000|Period 1: Titration Phase|Adverse Event|11|||
23667764|NCT00644787|66168666|FG001|Period 1: Titration Phase|Adverse Event|0|||
23667765|NCT00644787|66168667|FG002|Period 1: Titration Phase|Adverse Event|0|||
23667766|NCT00644787|66168665|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
23667767|NCT00644787|66168666|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
23667768|NCT00644787|66168667|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
23380601|NCT01562444|65137309|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
23380602|NCT01562444|65137310|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
23667769|NCT00644787|66168665|FG000|Period 1: Titration Phase|Physician Decision|1|||
23380603|NCT01562444|65137311|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
23380604|NCT01562444|65137309|FG000|Overall Study|Protocol forbidden medication|1|||
23380605|NCT01562444|65137310|FG001|Overall Study|Protocol forbidden medication|0|||
23380606|NCT01562444|65137311|FG002|Overall Study|Protocol forbidden medication|0|||
23667770|NCT00644787|66168666|FG001|Period 1: Titration Phase|Physician Decision|0|||
23667771|NCT00644787|66168667|FG002|Period 1: Titration Phase|Physician Decision|0|||
23667772|NCT00644787|66168665|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
23667773|NCT00644787|66168666|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
23667774|NCT00644787|66168667|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
23667775|NCT00644787|66168665|FG000|Period 1: Titration Phase|Worsening of complications|1|||
23667776|NCT00644787|66168666|FG001|Period 1: Titration Phase|Worsening of complications|0|||
23667777|NCT00644787|66168667|FG002|Period 1: Titration Phase|Worsening of complications|0|||
23667778|NCT00644787|66168665|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
23667779|NCT00644787|66168666|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
23667780|NCT00644787|66168667|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
23667781|NCT00644787|66168665|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
23667782|NCT00644787|66168666|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
23667783|NCT00644787|66168667|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
23667784|NCT00644787|66168665|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
23667785|NCT00644787|66168666|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
23667786|NCT00644787|66168667|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
23667787|NCT00644787|66168665|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
23667788|NCT00644787|66168666|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
23667789|NCT00644787|66168667|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
23667790|NCT00644787|66168665|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
23667791|NCT00644787|66168666|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
23667792|NCT00644787|66168667|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
23667793|NCT00644787|66168665|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
23667794|NCT00644787|66168666|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
23667795|NCT00644787|66168667|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
23667796|NCT00644787|66168665|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
23667797|NCT00644787|66168666|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
23667798|NCT00644787|66168667|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
23667799|NCT01131676|66168668|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
23667800|NCT01131676|66168669|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
23667801|NCT01131676|66168670|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
23667802|NCT01131676|66168668|FG000|Discontinuation From Treatment|Not treated|4|||
23667803|NCT01131676|66168669|FG001|Discontinuation From Treatment|Not treated|2|||
23380607|NCT02300610|65137312|FG000|Overall Study|Withdrawal by Subject|1|||
23380608|NCT02300610|65137313|FG001|Overall Study|Withdrawal by Subject|0|||
23380609|NCT02300610|65137314|FG002|Overall Study|Withdrawal by Subject|1|||
23380610|NCT02311478|65137315|FG000|Overall Study|Withdrawal by Subject|1|||
23380611|NCT02311478|65137315|FG000|Overall Study|Lost to Follow-up|5|||
23380612|NCT02311478|65137315|FG000|Overall Study|Failed IUD Insertion|1|||
23380613|NCT01137786|65137318|FG000|Overall Study|Lost to Follow-up|0|||
23380614|NCT01137786|65137319|FG001|Overall Study|Lost to Follow-up|2|||
23380615|NCT01137786|65137318|FG000|Overall Study|Withdrawal by Subject|1|||
23380616|NCT01137786|65137319|FG001|Overall Study|Withdrawal by Subject|1|||
23380617|NCT01129128|65137320|FG000|Overall Study|Lost to Follow-up|2|||
23380618|NCT01129128|65137321|FG001|Overall Study|Lost to Follow-up|2|||
23380619|NCT01129128|65137322|FG002|Overall Study|Lost to Follow-up|1|||
23380620|NCT01129128|65137320|FG000|Overall Study|Protocol Violation|0|||
23380621|NCT01129128|65137321|FG001|Overall Study|Protocol Violation|1|||
23380622|NCT01129128|65137322|FG002|Overall Study|Protocol Violation|0|||
23380623|NCT01129128|65137320|FG000|Overall Study|Withdrawal by Subject|0|||
23380624|NCT01129128|65137321|FG001|Overall Study|Withdrawal by Subject|1|||
23380625|NCT01129128|65137322|FG002|Overall Study|Withdrawal by Subject|3|||
23380626|NCT01129128|65137320|FG000|Overall Study|Physician Decision|1|||
23380627|NCT01129128|65137321|FG001|Overall Study|Physician Decision|0|||
23380628|NCT01129128|65137322|FG002|Overall Study|Physician Decision|0|||
23380629|NCT03550209|65137323|FG000|Overall Study|Lost to Follow-up|1|||
23380630|NCT03550209|65137324|FG001|Overall Study|Lost to Follow-up|0|||
23380631|NCT03550209|65137325|FG002|Overall Study|Lost to Follow-up|1|||
23380632|NCT03550209|65137326|FG003|Overall Study|Lost to Follow-up|0|||
23380633|NCT03550209|65137323|FG000|Overall Study|Withdrawal by Subject|0|||
23380634|NCT03550209|65137324|FG001|Overall Study|Withdrawal by Subject|3|||
23491687|NCT03633617|65545044|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23380635|NCT03550209|65137325|FG002|Overall Study|Withdrawal by Subject|1|||
23380636|NCT03550209|65137326|FG003|Overall Study|Withdrawal by Subject|2|||
23605924|NCT01640951|65947102|FG001|Overall Study|Lost to Follow-up|0|||
23667804|NCT01131676|66168670|FG002|Discontinuation From Treatment|Not treated|2|||
23667805|NCT01131676|66168668|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
23667806|NCT01131676|66168669|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
23380637|NCT03550209|65137323|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
23380638|NCT03550209|65137324|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
23380639|NCT03550209|65137325|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
23380640|NCT03550209|65137326|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
23380641|NCT00435942|65137327|FG000|Overall Study|Death|17|||
23380642|NCT00435942|65137328|FG001|Overall Study|Death|10|||
23380643|NCT00435942|65137327|FG000|Overall Study|Withdrawal by Subject|2|||
23380644|NCT00435942|65137328|FG001|Overall Study|Withdrawal by Subject|0|||
23380645|NCT00435942|65137327|FG000|Overall Study|Lost to Follow-up|0|||
23380646|NCT00435942|65137328|FG001|Overall Study|Lost to Follow-up|16|||
23380647|NCT00435942|65137327|FG000|Overall Study|Conversion to Open Repair|1|||
23380648|NCT00435942|65137328|FG001|Overall Study|Conversion to Open Repair|0|||
23380649|NCT00435942|65137327|FG000|Overall Study|Technical Failure|3|||
23380650|NCT00435942|65137328|FG001|Overall Study|Technical Failure|0|||
23380651|NCT00435942|65137327|FG000|Overall Study|Other|0|||
23380652|NCT00435942|65137328|FG001|Overall Study|Other|1|||
23380653|NCT05436288|65137330|FG000|Overall Study|Lost to Follow-up|1|||
23380654|NCT05436288|65137330|FG000|Overall Study|Adverse Event|1|||
23380655|NCT01171534|65137331|FG000|Overall Study|Lost to Follow-up|0|||
23380656|NCT01171534|65137332|FG001|Overall Study|Lost to Follow-up|2|||
23380657|NCT01171534|65137331|FG000|Overall Study|screen failure|0|||
23380658|NCT01171534|65137332|FG001|Overall Study|screen failure|1|||
23380659|NCT02568423|65137333|FG000|Overall Study|Lost to Follow-up|0|||
23380660|NCT02568423|65137334|FG001|Overall Study|Lost to Follow-up|2|||
23380661|NCT02568423|65137335|FG002|Overall Study|Lost to Follow-up|0|||
23380662|NCT02568423|65137336|FG003|Overall Study|Lost to Follow-up|0|||
23380663|NCT02568423|65137337|FG004|Overall Study|Lost to Follow-up|0|||
23380664|NCT02568423|65137338|FG005|Overall Study|Lost to Follow-up|0|||
23380665|NCT02568423|65137339|FG006|Overall Study|Lost to Follow-up|0|||
23380666|NCT02568423|65137340|FG007|Overall Study|Lost to Follow-up|0|||
23380667|NCT02568423|65137333|FG000|Overall Study|Physician Decision|0|||
23380668|NCT02568423|65137334|FG001|Overall Study|Physician Decision|0|||
23380669|NCT02568423|65137335|FG002|Overall Study|Physician Decision|0|||
23380670|NCT02568423|65137336|FG003|Overall Study|Physician Decision|0|||
23380671|NCT02568423|65137337|FG004|Overall Study|Physician Decision|0|||
23380672|NCT02568423|65137338|FG005|Overall Study|Physician Decision|1|||
23380673|NCT02568423|65137339|FG006|Overall Study|Physician Decision|0|||
23380674|NCT02568423|65137340|FG007|Overall Study|Physician Decision|0|||
23380675|NCT03743194|65137342|FG000|Overall Study|Protocol Violation|7|||
23380676|NCT03743194|65137343|FG001|Overall Study|Protocol Violation|7|||
23380677|NCT03743194|65137342|FG000|Overall Study|Physician Decision|0|||
23380678|NCT03743194|65137343|FG001|Overall Study|Physician Decision|2|||
23380679|NCT02309359|65137352|FG000|Overall Study|Adverse Event|4|||
23380680|NCT02309359|65137353|FG001|Overall Study|Adverse Event|5|||
23380681|NCT02309359|65137354|FG002|Overall Study|Adverse Event|5|||
23380682|NCT02309359|65137355|FG003|Overall Study|Adverse Event|4|||
23380683|NCT02309359|65137356|FG004|Overall Study|Adverse Event|4|||
23380684|NCT02309359|65137352|FG000|Overall Study|Death|1|||
23380685|NCT02309359|65137353|FG001|Overall Study|Death|0|||
23380686|NCT02309359|65137354|FG002|Overall Study|Death|0|||
23380687|NCT02309359|65137355|FG003|Overall Study|Death|0|||
23380688|NCT02309359|65137356|FG004|Overall Study|Death|0|||
23380689|NCT02309359|65137352|FG000|Overall Study|Withdrawal by Subject|2|||
23380690|NCT02309359|65137353|FG001|Overall Study|Withdrawal by Subject|2|||
23380691|NCT02309359|65137354|FG002|Overall Study|Withdrawal by Subject|4|||
23380692|NCT02309359|65137355|FG003|Overall Study|Withdrawal by Subject|4|||
23380693|NCT02309359|65137356|FG004|Overall Study|Withdrawal by Subject|0|||
23380694|NCT02309359|65137352|FG000|Overall Study|Lack of Efficacy|3|||
23380695|NCT02309359|65137353|FG001|Overall Study|Lack of Efficacy|1|||
23380696|NCT02309359|65137354|FG002|Overall Study|Lack of Efficacy|0|||
23380697|NCT02309359|65137355|FG003|Overall Study|Lack of Efficacy|0|||
23380698|NCT02309359|65137356|FG004|Overall Study|Lack of Efficacy|3|||
23380699|NCT02309359|65137352|FG000|Overall Study|Lost to Follow-up|0|||
23380700|NCT02309359|65137353|FG001|Overall Study|Lost to Follow-up|0|||
23380701|NCT02309359|65137354|FG002|Overall Study|Lost to Follow-up|0|||
23380702|NCT02309359|65137355|FG003|Overall Study|Lost to Follow-up|1|||
23380703|NCT02309359|65137356|FG004|Overall Study|Lost to Follow-up|0|||
23380704|NCT02309359|65137352|FG000|Overall Study|Other|2|||
23380705|NCT02309359|65137353|FG001|Overall Study|Other|0|||
23380706|NCT02309359|65137354|FG002|Overall Study|Other|2|||
23380707|NCT02309359|65137355|FG003|Overall Study|Other|3|||
23380708|NCT02309359|65137356|FG004|Overall Study|Other|2|||
23380709|NCT00720278|65137357|FG000|Overall Study|Adverse Event|5|||
23380710|NCT00720278|65137358|FG001|Overall Study|Adverse Event|3|||
23380711|NCT00720278|65137359|FG002|Overall Study|Adverse Event|4|||
23380712|NCT00720278|65137357|FG000|Overall Study|Withdrawal by Subject|0|||
23380713|NCT00720278|65137358|FG001|Overall Study|Withdrawal by Subject|1|||
23380714|NCT00720278|65137359|FG002|Overall Study|Withdrawal by Subject|0|||
23380715|NCT00720278|65137357|FG000|Overall Study|Lost to Follow-up|0|||
23380716|NCT00720278|65137358|FG001|Overall Study|Lost to Follow-up|0|||
23380717|NCT00720278|65137359|FG002|Overall Study|Lost to Follow-up|1|||
23380718|NCT00720278|65137357|FG000|Overall Study|Non-compliance|1|||
23380719|NCT00720278|65137358|FG001|Overall Study|Non-compliance|0|||
23380720|NCT00720278|65137359|FG002|Overall Study|Non-compliance|0|||
23667807|NCT01131676|66168670|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
23667808|NCT01131676|66168668|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
23667809|NCT01131676|66168669|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
23667810|NCT01131676|66168670|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
23667811|NCT01131676|66168668|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
23667812|NCT01131676|66168669|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
23667813|NCT01131676|66168670|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
23667814|NCT01131676|66168668|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
23667815|NCT01131676|66168669|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
23667816|NCT01131676|66168670|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
23667817|NCT01131676|66168668|FG000|Discontinuation From Treatment|Other than those specified|162|||
23667818|NCT01131676|66168669|FG001|Discontinuation From Treatment|Other than those specified|142|||
23667819|NCT01131676|66168670|FG002|Discontinuation From Treatment|Other than those specified|125|||
23667820|NCT01131676|66168668|FG000|Discontinuation From Treatment|Adverse Event|303|||
23667821|NCT01131676|66168669|FG001|Discontinuation From Treatment|Adverse Event|267|||
23667822|NCT01131676|66168670|FG002|Discontinuation From Treatment|Adverse Event|273|||
23667823|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
23667824|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
23667825|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
23380721|NCT00720278|65137357|FG000|Overall Study|eligibility criteria violation|1|||
23380722|NCT00720278|65137358|FG001|Overall Study|eligibility criteria violation|0|||
23380723|NCT00720278|65137359|FG002|Overall Study|eligibility criteria violation|1|||
23380724|NCT01755637|65137362|FG000|Period 1|Adverse Event|0|||
23667826|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
23667827|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
23380725|NCT01755637|65137363|FG001|Period 1|Adverse Event|1|||
23380726|NCT03600350|65137364|FG000|Overall Study|Death|1|||
23380727|NCT03600350|65137364|FG000|Overall Study|On Follow Up|18|||
23605925|NCT01640951|65947103|FG002|Overall Study|Lost to Follow-up|6|||
23380728|NCT01091259|65137370|FG000|Overall Study|Adverse Event|3|||
23380729|NCT01091259|65137370|FG000|Overall Study|Lack of Efficacy|2|||
23380730|NCT03298061|65137372|FG000|Overall Study|Adverse Event|3|||
23380731|NCT03298061|65137372|FG000|Overall Study|Lack of Efficacy|6|||
23380732|NCT03298061|65137372|FG000|Overall Study|Protocol Violation|1|||
23380733|NCT03298061|65137372|FG000|Overall Study|Physician Decision|7|||
23380734|NCT03298061|65137372|FG000|Overall Study|Withdrawal by Subject|10|||
23380735|NCT03325439|65137373|FG000|Overall Study|Ineligibility|3|||
23380736|NCT03197129|65137374|FG000|Overall Study|did not answer the VPT: shyness|4|||
23380737|NCT03197129|65137375|FG001|Overall Study|did not answer the VPT: shyness|5|||
23380738|NCT03320369|65137376|FG000|Overall Study|Adverse Event|1|||
23380739|NCT03320369|65137376|FG000|Overall Study|Withdrawal by Subject|2|||
23380740|NCT02397837|65137377|FG000|Overall Study|Withdrawal by Subject|6|||
23380741|NCT02397837|65137378|FG001|Overall Study|Withdrawal by Subject|5|||
23380742|NCT02397837|65137377|FG000|Overall Study|Physician Decision|1|||
23380743|NCT02397837|65137378|FG001|Overall Study|Physician Decision|1|||
23380744|NCT00876343|65137379|FG000|Overall Study|Adverse Event|7|||
23380745|NCT00876343|65137380|FG001|Overall Study|Adverse Event|8|||
23380746|NCT00876343|65137381|FG002|Overall Study|Adverse Event|2|||
23380747|NCT00876343|65137379|FG000|Overall Study|Withdrawal by Subject|4|||
23380748|NCT00876343|65137380|FG001|Overall Study|Withdrawal by Subject|4|||
23380749|NCT00876343|65137381|FG002|Overall Study|Withdrawal by Subject|3|||
23380750|NCT00876343|65137379|FG000|Overall Study|Lack of Efficacy|0|||
23380751|NCT00876343|65137380|FG001|Overall Study|Lack of Efficacy|0|||
23380752|NCT00876343|65137381|FG002|Overall Study|Lack of Efficacy|1|||
23380753|NCT00876343|65137379|FG000|Overall Study|Protocol Violation|4|||
23380754|NCT00876343|65137380|FG001|Overall Study|Protocol Violation|1|||
23380755|NCT00876343|65137381|FG002|Overall Study|Protocol Violation|1|||
23380756|NCT00876343|65137379|FG000|Overall Study|Physician Decision|0|||
23380757|NCT00876343|65137380|FG001|Overall Study|Physician Decision|1|||
23380758|NCT00876343|65137381|FG002|Overall Study|Physician Decision|1|||
23380759|NCT00876343|65137379|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
23380760|NCT00876343|65137380|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
23380761|NCT00876343|65137381|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
23380762|NCT00876343|65137379|FG000|Overall Study|Change of residence or other commitments|2|||
23380763|NCT00876343|65137380|FG001|Overall Study|Change of residence or other commitments|2|||
23380764|NCT00876343|65137381|FG002|Overall Study|Change of residence or other commitments|3|||
23380765|NCT00866320|65137382|FG000|Overall Study|Withdrawal by Subject|4|||
23380766|NCT00866320|65137382|FG000|Overall Study|Death|2|||
23380767|NCT02448043|65137386|FG000|Overall Study|Withdrawal by Subject|2|||
23380768|NCT02448043|65137387|FG001|Overall Study|Withdrawal by Subject|2|||
23380769|NCT02448043|65137386|FG000|Overall Study|Protocol Violation|1|||
23380770|NCT02448043|65137387|FG001|Overall Study|Protocol Violation|2|||
23380771|NCT04766333|65137393|FG000|Overall Study|Lost to Follow-up|40|||
23380772|NCT04766333|65137394|FG001|Overall Study|Lost to Follow-up|826|||
23380773|NCT00927472|65137401|FG000|Overall Study|Withdrawal by Subject|10|||
23380774|NCT00927472|65137402|FG001|Overall Study|Withdrawal by Subject|11|||
23380775|NCT00927472|65137401|FG000|Overall Study|Lost to Follow-up|1|||
23380776|NCT00927472|65137402|FG001|Overall Study|Lost to Follow-up|6|||
23380777|NCT00927472|65137401|FG000|Overall Study|Protocol Violation|0|||
23380778|NCT00927472|65137402|FG001|Overall Study|Protocol Violation|1|||
23380779|NCT00927472|65137401|FG000|Overall Study|Post treatment Assessment out of window|0|||
23380780|NCT00927472|65137402|FG001|Overall Study|Post treatment Assessment out of window|4|||
23380781|NCT01200355|65137407|FG000|Overall Study|Death|7|||
23380782|NCT01200355|65137408|FG001|Overall Study|Death|2|||
23380783|NCT04925934|65137409|FG000|Overall Study|Adverse Event|1|||
23667828|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
23705653|NCT01234402|66297585|FG001|Overall Study|Withdrawal by Subject|3|||
23380784|NCT04925934|65137410|FG001|Overall Study|Adverse Event|0|||
23380785|NCT04925934|65137411|FG002|Overall Study|Adverse Event|0|||
23380786|NCT04925934|65137409|FG000|Overall Study|Lost to Follow-up|2|||
23380787|NCT04925934|65137410|FG001|Overall Study|Lost to Follow-up|0|||
23380788|NCT04925934|65137411|FG002|Overall Study|Lost to Follow-up|1|||
23667829|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
23667830|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
23667831|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
23667832|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
23667833|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
23667834|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
23667835|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
23667836|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
23667837|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
23667838|NCT01131676|66168668|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
23667839|NCT01131676|66168669|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
23667840|NCT01131676|66168670|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
23667841|NCT01577186|66168671|FG000|Overall Study|Adverse Event|23|||
23667842|NCT01577186|66168671|FG000|Overall Study|Death|1|||
23667843|NCT01577186|66168671|FG000|Overall Study|Lost to Follow-up|28|||
23667844|NCT01577186|66168671|FG000|Overall Study|Withdrawal by Subject|35|||
23667845|NCT01577186|66168671|FG000|Overall Study|Insufficient Response|18|||
23667846|NCT01577186|66168671|FG000|Overall Study|Ineligible to Continue|15|||
23667847|NCT01577186|66168671|FG000|Overall Study|Non-Compliant|8|||
23667848|NCT01577186|66168671|FG000|Overall Study|Other|2|||
23667849|NCT04360551|66168672|FG000|Overall Study|Withdrawal by Subject|1|||
23667850|NCT04360551|66168673|FG001|Overall Study|Withdrawal by Subject|0|||
23667851|NCT04712110|66168681|FG000|Overall Study|Lost to Follow-up|0|||
23667852|NCT04712110|66168682|FG001|Overall Study|Lost to Follow-up|1|||
23667853|NCT04712110|66168681|FG000|Overall Study|Withdrawal by Subject|0|||
23667854|NCT04712110|66168682|FG001|Overall Study|Withdrawal by Subject|4|||
23667855|NCT04712110|66168681|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
23667856|NCT04712110|66168682|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
23667857|NCT00845650|66168683|FG000|Overall Study|Withdrawal by Subject|0|||
23667858|NCT00845650|66168684|FG001|Overall Study|Withdrawal by Subject|0|||
23667859|NCT00845650|66168685|FG002|Overall Study|Withdrawal by Subject|0|||
23667860|NCT00845650|66168686|FG003|Overall Study|Withdrawal by Subject|0|||
23667861|NCT00845650|66168687|FG004|Overall Study|Withdrawal by Subject|2|||
23667862|NCT00845650|66168688|FG005|Overall Study|Withdrawal by Subject|0|||
23667863|NCT00845650|66168683|FG000|Overall Study|Lost to Follow-up|0|||
23667864|NCT00845650|66168684|FG001|Overall Study|Lost to Follow-up|0|||
23667865|NCT00845650|66168685|FG002|Overall Study|Lost to Follow-up|3|||
23667866|NCT00845650|66168686|FG003|Overall Study|Lost to Follow-up|1|||
23667867|NCT00845650|66168687|FG004|Overall Study|Lost to Follow-up|0|||
23667868|NCT00845650|66168688|FG005|Overall Study|Lost to Follow-up|1|||
23667869|NCT00845650|66168683|FG000|Overall Study|Sponsor hold on dosing|0|||
23667870|NCT00845650|66168684|FG001|Overall Study|Sponsor hold on dosing|0|||
23380789|NCT04925934|65137409|FG000|Overall Study|Death|0|||
23380790|NCT04925934|65137410|FG001|Overall Study|Death|1|||
23380791|NCT04925934|65137411|FG002|Overall Study|Death|0|||
23380792|NCT04925934|65137409|FG000|Overall Study|Withdrawal by Subject|8|||
23380793|NCT04925934|65137410|FG001|Overall Study|Withdrawal by Subject|5|||
23380794|NCT04925934|65137411|FG002|Overall Study|Withdrawal by Subject|9|||
23380795|NCT04925934|65137409|FG000|Overall Study|Other|2|||
23380796|NCT04925934|65137410|FG001|Overall Study|Other|2|||
23380797|NCT04925934|65137411|FG002|Overall Study|Other|2|||
23667871|NCT00845650|66168685|FG002|Overall Study|Sponsor hold on dosing|0|||
23380798|NCT04925934|65137409|FG000|Overall Study|Eastern European Conflict|7|||
23380799|NCT04925934|65137410|FG001|Overall Study|Eastern European Conflict|3|||
23667872|NCT00845650|66168686|FG003|Overall Study|Sponsor hold on dosing|0|||
23667873|NCT00845650|66168687|FG004|Overall Study|Sponsor hold on dosing|1|||
23380800|NCT04925934|65137411|FG002|Overall Study|Eastern European Conflict|2|||
23380801|NCT03483103|65137414|FG000|Pre-Treatment Phase|Other reasons|1|||
23380802|NCT03483103|65137414|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
23380803|NCT03483103|65137414|FG000|Pre-Treatment Phase|Disease-related complications|1|||
23380804|NCT03483103|65137414|FG000|Pre-Treatment Phase|Death|5|||
23380805|NCT03483103|65137414|FG000|Treatment Phase|Withdrawal by Subject|7|||
23380806|NCT03483103|65137414|FG000|Treatment Phase|Other reasons|1|||
23380807|NCT03483103|65137414|FG000|Treatment Phase|Death|23|||
23380808|NCT03483103|65137414|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
23380809|NCT03483103|65137414|FG000|Treatment Phase|Received nonconforming product|1|||
23380810|NCT01668537|65140361|FG000|Overall Study|Request to Discontinue Prematurely|1|||
23380811|NCT01668537|65140362|FG001|Overall Study|Request to Discontinue Prematurely|1|||
23380812|NCT01668537|65140361|FG000|Overall Study|Subject unwilling/unable to comply|5|||
23380813|NCT01668537|65140362|FG001|Overall Study|Subject unwilling/unable to comply|0|||
23380814|NCT01668537|65140361|FG000|Overall Study|Reason Precludes Participation|1|||
23380815|NCT01668537|65140362|FG001|Overall Study|Reason Precludes Participation|0|||
23380816|NCT01668537|65140361|FG000|Overall Study|Lost to Follow-up|13|||
23380817|NCT01668537|65140362|FG001|Overall Study|Lost to Follow-up|6|||
23380818|NCT01668537|65140361|FG000|Overall Study|Other|2|||
23380819|NCT01668537|65140362|FG001|Overall Study|Other|3|||
23380820|NCT02513199|65140368|FG000|Treatment|Death|1|||
23380821|NCT02513199|65140368|FG000|Treatment|Lost to Follow-up|1|||
23380822|NCT02513199|65140368|FG000|Follow-Up|Death|11|||
23380823|NCT02412657|65140369|FG000|Overall Study|Lost to Follow-up|1|||
23380824|NCT02412657|65140370|FG001|Overall Study|Lost to Follow-up|0|||
23380825|NCT02412657|65140371|FG002|Overall Study|Lost to Follow-up|0|||
23380826|NCT02412657|65140369|FG000|Overall Study|Protocol Violation|0|||
23380827|NCT02412657|65140370|FG001|Overall Study|Protocol Violation|2|||
23380828|NCT02412657|65140371|FG002|Overall Study|Protocol Violation|3|||
23380829|NCT02609633|65140372|FG000|Overall Study|Consent Withdrawn|0|||
23380830|NCT02609633|65140373|FG001|Overall Study|Consent Withdrawn|1|||
23380831|NCT02609633|65140372|FG000|Overall Study|Protocol Deviation|1|||
23380832|NCT02609633|65140373|FG001|Overall Study|Protocol Deviation|0|||
23380833|NCT02609633|65140372|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
23380834|NCT02609633|65140373|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
23380835|NCT02609633|65140372|FG000|Overall Study|Reason not Specified|2|||
23380836|NCT02609633|65140373|FG001|Overall Study|Reason not Specified|1|||
23380837|NCT02293499|65140374|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
23380838|NCT02293499|65140375|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
23380839|NCT02293499|65140376|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
23380840|NCT02293499|65140374|FG000|Intervention - Camp|Withdrawal by Subject|3|||
23380841|NCT02293499|65140375|FG001|Intervention - Camp|Withdrawal by Subject|6|||
23380842|NCT02293499|65140376|FG002|Intervention - Camp|Withdrawal by Subject|2|||
23380843|NCT02293499|65140374|FG000|Intervention - Camp|these are those not showing up at camp|24|||
23380844|NCT02293499|65140375|FG001|Intervention - Camp|these are those not showing up at camp|28|||
23380845|NCT02293499|65140376|FG002|Intervention - Camp|these are those not showing up at camp|4|||
23380846|NCT02293499|65140374|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
23380847|NCT02293499|65140375|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
23380848|NCT02293499|65140376|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
23380849|NCT02293499|65140374|FG000|3 Month Follow Up|Lost to Follow-up|14|||
23380850|NCT02293499|65140375|FG001|3 Month Follow Up|Lost to Follow-up|15|||
23380851|NCT02293499|65140376|FG002|3 Month Follow Up|Lost to Follow-up|6|||
23380852|NCT02293499|65140374|FG000|6 Month Follow Up|Lost to Follow-up|17|||
23380853|NCT02293499|65140375|FG001|6 Month Follow Up|Lost to Follow-up|27|||
23380854|NCT02293499|65140376|FG002|6 Month Follow Up|Lost to Follow-up|6|||
23380855|NCT02293499|65140374|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
23380856|NCT02293499|65140375|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
23380857|NCT02293499|65140376|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
23380858|NCT02293499|65140374|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
23605926|NCT01640951|65947104|FG003|Overall Study|Lost to Follow-up|2|||
23380859|NCT02293499|65140375|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
23380860|NCT02293499|65140376|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
23667874|NCT00845650|66168688|FG005|Overall Study|Sponsor hold on dosing|1|||
23667875|NCT00845650|66168683|FG000|Overall Study|Unable to access IV line|1|||
23667876|NCT00845650|66168684|FG001|Overall Study|Unable to access IV line|0|||
23667877|NCT00845650|66168685|FG002|Overall Study|Unable to access IV line|0|||
23667878|NCT00845650|66168686|FG003|Overall Study|Unable to access IV line|0|||
23667879|NCT00845650|66168687|FG004|Overall Study|Unable to access IV line|0|||
23667880|NCT00845650|66168688|FG005|Overall Study|Unable to access IV line|0|||
23491688|NCT03633617|65545045|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491689|NCT03633617|65545046|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491690|NCT03633617|65545036|FG000|Part C (& Follow-up)|Adverse Event|0|||
23491691|NCT03633617|65545037|FG001|Part C (& Follow-up)|Adverse Event|0|||
23491692|NCT03633617|65545038|FG002|Part C (& Follow-up)|Adverse Event|0|||
23491693|NCT03633617|65545039|FG003|Part C (& Follow-up)|Adverse Event|0|||
23491694|NCT03633617|65545040|FG004|Part C (& Follow-up)|Adverse Event|0|||
23491695|NCT03633617|65545041|FG005|Part C (& Follow-up)|Adverse Event|1|||
23491696|NCT03633617|65545042|FG006|Part C (& Follow-up)|Adverse Event|0|||
23491697|NCT03633617|65545043|FG007|Part C (& Follow-up)|Adverse Event|1|||
23491698|NCT03633617|65545044|FG008|Part C (& Follow-up)|Adverse Event|0|||
23491699|NCT03633617|65545045|FG009|Part C (& Follow-up)|Adverse Event|0|||
23491700|NCT03633617|65545046|FG010|Part C (& Follow-up)|Adverse Event|0|||
23491701|NCT03633617|65545036|FG000|Part C (& Follow-up)|Pregnancy|0|||
23491702|NCT03633617|65545037|FG001|Part C (& Follow-up)|Pregnancy|0|||
23491703|NCT03633617|65545038|FG002|Part C (& Follow-up)|Pregnancy|0|||
23491704|NCT03633617|65545039|FG003|Part C (& Follow-up)|Pregnancy|0|||
23491705|NCT03633617|65545040|FG004|Part C (& Follow-up)|Pregnancy|0|||
23491706|NCT03633617|65545041|FG005|Part C (& Follow-up)|Pregnancy|0|||
23491707|NCT03633617|65545042|FG006|Part C (& Follow-up)|Pregnancy|0|||
23491708|NCT03633617|65545043|FG007|Part C (& Follow-up)|Pregnancy|0|||
23491709|NCT03633617|65545044|FG008|Part C (& Follow-up)|Pregnancy|0|||
23491710|NCT03633617|65545045|FG009|Part C (& Follow-up)|Pregnancy|1|||
23491711|NCT03633617|65545046|FG010|Part C (& Follow-up)|Pregnancy|0|||
23491712|NCT03633617|65545036|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491713|NCT03633617|65545037|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491714|NCT03633617|65545038|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491715|NCT03633617|65545039|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491716|NCT03633617|65545040|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
23667881|NCT00794157|66168689|FG000|Overall Study|Adverse Event|4|||
23667882|NCT00794157|66168690|FG001|Overall Study|Adverse Event|1|||
23380861|NCT02293499|65140374|FG000|9 Month Follow Up|Lost to Follow-up|24|||
23380862|NCT02293499|65140375|FG001|9 Month Follow Up|Lost to Follow-up|28|||
23380863|NCT02293499|65140376|FG002|9 Month Follow Up|Lost to Follow-up|4|||
23380864|NCT02293499|65140374|FG000|12 Month Follow Up|Lost to Follow-up|26|||
23380865|NCT02293499|65140375|FG001|12 Month Follow Up|Lost to Follow-up|25|||
23380866|NCT02293499|65140376|FG002|12 Month Follow Up|Lost to Follow-up|6|||
23380867|NCT02293499|65140374|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
23380868|NCT02293499|65140375|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
23380869|NCT02293499|65140376|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
23380870|NCT02293499|65140374|FG000|15 Month Follow Up|Lost to Follow-up|22|||
23380871|NCT02293499|65140375|FG001|15 Month Follow Up|Lost to Follow-up|22|||
23380872|NCT02293499|65140376|FG002|15 Month Follow Up|Lost to Follow-up|7|||
23380873|NCT00629239|65140377|FG000|Overall Study|Adverse Event|7|||
23380874|NCT00629239|65140378|FG001|Overall Study|Adverse Event|4|||
23667883|NCT00794157|66168691|FG002|Overall Study|Adverse Event|8|||
23667884|NCT00794157|66168689|FG000|Overall Study|Subject withdrew consent|2|||
23667885|NCT00794157|66168690|FG001|Overall Study|Subject withdrew consent|0|||
23667886|NCT00794157|66168691|FG002|Overall Study|Subject withdrew consent|3|||
23667887|NCT00794157|66168689|FG000|Overall Study|Lost to Follow-up|2|||
23667888|NCT00794157|66168690|FG001|Overall Study|Lost to Follow-up|0|||
23667889|NCT00794157|66168691|FG002|Overall Study|Lost to Follow-up|1|||
23667890|NCT00794157|66168689|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23667891|NCT00794157|66168690|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23667892|NCT00794157|66168691|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23667893|NCT00794157|66168689|FG000|Overall Study|Administrative problems|1|||
23667894|NCT00794157|66168690|FG001|Overall Study|Administrative problems|7|||
23380875|NCT00629239|65140377|FG000|Overall Study|Physician Decision|1|||
23380876|NCT00629239|65140378|FG001|Overall Study|Physician Decision|0|||
23380877|NCT04398134|65140379|FG000|Overall Study|Adverse Event|0|||
23380878|NCT04398134|65140380|FG001|Overall Study|Adverse Event|0|||
23380879|NCT04398134|65140381|FG002|Overall Study|Adverse Event|1|||
23491717|NCT03633617|65545041|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
23491718|NCT03633617|65545042|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
23491719|NCT03633617|65545043|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
23667895|NCT00794157|66168691|FG002|Overall Study|Administrative problems|4|||
23667896|NCT00794157|66168689|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23667897|NCT00794157|66168690|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23667898|NCT00794157|66168691|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23667899|NCT00794157|66168689|FG000|Overall Study|Protocol deviation|0|||
23667900|NCT00794157|66168690|FG001|Overall Study|Protocol deviation|1|||
23667901|NCT00794157|66168691|FG002|Overall Study|Protocol deviation|1|||
23667902|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
23667903|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
23667904|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
23667905|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
23667906|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
23380880|NCT04398134|65140382|FG003|Overall Study|Adverse Event|0|||
23380881|NCT04398134|65140379|FG000|Overall Study|Withdrawal by Subject|2|||
23380882|NCT04398134|65140380|FG001|Overall Study|Withdrawal by Subject|0|||
23380883|NCT04398134|65140381|FG002|Overall Study|Withdrawal by Subject|0|||
23380884|NCT04398134|65140382|FG003|Overall Study|Withdrawal by Subject|1|||
23380885|NCT04398134|65140379|FG000|Overall Study|Study Terminated by Sponsor|30|||
23380886|NCT04398134|65140380|FG001|Overall Study|Study Terminated by Sponsor|11|||
23380887|NCT04398134|65140381|FG002|Overall Study|Study Terminated by Sponsor|32|||
23380888|NCT04398134|65140382|FG003|Overall Study|Study Terminated by Sponsor|11|||
23380889|NCT00460798|65140383|FG000|Overall Study|Death|59|||
23380890|NCT00460798|65140383|FG000|Overall Study|Adverse Event|27|||
23380891|NCT00460798|65140383|FG000|Overall Study|Lost to Follow-up|19|||
23380892|NCT00460798|65140383|FG000|Overall Study|Progressive Disease|99|||
23380893|NCT00460798|65140383|FG000|Overall Study|Other|27|||
23380894|NCT00460798|65140383|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
23380895|NCT00460798|65140383|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
23380896|NCT00835978|65140387|FG000|Overall Study|Death|33|||
23380897|NCT00835978|65140388|FG001|Overall Study|Death|40|||
23667907|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
23667908|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
23667909|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
23667910|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
23667911|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
23380898|NCT00835978|65140389|FG002|Overall Study|Death|49|||
23380899|NCT00835978|65140390|FG003|Overall Study|Death|4|||
23380900|NCT00835978|65140387|FG000|Overall Study|Lost to Follow-up|3|||
23380901|NCT00835978|65140388|FG001|Overall Study|Lost to Follow-up|4|||
23380902|NCT00835978|65140389|FG002|Overall Study|Lost to Follow-up|2|||
23380903|NCT00835978|65140390|FG003|Overall Study|Lost to Follow-up|1|||
23380904|NCT00835978|65140387|FG000|Overall Study|Other|5|||
23380905|NCT00835978|65140388|FG001|Overall Study|Other|1|||
23380906|NCT00835978|65140389|FG002|Overall Study|Other|8|||
23380907|NCT00835978|65140390|FG003|Overall Study|Other|0|||
23380908|NCT00835978|65140387|FG000|Overall Study|Objective progression or relapse|2|||
23380909|NCT00835978|65140388|FG001|Overall Study|Objective progression or relapse|0|||
23380910|NCT00835978|65140389|FG002|Overall Study|Objective progression or relapse|1|||
23380911|NCT00835978|65140390|FG003|Overall Study|Objective progression or relapse|0|||
23380912|NCT00835978|65140387|FG000|Overall Study|Adverse Event|1|||
23380913|NCT00835978|65140388|FG001|Overall Study|Adverse Event|0|||
23380914|NCT00835978|65140389|FG002|Overall Study|Adverse Event|1|||
23380915|NCT00835978|65140390|FG003|Overall Study|Adverse Event|0|||
23380916|NCT00835978|65140387|FG000|Overall Study|Withdrawal by Subject|0|||
23380917|NCT00835978|65140388|FG001|Overall Study|Withdrawal by Subject|3|||
23380918|NCT00835978|65140389|FG002|Overall Study|Withdrawal by Subject|0|||
23380919|NCT00835978|65140390|FG003|Overall Study|Withdrawal by Subject|5|||
23380920|NCT00835978|65140387|FG000|Overall Study|Study terminated by sponsor|12|||
23380921|NCT00835978|65140388|FG001|Overall Study|Study terminated by sponsor|8|||
23380922|NCT00835978|65140389|FG002|Overall Study|Study terminated by sponsor|30|||
23380923|NCT00835978|65140390|FG003|Overall Study|Study terminated by sponsor|0|||
23380924|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
23380925|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
23380926|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
23380927|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
23380928|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
23380929|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
23380930|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380931|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380932|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380933|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380934|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380935|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
23380936|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380937|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380938|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380939|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380940|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380941|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
23380942|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380943|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
23380944|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
23380945|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
23380946|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380947|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380948|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
23380949|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
23380950|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
23380951|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
23380952|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
23380953|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
23380954|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
23380955|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
23380956|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
23380957|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
23380958|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
23380959|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
23380960|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
23667912|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
23667913|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
23667914|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
23667915|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
23667916|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
23667917|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
23667918|NCT00094770|66168693|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
23667919|NCT00094770|66168694|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
23667920|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
23667921|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
23667922|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
23667923|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
23380961|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380962|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380963|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380964|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380965|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
23380966|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380967|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
23380968|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380969|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380970|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
23380971|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
23380972|NCT00541229|65140391|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
23380973|NCT00541229|65140392|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
23380974|NCT00541229|65140393|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
23380975|NCT00541229|65140394|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
23380976|NCT00541229|65140395|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
23380977|NCT00541229|65140396|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
23380978|NCT00541229|65140391|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
23380979|NCT00541229|65140392|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380980|NCT00541229|65140393|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380981|NCT00541229|65140394|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380982|NCT00541229|65140395|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380983|NCT00541229|65140396|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
23380984|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
23380985|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380986|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380987|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380988|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
23667924|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
23667925|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
23380989|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380990|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380991|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380992|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380993|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380994|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
23380995|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380996|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23605927|NCT01640951|65947105|FG004|Overall Study|Lost to Follow-up|2|||
23380997|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
23380998|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
23380999|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
23381000|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23381001|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23381002|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
23381003|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
23381004|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
23381005|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
23381006|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
23381007|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
23381008|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381009|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381010|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381011|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381012|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381013|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
23381014|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381015|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381016|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
23381017|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381018|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381019|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381020|NCT00514917|65140399|FG000|Overall Study|Death|4|||
23381021|NCT00514917|65140400|FG001|Overall Study|Death|10|||
23381022|NCT00514917|65140399|FG000|Overall Study|Protocol Violation|1|||
23381023|NCT00514917|65140400|FG001|Overall Study|Protocol Violation|0|||
23381024|NCT00514917|65140399|FG000|Overall Study|Lost to Follow-up|4|||
23381025|NCT00514917|65140400|FG001|Overall Study|Lost to Follow-up|3|||
23381026|NCT00514917|65140399|FG000|Overall Study|Withdrawal by Subject|18|||
23381027|NCT00514917|65140400|FG001|Overall Study|Withdrawal by Subject|16|||
23381028|NCT00514917|65140399|FG000|Overall Study|Discontinued due to study closure|88|||
23381029|NCT00514917|65140400|FG001|Overall Study|Discontinued due to study closure|81|||
23381030|NCT00514917|65140399|FG000|Overall Study|Undefined|11|||
23381031|NCT00514917|65140400|FG001|Overall Study|Undefined|5|||
23381032|NCT03600428|65140407|FG000|Overall Study|Not eligible|0|||
23381033|NCT03600428|65140408|FG001|Overall Study|Not eligible|1|||
23381034|NCT03600428|65140407|FG000|Overall Study|Lost to Follow-up|5|||
23381035|NCT03600428|65140408|FG001|Overall Study|Lost to Follow-up|4|||
23381036|NCT02134028|65140409|FG000|Overall Study|Lack of Efficacy|1|||
23381037|NCT02134028|65140410|FG001|Overall Study|Lack of Efficacy|0|||
23381038|NCT02134028|65140411|FG002|Overall Study|Lack of Efficacy|3|||
23381039|NCT02134028|65140412|FG003|Overall Study|Lack of Efficacy|2|||
23381040|NCT02134028|65140413|FG004|Overall Study|Lack of Efficacy|1|||
23381041|NCT02134028|65140414|FG005|Overall Study|Lack of Efficacy|2|||
23381042|NCT02134028|65140415|FG006|Overall Study|Lack of Efficacy|1|||
23381043|NCT02134028|65140416|FG007|Overall Study|Lack of Efficacy|0|||
23381044|NCT02134028|65140409|FG000|Overall Study|Poor compliance to protocol|1|||
23381045|NCT02134028|65140410|FG001|Overall Study|Poor compliance to protocol|1|||
23381046|NCT02134028|65140411|FG002|Overall Study|Poor compliance to protocol|3|||
23381047|NCT02134028|65140412|FG003|Overall Study|Poor compliance to protocol|7|||
23381048|NCT02134028|65140413|FG004|Overall Study|Poor compliance to protocol|1|||
23381049|NCT02134028|65140414|FG005|Overall Study|Poor compliance to protocol|1|||
23381050|NCT02134028|65140415|FG006|Overall Study|Poor compliance to protocol|0|||
23381051|NCT02134028|65140416|FG007|Overall Study|Poor compliance to protocol|0|||
23381052|NCT02134028|65140409|FG000|Overall Study|Other unspecified|4|||
23381053|NCT02134028|65140410|FG001|Overall Study|Other unspecified|22|||
23381054|NCT02134028|65140411|FG002|Overall Study|Other unspecified|33|||
23381055|NCT02134028|65140412|FG003|Overall Study|Other unspecified|64|||
23381056|NCT02134028|65140413|FG004|Overall Study|Other unspecified|8|||
23381057|NCT02134028|65140414|FG005|Overall Study|Other unspecified|6|||
23381058|NCT02134028|65140415|FG006|Overall Study|Other unspecified|2|||
23381059|NCT02134028|65140416|FG007|Overall Study|Other unspecified|1|||
23381060|NCT02134028|65140409|FG000|Overall Study|Adverse Event|3|||
23381061|NCT02134028|65140410|FG001|Overall Study|Adverse Event|19|||
23381062|NCT02134028|65140411|FG002|Overall Study|Adverse Event|13|||
23381063|NCT02134028|65140412|FG003|Overall Study|Adverse Event|32|||
23381064|NCT02134028|65140413|FG004|Overall Study|Adverse Event|4|||
23381065|NCT02134028|65140414|FG005|Overall Study|Adverse Event|5|||
23381066|NCT02134028|65140415|FG006|Overall Study|Adverse Event|1|||
23381067|NCT02134028|65140416|FG007|Overall Study|Adverse Event|2|||
23381068|NCT00962650|65140417|FG000|Overall Study|Transgastric DP was not completed|2|||
23381069|NCT00968968|65140420|FG000|Overall Study|Study closed/terminated|10|||
23381070|NCT00968968|65140421|FG001|Overall Study|Study closed/terminated|10|||
23381071|NCT00968968|65140420|FG000|Overall Study|Protocol defined stopping criteria|3|||
23381072|NCT00968968|65140421|FG001|Overall Study|Protocol defined stopping criteria|1|||
23381073|NCT00968968|65140420|FG000|Overall Study|Withdrawal by Subject|2|||
23381074|NCT00968968|65140421|FG001|Overall Study|Withdrawal by Subject|0|||
23381075|NCT00968968|65140420|FG000|Overall Study|Physician Decision|1|||
23381076|NCT00968968|65140421|FG001|Overall Study|Physician Decision|2|||
23381077|NCT00968968|65140420|FG000|Overall Study|Lost to Follow-up|0|||
23381078|NCT00968968|65140421|FG001|Overall Study|Lost to Follow-up|1|||
23381079|NCT01049828|65140422|FG000|Overall Study|Claustrophibia and Frustration|2|||
23381080|NCT01900314|65140425|FG000|Overall Study|Lost to Follow-up|1|||
23381081|NCT01900314|65140426|FG001|Overall Study|Lost to Follow-up|0|||
23381082|NCT01900314|65140425|FG000|Overall Study|Protocol Violation|0|||
23381083|NCT01900314|65140426|FG001|Overall Study|Protocol Violation|1|||
23381084|NCT01900314|65140425|FG000|Overall Study|Withdrawal by Subject|3|||
23381085|NCT01900314|65140426|FG001|Overall Study|Withdrawal by Subject|3|||
23381086|NCT01564407|65140427|FG000|Overall Study|Lost to Follow-up|0|||
23381087|NCT01564407|65140428|FG001|Overall Study|Lost to Follow-up|1|||
23381088|NCT01564407|65140429|FG002|Overall Study|Lost to Follow-up|0|||
23381089|NCT01564407|65140430|FG003|Overall Study|Lost to Follow-up|0|||
23381090|NCT01564407|65140431|FG004|Overall Study|Lost to Follow-up|0|||
23491720|NCT03633617|65545044|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
23491721|NCT03633617|65545045|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
23667926|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
23667927|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
23381091|NCT01564407|65140427|FG000|Overall Study|Withdrawal by Subject|0|||
23381092|NCT01564407|65140428|FG001|Overall Study|Withdrawal by Subject|1|||
23381093|NCT01564407|65140429|FG002|Overall Study|Withdrawal by Subject|0|||
23381094|NCT01564407|65140430|FG003|Overall Study|Withdrawal by Subject|0|||
23381095|NCT01564407|65140431|FG004|Overall Study|Withdrawal by Subject|0|||
23381096|NCT01564407|65140427|FG000|Overall Study|funding lost, study ended|0|||
23491722|NCT03633617|65545046|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
23381097|NCT01564407|65140428|FG001|Overall Study|funding lost, study ended|0|||
23381098|NCT01564407|65140429|FG002|Overall Study|funding lost, study ended|0|||
23381099|NCT01564407|65140430|FG003|Overall Study|funding lost, study ended|1|||
23381100|NCT01564407|65140431|FG004|Overall Study|funding lost, study ended|0|||
23381101|NCT02932943|65140432|FG000|Overall Study|Lost to Follow-up|0|||
23491723|NCT03633617|65545036|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
23491724|NCT03633617|65545037|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
23491725|NCT03633617|65545038|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
23491726|NCT03633617|65545039|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
23491727|NCT03633617|65545040|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
23491728|NCT03633617|65545041|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
23491729|NCT03633617|65545042|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
23491730|NCT03633617|65545043|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
23491731|NCT03633617|65545044|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
23491732|NCT03633617|65545045|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
23491733|NCT03633617|65545046|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
23491734|NCT03633617|65545036|FG000|Part C (& Follow-up)|Physician Decision|0|||
23491735|NCT03633617|65545037|FG001|Part C (& Follow-up)|Physician Decision|0|||
23491736|NCT03633617|65545038|FG002|Part C (& Follow-up)|Physician Decision|0|||
23491737|NCT03633617|65545039|FG003|Part C (& Follow-up)|Physician Decision|0|||
23491738|NCT03633617|65545040|FG004|Part C (& Follow-up)|Physician Decision|0|||
23491739|NCT03633617|65545041|FG005|Part C (& Follow-up)|Physician Decision|0|||
23491740|NCT03633617|65545042|FG006|Part C (& Follow-up)|Physician Decision|0|||
23491741|NCT03633617|65545043|FG007|Part C (& Follow-up)|Physician Decision|1|||
23491742|NCT03633617|65545044|FG008|Part C (& Follow-up)|Physician Decision|0|||
23491743|NCT03633617|65545045|FG009|Part C (& Follow-up)|Physician Decision|0|||
23491744|NCT03633617|65545046|FG010|Part C (& Follow-up)|Physician Decision|1|||
23491745|NCT03633617|65545036|FG000|Part C (& Follow-up)|COVID-19 related|0|||
23491746|NCT03633617|65545037|FG001|Part C (& Follow-up)|COVID-19 related|0|||
23491747|NCT03633617|65545038|FG002|Part C (& Follow-up)|COVID-19 related|0|||
23491748|NCT03633617|65545039|FG003|Part C (& Follow-up)|COVID-19 related|0|||
23491749|NCT03633617|65545040|FG004|Part C (& Follow-up)|COVID-19 related|0|||
23491750|NCT03633617|65545041|FG005|Part C (& Follow-up)|COVID-19 related|1|||
23491751|NCT03633617|65545042|FG006|Part C (& Follow-up)|COVID-19 related|0|||
23491752|NCT03633617|65545043|FG007|Part C (& Follow-up)|COVID-19 related|0|||
23491753|NCT03633617|65545044|FG008|Part C (& Follow-up)|COVID-19 related|0|||
23491754|NCT03633617|65545045|FG009|Part C (& Follow-up)|COVID-19 related|0|||
23491755|NCT03633617|65545046|FG010|Part C (& Follow-up)|COVID-19 related|0|||
23491756|NCT03633617|65545036|FG000|Part C (& Follow-up)|Protocol Violation|0|||
23491757|NCT03633617|65545037|FG001|Part C (& Follow-up)|Protocol Violation|0|||
23491758|NCT03633617|65545038|FG002|Part C (& Follow-up)|Protocol Violation|0|||
23667928|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
23667929|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
23667930|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
23667931|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
23667932|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
23667933|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
23667934|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
23667935|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
23667936|NCT00094770|66168693|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
23667937|NCT00094770|66168694|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
23667938|NCT00761514|66168698|FG000|Overall Study|Adverse Event|1|||
23667939|NCT00761514|66168698|FG000|Overall Study|Withdrawal by Subject|2|||
23667940|NCT00761514|66168698|FG000|Overall Study|Lost to Follow-up|1|||
23667941|NCT00761514|66168698|FG000|Overall Study|Health insurance didn't cover study drug|1|||
23667942|NCT00761514|66168698|FG000|Overall Study|Problem complying with study visit|1|||
23667943|NCT00761514|66168698|FG000|Overall Study|Unable to pay for medications|1|||
23667944|NCT02484911|66168701|FG000|Overall Study|Withdrawal by Subject|2|||
23667945|NCT02484911|66168702|FG001|Overall Study|Withdrawal by Subject|1|||
23667946|NCT02484911|66168701|FG000|Overall Study|Protocol Violation|2|||
23667947|NCT02484911|66168702|FG001|Overall Study|Protocol Violation|1|||
23667948|NCT01183143|66168703|FG000|Overall Study|Protocol Violation|115|||
23667949|NCT01183143|66168703|FG000|Overall Study|Withdrawal by Subject|19|||
23667950|NCT01183143|66168703|FG000|Overall Study|Subject Questionnaires not returned|5|||
23667951|NCT01183143|66168703|FG000|Overall Study|Subjects enrolled, but not treated|11|||
23667952|NCT01560780|66168704|FG000|Overall Study|Death|2|||
23667953|NCT01560780|66168705|FG001|Overall Study|Death|1|||
23667954|NCT01560780|66168704|FG000|Overall Study|Patient Preference|11|||
23667955|NCT01560780|66168705|FG001|Overall Study|Patient Preference|11|||
23491759|NCT03633617|65545039|FG003|Part C (& Follow-up)|Protocol Violation|0|||
23667956|NCT00838331|66168708|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
23667957|NCT02069899|66168709|FG000|Overall Study|Adverse Event|6|||
23667958|NCT02069899|66168710|FG001|Overall Study|Adverse Event|0|||
23381102|NCT02932943|65140433|FG001|Overall Study|Lost to Follow-up|2|||
23667959|NCT02069899|66168711|FG002|Overall Study|Adverse Event|1|||
23491760|NCT03633617|65545040|FG004|Part C (& Follow-up)|Protocol Violation|0|||
23491761|NCT03633617|65545041|FG005|Part C (& Follow-up)|Protocol Violation|0|||
23491762|NCT03633617|65545042|FG006|Part C (& Follow-up)|Protocol Violation|0|||
23491763|NCT03633617|65545043|FG007|Part C (& Follow-up)|Protocol Violation|0|||
23491764|NCT03633617|65545044|FG008|Part C (& Follow-up)|Protocol Violation|0|||
23667960|NCT02069899|66168709|FG000|Overall Study|Withdrawal by Participant|2|||
23667961|NCT02069899|66168710|FG001|Overall Study|Withdrawal by Participant|0|||
23667962|NCT02069899|66168711|FG002|Overall Study|Withdrawal by Participant|0|||
23667963|NCT02069899|66168709|FG000|Overall Study|Lost to Follow-up|1|||
23381103|NCT02932943|65140432|FG000|Overall Study|Adverse Event|2|||
23381104|NCT02932943|65140433|FG001|Overall Study|Adverse Event|2|||
23381105|NCT02932943|65140432|FG000|Overall Study|Withdrawal by Subject|3|||
23381106|NCT02932943|65140433|FG001|Overall Study|Withdrawal by Subject|3|||
23381107|NCT00367458|65140439|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
23381108|NCT00367458|65140440|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
23381109|NCT01901562|65140441|FG000|Overall Study|Protocol Violation|5|||
23381110|NCT01901562|65140441|FG000|Overall Study|Excluded intraoperatively|4|||
23381111|NCT03624036|65140442|FG000|Overall Study|Death|2|||
23381112|NCT03624036|65140443|FG001|Overall Study|Death|3|||
23381113|NCT03624036|65140444|FG002|Overall Study|Death|0|||
23381114|NCT03624036|65140445|FG003|Overall Study|Death|1|||
23381115|NCT03624036|65140442|FG000|Overall Study|Withdrawal by Subject|1|||
23381116|NCT03624036|65140443|FG001|Overall Study|Withdrawal by Subject|0|||
23381117|NCT03624036|65140444|FG002|Overall Study|Withdrawal by Subject|1|||
23381118|NCT03624036|65140445|FG003|Overall Study|Withdrawal by Subject|0|||
23381119|NCT03624036|65140442|FG000|Overall Study|Enrolled but Never Treated|1|||
23381120|NCT03624036|65140443|FG001|Overall Study|Enrolled but Never Treated|0|||
23381121|NCT03624036|65140444|FG002|Overall Study|Enrolled but Never Treated|0|||
23381122|NCT03624036|65140445|FG003|Overall Study|Enrolled but Never Treated|0|||
23381123|NCT03624036|65140442|FG000|Overall Study|Reason not Specified|3|||
23381124|NCT03624036|65140443|FG001|Overall Study|Reason not Specified|0|||
23381125|NCT03624036|65140444|FG002|Overall Study|Reason not Specified|2|||
23381126|NCT03624036|65140445|FG003|Overall Study|Reason not Specified|2|||
23381127|NCT01028391|65140446|FG000|Overall Study|Adverse Event|4|||
23381128|NCT01028391|65140447|FG001|Overall Study|Adverse Event|0|||
23381129|NCT01028391|65140446|FG000|Overall Study|Lack of Efficacy|0|||
23381130|NCT01028391|65140447|FG001|Overall Study|Lack of Efficacy|2|||
23381131|NCT01028391|65140446|FG000|Overall Study|Lost to Follow-up|3|||
23381132|NCT01028391|65140447|FG001|Overall Study|Lost to Follow-up|4|||
23381133|NCT01028391|65140446|FG000|Overall Study|Physician Decision|0|||
23381134|NCT01028391|65140447|FG001|Overall Study|Physician Decision|1|||
23381135|NCT01028391|65140446|FG000|Overall Study|Withdrawal by Subject|6|||
23381136|NCT01028391|65140447|FG001|Overall Study|Withdrawal by Subject|3|||
23381137|NCT01028391|65140446|FG000|Overall Study|Needed excluded medication|1|||
23381138|NCT01028391|65140447|FG001|Overall Study|Needed excluded medication|1|||
23381139|NCT00472641|65140448|FG000|Overall Study|Lack of Efficacy|3|||
23381140|NCT00472641|65140448|FG000|Overall Study|Adverse Event|3|||
23381141|NCT00472641|65140448|FG000|Overall Study|Lost to Follow-up|1|||
23381142|NCT02547935|65140451|FG000|Overall Study|Other|0|||
23381143|NCT02547935|65140452|FG001|Overall Study|Other|1|||
23381144|NCT02547935|65140453|FG002|Overall Study|Other|0|||
23381145|NCT02547935|65140451|FG000|Overall Study|Withdrawal by Subject|2|||
23381146|NCT02547935|65140452|FG001|Overall Study|Withdrawal by Subject|3|||
23381147|NCT02547935|65140453|FG002|Overall Study|Withdrawal by Subject|4|||
23381148|NCT02547935|65140451|FG000|Overall Study|Screen Failure|2|||
23381149|NCT02547935|65140452|FG001|Overall Study|Screen Failure|0|||
23381150|NCT02547935|65140453|FG002|Overall Study|Screen Failure|0|||
23381151|NCT02547935|65140451|FG000|Overall Study|Physician Decision|0|||
23381152|NCT02547935|65140452|FG001|Overall Study|Physician Decision|1|||
23381153|NCT02547935|65140453|FG002|Overall Study|Physician Decision|0|||
23381154|NCT02547935|65140451|FG000|Overall Study|Lost to Follow-up|0|||
23667964|NCT02069899|66168710|FG001|Overall Study|Lost to Follow-up|0|||
23667965|NCT02069899|66168711|FG002|Overall Study|Lost to Follow-up|1|||
23667966|NCT02069899|66168709|FG000|Overall Study|Other|4|||
23667967|NCT02069899|66168710|FG001|Overall Study|Other|0|||
23667968|NCT02069899|66168711|FG002|Overall Study|Other|0|||
23667969|NCT02069899|66168709|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
23667970|NCT02069899|66168710|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
23667971|NCT02069899|66168711|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
23667972|NCT02069899|66168709|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
23667973|NCT02069899|66168710|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
23667974|NCT02069899|66168711|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
23667975|NCT00751400|66168712|FG000|Overall Study|Lost to Follow-up|10|||
23667976|NCT01624662|66168713|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
23667977|NCT01624662|66168714|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23667978|NCT01624662|66168715|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23667979|NCT01624662|66168716|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
23381155|NCT02547935|65140452|FG001|Overall Study|Lost to Follow-up|2|||
23381156|NCT02547935|65140453|FG002|Overall Study|Lost to Follow-up|1|||
23381157|NCT02547935|65140451|FG000|Overall Study|Death|1|||
23491765|NCT03633617|65545045|FG009|Part C (& Follow-up)|Protocol Violation|3|||
23491766|NCT03633617|65545046|FG010|Part C (& Follow-up)|Protocol Violation|1|||
23491767|NCT03633617|65545036|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
23491768|NCT03633617|65545037|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
23491769|NCT03633617|65545038|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
23491770|NCT03633617|65545039|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
23491771|NCT03633617|65545040|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
23491772|NCT03633617|65545041|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
23491773|NCT03633617|65545042|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
23491774|NCT03633617|65545043|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
23491775|NCT03633617|65545044|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
23491776|NCT03633617|65545045|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
23491777|NCT03633617|65545046|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
23491778|NCT03875768|65545047|FG000|Overall Study|Lost to Follow-up|16|||
23491779|NCT03875768|65545048|FG001|Overall Study|Lost to Follow-up|13|||
23491780|NCT03875768|65545047|FG000|Overall Study|Withdrawal by Subject|10|||
23491781|NCT03875768|65545048|FG001|Overall Study|Withdrawal by Subject|21|||
23491782|NCT03875768|65545047|FG000|Overall Study|Did not complete assessment|21|||
23491783|NCT03875768|65545048|FG001|Overall Study|Did not complete assessment|12|||
23491784|NCT03875768|65545047|FG000|Overall Study|Became ineligible|1|||
23491785|NCT03875768|65545048|FG001|Overall Study|Became ineligible|0|||
23491786|NCT03212690|65545049|FG000|Overall Study|Protocol Violation|1|||
23491787|NCT02955797|65545050|FG000|Overall Study|Protocol Violation|1|||
23491788|NCT02955797|65545051|FG001|Overall Study|Protocol Violation|0|||
23491789|NCT02955797|65545052|FG002|Overall Study|Protocol Violation|0|||
23491790|NCT02955797|65545053|FG003|Overall Study|Protocol Violation|1|||
23491791|NCT02955797|65545050|FG000|Overall Study|Withdrawal by Subject|2|||
23491792|NCT02955797|65545051|FG001|Overall Study|Withdrawal by Subject|2|||
23491793|NCT02955797|65545052|FG002|Overall Study|Withdrawal by Subject|0|||
23491794|NCT02955797|65545053|FG003|Overall Study|Withdrawal by Subject|1|||
23491795|NCT02955797|65545050|FG000|Overall Study|Lost to Follow-up|0|||
23491796|NCT02955797|65545051|FG001|Overall Study|Lost to Follow-up|1|||
23491797|NCT02955797|65545052|FG002|Overall Study|Lost to Follow-up|0|||
23491798|NCT02955797|65545053|FG003|Overall Study|Lost to Follow-up|0|||
23491799|NCT01669928|65545056|FG000|First Intervention|Withdrawal by Subject|3|||
23491800|NCT01669928|65545057|FG001|First Intervention|Withdrawal by Subject|5|||
23491801|NCT04879225|65545062|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
23491802|NCT04879225|65545062|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
23491803|NCT02357979|65545064|FG000|Overall Study|Lost to Follow-up|5|||
23491804|NCT02357979|65545065|FG001|Overall Study|Lost to Follow-up|5|||
23491805|NCT03793556|65545066|FG000|Overall Study|Withdrawal by Subject|12|||
23491806|NCT03793556|65545067|FG001|Overall Study|Withdrawal by Subject|1|||
23491807|NCT03793556|65545066|FG000|Overall Study|Lost to Follow-up|1|||
23491808|NCT03793556|65545067|FG001|Overall Study|Lost to Follow-up|1|||
23491809|NCT04327674|65545070|FG000|Overall Study|Protocol Violation|19|||
23491810|NCT02833350|65545074|FG000|Overall Study|Adverse Event|0|||
23491811|NCT02833350|65545075|FG001|Overall Study|Adverse Event|3|||
23491812|NCT02833350|65545076|FG002|Overall Study|Adverse Event|4|||
23491813|NCT02833350|65545077|FG003|Overall Study|Adverse Event|4|||
23667980|NCT01624662|66168713|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
23491814|NCT02833350|65545078|FG004|Overall Study|Adverse Event|1|||
23491815|NCT02833350|65545079|FG005|Overall Study|Adverse Event|0|||
23491816|NCT02833350|65545080|FG006|Overall Study|Adverse Event|1|||
23491817|NCT02833350|65545074|FG000|Overall Study|Death|0|||
23491818|NCT02833350|65545075|FG001|Overall Study|Death|0|||
23491819|NCT02833350|65545076|FG002|Overall Study|Death|1|||
23491820|NCT02833350|65545077|FG003|Overall Study|Death|0|||
23491821|NCT02833350|65545078|FG004|Overall Study|Death|0|||
23381158|NCT02547935|65140452|FG001|Overall Study|Death|1|||
23381159|NCT02547935|65140453|FG002|Overall Study|Death|0|||
23381160|NCT00250718|65140454|FG000|Overall Study|Death|1|||
23381161|NCT00250718|65140454|FG000|Overall Study|Adverse Event|1|||
23381162|NCT00250718|65140454|FG000|Overall Study|Withdrawal by Subject|1|||
23381163|NCT01334515|65140455|FG000|Overall Study|Adverse Event|1|||
23381164|NCT01334515|65140456|FG001|Overall Study|Adverse Event|6|||
23381165|NCT01334515|65140455|FG000|Overall Study|Death|1|||
23381166|NCT01334515|65140456|FG001|Overall Study|Death|0|||
23381167|NCT01334515|65140455|FG000|Overall Study|Lack of Efficacy|8|||
23381168|NCT01334515|65140456|FG001|Overall Study|Lack of Efficacy|21|||
23381169|NCT01334515|65140455|FG000|Overall Study|Physician Decision|1|||
23381170|NCT01334515|65140456|FG001|Overall Study|Physician Decision|1|||
23381171|NCT01334515|65140455|FG000|Overall Study|Withdrawal by Subject|1|||
23381172|NCT01334515|65140456|FG001|Overall Study|Withdrawal by Subject|1|||
23381173|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
23381174|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
23381175|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
23381176|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
23381177|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
23381178|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381179|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
23381180|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381181|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381182|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381183|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Death|0|||
23381184|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Death|0|||
23381185|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Death|1|||
23381186|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Death|0|||
23667981|NCT01624662|66168714|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
23667982|NCT01624662|66168715|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23667983|NCT01624662|66168716|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23667984|NCT01624662|66168713|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23667985|NCT01624662|66168714|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
23667986|NCT01624662|66168715|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23667987|NCT01624662|66168716|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23667988|NCT01624662|66168713|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
23667989|NCT01624662|66168714|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23667990|NCT01624662|66168715|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
23667991|NCT01624662|66168716|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23667992|NCT01624662|66168713|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23667993|NCT01624662|66168714|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23381187|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Death|0|||
23381188|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
23381189|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
23491822|NCT02833350|65545079|FG005|Overall Study|Death|0|||
23491823|NCT02833350|65545080|FG006|Overall Study|Death|0|||
23491824|NCT02833350|65545074|FG000|Overall Study|Lack of Efficacy|0|||
23491825|NCT02833350|65545075|FG001|Overall Study|Lack of Efficacy|2|||
23491826|NCT02833350|65545076|FG002|Overall Study|Lack of Efficacy|1|||
23491827|NCT02833350|65545077|FG003|Overall Study|Lack of Efficacy|4|||
23491828|NCT02833350|65545078|FG004|Overall Study|Lack of Efficacy|0|||
23491829|NCT02833350|65545079|FG005|Overall Study|Lack of Efficacy|1|||
23491830|NCT02833350|65545080|FG006|Overall Study|Lack of Efficacy|1|||
23491831|NCT02833350|65545074|FG000|Overall Study|Lost to Follow-up|0|||
23491832|NCT02833350|65545075|FG001|Overall Study|Lost to Follow-up|1|||
23491833|NCT02833350|65545076|FG002|Overall Study|Lost to Follow-up|0|||
23491834|NCT02833350|65545077|FG003|Overall Study|Lost to Follow-up|0|||
23491835|NCT02833350|65545078|FG004|Overall Study|Lost to Follow-up|0|||
23491836|NCT02833350|65545079|FG005|Overall Study|Lost to Follow-up|0|||
23491837|NCT02833350|65545080|FG006|Overall Study|Lost to Follow-up|1|||
23491838|NCT02833350|65545074|FG000|Overall Study|Withdrawal by Subject|3|||
23491839|NCT02833350|65545075|FG001|Overall Study|Withdrawal by Subject|3|||
23491840|NCT02833350|65545076|FG002|Overall Study|Withdrawal by Subject|2|||
23491841|NCT02833350|65545077|FG003|Overall Study|Withdrawal by Subject|0|||
23491842|NCT02833350|65545078|FG004|Overall Study|Withdrawal by Subject|2|||
23491843|NCT02833350|65545079|FG005|Overall Study|Withdrawal by Subject|0|||
23491844|NCT02833350|65545080|FG006|Overall Study|Withdrawal by Subject|2|||
23491845|NCT00004635|65545081|FG000|Period One|refused|2|||
23491846|NCT00004635|65545082|FG001|Period One|refused|1|||
23491847|NCT00004635|65545081|FG000|Period One|Withdrawal by Subject|1|||
23491848|NCT00004635|65545082|FG001|Period One|Withdrawal by Subject|1|||
23491849|NCT00004635|65545081|FG000|Period One|Protocol Violation|1|||
23491850|NCT00004635|65545082|FG001|Period One|Protocol Violation|0|||
23491851|NCT00004635|65545081|FG000|Period One|PSA did not go <5 ng/mL|1|||
23491852|NCT00004635|65545082|FG001|Period One|PSA did not go <5 ng/mL|0|||
23491853|NCT00004635|65545081|FG000|Period One|second malignancy|1|||
23491854|NCT00004635|65545082|FG001|Period One|second malignancy|0|||
23491855|NCT00004635|65545081|FG000|Period One|progressed|0|||
23491856|NCT00004635|65545082|FG001|Period One|progressed|2|||
23491857|NCT00004635|65545081|FG000|Period One|health problem|0|||
23491858|NCT00004635|65545082|FG001|Period One|health problem|1|||
23491859|NCT00004635|65545081|FG000|Period One|discrepancy in data entry|0|||
23491860|NCT00004635|65545082|FG001|Period One|discrepancy in data entry|1|||
23491861|NCT00004635|65545081|FG000|Period Two|progression|2|||
23491862|NCT00004635|65545082|FG001|Period Two|progression|3|||
23491863|NCT00004635|65545081|FG000|Period Two|Adverse Event|1|||
23491864|NCT00004635|65545082|FG001|Period Two|Adverse Event|0|||
23491865|NCT00004635|65545081|FG000|Period Two|refused|0|||
23491866|NCT00004635|65545082|FG001|Period Two|refused|2|||
23491867|NCT00004635|65545081|FG000|Period Two|health problem|1|||
23491868|NCT00004635|65545082|FG001|Period Two|health problem|1|||
23491869|NCT00004635|65545081|FG000|Period Two|travel issues|0|||
23491870|NCT00004635|65545082|FG001|Period Two|travel issues|1|||
23491871|NCT00004635|65545081|FG000|Period Two|secondary malignancy|1|||
23491872|NCT00004635|65545082|FG001|Period Two|secondary malignancy|1|||
23491873|NCT00004635|65545081|FG000|Period Two|Lost to Follow-up|1|||
23491874|NCT00004635|65545082|FG001|Period Two|Lost to Follow-up|0|||
23491875|NCT00004635|65545081|FG000|Period Two|discrepancy in data entry|0|||
23491876|NCT00004635|65545082|FG001|Period Two|discrepancy in data entry|1|||
23491877|NCT00721123|65545091|FG000|Overall Study|Adverse Event|96|||
23491878|NCT00721123|65545091|FG000|Overall Study|Death|10|||
23491879|NCT00721123|65545091|FG000|Overall Study|Insufficient Therapeutic Response|21|||
23491880|NCT00721123|65545091|FG000|Overall Study|Protocol Violation|1|||
23491881|NCT00721123|65545091|FG000|Overall Study|Refused Treatment|41|||
23491882|NCT00721123|65545091|FG000|Overall Study|Failure to Return|9|||
23491883|NCT00721123|65545091|FG000|Overall Study|Withdrawal by Subject|5|||
23491884|NCT04171765|65545092|FG000|Overall Study|Adverse Event|2|||
23491885|NCT04171765|65545093|FG001|Overall Study|Adverse Event|0|||
23491886|NCT04171765|65545094|FG002|Overall Study|Adverse Event|1|||
23491887|NCT04171765|65545095|FG003|Overall Study|Adverse Event|0|||
23491888|NCT04171765|65545092|FG000|Overall Study|Lost to Follow-up|0|||
23491889|NCT04171765|65545093|FG001|Overall Study|Lost to Follow-up|2|||
23491890|NCT04171765|65545094|FG002|Overall Study|Lost to Follow-up|2|||
23491891|NCT04171765|65545095|FG003|Overall Study|Lost to Follow-up|2|||
23491892|NCT04171765|65545092|FG000|Overall Study|Week 58 visit missed|0|||
23491893|NCT04171765|65545093|FG001|Overall Study|Week 58 visit missed|0|||
23491894|NCT04171765|65545094|FG002|Overall Study|Week 58 visit missed|1|||
23491895|NCT04171765|65545095|FG003|Overall Study|Week 58 visit missed|0|||
23491896|NCT04171765|65545092|FG000|Overall Study|Study terminated by sponsor|2|||
23491897|NCT04171765|65545093|FG001|Overall Study|Study terminated by sponsor|0|||
23491898|NCT04171765|65545094|FG002|Overall Study|Study terminated by sponsor|0|||
23491899|NCT04171765|65545095|FG003|Overall Study|Study terminated by sponsor|0|||
23491900|NCT04171765|65545092|FG000|Overall Study|Withdrawal by Subject|1|||
23491901|NCT04171765|65545093|FG001|Overall Study|Withdrawal by Subject|0|||
23491902|NCT04171765|65545094|FG002|Overall Study|Withdrawal by Subject|0|||
23491903|NCT04171765|65545095|FG003|Overall Study|Withdrawal by Subject|3|||
23491904|NCT00932126|65545097|FG000|Overall Study|Adverse Event|0|||
23491905|NCT00932126|65545098|FG001|Overall Study|Adverse Event|0|||
23667994|NCT01624662|66168715|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23667995|NCT01624662|66168716|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23491906|NCT00932126|65545099|FG002|Overall Study|Adverse Event|0|||
23491907|NCT00932126|65545100|FG003|Overall Study|Adverse Event|0|||
23491908|NCT00932126|65545101|FG004|Overall Study|Adverse Event|0|||
23491909|NCT00932126|65545102|FG005|Overall Study|Adverse Event|0|||
23491910|NCT00932126|65545103|FG006|Overall Study|Adverse Event|1|||
23491911|NCT00932126|65545104|FG007|Overall Study|Adverse Event|2|||
23491912|NCT00932126|65545097|FG000|Overall Study|Protocol Violation|0|||
23491913|NCT00932126|65545098|FG001|Overall Study|Protocol Violation|0|||
23491914|NCT00932126|65545099|FG002|Overall Study|Protocol Violation|0|||
23491915|NCT00932126|65545100|FG003|Overall Study|Protocol Violation|0|||
23491916|NCT00932126|65545101|FG004|Overall Study|Protocol Violation|1|||
23491917|NCT00932126|65545102|FG005|Overall Study|Protocol Violation|0|||
23491918|NCT00932126|65545103|FG006|Overall Study|Protocol Violation|0|||
23491919|NCT00932126|65545104|FG007|Overall Study|Protocol Violation|0|||
23491920|NCT00932126|65545097|FG000|Overall Study|Withdrawal by Subject|0|||
23491921|NCT00932126|65545098|FG001|Overall Study|Withdrawal by Subject|0|||
23491922|NCT00932126|65545099|FG002|Overall Study|Withdrawal by Subject|1|||
23491923|NCT00932126|65545100|FG003|Overall Study|Withdrawal by Subject|0|||
23491924|NCT00932126|65545101|FG004|Overall Study|Withdrawal by Subject|0|||
23491925|NCT00932126|65545102|FG005|Overall Study|Withdrawal by Subject|0|||
23491926|NCT00932126|65545103|FG006|Overall Study|Withdrawal by Subject|0|||
23491927|NCT00932126|65545104|FG007|Overall Study|Withdrawal by Subject|1|||
23491928|NCT00932126|65545097|FG000|Overall Study|Objective progression or relapse|3|||
23491929|NCT00932126|65545098|FG001|Overall Study|Objective progression or relapse|3|||
23491930|NCT00932126|65545099|FG002|Overall Study|Objective progression or relapse|2|||
23491931|NCT00932126|65545100|FG003|Overall Study|Objective progression or relapse|3|||
23491932|NCT00932126|65545101|FG004|Overall Study|Objective progression or relapse|3|||
23491933|NCT00932126|65545102|FG005|Overall Study|Objective progression or relapse|3|||
23491934|NCT00932126|65545103|FG006|Overall Study|Objective progression or relapse|3|||
23491935|NCT00932126|65545104|FG007|Overall Study|Objective progression or relapse|5|||
23491936|NCT00932126|65545097|FG000|Overall Study|Other|0|||
23491937|NCT00932126|65545098|FG001|Overall Study|Other|0|||
23491938|NCT00932126|65545099|FG002|Overall Study|Other|0|||
23491939|NCT00932126|65545100|FG003|Overall Study|Other|0|||
23491940|NCT00932126|65545101|FG004|Overall Study|Other|1|||
23491941|NCT00932126|65545102|FG005|Overall Study|Other|0|||
23491942|NCT00932126|65545103|FG006|Overall Study|Other|1|||
23491943|NCT00932126|65545104|FG007|Overall Study|Other|2|||
23491944|NCT00810693|65545105|FG000|Treatment Period|Adverse Event|8|||
23491945|NCT00810693|65545106|FG001|Treatment Period|Adverse Event|1|||
23491946|NCT00810693|65545107|FG002|Treatment Period|Adverse Event|7|||
23491947|NCT00810693|65545105|FG000|Treatment Period|Death|0|||
23491948|NCT00810693|65545106|FG001|Treatment Period|Death|1|||
23491949|NCT00810693|65545107|FG002|Treatment Period|Death|2|||
23491950|NCT00810693|65545105|FG000|Treatment Period|Lack of Efficacy|0|||
23491951|NCT00810693|65545106|FG001|Treatment Period|Lack of Efficacy|0|||
23491952|NCT00810693|65545107|FG002|Treatment Period|Lack of Efficacy|1|||
23491953|NCT00810693|65545105|FG000|Treatment Period|Lost to Follow-up|1|||
23491954|NCT00810693|65545106|FG001|Treatment Period|Lost to Follow-up|0|||
23491955|NCT00810693|65545107|FG002|Treatment Period|Lost to Follow-up|0|||
23491956|NCT00810693|65545105|FG000|Treatment Period|Non-compliance|1|||
23491957|NCT00810693|65545106|FG001|Treatment Period|Non-compliance|0|||
23491958|NCT00810693|65545107|FG002|Treatment Period|Non-compliance|0|||
23491959|NCT00810693|65545105|FG000|Treatment Period|Protocol Violation|1|||
23491960|NCT00810693|65545106|FG001|Treatment Period|Protocol Violation|2|||
23491961|NCT00810693|65545107|FG002|Treatment Period|Protocol Violation|2|||
23491962|NCT00810693|65545105|FG000|Treatment Period|Withdrawal by Subject|6|||
23491963|NCT00810693|65545106|FG001|Treatment Period|Withdrawal by Subject|2|||
23491964|NCT00810693|65545107|FG002|Treatment Period|Withdrawal by Subject|3|||
23491965|NCT00810693|65545105|FG000|Treatment Period|Not treated|0|||
23491966|NCT00810693|65545106|FG001|Treatment Period|Not treated|1|||
23491967|NCT00810693|65545107|FG002|Treatment Period|Not treated|1|||
23491968|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Adverse Event|3|||
23491969|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Adverse Event|1|||
23667996|NCT01624662|66168713|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23491970|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Adverse Event|1|||
23491971|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Death|2|||
23491972|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Death|0|||
23491973|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Death|1|||
23667997|NCT01624662|66168714|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
23491974|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
23491975|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
23491976|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
23491977|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
23491978|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
23491979|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
23491980|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
23491981|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
23491982|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
23491983|NCT00002651|65545108|FG000|Induction|Adverse Event|44|||
23491984|NCT00002651|65545109|FG001|Induction|Adverse Event|0|||
23491985|NCT00002651|65545110|FG002|Induction|Adverse Event|0|||
23491986|NCT00002651|65545108|FG000|Induction|Refusal unrelated to adverse event|50|||
23491987|NCT00002651|65545109|FG001|Induction|Refusal unrelated to adverse event|0|||
23491988|NCT00002651|65545110|FG002|Induction|Refusal unrelated to adverse event|0|||
23491989|NCT00002651|65545108|FG000|Induction|Progression/relapse|274|||
23491990|NCT00002651|65545109|FG001|Induction|Progression/relapse|0|||
23491991|NCT00002651|65545110|FG002|Induction|Progression/relapse|0|||
23491992|NCT00002651|65545108|FG000|Induction|Death|62|||
23491993|NCT00002651|65545109|FG001|Induction|Death|0|||
23491994|NCT00002651|65545110|FG002|Induction|Death|0|||
23491995|NCT00002651|65545108|FG000|Induction|Other|823|||
23491996|NCT00002651|65545109|FG001|Induction|Other|0|||
23491997|NCT00002651|65545110|FG002|Induction|Other|0|||
23491998|NCT00002651|65545108|FG000|Induction|not eligible|90|||
23491999|NCT00002651|65545109|FG001|Induction|not eligible|0|||
23492000|NCT00002651|65545110|FG002|Induction|not eligible|0|||
23492001|NCT00002651|65545108|FG000|Consolidation and Randomization|Adverse Event|0|||
23492002|NCT00002651|65545109|FG001|Consolidation and Randomization|Adverse Event|36|||
23492003|NCT00002651|65545110|FG002|Consolidation and Randomization|Adverse Event|14|||
23492004|NCT00002651|65545108|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
23492005|NCT00002651|65545109|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
23492006|NCT00002651|65545110|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
23492007|NCT00002651|65545108|FG000|Consolidation and Randomization|Progression/relapse|0|||
23492008|NCT00002651|65545109|FG001|Consolidation and Randomization|Progression/relapse|295|||
23492009|NCT00002651|65545110|FG002|Consolidation and Randomization|Progression/relapse|298|||
23492010|NCT00002651|65545108|FG000|Consolidation and Randomization|Death|0|||
23492011|NCT00002651|65545109|FG001|Consolidation and Randomization|Death|38|||
23492012|NCT00002651|65545110|FG002|Consolidation and Randomization|Death|48|||
23492013|NCT00002651|65545108|FG000|Consolidation and Randomization|Other|0|||
23667998|NCT01624662|66168715|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23667999|NCT01624662|66168716|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23668000|NCT01624662|66168713|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23668001|NCT01624662|66168714|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23668002|NCT01624662|66168715|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23668003|NCT01624662|66168716|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23668004|NCT00574275|66168721|FG000|Overall Study|Randomized but not treated|2|||
23668005|NCT00574275|66168722|FG001|Overall Study|Randomized but not treated|3|||
23668006|NCT00574275|66168721|FG000|Overall Study|Adverse Event|32|||
23668007|NCT00574275|66168722|FG001|Overall Study|Adverse Event|76|||
23668008|NCT00574275|66168721|FG000|Overall Study|Disease progression|160|||
23668009|NCT00574275|66168722|FG001|Overall Study|Disease progression|146|||
23668010|NCT00574275|66168721|FG000|Overall Study|Lost to Follow-up|2|||
23668011|NCT00574275|66168722|FG001|Overall Study|Lost to Follow-up|1|||
23668012|NCT00574275|66168721|FG000|Overall Study|Study stopped based on DMC decision|62|||
23668013|NCT00574275|66168722|FG001|Overall Study|Study stopped based on DMC decision|23|||
23668014|NCT00574275|66168721|FG000|Overall Study|Withdrawal by Subject|15|||
23668015|NCT00574275|66168722|FG001|Overall Study|Withdrawal by Subject|17|||
23668016|NCT00574275|66168721|FG000|Overall Study|Error calculating tumor measurement|1|||
23668017|NCT00574275|66168722|FG001|Overall Study|Error calculating tumor measurement|0|||
23668018|NCT00574275|66168721|FG000|Overall Study|Physician Decision|1|||
23668019|NCT00574275|66168722|FG001|Overall Study|Physician Decision|1|||
23668020|NCT00574275|66168721|FG000|Overall Study|Protocol Violation|0|||
23668021|NCT00574275|66168722|FG001|Overall Study|Protocol Violation|1|||
23668022|NCT00574275|66168721|FG000|Overall Study|Patient and Investigator decision|0|||
23668023|NCT00574275|66168722|FG001|Overall Study|Patient and Investigator decision|1|||
23668024|NCT00574275|66168721|FG000|Overall Study|Insurance change|0|||
23668025|NCT00574275|66168722|FG001|Overall Study|Insurance change|1|||
23668026|NCT00574275|66168721|FG000|Overall Study|Operation for curative intent|0|||
23668027|NCT00574275|66168722|FG001|Overall Study|Operation for curative intent|1|||
23668028|NCT04486950|66168727|FG000|Overall Study|Lost to Follow-up|0|||
23668029|NCT04486950|66168728|FG001|Overall Study|Lost to Follow-up|0|||
23668030|NCT04486950|66168729|FG002|Overall Study|Lost to Follow-up|0|||
23668031|NCT04486950|66168730|FG003|Overall Study|Lost to Follow-up|0|||
23668032|NCT04486950|66168731|FG004|Overall Study|Lost to Follow-up|0|||
23668033|NCT04486950|66168732|FG005|Overall Study|Lost to Follow-up|1|||
23492014|NCT00002651|65545109|FG001|Consolidation and Randomization|Other|314|||
23492015|NCT00002651|65545110|FG002|Consolidation and Randomization|Other|313|||
23492016|NCT00002651|65545108|FG000|Consolidation and Randomization|not eligible|0|||
23492017|NCT00002651|65545109|FG001|Consolidation and Randomization|not eligible|102|||
23381190|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
23381191|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
23381192|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
23381193|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Other|2|||
23668034|NCT04486950|66168733|FG006|Overall Study|Lost to Follow-up|0|||
23668035|NCT00886600|66168737|FG000|Double-blind Monotherapy|Adverse Event|1|||
23668036|NCT00886600|66168738|FG001|Double-blind Monotherapy|Adverse Event|1|||
23668037|NCT00886600|66168739|FG002|Double-blind Monotherapy|Adverse Event|1|||
23668038|NCT00886600|66168740|FG003|Double-blind Monotherapy|Adverse Event|1|||
23668039|NCT00886600|66168737|FG000|Double-blind Monotherapy|Protocol Violation|0|||
23381194|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Other|1|||
23381195|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Other|0|||
23381196|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Other|0|||
23381197|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Other|0|||
23381198|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381199|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381200|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
23381201|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381202|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381203|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23381204|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
23381205|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23492018|NCT00002651|65545110|FG002|Consolidation and Randomization|not eligible|112|||
23492019|NCT02476422|65545112|FG000|Overall Study|Subject/guardian decision|0|||
23492020|NCT02476422|65545113|FG001|Overall Study|Subject/guardian decision|1|||
23492021|NCT00369122|65545116|FG000|Overall Study|Ineligible|10|||
23492022|NCT00369122|65545116|FG000|Overall Study|No protocol treatment|1|||
23492023|NCT02215096|65545122|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
23492024|NCT02215096|65545123|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492025|NCT02215096|65545124|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492026|NCT02215096|65545125|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
23668040|NCT00886600|66168738|FG001|Double-blind Monotherapy|Protocol Violation|0|||
23668041|NCT00886600|66168739|FG002|Double-blind Monotherapy|Protocol Violation|0|||
23668042|NCT00886600|66168740|FG003|Double-blind Monotherapy|Protocol Violation|1|||
23668043|NCT00886600|66168737|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
23668044|NCT00886600|66168738|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
23668045|NCT00886600|66168739|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
23668046|NCT00886600|66168740|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
23668047|NCT00886600|66168737|FG000|Combination Therapy Period|Adverse Event|0|||
23668048|NCT00886600|66168738|FG001|Combination Therapy Period|Adverse Event|0|||
23668049|NCT00886600|66168739|FG002|Combination Therapy Period|Adverse Event|1|||
23668050|NCT00886600|66168740|FG003|Combination Therapy Period|Adverse Event|0|||
23668051|NCT00886600|66168737|FG000|Combination Therapy Period|Protocol Violation|0|||
23668052|NCT00886600|66168738|FG001|Combination Therapy Period|Protocol Violation|0|||
23668053|NCT00886600|66168739|FG002|Combination Therapy Period|Protocol Violation|1|||
23381206|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
23381207|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23492027|NCT02215096|65545126|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492028|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23668054|NCT00886600|66168740|FG003|Combination Therapy Period|Protocol Violation|0|||
23605928|NCT01640951|65947106|FG005|Overall Study|Lost to Follow-up|3|||
23381208|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
23381209|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
23381210|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
23381211|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
23381212|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
23381213|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
23381214|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381215|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381216|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381217|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381218|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381219|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381220|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
23381221|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381222|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381223|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
23381224|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
23381225|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
23381226|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
23381227|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
23381228|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
23381229|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
23381230|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
23381231|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
23381232|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
23381233|NCT03317496|65140466|FG000|Phase 2: Treatment|Adverse Event|0|||
23381234|NCT03317496|65140467|FG001|Phase 2: Treatment|Adverse Event|0|||
23381235|NCT03317496|65140468|FG002|Phase 2: Treatment|Adverse Event|0|||
23381236|NCT03317496|65140469|FG003|Phase 2: Treatment|Adverse Event|0|||
23381237|NCT03317496|65140470|FG004|Phase 2: Treatment|Adverse Event|6|||
23668055|NCT03505021|66168748|FG000|Overall Study|Protocol Violation|1|||
23668056|NCT03505021|66168749|FG001|Overall Study|Protocol Violation|0|||
23668057|NCT03505021|66168748|FG000|Overall Study|Death|9|||
23668058|NCT03505021|66168749|FG001|Overall Study|Death|8|||
23668059|NCT03505021|66168748|FG000|Overall Study|Consent withdrawn by subject|6|||
23668060|NCT03505021|66168749|FG001|Overall Study|Consent withdrawn by subject|1|||
23668061|NCT03505021|66168748|FG000|Overall Study|Lost to Follow-up|5|||
23668062|NCT03505021|66168749|FG001|Overall Study|Lost to Follow-up|3|||
23668063|NCT03505021|66168748|FG000|Overall Study|Adverse Event|26|||
23668064|NCT03505021|66168749|FG001|Overall Study|Adverse Event|9|||
23668065|NCT03505021|66168748|FG000|Overall Study|Disease progression|33|||
23668066|NCT03505021|66168749|FG001|Overall Study|Disease progression|17|||
23668067|NCT03505021|66168748|FG000|Overall Study|Other|11|||
23668068|NCT03505021|66168749|FG001|Overall Study|Other|5|||
23668069|NCT03505021|66168748|FG000|Overall Study|Personal reason|21|||
23668070|NCT03505021|66168749|FG001|Overall Study|Personal reason|12|||
23668071|NCT00583362|66168756|FG000|Overall Study|Adverse Event|44|||
23668072|NCT00583362|66168756|FG000|Overall Study|Lack of Efficacy|22|||
23668073|NCT00583362|66168756|FG000|Overall Study|Lost to Follow-up|4|||
23668074|NCT00583362|66168756|FG000|Overall Study|Non-compliance with study drug|28|||
23668075|NCT00583362|66168756|FG000|Overall Study|Pregnancy|7|||
23668076|NCT00583362|66168756|FG000|Overall Study|Miscommunication of visit window|5|||
23668077|NCT00583362|66168756|FG000|Overall Study|Current site closed|7|||
23668078|NCT00583362|66168756|FG000|Overall Study|Subject not dosed in LBSL99|1|||
23668079|NCT00583362|66168756|FG000|Overall Study|Subject moved out of the country/state|2|||
23668080|NCT00583362|66168756|FG000|Overall Study|Missed visits due to staff changes|1|||
23381238|NCT03317496|65140466|FG000|Phase 2: Treatment|Progressive disease|0|||
23381239|NCT03317496|65140467|FG001|Phase 2: Treatment|Progressive disease|0|||
23381240|NCT03317496|65140468|FG002|Phase 2: Treatment|Progressive disease|0|||
23381241|NCT03317496|65140469|FG003|Phase 2: Treatment|Progressive disease|0|||
23381242|NCT03317496|65140470|FG004|Phase 2: Treatment|Progressive disease|22|||
23668081|NCT00583362|66168756|FG000|Overall Study|Misunderstanding of protocol|1|||
23668082|NCT00583362|66168756|FG000|Overall Study|Behavioral problems and non-compliance|1|||
23668083|NCT00583362|66168756|FG000|Overall Study|Sponsor request due to missed doses|1|||
23668084|NCT00583362|66168756|FG000|Overall Study|Physician Decision|19|||
23668085|NCT00583362|66168756|FG000|Overall Study|Protocol Violation|2|||
23668086|NCT00583362|66168756|FG000|Overall Study|Withdrawal by Subject|57|||
23668087|NCT01356407|66168757|FG000|Overall Study|Lost to Follow-up|2|||
23668088|NCT01356407|66168758|FG001|Overall Study|Lost to Follow-up|0|||
23668089|NCT01356407|66168757|FG000|Overall Study|Patient Withdrew Consent|2|||
23668090|NCT01356407|66168758|FG001|Overall Study|Patient Withdrew Consent|1|||
23381243|NCT03317496|65140466|FG000|Phase 2: Treatment|Other|0|||
23381244|NCT03317496|65140467|FG001|Phase 2: Treatment|Other|0|||
23381245|NCT03317496|65140468|FG002|Phase 2: Treatment|Other|0|||
23381246|NCT03317496|65140469|FG003|Phase 2: Treatment|Other|0|||
23381247|NCT03317496|65140470|FG004|Phase 2: Treatment|Other|4|||
23381248|NCT03317496|65140466|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
23381249|NCT03317496|65140467|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
23381250|NCT03317496|65140468|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
23381251|NCT03317496|65140469|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
23381252|NCT03317496|65140470|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
23381253|NCT03317496|65140466|FG000|Phase 2: Treatment|Physician Decision|0|||
23381254|NCT03317496|65140467|FG001|Phase 2: Treatment|Physician Decision|0|||
23381255|NCT03317496|65140468|FG002|Phase 2: Treatment|Physician Decision|0|||
23381256|NCT03317496|65140469|FG003|Phase 2: Treatment|Physician Decision|0|||
23381257|NCT03317496|65140470|FG004|Phase 2: Treatment|Physician Decision|1|||
23381258|NCT03317496|65140466|FG000|Phase 2: Treatment|Death|0|||
23381259|NCT03317496|65140467|FG001|Phase 2: Treatment|Death|0|||
23381260|NCT03317496|65140468|FG002|Phase 2: Treatment|Death|0|||
23381261|NCT03317496|65140469|FG003|Phase 2: Treatment|Death|0|||
23381262|NCT03317496|65140470|FG004|Phase 2: Treatment|Death|1|||
23381263|NCT03317496|65140466|FG000|Phase 2: Follow-up|Death|0|||
23381264|NCT03317496|65140467|FG001|Phase 2: Follow-up|Death|0|||
23381265|NCT03317496|65140468|FG002|Phase 2: Follow-up|Death|0|||
23381266|NCT03317496|65140469|FG003|Phase 2: Follow-up|Death|0|||
23668091|NCT01356407|66168757|FG000|Overall Study|Could not afford IMP administration|0|||
23381267|NCT03317496|65140470|FG004|Phase 2: Follow-up|Death|24|||
23381268|NCT03317496|65140466|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
23381269|NCT03317496|65140467|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
23381270|NCT03317496|65140468|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
23381271|NCT03317496|65140469|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
23381272|NCT03317496|65140470|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
23381273|NCT03317496|65140466|FG000|Phase 2: Follow-up|Other|0|||
23381274|NCT03317496|65140467|FG001|Phase 2: Follow-up|Other|0|||
23381275|NCT03317496|65140468|FG002|Phase 2: Follow-up|Other|0|||
23668092|NCT01356407|66168758|FG001|Overall Study|Could not afford IMP administration|1|||
23668093|NCT01356407|66168757|FG000|Overall Study|Not complete Endoscopy|2|||
23668094|NCT01356407|66168758|FG001|Overall Study|Not complete Endoscopy|2|||
23668095|NCT00762892|66168761|FG000|Overall Study|Lost to Follow-up|2|||
23668096|NCT00762892|66168762|FG001|Overall Study|Lost to Follow-up|5|||
23668097|NCT00762892|66168761|FG000|Overall Study|Withdrawal by Subject|0|||
23668098|NCT00762892|66168762|FG001|Overall Study|Withdrawal by Subject|1|||
23668099|NCT00762892|66168761|FG000|Overall Study|Death|1|||
23668100|NCT00762892|66168762|FG001|Overall Study|Death|0|||
23668101|NCT00762892|66168761|FG000|Overall Study|Pregnancy|1|||
23668102|NCT00762892|66168762|FG001|Overall Study|Pregnancy|0|||
23668103|NCT00762892|66168761|FG000|Overall Study|Incarceration|1|||
23381276|NCT03317496|65140469|FG003|Phase 2: Follow-up|Other|0|||
23381277|NCT03317496|65140470|FG004|Phase 2: Follow-up|Other|1|||
23492029|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23668104|NCT00762892|66168762|FG001|Overall Study|Incarceration|0|||
23668105|NCT03864653|66168763|FG000|Overall Study|Withdrawal by Subject|1|||
23381278|NCT03317496|65140466|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
23668106|NCT01328951|66168766|FG000|Overall Study|Disease Progression|17|||
23668107|NCT01328951|66168767|FG001|Overall Study|Disease Progression|14|||
23668108|NCT01328951|66168766|FG000|Overall Study|Adverse Event|2|||
23668109|NCT01328951|66168767|FG001|Overall Study|Adverse Event|0|||
23668110|NCT01328951|66168766|FG000|Overall Study|Death|243|||
23668111|NCT01328951|66168767|FG001|Overall Study|Death|258|||
23668112|NCT01328951|66168766|FG000|Overall Study|Lost to Follow-up|6|||
23668113|NCT01328951|66168767|FG001|Overall Study|Lost to Follow-up|7|||
23668114|NCT01328951|66168766|FG000|Overall Study|Withdrawal by Subject|6|||
23668115|NCT01328951|66168767|FG001|Overall Study|Withdrawal by Subject|6|||
23668116|NCT01328951|66168766|FG000|Overall Study|Study Closed by the Sponsor|36|||
23668117|NCT01328951|66168767|FG001|Overall Study|Study Closed by the Sponsor|31|||
23668118|NCT01328951|66168766|FG000|Overall Study|Other|11|||
23668119|NCT01328951|66168767|FG001|Overall Study|Other|6|||
23668120|NCT03923426|66168768|FG000|Overall Study|Other|19|||
23668121|NCT03923426|66168768|FG000|Overall Study|Lost to Follow-up|16|||
23668122|NCT03923426|66168768|FG000|Overall Study|Death|107|||
23668123|NCT03923426|66168768|FG000|Overall Study|Incomplete response to question|13|||
23668124|NCT00606320|66168769|FG000|Overall Study|Adverse Event|3|||
23668125|NCT00606320|66168769|FG000|Overall Study|Lack of Efficacy|5|||
23668126|NCT00606320|66168769|FG000|Overall Study|Physician Decision|7|||
23668127|NCT00606320|66168769|FG000|Overall Study|Protocol Violation|8|||
23668128|NCT00606320|66168769|FG000|Overall Study|Withdrawal by Subject|10|||
23381279|NCT03317496|65140467|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
23381280|NCT03317496|65140468|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
23381281|NCT03317496|65140469|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
23605929|NCT01640951|65947107|FG006|Overall Study|Lost to Follow-up|1|||
23605930|NCT01640951|65947108|FG007|Overall Study|Lost to Follow-up|1|||
23605931|NCT01640951|65947101|FG000|Overall Study|Non-compliance with study treatment|0|||
23605932|NCT01640951|65947102|FG001|Overall Study|Non-compliance with study treatment|0|||
23605933|NCT01640951|65947103|FG002|Overall Study|Non-compliance with study treatment|1|||
23605934|NCT01640951|65947104|FG003|Overall Study|Non-compliance with study treatment|1|||
23605935|NCT01640951|65947105|FG004|Overall Study|Non-compliance with study treatment|1|||
23605936|NCT01640951|65947106|FG005|Overall Study|Non-compliance with study treatment|4|||
23605937|NCT01640951|65947107|FG006|Overall Study|Non-compliance with study treatment|1|||
23605938|NCT01640951|65947108|FG007|Overall Study|Non-compliance with study treatment|0|||
23605939|NCT01640951|65947101|FG000|Overall Study|Physician Decision|2|||
23605940|NCT01640951|65947102|FG001|Overall Study|Physician Decision|5|||
23605941|NCT01640951|65947103|FG002|Overall Study|Physician Decision|2|||
23605942|NCT01640951|65947104|FG003|Overall Study|Physician Decision|2|||
23605943|NCT01640951|65947105|FG004|Overall Study|Physician Decision|2|||
23605944|NCT01640951|65947106|FG005|Overall Study|Physician Decision|3|||
23605945|NCT01640951|65947107|FG006|Overall Study|Physician Decision|3|||
23605946|NCT01640951|65947108|FG007|Overall Study|Physician Decision|0|||
23605947|NCT01640951|65947101|FG000|Overall Study|Pregnancy|3|||
23605948|NCT01640951|65947102|FG001|Overall Study|Pregnancy|0|||
23605949|NCT01640951|65947103|FG002|Overall Study|Pregnancy|0|||
23605950|NCT01640951|65947104|FG003|Overall Study|Pregnancy|4|||
23605951|NCT01640951|65947105|FG004|Overall Study|Pregnancy|0|||
23605952|NCT01640951|65947106|FG005|Overall Study|Pregnancy|0|||
23605953|NCT01640951|65947107|FG006|Overall Study|Pregnancy|2|||
23605954|NCT01640951|65947108|FG007|Overall Study|Pregnancy|0|||
23605955|NCT01640951|65947101|FG000|Overall Study|Protocol Deviation|0|||
23605956|NCT01640951|65947102|FG001|Overall Study|Protocol Deviation|1|||
23605957|NCT01640951|65947103|FG002|Overall Study|Protocol Deviation|2|||
23381282|NCT03317496|65140470|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
23381283|NCT00884949|65140471|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
23381284|NCT00884949|65140471|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
23381285|NCT01013753|65140472|FG000|Overall Study|Adverse Event|8|||
23381286|NCT01013753|65140472|FG000|Overall Study|Protocol Violation|3|||
23381287|NCT01013753|65140472|FG000|Overall Study|Lost to Follow-up|1|||
23381288|NCT01013753|65140472|FG000|Overall Study|Withdrawal by Subject|2|||
23381289|NCT01013753|65140472|FG000|Overall Study|Other|2|||
23668129|NCT00606320|66168769|FG000|Overall Study|Progression to depressive phase|4|||
23381290|NCT02927145|65140473|FG000|Initial Recruitment|Withdrawal by Subject|0|||
23381291|NCT02927145|65140474|FG001|Initial Recruitment|Withdrawal by Subject|1|||
23381292|NCT02927145|65140475|FG002|Initial Recruitment|Withdrawal by Subject|1|||
23381293|NCT02927145|65140476|FG003|Initial Recruitment|Withdrawal by Subject|4|||
23381294|NCT02927145|65140477|FG004|Initial Recruitment|Withdrawal by Subject|1|||
23381295|NCT02927145|65140478|FG005|Initial Recruitment|Withdrawal by Subject|1|||
23668130|NCT00357500|66168770|FG000|Overall Study|Adverse Event|3|||
23668131|NCT00357500|66168770|FG000|Overall Study|Withdrawal by Subject|5|||
23668132|NCT00357500|66168770|FG000|Overall Study|Progressive Disease|65|||
23668133|NCT00357500|66168770|FG000|Overall Study|Not Started Protocol Therapy|4|||
23668134|NCT00825162|66168771|FG000|Overall Study|Withdrawal by Subject|11|||
23668135|NCT00825162|66168772|FG001|Overall Study|Withdrawal by Subject|13|||
23668136|NCT00825162|66168773|FG002|Overall Study|Withdrawal by Subject|3|||
23668137|NCT00825162|66168771|FG000|Overall Study|Lost to Follow-up|9|||
23668138|NCT00825162|66168772|FG001|Overall Study|Lost to Follow-up|6|||
23668139|NCT00825162|66168773|FG002|Overall Study|Lost to Follow-up|3|||
23668140|NCT00825162|66168771|FG000|Overall Study|Physician Decision|2|||
23668141|NCT00825162|66168772|FG001|Overall Study|Physician Decision|0|||
23668142|NCT00825162|66168773|FG002|Overall Study|Physician Decision|0|||
23668143|NCT00825162|66168771|FG000|Overall Study|Move away from the study area|1|||
23668144|NCT00825162|66168772|FG001|Overall Study|Move away from the study area|0|||
23668145|NCT00825162|66168773|FG002|Overall Study|Move away from the study area|0|||
23668146|NCT00825162|66168771|FG000|Overall Study|Unable to attend the study visit|5|||
23668147|NCT00825162|66168772|FG001|Overall Study|Unable to attend the study visit|2|||
23668148|NCT00825162|66168773|FG002|Overall Study|Unable to attend the study visit|0|||
23668149|NCT01709149|66168776|FG000|Open-label Lead-in Phase|Adverse Event|109|||
23668150|NCT01709149|66168777|FG001|Open-label Lead-in Phase|Adverse Event|0|||
23668151|NCT01709149|66168778|FG002|Open-label Lead-in Phase|Adverse Event|0|||
23668152|NCT01709149|66168776|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
23668153|NCT01709149|66168777|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
23668154|NCT01709149|66168778|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
23668155|NCT01709149|66168776|FG000|Open-label Lead-in Phase|Death|1|||
23668156|NCT01709149|66168777|FG001|Open-label Lead-in Phase|Death|0|||
23668157|NCT01709149|66168778|FG002|Open-label Lead-in Phase|Death|0|||
23668158|NCT01709149|66168776|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
23668159|NCT01709149|66168777|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
23668160|NCT01709149|66168778|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
23381296|NCT02927145|65140479|FG006|Initial Recruitment|Withdrawal by Subject|0|||
23381297|NCT02927145|65140480|FG007|Initial Recruitment|Withdrawal by Subject|0|||
23381298|NCT02927145|65140481|FG008|Initial Recruitment|Withdrawal by Subject|2|||
23668161|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23381299|NCT02927145|65140473|FG000|Initial Recruitment|Adverse Event|0|||
23381300|NCT02927145|65140474|FG001|Initial Recruitment|Adverse Event|0|||
23381301|NCT02927145|65140475|FG002|Initial Recruitment|Adverse Event|0|||
23381302|NCT02927145|65140476|FG003|Initial Recruitment|Adverse Event|0|||
23381303|NCT02927145|65140477|FG004|Initial Recruitment|Adverse Event|2|||
23381304|NCT02927145|65140478|FG005|Initial Recruitment|Adverse Event|0|||
23381305|NCT02927145|65140479|FG006|Initial Recruitment|Adverse Event|0|||
23381306|NCT02927145|65140480|FG007|Initial Recruitment|Adverse Event|0|||
23381307|NCT02927145|65140481|FG008|Initial Recruitment|Adverse Event|0|||
23381308|NCT02927145|65140473|FG000|Invitation for Additional Challenge|Pregnancy|0|||
23381309|NCT02927145|65140474|FG001|Invitation for Additional Challenge|Pregnancy|0|||
23381310|NCT02927145|65140475|FG002|Invitation for Additional Challenge|Pregnancy|0|||
23381311|NCT02927145|65140476|FG003|Invitation for Additional Challenge|Pregnancy|0|||
23381312|NCT02927145|65140477|FG004|Invitation for Additional Challenge|Pregnancy|0|||
23381313|NCT02927145|65140478|FG005|Invitation for Additional Challenge|Pregnancy|0|||
23381314|NCT02927145|65140479|FG006|Invitation for Additional Challenge|Pregnancy|1|||
23381315|NCT02927145|65140480|FG007|Invitation for Additional Challenge|Pregnancy|0|||
23381316|NCT02927145|65140481|FG008|Invitation for Additional Challenge|Pregnancy|0|||
23381317|NCT00221104|65140482|FG000|Overall Study|Adverse Event|1|||
23381318|NCT00221104|65140483|FG001|Overall Study|Adverse Event|0|||
23381319|NCT00221104|65140482|FG000|Overall Study|Physician Decision|1|||
23381320|NCT00221104|65140483|FG001|Overall Study|Physician Decision|0|||
23381321|NCT00221104|65140482|FG000|Overall Study|Protocol Violation|2|||
23381322|NCT00221104|65140483|FG001|Overall Study|Protocol Violation|0|||
23381323|NCT00221104|65140482|FG000|Overall Study|Withdrawal by Subject|42|||
23381324|NCT00221104|65140483|FG001|Overall Study|Withdrawal by Subject|29|||
23381325|NCT00221104|65140482|FG000|Overall Study|Others|37|||
23381326|NCT00221104|65140483|FG001|Overall Study|Others|47|||
23381327|NCT01149538|65140484|FG000|Overall Study|Lost to Follow-up|0|||
23381328|NCT01149538|65140485|FG001|Overall Study|Lost to Follow-up|1|||
23381329|NCT01149538|65140484|FG000|Overall Study|Withdrawal by Subject|5|||
23381330|NCT01149538|65140485|FG001|Overall Study|Withdrawal by Subject|3|||
23381331|NCT04401293|65140486|FG000|Overall Study|Withdrawal by Subject|1|||
23381332|NCT04401293|65140487|FG001|Overall Study|Withdrawal by Subject|3|||
23381333|NCT02401230|65140488|FG000|Overall Study|Adverse Event|3|||
23381334|NCT02401230|65140489|FG001|Overall Study|Adverse Event|2|||
23381335|NCT02401230|65140490|FG002|Overall Study|Adverse Event|0|||
23381336|NCT02401230|65140488|FG000|Overall Study|Withdrawal by Subject|2|||
23381337|NCT02401230|65140489|FG001|Overall Study|Withdrawal by Subject|1|||
23381338|NCT02401230|65140490|FG002|Overall Study|Withdrawal by Subject|1|||
23381339|NCT02401230|65140488|FG000|Overall Study|Lost to Follow-up|1|||
23381340|NCT02401230|65140489|FG001|Overall Study|Lost to Follow-up|3|||
23381341|NCT02401230|65140490|FG002|Overall Study|Lost to Follow-up|3|||
23381342|NCT00455455|65140491|FG000|Washout|Withdrawal by Subject|0|||
23381343|NCT00455455|65140492|FG001|Washout|Withdrawal by Subject|1|||
23381344|NCT00455455|65140491|FG000|Washout|Withdrawal by Subject|1|||
23381345|NCT00455455|65140492|FG001|Washout|Withdrawal by Subject|0|||
23381346|NCT02709369|65140493|FG000|Overall Study|Lost to Follow-up|15|||
23381347|NCT02709369|65140493|FG000|Overall Study|Withdrawal by Subject|10|||
23381348|NCT02709369|65140493|FG000|Overall Study|Did not received intervention|2|||
23381349|NCT03349515|65140495|FG000|Overall Study|Lack of Efficacy|2|||
23381350|NCT03349515|65140496|FG001|Overall Study|Lack of Efficacy|0|||
23381351|NCT03349515|65140495|FG000|Overall Study|Physician Decision|3|||
23381352|NCT03349515|65140496|FG001|Overall Study|Physician Decision|1|||
23381353|NCT04810962|65140497|FG000|Overall Study|Adverse Event|0|||
23668162|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
23381354|NCT04810962|65140498|FG001|Overall Study|Adverse Event|1|||
23381355|NCT04810962|65140497|FG000|Overall Study|Lost to Follow-up|2|||
23381356|NCT04810962|65140498|FG001|Overall Study|Lost to Follow-up|1|||
23381357|NCT04810962|65140497|FG000|Overall Study|Physician Decision|1|||
23381358|NCT04810962|65140498|FG001|Overall Study|Physician Decision|0|||
23381359|NCT04810962|65140497|FG000|Overall Study|Withdrawal by Subject|1|||
23668163|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
23381360|NCT04810962|65140498|FG001|Overall Study|Withdrawal by Subject|3|||
23381361|NCT04810962|65140497|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
23381362|NCT04810962|65140498|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
23492030|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23492031|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23492032|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
23668164|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23668165|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
23668166|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
23668167|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23492033|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492034|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492035|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492036|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
23492037|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492038|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
23492039|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
23492040|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
23492041|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
23492042|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
23492043|NCT01822678|65545127|FG000|Overall Study|Withdrawal by Subject|5|||
23492044|NCT01822678|65545128|FG001|Overall Study|Withdrawal by Subject|4|||
23492045|NCT01822678|65545129|FG002|Overall Study|Withdrawal by Subject|4|||
23492046|NCT01822678|65545127|FG000|Overall Study|Adverse Event|4|||
23492047|NCT01822678|65545128|FG001|Overall Study|Adverse Event|3|||
23492048|NCT01822678|65545129|FG002|Overall Study|Adverse Event|1|||
23492049|NCT01822678|65545127|FG000|Overall Study|Lack of Efficacy|3|||
23492050|NCT01822678|65545128|FG001|Overall Study|Lack of Efficacy|6|||
23492051|NCT01822678|65545129|FG002|Overall Study|Lack of Efficacy|5|||
23492052|NCT01822678|65545127|FG000|Overall Study|Lost to Follow-up|0|||
23492053|NCT01822678|65545128|FG001|Overall Study|Lost to Follow-up|2|||
23492054|NCT01822678|65545129|FG002|Overall Study|Lost to Follow-up|1|||
23492055|NCT02030938|65545130|FG000|Overall Study|Lost to Follow-up|4|||
23492056|NCT02030938|65545130|FG000|Overall Study|Withdrawal by Subject|1|||
23492057|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
23492058|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
23492059|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
23492060|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
23492061|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
23492062|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
23492063|NCT02846545|65545136|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
23492064|NCT02846545|65545137|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
23492065|NCT02846545|65545136|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
23492066|NCT02846545|65545137|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
23492067|NCT02663908|65545146|FG000|Overall Study|Withdrawal by Subject|8|||
23492068|NCT02663908|65545147|FG001|Overall Study|Withdrawal by Subject|5|||
23492069|NCT02663908|65545146|FG000|Overall Study|Lost to Follow-up|1|||
23492070|NCT02663908|65545147|FG001|Overall Study|Lost to Follow-up|5|||
23492071|NCT02663908|65545146|FG000|Overall Study|Adverse Event|13|||
23492072|NCT02663908|65545147|FG001|Overall Study|Adverse Event|11|||
23492073|NCT02663908|65545146|FG000|Overall Study|Protocol Violation|1|||
23492074|NCT02663908|65545147|FG001|Overall Study|Protocol Violation|2|||
23492075|NCT02663908|65545146|FG000|Overall Study|Lack of therapeutic response|2|||
23492076|NCT02663908|65545147|FG001|Overall Study|Lack of therapeutic response|0|||
23492077|NCT02663908|65545146|FG000|Overall Study|COVID-19|1|||
23492078|NCT02663908|65545147|FG001|Overall Study|COVID-19|0|||
23492079|NCT02663908|65545146|FG000|Overall Study|Site closed|1|||
23492080|NCT02663908|65545147|FG001|Overall Study|Site closed|0|||
23492081|NCT02663908|65545146|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
23492082|NCT02663908|65545147|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
23492083|NCT02663908|65545146|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
23492084|NCT02663908|65545147|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
23492085|NCT02663908|65545146|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
23492086|NCT02663908|65545147|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
23492087|NCT02663908|65545146|FG000|Overall Study|Death|1|||
23668168|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
23381363|NCT01774370|65140499|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
23492088|NCT02663908|65545147|FG001|Overall Study|Death|0|||
23492089|NCT02663908|65545146|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
23492090|NCT02663908|65545147|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
23492091|NCT02663908|65545146|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
23605958|NCT01640951|65947104|FG003|Overall Study|Protocol Deviation|1|||
23492092|NCT02663908|65545147|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
23492093|NCT00579098|65545148|FG000|Overall Study|Lost to Follow-up|2|||
23492094|NCT00579098|65545149|FG001|Overall Study|Lost to Follow-up|0|||
23668169|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
23668170|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
23668171|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
23668172|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
23492095|NCT00579098|65545148|FG000|Overall Study|Adverse Event|2|||
23492096|NCT00579098|65545149|FG001|Overall Study|Adverse Event|3|||
23492097|NCT00579098|65545148|FG000|Overall Study|Withdrawal by Subject|2|||
23492098|NCT00579098|65545149|FG001|Overall Study|Withdrawal by Subject|3|||
23668173|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
23668174|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
23668175|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
23668176|NCT01709149|66168776|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23668177|NCT01709149|66168777|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23668178|NCT01709149|66168778|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23668179|NCT01118351|66168781|FG000|Overall Study|Adverse Event|3|||
23668180|NCT01118351|66168781|FG000|Overall Study|Withdrawal by Subject|1|||
23492099|NCT00579098|65545148|FG000|Overall Study|AF returned after ablation|3|||
23492100|NCT00579098|65545149|FG001|Overall Study|AF returned after ablation|2|||
23492101|NCT01824342|65545150|FG000|Overall Study|Withdrawal by Subject|0|||
23492102|NCT01824342|65545151|FG001|Overall Study|Withdrawal by Subject|3|||
23492103|NCT01824342|65545150|FG000|Overall Study|Adverse Event|1|||
23492104|NCT01824342|65545151|FG001|Overall Study|Adverse Event|1|||
23492105|NCT01824342|65545150|FG000|Overall Study|Disease Progression|1|||
23492106|NCT01824342|65545151|FG001|Overall Study|Disease Progression|1|||
23492107|NCT01824342|65545150|FG000|Overall Study|Physician Decision|5|||
23492108|NCT01824342|65545151|FG001|Overall Study|Physician Decision|0|||
23492109|NCT01824342|65545150|FG000|Overall Study|Death|2|||
23492110|NCT01824342|65545151|FG001|Overall Study|Death|0|||
23492111|NCT01313312|65545154|FG000|Overall Study|Adverse Event|5|||
23492112|NCT01313312|65545154|FG000|Overall Study|Withdrawal by Subject|18|||
23668181|NCT04317274|66168786|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
23668182|NCT04317274|66168787|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
23668183|NCT04317274|66168788|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
23668184|NCT04317274|66168789|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
23668185|NCT01650636|66168797|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
23668186|NCT01650636|66168798|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
23492113|NCT01313312|65545154|FG000|Overall Study|Lack of Efficacy|3|||
23492114|NCT01313312|65545154|FG000|Overall Study|Investigator Decision|1|||
23668187|NCT01650636|66168797|FG000|Washout up to 5 Months|Physician Decision|2|||
23668188|NCT01650636|66168798|FG001|Washout up to 5 Months|Physician Decision|2|||
23668189|NCT01650636|66168797|FG000|Washout up to 5 Months|Death|1|||
23668190|NCT01650636|66168798|FG001|Washout up to 5 Months|Death|0|||
23668191|NCT01650636|66168797|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
23668192|NCT01650636|66168798|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
23492115|NCT01313312|65545154|FG000|Overall Study|Observational Phase|1|||
23492116|NCT01313312|65545154|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
23492117|NCT01313312|65545154|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
23381364|NCT01774370|65140499|FG000|Overall Study|Administered prior to the contract date|4|||
23381365|NCT01774370|65140499|FG000|Overall Study|Subjects of contraindications|34|||
23381366|NCT01774370|65140499|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
23381367|NCT01774370|65140499|FG000|Overall Study|Follow-up failure|34|||
23381368|NCT02403271|65140500|FG000|Period 1|Other varied reasons|1|||
23381369|NCT02403271|65140501|FG001|Period 1|Other varied reasons|0|||
23381370|NCT02403271|65140500|FG000|Period 2|Withdrawal by Subject|0|||
23381371|NCT02403271|65140501|FG001|Period 2|Withdrawal by Subject|14|||
23381372|NCT02403271|65140500|FG000|Period 2|Death|0|||
23381373|NCT02403271|65140501|FG001|Period 2|Death|84|||
23381374|NCT02403271|65140500|FG000|Period 2|Lost to Follow-up|0|||
23381375|NCT02403271|65140501|FG001|Period 2|Lost to Follow-up|2|||
23381376|NCT02403271|65140500|FG000|Period 2|Study Terminated by Sponsor|0|||
23381377|NCT02403271|65140501|FG001|Period 2|Study Terminated by Sponsor|14|||
23381378|NCT02403271|65140500|FG000|Period 2|Other varied reasons|0|||
23381379|NCT02403271|65140501|FG001|Period 2|Other varied reasons|10|||
23381380|NCT01432327|65140502|FG000|Posttest 3 Months|depression|3|||
23381381|NCT01432327|65140503|FG001|Posttest 3 Months|depression|0|||
23381382|NCT01432327|65140504|FG002|Posttest 3 Months|depression|0|||
23381383|NCT01432327|65140505|FG003|Posttest 3 Months|depression|0|||
23381384|NCT01432327|65140502|FG000|Posttest 3 Months|Lost to Follow-up|1|||
23668193|NCT01650636|66168797|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
23668194|NCT01650636|66168798|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
23668195|NCT01650636|66168797|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
23668196|NCT01650636|66168798|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
23668197|NCT01500278|66168799|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
23668198|NCT01500278|66168800|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
23381385|NCT01432327|65140503|FG001|Posttest 3 Months|Lost to Follow-up|0|||
23668199|NCT01500278|66168799|FG000|Week 0 - Week 12|Protocol Violation|10|||
23381386|NCT01432327|65140504|FG002|Posttest 3 Months|Lost to Follow-up|2|||
23381387|NCT01432327|65140505|FG003|Posttest 3 Months|Lost to Follow-up|1|||
23381388|NCT01432327|65140502|FG000|Posttest 3 Months|Allergic reaction|0|||
23381389|NCT01432327|65140503|FG001|Posttest 3 Months|Allergic reaction|2|||
23381390|NCT01432327|65140504|FG002|Posttest 3 Months|Allergic reaction|0|||
23381391|NCT01432327|65140505|FG003|Posttest 3 Months|Allergic reaction|0|||
23381392|NCT01432327|65140502|FG000|Posttest 6 Months|Lost to Follow-up|0|||
23381393|NCT01432327|65140503|FG001|Posttest 6 Months|Lost to Follow-up|0|||
23381394|NCT01432327|65140504|FG002|Posttest 6 Months|Lost to Follow-up|3|||
23381395|NCT01432327|65140505|FG003|Posttest 6 Months|Lost to Follow-up|2|||
23381396|NCT01432327|65140502|FG000|Posttest 6 Months|Allergic reaction|0|||
23381397|NCT01432327|65140503|FG001|Posttest 6 Months|Allergic reaction|0|||
23668200|NCT01500278|66168800|FG001|Week 0 - Week 12|Protocol Violation|16|||
23668201|NCT01500278|66168799|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
23668202|NCT01500278|66168800|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
23668203|NCT01500278|66168799|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
23668204|NCT01500278|66168800|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
23668205|NCT01500278|66168799|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
23668206|NCT01500278|66168800|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
23668207|NCT01500278|66168799|FG000|Week 0 - Week 12|Patient decision|1|||
23381398|NCT01432327|65140504|FG002|Posttest 6 Months|Allergic reaction|1|||
23381399|NCT01432327|65140505|FG003|Posttest 6 Months|Allergic reaction|0|||
23668208|NCT01500278|66168800|FG001|Week 0 - Week 12|Patient decision|0|||
23668209|NCT01500278|66168799|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
23668210|NCT01500278|66168800|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
23668211|NCT01500278|66168799|FG000|Week 0 - Week 12|Investigator decision|1|||
23668212|NCT01500278|66168800|FG001|Week 0 - Week 12|Investigator decision|0|||
23668213|NCT01500278|66168799|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
23668214|NCT01500278|66168800|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
23668215|NCT01500278|66168799|FG000|Week 0 - Week 12|Sponsor decision|1|||
23668216|NCT01500278|66168800|FG001|Week 0 - Week 12|Sponsor decision|0|||
23668217|NCT01500278|66168799|FG000|Week 0 - Week 12|Personal reason|0|||
23668218|NCT01500278|66168800|FG001|Week 0 - Week 12|Personal reason|1|||
23668219|NCT01500278|66168799|FG000|Week 0 - Week 12|Other serious disease|0|||
23668220|NCT01500278|66168800|FG001|Week 0 - Week 12|Other serious disease|1|||
23668221|NCT01500278|66168799|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
23668222|NCT01500278|66168800|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
23668223|NCT01500278|66168799|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
23668224|NCT01500278|66168800|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
23668225|NCT01500278|66168799|FG000|Week 13 - Week 104|Protocol Violation|6|||
23381400|NCT01432327|65140502|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
23381401|NCT01432327|65140503|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
23381402|NCT01432327|65140504|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
23381403|NCT01432327|65140505|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
23381404|NCT01432327|65140502|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
23381405|NCT01432327|65140503|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
23381406|NCT01432327|65140504|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
23381407|NCT01432327|65140505|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
23381408|NCT01432327|65140502|FG000|Posttest 1 Year|Lost to Follow-up|0|||
23381409|NCT01432327|65140503|FG001|Posttest 1 Year|Lost to Follow-up|0|||
23668226|NCT01500278|66168800|FG001|Week 13 - Week 104|Protocol Violation|6|||
23668227|NCT01500278|66168799|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
23668228|NCT01500278|66168800|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
23668229|NCT01500278|66168799|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
23668230|NCT01500278|66168800|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
23668231|NCT01500278|66168799|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
23668232|NCT01500278|66168800|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
23668233|NCT01500278|66168799|FG000|Week 13 - Week 104|Non/bad compliance|7|||
23492118|NCT04203498|65545155|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
23492119|NCT04203498|65545156|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
23492120|NCT04203498|65545155|FG000|Overall Study|Withdrawal of patient consent|7|||
23492121|NCT04203498|65545156|FG001|Overall Study|Withdrawal of patient consent|2|||
23492122|NCT04203498|65545155|FG000|Overall Study|Adverse Event|4|||
23492123|NCT04203498|65545156|FG001|Overall Study|Adverse Event|1|||
23492124|NCT04203498|65545155|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
23492125|NCT04203498|65545156|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
23492126|NCT04203498|65545155|FG000|Overall Study|Did not receive IMP|2|||
23492127|NCT04203498|65545156|FG001|Overall Study|Did not receive IMP|0|||
23492128|NCT00331422|65545157|FG000|Overall Study|Did not receive entire study regimen|5|||
23492129|NCT01419626|65545158|FG000|Overall Study|Protocol Violation|3|||
23492130|NCT01419626|65545159|FG001|Overall Study|Protocol Violation|2|||
23492131|NCT01419626|65545160|FG002|Overall Study|Protocol Violation|2|||
23492132|NCT01419626|65545158|FG000|Overall Study|Withdrawal by Subject|1|||
23492133|NCT01419626|65545159|FG001|Overall Study|Withdrawal by Subject|0|||
23492134|NCT01419626|65545160|FG002|Overall Study|Withdrawal by Subject|0|||
23668234|NCT01500278|66168800|FG001|Week 13 - Week 104|Non/bad compliance|5|||
23668235|NCT01500278|66168799|FG000|Week 13 - Week 104|Recurrent infections|1|||
23668236|NCT01500278|66168800|FG001|Week 13 - Week 104|Recurrent infections|0|||
23668237|NCT01500278|66168799|FG000|Week 13 - Week 104|False positive test|1|||
23668238|NCT01500278|66168800|FG001|Week 13 - Week 104|False positive test|2|||
23668239|NCT01500278|66168799|FG000|Week 13 - Week 104|Sponsor request|4|||
23668240|NCT01500278|66168800|FG001|Week 13 - Week 104|Sponsor request|0|||
23668241|NCT01500278|66168799|FG000|Week 13 - Week 104|Withdrawn in error|1|||
23668242|NCT01500278|66168800|FG001|Week 13 - Week 104|Withdrawn in error|0|||
23668243|NCT01500278|66168799|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
23668244|NCT01500278|66168800|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
23668245|NCT01500278|66168799|FG000|Week 13 - Week 104|Protocol deviation|1|||
23668246|NCT01500278|66168800|FG001|Week 13 - Week 104|Protocol deviation|0|||
23668247|NCT01500278|66168799|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
23668248|NCT01500278|66168800|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
23668249|NCT01500278|66168799|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
23668250|NCT01500278|66168800|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
23492135|NCT01419626|65545158|FG000|Overall Study|Lost to Follow-up|0|||
23492136|NCT01419626|65545159|FG001|Overall Study|Lost to Follow-up|1|||
23492137|NCT01419626|65545160|FG002|Overall Study|Lost to Follow-up|1|||
23668251|NCT01500278|66168799|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
23668252|NCT01500278|66168800|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
23668253|NCT01500278|66168799|FG000|Week 13 - Week 104|Relocation|0|||
23668254|NCT01500278|66168800|FG001|Week 13 - Week 104|Relocation|1|||
23668255|NCT01500278|66168799|FG000|Week 13 - Week 104|Sponsor decision|0|||
23668256|NCT01500278|66168800|FG001|Week 13 - Week 104|Sponsor decision|2|||
23668257|NCT01500278|66168799|FG000|Week 13 - Week 104|Medical monitor decision|0|||
23668258|NCT01500278|66168800|FG001|Week 13 - Week 104|Medical monitor decision|2|||
23668259|NCT01500278|66168799|FG000|Week 13 - Week 104|Personal reason|0|||
23668260|NCT01500278|66168800|FG001|Week 13 - Week 104|Personal reason|1|||
23668261|NCT01500278|66168799|FG000|Week 13 - Week 104|Not completed|0|||
23668262|NCT01500278|66168800|FG001|Week 13 - Week 104|Not completed|1|||
23668263|NCT01500278|66168799|FG000|Week 13 - Week 104|Death|2|||
23668264|NCT01500278|66168800|FG001|Week 13 - Week 104|Death|4|||
23668265|NCT01500278|66168799|FG000|Week 13 - Week 104|Adverse Event|54|||
23668266|NCT01500278|66168800|FG001|Week 13 - Week 104|Adverse Event|54|||
23668267|NCT00879645|66168801|FG000|Overall Study|Adverse Event|1|||
23668268|NCT00879645|66168802|FG001|Overall Study|Adverse Event|0|||
23668269|NCT00879645|66168803|FG002|Overall Study|Adverse Event|0|||
23668270|NCT00879645|66168804|FG003|Overall Study|Adverse Event|0|||
23668271|NCT00542269|66168807|FG000|Overall Study|Adverse Event|10|||
23668272|NCT00542269|66168808|FG001|Overall Study|Adverse Event|4|||
23668273|NCT00542269|66168809|FG002|Overall Study|Adverse Event|5|||
23668274|NCT00542269|66168807|FG000|Overall Study|Protocol Violation|1|||
23668275|NCT00542269|66168808|FG001|Overall Study|Protocol Violation|1|||
23668276|NCT00542269|66168809|FG002|Overall Study|Protocol Violation|0|||
23668277|NCT00542269|66168807|FG000|Overall Study|Withdrawal by Subject|1|||
23668278|NCT00542269|66168808|FG001|Overall Study|Withdrawal by Subject|0|||
23668279|NCT00542269|66168809|FG002|Overall Study|Withdrawal by Subject|0|||
23668280|NCT00542269|66168807|FG000|Overall Study|Administrative problems|1|||
23668281|NCT00542269|66168808|FG001|Overall Study|Administrative problems|1|||
23668282|NCT00542269|66168809|FG002|Overall Study|Administrative problems|1|||
23668283|NCT01081249|66168810|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
23668284|NCT01081249|66168811|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
23668285|NCT00545064|66168813|FG000|Overall Study|Lost to Follow-up|3|||
23668286|NCT00545064|66168813|FG000|Overall Study|Withdrawal by Subject|2|||
23668287|NCT00545064|66168813|FG000|Overall Study|did not complete course of treatment|1|||
23668288|NCT00545064|66168813|FG000|Overall Study|cancel all appointments, no rebooking|1|||
23668289|NCT00545064|66168813|FG000|Overall Study|inclement weather|1|||
23668290|NCT00930761|66168818|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
23668291|NCT00930761|66168819|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
23668292|NCT00930761|66168818|FG000|Overall Study|less than 3 music therapy sessions|0|||
23668293|NCT00930761|66168819|FG001|Overall Study|less than 3 music therapy sessions|3|||
23668294|NCT00346073|66168820|FG000|Overall Study|Serious Adverse Event|2|||
23668295|NCT00346073|66168821|FG001|Overall Study|Serious Adverse Event|0|||
23668296|NCT00346073|66168820|FG000|Overall Study|Lost to Follow-up|39|||
23668297|NCT00346073|66168821|FG001|Overall Study|Lost to Follow-up|24|||
23668298|NCT01321710|66168822|FG000|Overall Study|Lost to Follow-up|4|||
23668299|NCT01321710|66168823|FG001|Overall Study|Lost to Follow-up|5|||
23668300|NCT01321710|66168824|FG002|Overall Study|Lost to Follow-up|0|||
23668301|NCT02554019|66168825|FG000|Overall Study|Withdrawal by Subject|1|||
23668302|NCT02554019|66168826|FG001|Overall Study|Withdrawal by Subject|0|||
23668303|NCT02554019|66168827|FG002|Overall Study|Withdrawal by Subject|2|||
23668304|NCT02554019|66168825|FG000|Overall Study|Adverse Event|1|||
23668305|NCT02554019|66168826|FG001|Overall Study|Adverse Event|0|||
23668306|NCT02554019|66168827|FG002|Overall Study|Adverse Event|0|||
23668307|NCT03363321|66168828|FG000|Overall Study|Withdrawal by Subject|0|||
23668308|NCT03363321|66168829|FG001|Overall Study|Withdrawal by Subject|1|||
23668309|NCT03363321|66168830|FG002|Overall Study|Withdrawal by Subject|0|||
23668310|NCT03363321|66168831|FG003|Overall Study|Withdrawal by Subject|1|||
23668311|NCT03363321|66168832|FG004|Overall Study|Withdrawal by Subject|0|||
23668312|NCT00501007|66168833|FG000|Overall Study|Inclusion criteria not met.|29|||
23668313|NCT00501007|66168834|FG001|Overall Study|Inclusion criteria not met.|25|||
23668314|NCT00535132|66168835|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
23668315|NCT00535132|66168836|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
23668316|NCT00535132|66168835|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
23668317|NCT00535132|66168836|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
23668318|NCT01251367|66168837|FG000|Overall Study|Protocol Violation|1|||
23668319|NCT01251367|66168837|FG000|Overall Study|Lack of Efficacy|2|||
23381410|NCT01432327|65140504|FG002|Posttest 1 Year|Lost to Follow-up|4|||
23668320|NCT01251367|66168837|FG000|Overall Study|Adverse Event|19|||
23668321|NCT01251367|66168837|FG000|Overall Study|Withdrawal by Subject|36|||
23381411|NCT01432327|65140505|FG003|Posttest 1 Year|Lost to Follow-up|2|||
23381412|NCT01432327|65140502|FG000|Posttest 1 Year|Allergic reaction|0|||
23381413|NCT01432327|65140503|FG001|Posttest 1 Year|Allergic reaction|0|||
23668322|NCT01251367|66168837|FG000|Overall Study|Lost to Follow-up|5|||
23668323|NCT01251367|66168837|FG000|Overall Study|Subject Required Alternative Treatment|7|||
23668324|NCT01251367|66168837|FG000|Overall Study|No Study Drug Available|1|||
23668325|NCT01251367|66168837|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
23668326|NCT01251367|66168837|FG000|Overall Study|End of Study Visit Performed in Error|1|||
23668327|NCT01756040|66168838|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
23668328|NCT01756040|66168838|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
23668329|NCT01756040|66168838|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
23668330|NCT01087905|66168839|FG000|Overall Study|Lost to Follow-up|24|||
23668331|NCT01087905|66168840|FG001|Overall Study|Lost to Follow-up|28|||
23668332|NCT01087905|66168841|FG002|Overall Study|Lost to Follow-up|18|||
23668333|NCT01087905|66168842|FG003|Overall Study|Lost to Follow-up|31|||
23668334|NCT01087905|66168843|FG004|Overall Study|Lost to Follow-up|27|||
23668335|NCT01087905|66168844|FG005|Overall Study|Lost to Follow-up|25|||
23668336|NCT01087905|66168845|FG006|Overall Study|Lost to Follow-up|20|||
23668337|NCT01087905|66168846|FG007|Overall Study|Lost to Follow-up|24|||
23668338|NCT01087905|66168839|FG000|Overall Study|Withdrawal by Subject|5|||
23668339|NCT01087905|66168840|FG001|Overall Study|Withdrawal by Subject|4|||
23668340|NCT01087905|66168841|FG002|Overall Study|Withdrawal by Subject|4|||
23668341|NCT01087905|66168842|FG003|Overall Study|Withdrawal by Subject|5|||
23381414|NCT01432327|65140504|FG002|Posttest 1 Year|Allergic reaction|1|||
23668342|NCT01087905|66168843|FG004|Overall Study|Withdrawal by Subject|4|||
23381415|NCT01432327|65140505|FG003|Posttest 1 Year|Allergic reaction|1|||
23381416|NCT00141921|65140506|FG000|Overall Study|Remain on Study|28|||
23381417|NCT00141921|65140506|FG000|Overall Study|Withdrawal by Subject|42|||
23381418|NCT00141921|65140506|FG000|Overall Study|Lost to Follow-up|19|||
23381419|NCT00141921|65140506|FG000|Overall Study|Noncompliance|17|||
23381420|NCT00141921|65140506|FG000|Overall Study|Disease Progression|7|||
23381421|NCT00141921|65140506|FG000|Overall Study|Protocol Deviation|7|||
23381422|NCT00141921|65140506|FG000|Overall Study|Adverse Event|5|||
23381423|NCT00141921|65140506|FG000|Overall Study|Administrative Decision|2|||
23381424|NCT00141921|65140506|FG000|Overall Study|Pregnancy|4|||
23381425|NCT00141921|65140506|FG000|Overall Study|Ineligibility Determined|2|||
23381426|NCT00141921|65140506|FG000|Overall Study|Other|8|||
23381427|NCT02441283|65140507|FG000|Overall Study|Withdrew consent|15|||
23381428|NCT02441283|65140507|FG000|Overall Study|Lost to Follow-up|42|||
23381429|NCT02441283|65140507|FG000|Overall Study|Death|1|||
23381430|NCT02441283|65140507|FG000|Overall Study|Other, not specified|32|||
23381431|NCT03941483|65140508|FG000|Overall Study|Miscellaneous|2|||
23381432|NCT03941483|65140509|FG001|Overall Study|Miscellaneous|3|||
23381433|NCT03941483|65140510|FG002|Overall Study|Miscellaneous|0|||
23381434|NCT03941483|65140508|FG000|Overall Study|Study Terminated by Sponsor|1|||
23381435|NCT03941483|65140509|FG001|Overall Study|Study Terminated by Sponsor|0|||
23381436|NCT03941483|65140510|FG002|Overall Study|Study Terminated by Sponsor|0|||
23381437|NCT03941483|65140508|FG000|Overall Study|Withdrawal by Subject|1|||
23381438|NCT03941483|65140509|FG001|Overall Study|Withdrawal by Subject|4|||
23381439|NCT03941483|65140510|FG002|Overall Study|Withdrawal by Subject|1|||
23381440|NCT03941483|65140508|FG000|Overall Study|Lost to Follow-up|2|||
23381441|NCT03941483|65140509|FG001|Overall Study|Lost to Follow-up|1|||
23381442|NCT03941483|65140510|FG002|Overall Study|Lost to Follow-up|8|||
23381443|NCT03941483|65140508|FG000|Overall Study|Death|3|||
23381444|NCT03941483|65140509|FG001|Overall Study|Death|2|||
23381445|NCT03941483|65140510|FG002|Overall Study|Death|6|||
23381446|NCT04339972|65140511|FG000|Overall Study|Scheduling Issues|3|||
23381447|NCT04339972|65140512|FG001|Overall Study|Scheduling Issues|3|||
23381448|NCT04339972|65140511|FG000|Overall Study|dropout|1|||
23381449|NCT04339972|65140512|FG001|Overall Study|dropout|1|||
23668343|NCT01087905|66168844|FG005|Overall Study|Withdrawal by Subject|3|||
23668344|NCT01087905|66168845|FG006|Overall Study|Withdrawal by Subject|3|||
23668345|NCT01087905|66168846|FG007|Overall Study|Withdrawal by Subject|5|||
23668346|NCT03287219|66168847|FG000|Overall Study|Protocol Violation|0|||
23668347|NCT03287219|66168848|FG001|Overall Study|Protocol Violation|2|||
23668348|NCT01140451|66168849|FG000|Overall Study|Withdrawal by Subject|26|||
23668349|NCT01140451|66168850|FG001|Overall Study|Withdrawal by Subject|33|||
23668350|NCT01140451|66168849|FG000|Overall Study|Adverse Event|2|||
23668351|NCT01140451|66168850|FG001|Overall Study|Adverse Event|6|||
23668352|NCT01140451|66168849|FG000|Overall Study|Physician Decision|5|||
23668353|NCT01140451|66168850|FG001|Overall Study|Physician Decision|3|||
23668354|NCT01140451|66168849|FG000|Overall Study|Lost to Follow-up|2|||
23668355|NCT01140451|66168850|FG001|Overall Study|Lost to Follow-up|0|||
23668356|NCT01140451|66168849|FG000|Overall Study|Participants Planning Pregnancy|3|||
23668357|NCT01140451|66168850|FG001|Overall Study|Participants Planning Pregnancy|0|||
23668358|NCT01263483|66168851|FG000|Overall Study|Adverse Event|4|||
23668359|NCT01263483|66168852|FG001|Overall Study|Adverse Event|0|||
23668360|NCT01263483|66168853|FG002|Overall Study|Adverse Event|3|||
23668361|NCT01263483|66168851|FG000|Overall Study|Withdrawal by Subject|1|||
23668362|NCT01263483|66168852|FG001|Overall Study|Withdrawal by Subject|0|||
23668363|NCT01263483|66168853|FG002|Overall Study|Withdrawal by Subject|0|||
23668364|NCT01263483|66168851|FG000|Overall Study|Lack of Efficacy|2|||
23668365|NCT01263483|66168852|FG001|Overall Study|Lack of Efficacy|0|||
23668366|NCT01263483|66168853|FG002|Overall Study|Lack of Efficacy|0|||
23668367|NCT01263483|66168851|FG000|Overall Study|Protocol Violation|0|||
23668368|NCT01263483|66168852|FG001|Overall Study|Protocol Violation|1|||
23668369|NCT01263483|66168853|FG002|Overall Study|Protocol Violation|1|||
23668370|NCT01263483|66168851|FG000|Overall Study|Participant Unavailability|0|||
23668371|NCT01263483|66168852|FG001|Overall Study|Participant Unavailability|1|||
23668372|NCT01263483|66168853|FG002|Overall Study|Participant Unavailability|1|||
23668373|NCT00631371|66168856|FG000|Overall Study|Lost to Follow-up|24|||
23668374|NCT00631371|66168857|FG001|Overall Study|Lost to Follow-up|19|||
23668375|NCT00631371|66168856|FG000|Overall Study|Other reason|5|||
23668376|NCT00631371|66168857|FG001|Overall Study|Other reason|12|||
23668377|NCT00631371|66168856|FG000|Overall Study|subject request|38|||
23668378|NCT00631371|66168857|FG001|Overall Study|subject request|45|||
23668379|NCT00631371|66168856|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
23668380|NCT00631371|66168857|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
23668381|NCT00631371|66168856|FG000|Overall Study|Death|263|||
23668382|NCT00631371|66168857|FG001|Overall Study|Death|239|||
23668383|NCT01714687|66168860|FG000|Overall Study|Withdrawal by Subject|1|||
23668384|NCT01714687|66168861|FG001|Overall Study|Withdrawal by Subject|0|||
23668385|NCT01714687|66168860|FG000|Overall Study|Lost to Follow-up|2|||
23668386|NCT01714687|66168861|FG001|Overall Study|Lost to Follow-up|4|||
23668387|NCT02846532|66168862|FG000|Overall Study|Lost to Follow-up|0|||
23668388|NCT02846532|66168863|FG001|Overall Study|Lost to Follow-up|1|||
23668389|NCT02846532|66168864|FG002|Overall Study|Lost to Follow-up|1|||
23668390|NCT02846532|66168862|FG000|Overall Study|Withdrawal by Subject|1|||
23668391|NCT02846532|66168863|FG001|Overall Study|Withdrawal by Subject|2|||
23668392|NCT02846532|66168864|FG002|Overall Study|Withdrawal by Subject|0|||
23668393|NCT00326209|66168871|FG000|Overall Study|Adverse Event|28|||
23668394|NCT00326209|66168871|FG000|Overall Study|Withdrawal by Subject|22|||
23668395|NCT00326209|66168871|FG000|Overall Study|Lack of Efficacy|31|||
23668396|NCT00326209|66168871|FG000|Overall Study|Lost to Follow-up|18|||
23668397|NCT00326209|66168871|FG000|Overall Study|Participant non-compliant|6|||
23668398|NCT00326209|66168871|FG000|Overall Study|Sponsor closed study|173|||
23668399|NCT00326209|66168871|FG000|Overall Study|Prohibited medication use|1|||
23668400|NCT00326209|66168871|FG000|Overall Study|Violation of entry criteria|1|||
23668401|NCT00326209|66168871|FG000|Overall Study|Withdrawn in error|1|||
23668402|NCT00326209|66168871|FG000|Overall Study|Pregnancy|1|||
23668403|NCT01982292|66168872|FG000|Overall Study|Adverse Event|2|||
23668404|NCT01982292|66168873|FG001|Overall Study|Adverse Event|0|||
23668405|NCT01982292|66168872|FG000|Overall Study|Death|1|||
23668406|NCT01982292|66168873|FG001|Overall Study|Death|0|||
23668407|NCT01982292|66168872|FG000|Overall Study|Lost to Follow-up|2|||
23668408|NCT01982292|66168873|FG001|Overall Study|Lost to Follow-up|0|||
23668409|NCT01982292|66168872|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
23668410|NCT01982292|66168873|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
23668411|NCT01982292|66168872|FG000|Overall Study|Protocol Deviation|1|||
23668412|NCT01982292|66168873|FG001|Overall Study|Protocol Deviation|0|||
23668413|NCT01982292|66168872|FG000|Overall Study|Patient/Guardian Decision|3|||
23668414|NCT01982292|66168873|FG001|Overall Study|Patient/Guardian Decision|1|||
23668415|NCT01982292|66168872|FG000|Overall Study|Technical Problems|2|||
23668416|NCT01982292|66168873|FG001|Overall Study|Technical Problems|0|||
23668417|NCT05054114|66168874|FG000|Overall Study|Protocol Violation|13|||
23668418|NCT05054114|66168875|FG001|Overall Study|Protocol Violation|1|||
23668419|NCT05054114|66168874|FG000|Overall Study|Pregnancy|0|||
23668420|NCT05054114|66168875|FG001|Overall Study|Pregnancy|1|||
23668421|NCT02833974|66168887|FG000|Overall Study|Lost to Follow-up|1|||
23668422|NCT02833974|66168888|FG001|Overall Study|Lost to Follow-up|0|||
23668423|NCT02833974|66168887|FG000|Overall Study|Adverse Event|0|||
23668424|NCT02833974|66168888|FG001|Overall Study|Adverse Event|3|||
23668425|NCT04688775|66168889|FG000|Placebo-controlled Period|Randomized, not treated|1|||
23668426|NCT04688775|66168890|FG001|Placebo-controlled Period|Randomized, not treated|1|||
23668427|NCT04688775|66168891|FG002|Placebo-controlled Period|Randomized, not treated|0|||
23668428|NCT04688775|66168892|FG003|Placebo-controlled Period|Randomized, not treated|0|||
23668429|NCT04688775|66168889|FG000|Placebo-controlled Period|Adverse Event|2|||
23668430|NCT04688775|66168890|FG001|Placebo-controlled Period|Adverse Event|0|||
23668431|NCT04688775|66168891|FG002|Placebo-controlled Period|Adverse Event|0|||
23492138|NCT03468985|65545167|FG000|Overall Study|Adverse Event|0|||
23492139|NCT03468985|65545168|FG001|Overall Study|Adverse Event|2|||
23492140|NCT03468985|65545169|FG002|Overall Study|Adverse Event|0|||
23492141|NCT03468985|65545170|FG003|Overall Study|Adverse Event|0|||
23492142|NCT03468985|65545167|FG000|Overall Study|Withdrawal by Subject|0|||
23381450|NCT04339972|65140511|FG000|Overall Study|Technical issues|1|||
23381451|NCT04339972|65140512|FG001|Overall Study|Technical issues|0|||
23381452|NCT04339972|65140511|FG000|Overall Study|Claustraphobia|0|||
23381453|NCT04339972|65140512|FG001|Overall Study|Claustraphobia|1|||
23381454|NCT03111732|65140513|FG000|Overall Study|Enrolled in different study|1|||
23381455|NCT03111732|65140513|FG000|Overall Study|Progressive disease|3|||
23381456|NCT03111732|65140513|FG000|Overall Study|Withdrawal by Subject|1|||
23381457|NCT01704079|65140514|FG000|Overall Study|Withdrawal by Subject|5|||
23381458|NCT01704079|65140515|FG001|Overall Study|Withdrawal by Subject|7|||
23381459|NCT01704079|65140514|FG000|Overall Study|Lost to Follow-up|2|||
23381460|NCT01704079|65140515|FG001|Overall Study|Lost to Follow-up|5|||
23381461|NCT01704079|65140514|FG000|Overall Study|Adverse Event|4|||
23381462|NCT01704079|65140515|FG001|Overall Study|Adverse Event|7|||
23381463|NCT01704079|65140514|FG000|Overall Study|Protocol Violation|1|||
23381464|NCT01704079|65140515|FG001|Overall Study|Protocol Violation|0|||
23381465|NCT01704079|65140514|FG000|Overall Study|Subject noncompliance|2|||
23381466|NCT01704079|65140515|FG001|Overall Study|Subject noncompliance|3|||
23381467|NCT01704079|65140514|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
23381468|NCT01704079|65140515|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
23381469|NCT04727749|65140516|FG000|Overall Study|Lost to Follow-up|10|||
23381470|NCT04727749|65140517|FG001|Overall Study|Lost to Follow-up|3|||
23381471|NCT02299167|65140518|FG000|Overall Study|patients were excluded from the study|11|||
23381472|NCT01312129|65140519|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
23381473|NCT01312129|65140520|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
23381474|NCT00774748|65140521|FG000|Overall Study|Lost to Follow-up|3|||
23381475|NCT02930941|65140524|FG000|Overall Study|Lost to Follow-up|1|||
23381476|NCT02930941|65140525|FG001|Overall Study|Lost to Follow-up|2|||
23381477|NCT00785629|65140526|FG000|Overall Study|Adverse Event|2|||
23381478|NCT00785629|65140527|FG001|Overall Study|Adverse Event|1|||
23381479|NCT00785629|65140528|FG002|Overall Study|Adverse Event|1|||
23381480|NCT00785629|65140529|FG003|Overall Study|Adverse Event|5|||
23381481|NCT00785629|65140526|FG000|Overall Study|Protocol Violation|1|||
23381482|NCT00785629|65140527|FG001|Overall Study|Protocol Violation|2|||
23381483|NCT00785629|65140528|FG002|Overall Study|Protocol Violation|4|||
23381484|NCT00785629|65140529|FG003|Overall Study|Protocol Violation|5|||
23668432|NCT04688775|66168892|FG003|Placebo-controlled Period|Adverse Event|0|||
23381485|NCT00785629|65140526|FG000|Overall Study|administrative decision|5|||
23381486|NCT00785629|65140527|FG001|Overall Study|administrative decision|1|||
23381487|NCT00785629|65140528|FG002|Overall Study|administrative decision|3|||
23381488|NCT00785629|65140529|FG003|Overall Study|administrative decision|4|||
23605959|NCT01640951|65947105|FG004|Overall Study|Protocol Deviation|0|||
23668433|NCT04688775|66168889|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
23381489|NCT00785629|65140526|FG000|Overall Study|Withdrawal by Subject|0|||
23381490|NCT00785629|65140527|FG001|Overall Study|Withdrawal by Subject|1|||
23381491|NCT00785629|65140528|FG002|Overall Study|Withdrawal by Subject|2|||
23381492|NCT00785629|65140529|FG003|Overall Study|Withdrawal by Subject|2|||
23381493|NCT01138046|65140530|FG000|Overall Study|Withdrawal due to death|6|||
23381494|NCT03097315|65140533|FG000|Overall Study|Withdrawal by Subject|1|||
23381495|NCT04602000|65140534|FG000|Overall Study|Withdrawal by Subject|3|||
23381496|NCT04602000|65140535|FG001|Overall Study|Withdrawal by Subject|6|||
23381497|NCT04602000|65140536|FG002|Overall Study|Withdrawal by Subject|3|||
23381498|NCT04602000|65140537|FG003|Overall Study|Withdrawal by Subject|27|||
23381499|NCT04602000|65140538|FG004|Overall Study|Withdrawal by Subject|39|||
23381500|NCT04602000|65140534|FG000|Overall Study|Physician Decision|1|||
23381501|NCT04602000|65140535|FG001|Overall Study|Physician Decision|0|||
23381502|NCT04602000|65140536|FG002|Overall Study|Physician Decision|0|||
23381503|NCT04602000|65140537|FG003|Overall Study|Physician Decision|2|||
23381504|NCT04602000|65140538|FG004|Overall Study|Physician Decision|2|||
23381505|NCT04602000|65140534|FG000|Overall Study|Death|0|||
23381506|NCT04602000|65140535|FG001|Overall Study|Death|1|||
23381507|NCT04602000|65140536|FG002|Overall Study|Death|0|||
23381508|NCT04602000|65140537|FG003|Overall Study|Death|1|||
23492143|NCT03468985|65545168|FG001|Overall Study|Withdrawal by Subject|0|||
23492144|NCT03468985|65545169|FG002|Overall Study|Withdrawal by Subject|0|||
23492145|NCT03468985|65545170|FG003|Overall Study|Withdrawal by Subject|1|||
23492146|NCT01898208|65545173|FG000|Overall Study|Positive blood culture|17|||
23492147|NCT01898208|65545174|FG001|Overall Study|Positive blood culture|23|||
23492148|NCT01898208|65545175|FG002|Overall Study|Positive blood culture|15|||
23492149|NCT01898208|65545173|FG000|Overall Study|Death/comfort care within 24 hours|10|||
23492150|NCT01898208|65545174|FG001|Overall Study|Death/comfort care within 24 hours|9|||
23492151|NCT01898208|65545175|FG002|Overall Study|Death/comfort care within 24 hours|8|||
23492152|NCT01898208|65545173|FG000|Overall Study|Negative Gram Stain|6|||
23492153|NCT01898208|65545174|FG001|Overall Study|Negative Gram Stain|9|||
23668434|NCT04688775|66168890|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
23668435|NCT04688775|66168891|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
23668436|NCT04688775|66168892|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
23668437|NCT04688775|66168889|FG000|Placebo-controlled Period|Protocol Violation|0|||
23668438|NCT04688775|66168890|FG001|Placebo-controlled Period|Protocol Violation|1|||
23668439|NCT04688775|66168891|FG002|Placebo-controlled Period|Protocol Violation|0|||
23668440|NCT04688775|66168892|FG003|Placebo-controlled Period|Protocol Violation|0|||
23668441|NCT04688775|66168889|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
23668442|NCT04688775|66168890|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
23381509|NCT04602000|65140538|FG004|Overall Study|Death|2|||
23381510|NCT04602000|65140534|FG000|Overall Study|Lost to Follow-up|0|||
23381511|NCT04602000|65140535|FG001|Overall Study|Lost to Follow-up|0|||
23492154|NCT01898208|65545175|FG002|Overall Study|Negative Gram Stain|6|||
23492155|NCT01898208|65545173|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
23668443|NCT04688775|66168891|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
23668444|NCT04688775|66168892|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
23668445|NCT04688775|66168889|FG000|Placebo-controlled Period|Other reasons|0|||
23668446|NCT04688775|66168890|FG001|Placebo-controlled Period|Other reasons|1|||
23668447|NCT04688775|66168891|FG002|Placebo-controlled Period|Other reasons|0|||
23668448|NCT04688775|66168892|FG003|Placebo-controlled Period|Other reasons|0|||
23668449|NCT04688775|66168889|FG000|Delayed Start Period|Adverse Event|0|||
23668450|NCT04688775|66168890|FG001|Delayed Start Period|Adverse Event|0|||
23668451|NCT04688775|66168891|FG002|Delayed Start Period|Adverse Event|1|||
23668452|NCT04688775|66168892|FG003|Delayed Start Period|Adverse Event|0|||
23668453|NCT04688775|66168889|FG000|Delayed Start Period|Lack of Efficacy|0|||
23668454|NCT04688775|66168890|FG001|Delayed Start Period|Lack of Efficacy|0|||
23668455|NCT04688775|66168891|FG002|Delayed Start Period|Lack of Efficacy|0|||
23668456|NCT04688775|66168892|FG003|Delayed Start Period|Lack of Efficacy|3|||
23668457|NCT04688775|66168889|FG000|Delayed Start Period|Withdrawal by Subject|0|||
23668458|NCT04688775|66168890|FG001|Delayed Start Period|Withdrawal by Subject|0|||
23668459|NCT04688775|66168891|FG002|Delayed Start Period|Withdrawal by Subject|2|||
23492156|NCT01898208|65545174|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
23492157|NCT01898208|65545175|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
23492158|NCT01898208|65545173|FG000|Overall Study|System/Technical Error|1|||
23492159|NCT01898208|65545174|FG001|Overall Study|System/Technical Error|2|||
23492160|NCT01898208|65545175|FG002|Overall Study|System/Technical Error|3|||
23492161|NCT01898208|65545173|FG000|Overall Study|Lost to Follow-up|3|||
23492162|NCT01898208|65545174|FG001|Overall Study|Lost to Follow-up|1|||
23492163|NCT01898208|65545175|FG002|Overall Study|Lost to Follow-up|1|||
23492164|NCT02104752|65545177|FG000|Overall Study|Withdrawal by Subject|1|||
23492165|NCT02104752|65545178|FG001|Overall Study|Withdrawal by Subject|0|||
23492166|NCT02104752|65545177|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
23492167|NCT02104752|65545178|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
23492168|NCT00484094|65545181|FG000|Overall Study|Discontinued|39|||
23492169|NCT00484094|65545181|FG000|Overall Study|Other|3|||
23492170|NCT01626495|65545182|FG000|Overall Study|Adverse Event|3|||
23492171|NCT01626495|65545182|FG000|Overall Study|Disease progression|27|||
23492172|NCT01626495|65545182|FG000|Overall Study|Withdrawal by Subject|1|||
23492173|NCT01626495|65545182|FG000|Overall Study|Administrative problem|1|||
23492174|NCT01626495|65545182|FG000|Overall Study|Death|2|||
23492175|NCT01626495|65545182|FG000|Overall Study|Physician Decision|1|||
23492176|NCT01626495|65545182|FG000|Overall Study|New cancer therapy|16|||
23492177|NCT01626495|65545182|FG000|Overall Study|Manufacturing failure|1|||
23492178|NCT02020577|65545187|FG000|Overall Study|Progressive disease|3|||
23492179|NCT02020577|65545188|FG001|Overall Study|Progressive disease|38|||
23492180|NCT02020577|65545187|FG000|Overall Study|Other AE or clinical progression|0|||
23492181|NCT02020577|65545188|FG001|Overall Study|Other AE or clinical progression|15|||
23492182|NCT02020577|65545187|FG000|Overall Study|Withdrawal by Subject|0|||
23492183|NCT02020577|65545188|FG001|Overall Study|Withdrawal by Subject|1|||
23492184|NCT02020577|65545187|FG000|Overall Study|Other than stated above|0|||
23492185|NCT02020577|65545188|FG001|Overall Study|Other than stated above|1|||
23492186|NCT02081183|65545189|FG000|Overall Study|Lost to Follow-up|0|||
23492187|NCT02081183|65545190|FG001|Overall Study|Lost to Follow-up|1|||
23492188|NCT02081183|65545189|FG000|Overall Study|Protocol Violation|1|||
23492189|NCT02081183|65545190|FG001|Overall Study|Protocol Violation|0|||
23492190|NCT02081183|65545189|FG000|Overall Study|Other|3|||
23492191|NCT02081183|65545190|FG001|Overall Study|Other|3|||
23492192|NCT00215683|65545191|FG000|Overall Study|Adverse Event|15|||
23492193|NCT00215683|65545192|FG001|Overall Study|Adverse Event|16|||
23492194|NCT00215683|65545193|FG002|Overall Study|Adverse Event|15|||
23492195|NCT00215683|65545191|FG000|Overall Study|Lack of Efficacy|5|||
23492196|NCT00215683|65545192|FG001|Overall Study|Lack of Efficacy|1|||
23492197|NCT00215683|65545193|FG002|Overall Study|Lack of Efficacy|2|||
23492198|NCT00215683|65545191|FG000|Overall Study|Lost to Follow-up|0|||
23492199|NCT00215683|65545192|FG001|Overall Study|Lost to Follow-up|2|||
23492200|NCT00215683|65545193|FG002|Overall Study|Lost to Follow-up|1|||
23492201|NCT00215683|65545191|FG000|Overall Study|Withdrawal by Subject|9|||
23668460|NCT04688775|66168892|FG003|Delayed Start Period|Withdrawal by Subject|4|||
23668461|NCT04688775|66168889|FG000|Delayed Start Period|Lost to Follow-up|0|||
23668462|NCT04688775|66168890|FG001|Delayed Start Period|Lost to Follow-up|0|||
23668463|NCT04688775|66168891|FG002|Delayed Start Period|Lost to Follow-up|2|||
23492202|NCT00215683|65545192|FG001|Overall Study|Withdrawal by Subject|4|||
23492203|NCT00215683|65545193|FG002|Overall Study|Withdrawal by Subject|13|||
23492204|NCT00215683|65545191|FG000|Overall Study|Physician Decision|0|||
23492205|NCT00215683|65545192|FG001|Overall Study|Physician Decision|0|||
23492206|NCT00215683|65545193|FG002|Overall Study|Physician Decision|1|||
23492207|NCT00215683|65545191|FG000|Overall Study|Difficult to attend visits|0|||
23492208|NCT00215683|65545192|FG001|Overall Study|Difficult to attend visits|1|||
23492209|NCT00215683|65545193|FG002|Overall Study|Difficult to attend visits|0|||
23492210|NCT00215683|65545191|FG000|Overall Study|No study drug available|0|||
23492211|NCT00215683|65545192|FG001|Overall Study|No study drug available|1|||
23492212|NCT00215683|65545193|FG002|Overall Study|No study drug available|0|||
23492213|NCT00215683|65545191|FG000|Overall Study|Intermittent therapy required|0|||
23492214|NCT00215683|65545192|FG001|Overall Study|Intermittent therapy required|1|||
23492215|NCT00215683|65545193|FG002|Overall Study|Intermittent therapy required|0|||
23492216|NCT01092507|65545194|FG000|Overall Study|Withdrawal by Subject|2|||
23492217|NCT01092507|65545195|FG001|Overall Study|Withdrawal by Subject|0|||
23492218|NCT03595774|65545198|FG000|Overall Study|Adverse Event|1|||
23492219|NCT03595774|65545199|FG001|Overall Study|Adverse Event|0|||
23492220|NCT03595774|65545200|FG002|Overall Study|Adverse Event|1|||
23492221|NCT03595774|65545201|FG003|Overall Study|Adverse Event|0|||
23492222|NCT03595774|65545198|FG000|Overall Study|screen failure|0|||
23492223|NCT03595774|65545199|FG001|Overall Study|screen failure|1|||
23492224|NCT03595774|65545200|FG002|Overall Study|screen failure|0|||
23492225|NCT03595774|65545201|FG003|Overall Study|screen failure|1|||
23492226|NCT00113087|65545202|FG000|Overall Study|Death or Transplant|14|||
23492227|NCT00113087|65545203|FG001|Overall Study|Death or Transplant|16|||
23492228|NCT00113087|65545202|FG000|Overall Study|Family or MD withdrew subject|10|||
23492229|NCT00113087|65545203|FG001|Overall Study|Family or MD withdrew subject|5|||
23492230|NCT01680965|65545208|FG000|Overall Study|Death|0|||
23492231|NCT01680965|65545209|FG001|Overall Study|Death|0|||
23492232|NCT01680965|65545210|FG002|Overall Study|Death|0|||
23492233|NCT01680965|65545211|FG003|Overall Study|Death|6|||
23492234|NCT04587271|65547991|FG000|Overall Study|Lost to Follow-up|2|||
23492235|NCT04587271|65547992|FG001|Overall Study|Lost to Follow-up|2|||
23492236|NCT04587271|65547993|FG002|Overall Study|Lost to Follow-up|0|||
23492237|NCT04587271|65547994|FG003|Overall Study|Lost to Follow-up|2|||
23492238|NCT04587271|65547995|FG004|Overall Study|Lost to Follow-up|2|||
23492239|NCT04587271|65547996|FG005|Overall Study|Lost to Follow-up|0|||
23492240|NCT04587271|65547991|FG000|Overall Study|Caregiver brought child to visits|0|||
23492241|NCT04587271|65547992|FG001|Overall Study|Caregiver brought child to visits|0|||
23492242|NCT04587271|65547993|FG002|Overall Study|Caregiver brought child to visits|0|||
23492243|NCT04587271|65547994|FG003|Overall Study|Caregiver brought child to visits|1|||
23492244|NCT04587271|65547995|FG004|Overall Study|Caregiver brought child to visits|0|||
23492245|NCT04587271|65547996|FG005|Overall Study|Caregiver brought child to visits|0|||
23492246|NCT01032174|65547997|FG000|Overall Study|Adverse Event|0|||
23492247|NCT01032174|65547998|FG001|Overall Study|Adverse Event|1|||
23492248|NCT03386474|65548003|FG000|Overall Study|Death|1|||
23492249|NCT03386474|65548004|FG001|Overall Study|Death|0|||
23492250|NCT03386474|65548003|FG000|Overall Study|Adverse Event|0|||
23492251|NCT03386474|65548004|FG001|Overall Study|Adverse Event|1|||
23492252|NCT00910273|65548005|FG000|Overall Study|Lack of Efficacy|6|||
23492253|NCT00910273|65548006|FG001|Overall Study|Lack of Efficacy|9|||
23492254|NCT00910273|65548005|FG000|Overall Study|Adverse Event|1|||
23492255|NCT00910273|65548006|FG001|Overall Study|Adverse Event|1|||
23492256|NCT00910273|65548005|FG000|Overall Study|Withdrawal by Subject|1|||
23492257|NCT00910273|65548006|FG001|Overall Study|Withdrawal by Subject|0|||
23492258|NCT00910273|65548005|FG000|Overall Study|Discontinuation of study by sponsor|8|||
23492259|NCT00910273|65548006|FG001|Overall Study|Discontinuation of study by sponsor|2|||
23492260|NCT00910273|65548005|FG000|Overall Study|Protocol Violation|1|||
23492261|NCT00910273|65548006|FG001|Overall Study|Protocol Violation|0|||
23492262|NCT00910273|65548005|FG000|Overall Study|Lost to Follow-up|1|||
23492263|NCT00910273|65548006|FG001|Overall Study|Lost to Follow-up|1|||
23492264|NCT00936611|65548009|FG000|Overall Study|Progressive Disease|3|||
23492265|NCT00936611|65548009|FG000|Overall Study|New Systemic Therapy|22|||
23492266|NCT00936611|65548009|FG000|Overall Study|Lost to Follow-up|1|||
23492267|NCT00936611|65548009|FG000|Overall Study|Withdrawal by Subject|2|||
23492268|NCT00936611|65548009|FG000|Overall Study|Still on Follow-up|1|||
23668464|NCT04688775|66168892|FG003|Delayed Start Period|Lost to Follow-up|1|||
23492269|NCT00936611|65548009|FG000|Overall Study|Still on Active Therapy|7|||
23492270|NCT00936611|65548009|FG000|Overall Study|Ineligible for Study Drug|3|||
23492271|NCT02919696|65548010|FG000|Overall Study|Adverse Event|1|||
23492272|NCT02919696|65548011|FG001|Overall Study|Adverse Event|2|||
23492273|NCT02919696|65548010|FG000|Overall Study|Withdrawal by Subject|2|||
23492274|NCT02919696|65548011|FG001|Overall Study|Withdrawal by Subject|1|||
23492275|NCT02919696|65548010|FG000|Overall Study|Sponsor Decision|1|||
23492276|NCT02919696|65548011|FG001|Overall Study|Sponsor Decision|1|||
23492277|NCT02919696|65548010|FG000|Overall Study|Never Treated|0|||
23492278|NCT02919696|65548011|FG001|Overall Study|Never Treated|1|||
23668465|NCT04688775|66168889|FG000|Delayed Start Period|other reasons|0|||
23492279|NCT02247531|65548012|FG000|Overall Study|Adverse Event|3|||
23492280|NCT02247531|65548013|FG001|Overall Study|Adverse Event|4|||
23492281|NCT02247531|65548014|FG002|Overall Study|Adverse Event|9|||
23492282|NCT02247531|65548012|FG000|Overall Study|Death|8|||
23492283|NCT02247531|65548013|FG001|Overall Study|Death|9|||
23492284|NCT02247531|65548014|FG002|Overall Study|Death|5|||
23492285|NCT02247531|65548012|FG000|Overall Study|Lost to Follow-up|1|||
23492286|NCT02247531|65548013|FG001|Overall Study|Lost to Follow-up|8|||
23492287|NCT02247531|65548014|FG002|Overall Study|Lost to Follow-up|3|||
23492288|NCT02247531|65548012|FG000|Overall Study|Non-compliance|2|||
23492289|NCT02247531|65548013|FG001|Overall Study|Non-compliance|2|||
23492290|NCT02247531|65548014|FG002|Overall Study|Non-compliance|0|||
23492291|NCT02247531|65548012|FG000|Overall Study|Withdrawal by Subject|26|||
23492292|NCT02247531|65548013|FG001|Overall Study|Withdrawal by Subject|31|||
23492293|NCT02247531|65548014|FG002|Overall Study|Withdrawal by Subject|25|||
23492294|NCT02247531|65548012|FG000|Overall Study|Study Terminated by Sponsor|64|||
23492295|NCT02247531|65548013|FG001|Overall Study|Study Terminated by Sponsor|66|||
23492296|NCT02247531|65548014|FG002|Overall Study|Study Terminated by Sponsor|62|||
23492297|NCT02247531|65548012|FG000|Overall Study|Physician Decision|0|||
23492298|NCT02247531|65548013|FG001|Overall Study|Physician Decision|2|||
23492299|NCT02247531|65548014|FG002|Overall Study|Physician Decision|2|||
23492300|NCT02247531|65548012|FG000|Overall Study|Unspecified Reason|2|||
23492301|NCT02247531|65548013|FG001|Overall Study|Unspecified Reason|3|||
23492302|NCT02247531|65548014|FG002|Overall Study|Unspecified Reason|4|||
23492303|NCT01934972|65548015|FG000|Overall Study|Withdrawal by Subject|9|||
23492304|NCT01934972|65548016|FG001|Overall Study|Withdrawal by Subject|6|||
23492305|NCT02436304|65548017|FG000|Overall Study|Lost to Follow-up|0|||
23492306|NCT02436304|65548018|FG001|Overall Study|Lost to Follow-up|1|||
23492307|NCT02436304|65548019|FG002|Overall Study|Lost to Follow-up|0|||
23492308|NCT02436304|65548017|FG000|Overall Study|Withdrawal by Subject|0|||
23492309|NCT02436304|65548018|FG001|Overall Study|Withdrawal by Subject|1|||
23492310|NCT02436304|65548019|FG002|Overall Study|Withdrawal by Subject|0|||
23492311|NCT02436304|65548017|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
23492312|NCT02436304|65548018|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
23492313|NCT02436304|65548019|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
23492314|NCT02846324|65548020|FG000|Overall Study|Other|1|||
23492315|NCT02846324|65548021|FG001|Overall Study|Other|0|||
23492316|NCT02846324|65548022|FG002|Overall Study|Other|0|||
23492317|NCT02846324|65548023|FG003|Overall Study|Other|0|||
23492318|NCT02846324|65548020|FG000|Overall Study|Withdrawal by Subject|1|||
23492319|NCT02846324|65548021|FG001|Overall Study|Withdrawal by Subject|0|||
23492320|NCT02846324|65548022|FG002|Overall Study|Withdrawal by Subject|4|||
23492321|NCT02846324|65548023|FG003|Overall Study|Withdrawal by Subject|0|||
23492322|NCT02544074|65548030|FG000|Overall Study|Withdrawal by Subject|0|||
23492323|NCT02544074|65548031|FG001|Overall Study|Withdrawal by Subject|1|||
23492324|NCT02544074|65548032|FG002|Overall Study|Withdrawal by Subject|0|||
23492325|NCT02544074|65548033|FG003|Overall Study|Withdrawal by Subject|0|||
23492326|NCT02544074|65548034|FG004|Overall Study|Withdrawal by Subject|0|||
23492327|NCT02544074|65548035|FG005|Overall Study|Withdrawal by Subject|0|||
23492328|NCT02544074|65548036|FG006|Overall Study|Withdrawal by Subject|0|||
23492329|NCT02544074|65548037|FG007|Overall Study|Withdrawal by Subject|0|||
23492330|NCT02544074|65548038|FG008|Overall Study|Withdrawal by Subject|0|||
23492331|NCT02544074|65548039|FG009|Overall Study|Withdrawal by Subject|0|||
23492332|NCT02544074|65548040|FG010|Overall Study|Withdrawal by Subject|0|||
23492333|NCT02544074|65548041|FG011|Overall Study|Withdrawal by Subject|0|||
23492334|NCT02544074|65548042|FG012|Overall Study|Withdrawal by Subject|0|||
23668466|NCT04688775|66168890|FG001|Delayed Start Period|other reasons|0|||
23668467|NCT04688775|66168891|FG002|Delayed Start Period|other reasons|1|||
23668468|NCT04688775|66168892|FG003|Delayed Start Period|other reasons|0|||
23668469|NCT00094055|66168899|FG000|Overall Study|Adverse Event|11|||
23668470|NCT00094055|66168899|FG000|Overall Study|Death|4|||
23668471|NCT00094055|66168899|FG000|Overall Study|Lack of Efficacy|17|||
23668472|NCT00094055|66168899|FG000|Overall Study|Lost to Follow-up|2|||
23668473|NCT00094055|66168899|FG000|Overall Study|progressive disease|2|||
23381512|NCT04602000|65140536|FG002|Overall Study|Lost to Follow-up|0|||
23492335|NCT02544074|65548043|FG013|Overall Study|Withdrawal by Subject|0|||
23492336|NCT02544074|65548044|FG014|Overall Study|Withdrawal by Subject|0|||
23668474|NCT00094055|66168899|FG000|Overall Study|clinical progression|1|||
23668475|NCT00094055|66168899|FG000|Overall Study|roll-over to another study|14|||
23668476|NCT00094055|66168899|FG000|Overall Study|Withdrawal by Subject|9|||
23668477|NCT01773109|66168900|FG000|Overall Study|Symptomatic Progression|2|||
23668478|NCT01773109|66168900|FG000|Overall Study|Death|1|||
23668479|NCT02871778|66168902|FG000|Part A: Treatment Period 1|Adverse Event|1|||
23668480|NCT02871778|66168903|FG001|Part A: Treatment Period 1|Adverse Event|1|||
23668481|NCT02871778|66168904|FG002|Part A: Treatment Period 1|Adverse Event|1|||
23668482|NCT02871778|66168905|FG003|Part A: Treatment Period 1|Adverse Event|0|||
23668483|NCT02871778|66168906|FG004|Part A: Treatment Period 1|Adverse Event|0|||
23668484|NCT02871778|66168907|FG005|Part A: Treatment Period 1|Adverse Event|0|||
23668485|NCT02871778|66168908|FG006|Part A: Treatment Period 1|Adverse Event|0|||
23668486|NCT02871778|66168909|FG007|Part A: Treatment Period 1|Adverse Event|0|||
23668487|NCT02871778|66168902|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23668488|NCT02871778|66168903|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23668489|NCT02871778|66168904|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23668490|NCT02871778|66168905|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23668491|NCT02871778|66168906|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23668492|NCT02871778|66168907|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23492337|NCT02544074|65548045|FG015|Overall Study|Withdrawal by Subject|0|||
23668493|NCT02871778|66168908|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23381513|NCT04602000|65140537|FG003|Overall Study|Lost to Follow-up|3|||
23381514|NCT04602000|65140538|FG004|Overall Study|Lost to Follow-up|4|||
23381515|NCT04602000|65140534|FG000|Overall Study|Other|4|||
23381516|NCT04602000|65140535|FG001|Overall Study|Other|1|||
23381517|NCT04602000|65140536|FG002|Overall Study|Other|2|||
23381518|NCT04602000|65140537|FG003|Overall Study|Other|5|||
23381519|NCT04602000|65140538|FG004|Overall Study|Other|4|||
23381520|NCT04602000|65140534|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381521|NCT04602000|65140535|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381522|NCT04602000|65140536|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
23381523|NCT04602000|65140537|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381524|NCT04602000|65140538|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381525|NCT01970371|65140542|FG000|Overall Study|Death|8|||
23381526|NCT01970371|65140543|FG001|Overall Study|Death|13|||
23381527|NCT01970371|65140544|FG002|Overall Study|Death|12|||
23381528|NCT01970371|65140542|FG000|Overall Study|Lost to Follow-up|0|||
23381529|NCT01970371|65140543|FG001|Overall Study|Lost to Follow-up|0|||
23381530|NCT01970371|65140544|FG002|Overall Study|Lost to Follow-up|1|||
23381531|NCT01105130|65140545|FG000|Overall Study|Withdrawal by Subject|4|||
23381532|NCT01105130|65140546|FG001|Overall Study|Withdrawal by Subject|6|||
23381533|NCT01105130|65140547|FG002|Overall Study|Withdrawal by Subject|2|||
23381534|NCT01105130|65140545|FG000|Overall Study|Never Started|2|||
23381535|NCT01105130|65140546|FG001|Overall Study|Never Started|2|||
23381536|NCT01105130|65140547|FG002|Overall Study|Never Started|4|||
23381537|NCT01105130|65140545|FG000|Overall Study|Toxicity|1|||
23381538|NCT01105130|65140546|FG001|Overall Study|Toxicity|3|||
23381539|NCT01105130|65140547|FG002|Overall Study|Toxicity|2|||
23381540|NCT01105130|65140545|FG000|Overall Study|Multiple Reasons|3|||
23381541|NCT01105130|65140546|FG001|Overall Study|Multiple Reasons|0|||
23381542|NCT01105130|65140547|FG002|Overall Study|Multiple Reasons|2|||
23381543|NCT00853047|65140548|FG000|Core Phase|Participant Request|0|||
23381544|NCT00853047|65140549|FG001|Core Phase|Participant Request|0|||
23381545|NCT00853047|65140550|FG002|Core Phase|Participant Request|0|||
23381546|NCT00853047|65140551|FG003|Core Phase|Participant Request|1|||
23381547|NCT00853047|65140552|FG004|Core Phase|Participant Request|0|||
23381548|NCT00853047|65140553|FG005|Core Phase|Participant Request|0|||
23381549|NCT00853047|65140548|FG000|Open-Label Extension Phase|Participant Request|0|||
23381550|NCT00853047|65140549|FG001|Open-Label Extension Phase|Participant Request|0|||
23668494|NCT02871778|66168909|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23668495|NCT02871778|66168902|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668496|NCT02871778|66168903|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668497|NCT02871778|66168904|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
23668498|NCT02871778|66168905|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668499|NCT02871778|66168906|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668500|NCT02871778|66168907|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668501|NCT02871778|66168908|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668502|NCT02871778|66168909|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23668503|NCT02871778|66168902|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668504|NCT02871778|66168903|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23381551|NCT00853047|65140550|FG002|Open-Label Extension Phase|Participant Request|0|||
23381552|NCT00853047|65140551|FG003|Open-Label Extension Phase|Participant Request|0|||
23381553|NCT00853047|65140552|FG004|Open-Label Extension Phase|Participant Request|0|||
23381554|NCT00853047|65140553|FG005|Open-Label Extension Phase|Participant Request|7|||
23381555|NCT00853047|65140548|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23381556|NCT00853047|65140549|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23381557|NCT00853047|65140550|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23381558|NCT00853047|65140551|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
23492338|NCT02544074|65548046|FG016|Overall Study|Withdrawal by Subject|0|||
23492339|NCT02544074|65548047|FG017|Overall Study|Withdrawal by Subject|0|||
23492340|NCT02544074|65548048|FG018|Overall Study|Withdrawal by Subject|0|||
23492341|NCT02544074|65548049|FG019|Overall Study|Withdrawal by Subject|0|||
23381559|NCT00853047|65140552|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
23381560|NCT00853047|65140553|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
23381561|NCT00853047|65140548|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381562|NCT00853047|65140549|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381563|NCT00853047|65140550|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381564|NCT00853047|65140551|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381565|NCT00853047|65140552|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381566|NCT00853047|65140553|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
23381567|NCT00853047|65140548|FG000|Open-Label Extension Phase|Investigator Decision|0|||
23381568|NCT00853047|65140549|FG001|Open-Label Extension Phase|Investigator Decision|0|||
23381569|NCT00853047|65140550|FG002|Open-Label Extension Phase|Investigator Decision|0|||
23381570|NCT00853047|65140551|FG003|Open-Label Extension Phase|Investigator Decision|0|||
23381571|NCT00853047|65140552|FG004|Open-Label Extension Phase|Investigator Decision|0|||
23381572|NCT00853047|65140553|FG005|Open-Label Extension Phase|Investigator Decision|1|||
23381573|NCT00853047|65140548|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
23381574|NCT00853047|65140549|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
23381575|NCT00853047|65140550|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
23381576|NCT00853047|65140551|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
23381577|NCT00853047|65140552|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
23381578|NCT00853047|65140553|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
23381579|NCT00363467|65140554|FG000|Overall Study|Physician Decision|1|||
23381580|NCT04380753|65140556|FG000|Overall Study|Participants continuing study|4|||
23381581|NCT04380753|65140556|FG000|Overall Study|Death|2|||
23381582|NCT03601052|65140559|FG000|Overall Study|Lost to Follow-up|2|||
23381583|NCT02316613|65140560|FG000|Overall Study|Death|63|||
23381584|NCT02316613|65140560|FG000|Overall Study|Lost to Follow-up|9|||
23381585|NCT02316613|65140560|FG000|Overall Study|Lymphoma transformation|2|||
23381586|NCT02316613|65140560|FG000|Overall Study|Participant moved/changed medical team|11|||
23381587|NCT02316613|65140560|FG000|Overall Study|No data and duplicate cases|5|||
23381588|NCT02316613|65140560|FG000|Overall Study|Did not met selection criteria|14|||
23381589|NCT00870727|65140561|FG000|Overall Study|Lost to Follow-up|0|||
23381590|NCT00870727|65140562|FG001|Overall Study|Lost to Follow-up|1|||
23381591|NCT00870727|65140561|FG000|Overall Study|Lack of Efficacy|1|||
23381592|NCT00870727|65140562|FG001|Overall Study|Lack of Efficacy|3|||
23381593|NCT00870727|65140561|FG000|Overall Study|Adverse Event|0|||
23381594|NCT00870727|65140562|FG001|Overall Study|Adverse Event|1|||
23381595|NCT02949934|65140565|FG000|Natural Drinking Period|Adverse Event|1|||
23381596|NCT02949934|65140566|FG001|Natural Drinking Period|Adverse Event|0|||
23381597|NCT02949934|65140567|FG002|Natural Drinking Period|Adverse Event|0|||
23381598|NCT02949934|65140568|FG003|Natural Drinking Period|Adverse Event|1|||
23381599|NCT02949934|65140569|FG004|Natural Drinking Period|Adverse Event|0|||
23381600|NCT02949934|65140570|FG005|Natural Drinking Period|Adverse Event|0|||
23381601|NCT02949934|65140565|FG000|Natural Drinking Period|Lost to Follow-up|0|||
23668505|NCT02871778|66168904|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
23668506|NCT02871778|66168905|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668507|NCT02871778|66168906|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668508|NCT02871778|66168907|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668509|NCT02871778|66168908|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668510|NCT02871778|66168909|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23668511|NCT02871778|66168902|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
23668512|NCT02871778|66168903|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
23668513|NCT02871778|66168904|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
23381602|NCT02949934|65140566|FG001|Natural Drinking Period|Lost to Follow-up|0|||
23381603|NCT02949934|65140567|FG002|Natural Drinking Period|Lost to Follow-up|0|||
23381604|NCT02949934|65140568|FG003|Natural Drinking Period|Lost to Follow-up|0|||
23381605|NCT02949934|65140569|FG004|Natural Drinking Period|Lost to Follow-up|1|||
23381606|NCT02949934|65140570|FG005|Natural Drinking Period|Lost to Follow-up|0|||
23381607|NCT02949934|65140565|FG000|Neuroimaging|Protocol Violation|2|||
23381608|NCT02949934|65140566|FG001|Neuroimaging|Protocol Violation|0|||
23381609|NCT02949934|65140567|FG002|Neuroimaging|Protocol Violation|0|||
23381610|NCT02949934|65140568|FG003|Neuroimaging|Protocol Violation|0|||
23381611|NCT02949934|65140569|FG004|Neuroimaging|Protocol Violation|1|||
23381612|NCT02949934|65140570|FG005|Neuroimaging|Protocol Violation|0|||
23381613|NCT02949934|65140565|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
23381614|NCT02949934|65140566|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
23381615|NCT02949934|65140567|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
23381616|NCT02949934|65140568|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
23381617|NCT02949934|65140569|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
23381618|NCT02949934|65140570|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
23381619|NCT02949934|65140565|FG000|Neuroimaging|Not scanned|0|||
23381620|NCT02949934|65140566|FG001|Neuroimaging|Not scanned|0|||
23381621|NCT02949934|65140567|FG002|Neuroimaging|Not scanned|1|||
23381622|NCT02949934|65140568|FG003|Neuroimaging|Not scanned|0|||
23381623|NCT02949934|65140569|FG004|Neuroimaging|Not scanned|0|||
23381624|NCT02949934|65140570|FG005|Neuroimaging|Not scanned|2|||
23381625|NCT02949934|65140565|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
23381626|NCT02949934|65140566|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381627|NCT02949934|65140567|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381628|NCT02949934|65140568|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
23381629|NCT02949934|65140569|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381630|NCT02949934|65140570|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
23381631|NCT02949934|65140565|FG000|Bar Laboratory|Adverse Event|1|||
23381632|NCT02949934|65140566|FG001|Bar Laboratory|Adverse Event|0|||
23381633|NCT02949934|65140567|FG002|Bar Laboratory|Adverse Event|2|||
23381634|NCT02949934|65140568|FG003|Bar Laboratory|Adverse Event|0|||
23381635|NCT02949934|65140569|FG004|Bar Laboratory|Adverse Event|1|||
23492342|NCT02544074|65548050|FG020|Overall Study|Withdrawal by Subject|0|||
23381636|NCT02949934|65140570|FG005|Bar Laboratory|Adverse Event|0|||
23381637|NCT02949934|65140565|FG000|Bar Laboratory|Protocol Violation|0|||
23381638|NCT02949934|65140566|FG001|Bar Laboratory|Protocol Violation|0|||
23381639|NCT02949934|65140567|FG002|Bar Laboratory|Protocol Violation|0|||
23381640|NCT02949934|65140568|FG003|Bar Laboratory|Protocol Violation|1|||
23381641|NCT02949934|65140569|FG004|Bar Laboratory|Protocol Violation|0|||
23381642|NCT02949934|65140570|FG005|Bar Laboratory|Protocol Violation|0|||
23381643|NCT00992836|65140572|FG000|Overall Study|Lost to Follow-up|1|||
23381644|NCT00992836|65140572|FG000|Overall Study|Withdrawal by Subject|2|||
23381645|NCT00992836|65140572|FG000|Overall Study|Protocol Violation|2|||
23381646|NCT00805532|65140577|FG000|Overall Study|invalid data|0|||
23381647|NCT00805532|65140578|FG001|Overall Study|invalid data|1|||
23381648|NCT02405962|65140580|FG000|Overall Study|Lost to Follow-up|1|||
23381649|NCT02405962|65140581|FG001|Overall Study|Lost to Follow-up|4|||
23381650|NCT02405962|65140580|FG000|Overall Study|A participant has moved to another place|0|||
23381651|NCT02405962|65140581|FG001|Overall Study|A participant has moved to another place|1|||
23381652|NCT02530242|65140582|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
23381653|NCT02530242|65140583|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
23381654|NCT04575324|65140584|FG000|Overall Study|Lost to Follow-up|29|||
23381655|NCT04575324|65140585|FG001|Overall Study|Lost to Follow-up|25|||
23381656|NCT04575324|65140584|FG000|Overall Study|Death|1|||
23381657|NCT04575324|65140585|FG001|Overall Study|Death|2|||
23381658|NCT04575324|65140584|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
23381659|NCT04575324|65140585|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
23381660|NCT05607043|65140588|FG000|Overall Study|Lost to Follow-up|2|||
23492343|NCT02544074|65548030|FG000|Overall Study|Tablet error|0|||
23492344|NCT02544074|65548031|FG001|Overall Study|Tablet error|0|||
23492345|NCT02544074|65548032|FG002|Overall Study|Tablet error|0|||
23492346|NCT02544074|65548033|FG003|Overall Study|Tablet error|0|||
23492347|NCT02544074|65548034|FG004|Overall Study|Tablet error|0|||
23492348|NCT02544074|65548035|FG005|Overall Study|Tablet error|1|||
23492349|NCT02544074|65548036|FG006|Overall Study|Tablet error|0|||
23492350|NCT02544074|65548037|FG007|Overall Study|Tablet error|0|||
23492351|NCT02544074|65548038|FG008|Overall Study|Tablet error|0|||
23492352|NCT02544074|65548039|FG009|Overall Study|Tablet error|1|||
23492353|NCT02544074|65548040|FG010|Overall Study|Tablet error|0|||
23492354|NCT02544074|65548041|FG011|Overall Study|Tablet error|0|||
23668514|NCT02871778|66168905|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
23668515|NCT02871778|66168906|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
23381661|NCT02393755|65140589|FG000|Overall Study|Withdrawal by Subject|0|||
23492355|NCT02544074|65548042|FG012|Overall Study|Tablet error|0|||
23492356|NCT02544074|65548043|FG013|Overall Study|Tablet error|0|||
23668516|NCT02871778|66168907|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
23668517|NCT02871778|66168908|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
23381662|NCT02393755|65140590|FG001|Overall Study|Withdrawal by Subject|3|||
23381663|NCT02393755|65140589|FG000|Overall Study|Adverse Event|0|||
23492357|NCT02544074|65548044|FG014|Overall Study|Tablet error|0|||
23381664|NCT02393755|65140590|FG001|Overall Study|Adverse Event|2|||
23381665|NCT02393755|65140589|FG000|Overall Study|Physician Decision|0|||
23381666|NCT02393755|65140590|FG001|Overall Study|Physician Decision|2|||
23381667|NCT01107457|65140593|FG000|Part A|Adverse Event|1|||
23381668|NCT01107457|65140594|FG001|Part A|Adverse Event|2|||
23381669|NCT01107457|65140595|FG002|Part A|Adverse Event|1|||
23381670|NCT01107457|65140596|FG003|Part A|Adverse Event|0|||
23381671|NCT01107457|65140597|FG004|Part A|Adverse Event|0|||
23381672|NCT01107457|65140598|FG005|Part A|Adverse Event|0|||
23381673|NCT01107457|65140593|FG000|Part A|Withdrawal by Subject|3|||
23381674|NCT01107457|65140594|FG001|Part A|Withdrawal by Subject|3|||
23381675|NCT01107457|65140595|FG002|Part A|Withdrawal by Subject|0|||
23381676|NCT01107457|65140596|FG003|Part A|Withdrawal by Subject|3|||
23381677|NCT01107457|65140597|FG004|Part A|Withdrawal by Subject|1|||
23381678|NCT01107457|65140598|FG005|Part A|Withdrawal by Subject|0|||
23381679|NCT01107457|65140593|FG000|Part A|Lost to Follow-up|0|||
23381680|NCT01107457|65140594|FG001|Part A|Lost to Follow-up|1|||
23381681|NCT01107457|65140595|FG002|Part A|Lost to Follow-up|0|||
23381682|NCT01107457|65140596|FG003|Part A|Lost to Follow-up|0|||
23381683|NCT01107457|65140597|FG004|Part A|Lost to Follow-up|0|||
23381684|NCT01107457|65140598|FG005|Part A|Lost to Follow-up|0|||
23381685|NCT01107457|65140593|FG000|Part A|Lack of Efficacy|1|||
23381686|NCT01107457|65140594|FG001|Part A|Lack of Efficacy|0|||
23381687|NCT01107457|65140595|FG002|Part A|Lack of Efficacy|0|||
23381688|NCT01107457|65140596|FG003|Part A|Lack of Efficacy|0|||
23381689|NCT01107457|65140597|FG004|Part A|Lack of Efficacy|0|||
23381690|NCT01107457|65140598|FG005|Part A|Lack of Efficacy|0|||
23381691|NCT01107457|65140593|FG000|Part A|Protocol Violation|0|||
23381692|NCT01107457|65140594|FG001|Part A|Protocol Violation|1|||
23381693|NCT01107457|65140595|FG002|Part A|Protocol Violation|0|||
23381694|NCT01107457|65140596|FG003|Part A|Protocol Violation|0|||
23381695|NCT01107457|65140597|FG004|Part A|Protocol Violation|0|||
23381696|NCT01107457|65140598|FG005|Part A|Protocol Violation|0|||
23381697|NCT01107457|65140593|FG000|Part B and C|Adverse Event|0|||
23381698|NCT01107457|65140594|FG001|Part B and C|Adverse Event|0|||
23381699|NCT01107457|65140595|FG002|Part B and C|Adverse Event|0|||
23381700|NCT01107457|65140596|FG003|Part B and C|Adverse Event|0|||
23381701|NCT01107457|65140597|FG004|Part B and C|Adverse Event|0|||
23492358|NCT02544074|65548045|FG015|Overall Study|Tablet error|0|||
23492359|NCT02544074|65548046|FG016|Overall Study|Tablet error|0|||
23492360|NCT02544074|65548047|FG017|Overall Study|Tablet error|0|||
23492361|NCT02544074|65548048|FG018|Overall Study|Tablet error|0|||
23492362|NCT02544074|65548049|FG019|Overall Study|Tablet error|0|||
23492363|NCT02544074|65548050|FG020|Overall Study|Tablet error|0|||
23492364|NCT02601027|65548051|FG000|Registration to Surgery|Withdrawal by Subject|20|||
23492365|NCT02601027|65548052|FG001|Registration to Surgery|Withdrawal by Subject|10|||
23492366|NCT01683019|65548053|FG000|Overall Study|Withdrawal by Subject|2|||
23492367|NCT01683019|65548054|FG001|Overall Study|Withdrawal by Subject|1|||
23492368|NCT01683019|65548055|FG002|Overall Study|Withdrawal by Subject|4|||
23492369|NCT00423514|65548057|FG000|Overall Study|Ineligible|1|||
23492370|NCT00423514|65548058|FG001|Overall Study|Ineligible|0|||
23492371|NCT02019277|65548059|FG000|Overall Study|Withdrawal by Subject|3|||
23492372|NCT02019277|65548059|FG000|Overall Study|Death|7|||
23492373|NCT02019277|65548059|FG000|Overall Study|Did no Cooperate|1|||
23492374|NCT02019277|65548059|FG000|Overall Study|Adverse Event|1|||
23492375|NCT03308786|65548060|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
23492376|NCT04607980|65548063|FG000|Overall Study|Adverse Event|3|||
23492377|NCT04607980|65548064|FG001|Overall Study|Adverse Event|4|||
23492378|NCT04607980|65548063|FG000|Overall Study|Death|0|||
23492379|NCT04607980|65548064|FG001|Overall Study|Death|1|||
23668518|NCT02871778|66168909|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
23668519|NCT02871778|66168902|FG000|Part A: Treatment Period 2|Adverse Event|2|||
23668520|NCT02871778|66168903|FG001|Part A: Treatment Period 2|Adverse Event|2|||
23668521|NCT02871778|66168904|FG002|Part A: Treatment Period 2|Adverse Event|0|||
23668522|NCT02871778|66168905|FG003|Part A: Treatment Period 2|Adverse Event|0|||
23668523|NCT02871778|66168906|FG004|Part A: Treatment Period 2|Adverse Event|0|||
23668524|NCT02871778|66168907|FG005|Part A: Treatment Period 2|Adverse Event|0|||
23668525|NCT02871778|66168908|FG006|Part A: Treatment Period 2|Adverse Event|0|||
23381702|NCT01107457|65140598|FG005|Part B and C|Adverse Event|12|||
23381703|NCT01107457|65140593|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381704|NCT01107457|65140594|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381705|NCT01107457|65140595|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381706|NCT01107457|65140596|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381707|NCT01107457|65140597|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381708|NCT01107457|65140598|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
23668526|NCT02871778|66168909|FG007|Part A: Treatment Period 2|Adverse Event|0|||
23381709|NCT01107457|65140593|FG000|Part B and C|Physician Decision|0|||
23381710|NCT01107457|65140594|FG001|Part B and C|Physician Decision|0|||
23492380|NCT04607980|65548063|FG000|Overall Study|Withdrawal by Subject|2|||
23381711|NCT01107457|65140595|FG002|Part B and C|Physician Decision|0|||
23492381|NCT04607980|65548064|FG001|Overall Study|Withdrawal by Subject|5|||
23668527|NCT02871778|66168902|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668528|NCT02871778|66168903|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668529|NCT02871778|66168904|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668530|NCT02871778|66168905|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
23668531|NCT02871778|66168906|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668532|NCT02871778|66168907|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668533|NCT02871778|66168908|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668534|NCT02871778|66168909|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
23668535|NCT02871778|66168902|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
23668536|NCT02871778|66168903|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668537|NCT02871778|66168904|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
23668538|NCT02871778|66168905|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668539|NCT02871778|66168906|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668540|NCT02871778|66168907|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668541|NCT02871778|66168908|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668542|NCT02871778|66168909|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23668543|NCT02871778|66168902|FG000|Part B: Treatment Period 3|Adverse Event|0|||
23668544|NCT02871778|66168903|FG001|Part B: Treatment Period 3|Adverse Event|0|||
23668545|NCT02871778|66168904|FG002|Part B: Treatment Period 3|Adverse Event|0|||
23668546|NCT02871778|66168905|FG003|Part B: Treatment Period 3|Adverse Event|0|||
23668547|NCT02871778|66168906|FG004|Part B: Treatment Period 3|Adverse Event|1|||
23668548|NCT02871778|66168907|FG005|Part B: Treatment Period 3|Adverse Event|1|||
23668549|NCT02871778|66168908|FG006|Part B: Treatment Period 3|Adverse Event|1|||
23668550|NCT02871778|66168909|FG007|Part B: Treatment Period 3|Adverse Event|0|||
23668551|NCT02980224|66168910|FG000|Overall Study|Adverse Event|4|||
23668552|NCT02980224|66168911|FG001|Overall Study|Adverse Event|1|||
23668553|NCT02980224|66168910|FG000|Overall Study|Withdrawal by Subject|0|||
23668554|NCT02980224|66168911|FG001|Overall Study|Withdrawal by Subject|2|||
23668555|NCT04697628|66172134|FG000|Overall Study|Withdrawal by Subject|17|||
23668556|NCT04697628|66172135|FG001|Overall Study|Withdrawal by Subject|23|||
23668557|NCT04697628|66172134|FG000|Overall Study|Lost to Follow-up|0|||
23668558|NCT04697628|66172135|FG001|Overall Study|Lost to Follow-up|4|||
23381712|NCT01107457|65140596|FG003|Part B and C|Physician Decision|0|||
23492382|NCT04607980|65548063|FG000|Overall Study|Lost to Follow-up|4|||
23492383|NCT04607980|65548064|FG001|Overall Study|Lost to Follow-up|8|||
23492384|NCT04607980|65548063|FG000|Overall Study|Protocol Violation|0|||
23492385|NCT04607980|65548064|FG001|Overall Study|Protocol Violation|3|||
23492386|NCT04607980|65548063|FG000|Overall Study|Other|3|||
23492387|NCT04607980|65548064|FG001|Overall Study|Other|0|||
23492388|NCT04402060|65548071|FG000|Overall Study|Death|1|||
23492389|NCT04402060|65548072|FG001|Overall Study|Death|12|||
23492390|NCT04402060|65548073|FG002|Overall Study|Death|7|||
23492391|NCT04402060|65548071|FG000|Overall Study|Adverse Event|0|||
23492392|NCT04402060|65548072|FG001|Overall Study|Adverse Event|0|||
23492393|NCT04402060|65548073|FG002|Overall Study|Adverse Event|1|||
23492394|NCT04402060|65548071|FG000|Overall Study|Withdrawal by Subject|0|||
23492395|NCT04402060|65548072|FG001|Overall Study|Withdrawal by Subject|1|||
23492396|NCT04402060|65548073|FG002|Overall Study|Withdrawal by Subject|2|||
23492397|NCT04402060|65548071|FG000|Overall Study|Sponsor Request|0|||
23492398|NCT04402060|65548072|FG001|Overall Study|Sponsor Request|2|||
23492399|NCT04402060|65548073|FG002|Overall Study|Sponsor Request|0|||
23492400|NCT04402060|65548071|FG000|Overall Study|Physician Decision|0|||
23492401|NCT04402060|65548072|FG001|Overall Study|Physician Decision|0|||
23492402|NCT04402060|65548073|FG002|Overall Study|Physician Decision|1|||
23492403|NCT04402060|65548071|FG000|Overall Study|Other|0|||
23381713|NCT01107457|65140597|FG004|Part B and C|Physician Decision|0|||
23381714|NCT01107457|65140598|FG005|Part B and C|Physician Decision|3|||
23381715|NCT01107457|65140593|FG000|Part B and C|Lack of Efficacy|0|||
23381716|NCT01107457|65140594|FG001|Part B and C|Lack of Efficacy|0|||
23381717|NCT01107457|65140595|FG002|Part B and C|Lack of Efficacy|0|||
23381718|NCT01107457|65140596|FG003|Part B and C|Lack of Efficacy|0|||
23381719|NCT01107457|65140597|FG004|Part B and C|Lack of Efficacy|0|||
23381720|NCT01107457|65140598|FG005|Part B and C|Lack of Efficacy|7|||
23381721|NCT01107457|65140593|FG000|Part B and C|Lost to Follow-up|0|||
23381722|NCT01107457|65140594|FG001|Part B and C|Lost to Follow-up|0|||
23381723|NCT01107457|65140595|FG002|Part B and C|Lost to Follow-up|0|||
23381724|NCT01107457|65140596|FG003|Part B and C|Lost to Follow-up|0|||
23381725|NCT01107457|65140597|FG004|Part B and C|Lost to Follow-up|0|||
23381726|NCT01107457|65140598|FG005|Part B and C|Lost to Follow-up|10|||
23381727|NCT01107457|65140593|FG000|Part B and C|Protocol Violation|0|||
23381728|NCT01107457|65140594|FG001|Part B and C|Protocol Violation|0|||
23381729|NCT01107457|65140595|FG002|Part B and C|Protocol Violation|0|||
23381730|NCT01107457|65140596|FG003|Part B and C|Protocol Violation|0|||
23381731|NCT01107457|65140597|FG004|Part B and C|Protocol Violation|0|||
23381732|NCT01107457|65140598|FG005|Part B and C|Protocol Violation|1|||
23381733|NCT01107457|65140593|FG000|Part B and C|Sponsor Decision|0|||
23381734|NCT01107457|65140594|FG001|Part B and C|Sponsor Decision|0|||
23381735|NCT01107457|65140595|FG002|Part B and C|Sponsor Decision|0|||
23381736|NCT01107457|65140596|FG003|Part B and C|Sponsor Decision|0|||
23381737|NCT01107457|65140597|FG004|Part B and C|Sponsor Decision|0|||
23381738|NCT01107457|65140598|FG005|Part B and C|Sponsor Decision|66|||
23381739|NCT01107457|65140593|FG000|Part B and C|Withdrawal by Subject|0|||
23381740|NCT01107457|65140594|FG001|Part B and C|Withdrawal by Subject|0|||
23381741|NCT01107457|65140595|FG002|Part B and C|Withdrawal by Subject|0|||
23381742|NCT01107457|65140596|FG003|Part B and C|Withdrawal by Subject|0|||
23381743|NCT01107457|65140597|FG004|Part B and C|Withdrawal by Subject|0|||
23381744|NCT01107457|65140598|FG005|Part B and C|Withdrawal by Subject|16|||
23381745|NCT01107457|65140593|FG000|Part B and C|Clinical Relapse|0|||
23381746|NCT01107457|65140594|FG001|Part B and C|Clinical Relapse|0|||
23381747|NCT01107457|65140595|FG002|Part B and C|Clinical Relapse|0|||
23492404|NCT04402060|65548072|FG001|Overall Study|Other|1|||
23492405|NCT04402060|65548073|FG002|Overall Study|Other|0|||
23492406|NCT02298023|65548074|FG000|Overall Study|Withdrawal by Subject|1|||
23492407|NCT02298023|65548075|FG001|Overall Study|Withdrawal by Subject|0|||
23492408|NCT02298023|65548076|FG002|Overall Study|Withdrawal by Subject|0|||
23492409|NCT01025154|65548077|FG000|Overall Study|Lost to Follow-up|1|||
23492410|NCT01025154|65548077|FG000|Overall Study|Withdrawal by Subject|1|||
23668559|NCT04697628|66172134|FG000|Overall Study|On-going in study|122|||
23668560|NCT04697628|66172135|FG001|Overall Study|On-going in study|91|||
23668561|NCT02636582|66172136|FG000|Overall Study|Surgical Pathology|1|||
23668562|NCT02636582|66172137|FG001|Overall Study|Surgical Pathology|0|||
23668563|NCT00915681|66172141|FG000|Overall Study|Screening failures|46|||
23668564|NCT02193074|66172142|FG000|Overall Study|Withdrawal by Subject|1|||
23668565|NCT02193074|66172143|FG001|Overall Study|Withdrawal by Subject|2|||
23668566|NCT02193074|66172142|FG000|Overall Study|Adverse Event|16|||
23668567|NCT02193074|66172143|FG001|Overall Study|Adverse Event|13|||
23668568|NCT01119248|66172155|FG000|Overall Study|Physician Decision|5|||
23668569|NCT02595723|66172159|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
23668570|NCT02595723|66172160|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
23668571|NCT02595723|66172161|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
23668572|NCT02595723|66172159|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
23668573|NCT02595723|66172160|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
23668574|NCT02595723|66172161|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
23668575|NCT00769002|66172164|FG000|Overall Study|Study was not completed, no data|9|||
23668576|NCT00769002|66172165|FG001|Overall Study|Study was not completed, no data|9|||
23381748|NCT01107457|65140596|FG003|Part B and C|Clinical Relapse|0|||
23381749|NCT01107457|65140597|FG004|Part B and C|Clinical Relapse|0|||
23381750|NCT01107457|65140598|FG005|Part B and C|Clinical Relapse|4|||
23381751|NCT00191100|65140599|FG000|Overall Study|Adverse Event|18|||
23381752|NCT00191100|65140600|FG001|Overall Study|Adverse Event|1|||
23381753|NCT00191100|65140599|FG000|Overall Study|Lost to Follow-up|2|||
23381754|NCT00191100|65140600|FG001|Overall Study|Lost to Follow-up|0|||
23381755|NCT00191100|65140599|FG000|Overall Study|Patient Moved|0|||
23381756|NCT00191100|65140600|FG001|Overall Study|Patient Moved|1|||
23381757|NCT00191100|65140599|FG000|Overall Study|Withdrawal by Subject|9|||
23668577|NCT04417894|66172173|FG000|Overall Study|Lost to Follow-up|3|||
23668578|NCT04417894|66172174|FG001|Overall Study|Lost to Follow-up|0|||
23668579|NCT04417894|66172173|FG000|Overall Study|Withdrawal by Subject|7|||
23668580|NCT04417894|66172174|FG001|Overall Study|Withdrawal by Subject|6|||
23668581|NCT04417894|66172173|FG000|Overall Study|Lack of Efficacy|3|||
23381758|NCT00191100|65140600|FG001|Overall Study|Withdrawal by Subject|3|||
23381759|NCT00191100|65140599|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
23381760|NCT00191100|65140600|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
23492411|NCT01973569|65548079|FG000|Overall Study|Adverse Event|9|||
23492412|NCT01973569|65548080|FG001|Overall Study|Adverse Event|2|||
23492413|NCT01973569|65548081|FG002|Overall Study|Adverse Event|4|||
23492414|NCT01973569|65548079|FG000|Overall Study|Protocol Violation|2|||
23492415|NCT01973569|65548080|FG001|Overall Study|Protocol Violation|1|||
23492416|NCT01973569|65548081|FG002|Overall Study|Protocol Violation|3|||
23492417|NCT01973569|65548079|FG000|Overall Study|Withdrawal by Subject|7|||
23492418|NCT01973569|65548080|FG001|Overall Study|Withdrawal by Subject|5|||
23492419|NCT01973569|65548081|FG002|Overall Study|Withdrawal by Subject|2|||
23492420|NCT01973569|65548079|FG000|Overall Study|Invasive dental treatment|3|||
23492421|NCT01973569|65548080|FG001|Overall Study|Invasive dental treatment|5|||
23492422|NCT01973569|65548081|FG002|Overall Study|Invasive dental treatment|6|||
23492423|NCT01973569|65548079|FG000|Overall Study|Prohibited concomitant d|1|||
23492424|NCT01973569|65548080|FG001|Overall Study|Prohibited concomitant d|5|||
23492425|NCT01973569|65548081|FG002|Overall Study|Prohibited concomitant d|0|||
23492426|NCT01973569|65548079|FG000|Overall Study|Disease progression|0|||
23492427|NCT01973569|65548080|FG001|Overall Study|Disease progression|3|||
23492428|NCT01973569|65548081|FG002|Overall Study|Disease progression|0|||
23492429|NCT01973569|65548079|FG000|Overall Study|Other|1|||
23492430|NCT01973569|65548080|FG001|Overall Study|Other|1|||
23492431|NCT01973569|65548081|FG002|Overall Study|Other|0|||
23492432|NCT01973569|65548079|FG000|Overall Study|Did not receive study drug|6|||
23492433|NCT01973569|65548080|FG001|Overall Study|Did not receive study drug|3|||
23492434|NCT01973569|65548081|FG002|Overall Study|Did not receive study drug|3|||
23492435|NCT01146912|65548082|FG000|Overall Study|Already received influenza vaccination|817|||
23492436|NCT01146912|65548083|FG001|Overall Study|Already received influenza vaccination|822|||
23492437|NCT01146912|65548084|FG002|Overall Study|Already received influenza vaccination|13|||
23492438|NCT01146912|65548085|FG003|Overall Study|Already received influenza vaccination|15|||
23492439|NCT01146912|65548086|FG004|Overall Study|Already received influenza vaccination|41|||
23492440|NCT01146912|65548087|FG005|Overall Study|Already received influenza vaccination|61|||
23492441|NCT01146912|65548088|FG006|Overall Study|Already received influenza vaccination|56|||
23492442|NCT01146912|65548089|FG007|Overall Study|Already received influenza vaccination|0|||
23492443|NCT01146912|65548082|FG000|Overall Study|< 14 weeks gestational age|0|||
23492444|NCT01146912|65548083|FG001|Overall Study|< 14 weeks gestational age|0|||
23492445|NCT01146912|65548084|FG002|Overall Study|< 14 weeks gestational age|3|||
23492446|NCT01146912|65548085|FG003|Overall Study|< 14 weeks gestational age|2|||
23492447|NCT01146912|65548086|FG004|Overall Study|< 14 weeks gestational age|0|||
23492448|NCT01146912|65548087|FG005|Overall Study|< 14 weeks gestational age|0|||
23668582|NCT04417894|66172174|FG001|Overall Study|Lack of Efficacy|1|||
23668583|NCT00137111|66172177|FG000|Total Therapy|Death|35|||
23668584|NCT00137111|66172178|FG001|Total Therapy|Death|0|||
23668585|NCT00137111|66172179|FG002|Total Therapy|Death|0|||
23668586|NCT00137111|66172180|FG003|Total Therapy|Death|0|||
23668587|NCT00137111|66172177|FG000|Total Therapy|Non Compliance|5|||
23668588|NCT00137111|66172178|FG001|Total Therapy|Non Compliance|0|||
23668589|NCT00137111|66172179|FG002|Total Therapy|Non Compliance|0|||
23668590|NCT00137111|66172180|FG003|Total Therapy|Non Compliance|0|||
23668591|NCT03782376|66172183|FG000|Overall Study|Lost to Follow-up|2|||
23668592|NCT03782376|66172184|FG001|Overall Study|Lost to Follow-up|2|||
23668593|NCT03782376|66172183|FG000|Overall Study|Withdrawal by Subject|7|||
23668594|NCT03782376|66172184|FG001|Overall Study|Withdrawal by Subject|11|||
23668595|NCT03782376|66172183|FG000|Overall Study|Death|1|||
23668596|NCT03782376|66172184|FG001|Overall Study|Death|0|||
23492449|NCT01146912|65548088|FG006|Overall Study|< 14 weeks gestational age|0|||
23668597|NCT03782376|66172183|FG000|Overall Study|Other|16|||
23668598|NCT03782376|66172184|FG001|Overall Study|Other|17|||
23668599|NCT00385255|66172188|FG000|Overall Study|Serious Adverse Event|1|||
23668600|NCT00385255|66172189|FG001|Overall Study|Serious Adverse Event|2|||
23668601|NCT00385255|66172188|FG000|Overall Study|Protocol Violation|0|||
23668602|NCT00385255|66172189|FG001|Overall Study|Protocol Violation|4|||
23668603|NCT00385255|66172188|FG000|Overall Study|Withdrawal by Subject|0|||
23668604|NCT00385255|66172189|FG001|Overall Study|Withdrawal by Subject|8|||
23668605|NCT00385255|66172188|FG000|Overall Study|Migrated/moved from study area|0|||
23668606|NCT00385255|66172189|FG001|Overall Study|Migrated/moved from study area|1|||
23668607|NCT00385255|66172188|FG000|Overall Study|Lost to Follow-up|20|||
23668608|NCT00385255|66172189|FG001|Overall Study|Lost to Follow-up|58|||
23668609|NCT02646982|66172190|FG000|Overall Study|Adverse Event|1|||
23668610|NCT02646982|66172191|FG001|Overall Study|Adverse Event|1|||
23668611|NCT02646982|66172190|FG000|Overall Study|Withdrawal by Subject|2|||
23668612|NCT02646982|66172191|FG001|Overall Study|Withdrawal by Subject|1|||
23668613|NCT03074474|66172192|FG000|Overall Study|Lost to Follow-up|10|||
23668614|NCT03074474|66172192|FG000|Overall Study|Withdrawal by Subject|10|||
23668615|NCT03074474|66172192|FG000|Overall Study|Death|4|||
23668616|NCT03074474|66172192|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
23668617|NCT00750737|66172193|FG000|Overall Study|Withdrawal by Subject|3|||
23668618|NCT00750737|66172194|FG001|Overall Study|Withdrawal by Subject|3|||
23668619|NCT00408694|66172195|FG000|Overall Study|Ineligible|1|||
23668620|NCT00408694|66172195|FG000|Overall Study|No protocol treatment|1|||
23668621|NCT02457637|66172196|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
23668622|NCT02124564|66172197|FG000|Treatment Period|Adverse Event|2|||
23668623|NCT02124564|66172197|FG000|Treatment Period|Lack of Efficacy|3|||
23668624|NCT02124564|66172197|FG000|Treatment Period|Withdrawal by Subject|2|||
23668625|NCT00143455|66172198|FG000|Cohort 1|Adverse Event|8|||
23668626|NCT00143455|66172199|FG001|Cohort 1|Adverse Event|4|||
23668627|NCT00143455|66172200|FG002|Cohort 1|Adverse Event|0|||
23668628|NCT00143455|66172201|FG003|Cohort 1|Adverse Event|0|||
23668629|NCT00143455|66172198|FG000|Cohort 1|Death|5|||
23668630|NCT00143455|66172199|FG001|Cohort 1|Death|2|||
23668631|NCT00143455|66172200|FG002|Cohort 1|Death|0|||
23668632|NCT00143455|66172201|FG003|Cohort 1|Death|0|||
23668633|NCT00143455|66172198|FG000|Cohort 1|Progressive Disease|0|||
23668634|NCT00143455|66172199|FG001|Cohort 1|Progressive Disease|6|||
23668635|NCT00143455|66172200|FG002|Cohort 1|Progressive Disease|0|||
23668636|NCT00143455|66172201|FG003|Cohort 1|Progressive Disease|0|||
23668637|NCT00143455|66172198|FG000|Cohort 1|Withdrawal by Subject|1|||
23668638|NCT00143455|66172199|FG001|Cohort 1|Withdrawal by Subject|4|||
23668639|NCT00143455|66172200|FG002|Cohort 1|Withdrawal by Subject|0|||
23668640|NCT00143455|66172201|FG003|Cohort 1|Withdrawal by Subject|0|||
23668641|NCT00143455|66172198|FG000|Cohort 1|Randomized But Not Treated|0|||
23668642|NCT00143455|66172199|FG001|Cohort 1|Randomized But Not Treated|1|||
23668643|NCT00143455|66172200|FG002|Cohort 1|Randomized But Not Treated|0|||
23668644|NCT00143455|66172201|FG003|Cohort 1|Randomized But Not Treated|0|||
23668645|NCT00143455|66172198|FG000|Cohort 2|Adverse Event|0|||
23668646|NCT00143455|66172199|FG001|Cohort 2|Adverse Event|0|||
23668647|NCT00143455|66172200|FG002|Cohort 2|Adverse Event|42|||
23668648|NCT00143455|66172201|FG003|Cohort 2|Adverse Event|30|||
23668649|NCT00143455|66172198|FG000|Cohort 2|No Longer Required Study Treatment|0|||
23668650|NCT00143455|66172199|FG001|Cohort 2|No Longer Required Study Treatment|0|||
23668651|NCT00143455|66172200|FG002|Cohort 2|No Longer Required Study Treatment|1|||
23668652|NCT00143455|66172201|FG003|Cohort 2|No Longer Required Study Treatment|0|||
23668653|NCT00143455|66172198|FG000|Cohort 2|Protocol Violation|0|||
23668654|NCT00143455|66172199|FG001|Cohort 2|Protocol Violation|0|||
23668655|NCT00143455|66172200|FG002|Cohort 2|Protocol Violation|1|||
23668656|NCT00143455|66172201|FG003|Cohort 2|Protocol Violation|1|||
23668657|NCT00143455|66172198|FG000|Cohort 2|Lost to Follow-up|0|||
23668658|NCT00143455|66172199|FG001|Cohort 2|Lost to Follow-up|0|||
23668659|NCT00143455|66172200|FG002|Cohort 2|Lost to Follow-up|1|||
23668660|NCT00143455|66172201|FG003|Cohort 2|Lost to Follow-up|4|||
23668661|NCT00143455|66172198|FG000|Cohort 2|Death|0|||
23668662|NCT00143455|66172199|FG001|Cohort 2|Death|0|||
23668663|NCT00143455|66172200|FG002|Cohort 2|Death|20|||
23668664|NCT00143455|66172201|FG003|Cohort 2|Death|12|||
23668665|NCT00143455|66172198|FG000|Cohort 2|Progressive Disease|0|||
23668666|NCT00143455|66172199|FG001|Cohort 2|Progressive Disease|0|||
23668667|NCT00143455|66172200|FG002|Cohort 2|Progressive Disease|20|||
23668668|NCT00143455|66172201|FG003|Cohort 2|Progressive Disease|27|||
23668669|NCT00143455|66172198|FG000|Cohort 2|Withdrawal by Subject|0|||
23668670|NCT00143455|66172199|FG001|Cohort 2|Withdrawal by Subject|0|||
23668671|NCT00143455|66172200|FG002|Cohort 2|Withdrawal by Subject|13|||
23668672|NCT00143455|66172201|FG003|Cohort 2|Withdrawal by Subject|12|||
23668673|NCT00143455|66172198|FG000|Cohort 2|Other|0|||
23668674|NCT00143455|66172199|FG001|Cohort 2|Other|0|||
23668675|NCT00143455|66172200|FG002|Cohort 2|Other|7|||
23668676|NCT00143455|66172201|FG003|Cohort 2|Other|6|||
23668677|NCT00143455|66172198|FG000|Cohort 2|Randomized But Not Treated|0|||
23668678|NCT00143455|66172199|FG001|Cohort 2|Randomized But Not Treated|0|||
23668679|NCT00143455|66172200|FG002|Cohort 2|Randomized But Not Treated|1|||
23668680|NCT00143455|66172201|FG003|Cohort 2|Randomized But Not Treated|1|||
23668681|NCT00131469|66172202|FG000|Overall Study|Withdrawal by Subject|3|||
23668682|NCT00131469|66172203|FG001|Overall Study|Withdrawal by Subject|4|||
23668683|NCT00131469|66172202|FG000|Overall Study|Protocol Violation|3|||
23668684|NCT00131469|66172203|FG001|Overall Study|Protocol Violation|1|||
23492450|NCT01146912|65548089|FG007|Overall Study|< 14 weeks gestational age|0|||
23492451|NCT01146912|65548082|FG000|Overall Study|Duplicate patient|0|||
23492452|NCT01146912|65548083|FG001|Overall Study|Duplicate patient|0|||
23492453|NCT01146912|65548084|FG002|Overall Study|Duplicate patient|1|||
23492454|NCT01146912|65548085|FG003|Overall Study|Duplicate patient|0|||
23492455|NCT01146912|65548086|FG004|Overall Study|Duplicate patient|0|||
23492456|NCT01146912|65548087|FG005|Overall Study|Duplicate patient|0|||
23492457|NCT01146912|65548088|FG006|Overall Study|Duplicate patient|0|||
23492458|NCT01146912|65548089|FG007|Overall Study|Duplicate patient|0|||
23492459|NCT00474760|65548093|FG000|Overall Study|Death|0|||
23492460|NCT00474760|65548094|FG001|Overall Study|Death|0|||
23668685|NCT00131469|66172202|FG000|Overall Study|Death|0|||
23668686|NCT00131469|66172203|FG001|Overall Study|Death|1|||
23668687|NCT00131469|66172202|FG000|Overall Study|Lost to Follow-up|0|||
23668688|NCT00131469|66172203|FG001|Overall Study|Lost to Follow-up|1|||
23668689|NCT00131469|66172202|FG000|Overall Study|scan not analyzable|3|||
23668690|NCT00131469|66172203|FG001|Overall Study|scan not analyzable|6|||
23668691|NCT02018822|66172206|FG000|Overall Study|filling replaced by crown|0|||
23668692|NCT02018822|66172207|FG001|Overall Study|filling replaced by crown|1|||
23668693|NCT02018822|66172208|FG002|Overall Study|filling replaced by crown|0|||
23668694|NCT02018822|66172206|FG000|Overall Study|Physician Decision|0|||
23668695|NCT02018822|66172207|FG001|Overall Study|Physician Decision|1|||
23668696|NCT02018822|66172208|FG002|Overall Study|Physician Decision|1|||
23668697|NCT02018822|66172206|FG000|Overall Study|Lost to Follow-up|6|||
23668698|NCT02018822|66172207|FG001|Overall Study|Lost to Follow-up|6|||
23668699|NCT02018822|66172208|FG002|Overall Study|Lost to Follow-up|5|||
23668700|NCT01368835|66172209|FG000|Overall Study|Inclusion criteria/photography quality|22|||
23668701|NCT01368835|66172209|FG000|Overall Study|Lost to Follow-up|11|||
23668702|NCT00957008|66172210|FG000|Overall Study|Withdrawal by Subject|13|||
23668703|NCT00957008|66172211|FG001|Overall Study|Withdrawal by Subject|10|||
23668704|NCT00957008|66172212|FG002|Overall Study|Withdrawal by Subject|12|||
23668705|NCT00957008|66172213|FG003|Overall Study|Withdrawal by Subject|16|||
23668706|NCT00957008|66172210|FG000|Overall Study|Lost to Follow-up|3|||
23668707|NCT00957008|66172211|FG001|Overall Study|Lost to Follow-up|1|||
23668708|NCT00957008|66172212|FG002|Overall Study|Lost to Follow-up|3|||
23668709|NCT00957008|66172213|FG003|Overall Study|Lost to Follow-up|4|||
23668710|NCT00957008|66172210|FG000|Overall Study|Physician Decision|1|||
23668711|NCT00957008|66172211|FG001|Overall Study|Physician Decision|0|||
23668712|NCT00957008|66172212|FG002|Overall Study|Physician Decision|1|||
23668713|NCT00957008|66172213|FG003|Overall Study|Physician Decision|1|||
23668714|NCT00957008|66172210|FG000|Overall Study|Relocated; Family conflict|4|||
23668715|NCT00957008|66172211|FG001|Overall Study|Relocated; Family conflict|1|||
23668716|NCT00957008|66172212|FG002|Overall Study|Relocated; Family conflict|1|||
23668717|NCT00957008|66172213|FG003|Overall Study|Relocated; Family conflict|3|||
23668718|NCT03355300|66172214|FG000|Overall Study|Physician Decision|0|||
23492461|NCT00474760|65548095|FG002|Overall Study|Death|0|||
23668719|NCT03355300|66172215|FG001|Overall Study|Physician Decision|1|||
23668720|NCT03355300|66172214|FG000|Overall Study|Lack of Efficacy|2|||
23668721|NCT03355300|66172215|FG001|Overall Study|Lack of Efficacy|1|||
23668722|NCT03355300|66172214|FG000|Overall Study|Other reason|1|||
23668723|NCT03355300|66172215|FG001|Overall Study|Other reason|0|||
23668724|NCT01157364|66172216|FG000|Overall Study|Other Reasons|1|||
23668725|NCT01157364|66172217|FG001|Overall Study|Other Reasons|1|||
23668726|NCT01157364|66172218|FG002|Overall Study|Other Reasons|2|||
23668727|NCT01157364|66172219|FG003|Overall Study|Other Reasons|1|||
23668728|NCT01157364|66172220|FG004|Overall Study|Other Reasons|0|||
23668729|NCT01157364|66172221|FG005|Overall Study|Other Reasons|0|||
23668730|NCT01157364|66172216|FG000|Overall Study|Personal Reasons|0|||
23668731|NCT01157364|66172217|FG001|Overall Study|Personal Reasons|2|||
23668732|NCT01157364|66172218|FG002|Overall Study|Personal Reasons|0|||
23668733|NCT01157364|66172219|FG003|Overall Study|Personal Reasons|0|||
23668734|NCT01157364|66172220|FG004|Overall Study|Personal Reasons|1|||
23668735|NCT01157364|66172221|FG005|Overall Study|Personal Reasons|1|||
23668736|NCT01157364|66172216|FG000|Overall Study|Lost to Follow-up|1|||
23668737|NCT01157364|66172217|FG001|Overall Study|Lost to Follow-up|0|||
23492462|NCT00474760|65548096|FG003|Overall Study|Death|0|||
23668738|NCT01157364|66172218|FG002|Overall Study|Lost to Follow-up|1|||
23381761|NCT00191100|65140599|FG000|Overall Study|Clinical Relapse|2|||
23492463|NCT00474760|65548097|FG004|Overall Study|Death|2|||
23668739|NCT01157364|66172219|FG003|Overall Study|Lost to Follow-up|0|||
23668740|NCT01157364|66172220|FG004|Overall Study|Lost to Follow-up|0|||
23668741|NCT01157364|66172221|FG005|Overall Study|Lost to Follow-up|0|||
23668742|NCT01157364|66172216|FG000|Overall Study|Lack of Efficacy|0|||
23668743|NCT01157364|66172217|FG001|Overall Study|Lack of Efficacy|0|||
23668744|NCT01157364|66172218|FG002|Overall Study|Lack of Efficacy|0|||
23668745|NCT01157364|66172219|FG003|Overall Study|Lack of Efficacy|1|||
23492464|NCT00474760|65548098|FG005|Overall Study|Death|0|||
23492465|NCT00474760|65548099|FG006|Overall Study|Death|0|||
23492466|NCT00474760|65548093|FG000|Overall Study|Adverse Event|0|||
23668746|NCT01157364|66172220|FG004|Overall Study|Lack of Efficacy|0|||
23668747|NCT01157364|66172221|FG005|Overall Study|Lack of Efficacy|0|||
23381762|NCT00191100|65140600|FG001|Overall Study|Clinical Relapse|1|||
23381763|NCT00191100|65140599|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
23668748|NCT01157364|66172216|FG000|Overall Study|Adverse Event|0|||
23668749|NCT01157364|66172217|FG001|Overall Study|Adverse Event|1|||
23668750|NCT01157364|66172218|FG002|Overall Study|Adverse Event|1|||
23381764|NCT00191100|65140600|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
23381765|NCT00191100|65140599|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
23381766|NCT00191100|65140600|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
23381767|NCT00191100|65140599|FG000|Overall Study|Physician Decision|3|||
23381768|NCT00191100|65140600|FG001|Overall Study|Physician Decision|1|||
23381769|NCT00191100|65140599|FG000|Overall Study|Death from Study Drug Toxicity|2|||
23381770|NCT00191100|65140600|FG001|Overall Study|Death from Study Drug Toxicity|0|||
23381771|NCT00191100|65140599|FG000|Overall Study|Protocol Violation|1|||
23381772|NCT00191100|65140600|FG001|Overall Study|Protocol Violation|1|||
23381773|NCT00191100|65140599|FG000|Overall Study|Death from Other Cause|1|||
23381774|NCT00191100|65140600|FG001|Overall Study|Death from Other Cause|0|||
23381775|NCT00191100|65140599|FG000|Overall Study|Reason Not Specified|0|||
23668751|NCT01157364|66172219|FG003|Overall Study|Adverse Event|0|||
23668752|NCT01157364|66172220|FG004|Overall Study|Adverse Event|1|||
23668753|NCT01157364|66172221|FG005|Overall Study|Adverse Event|0|||
23668754|NCT04003389|66172225|FG000|Overall Study|Adverse Event|27|||
23668755|NCT04003389|66172226|FG001|Overall Study|Adverse Event|34|||
23381776|NCT00191100|65140600|FG001|Overall Study|Reason Not Specified|1|||
23668756|NCT04003389|66172227|FG002|Overall Study|Adverse Event|28|||
23668757|NCT04003389|66172225|FG000|Overall Study|Lost to Follow-up|39|||
23668758|NCT04003389|66172226|FG001|Overall Study|Lost to Follow-up|30|||
23668759|NCT04003389|66172227|FG002|Overall Study|Lost to Follow-up|33|||
23668760|NCT04003389|66172225|FG000|Overall Study|Protocol Violation|1|||
23668761|NCT04003389|66172226|FG001|Overall Study|Protocol Violation|6|||
23668762|NCT04003389|66172227|FG002|Overall Study|Protocol Violation|5|||
23668763|NCT04003389|66172225|FG000|Overall Study|Withdrawal by Subject|119|||
23668764|NCT04003389|66172226|FG001|Overall Study|Withdrawal by Subject|79|||
23668765|NCT04003389|66172227|FG002|Overall Study|Withdrawal by Subject|85|||
23668766|NCT04003389|66172225|FG000|Overall Study|Miscellaneous|14|||
23668767|NCT04003389|66172226|FG001|Overall Study|Miscellaneous|11|||
23668768|NCT04003389|66172227|FG002|Overall Study|Miscellaneous|14|||
23668769|NCT04003389|66172225|FG000|Overall Study|Participant did not receive study drug|1|||
23668770|NCT04003389|66172226|FG001|Overall Study|Participant did not receive study drug|0|||
23668771|NCT04003389|66172227|FG002|Overall Study|Participant did not receive study drug|0|||
23668772|NCT03468855|66172228|FG000|Overall Study|Adverse Event|2|||
23668773|NCT03468855|66172228|FG000|Overall Study|Lost to Follow-up|5|||
23668774|NCT03468855|66172228|FG000|Overall Study|Withdrawal by Subject|3|||
23668775|NCT03468855|66172228|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
23668776|NCT03581786|66172230|FG000|Overall Study|Death|17|||
23668777|NCT03581786|66172231|FG001|Overall Study|Death|12|||
23492467|NCT00474760|65548094|FG001|Overall Study|Adverse Event|0|||
23668778|NCT03581786|66172230|FG000|Overall Study|Withdrawal by Subject|2|||
23668779|NCT03581786|66172231|FG001|Overall Study|Withdrawal by Subject|4|||
23668780|NCT03581786|66172230|FG000|Overall Study|Lost to Follow-up|1|||
23668781|NCT03581786|66172231|FG001|Overall Study|Lost to Follow-up|0|||
23381777|NCT02497755|65140601|FG000|Overall Study|Protocol Violation|1|||
23381778|NCT02497755|65140602|FG001|Overall Study|Protocol Violation|0|||
23381779|NCT03607695|65140603|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
23381780|NCT03607695|65140603|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
23381781|NCT03723070|65140604|FG000|Overall Study|Lost to Follow-up|2|||
23381782|NCT03723070|65140604|FG000|Overall Study|Physician Decision|1|||
23381783|NCT03723070|65140604|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
23381784|NCT00296335|65140607|FG000|Overall Study|Recurrence|3|||
23381785|NCT00296335|65140608|FG001|Overall Study|Recurrence|51|||
23381786|NCT00296335|65140607|FG000|Overall Study|Adverse Event|17|||
23381787|NCT00296335|65140608|FG001|Overall Study|Adverse Event|27|||
23381788|NCT00296335|65140607|FG000|Overall Study|Lost to Follow-up|7|||
23381789|NCT00296335|65140608|FG001|Overall Study|Lost to Follow-up|33|||
23381790|NCT00296335|65140607|FG000|Overall Study|Physician Decision|3|||
23381791|NCT00296335|65140608|FG001|Overall Study|Physician Decision|11|||
23381792|NCT01671059|65140609|FG000|Overall Study|Adverse Event|4|||
23381793|NCT01671059|65140609|FG000|Overall Study|Lack of Efficacy|1|||
23381794|NCT03770455|65140610|FG000|Overall Study|Screen failures|3|||
23381795|NCT00498485|65140614|FG000|Overall Study|Adverse Event|1|||
23381796|NCT00498485|65140615|FG001|Overall Study|Adverse Event|5|||
23381797|NCT01174459|65140618|FG000|Overall Study|case report form (CRF) not collected|5|||
23381798|NCT00450749|65140619|FG000|Overall Study|Withdrawal by Subject|0|||
23381799|NCT00450749|65140620|FG001|Overall Study|Withdrawal by Subject|0|||
23381800|NCT00450749|65140621|FG002|Overall Study|Withdrawal by Subject|2|||
23381801|NCT00450749|65140619|FG000|Overall Study|Noncompliant|0|||
23381802|NCT00450749|65140620|FG001|Overall Study|Noncompliant|1|||
23381803|NCT00450749|65140621|FG002|Overall Study|Noncompliant|0|||
23381804|NCT01311661|65140625|FG000|Overall Study|Adverse Event|2|||
23381805|NCT01311661|65140625|FG000|Overall Study|Protocol Violation|3|||
23381806|NCT01311661|65140625|FG000|Overall Study|Withdrawal by Subject|2|||
23381807|NCT02336503|65140628|FG000|Overall Study|Lost to Follow-up|0|||
23381808|NCT02336503|65140629|FG001|Overall Study|Lost to Follow-up|3|||
23381809|NCT02336503|65140630|FG002|Overall Study|Lost to Follow-up|0|||
23381810|NCT02336503|65140631|FG003|Overall Study|Lost to Follow-up|2|||
23381811|NCT02336503|65140628|FG000|Overall Study|Withdrawal by Subject|2|||
23381812|NCT02336503|65140629|FG001|Overall Study|Withdrawal by Subject|0|||
23381813|NCT02336503|65140630|FG002|Overall Study|Withdrawal by Subject|0|||
23381814|NCT02336503|65140631|FG003|Overall Study|Withdrawal by Subject|4|||
23381815|NCT02336503|65140628|FG000|Overall Study|Adverse Event|0|||
23381816|NCT02336503|65140629|FG001|Overall Study|Adverse Event|0|||
23381817|NCT02336503|65140630|FG002|Overall Study|Adverse Event|1|||
23381818|NCT02336503|65140631|FG003|Overall Study|Adverse Event|0|||
23381819|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
23381820|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
23381821|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
23381822|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
23381823|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
23381824|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
23381825|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
23381826|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
23381827|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
23381828|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
23381829|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
23381830|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
23381831|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
23381832|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
23381833|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
23381834|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
23381835|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
23381836|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
23381837|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
23381838|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
23381839|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
23381840|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
23381841|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
23492468|NCT00474760|65548095|FG002|Overall Study|Adverse Event|0|||
23492469|NCT00474760|65548096|FG003|Overall Study|Adverse Event|0|||
23492470|NCT00474760|65548097|FG004|Overall Study|Adverse Event|1|||
23381842|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
23381843|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
23381844|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
23381845|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
23381846|NCT01181128|65140635|FG000|Overall Study|Withdrawal by Subject|2|||
23381847|NCT01181128|65140636|FG001|Overall Study|Withdrawal by Subject|2|||
23381848|NCT01181128|65140637|FG002|Overall Study|Withdrawal by Subject|0|||
23381849|NCT01181128|65140635|FG000|Overall Study|Death|1|||
23381850|NCT01181128|65140636|FG001|Overall Study|Death|0|||
23381851|NCT01181128|65140637|FG002|Overall Study|Death|0|||
23381852|NCT01181128|65140635|FG000|Overall Study|Physician Decision|2|||
23381853|NCT01181128|65140636|FG001|Overall Study|Physician Decision|0|||
23381854|NCT01181128|65140637|FG002|Overall Study|Physician Decision|0|||
23381855|NCT01181128|65140635|FG000|Overall Study|Adverse Event|0|||
23381856|NCT01181128|65140636|FG001|Overall Study|Adverse Event|2|||
23381857|NCT01181128|65140637|FG002|Overall Study|Adverse Event|0|||
23381858|NCT01181128|65140635|FG000|Overall Study|Other|1|||
23381859|NCT01181128|65140636|FG001|Overall Study|Other|1|||
23381860|NCT01181128|65140637|FG002|Overall Study|Other|1|||
23381861|NCT01132755|65140642|FG000|Overall Study|Procedure not done due to medical reason|23|||
23381862|NCT01132755|65140642|FG000|Overall Study|Protocol Violation|15|||
23381863|NCT01132755|65140642|FG000|Overall Study|Withdrawal by Subject|4|||
23381864|NCT00368550|65140643|FG000|Overall Study|Adverse Event|7|||
23381865|NCT00368550|65140644|FG001|Overall Study|Adverse Event|4|||
23381866|NCT00368550|65140643|FG000|Overall Study|Lack of Efficacy|4|||
23381867|NCT00368550|65140644|FG001|Overall Study|Lack of Efficacy|9|||
23381868|NCT00368550|65140643|FG000|Overall Study|Withdrawal by Subject|17|||
23381869|NCT00368550|65140644|FG001|Overall Study|Withdrawal by Subject|10|||
23381870|NCT00827242|65144870|FG000|Overall Study|Withdrawal by Subject|2|||
23381871|NCT00827242|65144871|FG001|Overall Study|Withdrawal by Subject|4|||
23381872|NCT00827242|65144870|FG000|Overall Study|Protocol Violation|1|||
23381873|NCT00827242|65144871|FG001|Overall Study|Protocol Violation|3|||
23381874|NCT00827242|65144870|FG000|Overall Study|Lost to Follow-up|0|||
23381875|NCT00827242|65144871|FG001|Overall Study|Lost to Follow-up|3|||
23381876|NCT00827242|65144870|FG000|Overall Study|Adverse Event Excluding Death|2|||
23381877|NCT00827242|65144871|FG001|Overall Study|Adverse Event Excluding Death|1|||
23381878|NCT00827242|65144870|FG000|Overall Study|Entry Criteria Not Met|4|||
23381879|NCT00827242|65144871|FG001|Overall Study|Entry Criteria Not Met|1|||
23381880|NCT00827242|65144870|FG000|Overall Study|Physician Decision|2|||
23381881|NCT00827242|65144871|FG001|Overall Study|Physician Decision|0|||
23381882|NCT00827242|65144870|FG000|Overall Study|Death|1|||
23381883|NCT00827242|65144871|FG001|Overall Study|Death|0|||
23381884|NCT00827242|65144870|FG000|Overall Study|Lack of Efficacy|1|||
23381885|NCT00827242|65144871|FG001|Overall Study|Lack of Efficacy|0|||
23381886|NCT01696968|65144874|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
23381887|NCT01696968|65144875|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
23381888|NCT01696968|65144874|FG000|Overall Study|Died Before Randomization|3|||
23381889|NCT01696968|65144875|FG001|Overall Study|Died Before Randomization|8|||
23381890|NCT01696968|65144874|FG000|Overall Study|Died Before ASU (Control)|278|||
23381891|NCT01696968|65144875|FG001|Overall Study|Died Before ASU (Control)|0|||
23381892|NCT01696968|65144874|FG000|Overall Study|Refused ASU (Control)|920|||
23381893|NCT01696968|65144875|FG001|Overall Study|Refused ASU (Control)|0|||
23381894|NCT01696968|65144874|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
23381895|NCT01696968|65144875|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
23381896|NCT00356590|65144878|FG000|Overall Study|Adverse Event|54|||
23381897|NCT00356590|65144878|FG000|Overall Study|Death|10|||
23381898|NCT00356590|65144878|FG000|Overall Study|Lost to Follow-up|35|||
23381899|NCT00356590|65144878|FG000|Overall Study|Physician Decision|46|||
23381900|NCT00356590|65144878|FG000|Overall Study|Withdrawal by Subject|41|||
23381901|NCT00356590|65144878|FG000|Overall Study|Completed month 12 only|2|||
23381902|NCT00356590|65144878|FG000|Overall Study|Protocol issues|6|||
23381903|NCT00356590|65144878|FG000|Overall Study|Response status|28|||
23381904|NCT00356590|65144878|FG000|Overall Study|Other|52|||
23381905|NCT01370538|65144882|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
23381906|NCT01370538|65144883|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
23381907|NCT01370538|65144882|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23381908|NCT01370538|65144883|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23381909|NCT01370538|65144882|FG000|Overall Study|Adverse Event|1|||
23381910|NCT01370538|65144883|FG001|Overall Study|Adverse Event|0|||
23381911|NCT01370538|65144882|FG000|Overall Study|Protocol Violation|8|||
23381912|NCT01370538|65144883|FG001|Overall Study|Protocol Violation|5|||
23381913|NCT01370538|65144882|FG000|Overall Study|Development of study specific withdrawal|1|||
23381914|NCT01370538|65144883|FG001|Overall Study|Development of study specific withdrawal|1|||
23381915|NCT01370538|65144882|FG000|Overall Study|Lost to follow up|6|||
23381916|NCT01370538|65144883|FG001|Overall Study|Lost to follow up|10|||
23381917|NCT04137887|65144884|FG000|Overall Study|Death|102|||
23381918|NCT04137887|65144885|FG001|Overall Study|Death|92|||
23381919|NCT04137887|65144884|FG000|Overall Study|Withdrawal by Subject|2|||
23381920|NCT04137887|65144885|FG001|Overall Study|Withdrawal by Subject|3|||
23381921|NCT04137887|65144884|FG000|Overall Study|Randomized but not treated|0|||
23381922|NCT04137887|65144885|FG001|Overall Study|Randomized but not treated|1|||
23381923|NCT00920816|65144888|FG000|Overall Study|Death|116|||
23381924|NCT00920816|65144889|FG001|Overall Study|Death|63|||
23381925|NCT00920816|65144890|FG002|Overall Study|Death|8|||
23381926|NCT00920816|65144891|FG003|Overall Study|Death|3|||
23381927|NCT00920816|65144888|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
23381928|NCT00920816|65144889|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
23381929|NCT00920816|65144890|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
23381930|NCT00920816|65144891|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
23381931|NCT00920816|65144888|FG000|Overall Study|Global deterioration of health status|2|||
23381932|NCT00920816|65144889|FG001|Overall Study|Global deterioration of health status|0|||
23381933|NCT00920816|65144890|FG002|Overall Study|Global deterioration of health status|0|||
23381934|NCT00920816|65144891|FG003|Overall Study|Global deterioration of health status|0|||
23381935|NCT00920816|65144888|FG000|Overall Study|Objective progression or relapse|6|||
23381936|NCT00920816|65144889|FG001|Overall Study|Objective progression or relapse|2|||
23381937|NCT00920816|65144890|FG002|Overall Study|Objective progression or relapse|0|||
23381938|NCT00920816|65144891|FG003|Overall Study|Objective progression or relapse|0|||
23381939|NCT00920816|65144888|FG000|Overall Study|Other|26|||
23381940|NCT00920816|65144889|FG001|Overall Study|Other|15|||
23381941|NCT00920816|65144890|FG002|Overall Study|Other|1|||
23381942|NCT00920816|65144891|FG003|Overall Study|Other|2|||
23381943|NCT00920816|65144888|FG000|Overall Study|Lost to Follow-up|11|||
23381944|NCT00920816|65144889|FG001|Overall Study|Lost to Follow-up|2|||
23381945|NCT00920816|65144890|FG002|Overall Study|Lost to Follow-up|0|||
23381946|NCT00920816|65144891|FG003|Overall Study|Lost to Follow-up|0|||
23381947|NCT00920816|65144888|FG000|Overall Study|Adverse Event|1|||
23381948|NCT00920816|65144889|FG001|Overall Study|Adverse Event|1|||
23381949|NCT00920816|65144890|FG002|Overall Study|Adverse Event|1|||
23381950|NCT00920816|65144891|FG003|Overall Study|Adverse Event|0|||
23381951|NCT00920816|65144888|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
23381952|NCT00920816|65144889|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
23381953|NCT00920816|65144890|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
23381954|NCT00920816|65144891|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
23381955|NCT00920816|65144888|FG000|Overall Study|Randomized but not treated|3|||
23381956|NCT00920816|65144889|FG001|Overall Study|Randomized but not treated|0|||
23381957|NCT00920816|65144890|FG002|Overall Study|Randomized but not treated|0|||
23381958|NCT00920816|65144891|FG003|Overall Study|Randomized but not treated|0|||
23381959|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Adverse Event|2|||
23381960|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
23381961|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
23381962|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
23381963|NCT02536794|65144892|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
23381964|NCT02536794|65144892|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
23381965|NCT00986232|65144893|FG000|Overall Study|Adverse Event|1|||
23381966|NCT00986232|65144894|FG001|Overall Study|Adverse Event|2|||
23381967|NCT00986232|65144895|FG002|Overall Study|Adverse Event|3|||
23381968|NCT00986232|65144896|FG003|Overall Study|Adverse Event|0|||
23381969|NCT00986232|65144893|FG000|Overall Study|Lost to Follow-up|19|||
23381970|NCT00986232|65144894|FG001|Overall Study|Lost to Follow-up|12|||
23381971|NCT00986232|65144895|FG002|Overall Study|Lost to Follow-up|12|||
23381972|NCT00986232|65144896|FG003|Overall Study|Lost to Follow-up|7|||
23381973|NCT00986232|65144893|FG000|Overall Study|Protocol Violation|2|||
23381974|NCT00986232|65144894|FG001|Overall Study|Protocol Violation|3|||
23381975|NCT00986232|65144895|FG002|Overall Study|Protocol Violation|0|||
23381976|NCT00986232|65144896|FG003|Overall Study|Protocol Violation|1|||
23381977|NCT00986232|65144893|FG000|Overall Study|Withdrawal by Subject|13|||
23381978|NCT00986232|65144894|FG001|Overall Study|Withdrawal by Subject|16|||
23381979|NCT00986232|65144895|FG002|Overall Study|Withdrawal by Subject|12|||
23381980|NCT00986232|65144896|FG003|Overall Study|Withdrawal by Subject|3|||
23381981|NCT00986232|65144893|FG000|Overall Study|Missed one or more bleeds|13|||
23381982|NCT00986232|65144894|FG001|Overall Study|Missed one or more bleeds|10|||
23381983|NCT00986232|65144895|FG002|Overall Study|Missed one or more bleeds|6|||
23381984|NCT00986232|65144896|FG003|Overall Study|Missed one or more bleeds|7|||
23381985|NCT00986232|65144893|FG000|Overall Study|Incomplete safety follow-up|3|||
23381986|NCT00986232|65144894|FG001|Overall Study|Incomplete safety follow-up|7|||
23381987|NCT00986232|65144895|FG002|Overall Study|Incomplete safety follow-up|2|||
23381988|NCT00986232|65144896|FG003|Overall Study|Incomplete safety follow-up|2|||
23381989|NCT02606253|65144897|FG000|Overall Study|Adverse Event|2|||
23381990|NCT02606253|65144898|FG001|Overall Study|Adverse Event|0|||
23381991|NCT02606253|65144899|FG002|Overall Study|Adverse Event|0|||
23381992|NCT02606253|65144897|FG000|Overall Study|Protocol Violation|2|||
23381993|NCT02606253|65144898|FG001|Overall Study|Protocol Violation|1|||
23381994|NCT02606253|65144899|FG002|Overall Study|Protocol Violation|0|||
23381995|NCT02606253|65144897|FG000|Overall Study|Physician Decision|1|||
23381996|NCT02606253|65144898|FG001|Overall Study|Physician Decision|1|||
23381997|NCT02606253|65144899|FG002|Overall Study|Physician Decision|0|||
23668782|NCT03581786|66172230|FG000|Overall Study|reason other than specified above|0|||
23668783|NCT03581786|66172231|FG001|Overall Study|reason other than specified above|1|||
23668784|NCT03581786|66172230|FG000|Overall Study|Ongoing in the study|123|||
23668785|NCT03581786|66172231|FG001|Overall Study|Ongoing in the study|129|||
23668786|NCT03703882|66172232|FG000|Overall Study|Adverse Event|1|||
23668787|NCT03703882|66172233|FG001|Overall Study|Adverse Event|0|||
23668788|NCT03703882|66172232|FG000|Overall Study|Lost to Follow-up|0|||
23668789|NCT03703882|66172233|FG001|Overall Study|Lost to Follow-up|2|||
23668790|NCT03703882|66172232|FG000|Overall Study|Non-compliance with study drug|0|||
23668791|NCT03703882|66172233|FG001|Overall Study|Non-compliance with study drug|1|||
23668792|NCT03703882|66172232|FG000|Overall Study|Physician Decision|0|||
23668793|NCT03703882|66172233|FG001|Overall Study|Physician Decision|1|||
23668794|NCT03703882|66172232|FG000|Overall Study|Progressive disease|1|||
23668795|NCT03703882|66172233|FG001|Overall Study|Progressive disease|0|||
23668796|NCT03703882|66172232|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23668797|NCT03703882|66172233|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23668798|NCT03703882|66172232|FG000|Overall Study|Starting another treatment|0|||
23668799|NCT03703882|66172233|FG001|Overall Study|Starting another treatment|1|||
23668800|NCT03703882|66172232|FG000|Overall Study|noncompliance with study procedures|0|||
23668801|NCT03703882|66172233|FG001|Overall Study|noncompliance with study procedures|1|||
23668802|NCT02443883|66172234|FG000|Overall Study|Adverse Event|0|||
23668803|NCT02443883|66172235|FG001|Overall Study|Adverse Event|1|||
23668804|NCT02443883|66172236|FG002|Overall Study|Adverse Event|0|||
23668805|NCT02443883|66172237|FG003|Overall Study|Adverse Event|0|||
23668806|NCT02443883|66172234|FG000|Overall Study|Lost to Follow-up|3|||
23668807|NCT02443883|66172235|FG001|Overall Study|Lost to Follow-up|2|||
23668808|NCT02443883|66172236|FG002|Overall Study|Lost to Follow-up|1|||
23668809|NCT02443883|66172237|FG003|Overall Study|Lost to Follow-up|0|||
23668810|NCT02443883|66172234|FG000|Overall Study|Physician Decision|1|||
23668811|NCT02443883|66172235|FG001|Overall Study|Physician Decision|1|||
23668812|NCT02443883|66172236|FG002|Overall Study|Physician Decision|0|||
23668813|NCT02443883|66172237|FG003|Overall Study|Physician Decision|3|||
23668814|NCT02443883|66172234|FG000|Overall Study|Withdrawal by Subject|1|||
23668815|NCT02443883|66172235|FG001|Overall Study|Withdrawal by Subject|0|||
23668816|NCT02443883|66172236|FG002|Overall Study|Withdrawal by Subject|0|||
23668817|NCT02443883|66172237|FG003|Overall Study|Withdrawal by Subject|2|||
23668818|NCT02443883|66172234|FG000|Overall Study|Randomized, but never treated|1|||
23381998|NCT01859741|65144907|FG000|Overall Study|Death|3|||
23668819|NCT02443883|66172235|FG001|Overall Study|Randomized, but never treated|0|||
23668820|NCT02443883|66172236|FG002|Overall Study|Randomized, but never treated|0|||
23668821|NCT02443883|66172237|FG003|Overall Study|Randomized, but never treated|0|||
23668822|NCT02551159|66172238|FG000|Overall Study|Death|352|||
23668823|NCT02551159|66172239|FG001|Overall Study|Death|174|||
23668824|NCT02551159|66172240|FG002|Overall Study|Death|161|||
23668825|NCT02551159|66172238|FG000|Overall Study|Withdrawal by Subject|8|||
23381999|NCT01859741|65144908|FG001|Overall Study|Death|2|||
23382000|NCT01859741|65144909|FG002|Overall Study|Death|4|||
23668826|NCT02551159|66172239|FG001|Overall Study|Withdrawal by Subject|5|||
23668827|NCT02551159|66172240|FG002|Overall Study|Withdrawal by Subject|16|||
23668828|NCT02551159|66172238|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
23668829|NCT02551159|66172239|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
23668830|NCT02551159|66172240|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
23668831|NCT01848288|66172241|FG000|Overall Study|Death|1|||
23668832|NCT01848288|66172241|FG000|Overall Study|Protocol Violation|1|||
23668833|NCT01848288|66172241|FG000|Overall Study|Withdrawal by Subject|1|||
23668834|NCT00490451|66172245|FG000|Overall Study|Adverse Event|3|||
23668835|NCT00490451|66172246|FG001|Overall Study|Adverse Event|3|||
23668836|NCT00490451|66172245|FG000|Overall Study|Death|3|||
23668837|NCT00490451|66172246|FG001|Overall Study|Death|1|||
23668838|NCT00490451|66172245|FG000|Overall Study|Withdrawal by Subject|2|||
23668839|NCT00490451|66172246|FG001|Overall Study|Withdrawal by Subject|0|||
23492471|NCT00474760|65548098|FG005|Overall Study|Adverse Event|7|||
23668840|NCT00490451|66172245|FG000|Overall Study|Investigator Decision|1|||
23382001|NCT01859741|65144910|FG003|Overall Study|Death|3|||
23382002|NCT01859741|65144911|FG004|Overall Study|Death|5|||
23382003|NCT01859741|65144912|FG005|Overall Study|Death|4|||
23382004|NCT01859741|65144913|FG006|Overall Study|Death|51|||
23382005|NCT01859741|65144914|FG007|Overall Study|Death|51|||
23382006|NCT01859741|65144907|FG000|Overall Study|Lost to Follow-up|0|||
23382007|NCT01859741|65144908|FG001|Overall Study|Lost to Follow-up|0|||
23382008|NCT01859741|65144909|FG002|Overall Study|Lost to Follow-up|0|||
23382009|NCT01859741|65144910|FG003|Overall Study|Lost to Follow-up|0|||
23382010|NCT01859741|65144911|FG004|Overall Study|Lost to Follow-up|0|||
23382011|NCT01859741|65144912|FG005|Overall Study|Lost to Follow-up|1|||
23382012|NCT01859741|65144913|FG006|Overall Study|Lost to Follow-up|0|||
23382013|NCT01859741|65144914|FG007|Overall Study|Lost to Follow-up|4|||
23382014|NCT01859741|65144907|FG000|Overall Study|Withdrawal by Subject|0|||
23382015|NCT01859741|65144908|FG001|Overall Study|Withdrawal by Subject|1|||
23382016|NCT01859741|65144909|FG002|Overall Study|Withdrawal by Subject|2|||
23382017|NCT01859741|65144910|FG003|Overall Study|Withdrawal by Subject|0|||
23382018|NCT01859741|65144911|FG004|Overall Study|Withdrawal by Subject|0|||
23382019|NCT01859741|65144912|FG005|Overall Study|Withdrawal by Subject|1|||
23382020|NCT01859741|65144913|FG006|Overall Study|Withdrawal by Subject|1|||
23382021|NCT01859741|65144914|FG007|Overall Study|Withdrawal by Subject|1|||
23382022|NCT01859741|65144907|FG000|Overall Study|Study Terminated by Sponsor|0|||
23382023|NCT01859741|65144908|FG001|Overall Study|Study Terminated by Sponsor|0|||
23382024|NCT01859741|65144909|FG002|Overall Study|Study Terminated by Sponsor|0|||
23382025|NCT01859741|65144910|FG003|Overall Study|Study Terminated by Sponsor|0|||
23382026|NCT01859741|65144911|FG004|Overall Study|Study Terminated by Sponsor|1|||
23382027|NCT01859741|65144912|FG005|Overall Study|Study Terminated by Sponsor|0|||
23492472|NCT00474760|65548099|FG006|Overall Study|Adverse Event|0|||
23668841|NCT00490451|66172246|FG001|Overall Study|Investigator Decision|0|||
23382028|NCT01859741|65144913|FG006|Overall Study|Study Terminated by Sponsor|16|||
23668842|NCT00490451|66172245|FG000|Overall Study|Protocol Violation|1|||
23668843|NCT00490451|66172246|FG001|Overall Study|Protocol Violation|0|||
23382029|NCT01859741|65144914|FG007|Overall Study|Study Terminated by Sponsor|14|||
23492473|NCT00474760|65548093|FG000|Overall Study|Laboratory abnormality|0|||
23668844|NCT00490451|66172245|FG000|Overall Study|Progressive Disease|53|||
23382030|NCT01859741|65144907|FG000|Overall Study|Other|0|||
23382031|NCT01859741|65144908|FG001|Overall Study|Other|0|||
23382032|NCT01859741|65144909|FG002|Overall Study|Other|0|||
23382033|NCT01859741|65144910|FG003|Overall Study|Other|0|||
23382034|NCT01859741|65144911|FG004|Overall Study|Other|0|||
23382035|NCT01859741|65144912|FG005|Overall Study|Other|0|||
23382036|NCT01859741|65144913|FG006|Overall Study|Other|2|||
23382037|NCT01859741|65144914|FG007|Overall Study|Other|0|||
23382038|NCT03422718|65144919|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
23382039|NCT03422718|65144920|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
23382040|NCT03422718|65144921|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
23668845|NCT00490451|66172246|FG001|Overall Study|Progressive Disease|34|||
23668846|NCT03073980|66172249|FG000|Overall Study|Lost to Follow-up|10|||
23668847|NCT03073980|66172250|FG001|Overall Study|Lost to Follow-up|2|||
23668848|NCT03073980|66172251|FG002|Overall Study|Lost to Follow-up|9|||
23668849|NCT03073980|66172249|FG000|Overall Study|No post-procedure data|0|||
23668850|NCT03073980|66172250|FG001|Overall Study|No post-procedure data|0|||
23668851|NCT03073980|66172251|FG002|Overall Study|No post-procedure data|2|||
23668852|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
23668853|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
23668854|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
23668855|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
23382041|NCT03422718|65144922|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
23382042|NCT03422718|65144923|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
23382043|NCT03422718|65144924|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
23382044|NCT03422718|65144925|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
23382045|NCT03422718|65144926|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
23382046|NCT03422718|65144919|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
23382047|NCT03422718|65144920|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
23382048|NCT03422718|65144921|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
23382049|NCT03422718|65144922|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
23382050|NCT03422718|65144923|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
23382051|NCT03422718|65144924|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
23382052|NCT03422718|65144925|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
23382053|NCT03422718|65144926|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
23382054|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
23382055|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
23382056|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
23382057|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382058|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
23382059|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382060|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382061|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
23382062|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382063|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
23382064|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382065|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382066|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
23382067|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
23382068|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382069|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382070|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
23382071|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
23382072|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
23382073|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
23668856|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
23668857|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
23668858|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
23668859|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
23668860|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
23668861|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
23668862|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
23668863|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
23668864|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
23668865|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
23668866|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
23492474|NCT00474760|65548094|FG001|Overall Study|Laboratory abnormality|0|||
23492475|NCT00474760|65548095|FG002|Overall Study|Laboratory abnormality|0|||
23492476|NCT00474760|65548096|FG003|Overall Study|Laboratory abnormality|0|||
23492477|NCT00474760|65548097|FG004|Overall Study|Laboratory abnormality|0|||
23492478|NCT00474760|65548098|FG005|Overall Study|Laboratory abnormality|1|||
23492479|NCT00474760|65548099|FG006|Overall Study|Laboratory abnormality|0|||
23492480|NCT00474760|65548093|FG000|Overall Study|Withdrawal by Subject|0|||
23492481|NCT00474760|65548094|FG001|Overall Study|Withdrawal by Subject|0|||
23492482|NCT00474760|65548095|FG002|Overall Study|Withdrawal by Subject|0|||
23492483|NCT00474760|65548096|FG003|Overall Study|Withdrawal by Subject|1|||
23492484|NCT00474760|65548097|FG004|Overall Study|Withdrawal by Subject|0|||
23492485|NCT00474760|65548098|FG005|Overall Study|Withdrawal by Subject|1|||
23492486|NCT00474760|65548099|FG006|Overall Study|Withdrawal by Subject|1|||
23492487|NCT00474760|65548093|FG000|Overall Study|Other|0|||
23492488|NCT00474760|65548094|FG001|Overall Study|Other|1|||
23492489|NCT00474760|65548095|FG002|Overall Study|Other|0|||
23492490|NCT00474760|65548096|FG003|Overall Study|Other|0|||
23492491|NCT00474760|65548097|FG004|Overall Study|Other|1|||
23492492|NCT00474760|65548098|FG005|Overall Study|Other|0|||
23492493|NCT00474760|65548099|FG006|Overall Study|Other|0|||
23492494|NCT00474760|65548093|FG000|Overall Study|Progressive disease|3|||
23492495|NCT00474760|65548094|FG001|Overall Study|Progressive disease|2|||
23492496|NCT00474760|65548095|FG002|Overall Study|Progressive disease|3|||
23492497|NCT00474760|65548096|FG003|Overall Study|Progressive disease|2|||
23492498|NCT00474760|65548097|FG004|Overall Study|Progressive disease|8|||
23492499|NCT00474760|65548098|FG005|Overall Study|Progressive disease|20|||
23492500|NCT00474760|65548099|FG006|Overall Study|Progressive disease|7|||
23492501|NCT00474760|65548093|FG000|Overall Study|Terminated by sponsor|0|||
23492502|NCT00474760|65548094|FG001|Overall Study|Terminated by sponsor|0|||
23492503|NCT00474760|65548095|FG002|Overall Study|Terminated by sponsor|0|||
23492504|NCT00474760|65548096|FG003|Overall Study|Terminated by sponsor|0|||
23492505|NCT00474760|65548097|FG004|Overall Study|Terminated by sponsor|0|||
23492506|NCT00474760|65548098|FG005|Overall Study|Terminated by sponsor|0|||
23492507|NCT00474760|65548099|FG006|Overall Study|Terminated by sponsor|2|||
23492508|NCT00354614|65548102|FG000|Overall Study|Lack of Efficacy|28|||
23492509|NCT03343067|65548103|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
23492510|NCT03343067|65548104|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
23492511|NCT03343067|65548105|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
23492512|NCT04223973|65548111|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
23492513|NCT04223973|65548112|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
23492514|NCT04223973|65548111|FG000|Overall Study|Adverse Event|4|||
23492515|NCT04223973|65548112|FG001|Overall Study|Adverse Event|0|||
23492516|NCT04223973|65548111|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
23492517|NCT04223973|65548112|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
23492518|NCT04223973|65548111|FG000|Overall Study|Physician Decision|1|||
23492519|NCT04223973|65548112|FG001|Overall Study|Physician Decision|1|||
23492520|NCT04223973|65548111|FG000|Overall Study|Withdrawal by Subject|0|||
23492521|NCT04223973|65548112|FG001|Overall Study|Withdrawal by Subject|1|||
23492522|NCT03576495|65548116|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
23492523|NCT03576495|65548117|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
23492524|NCT01772160|65548126|FG000|Overall Study|Death|3|||
23492525|NCT01772160|65548126|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
23492526|NCT01772160|65548126|FG000|Overall Study|Consent withdrawal|3|||
23492527|NCT01772160|65548126|FG000|Overall Study|Migrated / moved from the study area|4|||
23492528|NCT01772160|65548126|FG000|Overall Study|Lost to Follow-up|30|||
23492529|NCT01772160|65548126|FG000|Overall Study|Other|5|||
23492530|NCT03848065|65548128|FG000|Overall Study|Death|0|||
23492531|NCT03848065|65548129|FG001|Overall Study|Death|1|||
23492532|NCT03848065|65548130|FG002|Overall Study|Death|0|||
23492533|NCT03848065|65548128|FG000|Overall Study|Lost to Follow-up|0|||
23492534|NCT03848065|65548129|FG001|Overall Study|Lost to Follow-up|0|||
23492535|NCT03848065|65548130|FG002|Overall Study|Lost to Follow-up|1|||
23492536|NCT03848065|65548128|FG000|Overall Study|Physician Decision|0|||
23492537|NCT03848065|65548129|FG001|Overall Study|Physician Decision|0|||
23492538|NCT03848065|65548130|FG002|Overall Study|Physician Decision|1|||
23492539|NCT02122458|65548131|FG000|Overall Study|Withdrawal by Subject|0|||
23492540|NCT02122458|65548132|FG001|Overall Study|Withdrawal by Subject|0|||
23492541|NCT02122458|65548133|FG002|Overall Study|Withdrawal by Subject|0|||
23492542|NCT02122458|65548134|FG003|Overall Study|Withdrawal by Subject|4|||
23492543|NCT02122458|65548135|FG004|Overall Study|Withdrawal by Subject|4|||
23492544|NCT02122458|65548136|FG005|Overall Study|Withdrawal by Subject|4|||
23492545|NCT02122458|65548137|FG006|Overall Study|Withdrawal by Subject|0|||
23492546|NCT02122458|65548131|FG000|Overall Study|Lost to Follow-up|1|||
23492547|NCT02122458|65548132|FG001|Overall Study|Lost to Follow-up|3|||
23492548|NCT02122458|65548133|FG002|Overall Study|Lost to Follow-up|0|||
23492549|NCT02122458|65548134|FG003|Overall Study|Lost to Follow-up|7|||
23492550|NCT02122458|65548135|FG004|Overall Study|Lost to Follow-up|5|||
23492551|NCT02122458|65548136|FG005|Overall Study|Lost to Follow-up|15|||
23492552|NCT02122458|65548137|FG006|Overall Study|Lost to Follow-up|1|||
23492553|NCT02122458|65548131|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
23492554|NCT02122458|65548132|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492555|NCT02122458|65548133|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492556|NCT02122458|65548134|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492557|NCT02122458|65548135|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492558|NCT02122458|65548136|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492559|NCT02122458|65548137|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492560|NCT02122458|65548131|FG000|Overall Study|Adverse Event|1|||
23492561|NCT02122458|65548132|FG001|Overall Study|Adverse Event|0|||
23492562|NCT02122458|65548133|FG002|Overall Study|Adverse Event|0|||
23492563|NCT02122458|65548134|FG003|Overall Study|Adverse Event|0|||
23492564|NCT02122458|65548135|FG004|Overall Study|Adverse Event|0|||
23492565|NCT02122458|65548136|FG005|Overall Study|Adverse Event|0|||
23492566|NCT02122458|65548137|FG006|Overall Study|Adverse Event|0|||
23492567|NCT02122458|65548131|FG000|Overall Study|Experimental Error|0|||
23492568|NCT02122458|65548132|FG001|Overall Study|Experimental Error|0|||
23492569|NCT02122458|65548133|FG002|Overall Study|Experimental Error|0|||
23492570|NCT02122458|65548134|FG003|Overall Study|Experimental Error|0|||
23492571|NCT02122458|65548135|FG004|Overall Study|Experimental Error|3|||
23492572|NCT02122458|65548136|FG005|Overall Study|Experimental Error|0|||
23492573|NCT02122458|65548137|FG006|Overall Study|Experimental Error|0|||
23492574|NCT02122458|65548131|FG000|Overall Study|Deployed or Moved|0|||
23492575|NCT02122458|65548132|FG001|Overall Study|Deployed or Moved|0|||
23492576|NCT02122458|65548133|FG002|Overall Study|Deployed or Moved|0|||
23492577|NCT02122458|65548134|FG003|Overall Study|Deployed or Moved|0|||
23492578|NCT02122458|65548135|FG004|Overall Study|Deployed or Moved|1|||
23492579|NCT02122458|65548136|FG005|Overall Study|Deployed or Moved|0|||
23492580|NCT02122458|65548137|FG006|Overall Study|Deployed or Moved|0|||
23492581|NCT02122458|65548131|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492582|NCT02122458|65548132|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492583|NCT02122458|65548133|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492584|NCT02122458|65548134|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
23492585|NCT02122458|65548135|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492586|NCT02122458|65548136|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492587|NCT02122458|65548137|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492588|NCT02122458|65548131|FG000|Overall Study|Noncompliance|0|||
23492589|NCT02122458|65548132|FG001|Overall Study|Noncompliance|1|||
23492590|NCT02122458|65548133|FG002|Overall Study|Noncompliance|0|||
23492591|NCT02122458|65548134|FG003|Overall Study|Noncompliance|0|||
23492592|NCT02122458|65548135|FG004|Overall Study|Noncompliance|0|||
23492593|NCT02122458|65548136|FG005|Overall Study|Noncompliance|0|||
23492594|NCT02122458|65548137|FG006|Overall Study|Noncompliance|0|||
23492595|NCT00304239|65548138|FG000|Overall Study|Protocol Deviations/Violations|15|||
23492596|NCT00304239|65548139|FG001|Overall Study|Protocol Deviations/Violations|0|||
23492597|NCT00304239|65548138|FG000|Overall Study|Adverse Event|2|||
23492598|NCT00304239|65548139|FG001|Overall Study|Adverse Event|0|||
23492599|NCT00191906|65548140|FG000|Study Period II|Adverse Event|0|||
23492600|NCT00191906|65548141|FG001|Study Period II|Adverse Event|1|||
23492601|NCT00191906|65548142|FG002|Study Period II|Adverse Event|0|||
23492602|NCT00191906|65548143|FG003|Study Period II|Adverse Event|0|||
23492603|NCT00191906|65548140|FG000|Study Period II|Withdrawal by Subject|0|||
23492604|NCT00191906|65548141|FG001|Study Period II|Withdrawal by Subject|3|||
23492605|NCT00191906|65548142|FG002|Study Period II|Withdrawal by Subject|0|||
23492606|NCT00191906|65548143|FG003|Study Period II|Withdrawal by Subject|0|||
23492607|NCT00191906|65548140|FG000|Study Period II|Parent/Caregiver Decision|0|||
23492608|NCT00191906|65548141|FG001|Study Period II|Parent/Caregiver Decision|1|||
23492609|NCT00191906|65548142|FG002|Study Period II|Parent/Caregiver Decision|0|||
23492610|NCT00191906|65548143|FG003|Study Period II|Parent/Caregiver Decision|0|||
23492611|NCT00191906|65548140|FG000|Study Period II|Entry Criteria Exclusion|0|||
23492612|NCT00191906|65548141|FG001|Study Period II|Entry Criteria Exclusion|0|||
23492613|NCT00191906|65548142|FG002|Study Period II|Entry Criteria Exclusion|1|||
23492614|NCT00191906|65548143|FG003|Study Period II|Entry Criteria Exclusion|0|||
23668867|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
23492615|NCT00191906|65548140|FG000|Study Period III|Adverse Event|1|||
23492616|NCT00191906|65548141|FG001|Study Period III|Adverse Event|0|||
23492617|NCT00191906|65548142|FG002|Study Period III|Adverse Event|0|||
23492618|NCT00191906|65548143|FG003|Study Period III|Adverse Event|0|||
23492619|NCT00191906|65548140|FG000|Study Period III|Lost to Follow-up|0|||
23492620|NCT00191906|65548141|FG001|Study Period III|Lost to Follow-up|1|||
23492621|NCT00191906|65548142|FG002|Study Period III|Lost to Follow-up|0|||
23492622|NCT00191906|65548143|FG003|Study Period III|Lost to Follow-up|0|||
23492623|NCT00191906|65548140|FG000|Study Period III|Parent/Caregiver Decision|1|||
23492624|NCT00191906|65548141|FG001|Study Period III|Parent/Caregiver Decision|0|||
23492625|NCT00191906|65548142|FG002|Study Period III|Parent/Caregiver Decision|0|||
23492626|NCT00191906|65548143|FG003|Study Period III|Parent/Caregiver Decision|0|||
23492627|NCT00191906|65548140|FG000|Study Period III|Lack of Efficacy|3|||
23492628|NCT00191906|65548141|FG001|Study Period III|Lack of Efficacy|3|||
23492629|NCT00191906|65548142|FG002|Study Period III|Lack of Efficacy|0|||
23492630|NCT00191906|65548143|FG003|Study Period III|Lack of Efficacy|0|||
23492631|NCT00810108|65548144|FG000|Overall Study|Withdrawal by Subject|1|||
23492632|NCT00810108|65548145|FG001|Overall Study|Withdrawal by Subject|0|||
23492633|NCT01160211|65548146|FG000|Overall Study|ongoing|90|||
23492634|NCT01160211|65548147|FG001|Overall Study|ongoing|75|||
23492635|NCT01160211|65548148|FG002|Overall Study|ongoing|79|||
23492636|NCT01160211|65548146|FG000|Overall Study|Withdrawal by Subject|3|||
23492637|NCT01160211|65548147|FG001|Overall Study|Withdrawal by Subject|5|||
23492638|NCT01160211|65548148|FG002|Overall Study|Withdrawal by Subject|3|||
23492639|NCT01160211|65548146|FG000|Overall Study|Physician Decision|2|||
23492640|NCT01160211|65548147|FG001|Overall Study|Physician Decision|0|||
23492641|NCT01160211|65548148|FG002|Overall Study|Physician Decision|0|||
23492642|NCT01160211|65548146|FG000|Overall Study|Lost to Follow-up|4|||
23492643|NCT01160211|65548147|FG001|Overall Study|Lost to Follow-up|7|||
23492644|NCT01160211|65548148|FG002|Overall Study|Lost to Follow-up|5|||
23492645|NCT03540030|65548151|FG000|Overall Study|Withdrawal by Subject|2|||
23492646|NCT03540030|65548152|FG001|Overall Study|Withdrawal by Subject|1|||
23492647|NCT03540030|65548151|FG000|Overall Study|screen fail|7|||
23492648|NCT03540030|65548152|FG001|Overall Study|screen fail|1|||
23492649|NCT03540030|65548151|FG000|Overall Study|never had surgery after signing consent|9|||
23492650|NCT03540030|65548152|FG001|Overall Study|never had surgery after signing consent|1|||
23492651|NCT00864721|65548153|FG000|Overall Study|Patient request|11|||
23668868|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
23668869|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
23492652|NCT00864721|65548153|FG000|Overall Study|Hospitalized|1|||
23492653|NCT00864721|65548153|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
23492654|NCT00864721|65548153|FG000|Overall Study|Adverse Event|21|||
23492655|NCT01967173|65548156|FG000|Overall Study|Lost to Follow-up|5|||
23492656|NCT01967173|65548157|FG001|Overall Study|Lost to Follow-up|3|||
23492657|NCT01967173|65548158|FG002|Overall Study|Lost to Follow-up|2|||
23492658|NCT01967173|65548159|FG003|Overall Study|Lost to Follow-up|4|||
23492659|NCT01967173|65548160|FG004|Overall Study|Lost to Follow-up|8|||
23668870|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
23382074|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
23382075|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
23492660|NCT01967173|65548161|FG005|Overall Study|Lost to Follow-up|12|||
23492661|NCT01967173|65548162|FG006|Overall Study|Lost to Follow-up|6|||
23492662|NCT01967173|65548163|FG007|Overall Study|Lost to Follow-up|8|||
23492663|NCT01967173|65548156|FG000|Overall Study|Physician Decision|2|||
23492664|NCT01967173|65548157|FG001|Overall Study|Physician Decision|0|||
23668871|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
23492665|NCT01967173|65548158|FG002|Overall Study|Physician Decision|2|||
23492666|NCT01967173|65548159|FG003|Overall Study|Physician Decision|1|||
23492667|NCT01967173|65548160|FG004|Overall Study|Physician Decision|1|||
23492668|NCT01967173|65548161|FG005|Overall Study|Physician Decision|1|||
23492669|NCT01967173|65548162|FG006|Overall Study|Physician Decision|1|||
23492670|NCT01967173|65548163|FG007|Overall Study|Physician Decision|0|||
23492671|NCT01967173|65548156|FG000|Overall Study|Lack of Efficacy|2|||
23492672|NCT01967173|65548157|FG001|Overall Study|Lack of Efficacy|0|||
23492673|NCT01967173|65548158|FG002|Overall Study|Lack of Efficacy|2|||
23492674|NCT01967173|65548159|FG003|Overall Study|Lack of Efficacy|2|||
23492675|NCT01967173|65548160|FG004|Overall Study|Lack of Efficacy|0|||
23382076|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
23382077|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
23382078|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
23382079|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
23382080|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
23382081|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
23382082|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
23382083|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
23382084|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
23382085|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
23382086|NCT03147287|65144927|FG000|Overall Study|Randomized Not Treated|2|||
23382087|NCT03147287|65144928|FG001|Overall Study|Randomized Not Treated|1|||
23382088|NCT03147287|65144929|FG002|Overall Study|Randomized Not Treated|1|||
23382089|NCT03147287|65144927|FG000|Overall Study|Progressive Disease RECIST|31|||
23382090|NCT03147287|65144928|FG001|Overall Study|Progressive Disease RECIST|72|||
23382091|NCT03147287|65144929|FG002|Overall Study|Progressive Disease RECIST|32|||
23382092|NCT03147287|65144927|FG000|Overall Study|Progressive Disease not RECIST|13|||
23382093|NCT03147287|65144928|FG001|Overall Study|Progressive Disease not RECIST|21|||
23382094|NCT03147287|65144929|FG002|Overall Study|Progressive Disease not RECIST|13|||
23382095|NCT03147287|65144927|FG000|Overall Study|Physician Decision|1|||
23382096|NCT03147287|65144928|FG001|Overall Study|Physician Decision|2|||
23382097|NCT03147287|65144929|FG002|Overall Study|Physician Decision|1|||
23382098|NCT03147287|65144927|FG000|Overall Study|Intercurrent illness|0|||
23382099|NCT03147287|65144928|FG001|Overall Study|Intercurrent illness|1|||
23382100|NCT03147287|65144929|FG002|Overall Study|Intercurrent illness|0|||
23382101|NCT03147287|65144927|FG000|Overall Study|Withdrawal by Subject|2|||
23382102|NCT03147287|65144928|FG001|Overall Study|Withdrawal by Subject|3|||
23382103|NCT03147287|65144929|FG002|Overall Study|Withdrawal by Subject|2|||
23382104|NCT03147287|65144927|FG000|Overall Study|Patient Non-Compliance|0|||
23382105|NCT03147287|65144928|FG001|Overall Study|Patient Non-Compliance|2|||
23382106|NCT03147287|65144929|FG002|Overall Study|Patient Non-Compliance|0|||
23382107|NCT03147287|65144927|FG000|Overall Study|Patient moved|0|||
23382108|NCT03147287|65144928|FG001|Overall Study|Patient moved|1|||
23382109|NCT03147287|65144929|FG002|Overall Study|Patient moved|0|||
23382110|NCT03147287|65144927|FG000|Overall Study|Arm A crossover without PD|1|||
23382111|NCT03147287|65144928|FG001|Overall Study|Arm A crossover without PD|0|||
23382112|NCT03147287|65144929|FG002|Overall Study|Arm A crossover without PD|0|||
23382113|NCT03147287|65144927|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
23382114|NCT03147287|65144928|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
23382115|NCT03147287|65144929|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
23382116|NCT01531153|65144930|FG000|Overall Study|Withdrawal by Subject|10|||
23382117|NCT01531153|65144931|FG001|Overall Study|Withdrawal by Subject|9|||
23382118|NCT01531153|65144932|FG002|Overall Study|Withdrawal by Subject|15|||
23382119|NCT02034591|65144936|FG000|Overall Study|Withdrawal by Subject|0|||
23382120|NCT02034591|65144937|FG001|Overall Study|Withdrawal by Subject|0|||
23492676|NCT01967173|65548161|FG005|Overall Study|Lack of Efficacy|1|||
23492677|NCT01967173|65548162|FG006|Overall Study|Lack of Efficacy|0|||
23668872|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
23382121|NCT02034591|65144938|FG002|Overall Study|Withdrawal by Subject|0|||
23382122|NCT02034591|65144939|FG003|Overall Study|Withdrawal by Subject|0|||
23382123|NCT02034591|65144940|FG004|Overall Study|Withdrawal by Subject|1|||
23382124|NCT02034591|65144941|FG005|Overall Study|Withdrawal by Subject|0|||
23382125|NCT00790036|65144942|FG000|Overall Study|Abnormal lab values|3|||
23382126|NCT00790036|65144943|FG001|Overall Study|Abnormal lab values|2|||
23492678|NCT01967173|65548163|FG007|Overall Study|Lack of Efficacy|2|||
23492679|NCT01967173|65548156|FG000|Overall Study|Pregnancy|0|||
23492680|NCT01967173|65548157|FG001|Overall Study|Pregnancy|0|||
23492681|NCT01967173|65548158|FG002|Overall Study|Pregnancy|0|||
23492682|NCT01967173|65548159|FG003|Overall Study|Pregnancy|0|||
23492683|NCT01967173|65548160|FG004|Overall Study|Pregnancy|0|||
23492684|NCT01967173|65548161|FG005|Overall Study|Pregnancy|0|||
23492685|NCT01967173|65548162|FG006|Overall Study|Pregnancy|1|||
23492686|NCT01967173|65548163|FG007|Overall Study|Pregnancy|1|||
23492687|NCT01967173|65548156|FG000|Overall Study|Adverse Event|0|||
23492688|NCT01967173|65548157|FG001|Overall Study|Adverse Event|0|||
23492689|NCT01967173|65548158|FG002|Overall Study|Adverse Event|0|||
23492690|NCT01967173|65548159|FG003|Overall Study|Adverse Event|0|||
23492691|NCT01967173|65548160|FG004|Overall Study|Adverse Event|0|||
23492692|NCT01967173|65548161|FG005|Overall Study|Adverse Event|0|||
23492693|NCT01967173|65548162|FG006|Overall Study|Adverse Event|0|||
23492694|NCT01967173|65548163|FG007|Overall Study|Adverse Event|1|||
23492695|NCT01967173|65548156|FG000|Overall Study|Withdrawal by Subject|15|||
23492696|NCT01967173|65548157|FG001|Overall Study|Withdrawal by Subject|14|||
23492697|NCT01967173|65548158|FG002|Overall Study|Withdrawal by Subject|10|||
23492698|NCT01967173|65548159|FG003|Overall Study|Withdrawal by Subject|7|||
23492699|NCT01967173|65548160|FG004|Overall Study|Withdrawal by Subject|8|||
23492700|NCT01967173|65548161|FG005|Overall Study|Withdrawal by Subject|9|||
23492701|NCT01967173|65548162|FG006|Overall Study|Withdrawal by Subject|10|||
23492702|NCT01967173|65548163|FG007|Overall Study|Withdrawal by Subject|12|||
23492703|NCT00735254|65548166|FG000|Overall Study|Protocol Violation|1|||
23492704|NCT00735254|65548167|FG001|Overall Study|Protocol Violation|1|||
23492705|NCT00735254|65548168|FG002|Overall Study|Protocol Violation|1|||
23492706|NCT00735254|65548169|FG003|Overall Study|Protocol Violation|0|||
23492707|NCT04357782|65548170|FG000|Overall Study|Discharged from hospital|1|||
23492708|NCT04357782|65548171|FG001|Overall Study|Discharged from hospital|0|||
23492709|NCT04357782|65548170|FG000|Overall Study|Death|0|||
23492710|NCT04357782|65548171|FG001|Overall Study|Death|2|||
23492711|NCT03113916|65548172|FG000|Overall Study|Withdrawal by Subject|9|||
23492712|NCT03113916|65548173|FG001|Overall Study|Withdrawal by Subject|7|||
23492713|NCT03113916|65548172|FG000|Overall Study|Pregnancy|1|||
23492714|NCT03113916|65548173|FG001|Overall Study|Pregnancy|3|||
23492715|NCT03113916|65548172|FG000|Overall Study|Lost to Follow-up|1|||
23492716|NCT03113916|65548173|FG001|Overall Study|Lost to Follow-up|2|||
23492717|NCT01578330|65548176|FG000|Overall Study|Adverse Event|2|||
23492718|NCT01578330|65548176|FG000|Overall Study|Protocol Violation|5|||
23492719|NCT02121522|65548177|FG000|Overall Study|Adverse Event|1|||
23492720|NCT01612858|65548178|FG000|Overall Study|Withdrawal by Subject|5|||
23492721|NCT01612858|65548179|FG001|Overall Study|Withdrawal by Subject|1|||
23492722|NCT01042678|65548180|FG000|Overall Study|Physician Decision|1|||
23492723|NCT01042678|65548181|FG001|Overall Study|Physician Decision|0|||
23492724|NCT01042678|65548182|FG002|Overall Study|Physician Decision|0|||
23492725|NCT01042678|65548183|FG003|Overall Study|Physician Decision|0|||
23492726|NCT01042678|65548184|FG004|Overall Study|Physician Decision|0|||
23492727|NCT01042678|65548185|FG005|Overall Study|Physician Decision|0|||
23492728|NCT04308304|65548188|FG000|Overall Study|Withdrawal by Subject|4|||
23492729|NCT04308304|65548189|FG001|Overall Study|Withdrawal by Subject|0|||
23492730|NCT04308304|65548188|FG000|Overall Study|Protocol Violation|1|||
23492731|NCT04308304|65548189|FG001|Overall Study|Protocol Violation|0|||
23492732|NCT00595465|65548190|FG000|Overall Study|Adverse Event|4|||
23492733|NCT00595465|65548191|FG001|Overall Study|Adverse Event|3|||
23668873|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
23668874|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
23668875|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
23668876|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
23668877|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
23668878|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
23668879|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
23668880|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
23668881|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
23668882|NCT00784654|66172252|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
23668883|NCT00784654|66172253|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
23668884|NCT00784654|66172254|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
23668885|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
23668886|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
23668887|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
23668888|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
23668889|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
23668890|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
23668891|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23668892|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23668893|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
23668894|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
23668895|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
23668896|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
23668897|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23668898|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Adverse Event|1|||
23668899|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Adverse Event|1|||
23492734|NCT00595465|65548192|FG002|Overall Study|Adverse Event|3|||
23492735|NCT00595465|65548190|FG000|Overall Study|Pregnancy|0|||
23492736|NCT00595465|65548191|FG001|Overall Study|Pregnancy|0|||
23492737|NCT00595465|65548192|FG002|Overall Study|Pregnancy|1|||
23492738|NCT00595465|65548190|FG000|Overall Study|Protocol Violation|2|||
23492739|NCT00595465|65548191|FG001|Overall Study|Protocol Violation|1|||
23492740|NCT00595465|65548192|FG002|Overall Study|Protocol Violation|0|||
23492741|NCT00595465|65548190|FG000|Overall Study|Lost to Follow-up|0|||
23492742|NCT00595465|65548191|FG001|Overall Study|Lost to Follow-up|0|||
23492743|NCT00595465|65548192|FG002|Overall Study|Lost to Follow-up|2|||
23492744|NCT00595465|65548190|FG000|Overall Study|administrative reason|0|||
23492745|NCT00595465|65548191|FG001|Overall Study|administrative reason|0|||
23492746|NCT00595465|65548192|FG002|Overall Study|administrative reason|1|||
23492747|NCT00406718|65548195|FG000|Overall Study|Withdrawal by Subject|2|||
23492748|NCT00406718|65548196|FG001|Overall Study|Withdrawal by Subject|9|||
23492749|NCT00406718|65548197|FG002|Overall Study|Withdrawal by Subject|4|||
23492750|NCT00406718|65548195|FG000|Overall Study|Lost to Follow-up|2|||
23492751|NCT00406718|65548196|FG001|Overall Study|Lost to Follow-up|5|||
23492752|NCT00406718|65548197|FG002|Overall Study|Lost to Follow-up|4|||
23668900|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
23668901|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
23668902|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
23668903|NCT00784654|66172252|FG000|Randomized Withdrawal Period|Family reasons|0|||
23668904|NCT00784654|66172253|FG001|Randomized Withdrawal Period|Family reasons|0|||
23668905|NCT00784654|66172254|FG002|Randomized Withdrawal Period|Family reasons|1|||
23668906|NCT03223428|66172257|FG000|Overall Study|No longer taking Xermelo|27|||
23492753|NCT01868503|65548198|FG000|Overall Study|Withdrawal by Subject|1|||
23492754|NCT01868503|65548198|FG000|Overall Study|Protocol Violation|1|||
23492755|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
23492756|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
23492757|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Physician Decision|1|||
23492758|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Physician Decision|0|||
23492759|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
23492760|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
23492761|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
23492762|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
23492763|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Adverse Event|15|||
23492764|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Adverse Event|0|||
23492765|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
23492766|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
23492767|NCT03277690|65548199|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
23492768|NCT03277690|65548200|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
23668907|NCT03223428|66172257|FG000|Overall Study|Declined Consent|1|||
23668908|NCT03223428|66172257|FG000|Overall Study|Non-responders|56|||
23668909|NCT03223428|66172257|FG000|Overall Study|Withdrawal by Subject|14|||
23668910|NCT01372384|66172258|FG000|Overall Study|Progression of disease|3|||
23668911|NCT00885703|66172259|FG000|Overall Study|Death|9|||
23668912|NCT00885703|66172260|FG001|Overall Study|Death|7|||
23668913|NCT00885703|66172261|FG002|Overall Study|Death|8|||
23668914|NCT00885703|66172262|FG003|Overall Study|Death|7|||
23668915|NCT00885703|66172263|FG004|Overall Study|Death|7|||
23668916|NCT00885703|66172264|FG005|Overall Study|Death|8|||
23668917|NCT00885703|66172265|FG006|Overall Study|Death|4|||
23668918|NCT00885703|66172259|FG000|Overall Study|Lost to Follow-up|0|||
23668919|NCT00885703|66172260|FG001|Overall Study|Lost to Follow-up|0|||
23668920|NCT00885703|66172261|FG002|Overall Study|Lost to Follow-up|1|||
23668921|NCT00885703|66172262|FG003|Overall Study|Lost to Follow-up|0|||
23668922|NCT00885703|66172263|FG004|Overall Study|Lost to Follow-up|0|||
23668923|NCT00885703|66172264|FG005|Overall Study|Lost to Follow-up|1|||
23668924|NCT00885703|66172265|FG006|Overall Study|Lost to Follow-up|0|||
23668925|NCT00885703|66172259|FG000|Overall Study|Withdrawal by Subject|0|||
23668926|NCT00885703|66172260|FG001|Overall Study|Withdrawal by Subject|0|||
23668927|NCT00885703|66172261|FG002|Overall Study|Withdrawal by Subject|0|||
23668928|NCT00885703|66172262|FG003|Overall Study|Withdrawal by Subject|1|||
23668929|NCT00885703|66172263|FG004|Overall Study|Withdrawal by Subject|3|||
23668930|NCT00885703|66172264|FG005|Overall Study|Withdrawal by Subject|1|||
23668931|NCT00885703|66172265|FG006|Overall Study|Withdrawal by Subject|1|||
23668932|NCT00885703|66172259|FG000|Overall Study|Ineligible (no CM)|1|||
23668933|NCT00885703|66172260|FG001|Overall Study|Ineligible (no CM)|3|||
23492769|NCT02038881|65548209|FG000|Overall Study|Withdrawal by Subject|0|||
23492770|NCT02038881|65548210|FG001|Overall Study|Withdrawal by Subject|0|||
23668934|NCT00885703|66172261|FG002|Overall Study|Ineligible (no CM)|2|||
23668935|NCT00885703|66172262|FG003|Overall Study|Ineligible (no CM)|1|||
23668936|NCT00885703|66172263|FG004|Overall Study|Ineligible (no CM)|2|||
23668937|NCT00885703|66172264|FG005|Overall Study|Ineligible (no CM)|3|||
23668938|NCT00885703|66172265|FG006|Overall Study|Ineligible (no CM)|1|||
23668939|NCT02728830|66172266|FG000|Overall Study|Exclusionary Surgery|9|||
23668940|NCT02728830|66172266|FG000|Overall Study|Exclusionary Pathology|6|||
23668941|NCT02728830|66172266|FG000|Overall Study|Physician Decision|3|||
23668942|NCT02728830|66172266|FG000|Overall Study|Withdrawal by Subject|2|||
23668943|NCT02728830|66172266|FG000|Overall Study|Lost to Follow-up|1|||
23668944|NCT02728830|66172266|FG000|Overall Study|Exclusionary Lab Values|1|||
23668945|NCT02728830|66172266|FG000|Overall Study|Contraindicated Illness|1|||
23492771|NCT02038881|65548211|FG002|Overall Study|Withdrawal by Subject|1|||
23492772|NCT02038881|65548209|FG000|Overall Study|Lost to Follow-up|2|||
23492773|NCT02038881|65548210|FG001|Overall Study|Lost to Follow-up|0|||
23492774|NCT02038881|65548211|FG002|Overall Study|Lost to Follow-up|0|||
23492775|NCT02038881|65548209|FG000|Overall Study|incarcerated|1|||
23492776|NCT02038881|65548210|FG001|Overall Study|incarcerated|0|||
23492777|NCT02038881|65548211|FG002|Overall Study|incarcerated|0|||
23492778|NCT01254331|65548212|FG000|Initial Phase|Adverse Event|3|||
23492779|NCT01254331|65548212|FG000|Initial Phase|Withdrawal by Subject|1|||
23492780|NCT01254331|65548212|FG000|Initial Phase|Pregnancy|1|||
23492781|NCT01254331|65548212|FG000|Extension Phase|Lack of Efficacy|1|||
23492782|NCT01254331|65548212|FG000|Extension Phase|Lost to Follow-up|3|||
23492783|NCT00808483|65548213|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
23492784|NCT00808483|65548214|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
23492785|NCT00808483|65548213|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
23492786|NCT00808483|65548214|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
23492787|NCT00808483|65548213|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
23492788|NCT00808483|65548214|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
23492789|NCT02410551|65548215|FG000|Overall Study|Adverse Event|1|||
23492790|NCT02410551|65548215|FG000|Overall Study|Withdrawal by Subject|1|||
23492791|NCT02410551|65548215|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
23492792|NCT03096483|65548216|FG000|Overall Study|Withdrawal by site|1|||
23492793|NCT00354744|65548219|FG000|Overall Study|Adverse Event|2|||
23492794|NCT00354744|65548219|FG000|Overall Study|Death|2|||
23492795|NCT00354744|65548219|FG000|Overall Study|Lack of Efficacy|11|||
23492796|NCT00354744|65548219|FG000|Overall Study|Lost to Follow-up|2|||
23492797|NCT00354744|65548219|FG000|Overall Study|Physician Decision|11|||
23492798|NCT00354744|65548219|FG000|Overall Study|Withdrawal by Subject|14|||
23492799|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
23492800|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
23492801|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
23492802|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
23492803|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
23492804|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
23492805|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
23492806|NCT00445978|65548223|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
23492807|NCT00445978|65548223|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
23492808|NCT03954132|65548226|FG000|Overall Study|Adverse Event|2|||
23492809|NCT03954132|65548227|FG001|Overall Study|Adverse Event|0|||
23492810|NCT03954132|65548226|FG000|Overall Study|Patient's wish|5|||
23492811|NCT03954132|65548227|FG001|Overall Study|Patient's wish|0|||
23492812|NCT03954132|65548226|FG000|Overall Study|Lost to Follow-up|10|||
23492813|NCT03954132|65548227|FG001|Overall Study|Lost to Follow-up|0|||
23492814|NCT03954132|65548226|FG000|Overall Study|Screening failure|0|||
23492815|NCT03954132|65548227|FG001|Overall Study|Screening failure|1|||
23492816|NCT03954132|65548226|FG000|Overall Study|No registration after Visit 1|5|||
23492817|NCT03954132|65548227|FG001|Overall Study|No registration after Visit 1|2|||
23492818|NCT03954132|65548226|FG000|Overall Study|Other reason than listed|2|||
23492819|NCT03954132|65548227|FG001|Overall Study|Other reason than listed|2|||
23492820|NCT03954132|65548226|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
23492821|NCT03954132|65548227|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
23492822|NCT03954132|65548226|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
23492823|NCT03954132|65548227|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
23492824|NCT00331864|65548232|FG000|Overall Study|Adverse Event|30|||
23492825|NCT00331864|65548233|FG001|Overall Study|Adverse Event|1|||
23492826|NCT00331864|65548232|FG000|Overall Study|Lack of Efficacy|4|||
23492827|NCT00331864|65548233|FG001|Overall Study|Lack of Efficacy|0|||
23492828|NCT00331864|65548232|FG000|Overall Study|Protocol Violation|3|||
23492829|NCT00331864|65548233|FG001|Overall Study|Protocol Violation|0|||
23492830|NCT00331864|65548232|FG000|Overall Study|Withdrawal by Subject|10|||
23492831|NCT00331864|65548233|FG001|Overall Study|Withdrawal by Subject|0|||
23492832|NCT00331864|65548232|FG000|Overall Study|Lost to Follow-up|4|||
23492833|NCT00331864|65548233|FG001|Overall Study|Lost to Follow-up|3|||
23492834|NCT00331864|65548232|FG000|Overall Study|Administrative Problems|1|||
23492835|NCT00331864|65548233|FG001|Overall Study|Administrative Problems|0|||
23668946|NCT02728830|66172266|FG000|Overall Study|Language Barrier|1|||
23668947|NCT00464334|66172267|FG000|Overall Study|Adverse Event|0|||
23492836|NCT00331864|65548232|FG000|Overall Study|Death|6|||
23492837|NCT00331864|65548233|FG001|Overall Study|Death|0|||
23492838|NCT02360995|65548234|FG000|Overall Study|Lost to Follow-up|2|||
23492839|NCT02360995|65548235|FG001|Overall Study|Lost to Follow-up|0|||
23492840|NCT02360995|65548236|FG002|Overall Study|Lost to Follow-up|2|||
23492841|NCT02360995|65548234|FG000|Overall Study|Withdrawal by Subject|0|||
23668948|NCT00464334|66172268|FG001|Overall Study|Adverse Event|0|||
23668949|NCT00464334|66172269|FG002|Overall Study|Adverse Event|0|||
23668950|NCT00464334|66172270|FG003|Overall Study|Adverse Event|1|||
23668951|NCT00464334|66172271|FG004|Overall Study|Adverse Event|1|||
23668952|NCT00464334|66172272|FG005|Overall Study|Adverse Event|1|||
23668953|NCT00464334|66172273|FG006|Overall Study|Adverse Event|0|||
23668954|NCT00464334|66172274|FG007|Overall Study|Adverse Event|0|||
23668955|NCT00464334|66172275|FG008|Overall Study|Adverse Event|2|||
23668956|NCT00464334|66172276|FG009|Overall Study|Adverse Event|1|||
23668957|NCT00464334|66172277|FG010|Overall Study|Adverse Event|2|||
23668958|NCT00464334|66172267|FG000|Overall Study|Lack of Efficacy|0|||
23668959|NCT00464334|66172268|FG001|Overall Study|Lack of Efficacy|1|||
23668960|NCT00464334|66172269|FG002|Overall Study|Lack of Efficacy|0|||
23668961|NCT00464334|66172270|FG003|Overall Study|Lack of Efficacy|0|||
23382127|NCT00790036|65144942|FG000|Overall Study|Administrative problems|5|||
23382128|NCT00790036|65144943|FG001|Overall Study|Administrative problems|9|||
23382129|NCT00790036|65144942|FG000|Overall Study|Adverse Event|113|||
23382130|NCT00790036|65144943|FG001|Overall Study|Adverse Event|44|||
23382131|NCT00790036|65144942|FG000|Overall Study|Death|1|||
23382132|NCT00790036|65144943|FG001|Overall Study|Death|0|||
23382133|NCT00790036|65144942|FG000|Overall Study|Disease progression|24|||
23382134|NCT00790036|65144943|FG001|Overall Study|Disease progression|48|||
23382135|NCT00790036|65144942|FG000|Overall Study|Lost to Follow-up|1|||
23382136|NCT00790036|65144943|FG001|Overall Study|Lost to Follow-up|2|||
23382137|NCT00790036|65144942|FG000|Overall Study|Protocol Violation|10|||
23382138|NCT00790036|65144943|FG001|Overall Study|Protocol Violation|2|||
23382139|NCT00790036|65144942|FG000|Overall Study|Withdrawal by Subject|18|||
23382140|NCT00790036|65144943|FG001|Overall Study|Withdrawal by Subject|7|||
23382141|NCT00790036|65144942|FG000|Overall Study|Subject/guardian decision|20|||
23382142|NCT00790036|65144943|FG001|Overall Study|Subject/guardian decision|7|||
23382143|NCT01068912|65144946|FG000|Overall Study|Adverse Event|2|||
23492842|NCT02360995|65548235|FG001|Overall Study|Withdrawal by Subject|1|||
23492843|NCT02360995|65548236|FG002|Overall Study|Withdrawal by Subject|0|||
23492844|NCT01756053|65548237|FG000|Period 1 (10 Days)|Protocol Violation|1|||
23492845|NCT01756053|65548238|FG001|Period 1 (10 Days)|Protocol Violation|1|||
23492846|NCT01756053|65548237|FG000|Period 2 (10 Days)|Protocol Violation|0|||
23492847|NCT01756053|65548238|FG001|Period 2 (10 Days)|Protocol Violation|2|||
23492848|NCT02651467|65548239|FG000|Overall Study|Withdrawal by Subject|0|||
23492849|NCT02651467|65548240|FG001|Overall Study|Withdrawal by Subject|0|||
23492850|NCT02651467|65548241|FG002|Overall Study|Withdrawal by Subject|2|||
23492851|NCT02651467|65548239|FG000|Overall Study|Other (Not specified)|1|||
23492852|NCT02651467|65548240|FG001|Overall Study|Other (Not specified)|0|||
23492853|NCT02651467|65548241|FG002|Overall Study|Other (Not specified)|2|||
23668962|NCT00464334|66172271|FG004|Overall Study|Lack of Efficacy|0|||
23382144|NCT01068912|65144947|FG001|Overall Study|Adverse Event|3|||
23382145|NCT01068912|65144948|FG002|Overall Study|Adverse Event|2|||
23382146|NCT01068912|65144946|FG000|Overall Study|Withdrawal by Subject|5|||
23668963|NCT00464334|66172272|FG005|Overall Study|Lack of Efficacy|0|||
23668964|NCT00464334|66172273|FG006|Overall Study|Lack of Efficacy|0|||
23668965|NCT00464334|66172274|FG007|Overall Study|Lack of Efficacy|0|||
23382147|NCT01068912|65144947|FG001|Overall Study|Withdrawal by Subject|6|||
23492854|NCT02764333|65548242|FG000|Overall Study|Ineligible|1|||
23382148|NCT01068912|65144948|FG002|Overall Study|Withdrawal by Subject|6|||
23382149|NCT01068912|65144946|FG000|Overall Study|Lost to Follow-up|3|||
23382150|NCT01068912|65144947|FG001|Overall Study|Lost to Follow-up|7|||
23382151|NCT01068912|65144948|FG002|Overall Study|Lost to Follow-up|3|||
23382152|NCT01068912|65144946|FG000|Overall Study|Protocol Violation|0|||
23382153|NCT01068912|65144947|FG001|Overall Study|Protocol Violation|2|||
23382154|NCT01068912|65144948|FG002|Overall Study|Protocol Violation|0|||
23382155|NCT01068912|65144946|FG000|Overall Study|aggravation influenza|1|||
23382156|NCT01068912|65144947|FG001|Overall Study|aggravation influenza|1|||
23382157|NCT01068912|65144948|FG002|Overall Study|aggravation influenza|1|||
23382158|NCT01068912|65144946|FG000|Overall Study|other underlying illness|0|||
23382159|NCT01068912|65144947|FG001|Overall Study|other underlying illness|3|||
23382160|NCT01068912|65144948|FG002|Overall Study|other underlying illness|3|||
23382161|NCT01058005|65144949|FG000|Overall Study|Adverse Event|0|||
23382162|NCT01058005|65144950|FG001|Overall Study|Adverse Event|2|||
23382163|NCT01058005|65144951|FG002|Overall Study|Adverse Event|1|||
23382164|NCT01058005|65144949|FG000|Overall Study|Physician Decision|2|||
23382165|NCT01058005|65144950|FG001|Overall Study|Physician Decision|2|||
23382166|NCT01058005|65144951|FG002|Overall Study|Physician Decision|0|||
23382167|NCT01058005|65144949|FG000|Overall Study|Withdrawal by Subject|4|||
23382168|NCT01058005|65144950|FG001|Overall Study|Withdrawal by Subject|5|||
23382169|NCT01058005|65144951|FG002|Overall Study|Withdrawal by Subject|11|||
23382170|NCT01058005|65144949|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
23382171|NCT01058005|65144950|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
23382172|NCT01058005|65144951|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
23382173|NCT01058005|65144949|FG000|Overall Study|Reason Missing|5|||
23382174|NCT01058005|65144950|FG001|Overall Study|Reason Missing|3|||
23382175|NCT01058005|65144951|FG002|Overall Study|Reason Missing|1|||
23382176|NCT00456612|65144959|FG000|Overall Study|Withdrawal by Subject|3|||
23382177|NCT01214720|65144960|FG000|Overall Study|Alive and still on treatment|34|||
23382178|NCT01214720|65144961|FG001|Overall Study|Alive and still on treatment|18|||
23382179|NCT01214720|65144960|FG000|Overall Study|Alive and in follow-up|45|||
23382180|NCT01214720|65144961|FG001|Overall Study|Alive and in follow-up|48|||
23382181|NCT01214720|65144960|FG000|Overall Study|Lost to Follow-up|6|||
23382182|NCT01214720|65144961|FG001|Overall Study|Lost to Follow-up|2|||
23382183|NCT03339453|65144962|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
23382184|NCT03339453|65144963|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
23382185|NCT04795323|65144970|FG000|Overall Study|Did not interact with TARA|1|||
23382186|NCT04795323|65144971|FG001|Overall Study|Did not interact with TARA|0|||
23382187|NCT00855582|65144972|FG000|Overall Study|Adverse Event|2|||
23382188|NCT00855582|65144973|FG001|Overall Study|Adverse Event|6|||
23382189|NCT00855582|65144974|FG002|Overall Study|Adverse Event|3|||
23382190|NCT00855582|65144972|FG000|Overall Study|Death|1|||
23382191|NCT00855582|65144973|FG001|Overall Study|Death|0|||
23382192|NCT00855582|65144974|FG002|Overall Study|Death|0|||
23382193|NCT00855582|65144972|FG000|Overall Study|Lack of Efficacy|1|||
23382194|NCT00855582|65144973|FG001|Overall Study|Lack of Efficacy|3|||
23382195|NCT00855582|65144974|FG002|Overall Study|Lack of Efficacy|8|||
23382196|NCT00855582|65144972|FG000|Overall Study|Lost to Follow-up|1|||
23668966|NCT00464334|66172275|FG008|Overall Study|Lack of Efficacy|0|||
23668967|NCT00464334|66172276|FG009|Overall Study|Lack of Efficacy|0|||
23382197|NCT00855582|65144973|FG001|Overall Study|Lost to Follow-up|3|||
23492855|NCT02281773|65548243|FG000|Overall Study|Adverse Event|6|||
23492856|NCT02281773|65548244|FG001|Overall Study|Adverse Event|1|||
23492857|NCT02281773|65548245|FG002|Overall Study|Adverse Event|4|||
23492858|NCT02281773|65548246|FG003|Overall Study|Adverse Event|8|||
23492859|NCT02281773|65548247|FG004|Overall Study|Adverse Event|9|||
23492860|NCT02281773|65548243|FG000|Overall Study|Protocol Violation|1|||
23492861|NCT02281773|65548244|FG001|Overall Study|Protocol Violation|0|||
23492862|NCT02281773|65548245|FG002|Overall Study|Protocol Violation|0|||
23382198|NCT00855582|65144974|FG002|Overall Study|Lost to Follow-up|1|||
23492863|NCT02281773|65548246|FG003|Overall Study|Protocol Violation|2|||
23492864|NCT02281773|65548247|FG004|Overall Study|Protocol Violation|2|||
23492865|NCT02281773|65548243|FG000|Overall Study|Lost to Follow-up|2|||
23492866|NCT02281773|65548244|FG001|Overall Study|Lost to Follow-up|2|||
23668968|NCT00464334|66172277|FG010|Overall Study|Lack of Efficacy|0|||
23382199|NCT00855582|65144972|FG000|Overall Study|Physician Decision|0|||
23382200|NCT00855582|65144973|FG001|Overall Study|Physician Decision|0|||
23382201|NCT00855582|65144974|FG002|Overall Study|Physician Decision|1|||
23382202|NCT00855582|65144972|FG000|Overall Study|Protocol Violation|6|||
23382203|NCT00855582|65144973|FG001|Overall Study|Protocol Violation|2|||
23492867|NCT02281773|65548245|FG002|Overall Study|Lost to Follow-up|6|||
23492868|NCT02281773|65548246|FG003|Overall Study|Lost to Follow-up|2|||
23492869|NCT02281773|65548247|FG004|Overall Study|Lost to Follow-up|10|||
23382204|NCT00855582|65144974|FG002|Overall Study|Protocol Violation|6|||
23382205|NCT00855582|65144972|FG000|Overall Study|Entry Criteria Not Met|8|||
23382206|NCT00855582|65144973|FG001|Overall Study|Entry Criteria Not Met|6|||
23382207|NCT00855582|65144974|FG002|Overall Study|Entry Criteria Not Met|3|||
23668969|NCT00464334|66172267|FG000|Overall Study|Lost to Follow-up|0|||
23668970|NCT00464334|66172268|FG001|Overall Study|Lost to Follow-up|0|||
23605960|NCT01640951|65947106|FG005|Overall Study|Protocol Deviation|1|||
23668971|NCT00464334|66172269|FG002|Overall Study|Lost to Follow-up|1|||
23668972|NCT00464334|66172270|FG003|Overall Study|Lost to Follow-up|0|||
23668973|NCT00464334|66172271|FG004|Overall Study|Lost to Follow-up|1|||
23668974|NCT00464334|66172272|FG005|Overall Study|Lost to Follow-up|0|||
23668975|NCT00464334|66172273|FG006|Overall Study|Lost to Follow-up|1|||
23668976|NCT00464334|66172274|FG007|Overall Study|Lost to Follow-up|0|||
23668977|NCT00464334|66172275|FG008|Overall Study|Lost to Follow-up|0|||
23668978|NCT00464334|66172276|FG009|Overall Study|Lost to Follow-up|0|||
23668979|NCT00464334|66172277|FG010|Overall Study|Lost to Follow-up|2|||
23668980|NCT00464334|66172267|FG000|Overall Study|Progressive Disease|0|||
23668981|NCT00464334|66172268|FG001|Overall Study|Progressive Disease|0|||
23382208|NCT00855582|65144972|FG000|Overall Study|Withdrawal by Subject|7|||
23382209|NCT00855582|65144973|FG001|Overall Study|Withdrawal by Subject|4|||
23668982|NCT00464334|66172269|FG002|Overall Study|Progressive Disease|0|||
23668983|NCT00464334|66172270|FG003|Overall Study|Progressive Disease|0|||
23668984|NCT00464334|66172271|FG004|Overall Study|Progressive Disease|0|||
23668985|NCT00464334|66172272|FG005|Overall Study|Progressive Disease|1|||
23668986|NCT00464334|66172273|FG006|Overall Study|Progressive Disease|0|||
23668987|NCT00464334|66172274|FG007|Overall Study|Progressive Disease|0|||
23668988|NCT00464334|66172275|FG008|Overall Study|Progressive Disease|1|||
23668989|NCT00464334|66172276|FG009|Overall Study|Progressive Disease|0|||
23668990|NCT00464334|66172277|FG010|Overall Study|Progressive Disease|0|||
23668991|NCT00464334|66172267|FG000|Overall Study|Study Terminated by Sponsor|0|||
23668992|NCT00464334|66172268|FG001|Overall Study|Study Terminated by Sponsor|0|||
23668993|NCT00464334|66172269|FG002|Overall Study|Study Terminated by Sponsor|0|||
23668994|NCT00464334|66172270|FG003|Overall Study|Study Terminated by Sponsor|1|||
23668995|NCT00464334|66172271|FG004|Overall Study|Study Terminated by Sponsor|0|||
23668996|NCT00464334|66172272|FG005|Overall Study|Study Terminated by Sponsor|0|||
23668997|NCT00464334|66172273|FG006|Overall Study|Study Terminated by Sponsor|0|||
23668998|NCT00464334|66172274|FG007|Overall Study|Study Terminated by Sponsor|0|||
23668999|NCT00464334|66172275|FG008|Overall Study|Study Terminated by Sponsor|0|||
23669000|NCT00464334|66172276|FG009|Overall Study|Study Terminated by Sponsor|0|||
23669001|NCT00464334|66172277|FG010|Overall Study|Study Terminated by Sponsor|0|||
23669002|NCT00464334|66172267|FG000|Overall Study|Withdrawal by Subject|1|||
23669003|NCT00464334|66172268|FG001|Overall Study|Withdrawal by Subject|7|||
23669004|NCT00464334|66172269|FG002|Overall Study|Withdrawal by Subject|4|||
23669005|NCT00464334|66172270|FG003|Overall Study|Withdrawal by Subject|2|||
23669006|NCT00464334|66172271|FG004|Overall Study|Withdrawal by Subject|2|||
23669007|NCT00464334|66172272|FG005|Overall Study|Withdrawal by Subject|2|||
23382210|NCT00855582|65144974|FG002|Overall Study|Withdrawal by Subject|8|||
23382211|NCT02762604|65144980|FG000|Overall Study|Lost to Follow-up|2|||
23382212|NCT02762604|65144981|FG001|Overall Study|Lost to Follow-up|7|||
23382213|NCT02762604|65144980|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
23382214|NCT02762604|65144981|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
23382215|NCT00784875|65144982|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
23382216|NCT00784875|65144983|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
23382217|NCT00784875|65144984|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
23382218|NCT00784875|65144985|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
23382219|NCT00784875|65144982|FG000|Period A - Baseline|Adverse Event|0|||
23382220|NCT00784875|65144983|FG001|Period A - Baseline|Adverse Event|0|||
23382221|NCT00784875|65144984|FG002|Period A - Baseline|Adverse Event|0|||
23382222|NCT00784875|65144985|FG003|Period A - Baseline|Adverse Event|8|||
23382223|NCT00784875|65144982|FG000|Period A - Baseline|Protocol Violation|0|||
23382224|NCT00784875|65144983|FG001|Period A - Baseline|Protocol Violation|0|||
23382225|NCT00784875|65144984|FG002|Period A - Baseline|Protocol Violation|0|||
23382226|NCT00784875|65144985|FG003|Period A - Baseline|Protocol Violation|25|||
23382227|NCT00784875|65144982|FG000|Period A - Baseline|Withdrawal by Subject|0|||
23382228|NCT00784875|65144983|FG001|Period A - Baseline|Withdrawal by Subject|0|||
23382229|NCT00784875|65144984|FG002|Period A - Baseline|Withdrawal by Subject|0|||
23382230|NCT00784875|65144985|FG003|Period A - Baseline|Withdrawal by Subject|27|||
23382231|NCT00784875|65144982|FG000|Period A - Baseline|Physician Decision|0|||
23382232|NCT00784875|65144983|FG001|Period A - Baseline|Physician Decision|0|||
23382233|NCT00784875|65144984|FG002|Period A - Baseline|Physician Decision|0|||
23382234|NCT00784875|65144985|FG003|Period A - Baseline|Physician Decision|2|||
23382235|NCT00784875|65144982|FG000|Period A - Baseline|Sponsor Decision|0|||
23382236|NCT00784875|65144983|FG001|Period A - Baseline|Sponsor Decision|0|||
23382237|NCT00784875|65144984|FG002|Period A - Baseline|Sponsor Decision|0|||
23382238|NCT00784875|65144985|FG003|Period A - Baseline|Sponsor Decision|113|||
23382239|NCT00784875|65144982|FG000|Period A - Baseline|Lost to Follow-up|0|||
23382240|NCT00784875|65144983|FG001|Period A - Baseline|Lost to Follow-up|0|||
23382241|NCT00784875|65144984|FG002|Period A - Baseline|Lost to Follow-up|0|||
23382242|NCT00784875|65144985|FG003|Period A - Baseline|Lost to Follow-up|2|||
23382243|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
23382244|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
23669008|NCT00464334|66172273|FG006|Overall Study|Withdrawal by Subject|2|||
23669009|NCT00464334|66172274|FG007|Overall Study|Withdrawal by Subject|1|||
23669010|NCT00464334|66172275|FG008|Overall Study|Withdrawal by Subject|3|||
23669011|NCT00464334|66172276|FG009|Overall Study|Withdrawal by Subject|0|||
23669012|NCT00464334|66172277|FG010|Overall Study|Withdrawal by Subject|0|||
23669013|NCT02192827|66172281|FG000|Overall Study|Lost to Follow-up|25|||
23669014|NCT02192827|66172282|FG001|Overall Study|Lost to Follow-up|27|||
23669015|NCT02192827|66172281|FG000|Overall Study|Given additional steroids with admission|13|||
23669016|NCT02192827|66172282|FG001|Overall Study|Given additional steroids with admission|11|||
23382245|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
23382246|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
23382247|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
23382248|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
23382249|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
23382250|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
23382251|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
23382252|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
23382253|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
23382254|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
23382255|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382256|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
23382257|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382258|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382259|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
23382260|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
23382261|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
23382262|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
23382263|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
23382264|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
23382265|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
23382266|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
23382267|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
23382268|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
23382269|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
23382270|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
23382271|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382272|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382273|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
23382274|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382275|NCT00784875|65144982|FG000|Period C|Adverse Event|1|||
23382276|NCT00784875|65144983|FG001|Period C|Adverse Event|0|||
23382277|NCT00784875|65144984|FG002|Period C|Adverse Event|4|||
23382278|NCT00784875|65144985|FG003|Period C|Adverse Event|2|||
23382279|NCT00784875|65144982|FG000|Period C|Protocol Violation|0|||
23382280|NCT00784875|65144983|FG001|Period C|Protocol Violation|0|||
23382281|NCT00784875|65144984|FG002|Period C|Protocol Violation|1|||
23382282|NCT00784875|65144985|FG003|Period C|Protocol Violation|2|||
23382283|NCT00784875|65144982|FG000|Period C|Lack of Efficacy|0|||
23382284|NCT00784875|65144983|FG001|Period C|Lack of Efficacy|0|||
23382285|NCT00784875|65144984|FG002|Period C|Lack of Efficacy|1|||
23382286|NCT00784875|65144985|FG003|Period C|Lack of Efficacy|0|||
23382287|NCT00784875|65144982|FG000|Period C|Withdrawal by Subject|1|||
23382288|NCT00784875|65144983|FG001|Period C|Withdrawal by Subject|1|||
23382289|NCT00784875|65144984|FG002|Period C|Withdrawal by Subject|2|||
23382290|NCT00784875|65144985|FG003|Period C|Withdrawal by Subject|0|||
23382291|NCT00784875|65144982|FG000|Period C|Physician Decision|0|||
23382292|NCT00784875|65144983|FG001|Period C|Physician Decision|0|||
23382293|NCT00784875|65144984|FG002|Period C|Physician Decision|1|||
23382294|NCT00784875|65144985|FG003|Period C|Physician Decision|1|||
23382295|NCT00784875|65144982|FG000|Period C|Sponsor Decision|5|||
23382296|NCT00784875|65144983|FG001|Period C|Sponsor Decision|5|||
23382297|NCT00784875|65144984|FG002|Period C|Sponsor Decision|4|||
23382298|NCT00784875|65144985|FG003|Period C|Sponsor Decision|2|||
23382299|NCT00784875|65144982|FG000|Period D|Adverse Event|0|||
23382300|NCT00784875|65144983|FG001|Period D|Adverse Event|2|||
23382301|NCT00784875|65144984|FG002|Period D|Adverse Event|2|||
23382302|NCT00784875|65144985|FG003|Period D|Adverse Event|0|||
23382303|NCT00784875|65144982|FG000|Period D|Protocol Violation|1|||
23382304|NCT00784875|65144983|FG001|Period D|Protocol Violation|0|||
23382305|NCT00784875|65144984|FG002|Period D|Protocol Violation|0|||
23382306|NCT00784875|65144985|FG003|Period D|Protocol Violation|0|||
23382307|NCT00784875|65144982|FG000|Period D|Withdrawal by Subject|2|||
23382308|NCT00784875|65144983|FG001|Period D|Withdrawal by Subject|0|||
23382309|NCT00784875|65144984|FG002|Period D|Withdrawal by Subject|2|||
23382310|NCT00784875|65144985|FG003|Period D|Withdrawal by Subject|0|||
23382311|NCT00784875|65144982|FG000|Period D|Physician Decision|0|||
23382312|NCT00784875|65144983|FG001|Period D|Physician Decision|1|||
23382313|NCT00784875|65144984|FG002|Period D|Physician Decision|0|||
23382314|NCT00784875|65144985|FG003|Period D|Physician Decision|0|||
23382315|NCT00784875|65144982|FG000|Period D|Sponsor Decision|1|||
23382316|NCT00784875|65144983|FG001|Period D|Sponsor Decision|1|||
23382317|NCT00784875|65144984|FG002|Period D|Sponsor Decision|1|||
23382318|NCT00784875|65144985|FG003|Period D|Sponsor Decision|0|||
23382319|NCT00784875|65144982|FG000|Period D|Lost to Follow-up|1|||
23382320|NCT00784875|65144983|FG001|Period D|Lost to Follow-up|0|||
23382321|NCT00784875|65144984|FG002|Period D|Lost to Follow-up|1|||
23382322|NCT00784875|65144985|FG003|Period D|Lost to Follow-up|1|||
23382323|NCT02852434|65144993|FG000|Overall Study|Withdrawal by Subject|0|||
23382324|NCT02852434|65144994|FG001|Overall Study|Withdrawal by Subject|1|||
23382325|NCT02852434|65144993|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
23382326|NCT02852434|65144994|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
23382327|NCT03684057|65145001|FG000|Overall Study|Withdrawal by Subject|4|||
23382328|NCT03684057|65145002|FG001|Overall Study|Withdrawal by Subject|5|||
23382329|NCT00530075|65145005|FG000|Overall Study|Adverse Event|1|||
23382330|NCT00530075|65145005|FG000|Overall Study|Death|1|||
23382331|NCT00530075|65145005|FG000|Overall Study|Lack of Efficacy|3|||
23382332|NCT00530075|65145005|FG000|Overall Study|Protocol Violation|1|||
23382333|NCT00530075|65145005|FG000|Overall Study|Withdrawal by Subject|1|||
23382334|NCT00888849|65145012|FG000|Overall Study|Death|4|||
23382335|NCT00888849|65145013|FG001|Overall Study|Death|7|||
23382336|NCT00888849|65145012|FG000|Overall Study|Lost to Follow-up|1|||
23382337|NCT00888849|65145013|FG001|Overall Study|Lost to Follow-up|2|||
23382338|NCT01555931|65145014|FG000|Overall Study|Lost to Follow-up|2|||
23382339|NCT01555931|65145015|FG001|Overall Study|Lost to Follow-up|5|||
23382340|NCT01967277|65145019|FG000|Overall Study|Lost to Follow-up|1|||
23382341|NCT01967277|65145020|FG001|Overall Study|Lost to Follow-up|2|||
23382342|NCT01967277|65145019|FG000|Overall Study|Unrelated illness|0|||
23382343|NCT01967277|65145020|FG001|Overall Study|Unrelated illness|1|||
23382344|NCT01136915|65145021|FG000|Overall Study|Lost to Follow-up|2|||
23382345|NCT01136915|65145022|FG001|Overall Study|Lost to Follow-up|0|||
23382346|NCT01136915|65145021|FG000|Overall Study|Exclusion criterion met|0|||
23382347|NCT01136915|65145022|FG001|Overall Study|Exclusion criterion met|1|||
23382348|NCT02638493|65145024|FG000|Overall Study|Inability to provide semen samples|2|||
23382349|NCT02638493|65145025|FG001|Overall Study|Inability to provide semen samples|0|||
23382350|NCT02638493|65145026|FG002|Overall Study|Inability to provide semen samples|0|||
23382351|NCT03286504|65145029|FG000|Overall Study|Lost to Follow-up|19|||
23382352|NCT03286504|65145030|FG001|Overall Study|Lost to Follow-up|16|||
23382353|NCT00266812|65145035|FG000|Overall Study|Disease Progression|9|||
23382354|NCT00266812|65145036|FG001|Overall Study|Disease Progression|3|||
23382355|NCT00266812|65145035|FG000|Overall Study|Death|5|||
23382356|NCT00266812|65145036|FG001|Overall Study|Death|4|||
23382357|NCT00266812|65145035|FG000|Overall Study|Adverse Event|3|||
23382358|NCT00266812|65145036|FG001|Overall Study|Adverse Event|1|||
23382359|NCT00266812|65145035|FG000|Overall Study|Protocol Violation|0|||
23382360|NCT00266812|65145036|FG001|Overall Study|Protocol Violation|1|||
23382361|NCT00266812|65145035|FG000|Overall Study|Withdrawal by Subject|0|||
23382362|NCT00266812|65145036|FG001|Overall Study|Withdrawal by Subject|2|||
23382363|NCT00266812|65145035|FG000|Overall Study|Discontinued before starting study drug|4|||
23382364|NCT00266812|65145036|FG001|Overall Study|Discontinued before starting study drug|0|||
23382365|NCT01121926|65145037|FG000|First Intervention Period|Adverse Event|1|||
23382366|NCT01121926|65145038|FG001|First Intervention Period|Adverse Event|0|||
23382367|NCT01121926|65145037|FG000|Washout Period|Adverse Event|0|||
23382368|NCT01121926|65145038|FG001|Washout Period|Adverse Event|1|||
23382369|NCT01121926|65145037|FG000|Washout Period|Positive pregnancy test|0|||
23382370|NCT01121926|65145038|FG001|Washout Period|Positive pregnancy test|1|||
23382371|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
23382372|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
23382373|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
23382374|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
23382375|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
23382376|NCT00849472|65145041|FG000|Weekly Paclitaxel|Disease Progression|1|||
23382377|NCT00849472|65145041|FG000|Weekly Paclitaxel|Adverse Event|11|||
23382378|NCT00849472|65145041|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
23382379|NCT00849472|65145041|FG000|Weekly Paclitaxel|Physician Decision|3|||
23382380|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
23382381|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
23382382|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
23382383|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
23382384|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
23605961|NCT01640951|65947107|FG006|Overall Study|Protocol Deviation|0|||
23382385|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
23382386|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
23382387|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
23382388|NCT01363440|65145042|FG000|Overall Study|Adverse Event|5|||
23382389|NCT01363440|65145043|FG001|Overall Study|Adverse Event|4|||
23382390|NCT01363440|65145044|FG002|Overall Study|Adverse Event|4|||
23382391|NCT01363440|65145042|FG000|Overall Study|Death|3|||
23382392|NCT01363440|65145043|FG001|Overall Study|Death|7|||
23382393|NCT01363440|65145044|FG002|Overall Study|Death|5|||
23382394|NCT01363440|65145042|FG000|Overall Study|Withdrawal by Subject|9|||
23382395|NCT01363440|65145043|FG001|Overall Study|Withdrawal by Subject|11|||
23382396|NCT01363440|65145044|FG002|Overall Study|Withdrawal by Subject|11|||
23382397|NCT01363440|65145042|FG000|Overall Study|Lost to Follow-up|2|||
23382398|NCT01363440|65145043|FG001|Overall Study|Lost to Follow-up|4|||
23382399|NCT01363440|65145044|FG002|Overall Study|Lost to Follow-up|5|||
23382400|NCT01363440|65145042|FG000|Overall Study|Other|4|||
23382401|NCT01363440|65145043|FG001|Overall Study|Other|5|||
23382402|NCT01363440|65145044|FG002|Overall Study|Other|2|||
23382403|NCT02323334|65145046|FG000|Period 3|Lost to Follow-up|0|||
23382404|NCT02323334|65145047|FG001|Period 3|Lost to Follow-up|0|||
23382405|NCT02323334|65145048|FG002|Period 3|Lost to Follow-up|1|||
23382406|NCT02323334|65145049|FG003|Period 3|Lost to Follow-up|0|||
23492870|NCT02281773|65548243|FG000|Overall Study|Withdrawal by Subject|2|||
23492871|NCT02281773|65548244|FG001|Overall Study|Withdrawal by Subject|8|||
23492872|NCT02281773|65548245|FG002|Overall Study|Withdrawal by Subject|6|||
23492873|NCT02281773|65548246|FG003|Overall Study|Withdrawal by Subject|6|||
23492874|NCT02281773|65548247|FG004|Overall Study|Withdrawal by Subject|8|||
23492875|NCT02281773|65548243|FG000|Overall Study|Other Reason|0|||
23492876|NCT02281773|65548244|FG001|Overall Study|Other Reason|4|||
23492877|NCT02281773|65548245|FG002|Overall Study|Other Reason|2|||
23492878|NCT02281773|65548246|FG003|Overall Study|Other Reason|3|||
23492879|NCT02281773|65548247|FG004|Overall Study|Other Reason|1|||
23492880|NCT02213042|65548248|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
23492881|NCT02213042|65548249|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
23492882|NCT02213042|65548250|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
23492883|NCT02213042|65548248|FG000|Overall Study|Adverse Event|2|||
23492884|NCT02213042|65548249|FG001|Overall Study|Adverse Event|1|||
23492885|NCT02213042|65548250|FG002|Overall Study|Adverse Event|0|||
23492886|NCT02213042|65548248|FG000|Overall Study|Withdrawal by Subject|0|||
23492887|NCT02213042|65548249|FG001|Overall Study|Withdrawal by Subject|1|||
23492888|NCT02213042|65548250|FG002|Overall Study|Withdrawal by Subject|1|||
23492889|NCT02213042|65548248|FG000|Overall Study|Protocol Violation|1|||
23492890|NCT02213042|65548249|FG001|Overall Study|Protocol Violation|0|||
23492891|NCT02213042|65548250|FG002|Overall Study|Protocol Violation|0|||
23492892|NCT02213042|65548248|FG000|Overall Study|Investigator discretion|0|||
23492893|NCT02213042|65548249|FG001|Overall Study|Investigator discretion|0|||
23492894|NCT02213042|65548250|FG002|Overall Study|Investigator discretion|1|||
23492895|NCT02147184|65548255|FG000|Overall Study|Lost to Follow-up|28|||
23492896|NCT02147184|65548256|FG001|Overall Study|Lost to Follow-up|15|||
23492897|NCT02147184|65548255|FG000|Overall Study|Study Burden|11|||
23669017|NCT03201458|66172283|FG000|Overall Study|No longer eligible|2|||
23669018|NCT03201458|66172284|FG001|Overall Study|No longer eligible|5|||
23669019|NCT03201458|66172283|FG000|Overall Study|Health event before starting|1|||
23382407|NCT02323334|65145050|FG004|Period 3|Lost to Follow-up|0|||
23492898|NCT02147184|65548256|FG001|Overall Study|Study Burden|7|||
23492899|NCT02147184|65548255|FG000|Overall Study|Pregnancy|6|||
23492900|NCT02147184|65548256|FG001|Overall Study|Pregnancy|0|||
23492901|NCT02147184|65548255|FG000|Overall Study|Moved out of state|3|||
23492902|NCT02147184|65548256|FG001|Overall Study|Moved out of state|3|||
23492903|NCT02147184|65548255|FG000|Overall Study|Physician Decision|0|||
23669020|NCT03201458|66172284|FG001|Overall Study|Health event before starting|0|||
23382408|NCT02323334|65145051|FG005|Period 3|Lost to Follow-up|0|||
23492904|NCT02147184|65548256|FG001|Overall Study|Physician Decision|2|||
23492905|NCT02147184|65548255|FG000|Overall Study|Other|1|||
23492906|NCT02147184|65548256|FG001|Overall Study|Other|0|||
23669021|NCT03201458|66172283|FG000|Overall Study|Physician Decision|1|||
23669022|NCT03201458|66172284|FG001|Overall Study|Physician Decision|0|||
23669023|NCT00563186|66172297|FG000|Overall Study|LOS<48 hours|97|||
23669024|NCT00563186|66172298|FG001|Overall Study|LOS<48 hours|74|||
23669025|NCT00563186|66172297|FG000|Overall Study|Incomplete data|1|||
23669026|NCT00563186|66172298|FG001|Overall Study|Incomplete data|1|||
23669027|NCT04153188|66172303|FG000|Overall Study|Lost to Follow-up|1|||
23669028|NCT04153188|66172304|FG001|Overall Study|Lost to Follow-up|1|||
23669029|NCT04153188|66172303|FG000|Overall Study|Withdrawal by Subject|2|||
23669030|NCT04153188|66172304|FG001|Overall Study|Withdrawal by Subject|0|||
23669031|NCT04153188|66172303|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
23669032|NCT04153188|66172304|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
23669033|NCT04623242|66172305|FG000|Overall Study|Withdrawal by Subject|7|||
23669034|NCT04623242|66172306|FG001|Overall Study|Withdrawal by Subject|12|||
23669035|NCT04623242|66172307|FG002|Overall Study|Withdrawal by Subject|5|||
23669036|NCT04623242|66172308|FG003|Overall Study|Withdrawal by Subject|7|||
23669037|NCT04623242|66172309|FG004|Overall Study|Withdrawal by Subject|0|||
23669038|NCT04623242|66172305|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
23669039|NCT04623242|66172306|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
23669040|NCT04623242|66172307|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
23382409|NCT02323334|65145052|FG006|Period 3|Lost to Follow-up|0|||
23492907|NCT00370071|65548260|FG000|Overall Study|Withdrawal by Subject|2|||
23492908|NCT03643575|65548261|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
23382410|NCT02323334|65145053|FG007|Period 3|Lost to Follow-up|0|||
23382411|NCT02323334|65145054|FG008|Period 3|Lost to Follow-up|0|||
23382412|NCT02323334|65145055|FG009|Period 3|Lost to Follow-up|0|||
23382413|NCT02323334|65145056|FG010|Period 3|Lost to Follow-up|0|||
23382414|NCT02323334|65145057|FG011|Period 3|Lost to Follow-up|0|||
23382415|NCT02323334|65145058|FG012|Period 3|Lost to Follow-up|0|||
23382416|NCT02323334|65145059|FG013|Period 3|Lost to Follow-up|0|||
23382417|NCT02323334|65145060|FG014|Period 3|Lost to Follow-up|0|||
23382418|NCT02323334|65145061|FG015|Period 3|Lost to Follow-up|0|||
23382419|NCT02323334|65145062|FG016|Period 3|Lost to Follow-up|0|||
23382420|NCT02323334|65145046|FG000|Period 3|Withdrawal by Subject|1|||
23382421|NCT02323334|65145047|FG001|Period 3|Withdrawal by Subject|0|||
23382422|NCT02323334|65145048|FG002|Period 3|Withdrawal by Subject|0|||
23382423|NCT02323334|65145049|FG003|Period 3|Withdrawal by Subject|0|||
23382424|NCT02323334|65145050|FG004|Period 3|Withdrawal by Subject|0|||
23382425|NCT02323334|65145051|FG005|Period 3|Withdrawal by Subject|0|||
23382426|NCT02323334|65145052|FG006|Period 3|Withdrawal by Subject|0|||
23382427|NCT02323334|65145053|FG007|Period 3|Withdrawal by Subject|0|||
23382428|NCT02323334|65145054|FG008|Period 3|Withdrawal by Subject|0|||
23382429|NCT02323334|65145055|FG009|Period 3|Withdrawal by Subject|0|||
23382430|NCT02323334|65145056|FG010|Period 3|Withdrawal by Subject|0|||
23382431|NCT02323334|65145057|FG011|Period 3|Withdrawal by Subject|0|||
23382432|NCT02323334|65145058|FG012|Period 3|Withdrawal by Subject|0|||
23382433|NCT02323334|65145059|FG013|Period 3|Withdrawal by Subject|0|||
23382434|NCT02323334|65145060|FG014|Period 3|Withdrawal by Subject|0|||
23382435|NCT02323334|65145061|FG015|Period 3|Withdrawal by Subject|0|||
23382436|NCT02323334|65145062|FG016|Period 3|Withdrawal by Subject|0|||
23382437|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
23382438|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
23382439|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
23382440|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
23382441|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
23382442|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
23382443|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
23382444|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
23382445|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
23382446|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
23382447|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
23382448|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
23382449|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
23382450|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
23382451|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
23382452|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
23382453|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
23492909|NCT03643575|65548262|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
23492910|NCT03643575|65548263|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
23492911|NCT03643575|65548264|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
23492912|NCT03643575|65548265|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
23492913|NCT03643575|65548266|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
23492914|NCT03643575|65548261|FG000|Washout: 7 Days|Adverse Event|1|||
23492915|NCT03643575|65548262|FG001|Washout: 7 Days|Adverse Event|0|||
23492916|NCT03643575|65548263|FG002|Washout: 7 Days|Adverse Event|0|||
23492917|NCT03643575|65548264|FG003|Washout: 7 Days|Adverse Event|0|||
23492918|NCT03643575|65548265|FG004|Washout: 7 Days|Adverse Event|0|||
23492919|NCT03643575|65548266|FG005|Washout: 7 Days|Adverse Event|0|||
23492920|NCT03643575|65548261|FG000|Washout: 7 Days|Non compliance check in|0|||
23492921|NCT03643575|65548262|FG001|Washout: 7 Days|Non compliance check in|1|||
23492922|NCT03643575|65548263|FG002|Washout: 7 Days|Non compliance check in|0|||
23492923|NCT03643575|65548264|FG003|Washout: 7 Days|Non compliance check in|0|||
23492924|NCT03643575|65548265|FG004|Washout: 7 Days|Non compliance check in|0|||
23492925|NCT03643575|65548266|FG005|Washout: 7 Days|Non compliance check in|0|||
23669041|NCT04623242|66172308|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
23669042|NCT04623242|66172309|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
23669043|NCT04623242|66172305|FG000|Overall Study|Subject unblinded to mutation status|0|||
23382454|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
23382455|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
23382456|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
23382457|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
23382458|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
23382459|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
23492926|NCT02405780|65548267|FG000|Period I|Adverse Event|8|||
23492927|NCT02405780|65548268|FG001|Period I|Adverse Event|0|||
23492928|NCT02405780|65548269|FG002|Period I|Adverse Event|3|||
23492929|NCT02405780|65548270|FG003|Period I|Adverse Event|7|||
23492930|NCT02405780|65548267|FG000|Period I|Medical reasons|1|||
23492931|NCT02405780|65548268|FG001|Period I|Medical reasons|1|||
23669044|NCT04623242|66172306|FG001|Overall Study|Subject unblinded to mutation status|0|||
23669045|NCT04623242|66172307|FG002|Overall Study|Subject unblinded to mutation status|0|||
23382460|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
23382461|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
23382462|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
23382463|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
23382464|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
23382465|NCT02315625|65145065|FG000|First Intervention|Disease Progression|1|||
23382466|NCT02315625|65145066|FG001|First Intervention|Disease Progression|0|||
23382467|NCT02315625|65145065|FG000|Second Intervention|Physician Decision|2|||
23382468|NCT02315625|65145066|FG001|Second Intervention|Physician Decision|1|||
23382469|NCT02315625|65145065|FG000|Second Intervention|Study closure|1|||
23382470|NCT02315625|65145066|FG001|Second Intervention|Study closure|0|||
23382471|NCT02315625|65145065|FG000|Second Intervention|Disease Progression|1|||
23382472|NCT02315625|65145066|FG001|Second Intervention|Disease Progression|0|||
23382473|NCT01617967|65145067|FG000|Overall Study|Protocol Violation|0|||
23382474|NCT01617967|65145068|FG001|Overall Study|Protocol Violation|0|||
23382475|NCT01617967|65145069|FG002|Overall Study|Protocol Violation|0|||
23382476|NCT01617967|65145070|FG003|Overall Study|Protocol Violation|1|||
23382477|NCT01617967|65145071|FG004|Overall Study|Protocol Violation|0|||
23382478|NCT01617967|65145072|FG005|Overall Study|Protocol Violation|0|||
23382479|NCT01617967|65145067|FG000|Overall Study|Withdrawal by Subject|0|||
23669046|NCT04623242|66172308|FG003|Overall Study|Subject unblinded to mutation status|13|||
23669047|NCT04623242|66172309|FG004|Overall Study|Subject unblinded to mutation status|0|||
23669048|NCT01265550|66172310|FG000|Pre Randomization|Withdrawal by Subject|0|||
23669049|NCT01265550|66172311|FG001|Pre Randomization|Withdrawal by Subject|0|||
23669050|NCT01265550|66172312|FG002|Pre Randomization|Withdrawal by Subject|0|||
23669051|NCT01265550|66172313|FG003|Pre Randomization|Withdrawal by Subject|70|||
23669052|NCT01265550|66172310|FG000|Pre Randomization|Technical Exclusions|0|||
23669053|NCT01265550|66172311|FG001|Pre Randomization|Technical Exclusions|0|||
23669054|NCT01265550|66172312|FG002|Pre Randomization|Technical Exclusions|0|||
23669055|NCT01265550|66172313|FG003|Pre Randomization|Technical Exclusions|54|||
23669056|NCT01265550|66172310|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
23669057|NCT01265550|66172311|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
23669058|NCT01265550|66172312|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
23669059|NCT01265550|66172313|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
23669060|NCT01265550|66172310|FG000|Pre Randomization|Non-GERD organic disorders|0|||
23669061|NCT01265550|66172311|FG001|Pre Randomization|Non-GERD organic disorders|0|||
23669062|NCT01265550|66172312|FG002|Pre Randomization|Non-GERD organic disorders|0|||
23669063|NCT01265550|66172313|FG003|Pre Randomization|Non-GERD organic disorders|23|||
23669064|NCT01265550|66172310|FG000|Pre Randomization|Functional heartburn|0|||
23669065|NCT01265550|66172311|FG001|Pre Randomization|Functional heartburn|0|||
23669066|NCT01265550|66172312|FG002|Pre Randomization|Functional heartburn|0|||
23669067|NCT01265550|66172313|FG003|Pre Randomization|Functional heartburn|99|||
23669068|NCT02236520|66172314|FG000|Overall Study|Physician Decision|0|||
23669069|NCT02236520|66172315|FG001|Overall Study|Physician Decision|5|||
23669070|NCT02236520|66172316|FG002|Overall Study|Physician Decision|0|||
23669071|NCT02236520|66172317|FG003|Overall Study|Physician Decision|0|||
23382480|NCT01617967|65145068|FG001|Overall Study|Withdrawal by Subject|0|||
23382481|NCT01617967|65145069|FG002|Overall Study|Withdrawal by Subject|0|||
23382482|NCT01617967|65145070|FG003|Overall Study|Withdrawal by Subject|0|||
23492932|NCT02405780|65548269|FG002|Period I|Medical reasons|0|||
23669072|NCT02236520|66172314|FG000|Overall Study|Withdrawal by Subject|1|||
23669073|NCT02236520|66172315|FG001|Overall Study|Withdrawal by Subject|0|||
23669074|NCT02236520|66172316|FG002|Overall Study|Withdrawal by Subject|0|||
23669075|NCT02236520|66172317|FG003|Overall Study|Withdrawal by Subject|1|||
23669076|NCT02236520|66172314|FG000|Overall Study|Pregnancy|1|||
23669077|NCT02236520|66172315|FG001|Overall Study|Pregnancy|0|||
23669078|NCT02236520|66172316|FG002|Overall Study|Pregnancy|0|||
23669079|NCT02236520|66172317|FG003|Overall Study|Pregnancy|0|||
23669080|NCT00250835|66172322|FG000|Overall Study|Withdrawal by Subject|1|||
23669081|NCT02590588|66172327|FG000|Overall Study|Adverse Event|1|||
23382483|NCT01617967|65145071|FG004|Overall Study|Withdrawal by Subject|0|||
23669082|NCT03152019|66172330|FG000|Overall Study|Adverse Event|0|||
23669083|NCT03152019|66172331|FG001|Overall Study|Adverse Event|1|||
23669084|NCT03917823|66172332|FG000|Overall Study|Lost to Follow-up|1|||
23669085|NCT03917823|66172333|FG001|Overall Study|Lost to Follow-up|1|||
23669086|NCT03917823|66172332|FG000|Overall Study|Withdrawal by Subject|0|||
23669087|NCT03917823|66172333|FG001|Overall Study|Withdrawal by Subject|1|||
23669088|NCT00925015|66172334|FG000|Overall Study|Adverse Event|1|||
23382484|NCT01617967|65145072|FG005|Overall Study|Withdrawal by Subject|1|||
23382485|NCT01617967|65145067|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
23382486|NCT01617967|65145068|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
23382487|NCT01617967|65145069|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
23382488|NCT01617967|65145070|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
23382489|NCT01617967|65145071|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
23382490|NCT01617967|65145072|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
23382491|NCT01290731|65145073|FG000|Overall Study|Withdrawal by Subject|1|||
23382492|NCT03679884|65145078|FG000|Overall Study|Other|12|||
23382493|NCT03679884|65145079|FG001|Overall Study|Other|12|||
23382494|NCT03679884|65145080|FG002|Overall Study|Other|12|||
23382495|NCT03679884|65145081|FG003|Overall Study|Other|7|||
23382496|NCT03679884|65145082|FG004|Overall Study|Other|8|||
23382497|NCT03679884|65145078|FG000|Overall Study|Lack of Efficacy|15|||
23382498|NCT03679884|65145079|FG001|Overall Study|Lack of Efficacy|29|||
23382499|NCT03679884|65145080|FG002|Overall Study|Lack of Efficacy|13|||
23382500|NCT03679884|65145081|FG003|Overall Study|Lack of Efficacy|29|||
23382501|NCT03679884|65145082|FG004|Overall Study|Lack of Efficacy|10|||
23382502|NCT03679884|65145078|FG000|Overall Study|Death|1|||
23382503|NCT03679884|65145079|FG001|Overall Study|Death|0|||
23382504|NCT03679884|65145080|FG002|Overall Study|Death|0|||
23382505|NCT03679884|65145081|FG003|Overall Study|Death|0|||
23382506|NCT03679884|65145082|FG004|Overall Study|Death|0|||
23382507|NCT03679884|65145078|FG000|Overall Study|Adverse Event|2|||
23382508|NCT03679884|65145079|FG001|Overall Study|Adverse Event|10|||
23382509|NCT03679884|65145080|FG002|Overall Study|Adverse Event|9|||
23382510|NCT03679884|65145081|FG003|Overall Study|Adverse Event|6|||
23382511|NCT03679884|65145082|FG004|Overall Study|Adverse Event|6|||
23382512|NCT03679884|65145078|FG000|Overall Study|Withdrawal by Subject|12|||
23382513|NCT03679884|65145079|FG001|Overall Study|Withdrawal by Subject|23|||
23382514|NCT03679884|65145080|FG002|Overall Study|Withdrawal by Subject|8|||
23382515|NCT03679884|65145081|FG003|Overall Study|Withdrawal by Subject|8|||
23382516|NCT03679884|65145082|FG004|Overall Study|Withdrawal by Subject|9|||
23382517|NCT03679884|65145078|FG000|Overall Study|Lost to Follow-up|1|||
23382518|NCT03679884|65145079|FG001|Overall Study|Lost to Follow-up|4|||
23382519|NCT03679884|65145080|FG002|Overall Study|Lost to Follow-up|2|||
23382520|NCT03679884|65145081|FG003|Overall Study|Lost to Follow-up|0|||
23382521|NCT03679884|65145082|FG004|Overall Study|Lost to Follow-up|3|||
23382522|NCT03655470|65145083|FG000|Overall Study|Lost to Follow-up|6|||
23382523|NCT03655470|65145084|FG001|Overall Study|Lost to Follow-up|7|||
23382524|NCT01481779|65145092|FG000|Overall Study|Adverse Event|23|||
23382525|NCT01481779|65145093|FG001|Overall Study|Adverse Event|5|||
23382526|NCT01481779|65145092|FG000|Overall Study|Lost to Follow-up|3|||
23382527|NCT01481779|65145093|FG001|Overall Study|Lost to Follow-up|2|||
23382528|NCT01481779|65145092|FG000|Overall Study|Protocol Violation|2|||
23382529|NCT01481779|65145093|FG001|Overall Study|Protocol Violation|3|||
23382530|NCT01481779|65145092|FG000|Overall Study|Withdrawal by Subject|26|||
23382531|NCT01481779|65145093|FG001|Overall Study|Withdrawal by Subject|13|||
23382532|NCT01481779|65145092|FG000|Overall Study|Physician Decision|13|||
23382533|NCT01481779|65145093|FG001|Overall Study|Physician Decision|4|||
23382534|NCT01481779|65145092|FG000|Overall Study|Sponsor Decision|3|||
23669089|NCT00925015|66172335|FG001|Overall Study|Adverse Event|2|||
23382535|NCT01481779|65145093|FG001|Overall Study|Sponsor Decision|1|||
23382536|NCT00471354|65145094|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
23382537|NCT00471354|65145094|FG000|Overall Study|Adverse Event|13|||
23382538|NCT00471354|65145094|FG000|Overall Study|Protocol Violation|12|||
23382539|NCT00471354|65145094|FG000|Overall Study|Withdrawal by Subject|1|||
23382540|NCT00471354|65145094|FG000|Overall Study|Physician Decision|4|||
23382541|NCT00471354|65145094|FG000|Overall Study|Sponsor Decision|1|||
23669090|NCT00925015|66172336|FG002|Overall Study|Adverse Event|1|||
23669091|NCT00925015|66172334|FG000|Overall Study|Physician Decision|0|||
23669092|NCT00925015|66172335|FG001|Overall Study|Physician Decision|1|||
23669093|NCT00925015|66172336|FG002|Overall Study|Physician Decision|0|||
23382542|NCT00471354|65145094|FG000|Overall Study|Lost to Follow-up|3|||
23382543|NCT00471354|65145094|FG000|Overall Study|Lack of Efficacy|5|||
23382544|NCT00471354|65145094|FG000|Overall Study|Patient/Caregiver Decision|12|||
23382545|NCT01483651|65145096|FG000|Overall Study|Withdrawal by Subject|0|||
23382546|NCT01483651|65145097|FG001|Overall Study|Withdrawal by Subject|1|||
23382547|NCT01483651|65145098|FG002|Overall Study|Withdrawal by Subject|1|||
23382548|NCT01483651|65145099|FG003|Overall Study|Withdrawal by Subject|0|||
23382549|NCT01483651|65145100|FG004|Overall Study|Withdrawal by Subject|0|||
23382550|NCT01483651|65145101|FG005|Overall Study|Withdrawal by Subject|1|||
23382551|NCT00676052|65145104|FG000|Overall Study|Adverse Event|0|||
23382552|NCT00676052|65145105|FG001|Overall Study|Adverse Event|1|||
23382553|NCT00676052|65145106|FG002|Overall Study|Adverse Event|1|||
23382554|NCT00676052|65145107|FG003|Overall Study|Adverse Event|2|||
23669094|NCT00925015|66172334|FG000|Overall Study|Progressive Disease|7|||
23669095|NCT00925015|66172335|FG001|Overall Study|Progressive Disease|3|||
23669096|NCT00925015|66172336|FG002|Overall Study|Progressive Disease|4|||
23669097|NCT00925015|66172334|FG000|Overall Study|Withdrawal by Subject|0|||
23382555|NCT00676052|65145108|FG004|Overall Study|Adverse Event|2|||
23669098|NCT00925015|66172335|FG001|Overall Study|Withdrawal by Subject|0|||
23669099|NCT00925015|66172336|FG002|Overall Study|Withdrawal by Subject|1|||
23669100|NCT02813694|66172337|FG000|Overall Study|Physician Decision|0|||
23669101|NCT02813694|66172338|FG001|Overall Study|Physician Decision|1|||
23669102|NCT02813694|66172337|FG000|Overall Study|Withdrawal by Subject|10|||
23669103|NCT02813694|66172338|FG001|Overall Study|Withdrawal by Subject|9|||
23669104|NCT02813694|66172337|FG000|Overall Study|Lost to Follow-up|1|||
23669105|NCT02813694|66172338|FG001|Overall Study|Lost to Follow-up|1|||
23669106|NCT02813694|66172337|FG000|Overall Study|Death|3|||
23669107|NCT02813694|66172338|FG001|Overall Study|Death|3|||
23669108|NCT02813694|66172337|FG000|Overall Study|Randomized- did not receive study drug|2|||
23669109|NCT02813694|66172338|FG001|Overall Study|Randomized- did not receive study drug|0|||
23669110|NCT02813694|66172337|FG000|Overall Study|Patient hospitalized|1|||
23669111|NCT02813694|66172338|FG001|Overall Study|Patient hospitalized|0|||
23669112|NCT02424253|66172341|FG000|Overall Study|Other, unspecified|1|||
23669113|NCT02424253|66172342|FG001|Overall Study|Other, unspecified|0|||
23669114|NCT02424253|66172341|FG000|Overall Study|Compliance problems|1|||
23669115|NCT02424253|66172342|FG001|Overall Study|Compliance problems|0|||
23669116|NCT02424253|66172341|FG000|Overall Study|Physician Decision|2|||
23669117|NCT02424253|66172342|FG001|Overall Study|Physician Decision|0|||
23669118|NCT02424253|66172341|FG000|Overall Study|Lack of Efficacy|0|||
23669119|NCT02424253|66172342|FG001|Overall Study|Lack of Efficacy|7|||
23669120|NCT02424253|66172341|FG000|Overall Study|Adverse Event|2|||
23669121|NCT02424253|66172342|FG001|Overall Study|Adverse Event|0|||
23669122|NCT02424253|66172341|FG000|Overall Study|Consent withdrawn by subject|4|||
23669123|NCT02424253|66172342|FG001|Overall Study|Consent withdrawn by subject|1|||
23669124|NCT02424253|66172341|FG000|Overall Study|Lost to Follow-up|1|||
23669125|NCT02424253|66172342|FG001|Overall Study|Lost to Follow-up|1|||
23669126|NCT02081534|66172343|FG000|Overall Study|Adverse Event|5|||
23382556|NCT00676052|65145109|FG005|Overall Study|Adverse Event|2|||
23382557|NCT00676052|65145104|FG000|Overall Study|Lack of Efficacy|2|||
23382558|NCT00676052|65145105|FG001|Overall Study|Lack of Efficacy|2|||
23382559|NCT00676052|65145106|FG002|Overall Study|Lack of Efficacy|1|||
23382560|NCT00676052|65145107|FG003|Overall Study|Lack of Efficacy|1|||
23382561|NCT00676052|65145108|FG004|Overall Study|Lack of Efficacy|2|||
23382562|NCT00676052|65145109|FG005|Overall Study|Lack of Efficacy|1|||
23382563|NCT00676052|65145104|FG000|Overall Study|Protocol Violation|5|||
23382564|NCT00676052|65145105|FG001|Overall Study|Protocol Violation|3|||
23669127|NCT02081534|66172344|FG001|Overall Study|Adverse Event|4|||
23669128|NCT02081534|66172345|FG002|Overall Study|Adverse Event|3|||
23669129|NCT02081534|66172346|FG003|Overall Study|Adverse Event|10|||
23669130|NCT02081534|66172347|FG004|Overall Study|Adverse Event|2|||
23669131|NCT02081534|66172348|FG005|Overall Study|Adverse Event|8|||
23669132|NCT02081534|66172349|FG006|Overall Study|Adverse Event|2|||
23669133|NCT02081534|66172343|FG000|Overall Study|Withdrawal by Subject|0|||
23669134|NCT02081534|66172344|FG001|Overall Study|Withdrawal by Subject|1|||
23669135|NCT02081534|66172345|FG002|Overall Study|Withdrawal by Subject|1|||
23669136|NCT02081534|66172346|FG003|Overall Study|Withdrawal by Subject|1|||
23669137|NCT02081534|66172347|FG004|Overall Study|Withdrawal by Subject|1|||
23669138|NCT02081534|66172348|FG005|Overall Study|Withdrawal by Subject|0|||
23669139|NCT02081534|66172349|FG006|Overall Study|Withdrawal by Subject|1|||
23669140|NCT02081534|66172343|FG000|Overall Study|Protocol Violation|0|||
23382565|NCT00676052|65145106|FG002|Overall Study|Protocol Violation|2|||
23382566|NCT00676052|65145107|FG003|Overall Study|Protocol Violation|2|||
23382567|NCT00676052|65145108|FG004|Overall Study|Protocol Violation|1|||
23669141|NCT02081534|66172344|FG001|Overall Study|Protocol Violation|3|||
23669142|NCT02081534|66172345|FG002|Overall Study|Protocol Violation|0|||
23669143|NCT02081534|66172346|FG003|Overall Study|Protocol Violation|0|||
23669144|NCT02081534|66172347|FG004|Overall Study|Protocol Violation|0|||
23669145|NCT02081534|66172348|FG005|Overall Study|Protocol Violation|0|||
23669146|NCT02081534|66172349|FG006|Overall Study|Protocol Violation|1|||
23669147|NCT02081534|66172343|FG000|Overall Study|Lost to Follow-up|0|||
23382568|NCT00676052|65145109|FG005|Overall Study|Protocol Violation|2|||
23669148|NCT02081534|66172344|FG001|Overall Study|Lost to Follow-up|0|||
23669149|NCT02081534|66172345|FG002|Overall Study|Lost to Follow-up|0|||
23382569|NCT00676052|65145104|FG000|Overall Study|Lost to Follow-up|0|||
23382570|NCT00676052|65145105|FG001|Overall Study|Lost to Follow-up|0|||
23382571|NCT00676052|65145106|FG002|Overall Study|Lost to Follow-up|0|||
23382572|NCT00676052|65145107|FG003|Overall Study|Lost to Follow-up|0|||
23382573|NCT00676052|65145108|FG004|Overall Study|Lost to Follow-up|1|||
23382574|NCT00676052|65145109|FG005|Overall Study|Lost to Follow-up|0|||
23382575|NCT00676052|65145104|FG000|Overall Study|Physician Decision|1|||
23382576|NCT00676052|65145105|FG001|Overall Study|Physician Decision|1|||
23382577|NCT00676052|65145106|FG002|Overall Study|Physician Decision|1|||
23382578|NCT00676052|65145107|FG003|Overall Study|Physician Decision|0|||
23382579|NCT00676052|65145108|FG004|Overall Study|Physician Decision|0|||
23382580|NCT00676052|65145109|FG005|Overall Study|Physician Decision|1|||
23382581|NCT00676052|65145104|FG000|Overall Study|Withdrawal by Subject|1|||
23382582|NCT00676052|65145105|FG001|Overall Study|Withdrawal by Subject|0|||
23382583|NCT00676052|65145106|FG002|Overall Study|Withdrawal by Subject|1|||
23382584|NCT00676052|65145107|FG003|Overall Study|Withdrawal by Subject|0|||
23382585|NCT00676052|65145108|FG004|Overall Study|Withdrawal by Subject|0|||
23382586|NCT00676052|65145109|FG005|Overall Study|Withdrawal by Subject|0|||
23382587|NCT01185366|65145114|FG000|First Line Therapy|Insurance Coverage Denied|1|||
23382588|NCT01185366|65145115|FG001|First Line Therapy|Insurance Coverage Denied|1|||
23382589|NCT01185366|65145114|FG000|First Line Therapy|Withdrawal by Subject|1|||
23382590|NCT01185366|65145115|FG001|First Line Therapy|Withdrawal by Subject|0|||
23382591|NCT01185366|65145114|FG000|First Line Therapy|Lack of Metastatic Site|1|||
23382592|NCT01185366|65145115|FG001|First Line Therapy|Lack of Metastatic Site|0|||
23382593|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
23382594|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
23382595|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
23382596|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
23382597|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
23382598|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
23669150|NCT02081534|66172346|FG003|Overall Study|Lost to Follow-up|2|||
23382599|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
23382600|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
23382601|NCT03123588|65145116|FG000|Overall Study|Study Terminated by Sponsor|2|||
23382602|NCT03123588|65145117|FG001|Overall Study|Study Terminated by Sponsor|5|||
23382603|NCT03123588|65145116|FG000|Overall Study|Withdrawal by Subject|1|||
23382604|NCT03123588|65145117|FG001|Overall Study|Withdrawal by Subject|0|||
23382605|NCT03123588|65145116|FG000|Overall Study|Adverse Event|1|||
23382606|NCT03123588|65145117|FG001|Overall Study|Adverse Event|0|||
23382607|NCT03123588|65145116|FG000|Overall Study|Physician Decision|2|||
23382608|NCT03123588|65145117|FG001|Overall Study|Physician Decision|1|||
23382609|NCT02487199|65145120|FG000|Overall Study|Withdrew Consent|0|||
23382610|NCT02487199|65145121|FG001|Overall Study|Withdrew Consent|1|||
23382611|NCT01905683|65145122|FG000|Overall Study|Protocol Violation|1|||
23382612|NCT01905683|65145122|FG000|Overall Study|Re-injection criteria not met; others|13|||
23382613|NCT01905683|65145122|FG000|Overall Study|Physician Decision|1|||
23382614|NCT01905683|65145122|FG000|Overall Study|Lack of Efficacy|8|||
23382615|NCT01905683|65145122|FG000|Overall Study|Withdrawal by Subject|20|||
23382616|NCT01905683|65145122|FG000|Overall Study|Adverse Event|4|||
23382617|NCT01905683|65145122|FG000|Overall Study|Lost to Follow-up|4|||
23382618|NCT03033901|65145125|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
23382619|NCT03033901|65145125|FG000|Overall Study|Refused PSG|23|||
23382620|NCT03033901|65145125|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
23382621|NCT03033901|65145125|FG000|Overall Study|Missing Oximetry Data|3|||
23382622|NCT00544882|65145128|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
23382623|NCT00544882|65145129|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
23382624|NCT00544882|65145130|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
23382625|NCT00544882|65145128|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
23382626|NCT00544882|65145129|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
23382627|NCT00544882|65145130|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
23382628|NCT00544882|65145128|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
23669151|NCT02081534|66172347|FG004|Overall Study|Lost to Follow-up|1|||
23669152|NCT02081534|66172348|FG005|Overall Study|Lost to Follow-up|1|||
23669153|NCT02081534|66172349|FG006|Overall Study|Lost to Follow-up|0|||
23669154|NCT00677014|66172350|FG000|Overall Study|Lost to Follow-up|20|||
23669155|NCT00677014|66172351|FG001|Overall Study|Lost to Follow-up|12|||
23669156|NCT00677014|66172352|FG002|Overall Study|Lost to Follow-up|24|||
23382629|NCT00544882|65145129|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
23382630|NCT00544882|65145130|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
23382631|NCT00544882|65145128|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
23382632|NCT00544882|65145129|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
23382633|NCT00544882|65145130|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
23382634|NCT00544882|65145128|FG000|Cycle 3: Follow-up|Noncompliance|0|||
23669157|NCT00677014|66172350|FG000|Overall Study|Death|6|||
23382635|NCT00544882|65145129|FG001|Cycle 3: Follow-up|Noncompliance|1|||
23382636|NCT00544882|65145130|FG002|Cycle 3: Follow-up|Noncompliance|0|||
23382637|NCT00544882|65145128|FG000|Cycle 3: Follow-up|Pregnancy|0|||
23382638|NCT00544882|65145129|FG001|Cycle 3: Follow-up|Pregnancy|1|||
23382639|NCT00544882|65145130|FG002|Cycle 3: Follow-up|Pregnancy|0|||
23382640|NCT02582632|65145131|FG000|Overall Study|Other|1|||
23382641|NCT01180777|65145132|FG000|Overall Study|Protocol Violation|6|||
23382642|NCT01180777|65145132|FG000|Overall Study|Poor lens fit|4|||
23382643|NCT01180777|65145132|FG000|Overall Study|Lost to Follow-up|1|||
23382644|NCT01180777|65145132|FG000|Overall Study|Adverse Event|1|||
23382645|NCT04615507|65145135|FG000|Period 1|Covid-19 exposure|2|||
23382646|NCT04615507|65145136|FG001|Period 1|Covid-19 exposure|1|||
23382647|NCT04615507|65145135|FG000|Period 2|Covid-19 exposure|0|||
23492933|NCT02405780|65548270|FG003|Period I|Medical reasons|1|||
23492934|NCT02405780|65548267|FG000|Period I|Screening Failure|1|||
23492935|NCT02405780|65548268|FG001|Period I|Screening Failure|0|||
23492936|NCT02405780|65548269|FG002|Period I|Screening Failure|1|||
23492937|NCT02405780|65548270|FG003|Period I|Screening Failure|0|||
23492938|NCT02405780|65548267|FG000|Period I|Withdrawal by Subject|9|||
23492939|NCT02405780|65548268|FG001|Period I|Withdrawal by Subject|1|||
23492940|NCT02405780|65548269|FG002|Period I|Withdrawal by Subject|3|||
23492941|NCT02405780|65548270|FG003|Period I|Withdrawal by Subject|4|||
23492942|NCT02405780|65548267|FG000|Period I|Non-compliance with study procedures|8|||
23492943|NCT02405780|65548268|FG001|Period I|Non-compliance with study procedures|6|||
23492944|NCT02405780|65548269|FG002|Period I|Non-compliance with study procedures|8|||
23492945|NCT02405780|65548270|FG003|Period I|Non-compliance with study procedures|11|||
23492946|NCT02405780|65548267|FG000|Period II|Adverse Event|3|||
23492947|NCT02405780|65548268|FG001|Period II|Adverse Event|5|||
23492948|NCT02405780|65548269|FG002|Period II|Adverse Event|4|||
23492949|NCT02405780|65548270|FG003|Period II|Adverse Event|11|||
23492950|NCT02405780|65548267|FG000|Period II|Medical reason|0|||
23492951|NCT02405780|65548268|FG001|Period II|Medical reason|1|||
23492952|NCT02405780|65548269|FG002|Period II|Medical reason|0|||
23492953|NCT02405780|65548270|FG003|Period II|Medical reason|0|||
23492954|NCT02405780|65548267|FG000|Period II|Pregnancy|0|||
23492955|NCT02405780|65548268|FG001|Period II|Pregnancy|0|||
23492956|NCT02405780|65548269|FG002|Period II|Pregnancy|1|||
23492957|NCT02405780|65548270|FG003|Period II|Pregnancy|0|||
23492958|NCT02405780|65548267|FG000|Period II|Withdrawal by Subject|7|||
23492959|NCT02405780|65548268|FG001|Period II|Withdrawal by Subject|4|||
23492960|NCT02405780|65548269|FG002|Period II|Withdrawal by Subject|0|||
23492961|NCT02405780|65548270|FG003|Period II|Withdrawal by Subject|3|||
23492962|NCT02405780|65548267|FG000|Period II|Non-compliance with study procedures|5|||
23492963|NCT02405780|65548268|FG001|Period II|Non-compliance with study procedures|2|||
23492964|NCT02405780|65548269|FG002|Period II|Non-compliance with study procedures|7|||
23492965|NCT02405780|65548270|FG003|Period II|Non-compliance with study procedures|4|||
23492966|NCT02282358|65548271|FG000|Overall Study|Nonevaluable|1|||
23382648|NCT04615507|65145136|FG001|Period 2|Covid-19 exposure|1|||
23382649|NCT04615507|65145135|FG000|Period 2|Protocol Violation|1|||
23382650|NCT04615507|65145136|FG001|Period 2|Protocol Violation|0|||
23382651|NCT04615507|65145135|FG000|Period 2|Withdrawal by Subject|1|||
23492967|NCT02586064|65548273|FG000|Overall Study|Other Obligations|6|||
23492968|NCT02586064|65548274|FG001|Overall Study|Other Obligations|6|||
23492969|NCT02586064|65548273|FG000|Overall Study|Other|3|||
23492970|NCT02586064|65548274|FG001|Overall Study|Other|7|||
23492971|NCT02586064|65548273|FG000|Overall Study|Never Started|3|||
23382652|NCT04615507|65145136|FG001|Period 2|Withdrawal by Subject|0|||
23382653|NCT04615507|65145135|FG000|Period 2|Adverse Event|0|||
23382654|NCT04615507|65145136|FG001|Period 2|Adverse Event|1|||
23382655|NCT04615507|65145135|FG000|Period 3|Covid-19 exposure|0|||
23382656|NCT04615507|65145136|FG001|Period 3|Covid-19 exposure|1|||
23492972|NCT02586064|65548274|FG001|Overall Study|Never Started|3|||
23492973|NCT02586064|65548273|FG000|Overall Study|Lost Interest|1|||
23492974|NCT02586064|65548274|FG001|Overall Study|Lost Interest|4|||
23492975|NCT02586064|65548273|FG000|Overall Study|Miscellaneous Life Issues|0|||
23492976|NCT02586064|65548274|FG001|Overall Study|Miscellaneous Life Issues|5|||
23492977|NCT02586064|65548273|FG000|Overall Study|Infrequent Attendance|2|||
23492978|NCT02586064|65548274|FG001|Overall Study|Infrequent Attendance|1|||
23492979|NCT02586064|65548273|FG000|Overall Study|Timed Out|2|||
23492980|NCT02586064|65548274|FG001|Overall Study|Timed Out|0|||
23492981|NCT02586064|65548273|FG000|Overall Study|AUD relapse|0|||
23492982|NCT02586064|65548274|FG001|Overall Study|AUD relapse|2|||
23492983|NCT02586064|65548273|FG000|Overall Study|Legal Issue|1|||
23492984|NCT02586064|65548274|FG001|Overall Study|Legal Issue|0|||
23492985|NCT00573937|65548275|FG000|Overall Study|Study Terminated|0|||
23492986|NCT00573937|65548276|FG001|Overall Study|Study Terminated|1|||
23492987|NCT00395733|65548277|FG000|Period 2|Withdrawal by Subject|1|||
23492988|NCT00395733|65548278|FG001|Period 2|Withdrawal by Subject|2|||
23492989|NCT00395733|65548277|FG000|Period 2|Protocol Violation|0|||
23492990|NCT00395733|65548278|FG001|Period 2|Protocol Violation|1|||
23492991|NCT00395733|65548277|FG000|Period 2|Adverse Event|0|||
23492992|NCT00395733|65548278|FG001|Period 2|Adverse Event|2|||
23492993|NCT00395733|65548277|FG000|Period 2|Technical problems|1|||
23492994|NCT00395733|65548278|FG001|Period 2|Technical problems|0|||
23492995|NCT02202837|65548281|FG000|Overall Study|Enbrel treatment discontinued|36|||
23492996|NCT02202837|65548282|FG001|Overall Study|Enbrel treatment discontinued|4|||
23492997|NCT02202837|65548281|FG000|Overall Study|Other|10|||
23492998|NCT02202837|65548282|FG001|Overall Study|Other|0|||
23492999|NCT02202837|65548281|FG000|Overall Study|Lost to Follow-up|7|||
23493000|NCT02202837|65548282|FG001|Overall Study|Lost to Follow-up|1|||
23493001|NCT03208127|65548283|FG000|Overall Study|Death|1|||
23493002|NCT03398200|65548284|FG000|Overall Study|Withdrawal by Subject|0|||
23493003|NCT03398200|65548285|FG001|Overall Study|Withdrawal by Subject|1|||
23493004|NCT02106975|65548286|FG000|Overall Study|Death|25|||
23493005|NCT02106975|65548287|FG001|Overall Study|Death|39|||
23493006|NCT03608254|65548288|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
23493007|NCT03608254|65548288|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
23493008|NCT01758523|65551328|FG000|Overall Study|Adverse Event|2|||
23493009|NCT01758523|65551329|FG001|Overall Study|Adverse Event|1|||
23493010|NCT01758523|65551328|FG000|Overall Study|Lack of Efficacy|4|||
23493011|NCT01758523|65551329|FG001|Overall Study|Lack of Efficacy|2|||
23493012|NCT01758523|65551328|FG000|Overall Study|Lost to Follow-up|3|||
23493013|NCT01758523|65551329|FG001|Overall Study|Lost to Follow-up|4|||
23493014|NCT01758523|65551328|FG000|Overall Study|Withdrawal by Subject|12|||
23493015|NCT01758523|65551329|FG001|Overall Study|Withdrawal by Subject|7|||
23493016|NCT02609828|65551330|FG000|Overall Study|Adverse Event|8|||
23493017|NCT02609828|65551331|FG001|Overall Study|Adverse Event|1|||
23493018|NCT02609828|65551332|FG002|Overall Study|Adverse Event|0|||
23493019|NCT02609828|65551333|FG003|Overall Study|Adverse Event|6|||
23493020|NCT02609828|65551330|FG000|Overall Study|Death|15|||
23493021|NCT02609828|65551331|FG001|Overall Study|Death|1|||
23493022|NCT02609828|65551332|FG002|Overall Study|Death|1|||
23493023|NCT02609828|65551333|FG003|Overall Study|Death|19|||
23493024|NCT02609828|65551330|FG000|Overall Study|Insufficient clinical response|2|||
23493025|NCT02609828|65551331|FG001|Overall Study|Insufficient clinical response|1|||
23493026|NCT02609828|65551332|FG002|Overall Study|Insufficient clinical response|0|||
23493027|NCT02609828|65551333|FG003|Overall Study|Insufficient clinical response|0|||
23493028|NCT02609828|65551330|FG000|Overall Study|Lost to Follow-up|0|||
23493029|NCT02609828|65551331|FG001|Overall Study|Lost to Follow-up|0|||
23493030|NCT02609828|65551332|FG002|Overall Study|Lost to Follow-up|0|||
23493031|NCT02609828|65551333|FG003|Overall Study|Lost to Follow-up|1|||
23493032|NCT02609828|65551330|FG000|Overall Study|Protocol Violation|2|||
23493033|NCT02609828|65551331|FG001|Overall Study|Protocol Violation|0|||
23493034|NCT02609828|65551332|FG002|Overall Study|Protocol Violation|0|||
23493035|NCT02609828|65551333|FG003|Overall Study|Protocol Violation|1|||
23493036|NCT02609828|65551330|FG000|Overall Study|Withdrawal by Subject|12|||
23493037|NCT02609828|65551331|FG001|Overall Study|Withdrawal by Subject|1|||
23493038|NCT02609828|65551332|FG002|Overall Study|Withdrawal by Subject|0|||
23493039|NCT02609828|65551333|FG003|Overall Study|Withdrawal by Subject|10|||
23493040|NCT02609828|65551330|FG000|Overall Study|Other|3|||
23493041|NCT02609828|65551331|FG001|Overall Study|Other|0|||
23493042|NCT02609828|65551332|FG002|Overall Study|Other|0|||
23382657|NCT00433290|65145138|FG000|Overall Study|Adverse Event|24|||
23493043|NCT02609828|65551333|FG003|Overall Study|Other|6|||
23493044|NCT02609828|65551330|FG000|Overall Study|Randomized but not treated|1|||
23493045|NCT02609828|65551331|FG001|Overall Study|Randomized but not treated|0|||
23493046|NCT02609828|65551332|FG002|Overall Study|Randomized but not treated|0|||
23493047|NCT02609828|65551333|FG003|Overall Study|Randomized but not treated|0|||
23493048|NCT02477839|65551335|FG000|Overall Study|Adverse Event|0|||
23382658|NCT00433290|65145139|FG001|Overall Study|Adverse Event|7|||
23493049|NCT02477839|65551336|FG001|Overall Study|Adverse Event|1|||
23493050|NCT02477839|65551335|FG000|Overall Study|Protocol Violation|0|||
23493051|NCT02477839|65551336|FG001|Overall Study|Protocol Violation|2|||
23493052|NCT02477839|65551335|FG000|Overall Study|Withdrawal by Subject|3|||
23493053|NCT02477839|65551336|FG001|Overall Study|Withdrawal by Subject|3|||
23493054|NCT02477839|65551335|FG000|Overall Study|Participant had PGS during V6|0|||
23493055|NCT02477839|65551336|FG001|Overall Study|Participant had PGS during V6|1|||
23493056|NCT02477839|65551335|FG000|Overall Study|Parents decided to stop medication|0|||
23493057|NCT02477839|65551336|FG001|Overall Study|Parents decided to stop medication|1|||
23493058|NCT02477839|65551335|FG000|Overall Study|Lack of tolerability|0|||
23493059|NCT02477839|65551336|FG001|Overall Study|Lack of tolerability|1|||
23493060|NCT02477839|65551335|FG000|Overall Study|Exclusion criterion|0|||
23493061|NCT02477839|65551336|FG001|Overall Study|Exclusion criterion|1|||
23493062|NCT01696071|65551353|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
23493063|NCT01696071|65551354|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
23493064|NCT00810355|65551357|FG000|Overall Study|Lost to Follow-up|13|||
23493065|NCT00810355|65551358|FG001|Overall Study|Lost to Follow-up|17|||
23493066|NCT00810355|65551359|FG002|Overall Study|Lost to Follow-up|11|||
23493067|NCT00810355|65551357|FG000|Overall Study|Withdrawal by Subject|1|||
23493068|NCT00810355|65551358|FG001|Overall Study|Withdrawal by Subject|0|||
23493069|NCT00810355|65551359|FG002|Overall Study|Withdrawal by Subject|0|||
23493070|NCT00406354|65551360|FG000|All Randomized Patients|Protocol Violation|0|||
23493071|NCT00406354|65551361|FG001|All Randomized Patients|Protocol Violation|0|||
23493072|NCT00406354|65551362|FG002|All Randomized Patients|Protocol Violation|1|||
23493073|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
23493074|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
23493075|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
23493076|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Adverse Event|6|||
23493077|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Adverse Event|2|||
23493078|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Adverse Event|1|||
23493079|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
23493080|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
23493081|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
23493082|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
23493083|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
23493084|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
23493085|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Physician Decision|0|||
23493086|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Physician Decision|0|||
23493087|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Physician Decision|1|||
23493088|NCT00621959|65551363|FG000|Overall Study|Adverse Event|4|||
23493089|NCT00621959|65551364|FG001|Overall Study|Adverse Event|2|||
23493090|NCT00621959|65551363|FG000|Overall Study|Lack of Efficacy|1|||
23493091|NCT00621959|65551364|FG001|Overall Study|Lack of Efficacy|1|||
23493092|NCT00621959|65551363|FG000|Overall Study|Lost to Follow-up|0|||
23493093|NCT00621959|65551364|FG001|Overall Study|Lost to Follow-up|2|||
23493094|NCT00621959|65551363|FG000|Overall Study|Withdrawal by Subject|1|||
23493095|NCT00621959|65551364|FG001|Overall Study|Withdrawal by Subject|1|||
23493096|NCT00621959|65551363|FG000|Overall Study|Other|1|||
23493097|NCT00621959|65551364|FG001|Overall Study|Other|3|||
23493098|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Disease progression|3|||
23493099|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Disease progression|5|||
23493100|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Disease progression|1|||
23493101|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Disease progression|3|||
23493102|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Disease progression|0|||
23493103|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Disease progression|0|||
23493104|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
23669158|NCT00677014|66172351|FG001|Overall Study|Death|15|||
23669159|NCT00677014|66172352|FG002|Overall Study|Death|7|||
23669160|NCT00677014|66172350|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
23669161|NCT00677014|66172351|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
23669162|NCT00677014|66172352|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
23669163|NCT03594227|66172353|FG000|Overall Study|Adverse Event|2|||
23669164|NCT03594227|66172354|FG001|Overall Study|Adverse Event|1|||
23669165|NCT03594227|66172355|FG002|Overall Study|Adverse Event|0|||
23669166|NCT03594227|66172356|FG003|Overall Study|Adverse Event|2|||
23669167|NCT03594227|66172353|FG000|Overall Study|Lost to Follow-up|1|||
23669168|NCT03594227|66172354|FG001|Overall Study|Lost to Follow-up|1|||
23669169|NCT03594227|66172355|FG002|Overall Study|Lost to Follow-up|1|||
23493105|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
23669170|NCT03594227|66172356|FG003|Overall Study|Lost to Follow-up|0|||
23382659|NCT00433290|65145138|FG000|Overall Study|Lack of Efficacy|1|||
23382660|NCT00433290|65145139|FG001|Overall Study|Lack of Efficacy|5|||
23382661|NCT00433290|65145138|FG000|Overall Study|Withdrawal by Subject|4|||
23382662|NCT00433290|65145139|FG001|Overall Study|Withdrawal by Subject|2|||
23382663|NCT00433290|65145138|FG000|Overall Study|Protocol Violation|3|||
23382664|NCT00433290|65145139|FG001|Overall Study|Protocol Violation|2|||
23382665|NCT00433290|65145138|FG000|Overall Study|Physician Decision|2|||
23382666|NCT00433290|65145139|FG001|Overall Study|Physician Decision|0|||
23382667|NCT00433290|65145138|FG000|Overall Study|Entry Criteria Not Met|0|||
23382668|NCT00433290|65145139|FG001|Overall Study|Entry Criteria Not Met|1|||
23382669|NCT00433290|65145138|FG000|Overall Study|Lost to Follow-up|1|||
23382670|NCT00433290|65145139|FG001|Overall Study|Lost to Follow-up|0|||
23382671|NCT00103506|65145140|FG000|Overall Study|Study closed by sponsor|34|||
23382672|NCT00103506|65145141|FG001|Overall Study|Study closed by sponsor|37|||
23382673|NCT00103506|65145140|FG000|Overall Study|Death|257|||
23382674|NCT00103506|65145141|FG001|Overall Study|Death|253|||
23382675|NCT00103506|65145140|FG000|Overall Study|Lost to Follow-up|13|||
23382676|NCT00103506|65145141|FG001|Overall Study|Lost to Follow-up|13|||
23382677|NCT00103506|65145140|FG000|Overall Study|Withdrawal by Subject|18|||
23382678|NCT00103506|65145141|FG001|Overall Study|Withdrawal by Subject|21|||
23382679|NCT00790933|65145142|FG000|Overall Study|Adverse Event|94|||
23382680|NCT00790933|65145143|FG001|Overall Study|Adverse Event|119|||
23382681|NCT00790933|65145144|FG002|Overall Study|Adverse Event|65|||
23382682|NCT00790933|65145145|FG003|Overall Study|Adverse Event|5|||
23382683|NCT00790933|65145146|FG004|Overall Study|Adverse Event|69|||
23382684|NCT00790933|65145142|FG000|Overall Study|Protocol Violation(s)|8|||
23382685|NCT00790933|65145143|FG001|Overall Study|Protocol Violation(s)|18|||
23382686|NCT00790933|65145144|FG002|Overall Study|Protocol Violation(s)|7|||
23382687|NCT00790933|65145145|FG003|Overall Study|Protocol Violation(s)|0|||
23382688|NCT00790933|65145146|FG004|Overall Study|Protocol Violation(s)|12|||
23382689|NCT00790933|65145142|FG000|Overall Study|Lack of Efficacy|192|||
23382690|NCT00790933|65145143|FG001|Overall Study|Lack of Efficacy|176|||
23382691|NCT00790933|65145144|FG002|Overall Study|Lack of Efficacy|130|||
23382692|NCT00790933|65145145|FG003|Overall Study|Lack of Efficacy|1|||
23382693|NCT00790933|65145146|FG004|Overall Study|Lack of Efficacy|121|||
23382694|NCT00790933|65145142|FG000|Overall Study|Study Terminated by Sponsor|0|||
23382695|NCT00790933|65145143|FG001|Overall Study|Study Terminated by Sponsor|0|||
23382696|NCT00790933|65145144|FG002|Overall Study|Study Terminated by Sponsor|1|||
23382697|NCT00790933|65145145|FG003|Overall Study|Study Terminated by Sponsor|0|||
23382698|NCT00790933|65145146|FG004|Overall Study|Study Terminated by Sponsor|0|||
23382699|NCT00790933|65145142|FG000|Overall Study|Withdrawal by Subject|123|||
23382700|NCT00790933|65145143|FG001|Overall Study|Withdrawal by Subject|120|||
23382701|NCT00790933|65145144|FG002|Overall Study|Withdrawal by Subject|52|||
23382702|NCT00790933|65145145|FG003|Overall Study|Withdrawal by Subject|6|||
23382703|NCT00790933|65145146|FG004|Overall Study|Withdrawal by Subject|50|||
23382704|NCT00790933|65145142|FG000|Overall Study|Lost to Follow-up|13|||
23382705|NCT00790933|65145143|FG001|Overall Study|Lost to Follow-up|31|||
23382706|NCT00790933|65145144|FG002|Overall Study|Lost to Follow-up|10|||
23382707|NCT00790933|65145145|FG003|Overall Study|Lost to Follow-up|1|||
23669171|NCT03594227|66172353|FG000|Overall Study|Withdrawal by Subject|1|||
23382708|NCT00790933|65145146|FG004|Overall Study|Lost to Follow-up|15|||
23382709|NCT00790933|65145142|FG000|Overall Study|Reason Not Specified|8|||
23382710|NCT00790933|65145143|FG001|Overall Study|Reason Not Specified|16|||
23382711|NCT00790933|65145144|FG002|Overall Study|Reason Not Specified|4|||
23382712|NCT00790933|65145145|FG003|Overall Study|Reason Not Specified|1|||
23382713|NCT00790933|65145146|FG004|Overall Study|Reason Not Specified|9|||
23382714|NCT02697422|65145151|FG000|Overall Study|Declined exit survey|9|||
23382715|NCT02697422|65145152|FG001|Overall Study|Declined exit survey|2|||
23382716|NCT02697422|65145151|FG000|Overall Study|Lost to Follow-up|13|||
23382717|NCT02697422|65145152|FG001|Overall Study|Lost to Follow-up|8|||
23382718|NCT02697422|65145151|FG000|Overall Study|Death|2|||
23669172|NCT03594227|66172354|FG001|Overall Study|Withdrawal by Subject|1|||
23382719|NCT02697422|65145152|FG001|Overall Study|Death|1|||
23382720|NCT02697422|65145151|FG000|Overall Study|Withdrawal by Subject|0|||
23382721|NCT02697422|65145152|FG001|Overall Study|Withdrawal by Subject|1|||
23382722|NCT02697422|65145151|FG000|Overall Study|Physician Decision|1|||
23382723|NCT02697422|65145152|FG001|Overall Study|Physician Decision|1|||
23382724|NCT02697422|65145151|FG000|Overall Study|Exit survey data lost|1|||
23382725|NCT02697422|65145152|FG001|Overall Study|Exit survey data lost|0|||
23382726|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
23382727|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
23669173|NCT03594227|66172355|FG002|Overall Study|Withdrawal by Subject|1|||
23669174|NCT03594227|66172356|FG003|Overall Study|Withdrawal by Subject|1|||
23669175|NCT03594227|66172353|FG000|Overall Study|Pregnancy|0|||
23669176|NCT03594227|66172354|FG001|Overall Study|Pregnancy|1|||
23382728|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
23669177|NCT03594227|66172355|FG002|Overall Study|Pregnancy|0|||
23669178|NCT03594227|66172356|FG003|Overall Study|Pregnancy|0|||
23669179|NCT03594227|66172353|FG000|Overall Study|Sponsor Decision|0|||
23669180|NCT03594227|66172354|FG001|Overall Study|Sponsor Decision|0|||
23669181|NCT03594227|66172355|FG002|Overall Study|Sponsor Decision|0|||
23382729|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
23382730|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
23382731|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
23382732|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382733|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382734|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382735|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382736|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382737|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382738|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23382739|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23382740|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
23382741|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
23382742|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
23382743|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
23382744|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
23382745|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
23382746|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
23382747|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
23382748|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
23382749|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
23382750|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
23382751|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
23382752|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
23382753|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
23382754|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
23382755|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
23382756|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
23382757|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
23669182|NCT03594227|66172356|FG003|Overall Study|Sponsor Decision|1|||
23669183|NCT03594227|66172353|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
23669184|NCT03594227|66172354|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
23669185|NCT03594227|66172355|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
23669186|NCT03594227|66172356|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
23669187|NCT02290873|66172359|FG000|Overall Study|Withdrawal by Subject|0|||
23669188|NCT02290873|66172360|FG001|Overall Study|Withdrawal by Subject|1|||
23669189|NCT02290873|66172361|FG002|Overall Study|Withdrawal by Subject|1|||
23669190|NCT02290873|66172359|FG000|Overall Study|Nellcor device error|1|||
23669191|NCT02290873|66172360|FG001|Overall Study|Nellcor device error|0|||
23669192|NCT02290873|66172361|FG002|Overall Study|Nellcor device error|0|||
23669193|NCT02290873|66172359|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
23669194|NCT02290873|66172360|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
23669195|NCT02290873|66172361|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
23669196|NCT02290873|66172359|FG000|Overall Study|Protocol Violation|0|||
23669197|NCT02290873|66172360|FG001|Overall Study|Protocol Violation|0|||
23669198|NCT02290873|66172361|FG002|Overall Study|Protocol Violation|1|||
23669199|NCT00393887|66172364|FG000|Overall Study|Physician Decision|5|||
23669200|NCT00393887|66172365|FG001|Overall Study|Physician Decision|0|||
23669201|NCT00393887|66172364|FG000|Overall Study|Lost to Follow-up|11|||
23669202|NCT00393887|66172365|FG001|Overall Study|Lost to Follow-up|9|||
23669203|NCT00817531|66172369|FG000|Overall Study|Adverse Event|1|||
23669204|NCT00817531|66172369|FG000|Overall Study|Lack of Efficacy|1|||
23669205|NCT00258674|66172370|FG000|Overall Study|Death|32|||
23669206|NCT00258674|66172371|FG001|Overall Study|Death|53|||
23669207|NCT00258674|66172372|FG002|Overall Study|Death|34|||
23669208|NCT00473343|66172373|FG000|Overall Study|Adverse Event|9|||
23669209|NCT00473343|66172373|FG000|Overall Study|Lost to Follow-up|8|||
23669210|NCT00473343|66172373|FG000|Overall Study|Treatment failure|27|||
23669211|NCT00473343|66172373|FG000|Overall Study|Withdrew consent|3|||
23669212|NCT00473343|66172373|FG000|Overall Study|Other un-specified reason|3|||
23669213|NCT03084536|66172374|FG000|Overall Study|Determined to be ineligible|0|||
23669214|NCT03084536|66172375|FG001|Overall Study|Determined to be ineligible|0|||
23669215|NCT03084536|66172376|FG002|Overall Study|Determined to be ineligible|16|||
23669216|NCT03084536|66172374|FG000|Overall Study|Withdrawal by Subject|0|||
23669217|NCT03084536|66172375|FG001|Overall Study|Withdrawal by Subject|0|||
23669218|NCT03084536|66172376|FG002|Overall Study|Withdrawal by Subject|4|||
23669219|NCT03084536|66172374|FG000|Overall Study|Physician Decision|0|||
23669220|NCT03084536|66172375|FG001|Overall Study|Physician Decision|0|||
23669221|NCT03084536|66172376|FG002|Overall Study|Physician Decision|3|||
23669222|NCT03084536|66172374|FG000|Overall Study|Death|0|||
23669223|NCT03084536|66172375|FG001|Overall Study|Death|0|||
23669224|NCT03084536|66172376|FG002|Overall Study|Death|1|||
23669225|NCT03084536|66172374|FG000|Overall Study|Lost to Follow-up|0|||
23669226|NCT03084536|66172375|FG001|Overall Study|Lost to Follow-up|0|||
23669227|NCT03084536|66172376|FG002|Overall Study|Lost to Follow-up|1|||
23669228|NCT03084536|66172374|FG000|Overall Study|Protocol Violation|0|||
23669229|NCT03084536|66172375|FG001|Overall Study|Protocol Violation|0|||
23669230|NCT03084536|66172376|FG002|Overall Study|Protocol Violation|1|||
23669231|NCT03084536|66172374|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
23669232|NCT03084536|66172375|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
23669233|NCT03084536|66172376|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
23669234|NCT04418076|66172377|FG000|Overall Study|Death|1|||
23669235|NCT04418076|66172378|FG001|Overall Study|Death|0|||
23669236|NCT04418076|66172379|FG002|Overall Study|Death|0|||
23669237|NCT04418076|66172380|FG003|Overall Study|Death|0|||
23669238|NCT04418076|66172377|FG000|Overall Study|Lost to Follow-up|2|||
23669239|NCT04418076|66172378|FG001|Overall Study|Lost to Follow-up|5|||
23669240|NCT04418076|66172379|FG002|Overall Study|Lost to Follow-up|1|||
23382758|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
23382759|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
23382760|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
23382761|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
23382762|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
23382763|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
23382764|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
23382765|NCT04491994|65145170|FG000|Overall Study|Withdrawal by Subject|10|||
23382766|NCT04491994|65145171|FG001|Overall Study|Withdrawal by Subject|5|||
23382767|NCT04491994|65145170|FG000|Overall Study|developed fever > 3 days|4|||
23382768|NCT04491994|65145171|FG001|Overall Study|developed fever > 3 days|1|||
23382769|NCT04491994|65145170|FG000|Overall Study|Protocol Violation|11|||
23382770|NCT04491994|65145171|FG001|Overall Study|Protocol Violation|2|||
23382771|NCT04491994|65145170|FG000|Overall Study|Lost to Follow-up|4|||
23382772|NCT04491994|65145171|FG001|Overall Study|Lost to Follow-up|3|||
23382773|NCT05350423|65145176|FG000|Overall Study|Lost to Follow-up|3|||
23382774|NCT05350423|65145177|FG001|Overall Study|Lost to Follow-up|3|||
23382775|NCT05350423|65145176|FG000|Overall Study|screen failure|5|||
23382776|NCT05350423|65145177|FG001|Overall Study|screen failure|6|||
23382777|NCT03093870|65145178|FG000|Overall Study|Withdrawal by Subject|2|||
23382778|NCT03093870|65145179|FG001|Overall Study|Withdrawal by Subject|6|||
23382779|NCT03093870|65145180|FG002|Overall Study|Withdrawal by Subject|5|||
23382780|NCT03093870|65145178|FG000|Overall Study|Death|1|||
23382781|NCT03093870|65145179|FG001|Overall Study|Death|35|||
23382782|NCT03093870|65145180|FG002|Overall Study|Death|35|||
23382783|NCT03093870|65145178|FG000|Overall Study|Radiographic disease progression|10|||
23382784|NCT03093870|65145179|FG001|Overall Study|Radiographic disease progression|0|||
23382785|NCT03093870|65145180|FG002|Overall Study|Radiographic disease progression|0|||
23382786|NCT03093870|65145178|FG000|Overall Study|Clinical disease progression|1|||
23382787|NCT03093870|65145179|FG001|Overall Study|Clinical disease progression|0|||
23382788|NCT03093870|65145180|FG002|Overall Study|Clinical disease progression|0|||
23382789|NCT03093870|65145178|FG000|Overall Study|Physician Decision|2|||
23382790|NCT03093870|65145179|FG001|Overall Study|Physician Decision|0|||
23382791|NCT03093870|65145180|FG002|Overall Study|Physician Decision|0|||
23382792|NCT03093870|65145178|FG000|Overall Study|Adverse Event|7|||
23382793|NCT03093870|65145179|FG001|Overall Study|Adverse Event|0|||
23382794|NCT03093870|65145180|FG002|Overall Study|Adverse Event|0|||
23382795|NCT03093870|65145178|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
23382796|NCT03093870|65145179|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
23382797|NCT03093870|65145180|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
23382798|NCT03093870|65145178|FG000|Overall Study|Lost to Follow-up|0|||
23382799|NCT03093870|65145179|FG001|Overall Study|Lost to Follow-up|0|||
23382800|NCT03093870|65145180|FG002|Overall Study|Lost to Follow-up|1|||
23382801|NCT01111292|65145181|FG000|Treatment|Physician Decision|1|||
23382802|NCT01111292|65145182|FG001|Treatment|Physician Decision|1|||
23493106|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
23669241|NCT04418076|66172380|FG003|Overall Study|Lost to Follow-up|2|||
23669242|NCT04418076|66172377|FG000|Overall Study|Withdrawal by Subject|1|||
23669243|NCT04418076|66172378|FG001|Overall Study|Withdrawal by Subject|0|||
23669244|NCT04418076|66172379|FG002|Overall Study|Withdrawal by Subject|1|||
23669245|NCT04418076|66172380|FG003|Overall Study|Withdrawal by Subject|1|||
23669246|NCT04418076|66172377|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
23669247|NCT04418076|66172378|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
23669248|NCT04418076|66172379|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
23669249|NCT04418076|66172380|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
23669250|NCT02321436|66172381|FG000|Overall Study|Withdrawal by Subject|1|||
23669251|NCT02321436|66172382|FG001|Overall Study|Withdrawal by Subject|0|||
23669252|NCT02321436|66172381|FG000|Overall Study|Lost to Follow-up|0|||
23669253|NCT02321436|66172382|FG001|Overall Study|Lost to Follow-up|1|||
23669254|NCT01761292|66172394|FG000|Part 1|Adverse Event|1|||
23669255|NCT01761292|66172394|FG000|Part 1|not receiving treatment in Part 1|1|||
23669256|NCT01761292|66172394|FG000|Extension 1|Withdrawal by Subject|1|||
23382803|NCT00552058|65145183|FG000|Overall Study|Adverse Event|8|||
23382804|NCT00552058|65145184|FG001|Overall Study|Adverse Event|7|||
23382805|NCT00552058|65145183|FG000|Overall Study|Lack of Efficacy|1|||
23382806|NCT00552058|65145184|FG001|Overall Study|Lack of Efficacy|5|||
23382807|NCT00552058|65145183|FG000|Overall Study|Lost to Follow-up|1|||
23382808|NCT00552058|65145184|FG001|Overall Study|Lost to Follow-up|0|||
23382809|NCT00552058|65145183|FG000|Overall Study|Withdrawal by Subject|4|||
23382810|NCT00552058|65145184|FG001|Overall Study|Withdrawal by Subject|4|||
23382811|NCT00552058|65145183|FG000|Overall Study|Other: Protocol Violation|0|||
23669257|NCT00109707|66172395|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
23382812|NCT00552058|65145184|FG001|Overall Study|Other: Protocol Violation|1|||
23382813|NCT00552058|65145183|FG000|Overall Study|Other: Non Compliance|1|||
23382814|NCT00552058|65145184|FG001|Overall Study|Other: Non Compliance|2|||
23382815|NCT00552058|65145183|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
23382816|NCT00552058|65145184|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
23382817|NCT00552058|65145183|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
23382818|NCT00552058|65145184|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
23382819|NCT00552058|65145183|FG000|Overall Study|Other: Positive Stool Result|0|||
23382820|NCT00552058|65145184|FG001|Overall Study|Other: Positive Stool Result|1|||
23382821|NCT00552058|65145183|FG000|Overall Study|Other: Randomized in error|0|||
23382822|NCT00552058|65145184|FG001|Overall Study|Other: Randomized in error|1|||
23382823|NCT00552058|65145183|FG000|Overall Study|Other: Sponsors Decision|0|||
23382824|NCT00552058|65145184|FG001|Overall Study|Other: Sponsors Decision|1|||
23382825|NCT00552058|65145183|FG000|Overall Study|Other: Early Roll Over|1|||
23382826|NCT00552058|65145184|FG001|Overall Study|Other: Early Roll Over|0|||
23382827|NCT00981175|65145185|FG000|Primary Dose Vaccination|Adverse Event|1|||
23382828|NCT00981175|65145186|FG001|Primary Dose Vaccination|Adverse Event|0|||
23382829|NCT00981175|65145185|FG000|Primary Dose Vaccination|Protocol Violation|0|||
23382830|NCT00981175|65145186|FG001|Primary Dose Vaccination|Protocol Violation|1|||
23493107|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
23493108|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
23493109|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
23493110|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Other|0|||
23493111|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Other|1|||
23493112|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Other|0|||
23493113|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Other|0|||
23493114|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Other|0|||
23493115|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Other|0|||
23493116|NCT01897714|65551365|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
23493117|NCT01897714|65551366|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
23493118|NCT01897714|65551367|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
23493119|NCT01897714|65551368|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
23493120|NCT01897714|65551369|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
23493121|NCT01897714|65551370|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
23493122|NCT01897714|65551365|FG000|Phase II (MTD)|Lost to Follow-up|0|||
23493123|NCT01897714|65551366|FG001|Phase II (MTD)|Lost to Follow-up|0|||
23493124|NCT01897714|65551367|FG002|Phase II (MTD)|Lost to Follow-up|0|||
23493125|NCT01897714|65551368|FG003|Phase II (MTD)|Lost to Follow-up|0|||
23493126|NCT01897714|65551369|FG004|Phase II (MTD)|Lost to Follow-up|1|||
23493127|NCT01897714|65551370|FG005|Phase II (MTD)|Lost to Follow-up|0|||
23493128|NCT01897714|65551365|FG000|Phase II (MTD)|Death|0|||
23493129|NCT01897714|65551366|FG001|Phase II (MTD)|Death|0|||
23493130|NCT01897714|65551367|FG002|Phase II (MTD)|Death|0|||
23493131|NCT01897714|65551368|FG003|Phase II (MTD)|Death|0|||
23493132|NCT01897714|65551369|FG004|Phase II (MTD)|Death|25|||
23669258|NCT00109707|66172396|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
23669259|NCT00109707|66172397|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
23669260|NCT00109707|66172395|FG000|Overall Study|Abnormal laboratory values|1|||
23669261|NCT00109707|66172396|FG001|Overall Study|Abnormal laboratory values|0|||
23669262|NCT00109707|66172397|FG002|Overall Study|Abnormal laboratory values|0|||
23669263|NCT00109707|66172395|FG000|Overall Study|Administrative problems|2|||
23669264|NCT00109707|66172396|FG001|Overall Study|Administrative problems|0|||
23669265|NCT00109707|66172397|FG002|Overall Study|Administrative problems|1|||
23669266|NCT00109707|66172395|FG000|Overall Study|Adverse Event|10|||
23669267|NCT00109707|66172396|FG001|Overall Study|Adverse Event|2|||
23669268|NCT00109707|66172397|FG002|Overall Study|Adverse Event|3|||
23669269|NCT00109707|66172395|FG000|Overall Study|Death|4|||
23669270|NCT00109707|66172396|FG001|Overall Study|Death|0|||
23669271|NCT00109707|66172397|FG002|Overall Study|Death|0|||
23669272|NCT00109707|66172395|FG000|Overall Study|Disease progression|12|||
23669273|NCT00109707|66172396|FG001|Overall Study|Disease progression|4|||
23669274|NCT00109707|66172397|FG002|Overall Study|Disease progression|3|||
23669275|NCT00109707|66172395|FG000|Overall Study|Lost to Follow-up|3|||
23669276|NCT00109707|66172396|FG001|Overall Study|Lost to Follow-up|0|||
23669277|NCT00109707|66172397|FG002|Overall Study|Lost to Follow-up|0|||
23669278|NCT00109707|66172395|FG000|Overall Study|Protocol Violation|1|||
23669279|NCT00109707|66172396|FG001|Overall Study|Protocol Violation|0|||
23669280|NCT00109707|66172397|FG002|Overall Study|Protocol Violation|0|||
23669281|NCT00109707|66172395|FG000|Overall Study|Patient withdrew consent|6|||
23669282|NCT00109707|66172396|FG001|Overall Study|Patient withdrew consent|1|||
23669283|NCT00109707|66172397|FG002|Overall Study|Patient withdrew consent|0|||
23669284|NCT00763815|66172398|FG000|Overall Study|Adverse Event|14|||
23382831|NCT00981175|65145185|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
23382832|NCT00981175|65145186|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
23493133|NCT01897714|65551370|FG005|Phase II (MTD)|Death|10|||
23493134|NCT01897714|65551365|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
23382833|NCT00981175|65145185|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
23382834|NCT00981175|65145186|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
23382835|NCT02068599|65145196|FG000|Overall Study|Adverse Event|4|||
23382836|NCT02068599|65145197|FG001|Overall Study|Adverse Event|1|||
23382837|NCT02068599|65145198|FG002|Overall Study|Adverse Event|1|||
23382838|NCT02068599|65145196|FG000|Overall Study|Withdrawal by Subject|2|||
23382839|NCT02068599|65145197|FG001|Overall Study|Withdrawal by Subject|7|||
23382840|NCT02068599|65145198|FG002|Overall Study|Withdrawal by Subject|5|||
23382841|NCT02068599|65145196|FG000|Overall Study|Protocol Violation|4|||
23382842|NCT02068599|65145197|FG001|Overall Study|Protocol Violation|2|||
23382843|NCT02068599|65145198|FG002|Overall Study|Protocol Violation|3|||
23382844|NCT02068599|65145196|FG000|Overall Study|Lost to Follow-up|1|||
23382845|NCT02068599|65145197|FG001|Overall Study|Lost to Follow-up|0|||
23382846|NCT02068599|65145198|FG002|Overall Study|Lost to Follow-up|0|||
23382847|NCT02068599|65145196|FG000|Overall Study|Lack of Efficacy|0|||
23382848|NCT02068599|65145197|FG001|Overall Study|Lack of Efficacy|0|||
23382849|NCT02068599|65145198|FG002|Overall Study|Lack of Efficacy|3|||
23382850|NCT02068599|65145196|FG000|Overall Study|Noncompliance|0|||
23382851|NCT02068599|65145197|FG001|Overall Study|Noncompliance|0|||
23382852|NCT02068599|65145198|FG002|Overall Study|Noncompliance|1|||
23382853|NCT01227395|65145200|FG000|Overall Study|Protocol Violation|0|||
23382854|NCT01227395|65145201|FG001|Overall Study|Protocol Violation|1|||
23382855|NCT01567085|65145207|FG000|Overall Study|Death|6|||
23382856|NCT01567085|65145207|FG000|Overall Study|Adverse Event|6|||
23382857|NCT01567085|65145207|FG000|Overall Study|Lost to Follow-up|3|||
23382858|NCT01567085|65145207|FG000|Overall Study|Graft loss|2|||
23382859|NCT01567085|65145207|FG000|Overall Study|Renal transplantectomy|1|||
23382860|NCT01567085|65145207|FG000|Overall Study|Returned to chronic dialysis|1|||
23382861|NCT01567085|65145207|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
23382862|NCT00153920|65145208|FG000|Overall Study|Adverse Event|9|||
23382863|NCT00153920|65145208|FG000|Overall Study|Progressive Disease|9|||
23382864|NCT00153920|65145208|FG000|Overall Study|Physician Decision|3|||
23382865|NCT00153920|65145208|FG000|Overall Study|Lack of Response|3|||
23382866|NCT00153920|65145208|FG000|Overall Study|Death|2|||
23382867|NCT00153920|65145208|FG000|Overall Study|Withdrawal by Subject|1|||
23669285|NCT00763815|66172399|FG001|Overall Study|Adverse Event|29|||
23669286|NCT00763815|66172398|FG000|Overall Study|Lack of Efficacy|10|||
23669287|NCT00763815|66172399|FG001|Overall Study|Lack of Efficacy|11|||
23669288|NCT00763815|66172398|FG000|Overall Study|Poor Compliance to Protocol|6|||
23669289|NCT00763815|66172399|FG001|Overall Study|Poor Compliance to Protocol|6|||
23669290|NCT00763815|66172398|FG000|Overall Study|Lost to Follow-up|2|||
23669291|NCT00763815|66172399|FG001|Overall Study|Lost to Follow-up|4|||
23669292|NCT00763815|66172398|FG000|Overall Study|Early Termination|1|||
23669293|NCT00763815|66172399|FG001|Overall Study|Early Termination|0|||
23669294|NCT00763815|66172398|FG000|Overall Study|Familial and Personal Reasons|9|||
23669295|NCT00763815|66172399|FG001|Overall Study|Familial and Personal Reasons|16|||
23669296|NCT00763815|66172398|FG000|Overall Study|Physician Decision|1|||
23669297|NCT00763815|66172399|FG001|Overall Study|Physician Decision|0|||
23669298|NCT00763815|66172398|FG000|Overall Study|Withdrawal by Subject|7|||
23669299|NCT00763815|66172399|FG001|Overall Study|Withdrawal by Subject|12|||
23669300|NCT00763815|66172398|FG000|Overall Study|Protocol Violation|2|||
23669301|NCT00763815|66172399|FG001|Overall Study|Protocol Violation|5|||
23669302|NCT00763815|66172398|FG000|Overall Study|Sponsor's Decision|0|||
23669303|NCT00763815|66172399|FG001|Overall Study|Sponsor's Decision|1|||
23669304|NCT01239342|66172400|FG000|Overall Study|Adverse Event|1|||
23669305|NCT01239342|66172401|FG001|Overall Study|Adverse Event|0|||
23669306|NCT01239342|66172400|FG000|Overall Study|Withdrawal by Subject|1|||
23669307|NCT01239342|66172401|FG001|Overall Study|Withdrawal by Subject|5|||
23669308|NCT01239342|66172400|FG000|Overall Study|Reason Unknown|1|||
23669309|NCT01239342|66172401|FG001|Overall Study|Reason Unknown|1|||
23669310|NCT01611974|66172402|FG000|Overall Study|Death|10|||
23669311|NCT01611974|66172403|FG001|Overall Study|Death|12|||
23669312|NCT01611974|66172404|FG002|Overall Study|Death|10|||
23382868|NCT00153920|65145208|FG000|Overall Study|Non-Protocol Therapy|1|||
23382869|NCT00153920|65145208|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
23382870|NCT00153920|65145208|FG000|Overall Study|Progressive Disease before Trt|1|||
23382871|NCT03022630|65145209|FG000|Overall Study|Death|9|||
23382872|NCT03022630|65145210|FG001|Overall Study|Death|7|||
23382873|NCT03022630|65145209|FG000|Overall Study|Withdrawal by Subject|0|||
23669313|NCT01611974|66172402|FG000|Overall Study|Lost to Follow-up|0|||
23669314|NCT01611974|66172403|FG001|Overall Study|Lost to Follow-up|1|||
23669315|NCT01611974|66172404|FG002|Overall Study|Lost to Follow-up|0|||
23669316|NCT01611974|66172402|FG000|Overall Study|Physician Decision|5|||
23669317|NCT01611974|66172403|FG001|Overall Study|Physician Decision|1|||
23669318|NCT01611974|66172404|FG002|Overall Study|Physician Decision|2|||
23382874|NCT03022630|65145210|FG001|Overall Study|Withdrawal by Subject|5|||
23382875|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
23669319|NCT01611974|66172402|FG000|Overall Study|Withdrawal by Subject|0|||
23669320|NCT01611974|66172403|FG001|Overall Study|Withdrawal by Subject|1|||
23382876|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
23382877|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
23382878|NCT00837330|65145212|FG000|Overall Study|Lost to Follow-up|1|||
23382879|NCT00837330|65145213|FG001|Overall Study|Lost to Follow-up|3|||
23382880|NCT04518410|65145221|FG000|Overall Study|Lost to Follow-up|1|||
23382881|NCT04518410|65145222|FG001|Overall Study|Lost to Follow-up|1|||
23382882|NCT04518410|65145223|FG002|Overall Study|Lost to Follow-up|8|||
23382883|NCT04518410|65145224|FG003|Overall Study|Lost to Follow-up|5|||
23382884|NCT04518410|65145225|FG004|Overall Study|Lost to Follow-up|92|||
23382885|NCT04518410|65145226|FG005|Overall Study|Lost to Follow-up|25|||
23382886|NCT04518410|65145227|FG006|Overall Study|Lost to Follow-up|25|||
23382887|NCT04518410|65145228|FG007|Overall Study|Lost to Follow-up|3|||
23382888|NCT04518410|65145229|FG008|Overall Study|Lost to Follow-up|2|||
23382889|NCT04518410|65145230|FG009|Overall Study|Lost to Follow-up|13|||
23382890|NCT04518410|65145231|FG010|Overall Study|Lost to Follow-up|9|||
23382891|NCT04518410|65145232|FG011|Overall Study|Lost to Follow-up|13|||
23382892|NCT04518410|65145233|FG012|Overall Study|Lost to Follow-up|9|||
23382893|NCT04518410|65145234|FG013|Overall Study|Lost to Follow-up|13|||
23382894|NCT04518410|65145235|FG014|Overall Study|Lost to Follow-up|8|||
23382895|NCT04518410|65145236|FG015|Overall Study|Lost to Follow-up|10|||
23382896|NCT04518410|65145237|FG016|Overall Study|Lost to Follow-up|6|||
23382897|NCT04518410|65145238|FG017|Overall Study|Lost to Follow-up|13|||
23382898|NCT04518410|65145239|FG018|Overall Study|Lost to Follow-up|21|||
23382899|NCT04518410|65145240|FG019|Overall Study|Lost to Follow-up|6|||
23382900|NCT04518410|65145241|FG020|Overall Study|Lost to Follow-up|7|||
23382901|NCT04518410|65145242|FG021|Overall Study|Lost to Follow-up|21|||
23382902|NCT04518410|65145243|FG022|Overall Study|Lost to Follow-up|1|||
23382903|NCT04518410|65145244|FG023|Overall Study|Lost to Follow-up|7|||
23382904|NCT04518410|65145245|FG024|Overall Study|Lost to Follow-up|6|||
23382905|NCT04518410|65145221|FG000|Overall Study|Withdrawal by Subject|1|||
23382906|NCT04518410|65145222|FG001|Overall Study|Withdrawal by Subject|2|||
23382907|NCT04518410|65145223|FG002|Overall Study|Withdrawal by Subject|2|||
23382908|NCT04518410|65145224|FG003|Overall Study|Withdrawal by Subject|3|||
23382909|NCT04518410|65145225|FG004|Overall Study|Withdrawal by Subject|20|||
23382910|NCT04518410|65145226|FG005|Overall Study|Withdrawal by Subject|20|||
23382911|NCT04518410|65145227|FG006|Overall Study|Withdrawal by Subject|25|||
23382912|NCT04518410|65145228|FG007|Overall Study|Withdrawal by Subject|6|||
23382913|NCT04518410|65145229|FG008|Overall Study|Withdrawal by Subject|1|||
23382914|NCT04518410|65145230|FG009|Overall Study|Withdrawal by Subject|12|||
23382915|NCT04518410|65145231|FG010|Overall Study|Withdrawal by Subject|5|||
23382916|NCT04518410|65145232|FG011|Overall Study|Withdrawal by Subject|7|||
23382917|NCT04518410|65145233|FG012|Overall Study|Withdrawal by Subject|2|||
23382918|NCT04518410|65145234|FG013|Overall Study|Withdrawal by Subject|13|||
23382919|NCT04518410|65145235|FG014|Overall Study|Withdrawal by Subject|4|||
23382920|NCT04518410|65145236|FG015|Overall Study|Withdrawal by Subject|9|||
23382921|NCT04518410|65145237|FG016|Overall Study|Withdrawal by Subject|0|||
23382922|NCT04518410|65145238|FG017|Overall Study|Withdrawal by Subject|15|||
23382923|NCT04518410|65145239|FG018|Overall Study|Withdrawal by Subject|12|||
23382924|NCT04518410|65145240|FG019|Overall Study|Withdrawal by Subject|9|||
23382925|NCT04518410|65145241|FG020|Overall Study|Withdrawal by Subject|14|||
23382926|NCT04518410|65145242|FG021|Overall Study|Withdrawal by Subject|3|||
23382927|NCT04518410|65145243|FG022|Overall Study|Withdrawal by Subject|2|||
23382928|NCT04518410|65145244|FG023|Overall Study|Withdrawal by Subject|9|||
23382929|NCT04518410|65145245|FG024|Overall Study|Withdrawal by Subject|8|||
23382930|NCT04518410|65145221|FG000|Overall Study|Other|1|||
23382931|NCT04518410|65145222|FG001|Overall Study|Other|0|||
23382932|NCT04518410|65145223|FG002|Overall Study|Other|0|||
23382933|NCT04518410|65145224|FG003|Overall Study|Other|1|||
23669321|NCT01611974|66172404|FG002|Overall Study|Withdrawal by Subject|4|||
23669322|NCT02199080|66172405|FG000|Overall Study|Protocol Violation|12|||
23669323|NCT01152021|66172406|FG000|Overall Study|Adverse Event|4|||
23669324|NCT01152021|66172407|FG001|Overall Study|Adverse Event|4|||
23669325|NCT01152021|66172406|FG000|Overall Study|Study drug had expired|1|||
23382934|NCT04518410|65145225|FG004|Overall Study|Other|6|||
23382935|NCT04518410|65145226|FG005|Overall Study|Other|6|||
23382936|NCT04518410|65145227|FG006|Overall Study|Other|5|||
23382937|NCT04518410|65145228|FG007|Overall Study|Other|2|||
23605962|NCT01640951|65947108|FG007|Overall Study|Protocol Deviation|0|||
23382938|NCT04518410|65145229|FG008|Overall Study|Other|0|||
23382939|NCT04518410|65145230|FG009|Overall Study|Other|1|||
23382940|NCT04518410|65145231|FG010|Overall Study|Other|0|||
23382941|NCT04518410|65145232|FG011|Overall Study|Other|2|||
23669326|NCT01152021|66172407|FG001|Overall Study|Study drug had expired|0|||
23382942|NCT04518410|65145233|FG012|Overall Study|Other|0|||
23382943|NCT04518410|65145234|FG013|Overall Study|Other|0|||
23382944|NCT04518410|65145235|FG014|Overall Study|Other|0|||
23382945|NCT04518410|65145236|FG015|Overall Study|Other|3|||
23382946|NCT04518410|65145237|FG016|Overall Study|Other|1|||
23382947|NCT04518410|65145238|FG017|Overall Study|Other|1|||
23382948|NCT04518410|65145239|FG018|Overall Study|Other|1|||
23382949|NCT04518410|65145240|FG019|Overall Study|Other|0|||
23382950|NCT04518410|65145241|FG020|Overall Study|Other|1|||
23382951|NCT04518410|65145242|FG021|Overall Study|Other|0|||
23382952|NCT04518410|65145243|FG022|Overall Study|Other|1|||
23382953|NCT04518410|65145244|FG023|Overall Study|Other|2|||
23382954|NCT04518410|65145245|FG024|Overall Study|Other|2|||
23382955|NCT04518410|65145221|FG000|Overall Study|Protocol Violation|0|||
23382956|NCT04518410|65145222|FG001|Overall Study|Protocol Violation|0|||
23382957|NCT04518410|65145223|FG002|Overall Study|Protocol Violation|0|||
23382958|NCT04518410|65145224|FG003|Overall Study|Protocol Violation|2|||
23382959|NCT04518410|65145225|FG004|Overall Study|Protocol Violation|17|||
23382960|NCT04518410|65145226|FG005|Overall Study|Protocol Violation|1|||
23382961|NCT04518410|65145227|FG006|Overall Study|Protocol Violation|2|||
23669327|NCT01152021|66172406|FG000|Overall Study|Physician Decision|1|||
23382962|NCT04518410|65145228|FG007|Overall Study|Protocol Violation|1|||
23382963|NCT04518410|65145229|FG008|Overall Study|Protocol Violation|0|||
23382964|NCT04518410|65145230|FG009|Overall Study|Protocol Violation|0|||
23382965|NCT04518410|65145231|FG010|Overall Study|Protocol Violation|0|||
23669328|NCT01152021|66172407|FG001|Overall Study|Physician Decision|1|||
23669329|NCT01152021|66172406|FG000|Overall Study|No access to study drug in Pharmacy|0|||
23669330|NCT01152021|66172407|FG001|Overall Study|No access to study drug in Pharmacy|1|||
23669331|NCT03024970|66172408|FG000|First Intervention|Adverse Event|1|||
23669332|NCT03024970|66172409|FG001|First Intervention|Adverse Event|0|||
23669333|NCT03024970|66172408|FG000|Second Intervention|Lost to Follow-up|1|||
23669334|NCT03024970|66172409|FG001|Second Intervention|Lost to Follow-up|0|||
23669335|NCT01227187|66172410|FG000|Overall Study|Physician Decision|0|||
23669336|NCT01227187|66172411|FG001|Overall Study|Physician Decision|0|||
23669337|NCT01227187|66172412|FG002|Overall Study|Physician Decision|0|||
23669338|NCT01227187|66172413|FG003|Overall Study|Physician Decision|1|||
23669339|NCT00075400|66172414|FG000|Overall Study|Ineligible: wrong primary|1|||
23669340|NCT00075400|66172414|FG000|Overall Study|Never treated|2|||
23669341|NCT02037295|66172415|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
23669342|NCT02037295|66172416|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
23669343|NCT02037295|66172417|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
23669344|NCT02037295|66172418|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
23669345|NCT01820364|66172419|FG000|Part I: LGX818|Death|1|||
23669346|NCT01820364|66172420|FG001|Part I: LGX818|Death|0|||
23669347|NCT01820364|66172419|FG000|Part I: LGX818|Administrative Problems|3|||
23669348|NCT01820364|66172420|FG001|Part I: LGX818|Administrative Problems|0|||
23669349|NCT01820364|66172419|FG000|Part I: LGX818|Adverse Event|6|||
23669350|NCT01820364|66172420|FG001|Part I: LGX818|Adverse Event|0|||
23669351|NCT01820364|66172419|FG000|Part I: LGX818|Disease Progression|4|||
23669352|NCT01820364|66172420|FG001|Part I: LGX818|Disease Progression|0|||
23669353|NCT01820364|66172419|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
23669354|NCT01820364|66172420|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
23669355|NCT01970995|66172425|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23669356|NCT01970995|66172426|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23669357|NCT01970995|66172427|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23669358|NCT01970995|66172425|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
23669359|NCT01970995|66172426|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
23669360|NCT01970995|66172427|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
23669361|NCT04707157|66172428|FG000|Overall Study|Adverse Event|12|||
23669362|NCT04707157|66172429|FG001|Overall Study|Adverse Event|3|||
23382966|NCT04518410|65145232|FG011|Overall Study|Protocol Violation|0|||
23382967|NCT04518410|65145233|FG012|Overall Study|Protocol Violation|0|||
23382968|NCT04518410|65145234|FG013|Overall Study|Protocol Violation|0|||
23382969|NCT04518410|65145235|FG014|Overall Study|Protocol Violation|0|||
23669363|NCT04707157|66172428|FG000|Overall Study|Lost to Follow-up|2|||
23669364|NCT04707157|66172429|FG001|Overall Study|Lost to Follow-up|0|||
23669365|NCT04707157|66172428|FG000|Overall Study|Sponsor's decision|1|||
23669366|NCT04707157|66172429|FG001|Overall Study|Sponsor's decision|0|||
23669367|NCT04707157|66172428|FG000|Overall Study|Physician Decision|8|||
23669368|NCT04707157|66172429|FG001|Overall Study|Physician Decision|5|||
23669369|NCT04707157|66172428|FG000|Overall Study|Protocol Deviation|1|||
23669370|NCT04707157|66172429|FG001|Overall Study|Protocol Deviation|0|||
23669371|NCT04707157|66172428|FG000|Overall Study|Withdrawal by Subject|1|||
23669372|NCT04707157|66172429|FG001|Overall Study|Withdrawal by Subject|1|||
23669373|NCT01309659|66172431|FG000|Overall Study|Protocol Violation|0|||
23669374|NCT01309659|66172432|FG001|Overall Study|Protocol Violation|1|||
23669375|NCT00788372|66172433|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
23669376|NCT00788372|66172433|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
23669377|NCT00788372|66172433|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
23669378|NCT00788372|66172433|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
23669379|NCT00788372|66172433|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
23669380|NCT00788372|66172433|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
23382970|NCT04518410|65145236|FG015|Overall Study|Protocol Violation|0|||
23669381|NCT00788372|66172433|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
23669382|NCT01439204|66172434|FG000|Overall Study|Withdrawal by Subject|0|||
23669383|NCT01439204|66172435|FG001|Overall Study|Withdrawal by Subject|1|||
23669384|NCT01439204|66172434|FG000|Overall Study|Lost to Follow-up|0|||
23669385|NCT01439204|66172435|FG001|Overall Study|Lost to Follow-up|2|||
23669386|NCT01439204|66172434|FG000|Overall Study|No longer meets study criteria|1|||
23669387|NCT01439204|66172435|FG001|Overall Study|No longer meets study criteria|0|||
23669388|NCT01439204|66172434|FG000|Overall Study|poor/non-compliance|3|||
23669389|NCT01439204|66172435|FG001|Overall Study|poor/non-compliance|0|||
23605963|NCT01640951|65947101|FG000|Overall Study|Subject/Guardian decision|12|||
23605964|NCT01640951|65947102|FG001|Overall Study|Subject/Guardian decision|4|||
23605965|NCT01640951|65947103|FG002|Overall Study|Subject/Guardian decision|13|||
23605966|NCT01640951|65947104|FG003|Overall Study|Subject/Guardian decision|15|||
23605967|NCT01640951|65947105|FG004|Overall Study|Subject/Guardian decision|7|||
23605968|NCT01640951|65947106|FG005|Overall Study|Subject/Guardian decision|19|||
23605969|NCT01640951|65947107|FG006|Overall Study|Subject/Guardian decision|5|||
23605970|NCT01640951|65947108|FG007|Overall Study|Subject/Guardian decision|4|||
23605971|NCT01640951|65947101|FG000|Overall Study|Death|0|||
23605972|NCT01640951|65947102|FG001|Overall Study|Death|1|||
23605973|NCT01640951|65947103|FG002|Overall Study|Death|1|||
23605974|NCT01640951|65947104|FG003|Overall Study|Death|0|||
23605975|NCT01640951|65947105|FG004|Overall Study|Death|0|||
23605976|NCT01640951|65947106|FG005|Overall Study|Death|0|||
23605977|NCT01640951|65947107|FG006|Overall Study|Death|0|||
23669390|NCT00844753|66172438|FG000|Overall Study|Lack of Efficacy|1|||
23669391|NCT00844753|66172439|FG001|Overall Study|Lack of Efficacy|0|||
23669392|NCT00844753|66172440|FG002|Overall Study|Lack of Efficacy|2|||
23669393|NCT00844753|66172441|FG003|Overall Study|Lack of Efficacy|2|||
23669394|NCT00844753|66172438|FG000|Overall Study|Adverse Event|3|||
23669395|NCT00844753|66172439|FG001|Overall Study|Adverse Event|2|||
23669396|NCT00844753|66172440|FG002|Overall Study|Adverse Event|5|||
23669397|NCT00844753|66172441|FG003|Overall Study|Adverse Event|5|||
23669398|NCT00844753|66172438|FG000|Overall Study|Lost to Follow-up|1|||
23669399|NCT00844753|66172439|FG001|Overall Study|Lost to Follow-up|1|||
23669400|NCT00844753|66172440|FG002|Overall Study|Lost to Follow-up|0|||
23382971|NCT04518410|65145237|FG016|Overall Study|Protocol Violation|1|||
23382972|NCT04518410|65145238|FG017|Overall Study|Protocol Violation|1|||
23382973|NCT04518410|65145239|FG018|Overall Study|Protocol Violation|0|||
23382974|NCT04518410|65145240|FG019|Overall Study|Protocol Violation|0|||
23382975|NCT04518410|65145241|FG020|Overall Study|Protocol Violation|1|||
23382976|NCT04518410|65145242|FG021|Overall Study|Protocol Violation|2|||
23382977|NCT04518410|65145243|FG022|Overall Study|Protocol Violation|0|||
23382978|NCT04518410|65145244|FG023|Overall Study|Protocol Violation|3|||
23382979|NCT04518410|65145245|FG024|Overall Study|Protocol Violation|0|||
23382980|NCT04518410|65145221|FG000|Overall Study|Death|0|||
23382981|NCT04518410|65145222|FG001|Overall Study|Death|0|||
23382982|NCT04518410|65145223|FG002|Overall Study|Death|0|||
23382983|NCT04518410|65145224|FG003|Overall Study|Death|0|||
23382984|NCT04518410|65145225|FG004|Overall Study|Death|12|||
23382985|NCT04518410|65145226|FG005|Overall Study|Death|2|||
23382986|NCT04518410|65145227|FG006|Overall Study|Death|11|||
23382987|NCT04518410|65145228|FG007|Overall Study|Death|0|||
23382988|NCT04518410|65145229|FG008|Overall Study|Death|1|||
23382989|NCT04518410|65145230|FG009|Overall Study|Death|0|||
23382990|NCT04518410|65145231|FG010|Overall Study|Death|0|||
23382991|NCT04518410|65145232|FG011|Overall Study|Death|0|||
23382992|NCT04518410|65145233|FG012|Overall Study|Death|0|||
23382993|NCT04518410|65145234|FG013|Overall Study|Death|1|||
23382994|NCT04518410|65145235|FG014|Overall Study|Death|1|||
23382995|NCT04518410|65145236|FG015|Overall Study|Death|0|||
23382996|NCT04518410|65145237|FG016|Overall Study|Death|0|||
23382997|NCT04518410|65145238|FG017|Overall Study|Death|1|||
23382998|NCT04518410|65145239|FG018|Overall Study|Death|4|||
23382999|NCT04518410|65145240|FG019|Overall Study|Death|4|||
23383000|NCT04518410|65145241|FG020|Overall Study|Death|1|||
23383001|NCT04518410|65145242|FG021|Overall Study|Death|0|||
23383002|NCT04518410|65145243|FG022|Overall Study|Death|0|||
23383003|NCT04518410|65145244|FG023|Overall Study|Death|0|||
23383004|NCT04518410|65145245|FG024|Overall Study|Death|0|||
23383005|NCT04518410|65145221|FG000|Overall Study|Requirement to start alternative therapy|0|||
23383006|NCT04518410|65145222|FG001|Overall Study|Requirement to start alternative therapy|0|||
23383007|NCT04518410|65145223|FG002|Overall Study|Requirement to start alternative therapy|1|||
23383008|NCT04518410|65145224|FG003|Overall Study|Requirement to start alternative therapy|0|||
23669401|NCT00844753|66172441|FG003|Overall Study|Lost to Follow-up|1|||
23669402|NCT00844753|66172438|FG000|Overall Study|could not swallow medication|2|||
23669403|NCT00844753|66172439|FG001|Overall Study|could not swallow medication|0|||
23669404|NCT00844753|66172440|FG002|Overall Study|could not swallow medication|0|||
23383009|NCT04518410|65145225|FG004|Overall Study|Requirement to start alternative therapy|0|||
23383010|NCT04518410|65145226|FG005|Overall Study|Requirement to start alternative therapy|0|||
23605978|NCT01640951|65947108|FG007|Overall Study|Death|2|||
23383011|NCT04518410|65145227|FG006|Overall Study|Requirement to start alternative therapy|0|||
23383012|NCT04518410|65145228|FG007|Overall Study|Requirement to start alternative therapy|0|||
23383013|NCT04518410|65145229|FG008|Overall Study|Requirement to start alternative therapy|0|||
23383014|NCT04518410|65145230|FG009|Overall Study|Requirement to start alternative therapy|0|||
23383015|NCT04518410|65145231|FG010|Overall Study|Requirement to start alternative therapy|0|||
23383016|NCT04518410|65145232|FG011|Overall Study|Requirement to start alternative therapy|0|||
23383017|NCT04518410|65145233|FG012|Overall Study|Requirement to start alternative therapy|0|||
23383018|NCT04518410|65145234|FG013|Overall Study|Requirement to start alternative therapy|0|||
23383019|NCT04518410|65145235|FG014|Overall Study|Requirement to start alternative therapy|0|||
23383020|NCT04518410|65145236|FG015|Overall Study|Requirement to start alternative therapy|0|||
23383021|NCT04518410|65145237|FG016|Overall Study|Requirement to start alternative therapy|0|||
23383022|NCT04518410|65145238|FG017|Overall Study|Requirement to start alternative therapy|0|||
23383023|NCT04518410|65145239|FG018|Overall Study|Requirement to start alternative therapy|0|||
23669405|NCT00844753|66172441|FG003|Overall Study|could not swallow medication|0|||
23669406|NCT00844753|66172438|FG000|Overall Study|Withdrawal by Subject|1|||
23669407|NCT00844753|66172439|FG001|Overall Study|Withdrawal by Subject|0|||
23669408|NCT00844753|66172440|FG002|Overall Study|Withdrawal by Subject|0|||
23383024|NCT04518410|65145240|FG019|Overall Study|Requirement to start alternative therapy|0|||
23383025|NCT04518410|65145241|FG020|Overall Study|Requirement to start alternative therapy|0|||
23669409|NCT00844753|66172441|FG003|Overall Study|Withdrawal by Subject|3|||
23669410|NCT00081159|66172445|FG000|Overall Study|Withdrawal by Subject|0|||
23669411|NCT00081159|66172446|FG001|Overall Study|Withdrawal by Subject|3|||
23669412|NCT00081159|66172445|FG000|Overall Study|Myelosuppression prior to treatment|0|||
23669413|NCT00081159|66172446|FG001|Overall Study|Myelosuppression prior to treatment|1|||
23669414|NCT00081159|66172445|FG000|Overall Study|Lost to Follow-up|2|||
23669415|NCT00081159|66172446|FG001|Overall Study|Lost to Follow-up|1|||
23669416|NCT01136655|66172447|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
23669417|NCT01136655|66172447|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
23383026|NCT04518410|65145242|FG021|Overall Study|Requirement to start alternative therapy|0|||
23383027|NCT04518410|65145243|FG022|Overall Study|Requirement to start alternative therapy|0|||
23383028|NCT04518410|65145244|FG023|Overall Study|Requirement to start alternative therapy|0|||
23383029|NCT04518410|65145245|FG024|Overall Study|Requirement to start alternative therapy|0|||
23383030|NCT04518410|65145221|FG000|Overall Study|Randomized but not treated|0|||
23383031|NCT04518410|65145222|FG001|Overall Study|Randomized but not treated|0|||
23383032|NCT04518410|65145223|FG002|Overall Study|Randomized but not treated|0|||
23383033|NCT04518410|65145224|FG003|Overall Study|Randomized but not treated|2|||
23383034|NCT04518410|65145225|FG004|Overall Study|Randomized but not treated|6|||
23383035|NCT04518410|65145226|FG005|Overall Study|Randomized but not treated|4|||
23383036|NCT04518410|65145227|FG006|Overall Study|Randomized but not treated|3|||
23383037|NCT04518410|65145228|FG007|Overall Study|Randomized but not treated|3|||
23383038|NCT04518410|65145229|FG008|Overall Study|Randomized but not treated|0|||
23383039|NCT04518410|65145230|FG009|Overall Study|Randomized but not treated|4|||
23383040|NCT04518410|65145231|FG010|Overall Study|Randomized but not treated|0|||
23383041|NCT04518410|65145232|FG011|Overall Study|Randomized but not treated|0|||
23383042|NCT04518410|65145233|FG012|Overall Study|Randomized but not treated|1|||
23383043|NCT04518410|65145234|FG013|Overall Study|Randomized but not treated|3|||
23383044|NCT04518410|65145235|FG014|Overall Study|Randomized but not treated|3|||
23383045|NCT04518410|65145236|FG015|Overall Study|Randomized but not treated|3|||
23383046|NCT04518410|65145237|FG016|Overall Study|Randomized but not treated|4|||
23383047|NCT04518410|65145238|FG017|Overall Study|Randomized but not treated|5|||
23383048|NCT04518410|65145239|FG018|Overall Study|Randomized but not treated|4|||
23383049|NCT04518410|65145240|FG019|Overall Study|Randomized but not treated|0|||
23383050|NCT04518410|65145241|FG020|Overall Study|Randomized but not treated|0|||
23383051|NCT04518410|65145242|FG021|Overall Study|Randomized but not treated|5|||
23383052|NCT04518410|65145243|FG022|Overall Study|Randomized but not treated|0|||
23383053|NCT04518410|65145244|FG023|Overall Study|Randomized but not treated|3|||
23383054|NCT04518410|65145245|FG024|Overall Study|Randomized but not treated|1|||
23383055|NCT04518410|65145221|FG000|Overall Study|Screen Fail but Randomized|0|||
23383056|NCT04518410|65145222|FG001|Overall Study|Screen Fail but Randomized|0|||
23383057|NCT04518410|65145223|FG002|Overall Study|Screen Fail but Randomized|0|||
23383058|NCT04518410|65145224|FG003|Overall Study|Screen Fail but Randomized|0|||
23383059|NCT04518410|65145225|FG004|Overall Study|Screen Fail but Randomized|2|||
23383060|NCT04518410|65145226|FG005|Overall Study|Screen Fail but Randomized|0|||
23383061|NCT04518410|65145227|FG006|Overall Study|Screen Fail but Randomized|0|||
23383062|NCT04518410|65145228|FG007|Overall Study|Screen Fail but Randomized|0|||
23383063|NCT04518410|65145229|FG008|Overall Study|Screen Fail but Randomized|0|||
23383064|NCT04518410|65145230|FG009|Overall Study|Screen Fail but Randomized|0|||
23383065|NCT04518410|65145231|FG010|Overall Study|Screen Fail but Randomized|0|||
23383066|NCT04518410|65145232|FG011|Overall Study|Screen Fail but Randomized|0|||
23383067|NCT04518410|65145233|FG012|Overall Study|Screen Fail but Randomized|0|||
23383068|NCT04518410|65145234|FG013|Overall Study|Screen Fail but Randomized|0|||
23383069|NCT04518410|65145235|FG014|Overall Study|Screen Fail but Randomized|0|||
23383070|NCT04518410|65145236|FG015|Overall Study|Screen Fail but Randomized|0|||
23383071|NCT04518410|65145237|FG016|Overall Study|Screen Fail but Randomized|0|||
23383072|NCT04518410|65145238|FG017|Overall Study|Screen Fail but Randomized|0|||
23383073|NCT04518410|65145239|FG018|Overall Study|Screen Fail but Randomized|0|||
23383074|NCT04518410|65145240|FG019|Overall Study|Screen Fail but Randomized|0|||
23383075|NCT04518410|65145241|FG020|Overall Study|Screen Fail but Randomized|0|||
23383076|NCT04518410|65145242|FG021|Overall Study|Screen Fail but Randomized|0|||
23383077|NCT04518410|65145243|FG022|Overall Study|Screen Fail but Randomized|0|||
23383078|NCT04518410|65145244|FG023|Overall Study|Screen Fail but Randomized|0|||
23383079|NCT04518410|65145245|FG024|Overall Study|Screen Fail but Randomized|0|||
23383080|NCT04518410|65145221|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23669418|NCT01136655|66172447|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
23669419|NCT01136655|66172447|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
23383081|NCT04518410|65145222|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383082|NCT04518410|65145223|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383083|NCT04518410|65145224|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383084|NCT04518410|65145225|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
23383085|NCT04518410|65145226|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
23402831|NCT02185534|65220019|FG002|First Washout Period|Protocol Violation|0|||
23669420|NCT00790907|66172448|FG000|Overall Study|Adverse Event|9|||
23493135|NCT01897714|65551366|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
23493136|NCT01897714|65551367|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
23493137|NCT01897714|65551368|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
23493138|NCT01897714|65551369|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
23669421|NCT00790907|66172449|FG001|Overall Study|Adverse Event|7|||
23669422|NCT00790907|66172450|FG002|Overall Study|Adverse Event|6|||
23669423|NCT00790907|66172448|FG000|Overall Study|Physician Decision|304|||
23669424|NCT00790907|66172449|FG001|Overall Study|Physician Decision|271|||
23669425|NCT00790907|66172450|FG002|Overall Study|Physician Decision|255|||
23669426|NCT00790907|66172448|FG000|Overall Study|Withdrawal by Subject|1|||
23669427|NCT00790907|66172449|FG001|Overall Study|Withdrawal by Subject|7|||
23669428|NCT00790907|66172450|FG002|Overall Study|Withdrawal by Subject|5|||
23669429|NCT00790907|66172448|FG000|Overall Study|Bleeding Event|11|||
23669430|NCT00790907|66172449|FG001|Overall Study|Bleeding Event|16|||
23669431|NCT00790907|66172450|FG002|Overall Study|Bleeding Event|21|||
23669432|NCT00790907|66172448|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
23669433|NCT00790907|66172449|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
23669434|NCT00790907|66172450|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
23669435|NCT00790907|66172448|FG000|Overall Study|Qualifying Condition Not Present|29|||
23669436|NCT00790907|66172449|FG001|Overall Study|Qualifying Condition Not Present|14|||
23669437|NCT00790907|66172450|FG002|Overall Study|Qualifying Condition Not Present|16|||
23669438|NCT00790907|66172448|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
23669439|NCT00790907|66172449|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
23493139|NCT01897714|65551370|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
23493140|NCT01897714|65551365|FG000|Phase II (MTD)|Other|0|||
23493141|NCT01897714|65551366|FG001|Phase II (MTD)|Other|0|||
23493142|NCT01897714|65551367|FG002|Phase II (MTD)|Other|0|||
23493143|NCT01897714|65551368|FG003|Phase II (MTD)|Other|0|||
23493144|NCT01897714|65551369|FG004|Phase II (MTD)|Other|3|||
23493145|NCT01897714|65551370|FG005|Phase II (MTD)|Other|0|||
23493146|NCT00660673|65551371|FG000|Overall Study|Adverse Event|84|||
23493147|NCT00660673|65551371|FG000|Overall Study|Lack of Efficacy|7|||
23493148|NCT00660673|65551371|FG000|Overall Study|Withdrawal by Subject|22|||
23493149|NCT00660673|65551371|FG000|Overall Study|Administrative|2|||
23493150|NCT00660673|65551371|FG000|Overall Study|Protocol Violation|2|||
23669440|NCT00790907|66172450|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
23669441|NCT00790907|66172448|FG000|Overall Study|Did Not Receive Study Drug|10|||
23669442|NCT00790907|66172449|FG001|Overall Study|Did Not Receive Study Drug|0|||
23669443|NCT00790907|66172450|FG002|Overall Study|Did Not Receive Study Drug|0|||
23669444|NCT03861559|66172451|FG000|Overall Study|Adverse Event|0|||
23669445|NCT03861559|66172452|FG001|Overall Study|Adverse Event|2|||
23669446|NCT03861559|66172451|FG000|Overall Study|Treatment failure|0|||
23669447|NCT03861559|66172452|FG001|Overall Study|Treatment failure|2|||
23669448|NCT03861559|66172451|FG000|Overall Study|Noncompliance|1|||
23669449|NCT03861559|66172452|FG001|Overall Study|Noncompliance|1|||
23669450|NCT03861559|66172451|FG000|Overall Study|Did not meet eligibility requirements|1|||
23669451|NCT03861559|66172452|FG001|Overall Study|Did not meet eligibility requirements|0|||
23669452|NCT01278745|66172453|FG000|Overall Study|Death|2|||
23669453|NCT01278745|66172454|FG001|Overall Study|Death|5|||
23669454|NCT01278745|66172455|FG002|Overall Study|Death|7|||
23669455|NCT01278745|66172456|FG003|Overall Study|Death|0|||
23669456|NCT01278745|66172453|FG000|Overall Study|Physician Decision|1|||
23669457|NCT01278745|66172454|FG001|Overall Study|Physician Decision|0|||
23669458|NCT01278745|66172455|FG002|Overall Study|Physician Decision|0|||
23669459|NCT01278745|66172456|FG003|Overall Study|Physician Decision|9|||
23669460|NCT01278745|66172453|FG000|Overall Study|Withdrawal by Subject|1|||
23669461|NCT01278745|66172454|FG001|Overall Study|Withdrawal by Subject|1|||
23669462|NCT01278745|66172455|FG002|Overall Study|Withdrawal by Subject|5|||
23669463|NCT01278745|66172456|FG003|Overall Study|Withdrawal by Subject|1|||
23669464|NCT01278745|66172453|FG000|Overall Study|Sponsor Decision|1|||
23669465|NCT01278745|66172454|FG001|Overall Study|Sponsor Decision|0|||
23669466|NCT01278745|66172455|FG002|Overall Study|Sponsor Decision|62|||
23669467|NCT01278745|66172456|FG003|Overall Study|Sponsor Decision|6|||
23669468|NCT01278745|66172453|FG000|Overall Study|Ineligible|0|||
23669469|NCT01278745|66172454|FG001|Overall Study|Ineligible|0|||
23669470|NCT01278745|66172455|FG002|Overall Study|Ineligible|42|||
23669471|NCT01278745|66172456|FG003|Overall Study|Ineligible|61|||
23669472|NCT01278745|66172453|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
23669473|NCT01278745|66172454|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
23669474|NCT01278745|66172455|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
23669475|NCT01278745|66172456|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
23669476|NCT04247061|66172457|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
23669477|NCT04247061|66172457|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
23669478|NCT04247061|66172457|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
23669479|NCT01765920|66172458|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
23669480|NCT01765920|66172459|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
23669481|NCT01765920|66172458|FG000|Overall Study|Patient code disclosure|0|||
23669482|NCT01765920|66172459|FG001|Overall Study|Patient code disclosure|1|||
23669483|NCT03116698|66172460|FG000|Overall Study|Adverse Event|1|||
23669484|NCT03116698|66172461|FG001|Overall Study|Adverse Event|1|||
23669485|NCT03116698|66172462|FG002|Overall Study|Adverse Event|1|||
23669486|NCT03116698|66172463|FG003|Overall Study|Adverse Event|0|||
23669487|NCT03116698|66172460|FG000|Overall Study|Withdrawal by Subject|1|||
23669488|NCT03116698|66172461|FG001|Overall Study|Withdrawal by Subject|4|||
23669489|NCT03116698|66172462|FG002|Overall Study|Withdrawal by Subject|5|||
23669490|NCT03116698|66172463|FG003|Overall Study|Withdrawal by Subject|2|||
23669491|NCT03116698|66172460|FG000|Overall Study|Lost to Follow-up|2|||
23669492|NCT03116698|66172461|FG001|Overall Study|Lost to Follow-up|0|||
23669493|NCT03116698|66172462|FG002|Overall Study|Lost to Follow-up|0|||
23669494|NCT03116698|66172463|FG003|Overall Study|Lost to Follow-up|0|||
23669495|NCT03116698|66172460|FG000|Overall Study|Physician Decision|1|||
23669496|NCT03116698|66172461|FG001|Overall Study|Physician Decision|1|||
23669497|NCT03116698|66172462|FG002|Overall Study|Physician Decision|0|||
23669498|NCT03116698|66172463|FG003|Overall Study|Physician Decision|0|||
23669499|NCT03116698|66172460|FG000|Overall Study|Protocol Violation|1|||
23669500|NCT03116698|66172461|FG001|Overall Study|Protocol Violation|0|||
23669501|NCT03116698|66172462|FG002|Overall Study|Protocol Violation|0|||
23669502|NCT03116698|66172463|FG003|Overall Study|Protocol Violation|0|||
23669503|NCT03116698|66172460|FG000|Overall Study|Death|0|||
23669504|NCT03116698|66172461|FG001|Overall Study|Death|0|||
23669505|NCT03116698|66172462|FG002|Overall Study|Death|2|||
23669506|NCT03116698|66172463|FG003|Overall Study|Death|0|||
23669507|NCT01033734|66172465|FG000|Overall Study|Withdrawal by Subject|1|||
23669508|NCT00401375|66172468|FG000|Overall Study|Protocol Violation|2|||
23669509|NCT00401375|66172469|FG001|Overall Study|Protocol Violation|2|||
23669510|NCT00401375|66172470|FG002|Overall Study|Protocol Violation|1|||
23669511|NCT00401375|66172468|FG000|Overall Study|Adverse Event|6|||
23669512|NCT00401375|66172469|FG001|Overall Study|Adverse Event|11|||
23669513|NCT00401375|66172470|FG002|Overall Study|Adverse Event|10|||
23669514|NCT00401375|66172468|FG000|Overall Study|Withdrawal by Subject|9|||
23669515|NCT00401375|66172469|FG001|Overall Study|Withdrawal by Subject|7|||
23669516|NCT00401375|66172470|FG002|Overall Study|Withdrawal by Subject|7|||
23669517|NCT00401375|66172468|FG000|Overall Study|Lost to Follow-up|0|||
23669518|NCT00401375|66172469|FG001|Overall Study|Lost to Follow-up|1|||
23669519|NCT00401375|66172470|FG002|Overall Study|Lost to Follow-up|1|||
23669520|NCT00401375|66172468|FG000|Overall Study|Other than specified|2|||
23669521|NCT00401375|66172469|FG001|Overall Study|Other than specified|1|||
23669522|NCT00401375|66172470|FG002|Overall Study|Other than specified|3|||
23669523|NCT00401375|66172468|FG000|Overall Study|Randomized but not treated|3|||
23669524|NCT00401375|66172469|FG001|Overall Study|Randomized but not treated|3|||
23383086|NCT04518410|65145227|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
23383087|NCT04518410|65145228|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383088|NCT04518410|65145229|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
23383089|NCT04518410|65145230|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
23383090|NCT04518410|65145231|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383091|NCT04518410|65145232|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383092|NCT04518410|65145233|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383093|NCT04518410|65145234|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383094|NCT04518410|65145235|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383095|NCT04518410|65145236|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
23383096|NCT04518410|65145237|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
23383097|NCT04518410|65145238|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
23383098|NCT04518410|65145239|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
23383099|NCT04518410|65145240|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
23383100|NCT04518410|65145241|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
23383101|NCT04518410|65145242|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
23383102|NCT04518410|65145243|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
23383103|NCT04518410|65145244|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383104|NCT04518410|65145245|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
23383105|NCT04518410|65145221|FG000|Overall Study|Dual Enrolled Subject|0|||
23383106|NCT04518410|65145222|FG001|Overall Study|Dual Enrolled Subject|0|||
23383107|NCT04518410|65145223|FG002|Overall Study|Dual Enrolled Subject|0|||
23383108|NCT04518410|65145224|FG003|Overall Study|Dual Enrolled Subject|0|||
23383109|NCT04518410|65145225|FG004|Overall Study|Dual Enrolled Subject|0|||
23383110|NCT04518410|65145226|FG005|Overall Study|Dual Enrolled Subject|0|||
23383111|NCT04518410|65145227|FG006|Overall Study|Dual Enrolled Subject|0|||
23383112|NCT04518410|65145228|FG007|Overall Study|Dual Enrolled Subject|0|||
23383113|NCT04518410|65145229|FG008|Overall Study|Dual Enrolled Subject|0|||
23383114|NCT04518410|65145230|FG009|Overall Study|Dual Enrolled Subject|0|||
23383115|NCT04518410|65145231|FG010|Overall Study|Dual Enrolled Subject|0|||
23605979|NCT00452114|65947112|FG000|Overall Study|Physician Decision|3|||
23383116|NCT04518410|65145232|FG011|Overall Study|Dual Enrolled Subject|0|||
23383117|NCT04518410|65145233|FG012|Overall Study|Dual Enrolled Subject|0|||
23383118|NCT04518410|65145234|FG013|Overall Study|Dual Enrolled Subject|0|||
23383119|NCT04518410|65145235|FG014|Overall Study|Dual Enrolled Subject|0|||
23383120|NCT04518410|65145236|FG015|Overall Study|Dual Enrolled Subject|0|||
23383121|NCT04518410|65145237|FG016|Overall Study|Dual Enrolled Subject|0|||
23383122|NCT04518410|65145238|FG017|Overall Study|Dual Enrolled Subject|1|||
23383123|NCT04518410|65145239|FG018|Overall Study|Dual Enrolled Subject|0|||
23383124|NCT04518410|65145240|FG019|Overall Study|Dual Enrolled Subject|0|||
23383125|NCT04518410|65145241|FG020|Overall Study|Dual Enrolled Subject|0|||
23383126|NCT04518410|65145242|FG021|Overall Study|Dual Enrolled Subject|0|||
23383127|NCT04518410|65145243|FG022|Overall Study|Dual Enrolled Subject|0|||
23383128|NCT04518410|65145244|FG023|Overall Study|Dual Enrolled Subject|0|||
23383129|NCT04518410|65145245|FG024|Overall Study|Dual Enrolled Subject|0|||
23383130|NCT00898807|65145246|FG000|Overall Study|Withdrawal by Subject|5|||
23383131|NCT00898807|65145247|FG001|Overall Study|Withdrawal by Subject|3|||
23383132|NCT00898807|65145246|FG000|Overall Study|Family pressure to discontinue|2|||
23383133|NCT00898807|65145247|FG001|Overall Study|Family pressure to discontinue|2|||
23383134|NCT00898807|65145246|FG000|Overall Study|Lost to Follow-up|1|||
23383135|NCT00898807|65145247|FG001|Overall Study|Lost to Follow-up|3|||
23383136|NCT00898807|65145246|FG000|Overall Study|Death|0|||
23383137|NCT00898807|65145247|FG001|Overall Study|Death|1|||
23383138|NCT00114777|65145248|FG000|Randomization to Month 36|Death|10|||
23383139|NCT00114777|65145249|FG001|Randomization to Month 36|Death|4|||
23383140|NCT00114777|65145250|FG002|Randomization to Month 36|Death|3|||
23383141|NCT00114777|65145248|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
23383142|NCT00114777|65145249|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
23383143|NCT00114777|65145250|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
23383144|NCT00114777|65145248|FG000|Randomization to Month 36|Lack of Efficacy|19|||
23383145|NCT00114777|65145249|FG001|Randomization to Month 36|Lack of Efficacy|15|||
23383146|NCT00114777|65145250|FG002|Randomization to Month 36|Lack of Efficacy|17|||
23383147|NCT00114777|65145248|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
23383148|NCT00114777|65145249|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
23383149|NCT00114777|65145250|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
23383150|NCT00114777|65145248|FG000|Randomization to Month 36|Adverse Event|34|||
23383151|NCT00114777|65145249|FG001|Randomization to Month 36|Adverse Event|35|||
23383152|NCT00114777|65145250|FG002|Randomization to Month 36|Adverse Event|44|||
23383153|NCT00114777|65145248|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
23383154|NCT00114777|65145249|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
23383155|NCT00114777|65145250|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
23669525|NCT00401375|66172470|FG002|Overall Study|Randomized but not treated|3|||
23383156|NCT00114777|65145248|FG000|Randomization to Month 36|Other|9|||
23383157|NCT00114777|65145249|FG001|Randomization to Month 36|Other|3|||
23383158|NCT00114777|65145250|FG002|Randomization to Month 36|Other|12|||
23383159|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Death|8|||
23383160|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Death|13|||
23383161|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Death|7|||
23383162|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
23383163|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
23669526|NCT01967550|66175949|FG000|Overall Study|Withdrawal by Subject|1|||
23669527|NCT01967550|66175950|FG001|Overall Study|Withdrawal by Subject|0|||
23669528|NCT01967550|66175949|FG000|Overall Study|Adverse Event|2|||
23669529|NCT01967550|66175950|FG001|Overall Study|Adverse Event|0|||
23669530|NCT01967550|66175949|FG000|Overall Study|Protocol Violation|2|||
23669531|NCT01967550|66175950|FG001|Overall Study|Protocol Violation|1|||
23669532|NCT01967550|66175949|FG000|Overall Study|Non Compliance|0|||
23669533|NCT01967550|66175950|FG001|Overall Study|Non Compliance|1|||
23669534|NCT03354663|66175953|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
23669535|NCT03354663|66175953|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
23669536|NCT03354663|66175953|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
23669537|NCT03354663|66175953|FG000|Completed 30-day Visit|Missed Visit|1|||
23669538|NCT04818593|66175954|FG000|Overall Study|Low Oocyte Yield|8|||
23669539|NCT04818593|66175955|FG001|Overall Study|Low Oocyte Yield|8|||
23669540|NCT04818593|66175954|FG000|Overall Study|Not ICSI Insemination|7|||
23669541|NCT04818593|66175955|FG001|Overall Study|Not ICSI Insemination|7|||
23669542|NCT04818593|66175954|FG000|Overall Study|Poor Sperm Quality|2|||
23669543|NCT04818593|66175955|FG001|Overall Study|Poor Sperm Quality|2|||
23669544|NCT04818593|66175954|FG000|Overall Study|Withdrawal by Subject|2|||
23669545|NCT04818593|66175955|FG001|Overall Study|Withdrawal by Subject|2|||
23669546|NCT04818593|66175954|FG000|Overall Study|Conversion to IUI due to low response|1|||
23669547|NCT04818593|66175955|FG001|Overall Study|Conversion to IUI due to low response|1|||
23669548|NCT00879229|66175960|FG000|Overall Study|Study terminated by Sponsor|13|||
23669549|NCT00879229|66175961|FG001|Overall Study|Study terminated by Sponsor|12|||
23669550|NCT00879229|66175960|FG000|Overall Study|Death|4|||
23669551|NCT00879229|66175961|FG001|Overall Study|Death|2|||
23669552|NCT00879229|66175960|FG000|Overall Study|Adverse Event|2|||
23669553|NCT00879229|66175961|FG001|Overall Study|Adverse Event|0|||
23605980|NCT00452114|65947113|FG001|Overall Study|Physician Decision|3|||
23605981|NCT02771366|65947115|FG000|Period 1|Withdrawal by Subject|0|||
23605982|NCT02771366|65947116|FG001|Period 1|Withdrawal by Subject|2|||
23605983|NCT02771366|65947115|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
23605984|NCT02771366|65947116|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
23605985|NCT02993926|65947117|FG000|Enantone Treatment Phase|Adverse Event|1|||
23605986|NCT02993926|65947118|FG001|Enantone Treatment Phase|Adverse Event|0|||
23605987|NCT02993926|65947119|FG002|Enantone Treatment Phase|Adverse Event|0|||
23605988|NCT02993926|65947117|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
23605989|NCT02993926|65947118|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
23605990|NCT02993926|65947119|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
23605991|NCT02993926|65947117|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
23605992|NCT02993926|65947118|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
23605993|NCT02993926|65947119|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
23605994|NCT02993926|65947117|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
23605995|NCT02993926|65947118|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
23605996|NCT02993926|65947119|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
23605997|NCT02113449|65947120|FG000|Overall Study|Adverse Event|4|||
23605998|NCT01190124|65947122|FG000|Overall Study|Death|3|||
23605999|NCT01190124|65947123|FG001|Overall Study|Death|0|||
23606000|NCT01190124|65947124|FG002|Overall Study|Death|0|||
23606001|NCT01190124|65947122|FG000|Overall Study|Therapeutic Failure|12|||
23606002|NCT01190124|65947123|FG001|Overall Study|Therapeutic Failure|0|||
23606003|NCT01190124|65947124|FG002|Overall Study|Therapeutic Failure|1|||
23606004|NCT01190124|65947122|FG000|Overall Study|Lost to Follow-up|2|||
23606005|NCT01190124|65947123|FG001|Overall Study|Lost to Follow-up|0|||
23606006|NCT01190124|65947124|FG002|Overall Study|Lost to Follow-up|0|||
23606007|NCT03622580|65947125|FG000|Overall Study|Death|16|||
23606008|NCT03622580|65947126|FG001|Overall Study|Death|21|||
23606009|NCT03622580|65947127|FG002|Overall Study|Death|13|||
23606010|NCT03622580|65947125|FG000|Overall Study|Adverse Event|6|||
23606011|NCT03622580|65947126|FG001|Overall Study|Adverse Event|6|||
23606012|NCT03622580|65947127|FG002|Overall Study|Adverse Event|5|||
23606013|NCT03622580|65947125|FG000|Overall Study|Withdrawal by Subject|12|||
23606014|NCT03622580|65947126|FG001|Overall Study|Withdrawal by Subject|7|||
23606015|NCT03622580|65947127|FG002|Overall Study|Withdrawal by Subject|19|||
23606016|NCT03622580|65947125|FG000|Overall Study|Lost to Follow-up|12|||
23606017|NCT03622580|65947126|FG001|Overall Study|Lost to Follow-up|9|||
23606018|NCT03622580|65947127|FG002|Overall Study|Lost to Follow-up|9|||
23606019|NCT03622580|65947125|FG000|Overall Study|Protocol Violation|1|||
23606020|NCT03622580|65947126|FG001|Overall Study|Protocol Violation|0|||
23606021|NCT03622580|65947127|FG002|Overall Study|Protocol Violation|1|||
23606022|NCT03622580|65947125|FG000|Overall Study|Physician Decision|3|||
23606023|NCT03622580|65947126|FG001|Overall Study|Physician Decision|0|||
23606024|NCT03622580|65947127|FG002|Overall Study|Physician Decision|1|||
23606025|NCT03622580|65947125|FG000|Overall Study|Pregnancy|0|||
23606026|NCT03622580|65947126|FG001|Overall Study|Pregnancy|1|||
23606027|NCT03622580|65947127|FG002|Overall Study|Pregnancy|0|||
23383164|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
23383165|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
23383166|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
23383167|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
23383168|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
23383169|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
23383170|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
23383171|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
23383172|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
23383173|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
23383174|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
23383175|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
23383176|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
23383177|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
23383178|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
23383179|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
23383180|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
23383181|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
23383182|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
23383183|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Other|2|||
23383184|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Other|0|||
23383185|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Other|2|||
23383186|NCT01397747|65145251|FG000|Overall Study|Multitarget DNA test excluded|689|||
23383187|NCT01397747|65145251|FG000|Overall Study|Colonoscopy excluded|304|||
23383188|NCT01397747|65145251|FG000|Overall Study|FIT excluded|34|||
23383189|NCT04625972|65145252|FG000|Overall Study|Death|3|||
23383190|NCT04625972|65145253|FG001|Overall Study|Death|2|||
23383191|NCT04625972|65145252|FG000|Overall Study|Lost to Follow-up|82|||
23383192|NCT04625972|65145253|FG001|Overall Study|Lost to Follow-up|38|||
23383193|NCT04625972|65145252|FG000|Overall Study|Physician Decision|2|||
23383194|NCT04625972|65145253|FG001|Overall Study|Physician Decision|0|||
23383195|NCT04625972|65145252|FG000|Overall Study|Protocol Violation|0|||
23383196|NCT04625972|65145253|FG001|Overall Study|Protocol Violation|1|||
23383197|NCT04625972|65145252|FG000|Overall Study|Withdrawal by Subject|37|||
23383198|NCT04625972|65145253|FG001|Overall Study|Withdrawal by Subject|24|||
23383199|NCT04625972|65145252|FG000|Overall Study|Not specified elsewhere|8|||
23383200|NCT04625972|65145253|FG001|Overall Study|Not specified elsewhere|6|||
23383201|NCT00382070|65145254|FG000|Overall Study|No follow up data mapped to Other|17|||
23383202|NCT00382070|65145255|FG001|Overall Study|No follow up data mapped to Other|19|||
23383203|NCT00382070|65145254|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
23383204|NCT00382070|65145255|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
23383205|NCT00382070|65145254|FG000|Overall Study|No clinical assessment|9|||
23383206|NCT00382070|65145255|FG001|Overall Study|No clinical assessment|11|||
23383207|NCT00875667|65148045|FG000|Overall Study|Adverse Event|29|||
23383208|NCT00875667|65148046|FG001|Overall Study|Adverse Event|10|||
23383209|NCT00875667|65148045|FG000|Overall Study|Withdrawal by Subject|17|||
23383210|NCT00875667|65148046|FG001|Overall Study|Withdrawal by Subject|5|||
23383211|NCT00875667|65148045|FG000|Overall Study|Death|7|||
23383212|NCT00875667|65148046|FG001|Overall Study|Death|2|||
23383213|NCT00875667|65148045|FG000|Overall Study|Protocol Violation|2|||
23383214|NCT00875667|65148046|FG001|Overall Study|Protocol Violation|0|||
23383215|NCT00875667|65148045|FG000|Overall Study|Disease Progression|100|||
23383216|NCT00875667|65148046|FG001|Overall Study|Disease Progression|49|||
23383217|NCT00875667|65148045|FG000|Overall Study|Miscellaneous|12|||
23383218|NCT00875667|65148046|FG001|Overall Study|Miscellaneous|6|||
23383219|NCT00875667|65148045|FG000|Overall Study|Randomized but no Study Drug Given|3|||
23383220|NCT00875667|65148046|FG001|Overall Study|Randomized but no Study Drug Given|1|||
23383221|NCT00549328|65148051|FG000|Overall Study|Adverse Event|2|||
23383222|NCT00549328|65148051|FG000|Overall Study|Disease Progression|10|||
23383223|NCT00549328|65148051|FG000|Overall Study|Death|1|||
23383224|NCT00549328|65148051|FG000|Overall Study|Use of Prohibited Medication|1|||
23383225|NCT03695094|65148054|FG000|Overall Study|Adverse Event|1|||
23383226|NCT03695094|65148055|FG001|Overall Study|Adverse Event|1|||
23383227|NCT03695094|65148054|FG000|Overall Study|Withdrawal by Subject|1|||
23383228|NCT03695094|65148055|FG001|Overall Study|Withdrawal by Subject|0|||
23383229|NCT03994120|65148056|FG000|Overall Study|Lost to Follow-up|3|||
23383230|NCT03994120|65148057|FG001|Overall Study|Lost to Follow-up|1|||
23383231|NCT00726557|65148058|FG000|Overall Study|Screening failure|4|||
23383232|NCT00726557|65148058|FG000|Overall Study|No end of treatment documentation|37|||
23383233|NCT00726557|65148058|FG000|Overall Study|No follow-up documentation available|55|||
23383234|NCT00726557|65148058|FG000|Overall Study|Treatment less than 3 months|17|||
23383235|NCT00726557|65148058|FG000|Overall Study|Inclusion criteria not met|15|||
23383236|NCT00541775|65148059|FG000|Overall Study|Adverse Event|3|||
23383237|NCT00541775|65148060|FG001|Overall Study|Adverse Event|2|||
23669554|NCT00879229|66175960|FG000|Overall Study|Withdrawal by Subject|1|||
23669555|NCT00879229|66175961|FG001|Overall Study|Withdrawal by Subject|0|||
23383238|NCT00541775|65148061|FG002|Overall Study|Adverse Event|1|||
23383239|NCT00541775|65148059|FG000|Overall Study|Lack of Efficacy|0|||
23383240|NCT00541775|65148060|FG001|Overall Study|Lack of Efficacy|0|||
23383241|NCT00541775|65148061|FG002|Overall Study|Lack of Efficacy|3|||
23383242|NCT00541775|65148059|FG000|Overall Study|Lost to Follow-up|0|||
23383243|NCT00541775|65148060|FG001|Overall Study|Lost to Follow-up|0|||
23383244|NCT00541775|65148061|FG002|Overall Study|Lost to Follow-up|2|||
23383245|NCT00541775|65148059|FG000|Overall Study|Protocol Violation|1|||
23383246|NCT00541775|65148060|FG001|Overall Study|Protocol Violation|0|||
23383247|NCT00541775|65148061|FG002|Overall Study|Protocol Violation|0|||
23383248|NCT00541775|65148059|FG000|Overall Study|Withdrawal by Subject and Other|5|||
23383249|NCT00541775|65148060|FG001|Overall Study|Withdrawal by Subject and Other|0|||
23383250|NCT00541775|65148061|FG002|Overall Study|Withdrawal by Subject and Other|2|||
23383251|NCT00504309|65148062|FG000|Overall Study|Death|0|||
23383252|NCT00504309|65148063|FG001|Overall Study|Death|0|||
23383253|NCT00504309|65148064|FG002|Overall Study|Death|0|||
23383254|NCT00504309|65148065|FG003|Overall Study|Death|0|||
23383255|NCT00504309|65148066|FG004|Overall Study|Death|1|||
23383256|NCT00504309|65148067|FG005|Overall Study|Death|0|||
23383257|NCT00504309|65148062|FG000|Overall Study|Withdrawal by Subject|0|||
23383258|NCT00504309|65148063|FG001|Overall Study|Withdrawal by Subject|0|||
23383259|NCT00504309|65148064|FG002|Overall Study|Withdrawal by Subject|1|||
23383260|NCT00504309|65148065|FG003|Overall Study|Withdrawal by Subject|0|||
23383261|NCT00504309|65148066|FG004|Overall Study|Withdrawal by Subject|0|||
23383262|NCT00504309|65148067|FG005|Overall Study|Withdrawal by Subject|0|||
23383263|NCT01756235|65148068|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
23383264|NCT05064800|65148069|FG000|Period 3|Withdrawal by Subject|0|||
23383265|NCT05064800|65148070|FG001|Period 3|Withdrawal by Subject|0|||
23383266|NCT05064800|65148071|FG002|Period 3|Withdrawal by Subject|0|||
23383267|NCT05064800|65148072|FG003|Period 3|Withdrawal by Subject|0|||
23383268|NCT05064800|65148073|FG004|Period 3|Withdrawal by Subject|1|||
23383269|NCT05064800|65148074|FG005|Period 3|Withdrawal by Subject|0|||
23383270|NCT03767894|65148077|FG000|Overall Study|Withdrawal by Subject|1|||
23383271|NCT00021255|65148078|FG000|Overall Study|Death|1|||
23383272|NCT00021255|65148079|FG001|Overall Study|Death|0|||
23383273|NCT00021255|65148080|FG002|Overall Study|Death|2|||
23383274|NCT00021255|65148078|FG000|Overall Study|Breast cancer relapse|5|||
23383275|NCT00021255|65148079|FG001|Overall Study|Breast cancer relapse|18|||
23383276|NCT00021255|65148080|FG002|Overall Study|Breast cancer relapse|11|||
23383277|NCT00021255|65148078|FG000|Overall Study|Second primary malignancy|0|||
23383278|NCT00021255|65148079|FG001|Overall Study|Second primary malignancy|4|||
23669556|NCT00879229|66175960|FG000|Overall Study|Clinical status did not improve|1|||
23669557|NCT00879229|66175961|FG001|Overall Study|Clinical status did not improve|0|||
23669558|NCT00879229|66175960|FG000|Overall Study|Other|1|||
23669559|NCT00879229|66175961|FG001|Overall Study|Other|0|||
23669560|NCT01883635|66175962|FG000|Overall Study|Withdrawal by Subject|4|||
23669561|NCT01883635|66175963|FG001|Overall Study|Withdrawal by Subject|0|||
23669562|NCT00916357|66175965|FG000|Period 1|Withdrawal by Subject|1|||
23669563|NCT00916357|66175966|FG001|Period 1|Withdrawal by Subject|0|||
23669564|NCT00916357|66175967|FG002|Period 1|Withdrawal by Subject|0|||
23669565|NCT00916357|66175968|FG003|Period 1|Withdrawal by Subject|0|||
23669566|NCT00916357|66175969|FG004|Period 1|Withdrawal by Subject|0|||
23669567|NCT00916357|66175970|FG005|Period 1|Withdrawal by Subject|0|||
23669568|NCT00916357|66175965|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
23669569|NCT00916357|66175966|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
23383279|NCT00021255|65148080|FG002|Overall Study|Second primary malignancy|1|||
23383280|NCT00021255|65148078|FG000|Overall Study|Withdrawal by Subject|41|||
23383281|NCT00021255|65148079|FG001|Overall Study|Withdrawal by Subject|64|||
23383282|NCT00021255|65148080|FG002|Overall Study|Withdrawal by Subject|26|||
23383283|NCT00021255|65148078|FG000|Overall Study|Lost to Follow-up|0|||
23383284|NCT00021255|65148079|FG001|Overall Study|Lost to Follow-up|2|||
23669570|NCT00916357|66175967|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
23383285|NCT00021255|65148080|FG002|Overall Study|Lost to Follow-up|3|||
23383286|NCT00021255|65148078|FG000|Overall Study|Cardiac toxicity|0|||
23383287|NCT00021255|65148079|FG001|Overall Study|Cardiac toxicity|61|||
23383288|NCT00021255|65148080|FG002|Overall Study|Cardiac toxicity|32|||
23383289|NCT00021255|65148078|FG000|Overall Study|Herceptin toxicity|0|||
23383290|NCT00021255|65148079|FG001|Overall Study|Herceptin toxicity|22|||
23669571|NCT00916357|66175968|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
23669572|NCT00916357|66175969|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
23383291|NCT00021255|65148080|FG002|Overall Study|Herceptin toxicity|6|||
23383292|NCT00021255|65148078|FG000|Overall Study|Adverse Event|46|||
23383293|NCT00021255|65148079|FG001|Overall Study|Adverse Event|30|||
23383294|NCT00021255|65148080|FG002|Overall Study|Adverse Event|18|||
23383295|NCT00021255|65148078|FG000|Overall Study|Protocol Violation|0|||
23383296|NCT00021255|65148079|FG001|Overall Study|Protocol Violation|2|||
23383297|NCT00021255|65148080|FG002|Overall Study|Protocol Violation|0|||
23383298|NCT00021255|65148078|FG000|Overall Study|Other than specified above|0|||
23383299|NCT00021255|65148079|FG001|Overall Study|Other than specified above|38|||
23383300|NCT00021255|65148080|FG002|Overall Study|Other than specified above|19|||
23383301|NCT00021255|65148078|FG000|Overall Study|Missing|0|||
23383302|NCT00021255|65148079|FG001|Overall Study|Missing|27|||
23383303|NCT00021255|65148080|FG002|Overall Study|Missing|13|||
23383304|NCT00021255|65148078|FG000|Overall Study|Randomized but not treated|28|||
23383305|NCT00021255|65148079|FG001|Overall Study|Randomized but not treated|2|||
23383306|NCT00021255|65148080|FG002|Overall Study|Randomized but not treated|18|||
23383307|NCT00509600|65148081|FG000|Overall Study|Adverse Event|1|||
23383308|NCT00308685|65148082|FG000|Overall Study|Lost to Follow-up|1|||
23383309|NCT00308685|65148083|FG001|Overall Study|Lost to Follow-up|0|||
23383310|NCT00308685|65148082|FG000|Overall Study|Need to administer prohibited medication|1|||
23383311|NCT00308685|65148083|FG001|Overall Study|Need to administer prohibited medication|2|||
23669573|NCT00916357|66175970|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
23669574|NCT04766021|66175971|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
23669575|NCT04766021|66175971|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
23669576|NCT01566773|66175976|FG000|Overall Study|Protocol specified criteria|4|||
23669577|NCT01566773|66175976|FG000|Overall Study|Protocol Violation|4|||
23669578|NCT01566773|66175976|FG000|Overall Study|Withdrawal by Subject|9|||
23669579|NCT01566773|66175976|FG000|Overall Study|Administrative reason|1|||
23669580|NCT01566773|66175976|FG000|Overall Study|Adverse Event|10|||
23669581|NCT01566773|66175976|FG000|Overall Study|Physician Decision|2|||
23669582|NCT02370615|66175977|FG000|Overall Study|Adverse Event|1|||
23669583|NCT02370615|66175978|FG001|Overall Study|Adverse Event|0|||
23669584|NCT00264238|66175979|FG000|Overall Study|Protocol Violation|1|||
23383312|NCT00308685|65148082|FG000|Overall Study|Other than specified|1|||
23383313|NCT00308685|65148083|FG001|Overall Study|Other than specified|3|||
23383314|NCT01751685|65148086|FG000|6-mo Followup|Missed study visit|1|||
23383315|NCT01751685|65148087|FG001|6-mo Followup|Missed study visit|0|||
23383316|NCT01751685|65148086|FG000|6-mo Followup|Withdrawal by Subject|2|||
23383317|NCT01751685|65148087|FG001|6-mo Followup|Withdrawal by Subject|2|||
23383318|NCT01751685|65148086|FG000|6-mo Followup|Lost to Follow-up|0|||
23383319|NCT01751685|65148087|FG001|6-mo Followup|Lost to Follow-up|1|||
23383320|NCT01751685|65148086|FG000|12-mo Followup|Lost to Follow-up|5|||
23383321|NCT01751685|65148087|FG001|12-mo Followup|Lost to Follow-up|0|||
23383322|NCT02070991|65148088|FG000|Overall Study|Death|2|||
23383323|NCT02070991|65148089|FG001|Overall Study|Death|0|||
23383324|NCT02070991|65148088|FG000|Overall Study|Withdrawal by Subject|1|||
23383325|NCT02070991|65148089|FG001|Overall Study|Withdrawal by Subject|0|||
23383326|NCT01436500|65148091|FG000|Overall Study|Death|1|||
23383327|NCT01436500|65148092|FG001|Overall Study|Death|0|||
23383328|NCT01436500|65148093|FG002|Overall Study|Death|0|||
23383329|NCT01436500|65148094|FG003|Overall Study|Death|0|||
23383330|NCT01436500|65148095|FG004|Overall Study|Death|0|||
23383331|NCT01436500|65148091|FG000|Overall Study|Adverse Event|0|||
23383332|NCT01436500|65148092|FG001|Overall Study|Adverse Event|2|||
23383333|NCT01436500|65148093|FG002|Overall Study|Adverse Event|2|||
23383334|NCT01436500|65148094|FG003|Overall Study|Adverse Event|0|||
23383335|NCT01436500|65148095|FG004|Overall Study|Adverse Event|1|||
23383336|NCT01436500|65148091|FG000|Overall Study|Withdrawal by Subject|0|||
23383337|NCT01436500|65148092|FG001|Overall Study|Withdrawal by Subject|0|||
23383338|NCT01436500|65148093|FG002|Overall Study|Withdrawal by Subject|2|||
23383339|NCT01436500|65148094|FG003|Overall Study|Withdrawal by Subject|0|||
23383340|NCT01436500|65148095|FG004|Overall Study|Withdrawal by Subject|2|||
23383341|NCT01436500|65148091|FG000|Overall Study|Physician Decision|0|||
23383342|NCT01436500|65148092|FG001|Overall Study|Physician Decision|0|||
23383343|NCT01436500|65148093|FG002|Overall Study|Physician Decision|1|||
23383344|NCT01436500|65148094|FG003|Overall Study|Physician Decision|0|||
23383345|NCT01436500|65148095|FG004|Overall Study|Physician Decision|0|||
23493151|NCT01903031|65551372|FG000|Overall Study|Not Able to Attend Clinic|1|||
23669585|NCT00975156|66175982|FG000|Overall Study|Protocol Violation|0|||
23383346|NCT01436500|65148091|FG000|Overall Study|liver transplant|1|||
23383347|NCT01436500|65148092|FG001|Overall Study|liver transplant|0|||
23383348|NCT01436500|65148093|FG002|Overall Study|liver transplant|0|||
23383349|NCT01436500|65148094|FG003|Overall Study|liver transplant|0|||
23383350|NCT01436500|65148095|FG004|Overall Study|liver transplant|0|||
23383351|NCT01436500|65148091|FG000|Overall Study|initiation of dialysis|0|||
23383352|NCT01436500|65148092|FG001|Overall Study|initiation of dialysis|0|||
23383353|NCT01436500|65148093|FG002|Overall Study|initiation of dialysis|0|||
23383354|NCT01436500|65148094|FG003|Overall Study|initiation of dialysis|0|||
23383355|NCT01436500|65148095|FG004|Overall Study|initiation of dialysis|1|||
23383356|NCT01436500|65148091|FG000|Overall Study|discontinued study drug|1|||
23383357|NCT01436500|65148092|FG001|Overall Study|discontinued study drug|0|||
23383358|NCT01436500|65148093|FG002|Overall Study|discontinued study drug|0|||
23383359|NCT01436500|65148094|FG003|Overall Study|discontinued study drug|0|||
23383360|NCT01436500|65148095|FG004|Overall Study|discontinued study drug|0|||
23383361|NCT01436500|65148091|FG000|Overall Study|Other|0|||
23383362|NCT01436500|65148092|FG001|Overall Study|Other|1|||
23383363|NCT01436500|65148093|FG002|Overall Study|Other|0|||
23383364|NCT01436500|65148094|FG003|Overall Study|Other|1|||
23383365|NCT01436500|65148095|FG004|Overall Study|Other|0|||
23383366|NCT03501277|65148096|FG000|Intervention Period 1 (4 Days)|Other|0|||
23383367|NCT03501277|65148097|FG001|Intervention Period 1 (4 Days)|Other|0|||
23383368|NCT03501277|65148098|FG002|Intervention Period 1 (4 Days)|Other|1|||
23383369|NCT03501277|65148099|FG003|Intervention Period 1 (4 Days)|Other|0|||
23383370|NCT03501277|65148096|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
23383371|NCT03501277|65148097|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
23669586|NCT00975156|66175983|FG001|Overall Study|Protocol Violation|1|||
23669587|NCT03311711|66175984|FG000|Overall Study|Death|1|||
23669588|NCT03311711|66175985|FG001|Overall Study|Death|0|||
23669589|NCT03311711|66175986|FG002|Overall Study|Death|0|||
23669590|NCT03311711|66175987|FG003|Overall Study|Death|0|||
23669591|NCT03311711|66175988|FG004|Overall Study|Death|0|||
23669592|NCT03311711|66175989|FG005|Overall Study|Death|0|||
23669593|NCT03311711|66175990|FG006|Overall Study|Death|1|||
23669594|NCT03311711|66175991|FG007|Overall Study|Death|0|||
23669595|NCT03311711|66175992|FG008|Overall Study|Death|1|||
23669596|NCT03311711|66175993|FG009|Overall Study|Death|0|||
23669597|NCT03311711|66175984|FG000|Overall Study|Death of dyad partner|0|||
23669598|NCT03311711|66175985|FG001|Overall Study|Death of dyad partner|1|||
23669599|NCT03311711|66175986|FG002|Overall Study|Death of dyad partner|0|||
23669600|NCT03311711|66175987|FG003|Overall Study|Death of dyad partner|0|||
23669601|NCT03311711|66175988|FG004|Overall Study|Death of dyad partner|0|||
23669602|NCT03311711|66175989|FG005|Overall Study|Death of dyad partner|0|||
23669603|NCT03311711|66175990|FG006|Overall Study|Death of dyad partner|0|||
23669604|NCT03311711|66175991|FG007|Overall Study|Death of dyad partner|1|||
23669605|NCT03311711|66175992|FG008|Overall Study|Death of dyad partner|0|||
23669606|NCT03311711|66175993|FG009|Overall Study|Death of dyad partner|1|||
23669607|NCT03311711|66175984|FG000|Overall Study|Lost to Follow-up|2|||
23669608|NCT03311711|66175985|FG001|Overall Study|Lost to Follow-up|2|||
23669609|NCT03311711|66175986|FG002|Overall Study|Lost to Follow-up|0|||
23669610|NCT03311711|66175987|FG003|Overall Study|Lost to Follow-up|0|||
23669611|NCT03311711|66175988|FG004|Overall Study|Lost to Follow-up|0|||
23669612|NCT03311711|66175989|FG005|Overall Study|Lost to Follow-up|0|||
23669613|NCT03311711|66175990|FG006|Overall Study|Lost to Follow-up|1|||
23669614|NCT03311711|66175991|FG007|Overall Study|Lost to Follow-up|1|||
23669615|NCT03311711|66175992|FG008|Overall Study|Lost to Follow-up|0|||
23383372|NCT03501277|65148098|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
23383373|NCT03501277|65148099|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
23383374|NCT03501277|65148096|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
23669616|NCT03311711|66175993|FG009|Overall Study|Lost to Follow-up|0|||
23669617|NCT03311711|66175984|FG000|Overall Study|Withdrawal by Subject|1|||
23669618|NCT03311711|66175985|FG001|Overall Study|Withdrawal by Subject|1|||
23669619|NCT03311711|66175986|FG002|Overall Study|Withdrawal by Subject|0|||
23669620|NCT03311711|66175987|FG003|Overall Study|Withdrawal by Subject|0|||
23669621|NCT03311711|66175988|FG004|Overall Study|Withdrawal by Subject|0|||
23383375|NCT03501277|65148097|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
23383376|NCT03501277|65148098|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
23383377|NCT03501277|65148099|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
23383378|NCT03501277|65148096|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383379|NCT03501277|65148097|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383380|NCT03501277|65148098|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383381|NCT03501277|65148099|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
23383382|NCT00025233|65148100|FG000|Overall Study|Ineligible: wrong cell type|1|||
23383383|NCT00025233|65148100|FG000|Overall Study|Ineligible: wrong primary|1|||
23383384|NCT00025233|65148100|FG000|Overall Study|Ineligible: improper prior treatment|1|||
23383385|NCT00025233|65148100|FG000|Overall Study|Never treated|1|||
23383386|NCT00454142|65148101|FG000|Overall Study|Withdrawal by Subject|1|||
23383387|NCT01027416|65148102|FG000|Overall Study|Withdrawal by Subject|0|||
23383388|NCT01027416|65148103|FG001|Overall Study|Withdrawal by Subject|1|||
23383389|NCT01027416|65148102|FG000|Overall Study|Physician Decision|1|||
23383390|NCT01027416|65148103|FG001|Overall Study|Physician Decision|4|||
23383391|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
23383392|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
23383393|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
23383394|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
23383395|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
23383396|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
23383397|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
23383398|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
23383399|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
23383400|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
23383401|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
23383402|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
23383403|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
23383404|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
23383405|NCT01243424|65148104|FG000|Discontinuation From Treatment|Not treated|5|||
23383406|NCT01243424|65148105|FG001|Discontinuation From Treatment|Not treated|4|||
23383407|NCT01243424|65148104|FG000|Discontinuation From Treatment|Adverse Event|457|||
23383408|NCT01243424|65148105|FG001|Discontinuation From Treatment|Adverse Event|523|||
23383409|NCT01243424|65148104|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
23383410|NCT01243424|65148105|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
23383411|NCT01243424|65148104|FG000|Discontinuation From Treatment|Protocol Violation|46|||
23383412|NCT01243424|65148105|FG001|Discontinuation From Treatment|Protocol Violation|47|||
23383413|NCT01243424|65148104|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
23383414|NCT01243424|65148105|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
23383415|NCT01243424|65148104|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
23383416|NCT01243424|65148105|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
23383417|NCT01243424|65148104|FG000|Discontinuation From Treatment|Other than listed above|230|||
23383418|NCT01243424|65148105|FG001|Discontinuation From Treatment|Other than listed above|211|||
23383419|NCT04073407|65148107|FG000|Part 1|Withdrawal by Subject|1|||
23383420|NCT04073407|65148108|FG001|Part 1|Withdrawal by Subject|0|||
23383421|NCT04073407|65148107|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
23383422|NCT04073407|65148108|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
23383423|NCT04073407|65148107|FG000|Part 2|Withdrawal by Subject|0|||
23383424|NCT04073407|65148108|FG001|Part 2|Withdrawal by Subject|1|||
23383425|NCT04964388|65148109|FG000|Overall Study|Lost to Follow-up|3|||
23669622|NCT03311711|66175989|FG005|Overall Study|Withdrawal by Subject|0|||
23383426|NCT04964388|65148110|FG001|Overall Study|Lost to Follow-up|2|||
23383427|NCT01913470|65148111|FG000|Overall Study|Lost to Follow-up|0|||
23383428|NCT01913470|65148112|FG001|Overall Study|Lost to Follow-up|1|||
23383429|NCT01913470|65148111|FG000|Overall Study|Physician Decision|0|||
23383430|NCT01913470|65148112|FG001|Overall Study|Physician Decision|1|||
23383431|NCT01913470|65148111|FG000|Overall Study|Withdrawal by Subject|0|||
23383432|NCT01913470|65148112|FG001|Overall Study|Withdrawal by Subject|1|||
23383433|NCT02406612|65148113|FG000|Overall Study|Screening Failure|3|||
23383434|NCT02406612|65148114|FG001|Overall Study|Screening Failure|0|||
23383435|NCT02406612|65148113|FG000|Overall Study|Intra-procedural Exclusion|1|||
23383436|NCT02406612|65148114|FG001|Overall Study|Intra-procedural Exclusion|3|||
23383437|NCT02406612|65148113|FG000|Overall Study|Guidewire Failure|0|||
23383438|NCT02406612|65148114|FG001|Overall Study|Guidewire Failure|1|||
23383439|NCT03637374|65148115|FG000|Overall Study|Death|2|||
23383440|NCT03637374|65148116|FG001|Overall Study|Death|0|||
23383441|NCT01757847|65148121|FG000|Overall Study|Withdrawal by Subject|3|||
23383442|NCT01757847|65148122|FG001|Overall Study|Withdrawal by Subject|4|||
23383443|NCT02112552|65148124|FG000|Overall Study|Withdrawal by Subject|1|||
23383444|NCT02112552|65148124|FG000|Overall Study|Adverse Event|1|||
23383445|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Death|1|||
23383446|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Death|0|||
23383447|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
23383448|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
23383449|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
23383450|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
23383451|NCT02097277|65148127|FG000|Overall Study|Subject no longer meets study criteria|0|||
23383452|NCT02097277|65148128|FG001|Overall Study|Subject no longer meets study criteria|1|||
23383453|NCT02097277|65148129|FG002|Overall Study|Subject no longer meets study criteria|0|||
23383454|NCT02097277|65148130|FG003|Overall Study|Subject no longer meets study criteria|1|||
23383455|NCT02097277|65148131|FG004|Overall Study|Subject no longer meets study criteria|0|||
23383456|NCT02097277|65148127|FG000|Overall Study|Subject request to discontinue treatment|0|||
23383457|NCT02097277|65148128|FG001|Overall Study|Subject request to discontinue treatment|0|||
23383458|NCT02097277|65148129|FG002|Overall Study|Subject request to discontinue treatment|0|||
23383459|NCT02097277|65148130|FG003|Overall Study|Subject request to discontinue treatment|0|||
23383460|NCT02097277|65148131|FG004|Overall Study|Subject request to discontinue treatment|1|||
23383461|NCT02097277|65148127|FG000|Overall Study|Lost to Follow-up|0|||
23383462|NCT02097277|65148128|FG001|Overall Study|Lost to Follow-up|1|||
23383463|NCT02097277|65148129|FG002|Overall Study|Lost to Follow-up|1|||
23669623|NCT03311711|66175990|FG006|Overall Study|Withdrawal by Subject|3|||
23669624|NCT03311711|66175991|FG007|Overall Study|Withdrawal by Subject|3|||
23669625|NCT03311711|66175992|FG008|Overall Study|Withdrawal by Subject|0|||
23669626|NCT03311711|66175993|FG009|Overall Study|Withdrawal by Subject|0|||
23669627|NCT00746252|66175995|FG000|Overall Study|weight gain >7.5 %|1|||
23669628|NCT00746252|66175996|FG001|Overall Study|weight gain >7.5 %|2|||
23669629|NCT03368170|66175997|FG000|Overall Study|Adverse Event|2|||
23669630|NCT03368170|66175998|FG001|Overall Study|Adverse Event|1|||
23383464|NCT02097277|65148130|FG003|Overall Study|Lost to Follow-up|0|||
23383465|NCT02097277|65148131|FG004|Overall Study|Lost to Follow-up|0|||
23383466|NCT02097277|65148127|FG000|Overall Study|Withdrawal by Subject|2|||
23383467|NCT02097277|65148128|FG001|Overall Study|Withdrawal by Subject|1|||
23383468|NCT02097277|65148129|FG002|Overall Study|Withdrawal by Subject|0|||
23383469|NCT02097277|65148130|FG003|Overall Study|Withdrawal by Subject|1|||
23383470|NCT02097277|65148131|FG004|Overall Study|Withdrawal by Subject|0|||
23383471|NCT02097277|65148127|FG000|Overall Study|Adverse Event|0|||
23383472|NCT02097277|65148128|FG001|Overall Study|Adverse Event|0|||
23383473|NCT02097277|65148129|FG002|Overall Study|Adverse Event|1|||
23383474|NCT02097277|65148130|FG003|Overall Study|Adverse Event|2|||
23383475|NCT02097277|65148131|FG004|Overall Study|Adverse Event|0|||
23383476|NCT00683384|65148132|FG000|Overall Study|Death|1|||
23383477|NCT00683384|65148132|FG000|Overall Study|Adverse Event|1|||
23669631|NCT01081795|66175999|FG000|Overall Study|Adverse Event|18|||
23669632|NCT01081795|66176000|FG001|Overall Study|Adverse Event|23|||
23669633|NCT01081795|66176001|FG002|Overall Study|Adverse Event|6|||
23669634|NCT01081795|66175999|FG000|Overall Study|Lack of Efficacy|7|||
23669635|NCT01081795|66176000|FG001|Overall Study|Lack of Efficacy|5|||
23669636|NCT01081795|66176001|FG002|Overall Study|Lack of Efficacy|19|||
23669637|NCT01081795|66175999|FG000|Overall Study|Subject's schedule|1|||
23669638|NCT01081795|66176000|FG001|Overall Study|Subject's schedule|1|||
23669639|NCT01081795|66176001|FG002|Overall Study|Subject's schedule|2|||
23669640|NCT01081795|66175999|FG000|Overall Study|Revocation of informed consent|2|||
23669641|NCT01081795|66176000|FG001|Overall Study|Revocation of informed consent|0|||
23669642|NCT01081795|66176001|FG002|Overall Study|Revocation of informed consent|0|||
23669643|NCT01081795|66175999|FG000|Overall Study|Ineligible for participation|1|||
23669644|NCT01081795|66176000|FG001|Overall Study|Ineligible for participation|0|||
23669645|NCT01081795|66176001|FG002|Overall Study|Ineligible for participation|0|||
23669646|NCT01081795|66175999|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
23669647|NCT01081795|66176000|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
23669648|NCT01081795|66176001|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
23669649|NCT01081795|66175999|FG000|Overall Study|Using drug with restricted days of use|2|||
23669650|NCT01081795|66176000|FG001|Overall Study|Using drug with restricted days of use|3|||
23669651|NCT01081795|66176001|FG002|Overall Study|Using drug with restricted days of use|2|||
23669652|NCT01081795|66175999|FG000|Overall Study|Other|1|||
23669653|NCT01081795|66176000|FG001|Overall Study|Other|2|||
23669654|NCT01081795|66176001|FG002|Overall Study|Other|0|||
23669655|NCT04962022|66176003|FG000|Period 1|Withdrawal by Subject|1|||
23669656|NCT04962022|66176004|FG001|Period 1|Withdrawal by Subject|0|||
23669657|NCT01967537|66176005|FG000|Overall Study|Withdrawal by Subject|52|||
23669658|NCT01967537|66176005|FG000|Overall Study|Refuse treatment|2|||
23669659|NCT01967537|66176005|FG000|Overall Study|Lost to Follow-up|6|||
23669660|NCT00446511|66176006|FG000|Overall Study|Adverse Event|7|||
23669661|NCT00446511|66176007|FG001|Overall Study|Adverse Event|2|||
23669662|NCT00446511|66176008|FG002|Overall Study|Adverse Event|3|||
23669663|NCT00446511|66176009|FG003|Overall Study|Adverse Event|1|||
23669664|NCT00446511|66176006|FG000|Overall Study|Protocol Violation|0|||
23669665|NCT00446511|66176007|FG001|Overall Study|Protocol Violation|0|||
23669666|NCT00446511|66176008|FG002|Overall Study|Protocol Violation|0|||
23669667|NCT00446511|66176009|FG003|Overall Study|Protocol Violation|1|||
23669668|NCT00446511|66176006|FG000|Overall Study|Withdrawal by Subject|0|||
23669669|NCT00446511|66176007|FG001|Overall Study|Withdrawal by Subject|0|||
23669670|NCT00446511|66176008|FG002|Overall Study|Withdrawal by Subject|0|||
23669671|NCT00446511|66176009|FG003|Overall Study|Withdrawal by Subject|3|||
23669672|NCT00446511|66176006|FG000|Overall Study|Administrative Problems|3|||
23669673|NCT00446511|66176007|FG001|Overall Study|Administrative Problems|0|||
23669674|NCT00446511|66176008|FG002|Overall Study|Administrative Problems|4|||
23669675|NCT00446511|66176009|FG003|Overall Study|Administrative Problems|1|||
23669676|NCT01360554|66176010|FG000|Overall Study|Death|359|||
23669677|NCT01360554|66176011|FG001|Overall Study|Death|371|||
23669678|NCT01360554|66176010|FG000|Overall Study|Lost to Follow-up|4|||
23669679|NCT01360554|66176011|FG001|Overall Study|Lost to Follow-up|4|||
23669680|NCT01360554|66176010|FG000|Overall Study|Withdrawal by Subject|23|||
23669681|NCT01360554|66176011|FG001|Overall Study|Withdrawal by Subject|24|||
23669682|NCT01360554|66176010|FG000|Overall Study|Study terminated by sponsor|49|||
23669683|NCT01360554|66176011|FG001|Overall Study|Study terminated by sponsor|37|||
23669684|NCT01360554|66176010|FG000|Overall Study|Other, not specified|1|||
23669685|NCT01360554|66176011|FG001|Overall Study|Other, not specified|0|||
23669686|NCT01360554|66176010|FG000|Overall Study|Randomized but not treated.|3|||
23669687|NCT01360554|66176011|FG001|Overall Study|Randomized but not treated.|3|||
23669688|NCT01489527|66176012|FG000|Overall Study|Pregnancy|9|||
23669689|NCT01489527|66176013|FG001|Overall Study|Pregnancy|14|||
23669690|NCT01489527|66176012|FG000|Overall Study|Participant moved|6|||
23669691|NCT01489527|66176013|FG001|Overall Study|Participant moved|7|||
23669692|NCT01489527|66176012|FG000|Overall Study|Withdrawal by Subject|0|||
23669693|NCT01489527|66176013|FG001|Overall Study|Withdrawal by Subject|4|||
23669694|NCT01489527|66176012|FG000|Overall Study|Lost to Follow-up|5|||
23669695|NCT01489527|66176013|FG001|Overall Study|Lost to Follow-up|1|||
23669696|NCT01489527|66176012|FG000|Overall Study|Procedures|1|||
23669697|NCT01489527|66176013|FG001|Overall Study|Procedures|0|||
23669698|NCT01489527|66176012|FG000|Overall Study|Not compliant|1|||
23669699|NCT01489527|66176013|FG001|Overall Study|Not compliant|0|||
23669700|NCT00879697|66176016|FG000|Overall Study|Physician Decision|2|||
23669701|NCT00879697|66176017|FG001|Overall Study|Physician Decision|2|||
23669702|NCT04294719|66176019|FG000|Overall Study|Withdrawal by Subject|1|||
23669703|NCT01391507|66176022|FG000|Overall Study|Death|0|||
23669704|NCT01391507|66176023|FG001|Overall Study|Death|0|||
23669705|NCT01391507|66176024|FG002|Overall Study|Death|0|||
23669706|NCT01391507|66176025|FG003|Overall Study|Death|1|||
23669707|NCT01391507|66176022|FG000|Overall Study|Adverse Event|1|||
23669708|NCT01391507|66176023|FG001|Overall Study|Adverse Event|1|||
23669709|NCT01391507|66176024|FG002|Overall Study|Adverse Event|2|||
23669710|NCT01391507|66176025|FG003|Overall Study|Adverse Event|2|||
23669711|NCT01391507|66176022|FG000|Overall Study|Withdrawal by Subject|1|||
23669712|NCT01391507|66176023|FG001|Overall Study|Withdrawal by Subject|2|||
23669713|NCT01391507|66176024|FG002|Overall Study|Withdrawal by Subject|1|||
23669714|NCT01391507|66176025|FG003|Overall Study|Withdrawal by Subject|1|||
23669715|NCT01391507|66176022|FG000|Overall Study|Lack of Efficacy|0|||
23669716|NCT01391507|66176023|FG001|Overall Study|Lack of Efficacy|0|||
23669717|NCT01391507|66176024|FG002|Overall Study|Lack of Efficacy|0|||
23669718|NCT01391507|66176025|FG003|Overall Study|Lack of Efficacy|1|||
23669719|NCT01391507|66176022|FG000|Overall Study|Protocol Violation|2|||
23669720|NCT01391507|66176023|FG001|Overall Study|Protocol Violation|1|||
23669721|NCT01391507|66176024|FG002|Overall Study|Protocol Violation|1|||
23669722|NCT01391507|66176025|FG003|Overall Study|Protocol Violation|2|||
23669723|NCT03839459|66176026|FG000|Overall Study|Withdrawal by Subject|2|||
23669724|NCT03839459|66176026|FG000|Overall Study|progression of disease|3|||
23669725|NCT01389752|66176029|FG000|Study Period 1|Sponsor decision|0|||
23669726|NCT01389752|66176030|FG001|Study Period 1|Sponsor decision|2|||
23669727|NCT01389752|66176029|FG000|Study Period 2|Sponsor decision|1|||
23669728|NCT01389752|66176030|FG001|Study Period 2|Sponsor decision|0|||
23669729|NCT01425008|66176031|FG000|Dose Escalation Phase|Progressive Disease|2|||
23669730|NCT01425008|66176032|FG001|Dose Escalation Phase|Progressive Disease|3|||
23669731|NCT01425008|66176033|FG002|Dose Escalation Phase|Progressive Disease|2|||
23669732|NCT01425008|66176034|FG003|Dose Escalation Phase|Progressive Disease|3|||
23669733|NCT01425008|66176035|FG004|Dose Escalation Phase|Progressive Disease|5|||
23669734|NCT01425008|66176036|FG005|Dose Escalation Phase|Progressive Disease|4|||
23669735|NCT01425008|66176037|FG006|Dose Escalation Phase|Progressive Disease|0|||
23669736|NCT01425008|66176038|FG007|Dose Escalation Phase|Progressive Disease|2|||
23669737|NCT01425008|66176039|FG008|Dose Escalation Phase|Progressive Disease|6|||
23669738|NCT01425008|66176040|FG009|Dose Escalation Phase|Progressive Disease|2|||
23669739|NCT01425008|66176041|FG010|Dose Escalation Phase|Progressive Disease|0|||
23669740|NCT01425008|66176042|FG011|Dose Escalation Phase|Progressive Disease|0|||
23669741|NCT01425008|66176043|FG012|Dose Escalation Phase|Progressive Disease|0|||
23669742|NCT01425008|66176044|FG013|Dose Escalation Phase|Progressive Disease|0|||
23669743|NCT01425008|66176045|FG014|Dose Escalation Phase|Progressive Disease|0|||
23669744|NCT01425008|66176046|FG015|Dose Escalation Phase|Progressive Disease|0|||
23669745|NCT01425008|66176047|FG016|Dose Escalation Phase|Progressive Disease|0|||
23669746|NCT01425008|66176048|FG017|Dose Escalation Phase|Progressive Disease|0|||
23669747|NCT01425008|66176049|FG018|Dose Escalation Phase|Progressive Disease|0|||
23669748|NCT01425008|66176031|FG000|Dose Escalation Phase|Adverse Event|2|||
23669749|NCT01425008|66176032|FG001|Dose Escalation Phase|Adverse Event|0|||
23669750|NCT01425008|66176033|FG002|Dose Escalation Phase|Adverse Event|0|||
23669751|NCT01425008|66176034|FG003|Dose Escalation Phase|Adverse Event|0|||
23669752|NCT01425008|66176035|FG004|Dose Escalation Phase|Adverse Event|0|||
23669753|NCT01425008|66176036|FG005|Dose Escalation Phase|Adverse Event|2|||
23669754|NCT01425008|66176037|FG006|Dose Escalation Phase|Adverse Event|0|||
23669755|NCT01425008|66176038|FG007|Dose Escalation Phase|Adverse Event|0|||
23669756|NCT01425008|66176039|FG008|Dose Escalation Phase|Adverse Event|2|||
23669757|NCT01425008|66176040|FG009|Dose Escalation Phase|Adverse Event|0|||
23669758|NCT01425008|66176041|FG010|Dose Escalation Phase|Adverse Event|0|||
23669759|NCT01425008|66176042|FG011|Dose Escalation Phase|Adverse Event|0|||
23669760|NCT01425008|66176043|FG012|Dose Escalation Phase|Adverse Event|0|||
23669761|NCT01425008|66176044|FG013|Dose Escalation Phase|Adverse Event|0|||
23669762|NCT01425008|66176045|FG014|Dose Escalation Phase|Adverse Event|0|||
23669763|NCT01425008|66176046|FG015|Dose Escalation Phase|Adverse Event|0|||
23669764|NCT01425008|66176047|FG016|Dose Escalation Phase|Adverse Event|0|||
23669765|NCT01425008|66176048|FG017|Dose Escalation Phase|Adverse Event|0|||
23669766|NCT01425008|66176049|FG018|Dose Escalation Phase|Adverse Event|0|||
23669767|NCT01425008|66176031|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669768|NCT01425008|66176032|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669769|NCT01425008|66176033|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669770|NCT01425008|66176034|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669771|NCT01425008|66176035|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23669772|NCT01425008|66176036|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669773|NCT01425008|66176037|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
23606028|NCT03622580|65947125|FG000|Overall Study|Lack of Efficacy|0|||
23669774|NCT01425008|66176038|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23669775|NCT01425008|66176039|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23669776|NCT01425008|66176040|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23606029|NCT03622580|65947126|FG001|Overall Study|Lack of Efficacy|0|||
23606030|NCT03622580|65947127|FG002|Overall Study|Lack of Efficacy|1|||
23606031|NCT03622580|65947125|FG000|Overall Study|Other|2|||
23606032|NCT03622580|65947126|FG001|Overall Study|Other|0|||
23606033|NCT03622580|65947127|FG002|Overall Study|Other|3|||
23606034|NCT02506192|65947128|FG000|Overall Study|Withdrawal by Subject|1|||
23606035|NCT02506192|65947129|FG001|Overall Study|Withdrawal by Subject|1|||
23606036|NCT01853384|65947130|FG000|Randomized|Adverse Event|5|||
23606037|NCT01853384|65947131|FG001|Randomized|Adverse Event|3|||
23606038|NCT01853384|65947130|FG000|Randomized|Death|1|||
23606039|NCT01853384|65947131|FG001|Randomized|Death|2|||
23606040|NCT01853384|65947130|FG000|Randomized|Lost to Follow-up|1|||
23606041|NCT01853384|65947131|FG001|Randomized|Lost to Follow-up|1|||
23606042|NCT01853384|65947130|FG000|Randomized|Withdrawal by Subject|5|||
23606043|NCT01853384|65947131|FG001|Randomized|Withdrawal by Subject|3|||
23606044|NCT01853384|65947130|FG000|Randomized|Sponsor Decision|47|||
23606045|NCT01853384|65947131|FG001|Randomized|Sponsor Decision|34|||
23606046|NCT01853384|65947130|FG000|Randomized|Other|3|||
23606047|NCT01853384|65947131|FG001|Randomized|Other|3|||
23606048|NCT01853384|65947130|FG000|Completed Follow up Visit 1|Early Termination|13|||
23606049|NCT01853384|65947131|FG001|Completed Follow up Visit 1|Early Termination|9|||
23606050|NCT01853384|65947130|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
23606051|NCT01853384|65947131|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
23606052|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Adverse Event|1|||
23669777|NCT01425008|66176041|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669778|NCT01425008|66176042|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669779|NCT01425008|66176043|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669780|NCT01425008|66176044|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669781|NCT01425008|66176045|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669782|NCT01425008|66176046|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669783|NCT01425008|66176047|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669784|NCT01425008|66176048|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669785|NCT01425008|66176049|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23669786|NCT01425008|66176031|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23669787|NCT01425008|66176032|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23669788|NCT01425008|66176033|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23669789|NCT01425008|66176034|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23669790|NCT01425008|66176035|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
23669791|NCT01425008|66176036|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
23669792|NCT01425008|66176037|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
23669793|NCT01425008|66176038|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
23669794|NCT01425008|66176039|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
23669795|NCT01425008|66176040|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
23669796|NCT01425008|66176041|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
23669797|NCT01425008|66176042|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
23669798|NCT01425008|66176043|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
23669799|NCT01425008|66176044|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
23669800|NCT01425008|66176045|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
23669801|NCT01425008|66176046|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
23669802|NCT01425008|66176047|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
23669803|NCT01425008|66176048|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
23669804|NCT01425008|66176049|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
23669805|NCT01425008|66176031|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669806|NCT01425008|66176032|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669807|NCT01425008|66176033|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
23669808|NCT01425008|66176034|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669809|NCT01425008|66176035|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669810|NCT01425008|66176036|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669811|NCT01425008|66176037|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669812|NCT01425008|66176038|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669813|NCT01425008|66176039|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
23669814|NCT01425008|66176040|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
23669815|NCT01425008|66176041|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669816|NCT01425008|66176042|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669817|NCT01425008|66176043|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669818|NCT01425008|66176044|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669819|NCT01425008|66176045|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669820|NCT01425008|66176046|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669821|NCT01425008|66176047|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669822|NCT01425008|66176048|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669823|NCT01425008|66176049|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
23669824|NCT01425008|66176031|FG000|Dose Escalation Phase|Other|0|||
23669825|NCT01425008|66176032|FG001|Dose Escalation Phase|Other|0|||
23669826|NCT01425008|66176033|FG002|Dose Escalation Phase|Other|0|||
23669827|NCT01425008|66176034|FG003|Dose Escalation Phase|Other|0|||
23669828|NCT01425008|66176035|FG004|Dose Escalation Phase|Other|0|||
23669829|NCT01425008|66176036|FG005|Dose Escalation Phase|Other|0|||
23669830|NCT01425008|66176037|FG006|Dose Escalation Phase|Other|0|||
23669831|NCT01425008|66176038|FG007|Dose Escalation Phase|Other|0|||
23669832|NCT01425008|66176039|FG008|Dose Escalation Phase|Other|1|||
23669833|NCT01425008|66176040|FG009|Dose Escalation Phase|Other|0|||
23669834|NCT01425008|66176041|FG010|Dose Escalation Phase|Other|0|||
23669835|NCT01425008|66176042|FG011|Dose Escalation Phase|Other|0|||
23669836|NCT01425008|66176043|FG012|Dose Escalation Phase|Other|0|||
23669837|NCT01425008|66176044|FG013|Dose Escalation Phase|Other|0|||
23669838|NCT01425008|66176045|FG014|Dose Escalation Phase|Other|0|||
23669839|NCT01425008|66176046|FG015|Dose Escalation Phase|Other|0|||
23669840|NCT01425008|66176047|FG016|Dose Escalation Phase|Other|0|||
23669841|NCT01425008|66176048|FG017|Dose Escalation Phase|Other|0|||
23669842|NCT01425008|66176049|FG018|Dose Escalation Phase|Other|0|||
23669843|NCT01425008|66176031|FG000|Dose Expansion Phase|Progressive Disease|0|||
23669844|NCT01425008|66176032|FG001|Dose Expansion Phase|Progressive Disease|0|||
23669845|NCT01425008|66176033|FG002|Dose Expansion Phase|Progressive Disease|0|||
23669846|NCT01425008|66176034|FG003|Dose Expansion Phase|Progressive Disease|0|||
23669847|NCT01425008|66176035|FG004|Dose Expansion Phase|Progressive Disease|0|||
23669848|NCT01425008|66176036|FG005|Dose Expansion Phase|Progressive Disease|0|||
23669849|NCT01425008|66176037|FG006|Dose Expansion Phase|Progressive Disease|0|||
23669850|NCT01425008|66176038|FG007|Dose Expansion Phase|Progressive Disease|0|||
23669851|NCT01425008|66176039|FG008|Dose Expansion Phase|Progressive Disease|0|||
23669852|NCT01425008|66176040|FG009|Dose Expansion Phase|Progressive Disease|0|||
23669853|NCT01425008|66176041|FG010|Dose Expansion Phase|Progressive Disease|10|||
23669854|NCT01425008|66176042|FG011|Dose Expansion Phase|Progressive Disease|4|||
23669855|NCT01425008|66176043|FG012|Dose Expansion Phase|Progressive Disease|12|||
23669856|NCT01425008|66176044|FG013|Dose Expansion Phase|Progressive Disease|1|||
23669857|NCT01425008|66176045|FG014|Dose Expansion Phase|Progressive Disease|5|||
23669858|NCT01425008|66176046|FG015|Dose Expansion Phase|Progressive Disease|8|||
23669859|NCT01425008|66176047|FG016|Dose Expansion Phase|Progressive Disease|9|||
23669860|NCT01425008|66176048|FG017|Dose Expansion Phase|Progressive Disease|2|||
23669861|NCT01425008|66176049|FG018|Dose Expansion Phase|Progressive Disease|10|||
23669862|NCT01425008|66176031|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
23669863|NCT01425008|66176032|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
23669864|NCT01425008|66176033|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
23669865|NCT01425008|66176034|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
23669866|NCT01425008|66176035|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
23669867|NCT01425008|66176036|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
23669868|NCT01425008|66176037|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
23669869|NCT01425008|66176038|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
23669870|NCT01425008|66176039|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
23669871|NCT01425008|66176040|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
23669872|NCT01425008|66176041|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
23669873|NCT01425008|66176042|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
23669874|NCT01425008|66176043|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
23669875|NCT01425008|66176044|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
23669876|NCT01425008|66176045|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
23669877|NCT01425008|66176046|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
23669878|NCT01425008|66176047|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
23669879|NCT01425008|66176048|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
23669880|NCT01425008|66176049|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
23669881|NCT01425008|66176031|FG000|Dose Expansion Phase|Other|0|||
23669882|NCT01425008|66176032|FG001|Dose Expansion Phase|Other|0|||
23669883|NCT01425008|66176033|FG002|Dose Expansion Phase|Other|0|||
23669884|NCT01425008|66176034|FG003|Dose Expansion Phase|Other|0|||
23669885|NCT01425008|66176035|FG004|Dose Expansion Phase|Other|0|||
23669886|NCT01425008|66176036|FG005|Dose Expansion Phase|Other|0|||
23669887|NCT01425008|66176037|FG006|Dose Expansion Phase|Other|0|||
23669888|NCT01425008|66176038|FG007|Dose Expansion Phase|Other|0|||
23669889|NCT01425008|66176039|FG008|Dose Expansion Phase|Other|0|||
23669890|NCT01425008|66176040|FG009|Dose Expansion Phase|Other|0|||
23669891|NCT01425008|66176041|FG010|Dose Expansion Phase|Other|0|||
23669892|NCT01425008|66176042|FG011|Dose Expansion Phase|Other|0|||
23669893|NCT01425008|66176043|FG012|Dose Expansion Phase|Other|1|||
23669894|NCT01425008|66176044|FG013|Dose Expansion Phase|Other|0|||
23669895|NCT01425008|66176045|FG014|Dose Expansion Phase|Other|0|||
23669896|NCT01425008|66176046|FG015|Dose Expansion Phase|Other|0|||
23669897|NCT01425008|66176047|FG016|Dose Expansion Phase|Other|2|||
23669898|NCT01425008|66176048|FG017|Dose Expansion Phase|Other|0|||
23669899|NCT01425008|66176049|FG018|Dose Expansion Phase|Other|4|||
23669900|NCT01425008|66176031|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669901|NCT01425008|66176032|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669902|NCT01425008|66176033|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669903|NCT01425008|66176034|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669904|NCT01425008|66176035|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669905|NCT01425008|66176036|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669906|NCT01425008|66176037|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669907|NCT01425008|66176038|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669908|NCT01425008|66176039|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
23383478|NCT01410604|65148136|FG000|Overall Study|Adverse Event|2|||
23383479|NCT01410604|65148137|FG001|Overall Study|Adverse Event|1|||
23383480|NCT01410604|65148136|FG000|Overall Study|Lost to Follow-up|1|||
23383481|NCT01410604|65148137|FG001|Overall Study|Lost to Follow-up|0|||
23383482|NCT01410604|65148136|FG000|Overall Study|Physician Decision|0|||
23383483|NCT01410604|65148137|FG001|Overall Study|Physician Decision|1|||
23383484|NCT02827708|65148145|FG000|Overall Study|Lost to Follow-up|3|||
23383485|NCT02827708|65148146|FG001|Overall Study|Lost to Follow-up|1|||
23383486|NCT02827708|65148145|FG000|Overall Study|Withdrawal by Subject|1|||
23383487|NCT02827708|65148146|FG001|Overall Study|Withdrawal by Subject|2|||
23383488|NCT02827708|65148145|FG000|Overall Study|Death|1|||
23383489|NCT02827708|65148146|FG001|Overall Study|Death|2|||
23383490|NCT00003456|65148147|FG000|Overall Study|Not evaluable|8|||
23383491|NCT03018938|65148148|FG000|Overall Study|Death|0|||
23383492|NCT03018938|65148149|FG001|Overall Study|Death|1|||
23383493|NCT03018938|65148148|FG000|Overall Study|Lost to Follow-up|21|||
23383494|NCT03018938|65148149|FG001|Overall Study|Lost to Follow-up|32|||
23383495|NCT03018938|65148148|FG000|Overall Study|Withdrawal by Subject|38|||
23383496|NCT03018938|65148149|FG001|Overall Study|Withdrawal by Subject|45|||
23383497|NCT03018938|65148148|FG000|Overall Study|Physician Decision|3|||
23383498|NCT03018938|65148149|FG001|Overall Study|Physician Decision|2|||
23383499|NCT03018938|65148148|FG000|Overall Study|Sponsor Decision|0|||
23383500|NCT03018938|65148149|FG001|Overall Study|Sponsor Decision|1|||
23383501|NCT03018938|65148148|FG000|Overall Study|Screen failure-After randomization|4|||
23669909|NCT01425008|66176040|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669910|NCT01425008|66176041|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
23669911|NCT01425008|66176042|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
23669912|NCT01425008|66176043|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669913|NCT01425008|66176044|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669914|NCT01425008|66176045|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669915|NCT01425008|66176046|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
23669916|NCT01425008|66176047|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
23669917|NCT01425008|66176048|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
23669918|NCT01425008|66176049|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
23669919|NCT01425008|66176031|FG000|Dose Expansion Phase|Adverse Event|0|||
23669920|NCT01425008|66176032|FG001|Dose Expansion Phase|Adverse Event|0|||
23669921|NCT01425008|66176033|FG002|Dose Expansion Phase|Adverse Event|0|||
23669922|NCT01425008|66176034|FG003|Dose Expansion Phase|Adverse Event|0|||
23669923|NCT01425008|66176035|FG004|Dose Expansion Phase|Adverse Event|0|||
23669924|NCT01425008|66176036|FG005|Dose Expansion Phase|Adverse Event|0|||
23669925|NCT01425008|66176037|FG006|Dose Expansion Phase|Adverse Event|0|||
23669926|NCT01425008|66176038|FG007|Dose Expansion Phase|Adverse Event|0|||
23669927|NCT01425008|66176039|FG008|Dose Expansion Phase|Adverse Event|0|||
23669928|NCT01425008|66176040|FG009|Dose Expansion Phase|Adverse Event|0|||
23669929|NCT01425008|66176041|FG010|Dose Expansion Phase|Adverse Event|2|||
23669930|NCT01425008|66176042|FG011|Dose Expansion Phase|Adverse Event|3|||
23669931|NCT01425008|66176043|FG012|Dose Expansion Phase|Adverse Event|3|||
23669932|NCT01425008|66176044|FG013|Dose Expansion Phase|Adverse Event|0|||
23669933|NCT01425008|66176045|FG014|Dose Expansion Phase|Adverse Event|1|||
23669934|NCT01425008|66176046|FG015|Dose Expansion Phase|Adverse Event|1|||
23669935|NCT01425008|66176047|FG016|Dose Expansion Phase|Adverse Event|5|||
23669936|NCT01425008|66176048|FG017|Dose Expansion Phase|Adverse Event|0|||
23669937|NCT01425008|66176049|FG018|Dose Expansion Phase|Adverse Event|3|||
23383502|NCT03018938|65148149|FG001|Overall Study|Screen failure-After randomization|2|||
23383503|NCT03018938|65148148|FG000|Overall Study|Not recorded|0|||
23669938|NCT01425008|66176031|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
23669939|NCT01425008|66176032|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
23669940|NCT01425008|66176033|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
23669941|NCT01425008|66176034|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
23669942|NCT01425008|66176035|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
23383504|NCT03018938|65148149|FG001|Overall Study|Not recorded|2|||
23383505|NCT01851369|65148154|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383506|NCT01851369|65148155|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383507|NCT01851369|65148156|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383508|NCT01851369|65148157|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383509|NCT01851369|65148158|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383510|NCT01851369|65148159|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
23383511|NCT01851369|65148160|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383512|NCT01851369|65148161|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383513|NCT01851369|65148162|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383514|NCT01851369|65148163|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383515|NCT01851369|65148164|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383516|NCT01851369|65148165|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383517|NCT01851369|65148166|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383518|NCT00601107|65148169|FG000|Overall Study|Adverse Event|0|||
23383519|NCT00601107|65148170|FG001|Overall Study|Adverse Event|1|||
23383520|NCT00601107|65148171|FG002|Overall Study|Adverse Event|3|||
23383521|NCT00601107|65148172|FG003|Overall Study|Adverse Event|0|||
23383522|NCT00601107|65148169|FG000|Overall Study|Withdrawal by Subject|5|||
23383523|NCT00601107|65148170|FG001|Overall Study|Withdrawal by Subject|4|||
23383524|NCT00601107|65148171|FG002|Overall Study|Withdrawal by Subject|7|||
23383525|NCT00601107|65148172|FG003|Overall Study|Withdrawal by Subject|4|||
23383526|NCT00601107|65148169|FG000|Overall Study|Lost to Follow-up|3|||
23383527|NCT00601107|65148170|FG001|Overall Study|Lost to Follow-up|3|||
23383528|NCT00601107|65148171|FG002|Overall Study|Lost to Follow-up|0|||
23383529|NCT00601107|65148172|FG003|Overall Study|Lost to Follow-up|3|||
23383530|NCT00601107|65148169|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383531|NCT00601107|65148170|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383532|NCT00601107|65148171|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383533|NCT00601107|65148172|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
23383534|NCT00601107|65148169|FG000|Overall Study|Worsening of Psoriasis|4|||
23383535|NCT00601107|65148170|FG001|Overall Study|Worsening of Psoriasis|1|||
23383536|NCT00601107|65148171|FG002|Overall Study|Worsening of Psoriasis|1|||
23383537|NCT00601107|65148172|FG003|Overall Study|Worsening of Psoriasis|4|||
23383538|NCT00601107|65148169|FG000|Overall Study|Undefined|1|||
23383539|NCT00601107|65148170|FG001|Overall Study|Undefined|0|||
23383540|NCT00601107|65148171|FG002|Overall Study|Undefined|1|||
23383541|NCT00601107|65148172|FG003|Overall Study|Undefined|0|||
23383542|NCT01783938|65148173|FG000|Overall Study|Disease Progression|18|||
23383543|NCT01783938|65148174|FG001|Overall Study|Disease Progression|41|||
23383544|NCT01783938|65148173|FG000|Overall Study|Study Drug Toxicity|27|||
23383545|NCT01783938|65148174|FG001|Overall Study|Study Drug Toxicity|14|||
23383546|NCT01783938|65148173|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
23383547|NCT01783938|65148174|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23383548|NCT01783938|65148173|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
23383549|NCT01783938|65148174|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
23383550|NCT01783938|65148173|FG000|Overall Study|Participant Withdrew Consent|2|||
23383551|NCT01783938|65148174|FG001|Overall Study|Participant Withdrew Consent|0|||
23383552|NCT01783938|65148173|FG000|Overall Study|Maximum Clinical Benefit|1|||
23383553|NCT01783938|65148174|FG001|Overall Study|Maximum Clinical Benefit|0|||
23383554|NCT01783938|65148173|FG000|Overall Study|Other Reasons|3|||
23383555|NCT01783938|65148174|FG001|Overall Study|Other Reasons|1|||
23383556|NCT00429299|65148180|FG000|Overall Study|Disease Progression|1|||
23383557|NCT00429299|65148181|FG001|Overall Study|Disease Progression|1|||
23383558|NCT00429299|65148182|FG002|Overall Study|Disease Progression|0|||
23383559|NCT00429299|65148180|FG000|Overall Study|Adverse Event|2|||
23669943|NCT01425008|66176036|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
23669944|NCT01425008|66176037|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
23669945|NCT01425008|66176038|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
23669946|NCT01425008|66176039|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
23669947|NCT01425008|66176040|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
23669948|NCT01425008|66176041|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
23669949|NCT01425008|66176042|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
23669950|NCT01425008|66176043|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
23669951|NCT01425008|66176044|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
23669952|NCT01425008|66176045|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
23669953|NCT01425008|66176046|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
23669954|NCT01425008|66176047|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
23669955|NCT01425008|66176048|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
23383560|NCT00429299|65148181|FG001|Overall Study|Adverse Event|5|||
23383561|NCT00429299|65148182|FG002|Overall Study|Adverse Event|1|||
23383562|NCT00429299|65148180|FG000|Overall Study|Protocol Violation|1|||
23383563|NCT00429299|65148181|FG001|Overall Study|Protocol Violation|0|||
23383564|NCT00429299|65148182|FG002|Overall Study|Protocol Violation|0|||
23669956|NCT01425008|66176049|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
23669957|NCT01425008|66176031|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669958|NCT01425008|66176032|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669959|NCT01425008|66176033|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669960|NCT01425008|66176034|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669961|NCT01425008|66176035|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669962|NCT01425008|66176036|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669963|NCT01425008|66176037|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669964|NCT01425008|66176038|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669965|NCT01425008|66176039|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669966|NCT01425008|66176040|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669967|NCT01425008|66176041|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669968|NCT01425008|66176042|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669969|NCT01425008|66176043|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669970|NCT01425008|66176044|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669971|NCT01425008|66176045|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669972|NCT01425008|66176046|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669973|NCT01425008|66176047|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669974|NCT01425008|66176048|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23669975|NCT01425008|66176049|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
23669976|NCT01687712|66176058|FG000|Cycle 1|Not Biochemically Pregnant|386|||
23669977|NCT01687712|66176059|FG001|Cycle 1|Not Biochemically Pregnant|348|||
23669978|NCT01687712|66176058|FG000|Cycle 1|Early Pregnancy Loss|43|||
23669979|NCT01687712|66176059|FG001|Cycle 1|Early Pregnancy Loss|60|||
23669980|NCT01687712|66176058|FG000|Cycle 1|Ectopic Pregnancy|5|||
23669981|NCT01687712|66176059|FG001|Cycle 1|Ectopic Pregnancy|5|||
23669982|NCT01687712|66176058|FG000|Cycle 1|Heterotropic Pregnancy|1|||
23669983|NCT01687712|66176059|FG001|Cycle 1|Heterotropic Pregnancy|0|||
23669984|NCT01687712|66176058|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
23669985|NCT01687712|66176059|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
23669986|NCT01687712|66176058|FG000|Cycle 1|Abortion|3|||
23669987|NCT01687712|66176059|FG001|Cycle 1|Abortion|0|||
23669988|NCT01687712|66176058|FG000|Cycle 1|Intrauterine Fetal Death|0|||
23669989|NCT01687712|66176059|FG001|Cycle 1|Intrauterine Fetal Death|1|||
23669990|NCT01687712|66176058|FG000|Cycle 1|Lost to Follow-up|1|||
23669991|NCT01687712|66176059|FG001|Cycle 1|Lost to Follow-up|1|||
23669992|NCT01687712|66176058|FG000|Cycle 2|Not Biochemically Pregnant|74|||
23669993|NCT01687712|66176059|FG001|Cycle 2|Not Biochemically Pregnant|77|||
23669994|NCT01687712|66176058|FG000|Cycle 2|Early Pregnancy Loss|18|||
23669995|NCT01687712|66176059|FG001|Cycle 2|Early Pregnancy Loss|16|||
23669996|NCT01687712|66176058|FG000|Cycle 2|Ectopic Pregnancy|0|||
23669997|NCT01687712|66176059|FG001|Cycle 2|Ectopic Pregnancy|1|||
23669998|NCT01687712|66176058|FG000|Cycle 2|Still Birth|1|||
23669999|NCT01687712|66176059|FG001|Cycle 2|Still Birth|0|||
23670000|NCT01687712|66176058|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
23670001|NCT01687712|66176059|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
23670002|NCT01687712|66176058|FG000|Cycle 3|Not Biochemically Pregnant|21|||
23670003|NCT01687712|66176059|FG001|Cycle 3|Not Biochemically Pregnant|22|||
23670004|NCT01687712|66176058|FG000|Cycle 3|Early Pregnancy Loss|1|||
23670005|NCT01687712|66176059|FG001|Cycle 3|Early Pregnancy Loss|2|||
23670006|NCT01687712|66176058|FG000|Cycle 3|Ectopic Pregnancy|1|||
23670007|NCT01687712|66176059|FG001|Cycle 3|Ectopic Pregnancy|0|||
23493152|NCT01903031|65551373|FG001|Overall Study|Not Able to Attend Clinic|1|||
23670008|NCT01687712|66176058|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
23670009|NCT01687712|66176059|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
23670010|NCT00223496|66176062|FG000|Overall Study|screen failure|9|||
23670011|NCT00223496|66176062|FG000|Overall Study|Lost to Follow-up|4|||
23670012|NCT00223496|66176062|FG000|Overall Study|Lack of Efficacy|6|||
23670013|NCT00223496|66176062|FG000|Overall Study|Withdrawal by Subject|1|||
23670014|NCT00223496|66176062|FG000|Overall Study|Physician Decision|2|||
23383565|NCT00429299|65148180|FG000|Overall Study|Withdrawal by Subject|0|||
23383566|NCT00429299|65148181|FG001|Overall Study|Withdrawal by Subject|1|||
23383567|NCT00429299|65148182|FG002|Overall Study|Withdrawal by Subject|3|||
23383568|NCT04914000|65148183|FG000|Overall Study|Lost to Follow-up|8|||
23383569|NCT04914000|65148183|FG000|Overall Study|Withdrawal by Subject|1|||
23383570|NCT04069520|65148184|FG000|Overall Study|Lost to Follow-up|0|||
23383571|NCT04069520|65148185|FG001|Overall Study|Lost to Follow-up|2|||
23383572|NCT04069520|65148184|FG000|Overall Study|Withdrawal by Subject|0|||
23383573|NCT04069520|65148185|FG001|Overall Study|Withdrawal by Subject|1|||
23383574|NCT04069520|65148184|FG000|Overall Study|Prior Injury|1|||
23383575|NCT04069520|65148185|FG001|Overall Study|Prior Injury|0|||
23383576|NCT04069520|65148184|FG000|Overall Study|Orthodontia|1|||
23383577|NCT04069520|65148185|FG001|Overall Study|Orthodontia|0|||
23383578|NCT04069520|65148184|FG000|Overall Study|Cut from team|0|||
23383579|NCT04069520|65148185|FG001|Overall Study|Cut from team|2|||
23383580|NCT01732692|65148186|FG000|Overall Study|Adverse Event|0|||
23383581|NCT01732692|65148187|FG001|Overall Study|Adverse Event|1|||
23383582|NCT01945242|65148194|FG000|Overall Study|Physician Decision|3|||
23383583|NCT01945242|65148195|FG001|Overall Study|Physician Decision|3|||
23383584|NCT00997126|65148196|FG000|Overall Study|Physician Decision|7|||
23383585|NCT00997126|65148197|FG001|Overall Study|Physician Decision|11|||
23383586|NCT00574951|65148198|FG000|Overall Study|Ineligible - improper prior treatment|1|||
23383587|NCT01108796|65148202|FG000|Overall Study|Adverse Event|0|||
23383588|NCT01108796|65148203|FG001|Overall Study|Adverse Event|1|||
23383589|NCT01108796|65148202|FG000|Overall Study|Lost to Follow-up|7|||
23383590|NCT01108796|65148203|FG001|Overall Study|Lost to Follow-up|6|||
23383591|NCT01331005|65148204|FG000|Overall Study|Lost to Follow-up|2|||
23383592|NCT01331005|65148205|FG001|Overall Study|Lost to Follow-up|1|||
23383593|NCT01331005|65148204|FG000|Overall Study|Withdrawal by Subject|2|||
23383594|NCT01331005|65148205|FG001|Overall Study|Withdrawal by Subject|3|||
23383595|NCT01131585|65148206|FG000|Overall Study|Adverse Event|0|||
23383596|NCT01131585|65148207|FG001|Overall Study|Adverse Event|2|||
23383597|NCT01131585|65148206|FG000|Overall Study|Abnormal laboratory value|1|||
23383598|NCT01131585|65148207|FG001|Overall Study|Abnormal laboratory value|0|||
23383599|NCT01131585|65148206|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23383600|NCT01131585|65148207|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23383601|NCT01131585|65148206|FG000|Overall Study|Protocol Violation|2|||
23383602|NCT01131585|65148207|FG001|Overall Study|Protocol Violation|1|||
23383603|NCT01131585|65148206|FG000|Overall Study|Withdrawal by Subject|3|||
23383604|NCT01131585|65148207|FG001|Overall Study|Withdrawal by Subject|3|||
23383605|NCT01131585|65148206|FG000|Overall Study|Lost to Follow-up|0|||
23383606|NCT01131585|65148207|FG001|Overall Study|Lost to Follow-up|1|||
23383607|NCT01131585|65148206|FG000|Overall Study|Administrative problems|1|||
23383608|NCT01131585|65148207|FG001|Overall Study|Administrative problems|1|||
23383609|NCT01131585|65148206|FG000|Overall Study|Study termination|78|||
23383610|NCT01131585|65148207|FG001|Overall Study|Study termination|32|||
23383611|NCT02153827|65148211|FG000|Overall Study|Lost to Follow-up|3|||
23383612|NCT02153827|65148212|FG001|Overall Study|Lost to Follow-up|9|||
23383613|NCT00585585|65148213|FG000|Overall Study|Adverse Event|1|||
23383614|NCT00599313|65148214|FG000|Overall Study|Adverse Event|19|||
23383615|NCT00599313|65148214|FG000|Overall Study|Disease Progression|12|||
23383616|NCT00599313|65148214|FG000|Overall Study|Patient Request|4|||
23383617|NCT00599313|65148214|FG000|Overall Study|Ineligible|1|||
23383618|NCT01350973|65148215|FG000|Overall Study|Adverse Event|4|||
23383619|NCT01350973|65148216|FG001|Overall Study|Adverse Event|7|||
23383620|NCT01350973|65148217|FG002|Overall Study|Adverse Event|7|||
23383621|NCT01350973|65148215|FG000|Overall Study|Voluntary Withdrawal|2|||
23383622|NCT01350973|65148216|FG001|Overall Study|Voluntary Withdrawal|1|||
23383623|NCT01350973|65148217|FG002|Overall Study|Voluntary Withdrawal|1|||
23383624|NCT04167462|65148218|FG000|Overall Study|Other reasons|3|||
23383625|NCT04167462|65148219|FG001|Overall Study|Other reasons|2|||
23383626|NCT04167462|65148218|FG000|Overall Study|Withdrawal by Subject|6|||
23383627|NCT04167462|65148219|FG001|Overall Study|Withdrawal by Subject|7|||
23383628|NCT04167462|65148218|FG000|Overall Study|Adverse Event|4|||
23383629|NCT04167462|65148219|FG001|Overall Study|Adverse Event|0|||
23383630|NCT04167462|65148218|FG000|Overall Study|Pregnancy|1|||
23383631|NCT04167462|65148219|FG001|Overall Study|Pregnancy|0|||
23383632|NCT04167462|65148218|FG000|Overall Study|Lack of Efficacy|0|||
23383633|NCT04167462|65148219|FG001|Overall Study|Lack of Efficacy|1|||
23383634|NCT02314247|65148226|FG000|Overall Study|Adverse Event|2|||
23383635|NCT02314247|65148227|FG001|Overall Study|Adverse Event|1|||
23383636|NCT02314247|65148228|FG002|Overall Study|Adverse Event|0|||
23383637|NCT02314247|65148226|FG000|Overall Study|Withdrawal by Subject|1|||
23383638|NCT02314247|65148227|FG001|Overall Study|Withdrawal by Subject|3|||
23383639|NCT02314247|65148228|FG002|Overall Study|Withdrawal by Subject|1|||
23383640|NCT02314247|65148226|FG000|Overall Study|Progression of Disease|6|||
23383641|NCT02314247|65148227|FG001|Overall Study|Progression of Disease|2|||
23383642|NCT02314247|65148228|FG002|Overall Study|Progression of Disease|0|||
23383643|NCT04307394|65148229|FG000|Overall Study|Lost to Follow-up|3|||
23383644|NCT04307394|65148229|FG000|Overall Study|Withdrawal by Subject|2|||
23383645|NCT00387127|65148235|FG000|Overall Study|Lost to Follow-up|0|||
23383646|NCT00387127|65148236|FG001|Overall Study|Lost to Follow-up|4|||
23670015|NCT05661851|66176063|FG000|Overall Study|Protocol Violation|1|||
23670016|NCT05661851|66176064|FG001|Overall Study|Protocol Violation|1|||
23670017|NCT05661851|66176063|FG000|Overall Study|Covid-19 Related|3|||
23670018|NCT05661851|66176064|FG001|Overall Study|Covid-19 Related|4|||
23670019|NCT05661851|66176063|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
23670020|NCT05661851|66176064|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
23670021|NCT05661851|66176063|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
23670022|NCT05661851|66176064|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
23670023|NCT02228590|66176065|FG000|Overall Study|Withdrawal by Subject|1|||
23670024|NCT00964743|66176067|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
23670025|NCT00522431|66176068|FG000|Overall Study|Adverse Event|5|||
23670026|NCT00522431|66176068|FG000|Overall Study|Protocol Violation|2|||
23670027|NCT00522431|66176068|FG000|Overall Study|Withdrawal by Subject|2|||
23670028|NCT00522431|66176068|FG000|Overall Study|Subject non-compliance|1|||
23670029|NCT00522431|66176068|FG000|Overall Study|Other/unknown|1|||
23670030|NCT02830880|66176071|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
23670031|NCT02830880|66176071|FG000|Overall Study|Death|1|||
23670032|NCT02830880|66176071|FG000|Overall Study|Physician Decision|1|||
23670033|NCT03775421|66176072|FG000|Overall Study|Lost to Follow-up|2|||
23670034|NCT03775421|66176072|FG000|Overall Study|Withdrawal by Subject|10|||
23670035|NCT03775421|66176072|FG000|Overall Study|Physician Decision|3|||
23670036|NCT03775421|66176072|FG000|Overall Study|Death|1|||
23670037|NCT03775421|66176072|FG000|Overall Study|Study Terminated by Sponsor|94|||
23670038|NCT04342871|66176073|FG000|Overall Study|Death|4|||
23670039|NCT04342871|66176073|FG000|Overall Study|Clinical deterioration/illness progression|2|||
23670040|NCT04342871|66176073|FG000|Overall Study|Did not complete baseline assessments|5|||
23670041|NCT04342871|66176073|FG000|Overall Study|Lost to Follow-up|13|||
23670042|NCT01356589|66176074|FG000|Overall Study|Enrolled, but not treated|3|||
23670043|NCT01356589|66176074|FG000|Overall Study|Dose data not recorded|2|||
23670044|NCT00689871|66176076|FG000|Overall Study|Lost to Follow-up|123|||
23670045|NCT00689871|66176077|FG001|Overall Study|Lost to Follow-up|13|||
23670046|NCT00689871|66176078|FG002|Overall Study|Lost to Follow-up|37|||
23383647|NCT00387127|65148235|FG000|Overall Study|Death|16|||
23670047|NCT00689871|66176079|FG003|Overall Study|Lost to Follow-up|1|||
23383648|NCT00387127|65148236|FG001|Overall Study|Death|16|||
23670048|NCT00689871|66176076|FG000|Overall Study|Explanted of All Study Devices|36|||
23383649|NCT00387127|65148235|FG000|Overall Study|Physician Decision|0|||
23383650|NCT00387127|65148236|FG001|Overall Study|Physician Decision|1|||
23383651|NCT00387127|65148235|FG000|Overall Study|Withdrawal by Subject|3|||
23383652|NCT00387127|65148236|FG001|Overall Study|Withdrawal by Subject|2|||
23383653|NCT00387127|65148235|FG000|Overall Study|Required by Protocol Amendment #4|12|||
23383654|NCT00387127|65148236|FG001|Overall Study|Required by Protocol Amendment #4|10|||
23383655|NCT00387127|65148235|FG000|Overall Study|Serious Adverse Event|1|||
23383656|NCT00387127|65148236|FG001|Overall Study|Serious Adverse Event|1|||
23383657|NCT00387127|65148235|FG000|Overall Study|Sponsor Unblinded|1|||
23383658|NCT00387127|65148236|FG001|Overall Study|Sponsor Unblinded|0|||
23383659|NCT00864513|65148237|FG000|Overall Study|Withdrawal by Subject|3|||
23383660|NCT04090749|65148238|FG000|Open Label Pilot|Lost to Follow-up|1|||
23383661|NCT04090749|65148239|FG001|Open Label Pilot|Lost to Follow-up|0|||
23383662|NCT04090749|65148240|FG002|Open Label Pilot|Lost to Follow-up|0|||
23383663|NCT04090749|65148238|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
23383664|NCT04090749|65148239|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
23383665|NCT04090749|65148240|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
23670049|NCT00689871|66176077|FG001|Overall Study|Explanted of All Study Devices|25|||
23670050|NCT00689871|66176078|FG002|Overall Study|Explanted of All Study Devices|29|||
23670051|NCT00689871|66176079|FG003|Overall Study|Explanted of All Study Devices|3|||
23670052|NCT00689871|66176076|FG000|Overall Study|Withdrawal by Subject|13|||
23670053|NCT00689871|66176077|FG001|Overall Study|Withdrawal by Subject|3|||
23670054|NCT00689871|66176078|FG002|Overall Study|Withdrawal by Subject|4|||
23670055|NCT00689871|66176079|FG003|Overall Study|Withdrawal by Subject|1|||
23670056|NCT00689871|66176076|FG000|Overall Study|Death|1|||
23670057|NCT00689871|66176077|FG001|Overall Study|Death|10|||
23670058|NCT00689871|66176078|FG002|Overall Study|Death|2|||
23670059|NCT00689871|66176079|FG003|Overall Study|Death|2|||
23670060|NCT00689871|66176076|FG000|Overall Study|Physician Decision|2|||
23670061|NCT00689871|66176077|FG001|Overall Study|Physician Decision|1|||
23383666|NCT04090749|65148238|FG000|Pilot Trial|Lost to Follow-up|0|||
23383667|NCT04090749|65148239|FG001|Pilot Trial|Lost to Follow-up|1|||
23383668|NCT04090749|65148240|FG002|Pilot Trial|Lost to Follow-up|1|||
23670062|NCT00689871|66176078|FG002|Overall Study|Physician Decision|1|||
23383669|NCT05161936|65148241|FG000|Overall Study|Study terminated by Sponsor|1|||
23383670|NCT05161936|65148242|FG001|Overall Study|Study terminated by Sponsor|0|||
23383671|NCT05161936|65148243|FG002|Overall Study|Study terminated by Sponsor|0|||
23670063|NCT00689871|66176079|FG003|Overall Study|Physician Decision|0|||
23670064|NCT00971945|66176080|FG000|Overall Study|Progressive Disease|3|||
23670065|NCT00971945|66176080|FG000|Overall Study|Change in treatment policy|1|||
23670066|NCT00971945|66176080|FG000|Overall Study|Other reasons|2|||
23670067|NCT01318109|66176083|FG000|Overall Study|Adverse Event|0|||
23670068|NCT01318109|66176084|FG001|Overall Study|Adverse Event|2|||
23670069|NCT01318109|66176085|FG002|Overall Study|Adverse Event|0|||
23670070|NCT01318109|66176083|FG000|Overall Study|Withdrawal by Subject|1|||
23670071|NCT01318109|66176084|FG001|Overall Study|Withdrawal by Subject|0|||
23670072|NCT01318109|66176085|FG002|Overall Study|Withdrawal by Subject|0|||
23670073|NCT01318109|66176083|FG000|Overall Study|Schedule Conflict|0|||
23670074|NCT01318109|66176084|FG001|Overall Study|Schedule Conflict|1|||
23670075|NCT01318109|66176085|FG002|Overall Study|Schedule Conflict|0|||
23670076|NCT03927105|66176086|FG000|Overall Study|Death|1|||
23670077|NCT03927105|66176086|FG000|Overall Study|In observation for potential re-treatment|2|||
23670078|NCT03927105|66176086|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
23670079|NCT00271596|66176087|FG000|Overall Study|Protocol Violation|1|||
23670080|NCT00271596|66176088|FG001|Overall Study|Protocol Violation|0|||
23670081|NCT00271596|66176087|FG000|Overall Study|Withdrawal by Subject|0|||
23670082|NCT00271596|66176088|FG001|Overall Study|Withdrawal by Subject|1|||
23670083|NCT00513409|66176091|FG000|Overall Study|Adverse Event|0|||
23670084|NCT00513409|66176092|FG001|Overall Study|Adverse Event|1|||
23670085|NCT00513409|66176091|FG000|Overall Study|Withdrawal by Subject|0|||
23670086|NCT00513409|66176092|FG001|Overall Study|Withdrawal by Subject|2|||
23670087|NCT00513409|66176091|FG000|Overall Study|Lost to Follow-up|0|||
23670088|NCT00513409|66176092|FG001|Overall Study|Lost to Follow-up|1|||
23670089|NCT00513409|66176091|FG000|Overall Study|Physician Decision|1|||
23670090|NCT00513409|66176092|FG001|Overall Study|Physician Decision|0|||
23670091|NCT00513409|66176091|FG000|Overall Study|Visit 3 not done|1|||
23670092|NCT00513409|66176092|FG001|Overall Study|Visit 3 not done|2|||
23670093|NCT01277549|66176094|FG000|Overall Study|Failed to meet eligibility criteria|13|||
23670094|NCT01277549|66176095|FG001|Overall Study|Failed to meet eligibility criteria|9|||
23670095|NCT01277549|66176094|FG000|Overall Study|Withdrawal by Subject|1|||
23670096|NCT01277549|66176095|FG001|Overall Study|Withdrawal by Subject|3|||
23670097|NCT01277549|66176094|FG000|Overall Study|Protocol Violation|10|||
23670098|NCT01277549|66176095|FG001|Overall Study|Protocol Violation|1|||
23670099|NCT01277549|66176094|FG000|Overall Study|Physician Decision|2|||
23670100|NCT01277549|66176095|FG001|Overall Study|Physician Decision|1|||
23670101|NCT02109484|66176096|FG000|Overall Study|Lost to Follow-up|0|||
23670102|NCT02109484|66176097|FG001|Overall Study|Lost to Follow-up|0|||
23670103|NCT02109484|66176098|FG002|Overall Study|Lost to Follow-up|0|||
23670104|NCT02109484|66176099|FG003|Overall Study|Lost to Follow-up|1|||
23670105|NCT02109484|66176100|FG004|Overall Study|Lost to Follow-up|1|||
23670106|NCT02109484|66176101|FG005|Overall Study|Lost to Follow-up|0|||
23493153|NCT01903031|65551374|FG002|Overall Study|Not Able to Attend Clinic|0|||
23493154|NCT01903031|65551372|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
23493155|NCT01903031|65551373|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
23493156|NCT01903031|65551374|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
23493157|NCT01903031|65551372|FG000|Overall Study|Adverse Event|0|||
23493158|NCT01903031|65551373|FG001|Overall Study|Adverse Event|1|||
23493159|NCT01903031|65551374|FG002|Overall Study|Adverse Event|0|||
23493160|NCT01903031|65551372|FG000|Overall Study|Withdrawal by Subject|0|||
23493161|NCT01903031|65551373|FG001|Overall Study|Withdrawal by Subject|1|||
23493162|NCT01903031|65551374|FG002|Overall Study|Withdrawal by Subject|1|||
23493163|NCT01903031|65551372|FG000|Overall Study|Protocol Violation|0|||
23493164|NCT01903031|65551373|FG001|Overall Study|Protocol Violation|0|||
23493165|NCT01903031|65551374|FG002|Overall Study|Protocol Violation|2|||
23493166|NCT01903031|65551372|FG000|Overall Study|Lost to Follow-up|0|||
23493167|NCT01903031|65551373|FG001|Overall Study|Lost to Follow-up|0|||
23493168|NCT01903031|65551374|FG002|Overall Study|Lost to Follow-up|1|||
23493169|NCT01903031|65551372|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
23493170|NCT01903031|65551373|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
23493171|NCT01903031|65551374|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
23493172|NCT01871142|65551375|FG000|Overall Study|Adverse Event|1|||
23670107|NCT02109484|66176102|FG006|Overall Study|Lost to Follow-up|1|||
23670108|NCT02109484|66176103|FG007|Overall Study|Lost to Follow-up|0|||
23670109|NCT02109484|66176096|FG000|Overall Study|Withdrawal by Subject|0|||
23670110|NCT02109484|66176097|FG001|Overall Study|Withdrawal by Subject|0|||
23670111|NCT02109484|66176098|FG002|Overall Study|Withdrawal by Subject|0|||
23493173|NCT01050543|65551376|FG000|Overall Study|Withdrawal by Subject|0|||
23670112|NCT02109484|66176099|FG003|Overall Study|Withdrawal by Subject|0|||
23670113|NCT02109484|66176100|FG004|Overall Study|Withdrawal by Subject|1|||
23383672|NCT05161936|65148241|FG000|Overall Study|Withdrawal by Subject|0|||
23383673|NCT05161936|65148242|FG001|Overall Study|Withdrawal by Subject|0|||
23383674|NCT05161936|65148243|FG002|Overall Study|Withdrawal by Subject|1|||
23383675|NCT01245049|65148244|FG000|Overall Study|Migrated/moved from study area|0|||
23383676|NCT01245049|65148245|FG001|Overall Study|Migrated/moved from study area|1|||
23383677|NCT01245049|65148244|FG000|Overall Study|Withdrawal by Subject|0|||
23383678|NCT01245049|65148245|FG001|Overall Study|Withdrawal by Subject|1|||
23383679|NCT01245049|65148244|FG000|Overall Study|Lost to Follow-up|1|||
23383680|NCT01245049|65148245|FG001|Overall Study|Lost to Follow-up|2|||
23383681|NCT01011283|65148252|FG000|Overall Study|Adverse Event|4|||
23383682|NCT01011283|65148253|FG001|Overall Study|Adverse Event|2|||
23383683|NCT01011283|65148252|FG000|Overall Study|Progressive Disease|0|||
23383684|NCT01011283|65148253|FG001|Overall Study|Progressive Disease|2|||
23383685|NCT01011283|65148252|FG000|Overall Study|Terminated by Sponsor|5|||
23383686|NCT01011283|65148253|FG001|Overall Study|Terminated by Sponsor|5|||
23383687|NCT01011283|65148252|FG000|Overall Study|Other|2|||
23383688|NCT01011283|65148253|FG001|Overall Study|Other|2|||
23383689|NCT01093885|65148254|FG000|Overall Study|Adverse Event|4|||
23383690|NCT01093885|65148254|FG000|Overall Study|Lost to Follow-up|1|||
23383691|NCT01112267|65148255|FG000|Overall Study|Adverse Event|24|||
23383692|NCT01112267|65148256|FG001|Overall Study|Adverse Event|6|||
23383693|NCT01112267|65148255|FG000|Overall Study|Withdrawal by Subject|3|||
23383694|NCT01112267|65148256|FG001|Overall Study|Withdrawal by Subject|5|||
23383695|NCT01112267|65148255|FG000|Overall Study|Protocol Violation|5|||
23383696|NCT01112267|65148256|FG001|Overall Study|Protocol Violation|3|||
23383697|NCT01112267|65148255|FG000|Overall Study|Participants not compliant|1|||
23383698|NCT01112267|65148256|FG001|Overall Study|Participants not compliant|2|||
23383699|NCT01112267|65148255|FG000|Overall Study|Participants not receive any study drug|1|||
23383700|NCT01112267|65148256|FG001|Overall Study|Participants not receive any study drug|2|||
23383701|NCT00326495|65148257|FG000|Overall Study|Switched to alternative treatment|1|||
23383702|NCT00326495|65148257|FG000|Overall Study|Disease progression before treatment|1|||
23383703|NCT00326495|65148257|FG000|Overall Study|Refused further treatment|2|||
23383704|NCT00326495|65148257|FG000|Overall Study|Subject off study before assessment|1|||
23383705|NCT02413346|65148258|FG000|Overall Study|Adverse Event|6|||
23383706|NCT02413346|65148259|FG001|Overall Study|Adverse Event|6|||
23383707|NCT02413346|65148258|FG000|Overall Study|Withdrawal by Subject|30|||
23383708|NCT02413346|65148259|FG001|Overall Study|Withdrawal by Subject|40|||
23383709|NCT02413346|65148258|FG000|Overall Study|Lost to Follow-up|17|||
23383710|NCT02413346|65148259|FG001|Overall Study|Lost to Follow-up|21|||
23383711|NCT02413346|65148258|FG000|Overall Study|Protocol Violation|2|||
23383712|NCT02413346|65148259|FG001|Overall Study|Protocol Violation|0|||
23383713|NCT02413346|65148258|FG000|Overall Study|Other Miscellaneous Reasons|4|||
23383714|NCT02413346|65148259|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23383715|NCT01699685|65148260|FG000|Period 1|Adverse Event|1|||
23383716|NCT01699685|65148261|FG001|Period 1|Adverse Event|1|||
23383717|NCT01699685|65148260|FG000|Period 1|Medical or ethical, noncompliance|2|||
23383718|NCT01699685|65148261|FG001|Period 1|Medical or ethical, noncompliance|0|||
23383719|NCT01699685|65148260|FG000|Period 1|Other|0|||
23383720|NCT01699685|65148261|FG001|Period 1|Other|1|||
23383721|NCT01699685|65148260|FG000|Period 1|Patient request|0|||
23383722|NCT01699685|65148261|FG001|Period 1|Patient request|1|||
23383723|NCT01699685|65148260|FG000|Period 2|Lost to Follow-up|1|||
23383724|NCT01699685|65148261|FG001|Period 2|Lost to Follow-up|0|||
23383725|NCT03345004|65148268|FG000|Overall Study|Physician Decision|1|||
23383726|NCT03345004|65148269|FG001|Overall Study|Physician Decision|0|||
23383727|NCT03345004|65148268|FG000|Overall Study|Withdrawal by Subject|0|||
23383728|NCT03345004|65148269|FG001|Overall Study|Withdrawal by Subject|1|||
23383729|NCT01727154|65148270|FG000|Overall Study|Death|17|||
23383730|NCT01727154|65148270|FG000|Overall Study|Withdrawal by Subject|14|||
23383731|NCT01727154|65148270|FG000|Overall Study|Subject Withdrew Consent|18|||
23383732|NCT01727154|65148270|FG000|Overall Study|Study Terminated|6|||
23383733|NCT01727154|65148270|FG000|Overall Study|No Discontinuation Documentation|4|||
23383734|NCT00871000|65148271|FG000|Overall Study|Withdrawal by Subject|1|||
23383735|NCT00871000|65148272|FG001|Overall Study|Withdrawal by Subject|0|||
23383736|NCT01362270|65148273|FG000|Overall Study|Withdrawal by Subject|1|||
23670114|NCT02109484|66176101|FG005|Overall Study|Withdrawal by Subject|1|||
23383737|NCT01362270|65148274|FG001|Overall Study|Withdrawal by Subject|0|||
23383738|NCT01362270|65148273|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
23383739|NCT01362270|65148274|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
23383740|NCT01362270|65148273|FG000|Overall Study|Met excl. criteria before 1st session|1|||
23383741|NCT01362270|65148274|FG001|Overall Study|Met excl. criteria before 1st session|1|||
23383742|NCT01026038|65148275|FG000|Overall Study|Lost to Follow-up|1|||
23383743|NCT01026038|65148276|FG001|Overall Study|Lost to Follow-up|1|||
23383744|NCT01026038|65148277|FG002|Overall Study|Lost to Follow-up|0|||
23383745|NCT01793935|65148278|FG000|Overall Study|Pregnancy|1|||
23383746|NCT01793935|65148279|FG001|Overall Study|Pregnancy|0|||
23383747|NCT01793935|65148278|FG000|Overall Study|Protocol Violation|2|||
23383748|NCT01793935|65148279|FG001|Overall Study|Protocol Violation|1|||
23383749|NCT01793935|65148278|FG000|Overall Study|Adverse Event|2|||
23383750|NCT01793935|65148279|FG001|Overall Study|Adverse Event|0|||
23383751|NCT01793935|65148278|FG000|Overall Study|Patient did not take study medication|1|||
23383752|NCT01793935|65148279|FG001|Overall Study|Patient did not take study medication|1|||
23383753|NCT01793935|65148278|FG000|Overall Study|Lost to Follow-up|0|||
23383754|NCT01793935|65148279|FG001|Overall Study|Lost to Follow-up|1|||
23383755|NCT02782468|65148280|FG000|Overall Study|Progressive Disease|2|||
23383756|NCT02782468|65148281|FG001|Overall Study|Progressive Disease|5|||
23383757|NCT02782468|65148282|FG002|Overall Study|Progressive Disease|0|||
23383758|NCT02782468|65148283|FG003|Overall Study|Progressive Disease|4|||
23383759|NCT02782468|65148280|FG000|Overall Study|Adverse Event|0|||
23383760|NCT02782468|65148281|FG001|Overall Study|Adverse Event|2|||
23383761|NCT02782468|65148282|FG002|Overall Study|Adverse Event|2|||
23383762|NCT02782468|65148283|FG003|Overall Study|Adverse Event|3|||
23383763|NCT02782468|65148280|FG000|Overall Study|Other|0|||
23383764|NCT02782468|65148281|FG001|Overall Study|Other|0|||
23383765|NCT02782468|65148282|FG002|Overall Study|Other|1|||
23383766|NCT02782468|65148283|FG003|Overall Study|Other|1|||
23383767|NCT02782468|65148280|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383768|NCT02782468|65148281|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383769|NCT02782468|65148282|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383770|NCT02782468|65148283|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
23383771|NCT02782468|65148280|FG000|Overall Study|Symptomatic Deterioration|0|||
23383772|NCT02782468|65148281|FG001|Overall Study|Symptomatic Deterioration|0|||
23383773|NCT02782468|65148282|FG002|Overall Study|Symptomatic Deterioration|0|||
23383774|NCT02782468|65148283|FG003|Overall Study|Symptomatic Deterioration|1|||
23383775|NCT02782468|65148280|FG000|Overall Study|Withdrawal by Subject|1|||
23383776|NCT02782468|65148281|FG001|Overall Study|Withdrawal by Subject|0|||
23383777|NCT02782468|65148282|FG002|Overall Study|Withdrawal by Subject|0|||
23383778|NCT02782468|65148283|FG003|Overall Study|Withdrawal by Subject|0|||
23383779|NCT00290238|65148288|FG000|Overall Study|Study terminated|27|||
23383780|NCT00290238|65148289|FG001|Overall Study|Study terminated|27|||
23383781|NCT00290238|65148288|FG000|Overall Study|Lost to Follow-up|0|||
23383782|NCT00290238|65148289|FG001|Overall Study|Lost to Follow-up|1|||
23383783|NCT00290238|65148288|FG000|Overall Study|Withdrawal by Subject|15|||
23383784|NCT00290238|65148289|FG001|Overall Study|Withdrawal by Subject|13|||
23383785|NCT03142750|65148293|FG000|Overall Study|Lost to Follow-up|4|||
23383786|NCT03142750|65148294|FG001|Overall Study|Lost to Follow-up|1|||
23383787|NCT03520387|65148299|FG000|Pre-Randomization|Withdrawal by Subject|1|||
23383788|NCT03520387|65148300|FG001|Pre-Randomization|Withdrawal by Subject|0|||
23383789|NCT03520387|65148301|FG002|Pre-Randomization|Withdrawal by Subject|0|||
23383790|NCT03520387|65148302|FG003|Pre-Randomization|Withdrawal by Subject|0|||
23383791|NCT03520387|65148303|FG004|Pre-Randomization|Withdrawal by Subject|0|||
23383792|NCT03520387|65148299|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
23383793|NCT03520387|65148300|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383794|NCT03520387|65148301|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383795|NCT03520387|65148302|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383796|NCT03520387|65148303|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383797|NCT03259308|65148304|FG000|Overall Study|Adverse Event|5|||
23383798|NCT03259308|65148305|FG001|Overall Study|Adverse Event|4|||
23383799|NCT03259308|65148306|FG002|Overall Study|Adverse Event|1|||
23383800|NCT03259308|65148304|FG000|Overall Study|Withdrawal by Subject|2|||
23383801|NCT03259308|65148305|FG001|Overall Study|Withdrawal by Subject|1|||
23383802|NCT03259308|65148306|FG002|Overall Study|Withdrawal by Subject|3|||
23383803|NCT03259308|65148304|FG000|Overall Study|Lost to Follow-up|0|||
23493174|NCT01050543|65551377|FG001|Overall Study|Withdrawal by Subject|2|||
23670115|NCT02109484|66176102|FG006|Overall Study|Withdrawal by Subject|1|||
23383804|NCT03259308|65148305|FG001|Overall Study|Lost to Follow-up|0|||
23383805|NCT03259308|65148306|FG002|Overall Study|Lost to Follow-up|1|||
23383806|NCT03259308|65148304|FG000|Overall Study|Pregnancy|0|||
23383807|NCT03259308|65148305|FG001|Overall Study|Pregnancy|0|||
23383808|NCT03259308|65148306|FG002|Overall Study|Pregnancy|1|||
23383809|NCT03259308|65148304|FG000|Overall Study|Protocol Deviation|0|||
23383810|NCT03259308|65148305|FG001|Overall Study|Protocol Deviation|3|||
23383811|NCT03259308|65148306|FG002|Overall Study|Protocol Deviation|0|||
23383812|NCT03259308|65148304|FG000|Overall Study|Lack of Efficacy|0|||
23383813|NCT03259308|65148305|FG001|Overall Study|Lack of Efficacy|0|||
23383814|NCT03259308|65148306|FG002|Overall Study|Lack of Efficacy|1|||
23383815|NCT00663351|65148307|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
23383816|NCT00663351|65148308|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
23383817|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
23383818|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
23383819|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
23383820|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
23383821|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
23383822|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
23383823|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
23383824|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
23383825|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
23383826|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
23383827|NCT00577408|65148309|FG000|Overall Study|Stopped attending study visits|9|||
23383828|NCT00577408|65148310|FG001|Overall Study|Stopped attending study visits|11|||
23383829|NCT00577408|65148309|FG000|Overall Study|Continued opioid use|3|||
23383830|NCT00577408|65148310|FG001|Overall Study|Continued opioid use|2|||
23383831|NCT00577408|65148309|FG000|Overall Study|Non-compliance with study meds|0|||
23670116|NCT02109484|66176103|FG007|Overall Study|Withdrawal by Subject|0|||
23670117|NCT02109484|66176096|FG000|Overall Study|Physician Decision|0|||
23670118|NCT02109484|66176097|FG001|Overall Study|Physician Decision|0|||
23670119|NCT02109484|66176098|FG002|Overall Study|Physician Decision|0|||
23670120|NCT02109484|66176099|FG003|Overall Study|Physician Decision|0|||
23670121|NCT02109484|66176100|FG004|Overall Study|Physician Decision|2|||
23670122|NCT02109484|66176101|FG005|Overall Study|Physician Decision|0|||
23670123|NCT02109484|66176102|FG006|Overall Study|Physician Decision|0|||
23670124|NCT02109484|66176103|FG007|Overall Study|Physician Decision|0|||
23670125|NCT02109484|66176096|FG000|Overall Study|Death|0|||
23670126|NCT02109484|66176097|FG001|Overall Study|Death|0|||
23670127|NCT02109484|66176098|FG002|Overall Study|Death|0|||
23383832|NCT00577408|65148310|FG001|Overall Study|Non-compliance with study meds|3|||
23383833|NCT00577408|65148309|FG000|Overall Study|Refused Oral Naltrexone|0|||
23670128|NCT02109484|66176099|FG003|Overall Study|Death|0|||
23670129|NCT02109484|66176100|FG004|Overall Study|Death|0|||
23670130|NCT02109484|66176101|FG005|Overall Study|Death|0|||
23670131|NCT02109484|66176102|FG006|Overall Study|Death|0|||
23670132|NCT02109484|66176103|FG007|Overall Study|Death|2|||
23670133|NCT02109484|66176096|FG000|Overall Study|Moved away from study area|0|||
23670134|NCT02109484|66176097|FG001|Overall Study|Moved away from study area|0|||
23670135|NCT02109484|66176098|FG002|Overall Study|Moved away from study area|0|||
23670136|NCT02109484|66176099|FG003|Overall Study|Moved away from study area|0|||
23670137|NCT02109484|66176100|FG004|Overall Study|Moved away from study area|0|||
23670138|NCT02109484|66176101|FG005|Overall Study|Moved away from study area|0|||
23670139|NCT02109484|66176102|FG006|Overall Study|Moved away from study area|1|||
23670140|NCT02109484|66176103|FG007|Overall Study|Moved away from study area|1|||
23670141|NCT01709435|66176104|FG000|Overall Study|Adverse Event|1|||
23670142|NCT01709435|66176105|FG001|Overall Study|Adverse Event|1|||
23670143|NCT01709435|66176106|FG002|Overall Study|Adverse Event|1|||
23670144|NCT01709435|66176107|FG003|Overall Study|Adverse Event|0|||
23670145|NCT01709435|66176108|FG004|Overall Study|Adverse Event|0|||
23670146|NCT01709435|66176109|FG005|Overall Study|Adverse Event|1|||
23670147|NCT01709435|66176104|FG000|Overall Study|Lack of Efficacy|5|||
23670148|NCT01709435|66176105|FG001|Overall Study|Lack of Efficacy|7|||
23670149|NCT01709435|66176106|FG002|Overall Study|Lack of Efficacy|2|||
23670150|NCT01709435|66176107|FG003|Overall Study|Lack of Efficacy|2|||
23670151|NCT01709435|66176108|FG004|Overall Study|Lack of Efficacy|6|||
23670152|NCT01709435|66176109|FG005|Overall Study|Lack of Efficacy|3|||
23670153|NCT01709435|66176104|FG000|Overall Study|Physician Decision|0|||
23670154|NCT01709435|66176105|FG001|Overall Study|Physician Decision|1|||
23670155|NCT01709435|66176106|FG002|Overall Study|Physician Decision|0|||
23670156|NCT01709435|66176107|FG003|Overall Study|Physician Decision|1|||
23670157|NCT01709435|66176108|FG004|Overall Study|Physician Decision|2|||
23670158|NCT01709435|66176109|FG005|Overall Study|Physician Decision|0|||
23670159|NCT01709435|66176104|FG000|Overall Study|Withdrawal by Subject|0|||
23670160|NCT01709435|66176105|FG001|Overall Study|Withdrawal by Subject|0|||
23670161|NCT01709435|66176106|FG002|Overall Study|Withdrawal by Subject|3|||
23670162|NCT01709435|66176107|FG003|Overall Study|Withdrawal by Subject|0|||
23670163|NCT01709435|66176108|FG004|Overall Study|Withdrawal by Subject|2|||
23670164|NCT01709435|66176109|FG005|Overall Study|Withdrawal by Subject|2|||
23670165|NCT00772954|66176110|FG000|Overall Study|Adverse Event|0|||
23670166|NCT00772954|66176111|FG001|Overall Study|Adverse Event|0|||
23670167|NCT00772954|66176112|FG002|Overall Study|Adverse Event|1|||
23670168|NCT00262873|66176113|FG000|Overall Study|Adverse Event|3|||
23670169|NCT00262873|66176113|FG000|Overall Study|Withdrawal by Subject|5|||
23670170|NCT02187471|66176114|FG000|Overall Study|Protocol Violation|4|||
23670171|NCT02187471|66176115|FG001|Overall Study|Protocol Violation|5|||
23670172|NCT02187471|66176116|FG002|Overall Study|Protocol Violation|4|||
23670173|NCT02187471|66176117|FG003|Overall Study|Protocol Violation|4|||
23670174|NCT02187471|66176114|FG000|Overall Study|Missing|0|||
23670175|NCT02187471|66176115|FG001|Overall Study|Missing|0|||
23670176|NCT02187471|66176116|FG002|Overall Study|Missing|0|||
23670177|NCT02187471|66176117|FG003|Overall Study|Missing|1|||
23670178|NCT02187471|66176114|FG000|Overall Study|Lack of Efficacy|18|||
23670179|NCT02187471|66176115|FG001|Overall Study|Lack of Efficacy|9|||
23670180|NCT02187471|66176116|FG002|Overall Study|Lack of Efficacy|13|||
23670181|NCT02187471|66176117|FG003|Overall Study|Lack of Efficacy|11|||
23670182|NCT02187471|66176114|FG000|Overall Study|Adverse Event|24|||
23670183|NCT02187471|66176115|FG001|Overall Study|Adverse Event|34|||
23670184|NCT02187471|66176116|FG002|Overall Study|Adverse Event|44|||
23670185|NCT02187471|66176117|FG003|Overall Study|Adverse Event|36|||
23670186|NCT02187471|66176114|FG000|Overall Study|Withdrawal by Subject|23|||
23670187|NCT02187471|66176115|FG001|Overall Study|Withdrawal by Subject|29|||
23670188|NCT02187471|66176116|FG002|Overall Study|Withdrawal by Subject|22|||
23670189|NCT02187471|66176117|FG003|Overall Study|Withdrawal by Subject|24|||
23670190|NCT02187471|66176114|FG000|Overall Study|Other|7|||
23670191|NCT02187471|66176115|FG001|Overall Study|Other|5|||
23670192|NCT02187471|66176116|FG002|Overall Study|Other|3|||
23670193|NCT02187471|66176117|FG003|Overall Study|Other|4|||
23670194|NCT03344003|66176118|FG000|Overall Study|Switched to alternative treatment|1|||
23670195|NCT03344003|66176119|FG001|Overall Study|Switched to alternative treatment|0|||
23670196|NCT03344003|66176118|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
23670197|NCT03344003|66176119|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
23670198|NCT00085735|66176121|FG000|Overall Study|Adverse Event|1|||
23670199|NCT00085735|66176122|FG001|Overall Study|Adverse Event|0|||
23670200|NCT00085735|66176123|FG002|Overall Study|Adverse Event|0|||
23670201|NCT00085735|66176124|FG003|Overall Study|Adverse Event|0|||
23670202|NCT00085735|66176125|FG004|Overall Study|Adverse Event|0|||
23670203|NCT00085735|66176126|FG005|Overall Study|Adverse Event|0|||
23670204|NCT00085735|66176121|FG000|Overall Study|Lack of Efficacy|2|||
23670205|NCT00085735|66176122|FG001|Overall Study|Lack of Efficacy|4|||
23670206|NCT00085735|66176123|FG002|Overall Study|Lack of Efficacy|6|||
23670207|NCT00085735|66176124|FG003|Overall Study|Lack of Efficacy|3|||
23670208|NCT00085735|66176125|FG004|Overall Study|Lack of Efficacy|4|||
23670209|NCT00085735|66176126|FG005|Overall Study|Lack of Efficacy|3|||
23670210|NCT00085735|66176121|FG000|Overall Study|Lost to Follow-up|0|||
23670211|NCT00085735|66176122|FG001|Overall Study|Lost to Follow-up|1|||
23670212|NCT00085735|66176123|FG002|Overall Study|Lost to Follow-up|0|||
23670213|NCT00085735|66176124|FG003|Overall Study|Lost to Follow-up|0|||
23670214|NCT00085735|66176125|FG004|Overall Study|Lost to Follow-up|1|||
23670215|NCT00085735|66176126|FG005|Overall Study|Lost to Follow-up|0|||
23670216|NCT00085735|66176121|FG000|Overall Study|Physician Decision|2|||
23670217|NCT00085735|66176122|FG001|Overall Study|Physician Decision|3|||
23670218|NCT00085735|66176123|FG002|Overall Study|Physician Decision|2|||
23670219|NCT00085735|66176124|FG003|Overall Study|Physician Decision|3|||
23670220|NCT00085735|66176125|FG004|Overall Study|Physician Decision|11|||
23670221|NCT00085735|66176126|FG005|Overall Study|Physician Decision|8|||
23670222|NCT00085735|66176121|FG000|Overall Study|Protocol Violation|1|||
23670223|NCT00085735|66176122|FG001|Overall Study|Protocol Violation|0|||
23670224|NCT00085735|66176123|FG002|Overall Study|Protocol Violation|0|||
23670225|NCT00085735|66176124|FG003|Overall Study|Protocol Violation|0|||
23670226|NCT00085735|66176125|FG004|Overall Study|Protocol Violation|0|||
23383834|NCT00577408|65148310|FG001|Overall Study|Refused Oral Naltrexone|1|||
23383835|NCT00577408|65148309|FG000|Overall Study|Moved out of state|0|||
23383836|NCT00577408|65148310|FG001|Overall Study|Moved out of state|1|||
23383837|NCT00577408|65148309|FG000|Overall Study|Scheduling Issues|0|||
23383838|NCT00577408|65148310|FG001|Overall Study|Scheduling Issues|3|||
23383839|NCT00577408|65148309|FG000|Overall Study|Death|0|||
23383840|NCT00577408|65148310|FG001|Overall Study|Death|1|||
23383841|NCT00577408|65148309|FG000|Overall Study|Psychiatric hospitalization|0|||
23383842|NCT00577408|65148310|FG001|Overall Study|Psychiatric hospitalization|1|||
23383843|NCT00724503|65148311|FG000|Overall Study|Lost to Follow-up|4|||
23383844|NCT00724503|65148312|FG001|Overall Study|Lost to Follow-up|8|||
23383845|NCT00724503|65148311|FG000|Overall Study|Withdrawal by Subject|11|||
23383846|NCT00724503|65148312|FG001|Overall Study|Withdrawal by Subject|23|||
23383847|NCT00724503|65148311|FG000|Overall Study|Death|190|||
23383848|NCT00724503|65148312|FG001|Overall Study|Death|182|||
23383849|NCT00724503|65148311|FG000|Overall Study|Adverse Event|1|||
23383850|NCT00724503|65148312|FG001|Overall Study|Adverse Event|0|||
23383851|NCT00724503|65148311|FG000|Overall Study|Not otherwise specified|4|||
23383852|NCT00724503|65148312|FG001|Overall Study|Not otherwise specified|7|||
23383853|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
23383854|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
23383855|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
23383856|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
23383857|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
23383858|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
23383859|NCT03983109|65148319|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
23383860|NCT03983109|65148320|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
23383861|NCT01943825|65148321|FG000|Overall Study|Lost to Follow-up|9|||
23383862|NCT01943825|65148322|FG001|Overall Study|Lost to Follow-up|3|||
23383863|NCT01943825|65148323|FG002|Overall Study|Lost to Follow-up|12|||
23383864|NCT01943825|65148324|FG003|Overall Study|Lost to Follow-up|8|||
23383865|NCT01943825|65148321|FG000|Overall Study|Withdrawal by Subject|1|||
23383866|NCT01943825|65148322|FG001|Overall Study|Withdrawal by Subject|0|||
23383867|NCT01943825|65148323|FG002|Overall Study|Withdrawal by Subject|3|||
23383868|NCT01943825|65148324|FG003|Overall Study|Withdrawal by Subject|2|||
23383869|NCT01943825|65148321|FG000|Overall Study|Other than specified above|0|||
23383870|NCT01943825|65148322|FG001|Overall Study|Other than specified above|1|||
23383871|NCT01943825|65148323|FG002|Overall Study|Other than specified above|0|||
23670227|NCT00085735|66176126|FG005|Overall Study|Protocol Violation|0|||
23670228|NCT00085735|66176121|FG000|Overall Study|Withdrawal by Subject|1|||
23670229|NCT00085735|66176122|FG001|Overall Study|Withdrawal by Subject|0|||
23670230|NCT00085735|66176123|FG002|Overall Study|Withdrawal by Subject|4|||
23670231|NCT00085735|66176124|FG003|Overall Study|Withdrawal by Subject|5|||
23670232|NCT00085735|66176125|FG004|Overall Study|Withdrawal by Subject|7|||
23670233|NCT00085735|66176126|FG005|Overall Study|Withdrawal by Subject|8|||
23670234|NCT00085735|66176121|FG000|Overall Study|Patient ineligible|1|||
23383872|NCT01943825|65148324|FG003|Overall Study|Other than specified above|1|||
23383873|NCT01452789|65148327|FG000|Overall Study|Withdrawal by Subject|3|||
23383874|NCT01452789|65148328|FG001|Overall Study|Withdrawal by Subject|2|||
23383875|NCT00604383|65148329|FG000|Overall Study|Withdrawal by Subject|33|||
23383876|NCT00604383|65148330|FG001|Overall Study|Withdrawal by Subject|31|||
23383877|NCT00604383|65148329|FG000|Overall Study|Lost to Follow-up|24|||
23383878|NCT00604383|65148330|FG001|Overall Study|Lost to Follow-up|19|||
23383879|NCT00604383|65148329|FG000|Overall Study|Death|14|||
23670235|NCT00085735|66176122|FG001|Overall Study|Patient ineligible|0|||
23670236|NCT00085735|66176123|FG002|Overall Study|Patient ineligible|3|||
23670237|NCT00085735|66176124|FG003|Overall Study|Patient ineligible|7|||
23670238|NCT00085735|66176125|FG004|Overall Study|Patient ineligible|17|||
23670239|NCT00085735|66176126|FG005|Overall Study|Patient ineligible|8|||
23670240|NCT00085735|66176121|FG000|Overall Study|Excess residual disease|2|||
23383880|NCT00604383|65148330|FG001|Overall Study|Death|22|||
23383881|NCT00604383|65148329|FG000|Overall Study|Adverse Event|16|||
23383882|NCT00604383|65148330|FG001|Overall Study|Adverse Event|9|||
23383883|NCT00604383|65148329|FG000|Overall Study|Physician Decision|0|||
23383884|NCT00604383|65148330|FG001|Overall Study|Physician Decision|3|||
23383885|NCT01198548|65148333|FG000|Overall Study|Disease Progression|9|||
23383886|NCT01198548|65148333|FG000|Overall Study|Administrative Decision|1|||
23383887|NCT04706403|65148336|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
23383888|NCT04706403|65148337|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
23383889|NCT04706403|65148338|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
23383890|NCT04706403|65148339|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
23383891|NCT04706403|65148340|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
23383892|NCT00309244|65148341|FG000|Overall Study|Adverse Event|29|||
23383893|NCT00309244|65148342|FG001|Overall Study|Adverse Event|12|||
23383894|NCT00309244|65148341|FG000|Overall Study|Lost to Follow-up|6|||
23383895|NCT00309244|65148342|FG001|Overall Study|Lost to Follow-up|22|||
23383896|NCT00309244|65148341|FG000|Overall Study|Physician Decision|5|||
23383897|NCT00309244|65148342|FG001|Overall Study|Physician Decision|8|||
23383898|NCT00309244|65148341|FG000|Overall Study|Protocol Violation|6|||
23383899|NCT00309244|65148342|FG001|Overall Study|Protocol Violation|3|||
23383900|NCT00309244|65148341|FG000|Overall Study|Withdrawal by Subject|50|||
23383901|NCT00309244|65148342|FG001|Overall Study|Withdrawal by Subject|32|||
23383902|NCT00309244|65148341|FG000|Overall Study|Various|7|||
23383903|NCT00309244|65148342|FG001|Overall Study|Various|7|||
23383904|NCT00309244|65148341|FG000|Overall Study|Randomized but not dosed|11|||
23383905|NCT00309244|65148342|FG001|Overall Study|Randomized but not dosed|12|||
23383906|NCT00309244|65148341|FG000|Overall Study|Death|4|||
23383907|NCT00309244|65148342|FG001|Overall Study|Death|1|||
23383908|NCT03828383|65151433|FG000|Overall Study|Lost to Follow-up|3|||
23383909|NCT03828383|65151434|FG001|Overall Study|Lost to Follow-up|2|||
23383910|NCT03828383|65151433|FG000|Overall Study|Withdrawal by Subject|4|||
23383911|NCT03828383|65151434|FG001|Overall Study|Withdrawal by Subject|5|||
23383912|NCT02320396|65151442|FG000|Overall Study|Adverse Event|2|||
23383913|NCT02320396|65151443|FG001|Overall Study|Adverse Event|2|||
23383914|NCT02320396|65151442|FG000|Overall Study|Pregnancy|0|||
23383915|NCT02320396|65151443|FG001|Overall Study|Pregnancy|1|||
23383916|NCT02320396|65151442|FG000|Overall Study|Protocol Violation|0|||
23383917|NCT02320396|65151443|FG001|Overall Study|Protocol Violation|1|||
23383918|NCT02320396|65151442|FG000|Overall Study|Withdrawal by Subject|2|||
23383919|NCT02320396|65151443|FG001|Overall Study|Withdrawal by Subject|0|||
23383920|NCT00977561|65151444|FG000|Overall Study|Death|3|||
23383921|NCT00977561|65151445|FG001|Overall Study|Death|2|||
23383922|NCT00977561|65151444|FG000|Overall Study|Study terminated|0|||
23383923|NCT00977561|65151445|FG001|Overall Study|Study terminated|2|||
23383924|NCT00977561|65151444|FG000|Overall Study|Other|2|||
23383925|NCT00977561|65151445|FG001|Overall Study|Other|0|||
23383926|NCT03722030|65151446|FG000|Overall Study|Withdrawal by Subject|1|||
23383927|NCT03722030|65151447|FG001|Overall Study|Withdrawal by Subject|0|||
23383928|NCT00032487|65151453|FG000|Overall Study|Withdrawal by Subject|67|||
23383929|NCT00032487|65151454|FG001|Overall Study|Withdrawal by Subject|43|||
23383930|NCT00032487|65151453|FG000|Overall Study|Adverse Event|3|||
23383931|NCT00032487|65151454|FG001|Overall Study|Adverse Event|7|||
23383932|NCT00032487|65151453|FG000|Overall Study|Lost to Follow-up|57|||
23383933|NCT00032487|65151454|FG001|Overall Study|Lost to Follow-up|58|||
23383934|NCT00032487|65151453|FG000|Overall Study|Had other reason|12|||
23383935|NCT00032487|65151454|FG001|Overall Study|Had other reason|12|||
23383936|NCT00560404|65151459|FG000|Overall Study|Adverse Event|2|||
23383937|NCT00560404|65151460|FG001|Overall Study|Adverse Event|3|||
23383938|NCT00560404|65151459|FG000|Overall Study|Death|3|||
23383939|NCT00560404|65151460|FG001|Overall Study|Death|3|||
23383940|NCT00560404|65151459|FG000|Overall Study|Protocol Violation|12|||
23383941|NCT00560404|65151460|FG001|Overall Study|Protocol Violation|7|||
23383942|NCT00560404|65151459|FG000|Overall Study|Administrative Reasons|1|||
23383943|NCT00560404|65151460|FG001|Overall Study|Administrative Reasons|1|||
23383944|NCT00560404|65151459|FG000|Overall Study|Withdrew Consent|4|||
23383945|NCT00560404|65151460|FG001|Overall Study|Withdrew Consent|0|||
23383946|NCT00560404|65151459|FG000|Overall Study|Failure to return|1|||
23383947|NCT00560404|65151460|FG001|Overall Study|Failure to return|2|||
23383948|NCT00560404|65151459|FG000|Overall Study|Other withdrawal reason|13|||
23383949|NCT00560404|65151460|FG001|Overall Study|Other withdrawal reason|5|||
23383950|NCT00004859|65151461|FG000|Overall Study|Lack of Efficacy|43|||
23383951|NCT00004859|65151462|FG001|Overall Study|Lack of Efficacy|113|||
23383952|NCT00004859|65151461|FG000|Overall Study|Adverse Event|31|||
23670241|NCT00085735|66176122|FG001|Overall Study|Excess residual disease|2|||
23383953|NCT00004859|65151462|FG001|Overall Study|Adverse Event|93|||
23383954|NCT00004859|65151461|FG000|Overall Study|Death|5|||
23383955|NCT00004859|65151462|FG001|Overall Study|Death|5|||
23493175|NCT01050543|65551376|FG000|Overall Study|Protocol Violation|0|||
23493176|NCT01050543|65551377|FG001|Overall Study|Protocol Violation|1|||
23383956|NCT00004859|65151461|FG000|Overall Study|Withdrawal by Subject|7|||
23383957|NCT00004859|65151462|FG001|Overall Study|Withdrawal by Subject|33|||
23383958|NCT00004859|65151461|FG000|Overall Study|Protocol Violation|2|||
23383959|NCT00004859|65151462|FG001|Overall Study|Protocol Violation|2|||
23383960|NCT00004859|65151461|FG000|Overall Study|other disease|0|||
23383961|NCT00004859|65151462|FG001|Overall Study|other disease|3|||
23383962|NCT00004859|65151461|FG000|Overall Study|error|3|||
23383963|NCT00004859|65151462|FG001|Overall Study|error|1|||
23383964|NCT00004859|65151461|FG000|Overall Study|missing data|14|||
23383965|NCT00004859|65151462|FG001|Overall Study|missing data|11|||
23383966|NCT00004859|65151461|FG000|Overall Study|Other|13|||
23383967|NCT00004859|65151462|FG001|Overall Study|Other|21|||
23383968|NCT01316900|65151482|FG000|Overall Study|Adverse Event|10|||
23383969|NCT01316900|65151483|FG001|Overall Study|Adverse Event|10|||
23383970|NCT01316900|65151484|FG002|Overall Study|Adverse Event|15|||
23383971|NCT01316900|65151485|FG003|Overall Study|Adverse Event|9|||
23670242|NCT00085735|66176123|FG002|Overall Study|Excess residual disease|1|||
23670243|NCT00085735|66176124|FG003|Overall Study|Excess residual disease|1|||
23670244|NCT00085735|66176125|FG004|Overall Study|Excess residual disease|1|||
23670245|NCT00085735|66176126|FG005|Overall Study|Excess residual disease|4|||
23670246|NCT00085735|66176121|FG000|Overall Study|Reason not documented|1|||
23670247|NCT00085735|66176122|FG001|Overall Study|Reason not documented|0|||
23670248|NCT00085735|66176123|FG002|Overall Study|Reason not documented|1|||
23670249|NCT00085735|66176124|FG003|Overall Study|Reason not documented|0|||
23670250|NCT00085735|66176125|FG004|Overall Study|Reason not documented|1|||
23670251|NCT00085735|66176126|FG005|Overall Study|Reason not documented|0|||
23670252|NCT00085735|66176121|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
23670253|NCT00085735|66176122|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
23670254|NCT00085735|66176123|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
23670255|NCT00085735|66176124|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
23670256|NCT00085735|66176125|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
23670257|NCT00085735|66176126|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
23670258|NCT01806779|66176131|FG000|Overall Study|Physician Decision|2|||
23670259|NCT01806779|66176132|FG001|Overall Study|Physician Decision|0|||
23670260|NCT01806779|66176133|FG002|Overall Study|Physician Decision|1|||
23670261|NCT01806779|66176131|FG000|Overall Study|Lack of Efficacy|1|||
23670262|NCT01806779|66176132|FG001|Overall Study|Lack of Efficacy|1|||
23670263|NCT01806779|66176133|FG002|Overall Study|Lack of Efficacy|0|||
23670264|NCT01806779|66176131|FG000|Overall Study|Lost to Follow-up|19|||
23670265|NCT01806779|66176132|FG001|Overall Study|Lost to Follow-up|20|||
23670266|NCT01806779|66176133|FG002|Overall Study|Lost to Follow-up|0|||
23670267|NCT01806779|66176131|FG000|Overall Study|Withdrawal by Subject|20|||
23670268|NCT01806779|66176132|FG001|Overall Study|Withdrawal by Subject|23|||
23670269|NCT01806779|66176133|FG002|Overall Study|Withdrawal by Subject|22|||
23670270|NCT02500121|66176134|FG000|Overall Study|Lost to Follow-up|0|||
23670271|NCT02500121|66176135|FG001|Overall Study|Lost to Follow-up|1|||
23670272|NCT02500121|66176134|FG000|Overall Study|Withdrawal by Subject|1|||
23670273|NCT02500121|66176135|FG001|Overall Study|Withdrawal by Subject|1|||
23670274|NCT02500121|66176134|FG000|Overall Study|Death|26|||
23670275|NCT02500121|66176135|FG001|Overall Study|Death|24|||
23670276|NCT00914927|66176136|FG000|Overall Study|Adverse Event|0|||
23670277|NCT00914927|66176137|FG001|Overall Study|Adverse Event|0|||
23383972|NCT01316900|65151482|FG000|Overall Study|Lack of Efficacy|17|||
23383973|NCT01316900|65151483|FG001|Overall Study|Lack of Efficacy|9|||
23383974|NCT01316900|65151484|FG002|Overall Study|Lack of Efficacy|5|||
23383975|NCT01316900|65151485|FG003|Overall Study|Lack of Efficacy|7|||
23670278|NCT00914927|66176138|FG002|Overall Study|Adverse Event|0|||
23383976|NCT01316900|65151482|FG000|Overall Study|Protocol Violation|7|||
23383977|NCT01316900|65151483|FG001|Overall Study|Protocol Violation|1|||
23383978|NCT01316900|65151484|FG002|Overall Study|Protocol Violation|4|||
23383979|NCT01316900|65151485|FG003|Overall Study|Protocol Violation|0|||
23383980|NCT01316900|65151482|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
23383981|NCT01316900|65151483|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
23383982|NCT01316900|65151484|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
23383983|NCT01316900|65151485|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
23670279|NCT00914927|66176139|FG003|Overall Study|Adverse Event|0|||
23383984|NCT01316900|65151482|FG000|Overall Study|Lost to Follow-up|1|||
23383985|NCT01316900|65151483|FG001|Overall Study|Lost to Follow-up|0|||
23383986|NCT01316900|65151484|FG002|Overall Study|Lost to Follow-up|1|||
23383987|NCT01316900|65151485|FG003|Overall Study|Lost to Follow-up|1|||
23670280|NCT00914927|66176140|FG004|Overall Study|Adverse Event|1|||
23670281|NCT00914927|66176141|FG005|Overall Study|Adverse Event|0|||
23383988|NCT01316900|65151482|FG000|Overall Study|Withdrawal by Subject|7|||
23670282|NCT00914927|66176142|FG006|Overall Study|Adverse Event|0|||
23670283|NCT00914927|66176136|FG000|Overall Study|Withdrawal by Subject|0|||
23383989|NCT01316900|65151483|FG001|Overall Study|Withdrawal by Subject|8|||
23383990|NCT01316900|65151484|FG002|Overall Study|Withdrawal by Subject|6|||
23670284|NCT00914927|66176137|FG001|Overall Study|Withdrawal by Subject|1|||
23383991|NCT01316900|65151485|FG003|Overall Study|Withdrawal by Subject|9|||
23383992|NCT02370394|65151498|FG000|Overall Study|Lost to Follow-up|2|||
23383993|NCT02370394|65151499|FG001|Overall Study|Lost to Follow-up|1|||
23383994|NCT02370394|65151498|FG000|Overall Study|Withdrawal by Subject|0|||
23383995|NCT02370394|65151499|FG001|Overall Study|Withdrawal by Subject|1|||
23383996|NCT01121575|65151502|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
23383997|NCT01121575|65151503|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
23670285|NCT00914927|66176138|FG002|Overall Study|Withdrawal by Subject|0|||
23670286|NCT00914927|66176139|FG003|Overall Study|Withdrawal by Subject|1|||
23670287|NCT00914927|66176140|FG004|Overall Study|Withdrawal by Subject|0|||
23670288|NCT00914927|66176141|FG005|Overall Study|Withdrawal by Subject|0|||
23670289|NCT00914927|66176142|FG006|Overall Study|Withdrawal by Subject|0|||
23383998|NCT01121575|65151504|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
23383999|NCT01121575|65151505|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
23384000|NCT01121575|65151506|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
23384001|NCT01121575|65151507|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
23384002|NCT01121575|65151502|FG000|Overall Study|Unspecified Reasons|8|||
23384003|NCT01121575|65151503|FG001|Overall Study|Unspecified Reasons|6|||
23384004|NCT01121575|65151504|FG002|Overall Study|Unspecified Reasons|7|||
23384005|NCT01121575|65151505|FG003|Overall Study|Unspecified Reasons|5|||
23384006|NCT01121575|65151506|FG004|Overall Study|Unspecified Reasons|13|||
23384007|NCT01121575|65151507|FG005|Overall Study|Unspecified Reasons|10|||
23384008|NCT01121575|65151502|FG000|Overall Study|Death|6|||
23384009|NCT01121575|65151503|FG001|Overall Study|Death|0|||
23384010|NCT01121575|65151504|FG002|Overall Study|Death|0|||
23384011|NCT01121575|65151505|FG003|Overall Study|Death|1|||
23384012|NCT01121575|65151506|FG004|Overall Study|Death|7|||
23384013|NCT01121575|65151507|FG005|Overall Study|Death|1|||
23384014|NCT02280499|65151509|FG000|Overall Study|Death|14|||
23384015|NCT02280499|65151509|FG000|Overall Study|Lost to Follow-up|42|||
23384016|NCT02280499|65151509|FG000|Overall Study|Adverse Event|5|||
23384017|NCT03558672|65151510|FG000|Overall Study|Study Early Termination|10|||
23384018|NCT01186419|65151511|FG000|Overall Study|Withdrawal by Subject|5|||
23384019|NCT01186419|65151512|FG001|Overall Study|Withdrawal by Subject|3|||
23384020|NCT01186419|65151511|FG000|Overall Study|Adverse Event|1|||
23384021|NCT01186419|65151512|FG001|Overall Study|Adverse Event|2|||
23384022|NCT01186419|65151511|FG000|Overall Study|Physician Decision|0|||
23384023|NCT01186419|65151512|FG001|Overall Study|Physician Decision|3|||
23384024|NCT01186419|65151511|FG000|Overall Study|Other|1|||
23384025|NCT01186419|65151512|FG001|Overall Study|Other|1|||
23384026|NCT01666314|65151513|FG000|Overall Study|Adverse Event|3|||
23384027|NCT01666314|65151514|FG001|Overall Study|Adverse Event|13|||
23384028|NCT01666314|65151515|FG002|Overall Study|Adverse Event|7|||
23384029|NCT01666314|65151516|FG003|Overall Study|Adverse Event|7|||
23384030|NCT01666314|65151513|FG000|Overall Study|Progressive Disease|11|||
23384031|NCT01666314|65151514|FG001|Overall Study|Progressive Disease|9|||
23384032|NCT01666314|65151515|FG002|Overall Study|Progressive Disease|19|||
23384033|NCT01666314|65151516|FG003|Overall Study|Progressive Disease|20|||
23384034|NCT01666314|65151513|FG000|Overall Study|Symptomatic Deterioration|1|||
23384035|NCT01666314|65151514|FG001|Overall Study|Symptomatic Deterioration|0|||
23384036|NCT01666314|65151515|FG002|Overall Study|Symptomatic Deterioration|2|||
23384037|NCT01666314|65151516|FG003|Overall Study|Symptomatic Deterioration|0|||
23384038|NCT01666314|65151513|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
23384039|NCT01666314|65151514|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
23384040|NCT01666314|65151515|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
23670290|NCT00914927|66176136|FG000|Overall Study|Lost to Follow-up|0|||
23670291|NCT00914927|66176137|FG001|Overall Study|Lost to Follow-up|0|||
23384041|NCT01666314|65151516|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
23384042|NCT01666314|65151513|FG000|Overall Study|Withdrawal by Subject|1|||
23384043|NCT01666314|65151514|FG001|Overall Study|Withdrawal by Subject|1|||
23384044|NCT01666314|65151515|FG002|Overall Study|Withdrawal by Subject|2|||
23384045|NCT01666314|65151516|FG003|Overall Study|Withdrawal by Subject|3|||
23384046|NCT01666314|65151513|FG000|Overall Study|Reason not Specified|10|||
23384047|NCT01666314|65151514|FG001|Overall Study|Reason not Specified|7|||
23670292|NCT00914927|66176138|FG002|Overall Study|Lost to Follow-up|0|||
23670293|NCT00914927|66176139|FG003|Overall Study|Lost to Follow-up|1|||
23670294|NCT00914927|66176140|FG004|Overall Study|Lost to Follow-up|0|||
23670295|NCT00914927|66176141|FG005|Overall Study|Lost to Follow-up|0|||
23670296|NCT00914927|66176142|FG006|Overall Study|Lost to Follow-up|0|||
23670297|NCT00914927|66176136|FG000|Overall Study|Administrative/Other|2|||
23670298|NCT00914927|66176137|FG001|Overall Study|Administrative/Other|1|||
23670299|NCT00914927|66176138|FG002|Overall Study|Administrative/Other|0|||
23670300|NCT00914927|66176139|FG003|Overall Study|Administrative/Other|0|||
23670301|NCT00914927|66176140|FG004|Overall Study|Administrative/Other|1|||
23670302|NCT00914927|66176141|FG005|Overall Study|Administrative/Other|0|||
23670303|NCT00914927|66176142|FG006|Overall Study|Administrative/Other|0|||
23670304|NCT04225923|66176144|FG000|Overall Study|Protocol Violation|1|||
23670305|NCT04225923|66176145|FG001|Overall Study|Protocol Violation|0|||
23670306|NCT04225923|66176146|FG002|Overall Study|Protocol Violation|1|||
23670307|NCT04225923|66176144|FG000|Overall Study|Withdrawal by Subject|4|||
23670308|NCT04225923|66176145|FG001|Overall Study|Withdrawal by Subject|1|||
23670309|NCT04225923|66176146|FG002|Overall Study|Withdrawal by Subject|3|||
23670310|NCT04225923|66176144|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
23670311|NCT04225923|66176145|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
23670312|NCT04225923|66176146|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
23670313|NCT01661140|66176147|FG000|Open-Label Period|Adverse Event|44|||
23670314|NCT01661140|66176148|FG001|Open-Label Period|Adverse Event|0|||
23670315|NCT01661140|66176149|FG002|Open-Label Period|Adverse Event|0|||
23670316|NCT01661140|66176147|FG000|Open-Label Period|Protocol Violation|3|||
23670317|NCT01661140|66176148|FG001|Open-Label Period|Protocol Violation|0|||
23670318|NCT01661140|66176149|FG002|Open-Label Period|Protocol Violation|0|||
23670319|NCT01661140|66176147|FG000|Open-Label Period|Withdrawal by Subject|5|||
23670320|NCT01661140|66176148|FG001|Open-Label Period|Withdrawal by Subject|0|||
23670321|NCT01661140|66176149|FG002|Open-Label Period|Withdrawal by Subject|0|||
23670322|NCT01661140|66176147|FG000|Open-Label Period|Investigator Decision|3|||
23670323|NCT01661140|66176148|FG001|Open-Label Period|Investigator Decision|0|||
23670324|NCT01661140|66176149|FG002|Open-Label Period|Investigator Decision|0|||
23670325|NCT01661140|66176147|FG000|Open-Label Period|Death|1|||
23670326|NCT01661140|66176148|FG001|Open-Label Period|Death|0|||
23670327|NCT01661140|66176149|FG002|Open-Label Period|Death|0|||
23670328|NCT01661140|66176147|FG000|Open-Label Period|Administrative/Other|1|||
23670329|NCT01661140|66176148|FG001|Open-Label Period|Administrative/Other|0|||
23670330|NCT01661140|66176149|FG002|Open-Label Period|Administrative/Other|0|||
23670331|NCT01661140|66176147|FG000|Open-Label Period|Sponsor termination|16|||
23670332|NCT01661140|66176148|FG001|Open-Label Period|Sponsor termination|0|||
23670333|NCT01661140|66176149|FG002|Open-Label Period|Sponsor termination|0|||
23670334|NCT01661140|66176147|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
23670335|NCT01661140|66176148|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
23493177|NCT01050543|65551376|FG000|Overall Study|Administrative|4|||
23670336|NCT01661140|66176149|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
23670337|NCT01661140|66176147|FG000|Open-Label Period|Lost to Follow-up|2|||
23670338|NCT01661140|66176148|FG001|Open-Label Period|Lost to Follow-up|0|||
23384048|NCT01666314|65151515|FG002|Overall Study|Reason not Specified|5|||
23384049|NCT01666314|65151516|FG003|Overall Study|Reason not Specified|5|||
23384050|NCT01898091|65151517|FG000|Overall Study|Lost to Follow-up|1|||
23384051|NCT01898091|65151518|FG001|Overall Study|Lost to Follow-up|1|||
23384052|NCT01898091|65151517|FG000|Overall Study|Withdrawal by Subject|1|||
23384053|NCT01898091|65151518|FG001|Overall Study|Withdrawal by Subject|5|||
23384054|NCT01479530|65151519|FG000|Overall Study|Adverse Event|5|||
23384055|NCT01479530|65151520|FG001|Overall Study|Adverse Event|6|||
23384056|NCT01479530|65151519|FG000|Overall Study|Lack of Efficacy|0|||
23384057|NCT01479530|65151520|FG001|Overall Study|Lack of Efficacy|1|||
23384058|NCT01479530|65151519|FG000|Overall Study|Protocol Violation|2|||
23384059|NCT01479530|65151520|FG001|Overall Study|Protocol Violation|3|||
23384060|NCT01479530|65151519|FG000|Overall Study|Withdrawal of Consent|3|||
23384061|NCT01479530|65151520|FG001|Overall Study|Withdrawal of Consent|2|||
23384062|NCT00416949|65151521|FG000|Overall Study|Patients refused to participate|5|||
23384063|NCT01108055|65151523|FG000|Overall Study|Ineligible|11|||
23384064|NCT01108055|65151523|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
23384065|NCT01968785|65151524|FG000|Overall Study|Withdrawal by Subject|1|||
23384066|NCT01968785|65151525|FG001|Overall Study|Withdrawal by Subject|0|||
23384067|NCT02547987|65151526|FG000|Overall Study|Withdrawal by Subject|1|||
23384068|NCT02547987|65151526|FG000|Overall Study|Adverse Event|2|||
23384069|NCT03336866|65151527|FG000|Overall Study|Lost to Follow-up|2|||
23384070|NCT03336866|65151528|FG001|Overall Study|Lost to Follow-up|0|||
23384071|NCT03336866|65151529|FG002|Overall Study|Lost to Follow-up|3|||
23384072|NCT03336866|65151527|FG000|Overall Study|Withdrawal by Subject|1|||
23384073|NCT03336866|65151528|FG001|Overall Study|Withdrawal by Subject|1|||
23384074|NCT03336866|65151529|FG002|Overall Study|Withdrawal by Subject|0|||
23670339|NCT01661140|66176149|FG002|Open-Label Period|Lost to Follow-up|0|||
23384075|NCT03336866|65151527|FG000|Overall Study|Noncompliance with clinic house rules|0|||
23384076|NCT03336866|65151528|FG001|Overall Study|Noncompliance with clinic house rules|0|||
23384077|NCT03336866|65151529|FG002|Overall Study|Noncompliance with clinic house rules|1|||
23384078|NCT00284934|65151530|FG000|Overall Study|Adverse Event|1|||
23670340|NCT01661140|66176147|FG000|Double-Blind Period|Refused Treatment|0|||
23670341|NCT01661140|66176148|FG001|Double-Blind Period|Refused Treatment|0|||
23670342|NCT01661140|66176149|FG002|Double-Blind Period|Refused Treatment|1|||
23670343|NCT01661140|66176147|FG000|Double-Blind Period|Adverse Event|0|||
23670344|NCT01661140|66176148|FG001|Double-Blind Period|Adverse Event|16|||
23670345|NCT01661140|66176149|FG002|Double-Blind Period|Adverse Event|18|||
23670346|NCT01661140|66176147|FG000|Double-Blind Period|Protocol Violation|0|||
23670347|NCT01661140|66176148|FG001|Double-Blind Period|Protocol Violation|2|||
23670348|NCT01661140|66176149|FG002|Double-Blind Period|Protocol Violation|3|||
23670349|NCT01661140|66176147|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23670350|NCT01661140|66176148|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23670351|NCT01661140|66176149|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23670352|NCT01661140|66176147|FG000|Double-Blind Period|Investigator's Decision|0|||
23670353|NCT01661140|66176148|FG001|Double-Blind Period|Investigator's Decision|1|||
23670354|NCT01661140|66176149|FG002|Double-Blind Period|Investigator's Decision|2|||
23670355|NCT01661140|66176147|FG000|Double-Blind Period|Sponsor Termination|0|||
23670356|NCT01661140|66176148|FG001|Double-Blind Period|Sponsor Termination|14|||
23670357|NCT01661140|66176149|FG002|Double-Blind Period|Sponsor Termination|17|||
23670358|NCT01661140|66176147|FG000|Double-Blind Period|Administrative/Other|0|||
23670359|NCT01661140|66176148|FG001|Double-Blind Period|Administrative/Other|7|||
23670360|NCT01661140|66176149|FG002|Double-Blind Period|Administrative/Other|6|||
23670361|NCT03178487|66176150|FG000|Period 1|Adverse Event|1|||
23670362|NCT03178487|66176151|FG001|Period 1|Adverse Event|2|||
23670363|NCT03178487|66176150|FG000|Period 1|Withdrawal by Subject|2|||
23670364|NCT03178487|66176151|FG001|Period 1|Withdrawal by Subject|1|||
23670365|NCT03178487|66176150|FG000|Period 1|Lost to Follow-up|1|||
23670366|NCT03178487|66176151|FG001|Period 1|Lost to Follow-up|0|||
23670367|NCT03178487|66176150|FG000|Period 1|Other|0|||
23670368|NCT03178487|66176151|FG001|Period 1|Other|1|||
23670369|NCT03178487|66176150|FG000|Period 2|Adverse Event|4|||
23670370|NCT03178487|66176151|FG001|Period 2|Adverse Event|4|||
23670371|NCT03178487|66176150|FG000|Period 2|Withdrawal by Subject|6|||
23670372|NCT03178487|66176151|FG001|Period 2|Withdrawal by Subject|6|||
23384079|NCT00284934|65151531|FG001|Overall Study|Adverse Event|2|||
23384080|NCT00284934|65151530|FG000|Overall Study|Other reasons|3|||
23384081|NCT00284934|65151531|FG001|Overall Study|Other reasons|1|||
23670373|NCT03178487|66176150|FG000|Period 2|Lost to Follow-up|2|||
23670374|NCT03178487|66176151|FG001|Period 2|Lost to Follow-up|2|||
23670375|NCT03178487|66176150|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
23670376|NCT03178487|66176151|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
23670377|NCT03178487|66176150|FG000|Period 2|Other|8|||
23670378|NCT03178487|66176151|FG001|Period 2|Other|7|||
23670379|NCT00457015|66176153|FG000|Overall Study|Left study site against medical advice|0|||
23384082|NCT02384460|65151532|FG000|Overall Study|Protocol Violation|0|||
23384083|NCT02384460|65151533|FG001|Overall Study|Protocol Violation|1|||
23670380|NCT00457015|66176154|FG001|Overall Study|Left study site against medical advice|1|||
23670381|NCT01006265|66176155|FG000|Overall Study|Lost to Follow-up|1|||
23670382|NCT01006265|66176156|FG001|Overall Study|Lost to Follow-up|0|||
23670383|NCT01006265|66176157|FG002|Overall Study|Lost to Follow-up|1|||
23670384|NCT01006265|66176158|FG003|Overall Study|Lost to Follow-up|0|||
23670385|NCT01006265|66176155|FG000|Overall Study|Withdrawal by Subject|4|||
23670386|NCT01006265|66176156|FG001|Overall Study|Withdrawal by Subject|7|||
23670387|NCT01006265|66176157|FG002|Overall Study|Withdrawal by Subject|5|||
23670388|NCT01006265|66176158|FG003|Overall Study|Withdrawal by Subject|5|||
23670389|NCT01006265|66176155|FG000|Overall Study|Administrative reason|1|||
23670390|NCT01006265|66176156|FG001|Overall Study|Administrative reason|2|||
23670391|NCT01006265|66176157|FG002|Overall Study|Administrative reason|3|||
23670392|NCT01006265|66176158|FG003|Overall Study|Administrative reason|0|||
23670393|NCT03313076|66176159|FG000|Overall Study|Withdrawal by Subject|2|||
23670394|NCT03313076|66176160|FG001|Overall Study|Withdrawal by Subject|0|||
23384084|NCT02384460|65151532|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
23384085|NCT02384460|65151533|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
23384086|NCT02384460|65151532|FG000|Overall Study|Adverse Event|5|||
23384087|NCT02384460|65151533|FG001|Overall Study|Adverse Event|2|||
23384088|NCT02384460|65151532|FG000|Overall Study|Withdrawal by Subject|0|||
23384089|NCT02384460|65151533|FG001|Overall Study|Withdrawal by Subject|3|||
23384090|NCT02384460|65151532|FG000|Overall Study|Elective medical treatment|1|||
23384091|NCT02384460|65151533|FG001|Overall Study|Elective medical treatment|0|||
23384092|NCT02384460|65151532|FG000|Overall Study|Non-compliance|1|||
23384093|NCT02384460|65151533|FG001|Overall Study|Non-compliance|0|||
23384094|NCT00474968|65151534|FG000|Overall Study|Withdrawal by Subject|8|||
23384095|NCT00474968|65151535|FG001|Overall Study|Withdrawal by Subject|7|||
23384096|NCT00474968|65151534|FG000|Overall Study|Protocol Violation|9|||
23384097|NCT00474968|65151535|FG001|Overall Study|Protocol Violation|8|||
23384098|NCT00474968|65151534|FG000|Overall Study|Sample not collected|1|||
23384099|NCT00474968|65151535|FG001|Overall Study|Sample not collected|1|||
23384100|NCT00127933|65151540|FG000|Overall Study|Randomized but not dosed|1|||
23384101|NCT00127933|65151541|FG001|Overall Study|Randomized but not dosed|0|||
23384102|NCT00964678|65151542|FG000|Overall Study|Physician Decision|4|||
23384103|NCT00327171|65151546|FG000|Overall Study|Did not receive study medication|3|||
23384104|NCT00327171|65151547|FG001|Overall Study|Did not receive study medication|0|||
23384105|NCT00327171|65151546|FG000|Overall Study|Adverse Event|23|||
23384106|NCT00327171|65151547|FG001|Overall Study|Adverse Event|23|||
23384107|NCT00327171|65151546|FG000|Overall Study|Disease progression/lack of efficacy|68|||
23384108|NCT00327171|65151547|FG001|Overall Study|Disease progression/lack of efficacy|69|||
23384109|NCT00327171|65151546|FG000|Overall Study|Investigator/participant request|1|||
23384110|NCT00327171|65151547|FG001|Overall Study|Investigator/participant request|8|||
23384111|NCT00327171|65151546|FG000|Overall Study|Clinical progression|12|||
23384112|NCT00327171|65151547|FG001|Overall Study|Clinical progression|8|||
23384113|NCT00327171|65151546|FG000|Overall Study|Undisclosed history of ischemia|0|||
23493178|NCT01050543|65551377|FG001|Overall Study|Administrative|1|||
23670395|NCT03313076|66176161|FG002|Overall Study|Withdrawal by Subject|0|||
23493179|NCT01206166|65551379|FG000|Overall Study|No evaluable data|2|||
23670396|NCT03313076|66176162|FG003|Overall Study|Withdrawal by Subject|0|||
23493180|NCT01206166|65551380|FG001|Overall Study|No evaluable data|3|||
23670397|NCT03313076|66176159|FG000|Overall Study|Lost to Follow-up|0|||
23670398|NCT03313076|66176160|FG001|Overall Study|Lost to Follow-up|2|||
23670399|NCT03313076|66176161|FG002|Overall Study|Lost to Follow-up|2|||
23670400|NCT03313076|66176162|FG003|Overall Study|Lost to Follow-up|2|||
23670401|NCT05121480|66176165|FG000|Overall Study|Lack of Efficacy|2|||
23670402|NCT05121480|66176166|FG001|Overall Study|Lack of Efficacy|2|||
23670403|NCT05121480|66176167|FG002|Overall Study|Lack of Efficacy|1|||
23670404|NCT05121480|66176168|FG003|Overall Study|Lack of Efficacy|4|||
23670405|NCT05121480|66176169|FG004|Overall Study|Lack of Efficacy|0|||
23670406|NCT05121480|66176170|FG005|Overall Study|Lack of Efficacy|1|||
23670407|NCT05121480|66176171|FG006|Overall Study|Lack of Efficacy|0|||
23670408|NCT05121480|66176172|FG007|Overall Study|Lack of Efficacy|2|||
23670409|NCT05121480|66176165|FG000|Overall Study|Treatment Failure|0|||
23670410|NCT05121480|66176166|FG001|Overall Study|Treatment Failure|2|||
23670411|NCT05121480|66176167|FG002|Overall Study|Treatment Failure|0|||
23670412|NCT05121480|66176168|FG003|Overall Study|Treatment Failure|1|||
23670413|NCT05121480|66176169|FG004|Overall Study|Treatment Failure|0|||
23670414|NCT05121480|66176170|FG005|Overall Study|Treatment Failure|0|||
23670415|NCT05121480|66176171|FG006|Overall Study|Treatment Failure|0|||
23670416|NCT05121480|66176172|FG007|Overall Study|Treatment Failure|0|||
23670417|NCT05121480|66176165|FG000|Overall Study|Adverse Event|0|||
23670418|NCT05121480|66176166|FG001|Overall Study|Adverse Event|1|||
23670419|NCT05121480|66176167|FG002|Overall Study|Adverse Event|0|||
23670420|NCT05121480|66176168|FG003|Overall Study|Adverse Event|5|||
23670421|NCT05121480|66176169|FG004|Overall Study|Adverse Event|3|||
23670422|NCT05121480|66176170|FG005|Overall Study|Adverse Event|2|||
23670423|NCT05121480|66176171|FG006|Overall Study|Adverse Event|0|||
23670424|NCT05121480|66176172|FG007|Overall Study|Adverse Event|4|||
23670425|NCT05121480|66176165|FG000|Overall Study|Withdrawal by Subject|4|||
23670426|NCT05121480|66176166|FG001|Overall Study|Withdrawal by Subject|9|||
23670427|NCT05121480|66176167|FG002|Overall Study|Withdrawal by Subject|1|||
23670428|NCT05121480|66176168|FG003|Overall Study|Withdrawal by Subject|8|||
23670429|NCT05121480|66176169|FG004|Overall Study|Withdrawal by Subject|0|||
23670430|NCT05121480|66176170|FG005|Overall Study|Withdrawal by Subject|9|||
23670431|NCT05121480|66176171|FG006|Overall Study|Withdrawal by Subject|0|||
23670432|NCT05121480|66176172|FG007|Overall Study|Withdrawal by Subject|4|||
23670433|NCT05121480|66176165|FG000|Overall Study|Non-compliance with the protocol|0|||
23670434|NCT05121480|66176166|FG001|Overall Study|Non-compliance with the protocol|0|||
23670435|NCT05121480|66176167|FG002|Overall Study|Non-compliance with the protocol|0|||
23670436|NCT05121480|66176168|FG003|Overall Study|Non-compliance with the protocol|0|||
23670437|NCT05121480|66176169|FG004|Overall Study|Non-compliance with the protocol|1|||
23670438|NCT05121480|66176170|FG005|Overall Study|Non-compliance with the protocol|6|||
23670439|NCT05121480|66176171|FG006|Overall Study|Non-compliance with the protocol|0|||
23670440|NCT05121480|66176172|FG007|Overall Study|Non-compliance with the protocol|1|||
23670441|NCT05121480|66176165|FG000|Overall Study|Lost to Follow-up|0|||
23670442|NCT05121480|66176166|FG001|Overall Study|Lost to Follow-up|4|||
23670443|NCT05121480|66176167|FG002|Overall Study|Lost to Follow-up|1|||
23670444|NCT05121480|66176168|FG003|Overall Study|Lost to Follow-up|3|||
23670445|NCT05121480|66176169|FG004|Overall Study|Lost to Follow-up|1|||
23670446|NCT05121480|66176170|FG005|Overall Study|Lost to Follow-up|1|||
23670447|NCT05121480|66176171|FG006|Overall Study|Lost to Follow-up|1|||
23670448|NCT05121480|66176172|FG007|Overall Study|Lost to Follow-up|4|||
23670449|NCT05121480|66176165|FG000|Overall Study|Physician Decision|0|||
23670450|NCT05121480|66176166|FG001|Overall Study|Physician Decision|0|||
23670451|NCT05121480|66176167|FG002|Overall Study|Physician Decision|0|||
23670452|NCT05121480|66176168|FG003|Overall Study|Physician Decision|0|||
23670453|NCT05121480|66176169|FG004|Overall Study|Physician Decision|0|||
23670454|NCT05121480|66176170|FG005|Overall Study|Physician Decision|1|||
23670455|NCT05121480|66176171|FG006|Overall Study|Physician Decision|0|||
23670456|NCT05121480|66176172|FG007|Overall Study|Physician Decision|1|||
23670457|NCT05121480|66176165|FG000|Overall Study|Other Reason|0|||
23670458|NCT05121480|66176166|FG001|Overall Study|Other Reason|0|||
23670459|NCT05121480|66176167|FG002|Overall Study|Other Reason|0|||
23670460|NCT05121480|66176168|FG003|Overall Study|Other Reason|0|||
23670461|NCT05121480|66176169|FG004|Overall Study|Other Reason|0|||
23670462|NCT05121480|66176170|FG005|Overall Study|Other Reason|1|||
23670463|NCT05121480|66176171|FG006|Overall Study|Other Reason|1|||
23670464|NCT05121480|66176172|FG007|Overall Study|Other Reason|1|||
23670465|NCT03548935|66176173|FG000|Overall Study|Withdrawal by Subject|26|||
23493181|NCT03650556|65551383|FG000|Overall Study|Death|2|||
23670466|NCT03548935|66176174|FG001|Overall Study|Withdrawal by Subject|17|||
23670467|NCT03548935|66176173|FG000|Overall Study|Lost to Follow-up|39|||
23670468|NCT03548935|66176174|FG001|Overall Study|Lost to Follow-up|28|||
23670469|NCT03548935|66176173|FG000|Overall Study|Death|1|||
23670470|NCT03548935|66176174|FG001|Overall Study|Death|1|||
23670471|NCT04288154|66176179|FG000|Overall Study|Withdrawal by Subject|9|||
23493182|NCT03650556|65551383|FG000|Overall Study|Withdrawal by Subject|20|||
23670472|NCT04288154|66176180|FG001|Overall Study|Withdrawal by Subject|9|||
23670473|NCT01227902|66176181|FG000|Overall Study|Adverse Event|12|||
23670474|NCT01227902|66176182|FG001|Overall Study|Adverse Event|8|||
23670475|NCT01227902|66176183|FG002|Overall Study|Adverse Event|11|||
23670476|NCT01227902|66176184|FG003|Overall Study|Adverse Event|4|||
23670477|NCT01227902|66176181|FG000|Overall Study|Lack of Efficacy|1|||
23670478|NCT01227902|66176182|FG001|Overall Study|Lack of Efficacy|2|||
23670479|NCT01227902|66176183|FG002|Overall Study|Lack of Efficacy|2|||
23670480|NCT01227902|66176184|FG003|Overall Study|Lack of Efficacy|1|||
23670481|NCT01227902|66176181|FG000|Overall Study|Protocol Violation|1|||
23670482|NCT01227902|66176182|FG001|Overall Study|Protocol Violation|0|||
23670483|NCT01227902|66176183|FG002|Overall Study|Protocol Violation|0|||
23670484|NCT01227902|66176184|FG003|Overall Study|Protocol Violation|0|||
23670485|NCT01227902|66176181|FG000|Overall Study|Lost to Follow-up|0|||
23670486|NCT01227902|66176182|FG001|Overall Study|Lost to Follow-up|0|||
23670487|NCT01227902|66176183|FG002|Overall Study|Lost to Follow-up|1|||
23670488|NCT01227902|66176184|FG003|Overall Study|Lost to Follow-up|2|||
23670489|NCT01227902|66176181|FG000|Overall Study|Physician Decision|0|||
23670490|NCT01227902|66176182|FG001|Overall Study|Physician Decision|1|||
23670491|NCT01227902|66176183|FG002|Overall Study|Physician Decision|1|||
23670492|NCT01227902|66176184|FG003|Overall Study|Physician Decision|0|||
23670493|NCT01227902|66176181|FG000|Overall Study|Withdrawal by Subject|4|||
23670494|NCT01227902|66176182|FG001|Overall Study|Withdrawal by Subject|2|||
23384114|NCT00327171|65151547|FG001|Overall Study|Undisclosed history of ischemia|1|||
23384115|NCT00327171|65151546|FG000|Overall Study|Other|1|||
23384116|NCT00327171|65151547|FG001|Overall Study|Other|0|||
23384117|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
23384118|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
23384119|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
23384120|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
23384121|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
23384122|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
23384123|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
23384124|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
23384125|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
23384126|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
23384127|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
23384128|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
23384129|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
23384130|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
23384131|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
23384132|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
23384133|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
23384134|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
23384135|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
23384136|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
23384137|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
23384138|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
23384139|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
23384140|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
23384141|NCT02337946|65151549|FG000|In-between Period|Without Informed Consent|1|||
23384142|NCT02337946|65151550|FG001|In-between Period|Without Informed Consent|0|||
23384143|NCT02337946|65151551|FG002|In-between Period|Without Informed Consent|0|||
23384144|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
23384145|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
23384146|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
23384147|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
23384148|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
23384149|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
23384150|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
23384151|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
23384152|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
23384153|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
23384154|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
23384155|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
23384156|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
23384157|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
23384158|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
23384159|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
23384160|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
23384161|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
23670495|NCT01227902|66176183|FG002|Overall Study|Withdrawal by Subject|4|||
23670496|NCT01227902|66176184|FG003|Overall Study|Withdrawal by Subject|3|||
23670497|NCT04718974|66176189|FG000|Overall Study|Death|0|||
23384162|NCT00105508|65151552|FG000|Overall Study|Prephase Dropout|1|||
23384163|NCT00105508|65151553|FG001|Overall Study|Prephase Dropout|0|||
23384164|NCT00105508|65151552|FG000|Overall Study|Adverse Event|16|||
23384165|NCT00105508|65151553|FG001|Overall Study|Adverse Event|19|||
23384166|NCT00105508|65151552|FG000|Overall Study|Insufficient Efficacy|1|||
23384167|NCT00105508|65151553|FG001|Overall Study|Insufficient Efficacy|0|||
23384168|NCT00105508|65151552|FG000|Overall Study|Withdrawal by Subject|10|||
23384169|NCT00105508|65151553|FG001|Overall Study|Withdrawal by Subject|6|||
23384170|NCT00105508|65151552|FG000|Overall Study|Lost to Follow-up|3|||
23384171|NCT00105508|65151553|FG001|Overall Study|Lost to Follow-up|0|||
23384172|NCT00105508|65151552|FG000|Overall Study|Protocol Violation|1|||
23384173|NCT00105508|65151553|FG001|Overall Study|Protocol Violation|2|||
23384174|NCT00105508|65151552|FG000|Overall Study|Other|8|||
23384175|NCT00105508|65151553|FG001|Overall Study|Other|9|||
23384176|NCT01814332|65151554|FG000|Overall Study|Adverse Event|8|||
23384177|NCT01814332|65151555|FG001|Overall Study|Adverse Event|3|||
23384178|NCT01814332|65151554|FG000|Overall Study|Withdrawal by Subject|3|||
23384179|NCT01814332|65151555|FG001|Overall Study|Withdrawal by Subject|8|||
23384180|NCT01814332|65151554|FG000|Overall Study|Protocol Violation|0|||
23384181|NCT01814332|65151555|FG001|Overall Study|Protocol Violation|4|||
23384182|NCT01814332|65151554|FG000|Overall Study|Lost to Follow-up|5|||
23384183|NCT01814332|65151555|FG001|Overall Study|Lost to Follow-up|1|||
23384184|NCT03312907|65151556|FG000|Overall Study|Adverse Event|1|||
23384185|NCT03312907|65151557|FG001|Overall Study|Adverse Event|6|||
23384186|NCT03312907|65151558|FG002|Overall Study|Adverse Event|1|||
23384187|NCT03312907|65151556|FG000|Overall Study|Protocol Violation|2|||
23384188|NCT03312907|65151557|FG001|Overall Study|Protocol Violation|3|||
23384189|NCT03312907|65151558|FG002|Overall Study|Protocol Violation|4|||
23384190|NCT03312907|65151556|FG000|Overall Study|Lost to Follow-up|2|||
23384191|NCT03312907|65151557|FG001|Overall Study|Lost to Follow-up|3|||
23384192|NCT03312907|65151558|FG002|Overall Study|Lost to Follow-up|2|||
23384193|NCT03312907|65151556|FG000|Overall Study|Physician Decision|3|||
23384194|NCT03312907|65151557|FG001|Overall Study|Physician Decision|4|||
23384195|NCT03312907|65151558|FG002|Overall Study|Physician Decision|2|||
23384196|NCT03312907|65151556|FG000|Overall Study|Withdrawal by Subject|9|||
23384197|NCT03312907|65151557|FG001|Overall Study|Withdrawal by Subject|14|||
23384198|NCT03312907|65151558|FG002|Overall Study|Withdrawal by Subject|10|||
23384199|NCT01691482|65151560|FG000|Treatment Period 2|Adverse Event|0|||
23384200|NCT01691482|65151561|FG001|Treatment Period 2|Adverse Event|1|||
23384201|NCT01691482|65151560|FG000|Treatment Period 2|Protocol Violation|1|||
23384202|NCT01691482|65151561|FG001|Treatment Period 2|Protocol Violation|1|||
23384203|NCT04027946|65151564|FG000|Overall Study|Screen failures|3|||
23384204|NCT04149353|65151565|FG000|Overall Study|Study terminated|1|||
23384205|NCT01127061|65151566|FG000|Overall Study|Lost to Follow-up|7|||
23384206|NCT01127061|65151567|FG001|Overall Study|Lost to Follow-up|10|||
23384207|NCT01127061|65151566|FG000|Overall Study|Physician Decision|3|||
23384208|NCT01127061|65151567|FG001|Overall Study|Physician Decision|3|||
23384209|NCT04389671|65151568|FG000|Overall Study|Death|7|||
23384210|NCT01750281|65151569|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
23384211|NCT01750281|65151570|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
23384212|NCT01750281|65151571|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
23384213|NCT01750281|65151569|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
23384214|NCT01750281|65151570|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
23384215|NCT01750281|65151571|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
23384216|NCT01750281|65151569|FG000|Overall Study|Did not receive treatment|0|||
23384217|NCT01750281|65151570|FG001|Overall Study|Did not receive treatment|1|||
23384218|NCT01750281|65151571|FG002|Overall Study|Did not receive treatment|0|||
23384219|NCT01281306|65151572|FG000|Overall Study|Lack of Efficacy|0|||
23384220|NCT01281306|65151573|FG001|Overall Study|Lack of Efficacy|1|||
23384221|NCT01281306|65151574|FG002|Overall Study|Lack of Efficacy|3|||
23384222|NCT01281306|65151575|FG003|Overall Study|Lack of Efficacy|0|||
23384223|NCT01281306|65151576|FG004|Overall Study|Lack of Efficacy|2|||
23384224|NCT01281306|65151577|FG005|Overall Study|Lack of Efficacy|0|||
23384225|NCT01281306|65151578|FG006|Overall Study|Lack of Efficacy|1|||
23384226|NCT01281306|65151572|FG000|Overall Study|Withdrawal by Subject|1|||
23493183|NCT03650556|65551383|FG000|Overall Study|Physician Decision|2|||
23384227|NCT01281306|65151573|FG001|Overall Study|Withdrawal by Subject|0|||
23384228|NCT01281306|65151574|FG002|Overall Study|Withdrawal by Subject|2|||
23384229|NCT01281306|65151575|FG003|Overall Study|Withdrawal by Subject|4|||
23384230|NCT01281306|65151576|FG004|Overall Study|Withdrawal by Subject|1|||
23384231|NCT01281306|65151577|FG005|Overall Study|Withdrawal by Subject|3|||
23384232|NCT01281306|65151578|FG006|Overall Study|Withdrawal by Subject|1|||
23384233|NCT01281306|65151572|FG000|Overall Study|Protocol deviation|0|||
23384234|NCT01281306|65151573|FG001|Overall Study|Protocol deviation|1|||
23384235|NCT01281306|65151574|FG002|Overall Study|Protocol deviation|1|||
23384236|NCT01281306|65151575|FG003|Overall Study|Protocol deviation|1|||
23384237|NCT01281306|65151576|FG004|Overall Study|Protocol deviation|1|||
23384238|NCT01281306|65151577|FG005|Overall Study|Protocol deviation|0|||
23384239|NCT01281306|65151578|FG006|Overall Study|Protocol deviation|0|||
23670498|NCT04718974|66176190|FG001|Overall Study|Death|2|||
23670499|NCT04718974|66176189|FG000|Overall Study|Lost to Follow-up|10|||
23670500|NCT04718974|66176190|FG001|Overall Study|Lost to Follow-up|20|||
23670501|NCT04718974|66176189|FG000|Overall Study|Transferred out|2|||
23670502|NCT04718974|66176190|FG001|Overall Study|Transferred out|4|||
23670503|NCT03652662|66176191|FG000|Overall Study|Withdrawal by Subject|2|||
23670504|NCT03652662|66176192|FG001|Overall Study|Withdrawal by Subject|1|||
23670505|NCT03652662|66176191|FG000|Overall Study|Lost to Follow-up|1|||
23670506|NCT03652662|66176192|FG001|Overall Study|Lost to Follow-up|0|||
23670507|NCT00193063|66176195|FG000|Overall Study|Lack of Efficacy|3|||
23670508|NCT00193063|66176195|FG000|Overall Study|Adverse Event|1|||
23670509|NCT01391000|66176196|FG000|Overall Study|Lost to Follow-up|2|||
23670510|NCT01391000|66176197|FG001|Overall Study|Lost to Follow-up|0|||
23670511|NCT03461757|66176198|FG000|Overall Study|Adverse Event|1|||
23670512|NCT03461757|66176199|FG001|Overall Study|Adverse Event|0|||
23670513|NCT03461757|66176198|FG000|Overall Study|Lost to Follow-up|13|||
23670514|NCT03461757|66176199|FG001|Overall Study|Lost to Follow-up|7|||
23670515|NCT03461757|66176198|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
23670516|NCT03461757|66176199|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
23384240|NCT01281306|65151572|FG000|Overall Study|Condition no longer requires study drug|1|||
23384241|NCT01281306|65151573|FG001|Overall Study|Condition no longer requires study drug|0|||
23384242|NCT01281306|65151574|FG002|Overall Study|Condition no longer requires study drug|0|||
23384243|NCT01281306|65151575|FG003|Overall Study|Condition no longer requires study drug|0|||
23384244|NCT01281306|65151576|FG004|Overall Study|Condition no longer requires study drug|0|||
23384245|NCT01281306|65151577|FG005|Overall Study|Condition no longer requires study drug|1|||
23384246|NCT01281306|65151578|FG006|Overall Study|Condition no longer requires study drug|1|||
23384247|NCT01281306|65151572|FG000|Overall Study|Lost to Follow-up|1|||
23384248|NCT01281306|65151573|FG001|Overall Study|Lost to Follow-up|0|||
23384249|NCT01281306|65151574|FG002|Overall Study|Lost to Follow-up|0|||
23670517|NCT03461757|66176198|FG000|Overall Study|Non-compliance with study treatment|0|||
23670518|NCT03461757|66176199|FG001|Overall Study|Non-compliance with study treatment|1|||
23670519|NCT03461757|66176198|FG000|Overall Study|Pregnancy|2|||
23670520|NCT03461757|66176199|FG001|Overall Study|Pregnancy|0|||
23670521|NCT03461757|66176198|FG000|Overall Study|Protocol Violation|1|||
23670522|NCT03461757|66176199|FG001|Overall Study|Protocol Violation|1|||
23670523|NCT03461757|66176198|FG000|Overall Study|Withdrawal by Subject|7|||
23670524|NCT03461757|66176199|FG001|Overall Study|Withdrawal by Subject|7|||
23670525|NCT03461757|66176198|FG000|Overall Study|Other Reasons|1|||
23670526|NCT03461757|66176199|FG001|Overall Study|Other Reasons|4|||
23670527|NCT02937818|66176202|FG000|Overall Study|Participants decision|2|||
23670528|NCT02937818|66176203|FG001|Overall Study|Participants decision|1|||
23670529|NCT02937818|66176204|FG002|Overall Study|Participants decision|1|||
23670530|NCT02937818|66176205|FG003|Overall Study|Participants decision|1|||
23670531|NCT02937818|66176202|FG000|Overall Study|Adverse Event|2|||
23670532|NCT02937818|66176203|FG001|Overall Study|Adverse Event|4|||
23670533|NCT02937818|66176204|FG002|Overall Study|Adverse Event|1|||
23670534|NCT02937818|66176205|FG003|Overall Study|Adverse Event|1|||
23670535|NCT02937818|66176202|FG000|Overall Study|Disease progression|17|||
23670536|NCT02937818|66176203|FG001|Overall Study|Disease progression|15|||
23670537|NCT02937818|66176204|FG002|Overall Study|Disease progression|7|||
23670538|NCT02937818|66176205|FG003|Overall Study|Disease progression|19|||
23670539|NCT02937818|66176202|FG000|Overall Study|Condition under investigation worsened|0|||
23670540|NCT02937818|66176203|FG001|Overall Study|Condition under investigation worsened|0|||
23670541|NCT02937818|66176204|FG002|Overall Study|Condition under investigation worsened|1|||
23670542|NCT02937818|66176205|FG003|Overall Study|Condition under investigation worsened|0|||
23670543|NCT01032915|66176213|FG000|Overall Study|Adverse Event|2|||
23670544|NCT01032915|66176214|FG001|Overall Study|Adverse Event|2|||
23670545|NCT01032915|66176215|FG002|Overall Study|Adverse Event|1|||
23670546|NCT01032915|66176216|FG003|Overall Study|Adverse Event|1|||
23670547|NCT01032915|66176213|FG000|Overall Study|Abnormal test procedure result|0|||
23670548|NCT01032915|66176214|FG001|Overall Study|Abnormal test procedure result|0|||
23670549|NCT01032915|66176215|FG002|Overall Study|Abnormal test procedure result|1|||
23670550|NCT01032915|66176216|FG003|Overall Study|Abnormal test procedure result|0|||
23670551|NCT01032915|66176213|FG000|Overall Study|Withdrawal by Subject|0|||
23670552|NCT01032915|66176214|FG001|Overall Study|Withdrawal by Subject|3|||
23670553|NCT01032915|66176215|FG002|Overall Study|Withdrawal by Subject|1|||
23670554|NCT01032915|66176216|FG003|Overall Study|Withdrawal by Subject|1|||
23670555|NCT01032915|66176213|FG000|Overall Study|Administrative reasons|5|||
23670556|NCT01032915|66176214|FG001|Overall Study|Administrative reasons|6|||
23670557|NCT01032915|66176215|FG002|Overall Study|Administrative reasons|4|||
23670558|NCT01032915|66176216|FG003|Overall Study|Administrative reasons|4|||
23670559|NCT01032915|66176213|FG000|Overall Study|Protocol Violation|1|||
23670560|NCT01032915|66176214|FG001|Overall Study|Protocol Violation|0|||
23670561|NCT01032915|66176215|FG002|Overall Study|Protocol Violation|0|||
23670562|NCT01032915|66176216|FG003|Overall Study|Protocol Violation|1|||
23670563|NCT03972969|66176217|FG000|3-month Follow-up|Death|1|||
23670564|NCT03972969|66176218|FG001|3-month Follow-up|Death|1|||
23670565|NCT03972969|66176219|FG002|3-month Follow-up|Death|0|||
23670566|NCT03972969|66176217|FG000|6-month Follow-up|Death|1|||
23670567|NCT03972969|66176218|FG001|6-month Follow-up|Death|1|||
23670568|NCT03972969|66176219|FG002|6-month Follow-up|Death|1|||
23670569|NCT03972969|66176217|FG000|6-month Follow-up|Lost to Follow-up|2|||
23670570|NCT03972969|66176218|FG001|6-month Follow-up|Lost to Follow-up|2|||
23670571|NCT03972969|66176219|FG002|6-month Follow-up|Lost to Follow-up|2|||
23670572|NCT00135668|66176220|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
23670573|NCT00135668|66176221|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
23670574|NCT00135668|66176222|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
23670575|NCT00135668|66176223|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
23670576|NCT02787863|66176224|FG000|Overall Study|Death|1|||
23670577|NCT02787863|66176225|FG001|Overall Study|Death|0|||
23670578|NCT02787863|66176226|FG002|Overall Study|Death|1|||
23670579|NCT02787863|66176227|FG003|Overall Study|Death|0|||
23670580|NCT02787863|66176228|FG004|Overall Study|Death|0|||
23670581|NCT02787863|66176229|FG005|Overall Study|Death|0|||
23670582|NCT02787863|66176230|FG006|Overall Study|Death|0|||
23670583|NCT02787863|66176231|FG007|Overall Study|Death|0|||
23384250|NCT01281306|65151575|FG003|Overall Study|Lost to Follow-up|2|||
23493184|NCT03650556|65551383|FG000|Overall Study|Lost to Follow-up|8|||
23670584|NCT02787863|66176224|FG000|Overall Study|Withdrawal by Subject|0|||
23670585|NCT02787863|66176225|FG001|Overall Study|Withdrawal by Subject|1|||
23670586|NCT02787863|66176226|FG002|Overall Study|Withdrawal by Subject|1|||
23670587|NCT02787863|66176227|FG003|Overall Study|Withdrawal by Subject|0|||
23670588|NCT02787863|66176228|FG004|Overall Study|Withdrawal by Subject|0|||
23670589|NCT02787863|66176229|FG005|Overall Study|Withdrawal by Subject|0|||
23670590|NCT02787863|66176230|FG006|Overall Study|Withdrawal by Subject|0|||
23670591|NCT02787863|66176231|FG007|Overall Study|Withdrawal by Subject|0|||
23670592|NCT01026831|66176232|FG000|Overall Study|Adverse Event|4|||
23670593|NCT01026831|66176233|FG001|Overall Study|Adverse Event|3|||
23670594|NCT01026831|66176232|FG000|Overall Study|Lost to Follow-up|2|||
23670595|NCT01026831|66176233|FG001|Overall Study|Lost to Follow-up|0|||
23670596|NCT01026831|66176232|FG000|Overall Study|Physician Decision|1|||
23670597|NCT01026831|66176233|FG001|Overall Study|Physician Decision|1|||
23670598|NCT01026831|66176232|FG000|Overall Study|Protocol Violation|0|||
23670599|NCT01026831|66176233|FG001|Overall Study|Protocol Violation|2|||
23670600|NCT01026831|66176232|FG000|Overall Study|Withdrawal by Subject|7|||
23670601|NCT01026831|66176233|FG001|Overall Study|Withdrawal by Subject|5|||
23670602|NCT00450723|66176236|FG000|Overall Study|Physician Decision|5|||
23670603|NCT00732303|66176241|FG000|Overall Study|Study Terminated|2|||
23670604|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
23670605|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
23670606|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
23670607|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
23670608|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
23670609|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
23670610|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
23670611|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
23670612|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to death|4|||
23670613|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to death|3|||
23670614|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
23670615|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
23670616|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
23670617|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
23670618|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
23384251|NCT01281306|65151576|FG004|Overall Study|Lost to Follow-up|0|||
23384252|NCT01281306|65151577|FG005|Overall Study|Lost to Follow-up|0|||
23384253|NCT01281306|65151578|FG006|Overall Study|Lost to Follow-up|1|||
23384254|NCT01281306|65151572|FG000|Overall Study|Death|1|||
23384255|NCT01281306|65151573|FG001|Overall Study|Death|0|||
23384256|NCT01281306|65151574|FG002|Overall Study|Death|0|||
23384257|NCT01281306|65151575|FG003|Overall Study|Death|0|||
23384258|NCT01281306|65151576|FG004|Overall Study|Death|0|||
23384259|NCT01281306|65151577|FG005|Overall Study|Death|0|||
23384260|NCT01281306|65151578|FG006|Overall Study|Death|0|||
23384261|NCT01281306|65151572|FG000|Overall Study|Adverse Event|3|||
23384262|NCT01281306|65151573|FG001|Overall Study|Adverse Event|2|||
23384263|NCT01281306|65151574|FG002|Overall Study|Adverse Event|2|||
23384264|NCT01281306|65151575|FG003|Overall Study|Adverse Event|3|||
23384265|NCT01281306|65151576|FG004|Overall Study|Adverse Event|5|||
23384266|NCT01281306|65151577|FG005|Overall Study|Adverse Event|3|||
23384267|NCT01281306|65151578|FG006|Overall Study|Adverse Event|3|||
23384268|NCT01281306|65151572|FG000|Overall Study|Randomized in error|1|||
23384269|NCT01281306|65151573|FG001|Overall Study|Randomized in error|0|||
23493185|NCT03650556|65551383|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
23670619|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
23670620|NCT02258451|66176242|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
23670621|NCT02258451|66176243|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
23670622|NCT02258451|66176242|FG000|Overall Study|Other reason|1|||
23670623|NCT02258451|66176243|FG001|Overall Study|Other reason|1|||
23670624|NCT02258451|66176242|FG000|Overall Study|Never treated|2|||
23670625|NCT02258451|66176243|FG001|Overall Study|Never treated|3|||
23670626|NCT03099187|66176247|FG000|Double-blind Treatment|Adverse Event|19|||
23670627|NCT03099187|66176248|FG001|Double-blind Treatment|Adverse Event|1|||
23670628|NCT03099187|66176249|FG002|Double-blind Treatment|Adverse Event|0|||
23670629|NCT03099187|66176250|FG003|Double-blind Treatment|Adverse Event|0|||
23384270|NCT01281306|65151574|FG002|Overall Study|Randomized in error|0|||
23384271|NCT01281306|65151575|FG003|Overall Study|Randomized in error|1|||
23384272|NCT01281306|65151576|FG004|Overall Study|Randomized in error|0|||
23384273|NCT01281306|65151577|FG005|Overall Study|Randomized in error|0|||
23384274|NCT01281306|65151578|FG006|Overall Study|Randomized in error|0|||
23384275|NCT02939781|65151583|FG000|Overall Study|Protocol Violation|8|||
23384276|NCT02939781|65151583|FG000|Overall Study|Withdrawal by Subject|1|||
23384277|NCT00191152|65151589|FG000|Initial Treatment|Adverse Event|43|||
23384278|NCT00191152|65151590|FG001|Initial Treatment|Adverse Event|67|||
23384279|NCT00191152|65151589|FG000|Initial Treatment|Physician Decision|40|||
23384280|NCT00191152|65151590|FG001|Initial Treatment|Physician Decision|31|||
23384281|NCT00191152|65151589|FG000|Initial Treatment|Withdrawal by Subject|40|||
23384282|NCT00191152|65151590|FG001|Initial Treatment|Withdrawal by Subject|28|||
23384283|NCT00191152|65151589|FG000|Initial Treatment|Lost to Follow-up|0|||
23384284|NCT00191152|65151590|FG001|Initial Treatment|Lost to Follow-up|6|||
23384285|NCT00191152|65151589|FG000|Initial Treatment|Other|18|||
23384286|NCT00191152|65151590|FG001|Initial Treatment|Other|21|||
23384287|NCT00191152|65151589|FG000|Crossover Treatment|Adverse Event|8|||
23384288|NCT00191152|65151590|FG001|Crossover Treatment|Adverse Event|8|||
23384289|NCT00191152|65151589|FG000|Crossover Treatment|Physician Decision|7|||
23384290|NCT00191152|65151590|FG001|Crossover Treatment|Physician Decision|7|||
23384291|NCT00191152|65151589|FG000|Crossover Treatment|Withdrawal by Subject|6|||
23384292|NCT00191152|65151590|FG001|Crossover Treatment|Withdrawal by Subject|9|||
23384293|NCT00191152|65151589|FG000|Crossover Treatment|Lost to Follow-up|2|||
23384294|NCT00191152|65151590|FG001|Crossover Treatment|Lost to Follow-up|1|||
23384295|NCT00191152|65151589|FG000|Crossover Treatment|Other|4|||
23384296|NCT00191152|65151590|FG001|Crossover Treatment|Other|3|||
23384297|NCT01946802|65151591|FG000|Overall Study|Death|1|||
23384298|NCT01946802|65151591|FG000|Overall Study|Withdrawal by Subject|2|||
23384299|NCT01946802|65151591|FG000|Overall Study|Combined septic shock|1|||
23384300|NCT01946802|65151591|FG000|Overall Study|Protocol Violation|1|||
23384301|NCT02989389|65151593|FG000|Period 1|Lost to Follow-up|0|||
23384302|NCT02989389|65151594|FG001|Period 1|Lost to Follow-up|1|||
23384303|NCT02989389|65151595|FG002|Period 1|Lost to Follow-up|0|||
23384304|NCT02989389|65151596|FG003|Period 1|Lost to Follow-up|0|||
23384305|NCT02989389|65151597|FG004|Period 1|Lost to Follow-up|0|||
23384306|NCT02989389|65151598|FG005|Period 1|Lost to Follow-up|0|||
23384307|NCT02989389|65151599|FG006|Period 1|Lost to Follow-up|0|||
23384308|NCT02989389|65151600|FG007|Period 1|Lost to Follow-up|0|||
23384309|NCT02989389|65151601|FG008|Period 1|Lost to Follow-up|0|||
23384310|NCT02989389|65151602|FG009|Period 1|Lost to Follow-up|0|||
23670630|NCT03099187|66176247|FG000|Double-blind Treatment|Death|1|||
23384311|NCT02989389|65151593|FG000|Period 1|Physician Decision|0|||
23384312|NCT02989389|65151594|FG001|Period 1|Physician Decision|0|||
23384313|NCT02989389|65151595|FG002|Period 1|Physician Decision|0|||
23384314|NCT02989389|65151596|FG003|Period 1|Physician Decision|0|||
23384315|NCT02989389|65151597|FG004|Period 1|Physician Decision|0|||
23384316|NCT02989389|65151598|FG005|Period 1|Physician Decision|0|||
23384317|NCT02989389|65151599|FG006|Period 1|Physician Decision|0|||
23384318|NCT02989389|65151600|FG007|Period 1|Physician Decision|0|||
23384319|NCT02989389|65151601|FG008|Period 1|Physician Decision|1|||
23670631|NCT03099187|66176248|FG001|Double-blind Treatment|Death|3|||
23670632|NCT03099187|66176249|FG002|Double-blind Treatment|Death|0|||
23670633|NCT03099187|66176250|FG003|Double-blind Treatment|Death|0|||
23670634|NCT03099187|66176247|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23670635|NCT03099187|66176248|FG001|Double-blind Treatment|Lack of Efficacy|0|||
23670636|NCT03099187|66176249|FG002|Double-blind Treatment|Lack of Efficacy|0|||
23384320|NCT02989389|65151602|FG009|Period 1|Physician Decision|0|||
23384321|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
23384322|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
23670637|NCT03099187|66176250|FG003|Double-blind Treatment|Lack of Efficacy|0|||
23670638|NCT03099187|66176247|FG000|Double-blind Treatment|Physician Decision|2|||
23670639|NCT03099187|66176248|FG001|Double-blind Treatment|Physician Decision|1|||
23670640|NCT03099187|66176249|FG002|Double-blind Treatment|Physician Decision|0|||
23670641|NCT03099187|66176250|FG003|Double-blind Treatment|Physician Decision|0|||
23670642|NCT03099187|66176247|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
23670643|NCT03099187|66176248|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
23670644|NCT03099187|66176249|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
23670645|NCT03099187|66176250|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
23670646|NCT03099187|66176247|FG000|Double-blind Treatment|Lung transplantation|0|||
23670647|NCT03099187|66176248|FG001|Double-blind Treatment|Lung transplantation|1|||
23670648|NCT03099187|66176249|FG002|Double-blind Treatment|Lung transplantation|0|||
23670649|NCT03099187|66176250|FG003|Double-blind Treatment|Lung transplantation|0|||
23670650|NCT03099187|66176247|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
23670651|NCT03099187|66176248|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
23670652|NCT03099187|66176249|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
23670653|NCT03099187|66176250|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
23670654|NCT03099187|66176247|FG000|Double-blind Treatment|Disease progression|0|||
23670655|NCT03099187|66176248|FG001|Double-blind Treatment|Disease progression|1|||
23670656|NCT03099187|66176249|FG002|Double-blind Treatment|Disease progression|0|||
23670657|NCT03099187|66176250|FG003|Double-blind Treatment|Disease progression|0|||
23670658|NCT03099187|66176247|FG000|Double-blind Treatment|Randomization error|0|||
23670659|NCT03099187|66176248|FG001|Double-blind Treatment|Randomization error|2|||
23670660|NCT03099187|66176249|FG002|Double-blind Treatment|Randomization error|0|||
23670661|NCT03099187|66176250|FG003|Double-blind Treatment|Randomization error|0|||
23670662|NCT03099187|66176247|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
23670663|NCT03099187|66176248|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
23670664|NCT03099187|66176249|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
23670665|NCT03099187|66176250|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
23670666|NCT03099187|66176247|FG000|12-month Safety Follow-up|Adverse Event|0|||
23670667|NCT03099187|66176248|FG001|12-month Safety Follow-up|Adverse Event|0|||
23670668|NCT03099187|66176249|FG002|12-month Safety Follow-up|Adverse Event|5|||
23670669|NCT03099187|66176250|FG003|12-month Safety Follow-up|Adverse Event|12|||
23670670|NCT03099187|66176247|FG000|12-month Safety Follow-up|Death|0|||
23670671|NCT03099187|66176248|FG001|12-month Safety Follow-up|Death|0|||
23670672|NCT03099187|66176249|FG002|12-month Safety Follow-up|Death|7|||
23670673|NCT03099187|66176250|FG003|12-month Safety Follow-up|Death|9|||
23670674|NCT03099187|66176247|FG000|12-month Safety Follow-up|Lung transplantation|0|||
23670675|NCT03099187|66176248|FG001|12-month Safety Follow-up|Lung transplantation|0|||
23670676|NCT03099187|66176249|FG002|12-month Safety Follow-up|Lung transplantation|2|||
23670677|NCT03099187|66176250|FG003|12-month Safety Follow-up|Lung transplantation|1|||
23670678|NCT03099187|66176247|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
23670679|NCT03099187|66176248|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
23670680|NCT03099187|66176249|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
23670681|NCT03099187|66176250|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
23670682|NCT03099187|66176247|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
23670683|NCT03099187|66176248|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
23670684|NCT03099187|66176249|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
23670685|NCT03099187|66176250|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
23670686|NCT03099187|66176247|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
23670687|NCT03099187|66176248|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
23670688|NCT03099187|66176249|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
23670689|NCT03099187|66176250|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
23670690|NCT03099187|66176247|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
23670691|NCT03099187|66176248|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
23670692|NCT03099187|66176249|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
23670693|NCT03099187|66176250|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
23670694|NCT00307151|66176251|FG000|Overall Study|Death|4|||
23670695|NCT00307151|66176252|FG001|Overall Study|Death|3|||
23670696|NCT00307151|66176253|FG002|Overall Study|Death|10|||
23670697|NCT00307151|66176254|FG003|Overall Study|Death|3|||
23670698|NCT00307151|66176251|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23670699|NCT00307151|66176252|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23670700|NCT00307151|66176253|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23670701|NCT00307151|66176254|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23670702|NCT00307151|66176251|FG000|Overall Study|Subject unable to get to clinic|1|||
23670703|NCT00307151|66176252|FG001|Overall Study|Subject unable to get to clinic|0|||
23670704|NCT00307151|66176253|FG002|Overall Study|Subject unable to get to clinic|6|||
23670705|NCT00307151|66176254|FG003|Overall Study|Subject unable to get to clinic|2|||
23670706|NCT00307151|66176251|FG000|Overall Study|Withdrew consent|0|||
23670707|NCT00307151|66176252|FG001|Overall Study|Withdrew consent|1|||
23670708|NCT00307151|66176253|FG002|Overall Study|Withdrew consent|1|||
23384323|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
23670709|NCT00307151|66176254|FG003|Overall Study|Withdrew consent|3|||
23670710|NCT00307151|66176251|FG000|Overall Study|Not willing to adhere to study reqs|2|||
23670711|NCT00307151|66176252|FG001|Overall Study|Not willing to adhere to study reqs|0|||
23670712|NCT00307151|66176253|FG002|Overall Study|Not willing to adhere to study reqs|2|||
23670713|NCT00307151|66176254|FG003|Overall Study|Not willing to adhere to study reqs|2|||
23670714|NCT00307151|66176251|FG000|Overall Study|Clinic unable to contact subject|3|||
23670715|NCT00307151|66176252|FG001|Overall Study|Clinic unable to contact subject|3|||
23384324|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
23384325|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
23384326|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
23384327|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
23384328|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
23384329|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
23384330|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
23384331|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
23384332|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
23384333|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
23384334|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
23384335|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
23384336|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
23384337|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
23384338|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
23384339|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
23384340|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
23384341|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
23384342|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
23384343|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
23384344|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
23384345|NCT02460380|65151605|FG000|Overall Study|Withdrawal by Subject|10|||
23384346|NCT02460380|65151606|FG001|Overall Study|Withdrawal by Subject|5|||
23384347|NCT01018953|65151607|FG000|Overall Study|Adverse Event|2|||
23384348|NCT01018953|65151607|FG000|Overall Study|Withdrawal by Subject|1|||
23384349|NCT01018953|65151607|FG000|Overall Study|Study termination by sponsor|5|||
23384350|NCT03718000|65151608|FG000|Overall Study|Relocation|2|||
23384351|NCT03718000|65151609|FG001|Overall Study|Relocation|4|||
23384352|NCT03718000|65151608|FG000|Overall Study|Pregnancy|0|||
23384353|NCT03718000|65151609|FG001|Overall Study|Pregnancy|1|||
23384354|NCT01646216|65151612|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
23384355|NCT01646216|65151613|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
23384356|NCT01646216|65151612|FG000|Overall Study|Did not complete training|0|||
23384357|NCT01646216|65151613|FG001|Overall Study|Did not complete training|2|||
23384358|NCT01646216|65151612|FG000|Overall Study|Investigator decision|1|||
23384359|NCT01646216|65151613|FG001|Overall Study|Investigator decision|1|||
23384360|NCT03418675|65151614|FG000|Overall Study|Lost to Follow-up|13|||
23384361|NCT03418675|65151615|FG001|Overall Study|Lost to Follow-up|10|||
23384362|NCT03418675|65151614|FG000|Overall Study|Adverse Event|2|||
23384363|NCT03418675|65151615|FG001|Overall Study|Adverse Event|0|||
23384364|NCT01016015|65151616|FG000|Overall Study|Not Treated|3|||
23384365|NCT01016015|65151616|FG000|Overall Study|Withdrawal by Subject|1|||
23384366|NCT01016015|65151616|FG000|Overall Study|Adverse Event|15|||
23384367|NCT01684033|65151618|FG000|Period 1, First 30 Days|Adverse Event|1|||
23384368|NCT01684033|65151619|FG001|Period 1, First 30 Days|Adverse Event|1|||
23384369|NCT01684033|65151618|FG000|Period 1, First 30 Days|Noncompliance|1|||
23384370|NCT01684033|65151619|FG001|Period 1, First 30 Days|Noncompliance|0|||
23384371|NCT01684033|65151618|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
23384372|NCT01684033|65151619|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
23384373|NCT01684033|65151618|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
23384374|NCT01684033|65151619|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
23384375|NCT01684033|65151618|FG000|Period 2, Second 30 Days|Adverse Event|1|||
23384376|NCT01684033|65151619|FG001|Period 2, Second 30 Days|Adverse Event|0|||
23384377|NCT00927082|65151620|FG000|Overall Study|Lost to Follow-up|9|||
23384378|NCT00927082|65151621|FG001|Overall Study|Lost to Follow-up|8|||
23384379|NCT00927082|65151622|FG002|Overall Study|Lost to Follow-up|12|||
23384380|NCT00927082|65151623|FG003|Overall Study|Lost to Follow-up|16|||
23384381|NCT00927082|65151620|FG000|Overall Study|Withdrawal by Subject|3|||
23384382|NCT00927082|65151621|FG001|Overall Study|Withdrawal by Subject|2|||
23384383|NCT00927082|65151622|FG002|Overall Study|Withdrawal by Subject|7|||
23384384|NCT00927082|65151623|FG003|Overall Study|Withdrawal by Subject|2|||
23384385|NCT00927082|65151620|FG000|Overall Study|Death|0|||
23384386|NCT00927082|65151621|FG001|Overall Study|Death|0|||
23384387|NCT00927082|65151622|FG002|Overall Study|Death|1|||
23384388|NCT00927082|65151623|FG003|Overall Study|Death|0|||
23670716|NCT00307151|66176253|FG002|Overall Study|Clinic unable to contact subject|1|||
23384389|NCT00927082|65151620|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
23384390|NCT00927082|65151621|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
23384391|NCT00927082|65151622|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
23384392|NCT00927082|65151623|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
23384393|NCT02318277|65151624|FG000|Overall Study|Physician Decision|0|||
23384394|NCT02318277|65151625|FG001|Overall Study|Physician Decision|0|||
23670717|NCT00307151|66176254|FG003|Overall Study|Clinic unable to contact subject|1|||
23670718|NCT00993928|66176255|FG000|Overall Study|Withdrawal by Subject|4|||
23670719|NCT00993928|66176256|FG001|Overall Study|Withdrawal by Subject|7|||
23670720|NCT00993928|66176255|FG000|Overall Study|ineligible|1|||
23670721|NCT00993928|66176256|FG001|Overall Study|ineligible|0|||
23670722|NCT00811135|66176257|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
23670723|NCT00811135|66176257|FG000|Overall Study|Death|3|||
23670724|NCT00811135|66176257|FG000|Overall Study|Protocol Violation|2|||
23670725|NCT00811135|66176257|FG000|Overall Study|Violation of Selection Criteria|1|||
23670726|NCT00811135|66176257|FG000|Overall Study|Refused Treatment|1|||
23670727|NCT00811135|66176257|FG000|Overall Study|Withdrawal by Subject|3|||
23670728|NCT00811135|66176257|FG000|Overall Study|Administrative/Other Unspecified|11|||
23670729|NCT00811135|66176257|FG000|Overall Study|Ongoing|59|||
23670730|NCT03631732|66176258|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
23670731|NCT03631732|66176259|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
23670732|NCT03631732|66176258|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
23670733|NCT03631732|66176259|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
23670734|NCT03631732|66176258|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
23670735|NCT03631732|66176259|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
23670736|NCT03631732|66176258|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
23670737|NCT03631732|66176259|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
23670738|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
23670739|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
23670740|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
23670741|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
23670742|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
23670743|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
23670744|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
23670745|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
23670746|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
23670747|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
23670748|NCT03631732|66176258|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
23670749|NCT03631732|66176259|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
23670750|NCT01308008|66176260|FG000|4 Weeks|Illness, disinterest, time|9|||
23670751|NCT01308008|66176261|FG001|4 Weeks|Illness, disinterest, time|2|||
23670752|NCT00835237|66176262|FG000|Overall Study|Lost to Follow-up|4|||
23670753|NCT00835237|66176263|FG001|Overall Study|Lost to Follow-up|0|||
23670754|NCT00835237|66176262|FG000|Overall Study|Withdrawal by Subject|2|||
23670755|NCT00835237|66176263|FG001|Overall Study|Withdrawal by Subject|0|||
23670756|NCT02969707|66176264|FG000|Overall Study|Adverse Event|1|||
23670757|NCT02969707|66176265|FG001|Overall Study|Adverse Event|2|||
23670758|NCT02969707|66176264|FG000|Overall Study|Lost to Follow-up|3|||
23670759|NCT02969707|66176265|FG001|Overall Study|Lost to Follow-up|0|||
23670760|NCT02969707|66176264|FG000|Overall Study|Physician Decision|0|||
23670761|NCT02969707|66176265|FG001|Overall Study|Physician Decision|1|||
23670762|NCT02969707|66176264|FG000|Overall Study|Protocol Violation|1|||
23670763|NCT02969707|66176265|FG001|Overall Study|Protocol Violation|1|||
23670764|NCT02969707|66176264|FG000|Overall Study|Withdrawal by Subject|3|||
23670765|NCT02969707|66176265|FG001|Overall Study|Withdrawal by Subject|4|||
23670766|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Adverse Event|11|||
23670767|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Adverse Event|15|||
23670768|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
23670769|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
23670770|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
23670771|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
23670772|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
23670773|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
23670774|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23670775|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23670776|NCT01058096|66176266|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
23670777|NCT01058096|66176267|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
23670778|NCT04093531|66176269|FG000|Overall Study|failed screening|4|||
23670779|NCT02318667|66176270|FG000|Overall Study|Adverse Event|1|||
23670780|NCT02318667|66176270|FG000|Overall Study|Lack of Efficacy|6|||
23670781|NCT02318667|66176270|FG000|Overall Study|Protocol Violation|2|||
23670782|NCT01180660|66176273|FG000|Overall Study|Changed to open surgery|1|||
23670783|NCT01180660|66176274|FG001|Overall Study|Changed to open surgery|0|||
23670784|NCT03124784|66179605|FG000|Overall Study|Adverse Event|1|||
23670785|NCT03124784|66179605|FG000|Overall Study|Computer/Equip Malfunction|1|||
23670786|NCT01212185|66179606|FG000|Overall Study|Protocol Violation|2|||
23670787|NCT01212185|66179607|FG001|Overall Study|Protocol Violation|1|||
23670788|NCT00517829|66179608|FG000|Overall Study|Adverse Event|22|||
23670789|NCT00517829|66179609|FG001|Overall Study|Adverse Event|34|||
23670790|NCT00517829|66179608|FG000|Overall Study|Disease Progression|39|||
23670791|NCT00517829|66179609|FG001|Overall Study|Disease Progression|32|||
23670792|NCT00517829|66179608|FG000|Overall Study|Patient Request|6|||
23670793|NCT00517829|66179609|FG001|Overall Study|Patient Request|5|||
23670794|NCT00517829|66179608|FG000|Overall Study|Investigator Request|5|||
23670795|NCT00517829|66179609|FG001|Overall Study|Investigator Request|3|||
23670796|NCT00517829|66179608|FG000|Overall Study|Other|3|||
23670797|NCT00517829|66179609|FG001|Overall Study|Other|1|||
23670798|NCT00996944|66179611|FG000|Double-blind Treatment Period|Adverse Event|2|||
23670799|NCT00996944|66179612|FG001|Double-blind Treatment Period|Adverse Event|1|||
23670800|NCT00996944|66179611|FG000|Double-blind Treatment Period|Protocol Violation|1|||
23670801|NCT00996944|66179612|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23670802|NCT00996944|66179611|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
23670803|NCT00996944|66179612|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
23670804|NCT00996944|66179611|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23670805|NCT00996944|66179612|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23670806|NCT00996944|66179611|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
23670807|NCT00996944|66179612|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
23670808|NCT03259074|66179614|FG000|Overall Study|Adverse Event|9|||
23670809|NCT03259074|66179615|FG001|Overall Study|Adverse Event|12|||
23670810|NCT03259074|66179616|FG002|Overall Study|Adverse Event|8|||
23670811|NCT03259074|66179614|FG000|Overall Study|Death|1|||
23670812|NCT03259074|66179615|FG001|Overall Study|Death|1|||
23384395|NCT02318277|65151626|FG002|Overall Study|Physician Decision|0|||
23670813|NCT03259074|66179616|FG002|Overall Study|Death|3|||
23670814|NCT03259074|66179614|FG000|Overall Study|Lost to Follow-up|2|||
23670815|NCT03259074|66179615|FG001|Overall Study|Lost to Follow-up|4|||
23670816|NCT03259074|66179616|FG002|Overall Study|Lost to Follow-up|3|||
23670817|NCT03259074|66179614|FG000|Overall Study|New Therapy For Study Indication|1|||
23670818|NCT03259074|66179615|FG001|Overall Study|New Therapy For Study Indication|2|||
23670819|NCT03259074|66179616|FG002|Overall Study|New Therapy For Study Indication|2|||
23670820|NCT03259074|66179614|FG000|Overall Study|Physician Decision|4|||
23670821|NCT03259074|66179615|FG001|Overall Study|Physician Decision|12|||
23670822|NCT03259074|66179616|FG002|Overall Study|Physician Decision|10|||
23670823|NCT03259074|66179614|FG000|Overall Study|Pregnancy|1|||
23670824|NCT03259074|66179615|FG001|Overall Study|Pregnancy|1|||
23670825|NCT03259074|66179616|FG002|Overall Study|Pregnancy|0|||
23670826|NCT03259074|66179614|FG000|Overall Study|Progressive Disease|1|||
23384396|NCT02318277|65151627|FG003|Overall Study|Physician Decision|0|||
23384397|NCT02318277|65151628|FG004|Overall Study|Physician Decision|0|||
23384398|NCT02318277|65151629|FG005|Overall Study|Physician Decision|0|||
23384399|NCT02318277|65151630|FG006|Overall Study|Physician Decision|0|||
23384400|NCT02318277|65151631|FG007|Overall Study|Physician Decision|1|||
23384401|NCT02318277|65151624|FG000|Overall Study|Other|0|||
23384402|NCT02318277|65151625|FG001|Overall Study|Other|0|||
23384403|NCT02318277|65151626|FG002|Overall Study|Other|0|||
23384404|NCT02318277|65151627|FG003|Overall Study|Other|0|||
23384405|NCT02318277|65151628|FG004|Overall Study|Other|0|||
23384406|NCT02318277|65151629|FG005|Overall Study|Other|0|||
23384407|NCT02318277|65151630|FG006|Overall Study|Other|1|||
23384408|NCT02318277|65151631|FG007|Overall Study|Other|0|||
23384409|NCT02318277|65151624|FG000|Overall Study|Withdrawal by Subject|0|||
23384410|NCT02318277|65151625|FG001|Overall Study|Withdrawal by Subject|0|||
23384411|NCT02318277|65151626|FG002|Overall Study|Withdrawal by Subject|1|||
23384412|NCT02318277|65151627|FG003|Overall Study|Withdrawal by Subject|0|||
23384413|NCT02318277|65151628|FG004|Overall Study|Withdrawal by Subject|1|||
23384414|NCT02318277|65151629|FG005|Overall Study|Withdrawal by Subject|1|||
23384415|NCT02318277|65151630|FG006|Overall Study|Withdrawal by Subject|6|||
23384416|NCT02318277|65151631|FG007|Overall Study|Withdrawal by Subject|14|||
23384417|NCT02318277|65151624|FG000|Overall Study|Participant trial terminated by sponsor|0|||
23384418|NCT02318277|65151625|FG001|Overall Study|Participant trial terminated by sponsor|0|||
23670827|NCT03259074|66179615|FG001|Overall Study|Progressive Disease|0|||
23670828|NCT03259074|66179616|FG002|Overall Study|Progressive Disease|0|||
23670829|NCT03259074|66179614|FG000|Overall Study|Protocol Deviation|1|||
23384419|NCT02318277|65151626|FG002|Overall Study|Participant trial terminated by sponsor|1|||
23384420|NCT02318277|65151627|FG003|Overall Study|Participant trial terminated by sponsor|0|||
23384421|NCT02318277|65151628|FG004|Overall Study|Participant trial terminated by sponsor|1|||
23384422|NCT02318277|65151629|FG005|Overall Study|Participant trial terminated by sponsor|2|||
23384423|NCT02318277|65151630|FG006|Overall Study|Participant trial terminated by sponsor|5|||
23384424|NCT02318277|65151631|FG007|Overall Study|Participant trial terminated by sponsor|16|||
23384425|NCT02318277|65151624|FG000|Overall Study|Lost to Follow-up|1|||
23384426|NCT02318277|65151625|FG001|Overall Study|Lost to Follow-up|0|||
23384427|NCT02318277|65151626|FG002|Overall Study|Lost to Follow-up|1|||
23384428|NCT02318277|65151627|FG003|Overall Study|Lost to Follow-up|0|||
23384429|NCT02318277|65151628|FG004|Overall Study|Lost to Follow-up|0|||
23384430|NCT02318277|65151629|FG005|Overall Study|Lost to Follow-up|0|||
23384431|NCT02318277|65151630|FG006|Overall Study|Lost to Follow-up|3|||
23384432|NCT02318277|65151631|FG007|Overall Study|Lost to Follow-up|4|||
23384433|NCT02318277|65151624|FG000|Overall Study|Death|5|||
23384434|NCT02318277|65151625|FG001|Overall Study|Death|3|||
23384435|NCT02318277|65151626|FG002|Overall Study|Death|1|||
23384436|NCT02318277|65151627|FG003|Overall Study|Death|4|||
23384437|NCT02318277|65151628|FG004|Overall Study|Death|6|||
23384438|NCT02318277|65151629|FG005|Overall Study|Death|5|||
23384439|NCT02318277|65151630|FG006|Overall Study|Death|34|||
23384440|NCT02318277|65151631|FG007|Overall Study|Death|58|||
23670830|NCT03259074|66179615|FG001|Overall Study|Protocol Deviation|1|||
23670831|NCT03259074|66179616|FG002|Overall Study|Protocol Deviation|3|||
23670832|NCT03259074|66179614|FG000|Overall Study|Subject/Guardian Decision|13|||
23670833|NCT03259074|66179615|FG001|Overall Study|Subject/Guardian Decision|16|||
23670834|NCT03259074|66179616|FG002|Overall Study|Subject/Guardian Decision|14|||
23670835|NCT01999582|66179617|FG000|Overall Study|Withdrawal by Subject|0|||
23670836|NCT01999582|66179618|FG001|Overall Study|Withdrawal by Subject|0|||
23670837|NCT01999582|66179619|FG002|Overall Study|Withdrawal by Subject|0|||
23670838|NCT01999582|66179620|FG003|Overall Study|Withdrawal by Subject|1|||
23670839|NCT01999582|66179621|FG004|Overall Study|Withdrawal by Subject|0|||
23670840|NCT01999582|66179622|FG005|Overall Study|Withdrawal by Subject|0|||
23670841|NCT01999582|66179617|FG000|Overall Study|Adverse Event|0|||
23670842|NCT01999582|66179618|FG001|Overall Study|Adverse Event|0|||
23670843|NCT01999582|66179619|FG002|Overall Study|Adverse Event|3|||
23670844|NCT01999582|66179620|FG003|Overall Study|Adverse Event|0|||
23670845|NCT01999582|66179621|FG004|Overall Study|Adverse Event|1|||
23670846|NCT01999582|66179622|FG005|Overall Study|Adverse Event|0|||
23670847|NCT01999582|66179617|FG000|Overall Study|Other Reasons|1|||
23670848|NCT01999582|66179618|FG001|Overall Study|Other Reasons|0|||
23670849|NCT01999582|66179619|FG002|Overall Study|Other Reasons|3|||
23670850|NCT01999582|66179620|FG003|Overall Study|Other Reasons|1|||
23670851|NCT01999582|66179621|FG004|Overall Study|Other Reasons|1|||
23384441|NCT02318277|65151624|FG000|Overall Study|Transitioned to Hospice|0|||
23384442|NCT02318277|65151625|FG001|Overall Study|Transitioned to Hospice|0|||
23384443|NCT02318277|65151626|FG002|Overall Study|Transitioned to Hospice|0|||
23384444|NCT02318277|65151627|FG003|Overall Study|Transitioned to Hospice|0|||
23384445|NCT02318277|65151628|FG004|Overall Study|Transitioned to Hospice|0|||
23384446|NCT02318277|65151629|FG005|Overall Study|Transitioned to Hospice|1|||
23384447|NCT02318277|65151630|FG006|Overall Study|Transitioned to Hospice|0|||
23384448|NCT02318277|65151631|FG007|Overall Study|Transitioned to Hospice|0|||
23670852|NCT01999582|66179622|FG005|Overall Study|Other Reasons|2|||
23670853|NCT01999582|66179617|FG000|Overall Study|Protocol Violation|1|||
23670854|NCT01999582|66179618|FG001|Overall Study|Protocol Violation|0|||
23670855|NCT01999582|66179619|FG002|Overall Study|Protocol Violation|0|||
23670856|NCT01999582|66179620|FG003|Overall Study|Protocol Violation|0|||
23670857|NCT01999582|66179621|FG004|Overall Study|Protocol Violation|0|||
23670858|NCT01999582|66179622|FG005|Overall Study|Protocol Violation|1|||
23670859|NCT01999582|66179617|FG000|Overall Study|Lack of Efficacy|1|||
23670860|NCT01999582|66179618|FG001|Overall Study|Lack of Efficacy|3|||
23670861|NCT01999582|66179619|FG002|Overall Study|Lack of Efficacy|0|||
23670862|NCT01999582|66179620|FG003|Overall Study|Lack of Efficacy|1|||
23670863|NCT01999582|66179621|FG004|Overall Study|Lack of Efficacy|0|||
23670864|NCT01999582|66179622|FG005|Overall Study|Lack of Efficacy|0|||
23670865|NCT03776175|66179623|FG000|Treatment Period (42 Days)|Adverse Event|0|||
23670866|NCT03776175|66179624|FG001|Treatment Period (42 Days)|Adverse Event|1|||
23670867|NCT03776175|66179625|FG002|Treatment Period (42 Days)|Adverse Event|1|||
23670868|NCT03776175|66179626|FG003|Treatment Period (42 Days)|Adverse Event|0|||
23670869|NCT03776175|66179623|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
23670870|NCT03776175|66179624|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
23670871|NCT03776175|66179625|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
23670872|NCT03776175|66179626|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
23670873|NCT03776175|66179623|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
23670874|NCT03776175|66179624|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
23670875|NCT03776175|66179625|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
23670876|NCT03776175|66179626|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
23670877|NCT03776175|66179623|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
23670878|NCT03776175|66179624|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
23670879|NCT03776175|66179625|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
23670880|NCT03776175|66179626|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
23670881|NCT03776175|66179623|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
23670882|NCT03776175|66179624|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
23670883|NCT03776175|66179625|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
23670884|NCT03776175|66179626|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
23670885|NCT03776175|66179623|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23670886|NCT03776175|66179624|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23670887|NCT03776175|66179625|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23670888|NCT03776175|66179626|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
23670889|NCT00490568|66179627|FG000|Overall Study|Adverse Event|116|||
23670890|NCT00490568|66179627|FG000|Overall Study|Lost to Follow-up|13|||
23670891|NCT00490568|66179627|FG000|Overall Study|Protocol Violation|45|||
23670892|NCT00490568|66179627|FG000|Overall Study|Withdrawal by Subject|135|||
23670893|NCT00490568|66179627|FG000|Overall Study|Still in the study at termination|974|||
23670894|NCT00490568|66179627|FG000|Overall Study|Other|1|||
23670895|NCT00490568|66179627|FG000|Overall Study|Exclusion criteria met|1|||
23670896|NCT00490568|66179627|FG000|Overall Study|Caregiver related|20|||
23670897|NCT00490568|66179627|FG000|Overall Study|Abnormal ECG|25|||
23670898|NCT00490568|66179627|FG000|Overall Study|Participant refused follow-up|9|||
23670899|NCT00490568|66179627|FG000|Overall Study|Legal representative withdrew consent|1|||
23670900|NCT00490568|66179627|FG000|Overall Study|Disease progression|4|||
23670901|NCT00490568|66179627|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
23670902|NCT00490568|66179627|FG000|Overall Study|Investigator decision|3|||
23670903|NCT00490568|66179627|FG000|Overall Study|Non-Compliance|7|||
23670904|NCT00490568|66179627|FG000|Overall Study|Efficacy related|3|||
23670905|NCT00490568|66179627|FG000|Overall Study|Participant died|1|||
23670906|NCT00490568|66179627|FG000|Overall Study|Participant withdrawal due to surgery|1|||
23670907|NCT00487539|66179628|FG000|Overall Study|Adverse Event|3|||
23670908|NCT00487539|66179629|FG001|Overall Study|Adverse Event|2|||
23670909|NCT00487539|66179630|FG002|Overall Study|Adverse Event|1|||
23670910|NCT00487539|66179631|FG003|Overall Study|Adverse Event|1|||
23670911|NCT00487539|66179628|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23670912|NCT00487539|66179629|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23670913|NCT00487539|66179630|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23670914|NCT00487539|66179631|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
23670915|NCT00487539|66179628|FG000|Overall Study|Other|3|||
23670916|NCT00487539|66179629|FG001|Overall Study|Other|1|||
23670917|NCT00487539|66179630|FG002|Overall Study|Other|2|||
23670918|NCT00487539|66179631|FG003|Overall Study|Other|2|||
23670919|NCT00640328|66179632|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23670920|NCT00640328|66179633|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
23670921|NCT00640328|66179634|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23670922|NCT00640328|66179635|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23670923|NCT00640328|66179636|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23670924|NCT00640328|66179637|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23670925|NCT00640328|66179632|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23670926|NCT00640328|66179633|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23670927|NCT00640328|66179634|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23670928|NCT00640328|66179635|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23670929|NCT00640328|66179636|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
23670930|NCT00640328|66179637|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23670931|NCT00640328|66179632|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23670932|NCT00640328|66179633|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23670933|NCT00640328|66179634|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
23670934|NCT00640328|66179635|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23670935|NCT00640328|66179636|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23670936|NCT00640328|66179637|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23670937|NCT00640328|66179632|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23670938|NCT00640328|66179633|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
23670939|NCT00640328|66179634|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23670940|NCT00640328|66179635|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
23670941|NCT00640328|66179636|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23670942|NCT00640328|66179637|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23670943|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
23670944|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
23670945|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
23670946|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
23384449|NCT01178411|65151632|FG000|Overall Study|Adverse Event|5|||
23384450|NCT01178411|65151632|FG000|Overall Study|Withdrawal by Subject|4|||
23670947|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
23670948|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
23670949|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
23670950|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
23670951|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
23670952|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
23670953|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
23670954|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
23670955|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
23670956|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
23670957|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
23670958|NCT00960661|66179640|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
23670959|NCT00960661|66179641|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
23670960|NCT00960661|66179642|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
23670961|NCT00960661|66179640|FG000|Interventional Phase|Adverse Event|0|||
23670962|NCT00960661|66179641|FG001|Interventional Phase|Adverse Event|17|||
23670963|NCT00960661|66179642|FG002|Interventional Phase|Adverse Event|8|||
23670964|NCT00960661|66179640|FG000|Interventional Phase|Death|0|||
23670965|NCT00960661|66179641|FG001|Interventional Phase|Death|1|||
23670966|NCT00960661|66179642|FG002|Interventional Phase|Death|0|||
23670967|NCT00960661|66179640|FG000|Interventional Phase|Lost to Follow-up|0|||
23670968|NCT00960661|66179641|FG001|Interventional Phase|Lost to Follow-up|0|||
23670969|NCT00960661|66179642|FG002|Interventional Phase|Lost to Follow-up|2|||
23670970|NCT00960661|66179640|FG000|Interventional Phase|entry criteria not met|0|||
23670971|NCT00960661|66179641|FG001|Interventional Phase|entry criteria not met|3|||
23670972|NCT00960661|66179642|FG002|Interventional Phase|entry criteria not met|0|||
23670973|NCT00960661|66179640|FG000|Interventional Phase|Protocol Violation|0|||
23670974|NCT00960661|66179641|FG001|Interventional Phase|Protocol Violation|7|||
23670975|NCT00960661|66179642|FG002|Interventional Phase|Protocol Violation|2|||
23670976|NCT00960661|66179640|FG000|Interventional Phase|Withdrawal by Subject|0|||
23670977|NCT00960661|66179641|FG001|Interventional Phase|Withdrawal by Subject|18|||
23670978|NCT00960661|66179642|FG002|Interventional Phase|Withdrawal by Subject|29|||
23670979|NCT00960661|66179640|FG000|Interventional Phase|Physician Decision|0|||
23384451|NCT01178411|65151632|FG000|Overall Study|Protocol Violation|1|||
23384452|NCT01178411|65151632|FG000|Overall Study|Progressive disease per RECIST|32|||
23670980|NCT00960661|66179641|FG001|Interventional Phase|Physician Decision|3|||
23670981|NCT00960661|66179642|FG002|Interventional Phase|Physician Decision|5|||
23670982|NCT00960661|66179640|FG000|Interventional Phase|sponsor decision|0|||
23670983|NCT00960661|66179641|FG001|Interventional Phase|sponsor decision|1|||
23670984|NCT00960661|66179642|FG002|Interventional Phase|sponsor decision|0|||
23670985|NCT00960661|66179640|FG000|Interventional Phase|Lack of Efficacy|0|||
23670986|NCT00960661|66179641|FG001|Interventional Phase|Lack of Efficacy|2|||
23670987|NCT00960661|66179642|FG002|Interventional Phase|Lack of Efficacy|0|||
23670988|NCT00805480|66179643|FG000|Overall Study|Withdrawal by Subject|13|||
23670989|NCT00805480|66179644|FG001|Overall Study|Withdrawal by Subject|5|||
23670990|NCT00805480|66179645|FG002|Overall Study|Withdrawal by Subject|11|||
23670991|NCT00805480|66179646|FG003|Overall Study|Withdrawal by Subject|5|||
23670992|NCT00805480|66179643|FG000|Overall Study|Lost to Follow-up|1|||
23670993|NCT00805480|66179644|FG001|Overall Study|Lost to Follow-up|2|||
23384453|NCT01178411|65151632|FG000|Overall Study|Progressive disease per clinician|9|||
23670994|NCT00805480|66179645|FG002|Overall Study|Lost to Follow-up|0|||
23670995|NCT00805480|66179646|FG003|Overall Study|Lost to Follow-up|0|||
23670996|NCT00805480|66179643|FG000|Overall Study|Adverse Event|0|||
23670997|NCT00805480|66179644|FG001|Overall Study|Adverse Event|0|||
23670998|NCT00805480|66179645|FG002|Overall Study|Adverse Event|1|||
23670999|NCT00805480|66179646|FG003|Overall Study|Adverse Event|0|||
23671000|NCT02937350|66179648|FG000|Overall Study|Withdrawal by Subject|0|||
23671001|NCT02937350|66179649|FG001|Overall Study|Withdrawal by Subject|1|||
23671002|NCT02937350|66179650|FG002|Overall Study|Withdrawal by Subject|0|||
23671003|NCT04677959|66179651|FG000|Overall Study|Adverse Event|1|||
23671004|NCT04677959|66179652|FG001|Overall Study|Adverse Event|9|||
23671005|NCT04677959|66179651|FG000|Overall Study|Withdrawal by Subject|2|||
23671006|NCT04677959|66179652|FG001|Overall Study|Withdrawal by Subject|15|||
23671007|NCT04677959|66179651|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23671008|NCT04677959|66179652|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23384454|NCT01178411|65151632|FG000|Overall Study|Physician Decision|6|||
23671009|NCT04677959|66179651|FG000|Overall Study|Non-compliance with study drug|0|||
23384455|NCT01178411|65151632|FG000|Overall Study|Death|1|||
23384456|NCT01178411|65151632|FG000|Overall Study|No reason provided|1|||
23384457|NCT01178411|65151632|FG000|Overall Study|Drug manufacturing ended|1|||
23384458|NCT01797185|65151633|FG000|Overall Study|Adverse Event|5|||
23384459|NCT01797185|65151634|FG001|Overall Study|Adverse Event|15|||
23384460|NCT01797185|65151635|FG002|Overall Study|Adverse Event|6|||
23384461|NCT01797185|65151633|FG000|Overall Study|Withdrawal by Subject|6|||
23384462|NCT01797185|65151634|FG001|Overall Study|Withdrawal by Subject|9|||
23384463|NCT01797185|65151635|FG002|Overall Study|Withdrawal by Subject|5|||
23384464|NCT01797185|65151633|FG000|Overall Study|Site terminated|8|||
23384465|NCT01797185|65151634|FG001|Overall Study|Site terminated|4|||
23384466|NCT01797185|65151635|FG002|Overall Study|Site terminated|0|||
23384467|NCT01797185|65151633|FG000|Overall Study|Lost to Follow-up|2|||
23384468|NCT01797185|65151634|FG001|Overall Study|Lost to Follow-up|6|||
23384469|NCT01797185|65151635|FG002|Overall Study|Lost to Follow-up|1|||
23384470|NCT01797185|65151633|FG000|Overall Study|Withdrawn per sponsor|5|||
23384471|NCT01797185|65151634|FG001|Overall Study|Withdrawn per sponsor|0|||
23384472|NCT01797185|65151635|FG002|Overall Study|Withdrawn per sponsor|0|||
23384473|NCT01797185|65151633|FG000|Overall Study|Physician Decision|1|||
23384474|NCT01797185|65151634|FG001|Overall Study|Physician Decision|3|||
23384475|NCT01797185|65151635|FG002|Overall Study|Physician Decision|0|||
23384476|NCT01797185|65151633|FG000|Overall Study|Protocol Violation|1|||
23384477|NCT01797185|65151634|FG001|Overall Study|Protocol Violation|1|||
23384478|NCT01797185|65151635|FG002|Overall Study|Protocol Violation|0|||
23384479|NCT01698008|65151645|FG000|Overall Study|Withdrawal by Subject|1|||
23671010|NCT04677959|66179652|FG001|Overall Study|Non-compliance with study drug|2|||
23671011|NCT04677959|66179651|FG000|Overall Study|Protocol deviation|0|||
23671012|NCT04677959|66179652|FG001|Overall Study|Protocol deviation|11|||
23671013|NCT04677959|66179651|FG000|Overall Study|Lost to Follow-up|9|||
23671014|NCT04677959|66179652|FG001|Overall Study|Lost to Follow-up|13|||
23671015|NCT04677959|66179651|FG000|Overall Study|Other than specified|0|||
23671016|NCT04677959|66179652|FG001|Overall Study|Other than specified|8|||
23671017|NCT01836783|66179653|FG000|Overall Study|Withdrawal by Subject|0|||
23671018|NCT01836783|66179654|FG001|Overall Study|Withdrawal by Subject|2|||
23671019|NCT04191382|66179658|FG000|Overall Study|Withdrawal by Subject|1|||
23671020|NCT04191382|66179659|FG001|Overall Study|Withdrawal by Subject|0|||
23671021|NCT04191382|66179660|FG002|Overall Study|Withdrawal by Subject|0|||
23671022|NCT01452152|66179661|FG000|Overall Study|Study termination by sponsor|5|||
23671023|NCT01452152|66179662|FG001|Overall Study|Study termination by sponsor|0|||
23671024|NCT01452152|66179663|FG002|Overall Study|Study termination by sponsor|4|||
23671025|NCT04042103|66179664|FG000|Overall Study|Lost to Follow-up|1|||
23671026|NCT04042103|66179664|FG000|Overall Study|Withdrawal by Subject|1|||
23671027|NCT03809611|66179669|FG000|Overall Study|Withdrawal by Subject|1|||
23671028|NCT03809611|66179670|FG001|Overall Study|Withdrawal by Subject|1|||
23671029|NCT00053417|66179671|FG000|Overall Study|Adverse Event|1|||
23671030|NCT00053417|66179672|FG001|Overall Study|Adverse Event|0|||
23671031|NCT00053417|66179673|FG002|Overall Study|Adverse Event|1|||
23384480|NCT01698008|65151646|FG001|Overall Study|Withdrawal by Subject|2|||
23384481|NCT00397930|65151647|FG000|Overall Study|Personal reasons|14|||
23384482|NCT00397930|65151648|FG001|Overall Study|Personal reasons|8|||
23384483|NCT00397930|65151647|FG000|Overall Study|Other medical|9|||
23384484|NCT00397930|65151648|FG001|Overall Study|Other medical|4|||
23384485|NCT00397930|65151647|FG000|Overall Study|Unknown reasons|9|||
23671032|NCT00053417|66179674|FG003|Overall Study|Adverse Event|5|||
23671033|NCT00053417|66179671|FG000|Overall Study|Non-Compliance|0|||
23671034|NCT00053417|66179672|FG001|Overall Study|Non-Compliance|0|||
23384486|NCT00397930|65151648|FG001|Overall Study|Unknown reasons|14|||
23384487|NCT00397930|65151647|FG000|Overall Study|Noncompliant|3|||
23384488|NCT00397930|65151648|FG001|Overall Study|Noncompliant|2|||
23384489|NCT00397930|65151647|FG000|Overall Study|Too time-consuming|2|||
23384490|NCT00397930|65151648|FG001|Overall Study|Too time-consuming|9|||
23384491|NCT00397930|65151647|FG000|Overall Study|Started own yoga program|1|||
23671035|NCT00053417|66179673|FG002|Overall Study|Non-Compliance|0|||
23671036|NCT00053417|66179674|FG003|Overall Study|Non-Compliance|1|||
23384492|NCT00397930|65151648|FG001|Overall Study|Started own yoga program|1|||
23384493|NCT00397930|65151647|FG000|Overall Study|Did not want to be in control group|0|||
23384494|NCT00397930|65151648|FG001|Overall Study|Did not want to be in control group|1|||
23384495|NCT00397930|65151647|FG000|Overall Study|Withdrawal by Subject|0|||
23384496|NCT00397930|65151648|FG001|Overall Study|Withdrawal by Subject|8|||
23384497|NCT00397930|65151647|FG000|Overall Study|Missing data|0|||
23384498|NCT00397930|65151648|FG001|Overall Study|Missing data|4|||
23384499|NCT01716156|65151650|FG000|Overall Study|Protocol Violation|1|||
23384500|NCT01716156|65151651|FG001|Overall Study|Protocol Violation|0|||
23384501|NCT01716156|65151652|FG002|Overall Study|Protocol Violation|0|||
23384502|NCT01716156|65151650|FG000|Overall Study|Withdrawal by Subject|0|||
23384503|NCT01716156|65151651|FG001|Overall Study|Withdrawal by Subject|1|||
23384504|NCT01716156|65151652|FG002|Overall Study|Withdrawal by Subject|2|||
23384505|NCT01716156|65151650|FG000|Overall Study|Lost to Follow-up|1|||
23384506|NCT01716156|65151651|FG001|Overall Study|Lost to Follow-up|0|||
23384507|NCT01716156|65151652|FG002|Overall Study|Lost to Follow-up|0|||
23384508|NCT02082483|65151653|FG000|Overall Study|Lost to Follow-up|1|||
23384509|NCT02082483|65151654|FG001|Overall Study|Lost to Follow-up|1|||
23384510|NCT02082483|65151653|FG000|Overall Study|Withdrawal by Subject|2|||
23384511|NCT02082483|65151654|FG001|Overall Study|Withdrawal by Subject|1|||
23384512|NCT02082483|65151653|FG000|Overall Study|Physician Decision|1|||
23384513|NCT02082483|65151654|FG001|Overall Study|Physician Decision|1|||
23384514|NCT02082483|65151653|FG000|Overall Study|Death|2|||
23384515|NCT02082483|65151654|FG001|Overall Study|Death|3|||
23384516|NCT00368849|65151659|FG000|Overall Study|Withdrawal by Subject|0|||
23384517|NCT00368849|65151660|FG001|Overall Study|Withdrawal by Subject|1|||
23384518|NCT00368849|65151659|FG000|Overall Study|Physician Decision|0|||
23384519|NCT00368849|65151660|FG001|Overall Study|Physician Decision|1|||
23384520|NCT01896986|65151661|FG000|Overall Study|samples lost|14|||
23384521|NCT01896986|65151662|FG001|Overall Study|samples lost|23|||
23384522|NCT02218268|65151663|FG000|24 Hour Washout|Physician Decision|11|||
23384523|NCT02218268|65151664|FG001|24 Hour Washout|Physician Decision|9|||
23384524|NCT00639379|65151665|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
23384525|NCT00639379|65151666|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
23384526|NCT00639379|65151665|FG000|Period 1 - 2 Weeks|lens issue|3|||
23384527|NCT00639379|65151666|FG001|Period 1 - 2 Weeks|lens issue|0|||
23384528|NCT02541903|65151669|FG000|Overall Study|Death|1|||
23384529|NCT03178942|65151670|FG000|Overall Study|Withdrawal by Subject|2|||
23384530|NCT03178942|65151671|FG001|Overall Study|Withdrawal by Subject|0|||
23384531|NCT03178942|65151670|FG000|Overall Study|Lost to Follow-up|1|||
23384532|NCT03178942|65151671|FG001|Overall Study|Lost to Follow-up|2|||
23384533|NCT02493855|65151672|FG000|Overall Study|Non-compliance|1|||
23384534|NCT02493855|65151673|FG001|Overall Study|Non-compliance|0|||
23384535|NCT02493855|65151674|FG002|Overall Study|Non-compliance|0|||
23384536|NCT02493855|65151672|FG000|Overall Study|Adverse Event|0|||
23384537|NCT02493855|65151673|FG001|Overall Study|Adverse Event|1|||
23384538|NCT02493855|65151674|FG002|Overall Study|Adverse Event|0|||
23384539|NCT02493855|65151672|FG000|Overall Study|Withdrawal by Subject|1|||
23384540|NCT02493855|65151673|FG001|Overall Study|Withdrawal by Subject|0|||
23384541|NCT02493855|65151674|FG002|Overall Study|Withdrawal by Subject|0|||
23384542|NCT02533674|65151677|FG000|Dose Level I|Progressive disease|1|||
23384543|NCT02533674|65151678|FG001|Dose Level I|Progressive disease|0|||
23384544|NCT02533674|65151679|FG002|Dose Level I|Progressive disease|0|||
23384545|NCT02533674|65151680|FG003|Dose Level I|Progressive disease|0|||
23384546|NCT02533674|65151681|FG004|Dose Level I|Progressive disease|0|||
23384547|NCT02533674|65151682|FG005|Dose Level I|Progressive disease|0|||
23384548|NCT02533674|65151683|FG006|Dose Level I|Progressive disease|0|||
23384549|NCT02533674|65151684|FG007|Dose Level I|Progressive disease|0|||
23384550|NCT02533674|65151677|FG000|Dose Level I|Withdrawal by Subject|1|||
23384551|NCT02533674|65151678|FG001|Dose Level I|Withdrawal by Subject|0|||
23671037|NCT00053417|66179671|FG000|Overall Study|Withdrawal by Subject|0|||
23671038|NCT00053417|66179672|FG001|Overall Study|Withdrawal by Subject|1|||
23671039|NCT00053417|66179673|FG002|Overall Study|Withdrawal by Subject|0|||
23671040|NCT00053417|66179674|FG003|Overall Study|Withdrawal by Subject|0|||
23671041|NCT00053417|66179671|FG000|Overall Study|Lost to Follow-up|1|||
23671042|NCT00053417|66179672|FG001|Overall Study|Lost to Follow-up|1|||
23671043|NCT00053417|66179673|FG002|Overall Study|Lost to Follow-up|0|||
23671044|NCT00053417|66179674|FG003|Overall Study|Lost to Follow-up|0|||
23671045|NCT03189446|66179676|FG000|Overall Study|Adverse Event|2|||
23384552|NCT02533674|65151679|FG002|Dose Level I|Withdrawal by Subject|0|||
23384553|NCT02533674|65151680|FG003|Dose Level I|Withdrawal by Subject|0|||
23384554|NCT02533674|65151681|FG004|Dose Level I|Withdrawal by Subject|0|||
23384555|NCT02533674|65151682|FG005|Dose Level I|Withdrawal by Subject|0|||
23384556|NCT02533674|65151683|FG006|Dose Level I|Withdrawal by Subject|0|||
23384557|NCT02533674|65151684|FG007|Dose Level I|Withdrawal by Subject|0|||
23384558|NCT02533674|65151677|FG000|Dose Level I|Physician Decision|1|||
23384559|NCT02533674|65151678|FG001|Dose Level I|Physician Decision|0|||
23384560|NCT02533674|65151679|FG002|Dose Level I|Physician Decision|0|||
23671046|NCT03189446|66179676|FG000|Overall Study|Withdrawal by Subject|2|||
23671047|NCT03189446|66179676|FG000|Overall Study|Physician Decision|1|||
23671048|NCT03286842|66179677|FG000|Overall Study|Patients rolled over to another study|80|||
23671049|NCT00088374|66179678|FG000|Overall Study|patient did not receive any 17AAG|1|||
23671050|NCT00088374|66179678|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
23671051|NCT03033875|66179679|FG000|Overall Study|Withdrawal by Subject|5|||
23671052|NCT03033875|66179680|FG001|Overall Study|Withdrawal by Subject|9|||
23671053|NCT03033875|66179681|FG002|Overall Study|Withdrawal by Subject|4|||
23671054|NCT03033875|66179679|FG000|Overall Study|Other|14|||
23671055|NCT03033875|66179680|FG001|Overall Study|Other|15|||
23671056|NCT03033875|66179681|FG002|Overall Study|Other|8|||
23671057|NCT00004259|66179684|FG000|Overall Study|Protocol Violation|1|||
23384561|NCT02533674|65151680|FG003|Dose Level I|Physician Decision|0|||
23384562|NCT02533674|65151681|FG004|Dose Level I|Physician Decision|0|||
23384563|NCT02533674|65151682|FG005|Dose Level I|Physician Decision|0|||
23384564|NCT02533674|65151683|FG006|Dose Level I|Physician Decision|0|||
23384565|NCT02533674|65151684|FG007|Dose Level I|Physician Decision|0|||
23384566|NCT02533674|65151677|FG000|Dose Level I|Death|1|||
23384567|NCT02533674|65151678|FG001|Dose Level I|Death|0|||
23384568|NCT02533674|65151679|FG002|Dose Level I|Death|0|||
23384569|NCT02533674|65151680|FG003|Dose Level I|Death|0|||
23384570|NCT02533674|65151681|FG004|Dose Level I|Death|0|||
23671058|NCT00004259|66179685|FG001|Overall Study|Protocol Violation|2|||
23671059|NCT00004259|66179686|FG002|Overall Study|Protocol Violation|0|||
23671060|NCT00004259|66179687|FG003|Overall Study|Protocol Violation|0|||
23671061|NCT00004259|66179684|FG000|Overall Study|Withdrawal by Subject|0|||
23671062|NCT00004259|66179685|FG001|Overall Study|Withdrawal by Subject|2|||
23671063|NCT00004259|66179686|FG002|Overall Study|Withdrawal by Subject|0|||
23671064|NCT00004259|66179687|FG003|Overall Study|Withdrawal by Subject|0|||
23671065|NCT01888640|66179688|FG000|Overall Study|Lost to Follow-up|1|||
23671066|NCT01888640|66179689|FG001|Overall Study|Lost to Follow-up|2|||
23671067|NCT01888640|66179690|FG002|Overall Study|Lost to Follow-up|0|||
23671068|NCT01888640|66179688|FG000|Overall Study|Withdrawal by Subject|15|||
23671069|NCT01888640|66179689|FG001|Overall Study|Withdrawal by Subject|11|||
23671070|NCT01888640|66179690|FG002|Overall Study|Withdrawal by Subject|4|||
23671071|NCT01888640|66179688|FG000|Overall Study|Minimum dose not met|10|||
23671072|NCT01888640|66179689|FG001|Overall Study|Minimum dose not met|16|||
23671073|NCT01888640|66179690|FG002|Overall Study|Minimum dose not met|0|||
23671074|NCT01888640|66179688|FG000|Overall Study|Given wrong unit (placebo)|1|||
23671075|NCT01888640|66179689|FG001|Overall Study|Given wrong unit (placebo)|0|||
23671076|NCT01888640|66179690|FG002|Overall Study|Given wrong unit (placebo)|0|||
23671077|NCT01888640|66179688|FG000|Overall Study|Excluded for prior TENS|0|||
23671078|NCT01888640|66179689|FG001|Overall Study|Excluded for prior TENS|1|||
23671079|NCT01888640|66179690|FG002|Overall Study|Excluded for prior TENS|0|||
23671080|NCT01888640|66179688|FG000|Overall Study|Researcher Termination of Participant|0|||
23384571|NCT02533674|65151682|FG005|Dose Level I|Death|0|||
23384572|NCT02533674|65151683|FG006|Dose Level I|Death|0|||
23384573|NCT02533674|65151684|FG007|Dose Level I|Death|0|||
23606053|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Adverse Event|0|||
23671081|NCT01888640|66179689|FG001|Overall Study|Researcher Termination of Participant|1|||
23671082|NCT01888640|66179690|FG002|Overall Study|Researcher Termination of Participant|1|||
23671083|NCT03075527|66179691|FG000|Overall Study|Ongoing treatment|2|||
23671084|NCT04036708|66179692|FG000|Overall Study|Lost to Follow-up|14|||
23671085|NCT04036708|66179693|FG001|Overall Study|Lost to Follow-up|4|||
23671086|NCT04036708|66179694|FG002|Overall Study|Lost to Follow-up|14|||
23671087|NCT04036708|66179695|FG003|Overall Study|Lost to Follow-up|4|||
23384574|NCT02533674|65151677|FG000|Dose Level I|Never Treated|1|||
23384575|NCT02533674|65151678|FG001|Dose Level I|Never Treated|0|||
23671088|NCT00866307|66179696|FG000|Induction|Adverse Event|5|||
23671089|NCT00866307|66179697|FG001|Induction|Adverse Event|0|||
23671090|NCT00866307|66179698|FG002|Induction|Adverse Event|0|||
23671091|NCT00866307|66179696|FG000|Induction|Death|2|||
23671092|NCT00866307|66179697|FG001|Induction|Death|0|||
23671093|NCT00866307|66179698|FG002|Induction|Death|0|||
23493186|NCT03650556|65551383|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
23671094|NCT00866307|66179696|FG000|Induction|Physician Decision|5|||
23384576|NCT02533674|65151679|FG002|Dose Level I|Never Treated|0|||
23671095|NCT00866307|66179697|FG001|Induction|Physician Decision|0|||
23384577|NCT02533674|65151680|FG003|Dose Level I|Never Treated|0|||
23384578|NCT02533674|65151681|FG004|Dose Level I|Never Treated|0|||
23384579|NCT02533674|65151682|FG005|Dose Level I|Never Treated|0|||
23384580|NCT02533674|65151683|FG006|Dose Level I|Never Treated|0|||
23384581|NCT02533674|65151684|FG007|Dose Level I|Never Treated|0|||
23384582|NCT02533674|65151677|FG000|Dose Level II|Progressive disease|0|||
23384583|NCT02533674|65151678|FG001|Dose Level II|Progressive disease|3|||
23384584|NCT02533674|65151679|FG002|Dose Level II|Progressive disease|0|||
23384585|NCT02533674|65151680|FG003|Dose Level II|Progressive disease|0|||
23384586|NCT02533674|65151681|FG004|Dose Level II|Progressive disease|0|||
23384587|NCT02533674|65151682|FG005|Dose Level II|Progressive disease|0|||
23384588|NCT02533674|65151683|FG006|Dose Level II|Progressive disease|0|||
23384589|NCT02533674|65151684|FG007|Dose Level II|Progressive disease|0|||
23384590|NCT02533674|65151677|FG000|Dose Level II|Withdrawal by Subject|0|||
23384591|NCT02533674|65151678|FG001|Dose Level II|Withdrawal by Subject|1|||
23384592|NCT02533674|65151679|FG002|Dose Level II|Withdrawal by Subject|0|||
23384593|NCT02533674|65151680|FG003|Dose Level II|Withdrawal by Subject|0|||
23384594|NCT02533674|65151681|FG004|Dose Level II|Withdrawal by Subject|0|||
23384595|NCT02533674|65151682|FG005|Dose Level II|Withdrawal by Subject|0|||
23384596|NCT02533674|65151683|FG006|Dose Level II|Withdrawal by Subject|0|||
23384597|NCT02533674|65151684|FG007|Dose Level II|Withdrawal by Subject|0|||
23384598|NCT02533674|65151677|FG000|Dose Level II|Treatment-related AE|0|||
23384599|NCT02533674|65151678|FG001|Dose Level II|Treatment-related AE|1|||
23384600|NCT02533674|65151679|FG002|Dose Level II|Treatment-related AE|0|||
23384601|NCT02533674|65151680|FG003|Dose Level II|Treatment-related AE|0|||
23384602|NCT02533674|65151681|FG004|Dose Level II|Treatment-related AE|0|||
23384603|NCT02533674|65151682|FG005|Dose Level II|Treatment-related AE|0|||
23384604|NCT02533674|65151683|FG006|Dose Level II|Treatment-related AE|0|||
23384605|NCT02533674|65151684|FG007|Dose Level II|Treatment-related AE|0|||
23384606|NCT02533674|65151677|FG000|Dose Level II|Physician Decision|0|||
23384607|NCT02533674|65151678|FG001|Dose Level II|Physician Decision|1|||
23384608|NCT02533674|65151679|FG002|Dose Level II|Physician Decision|0|||
23384609|NCT02533674|65151680|FG003|Dose Level II|Physician Decision|0|||
23384610|NCT02533674|65151681|FG004|Dose Level II|Physician Decision|0|||
23384611|NCT02533674|65151682|FG005|Dose Level II|Physician Decision|0|||
23384612|NCT02533674|65151683|FG006|Dose Level II|Physician Decision|0|||
23384613|NCT02533674|65151684|FG007|Dose Level II|Physician Decision|0|||
23384614|NCT02533674|65151677|FG000|Dose Level II|Non-treatment-related AE|0|||
23384615|NCT02533674|65151678|FG001|Dose Level II|Non-treatment-related AE|1|||
23384616|NCT02533674|65151679|FG002|Dose Level II|Non-treatment-related AE|0|||
23384617|NCT02533674|65151680|FG003|Dose Level II|Non-treatment-related AE|0|||
23384618|NCT02533674|65151681|FG004|Dose Level II|Non-treatment-related AE|0|||
23671096|NCT00866307|66179698|FG002|Induction|Physician Decision|0|||
23671097|NCT00866307|66179696|FG000|Induction|Progressive Disease|1|||
23671098|NCT00866307|66179697|FG001|Induction|Progressive Disease|0|||
23671099|NCT00866307|66179698|FG002|Induction|Progressive Disease|0|||
23671100|NCT00866307|66179696|FG000|Induction|Identification of Patients with Day 29 M|3|||
23671101|NCT00866307|66179697|FG001|Induction|Identification of Patients with Day 29 M|0|||
23671102|NCT00866307|66179698|FG002|Induction|Identification of Patients with Day 29 M|0|||
23671103|NCT00866307|66179696|FG000|Induction|Inadequate cytognetic samples th|1|||
23671104|NCT00866307|66179697|FG001|Induction|Inadequate cytognetic samples th|0|||
23671105|NCT00866307|66179698|FG002|Induction|Inadequate cytognetic samples th|0|||
23671106|NCT00866307|66179696|FG000|Induction|Improper post-induction consent|2|||
23671107|NCT00866307|66179697|FG001|Induction|Improper post-induction consent|0|||
23671108|NCT00866307|66179698|FG002|Induction|Improper post-induction consent|0|||
23671109|NCT00866307|66179696|FG000|Induction|Study was closed at the time|1|||
23671110|NCT00866307|66179697|FG001|Induction|Study was closed at the time|0|||
23671111|NCT00866307|66179698|FG002|Induction|Study was closed at the time|0|||
23671112|NCT00866307|66179696|FG000|Consolidation/Maintenance|Adverse Event|0|||
23671113|NCT00866307|66179697|FG001|Consolidation/Maintenance|Adverse Event|0|||
23671114|NCT00866307|66179698|FG002|Consolidation/Maintenance|Adverse Event|8|||
23671115|NCT00866307|66179696|FG000|Consolidation/Maintenance|Death|0|||
23671116|NCT00866307|66179697|FG001|Consolidation/Maintenance|Death|0|||
23384619|NCT02533674|65151682|FG005|Dose Level II|Non-treatment-related AE|0|||
23384620|NCT02533674|65151683|FG006|Dose Level II|Non-treatment-related AE|0|||
23384621|NCT02533674|65151684|FG007|Dose Level II|Non-treatment-related AE|0|||
23384622|NCT02533674|65151677|FG000|Dose Level III|Progressive disease|0|||
23384623|NCT02533674|65151678|FG001|Dose Level III|Progressive disease|0|||
23384624|NCT02533674|65151679|FG002|Dose Level III|Progressive disease|2|||
23384625|NCT02533674|65151680|FG003|Dose Level III|Progressive disease|0|||
23671117|NCT00866307|66179698|FG002|Consolidation/Maintenance|Death|1|||
23671118|NCT00866307|66179696|FG000|Consolidation/Maintenance|Physician Decision|0|||
23384626|NCT02533674|65151681|FG004|Dose Level III|Progressive disease|0|||
23384627|NCT02533674|65151682|FG005|Dose Level III|Progressive disease|0|||
23384628|NCT02533674|65151683|FG006|Dose Level III|Progressive disease|0|||
23384629|NCT02533674|65151684|FG007|Dose Level III|Progressive disease|0|||
23384630|NCT02533674|65151677|FG000|Dose Level III|Withdrawal by Subject|0|||
23384631|NCT02533674|65151678|FG001|Dose Level III|Withdrawal by Subject|0|||
23384632|NCT02533674|65151679|FG002|Dose Level III|Withdrawal by Subject|1|||
23384633|NCT02533674|65151680|FG003|Dose Level III|Withdrawal by Subject|0|||
23384634|NCT02533674|65151681|FG004|Dose Level III|Withdrawal by Subject|0|||
23384635|NCT02533674|65151682|FG005|Dose Level III|Withdrawal by Subject|0|||
23384636|NCT02533674|65151683|FG006|Dose Level III|Withdrawal by Subject|0|||
23384637|NCT02533674|65151684|FG007|Dose Level III|Withdrawal by Subject|0|||
23384638|NCT02533674|65151677|FG000|Dose Level III|Treatment-related AE|0|||
23384639|NCT02533674|65151678|FG001|Dose Level III|Treatment-related AE|0|||
23384640|NCT02533674|65151679|FG002|Dose Level III|Treatment-related AE|1|||
23384641|NCT02533674|65151680|FG003|Dose Level III|Treatment-related AE|0|||
23384642|NCT02533674|65151681|FG004|Dose Level III|Treatment-related AE|0|||
23384643|NCT02533674|65151682|FG005|Dose Level III|Treatment-related AE|0|||
23384644|NCT02533674|65151683|FG006|Dose Level III|Treatment-related AE|0|||
23384645|NCT02533674|65151684|FG007|Dose Level III|Treatment-related AE|0|||
23384646|NCT02533674|65151677|FG000|Dose Level IV|Progressive disease|0|||
23384647|NCT02533674|65151678|FG001|Dose Level IV|Progressive disease|0|||
23384648|NCT02533674|65151679|FG002|Dose Level IV|Progressive disease|0|||
23384649|NCT02533674|65151680|FG003|Dose Level IV|Progressive disease|3|||
23384650|NCT02533674|65151681|FG004|Dose Level IV|Progressive disease|0|||
23384651|NCT02533674|65151682|FG005|Dose Level IV|Progressive disease|0|||
23384652|NCT02533674|65151683|FG006|Dose Level IV|Progressive disease|0|||
23384653|NCT02533674|65151684|FG007|Dose Level IV|Progressive disease|0|||
23384654|NCT02533674|65151677|FG000|Dose Level IV|Withdrawal by Subject|0|||
23384655|NCT02533674|65151678|FG001|Dose Level IV|Withdrawal by Subject|0|||
23384656|NCT02533674|65151679|FG002|Dose Level IV|Withdrawal by Subject|0|||
23384657|NCT02533674|65151680|FG003|Dose Level IV|Withdrawal by Subject|1|||
23384658|NCT02533674|65151681|FG004|Dose Level IV|Withdrawal by Subject|0|||
23384659|NCT02533674|65151682|FG005|Dose Level IV|Withdrawal by Subject|0|||
23384660|NCT02533674|65151683|FG006|Dose Level IV|Withdrawal by Subject|0|||
23384661|NCT02533674|65151684|FG007|Dose Level IV|Withdrawal by Subject|0|||
23384662|NCT02533674|65151677|FG000|Dose Level IV|Physician Decision|0|||
23384663|NCT02533674|65151678|FG001|Dose Level IV|Physician Decision|0|||
23384664|NCT02533674|65151679|FG002|Dose Level IV|Physician Decision|0|||
23384665|NCT02533674|65151680|FG003|Dose Level IV|Physician Decision|1|||
23384666|NCT02533674|65151681|FG004|Dose Level IV|Physician Decision|0|||
23384667|NCT02533674|65151682|FG005|Dose Level IV|Physician Decision|0|||
23384668|NCT02533674|65151683|FG006|Dose Level IV|Physician Decision|0|||
23384669|NCT02533674|65151684|FG007|Dose Level IV|Physician Decision|0|||
23384670|NCT02533674|65151677|FG000|Dose Level V|Progressive disease|0|||
23384671|NCT02533674|65151678|FG001|Dose Level V|Progressive disease|0|||
23384672|NCT02533674|65151679|FG002|Dose Level V|Progressive disease|0|||
23384673|NCT02533674|65151680|FG003|Dose Level V|Progressive disease|0|||
23384674|NCT02533674|65151681|FG004|Dose Level V|Progressive disease|3|||
23384675|NCT02533674|65151682|FG005|Dose Level V|Progressive disease|0|||
23384676|NCT02533674|65151683|FG006|Dose Level V|Progressive disease|0|||
23384677|NCT02533674|65151684|FG007|Dose Level V|Progressive disease|0|||
23384678|NCT02533674|65151677|FG000|Dose Level V|Withdrawal by Subject|0|||
23384679|NCT02533674|65151678|FG001|Dose Level V|Withdrawal by Subject|0|||
23384680|NCT02533674|65151679|FG002|Dose Level V|Withdrawal by Subject|0|||
23384681|NCT02533674|65151680|FG003|Dose Level V|Withdrawal by Subject|0|||
23384682|NCT02533674|65151681|FG004|Dose Level V|Withdrawal by Subject|1|||
23384683|NCT02533674|65151682|FG005|Dose Level V|Withdrawal by Subject|0|||
23384684|NCT02533674|65151683|FG006|Dose Level V|Withdrawal by Subject|0|||
23384685|NCT02533674|65151684|FG007|Dose Level V|Withdrawal by Subject|0|||
23384686|NCT02533674|65151677|FG000|Dose Level V|Physician Decision|0|||
23384687|NCT02533674|65151678|FG001|Dose Level V|Physician Decision|0|||
23384688|NCT02533674|65151679|FG002|Dose Level V|Physician Decision|0|||
23384689|NCT02533674|65151680|FG003|Dose Level V|Physician Decision|0|||
23384690|NCT02533674|65151681|FG004|Dose Level V|Physician Decision|1|||
23384691|NCT02533674|65151682|FG005|Dose Level V|Physician Decision|0|||
23384692|NCT02533674|65151683|FG006|Dose Level V|Physician Decision|0|||
23384693|NCT02533674|65151684|FG007|Dose Level V|Physician Decision|0|||
23384694|NCT02533674|65151677|FG000|Dose Level VI|Progressive disease|0|||
23384695|NCT02533674|65151678|FG001|Dose Level VI|Progressive disease|0|||
23493187|NCT00917501|65551384|FG000|Overall Study|Lost to Follow-up|4|||
23384696|NCT02533674|65151679|FG002|Dose Level VI|Progressive disease|0|||
23384697|NCT02533674|65151680|FG003|Dose Level VI|Progressive disease|0|||
23384698|NCT02533674|65151681|FG004|Dose Level VI|Progressive disease|0|||
23384699|NCT02533674|65151682|FG005|Dose Level VI|Progressive disease|7|||
23384700|NCT02533674|65151683|FG006|Dose Level VI|Progressive disease|0|||
23384701|NCT02533674|65151684|FG007|Dose Level VI|Progressive disease|0|||
23384702|NCT02533674|65151677|FG000|Dose Level VI|Withdrawal by Subject|0|||
23384703|NCT02533674|65151678|FG001|Dose Level VI|Withdrawal by Subject|0|||
23384704|NCT02533674|65151679|FG002|Dose Level VI|Withdrawal by Subject|0|||
23671119|NCT00866307|66179697|FG001|Consolidation/Maintenance|Physician Decision|3|||
23671120|NCT00866307|66179698|FG002|Consolidation/Maintenance|Physician Decision|2|||
23671121|NCT00866307|66179696|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
23671122|NCT00866307|66179697|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
23671123|NCT00866307|66179698|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
23671124|NCT00866307|66179696|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
23671125|NCT00866307|66179697|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
23671126|NCT00866307|66179698|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
23671127|NCT00866307|66179696|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
23671128|NCT00866307|66179697|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
23671129|NCT00866307|66179698|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
23671130|NCT00866307|66179696|FG000|Consolidation/Maintenance|Therapy error|0|||
23671131|NCT00866307|66179697|FG001|Consolidation/Maintenance|Therapy error|1|||
23671132|NCT00866307|66179698|FG002|Consolidation/Maintenance|Therapy error|0|||
23671133|NCT00866307|66179696|FG000|Consolidation/Maintenance|Non-compliance|0|||
23671134|NCT00866307|66179697|FG001|Consolidation/Maintenance|Non-compliance|0|||
23671135|NCT00866307|66179698|FG002|Consolidation/Maintenance|Non-compliance|1|||
23671136|NCT00866307|66179696|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
23671137|NCT00866307|66179697|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
23671138|NCT00866307|66179698|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
23671139|NCT03709654|66179701|FG000|Overall Study|Lost to Follow-up|1|||
23671140|NCT03709654|66179702|FG001|Overall Study|Lost to Follow-up|1|||
23671141|NCT03709654|66179701|FG000|Overall Study|Withdrawal by Subject|1|||
23671142|NCT03709654|66179702|FG001|Overall Study|Withdrawal by Subject|1|||
23671143|NCT03709654|66179701|FG000|Overall Study|Adverse Event|1|||
23671144|NCT03709654|66179702|FG001|Overall Study|Adverse Event|0|||
23671145|NCT00584194|66179703|FG000|Overall Study|Other|135|||
23671146|NCT00730639|66179706|FG000|Overall Study|Adverse Event|3|||
23671147|NCT00730639|66179707|FG001|Overall Study|Adverse Event|0|||
23671148|NCT00730639|66179708|FG002|Overall Study|Adverse Event|9|||
23671149|NCT00730639|66179709|FG003|Overall Study|Adverse Event|8|||
23671150|NCT00730639|66179710|FG004|Overall Study|Adverse Event|23|||
23671151|NCT00730639|66179706|FG000|Overall Study|Complete Response|0|||
23671152|NCT00730639|66179707|FG001|Overall Study|Complete Response|0|||
23671153|NCT00730639|66179708|FG002|Overall Study|Complete Response|2|||
23671154|NCT00730639|66179709|FG003|Overall Study|Complete Response|2|||
23671155|NCT00730639|66179710|FG004|Overall Study|Complete Response|1|||
23671156|NCT00730639|66179706|FG000|Overall Study|Completed Maximum Cycles|0|||
23671157|NCT00730639|66179707|FG001|Overall Study|Completed Maximum Cycles|0|||
23671158|NCT00730639|66179708|FG002|Overall Study|Completed Maximum Cycles|11|||
23671159|NCT00730639|66179709|FG003|Overall Study|Completed Maximum Cycles|3|||
23671160|NCT00730639|66179710|FG004|Overall Study|Completed Maximum Cycles|6|||
23671161|NCT00730639|66179706|FG000|Overall Study|Death|0|||
23671162|NCT00730639|66179707|FG001|Overall Study|Death|0|||
23671163|NCT00730639|66179708|FG002|Overall Study|Death|0|||
23671164|NCT00730639|66179709|FG003|Overall Study|Death|0|||
23671165|NCT00730639|66179710|FG004|Overall Study|Death|2|||
23671166|NCT00730639|66179706|FG000|Overall Study|Disease Progression|12|||
23671167|NCT00730639|66179707|FG001|Overall Study|Disease Progression|13|||
23671168|NCT00730639|66179708|FG002|Overall Study|Disease Progression|48|||
23671169|NCT00730639|66179709|FG003|Overall Study|Disease Progression|32|||
23671170|NCT00730639|66179710|FG004|Overall Study|Disease Progression|88|||
23671171|NCT00730639|66179706|FG000|Overall Study|non-specified|0|||
23671172|NCT00730639|66179707|FG001|Overall Study|non-specified|0|||
23671173|NCT00730639|66179708|FG002|Overall Study|non-specified|4|||
23671174|NCT00730639|66179709|FG003|Overall Study|non-specified|2|||
23671175|NCT00730639|66179710|FG004|Overall Study|non-specified|3|||
23671176|NCT00730639|66179706|FG000|Overall Study|Protocol Violation|0|||
23671177|NCT00730639|66179707|FG001|Overall Study|Protocol Violation|0|||
23671178|NCT00730639|66179708|FG002|Overall Study|Protocol Violation|1|||
23671179|NCT00730639|66179709|FG003|Overall Study|Protocol Violation|0|||
23671180|NCT00730639|66179710|FG004|Overall Study|Protocol Violation|0|||
23671181|NCT00730639|66179706|FG000|Overall Study|Withdrawal by Subject|0|||
23671182|NCT00730639|66179707|FG001|Overall Study|Withdrawal by Subject|0|||
23671183|NCT00730639|66179708|FG002|Overall Study|Withdrawal by Subject|6|||
23671184|NCT00730639|66179709|FG003|Overall Study|Withdrawal by Subject|3|||
23384705|NCT02533674|65151680|FG003|Dose Level VI|Withdrawal by Subject|0|||
23384706|NCT02533674|65151681|FG004|Dose Level VI|Withdrawal by Subject|0|||
23671185|NCT00730639|66179710|FG004|Overall Study|Withdrawal by Subject|4|||
23671186|NCT00730639|66179706|FG000|Overall Study|Treatment on-going|2|||
23671187|NCT00730639|66179707|FG001|Overall Study|Treatment on-going|5|||
23671188|NCT00730639|66179708|FG002|Overall Study|Treatment on-going|5|||
23671189|NCT00730639|66179709|FG003|Overall Study|Treatment on-going|4|||
23671190|NCT00730639|66179710|FG004|Overall Study|Treatment on-going|4|||
23671191|NCT03723707|66179712|FG000|Overall Study|Death|32|||
23671192|NCT03723707|66179713|FG001|Overall Study|Death|32|||
23384707|NCT02533674|65151682|FG005|Dose Level VI|Withdrawal by Subject|1|||
23671193|NCT03723707|66179712|FG000|Overall Study|Admitted to long term care|12|||
23671194|NCT03723707|66179713|FG001|Overall Study|Admitted to long term care|12|||
23671195|NCT03723707|66179712|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
23384708|NCT02533674|65151683|FG006|Dose Level VI|Withdrawal by Subject|0|||
23384709|NCT02533674|65151684|FG007|Dose Level VI|Withdrawal by Subject|0|||
23384710|NCT02533674|65151677|FG000|Dose Level VI|Treatment-related AE|0|||
23384711|NCT02533674|65151678|FG001|Dose Level VI|Treatment-related AE|0|||
23384712|NCT02533674|65151679|FG002|Dose Level VI|Treatment-related AE|0|||
23384713|NCT02533674|65151680|FG003|Dose Level VI|Treatment-related AE|0|||
23384714|NCT02533674|65151681|FG004|Dose Level VI|Treatment-related AE|0|||
23384715|NCT02533674|65151682|FG005|Dose Level VI|Treatment-related AE|1|||
23384716|NCT02533674|65151683|FG006|Dose Level VI|Treatment-related AE|0|||
23384717|NCT02533674|65151684|FG007|Dose Level VI|Treatment-related AE|0|||
23384718|NCT02533674|65151677|FG000|Dose Level VII|Progressive disease|0|||
23384719|NCT02533674|65151678|FG001|Dose Level VII|Progressive disease|0|||
23384720|NCT02533674|65151679|FG002|Dose Level VII|Progressive disease|0|||
23384721|NCT02533674|65151680|FG003|Dose Level VII|Progressive disease|0|||
23384722|NCT02533674|65151681|FG004|Dose Level VII|Progressive disease|0|||
23384723|NCT02533674|65151682|FG005|Dose Level VII|Progressive disease|0|||
23384724|NCT02533674|65151683|FG006|Dose Level VII|Progressive disease|10|||
23384725|NCT02533674|65151684|FG007|Dose Level VII|Progressive disease|0|||
23384726|NCT02533674|65151677|FG000|Dose Level VII|Withdrawal by Subject|0|||
23384727|NCT02533674|65151678|FG001|Dose Level VII|Withdrawal by Subject|0|||
23384728|NCT02533674|65151679|FG002|Dose Level VII|Withdrawal by Subject|0|||
23384729|NCT02533674|65151680|FG003|Dose Level VII|Withdrawal by Subject|0|||
23384730|NCT02533674|65151681|FG004|Dose Level VII|Withdrawal by Subject|0|||
23493188|NCT00917501|65551385|FG001|Overall Study|Lost to Follow-up|1|||
23671196|NCT03723707|66179713|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
23384731|NCT02533674|65151682|FG005|Dose Level VII|Withdrawal by Subject|0|||
23671197|NCT03723707|66179712|FG000|Overall Study|Lost to Follow-up|40|||
23384732|NCT02533674|65151683|FG006|Dose Level VII|Withdrawal by Subject|3|||
23384733|NCT02533674|65151684|FG007|Dose Level VII|Withdrawal by Subject|0|||
23384734|NCT02533674|65151677|FG000|Dose Level VII|Treatment-related AE|0|||
23384735|NCT02533674|65151678|FG001|Dose Level VII|Treatment-related AE|0|||
23384736|NCT02533674|65151679|FG002|Dose Level VII|Treatment-related AE|0|||
23384737|NCT02533674|65151680|FG003|Dose Level VII|Treatment-related AE|0|||
23384738|NCT02533674|65151681|FG004|Dose Level VII|Treatment-related AE|0|||
23384739|NCT02533674|65151682|FG005|Dose Level VII|Treatment-related AE|0|||
23384740|NCT02533674|65151683|FG006|Dose Level VII|Treatment-related AE|1|||
23384741|NCT02533674|65151684|FG007|Dose Level VII|Treatment-related AE|0|||
23384742|NCT02533674|65151677|FG000|Dose Level VII|Death|0|||
23384743|NCT02533674|65151678|FG001|Dose Level VII|Death|0|||
23384744|NCT02533674|65151679|FG002|Dose Level VII|Death|0|||
23384745|NCT02533674|65151680|FG003|Dose Level VII|Death|0|||
23384746|NCT02533674|65151681|FG004|Dose Level VII|Death|0|||
23384747|NCT02533674|65151682|FG005|Dose Level VII|Death|0|||
23384748|NCT02533674|65151683|FG006|Dose Level VII|Death|2|||
23384749|NCT02533674|65151684|FG007|Dose Level VII|Death|0|||
23384750|NCT02533674|65151677|FG000|Dose Level VIII|Progressive disease|0|||
23384751|NCT02533674|65151678|FG001|Dose Level VIII|Progressive disease|0|||
23384752|NCT02533674|65151679|FG002|Dose Level VIII|Progressive disease|0|||
23384753|NCT02533674|65151680|FG003|Dose Level VIII|Progressive disease|0|||
23384754|NCT02533674|65151681|FG004|Dose Level VIII|Progressive disease|0|||
23384755|NCT02533674|65151682|FG005|Dose Level VIII|Progressive disease|0|||
23384756|NCT02533674|65151683|FG006|Dose Level VIII|Progressive disease|0|||
23384757|NCT02533674|65151684|FG007|Dose Level VIII|Progressive disease|3|||
23384758|NCT02533674|65151677|FG000|Dose Level VIII|Withdrawal by Subject|0|||
23384759|NCT02533674|65151678|FG001|Dose Level VIII|Withdrawal by Subject|0|||
23384760|NCT02533674|65151679|FG002|Dose Level VIII|Withdrawal by Subject|0|||
23384761|NCT02533674|65151680|FG003|Dose Level VIII|Withdrawal by Subject|0|||
23384762|NCT02533674|65151681|FG004|Dose Level VIII|Withdrawal by Subject|0|||
23384763|NCT02533674|65151682|FG005|Dose Level VIII|Withdrawal by Subject|0|||
23384764|NCT02533674|65151683|FG006|Dose Level VIII|Withdrawal by Subject|0|||
23384765|NCT02533674|65151684|FG007|Dose Level VIII|Withdrawal by Subject|1|||
23384766|NCT02533674|65151677|FG000|Dose Level VIII|Treatment-related AE|0|||
23384767|NCT02533674|65151678|FG001|Dose Level VIII|Treatment-related AE|0|||
23384768|NCT02533674|65151679|FG002|Dose Level VIII|Treatment-related AE|0|||
23384769|NCT02533674|65151680|FG003|Dose Level VIII|Treatment-related AE|0|||
23384770|NCT02533674|65151681|FG004|Dose Level VIII|Treatment-related AE|0|||
23384771|NCT02533674|65151682|FG005|Dose Level VIII|Treatment-related AE|0|||
23384772|NCT02533674|65151683|FG006|Dose Level VIII|Treatment-related AE|0|||
23384773|NCT02533674|65151684|FG007|Dose Level VIII|Treatment-related AE|1|||
23384774|NCT02533674|65151677|FG000|Dose Level VIII|Never treated|0|||
23384775|NCT02533674|65151678|FG001|Dose Level VIII|Never treated|0|||
23384776|NCT02533674|65151679|FG002|Dose Level VIII|Never treated|0|||
23384777|NCT02533674|65151680|FG003|Dose Level VIII|Never treated|0|||
23384778|NCT02533674|65151681|FG004|Dose Level VIII|Never treated|0|||
23384779|NCT02533674|65151682|FG005|Dose Level VIII|Never treated|0|||
23384780|NCT02533674|65151683|FG006|Dose Level VIII|Never treated|0|||
23384781|NCT02533674|65151684|FG007|Dose Level VIII|Never treated|1|||
23384782|NCT01472835|65151687|FG000|Overall Study|Lost to Follow-up|2|||
23384783|NCT01472835|65151688|FG001|Overall Study|Lost to Follow-up|0|||
23384784|NCT00927186|65151690|FG000|12 Months Primary Study|Adverse Event|5|||
23384785|NCT00927186|65151691|FG001|12 Months Primary Study|Adverse Event|2|||
23384786|NCT00927186|65151690|FG000|12 Months Primary Study|Lost to Follow-up|1|||
23384787|NCT00927186|65151691|FG001|12 Months Primary Study|Lost to Follow-up|0|||
23384788|NCT00927186|65151690|FG000|12 Months Primary Study|Protocol Violation|0|||
23384789|NCT00927186|65151691|FG001|12 Months Primary Study|Protocol Violation|1|||
23384790|NCT00927186|65151690|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
23384791|NCT00927186|65151691|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
23384792|NCT01902303|65151692|FG000|Overall Study|Adverse Event|0|||
23384793|NCT01902303|65151693|FG001|Overall Study|Adverse Event|1|||
23384794|NCT01902303|65151692|FG000|Overall Study|Lost to Follow-up|0|||
23384795|NCT01902303|65151693|FG001|Overall Study|Lost to Follow-up|1|||
23384796|NCT01902303|65151692|FG000|Overall Study|Protocol Violation|2|||
23384797|NCT01902303|65151693|FG001|Overall Study|Protocol Violation|2|||
23384798|NCT01902303|65151692|FG000|Overall Study|subject lost investigational product|0|||
23384799|NCT01902303|65151693|FG001|Overall Study|subject lost investigational product|1|||
23384800|NCT01902303|65151692|FG000|Overall Study|Did not develop a cold sore|21|||
23384801|NCT01902303|65151693|FG001|Overall Study|Did not develop a cold sore|19|||
23384802|NCT01390584|65151705|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
23384803|NCT01390584|65151706|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
23384804|NCT01390584|65151707|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
23384805|NCT02205359|65151708|FG000|Overall Study|Death|293|||
23384806|NCT02205359|65151709|FG001|Overall Study|Death|327|||
23384807|NCT02205359|65151708|FG000|Overall Study|Lost to Follow-up|182|||
23384808|NCT02205359|65151709|FG001|Overall Study|Lost to Follow-up|162|||
23671198|NCT03723707|66179713|FG001|Overall Study|Lost to Follow-up|22|||
23671199|NCT03723707|66179712|FG000|Overall Study|Discontinued after study closure|24|||
23671200|NCT03723707|66179713|FG001|Overall Study|Discontinued after study closure|12|||
23671201|NCT03237065|66179714|FG000|Overall Study|Adverse Event|0|||
23671202|NCT03237065|66179715|FG001|Overall Study|Adverse Event|2|||
23671203|NCT03237065|66179714|FG000|Overall Study|Protocol Violation|0|||
23671204|NCT03237065|66179715|FG001|Overall Study|Protocol Violation|1|||
23671205|NCT03237065|66179714|FG000|Overall Study|Withdrawal by Subject|3|||
23671206|NCT03237065|66179715|FG001|Overall Study|Withdrawal by Subject|0|||
23671207|NCT03237065|66179714|FG000|Overall Study|Lost to Follow-up|1|||
23671208|NCT03237065|66179715|FG001|Overall Study|Lost to Follow-up|0|||
23671209|NCT03237065|66179714|FG000|Overall Study|Unable to obtain venous access|0|||
23671210|NCT03237065|66179715|FG001|Overall Study|Unable to obtain venous access|1|||
23671211|NCT01576549|66179716|FG000|Overall Study|Sponsor Decision|2|||
23671212|NCT01079182|66179717|FG000|Overall Study|Lost to Follow-up|1634|||
23671213|NCT01079182|66179717|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
23671214|NCT01079182|66179717|FG000|Overall Study|Lack of Efficacy|514|||
23671215|NCT01079182|66179717|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
23671216|NCT01079182|66179717|FG000|Overall Study|Reasons not Evaluated|271|||
23671217|NCT02821715|66179718|FG000|Overall Study|Protocol Violation|1|||
23671218|NCT02821715|66179719|FG001|Overall Study|Protocol Violation|0|||
23671219|NCT02821715|66179720|FG002|Overall Study|Protocol Violation|0|||
23671220|NCT02821715|66179721|FG003|Overall Study|Protocol Violation|0|||
23671221|NCT02821715|66179722|FG004|Overall Study|Protocol Violation|0|||
23671222|NCT02821715|66179723|FG005|Overall Study|Protocol Violation|0|||
23671223|NCT03657043|66179728|FG000|Overall Study|Withdrawal by Subject|1|||
23671224|NCT03657043|66179729|FG001|Overall Study|Withdrawal by Subject|1|||
23671225|NCT03657043|66179730|FG002|Overall Study|Withdrawal by Subject|0|||
23671226|NCT03657043|66179731|FG003|Overall Study|Withdrawal by Subject|0|||
23671227|NCT03657043|66179732|FG004|Overall Study|Withdrawal by Subject|4|||
23384809|NCT02205359|65151708|FG000|Overall Study|Physician Decision|51|||
23384810|NCT02205359|65151709|FG001|Overall Study|Physician Decision|53|||
23671228|NCT03657043|66179728|FG000|Overall Study|Study closure by Sponsor|0|||
23671229|NCT03657043|66179729|FG001|Overall Study|Study closure by Sponsor|2|||
23671230|NCT03657043|66179730|FG002|Overall Study|Study closure by Sponsor|0|||
23671231|NCT03657043|66179731|FG003|Overall Study|Study closure by Sponsor|0|||
23384811|NCT02205359|65151708|FG000|Overall Study|Withdrawal by Subject|167|||
23384812|NCT02205359|65151709|FG001|Overall Study|Withdrawal by Subject|169|||
23384813|NCT00806026|65151710|FG000|Overall Study|Death|0|||
23384814|NCT00806026|65151711|FG001|Overall Study|Death|0|||
23384815|NCT00806026|65151712|FG002|Overall Study|Death|0|||
23384816|NCT00806026|65151713|FG003|Overall Study|Death|1|||
23384817|NCT00806026|65151714|FG004|Overall Study|Death|0|||
23384818|NCT00806026|65151715|FG005|Overall Study|Death|0|||
23384819|NCT00806026|65151710|FG000|Overall Study|Did not meet entrance criteria|4|||
23384820|NCT00806026|65151711|FG001|Overall Study|Did not meet entrance criteria|1|||
23384821|NCT00806026|65151712|FG002|Overall Study|Did not meet entrance criteria|2|||
23384822|NCT00806026|65151713|FG003|Overall Study|Did not meet entrance criteria|1|||
23384823|NCT00806026|65151714|FG004|Overall Study|Did not meet entrance criteria|0|||
23384824|NCT00806026|65151715|FG005|Overall Study|Did not meet entrance criteria|0|||
23384825|NCT00806026|65151710|FG000|Overall Study|Lack of Efficacy|5|||
23384826|NCT00806026|65151711|FG001|Overall Study|Lack of Efficacy|18|||
23384827|NCT00806026|65151712|FG002|Overall Study|Lack of Efficacy|13|||
23384828|NCT00806026|65151713|FG003|Overall Study|Lack of Efficacy|4|||
23384829|NCT00806026|65151714|FG004|Overall Study|Lack of Efficacy|8|||
23384830|NCT00806026|65151715|FG005|Overall Study|Lack of Efficacy|7|||
23384831|NCT00806026|65151710|FG000|Overall Study|Lost to Follow-up|8|||
23493189|NCT00917501|65551384|FG000|Overall Study|Withdrawal by Subject|3|||
23384832|NCT00806026|65151711|FG001|Overall Study|Lost to Follow-up|15|||
23493190|NCT00917501|65551385|FG001|Overall Study|Withdrawal by Subject|1|||
23493191|NCT00917501|65551384|FG000|Overall Study|Lack of Efficacy|1|||
23384833|NCT00806026|65151712|FG002|Overall Study|Lost to Follow-up|8|||
23384834|NCT00806026|65151713|FG003|Overall Study|Lost to Follow-up|2|||
23384835|NCT00806026|65151714|FG004|Overall Study|Lost to Follow-up|6|||
23384836|NCT00806026|65151715|FG005|Overall Study|Lost to Follow-up|6|||
23384837|NCT00806026|65151710|FG000|Overall Study|Withdrawal by Subject|14|||
23384838|NCT00806026|65151711|FG001|Overall Study|Withdrawal by Subject|17|||
23384839|NCT00806026|65151712|FG002|Overall Study|Withdrawal by Subject|9|||
23384840|NCT00806026|65151713|FG003|Overall Study|Withdrawal by Subject|2|||
23384841|NCT00806026|65151714|FG004|Overall Study|Withdrawal by Subject|5|||
23384842|NCT00806026|65151715|FG005|Overall Study|Withdrawal by Subject|3|||
23384843|NCT00806026|65151710|FG000|Overall Study|Other|3|||
23384844|NCT00806026|65151711|FG001|Overall Study|Other|6|||
23384845|NCT00806026|65151712|FG002|Overall Study|Other|8|||
23384846|NCT00806026|65151713|FG003|Overall Study|Other|2|||
23384847|NCT00806026|65151714|FG004|Overall Study|Other|0|||
23384848|NCT00806026|65151715|FG005|Overall Study|Other|4|||
23384849|NCT00806026|65151710|FG000|Overall Study|Protocol Violation|6|||
23384850|NCT00806026|65151711|FG001|Overall Study|Protocol Violation|9|||
23384851|NCT00806026|65151712|FG002|Overall Study|Protocol Violation|9|||
23384852|NCT00806026|65151713|FG003|Overall Study|Protocol Violation|0|||
23384853|NCT00806026|65151714|FG004|Overall Study|Protocol Violation|2|||
23384854|NCT00806026|65151715|FG005|Overall Study|Protocol Violation|3|||
23384855|NCT00806026|65151710|FG000|Overall Study|Adverse Event|52|||
23384856|NCT00806026|65151711|FG001|Overall Study|Adverse Event|35|||
23384857|NCT00806026|65151712|FG002|Overall Study|Adverse Event|44|||
23671232|NCT03657043|66179732|FG004|Overall Study|Study closure by Sponsor|17|||
23384858|NCT00806026|65151713|FG003|Overall Study|Adverse Event|17|||
23384859|NCT00806026|65151714|FG004|Overall Study|Adverse Event|9|||
23384860|NCT00806026|65151715|FG005|Overall Study|Adverse Event|9|||
23384861|NCT01402700|65151716|FG000|Overall Study|Death|3|||
23384862|NCT01402700|65151716|FG000|Overall Study|Withdrawal by Subject|3|||
23384863|NCT01402700|65151716|FG000|Overall Study|Missed Visit|1|||
23384864|NCT01421134|65151717|FG000|Overall Study|Adverse Event|3|||
23384865|NCT01421134|65151718|FG001|Overall Study|Adverse Event|5|||
23384866|NCT01421134|65151717|FG000|Overall Study|Lack of Efficacy|2|||
23384867|NCT01421134|65151718|FG001|Overall Study|Lack of Efficacy|4|||
23384868|NCT01421134|65151717|FG000|Overall Study|Protocol Violation|0|||
23384869|NCT01421134|65151718|FG001|Overall Study|Protocol Violation|3|||
23384870|NCT01421134|65151717|FG000|Overall Study|Withdrawal by Subject|1|||
23384871|NCT01421134|65151718|FG001|Overall Study|Withdrawal by Subject|1|||
23384872|NCT01421134|65151717|FG000|Overall Study|Administrative|0|||
23384873|NCT01421134|65151718|FG001|Overall Study|Administrative|1|||
23384874|NCT01421134|65151717|FG000|Overall Study|Lost to Follow-up|1|||
23384875|NCT01421134|65151718|FG001|Overall Study|Lost to Follow-up|1|||
23384876|NCT02821000|65151720|FG000|Overall Study|Death|89|||
23384877|NCT02821000|65151720|FG000|Overall Study|Sponsor Decision|12|||
23384878|NCT02821000|65151720|FG000|Overall Study|Withdrawal by Subject|2|||
23384879|NCT04495478|65151721|FG000|Overall Study|Withdrawal by Subject|0|||
23384880|NCT04495478|65151722|FG001|Overall Study|Withdrawal by Subject|0|||
23384881|NCT04495478|65151723|FG002|Overall Study|Withdrawal by Subject|0|||
23384882|NCT04495478|65151724|FG003|Overall Study|Withdrawal by Subject|1|||
23384883|NCT04495478|65151725|FG004|Overall Study|Withdrawal by Subject|0|||
23384884|NCT04495478|65151726|FG005|Overall Study|Withdrawal by Subject|0|||
23384885|NCT04495478|65151727|FG006|Overall Study|Withdrawal by Subject|0|||
23384886|NCT04495478|65151721|FG000|Overall Study|Physician Decision|0|||
23384887|NCT04495478|65151722|FG001|Overall Study|Physician Decision|1|||
23384888|NCT04495478|65151723|FG002|Overall Study|Physician Decision|0|||
23384889|NCT04495478|65151724|FG003|Overall Study|Physician Decision|0|||
23384890|NCT04495478|65151725|FG004|Overall Study|Physician Decision|1|||
23384891|NCT04495478|65151726|FG005|Overall Study|Physician Decision|0|||
23384892|NCT04495478|65151727|FG006|Overall Study|Physician Decision|0|||
23384893|NCT03055195|65154901|FG000|Overall Study|Lack of Efficacy|1|||
23384894|NCT03055195|65154902|FG001|Overall Study|Lack of Efficacy|0|||
23384895|NCT03055195|65154901|FG000|Overall Study|Withdrawal by Subject|6|||
23384896|NCT03055195|65154902|FG001|Overall Study|Withdrawal by Subject|7|||
23384897|NCT03055195|65154901|FG000|Overall Study|Study Terminated by Sponsor|2|||
23384898|NCT03055195|65154902|FG001|Overall Study|Study Terminated by Sponsor|6|||
23384899|NCT03055195|65154901|FG000|Overall Study|Protocol Violation|2|||
23384900|NCT03055195|65154902|FG001|Overall Study|Protocol Violation|1|||
23384901|NCT03055195|65154901|FG000|Overall Study|Physician Decision|1|||
23384902|NCT03055195|65154902|FG001|Overall Study|Physician Decision|0|||
23384903|NCT03020888|65154903|FG000|Overall Study|Physician Decision|4|||
23493192|NCT00917501|65551385|FG001|Overall Study|Lack of Efficacy|2|||
23493193|NCT00917501|65551384|FG000|Overall Study|trouble swollowing capsules|0|||
23384904|NCT03020888|65154903|FG000|Overall Study|Withdrawal by Subject|6|||
23384905|NCT03020888|65154903|FG000|Overall Study|Insurance coverage|2|||
23493194|NCT00917501|65551385|FG001|Overall Study|trouble swollowing capsules|1|||
23384906|NCT03020888|65154903|FG000|Overall Study|Lost to Follow-up|1|||
23384907|NCT01208051|65154904|FG000|Total Enrollment|Withdrawal by Subject|0|||
23384908|NCT01208051|65154905|FG001|Total Enrollment|Withdrawal by Subject|1|||
23384909|NCT01208051|65154906|FG002|Total Enrollment|Withdrawal by Subject|0|||
23384910|NCT01208051|65154907|FG003|Total Enrollment|Withdrawal by Subject|0|||
23384911|NCT01208051|65154908|FG004|Total Enrollment|Withdrawal by Subject|2|||
23384912|NCT01208051|65154904|FG000|Total Enrollment|Brain metastases|0|||
23384913|NCT01208051|65154905|FG001|Total Enrollment|Brain metastases|0|||
23384914|NCT01208051|65154906|FG002|Total Enrollment|Brain metastases|1|||
23384915|NCT01208051|65154907|FG003|Total Enrollment|Brain metastases|0|||
23384916|NCT01208051|65154908|FG004|Total Enrollment|Brain metastases|0|||
23384917|NCT04243837|65154910|FG000|Overall Study|Adverse Event|2|||
23384918|NCT04243837|65154911|FG001|Overall Study|Adverse Event|1|||
23384919|NCT04243837|65154910|FG000|Overall Study|Withdrawal by Subject|4|||
23384920|NCT04243837|65154911|FG001|Overall Study|Withdrawal by Subject|2|||
23384921|NCT04243837|65154910|FG000|Overall Study|Covid-19 lock down|1|||
23384922|NCT04243837|65154911|FG001|Overall Study|Covid-19 lock down|0|||
23384923|NCT04243837|65154910|FG000|Overall Study|Study Terminated by Sponsor|11|||
23384924|NCT04243837|65154911|FG001|Overall Study|Study Terminated by Sponsor|12|||
23384925|NCT03478787|65154915|FG000|Overall Study|Adverse Event|5|||
23384926|NCT03478787|65154916|FG001|Overall Study|Adverse Event|1|||
23384927|NCT03478787|65154915|FG000|Overall Study|Protocol Violation|3|||
23384928|NCT03478787|65154916|FG001|Overall Study|Protocol Violation|0|||
23384929|NCT03478787|65154915|FG000|Overall Study|Lack of Efficacy|7|||
23384930|NCT03478787|65154916|FG001|Overall Study|Lack of Efficacy|1|||
23493195|NCT00100178|65551386|FG000|Overall Study|Lost to Follow-up|0|||
23384931|NCT03478787|65154915|FG000|Overall Study|Lost to Follow-up|9|||
23384932|NCT03478787|65154916|FG001|Overall Study|Lost to Follow-up|5|||
23384933|NCT03478787|65154915|FG000|Overall Study|Withdrawal by Subject|2|||
23384934|NCT03478787|65154916|FG001|Overall Study|Withdrawal by Subject|6|||
23384935|NCT03478787|65154915|FG000|Overall Study|Other, Not Specified|3|||
23384936|NCT03478787|65154916|FG001|Overall Study|Other, Not Specified|0|||
23671233|NCT03657043|66179728|FG000|Overall Study|Lost to Follow-up|0|||
23671234|NCT03657043|66179729|FG001|Overall Study|Lost to Follow-up|0|||
23384937|NCT01524705|65154917|FG000|Overall Study|Adverse Event|2|||
23671235|NCT03657043|66179730|FG002|Overall Study|Lost to Follow-up|0|||
23384938|NCT01524705|65154918|FG001|Overall Study|Adverse Event|0|||
23384939|NCT01524705|65154917|FG000|Overall Study|Death|1|||
23384940|NCT01524705|65154918|FG001|Overall Study|Death|0|||
23384941|NCT01524705|65154917|FG000|Overall Study|Lost to Follow-up|0|||
23384942|NCT01524705|65154918|FG001|Overall Study|Lost to Follow-up|1|||
23384943|NCT01524705|65154917|FG000|Overall Study|Withdrawal by Subject|0|||
23671236|NCT03657043|66179731|FG003|Overall Study|Lost to Follow-up|0|||
23384944|NCT01524705|65154918|FG001|Overall Study|Withdrawal by Subject|1|||
23384945|NCT01524705|65154917|FG000|Overall Study|Pancreatic Cancer|0|||
23384946|NCT01524705|65154918|FG001|Overall Study|Pancreatic Cancer|1|||
23384947|NCT01734928|65154921|FG000|Randomization|Physician Decision|0|||
23384948|NCT01734928|65154922|FG001|Randomization|Physician Decision|1|||
23384949|NCT01734928|65154921|FG000|Randomization|clinical progression|0|||
23384950|NCT01734928|65154922|FG001|Randomization|clinical progression|1|||
23384951|NCT01734928|65154921|FG000|Randomization|progressive disease|0|||
23384952|NCT01734928|65154922|FG001|Randomization|progressive disease|2|||
23384953|NCT01734928|65154921|FG000|Randomization|Withdrew informed consent|0|||
23384954|NCT01734928|65154922|FG001|Randomization|Withdrew informed consent|4|||
23384955|NCT01734928|65154921|FG000|Randomization|Death|1|||
23384956|NCT01734928|65154922|FG001|Randomization|Death|0|||
23384957|NCT01734928|65154921|FG000|Randomization|Randomization error|1|||
23384958|NCT01734928|65154922|FG001|Randomization|Randomization error|0|||
23384959|NCT01734928|65154921|FG000|Randomization|Lost to Follow-up|1|||
23384960|NCT01734928|65154922|FG001|Randomization|Lost to Follow-up|0|||
23384961|NCT01734928|65154921|FG000|Treatment Period|Lost to Follow-up|0|||
23384962|NCT01734928|65154922|FG001|Treatment Period|Lost to Follow-up|2|||
23384963|NCT01734928|65154921|FG000|Treatment Period|Progressive Disease|167|||
23384964|NCT01734928|65154922|FG001|Treatment Period|Progressive Disease|165|||
23671237|NCT03657043|66179732|FG004|Overall Study|Lost to Follow-up|4|||
23671238|NCT03657043|66179728|FG000|Overall Study|Death|6|||
23671239|NCT03657043|66179729|FG001|Overall Study|Death|5|||
23671240|NCT03657043|66179730|FG002|Overall Study|Death|0|||
23671241|NCT03657043|66179731|FG003|Overall Study|Death|0|||
23671242|NCT03657043|66179732|FG004|Overall Study|Death|53|||
23671243|NCT03657043|66179728|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
23671244|NCT03657043|66179729|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
23671245|NCT03657043|66179730|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
23671246|NCT03657043|66179731|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
23671247|NCT03657043|66179732|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
23671248|NCT03657043|66179728|FG000|Overall Study|Adverse Event|0|||
23671249|NCT03657043|66179729|FG001|Overall Study|Adverse Event|0|||
23671250|NCT03657043|66179730|FG002|Overall Study|Adverse Event|0|||
23671251|NCT03657043|66179731|FG003|Overall Study|Adverse Event|0|||
23671252|NCT03657043|66179732|FG004|Overall Study|Adverse Event|2|||
23671253|NCT03657043|66179728|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
23384965|NCT01734928|65154921|FG000|Treatment Period|Adverse Event|39|||
23384966|NCT01734928|65154922|FG001|Treatment Period|Adverse Event|52|||
23384967|NCT01734928|65154921|FG000|Treatment Period|Withdrawal of Consent|25|||
23671254|NCT03657043|66179729|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
23384968|NCT01734928|65154922|FG001|Treatment Period|Withdrawal of Consent|22|||
23384969|NCT01734928|65154921|FG000|Treatment Period|Death|20|||
23384970|NCT01734928|65154922|FG001|Treatment Period|Death|9|||
23384971|NCT01734928|65154921|FG000|Treatment Period|Other Reasons|27|||
23671255|NCT03657043|66179730|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
23671256|NCT03657043|66179731|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
23671257|NCT03657043|66179732|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
23671258|NCT03657043|66179728|FG000|Overall Study|Withdrawal - declined follow-up|0|||
23671259|NCT03657043|66179729|FG001|Overall Study|Withdrawal - declined follow-up|0|||
23671260|NCT03657043|66179730|FG002|Overall Study|Withdrawal - declined follow-up|0|||
23671261|NCT03657043|66179731|FG003|Overall Study|Withdrawal - declined follow-up|0|||
23671262|NCT03657043|66179732|FG004|Overall Study|Withdrawal - declined follow-up|1|||
23671263|NCT03021642|66179733|FG000|Washout Period (21 Days)|Adverse Event|1|||
23671264|NCT03021642|66179734|FG001|Washout Period (21 Days)|Adverse Event|1|||
23671265|NCT00980200|66179735|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
23671266|NCT00980200|66179736|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
23671267|NCT00980200|66179737|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
23671268|NCT00980200|66179738|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
23671269|NCT00980200|66179739|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
23671270|NCT00980200|66179735|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
23671271|NCT00980200|66179736|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
23671272|NCT00980200|66179737|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
23671273|NCT00980200|66179738|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
23671274|NCT00980200|66179739|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
23671275|NCT03499028|66179741|FG000|Overall Study|Lost to Follow-up|12|||
23671276|NCT03499028|66179742|FG001|Overall Study|Lost to Follow-up|9|||
23671277|NCT03499028|66179741|FG000|Overall Study|Withdrawal by Subject|5|||
23671278|NCT03499028|66179742|FG001|Overall Study|Withdrawal by Subject|8|||
23671279|NCT03499028|66179741|FG000|Overall Study|Unplanned SNF discharge|5|||
23671280|NCT03499028|66179742|FG001|Overall Study|Unplanned SNF discharge|8|||
23671281|NCT03577730|66179743|FG000|Overall Study|Physician Decision|3|||
23671282|NCT03577730|66179744|FG001|Overall Study|Physician Decision|1|||
23671283|NCT03577730|66179743|FG000|Overall Study|Did not receive allocated intervention|1|||
23671284|NCT03577730|66179744|FG001|Overall Study|Did not receive allocated intervention|0|||
23671285|NCT00179309|66179749|FG000|Treatment|Toxicity|2|||
23671286|NCT00179309|66179750|FG001|Treatment|Toxicity|3|||
23671287|NCT00179309|66179749|FG000|Treatment|Withdrawal by Subject|1|||
23671288|NCT00179309|66179750|FG001|Treatment|Withdrawal by Subject|2|||
23671289|NCT00179309|66179749|FG000|Treatment|Allergy|1|||
23671290|NCT00179309|66179750|FG001|Treatment|Allergy|0|||
23671291|NCT03031301|66179751|FG000|Overall Study|Protocol Violation|4|||
23671292|NCT03031301|66179752|FG001|Overall Study|Protocol Violation|8|||
23671293|NCT03031301|66179751|FG000|Overall Study|Withdrawal by Subject|7|||
23671294|NCT03031301|66179752|FG001|Overall Study|Withdrawal by Subject|4|||
23671295|NCT03031301|66179751|FG000|Overall Study|Lost to Follow-up|4|||
23671296|NCT03031301|66179752|FG001|Overall Study|Lost to Follow-up|12|||
23671297|NCT03031301|66179751|FG000|Overall Study|Noncompliance|1|||
23671298|NCT03031301|66179752|FG001|Overall Study|Noncompliance|3|||
23671299|NCT03031301|66179751|FG000|Overall Study|Technical issue|1|||
23671300|NCT03031301|66179752|FG001|Overall Study|Technical issue|1|||
23671301|NCT03031301|66179751|FG000|Overall Study|Adverse Event|1|||
23671302|NCT03031301|66179752|FG001|Overall Study|Adverse Event|0|||
23671303|NCT02770547|66179753|FG000|Overall Study|Patient non-compliant|1|||
23671304|NCT02770547|66179754|FG001|Overall Study|Patient non-compliant|0|||
23671305|NCT02770547|66179753|FG000|Overall Study|Adverse Event|0|||
23671306|NCT02770547|66179754|FG001|Overall Study|Adverse Event|1|||
23671307|NCT01681433|66179755|FG000|Overall Study|Lack of Efficacy|23|||
23671308|NCT01681433|66179756|FG001|Overall Study|Lack of Efficacy|23|||
23671309|NCT01681433|66179755|FG000|Overall Study|Withdrawal by Subject|5|||
23671310|NCT01681433|66179756|FG001|Overall Study|Withdrawal by Subject|5|||
23671311|NCT01681433|66179755|FG000|Overall Study|Protocol Violation|2|||
23671312|NCT01681433|66179756|FG001|Overall Study|Protocol Violation|0|||
23384972|NCT01734928|65154922|FG001|Treatment Period|Other Reasons|19|||
23384973|NCT01734928|65154921|FG000|Treatment Period|Pregnancy|0|||
23384974|NCT01734928|65154922|FG001|Treatment Period|Pregnancy|1|||
23384975|NCT01829165|65154924|FG000|Overall Study|Did not complete intervention|2|||
23384976|NCT01829165|65154925|FG001|Overall Study|Did not complete intervention|0|||
23384977|NCT01720602|65154929|FG000|Overall Study|Adverse Event|3|||
23384978|NCT01720602|65154929|FG000|Overall Study|Progressive disease on therapy|2|||
23384979|NCT01370642|65154930|FG000|Overall Study|Adverse Event|2|||
23384980|NCT01370642|65154931|FG001|Overall Study|Adverse Event|1|||
23384981|NCT01370642|65154932|FG002|Overall Study|Adverse Event|1|||
23384982|NCT01370642|65154930|FG000|Overall Study|Detectable HCV RNA|0|||
23671313|NCT01681433|66179755|FG000|Overall Study|Adverse Event|2|||
23384983|NCT01370642|65154931|FG001|Overall Study|Detectable HCV RNA|0|||
23384984|NCT01370642|65154932|FG002|Overall Study|Detectable HCV RNA|22|||
23384985|NCT01370642|65154930|FG000|Overall Study|Lost to Follow-up|0|||
23384986|NCT01370642|65154931|FG001|Overall Study|Lost to Follow-up|0|||
23384987|NCT01370642|65154932|FG002|Overall Study|Lost to Follow-up|1|||
23384988|NCT01370642|65154930|FG000|Overall Study|Physician Decision|4|||
23384989|NCT01370642|65154931|FG001|Overall Study|Physician Decision|1|||
23384990|NCT01370642|65154932|FG002|Overall Study|Physician Decision|2|||
23384991|NCT01370642|65154930|FG000|Overall Study|Withdrawal by Subject|2|||
23384992|NCT01370642|65154931|FG001|Overall Study|Withdrawal by Subject|4|||
23384993|NCT01370642|65154932|FG002|Overall Study|Withdrawal by Subject|3|||
23384994|NCT01283386|65154937|FG000|Overall Study|Death|2|||
23384995|NCT01283386|65154938|FG001|Overall Study|Death|0|||
23384996|NCT01283386|65154937|FG000|Overall Study|Withdrawal by Subject|2|||
23384997|NCT01283386|65154938|FG001|Overall Study|Withdrawal by Subject|1|||
23384998|NCT01283386|65154937|FG000|Overall Study|Relapse of underlying disease|1|||
23384999|NCT01283386|65154938|FG001|Overall Study|Relapse of underlying disease|3|||
23385000|NCT01283386|65154937|FG000|Overall Study|Progression of underlying disease|2|||
23385001|NCT01283386|65154938|FG001|Overall Study|Progression of underlying disease|7|||
23385002|NCT01283386|65154937|FG000|Overall Study|Reason not specified|1|||
23385003|NCT01283386|65154938|FG001|Overall Study|Reason not specified|0|||
23385004|NCT01283386|65154937|FG000|Overall Study|Protocol Violation|0|||
23385005|NCT01283386|65154938|FG001|Overall Study|Protocol Violation|1|||
23385006|NCT00176254|65154939|FG000|Overall Study|Lost to Follow-up|1|||
23385007|NCT03156621|65154944|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
23385008|NCT03156621|65154945|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
23385009|NCT03156621|65154944|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23385010|NCT03156621|65154945|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23385011|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385012|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385013|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
23385014|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385015|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
23385016|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
23385017|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
23385018|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
23385019|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
23493196|NCT00100178|65551387|FG001|Overall Study|Lost to Follow-up|6|||
23671314|NCT01681433|66179756|FG001|Overall Study|Adverse Event|4|||
23671315|NCT01681433|66179755|FG000|Overall Study|Lost to Follow-up|0|||
23671316|NCT01681433|66179756|FG001|Overall Study|Lost to Follow-up|1|||
23671317|NCT04091087|66179757|FG000|Overall Study|Not treated|1|||
23671318|NCT04091087|66179758|FG001|Overall Study|Not treated|0|||
23671319|NCT04091087|66179757|FG000|Overall Study|Adverse Event|4|||
23671320|NCT04091087|66179758|FG001|Overall Study|Adverse Event|4|||
23671321|NCT04091087|66179757|FG000|Overall Study|Protocol Violation|0|||
23671322|NCT04091087|66179758|FG001|Overall Study|Protocol Violation|1|||
23671323|NCT04091087|66179757|FG000|Overall Study|Withdrawal by Subject|5|||
23671324|NCT04091087|66179758|FG001|Overall Study|Withdrawal by Subject|2|||
23671325|NCT01464307|66179759|FG000|Main Period|Death|0|||
23671326|NCT01464307|66179760|FG001|Main Period|Death|1|||
23671327|NCT01464307|66179759|FG000|Main Period|Adverse Event|6|||
23671328|NCT01464307|66179760|FG001|Main Period|Adverse Event|1|||
23671329|NCT01464307|66179759|FG000|Main Period|Lack of Efficacy|2|||
23385020|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
23385021|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
23385022|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
23385023|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
23385024|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
23385025|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
23385026|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
23671330|NCT01464307|66179760|FG001|Main Period|Lack of Efficacy|0|||
23671331|NCT01464307|66179759|FG000|Main Period|Withdrawal by Subject|5|||
23671332|NCT01464307|66179760|FG001|Main Period|Withdrawal by Subject|2|||
23385027|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Death|1|||
23385028|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Death|1|||
23385029|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Death|0|||
23385030|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Death|1|||
23385031|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
23385032|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
23385033|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
23385034|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
23385035|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
23385036|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
23385037|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
23385038|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
23385039|NCT01429623|65154951|FG000|Overall Study|Death|1|||
23385040|NCT01429623|65154952|FG001|Overall Study|Death|0|||
23385041|NCT01429623|65154951|FG000|Overall Study|Adverse Event|7|||
23385042|NCT01429623|65154952|FG001|Overall Study|Adverse Event|14|||
23385043|NCT01429623|65154951|FG000|Overall Study|Withdrawal by Subject|19|||
23385044|NCT01429623|65154952|FG001|Overall Study|Withdrawal by Subject|13|||
23385045|NCT01429623|65154951|FG000|Overall Study|Physician Decision|2|||
23385046|NCT01429623|65154952|FG001|Overall Study|Physician Decision|3|||
23385047|NCT01429623|65154951|FG000|Overall Study|Protocol Violation|3|||
23385048|NCT01429623|65154952|FG001|Overall Study|Protocol Violation|2|||
23385049|NCT01429623|65154951|FG000|Overall Study|Assorted|1|||
23385050|NCT01429623|65154952|FG001|Overall Study|Assorted|2|||
23385051|NCT01429623|65154951|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
23385052|NCT01429623|65154952|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
23385053|NCT01429623|65154951|FG000|Overall Study|No post baseline data|4|||
23385054|NCT01429623|65154952|FG001|Overall Study|No post baseline data|4|||
23385055|NCT00834587|65154958|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23385056|NCT00834587|65154959|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23385057|NCT00414609|65154962|FG000|Core Study|Adverse Event|9|||
23385058|NCT00414609|65154963|FG001|Core Study|Adverse Event|11|||
23385059|NCT00414609|65154964|FG002|Core Study|Adverse Event|0|||
23385060|NCT00414609|65154962|FG000|Core Study|Abnormal laboratory values|0|||
23385061|NCT00414609|65154963|FG001|Core Study|Abnormal laboratory values|1|||
23385062|NCT00414609|65154964|FG002|Core Study|Abnormal laboratory values|0|||
23385063|NCT00414609|65154962|FG000|Core Study|Abnormal test procedure results|1|||
23385064|NCT00414609|65154963|FG001|Core Study|Abnormal test procedure results|1|||
23385065|NCT00414609|65154964|FG002|Core Study|Abnormal test procedure results|0|||
23385066|NCT00414609|65154962|FG000|Core Study|Protocol deviation|0|||
23385067|NCT00414609|65154963|FG001|Core Study|Protocol deviation|1|||
23385068|NCT00414609|65154964|FG002|Core Study|Protocol deviation|0|||
23385069|NCT00414609|65154962|FG000|Core Study|Patient withdrew consent|10|||
23385070|NCT00414609|65154963|FG001|Core Study|Patient withdrew consent|11|||
23385071|NCT00414609|65154964|FG002|Core Study|Patient withdrew consent|0|||
23385072|NCT00414609|65154962|FG000|Core Study|Lost to Follow-up|7|||
23385073|NCT00414609|65154963|FG001|Core Study|Lost to Follow-up|4|||
23385074|NCT00414609|65154964|FG002|Core Study|Lost to Follow-up|0|||
23385075|NCT00414609|65154962|FG000|Core Study|Administrative problems|0|||
23385076|NCT00414609|65154963|FG001|Core Study|Administrative problems|2|||
23385077|NCT00414609|65154964|FG002|Core Study|Administrative problems|0|||
23385078|NCT00414609|65154962|FG000|Core Study|Death|7|||
23385079|NCT00414609|65154963|FG001|Core Study|Death|14|||
23385080|NCT00414609|65154964|FG002|Core Study|Death|0|||
23385081|NCT00414609|65154962|FG000|Extension Study|Adverse Event|0|||
23385082|NCT00414609|65154963|FG001|Extension Study|Adverse Event|0|||
23385083|NCT00414609|65154964|FG002|Extension Study|Adverse Event|14|||
23385084|NCT00414609|65154962|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
23385085|NCT00414609|65154963|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
23385086|NCT00414609|65154964|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
23385087|NCT00414609|65154962|FG000|Extension Study|Withdrawal by Subject|0|||
23385088|NCT00414609|65154963|FG001|Extension Study|Withdrawal by Subject|0|||
23385089|NCT00414609|65154964|FG002|Extension Study|Withdrawal by Subject|13|||
23385090|NCT00414609|65154962|FG000|Extension Study|Lost to Follow-up|0|||
23385091|NCT00414609|65154963|FG001|Extension Study|Lost to Follow-up|0|||
23385092|NCT00414609|65154964|FG002|Extension Study|Lost to Follow-up|10|||
23385093|NCT00414609|65154962|FG000|Extension Study|Administrative problems|0|||
23385094|NCT00414609|65154963|FG001|Extension Study|Administrative problems|0|||
23385095|NCT00414609|65154964|FG002|Extension Study|Administrative problems|1|||
23385096|NCT00414609|65154962|FG000|Extension Study|Death|0|||
23385097|NCT00414609|65154963|FG001|Extension Study|Death|0|||
23385098|NCT00414609|65154964|FG002|Extension Study|Death|17|||
23385099|NCT00585169|65154965|FG000|Overall Study|Withdrawal by Subject|1|||
23385100|NCT02545127|65154971|FG000|Overall Study|Lost to Follow-up|1|||
23385101|NCT02545127|65154972|FG001|Overall Study|Lost to Follow-up|0|||
23385102|NCT03055221|65154973|FG000|Overall Study|Adverse Event|2|||
23385103|NCT03055221|65154973|FG000|Overall Study|Withdrawal by Subject|4|||
23385104|NCT03055221|65154973|FG000|Overall Study|Death|6|||
23385105|NCT03055221|65154973|FG000|Overall Study|Physician Decision|1|||
23385106|NCT03055221|65154973|FG000|Overall Study|Study terminated by Sponsor|3|||
23385107|NCT03055221|65154973|FG000|Overall Study|Lost to Follow-up|4|||
23385108|NCT01028053|65154977|FG000|Overall Study|Screen Failure|113|||
23385109|NCT01028053|65154977|FG000|Overall Study|Patient Request|11|||
23385110|NCT01028053|65154977|FG000|Overall Study|Protocol Violation|1|||
23385111|NCT01028053|65154977|FG000|Overall Study|Physician Decision|2|||
23385112|NCT01028053|65154977|FG000|Overall Study|Technical Problem|1|||
23385113|NCT01028053|65154977|FG000|Overall Study|Terminated by Sponsor|1|||
23385114|NCT01028053|65154977|FG000|Overall Study|Various reasons|4|||
23385115|NCT03753542|65154978|FG000|Overall Study|Lost to Follow-up|9|||
23385116|NCT03753542|65154979|FG001|Overall Study|Lost to Follow-up|14|||
23385117|NCT00520572|65154982|FG000|Overall Study|Adverse Event|9|||
23385118|NCT00520572|65154983|FG001|Overall Study|Adverse Event|3|||
23385119|NCT00520572|65154984|FG002|Overall Study|Adverse Event|6|||
23385120|NCT00520572|65154985|FG003|Overall Study|Adverse Event|9|||
23385121|NCT00520572|65154986|FG004|Overall Study|Adverse Event|7|||
23385122|NCT00520572|65154987|FG005|Overall Study|Adverse Event|2|||
23385123|NCT00520572|65154982|FG000|Overall Study|Withdrawal by Subject|0|||
23385124|NCT00520572|65154983|FG001|Overall Study|Withdrawal by Subject|9|||
23385125|NCT00520572|65154984|FG002|Overall Study|Withdrawal by Subject|5|||
23385126|NCT00520572|65154985|FG003|Overall Study|Withdrawal by Subject|2|||
23385127|NCT00520572|65154986|FG004|Overall Study|Withdrawal by Subject|2|||
23385128|NCT00520572|65154987|FG005|Overall Study|Withdrawal by Subject|0|||
23385129|NCT00520572|65154982|FG000|Overall Study|Protocol Violation|0|||
23385130|NCT00520572|65154983|FG001|Overall Study|Protocol Violation|0|||
23385131|NCT00520572|65154984|FG002|Overall Study|Protocol Violation|1|||
23385132|NCT00520572|65154985|FG003|Overall Study|Protocol Violation|0|||
23385133|NCT00520572|65154986|FG004|Overall Study|Protocol Violation|0|||
23385134|NCT00520572|65154987|FG005|Overall Study|Protocol Violation|0|||
23385135|NCT00520572|65154982|FG000|Overall Study|Lack of Efficacy|1|||
23385136|NCT00520572|65154983|FG001|Overall Study|Lack of Efficacy|1|||
23385137|NCT00520572|65154984|FG002|Overall Study|Lack of Efficacy|1|||
23385138|NCT00520572|65154985|FG003|Overall Study|Lack of Efficacy|2|||
23385139|NCT00520572|65154986|FG004|Overall Study|Lack of Efficacy|1|||
23385140|NCT00520572|65154987|FG005|Overall Study|Lack of Efficacy|0|||
23385141|NCT00520572|65154982|FG000|Overall Study|Lost to Follow-up|0|||
23385142|NCT00520572|65154983|FG001|Overall Study|Lost to Follow-up|0|||
23385143|NCT00520572|65154984|FG002|Overall Study|Lost to Follow-up|0|||
23385144|NCT00520572|65154985|FG003|Overall Study|Lost to Follow-up|0|||
23385145|NCT00520572|65154986|FG004|Overall Study|Lost to Follow-up|1|||
23385146|NCT00520572|65154987|FG005|Overall Study|Lost to Follow-up|0|||
23385147|NCT00520572|65154982|FG000|Overall Study|Incorrect enrollment|1|||
23385148|NCT00520572|65154983|FG001|Overall Study|Incorrect enrollment|0|||
23385149|NCT00520572|65154984|FG002|Overall Study|Incorrect enrollment|1|||
23385150|NCT00520572|65154985|FG003|Overall Study|Incorrect enrollment|0|||
23385151|NCT00520572|65154986|FG004|Overall Study|Incorrect enrollment|1|||
23671333|NCT01464307|66179759|FG000|Main Period|Predefined discontinuation criteria|2|||
23671334|NCT01464307|66179760|FG001|Main Period|Predefined discontinuation criteria|1|||
23385152|NCT00520572|65154987|FG005|Overall Study|Incorrect enrollment|0|||
23385153|NCT00520572|65154982|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385154|NCT00520572|65154983|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
23385155|NCT00520572|65154984|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385156|NCT00520572|65154985|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385157|NCT00520572|65154986|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
23671335|NCT01464307|66179759|FG000|Open-Label Extension Period|Adverse Event|15|||
23385158|NCT00520572|65154987|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385159|NCT00520572|65154982|FG000|Overall Study|Long break in taking Medication|0|||
23385160|NCT00520572|65154983|FG001|Overall Study|Long break in taking Medication|0|||
23385161|NCT00520572|65154984|FG002|Overall Study|Long break in taking Medication|0|||
23385162|NCT00520572|65154985|FG003|Overall Study|Long break in taking Medication|1|||
23385163|NCT00520572|65154986|FG004|Overall Study|Long break in taking Medication|0|||
23385164|NCT00520572|65154987|FG005|Overall Study|Long break in taking Medication|0|||
23385165|NCT00520572|65154982|FG000|Overall Study|Did not receive Treatment|1|||
23385166|NCT00520572|65154983|FG001|Overall Study|Did not receive Treatment|0|||
23385167|NCT00520572|65154984|FG002|Overall Study|Did not receive Treatment|1|||
23385168|NCT00520572|65154985|FG003|Overall Study|Did not receive Treatment|0|||
23385169|NCT00520572|65154986|FG004|Overall Study|Did not receive Treatment|0|||
23385170|NCT00520572|65154987|FG005|Overall Study|Did not receive Treatment|0|||
23385171|NCT00452400|65155003|FG000|Overall Study|Adverse Event|1|||
23385172|NCT00452400|65155004|FG001|Overall Study|Adverse Event|1|||
23385173|NCT00452400|65155005|FG002|Overall Study|Adverse Event|5|||
23385174|NCT00452400|65155006|FG003|Overall Study|Adverse Event|0|||
23385175|NCT00452400|65155007|FG004|Overall Study|Adverse Event|2|||
23385176|NCT00452400|65155003|FG000|Overall Study|Protocol Violation|0|||
23385177|NCT00452400|65155004|FG001|Overall Study|Protocol Violation|0|||
23385178|NCT00452400|65155005|FG002|Overall Study|Protocol Violation|1|||
23385179|NCT00452400|65155006|FG003|Overall Study|Protocol Violation|0|||
23385180|NCT00452400|65155007|FG004|Overall Study|Protocol Violation|0|||
23385181|NCT00452400|65155003|FG000|Overall Study|Lost to Follow-up|1|||
23385182|NCT00452400|65155004|FG001|Overall Study|Lost to Follow-up|0|||
23385183|NCT00452400|65155005|FG002|Overall Study|Lost to Follow-up|0|||
23385184|NCT00452400|65155006|FG003|Overall Study|Lost to Follow-up|0|||
23385185|NCT00452400|65155007|FG004|Overall Study|Lost to Follow-up|0|||
23385186|NCT00452400|65155003|FG000|Overall Study|Withdrawal by Subject|1|||
23385187|NCT00452400|65155004|FG001|Overall Study|Withdrawal by Subject|0|||
23385188|NCT00452400|65155005|FG002|Overall Study|Withdrawal by Subject|1|||
23385189|NCT00452400|65155006|FG003|Overall Study|Withdrawal by Subject|0|||
23385190|NCT00452400|65155007|FG004|Overall Study|Withdrawal by Subject|0|||
23385191|NCT00452400|65155003|FG000|Overall Study|Lack of Efficacy|2|||
23385192|NCT00452400|65155004|FG001|Overall Study|Lack of Efficacy|0|||
23385193|NCT00452400|65155005|FG002|Overall Study|Lack of Efficacy|0|||
23385194|NCT00452400|65155006|FG003|Overall Study|Lack of Efficacy|0|||
23385195|NCT00452400|65155007|FG004|Overall Study|Lack of Efficacy|0|||
23671336|NCT01464307|66179760|FG001|Open-Label Extension Period|Adverse Event|0|||
23671337|NCT01464307|66179759|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
23671338|NCT01464307|66179760|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
23671339|NCT01464307|66179759|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
23671340|NCT01464307|66179760|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23671341|NCT01464307|66179759|FG000|Open-Label Extension Period|Death|1|||
23671342|NCT01464307|66179760|FG001|Open-Label Extension Period|Death|0|||
23671343|NCT01464307|66179759|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23671344|NCT01464307|66179760|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
23671345|NCT01464307|66179759|FG000|Open-Label Extension Period|Non-compliance|9|||
23671346|NCT01464307|66179760|FG001|Open-Label Extension Period|Non-compliance|0|||
23671347|NCT01464307|66179759|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
23671348|NCT01464307|66179760|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
23671349|NCT03603496|66179762|FG000|Overall Study|Death|19|||
23671350|NCT03603496|66179763|FG001|Overall Study|Death|24|||
23671351|NCT03603496|66179762|FG000|Overall Study|Lost to Follow-up|141|||
23671352|NCT03603496|66179763|FG001|Overall Study|Lost to Follow-up|141|||
23671353|NCT03603496|66179762|FG000|Overall Study|Withdrawal by Subject|26|||
23671354|NCT03603496|66179763|FG001|Overall Study|Withdrawal by Subject|20|||
23671355|NCT02788747|66179764|FG000|Overall Study|Adverse Event|1|||
23671356|NCT02788747|66179765|FG001|Overall Study|Adverse Event|0|||
23671357|NCT02788747|66179766|FG002|Overall Study|Adverse Event|0|||
23671358|NCT01227044|66179773|FG000|Overall Study|Lost to Follow-up|5|||
23671359|NCT01227044|66179774|FG001|Overall Study|Lost to Follow-up|7|||
23671360|NCT01227044|66179773|FG000|Overall Study|Discontinued Intervention|1|||
23671361|NCT01227044|66179774|FG001|Overall Study|Discontinued Intervention|2|||
23671362|NCT03113500|66179776|FG000|Overall Study|Withdrawal by Subject|1|||
23671363|NCT00513500|66179777|FG000|Overall Study|Lost to Follow-up|35|||
23671364|NCT00513500|66179778|FG001|Overall Study|Lost to Follow-up|39|||
23671365|NCT00513500|66179777|FG000|Overall Study|Death|2|||
23385196|NCT00452400|65155003|FG000|Overall Study|Other reasons not listed above|0|||
23671366|NCT00513500|66179778|FG001|Overall Study|Death|1|||
23671367|NCT00513500|66179777|FG000|Overall Study|Hospitalized|4|||
23671368|NCT00513500|66179778|FG001|Overall Study|Hospitalized|14|||
23385197|NCT00452400|65155004|FG001|Overall Study|Other reasons not listed above|0|||
23385198|NCT00452400|65155005|FG002|Overall Study|Other reasons not listed above|0|||
23671369|NCT02695628|66179779|FG000|Overall Study|Withdrawal by Subject|1|||
23385199|NCT00452400|65155006|FG003|Overall Study|Other reasons not listed above|1|||
23385200|NCT00452400|65155007|FG004|Overall Study|Other reasons not listed above|1|||
23385201|NCT01471574|65155008|FG000|Treatment Period|Lack of Efficacy|12|||
23385202|NCT01471574|65155009|FG001|Treatment Period|Lack of Efficacy|4|||
23671370|NCT01934556|66179780|FG000|Overall Study|Withdrawal by Subject|0|||
23493197|NCT00100178|65551388|FG002|Overall Study|Lost to Follow-up|5|||
23385203|NCT01471574|65155010|FG002|Treatment Period|Lack of Efficacy|14|||
23671371|NCT01934556|66179781|FG001|Overall Study|Withdrawal by Subject|1|||
23671372|NCT01934556|66179782|FG002|Overall Study|Withdrawal by Subject|1|||
23671373|NCT01934556|66179780|FG000|Overall Study|Lost to Follow-up|4|||
23671374|NCT01934556|66179781|FG001|Overall Study|Lost to Follow-up|10|||
23671375|NCT01934556|66179782|FG002|Overall Study|Lost to Follow-up|7|||
23671376|NCT01934556|66179780|FG000|Overall Study|Death|1|||
23671377|NCT01934556|66179781|FG001|Overall Study|Death|5|||
23671378|NCT01934556|66179782|FG002|Overall Study|Death|2|||
23671379|NCT01902290|66179783|FG000|Overall Study|Withdrawal by Subject|19|||
23671380|NCT01902290|66179784|FG001|Overall Study|Withdrawal by Subject|27|||
23671381|NCT01902290|66179783|FG000|Overall Study|Lost to Follow-up|2|||
23671382|NCT01902290|66179784|FG001|Overall Study|Lost to Follow-up|2|||
23671383|NCT01902290|66179783|FG000|Overall Study|Death|1|||
23671384|NCT01902290|66179784|FG001|Overall Study|Death|0|||
23671385|NCT01902290|66179783|FG000|Overall Study|Sponsor Decision|26|||
23671386|NCT01902290|66179784|FG001|Overall Study|Sponsor Decision|24|||
23671387|NCT03110900|66179785|FG000|Overall Study|Sponsor withdrew|1|||
23671388|NCT03110900|66179786|FG001|Overall Study|Sponsor withdrew|1|||
23671389|NCT00845728|66179788|FG000|Overall Study|Abnormal laboratory value (s)|2|||
23385204|NCT01471574|65155011|FG003|Treatment Period|Lack of Efficacy|1|||
23671390|NCT00845728|66179789|FG001|Overall Study|Abnormal laboratory value (s)|2|||
23671391|NCT00845728|66179788|FG000|Overall Study|Patient's inability to use the device|4|||
23671392|NCT00845728|66179789|FG001|Overall Study|Patient's inability to use the device|6|||
23671393|NCT00845728|66179788|FG000|Overall Study|Abnormal test procedure result (s)|7|||
23671394|NCT00845728|66179789|FG001|Overall Study|Abnormal test procedure result (s)|2|||
23671395|NCT00845728|66179788|FG000|Overall Study|Lost to Follow-up|22|||
23671396|NCT00845728|66179789|FG001|Overall Study|Lost to Follow-up|13|||
23385205|NCT01471574|65155008|FG000|Treatment Period|Adverse Event|7|||
23385206|NCT01471574|65155009|FG001|Treatment Period|Adverse Event|3|||
23385207|NCT01471574|65155010|FG002|Treatment Period|Adverse Event|6|||
23385208|NCT01471574|65155011|FG003|Treatment Period|Adverse Event|1|||
23385209|NCT01471574|65155008|FG000|Treatment Period|Withdrawal by Subject|5|||
23385210|NCT01471574|65155009|FG001|Treatment Period|Withdrawal by Subject|1|||
23385211|NCT01471574|65155010|FG002|Treatment Period|Withdrawal by Subject|1|||
23385212|NCT01471574|65155011|FG003|Treatment Period|Withdrawal by Subject|0|||
23385213|NCT01471574|65155008|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
23385214|NCT01471574|65155009|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
23385215|NCT01471574|65155010|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
23385216|NCT01471574|65155011|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
23385217|NCT01471574|65155008|FG000|Treatment Period|Lost to Follow-up|1|||
23385218|NCT01471574|65155009|FG001|Treatment Period|Lost to Follow-up|2|||
23385219|NCT01471574|65155010|FG002|Treatment Period|Lost to Follow-up|2|||
23385220|NCT01471574|65155011|FG003|Treatment Period|Lost to Follow-up|0|||
23385221|NCT01471574|65155008|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
23385222|NCT01471574|65155009|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385223|NCT01471574|65155010|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385224|NCT01471574|65155011|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385225|NCT01471574|65155008|FG000|Treatment Period|Other|1|||
23385226|NCT01471574|65155009|FG001|Treatment Period|Other|0|||
23385227|NCT01471574|65155010|FG002|Treatment Period|Other|0|||
23385228|NCT01471574|65155011|FG003|Treatment Period|Other|0|||
23385229|NCT01471574|65155008|FG000|Follow-up Period|Withdrawal by Subject|3|||
23385230|NCT01471574|65155009|FG001|Follow-up Period|Withdrawal by Subject|0|||
23385231|NCT01471574|65155010|FG002|Follow-up Period|Withdrawal by Subject|3|||
23385232|NCT01471574|65155011|FG003|Follow-up Period|Withdrawal by Subject|1|||
23385233|NCT01471574|65155008|FG000|Follow-up Period|Lost to Follow-up|4|||
23385234|NCT01471574|65155009|FG001|Follow-up Period|Lost to Follow-up|1|||
23385235|NCT01471574|65155010|FG002|Follow-up Period|Lost to Follow-up|3|||
23385236|NCT01471574|65155011|FG003|Follow-up Period|Lost to Follow-up|2|||
23385237|NCT01471574|65155008|FG000|Follow-up Period|Death|0|||
23385238|NCT01471574|65155009|FG001|Follow-up Period|Death|0|||
23385239|NCT01471574|65155010|FG002|Follow-up Period|Death|1|||
23385240|NCT01471574|65155011|FG003|Follow-up Period|Death|0|||
23385241|NCT01471574|65155008|FG000|Follow-up Period|Follow-up no longer required|0|||
23385242|NCT01471574|65155009|FG001|Follow-up Period|Follow-up no longer required|1|||
23385243|NCT01471574|65155010|FG002|Follow-up Period|Follow-up no longer required|0|||
23385244|NCT01471574|65155011|FG003|Follow-up Period|Follow-up no longer required|0|||
23385245|NCT00728182|65155012|FG000|Overall Study|Adverse Event|1|||
23385246|NCT00728182|65155013|FG001|Overall Study|Adverse Event|0|||
23385247|NCT00728182|65155012|FG000|Overall Study|Lost to Follow-up|2|||
23385248|NCT00728182|65155013|FG001|Overall Study|Lost to Follow-up|0|||
23671397|NCT00845728|66179788|FG000|Overall Study|Death|24|||
23671398|NCT00845728|66179789|FG001|Overall Study|Death|26|||
23385249|NCT00728182|65155012|FG000|Overall Study|Death|0|||
23671399|NCT00845728|66179788|FG000|Overall Study|Administrative Problems|34|||
23385250|NCT00728182|65155013|FG001|Overall Study|Death|2|||
23385251|NCT00728182|65155012|FG000|Overall Study|Protocol Noncompliance|0|||
23385252|NCT00728182|65155013|FG001|Overall Study|Protocol Noncompliance|1|||
23385253|NCT02056288|65155014|FG000|In-Hospital Data|Surgery cancelled|1|||
23385254|NCT02056288|65155015|FG001|In-Hospital Data|Surgery cancelled|0|||
23385255|NCT02056288|65155014|FG000|In-Hospital Data|Protocol Violation|3|||
23671400|NCT00845728|66179789|FG001|Overall Study|Administrative Problems|26|||
23671401|NCT00845728|66179788|FG000|Overall Study|Protocol Violation|36|||
23671402|NCT00845728|66179789|FG001|Overall Study|Protocol Violation|24|||
23671403|NCT00845728|66179788|FG000|Overall Study|Lack of Efficacy|51|||
23671404|NCT00845728|66179789|FG001|Overall Study|Lack of Efficacy|39|||
23671405|NCT00845728|66179788|FG000|Overall Study|Adverse Event|101|||
23671406|NCT00845728|66179789|FG001|Overall Study|Adverse Event|96|||
23671407|NCT00845728|66179788|FG000|Overall Study|Withdrawal by Subject|105|||
23671408|NCT00845728|66179789|FG001|Overall Study|Withdrawal by Subject|108|||
23671409|NCT02002975|66179790|FG000|Overall Study|Case Report Forms Uncollected|135|||
23671410|NCT02002975|66179790|FG000|Overall Study|Protocol Deviation|437|||
23671411|NCT01453855|66179791|FG000|Overall Study|Adverse Event|3|||
23671412|NCT01453855|66179792|FG001|Overall Study|Adverse Event|4|||
23671413|NCT01453855|66179791|FG000|Overall Study|Lost to Follow-up|2|||
23671414|NCT01453855|66179792|FG001|Overall Study|Lost to Follow-up|1|||
23671415|NCT01453855|66179791|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
23671416|NCT01453855|66179792|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
23671417|NCT01453855|66179791|FG000|Overall Study|Noncompliance|1|||
23671418|NCT01453855|66179792|FG001|Overall Study|Noncompliance|0|||
23671419|NCT01453855|66179791|FG000|Overall Study|Inadequate Control of IOP|1|||
23671420|NCT01453855|66179792|FG001|Overall Study|Inadequate Control of IOP|5|||
23671421|NCT01453855|66179791|FG000|Overall Study|Other|0|||
23671422|NCT01453855|66179792|FG001|Overall Study|Other|1|||
23671423|NCT02095535|66179795|FG000|Recruitment|Protocol Violation|2|||
23671424|NCT02918864|66179796|FG000|Overall Study|Withdrawal by Subject|1|||
23671425|NCT02918864|66179797|FG001|Overall Study|Withdrawal by Subject|1|||
23671426|NCT02918864|66179796|FG000|Overall Study|Lost to Follow-up|3|||
23671427|NCT02918864|66179797|FG001|Overall Study|Lost to Follow-up|2|||
23671428|NCT00205855|66179798|FG000|Overall Study|Only received temporary implants|16|||
23671429|NCT00205855|66179798|FG000|Overall Study|Withdrawal by Subject|5|||
23671430|NCT00091832|66179799|FG000|Overall Study|Physician Decision|1|||
23671431|NCT00091832|66179800|FG001|Overall Study|Physician Decision|0|||
23671432|NCT00091832|66179801|FG002|Overall Study|Physician Decision|0|||
23671433|NCT00091832|66179802|FG003|Overall Study|Physician Decision|0|||
23671434|NCT00091832|66179803|FG004|Overall Study|Physician Decision|0|||
23671435|NCT00091832|66179804|FG005|Overall Study|Physician Decision|0|||
23671436|NCT00091832|66179799|FG000|Overall Study|Adverse Event|0|||
23671437|NCT00091832|66179800|FG001|Overall Study|Adverse Event|0|||
23671438|NCT00091832|66179801|FG002|Overall Study|Adverse Event|0|||
23671439|NCT00091832|66179802|FG003|Overall Study|Adverse Event|1|||
23671440|NCT00091832|66179803|FG004|Overall Study|Adverse Event|3|||
23671441|NCT00091832|66179804|FG005|Overall Study|Adverse Event|0|||
23671442|NCT00091832|66179799|FG000|Overall Study|Withdrawal by Subject|4|||
23671443|NCT00091832|66179800|FG001|Overall Study|Withdrawal by Subject|5|||
23671444|NCT00091832|66179801|FG002|Overall Study|Withdrawal by Subject|0|||
23671445|NCT00091832|66179802|FG003|Overall Study|Withdrawal by Subject|1|||
23493198|NCT00100178|65551386|FG000|Overall Study|Adverse Event|2|||
23671446|NCT00091832|66179803|FG004|Overall Study|Withdrawal by Subject|3|||
23671447|NCT00091832|66179804|FG005|Overall Study|Withdrawal by Subject|1|||
23671448|NCT00091832|66179799|FG000|Overall Study|Death|6|||
23671449|NCT00091832|66179800|FG001|Overall Study|Death|4|||
23671450|NCT00091832|66179801|FG002|Overall Study|Death|5|||
23671451|NCT00091832|66179802|FG003|Overall Study|Death|8|||
23671452|NCT00091832|66179803|FG004|Overall Study|Death|5|||
23671453|NCT00091832|66179804|FG005|Overall Study|Death|6|||
23671454|NCT00091832|66179799|FG000|Overall Study|Disease Progression|2|||
23671455|NCT00091832|66179800|FG001|Overall Study|Disease Progression|0|||
23671456|NCT00091832|66179801|FG002|Overall Study|Disease Progression|0|||
23671457|NCT00091832|66179802|FG003|Overall Study|Disease Progression|1|||
23671458|NCT00091832|66179803|FG004|Overall Study|Disease Progression|1|||
23671459|NCT00091832|66179804|FG005|Overall Study|Disease Progression|2|||
23671460|NCT00091832|66179799|FG000|Overall Study|Ineligibility Determined|0|||
23671461|NCT00091832|66179800|FG001|Overall Study|Ineligibility Determined|0|||
23671462|NCT00091832|66179801|FG002|Overall Study|Ineligibility Determined|1|||
23671463|NCT00091832|66179802|FG003|Overall Study|Ineligibility Determined|0|||
23671464|NCT00091832|66179803|FG004|Overall Study|Ineligibility Determined|1|||
23671465|NCT00091832|66179804|FG005|Overall Study|Ineligibility Determined|0|||
23671466|NCT00091832|66179799|FG000|Overall Study|Lost to Follow-up|1|||
23671467|NCT00091832|66179800|FG001|Overall Study|Lost to Follow-up|0|||
23671468|NCT00091832|66179801|FG002|Overall Study|Lost to Follow-up|3|||
23671469|NCT00091832|66179802|FG003|Overall Study|Lost to Follow-up|3|||
23671470|NCT00091832|66179803|FG004|Overall Study|Lost to Follow-up|2|||
23671471|NCT00091832|66179804|FG005|Overall Study|Lost to Follow-up|1|||
23671472|NCT00091832|66179799|FG000|Overall Study|Noncompliance|0|||
23671473|NCT00091832|66179800|FG001|Overall Study|Noncompliance|1|||
23671474|NCT00091832|66179801|FG002|Overall Study|Noncompliance|0|||
23671475|NCT00091832|66179802|FG003|Overall Study|Noncompliance|0|||
23671476|NCT00091832|66179803|FG004|Overall Study|Noncompliance|0|||
23671477|NCT00091832|66179804|FG005|Overall Study|Noncompliance|0|||
23671478|NCT00091832|66179799|FG000|Overall Study|Other|0|||
23671479|NCT00091832|66179800|FG001|Overall Study|Other|1|||
23671480|NCT00091832|66179801|FG002|Overall Study|Other|2|||
23671481|NCT00091832|66179802|FG003|Overall Study|Other|0|||
23671482|NCT00091832|66179803|FG004|Overall Study|Other|0|||
23671483|NCT00091832|66179804|FG005|Overall Study|Other|0|||
23671484|NCT00091832|66179799|FG000|Overall Study|Protocol Violation|0|||
23671485|NCT00091832|66179800|FG001|Overall Study|Protocol Violation|0|||
23671486|NCT00091832|66179801|FG002|Overall Study|Protocol Violation|1|||
23671487|NCT00091832|66179802|FG003|Overall Study|Protocol Violation|0|||
23671488|NCT00091832|66179803|FG004|Overall Study|Protocol Violation|0|||
23671489|NCT00091832|66179804|FG005|Overall Study|Protocol Violation|1|||
23671490|NCT00430508|66179808|FG000|Overall Study|Adverse Event|2|||
23671491|NCT00430508|66179809|FG001|Overall Study|Adverse Event|3|||
23671492|NCT00430508|66179810|FG002|Overall Study|Adverse Event|5|||
23671493|NCT00430508|66179811|FG003|Overall Study|Adverse Event|3|||
23671494|NCT00430508|66179808|FG000|Overall Study|Withdrawal by Subject|0|||
23671495|NCT00430508|66179809|FG001|Overall Study|Withdrawal by Subject|1|||
23671496|NCT00430508|66179810|FG002|Overall Study|Withdrawal by Subject|1|||
23671497|NCT00430508|66179811|FG003|Overall Study|Withdrawal by Subject|1|||
23671498|NCT00430508|66179808|FG000|Overall Study|responder at visit 4|0|||
23671499|NCT00430508|66179809|FG001|Overall Study|responder at visit 4|0|||
23671500|NCT00430508|66179810|FG002|Overall Study|responder at visit 4|2|||
23671501|NCT00430508|66179811|FG003|Overall Study|responder at visit 4|0|||
23671502|NCT00430508|66179808|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
23671503|NCT00430508|66179809|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
23671504|NCT00430508|66179810|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
23671505|NCT00430508|66179811|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
23671506|NCT00430508|66179808|FG000|Overall Study|Other|1|||
23671507|NCT00430508|66179809|FG001|Overall Study|Other|1|||
23671508|NCT00430508|66179810|FG002|Overall Study|Other|3|||
23671509|NCT00430508|66179811|FG003|Overall Study|Other|0|||
23671510|NCT02164981|66179815|FG000|Started|Withdrawal by Subject|2|||
23671511|NCT02164981|66179816|FG001|Started|Withdrawal by Subject|1|||
23671512|NCT02164981|66179817|FG002|Started|Withdrawal by Subject|0|||
23671513|NCT02164981|66179815|FG000|Started|Protocol Violation|2|||
23671514|NCT02164981|66179816|FG001|Started|Protocol Violation|0|||
23671515|NCT02164981|66179817|FG002|Started|Protocol Violation|0|||
23671516|NCT02164981|66179815|FG000|Started|Adverse Event|1|||
23671517|NCT02164981|66179816|FG001|Started|Adverse Event|2|||
23671518|NCT02164981|66179817|FG002|Started|Adverse Event|0|||
23671519|NCT02164981|66179815|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
23671520|NCT02164981|66179816|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
23671521|NCT02164981|66179817|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
23671522|NCT02164981|66179815|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
23671523|NCT02164981|66179816|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
23671524|NCT02164981|66179817|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
23671525|NCT02164981|66179815|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
23671526|NCT02164981|66179816|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
23671527|NCT02164981|66179817|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
23671528|NCT00903175|66179818|FG000|Period 1 - First Line|Adverse Event|36|||
23671529|NCT00903175|66179819|FG001|Period 1 - First Line|Adverse Event|50|||
23671530|NCT00903175|66179818|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
23671531|NCT00903175|66179819|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
23671532|NCT00903175|66179818|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
23671533|NCT00903175|66179819|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
23671534|NCT00903175|66179818|FG000|Period 1 - First Line|Protocol Violation|3|||
23671535|NCT00903175|66179819|FG001|Period 1 - First Line|Protocol Violation|3|||
23671536|NCT00903175|66179818|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
23671537|NCT00903175|66179819|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
23671538|NCT00903175|66179818|FG000|Period 1 - First Line|Administrative problems|12|||
23671539|NCT00903175|66179819|FG001|Period 1 - First Line|Administrative problems|13|||
23671540|NCT00903175|66179818|FG000|Period 1 - First Line|Death|17|||
23671541|NCT00903175|66179819|FG001|Period 1 - First Line|Death|10|||
23671542|NCT00903175|66179818|FG000|Period 2 - Second Line|Missing|1|||
23671543|NCT00903175|66179819|FG001|Period 2 - Second Line|Missing|0|||
23671544|NCT00903175|66179818|FG000|Period 2 - Second Line|Adverse Event|16|||
23671545|NCT00903175|66179819|FG001|Period 2 - Second Line|Adverse Event|20|||
23671546|NCT00903175|66179818|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
23671547|NCT00903175|66179819|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
23671548|NCT00903175|66179818|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
23671549|NCT00903175|66179819|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
23671550|NCT00903175|66179818|FG000|Period 2 - Second Line|Administrative problems|19|||
23671551|NCT00903175|66179819|FG001|Period 2 - Second Line|Administrative problems|9|||
23671552|NCT00903175|66179818|FG000|Period 2 - Second Line|Death|5|||
23671553|NCT00903175|66179819|FG001|Period 2 - Second Line|Death|2|||
23671554|NCT00283595|66179820|FG000|Overall Study|Withdrawal by Subject|1|||
23671555|NCT00283595|66179821|FG001|Overall Study|Withdrawal by Subject|2|||
23671556|NCT01135498|66179827|FG000|Overall Study|Adverse Event|20|||
23671557|NCT01135498|66179827|FG000|Overall Study|Progressive disease|38|||
23671558|NCT01135498|66179827|FG000|Overall Study|Investigator judgement|25|||
23671559|NCT01135498|66179827|FG000|Overall Study|Withdrawal by Subject|4|||
23671560|NCT01135498|66179827|FG000|Overall Study|Death|1|||
23671561|NCT01135498|66179827|FG000|Overall Study|Ongoing at time of analysis|2|||
23671562|NCT00414453|66179828|FG000|Overall Study|Abnormal lab work|16|||
23671563|NCT00253630|66179829|FG000|Overall Study|ineligible|2|||
23671564|NCT01536860|66179830|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
23671565|NCT01536860|66179831|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
23671566|NCT01536860|66179832|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
23671567|NCT01074190|66179833|FG000|Overall Study|Emergency Cesarean Delivery|1|||
23671568|NCT01074190|66179834|FG001|Overall Study|Emergency Cesarean Delivery|2|||
23671569|NCT01074190|66179835|FG002|Overall Study|Emergency Cesarean Delivery|1|||
23671570|NCT01074190|66179833|FG000|Overall Study|Protocol Violation|2|||
23671571|NCT01074190|66179834|FG001|Overall Study|Protocol Violation|1|||
23671572|NCT01074190|66179835|FG002|Overall Study|Protocol Violation|0|||
23671573|NCT01074190|66179833|FG000|Overall Study|Delivered in under 90 minutes|0|||
23671574|NCT01074190|66179834|FG001|Overall Study|Delivered in under 90 minutes|2|||
23671575|NCT01074190|66179835|FG002|Overall Study|Delivered in under 90 minutes|1|||
23671576|NCT01074190|66179833|FG000|Overall Study|Subject withdrew consent|1|||
23671577|NCT01074190|66179834|FG001|Overall Study|Subject withdrew consent|1|||
23671578|NCT01074190|66179835|FG002|Overall Study|Subject withdrew consent|1|||
23671579|NCT01390272|66179841|FG000|Overall Study|Death|3|||
23671580|NCT01390272|66179842|FG001|Overall Study|Death|2|||
23671581|NCT01390272|66179841|FG000|Overall Study|Withdrawal by Subject|9|||
23671582|NCT01390272|66179842|FG001|Overall Study|Withdrawal by Subject|5|||
23671583|NCT01390272|66179841|FG000|Overall Study|Patient moved, no longer eligible|5|||
23671584|NCT01390272|66179842|FG001|Overall Study|Patient moved, no longer eligible|8|||
23671585|NCT03325673|66179843|FG000|Overall Study|Adverse Event|4|||
23671586|NCT03325673|66179844|FG001|Overall Study|Adverse Event|0|||
23671587|NCT03571646|66179849|FG000|Overall Study|Adverse Event|1|||
23671588|NCT03571646|66179850|FG001|Overall Study|Adverse Event|0|||
23671589|NCT03571646|66179849|FG000|Overall Study|Withdrawal by Subject|1|||
23671590|NCT03571646|66179850|FG001|Overall Study|Withdrawal by Subject|1|||
23671591|NCT02436876|66179852|FG000|Overall Study|Lost to Follow-up|0|||
23671592|NCT02436876|66179853|FG001|Overall Study|Lost to Follow-up|1|||
23671593|NCT02436876|66179854|FG002|Overall Study|Lost to Follow-up|1|||
23671594|NCT02436876|66179855|FG003|Overall Study|Lost to Follow-up|1|||
23671595|NCT02436876|66179852|FG000|Overall Study|Withdrawal by Subject|1|||
23671596|NCT02436876|66179853|FG001|Overall Study|Withdrawal by Subject|0|||
23671597|NCT02436876|66179854|FG002|Overall Study|Withdrawal by Subject|0|||
23671598|NCT02436876|66179855|FG003|Overall Study|Withdrawal by Subject|1|||
23671599|NCT02436876|66179852|FG000|Overall Study|Physician Decision|0|||
23671600|NCT02436876|66179853|FG001|Overall Study|Physician Decision|2|||
23671601|NCT02436876|66179854|FG002|Overall Study|Physician Decision|1|||
23671602|NCT02436876|66179855|FG003|Overall Study|Physician Decision|0|||
23671603|NCT02436876|66179852|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
23671604|NCT02436876|66179853|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
23671605|NCT02436876|66179854|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
23671606|NCT02436876|66179855|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
23671607|NCT00953758|66179856|FG000|Overall Study|Death|2|||
23671608|NCT00953758|66179857|FG001|Overall Study|Death|0|||
23671609|NCT00953758|66179858|FG002|Overall Study|Death|1|||
23671610|NCT00953758|66179859|FG003|Overall Study|Death|1|||
23671611|NCT00953758|66179860|FG004|Overall Study|Death|1|||
23671612|NCT00953758|66179861|FG005|Overall Study|Death|1|||
23671613|NCT00953758|66179862|FG006|Overall Study|Death|1|||
23671614|NCT00953758|66179863|FG007|Overall Study|Death|3|||
23671615|NCT00953758|66179864|FG008|Overall Study|Death|1|||
23671616|NCT00953758|66179865|FG009|Overall Study|Death|0|||
23671617|NCT00953758|66179856|FG000|Overall Study|Participant refused further follow-up|0|||
23671618|NCT00953758|66179857|FG001|Overall Study|Participant refused further follow-up|0|||
23671619|NCT00953758|66179858|FG002|Overall Study|Participant refused further follow-up|1|||
23671620|NCT00953758|66179859|FG003|Overall Study|Participant refused further follow-up|0|||
23671621|NCT00953758|66179860|FG004|Overall Study|Participant refused further follow-up|3|||
23671622|NCT00953758|66179861|FG005|Overall Study|Participant refused further follow-up|0|||
23671623|NCT00953758|66179862|FG006|Overall Study|Participant refused further follow-up|0|||
23671624|NCT00953758|66179863|FG007|Overall Study|Participant refused further follow-up|0|||
23671625|NCT00953758|66179864|FG008|Overall Study|Participant refused further follow-up|1|||
23671626|NCT00953758|66179865|FG009|Overall Study|Participant refused further follow-up|0|||
23671627|NCT00953758|66179856|FG000|Overall Study|Lost to Follow-up|0|||
23671628|NCT00953758|66179857|FG001|Overall Study|Lost to Follow-up|0|||
23671629|NCT00953758|66179858|FG002|Overall Study|Lost to Follow-up|0|||
23671630|NCT00953758|66179859|FG003|Overall Study|Lost to Follow-up|1|||
23671631|NCT00953758|66179860|FG004|Overall Study|Lost to Follow-up|0|||
23671632|NCT00953758|66179861|FG005|Overall Study|Lost to Follow-up|0|||
23671633|NCT00953758|66179862|FG006|Overall Study|Lost to Follow-up|0|||
23671634|NCT00953758|66179863|FG007|Overall Study|Lost to Follow-up|1|||
23671635|NCT00953758|66179864|FG008|Overall Study|Lost to Follow-up|0|||
23671636|NCT00953758|66179865|FG009|Overall Study|Lost to Follow-up|1|||
23671637|NCT00953758|66179856|FG000|Overall Study|Physician Decision|0|||
23671638|NCT00953758|66179857|FG001|Overall Study|Physician Decision|0|||
23671639|NCT00953758|66179858|FG002|Overall Study|Physician Decision|0|||
23671640|NCT00953758|66179859|FG003|Overall Study|Physician Decision|0|||
23671641|NCT00953758|66179860|FG004|Overall Study|Physician Decision|1|||
23671642|NCT00953758|66179861|FG005|Overall Study|Physician Decision|0|||
23671643|NCT00953758|66179862|FG006|Overall Study|Physician Decision|0|||
23671644|NCT00953758|66179863|FG007|Overall Study|Physician Decision|0|||
23671645|NCT00953758|66179864|FG008|Overall Study|Physician Decision|0|||
23671646|NCT00953758|66179865|FG009|Overall Study|Physician Decision|0|||
23671647|NCT00953758|66179856|FG000|Overall Study|Disease progression|0|||
23671648|NCT00953758|66179857|FG001|Overall Study|Disease progression|0|||
23671649|NCT00953758|66179858|FG002|Overall Study|Disease progression|0|||
23671650|NCT00953758|66179859|FG003|Overall Study|Disease progression|0|||
23671651|NCT00953758|66179860|FG004|Overall Study|Disease progression|1|||
23671652|NCT00953758|66179861|FG005|Overall Study|Disease progression|0|||
23671653|NCT00953758|66179862|FG006|Overall Study|Disease progression|0|||
23671654|NCT00953758|66179863|FG007|Overall Study|Disease progression|0|||
23671655|NCT00953758|66179864|FG008|Overall Study|Disease progression|0|||
23671656|NCT00953758|66179865|FG009|Overall Study|Disease progression|0|||
23671657|NCT00953758|66179856|FG000|Overall Study|Participant went for transplant|0|||
23671658|NCT00953758|66179857|FG001|Overall Study|Participant went for transplant|0|||
23671659|NCT00953758|66179858|FG002|Overall Study|Participant went for transplant|0|||
23671660|NCT00953758|66179859|FG003|Overall Study|Participant went for transplant|0|||
23671661|NCT00953758|66179860|FG004|Overall Study|Participant went for transplant|0|||
23671662|NCT00953758|66179861|FG005|Overall Study|Participant went for transplant|0|||
23671663|NCT00953758|66179862|FG006|Overall Study|Participant went for transplant|0|||
23671664|NCT00953758|66179863|FG007|Overall Study|Participant went for transplant|0|||
23671665|NCT00953758|66179864|FG008|Overall Study|Participant went for transplant|1|||
23671666|NCT00953758|66179865|FG009|Overall Study|Participant went for transplant|0|||
23671667|NCT03011333|66179868|FG000|Overall Study|Lost to Follow-up|0|||
23671668|NCT03011333|66179869|FG001|Overall Study|Lost to Follow-up|1|||
23671669|NCT03011333|66179870|FG002|Overall Study|Lost to Follow-up|0|||
23671670|NCT03011333|66179871|FG003|Overall Study|Lost to Follow-up|1|||
23671671|NCT03011333|66179872|FG004|Overall Study|Lost to Follow-up|4|||
23671672|NCT03011333|66179873|FG005|Overall Study|Lost to Follow-up|4|||
23671673|NCT03011333|66179874|FG006|Overall Study|Lost to Follow-up|5|||
23671674|NCT02970292|66179877|FG000|Overall Study|Physician Decision|1|||
23671675|NCT02970292|66179878|FG001|Overall Study|Physician Decision|1|||
23671676|NCT02970292|66179877|FG000|Overall Study|Withdrawal by Subject|11|||
23671677|NCT02970292|66179878|FG001|Overall Study|Withdrawal by Subject|5|||
23671678|NCT02970292|66179877|FG000|Overall Study|Noncompliance with study drug|2|||
23671679|NCT02970292|66179878|FG001|Overall Study|Noncompliance with study drug|2|||
23671680|NCT02970292|66179877|FG000|Overall Study|Adverse Event|5|||
23671681|NCT02970292|66179878|FG001|Overall Study|Adverse Event|0|||
23671682|NCT02970292|66179877|FG000|Overall Study|Lack of Efficacy|1|||
23671683|NCT02970292|66179878|FG001|Overall Study|Lack of Efficacy|0|||
23671684|NCT02970292|66179877|FG000|Overall Study|Lost to Follow-up|1|||
23671685|NCT02970292|66179878|FG001|Overall Study|Lost to Follow-up|0|||
23671686|NCT02970292|66179877|FG000|Overall Study|Protocol Violation|2|||
23671687|NCT02970292|66179878|FG001|Overall Study|Protocol Violation|0|||
23671688|NCT02970292|66179877|FG000|Overall Study|Other|1|||
23671689|NCT02970292|66179878|FG001|Overall Study|Other|0|||
23671690|NCT01314716|66179879|FG000|Double-Blind Phase|Randomized but not treated|1|||
23671691|NCT01314716|66179880|FG001|Double-Blind Phase|Randomized but not treated|1|||
23671692|NCT01314716|66179879|FG000|Double-Blind Phase|Adverse Event|10|||
23671693|NCT01314716|66179880|FG001|Double-Blind Phase|Adverse Event|4|||
23671694|NCT01314716|66179879|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
23671695|NCT01314716|66179880|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23671696|NCT01314716|66179879|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23671697|NCT01314716|66179880|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23671698|NCT01314716|66179879|FG000|Double-Blind Phase|Sponsor request|1|||
23671699|NCT01314716|66179880|FG001|Double-Blind Phase|Sponsor request|2|||
23671700|NCT01314716|66179879|FG000|Double-Blind Phase|Physician Decision|0|||
23671701|NCT01314716|66179880|FG001|Double-Blind Phase|Physician Decision|1|||
23671702|NCT01314716|66179879|FG000|Open-Label Phase|Adverse Event|4|||
23671703|NCT01314716|66179880|FG001|Open-Label Phase|Adverse Event|6|||
23671704|NCT01314716|66179879|FG000|Open-Label Phase|Withdrawal by Subject|1|||
23671705|NCT01314716|66179880|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23671706|NCT01314716|66179879|FG000|Open-Label Phase|Physician Decision|5|||
23671707|NCT01314716|66179880|FG001|Open-Label Phase|Physician Decision|4|||
23671708|NCT00333359|66179883|FG000|Overall Study|Adverse Event|29|||
23671709|NCT00333359|66179884|FG001|Overall Study|Adverse Event|35|||
23671710|NCT00333359|66179883|FG000|Overall Study|Withdrawal by Subject|19|||
23671711|NCT00333359|66179884|FG001|Overall Study|Withdrawal by Subject|37|||
23385256|NCT02056288|65155015|FG001|In-Hospital Data|Protocol Violation|0|||
23385257|NCT02056288|65155014|FG000|In-Hospital Data|Physician Decision|1|||
23671712|NCT00333359|66179883|FG000|Overall Study|Physician Decision|2|||
23671713|NCT00333359|66179884|FG001|Overall Study|Physician Decision|2|||
23671714|NCT00333359|66179883|FG000|Overall Study|Protocol Non-compliance|2|||
23671715|NCT00333359|66179884|FG001|Overall Study|Protocol Non-compliance|8|||
23671716|NCT00333359|66179883|FG000|Overall Study|Lost to Follow-up|15|||
23671717|NCT00333359|66179884|FG001|Overall Study|Lost to Follow-up|25|||
23671718|NCT00333359|66179883|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
23385258|NCT02056288|65155015|FG001|In-Hospital Data|Physician Decision|0|||
23385259|NCT02056288|65155014|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
23385260|NCT02056288|65155015|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
23385261|NCT02568254|65155019|FG000|Period 2|Adverse Event|0|||
23385262|NCT02568254|65155020|FG001|Period 2|Adverse Event|0|||
23385263|NCT02568254|65155021|FG002|Period 2|Adverse Event|1|||
23385264|NCT02568254|65155022|FG003|Period 2|Adverse Event|0|||
23385265|NCT02568254|65155023|FG004|Period 2|Adverse Event|0|||
23385266|NCT02568254|65155024|FG005|Period 2|Adverse Event|0|||
23385267|NCT02568254|65155019|FG000|Period 3|Unstatisfactory Lens fitting|0|||
23385268|NCT02568254|65155020|FG001|Period 3|Unstatisfactory Lens fitting|0|||
23385269|NCT02568254|65155021|FG002|Period 3|Unstatisfactory Lens fitting|0|||
23385270|NCT02568254|65155022|FG003|Period 3|Unstatisfactory Lens fitting|0|||
23385271|NCT02568254|65155023|FG004|Period 3|Unstatisfactory Lens fitting|1|||
23385272|NCT02568254|65155024|FG005|Period 3|Unstatisfactory Lens fitting|0|||
23671719|NCT00333359|66179884|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
23671720|NCT00333359|66179883|FG000|Overall Study|Treatment Failure|3|||
23671721|NCT00333359|66179884|FG001|Overall Study|Treatment Failure|8|||
23671722|NCT00333359|66179883|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
23671723|NCT00333359|66179884|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
23671724|NCT02064387|66179887|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23385273|NCT03548415|65155025|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23385274|NCT03548415|65155026|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23671725|NCT02064387|66179888|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23385275|NCT03548415|65155027|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
23385276|NCT03548415|65155028|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
23671726|NCT02064387|66179889|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671727|NCT02064387|66179890|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671728|NCT02064387|66179891|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671729|NCT02064387|66179892|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671730|NCT02064387|66179893|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671731|NCT02064387|66179894|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
23671732|NCT02064387|66179895|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671733|NCT02064387|66179896|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
23671734|NCT02064387|66179897|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671735|NCT02064387|66179898|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23671736|NCT02064387|66179887|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671737|NCT02064387|66179888|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671738|NCT02064387|66179889|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671739|NCT02064387|66179890|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671740|NCT02064387|66179891|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671741|NCT02064387|66179892|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671742|NCT02064387|66179893|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671743|NCT02064387|66179894|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
23671744|NCT02064387|66179895|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23385277|NCT03548415|65155029|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
23385278|NCT03309605|65155030|FG000|Overall Study|Adverse Event|0|||
23385279|NCT03309605|65155031|FG001|Overall Study|Adverse Event|0|||
23385280|NCT03309605|65155032|FG002|Overall Study|Adverse Event|0|||
23385281|NCT03309605|65155033|FG003|Overall Study|Adverse Event|1|||
23385282|NCT03309605|65155034|FG004|Overall Study|Adverse Event|0|||
23385283|NCT03309605|65155035|FG005|Overall Study|Adverse Event|0|||
23385284|NCT03309605|65155036|FG006|Overall Study|Adverse Event|2|||
23385285|NCT03309605|65155037|FG007|Overall Study|Adverse Event|1|||
23385286|NCT03309605|65155030|FG000|Overall Study|Withdrawal by Subject|0|||
23385287|NCT03309605|65155031|FG001|Overall Study|Withdrawal by Subject|0|||
23385288|NCT03309605|65155032|FG002|Overall Study|Withdrawal by Subject|0|||
23385289|NCT03309605|65155033|FG003|Overall Study|Withdrawal by Subject|0|||
23385290|NCT03309605|65155034|FG004|Overall Study|Withdrawal by Subject|1|||
23385291|NCT03309605|65155035|FG005|Overall Study|Withdrawal by Subject|0|||
23385292|NCT03309605|65155036|FG006|Overall Study|Withdrawal by Subject|1|||
23385293|NCT03309605|65155037|FG007|Overall Study|Withdrawal by Subject|1|||
23385294|NCT04289298|65155038|FG000|Overall Study|Lost to Follow-up|5|||
23385295|NCT04289298|65155039|FG001|Overall Study|Lost to Follow-up|0|||
23385296|NCT04289298|65155038|FG000|Overall Study|Withdrawal by Subject|2|||
23385297|NCT04289298|65155039|FG001|Overall Study|Withdrawal by Subject|0|||
23385298|NCT03019588|65155040|FG000|Overall Study|Death|44|||
23385299|NCT03019588|65155041|FG001|Overall Study|Death|46|||
23385300|NCT03019588|65155040|FG000|Overall Study|Study terminated by Sponsor|3|||
23385301|NCT03019588|65155041|FG001|Overall Study|Study terminated by Sponsor|1|||
23385302|NCT00120250|65155044|FG000|Overall Study|Lost to Follow-up|1|||
23385303|NCT00120250|65155045|FG001|Overall Study|Lost to Follow-up|1|||
23385304|NCT00120250|65155044|FG000|Overall Study|Protocol Violation|0|||
23385305|NCT00120250|65155045|FG001|Overall Study|Protocol Violation|1|||
23385306|NCT00289900|65155051|FG000|Overall Study|Adverse Event|28|||
23385307|NCT00289900|65155052|FG001|Overall Study|Adverse Event|40|||
23385308|NCT00289900|65155053|FG002|Overall Study|Adverse Event|13|||
23385309|NCT00289900|65155054|FG003|Overall Study|Adverse Event|19|||
23385310|NCT00289900|65155055|FG004|Overall Study|Adverse Event|20|||
23385311|NCT00289900|65155056|FG005|Overall Study|Adverse Event|33|||
23385312|NCT00289900|65155051|FG000|Overall Study|Lost to Follow-up|7|||
23385313|NCT00289900|65155052|FG001|Overall Study|Lost to Follow-up|7|||
23385314|NCT00289900|65155053|FG002|Overall Study|Lost to Follow-up|8|||
23385315|NCT00289900|65155054|FG003|Overall Study|Lost to Follow-up|8|||
23671745|NCT02064387|66179896|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671746|NCT02064387|66179897|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671747|NCT02064387|66179898|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23671748|NCT02064387|66179887|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671749|NCT02064387|66179888|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671750|NCT02064387|66179889|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671751|NCT02064387|66179890|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23385316|NCT00289900|65155055|FG004|Overall Study|Lost to Follow-up|4|||
23385317|NCT00289900|65155056|FG005|Overall Study|Lost to Follow-up|8|||
23385318|NCT00289900|65155051|FG000|Overall Study|Participant had flushing|18|||
23385319|NCT00289900|65155052|FG001|Overall Study|Participant had flushing|42|||
23385320|NCT00289900|65155053|FG002|Overall Study|Participant had flushing|1|||
23385321|NCT00289900|65155054|FG003|Overall Study|Participant had flushing|2|||
23385322|NCT00289900|65155055|FG004|Overall Study|Participant had flushing|0|||
23385323|NCT00289900|65155056|FG005|Overall Study|Participant had flushing|4|||
23671752|NCT02064387|66179891|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671753|NCT02064387|66179892|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671754|NCT02064387|66179893|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671755|NCT02064387|66179894|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671756|NCT02064387|66179895|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
23671757|NCT02064387|66179896|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671758|NCT02064387|66179897|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671759|NCT02064387|66179898|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23671760|NCT02064387|66179887|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
23671761|NCT02064387|66179888|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
23671762|NCT02064387|66179889|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
23671763|NCT02064387|66179890|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
23671764|NCT02064387|66179891|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
23671765|NCT02064387|66179892|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
23385324|NCT00289900|65155051|FG000|Overall Study|Other|0|||
23385325|NCT00289900|65155052|FG001|Overall Study|Other|0|||
23385326|NCT00289900|65155053|FG002|Overall Study|Other|0|||
23385327|NCT00289900|65155054|FG003|Overall Study|Other|5|||
23385328|NCT00289900|65155055|FG004|Overall Study|Other|1|||
23385329|NCT00289900|65155056|FG005|Overall Study|Other|0|||
23385330|NCT00289900|65155051|FG000|Overall Study|Participant moved|1|||
23385331|NCT00289900|65155052|FG001|Overall Study|Participant moved|0|||
23385332|NCT00289900|65155053|FG002|Overall Study|Participant moved|0|||
23385333|NCT00289900|65155054|FG003|Overall Study|Participant moved|1|||
23385334|NCT00289900|65155055|FG004|Overall Study|Participant moved|1|||
23385335|NCT00289900|65155056|FG005|Overall Study|Participant moved|1|||
23385336|NCT00289900|65155051|FG000|Overall Study|Withdrawal by Subject|10|||
23385337|NCT00289900|65155052|FG001|Overall Study|Withdrawal by Subject|21|||
23385338|NCT00289900|65155053|FG002|Overall Study|Withdrawal by Subject|8|||
23385339|NCT00289900|65155054|FG003|Overall Study|Withdrawal by Subject|18|||
23385340|NCT00289900|65155055|FG004|Overall Study|Withdrawal by Subject|12|||
23385341|NCT00289900|65155056|FG005|Overall Study|Withdrawal by Subject|11|||
23385342|NCT00289900|65155051|FG000|Overall Study|Protocol Violation|3|||
23385343|NCT00289900|65155052|FG001|Overall Study|Protocol Violation|9|||
23385344|NCT00289900|65155053|FG002|Overall Study|Protocol Violation|2|||
23385345|NCT00289900|65155054|FG003|Overall Study|Protocol Violation|6|||
23385346|NCT00289900|65155055|FG004|Overall Study|Protocol Violation|7|||
23385347|NCT00289900|65155056|FG005|Overall Study|Protocol Violation|4|||
23385348|NCT00289900|65155051|FG000|Overall Study|site terminated|1|||
23385349|NCT00289900|65155052|FG001|Overall Study|site terminated|0|||
23385350|NCT00289900|65155053|FG002|Overall Study|site terminated|1|||
23385351|NCT00289900|65155054|FG003|Overall Study|site terminated|0|||
23385352|NCT00289900|65155055|FG004|Overall Study|site terminated|0|||
23385353|NCT00289900|65155056|FG005|Overall Study|site terminated|0|||
23385354|NCT00289900|65155051|FG000|Overall Study|Not treated|0|||
23385355|NCT00289900|65155052|FG001|Overall Study|Not treated|1|||
23385356|NCT00289900|65155053|FG002|Overall Study|Not treated|0|||
23385357|NCT00289900|65155054|FG003|Overall Study|Not treated|0|||
23385358|NCT00289900|65155055|FG004|Overall Study|Not treated|0|||
23385359|NCT00289900|65155056|FG005|Overall Study|Not treated|0|||
23385360|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
23385361|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
23385362|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
23493199|NCT00100178|65551387|FG001|Overall Study|Adverse Event|2|||
23671766|NCT02064387|66179893|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
23671767|NCT02064387|66179894|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
23671768|NCT02064387|66179895|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
23671769|NCT02064387|66179896|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
23385363|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
23385364|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
23385365|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
23385366|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
23385367|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
23385368|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
23385369|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
23385370|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
23385371|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
23385372|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
23385373|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
23385374|NCT00290758|65155058|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
23385375|NCT00290758|65155059|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
23385376|NCT02400580|65155061|FG000|Overall Study|Withdrawal by Subject|1|||
23385377|NCT02400580|65155062|FG001|Overall Study|Withdrawal by Subject|1|||
23385378|NCT02400580|65155061|FG000|Overall Study|Adverse Event|1|||
23385379|NCT02400580|65155062|FG001|Overall Study|Adverse Event|0|||
23385380|NCT02923180|65155063|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
23385381|NCT02923180|65155063|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
23385382|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Other|4|||
23385383|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Other|1|||
23385384|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
23385385|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23385386|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
23385387|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
23385388|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
23385389|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23385390|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Death|1|||
23385391|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Death|2|||
23385392|NCT01879852|65155070|FG000|Overall Study|Withdrawal by Subject|2|||
23385393|NCT01879852|65155071|FG001|Overall Study|Withdrawal by Subject|0|||
23385394|NCT02665455|65155073|FG000|Overall Study|Withdrawal by Subject|6|||
23385395|NCT02665455|65155073|FG000|Overall Study|Lost to Follow-up|1|||
23385396|NCT02665455|65155073|FG000|Overall Study|Adverse Event|1|||
23385397|NCT02665455|65155073|FG000|Overall Study|Protocol Violation|1|||
23385398|NCT00086307|65155079|FG000|Overall Study|Lack of Efficacy|1|||
23385399|NCT00086307|65155080|FG001|Overall Study|Lack of Efficacy|1|||
23385400|NCT00086307|65155081|FG002|Overall Study|Lack of Efficacy|2|||
23385401|NCT00086307|65155079|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
23385402|NCT00086307|65155080|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
23385403|NCT00086307|65155081|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
23385404|NCT00086307|65155079|FG000|Overall Study|Nausea and headaches|0|||
23385405|NCT00086307|65155080|FG001|Overall Study|Nausea and headaches|0|||
23385406|NCT00086307|65155081|FG002|Overall Study|Nausea and headaches|1|||
23385407|NCT00086307|65155079|FG000|Overall Study|Constipation and sleepiness|0|||
23385408|NCT00086307|65155080|FG001|Overall Study|Constipation and sleepiness|0|||
23385409|NCT00086307|65155081|FG002|Overall Study|Constipation and sleepiness|1|||
23385410|NCT00086307|65155079|FG000|Overall Study|Suicidal ideation|0|||
23385411|NCT00086307|65155080|FG001|Overall Study|Suicidal ideation|0|||
23385412|NCT00086307|65155081|FG002|Overall Study|Suicidal ideation|1|||
23385413|NCT00086307|65155079|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
23385414|NCT00086307|65155080|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
23385415|NCT00086307|65155081|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
23385416|NCT00086307|65155079|FG000|Overall Study|Withdrawal by Subject|0|||
23385417|NCT00086307|65155080|FG001|Overall Study|Withdrawal by Subject|0|||
23385418|NCT00086307|65155081|FG002|Overall Study|Withdrawal by Subject|2|||
23385419|NCT00501085|65155082|FG000|Overall Study|Lost to Follow-up|195|||
23385420|NCT00501085|65155082|FG000|Overall Study|Withdrawal by Subject|34|||
23385421|NCT00501085|65155082|FG000|Overall Study|Subject Decision|1|||
23385422|NCT00501085|65155082|FG000|Overall Study|Revision Surgery|7|||
23385423|NCT00501085|65155082|FG000|Overall Study|Explantation Surgery|26|||
23385424|NCT00501085|65155082|FG000|Overall Study|Adverse Event|4|||
23385425|NCT00501085|65155082|FG000|Overall Study|Non-Compliance|24|||
23385426|NCT00501085|65155082|FG000|Overall Study|Study closed by sponsor|109|||
23385427|NCT00501085|65155082|FG000|Overall Study|Other loss to follow-up|32|||
23385428|NCT03528577|65155083|FG000|Sequence 1|Failed Spirometry|1|||
23385429|NCT03528577|65155083|FG000|Sequence 1|Restricted medication|1|||
23385430|NCT03528577|65155083|FG000|Sequence 2|Adverse Event|1|||
23385431|NCT03528577|65155083|FG000|Sequence 2|Withdrawal by Subject|1|||
23385432|NCT03528577|65155083|FG000|Sequence 2|Failed Spirometry|1|||
23385433|NCT03528577|65155083|FG000|Sequence 3|Failed Spirometry|1|||
23385434|NCT03528577|65155083|FG000|Sequence 4|Failed Spirometry|2|||
23385435|NCT03528577|65155083|FG000|Sequence 4|Adverse Event|1|||
23385436|NCT04193527|65155084|FG000|Overall Study|Other|1|||
23385437|NCT04193527|65155085|FG001|Overall Study|Other|1|||
23385438|NCT04193527|65155086|FG002|Overall Study|Other|0|||
23385439|NCT02755090|65155089|FG000|Overall Study|equipment malfunction|1|||
23385440|NCT02755090|65155090|FG001|Overall Study|equipment malfunction|0|||
23385441|NCT00710970|65155091|FG000|Overall Study|Never took drug|3|||
23385442|NCT01905267|65155094|FG000|Overall Study|Physician Decision|2|||
23385443|NCT01905267|65155095|FG001|Overall Study|Physician Decision|2|||
23385444|NCT00770484|65155096|FG000|Overall Study|Withdrawal by Subject|1|||
23493200|NCT00100178|65551388|FG002|Overall Study|Adverse Event|1|||
23385445|NCT00770484|65155097|FG001|Overall Study|Withdrawal by Subject|0|||
23385446|NCT00066170|65155098|FG000|Overall Study|Adverse Event|2|||
23385447|NCT00066170|65155099|FG001|Overall Study|Adverse Event|4|||
23385448|NCT00066170|65155100|FG002|Overall Study|Adverse Event|1|||
23385449|NCT00066170|65155101|FG003|Overall Study|Adverse Event|7|||
23385450|NCT00066170|65155098|FG000|Overall Study|Serious Adverse Event|0|||
23385451|NCT00066170|65155099|FG001|Overall Study|Serious Adverse Event|0|||
23385452|NCT00066170|65155100|FG002|Overall Study|Serious Adverse Event|1|||
23385453|NCT00066170|65155101|FG003|Overall Study|Serious Adverse Event|1|||
23385454|NCT00066170|65155098|FG000|Overall Study|Lost to Follow-up|0|||
23385455|NCT00066170|65155099|FG001|Overall Study|Lost to Follow-up|1|||
23385456|NCT00066170|65155100|FG002|Overall Study|Lost to Follow-up|0|||
23385457|NCT00066170|65155101|FG003|Overall Study|Lost to Follow-up|0|||
23385458|NCT00066170|65155098|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
23385459|NCT00066170|65155099|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
23385460|NCT00066170|65155100|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
23385461|NCT00066170|65155101|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
23385462|NCT00066170|65155098|FG000|Overall Study|Protocol Violation|3|||
23385463|NCT00066170|65155099|FG001|Overall Study|Protocol Violation|0|||
23385464|NCT00066170|65155100|FG002|Overall Study|Protocol Violation|0|||
23385465|NCT00066170|65155101|FG003|Overall Study|Protocol Violation|0|||
23385466|NCT00066170|65155098|FG000|Overall Study|Other|1|||
23385467|NCT00066170|65155099|FG001|Overall Study|Other|5|||
23385468|NCT00066170|65155100|FG002|Overall Study|Other|2|||
23385469|NCT00066170|65155101|FG003|Overall Study|Other|0|||
23385470|NCT02619812|65155102|FG000|Overall Study|Withdrawal by Subject|0|||
23385471|NCT02619812|65155103|FG001|Overall Study|Withdrawal by Subject|0|||
23385472|NCT02619812|65155104|FG002|Overall Study|Withdrawal by Subject|1|||
23385473|NCT02619812|65155105|FG003|Overall Study|Withdrawal by Subject|2|||
23385474|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|No Data|249|||
23385475|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|No Data|66|||
23385476|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|No Data|2|||
23385477|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Other|33|||
23385478|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Other|20|||
23385479|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Other|0|||
23385480|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
23385481|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
23385482|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
23385483|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
23385484|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
23385485|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
23385486|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
23385487|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
23385488|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
23385489|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Other|5|||
23385490|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Other|1|||
23385491|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Other|0|||
23385492|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|No Data|43|||
23385493|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|No Data|11|||
23385494|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|No Data|0|||
23385495|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
23385496|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
23385497|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
23385498|NCT02287025|65155111|FG000|Overall Study|Not treated|2|||
23385499|NCT02287025|65155112|FG001|Overall Study|Not treated|0|||
23385500|NCT02287025|65155111|FG000|Overall Study|Progression of disease|3|||
23385501|NCT02287025|65155112|FG001|Overall Study|Progression of disease|2|||
23385502|NCT02287025|65155111|FG000|Overall Study|Adverse Event|2|||
23385503|NCT02287025|65155112|FG001|Overall Study|Adverse Event|4|||
23385504|NCT02287025|65155111|FG000|Overall Study|Withdrawal by Subject|2|||
23385505|NCT02287025|65155112|FG001|Overall Study|Withdrawal by Subject|2|||
23385506|NCT02287025|65155111|FG000|Overall Study|Screening failed|1|||
23385507|NCT02287025|65155112|FG001|Overall Study|Screening failed|1|||
23385508|NCT03888482|65155114|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
23385509|NCT03888482|65155115|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
23385510|NCT03888482|65155114|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
23385511|NCT03888482|65155115|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
23385512|NCT00195429|65155117|FG000|Overall Study|Adverse Event|2|||
23385513|NCT00195429|65155118|FG001|Overall Study|Adverse Event|4|||
23385514|NCT00195429|65155117|FG000|Overall Study|Lack of Efficacy|2|||
23385515|NCT00195429|65155118|FG001|Overall Study|Lack of Efficacy|1|||
23385516|NCT00195429|65155117|FG000|Overall Study|Lost to Follow-up|1|||
23385517|NCT00195429|65155118|FG001|Overall Study|Lost to Follow-up|0|||
23385518|NCT01960842|65155131|FG000|Overall Study|Adverse Event|1|||
23385519|NCT01960842|65155131|FG000|Overall Study|Withdrawal by Subject|2|||
23385520|NCT00145327|65155133|FG000|Overall Study|Withdrawal by Subject|77|||
23385521|NCT00145327|65155134|FG001|Overall Study|Withdrawal by Subject|72|||
23385522|NCT00145327|65155135|FG002|Overall Study|Withdrawal by Subject|164|||
23385523|NCT00145327|65155133|FG000|Overall Study|Death|26|||
23385524|NCT00145327|65155134|FG001|Overall Study|Death|18|||
23385525|NCT00145327|65155135|FG002|Overall Study|Death|30|||
23385526|NCT00145327|65155133|FG000|Overall Study|Adverse Event|14|||
23385527|NCT00145327|65155134|FG001|Overall Study|Adverse Event|11|||
23385528|NCT00145327|65155135|FG002|Overall Study|Adverse Event|22|||
23385529|NCT00145327|65155133|FG000|Overall Study|Lost to Follow-up|9|||
23385530|NCT00145327|65155134|FG001|Overall Study|Lost to Follow-up|14|||
23385531|NCT00145327|65155135|FG002|Overall Study|Lost to Follow-up|14|||
23385532|NCT00145327|65155133|FG000|Overall Study|Administrative problems|12|||
23385533|NCT00145327|65155134|FG001|Overall Study|Administrative problems|9|||
23385534|NCT00145327|65155135|FG002|Overall Study|Administrative problems|13|||
23385535|NCT00145327|65155133|FG000|Overall Study|Protocol Violation|2|||
23385536|NCT00145327|65155134|FG001|Overall Study|Protocol Violation|0|||
23385537|NCT00145327|65155135|FG002|Overall Study|Protocol Violation|2|||
23385538|NCT00145327|65155133|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23385539|NCT00145327|65155134|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23493201|NCT00100178|65551386|FG000|Overall Study|Withdrawal by Subject|1|||
23671770|NCT02064387|66179897|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
23671771|NCT02064387|66179898|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
23671772|NCT02064387|66179887|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671773|NCT02064387|66179888|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671774|NCT02064387|66179889|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671775|NCT02064387|66179890|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671776|NCT02064387|66179891|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671777|NCT02064387|66179892|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671778|NCT02064387|66179893|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671779|NCT02064387|66179894|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671780|NCT02064387|66179895|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671781|NCT02064387|66179896|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671782|NCT02064387|66179897|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
23671783|NCT02064387|66179898|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23671784|NCT00252057|66179899|FG000|Overall Study|Withdrawal by Subject|2|||
23671785|NCT00252057|66179900|FG001|Overall Study|Withdrawal by Subject|5|||
23671786|NCT00252057|66179899|FG000|Overall Study|Death|1|||
23671787|NCT00252057|66179900|FG001|Overall Study|Death|2|||
23385540|NCT00145327|65155135|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23385541|NCT00145327|65155133|FG000|Overall Study|Missing - not stated|1|||
23385542|NCT00145327|65155134|FG001|Overall Study|Missing - not stated|0|||
23385543|NCT00145327|65155135|FG002|Overall Study|Missing - not stated|1|||
23385544|NCT03338023|65155136|FG000|Overall Study|Withdrawal by Subject|3|||
23385545|NCT03338023|65155137|FG001|Overall Study|Withdrawal by Subject|4|||
23385546|NCT03338023|65155136|FG000|Overall Study|Protocol Violation|3|||
23671788|NCT00252057|66179899|FG000|Overall Study|Participant previously enrolled|0|||
23671789|NCT00252057|66179900|FG001|Overall Study|Participant previously enrolled|1|||
23671790|NCT01984268|66179901|FG000|Overall Study|Study Terminated|15|||
23671791|NCT00390546|66179902|FG000|Overall Study|Renal impairment|1|||
23671792|NCT00390546|66179903|FG001|Overall Study|Renal impairment|0|||
23671793|NCT00390546|66179902|FG000|Overall Study|Physician Decision|5|||
23671794|NCT00390546|66179903|FG001|Overall Study|Physician Decision|5|||
23671795|NCT02797808|66179905|FG000|Overall Study|Withdrawal by Subject|1|||
23671796|NCT02797808|66179906|FG001|Overall Study|Withdrawal by Subject|1|||
23671797|NCT02797808|66179905|FG000|Overall Study|Physician Decision|6|||
23671798|NCT02797808|66179906|FG001|Overall Study|Physician Decision|2|||
23671799|NCT02966509|66179908|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
23671800|NCT02966509|66179909|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
23671801|NCT02966509|66179908|FG000|Baseline Satisfaction Survey|Death|0|||
23671802|NCT02966509|66179909|FG001|Baseline Satisfaction Survey|Death|1|||
23671803|NCT02966509|66179908|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
23671804|NCT02966509|66179909|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
23671805|NCT02966509|66179908|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
23671806|NCT02966509|66179909|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
23671807|NCT02966509|66179908|FG000|6 Month Satisfaction Decision Survey|Death|22|||
23671808|NCT02966509|66179909|FG001|6 Month Satisfaction Decision Survey|Death|25|||
23671809|NCT02966509|66179908|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
23671810|NCT02966509|66179909|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
23671811|NCT02966509|66179908|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
23671812|NCT02966509|66179909|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
23671813|NCT02966509|66179908|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
23671814|NCT02966509|66179909|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
23671815|NCT02966509|66179908|FG000|6 Month Satisfaction Survey|Death|36|||
23671816|NCT02966509|66179909|FG001|6 Month Satisfaction Survey|Death|33|||
23671817|NCT02966509|66179908|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
23671818|NCT02966509|66179909|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
23671819|NCT02966509|66179908|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
23671820|NCT02966509|66179909|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
23671821|NCT02966509|66179908|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
23671822|NCT02966509|66179909|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
23671823|NCT02966509|66179908|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
23671824|NCT02966509|66179909|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
23671825|NCT02966509|66179908|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
23671826|NCT02966509|66179909|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
23671827|NCT00082888|66179911|FG000|Overall Study|Ineligible|1|||
23671828|NCT00082888|66179912|FG001|Overall Study|Ineligible|0|||
23671829|NCT00082888|66179913|FG002|Overall Study|Ineligible|0|||
23671830|NCT03124563|66179914|FG000|Overall Study|Lost to Follow-up|1|||
23671831|NCT03124563|66179915|FG001|Overall Study|Lost to Follow-up|1|||
23671832|NCT03124563|66179914|FG000|Overall Study|Withdrawal by Subject|1|||
23671833|NCT03124563|66179915|FG001|Overall Study|Withdrawal by Subject|1|||
23671834|NCT01617460|66182840|FG000|Overall Study|Adverse Event|10|||
23671835|NCT01617460|66182840|FG000|Overall Study|Physician Decision|16|||
23671836|NCT01617460|66182840|FG000|Overall Study|Protocol Violation|5|||
23671837|NCT01617460|66182840|FG000|Overall Study|Withdrawal by Subject|9|||
23671838|NCT02665286|66182841|FG000|Overall Study|Lost to Follow-up|3|||
23671839|NCT02665286|66182842|FG001|Overall Study|Lost to Follow-up|2|||
23671840|NCT02665286|66182843|FG002|Overall Study|Lost to Follow-up|1|||
23671841|NCT01618214|66182849|FG000|Overall Study|Adverse Event|3|||
23671842|NCT01618214|66182850|FG001|Overall Study|Adverse Event|1|||
23385547|NCT03338023|65155137|FG001|Overall Study|Protocol Violation|3|||
23385548|NCT03338023|65155136|FG000|Overall Study|Lost to Follow-up|2|||
23385549|NCT03338023|65155137|FG001|Overall Study|Lost to Follow-up|1|||
23385550|NCT03338023|65155136|FG000|Overall Study|Physician Decision|1|||
23385551|NCT03338023|65155137|FG001|Overall Study|Physician Decision|2|||
23385552|NCT00122187|65155138|FG000|Overall Study|Withdrew because of resource limitations|2|||
23385553|NCT00122187|65155139|FG001|Overall Study|Withdrew because of resource limitations|2|||
23385554|NCT00182637|65155140|FG000|Overall Study|Adverse Event|2|||
23385555|NCT00182637|65155140|FG000|Overall Study|Disease Progression|1|||
23385556|NCT01716559|65155146|FG000|Overall Study|Adverse Event|11|||
23385557|NCT01716559|65155146|FG000|Overall Study|Death|21|||
23385558|NCT01716559|65155146|FG000|Overall Study|Withdrawal by Subject|4|||
23385559|NCT01716559|65155146|FG000|Overall Study|Other withdrawal reason|75|||
23385560|NCT01570192|65155147|FG000|Overall Study|no qualifying organism|6|||
23385561|NCT01570192|65155148|FG001|Overall Study|no qualifying organism|12|||
23385562|NCT01570192|65155147|FG000|Overall Study|changed to palliative care|1|||
23385563|NCT01570192|65155148|FG001|Overall Study|changed to palliative care|0|||
23385564|NCT01570192|65155147|FG000|Overall Study|Physician Decision|0|||
23385565|NCT01570192|65155148|FG001|Overall Study|Physician Decision|1|||
23385566|NCT02346370|65155149|FG000|Overall Study|Not treated|1|||
23385567|NCT02346370|65155150|FG001|Overall Study|Not treated|0|||
23385568|NCT02346370|65155151|FG002|Overall Study|Not treated|0|||
23385569|NCT02346370|65155149|FG000|Overall Study|Withdrawal of consent|1|||
23385570|NCT02346370|65155150|FG001|Overall Study|Withdrawal of consent|0|||
23385571|NCT02346370|65155151|FG002|Overall Study|Withdrawal of consent|0|||
23385572|NCT02346370|65155149|FG000|Overall Study|Death|1|||
23385573|NCT02346370|65155150|FG001|Overall Study|Death|3|||
23385574|NCT02346370|65155151|FG002|Overall Study|Death|1|||
23385575|NCT02346370|65155149|FG000|Overall Study|Sponsor discontinued study|5|||
23385576|NCT02346370|65155150|FG001|Overall Study|Sponsor discontinued study|0|||
23385577|NCT02346370|65155151|FG002|Overall Study|Sponsor discontinued study|2|||
23385578|NCT02346370|65155149|FG000|Overall Study|Radiologic progression|0|||
23385579|NCT02346370|65155150|FG001|Overall Study|Radiologic progression|0|||
23385580|NCT02346370|65155151|FG002|Overall Study|Radiologic progression|1|||
23385581|NCT02346370|65155149|FG000|Overall Study|Physician Decision|0|||
23385582|NCT02346370|65155150|FG001|Overall Study|Physician Decision|1|||
23385583|NCT02346370|65155151|FG002|Overall Study|Physician Decision|0|||
23385584|NCT01155323|65155152|FG000|First Intervention|exclusion criteria|1|||
23385585|NCT01155323|65155153|FG001|First Intervention|exclusion criteria|1|||
23385586|NCT01155323|65155152|FG000|Second Intervention|Lost to Follow-up|1|||
23385587|NCT01155323|65155153|FG001|Second Intervention|Lost to Follow-up|1|||
23385588|NCT03462563|65155156|FG000|Overall Study|Death|1|||
23385589|NCT03462563|65155157|FG001|Overall Study|Death|1|||
23385590|NCT03462563|65155156|FG000|Overall Study|Termination of study|2|||
23385591|NCT03462563|65155157|FG001|Overall Study|Termination of study|1|||
23385592|NCT03462563|65155156|FG000|Overall Study|Adverse Event|1|||
23385593|NCT03462563|65155157|FG001|Overall Study|Adverse Event|3|||
23385594|NCT03462563|65155156|FG000|Overall Study|Unspecified reason|10|||
23385595|NCT03462563|65155157|FG001|Overall Study|Unspecified reason|12|||
23385596|NCT03462563|65155156|FG000|Overall Study|Physician Decision|1|||
23385597|NCT03462563|65155157|FG001|Overall Study|Physician Decision|0|||
23385598|NCT02945046|65155158|FG000|Overall Study|Adverse Event|1|||
23385599|NCT02945046|65155159|FG001|Overall Study|Adverse Event|0|||
23385600|NCT02945046|65155160|FG002|Overall Study|Adverse Event|2|||
23385601|NCT02945046|65155158|FG000|Overall Study|Withdrawal by Subject|3|||
23385602|NCT02945046|65155159|FG001|Overall Study|Withdrawal by Subject|3|||
23385603|NCT02945046|65155160|FG002|Overall Study|Withdrawal by Subject|3|||
23385604|NCT02945046|65155158|FG000|Overall Study|Protocol Violation|2|||
23385605|NCT02945046|65155159|FG001|Overall Study|Protocol Violation|3|||
23385606|NCT02945046|65155160|FG002|Overall Study|Protocol Violation|2|||
23385607|NCT02945046|65155158|FG000|Overall Study|Lost to Follow-up|1|||
23385608|NCT02945046|65155159|FG001|Overall Study|Lost to Follow-up|1|||
23385609|NCT02945046|65155160|FG002|Overall Study|Lost to Follow-up|0|||
23671843|NCT01618214|66182849|FG000|Overall Study|Lack of Efficacy|1|||
23671844|NCT01618214|66182850|FG001|Overall Study|Lack of Efficacy|1|||
23385610|NCT02945046|65155158|FG000|Overall Study|Lack of Efficacy|1|||
23385611|NCT02945046|65155159|FG001|Overall Study|Lack of Efficacy|2|||
23385612|NCT02945046|65155160|FG002|Overall Study|Lack of Efficacy|1|||
23385613|NCT02945046|65155158|FG000|Overall Study|Other than specified|5|||
23385614|NCT02945046|65155159|FG001|Overall Study|Other than specified|4|||
23385615|NCT02945046|65155160|FG002|Overall Study|Other than specified|7|||
23385616|NCT02965976|65155161|FG000|Overall Study|Withdrawal by Subject|2|||
23385617|NCT02965976|65155162|FG001|Overall Study|Withdrawal by Subject|0|||
23385618|NCT02691663|65155163|FG000|Overall Study|Screen failure after baseline|2|||
23385619|NCT02691663|65155164|FG001|Overall Study|Screen failure after baseline|2|||
23385620|NCT02691663|65155163|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
23385621|NCT02691663|65155164|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
23385622|NCT02691663|65155163|FG000|Overall Study|Withdrawn after Follow up 2|1|||
23671845|NCT01618214|66182849|FG000|Overall Study|Protocol Violation|1|||
23671846|NCT01618214|66182850|FG001|Overall Study|Protocol Violation|4|||
23671847|NCT01618214|66182849|FG000|Overall Study|Withdrawal Criteria|1|||
23671848|NCT01618214|66182850|FG001|Overall Study|Withdrawal Criteria|2|||
23671849|NCT01618214|66182849|FG000|Overall Study|Unclassified|4|||
23671850|NCT01618214|66182850|FG001|Overall Study|Unclassified|5|||
23671851|NCT00772668|66182851|FG000|Overall Study|Physician Decision|3|||
23385623|NCT02691663|65155164|FG001|Overall Study|Withdrawn after Follow up 2|1|||
23385624|NCT02691663|65155163|FG000|Overall Study|Lost to Follow-up|3|||
23385625|NCT02691663|65155164|FG001|Overall Study|Lost to Follow-up|2|||
23385626|NCT05427916|65155179|FG000|Overall Study|Adverse Event|3|||
23385627|NCT05427916|65155180|FG001|Overall Study|Adverse Event|0|||
23385628|NCT05427916|65155179|FG000|Overall Study|Lack of Efficacy|6|||
23385629|NCT05427916|65155180|FG001|Overall Study|Lack of Efficacy|0|||
23385630|NCT05427916|65155179|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
23385631|NCT05427916|65155180|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
23385632|NCT01717859|65155182|FG000|Overall Study|Adverse Event|5|||
23385633|NCT01717859|65155182|FG000|Overall Study|Moved out of state|1|||
23385634|NCT01717859|65155182|FG000|Overall Study|Patient concerned about mental health|1|||
23385635|NCT01717859|65155182|FG000|Overall Study|Lost to Follow-up|1|||
23385636|NCT01717859|65155182|FG000|Overall Study|Withdrawal by Subject|2|||
23385637|NCT01953354|65155183|FG000|Overall Study|Withdrawal by Subject|0|||
23385638|NCT01953354|65155184|FG001|Overall Study|Withdrawal by Subject|1|||
23385639|NCT01953354|65155183|FG000|Overall Study|Decision of Sponsor|0|||
23385640|NCT01953354|65155184|FG001|Overall Study|Decision of Sponsor|1|||
23385641|NCT01953354|65155183|FG000|Overall Study|Disease Exacerbation|1|||
23385642|NCT01953354|65155184|FG001|Overall Study|Disease Exacerbation|0|||
23385643|NCT02739828|65155185|FG000|Overall Study|Adverse Event|1|||
23385644|NCT02739828|65155185|FG000|Overall Study|Lost to Follow-up|4|||
23385645|NCT05085405|65155186|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385646|NCT05085405|65155187|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385647|NCT05085405|65155188|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
23385648|NCT05085405|65155189|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
23385649|NCT05085405|65155190|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385650|NCT05085405|65155191|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385651|NCT05085405|65155186|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23671852|NCT01137773|66182852|FG000|Overall Study|Death|3|||
23671853|NCT01137773|66182853|FG001|Overall Study|Death|3|||
23671854|NCT01137773|66182852|FG000|Overall Study|Lost to Follow-up|6|||
23385652|NCT05085405|65155187|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385653|NCT05085405|65155188|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385654|NCT05085405|65155189|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
23385655|NCT05085405|65155190|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385656|NCT05085405|65155191|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385657|NCT03142451|65155203|FG000|Overall Study|Adverse Event|5|||
23385658|NCT03142451|65155204|FG001|Overall Study|Adverse Event|2|||
23385659|NCT03142451|65155203|FG000|Overall Study|Lost to Follow-up|25|||
23385660|NCT03142451|65155204|FG001|Overall Study|Lost to Follow-up|8|||
23385661|NCT03142451|65155203|FG000|Overall Study|Participant request|24|||
23385662|NCT03142451|65155204|FG001|Overall Study|Participant request|12|||
23385663|NCT03142451|65155203|FG000|Overall Study|Protocol Violation|3|||
23385664|NCT03142451|65155204|FG001|Overall Study|Protocol Violation|1|||
23671855|NCT01137773|66182853|FG001|Overall Study|Lost to Follow-up|0|||
23671856|NCT01895322|66182855|FG000|Overall Study|Adverse Event|1|||
23385665|NCT03142451|65155203|FG000|Overall Study|Other|1|||
23385666|NCT03142451|65155204|FG001|Overall Study|Other|1|||
23385667|NCT00366535|65155205|FG000|First Phase: 12 Weeks|Adverse Event|1|||
23385668|NCT00366535|65155206|FG001|First Phase: 12 Weeks|Adverse Event|3|||
23385669|NCT00366535|65155205|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
23385670|NCT00366535|65155206|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
23385671|NCT00366535|65155205|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
23385672|NCT00366535|65155206|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
23385673|NCT00366535|65155205|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
23385674|NCT00366535|65155206|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
23385675|NCT00655746|65155207|FG000|Overall Study|Withdrawal by Subject|1|||
23385676|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Adverse Event|14|||
23385677|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Adverse Event|27|||
23385678|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Adverse Event|60|||
23385679|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Adverse Event|0|||
23493202|NCT00100178|65551387|FG001|Overall Study|Withdrawal by Subject|1|||
23493203|NCT00100178|65551388|FG002|Overall Study|Withdrawal by Subject|1|||
23671857|NCT01895322|66182855|FG000|Overall Study|Withdrawal by Subject|2|||
23671858|NCT01895322|66182855|FG000|Overall Study|Protocol Violation|10|||
23671859|NCT02474082|66182856|FG000|Overall Study|Adverse Event|2|||
23671860|NCT02474082|66182857|FG001|Overall Study|Adverse Event|32|||
23671861|NCT02474082|66182856|FG000|Overall Study|Withdrawal of informed consent|1|||
23671862|NCT02474082|66182857|FG001|Overall Study|Withdrawal of informed consent|11|||
23671863|NCT02474082|66182856|FG000|Overall Study|Lost to Follow-up|2|||
23671864|NCT02474082|66182857|FG001|Overall Study|Lost to Follow-up|2|||
23671865|NCT02474082|66182856|FG000|Overall Study|Dose tapering not achieved|0|||
23671866|NCT02474082|66182857|FG001|Overall Study|Dose tapering not achieved|4|||
23671867|NCT02474082|66182856|FG000|Overall Study|Participant/guardian decision|1|||
23671868|NCT02474082|66182857|FG001|Overall Study|Participant/guardian decision|2|||
23385680|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Adverse Event|0|||
23671869|NCT02474082|66182856|FG000|Overall Study|Non-compliance with study treatment|0|||
23671870|NCT02474082|66182857|FG001|Overall Study|Non-compliance with study treatment|2|||
23671871|NCT02474082|66182856|FG000|Overall Study|Protocol deviation|0|||
23671872|NCT02474082|66182857|FG001|Overall Study|Protocol deviation|1|||
23671873|NCT03979274|66182865|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23671874|NCT03979274|66182866|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23671875|NCT01263639|66182867|FG000|Overall Study|Lost to Follow-up|66|||
23671876|NCT01263639|66182868|FG001|Overall Study|Lost to Follow-up|70|||
23671877|NCT01263639|66182867|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
23671878|NCT01263639|66182868|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
23671879|NCT02111993|66182869|FG000|Overall Study|Physician Decision|5|||
23671880|NCT02111993|66182870|FG001|Overall Study|Physician Decision|4|||
23671881|NCT03115151|66182879|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
23671882|NCT03115151|66182880|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
23671883|NCT03115151|66182879|FG000|Overall Study|Epidural catheter removal|1|||
23671884|NCT03115151|66182880|FG001|Overall Study|Epidural catheter removal|0|||
23671885|NCT03115151|66182879|FG000|Overall Study|Withdrawal by Subject|0|||
23671886|NCT03115151|66182880|FG001|Overall Study|Withdrawal by Subject|1|||
23671887|NCT03115151|66182879|FG000|Overall Study|Intervention not received according to the protocol.|1|||
23671888|NCT03115151|66182880|FG001|Overall Study|Intervention not received according to the protocol.|1|||
23671889|NCT03115151|66182879|FG000|Overall Study|Physician Decision|1|||
23671890|NCT03115151|66182880|FG001|Overall Study|Physician Decision|0|||
23671891|NCT03115151|66182879|FG000|Overall Study|Randomization not applied|1|||
23671892|NCT03115151|66182880|FG001|Overall Study|Randomization not applied|1|||
23671893|NCT00812214|66182890|FG000|Overall Study|Lost to Follow-up|3|||
23671894|NCT00812214|66182891|FG001|Overall Study|Lost to Follow-up|1|||
23671895|NCT01594853|66182894|FG000|Overall Study|Withdrawal by Subject|1|||
23671896|NCT01594853|66182895|FG001|Overall Study|Withdrawal by Subject|1|||
23671897|NCT01594853|66182894|FG000|Overall Study|Lost to Follow-up|1|||
23671898|NCT01594853|66182895|FG001|Overall Study|Lost to Follow-up|1|||
23671899|NCT01594853|66182894|FG000|Overall Study|noncompliance with exercise|0|||
23671900|NCT01594853|66182895|FG001|Overall Study|noncompliance with exercise|1|||
23671901|NCT01496066|66182896|FG000|Overall Study|Lost to Follow-up|8|||
23671902|NCT01496066|66182897|FG001|Overall Study|Lost to Follow-up|5|||
23385681|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Pregnancy|0|||
23385682|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Pregnancy|7|||
23385683|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Pregnancy|9|||
23385684|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Pregnancy|0|||
23493204|NCT00100178|65551386|FG000|Overall Study|Physician Decision|6|||
23493205|NCT00100178|65551387|FG001|Overall Study|Physician Decision|1|||
23671903|NCT01496066|66182896|FG000|Overall Study|Explant|3|||
23671904|NCT01496066|66182897|FG001|Overall Study|Explant|0|||
23671905|NCT01496066|66182896|FG000|Overall Study|Death|1|||
23671906|NCT01496066|66182897|FG001|Overall Study|Death|4|||
23671907|NCT00290433|66182898|FG000|Overall Study|Disease Progression|13|||
23385685|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Pregnancy|0|||
23671908|NCT00290433|66182898|FG000|Overall Study|Adverse Event|14|||
23671909|NCT00290433|66182898|FG000|Overall Study|Withdrawal by Subject|1|||
23671910|NCT00290433|66182898|FG000|Overall Study|Non-Compliance|1|||
23671911|NCT00290433|66182898|FG000|Overall Study|Congestive Heart Failure|1|||
23671912|NCT00290433|66182898|FG000|Overall Study|Transplant in CR|5|||
23671913|NCT00290433|66182898|FG000|Overall Study|Unrelated Infection/Death|1|||
23671914|NCT01964352|66182899|FG000|Overall Study|Adverse Event|13|||
23671915|NCT01964352|66182900|FG001|Overall Study|Adverse Event|3|||
23671916|NCT01964352|66182901|FG002|Overall Study|Adverse Event|4|||
23671917|NCT01964352|66182902|FG003|Overall Study|Adverse Event|3|||
23671918|NCT01964352|66182899|FG000|Overall Study|Lack of Efficacy|6|||
23671919|NCT01964352|66182900|FG001|Overall Study|Lack of Efficacy|0|||
23671920|NCT01964352|66182901|FG002|Overall Study|Lack of Efficacy|0|||
23671921|NCT01964352|66182902|FG003|Overall Study|Lack of Efficacy|0|||
23671922|NCT01964352|66182899|FG000|Overall Study|Protocol Violation|2|||
23671923|NCT01964352|66182900|FG001|Overall Study|Protocol Violation|4|||
23671924|NCT01964352|66182901|FG002|Overall Study|Protocol Violation|0|||
23671925|NCT01964352|66182902|FG003|Overall Study|Protocol Violation|2|||
23671926|NCT01964352|66182899|FG000|Overall Study|Lost to Follow-up|1|||
23671927|NCT01964352|66182900|FG001|Overall Study|Lost to Follow-up|0|||
23671928|NCT01964352|66182901|FG002|Overall Study|Lost to Follow-up|0|||
23671929|NCT01964352|66182902|FG003|Overall Study|Lost to Follow-up|1|||
23671930|NCT01964352|66182899|FG000|Overall Study|Withdrawal by Subject|4|||
23671931|NCT01964352|66182900|FG001|Overall Study|Withdrawal by Subject|2|||
23671932|NCT01964352|66182901|FG002|Overall Study|Withdrawal by Subject|1|||
23671933|NCT01964352|66182902|FG003|Overall Study|Withdrawal by Subject|0|||
23671934|NCT01964352|66182899|FG000|Overall Study|Other than stated above|0|||
23671935|NCT01964352|66182900|FG001|Overall Study|Other than stated above|2|||
23671936|NCT01964352|66182901|FG002|Overall Study|Other than stated above|1|||
23671937|NCT01964352|66182902|FG003|Overall Study|Other than stated above|2|||
23671938|NCT01437397|66182907|FG000|Overall Study|Lost to Follow-up|9|||
23671939|NCT01437397|66182908|FG001|Overall Study|Lost to Follow-up|4|||
23671940|NCT01437397|66182909|FG002|Overall Study|Lost to Follow-up|2|||
23671941|NCT01437397|66182910|FG003|Overall Study|Lost to Follow-up|4|||
23671942|NCT01437397|66182911|FG004|Overall Study|Lost to Follow-up|5|||
23671943|NCT01437397|66182907|FG000|Overall Study|Withdrawal by Subject|11|||
23671944|NCT01437397|66182908|FG001|Overall Study|Withdrawal by Subject|12|||
23671945|NCT01437397|66182909|FG002|Overall Study|Withdrawal by Subject|24|||
23671946|NCT01437397|66182910|FG003|Overall Study|Withdrawal by Subject|11|||
23671947|NCT01437397|66182911|FG004|Overall Study|Withdrawal by Subject|22|||
23671948|NCT01437397|66182907|FG000|Overall Study|Protocol Violation|10|||
23671949|NCT01437397|66182908|FG001|Overall Study|Protocol Violation|12|||
23671950|NCT01437397|66182909|FG002|Overall Study|Protocol Violation|13|||
23671951|NCT01437397|66182910|FG003|Overall Study|Protocol Violation|21|||
23671952|NCT01437397|66182911|FG004|Overall Study|Protocol Violation|19|||
23671953|NCT01437397|66182907|FG000|Overall Study|Lack of Efficacy|5|||
23671954|NCT01437397|66182908|FG001|Overall Study|Lack of Efficacy|4|||
23671955|NCT01437397|66182909|FG002|Overall Study|Lack of Efficacy|8|||
23671956|NCT01437397|66182910|FG003|Overall Study|Lack of Efficacy|10|||
23671957|NCT01437397|66182911|FG004|Overall Study|Lack of Efficacy|20|||
23671958|NCT01437397|66182907|FG000|Overall Study|Adverse Event|21|||
23671959|NCT01437397|66182908|FG001|Overall Study|Adverse Event|22|||
23671960|NCT01437397|66182909|FG002|Overall Study|Adverse Event|16|||
23671961|NCT01437397|66182910|FG003|Overall Study|Adverse Event|14|||
23671962|NCT01437397|66182911|FG004|Overall Study|Adverse Event|21|||
23671963|NCT01437397|66182907|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
23671964|NCT01437397|66182908|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
23671965|NCT01437397|66182909|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
23671966|NCT01437397|66182910|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
23671967|NCT01437397|66182911|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
23671968|NCT02573155|66182912|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
23671969|NCT02573155|66182913|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
23671970|NCT02573155|66182912|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
23671971|NCT02573155|66182913|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
23671972|NCT02573155|66182912|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
23671973|NCT02573155|66182913|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
23671974|NCT02573155|66182912|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
23671975|NCT02573155|66182913|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
23671976|NCT02573155|66182912|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
23671977|NCT02573155|66182913|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
23671978|NCT02573155|66182912|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
23671979|NCT02573155|66182913|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
23671980|NCT02573155|66182912|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
23671981|NCT02573155|66182913|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
23671982|NCT02573155|66182912|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
23671983|NCT02573155|66182913|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
23671984|NCT00243659|66182914|FG000|Overall Study|Withdrawal by Subject|1|||
23671985|NCT00243659|66182915|FG001|Overall Study|Withdrawal by Subject|1|||
23671986|NCT00243659|66182914|FG000|Overall Study|Protocol Violation|1|||
23671987|NCT00243659|66182915|FG001|Overall Study|Protocol Violation|2|||
23671988|NCT02889796|66182916|FG000|Overall Study|Withdrew Consent|18|||
23671989|NCT02889796|66182917|FG001|Overall Study|Withdrew Consent|29|||
23606054|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
23606055|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
23671990|NCT02889796|66182918|FG002|Overall Study|Withdrew Consent|20|||
23671991|NCT02889796|66182919|FG003|Overall Study|Withdrew Consent|1|||
23671992|NCT02889796|66182920|FG004|Overall Study|Withdrew Consent|2|||
23671993|NCT02889796|66182921|FG005|Overall Study|Withdrew Consent|35|||
23671994|NCT02889796|66182916|FG000|Overall Study|Investigator's Discretion|10|||
23671995|NCT02889796|66182917|FG001|Overall Study|Investigator's Discretion|9|||
23671996|NCT02889796|66182918|FG002|Overall Study|Investigator's Discretion|10|||
23671997|NCT02889796|66182919|FG003|Overall Study|Investigator's Discretion|3|||
23671998|NCT02889796|66182920|FG004|Overall Study|Investigator's Discretion|0|||
23671999|NCT02889796|66182921|FG005|Overall Study|Investigator's Discretion|15|||
23672000|NCT02889796|66182916|FG000|Overall Study|Adverse Event|17|||
23672001|NCT02889796|66182917|FG001|Overall Study|Adverse Event|8|||
23672002|NCT02889796|66182918|FG002|Overall Study|Adverse Event|8|||
23672003|NCT02889796|66182919|FG003|Overall Study|Adverse Event|4|||
23672004|NCT02889796|66182920|FG004|Overall Study|Adverse Event|1|||
23672005|NCT02889796|66182921|FG005|Overall Study|Adverse Event|7|||
23672006|NCT02889796|66182916|FG000|Overall Study|Lost to Follow-up|5|||
23672007|NCT02889796|66182917|FG001|Overall Study|Lost to Follow-up|7|||
23672008|NCT02889796|66182918|FG002|Overall Study|Lost to Follow-up|2|||
23672009|NCT02889796|66182919|FG003|Overall Study|Lost to Follow-up|0|||
23672010|NCT02889796|66182920|FG004|Overall Study|Lost to Follow-up|2|||
23672011|NCT02889796|66182921|FG005|Overall Study|Lost to Follow-up|6|||
23672012|NCT02889796|66182916|FG000|Overall Study|Protocol Violation|0|||
23672013|NCT02889796|66182917|FG001|Overall Study|Protocol Violation|1|||
23672014|NCT02889796|66182918|FG002|Overall Study|Protocol Violation|3|||
23672015|NCT02889796|66182919|FG003|Overall Study|Protocol Violation|0|||
23672016|NCT02889796|66182920|FG004|Overall Study|Protocol Violation|0|||
23672017|NCT02889796|66182921|FG005|Overall Study|Protocol Violation|4|||
23672018|NCT02889796|66182916|FG000|Overall Study|Non-compliance With Study Drug|0|||
23672019|NCT02889796|66182917|FG001|Overall Study|Non-compliance With Study Drug|2|||
23672020|NCT02889796|66182918|FG002|Overall Study|Non-compliance With Study Drug|0|||
23672021|NCT02889796|66182919|FG003|Overall Study|Non-compliance With Study Drug|0|||
23672022|NCT02889796|66182920|FG004|Overall Study|Non-compliance With Study Drug|1|||
23672023|NCT02889796|66182921|FG005|Overall Study|Non-compliance With Study Drug|2|||
23672024|NCT02889796|66182916|FG000|Overall Study|Death|1|||
23672025|NCT02889796|66182917|FG001|Overall Study|Death|1|||
23672026|NCT02889796|66182918|FG002|Overall Study|Death|0|||
23672027|NCT02889796|66182919|FG003|Overall Study|Death|1|||
23672028|NCT02889796|66182920|FG004|Overall Study|Death|0|||
23672029|NCT02889796|66182921|FG005|Overall Study|Death|1|||
23672030|NCT02889796|66182916|FG000|Overall Study|Pregnancy|0|||
23606056|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Death|1|||
23606057|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Death|0|||
23606058|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
23606059|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
23606060|NCT03136159|65947134|FG000|Overall Study|chorioamnionitis|2|||
23606061|NCT03136159|65947135|FG001|Overall Study|chorioamnionitis|0|||
23606062|NCT03136159|65947134|FG000|Overall Study|vertical skin incision|1|||
23606063|NCT03136159|65947135|FG001|Overall Study|vertical skin incision|0|||
23606064|NCT03136159|65947134|FG000|Overall Study|additional dressing|1|||
23606065|NCT03136159|65947135|FG001|Overall Study|additional dressing|0|||
23606066|NCT03136159|65947134|FG000|Overall Study|never got dressing placed|1|||
23606067|NCT03136159|65947135|FG001|Overall Study|never got dressing placed|0|||
23672031|NCT02889796|66182917|FG001|Overall Study|Pregnancy|1|||
23672032|NCT02889796|66182918|FG002|Overall Study|Pregnancy|1|||
23672033|NCT02889796|66182919|FG003|Overall Study|Pregnancy|0|||
23672034|NCT02889796|66182920|FG004|Overall Study|Pregnancy|0|||
23672035|NCT02889796|66182921|FG005|Overall Study|Pregnancy|0|||
23672036|NCT02889796|66182916|FG000|Overall Study|Randomized but not Dosed|2|||
23672037|NCT02889796|66182917|FG001|Overall Study|Randomized but not Dosed|0|||
23672038|NCT02889796|66182918|FG002|Overall Study|Randomized but not Dosed|0|||
23672039|NCT02889796|66182919|FG003|Overall Study|Randomized but not Dosed|0|||
23672040|NCT02889796|66182920|FG004|Overall Study|Randomized but not Dosed|0|||
23672041|NCT02889796|66182921|FG005|Overall Study|Randomized but not Dosed|2|||
23672042|NCT03451773|66182923|FG000|Overall Study|Death on study|1|||
23672043|NCT03451773|66182924|FG001|Overall Study|Death on study|5|||
23672044|NCT03451773|66182923|FG000|Overall Study|Death during follow-up period|0|||
23672045|NCT03451773|66182924|FG001|Overall Study|Death during follow-up period|1|||
23672046|NCT03048422|66182931|FG000|Overall Study|Death|1|||
23672047|NCT03048422|66182932|FG001|Overall Study|Death|0|||
23672048|NCT03048422|66182933|FG002|Overall Study|Death|0|||
23672049|NCT03048422|66182931|FG000|Overall Study|Lost to Follow-up|5|||
23672050|NCT03048422|66182932|FG001|Overall Study|Lost to Follow-up|0|||
23672051|NCT03048422|66182933|FG002|Overall Study|Lost to Follow-up|1|||
23672052|NCT03048422|66182931|FG000|Overall Study|Withdrawal by Subject|5|||
23672053|NCT03048422|66182932|FG001|Overall Study|Withdrawal by Subject|7|||
23672054|NCT03048422|66182933|FG002|Overall Study|Withdrawal by Subject|4|||
23672055|NCT03048422|66182931|FG000|Overall Study|Moved|3|||
23672056|NCT03048422|66182932|FG001|Overall Study|Moved|2|||
23672057|NCT03048422|66182933|FG002|Overall Study|Moved|2|||
23672058|NCT03048422|66182931|FG000|Overall Study|Noncompliant with Study Requirements|2|||
23672059|NCT03048422|66182932|FG001|Overall Study|Noncompliant with Study Requirements|1|||
23672060|NCT03048422|66182933|FG002|Overall Study|Noncompliant with Study Requirements|2|||
23672061|NCT03048422|66182931|FG000|Overall Study|Not Able to Get to Clinic|1|||
23672062|NCT03048422|66182932|FG001|Overall Study|Not Able to Get to Clinic|0|||
23672063|NCT03048422|66182933|FG002|Overall Study|Not Able to Get to Clinic|0|||
23672064|NCT00264875|66182940|FG000|Overall Study|Adverse Event|6|||
23672065|NCT00264875|66182940|FG000|Overall Study|Lost to Follow-up|6|||
23672066|NCT00264875|66182940|FG000|Overall Study|Protocol Violation|11|||
23672067|NCT00264875|66182940|FG000|Overall Study|Withdrawal by Subject|7|||
23672068|NCT00720109|66182941|FG000|Induction Period|Did not meet eligibility criteria|3|||
23672069|NCT00720109|66182942|FG001|Induction Period|Did not meet eligibility criteria|0|||
23672070|NCT00720109|66182943|FG002|Induction Period|Did not meet eligibility criteria|0|||
23672071|NCT00720109|66182941|FG000|Induction Period|Bone Marrow Transplant|2|||
23672072|NCT00720109|66182942|FG001|Induction Period|Bone Marrow Transplant|0|||
23672073|NCT00720109|66182943|FG002|Induction Period|Bone Marrow Transplant|0|||
23672074|NCT00720109|66182941|FG000|Induction Period|Physician Decision|1|||
23672075|NCT00720109|66182942|FG001|Induction Period|Physician Decision|0|||
23672076|NCT00720109|66182943|FG002|Induction Period|Physician Decision|0|||
23672077|NCT00720109|66182941|FG000|Risk Stratification Period|Adverse Event|0|||
23672078|NCT00720109|66182942|FG001|Risk Stratification Period|Adverse Event|1|||
23672079|NCT00720109|66182943|FG002|Risk Stratification Period|Adverse Event|0|||
23672080|NCT00720109|66182941|FG000|Risk Stratification Period|Physician Decision|0|||
23672081|NCT00720109|66182942|FG001|Risk Stratification Period|Physician Decision|2|||
23672082|NCT00720109|66182943|FG002|Risk Stratification Period|Physician Decision|1|||
23672083|NCT00720109|66182941|FG000|Risk Stratification Period|Bone marrow transplant|0|||
23672084|NCT00720109|66182942|FG001|Risk Stratification Period|Bone marrow transplant|9|||
23672085|NCT00720109|66182943|FG002|Risk Stratification Period|Bone marrow transplant|7|||
23672086|NCT00720109|66182941|FG000|Risk Stratification Period|Disease progression or relapse|0|||
23672087|NCT00720109|66182942|FG001|Risk Stratification Period|Disease progression or relapse|2|||
23672088|NCT00720109|66182943|FG002|Risk Stratification Period|Disease progression or relapse|0|||
23672089|NCT00720109|66182941|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
23672090|NCT00720109|66182942|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
23672091|NCT00720109|66182943|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
23672092|NCT04029519|66182948|FG000|Overall Study|Protocol Violation|1|||
23672093|NCT04029519|66182948|FG000|Overall Study|Withdrawal by Subject|3|||
23672094|NCT04029519|66182948|FG000|Overall Study|Lost to Follow-up|1|||
23672095|NCT00411554|66182951|FG000|Overall Study|Adverse Event|2|||
23672096|NCT00411554|66182952|FG001|Overall Study|Adverse Event|4|||
23672097|NCT00411554|66182951|FG000|Overall Study|Lack of Efficacy|2|||
23672098|NCT00411554|66182952|FG001|Overall Study|Lack of Efficacy|5|||
23672099|NCT00411554|66182951|FG000|Overall Study|Withdrawal by Subject|3|||
23672100|NCT00411554|66182952|FG001|Overall Study|Withdrawal by Subject|0|||
23672101|NCT00411554|66182951|FG000|Overall Study|Patient Moved|1|||
23672102|NCT00411554|66182952|FG001|Overall Study|Patient Moved|0|||
23672103|NCT01411085|66182959|FG000|Overall Study|Physician Decision|1|||
23672104|NCT01411085|66182959|FG000|Overall Study|Protocol Violation|1|||
23672105|NCT01411085|66182959|FG000|Overall Study|Adverse Event|1|||
23672106|NCT00546052|66182961|FG000|Overall Study|Adverse Event|47|||
23672107|NCT00546052|66182961|FG000|Overall Study|Lost to Follow-up|144|||
23672108|NCT00546052|66182961|FG000|Overall Study|Protocol Violation|9|||
23672109|NCT00546052|66182961|FG000|Overall Study|Withdrawal by Subject|20|||
23672110|NCT00546052|66182961|FG000|Overall Study|Non Compliance|7|||
23672111|NCT00267748|66182964|FG000|Non-randomized Period|Progressive disease|10|||
23672112|NCT00267748|66182965|FG001|Non-randomized Period|Progressive disease|0|||
23672113|NCT00267748|66182966|FG002|Non-randomized Period|Progressive disease|0|||
23672114|NCT00267748|66182964|FG000|Non-randomized Period|Adverse Event|8|||
23672115|NCT00267748|66182965|FG001|Non-randomized Period|Adverse Event|0|||
23672116|NCT00267748|66182966|FG002|Non-randomized Period|Adverse Event|0|||
23672117|NCT00267748|66182964|FG000|Non-randomized Period|Death|1|||
23672118|NCT00267748|66182965|FG001|Non-randomized Period|Death|0|||
23672119|NCT00267748|66182966|FG002|Non-randomized Period|Death|0|||
23672120|NCT00267748|66182964|FG000|Non-randomized Period|Participant not willing to participate|1|||
23672121|NCT00267748|66182965|FG001|Non-randomized Period|Participant not willing to participate|0|||
23672122|NCT00267748|66182966|FG002|Non-randomized Period|Participant not willing to participate|0|||
23672123|NCT00267748|66182964|FG000|Non-randomized Period|Other|3|||
23672124|NCT00267748|66182965|FG001|Non-randomized Period|Other|0|||
23672125|NCT00267748|66182966|FG002|Non-randomized Period|Other|0|||
23672126|NCT00267748|66182964|FG000|Randomized Period|Death|0|||
23672127|NCT00267748|66182965|FG001|Randomized Period|Death|2|||
23672128|NCT00267748|66182966|FG002|Randomized Period|Death|3|||
23672129|NCT00267748|66182964|FG000|Randomized Period|Adverse Event|0|||
23672130|NCT00267748|66182965|FG001|Randomized Period|Adverse Event|23|||
23672131|NCT00267748|66182966|FG002|Randomized Period|Adverse Event|25|||
23672132|NCT00267748|66182964|FG000|Randomized Period|Global deterioration of health status|0|||
23672133|NCT00267748|66182965|FG001|Randomized Period|Global deterioration of health status|6|||
23672134|NCT00267748|66182966|FG002|Randomized Period|Global deterioration of health status|7|||
23672135|NCT00267748|66182964|FG000|Randomized Period|Lost to Follow-up|0|||
23672136|NCT00267748|66182965|FG001|Randomized Period|Lost to Follow-up|1|||
23672137|NCT00267748|66182966|FG002|Randomized Period|Lost to Follow-up|0|||
23672138|NCT00267748|66182964|FG000|Randomized Period|Objective progression or relapse|0|||
23672139|NCT00267748|66182965|FG001|Randomized Period|Objective progression or relapse|77|||
23672140|NCT00267748|66182966|FG002|Randomized Period|Objective progression or relapse|86|||
23672141|NCT00267748|66182964|FG000|Randomized Period|Withdrawal by Subject|0|||
23672142|NCT00267748|66182965|FG001|Randomized Period|Withdrawal by Subject|9|||
23672143|NCT00267748|66182966|FG002|Randomized Period|Withdrawal by Subject|2|||
23672144|NCT00267748|66182964|FG000|Randomized Period|Other|0|||
23672145|NCT00267748|66182965|FG001|Randomized Period|Other|9|||
23672146|NCT00267748|66182966|FG002|Randomized Period|Other|6|||
23672147|NCT00267748|66182964|FG000|Randomized Period|randomized but not treated|0|||
23672148|NCT00267748|66182965|FG001|Randomized Period|randomized but not treated|0|||
23672149|NCT00267748|66182966|FG002|Randomized Period|randomized but not treated|3|||
23672150|NCT03691974|66182969|FG000|Overall Study|Physician Decision|1|||
23672151|NCT03691974|66182970|FG001|Overall Study|Physician Decision|0|||
23672152|NCT03691974|66182969|FG000|Overall Study|Adverse Event|1|||
23672153|NCT03691974|66182970|FG001|Overall Study|Adverse Event|0|||
23672154|NCT03691974|66182969|FG000|Overall Study|Withdrawal by Subject|11|||
23672155|NCT03691974|66182970|FG001|Overall Study|Withdrawal by Subject|9|||
23672156|NCT03691974|66182969|FG000|Overall Study|Protocol Violation|1|||
23672157|NCT03691974|66182970|FG001|Overall Study|Protocol Violation|0|||
23672158|NCT03691974|66182969|FG000|Overall Study|Lost to Follow-up|8|||
23672159|NCT03691974|66182970|FG001|Overall Study|Lost to Follow-up|7|||
23672160|NCT03670953|66182971|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
23672161|NCT03670953|66182972|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23672162|NCT03670953|66182973|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23672163|NCT03670953|66182974|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23672164|NCT03670953|66182971|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
23672165|NCT03670953|66182972|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23672166|NCT03670953|66182973|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23672167|NCT03670953|66182974|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23672168|NCT03670953|66182971|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
23672169|NCT03670953|66182972|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23672170|NCT03670953|66182973|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23672171|NCT03670953|66182974|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23672172|NCT03670953|66182971|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
23672173|NCT03670953|66182972|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23672174|NCT03670953|66182973|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23672175|NCT03670953|66182974|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23672176|NCT03670953|66182971|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
23672177|NCT03670953|66182972|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23672178|NCT03670953|66182973|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23672179|NCT03670953|66182974|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23672180|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23672181|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
23672182|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23672183|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23672184|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23672185|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
23672186|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23672187|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23672188|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23672189|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
23672190|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23672191|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23672192|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23672193|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
23672194|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23672195|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23672196|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23672197|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
23672198|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23672199|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23672200|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23672201|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
23672202|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23672203|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23672204|NCT03670953|66182971|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23672205|NCT03670953|66182972|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
23672206|NCT03670953|66182973|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23493206|NCT00100178|65551388|FG002|Overall Study|Physician Decision|3|||
23493207|NCT00413244|65551389|FG000|Overall Study|Withdrawal by Subject|10|||
23672207|NCT03670953|66182974|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23672208|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
23672209|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
23672210|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
23672211|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
23672212|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
23672213|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
23672214|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
23385686|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
23385687|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
23385688|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
23385689|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
23385690|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
23672215|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
23672216|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
23385691|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
23385692|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
23385693|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
23385694|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
23385695|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
23385696|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Death|1|||
23385697|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Death|2|||
23385698|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Death|2|||
23385699|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Death|0|||
23385700|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Death|0|||
23385701|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
23385702|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
23385703|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
23385704|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
23385705|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
23385706|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
23385707|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
23385708|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
23385709|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
23385710|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
23385711|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
23385712|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385713|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385714|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385715|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385716|NCT00098293|65155208|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385717|NCT00098293|65155209|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23606068|NCT00454194|65947137|FG000|Overall Study|Adverse Event|7|||
23606069|NCT00454194|65947138|FG001|Overall Study|Adverse Event|2|||
23606070|NCT00454194|65947137|FG000|Overall Study|Withdrawal by Subject|12|||
23606071|NCT00454194|65947138|FG001|Overall Study|Withdrawal by Subject|8|||
23606072|NCT00454194|65947137|FG000|Overall Study|Other Medical Problems|1|||
23606073|NCT00454194|65947138|FG001|Overall Study|Other Medical Problems|2|||
23606074|NCT00454194|65947137|FG000|Overall Study|Other Unspecified Reason|2|||
23606075|NCT00454194|65947138|FG001|Overall Study|Other Unspecified Reason|2|||
23606076|NCT04213807|65947139|FG000|Overall Study|Physician Decision|0|||
23606077|NCT04213807|65947140|FG001|Overall Study|Physician Decision|0|||
23606078|NCT04213807|65947141|FG002|Overall Study|Physician Decision|1|||
23606079|NCT02137785|65947146|FG000|Overall Study|Lost to Follow-up|1|||
23606080|NCT02137785|65947147|FG001|Overall Study|Lost to Follow-up|0|||
23606081|NCT02137785|65947146|FG000|Overall Study|Withdrawal by Subject|1|||
23606082|NCT02137785|65947147|FG001|Overall Study|Withdrawal by Subject|4|||
23606083|NCT02137785|65947146|FG000|Overall Study|subject moved out of state|1|||
23606084|NCT02137785|65947147|FG001|Overall Study|subject moved out of state|0|||
23606085|NCT00614614|65947148|FG000|Primary Vaccination Phase|Adverse Event|6|||
23606086|NCT00614614|65947149|FG001|Primary Vaccination Phase|Adverse Event|0|||
23606087|NCT00614614|65947150|FG002|Primary Vaccination Phase|Adverse Event|0|||
23606088|NCT00614614|65947151|FG003|Primary Vaccination Phase|Adverse Event|0|||
23606089|NCT00614614|65947152|FG004|Primary Vaccination Phase|Adverse Event|0|||
23672217|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
23672218|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
23672219|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
23672220|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23672221|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23493208|NCT00413244|65551390|FG001|Overall Study|Withdrawal by Subject|1|||
23672222|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
23672223|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23672224|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
23672225|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
23672226|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
23672227|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
23672228|NCT03670953|66182971|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23672229|NCT03670953|66182972|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23672230|NCT03670953|66182973|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
23672231|NCT03670953|66182974|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23672232|NCT01121393|66182975|FG000|Overall Study|Progressive disease|201|||
23672233|NCT01121393|66182976|FG001|Overall Study|Progressive disease|20|||
23672234|NCT01121393|66182975|FG000|Overall Study|Other Adverse events|24|||
23672235|NCT01121393|66182976|FG001|Overall Study|Other Adverse events|45|||
23672236|NCT01121393|66182975|FG000|Overall Study|Non-compliant with protocol|0|||
23672237|NCT01121393|66182976|FG001|Overall Study|Non-compliant with protocol|3|||
23672238|NCT01121393|66182975|FG000|Overall Study|Lost to Follow-up|1|||
23672239|NCT01121393|66182976|FG001|Overall Study|Lost to Follow-up|0|||
23672240|NCT01121393|66182975|FG000|Overall Study|Refused cont. medication|7|||
23672241|NCT01121393|66182976|FG001|Overall Study|Refused cont. medication|7|||
23672242|NCT01121393|66182975|FG000|Overall Study|Not treated|3|||
23672243|NCT01121393|66182976|FG001|Overall Study|Not treated|9|||
23672244|NCT01121393|66182975|FG000|Overall Study|Other than listed|6|||
23672245|NCT01121393|66182976|FG001|Overall Study|Other than listed|0|||
23672246|NCT00401752|66182977|FG000|Overall Study|Adverse Event|2|||
23672247|NCT00401752|66182978|FG001|Overall Study|Adverse Event|5|||
23672248|NCT00401752|66182977|FG000|Overall Study|Withdrawal by Subject|2|||
23672249|NCT00401752|66182978|FG001|Overall Study|Withdrawal by Subject|6|||
23672250|NCT00401752|66182977|FG000|Overall Study|Lost to Follow-up|1|||
23672251|NCT00401752|66182978|FG001|Overall Study|Lost to Follow-up|4|||
23672252|NCT00401752|66182977|FG000|Overall Study|Development of any exclusion criteria|4|||
23672253|NCT00401752|66182978|FG001|Overall Study|Development of any exclusion criteria|2|||
23672254|NCT00401752|66182977|FG000|Overall Study|Physician Decision|1|||
23672255|NCT00401752|66182978|FG001|Overall Study|Physician Decision|1|||
23672256|NCT01535729|66182979|FG000|Overall Study|Withdrawal by Subject|2|||
23672257|NCT01535729|66182979|FG000|Overall Study|Disease progression|230|||
23672258|NCT01535729|66182979|FG000|Overall Study|Discontinued treatment|25|||
23672259|NCT01535729|66182979|FG000|Overall Study|Lost to Follow-up|8|||
23672260|NCT01535729|66182979|FG000|Overall Study|Death|52|||
23672261|NCT01535729|66182979|FG000|Overall Study|Other|19|||
23672262|NCT01535729|66182979|FG000|Overall Study|Did not sign informed consent|1|||
23672263|NCT01535729|66182979|FG000|Overall Study|No previous chemotherapy|33|||
23672264|NCT01535729|66182979|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
23672265|NCT01535729|66182979|FG000|Overall Study|Protocol Violation|11|||
23672266|NCT01535729|66182979|FG000|Overall Study|Screening failure|1|||
23672267|NCT01535729|66182979|FG000|Overall Study|Not treated|9|||
23672268|NCT01535729|66182979|FG000|Overall Study|No participant record available|5|||
23672269|NCT02699892|66182982|FG000|Overall Study|Other|36|||
23672270|NCT00713700|66182984|FG000|Overall Study|Lost to Follow-up|3|||
23672271|NCT00713700|66182984|FG000|Overall Study|Withdrawal by Subject|1|||
23672272|NCT01604265|66182985|FG000|Overall Study|Adverse Event|1|||
23672273|NCT01604265|66182986|FG001|Overall Study|Adverse Event|0|||
23672274|NCT01604265|66182985|FG000|Overall Study|Withdrawal by Subject|1|||
23672275|NCT01604265|66182986|FG001|Overall Study|Withdrawal by Subject|0|||
23672276|NCT01339559|66182987|FG000|Overall Study|Adverse Event|92|||
23672277|NCT01339559|66182987|FG000|Overall Study|Death|5|||
23672278|NCT01339559|66182987|FG000|Overall Study|Lack of Efficacy|164|||
23672279|NCT01339559|66182987|FG000|Overall Study|Lost to Follow-up|22|||
23672280|NCT01339559|66182987|FG000|Overall Study|Subject choice|89|||
23672281|NCT01339559|66182987|FG000|Overall Study|Protocol Violation|15|||
23672282|NCT01339559|66182987|FG000|Overall Study|Study closure at site|1|||
23672283|NCT01339559|66182987|FG000|Overall Study|Incarcerated|2|||
23672284|NCT01339559|66182987|FG000|Overall Study|Epilepsy surgery|1|||
23672285|NCT01339559|66182987|FG000|Overall Study|Pregnancy planned|2|||
23672286|NCT01339559|66182987|FG000|Overall Study|Left the country|1|||
23672287|NCT01339559|66182987|FG000|Overall Study|Investigator decision|2|||
23672288|NCT01339559|66182987|FG000|Overall Study|Patient didn't wish to continue|1|||
23672289|NCT01339559|66182987|FG000|Overall Study|PI decision|1|||
23672290|NCT04101331|66182988|FG000|Overall Study|Adverse Event|7|||
23672291|NCT04101331|66182988|FG000|Overall Study|Disease progression|79|||
23672292|NCT04101331|66182988|FG000|Overall Study|Withdrawal by Subject|1|||
23672293|NCT04101331|66182988|FG000|Overall Study|Investigator decision|6|||
23672294|NCT04101331|66182988|FG000|Overall Study|Death|6|||
23672295|NCT04101331|66182988|FG000|Overall Study|Allogenic transplant|1|||
23672296|NCT02347176|66182991|FG000|Overall Study|Lost to Follow-up|2|||
23672297|NCT02347176|66182992|FG001|Overall Study|Lost to Follow-up|3|||
23672298|NCT02347176|66182993|FG002|Overall Study|Lost to Follow-up|1|||
23672299|NCT02347176|66182994|FG003|Overall Study|Lost to Follow-up|1|||
23672300|NCT02347176|66182991|FG000|Overall Study|Withdrawal by Subject|9|||
23672301|NCT02347176|66182992|FG001|Overall Study|Withdrawal by Subject|5|||
23672302|NCT02347176|66182993|FG002|Overall Study|Withdrawal by Subject|5|||
23672303|NCT02347176|66182994|FG003|Overall Study|Withdrawal by Subject|3|||
23672304|NCT02347176|66182991|FG000|Overall Study|Other|1|||
23672305|NCT02347176|66182992|FG001|Overall Study|Other|2|||
23672306|NCT02347176|66182993|FG002|Overall Study|Other|2|||
23672307|NCT02347176|66182994|FG003|Overall Study|Other|0|||
23672308|NCT01908101|66182995|FG000|Overall Study|Physician Decision|1|||
23672309|NCT01908101|66182995|FG000|Overall Study|Withdrawal by Subject|1|||
23672310|NCT01908101|66182995|FG000|Overall Study|Incorrect Diagnosis|2|||
23672311|NCT01908101|66182995|FG000|Overall Study|Incorrect Starting Dose|1|||
23672312|NCT01908101|66182995|FG000|Overall Study|Did not complete the first cycle|4|||
23672313|NCT04016311|66182996|FG000|Overall Study|Withdrawal by Subject|1|||
23672314|NCT04016311|66182997|FG001|Overall Study|Withdrawal by Subject|0|||
23672315|NCT03548051|66182998|FG000|Overall Study|Death|1|||
23672316|NCT03548051|66182999|FG001|Overall Study|Death|1|||
23672317|NCT03548051|66182998|FG000|Overall Study|Withdrawal by Subject|1|||
23672318|NCT03548051|66182999|FG001|Overall Study|Withdrawal by Subject|0|||
23672319|NCT01445951|66183000|FG000|Overall Study|Adverse Event|16|||
23672320|NCT01445951|66183001|FG001|Overall Study|Adverse Event|9|||
23672321|NCT01445951|66183002|FG002|Overall Study|Adverse Event|0|||
23672322|NCT01445951|66183000|FG000|Overall Study|Protocol Violation|2|||
23672323|NCT01445951|66183001|FG001|Overall Study|Protocol Violation|2|||
23672324|NCT01445951|66183002|FG002|Overall Study|Protocol Violation|2|||
23672325|NCT01445951|66183000|FG000|Overall Study|Withdrawal by Subject|21|||
23672326|NCT01445951|66183001|FG001|Overall Study|Withdrawal by Subject|16|||
23672327|NCT01445951|66183002|FG002|Overall Study|Withdrawal by Subject|8|||
23672328|NCT01445951|66183000|FG000|Overall Study|Physician Decision|3|||
23672329|NCT01445951|66183001|FG001|Overall Study|Physician Decision|1|||
23672330|NCT01445951|66183002|FG002|Overall Study|Physician Decision|0|||
23672331|NCT01445951|66183000|FG000|Overall Study|Lost to Follow-up|1|||
23672332|NCT01445951|66183001|FG001|Overall Study|Lost to Follow-up|2|||
23672333|NCT01445951|66183002|FG002|Overall Study|Lost to Follow-up|4|||
23672334|NCT01445951|66183000|FG000|Overall Study|Pregnancy|0|||
23672335|NCT01445951|66183001|FG001|Overall Study|Pregnancy|1|||
23672336|NCT01445951|66183002|FG002|Overall Study|Pregnancy|4|||
23672337|NCT01445951|66183000|FG000|Overall Study|Death|0|||
23672338|NCT01445951|66183001|FG001|Overall Study|Death|0|||
23672339|NCT01445951|66183002|FG002|Overall Study|Death|1|||
23672340|NCT01445951|66183000|FG000|Overall Study|Non-compliance with study drug|1|||
23672341|NCT01445951|66183001|FG001|Overall Study|Non-compliance with study drug|2|||
23672342|NCT01445951|66183002|FG002|Overall Study|Non-compliance with study drug|0|||
23672343|NCT01445951|66183000|FG000|Overall Study|Non-compliance with protocol|0|||
23672344|NCT01445951|66183001|FG001|Overall Study|Non-compliance with protocol|1|||
23672345|NCT01445951|66183002|FG002|Overall Study|Non-compliance with protocol|0|||
23672346|NCT01445951|66183000|FG000|Overall Study|Sponsor decision - subject travel|0|||
23672347|NCT01445951|66183001|FG001|Overall Study|Sponsor decision - subject travel|1|||
23672348|NCT01445951|66183002|FG002|Overall Study|Sponsor decision - subject travel|0|||
23672349|NCT01445951|66183000|FG000|Overall Study|Cough|0|||
23672350|NCT01445951|66183001|FG001|Overall Study|Cough|1|||
23672351|NCT01445951|66183002|FG002|Overall Study|Cough|0|||
23385718|NCT00098293|65155210|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
23385719|NCT00098293|65155211|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385720|NCT00098293|65155212|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385721|NCT00098293|65155208|FG000|Open-label (OL) Phase|Adverse Event|0|||
23385722|NCT00098293|65155209|FG001|Open-label (OL) Phase|Adverse Event|3|||
23385723|NCT00098293|65155210|FG002|Open-label (OL) Phase|Adverse Event|7|||
23385724|NCT00098293|65155211|FG003|Open-label (OL) Phase|Adverse Event|6|||
23385725|NCT00098293|65155212|FG004|Open-label (OL) Phase|Adverse Event|0|||
23385726|NCT00098293|65155208|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
23385727|NCT00098293|65155209|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
23385728|NCT00098293|65155210|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
23672352|NCT00498173|66183003|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
23672353|NCT00498173|66183004|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
23672354|NCT00498173|66183005|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
23672355|NCT01285908|66183011|FG000|Baseline Measurement|unable to insert catheter|1|||
23672356|NCT01285908|66183012|FG001|Baseline Measurement|unable to insert catheter|0|||
23672357|NCT01285908|66183013|FG002|Baseline Measurement|unable to insert catheter|0|||
23672358|NCT01285908|66183011|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
23672359|NCT01285908|66183012|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
23672360|NCT01285908|66183013|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
23672361|NCT01285908|66183011|FG000|Baseline Measurement|unable to tolerate procedure|1|||
23672362|NCT01285908|66183012|FG001|Baseline Measurement|unable to tolerate procedure|0|||
23672363|NCT01285908|66183013|FG002|Baseline Measurement|unable to tolerate procedure|0|||
23672364|NCT00936208|66183014|FG000|Overall Study|Protocol Violation|37|||
23672365|NCT00936208|66183015|FG001|Overall Study|Protocol Violation|22|||
23672366|NCT02482129|66183016|FG000|Overall Study|Adverse Event-prior to treatment|0|||
23672367|NCT02482129|66183017|FG001|Overall Study|Adverse Event-prior to treatment|1|||
23672368|NCT02482129|66183016|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
23672369|NCT02482129|66183017|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
23672370|NCT02482129|66183016|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
23672371|NCT02482129|66183017|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
23672372|NCT02482129|66183016|FG000|Overall Study|Criteria not met-prior to treatment|1|||
23672373|NCT02482129|66183017|FG001|Overall Study|Criteria not met-prior to treatment|0|||
23672374|NCT02482129|66183016|FG000|Overall Study|Adverse Event|1|||
23672375|NCT02482129|66183017|FG001|Overall Study|Adverse Event|0|||
23672376|NCT02482129|66183016|FG000|Overall Study|Withdrawal by Subject|2|||
23672377|NCT02482129|66183017|FG001|Overall Study|Withdrawal by Subject|0|||
23672378|NCT02482129|66183016|FG000|Overall Study|Criteria not met|1|||
23672379|NCT02482129|66183017|FG001|Overall Study|Criteria not met|0|||
23672380|NCT02462473|66183018|FG000|Overall Study|Death|1|||
23672381|NCT02462473|66183018|FG000|Overall Study|Other|3|||
23672382|NCT02239939|66183020|FG000|Overall Study|Adverse Event|1|||
23672383|NCT02239939|66183021|FG001|Overall Study|Adverse Event|0|||
23672384|NCT02239939|66183020|FG000|Overall Study|Withdrawal by Subject|1|||
23672385|NCT02239939|66183021|FG001|Overall Study|Withdrawal by Subject|1|||
23672386|NCT02239939|66183020|FG000|Overall Study|Lost to Follow-up|0|||
23672387|NCT02239939|66183021|FG001|Overall Study|Lost to Follow-up|1|||
23672388|NCT02182687|66183022|FG000|Overall Study|Withdrawal by Subject|4|||
23672389|NCT02182687|66183023|FG001|Overall Study|Withdrawal by Subject|0|||
23672390|NCT02182687|66183022|FG000|Overall Study|Adverse Event|1|||
23385729|NCT00098293|65155211|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
23385730|NCT00098293|65155212|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
23385731|NCT00098293|65155208|FG000|Open-label (OL) Phase|Pregnancy|0|||
23385732|NCT00098293|65155209|FG001|Open-label (OL) Phase|Pregnancy|1|||
23385733|NCT00098293|65155210|FG002|Open-label (OL) Phase|Pregnancy|0|||
23672391|NCT02182687|66183023|FG001|Overall Study|Adverse Event|0|||
23672392|NCT02182687|66183022|FG000|Overall Study|Lost to Follow-up|0|||
23672393|NCT02182687|66183023|FG001|Overall Study|Lost to Follow-up|1|||
23672394|NCT02926209|66183026|FG000|Study Cohort|Poor Bowel Preparation|1|||
23672395|NCT02926209|66183027|FG001|Study Cohort|Poor Bowel Preparation|0|||
23672396|NCT03002155|66183031|FG000|Overall Study|Lost to Follow-up|1|||
23672397|NCT03002155|66183032|FG001|Overall Study|Lost to Follow-up|2|||
23672398|NCT03002155|66183031|FG000|Overall Study|Withdrawal by Subject|1|||
23672399|NCT03002155|66183032|FG001|Overall Study|Withdrawal by Subject|0|||
23672400|NCT03002155|66183031|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
23672401|NCT03002155|66183032|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
23672402|NCT02919436|66183033|FG000|Overall Study|Did not undergo surgery|16|||
23672403|NCT02919436|66183034|FG001|Overall Study|Did not undergo surgery|20|||
23672404|NCT02919436|66183033|FG000|Overall Study|Enrolled before trial registration|44|||
23672405|NCT02919436|66183034|FG001|Overall Study|Enrolled before trial registration|33|||
23672406|NCT04951037|66183038|FG000|Overall Study|Lost to Follow-up|16|||
23672407|NCT04951037|66183038|FG000|Overall Study|Withdrawal by Subject|5|||
23672408|NCT04951037|66183038|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
23672409|NCT02474329|66183039|FG000|Overall Study|Withdraw or did not contribute data.|13|||
23672410|NCT00852995|66183042|FG000|Overall Study|Adverse Event|1|||
23672411|NCT00852995|66183043|FG001|Overall Study|Adverse Event|0|||
23672412|NCT00852995|66183044|FG002|Overall Study|Adverse Event|4|||
23672413|NCT00852995|66183045|FG003|Overall Study|Adverse Event|0|||
23672414|NCT00852995|66183046|FG004|Overall Study|Adverse Event|0|||
23672415|NCT00852995|66183042|FG000|Overall Study|Lost to Follow-up|0|||
23672416|NCT00852995|66183043|FG001|Overall Study|Lost to Follow-up|1|||
23672417|NCT00852995|66183044|FG002|Overall Study|Lost to Follow-up|1|||
23672418|NCT00852995|66183045|FG003|Overall Study|Lost to Follow-up|0|||
23672419|NCT00852995|66183046|FG004|Overall Study|Lost to Follow-up|0|||
23672420|NCT00852995|66183042|FG000|Overall Study|Withdrawal by Subject|4|||
23672421|NCT00852995|66183043|FG001|Overall Study|Withdrawal by Subject|0|||
23672422|NCT00852995|66183044|FG002|Overall Study|Withdrawal by Subject|0|||
23672423|NCT00852995|66183045|FG003|Overall Study|Withdrawal by Subject|1|||
23672424|NCT00852995|66183046|FG004|Overall Study|Withdrawal by Subject|2|||
23672425|NCT00852995|66183042|FG000|Overall Study|Non-Compliance|0|||
23672426|NCT00852995|66183043|FG001|Overall Study|Non-Compliance|0|||
23672427|NCT00852995|66183044|FG002|Overall Study|Non-Compliance|0|||
23672428|NCT00852995|66183045|FG003|Overall Study|Non-Compliance|2|||
23672429|NCT00852995|66183046|FG004|Overall Study|Non-Compliance|0|||
23672430|NCT00852995|66183042|FG000|Overall Study|Progressive Disease|1|||
23672431|NCT00852995|66183043|FG001|Overall Study|Progressive Disease|0|||
23672432|NCT00852995|66183044|FG002|Overall Study|Progressive Disease|0|||
23672433|NCT00852995|66183045|FG003|Overall Study|Progressive Disease|2|||
23672434|NCT00852995|66183046|FG004|Overall Study|Progressive Disease|1|||
23672435|NCT00852995|66183042|FG000|Overall Study|Physician Decision|1|||
23672436|NCT00852995|66183043|FG001|Overall Study|Physician Decision|0|||
23672437|NCT00852995|66183044|FG002|Overall Study|Physician Decision|0|||
23672438|NCT00852995|66183045|FG003|Overall Study|Physician Decision|0|||
23672439|NCT00852995|66183046|FG004|Overall Study|Physician Decision|0|||
23672440|NCT00852995|66183042|FG000|Overall Study|Protocol Violation|0|||
23672441|NCT00852995|66183043|FG001|Overall Study|Protocol Violation|0|||
23672442|NCT00852995|66183044|FG002|Overall Study|Protocol Violation|0|||
23672443|NCT00852995|66183045|FG003|Overall Study|Protocol Violation|0|||
23672444|NCT00852995|66183046|FG004|Overall Study|Protocol Violation|1|||
23672445|NCT00852995|66183042|FG000|Overall Study|Moved Out of Area|1|||
23672446|NCT00852995|66183043|FG001|Overall Study|Moved Out of Area|0|||
23672447|NCT00852995|66183044|FG002|Overall Study|Moved Out of Area|0|||
23672448|NCT00852995|66183045|FG003|Overall Study|Moved Out of Area|0|||
23672449|NCT00852995|66183046|FG004|Overall Study|Moved Out of Area|0|||
23672450|NCT01634555|66183047|FG000|Overall Study|Adverse Event|3|||
23672451|NCT01634555|66183047|FG000|Overall Study|Physician Decision|1|||
23672452|NCT03699007|66183048|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
23672453|NCT03699007|66183049|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
23672454|NCT03699007|66183048|FG000|6-month Follow Up|Lost to Follow-up|2|||
23672455|NCT03699007|66183049|FG001|6-month Follow Up|Lost to Follow-up|3|||
23672456|NCT01414257|66183051|FG000|Overall Study|No Visit After First Day of Treatment|12|||
23672457|NCT01414257|66183051|FG000|Overall Study|Protocol Violation|10|||
23672458|NCT03655756|66183052|FG000|Overall Study|Death|1|||
23672459|NCT00861744|66183054|FG000|Overall Study|Adverse Event|0|||
23672460|NCT00861744|66183055|FG001|Overall Study|Adverse Event|0|||
23672461|NCT00861744|66183056|FG002|Overall Study|Adverse Event|0|||
23672462|NCT00861744|66183057|FG003|Overall Study|Adverse Event|1|||
23672463|NCT00861744|66183054|FG000|Overall Study|Lost to Follow-up|7|||
23672464|NCT00861744|66183055|FG001|Overall Study|Lost to Follow-up|19|||
23672465|NCT00861744|66183056|FG002|Overall Study|Lost to Follow-up|17|||
23672466|NCT00861744|66183057|FG003|Overall Study|Lost to Follow-up|12|||
23385734|NCT00098293|65155211|FG003|Open-label (OL) Phase|Pregnancy|3|||
23385735|NCT00098293|65155212|FG004|Open-label (OL) Phase|Pregnancy|0|||
23385736|NCT00098293|65155208|FG000|Open-label (OL) Phase|Protocol Violation|0|||
23385737|NCT00098293|65155209|FG001|Open-label (OL) Phase|Protocol Violation|6|||
23385738|NCT00098293|65155210|FG002|Open-label (OL) Phase|Protocol Violation|13|||
23385739|NCT00098293|65155211|FG003|Open-label (OL) Phase|Protocol Violation|16|||
23385740|NCT00098293|65155212|FG004|Open-label (OL) Phase|Protocol Violation|0|||
23385741|NCT00098293|65155208|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
23385742|NCT00098293|65155209|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
23385743|NCT00098293|65155210|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
23385744|NCT00098293|65155211|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
23385745|NCT00098293|65155212|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
23385746|NCT00098293|65155208|FG000|Open-label (OL) Phase|Death|0|||
23385747|NCT00098293|65155209|FG001|Open-label (OL) Phase|Death|2|||
23385748|NCT00098293|65155210|FG002|Open-label (OL) Phase|Death|3|||
23385749|NCT00098293|65155211|FG003|Open-label (OL) Phase|Death|0|||
23385750|NCT00098293|65155212|FG004|Open-label (OL) Phase|Death|0|||
23385751|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Death|0|||
23385752|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Death|0|||
23385753|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Death|0|||
23385754|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Death|0|||
23385755|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Death|1|||
23385756|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385757|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385758|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385759|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385760|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
23385761|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385762|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385763|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385764|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385765|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
23385766|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Other|0|||
23385767|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Other|0|||
23493209|NCT00397215|65551392|FG000|Month 0 (Day 0)|Adverse Event|0|||
23672467|NCT00861744|66183054|FG000|Overall Study|Withdrawal by Subject|10|||
23672468|NCT00861744|66183055|FG001|Overall Study|Withdrawal by Subject|6|||
23672469|NCT00861744|66183056|FG002|Overall Study|Withdrawal by Subject|6|||
23672470|NCT00861744|66183057|FG003|Overall Study|Withdrawal by Subject|19|||
23672471|NCT00861744|66183054|FG000|Overall Study|Protocol Violation|0|||
23672472|NCT00861744|66183055|FG001|Overall Study|Protocol Violation|1|||
23672473|NCT00861744|66183056|FG002|Overall Study|Protocol Violation|0|||
23385768|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Other|0|||
23385769|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Other|0|||
23385770|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Other|22|||
23385771|NCT01428128|65155218|FG000|Overall Study|Withdrawal by Subject|4|||
23385772|NCT01428128|65155218|FG000|Overall Study|Screen failure by p53|10|||
23385773|NCT01428128|65155218|FG000|Overall Study|Received Neulasta in one cycle|2|||
23385774|NCT01428128|65155218|FG000|Overall Study|Adverse Event|1|||
23385775|NCT00923702|65155219|FG000|Overall Study|Ongoing enrollment|0|||
23385776|NCT00923702|65155220|FG001|Overall Study|Ongoing enrollment|0|||
23385777|NCT00923702|65155221|FG002|Overall Study|Ongoing enrollment|0|||
23385778|NCT00923702|65155222|FG003|Overall Study|Ongoing enrollment|0|||
23385779|NCT00923702|65155223|FG004|Overall Study|Ongoing enrollment|354|||
23385780|NCT00478140|65155225|FG000|Overall Study|Clinical Disease Progression|1|||
23385781|NCT03331562|65155226|FG000|Overall Study|Adverse Event|2|||
23385782|NCT03331562|65155227|FG001|Overall Study|Adverse Event|0|||
23385783|NCT03331562|65155226|FG000|Overall Study|Death|1|||
23385784|NCT03331562|65155227|FG001|Overall Study|Death|0|||
23385785|NCT00812097|65155228|FG000|Overall Study|Death|3|||
23385786|NCT00812097|65155229|FG001|Overall Study|Death|10|||
23385787|NCT00812097|65155230|FG002|Overall Study|Death|3|||
23385788|NCT00812097|65155231|FG003|Overall Study|Death|3|||
23385789|NCT00812097|65155228|FG000|Overall Study|Withdrawal by Subject|14|||
23385790|NCT00812097|65155229|FG001|Overall Study|Withdrawal by Subject|12|||
23385791|NCT00812097|65155230|FG002|Overall Study|Withdrawal by Subject|8|||
23385792|NCT00812097|65155231|FG003|Overall Study|Withdrawal by Subject|2|||
23385793|NCT00812097|65155228|FG000|Overall Study|Lost to Follow-up|90|||
23385794|NCT00812097|65155229|FG001|Overall Study|Lost to Follow-up|14|||
23385795|NCT00812097|65155230|FG002|Overall Study|Lost to Follow-up|17|||
23385796|NCT00812097|65155231|FG003|Overall Study|Lost to Follow-up|5|||
23385797|NCT00812097|65155228|FG000|Overall Study|Explantation of study device(s)|27|||
23385798|NCT00812097|65155229|FG001|Overall Study|Explantation of study device(s)|29|||
23385799|NCT00812097|65155230|FG002|Overall Study|Explantation of study device(s)|14|||
23385800|NCT00812097|65155231|FG003|Overall Study|Explantation of study device(s)|20|||
23385801|NCT00812097|65155228|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
23385802|NCT00812097|65155229|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
23385803|NCT00812097|65155230|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
23385804|NCT00812097|65155231|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
23385805|NCT00992394|65155235|FG000|Overall Study|Lack of Efficacy|6|||
23385806|NCT00992394|65155236|FG001|Overall Study|Lack of Efficacy|3|||
23385807|NCT00992394|65155235|FG000|Overall Study|Adverse Event|4|||
23385808|NCT00992394|65155236|FG001|Overall Study|Adverse Event|5|||
23385809|NCT00992394|65155235|FG000|Overall Study|Withdrawal by Subject|8|||
23385810|NCT00992394|65155236|FG001|Overall Study|Withdrawal by Subject|2|||
23385811|NCT00992394|65155235|FG000|Overall Study|Physician Decision|1|||
23385812|NCT00992394|65155236|FG001|Overall Study|Physician Decision|0|||
23385813|NCT00992394|65155235|FG000|Overall Study|Protocol Violation|2|||
23385814|NCT00992394|65155236|FG001|Overall Study|Protocol Violation|4|||
23385815|NCT00992394|65155235|FG000|Overall Study|Lost to Follow-up|2|||
23385816|NCT00992394|65155236|FG001|Overall Study|Lost to Follow-up|0|||
23385817|NCT00992394|65155235|FG000|Overall Study|Other event|1|||
23385818|NCT00992394|65155236|FG001|Overall Study|Other event|0|||
23385819|NCT01521364|65155238|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
23385820|NCT01521364|65155238|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
23385821|NCT02400736|65155239|FG000|Overall Study|Lost to Follow-up|6|||
23385822|NCT02400736|65155240|FG001|Overall Study|Lost to Follow-up|6|||
23385823|NCT02400736|65155239|FG000|Overall Study|Withdrawal by Subject|2|||
23385824|NCT02400736|65155240|FG001|Overall Study|Withdrawal by Subject|1|||
23385825|NCT02400736|65155239|FG000|Overall Study|Moved from the area|3|||
23385826|NCT02400736|65155240|FG001|Overall Study|Moved from the area|1|||
23385827|NCT03072875|65155241|FG000|Overall Study|Lost to Follow-up|1|||
23385828|NCT01060111|65155243|FG000|Overall Study|Adverse Event|9|||
23385829|NCT01060111|65155244|FG001|Overall Study|Adverse Event|5|||
23385830|NCT01060111|65155245|FG002|Overall Study|Adverse Event|18|||
23385831|NCT01060111|65155243|FG000|Overall Study|Lack of Efficacy|2|||
23385832|NCT01060111|65155244|FG001|Overall Study|Lack of Efficacy|1|||
23385833|NCT01060111|65155245|FG002|Overall Study|Lack of Efficacy|0|||
23385834|NCT01060111|65155243|FG000|Overall Study|Inappropriate participant|5|||
23385835|NCT01060111|65155244|FG001|Overall Study|Inappropriate participant|4|||
23385836|NCT01060111|65155245|FG002|Overall Study|Inappropriate participant|5|||
23385837|NCT01060111|65155243|FG000|Overall Study|Participants' evasion for hospital visit|0|||
23385838|NCT01060111|65155244|FG001|Overall Study|Participants' evasion for hospital visit|3|||
23385839|NCT01060111|65155245|FG002|Overall Study|Participants' evasion for hospital visit|2|||
23385840|NCT01060111|65155243|FG000|Overall Study|Participants' non-cooperation|8|||
23385841|NCT01060111|65155244|FG001|Overall Study|Participants' non-cooperation|6|||
23385842|NCT01060111|65155245|FG002|Overall Study|Participants' non-cooperation|6|||
23385843|NCT01060111|65155243|FG000|Overall Study|Adverse event and insufficient effect|0|||
23385844|NCT01060111|65155244|FG001|Overall Study|Adverse event and insufficient effect|1|||
23385845|NCT01060111|65155245|FG002|Overall Study|Adverse event and insufficient effect|0|||
23385846|NCT01060111|65155243|FG000|Overall Study|Participants' non-cooperation|1|||
23385847|NCT01060111|65155244|FG001|Overall Study|Participants' non-cooperation|0|||
23385848|NCT01060111|65155245|FG002|Overall Study|Participants' non-cooperation|0|||
23385849|NCT01060111|65155243|FG000|Overall Study|Other|2|||
23385850|NCT01060111|65155244|FG001|Overall Study|Other|3|||
23385851|NCT01060111|65155245|FG002|Overall Study|Other|4|||
23385852|NCT02916433|65158488|FG000|Overall Study|Withdrawal by Subject|1|||
23385853|NCT02916433|65158489|FG001|Overall Study|Withdrawal by Subject|0|||
23385854|NCT02916433|65158488|FG000|Overall Study|Physician Decision|1|||
23385855|NCT02916433|65158489|FG001|Overall Study|Physician Decision|0|||
23385856|NCT01986751|65158490|FG000|Overall Study|improperly consented|10|||
23385857|NCT01986751|65158491|FG001|Overall Study|improperly consented|2|||
23385858|NCT00500110|65158492|FG000|Overall Study|Withdrawal by Subject|3|||
23385859|NCT03197935|65158493|FG000|Overall Study|Death due to any cause|26|||
23385860|NCT03197935|65158494|FG001|Overall Study|Death due to any cause|15|||
23385861|NCT03197935|65158493|FG000|Overall Study|Lost to Follow-up|3|||
23385862|NCT03197935|65158494|FG001|Overall Study|Lost to Follow-up|5|||
23385863|NCT03197935|65158493|FG000|Overall Study|Physician Decision|2|||
23385864|NCT03197935|65158494|FG001|Overall Study|Physician Decision|1|||
23385865|NCT03197935|65158493|FG000|Overall Study|Withdrawal by Subject|16|||
23385866|NCT03197935|65158494|FG001|Overall Study|Withdrawal by Subject|8|||
23385867|NCT03016403|65158495|FG000|Baseline|Death|5|||
23385868|NCT03016403|65158496|FG001|Baseline|Death|8|||
23385869|NCT03016403|65158497|FG002|Baseline|Death|1|||
23385870|NCT03016403|65158498|FG003|Baseline|Death|0|||
23385871|NCT03016403|65158495|FG000|Baseline|Withdrawal by Subject|2|||
23385872|NCT03016403|65158496|FG001|Baseline|Withdrawal by Subject|8|||
23385873|NCT03016403|65158497|FG002|Baseline|Withdrawal by Subject|4|||
23385874|NCT03016403|65158498|FG003|Baseline|Withdrawal by Subject|10|||
23385875|NCT03016403|65158495|FG000|Baseline|Lost to Follow-up|9|||
23385876|NCT03016403|65158496|FG001|Baseline|Lost to Follow-up|11|||
23385877|NCT03016403|65158497|FG002|Baseline|Lost to Follow-up|6|||
23385878|NCT03016403|65158498|FG003|Baseline|Lost to Follow-up|24|||
23385879|NCT03016403|65158495|FG000|6-week Follow-up|Death|1|||
23385880|NCT03016403|65158496|FG001|6-week Follow-up|Death|4|||
23385881|NCT03016403|65158497|FG002|6-week Follow-up|Death|0|||
23385882|NCT03016403|65158498|FG003|6-week Follow-up|Death|0|||
23385883|NCT03016403|65158495|FG000|6-week Follow-up|Lost to Follow-up|2|||
23385884|NCT03016403|65158496|FG001|6-week Follow-up|Lost to Follow-up|7|||
23385885|NCT03016403|65158497|FG002|6-week Follow-up|Lost to Follow-up|4|||
23385886|NCT03016403|65158498|FG003|6-week Follow-up|Lost to Follow-up|8|||
23385887|NCT03016403|65158495|FG000|6-week Follow-up|Withdrawal by Subject|0|||
23385888|NCT03016403|65158496|FG001|6-week Follow-up|Withdrawal by Subject|2|||
23385889|NCT03016403|65158497|FG002|6-week Follow-up|Withdrawal by Subject|0|||
23385890|NCT03016403|65158498|FG003|6-week Follow-up|Withdrawal by Subject|1|||
23385891|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
23385892|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
23385893|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
23385894|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
23385895|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
23385896|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
23385897|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
23385898|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
23385899|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23385900|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23672474|NCT00861744|66183057|FG003|Overall Study|Protocol Violation|0|||
23672475|NCT00861744|66183054|FG000|Overall Study|Migration from study area|0|||
23672476|NCT00861744|66183055|FG001|Overall Study|Migration from study area|3|||
23385901|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23385902|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
23385903|NCT01630811|65158499|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23385904|NCT01630811|65158500|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23385905|NCT03566550|65158501|FG000|Overall Study|Withdrawal by Subject|0|||
23385906|NCT03566550|65158502|FG001|Overall Study|Withdrawal by Subject|1|||
23385907|NCT01489358|65158503|FG000|Overall Study|Lost to Follow-up|0|||
23493210|NCT00397215|65551393|FG001|Month 0 (Day 0)|Adverse Event|1|||
23385908|NCT01489358|65158504|FG001|Overall Study|Lost to Follow-up|0|||
23385909|NCT01489358|65158505|FG002|Overall Study|Lost to Follow-up|2|||
23385910|NCT01783015|65158506|FG000|Blinded Treatment|Adverse Event|0|||
23672477|NCT00861744|66183056|FG002|Overall Study|Migration from study area|1|||
23672478|NCT00861744|66183057|FG003|Overall Study|Migration from study area|0|||
23672479|NCT00861744|66183054|FG000|Overall Study|Blood draws|0|||
23672480|NCT00861744|66183055|FG001|Overall Study|Blood draws|0|||
23385911|NCT01783015|65158507|FG001|Blinded Treatment|Adverse Event|1|||
23385912|NCT01783015|65158508|FG002|Blinded Treatment|Adverse Event|0|||
23493211|NCT00397215|65551394|FG002|Month 0 (Day 0)|Adverse Event|0|||
23672481|NCT00861744|66183056|FG002|Overall Study|Blood draws|0|||
23385913|NCT01783015|65158506|FG000|Blinded Treatment|Protocol Violation|0|||
23385914|NCT01783015|65158507|FG001|Blinded Treatment|Protocol Violation|1|||
23385915|NCT01783015|65158508|FG002|Blinded Treatment|Protocol Violation|0|||
23385916|NCT01783015|65158506|FG000|Blinded Treatment|Withdrawal by Subject|0|||
23385917|NCT01783015|65158507|FG001|Blinded Treatment|Withdrawal by Subject|1|||
23385918|NCT01783015|65158508|FG002|Blinded Treatment|Withdrawal by Subject|0|||
23385919|NCT01783015|65158506|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
23385920|NCT01783015|65158507|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
23385921|NCT01783015|65158508|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
23385922|NCT01783015|65158506|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
23385923|NCT01783015|65158507|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
23385924|NCT01783015|65158508|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
23385925|NCT00356421|65158512|FG000|Overall Study|Lack of Efficacy|3|||
23385926|NCT00356421|65158513|FG001|Overall Study|Lack of Efficacy|0|||
23385927|NCT00356421|65158512|FG000|Overall Study|Withdrawal by Subject|9|||
23385928|NCT00356421|65158513|FG001|Overall Study|Withdrawal by Subject|2|||
23385929|NCT00356421|65158512|FG000|Overall Study|Related to study drug|15|||
23385930|NCT00356421|65158513|FG001|Overall Study|Related to study drug|12|||
23385931|NCT00356421|65158512|FG000|Overall Study|Not related to study drug|5|||
23385932|NCT00356421|65158513|FG001|Overall Study|Not related to study drug|3|||
23385933|NCT00452530|65158514|FG000|Overall Study|Death|1|||
23385934|NCT00452530|65158515|FG001|Overall Study|Death|0|||
23385935|NCT00452530|65158514|FG000|Overall Study|Adverse Event|40|||
23385936|NCT00452530|65158515|FG001|Overall Study|Adverse Event|44|||
23385937|NCT00452530|65158514|FG000|Overall Study|Withdrawal by Subject|68|||
23385938|NCT00452530|65158515|FG001|Overall Study|Withdrawal by Subject|57|||
23385939|NCT00452530|65158514|FG000|Overall Study|Lost to Follow-up|1|||
23385940|NCT00452530|65158515|FG001|Overall Study|Lost to Follow-up|0|||
23385941|NCT00452530|65158514|FG000|Overall Study|Poor compliance/noncompliance|1|||
23385942|NCT00452530|65158515|FG001|Overall Study|Poor compliance/noncompliance|2|||
23385943|NCT00452530|65158514|FG000|Overall Study|No longer met study criteria|18|||
23385944|NCT00452530|65158515|FG001|Overall Study|No longer met study criteria|22|||
23385945|NCT00452530|65158514|FG000|Overall Study|Other|7|||
23385946|NCT00452530|65158515|FG001|Overall Study|Other|11|||
23385947|NCT00620035|65158516|FG000|Overall Study|Adverse Event|106|||
23385948|NCT00620035|65158516|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23385949|NCT00620035|65158516|FG000|Overall Study|Other Reason|38|||
23385950|NCT00762788|65158517|FG000|Overall Study|Lost to Follow-up|26|||
23385951|NCT00762788|65158518|FG001|Overall Study|Lost to Follow-up|37|||
23385952|NCT00762788|65158519|FG002|Overall Study|Lost to Follow-up|21|||
23385953|NCT00762788|65158520|FG003|Overall Study|Lost to Follow-up|26|||
23385954|NCT00762788|65158521|FG004|Overall Study|Lost to Follow-up|13|||
23385955|NCT00762788|65158522|FG005|Overall Study|Lost to Follow-up|21|||
23385956|NCT02061592|65158523|FG000|Period 1|Withdrawal by Subject|1|||
23385957|NCT02061592|65158524|FG001|Period 1|Withdrawal by Subject|0|||
23385958|NCT02061592|65158523|FG000|Period 1|Protocol Violation|1|||
23385959|NCT02061592|65158524|FG001|Period 1|Protocol Violation|0|||
23385960|NCT02061592|65158523|FG000|Period 2|Lost to Follow-up|0|||
23385961|NCT02061592|65158524|FG001|Period 2|Lost to Follow-up|1|||
23385962|NCT01301001|65158526|FG000|First Intervention|Lost to Follow-up|4|||
23385963|NCT01301001|65158527|FG001|First Intervention|Lost to Follow-up|4|||
23385964|NCT01301001|65158526|FG000|First Intervention|Withdrawal by Subject|1|||
23385965|NCT01301001|65158527|FG001|First Intervention|Withdrawal by Subject|4|||
23385966|NCT01301001|65158526|FG000|First Intervention|Adverse Event|5|||
23385967|NCT01301001|65158527|FG001|First Intervention|Adverse Event|0|||
23385968|NCT01301001|65158526|FG000|First Intervention|Protocol Violation|0|||
23385969|NCT01301001|65158527|FG001|First Intervention|Protocol Violation|1|||
23385970|NCT01301001|65158526|FG000|Second Intervention|Adverse Event|2|||
23672482|NCT00861744|66183057|FG003|Overall Study|Blood draws|1|||
23385971|NCT01301001|65158527|FG001|Second Intervention|Adverse Event|0|||
23385972|NCT01301001|65158526|FG000|Second Intervention|Withdrawal by Subject|2|||
23385973|NCT01301001|65158527|FG001|Second Intervention|Withdrawal by Subject|0|||
23385974|NCT01451203|65158530|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
23385975|NCT01451203|65158531|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
23672483|NCT01929408|66183060|FG000|Overall Study|received HCT as initial treatment|8|||
23672484|NCT02264990|66183063|FG000|Overall Study|Death|255|||
23672485|NCT02264990|66183064|FG001|Overall Study|Death|250|||
23672486|NCT02264990|66183063|FG000|Overall Study|Withdrawal by Subject|4|||
23672487|NCT02264990|66183064|FG001|Overall Study|Withdrawal by Subject|5|||
23672488|NCT02264990|66183063|FG000|Overall Study|Lost to Follow-up|1|||
23672489|NCT02264990|66183064|FG001|Overall Study|Lost to Follow-up|3|||
23672490|NCT02264990|66183063|FG000|Overall Study|Other|0|||
23672491|NCT02264990|66183064|FG001|Overall Study|Other|1|||
23672492|NCT04899232|66183072|FG000|Screening Period|Physician Decision|1|||
23672493|NCT04899232|66183073|FG001|Screening Period|Physician Decision|0|||
23672494|NCT04899232|66183074|FG002|Screening Period|Physician Decision|0|||
23672495|NCT04899232|66183072|FG000|Screening Period|Withdrawal by Subject|1|||
23672496|NCT04899232|66183073|FG001|Screening Period|Withdrawal by Subject|0|||
23672497|NCT04899232|66183074|FG002|Screening Period|Withdrawal by Subject|0|||
23672498|NCT04899232|66183072|FG000|Screening Period|Participant discharged before receiving intervention|3|||
23672499|NCT04899232|66183073|FG001|Screening Period|Participant discharged before receiving intervention|0|||
23672500|NCT04899232|66183074|FG002|Screening Period|Participant discharged before receiving intervention|0|||
23672501|NCT02135692|66183080|FG000|Overall Study|Adverse Event|3|||
23672502|NCT02135692|66183080|FG000|Overall Study|Lack of Efficacy|2|||
23672503|NCT02135692|66183080|FG000|Overall Study|Protocol Violation|2|||
23672504|NCT02135692|66183080|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
23672505|NCT02135692|66183080|FG000|Overall Study|Product commercially available|159|||
23672506|NCT02135692|66183080|FG000|Overall Study|Study closed/terminated|153|||
23672507|NCT02135692|66183080|FG000|Overall Study|Lost to Follow-up|4|||
23672508|NCT02135692|66183080|FG000|Overall Study|Withdrawal by Subject|15|||
23672509|NCT02597946|66183081|FG000|Overall Study|Withdrawal by Subject|1|||
23672510|NCT02597946|66183081|FG000|Overall Study|Progressive disease|16|||
23672511|NCT02597946|66183081|FG000|Overall Study|Other than above|1|||
23672512|NCT01534533|66183082|FG000|Overall Study|Lost to Follow-up|3|||
23672513|NCT01534533|66183083|FG001|Overall Study|Lost to Follow-up|0|||
23672514|NCT01534533|66183084|FG002|Overall Study|Lost to Follow-up|4|||
23672515|NCT01534533|66183085|FG003|Overall Study|Lost to Follow-up|3|||
23672516|NCT01534533|66183082|FG000|Overall Study|Withdrawal by Subject|5|||
23672517|NCT01534533|66183083|FG001|Overall Study|Withdrawal by Subject|3|||
23672518|NCT01534533|66183084|FG002|Overall Study|Withdrawal by Subject|4|||
23672519|NCT01534533|66183085|FG003|Overall Study|Withdrawal by Subject|1|||
23672520|NCT00797823|66183086|FG000|First Period (Initial Randomization)|Physician Decision|1|||
23672521|NCT00797823|66183087|FG001|First Period (Initial Randomization)|Physician Decision|0|||
23672522|NCT00797823|66183088|FG002|First Period (Initial Randomization)|Physician Decision|0|||
23672523|NCT00424827|66183090|FG000|Overall Study|Adverse Event|1|||
23672524|NCT00075023|66183099|FG000|Pilot Study|Physician Decision|1|||
23672525|NCT00075023|66183100|FG001|Pilot Study|Physician Decision|2|||
23672526|NCT00075023|66183099|FG000|Pilot Study|Withdrawal by Subject|1|||
23672527|NCT00075023|66183100|FG001|Pilot Study|Withdrawal by Subject|0|||
23672528|NCT00183274|66183101|FG000|Phase 1: Open-Label|Adverse Event|31|||
23672529|NCT00183274|66183102|FG001|Phase 1: Open-Label|Adverse Event|0|||
23672530|NCT00183274|66183103|FG002|Phase 1: Open-Label|Adverse Event|0|||
23672531|NCT00183274|66183104|FG003|Phase 1: Open-Label|Adverse Event|0|||
23672532|NCT00183274|66183105|FG004|Phase 1: Open-Label|Adverse Event|0|||
23672533|NCT00183274|66183106|FG005|Phase 1: Open-Label|Adverse Event|0|||
23672534|NCT00183274|66183101|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
23672535|NCT00183274|66183102|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
23672536|NCT00183274|66183103|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
23672537|NCT00183274|66183104|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
23672538|NCT00183274|66183105|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
23672539|NCT00183274|66183106|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
23672540|NCT00183274|66183101|FG000|Phase 1: Open-Label|Protocol Violation|11|||
23672541|NCT00183274|66183102|FG001|Phase 1: Open-Label|Protocol Violation|0|||
23672542|NCT00183274|66183103|FG002|Phase 1: Open-Label|Protocol Violation|0|||
23672543|NCT00183274|66183104|FG003|Phase 1: Open-Label|Protocol Violation|0|||
23672544|NCT00183274|66183105|FG004|Phase 1: Open-Label|Protocol Violation|0|||
23672545|NCT00183274|66183106|FG005|Phase 1: Open-Label|Protocol Violation|0|||
23672546|NCT00183274|66183101|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
23672547|NCT00183274|66183102|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
23672548|NCT00183274|66183103|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
23672549|NCT00183274|66183104|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
23672550|NCT00183274|66183105|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
23672551|NCT00183274|66183106|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
23672552|NCT00183274|66183101|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
23672553|NCT00183274|66183102|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
23672554|NCT00183274|66183103|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
23672555|NCT00183274|66183104|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
23672556|NCT00183274|66183105|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
23385976|NCT01451203|65158530|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
23672557|NCT00183274|66183106|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
23672558|NCT00183274|66183101|FG000|Phase 1: Open-Label|Other|9|||
23672559|NCT00183274|66183102|FG001|Phase 1: Open-Label|Other|0|||
23672560|NCT00183274|66183103|FG002|Phase 1: Open-Label|Other|0|||
23385977|NCT01451203|65158531|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
23385978|NCT01451203|65158530|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
23385979|NCT01451203|65158531|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
23385980|NCT01451203|65158530|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
23385981|NCT01451203|65158531|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
23385982|NCT01451203|65158530|FG000|Double-blind Treatment Period|Adverse Event|6|||
23385983|NCT01451203|65158531|FG001|Double-blind Treatment Period|Adverse Event|9|||
23385984|NCT01451203|65158530|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
23385985|NCT01451203|65158531|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
23385986|NCT01451203|65158530|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
23385987|NCT01451203|65158531|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
23385988|NCT01451203|65158530|FG000|Double-blind Treatment Period|Investigator decision|2|||
23385989|NCT01451203|65158531|FG001|Double-blind Treatment Period|Investigator decision|0|||
23385990|NCT01451203|65158530|FG000|Post-treatment Period|Consent withdrawn|2|||
23385991|NCT01451203|65158531|FG001|Post-treatment Period|Consent withdrawn|4|||
23385992|NCT01451203|65158530|FG000|Post-treatment Period|Lack of Efficacy|12|||
23385993|NCT01451203|65158531|FG001|Post-treatment Period|Lack of Efficacy|28|||
23385994|NCT01451203|65158530|FG000|Post-treatment Period|Adverse Event|0|||
23385995|NCT01451203|65158531|FG001|Post-treatment Period|Adverse Event|1|||
23385996|NCT01451203|65158530|FG000|Post-treatment Period|Investigator decision|0|||
23385997|NCT01451203|65158531|FG001|Post-treatment Period|Investigator decision|1|||
23672561|NCT00183274|66183104|FG003|Phase 1: Open-Label|Other|0|||
23672562|NCT00183274|66183105|FG004|Phase 1: Open-Label|Other|0|||
23385998|NCT01530256|65158532|FG000|Overall Study|Death|2|||
23385999|NCT02802865|65158533|FG000|Overall Study|Pregnancy|1|||
23386000|NCT02802865|65158534|FG001|Overall Study|Pregnancy|1|||
23386001|NCT02802865|65158533|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
23386002|NCT02802865|65158534|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
23386003|NCT02569242|65158535|FG000|Overall Study|Death|1|||
23386004|NCT02569242|65158536|FG001|Overall Study|Death|0|||
23386005|NCT02569242|65158535|FG000|Overall Study|Withdrawal by Subject|0|||
23386006|NCT02569242|65158536|FG001|Overall Study|Withdrawal by Subject|1|||
23672563|NCT00183274|66183106|FG005|Phase 1: Open-Label|Other|0|||
23672564|NCT00183274|66183101|FG000|Phase 2: Double-Blind|Relapsed|0|||
23672565|NCT00183274|66183102|FG001|Phase 2: Double-Blind|Relapsed|8|||
23672566|NCT00183274|66183103|FG002|Phase 2: Double-Blind|Relapsed|29|||
23672567|NCT00183274|66183104|FG003|Phase 2: Double-Blind|Relapsed|0|||
23672568|NCT00183274|66183105|FG004|Phase 2: Double-Blind|Relapsed|0|||
23672569|NCT00183274|66183106|FG005|Phase 2: Double-Blind|Relapsed|0|||
23672570|NCT00183274|66183101|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23672571|NCT00183274|66183102|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
23672572|NCT00183274|66183103|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
23672573|NCT00183274|66183104|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23672574|NCT00183274|66183105|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23493212|NCT00397215|65551395|FG003|Month 0 (Day 0)|Adverse Event|0|||
23672575|NCT00183274|66183106|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23672576|NCT00183274|66183101|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23672577|NCT00183274|66183102|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23672578|NCT00183274|66183103|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23672579|NCT00183274|66183104|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
23672580|NCT00183274|66183105|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
23672581|NCT00183274|66183106|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
23672582|NCT00183274|66183101|FG000|Phase 3: Double-Blind|Relapsed|0|||
23672583|NCT00183274|66183102|FG001|Phase 3: Double-Blind|Relapsed|0|||
23672584|NCT00183274|66183103|FG002|Phase 3: Double-Blind|Relapsed|0|||
23672585|NCT00183274|66183104|FG003|Phase 3: Double-Blind|Relapsed|1|||
23672586|NCT00183274|66183105|FG004|Phase 3: Double-Blind|Relapsed|11|||
23672587|NCT00183274|66183106|FG005|Phase 3: Double-Blind|Relapsed|2|||
23672588|NCT00847912|66183111|FG000|Overall Study|Protocol Violation|6|||
23672589|NCT00847912|66183112|FG001|Overall Study|Protocol Violation|7|||
23672590|NCT00847912|66183111|FG000|Overall Study|Withdrawal by Subject|3|||
23672591|NCT00847912|66183112|FG001|Overall Study|Withdrawal by Subject|6|||
23672592|NCT02268058|66183114|FG000|Overall Study|Protocol Violation|1|||
23672593|NCT02268058|66183115|FG001|Overall Study|Protocol Violation|0|||
23672594|NCT02268058|66183116|FG002|Overall Study|Protocol Violation|0|||
23672595|NCT02268058|66183117|FG003|Overall Study|Protocol Violation|0|||
23672596|NCT00075504|66183118|FG000|Overall Study|Withdrawal by Subject|9|||
23672597|NCT00075504|66183119|FG001|Overall Study|Withdrawal by Subject|7|||
23672598|NCT02425826|66183120|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
23672599|NCT02425826|66183121|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
23672600|NCT02425826|66183122|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
23672601|NCT02425826|66183120|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
23672602|NCT02425826|66183121|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
23672603|NCT02425826|66183122|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
23672604|NCT02425826|66183120|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
23672605|NCT02425826|66183121|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
23672606|NCT02425826|66183122|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
23672607|NCT02425826|66183120|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
23672608|NCT02425826|66183121|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
23672609|NCT02425826|66183122|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
23672610|NCT02425826|66183120|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
23672611|NCT02425826|66183121|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
23672612|NCT02425826|66183122|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
23672613|NCT02425826|66183120|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
23672614|NCT02425826|66183121|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
23672615|NCT02425826|66183122|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
23672616|NCT02425826|66183120|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
23672617|NCT02425826|66183121|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
23672618|NCT02425826|66183122|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
23672619|NCT02425826|66183120|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
23672620|NCT02425826|66183121|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
23672621|NCT02425826|66183122|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
23672622|NCT02425826|66183120|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
23386007|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
23386008|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
23672623|NCT02425826|66183121|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
23672624|NCT02425826|66183122|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
23672625|NCT02425826|66183120|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
23672626|NCT02425826|66183121|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
23386009|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
23386010|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
23672627|NCT02425826|66183122|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
23672628|NCT00278993|66183126|FG000|Overall Study|Adverse Event|24|||
23386011|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
23386012|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
23386013|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
23386014|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
23386015|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
23386016|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
23386017|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
23386018|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
23386019|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
23672629|NCT00278993|66183126|FG000|Overall Study|Withdrawal by Subject|5|||
23672630|NCT00278993|66183126|FG000|Overall Study|Progressive Disease|65|||
23672631|NCT00278993|66183126|FG000|Overall Study|Physician Decision|9|||
23672632|NCT00278993|66183126|FG000|Overall Study|Not Otherwise Specified|4|||
23672633|NCT00744874|66186654|FG000|Overall Study|Lost to Follow-up|1|||
23672634|NCT00744874|66186654|FG000|Overall Study|Withdrawal by Subject|1|||
23672635|NCT00744874|66186654|FG000|Overall Study|Study Device not available at procedure|1|||
23672636|NCT00744874|66186654|FG000|Overall Study|Unable to accomodate schedule|1|||
23672637|NCT00429858|66186658|FG000|Overall Study|Withdrawal by Subject|1|||
23672638|NCT00429858|66186658|FG000|Overall Study|Study Termination|1|||
23672639|NCT02286947|66186659|FG000|Overall Study|Withdrawal by Subject|2|||
23672640|NCT01340209|66186660|FG000|Overall Study|Adverse Event|1|||
23672641|NCT01340209|66186661|FG001|Overall Study|Adverse Event|1|||
23672642|NCT01340209|66186662|FG002|Overall Study|Adverse Event|2|||
23672643|NCT01340209|66186660|FG000|Overall Study|Protocol Violation|1|||
23672644|NCT01340209|66186661|FG001|Overall Study|Protocol Violation|2|||
23672645|NCT01340209|66186662|FG002|Overall Study|Protocol Violation|1|||
23672646|NCT01340209|66186660|FG000|Overall Study|Withdrawal by Subject|0|||
23672647|NCT01340209|66186661|FG001|Overall Study|Withdrawal by Subject|0|||
23672648|NCT01340209|66186662|FG002|Overall Study|Withdrawal by Subject|1|||
23672649|NCT01340209|66186660|FG000|Overall Study|Other reason not defined above|3|||
23672650|NCT01340209|66186661|FG001|Overall Study|Other reason not defined above|5|||
23672651|NCT01340209|66186662|FG002|Overall Study|Other reason not defined above|4|||
23672652|NCT01849874|66186670|FG000|Overall Study|Death|89|||
23672653|NCT01849874|66186671|FG001|Overall Study|Death|42|||
23672654|NCT01849874|66186670|FG000|Overall Study|Withdrawal by Subject|17|||
23672655|NCT01849874|66186671|FG001|Overall Study|Withdrawal by Subject|16|||
23672656|NCT01849874|66186670|FG000|Overall Study|Lost to Follow-up|3|||
23672657|NCT01849874|66186671|FG001|Overall Study|Lost to Follow-up|2|||
23672658|NCT01849874|66186670|FG000|Overall Study|Study Termination By Sponsor|93|||
23672659|NCT01849874|66186671|FG001|Overall Study|Study Termination By Sponsor|48|||
23672660|NCT01849874|66186670|FG000|Overall Study|Completed as per protocol amendment 6|3|||
23672661|NCT01849874|66186671|FG001|Overall Study|Completed as per protocol amendment 6|0|||
23672662|NCT01849874|66186670|FG000|Overall Study|Physician Decision|7|||
23672663|NCT01849874|66186671|FG001|Overall Study|Physician Decision|1|||
23672664|NCT01849874|66186670|FG000|Overall Study|Other|16|||
23672665|NCT01849874|66186671|FG001|Overall Study|Other|4|||
23493213|NCT00397215|65551392|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493214|NCT00397215|65551393|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493215|NCT00397215|65551394|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493216|NCT00397215|65551395|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
23493217|NCT00397215|65551392|FG000|Month 0 (Day 0)|Other|4|||
23672666|NCT00927095|66186675|FG000|Overall Study|Adverse Event|3|||
23672667|NCT00927095|66186676|FG001|Overall Study|Adverse Event|1|||
23672668|NCT00927095|66186677|FG002|Overall Study|Adverse Event|0|||
23672669|NCT00927095|66186675|FG000|Overall Study|Withdrawal by Subject|2|||
23672670|NCT00927095|66186676|FG001|Overall Study|Withdrawal by Subject|1|||
23672671|NCT00927095|66186677|FG002|Overall Study|Withdrawal by Subject|1|||
23672672|NCT00927095|66186675|FG000|Overall Study|Physician Decision|1|||
23672673|NCT00927095|66186676|FG001|Overall Study|Physician Decision|2|||
23672674|NCT00927095|66186677|FG002|Overall Study|Physician Decision|1|||
23672675|NCT01445678|66186678|FG000|Overall Study|Adverse Event|12|||
23672676|NCT01445678|66186679|FG001|Overall Study|Adverse Event|8|||
23672677|NCT01445678|66186678|FG000|Overall Study|Lack of Efficacy|0|||
23672678|NCT01445678|66186679|FG001|Overall Study|Lack of Efficacy|2|||
23672679|NCT01445678|66186678|FG000|Overall Study|Lost to Follow-up|8|||
23672680|NCT01445678|66186679|FG001|Overall Study|Lost to Follow-up|5|||
23672681|NCT01445678|66186678|FG000|Overall Study|Protocol Violation|1|||
23672682|NCT01445678|66186679|FG001|Overall Study|Protocol Violation|1|||
23672683|NCT01445678|66186678|FG000|Overall Study|Withdrawal by Subject|9|||
23672684|NCT01445678|66186679|FG001|Overall Study|Withdrawal by Subject|5|||
23672685|NCT03245450|66186682|FG000|Overall Study|Radiological disease progression|3|||
23672686|NCT03245450|66186683|FG001|Overall Study|Radiological disease progression|3|||
23672687|NCT03245450|66186684|FG002|Overall Study|Radiological disease progression|2|||
23672688|NCT03245450|66186685|FG003|Overall Study|Radiological disease progression|2|||
23672689|NCT03245450|66186686|FG004|Overall Study|Radiological disease progression|7|||
23672690|NCT03245450|66186687|FG005|Overall Study|Radiological disease progression|6|||
23672691|NCT03245450|66186688|FG006|Overall Study|Radiological disease progression|6|||
23672692|NCT03245450|66186682|FG000|Overall Study|Clinical disease progression|0|||
23672693|NCT03245450|66186683|FG001|Overall Study|Clinical disease progression|0|||
23672694|NCT03245450|66186684|FG002|Overall Study|Clinical disease progression|1|||
23672695|NCT03245450|66186685|FG003|Overall Study|Clinical disease progression|0|||
23672696|NCT03245450|66186686|FG004|Overall Study|Clinical disease progression|0|||
23672697|NCT03245450|66186687|FG005|Overall Study|Clinical disease progression|2|||
23672698|NCT03245450|66186688|FG006|Overall Study|Clinical disease progression|0|||
23672699|NCT03245450|66186682|FG000|Overall Study|Other|0|||
23672700|NCT03245450|66186683|FG001|Overall Study|Other|0|||
23386020|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
23386021|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
23386022|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
23386023|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
23386024|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
23386025|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
23386026|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
23386027|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
23386028|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
23672701|NCT03245450|66186684|FG002|Overall Study|Other|0|||
23386029|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
23386030|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
23386031|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
23386032|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
23386033|NCT01657500|65158539|FG000|Overall Study|set impropperly matched|3|||
23386034|NCT01657500|65158540|FG001|Overall Study|set impropperly matched|3|||
23386035|NCT01657500|65158539|FG000|Overall Study|Lost to Follow-up|2|||
23386036|NCT01657500|65158540|FG001|Overall Study|Lost to Follow-up|2|||
23386037|NCT02294019|65158543|FG000|Overall Study|Adverse Event|2|||
23386038|NCT02294019|65158543|FG000|Overall Study|Protocol Violation|68|||
23386039|NCT02294019|65158543|FG000|Overall Study|Lost to Follow-up|31|||
23386040|NCT02294019|65158543|FG000|Overall Study|Other|1|||
23386041|NCT02294019|65158543|FG000|Overall Study|Withdrawal by Subject|1|||
23386042|NCT03164356|65158544|FG000|Overall Study|Lost to Follow-up|1|||
23386043|NCT03164356|65158545|FG001|Overall Study|Lost to Follow-up|1|||
23386044|NCT03164356|65158546|FG002|Overall Study|Lost to Follow-up|2|||
23386045|NCT03164356|65158547|FG003|Overall Study|Lost to Follow-up|1|||
23386046|NCT03164356|65158544|FG000|Overall Study|Physician Decision|0|||
23386047|NCT03164356|65158545|FG001|Overall Study|Physician Decision|0|||
23386048|NCT03164356|65158546|FG002|Overall Study|Physician Decision|3|||
23386049|NCT03164356|65158547|FG003|Overall Study|Physician Decision|0|||
23386050|NCT03164356|65158544|FG000|Overall Study|Protocol Violation|2|||
23386051|NCT03164356|65158545|FG001|Overall Study|Protocol Violation|1|||
23386052|NCT03164356|65158546|FG002|Overall Study|Protocol Violation|0|||
23386053|NCT03164356|65158547|FG003|Overall Study|Protocol Violation|0|||
23386054|NCT03164356|65158544|FG000|Overall Study|Withdrawal by Subject|1|||
23386055|NCT03164356|65158545|FG001|Overall Study|Withdrawal by Subject|0|||
23386056|NCT03164356|65158546|FG002|Overall Study|Withdrawal by Subject|0|||
23386057|NCT03164356|65158547|FG003|Overall Study|Withdrawal by Subject|0|||
23386058|NCT03164356|65158544|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
23386059|NCT03164356|65158545|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
23386060|NCT03164356|65158546|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
23386061|NCT03164356|65158547|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
23386062|NCT03164356|65158544|FG000|Overall Study|Subject Incarcerated|0|||
23386063|NCT03164356|65158545|FG001|Overall Study|Subject Incarcerated|1|||
23386064|NCT03164356|65158546|FG002|Overall Study|Subject Incarcerated|0|||
23386065|NCT03164356|65158547|FG003|Overall Study|Subject Incarcerated|0|||
23386066|NCT03164356|65158544|FG000|Overall Study|Prosthetist unable to participate|0|||
23386067|NCT03164356|65158545|FG001|Overall Study|Prosthetist unable to participate|2|||
23672702|NCT03245450|66186685|FG003|Overall Study|Other|1|||
23672703|NCT03245450|66186686|FG004|Overall Study|Other|1|||
23672704|NCT03245450|66186687|FG005|Overall Study|Other|1|||
23672705|NCT03245450|66186688|FG006|Overall Study|Other|1|||
23672706|NCT03245450|66186682|FG000|Overall Study|Withdrawal by Subject|0|||
23672707|NCT03245450|66186683|FG001|Overall Study|Withdrawal by Subject|1|||
23672708|NCT03245450|66186684|FG002|Overall Study|Withdrawal by Subject|0|||
23672709|NCT03245450|66186685|FG003|Overall Study|Withdrawal by Subject|0|||
23672710|NCT03245450|66186686|FG004|Overall Study|Withdrawal by Subject|0|||
23672711|NCT03245450|66186687|FG005|Overall Study|Withdrawal by Subject|0|||
23672712|NCT03245450|66186688|FG006|Overall Study|Withdrawal by Subject|0|||
23672713|NCT03245450|66186682|FG000|Overall Study|Adverse Event|0|||
23672714|NCT03245450|66186683|FG001|Overall Study|Adverse Event|0|||
23672715|NCT03245450|66186684|FG002|Overall Study|Adverse Event|0|||
23672716|NCT03245450|66186685|FG003|Overall Study|Adverse Event|0|||
23672717|NCT03245450|66186686|FG004|Overall Study|Adverse Event|1|||
23672718|NCT03245450|66186687|FG005|Overall Study|Adverse Event|0|||
23672719|NCT03245450|66186688|FG006|Overall Study|Adverse Event|2|||
23672720|NCT04315181|66186689|FG000|Overall Study|Non-responsive to drug conditions.|1|||
23672721|NCT02161211|66186690|FG000|Overall Study|Lost to Follow-up|21|||
23386068|NCT03164356|65158546|FG002|Overall Study|Prosthetist unable to participate|1|||
23386069|NCT03164356|65158547|FG003|Overall Study|Prosthetist unable to participate|0|||
23386070|NCT04359680|65158548|FG000|Overall Study|Withdrawal by Subject|29|||
23386071|NCT04359680|65158549|FG001|Overall Study|Withdrawal by Subject|24|||
23386072|NCT04359680|65158548|FG000|Overall Study|Adverse Event|6|||
23672722|NCT02161211|66186691|FG001|Overall Study|Lost to Follow-up|27|||
23672723|NCT02161211|66186692|FG002|Overall Study|Lost to Follow-up|21|||
23386073|NCT04359680|65158549|FG001|Overall Study|Adverse Event|2|||
23386074|NCT04359680|65158548|FG000|Overall Study|Lost to Follow-up|56|||
23386075|NCT04359680|65158549|FG001|Overall Study|Lost to Follow-up|59|||
23386076|NCT04359680|65158548|FG000|Overall Study|Protocol Violation|3|||
23386077|NCT04359680|65158549|FG001|Overall Study|Protocol Violation|5|||
23386078|NCT04359680|65158548|FG000|Overall Study|Physician Decision|1|||
23386079|NCT04359680|65158549|FG001|Overall Study|Physician Decision|1|||
23386080|NCT04359680|65158548|FG000|Overall Study|Sponsor Decision|0|||
23386081|NCT04359680|65158549|FG001|Overall Study|Sponsor Decision|1|||
23386082|NCT00784927|65158550|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
23386083|NCT00784927|65158550|FG000|Overall Study|Protocol Violation|1|||
23386084|NCT00784927|65158550|FG000|Overall Study|Ineligible|1|||
23386085|NCT01618708|65158551|FG000|Overall Study|Adverse Event|10|||
23386086|NCT01618708|65158552|FG001|Overall Study|Adverse Event|10|||
23386087|NCT01618708|65158551|FG000|Overall Study|Lost to Follow-up|3|||
23386088|NCT01618708|65158552|FG001|Overall Study|Lost to Follow-up|3|||
23386089|NCT01618708|65158551|FG000|Overall Study|Withdrawal by Subject|17|||
23386090|NCT01618708|65158552|FG001|Overall Study|Withdrawal by Subject|22|||
23493218|NCT00397215|65551393|FG001|Month 0 (Day 0)|Other|1|||
23493219|NCT00397215|65551394|FG002|Month 0 (Day 0)|Other|3|||
23493220|NCT00397215|65551395|FG003|Month 0 (Day 0)|Other|3|||
23493221|NCT00397215|65551392|FG000|Month 6 (Day 180)|Adverse Event|0|||
23493222|NCT00397215|65551393|FG001|Month 6 (Day 180)|Adverse Event|3|||
23493223|NCT00397215|65551394|FG002|Month 6 (Day 180)|Adverse Event|2|||
23493224|NCT00397215|65551395|FG003|Month 6 (Day 180)|Adverse Event|0|||
23493225|NCT00397215|65551392|FG000|Month 6 (Day 180)|Other|2|||
23493226|NCT00397215|65551393|FG001|Month 6 (Day 180)|Other|0|||
23493227|NCT00397215|65551394|FG002|Month 6 (Day 180)|Other|3|||
23493228|NCT00397215|65551395|FG003|Month 6 (Day 180)|Other|0|||
23493229|NCT03403374|65551397|FG000|Overall Study|Lost to Follow-up|1|||
23493230|NCT02423109|65551402|FG000|Lens 1|Adverse Event|1|||
23493231|NCT02423109|65551403|FG001|Lens 1|Adverse Event|0|||
23493232|NCT00422097|65551416|FG000|Dose Level 2|Still on treatment|0|||
23493233|NCT00422097|65551417|FG001|Dose Level 2|Still on treatment|1|||
23493234|NCT00422097|65551418|FG002|Dose Level 2|Still on treatment|0|||
23493235|NCT00422097|65551419|FG003|Dose Level 2|Still on treatment|0|||
23493236|NCT00422097|65551420|FG004|Dose Level 2|Still on treatment|0|||
23493237|NCT00422097|65551421|FG005|Dose Level 2|Still on treatment|0|||
23493238|NCT00422097|65551422|FG006|Dose Level 2|Still on treatment|0|||
23493239|NCT00422097|65551423|FG007|Dose Level 2|Still on treatment|0|||
23493240|NCT01786148|65551424|FG000|Overall Study|Lost to Follow-up|21|||
23493241|NCT01786148|65551425|FG001|Overall Study|Lost to Follow-up|13|||
23493242|NCT01786148|65551424|FG000|Overall Study|Death|0|||
23493243|NCT01786148|65551425|FG001|Overall Study|Death|1|||
23493244|NCT01786148|65551424|FG000|Overall Study|Withdrawal by Subject|0|||
23493245|NCT01786148|65551425|FG001|Overall Study|Withdrawal by Subject|7|||
23493246|NCT01786148|65551424|FG000|Overall Study|Incarceration|1|||
23493247|NCT01786148|65551425|FG001|Overall Study|Incarceration|1|||
23493248|NCT01705730|65551426|FG000|Overall Study|Lack of Efficacy|1|||
23493249|NCT01705730|65551426|FG000|Overall Study|Adverse Event|3|||
23493250|NCT01705730|65551426|FG000|Overall Study|Lost to Follow-up|1|||
23493251|NCT01705730|65551426|FG000|Overall Study|Reason not Specified|4|||
23493252|NCT01058655|65551429|FG000|Overall Study|Withdrawal by Subject|1|||
23493253|NCT01058655|65551430|FG001|Overall Study|Withdrawal by Subject|0|||
23493254|NCT01058655|65551431|FG002|Overall Study|Withdrawal by Subject|3|||
23493255|NCT01058655|65551432|FG003|Overall Study|Withdrawal by Subject|4|||
23493256|NCT01058655|65551429|FG000|Overall Study|Prolonged Treatment Delay|0|||
23493257|NCT01058655|65551430|FG001|Overall Study|Prolonged Treatment Delay|0|||
23493258|NCT01058655|65551431|FG002|Overall Study|Prolonged Treatment Delay|0|||
23493259|NCT01058655|65551432|FG003|Overall Study|Prolonged Treatment Delay|2|||
23493260|NCT01058655|65551429|FG000|Overall Study|Symptomatic Deterioration|0|||
23493261|NCT01058655|65551430|FG001|Overall Study|Symptomatic Deterioration|0|||
23493262|NCT01058655|65551431|FG002|Overall Study|Symptomatic Deterioration|0|||
23493263|NCT01058655|65551432|FG003|Overall Study|Symptomatic Deterioration|1|||
23493264|NCT01058655|65551429|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
23672724|NCT02161211|66186690|FG000|Overall Study|Dropped|12|||
23493265|NCT01058655|65551430|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
23493266|NCT01058655|65551431|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
23493267|NCT01058655|65551432|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
23493268|NCT01058655|65551429|FG000|Overall Study|Death|0|||
23493269|NCT01058655|65551430|FG001|Overall Study|Death|1|||
23493270|NCT01058655|65551431|FG002|Overall Study|Death|1|||
23493271|NCT01058655|65551432|FG003|Overall Study|Death|0|||
23493272|NCT01058655|65551429|FG000|Overall Study|Disease Progression|1|||
23493273|NCT01058655|65551430|FG001|Overall Study|Disease Progression|2|||
23493274|NCT01058655|65551431|FG002|Overall Study|Disease Progression|4|||
23386091|NCT01618708|65158551|FG000|Overall Study|Lack of Efficacy|8|||
23386092|NCT01618708|65158552|FG001|Overall Study|Lack of Efficacy|8|||
23386093|NCT01618708|65158551|FG000|Overall Study|Technical problems|2|||
23386094|NCT01618708|65158552|FG001|Overall Study|Technical problems|0|||
23493275|NCT01058655|65551432|FG003|Overall Study|Disease Progression|24|||
23493276|NCT01058655|65551429|FG000|Overall Study|Other|0|||
23493277|NCT01058655|65551430|FG001|Overall Study|Other|0|||
23386095|NCT01618708|65158551|FG000|Overall Study|Other than specified above|1|||
23386096|NCT01618708|65158552|FG001|Overall Study|Other than specified above|1|||
23386097|NCT01618708|65158551|FG000|Overall Study|Randomized but not treated|3|||
23386098|NCT01618708|65158552|FG001|Overall Study|Randomized but not treated|2|||
23386099|NCT01835431|65158560|FG000|Overall Study|Adverse Event|1|||
23386100|NCT01835431|65158561|FG001|Overall Study|Adverse Event|0|||
23386101|NCT01835431|65158560|FG000|Overall Study|other|0|||
23386102|NCT01835431|65158561|FG001|Overall Study|other|2|||
23386103|NCT01835431|65158560|FG000|Overall Study|Withdrawal by Subject|6|||
23386104|NCT01835431|65158561|FG001|Overall Study|Withdrawal by Subject|10|||
23386105|NCT01835431|65158560|FG000|Overall Study|Protocol Violation|1|||
23386106|NCT01835431|65158561|FG001|Overall Study|Protocol Violation|0|||
23386107|NCT01666652|65158565|FG000|Overall Study|Serious Adverse Event|0|||
23386108|NCT01666652|65158566|FG001|Overall Study|Serious Adverse Event|0|||
23386109|NCT01666652|65158567|FG002|Overall Study|Serious Adverse Event|0|||
23493278|NCT01058655|65551431|FG002|Overall Study|Other|0|||
23386110|NCT01666652|65158568|FG003|Overall Study|Serious Adverse Event|1|||
23386111|NCT01666652|65158569|FG004|Overall Study|Serious Adverse Event|0|||
23386112|NCT01666652|65158565|FG000|Overall Study|Withdrawal by Subject|0|||
23386113|NCT01666652|65158566|FG001|Overall Study|Withdrawal by Subject|0|||
23493279|NCT01058655|65551432|FG003|Overall Study|Other|4|||
23672725|NCT02161211|66186691|FG001|Overall Study|Dropped|5|||
23672726|NCT02161211|66186692|FG002|Overall Study|Dropped|9|||
23672727|NCT00705783|66186695|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
23672728|NCT00705783|66186696|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
23672729|NCT00705783|66186697|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
23672730|NCT00705783|66186695|FG000|Conversion Phase|Lost to Follow-up|13|||
23672731|NCT00705783|66186696|FG001|Conversion Phase|Lost to Follow-up|0|||
23672732|NCT00705783|66186697|FG002|Conversion Phase|Lost to Follow-up|0|||
23672733|NCT00705783|66186695|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
23672734|NCT00705783|66186696|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
23672735|NCT00705783|66186697|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
23672736|NCT00705783|66186695|FG000|Conversion Phase|Withdrawn by Investigator|4|||
23672737|NCT00705783|66186696|FG001|Conversion Phase|Withdrawn by Investigator|0|||
23672738|NCT00705783|66186697|FG002|Conversion Phase|Withdrawn by Investigator|0|||
23672739|NCT00705783|66186695|FG000|Conversion Phase|Withdrew Consent|24|||
23672740|NCT00705783|66186696|FG001|Conversion Phase|Withdrew Consent|0|||
23672741|NCT00705783|66186697|FG002|Conversion Phase|Withdrew Consent|0|||
23672742|NCT00705783|66186695|FG000|Conversion Phase|Protocol Deviation|2|||
23672743|NCT00705783|66186696|FG001|Conversion Phase|Protocol Deviation|0|||
23672744|NCT00705783|66186697|FG002|Conversion Phase|Protocol Deviation|0|||
23672745|NCT00705783|66186695|FG000|Conversion Phase|Adverse Event|11|||
23672746|NCT00705783|66186696|FG001|Conversion Phase|Adverse Event|0|||
23672747|NCT00705783|66186697|FG002|Conversion Phase|Adverse Event|0|||
23672748|NCT00705783|66186695|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
23672749|NCT00705783|66186696|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23672750|NCT00705783|66186697|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23672751|NCT00705783|66186695|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
23672752|NCT00705783|66186696|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23672753|NCT00705783|66186697|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23672754|NCT00705783|66186695|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
23672755|NCT00705783|66186696|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
23672756|NCT00705783|66186697|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
23672757|NCT00705783|66186695|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
23672758|NCT00705783|66186696|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
23672759|NCT00705783|66186697|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
23672760|NCT00705783|66186695|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
23672761|NCT00705783|66186696|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23672762|NCT00705783|66186697|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23672763|NCT00705783|66186695|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
23672764|NCT00705783|66186696|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23672765|NCT00705783|66186697|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23672766|NCT00705783|66186695|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
23672767|NCT00705783|66186696|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
23672768|NCT00705783|66186697|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
23672769|NCT00705783|66186695|FG000|Oral Stabilization Phase|Adverse Event|14|||
23493280|NCT01752985|65551433|FG000|Treatment Period|Subject request to discontinue treatment|1|||
23672770|NCT00705783|66186696|FG001|Oral Stabilization Phase|Adverse Event|0|||
23493281|NCT01752985|65551434|FG001|Treatment Period|Subject request to discontinue treatment|0|||
23493282|NCT01752985|65551435|FG002|Treatment Period|Subject request to discontinue treatment|1|||
23672771|NCT00705783|66186697|FG002|Oral Stabilization Phase|Adverse Event|0|||
23672772|NCT00705783|66186695|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
23672773|NCT00705783|66186696|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23672774|NCT00705783|66186697|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23672775|NCT00705783|66186695|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
23672776|NCT00705783|66186696|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23672777|NCT00705783|66186697|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23672778|NCT00705783|66186695|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
23672779|NCT00705783|66186696|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
23672780|NCT00705783|66186697|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
23672781|NCT00705783|66186695|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
23672782|NCT00705783|66186696|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
23672783|NCT00705783|66186697|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
23672784|NCT00705783|66186695|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
23672785|NCT00705783|66186696|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
23672786|NCT00705783|66186697|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
23672787|NCT00705783|66186695|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
23672788|NCT00705783|66186696|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
23672789|NCT00705783|66186697|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
23672790|NCT00705783|66186695|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
23672791|NCT00705783|66186696|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
23493283|NCT01752985|65551433|FG000|Treatment Period|Subject no longer meets study criteria|0|||
23672792|NCT00705783|66186697|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
23672793|NCT00705783|66186695|FG000|Depot Stabilization Phase|Adverse Event|17|||
23672794|NCT00705783|66186696|FG001|Depot Stabilization Phase|Adverse Event|0|||
23672795|NCT00705783|66186697|FG002|Depot Stabilization Phase|Adverse Event|0|||
23672796|NCT00705783|66186695|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
23672797|NCT00705783|66186696|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23672798|NCT00705783|66186697|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23672799|NCT00705783|66186695|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
23672800|NCT00705783|66186696|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23672801|NCT00705783|66186697|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23672802|NCT00705783|66186695|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
23672803|NCT00705783|66186696|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
23672804|NCT00705783|66186697|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
23672805|NCT00705783|66186695|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
23672806|NCT00705783|66186696|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
23672807|NCT00705783|66186697|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
23672808|NCT00705783|66186695|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
23672809|NCT00705783|66186696|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
23672810|NCT00705783|66186697|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
23672811|NCT00705783|66186695|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
23672812|NCT00705783|66186696|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23672813|NCT00705783|66186697|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
23672814|NCT00705783|66186695|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
23672815|NCT00705783|66186696|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
23672816|NCT00705783|66186697|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
23672817|NCT00705783|66186695|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
23672818|NCT00705783|66186696|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
23672819|NCT00705783|66186697|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
23672820|NCT00705783|66186695|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
23672821|NCT00705783|66186696|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
23672822|NCT00705783|66186697|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
23672823|NCT00705783|66186695|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
23672824|NCT00705783|66186696|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
23672825|NCT00705783|66186697|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
23672826|NCT00705783|66186695|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
23672827|NCT00705783|66186696|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
23672828|NCT00705783|66186697|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
23672829|NCT01148537|66186698|FG000|Overall Study|Withdrawal by Subject|1|||
23672830|NCT01148537|66186699|FG001|Overall Study|Withdrawal by Subject|0|||
23672831|NCT01148537|66186700|FG002|Overall Study|Withdrawal by Subject|2|||
23672832|NCT01148537|66186698|FG000|Overall Study|Adverse Event|2|||
23672833|NCT01148537|66186699|FG001|Overall Study|Adverse Event|0|||
23672834|NCT01148537|66186700|FG002|Overall Study|Adverse Event|1|||
23672835|NCT01665144|66186701|FG000|Core Part|Withdrawal by Subject|96|||
23672836|NCT01665144|66186702|FG001|Core Part|Withdrawal by Subject|77|||
23672837|NCT01665144|66186703|FG002|Core Part|Withdrawal by Subject|0|||
23672838|NCT01665144|66186701|FG000|Core Part|Adverse Event|45|||
23672839|NCT01665144|66186702|FG001|Core Part|Adverse Event|18|||
23672840|NCT01665144|66186703|FG002|Core Part|Adverse Event|0|||
23672841|NCT01665144|66186701|FG000|Core Part|Lack of Efficacy|16|||
23672842|NCT01665144|66186702|FG001|Core Part|Lack of Efficacy|11|||
23672843|NCT01665144|66186703|FG002|Core Part|Lack of Efficacy|0|||
23672844|NCT01665144|66186701|FG000|Core Part|Lost to Follow-up|9|||
23672845|NCT01665144|66186702|FG001|Core Part|Lost to Follow-up|8|||
23672846|NCT01665144|66186703|FG002|Core Part|Lost to Follow-up|0|||
23672847|NCT01665144|66186701|FG000|Core Part|Physician Decision|13|||
23672848|NCT01665144|66186702|FG001|Core Part|Physician Decision|1|||
23672849|NCT01665144|66186703|FG002|Core Part|Physician Decision|0|||
23672850|NCT01665144|66186701|FG000|Core Part|Progressive disease|8|||
23672851|NCT01665144|66186702|FG001|Core Part|Progressive disease|4|||
23672852|NCT01665144|66186703|FG002|Core Part|Progressive disease|0|||
23672853|NCT01665144|66186701|FG000|Core Part|Non-compliance with study treatment|5|||
23672854|NCT01665144|66186702|FG001|Core Part|Non-compliance with study treatment|0|||
23672855|NCT01665144|66186703|FG002|Core Part|Non-compliance with study treatment|0|||
23672856|NCT01665144|66186701|FG000|Core Part|Death|3|||
23672857|NCT01665144|66186702|FG001|Core Part|Death|1|||
23672858|NCT01665144|66186703|FG002|Core Part|Death|0|||
23672859|NCT01665144|66186701|FG000|Core Part|Protocol deviation|3|||
23672860|NCT01665144|66186702|FG001|Core Part|Protocol deviation|1|||
23672861|NCT01665144|66186703|FG002|Core Part|Protocol deviation|0|||
23672862|NCT01665144|66186701|FG000|Core Part|New therapy for study indication|2|||
23672863|NCT01665144|66186702|FG001|Core Part|New therapy for study indication|1|||
23672864|NCT01665144|66186703|FG002|Core Part|New therapy for study indication|0|||
23672865|NCT01665144|66186701|FG000|Core Part|Technical problems|2|||
23672866|NCT01665144|66186702|FG001|Core Part|Technical problems|0|||
23672867|NCT01665144|66186703|FG002|Core Part|Technical problems|0|||
23672868|NCT01665144|66186701|FG000|Extension Part|Patient/guardian decision|180|||
23672869|NCT01665144|66186702|FG001|Extension Part|Patient/guardian decision|0|||
23672870|NCT01665144|66186703|FG002|Extension Part|Patient/guardian decision|98|||
23672871|NCT01665144|66186701|FG000|Extension Part|Adverse Event|104|||
23672872|NCT01665144|66186702|FG001|Extension Part|Adverse Event|0|||
23672873|NCT01665144|66186703|FG002|Extension Part|Adverse Event|59|||
23672874|NCT01665144|66186701|FG000|Extension Part|Study closed early|42|||
23672875|NCT01665144|66186702|FG001|Extension Part|Study closed early|0|||
23672876|NCT01665144|66186703|FG002|Extension Part|Study closed early|19|||
23672877|NCT01665144|66186701|FG000|Extension Part|Progressive disease|36|||
23672878|NCT01665144|66186702|FG001|Extension Part|Progressive disease|0|||
23672879|NCT01665144|66186703|FG002|Extension Part|Progressive disease|14|||
23672880|NCT01665144|66186701|FG000|Extension Part|Lack of Efficacy|37|||
23672881|NCT01665144|66186702|FG001|Extension Part|Lack of Efficacy|0|||
23672882|NCT01665144|66186703|FG002|Extension Part|Lack of Efficacy|12|||
23672883|NCT01665144|66186701|FG000|Extension Part|Physician Decision|29|||
23672884|NCT01665144|66186702|FG001|Extension Part|Physician Decision|0|||
23672885|NCT01665144|66186703|FG002|Extension Part|Physician Decision|13|||
23672886|NCT01665144|66186701|FG000|Extension Part|Technical problems|20|||
23672887|NCT01665144|66186702|FG001|Extension Part|Technical problems|0|||
23672888|NCT01665144|66186703|FG002|Extension Part|Technical problems|8|||
23672889|NCT01665144|66186701|FG000|Extension Part|Death|20|||
23672890|NCT01665144|66186702|FG001|Extension Part|Death|0|||
23672891|NCT01665144|66186703|FG002|Extension Part|Death|4|||
23672892|NCT01665144|66186701|FG000|Extension Part|Missing|12|||
23672893|NCT01665144|66186702|FG001|Extension Part|Missing|0|||
23672894|NCT01665144|66186703|FG002|Extension Part|Missing|6|||
23672895|NCT01665144|66186701|FG000|Extension Part|Lost to Follow-up|9|||
23672896|NCT01665144|66186702|FG001|Extension Part|Lost to Follow-up|0|||
23672897|NCT01665144|66186703|FG002|Extension Part|Lost to Follow-up|5|||
23672898|NCT01665144|66186701|FG000|Extension Part|New therapy for study indication|3|||
23672899|NCT01665144|66186702|FG001|Extension Part|New therapy for study indication|0|||
23672900|NCT01665144|66186703|FG002|Extension Part|New therapy for study indication|2|||
23672901|NCT01665144|66186701|FG000|Extension Part|Protocol deviation|3|||
23672902|NCT01665144|66186702|FG001|Extension Part|Protocol deviation|0|||
23672903|NCT01665144|66186703|FG002|Extension Part|Protocol deviation|0|||
23672904|NCT04562090|66186704|FG000|Overall Study|Withdrawal by Subject|3|||
23672905|NCT04562090|66186705|FG001|Overall Study|Withdrawal by Subject|4|||
23672906|NCT04562090|66186704|FG000|Overall Study|Protocol Violation|2|||
23672907|NCT04562090|66186705|FG001|Overall Study|Protocol Violation|0|||
23672908|NCT04562090|66186704|FG000|Overall Study|Lack of Efficacy|0|||
23672909|NCT04562090|66186705|FG001|Overall Study|Lack of Efficacy|1|||
23672910|NCT04562090|66186704|FG000|Overall Study|Adverse Event|1|||
23672911|NCT04562090|66186705|FG001|Overall Study|Adverse Event|4|||
23672912|NCT04562090|66186704|FG000|Overall Study|Miscellaneous|0|||
23672913|NCT04562090|66186705|FG001|Overall Study|Miscellaneous|3|||
23672914|NCT00708500|66186711|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
23672915|NCT00708500|66186712|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
23672916|NCT00708500|66186713|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
23672917|NCT00708500|66186711|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
23672918|NCT00708500|66186712|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
23672919|NCT00708500|66186713|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
23672920|NCT00708500|66186711|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
23672921|NCT00708500|66186712|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
23672922|NCT00708500|66186713|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
23672923|NCT00708500|66186711|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
23672924|NCT00708500|66186712|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
23672925|NCT00708500|66186713|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
23672926|NCT00708500|66186711|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
23672927|NCT00708500|66186712|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
23672928|NCT00708500|66186713|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
23672929|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
23672930|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
23672931|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
23672932|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
23672933|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
23672934|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
23672935|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
23672936|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
23672937|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
23672938|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
23672939|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
23672940|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
23672941|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
23672942|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
23672943|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
23672944|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
23672945|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
23672946|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
23672947|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
23672948|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
23672949|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
23672950|NCT00708500|66186711|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
23672951|NCT00708500|66186712|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
23672952|NCT00708500|66186713|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
23672953|NCT00708500|66186711|FG000|FOLLOWUP|Adverse Event|0|||
23672954|NCT00708500|66186712|FG001|FOLLOWUP|Adverse Event|1|||
23672955|NCT00708500|66186713|FG002|FOLLOWUP|Adverse Event|0|||
23672956|NCT00708500|66186711|FG000|FOLLOWUP|Lost to Follow-up|1|||
23672957|NCT00708500|66186712|FG001|FOLLOWUP|Lost to Follow-up|6|||
23672958|NCT00708500|66186713|FG002|FOLLOWUP|Lost to Follow-up|4|||
23672959|NCT00708500|66186711|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
23672960|NCT00708500|66186712|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
23672961|NCT00708500|66186713|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
23672962|NCT00708500|66186711|FG000|FOLLOWUP|Subject withdrew consent|31|||
23672963|NCT00708500|66186712|FG001|FOLLOWUP|Subject withdrew consent|4|||
23672964|NCT00708500|66186713|FG002|FOLLOWUP|Subject withdrew consent|5|||
23672965|NCT00708500|66186711|FG000|FOLLOWUP|Non-compliance with protocol|5|||
23672966|NCT00708500|66186712|FG001|FOLLOWUP|Non-compliance with protocol|0|||
23672967|NCT00708500|66186713|FG002|FOLLOWUP|Non-compliance with protocol|1|||
23672968|NCT00749996|66186718|FG000|Overall Study|Lost to Follow-up|7|||
23672969|NCT00749996|66186719|FG001|Overall Study|Lost to Follow-up|4|||
23672970|NCT00749996|66186718|FG000|Overall Study|Withdrawal by Subject|5|||
23672971|NCT00749996|66186719|FG001|Overall Study|Withdrawal by Subject|4|||
23672972|NCT00749996|66186718|FG000|Overall Study|Protocol Violation|2|||
23672973|NCT00749996|66186719|FG001|Overall Study|Protocol Violation|3|||
23672974|NCT00749996|66186718|FG000|Overall Study|Physician Decision|2|||
23672975|NCT00749996|66186719|FG001|Overall Study|Physician Decision|0|||
23672976|NCT00749996|66186718|FG000|Overall Study|Pregnancy|0|||
23672977|NCT00749996|66186719|FG001|Overall Study|Pregnancy|2|||
23672978|NCT00749996|66186718|FG000|Overall Study|Adverse Event|1|||
23672979|NCT00749996|66186719|FG001|Overall Study|Adverse Event|0|||
23672980|NCT00749996|66186718|FG000|Overall Study|Death|1|||
23672981|NCT00749996|66186719|FG001|Overall Study|Death|0|||
23672982|NCT01844895|66186720|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
23672983|NCT01844895|66186720|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
23672984|NCT01844895|66186720|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
23672985|NCT01844895|66186720|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
23672986|NCT01844895|66186720|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
23672987|NCT01844895|66186720|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
23672988|NCT01844895|66186720|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
23672989|NCT00291551|66186721|FG000|Overall Study|Death|7|||
23672990|NCT00291551|66186721|FG000|Overall Study|Withdrawal by Subject|6|||
23672991|NCT01394939|66186722|FG000|Overall Study|Adverse Event|1|||
23672992|NCT01394939|66186723|FG001|Overall Study|Adverse Event|3|||
23672993|NCT01394939|66186724|FG002|Overall Study|Adverse Event|0|||
23672994|NCT01394939|66186725|FG003|Overall Study|Adverse Event|2|||
23672995|NCT01394939|66186722|FG000|Overall Study|Death|0|||
23672996|NCT01394939|66186723|FG001|Overall Study|Death|2|||
23672997|NCT01394939|66186724|FG002|Overall Study|Death|0|||
23672998|NCT01394939|66186725|FG003|Overall Study|Death|0|||
23672999|NCT01394939|66186722|FG000|Overall Study|Physician Decision|0|||
23673000|NCT01394939|66186723|FG001|Overall Study|Physician Decision|1|||
23673001|NCT01394939|66186724|FG002|Overall Study|Physician Decision|0|||
23673002|NCT01394939|66186725|FG003|Overall Study|Physician Decision|0|||
23673003|NCT01394939|66186722|FG000|Overall Study|Withdrawal by Subject|0|||
23673004|NCT01394939|66186723|FG001|Overall Study|Withdrawal by Subject|2|||
23673005|NCT01394939|66186724|FG002|Overall Study|Withdrawal by Subject|0|||
23673006|NCT01394939|66186725|FG003|Overall Study|Withdrawal by Subject|2|||
23673007|NCT01394939|66186722|FG000|Overall Study|Others|0|||
23673008|NCT01394939|66186723|FG001|Overall Study|Others|2|||
23673009|NCT01394939|66186724|FG002|Overall Study|Others|0|||
23673010|NCT01394939|66186725|FG003|Overall Study|Others|3|||
23673011|NCT01543087|66186726|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
23673012|NCT01543087|66186727|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
23673013|NCT01543087|66186728|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
23673014|NCT01543087|66186729|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
23673015|NCT01543087|66186730|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
23673016|NCT01543087|66186731|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
23673017|NCT01543087|66186726|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
23673018|NCT01543087|66186727|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23673019|NCT01543087|66186728|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
23493284|NCT01752985|65551434|FG001|Treatment Period|Subject no longer meets study criteria|1|||
23673020|NCT01543087|66186729|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
23673021|NCT01543087|66186730|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23673022|NCT01543087|66186731|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23673023|NCT01543087|66186726|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
23673024|NCT01543087|66186727|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
23673025|NCT01543087|66186728|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
23673026|NCT01543087|66186729|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
23673027|NCT01543087|66186730|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
23673028|NCT01543087|66186731|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
23673029|NCT01543087|66186726|FG000|Stage 1 (48 Months)|Other than specified|5|||
23673030|NCT01543087|66186727|FG001|Stage 1 (48 Months)|Other than specified|0|||
23673031|NCT01543087|66186728|FG002|Stage 1 (48 Months)|Other than specified|9|||
23673032|NCT01543087|66186729|FG003|Stage 1 (48 Months)|Other than specified|0|||
23673033|NCT01543087|66186730|FG004|Stage 1 (48 Months)|Other than specified|0|||
23673034|NCT01543087|66186731|FG005|Stage 1 (48 Months)|Other than specified|0|||
23673035|NCT01543087|66186726|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
23673036|NCT01543087|66186727|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
23673037|NCT01543087|66186728|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
23673038|NCT01543087|66186729|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
23673039|NCT01543087|66186730|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
23673040|NCT01543087|66186731|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
23673041|NCT01543087|66186726|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23673042|NCT01543087|66186727|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
23673043|NCT01543087|66186728|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23673044|NCT01543087|66186729|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23673045|NCT01543087|66186730|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
23673046|NCT01543087|66186731|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23673047|NCT01543087|66186726|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
23673048|NCT01543087|66186727|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
23673049|NCT01543087|66186728|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
23673050|NCT01543087|66186729|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
23673051|NCT01543087|66186730|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
23673052|NCT01543087|66186731|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
23673053|NCT04081363|66186732|FG000|Overall Study|Withdrawal by Subject|1|||
23673054|NCT04081363|66186733|FG001|Overall Study|Withdrawal by Subject|0|||
23673055|NCT03728309|66186734|FG000|Overall Study|Randomized but not Treated|0|||
23673056|NCT03728309|66186735|FG001|Overall Study|Randomized but not Treated|1|||
23673057|NCT03728309|66186734|FG000|Overall Study|Adverse Event|0|||
23673058|NCT03728309|66186735|FG001|Overall Study|Adverse Event|1|||
23673059|NCT03728309|66186734|FG000|Overall Study|Withdrawal by Subject|2|||
23673060|NCT03728309|66186735|FG001|Overall Study|Withdrawal by Subject|8|||
23673061|NCT03728309|66186734|FG000|Overall Study|Lost to Follow-up|9|||
23673062|NCT03728309|66186735|FG001|Overall Study|Lost to Follow-up|10|||
23673063|NCT03728309|66186734|FG000|Overall Study|Protocol Deviation|0|||
23673064|NCT03728309|66186735|FG001|Overall Study|Protocol Deviation|1|||
23673065|NCT03728309|66186734|FG000|Overall Study|Due to COVID|1|||
23673066|NCT03728309|66186735|FG001|Overall Study|Due to COVID|3|||
23673067|NCT01678144|66186744|FG000|Stage 1: MAR Classic|Adverse Event|1|||
23673068|NCT00356278|66186745|FG000|Overall Study|Withdrawal by Subject|25|||
23673069|NCT00356278|66186746|FG001|Overall Study|Withdrawal by Subject|15|||
23673070|NCT00356278|66186747|FG002|Overall Study|Withdrawal by Subject|19|||
23673071|NCT01290692|66186752|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
23673072|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
23673073|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
23673074|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23673075|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23673076|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23673077|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
23673078|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
23673079|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23673080|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23673081|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23673082|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
23673083|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
23673084|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23673085|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23673086|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23673087|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
23673088|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
23673089|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23673090|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23673091|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23673092|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
23673093|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
23673094|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23673095|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23673096|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23673097|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
23673098|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
23673099|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23673100|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23673101|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23673102|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
23673103|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
23673104|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23673105|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23673106|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23673107|NCT02831673|66186753|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
23673108|NCT02831673|66186754|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
23673109|NCT02831673|66186755|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23673110|NCT02831673|66186756|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23673111|NCT02831673|66186757|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23673112|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23673113|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23673114|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
23673115|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
23673116|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23673117|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23673118|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23673119|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
23673120|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
23673121|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23673122|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23673123|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23673124|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23673125|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
23673126|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23673127|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23673128|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23673129|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
23673130|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
23673131|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23673132|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23673133|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23673134|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
23673135|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
23673136|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23673137|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23673138|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23673139|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
23673140|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
23673141|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23673142|NCT02831673|66186753|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23673143|NCT02831673|66186754|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23673144|NCT02831673|66186755|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
23673145|NCT02831673|66186756|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
23673146|NCT02831673|66186757|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23673147|NCT02831673|66186753|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23673148|NCT02831673|66186754|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23673149|NCT02831673|66186755|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23673150|NCT02831673|66186756|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23673151|NCT02831673|66186757|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
23673152|NCT02831673|66186753|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23673153|NCT02831673|66186754|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23673154|NCT02831673|66186755|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23673155|NCT02831673|66186756|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23673156|NCT02831673|66186757|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
23673157|NCT02831673|66186753|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23673158|NCT02831673|66186754|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23673159|NCT02831673|66186755|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23673160|NCT02831673|66186756|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23673161|NCT02831673|66186757|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
23673162|NCT02831673|66186753|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23673163|NCT02831673|66186754|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23673164|NCT02831673|66186755|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23673165|NCT02831673|66186756|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23673166|NCT02831673|66186757|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
23673167|NCT02831673|66186753|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23673168|NCT02831673|66186754|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23673169|NCT02831673|66186755|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23673170|NCT02831673|66186756|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23673171|NCT02831673|66186757|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
23673172|NCT00841763|66186762|FG000|Overall Study|Withdrawal by Subject|60|||
23673173|NCT00841763|66186763|FG001|Overall Study|Withdrawal by Subject|17|||
23673174|NCT00841763|66186764|FG002|Overall Study|Withdrawal by Subject|4|||
23673175|NCT00841763|66186765|FG003|Overall Study|Withdrawal by Subject|1|||
23673176|NCT00841763|66186762|FG000|Overall Study|Adverse Event|9|||
23673177|NCT00841763|66186763|FG001|Overall Study|Adverse Event|10|||
23673178|NCT00841763|66186764|FG002|Overall Study|Adverse Event|3|||
23673179|NCT00841763|66186765|FG003|Overall Study|Adverse Event|2|||
23386114|NCT01666652|65158567|FG002|Overall Study|Withdrawal by Subject|0|||
23386115|NCT01666652|65158568|FG003|Overall Study|Withdrawal by Subject|0|||
23386116|NCT01666652|65158569|FG004|Overall Study|Withdrawal by Subject|1|||
23386117|NCT01666652|65158565|FG000|Overall Study|Moved from study area|1|||
23386118|NCT01666652|65158566|FG001|Overall Study|Moved from study area|0|||
23386119|NCT01666652|65158567|FG002|Overall Study|Moved from study area|0|||
23386120|NCT01666652|65158568|FG003|Overall Study|Moved from study area|2|||
23386121|NCT01666652|65158569|FG004|Overall Study|Moved from study area|0|||
23386122|NCT01666652|65158565|FG000|Overall Study|Lost to Follow-up|1|||
23386123|NCT01666652|65158566|FG001|Overall Study|Lost to Follow-up|1|||
23386124|NCT01666652|65158567|FG002|Overall Study|Lost to Follow-up|1|||
23386125|NCT01666652|65158568|FG003|Overall Study|Lost to Follow-up|1|||
23386126|NCT01666652|65158569|FG004|Overall Study|Lost to Follow-up|0|||
23386127|NCT03073109|65158572|FG000|Overall Study|Adverse Event|0|||
23386128|NCT03073109|65158573|FG001|Overall Study|Adverse Event|1|||
23386129|NCT03073109|65158572|FG000|Overall Study|Other|2|||
23493285|NCT01752985|65551435|FG002|Treatment Period|Subject no longer meets study criteria|1|||
23493286|NCT01752985|65551433|FG000|Treatment Period|Adverse Event|2|||
23493287|NCT01752985|65551434|FG001|Treatment Period|Adverse Event|1|||
23493288|NCT01752985|65551435|FG002|Treatment Period|Adverse Event|2|||
23493289|NCT01752985|65551433|FG000|Treatment Period|Withdrawal by Subject|1|||
23493290|NCT01752985|65551434|FG001|Treatment Period|Withdrawal by Subject|1|||
23493291|NCT01752985|65551435|FG002|Treatment Period|Withdrawal by Subject|0|||
23493292|NCT01752985|65551433|FG000|Treatment Period|Lost to Follow-up|0|||
23493293|NCT01752985|65551434|FG001|Treatment Period|Lost to Follow-up|0|||
23493294|NCT01752985|65551435|FG002|Treatment Period|Lost to Follow-up|1|||
23493295|NCT01328431|65551439|FG000|Baseline|Protocol Violation|0|||
23493296|NCT01328431|65551440|FG001|Baseline|Protocol Violation|2|||
23493297|NCT01328431|65551439|FG000|1 Month (1M)|Lost to Follow-up|55|||
23673180|NCT00841763|66186762|FG000|Overall Study|Lost to Follow-up|63|||
23493298|NCT01328431|65551440|FG001|1 Month (1M)|Lost to Follow-up|58|||
23673181|NCT00841763|66186763|FG001|Overall Study|Lost to Follow-up|25|||
23386130|NCT03073109|65158573|FG001|Overall Study|Other|0|||
23386131|NCT03073109|65158572|FG000|Overall Study|Lost to Follow-up|8|||
23386132|NCT03073109|65158573|FG001|Overall Study|Lost to Follow-up|1|||
23493299|NCT01328431|65551439|FG000|3 Month (3M)|Death|2|||
23493300|NCT01328431|65551440|FG001|3 Month (3M)|Death|2|||
23386133|NCT02369159|65158576|FG000|Overall Study|Adverse Event|0|||
23493301|NCT01328431|65551439|FG000|3 Month (3M)|Lost to Follow-up|75|||
23673182|NCT00841763|66186764|FG002|Overall Study|Lost to Follow-up|0|||
23386134|NCT02369159|65158577|FG001|Overall Study|Adverse Event|1|||
23386135|NCT02369159|65158576|FG000|Overall Study|Lost to Follow-up|1|||
23386136|NCT02369159|65158577|FG001|Overall Study|Lost to Follow-up|1|||
23386137|NCT02369159|65158576|FG000|Overall Study|Withdrawal by Subject|7|||
23386138|NCT02369159|65158577|FG001|Overall Study|Withdrawal by Subject|0|||
23386139|NCT01166945|65158578|FG000|Randomized|diagnosed with Group A strep|4|||
23386140|NCT01166945|65158579|FG001|Randomized|diagnosed with Group A strep|4|||
23386141|NCT01166945|65158578|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
23386142|NCT01166945|65158579|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
23386143|NCT01166945|65158578|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
23386144|NCT01166945|65158579|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
23386145|NCT01166945|65158578|FG000|Day 30|Lost to Follow-up|4|||
23386146|NCT01166945|65158579|FG001|Day 30|Lost to Follow-up|3|||
23386147|NCT03473301|65158580|FG000|Overall Study|Protocol Violation|4|||
23386148|NCT03473301|65158581|FG001|Overall Study|Protocol Violation|0|||
23386149|NCT03473301|65158582|FG002|Overall Study|Protocol Violation|0|||
23386150|NCT03473301|65158580|FG000|Overall Study|Withdrawal by Subject|0|||
23386151|NCT03473301|65158581|FG001|Overall Study|Withdrawal by Subject|1|||
23386152|NCT03473301|65158582|FG002|Overall Study|Withdrawal by Subject|0|||
23386153|NCT03473301|65158580|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
23386154|NCT03473301|65158581|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
23386155|NCT03473301|65158582|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
23386156|NCT02391584|65158583|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
23386157|NCT02391584|65158584|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
23386158|NCT02391584|65158583|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
23386159|NCT02391584|65158584|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
23386160|NCT02391584|65158583|FG000|3 Month|Lost to Follow-up|1|||
23386161|NCT02391584|65158584|FG001|3 Month|Lost to Follow-up|0|||
23386162|NCT02391584|65158583|FG000|6 Month|Withdrawal by Subject|1|||
23386163|NCT02391584|65158584|FG001|6 Month|Withdrawal by Subject|0|||
23386164|NCT02391584|65158583|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
23386165|NCT02391584|65158584|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
23386166|NCT01089543|65158585|FG000|Overall Study|Withdrawal by Subject|2|||
23386167|NCT01089543|65158586|FG001|Overall Study|Withdrawal by Subject|3|||
23386168|NCT01089543|65158587|FG002|Overall Study|Withdrawal by Subject|3|||
23386169|NCT01089543|65158588|FG003|Overall Study|Withdrawal by Subject|1|||
23386170|NCT01089543|65158585|FG000|Overall Study|Physician Decision|1|||
23386171|NCT01089543|65158586|FG001|Overall Study|Physician Decision|0|||
23386172|NCT01089543|65158587|FG002|Overall Study|Physician Decision|0|||
23386173|NCT01089543|65158588|FG003|Overall Study|Physician Decision|1|||
23386174|NCT01089543|65158585|FG000|Overall Study|Adverse Event|0|||
23386175|NCT01089543|65158586|FG001|Overall Study|Adverse Event|1|||
23386176|NCT01089543|65158587|FG002|Overall Study|Adverse Event|0|||
23386177|NCT01089543|65158588|FG003|Overall Study|Adverse Event|0|||
23386178|NCT00376506|65158589|FG000|Overall Study|Death|0|||
23386179|NCT00376506|65158590|FG001|Overall Study|Death|2|||
23673183|NCT00841763|66186765|FG003|Overall Study|Lost to Follow-up|0|||
23673184|NCT00841763|66186762|FG000|Overall Study|Protocol Violation|20|||
23673185|NCT00841763|66186763|FG001|Overall Study|Protocol Violation|3|||
23673186|NCT00841763|66186764|FG002|Overall Study|Protocol Violation|1|||
23386180|NCT03520569|65158591|FG000|Overall Study|Withdrawal by Subject|1|||
23386181|NCT03760068|65158592|FG000|Overall Study|Withdrawal by Subject|7|||
23673187|NCT00841763|66186765|FG003|Overall Study|Protocol Violation|0|||
23673188|NCT00841763|66186762|FG000|Overall Study|Administrative Reasons|3|||
23673189|NCT00841763|66186763|FG001|Overall Study|Administrative Reasons|1|||
23673190|NCT00841763|66186764|FG002|Overall Study|Administrative Reasons|0|||
23673191|NCT00841763|66186765|FG003|Overall Study|Administrative Reasons|0|||
23673192|NCT00841763|66186762|FG000|Overall Study|Unable to Classify|7|||
23673193|NCT00841763|66186763|FG001|Overall Study|Unable to Classify|1|||
23386182|NCT03760068|65158593|FG001|Overall Study|Withdrawal by Subject|8|||
23386183|NCT03760068|65158592|FG000|Overall Study|Adverse Event|1|||
23386184|NCT03760068|65158593|FG001|Overall Study|Adverse Event|2|||
23386185|NCT03760068|65158592|FG000|Overall Study|Administrative Decision by Sponsor|0|||
23386186|NCT03760068|65158593|FG001|Overall Study|Administrative Decision by Sponsor|2|||
23386187|NCT03760068|65158592|FG000|Overall Study|Physician Decision|1|||
23386188|NCT03760068|65158593|FG001|Overall Study|Physician Decision|2|||
23673194|NCT00841763|66186764|FG002|Overall Study|Unable to Classify|0|||
23673195|NCT00841763|66186765|FG003|Overall Study|Unable to Classify|0|||
23673196|NCT01834729|66186768|FG000|Overall Study|Did not return bowel diaries|0|||
23673197|NCT01834729|66186769|FG001|Overall Study|Did not return bowel diaries|0|||
23673198|NCT01834729|66186770|FG002|Overall Study|Did not return bowel diaries|3|||
23673199|NCT01834729|66186771|FG003|Overall Study|Did not return bowel diaries|0|||
23673200|NCT01834729|66186768|FG000|Overall Study|Withdrawal by Subject|1|||
23673201|NCT01834729|66186769|FG001|Overall Study|Withdrawal by Subject|1|||
23673202|NCT01834729|66186770|FG002|Overall Study|Withdrawal by Subject|0|||
23673203|NCT01834729|66186771|FG003|Overall Study|Withdrawal by Subject|0|||
23673204|NCT01834729|66186768|FG000|Overall Study|Adverse Event|0|||
23673205|NCT01834729|66186769|FG001|Overall Study|Adverse Event|0|||
23673206|NCT01834729|66186770|FG002|Overall Study|Adverse Event|0|||
23673207|NCT01834729|66186771|FG003|Overall Study|Adverse Event|2|||
23673208|NCT00209339|66186772|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
23673209|NCT00209339|66186772|FG000|At 12 Months Follow-up|Death|1|||
23673210|NCT00209339|66186772|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
23673211|NCT00209339|66186772|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
23673212|NCT00209339|66186772|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
23673213|NCT00209339|66186772|FG000|At 24 Months Follow-up|Death|1|||
23673214|NCT00209339|66186772|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
23673215|NCT00209339|66186772|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
23673216|NCT00209339|66186772|FG000|At 4 Years Follow-up|Death|1|||
23673217|NCT00209339|66186772|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
23673218|NCT00209339|66186772|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
23673219|NCT00209339|66186772|FG000|At 5 Years Follow-up|Death|1|||
23673220|NCT01294800|66186773|FG000|Overall Study|Adverse Event|7|||
23673221|NCT01294800|66186774|FG001|Overall Study|Adverse Event|6|||
23673222|NCT01294800|66186775|FG002|Overall Study|Adverse Event|12|||
23673223|NCT01294800|66186776|FG003|Overall Study|Adverse Event|5|||
23673224|NCT01294800|66186773|FG000|Overall Study|Subject Withdrew Consent|2|||
23673225|NCT01294800|66186774|FG001|Overall Study|Subject Withdrew Consent|2|||
23673226|NCT01294800|66186775|FG002|Overall Study|Subject Withdrew Consent|2|||
23673227|NCT01294800|66186776|FG003|Overall Study|Subject Withdrew Consent|11|||
23673228|NCT01294800|66186773|FG000|Overall Study|Lost to Follow-up|0|||
23673229|NCT01294800|66186774|FG001|Overall Study|Lost to Follow-up|0|||
23673230|NCT01294800|66186775|FG002|Overall Study|Lost to Follow-up|1|||
23673231|NCT01294800|66186776|FG003|Overall Study|Lost to Follow-up|0|||
23673232|NCT01294800|66186773|FG000|Overall Study|Non-compliance With Protocol|0|||
23673233|NCT01294800|66186774|FG001|Overall Study|Non-compliance With Protocol|1|||
23673234|NCT01294800|66186775|FG002|Overall Study|Non-compliance With Protocol|1|||
23673235|NCT01294800|66186776|FG003|Overall Study|Non-compliance With Protocol|0|||
23673236|NCT01294800|66186773|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
23673237|NCT01294800|66186774|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23673238|NCT01294800|66186775|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
23673239|NCT01294800|66186776|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
23673240|NCT00880893|66186779|FG000|Overall Study|Protocol Violation|13|||
23673241|NCT00880893|66186780|FG001|Overall Study|Protocol Violation|1|||
23673242|NCT00880893|66186779|FG000|Overall Study|Withdrawal by Subject|15|||
23673243|NCT00880893|66186780|FG001|Overall Study|Withdrawal by Subject|11|||
23673244|NCT00880893|66186779|FG000|Overall Study|Lost to Follow-up|76|||
23673245|NCT00880893|66186780|FG001|Overall Study|Lost to Follow-up|33|||
23673246|NCT00880893|66186779|FG000|Overall Study|Serious adverse event|3|||
23673247|NCT00880893|66186780|FG001|Overall Study|Serious adverse event|0|||
23673248|NCT03047980|66186781|FG000|Overall Study|Adverse Event|1|||
23673249|NCT00606086|66186782|FG000|Overall Study|Adverse Event|1|||
23673250|NCT00606086|66186783|FG001|Overall Study|Adverse Event|1|||
23673251|NCT00606086|66186782|FG000|Overall Study|Lost to Follow-up|4|||
23673252|NCT00606086|66186783|FG001|Overall Study|Lost to Follow-up|8|||
23673253|NCT00606086|66186782|FG000|Overall Study|Protocol Violation|1|||
23673254|NCT00606086|66186783|FG001|Overall Study|Protocol Violation|0|||
23673255|NCT00606086|66186782|FG000|Overall Study|Withdrawal by Subject|5|||
23673256|NCT00606086|66186783|FG001|Overall Study|Withdrawal by Subject|3|||
23673257|NCT00606086|66186782|FG000|Overall Study|Non-compliance|0|||
23673258|NCT00606086|66186783|FG001|Overall Study|Non-compliance|1|||
23673259|NCT00606086|66186782|FG000|Overall Study|Randomized, not treated|1|||
23673260|NCT00606086|66186783|FG001|Overall Study|Randomized, not treated|2|||
23673261|NCT01587079|66186784|FG000|Overall Study|Protocol-specified criteria|9|||
23673262|NCT01587079|66186784|FG000|Overall Study|Protocol Violation|5|||
23673263|NCT01587079|66186784|FG000|Overall Study|Lost to Follow-up|2|||
23673264|NCT01587079|66186784|FG000|Overall Study|Physician Decision|2|||
23673265|NCT01587079|66186784|FG000|Overall Study|Withdrawal by Subject|7|||
23673266|NCT01587079|66186784|FG000|Overall Study|Adverse Event|14|||
23673267|NCT00132132|66186785|FG000|Overall Study|Lost to Follow-up|7|||
23673268|NCT00132132|66186786|FG001|Overall Study|Lost to Follow-up|2|||
23673269|NCT00999908|66186787|FG000|Treatment Period 1|Subject withdrew consent|2|||
23673270|NCT00999908|66186788|FG001|Treatment Period 1|Subject withdrew consent|0|||
23673271|NCT00999908|66186789|FG002|Treatment Period 1|Subject withdrew consent|0|||
23673272|NCT00999908|66186787|FG000|Treatment Period 2|Protocol Violation|1|||
23673273|NCT00999908|66186788|FG001|Treatment Period 2|Protocol Violation|0|||
23673274|NCT00999908|66186789|FG002|Treatment Period 2|Protocol Violation|0|||
23673275|NCT00326898|66186790|FG000|Overall Study|Disease progression|52|||
23673276|NCT00326898|66186791|FG001|Overall Study|Disease progression|54|||
23673277|NCT00326898|66186792|FG002|Overall Study|Disease progression|102|||
23673278|NCT00326898|66186790|FG000|Overall Study|Adverse Event|124|||
23673279|NCT00326898|66186791|FG001|Overall Study|Adverse Event|128|||
23673280|NCT00326898|66186792|FG002|Overall Study|Adverse Event|33|||
23673281|NCT00326898|66186790|FG000|Overall Study|Death|2|||
23673282|NCT00326898|66186791|FG001|Overall Study|Death|0|||
23673283|NCT00326898|66186792|FG002|Overall Study|Death|0|||
23673284|NCT00326898|66186790|FG000|Overall Study|Withdrawal by Subject|134|||
23386189|NCT03760068|65158592|FG000|Overall Study|Lost to Follow-up|4|||
23386190|NCT03760068|65158593|FG001|Overall Study|Lost to Follow-up|9|||
23386191|NCT03760068|65158592|FG000|Overall Study|Subject Moved Out of State|1|||
23386192|NCT03760068|65158593|FG001|Overall Study|Subject Moved Out of State|0|||
23386193|NCT01560988|65158594|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
23386194|NCT01560988|65158595|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
23386195|NCT01560988|65158594|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
23386196|NCT01560988|65158595|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
23386197|NCT01560988|65158594|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
23386198|NCT01560988|65158595|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
23386199|NCT03364686|65158600|FG000|Overall Study|Physician Decision|2|||
23386200|NCT01696214|65158603|FG000|Overall Study|Lost to Follow-up|1|||
23386201|NCT01696214|65158604|FG001|Overall Study|Lost to Follow-up|0|||
23386202|NCT01696214|65158605|FG002|Overall Study|Lost to Follow-up|0|||
23386203|NCT01696214|65158606|FG003|Overall Study|Lost to Follow-up|0|||
23386204|NCT04091438|65158607|FG000|Treatment Period 1 (1 Day)|Other|1|||
23386205|NCT04091438|65158608|FG001|Treatment Period 1 (1 Day)|Other|0|||
23386206|NCT04091438|65158607|FG000|Washout Period (1 Day)|Protocol deviation|0|||
23386207|NCT04091438|65158608|FG001|Washout Period (1 Day)|Protocol deviation|1|||
23386208|NCT04091438|65158607|FG000|Washout Period (1 Day)|Other|0|||
23673285|NCT00326898|66186791|FG001|Overall Study|Withdrawal by Subject|128|||
23673286|NCT00326898|66186792|FG002|Overall Study|Withdrawal by Subject|32|||
23673287|NCT00326898|66186790|FG000|Overall Study|Alternative therapy|1|||
23673288|NCT00326898|66186791|FG001|Overall Study|Alternative therapy|0|||
23673289|NCT00326898|66186792|FG002|Overall Study|Alternative therapy|0|||
23673290|NCT00326898|66186790|FG000|Overall Study|Other complicating disease|5|||
23673291|NCT00326898|66186791|FG001|Overall Study|Other complicating disease|5|||
23673292|NCT00326898|66186792|FG002|Overall Study|Other complicating disease|4|||
23673293|NCT00326898|66186790|FG000|Overall Study|Other/Missing/Unknown|33|||
23673294|NCT00326898|66186791|FG001|Overall Study|Other/Missing/Unknown|28|||
23673295|NCT00326898|66186792|FG002|Overall Study|Other/Missing/Unknown|32|||
23673296|NCT00272038|66186793|FG000|Overall Study|withdrew before they received 2 cycles|7|||
23673297|NCT03988907|66186795|FG000|Overall Study|Unable to complete visit|0|||
23673298|NCT03988907|66186796|FG001|Overall Study|Unable to complete visit|1|||
23673299|NCT03310970|66186797|FG000|Overall Study|Withdrawal by Subject|0|||
23673300|NCT03310970|66186798|FG001|Overall Study|Withdrawal by Subject|1|||
23673301|NCT01324232|66186799|FG000|Overall Study|Protocol Violation|0|||
23673302|NCT01324232|66186800|FG001|Overall Study|Protocol Violation|0|||
23673303|NCT01324232|66186801|FG002|Overall Study|Protocol Violation|0|||
23673304|NCT01324232|66186802|FG003|Overall Study|Protocol Violation|2|||
23673305|NCT01324232|66186799|FG000|Overall Study|Missing|0|||
23673306|NCT01324232|66186800|FG001|Overall Study|Missing|0|||
23673307|NCT01324232|66186801|FG002|Overall Study|Missing|1|||
23673308|NCT01324232|66186802|FG003|Overall Study|Missing|0|||
23673309|NCT01324232|66186799|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
23673310|NCT01324232|66186800|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
23673311|NCT01324232|66186801|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
23673312|NCT01324232|66186802|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
23673313|NCT01324232|66186799|FG000|Overall Study|Lack of Efficacy|2|||
23673314|NCT01324232|66186800|FG001|Overall Study|Lack of Efficacy|1|||
23673315|NCT01324232|66186801|FG002|Overall Study|Lack of Efficacy|2|||
23673316|NCT01324232|66186802|FG003|Overall Study|Lack of Efficacy|2|||
23673317|NCT01324232|66186799|FG000|Overall Study|Participant Refused Medication|0|||
23673318|NCT01324232|66186800|FG001|Overall Study|Participant Refused Medication|1|||
23673319|NCT01324232|66186801|FG002|Overall Study|Participant Refused Medication|0|||
23673320|NCT01324232|66186802|FG003|Overall Study|Participant Refused Medication|0|||
23673321|NCT01324232|66186799|FG000|Overall Study|Intercurrent illness|0|||
23673322|NCT01324232|66186800|FG001|Overall Study|Intercurrent illness|0|||
23673323|NCT01324232|66186801|FG002|Overall Study|Intercurrent illness|0|||
23673324|NCT01324232|66186802|FG003|Overall Study|Intercurrent illness|1|||
23673325|NCT01324232|66186799|FG000|Overall Study|Adverse Event|2|||
23673326|NCT01324232|66186800|FG001|Overall Study|Adverse Event|5|||
23673327|NCT01324232|66186801|FG002|Overall Study|Adverse Event|6|||
23673328|NCT01324232|66186802|FG003|Overall Study|Adverse Event|6|||
23673329|NCT01324232|66186799|FG000|Overall Study|Withdrawal by Subject|0|||
23673330|NCT01324232|66186800|FG001|Overall Study|Withdrawal by Subject|3|||
23673331|NCT01324232|66186801|FG002|Overall Study|Withdrawal by Subject|4|||
23673332|NCT01324232|66186802|FG003|Overall Study|Withdrawal by Subject|0|||
23673333|NCT01324232|66186799|FG000|Overall Study|Lost to Follow-up|1|||
23673334|NCT01324232|66186800|FG001|Overall Study|Lost to Follow-up|0|||
23673335|NCT01324232|66186801|FG002|Overall Study|Lost to Follow-up|0|||
23673336|NCT01324232|66186802|FG003|Overall Study|Lost to Follow-up|0|||
23673337|NCT00288080|66186803|FG000|Overall Study|Withdrawal by Subject|1|||
23673338|NCT00288080|66186804|FG001|Overall Study|Withdrawal by Subject|3|||
23673339|NCT00288080|66186803|FG000|Overall Study|Protocol Violation|25|||
23673340|NCT00288080|66186804|FG001|Overall Study|Protocol Violation|20|||
23673341|NCT02229552|66186807|FG000|Baseline|Withdrawal by Subject|6|||
23673342|NCT02229552|66186807|FG000|1-year Follow up|Withdrawal by Subject|7|||
23673343|NCT02229552|66186807|FG000|1-year Follow up|Lost to Follow-up|18|||
23673344|NCT02229552|66186807|FG000|2-Year Follow up|Withdrawal by Subject|9|||
23673345|NCT02229552|66186807|FG000|2-Year Follow up|Lost to Follow-up|17|||
23673346|NCT02678390|66186808|FG000|AE (1 Day)|Withdrawal by Subject|0|||
23673347|NCT02678390|66186809|FG001|AE (1 Day)|Withdrawal by Subject|1|||
23673348|NCT01890421|66186812|FG000|Overall Study|Adverse Event|1|||
23673349|NCT01890421|66186812|FG000|Overall Study|Other reason|10|||
23493302|NCT01328431|65551440|FG001|3 Month (3M)|Lost to Follow-up|70|||
23673350|NCT01632566|66186813|FG000|Overall Study|Withdrawal by Subject|0|||
23673351|NCT01632566|66186814|FG001|Overall Study|Withdrawal by Subject|1|||
23673352|NCT01632566|66186815|FG002|Overall Study|Withdrawal by Subject|0|||
23673353|NCT01632566|66186816|FG003|Overall Study|Withdrawal by Subject|0|||
23673354|NCT01632566|66186817|FG004|Overall Study|Withdrawal by Subject|0|||
23673355|NCT01632566|66186813|FG000|Overall Study|Sponsor Decision|0|||
23673356|NCT01632566|66186814|FG001|Overall Study|Sponsor Decision|2|||
23386209|NCT04091438|65158608|FG001|Washout Period (1 Day)|Other|1|||
23386210|NCT00924651|65158609|FG000|Overall Study|Chemo started too soon|2|||
23386211|NCT00924651|65158610|FG001|Overall Study|Chemo started too soon|3|||
23386212|NCT00924651|65158609|FG000|Overall Study|No Reason|3|||
23386213|NCT00924651|65158610|FG001|Overall Study|No Reason|7|||
23386214|NCT00924651|65158609|FG000|Overall Study|Overwhelmed|6|||
23386215|NCT00924651|65158610|FG001|Overall Study|Overwhelmed|6|||
23386216|NCT00924651|65158609|FG000|Overall Study|Noncompliant|1|||
23386217|NCT00924651|65158610|FG001|Overall Study|Noncompliant|4|||
23386218|NCT00924651|65158609|FG000|Overall Study|Medical|1|||
23386219|NCT00924651|65158610|FG001|Overall Study|Medical|3|||
23673357|NCT01632566|66186815|FG002|Overall Study|Sponsor Decision|9|||
23673358|NCT01632566|66186816|FG003|Overall Study|Sponsor Decision|2|||
23673359|NCT01632566|66186817|FG004|Overall Study|Sponsor Decision|2|||
23673360|NCT00371865|66186818|FG000|Overall Study|Lack of Efficacy|0|||
23673361|NCT00371865|66186819|FG001|Overall Study|Lack of Efficacy|2|||
23673362|NCT00371865|66186818|FG000|Overall Study|Protocol Violation|3|||
23673363|NCT00371865|66186819|FG001|Overall Study|Protocol Violation|2|||
23673364|NCT00371865|66186818|FG000|Overall Study|Withdrawal by Subject|12|||
23673365|NCT00371865|66186819|FG001|Overall Study|Withdrawal by Subject|10|||
23673366|NCT02175680|66186822|FG000|Overall Study|non-compliance|1|||
23673367|NCT02175680|66186822|FG000|Overall Study|other non-medical reason|1|||
23673368|NCT02104583|66186823|FG000|Overall Study|New ICD or CRT-D implanted|2|||
23673369|NCT02104583|66186824|FG001|Overall Study|New ICD or CRT-D implanted|0|||
23673370|NCT02104583|66186825|FG002|Overall Study|New ICD or CRT-D implanted|1|||
23673371|NCT02104583|66186826|FG003|Overall Study|New ICD or CRT-D implanted|0|||
23673372|NCT02104583|66186827|FG004|Overall Study|New ICD or CRT-D implanted|0|||
23673373|NCT02104583|66186823|FG000|Overall Study|Death|2|||
23673374|NCT02104583|66186824|FG001|Overall Study|Death|1|||
23673375|NCT02104583|66186825|FG002|Overall Study|Death|3|||
23673376|NCT02104583|66186826|FG003|Overall Study|Death|3|||
23673377|NCT02104583|66186827|FG004|Overall Study|Death|5|||
23673378|NCT02104583|66186823|FG000|Overall Study|Subject required cardiac ablation|6|||
23673379|NCT02104583|66186824|FG001|Overall Study|Subject required cardiac ablation|4|||
23673380|NCT02104583|66186825|FG002|Overall Study|Subject required cardiac ablation|4|||
23673381|NCT02104583|66186826|FG003|Overall Study|Subject required cardiac ablation|5|||
23386220|NCT00924651|65158609|FG000|Overall Study|Changed Mind|10|||
23386221|NCT00924651|65158610|FG001|Overall Study|Changed Mind|1|||
23386222|NCT00924651|65158609|FG000|Overall Study|Incomplete Form|2|||
23673382|NCT02104583|66186827|FG004|Overall Study|Subject required cardiac ablation|4|||
23673383|NCT02104583|66186823|FG000|Overall Study|Subject required prohibited medication|0|||
23673384|NCT02104583|66186824|FG001|Overall Study|Subject required prohibited medication|1|||
23673385|NCT02104583|66186825|FG002|Overall Study|Subject required prohibited medication|1|||
23673386|NCT02104583|66186826|FG003|Overall Study|Subject required prohibited medication|0|||
23673387|NCT02104583|66186827|FG004|Overall Study|Subject required prohibited medication|1|||
23673388|NCT02104583|66186823|FG000|Overall Study|Withdrew Consent|3|||
23386223|NCT00924651|65158610|FG001|Overall Study|Incomplete Form|1|||
23386224|NCT00800384|65158611|FG000|Overall Study|Withdrawal by Subject|24|||
23386225|NCT00800384|65158612|FG001|Overall Study|Withdrawal by Subject|17|||
23386226|NCT00800384|65158611|FG000|Overall Study|Lost to Follow-up|17|||
23386227|NCT00800384|65158612|FG001|Overall Study|Lost to Follow-up|26|||
23386228|NCT00899847|65158613|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
23386229|NCT00710554|65158615|FG000|Overall Study|Adverse Event|24|||
23386230|NCT00710554|65158616|FG001|Overall Study|Adverse Event|7|||
23386231|NCT00710554|65158615|FG000|Overall Study|Withdrawal by Subject|7|||
23386232|NCT00710554|65158616|FG001|Overall Study|Withdrawal by Subject|3|||
23386233|NCT00710554|65158615|FG000|Overall Study|Lost to Follow-up|7|||
23386234|NCT00710554|65158616|FG001|Overall Study|Lost to Follow-up|1|||
23386235|NCT00710554|65158615|FG000|Overall Study|Lack of Efficacy|11|||
23386236|NCT00710554|65158616|FG001|Overall Study|Lack of Efficacy|12|||
23386237|NCT00710554|65158615|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
23386238|NCT00710554|65158616|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
23386239|NCT01520714|65158617|FG000|Overall Study|Protocol Violation|0|||
23386240|NCT01520714|65158618|FG001|Overall Study|Protocol Violation|3|||
23386241|NCT01520714|65158617|FG000|Overall Study|Adverse Event|0|||
23386242|NCT01520714|65158618|FG001|Overall Study|Adverse Event|2|||
23386243|NCT01520714|65158617|FG000|Overall Study|Lack of Efficacy|0|||
23386244|NCT01520714|65158618|FG001|Overall Study|Lack of Efficacy|1|||
23386245|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23386246|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
23386247|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23386248|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
23386249|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
23386250|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
23386251|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
23386252|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23386253|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23386254|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
23386255|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23386256|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23386257|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23386258|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23386259|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
23386260|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
23386261|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
23386262|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
23386263|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
23386264|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
23386265|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
23386266|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
23386267|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
23386268|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
23386269|NCT03931785|65158622|FG000|Overall Study|Lost to Follow-up|4|||
23386270|NCT03931785|65158623|FG001|Overall Study|Lost to Follow-up|1|||
23386271|NCT03931785|65158624|FG002|Overall Study|Lost to Follow-up|4|||
23386272|NCT03931785|65158625|FG003|Overall Study|Lost to Follow-up|3|||
23386273|NCT03931785|65158622|FG000|Overall Study|Adverse Event|1|||
23386274|NCT03931785|65158623|FG001|Overall Study|Adverse Event|0|||
23386275|NCT03931785|65158624|FG002|Overall Study|Adverse Event|3|||
23386276|NCT03931785|65158625|FG003|Overall Study|Adverse Event|4|||
23386277|NCT03931785|65158622|FG000|Overall Study|Protocol Violation|0|||
23386278|NCT03931785|65158623|FG001|Overall Study|Protocol Violation|1|||
23386279|NCT03931785|65158624|FG002|Overall Study|Protocol Violation|0|||
23386280|NCT03931785|65158625|FG003|Overall Study|Protocol Violation|0|||
23386281|NCT03931785|65158622|FG000|Overall Study|Noncompliance With Study drug|0|||
23386282|NCT03931785|65158623|FG001|Overall Study|Noncompliance With Study drug|1|||
23386283|NCT03931785|65158624|FG002|Overall Study|Noncompliance With Study drug|0|||
23386284|NCT03931785|65158625|FG003|Overall Study|Noncompliance With Study drug|0|||
23386285|NCT03931785|65158622|FG000|Overall Study|Other Not specified|0|||
23386286|NCT03931785|65158623|FG001|Overall Study|Other Not specified|2|||
23386287|NCT03931785|65158624|FG002|Overall Study|Other Not specified|2|||
23386288|NCT03931785|65158625|FG003|Overall Study|Other Not specified|2|||
23493303|NCT01328431|65551439|FG000|12 Month (12M)|Death|2|||
23493304|NCT01328431|65551440|FG001|12 Month (12M)|Death|6|||
23386289|NCT03931785|65158622|FG000|Overall Study|Withdrawal by Subject|0|||
23386290|NCT03931785|65158623|FG001|Overall Study|Withdrawal by Subject|2|||
23493305|NCT01328431|65551439|FG000|12 Month (12M)|Lost to Follow-up|82|||
23493306|NCT01328431|65551440|FG001|12 Month (12M)|Lost to Follow-up|91|||
23386291|NCT03931785|65158624|FG002|Overall Study|Withdrawal by Subject|4|||
23386292|NCT03931785|65158625|FG003|Overall Study|Withdrawal by Subject|1|||
23386293|NCT03931785|65158622|FG000|Overall Study|Pregnancy|0|||
23386294|NCT03931785|65158623|FG001|Overall Study|Pregnancy|0|||
23386295|NCT03931785|65158624|FG002|Overall Study|Pregnancy|0|||
23386296|NCT03931785|65158625|FG003|Overall Study|Pregnancy|1|||
23386297|NCT02571244|65158626|FG000|Overall Study|Lost to Follow-up|0|||
23493307|NCT02180165|65551444|FG000|Overall Study|Not Treated|0|||
23673389|NCT02104583|66186824|FG001|Overall Study|Withdrew Consent|2|||
23673390|NCT02104583|66186825|FG002|Overall Study|Withdrew Consent|0|||
23673391|NCT02104583|66186826|FG003|Overall Study|Withdrew Consent|2|||
23673392|NCT02104583|66186827|FG004|Overall Study|Withdrew Consent|1|||
23673393|NCT02104583|66186823|FG000|Overall Study|Investigator's Discretion|1|||
23673394|NCT02104583|66186824|FG001|Overall Study|Investigator's Discretion|0|||
23673395|NCT02104583|66186825|FG002|Overall Study|Investigator's Discretion|0|||
23673396|NCT02104583|66186826|FG003|Overall Study|Investigator's Discretion|0|||
23673397|NCT02104583|66186827|FG004|Overall Study|Investigator's Discretion|0|||
23386298|NCT02571244|65158627|FG001|Overall Study|Lost to Follow-up|1|||
23386299|NCT02571244|65158626|FG000|Overall Study|Unable to reach out post discharge|3|||
23386300|NCT02571244|65158627|FG001|Overall Study|Unable to reach out post discharge|0|||
23386301|NCT01152385|65158630|FG000|Overall Study|Withdrawal by Subject|3|||
23386302|NCT01152385|65158631|FG001|Overall Study|Withdrawal by Subject|1|||
23386303|NCT01152385|65158632|FG002|Overall Study|Withdrawal by Subject|1|||
23386304|NCT01152385|65158633|FG003|Overall Study|Withdrawal by Subject|1|||
23386305|NCT01152385|65158630|FG000|Overall Study|Protocol Violation|0|||
23386306|NCT01152385|65158631|FG001|Overall Study|Protocol Violation|0|||
23386307|NCT01152385|65158632|FG002|Overall Study|Protocol Violation|0|||
23386308|NCT01152385|65158633|FG003|Overall Study|Protocol Violation|1|||
23386309|NCT01152385|65158630|FG000|Overall Study|Adverse Event|1|||
23386310|NCT01152385|65158631|FG001|Overall Study|Adverse Event|1|||
23673398|NCT02104583|66186823|FG000|Overall Study|Protocol Violation|0|||
23673399|NCT02104583|66186824|FG001|Overall Study|Protocol Violation|0|||
23673400|NCT02104583|66186825|FG002|Overall Study|Protocol Violation|1|||
23673401|NCT02104583|66186826|FG003|Overall Study|Protocol Violation|0|||
23673402|NCT02104583|66186827|FG004|Overall Study|Protocol Violation|0|||
23386311|NCT01152385|65158632|FG002|Overall Study|Adverse Event|0|||
23386312|NCT01152385|65158633|FG003|Overall Study|Adverse Event|0|||
23386313|NCT01152385|65158630|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23386314|NCT01152385|65158631|FG001|Overall Study|Study-specific withdrawal criteria|1|||
23386315|NCT01152385|65158632|FG002|Overall Study|Study-specific withdrawal criteria|2|||
23386316|NCT01152385|65158633|FG003|Overall Study|Study-specific withdrawal criteria|0|||
23386317|NCT01152385|65158630|FG000|Overall Study|Other|4|||
23386318|NCT01152385|65158631|FG001|Overall Study|Other|3|||
23386319|NCT01152385|65158632|FG002|Overall Study|Other|2|||
23386320|NCT01152385|65158633|FG003|Overall Study|Other|3|||
23386321|NCT00776997|65158634|FG000|Overall Study|Adverse Event|2|||
23386322|NCT02453191|65158635|FG000|Overall Study|Withdrawal by Subject|1|||
23386323|NCT03412890|65158638|FG000|Overall Study|Adverse Event|5|||
23386324|NCT03412890|65158639|FG001|Overall Study|Adverse Event|5|||
23386325|NCT03412890|65158640|FG002|Overall Study|Adverse Event|9|||
23386326|NCT03412890|65158638|FG000|Overall Study|Protocol deviation|2|||
23386327|NCT03412890|65158639|FG001|Overall Study|Protocol deviation|1|||
23386328|NCT03412890|65158640|FG002|Overall Study|Protocol deviation|2|||
23386329|NCT03412890|65158638|FG000|Overall Study|Lost to Follow-up|7|||
23386330|NCT03412890|65158639|FG001|Overall Study|Lost to Follow-up|10|||
23386331|NCT03412890|65158640|FG002|Overall Study|Lost to Follow-up|10|||
23386332|NCT03412890|65158638|FG000|Overall Study|Withdrawal by Subject|9|||
23386333|NCT03412890|65158639|FG001|Overall Study|Withdrawal by Subject|12|||
23386334|NCT03412890|65158640|FG002|Overall Study|Withdrawal by Subject|11|||
23386335|NCT03412890|65158638|FG000|Overall Study|Lack of Efficacy|2|||
23386336|NCT03412890|65158639|FG001|Overall Study|Lack of Efficacy|7|||
23386337|NCT03412890|65158640|FG002|Overall Study|Lack of Efficacy|5|||
23386338|NCT03412890|65158638|FG000|Overall Study|Other|5|||
23386339|NCT03412890|65158639|FG001|Overall Study|Other|6|||
23386340|NCT03412890|65158640|FG002|Overall Study|Other|5|||
23673403|NCT02104583|66186823|FG000|Overall Study|Adverse Event|3|||
23673404|NCT02104583|66186824|FG001|Overall Study|Adverse Event|3|||
23673405|NCT02104583|66186825|FG002|Overall Study|Adverse Event|6|||
23673406|NCT02104583|66186826|FG003|Overall Study|Adverse Event|6|||
23673407|NCT02104583|66186827|FG004|Overall Study|Adverse Event|1|||
23673408|NCT02104583|66186823|FG000|Overall Study|Lost to Follow-up|1|||
23386341|NCT03412890|65158638|FG000|Overall Study|Participants who did not receive any study drug|0|||
23386342|NCT03412890|65158639|FG001|Overall Study|Participants who did not receive any study drug|1|||
23386343|NCT03412890|65158640|FG002|Overall Study|Participants who did not receive any study drug|0|||
23386344|NCT01873833|65158641|FG000|Overall Study|Withdrawal by Subject|1|||
23386345|NCT00507507|65158642|FG000|Treatment Period|Lost to Follow-up|0|||
23673409|NCT02104583|66186824|FG001|Overall Study|Lost to Follow-up|0|||
23673410|NCT02104583|66186825|FG002|Overall Study|Lost to Follow-up|0|||
23386346|NCT00507507|65158643|FG001|Treatment Period|Lost to Follow-up|2|||
23386347|NCT00507507|65158642|FG000|Treatment Period|Physician Decision|4|||
23386348|NCT00507507|65158643|FG001|Treatment Period|Physician Decision|1|||
23386349|NCT00507507|65158642|FG000|Treatment Period|Protocol Violation|1|||
23673411|NCT02104583|66186826|FG003|Overall Study|Lost to Follow-up|0|||
23673412|NCT02104583|66186827|FG004|Overall Study|Lost to Follow-up|0|||
23673413|NCT02104583|66186823|FG000|Overall Study|Randomized but Never Treated|0|||
23673414|NCT02104583|66186824|FG001|Overall Study|Randomized but Never Treated|0|||
23673415|NCT02104583|66186825|FG002|Overall Study|Randomized but Never Treated|0|||
23673416|NCT02104583|66186826|FG003|Overall Study|Randomized but Never Treated|1|||
23673417|NCT02104583|66186827|FG004|Overall Study|Randomized but Never Treated|0|||
23673418|NCT02595450|66186828|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
23673419|NCT02595450|66186828|FG000|Overall Study|Enrolled, but not treated|8|||
23673420|NCT02867761|66186829|FG000|Overall Study|Participant withdrawn by investigator|0|||
23673421|NCT02867761|66186830|FG001|Overall Study|Participant withdrawn by investigator|1|||
23673422|NCT02867761|66186829|FG000|Overall Study|Lost to Follow-up|25|||
23673423|NCT02867761|66186830|FG001|Overall Study|Lost to Follow-up|18|||
23673424|NCT02867761|66186829|FG000|Overall Study|Unable to complete protocol|3|||
23673425|NCT02867761|66186830|FG001|Overall Study|Unable to complete protocol|7|||
23673426|NCT02415712|66186831|FG000|Overall Study|Protocol Violation|16|||
23673427|NCT00774345|66186834|FG000|Pre-treatment|Other reasons|2|||
23673428|NCT00774345|66186835|FG001|Pre-treatment|Other reasons|0|||
23673429|NCT00774345|66186834|FG000|Treatment|Adverse Event|61|||
23673430|NCT00774345|66186835|FG001|Treatment|Adverse Event|15|||
23386350|NCT00507507|65158643|FG001|Treatment Period|Protocol Violation|2|||
23386351|NCT00507507|65158642|FG000|Treatment Period|Adverse Event|1|||
23386352|NCT00507507|65158643|FG001|Treatment Period|Adverse Event|1|||
23386353|NCT00507507|65158642|FG000|Treatment Period|Withdrawal by Subject|46|||
23386354|NCT00507507|65158643|FG001|Treatment Period|Withdrawal by Subject|47|||
23386355|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
23386356|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
23493308|NCT02180165|65551445|FG001|Overall Study|Not Treated|0|||
23493309|NCT02180165|65551446|FG002|Overall Study|Not Treated|1|||
23493310|NCT02180165|65551447|FG003|Overall Study|Not Treated|0|||
23493311|NCT02180165|65551444|FG000|Overall Study|Adverse Event|7|||
23493312|NCT02180165|65551445|FG001|Overall Study|Adverse Event|0|||
23493313|NCT02180165|65551446|FG002|Overall Study|Adverse Event|18|||
23493314|NCT02180165|65551447|FG003|Overall Study|Adverse Event|3|||
23493315|NCT02180165|65551444|FG000|Overall Study|Lack of Efficacy|0|||
23493316|NCT02180165|65551445|FG001|Overall Study|Lack of Efficacy|1|||
23493317|NCT02180165|65551446|FG002|Overall Study|Lack of Efficacy|3|||
23493318|NCT02180165|65551447|FG003|Overall Study|Lack of Efficacy|2|||
23493319|NCT02180165|65551444|FG000|Overall Study|Physician Decision|1|||
23493320|NCT02180165|65551445|FG001|Overall Study|Physician Decision|0|||
23493321|NCT02180165|65551446|FG002|Overall Study|Physician Decision|5|||
23493322|NCT02180165|65551447|FG003|Overall Study|Physician Decision|0|||
23493323|NCT02180165|65551444|FG000|Overall Study|Withdrawal by Subject|3|||
23673431|NCT00774345|66186834|FG000|Treatment|Progressive Disease without histologic transformation|51|||
23673432|NCT00774345|66186835|FG001|Treatment|Progressive Disease without histologic transformation|111|||
23673433|NCT00774345|66186834|FG000|Treatment|Progressive Disease with histologic transformation|4|||
23673434|NCT00774345|66186835|FG001|Treatment|Progressive Disease with histologic transformation|2|||
23386357|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
23493324|NCT02180165|65551445|FG001|Overall Study|Withdrawal by Subject|0|||
23493325|NCT02180165|65551446|FG002|Overall Study|Withdrawal by Subject|2|||
23493326|NCT02180165|65551447|FG003|Overall Study|Withdrawal by Subject|1|||
23493327|NCT00137631|65551449|FG000|Overall Study|Lost to Follow-up|37|||
23673435|NCT00774345|66186834|FG000|Treatment|Withdrawal by Subject|5|||
23673436|NCT00774345|66186835|FG001|Treatment|Withdrawal by Subject|2|||
23673437|NCT00774345|66186834|FG000|Treatment|Lost to Follow-up|1|||
23673438|NCT00774345|66186835|FG001|Treatment|Lost to Follow-up|1|||
23673439|NCT00774345|66186834|FG000|Treatment|Death|4|||
23673440|NCT00774345|66186835|FG001|Treatment|Death|0|||
23673441|NCT00774345|66186834|FG000|Treatment|Other Reasons|32|||
23673442|NCT00774345|66186835|FG001|Treatment|Other Reasons|26|||
23673443|NCT01500057|66186836|FG000|Overall Study|Lost to Follow-up|6|||
23673444|NCT01500057|66186837|FG001|Overall Study|Lost to Follow-up|4|||
23673445|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
23673446|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
23673447|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
23673448|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
23673449|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
23673450|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
23673451|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
23673452|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
23673453|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
23673454|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23673455|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
23673456|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
23673457|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
23673458|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
23673459|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
23673460|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
23673461|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
23673462|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
23673463|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
23673464|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
23673465|NCT02706873|66186838|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
23673466|NCT02706873|66186839|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
23673467|NCT02706873|66186840|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
23673468|NCT02706873|66186841|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
23673469|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
23673470|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
23673471|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
23673472|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
23673473|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
23673474|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
23673475|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
23673476|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
23673477|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
23673478|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
23673479|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
23673480|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
23673481|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
23673482|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
23673483|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
23673484|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
23673485|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23673486|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23673487|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23673488|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
23673489|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
23673490|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
23673491|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
23673492|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
23673493|NCT02706873|66186838|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
23673494|NCT02706873|66186839|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
23673495|NCT02706873|66186840|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
23673496|NCT02706873|66186841|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
23673497|NCT00603915|66186842|FG000|Overall Study|Physician Decision|1|||
23673498|NCT04327388|66186847|FG000|Overall Study|Adverse Event|17|||
23673499|NCT04327388|66186848|FG001|Overall Study|Adverse Event|18|||
23673500|NCT04327388|66186849|FG002|Overall Study|Adverse Event|9|||
23673501|NCT04327388|66186847|FG000|Overall Study|Other|1|||
23673502|NCT04327388|66186848|FG001|Overall Study|Other|2|||
23673503|NCT04327388|66186849|FG002|Overall Study|Other|0|||
23673504|NCT04327388|66186847|FG000|Overall Study|Randomized and not treated|2|||
23673505|NCT04327388|66186848|FG001|Overall Study|Randomized and not treated|0|||
23673506|NCT04327388|66186849|FG002|Overall Study|Randomized and not treated|2|||
23673507|NCT01029366|66186850|FG000|Overall Study|Withdrawal by Subject|1|||
23673508|NCT01029366|66186851|FG001|Overall Study|Withdrawal by Subject|0|||
23673509|NCT01029366|66186850|FG000|Overall Study|Death|1|||
23673510|NCT01029366|66186851|FG001|Overall Study|Death|1|||
23673511|NCT01029366|66186850|FG000|Overall Study|disease progression|2|||
23673512|NCT01029366|66186851|FG001|Overall Study|disease progression|0|||
23673513|NCT01029366|66186850|FG000|Overall Study|manufacturing failure|0|||
23673514|NCT01029366|66186851|FG001|Overall Study|manufacturing failure|1|||
23673515|NCT00884273|66186852|FG000|Overall Study|Adverse Event|0|||
23673516|NCT00884273|66186853|FG001|Overall Study|Adverse Event|2|||
23673517|NCT00884273|66186852|FG000|Overall Study|Protocol Violation|1|||
23673518|NCT00884273|66186853|FG001|Overall Study|Protocol Violation|3|||
23673519|NCT00884273|66186852|FG000|Overall Study|Practical reasons|1|||
23673520|NCT00884273|66186853|FG001|Overall Study|Practical reasons|0|||
23673521|NCT00661531|66186855|FG000|Overall Study|Withdrawal by Subject|3|||
23673522|NCT03595553|66186858|FG000|Overall Study|Withdrawal by Subject|20|||
23673523|NCT03595553|66186859|FG001|Overall Study|Withdrawal by Subject|8|||
23673524|NCT03595553|66186858|FG000|Overall Study|Physician Decision|3|||
23673525|NCT03595553|66186859|FG001|Overall Study|Physician Decision|2|||
23673526|NCT03595553|66186858|FG000|Overall Study|Adverse Event|2|||
23673527|NCT03595553|66186859|FG001|Overall Study|Adverse Event|5|||
23673528|NCT03595553|66186858|FG000|Overall Study|Death|24|||
23673529|NCT03595553|66186859|FG001|Overall Study|Death|22|||
23673530|NCT03595553|66186858|FG000|Overall Study|Lost to Follow-up|6|||
23673531|NCT03595553|66186859|FG001|Overall Study|Lost to Follow-up|7|||
23673532|NCT03595553|66186858|FG000|Overall Study|Other as indicated in CSR|3|||
23673533|NCT03595553|66186859|FG001|Overall Study|Other as indicated in CSR|3|||
23673534|NCT03595553|66186858|FG000|Overall Study|Sponsor Decision|0|||
23673535|NCT03595553|66186859|FG001|Overall Study|Sponsor Decision|1|||
23673536|NCT03548558|66186860|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
23673537|NCT03548558|66186861|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
23673538|NCT03548558|66186862|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23673539|NCT03548558|66186863|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
23673540|NCT03548558|66186864|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23673541|NCT03548558|66186865|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23673542|NCT03548558|66186866|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23673543|NCT03548558|66186860|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
23673544|NCT03548558|66186861|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
23673545|NCT03548558|66186862|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
23673546|NCT03548558|66186863|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
23673547|NCT03548558|66186864|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
23673548|NCT03548558|66186865|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
23673549|NCT03548558|66186866|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
23673550|NCT03548558|66186860|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
23673551|NCT03548558|66186861|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
23673552|NCT03548558|66186862|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
23673553|NCT03548558|66186863|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
23673554|NCT03548558|66186864|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
23673555|NCT03548558|66186865|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
23673556|NCT03548558|66186866|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
23673557|NCT03548558|66186860|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23386358|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
23386359|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
23386360|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
23386361|NCT00401830|65158646|FG000|Overall Study|Adverse Event|10|||
23386362|NCT00401830|65158647|FG001|Overall Study|Adverse Event|18|||
23386363|NCT00401830|65158646|FG000|Overall Study|Lack of Efficacy|11|||
23386364|NCT00401830|65158647|FG001|Overall Study|Lack of Efficacy|5|||
23386365|NCT00401830|65158646|FG000|Overall Study|Withdrawal by Subject|4|||
23386366|NCT00401830|65158647|FG001|Overall Study|Withdrawal by Subject|3|||
23386367|NCT00401830|65158646|FG000|Overall Study|Protocol Violation|3|||
23386368|NCT00401830|65158647|FG001|Overall Study|Protocol Violation|3|||
23673558|NCT03548558|66186861|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23673559|NCT03548558|66186862|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23386369|NCT00401830|65158646|FG000|Overall Study|Non-compliance with drug study|1|||
23386370|NCT00401830|65158647|FG001|Overall Study|Non-compliance with drug study|0|||
23386371|NCT00401830|65158646|FG000|Overall Study|Lost to Follow-up|1|||
23386372|NCT00401830|65158647|FG001|Overall Study|Lost to Follow-up|3|||
23386373|NCT00401830|65158646|FG000|Overall Study|Other: Personal / Family problems|1|||
23386374|NCT00401830|65158647|FG001|Overall Study|Other: Personal / Family problems|0|||
23386375|NCT02830087|65158654|FG000|Overall Study|No study staff to follow-up patients|4|||
23386376|NCT02830087|65158655|FG001|Overall Study|No study staff to follow-up patients|4|||
23386377|NCT02830087|65158656|FG002|Overall Study|No study staff to follow-up patients|4|||
23386378|NCT02830087|65158657|FG003|Overall Study|No study staff to follow-up patients|3|||
23386379|NCT02830087|65158658|FG004|Overall Study|No study staff to follow-up patients|3|||
23386380|NCT02830087|65158659|FG005|Overall Study|No study staff to follow-up patients|3|||
23673560|NCT03548558|66186863|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23673561|NCT03548558|66186864|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
23386381|NCT01412983|65158660|FG000|1st Period|Ineligible|0|||
23386382|NCT01412983|65158661|FG001|1st Period|Ineligible|1|||
23673562|NCT03548558|66186865|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
23673563|NCT03548558|66186866|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
23673564|NCT03548558|66186860|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23673565|NCT03548558|66186861|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23673566|NCT03548558|66186862|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23673567|NCT03548558|66186863|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23673568|NCT03548558|66186864|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
23673569|NCT03548558|66186865|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
23673570|NCT03548558|66186866|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
23673571|NCT03548558|66186860|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23673572|NCT03548558|66186861|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23673573|NCT03548558|66186862|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23673574|NCT03548558|66186863|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23673575|NCT03548558|66186864|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
23493328|NCT00137631|65551450|FG001|Overall Study|Lost to Follow-up|41|||
23673576|NCT03548558|66186865|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
23673577|NCT03548558|66186866|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
23673578|NCT01928381|66186869|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
23673579|NCT01928381|66186870|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673580|NCT01928381|66186871|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673581|NCT01928381|66186872|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673582|NCT01928381|66186873|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673583|NCT01928381|66186874|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673584|NCT01928381|66186875|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23673585|NCT01928381|66186869|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
23673586|NCT01928381|66186870|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
23673587|NCT01928381|66186871|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
23673588|NCT01928381|66186872|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
23673589|NCT01928381|66186873|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
23673590|NCT01928381|66186874|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
23673591|NCT01928381|66186875|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
23673592|NCT01928381|66186869|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
23673593|NCT01928381|66186870|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673594|NCT01928381|66186871|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673595|NCT01928381|66186872|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673596|NCT01928381|66186873|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673597|NCT01928381|66186874|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673598|NCT01928381|66186875|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
23673599|NCT01928381|66186869|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
23673600|NCT01928381|66186870|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
23673601|NCT01928381|66186871|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
23673602|NCT01928381|66186872|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
23493329|NCT03082261|65551451|FG000|Overall Study|Death|4|||
23606090|NCT00614614|65947148|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
23606091|NCT00614614|65947149|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
23606092|NCT00614614|65947150|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606093|NCT00614614|65947151|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606094|NCT00614614|65947152|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606095|NCT00614614|65947148|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
23606096|NCT00614614|65947149|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
23606097|NCT00614614|65947150|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
23606098|NCT00614614|65947151|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
23606099|NCT00614614|65947152|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
23606100|NCT00614614|65947148|FG000|Primary Vaccination Phase|Protocol Violation|9|||
23606101|NCT00614614|65947149|FG001|Primary Vaccination Phase|Protocol Violation|3|||
23606102|NCT00614614|65947150|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23606103|NCT00614614|65947151|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23606104|NCT00614614|65947152|FG004|Primary Vaccination Phase|Protocol Violation|0|||
23606105|NCT00614614|65947148|FG000|Primary Vaccination Phase|Other|4|||
23606106|NCT00614614|65947149|FG001|Primary Vaccination Phase|Other|0|||
23606107|NCT00614614|65947150|FG002|Primary Vaccination Phase|Other|0|||
23606108|NCT00614614|65947151|FG003|Primary Vaccination Phase|Other|0|||
23606109|NCT00614614|65947152|FG004|Primary Vaccination Phase|Other|0|||
23606110|NCT00614614|65947148|FG000|Booster Vaccination Phase|Adverse Event|0|||
23606111|NCT00614614|65947149|FG001|Booster Vaccination Phase|Adverse Event|0|||
23606112|NCT00614614|65947150|FG002|Booster Vaccination Phase|Adverse Event|1|||
23606113|NCT00614614|65947151|FG003|Booster Vaccination Phase|Adverse Event|1|||
23673603|NCT01928381|66186873|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
23673604|NCT01928381|66186874|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
23673605|NCT01928381|66186875|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
23673606|NCT01928381|66186869|FG000|Part 1 - Pain Training|Protocol Violation|1|||
23673607|NCT01928381|66186870|FG001|Part 1 - Pain Training|Protocol Violation|0|||
23673608|NCT01928381|66186871|FG002|Part 1 - Pain Training|Protocol Violation|0|||
23673609|NCT01928381|66186872|FG003|Part 1 - Pain Training|Protocol Violation|0|||
23673610|NCT01928381|66186873|FG004|Part 1 - Pain Training|Protocol Violation|0|||
23673611|NCT01928381|66186874|FG005|Part 1 - Pain Training|Protocol Violation|0|||
23673612|NCT01928381|66186875|FG006|Part 1 - Pain Training|Protocol Violation|0|||
23673613|NCT01928381|66186869|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
23673614|NCT01928381|66186870|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673615|NCT01928381|66186871|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673616|NCT01928381|66186872|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673617|NCT01928381|66186873|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673618|NCT01928381|66186874|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673619|NCT01928381|66186875|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23673620|NCT01928381|66186869|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
23673621|NCT01928381|66186870|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673622|NCT01928381|66186871|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673623|NCT01928381|66186872|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673624|NCT01928381|66186873|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673625|NCT01928381|66186874|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673626|NCT01928381|66186875|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23673627|NCT01928381|66186869|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
23673628|NCT01928381|66186870|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673629|NCT01928381|66186871|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673630|NCT01928381|66186872|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673631|NCT01928381|66186873|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673632|NCT01928381|66186874|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673633|NCT01928381|66186875|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23673634|NCT01928381|66186869|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
23673635|NCT01928381|66186870|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673636|NCT01928381|66186871|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673637|NCT01928381|66186872|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673638|NCT01928381|66186873|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673639|NCT01928381|66186874|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673640|NCT01928381|66186875|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23673641|NCT01928381|66186869|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673642|NCT01928381|66186870|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673643|NCT01928381|66186871|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
23673644|NCT01928381|66186872|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673645|NCT01928381|66186873|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673646|NCT01928381|66186874|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673647|NCT01928381|66186875|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
23673648|NCT01928381|66186869|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673649|NCT01928381|66186870|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673650|NCT01928381|66186871|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
23673651|NCT01928381|66186872|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673652|NCT01928381|66186873|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673653|NCT01928381|66186874|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673654|NCT01928381|66186875|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23673655|NCT01928381|66186869|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
23673656|NCT01928381|66186870|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
23673657|NCT01928381|66186871|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
23673658|NCT01928381|66186872|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
23673659|NCT01928381|66186873|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
23673660|NCT01928381|66186874|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
23673661|NCT01928381|66186875|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
23673662|NCT01928381|66186869|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
23673663|NCT01928381|66186870|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
23673664|NCT01928381|66186871|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
23673665|NCT01928381|66186872|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
23673666|NCT01928381|66186873|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
23673667|NCT01928381|66186874|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
23673668|NCT01928381|66186875|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
23673669|NCT01928381|66186869|FG000|Washout First Intervention|Protocol Violation|0|||
23673670|NCT01928381|66186870|FG001|Washout First Intervention|Protocol Violation|0|||
23673671|NCT01928381|66186871|FG002|Washout First Intervention|Protocol Violation|0|||
23673672|NCT01928381|66186872|FG003|Washout First Intervention|Protocol Violation|0|||
23673673|NCT01928381|66186873|FG004|Washout First Intervention|Protocol Violation|1|||
23673674|NCT01928381|66186874|FG005|Washout First Intervention|Protocol Violation|0|||
23673675|NCT01928381|66186875|FG006|Washout First Intervention|Protocol Violation|0|||
23673676|NCT01928381|66186869|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
23673677|NCT01928381|66186870|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
23673678|NCT01928381|66186871|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
23673679|NCT01928381|66186872|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
23673680|NCT01928381|66186873|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
23673681|NCT01928381|66186874|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
23673682|NCT01928381|66186875|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
23673683|NCT01928381|66186869|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673684|NCT01928381|66186870|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673685|NCT01928381|66186871|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
23673686|NCT01928381|66186872|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673687|NCT01928381|66186873|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673688|NCT01928381|66186874|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673689|NCT01928381|66186875|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
23673690|NCT02429414|66186878|FG000|Overall Study|Physician Decision|0|||
23673691|NCT02429414|66186879|FG001|Overall Study|Physician Decision|1|||
23673692|NCT02669017|66186880|FG000|Overall Study|Death|1|||
23673693|NCT02669017|66186881|FG001|Overall Study|Death|2|||
23673694|NCT02669017|66186882|FG002|Overall Study|Death|2|||
23673695|NCT02669017|66186883|FG003|Overall Study|Death|3|||
23673696|NCT02669017|66186884|FG004|Overall Study|Death|8|||
23673697|NCT02669017|66186885|FG005|Overall Study|Death|18|||
23673698|NCT02669017|66186886|FG006|Overall Study|Death|10|||
23673699|NCT02669017|66186887|FG007|Overall Study|Death|47|||
23673700|NCT02669017|66186888|FG008|Overall Study|Death|20|||
23673701|NCT02669017|66186880|FG000|Overall Study|Withdrawal by Subject|0|||
23673702|NCT02669017|66186881|FG001|Overall Study|Withdrawal by Subject|0|||
23673703|NCT02669017|66186882|FG002|Overall Study|Withdrawal by Subject|0|||
23673704|NCT02669017|66186883|FG003|Overall Study|Withdrawal by Subject|1|||
23673705|NCT02669017|66186884|FG004|Overall Study|Withdrawal by Subject|2|||
23673706|NCT02669017|66186885|FG005|Overall Study|Withdrawal by Subject|0|||
23673707|NCT02669017|66186886|FG006|Overall Study|Withdrawal by Subject|0|||
23673708|NCT02669017|66186887|FG007|Overall Study|Withdrawal by Subject|2|||
23673709|NCT02669017|66186888|FG008|Overall Study|Withdrawal by Subject|2|||
23673710|NCT02669017|66186880|FG000|Overall Study|Lost to Follow-up|0|||
23673711|NCT02669017|66186881|FG001|Overall Study|Lost to Follow-up|0|||
23673712|NCT02669017|66186882|FG002|Overall Study|Lost to Follow-up|0|||
23673713|NCT02669017|66186883|FG003|Overall Study|Lost to Follow-up|0|||
23673714|NCT02669017|66186884|FG004|Overall Study|Lost to Follow-up|0|||
23673715|NCT02669017|66186885|FG005|Overall Study|Lost to Follow-up|0|||
23673716|NCT02669017|66186886|FG006|Overall Study|Lost to Follow-up|0|||
23673717|NCT02669017|66186887|FG007|Overall Study|Lost to Follow-up|0|||
23673718|NCT02669017|66186888|FG008|Overall Study|Lost to Follow-up|1|||
23673719|NCT02669017|66186880|FG000|Overall Study|Miscellaneous|0|||
23673720|NCT02669017|66186881|FG001|Overall Study|Miscellaneous|0|||
23673721|NCT02669017|66186882|FG002|Overall Study|Miscellaneous|0|||
23673722|NCT02669017|66186883|FG003|Overall Study|Miscellaneous|0|||
23673723|NCT02669017|66186884|FG004|Overall Study|Miscellaneous|2|||
23673724|NCT02669017|66186885|FG005|Overall Study|Miscellaneous|1|||
23673725|NCT02669017|66186886|FG006|Overall Study|Miscellaneous|1|||
23673726|NCT02669017|66186887|FG007|Overall Study|Miscellaneous|13|||
23673727|NCT02669017|66186888|FG008|Overall Study|Miscellaneous|2|||
23493330|NCT03082261|65551451|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
23493331|NCT03082261|65551451|FG000|Overall Study|Insurance denial|1|||
23493332|NCT03082261|65551451|FG000|Overall Study|Peripheral lead added|1|||
23493333|NCT03082261|65551451|FG000|Overall Study|Withdrawal by Subject|40|||
23493334|NCT03082261|65551451|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
23493335|NCT03082261|65551451|FG000|Overall Study|Subject implanted with device other than study device|1|||
23493336|NCT03082261|65551451|FG000|Overall Study|Lost to Follow-up|14|||
23493337|NCT03082261|65551451|FG000|Overall Study|Subject moved to a different state|1|||
23493338|NCT03082261|65551451|FG000|Overall Study|Subject non-compliance|2|||
23493339|NCT03082261|65551451|FG000|Overall Study|Subject participation terminated by investigator|9|||
23493340|NCT03082261|65551451|FG000|Overall Study|Subject participation terminated by sponsor|4|||
23493341|NCT03082261|65551451|FG000|Overall Study|System explant|19|||
23493342|NCT03082261|65551451|FG000|Overall Study|Unable to place lead(s)|2|||
23493343|NCT03082261|65551451|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
23493344|NCT00968864|65551452|FG000|Overall Study|Protocol exception/ not evaluable|1|||
23493345|NCT00631696|65551453|FG000|Overall Study|Entered, not randomized to treatment|1|||
23493346|NCT00631696|65551454|FG001|Overall Study|Entered, not randomized to treatment|1|||
23493347|NCT00631696|65551453|FG000|Overall Study|Discontinued after database release date|1|||
23493348|NCT00631696|65551454|FG001|Overall Study|Discontinued after database release date|0|||
23493349|NCT00631696|65551453|FG000|Overall Study|Follow up after database release date|1|||
23493350|NCT00631696|65551454|FG001|Overall Study|Follow up after database release date|0|||
23493351|NCT00631696|65551453|FG000|Overall Study|Lost to Follow-up|7|||
23493352|NCT00631696|65551454|FG001|Overall Study|Lost to Follow-up|10|||
23493353|NCT00631696|65551453|FG000|Overall Study|Withdrawal by Subject|2|||
23493354|NCT00631696|65551454|FG001|Overall Study|Withdrawal by Subject|9|||
23493355|NCT00631696|65551453|FG000|Overall Study|Other|8|||
23493356|NCT00631696|65551454|FG001|Overall Study|Other|8|||
23493357|NCT00631696|65551453|FG000|Overall Study|Protocol Violation|9|||
23493358|NCT00631696|65551454|FG001|Overall Study|Protocol Violation|9|||
23493359|NCT00631696|65551453|FG000|Overall Study|Study terminated by sponsor|3|||
23493360|NCT00631696|65551454|FG001|Overall Study|Study terminated by sponsor|3|||
23493361|NCT00631696|65551453|FG000|Overall Study|Adverse Event|5|||
23493362|NCT00631696|65551454|FG001|Overall Study|Adverse Event|0|||
23493363|NCT01560403|65551455|FG000|Overall Study|Lost to Follow-up|0|||
23493364|NCT01560403|65551456|FG001|Overall Study|Lost to Follow-up|1|||
23493365|NCT04622306|65551457|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493366|NCT04622306|65551458|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493367|NCT04622306|65551459|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
23493368|NCT04622306|65551460|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
23493369|NCT04622306|65551461|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493370|NCT04622306|65551462|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
23493371|NCT04622306|65551457|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493372|NCT04622306|65551458|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23673728|NCT03686397|66186889|FG000|Overall Study|Lack of Efficacy|3|||
23673729|NCT03686397|66186890|FG001|Overall Study|Lack of Efficacy|5|||
23673730|NCT03686397|66186889|FG000|Overall Study|Adverse Event|0|||
23673731|NCT03686397|66186890|FG001|Overall Study|Adverse Event|1|||
23673732|NCT03686397|66186889|FG000|Overall Study|Protocol Violation|0|||
23673733|NCT03686397|66186890|FG001|Overall Study|Protocol Violation|1|||
23673734|NCT03686397|66186889|FG000|Overall Study|Withdrawal by Subject|0|||
23673735|NCT03686397|66186890|FG001|Overall Study|Withdrawal by Subject|1|||
23673736|NCT03686397|66186889|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
23673737|NCT03686397|66186890|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
23673738|NCT02751502|66186894|FG000|Overall Study|Lack of funding|4|||
23673739|NCT00623480|66186899|FG000|Overall Study|Lost to Follow-up|0|||
23673740|NCT00623480|66186900|FG001|Overall Study|Lost to Follow-up|1|||
23673741|NCT00623480|66186899|FG000|Overall Study|Withdrawal by Subject|2|||
23673742|NCT00623480|66186900|FG001|Overall Study|Withdrawal by Subject|4|||
23673743|NCT00623480|66186899|FG000|Overall Study|Lack of Efficacy|1|||
23673744|NCT00623480|66186900|FG001|Overall Study|Lack of Efficacy|0|||
23673745|NCT00623480|66186899|FG000|Overall Study|Non-compliant with study medication|4|||
23673746|NCT00623480|66186900|FG001|Overall Study|Non-compliant with study medication|0|||
23673747|NCT00623480|66186899|FG000|Overall Study|Protocol Violation|0|||
23673748|NCT00623480|66186900|FG001|Overall Study|Protocol Violation|1|||
23673749|NCT00623480|66186899|FG000|Overall Study|Site closed by sponsor|0|||
23673750|NCT00623480|66186900|FG001|Overall Study|Site closed by sponsor|1|||
23673751|NCT03920670|66186903|FG000|Overall Study|Protocol Violation|2|||
23673752|NCT03920670|66186904|FG001|Overall Study|Protocol Violation|2|||
23673753|NCT03920670|66186903|FG000|Overall Study|Adverse Event|1|||
23673754|NCT03920670|66186904|FG001|Overall Study|Adverse Event|0|||
23673755|NCT01870401|66186907|FG000|Overall Study|Death|48|||
23673756|NCT01870401|66186908|FG001|Overall Study|Death|24|||
23673757|NCT01870401|66186907|FG000|Overall Study|Withdrawal by Subject|39|||
23673758|NCT01870401|66186908|FG001|Overall Study|Withdrawal by Subject|26|||
23673759|NCT01870401|66186907|FG000|Overall Study|Lost to Follow-up|19|||
23673760|NCT01870401|66186908|FG001|Overall Study|Lost to Follow-up|14|||
23673761|NCT01870401|66186907|FG000|Overall Study|Other|9|||
23673762|NCT01870401|66186908|FG001|Overall Study|Other|7|||
23673763|NCT01870401|66186907|FG000|Overall Study|On-going in the Study|35|||
23673764|NCT01870401|66186908|FG001|Overall Study|On-going in the Study|25|||
23673765|NCT01395394|66186912|FG000|Baseline Study Visit|Protocol Violation|1|||
23673766|NCT01395394|66186913|FG001|Baseline Study Visit|Protocol Violation|0|||
23673767|NCT01395394|66186914|FG002|Baseline Study Visit|Protocol Violation|0|||
23673768|NCT03434977|66186915|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
23673769|NCT03434977|66186916|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
23673770|NCT01064167|66186917|FG000|Overall Study|Protocol Violation|14|||
23673771|NCT01064167|66186918|FG001|Overall Study|Protocol Violation|15|||
23673772|NCT01462266|66186921|FG000|Overall Study|Adverse Event|7|||
23673773|NCT01462266|66186922|FG001|Overall Study|Adverse Event|6|||
23673774|NCT01462266|66186921|FG000|Overall Study|Death|2|||
23673775|NCT01462266|66186922|FG001|Overall Study|Death|1|||
23673776|NCT01462266|66186921|FG000|Overall Study|Lack of Efficacy|0|||
23673777|NCT01462266|66186922|FG001|Overall Study|Lack of Efficacy|2|||
23673778|NCT01462266|66186921|FG000|Overall Study|Lost to Follow-up|4|||
23673779|NCT01462266|66186922|FG001|Overall Study|Lost to Follow-up|3|||
23673780|NCT01462266|66186921|FG000|Overall Study|Non-compliance with study drug|3|||
23673781|NCT01462266|66186922|FG001|Overall Study|Non-compliance with study drug|0|||
23673782|NCT01462266|66186921|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
23673783|NCT01462266|66186922|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
23673784|NCT01462266|66186921|FG000|Overall Study|Physician Decision|2|||
23673785|NCT01462266|66186922|FG001|Overall Study|Physician Decision|5|||
23673786|NCT01462266|66186921|FG000|Overall Study|Protocol Violation|1|||
23673787|NCT01462266|66186922|FG001|Overall Study|Protocol Violation|3|||
23673788|NCT01462266|66186921|FG000|Overall Study|Withdrawal by Subject|7|||
23673789|NCT01462266|66186922|FG001|Overall Study|Withdrawal by Subject|2|||
23673790|NCT01462266|66186921|FG000|Overall Study|Screen failure|1|||
23673791|NCT01462266|66186922|FG001|Overall Study|Screen failure|1|||
23673792|NCT02217566|66186923|FG000|Overall Study|Lost to Follow-up|2|||
23673793|NCT02217566|66186923|FG000|Overall Study|Death|3|||
23673794|NCT02217566|66186923|FG000|Overall Study|Early study termination|6|||
23673795|NCT00820898|66186925|FG000|Overall Study|Inelgible - wrong primary site|1|||
23673796|NCT00623428|66186928|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
23673797|NCT00623428|66186929|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
23673798|NCT00623428|66186928|FG000|Treatment Period|Death|0|||
23673799|NCT00623428|66186929|FG001|Treatment Period|Death|1|||
23673800|NCT00623428|66186928|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
23673801|NCT00623428|66186929|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
23673802|NCT00623428|66186928|FG000|Treatment Period|Insufficient therapeutic response|0|||
23673803|NCT00623428|66186929|FG001|Treatment Period|Insufficient therapeutic response|2|||
23673804|NCT00623428|66186928|FG000|Treatment Period|Other|0|||
23673805|NCT00623428|66186929|FG001|Treatment Period|Other|1|||
23673806|NCT00623428|66186928|FG000|Treatment Period|Withdrawal by Subject|0|||
23673807|NCT00623428|66186929|FG001|Treatment Period|Withdrawal by Subject|1|||
23673808|NCT00623428|66186928|FG000|Follow-up Period|Relapse post-treatment|11|||
23673809|NCT00623428|66186929|FG001|Follow-up Period|Relapse post-treatment|3|||
23673810|NCT00623428|66186928|FG000|Follow-up Period|Failure to return|10|||
23673811|NCT00623428|66186929|FG001|Follow-up Period|Failure to return|2|||
23673812|NCT00623428|66186928|FG000|Follow-up Period|Patient withdrew consent|5|||
23673813|NCT00623428|66186929|FG001|Follow-up Period|Patient withdrew consent|4|||
23673814|NCT00623428|66186928|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
23673815|NCT00623428|66186929|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
23673816|NCT00623428|66186928|FG000|Follow-up Period|Did not cooperate|0|||
23673817|NCT00623428|66186929|FG001|Follow-up Period|Did not cooperate|3|||
23673818|NCT00623428|66186928|FG000|Follow-up Period|Reason not specified|1|||
23673819|NCT00623428|66186929|FG001|Follow-up Period|Reason not specified|1|||
23673820|NCT00623428|66186928|FG000|Follow-up Period|Death|0|||
23673821|NCT00623428|66186929|FG001|Follow-up Period|Death|1|||
23673822|NCT03529773|66186932|FG000|Overall Study|Adverse Event|0|||
23673823|NCT03529773|66186933|FG001|Overall Study|Adverse Event|0|||
23673824|NCT03529773|66186934|FG002|Overall Study|Adverse Event|0|||
23673825|NCT03529773|66186935|FG003|Overall Study|Adverse Event|0|||
23673826|NCT03529773|66186936|FG004|Overall Study|Adverse Event|0|||
23673827|NCT03529773|66186937|FG005|Overall Study|Adverse Event|0|||
23673828|NCT03529773|66186938|FG006|Overall Study|Adverse Event|0|||
23673829|NCT03529773|66186939|FG007|Overall Study|Adverse Event|0|||
23673830|NCT03529773|66186940|FG008|Overall Study|Adverse Event|0|||
23673831|NCT03529773|66186941|FG009|Overall Study|Adverse Event|0|||
23673832|NCT03529773|66186942|FG010|Overall Study|Adverse Event|0|||
23673833|NCT03529773|66186943|FG011|Overall Study|Adverse Event|0|||
23673834|NCT03529773|66186944|FG012|Overall Study|Adverse Event|0|||
23673835|NCT03529773|66186945|FG013|Overall Study|Adverse Event|0|||
23673836|NCT03529773|66186946|FG014|Overall Study|Adverse Event|0|||
23673837|NCT03529773|66186947|FG015|Overall Study|Adverse Event|0|||
23673838|NCT03529773|66186948|FG016|Overall Study|Adverse Event|0|||
23673839|NCT03529773|66186949|FG017|Overall Study|Adverse Event|0|||
23673840|NCT03529773|66186950|FG018|Overall Study|Adverse Event|0|||
23673841|NCT03529773|66186951|FG019|Overall Study|Adverse Event|0|||
23673842|NCT03529773|66186952|FG020|Overall Study|Adverse Event|0|||
23673843|NCT03529773|66186953|FG021|Overall Study|Adverse Event|0|||
23673844|NCT03529773|66186954|FG022|Overall Study|Adverse Event|0|||
23673845|NCT03529773|66186955|FG023|Overall Study|Adverse Event|0|||
23673846|NCT03529773|66186956|FG024|Overall Study|Adverse Event|0|||
23673847|NCT03529773|66186957|FG025|Overall Study|Adverse Event|0|||
23673848|NCT03529773|66186958|FG026|Overall Study|Adverse Event|0|||
23673849|NCT03529773|66186959|FG027|Overall Study|Adverse Event|0|||
23673850|NCT03529773|66186960|FG028|Overall Study|Adverse Event|0|||
23673851|NCT03529773|66186961|FG029|Overall Study|Adverse Event|0|||
23673852|NCT03529773|66186962|FG030|Overall Study|Adverse Event|1|||
23673853|NCT03529773|66186963|FG031|Overall Study|Adverse Event|0|||
23673854|NCT03529773|66186964|FG032|Overall Study|Adverse Event|0|||
23673855|NCT03529773|66186965|FG033|Overall Study|Adverse Event|0|||
23673856|NCT03529773|66186966|FG034|Overall Study|Adverse Event|0|||
23673857|NCT03529773|66186967|FG035|Overall Study|Adverse Event|1|||
23673858|NCT03529773|66186968|FG036|Overall Study|Adverse Event|0|||
23673859|NCT03529773|66186969|FG037|Overall Study|Adverse Event|0|||
23673860|NCT03529773|66186970|FG038|Overall Study|Adverse Event|1|||
23673861|NCT03529773|66186971|FG039|Overall Study|Adverse Event|1|||
23673862|NCT03529773|66186932|FG000|Overall Study|Death|0|||
23673863|NCT03529773|66186933|FG001|Overall Study|Death|0|||
23673864|NCT03529773|66186934|FG002|Overall Study|Death|0|||
23673865|NCT03529773|66186935|FG003|Overall Study|Death|0|||
23673866|NCT03529773|66186936|FG004|Overall Study|Death|0|||
23673867|NCT03529773|66186937|FG005|Overall Study|Death|0|||
23673868|NCT03529773|66186938|FG006|Overall Study|Death|0|||
23673869|NCT03529773|66186939|FG007|Overall Study|Death|0|||
23673870|NCT03529773|66186940|FG008|Overall Study|Death|0|||
23673871|NCT03529773|66186941|FG009|Overall Study|Death|0|||
23673872|NCT03529773|66186942|FG010|Overall Study|Death|0|||
23673873|NCT03529773|66186943|FG011|Overall Study|Death|0|||
23673874|NCT03529773|66186944|FG012|Overall Study|Death|1|||
23673875|NCT03529773|66186945|FG013|Overall Study|Death|0|||
23673876|NCT03529773|66186946|FG014|Overall Study|Death|0|||
23673877|NCT03529773|66186947|FG015|Overall Study|Death|0|||
23673878|NCT03529773|66186948|FG016|Overall Study|Death|0|||
23673879|NCT03529773|66186949|FG017|Overall Study|Death|0|||
23673880|NCT03529773|66186950|FG018|Overall Study|Death|0|||
23673881|NCT03529773|66186951|FG019|Overall Study|Death|1|||
23673882|NCT03529773|66186952|FG020|Overall Study|Death|0|||
23673883|NCT03529773|66186953|FG021|Overall Study|Death|0|||
23673884|NCT03529773|66186954|FG022|Overall Study|Death|1|||
23673885|NCT03529773|66186955|FG023|Overall Study|Death|0|||
23673886|NCT03529773|66186956|FG024|Overall Study|Death|0|||
23673887|NCT03529773|66186957|FG025|Overall Study|Death|0|||
23673888|NCT03529773|66186958|FG026|Overall Study|Death|0|||
23673889|NCT03529773|66186959|FG027|Overall Study|Death|0|||
23673890|NCT03529773|66186960|FG028|Overall Study|Death|0|||
23673891|NCT03529773|66186961|FG029|Overall Study|Death|0|||
23673892|NCT03529773|66186962|FG030|Overall Study|Death|0|||
23673893|NCT03529773|66186963|FG031|Overall Study|Death|0|||
23673894|NCT03529773|66186964|FG032|Overall Study|Death|0|||
23673895|NCT03529773|66186965|FG033|Overall Study|Death|1|||
23673896|NCT03529773|66186966|FG034|Overall Study|Death|1|||
23673897|NCT03529773|66186967|FG035|Overall Study|Death|0|||
23673898|NCT03529773|66186968|FG036|Overall Study|Death|1|||
23673899|NCT03529773|66186969|FG037|Overall Study|Death|0|||
23673900|NCT03529773|66186970|FG038|Overall Study|Death|0|||
23673901|NCT03529773|66186971|FG039|Overall Study|Death|0|||
23673902|NCT03529773|66186932|FG000|Overall Study|Lost to Follow-up|0|||
23673903|NCT03529773|66186933|FG001|Overall Study|Lost to Follow-up|0|||
23673904|NCT03529773|66186934|FG002|Overall Study|Lost to Follow-up|1|||
23673905|NCT03529773|66186935|FG003|Overall Study|Lost to Follow-up|0|||
23673906|NCT03529773|66186936|FG004|Overall Study|Lost to Follow-up|1|||
23673907|NCT03529773|66186937|FG005|Overall Study|Lost to Follow-up|1|||
23673908|NCT03529773|66186938|FG006|Overall Study|Lost to Follow-up|0|||
23673909|NCT03529773|66186939|FG007|Overall Study|Lost to Follow-up|0|||
23673910|NCT03529773|66186940|FG008|Overall Study|Lost to Follow-up|0|||
23673911|NCT03529773|66186941|FG009|Overall Study|Lost to Follow-up|0|||
23673912|NCT03529773|66186942|FG010|Overall Study|Lost to Follow-up|0|||
23673913|NCT03529773|66186943|FG011|Overall Study|Lost to Follow-up|0|||
23673914|NCT03529773|66186944|FG012|Overall Study|Lost to Follow-up|0|||
23673915|NCT03529773|66186945|FG013|Overall Study|Lost to Follow-up|1|||
23673916|NCT03529773|66186946|FG014|Overall Study|Lost to Follow-up|4|||
23673917|NCT03529773|66186947|FG015|Overall Study|Lost to Follow-up|1|||
23673918|NCT03529773|66186948|FG016|Overall Study|Lost to Follow-up|1|||
23673919|NCT03529773|66186949|FG017|Overall Study|Lost to Follow-up|0|||
23673920|NCT03529773|66186950|FG018|Overall Study|Lost to Follow-up|1|||
23673921|NCT03529773|66186951|FG019|Overall Study|Lost to Follow-up|1|||
23673922|NCT03529773|66186952|FG020|Overall Study|Lost to Follow-up|2|||
23673923|NCT03529773|66186953|FG021|Overall Study|Lost to Follow-up|4|||
23673924|NCT03529773|66186954|FG022|Overall Study|Lost to Follow-up|3|||
23673925|NCT03529773|66186955|FG023|Overall Study|Lost to Follow-up|4|||
23673926|NCT03529773|66186956|FG024|Overall Study|Lost to Follow-up|3|||
23673927|NCT03529773|66186957|FG025|Overall Study|Lost to Follow-up|5|||
23673928|NCT03529773|66186958|FG026|Overall Study|Lost to Follow-up|5|||
23673929|NCT03529773|66186959|FG027|Overall Study|Lost to Follow-up|0|||
23673930|NCT03529773|66186960|FG028|Overall Study|Lost to Follow-up|0|||
23673931|NCT03529773|66186961|FG029|Overall Study|Lost to Follow-up|0|||
23673932|NCT03529773|66186962|FG030|Overall Study|Lost to Follow-up|1|||
23673933|NCT03529773|66186963|FG031|Overall Study|Lost to Follow-up|0|||
23673934|NCT03529773|66186964|FG032|Overall Study|Lost to Follow-up|0|||
23673935|NCT03529773|66186965|FG033|Overall Study|Lost to Follow-up|1|||
23673936|NCT03529773|66186966|FG034|Overall Study|Lost to Follow-up|1|||
23673937|NCT03529773|66186967|FG035|Overall Study|Lost to Follow-up|0|||
23673938|NCT03529773|66186968|FG036|Overall Study|Lost to Follow-up|0|||
23673939|NCT03529773|66186969|FG037|Overall Study|Lost to Follow-up|3|||
23673940|NCT03529773|66186970|FG038|Overall Study|Lost to Follow-up|1|||
23673941|NCT03529773|66186971|FG039|Overall Study|Lost to Follow-up|1|||
23673942|NCT03529773|66186932|FG000|Overall Study|No longer meets eligibility criteria|0|||
23673943|NCT03529773|66186933|FG001|Overall Study|No longer meets eligibility criteria|0|||
23673944|NCT03529773|66186934|FG002|Overall Study|No longer meets eligibility criteria|0|||
23673945|NCT03529773|66186935|FG003|Overall Study|No longer meets eligibility criteria|0|||
23673946|NCT03529773|66186936|FG004|Overall Study|No longer meets eligibility criteria|0|||
23673947|NCT03529773|66186937|FG005|Overall Study|No longer meets eligibility criteria|0|||
23673948|NCT03529773|66186938|FG006|Overall Study|No longer meets eligibility criteria|0|||
23673949|NCT03529773|66186939|FG007|Overall Study|No longer meets eligibility criteria|0|||
23673950|NCT03529773|66186940|FG008|Overall Study|No longer meets eligibility criteria|0|||
23673951|NCT03529773|66186941|FG009|Overall Study|No longer meets eligibility criteria|0|||
23673952|NCT03529773|66186942|FG010|Overall Study|No longer meets eligibility criteria|0|||
23673953|NCT03529773|66186943|FG011|Overall Study|No longer meets eligibility criteria|0|||
23673954|NCT03529773|66186944|FG012|Overall Study|No longer meets eligibility criteria|0|||
23673955|NCT03529773|66186945|FG013|Overall Study|No longer meets eligibility criteria|0|||
23673956|NCT03529773|66186946|FG014|Overall Study|No longer meets eligibility criteria|0|||
23673957|NCT03529773|66186947|FG015|Overall Study|No longer meets eligibility criteria|0|||
23673958|NCT03529773|66186948|FG016|Overall Study|No longer meets eligibility criteria|0|||
23673959|NCT03529773|66186949|FG017|Overall Study|No longer meets eligibility criteria|0|||
23673960|NCT03529773|66186950|FG018|Overall Study|No longer meets eligibility criteria|0|||
23673961|NCT03529773|66186951|FG019|Overall Study|No longer meets eligibility criteria|0|||
23673962|NCT03529773|66186952|FG020|Overall Study|No longer meets eligibility criteria|0|||
23673963|NCT03529773|66186953|FG021|Overall Study|No longer meets eligibility criteria|0|||
23673964|NCT03529773|66186954|FG022|Overall Study|No longer meets eligibility criteria|1|||
23673965|NCT03529773|66186955|FG023|Overall Study|No longer meets eligibility criteria|0|||
23673966|NCT03529773|66186956|FG024|Overall Study|No longer meets eligibility criteria|0|||
23673967|NCT03529773|66186957|FG025|Overall Study|No longer meets eligibility criteria|0|||
23673968|NCT03529773|66186958|FG026|Overall Study|No longer meets eligibility criteria|0|||
23673969|NCT03529773|66186959|FG027|Overall Study|No longer meets eligibility criteria|0|||
23673970|NCT03529773|66186960|FG028|Overall Study|No longer meets eligibility criteria|0|||
23673971|NCT03529773|66186961|FG029|Overall Study|No longer meets eligibility criteria|0|||
23673972|NCT03529773|66186962|FG030|Overall Study|No longer meets eligibility criteria|0|||
23673973|NCT03529773|66186963|FG031|Overall Study|No longer meets eligibility criteria|0|||
23673974|NCT03529773|66186964|FG032|Overall Study|No longer meets eligibility criteria|0|||
23673975|NCT03529773|66186965|FG033|Overall Study|No longer meets eligibility criteria|0|||
23673976|NCT03529773|66186966|FG034|Overall Study|No longer meets eligibility criteria|0|||
23673977|NCT03529773|66186967|FG035|Overall Study|No longer meets eligibility criteria|0|||
23673978|NCT03529773|66186968|FG036|Overall Study|No longer meets eligibility criteria|0|||
23673979|NCT03529773|66186969|FG037|Overall Study|No longer meets eligibility criteria|0|||
23673980|NCT03529773|66186970|FG038|Overall Study|No longer meets eligibility criteria|1|||
23673981|NCT03529773|66186971|FG039|Overall Study|No longer meets eligibility criteria|0|||
23673982|NCT03529773|66186932|FG000|Overall Study|Other|0|||
23673983|NCT03529773|66186933|FG001|Overall Study|Other|0|||
23673984|NCT03529773|66186934|FG002|Overall Study|Other|0|||
23673985|NCT03529773|66186935|FG003|Overall Study|Other|0|||
23673986|NCT03529773|66186936|FG004|Overall Study|Other|0|||
23673987|NCT03529773|66186937|FG005|Overall Study|Other|0|||
23673988|NCT03529773|66186938|FG006|Overall Study|Other|0|||
23673989|NCT03529773|66186939|FG007|Overall Study|Other|0|||
23673990|NCT03529773|66186940|FG008|Overall Study|Other|0|||
23673991|NCT03529773|66186941|FG009|Overall Study|Other|0|||
23673992|NCT03529773|66186942|FG010|Overall Study|Other|0|||
23673993|NCT03529773|66186943|FG011|Overall Study|Other|0|||
23673994|NCT03529773|66186944|FG012|Overall Study|Other|1|||
23673995|NCT03529773|66186945|FG013|Overall Study|Other|0|||
23673996|NCT03529773|66186946|FG014|Overall Study|Other|2|||
23673997|NCT03529773|66186947|FG015|Overall Study|Other|0|||
23673998|NCT03529773|66186948|FG016|Overall Study|Other|0|||
23673999|NCT03529773|66186949|FG017|Overall Study|Other|3|||
23674000|NCT03529773|66186950|FG018|Overall Study|Other|0|||
23674001|NCT03529773|66186951|FG019|Overall Study|Other|0|||
23674002|NCT03529773|66186952|FG020|Overall Study|Other|1|||
23674003|NCT03529773|66186953|FG021|Overall Study|Other|0|||
23674004|NCT03529773|66186954|FG022|Overall Study|Other|1|||
23674005|NCT03529773|66186955|FG023|Overall Study|Other|0|||
23674006|NCT03529773|66186956|FG024|Overall Study|Other|3|||
23674007|NCT03529773|66186957|FG025|Overall Study|Other|2|||
23674008|NCT03529773|66186958|FG026|Overall Study|Other|2|||
23674009|NCT03529773|66186959|FG027|Overall Study|Other|0|||
23674010|NCT03529773|66186960|FG028|Overall Study|Other|0|||
23674011|NCT03529773|66186961|FG029|Overall Study|Other|0|||
23674012|NCT03529773|66186962|FG030|Overall Study|Other|0|||
23674013|NCT03529773|66186963|FG031|Overall Study|Other|0|||
23674014|NCT03529773|66186964|FG032|Overall Study|Other|0|||
23674015|NCT03529773|66186965|FG033|Overall Study|Other|0|||
23674016|NCT03529773|66186966|FG034|Overall Study|Other|1|||
23674017|NCT03529773|66186967|FG035|Overall Study|Other|1|||
23674018|NCT03529773|66186968|FG036|Overall Study|Other|0|||
23674019|NCT03529773|66186969|FG037|Overall Study|Other|0|||
23674020|NCT03529773|66186970|FG038|Overall Study|Other|0|||
23674021|NCT03529773|66186971|FG039|Overall Study|Other|0|||
23674022|NCT03529773|66186932|FG000|Overall Study|Physician Decision|0|||
23674023|NCT03529773|66186933|FG001|Overall Study|Physician Decision|0|||
23674024|NCT03529773|66186934|FG002|Overall Study|Physician Decision|0|||
23674025|NCT03529773|66186935|FG003|Overall Study|Physician Decision|0|||
23674026|NCT03529773|66186936|FG004|Overall Study|Physician Decision|0|||
23674027|NCT03529773|66186937|FG005|Overall Study|Physician Decision|0|||
23674028|NCT03529773|66186938|FG006|Overall Study|Physician Decision|0|||
23674029|NCT03529773|66186939|FG007|Overall Study|Physician Decision|0|||
23674030|NCT03529773|66186940|FG008|Overall Study|Physician Decision|0|||
23493373|NCT04622306|65551459|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
23493374|NCT04622306|65551460|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
23493375|NCT04622306|65551461|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493376|NCT04622306|65551462|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493377|NCT00722800|65551469|FG000|Overall Study|Withdrawal by Subject|1|||
23493378|NCT00722800|65551470|FG001|Overall Study|Withdrawal by Subject|0|||
23493379|NCT00722800|65551469|FG000|Overall Study|Physician Decision|1|||
23493380|NCT00722800|65551470|FG001|Overall Study|Physician Decision|0|||
23493381|NCT00788073|65551471|FG000|STX209 Then Placebo|Adverse Event|1|||
23493382|NCT00788073|65551472|FG001|STX209 Then Placebo|Adverse Event|0|||
23493383|NCT00788073|65551471|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
23493384|NCT00788073|65551472|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
23493385|NCT00788073|65551471|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
23493386|NCT00788073|65551472|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
23493387|NCT00788073|65551471|FG000|STX209 Then Placebo|unable to return due to travel|0|||
23493388|NCT00788073|65551472|FG001|STX209 Then Placebo|unable to return due to travel|1|||
23493389|NCT00788073|65551471|FG000|Placebo Then STX209|Adverse Event|2|||
23493390|NCT00788073|65551472|FG001|Placebo Then STX209|Adverse Event|0|||
23493391|NCT00788073|65551471|FG000|Placebo Then STX209|Protocol Violation|0|||
23493392|NCT00788073|65551472|FG001|Placebo Then STX209|Protocol Violation|1|||
23493393|NCT00285818|65551473|FG000|Overall Study|Withdrawal by Subject|3|||
23493394|NCT00285818|65551474|FG001|Overall Study|Withdrawal by Subject|2|||
23493395|NCT00285818|65551473|FG000|Overall Study|Lost to Follow-up|1|||
23493396|NCT00285818|65551474|FG001|Overall Study|Lost to Follow-up|0|||
23493397|NCT00723398|65551475|FG000|Overall Study|Withdrawal by Subject|2|||
23493398|NCT00723398|65551476|FG001|Overall Study|Withdrawal by Subject|6|||
23493399|NCT00723398|65551477|FG002|Overall Study|Withdrawal by Subject|4|||
23493400|NCT00723398|65551478|FG003|Overall Study|Withdrawal by Subject|4|||
23493401|NCT00723398|65551479|FG004|Overall Study|Withdrawal by Subject|4|||
23493402|NCT00723398|65551475|FG000|Overall Study|Protocol Violation|2|||
23493403|NCT00723398|65551476|FG001|Overall Study|Protocol Violation|1|||
23493404|NCT00723398|65551477|FG002|Overall Study|Protocol Violation|5|||
23493405|NCT00723398|65551478|FG003|Overall Study|Protocol Violation|0|||
23493406|NCT00723398|65551479|FG004|Overall Study|Protocol Violation|0|||
23493407|NCT00723398|65551475|FG000|Overall Study|Physician Decision|2|||
23493408|NCT00723398|65551476|FG001|Overall Study|Physician Decision|2|||
23493409|NCT00723398|65551477|FG002|Overall Study|Physician Decision|5|||
23493410|NCT00723398|65551478|FG003|Overall Study|Physician Decision|0|||
23493411|NCT00723398|65551479|FG004|Overall Study|Physician Decision|1|||
23493412|NCT00723398|65551475|FG000|Overall Study|Adverse Event|0|||
23493413|NCT00723398|65551476|FG001|Overall Study|Adverse Event|5|||
23493414|NCT00723398|65551477|FG002|Overall Study|Adverse Event|3|||
23493415|NCT00723398|65551478|FG003|Overall Study|Adverse Event|1|||
23493416|NCT00723398|65551479|FG004|Overall Study|Adverse Event|4|||
23493417|NCT00723398|65551475|FG000|Overall Study|Lost to Follow-up|0|||
23493418|NCT00723398|65551476|FG001|Overall Study|Lost to Follow-up|1|||
23493419|NCT00723398|65551477|FG002|Overall Study|Lost to Follow-up|0|||
23674031|NCT03529773|66186941|FG009|Overall Study|Physician Decision|0|||
23674032|NCT03529773|66186942|FG010|Overall Study|Physician Decision|0|||
23674033|NCT03529773|66186943|FG011|Overall Study|Physician Decision|0|||
23674034|NCT03529773|66186944|FG012|Overall Study|Physician Decision|0|||
23674035|NCT03529773|66186945|FG013|Overall Study|Physician Decision|0|||
23674036|NCT03529773|66186946|FG014|Overall Study|Physician Decision|0|||
23493420|NCT00723398|65551478|FG003|Overall Study|Lost to Follow-up|0|||
23493421|NCT00723398|65551479|FG004|Overall Study|Lost to Follow-up|0|||
23493422|NCT00691301|65551480|FG000|Overall Study|Adverse Event|10|||
23493423|NCT00691301|65551480|FG000|Overall Study|Death|2|||
23493424|NCT00691301|65551480|FG000|Overall Study|Lack of Efficacy|32|||
23493425|NCT00691301|65551480|FG000|Overall Study|Withdrawal by Subject|4|||
23493426|NCT00691301|65551480|FG000|Overall Study|Concurrent illness|2|||
23674037|NCT03529773|66186947|FG015|Overall Study|Physician Decision|0|||
23674038|NCT03529773|66186948|FG016|Overall Study|Physician Decision|0|||
23674039|NCT03529773|66186949|FG017|Overall Study|Physician Decision|0|||
23674040|NCT03529773|66186950|FG018|Overall Study|Physician Decision|0|||
23674041|NCT03529773|66186951|FG019|Overall Study|Physician Decision|1|||
23674042|NCT03529773|66186952|FG020|Overall Study|Physician Decision|1|||
23674043|NCT03529773|66186953|FG021|Overall Study|Physician Decision|0|||
23674044|NCT03529773|66186954|FG022|Overall Study|Physician Decision|0|||
23674045|NCT03529773|66186955|FG023|Overall Study|Physician Decision|0|||
23674046|NCT03529773|66186956|FG024|Overall Study|Physician Decision|0|||
23674047|NCT03529773|66186957|FG025|Overall Study|Physician Decision|0|||
23674048|NCT03529773|66186958|FG026|Overall Study|Physician Decision|0|||
23493427|NCT00691301|65551480|FG000|Overall Study|other reason|3|||
23493428|NCT00691301|65551480|FG000|Overall Study|Did not initiate study treatment|1|||
23493429|NCT00257608|65551482|FG000|Chemotherapy Phase|Adverse Event|138|||
23493430|NCT00257608|65551483|FG001|Chemotherapy Phase|Adverse Event|0|||
23493431|NCT00257608|65551484|FG002|Chemotherapy Phase|Adverse Event|0|||
23493432|NCT00257608|65551482|FG000|Chemotherapy Phase|Disease progression|139|||
23493433|NCT00257608|65551483|FG001|Chemotherapy Phase|Disease progression|0|||
23493434|NCT00257608|65551484|FG002|Chemotherapy Phase|Disease progression|0|||
23493435|NCT00257608|65551482|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
23493436|NCT00257608|65551483|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
23674049|NCT03529773|66186959|FG027|Overall Study|Physician Decision|0|||
23674050|NCT03529773|66186960|FG028|Overall Study|Physician Decision|0|||
23674051|NCT03529773|66186961|FG029|Overall Study|Physician Decision|0|||
23674052|NCT03529773|66186962|FG030|Overall Study|Physician Decision|0|||
23674053|NCT03529773|66186963|FG031|Overall Study|Physician Decision|0|||
23674054|NCT03529773|66186964|FG032|Overall Study|Physician Decision|0|||
23674055|NCT03529773|66186965|FG033|Overall Study|Physician Decision|0|||
23674056|NCT03529773|66186966|FG034|Overall Study|Physician Decision|0|||
23674057|NCT03529773|66186967|FG035|Overall Study|Physician Decision|0|||
23674058|NCT03529773|66186968|FG036|Overall Study|Physician Decision|0|||
23674059|NCT03529773|66186969|FG037|Overall Study|Physician Decision|0|||
23674060|NCT03529773|66186970|FG038|Overall Study|Physician Decision|0|||
23674061|NCT03529773|66186971|FG039|Overall Study|Physician Decision|0|||
23674062|NCT03529773|66186932|FG000|Overall Study|Protocol Violation|0|||
23674063|NCT03529773|66186933|FG001|Overall Study|Protocol Violation|0|||
23674064|NCT03529773|66186934|FG002|Overall Study|Protocol Violation|0|||
23674065|NCT03529773|66186935|FG003|Overall Study|Protocol Violation|0|||
23674066|NCT03529773|66186936|FG004|Overall Study|Protocol Violation|0|||
23674067|NCT03529773|66186937|FG005|Overall Study|Protocol Violation|0|||
23674068|NCT03529773|66186938|FG006|Overall Study|Protocol Violation|0|||
23674069|NCT03529773|66186939|FG007|Overall Study|Protocol Violation|0|||
23674070|NCT03529773|66186940|FG008|Overall Study|Protocol Violation|0|||
23674071|NCT03529773|66186941|FG009|Overall Study|Protocol Violation|0|||
23674072|NCT03529773|66186942|FG010|Overall Study|Protocol Violation|0|||
23674073|NCT03529773|66186943|FG011|Overall Study|Protocol Violation|0|||
23674074|NCT03529773|66186944|FG012|Overall Study|Protocol Violation|0|||
23674075|NCT03529773|66186945|FG013|Overall Study|Protocol Violation|0|||
23674076|NCT03529773|66186946|FG014|Overall Study|Protocol Violation|0|||
23674077|NCT03529773|66186947|FG015|Overall Study|Protocol Violation|0|||
23674078|NCT03529773|66186948|FG016|Overall Study|Protocol Violation|0|||
23674079|NCT03529773|66186949|FG017|Overall Study|Protocol Violation|0|||
23493437|NCT00257608|65551484|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
23674080|NCT03529773|66186950|FG018|Overall Study|Protocol Violation|0|||
23493438|NCT00257608|65551482|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
23493439|NCT00257608|65551483|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493440|NCT00257608|65551484|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493441|NCT00257608|65551482|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
23493442|NCT00257608|65551483|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
23493443|NCT00257608|65551484|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
23493444|NCT00257608|65551482|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
23674081|NCT03529773|66186951|FG019|Overall Study|Protocol Violation|0|||
23674082|NCT03529773|66186952|FG020|Overall Study|Protocol Violation|0|||
23674083|NCT03529773|66186953|FG021|Overall Study|Protocol Violation|0|||
23674084|NCT03529773|66186954|FG022|Overall Study|Protocol Violation|0|||
23674085|NCT03529773|66186955|FG023|Overall Study|Protocol Violation|0|||
23674086|NCT03529773|66186956|FG024|Overall Study|Protocol Violation|0|||
23493445|NCT00257608|65551483|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493446|NCT00257608|65551484|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493447|NCT00257608|65551482|FG000|Chemotherapy Phase|Physician Decision|28|||
23493448|NCT00257608|65551483|FG001|Chemotherapy Phase|Physician Decision|0|||
23493449|NCT00257608|65551484|FG002|Chemotherapy Phase|Physician Decision|0|||
23493450|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Adverse Event|0|||
23493451|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Adverse Event|34|||
23493452|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Adverse Event|38|||
23493453|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Disease progression|0|||
23493454|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Disease progression|204|||
23493455|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Disease progression|168|||
23493456|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
23493457|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
23493458|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
23493459|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493460|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
23493461|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
23493462|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
23493463|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
23493464|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
23493465|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493466|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493467|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
23493468|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
23493469|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
23493470|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
23493471|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Physician Decision|0|||
23493472|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Physician Decision|8|||
23674087|NCT03529773|66186957|FG025|Overall Study|Protocol Violation|0|||
23674088|NCT03529773|66186958|FG026|Overall Study|Protocol Violation|0|||
23493473|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Physician Decision|11|||
23674089|NCT03529773|66186959|FG027|Overall Study|Protocol Violation|0|||
23493474|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
23493475|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
23493476|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
23493477|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Not treated|0|||
23493478|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Not treated|4|||
23493479|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Not treated|7|||
23493480|NCT03417219|65551485|FG000|Overall Study|Lost to Follow-up|0|||
23493481|NCT03417219|65551486|FG001|Overall Study|Lost to Follow-up|3|||
23493482|NCT02349542|65551492|FG000|Overall Study|Withdrawal by Subject|5|||
23493483|NCT04154930|65551493|FG000|Overall Study|Withdrawal by Subject|15|||
23493484|NCT04154930|65551494|FG001|Overall Study|Withdrawal by Subject|6|||
23674090|NCT03529773|66186960|FG028|Overall Study|Protocol Violation|0|||
23674091|NCT03529773|66186961|FG029|Overall Study|Protocol Violation|0|||
23674092|NCT03529773|66186962|FG030|Overall Study|Protocol Violation|1|||
23674093|NCT03529773|66186963|FG031|Overall Study|Protocol Violation|0|||
23674094|NCT03529773|66186964|FG032|Overall Study|Protocol Violation|0|||
23493485|NCT04154930|65551493|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
23493486|NCT04154930|65551494|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
23493487|NCT04154930|65551493|FG000|Overall Study|Lost to Follow-up|14|||
23493488|NCT04154930|65551494|FG001|Overall Study|Lost to Follow-up|6|||
23493489|NCT04154930|65551493|FG000|Overall Study|Other|6|||
23493490|NCT04154930|65551494|FG001|Overall Study|Other|0|||
23493491|NCT04195906|65551495|FG000|Part 1|Adverse Event|3|||
23493492|NCT04195906|65551496|FG001|Part 1|Adverse Event|7|||
23493493|NCT04195906|65551495|FG000|Part 1|Withdrawal by Subject|0|||
23493494|NCT04195906|65551496|FG001|Part 1|Withdrawal by Subject|1|||
23493495|NCT04195906|65551495|FG000|Part 2|Adverse Event|1|||
23493496|NCT04195906|65551496|FG001|Part 2|Adverse Event|1|||
23493497|NCT04195906|65551495|FG000|Part 2|Withdrawal by Subject|0|||
23493498|NCT04195906|65551496|FG001|Part 2|Withdrawal by Subject|3|||
23493499|NCT04195906|65551495|FG000|Part 2|Other|1|||
23493500|NCT04195906|65551496|FG001|Part 2|Other|3|||
23493501|NCT02476201|65551497|FG000|Overall Study|Unable to program MPP|9|||
23493502|NCT02476201|65551497|FG000|Overall Study|Study echo not performed|5|||
23493503|NCT02476201|65551497|FG000|Overall Study|Adverse Event|4|||
23493504|NCT02476201|65551497|FG000|Overall Study|Death|2|||
23493505|NCT02476201|65551497|FG000|Overall Study|Lost to Follow-up|2|||
23493506|NCT02476201|65551497|FG000|Overall Study|MPP programmed to OFF|2|||
23493507|NCT02476201|65551497|FG000|Overall Study|Withdrawal by Subject|1|||
23674095|NCT03529773|66186965|FG033|Overall Study|Protocol Violation|0|||
23674096|NCT03529773|66186966|FG034|Overall Study|Protocol Violation|0|||
23674097|NCT03529773|66186967|FG035|Overall Study|Protocol Violation|0|||
23493508|NCT02476201|65551497|FG000|Overall Study|Unsuccessful implant|1|||
23493509|NCT02486302|65551498|FG000|Overall Study|Discontinued prematurely|410|||
23493510|NCT02486302|65551498|FG000|Overall Study|Documentation not completed|255|||
23493511|NCT02486302|65551498|FG000|Overall Study|Excluded due to legal reasons|8|||
23674098|NCT03529773|66186968|FG036|Overall Study|Protocol Violation|0|||
23674099|NCT03529773|66186969|FG037|Overall Study|Protocol Violation|0|||
23674100|NCT03529773|66186970|FG038|Overall Study|Protocol Violation|0|||
23674101|NCT03529773|66186971|FG039|Overall Study|Protocol Violation|0|||
23674102|NCT03529773|66186932|FG000|Overall Study|Withdrawal by Subject|0|||
23674103|NCT03529773|66186933|FG001|Overall Study|Withdrawal by Subject|0|||
23674104|NCT03529773|66186934|FG002|Overall Study|Withdrawal by Subject|0|||
23674105|NCT03529773|66186935|FG003|Overall Study|Withdrawal by Subject|0|||
23674106|NCT03529773|66186936|FG004|Overall Study|Withdrawal by Subject|0|||
23674107|NCT03529773|66186937|FG005|Overall Study|Withdrawal by Subject|0|||
23674108|NCT03529773|66186938|FG006|Overall Study|Withdrawal by Subject|0|||
23674109|NCT03529773|66186939|FG007|Overall Study|Withdrawal by Subject|1|||
23674110|NCT03529773|66186940|FG008|Overall Study|Withdrawal by Subject|0|||
23674111|NCT03529773|66186941|FG009|Overall Study|Withdrawal by Subject|1|||
23674112|NCT03529773|66186942|FG010|Overall Study|Withdrawal by Subject|1|||
23674113|NCT03529773|66186943|FG011|Overall Study|Withdrawal by Subject|0|||
23674114|NCT03529773|66186944|FG012|Overall Study|Withdrawal by Subject|0|||
23674115|NCT03529773|66186945|FG013|Overall Study|Withdrawal by Subject|0|||
23674116|NCT03529773|66186946|FG014|Overall Study|Withdrawal by Subject|0|||
23674117|NCT03529773|66186947|FG015|Overall Study|Withdrawal by Subject|3|||
23674118|NCT03529773|66186948|FG016|Overall Study|Withdrawal by Subject|0|||
23674119|NCT03529773|66186949|FG017|Overall Study|Withdrawal by Subject|2|||
23674120|NCT03529773|66186950|FG018|Overall Study|Withdrawal by Subject|3|||
23674121|NCT03529773|66186951|FG019|Overall Study|Withdrawal by Subject|1|||
23674122|NCT03529773|66186952|FG020|Overall Study|Withdrawal by Subject|3|||
23674123|NCT03529773|66186953|FG021|Overall Study|Withdrawal by Subject|1|||
23674124|NCT03529773|66186954|FG022|Overall Study|Withdrawal by Subject|1|||
23674125|NCT03529773|66186955|FG023|Overall Study|Withdrawal by Subject|2|||
23674126|NCT03529773|66186956|FG024|Overall Study|Withdrawal by Subject|2|||
23674127|NCT03529773|66186957|FG025|Overall Study|Withdrawal by Subject|4|||
23674128|NCT03529773|66186958|FG026|Overall Study|Withdrawal by Subject|2|||
23674129|NCT03529773|66186959|FG027|Overall Study|Withdrawal by Subject|1|||
23674130|NCT03529773|66186960|FG028|Overall Study|Withdrawal by Subject|1|||
23674131|NCT03529773|66186961|FG029|Overall Study|Withdrawal by Subject|0|||
23674132|NCT03529773|66186962|FG030|Overall Study|Withdrawal by Subject|0|||
23674133|NCT03529773|66186963|FG031|Overall Study|Withdrawal by Subject|0|||
23674134|NCT03529773|66186964|FG032|Overall Study|Withdrawal by Subject|0|||
23674135|NCT03529773|66186965|FG033|Overall Study|Withdrawal by Subject|0|||
23674136|NCT03529773|66186966|FG034|Overall Study|Withdrawal by Subject|1|||
23674137|NCT03529773|66186967|FG035|Overall Study|Withdrawal by Subject|2|||
23674138|NCT03529773|66186968|FG036|Overall Study|Withdrawal by Subject|0|||
23674139|NCT03529773|66186969|FG037|Overall Study|Withdrawal by Subject|2|||
23674140|NCT03529773|66186970|FG038|Overall Study|Withdrawal by Subject|1|||
23386383|NCT01412983|65158660|FG000|1st Period|Positive slit lamp finding|0|||
23386384|NCT01412983|65158661|FG001|1st Period|Positive slit lamp finding|1|||
23386385|NCT01412983|65158660|FG000|1st Period|Unacceptable lens movement|0|||
23386386|NCT01412983|65158661|FG001|1st Period|Unacceptable lens movement|1|||
23386387|NCT01412983|65158660|FG000|1st Period|Inability to maintain wear|0|||
23386388|NCT01412983|65158661|FG001|1st Period|Inability to maintain wear|1|||
23493512|NCT02486302|65551498|FG000|Overall Study|Not treated|3|||
23674141|NCT03529773|66186971|FG039|Overall Study|Withdrawal by Subject|1|||
23674142|NCT03529773|66186932|FG000|Overall Study|Screen Failure|0|||
23674143|NCT03529773|66186933|FG001|Overall Study|Screen Failure|0|||
23674144|NCT03529773|66186934|FG002|Overall Study|Screen Failure|0|||
23674145|NCT03529773|66186935|FG003|Overall Study|Screen Failure|0|||
23674146|NCT03529773|66186936|FG004|Overall Study|Screen Failure|0|||
23674147|NCT03529773|66186937|FG005|Overall Study|Screen Failure|0|||
23674148|NCT03529773|66186938|FG006|Overall Study|Screen Failure|0|||
23493513|NCT03330288|65551499|FG000|Overall Study|Other reason|1|||
23386389|NCT02636283|65158663|FG000|Overall Study|Adverse Event|2|||
23386390|NCT02636283|65158664|FG001|Overall Study|Adverse Event|0|||
23386391|NCT02636283|65158663|FG000|Overall Study|Trial Terminated Prematurely|0|||
23386392|NCT02636283|65158664|FG001|Overall Study|Trial Terminated Prematurely|3|||
23386393|NCT01441414|65158665|FG000|Overall Study|Participant died|9|||
23386394|NCT01441414|65158665|FG000|Overall Study|Other reasons|3|||
23386395|NCT01441414|65158665|FG000|Overall Study|Study terminated by sponsor|2|||
23493514|NCT03330288|65551500|FG001|Overall Study|Other reason|1|||
23386396|NCT01441414|65158665|FG000|Overall Study|Subject refused further follow-up|1|||
23386397|NCT05059080|65158666|FG000|Overall Study|Withdrawal by Subject|3|||
23386398|NCT05059080|65158666|FG000|Overall Study|Study Terminated by Sponsor|64|||
23386399|NCT04648241|65158669|FG000|Overall Study|Lost to Follow-up|1|||
23386400|NCT04648241|65158670|FG001|Overall Study|Lost to Follow-up|0|||
23386401|NCT01160744|65158671|FG000|Overall Study|Withdrawal by Subject|11|||
23386402|NCT01160744|65158672|FG001|Overall Study|Withdrawal by Subject|5|||
23386403|NCT01160744|65158673|FG002|Overall Study|Withdrawal by Subject|6|||
23386404|NCT01160744|65158674|FG003|Overall Study|Withdrawal by Subject|4|||
23386405|NCT01160744|65158671|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386406|NCT01160744|65158672|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386407|NCT01160744|65158673|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
23386408|NCT01160744|65158674|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386409|NCT00471107|65158675|FG000|Overall Study|Technical problems/data loss|3|||
23386410|NCT00471107|65158676|FG001|Overall Study|Technical problems/data loss|1|||
23386411|NCT00471107|65158677|FG002|Overall Study|Technical problems/data loss|3|||
23386412|NCT00303628|65158678|FG000|Overall Study|Disease progression|0|||
23386413|NCT00303628|65158679|FG001|Overall Study|Disease progression|1|||
23386414|NCT00303628|65158678|FG000|Overall Study|Adverse Event|26|||
23386415|NCT00303628|65158679|FG001|Overall Study|Adverse Event|36|||
23386416|NCT00303628|65158678|FG000|Overall Study|Death|0|||
23386417|NCT00303628|65158679|FG001|Overall Study|Death|1|||
23386418|NCT00303628|65158678|FG000|Overall Study|Withdrawal by Subject|11|||
23386419|NCT00303628|65158679|FG001|Overall Study|Withdrawal by Subject|20|||
23386420|NCT00303628|65158678|FG000|Overall Study|Alternative therapy|2|||
23386421|NCT00303628|65158679|FG001|Overall Study|Alternative therapy|0|||
23386422|NCT00303628|65158678|FG000|Overall Study|Other complicating disease|0|||
23386423|NCT00303628|65158679|FG001|Overall Study|Other complicating disease|1|||
23386424|NCT00303628|65158678|FG000|Overall Study|Not start protocol therapy|3|||
23386425|NCT00303628|65158679|FG001|Overall Study|Not start protocol therapy|5|||
23386426|NCT00303628|65158678|FG000|Overall Study|Other|8|||
23386427|NCT00303628|65158679|FG001|Overall Study|Other|9|||
23386428|NCT02441114|65158680|FG000|Washout2|Withdrawal by Subject|4|||
23493515|NCT03330288|65551499|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
23493516|NCT03330288|65551500|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
23493517|NCT03330288|65551499|FG000|Overall Study|Adverse Event|1|||
23493518|NCT03330288|65551500|FG001|Overall Study|Adverse Event|0|||
23493519|NCT03330288|65551499|FG000|Overall Study|Withdrawal by Subject|1|||
23493520|NCT03330288|65551500|FG001|Overall Study|Withdrawal by Subject|0|||
23493521|NCT03330288|65551499|FG000|Overall Study|Lost to Follow-up|26|||
23493522|NCT03330288|65551500|FG001|Overall Study|Lost to Follow-up|7|||
23386429|NCT02366130|65158681|FG000|Overall Study|Withdrawal by Subject|3|||
23386430|NCT02366130|65158681|FG000|Overall Study|Ineligible|6|||
23386431|NCT03158311|65158682|FG000|Overall Study|Subject/Guardian Decision|10|||
23493523|NCT03953820|65551501|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
23493524|NCT03953820|65551502|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
23493525|NCT03953820|65551503|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
23493526|NCT03953820|65551501|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
23493527|NCT03953820|65551502|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
23493528|NCT03953820|65551503|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
23493529|NCT03896165|65551506|FG000|Overall Study|Withdrawal by Subject|2|||
23493530|NCT00066729|65551507|FG000|Overall Study|Lost to Follow-up|1|||
23493531|NCT00066729|65551507|FG000|Overall Study|Disease progression|1|||
23493532|NCT01938573|65551508|FG000|Overall Study|Lack of Efficacy|1|||
23493533|NCT01938573|65551509|FG001|Overall Study|Lack of Efficacy|0|||
23493534|NCT01938573|65551508|FG000|Overall Study|Operation at other hospital|1|||
23386432|NCT03158311|65158683|FG001|Overall Study|Subject/Guardian Decision|6|||
23386433|NCT03158311|65158684|FG002|Overall Study|Subject/Guardian Decision|11|||
23386434|NCT03158311|65158682|FG000|Overall Study|Adverse Event|5|||
23386435|NCT03158311|65158683|FG001|Overall Study|Adverse Event|3|||
23386436|NCT03158311|65158684|FG002|Overall Study|Adverse Event|3|||
23386437|NCT03158311|65158682|FG000|Overall Study|Techinical Problems|3|||
23493535|NCT01938573|65551509|FG001|Overall Study|Operation at other hospital|0|||
23493536|NCT00181155|65551510|FG000|Overall Study|Physician Decision|1|||
23493537|NCT00181155|65551511|FG001|Overall Study|Physician Decision|0|||
23493538|NCT00181155|65551510|FG000|Overall Study|Withdrawal by Subject|1|||
23493539|NCT00181155|65551511|FG001|Overall Study|Withdrawal by Subject|0|||
23674149|NCT03529773|66186939|FG007|Overall Study|Screen Failure|0|||
23674150|NCT03529773|66186940|FG008|Overall Study|Screen Failure|0|||
23674151|NCT03529773|66186941|FG009|Overall Study|Screen Failure|0|||
23674152|NCT03529773|66186942|FG010|Overall Study|Screen Failure|0|||
23674153|NCT03529773|66186943|FG011|Overall Study|Screen Failure|0|||
23674154|NCT03529773|66186944|FG012|Overall Study|Screen Failure|0|||
23674155|NCT03529773|66186945|FG013|Overall Study|Screen Failure|0|||
23674156|NCT03529773|66186946|FG014|Overall Study|Screen Failure|0|||
23674157|NCT03529773|66186947|FG015|Overall Study|Screen Failure|0|||
23674158|NCT03529773|66186948|FG016|Overall Study|Screen Failure|0|||
23674159|NCT03529773|66186949|FG017|Overall Study|Screen Failure|0|||
23674160|NCT03529773|66186950|FG018|Overall Study|Screen Failure|0|||
23674161|NCT03529773|66186951|FG019|Overall Study|Screen Failure|0|||
23674162|NCT03529773|66186952|FG020|Overall Study|Screen Failure|0|||
23674163|NCT03529773|66186953|FG021|Overall Study|Screen Failure|0|||
23674164|NCT03529773|66186954|FG022|Overall Study|Screen Failure|0|||
23674165|NCT03529773|66186955|FG023|Overall Study|Screen Failure|0|||
23674166|NCT03529773|66186956|FG024|Overall Study|Screen Failure|0|||
23674167|NCT03529773|66186957|FG025|Overall Study|Screen Failure|0|||
23674168|NCT03529773|66186958|FG026|Overall Study|Screen Failure|0|||
23674169|NCT03529773|66186959|FG027|Overall Study|Screen Failure|0|||
23674170|NCT03529773|66186960|FG028|Overall Study|Screen Failure|0|||
23674171|NCT03529773|66186961|FG029|Overall Study|Screen Failure|0|||
23674172|NCT03529773|66186962|FG030|Overall Study|Screen Failure|0|||
23674173|NCT03529773|66186963|FG031|Overall Study|Screen Failure|0|||
23674174|NCT03529773|66186964|FG032|Overall Study|Screen Failure|0|||
23674175|NCT03529773|66186965|FG033|Overall Study|Screen Failure|0|||
23674176|NCT03529773|66186966|FG034|Overall Study|Screen Failure|0|||
23674177|NCT03529773|66186967|FG035|Overall Study|Screen Failure|0|||
23674178|NCT03529773|66186968|FG036|Overall Study|Screen Failure|1|||
23674179|NCT03529773|66186969|FG037|Overall Study|Screen Failure|1|||
23674180|NCT03529773|66186970|FG038|Overall Study|Screen Failure|0|||
23674181|NCT03529773|66186971|FG039|Overall Study|Screen Failure|1|||
23674182|NCT03529773|66186932|FG000|Overall Study|Randomized but not vaccinated|0|||
23674183|NCT03529773|66186933|FG001|Overall Study|Randomized but not vaccinated|0|||
23674184|NCT03529773|66186934|FG002|Overall Study|Randomized but not vaccinated|0|||
23674185|NCT03529773|66186935|FG003|Overall Study|Randomized but not vaccinated|0|||
23674186|NCT03529773|66186936|FG004|Overall Study|Randomized but not vaccinated|0|||
23674187|NCT03529773|66186937|FG005|Overall Study|Randomized but not vaccinated|0|||
23674188|NCT03529773|66186938|FG006|Overall Study|Randomized but not vaccinated|0|||
23674189|NCT03529773|66186939|FG007|Overall Study|Randomized but not vaccinated|0|||
23674190|NCT03529773|66186940|FG008|Overall Study|Randomized but not vaccinated|0|||
23674191|NCT03529773|66186941|FG009|Overall Study|Randomized but not vaccinated|0|||
23674192|NCT03529773|66186942|FG010|Overall Study|Randomized but not vaccinated|0|||
23674193|NCT03529773|66186943|FG011|Overall Study|Randomized but not vaccinated|0|||
23674194|NCT03529773|66186944|FG012|Overall Study|Randomized but not vaccinated|0|||
23674195|NCT03529773|66186945|FG013|Overall Study|Randomized but not vaccinated|0|||
23674196|NCT03529773|66186946|FG014|Overall Study|Randomized but not vaccinated|0|||
23674197|NCT03529773|66186947|FG015|Overall Study|Randomized but not vaccinated|0|||
23674198|NCT03529773|66186948|FG016|Overall Study|Randomized but not vaccinated|0|||
23674199|NCT03529773|66186949|FG017|Overall Study|Randomized but not vaccinated|1|||
23674200|NCT03529773|66186950|FG018|Overall Study|Randomized but not vaccinated|0|||
23674201|NCT03529773|66186951|FG019|Overall Study|Randomized but not vaccinated|0|||
23674202|NCT03529773|66186952|FG020|Overall Study|Randomized but not vaccinated|0|||
23674203|NCT03529773|66186953|FG021|Overall Study|Randomized but not vaccinated|0|||
23674204|NCT03529773|66186954|FG022|Overall Study|Randomized but not vaccinated|0|||
23674205|NCT03529773|66186955|FG023|Overall Study|Randomized but not vaccinated|0|||
23674206|NCT03529773|66186956|FG024|Overall Study|Randomized but not vaccinated|0|||
23674207|NCT03529773|66186957|FG025|Overall Study|Randomized but not vaccinated|0|||
23674208|NCT03529773|66186958|FG026|Overall Study|Randomized but not vaccinated|0|||
23674209|NCT03529773|66186959|FG027|Overall Study|Randomized but not vaccinated|1|||
23674210|NCT03529773|66186960|FG028|Overall Study|Randomized but not vaccinated|0|||
23674211|NCT03529773|66186961|FG029|Overall Study|Randomized but not vaccinated|0|||
23674212|NCT03529773|66186962|FG030|Overall Study|Randomized but not vaccinated|0|||
23674213|NCT03529773|66186963|FG031|Overall Study|Randomized but not vaccinated|0|||
23674214|NCT03529773|66186964|FG032|Overall Study|Randomized but not vaccinated|0|||
23674215|NCT03529773|66186965|FG033|Overall Study|Randomized but not vaccinated|0|||
23674216|NCT03529773|66186966|FG034|Overall Study|Randomized but not vaccinated|0|||
23674217|NCT03529773|66186967|FG035|Overall Study|Randomized but not vaccinated|0|||
23674218|NCT03529773|66186968|FG036|Overall Study|Randomized but not vaccinated|0|||
23674219|NCT03529773|66186969|FG037|Overall Study|Randomized but not vaccinated|0|||
23674220|NCT03529773|66186970|FG038|Overall Study|Randomized but not vaccinated|0|||
23674221|NCT03529773|66186971|FG039|Overall Study|Randomized but not vaccinated|0|||
23674222|NCT01902966|66186972|FG000|Overall Study|Death|1|||
23674223|NCT01902966|66186972|FG000|Overall Study|Physician Decision|1|||
23674224|NCT01902966|66186972|FG000|Overall Study|Withdrawal by Subject|1|||
23674225|NCT01780662|66186973|FG000|Overall Study|Adverse Event|1|||
23674226|NCT01780662|66186974|FG001|Overall Study|Adverse Event|0|||
23674227|NCT01780662|66186975|FG002|Overall Study|Adverse Event|2|||
23674228|NCT01780662|66186973|FG000|Overall Study|Physician Decision|0|||
23674229|NCT01780662|66186974|FG001|Overall Study|Physician Decision|5|||
23674230|NCT01780662|66186975|FG002|Overall Study|Physician Decision|7|||
23674231|NCT01780662|66186973|FG000|Overall Study|Protocol Violation|0|||
23674232|NCT01780662|66186974|FG001|Overall Study|Protocol Violation|1|||
23674233|NCT01780662|66186975|FG002|Overall Study|Protocol Violation|0|||
23674234|NCT01780662|66186973|FG000|Overall Study|Ineligible|0|||
23674235|NCT01780662|66186974|FG001|Overall Study|Ineligible|0|||
23674236|NCT01780662|66186975|FG002|Overall Study|Ineligible|1|||
23674237|NCT04942925|66186988|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23674238|NCT04942925|66186989|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23674239|NCT04942925|66186988|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
23674240|NCT04942925|66186989|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
23674241|NCT00049673|66186990|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
23674242|NCT00049673|66186991|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
23674243|NCT01780831|66186993|FG000|Overall Study|Withdrawal by Subject|0|||
23674244|NCT01780831|66186994|FG001|Overall Study|Withdrawal by Subject|0|||
23674245|NCT01780831|66186995|FG002|Overall Study|Withdrawal by Subject|4|||
23674246|NCT01780831|66186996|FG003|Overall Study|Withdrawal by Subject|0|||
23674247|NCT01780831|66186993|FG000|Overall Study|Lost to Follow-up|0|||
23674248|NCT01780831|66186994|FG001|Overall Study|Lost to Follow-up|0|||
23674249|NCT01780831|66186995|FG002|Overall Study|Lost to Follow-up|0|||
23674250|NCT01780831|66186996|FG003|Overall Study|Lost to Follow-up|1|||
23674251|NCT04677712|66186997|FG000|Overall Study|Lost to Follow-up|0|||
23674252|NCT04677712|66186998|FG001|Overall Study|Lost to Follow-up|1|||
23674253|NCT04677712|66186999|FG002|Overall Study|Lost to Follow-up|0|||
23674254|NCT04677712|66187000|FG003|Overall Study|Lost to Follow-up|0|||
23674255|NCT04677712|66187001|FG004|Overall Study|Lost to Follow-up|0|||
23674256|NCT04677712|66187002|FG005|Overall Study|Lost to Follow-up|0|||
23674257|NCT00903929|66187003|FG000|Overall Study|Withdrawal by Subject|0|||
23674258|NCT00903929|66187004|FG001|Overall Study|Withdrawal by Subject|0|||
23674259|NCT00903929|66187005|FG002|Overall Study|Withdrawal by Subject|1|||
23674260|NCT00903929|66187006|FG003|Overall Study|Withdrawal by Subject|2|||
23674261|NCT00903929|66187003|FG000|Overall Study|Adverse Event|0|||
23674262|NCT00903929|66187004|FG001|Overall Study|Adverse Event|0|||
23674263|NCT00903929|66187005|FG002|Overall Study|Adverse Event|0|||
23674264|NCT00903929|66187006|FG003|Overall Study|Adverse Event|1|||
23674265|NCT03713944|66187007|FG000|Study Treatment|Patient non-compliance|1|||
23674266|NCT03713944|66187007|FG000|Study Treatment|Alternative Cancer Therapy|3|||
23674267|NCT03713944|66187007|FG000|Study Treatment|Disease Progression|18|||
23674268|NCT03713944|66187007|FG000|Study Treatment|AE/Side Effects/Complications|2|||
23674269|NCT03713944|66187007|FG000|Study Treatment|Death|2|||
23674270|NCT03713944|66187007|FG000|Study Treatment|Withdrawal by Subject|1|||
23674271|NCT03713944|66187007|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
23674272|NCT03713944|66187007|FG000|Study Treatment|Symptomatic Deterioration|2|||
23674273|NCT03713944|66187007|FG000|Follow up|Withdrawal by Subject|2|||
23674274|NCT03713944|66187007|FG000|Follow up|Death|11|||
23674275|NCT03713944|66187007|FG000|Follow up|Study Terminated|3|||
23674276|NCT01659320|66187011|FG000|Overall Study|Withdrawal by Subject|2|||
23674277|NCT01659320|66187011|FG000|Overall Study|Physician Decision|1|||
23674278|NCT01562548|66187012|FG000|Overall Study|Lost to Follow-up|0|||
23674279|NCT01562548|66187013|FG001|Overall Study|Lost to Follow-up|0|||
23674280|NCT01562548|66187014|FG002|Overall Study|Lost to Follow-up|1|||
23674281|NCT01562548|66187015|FG003|Overall Study|Lost to Follow-up|0|||
23674282|NCT00711100|66187016|FG000|Overall Study|Lack of Efficacy|5|||
23674283|NCT00711100|66187016|FG000|Overall Study|Withdrawal by Subject|8|||
23674284|NCT02222207|66190635|FG000|Overall Study|Death|1|||
23674285|NCT02222207|66190635|FG000|Overall Study|Other reasons|2|||
23674286|NCT02222207|66190635|FG000|Overall Study|Adverse Event|1|||
23674287|NCT02559687|66190639|FG000|Overall Study|Death|112|||
23674288|NCT02559687|66190639|FG000|Overall Study|Sponsor Decision|5|||
23674289|NCT02559687|66190639|FG000|Overall Study|Withdrawal by Subject|4|||
23674290|NCT00874120|66190640|FG000|First Intervention|Adverse Event|0|||
23674291|NCT00874120|66190641|FG001|First Intervention|Adverse Event|1|||
23674292|NCT00874120|66190640|FG000|First Intervention|Withdrawal by Subject|2|||
23674293|NCT00874120|66190641|FG001|First Intervention|Withdrawal by Subject|0|||
23674294|NCT00874120|66190640|FG000|First Intervention|Lost to Follow-up|0|||
23674295|NCT00874120|66190641|FG001|First Intervention|Lost to Follow-up|1|||
23674296|NCT00874120|66190640|FG000|First Intervention|Protocol Violation|3|||
23674297|NCT00874120|66190641|FG001|First Intervention|Protocol Violation|0|||
23674298|NCT00874120|66190640|FG000|First Intervention|positive drug test|1|||
23674299|NCT00874120|66190641|FG001|First Intervention|positive drug test|0|||
23674300|NCT00874120|66190640|FG000|Second Intervention|Withdrawal by Subject|1|||
23674301|NCT00874120|66190641|FG001|Second Intervention|Withdrawal by Subject|0|||
23674302|NCT00874120|66190640|FG000|Second Intervention|Protocol Violation|1|||
23674303|NCT00874120|66190641|FG001|Second Intervention|Protocol Violation|0|||
23674304|NCT00590590|66190642|FG000|Overall Study|Lack of Efficacy|1|||
23674305|NCT00590590|66190643|FG001|Overall Study|Lack of Efficacy|2|||
23674306|NCT00590590|66190644|FG002|Overall Study|Lack of Efficacy|0|||
23674307|NCT00590590|66190642|FG000|Overall Study|Adverse Event|1|||
23674308|NCT00590590|66190643|FG001|Overall Study|Adverse Event|0|||
23674309|NCT00590590|66190644|FG002|Overall Study|Adverse Event|0|||
23674310|NCT00590590|66190642|FG000|Overall Study|Protocol Violation|0|||
23674311|NCT00590590|66190643|FG001|Overall Study|Protocol Violation|0|||
23674312|NCT00590590|66190644|FG002|Overall Study|Protocol Violation|2|||
23674313|NCT00590590|66190642|FG000|Overall Study|Lost to Follow-up|4|||
23674314|NCT00590590|66190643|FG001|Overall Study|Lost to Follow-up|1|||
23674315|NCT00590590|66190644|FG002|Overall Study|Lost to Follow-up|2|||
23674316|NCT00590590|66190642|FG000|Overall Study|Withdrawal by Subject|0|||
23674317|NCT00590590|66190643|FG001|Overall Study|Withdrawal by Subject|1|||
23674318|NCT00590590|66190644|FG002|Overall Study|Withdrawal by Subject|1|||
23674319|NCT00590590|66190642|FG000|Overall Study|Did not complete due to study closure|1|||
23674320|NCT00590590|66190643|FG001|Overall Study|Did not complete due to study closure|1|||
23674321|NCT00590590|66190644|FG002|Overall Study|Did not complete due to study closure|1|||
23674322|NCT00590590|66190642|FG000|Overall Study|Did not complete study|0|||
23674323|NCT00590590|66190643|FG001|Overall Study|Did not complete study|1|||
23674324|NCT00590590|66190644|FG002|Overall Study|Did not complete study|0|||
23674325|NCT02828358|66190647|FG000|Overall Study|Physician Decision|7|||
23674326|NCT02828358|66190648|FG001|Overall Study|Physician Decision|1|||
23674327|NCT02828358|66190647|FG000|Overall Study|Treatment Failure|6|||
23674328|NCT02828358|66190648|FG001|Overall Study|Treatment Failure|0|||
23674329|NCT02828358|66190647|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
23674330|NCT02828358|66190648|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
23674331|NCT02828358|66190647|FG000|Overall Study|Refusal of further protocol therapy|2|||
23674332|NCT02828358|66190648|FG001|Overall Study|Refusal of further protocol therapy|0|||
23674333|NCT02828358|66190647|FG000|Overall Study|Relapse|25|||
23674334|NCT02828358|66190648|FG001|Overall Study|Relapse|0|||
23674335|NCT02828358|66190647|FG000|Overall Study|Still on therapy|5|||
23386438|NCT03158311|65158683|FG001|Overall Study|Techinical Problems|1|||
23386439|NCT03158311|65158684|FG002|Overall Study|Techinical Problems|5|||
23386440|NCT03158311|65158682|FG000|Overall Study|Physician Decision|2|||
23386441|NCT03158311|65158683|FG001|Overall Study|Physician Decision|3|||
23386442|NCT03158311|65158684|FG002|Overall Study|Physician Decision|7|||
23386443|NCT03158311|65158682|FG000|Overall Study|Lost to Follow-up|1|||
23386444|NCT03158311|65158683|FG001|Overall Study|Lost to Follow-up|1|||
23386445|NCT03158311|65158684|FG002|Overall Study|Lost to Follow-up|1|||
23386446|NCT03158311|65158682|FG000|Overall Study|Sponsor decision|1|||
23386447|NCT03158311|65158683|FG001|Overall Study|Sponsor decision|0|||
23386448|NCT03158311|65158684|FG002|Overall Study|Sponsor decision|0|||
23386449|NCT03158311|65158682|FG000|Overall Study|Pregnancy|0|||
23386450|NCT03158311|65158683|FG001|Overall Study|Pregnancy|2|||
23493540|NCT00239590|65551514|FG000|Randomized|Lost to Follow-up|0|||
23493541|NCT00239590|65551515|FG001|Randomized|Lost to Follow-up|1|||
23493542|NCT00239590|65551514|FG000|Randomized|Withdrawal by Subject|0|||
23493543|NCT00239590|65551515|FG001|Randomized|Withdrawal by Subject|1|||
23493544|NCT00239590|65551514|FG000|Completed Study Protocol|Adverse Event|1|||
23493545|NCT00239590|65551515|FG001|Completed Study Protocol|Adverse Event|1|||
23493546|NCT00239590|65551514|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
23493547|NCT00239590|65551515|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
23493548|NCT02906332|65551516|FG000|Overall Study|Withdrawal by Subject|1|||
23493549|NCT02949700|65551523|FG000|Phase I|Withdrawal by Subject|1|||
23386451|NCT03158311|65158684|FG002|Overall Study|Pregnancy|0|||
23386452|NCT03158311|65158682|FG000|Overall Study|Randomized in error|0|||
23674336|NCT02828358|66190648|FG001|Overall Study|Still on therapy|0|||
23674337|NCT02068547|66190649|FG000|Overall Study|Lost to Follow-up|3|||
23674338|NCT02068547|66190650|FG001|Overall Study|Lost to Follow-up|3|||
23674339|NCT02068547|66190649|FG000|Overall Study|Physician Decision|1|||
23386453|NCT03158311|65158683|FG001|Overall Study|Randomized in error|0|||
23386454|NCT03158311|65158684|FG002|Overall Study|Randomized in error|1|||
23386455|NCT00758043|65158685|FG000|Overall Study|Adverse Event|1|||
23386456|NCT00758043|65158686|FG001|Overall Study|Adverse Event|20|||
23386457|NCT00758043|65158687|FG002|Overall Study|Adverse Event|12|||
23493550|NCT02949700|65551524|FG001|Phase I|Withdrawal by Subject|1|||
23674340|NCT02068547|66190650|FG001|Overall Study|Physician Decision|0|||
23674341|NCT01662895|66190652|FG000|Overall Study|Lost to Follow-up|0|||
23674342|NCT01662895|66190653|FG001|Overall Study|Lost to Follow-up|1|||
23674343|NCT00516737|66190654|FG000|Overall Study|Lost to Follow-up|2|||
23674344|NCT00516737|66190655|FG001|Overall Study|Lost to Follow-up|0|||
23674345|NCT00516737|66190654|FG000|Overall Study|Physician Decision|0|||
23674346|NCT00516737|66190655|FG001|Overall Study|Physician Decision|1|||
23386458|NCT00758043|65158688|FG003|Overall Study|Adverse Event|62|||
23386459|NCT00758043|65158685|FG000|Overall Study|Lack of Efficacy|0|||
23386460|NCT00758043|65158686|FG001|Overall Study|Lack of Efficacy|6|||
23386461|NCT00758043|65158687|FG002|Overall Study|Lack of Efficacy|18|||
23386462|NCT00758043|65158688|FG003|Overall Study|Lack of Efficacy|12|||
23386463|NCT00758043|65158685|FG000|Overall Study|Refused Further Treatment|0|||
23386464|NCT00758043|65158686|FG001|Overall Study|Refused Further Treatment|11|||
23386465|NCT00758043|65158687|FG002|Overall Study|Refused Further Treatment|5|||
23386466|NCT00758043|65158688|FG003|Overall Study|Refused Further Treatment|8|||
23386467|NCT00758043|65158685|FG000|Overall Study|Lost to Follow-up|0|||
23386468|NCT00758043|65158686|FG001|Overall Study|Lost to Follow-up|2|||
23386469|NCT00758043|65158687|FG002|Overall Study|Lost to Follow-up|2|||
23493551|NCT02949700|65551525|FG002|Phase I|Withdrawal by Subject|0|||
23493552|NCT02949700|65551526|FG003|Phase I|Withdrawal by Subject|0|||
23493553|NCT02949700|65551523|FG000|Phase I|Protocol Violation|1|||
23493554|NCT02949700|65551524|FG001|Phase I|Protocol Violation|0|||
23493555|NCT02949700|65551525|FG002|Phase I|Protocol Violation|0|||
23493556|NCT02949700|65551526|FG003|Phase I|Protocol Violation|0|||
23493557|NCT02949700|65551523|FG000|Phase II|Withdrawal by Subject|0|||
23493558|NCT02949700|65551524|FG001|Phase II|Withdrawal by Subject|0|||
23674347|NCT00516737|66190654|FG000|Overall Study|Withdrawal by Subject|0|||
23674348|NCT00516737|66190655|FG001|Overall Study|Withdrawal by Subject|1|||
23493559|NCT02949700|65551525|FG002|Phase II|Withdrawal by Subject|0|||
23493560|NCT02949700|65551526|FG003|Phase II|Withdrawal by Subject|2|||
23493561|NCT02949700|65551523|FG000|Phase II|Protocol Violation|0|||
23493562|NCT02949700|65551524|FG001|Phase II|Protocol Violation|0|||
23674349|NCT00516737|66190654|FG000|Overall Study|Lack of Qualifying Event|9|||
23674350|NCT00516737|66190655|FG001|Overall Study|Lack of Qualifying Event|6|||
23674351|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
23674352|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
23674353|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
23674354|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
23674355|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
23674356|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
23674357|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
23674358|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
23493563|NCT02949700|65551525|FG002|Phase II|Protocol Violation|1|||
23493564|NCT02949700|65551526|FG003|Phase II|Protocol Violation|3|||
23674359|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
23674360|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
23493565|NCT02716805|65551531|FG000|Overall Study|Progressive disease|2|||
23493566|NCT02716805|65551532|FG001|Overall Study|Progressive disease|0|||
23386470|NCT00758043|65158688|FG003|Overall Study|Lost to Follow-up|5|||
23386471|NCT00758043|65158685|FG000|Overall Study|Withdrawal by Subject|0|||
23674361|NCT02361216|66190656|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
23674362|NCT02361216|66190657|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
23674363|NCT01926782|66190662|FG000|Overall Study|Participant moved|2|||
23674364|NCT01926782|66190663|FG001|Overall Study|Participant moved|0|||
23674365|NCT01926782|66190664|FG002|Overall Study|Participant moved|1|||
23674366|NCT01926782|66190665|FG003|Overall Study|Participant moved|1|||
23674367|NCT01926782|66190666|FG004|Overall Study|Participant moved|0|||
23674368|NCT01926782|66190667|FG005|Overall Study|Participant moved|3|||
23674369|NCT01926782|66190662|FG000|Overall Study|Physician Decision|0|||
23674370|NCT01926782|66190663|FG001|Overall Study|Physician Decision|2|||
23674371|NCT01926782|66190664|FG002|Overall Study|Physician Decision|1|||
23674372|NCT01926782|66190665|FG003|Overall Study|Physician Decision|1|||
23674373|NCT01926782|66190666|FG004|Overall Study|Physician Decision|0|||
23674374|NCT01926782|66190667|FG005|Overall Study|Physician Decision|0|||
23674375|NCT01926782|66190662|FG000|Overall Study|Other than specified|2|||
23674376|NCT01926782|66190663|FG001|Overall Study|Other than specified|3|||
23674377|NCT01926782|66190664|FG002|Overall Study|Other than specified|5|||
23674378|NCT01926782|66190665|FG003|Overall Study|Other than specified|12|||
23674379|NCT01926782|66190666|FG004|Overall Study|Other than specified|4|||
23674380|NCT01926782|66190667|FG005|Overall Study|Other than specified|11|||
23674381|NCT01926782|66190662|FG000|Overall Study|Adverse Event|13|||
23674382|NCT01926782|66190663|FG001|Overall Study|Adverse Event|4|||
23674383|NCT01926782|66190664|FG002|Overall Study|Adverse Event|17|||
23674384|NCT01926782|66190665|FG003|Overall Study|Adverse Event|4|||
23674385|NCT01926782|66190666|FG004|Overall Study|Adverse Event|3|||
23674386|NCT01926782|66190667|FG005|Overall Study|Adverse Event|14|||
23674387|NCT01926782|66190662|FG000|Overall Study|Poor compliance to protocol|5|||
23674388|NCT01926782|66190663|FG001|Overall Study|Poor compliance to protocol|3|||
23674389|NCT01926782|66190664|FG002|Overall Study|Poor compliance to protocol|8|||
23674390|NCT01926782|66190665|FG003|Overall Study|Poor compliance to protocol|0|||
23674391|NCT01926782|66190666|FG004|Overall Study|Poor compliance to protocol|1|||
23674392|NCT01926782|66190667|FG005|Overall Study|Poor compliance to protocol|6|||
23674393|NCT01926782|66190662|FG000|Overall Study|Randomized and not treated|0|||
23674394|NCT01926782|66190663|FG001|Overall Study|Randomized and not treated|0|||
23674395|NCT01926782|66190664|FG002|Overall Study|Randomized and not treated|0|||
23674396|NCT01926782|66190665|FG003|Overall Study|Randomized and not treated|1|||
23674397|NCT01926782|66190666|FG004|Overall Study|Randomized and not treated|0|||
23674398|NCT01926782|66190667|FG005|Overall Study|Randomized and not treated|0|||
23493567|NCT02716805|65551533|FG002|Overall Study|Progressive disease|0|||
23493568|NCT02716805|65551534|FG003|Overall Study|Progressive disease|0|||
23493569|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
23493570|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
23493571|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493572|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493573|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493574|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
23493575|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
23493576|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493577|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493578|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493579|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
23493580|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
23493581|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493582|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493583|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493584|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23493585|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23493586|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
23493587|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
23674399|NCT01926782|66190662|FG000|Overall Study|Withdrawal by Subject|6|||
23674400|NCT01926782|66190663|FG001|Overall Study|Withdrawal by Subject|1|||
23386472|NCT00758043|65158686|FG001|Overall Study|Withdrawal by Subject|1|||
23674401|NCT01926782|66190664|FG002|Overall Study|Withdrawal by Subject|8|||
23674402|NCT01926782|66190665|FG003|Overall Study|Withdrawal by Subject|1|||
23674403|NCT01926782|66190666|FG004|Overall Study|Withdrawal by Subject|0|||
23674404|NCT01926782|66190667|FG005|Overall Study|Withdrawal by Subject|5|||
23674405|NCT01926782|66190662|FG000|Overall Study|Related to study drug administration|0|||
23674406|NCT01926782|66190663|FG001|Overall Study|Related to study drug administration|0|||
23674407|NCT01926782|66190664|FG002|Overall Study|Related to study drug administration|0|||
23674408|NCT01926782|66190665|FG003|Overall Study|Related to study drug administration|0|||
23674409|NCT01926782|66190666|FG004|Overall Study|Related to study drug administration|0|||
23674410|NCT01926782|66190667|FG005|Overall Study|Related to study drug administration|2|||
23674411|NCT01133171|66190668|FG000|Overall Study|Withdrawal by Subject|1|||
23674412|NCT01133171|66190669|FG001|Overall Study|Withdrawal by Subject|2|||
23674413|NCT01133171|66190670|FG002|Overall Study|Withdrawal by Subject|0|||
23674414|NCT02486757|66190671|FG000|Overall Study|Lost to Follow-up|1|||
23674415|NCT00586495|66190672|FG000|Treatment Period|Adverse Event|11|||
23674416|NCT00586495|66190672|FG000|Treatment Period|Death|1|||
23674417|NCT00586495|66190672|FG000|Treatment Period|Protocol Violation|1|||
23674418|NCT00586495|66190672|FG000|Treatment Period|Withdrawal by Subject|1|||
23674419|NCT00586495|66190672|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
23674420|NCT00586495|66190672|FG000|Treatment Period|Switch to commercial drug|10|||
23674421|NCT00586495|66190672|FG000|Follow-up|Death|40|||
23674422|NCT00586495|66190672|FG000|Follow-up|Lost to Follow-up|1|||
23674423|NCT00586495|66190672|FG000|Follow-up|Withdrawal by Subject|4|||
23674424|NCT00586495|66190672|FG000|Follow-up|Protocol driven decision point|37|||
23674425|NCT00586495|66190672|FG000|Follow-up|Switch to commercial drug|10|||
23674426|NCT02568046|66190673|FG000|Overall Study|Adverse Event|0|||
23674427|NCT02568046|66190674|FG001|Overall Study|Adverse Event|1|||
23674428|NCT02568046|66190673|FG000|Overall Study|Death|2|||
23674429|NCT02568046|66190674|FG001|Overall Study|Death|0|||
23386473|NCT00758043|65158687|FG002|Overall Study|Withdrawal by Subject|1|||
23674430|NCT02568046|66190673|FG000|Overall Study|Progressive Disease|1|||
23674431|NCT02568046|66190674|FG001|Overall Study|Progressive Disease|0|||
23674432|NCT02568046|66190673|FG000|Overall Study|Withdrawal by Subject|2|||
23674433|NCT02568046|66190674|FG001|Overall Study|Withdrawal by Subject|1|||
23674434|NCT02568046|66190673|FG000|Overall Study|Other Events|0|||
23674435|NCT02568046|66190674|FG001|Overall Study|Other Events|1|||
23674436|NCT04849780|66190675|FG000|Period 1|Covid-19 Related|1|||
23674437|NCT04849780|66190676|FG001|Period 1|Covid-19 Related|0|||
23386474|NCT00758043|65158688|FG003|Overall Study|Withdrawal by Subject|4|||
23674438|NCT04849780|66190675|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
23674439|NCT04849780|66190676|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
23674440|NCT04849780|66190675|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
23674441|NCT04849780|66190676|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
23674442|NCT00150592|66190677|FG000|Overall Study|Adverse Event|4|||
23674443|NCT00150592|66190678|FG001|Overall Study|Adverse Event|1|||
23674444|NCT00150592|66190677|FG000|Overall Study|Protocol Violation|1|||
23674445|NCT00150592|66190678|FG001|Overall Study|Protocol Violation|0|||
23674446|NCT00150592|66190677|FG000|Overall Study|Withdrawal by Subject|1|||
23674447|NCT00150592|66190678|FG001|Overall Study|Withdrawal by Subject|2|||
23674448|NCT00150592|66190677|FG000|Overall Study|Non-compliance|1|||
23674449|NCT00150592|66190678|FG001|Overall Study|Non-compliance|0|||
23674450|NCT00412750|66190679|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23674451|NCT00412750|66190680|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23674452|NCT00412750|66190681|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23674453|NCT00412750|66190679|FG000|Overall Study|Administrative problems|21|||
23674454|NCT00412750|66190680|FG001|Overall Study|Administrative problems|17|||
23674455|NCT00412750|66190681|FG002|Overall Study|Administrative problems|14|||
23674456|NCT00412750|66190679|FG000|Overall Study|Adverse Event|8|||
23674457|NCT00412750|66190680|FG001|Overall Study|Adverse Event|3|||
23674458|NCT00412750|66190681|FG002|Overall Study|Adverse Event|3|||
23674459|NCT00412750|66190679|FG000|Overall Study|Lost to Follow-up|1|||
23674460|NCT00412750|66190680|FG001|Overall Study|Lost to Follow-up|0|||
23674461|NCT00412750|66190681|FG002|Overall Study|Lost to Follow-up|1|||
23674462|NCT00412750|66190679|FG000|Overall Study|Withdrawal by Subject|0|||
23674463|NCT00412750|66190680|FG001|Overall Study|Withdrawal by Subject|1|||
23674464|NCT00412750|66190681|FG002|Overall Study|Withdrawal by Subject|2|||
23674465|NCT00412750|66190679|FG000|Overall Study|Lack of Efficacy|0|||
23674466|NCT00412750|66190680|FG001|Overall Study|Lack of Efficacy|0|||
23674467|NCT00412750|66190681|FG002|Overall Study|Lack of Efficacy|3|||
23674468|NCT02556255|66190682|FG000|Overall Study|Lost to Follow-up|4|||
23674469|NCT01273883|66190683|FG000|First Intervention|Adverse Event|2|||
23674470|NCT01273883|66190684|FG001|First Intervention|Adverse Event|1|||
23674471|NCT01273883|66190683|FG000|Second Intervention|Lost to Follow-up|1|||
23674472|NCT01273883|66190684|FG001|Second Intervention|Lost to Follow-up|1|||
23674473|NCT01273883|66190683|FG000|Second Intervention|Lack of Efficacy|1|||
23674474|NCT01273883|66190684|FG001|Second Intervention|Lack of Efficacy|0|||
23674475|NCT00512798|66190690|FG000|Overall Study|Death|0|||
23674476|NCT00512798|66190691|FG001|Overall Study|Death|3|||
23674477|NCT00512798|66190690|FG000|Overall Study|Adverse Event|2|||
23674478|NCT00512798|66190691|FG001|Overall Study|Adverse Event|4|||
23674479|NCT00512798|66190690|FG000|Overall Study|Progression of disease|14|||
23674480|NCT00512798|66190691|FG001|Overall Study|Progression of disease|20|||
23674481|NCT00512798|66190690|FG000|Overall Study|Withdrawal by Subject|3|||
23674482|NCT00512798|66190691|FG001|Overall Study|Withdrawal by Subject|0|||
23674483|NCT01568593|66190694|FG000|Overall Study|Lack of Efficacy|4|||
23674484|NCT01568593|66190695|FG001|Overall Study|Lack of Efficacy|1|||
23674485|NCT01568593|66190694|FG000|Overall Study|Adverse Event|3|||
23674486|NCT01568593|66190695|FG001|Overall Study|Adverse Event|2|||
23674487|NCT04428424|66190696|FG000|Overall Study|Does not meet entrance criteria|132|||
23674488|NCT04428424|66190696|FG000|Overall Study|Lost to Follow-up|115|||
23674489|NCT01294670|66190701|FG000|Overall Study|Not treated|1|||
23493588|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
23493589|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493590|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493591|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493592|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
23493593|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493594|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
23493595|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
23493596|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
23674490|NCT01294670|66190702|FG001|Overall Study|Not treated|0|||
23674491|NCT01294670|66190703|FG002|Overall Study|Not treated|0|||
23674492|NCT01294670|66190704|FG003|Overall Study|Not treated|0|||
23674493|NCT01294670|66190705|FG004|Overall Study|Not treated|0|||
23674494|NCT00695565|66190708|FG000|Overall Study|Lost to Follow-up|4|||
23674495|NCT00695565|66190709|FG001|Overall Study|Lost to Follow-up|4|||
23674496|NCT00695565|66190708|FG000|Overall Study|Adverse Event|3|||
23674497|NCT00695565|66190709|FG001|Overall Study|Adverse Event|1|||
23674498|NCT00695565|66190708|FG000|Overall Study|Protocol Violation|3|||
23674499|NCT00695565|66190709|FG001|Overall Study|Protocol Violation|1|||
23674500|NCT00695565|66190708|FG000|Overall Study|Withdrawal by Subject|1|||
23674501|NCT00695565|66190709|FG001|Overall Study|Withdrawal by Subject|1|||
23674502|NCT00695565|66190708|FG000|Overall Study|Lack of Efficacy|1|||
23674503|NCT00695565|66190709|FG001|Overall Study|Lack of Efficacy|1|||
23493597|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
23493598|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
23493599|NCT00734474|65551548|FG000|Overall Study|Entry Criteria Not Met|0|||
23493600|NCT00734474|65551549|FG001|Overall Study|Entry Criteria Not Met|0|||
23493601|NCT00734474|65551550|FG002|Overall Study|Entry Criteria Not Met|5|||
23493602|NCT00734474|65551551|FG003|Overall Study|Entry Criteria Not Met|0|||
23493603|NCT00734474|65551552|FG004|Overall Study|Entry Criteria Not Met|3|||
23493604|NCT00734474|65551553|FG005|Overall Study|Entry Criteria Not Met|1|||
23493605|NCT00734474|65551554|FG006|Overall Study|Entry Criteria Not Met|0|||
23493606|NCT00734474|65551555|FG007|Overall Study|Entry Criteria Not Met|1|||
23493607|NCT00734474|65551556|FG008|Overall Study|Entry Criteria Not Met|1|||
23493608|NCT00734474|65551548|FG000|Overall Study|Lost to Follow-up|1|||
23493609|NCT00734474|65551549|FG001|Overall Study|Lost to Follow-up|0|||
23493610|NCT00734474|65551550|FG002|Overall Study|Lost to Follow-up|13|||
23493611|NCT00734474|65551551|FG003|Overall Study|Lost to Follow-up|0|||
23493612|NCT00734474|65551552|FG004|Overall Study|Lost to Follow-up|11|||
23493613|NCT00734474|65551553|FG005|Overall Study|Lost to Follow-up|1|||
23493614|NCT00734474|65551554|FG006|Overall Study|Lost to Follow-up|0|||
23493615|NCT00734474|65551555|FG007|Overall Study|Lost to Follow-up|9|||
23493616|NCT00734474|65551556|FG008|Overall Study|Lost to Follow-up|4|||
23493617|NCT00734474|65551548|FG000|Overall Study|Withdrawal by Subject|2|||
23493618|NCT00734474|65551549|FG001|Overall Study|Withdrawal by Subject|1|||
23493619|NCT00734474|65551550|FG002|Overall Study|Withdrawal by Subject|18|||
23493620|NCT00734474|65551551|FG003|Overall Study|Withdrawal by Subject|0|||
23493621|NCT00734474|65551552|FG004|Overall Study|Withdrawal by Subject|24|||
23493622|NCT00734474|65551553|FG005|Overall Study|Withdrawal by Subject|2|||
23493623|NCT00734474|65551554|FG006|Overall Study|Withdrawal by Subject|0|||
23493624|NCT00734474|65551555|FG007|Overall Study|Withdrawal by Subject|36|||
23493625|NCT00734474|65551556|FG008|Overall Study|Withdrawal by Subject|21|||
23493626|NCT00734474|65551548|FG000|Overall Study|Physician Decision|0|||
23493627|NCT00734474|65551549|FG001|Overall Study|Physician Decision|0|||
23493628|NCT00734474|65551550|FG002|Overall Study|Physician Decision|4|||
23493629|NCT00734474|65551551|FG003|Overall Study|Physician Decision|1|||
23493630|NCT00734474|65551552|FG004|Overall Study|Physician Decision|11|||
23493631|NCT00734474|65551553|FG005|Overall Study|Physician Decision|0|||
23493632|NCT00734474|65551554|FG006|Overall Study|Physician Decision|0|||
23493633|NCT00734474|65551555|FG007|Overall Study|Physician Decision|9|||
23493634|NCT00734474|65551556|FG008|Overall Study|Physician Decision|9|||
23493635|NCT00734474|65551548|FG000|Overall Study|Adverse Event|4|||
23674504|NCT00695565|66190708|FG000|Overall Study|Subject did not follow instructions|1|||
23674505|NCT00695565|66190709|FG001|Overall Study|Subject did not follow instructions|1|||
23674506|NCT03718143|66190710|FG000|Overall Study|Death|1|||
23674507|NCT03718143|66190711|FG001|Overall Study|Death|0|||
23674508|NCT03718143|66190712|FG002|Overall Study|Death|0|||
23674509|NCT03718143|66190710|FG000|Overall Study|Progression of Disease|1|||
23674510|NCT03718143|66190711|FG001|Overall Study|Progression of Disease|0|||
23674511|NCT03718143|66190712|FG002|Overall Study|Progression of Disease|0|||
23674512|NCT03718143|66190710|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23674513|NCT03718143|66190711|FG001|Overall Study|Withdrawal of Informed Consent|2|||
23674514|NCT03718143|66190712|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23493636|NCT00734474|65551549|FG001|Overall Study|Adverse Event|4|||
23493637|NCT00734474|65551550|FG002|Overall Study|Adverse Event|63|||
23493638|NCT00734474|65551551|FG003|Overall Study|Adverse Event|1|||
23493639|NCT00734474|65551552|FG004|Overall Study|Adverse Event|64|||
23493640|NCT00734474|65551553|FG005|Overall Study|Adverse Event|0|||
23493641|NCT00734474|65551554|FG006|Overall Study|Adverse Event|1|||
23493642|NCT00734474|65551555|FG007|Overall Study|Adverse Event|65|||
23493643|NCT00734474|65551556|FG008|Overall Study|Adverse Event|39|||
23674515|NCT01745146|66190718|FG000|Overall Study|Withdrawal by Subject|1|||
23493644|NCT00734474|65551548|FG000|Overall Study|Protocol Violation|0|||
23493645|NCT00734474|65551549|FG001|Overall Study|Protocol Violation|0|||
23493646|NCT00734474|65551550|FG002|Overall Study|Protocol Violation|4|||
23493647|NCT00734474|65551551|FG003|Overall Study|Protocol Violation|0|||
23493648|NCT00734474|65551552|FG004|Overall Study|Protocol Violation|3|||
23493649|NCT00734474|65551553|FG005|Overall Study|Protocol Violation|0|||
23493650|NCT00734474|65551554|FG006|Overall Study|Protocol Violation|0|||
23493651|NCT00734474|65551555|FG007|Overall Study|Protocol Violation|3|||
23493652|NCT00734474|65551556|FG008|Overall Study|Protocol Violation|1|||
23674516|NCT01745146|66190719|FG001|Overall Study|Withdrawal by Subject|3|||
23674517|NCT01745146|66190718|FG000|Overall Study|Lost to Follow-up|2|||
23674518|NCT01745146|66190719|FG001|Overall Study|Lost to Follow-up|0|||
23674519|NCT01060059|66190720|FG000|Overall Study|Adverse Event|1|||
23674520|NCT01060059|66190721|FG001|Overall Study|Adverse Event|1|||
23674521|NCT01060059|66190720|FG000|Overall Study|Death|2|||
23674522|NCT01060059|66190721|FG001|Overall Study|Death|3|||
23674523|NCT01060059|66190720|FG000|Overall Study|Lost to Follow-up|18|||
23674524|NCT01060059|66190721|FG001|Overall Study|Lost to Follow-up|34|||
23674525|NCT01060059|66190720|FG000|Overall Study|entry criteria not met|4|||
23674526|NCT01060059|66190721|FG001|Overall Study|entry criteria not met|3|||
23674527|NCT01060059|66190720|FG000|Overall Study|Withdrawal by Subject|35|||
23493653|NCT00734474|65551548|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
23493654|NCT00734474|65551549|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
23493655|NCT00734474|65551550|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493656|NCT00734474|65551551|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
23493657|NCT00734474|65551552|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493658|NCT00734474|65551553|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
23493659|NCT00734474|65551554|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
23493660|NCT00734474|65551555|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493661|NCT00734474|65551556|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493662|NCT00734474|65551548|FG000|Overall Study|Sponsor Decision|0|||
23493663|NCT00734474|65551549|FG001|Overall Study|Sponsor Decision|0|||
23493664|NCT00734474|65551550|FG002|Overall Study|Sponsor Decision|0|||
23493665|NCT00734474|65551551|FG003|Overall Study|Sponsor Decision|0|||
23493666|NCT00734474|65551552|FG004|Overall Study|Sponsor Decision|2|||
23493667|NCT00734474|65551553|FG005|Overall Study|Sponsor Decision|0|||
23493668|NCT00734474|65551554|FG006|Overall Study|Sponsor Decision|0|||
23493669|NCT00734474|65551555|FG007|Overall Study|Sponsor Decision|0|||
23493670|NCT00734474|65551556|FG008|Overall Study|Sponsor Decision|0|||
23493671|NCT00734474|65551548|FG000|Overall Study|Death|0|||
23493672|NCT00734474|65551549|FG001|Overall Study|Death|0|||
23493673|NCT00734474|65551550|FG002|Overall Study|Death|1|||
23493674|NCT00734474|65551551|FG003|Overall Study|Death|0|||
23493675|NCT00734474|65551552|FG004|Overall Study|Death|0|||
23674528|NCT01060059|66190721|FG001|Overall Study|Withdrawal by Subject|23|||
23674529|NCT01060059|66190720|FG000|Overall Study|lack of glycemic control|2|||
23674530|NCT01060059|66190721|FG001|Overall Study|lack of glycemic control|1|||
23674531|NCT01060059|66190720|FG000|Overall Study|lack of compliance|5|||
23674532|NCT01060059|66190721|FG001|Overall Study|lack of compliance|2|||
23674533|NCT00700271|66190722|FG000|Overall Study|Adverse Event|4|||
23674534|NCT00700271|66190723|FG001|Overall Study|Adverse Event|6|||
23674535|NCT00700271|66190722|FG000|Overall Study|Protocol Violation|1|||
23674536|NCT00700271|66190723|FG001|Overall Study|Protocol Violation|0|||
23674537|NCT00700271|66190722|FG000|Overall Study|Administrative Reasons|1|||
23674538|NCT00700271|66190723|FG001|Overall Study|Administrative Reasons|0|||
23674539|NCT00700271|66190722|FG000|Overall Study|Withdrawal by Subject|6|||
23674540|NCT00700271|66190723|FG001|Overall Study|Withdrawal by Subject|4|||
23386475|NCT00758043|65158685|FG000|Overall Study|Required Prohibited Medication|0|||
23493676|NCT00734474|65551553|FG005|Overall Study|Death|0|||
23493677|NCT00734474|65551554|FG006|Overall Study|Death|0|||
23493678|NCT00734474|65551555|FG007|Overall Study|Death|2|||
23493679|NCT00734474|65551556|FG008|Overall Study|Death|1|||
23493680|NCT00734474|65551548|FG000|Overall Study|Lack of Efficacy|0|||
23493681|NCT00734474|65551549|FG001|Overall Study|Lack of Efficacy|0|||
23493682|NCT00734474|65551550|FG002|Overall Study|Lack of Efficacy|4|||
23493683|NCT00734474|65551551|FG003|Overall Study|Lack of Efficacy|0|||
23493684|NCT00734474|65551552|FG004|Overall Study|Lack of Efficacy|0|||
23674541|NCT00700271|66190722|FG000|Overall Study|Lost to Follow-up|2|||
23674542|NCT00700271|66190723|FG001|Overall Study|Lost to Follow-up|2|||
23493685|NCT00734474|65551553|FG005|Overall Study|Lack of Efficacy|0|||
23493686|NCT00734474|65551554|FG006|Overall Study|Lack of Efficacy|0|||
23493687|NCT00734474|65551555|FG007|Overall Study|Lack of Efficacy|4|||
23493688|NCT00734474|65551556|FG008|Overall Study|Lack of Efficacy|6|||
23493689|NCT03841448|65551557|FG000|Double-blind Treatment (DBT) Period|Death|1|||
23493690|NCT03841448|65551558|FG001|Double-blind Treatment (DBT) Period|Death|1|||
23493691|NCT03841448|65551559|FG002|Double-blind Treatment (DBT) Period|Death|0|||
23493692|NCT03841448|65551560|FG003|Double-blind Treatment (DBT) Period|Death|0|||
23493693|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
23493694|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
23493695|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
23674543|NCT01046877|66190729|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
23674544|NCT01046877|66190729|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
23674545|NCT01098071|66190734|FG000|Overall Study|Surgery (adenoidectomy)|2|||
23674546|NCT01098071|66190734|FG000|Overall Study|Lost to Follow-up|13|||
23386476|NCT00758043|65158686|FG001|Overall Study|Required Prohibited Medication|0|||
23386477|NCT00758043|65158687|FG002|Overall Study|Required Prohibited Medication|1|||
23386478|NCT00758043|65158688|FG003|Overall Study|Required Prohibited Medication|3|||
23386479|NCT00758043|65158685|FG000|Overall Study|Non-Compliant With study Drug|0|||
23674547|NCT02301403|66190735|FG000|Overall Study|Withdrawal by Subject|28|||
23674548|NCT02301403|66190736|FG001|Overall Study|Withdrawal by Subject|41|||
23674549|NCT01396005|66190742|FG000|Overall Study|Withdrawal by Subject|0|||
23674550|NCT01396005|66190743|FG001|Overall Study|Withdrawal by Subject|1|||
23674551|NCT01396005|66190742|FG000|Overall Study|Non-compliance with protocol|0|||
23674552|NCT01396005|66190743|FG001|Overall Study|Non-compliance with protocol|1|||
23674553|NCT02363686|66190749|FG000|Overall Study|Withdrawal by Subject|22|||
23674554|NCT02363686|66190749|FG000|Overall Study|incomplete FEES examinations|13|||
23674555|NCT00789529|66190750|FG000|Overall Study|Withdrawal by Subject|0|||
23674556|NCT00789529|66190751|FG001|Overall Study|Withdrawal by Subject|1|||
23674557|NCT00789529|66190750|FG000|Overall Study|Other Reason|1|||
23674558|NCT00789529|66190751|FG001|Overall Study|Other Reason|0|||
23674559|NCT01784965|66190752|FG000|Overall Study|Withdrawal by Subject|6|||
23674560|NCT01784965|66190753|FG001|Overall Study|Withdrawal by Subject|3|||
23674561|NCT01784965|66190752|FG000|Overall Study|Adverse Event|0|||
23674562|NCT01784965|66190753|FG001|Overall Study|Adverse Event|8|||
23674563|NCT00452699|66190754|FG000|Overall Study|Adverse Event|10|||
23674564|NCT00452699|66190755|FG001|Overall Study|Adverse Event|3|||
23674565|NCT00452699|66190754|FG000|Overall Study|Lack of Efficacy|6|||
23674566|NCT00452699|66190755|FG001|Overall Study|Lack of Efficacy|4|||
23674567|NCT00452699|66190754|FG000|Overall Study|Lost to Follow-up|6|||
23674568|NCT00452699|66190755|FG001|Overall Study|Lost to Follow-up|9|||
23674569|NCT00452699|66190754|FG000|Overall Study|Protocol Violation|21|||
23386480|NCT00758043|65158686|FG001|Overall Study|Non-Compliant With study Drug|0|||
23386481|NCT00758043|65158687|FG002|Overall Study|Non-Compliant With study Drug|0|||
23386482|NCT00758043|65158688|FG003|Overall Study|Non-Compliant With study Drug|1|||
23493696|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
23386483|NCT00758043|65158685|FG000|Overall Study|Other Reasons|0|||
23493697|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Death|0|||
23493698|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Death|0|||
23493699|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Death|0|||
23674570|NCT00452699|66190755|FG001|Overall Study|Protocol Violation|25|||
23674571|NCT00452699|66190754|FG000|Overall Study|Withdrawal by Subject|26|||
23674572|NCT00452699|66190755|FG001|Overall Study|Withdrawal by Subject|25|||
23386484|NCT00758043|65158686|FG001|Overall Study|Other Reasons|1|||
23386485|NCT00758043|65158687|FG002|Overall Study|Other Reasons|0|||
23386486|NCT00758043|65158688|FG003|Overall Study|Other Reasons|5|||
23386487|NCT01297244|65158689|FG000|Overall Study|Progressive disease|22|||
23386488|NCT01297244|65158690|FG001|Overall Study|Progressive disease|3|||
23386489|NCT01297244|65158689|FG000|Overall Study|Adverse Event|9|||
23386490|NCT01297244|65158690|FG001|Overall Study|Adverse Event|1|||
23386491|NCT01297244|65158689|FG000|Overall Study|Death|1|||
23386492|NCT01297244|65158690|FG001|Overall Study|Death|1|||
23386493|NCT01297244|65158689|FG000|Overall Study|Clinical progression|1|||
23386494|NCT01297244|65158690|FG001|Overall Study|Clinical progression|1|||
23386495|NCT01297244|65158689|FG000|Overall Study|Withdrawal by Subject|2|||
23386496|NCT01297244|65158690|FG001|Overall Study|Withdrawal by Subject|0|||
23674573|NCT00452699|66190754|FG000|Overall Study|Other|12|||
23674574|NCT00452699|66190755|FG001|Overall Study|Other|7|||
23674575|NCT01736579|66190759|FG000|Overall Study|Termination of Study by Sponsor|2|||
23674576|NCT01736579|66190760|FG001|Overall Study|Termination of Study by Sponsor|2|||
23674577|NCT02740478|66190761|FG000|Overall Study|Withdrawal by Subject|1|||
23674578|NCT01731678|66190762|FG000|Overall Study|Withdrawal by Subject|3|||
23674579|NCT01731678|66190762|FG000|Overall Study|Did not meet inclusion criteria|1|||
23674580|NCT01731678|66190762|FG000|Overall Study|RMT too high, making TMS difficult|3|||
23674581|NCT01338415|66190763|FG000|Core + Extension|Adverse Event|8|||
23674582|NCT01338415|66190764|FG001|Core + Extension|Adverse Event|6|||
23674583|NCT01338415|66190765|FG002|Core + Extension|Adverse Event|0|||
23674584|NCT01338415|66190763|FG000|Core + Extension|Withdrawal by Subject|1|||
23674585|NCT01338415|66190764|FG001|Core + Extension|Withdrawal by Subject|1|||
23674586|NCT01338415|66190765|FG002|Core + Extension|Withdrawal by Subject|0|||
23674587|NCT01338415|66190763|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
23674588|NCT01338415|66190764|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
23674589|NCT01338415|66190765|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
23674590|NCT01338415|66190763|FG000|Core + Extension|Other (administrative reason)|1|||
23674591|NCT01338415|66190764|FG001|Core + Extension|Other (administrative reason)|0|||
23674592|NCT01338415|66190765|FG002|Core + Extension|Other (administrative reason)|0|||
23674593|NCT01338415|66190763|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
23674594|NCT01338415|66190764|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
23674595|NCT01338415|66190765|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
23674596|NCT01338415|66190763|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
23674597|NCT01338415|66190764|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
23674598|NCT01338415|66190765|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
23674599|NCT01338415|66190763|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
23674600|NCT01338415|66190764|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
23674601|NCT01338415|66190765|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
23674602|NCT01338415|66190763|FG000|Exceptional Use Treatment Period|Death|0|||
23674603|NCT01338415|66190764|FG001|Exceptional Use Treatment Period|Death|0|||
23674604|NCT01338415|66190765|FG002|Exceptional Use Treatment Period|Death|1|||
23674605|NCT01777152|66190767|FG000|Overall Study|Withdrawal by Subject|22|||
23674606|NCT01777152|66190768|FG001|Overall Study|Withdrawal by Subject|16|||
23674607|NCT01777152|66190767|FG000|Overall Study|Lost to Follow-up|3|||
23674608|NCT01777152|66190768|FG001|Overall Study|Lost to Follow-up|5|||
23674609|NCT01777152|66190767|FG000|Overall Study|Death|68|||
23386497|NCT00965094|65158692|FG000|Overall Study|Adverse Event|5|||
23674610|NCT01777152|66190768|FG001|Overall Study|Death|89|||
23674611|NCT01777152|66190767|FG000|Overall Study|Not eligible, no study drug received|1|||
23674612|NCT01777152|66190768|FG001|Overall Study|Not eligible, no study drug received|0|||
23674613|NCT01777152|66190767|FG000|Overall Study|Change of diagnosis|1|||
23674614|NCT01777152|66190768|FG001|Overall Study|Change of diagnosis|0|||
23674615|NCT01580488|66190769|FG000|Overall Study|Withdrawal by Subject|1|||
23674616|NCT01375764|66190770|FG000|Overall Study|Lost to Follow-up|0|||
23674617|NCT01375764|66190771|FG001|Overall Study|Lost to Follow-up|1|||
23674618|NCT01375764|66190772|FG002|Overall Study|Lost to Follow-up|0|||
23674619|NCT01375764|66190773|FG003|Overall Study|Lost to Follow-up|0|||
23674620|NCT01375764|66190774|FG004|Overall Study|Lost to Follow-up|0|||
23674621|NCT01375764|66190770|FG000|Overall Study|Withdrawal by Subject|2|||
23674622|NCT01375764|66190771|FG001|Overall Study|Withdrawal by Subject|0|||
23674623|NCT01375764|66190772|FG002|Overall Study|Withdrawal by Subject|0|||
23674624|NCT01375764|66190773|FG003|Overall Study|Withdrawal by Subject|0|||
23674625|NCT01375764|66190774|FG004|Overall Study|Withdrawal by Subject|1|||
23674626|NCT01375764|66190770|FG000|Overall Study|Other|0|||
23674627|NCT01375764|66190771|FG001|Overall Study|Other|0|||
23674628|NCT01375764|66190772|FG002|Overall Study|Other|0|||
23674629|NCT01375764|66190773|FG003|Overall Study|Other|1|||
23674630|NCT01375764|66190774|FG004|Overall Study|Other|0|||
23674631|NCT00705939|66190775|FG000|Overall Study|Protocol Violation|0|||
23674632|NCT00705939|66190776|FG001|Overall Study|Protocol Violation|0|||
23674633|NCT00705939|66190777|FG002|Overall Study|Protocol Violation|1|||
23386498|NCT00965094|65158693|FG001|Overall Study|Adverse Event|0|||
23386499|NCT00965094|65158692|FG000|Overall Study|Lost to Follow-up|0|||
23386500|NCT00965094|65158693|FG001|Overall Study|Lost to Follow-up|1|||
23386501|NCT01052428|65158694|FG000|Overall Study|Death|1|||
23386502|NCT01052428|65158695|FG001|Overall Study|Death|0|||
23386503|NCT01052428|65158694|FG000|Overall Study|Withdrawal by Subject|0|||
23386504|NCT01052428|65158695|FG001|Overall Study|Withdrawal by Subject|1|||
23386505|NCT00003474|65158699|FG000|Overall Study|Not Evaluable|14|||
23386506|NCT00422461|65158700|FG000|Overall Study|Adverse Event|1|||
23386507|NCT00422461|65158701|FG001|Overall Study|Adverse Event|2|||
23386508|NCT00422461|65158702|FG002|Overall Study|Adverse Event|1|||
23386509|NCT00422461|65158703|FG003|Overall Study|Adverse Event|1|||
23674634|NCT00705939|66190775|FG000|Overall Study|Withdrawal by Subject|0|||
23674635|NCT00705939|66190776|FG001|Overall Study|Withdrawal by Subject|1|||
23674636|NCT00705939|66190777|FG002|Overall Study|Withdrawal by Subject|3|||
23674637|NCT00705939|66190775|FG000|Overall Study|Physician Decision|0|||
23674638|NCT00705939|66190776|FG001|Overall Study|Physician Decision|1|||
23674639|NCT00705939|66190777|FG002|Overall Study|Physician Decision|0|||
23674640|NCT01823679|66190778|FG000|Overall Study|Death|1|||
23386510|NCT00422461|65158700|FG000|Overall Study|Other|0|||
23386511|NCT00422461|65158701|FG001|Overall Study|Other|0|||
23386512|NCT00422461|65158702|FG002|Overall Study|Other|0|||
23386513|NCT00422461|65158703|FG003|Overall Study|Other|2|||
23386514|NCT00422461|65158700|FG000|Overall Study|Participants no longer willing to participate in study|1|||
23386515|NCT00422461|65158701|FG001|Overall Study|Participants no longer willing to participate in study|0|||
23386516|NCT00422461|65158702|FG002|Overall Study|Participants no longer willing to participate in study|0|||
23386517|NCT00422461|65158703|FG003|Overall Study|Participants no longer willing to participate in study|0|||
23386518|NCT00422461|65158700|FG000|Overall Study|Randomized but not treated|1|||
23674641|NCT01514682|66190779|FG000|Overall Study|Withdrawal by Subject|2|||
23674642|NCT01514682|66190780|FG001|Overall Study|Withdrawal by Subject|3|||
23674643|NCT01514682|66190779|FG000|Overall Study|Physician Decision|4|||
23674644|NCT01514682|66190780|FG001|Overall Study|Physician Decision|3|||
23674645|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
23674646|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
23674647|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
23674648|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
23674649|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
23674650|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
23674651|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
23674652|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
23674653|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
23674654|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
23674655|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
23674656|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
23674657|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
23674658|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
23674659|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
23674660|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
23674661|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
23674662|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
23386519|NCT00422461|65158701|FG001|Overall Study|Randomized but not treated|1|||
23386520|NCT00422461|65158702|FG002|Overall Study|Randomized but not treated|0|||
23386521|NCT00422461|65158703|FG003|Overall Study|Randomized but not treated|0|||
23386522|NCT04621760|65158704|FG000|Overall Study|Lost to Follow-up|2|||
23386523|NCT04621760|65158705|FG001|Overall Study|Lost to Follow-up|4|||
23386524|NCT04621760|65158704|FG000|Overall Study|Withdrawal by Subject|1|||
23386525|NCT04621760|65158705|FG001|Overall Study|Withdrawal by Subject|0|||
23386526|NCT00985790|65158706|FG000|Overall Study|Withdrawal by Subject|1|||
23386527|NCT00985790|65158707|FG001|Overall Study|Withdrawal by Subject|1|||
23386528|NCT00985790|65158706|FG000|Overall Study|Lost to Follow-up|6|||
23674663|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
23674664|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
23674665|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
23674666|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
23386529|NCT00985790|65158707|FG001|Overall Study|Lost to Follow-up|7|||
23386530|NCT01229111|65158708|FG000|Overall Study|Death|1|||
23674667|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
23674668|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
23386531|NCT00930176|65158709|FG000|Overall Study|Death|1|||
23386532|NCT01239745|65158710|FG000|Overall Study|Study terminated by sponsor|45|||
23386533|NCT01239745|65158710|FG000|Overall Study|Adverse Event|1|||
23386534|NCT00120874|65158711|FG000|Overall Study|Death|0|||
23386535|NCT00120874|65158712|FG001|Overall Study|Death|1|||
23386536|NCT00362609|65158715|FG000|Overall Study|Withdrawal by Subject|0|||
23386537|NCT00362609|65158716|FG001|Overall Study|Withdrawal by Subject|1|||
23386538|NCT00362609|65158715|FG000|Overall Study|Protocol Violation|0|||
23386539|NCT00362609|65158716|FG001|Overall Study|Protocol Violation|1|||
23386540|NCT03808909|65158720|FG000|Overall Study|Lost to Follow-up|3|||
23386541|NCT03808909|65158721|FG001|Overall Study|Lost to Follow-up|0|||
23386542|NCT03437733|65158723|FG000|Overall Study|Eligibility criteria not met|0|||
23386543|NCT03437733|65158724|FG001|Overall Study|Eligibility criteria not met|3|||
23386544|NCT03436420|65158731|FG000|Overall Study|Lack of Efficacy|3|||
23386545|NCT00609973|65158734|FG000|Overall Study|Adverse Event|2|||
23386546|NCT00609973|65158735|FG001|Overall Study|Adverse Event|1|||
23386547|NCT00609973|65158734|FG000|Overall Study|Protocol Violation|4|||
23386548|NCT00609973|65158735|FG001|Overall Study|Protocol Violation|3|||
23386549|NCT00609973|65158734|FG000|Overall Study|Lost to Follow-up|2|||
23386550|NCT00609973|65158735|FG001|Overall Study|Lost to Follow-up|1|||
23386551|NCT00609973|65158734|FG000|Overall Study|Withdrawal by Subject|0|||
23386552|NCT00609973|65158735|FG001|Overall Study|Withdrawal by Subject|1|||
23386553|NCT00394472|65158736|FG000|Overall Study|Protocol Violation|1|||
23386554|NCT00394472|65158737|FG001|Overall Study|Protocol Violation|3|||
23386555|NCT00394472|65158736|FG000|Overall Study|incorrect enrolment|4|||
23386556|NCT00394472|65158737|FG001|Overall Study|incorrect enrolment|2|||
23386557|NCT00394472|65158736|FG000|Overall Study|Adverse Event|4|||
23386558|NCT00394472|65158737|FG001|Overall Study|Adverse Event|2|||
23386559|NCT00394472|65158736|FG000|Overall Study|Withdrawal by Subject|0|||
23386560|NCT00394472|65158737|FG001|Overall Study|Withdrawal by Subject|2|||
23386561|NCT00394472|65158736|FG000|Overall Study|Physician Decision|0|||
23386562|NCT00394472|65158737|FG001|Overall Study|Physician Decision|1|||
23386563|NCT00394472|65158736|FG000|Overall Study|Lost to Follow-up|0|||
23386564|NCT00394472|65158737|FG001|Overall Study|Lost to Follow-up|1|||
23386565|NCT02175758|65158740|FG000|Treatment Phase|Lost to Follow-up|0|||
23386566|NCT02175758|65158741|FG001|Treatment Phase|Lost to Follow-up|1|||
23386567|NCT02175758|65158742|FG002|Treatment Phase|Lost to Follow-up|0|||
23386568|NCT02175758|65158743|FG003|Treatment Phase|Lost to Follow-up|0|||
23386569|NCT02175758|65158744|FG004|Treatment Phase|Lost to Follow-up|0|||
23386570|NCT02175758|65158745|FG005|Treatment Phase|Lost to Follow-up|0|||
23386571|NCT02175758|65158740|FG000|Treatment Phase|Adverse Event|0|||
23386572|NCT02175758|65158741|FG001|Treatment Phase|Adverse Event|0|||
23386573|NCT02175758|65158742|FG002|Treatment Phase|Adverse Event|0|||
23386574|NCT02175758|65158743|FG003|Treatment Phase|Adverse Event|0|||
23386575|NCT02175758|65158744|FG004|Treatment Phase|Adverse Event|1|||
23386576|NCT02175758|65158745|FG005|Treatment Phase|Adverse Event|0|||
23386577|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
23386578|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
23386579|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
23386580|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
23386581|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Progression|1|||
23386582|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
23386583|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
23386584|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Progression|1|||
23386585|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Adverse Event|3|||
23386586|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
23386587|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Progression|1|||
23386588|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
23386589|NCT01117350|65158749|FG000|Comparative Period|Not Treated|5|||
23386590|NCT01117350|65158750|FG001|Comparative Period|Not Treated|8|||
23386591|NCT01117350|65158749|FG000|Comparative Period|Adverse Event|6|||
23386592|NCT01117350|65158750|FG001|Comparative Period|Adverse Event|33|||
23386593|NCT01117350|65158749|FG000|Comparative Period|Lost to Follow-up|11|||
23386594|NCT01117350|65158750|FG001|Comparative Period|Lost to Follow-up|7|||
23386595|NCT01117350|65158749|FG000|Comparative Period|Withdrawal by Subject|9|||
23386596|NCT01117350|65158750|FG001|Comparative Period|Withdrawal by Subject|13|||
23386597|NCT01117350|65158749|FG000|Comparative Period|Protocol Violation|8|||
23386598|NCT01117350|65158750|FG001|Comparative Period|Protocol Violation|12|||
23386599|NCT01117350|65158749|FG000|Comparative Period|Lack of Efficacy|1|||
23386600|NCT01117350|65158750|FG001|Comparative Period|Lack of Efficacy|0|||
23386601|NCT01117350|65158749|FG000|Comparative Period|Physician Decision|0|||
23386602|NCT01117350|65158750|FG001|Comparative Period|Physician Decision|1|||
23386603|NCT01117350|65158749|FG000|Comparative Period|Move to another city/country|2|||
23386604|NCT01117350|65158750|FG001|Comparative Period|Move to another city/country|1|||
23386605|NCT01117350|65158749|FG000|Extension Period|Not included in extension, not treated|0|||
23386606|NCT01117350|65158750|FG001|Extension Period|Not included in extension, not treated|50|||
23386607|NCT01117350|65158749|FG000|Extension Period|Adverse Event|0|||
23386608|NCT01117350|65158750|FG001|Extension Period|Adverse Event|2|||
23386609|NCT01117350|65158749|FG000|Extension Period|Protocol Violation|0|||
23386610|NCT01117350|65158750|FG001|Extension Period|Protocol Violation|2|||
23386611|NCT01117350|65158749|FG000|Extension Period|Lost to Follow-up|0|||
23386612|NCT01117350|65158750|FG001|Extension Period|Lost to Follow-up|2|||
23386613|NCT01117350|65158749|FG000|Extension Period|Withdrawal by Subject|0|||
23386614|NCT01117350|65158750|FG001|Extension Period|Withdrawal by Subject|3|||
23386615|NCT01117350|65158749|FG000|Extension Period|Lack of Efficacy|0|||
23386616|NCT01117350|65158750|FG001|Extension Period|Lack of Efficacy|2|||
23386617|NCT01117350|65158749|FG000|Extension Period|Inclusion criteria not respected|0|||
23386618|NCT01117350|65158750|FG001|Extension Period|Inclusion criteria not respected|1|||
23386619|NCT01117350|65158749|FG000|Extension Period|Prohibited medication|0|||
23386620|NCT01117350|65158750|FG001|Extension Period|Prohibited medication|1|||
23386621|NCT04832971|65158753|FG000|Overall Study|Death|1|||
23386622|NCT04832971|65158754|FG001|Overall Study|Death|0|||
23386623|NCT04832971|65158755|FG002|Overall Study|Death|0|||
23386624|NCT04832971|65158756|FG003|Overall Study|Death|0|||
23386625|NCT04832971|65158753|FG000|Overall Study|Lost to Follow-up|1|||
23386626|NCT04832971|65158754|FG001|Overall Study|Lost to Follow-up|1|||
23386627|NCT04832971|65158755|FG002|Overall Study|Lost to Follow-up|1|||
23386628|NCT04832971|65158756|FG003|Overall Study|Lost to Follow-up|0|||
23386629|NCT04832971|65158753|FG000|Overall Study|Withdrawal by Subject|1|||
23386630|NCT04832971|65158754|FG001|Overall Study|Withdrawal by Subject|3|||
23386631|NCT04832971|65158755|FG002|Overall Study|Withdrawal by Subject|2|||
23386632|NCT04832971|65158756|FG003|Overall Study|Withdrawal by Subject|2|||
23386633|NCT04832971|65158753|FG000|Overall Study|Other, Not Specified|0|||
23386634|NCT04832971|65158754|FG001|Overall Study|Other, Not Specified|0|||
23386635|NCT04832971|65158755|FG002|Overall Study|Other, Not Specified|1|||
23674669|NCT04660643|66190781|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
23386636|NCT04832971|65158756|FG003|Overall Study|Other, Not Specified|0|||
23386637|NCT01778985|65158757|FG000|Overall Study|Lost to Follow-up|1|||
23386638|NCT01778985|65158758|FG001|Overall Study|Lost to Follow-up|0|||
23386639|NCT01778985|65158757|FG000|Overall Study|Physician Decision|2|||
23386640|NCT01778985|65158758|FG001|Overall Study|Physician Decision|2|||
23386641|NCT01778985|65158757|FG000|Overall Study|Protocol Violation|4|||
23386642|NCT01778985|65158758|FG001|Overall Study|Protocol Violation|1|||
23386643|NCT02958527|65158763|FG000|Overall Study|Not collected CRFs|12|||
23386644|NCT03315689|65158768|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
23386645|NCT03315689|65158769|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
23386646|NCT03315689|65158768|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
23386647|NCT03315689|65158769|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
23386648|NCT03315689|65158768|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
23386649|NCT03315689|65158769|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
23386650|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Death|2|||
23386651|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
23386652|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
23386653|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
23386654|NCT00974233|65158770|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
23386655|NCT00974233|65158770|FG000|Maintenance Lenalidomide|Adverse Event|8|||
23386656|NCT00263562|65158771|FG000|Overall Study|Protocol Violation|3|||
23386657|NCT00263562|65158772|FG001|Overall Study|Protocol Violation|0|||
23386658|NCT00723944|65158773|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
23386659|NCT00723944|65158774|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
23386660|NCT00723944|65158773|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
23386661|NCT00723944|65158774|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
23386662|NCT00723944|65158773|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
23386663|NCT00723944|65158774|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
23386664|NCT01964560|65158777|FG000|Overall Study|Adverse Event|23|||
23386665|NCT01964560|65158777|FG000|Overall Study|Lack of Efficacy|46|||
23386666|NCT01964560|65158777|FG000|Overall Study|Protocol deviation|2|||
23386667|NCT01964560|65158777|FG000|Overall Study|Lost to Follow-up|4|||
23386668|NCT01964560|65158777|FG000|Overall Study|Withdrawal by Subject|64|||
23386669|NCT01964560|65158777|FG000|Overall Study|Surgery-hemispherotomy|1|||
23386670|NCT01964560|65158777|FG000|Overall Study|Surgery|1|||
23386671|NCT01964560|65158777|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
23386672|NCT01964560|65158777|FG000|Overall Study|Patient and Investigator choice|1|||
23386673|NCT01964560|65158777|FG000|Overall Study|Patient was prescribed CBD|1|||
23386674|NCT01964560|65158777|FG000|Overall Study|Participant moved to another country|1|||
23386675|NCT02186171|65158778|FG000|Overall Study|Withdrawal by Subject|1|||
23386676|NCT02186171|65158779|FG001|Overall Study|Withdrawal by Subject|9|||
23386677|NCT02186171|65158778|FG000|Overall Study|Lost to Follow-up|2|||
23386678|NCT02186171|65158779|FG001|Overall Study|Lost to Follow-up|2|||
23386679|NCT02186171|65158778|FG000|Overall Study|Death|1|||
23386680|NCT02186171|65158779|FG001|Overall Study|Death|2|||
23386681|NCT02186171|65158778|FG000|Overall Study|Protocol-specified Criteria|0|||
23386682|NCT02186171|65158779|FG001|Overall Study|Protocol-specified Criteria|2|||
23386683|NCT02489773|65158781|FG000|Overall Study|Lost to Follow-up|4|||
23386684|NCT02489773|65158782|FG001|Overall Study|Lost to Follow-up|1|||
23386685|NCT02489773|65158781|FG000|Overall Study|Physician Decision|1|||
23386686|NCT02489773|65158782|FG001|Overall Study|Physician Decision|0|||
23386687|NCT02489773|65158781|FG000|Overall Study|Withdrawal by Subject|1|||
23386688|NCT02489773|65158782|FG001|Overall Study|Withdrawal by Subject|0|||
23386689|NCT02489773|65158781|FG000|Overall Study|Leave the country or the state|1|||
23386690|NCT02489773|65158782|FG001|Overall Study|Leave the country or the state|1|||
23386691|NCT00504231|65158787|FG000|Overall Study|Discrepant chart documentation re route|0|||
23386692|NCT00504231|65158788|FG001|Overall Study|Discrepant chart documentation re route|0|||
23386693|NCT00504231|65158789|FG002|Overall Study|Discrepant chart documentation re route|1|||
23386694|NCT00504231|65158790|FG003|Overall Study|Discrepant chart documentation re route|0|||
23386695|NCT01158404|65158791|FG000|Overall Study|Withdrawal by Subject|0|||
23386696|NCT01158404|65158792|FG001|Overall Study|Withdrawal by Subject|1|||
23386697|NCT01158404|65158793|FG002|Overall Study|Withdrawal by Subject|0|||
23386698|NCT01158404|65158794|FG003|Overall Study|Withdrawal by Subject|0|||
23386699|NCT01158404|65158795|FG004|Overall Study|Withdrawal by Subject|3|||
23386700|NCT01158404|65158796|FG005|Overall Study|Withdrawal by Subject|1|||
23386701|NCT01158404|65158797|FG006|Overall Study|Withdrawal by Subject|0|||
23386702|NCT01158404|65158798|FG007|Overall Study|Withdrawal by Subject|1|||
23386703|NCT01158404|65158791|FG000|Overall Study|Physician Decision|0|||
23386704|NCT01158404|65158792|FG001|Overall Study|Physician Decision|0|||
23386705|NCT01158404|65158793|FG002|Overall Study|Physician Decision|0|||
23386706|NCT01158404|65158794|FG003|Overall Study|Physician Decision|0|||
23386707|NCT01158404|65158795|FG004|Overall Study|Physician Decision|0|||
23386708|NCT01158404|65158796|FG005|Overall Study|Physician Decision|0|||
23386709|NCT01158404|65158797|FG006|Overall Study|Physician Decision|0|||
23386710|NCT01158404|65158798|FG007|Overall Study|Physician Decision|1|||
23386711|NCT01158404|65158791|FG000|Overall Study|Progressive Disease|0|||
23386712|NCT01158404|65158792|FG001|Overall Study|Progressive Disease|0|||
23386713|NCT01158404|65158793|FG002|Overall Study|Progressive Disease|0|||
23386714|NCT01158404|65158794|FG003|Overall Study|Progressive Disease|0|||
23386715|NCT01158404|65158795|FG004|Overall Study|Progressive Disease|0|||
23386716|NCT01158404|65158796|FG005|Overall Study|Progressive Disease|0|||
23386717|NCT01158404|65158797|FG006|Overall Study|Progressive Disease|1|||
23386718|NCT01158404|65158798|FG007|Overall Study|Progressive Disease|0|||
23386719|NCT02528305|65158802|FG000|Overall Study|Withdrawal by Subject|1|||
23386720|NCT02528305|65158802|FG000|Overall Study|Adverse Event|1|||
23386721|NCT02528305|65158802|FG000|Overall Study|Physician Decision|1|||
23386722|NCT01263028|65162619|FG000|Overall Study|Withdrawal by Subject|1|||
23386723|NCT01263028|65162619|FG000|Overall Study|Adverse Event|1|||
23386724|NCT01263028|65162619|FG000|Overall Study|Study terminated due to low enrollment.|4|||
23386725|NCT00537082|65162620|FG000|Overall Study|Adverse Event|6|||
23386726|NCT00537082|65162621|FG001|Overall Study|Adverse Event|6|||
23386727|NCT00537082|65162622|FG002|Overall Study|Adverse Event|3|||
23386728|NCT00537082|65162620|FG000|Overall Study|Protocol Violation|0|||
23386729|NCT00537082|65162621|FG001|Overall Study|Protocol Violation|2|||
23386730|NCT00537082|65162622|FG002|Overall Study|Protocol Violation|1|||
23386731|NCT00537082|65162620|FG000|Overall Study|Lack of Efficacy|0|||
23386732|NCT00537082|65162621|FG001|Overall Study|Lack of Efficacy|0|||
23386733|NCT00537082|65162622|FG002|Overall Study|Lack of Efficacy|2|||
23386734|NCT00537082|65162620|FG000|Overall Study|Withdrawal by Subject|0|||
23386735|NCT00537082|65162621|FG001|Overall Study|Withdrawal by Subject|1|||
23386736|NCT00537082|65162622|FG002|Overall Study|Withdrawal by Subject|0|||
23386737|NCT00537082|65162620|FG000|Overall Study|Discontinued before initiating treatment|3|||
23386738|NCT00537082|65162621|FG001|Overall Study|Discontinued before initiating treatment|0|||
23386739|NCT00537082|65162622|FG002|Overall Study|Discontinued before initiating treatment|0|||
23386740|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
23386741|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
23386742|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
23386743|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
23386744|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
23386745|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
23386746|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
23386747|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
23386748|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
23386749|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
23386750|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
23386751|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
23386752|NCT00292370|65162625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
23386753|NCT00292370|65162626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
23386754|NCT00292370|65162627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
23386755|NCT00292370|65162625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
23386756|NCT00292370|65162626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
23386757|NCT00292370|65162627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
23386758|NCT02123511|65162628|FG000|Overall Study|Cancelled treatment|1|||
23386759|NCT02123511|65162629|FG001|Overall Study|Cancelled treatment|0|||
23386760|NCT02123511|65162628|FG000|Overall Study|Incomplete data|1|||
23386761|NCT02123511|65162629|FG001|Overall Study|Incomplete data|3|||
23386762|NCT02123511|65162628|FG000|Overall Study|Ineligible|0|||
23386763|NCT02123511|65162629|FG001|Overall Study|Ineligible|1|||
23493700|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Death|1|||
23493701|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
23386764|NCT01927861|65162630|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
23386765|NCT01927861|65162631|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
23386766|NCT01927861|65162630|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
23493702|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
23674670|NCT04660643|66190782|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
23674671|NCT04660643|66190783|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
23674672|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
23674673|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
23674674|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
23674675|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
23674676|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
23674677|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
23674678|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
23674679|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
23674680|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
23674681|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
23674682|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
23674683|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
23674684|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
23674685|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
23674686|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
23674687|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
23674688|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
23674689|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
23674690|NCT04660643|66190781|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
23674691|NCT04660643|66190782|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
23674692|NCT04660643|66190783|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
23674693|NCT00523991|66190784|FG000|Overall Study|Adverse Event|6|||
23674694|NCT00523991|66190785|FG001|Overall Study|Adverse Event|5|||
23674695|NCT00523991|66190784|FG000|Overall Study|Protocol Violation|1|||
23674696|NCT00523991|66190785|FG001|Overall Study|Protocol Violation|4|||
23674697|NCT00523991|66190784|FG000|Overall Study|Lost to Follow-up|4|||
23674698|NCT00523991|66190785|FG001|Overall Study|Lost to Follow-up|1|||
23674699|NCT00523991|66190784|FG000|Overall Study|Withdrawal by Subject|7|||
23674700|NCT00523991|66190785|FG001|Overall Study|Withdrawal by Subject|17|||
23386767|NCT01927861|65162631|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
23386768|NCT02184442|65162633|FG000|Overall Study|Death|61|||
23386769|NCT02184442|65162634|FG001|Overall Study|Death|65|||
23386770|NCT02184442|65162633|FG000|Overall Study|Withdrawal by Subject|3|||
23386771|NCT02184442|65162634|FG001|Overall Study|Withdrawal by Subject|11|||
23674701|NCT00523991|66190784|FG000|Overall Study|Other reason (not specified)|3|||
23674702|NCT00523991|66190785|FG001|Overall Study|Other reason (not specified)|0|||
23674703|NCT04673786|66190786|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
23674704|NCT04673786|66190787|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
23674705|NCT04673786|66190788|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
23674706|NCT04673786|66190786|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
23674707|NCT04673786|66190787|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
23674708|NCT04673786|66190788|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
23674709|NCT04673786|66190786|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
23674710|NCT04673786|66190787|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
23674711|NCT04673786|66190788|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
23674712|NCT04673786|66190786|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
23674713|NCT04673786|66190787|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
23674714|NCT04673786|66190788|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
23674715|NCT04673786|66190786|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
23674716|NCT04673786|66190787|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
23674717|NCT04673786|66190788|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
23674718|NCT04673786|66190786|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
23674719|NCT04673786|66190787|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
23674720|NCT04673786|66190788|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
23674721|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
23674722|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
23674723|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
23674724|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
23674725|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
23674726|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
23674727|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
23674728|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
23674729|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
23674730|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
23674731|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
23674732|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
23674733|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
23674734|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
23674735|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
23674736|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
23674737|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
23674738|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
23674739|NCT04418765|66190789|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
23674740|NCT04418765|66190790|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
23386772|NCT02583477|65162635|FG000|Overall Study|Adverse Event|0|||
23386773|NCT02583477|65162636|FG001|Overall Study|Adverse Event|2|||
23386774|NCT02583477|65162635|FG000|Overall Study|Death|1|||
23386775|NCT02583477|65162636|FG001|Overall Study|Death|16|||
23386776|NCT02583477|65162635|FG000|Overall Study|Study terminated|2|||
23386777|NCT02583477|65162636|FG001|Overall Study|Study terminated|2|||
23386778|NCT01543503|65162637|FG000|Overall Study|Lost to Follow-up|32|||
23386779|NCT01543503|65162638|FG001|Overall Study|Lost to Follow-up|36|||
23386780|NCT01543503|65162637|FG000|Overall Study|Adverse Event|9|||
23386781|NCT01543503|65162638|FG001|Overall Study|Adverse Event|13|||
23386782|NCT01543503|65162637|FG000|Overall Study|Lack of Efficacy|4|||
23386783|NCT01543503|65162638|FG001|Overall Study|Lack of Efficacy|16|||
23386784|NCT01543503|65162637|FG000|Overall Study|Participant withdrew informed consent|8|||
23386785|NCT01543503|65162638|FG001|Overall Study|Participant withdrew informed consent|10|||
23386786|NCT01543503|65162637|FG000|Overall Study|Change of jobs|0|||
23386787|NCT01543503|65162638|FG001|Overall Study|Change of jobs|1|||
23386788|NCT01543503|65162637|FG000|Overall Study|Intolerance to the biologic treatment|0|||
23386789|NCT01543503|65162638|FG001|Overall Study|Intolerance to the biologic treatment|1|||
23386790|NCT01543503|65162637|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
23386791|NCT01543503|65162638|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
23386792|NCT01543503|65162637|FG000|Overall Study|Participant did not complete last visit|0|||
23674741|NCT04418765|66190791|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
23386793|NCT01543503|65162638|FG001|Overall Study|Participant did not complete last visit|2|||
23674742|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
23493703|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
23674743|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
23674744|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
23674745|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
23674746|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
23386794|NCT01543503|65162637|FG000|Overall Study|Refused to continue treatment|7|||
23386795|NCT01543503|65162638|FG001|Overall Study|Refused to continue treatment|0|||
23386796|NCT01543503|65162637|FG000|Overall Study|Incorrect medication received|1|||
23386797|NCT01543503|65162638|FG001|Overall Study|Incorrect medication received|0|||
23386798|NCT01543503|65162637|FG000|Overall Study|Participant moved to another city|2|||
23386799|NCT01543503|65162638|FG001|Overall Study|Participant moved to another city|0|||
23386800|NCT01543503|65162637|FG000|Overall Study|Participant will not return for visits|0|||
23386801|NCT01543503|65162638|FG001|Overall Study|Participant will not return for visits|2|||
23386802|NCT01543503|65162637|FG000|Overall Study|Participant transferred to another city|1|||
23386803|NCT01543503|65162638|FG001|Overall Study|Participant transferred to another city|0|||
23386804|NCT01543503|65162637|FG000|Overall Study|Participant moved to Scotland|1|||
23386805|NCT01543503|65162638|FG001|Overall Study|Participant moved to Scotland|0|||
23386806|NCT01543503|65162637|FG000|Overall Study|Participant decision to stop treatment|1|||
23386807|NCT01543503|65162638|FG001|Overall Study|Participant decision to stop treatment|0|||
23386808|NCT01543503|65162637|FG000|Overall Study|Investigator did not wish to participate|1|||
23386809|NCT01543503|65162638|FG001|Overall Study|Investigator did not wish to participate|1|||
23386810|NCT01543503|65162637|FG000|Overall Study|Participant recruited after closing date|0|||
23386811|NCT01543503|65162638|FG001|Overall Study|Participant recruited after closing date|1|||
23386812|NCT01543503|65162637|FG000|Overall Study|Site stopped participation|5|||
23386813|NCT01543503|65162638|FG001|Overall Study|Site stopped participation|1|||
23386814|NCT01543503|65162637|FG000|Overall Study|Participant did not attend a visit|1|||
23386815|NCT01543503|65162638|FG001|Overall Study|Participant did not attend a visit|0|||
23386816|NCT01543503|65162637|FG000|Overall Study|Moved to other rheumatologic site|0|||
23386817|NCT01543503|65162638|FG001|Overall Study|Moved to other rheumatologic site|1|||
23386818|NCT01543503|65162637|FG000|Overall Study|Participant consented to another study|0|||
23386819|NCT01543503|65162638|FG001|Overall Study|Participant consented to another study|2|||
23386820|NCT01543503|65162637|FG000|Overall Study|Participant went to United States|1|||
23386821|NCT01543503|65162638|FG001|Overall Study|Participant went to United States|0|||
23386822|NCT01543503|65162637|FG000|Overall Study|Screen failure|1|||
23386823|NCT01543503|65162638|FG001|Overall Study|Screen failure|0|||
23386824|NCT01096186|65162639|FG000|Overall Study|Adverse Event|16|||
23386825|NCT01096186|65162639|FG000|Overall Study|Death|4|||
23386826|NCT01096186|65162639|FG000|Overall Study|Lack of Efficacy|4|||
23386827|NCT01096186|65162639|FG000|Overall Study|Lost to Follow-up|2|||
23386828|NCT01096186|65162639|FG000|Overall Study|Withdrawal by Subject|22|||
23386829|NCT01096186|65162639|FG000|Overall Study|Physician Decision|1|||
23386830|NCT01096186|65162639|FG000|Overall Study|Noncompliance with study drug|1|||
23386831|NCT04432298|65162641|FG000|Overall Study|Other than specified|1|||
23386832|NCT04432298|65162642|FG001|Overall Study|Other than specified|0|||
23386833|NCT04432298|65162641|FG000|Overall Study|Lost to Follow-up|0|||
23386834|NCT04432298|65162642|FG001|Overall Study|Lost to Follow-up|1|||
23386835|NCT04432298|65162641|FG000|Overall Study|Death|3|||
23386836|NCT04432298|65162642|FG001|Overall Study|Death|2|||
23386837|NCT04432298|65162641|FG000|Overall Study|Withdrawal by Subject|2|||
23386838|NCT04432298|65162642|FG001|Overall Study|Withdrawal by Subject|0|||
23386839|NCT03211832|65162645|FG000|Overall Study|No longer with agency|32|||
23386840|NCT03211832|65162646|FG001|Overall Study|No longer with agency|49|||
23386841|NCT03211832|65162647|FG002|Overall Study|No longer with agency|30|||
23386842|NCT03211832|65162645|FG000|Overall Study|Declined survey|3|||
23386843|NCT03211832|65162646|FG001|Overall Study|Declined survey|3|||
23386844|NCT03211832|65162647|FG002|Overall Study|Declined survey|2|||
23386845|NCT03211832|65162645|FG000|Overall Study|Not available during data collection|1|||
23386846|NCT03211832|65162646|FG001|Overall Study|Not available during data collection|0|||
23386847|NCT03211832|65162647|FG002|Overall Study|Not available during data collection|2|||
23386848|NCT02037984|65162648|FG000|Overall Study|Lack of Efficacy|0|||
23386849|NCT02037984|65162649|FG001|Overall Study|Lack of Efficacy|0|||
23386850|NCT02037984|65162650|FG002|Overall Study|Lack of Efficacy|3|||
23386851|NCT02037984|65162651|FG003|Overall Study|Lack of Efficacy|10|||
23386852|NCT02037984|65162652|FG004|Overall Study|Lack of Efficacy|2|||
23386853|NCT02037984|65162653|FG005|Overall Study|Lack of Efficacy|2|||
23386854|NCT02037984|65162654|FG006|Overall Study|Lack of Efficacy|4|||
23386855|NCT02037984|65162655|FG007|Overall Study|Lack of Efficacy|3|||
23386856|NCT02037984|65162648|FG000|Overall Study|Lost to Follow-up|1|||
23386857|NCT02037984|65162649|FG001|Overall Study|Lost to Follow-up|0|||
23386858|NCT02037984|65162650|FG002|Overall Study|Lost to Follow-up|3|||
23386859|NCT02037984|65162651|FG003|Overall Study|Lost to Follow-up|5|||
23386860|NCT02037984|65162652|FG004|Overall Study|Lost to Follow-up|2|||
23386861|NCT02037984|65162653|FG005|Overall Study|Lost to Follow-up|2|||
23386862|NCT02037984|65162654|FG006|Overall Study|Lost to Follow-up|2|||
23386863|NCT02037984|65162655|FG007|Overall Study|Lost to Follow-up|4|||
23674747|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
23674748|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
23674749|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
23674750|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
23674751|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
23674752|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
23674753|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
23674754|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
23674755|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
23674756|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
23674757|NCT04418765|66190789|FG000|Extension Period (48 Weeks)|Other than specified|0|||
23674758|NCT04418765|66190790|FG001|Extension Period (48 Weeks)|Other than specified|5|||
23674759|NCT04418765|66190791|FG002|Extension Period (48 Weeks)|Other than specified|2|||
23674760|NCT03557281|66190795|FG000|Overall Study|Investigator discretion|0|||
23674761|NCT03557281|66190796|FG001|Overall Study|Investigator discretion|0|||
23674762|NCT03557281|66190797|FG002|Overall Study|Investigator discretion|1|||
23674763|NCT03557281|66190798|FG003|Overall Study|Investigator discretion|0|||
23674764|NCT03557281|66190799|FG004|Overall Study|Investigator discretion|0|||
23674765|NCT03557281|66190795|FG000|Overall Study|Withdrawal by Subject|0|||
23386864|NCT02037984|65162648|FG000|Overall Study|Physician Decision|0|||
23386865|NCT02037984|65162649|FG001|Overall Study|Physician Decision|0|||
23386866|NCT02037984|65162650|FG002|Overall Study|Physician Decision|0|||
23674766|NCT03557281|66190796|FG001|Overall Study|Withdrawal by Subject|1|||
23674767|NCT03557281|66190797|FG002|Overall Study|Withdrawal by Subject|1|||
23674768|NCT03557281|66190798|FG003|Overall Study|Withdrawal by Subject|1|||
23386867|NCT02037984|65162651|FG003|Overall Study|Physician Decision|0|||
23386868|NCT02037984|65162652|FG004|Overall Study|Physician Decision|0|||
23386869|NCT02037984|65162653|FG005|Overall Study|Physician Decision|0|||
23386870|NCT02037984|65162654|FG006|Overall Study|Physician Decision|1|||
23386871|NCT02037984|65162655|FG007|Overall Study|Physician Decision|0|||
23386872|NCT02037984|65162648|FG000|Overall Study|Protocol Violation|0|||
23386873|NCT02037984|65162649|FG001|Overall Study|Protocol Violation|0|||
23386874|NCT02037984|65162650|FG002|Overall Study|Protocol Violation|0|||
23386875|NCT02037984|65162651|FG003|Overall Study|Protocol Violation|0|||
23386876|NCT02037984|65162652|FG004|Overall Study|Protocol Violation|0|||
23386877|NCT02037984|65162653|FG005|Overall Study|Protocol Violation|1|||
23386878|NCT02037984|65162654|FG006|Overall Study|Protocol Violation|2|||
23386879|NCT02037984|65162655|FG007|Overall Study|Protocol Violation|0|||
23386880|NCT02037984|65162648|FG000|Overall Study|Technical Problems|0|||
23674769|NCT03557281|66190799|FG004|Overall Study|Withdrawal by Subject|2|||
23674770|NCT03557281|66190795|FG000|Overall Study|Randomized, but did not receive treatment|0|||
23674771|NCT03557281|66190796|FG001|Overall Study|Randomized, but did not receive treatment|0|||
23674772|NCT03557281|66190797|FG002|Overall Study|Randomized, but did not receive treatment|0|||
23674773|NCT03557281|66190798|FG003|Overall Study|Randomized, but did not receive treatment|0|||
23674774|NCT03557281|66190799|FG004|Overall Study|Randomized, but did not receive treatment|1|||
23674775|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
23674776|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23674777|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23674778|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23674779|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
23674780|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23674781|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23674782|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23674783|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
23674784|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23674785|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23674786|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23674787|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
23674788|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23674789|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23386881|NCT02037984|65162649|FG001|Overall Study|Technical Problems|0|||
23386882|NCT02037984|65162650|FG002|Overall Study|Technical Problems|3|||
23386883|NCT02037984|65162651|FG003|Overall Study|Technical Problems|3|||
23386884|NCT02037984|65162652|FG004|Overall Study|Technical Problems|2|||
23386885|NCT02037984|65162653|FG005|Overall Study|Technical Problems|3|||
23386886|NCT02037984|65162654|FG006|Overall Study|Technical Problems|4|||
23386887|NCT02037984|65162655|FG007|Overall Study|Technical Problems|2|||
23386888|NCT02037984|65162648|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23386889|NCT02037984|65162649|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23386890|NCT02037984|65162650|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
23386891|NCT02037984|65162651|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
23386892|NCT02037984|65162652|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
23674790|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23674791|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
23674792|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23386893|NCT02037984|65162653|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
23493704|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
23674793|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23674794|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23674795|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
23674796|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23674797|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23674798|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23674799|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
23674800|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23674801|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23674802|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23674803|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
23674804|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23674805|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23674806|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23674807|NCT03605680|66190800|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
23674808|NCT03605680|66190801|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23674809|NCT03605680|66190802|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23674810|NCT03605680|66190803|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23674811|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
23674812|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
23674813|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
23674814|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
23674815|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
23674816|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
23674817|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
23674818|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
23674819|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23674820|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23674821|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23674822|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23674823|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23674824|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23674825|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
23674826|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23674827|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
23674828|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
23674829|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
23674830|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
23674831|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
23674832|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
23674833|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
23674834|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
23674835|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
23386894|NCT02037984|65162654|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
23386895|NCT02037984|65162655|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
23386896|NCT02037984|65162648|FG000|Overall Study|Withdrawal by Subject|0|||
23386897|NCT02037984|65162649|FG001|Overall Study|Withdrawal by Subject|0|||
23386898|NCT02037984|65162650|FG002|Overall Study|Withdrawal by Subject|0|||
23386899|NCT02037984|65162651|FG003|Overall Study|Withdrawal by Subject|1|||
23386900|NCT02037984|65162652|FG004|Overall Study|Withdrawal by Subject|1|||
23386901|NCT02037984|65162653|FG005|Overall Study|Withdrawal by Subject|3|||
23386902|NCT02037984|65162654|FG006|Overall Study|Withdrawal by Subject|0|||
23386903|NCT02037984|65162655|FG007|Overall Study|Withdrawal by Subject|1|||
23386904|NCT01392495|65162662|FG000|Overall Study|Death|3|||
23386905|NCT01392495|65162662|FG000|Overall Study|Administrative problems|8|||
23386906|NCT01392495|65162662|FG000|Overall Study|Withdrawal by Subject|2|||
23386907|NCT01392495|65162662|FG000|Overall Study|Adverse Event|3|||
23386908|NCT00215553|65162663|FG000|Overall Study|Adverse Event|0|||
23386909|NCT00215553|65162664|FG001|Overall Study|Adverse Event|1|||
23674836|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23386910|NCT00215553|65162665|FG002|Overall Study|Adverse Event|2|||
23386911|NCT00215553|65162666|FG003|Overall Study|Adverse Event|1|||
23386912|NCT00215553|65162667|FG004|Overall Study|Adverse Event|2|||
23386913|NCT00215553|65162668|FG005|Overall Study|Adverse Event|6|||
23386914|NCT00215553|65162669|FG006|Overall Study|Adverse Event|0|||
23386915|NCT02176525|65162672|FG000|Overall Study|Adverse Event|0|||
23386916|NCT02176525|65162673|FG001|Overall Study|Adverse Event|0|||
23386917|NCT02176525|65162674|FG002|Overall Study|Adverse Event|0|||
23386918|NCT02176525|65162675|FG003|Overall Study|Adverse Event|1|||
23386919|NCT02176525|65162676|FG004|Overall Study|Adverse Event|1|||
23386920|NCT02176525|65162677|FG005|Overall Study|Adverse Event|0|||
23386921|NCT02176525|65162678|FG006|Overall Study|Adverse Event|1|||
23386922|NCT02176525|65162679|FG007|Overall Study|Adverse Event|0|||
23386923|NCT02176525|65162672|FG000|Overall Study|not treated|1|||
23386924|NCT02176525|65162673|FG001|Overall Study|not treated|0|||
23386925|NCT02176525|65162674|FG002|Overall Study|not treated|0|||
23386926|NCT02176525|65162675|FG003|Overall Study|not treated|0|||
23386927|NCT02176525|65162676|FG004|Overall Study|not treated|0|||
23386928|NCT02176525|65162677|FG005|Overall Study|not treated|1|||
23386929|NCT02176525|65162678|FG006|Overall Study|not treated|0|||
23386930|NCT02176525|65162679|FG007|Overall Study|not treated|0|||
23386931|NCT02301429|65162680|FG000|Overall Study|not acceptable vascular anatomy|3|||
23386932|NCT00311168|65162681|FG000|First Intervention|Withdrawal by Subject|2|||
23386933|NCT00311168|65162682|FG001|First Intervention|Withdrawal by Subject|2|||
23386934|NCT00311168|65162681|FG000|First Intervention|Lost to Follow-up|1|||
23386935|NCT00311168|65162682|FG001|First Intervention|Lost to Follow-up|1|||
23386936|NCT00311168|65162681|FG000|First Intervention|Protocol Violation|1|||
23386937|NCT00311168|65162682|FG001|First Intervention|Protocol Violation|1|||
23386938|NCT00311168|65162681|FG000|First Intervention|Adverse Event|1|||
23386939|NCT00311168|65162682|FG001|First Intervention|Adverse Event|0|||
23386940|NCT00311168|65162681|FG000|First Intervention|Other|2|||
23386941|NCT00311168|65162682|FG001|First Intervention|Other|2|||
23386942|NCT00311168|65162681|FG000|Second Intervention|Lost to Follow-up|9|||
23386943|NCT00311168|65162682|FG001|Second Intervention|Lost to Follow-up|2|||
23386944|NCT00311168|65162681|FG000|Second Intervention|Withdrawal by Subject|0|||
23386945|NCT00311168|65162682|FG001|Second Intervention|Withdrawal by Subject|1|||
23386946|NCT00311168|65162681|FG000|Second Intervention|Other|1|||
23386947|NCT00311168|65162682|FG001|Second Intervention|Other|1|||
23386948|NCT03511066|65162684|FG000|Overall Study|Withdrawal by Subject|1|||
23386949|NCT03511066|65162685|FG001|Overall Study|Withdrawal by Subject|2|||
23386950|NCT03511066|65162686|FG002|Overall Study|Withdrawal by Subject|3|||
23386951|NCT03511066|65162684|FG000|Overall Study|Lost to Follow-up|2|||
23386952|NCT03511066|65162685|FG001|Overall Study|Lost to Follow-up|3|||
23674837|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23386953|NCT03511066|65162686|FG002|Overall Study|Lost to Follow-up|0|||
23386954|NCT01230814|65162687|FG000|Overall Study|Lost to Follow-up|11|||
23386955|NCT01230814|65162688|FG001|Overall Study|Lost to Follow-up|3|||
23386956|NCT01230814|65162687|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
23386957|NCT01230814|65162688|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
23386958|NCT00159874|65162691|FG000|Overall Study|Adverse Event|2|||
23386959|NCT00159874|65162692|FG001|Overall Study|Adverse Event|2|||
23386960|NCT00159874|65162693|FG002|Overall Study|Adverse Event|5|||
23674838|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
23674839|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
23674840|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
23674841|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
23674842|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
23674843|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
23674844|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
23674845|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
23674846|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
23674847|NCT03605680|66190800|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
23674848|NCT03605680|66190801|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
23674849|NCT03605680|66190802|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
23674850|NCT03605680|66190803|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
23674851|NCT01446419|66190804|FG000|Overall Study|Death|1|||
23674852|NCT01446419|66190805|FG001|Overall Study|Death|0|||
23674853|NCT01446419|66190804|FG000|Overall Study|Withdrawal by Subject|1|||
23674854|NCT01446419|66190805|FG001|Overall Study|Withdrawal by Subject|1|||
23674855|NCT01446419|66190804|FG000|Overall Study|Terminated per protocol|3|||
23674856|NCT01446419|66190805|FG001|Overall Study|Terminated per protocol|0|||
23674857|NCT02387580|66190808|FG000|Overall Study|Withdrawal by Subject|0|||
23674858|NCT02387580|66190809|FG001|Overall Study|Withdrawal by Subject|0|||
23674859|NCT02387580|66190810|FG002|Overall Study|Withdrawal by Subject|0|||
23674860|NCT02387580|66190811|FG003|Overall Study|Withdrawal by Subject|1|||
23674861|NCT02387580|66190812|FG004|Overall Study|Withdrawal by Subject|0|||
23674862|NCT02387580|66190813|FG005|Overall Study|Withdrawal by Subject|0|||
23674863|NCT00268242|66190818|FG000|Overall Study|Death|1|||
23674864|NCT01816243|66190819|FG000|Overall Study|Adverse Event|6|||
23674865|NCT01816243|66190819|FG000|Overall Study|Lost to Follow-up|1|||
23674866|NCT01816243|66190819|FG000|Overall Study|Lack of Efficacy|1|||
23674867|NCT01816243|66190819|FG000|Overall Study|Not eligible for the study|1|||
23674868|NCT01816243|66190819|FG000|Overall Study|Amputation|3|||
23674869|NCT04356183|66190823|FG000|Overall Study|Lost to Follow-up|1|||
23674870|NCT04356183|66190824|FG001|Overall Study|Lost to Follow-up|0|||
23674871|NCT04356183|66190823|FG000|Overall Study|Withdrawal by Subject|1|||
23674872|NCT04356183|66190824|FG001|Overall Study|Withdrawal by Subject|1|||
23386961|NCT00159874|65162694|FG003|Overall Study|Adverse Event|1|||
23674873|NCT01035905|66190825|FG000|Overall Study|Lack of Efficacy|1|||
23674874|NCT01035905|66190826|FG001|Overall Study|Lack of Efficacy|1|||
23674875|NCT00464178|66190829|FG000|Overall Study|Protocol Violation|1|||
23674876|NCT00464178|66190829|FG000|Overall Study|Withdrawal by Subject|1|||
23674877|NCT02105454|66190830|FG000|Overall Study|Withdrawal by Subject|1|||
23674878|NCT00433329|66190831|FG000|Overall Study|Adverse Event|9|||
23674879|NCT00433329|66190831|FG000|Overall Study|Death|4|||
23674880|NCT00433329|66190831|FG000|Overall Study|Withdrew consent|3|||
23674881|NCT00433329|66190831|FG000|Overall Study|Discontinued sildenafil|2|||
23386962|NCT00159874|65162695|FG004|Overall Study|Adverse Event|1|||
23386963|NCT00159874|65162696|FG005|Overall Study|Adverse Event|2|||
23386964|NCT00159874|65162697|FG006|Overall Study|Adverse Event|0|||
23386965|NCT00159874|65162691|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
23386966|NCT00159874|65162692|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
23386967|NCT00159874|65162693|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
23386968|NCT00159874|65162694|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
23386969|NCT00159874|65162695|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
23386970|NCT00159874|65162696|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
23386971|NCT00159874|65162697|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
23386972|NCT00159874|65162691|FG000|Overall Study|Lack of Efficacy|2|||
23386973|NCT00159874|65162692|FG001|Overall Study|Lack of Efficacy|0|||
23674882|NCT00433329|66190831|FG000|Overall Study|Moved out of state|1|||
23674883|NCT00433329|66190831|FG000|Overall Study|Lost to Follow-up|1|||
23674884|NCT00433329|66190831|FG000|Overall Study|Physician Decision|1|||
23674885|NCT01965262|66190832|FG000|Second Intervention (7 Days)|Discontinued|0|||
23386974|NCT00159874|65162693|FG002|Overall Study|Lack of Efficacy|1|||
23493705|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
23674886|NCT01965262|66190833|FG001|Second Intervention (7 Days)|Discontinued|1|||
23674887|NCT01965262|66190832|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
23674888|NCT01965262|66190833|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
23674889|NCT01965262|66190832|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
23674890|NCT01965262|66190833|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
23674891|NCT00699907|66190834|FG000|Overall Study|Withdrawal by Subject|2|||
23674892|NCT00699907|66190835|FG001|Overall Study|Withdrawal by Subject|1|||
23674893|NCT00699907|66190836|FG002|Overall Study|Withdrawal by Subject|0|||
23674894|NCT00699907|66190834|FG000|Overall Study|No usable sample|0|||
23674895|NCT00699907|66190835|FG001|Overall Study|No usable sample|9|||
23674896|NCT00699907|66190836|FG002|Overall Study|No usable sample|8|||
23674897|NCT00391222|66190837|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23674898|NCT00391222|66190838|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23674899|NCT00391222|66190839|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23674900|NCT00391222|66190840|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
23674901|NCT00391222|66190837|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23674902|NCT00391222|66190838|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23674903|NCT00391222|66190839|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23674904|NCT00391222|66190840|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
23674905|NCT00391222|66190837|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23674906|NCT00391222|66190838|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23674907|NCT00391222|66190839|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23674908|NCT00391222|66190840|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
23674909|NCT00391222|66190837|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23674910|NCT00391222|66190838|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23674911|NCT00391222|66190839|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23674912|NCT00391222|66190840|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
23674913|NCT00391222|66190837|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
23674914|NCT00391222|66190838|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
23386975|NCT00159874|65162694|FG003|Overall Study|Lack of Efficacy|1|||
23386976|NCT00159874|65162695|FG004|Overall Study|Lack of Efficacy|0|||
23386977|NCT00159874|65162696|FG005|Overall Study|Lack of Efficacy|3|||
23386978|NCT00159874|65162697|FG006|Overall Study|Lack of Efficacy|0|||
23386979|NCT00159874|65162691|FG000|Overall Study|Lost to Follow-up|1|||
23386980|NCT00159874|65162692|FG001|Overall Study|Lost to Follow-up|0|||
23386981|NCT00159874|65162693|FG002|Overall Study|Lost to Follow-up|3|||
23386982|NCT00159874|65162694|FG003|Overall Study|Lost to Follow-up|0|||
23386983|NCT00159874|65162695|FG004|Overall Study|Lost to Follow-up|1|||
23674915|NCT00391222|66190839|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
23674916|NCT00391222|66190840|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
23674917|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
23674918|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
23674919|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
23674920|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
23674921|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
23674922|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
23674923|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
23674924|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
23674925|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
23674926|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
23674927|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
23674928|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
23674929|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
23674930|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
23674931|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
23674932|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
23674933|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
23674934|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
23674935|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
23674936|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
23674937|NCT00391222|66190837|FG000|Period III (Double-Blind Treatment)|Other|6|||
23674938|NCT00391222|66190838|FG001|Period III (Double-Blind Treatment)|Other|1|||
23674939|NCT00391222|66190839|FG002|Period III (Double-Blind Treatment)|Other|6|||
23674940|NCT00391222|66190840|FG003|Period III (Double-Blind Treatment)|Other|0|||
23674941|NCT03969888|66190841|FG000|Overall Study|Never Received Study Drug|0|||
23674942|NCT03969888|66190842|FG001|Overall Study|Never Received Study Drug|0|||
23674943|NCT03969888|66190843|FG002|Overall Study|Never Received Study Drug|1|||
23674944|NCT03969888|66190844|FG003|Overall Study|Never Received Study Drug|0|||
23674945|NCT03969888|66190845|FG004|Overall Study|Never Received Study Drug|0|||
23674946|NCT03969888|66190846|FG005|Overall Study|Never Received Study Drug|0|||
23674947|NCT03969888|66190847|FG006|Overall Study|Never Received Study Drug|1|||
23674948|NCT03969888|66190848|FG007|Overall Study|Never Received Study Drug|0|||
23674949|NCT03969888|66190841|FG000|Overall Study|Reason Not Specified|0|||
23674950|NCT03969888|66190842|FG001|Overall Study|Reason Not Specified|0|||
23674951|NCT03969888|66190843|FG002|Overall Study|Reason Not Specified|0|||
23674952|NCT03969888|66190844|FG003|Overall Study|Reason Not Specified|0|||
23674953|NCT03969888|66190845|FG004|Overall Study|Reason Not Specified|0|||
23674954|NCT03969888|66190846|FG005|Overall Study|Reason Not Specified|0|||
23386984|NCT00159874|65162696|FG005|Overall Study|Lost to Follow-up|2|||
23674955|NCT03969888|66190847|FG006|Overall Study|Reason Not Specified|0|||
23674956|NCT03969888|66190848|FG007|Overall Study|Reason Not Specified|1|||
23674957|NCT03847987|66190849|FG000|Overall Study|Lost to Follow-up|1|||
23386985|NCT00159874|65162697|FG006|Overall Study|Lost to Follow-up|1|||
23386986|NCT00159874|65162691|FG000|Overall Study|Other|8|||
23386987|NCT00159874|65162692|FG001|Overall Study|Other|8|||
23386988|NCT00159874|65162693|FG002|Overall Study|Other|8|||
23386989|NCT00159874|65162694|FG003|Overall Study|Other|0|||
23386990|NCT00159874|65162695|FG004|Overall Study|Other|2|||
23386991|NCT00159874|65162696|FG005|Overall Study|Other|1|||
23386992|NCT00159874|65162697|FG006|Overall Study|Other|3|||
23386993|NCT00159874|65162691|FG000|Overall Study|Protocol Violation|0|||
23386994|NCT00159874|65162692|FG001|Overall Study|Protocol Violation|5|||
23386995|NCT00159874|65162693|FG002|Overall Study|Protocol Violation|2|||
23386996|NCT00159874|65162694|FG003|Overall Study|Protocol Violation|0|||
23386997|NCT00159874|65162695|FG004|Overall Study|Protocol Violation|0|||
23493706|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
23493707|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
23493708|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
23493709|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
23493710|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
23493711|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
23493712|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
23674958|NCT03847987|66190850|FG001|Overall Study|Lost to Follow-up|0|||
23674959|NCT03847987|66190849|FG000|Overall Study|Adverse Event|2|||
23674960|NCT03847987|66190850|FG001|Overall Study|Adverse Event|0|||
23674961|NCT03509350|66190851|FG000|Overall Study|Withdrawal by Subject|0|||
23674962|NCT03509350|66190852|FG001|Overall Study|Withdrawal by Subject|2|||
23674963|NCT01692301|66190853|FG000|Overall Study|Adverse Event|15|||
23674964|NCT01692301|66190854|FG001|Overall Study|Adverse Event|12|||
23674965|NCT01692301|66190853|FG000|Overall Study|Death|1|||
23674966|NCT01692301|66190854|FG001|Overall Study|Death|2|||
23674967|NCT01692301|66190853|FG000|Overall Study|Lack of Efficacy|0|||
23674968|NCT01692301|66190854|FG001|Overall Study|Lack of Efficacy|5|||
23674969|NCT01692301|66190853|FG000|Overall Study|Non-compliance with study treatment|1|||
23674970|NCT01692301|66190854|FG001|Overall Study|Non-compliance with study treatment|2|||
23674971|NCT01692301|66190853|FG000|Overall Study|Protocol deviation|9|||
23674972|NCT01692301|66190854|FG001|Overall Study|Protocol deviation|2|||
23674973|NCT01692301|66190853|FG000|Overall Study|Patient/guardian decision|16|||
23674974|NCT01692301|66190854|FG001|Overall Study|Patient/guardian decision|15|||
23674975|NCT01692301|66190853|FG000|Overall Study|Technical problems|0|||
23674976|NCT01692301|66190854|FG001|Overall Study|Technical problems|1|||
23674977|NCT01692301|66190853|FG000|Overall Study|Physician Decision|2|||
23674978|NCT01692301|66190854|FG001|Overall Study|Physician Decision|2|||
23674979|NCT01692301|66190853|FG000|Overall Study|Lost to Follow-up|1|||
23674980|NCT01692301|66190854|FG001|Overall Study|Lost to Follow-up|1|||
23674981|NCT00511355|66190855|FG000|Overall Study|Adverse Event|4|||
23674982|NCT00511355|66190856|FG001|Overall Study|Adverse Event|4|||
23674983|NCT00511355|66190855|FG000|Overall Study|Pregnancy Wish|1|||
23674984|NCT00511355|66190856|FG001|Overall Study|Pregnancy Wish|0|||
23674985|NCT00511355|66190855|FG000|Overall Study|Lost to Follow-up|2|||
23674986|NCT00511355|66190856|FG001|Overall Study|Lost to Follow-up|1|||
23674987|NCT00511355|66190855|FG000|Overall Study|Other Reason|0|||
23674988|NCT00511355|66190856|FG001|Overall Study|Other Reason|1|||
23386998|NCT00159874|65162696|FG005|Overall Study|Protocol Violation|0|||
23386999|NCT00159874|65162697|FG006|Overall Study|Protocol Violation|0|||
23387000|NCT00159874|65162691|FG000|Overall Study|Death|3|||
23387001|NCT00159874|65162692|FG001|Overall Study|Death|8|||
23387002|NCT00159874|65162693|FG002|Overall Study|Death|15|||
23493713|NCT02264639|65551562|FG000|Overall Study|Death (after completing single-dose phase)|1|||
23493714|NCT02264639|65551563|FG001|Overall Study|Death (after completing single-dose phase)|0|||
23493715|NCT02264639|65551564|FG002|Overall Study|Death (after completing single-dose phase)|0|||
23493716|NCT02264639|65551565|FG003|Overall Study|Death (after completing single-dose phase)|0|||
23493717|NCT02264639|65551566|FG004|Overall Study|Death (after completing single-dose phase)|0|||
23493718|NCT02264639|65551562|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
23493719|NCT02264639|65551563|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493720|NCT02264639|65551564|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493721|NCT02264639|65551565|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23387003|NCT00159874|65162694|FG003|Overall Study|Death|0|||
23387004|NCT00159874|65162695|FG004|Overall Study|Death|1|||
23387005|NCT00159874|65162696|FG005|Overall Study|Death|2|||
23387006|NCT00159874|65162697|FG006|Overall Study|Death|0|||
23387007|NCT00159874|65162691|FG000|Overall Study|Withdrawal by Subject|2|||
23387008|NCT00159874|65162692|FG001|Overall Study|Withdrawal by Subject|6|||
23387009|NCT00159874|65162693|FG002|Overall Study|Withdrawal by Subject|8|||
23387010|NCT00159874|65162694|FG003|Overall Study|Withdrawal by Subject|4|||
23387011|NCT00159874|65162695|FG004|Overall Study|Withdrawal by Subject|3|||
23387012|NCT00159874|65162696|FG005|Overall Study|Withdrawal by Subject|2|||
23387013|NCT00159874|65162697|FG006|Overall Study|Withdrawal by Subject|1|||
23387014|NCT00159874|65162691|FG000|Overall Study|Pregnancy|1|||
23387015|NCT00159874|65162692|FG001|Overall Study|Pregnancy|1|||
23387016|NCT00159874|65162693|FG002|Overall Study|Pregnancy|0|||
23387017|NCT00159874|65162694|FG003|Overall Study|Pregnancy|0|||
23387018|NCT00159874|65162695|FG004|Overall Study|Pregnancy|0|||
23387019|NCT00159874|65162696|FG005|Overall Study|Pregnancy|0|||
23387020|NCT00159874|65162697|FG006|Overall Study|Pregnancy|0|||
23387021|NCT01065766|65162700|FG000|Overall Study|Assessed before the contracted date|1|||
23387022|NCT01065766|65162700|FG000|Overall Study|Contraindication to administration|6|||
23387023|NCT01065766|65162700|FG000|Overall Study|Violated dosage/administration|25|||
23387024|NCT01184118|65162701|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
23387025|NCT01184118|65162701|FG000|Overall Study|No physiologic confirmation of asthma|8|||
23387026|NCT01184118|65162701|FG000|Overall Study|FEV1 <60% predicted|2|||
23387027|NCT01184118|65162701|FG000|Overall Study|Exclusionary medical condition|2|||
23387028|NCT01184118|65162701|FG000|Overall Study|Withdrawal by Subject|5|||
23387029|NCT00562861|65162702|FG000|Overall Study|Adverse Event|1|||
23387030|NCT00562861|65162703|FG001|Overall Study|Adverse Event|1|||
23387031|NCT00562861|65162702|FG000|Overall Study|Lack of Efficacy|5|||
23387032|NCT00562861|65162703|FG001|Overall Study|Lack of Efficacy|5|||
23387033|NCT00562861|65162702|FG000|Overall Study|noncompliance, moved|7|||
23387034|NCT00562861|65162703|FG001|Overall Study|noncompliance, moved|2|||
23387035|NCT00562861|65162702|FG000|Overall Study|Lost to Follow-up|7|||
23387036|NCT00562861|65162703|FG001|Overall Study|Lost to Follow-up|3|||
23387037|NCT00896233|65162707|FG000|Overall Study|Claustrophobia during MRI|1|||
23387038|NCT01658735|65162712|FG000|Overall Study|Lack of Efficacy|1|||
23674989|NCT00511355|66190855|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
23674990|NCT00511355|66190856|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
23387039|NCT01658735|65162713|FG001|Overall Study|Lack of Efficacy|0|||
23387040|NCT01658735|65162714|FG002|Overall Study|Lack of Efficacy|1|||
23387041|NCT01658735|65162712|FG000|Overall Study|Lost to Follow-up|1|||
23387042|NCT01658735|65162713|FG001|Overall Study|Lost to Follow-up|1|||
23387043|NCT01658735|65162714|FG002|Overall Study|Lost to Follow-up|0|||
23387044|NCT01658735|65162712|FG000|Overall Study|Protocol Violation|0|||
23387045|NCT01658735|65162713|FG001|Overall Study|Protocol Violation|1|||
23387046|NCT01658735|65162714|FG002|Overall Study|Protocol Violation|0|||
23387047|NCT01658735|65162712|FG000|Overall Study|Withdrawal by Subject|3|||
23387048|NCT01658735|65162713|FG001|Overall Study|Withdrawal by Subject|5|||
23674991|NCT00511355|66190855|FG000|Overall Study|Withdrawal of informed consent|0|||
23674992|NCT00511355|66190856|FG001|Overall Study|Withdrawal of informed consent|1|||
23674993|NCT00511355|66190855|FG000|Overall Study|Other reason pre-treatment|0|||
23674994|NCT00511355|66190856|FG001|Overall Study|Other reason pre-treatment|1|||
23674995|NCT02921971|66190870|FG000|Overall Study|Adverse Event|1|||
23674996|NCT02921971|66190871|FG001|Overall Study|Adverse Event|2|||
23674997|NCT02921971|66190870|FG000|Overall Study|Lack of Efficacy|3|||
23674998|NCT02921971|66190871|FG001|Overall Study|Lack of Efficacy|1|||
23674999|NCT02921971|66190870|FG000|Overall Study|Other than specified above|2|||
23675000|NCT02921971|66190871|FG001|Overall Study|Other than specified above|1|||
23675001|NCT02926950|66190879|FG000|Overall Study|Adverse Event|4|||
23675002|NCT02926950|66190880|FG001|Overall Study|Adverse Event|6|||
23675003|NCT02926950|66190879|FG000|Overall Study|At the participant's own request|21|||
23675004|NCT02926950|66190880|FG001|Overall Study|At the participant's own request|25|||
23675005|NCT02926950|66190879|FG000|Overall Study|Reason not Specified|17|||
23675006|NCT02926950|66190880|FG001|Overall Study|Reason not Specified|9|||
23675007|NCT02926950|66190879|FG000|Overall Study|Lost to Follow-up|7|||
23675008|NCT02926950|66190880|FG001|Overall Study|Lost to Follow-up|8|||
23387049|NCT01658735|65162714|FG002|Overall Study|Withdrawal by Subject|3|||
23387050|NCT04560309|65162718|FG000|Overall Study|Meet drop out criteria|1|||
23675009|NCT01100437|66190881|FG000|Titration/Stabilization|Adverse Event|0|||
23675010|NCT01100437|66190882|FG001|Titration/Stabilization|Adverse Event|0|||
23387051|NCT04560309|65162719|FG001|Overall Study|Meet drop out criteria|1|||
23387052|NCT01694771|65162720|FG000|Overall Study|Adverse Event|18|||
23387053|NCT01694771|65162721|FG001|Overall Study|Adverse Event|16|||
23675011|NCT01100437|66190883|FG002|Titration/Stabilization|Adverse Event|4|||
23675012|NCT01100437|66190881|FG000|Titration/Stabilization|Non-compliance|0|||
23387054|NCT01694771|65162720|FG000|Overall Study|Lack of Efficacy|1|||
23387055|NCT01694771|65162721|FG001|Overall Study|Lack of Efficacy|0|||
23387056|NCT01694771|65162720|FG000|Overall Study|Non compliance protocol|7|||
23387057|NCT01694771|65162721|FG001|Overall Study|Non compliance protocol|6|||
23387058|NCT01694771|65162720|FG000|Overall Study|Lost to Follow-up|2|||
23387059|NCT01694771|65162721|FG001|Overall Study|Lost to Follow-up|3|||
23387060|NCT01694771|65162720|FG000|Overall Study|Consent withdrawn|7|||
23387061|NCT01694771|65162721|FG001|Overall Study|Consent withdrawn|9|||
23387062|NCT01694771|65162720|FG000|Overall Study|Other reasons|5|||
23387063|NCT01694771|65162721|FG001|Overall Study|Other reasons|6|||
23493722|NCT02264639|65551566|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493723|NCT02264639|65551562|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493724|NCT02264639|65551563|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493725|NCT02264639|65551564|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
23493726|NCT02264639|65551565|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493727|NCT02264639|65551566|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493728|NCT02264639|65551562|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493729|NCT02264639|65551563|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493730|NCT02264639|65551564|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493731|NCT02264639|65551565|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493732|NCT02264639|65551566|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
23493733|NCT05047770|65551568|FG000|Overall Study|Withdrawal by Subject|15|||
23493734|NCT05047770|65551569|FG001|Overall Study|Withdrawal by Subject|10|||
23493735|NCT05047770|65551570|FG002|Overall Study|Withdrawal by Subject|6|||
23493736|NCT05047770|65551571|FG003|Overall Study|Withdrawal by Subject|12|||
23493737|NCT05047770|65551568|FG000|Overall Study|Lost to Follow-up|7|||
23493738|NCT05047770|65551569|FG001|Overall Study|Lost to Follow-up|5|||
23493739|NCT05047770|65551570|FG002|Overall Study|Lost to Follow-up|12|||
23493740|NCT05047770|65551571|FG003|Overall Study|Lost to Follow-up|13|||
23493741|NCT05047770|65551568|FG000|Overall Study|Other|1|||
23493742|NCT05047770|65551569|FG001|Overall Study|Other|0|||
23493743|NCT05047770|65551570|FG002|Overall Study|Other|1|||
23493744|NCT05047770|65551571|FG003|Overall Study|Other|0|||
23493745|NCT02345226|65551572|FG000|Double-Blind Phase|Adverse Event|5|||
23493746|NCT02345226|65551573|FG001|Double-Blind Phase|Adverse Event|6|||
23493747|NCT02345226|65551572|FG000|Double-Blind Phase|Death|3|||
23493748|NCT02345226|65551573|FG001|Double-Blind Phase|Death|0|||
23493749|NCT02345226|65551572|FG000|Double-Blind Phase|Pregnancy|0|||
23493750|NCT02345226|65551573|FG001|Double-Blind Phase|Pregnancy|1|||
23493751|NCT02345226|65551572|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23493752|NCT02345226|65551573|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23493753|NCT02345226|65551572|FG000|Double-Blind Phase|Investigator's Discretion|4|||
23493754|NCT02345226|65551573|FG001|Double-Blind Phase|Investigator's Discretion|3|||
23493755|NCT02345226|65551572|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23493756|NCT02345226|65551573|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
23493757|NCT02345226|65551572|FG000|Double-Blind Phase|Withdrew Consent|41|||
23493758|NCT02345226|65551573|FG001|Double-Blind Phase|Withdrew Consent|39|||
23493759|NCT02345226|65551572|FG000|Double-Blind Phase|Lost to Follow-up|12|||
23493760|NCT02345226|65551573|FG001|Double-Blind Phase|Lost to Follow-up|16|||
23493761|NCT02345226|65551572|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
23493762|NCT02345226|65551573|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
23493763|NCT02345226|65551572|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23493764|NCT02345226|65551573|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23493765|NCT04295772|65551574|FG000|Overall Study|Protocol Violation|1|||
23493766|NCT04295772|65551575|FG001|Overall Study|Protocol Violation|0|||
23493767|NCT04295772|65551574|FG000|Overall Study|Ongoing for safety monitoring|14|||
23493768|NCT04295772|65551575|FG001|Overall Study|Ongoing for safety monitoring|1|||
23493769|NCT04295772|65551574|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
23675013|NCT01100437|66190882|FG001|Titration/Stabilization|Non-compliance|0|||
23675014|NCT01100437|66190883|FG002|Titration/Stabilization|Non-compliance|1|||
23387064|NCT04233580|65162723|FG000|Overall Study|Adverse Event|3|||
23387065|NCT04233580|65162724|FG001|Overall Study|Adverse Event|3|||
23387066|NCT04233580|65162723|FG000|Overall Study|Withdrawal by Subject|2|||
23493770|NCT04295772|65551575|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
23493771|NCT00241358|65551576|FG000|Overall Study|Determined to be not ineligible|0|||
23493772|NCT00241358|65551577|FG001|Overall Study|Determined to be not ineligible|1|||
23493773|NCT00241358|65551578|FG002|Overall Study|Determined to be not ineligible|1|||
23493774|NCT00451451|65551581|FG000|Overall Study|Adverse Event|11|||
23493775|NCT00451451|65551582|FG001|Overall Study|Adverse Event|21|||
23493776|NCT00451451|65551583|FG002|Overall Study|Adverse Event|26|||
23493777|NCT00451451|65551584|FG003|Overall Study|Adverse Event|10|||
23493778|NCT00451451|65551581|FG000|Overall Study|Lost to Follow-up|11|||
23675015|NCT01100437|66190881|FG000|Titration/Stabilization|Sponsor canceled study|0|||
23387067|NCT04233580|65162724|FG001|Overall Study|Withdrawal by Subject|1|||
23387068|NCT03632720|65162725|FG000|Overall Study|Adverse Event|2|||
23493779|NCT00451451|65551582|FG001|Overall Study|Lost to Follow-up|9|||
23493780|NCT00451451|65551583|FG002|Overall Study|Lost to Follow-up|8|||
23493781|NCT00451451|65551584|FG003|Overall Study|Lost to Follow-up|11|||
23493782|NCT00451451|65551581|FG000|Overall Study|Consent Withdrawn|14|||
23493783|NCT00451451|65551582|FG001|Overall Study|Consent Withdrawn|9|||
23493784|NCT00451451|65551583|FG002|Overall Study|Consent Withdrawn|17|||
23493785|NCT00451451|65551584|FG003|Overall Study|Consent Withdrawn|17|||
23493786|NCT00451451|65551581|FG000|Overall Study|Investigator Decision|6|||
23493787|NCT00451451|65551582|FG001|Overall Study|Investigator Decision|2|||
23493788|NCT00451451|65551583|FG002|Overall Study|Investigator Decision|1|||
23493789|NCT00451451|65551584|FG003|Overall Study|Investigator Decision|2|||
23493790|NCT00451451|65551581|FG000|Overall Study|Subject Non-Compliance|8|||
23493791|NCT00451451|65551582|FG001|Overall Study|Subject Non-Compliance|4|||
23493792|NCT00451451|65551583|FG002|Overall Study|Subject Non-Compliance|3|||
23493793|NCT00451451|65551584|FG003|Overall Study|Subject Non-Compliance|3|||
23493794|NCT00451451|65551581|FG000|Overall Study|Death|1|||
23493795|NCT00451451|65551582|FG001|Overall Study|Death|0|||
23493796|NCT00451451|65551583|FG002|Overall Study|Death|0|||
23493797|NCT00451451|65551584|FG003|Overall Study|Death|1|||
23493798|NCT00451451|65551581|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
23493799|NCT00451451|65551582|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
23493800|NCT00451451|65551583|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
23493801|NCT00451451|65551584|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
23493802|NCT00142935|65551588|FG000|Overall Study|Other reason|1|||
23493803|NCT00142935|65551589|FG001|Overall Study|Other reason|1|||
23493804|NCT00142935|65551590|FG002|Overall Study|Other reason|1|||
23493805|NCT00142935|65551588|FG000|Overall Study|Lost to Follow-up|2|||
23493806|NCT00142935|65551589|FG001|Overall Study|Lost to Follow-up|5|||
23675016|NCT01100437|66190882|FG001|Titration/Stabilization|Sponsor canceled study|0|||
23493807|NCT00142935|65551590|FG002|Overall Study|Lost to Follow-up|5|||
23493808|NCT00142935|65551588|FG000|Overall Study|Death|0|||
23493809|NCT00142935|65551589|FG001|Overall Study|Death|2|||
23675017|NCT01100437|66190883|FG002|Titration/Stabilization|Sponsor canceled study|1|||
23675018|NCT01100437|66190881|FG000|Maintenance|Withdrawal by Subject|0|||
23675019|NCT01100437|66190882|FG001|Maintenance|Withdrawal by Subject|0|||
23675020|NCT01100437|66190883|FG002|Maintenance|Withdrawal by Subject|1|||
23675021|NCT01100437|66190881|FG000|Maintenance|Sponsor termination of study|0|||
23675022|NCT01100437|66190882|FG001|Maintenance|Sponsor termination of study|0|||
23675023|NCT01100437|66190883|FG002|Maintenance|Sponsor termination of study|1|||
23675024|NCT00691483|66190886|FG000|Overall Study|Adverse Event|14|||
23675025|NCT00691483|66190887|FG001|Overall Study|Adverse Event|6|||
23675026|NCT00691483|66190886|FG000|Overall Study|Lost to Follow-up|17|||
23493810|NCT00142935|65551590|FG002|Overall Study|Death|1|||
23493811|NCT00669396|65551591|FG000|Overall Study|Lost to Follow-up|10|||
23493812|NCT00669396|65551592|FG001|Overall Study|Lost to Follow-up|12|||
23493813|NCT01361568|65551593|FG000|Overall Study|Adverse Event|0|||
23675027|NCT00691483|66190887|FG001|Overall Study|Lost to Follow-up|10|||
23675028|NCT00691483|66190886|FG000|Overall Study|Withdrawal by Subject|24|||
23675029|NCT00691483|66190887|FG001|Overall Study|Withdrawal by Subject|7|||
23675030|NCT00691483|66190886|FG000|Overall Study|Other known cause|6|||
23675031|NCT00691483|66190887|FG001|Overall Study|Other known cause|1|||
23675032|NCT00691483|66190886|FG000|Overall Study|Randomized by not treated|7|||
23675033|NCT00691483|66190887|FG001|Overall Study|Randomized by not treated|1|||
23675034|NCT01614093|66190888|FG000|Overall Study|Withdrawal by Subject|1|||
23675035|NCT01110200|66190889|FG000|Overall Study|Adverse Event|28|||
23493814|NCT01361568|65551594|FG001|Overall Study|Adverse Event|0|||
23493815|NCT01361568|65551595|FG002|Overall Study|Adverse Event|0|||
23493816|NCT01361568|65551596|FG003|Overall Study|Adverse Event|0|||
23493817|NCT01361568|65551597|FG004|Overall Study|Adverse Event|1|||
23493818|NCT01361568|65551598|FG005|Overall Study|Adverse Event|0|||
23493819|NCT01361568|65551593|FG000|Overall Study|Physician Decision|0|||
23493820|NCT01361568|65551594|FG001|Overall Study|Physician Decision|0|||
23493821|NCT01361568|65551595|FG002|Overall Study|Physician Decision|0|||
23493822|NCT01361568|65551596|FG003|Overall Study|Physician Decision|0|||
23493823|NCT01361568|65551597|FG004|Overall Study|Physician Decision|0|||
23675036|NCT01110200|66190890|FG001|Overall Study|Adverse Event|28|||
23675037|NCT01110200|66190889|FG000|Overall Study|Withdrawal by Subject|25|||
23675038|NCT01110200|66190890|FG001|Overall Study|Withdrawal by Subject|32|||
23675039|NCT01110200|66190889|FG000|Overall Study|Lack of Efficacy|16|||
23675040|NCT01110200|66190890|FG001|Overall Study|Lack of Efficacy|25|||
23675041|NCT01110200|66190889|FG000|Overall Study|Protocol Violation|14|||
23493824|NCT01361568|65551598|FG005|Overall Study|Physician Decision|1|||
23493825|NCT01361568|65551593|FG000|Overall Study|Withdrawal by Subject|2|||
23493826|NCT01361568|65551594|FG001|Overall Study|Withdrawal by Subject|1|||
23493827|NCT01361568|65551595|FG002|Overall Study|Withdrawal by Subject|0|||
23493828|NCT01361568|65551596|FG003|Overall Study|Withdrawal by Subject|0|||
23493829|NCT01361568|65551597|FG004|Overall Study|Withdrawal by Subject|0|||
23675042|NCT01110200|66190890|FG001|Overall Study|Protocol Violation|12|||
23675043|NCT01110200|66190889|FG000|Overall Study|Physician Decision|13|||
23675044|NCT01110200|66190890|FG001|Overall Study|Physician Decision|17|||
23675045|NCT01110200|66190889|FG000|Overall Study|Lost to Follow-up|10|||
23675046|NCT01110200|66190890|FG001|Overall Study|Lost to Follow-up|7|||
23675047|NCT05490771|66190891|FG000|Overall Study|Disease progression|18|||
23675048|NCT05490771|66190891|FG000|Overall Study|Adverse Event|3|||
23675049|NCT05490771|66190891|FG000|Overall Study|Other complicating disease|1|||
23387069|NCT03632720|65162726|FG001|Overall Study|Adverse Event|0|||
23387070|NCT03632720|65162727|FG002|Overall Study|Adverse Event|0|||
23675050|NCT05490771|66190891|FG000|Overall Study|Withdrawal by Subject|3|||
23675051|NCT05490771|66190891|FG000|Overall Study|Physician Decision|1|||
23675052|NCT05490771|66190891|FG000|Overall Study|Still on treatment|2|||
23675053|NCT05490771|66190891|FG000|Overall Study|Never start protocol therapy|5|||
23675054|NCT05490771|66190891|FG000|Overall Study|Ineligible|2|||
23675055|NCT01700192|66190894|FG000|Overall Study|Adverse Event|73|||
23675056|NCT01700192|66190895|FG001|Overall Study|Adverse Event|18|||
23675057|NCT01700192|66190894|FG000|Overall Study|Lack of Efficacy|1|||
23675058|NCT01700192|66190895|FG001|Overall Study|Lack of Efficacy|0|||
23675059|NCT01700192|66190894|FG000|Overall Study|Lost to Follow-up|42|||
23675060|NCT01700192|66190895|FG001|Overall Study|Lost to Follow-up|29|||
23675061|NCT01700192|66190894|FG000|Overall Study|Noncompliance with study drug|0|||
23675062|NCT01700192|66190895|FG001|Overall Study|Noncompliance with study drug|5|||
23675063|NCT01700192|66190894|FG000|Overall Study|Physician Decision|2|||
23675064|NCT01700192|66190895|FG001|Overall Study|Physician Decision|3|||
23675065|NCT01700192|66190894|FG000|Overall Study|Pregnancy|1|||
23675066|NCT01700192|66190895|FG001|Overall Study|Pregnancy|4|||
23675067|NCT01700192|66190894|FG000|Overall Study|Progressive disease|1|||
23675068|NCT01700192|66190895|FG001|Overall Study|Progressive disease|0|||
23675069|NCT01700192|66190894|FG000|Overall Study|Protocol Violation|3|||
23675070|NCT01700192|66190895|FG001|Overall Study|Protocol Violation|4|||
23675071|NCT01700192|66190894|FG000|Overall Study|Technical problems|0|||
23675072|NCT01700192|66190895|FG001|Overall Study|Technical problems|1|||
23675073|NCT01700192|66190894|FG000|Overall Study|Withdrawal by Subject|56|||
23675074|NCT01700192|66190895|FG001|Overall Study|Withdrawal by Subject|64|||
23675075|NCT01700192|66190894|FG000|Overall Study|Never received study drug|1|||
23675076|NCT01700192|66190895|FG001|Overall Study|Never received study drug|0|||
23675077|NCT04372927|66190896|FG000|Overall Study|Death|1|||
23675078|NCT00783094|66190897|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
23675079|NCT00783094|66190898|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
23675080|NCT00783094|66190899|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
23675081|NCT00783094|66190897|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
23675082|NCT00783094|66190898|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
23675083|NCT00783094|66190899|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
23675084|NCT00783094|66190897|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
23675085|NCT00783094|66190898|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
23675086|NCT00783094|66190899|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
23675087|NCT00783094|66190897|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
23675088|NCT00783094|66190898|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
23675089|NCT00783094|66190899|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
23675090|NCT00783094|66190897|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
23675091|NCT00783094|66190898|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
23675092|NCT00783094|66190899|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
23675093|NCT00783094|66190897|FG000|Open-Label Extension Period|Adverse Event|12|||
23675094|NCT00783094|66190898|FG001|Open-Label Extension Period|Adverse Event|7|||
23675095|NCT00783094|66190899|FG002|Open-Label Extension Period|Adverse Event|16|||
23675096|NCT00783094|66190897|FG000|Open-Label Extension Period|Death|0|||
23675097|NCT00783094|66190898|FG001|Open-Label Extension Period|Death|0|||
23675098|NCT00783094|66190899|FG002|Open-Label Extension Period|Death|1|||
23675099|NCT00783094|66190897|FG000|Open-Label Extension Period|Protocol Violation|4|||
23675100|NCT00783094|66190898|FG001|Open-Label Extension Period|Protocol Violation|5|||
23675101|NCT00783094|66190899|FG002|Open-Label Extension Period|Protocol Violation|7|||
23675102|NCT00783094|66190897|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
23675103|NCT00783094|66190898|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
23675104|NCT00783094|66190899|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
23675105|NCT00783094|66190897|FG000|Open-Label Extension Period|Physician Decision|4|||
23675106|NCT00783094|66190898|FG001|Open-Label Extension Period|Physician Decision|2|||
23675107|NCT00783094|66190899|FG002|Open-Label Extension Period|Physician Decision|3|||
23675108|NCT00783094|66190897|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
23675109|NCT00783094|66190898|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
23387071|NCT03632720|65162725|FG000|Overall Study|Lost to Follow-up|0|||
23387072|NCT03632720|65162726|FG001|Overall Study|Lost to Follow-up|1|||
23675110|NCT00783094|66190899|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
23675111|NCT01262365|66190905|FG000|Overall Study|Lack of Efficacy|35|||
23675112|NCT01262365|66190906|FG001|Overall Study|Lack of Efficacy|30|||
23493830|NCT01361568|65551598|FG005|Overall Study|Withdrawal by Subject|1|||
23493831|NCT00074984|65551606|FG000|Overall Study|Death|1|||
23493832|NCT00074984|65551607|FG001|Overall Study|Death|2|||
23493833|NCT00074984|65551606|FG000|Overall Study|Withdrawal by Subject|2|||
23493834|NCT00074984|65551607|FG001|Overall Study|Withdrawal by Subject|3|||
23493835|NCT00074984|65551606|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
23493836|NCT00074984|65551607|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
23493837|NCT03555435|65551608|FG000|Overall Study|Lost to Follow-up|17|||
23493838|NCT03555435|65551609|FG001|Overall Study|Lost to Follow-up|19|||
23493839|NCT03555435|65551610|FG002|Overall Study|Lost to Follow-up|8|||
23493840|NCT02024555|65551621|FG000|Overall Study|Lost to Follow-up|1|||
23493841|NCT02024555|65551622|FG001|Overall Study|Lost to Follow-up|1|||
23493842|NCT02024555|65551621|FG000|Overall Study|Withdrawal by Subject|5|||
23493843|NCT02024555|65551622|FG001|Overall Study|Withdrawal by Subject|1|||
23493844|NCT03822182|65551623|FG000|Overall Study|Protocol Violation|0|||
23493845|NCT03822182|65551624|FG001|Overall Study|Protocol Violation|1|||
23493846|NCT03822182|65551625|FG002|Overall Study|Protocol Violation|1|||
23493847|NCT00657358|65554819|FG000|Overall Study|Lack of Efficacy|6|||
23493848|NCT01426438|65554820|FG000|Overall Study|Lost to Follow-up|1|||
23493849|NCT01426438|65554821|FG001|Overall Study|Lost to Follow-up|3|||
23493850|NCT01426438|65554820|FG000|Overall Study|Off study Treatment|9|||
23493851|NCT01426438|65554821|FG001|Overall Study|Off study Treatment|3|||
23493852|NCT01426438|65554820|FG000|Overall Study|Poor scan quality|3|||
23493853|NCT01426438|65554821|FG001|Overall Study|Poor scan quality|2|||
23493854|NCT01426438|65554820|FG000|Overall Study|Missed Scan|2|||
23493855|NCT01426438|65554821|FG001|Overall Study|Missed Scan|2|||
23493856|NCT00590135|65554822|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
23493857|NCT00423722|65554826|FG000|Overall Study|Death|4|||
23493858|NCT00423722|65554827|FG001|Overall Study|Death|4|||
23493859|NCT00423722|65554826|FG000|Overall Study|Declined to participate|2|||
23493860|NCT00423722|65554827|FG001|Overall Study|Declined to participate|3|||
23493861|NCT00423722|65554826|FG000|Overall Study|Unable to complete questionnaires|4|||
23493862|NCT00423722|65554827|FG001|Overall Study|Unable to complete questionnaires|4|||
23493863|NCT00423722|65554826|FG000|Overall Study|Withdrawal by Subject|4|||
23493864|NCT00423722|65554827|FG001|Overall Study|Withdrawal by Subject|2|||
23493865|NCT02840721|65554828|FG000|Treatment Period|Adverse Event|1|||
23493866|NCT02840721|65554828|FG000|Follow-Up|Lack of Efficacy|1|||
23493867|NCT02840721|65554828|FG000|Follow-Up|Withdrawal by Subject|4|||
23493868|NCT02840721|65554828|FG000|Follow-Up|Withdrawal of Consent|2|||
23493869|NCT01453725|65554830|FG000|Overall Study|Adverse Event|3|||
23493870|NCT01453725|65554831|FG001|Overall Study|Adverse Event|3|||
23493871|NCT01453725|65554830|FG000|Overall Study|Lost to Follow-up|4|||
23493872|NCT01453725|65554831|FG001|Overall Study|Lost to Follow-up|0|||
23493873|NCT01453725|65554830|FG000|Overall Study|Non-compliance With Protocol|1|||
23493874|NCT01453725|65554831|FG001|Overall Study|Non-compliance With Protocol|2|||
23493875|NCT01453725|65554830|FG000|Overall Study|Protocol Violation|1|||
23493876|NCT01453725|65554831|FG001|Overall Study|Protocol Violation|0|||
23493877|NCT01453725|65554830|FG000|Overall Study|Withdrawal by Subject|2|||
23493878|NCT01453725|65554831|FG001|Overall Study|Withdrawal by Subject|3|||
23493879|NCT01453725|65554830|FG000|Overall Study|Pregnancy Wish|0|||
23493880|NCT01453725|65554831|FG001|Overall Study|Pregnancy Wish|2|||
23493881|NCT01453725|65554830|FG000|Overall Study|Pregnancy|1|||
23493882|NCT01453725|65554831|FG001|Overall Study|Pregnancy|0|||
23493883|NCT01453725|65554830|FG000|Overall Study|Physician Decision|1|||
23493884|NCT01453725|65554831|FG001|Overall Study|Physician Decision|1|||
23493885|NCT01484275|65554832|FG000|Overall Study|Study terminated by sponsor|28|||
23493886|NCT01484275|65554833|FG001|Overall Study|Study terminated by sponsor|32|||
23493887|NCT01484275|65554832|FG000|Overall Study|Other|10|||
23493888|NCT01484275|65554833|FG001|Overall Study|Other|0|||
23493889|NCT01484275|65554832|FG000|Overall Study|Death|3|||
23493890|NCT01484275|65554833|FG001|Overall Study|Death|4|||
23387073|NCT03632720|65162727|FG002|Overall Study|Lost to Follow-up|0|||
23387074|NCT03632720|65162725|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
23493891|NCT01484275|65554832|FG000|Overall Study|Withdrawal by Subject|1|||
23493892|NCT01484275|65554833|FG001|Overall Study|Withdrawal by Subject|5|||
23493893|NCT01484275|65554832|FG000|Overall Study|Lost to Follow-up|1|||
23493894|NCT01484275|65554833|FG001|Overall Study|Lost to Follow-up|1|||
23493895|NCT00066365|65554834|FG000|Overall Study|Adverse Event|1|||
23493896|NCT00066365|65554835|FG001|Overall Study|Adverse Event|0|||
23493897|NCT00066365|65554834|FG000|Overall Study|Lack of Efficacy|15|||
23493898|NCT00066365|65554835|FG001|Overall Study|Lack of Efficacy|12|||
23493899|NCT00066365|65554834|FG000|Overall Study|Physician Decision|1|||
23493900|NCT00066365|65554835|FG001|Overall Study|Physician Decision|0|||
23493901|NCT00066365|65554834|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
23493902|NCT00066365|65554835|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
23493903|NCT00066365|65554834|FG000|Overall Study|Ineligible|4|||
23493904|NCT00066365|65554835|FG001|Overall Study|Ineligible|2|||
23493905|NCT04744831|65554836|FG000|Overall Study|Progressive Disease|31|||
23493906|NCT04744831|65554837|FG001|Overall Study|Progressive Disease|27|||
23493907|NCT04744831|65554838|FG002|Overall Study|Progressive Disease|25|||
23493908|NCT04744831|65554836|FG000|Overall Study|Adverse Event|3|||
23493909|NCT04744831|65554837|FG001|Overall Study|Adverse Event|3|||
23493910|NCT04744831|65554838|FG002|Overall Study|Adverse Event|3|||
23493911|NCT04744831|65554836|FG000|Overall Study|Clinical Progression|3|||
23493912|NCT04744831|65554837|FG001|Overall Study|Clinical Progression|2|||
23493913|NCT04744831|65554838|FG002|Overall Study|Clinical Progression|5|||
23493914|NCT04744831|65554836|FG000|Overall Study|Other|0|||
23493915|NCT04744831|65554837|FG001|Overall Study|Other|2|||
23493916|NCT04744831|65554838|FG002|Overall Study|Other|1|||
23493917|NCT04744831|65554836|FG000|Overall Study|Death|0|||
23493918|NCT04744831|65554837|FG001|Overall Study|Death|2|||
23387075|NCT03632720|65162726|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
23387076|NCT03632720|65162727|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
23387077|NCT03632720|65162725|FG000|Overall Study|Screen failure|0|||
23387078|NCT03632720|65162726|FG001|Overall Study|Screen failure|1|||
23387079|NCT03632720|65162727|FG002|Overall Study|Screen failure|0|||
23387080|NCT01663987|65162736|FG000|Overall Study|Adverse Event|7|||
23387081|NCT01663987|65162737|FG001|Overall Study|Adverse Event|2|||
23387082|NCT01663987|65162736|FG000|Overall Study|Lost to Follow-up|1|||
23387083|NCT01663987|65162737|FG001|Overall Study|Lost to Follow-up|1|||
23387084|NCT01663987|65162736|FG000|Overall Study|Withdrawal by Subject|2|||
23387085|NCT01663987|65162737|FG001|Overall Study|Withdrawal by Subject|3|||
23387086|NCT01663987|65162736|FG000|Overall Study|Other reason not defined above|3|||
23387087|NCT01663987|65162737|FG001|Overall Study|Other reason not defined above|0|||
23387088|NCT02872142|65162738|FG000|Overall Study|Adverse Event|2|||
23387089|NCT02872142|65162738|FG000|Overall Study|Death|1|||
23387090|NCT02872142|65162738|FG000|Overall Study|Participant Decision|3|||
23387091|NCT00756314|65162751|FG000|Overall Study|Lost to Follow-up|2|||
23387092|NCT00756314|65162752|FG001|Overall Study|Lost to Follow-up|59|||
23387093|NCT02539394|65162753|FG000|Overall Study|Protocol Violation|1|||
23387094|NCT02539394|65162754|FG001|Overall Study|Protocol Violation|3|||
23387095|NCT02539394|65162753|FG000|Overall Study|Lost to Follow-up|1|||
23387096|NCT02539394|65162754|FG001|Overall Study|Lost to Follow-up|2|||
23387097|NCT02539394|65162753|FG000|Overall Study|Incomplete dataset|6|||
23387098|NCT02539394|65162754|FG001|Overall Study|Incomplete dataset|6|||
23387099|NCT04102111|65162761|FG000|Overall Study|Withdrawal by Subject|2|||
23387100|NCT04102111|65162762|FG001|Overall Study|Withdrawal by Subject|3|||
23387101|NCT04102111|65162761|FG000|Overall Study|Adverse Event|1|||
23387102|NCT04102111|65162762|FG001|Overall Study|Adverse Event|1|||
23387103|NCT04102111|65162761|FG000|Overall Study|Study terminated by sponsor|1|||
23387104|NCT04102111|65162762|FG001|Overall Study|Study terminated by sponsor|3|||
23387105|NCT04189588|65162763|FG000|Overall Study|Death|0|||
23387106|NCT04189588|65162764|FG001|Overall Study|Death|1|||
23387107|NCT04189588|65162763|FG000|Overall Study|Lost to Follow-up|0|||
23387108|NCT04189588|65162764|FG001|Overall Study|Lost to Follow-up|1|||
23387109|NCT00063999|65162770|FG000|Overall Study|Withdrawal by Subject|1|||
23387110|NCT00063999|65162771|FG001|Overall Study|Withdrawal by Subject|0|||
23387111|NCT00063999|65162770|FG000|Overall Study|Ineligible|44|||
23387112|NCT00063999|65162771|FG001|Overall Study|Ineligible|24|||
23387113|NCT00862277|65162776|FG000|Overall Study|Protocol Violation|1|||
23387114|NCT00862277|65162777|FG001|Overall Study|Protocol Violation|2|||
23387115|NCT00862277|65162778|FG002|Overall Study|Protocol Violation|5|||
23387116|NCT00300495|65162780|FG000|Overall Study|Protocol Violation|4|||
23387117|NCT00300495|65162781|FG001|Overall Study|Protocol Violation|1|||
23387118|NCT00567112|65162782|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
23387119|NCT00567112|65162783|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
23387120|NCT00567112|65162784|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
23387121|NCT00567112|65162782|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
23387122|NCT00567112|65162783|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
23387123|NCT00567112|65162784|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
23387124|NCT00567112|65162782|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
23387125|NCT00567112|65162783|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
23493919|NCT04744831|65554838|FG002|Overall Study|Death|1|||
23493920|NCT01030536|65554839|FG000|Overall Study|Withdrawal by Subject|0|||
23493921|NCT01030536|65554840|FG001|Overall Study|Withdrawal by Subject|0|||
23675113|NCT01262365|66190907|FG002|Overall Study|Lack of Efficacy|47|||
23675114|NCT01262365|66190905|FG000|Overall Study|Protocol Violation|3|||
23675115|NCT01262365|66190906|FG001|Overall Study|Protocol Violation|1|||
23675116|NCT01262365|66190907|FG002|Overall Study|Protocol Violation|1|||
23675117|NCT01262365|66190905|FG000|Overall Study|Lost to Follow-up|3|||
23675118|NCT01262365|66190906|FG001|Overall Study|Lost to Follow-up|7|||
23675119|NCT01262365|66190907|FG002|Overall Study|Lost to Follow-up|6|||
23675120|NCT01262365|66190905|FG000|Overall Study|Withdrawal by Subject|17|||
23675121|NCT01262365|66190906|FG001|Overall Study|Withdrawal by Subject|22|||
23675122|NCT01262365|66190907|FG002|Overall Study|Withdrawal by Subject|22|||
23675123|NCT01262365|66190905|FG000|Overall Study|Death|1|||
23675124|NCT01262365|66190906|FG001|Overall Study|Death|2|||
23675125|NCT01262365|66190907|FG002|Overall Study|Death|1|||
23675126|NCT01262365|66190905|FG000|Overall Study|Adverse Event|26|||
23675127|NCT01262365|66190906|FG001|Overall Study|Adverse Event|16|||
23675128|NCT01262365|66190907|FG002|Overall Study|Adverse Event|11|||
23387126|NCT00567112|65162784|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
23387127|NCT01346709|65162787|FG000|Overall Study|Protocol Violation|35|||
23387128|NCT01346709|65162787|FG000|Overall Study|Lost to Follow-up|31|||
23387129|NCT01346709|65162787|FG000|Overall Study|Missing data in candidate risk factor|285|||
23387130|NCT00348374|65162788|FG000|Overall Study|Adverse Event|1|||
23675129|NCT01262365|66190905|FG000|Overall Study|sponsor decision|1|||
23675130|NCT01262365|66190906|FG001|Overall Study|sponsor decision|1|||
23675131|NCT01262365|66190907|FG002|Overall Study|sponsor decision|0|||
23675132|NCT01262365|66190905|FG000|Overall Study|Randomization error|1|||
23675133|NCT01262365|66190906|FG001|Overall Study|Randomization error|0|||
23675134|NCT01262365|66190907|FG002|Overall Study|Randomization error|2|||
23675135|NCT01262365|66190905|FG000|Overall Study|Non-compliance|1|||
23675136|NCT01262365|66190906|FG001|Overall Study|Non-compliance|0|||
23675137|NCT01262365|66190907|FG002|Overall Study|Non-compliance|2|||
23675138|NCT01262365|66190905|FG000|Overall Study|Suspected pregnancy|1|||
23387131|NCT00348374|65162789|FG001|Overall Study|Adverse Event|4|||
23387132|NCT00348374|65162788|FG000|Overall Study|Lost to Follow-up|1|||
23387133|NCT00348374|65162789|FG001|Overall Study|Lost to Follow-up|3|||
23387134|NCT00348374|65162788|FG000|Overall Study|Withdrawal by Subject|5|||
23387135|NCT00348374|65162789|FG001|Overall Study|Withdrawal by Subject|5|||
23387136|NCT00348374|65162788|FG000|Overall Study|Other|11|||
23387137|NCT00348374|65162789|FG001|Overall Study|Other|12|||
23387138|NCT00348374|65162788|FG000|Overall Study|ongoing at date of cutoff|1|||
23387139|NCT00348374|65162789|FG001|Overall Study|ongoing at date of cutoff|1|||
23387140|NCT00348374|65162788|FG000|Overall Study|randomized but did not receive treatment|0|||
23387141|NCT00348374|65162789|FG001|Overall Study|randomized but did not receive treatment|7|||
23387142|NCT00090402|65162790|FG000|Overall Study|Death|1|||
23387143|NCT00090402|65162791|FG001|Overall Study|Death|1|||
23387144|NCT00090402|65162792|FG002|Overall Study|Death|0|||
23387145|NCT00090402|65162790|FG000|Overall Study|subject moved|0|||
23387146|NCT00090402|65162791|FG001|Overall Study|subject moved|1|||
23387147|NCT00090402|65162792|FG002|Overall Study|subject moved|0|||
23675139|NCT01262365|66190906|FG001|Overall Study|Suspected pregnancy|0|||
23387148|NCT00090402|65162790|FG000|Overall Study|stopped taking study medication|1|||
23493922|NCT01030536|65554841|FG002|Overall Study|Withdrawal by Subject|1|||
23675140|NCT01262365|66190907|FG002|Overall Study|Suspected pregnancy|0|||
23675141|NCT01262365|66190905|FG000|Overall Study|Patient pregnant|1|||
23675142|NCT01262365|66190906|FG001|Overall Study|Patient pregnant|0|||
23675143|NCT01262365|66190907|FG002|Overall Study|Patient pregnant|1|||
23675144|NCT01262365|66190905|FG000|Overall Study|Toxicity related to study drug|0|||
23675145|NCT01262365|66190906|FG001|Overall Study|Toxicity related to study drug|1|||
23675146|NCT01262365|66190907|FG002|Overall Study|Toxicity related to study drug|0|||
23675147|NCT01262365|66190905|FG000|Overall Study|Cannot tolerate the protocol|0|||
23675148|NCT01262365|66190906|FG001|Overall Study|Cannot tolerate the protocol|1|||
23675149|NCT01262365|66190907|FG002|Overall Study|Cannot tolerate the protocol|0|||
23675150|NCT01262365|66190905|FG000|Overall Study|Patient unavailable|0|||
23387149|NCT00090402|65162791|FG001|Overall Study|stopped taking study medication|0|||
23387150|NCT00090402|65162792|FG002|Overall Study|stopped taking study medication|1|||
23387151|NCT04341662|65162793|FG000|Overall Study|Did not have source-verified blood loss data|423|||
23387152|NCT04341662|65162794|FG001|Overall Study|Did not have source-verified blood loss data|514|||
23387153|NCT00894647|65162797|FG000|Overall Study|Adverse Event|5|||
23387154|NCT00894647|65162798|FG001|Overall Study|Adverse Event|4|||
23387155|NCT00894647|65162797|FG000|Overall Study|Withdrawal by Subject|4|||
23387156|NCT00894647|65162798|FG001|Overall Study|Withdrawal by Subject|4|||
23387157|NCT00894647|65162797|FG000|Overall Study|Lost to Follow-up|0|||
23387158|NCT00894647|65162798|FG001|Overall Study|Lost to Follow-up|2|||
23387159|NCT00894647|65162797|FG000|Overall Study|Non-compliance with study procedures|0|||
23387160|NCT00894647|65162798|FG001|Overall Study|Non-compliance with study procedures|2|||
23387161|NCT00894647|65162797|FG000|Overall Study|Other, not due to AE|1|||
23387162|NCT00894647|65162798|FG001|Overall Study|Other, not due to AE|2|||
23387163|NCT00676689|65162799|FG000|Overall Study|Screen Failure|2|||
23387164|NCT00676689|65162799|FG000|Overall Study|Death|2|||
23387165|NCT00676689|65162799|FG000|Overall Study|Lost to Follow-up|4|||
23387166|NCT00676689|65162799|FG000|Overall Study|Physician Decision|1|||
23387167|NCT00676689|65162799|FG000|Overall Study|Withdrawal by Subject|3|||
23387168|NCT00676689|65162799|FG000|Overall Study|Continuing FU|49|||
23387169|NCT02383173|65162800|FG000|Overall Study|Palliative Care Team withdrew|0|||
23387170|NCT02383173|65162801|FG001|Overall Study|Palliative Care Team withdrew|2|||
23387171|NCT00689052|65162802|FG000|Overall Study|Adverse Event|4|||
23387172|NCT00689052|65162803|FG001|Overall Study|Adverse Event|6|||
23387173|NCT00689052|65162802|FG000|Overall Study|Protocol Violation|1|||
23387174|NCT00689052|65162803|FG001|Overall Study|Protocol Violation|0|||
23387175|NCT00689052|65162802|FG000|Overall Study|Lost to Follow-up|2|||
23387176|NCT00689052|65162803|FG001|Overall Study|Lost to Follow-up|0|||
23387177|NCT00689052|65162802|FG000|Overall Study|Withdrawal by Subject|2|||
23387178|NCT00689052|65162803|FG001|Overall Study|Withdrawal by Subject|0|||
23387179|NCT00689052|65162802|FG000|Overall Study|Early termination of the trial|22|||
23387180|NCT00689052|65162803|FG001|Overall Study|Early termination of the trial|24|||
23387181|NCT03425188|65162804|FG000|Overall Study|Withdrawal by Subject|1|||
23387182|NCT00160615|65162805|FG000|Overall Study|Adverse Event|5|||
23387183|NCT00160615|65162806|FG001|Overall Study|Adverse Event|12|||
23387184|NCT00160615|65162805|FG000|Overall Study|Withdrawal by Subject|0|||
23387185|NCT00160615|65162806|FG001|Overall Study|Withdrawal by Subject|2|||
23387186|NCT00160615|65162805|FG000|Overall Study|Lack of Efficacy|11|||
23387187|NCT00160615|65162806|FG001|Overall Study|Lack of Efficacy|23|||
23387188|NCT00160615|65162805|FG000|Overall Study|Patient decision|1|||
23387189|NCT00160615|65162806|FG001|Overall Study|Patient decision|2|||
23387190|NCT00160615|65162805|FG000|Overall Study|Investigator decision|1|||
23387191|NCT00160615|65162806|FG001|Overall Study|Investigator decision|1|||
23387192|NCT00160615|65162805|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
23387193|NCT00160615|65162806|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
23387194|NCT00160615|65162805|FG000|Overall Study|Switch to surgical treatment|0|||
23387195|NCT00160615|65162806|FG001|Overall Study|Switch to surgical treatment|2|||
23387196|NCT00160615|65162805|FG000|Overall Study|Non-compliance was suspected|0|||
23387197|NCT00160615|65162806|FG001|Overall Study|Non-compliance was suspected|1|||
23387198|NCT00160615|65162805|FG000|Overall Study|Poor compliance|0|||
23387199|NCT00160615|65162806|FG001|Overall Study|Poor compliance|1|||
23387200|NCT01852214|65162807|FG000|Period 1|Adverse Event|1|||
23387201|NCT01852214|65162808|FG001|Period 1|Adverse Event|2|||
23387202|NCT01852214|65162807|FG000|Period 1|Withdrawal by Subject|0|||
23387203|NCT01852214|65162808|FG001|Period 1|Withdrawal by Subject|1|||
23387204|NCT01852214|65162807|FG000|Washout Period|Withdrawal by Subject|0|||
23387205|NCT01852214|65162808|FG001|Washout Period|Withdrawal by Subject|1|||
23387206|NCT00799864|65162813|FG000|Overall Study|Participant reached a virologic endpoint|9|||
23387207|NCT00799864|65162814|FG001|Overall Study|Participant reached a virologic endpoint|2|||
23387208|NCT00799864|65162815|FG002|Overall Study|Participant reached a virologic endpoint|2|||
23387209|NCT00799864|65162816|FG003|Overall Study|Participant reached a virologic endpoint|0|||
23675151|NCT01262365|66190906|FG001|Overall Study|Patient unavailable|0|||
23675152|NCT01262365|66190907|FG002|Overall Study|Patient unavailable|1|||
23387210|NCT00799864|65162817|FG004|Overall Study|Participant reached a virologic endpoint|0|||
23387211|NCT00799864|65162813|FG000|Overall Study|Other|2|||
23387212|NCT00799864|65162814|FG001|Overall Study|Other|1|||
23387213|NCT00799864|65162815|FG002|Overall Study|Other|0|||
23387214|NCT00799864|65162816|FG003|Overall Study|Other|0|||
23675153|NCT00978029|66190908|FG000|Overall Study|Adverse Event|1|||
23387215|NCT00799864|65162817|FG004|Overall Study|Other|0|||
23387216|NCT00147537|65162818|FG000|Phase 1b|Death|0|||
23387217|NCT00147537|65162819|FG001|Phase 1b|Death|1|||
23387218|NCT00147537|65162820|FG002|Phase 1b|Death|2|||
23387219|NCT00147537|65162821|FG003|Phase 1b|Death|1|||
23387220|NCT00147537|65162822|FG004|Phase 1b|Death|2|||
23387221|NCT00147537|65162823|FG005|Phase 1b|Death|2|||
23387222|NCT00147537|65162824|FG006|Phase 1b|Death|1|||
23387223|NCT00147537|65162825|FG007|Phase 1b|Death|3|||
23387224|NCT00147537|65162826|FG008|Phase 1b|Death|9|||
23387225|NCT00147537|65162827|FG009|Phase 1b|Death|0|||
23387226|NCT00147537|65162828|FG010|Phase 1b|Death|0|||
23387227|NCT00147537|65162818|FG000|Phase 1b|Lost to Follow-up|2|||
23387228|NCT00147537|65162819|FG001|Phase 1b|Lost to Follow-up|1|||
23387229|NCT00147537|65162820|FG002|Phase 1b|Lost to Follow-up|0|||
23387230|NCT00147537|65162821|FG003|Phase 1b|Lost to Follow-up|0|||
23387231|NCT00147537|65162822|FG004|Phase 1b|Lost to Follow-up|0|||
23387232|NCT00147537|65162823|FG005|Phase 1b|Lost to Follow-up|0|||
23387233|NCT00147537|65162824|FG006|Phase 1b|Lost to Follow-up|2|||
23493923|NCT01030536|65554842|FG003|Overall Study|Withdrawal by Subject|0|||
23493924|NCT01030536|65554843|FG004|Overall Study|Withdrawal by Subject|0|||
23493925|NCT01030536|65554839|FG000|Overall Study|undefined|1|||
23493926|NCT01030536|65554840|FG001|Overall Study|undefined|0|||
23493927|NCT01030536|65554841|FG002|Overall Study|undefined|1|||
23493928|NCT01030536|65554842|FG003|Overall Study|undefined|1|||
23493929|NCT01030536|65554843|FG004|Overall Study|undefined|0|||
23493930|NCT01030536|65554839|FG000|Overall Study|Adverse Event|0|||
23493931|NCT01030536|65554840|FG001|Overall Study|Adverse Event|3|||
23493932|NCT01030536|65554841|FG002|Overall Study|Adverse Event|1|||
23493933|NCT01030536|65554842|FG003|Overall Study|Adverse Event|0|||
23493934|NCT01030536|65554843|FG004|Overall Study|Adverse Event|1|||
23493935|NCT01030536|65554839|FG000|Overall Study|Progressive disease|6|||
23493936|NCT01030536|65554840|FG001|Overall Study|Progressive disease|2|||
23493937|NCT01030536|65554841|FG002|Overall Study|Progressive disease|3|||
23493938|NCT01030536|65554842|FG003|Overall Study|Progressive disease|2|||
23493939|NCT01030536|65554843|FG004|Overall Study|Progressive disease|0|||
23493940|NCT01030536|65554839|FG000|Overall Study|Death|0|||
23493941|NCT01030536|65554840|FG001|Overall Study|Death|1|||
23493942|NCT01030536|65554841|FG002|Overall Study|Death|0|||
23493943|NCT01030536|65554842|FG003|Overall Study|Death|0|||
23493944|NCT01030536|65554843|FG004|Overall Study|Death|0|||
23493945|NCT01386008|65554845|FG000|Overall Study|exited w/o incident /study discontinued|17|||
23493946|NCT01386008|65554845|FG000|Overall Study|Adverse Event|3|||
23493947|NCT00961649|65554852|FG000|Overall Study|Adverse Event|4|||
23493948|NCT00961649|65554853|FG001|Overall Study|Adverse Event|0|||
23493949|NCT00961649|65554854|FG002|Overall Study|Adverse Event|0|||
23493950|NCT00961649|65554855|FG003|Overall Study|Adverse Event|2|||
23493951|NCT00961649|65554852|FG000|Overall Study|Inadequate control of IOP|0|||
23493952|NCT00961649|65554853|FG001|Overall Study|Inadequate control of IOP|0|||
23493953|NCT00961649|65554854|FG002|Overall Study|Inadequate control of IOP|0|||
23493954|NCT00961649|65554855|FG003|Overall Study|Inadequate control of IOP|1|||
23493955|NCT00961649|65554852|FG000|Overall Study|Patient has travel plans during holidays|0|||
23675154|NCT00978029|66190909|FG001|Overall Study|Adverse Event|2|||
23387234|NCT00147537|65162825|FG007|Phase 1b|Lost to Follow-up|0|||
23387235|NCT00147537|65162826|FG008|Phase 1b|Lost to Follow-up|1|||
23387236|NCT00147537|65162827|FG009|Phase 1b|Lost to Follow-up|0|||
23387237|NCT00147537|65162828|FG010|Phase 1b|Lost to Follow-up|0|||
23387238|NCT00147537|65162818|FG000|Phase 1b|Other|0|||
23493956|NCT00961649|65554853|FG001|Overall Study|Patient has travel plans during holidays|0|||
23493957|NCT00961649|65554854|FG002|Overall Study|Patient has travel plans during holidays|1|||
23387239|NCT00147537|65162819|FG001|Phase 1b|Other|0|||
23387240|NCT00147537|65162820|FG002|Phase 1b|Other|2|||
23387241|NCT00147537|65162821|FG003|Phase 1b|Other|1|||
23387242|NCT00147537|65162822|FG004|Phase 1b|Other|1|||
23387243|NCT00147537|65162823|FG005|Phase 1b|Other|1|||
23387244|NCT00147537|65162824|FG006|Phase 1b|Other|14|||
23387245|NCT00147537|65162825|FG007|Phase 1b|Other|4|||
23387246|NCT00147537|65162826|FG008|Phase 1b|Other|4|||
23387247|NCT00147537|65162827|FG009|Phase 1b|Other|0|||
23387248|NCT00147537|65162828|FG010|Phase 1b|Other|0|||
23387249|NCT00147537|65162818|FG000|Phase 1b|Withdrawal by Subject|0|||
23387250|NCT00147537|65162819|FG001|Phase 1b|Withdrawal by Subject|0|||
23387251|NCT00147537|65162820|FG002|Phase 1b|Withdrawal by Subject|0|||
23387252|NCT00147537|65162821|FG003|Phase 1b|Withdrawal by Subject|0|||
23387253|NCT00147537|65162822|FG004|Phase 1b|Withdrawal by Subject|0|||
23387254|NCT00147537|65162823|FG005|Phase 1b|Withdrawal by Subject|0|||
23387255|NCT00147537|65162824|FG006|Phase 1b|Withdrawal by Subject|0|||
23387256|NCT00147537|65162825|FG007|Phase 1b|Withdrawal by Subject|0|||
23387257|NCT00147537|65162826|FG008|Phase 1b|Withdrawal by Subject|2|||
23387258|NCT00147537|65162827|FG009|Phase 1b|Withdrawal by Subject|0|||
23387259|NCT00147537|65162828|FG010|Phase 1b|Withdrawal by Subject|0|||
23387260|NCT00147537|65162818|FG000|Phase 1b|Randomized but not treated|0|||
23493958|NCT00961649|65554855|FG003|Overall Study|Patient has travel plans during holidays|0|||
23493959|NCT00961649|65554852|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
23493960|NCT00961649|65554853|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
23493961|NCT00961649|65554854|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
23387261|NCT00147537|65162819|FG001|Phase 1b|Randomized but not treated|0|||
23387262|NCT00147537|65162820|FG002|Phase 1b|Randomized but not treated|0|||
23387263|NCT00147537|65162821|FG003|Phase 1b|Randomized but not treated|0|||
23387264|NCT00147537|65162822|FG004|Phase 1b|Randomized but not treated|0|||
23675155|NCT00978029|66190910|FG002|Overall Study|Adverse Event|5|||
23387265|NCT00147537|65162823|FG005|Phase 1b|Randomized but not treated|0|||
23387266|NCT00147537|65162824|FG006|Phase 1b|Randomized but not treated|1|||
23387267|NCT00147537|65162825|FG007|Phase 1b|Randomized but not treated|0|||
23675156|NCT00978029|66190908|FG000|Overall Study|Withdrawal by Subject|0|||
23675157|NCT00978029|66190909|FG001|Overall Study|Withdrawal by Subject|0|||
23675158|NCT00978029|66190910|FG002|Overall Study|Withdrawal by Subject|1|||
23675159|NCT00978029|66190908|FG000|Overall Study|Protocol Violation|0|||
23675160|NCT00978029|66190909|FG001|Overall Study|Protocol Violation|1|||
23675161|NCT00978029|66190910|FG002|Overall Study|Protocol Violation|0|||
23675162|NCT02447848|66190911|FG000|Overall Study|Patient discharged|3|||
23675163|NCT02447848|66190911|FG000|Overall Study|Lack of Efficacy|4|||
23387268|NCT00147537|65162826|FG008|Phase 1b|Randomized but not treated|1|||
23675164|NCT02447848|66190911|FG000|Overall Study|Withdrawal by Subject|4|||
23675165|NCT01325428|66190912|FG000|Part A|Progressive disease according to RECIST|9|||
23675166|NCT01325428|66190912|FG000|Part A|Clinical signs, symptoms of progression|2|||
23675167|NCT01325428|66190912|FG000|Part A|Other adverse event|1|||
23675168|NCT01325428|66190912|FG000|Part A|Refused continue taking trial medication|2|||
23675169|NCT01325428|66190912|FG000|Part A|Other reason not defined above|2|||
23675170|NCT01325428|66190912|FG000|Part B|Refused continue taking trial medication|2|||
23675171|NCT01325428|66190912|FG000|Part B|Other reason not defined above|1|||
23675172|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
23675173|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
23675174|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
23387269|NCT00147537|65162827|FG009|Phase 1b|Randomized but not treated|0|||
23387270|NCT00147537|65162828|FG010|Phase 1b|Randomized but not treated|0|||
23387271|NCT00147537|65162818|FG000|Phase 2|Death|0|||
23387272|NCT00147537|65162819|FG001|Phase 2|Death|0|||
23387273|NCT00147537|65162820|FG002|Phase 2|Death|0|||
23493962|NCT00961649|65554855|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
23493963|NCT00961649|65554852|FG000|Overall Study|Study terminated by sponsor|4|||
23493964|NCT00961649|65554853|FG001|Overall Study|Study terminated by sponsor|4|||
23493965|NCT00961649|65554854|FG002|Overall Study|Study terminated by sponsor|4|||
23493966|NCT00961649|65554855|FG003|Overall Study|Study terminated by sponsor|1|||
23493967|NCT01952145|65554856|FG000|Overall Study|Protocol Violation|2|||
23493968|NCT01952145|65554857|FG001|Overall Study|Protocol Violation|1|||
23493969|NCT01952145|65554856|FG000|Overall Study|Death|0|||
23675175|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
23675176|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
23675177|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
23387274|NCT00147537|65162821|FG003|Phase 2|Death|0|||
23493970|NCT01952145|65554857|FG001|Overall Study|Death|1|||
23493971|NCT01952145|65554856|FG000|Overall Study|Adverse Event|9|||
23493972|NCT01952145|65554857|FG001|Overall Study|Adverse Event|0|||
23675178|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
23675179|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
23387275|NCT00147537|65162822|FG004|Phase 2|Death|0|||
23387276|NCT00147537|65162823|FG005|Phase 2|Death|0|||
23387277|NCT00147537|65162824|FG006|Phase 2|Death|0|||
23387278|NCT00147537|65162825|FG007|Phase 2|Death|0|||
23675180|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
23675181|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
23675182|NCT04041284|66190915|FG000|DB Phase (12 Weeks)|Other than specified|1|||
23675183|NCT04041284|66190916|FG001|DB Phase (12 Weeks)|Other than specified|0|||
23675184|NCT04041284|66190915|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
23675185|NCT04041284|66190916|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
23675186|NCT04041284|66190915|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
23675187|NCT04041284|66190916|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
23675188|NCT04041284|66190915|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
23675189|NCT04041284|66190916|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
23675190|NCT04041284|66190915|FG000|OL Phase (12 Weeks)|Other than specified|6|||
23675191|NCT04041284|66190916|FG001|OL Phase (12 Weeks)|Other than specified|2|||
23675192|NCT01192022|66190917|FG000|Overall Study|Withdrawal of Consent|3|||
23675193|NCT01192022|66190918|FG001|Overall Study|Withdrawal of Consent|1|||
23675194|NCT01192022|66190919|FG002|Overall Study|Withdrawal of Consent|0|||
23675195|NCT01192022|66190920|FG003|Overall Study|Withdrawal of Consent|0|||
23675196|NCT01192022|66190921|FG004|Overall Study|Withdrawal of Consent|0|||
23675197|NCT01192022|66190917|FG000|Overall Study|Lost to Follow-up|4|||
23675198|NCT01192022|66190918|FG001|Overall Study|Lost to Follow-up|2|||
23675199|NCT01192022|66190919|FG002|Overall Study|Lost to Follow-up|1|||
23675200|NCT01192022|66190920|FG003|Overall Study|Lost to Follow-up|1|||
23675201|NCT01192022|66190921|FG004|Overall Study|Lost to Follow-up|0|||
23675202|NCT01192022|66190917|FG000|Overall Study|Adverse Event|1|||
23675203|NCT01192022|66190918|FG001|Overall Study|Adverse Event|0|||
23675204|NCT01192022|66190919|FG002|Overall Study|Adverse Event|0|||
23675205|NCT01192022|66190920|FG003|Overall Study|Adverse Event|0|||
23493973|NCT01952145|65554856|FG000|Overall Study|Withdrawal Criteria|16|||
23493974|NCT01952145|65554857|FG001|Overall Study|Withdrawal Criteria|11|||
23493975|NCT01952145|65554856|FG000|Overall Study|Unclassified|1|||
23493976|NCT01952145|65554857|FG001|Overall Study|Unclassified|1|||
23493977|NCT05447897|65554858|FG000|Overall Study|Did not participate in survey|2|||
23493978|NCT01811225|65554859|FG000|Treatment Period 1|Adverse Event|2|||
23493979|NCT01811225|65554860|FG001|Treatment Period 1|Adverse Event|3|||
23493980|NCT01811225|65554859|FG000|Treatment Period 1|Lost to Follow-up|12|||
23493981|NCT01811225|65554860|FG001|Treatment Period 1|Lost to Follow-up|8|||
23493982|NCT01811225|65554859|FG000|Treatment Period 1|transporation|1|||
23493983|NCT01811225|65554860|FG001|Treatment Period 1|transporation|0|||
23493984|NCT01811225|65554859|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
23493985|NCT01811225|65554860|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
23493986|NCT01811225|65554859|FG000|Treatment Period 2|Lost to Follow-up|1|||
23493987|NCT01811225|65554860|FG001|Treatment Period 2|Lost to Follow-up|2|||
23493988|NCT01811225|65554859|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
23493989|NCT01811225|65554860|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
23493990|NCT00633750|65554863|FG000|Overall Study|Adverse Event|2|||
23493991|NCT00633750|65554863|FG000|Overall Study|Withdrawal by Subject|3|||
23493992|NCT00108433|65554869|FG000|Overall Study|Lack of Efficacy|1|||
23493993|NCT00108433|65554870|FG001|Overall Study|Lack of Efficacy|2|||
23493994|NCT00108433|65554869|FG000|Overall Study|Death|3|||
23493995|NCT00108433|65554870|FG001|Overall Study|Death|0|||
23493996|NCT00108433|65554869|FG000|Overall Study|Adverse Event|3|||
23493997|NCT00108433|65554870|FG001|Overall Study|Adverse Event|1|||
23493998|NCT00108433|65554869|FG000|Overall Study|Other|14|||
23493999|NCT00108433|65554870|FG001|Overall Study|Other|14|||
23494000|NCT03945214|65554871|FG000|Overall Study|Lost to Follow-up|3|||
23494001|NCT03945214|65554872|FG001|Overall Study|Lost to Follow-up|4|||
23494002|NCT03945214|65554873|FG002|Overall Study|Lost to Follow-up|7|||
23494003|NCT03945214|65554874|FG003|Overall Study|Lost to Follow-up|4|||
23494004|NCT01495975|65554875|FG000|Overall Study|Lost to Follow-up|1|||
23494005|NCT01495975|65554876|FG001|Overall Study|Lost to Follow-up|0|||
23675206|NCT01192022|66190921|FG004|Overall Study|Adverse Event|0|||
23675207|NCT01192022|66190917|FG000|Overall Study|Fatal Adverse Event|4|||
23675208|NCT01192022|66190918|FG001|Overall Study|Fatal Adverse Event|6|||
23494006|NCT00722423|65554884|FG000|Overall Study|Protocol Violation|0|||
23675209|NCT01192022|66190919|FG002|Overall Study|Fatal Adverse Event|0|||
23675210|NCT01192022|66190920|FG003|Overall Study|Fatal Adverse Event|0|||
23494007|NCT00722423|65554885|FG001|Overall Study|Protocol Violation|1|||
23494008|NCT01128842|65554887|FG000|Overall Study|Adverse Event|1|||
23675211|NCT01192022|66190921|FG004|Overall Study|Fatal Adverse Event|1|||
23494009|NCT01128842|65554887|FG000|Overall Study|Disease Progression|6|||
23494010|NCT04638660|65554888|FG000|Overall Study|Withdrawal by Subject|2|||
23494011|NCT04638660|65554889|FG001|Overall Study|Withdrawal by Subject|0|||
23494012|NCT04638660|65554888|FG000|Overall Study|Lost to Follow-up|1|||
23494013|NCT04638660|65554889|FG001|Overall Study|Lost to Follow-up|0|||
23494014|NCT03546062|65554890|FG000|Overall Study|Adverse Event|6|||
23494015|NCT03546062|65554891|FG001|Overall Study|Adverse Event|5|||
23494016|NCT03546062|65554892|FG002|Overall Study|Adverse Event|8|||
23494017|NCT02935842|65554893|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
23494018|NCT02935842|65554894|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494019|NCT02935842|65554895|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494020|NCT02935842|65554896|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494021|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
23494022|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
23494023|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
23494024|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
23494025|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
23494026|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
23494027|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
23494028|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
23494029|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494030|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494031|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494032|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
23494033|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494034|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494035|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
23494036|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494037|NCT00566111|65554897|FG000|Overall Study|Adverse Event|0|||
23494038|NCT00566111|65554898|FG001|Overall Study|Adverse Event|2|||
23494039|NCT00697788|65554899|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494040|NCT00697788|65554900|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
23494041|NCT00697788|65554901|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494042|NCT00697788|65554902|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494043|NCT00697788|65554903|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494044|NCT00697788|65554904|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494045|NCT00697788|65554905|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494046|NCT00697788|65554906|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494047|NCT00697788|65554899|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494048|NCT00697788|65554900|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494049|NCT00697788|65554901|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494050|NCT00697788|65554902|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494051|NCT00697788|65554903|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
23494052|NCT00697788|65554904|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494053|NCT00697788|65554905|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494054|NCT00697788|65554906|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494055|NCT01447433|65554907|FG000|Overall Study|Lost to Follow-up|0|||
23494056|NCT01447433|65554908|FG001|Overall Study|Lost to Follow-up|2|||
23494057|NCT01447433|65554907|FG000|Overall Study|Withdrawal by Subject|3|||
23494058|NCT01447433|65554908|FG001|Overall Study|Withdrawal by Subject|3|||
23494059|NCT01447433|65554907|FG000|Overall Study|Protocol Violation|1|||
23494060|NCT01447433|65554908|FG001|Overall Study|Protocol Violation|1|||
23494061|NCT00369824|65554909|FG000|Overall Study|Adverse Event|0|||
23494062|NCT00369824|65554910|FG001|Overall Study|Adverse Event|2|||
23494063|NCT00369824|65554911|FG002|Overall Study|Adverse Event|0|||
23494064|NCT00369824|65554912|FG003|Overall Study|Adverse Event|0|||
23494065|NCT00369824|65554913|FG004|Overall Study|Adverse Event|1|||
23494066|NCT00369824|65554914|FG005|Overall Study|Adverse Event|0|||
23494067|NCT00369824|65554909|FG000|Overall Study|Protocol Violation|0|||
23494068|NCT00369824|65554910|FG001|Overall Study|Protocol Violation|1|||
23494069|NCT00369824|65554911|FG002|Overall Study|Protocol Violation|0|||
23494070|NCT00369824|65554912|FG003|Overall Study|Protocol Violation|1|||
23494071|NCT00369824|65554913|FG004|Overall Study|Protocol Violation|1|||
23494072|NCT00369824|65554914|FG005|Overall Study|Protocol Violation|0|||
23494073|NCT00369824|65554909|FG000|Overall Study|Withdrawal by Subject|9|||
23494074|NCT00369824|65554910|FG001|Overall Study|Withdrawal by Subject|5|||
23494075|NCT00369824|65554911|FG002|Overall Study|Withdrawal by Subject|5|||
23494076|NCT00369824|65554912|FG003|Overall Study|Withdrawal by Subject|4|||
23494077|NCT00369824|65554913|FG004|Overall Study|Withdrawal by Subject|6|||
23494078|NCT00369824|65554914|FG005|Overall Study|Withdrawal by Subject|2|||
23494079|NCT00369824|65554909|FG000|Overall Study|Lost to Follow-up|6|||
23494080|NCT00369824|65554910|FG001|Overall Study|Lost to Follow-up|11|||
23494081|NCT00369824|65554911|FG002|Overall Study|Lost to Follow-up|7|||
23494082|NCT00369824|65554912|FG003|Overall Study|Lost to Follow-up|8|||
23494083|NCT00369824|65554913|FG004|Overall Study|Lost to Follow-up|9|||
23494084|NCT00369824|65554914|FG005|Overall Study|Lost to Follow-up|6|||
23494085|NCT00369824|65554909|FG000|Overall Study|Other|0|||
23494086|NCT00369824|65554910|FG001|Overall Study|Other|0|||
23494087|NCT00369824|65554911|FG002|Overall Study|Other|0|||
23494088|NCT00369824|65554912|FG003|Overall Study|Other|2|||
23494089|NCT00369824|65554913|FG004|Overall Study|Other|1|||
23494090|NCT00369824|65554914|FG005|Overall Study|Other|3|||
23494091|NCT01390649|65554915|FG000|Overall Study|Physician Decision|1|||
23494092|NCT00850070|65554916|FG000|Overall Study|Lack of Efficacy|1|||
23494093|NCT00850070|65554917|FG001|Overall Study|Lack of Efficacy|1|||
23494094|NCT00850070|65554916|FG000|Overall Study|Adverse Event|2|||
23494095|NCT00850070|65554917|FG001|Overall Study|Adverse Event|0|||
23494096|NCT02980783|65554918|FG000|Overall Study|Lost to Follow-up|1|||
23494097|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494098|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
23494099|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494100|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494101|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494102|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
23494103|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494104|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494105|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494106|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494107|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494108|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494109|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494110|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
23494111|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494112|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
23494113|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494114|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494115|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
23494116|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494117|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494118|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494119|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494120|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494121|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
23494122|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
23494123|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
23494124|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
23494125|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
23494126|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
23494127|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
23494128|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494129|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494130|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494131|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494132|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494133|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
23494134|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
23494135|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
23494136|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
23494137|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
23494138|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
23494139|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
23494140|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494141|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494142|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494143|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494144|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494145|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494146|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494147|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494148|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494149|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494150|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494151|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494152|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494153|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
23494154|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494155|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494156|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494157|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494158|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494159|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494160|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494161|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494162|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494163|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494164|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
23494165|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
23494166|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
23494167|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
23494168|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
23494169|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494170|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494171|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494172|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494173|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494174|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494175|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494176|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494177|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494178|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494179|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23675212|NCT01192022|66190917|FG000|Overall Study|Physician withdrew-patient hardship|1|||
23675213|NCT01192022|66190918|FG001|Overall Study|Physician withdrew-patient hardship|0|||
23675214|NCT01192022|66190919|FG002|Overall Study|Physician withdrew-patient hardship|0|||
23675215|NCT01192022|66190920|FG003|Overall Study|Physician withdrew-patient hardship|0|||
23675216|NCT01192022|66190921|FG004|Overall Study|Physician withdrew-patient hardship|0|||
23675217|NCT01192022|66190917|FG000|Overall Study|Patient too sick from chemotherapy|0|||
23675218|NCT01192022|66190918|FG001|Overall Study|Patient too sick from chemotherapy|1|||
23675219|NCT01192022|66190919|FG002|Overall Study|Patient too sick from chemotherapy|0|||
23675220|NCT01192022|66190920|FG003|Overall Study|Patient too sick from chemotherapy|0|||
23675221|NCT01192022|66190921|FG004|Overall Study|Patient too sick from chemotherapy|0|||
23675222|NCT01192022|66190917|FG000|Overall Study|Patient needed surgery|0|||
23675223|NCT01192022|66190918|FG001|Overall Study|Patient needed surgery|1|||
23675224|NCT01192022|66190919|FG002|Overall Study|Patient needed surgery|0|||
23675225|NCT01192022|66190920|FG003|Overall Study|Patient needed surgery|0|||
23675226|NCT01192022|66190921|FG004|Overall Study|Patient needed surgery|0|||
23675227|NCT01192022|66190917|FG000|Overall Study|Parents did not allow all follow up|0|||
23675228|NCT01192022|66190918|FG001|Overall Study|Parents did not allow all follow up|0|||
23675229|NCT01192022|66190919|FG002|Overall Study|Parents did not allow all follow up|0|||
23675230|NCT01192022|66190920|FG003|Overall Study|Parents did not allow all follow up|1|||
23675231|NCT01192022|66190921|FG004|Overall Study|Parents did not allow all follow up|0|||
23675232|NCT03436862|66190922|FG000|Overall Study|Adverse Event|4|||
23675233|NCT03436862|66190922|FG000|Overall Study|Progressive Disease|2|||
23675234|NCT02793232|66190923|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675235|NCT02793232|66190924|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675236|NCT02793232|66190925|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675237|NCT02793232|66190926|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675238|NCT02793232|66190927|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
23387279|NCT00147537|65162826|FG008|Phase 2|Death|0|||
23387280|NCT00147537|65162827|FG009|Phase 2|Death|85|||
23387281|NCT00147537|65162828|FG010|Phase 2|Death|31|||
23675239|NCT02793232|66190928|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675240|NCT02793232|66190929|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
23675241|NCT02793232|66190930|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675242|NCT02793232|66190931|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23675243|NCT01903837|66190932|FG000|Part A|Withdrawal by Subject|4|||
23675244|NCT01903837|66190933|FG001|Part A|Withdrawal by Subject|9|||
23675245|NCT01903837|66190934|FG002|Part A|Withdrawal by Subject|8|||
23494180|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494181|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
23494182|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
23494183|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
23494184|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
23494185|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
23494186|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
23494187|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
23494188|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
23494189|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
23675246|NCT01903837|66190935|FG003|Part A|Withdrawal by Subject|5|||
23675247|NCT01903837|66190932|FG000|Part A|Adverse Event|3|||
23675248|NCT01903837|66190933|FG001|Part A|Adverse Event|6|||
23675249|NCT01903837|66190934|FG002|Part A|Adverse Event|9|||
23675250|NCT01903837|66190935|FG003|Part A|Adverse Event|6|||
23675251|NCT01903837|66190932|FG000|Part A|Lost to Follow-up|9|||
23675252|NCT01903837|66190933|FG001|Part A|Lost to Follow-up|7|||
23675253|NCT01903837|66190934|FG002|Part A|Lost to Follow-up|7|||
23675254|NCT01903837|66190935|FG003|Part A|Lost to Follow-up|2|||
23494190|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
23675255|NCT01903837|66190932|FG000|Part A|Non-compliance with study drug|1|||
23675256|NCT01903837|66190933|FG001|Part A|Non-compliance with study drug|4|||
23675257|NCT01903837|66190934|FG002|Part A|Non-compliance with study drug|4|||
23675258|NCT01903837|66190935|FG003|Part A|Non-compliance with study drug|0|||
23675259|NCT01903837|66190932|FG000|Part A|Physician Decision|1|||
23675260|NCT01903837|66190933|FG001|Part A|Physician Decision|1|||
23675261|NCT01903837|66190934|FG002|Part A|Physician Decision|0|||
23675262|NCT01903837|66190935|FG003|Part A|Physician Decision|0|||
23675263|NCT01903837|66190932|FG000|Part A|Protocol Violation|1|||
23675264|NCT01903837|66190933|FG001|Part A|Protocol Violation|1|||
23675265|NCT01903837|66190934|FG002|Part A|Protocol Violation|0|||
23675266|NCT01903837|66190935|FG003|Part A|Protocol Violation|0|||
23675267|NCT01903837|66190932|FG000|Part B|Lost to Follow-up|0|||
23675268|NCT01903837|66190933|FG001|Part B|Lost to Follow-up|3|||
23675269|NCT01903837|66190934|FG002|Part B|Lost to Follow-up|3|||
23675270|NCT01903837|66190935|FG003|Part B|Lost to Follow-up|4|||
23675271|NCT01903837|66190932|FG000|Part B|Withdrawal by Subject|1|||
23675272|NCT01903837|66190933|FG001|Part B|Withdrawal by Subject|2|||
23675273|NCT01903837|66190934|FG002|Part B|Withdrawal by Subject|0|||
23675274|NCT01903837|66190935|FG003|Part B|Withdrawal by Subject|3|||
23675275|NCT01903837|66190932|FG000|Part B|Adverse Event|3|||
23494191|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
23494192|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
23494193|NCT04447794|65554936|FG000|Overall Study|Lost to Follow-up|2|||
23494194|NCT04447794|65554937|FG001|Overall Study|Lost to Follow-up|3|||
23494195|NCT04447794|65554938|FG002|Overall Study|Lost to Follow-up|8|||
23494196|NCT04447794|65554936|FG000|Overall Study|Withdrawal by Subject|1|||
23494197|NCT04447794|65554937|FG001|Overall Study|Withdrawal by Subject|1|||
23494198|NCT04447794|65554938|FG002|Overall Study|Withdrawal by Subject|0|||
23675276|NCT01903837|66190933|FG001|Part B|Adverse Event|0|||
23675277|NCT01903837|66190934|FG002|Part B|Adverse Event|2|||
23494199|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
23494200|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
23494201|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
23675278|NCT01903837|66190935|FG003|Part B|Adverse Event|0|||
23675279|NCT01903837|66190932|FG000|Part B|Non-compliance with study drug|2|||
23675280|NCT01903837|66190933|FG001|Part B|Non-compliance with study drug|0|||
23675281|NCT01903837|66190934|FG002|Part B|Non-compliance with study drug|0|||
23675282|NCT01903837|66190935|FG003|Part B|Non-compliance with study drug|1|||
23387282|NCT00147537|65162818|FG000|Phase 2|Lost to Follow-up|0|||
23387283|NCT00147537|65162819|FG001|Phase 2|Lost to Follow-up|0|||
23387284|NCT00147537|65162820|FG002|Phase 2|Lost to Follow-up|0|||
23387285|NCT00147537|65162821|FG003|Phase 2|Lost to Follow-up|0|||
23387286|NCT00147537|65162822|FG004|Phase 2|Lost to Follow-up|0|||
23387287|NCT00147537|65162823|FG005|Phase 2|Lost to Follow-up|0|||
23387288|NCT00147537|65162824|FG006|Phase 2|Lost to Follow-up|0|||
23387289|NCT00147537|65162825|FG007|Phase 2|Lost to Follow-up|0|||
23387290|NCT00147537|65162826|FG008|Phase 2|Lost to Follow-up|0|||
23387291|NCT00147537|65162827|FG009|Phase 2|Lost to Follow-up|12|||
23387292|NCT00147537|65162828|FG010|Phase 2|Lost to Follow-up|4|||
23387293|NCT00147537|65162818|FG000|Phase 2|Other|0|||
23387294|NCT00147537|65162819|FG001|Phase 2|Other|0|||
23387295|NCT00147537|65162820|FG002|Phase 2|Other|0|||
23387296|NCT00147537|65162821|FG003|Phase 2|Other|0|||
23387297|NCT00147537|65162822|FG004|Phase 2|Other|0|||
23387298|NCT00147537|65162823|FG005|Phase 2|Other|0|||
23387299|NCT00147537|65162824|FG006|Phase 2|Other|0|||
23494202|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
23494203|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
23494204|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
23494205|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
23494206|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
23494207|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
23494208|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
23494209|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
23494210|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
23494211|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
23494212|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
23494213|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
23494214|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
23494215|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
23675283|NCT01903837|66190932|FG000|Part B|Incarceration|2|||
23387300|NCT00147537|65162825|FG007|Phase 2|Other|0|||
23387301|NCT00147537|65162826|FG008|Phase 2|Other|0|||
23387302|NCT00147537|65162827|FG009|Phase 2|Other|47|||
23387303|NCT00147537|65162828|FG010|Phase 2|Other|12|||
23387304|NCT00147537|65162818|FG000|Phase 2|Withdrawal by Subject|0|||
23387305|NCT00147537|65162819|FG001|Phase 2|Withdrawal by Subject|0|||
23387306|NCT00147537|65162820|FG002|Phase 2|Withdrawal by Subject|0|||
23387307|NCT00147537|65162821|FG003|Phase 2|Withdrawal by Subject|0|||
23387308|NCT00147537|65162822|FG004|Phase 2|Withdrawal by Subject|0|||
23387309|NCT00147537|65162823|FG005|Phase 2|Withdrawal by Subject|0|||
23387310|NCT00147537|65162824|FG006|Phase 2|Withdrawal by Subject|0|||
23387311|NCT00147537|65162825|FG007|Phase 2|Withdrawal by Subject|0|||
23387312|NCT00147537|65162826|FG008|Phase 2|Withdrawal by Subject|0|||
23675284|NCT01903837|66190933|FG001|Part B|Incarceration|0|||
23675285|NCT01903837|66190934|FG002|Part B|Incarceration|0|||
23387313|NCT00147537|65162827|FG009|Phase 2|Withdrawal by Subject|16|||
23387314|NCT00147537|65162828|FG010|Phase 2|Withdrawal by Subject|4|||
23387315|NCT00147537|65162818|FG000|Phase 2|Randomized but not treated|0|||
23387316|NCT00147537|65162819|FG001|Phase 2|Randomized but not treated|0|||
23387317|NCT00147537|65162820|FG002|Phase 2|Randomized but not treated|0|||
23387318|NCT00147537|65162821|FG003|Phase 2|Randomized but not treated|0|||
23387319|NCT00147537|65162822|FG004|Phase 2|Randomized but not treated|0|||
23387320|NCT00147537|65162823|FG005|Phase 2|Randomized but not treated|0|||
23387321|NCT00147537|65162824|FG006|Phase 2|Randomized but not treated|0|||
23387322|NCT00147537|65162825|FG007|Phase 2|Randomized but not treated|0|||
23387323|NCT00147537|65162826|FG008|Phase 2|Randomized but not treated|0|||
23387324|NCT00147537|65162827|FG009|Phase 2|Randomized but not treated|1|||
23387325|NCT00147537|65162828|FG010|Phase 2|Randomized but not treated|1|||
23387326|NCT02639559|65162829|FG000|Overall Study|Mobilization failure|0|||
23494216|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
23675286|NCT01903837|66190935|FG003|Part B|Incarceration|1|||
23675287|NCT01903837|66190932|FG000|Part B|Physician Decision|1|||
23675288|NCT01903837|66190933|FG001|Part B|Physician Decision|0|||
23675289|NCT01903837|66190934|FG002|Part B|Physician Decision|0|||
23387327|NCT02639559|65162830|FG001|Overall Study|Mobilization failure|3|||
23387328|NCT02639559|65162829|FG000|Overall Study|Issues with vascular acess|1|||
23387329|NCT02639559|65162830|FG001|Overall Study|Issues with vascular acess|0|||
23387330|NCT00245570|65162833|FG000|Washout Between Periods III and IV|Adverse Event|0|||
23387331|NCT00245570|65162834|FG001|Washout Between Periods III and IV|Adverse Event|1|||
23387332|NCT00245570|65162835|FG002|Washout Between Periods III and IV|Adverse Event|0|||
23387333|NCT00245570|65162836|FG003|Washout Between Periods III and IV|Adverse Event|0|||
23387334|NCT00245570|65162837|FG004|Washout Between Periods III and IV|Adverse Event|0|||
23387335|NCT00245570|65162838|FG005|Washout Between Periods III and IV|Adverse Event|0|||
23387336|NCT00183391|65162839|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
23387337|NCT00183391|65162840|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
23675290|NCT01903837|66190935|FG003|Part B|Physician Decision|2|||
23387338|NCT00183391|65162839|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
23387339|NCT00183391|65162840|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
23387340|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
23387341|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
23387342|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
23387343|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Adverse Event|5|||
23387344|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Adverse Event|1|||
23387345|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Adverse Event|0|||
23387346|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
23387347|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
23387348|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
23387349|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Death|8|||
23387350|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Death|24|||
23387351|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Death|0|||
23387352|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
23387353|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
23387354|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
23387355|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
23387356|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
23387357|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
23387358|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
23387359|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
23387360|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
23387361|NCT02931539|65162841|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
23387362|NCT02931539|65162842|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
23387363|NCT02931539|65162843|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
23387364|NCT01803737|65162844|FG000|Overall Study|Lack of Time|1|||
23387365|NCT01803737|65162845|FG001|Overall Study|Lack of Time|0|||
23387366|NCT01803737|65162844|FG000|Overall Study|Medical Reason|0|||
23387367|NCT01803737|65162845|FG001|Overall Study|Medical Reason|1|||
23387368|NCT01803737|65162844|FG000|Overall Study|Lost to Follow-up|0|||
23387369|NCT01803737|65162845|FG001|Overall Study|Lost to Follow-up|2|||
23387370|NCT02151604|65162846|FG000|Overall Study|Lost to Follow-up|3|||
23387371|NCT02151604|65162846|FG000|Overall Study|Withdrawal by Subject|2|||
23387372|NCT02151604|65162846|FG000|Overall Study|Physician Decision|3|||
23387373|NCT02151604|65162846|FG000|Overall Study|Death|1|||
23387374|NCT01133977|65162847|FG000|Overall Study|Adverse Event|0|||
23387375|NCT01133977|65162848|FG001|Overall Study|Adverse Event|0|||
23387376|NCT01133977|65162849|FG002|Overall Study|Adverse Event|1|||
23387377|NCT01133977|65162850|FG003|Overall Study|Adverse Event|0|||
23387378|NCT01133977|65162851|FG004|Overall Study|Adverse Event|0|||
23387379|NCT01133977|65162847|FG000|Overall Study|Death|1|||
23387380|NCT01133977|65162848|FG001|Overall Study|Death|1|||
23387381|NCT01133977|65162849|FG002|Overall Study|Death|1|||
23387382|NCT01133977|65162850|FG003|Overall Study|Death|7|||
23387383|NCT01133977|65162851|FG004|Overall Study|Death|3|||
23387384|NCT01133977|65162847|FG000|Overall Study|Started a New Line of Therapy|2|||
23387385|NCT01133977|65162848|FG001|Overall Study|Started a New Line of Therapy|6|||
23387386|NCT01133977|65162849|FG002|Overall Study|Started a New Line of Therapy|4|||
23387387|NCT01133977|65162850|FG003|Overall Study|Started a New Line of Therapy|25|||
23387388|NCT01133977|65162851|FG004|Overall Study|Started a New Line of Therapy|33|||
23387389|NCT01133977|65162847|FG000|Overall Study|Lost to Follow-up|0|||
23387390|NCT01133977|65162848|FG001|Overall Study|Lost to Follow-up|0|||
23387391|NCT01133977|65162849|FG002|Overall Study|Lost to Follow-up|0|||
23387392|NCT01133977|65162850|FG003|Overall Study|Lost to Follow-up|2|||
23387393|NCT01133977|65162851|FG004|Overall Study|Lost to Follow-up|1|||
23387394|NCT01133977|65162847|FG000|Overall Study|Withdrawal by Subject|0|||
23387395|NCT01133977|65162848|FG001|Overall Study|Withdrawal by Subject|0|||
23387396|NCT01133977|65162849|FG002|Overall Study|Withdrawal by Subject|0|||
23387397|NCT01133977|65162850|FG003|Overall Study|Withdrawal by Subject|5|||
23387398|NCT01133977|65162851|FG004|Overall Study|Withdrawal by Subject|1|||
23387399|NCT00421733|65162853|FG000|Overall Study|Adverse Event|4|||
23387400|NCT00421733|65162854|FG001|Overall Study|Adverse Event|9|||
23387401|NCT00421733|65162855|FG002|Overall Study|Adverse Event|2|||
23387402|NCT00421733|65162853|FG000|Overall Study|Lost to Follow-up|1|||
23387403|NCT00421733|65162854|FG001|Overall Study|Lost to Follow-up|2|||
23387404|NCT00421733|65162855|FG002|Overall Study|Lost to Follow-up|4|||
23494217|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
23387405|NCT00421733|65162853|FG000|Overall Study|Withdrawal by Subject|1|||
23387406|NCT00421733|65162854|FG001|Overall Study|Withdrawal by Subject|2|||
23387407|NCT00421733|65162855|FG002|Overall Study|Withdrawal by Subject|7|||
23387408|NCT00421733|65162853|FG000|Overall Study|Death|0|||
23387409|NCT00421733|65162854|FG001|Overall Study|Death|3|||
23387410|NCT00421733|65162855|FG002|Overall Study|Death|0|||
23387411|NCT00421733|65162853|FG000|Overall Study|Required dialysis|1|||
23387412|NCT00421733|65162854|FG001|Overall Study|Required dialysis|0|||
23675291|NCT01903837|66190932|FG000|Part B|Lack of Efficacy|0|||
23675292|NCT01903837|66190933|FG001|Part B|Lack of Efficacy|1|||
23675293|NCT01903837|66190934|FG002|Part B|Lack of Efficacy|0|||
23675294|NCT01903837|66190935|FG003|Part B|Lack of Efficacy|0|||
23675295|NCT01127165|66190936|FG000|Overall Study|Adverse Event|2|||
23675296|NCT01127165|66190937|FG001|Overall Study|Adverse Event|2|||
23675297|NCT01127165|66190936|FG000|Overall Study|Lack of Efficacy|10|||
23675298|NCT01127165|66190937|FG001|Overall Study|Lack of Efficacy|8|||
23675299|NCT01127165|66190936|FG000|Overall Study|Lost to Follow-up|3|||
23675300|NCT01127165|66190937|FG001|Overall Study|Lost to Follow-up|5|||
23675301|NCT01127165|66190936|FG000|Overall Study|Withdrawal by Subject|1|||
23675302|NCT01127165|66190937|FG001|Overall Study|Withdrawal by Subject|3|||
23675303|NCT01127165|66190936|FG000|Overall Study|Protocol Violation|0|||
23675304|NCT01127165|66190937|FG001|Overall Study|Protocol Violation|1|||
23675305|NCT00676715|66190938|FG000|Overall Study|Withdrawal by Subject|7|||
23675306|NCT00676715|66190939|FG001|Overall Study|Withdrawal by Subject|9|||
23675307|NCT00676715|66190940|FG002|Overall Study|Withdrawal by Subject|10|||
23675308|NCT00676715|66190941|FG003|Overall Study|Withdrawal by Subject|10|||
23675309|NCT00676715|66190938|FG000|Overall Study|Other|2|||
23675310|NCT00676715|66190939|FG001|Overall Study|Other|6|||
23675311|NCT00676715|66190940|FG002|Overall Study|Other|4|||
23675312|NCT00676715|66190941|FG003|Overall Study|Other|3|||
23675313|NCT00676715|66190938|FG000|Overall Study|Lost to Follow-up|1|||
23675314|NCT00676715|66190939|FG001|Overall Study|Lost to Follow-up|1|||
23675315|NCT00676715|66190940|FG002|Overall Study|Lost to Follow-up|7|||
23675316|NCT00676715|66190941|FG003|Overall Study|Lost to Follow-up|3|||
23675317|NCT00676715|66190938|FG000|Overall Study|Death|1|||
23675318|NCT00676715|66190939|FG001|Overall Study|Death|1|||
23675319|NCT00676715|66190940|FG002|Overall Study|Death|1|||
23675320|NCT00676715|66190941|FG003|Overall Study|Death|0|||
23675321|NCT00676715|66190938|FG000|Overall Study|Adverse Event|0|||
23675322|NCT00676715|66190939|FG001|Overall Study|Adverse Event|1|||
23675323|NCT00676715|66190940|FG002|Overall Study|Adverse Event|2|||
23675324|NCT00676715|66190941|FG003|Overall Study|Adverse Event|0|||
23675325|NCT00676715|66190938|FG000|Overall Study|Participants Ongoing|29|||
23675326|NCT00676715|66190939|FG001|Overall Study|Participants Ongoing|29|||
23675327|NCT00676715|66190940|FG002|Overall Study|Participants Ongoing|17|||
23675328|NCT00676715|66190941|FG003|Overall Study|Participants Ongoing|24|||
23675329|NCT01097863|66190944|FG000|Overall Study|Discomfort|1|||
23675330|NCT01097863|66190945|FG001|Overall Study|Discomfort|0|||
23675331|NCT01097863|66190946|FG002|Overall Study|Discomfort|1|||
23675332|NCT01097863|66190944|FG000|Overall Study|Did not return for final visit|0|||
23675333|NCT01097863|66190945|FG001|Overall Study|Did not return for final visit|0|||
23675334|NCT01097863|66190946|FG002|Overall Study|Did not return for final visit|1|||
23675335|NCT02982954|66190947|FG000|Overall Study|Death|55|||
23675336|NCT02982954|66190948|FG001|Overall Study|Death|29|||
23675337|NCT02982954|66190949|FG002|Overall Study|Death|15|||
23675338|NCT02982954|66190950|FG003|Overall Study|Death|20|||
23675339|NCT02982954|66190947|FG000|Overall Study|Lost to Follow-up|2|||
23675340|NCT02982954|66190948|FG001|Overall Study|Lost to Follow-up|1|||
23675341|NCT02982954|66190949|FG002|Overall Study|Lost to Follow-up|0|||
23675342|NCT02982954|66190950|FG003|Overall Study|Lost to Follow-up|0|||
23675343|NCT02982954|66190947|FG000|Overall Study|Participant withdrew consent|7|||
23675344|NCT02982954|66190948|FG001|Overall Study|Participant withdrew consent|5|||
23387413|NCT00421733|65162855|FG002|Overall Study|Required dialysis|0|||
23675345|NCT02982954|66190949|FG002|Overall Study|Participant withdrew consent|1|||
23675346|NCT02982954|66190950|FG003|Overall Study|Participant withdrew consent|1|||
23675347|NCT02982954|66190947|FG000|Overall Study|Other reasons|42|||
23675348|NCT02982954|66190948|FG001|Overall Study|Other reasons|17|||
23494218|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
23494219|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
23494220|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
23494221|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
23675349|NCT02982954|66190949|FG002|Overall Study|Other reasons|12|||
23675350|NCT02982954|66190950|FG003|Overall Study|Other reasons|3|||
23675351|NCT02982954|66190947|FG000|Overall Study|Premature site closure|0|||
23675352|NCT02982954|66190948|FG001|Overall Study|Premature site closure|0|||
23675353|NCT02982954|66190949|FG002|Overall Study|Premature site closure|0|||
23675354|NCT02982954|66190950|FG003|Overall Study|Premature site closure|1|||
23675355|NCT02362503|66190951|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
23675356|NCT02362503|66190952|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
23675357|NCT02362503|66190953|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
23675358|NCT02362503|66190951|FG000|Double-blind Period-Up to 8 Days|Death|1|||
23675359|NCT02362503|66190952|FG001|Double-blind Period-Up to 8 Days|Death|0|||
23675360|NCT02362503|66190953|FG002|Double-blind Period-Up to 8 Days|Death|0|||
23675361|NCT02362503|66190951|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
23675362|NCT02362503|66190952|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
23494222|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
23675363|NCT02362503|66190953|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
23675364|NCT02362503|66190951|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
23494223|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Death|2|||
23387414|NCT00421733|65162853|FG000|Overall Study|Administrative|2|||
23387415|NCT00421733|65162854|FG001|Overall Study|Administrative|0|||
23387416|NCT00421733|65162855|FG002|Overall Study|Administrative|0|||
23387417|NCT00421733|65162853|FG000|Overall Study|Did not satisfy entry criteria|1|||
23387418|NCT00421733|65162854|FG001|Overall Study|Did not satisfy entry criteria|3|||
23387419|NCT00421733|65162855|FG002|Overall Study|Did not satisfy entry criteria|2|||
23387420|NCT00421733|65162853|FG000|Overall Study|Sponsor request|1|||
23387421|NCT00421733|65162854|FG001|Overall Study|Sponsor request|0|||
23387422|NCT00421733|65162855|FG002|Overall Study|Sponsor request|3|||
23387423|NCT00421733|65162853|FG000|Overall Study|Protocol deviation|4|||
23387424|NCT00421733|65162854|FG001|Overall Study|Protocol deviation|7|||
23387425|NCT00421733|65162855|FG002|Overall Study|Protocol deviation|2|||
23387426|NCT01769443|65162856|FG000|Overall Study|Study closure|1|||
23387427|NCT01769443|65162857|FG001|Overall Study|Study closure|0|||
23387428|NCT01712074|65162858|FG000|Placebo Run-in Period|Adverse Event|2|||
23387429|NCT01712074|65162859|FG001|Placebo Run-in Period|Adverse Event|0|||
23387430|NCT01712074|65162860|FG002|Placebo Run-in Period|Adverse Event|0|||
23387431|NCT01712074|65162858|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
23387432|NCT01712074|65162859|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
23387433|NCT01712074|65162860|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
23387434|NCT01712074|65162858|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
23387435|NCT01712074|65162859|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
23387436|NCT01712074|65162860|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
23387437|NCT01712074|65162858|FG000|Placebo Run-in Period|Other|1|||
23387438|NCT01712074|65162859|FG001|Placebo Run-in Period|Other|0|||
23387439|NCT01712074|65162860|FG002|Placebo Run-in Period|Other|0|||
23387440|NCT01712074|65162858|FG000|Placebo Run-in Period|No longer willing to participate|1|||
23387441|NCT01712074|65162859|FG001|Placebo Run-in Period|No longer willing to participate|0|||
23387442|NCT01712074|65162860|FG002|Placebo Run-in Period|No longer willing to participate|0|||
23387443|NCT01712074|65162858|FG000|Double Blind Period|Adverse Event|0|||
23387444|NCT01712074|65162859|FG001|Double Blind Period|Adverse Event|2|||
23675365|NCT02362503|66190952|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
23675366|NCT02362503|66190953|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
23675367|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
23675368|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
23675369|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
23675370|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
23675371|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
23675372|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
23675373|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
23675374|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
23675375|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
23675376|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
23675377|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
23675378|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
23675379|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
23675380|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
23675381|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
23675382|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
23675383|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
23675384|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
23675385|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
23387445|NCT01712074|65162860|FG002|Double Blind Period|Adverse Event|1|||
23387446|NCT01712074|65162858|FG000|Double Blind Period|No longer willing to participate|0|||
23387447|NCT01712074|65162859|FG001|Double Blind Period|No longer willing to participate|2|||
23387448|NCT01712074|65162860|FG002|Double Blind Period|No longer willing to participate|4|||
23675386|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
23675387|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
23675388|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
23675389|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
23675390|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
23675391|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
23675392|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
23675393|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
23494224|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Death|1|||
23675394|NCT02362503|66190951|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
23675395|NCT02362503|66190952|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
23675396|NCT02362503|66190953|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
23675397|NCT01913483|66194399|FG000|Overall Study|Withdrawal by Subject|1|||
23675398|NCT01913483|66194400|FG001|Overall Study|Withdrawal by Subject|2|||
23675399|NCT01913483|66194399|FG000|Overall Study|Lost to Follow-up|6|||
23675400|NCT01913483|66194400|FG001|Overall Study|Lost to Follow-up|3|||
23675401|NCT01913483|66194399|FG000|Overall Study|Death|14|||
23675402|NCT01913483|66194400|FG001|Overall Study|Death|17|||
23675403|NCT01353703|66194402|FG000|Overall Study|Migrated/moved from study area|1|||
23675404|NCT01353703|66194403|FG001|Overall Study|Migrated/moved from study area|0|||
23675405|NCT02302963|66194408|FG000|Overall Study|Withdrawal by Subject|2|||
23675406|NCT02302963|66194409|FG001|Overall Study|Withdrawal by Subject|1|||
23675407|NCT02302963|66194408|FG000|Overall Study|Steroid injection|0|||
23675408|NCT02302963|66194409|FG001|Overall Study|Steroid injection|1|||
23675409|NCT02302963|66194408|FG000|Overall Study|Physician Decision|1|||
23675410|NCT02302963|66194409|FG001|Overall Study|Physician Decision|0|||
23675411|NCT02469090|66194410|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
23675412|NCT02469090|66194411|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
23675413|NCT02469090|66194412|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
23675414|NCT02469090|66194410|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
23675415|NCT02469090|66194411|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
23675416|NCT02469090|66194412|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
23675417|NCT02469090|66194410|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
23675418|NCT02469090|66194411|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
23675419|NCT02469090|66194412|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
23675420|NCT02469090|66194410|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
23675421|NCT02469090|66194411|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
23675422|NCT02469090|66194412|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
23675423|NCT02469090|66194410|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
23675424|NCT02469090|66194411|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
23494225|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Death|0|||
23675425|NCT02469090|66194412|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
23675426|NCT02469090|66194410|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
23675427|NCT02469090|66194411|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
23675428|NCT02469090|66194412|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
23675429|NCT02469090|66194410|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
23675430|NCT02469090|66194411|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
23675431|NCT02469090|66194412|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
23675432|NCT02469090|66194410|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
23675433|NCT02469090|66194411|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
23675434|NCT02469090|66194412|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
23675435|NCT03107793|66194418|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
23675436|NCT03107793|66194419|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
23675437|NCT03107793|66194420|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23675438|NCT03107793|66194421|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
23675439|NCT03107793|66194422|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23675440|NCT03107793|66194418|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
23675441|NCT03107793|66194419|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
23675442|NCT03107793|66194420|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
23675443|NCT03107793|66194421|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
23675444|NCT03107793|66194422|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
23675445|NCT03107793|66194418|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
23387449|NCT01712074|65162858|FG000|Double Blind Period|Death|0|||
23387450|NCT01712074|65162859|FG001|Double Blind Period|Death|1|||
23387451|NCT01712074|65162860|FG002|Double Blind Period|Death|0|||
23387452|NCT01712074|65162858|FG000|Double Blind Period|Lost to Follow-up|0|||
23387453|NCT01712074|65162859|FG001|Double Blind Period|Lost to Follow-up|2|||
23387454|NCT01712074|65162860|FG002|Double Blind Period|Lost to Follow-up|1|||
23387455|NCT01712074|65162858|FG000|Double Blind Period|Other|0|||
23387456|NCT01712074|65162859|FG001|Double Blind Period|Other|4|||
23387457|NCT01712074|65162860|FG002|Double Blind Period|Other|1|||
23387458|NCT01712074|65162858|FG000|Double Blind Period|Protocol Violation|0|||
23387459|NCT01712074|65162859|FG001|Double Blind Period|Protocol Violation|0|||
23387460|NCT01712074|65162860|FG002|Double Blind Period|Protocol Violation|1|||
23387461|NCT01712074|65162858|FG000|Double Blind Period|No longer met eligibility criteria|0|||
23387462|NCT01712074|65162859|FG001|Double Blind Period|No longer met eligibility criteria|3|||
23387463|NCT01712074|65162860|FG002|Double Blind Period|No longer met eligibility criteria|0|||
23387464|NCT01795937|65162867|FG000|Overall Study|Withdrawal by Subject|1|||
23387465|NCT01795937|65162868|FG001|Overall Study|Withdrawal by Subject|0|||
23494226|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Death|0|||
23494227|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
23675446|NCT03107793|66194419|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
23675447|NCT03107793|66194420|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
23675448|NCT03107793|66194421|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
23675449|NCT03107793|66194422|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
23675450|NCT03107793|66194418|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
23675451|NCT03107793|66194419|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23675452|NCT03107793|66194420|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23675453|NCT03107793|66194421|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23675454|NCT03107793|66194422|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23675455|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23675456|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
23675457|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
23675458|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23675459|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23675460|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23675461|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23387466|NCT01795937|65162869|FG002|Overall Study|Withdrawal by Subject|0|||
23675462|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
23675463|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23387467|NCT01795937|65162867|FG000|Overall Study|Physician Decision|0|||
23387468|NCT01795937|65162868|FG001|Overall Study|Physician Decision|1|||
23675464|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23387469|NCT01795937|65162869|FG002|Overall Study|Physician Decision|0|||
23387470|NCT00281580|65162870|FG000|Overall Study|Adverse Event|2|||
23387471|NCT00281580|65162871|FG001|Overall Study|Adverse Event|0|||
23387472|NCT00281580|65162872|FG002|Overall Study|Adverse Event|2|||
23387473|NCT00281580|65162873|FG003|Overall Study|Adverse Event|4|||
23387474|NCT00281580|65162874|FG004|Overall Study|Adverse Event|1|||
23387475|NCT00281580|65162875|FG005|Overall Study|Adverse Event|0|||
23387476|NCT00281580|65162876|FG006|Overall Study|Adverse Event|1|||
23387477|NCT00281580|65162877|FG007|Overall Study|Adverse Event|0|||
23387478|NCT00281580|65162878|FG008|Overall Study|Adverse Event|1|||
23387479|NCT00281580|65162879|FG009|Overall Study|Adverse Event|6|||
23387480|NCT00281580|65162880|FG010|Overall Study|Adverse Event|0|||
23387481|NCT00281580|65162881|FG011|Overall Study|Adverse Event|5|||
23387482|NCT00281580|65162882|FG012|Overall Study|Adverse Event|8|||
23387483|NCT00281580|65162883|FG013|Overall Study|Adverse Event|2|||
23387484|NCT00281580|65162884|FG014|Overall Study|Adverse Event|3|||
23387485|NCT00281580|65162885|FG015|Overall Study|Adverse Event|3|||
23675465|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23675466|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23387486|NCT00281580|65162870|FG000|Overall Study|Protocol Violation|0|||
23387487|NCT00281580|65162871|FG001|Overall Study|Protocol Violation|0|||
23387488|NCT00281580|65162872|FG002|Overall Study|Protocol Violation|1|||
23387489|NCT00281580|65162873|FG003|Overall Study|Protocol Violation|1|||
23387490|NCT00281580|65162874|FG004|Overall Study|Protocol Violation|0|||
23494228|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494229|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494230|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494231|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23494232|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23387491|NCT00281580|65162875|FG005|Overall Study|Protocol Violation|0|||
23387492|NCT00281580|65162876|FG006|Overall Study|Protocol Violation|1|||
23387493|NCT00281580|65162877|FG007|Overall Study|Protocol Violation|0|||
23387494|NCT00281580|65162878|FG008|Overall Study|Protocol Violation|2|||
23387495|NCT00281580|65162879|FG009|Overall Study|Protocol Violation|0|||
23387496|NCT00281580|65162880|FG010|Overall Study|Protocol Violation|1|||
23387497|NCT00281580|65162881|FG011|Overall Study|Protocol Violation|2|||
23387498|NCT00281580|65162882|FG012|Overall Study|Protocol Violation|0|||
23387499|NCT00281580|65162883|FG013|Overall Study|Protocol Violation|1|||
23387500|NCT00281580|65162884|FG014|Overall Study|Protocol Violation|1|||
23387501|NCT00281580|65162885|FG015|Overall Study|Protocol Violation|3|||
23494233|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
23494234|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
23387502|NCT00281580|65162870|FG000|Overall Study|Withdrawal by Subject|3|||
23387503|NCT00281580|65162871|FG001|Overall Study|Withdrawal by Subject|0|||
23675467|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
23675468|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23675469|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23675470|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23675471|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
23675472|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
23675473|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23675474|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23675475|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
23675476|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
23675477|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
23675478|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
23675479|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
23675480|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23675481|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
23675482|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
23675483|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23675484|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23675485|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23675486|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23675487|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23675488|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23675489|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23675490|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23387504|NCT00281580|65162872|FG002|Overall Study|Withdrawal by Subject|1|||
23675491|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
23387505|NCT00281580|65162873|FG003|Overall Study|Withdrawal by Subject|1|||
23387506|NCT00281580|65162874|FG004|Overall Study|Withdrawal by Subject|1|||
23387507|NCT00281580|65162875|FG005|Overall Study|Withdrawal by Subject|2|||
23675492|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
23675493|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23387508|NCT00281580|65162876|FG006|Overall Study|Withdrawal by Subject|2|||
23387509|NCT00281580|65162877|FG007|Overall Study|Withdrawal by Subject|0|||
23675494|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23675495|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23675496|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23675497|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
23675498|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23675499|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23675500|NCT03107793|66194418|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23675501|NCT03107793|66194419|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
23675502|NCT03107793|66194420|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
23675503|NCT03107793|66194421|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23675504|NCT03107793|66194422|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23675505|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23675506|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23675507|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23675508|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
23675509|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
23675510|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23675511|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23675512|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23675513|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23675514|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
23675515|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23675516|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23675517|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23675518|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
23675519|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
23675520|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Death|0|||
23675521|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Death|0|||
23675522|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Death|0|||
23675523|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Death|0|||
23675524|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Death|1|||
23675525|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23675526|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23675527|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23675528|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23675529|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
23675530|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23675531|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23675532|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23675533|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
23675534|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
23675535|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23387510|NCT00281580|65162878|FG008|Overall Study|Withdrawal by Subject|1|||
23387511|NCT00281580|65162879|FG009|Overall Study|Withdrawal by Subject|4|||
23387512|NCT00281580|65162880|FG010|Overall Study|Withdrawal by Subject|1|||
23387513|NCT00281580|65162881|FG011|Overall Study|Withdrawal by Subject|1|||
23387514|NCT00281580|65162882|FG012|Overall Study|Withdrawal by Subject|2|||
23675536|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23387515|NCT00281580|65162883|FG013|Overall Study|Withdrawal by Subject|2|||
23675537|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23675538|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
23675539|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
23675540|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23675541|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23675542|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23675543|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23675544|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
23675545|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23675546|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23675547|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23675548|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
23675549|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23675550|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Other|0|||
23675551|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Other|0|||
23675552|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Other|0|||
23675553|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Other|1|||
23675554|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Other|3|||
23675555|NCT03107793|66194418|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23675556|NCT03107793|66194419|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23675557|NCT03107793|66194420|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23675558|NCT03107793|66194421|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
23675559|NCT03107793|66194422|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
23675560|NCT01463098|66194425|FG000|Part A (11 Days)|Participant Choice|2|||
23675561|NCT01463098|66194426|FG001|Part A (11 Days)|Participant Choice|0|||
23675562|NCT01463098|66194427|FG002|Part A (11 Days)|Participant Choice|0|||
23675563|NCT01463098|66194428|FG003|Part A (11 Days)|Participant Choice|0|||
23675564|NCT01463098|66194429|FG004|Part A (11 Days)|Participant Choice|0|||
23675565|NCT01463098|66194430|FG005|Part A (11 Days)|Participant Choice|0|||
23675566|NCT01463098|66194431|FG006|Part A (11 Days)|Participant Choice|0|||
23675567|NCT01463098|66194432|FG007|Part A (11 Days)|Participant Choice|0|||
23675568|NCT01463098|66194433|FG008|Part A (11 Days)|Participant Choice|1|||
23675569|NCT01463098|66194434|FG009|Part A (11 Days)|Participant Choice|0|||
23675570|NCT01463098|66194435|FG010|Part A (11 Days)|Participant Choice|0|||
23675571|NCT01463098|66194436|FG011|Part A (11 Days)|Participant Choice|0|||
23675572|NCT01463098|66194437|FG012|Part A (11 Days)|Participant Choice|0|||
23675573|NCT01463098|66194438|FG013|Part A (11 Days)|Participant Choice|0|||
23675574|NCT01463098|66194425|FG000|Part A (11 Days)|Lost to Follow-up|0|||
23675575|NCT01463098|66194426|FG001|Part A (11 Days)|Lost to Follow-up|0|||
23675576|NCT01463098|66194427|FG002|Part A (11 Days)|Lost to Follow-up|0|||
23675577|NCT01463098|66194428|FG003|Part A (11 Days)|Lost to Follow-up|0|||
23675578|NCT01463098|66194429|FG004|Part A (11 Days)|Lost to Follow-up|1|||
23675579|NCT01463098|66194430|FG005|Part A (11 Days)|Lost to Follow-up|0|||
23675580|NCT01463098|66194431|FG006|Part A (11 Days)|Lost to Follow-up|0|||
23675581|NCT01463098|66194432|FG007|Part A (11 Days)|Lost to Follow-up|0|||
23675582|NCT01463098|66194433|FG008|Part A (11 Days)|Lost to Follow-up|0|||
23675583|NCT01463098|66194434|FG009|Part A (11 Days)|Lost to Follow-up|0|||
23675584|NCT01463098|66194435|FG010|Part A (11 Days)|Lost to Follow-up|0|||
23675585|NCT01463098|66194436|FG011|Part A (11 Days)|Lost to Follow-up|0|||
23675586|NCT01463098|66194437|FG012|Part A (11 Days)|Lost to Follow-up|0|||
23675587|NCT01463098|66194438|FG013|Part A (11 Days)|Lost to Follow-up|0|||
23675588|NCT01463098|66194425|FG000|Part B (11 Days)|Participant Choice|0|||
23675589|NCT01463098|66194426|FG001|Part B (11 Days)|Participant Choice|0|||
23675590|NCT01463098|66194427|FG002|Part B (11 Days)|Participant Choice|0|||
23675591|NCT01463098|66194428|FG003|Part B (11 Days)|Participant Choice|0|||
23675592|NCT01463098|66194429|FG004|Part B (11 Days)|Participant Choice|0|||
23675593|NCT01463098|66194430|FG005|Part B (11 Days)|Participant Choice|0|||
23675594|NCT01463098|66194431|FG006|Part B (11 Days)|Participant Choice|0|||
23675595|NCT01463098|66194432|FG007|Part B (11 Days)|Participant Choice|0|||
23675596|NCT01463098|66194433|FG008|Part B (11 Days)|Participant Choice|0|||
23675597|NCT01463098|66194434|FG009|Part B (11 Days)|Participant Choice|0|||
23675598|NCT01463098|66194435|FG010|Part B (11 Days)|Participant Choice|0|||
23675599|NCT01463098|66194436|FG011|Part B (11 Days)|Participant Choice|1|||
23675600|NCT01463098|66194437|FG012|Part B (11 Days)|Participant Choice|0|||
23675601|NCT01463098|66194438|FG013|Part B (11 Days)|Participant Choice|0|||
23675602|NCT03804684|66194439|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
23675603|NCT03804684|66194440|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
23675604|NCT00911989|66194449|FG000|Overall Study|Adverse Event|1|||
23675605|NCT00803179|66194450|FG000|Overall Study|Lost to Follow-up|3|||
23387516|NCT00281580|65162884|FG014|Overall Study|Withdrawal by Subject|1|||
23387517|NCT00281580|65162885|FG015|Overall Study|Withdrawal by Subject|5|||
23387518|NCT00281580|65162870|FG000|Overall Study|Lack of Efficacy|2|||
23387519|NCT00281580|65162871|FG001|Overall Study|Lack of Efficacy|1|||
23387520|NCT00281580|65162872|FG002|Overall Study|Lack of Efficacy|1|||
23387521|NCT00281580|65162873|FG003|Overall Study|Lack of Efficacy|6|||
23387522|NCT00281580|65162874|FG004|Overall Study|Lack of Efficacy|2|||
23387523|NCT00281580|65162875|FG005|Overall Study|Lack of Efficacy|0|||
23387524|NCT00281580|65162876|FG006|Overall Study|Lack of Efficacy|0|||
23387525|NCT00281580|65162877|FG007|Overall Study|Lack of Efficacy|0|||
23387526|NCT00281580|65162878|FG008|Overall Study|Lack of Efficacy|0|||
23387527|NCT00281580|65162879|FG009|Overall Study|Lack of Efficacy|0|||
23387528|NCT00281580|65162880|FG010|Overall Study|Lack of Efficacy|0|||
23675606|NCT02356562|66194459|FG000|Overall Study|Withdrawal by Subject|0|||
23675607|NCT02356562|66194460|FG001|Overall Study|Withdrawal by Subject|1|||
23675608|NCT02356562|66194459|FG000|Overall Study|Re-entered treatment in a previous study|1|||
23675609|NCT02356562|66194460|FG001|Overall Study|Re-entered treatment in a previous study|0|||
23675610|NCT02356562|66194459|FG000|Overall Study|site closure|1|||
23675611|NCT02356562|66194460|FG001|Overall Study|site closure|0|||
23675612|NCT01783678|66194465|FG000|Overall Study|Randomized but Not Treated|0|||
23675613|NCT01783678|66194466|FG001|Overall Study|Randomized but Not Treated|0|||
23675614|NCT01783678|66194467|FG002|Overall Study|Randomized but Not Treated|0|||
23675615|NCT01783678|66194468|FG003|Overall Study|Randomized but Not Treated|1|||
23675616|NCT01783678|66194469|FG004|Overall Study|Randomized but Not Treated|0|||
23675617|NCT01783678|66194470|FG005|Overall Study|Randomized but Not Treated|0|||
23675618|NCT01783678|66194465|FG000|Overall Study|Lack of Efficacy|1|||
23675619|NCT01783678|66194466|FG001|Overall Study|Lack of Efficacy|13|||
23675620|NCT01783678|66194467|FG002|Overall Study|Lack of Efficacy|1|||
23675621|NCT01783678|66194468|FG003|Overall Study|Lack of Efficacy|3|||
23675622|NCT01783678|66194469|FG004|Overall Study|Lack of Efficacy|6|||
23675623|NCT01783678|66194470|FG005|Overall Study|Lack of Efficacy|5|||
23675624|NCT01783678|66194465|FG000|Overall Study|Lost to Follow-up|0|||
23675625|NCT01783678|66194466|FG001|Overall Study|Lost to Follow-up|4|||
23675626|NCT01783678|66194467|FG002|Overall Study|Lost to Follow-up|0|||
23675627|NCT01783678|66194468|FG003|Overall Study|Lost to Follow-up|2|||
23675628|NCT01783678|66194469|FG004|Overall Study|Lost to Follow-up|1|||
23675629|NCT01783678|66194470|FG005|Overall Study|Lost to Follow-up|0|||
23675630|NCT01783678|66194465|FG000|Overall Study|Withdrew Consent|1|||
23675631|NCT01783678|66194466|FG001|Overall Study|Withdrew Consent|1|||
23675632|NCT01783678|66194467|FG002|Overall Study|Withdrew Consent|0|||
23675633|NCT01783678|66194468|FG003|Overall Study|Withdrew Consent|2|||
23675634|NCT01783678|66194469|FG004|Overall Study|Withdrew Consent|0|||
23675635|NCT01783678|66194470|FG005|Overall Study|Withdrew Consent|0|||
23675636|NCT00684957|66194471|FG000|Overall Study|Withdrawal by Subject|1|||
23675637|NCT00684957|66194472|FG001|Overall Study|Withdrawal by Subject|1|||
23675638|NCT00684957|66194471|FG000|Overall Study|Lost to Follow-up|1|||
23387529|NCT00281580|65162881|FG011|Overall Study|Lack of Efficacy|1|||
23387530|NCT00281580|65162882|FG012|Overall Study|Lack of Efficacy|0|||
23387531|NCT00281580|65162883|FG013|Overall Study|Lack of Efficacy|2|||
23387532|NCT00281580|65162884|FG014|Overall Study|Lack of Efficacy|1|||
23675639|NCT00684957|66194472|FG001|Overall Study|Lost to Follow-up|0|||
23675640|NCT00105443|66194481|FG000|Double-Blind Treatment|Adverse Event|1|||
23675641|NCT00105443|66194482|FG001|Double-Blind Treatment|Adverse Event|0|||
23675642|NCT00105443|66194483|FG002|Double-Blind Treatment|Adverse Event|0|||
23675643|NCT00105443|66194484|FG003|Double-Blind Treatment|Adverse Event|0|||
23675644|NCT00105443|66194481|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
23675645|NCT00105443|66194482|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
23387533|NCT00281580|65162885|FG015|Overall Study|Lack of Efficacy|0|||
23387534|NCT00281580|65162870|FG000|Overall Study|Lost to Follow-up|0|||
23387535|NCT00281580|65162871|FG001|Overall Study|Lost to Follow-up|0|||
23387536|NCT00281580|65162872|FG002|Overall Study|Lost to Follow-up|0|||
23387537|NCT00281580|65162873|FG003|Overall Study|Lost to Follow-up|3|||
23387538|NCT00281580|65162874|FG004|Overall Study|Lost to Follow-up|0|||
23387539|NCT00281580|65162875|FG005|Overall Study|Lost to Follow-up|1|||
23387540|NCT00281580|65162876|FG006|Overall Study|Lost to Follow-up|0|||
23387541|NCT00281580|65162877|FG007|Overall Study|Lost to Follow-up|1|||
23387542|NCT00281580|65162878|FG008|Overall Study|Lost to Follow-up|2|||
23387543|NCT00281580|65162879|FG009|Overall Study|Lost to Follow-up|1|||
23387544|NCT00281580|65162880|FG010|Overall Study|Lost to Follow-up|1|||
23387545|NCT00281580|65162881|FG011|Overall Study|Lost to Follow-up|0|||
23387546|NCT00281580|65162882|FG012|Overall Study|Lost to Follow-up|1|||
23387547|NCT00281580|65162883|FG013|Overall Study|Lost to Follow-up|0|||
23387548|NCT00281580|65162884|FG014|Overall Study|Lost to Follow-up|0|||
23387549|NCT00281580|65162885|FG015|Overall Study|Lost to Follow-up|0|||
23387550|NCT00281580|65162870|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
23387551|NCT00281580|65162871|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
23387552|NCT00281580|65162872|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
23387553|NCT00281580|65162873|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
23387554|NCT00281580|65162874|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
23387555|NCT00281580|65162875|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
23387556|NCT00281580|65162876|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
23387557|NCT00281580|65162877|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
23387558|NCT00281580|65162878|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
23387559|NCT00281580|65162879|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
23387560|NCT00281580|65162880|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
23387561|NCT00281580|65162881|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
23387562|NCT00281580|65162882|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
23387563|NCT00281580|65162883|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
23387564|NCT00281580|65162884|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
23387565|NCT00281580|65162885|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
23387566|NCT02255279|65162888|FG000|Overall Study|Lost to Follow-up|2|||
23387567|NCT02255279|65162889|FG001|Overall Study|Lost to Follow-up|2|||
23387568|NCT02255279|65162888|FG000|Overall Study|Protocol Violation|0|||
23387569|NCT02255279|65162889|FG001|Overall Study|Protocol Violation|1|||
23387570|NCT02255279|65162888|FG000|Overall Study|Withdrawal by Subject|3|||
23387571|NCT02255279|65162889|FG001|Overall Study|Withdrawal by Subject|6|||
23387572|NCT02191397|65162890|FG000|Overall Study|Adverse Event|28|||
23387573|NCT02191397|65162891|FG001|Overall Study|Adverse Event|17|||
23387574|NCT02191397|65162890|FG000|Overall Study|Lack of Efficacy|10|||
23387575|NCT02191397|65162891|FG001|Overall Study|Lack of Efficacy|5|||
23387576|NCT02191397|65162890|FG000|Overall Study|Protocol Violation|0|||
23387577|NCT02191397|65162891|FG001|Overall Study|Protocol Violation|3|||
23387578|NCT02191397|65162890|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
23494235|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
23675646|NCT00105443|66194483|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
23675647|NCT00105443|66194484|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
23675648|NCT00105443|66194481|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
23675649|NCT00105443|66194482|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
23675650|NCT00105443|66194483|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
23675651|NCT00105443|66194484|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
23675652|NCT00105443|66194481|FG000|Double-Blind Treatment|Physician Decision|1|||
23675653|NCT00105443|66194482|FG001|Double-Blind Treatment|Physician Decision|0|||
23675654|NCT00105443|66194483|FG002|Double-Blind Treatment|Physician Decision|2|||
23675655|NCT00105443|66194484|FG003|Double-Blind Treatment|Physician Decision|0|||
23675656|NCT00105443|66194481|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
23675657|NCT00105443|66194482|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
23675658|NCT00105443|66194483|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
23675659|NCT00105443|66194484|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
23675660|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
23675661|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
23675662|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
23675663|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
23387579|NCT02191397|65162891|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
23387580|NCT02191397|65162890|FG000|Overall Study|Lost to Follow-up|10|||
23387581|NCT02191397|65162891|FG001|Overall Study|Lost to Follow-up|11|||
23387582|NCT02191397|65162890|FG000|Overall Study|Physician Decision|8|||
23387583|NCT02191397|65162891|FG001|Overall Study|Physician Decision|3|||
23387584|NCT02191397|65162890|FG000|Overall Study|Withdrawal by Subject|22|||
23675664|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
23675665|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
23675666|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
23675667|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
23675668|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
23675669|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
23675670|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
23675671|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
23675672|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
23675673|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
23675674|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
23675675|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
23675676|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
23675677|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
23675678|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
23675679|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
23675680|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23675681|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
23675682|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23675683|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23675684|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
23675685|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
23675686|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
23675687|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
23675688|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
23675689|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
23675690|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
23675691|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
23675692|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
23675693|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
23675694|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
23675695|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
23675696|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23675697|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23675698|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
23675699|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23675700|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
23675701|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23675702|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23675703|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23675704|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23675705|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23675706|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23675707|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
23675708|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
23675709|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
23675710|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
23675711|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
23675712|NCT00105443|66194481|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
23675713|NCT00105443|66194482|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
23675714|NCT00105443|66194483|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
23675715|NCT00105443|66194484|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
23675716|NCT03273166|66194491|FG000|Overall Study|Withdrawn prior to Completion|31|||
23675717|NCT02867995|66194493|FG000|Overall Study|Withdrawal by Subject|0|||
23675718|NCT02867995|66194494|FG001|Overall Study|Withdrawal by Subject|1|||
23494236|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
23675719|NCT02867995|66194493|FG000|Overall Study|Lost to Follow-up|0|||
23675720|NCT02867995|66194494|FG001|Overall Study|Lost to Follow-up|2|||
23675721|NCT01049035|66194497|FG000|Overall Study|Serious adverse event|0|||
23675722|NCT01049035|66194498|FG001|Overall Study|Serious adverse event|1|||
23675723|NCT01049035|66194499|FG002|Overall Study|Serious adverse event|1|||
23675724|NCT01049035|66194500|FG003|Overall Study|Serious adverse event|2|||
23675725|NCT01049035|66194501|FG004|Overall Study|Serious adverse event|0|||
23675726|NCT01049035|66194502|FG005|Overall Study|Serious adverse event|0|||
23675727|NCT01049035|66194503|FG006|Overall Study|Serious adverse event|0|||
23675728|NCT01049035|66194497|FG000|Overall Study|Other adverse event (AE)|0|||
23675729|NCT01049035|66194498|FG001|Overall Study|Other adverse event (AE)|0|||
23675730|NCT01049035|66194499|FG002|Overall Study|Other adverse event (AE)|0|||
23675731|NCT01049035|66194500|FG003|Overall Study|Other adverse event (AE)|1|||
23675732|NCT01049035|66194501|FG004|Overall Study|Other adverse event (AE)|0|||
23675733|NCT01049035|66194502|FG005|Overall Study|Other adverse event (AE)|0|||
23675734|NCT01049035|66194503|FG006|Overall Study|Other adverse event (AE)|0|||
23675735|NCT01049035|66194497|FG000|Overall Study|Non-compliance with the protocol|12|||
23675736|NCT01049035|66194498|FG001|Overall Study|Non-compliance with the protocol|6|||
23675737|NCT01049035|66194499|FG002|Overall Study|Non-compliance with the protocol|14|||
23675738|NCT01049035|66194500|FG003|Overall Study|Non-compliance with the protocol|5|||
23675739|NCT01049035|66194501|FG004|Overall Study|Non-compliance with the protocol|3|||
23675740|NCT01049035|66194502|FG005|Overall Study|Non-compliance with the protocol|4|||
23675741|NCT01049035|66194503|FG006|Overall Study|Non-compliance with the protocol|10|||
23675742|NCT01049035|66194497|FG000|Overall Study|Lost to Follow-up|5|||
23675743|NCT01049035|66194498|FG001|Overall Study|Lost to Follow-up|4|||
23675744|NCT01049035|66194499|FG002|Overall Study|Lost to Follow-up|4|||
23675745|NCT01049035|66194500|FG003|Overall Study|Lost to Follow-up|1|||
23675746|NCT01049035|66194501|FG004|Overall Study|Lost to Follow-up|0|||
23675747|NCT01049035|66194502|FG005|Overall Study|Lost to Follow-up|3|||
23675748|NCT01049035|66194503|FG006|Overall Study|Lost to Follow-up|3|||
23675749|NCT01049035|66194497|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
23387585|NCT02191397|65162891|FG001|Overall Study|Withdrawal by Subject|27|||
23387586|NCT01129284|65162895|FG000|Overall Study|Adverse Event|2|||
23387587|NCT01129284|65162896|FG001|Overall Study|Adverse Event|0|||
23387588|NCT01129284|65162897|FG002|Overall Study|Adverse Event|1|||
23387589|NCT00212355|65162898|FG000|Overall Study|Adverse Event|1|||
23387590|NCT00212355|65162898|FG000|Overall Study|Withdrawal by Subject|1|||
23387591|NCT00212355|65162898|FG000|Overall Study|A change of address|1|||
23387592|NCT00553475|65162906|FG000|Overall Study|Adverse Event|7|||
23387593|NCT00553475|65162907|FG001|Overall Study|Adverse Event|17|||
23387594|NCT00553475|65162908|FG002|Overall Study|Adverse Event|13|||
23387595|NCT00553475|65162906|FG000|Overall Study|Lack of Efficacy|7|||
23387596|NCT00553475|65162907|FG001|Overall Study|Lack of Efficacy|1|||
23387597|NCT00553475|65162908|FG002|Overall Study|Lack of Efficacy|0|||
23387598|NCT00553475|65162906|FG000|Overall Study|Withdrawal by Subject|1|||
23387599|NCT00553475|65162907|FG001|Overall Study|Withdrawal by Subject|1|||
23387600|NCT00553475|65162908|FG002|Overall Study|Withdrawal by Subject|0|||
23387601|NCT00553475|65162906|FG000|Overall Study|Physician Decision|1|||
23387602|NCT00553475|65162907|FG001|Overall Study|Physician Decision|0|||
23387603|NCT00553475|65162908|FG002|Overall Study|Physician Decision|0|||
23387604|NCT00553475|65162906|FG000|Overall Study|Due to moving|0|||
23387605|NCT00553475|65162907|FG001|Overall Study|Due to moving|1|||
23387606|NCT00553475|65162908|FG002|Overall Study|Due to moving|0|||
23387607|NCT01292473|65162909|FG000|Overall Study|Adverse Event|1|||
23675750|NCT01049035|66194498|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
23675751|NCT01049035|66194499|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
23675752|NCT01049035|66194500|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
23387608|NCT01292473|65162910|FG001|Overall Study|Adverse Event|0|||
23387609|NCT01292473|65162911|FG002|Overall Study|Adverse Event|1|||
23387610|NCT01292473|65162912|FG003|Overall Study|Adverse Event|1|||
23387611|NCT01292473|65162909|FG000|Overall Study|Lost to Follow-up|1|||
23387612|NCT01292473|65162910|FG001|Overall Study|Lost to Follow-up|1|||
23675753|NCT01049035|66194501|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
23675754|NCT01049035|66194502|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
23675755|NCT01049035|66194503|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
23675756|NCT04599062|66194504|FG000|Overall Study|Physician Decision|1|||
23675757|NCT04599062|66194505|FG001|Overall Study|Physician Decision|0|||
23675758|NCT02863809|66194508|FG000|Overall Study|Adverse Event|8|||
23675759|NCT02863809|66194509|FG001|Overall Study|Adverse Event|8|||
23675760|NCT02863809|66194508|FG000|Overall Study|Withdrawal by Subject|0|||
23675761|NCT02863809|66194509|FG001|Overall Study|Withdrawal by Subject|1|||
23675762|NCT02863809|66194508|FG000|Overall Study|Lost to Follow-up|1|||
23675763|NCT02863809|66194509|FG001|Overall Study|Lost to Follow-up|1|||
23675764|NCT02863809|66194508|FG000|Overall Study|Death|1|||
23675765|NCT02863809|66194509|FG001|Overall Study|Death|0|||
23675766|NCT03984305|66194512|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
23675767|NCT03984305|66194513|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
23675768|NCT03984305|66194512|FG000|Overall Study|Withdrawal by Subject|3|||
23675769|NCT03984305|66194513|FG001|Overall Study|Withdrawal by Subject|3|||
23675770|NCT03984305|66194512|FG000|Overall Study|Lost to Follow-up|1|||
23675771|NCT03984305|66194513|FG001|Overall Study|Lost to Follow-up|0|||
23675772|NCT01738971|66194514|FG000|Overall Study|Lost to Follow-up|19|||
23675773|NCT01738971|66194515|FG001|Overall Study|Lost to Follow-up|30|||
23675774|NCT01738971|66194516|FG002|Overall Study|Lost to Follow-up|17|||
23675775|NCT01145066|66194518|FG000|Overall Study|To resume NSAIDs|2|||
23675776|NCT01145066|66194519|FG001|Overall Study|To resume NSAIDs|2|||
23675777|NCT01145066|66194520|FG002|Overall Study|To resume NSAIDs|1|||
23675778|NCT01145066|66194518|FG000|Overall Study|Non-related surgery|0|||
23675779|NCT01145066|66194519|FG001|Overall Study|Non-related surgery|0|||
23675780|NCT01145066|66194520|FG002|Overall Study|Non-related surgery|1|||
23675781|NCT01145066|66194518|FG000|Overall Study|Withdrawal by Subject|0|||
23675782|NCT01145066|66194519|FG001|Overall Study|Withdrawal by Subject|0|||
23387613|NCT01292473|65162911|FG002|Overall Study|Lost to Follow-up|2|||
23387614|NCT01292473|65162912|FG003|Overall Study|Lost to Follow-up|2|||
23387615|NCT01292473|65162909|FG000|Overall Study|Withdrawal by Subject|3|||
23387616|NCT01292473|65162910|FG001|Overall Study|Withdrawal by Subject|4|||
23387617|NCT01292473|65162911|FG002|Overall Study|Withdrawal by Subject|3|||
23387618|NCT01292473|65162912|FG003|Overall Study|Withdrawal by Subject|3|||
23675783|NCT01145066|66194520|FG002|Overall Study|Withdrawal by Subject|2|||
23675784|NCT01145066|66194518|FG000|Overall Study|To start new med|1|||
23675785|NCT01145066|66194519|FG001|Overall Study|To start new med|0|||
23675786|NCT01145066|66194520|FG002|Overall Study|To start new med|0|||
23675787|NCT01145066|66194518|FG000|Overall Study|problems swallowing capsule|1|||
23675788|NCT01145066|66194519|FG001|Overall Study|problems swallowing capsule|0|||
23675789|NCT01145066|66194520|FG002|Overall Study|problems swallowing capsule|0|||
23675790|NCT01145066|66194518|FG000|Overall Study|Abdominal discomfort|0|||
23675791|NCT01145066|66194519|FG001|Overall Study|Abdominal discomfort|1|||
23675792|NCT01145066|66194520|FG002|Overall Study|Abdominal discomfort|0|||
23675793|NCT01145066|66194518|FG000|Overall Study|Low platelet count|0|||
23675794|NCT01145066|66194519|FG001|Overall Study|Low platelet count|1|||
23675795|NCT01145066|66194520|FG002|Overall Study|Low platelet count|0|||
23675796|NCT00666458|66194521|FG000|Overall Study|Adverse Event|8|||
23675797|NCT00666458|66194522|FG001|Overall Study|Adverse Event|7|||
23675798|NCT00666458|66194521|FG000|Overall Study|Withdrawal by Subject|5|||
23675799|NCT00666458|66194522|FG001|Overall Study|Withdrawal by Subject|4|||
23675800|NCT00666458|66194521|FG000|Overall Study|Lost to Follow-up|0|||
23675801|NCT00666458|66194522|FG001|Overall Study|Lost to Follow-up|3|||
23675802|NCT00666458|66194521|FG000|Overall Study|Administrative reason by sponsor|1|||
23675803|NCT00666458|66194522|FG001|Overall Study|Administrative reason by sponsor|1|||
23387619|NCT01292473|65162909|FG000|Overall Study|Physician Decision|0|||
23387620|NCT01292473|65162910|FG001|Overall Study|Physician Decision|1|||
23387621|NCT01292473|65162911|FG002|Overall Study|Physician Decision|0|||
23387622|NCT01292473|65162912|FG003|Overall Study|Physician Decision|0|||
23387623|NCT01292473|65162909|FG000|Overall Study|Disease Progression|0|||
23387624|NCT01292473|65162910|FG001|Overall Study|Disease Progression|1|||
23387625|NCT01292473|65162911|FG002|Overall Study|Disease Progression|3|||
23387626|NCT01292473|65162912|FG003|Overall Study|Disease Progression|6|||
23387627|NCT03681093|65162913|FG000|Overall Study|Subject decision|0|||
23675804|NCT00666458|66194521|FG000|Overall Study|Incorrect enrollment|7|||
23675805|NCT00666458|66194522|FG001|Overall Study|Incorrect enrollment|1|||
23675806|NCT00666458|66194521|FG000|Overall Study|Study specific discontinuation criteria|14|||
23675807|NCT00666458|66194522|FG001|Overall Study|Study specific discontinuation criteria|7|||
23675808|NCT00666458|66194521|FG000|Overall Study|Severe non-compliance to the protocol|1|||
23675809|NCT00666458|66194522|FG001|Overall Study|Severe non-compliance to the protocol|1|||
23675810|NCT00666458|66194521|FG000|Overall Study|Safety reasons|1|||
23675811|NCT00666458|66194522|FG001|Overall Study|Safety reasons|0|||
23675812|NCT00666458|66194521|FG000|Overall Study|Medical history of anemia|1|||
23675813|NCT00666458|66194522|FG001|Overall Study|Medical history of anemia|0|||
23675814|NCT01857869|66194523|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
23675815|NCT01857869|66194524|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
23675816|NCT01857869|66194525|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
23675817|NCT01857869|66194526|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
23675818|NCT01857869|66194527|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
23675819|NCT01857869|66194528|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
23675820|NCT01857869|66194529|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
23675821|NCT01857869|66194530|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
23675822|NCT01857869|66194531|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
23675823|NCT01857869|66194532|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
23675824|NCT01857869|66194523|FG000|Primary/Challenge Phase|Pregnancy|1|||
23675825|NCT01857869|66194524|FG001|Primary/Challenge Phase|Pregnancy|0|||
23675826|NCT01857869|66194525|FG002|Primary/Challenge Phase|Pregnancy|0|||
23675827|NCT01857869|66194526|FG003|Primary/Challenge Phase|Pregnancy|0|||
23387628|NCT03681093|65162914|FG001|Overall Study|Subject decision|2|||
23387629|NCT03681093|65162915|FG002|Overall Study|Subject decision|1|||
23387630|NCT01898130|65162918|FG000|Treatment|Withdrawal by Subject|2|||
23387631|NCT01898130|65162918|FG000|Treatment|Progressive Disease|4|||
23675828|NCT01857869|66194527|FG004|Primary/Challenge Phase|Pregnancy|0|||
23675829|NCT01857869|66194528|FG005|Primary/Challenge Phase|Pregnancy|0|||
23675830|NCT01857869|66194529|FG006|Primary/Challenge Phase|Pregnancy|0|||
23675831|NCT01857869|66194530|FG007|Primary/Challenge Phase|Pregnancy|0|||
23675832|NCT01857869|66194531|FG008|Primary/Challenge Phase|Pregnancy|0|||
23675833|NCT01857869|66194532|FG009|Primary/Challenge Phase|Pregnancy|0|||
23675834|NCT01857869|66194523|FG000|Primary/Challenge Phase|Protocol Violation|1|||
23675835|NCT01857869|66194524|FG001|Primary/Challenge Phase|Protocol Violation|0|||
23675836|NCT01857869|66194525|FG002|Primary/Challenge Phase|Protocol Violation|0|||
23675837|NCT01857869|66194526|FG003|Primary/Challenge Phase|Protocol Violation|0|||
23387632|NCT01898130|65162918|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
23675838|NCT01857869|66194527|FG004|Primary/Challenge Phase|Protocol Violation|0|||
23675839|NCT01857869|66194528|FG005|Primary/Challenge Phase|Protocol Violation|0|||
23675840|NCT01857869|66194529|FG006|Primary/Challenge Phase|Protocol Violation|0|||
23675841|NCT01857869|66194530|FG007|Primary/Challenge Phase|Protocol Violation|0|||
23675842|NCT01857869|66194531|FG008|Primary/Challenge Phase|Protocol Violation|0|||
23675843|NCT01857869|66194532|FG009|Primary/Challenge Phase|Protocol Violation|0|||
23675844|NCT01857869|66194523|FG000|Primary/Challenge Phase|Other|1|||
23675845|NCT01857869|66194524|FG001|Primary/Challenge Phase|Other|1|||
23675846|NCT01857869|66194525|FG002|Primary/Challenge Phase|Other|0|||
23675847|NCT01857869|66194526|FG003|Primary/Challenge Phase|Other|0|||
23675848|NCT01857869|66194527|FG004|Primary/Challenge Phase|Other|0|||
23675849|NCT01857869|66194528|FG005|Primary/Challenge Phase|Other|0|||
23675850|NCT01857869|66194529|FG006|Primary/Challenge Phase|Other|0|||
23675851|NCT01857869|66194530|FG007|Primary/Challenge Phase|Other|0|||
23675852|NCT01857869|66194531|FG008|Primary/Challenge Phase|Other|0|||
23675853|NCT01857869|66194532|FG009|Primary/Challenge Phase|Other|0|||
23675854|NCT01857869|66194523|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675855|NCT01857869|66194524|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675856|NCT01857869|66194525|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675857|NCT01857869|66194526|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
23675858|NCT01857869|66194527|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675859|NCT01857869|66194528|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675860|NCT01857869|66194529|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675861|NCT01857869|66194530|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675862|NCT01857869|66194531|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675863|NCT01857869|66194532|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23675864|NCT01857869|66194523|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675865|NCT01857869|66194524|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675866|NCT01857869|66194525|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675867|NCT01857869|66194526|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
23675868|NCT01857869|66194527|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675869|NCT01857869|66194528|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675870|NCT01857869|66194529|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675871|NCT01857869|66194530|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675872|NCT01857869|66194531|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675873|NCT01857869|66194532|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23675874|NCT04506294|66194534|FG000|Overall Study|Lost to Follow-up|70|||
23675875|NCT04506294|66194535|FG001|Overall Study|Lost to Follow-up|20|||
23675876|NCT04506294|66194534|FG000|Overall Study|Withdrawal by Subject|16|||
23675877|NCT04506294|66194535|FG001|Overall Study|Withdrawal by Subject|2|||
23675878|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Death|3|||
23675879|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Death|0|||
23675880|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Adverse Event|12|||
23387633|NCT00825175|65162919|FG000|Overall Study|Withdrawal by Subject|0|||
23675881|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Adverse Event|6|||
23675882|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
23675883|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
23675884|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
23675885|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
23675886|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
23675887|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
23675888|NCT00159861|66194536|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
23675889|NCT00159861|66194537|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
23675890|NCT00159861|66194536|FG000|Extension Study - up to 3 Years|Death|24|||
23675891|NCT00159861|66194537|FG001|Extension Study - up to 3 Years|Death|28|||
23675892|NCT00159861|66194536|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
23675893|NCT00159861|66194537|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
23675894|NCT00159861|66194536|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
23675895|NCT00159861|66194537|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
23675896|NCT00159861|66194536|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
23675897|NCT00159861|66194537|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
23675898|NCT00159861|66194536|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
23675899|NCT00159861|66194537|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
23675900|NCT03806127|66194538|FG000|Overall Study|Withdrawal by Subject|4|||
23675901|NCT03806127|66194539|FG001|Overall Study|Withdrawal by Subject|5|||
23387634|NCT00825175|65162920|FG001|Overall Study|Withdrawal by Subject|5|||
23387635|NCT00682435|65162921|FG000|Overall Study|Insufficient data|5|||
23675902|NCT03806127|66194538|FG000|Overall Study|Protocol Violation|3|||
23675903|NCT03806127|66194539|FG001|Overall Study|Protocol Violation|1|||
23675904|NCT03806127|66194538|FG000|Overall Study|Adverse Event|3|||
23675905|NCT03806127|66194539|FG001|Overall Study|Adverse Event|0|||
23675906|NCT03806127|66194538|FG000|Overall Study|Unable to Complete Procedures|0|||
23675907|NCT03806127|66194539|FG001|Overall Study|Unable to Complete Procedures|1|||
23675908|NCT03806127|66194538|FG000|Overall Study|Pregnancy|0|||
23675909|NCT03806127|66194539|FG001|Overall Study|Pregnancy|1|||
23675910|NCT03806127|66194538|FG000|Overall Study|Lost to Follow-up|5|||
23675911|NCT03806127|66194539|FG001|Overall Study|Lost to Follow-up|1|||
23675912|NCT03806127|66194538|FG000|Overall Study|Physician Decision|1|||
23675913|NCT03806127|66194539|FG001|Overall Study|Physician Decision|1|||
23387636|NCT00682435|65162921|FG000|Overall Study|Erroneously enrolled twice|2|||
23387637|NCT01623154|65162922|FG000|Overall Study|Did not drink Pranactin Citric|4|||
23387638|NCT00887588|65162923|FG000|Core Period|Death|1|||
23387639|NCT00887588|65162924|FG001|Core Period|Death|1|||
23387640|NCT00887588|65162923|FG000|Core Period|Lost to Follow-up|3|||
23387641|NCT00887588|65162924|FG001|Core Period|Lost to Follow-up|1|||
23387642|NCT00887588|65162923|FG000|Core Period|Withdrawal by Subject|6|||
23387643|NCT00887588|65162924|FG001|Core Period|Withdrawal by Subject|8|||
23387644|NCT00887588|65162923|FG000|Core Period|Adverse Event|9|||
23387645|NCT00887588|65162924|FG001|Core Period|Adverse Event|11|||
23387646|NCT00887588|65162923|FG000|Extension Period|Adverse Event|4|||
23387647|NCT00887588|65162924|FG001|Extension Period|Adverse Event|4|||
23387648|NCT00887588|65162923|FG000|Extension Period|Death|0|||
23387649|NCT00887588|65162924|FG001|Extension Period|Death|1|||
23387650|NCT00887588|65162923|FG000|Extension Period|Protocol deviation|1|||
23675914|NCT03806127|66194538|FG000|Overall Study|Could Not Come Due to Covid|1|||
23387651|NCT00887588|65162924|FG001|Extension Period|Protocol deviation|0|||
23387652|NCT00887588|65162923|FG000|Extension Period|Lost to Follow-up|1|||
23387653|NCT00887588|65162924|FG001|Extension Period|Lost to Follow-up|0|||
23675915|NCT03806127|66194539|FG001|Overall Study|Could Not Come Due to Covid|0|||
23675916|NCT03806127|66194538|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
23675917|NCT03806127|66194539|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
23675918|NCT03806127|66194538|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
23675919|NCT03806127|66194539|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
23675920|NCT03806127|66194538|FG000|Overall Study|Covid 19 Restrictions|2|||
23675921|NCT03806127|66194539|FG001|Overall Study|Covid 19 Restrictions|0|||
23675922|NCT03806127|66194538|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
23675923|NCT03806127|66194539|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
23675924|NCT03806127|66194538|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
23675925|NCT03806127|66194539|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
23675926|NCT00781456|66194546|FG000|Overall Study|Adverse Event|3|||
23675927|NCT00781456|66194547|FG001|Overall Study|Adverse Event|3|||
23494237|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
23494238|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
23494239|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
23494240|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
23494241|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
23494242|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
23494243|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
23494244|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
23494245|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
23494246|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
23494247|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
23494248|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
23494249|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
23494250|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
23494251|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
23494252|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
23494253|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
23494254|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
23494255|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
23494256|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
23494257|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
23494258|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
23494259|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494260|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494261|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
23494262|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494263|NCT02404220|65554953|FG000|Overall Study|Adverse Event|0|||
23494264|NCT02404220|65554954|FG001|Overall Study|Adverse Event|0|||
23494265|NCT02404220|65554955|FG002|Overall Study|Adverse Event|1|||
23494266|NCT02404220|65554956|FG003|Overall Study|Adverse Event|0|||
23494267|NCT02404220|65554953|FG000|Overall Study|Death|5|||
23494268|NCT02404220|65554954|FG001|Overall Study|Death|5|||
23494269|NCT02404220|65554955|FG002|Overall Study|Death|3|||
23494270|NCT02404220|65554956|FG003|Overall Study|Death|8|||
23494271|NCT02404220|65554953|FG000|Overall Study|Progressive Disease|0|||
23494272|NCT02404220|65554954|FG001|Overall Study|Progressive Disease|0|||
23494273|NCT02404220|65554955|FG002|Overall Study|Progressive Disease|1|||
23494274|NCT02404220|65554956|FG003|Overall Study|Progressive Disease|1|||
23494275|NCT02404220|65554953|FG000|Overall Study|Study Terminated by Sponsor|0|||
23494276|NCT02404220|65554954|FG001|Overall Study|Study Terminated by Sponsor|0|||
23494277|NCT02404220|65554955|FG002|Overall Study|Study Terminated by Sponsor|2|||
23494278|NCT02404220|65554956|FG003|Overall Study|Study Terminated by Sponsor|1|||
23494279|NCT02404220|65554953|FG000|Overall Study|Withdrawal by Subject|0|||
23494280|NCT02404220|65554954|FG001|Overall Study|Withdrawal by Subject|1|||
23494281|NCT02404220|65554955|FG002|Overall Study|Withdrawal by Subject|0|||
23494282|NCT02404220|65554956|FG003|Overall Study|Withdrawal by Subject|0|||
23494283|NCT02404220|65554953|FG000|Overall Study|Enrolled but Never Treated|0|||
23494284|NCT02404220|65554954|FG001|Overall Study|Enrolled but Never Treated|2|||
23494285|NCT02404220|65554955|FG002|Overall Study|Enrolled but Never Treated|0|||
23494286|NCT02404220|65554956|FG003|Overall Study|Enrolled but Never Treated|0|||
23494287|NCT01824875|65554962|FG000|Overall Study|Disease progression|22|||
23494288|NCT01824875|65554963|FG001|Overall Study|Disease progression|15|||
23494289|NCT01824875|65554962|FG000|Overall Study|Withdrawal by Subject|5|||
23494290|NCT01824875|65554963|FG001|Overall Study|Withdrawal by Subject|4|||
23494291|NCT01824875|65554962|FG000|Overall Study|Adverse Event|4|||
23494292|NCT01824875|65554963|FG001|Overall Study|Adverse Event|10|||
23494293|NCT01824875|65554962|FG000|Overall Study|Alternative therapy|3|||
23494294|NCT01824875|65554963|FG001|Overall Study|Alternative therapy|0|||
23494295|NCT01824875|65554962|FG000|Overall Study|Complicating disease|1|||
23494296|NCT01824875|65554963|FG001|Overall Study|Complicating disease|0|||
23494297|NCT01824875|65554962|FG000|Overall Study|Physician Decision|0|||
23494298|NCT01824875|65554963|FG001|Overall Study|Physician Decision|1|||
23494299|NCT01824875|65554962|FG000|Overall Study|Non-compliance|1|||
23494300|NCT01824875|65554963|FG001|Overall Study|Non-compliance|1|||
23494301|NCT01824875|65554962|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
23494302|NCT01824875|65554963|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
23494303|NCT01824875|65554962|FG000|Overall Study|Administrative issues|0|||
23494304|NCT01824875|65554963|FG001|Overall Study|Administrative issues|2|||
23494305|NCT01824875|65554962|FG000|Overall Study|Ineligible or never started treatment|9|||
23494306|NCT01824875|65554963|FG001|Overall Study|Ineligible or never started treatment|5|||
23494307|NCT01824875|65554962|FG000|Overall Study|Other|0|||
23494308|NCT01824875|65554963|FG001|Overall Study|Other|2|||
23494309|NCT02243696|65554965|FG000|Overall Study|Death|282|||
23387654|NCT00669331|65162928|FG000|Randomisation to First Dose|Adverse Event|1|||
23387655|NCT00669331|65162929|FG001|Randomisation to First Dose|Adverse Event|0|||
23387656|NCT00669331|65162928|FG000|Randomisation to First Dose|Protocol Violation|1|||
23387657|NCT00669331|65162929|FG001|Randomisation to First Dose|Protocol Violation|0|||
23387658|NCT00669331|65162928|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
23387659|NCT00669331|65162929|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
23387660|NCT00669331|65162928|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
23387661|NCT00669331|65162929|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
23387662|NCT00669331|65162928|FG000|Randomisation to First Dose|Death|1|||
23675928|NCT00781456|66194546|FG000|Overall Study|Withdrawal by Subject|3|||
23675929|NCT00781456|66194547|FG001|Overall Study|Withdrawal by Subject|5|||
23675930|NCT00781456|66194546|FG000|Overall Study|Protocol Violation|4|||
23675931|NCT00781456|66194547|FG001|Overall Study|Protocol Violation|1|||
23675932|NCT00781456|66194546|FG000|Overall Study|Noncompliance With Protocol|1|||
23675933|NCT00781456|66194547|FG001|Overall Study|Noncompliance With Protocol|1|||
23675934|NCT00781456|66194546|FG000|Overall Study|Lost to Follow-up|10|||
23675935|NCT00781456|66194547|FG001|Overall Study|Lost to Follow-up|5|||
23675936|NCT00781456|66194546|FG000|Overall Study|Other Reason, Unknown|0|||
23675937|NCT00781456|66194547|FG001|Overall Study|Other Reason, Unknown|1|||
23675938|NCT03298022|66194548|FG000|Overall Study|Lack of Efficacy|4|||
23675939|NCT03298022|66194548|FG000|Overall Study|Withdrawal by Subject|7|||
23675940|NCT03298022|66194548|FG000|Overall Study|Adverse Event|1|||
23675941|NCT03298022|66194548|FG000|Overall Study|disease relapse|1|||
23675942|NCT03665285|66194551|FG000|Overall Study|Started New Anticancer Treatment|1|||
23675943|NCT03665285|66194552|FG001|Overall Study|Started New Anticancer Treatment|1|||
23675944|NCT03665285|66194553|FG002|Overall Study|Started New Anticancer Treatment|2|||
23675945|NCT03665285|66194554|FG003|Overall Study|Started New Anticancer Treatment|4|||
23675946|NCT03665285|66194555|FG004|Overall Study|Started New Anticancer Treatment|1|||
23675947|NCT03665285|66194556|FG005|Overall Study|Started New Anticancer Treatment|1|||
23675948|NCT03665285|66194557|FG006|Overall Study|Started New Anticancer Treatment|2|||
23675949|NCT03665285|66194558|FG007|Overall Study|Started New Anticancer Treatment|15|||
23675950|NCT03665285|66194559|FG008|Overall Study|Started New Anticancer Treatment|1|||
23675951|NCT03665285|66194551|FG000|Overall Study|Disease Progression|0|||
23675952|NCT03665285|66194552|FG001|Overall Study|Disease Progression|0|||
23675953|NCT03665285|66194553|FG002|Overall Study|Disease Progression|3|||
23675954|NCT03665285|66194554|FG003|Overall Study|Disease Progression|1|||
23387663|NCT00669331|65162929|FG001|Randomisation to First Dose|Death|0|||
23387664|NCT00669331|65162928|FG000|Randomisation to First Dose|Sponsor decision|0|||
23387665|NCT00669331|65162929|FG001|Randomisation to First Dose|Sponsor decision|1|||
23675955|NCT03665285|66194555|FG004|Overall Study|Disease Progression|0|||
23675956|NCT03665285|66194556|FG005|Overall Study|Disease Progression|0|||
23675957|NCT03665285|66194557|FG006|Overall Study|Disease Progression|0|||
23675958|NCT03665285|66194558|FG007|Overall Study|Disease Progression|7|||
23675959|NCT03665285|66194559|FG008|Overall Study|Disease Progression|1|||
23387666|NCT00669331|65162928|FG000|Randomisation to First Dose|Randomised in error|3|||
23387667|NCT00669331|65162929|FG001|Randomisation to First Dose|Randomised in error|10|||
23675960|NCT03665285|66194551|FG000|Overall Study|Hospice|0|||
23675961|NCT03665285|66194552|FG001|Overall Study|Hospice|0|||
23675962|NCT03665285|66194553|FG002|Overall Study|Hospice|0|||
23675963|NCT03665285|66194554|FG003|Overall Study|Hospice|0|||
23387668|NCT00669331|65162928|FG000|Blinded Treatment Period|Adverse Event|16|||
23387669|NCT00669331|65162929|FG001|Blinded Treatment Period|Adverse Event|10|||
23387670|NCT00669331|65162928|FG000|Blinded Treatment Period|Protocol Violation|1|||
23387671|NCT00669331|65162929|FG001|Blinded Treatment Period|Protocol Violation|1|||
23387672|NCT00669331|65162928|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
23387673|NCT00669331|65162929|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
23387674|NCT00669331|65162928|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
23387675|NCT00669331|65162929|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
23387676|NCT00669331|65162928|FG000|Blinded Treatment Period|Death|0|||
23675964|NCT03665285|66194555|FG004|Overall Study|Hospice|0|||
23675965|NCT03665285|66194556|FG005|Overall Study|Hospice|0|||
23675966|NCT03665285|66194557|FG006|Overall Study|Hospice|0|||
23675967|NCT03665285|66194558|FG007|Overall Study|Hospice|2|||
23675968|NCT03665285|66194559|FG008|Overall Study|Hospice|0|||
23675969|NCT03665285|66194551|FG000|Overall Study|Withdrawal by Subject|0|||
23675970|NCT03665285|66194552|FG001|Overall Study|Withdrawal by Subject|0|||
23675971|NCT03665285|66194553|FG002|Overall Study|Withdrawal by Subject|0|||
23675972|NCT03665285|66194554|FG003|Overall Study|Withdrawal by Subject|0|||
23675973|NCT03665285|66194555|FG004|Overall Study|Withdrawal by Subject|1|||
23675974|NCT03665285|66194556|FG005|Overall Study|Withdrawal by Subject|0|||
23675975|NCT03665285|66194557|FG006|Overall Study|Withdrawal by Subject|0|||
23675976|NCT03665285|66194558|FG007|Overall Study|Withdrawal by Subject|2|||
23675977|NCT03665285|66194559|FG008|Overall Study|Withdrawal by Subject|0|||
23675978|NCT03665285|66194551|FG000|Overall Study|Physician Decision|0|||
23675979|NCT03665285|66194552|FG001|Overall Study|Physician Decision|0|||
23675980|NCT03665285|66194553|FG002|Overall Study|Physician Decision|0|||
23675981|NCT03665285|66194554|FG003|Overall Study|Physician Decision|0|||
23675982|NCT03665285|66194555|FG004|Overall Study|Physician Decision|0|||
23675983|NCT03665285|66194556|FG005|Overall Study|Physician Decision|0|||
23675984|NCT03665285|66194557|FG006|Overall Study|Physician Decision|0|||
23675985|NCT03665285|66194558|FG007|Overall Study|Physician Decision|2|||
23675986|NCT03665285|66194559|FG008|Overall Study|Physician Decision|0|||
23675987|NCT02721355|66194560|FG000|Overall Study|Lost to Follow-up|6|||
23675988|NCT02721355|66194561|FG001|Overall Study|Lost to Follow-up|1|||
23675989|NCT01609842|66194562|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
23675990|NCT01609842|66194563|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
23675991|NCT02532855|66194565|FG000|Overall Study|Lost to Follow-up|4|||
23387677|NCT00669331|65162929|FG001|Blinded Treatment Period|Death|2|||
23494310|NCT02243696|65554965|FG000|Overall Study|Withdrawal by Subject|79|||
23494311|NCT02243696|65554965|FG000|Overall Study|Lost to Follow-up|57|||
23494312|NCT02243696|65554965|FG000|Overall Study|Subject No Longer has Study System|42|||
23494313|NCT02243696|65554965|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
23494314|NCT02243696|65554965|FG000|Overall Study|Study Terminated for EP PASSION|961|||
23494315|NCT03945266|65554966|FG000|Overall Study|Withdrawal by Subject|1|||
23494316|NCT03945266|65554967|FG001|Overall Study|Withdrawal by Subject|0|||
23494317|NCT03945266|65554966|FG000|Overall Study|Miscarriage|0|||
23494318|NCT03945266|65554967|FG001|Overall Study|Miscarriage|2|||
23494319|NCT03945266|65554966|FG000|Overall Study|Lost to Follow-up|1|||
23494320|NCT03945266|65554967|FG001|Overall Study|Lost to Follow-up|0|||
23494321|NCT02191137|65554971|FG000|Treatment|Death|4|||
23675992|NCT02532855|66194566|FG001|Overall Study|Lost to Follow-up|3|||
23675993|NCT02532855|66194565|FG000|Overall Study|Withdrawal by Subject|4|||
23675994|NCT02532855|66194566|FG001|Overall Study|Withdrawal by Subject|8|||
23494322|NCT02191137|65554971|FG000|Treatment|Withdrawal by Subject|3|||
23494323|NCT02191137|65554971|FG000|Treatment|Adverse Event|2|||
23675995|NCT01182428|66194567|FG000|Overall Study|Physician Decision|1|||
23675996|NCT01182428|66194568|FG001|Overall Study|Physician Decision|0|||
23675997|NCT01182428|66194567|FG000|Overall Study|Lost to Follow-up|9|||
23675998|NCT01182428|66194568|FG001|Overall Study|Lost to Follow-up|1|||
23675999|NCT01182428|66194567|FG000|Overall Study|Withdrawal by Subject|1|||
23676000|NCT01182428|66194568|FG001|Overall Study|Withdrawal by Subject|0|||
23676001|NCT00191451|66194571|FG000|Overall Study|Withdrawal by Subject|2|||
23676002|NCT00191451|66194572|FG001|Overall Study|Withdrawal by Subject|3|||
23676003|NCT00191451|66194573|FG002|Overall Study|Withdrawal by Subject|5|||
23676004|NCT00191451|66194571|FG000|Overall Study|Physician Decision|2|||
23676005|NCT00191451|66194572|FG001|Overall Study|Physician Decision|9|||
23676006|NCT00191451|66194573|FG002|Overall Study|Physician Decision|6|||
23676007|NCT00191451|66194571|FG000|Overall Study|Sponsor Decision|1|||
23387678|NCT00669331|65162928|FG000|Blinded Treatment Period|Physician Decision|3|||
23387679|NCT00669331|65162929|FG001|Blinded Treatment Period|Physician Decision|3|||
23387680|NCT00669331|65162928|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
23387681|NCT00669331|65162929|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
23387682|NCT01653262|65162930|FG000|Overall Study|Lack of Efficacy|1|||
23387683|NCT01653262|65162930|FG000|Overall Study|SAE, non-fatal|1|||
23387684|NCT01653262|65162930|FG000|Overall Study|AE, non-serious non-fatal|1|||
23387685|NCT00345592|65162935|FG000|Overall Study|Death|14|||
23387686|NCT00345592|65162936|FG001|Overall Study|Death|16|||
23387687|NCT00345592|65162935|FG000|Overall Study|Withdrawal by Subject|11|||
23387688|NCT00345592|65162936|FG001|Overall Study|Withdrawal by Subject|8|||
23387689|NCT03467945|65162937|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23387690|NCT03467945|65162938|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23387691|NCT03467945|65162939|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23387692|NCT03467945|65162940|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23387693|NCT03467945|65162937|FG000|Treatment Period 3|Withdrawal by Subject|1|||
23387694|NCT03467945|65162938|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23387695|NCT03467945|65162939|FG002|Treatment Period 3|Withdrawal by Subject|2|||
23387696|NCT03467945|65162940|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23387697|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
23387698|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
23387699|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23387700|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23387701|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23387702|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23387703|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
23387704|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387705|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387706|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
23387707|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
23387708|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
23387709|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Other|6|||
23387710|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Other|3|||
23387711|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Other|0|||
23387712|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
23387713|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23387714|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23387715|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
23387716|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
23676008|NCT00191451|66194572|FG001|Overall Study|Sponsor Decision|0|||
23676009|NCT00191451|66194573|FG002|Overall Study|Sponsor Decision|0|||
23676010|NCT00191451|66194571|FG000|Overall Study|Ineligible|0|||
23387717|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
23387718|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Adverse Event|0|||
23387719|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Adverse Event|0|||
23676011|NCT00191451|66194572|FG001|Overall Study|Ineligible|1|||
23676012|NCT00191451|66194573|FG002|Overall Study|Ineligible|0|||
23676013|NCT00191451|66194571|FG000|Overall Study|Reason Not Specified|2|||
23387720|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Adverse Event|21|||
23676014|NCT00191451|66194572|FG001|Overall Study|Reason Not Specified|1|||
23676015|NCT00191451|66194573|FG002|Overall Study|Reason Not Specified|3|||
23676016|NCT03948178|66194574|FG000|Overall Study|Protocol Violation|1|||
23676017|NCT03948178|66194574|FG000|Overall Study|Lost to Follow-up|2|||
23676018|NCT03948178|66194574|FG000|Overall Study|Withdrawal by Subject|2|||
23676019|NCT03948178|66194574|FG000|Overall Study|Reason not known|2|||
23676020|NCT03948178|66194574|FG000|Overall Study|Personal reason|14|||
23676021|NCT03948178|66194574|FG000|Overall Study|Disease progression|30|||
23676022|NCT03948178|66194574|FG000|Overall Study|Adverse Event|12|||
23676023|NCT03948178|66194574|FG000|Overall Study|Sponsor terminated study|164|||
23676024|NCT02971670|66194583|FG000|Overall Study|Withdrawal by Subject|4|||
23676025|NCT02971670|66194584|FG001|Overall Study|Withdrawal by Subject|1|||
23676026|NCT02971670|66194585|FG002|Overall Study|Withdrawal by Subject|1|||
23676027|NCT02971670|66194586|FG003|Overall Study|Withdrawal by Subject|2|||
23676028|NCT00506883|66194592|FG000|Overall Study|Lost to Follow-up|1|||
23676029|NCT00506883|66194593|FG001|Overall Study|Lost to Follow-up|1|||
23676030|NCT00506883|66194594|FG002|Overall Study|Lost to Follow-up|1|||
23676031|NCT00506883|66194592|FG000|Overall Study|Withdrawal by Subject|1|||
23676032|NCT00506883|66194593|FG001|Overall Study|Withdrawal by Subject|0|||
23676033|NCT00506883|66194594|FG002|Overall Study|Withdrawal by Subject|1|||
23676034|NCT00506883|66194592|FG000|Overall Study|Lack of Efficacy|0|||
23676035|NCT00506883|66194593|FG001|Overall Study|Lack of Efficacy|1|||
23676036|NCT00506883|66194594|FG002|Overall Study|Lack of Efficacy|1|||
23676037|NCT00506883|66194592|FG000|Overall Study|Other|5|||
23676038|NCT00506883|66194593|FG001|Overall Study|Other|1|||
23387721|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
23387722|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
23387723|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
23387724|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387725|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387726|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
23387727|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
23387728|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
23387729|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
23494324|NCT02191137|65554971|FG000|Treatment|Other|1|||
23494325|NCT02191137|65554971|FG000|Follow-up|Lost to Follow-up|2|||
23676039|NCT00506883|66194594|FG002|Overall Study|Other|1|||
23676040|NCT00915343|66194598|FG000|Part B - Open Label Period|Treatment switch|0|||
23676041|NCT00915343|66194599|FG001|Part B - Open Label Period|Treatment switch|0|||
23387730|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Administrative|0|||
23387731|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Administrative|0|||
23494326|NCT02191137|65554971|FG000|Follow-up|Ongoing/unknown|2|||
23676042|NCT00915343|66194600|FG002|Part B - Open Label Period|Treatment switch|1|||
23676043|NCT00915343|66194598|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
23676044|NCT00915343|66194599|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
23676045|NCT00915343|66194600|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
23494327|NCT02191137|65554971|FG000|Follow-up|Adverse Event|1|||
23494328|NCT02095223|65554975|FG000|Overall Study|Withdrawal by Subject|1|||
23676046|NCT03551743|66194601|FG000|Overall Study|Adverse Event|1|||
23676047|NCT03551743|66194602|FG001|Overall Study|Adverse Event|0|||
23676048|NCT03551743|66194603|FG002|Overall Study|Adverse Event|0|||
23676049|NCT03551743|66194604|FG003|Overall Study|Adverse Event|0|||
23676050|NCT03551743|66194601|FG000|Overall Study|Withdrawal by Subject|1|||
23676051|NCT03551743|66194602|FG001|Overall Study|Withdrawal by Subject|0|||
23676052|NCT03551743|66194603|FG002|Overall Study|Withdrawal by Subject|0|||
23676053|NCT03551743|66194604|FG003|Overall Study|Withdrawal by Subject|0|||
23676054|NCT04312009|66194605|FG000|Overall Study|Withdrawal by Subject|2|||
23676055|NCT04312009|66194606|FG001|Overall Study|Withdrawal by Subject|1|||
23676056|NCT02615990|66194621|FG000|Overall Study|study terminated|1|||
23676057|NCT02615990|66194622|FG001|Overall Study|study terminated|1|||
23676058|NCT05779072|66194623|FG000|Overall Study|Lost to Follow-up|0|||
23676059|NCT05779072|66194624|FG001|Overall Study|Lost to Follow-up|1|||
23676060|NCT05779072|66194623|FG000|Overall Study|Withdrawal by Subject|1|||
23676061|NCT05779072|66194624|FG001|Overall Study|Withdrawal by Subject|5|||
23676062|NCT01978093|66194627|FG000|Overall Study|Death|1|||
23676063|NCT01978093|66194628|FG001|Overall Study|Death|0|||
23676064|NCT01978093|66194627|FG000|Overall Study|Adverse Event|0|||
23676065|NCT01978093|66194628|FG001|Overall Study|Adverse Event|5|||
23676066|NCT01978093|66194627|FG000|Overall Study|Protocol Violation|8|||
23676067|NCT01978093|66194628|FG001|Overall Study|Protocol Violation|2|||
23676068|NCT01978093|66194627|FG000|Overall Study|Withdrawal by Subject|29|||
23676069|NCT01978093|66194628|FG001|Overall Study|Withdrawal by Subject|25|||
23676070|NCT01978093|66194627|FG000|Overall Study|Lost to Follow-up|11|||
23676071|NCT01978093|66194628|FG001|Overall Study|Lost to Follow-up|15|||
23676072|NCT01978093|66194627|FG000|Overall Study|Migrated/moved from study area|11|||
23676073|NCT01978093|66194628|FG001|Overall Study|Migrated/moved from study area|13|||
23676074|NCT01978093|66194627|FG000|Overall Study|Loss of kaiser coverage|4|||
23676075|NCT01978093|66194628|FG001|Overall Study|Loss of kaiser coverage|10|||
23676076|NCT01978093|66194627|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
23676077|NCT01978093|66194628|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
23676078|NCT01978093|66194627|FG000|Overall Study|Mother lost custody of child|0|||
23676079|NCT01978093|66194628|FG001|Overall Study|Mother lost custody of child|1|||
23387732|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Administrative|36|||
23387733|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Other|0|||
23387734|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Other|0|||
23387735|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Other|9|||
23387736|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
23676080|NCT01978093|66194627|FG000|Overall Study|Child was in care of grandmother|0|||
23676081|NCT01978093|66194628|FG001|Overall Study|Child was in care of grandmother|1|||
23387737|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
23387738|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
23387739|NCT00079781|65165777|FG000|Pre-implant Period|Withdrawal by Subject|2|||
23387740|NCT00079781|65165778|FG001|Pre-implant Period|Withdrawal by Subject|0|||
23387741|NCT00079781|65165779|FG002|Pre-implant Period|Withdrawal by Subject|0|||
23387742|NCT00079781|65165777|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
23387743|NCT00079781|65165778|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
23387744|NCT00079781|65165779|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
23387745|NCT00079781|65165777|FG000|Follow-up Period|Withdrawal by Subject|3|||
23387746|NCT00079781|65165778|FG001|Follow-up Period|Withdrawal by Subject|0|||
23387747|NCT00079781|65165779|FG002|Follow-up Period|Withdrawal by Subject|1|||
23387748|NCT00079781|65165777|FG000|Follow-up Period|Lost to Follow-up|1|||
23387749|NCT00079781|65165778|FG001|Follow-up Period|Lost to Follow-up|0|||
23387750|NCT00079781|65165779|FG002|Follow-up Period|Lost to Follow-up|0|||
23387751|NCT00079781|65165777|FG000|Follow-up Period|Death|0|||
23387752|NCT00079781|65165778|FG001|Follow-up Period|Death|0|||
23387753|NCT00079781|65165779|FG002|Follow-up Period|Death|1|||
23387754|NCT02070380|65165780|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
23676082|NCT01978093|66194627|FG000|Overall Study|N/A for vaccine administration|0|||
23676083|NCT01978093|66194628|FG001|Overall Study|N/A for vaccine administration|1|||
23676084|NCT04142983|66194629|FG000|Overall Study|Lost to Follow-up|73|||
23676085|NCT04142983|66194629|FG000|Overall Study|Withdrawal by Subject|10|||
23387755|NCT02070380|65165781|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
23387756|NCT02070380|65165782|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
23676086|NCT04142983|66194629|FG000|Overall Study|Physician Decision|1|||
23676087|NCT04142983|66194629|FG000|Overall Study|Adverse Event|1|||
23676088|NCT04142983|66194629|FG000|Overall Study|No longer eligible|4|||
23387757|NCT02070380|65165783|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
23387758|NCT02070380|65165780|FG000|Second Injection|Image sets missing or technically inadeq|0|||
23387759|NCT02070380|65165781|FG001|Second Injection|Image sets missing or technically inadeq|1|||
23387760|NCT02070380|65165782|FG002|Second Injection|Image sets missing or technically inadeq|0|||
23387761|NCT02070380|65165783|FG003|Second Injection|Image sets missing or technically inadeq|0|||
23676089|NCT04142983|66194629|FG000|Overall Study|Screen Failure|10|||
23676090|NCT03891901|66194630|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
23387762|NCT02070380|65165780|FG000|Second Injection|Protocol Violation|0|||
23387763|NCT02070380|65165781|FG001|Second Injection|Protocol Violation|1|||
23387764|NCT02070380|65165782|FG002|Second Injection|Protocol Violation|1|||
23387765|NCT02070380|65165783|FG003|Second Injection|Protocol Violation|5|||
23387766|NCT01336972|65165787|FG000|Overall Study|Adverse Event|1|||
23387767|NCT01336972|65165788|FG001|Overall Study|Adverse Event|1|||
23387768|NCT01336972|65165789|FG002|Overall Study|Adverse Event|0|||
23387769|NCT03721107|65165791|FG000|Overall Study|Adverse Event|1|||
23387770|NCT03721107|65165792|FG001|Overall Study|Adverse Event|1|||
23387771|NCT03721107|65165793|FG002|Overall Study|Adverse Event|6|||
23387772|NCT03721107|65165794|FG003|Overall Study|Adverse Event|5|||
23387773|NCT03721107|65165791|FG000|Overall Study|Lost to Follow-up|2|||
23387774|NCT03721107|65165792|FG001|Overall Study|Lost to Follow-up|0|||
23387775|NCT03721107|65165793|FG002|Overall Study|Lost to Follow-up|3|||
23387776|NCT03721107|65165794|FG003|Overall Study|Lost to Follow-up|0|||
23387777|NCT03721107|65165791|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387778|NCT03721107|65165792|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387779|NCT03721107|65165793|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387780|NCT03721107|65165794|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
23387781|NCT03721107|65165791|FG000|Overall Study|Physician Decision|0|||
23387782|NCT03721107|65165792|FG001|Overall Study|Physician Decision|1|||
23387783|NCT03721107|65165793|FG002|Overall Study|Physician Decision|0|||
23387784|NCT03721107|65165794|FG003|Overall Study|Physician Decision|0|||
23387785|NCT03721107|65165791|FG000|Overall Study|Pregnancy|0|||
23387786|NCT03721107|65165792|FG001|Overall Study|Pregnancy|0|||
23387787|NCT03721107|65165793|FG002|Overall Study|Pregnancy|1|||
23387788|NCT03721107|65165794|FG003|Overall Study|Pregnancy|0|||
23387789|NCT03721107|65165791|FG000|Overall Study|Withdrawal by Subject|1|||
23387790|NCT03721107|65165792|FG001|Overall Study|Withdrawal by Subject|1|||
23387791|NCT03721107|65165793|FG002|Overall Study|Withdrawal by Subject|5|||
23387792|NCT03721107|65165794|FG003|Overall Study|Withdrawal by Subject|5|||
23387793|NCT03721107|65165791|FG000|Overall Study|Other|1|||
23387794|NCT03721107|65165792|FG001|Overall Study|Other|0|||
23387795|NCT03721107|65165793|FG002|Overall Study|Other|0|||
23387796|NCT03721107|65165794|FG003|Overall Study|Other|1|||
23387797|NCT03061214|65165795|FG000|Overall Study|Withdrawal by Subject|21|||
23387798|NCT03061214|65165796|FG001|Overall Study|Withdrawal by Subject|26|||
23387799|NCT03061214|65165797|FG002|Overall Study|Withdrawal by Subject|9|||
23387800|NCT03061214|65165795|FG000|Overall Study|Lost to Follow-up|3|||
23387801|NCT03061214|65165796|FG001|Overall Study|Lost to Follow-up|1|||
23387802|NCT03061214|65165797|FG002|Overall Study|Lost to Follow-up|1|||
23387803|NCT03061214|65165795|FG000|Overall Study|Death|1|||
23387804|NCT03061214|65165796|FG001|Overall Study|Death|1|||
23387805|NCT03061214|65165797|FG002|Overall Study|Death|0|||
23387806|NCT03518203|65165798|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
23387807|NCT03518203|65165798|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
23387808|NCT00561821|65165799|FG000|Overall Study|Not treated|0|||
23387809|NCT00561821|65165800|FG001|Overall Study|Not treated|0|||
23387810|NCT00561821|65165801|FG002|Overall Study|Not treated|1|||
23387811|NCT00561821|65165802|FG003|Overall Study|Not treated|0|||
23387812|NCT00561821|65165799|FG000|Overall Study|Withdrawal by Subject|0|||
23387813|NCT00561821|65165800|FG001|Overall Study|Withdrawal by Subject|1|||
23387814|NCT00561821|65165801|FG002|Overall Study|Withdrawal by Subject|0|||
23387815|NCT00561821|65165802|FG003|Overall Study|Withdrawal by Subject|2|||
23387816|NCT00561821|65165799|FG000|Overall Study|Reasons not related to trial|2|||
23387817|NCT00561821|65165800|FG001|Overall Study|Reasons not related to trial|1|||
23387818|NCT00561821|65165801|FG002|Overall Study|Reasons not related to trial|0|||
23387819|NCT00561821|65165802|FG003|Overall Study|Reasons not related to trial|0|||
23387820|NCT00561821|65165799|FG000|Overall Study|Other (reason not specified)|1|||
23387821|NCT00561821|65165800|FG001|Overall Study|Other (reason not specified)|1|||
23387822|NCT00561821|65165801|FG002|Overall Study|Other (reason not specified)|0|||
23387823|NCT00561821|65165802|FG003|Overall Study|Other (reason not specified)|0|||
23387824|NCT00561821|65165799|FG000|Overall Study|Adverse Event|2|||
23387825|NCT00561821|65165800|FG001|Overall Study|Adverse Event|3|||
23494329|NCT02095223|65554976|FG001|Overall Study|Withdrawal by Subject|0|||
23494330|NCT01914757|65554977|FG000|Overall Study|Severe non-compliance to protocol|3|||
23676091|NCT03891901|66194631|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23387826|NCT00561821|65165801|FG002|Overall Study|Adverse Event|1|||
23387827|NCT00561821|65165802|FG003|Overall Study|Adverse Event|1|||
23387828|NCT05029362|65165805|FG000|Overall Study|Lost to Follow-up|9|||
23387829|NCT00655356|65165808|FG000|Overall Study|Withdrawal by Subject|3|||
23387830|NCT00655356|65165809|FG001|Overall Study|Withdrawal by Subject|4|||
23387831|NCT00655356|65165808|FG000|Overall Study|Sponsor Request|10|||
23387832|NCT00655356|65165809|FG001|Overall Study|Sponsor Request|4|||
23387833|NCT00655356|65165808|FG000|Overall Study|Adverse Event|1|||
23387834|NCT00655356|65165809|FG001|Overall Study|Adverse Event|1|||
23387835|NCT00655356|65165808|FG000|Overall Study|Protocol Violation|2|||
23387836|NCT00655356|65165809|FG001|Overall Study|Protocol Violation|1|||
23387837|NCT00655356|65165808|FG000|Overall Study|Other Reason|1|||
23387838|NCT00655356|65165809|FG001|Overall Study|Other Reason|0|||
23676092|NCT03891901|66194632|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23676093|NCT03891901|66194633|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23387839|NCT01478087|65165810|FG000|Overall Study|due to sponsor closing study|1|||
23387840|NCT01529112|65165814|FG000|Overall Study|Adverse Event|2|||
23387841|NCT01529112|65165815|FG001|Overall Study|Adverse Event|0|||
23676094|NCT03891901|66194634|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23676095|NCT03891901|66194635|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23676096|NCT03891901|66194636|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23387842|NCT01529112|65165814|FG000|Overall Study|Death|59|||
23387843|NCT01529112|65165815|FG001|Overall Study|Death|38|||
23387844|NCT01529112|65165814|FG000|Overall Study|Protocol Violation|1|||
23387845|NCT01529112|65165815|FG001|Overall Study|Protocol Violation|0|||
23387846|NCT01529112|65165814|FG000|Overall Study|Withdrawal by Subject|7|||
23387847|NCT01529112|65165815|FG001|Overall Study|Withdrawal by Subject|3|||
23387848|NCT01502072|65165816|FG000|Overall Study|Withdrawal by Subject|1|||
23387849|NCT01502072|65165817|FG001|Overall Study|Withdrawal by Subject|0|||
23387850|NCT01502072|65165818|FG002|Overall Study|Withdrawal by Subject|0|||
23387851|NCT01502072|65165816|FG000|Overall Study|Death|0|||
23387852|NCT01502072|65165817|FG001|Overall Study|Death|1|||
23387853|NCT01502072|65165818|FG002|Overall Study|Death|0|||
23387854|NCT00420407|65165819|FG000|Overall Study|Lost to Follow-up|0|||
23387855|NCT00420407|65165820|FG001|Overall Study|Lost to Follow-up|3|||
23387856|NCT00420407|65165819|FG000|Overall Study|Physician Decision|2|||
23387857|NCT00420407|65165820|FG001|Overall Study|Physician Decision|1|||
23387858|NCT00420407|65165819|FG000|Overall Study|subject identified as detainee|1|||
23387859|NCT00420407|65165820|FG001|Overall Study|subject identified as detainee|0|||
23387860|NCT00420407|65165819|FG000|Overall Study|subject identified as Jehovah's witness|1|||
23387861|NCT00420407|65165820|FG001|Overall Study|subject identified as Jehovah's witness|0|||
23387862|NCT00420407|65165819|FG000|Overall Study|Withdrawal by Subject|0|||
23387863|NCT00420407|65165820|FG001|Overall Study|Withdrawal by Subject|2|||
23387864|NCT02181621|65165821|FG000|Overall Study|Adverse Event|1|||
23387865|NCT02181621|65165822|FG001|Overall Study|Adverse Event|0|||
23387866|NCT02181621|65165821|FG000|Overall Study|Previously Enrolled|0|||
23387867|NCT02181621|65165822|FG001|Overall Study|Previously Enrolled|1|||
23387868|NCT02181621|65165821|FG000|Overall Study|Enrollment Hold|1|||
23387869|NCT02181621|65165822|FG001|Overall Study|Enrollment Hold|1|||
23387870|NCT00960856|65165823|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387871|NCT00960856|65165824|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23387872|NCT00960856|65165825|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387873|NCT00960856|65165826|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387874|NCT00960856|65165823|FG000|Washout Period of 7 Days|Adverse Event|0|||
23387875|NCT00960856|65165824|FG001|Washout Period of 7 Days|Adverse Event|0|||
23387876|NCT00960856|65165825|FG002|Washout Period of 7 Days|Adverse Event|1|||
23387877|NCT00960856|65165826|FG003|Washout Period of 7 Days|Adverse Event|0|||
23387878|NCT01423084|65165830|FG000|Overall Study|Adverse Event|0|||
23387879|NCT01423084|65165831|FG001|Overall Study|Adverse Event|1|||
23676097|NCT03891901|66194637|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23676098|NCT03891901|66194638|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23676099|NCT03891901|66194630|FG000|Overall Study|Adverse Event|2|||
23676100|NCT03891901|66194631|FG001|Overall Study|Adverse Event|2|||
23676101|NCT03891901|66194632|FG002|Overall Study|Adverse Event|0|||
23676102|NCT03891901|66194633|FG003|Overall Study|Adverse Event|0|||
23676103|NCT03891901|66194634|FG004|Overall Study|Adverse Event|0|||
23676104|NCT03891901|66194635|FG005|Overall Study|Adverse Event|0|||
23676105|NCT03891901|66194636|FG006|Overall Study|Adverse Event|0|||
23676106|NCT03891901|66194637|FG007|Overall Study|Adverse Event|0|||
23676107|NCT03891901|66194638|FG008|Overall Study|Adverse Event|0|||
23676108|NCT03891901|66194630|FG000|Overall Study|Poor venous access|1|||
23676109|NCT03891901|66194631|FG001|Overall Study|Poor venous access|0|||
23676110|NCT03891901|66194632|FG002|Overall Study|Poor venous access|0|||
23676111|NCT03891901|66194633|FG003|Overall Study|Poor venous access|0|||
23676112|NCT03891901|66194634|FG004|Overall Study|Poor venous access|0|||
23676113|NCT03891901|66194635|FG005|Overall Study|Poor venous access|0|||
23676114|NCT03891901|66194636|FG006|Overall Study|Poor venous access|0|||
23387880|NCT01423084|65165830|FG000|Overall Study|Withdrawal by Subject|2|||
23387881|NCT01423084|65165831|FG001|Overall Study|Withdrawal by Subject|3|||
23387882|NCT04821245|65165834|FG000|Overall Study|Withdrawal by Subject|3|||
23387883|NCT04821245|65165834|FG000|Overall Study|Physician Decision|1|||
23387884|NCT04821245|65165834|FG000|Overall Study|Protocol Violation|5|||
23387885|NCT03280615|65165835|FG000|Overall Study|Lost to Follow-up|1|||
23387886|NCT03280615|65165836|FG001|Overall Study|Lost to Follow-up|2|||
23387887|NCT03280615|65165835|FG000|Overall Study|Adverse Event|1|||
23387888|NCT03280615|65165836|FG001|Overall Study|Adverse Event|1|||
23387889|NCT03280615|65165835|FG000|Overall Study|Withdrawal by Subject|2|||
23387890|NCT03280615|65165836|FG001|Overall Study|Withdrawal by Subject|2|||
23387891|NCT04223687|65165847|FG000|Overall Study|Missing primary outcome|1|||
23387892|NCT04223687|65165848|FG001|Overall Study|Missing primary outcome|0|||
23387893|NCT01682720|65165855|FG000|Overall Study|Randomized but Not Treated|0|||
23387894|NCT01682720|65165856|FG001|Overall Study|Randomized but Not Treated|1|||
23387895|NCT01682720|65165857|FG002|Overall Study|Randomized but Not Treated|1|||
23387896|NCT01682720|65165858|FG003|Overall Study|Randomized but Not Treated|0|||
23387897|NCT01682720|65165855|FG000|Overall Study|Terminated by Sponsor|83|||
23387898|NCT01682720|65165856|FG001|Overall Study|Terminated by Sponsor|0|||
23387899|NCT01682720|65165857|FG002|Overall Study|Terminated by Sponsor|0|||
23387900|NCT01682720|65165858|FG003|Overall Study|Terminated by Sponsor|0|||
23387901|NCT01682720|65165855|FG000|Overall Study|Efficacy Failure|0|||
23387902|NCT01682720|65165856|FG001|Overall Study|Efficacy Failure|3|||
23387903|NCT01682720|65165857|FG002|Overall Study|Efficacy Failure|3|||
23387904|NCT01682720|65165858|FG003|Overall Study|Efficacy Failure|30|||
23387905|NCT01682720|65165855|FG000|Overall Study|Lost to Follow-up|1|||
23387906|NCT01682720|65165856|FG001|Overall Study|Lost to Follow-up|1|||
23387907|NCT01682720|65165857|FG002|Overall Study|Lost to Follow-up|0|||
23387908|NCT01682720|65165858|FG003|Overall Study|Lost to Follow-up|6|||
23387909|NCT01682720|65165855|FG000|Overall Study|Subject Withdrew Consent|0|||
23387910|NCT01682720|65165856|FG001|Overall Study|Subject Withdrew Consent|0|||
23387911|NCT01682720|65165857|FG002|Overall Study|Subject Withdrew Consent|2|||
23387912|NCT01682720|65165858|FG003|Overall Study|Subject Withdrew Consent|2|||
23387913|NCT01682720|65165855|FG000|Overall Study|Adverse Event|1|||
23387914|NCT01682720|65165856|FG001|Overall Study|Adverse Event|0|||
23387915|NCT01682720|65165857|FG002|Overall Study|Adverse Event|1|||
23387916|NCT01682720|65165858|FG003|Overall Study|Adverse Event|1|||
23387917|NCT00225758|65165859|FG000|Overall Study|Adverse Event|4|||
23387918|NCT03438656|65165861|FG000|Overall Study|Lost to Follow-up|2|||
23387919|NCT04621786|65165863|FG000|Overall Study|Lost to Follow-up|9|||
23387920|NCT04621786|65165863|FG000|Overall Study|Protocol Violation|3|||
23387921|NCT00378560|65165864|FG000|Overall Study|Adverse Event|1|||
23387922|NCT00378560|65165865|FG001|Overall Study|Adverse Event|0|||
23387923|NCT00378560|65165864|FG000|Overall Study|Lost to Follow-up|24|||
23387924|NCT00378560|65165865|FG001|Overall Study|Lost to Follow-up|29|||
23387925|NCT00378560|65165864|FG000|Overall Study|Protocol Violation|2|||
23387926|NCT00378560|65165865|FG001|Overall Study|Protocol Violation|0|||
23387927|NCT00378560|65165864|FG000|Overall Study|Withdrawal by Subject|17|||
23387928|NCT00378560|65165865|FG001|Overall Study|Withdrawal by Subject|21|||
23676115|NCT03891901|66194637|FG007|Overall Study|Poor venous access|0|||
23387929|NCT00378560|65165864|FG000|Overall Study|Moved|4|||
23387930|NCT00378560|65165865|FG001|Overall Study|Moved|3|||
23387931|NCT00378560|65165864|FG000|Overall Study|Pregnancy|7|||
23387932|NCT00378560|65165865|FG001|Overall Study|Pregnancy|5|||
23387933|NCT00378560|65165864|FG000|Overall Study|Laboratory test values abnormal|1|||
23387934|NCT00378560|65165865|FG001|Overall Study|Laboratory test values abnormal|0|||
23387935|NCT01433978|65165866|FG000|Core Study|Adverse Event, Non-Fatal|0|||
23387936|NCT01433978|65165867|FG001|Core Study|Adverse Event, Non-Fatal|1|||
23387937|NCT01433978|65165868|FG002|Core Study|Adverse Event, Non-Fatal|0|||
23387938|NCT01433978|65165866|FG000|Core Study|Lack of Efficacy|5|||
23387939|NCT01433978|65165867|FG001|Core Study|Lack of Efficacy|1|||
23387940|NCT01433978|65165868|FG002|Core Study|Lack of Efficacy|0|||
23387941|NCT01433978|65165866|FG000|Core Study|Study Terminated by Sponsor|6|||
23387942|NCT01433978|65165867|FG001|Core Study|Study Terminated by Sponsor|9|||
23387943|NCT01433978|65165868|FG002|Core Study|Study Terminated by Sponsor|0|||
23387944|NCT01433978|65165866|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
23387945|NCT01433978|65165867|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
23387946|NCT01433978|65165868|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
23387947|NCT01433978|65165866|FG000|Extension Phase|Lack of Efficacy|0|||
23387948|NCT01433978|65165867|FG001|Extension Phase|Lack of Efficacy|0|||
23387949|NCT01433978|65165868|FG002|Extension Phase|Lack of Efficacy|1|||
23387950|NCT01433978|65165866|FG000|Extension Phase|Study Terminated by Sponsor|0|||
23387951|NCT01433978|65165867|FG001|Extension Phase|Study Terminated by Sponsor|0|||
23387952|NCT01433978|65165868|FG002|Extension Phase|Study Terminated by Sponsor|4|||
23387953|NCT02514746|65165869|FG000|Overall Study|Chronically Ill|1|||
23387954|NCT02514746|65165870|FG001|Overall Study|Chronically Ill|2|||
23387955|NCT02514746|65165869|FG000|Overall Study|Physician Decision|4|||
23387956|NCT02514746|65165870|FG001|Overall Study|Physician Decision|2|||
23387957|NCT02514746|65165869|FG000|Overall Study|Withdrawal by Subject|12|||
23387958|NCT02514746|65165870|FG001|Overall Study|Withdrawal by Subject|10|||
23387959|NCT02514746|65165869|FG000|Overall Study|Other|5|||
23387960|NCT02514746|65165870|FG001|Overall Study|Other|1|||
23387961|NCT01691092|65165871|FG000|Overall Study|Lost to Follow-up|10|||
23387962|NCT01691092|65165871|FG000|Overall Study|Physician Decision|4|||
23387963|NCT01691092|65165871|FG000|Overall Study|Withdrawal by Subject|3|||
23387964|NCT01691092|65165871|FG000|Overall Study|non-compliance|3|||
23387965|NCT01691092|65165871|FG000|Overall Study|used for different study|2|||
23387966|NCT01691092|65165871|FG000|Overall Study|screen fail|19|||
23387967|NCT01975285|65165872|FG000|Overall Study|Failed Block and follow up|2|||
23387968|NCT01975285|65165873|FG001|Overall Study|Failed Block and follow up|2|||
23387969|NCT01210443|65165874|FG000|Overall Study|Study terminated by sponsor|2|||
23387970|NCT01061710|65165881|FG000|Overall Study|Protocol Violation|14|||
23387971|NCT04076579|65165882|FG000|Overall Study|Adverse Event|2|||
23387972|NCT04076579|65165883|FG001|Overall Study|Adverse Event|0|||
23387973|NCT04076579|65165882|FG000|Overall Study|discontinued due to toxicity|1|||
23387974|NCT04076579|65165883|FG001|Overall Study|discontinued due to toxicity|0|||
23387975|NCT04076579|65165882|FG000|Overall Study|Physician Decision|1|||
23387976|NCT04076579|65165883|FG001|Overall Study|Physician Decision|0|||
23387977|NCT04076579|65165882|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
23387978|NCT04076579|65165883|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
23387979|NCT04076579|65165882|FG000|Overall Study|Noncompliance|0|||
23387980|NCT04076579|65165883|FG001|Overall Study|Noncompliance|1|||
23387981|NCT04076579|65165882|FG000|Overall Study|Withdrawal by Subject|0|||
23387982|NCT04076579|65165883|FG001|Overall Study|Withdrawal by Subject|2|||
23387983|NCT01827943|65165884|FG000|Overall Study|Protocol Violation|8|||
23387984|NCT01827943|65165884|FG000|Overall Study|Never treated because of an rapid progression|1|||
23387985|NCT00276380|65165885|FG000|Overall Study|Adverse Event|5|||
23676116|NCT03891901|66194638|FG008|Overall Study|Poor venous access|0|||
23387986|NCT00276380|65165886|FG001|Overall Study|Adverse Event|3|||
23387987|NCT00276380|65165885|FG000|Overall Study|Lost to Follow-up|1|||
23387988|NCT00276380|65165886|FG001|Overall Study|Lost to Follow-up|1|||
23387989|NCT00276380|65165885|FG000|Overall Study|Withdrawal by Subject|3|||
23387990|NCT00276380|65165886|FG001|Overall Study|Withdrawal by Subject|6|||
23387991|NCT00276380|65165885|FG000|Overall Study|Death|5|||
23387992|NCT00276380|65165886|FG001|Overall Study|Death|3|||
23387993|NCT00276380|65165885|FG000|Overall Study|Abnormal aPPT Levels|0|||
23387994|NCT00276380|65165886|FG001|Overall Study|Abnormal aPPT Levels|1|||
23387995|NCT04146909|65165887|FG000|Overall Study|Withdrawal by Subject|3|||
23387996|NCT04146909|65165887|FG000|Overall Study|Did not qualify after consented|1|||
23387997|NCT00621322|65165888|FG000|Overall Study|Lost to Follow-up|0|||
23387998|NCT00621322|65165889|FG001|Overall Study|Lost to Follow-up|0|||
23387999|NCT00621322|65165890|FG002|Overall Study|Lost to Follow-up|0|||
23388000|NCT00621322|65165891|FG003|Overall Study|Lost to Follow-up|0|||
23388001|NCT00621322|65165892|FG004|Overall Study|Lost to Follow-up|1|||
23388002|NCT00621322|65165893|FG005|Overall Study|Lost to Follow-up|0|||
23388003|NCT00621322|65165888|FG000|Overall Study|Physician Decision|0|||
23388004|NCT00621322|65165889|FG001|Overall Study|Physician Decision|0|||
23388005|NCT00621322|65165890|FG002|Overall Study|Physician Decision|1|||
23388006|NCT00621322|65165891|FG003|Overall Study|Physician Decision|1|||
23388007|NCT00621322|65165892|FG004|Overall Study|Physician Decision|0|||
23388008|NCT00621322|65165893|FG005|Overall Study|Physician Decision|0|||
23388009|NCT00621322|65165888|FG000|Overall Study|Withdrawal by Subject|0|||
23388010|NCT00621322|65165889|FG001|Overall Study|Withdrawal by Subject|0|||
23388011|NCT00621322|65165890|FG002|Overall Study|Withdrawal by Subject|0|||
23388012|NCT00621322|65165891|FG003|Overall Study|Withdrawal by Subject|1|||
23388013|NCT00621322|65165892|FG004|Overall Study|Withdrawal by Subject|0|||
23388014|NCT00621322|65165893|FG005|Overall Study|Withdrawal by Subject|2|||
23388015|NCT00621322|65165888|FG000|Overall Study|Migrated/moved from study area|1|||
23388016|NCT00621322|65165889|FG001|Overall Study|Migrated/moved from study area|0|||
23388017|NCT00621322|65165890|FG002|Overall Study|Migrated/moved from study area|1|||
23388018|NCT00621322|65165891|FG003|Overall Study|Migrated/moved from study area|1|||
23388019|NCT00621322|65165892|FG004|Overall Study|Migrated/moved from study area|0|||
23388020|NCT00621322|65165893|FG005|Overall Study|Migrated/moved from study area|2|||
23388021|NCT00625378|65165894|FG000|Overall Study|Adverse Event|22|||
23388022|NCT00625378|65165895|FG001|Overall Study|Adverse Event|0|||
23388023|NCT00625378|65165894|FG000|Overall Study|Withdrawal by Subject|16|||
23388024|NCT00625378|65165895|FG001|Overall Study|Withdrawal by Subject|0|||
23388025|NCT00625378|65165894|FG000|Overall Study|Death|38|||
23388026|NCT00625378|65165895|FG001|Overall Study|Death|0|||
23388027|NCT00625378|65165894|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
23388028|NCT00625378|65165895|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
23388029|NCT00625378|65165894|FG000|Overall Study|Lost to Follow-up|17|||
23388030|NCT00625378|65165895|FG001|Overall Study|Lost to Follow-up|0|||
23388031|NCT00625378|65165894|FG000|Overall Study|Non-compliant with study medication|3|||
23388032|NCT00625378|65165895|FG001|Overall Study|Non-compliant with study medication|0|||
23388033|NCT00625378|65165894|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
23388034|NCT00625378|65165895|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
23388035|NCT00625378|65165894|FG000|Overall Study|Medical decision|1|||
23388036|NCT00625378|65165895|FG001|Overall Study|Medical decision|0|||
23388037|NCT00625378|65165894|FG000|Overall Study|Multiple toxicities|1|||
23388038|NCT00625378|65165895|FG001|Overall Study|Multiple toxicities|0|||
23388039|NCT00625378|65165894|FG000|Overall Study|New cancer|1|||
23388040|NCT00625378|65165895|FG001|Overall Study|New cancer|0|||
23388041|NCT00625378|65165894|FG000|Overall Study|PTA program|2|||
23388042|NCT00625378|65165895|FG001|Overall Study|PTA program|0|||
23388043|NCT00625378|65165894|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
23388044|NCT00625378|65165895|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
23676117|NCT03891901|66194630|FG000|Overall Study|Withdrawal by Subject|0|||
23388045|NCT00625378|65165894|FG000|Overall Study|Sponsor decision|1|||
23676118|NCT03891901|66194631|FG001|Overall Study|Withdrawal by Subject|2|||
23676119|NCT03891901|66194632|FG002|Overall Study|Withdrawal by Subject|0|||
23676120|NCT03891901|66194633|FG003|Overall Study|Withdrawal by Subject|0|||
23676121|NCT03891901|66194634|FG004|Overall Study|Withdrawal by Subject|0|||
23676122|NCT03891901|66194635|FG005|Overall Study|Withdrawal by Subject|0|||
23676123|NCT03891901|66194636|FG006|Overall Study|Withdrawal by Subject|0|||
23676124|NCT03891901|66194637|FG007|Overall Study|Withdrawal by Subject|0|||
23676125|NCT03891901|66194638|FG008|Overall Study|Withdrawal by Subject|0|||
23676126|NCT02531646|66194639|FG000|Overall Study|equip. image processing issue|5|||
23676127|NCT02531646|66194640|FG001|Overall Study|equip. image processing issue|1|||
23676128|NCT02531646|66194641|FG002|Overall Study|equip. image processing issue|0|||
23676129|NCT00763139|66194642|FG000|Overall Study|Adverse Event|4|||
23676130|NCT00763139|66194643|FG001|Overall Study|Adverse Event|2|||
23676131|NCT00763139|66194642|FG000|Overall Study|Withdrawal by Subject|0|||
23676132|NCT00763139|66194643|FG001|Overall Study|Withdrawal by Subject|1|||
23676133|NCT00763139|66194642|FG000|Overall Study|med change not allowed by protocol|1|||
23676134|NCT00763139|66194643|FG001|Overall Study|med change not allowed by protocol|0|||
23676135|NCT01789970|66194644|FG000|Open-label Titration Period|Adverse Event|68|||
23676136|NCT01789970|66194645|FG001|Open-label Titration Period|Adverse Event|0|||
23676137|NCT01789970|66194646|FG002|Open-label Titration Period|Adverse Event|0|||
23676138|NCT01789970|66194644|FG000|Open-label Titration Period|Lack of Efficacy|31|||
23676139|NCT01789970|66194645|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23676140|NCT01789970|66194646|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23676141|NCT01789970|66194644|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
23676142|NCT01789970|66194645|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23676143|NCT01789970|66194646|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23676144|NCT01789970|66194644|FG000|Open-label Titration Period|Protocol Violation|18|||
23676145|NCT01789970|66194645|FG001|Open-label Titration Period|Protocol Violation|0|||
23676146|NCT01789970|66194646|FG002|Open-label Titration Period|Protocol Violation|0|||
23676147|NCT01789970|66194644|FG000|Open-label Titration Period|Lost to Follow-up|5|||
23676148|NCT01789970|66194645|FG001|Open-label Titration Period|Lost to Follow-up|0|||
23676149|NCT01789970|66194646|FG002|Open-label Titration Period|Lost to Follow-up|0|||
23676150|NCT01789970|66194644|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
23676151|NCT01789970|66194645|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
23676152|NCT01789970|66194646|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
23676153|NCT01789970|66194644|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
23676154|NCT01789970|66194645|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
23676155|NCT01789970|66194646|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
23676156|NCT01789970|66194644|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
23676157|NCT01789970|66194645|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
23676158|NCT01789970|66194646|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
23676159|NCT01789970|66194644|FG000|Open-label Titration Period|Pregnancy|2|||
23676160|NCT01789970|66194645|FG001|Open-label Titration Period|Pregnancy|0|||
23676161|NCT01789970|66194646|FG002|Open-label Titration Period|Pregnancy|0|||
23676162|NCT01789970|66194644|FG000|Open-label Titration Period|Other|76|||
23676163|NCT01789970|66194645|FG001|Open-label Titration Period|Other|0|||
23676164|NCT01789970|66194646|FG002|Open-label Titration Period|Other|0|||
23676165|NCT01789970|66194644|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
23676166|NCT01789970|66194645|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
23676167|NCT01789970|66194646|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
23676168|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
23676169|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
23388046|NCT00625378|65165895|FG001|Overall Study|Sponsor decision|0|||
23388047|NCT00625378|65165894|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
23388048|NCT00625378|65165895|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
23388049|NCT00625378|65165894|FG000|Overall Study|Switch to commercial drug|6|||
23388050|NCT00625378|65165895|FG001|Overall Study|Switch to commercial drug|1|||
23388051|NCT00625378|65165894|FG000|Overall Study|Missing|2|||
23676170|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
23676171|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23676172|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
23676173|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
23676174|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23676175|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
23676176|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
23676177|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
23388052|NCT00625378|65165895|FG001|Overall Study|Missing|0|||
23676178|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
23494331|NCT01914757|65554978|FG001|Overall Study|Severe non-compliance to protocol|1|||
23494332|NCT01914757|65554979|FG002|Overall Study|Severe non-compliance to protocol|2|||
23494333|NCT01914757|65554977|FG000|Overall Study|Lost to Follow-up|5|||
23676179|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
23676180|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
23676181|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
23676182|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
23676183|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
23676184|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
23676185|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
23676186|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23676187|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23676188|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
23676189|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
23676190|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
23676191|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
23676192|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
23676193|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
23676194|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
23676195|NCT01789970|66194644|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
23676196|NCT01789970|66194645|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
23494334|NCT01914757|65554978|FG001|Overall Study|Lost to Follow-up|8|||
23494335|NCT01914757|65554979|FG002|Overall Study|Lost to Follow-up|6|||
23494336|NCT01914757|65554977|FG000|Overall Study|Withdrawal by Subject|15|||
23676197|NCT01789970|66194646|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
23676198|NCT02437162|66194647|FG000|Overall Study|Protocol Violation|0|||
23676199|NCT02437162|66194648|FG001|Overall Study|Protocol Violation|1|||
23676200|NCT02437162|66194649|FG002|Overall Study|Protocol Violation|0|||
23676201|NCT02437162|66194647|FG000|Overall Study|Randomized but not treated|0|||
23676202|NCT02437162|66194648|FG001|Overall Study|Randomized but not treated|0|||
23676203|NCT02437162|66194649|FG002|Overall Study|Randomized but not treated|1|||
23676204|NCT02437162|66194647|FG000|Overall Study|Study discontinued by Sponsor|93|||
23676205|NCT02437162|66194648|FG001|Overall Study|Study discontinued by Sponsor|98|||
23676206|NCT02437162|66194649|FG002|Overall Study|Study discontinued by Sponsor|97|||
23676207|NCT02437162|66194647|FG000|Overall Study|Withdrawal by Subject|13|||
23676208|NCT02437162|66194648|FG001|Overall Study|Withdrawal by Subject|7|||
23676209|NCT02437162|66194649|FG002|Overall Study|Withdrawal by Subject|9|||
23676210|NCT02437162|66194647|FG000|Overall Study|Adverse Event|0|||
23676211|NCT02437162|66194648|FG001|Overall Study|Adverse Event|1|||
23676212|NCT02437162|66194649|FG002|Overall Study|Adverse Event|0|||
23676213|NCT02437162|66194647|FG000|Overall Study|Lost to Follow-up|1|||
23388053|NCT00625378|65165894|FG000|Overall Study|End of treatment not available|2|||
23388054|NCT00625378|65165895|FG001|Overall Study|End of treatment not available|0|||
23494337|NCT01914757|65554978|FG001|Overall Study|Withdrawal by Subject|27|||
23494338|NCT01914757|65554979|FG002|Overall Study|Withdrawal by Subject|19|||
23676214|NCT02437162|66194648|FG001|Overall Study|Lost to Follow-up|0|||
23676215|NCT02437162|66194649|FG002|Overall Study|Lost to Follow-up|1|||
23494339|NCT01914757|65554977|FG000|Overall Study|Death|2|||
23388055|NCT00625378|65165894|FG000|Overall Study|Never treated|2|||
23388056|NCT00625378|65165895|FG001|Overall Study|Never treated|0|||
23388057|NCT01654250|65165896|FG000|Overall Study|Lost to Follow-up|1|||
23388058|NCT01654250|65165897|FG001|Overall Study|Lost to Follow-up|0|||
23388059|NCT01259024|65165898|FG000|Overall Study|Physician Decision|1|||
23388060|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
23388061|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
23388062|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
23388063|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
23388064|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
23388065|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
23388066|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
23388067|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
23388068|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
23388069|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
23388070|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
23388071|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
23388072|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
23388073|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
23388074|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
23388075|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
23388076|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
23388077|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
23388078|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23388079|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
23388080|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
23388081|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
23388082|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
23388083|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
23388084|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
23388085|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
23388086|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
23388087|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23388088|NCT01862029|65165904|FG000|Overall Study|Physician Decision|1|||
23388089|NCT03378635|65165907|FG000|Overall Study|Adverse Event|1|||
23388090|NCT03378635|65165908|FG001|Overall Study|Adverse Event|0|||
23388091|NCT03378635|65165909|FG002|Overall Study|Adverse Event|0|||
23388092|NCT03378635|65165907|FG000|Overall Study|Withdrawal by Subject|1|||
23388093|NCT03378635|65165908|FG001|Overall Study|Withdrawal by Subject|0|||
23388094|NCT03378635|65165909|FG002|Overall Study|Withdrawal by Subject|0|||
23388095|NCT03253627|65165936|FG000|Overall Study|Lost to Follow-up|1|||
23388096|NCT03253627|65165937|FG001|Overall Study|Lost to Follow-up|2|||
23388097|NCT03253627|65165936|FG000|Overall Study|Withdrawal by Subject|0|||
23676216|NCT02437162|66194647|FG000|Overall Study|Death|0|||
23676217|NCT02437162|66194648|FG001|Overall Study|Death|1|||
23388098|NCT03253627|65165937|FG001|Overall Study|Withdrawal by Subject|2|||
23494340|NCT01914757|65554978|FG001|Overall Study|Death|2|||
23676218|NCT02437162|66194649|FG002|Overall Study|Death|0|||
23494341|NCT01914757|65554979|FG002|Overall Study|Death|1|||
23388099|NCT03253627|65165936|FG000|Overall Study|Inability to complete MRI|1|||
23388100|NCT03253627|65165937|FG001|Overall Study|Inability to complete MRI|0|||
23388101|NCT02773537|65165938|FG000|Overall Study|Lost to Follow-up|0|||
23388102|NCT02773537|65165939|FG001|Overall Study|Lost to Follow-up|1|||
23388103|NCT02773537|65165940|FG002|Overall Study|Lost to Follow-up|4|||
23676219|NCT02437162|66194647|FG000|Overall Study|Other|0|||
23388104|NCT00395447|65165942|FG000|Overall Study|Death|37|||
23388105|NCT00395447|65165943|FG001|Overall Study|Death|32|||
23388106|NCT00395447|65165942|FG000|Overall Study|Lost to Follow-up|52|||
23388107|NCT00395447|65165943|FG001|Overall Study|Lost to Follow-up|43|||
23388108|NCT00395447|65165942|FG000|Overall Study|Withdrawal by Subject|24|||
23388109|NCT00395447|65165943|FG001|Overall Study|Withdrawal by Subject|19|||
23676220|NCT02437162|66194648|FG001|Overall Study|Other|0|||
23676221|NCT02437162|66194649|FG002|Overall Study|Other|1|||
23676222|NCT00848354|66194650|FG000|Phase 1|Adverse Event|5|||
23388110|NCT00395447|65165942|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
23388111|NCT00395447|65165943|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
23388112|NCT03211858|65165944|FG000|Overall Study|Adverse Event|8|||
23388113|NCT03211858|65165945|FG001|Overall Study|Adverse Event|6|||
23388114|NCT03211858|65165944|FG000|Overall Study|Lack of Efficacy|0|||
23388115|NCT03211858|65165945|FG001|Overall Study|Lack of Efficacy|4|||
23388116|NCT03211858|65165944|FG000|Overall Study|Poor compliance to protocol|6|||
23388117|NCT03211858|65165945|FG001|Overall Study|Poor compliance to protocol|2|||
23388118|NCT03211858|65165944|FG000|Overall Study|Non-serious Hypoglycemia|1|||
23388119|NCT03211858|65165945|FG001|Overall Study|Non-serious Hypoglycemia|0|||
23388120|NCT03211858|65165944|FG000|Overall Study|Other than specified above|22|||
23388121|NCT03211858|65165945|FG001|Overall Study|Other than specified above|21|||
23388122|NCT02769481|65165946|FG000|Overall Study|Protocol Violation|1|||
23388123|NCT02769481|65165947|FG001|Overall Study|Protocol Violation|0|||
23388124|NCT02769481|65165946|FG000|Overall Study|Adverse Event|3|||
23388125|NCT02769481|65165947|FG001|Overall Study|Adverse Event|6|||
23388126|NCT02769481|65165946|FG000|Overall Study|Entry Criteria Not Met|1|||
23388127|NCT02769481|65165947|FG001|Overall Study|Entry Criteria Not Met|2|||
23388128|NCT02769481|65165946|FG000|Overall Study|Withdrawal by Subject|14|||
23388129|NCT02769481|65165947|FG001|Overall Study|Withdrawal by Subject|16|||
23388130|NCT02769481|65165946|FG000|Overall Study|Lost to Follow-up|9|||
23388131|NCT02769481|65165947|FG001|Overall Study|Lost to Follow-up|9|||
23388132|NCT02769481|65165946|FG000|Overall Study|Physician Decision|0|||
23388133|NCT02769481|65165947|FG001|Overall Study|Physician Decision|1|||
23388134|NCT02769481|65165946|FG000|Overall Study|Terminated by Sponsor|1|||
23388135|NCT02769481|65165947|FG001|Overall Study|Terminated by Sponsor|0|||
23388136|NCT02769481|65165946|FG000|Overall Study|Death|0|||
23388137|NCT02769481|65165947|FG001|Overall Study|Death|1|||
23388138|NCT02769481|65165946|FG000|Overall Study|Undefined|4|||
23388139|NCT02769481|65165947|FG001|Overall Study|Undefined|1|||
23388140|NCT00420056|65165948|FG000|Overall Study|Objective progression or relapse|17|||
23388141|NCT01748552|65165949|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
23388142|NCT01748552|65165950|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
23388143|NCT01748552|65165951|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
23388144|NCT01748552|65165952|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
23388145|NCT01748552|65165953|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
23388146|NCT01748552|65165954|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
23494342|NCT01914757|65554977|FG000|Overall Study|Adverse Event|4|||
23494343|NCT01914757|65554978|FG001|Overall Study|Adverse Event|3|||
23494344|NCT01914757|65554979|FG002|Overall Study|Adverse Event|4|||
23494345|NCT01914757|65554977|FG000|Overall Study|Study specific withdrawal criteria|0|||
23494346|NCT01914757|65554978|FG001|Overall Study|Study specific withdrawal criteria|1|||
23494347|NCT01914757|65554979|FG002|Overall Study|Study specific withdrawal criteria|0|||
23494348|NCT01914757|65554977|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23494349|NCT01914757|65554978|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23388147|NCT01748552|65165955|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
23388148|NCT01748552|65165956|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
23494350|NCT01914757|65554979|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23494351|NCT01914757|65554977|FG000|Overall Study|Other reasons|5|||
23494352|NCT01914757|65554978|FG001|Overall Study|Other reasons|9|||
23494353|NCT01914757|65554979|FG002|Overall Study|Other reasons|4|||
23494354|NCT04218695|65554980|FG000|Overall Study|Adverse Event|1|||
23494355|NCT04218695|65554981|FG001|Overall Study|Adverse Event|0|||
23676223|NCT00848354|66194651|FG001|Phase 1|Adverse Event|4|||
23676224|NCT00848354|66194650|FG000|Phase 1|Discontinuation of study by sponsor|2|||
23494356|NCT00347360|65554982|FG000|Overall Study|Adverse Event|1|||
23676225|NCT00848354|66194651|FG001|Phase 1|Discontinuation of study by sponsor|1|||
23676226|NCT00848354|66194650|FG000|Phase 1|Failed to return|0|||
23676227|NCT00848354|66194651|FG001|Phase 1|Failed to return|1|||
23676228|NCT00848354|66194650|FG000|Phase 1|Lost to Follow-up|1|||
23676229|NCT00848354|66194651|FG001|Phase 1|Lost to Follow-up|1|||
23676230|NCT00848354|66194650|FG000|Phase 1|Unspecified Reason|1|||
23388149|NCT01748552|65165957|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
23494357|NCT00347360|65554983|FG001|Overall Study|Adverse Event|2|||
23676231|NCT00848354|66194651|FG001|Phase 1|Unspecified Reason|1|||
23388150|NCT01748552|65165958|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
23676232|NCT00848354|66194650|FG000|Phase 1|Protocol Violation|1|||
23676233|NCT00848354|66194651|FG001|Phase 1|Protocol Violation|1|||
23494358|NCT00347360|65554984|FG002|Overall Study|Adverse Event|0|||
23494359|NCT00347360|65554985|FG003|Overall Study|Adverse Event|4|||
23494360|NCT00347360|65554986|FG004|Overall Study|Adverse Event|1|||
23494361|NCT00347360|65554987|FG005|Overall Study|Adverse Event|2|||
23494362|NCT00347360|65554988|FG006|Overall Study|Adverse Event|2|||
23494363|NCT00347360|65554989|FG007|Overall Study|Adverse Event|0|||
23494364|NCT00347360|65554990|FG008|Overall Study|Adverse Event|2|||
23494365|NCT00347360|65554991|FG009|Overall Study|Adverse Event|3|||
23494366|NCT00347360|65554992|FG010|Overall Study|Adverse Event|3|||
23494367|NCT00347360|65554993|FG011|Overall Study|Adverse Event|1|||
23494368|NCT00347360|65554994|FG012|Overall Study|Adverse Event|3|||
23494369|NCT00347360|65554995|FG013|Overall Study|Adverse Event|2|||
23494370|NCT00347360|65554996|FG014|Overall Study|Adverse Event|2|||
23494371|NCT00347360|65554982|FG000|Overall Study|Lost to Follow-up|0|||
23494372|NCT00347360|65554983|FG001|Overall Study|Lost to Follow-up|0|||
23494373|NCT00347360|65554984|FG002|Overall Study|Lost to Follow-up|0|||
23494374|NCT00347360|65554985|FG003|Overall Study|Lost to Follow-up|2|||
23494375|NCT00347360|65554986|FG004|Overall Study|Lost to Follow-up|1|||
23494376|NCT00347360|65554987|FG005|Overall Study|Lost to Follow-up|1|||
23494377|NCT00347360|65554988|FG006|Overall Study|Lost to Follow-up|0|||
23494378|NCT00347360|65554989|FG007|Overall Study|Lost to Follow-up|1|||
23494379|NCT00347360|65554990|FG008|Overall Study|Lost to Follow-up|1|||
23494380|NCT00347360|65554991|FG009|Overall Study|Lost to Follow-up|2|||
23494381|NCT00347360|65554992|FG010|Overall Study|Lost to Follow-up|0|||
23494382|NCT00347360|65554993|FG011|Overall Study|Lost to Follow-up|0|||
23494383|NCT00347360|65554994|FG012|Overall Study|Lost to Follow-up|1|||
23494384|NCT00347360|65554995|FG013|Overall Study|Lost to Follow-up|0|||
23494385|NCT00347360|65554996|FG014|Overall Study|Lost to Follow-up|0|||
23494386|NCT00347360|65554982|FG000|Overall Study|Protocol Violation|2|||
23494387|NCT00347360|65554983|FG001|Overall Study|Protocol Violation|3|||
23494388|NCT00347360|65554984|FG002|Overall Study|Protocol Violation|1|||
23494389|NCT00347360|65554985|FG003|Overall Study|Protocol Violation|2|||
23494390|NCT00347360|65554986|FG004|Overall Study|Protocol Violation|1|||
23494391|NCT00347360|65554987|FG005|Overall Study|Protocol Violation|2|||
23494392|NCT00347360|65554988|FG006|Overall Study|Protocol Violation|0|||
23494393|NCT00347360|65554989|FG007|Overall Study|Protocol Violation|0|||
23494394|NCT00347360|65554990|FG008|Overall Study|Protocol Violation|1|||
23494395|NCT00347360|65554991|FG009|Overall Study|Protocol Violation|2|||
23494396|NCT00347360|65554992|FG010|Overall Study|Protocol Violation|0|||
23494397|NCT00347360|65554993|FG011|Overall Study|Protocol Violation|0|||
23494398|NCT00347360|65554994|FG012|Overall Study|Protocol Violation|0|||
23494399|NCT00347360|65554995|FG013|Overall Study|Protocol Violation|1|||
23494400|NCT00347360|65554996|FG014|Overall Study|Protocol Violation|0|||
23494401|NCT00347360|65554982|FG000|Overall Study|Withdrawal by Subject|0|||
23494402|NCT00347360|65554983|FG001|Overall Study|Withdrawal by Subject|1|||
23494403|NCT00347360|65554984|FG002|Overall Study|Withdrawal by Subject|2|||
23494404|NCT00347360|65554985|FG003|Overall Study|Withdrawal by Subject|4|||
23494405|NCT00347360|65554986|FG004|Overall Study|Withdrawal by Subject|1|||
23494406|NCT00347360|65554987|FG005|Overall Study|Withdrawal by Subject|2|||
23676234|NCT00848354|66194650|FG000|Phase 1|Withdrawal by Subject|2|||
23494407|NCT00347360|65554988|FG006|Overall Study|Withdrawal by Subject|1|||
23494408|NCT00347360|65554989|FG007|Overall Study|Withdrawal by Subject|1|||
23494409|NCT00347360|65554990|FG008|Overall Study|Withdrawal by Subject|1|||
23494410|NCT00347360|65554991|FG009|Overall Study|Withdrawal by Subject|1|||
23494411|NCT00347360|65554992|FG010|Overall Study|Withdrawal by Subject|0|||
23494412|NCT00347360|65554993|FG011|Overall Study|Withdrawal by Subject|3|||
23494413|NCT00347360|65554994|FG012|Overall Study|Withdrawal by Subject|4|||
23494414|NCT00347360|65554995|FG013|Overall Study|Withdrawal by Subject|2|||
23494415|NCT00347360|65554996|FG014|Overall Study|Withdrawal by Subject|1|||
23494416|NCT00347360|65554982|FG000|Overall Study|Lack of Efficacy|1|||
23494417|NCT00347360|65554983|FG001|Overall Study|Lack of Efficacy|1|||
23494418|NCT00347360|65554984|FG002|Overall Study|Lack of Efficacy|3|||
23494419|NCT00347360|65554985|FG003|Overall Study|Lack of Efficacy|1|||
23494420|NCT00347360|65554986|FG004|Overall Study|Lack of Efficacy|0|||
23494421|NCT00347360|65554987|FG005|Overall Study|Lack of Efficacy|1|||
23676235|NCT00848354|66194651|FG001|Phase 1|Withdrawal by Subject|4|||
23676236|NCT00848354|66194650|FG000|Phase 1|Lack of Efficacy|0|||
23494422|NCT00347360|65554988|FG006|Overall Study|Lack of Efficacy|0|||
23494423|NCT00347360|65554989|FG007|Overall Study|Lack of Efficacy|1|||
23494424|NCT00347360|65554990|FG008|Overall Study|Lack of Efficacy|1|||
23494425|NCT00347360|65554991|FG009|Overall Study|Lack of Efficacy|0|||
23494426|NCT00347360|65554992|FG010|Overall Study|Lack of Efficacy|0|||
23494427|NCT00347360|65554993|FG011|Overall Study|Lack of Efficacy|0|||
23494428|NCT00347360|65554994|FG012|Overall Study|Lack of Efficacy|0|||
23494429|NCT00347360|65554995|FG013|Overall Study|Lack of Efficacy|0|||
23494430|NCT00347360|65554996|FG014|Overall Study|Lack of Efficacy|0|||
23494431|NCT00347360|65554982|FG000|Overall Study|Reason not listed/blank|1|||
23494432|NCT00347360|65554983|FG001|Overall Study|Reason not listed/blank|0|||
23494433|NCT00347360|65554984|FG002|Overall Study|Reason not listed/blank|0|||
23494434|NCT00347360|65554985|FG003|Overall Study|Reason not listed/blank|0|||
23494435|NCT00347360|65554986|FG004|Overall Study|Reason not listed/blank|0|||
23494436|NCT00347360|65554987|FG005|Overall Study|Reason not listed/blank|0|||
23494437|NCT00347360|65554988|FG006|Overall Study|Reason not listed/blank|1|||
23494438|NCT00347360|65554989|FG007|Overall Study|Reason not listed/blank|0|||
23494439|NCT00347360|65554990|FG008|Overall Study|Reason not listed/blank|0|||
23494440|NCT00347360|65554991|FG009|Overall Study|Reason not listed/blank|0|||
23494441|NCT00347360|65554992|FG010|Overall Study|Reason not listed/blank|0|||
23494442|NCT00347360|65554993|FG011|Overall Study|Reason not listed/blank|0|||
23494443|NCT00347360|65554994|FG012|Overall Study|Reason not listed/blank|0|||
23494444|NCT00347360|65554995|FG013|Overall Study|Reason not listed/blank|1|||
23494445|NCT00347360|65554996|FG014|Overall Study|Reason not listed/blank|0|||
23494446|NCT00347360|65554982|FG000|Overall Study|Per sponsors instruction|0|||
23494447|NCT00347360|65554983|FG001|Overall Study|Per sponsors instruction|1|||
23494448|NCT00347360|65554984|FG002|Overall Study|Per sponsors instruction|0|||
23494449|NCT00347360|65554985|FG003|Overall Study|Per sponsors instruction|0|||
23494450|NCT00347360|65554986|FG004|Overall Study|Per sponsors instruction|0|||
23494451|NCT00347360|65554987|FG005|Overall Study|Per sponsors instruction|0|||
23494452|NCT00347360|65554988|FG006|Overall Study|Per sponsors instruction|0|||
23494453|NCT00347360|65554989|FG007|Overall Study|Per sponsors instruction|0|||
23494454|NCT00347360|65554990|FG008|Overall Study|Per sponsors instruction|0|||
23494455|NCT00347360|65554991|FG009|Overall Study|Per sponsors instruction|0|||
23494456|NCT00347360|65554992|FG010|Overall Study|Per sponsors instruction|0|||
23494457|NCT00347360|65554993|FG011|Overall Study|Per sponsors instruction|0|||
23494458|NCT00347360|65554994|FG012|Overall Study|Per sponsors instruction|0|||
23676237|NCT00848354|66194651|FG001|Phase 1|Lack of Efficacy|1|||
23676238|NCT00848354|66194650|FG000|Phase 2 Year 1|Adverse Event|7|||
23676239|NCT00848354|66194651|FG001|Phase 2 Year 1|Adverse Event|2|||
23676240|NCT00848354|66194650|FG000|Phase 2 Year 1|Death|1|||
23676241|NCT00848354|66194651|FG001|Phase 2 Year 1|Death|0|||
23676242|NCT00848354|66194650|FG000|Phase 2 Year 1|Failed to Return|1|||
23676243|NCT00848354|66194651|FG001|Phase 2 Year 1|Failed to Return|1|||
23676244|NCT00848354|66194650|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
23676245|NCT00848354|66194651|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
23676246|NCT00848354|66194650|FG000|Phase 2 Year 1|Unspecified Reason|3|||
23676247|NCT00848354|66194651|FG001|Phase 2 Year 1|Unspecified Reason|0|||
23676248|NCT00848354|66194650|FG000|Phase 2 Year 1|Protocol Violation|4|||
23676249|NCT00848354|66194651|FG001|Phase 2 Year 1|Protocol Violation|1|||
23676250|NCT00848354|66194650|FG000|Phase 2 Year 1|Subject Request|1|||
23494459|NCT00347360|65554995|FG013|Overall Study|Per sponsors instruction|0|||
23494460|NCT00347360|65554996|FG014|Overall Study|Per sponsors instruction|0|||
23494461|NCT00347360|65554982|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
23494462|NCT00347360|65554983|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
23494463|NCT00347360|65554984|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
23494464|NCT00347360|65554985|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
23676251|NCT00848354|66194651|FG001|Phase 2 Year 1|Subject Request|2|||
23676252|NCT00848354|66194650|FG000|Phase 2 Year 2|Adverse Event|12|||
23676253|NCT00848354|66194651|FG001|Phase 2 Year 2|Adverse Event|2|||
23676254|NCT00848354|66194650|FG000|Phase 2 Year 2|Death|2|||
23676255|NCT00848354|66194651|FG001|Phase 2 Year 2|Death|0|||
23676256|NCT00848354|66194650|FG000|Phase 2 Year 2|Failed to return|3|||
23494465|NCT00347360|65554986|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
23494466|NCT00347360|65554987|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
23494467|NCT00347360|65554988|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
23494468|NCT00347360|65554989|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
23494469|NCT00347360|65554990|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
23494470|NCT00347360|65554991|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
23494471|NCT00347360|65554992|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
23494472|NCT00347360|65554993|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
23494473|NCT00347360|65554994|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
23494474|NCT00347360|65554995|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
23494475|NCT00347360|65554996|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
23494476|NCT00347360|65554982|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
23494477|NCT00347360|65554983|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
23494478|NCT00347360|65554984|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
23494479|NCT00347360|65554985|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
23494480|NCT00347360|65554986|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
23494481|NCT00347360|65554987|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
23676257|NCT00848354|66194651|FG001|Phase 2 Year 2|Failed to return|0|||
23494482|NCT00347360|65554988|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
23494483|NCT00347360|65554989|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
23494484|NCT00347360|65554990|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
23494485|NCT00347360|65554991|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
23494486|NCT00347360|65554992|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
23494487|NCT00347360|65554993|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
23494488|NCT00347360|65554994|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
23494489|NCT00347360|65554995|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
23494490|NCT00347360|65554996|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
23494491|NCT00347360|65554982|FG000|Overall Study|Abnormal lab values|0|||
23494492|NCT00347360|65554983|FG001|Overall Study|Abnormal lab values|0|||
23494493|NCT00347360|65554984|FG002|Overall Study|Abnormal lab values|0|||
23494494|NCT00347360|65554985|FG003|Overall Study|Abnormal lab values|0|||
23676258|NCT00848354|66194650|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
23676259|NCT00848354|66194651|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
23676260|NCT00848354|66194650|FG000|Phase 2 Year 2|Unspecified Reason|1|||
23676261|NCT00848354|66194651|FG001|Phase 2 Year 2|Unspecified Reason|0|||
23494495|NCT00347360|65554986|FG004|Overall Study|Abnormal lab values|0|||
23676262|NCT00848354|66194650|FG000|Phase 2 Year 2|Protocol Violation|1|||
23676263|NCT00848354|66194651|FG001|Phase 2 Year 2|Protocol Violation|1|||
23676264|NCT00848354|66194650|FG000|Phase 2 Year 2|Subject Request|1|||
23494496|NCT00347360|65554987|FG005|Overall Study|Abnormal lab values|0|||
23494497|NCT00347360|65554988|FG006|Overall Study|Abnormal lab values|1|||
23494498|NCT00347360|65554989|FG007|Overall Study|Abnormal lab values|0|||
23494499|NCT00347360|65554990|FG008|Overall Study|Abnormal lab values|0|||
23494500|NCT00347360|65554991|FG009|Overall Study|Abnormal lab values|0|||
23494501|NCT00347360|65554992|FG010|Overall Study|Abnormal lab values|0|||
23494502|NCT00347360|65554993|FG011|Overall Study|Abnormal lab values|0|||
23494503|NCT00347360|65554994|FG012|Overall Study|Abnormal lab values|0|||
23494504|NCT00347360|65554995|FG013|Overall Study|Abnormal lab values|0|||
23494505|NCT00347360|65554996|FG014|Overall Study|Abnormal lab values|0|||
23494506|NCT00347360|65554982|FG000|Overall Study|PI recommended early withdrawal|0|||
23494507|NCT00347360|65554983|FG001|Overall Study|PI recommended early withdrawal|0|||
23494508|NCT00347360|65554984|FG002|Overall Study|PI recommended early withdrawal|0|||
23494509|NCT00347360|65554985|FG003|Overall Study|PI recommended early withdrawal|0|||
23494510|NCT00347360|65554986|FG004|Overall Study|PI recommended early withdrawal|0|||
23494511|NCT00347360|65554987|FG005|Overall Study|PI recommended early withdrawal|0|||
23494512|NCT00347360|65554988|FG006|Overall Study|PI recommended early withdrawal|0|||
23494513|NCT00347360|65554989|FG007|Overall Study|PI recommended early withdrawal|0|||
23676265|NCT00848354|66194651|FG001|Phase 2 Year 2|Subject Request|1|||
23676266|NCT00848354|66194650|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
23676267|NCT00848354|66194651|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
23676268|NCT01534676|66194652|FG000|Overall Study|Study closed due to poor enrollment|2|||
23676269|NCT01534676|66194653|FG001|Overall Study|Study closed due to poor enrollment|1|||
23676270|NCT01344876|66194654|FG000|Overall Study|Adverse Event|0|||
23676271|NCT01344876|66194655|FG001|Overall Study|Adverse Event|0|||
23676272|NCT01344876|66194656|FG002|Overall Study|Adverse Event|0|||
23676273|NCT01344876|66194657|FG003|Overall Study|Adverse Event|0|||
23676274|NCT01344876|66194658|FG004|Overall Study|Adverse Event|1|||
23676275|NCT01344876|66194654|FG000|Overall Study|Withdrawal by Subject|0|||
23676276|NCT01344876|66194655|FG001|Overall Study|Withdrawal by Subject|0|||
23676277|NCT01344876|66194656|FG002|Overall Study|Withdrawal by Subject|1|||
23676278|NCT01344876|66194657|FG003|Overall Study|Withdrawal by Subject|0|||
23676279|NCT01344876|66194658|FG004|Overall Study|Withdrawal by Subject|0|||
23676280|NCT01344876|66194654|FG000|Overall Study|Definite progression of primary disease|1|||
23676281|NCT01344876|66194655|FG001|Overall Study|Definite progression of primary disease|0|||
23676282|NCT01344876|66194656|FG002|Overall Study|Definite progression of primary disease|0|||
23676283|NCT01344876|66194657|FG003|Overall Study|Definite progression of primary disease|3|||
23676284|NCT01344876|66194658|FG004|Overall Study|Definite progression of primary disease|0|||
23676285|NCT01425203|66194659|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
23676286|NCT01425203|66194660|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
23676287|NCT01425203|66194661|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
23676288|NCT01425203|66194659|FG000|Treatment Phase|Failure at futility timepoint|8|||
23676289|NCT01425203|66194660|FG001|Treatment Phase|Failure at futility timepoint|27|||
23676290|NCT01425203|66194661|FG002|Treatment Phase|Failure at futility timepoint|0|||
23676291|NCT01425203|66194659|FG000|Treatment Phase|Other virologic failure criteria|5|||
23676292|NCT01425203|66194660|FG001|Treatment Phase|Other virologic failure criteria|3|||
23676293|NCT01425203|66194661|FG002|Treatment Phase|Other virologic failure criteria|0|||
23676294|NCT01425203|66194659|FG000|Treatment Phase|Unidentified reasons|11|||
23676295|NCT01425203|66194660|FG001|Treatment Phase|Unidentified reasons|5|||
23676296|NCT01425203|66194661|FG002|Treatment Phase|Unidentified reasons|0|||
23676297|NCT01425203|66194659|FG000|Treatment Phase|Did not receive treatment|0|||
23676298|NCT01425203|66194660|FG001|Treatment Phase|Did not receive treatment|1|||
23676299|NCT01425203|66194661|FG002|Treatment Phase|Did not receive treatment|0|||
23676300|NCT01425203|66194659|FG000|Crossover Phase|Failure at futility timepoint|0|||
23676301|NCT01425203|66194660|FG001|Crossover Phase|Failure at futility timepoint|0|||
23676302|NCT01425203|66194661|FG002|Crossover Phase|Failure at futility timepoint|3|||
23494514|NCT00347360|65554990|FG008|Overall Study|PI recommended early withdrawal|0|||
23494515|NCT00347360|65554991|FG009|Overall Study|PI recommended early withdrawal|1|||
23676303|NCT01425203|66194659|FG000|Crossover Phase|Other virologic failure criteria|0|||
23676304|NCT01425203|66194660|FG001|Crossover Phase|Other virologic failure criteria|0|||
23494516|NCT00347360|65554992|FG010|Overall Study|PI recommended early withdrawal|0|||
23494517|NCT00347360|65554993|FG011|Overall Study|PI recommended early withdrawal|0|||
23494518|NCT00347360|65554994|FG012|Overall Study|PI recommended early withdrawal|0|||
23676305|NCT01425203|66194661|FG002|Crossover Phase|Other virologic failure criteria|3|||
23676306|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
23676307|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
23676308|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
23676309|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
23676310|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23676311|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23676312|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
23676313|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23676314|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
23676315|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23676316|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23676317|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23676318|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
23676319|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
23676320|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
23676321|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
23676322|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
23676323|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
23676324|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
23676325|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
23676326|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23676327|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23676328|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23676329|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23676330|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
23676331|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23676332|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23676333|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23676334|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23676335|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23676336|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23676337|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
23676338|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23676339|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23676340|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23676341|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23676342|NCT03403205|66194663|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
23676343|NCT03403205|66194664|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23676344|NCT03403205|66194665|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
23676345|NCT03403205|66194666|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
23676346|NCT03403205|66194667|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23676347|NCT03403205|66194668|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23676348|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
23676349|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
23676350|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
23676351|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
23676352|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
23676353|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
23676354|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
23676355|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
23494519|NCT00347360|65554995|FG013|Overall Study|PI recommended early withdrawal|0|||
23494520|NCT00347360|65554996|FG014|Overall Study|PI recommended early withdrawal|0|||
23494521|NCT00347360|65554982|FG000|Overall Study|Did not meet criteria before ABPM|0|||
23494522|NCT00347360|65554983|FG001|Overall Study|Did not meet criteria before ABPM|0|||
23494523|NCT00347360|65554984|FG002|Overall Study|Did not meet criteria before ABPM|0|||
23494524|NCT00347360|65554985|FG003|Overall Study|Did not meet criteria before ABPM|0|||
23494525|NCT00347360|65554986|FG004|Overall Study|Did not meet criteria before ABPM|0|||
23494526|NCT00347360|65554987|FG005|Overall Study|Did not meet criteria before ABPM|0|||
23494527|NCT00347360|65554988|FG006|Overall Study|Did not meet criteria before ABPM|0|||
23494528|NCT00347360|65554989|FG007|Overall Study|Did not meet criteria before ABPM|0|||
23494529|NCT00347360|65554990|FG008|Overall Study|Did not meet criteria before ABPM|0|||
23494530|NCT00347360|65554991|FG009|Overall Study|Did not meet criteria before ABPM|0|||
23494531|NCT00347360|65554992|FG010|Overall Study|Did not meet criteria before ABPM|1|||
23676356|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
23676357|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
23676358|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
23676359|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
23676360|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Death|1|||
23676361|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Death|0|||
23676362|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Death|0|||
23676363|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Death|0|||
23676364|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Death|0|||
23676365|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Death|0|||
23676366|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
23676367|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23676368|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23676369|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23676370|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23676371|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23676372|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
23676373|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
23676374|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
23676375|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
23676376|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
23676377|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
23676378|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
23676379|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23676380|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23676381|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23676382|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23676383|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23676384|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
23676385|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
23676386|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
23676387|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
23676388|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
23676389|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
23676390|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
23676391|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
23676392|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
23676393|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
23676394|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
23676395|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
23676396|NCT03403205|66194663|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
23676397|NCT03403205|66194664|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
23676398|NCT03403205|66194665|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
23676399|NCT03403205|66194666|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
23676400|NCT03403205|66194667|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
23676401|NCT03403205|66194668|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
23676402|NCT01564862|66194669|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23494532|NCT00347360|65554993|FG011|Overall Study|Did not meet criteria before ABPM|0|||
23494533|NCT00347360|65554994|FG012|Overall Study|Did not meet criteria before ABPM|0|||
23494534|NCT00347360|65554995|FG013|Overall Study|Did not meet criteria before ABPM|0|||
23494535|NCT00347360|65554996|FG014|Overall Study|Did not meet criteria before ABPM|0|||
23494536|NCT00347360|65554982|FG000|Overall Study|Randomized in error|0|||
23676403|NCT01564862|66194670|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
23676404|NCT01564862|66194671|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23676405|NCT01564862|66194669|FG000|Overall Study|Major Protocol Deviation|3|||
23676406|NCT01564862|66194670|FG001|Overall Study|Major Protocol Deviation|3|||
23676407|NCT01564862|66194671|FG002|Overall Study|Major Protocol Deviation|4|||
23676408|NCT01564862|66194669|FG000|Overall Study|Lost to Follow-up|10|||
23676409|NCT01564862|66194670|FG001|Overall Study|Lost to Follow-up|8|||
23676410|NCT01564862|66194671|FG002|Overall Study|Lost to Follow-up|6|||
23676411|NCT01564862|66194669|FG000|Overall Study|Voluntary Withdrawal|9|||
23676412|NCT01564862|66194670|FG001|Overall Study|Voluntary Withdrawal|6|||
23676413|NCT01564862|66194671|FG002|Overall Study|Voluntary Withdrawal|8|||
23676414|NCT01564862|66194669|FG000|Overall Study|Lack of Efficacy|1|||
23676415|NCT01564862|66194670|FG001|Overall Study|Lack of Efficacy|5|||
23676416|NCT01564862|66194671|FG002|Overall Study|Lack of Efficacy|6|||
23676417|NCT01564862|66194669|FG000|Overall Study|Other reason(s)|1|||
23676418|NCT01564862|66194670|FG001|Overall Study|Other reason(s)|0|||
23676419|NCT01564862|66194671|FG002|Overall Study|Other reason(s)|0|||
23676420|NCT01106846|66194674|FG000|Overall Study|Change in surgical procedure|0|||
23676421|NCT01106846|66194675|FG001|Overall Study|Change in surgical procedure|1|||
23676422|NCT00577993|66194676|FG000|Overall Study|Adverse Event|1|||
23676423|NCT00577993|66194677|FG001|Overall Study|Adverse Event|0|||
23676424|NCT00577993|66194678|FG002|Overall Study|Adverse Event|0|||
23676425|NCT00577993|66194676|FG000|Overall Study|Death|0|||
23676426|NCT00577993|66194677|FG001|Overall Study|Death|1|||
23676427|NCT00577993|66194678|FG002|Overall Study|Death|1|||
23676428|NCT00577993|66194676|FG000|Overall Study|Lack of Efficacy|0|||
23676429|NCT00577993|66194677|FG001|Overall Study|Lack of Efficacy|1|||
23676430|NCT00577993|66194678|FG002|Overall Study|Lack of Efficacy|0|||
23676431|NCT00577993|66194676|FG000|Overall Study|Protocol Violation|2|||
23676432|NCT00577993|66194677|FG001|Overall Study|Protocol Violation|3|||
23676433|NCT00577993|66194678|FG002|Overall Study|Protocol Violation|0|||
23676434|NCT00577993|66194676|FG000|Overall Study|Withdrawal by Subject|1|||
23676435|NCT00577993|66194677|FG001|Overall Study|Withdrawal by Subject|0|||
23676436|NCT00577993|66194678|FG002|Overall Study|Withdrawal by Subject|2|||
23676437|NCT00577993|66194676|FG000|Overall Study|Conversion|2|||
23676438|NCT00577993|66194677|FG001|Overall Study|Conversion|5|||
23676439|NCT00577993|66194678|FG002|Overall Study|Conversion|0|||
23676440|NCT00577993|66194676|FG000|Overall Study|Uninsured|1|||
23676441|NCT00577993|66194677|FG001|Overall Study|Uninsured|0|||
23494537|NCT00347360|65554983|FG001|Overall Study|Randomized in error|0|||
23494538|NCT00347360|65554984|FG002|Overall Study|Randomized in error|0|||
23676442|NCT00577993|66194678|FG002|Overall Study|Uninsured|0|||
23676443|NCT02627495|66194679|FG000|Overall Study|Withdrawal by Subject|4|||
23676444|NCT02810964|66194688|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
23676445|NCT02810964|66194689|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
23676446|NCT02810964|66194688|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
23676447|NCT02810964|66194689|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
23676448|NCT02810964|66194688|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
23676449|NCT02810964|66194689|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
23676450|NCT02810964|66194688|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
23676451|NCT02810964|66194689|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
23676452|NCT00772629|66194691|FG000|Overall Study|Subject was not vaccinated|1|||
23676453|NCT00772629|66194692|FG001|Overall Study|Subject was not vaccinated|0|||
23676454|NCT00993031|66194693|FG000|Overall Study|Death|0|||
23676455|NCT00993031|66194694|FG001|Overall Study|Death|1|||
23676456|NCT00993031|66194693|FG000|Overall Study|Physician Decision|0|||
23676457|NCT00993031|66194694|FG001|Overall Study|Physician Decision|2|||
23676458|NCT00993031|66194693|FG000|Overall Study|Withdrawal by Subject|3|||
23676459|NCT00993031|66194694|FG001|Overall Study|Withdrawal by Subject|3|||
23676460|NCT00993031|66194693|FG000|Overall Study|Lost to Follow-up|19|||
23676461|NCT00993031|66194694|FG001|Overall Study|Lost to Follow-up|13|||
23676462|NCT01877083|66194695|FG000|Treatment Phase|Disease Progression|10|||
23676463|NCT01877083|66194695|FG000|Treatment Phase|Clinical Progression|1|||
23676464|NCT01877083|66194695|FG000|Treatment Phase|Adverse Event|6|||
23676465|NCT01877083|66194695|FG000|Treatment Phase|Withdrawal by Subject|2|||
23676466|NCT01877083|66194695|FG000|Treatment Phase|Lost to Follow-up|1|||
23676467|NCT01877083|66194695|FG000|Extension Phase|Disease Progression|3|||
23676468|NCT01877083|66194695|FG000|Extension Phase|Adverse Event|2|||
23676469|NCT03064841|66194702|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
23494539|NCT00347360|65554985|FG003|Overall Study|Randomized in error|0|||
23676470|NCT03064841|66194702|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
23676471|NCT03064841|66194702|FG000|Overall Study|Screen failure|2|||
23676472|NCT02432235|66194703|FG000|Overall Study|Death|1|||
23676473|NCT02432235|66194704|FG001|Overall Study|Death|1|||
23676474|NCT02432235|66194705|FG002|Overall Study|Death|2|||
23676475|NCT02432235|66194706|FG003|Overall Study|Death|2|||
23676476|NCT02432235|66194707|FG004|Overall Study|Death|1|||
23676477|NCT02432235|66194708|FG005|Overall Study|Death|3|||
23676478|NCT02432235|66194709|FG006|Overall Study|Death|11|||
23676479|NCT02432235|66194710|FG007|Overall Study|Death|15|||
23676480|NCT02432235|66194711|FG008|Overall Study|Death|15|||
23676481|NCT02432235|66194712|FG009|Overall Study|Death|3|||
23676482|NCT02432235|66194713|FG010|Overall Study|Death|1|||
23676483|NCT02432235|66194714|FG011|Overall Study|Death|0|||
23676484|NCT02432235|66194703|FG000|Overall Study|Withdrawal by Subject|0|||
23676485|NCT02432235|66194704|FG001|Overall Study|Withdrawal by Subject|1|||
23676486|NCT02432235|66194705|FG002|Overall Study|Withdrawal by Subject|0|||
23676487|NCT02432235|66194706|FG003|Overall Study|Withdrawal by Subject|0|||
23676488|NCT02432235|66194707|FG004|Overall Study|Withdrawal by Subject|0|||
23676489|NCT02432235|66194708|FG005|Overall Study|Withdrawal by Subject|2|||
23676490|NCT02432235|66194709|FG006|Overall Study|Withdrawal by Subject|5|||
23676491|NCT02432235|66194710|FG007|Overall Study|Withdrawal by Subject|3|||
23676492|NCT02432235|66194711|FG008|Overall Study|Withdrawal by Subject|1|||
23676493|NCT02432235|66194712|FG009|Overall Study|Withdrawal by Subject|0|||
23676494|NCT02432235|66194713|FG010|Overall Study|Withdrawal by Subject|0|||
23676495|NCT02432235|66194714|FG011|Overall Study|Withdrawal by Subject|0|||
23676496|NCT02432235|66194703|FG000|Overall Study|Lost to Follow-up|0|||
23676497|NCT02432235|66194704|FG001|Overall Study|Lost to Follow-up|0|||
23676498|NCT02432235|66194705|FG002|Overall Study|Lost to Follow-up|0|||
23676499|NCT02432235|66194706|FG003|Overall Study|Lost to Follow-up|0|||
23676500|NCT02432235|66194707|FG004|Overall Study|Lost to Follow-up|0|||
23676501|NCT02432235|66194708|FG005|Overall Study|Lost to Follow-up|1|||
23676502|NCT02432235|66194709|FG006|Overall Study|Lost to Follow-up|0|||
23676503|NCT02432235|66194710|FG007|Overall Study|Lost to Follow-up|0|||
23676504|NCT02432235|66194711|FG008|Overall Study|Lost to Follow-up|1|||
23676505|NCT02432235|66194712|FG009|Overall Study|Lost to Follow-up|0|||
23676506|NCT02432235|66194713|FG010|Overall Study|Lost to Follow-up|0|||
23676507|NCT02432235|66194714|FG011|Overall Study|Lost to Follow-up|0|||
23676508|NCT02432235|66194703|FG000|Overall Study|Miscellaneous|0|||
23676509|NCT02432235|66194704|FG001|Overall Study|Miscellaneous|0|||
23676510|NCT02432235|66194705|FG002|Overall Study|Miscellaneous|0|||
23676511|NCT02432235|66194706|FG003|Overall Study|Miscellaneous|0|||
23676512|NCT02432235|66194707|FG004|Overall Study|Miscellaneous|1|||
23676513|NCT02432235|66194708|FG005|Overall Study|Miscellaneous|6|||
23676514|NCT02432235|66194709|FG006|Overall Study|Miscellaneous|2|||
23676515|NCT02432235|66194710|FG007|Overall Study|Miscellaneous|2|||
23676516|NCT02432235|66194711|FG008|Overall Study|Miscellaneous|4|||
23676517|NCT02432235|66194712|FG009|Overall Study|Miscellaneous|0|||
23676518|NCT02432235|66194713|FG010|Overall Study|Miscellaneous|0|||
23676519|NCT02432235|66194714|FG011|Overall Study|Miscellaneous|1|||
23676520|NCT03847610|66194721|FG000|Overall Study|Withdrawal by Subject|1|||
23676521|NCT00797732|66194722|FG000|Overall Study|Withdrawal by Subject|3|||
23676522|NCT00797732|66194723|FG001|Overall Study|Withdrawal by Subject|3|||
23676523|NCT00797732|66194724|FG002|Overall Study|Withdrawal by Subject|0|||
23676524|NCT00797732|66194722|FG000|Overall Study|Lost to Follow-up|1|||
23676525|NCT00797732|66194723|FG001|Overall Study|Lost to Follow-up|0|||
23676526|NCT00797732|66194724|FG002|Overall Study|Lost to Follow-up|0|||
23676527|NCT00797732|66194722|FG000|Overall Study|Death|1|||
23676528|NCT00797732|66194723|FG001|Overall Study|Death|0|||
23676529|NCT00797732|66194724|FG002|Overall Study|Death|0|||
23676530|NCT00797732|66194722|FG000|Overall Study|Not meet inclusion criteria|0|||
23676531|NCT00797732|66194723|FG001|Overall Study|Not meet inclusion criteria|0|||
23676532|NCT00797732|66194724|FG002|Overall Study|Not meet inclusion criteria|7|||
23676533|NCT00797732|66194722|FG000|Overall Study|Excluded due to time constraints|0|||
23676534|NCT00797732|66194723|FG001|Overall Study|Excluded due to time constraints|0|||
23676535|NCT00797732|66194724|FG002|Overall Study|Excluded due to time constraints|24|||
23676536|NCT00797732|66194722|FG000|Overall Study|Refused to Participate|0|||
23676537|NCT00797732|66194723|FG001|Overall Study|Refused to Participate|0|||
23676538|NCT00797732|66194724|FG002|Overall Study|Refused to Participate|123|||
23676539|NCT01637142|66194725|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
23676540|NCT01297270|66194726|FG000|Overall Study|Adverse Event|19|||
23676541|NCT01297270|66194727|FG001|Overall Study|Adverse Event|32|||
23676542|NCT01297270|66194728|FG002|Overall Study|Adverse Event|5|||
23676543|NCT01297270|66194726|FG000|Overall Study|Lack of Efficacy|15|||
23676544|NCT01297270|66194727|FG001|Overall Study|Lack of Efficacy|17|||
23676545|NCT01297270|66194728|FG002|Overall Study|Lack of Efficacy|15|||
23676546|NCT01297270|66194726|FG000|Overall Study|Lost to Follow-up|1|||
23676547|NCT01297270|66194727|FG001|Overall Study|Lost to Follow-up|2|||
23676548|NCT01297270|66194728|FG002|Overall Study|Lost to Follow-up|1|||
23676549|NCT01297270|66194726|FG000|Overall Study|Protocol Violation|0|||
23676550|NCT01297270|66194727|FG001|Overall Study|Protocol Violation|2|||
23676551|NCT01297270|66194728|FG002|Overall Study|Protocol Violation|0|||
23676552|NCT01297270|66194726|FG000|Overall Study|Withdrawal by Subject|7|||
23676553|NCT01297270|66194727|FG001|Overall Study|Withdrawal by Subject|15|||
23676554|NCT01297270|66194728|FG002|Overall Study|Withdrawal by Subject|7|||
23676555|NCT01297270|66194726|FG000|Overall Study|Other reason not defined above|3|||
23676556|NCT01297270|66194727|FG001|Overall Study|Other reason not defined above|3|||
23676557|NCT01297270|66194728|FG002|Overall Study|Other reason not defined above|1|||
23676558|NCT01297270|66194726|FG000|Overall Study|Not treated|0|||
23676559|NCT01297270|66194727|FG001|Overall Study|Not treated|1|||
23676560|NCT01297270|66194728|FG002|Overall Study|Not treated|0|||
23676561|NCT02599961|66194729|FG000|Overall Study|Withdrawal by Subject|1|||
23676562|NCT02599961|66194729|FG000|Overall Study|Subject Non-Compliance|2|||
23676563|NCT02599961|66194729|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
23676564|NCT02599961|66194729|FG000|Overall Study|Other, Not Specified|3|||
23676565|NCT01073566|66194730|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
23676566|NCT01073566|66194731|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
23676567|NCT02275338|66194732|FG000|Overall Study|Adverse Event|15|||
23676568|NCT02275338|66194732|FG000|Overall Study|Lack of Efficacy|3|||
23676569|NCT02275338|66194732|FG000|Overall Study|Withdrawal by Subject|4|||
23676570|NCT02275338|66194732|FG000|Overall Study|Disease progression (death)|1|||
23676571|NCT02275338|66194732|FG000|Overall Study|Ineligible to start Phase 2|4|||
23676572|NCT02275338|66194732|FG000|Overall Study|Reason not specified|5|||
23676573|NCT02275338|66194732|FG000|Overall Study|Does not meet entry criteria|1|||
23676574|NCT02682901|66194733|FG000|Overall Study|Adverse Event|10|||
23676575|NCT02682901|66194734|FG001|Overall Study|Adverse Event|3|||
23676576|NCT02682901|66194733|FG000|Overall Study|Lack of Efficacy|0|||
23676577|NCT02682901|66194734|FG001|Overall Study|Lack of Efficacy|1|||
23676578|NCT00323557|66198984|FG000|Overall Study|Physician Decision|1|||
23676579|NCT00323557|66198985|FG001|Overall Study|Physician Decision|0|||
23676580|NCT02307370|66198986|FG000|Overall Study|Death|5|||
23676581|NCT02307370|66198986|FG000|Overall Study|Lost to Follow-up|1|||
23676582|NCT02307370|66198986|FG000|Overall Study|Withdrawal by Subject|1|||
23676583|NCT02307370|66198986|FG000|Overall Study|Declined Addendum ICF|6|||
23676584|NCT02307370|66198986|FG000|Overall Study|No response during telephone contact|5|||
23676585|NCT02307370|66198986|FG000|Overall Study|Protocol Violation|1|||
23676586|NCT01400451|66198987|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
23676587|NCT01400451|66198988|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
23676588|NCT01400451|66198989|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
23676589|NCT01400451|66198987|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
23676590|NCT01400451|66198988|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
23676591|NCT01400451|66198989|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
23676592|NCT01400451|66198987|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
23676593|NCT01400451|66198988|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
23676594|NCT01400451|66198989|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
23676595|NCT01400451|66198987|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
23676596|NCT01400451|66198988|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
23676597|NCT01400451|66198989|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
23676598|NCT01400451|66198987|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
23676599|NCT01400451|66198988|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
23676600|NCT01400451|66198989|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
23676601|NCT02634580|66198997|FG000|Double-blind Treatment Period|Subject Request|1|||
23676602|NCT02634580|66198998|FG001|Double-blind Treatment Period|Subject Request|0|||
23676603|NCT02634580|66198999|FG002|Double-blind Treatment Period|Subject Request|1|||
23676604|NCT02634580|66199000|FG003|Double-blind Treatment Period|Subject Request|1|||
23676605|NCT02634580|66198997|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23676606|NCT02634580|66198998|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
23676607|NCT02634580|66198999|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
23676608|NCT02634580|66199000|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
23676609|NCT00573794|66199003|FG000|Overall Study|Adverse Event|81|||
23676610|NCT00573794|66199003|FG000|Overall Study|Withdrew Consent|90|||
23676611|NCT00573794|66199003|FG000|Overall Study|Lost to Follow-up|13|||
23676612|NCT00573794|66199003|FG000|Overall Study|Protocol Violation|6|||
23676613|NCT00573794|66199003|FG000|Overall Study|Lack of Efficacy|94|||
23676614|NCT00573794|66199003|FG000|Overall Study|Other|46|||
23676615|NCT02543528|66199010|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23676616|NCT02543528|66199011|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23676617|NCT02543528|66199012|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23676618|NCT02543528|66199013|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23676619|NCT02543528|66199014|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
23676620|NCT02543528|66199010|FG000|Adaptation Period|Lens Handling Difficultes|0|||
23676621|NCT02543528|66199011|FG001|Adaptation Period|Lens Handling Difficultes|0|||
23676622|NCT02543528|66199012|FG002|Adaptation Period|Lens Handling Difficultes|0|||
23676623|NCT02543528|66199013|FG003|Adaptation Period|Lens Handling Difficultes|0|||
23494540|NCT00347360|65554986|FG004|Overall Study|Randomized in error|0|||
23494541|NCT00347360|65554987|FG005|Overall Study|Randomized in error|0|||
23494542|NCT00347360|65554988|FG006|Overall Study|Randomized in error|0|||
23494543|NCT00347360|65554989|FG007|Overall Study|Randomized in error|0|||
23494544|NCT00347360|65554990|FG008|Overall Study|Randomized in error|0|||
23494545|NCT00347360|65554991|FG009|Overall Study|Randomized in error|0|||
23494546|NCT00347360|65554992|FG010|Overall Study|Randomized in error|0|||
23494547|NCT00347360|65554993|FG011|Overall Study|Randomized in error|1|||
23494548|NCT00347360|65554994|FG012|Overall Study|Randomized in error|0|||
23494549|NCT00347360|65554995|FG013|Overall Study|Randomized in error|0|||
23494550|NCT00347360|65554996|FG014|Overall Study|Randomized in error|0|||
23676624|NCT02543528|66199014|FG004|Adaptation Period|Lens Handling Difficultes|8|||
23676625|NCT02543528|66199010|FG000|Adaptation Period|Lost to Follow-up|0|||
23676626|NCT02543528|66199011|FG001|Adaptation Period|Lost to Follow-up|0|||
23676627|NCT02543528|66199012|FG002|Adaptation Period|Lost to Follow-up|0|||
23676628|NCT02543528|66199013|FG003|Adaptation Period|Lost to Follow-up|0|||
23676629|NCT02543528|66199014|FG004|Adaptation Period|Lost to Follow-up|14|||
23676630|NCT02543528|66199010|FG000|Adaptation Period|Adverse Event|0|||
23676631|NCT02543528|66199011|FG001|Adaptation Period|Adverse Event|0|||
23676632|NCT02543528|66199012|FG002|Adaptation Period|Adverse Event|0|||
23676633|NCT02543528|66199013|FG003|Adaptation Period|Adverse Event|0|||
23676634|NCT02543528|66199014|FG004|Adaptation Period|Adverse Event|2|||
23676635|NCT02543528|66199010|FG000|Extended Wear Period|Adverse Event|17|||
23676636|NCT02543528|66199011|FG001|Extended Wear Period|Adverse Event|11|||
23676637|NCT02543528|66199012|FG002|Extended Wear Period|Adverse Event|16|||
23676638|NCT02543528|66199013|FG003|Extended Wear Period|Adverse Event|3|||
23676639|NCT02543528|66199014|FG004|Extended Wear Period|Adverse Event|0|||
23676640|NCT02543528|66199010|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
23676641|NCT02543528|66199011|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
23676642|NCT02543528|66199012|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
23676643|NCT02543528|66199013|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
23676644|NCT02543528|66199014|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
23676645|NCT02543528|66199010|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
23676646|NCT02543528|66199011|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23676647|NCT02543528|66199012|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23676648|NCT02543528|66199013|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23676649|NCT02543528|66199014|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23676650|NCT02543528|66199010|FG000|Extended Wear Period|Lost to Follow-up|0|||
23676651|NCT02543528|66199011|FG001|Extended Wear Period|Lost to Follow-up|1|||
23676652|NCT02543528|66199012|FG002|Extended Wear Period|Lost to Follow-up|2|||
23494551|NCT00347360|65554982|FG000|Overall Study|Failed inclusion criteria #4|0|||
23494552|NCT00347360|65554983|FG001|Overall Study|Failed inclusion criteria #4|0|||
23676653|NCT02543528|66199013|FG003|Extended Wear Period|Lost to Follow-up|1|||
23676654|NCT02543528|66199014|FG004|Extended Wear Period|Lost to Follow-up|0|||
23676655|NCT02543528|66199010|FG000|Extended Wear Period|Withdrawal by Subject|10|||
23676656|NCT02543528|66199011|FG001|Extended Wear Period|Withdrawal by Subject|9|||
23676657|NCT02543528|66199012|FG002|Extended Wear Period|Withdrawal by Subject|4|||
23676658|NCT02543528|66199013|FG003|Extended Wear Period|Withdrawal by Subject|5|||
23676659|NCT02543528|66199014|FG004|Extended Wear Period|Withdrawal by Subject|0|||
23676660|NCT01707693|66199015|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
23676661|NCT01707693|66199016|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
23676662|NCT01707693|66199015|FG000|Overall Study Allocation|Protocol Violation|4|||
23676663|NCT01707693|66199016|FG001|Overall Study Allocation|Protocol Violation|3|||
23676664|NCT01707693|66199015|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
23676665|NCT01707693|66199016|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
23676666|NCT01707693|66199015|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
23676667|NCT01707693|66199016|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
23676668|NCT01784861|66199017|FG000|Overall Study|Adverse Event|0|||
23676669|NCT01784861|66199018|FG001|Overall Study|Adverse Event|0|||
23676670|NCT01784861|66199019|FG002|Overall Study|Adverse Event|1|||
23676671|NCT01784861|66199020|FG003|Overall Study|Adverse Event|2|||
23676672|NCT01784861|66199021|FG004|Overall Study|Adverse Event|1|||
23676673|NCT01784861|66199022|FG005|Overall Study|Adverse Event|0|||
23676674|NCT01784861|66199017|FG000|Overall Study|Withdrawal by Subject|0|||
23676675|NCT01784861|66199018|FG001|Overall Study|Withdrawal by Subject|0|||
23676676|NCT01784861|66199019|FG002|Overall Study|Withdrawal by Subject|0|||
23676677|NCT01784861|66199020|FG003|Overall Study|Withdrawal by Subject|1|||
23388151|NCT01748552|65165959|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
23388152|NCT01748552|65165960|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
23388153|NCT01748552|65165949|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388154|NCT01748552|65165950|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388155|NCT01748552|65165951|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388156|NCT01748552|65165952|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388157|NCT01748552|65165953|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388158|NCT01748552|65165954|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388159|NCT01748552|65165955|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23388160|NCT01748552|65165956|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23388161|NCT01748552|65165957|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23676678|NCT01784861|66199021|FG004|Overall Study|Withdrawal by Subject|0|||
23676679|NCT01784861|66199022|FG005|Overall Study|Withdrawal by Subject|0|||
23494553|NCT00347360|65554984|FG002|Overall Study|Failed inclusion criteria #4|0|||
23494554|NCT00347360|65554985|FG003|Overall Study|Failed inclusion criteria #4|0|||
23494555|NCT00347360|65554986|FG004|Overall Study|Failed inclusion criteria #4|0|||
23494556|NCT00347360|65554987|FG005|Overall Study|Failed inclusion criteria #4|0|||
23494557|NCT00347360|65554988|FG006|Overall Study|Failed inclusion criteria #4|0|||
23494558|NCT00347360|65554989|FG007|Overall Study|Failed inclusion criteria #4|0|||
23494559|NCT00347360|65554990|FG008|Overall Study|Failed inclusion criteria #4|0|||
23494560|NCT00347360|65554991|FG009|Overall Study|Failed inclusion criteria #4|0|||
23494561|NCT00347360|65554992|FG010|Overall Study|Failed inclusion criteria #4|0|||
23494562|NCT00347360|65554993|FG011|Overall Study|Failed inclusion criteria #4|1|||
23494563|NCT00347360|65554994|FG012|Overall Study|Failed inclusion criteria #4|0|||
23494564|NCT00347360|65554995|FG013|Overall Study|Failed inclusion criteria #4|0|||
23494565|NCT00347360|65554996|FG014|Overall Study|Failed inclusion criteria #4|0|||
23494566|NCT00347360|65554982|FG000|Overall Study|Prolonged duration between visits|0|||
23494567|NCT00347360|65554983|FG001|Overall Study|Prolonged duration between visits|0|||
23494568|NCT00347360|65554984|FG002|Overall Study|Prolonged duration between visits|0|||
23494569|NCT00347360|65554985|FG003|Overall Study|Prolonged duration between visits|0|||
23494570|NCT00347360|65554986|FG004|Overall Study|Prolonged duration between visits|0|||
23494571|NCT00347360|65554987|FG005|Overall Study|Prolonged duration between visits|0|||
23494572|NCT00347360|65554988|FG006|Overall Study|Prolonged duration between visits|0|||
23494573|NCT00347360|65554989|FG007|Overall Study|Prolonged duration between visits|0|||
23494574|NCT00347360|65554990|FG008|Overall Study|Prolonged duration between visits|0|||
23494575|NCT00347360|65554991|FG009|Overall Study|Prolonged duration between visits|0|||
23494576|NCT00347360|65554992|FG010|Overall Study|Prolonged duration between visits|0|||
23494577|NCT00347360|65554993|FG011|Overall Study|Prolonged duration between visits|0|||
23494578|NCT00347360|65554994|FG012|Overall Study|Prolonged duration between visits|1|||
23494579|NCT00347360|65554995|FG013|Overall Study|Prolonged duration between visits|0|||
23494580|NCT00347360|65554996|FG014|Overall Study|Prolonged duration between visits|0|||
23676680|NCT01784861|66199017|FG000|Overall Study|Physician Decision|0|||
23676681|NCT01784861|66199018|FG001|Overall Study|Physician Decision|0|||
23676682|NCT01784861|66199019|FG002|Overall Study|Physician Decision|0|||
23676683|NCT01784861|66199020|FG003|Overall Study|Physician Decision|2|||
23676684|NCT01784861|66199021|FG004|Overall Study|Physician Decision|0|||
23676685|NCT01784861|66199022|FG005|Overall Study|Physician Decision|1|||
23676686|NCT00500682|66199023|FG000|Overall Study|Adverse Event|37|||
23676687|NCT00500682|66199024|FG001|Overall Study|Adverse Event|29|||
23676688|NCT00500682|66199023|FG000|Overall Study|Death|25|||
23676689|NCT00500682|66199024|FG001|Overall Study|Death|16|||
23676690|NCT00500682|66199023|FG000|Overall Study|Lost to Follow-up|11|||
23676691|NCT00500682|66199024|FG001|Overall Study|Lost to Follow-up|11|||
23676692|NCT00500682|66199023|FG000|Overall Study|Physician Decision|6|||
23388162|NCT01748552|65165958|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23494581|NCT00347360|65554982|FG000|Overall Study|Subject left town, ran out of study drug|0|||
23676693|NCT00500682|66199024|FG001|Overall Study|Physician Decision|10|||
23676694|NCT00500682|66199023|FG000|Overall Study|Pregnancy|2|||
23676695|NCT00500682|66199024|FG001|Overall Study|Pregnancy|0|||
23676696|NCT00500682|66199023|FG000|Overall Study|Protocol Violation|1|||
23676697|NCT00500682|66199024|FG001|Overall Study|Protocol Violation|3|||
23676698|NCT00500682|66199023|FG000|Overall Study|Withdrawal by Subject|80|||
23676699|NCT00500682|66199024|FG001|Overall Study|Withdrawal by Subject|74|||
23676700|NCT00500682|66199023|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
23676701|NCT00500682|66199024|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
23676702|NCT02317562|66199028|FG000|Overall Study|Physician Decision|1|||
23676703|NCT02317562|66199028|FG000|Overall Study|early termination of the study|8|||
23494582|NCT00347360|65554983|FG001|Overall Study|Subject left town, ran out of study drug|0|||
23494583|NCT00347360|65554984|FG002|Overall Study|Subject left town, ran out of study drug|0|||
23676704|NCT02317562|66199028|FG000|Overall Study|Lack of Efficacy|4|||
23676705|NCT02317562|66199028|FG000|Overall Study|Withdrawal by Subject|1|||
23676706|NCT01582308|66199029|FG000|Period 1|Withdrawal by Subject|0|||
23676707|NCT01582308|66199030|FG001|Period 1|Withdrawal by Subject|0|||
23676708|NCT01582308|66199031|FG002|Period 1|Withdrawal by Subject|0|||
23676709|NCT01582308|66199032|FG003|Period 1|Withdrawal by Subject|0|||
23676710|NCT01582308|66199033|FG004|Period 1|Withdrawal by Subject|0|||
23676711|NCT01582308|66199034|FG005|Period 1|Withdrawal by Subject|0|||
23676712|NCT01582308|66199035|FG006|Period 1|Withdrawal by Subject|1|||
23676713|NCT01582308|66199036|FG007|Period 1|Withdrawal by Subject|0|||
23676714|NCT01582308|66199037|FG008|Period 1|Withdrawal by Subject|0|||
23676715|NCT01582308|66199038|FG009|Period 1|Withdrawal by Subject|0|||
23676716|NCT01582308|66199029|FG000|10-day Washout Following Period 1|Physician Decision|0|||
23676717|NCT01582308|66199030|FG001|10-day Washout Following Period 1|Physician Decision|0|||
23676718|NCT01582308|66199031|FG002|10-day Washout Following Period 1|Physician Decision|0|||
23676719|NCT01582308|66199032|FG003|10-day Washout Following Period 1|Physician Decision|0|||
23676720|NCT01582308|66199033|FG004|10-day Washout Following Period 1|Physician Decision|1|||
23676721|NCT01582308|66199034|FG005|10-day Washout Following Period 1|Physician Decision|0|||
23676722|NCT01582308|66199035|FG006|10-day Washout Following Period 1|Physician Decision|0|||
23676723|NCT01582308|66199036|FG007|10-day Washout Following Period 1|Physician Decision|0|||
23676724|NCT01582308|66199037|FG008|10-day Washout Following Period 1|Physician Decision|0|||
23676725|NCT01582308|66199038|FG009|10-day Washout Following Period 1|Physician Decision|0|||
23676726|NCT01582308|66199029|FG000|Period 4|Physician Decision|1|||
23676727|NCT01582308|66199030|FG001|Period 4|Physician Decision|0|||
23676728|NCT01582308|66199031|FG002|Period 4|Physician Decision|0|||
23676729|NCT01582308|66199032|FG003|Period 4|Physician Decision|0|||
23676730|NCT01582308|66199033|FG004|Period 4|Physician Decision|0|||
23676731|NCT01582308|66199034|FG005|Period 4|Physician Decision|1|||
23676732|NCT01582308|66199035|FG006|Period 4|Physician Decision|0|||
23676733|NCT01582308|66199036|FG007|Period 4|Physician Decision|0|||
23676734|NCT01582308|66199037|FG008|Period 4|Physician Decision|0|||
23676735|NCT01582308|66199038|FG009|Period 4|Physician Decision|1|||
23676736|NCT04607733|66199039|FG000|Overall Study|Lost to Follow-up|1|||
23676737|NCT04607733|66199040|FG001|Overall Study|Lost to Follow-up|0|||
23676738|NCT04607733|66199041|FG002|Overall Study|Lost to Follow-up|0|||
23676739|NCT04607733|66199042|FG003|Overall Study|Lost to Follow-up|1|||
23676740|NCT04607733|66199043|FG004|Overall Study|Lost to Follow-up|1|||
23676741|NCT04607733|66199044|FG005|Overall Study|Lost to Follow-up|0|||
23676742|NCT04607733|66199039|FG000|Overall Study|Withdrawal by Subject|0|||
23676743|NCT04607733|66199040|FG001|Overall Study|Withdrawal by Subject|0|||
23676744|NCT04607733|66199041|FG002|Overall Study|Withdrawal by Subject|0|||
23676745|NCT04607733|66199042|FG003|Overall Study|Withdrawal by Subject|0|||
23676746|NCT04607733|66199043|FG004|Overall Study|Withdrawal by Subject|1|||
23676747|NCT04607733|66199044|FG005|Overall Study|Withdrawal by Subject|0|||
23676748|NCT02435849|66199045|FG000|Overall Study|Death|23|||
23676749|NCT02435849|66199046|FG001|Overall Study|Death|0|||
23676750|NCT02435849|66199045|FG000|Overall Study|Lack of Efficacy|10|||
23676751|NCT02435849|66199046|FG001|Overall Study|Lack of Efficacy|0|||
23676752|NCT02435849|66199045|FG000|Overall Study|New therapy for study indication|8|||
23676753|NCT02435849|66199046|FG001|Overall Study|New therapy for study indication|0|||
23676754|NCT02435849|66199045|FG000|Overall Study|Subject/guardian decision|5|||
23676755|NCT02435849|66199046|FG001|Overall Study|Subject/guardian decision|1|||
23676756|NCT02435849|66199045|FG000|Overall Study|Lost to Follow-up|1|||
23676757|NCT02435849|66199046|FG001|Overall Study|Lost to Follow-up|0|||
23676758|NCT02435849|66199045|FG000|Overall Study|Physician Decision|1|||
23676759|NCT02435849|66199046|FG001|Overall Study|Physician Decision|0|||
23676760|NCT00343512|66199047|FG000|Overall Study|Withdrawal by Subject|2|||
23676761|NCT01668654|66199048|FG000|Overall Study|Study Closed/Terminated|3|||
23676762|NCT01668654|66199048|FG000|Overall Study|Withdrawal by Subject|1|||
23676763|NCT01641939|66199049|FG000|Overall Study|Death|90|||
23676764|NCT01641939|66199050|FG001|Overall Study|Death|187|||
23676765|NCT01641939|66199051|FG002|Overall Study|Death|61|||
23676766|NCT01641939|66199049|FG000|Overall Study|Lost to Follow-up|3|||
23676767|NCT01641939|66199050|FG001|Overall Study|Lost to Follow-up|2|||
23676768|NCT01641939|66199051|FG002|Overall Study|Lost to Follow-up|1|||
23676769|NCT01641939|66199049|FG000|Overall Study|Withdrawal by Subject|14|||
23676770|NCT01641939|66199050|FG001|Overall Study|Withdrawal by Subject|11|||
23676771|NCT01641939|66199051|FG002|Overall Study|Withdrawal by Subject|5|||
23676772|NCT01641939|66199049|FG000|Overall Study|Study Terminated by Sponsor|10|||
23676773|NCT01641939|66199050|FG001|Overall Study|Study Terminated by Sponsor|28|||
23676774|NCT01641939|66199051|FG002|Overall Study|Study Terminated by Sponsor|3|||
23676775|NCT02526550|66199053|FG000|Overall Study|Lost to Follow-up|1|||
23676776|NCT01537211|66199054|FG000|Overall Study|Lost to Follow-up|0|||
23676777|NCT01537211|66199055|FG001|Overall Study|Lost to Follow-up|1|||
23676778|NCT00494091|66199056|FG000|Overall Study|Death|5|||
23676779|NCT00494091|66199057|FG001|Overall Study|Death|54|||
23676780|NCT00494091|66199056|FG000|Overall Study|Lost to Follow-up|0|||
23676781|NCT00494091|66199057|FG001|Overall Study|Lost to Follow-up|4|||
23676782|NCT00494091|66199056|FG000|Overall Study|Other|1|||
23676783|NCT00494091|66199057|FG001|Overall Study|Other|11|||
23676784|NCT00494091|66199056|FG000|Overall Study|Withdrawal by Subject|0|||
23676785|NCT00494091|66199057|FG001|Overall Study|Withdrawal by Subject|7|||
23676786|NCT01512264|66199058|FG000|Overall Study|Lost to Follow-up|0|||
23676787|NCT01512264|66199059|FG001|Overall Study|Lost to Follow-up|0|||
23676788|NCT01512264|66199060|FG002|Overall Study|Lost to Follow-up|0|||
23676789|NCT01512264|66199061|FG003|Overall Study|Lost to Follow-up|1|||
23676790|NCT00883337|66199062|FG000|Core Treatment Period|Adverse Event|9|||
23676791|NCT00883337|66199063|FG001|Core Treatment Period|Adverse Event|12|||
23676792|NCT00883337|66199064|FG002|Core Treatment Period|Adverse Event|22|||
23676793|NCT00883337|66199062|FG000|Core Treatment Period|Lack of Efficacy|7|||
23676794|NCT00883337|66199063|FG001|Core Treatment Period|Lack of Efficacy|4|||
23676795|NCT00883337|66199064|FG002|Core Treatment Period|Lack of Efficacy|2|||
23676796|NCT00883337|66199062|FG000|Core Treatment Period|Lost to Follow-up|1|||
23676797|NCT00883337|66199063|FG001|Core Treatment Period|Lost to Follow-up|1|||
23676798|NCT00883337|66199064|FG002|Core Treatment Period|Lost to Follow-up|0|||
23676799|NCT00883337|66199062|FG000|Core Treatment Period|Withdrawal by Subject|2|||
23676800|NCT00883337|66199063|FG001|Core Treatment Period|Withdrawal by Subject|2|||
23676801|NCT00883337|66199064|FG002|Core Treatment Period|Withdrawal by Subject|6|||
23676802|NCT00883337|66199062|FG000|Core Treatment Period|Wish to be pregnant|1|||
23676803|NCT00883337|66199063|FG001|Core Treatment Period|Wish to be pregnant|2|||
23676804|NCT00883337|66199064|FG002|Core Treatment Period|Wish to be pregnant|1|||
23676805|NCT00883337|66199062|FG000|Core Treatment Period|Poor compliance to protocol|0|||
23676806|NCT00883337|66199063|FG001|Core Treatment Period|Poor compliance to protocol|0|||
23676807|NCT00883337|66199064|FG002|Core Treatment Period|Poor compliance to protocol|1|||
23676808|NCT00883337|66199062|FG000|Core Treatment Period|Other than above|0|||
23676809|NCT00883337|66199063|FG001|Core Treatment Period|Other than above|1|||
23676810|NCT00883337|66199064|FG002|Core Treatment Period|Other than above|1|||
23676811|NCT00883337|66199062|FG000|Extension Treatment Period|Adverse Event|8|||
23676812|NCT00883337|66199063|FG001|Extension Treatment Period|Adverse Event|5|||
23676813|NCT00883337|66199064|FG002|Extension Treatment Period|Adverse Event|5|||
23676814|NCT00883337|66199062|FG000|Extension Treatment Period|Lack of Efficacy|8|||
23676815|NCT00883337|66199063|FG001|Extension Treatment Period|Lack of Efficacy|8|||
23676816|NCT00883337|66199064|FG002|Extension Treatment Period|Lack of Efficacy|8|||
23676817|NCT00883337|66199062|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
23676818|NCT00883337|66199063|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
23676819|NCT00883337|66199064|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
23676820|NCT00883337|66199062|FG000|Extension Treatment Period|Lost to Follow-up|1|||
23676821|NCT00883337|66199063|FG001|Extension Treatment Period|Lost to Follow-up|0|||
23676822|NCT00883337|66199064|FG002|Extension Treatment Period|Lost to Follow-up|0|||
23676823|NCT00883337|66199062|FG000|Extension Treatment Period|Other than above|10|||
23676824|NCT00883337|66199063|FG001|Extension Treatment Period|Other than above|9|||
23676825|NCT00883337|66199064|FG002|Extension Treatment Period|Other than above|5|||
23676826|NCT00608985|66199065|FG000|Overall Study|Adverse Event|2|||
23676827|NCT00608985|66199066|FG001|Overall Study|Adverse Event|7|||
23676828|NCT00608985|66199067|FG002|Overall Study|Adverse Event|4|||
23388163|NCT01748552|65165959|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388164|NCT01748552|65165960|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388165|NCT02959892|65165961|FG000|Overall Study|PET tracer synthesis failure|1|||
23388166|NCT02959892|65165962|FG001|Overall Study|PET tracer synthesis failure|0|||
23388167|NCT02959892|65165961|FG000|Overall Study|Study termination|0|||
23388168|NCT02959892|65165962|FG001|Overall Study|Study termination|1|||
23388169|NCT01936974|65165963|FG000|Overall Study|Physician Decision|2|||
23388170|NCT01936974|65165964|FG001|Overall Study|Physician Decision|5|||
23494584|NCT00347360|65554985|FG003|Overall Study|Subject left town, ran out of study drug|0|||
23494585|NCT00347360|65554986|FG004|Overall Study|Subject left town, ran out of study drug|0|||
23494586|NCT00347360|65554987|FG005|Overall Study|Subject left town, ran out of study drug|0|||
23494587|NCT00347360|65554988|FG006|Overall Study|Subject left town, ran out of study drug|0|||
23494588|NCT00347360|65554989|FG007|Overall Study|Subject left town, ran out of study drug|0|||
23494589|NCT00347360|65554990|FG008|Overall Study|Subject left town, ran out of study drug|0|||
23494590|NCT00347360|65554991|FG009|Overall Study|Subject left town, ran out of study drug|0|||
23494591|NCT00347360|65554992|FG010|Overall Study|Subject left town, ran out of study drug|0|||
23494592|NCT00347360|65554993|FG011|Overall Study|Subject left town, ran out of study drug|0|||
23494593|NCT00347360|65554994|FG012|Overall Study|Subject left town, ran out of study drug|0|||
23494594|NCT00347360|65554995|FG013|Overall Study|Subject left town, ran out of study drug|1|||
23494595|NCT00347360|65554996|FG014|Overall Study|Subject left town, ran out of study drug|0|||
23494596|NCT00347360|65554982|FG000|Overall Study|Subject refuse to sign updated consent|0|||
23494597|NCT00347360|65554983|FG001|Overall Study|Subject refuse to sign updated consent|0|||
23494598|NCT00347360|65554984|FG002|Overall Study|Subject refuse to sign updated consent|0|||
23494599|NCT00347360|65554985|FG003|Overall Study|Subject refuse to sign updated consent|0|||
23494600|NCT00347360|65554986|FG004|Overall Study|Subject refuse to sign updated consent|0|||
23494601|NCT00347360|65554987|FG005|Overall Study|Subject refuse to sign updated consent|0|||
23494602|NCT00347360|65554988|FG006|Overall Study|Subject refuse to sign updated consent|0|||
23494603|NCT00347360|65554989|FG007|Overall Study|Subject refuse to sign updated consent|0|||
23494604|NCT00347360|65554990|FG008|Overall Study|Subject refuse to sign updated consent|0|||
23494605|NCT00347360|65554991|FG009|Overall Study|Subject refuse to sign updated consent|0|||
23494606|NCT00347360|65554992|FG010|Overall Study|Subject refuse to sign updated consent|0|||
23494607|NCT00347360|65554993|FG011|Overall Study|Subject refuse to sign updated consent|0|||
23494608|NCT00347360|65554994|FG012|Overall Study|Subject refuse to sign updated consent|0|||
23494609|NCT00347360|65554995|FG013|Overall Study|Subject refuse to sign updated consent|0|||
23494610|NCT00347360|65554996|FG014|Overall Study|Subject refuse to sign updated consent|1|||
23494611|NCT00347360|65554982|FG000|Overall Study|Visits conflicted with new job|0|||
23494612|NCT00347360|65554983|FG001|Overall Study|Visits conflicted with new job|0|||
23494613|NCT00347360|65554984|FG002|Overall Study|Visits conflicted with new job|0|||
23494614|NCT00347360|65554985|FG003|Overall Study|Visits conflicted with new job|0|||
23494615|NCT00347360|65554986|FG004|Overall Study|Visits conflicted with new job|0|||
23676829|NCT00608985|66199068|FG003|Overall Study|Adverse Event|6|||
23676830|NCT00608985|66199065|FG000|Overall Study|Administrative/Other|7|||
23676831|NCT00608985|66199066|FG001|Overall Study|Administrative/Other|4|||
23676832|NCT00608985|66199067|FG002|Overall Study|Administrative/Other|1|||
23676833|NCT00608985|66199068|FG003|Overall Study|Administrative/Other|2|||
23676834|NCT00608985|66199065|FG000|Overall Study|Withdrawal of Consent|5|||
23676835|NCT00608985|66199066|FG001|Overall Study|Withdrawal of Consent|1|||
23676836|NCT00608985|66199067|FG002|Overall Study|Withdrawal of Consent|1|||
23676837|NCT00608985|66199068|FG003|Overall Study|Withdrawal of Consent|1|||
23388171|NCT03760666|65165967|FG000|Overall Study|Adverse Event|2|||
23388172|NCT03760666|65165968|FG001|Overall Study|Adverse Event|4|||
23676838|NCT00608985|66199065|FG000|Overall Study|Lost to Follow-up|2|||
23676839|NCT00608985|66199066|FG001|Overall Study|Lost to Follow-up|1|||
23676840|NCT00608985|66199067|FG002|Overall Study|Lost to Follow-up|0|||
23676841|NCT00608985|66199068|FG003|Overall Study|Lost to Follow-up|0|||
23388173|NCT03760666|65165969|FG002|Overall Study|Adverse Event|1|||
23388174|NCT03760666|65165967|FG000|Overall Study|AML Disease Progression|3|||
23388175|NCT03760666|65165968|FG001|Overall Study|AML Disease Progression|3|||
23388176|NCT03760666|65165969|FG002|Overall Study|AML Disease Progression|0|||
23388177|NCT03760666|65165967|FG000|Overall Study|Physician Decision|0|||
23388178|NCT03760666|65165968|FG001|Overall Study|Physician Decision|3|||
23388179|NCT03760666|65165969|FG002|Overall Study|Physician Decision|0|||
23388180|NCT03760666|65165967|FG000|Overall Study|Withdrawal by Subject|0|||
23388181|NCT03760666|65165968|FG001|Overall Study|Withdrawal by Subject|1|||
23388182|NCT03760666|65165969|FG002|Overall Study|Withdrawal by Subject|0|||
23676842|NCT03175549|66199069|FG000|Overall Study|Lost to Follow-up|2|||
23676843|NCT03175549|66199070|FG001|Overall Study|Lost to Follow-up|2|||
23676844|NCT03175549|66199069|FG000|Overall Study|Medication non-compliance|2|||
23676845|NCT03175549|66199070|FG001|Overall Study|Medication non-compliance|2|||
23676846|NCT04429061|66199073|FG000|Overall Study|Lost to Follow-up|62|||
23676847|NCT04429061|66199074|FG001|Overall Study|Lost to Follow-up|87|||
23676848|NCT04429061|66199073|FG000|Overall Study|Withdrawal by Subject|3|||
23676849|NCT04429061|66199074|FG001|Overall Study|Withdrawal by Subject|4|||
23676850|NCT01298492|66199077|FG000|Overall Study|Death|2|||
23676851|NCT01298492|66199077|FG000|Overall Study|Insufficient Clinical Response|22|||
23388183|NCT01903720|65165975|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
23388184|NCT01903720|65165975|FG000|Overall Study|Adverse Event|1|||
23388185|NCT01903720|65165975|FG000|Overall Study|Rescinding of informed consent|2|||
23388186|NCT01903720|65165975|FG000|Overall Study|Lost to Follow-up|2|||
23388187|NCT01903720|65165975|FG000|Overall Study|Treatment with alternative drug|1|||
23388188|NCT00595075|65165980|FG000|Overall Study|Withdrawal by Subject|1|||
23388189|NCT00595075|65165981|FG001|Overall Study|Withdrawal by Subject|0|||
23388190|NCT03302936|65165983|FG000|Overall Study|Protocol Violation|3|||
23388191|NCT03302936|65165984|FG001|Overall Study|Protocol Violation|4|||
23388192|NCT00736476|65165985|FG000|Overall Study|Adverse Event|1|||
23388193|NCT00736476|65165986|FG001|Overall Study|Adverse Event|0|||
23388194|NCT00576407|65165987|FG000|Overall Study|Death|7|||
23388195|NCT00576407|65165987|FG000|Overall Study|Physician Decision|1|||
23388196|NCT00395512|65165988|FG000|Overall Study|Adverse Event|3|||
23388197|NCT00395512|65165989|FG001|Overall Study|Adverse Event|8|||
23388198|NCT00395512|65165990|FG002|Overall Study|Adverse Event|6|||
23388199|NCT00395512|65165991|FG003|Overall Study|Adverse Event|6|||
23388200|NCT00395512|65165988|FG000|Overall Study|Protocol Violation|2|||
23676852|NCT01298492|66199077|FG000|Overall Study|Lost to Follow-up|12|||
23676853|NCT01298492|66199077|FG000|Overall Study|Withdrawal by Subject|47|||
23676854|NCT01298492|66199077|FG000|Overall Study|Other (Unspecified)|7|||
23388201|NCT00395512|65165989|FG001|Overall Study|Protocol Violation|3|||
23388202|NCT00395512|65165990|FG002|Overall Study|Protocol Violation|6|||
23388203|NCT00395512|65165991|FG003|Overall Study|Protocol Violation|7|||
23388204|NCT00395512|65165988|FG000|Overall Study|Lost to Follow-up|2|||
23388205|NCT00395512|65165989|FG001|Overall Study|Lost to Follow-up|6|||
23388206|NCT00395512|65165990|FG002|Overall Study|Lost to Follow-up|5|||
23388207|NCT00395512|65165991|FG003|Overall Study|Lost to Follow-up|5|||
23388208|NCT00395512|65165988|FG000|Overall Study|Withdrawal by Subject|6|||
23676855|NCT01298492|66199077|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
23676856|NCT01298492|66199077|FG000|Overall Study|Protocol Violation|2|||
23676857|NCT01298492|66199077|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
23388209|NCT00395512|65165989|FG001|Overall Study|Withdrawal by Subject|5|||
23388210|NCT00395512|65165990|FG002|Overall Study|Withdrawal by Subject|5|||
23388211|NCT00395512|65165991|FG003|Overall Study|Withdrawal by Subject|12|||
23388212|NCT00395512|65165988|FG000|Overall Study|Physician Decision|6|||
23388213|NCT00395512|65165989|FG001|Overall Study|Physician Decision|4|||
23388214|NCT00395512|65165990|FG002|Overall Study|Physician Decision|2|||
23388215|NCT00395512|65165991|FG003|Overall Study|Physician Decision|2|||
23388216|NCT00395512|65165988|FG000|Overall Study|Other|1|||
23388217|NCT00395512|65165989|FG001|Overall Study|Other|1|||
23388218|NCT00395512|65165990|FG002|Overall Study|Other|0|||
23388219|NCT00395512|65165991|FG003|Overall Study|Other|0|||
23388220|NCT00395512|65165988|FG000|Overall Study|Hyperglycemic Rescue|18|||
23388221|NCT00395512|65165989|FG001|Overall Study|Hyperglycemic Rescue|10|||
23388222|NCT00395512|65165990|FG002|Overall Study|Hyperglycemic Rescue|4|||
23388223|NCT00395512|65165991|FG003|Overall Study|Hyperglycemic Rescue|6|||
23388224|NCT02143778|65166002|FG000|Overall Study|Withdrawal by Subject|2|||
23388225|NCT02143778|65166002|FG000|Overall Study|Device malfunction|1|||
23388226|NCT02503865|65166003|FG000|Overall Study|Moved out of area|1|||
23388227|NCT02503865|65166004|FG001|Overall Study|Moved out of area|8|||
23388228|NCT02503865|65166005|FG002|Overall Study|Moved out of area|0|||
23388229|NCT02503865|65166003|FG000|Overall Study|Refused treatment|4|||
23388230|NCT02503865|65166004|FG001|Overall Study|Refused treatment|39|||
23388231|NCT02503865|65166005|FG002|Overall Study|Refused treatment|2|||
23388232|NCT00983957|65166006|FG000|Overall Study|Adverse Event|1|||
23388233|NCT00983957|65166006|FG000|Overall Study|Personal Reasons|1|||
23388234|NCT03954938|65166007|FG000|Overall Study|Withdrawal by Subject|2|||
23388235|NCT03954938|65166007|FG000|Overall Study|Adverse Event|1|||
23494616|NCT00347360|65554987|FG005|Overall Study|Visits conflicted with new job|0|||
23494617|NCT00347360|65554988|FG006|Overall Study|Visits conflicted with new job|1|||
23494618|NCT00347360|65554989|FG007|Overall Study|Visits conflicted with new job|0|||
23388236|NCT04829214|65166008|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
23388237|NCT04829214|65166009|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
23388238|NCT04829214|65166008|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
23388239|NCT04829214|65166009|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
23388240|NCT00425854|65166010|FG000|Overall Study|Progressive Disease|19|||
23494619|NCT00347360|65554990|FG008|Overall Study|Visits conflicted with new job|0|||
23494620|NCT00347360|65554991|FG009|Overall Study|Visits conflicted with new job|0|||
23494621|NCT00347360|65554992|FG010|Overall Study|Visits conflicted with new job|0|||
23494622|NCT00347360|65554993|FG011|Overall Study|Visits conflicted with new job|0|||
23494623|NCT00347360|65554994|FG012|Overall Study|Visits conflicted with new job|0|||
23494624|NCT00347360|65554995|FG013|Overall Study|Visits conflicted with new job|0|||
23494625|NCT00347360|65554996|FG014|Overall Study|Visits conflicted with new job|0|||
23494626|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
23494627|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
23494628|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
23494629|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
23494630|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
23494631|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
23494632|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
23494633|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
23494634|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
23494635|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
23494636|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
23494637|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
23494638|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
23494639|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494640|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494641|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494642|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494643|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494644|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494645|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494646|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494647|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494648|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Death|4|||
23494649|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Death|4|||
23494650|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Death|0|||
23494651|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Death|0|||
23494652|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Death|0|||
23494653|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Death|0|||
23494654|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Death|0|||
23494655|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Death|0|||
23494656|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Death|0|||
23494657|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Death|0|||
23494658|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Death|0|||
23494659|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
23494660|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
23494661|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
23494662|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
23494663|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
23494664|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
23494665|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
23494666|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
23494667|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
23494668|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
23494669|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
23494670|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
23388241|NCT00425854|65166011|FG001|Overall Study|Progressive Disease|12|||
23388242|NCT00425854|65166010|FG000|Overall Study|Dose reduction toxicity AE|8|||
23388243|NCT00425854|65166011|FG001|Overall Study|Dose reduction toxicity AE|7|||
23388244|NCT00425854|65166010|FG000|Overall Study|Other Adverse Event|2|||
23388245|NCT00425854|65166011|FG001|Overall Study|Other Adverse Event|2|||
23388246|NCT00985192|65166024|FG000|Overall Study|Withdrawal by Subject|1|||
23388247|NCT00985192|65166024|FG000|Overall Study|Disease Progression|1|||
23388248|NCT00985192|65166024|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
23388249|NCT00754559|65166025|FG000|Overall Study|Adverse Event|15|||
23388250|NCT00754559|65166025|FG000|Overall Study|Protocol Violation|11|||
23388251|NCT00754559|65166025|FG000|Overall Study|Lack of Efficacy|10|||
23388252|NCT00754559|65166025|FG000|Overall Study|Lost to Follow-up|2|||
23388253|NCT00754559|65166025|FG000|Overall Study|Administrative reason|1|||
23388254|NCT00754559|65166025|FG000|Overall Study|Other|5|||
23388255|NCT00754559|65166025|FG000|Overall Study|Withdrawal by Subject|3|||
23388256|NCT01454063|65166026|FG000|Randomized|Adverse Event|1|||
23388257|NCT01454063|65166027|FG001|Randomized|Adverse Event|1|||
23388258|NCT01454063|65166026|FG000|Randomized|Protocol Violation|0|||
23388259|NCT01454063|65166027|FG001|Randomized|Protocol Violation|1|||
23388260|NCT00819832|65166028|FG000|Overall Study|Sponsor Termination of Study|3|||
23388261|NCT00819832|65166029|FG001|Overall Study|Sponsor Termination of Study|0|||
23388262|NCT00819832|65166030|FG002|Overall Study|Sponsor Termination of Study|0|||
23388263|NCT00819832|65166031|FG003|Overall Study|Sponsor Termination of Study|0|||
23388264|NCT00819832|65166032|FG004|Overall Study|Sponsor Termination of Study|0|||
23388265|NCT00819832|65166033|FG005|Overall Study|Sponsor Termination of Study|0|||
23388266|NCT03335566|65166034|FG000|Overall Study|Adverse Event|0|||
23388267|NCT03335566|65166035|FG001|Overall Study|Adverse Event|1|||
23388268|NCT03335566|65166034|FG000|Overall Study|Lost to Follow-up|1|||
23388269|NCT03335566|65166035|FG001|Overall Study|Lost to Follow-up|0|||
23388270|NCT03335566|65166034|FG000|Overall Study|Technical Problems|1|||
23388271|NCT03335566|65166035|FG001|Overall Study|Technical Problems|0|||
23388272|NCT03335566|65166034|FG000|Overall Study|Protocol Violation|1|||
23388273|NCT03335566|65166035|FG001|Overall Study|Protocol Violation|0|||
23388274|NCT03335566|65166034|FG000|Overall Study|Other than specified above|1|||
23388275|NCT03335566|65166035|FG001|Overall Study|Other than specified above|2|||
23388276|NCT01189227|65166039|FG000|Overall Study|Study terminated due to low accrual|6|||
23388277|NCT01189227|65166040|FG001|Overall Study|Study terminated due to low accrual|3|||
23388278|NCT01371565|65166041|FG000|Overall Study|Withdrawal by Subject|1|||
23388279|NCT01371565|65166041|FG000|Overall Study|Death|1|||
23388280|NCT01371565|65166041|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
23388281|NCT04191733|65166046|FG000|Overall Study|Withdrawn due to study closure|13|||
23388282|NCT04191733|65166047|FG001|Overall Study|Withdrawn due to study closure|14|||
23388283|NCT04191733|65166046|FG000|Overall Study|Withdrawal by Subject|2|||
23388284|NCT04191733|65166047|FG001|Overall Study|Withdrawal by Subject|4|||
23388285|NCT04191733|65166046|FG000|Overall Study|Physician Decision|1|||
23388286|NCT04191733|65166047|FG001|Overall Study|Physician Decision|1|||
23388287|NCT04191733|65166046|FG000|Overall Study|Lost to Follow-up|5|||
23388288|NCT04191733|65166047|FG001|Overall Study|Lost to Follow-up|6|||
23388289|NCT04191733|65166046|FG000|Overall Study|Death|0|||
23388290|NCT04191733|65166047|FG001|Overall Study|Death|1|||
23388291|NCT04605588|65166048|FG000|Overall Study|Withdrawal by Subject|1|||
23388292|NCT04605588|65166049|FG001|Overall Study|Withdrawal by Subject|0|||
23388293|NCT02642679|65166050|FG000|Overall Study|Withdrawal by Subject|1|||
23388294|NCT02642679|65166050|FG000|Overall Study|Physician Decision|1|||
23388295|NCT02642679|65166050|FG000|Overall Study|Physician Decision|1|||
23388296|NCT00890097|65166053|FG000|Overall Study|Adverse Event|21|||
23388297|NCT00890097|65166054|FG001|Overall Study|Adverse Event|32|||
23388298|NCT00890097|65166055|FG002|Overall Study|Adverse Event|28|||
23388299|NCT00890097|65166053|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
23494671|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
23388300|NCT00890097|65166054|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
23388301|NCT00890097|65166055|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
23388302|NCT00890097|65166053|FG000|Overall Study|Withdrew Consent|9|||
23388303|NCT00890097|65166054|FG001|Overall Study|Withdrew Consent|6|||
23388304|NCT00890097|65166055|FG002|Overall Study|Withdrew Consent|9|||
23388305|NCT00890097|65166053|FG000|Overall Study|Lost to Follow-up|5|||
23388306|NCT00890097|65166054|FG001|Overall Study|Lost to Follow-up|5|||
23388307|NCT00890097|65166055|FG002|Overall Study|Lost to Follow-up|5|||
23388308|NCT00890097|65166053|FG000|Overall Study|Noncompliance|0|||
23388309|NCT00890097|65166054|FG001|Overall Study|Noncompliance|4|||
23388310|NCT00890097|65166055|FG002|Overall Study|Noncompliance|4|||
23388311|NCT00890097|65166053|FG000|Overall Study|Sponsor Decision|7|||
23388312|NCT00890097|65166054|FG001|Overall Study|Sponsor Decision|11|||
23388313|NCT00890097|65166055|FG002|Overall Study|Sponsor Decision|7|||
23388314|NCT00890097|65166053|FG000|Overall Study|Did not attend final visit|2|||
23388315|NCT00890097|65166054|FG001|Overall Study|Did not attend final visit|3|||
23388316|NCT00890097|65166055|FG002|Overall Study|Did not attend final visit|0|||
23388317|NCT00890097|65166053|FG000|Overall Study|Subject Decision|3|||
23388318|NCT00890097|65166054|FG001|Overall Study|Subject Decision|2|||
23388319|NCT00890097|65166055|FG002|Overall Study|Subject Decision|6|||
23388320|NCT00890097|65166053|FG000|Overall Study|Randomization Error|2|||
23388321|NCT00890097|65166054|FG001|Overall Study|Randomization Error|0|||
23388322|NCT00890097|65166055|FG002|Overall Study|Randomization Error|0|||
23388323|NCT00890097|65166053|FG000|Overall Study|Failed inclusion criteria|3|||
23388324|NCT00890097|65166054|FG001|Overall Study|Failed inclusion criteria|4|||
23388325|NCT00890097|65166055|FG002|Overall Study|Failed inclusion criteria|0|||
23388326|NCT00890097|65166053|FG000|Overall Study|Transportation|0|||
23388327|NCT00890097|65166054|FG001|Overall Study|Transportation|2|||
23388328|NCT00890097|65166055|FG002|Overall Study|Transportation|0|||
23388329|NCT00890097|65166053|FG000|Overall Study|Subject Moved|0|||
23388330|NCT00890097|65166054|FG001|Overall Study|Subject Moved|4|||
23388331|NCT00890097|65166055|FG002|Overall Study|Subject Moved|0|||
23388332|NCT00890097|65166053|FG000|Overall Study|Protocol Deviation|1|||
23388333|NCT00890097|65166054|FG001|Overall Study|Protocol Deviation|1|||
23388334|NCT00890097|65166055|FG002|Overall Study|Protocol Deviation|1|||
23388335|NCT00231465|65166056|FG000|Overall Study|Completed only one cycle|1|||
23388336|NCT00231465|65166056|FG000|Overall Study|Did not have follow up CT scans|1|||
23388337|NCT01341990|65166059|FG000|Overall Study|Adverse Event|0|||
23388338|NCT01341990|65166060|FG001|Overall Study|Adverse Event|1|||
23388339|NCT01341990|65166059|FG000|Overall Study|Torn Study Lens|1|||
23388340|NCT01341990|65166060|FG001|Overall Study|Torn Study Lens|0|||
23388341|NCT01341990|65166059|FG000|Overall Study|Withdrawal by Subject|2|||
23676858|NCT01298492|66199077|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
23676859|NCT00429585|66199078|FG000|Overall Study|Death|1|||
23676860|NCT00429585|66199079|FG001|Overall Study|Death|0|||
23676861|NCT00429585|66199078|FG000|Overall Study|Lost to Follow-up|27|||
23676862|NCT00429585|66199079|FG001|Overall Study|Lost to Follow-up|20|||
23676863|NCT00429585|66199078|FG000|Overall Study|Physician Decision|2|||
23676864|NCT00429585|66199079|FG001|Overall Study|Physician Decision|0|||
23676865|NCT00704964|66199082|FG000|Overall Study|Not completed on time|328|||
23676866|NCT02684981|66199083|FG000|Overall Study|Permanently discontinued the treatment|157|||
23676867|NCT02684981|66199084|FG001|Overall Study|Permanently discontinued the treatment|161|||
23676868|NCT02684981|66199085|FG002|Overall Study|Permanently discontinued the treatment|110|||
23676869|NCT02684981|66199083|FG000|Overall Study|Other|83|||
23676870|NCT02684981|66199084|FG001|Overall Study|Other|49|||
23676871|NCT02684981|66199085|FG002|Overall Study|Other|17|||
23676872|NCT01703858|66199093|FG000|Overall Study|Withdrawal by Subject|0|||
23676873|NCT01703858|66199094|FG001|Overall Study|Withdrawal by Subject|1|||
23676874|NCT01703858|66199095|FG002|Overall Study|Withdrawal by Subject|0|||
23676875|NCT01777581|66199104|FG000|Overall Study|Lost to Follow-up|1|||
23676876|NCT01777581|66199105|FG001|Overall Study|Lost to Follow-up|1|||
23676877|NCT01777581|66199104|FG000|Overall Study|Adverse Event|2|||
23388342|NCT01341990|65166060|FG001|Overall Study|Withdrawal by Subject|0|||
23676878|NCT01777581|66199105|FG001|Overall Study|Adverse Event|0|||
23676879|NCT01777581|66199104|FG000|Overall Study|Lack of Efficacy|0|||
23676880|NCT01777581|66199105|FG001|Overall Study|Lack of Efficacy|1|||
23388343|NCT02829957|65166063|FG000|Overall Study|Lost to Follow-up|2|||
23676881|NCT02499029|66199108|FG000|Overall Study|Lost to Follow-up|2|||
23388344|NCT02829957|65166064|FG001|Overall Study|Lost to Follow-up|1|||
23388345|NCT00489476|65168704|FG000|Overall Study|Lost to Follow-up|0|||
23388346|NCT00489476|65168705|FG001|Overall Study|Lost to Follow-up|1|||
23388347|NCT00489476|65168706|FG002|Overall Study|Lost to Follow-up|0|||
23676882|NCT02499029|66199109|FG001|Overall Study|Lost to Follow-up|2|||
23388348|NCT00489476|65168707|FG003|Overall Study|Lost to Follow-up|0|||
23388349|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Adverse Event|2|||
23388350|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Adverse Event|0|||
23388351|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Physician Decision|0|||
23494672|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
23494673|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
23388352|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Physician Decision|1|||
23494674|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494675|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494676|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
23388353|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
23388354|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
23388355|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
23388356|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
23388357|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
23388358|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
23388359|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
23388360|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
23388361|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
23388362|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
23388363|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
23388364|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
23388365|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
23388366|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
23388367|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
23388368|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
23388369|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
23388370|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
23388371|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
23388372|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
23388373|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
23494677|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
23676883|NCT02499029|66199108|FG000|Overall Study|Physician Decision|2|||
23676884|NCT02499029|66199109|FG001|Overall Study|Physician Decision|1|||
23676885|NCT02499029|66199108|FG000|Overall Study|Death|1|||
23676886|NCT02499029|66199109|FG001|Overall Study|Death|0|||
23676887|NCT00074958|66199111|FG000|Overall Study|Adverse Event|1|||
23676888|NCT05594173|66199112|FG000|Overall Study|Adverse Event|1|||
23676889|NCT05594173|66199112|FG000|Overall Study|COVID-19 Pandemic|2|||
23676890|NCT00328627|66199113|FG000|Overall Study|Hyperglycemic Rescue|41|||
23676891|NCT00328627|66199114|FG001|Overall Study|Hyperglycemic Rescue|18|||
23676892|NCT00328627|66199115|FG002|Overall Study|Hyperglycemic Rescue|16|||
23676893|NCT00328627|66199116|FG003|Overall Study|Hyperglycemic Rescue|13|||
23676894|NCT00328627|66199117|FG004|Overall Study|Hyperglycemic Rescue|6|||
23676895|NCT00328627|66199118|FG005|Overall Study|Hyperglycemic Rescue|5|||
23676896|NCT00328627|66199119|FG006|Overall Study|Hyperglycemic Rescue|19|||
23676897|NCT00328627|66199120|FG007|Overall Study|Hyperglycemic Rescue|6|||
23676898|NCT00328627|66199121|FG008|Overall Study|Hyperglycemic Rescue|6|||
23676899|NCT00328627|66199122|FG009|Overall Study|Hyperglycemic Rescue|11|||
23676900|NCT00328627|66199123|FG010|Overall Study|Hyperglycemic Rescue|3|||
23676901|NCT00328627|66199124|FG011|Overall Study|Hyperglycemic Rescue|2|||
23676902|NCT00328627|66199113|FG000|Overall Study|Adverse Event|3|||
23676903|NCT00328627|66199114|FG001|Overall Study|Adverse Event|1|||
23676904|NCT00328627|66199115|FG002|Overall Study|Adverse Event|2|||
23676905|NCT00328627|66199116|FG003|Overall Study|Adverse Event|3|||
23388374|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
23388375|NCT02633527|65168710|FG000|Overall Study|Failed to meet eligibility|0|||
23388376|NCT02633527|65168711|FG001|Overall Study|Failed to meet eligibility|1|||
23388377|NCT02633527|65168712|FG002|Overall Study|Failed to meet eligibility|1|||
23676906|NCT00328627|66199117|FG004|Overall Study|Adverse Event|1|||
23676907|NCT00328627|66199118|FG005|Overall Study|Adverse Event|2|||
23676908|NCT00328627|66199119|FG006|Overall Study|Adverse Event|1|||
23676909|NCT00328627|66199120|FG007|Overall Study|Adverse Event|2|||
23676910|NCT00328627|66199121|FG008|Overall Study|Adverse Event|0|||
23676911|NCT00328627|66199122|FG009|Overall Study|Adverse Event|7|||
23676912|NCT00328627|66199123|FG010|Overall Study|Adverse Event|5|||
23676913|NCT00328627|66199124|FG011|Overall Study|Adverse Event|4|||
23676914|NCT00328627|66199113|FG000|Overall Study|Protocol Violation|2|||
23676915|NCT00328627|66199114|FG001|Overall Study|Protocol Violation|2|||
23676916|NCT00328627|66199115|FG002|Overall Study|Protocol Violation|2|||
23676917|NCT00328627|66199116|FG003|Overall Study|Protocol Violation|8|||
23676918|NCT00328627|66199117|FG004|Overall Study|Protocol Violation|5|||
23676919|NCT00328627|66199118|FG005|Overall Study|Protocol Violation|5|||
23676920|NCT00328627|66199119|FG006|Overall Study|Protocol Violation|6|||
23676921|NCT00328627|66199120|FG007|Overall Study|Protocol Violation|2|||
23676922|NCT00328627|66199121|FG008|Overall Study|Protocol Violation|1|||
23676923|NCT00328627|66199122|FG009|Overall Study|Protocol Violation|4|||
23676924|NCT00328627|66199123|FG010|Overall Study|Protocol Violation|6|||
23676925|NCT00328627|66199124|FG011|Overall Study|Protocol Violation|2|||
23676926|NCT00328627|66199113|FG000|Overall Study|Lost to Follow-up|4|||
23676927|NCT00328627|66199114|FG001|Overall Study|Lost to Follow-up|2|||
23676928|NCT00328627|66199115|FG002|Overall Study|Lost to Follow-up|2|||
23676929|NCT00328627|66199116|FG003|Overall Study|Lost to Follow-up|4|||
23676930|NCT00328627|66199117|FG004|Overall Study|Lost to Follow-up|0|||
23676931|NCT00328627|66199118|FG005|Overall Study|Lost to Follow-up|2|||
23676932|NCT00328627|66199119|FG006|Overall Study|Lost to Follow-up|3|||
23676933|NCT00328627|66199120|FG007|Overall Study|Lost to Follow-up|0|||
23676934|NCT00328627|66199121|FG008|Overall Study|Lost to Follow-up|3|||
23676935|NCT00328627|66199122|FG009|Overall Study|Lost to Follow-up|2|||
23676936|NCT00328627|66199123|FG010|Overall Study|Lost to Follow-up|0|||
23676937|NCT00328627|66199124|FG011|Overall Study|Lost to Follow-up|1|||
23676938|NCT00328627|66199113|FG000|Overall Study|Withdrawal by Subject|5|||
23676939|NCT00328627|66199114|FG001|Overall Study|Withdrawal by Subject|4|||
23676940|NCT00328627|66199115|FG002|Overall Study|Withdrawal by Subject|5|||
23676941|NCT00328627|66199116|FG003|Overall Study|Withdrawal by Subject|6|||
23676942|NCT00328627|66199117|FG004|Overall Study|Withdrawal by Subject|2|||
23676943|NCT00328627|66199118|FG005|Overall Study|Withdrawal by Subject|5|||
23388378|NCT02633527|65168713|FG003|Overall Study|Failed to meet eligibility|0|||
23388379|NCT02633527|65168714|FG004|Overall Study|Failed to meet eligibility|1|||
23388380|NCT02633527|65168710|FG000|Overall Study|Adverse Event|0|||
23388381|NCT02633527|65168711|FG001|Overall Study|Adverse Event|4|||
23388382|NCT02633527|65168712|FG002|Overall Study|Adverse Event|3|||
23388383|NCT02633527|65168713|FG003|Overall Study|Adverse Event|1|||
23388384|NCT02633527|65168714|FG004|Overall Study|Adverse Event|5|||
23388385|NCT02633527|65168710|FG000|Overall Study|Lost to Follow-up|1|||
23388386|NCT02633527|65168711|FG001|Overall Study|Lost to Follow-up|2|||
23388387|NCT02633527|65168712|FG002|Overall Study|Lost to Follow-up|5|||
23388388|NCT02633527|65168713|FG003|Overall Study|Lost to Follow-up|5|||
23388389|NCT02633527|65168714|FG004|Overall Study|Lost to Follow-up|4|||
23388390|NCT02633527|65168710|FG000|Overall Study|Withdrawal by Subject|0|||
23388391|NCT02633527|65168711|FG001|Overall Study|Withdrawal by Subject|3|||
23676944|NCT00328627|66199119|FG006|Overall Study|Withdrawal by Subject|4|||
23676945|NCT00328627|66199120|FG007|Overall Study|Withdrawal by Subject|4|||
23676946|NCT00328627|66199121|FG008|Overall Study|Withdrawal by Subject|4|||
23388392|NCT02633527|65168712|FG002|Overall Study|Withdrawal by Subject|5|||
23494678|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
23676947|NCT00328627|66199122|FG009|Overall Study|Withdrawal by Subject|5|||
23676948|NCT00328627|66199123|FG010|Overall Study|Withdrawal by Subject|2|||
23676949|NCT00328627|66199124|FG011|Overall Study|Withdrawal by Subject|7|||
23388393|NCT02633527|65168713|FG003|Overall Study|Withdrawal by Subject|4|||
23388394|NCT02633527|65168714|FG004|Overall Study|Withdrawal by Subject|4|||
23676950|NCT00328627|66199113|FG000|Overall Study|Pregnancy|0|||
23676951|NCT00328627|66199114|FG001|Overall Study|Pregnancy|1|||
23388395|NCT02633527|65168710|FG000|Overall Study|Protocol Violation|0|||
23388396|NCT02633527|65168711|FG001|Overall Study|Protocol Violation|1|||
23388397|NCT02633527|65168712|FG002|Overall Study|Protocol Violation|1|||
23388398|NCT02633527|65168713|FG003|Overall Study|Protocol Violation|1|||
23388399|NCT02633527|65168714|FG004|Overall Study|Protocol Violation|1|||
23388400|NCT02633527|65168710|FG000|Overall Study|Physician Decision|0|||
23388401|NCT02633527|65168711|FG001|Overall Study|Physician Decision|0|||
23388402|NCT02633527|65168712|FG002|Overall Study|Physician Decision|0|||
23388403|NCT02633527|65168713|FG003|Overall Study|Physician Decision|0|||
23388404|NCT02633527|65168714|FG004|Overall Study|Physician Decision|1|||
23388405|NCT02633527|65168710|FG000|Overall Study|Administrative reason|1|||
23388406|NCT02633527|65168711|FG001|Overall Study|Administrative reason|0|||
23388407|NCT02633527|65168712|FG002|Overall Study|Administrative reason|0|||
23388408|NCT02633527|65168713|FG003|Overall Study|Administrative reason|1|||
23388409|NCT02633527|65168714|FG004|Overall Study|Administrative reason|0|||
23388410|NCT02633527|65168710|FG000|Overall Study|Multiple reasons|1|||
23388411|NCT02633527|65168711|FG001|Overall Study|Multiple reasons|0|||
23388412|NCT02633527|65168712|FG002|Overall Study|Multiple reasons|2|||
23388413|NCT02633527|65168713|FG003|Overall Study|Multiple reasons|2|||
23388414|NCT02633527|65168714|FG004|Overall Study|Multiple reasons|1|||
23388415|NCT00107614|65168716|FG000|Overall Study|Physician Decision|10|||
23388416|NCT00107614|65168716|FG000|Overall Study|Death|2|||
23388417|NCT01903733|65168717|FG000|Overall Study|Death|23|||
23676952|NCT00328627|66199115|FG002|Overall Study|Pregnancy|0|||
23676953|NCT00328627|66199116|FG003|Overall Study|Pregnancy|0|||
23676954|NCT00328627|66199117|FG004|Overall Study|Pregnancy|0|||
23676955|NCT00328627|66199118|FG005|Overall Study|Pregnancy|0|||
23676956|NCT00328627|66199119|FG006|Overall Study|Pregnancy|0|||
23676957|NCT00328627|66199120|FG007|Overall Study|Pregnancy|0|||
23676958|NCT00328627|66199121|FG008|Overall Study|Pregnancy|0|||
23676959|NCT00328627|66199122|FG009|Overall Study|Pregnancy|0|||
23388418|NCT01903733|65168718|FG001|Overall Study|Death|54|||
23388419|NCT01903733|65168719|FG002|Overall Study|Death|30|||
23388420|NCT01903733|65168720|FG003|Overall Study|Death|98|||
23388421|NCT01903733|65168717|FG000|Overall Study|Participant refused further follow-up|35|||
23388422|NCT01903733|65168718|FG001|Overall Study|Participant refused further follow-up|38|||
23388423|NCT01903733|65168719|FG002|Overall Study|Participant refused further follow-up|13|||
23676960|NCT00328627|66199123|FG010|Overall Study|Pregnancy|0|||
23388424|NCT01903733|65168720|FG003|Overall Study|Participant refused further follow-up|9|||
23676961|NCT00328627|66199124|FG011|Overall Study|Pregnancy|0|||
23676962|NCT00328627|66199113|FG000|Overall Study|Physician Decision|4|||
23388425|NCT01903733|65168717|FG000|Overall Study|Lost to Follow-up|18|||
23388426|NCT01903733|65168718|FG001|Overall Study|Lost to Follow-up|19|||
23388427|NCT01903733|65168719|FG002|Overall Study|Lost to Follow-up|6|||
23388428|NCT01903733|65168720|FG003|Overall Study|Lost to Follow-up|9|||
23388429|NCT01903733|65168717|FG000|Overall Study|Other|10|||
23388430|NCT01903733|65168718|FG001|Overall Study|Other|15|||
23388431|NCT01903733|65168719|FG002|Overall Study|Other|12|||
23388432|NCT01903733|65168720|FG003|Overall Study|Other|3|||
23388433|NCT01903733|65168717|FG000|Overall Study|Missing|2|||
23388434|NCT01903733|65168718|FG001|Overall Study|Missing|0|||
23388435|NCT01903733|65168719|FG002|Overall Study|Missing|0|||
23388436|NCT01903733|65168720|FG003|Overall Study|Missing|0|||
23388437|NCT01903733|65168717|FG000|Overall Study|Investigator request|18|||
23388438|NCT01903733|65168718|FG001|Overall Study|Investigator request|0|||
23388439|NCT01903733|65168719|FG002|Overall Study|Investigator request|0|||
23388440|NCT01903733|65168720|FG003|Overall Study|Investigator request|0|||
23388441|NCT00052715|65168722|FG000|Overall Study|wrong histology|1|||
23388442|NCT03721965|65168723|FG000|Overall Study|Death|1|||
23388443|NCT03721965|65168723|FG000|Overall Study|Study Terminated by Sponsor|1|||
23388444|NCT02100644|65168726|FG000|LTG Escalation Phase|Adverse Event|9|||
23388445|NCT02100644|65168727|FG001|LTG Escalation Phase|Adverse Event|0|||
23388446|NCT02100644|65168728|FG002|LTG Escalation Phase|Adverse Event|0|||
23388447|NCT02100644|65168726|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
23388448|NCT02100644|65168727|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
23388449|NCT02100644|65168728|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
23388450|NCT02100644|65168726|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
23388451|NCT02100644|65168727|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
23388452|NCT02100644|65168728|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
23388453|NCT03048019|65168729|FG000|Overall Study|Adverse Event|1|||
23388454|NCT03048019|65168730|FG001|Overall Study|Adverse Event|0|||
23388455|NCT04634331|65168731|FG000|Overall Study|Withdrawal by Subject|2|||
23388456|NCT04634331|65168732|FG001|Overall Study|Withdrawal by Subject|2|||
23388457|NCT02837952|65168734|FG000|Overall Study|Adverse Event|0|||
23388458|NCT02837952|65168735|FG001|Overall Study|Adverse Event|1|||
23388459|NCT02837952|65168734|FG000|Overall Study|Withdrawal by Subject|4|||
23388460|NCT02837952|65168735|FG001|Overall Study|Withdrawal by Subject|5|||
23388461|NCT02837952|65168734|FG000|Overall Study|Medication Error|1|||
23388462|NCT02837952|65168735|FG001|Overall Study|Medication Error|0|||
23388463|NCT01786109|65168736|FG000|Overall Study|fail manometry barostat tube placement|1|||
23388464|NCT01786109|65168737|FG001|Overall Study|fail manometry barostat tube placement|0|||
23388465|NCT01786109|65168738|FG002|Overall Study|fail manometry barostat tube placement|0|||
23494679|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494680|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
23388466|NCT01786109|65168736|FG000|Overall Study|unrelated illness|0|||
23388467|NCT01786109|65168737|FG001|Overall Study|unrelated illness|0|||
23388468|NCT01786109|65168738|FG002|Overall Study|unrelated illness|1|||
23388469|NCT01786109|65168736|FG000|Overall Study|adverse effects colon preparation|0|||
23388470|NCT01786109|65168737|FG001|Overall Study|adverse effects colon preparation|0|||
23388471|NCT01786109|65168738|FG002|Overall Study|adverse effects colon preparation|1|||
23388472|NCT00236197|65168740|FG000|Overall Study|Withdrawal by Subject|3|||
23676963|NCT00328627|66199114|FG001|Overall Study|Physician Decision|3|||
23676964|NCT00328627|66199115|FG002|Overall Study|Physician Decision|1|||
23676965|NCT00328627|66199116|FG003|Overall Study|Physician Decision|2|||
23676966|NCT00328627|66199117|FG004|Overall Study|Physician Decision|1|||
23676967|NCT00328627|66199118|FG005|Overall Study|Physician Decision|1|||
23676968|NCT00328627|66199119|FG006|Overall Study|Physician Decision|1|||
23676969|NCT00328627|66199120|FG007|Overall Study|Physician Decision|0|||
23388473|NCT00236197|65168741|FG001|Overall Study|Withdrawal by Subject|2|||
23388474|NCT00236197|65168740|FG000|Overall Study|Lost to Follow-up|1|||
23388475|NCT00236197|65168741|FG001|Overall Study|Lost to Follow-up|5|||
23388476|NCT00236197|65168740|FG000|Overall Study|Protocol Violation|0|||
23388477|NCT00236197|65168741|FG001|Overall Study|Protocol Violation|3|||
23388478|NCT00236197|65168740|FG000|Overall Study|Medication non-compliance|1|||
23388479|NCT00236197|65168741|FG001|Overall Study|Medication non-compliance|2|||
23388480|NCT00236197|65168740|FG000|Overall Study|Other|0|||
23388481|NCT00236197|65168741|FG001|Overall Study|Other|2|||
23388482|NCT04065841|65168743|FG000|Overall Study|Adverse Event|4|||
23388483|NCT04065841|65168744|FG001|Overall Study|Adverse Event|2|||
23388484|NCT04065841|65168745|FG002|Overall Study|Adverse Event|10|||
23388485|NCT04065841|65168746|FG003|Overall Study|Adverse Event|1|||
23388486|NCT04065841|65168743|FG000|Overall Study|Lost to Follow-up|1|||
23676970|NCT00328627|66199121|FG008|Overall Study|Physician Decision|3|||
23676971|NCT00328627|66199122|FG009|Overall Study|Physician Decision|2|||
23388487|NCT04065841|65168744|FG001|Overall Study|Lost to Follow-up|2|||
23388488|NCT04065841|65168745|FG002|Overall Study|Lost to Follow-up|2|||
23676972|NCT00328627|66199123|FG010|Overall Study|Physician Decision|1|||
23676973|NCT00328627|66199124|FG011|Overall Study|Physician Decision|0|||
23388489|NCT04065841|65168746|FG003|Overall Study|Lost to Follow-up|2|||
23388490|NCT04065841|65168743|FG000|Overall Study|Physician Decision|1|||
23388491|NCT04065841|65168744|FG001|Overall Study|Physician Decision|0|||
23676974|NCT00328627|66199113|FG000|Overall Study|Other|0|||
23676975|NCT00328627|66199114|FG001|Overall Study|Other|0|||
23676976|NCT00328627|66199115|FG002|Overall Study|Other|0|||
23676977|NCT00328627|66199116|FG003|Overall Study|Other|1|||
23676978|NCT00328627|66199117|FG004|Overall Study|Other|0|||
23676979|NCT00328627|66199118|FG005|Overall Study|Other|0|||
23676980|NCT00328627|66199119|FG006|Overall Study|Other|1|||
23676981|NCT00328627|66199120|FG007|Overall Study|Other|0|||
23676982|NCT00328627|66199121|FG008|Overall Study|Other|0|||
23676983|NCT00328627|66199122|FG009|Overall Study|Other|1|||
23676984|NCT00328627|66199123|FG010|Overall Study|Other|1|||
23676985|NCT00328627|66199124|FG011|Overall Study|Other|0|||
23676986|NCT03694925|66199125|FG000|Overall Study|Inadequate laboratory testing|0|||
23676987|NCT03694925|66199126|FG001|Overall Study|Inadequate laboratory testing|3|||
23676988|NCT03694925|66199127|FG002|Overall Study|Inadequate laboratory testing|0|||
23676989|NCT01847885|66199132|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
23676990|NCT01847885|66199133|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
23676991|NCT01847885|66199134|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
23676992|NCT01847885|66199132|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
23676993|NCT01847885|66199133|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
23676994|NCT01847885|66199134|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
23676995|NCT01847885|66199132|FG000|Initial Enrollment (Consented)|Screen failure|39|||
23676996|NCT01847885|66199133|FG001|Initial Enrollment (Consented)|Screen failure|0|||
23676997|NCT01847885|66199134|FG002|Initial Enrollment (Consented)|Screen failure|0|||
23676998|NCT01847885|66199132|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
23676999|NCT01847885|66199133|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
23677000|NCT01847885|66199134|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
23677001|NCT01847885|66199132|FG000|Randomization|Protocol Violation|0|||
23677002|NCT01847885|66199133|FG001|Randomization|Protocol Violation|1|||
23677003|NCT01847885|66199134|FG002|Randomization|Protocol Violation|0|||
23677004|NCT01847885|66199132|FG000|Randomization|Withdrawal by Subject|0|||
23677005|NCT01847885|66199133|FG001|Randomization|Withdrawal by Subject|0|||
23677006|NCT01847885|66199134|FG002|Randomization|Withdrawal by Subject|2|||
23677007|NCT01847885|66199132|FG000|Randomization|Screen Failure|0|||
23677008|NCT01847885|66199133|FG001|Randomization|Screen Failure|3|||
23677009|NCT01847885|66199134|FG002|Randomization|Screen Failure|0|||
23677010|NCT01239160|66199135|FG000|Overall Study|Lost to Follow-up|3|||
23677011|NCT01239160|66199136|FG001|Overall Study|Lost to Follow-up|5|||
23677012|NCT01239160|66199137|FG002|Overall Study|Lost to Follow-up|0|||
23677013|NCT01239160|66199135|FG000|Overall Study|Withdrawal by Subject|17|||
23677014|NCT01239160|66199136|FG001|Overall Study|Withdrawal by Subject|6|||
23677015|NCT01239160|66199137|FG002|Overall Study|Withdrawal by Subject|2|||
23677016|NCT01239160|66199135|FG000|Overall Study|Physician Decision|5|||
23677017|NCT01239160|66199136|FG001|Overall Study|Physician Decision|7|||
23677018|NCT01239160|66199137|FG002|Overall Study|Physician Decision|2|||
23677019|NCT01239160|66199135|FG000|Overall Study|Early Termination Due to Study Closure|0|||
23677020|NCT01239160|66199136|FG001|Overall Study|Early Termination Due to Study Closure|1|||
23677021|NCT01239160|66199137|FG002|Overall Study|Early Termination Due to Study Closure|6|||
23677022|NCT04002310|66199170|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
23677023|NCT04002310|66199171|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
23677024|NCT04002310|66199172|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
23677025|NCT04002310|66199173|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
23677026|NCT04002310|66199174|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
23677027|NCT02340663|66199175|FG000|Overall Study|Lost to Follow-up|1|||
23677028|NCT02340663|66199176|FG001|Overall Study|Lost to Follow-up|0|||
23677029|NCT02340663|66199175|FG000|Overall Study|Protocol Violation|1|||
23677030|NCT02340663|66199176|FG001|Overall Study|Protocol Violation|0|||
23677031|NCT02340663|66199175|FG000|Overall Study|Withdrawal by Subject|3|||
23677032|NCT02340663|66199176|FG001|Overall Study|Withdrawal by Subject|1|||
23677033|NCT02706730|66199177|FG000|Overall Study|Adverse Event|3|||
23677034|NCT02706730|66199177|FG000|Overall Study|Lack of Efficacy|5|||
23677035|NCT02706730|66199177|FG000|Overall Study|Withdrawal by Subject|11|||
23677036|NCT02706730|66199177|FG000|Overall Study|Study Terminated by Sponsor|11|||
23677037|NCT02706730|66199177|FG000|Overall Study|Subject chose not to receive injection|3|||
23677038|NCT02918019|66199179|FG000|Overall Study|Death|0|||
23677039|NCT02918019|66199180|FG001|Overall Study|Death|0|||
23677040|NCT02918019|66199181|FG002|Overall Study|Death|1|||
23677041|NCT02918019|66199182|FG003|Overall Study|Death|0|||
23677042|NCT02918019|66199179|FG000|Overall Study|Lost to Follow-up|1|||
23677043|NCT02918019|66199180|FG001|Overall Study|Lost to Follow-up|1|||
23677044|NCT02918019|66199181|FG002|Overall Study|Lost to Follow-up|0|||
23677045|NCT02918019|66199182|FG003|Overall Study|Lost to Follow-up|1|||
23677046|NCT02918019|66199179|FG000|Overall Study|Principal investigator request|0|||
23677047|NCT02918019|66199180|FG001|Overall Study|Principal investigator request|0|||
23677048|NCT02918019|66199181|FG002|Overall Study|Principal investigator request|0|||
23677049|NCT02918019|66199182|FG003|Overall Study|Principal investigator request|1|||
23677050|NCT02918019|66199179|FG000|Overall Study|Physician Decision|1|||
23677051|NCT02918019|66199180|FG001|Overall Study|Physician Decision|3|||
23677052|NCT02918019|66199181|FG002|Overall Study|Physician Decision|2|||
23677053|NCT02918019|66199182|FG003|Overall Study|Physician Decision|0|||
23677054|NCT02918019|66199179|FG000|Overall Study|Protocol deviation|1|||
23677055|NCT02918019|66199180|FG001|Overall Study|Protocol deviation|1|||
23677056|NCT02918019|66199181|FG002|Overall Study|Protocol deviation|0|||
23677057|NCT02918019|66199182|FG003|Overall Study|Protocol deviation|2|||
23677058|NCT02918019|66199179|FG000|Overall Study|Withdrawal by Subject|3|||
23677059|NCT02918019|66199180|FG001|Overall Study|Withdrawal by Subject|4|||
23677060|NCT02918019|66199181|FG002|Overall Study|Withdrawal by Subject|6|||
23677061|NCT02918019|66199182|FG003|Overall Study|Withdrawal by Subject|4|||
23677062|NCT02918019|66199179|FG000|Overall Study|Adverse Event|0|||
23677063|NCT02918019|66199180|FG001|Overall Study|Adverse Event|1|||
23677064|NCT02918019|66199181|FG002|Overall Study|Adverse Event|0|||
23677065|NCT02918019|66199182|FG003|Overall Study|Adverse Event|1|||
23677066|NCT01870739|66199184|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
23677067|NCT01870739|66199185|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
23494681|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Death|0|||
23494682|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Death|0|||
23677068|NCT01870739|66199184|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
23677069|NCT01870739|66199185|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
23677070|NCT01870739|66199184|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
23677071|NCT01870739|66199185|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
23677072|NCT01870739|66199184|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
23677073|NCT01870739|66199185|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
23677074|NCT01870739|66199184|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
23677075|NCT01870739|66199185|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
23677076|NCT01870739|66199184|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
23677077|NCT01870739|66199185|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
23677078|NCT01870739|66199184|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
23677079|NCT01870739|66199185|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
23677080|NCT01496885|66199186|FG000|Overall Study|Lost to Follow-up|13|||
23677081|NCT01496885|66199186|FG000|Overall Study|Withdrawal by Subject|7|||
23677082|NCT01496885|66199186|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
23677083|NCT01496885|66199186|FG000|Overall Study|Death|1|||
23677084|NCT00626093|66199200|FG000|Overall Study|Lost to Follow-up|5|||
23677085|NCT00626093|66199200|FG000|Overall Study|Death|1|||
23677086|NCT00626093|66199200|FG000|Overall Study|Physician Decision|4|||
23677087|NCT00626093|66199200|FG000|Overall Study|Withdrawal by Subject|6|||
23677088|NCT00626093|66199200|FG000|Overall Study|Protocol Violation|1|||
23677089|NCT00626093|66199200|FG000|Overall Study|One of the required devices not implante|6|||
23677090|NCT00493870|66199201|FG000|Overall Study|Lost to Follow-up|12|||
23677091|NCT00493870|66199202|FG001|Overall Study|Lost to Follow-up|15|||
23677092|NCT01363986|66199203|FG000|Overall Study|Disease progression|1|||
23677093|NCT01765673|66199207|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
23677094|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
23677095|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
23677096|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
23677097|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677098|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677099|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677100|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677101|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677102|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23677103|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
23677104|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
23677105|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
23677106|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677107|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677108|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677109|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677110|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677111|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23677112|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23677113|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23677114|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677115|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677116|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677117|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677118|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677119|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677120|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23677121|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
23677122|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
23677123|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
23677124|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677125|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677126|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677127|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677128|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677129|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23677130|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
23677131|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
23677132|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23677133|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23677134|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23677135|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23677136|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23388492|NCT04065841|65168745|FG002|Overall Study|Physician Decision|0|||
23388493|NCT04065841|65168746|FG003|Overall Study|Physician Decision|0|||
23388494|NCT04065841|65168743|FG000|Overall Study|Protocol Violation|0|||
23677137|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23677138|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23388495|NCT04065841|65168744|FG001|Overall Study|Protocol Violation|1|||
23388496|NCT04065841|65168745|FG002|Overall Study|Protocol Violation|0|||
23388497|NCT04065841|65168746|FG003|Overall Study|Protocol Violation|0|||
23388498|NCT04065841|65168743|FG000|Overall Study|Study terminated by Sponsor|22|||
23388499|NCT04065841|65168744|FG001|Overall Study|Study terminated by Sponsor|16|||
23388500|NCT04065841|65168745|FG002|Overall Study|Study terminated by Sponsor|28|||
23388501|NCT04065841|65168746|FG003|Overall Study|Study terminated by Sponsor|17|||
23388502|NCT04065841|65168743|FG000|Overall Study|Withdrawal by Subject|1|||
23388503|NCT04065841|65168744|FG001|Overall Study|Withdrawal by Subject|1|||
23388504|NCT04065841|65168745|FG002|Overall Study|Withdrawal by Subject|2|||
23388505|NCT04065841|65168746|FG003|Overall Study|Withdrawal by Subject|0|||
23388506|NCT00101400|65168747|FG000|Survival Follow-Up|Alive|7|||
23388507|NCT01346592|65168748|FG000|Overall Study|Lost to Follow-up|62|||
23388508|NCT01346592|65168749|FG001|Overall Study|Lost to Follow-up|29|||
23388509|NCT01346592|65168750|FG002|Overall Study|Lost to Follow-up|29|||
23388510|NCT01346592|65168748|FG000|Overall Study|Protocol Violation|2|||
23388511|NCT01346592|65168749|FG001|Overall Study|Protocol Violation|1|||
23388512|NCT01346592|65168750|FG002|Overall Study|Protocol Violation|0|||
23494683|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Death|7|||
23494684|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Death|0|||
23494685|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Death|0|||
23494686|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Death|0|||
23494687|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Death|0|||
23494688|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Death|0|||
23494689|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Death|0|||
23494690|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Death|0|||
23494691|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Death|0|||
23494692|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494693|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494694|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
23494695|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494696|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494697|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494698|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494699|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494700|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494701|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494702|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494703|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494704|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494705|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
23494706|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494707|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494708|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494709|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494710|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494711|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494712|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494713|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494714|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494715|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494716|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
23677139|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23388513|NCT01346592|65168748|FG000|Overall Study|Death|1|||
23388514|NCT01346592|65168749|FG001|Overall Study|Death|3|||
23388515|NCT01346592|65168750|FG002|Overall Study|Death|4|||
23388516|NCT01346592|65168748|FG000|Overall Study|Adverse Event|0|||
23388517|NCT01346592|65168749|FG001|Overall Study|Adverse Event|1|||
23388518|NCT01346592|65168750|FG002|Overall Study|Adverse Event|0|||
23388519|NCT01346592|65168748|FG000|Overall Study|Withdrawal by Subject|77|||
23388520|NCT01346592|65168749|FG001|Overall Study|Withdrawal by Subject|51|||
23388521|NCT01346592|65168750|FG002|Overall Study|Withdrawal by Subject|38|||
23388522|NCT01346592|65168748|FG000|Overall Study|Inappropriate enrollment|3|||
23388523|NCT01346592|65168749|FG001|Overall Study|Inappropriate enrollment|1|||
23388524|NCT01346592|65168750|FG002|Overall Study|Inappropriate enrollment|1|||
23388525|NCT01346592|65168748|FG000|Overall Study|Administrative reason|1|||
23677140|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677141|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
23677142|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677143|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677144|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677145|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677146|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677147|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23677148|NCT01583374|66199208|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677149|NCT01583374|66199209|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
23677150|NCT01583374|66199210|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677151|NCT01583374|66199211|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677152|NCT01583374|66199212|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677153|NCT01583374|66199213|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677154|NCT01583374|66199214|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677155|NCT01583374|66199215|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677156|NCT01583374|66199216|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
23677157|NCT01583374|66199208|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677158|NCT01583374|66199209|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677159|NCT01583374|66199210|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677160|NCT01583374|66199211|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677161|NCT01583374|66199212|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677162|NCT01583374|66199213|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677163|NCT01583374|66199214|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677164|NCT01583374|66199215|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
23677165|NCT01583374|66199216|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23677166|NCT01583374|66199208|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23677167|NCT01583374|66199209|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23677168|NCT01583374|66199210|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
23677169|NCT01583374|66199211|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23677170|NCT01583374|66199212|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23677171|NCT01583374|66199213|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23677172|NCT01583374|66199214|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23677173|NCT01583374|66199215|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23677174|NCT01583374|66199216|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23677175|NCT01583374|66199208|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23677176|NCT01583374|66199209|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23677177|NCT01583374|66199210|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23677178|NCT01583374|66199211|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
23677179|NCT01583374|66199212|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
23677180|NCT01583374|66199213|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23677181|NCT01583374|66199214|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
23677182|NCT01583374|66199215|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
23677183|NCT01583374|66199216|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23677184|NCT01583374|66199208|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677185|NCT01583374|66199209|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
23677186|NCT01583374|66199210|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
23677187|NCT01583374|66199211|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677188|NCT01583374|66199212|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
23677189|NCT01583374|66199213|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677190|NCT01583374|66199214|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677191|NCT01583374|66199215|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677192|NCT01583374|66199216|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23677193|NCT01583374|66199208|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677194|NCT01583374|66199209|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677195|NCT01583374|66199210|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23677196|NCT01583374|66199211|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677197|NCT01583374|66199212|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23677198|NCT01583374|66199213|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
23677199|NCT01583374|66199214|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677200|NCT01583374|66199215|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677201|NCT01583374|66199216|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23677202|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
23677203|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
23677204|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23677205|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23677206|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
23677207|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23677208|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23677209|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
23677210|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
23677211|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
23677212|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23677213|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
23677214|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
23677215|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
23677216|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
23677217|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23677218|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
23677219|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23677220|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677221|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677222|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677223|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677224|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23677225|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677226|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23677227|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23677228|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23677229|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
23677230|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
23677231|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
23677232|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
23677233|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
23677234|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
23677235|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
23677236|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
23677237|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
23677238|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677239|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677240|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677241|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677242|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
23677243|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677244|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
23677245|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677246|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
23677247|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23677248|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23677249|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23677250|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23677251|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23677252|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23677253|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23677254|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23677255|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23677256|NCT01583374|66199208|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23677257|NCT01583374|66199209|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
23677258|NCT01583374|66199210|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23677259|NCT01583374|66199211|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
23677260|NCT01583374|66199212|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23677261|NCT01583374|66199213|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23677262|NCT01583374|66199214|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
23677263|NCT01583374|66199215|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23677264|NCT01583374|66199216|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23677265|NCT04161131|66199217|FG000|Overall Study|Ineligible|2|||
23677266|NCT04161131|66199217|FG000|Overall Study|Lost to Follow-up|4|||
23677267|NCT03434379|66199218|FG000|Global Period|Lost to Follow-up|3|||
23677268|NCT03434379|66199219|FG001|Global Period|Lost to Follow-up|6|||
23677269|NCT03434379|66199220|FG002|Global Period|Lost to Follow-up|0|||
23677270|NCT03434379|66199221|FG003|Global Period|Lost to Follow-up|0|||
23677271|NCT03434379|66199218|FG000|Global Period|Death|115|||
23677272|NCT03434379|66199219|FG001|Global Period|Death|228|||
23677273|NCT03434379|66199220|FG002|Global Period|Death|0|||
23677274|NCT03434379|66199221|FG003|Global Period|Death|0|||
23677275|NCT03434379|66199218|FG000|Global Period|Withdrawal by Subject|20|||
23677276|NCT03434379|66199219|FG001|Global Period|Withdrawal by Subject|21|||
23677277|NCT03434379|66199220|FG002|Global Period|Withdrawal by Subject|0|||
23677278|NCT03434379|66199221|FG003|Global Period|Withdrawal by Subject|0|||
23677279|NCT03434379|66199218|FG000|Global Period|Reason Unspecified|0|||
23677280|NCT03434379|66199219|FG001|Global Period|Reason Unspecified|1|||
23677281|NCT03434379|66199220|FG002|Global Period|Reason Unspecified|0|||
23677282|NCT03434379|66199221|FG003|Global Period|Reason Unspecified|0|||
23677283|NCT03434379|66199218|FG000|Global Period|Study Ended by Sponsor|26|||
23677284|NCT03434379|66199219|FG001|Global Period|Study Ended by Sponsor|80|||
23677285|NCT03434379|66199220|FG002|Global Period|Study Ended by Sponsor|0|||
23677286|NCT03434379|66199221|FG003|Global Period|Study Ended by Sponsor|0|||
23677287|NCT03434379|66199218|FG000|Global Period|Physician Decision|1|||
23677288|NCT03434379|66199219|FG001|Global Period|Physician Decision|0|||
23677289|NCT03434379|66199220|FG002|Global Period|Physician Decision|0|||
23677290|NCT03434379|66199221|FG003|Global Period|Physician Decision|0|||
23677291|NCT03434379|66199218|FG000|China Extension Period|Lost to Follow-up|0|||
23677292|NCT03434379|66199219|FG001|China Extension Period|Lost to Follow-up|0|||
23677293|NCT03434379|66199220|FG002|China Extension Period|Lost to Follow-up|2|||
23677294|NCT03434379|66199221|FG003|China Extension Period|Lost to Follow-up|3|||
23677295|NCT03434379|66199218|FG000|China Extension Period|Death|0|||
23677296|NCT03434379|66199219|FG001|China Extension Period|Death|0|||
23677297|NCT03434379|66199220|FG002|China Extension Period|Death|46|||
23677298|NCT03434379|66199221|FG003|China Extension Period|Death|88|||
23677299|NCT03434379|66199218|FG000|China Extension Period|Withdrawal by Subject|0|||
23677300|NCT03434379|66199219|FG001|China Extension Period|Withdrawal by Subject|0|||
23677301|NCT03434379|66199220|FG002|China Extension Period|Withdrawal by Subject|8|||
23677302|NCT03434379|66199221|FG003|China Extension Period|Withdrawal by Subject|6|||
23677303|NCT03434379|66199218|FG000|China Extension Period|Study Ended by Sponsor|0|||
23677304|NCT03434379|66199219|FG001|China Extension Period|Study Ended by Sponsor|0|||
23677305|NCT03434379|66199220|FG002|China Extension Period|Study Ended by Sponsor|5|||
23677306|NCT03434379|66199221|FG003|China Extension Period|Study Ended by Sponsor|36|||
23677307|NCT03733392|66199222|FG000|Overall Study|Withdrawal by Subject|11|||
23677308|NCT03733392|66199223|FG001|Overall Study|Withdrawal by Subject|1|||
23677309|NCT03733392|66199222|FG000|Overall Study|Death|1|||
23677310|NCT03733392|66199223|FG001|Overall Study|Death|0|||
23677311|NCT03733392|66199222|FG000|Overall Study|Lost to Follow-up|5|||
23677312|NCT03733392|66199223|FG001|Overall Study|Lost to Follow-up|0|||
23677313|NCT03733392|66199222|FG000|Overall Study|Protocol Violation|0|||
23677314|NCT03733392|66199223|FG001|Overall Study|Protocol Violation|1|||
23677315|NCT03733392|66199222|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
23677316|NCT03733392|66199223|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
23677317|NCT03733392|66199222|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
23677318|NCT03733392|66199223|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
23677319|NCT03733392|66199222|FG000|Overall Study|Patient Non-Compliance|2|||
23677320|NCT03733392|66199223|FG001|Overall Study|Patient Non-Compliance|1|||
23677321|NCT03733392|66199222|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
23677322|NCT03733392|66199223|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
23677323|NCT03733392|66199222|FG000|Overall Study|Withdrawal prior to procedure|5|||
23677324|NCT03733392|66199223|FG001|Overall Study|Withdrawal prior to procedure|2|||
23677325|NCT02792842|66199224|FG000|Overall Study|Adverse Event|4|||
23677326|NCT02792842|66199225|FG001|Overall Study|Adverse Event|2|||
23677327|NCT02792842|66199226|FG002|Overall Study|Adverse Event|3|||
23388526|NCT01346592|65168749|FG001|Overall Study|Administrative reason|0|||
23388527|NCT01346592|65168750|FG002|Overall Study|Administrative reason|0|||
23677328|NCT02792842|66199224|FG000|Overall Study|Withdrawal by Subject|0|||
23677329|NCT02792842|66199225|FG001|Overall Study|Withdrawal by Subject|1|||
23677330|NCT02792842|66199226|FG002|Overall Study|Withdrawal by Subject|2|||
23677331|NCT02792842|66199224|FG000|Overall Study|Lost to Follow-up|0|||
23677332|NCT02792842|66199225|FG001|Overall Study|Lost to Follow-up|0|||
23677333|NCT02792842|66199226|FG002|Overall Study|Lost to Follow-up|1|||
23677334|NCT02792842|66199224|FG000|Overall Study|Schedule delay|0|||
23677335|NCT02792842|66199225|FG001|Overall Study|Schedule delay|1|||
23677336|NCT02792842|66199226|FG002|Overall Study|Schedule delay|1|||
23677337|NCT02631538|66199231|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
23677338|NCT02631538|66199232|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
23677339|NCT02631538|66199233|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
23388528|NCT01346592|65168748|FG000|Overall Study|Unable to Classify|7|||
23677340|NCT02631538|66199234|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
23677341|NCT02631538|66199231|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
23677342|NCT02631538|66199232|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
23677343|NCT02631538|66199233|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
23677344|NCT02631538|66199234|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
23677345|NCT02631538|66199231|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
23677346|NCT02631538|66199232|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
23677347|NCT02631538|66199233|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
23677348|NCT02631538|66199234|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
23677349|NCT02631538|66199231|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
23677350|NCT02631538|66199232|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
23677351|NCT02631538|66199233|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
23677352|NCT02631538|66199234|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
23677353|NCT02631538|66199231|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23677354|NCT02631538|66199232|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23677355|NCT02631538|66199233|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
23677356|NCT02631538|66199234|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23677357|NCT02631538|66199231|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
23677358|NCT02631538|66199232|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
23677359|NCT02631538|66199233|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
23677360|NCT02631538|66199234|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
23677361|NCT00527605|66199235|FG000|Overall Study|Adverse Event|3|||
23677362|NCT00527605|66199236|FG001|Overall Study|Adverse Event|0|||
23677363|NCT00527605|66199235|FG000|Overall Study|Withdrawal by Subject|3|||
23677364|NCT00527605|66199236|FG001|Overall Study|Withdrawal by Subject|7|||
23677365|NCT00527605|66199235|FG000|Overall Study|Lost to Follow-up|6|||
23677366|NCT00527605|66199236|FG001|Overall Study|Lost to Follow-up|2|||
23677367|NCT00527605|66199235|FG000|Overall Study|Protocol Violation|1|||
23677368|NCT00527605|66199236|FG001|Overall Study|Protocol Violation|2|||
23677369|NCT00684515|66199245|FG000|Overall Study|Adverse Event|3|||
23677370|NCT00684515|66199246|FG001|Overall Study|Adverse Event|3|||
23677371|NCT00684515|66199247|FG002|Overall Study|Adverse Event|1|||
23677372|NCT00684515|66199245|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
23677373|NCT00684515|66199246|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
23677374|NCT00684515|66199247|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
23677375|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
23677376|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23677377|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23677378|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23677379|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23677380|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
23677381|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
23677382|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
23677383|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
23677384|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
23677385|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
23677386|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23677387|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23677388|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23677389|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23677390|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
23677391|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23677392|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23677393|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23677394|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23677395|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
23388529|NCT01346592|65168749|FG001|Overall Study|Unable to Classify|3|||
23388530|NCT01346592|65168750|FG002|Overall Study|Unable to Classify|6|||
23388531|NCT01877278|65168759|FG000|Overall Study|Lost to Follow-up|3|||
23388532|NCT01877278|65168760|FG001|Overall Study|Lost to Follow-up|3|||
23677396|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
23677397|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
23388533|NCT03180138|65168764|FG000|Overall Study|Mobile-phone could not be verified|2|||
23388534|NCT03180138|65168765|FG001|Overall Study|Mobile-phone could not be verified|13|||
23388535|NCT03180138|65168766|FG002|Overall Study|Mobile-phone could not be verified|15|||
23677398|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
23677399|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
23677400|NCT01017952|66199248|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
23677401|NCT01017952|66199249|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23677402|NCT01017952|66199250|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23677403|NCT01017952|66199251|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23677404|NCT01017952|66199252|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23677405|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
23677406|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
23677407|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
23677408|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
23677409|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
23677410|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23677411|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
23677412|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
23677413|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
23677414|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
23677415|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23677416|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
23677417|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
23677418|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
23677419|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
23677420|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
23677421|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23677422|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
23677423|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
23677424|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23677425|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23388536|NCT03180138|65168764|FG000|Overall Study|No prior immunization records|17|||
23388537|NCT03180138|65168765|FG001|Overall Study|No prior immunization records|0|||
23388538|NCT03180138|65168766|FG002|Overall Study|No prior immunization records|6|||
23388539|NCT03180138|65168764|FG000|Overall Study|Found to be >24 mon after randomization|3|||
23677426|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
23677427|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23388540|NCT03180138|65168765|FG001|Overall Study|Found to be >24 mon after randomization|0|||
23388541|NCT03180138|65168766|FG002|Overall Study|Found to be >24 mon after randomization|3|||
23388542|NCT02942407|65168772|FG000|Overall Study|Lost to Follow-up|3|||
23388543|NCT02942407|65168773|FG001|Overall Study|Lost to Follow-up|2|||
23388544|NCT02942407|65168772|FG000|Overall Study|Withdrawal by Subject|7|||
23388545|NCT02942407|65168773|FG001|Overall Study|Withdrawal by Subject|9|||
23388546|NCT02942407|65168772|FG000|Overall Study|Death|16|||
23388547|NCT02942407|65168773|FG001|Overall Study|Death|13|||
23388548|NCT01385995|65168774|FG000|Period 1, 2 Months|Physician Decision|1|||
23388549|NCT01385995|65168775|FG001|Period 1, 2 Months|Physician Decision|0|||
23388550|NCT00752219|65168776|FG000|Overall Study|Clinical failure|0|||
23388551|NCT00752219|65168777|FG001|Overall Study|Clinical failure|1|||
23388552|NCT00752219|65168776|FG000|Overall Study|Adverse Event|5|||
23388553|NCT00752219|65168777|FG001|Overall Study|Adverse Event|3|||
23388554|NCT00752219|65168776|FG000|Overall Study|Protocol deviation|1|||
23388555|NCT00752219|65168777|FG001|Overall Study|Protocol deviation|0|||
23388556|NCT00752219|65168776|FG000|Overall Study|Lost to Follow-up|1|||
23388557|NCT00752219|65168777|FG001|Overall Study|Lost to Follow-up|2|||
23388558|NCT00752219|65168776|FG000|Overall Study|Randomized but not treated|1|||
23388559|NCT00752219|65168777|FG001|Overall Study|Randomized but not treated|0|||
23388560|NCT00752219|65168776|FG000|Overall Study|Other|3|||
23388561|NCT00752219|65168777|FG001|Overall Study|Other|0|||
23388562|NCT02661815|65168778|FG000|Overall Study|Withdrawal by Subject|1|||
23388563|NCT02661815|65168779|FG001|Overall Study|Withdrawal by Subject|0|||
23388564|NCT02661815|65168780|FG002|Overall Study|Withdrawal by Subject|0|||
23388565|NCT02661815|65168781|FG003|Overall Study|Withdrawal by Subject|0|||
23388566|NCT04105725|65168786|FG000|Primary Intervention|Lost to Follow-up|0|||
23388567|NCT04105725|65168787|FG001|Primary Intervention|Lost to Follow-up|2|||
23388568|NCT04105725|65168786|FG000|Primary Intervention|Withdrawal by Subject|0|||
23388569|NCT04105725|65168787|FG001|Primary Intervention|Withdrawal by Subject|1|||
23388570|NCT03715829|65168788|FG000|Dose Ranging Period|Adverse Event|2|||
23388571|NCT03715829|65168789|FG001|Dose Ranging Period|Adverse Event|4|||
23388572|NCT03715829|65168790|FG002|Dose Ranging Period|Adverse Event|5|||
23388573|NCT03715829|65168791|FG003|Dose Ranging Period|Adverse Event|2|||
23388574|NCT03715829|65168792|FG004|Dose Ranging Period|Adverse Event|3|||
23388575|NCT03715829|65168793|FG005|Dose Ranging Period|Adverse Event|3|||
23388576|NCT03715829|65168794|FG006|Dose Ranging Period|Adverse Event|0|||
23388577|NCT03715829|65168795|FG007|Dose Ranging Period|Adverse Event|0|||
23388578|NCT03715829|65168796|FG008|Dose Ranging Period|Adverse Event|0|||
23388579|NCT03715829|65168797|FG009|Dose Ranging Period|Adverse Event|0|||
23388580|NCT03715829|65168798|FG010|Dose Ranging Period|Adverse Event|0|||
23388581|NCT03715829|65168788|FG000|Dose Ranging Period|Lack of Efficacy|0|||
23388582|NCT03715829|65168789|FG001|Dose Ranging Period|Lack of Efficacy|1|||
23388583|NCT03715829|65168790|FG002|Dose Ranging Period|Lack of Efficacy|0|||
23388584|NCT03715829|65168791|FG003|Dose Ranging Period|Lack of Efficacy|1|||
23388585|NCT03715829|65168792|FG004|Dose Ranging Period|Lack of Efficacy|0|||
23388586|NCT03715829|65168793|FG005|Dose Ranging Period|Lack of Efficacy|0|||
23388587|NCT03715829|65168794|FG006|Dose Ranging Period|Lack of Efficacy|0|||
23388588|NCT03715829|65168795|FG007|Dose Ranging Period|Lack of Efficacy|0|||
23388589|NCT03715829|65168796|FG008|Dose Ranging Period|Lack of Efficacy|0|||
23388590|NCT03715829|65168797|FG009|Dose Ranging Period|Lack of Efficacy|0|||
23388591|NCT03715829|65168798|FG010|Dose Ranging Period|Lack of Efficacy|0|||
23388592|NCT03715829|65168788|FG000|Dose Ranging Period|Lost to Follow-up|2|||
23388593|NCT03715829|65168789|FG001|Dose Ranging Period|Lost to Follow-up|0|||
23388594|NCT03715829|65168790|FG002|Dose Ranging Period|Lost to Follow-up|1|||
23388595|NCT03715829|65168791|FG003|Dose Ranging Period|Lost to Follow-up|1|||
23388596|NCT03715829|65168792|FG004|Dose Ranging Period|Lost to Follow-up|1|||
23388597|NCT03715829|65168793|FG005|Dose Ranging Period|Lost to Follow-up|2|||
23388598|NCT03715829|65168794|FG006|Dose Ranging Period|Lost to Follow-up|0|||
23388599|NCT03715829|65168795|FG007|Dose Ranging Period|Lost to Follow-up|0|||
23388600|NCT03715829|65168796|FG008|Dose Ranging Period|Lost to Follow-up|0|||
23388601|NCT03715829|65168797|FG009|Dose Ranging Period|Lost to Follow-up|0|||
23388602|NCT03715829|65168798|FG010|Dose Ranging Period|Lost to Follow-up|0|||
23388603|NCT03715829|65168788|FG000|Dose Ranging Period|Protocol Violation|0|||
23388604|NCT03715829|65168789|FG001|Dose Ranging Period|Protocol Violation|0|||
23388605|NCT03715829|65168790|FG002|Dose Ranging Period|Protocol Violation|0|||
23388606|NCT03715829|65168791|FG003|Dose Ranging Period|Protocol Violation|1|||
23388607|NCT03715829|65168792|FG004|Dose Ranging Period|Protocol Violation|0|||
23388608|NCT03715829|65168793|FG005|Dose Ranging Period|Protocol Violation|0|||
23388609|NCT03715829|65168794|FG006|Dose Ranging Period|Protocol Violation|0|||
23388610|NCT03715829|65168795|FG007|Dose Ranging Period|Protocol Violation|0|||
23388611|NCT03715829|65168796|FG008|Dose Ranging Period|Protocol Violation|0|||
23388612|NCT03715829|65168797|FG009|Dose Ranging Period|Protocol Violation|0|||
23388613|NCT03715829|65168798|FG010|Dose Ranging Period|Protocol Violation|0|||
23388614|NCT03715829|65168788|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
23388615|NCT03715829|65168789|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
23388616|NCT03715829|65168790|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
23388617|NCT03715829|65168791|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
23388618|NCT03715829|65168792|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
23388619|NCT03715829|65168793|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
23388620|NCT03715829|65168794|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
23388621|NCT03715829|65168795|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
23388622|NCT03715829|65168796|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
23388623|NCT03715829|65168797|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
23388624|NCT03715829|65168798|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
23388625|NCT03715829|65168788|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23677428|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
23677429|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
23388626|NCT03715829|65168789|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388627|NCT03715829|65168790|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
23677430|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23677431|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23677432|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23677433|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23677434|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23388628|NCT03715829|65168791|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388629|NCT03715829|65168792|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388630|NCT03715829|65168793|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388631|NCT03715829|65168794|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388632|NCT03715829|65168795|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23677435|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23677436|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23677437|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
23677438|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23677439|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
23677440|NCT01017952|66199248|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
23677441|NCT01017952|66199249|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
23677442|NCT01017952|66199250|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
23677443|NCT01017952|66199251|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
23677444|NCT01017952|66199252|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
23677445|NCT01192347|66199253|FG000|Overall Study|Death|3|||
23677446|NCT01192347|66199253|FG000|Overall Study|Lost to Follow-up|3|||
23677447|NCT01192347|66199253|FG000|Overall Study|Withdrawal by Subject|1|||
23677448|NCT01192347|66199253|FG000|Overall Study|Adverse Event|1|||
23677449|NCT01192347|66199253|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
23677450|NCT01192347|66199253|FG000|Overall Study|Patient seen in different hospital|1|||
23677451|NCT01192347|66199253|FG000|Overall Study|Patient not visiting hospital regularly|1|||
23677452|NCT01192347|66199253|FG000|Overall Study|Patient did not show up for visits|1|||
23677453|NCT00419380|66199254|FG000|Overall Study|Lack of Efficacy|1|||
23677454|NCT00419380|66199255|FG001|Overall Study|Lack of Efficacy|7|||
23677455|NCT00419380|66199254|FG000|Overall Study|Physician Decision|0|||
23677456|NCT00419380|66199255|FG001|Overall Study|Physician Decision|1|||
23677457|NCT00419380|66199254|FG000|Overall Study|Lost to Follow-up|0|||
23677458|NCT00419380|66199255|FG001|Overall Study|Lost to Follow-up|1|||
23677459|NCT00419380|66199254|FG000|Overall Study|Withdrawal by Subject|0|||
23677460|NCT00419380|66199255|FG001|Overall Study|Withdrawal by Subject|1|||
23677461|NCT00382993|66199257|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
23677462|NCT00382993|66199258|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
23677463|NCT00382993|66199257|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
23677464|NCT00382993|66199258|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
23677465|NCT00382993|66199257|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
23677466|NCT00382993|66199258|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
23677467|NCT00382993|66199257|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
23677468|NCT00382993|66199258|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
23677469|NCT00382993|66199257|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
23677470|NCT00382993|66199258|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
23677471|NCT00382993|66199257|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
23677472|NCT00382993|66199258|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
23677473|NCT00382993|66199257|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
23677474|NCT00382993|66199258|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
23677475|NCT00382993|66199257|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
23677476|NCT00382993|66199258|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
23677477|NCT00382993|66199257|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
23677478|NCT00382993|66199258|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
23677479|NCT00382993|66199257|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
23677480|NCT00382993|66199258|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
23677481|NCT00293579|66199259|FG000|Overall Study|Withdrawal by Subject|1|||
23677482|NCT03213366|66199261|FG000|Overall Study|Lost to Follow-up|9|||
23677483|NCT03213366|66199262|FG001|Overall Study|Lost to Follow-up|4|||
23677484|NCT00725075|66199265|FG000|Overall Study|Use of Excluded Medication|0|||
23677485|NCT00725075|66199266|FG001|Overall Study|Use of Excluded Medication|1|||
23677486|NCT00725075|66199267|FG002|Overall Study|Use of Excluded Medication|0|||
23677487|NCT00725075|66199265|FG000|Overall Study|Protocol Violation|0|||
23677488|NCT00725075|66199266|FG001|Overall Study|Protocol Violation|0|||
23677489|NCT00725075|66199267|FG002|Overall Study|Protocol Violation|1|||
23677490|NCT00725075|66199265|FG000|Overall Study|Lost to Follow-up|1|||
23677491|NCT00725075|66199266|FG001|Overall Study|Lost to Follow-up|0|||
23677492|NCT00725075|66199267|FG002|Overall Study|Lost to Follow-up|0|||
23677493|NCT00725075|66199265|FG000|Overall Study|Withdrawal by Subject|4|||
23677494|NCT00725075|66199266|FG001|Overall Study|Withdrawal by Subject|5|||
23677495|NCT00725075|66199267|FG002|Overall Study|Withdrawal by Subject|4|||
23677496|NCT00725075|66199265|FG000|Overall Study|Adverse Event|2|||
23677497|NCT00725075|66199266|FG001|Overall Study|Adverse Event|1|||
23677498|NCT00725075|66199267|FG002|Overall Study|Adverse Event|1|||
23677499|NCT00725075|66199265|FG000|Overall Study|Worsening of Disease|2|||
23677500|NCT00725075|66199266|FG001|Overall Study|Worsening of Disease|1|||
23388633|NCT03715829|65168796|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23677501|NCT00725075|66199267|FG002|Overall Study|Worsening of Disease|2|||
23677502|NCT00725075|66199265|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
23677503|NCT00725075|66199266|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23677504|NCT00725075|66199267|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
23677505|NCT00725075|66199265|FG000|Overall Study|Other|1|||
23677506|NCT00725075|66199266|FG001|Overall Study|Other|0|||
23677507|NCT00725075|66199267|FG002|Overall Study|Other|0|||
23677508|NCT02902120|66199268|FG000|Overall Study|Lack of Efficacy|1|||
23677509|NCT02296242|66199272|FG000|Overall Study|Death|1|||
23677510|NCT02296242|66199273|FG001|Overall Study|Death|1|||
23677511|NCT02296242|66199274|FG002|Overall Study|Death|1|||
23677512|NCT02296242|66199275|FG003|Overall Study|Death|1|||
23677513|NCT02296242|66199276|FG004|Overall Study|Death|1|||
23677514|NCT02296242|66199272|FG000|Overall Study|Withdrawal by Subject|0|||
23677515|NCT02296242|66199273|FG001|Overall Study|Withdrawal by Subject|0|||
23677516|NCT02296242|66199274|FG002|Overall Study|Withdrawal by Subject|1|||
23677517|NCT02296242|66199275|FG003|Overall Study|Withdrawal by Subject|1|||
23677518|NCT02296242|66199276|FG004|Overall Study|Withdrawal by Subject|3|||
23677519|NCT02296242|66199272|FG000|Overall Study|Disease Progression|1|||
23677520|NCT02296242|66199273|FG001|Overall Study|Disease Progression|3|||
23677521|NCT02296242|66199274|FG002|Overall Study|Disease Progression|2|||
23677522|NCT02296242|66199275|FG003|Overall Study|Disease Progression|8|||
23388634|NCT03715829|65168797|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388635|NCT03715829|65168798|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388636|NCT03715829|65168788|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388637|NCT03715829|65168789|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388638|NCT03715829|65168790|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
23388639|NCT03715829|65168791|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388640|NCT03715829|65168792|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
23388641|NCT03715829|65168793|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388642|NCT03715829|65168794|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388643|NCT03715829|65168795|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388644|NCT03715829|65168796|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388645|NCT03715829|65168797|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388646|NCT03715829|65168798|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388647|NCT03715829|65168788|FG000|Dose Ranging Period|Other|0|||
23388648|NCT03715829|65168789|FG001|Dose Ranging Period|Other|0|||
23388649|NCT03715829|65168790|FG002|Dose Ranging Period|Other|2|||
23388650|NCT03715829|65168791|FG003|Dose Ranging Period|Other|0|||
23388651|NCT03715829|65168792|FG004|Dose Ranging Period|Other|0|||
23388652|NCT03715829|65168793|FG005|Dose Ranging Period|Other|3|||
23494717|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23388653|NCT03715829|65168794|FG006|Dose Ranging Period|Other|0|||
23388654|NCT03715829|65168795|FG007|Dose Ranging Period|Other|0|||
23494718|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494719|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494720|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23677523|NCT02296242|66199276|FG004|Overall Study|Disease Progression|11|||
23677524|NCT02296242|66199272|FG000|Overall Study|Unacceptable Toxicity|0|||
23677525|NCT02296242|66199273|FG001|Overall Study|Unacceptable Toxicity|0|||
23388655|NCT03715829|65168796|FG008|Dose Ranging Period|Other|0|||
23388656|NCT03715829|65168797|FG009|Dose Ranging Period|Other|0|||
23388657|NCT03715829|65168798|FG010|Dose Ranging Period|Other|0|||
23677526|NCT02296242|66199274|FG002|Overall Study|Unacceptable Toxicity|0|||
23388658|NCT03715829|65168788|FG000|Extension Period|Adverse Event|0|||
23677527|NCT02296242|66199275|FG003|Overall Study|Unacceptable Toxicity|0|||
23677528|NCT02296242|66199276|FG004|Overall Study|Unacceptable Toxicity|1|||
23677529|NCT02296242|66199272|FG000|Overall Study|Patient Condition Changed|0|||
23388659|NCT03715829|65168789|FG001|Extension Period|Adverse Event|0|||
23388660|NCT03715829|65168790|FG002|Extension Period|Adverse Event|0|||
23388661|NCT03715829|65168791|FG003|Extension Period|Adverse Event|0|||
23388662|NCT03715829|65168792|FG004|Extension Period|Adverse Event|0|||
23388663|NCT03715829|65168793|FG005|Extension Period|Adverse Event|0|||
23388664|NCT03715829|65168794|FG006|Extension Period|Adverse Event|3|||
23388665|NCT03715829|65168795|FG007|Extension Period|Adverse Event|1|||
23388666|NCT03715829|65168796|FG008|Extension Period|Adverse Event|6|||
23677530|NCT02296242|66199273|FG001|Overall Study|Patient Condition Changed|0|||
23677531|NCT02296242|66199274|FG002|Overall Study|Patient Condition Changed|2|||
23677532|NCT02296242|66199275|FG003|Overall Study|Patient Condition Changed|0|||
23677533|NCT02296242|66199276|FG004|Overall Study|Patient Condition Changed|1|||
23677534|NCT02296242|66199272|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
23677535|NCT02296242|66199273|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
23677536|NCT02296242|66199274|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
23677537|NCT02296242|66199275|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
23677538|NCT02296242|66199276|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
23677539|NCT02296242|66199272|FG000|Overall Study|Lost to Follow-up|1|||
23677540|NCT02296242|66199273|FG001|Overall Study|Lost to Follow-up|0|||
23677541|NCT02296242|66199274|FG002|Overall Study|Lost to Follow-up|0|||
23677542|NCT02296242|66199275|FG003|Overall Study|Lost to Follow-up|0|||
23677543|NCT02296242|66199276|FG004|Overall Study|Lost to Follow-up|0|||
23677544|NCT02296242|66199272|FG000|Overall Study|Need for Hydroxyurea|2|||
23677545|NCT02296242|66199273|FG001|Overall Study|Need for Hydroxyurea|0|||
23677546|NCT02296242|66199274|FG002|Overall Study|Need for Hydroxyurea|0|||
23677547|NCT02296242|66199275|FG003|Overall Study|Need for Hydroxyurea|0|||
23677548|NCT02296242|66199276|FG004|Overall Study|Need for Hydroxyurea|0|||
23677549|NCT02296242|66199272|FG000|Overall Study|Screened for Other Protocol|0|||
23677550|NCT02296242|66199273|FG001|Overall Study|Screened for Other Protocol|1|||
23388667|NCT03715829|65168797|FG009|Extension Period|Adverse Event|0|||
23388668|NCT03715829|65168798|FG010|Extension Period|Adverse Event|0|||
23388669|NCT03715829|65168788|FG000|Extension Period|Lack of Efficacy|0|||
23388670|NCT03715829|65168789|FG001|Extension Period|Lack of Efficacy|0|||
23388671|NCT03715829|65168790|FG002|Extension Period|Lack of Efficacy|0|||
23388672|NCT03715829|65168791|FG003|Extension Period|Lack of Efficacy|0|||
23388673|NCT03715829|65168792|FG004|Extension Period|Lack of Efficacy|0|||
23388674|NCT03715829|65168793|FG005|Extension Period|Lack of Efficacy|0|||
23388675|NCT03715829|65168794|FG006|Extension Period|Lack of Efficacy|1|||
23388676|NCT03715829|65168795|FG007|Extension Period|Lack of Efficacy|9|||
23388677|NCT03715829|65168796|FG008|Extension Period|Lack of Efficacy|2|||
23677551|NCT02296242|66199274|FG002|Overall Study|Screened for Other Protocol|0|||
23677552|NCT02296242|66199275|FG003|Overall Study|Screened for Other Protocol|0|||
23677553|NCT02296242|66199276|FG004|Overall Study|Screened for Other Protocol|0|||
23677554|NCT02296242|66199272|FG000|Overall Study|Physician Decision|0|||
23677555|NCT02296242|66199273|FG001|Overall Study|Physician Decision|1|||
23388678|NCT03715829|65168797|FG009|Extension Period|Lack of Efficacy|0|||
23388679|NCT03715829|65168798|FG010|Extension Period|Lack of Efficacy|0|||
23388680|NCT03715829|65168788|FG000|Extension Period|Lost to Follow-up|0|||
23388681|NCT03715829|65168789|FG001|Extension Period|Lost to Follow-up|0|||
23388682|NCT03715829|65168790|FG002|Extension Period|Lost to Follow-up|0|||
23677556|NCT02296242|66199274|FG002|Overall Study|Physician Decision|0|||
23388683|NCT03715829|65168791|FG003|Extension Period|Lost to Follow-up|0|||
23677557|NCT02296242|66199275|FG003|Overall Study|Physician Decision|1|||
23677558|NCT02296242|66199276|FG004|Overall Study|Physician Decision|0|||
23677559|NCT02296242|66199272|FG000|Overall Study|Alternative Treatment|0|||
23677560|NCT02296242|66199273|FG001|Overall Study|Alternative Treatment|0|||
23677561|NCT02296242|66199274|FG002|Overall Study|Alternative Treatment|0|||
23677562|NCT02296242|66199275|FG003|Overall Study|Alternative Treatment|1|||
23677563|NCT02296242|66199276|FG004|Overall Study|Alternative Treatment|0|||
23677564|NCT02296242|66199272|FG000|Overall Study|Adverse Event|0|||
23677565|NCT02296242|66199273|FG001|Overall Study|Adverse Event|0|||
23677566|NCT02296242|66199274|FG002|Overall Study|Adverse Event|0|||
23677567|NCT02296242|66199275|FG003|Overall Study|Adverse Event|1|||
23677568|NCT02296242|66199276|FG004|Overall Study|Adverse Event|0|||
23677569|NCT02296242|66199272|FG000|Overall Study|Lack of Efficacy|0|||
23677570|NCT02296242|66199273|FG001|Overall Study|Lack of Efficacy|0|||
23677571|NCT02296242|66199274|FG002|Overall Study|Lack of Efficacy|0|||
23677572|NCT02296242|66199275|FG003|Overall Study|Lack of Efficacy|0|||
23677573|NCT02296242|66199276|FG004|Overall Study|Lack of Efficacy|3|||
23677574|NCT01042600|66199277|FG000|Overall Study|Ineligible|1|||
23677575|NCT01042600|66199278|FG001|Overall Study|Ineligible|0|||
23677576|NCT00493038|66199279|FG000|Treatment|Adverse Event|8|||
23677577|NCT00493038|66199280|FG001|Treatment|Adverse Event|4|||
23677578|NCT00493038|66199279|FG000|Treatment|Lost to Follow-up|5|||
23677579|NCT00493038|66199280|FG001|Treatment|Lost to Follow-up|3|||
23677580|NCT00493038|66199279|FG000|Treatment|Withdrawal by Subject|11|||
23677581|NCT00493038|66199280|FG001|Treatment|Withdrawal by Subject|12|||
23677582|NCT00493038|66199279|FG000|Treatment|Other|0|||
23677583|NCT00493038|66199280|FG001|Treatment|Other|1|||
23677584|NCT00493038|66199279|FG000|Follow-up|Lost to Follow-up|1|||
23677585|NCT00493038|66199280|FG001|Follow-up|Lost to Follow-up|0|||
23677586|NCT00364689|66199291|FG000|Overall Study|Lost to Follow-up|1|||
23677587|NCT05162066|66199292|FG000|Overall Study|Adverse Event|1|||
23677588|NCT05162066|66199293|FG001|Overall Study|Adverse Event|0|||
23677589|NCT05162066|66199294|FG002|Overall Study|Adverse Event|0|||
23677590|NCT05162066|66199292|FG000|Overall Study|Perceived lack of efficacy|1|||
23677591|NCT05162066|66199293|FG001|Overall Study|Perceived lack of efficacy|0|||
23677592|NCT05162066|66199294|FG002|Overall Study|Perceived lack of efficacy|0|||
23677593|NCT02450578|66199300|FG000|Overall Study|ECG abnormality so not treated|1|||
23677594|NCT02450578|66199301|FG001|Overall Study|ECG abnormality so not treated|0|||
23677595|NCT02450578|66199302|FG002|Overall Study|ECG abnormality so not treated|0|||
23677596|NCT02450578|66199303|FG003|Overall Study|ECG abnormality so not treated|0|||
23677597|NCT00354601|66199305|FG000|Overall Study|Protocol Violation|1|||
23677598|NCT00354601|66199305|FG000|Overall Study|progression|1|||
23677599|NCT00763321|66199306|FG000|Open-label Period|Adverse Event|24|||
23677600|NCT00763321|66199307|FG001|Open-label Period|Adverse Event|0|||
23677601|NCT00763321|66199308|FG002|Open-label Period|Adverse Event|0|||
23677602|NCT00763321|66199306|FG000|Open-label Period|Lost to Follow-up|14|||
23677603|NCT00763321|66199307|FG001|Open-label Period|Lost to Follow-up|0|||
23677604|NCT00763321|66199308|FG002|Open-label Period|Lost to Follow-up|0|||
23677605|NCT00763321|66199306|FG000|Open-label Period|Withdrawal by Subject|7|||
23677606|NCT00763321|66199307|FG001|Open-label Period|Withdrawal by Subject|0|||
23677607|NCT00763321|66199308|FG002|Open-label Period|Withdrawal by Subject|0|||
23677608|NCT00763321|66199306|FG000|Open-label Period|Subject noncompliant|7|||
23677609|NCT00763321|66199307|FG001|Open-label Period|Subject noncompliant|0|||
23677610|NCT00763321|66199308|FG002|Open-label Period|Subject noncompliant|0|||
23677611|NCT00763321|66199306|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
23677612|NCT00763321|66199307|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
23677613|NCT00763321|66199308|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
23677614|NCT00763321|66199306|FG000|Open-label Period|Lack of Efficacy|2|||
23677615|NCT00763321|66199307|FG001|Open-label Period|Lack of Efficacy|0|||
23677616|NCT00763321|66199308|FG002|Open-label Period|Lack of Efficacy|0|||
23677617|NCT00763321|66199306|FG000|Open-label Period|Other|4|||
23677618|NCT00763321|66199307|FG001|Open-label Period|Other|0|||
23677619|NCT00763321|66199308|FG002|Open-label Period|Other|0|||
23677620|NCT00763321|66199306|FG000|Double-blind Period|Lack of Efficacy|0|||
23677621|NCT00763321|66199307|FG001|Double-blind Period|Lack of Efficacy|9|||
23677622|NCT00763321|66199308|FG002|Double-blind Period|Lack of Efficacy|17|||
23677623|NCT00763321|66199306|FG000|Double-blind Period|Adverse Event|0|||
23677624|NCT00763321|66199307|FG001|Double-blind Period|Adverse Event|4|||
23677625|NCT00763321|66199308|FG002|Double-blind Period|Adverse Event|4|||
23677626|NCT00763321|66199306|FG000|Double-blind Period|Lost to Follow-up|0|||
23677627|NCT00763321|66199307|FG001|Double-blind Period|Lost to Follow-up|4|||
23677628|NCT00763321|66199308|FG002|Double-blind Period|Lost to Follow-up|2|||
23677629|NCT00763321|66199306|FG000|Double-blind Period|Withdrawal by Subject|0|||
23677630|NCT00763321|66199307|FG001|Double-blind Period|Withdrawal by Subject|2|||
23677631|NCT00763321|66199308|FG002|Double-blind Period|Withdrawal by Subject|3|||
23677632|NCT00763321|66199306|FG000|Double-blind Period|Other|0|||
23677633|NCT00763321|66199307|FG001|Double-blind Period|Other|2|||
23677634|NCT00763321|66199308|FG002|Double-blind Period|Other|3|||
23677635|NCT01995071|66199309|FG000|Overall Study|Adverse Event|0|||
23677636|NCT01995071|66199310|FG001|Overall Study|Adverse Event|0|||
23677637|NCT01995071|66199311|FG002|Overall Study|Adverse Event|0|||
23677638|NCT01995071|66199312|FG003|Overall Study|Adverse Event|0|||
23677639|NCT01995071|66199313|FG004|Overall Study|Adverse Event|0|||
23677640|NCT01995071|66199314|FG005|Overall Study|Adverse Event|0|||
23677641|NCT01995071|66199315|FG006|Overall Study|Adverse Event|1|||
23677642|NCT01995071|66199316|FG007|Overall Study|Adverse Event|0|||
23677643|NCT01995071|66199317|FG008|Overall Study|Adverse Event|0|||
23677644|NCT01995071|66199318|FG009|Overall Study|Adverse Event|0|||
23677645|NCT01995071|66199319|FG010|Overall Study|Adverse Event|0|||
23677646|NCT01995071|66199320|FG011|Overall Study|Adverse Event|0|||
23677647|NCT01995071|66199309|FG000|Overall Study|Moved|0|||
23677648|NCT01995071|66199310|FG001|Overall Study|Moved|0|||
23677649|NCT01995071|66199311|FG002|Overall Study|Moved|1|||
23677650|NCT01995071|66199312|FG003|Overall Study|Moved|0|||
23677651|NCT01995071|66199313|FG004|Overall Study|Moved|1|||
23677652|NCT01995071|66199314|FG005|Overall Study|Moved|0|||
23677653|NCT01995071|66199315|FG006|Overall Study|Moved|0|||
23677654|NCT01995071|66199316|FG007|Overall Study|Moved|0|||
23677655|NCT01995071|66199317|FG008|Overall Study|Moved|0|||
23677656|NCT01995071|66199318|FG009|Overall Study|Moved|0|||
23677657|NCT01995071|66199319|FG010|Overall Study|Moved|1|||
23677658|NCT01995071|66199320|FG011|Overall Study|Moved|0|||
23677659|NCT01995071|66199309|FG000|Overall Study|Lost to Follow-up|1|||
23677660|NCT01995071|66199310|FG001|Overall Study|Lost to Follow-up|0|||
23677661|NCT01995071|66199311|FG002|Overall Study|Lost to Follow-up|0|||
23677662|NCT01995071|66199312|FG003|Overall Study|Lost to Follow-up|0|||
23677663|NCT01995071|66199313|FG004|Overall Study|Lost to Follow-up|0|||
23677664|NCT01995071|66199314|FG005|Overall Study|Lost to Follow-up|0|||
23677665|NCT01995071|66199315|FG006|Overall Study|Lost to Follow-up|0|||
23677666|NCT01995071|66199316|FG007|Overall Study|Lost to Follow-up|1|||
23677667|NCT01995071|66199317|FG008|Overall Study|Lost to Follow-up|1|||
23677668|NCT01995071|66199318|FG009|Overall Study|Lost to Follow-up|0|||
23677669|NCT01995071|66199319|FG010|Overall Study|Lost to Follow-up|0|||
23677670|NCT01995071|66199320|FG011|Overall Study|Lost to Follow-up|0|||
23677671|NCT01995071|66199309|FG000|Overall Study|Incarcerated|0|||
23677672|NCT01995071|66199310|FG001|Overall Study|Incarcerated|0|||
23677673|NCT01995071|66199311|FG002|Overall Study|Incarcerated|0|||
23677674|NCT01995071|66199312|FG003|Overall Study|Incarcerated|0|||
23677675|NCT01995071|66199313|FG004|Overall Study|Incarcerated|0|||
23677676|NCT01995071|66199314|FG005|Overall Study|Incarcerated|0|||
23677677|NCT01995071|66199315|FG006|Overall Study|Incarcerated|0|||
23677678|NCT01995071|66199316|FG007|Overall Study|Incarcerated|1|||
23677679|NCT01995071|66199317|FG008|Overall Study|Incarcerated|0|||
23677680|NCT01995071|66199318|FG009|Overall Study|Incarcerated|0|||
23677681|NCT01995071|66199319|FG010|Overall Study|Incarcerated|0|||
23677682|NCT01995071|66199320|FG011|Overall Study|Incarcerated|0|||
23677683|NCT02285114|66199321|FG000|Overall Study|Investigator's Discretion|0|||
23677684|NCT02285114|66199322|FG001|Overall Study|Investigator's Discretion|2|||
23677685|NCT02285114|66199323|FG002|Overall Study|Investigator's Discretion|0|||
23677686|NCT02285114|66199321|FG000|Overall Study|Withdrew Consent|0|||
23677687|NCT02285114|66199322|FG001|Overall Study|Withdrew Consent|0|||
23677688|NCT02285114|66199323|FG002|Overall Study|Withdrew Consent|1|||
23677689|NCT02285114|66199321|FG000|Overall Study|Enrolled but not treated|1|||
23677690|NCT02285114|66199322|FG001|Overall Study|Enrolled but not treated|0|||
23677691|NCT02285114|66199323|FG002|Overall Study|Enrolled but not treated|0|||
23677692|NCT02285114|66199321|FG000|Overall Study|Still on study|21|||
23677693|NCT02285114|66199322|FG001|Overall Study|Still on study|5|||
23677694|NCT02285114|66199323|FG002|Overall Study|Still on study|2|||
23677695|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677696|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
23677697|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677698|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677699|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677700|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677701|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23677702|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23677703|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
23677704|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
23677705|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23677706|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23677707|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
23677708|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
23677709|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
23677710|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
23677711|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
23677712|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
23677713|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
23677714|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
23677715|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
23677716|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23677717|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
23677718|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23677719|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23677720|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23677721|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
23677722|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23677723|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
23677724|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
23677725|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
23677726|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
23677727|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
23677728|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
23677729|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
23677730|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677731|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677732|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677733|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677734|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677735|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
23677736|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23677737|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23677738|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23677739|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23677740|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23677741|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23677742|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23677743|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
23677744|NCT03742037|66199324|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677745|NCT03742037|66199325|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677746|NCT03742037|66199326|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677747|NCT03742037|66199327|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677748|NCT03742037|66199328|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677749|NCT03742037|66199329|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23677750|NCT03742037|66199330|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
23677751|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
23677752|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
23677753|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
23677754|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
23677755|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
23677756|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
23677757|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
23677758|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23677759|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23677760|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
23677761|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
23677762|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23677763|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23388684|NCT03715829|65168792|FG004|Extension Period|Lost to Follow-up|0|||
23388685|NCT03715829|65168793|FG005|Extension Period|Lost to Follow-up|0|||
23388686|NCT03715829|65168794|FG006|Extension Period|Lost to Follow-up|0|||
23388687|NCT03715829|65168795|FG007|Extension Period|Lost to Follow-up|0|||
23388688|NCT03715829|65168796|FG008|Extension Period|Lost to Follow-up|2|||
23388689|NCT03715829|65168797|FG009|Extension Period|Lost to Follow-up|0|||
23388690|NCT03715829|65168798|FG010|Extension Period|Lost to Follow-up|0|||
23388691|NCT03715829|65168788|FG000|Extension Period|Protocol Violation|0|||
23388692|NCT03715829|65168789|FG001|Extension Period|Protocol Violation|0|||
23388693|NCT03715829|65168790|FG002|Extension Period|Protocol Violation|0|||
23388694|NCT03715829|65168791|FG003|Extension Period|Protocol Violation|0|||
23388695|NCT03715829|65168792|FG004|Extension Period|Protocol Violation|0|||
23388696|NCT03715829|65168793|FG005|Extension Period|Protocol Violation|0|||
23388697|NCT03715829|65168794|FG006|Extension Period|Protocol Violation|0|||
23388698|NCT03715829|65168795|FG007|Extension Period|Protocol Violation|0|||
23388699|NCT03715829|65168796|FG008|Extension Period|Protocol Violation|1|||
23388700|NCT03715829|65168797|FG009|Extension Period|Protocol Violation|0|||
23388701|NCT03715829|65168798|FG010|Extension Period|Protocol Violation|0|||
23388702|NCT03715829|65168788|FG000|Extension Period|Withdrawal by Subject|0|||
23494721|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23388703|NCT03715829|65168789|FG001|Extension Period|Withdrawal by Subject|0|||
23388704|NCT03715829|65168790|FG002|Extension Period|Withdrawal by Subject|0|||
23677764|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
23677765|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23677766|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
23677767|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
23677768|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23677769|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23677770|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23677771|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23677772|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
23677773|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23677774|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23677775|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23677776|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23677777|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23677778|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
23677779|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23677780|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
23677781|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
23677782|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
23677783|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23677784|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23677785|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
23677786|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
23677787|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23677788|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
23677789|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23677790|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23677791|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23677792|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
23677793|NCT03742037|66199324|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677794|NCT03742037|66199325|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677795|NCT03742037|66199326|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
23677796|NCT03742037|66199327|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677797|NCT03742037|66199328|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677798|NCT03742037|66199329|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677799|NCT03742037|66199330|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23677800|NCT00044512|66202633|FG000|Follow Up|Lost to Follow-up|2|||
23677801|NCT02513329|66202634|FG000|Overall Study|Lost to Follow-up|5|||
23677802|NCT02513329|66202635|FG001|Overall Study|Lost to Follow-up|2|||
23677803|NCT02452762|66202636|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
23677804|NCT02452762|66202637|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
23677805|NCT02452762|66202636|FG000|Overall Study|Withdrawal by Subject|1|||
23677806|NCT02452762|66202637|FG001|Overall Study|Withdrawal by Subject|0|||
23677807|NCT01292057|66202638|FG000|Overall Study|Protocol Violation|1|||
23677808|NCT01292057|66202639|FG001|Overall Study|Protocol Violation|1|||
23677809|NCT01292057|66202638|FG000|Overall Study|Lost to Follow-up|1|||
23677810|NCT01292057|66202639|FG001|Overall Study|Lost to Follow-up|1|||
23677811|NCT01323478|66202640|FG000|Overall Study|Adverse Event|7|||
23677812|NCT01323478|66202640|FG000|Overall Study|Lack of Efficacy|4|||
23677813|NCT01323478|66202640|FG000|Overall Study|Non-compliance With Study Product|3|||
23677814|NCT01323478|66202640|FG000|Overall Study|Protocol Violation|1|||
23677815|NCT01323478|66202640|FG000|Overall Study|Withdrawal of Consent|1|||
23677816|NCT01323478|66202640|FG000|Overall Study|Administrative or Other Reasons|8|||
23677817|NCT03538743|66202641|FG000|Overall Study|Adverse Event|0|||
23677818|NCT03538743|66202642|FG001|Overall Study|Adverse Event|0|||
23677819|NCT03538743|66202643|FG002|Overall Study|Adverse Event|1|||
23677820|NCT03538743|66202644|FG003|Overall Study|Adverse Event|1|||
23677821|NCT03538743|66202645|FG004|Overall Study|Adverse Event|0|||
23677822|NCT03538743|66202646|FG005|Overall Study|Adverse Event|0|||
23677823|NCT03538743|66202647|FG006|Overall Study|Adverse Event|0|||
23677824|NCT03538743|66202648|FG007|Overall Study|Adverse Event|0|||
23677825|NCT03538743|66202649|FG008|Overall Study|Adverse Event|0|||
23677826|NCT03538743|66202641|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
23677827|NCT03538743|66202642|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
23677828|NCT03538743|66202643|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
23677829|NCT03538743|66202644|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
23677830|NCT03538743|66202645|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
23388705|NCT03715829|65168791|FG003|Extension Period|Withdrawal by Subject|0|||
23388706|NCT03715829|65168792|FG004|Extension Period|Withdrawal by Subject|0|||
23388707|NCT03715829|65168793|FG005|Extension Period|Withdrawal by Subject|0|||
23388708|NCT03715829|65168794|FG006|Extension Period|Withdrawal by Subject|3|||
23388709|NCT03715829|65168795|FG007|Extension Period|Withdrawal by Subject|3|||
23388710|NCT03715829|65168796|FG008|Extension Period|Withdrawal by Subject|12|||
23388711|NCT03715829|65168797|FG009|Extension Period|Withdrawal by Subject|3|||
23494722|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23677831|NCT03538743|66202646|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
23388712|NCT03715829|65168798|FG010|Extension Period|Withdrawal by Subject|0|||
23677832|NCT03538743|66202647|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
23677833|NCT03538743|66202648|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
23677834|NCT03538743|66202649|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
23677835|NCT03538743|66202641|FG000|Overall Study|Withdrawal by Subject|0|||
23677836|NCT03538743|66202642|FG001|Overall Study|Withdrawal by Subject|0|||
23677837|NCT03538743|66202643|FG002|Overall Study|Withdrawal by Subject|0|||
23677838|NCT03538743|66202644|FG003|Overall Study|Withdrawal by Subject|1|||
23677839|NCT03538743|66202645|FG004|Overall Study|Withdrawal by Subject|0|||
23677840|NCT03538743|66202646|FG005|Overall Study|Withdrawal by Subject|0|||
23677841|NCT03538743|66202647|FG006|Overall Study|Withdrawal by Subject|0|||
23677842|NCT03538743|66202648|FG007|Overall Study|Withdrawal by Subject|0|||
23677843|NCT03538743|66202649|FG008|Overall Study|Withdrawal by Subject|0|||
23677844|NCT05098041|66202651|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
23677845|NCT01848145|66202652|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
23677846|NCT01848145|66202652|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
23677847|NCT01848145|66202652|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
23677848|NCT01848145|66202652|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
23677849|NCT01848145|66202652|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
23677850|NCT01848145|66202652|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
23677851|NCT01848145|66202652|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
23677852|NCT01623271|66202658|FG000|Overall Study|Withdrawal by Subject|2|||
23677853|NCT00768898|66202662|FG000|Overall Study|Unrelated injury|1|||
23677854|NCT00768898|66202662|FG000|Overall Study|Headache|1|||
23677855|NCT00272987|66202665|FG000|Overall Study|Adverse Event|1|||
23677856|NCT00272987|66202666|FG001|Overall Study|Adverse Event|0|||
23677857|NCT00272987|66202667|FG002|Overall Study|Adverse Event|0|||
23677858|NCT00272987|66202665|FG000|Overall Study|Lost to Follow-up|3|||
23677859|NCT00272987|66202666|FG001|Overall Study|Lost to Follow-up|1|||
23677860|NCT00272987|66202667|FG002|Overall Study|Lost to Follow-up|1|||
23677861|NCT00272987|66202665|FG000|Overall Study|Withdrawal by Subject|1|||
23677862|NCT00272987|66202666|FG001|Overall Study|Withdrawal by Subject|0|||
23677863|NCT00272987|66202667|FG002|Overall Study|Withdrawal by Subject|3|||
23677864|NCT00272987|66202665|FG000|Overall Study|Sponsor Terminated study|0|||
23677865|NCT00272987|66202666|FG001|Overall Study|Sponsor Terminated study|1|||
23677866|NCT00272987|66202667|FG002|Overall Study|Sponsor Terminated study|1|||
23677867|NCT00272987|66202665|FG000|Overall Study|Disease progression|1|||
23677868|NCT00272987|66202666|FG001|Overall Study|Disease progression|1|||
23677869|NCT00272987|66202667|FG002|Overall Study|Disease progression|2|||
23677870|NCT00272987|66202665|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
23677871|NCT00272987|66202666|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
23677872|NCT00272987|66202667|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
23677873|NCT00272987|66202665|FG000|Overall Study|Death|1|||
23677874|NCT00272987|66202666|FG001|Overall Study|Death|0|||
23677875|NCT00272987|66202667|FG002|Overall Study|Death|0|||
23677876|NCT01580397|66202668|FG000|Overall Study|Lack of Efficacy|14|||
23677877|NCT00687362|66202669|FG000|Overall Study|Protocol Violation|2|||
23677878|NCT00687362|66202669|FG000|Overall Study|Withdrawal by Subject|1|||
23677879|NCT02154087|66202672|FG000|Overall Study|Study Termination|1|||
23677880|NCT01656434|66202675|FG000|Overall Study|Adverse Event|199|||
23677881|NCT01656434|66202676|FG001|Overall Study|Adverse Event|63|||
23677882|NCT01656434|66202675|FG000|Overall Study|Enrollment terminated at trial site|2|||
23677883|NCT01656434|66202676|FG001|Overall Study|Enrollment terminated at trial site|0|||
23677884|NCT01656434|66202675|FG000|Overall Study|Lost to Follow-up|309|||
23677885|NCT01656434|66202676|FG001|Overall Study|Lost to Follow-up|76|||
23677886|NCT01656434|66202675|FG000|Overall Study|Site discontinued study participation|24|||
23677887|NCT01656434|66202676|FG001|Overall Study|Site discontinued study participation|9|||
23677888|NCT01656434|66202675|FG000|Overall Study|Screen failure|2|||
23677889|NCT01656434|66202676|FG001|Overall Study|Screen failure|0|||
23677890|NCT01656434|66202675|FG000|Overall Study|Protocol Violation|7|||
23677891|NCT01656434|66202676|FG001|Overall Study|Protocol Violation|0|||
23677892|NCT01656434|66202675|FG000|Overall Study|Pregnancy wish|18|||
23677893|NCT01656434|66202676|FG001|Overall Study|Pregnancy wish|6|||
23677894|NCT01656434|66202675|FG000|Overall Study|Pregnancy|45|||
23677895|NCT01656434|66202676|FG001|Overall Study|Pregnancy|10|||
23677896|NCT01656434|66202675|FG000|Overall Study|Physician Decision|7|||
23677897|NCT01656434|66202676|FG001|Overall Study|Physician Decision|2|||
23677898|NCT01656434|66202675|FG000|Overall Study|Non-compliance with study drug|48|||
23677899|NCT01656434|66202676|FG001|Overall Study|Non-compliance with study drug|9|||
23677900|NCT01656434|66202675|FG000|Overall Study|Study terminated by sponsor|1501|||
23677901|NCT01656434|66202676|FG001|Overall Study|Study terminated by sponsor|348|||
23677902|NCT01656434|66202675|FG000|Overall Study|Participant discontinued; drug related|13|||
23677903|NCT01656434|66202676|FG001|Overall Study|Participant discontinued; drug related|4|||
23677904|NCT01656434|66202675|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
23677905|NCT01656434|66202676|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
23677906|NCT01656434|66202675|FG000|Overall Study|Non-compliance with protocol|39|||
23677907|NCT01656434|66202676|FG001|Overall Study|Non-compliance with protocol|15|||
23677908|NCT01656434|66202675|FG000|Overall Study|Participant moved|40|||
23677909|NCT01656434|66202676|FG001|Overall Study|Participant moved|12|||
23677910|NCT01656434|66202675|FG000|Overall Study|Participant withdrew consent|28|||
23677911|NCT01656434|66202676|FG001|Overall Study|Participant withdrew consent|9|||
23677912|NCT01656434|66202675|FG000|Overall Study|Withdrawal by Subject|64|||
23677913|NCT01656434|66202676|FG001|Overall Study|Withdrawal by Subject|7|||
23677914|NCT00706030|66202680|FG000|Overall Study|Disease Progression|4|||
23677915|NCT00706030|66202681|FG001|Overall Study|Disease Progression|6|||
23677916|NCT00706030|66202682|FG002|Overall Study|Disease Progression|46|||
23677917|NCT00706030|66202683|FG003|Overall Study|Disease Progression|12|||
23677918|NCT00706030|66202680|FG000|Overall Study|Adverse Event|1|||
23677919|NCT00706030|66202681|FG001|Overall Study|Adverse Event|0|||
23677920|NCT00706030|66202682|FG002|Overall Study|Adverse Event|4|||
23677921|NCT00706030|66202683|FG003|Overall Study|Adverse Event|2|||
23677922|NCT00706030|66202680|FG000|Overall Study|Withdrawal by Subject|1|||
23677923|NCT00706030|66202681|FG001|Overall Study|Withdrawal by Subject|0|||
23677924|NCT00706030|66202682|FG002|Overall Study|Withdrawal by Subject|2|||
23677925|NCT00706030|66202683|FG003|Overall Study|Withdrawal by Subject|0|||
23677926|NCT00706030|66202680|FG000|Overall Study|Physician Decision|0|||
23677927|NCT00706030|66202681|FG001|Overall Study|Physician Decision|0|||
23677928|NCT00706030|66202682|FG002|Overall Study|Physician Decision|2|||
23677929|NCT00706030|66202683|FG003|Overall Study|Physician Decision|0|||
23677930|NCT00706030|66202680|FG000|Overall Study|Not recorded|0|||
23677931|NCT00706030|66202681|FG001|Overall Study|Not recorded|0|||
23677932|NCT00706030|66202682|FG002|Overall Study|Not recorded|2|||
23677933|NCT00706030|66202683|FG003|Overall Study|Not recorded|0|||
23677934|NCT00706030|66202680|FG000|Overall Study|Protocol Violation|0|||
23677935|NCT00706030|66202681|FG001|Overall Study|Protocol Violation|0|||
23677936|NCT00706030|66202682|FG002|Overall Study|Protocol Violation|1|||
23677937|NCT00706030|66202683|FG003|Overall Study|Protocol Violation|1|||
23677938|NCT00706030|66202680|FG000|Overall Study|Failed to return|0|||
23677939|NCT00706030|66202681|FG001|Overall Study|Failed to return|0|||
23677940|NCT00706030|66202682|FG002|Overall Study|Failed to return|1|||
23677941|NCT00706030|66202683|FG003|Overall Study|Failed to return|0|||
23677942|NCT00706030|66202680|FG000|Overall Study|Symptomatic Deterioration|0|||
23677943|NCT00706030|66202681|FG001|Overall Study|Symptomatic Deterioration|0|||
23677944|NCT00706030|66202682|FG002|Overall Study|Symptomatic Deterioration|1|||
23677945|NCT00706030|66202683|FG003|Overall Study|Symptomatic Deterioration|0|||
23677946|NCT00706030|66202680|FG000|Overall Study|No treatment received|0|||
23677947|NCT00706030|66202681|FG001|Overall Study|No treatment received|0|||
23677948|NCT00706030|66202682|FG002|Overall Study|No treatment received|0|||
23677949|NCT00706030|66202683|FG003|Overall Study|No treatment received|1|||
23677950|NCT00706030|66202680|FG000|Overall Study|Death|0|||
23677951|NCT00706030|66202681|FG001|Overall Study|Death|0|||
23677952|NCT00706030|66202682|FG002|Overall Study|Death|1|||
23677953|NCT00706030|66202683|FG003|Overall Study|Death|0|||
23677954|NCT02883244|66202694|FG000|Overall Study|Lost to Follow-up|0|||
23677955|NCT02883244|66202695|FG001|Overall Study|Lost to Follow-up|1|||
23677956|NCT03222349|66202697|FG000|Overall Study|Treatment B not done|5|||
23677957|NCT03222349|66202698|FG001|Overall Study|Treatment B not done|0|||
23677958|NCT03222349|66202697|FG000|Overall Study|Lost to Follow-up|1|||
23677959|NCT03222349|66202698|FG001|Overall Study|Lost to Follow-up|2|||
23677960|NCT03222349|66202697|FG000|Overall Study|Withdrawal by Subject|1|||
23677961|NCT03222349|66202698|FG001|Overall Study|Withdrawal by Subject|0|||
23677962|NCT03222349|66202697|FG000|Overall Study|Treatment A not done|0|||
23677963|NCT03222349|66202698|FG001|Overall Study|Treatment A not done|5|||
23677964|NCT03222349|66202697|FG000|Overall Study|Study terminated by sponsor|1|||
23677965|NCT03222349|66202698|FG001|Overall Study|Study terminated by sponsor|0|||
23677966|NCT00796315|66202699|FG000|Overall Study|Protocol Violation|0|||
23677967|NCT00796315|66202700|FG001|Overall Study|Protocol Violation|1|||
23677968|NCT00796315|66202701|FG002|Overall Study|Protocol Violation|0|||
23677969|NCT00413959|66202702|FG000|Overall Study|Pt had only one cycle.|1|||
23677970|NCT01459614|66202703|FG000|Overall Study|Adverse Event|1|||
23677971|NCT01459614|66202704|FG001|Overall Study|Adverse Event|0|||
23677972|NCT05019131|66202706|FG000|Overall Study|Lost to Follow-up|0|||
23677973|NCT05019131|66202707|FG001|Overall Study|Lost to Follow-up|3|||
23677974|NCT01699087|66202708|FG000|Overall Study|Lost to Follow-up|7|||
23677975|NCT01699087|66202708|FG000|Overall Study|Screen failure (prior to treatment)|15|||
23677976|NCT01699087|66202708|FG000|Overall Study|Unable to make future visits|2|||
23677977|NCT02083380|66202711|FG000|Overall Study|Lack of Efficacy|68|||
23677978|NCT02083380|66202712|FG001|Overall Study|Lack of Efficacy|79|||
23677979|NCT02083380|66202713|FG002|Overall Study|Lack of Efficacy|64|||
23677980|NCT02083380|66202711|FG000|Overall Study|Withdrawal by Subject|9|||
23677981|NCT02083380|66202712|FG001|Overall Study|Withdrawal by Subject|3|||
23677982|NCT02083380|66202713|FG002|Overall Study|Withdrawal by Subject|7|||
23677983|NCT02083380|66202711|FG000|Overall Study|Physician Decision|1|||
23677984|NCT02083380|66202712|FG001|Overall Study|Physician Decision|6|||
23677985|NCT02083380|66202713|FG002|Overall Study|Physician Decision|3|||
23677986|NCT02083380|66202711|FG000|Overall Study|Adverse Event|0|||
23677987|NCT02083380|66202712|FG001|Overall Study|Adverse Event|0|||
23677988|NCT02083380|66202713|FG002|Overall Study|Adverse Event|1|||
23677989|NCT02083380|66202711|FG000|Overall Study|Lost to Follow-up|5|||
23677990|NCT02083380|66202712|FG001|Overall Study|Lost to Follow-up|3|||
23677991|NCT02083380|66202713|FG002|Overall Study|Lost to Follow-up|3|||
23388713|NCT03715829|65168788|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388714|NCT03715829|65168789|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388715|NCT03715829|65168790|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388716|NCT03715829|65168791|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388717|NCT03715829|65168792|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388718|NCT03715829|65168793|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388719|NCT03715829|65168794|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388720|NCT03715829|65168795|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
23494723|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23677992|NCT02083380|66202711|FG000|Overall Study|Other|8|||
23677993|NCT02083380|66202712|FG001|Overall Study|Other|4|||
23677994|NCT02083380|66202713|FG002|Overall Study|Other|6|||
23494724|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494725|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494726|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494727|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23677995|NCT03870555|66202714|FG000|Period 3 (2 Days)|Adverse Event|1|||
23677996|NCT03870555|66202715|FG001|Period 3 (2 Days)|Adverse Event|0|||
23677997|NCT03870555|66202716|FG002|Period 3 (2 Days)|Adverse Event|0|||
23677998|NCT04557384|66202717|FG000|Overall Study|Study Terminated by Sponsor|1|||
23677999|NCT04557384|66202717|FG000|Overall Study|Death|1|||
23678000|NCT01764633|66202718|FG000|Overall Study|Withdrawal by Subject|105|||
23678001|NCT01764633|66202719|FG001|Overall Study|Withdrawal by Subject|88|||
23678002|NCT01764633|66202718|FG000|Overall Study|Lost to Follow-up|13|||
23494728|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
23678003|NCT01764633|66202719|FG001|Overall Study|Lost to Follow-up|5|||
23678004|NCT01142726|66202723|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
23678005|NCT01142726|66202724|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
23388721|NCT03715829|65168796|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
23494729|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
23678006|NCT01142726|66202725|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
23678007|NCT01142726|66202723|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
23678008|NCT01142726|66202724|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
23678009|NCT01142726|66202725|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
23678010|NCT01142726|66202723|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
23678011|NCT01142726|66202724|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
23678012|NCT01142726|66202725|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
23678013|NCT01142726|66202723|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
23678014|NCT01142726|66202724|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
23678015|NCT01142726|66202725|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
23678016|NCT01142726|66202723|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
23678017|NCT01142726|66202724|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
23678018|NCT01142726|66202725|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
23678019|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
23678020|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
23678021|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
23678022|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
23678023|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
23678024|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
23678025|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
23678026|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
23678027|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
23678028|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
23678029|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
23678030|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
23678031|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
23678032|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
23678033|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
23678034|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
23678035|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
23678036|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
23678037|NCT01142726|66202723|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
23678038|NCT01142726|66202724|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
23678039|NCT01142726|66202725|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
23678040|NCT01142726|66202723|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
23678041|NCT01142726|66202724|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
23678042|NCT01142726|66202725|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
23678043|NCT01142726|66202723|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23678044|NCT01142726|66202724|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23678045|NCT01142726|66202725|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23678046|NCT01142726|66202723|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
23678047|NCT01142726|66202724|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
23678048|NCT01142726|66202725|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
23678049|NCT01142726|66202723|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
23678050|NCT01142726|66202724|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
23678051|NCT01142726|66202725|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
23678052|NCT03604445|66202726|FG000|Overall Study|Death|0|||
23678053|NCT03604445|66202727|FG001|Overall Study|Death|0|||
23678054|NCT03604445|66202728|FG002|Overall Study|Death|0|||
23678055|NCT03604445|66202729|FG003|Overall Study|Death|0|||
23678056|NCT03604445|66202730|FG004|Overall Study|Death|0|||
23678057|NCT03604445|66202731|FG005|Overall Study|Death|0|||
23678058|NCT03604445|66202732|FG006|Overall Study|Death|0|||
23678059|NCT03604445|66202733|FG007|Overall Study|Death|0|||
23678060|NCT03604445|66202734|FG008|Overall Study|Death|1|||
23678061|NCT03604445|66202726|FG000|Overall Study|Withdrawal by Subject|0|||
23678062|NCT03604445|66202727|FG001|Overall Study|Withdrawal by Subject|0|||
23678063|NCT03604445|66202728|FG002|Overall Study|Withdrawal by Subject|0|||
23678064|NCT03604445|66202729|FG003|Overall Study|Withdrawal by Subject|0|||
23678065|NCT03604445|66202730|FG004|Overall Study|Withdrawal by Subject|0|||
23678066|NCT03604445|66202731|FG005|Overall Study|Withdrawal by Subject|0|||
23678067|NCT03604445|66202732|FG006|Overall Study|Withdrawal by Subject|1|||
23678068|NCT03604445|66202733|FG007|Overall Study|Withdrawal by Subject|0|||
23678069|NCT03604445|66202734|FG008|Overall Study|Withdrawal by Subject|0|||
23678070|NCT03604445|66202726|FG000|Overall Study|Missing visit|0|||
23678071|NCT03604445|66202727|FG001|Overall Study|Missing visit|0|||
23678072|NCT03604445|66202728|FG002|Overall Study|Missing visit|0|||
23678073|NCT03604445|66202729|FG003|Overall Study|Missing visit|0|||
23678074|NCT03604445|66202730|FG004|Overall Study|Missing visit|0|||
23678075|NCT03604445|66202731|FG005|Overall Study|Missing visit|1|||
23678076|NCT03604445|66202732|FG006|Overall Study|Missing visit|0|||
23678077|NCT03604445|66202733|FG007|Overall Study|Missing visit|1|||
23678078|NCT03604445|66202734|FG008|Overall Study|Missing visit|0|||
23678079|NCT03604445|66202726|FG000|Overall Study|Adverse Event|0|||
23678080|NCT03604445|66202727|FG001|Overall Study|Adverse Event|0|||
23678081|NCT03604445|66202728|FG002|Overall Study|Adverse Event|0|||
23678082|NCT03604445|66202729|FG003|Overall Study|Adverse Event|1|||
23678083|NCT03604445|66202730|FG004|Overall Study|Adverse Event|0|||
23678084|NCT03604445|66202731|FG005|Overall Study|Adverse Event|0|||
23678085|NCT03604445|66202732|FG006|Overall Study|Adverse Event|0|||
23678086|NCT03604445|66202733|FG007|Overall Study|Adverse Event|0|||
23678087|NCT03604445|66202734|FG008|Overall Study|Adverse Event|1|||
23678088|NCT02167945|66202735|FG000|Overall Study|Adverse Event|16|||
23678089|NCT02167945|66202735|FG000|Overall Study|Withdrew Consent|42|||
23678090|NCT02167945|66202735|FG000|Overall Study|Lost to Follow-up|122|||
23678091|NCT02167945|66202735|FG000|Overall Study|COVID-19 logistical restrictions|6|||
23678092|NCT02167945|66202735|FG000|Overall Study|Other, not specified|63|||
23678093|NCT01422239|66202737|FG000|Overall Study|Lost to Follow-up|4|||
23678094|NCT01422239|66202738|FG001|Overall Study|Lost to Follow-up|3|||
23678095|NCT02475655|66202739|FG000|Overall Study|Lost to Follow-up|0|||
23678096|NCT02475655|66202740|FG001|Overall Study|Lost to Follow-up|1|||
23678097|NCT01100944|66202745|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
23678098|NCT01100944|66202746|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
23388722|NCT03715829|65168797|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388723|NCT03715829|65168798|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388724|NCT03715829|65168788|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388725|NCT03715829|65168789|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388726|NCT03715829|65168790|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388727|NCT03715829|65168791|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388728|NCT03715829|65168792|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
23678099|NCT01100944|66202747|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
23678100|NCT01100944|66202745|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
23678101|NCT01100944|66202746|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
23678102|NCT01100944|66202747|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
23678103|NCT01100944|66202745|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
23678104|NCT01100944|66202746|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
23678105|NCT01100944|66202747|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
23678106|NCT01100944|66202745|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
23678107|NCT01100944|66202746|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
23678108|NCT01100944|66202747|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
23678109|NCT00217087|66202750|FG000|Overall Study|decided to have esophagectomy|1|||
23678110|NCT00217087|66202751|FG001|Overall Study|decided to have esophagectomy|2|||
23678111|NCT00217087|66202750|FG000|Overall Study|completed less than 12 months return|10|||
23678112|NCT00217087|66202751|FG001|Overall Study|completed less than 12 months return|18|||
23678113|NCT02319044|66202752|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
23678114|NCT02319044|66202753|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
23678115|NCT02319044|66202754|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
23678116|NCT02319044|66202752|FG000|Overall Study|Withdrawal by Subject|3|||
23678117|NCT02319044|66202753|FG001|Overall Study|Withdrawal by Subject|3|||
23678118|NCT02319044|66202754|FG002|Overall Study|Withdrawal by Subject|6|||
23678119|NCT02319044|66202752|FG000|Overall Study|Condition under investigation worsened|100|||
23678120|NCT02319044|66202753|FG001|Overall Study|Condition under investigation worsened|50|||
23678121|NCT02319044|66202754|FG002|Overall Study|Condition under investigation worsened|46|||
23678122|NCT02319044|66202752|FG000|Overall Study|Adverse Event|17|||
23678123|NCT02319044|66202753|FG001|Overall Study|Adverse Event|2|||
23678124|NCT02319044|66202754|FG002|Overall Study|Adverse Event|8|||
23678125|NCT02319044|66202752|FG000|Overall Study|Study specific discontinuation criteria|2|||
23678126|NCT02319044|66202753|FG001|Overall Study|Study specific discontinuation criteria|2|||
23678127|NCT02319044|66202754|FG002|Overall Study|Study specific discontinuation criteria|1|||
23678128|NCT02319044|66202752|FG000|Overall Study|Not treated|0|||
23678129|NCT02319044|66202753|FG001|Overall Study|Not treated|2|||
23678130|NCT02319044|66202754|FG002|Overall Study|Not treated|2|||
23678131|NCT00662792|66202757|FG000|Period 1|Personal Reasons|0|||
23678132|NCT00662792|66202758|FG001|Period 1|Personal Reasons|0|||
23678133|NCT00662792|66202759|FG002|Period 1|Personal Reasons|1|||
23678134|NCT00662792|66202760|FG003|Period 1|Personal Reasons|0|||
23678135|NCT00662792|66202757|FG000|Period 1|Refused continuing medication|0|||
23678136|NCT00662792|66202758|FG001|Period 1|Refused continuing medication|1|||
23678137|NCT00662792|66202759|FG002|Period 1|Refused continuing medication|1|||
23678138|NCT00662792|66202760|FG003|Period 1|Refused continuing medication|0|||
23678139|NCT00662792|66202757|FG000|Period 1|Lost to Follow-up|1|||
23678140|NCT00662792|66202758|FG001|Period 1|Lost to Follow-up|0|||
23678141|NCT00662792|66202759|FG002|Period 1|Lost to Follow-up|0|||
23678142|NCT00662792|66202760|FG003|Period 1|Lost to Follow-up|0|||
23678143|NCT00662792|66202757|FG000|Period 1|Other adverse event (AE)|0|||
23678144|NCT00662792|66202758|FG001|Period 1|Other adverse event (AE)|2|||
23678145|NCT00662792|66202759|FG002|Period 1|Other adverse event (AE)|0|||
23678146|NCT00662792|66202760|FG003|Period 1|Other adverse event (AE)|0|||
23678147|NCT00662792|66202757|FG000|Period 1|Worsening of disease under study (AE)|1|||
23678148|NCT00662792|66202758|FG001|Period 1|Worsening of disease under study (AE)|3|||
23388729|NCT03715829|65168793|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388730|NCT03715829|65168794|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388731|NCT03715829|65168795|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388732|NCT03715829|65168796|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
23388733|NCT03715829|65168797|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
23678149|NCT00662792|66202759|FG002|Period 1|Worsening of disease under study (AE)|2|||
23678150|NCT00662792|66202760|FG003|Period 1|Worsening of disease under study (AE)|0|||
23678151|NCT00662792|66202757|FG000|Period 1|Not treated|0|||
23678152|NCT00662792|66202758|FG001|Period 1|Not treated|1|||
23678153|NCT00662792|66202759|FG002|Period 1|Not treated|0|||
23678154|NCT00662792|66202760|FG003|Period 1|Not treated|0|||
23678155|NCT00662792|66202757|FG000|Period 2|Worsening of disease under study|1|||
23678156|NCT00662792|66202758|FG001|Period 2|Worsening of disease under study|0|||
23678157|NCT00662792|66202759|FG002|Period 2|Worsening of disease under study|0|||
23678158|NCT00662792|66202760|FG003|Period 2|Worsening of disease under study|3|||
23678159|NCT00662792|66202757|FG000|Period 3|Refused continuing medication|1|||
23678160|NCT00662792|66202758|FG001|Period 3|Refused continuing medication|0|||
23678161|NCT00662792|66202759|FG002|Period 3|Refused continuing medication|1|||
23678162|NCT00662792|66202760|FG003|Period 3|Refused continuing medication|0|||
23678163|NCT00662792|66202757|FG000|Period 3|Other adverse event (AE)|0|||
23678164|NCT00662792|66202758|FG001|Period 3|Other adverse event (AE)|0|||
23678165|NCT00662792|66202759|FG002|Period 3|Other adverse event (AE)|1|||
23678166|NCT00662792|66202760|FG003|Period 3|Other adverse event (AE)|1|||
23678167|NCT00662792|66202757|FG000|Period 4|Refused continuing medication|0|||
23678168|NCT00662792|66202758|FG001|Period 4|Refused continuing medication|1|||
23678169|NCT00662792|66202759|FG002|Period 4|Refused continuing medication|0|||
23678170|NCT00662792|66202760|FG003|Period 4|Refused continuing medication|0|||
23678171|NCT00662792|66202757|FG000|Period 4|Other adverse event (AE)|1|||
23678172|NCT00662792|66202758|FG001|Period 4|Other adverse event (AE)|0|||
23678173|NCT00662792|66202759|FG002|Period 4|Other adverse event (AE)|0|||
23678174|NCT00662792|66202760|FG003|Period 4|Other adverse event (AE)|0|||
23678175|NCT00662792|66202757|FG000|Period 4|Worsening of disease under study (AE)|0|||
23678176|NCT00662792|66202758|FG001|Period 4|Worsening of disease under study (AE)|0|||
23678177|NCT00662792|66202759|FG002|Period 4|Worsening of disease under study (AE)|0|||
23678178|NCT00662792|66202760|FG003|Period 4|Worsening of disease under study (AE)|1|||
23678179|NCT04428411|66202761|FG000|Overall Study|Lost to Follow-up|114|||
23678180|NCT01486199|66202762|FG000|Two Year Period Between Study Days|Physician Decision|1|||
23678181|NCT01486199|66202763|FG001|Two Year Period Between Study Days|Physician Decision|0|||
23678182|NCT01972074|66202764|FG000|Overall Study|Adverse Event|4|||
23678183|NCT01972074|66202765|FG001|Overall Study|Adverse Event|1|||
23678184|NCT01972074|66202766|FG002|Overall Study|Adverse Event|0|||
23678185|NCT01972074|66202764|FG000|Overall Study|Lack of Efficacy|1|||
23678186|NCT01972074|66202765|FG001|Overall Study|Lack of Efficacy|1|||
23678187|NCT01972074|66202766|FG002|Overall Study|Lack of Efficacy|0|||
23678188|NCT01972074|66202764|FG000|Overall Study|Lost to Follow-up|0|||
23678189|NCT01972074|66202765|FG001|Overall Study|Lost to Follow-up|1|||
23678190|NCT01972074|66202766|FG002|Overall Study|Lost to Follow-up|1|||
23678191|NCT01972074|66202764|FG000|Overall Study|Withdrawal by Subject|1|||
23678192|NCT01972074|66202765|FG001|Overall Study|Withdrawal by Subject|1|||
23678193|NCT01972074|66202766|FG002|Overall Study|Withdrawal by Subject|1|||
23678194|NCT01972074|66202764|FG000|Overall Study|Scanner Unavailable|0|||
23678195|NCT01972074|66202765|FG001|Overall Study|Scanner Unavailable|0|||
23678196|NCT01972074|66202766|FG002|Overall Study|Scanner Unavailable|1|||
23678197|NCT01639833|66202767|FG000|Overall Study|Death|4|||
23678198|NCT01639833|66202768|FG001|Overall Study|Death|2|||
23678199|NCT01639833|66202767|FG000|Overall Study|Withdrawal by Subject|2|||
23678200|NCT01639833|66202768|FG001|Overall Study|Withdrawal by Subject|2|||
23678201|NCT00090545|66202769|FG000|Overall Study|Disease progression on study|21|||
23678202|NCT00090545|66202770|FG001|Overall Study|Disease progression on study|17|||
23678203|NCT00090545|66202769|FG000|Overall Study|Refused further treatment|1|||
23678204|NCT00090545|66202770|FG001|Overall Study|Refused further treatment|4|||
23678205|NCT00090545|66202769|FG000|Overall Study|Death|0|||
23678206|NCT00090545|66202770|FG001|Overall Study|Death|1|||
23678207|NCT00090545|66202769|FG000|Overall Study|Adverse Event|0|||
23678208|NCT00090545|66202770|FG001|Overall Study|Adverse Event|2|||
23678209|NCT03980938|66202774|FG000|Treatment Period 1|Study Terminated|1|||
23678210|NCT03980938|66202775|FG001|Treatment Period 1|Study Terminated|1|||
23678211|NCT03980938|66202774|FG000|Treatment Period 2|Study Terminated|2|||
23678212|NCT03980938|66202775|FG001|Treatment Period 2|Study Terminated|2|||
23678213|NCT00666926|66202777|FG000|Overall Study|Adverse Event|0|||
23678214|NCT00666926|66202778|FG001|Overall Study|Adverse Event|0|||
23678215|NCT00666926|66202779|FG002|Overall Study|Adverse Event|0|||
23678216|NCT00666926|66202780|FG003|Overall Study|Adverse Event|0|||
23678217|NCT00666926|66202781|FG004|Overall Study|Adverse Event|0|||
23678218|NCT00666926|66202782|FG005|Overall Study|Adverse Event|0|||
23678219|NCT00666926|66202783|FG006|Overall Study|Adverse Event|0|||
23678220|NCT00666926|66202784|FG007|Overall Study|Adverse Event|0|||
23678221|NCT00666926|66202785|FG008|Overall Study|Adverse Event|0|||
23678222|NCT00666926|66202786|FG009|Overall Study|Adverse Event|2|||
23678223|NCT00666926|66202787|FG010|Overall Study|Adverse Event|2|||
23678224|NCT00666926|66202788|FG011|Overall Study|Adverse Event|2|||
23678225|NCT00666926|66202789|FG012|Overall Study|Adverse Event|0|||
23678226|NCT00666926|66202790|FG013|Overall Study|Adverse Event|1|||
23678227|NCT00666926|66202791|FG014|Overall Study|Adverse Event|0|||
23678228|NCT00666926|66202792|FG015|Overall Study|Adverse Event|0|||
23678229|NCT00666926|66202777|FG000|Overall Study|Laboratory abnormality|0|||
23678230|NCT00666926|66202778|FG001|Overall Study|Laboratory abnormality|0|||
23678231|NCT00666926|66202779|FG002|Overall Study|Laboratory abnormality|0|||
23678232|NCT00666926|66202780|FG003|Overall Study|Laboratory abnormality|0|||
23678233|NCT00666926|66202781|FG004|Overall Study|Laboratory abnormality|0|||
23678234|NCT00666926|66202782|FG005|Overall Study|Laboratory abnormality|0|||
23678235|NCT00666926|66202783|FG006|Overall Study|Laboratory abnormality|0|||
23678236|NCT00666926|66202784|FG007|Overall Study|Laboratory abnormality|0|||
23678237|NCT00666926|66202785|FG008|Overall Study|Laboratory abnormality|0|||
23678238|NCT00666926|66202786|FG009|Overall Study|Laboratory abnormality|0|||
23678239|NCT00666926|66202787|FG010|Overall Study|Laboratory abnormality|1|||
23678240|NCT00666926|66202788|FG011|Overall Study|Laboratory abnormality|0|||
23678241|NCT00666926|66202789|FG012|Overall Study|Laboratory abnormality|0|||
23678242|NCT00666926|66202790|FG013|Overall Study|Laboratory abnormality|0|||
23678243|NCT00666926|66202791|FG014|Overall Study|Laboratory abnormality|0|||
23678244|NCT00666926|66202792|FG015|Overall Study|Laboratory abnormality|1|||
23678245|NCT00666926|66202777|FG000|Overall Study|Lack of Efficacy|0|||
23678246|NCT00666926|66202778|FG001|Overall Study|Lack of Efficacy|0|||
23678247|NCT00666926|66202779|FG002|Overall Study|Lack of Efficacy|0|||
23678248|NCT00666926|66202780|FG003|Overall Study|Lack of Efficacy|0|||
23678249|NCT00666926|66202781|FG004|Overall Study|Lack of Efficacy|0|||
23678250|NCT00666926|66202782|FG005|Overall Study|Lack of Efficacy|1|||
23678251|NCT00666926|66202783|FG006|Overall Study|Lack of Efficacy|0|||
23678252|NCT00666926|66202784|FG007|Overall Study|Lack of Efficacy|0|||
23678253|NCT00666926|66202785|FG008|Overall Study|Lack of Efficacy|0|||
23678254|NCT00666926|66202786|FG009|Overall Study|Lack of Efficacy|0|||
23678255|NCT00666926|66202787|FG010|Overall Study|Lack of Efficacy|0|||
23678256|NCT00666926|66202788|FG011|Overall Study|Lack of Efficacy|1|||
23678257|NCT00666926|66202789|FG012|Overall Study|Lack of Efficacy|0|||
23678258|NCT00666926|66202790|FG013|Overall Study|Lack of Efficacy|0|||
23678259|NCT00666926|66202791|FG014|Overall Study|Lack of Efficacy|0|||
23678260|NCT00666926|66202792|FG015|Overall Study|Lack of Efficacy|0|||
23678261|NCT00666926|66202777|FG000|Overall Study|Lost to Follow-up|0|||
23678262|NCT00666926|66202778|FG001|Overall Study|Lost to Follow-up|0|||
23678263|NCT00666926|66202779|FG002|Overall Study|Lost to Follow-up|0|||
23678264|NCT00666926|66202780|FG003|Overall Study|Lost to Follow-up|1|||
23678265|NCT00666926|66202781|FG004|Overall Study|Lost to Follow-up|0|||
23678266|NCT00666926|66202782|FG005|Overall Study|Lost to Follow-up|0|||
23678267|NCT00666926|66202783|FG006|Overall Study|Lost to Follow-up|0|||
23678268|NCT00666926|66202784|FG007|Overall Study|Lost to Follow-up|0|||
23678269|NCT00666926|66202785|FG008|Overall Study|Lost to Follow-up|0|||
23678270|NCT00666926|66202786|FG009|Overall Study|Lost to Follow-up|0|||
23494730|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23678271|NCT00666926|66202787|FG010|Overall Study|Lost to Follow-up|0|||
23678272|NCT00666926|66202788|FG011|Overall Study|Lost to Follow-up|0|||
23678273|NCT00666926|66202789|FG012|Overall Study|Lost to Follow-up|0|||
23678274|NCT00666926|66202790|FG013|Overall Study|Lost to Follow-up|0|||
23678275|NCT00666926|66202791|FG014|Overall Study|Lost to Follow-up|0|||
23678276|NCT00666926|66202792|FG015|Overall Study|Lost to Follow-up|0|||
23678277|NCT00666926|66202777|FG000|Overall Study|Other|2|||
23678278|NCT00666926|66202778|FG001|Overall Study|Other|4|||
23678279|NCT00666926|66202779|FG002|Overall Study|Other|3|||
23678280|NCT00666926|66202780|FG003|Overall Study|Other|3|||
23678281|NCT00666926|66202781|FG004|Overall Study|Other|3|||
23678282|NCT00666926|66202782|FG005|Overall Study|Other|3|||
23678283|NCT00666926|66202783|FG006|Overall Study|Other|4|||
23678284|NCT00666926|66202784|FG007|Overall Study|Other|0|||
23678285|NCT00666926|66202785|FG008|Overall Study|Other|3|||
23678286|NCT00666926|66202786|FG009|Overall Study|Other|5|||
23678287|NCT00666926|66202787|FG010|Overall Study|Other|3|||
23678288|NCT00666926|66202788|FG011|Overall Study|Other|26|||
23678289|NCT00666926|66202789|FG012|Overall Study|Other|3|||
23678290|NCT00666926|66202790|FG013|Overall Study|Other|2|||
23678291|NCT00666926|66202791|FG014|Overall Study|Other|4|||
23678292|NCT00666926|66202792|FG015|Overall Study|Other|4|||
23678293|NCT00666926|66202777|FG000|Overall Study|Withdrawal by Subject|0|||
23678294|NCT00666926|66202778|FG001|Overall Study|Withdrawal by Subject|0|||
23678295|NCT00666926|66202779|FG002|Overall Study|Withdrawal by Subject|0|||
23678296|NCT00666926|66202780|FG003|Overall Study|Withdrawal by Subject|0|||
23678297|NCT00666926|66202781|FG004|Overall Study|Withdrawal by Subject|0|||
23678298|NCT00666926|66202782|FG005|Overall Study|Withdrawal by Subject|0|||
23678299|NCT00666926|66202783|FG006|Overall Study|Withdrawal by Subject|0|||
23678300|NCT00666926|66202784|FG007|Overall Study|Withdrawal by Subject|1|||
23678301|NCT00666926|66202785|FG008|Overall Study|Withdrawal by Subject|0|||
23678302|NCT00666926|66202786|FG009|Overall Study|Withdrawal by Subject|3|||
23678303|NCT00666926|66202787|FG010|Overall Study|Withdrawal by Subject|0|||
23678304|NCT00666926|66202788|FG011|Overall Study|Withdrawal by Subject|3|||
23678305|NCT00666926|66202789|FG012|Overall Study|Withdrawal by Subject|0|||
23678306|NCT00666926|66202790|FG013|Overall Study|Withdrawal by Subject|1|||
23678307|NCT00666926|66202791|FG014|Overall Study|Withdrawal by Subject|3|||
23678308|NCT00666926|66202792|FG015|Overall Study|Withdrawal by Subject|3|||
23678309|NCT00666926|66202777|FG000|Overall Study|Death|0|||
23678310|NCT00666926|66202778|FG001|Overall Study|Death|0|||
23678311|NCT00666926|66202779|FG002|Overall Study|Death|0|||
23678312|NCT00666926|66202780|FG003|Overall Study|Death|0|||
23678313|NCT00666926|66202781|FG004|Overall Study|Death|0|||
23678314|NCT00666926|66202782|FG005|Overall Study|Death|0|||
23678315|NCT00666926|66202783|FG006|Overall Study|Death|0|||
23678316|NCT00666926|66202784|FG007|Overall Study|Death|0|||
23678317|NCT00666926|66202785|FG008|Overall Study|Death|0|||
23678318|NCT00666926|66202786|FG009|Overall Study|Death|0|||
23678319|NCT00666926|66202787|FG010|Overall Study|Death|0|||
23678320|NCT00666926|66202788|FG011|Overall Study|Death|1|||
23678321|NCT00666926|66202789|FG012|Overall Study|Death|0|||
23678322|NCT00666926|66202790|FG013|Overall Study|Death|0|||
23678323|NCT00666926|66202791|FG014|Overall Study|Death|0|||
23678324|NCT00666926|66202792|FG015|Overall Study|Death|0|||
23678325|NCT01445769|66202795|FG000|Overall Study|Consent Withdrawn|2|||
23678326|NCT01445769|66202795|FG000|Overall Study|Disease Progression|1|||
23678327|NCT01445769|66202795|FG000|Overall Study|Lost to Follow-up|5|||
23678328|NCT02979431|66202798|FG000|Overall Study|Parent/guardian withdrew consent|2|||
23678329|NCT02979431|66202799|FG001|Overall Study|Parent/guardian withdrew consent|1|||
23678330|NCT02979431|66202800|FG002|Overall Study|Parent/guardian withdrew consent|1|||
23678331|NCT02979431|66202801|FG003|Overall Study|Parent/guardian withdrew consent|1|||
23678332|NCT02979431|66202798|FG000|Overall Study|Randomized but received no study drug|1|||
23678333|NCT02979431|66202799|FG001|Overall Study|Randomized but received no study drug|1|||
23678334|NCT02979431|66202800|FG002|Overall Study|Randomized but received no study drug|0|||
23678335|NCT02979431|66202801|FG003|Overall Study|Randomized but received no study drug|0|||
23678336|NCT02979431|66202798|FG000|Overall Study|Adverse Event|0|||
23678337|NCT02979431|66202799|FG001|Overall Study|Adverse Event|0|||
23678338|NCT02979431|66202800|FG002|Overall Study|Adverse Event|1|||
23678339|NCT02979431|66202801|FG003|Overall Study|Adverse Event|0|||
23678340|NCT02979431|66202798|FG000|Overall Study|Subject left country after Day14|1|||
23678341|NCT02979431|66202799|FG001|Overall Study|Subject left country after Day14|0|||
23678342|NCT02979431|66202800|FG002|Overall Study|Subject left country after Day14|0|||
23678343|NCT02979431|66202801|FG003|Overall Study|Subject left country after Day14|0|||
23678344|NCT00686647|66202802|FG000|Overall Study|Lost to Follow-up|1|||
23678345|NCT00686647|66202802|FG000|Overall Study|Death|1|||
23678346|NCT03705793|66202803|FG000|Overall Study|Lost to Follow-up|3|||
23678347|NCT03705793|66202804|FG001|Overall Study|Lost to Follow-up|4|||
23678348|NCT03705793|66202803|FG000|Overall Study|Withdrawal by Subject|2|||
23678349|NCT03705793|66202804|FG001|Overall Study|Withdrawal by Subject|1|||
23678350|NCT02658812|66202809|FG000|Overall Study|Disease Progression|7|||
23678351|NCT02658812|66202809|FG000|Overall Study|Unrelated to study treatment|1|||
23678352|NCT02658812|66202809|FG000|Overall Study|Adverse Event|1|||
23678353|NCT00482014|66202810|FG000|Overall Study|Withdrawal by Subject|1|||
23678354|NCT00482014|66202811|FG001|Overall Study|Withdrawal by Subject|2|||
23678355|NCT00482014|66202812|FG002|Overall Study|Withdrawal by Subject|3|||
23678356|NCT00482014|66202813|FG003|Overall Study|Withdrawal by Subject|4|||
23678357|NCT00482014|66202810|FG000|Overall Study|Adverse Event|3|||
23678358|NCT00482014|66202811|FG001|Overall Study|Adverse Event|0|||
23678359|NCT00482014|66202812|FG002|Overall Study|Adverse Event|2|||
23678360|NCT00482014|66202813|FG003|Overall Study|Adverse Event|8|||
23678361|NCT00482014|66202810|FG000|Overall Study|Death|1|||
23678362|NCT00482014|66202811|FG001|Overall Study|Death|2|||
23678363|NCT00482014|66202812|FG002|Overall Study|Death|1|||
23678364|NCT00482014|66202813|FG003|Overall Study|Death|4|||
23678365|NCT00482014|66202810|FG000|Overall Study|Lack of Efficacy|1|||
23678366|NCT00482014|66202811|FG001|Overall Study|Lack of Efficacy|0|||
23678367|NCT00482014|66202812|FG002|Overall Study|Lack of Efficacy|4|||
23678368|NCT00482014|66202813|FG003|Overall Study|Lack of Efficacy|6|||
23678369|NCT00482014|66202810|FG000|Overall Study|Sponsor Decision|1|||
23678370|NCT00482014|66202811|FG001|Overall Study|Sponsor Decision|2|||
23678371|NCT00482014|66202812|FG002|Overall Study|Sponsor Decision|1|||
23678372|NCT00482014|66202813|FG003|Overall Study|Sponsor Decision|1|||
23678373|NCT01157078|66202814|FG000|Overall Study|Withdrawal by Subject|12|||
23678374|NCT01157078|66202815|FG001|Overall Study|Withdrawal by Subject|14|||
23678375|NCT01157078|66202814|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23678376|NCT01157078|66202815|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23678377|NCT01157078|66202814|FG000|Overall Study|Adverse Event|6|||
23678378|NCT01157078|66202815|FG001|Overall Study|Adverse Event|6|||
23678379|NCT01157078|66202814|FG000|Overall Study|Severe non-compliance to protocol|2|||
23678380|NCT01157078|66202815|FG001|Overall Study|Severe non-compliance to protocol|4|||
23678381|NCT01157078|66202814|FG000|Overall Study|Condition under investigation worsened|0|||
23678382|NCT01157078|66202815|FG001|Overall Study|Condition under investigation worsened|1|||
23678383|NCT01157078|66202814|FG000|Overall Study|Lack of Efficacy|2|||
23678384|NCT01157078|66202815|FG001|Overall Study|Lack of Efficacy|0|||
23678385|NCT01157078|66202814|FG000|Overall Study|Study-specific withdrawal criteria|2|||
23678386|NCT01157078|66202815|FG001|Overall Study|Study-specific withdrawal criteria|2|||
23678387|NCT01157078|66202814|FG000|Overall Study|Lost to Follow-up|7|||
23678388|NCT01157078|66202815|FG001|Overall Study|Lost to Follow-up|5|||
23678389|NCT01157078|66202814|FG000|Overall Study|Other|2|||
23678390|NCT01157078|66202815|FG001|Overall Study|Other|4|||
23678391|NCT02894840|66202816|FG000|Overall Study|Lost to Follow-up|1|||
23678392|NCT02894840|66202817|FG001|Overall Study|Lost to Follow-up|0|||
23678393|NCT02894840|66202818|FG002|Overall Study|Lost to Follow-up|3|||
23678394|NCT02894840|66202819|FG003|Overall Study|Lost to Follow-up|0|||
23678395|NCT01931059|66202820|FG000|Day 1|Pregnancy|0|||
23678396|NCT01931059|66202821|FG001|Day 1|Pregnancy|1|||
23678397|NCT01931059|66202820|FG000|Day3|Lost to Follow-up|1|||
23678398|NCT01931059|66202821|FG001|Day3|Lost to Follow-up|0|||
23678399|NCT02623335|66202824|FG000|Overall Study|Death|8|||
23678400|NCT02623335|66202825|FG001|Overall Study|Death|7|||
23678401|NCT02623335|66202824|FG000|Overall Study|Lost to Follow-up|15|||
23678402|NCT02623335|66202825|FG001|Overall Study|Lost to Follow-up|23|||
23678403|NCT02623335|66202824|FG000|Overall Study|Withdrawal by Subject|2|||
23678404|NCT02623335|66202825|FG001|Overall Study|Withdrawal by Subject|5|||
23678405|NCT02623335|66202824|FG000|Overall Study|Protocol Violation|2|||
23678406|NCT02623335|66202825|FG001|Overall Study|Protocol Violation|1|||
23678407|NCT01986062|66202826|FG000|Overall Study|Lost to Follow-up|1|||
23678408|NCT01986062|66202827|FG001|Overall Study|Lost to Follow-up|0|||
23388734|NCT03715829|65168798|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388735|NCT03715829|65168788|FG000|Extension Period|Other|0|||
23388736|NCT03715829|65168789|FG001|Extension Period|Other|0|||
23388737|NCT03715829|65168790|FG002|Extension Period|Other|0|||
23388738|NCT03715829|65168791|FG003|Extension Period|Other|0|||
23388739|NCT03715829|65168792|FG004|Extension Period|Other|0|||
23388740|NCT03715829|65168793|FG005|Extension Period|Other|0|||
23388741|NCT03715829|65168794|FG006|Extension Period|Other|1|||
23388742|NCT03715829|65168795|FG007|Extension Period|Other|2|||
23388743|NCT03715829|65168796|FG008|Extension Period|Other|4|||
23388744|NCT03715829|65168797|FG009|Extension Period|Other|0|||
23388745|NCT03715829|65168798|FG010|Extension Period|Other|0|||
23388746|NCT02004275|65168799|FG000|Phase 1|Ineligible|0|||
23388747|NCT02004275|65168800|FG001|Phase 1|Ineligible|0|||
23388748|NCT02004275|65168801|FG002|Phase 1|Ineligible|0|||
23388749|NCT02004275|65168802|FG003|Phase 1|Ineligible|1|||
23388750|NCT02004275|65168803|FG004|Phase 1|Ineligible|1|||
23388751|NCT02004275|65168804|FG005|Phase 1|Ineligible|0|||
23388752|NCT02004275|65168799|FG000|Phase 1|Protocol Violation|0|||
23388753|NCT02004275|65168800|FG001|Phase 1|Protocol Violation|0|||
23388754|NCT02004275|65168801|FG002|Phase 1|Protocol Violation|0|||
23388755|NCT02004275|65168802|FG003|Phase 1|Protocol Violation|1|||
23388756|NCT02004275|65168803|FG004|Phase 1|Protocol Violation|0|||
23388757|NCT02004275|65168804|FG005|Phase 1|Protocol Violation|5|||
23388758|NCT02004275|65168799|FG000|Phase 2 Part 1|Ineligible|6|||
23388759|NCT02004275|65168800|FG001|Phase 2 Part 1|Ineligible|9|||
23388760|NCT02004275|65168801|FG002|Phase 2 Part 1|Ineligible|0|||
23388761|NCT02004275|65168802|FG003|Phase 2 Part 1|Ineligible|0|||
23388762|NCT02004275|65168803|FG004|Phase 2 Part 1|Ineligible|0|||
23388763|NCT02004275|65168804|FG005|Phase 2 Part 1|Ineligible|0|||
23388764|NCT02004275|65168799|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
23388765|NCT02004275|65168800|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
23494731|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23678409|NCT01986062|66202826|FG000|Overall Study|Withdrawal by Subject|0|||
23678410|NCT01986062|66202827|FG001|Overall Study|Withdrawal by Subject|1|||
23388766|NCT02004275|65168801|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
23388767|NCT02004275|65168802|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
23388768|NCT02004275|65168803|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
23388769|NCT02004275|65168804|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
23388770|NCT02536339|65168809|FG000|Overall Study|Death|20|||
23388771|NCT02536339|65168809|FG000|Overall Study|Withdrawal by Subject|3|||
23388772|NCT02536339|65168809|FG000|Overall Study|Lost to Follow-up|2|||
23388773|NCT02536339|65168809|FG000|Overall Study|Treatment discontinued|2|||
23388774|NCT02536339|65168809|FG000|Overall Study|Physician Decision|1|||
23388775|NCT02226653|65168812|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
23388776|NCT02226653|65168813|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
23388777|NCT02226653|65168812|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
23388778|NCT02226653|65168813|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
23388779|NCT02242903|65168814|FG000|Overall Study|Withdrawal by Subject|1|||
23388780|NCT02242903|65168815|FG001|Overall Study|Withdrawal by Subject|0|||
23388781|NCT02242903|65168816|FG002|Overall Study|Withdrawal by Subject|0|||
23388782|NCT02242903|65168817|FG003|Overall Study|Withdrawal by Subject|0|||
23388783|NCT02242903|65168818|FG004|Overall Study|Withdrawal by Subject|0|||
23388784|NCT02242903|65168819|FG005|Overall Study|Withdrawal by Subject|0|||
23388785|NCT02242903|65168820|FG006|Overall Study|Withdrawal by Subject|0|||
23388786|NCT01093573|65168823|FG000|Overall Study|Physician Decision|0|||
23388787|NCT01093573|65168824|FG001|Overall Study|Physician Decision|0|||
23388788|NCT01093573|65168825|FG002|Overall Study|Physician Decision|1|||
23494732|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23388789|NCT01093573|65168823|FG000|Overall Study|Insurance Denied|0|||
23388790|NCT01093573|65168824|FG001|Overall Study|Insurance Denied|0|||
23388791|NCT01093573|65168825|FG002|Overall Study|Insurance Denied|1|||
23494733|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494734|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494735|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494736|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Death|0|||
23494737|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Death|0|||
23494738|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Death|0|||
23494739|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Death|2|||
23494740|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Death|5|||
23494741|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Death|0|||
23494742|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Death|0|||
23388792|NCT00069953|65168826|FG000|Overall Study|Protocol Violation|2|||
23494743|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Death|0|||
23494744|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Death|0|||
23494745|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Death|0|||
23678411|NCT00634569|66202828|FG000|Overall Study|Withdrawal by Subject|0|||
23678412|NCT00634569|66202829|FG001|Overall Study|Withdrawal by Subject|4|||
23678413|NCT00634569|66202828|FG000|Overall Study|Physician Decision|0|||
23678414|NCT00634569|66202829|FG001|Overall Study|Physician Decision|1|||
23678415|NCT03683394|66202833|FG000|Overall Study|Withdrawal by Subject|4|||
23388793|NCT01386645|65168828|FG000|Overall Study|Physician Decision|0|||
23388794|NCT01386645|65168829|FG001|Overall Study|Physician Decision|0|||
23388795|NCT01386645|65168830|FG002|Overall Study|Physician Decision|1|||
23388796|NCT01386645|65168828|FG000|Overall Study|Withdrawal by Subject|0|||
23388797|NCT01386645|65168829|FG001|Overall Study|Withdrawal by Subject|1|||
23388798|NCT01386645|65168830|FG002|Overall Study|Withdrawal by Subject|1|||
23388799|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
23388800|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
23388801|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
23388802|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
23388803|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
23388804|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
23388805|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
23388806|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
23388807|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23388808|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23388809|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23388810|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
23388811|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
23388812|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
23388813|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
23388814|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
23388815|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
23388816|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
23388817|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
23388818|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
23388819|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
23388820|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
23388821|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
23388822|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
23388823|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
23388824|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23678416|NCT03683394|66202834|FG001|Overall Study|Withdrawal by Subject|8|||
23678417|NCT03683394|66202833|FG000|Overall Study|Lost to Follow-up|7|||
23678418|NCT03683394|66202834|FG001|Overall Study|Lost to Follow-up|0|||
23678419|NCT03683394|66202833|FG000|Overall Study|Death|3|||
23678420|NCT03683394|66202834|FG001|Overall Study|Death|1|||
23678421|NCT01920711|66202836|FG000|Overall Study|Death|347|||
23678422|NCT01920711|66202837|FG001|Overall Study|Death|356|||
23678423|NCT01920711|66202836|FG000|Overall Study|Lost to Follow-up|13|||
23678424|NCT01920711|66202837|FG001|Overall Study|Lost to Follow-up|14|||
23678425|NCT01920711|66202836|FG000|Overall Study|Withdrawal by Subject|4|||
23678426|NCT01920711|66202837|FG001|Overall Study|Withdrawal by Subject|3|||
23678427|NCT01441063|66202842|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
23678428|NCT01441063|66202842|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
23678429|NCT02161562|66202846|FG000|Overall Study|Withdrawal by Subject|5|||
23678430|NCT02161562|66202847|FG001|Overall Study|Withdrawal by Subject|8|||
23678431|NCT02161562|66202846|FG000|Overall Study|Protocol Violation|9|||
23678432|NCT02161562|66202847|FG001|Overall Study|Protocol Violation|4|||
23678433|NCT02161562|66202846|FG000|Overall Study|Pregnancy|1|||
23678434|NCT02161562|66202847|FG001|Overall Study|Pregnancy|2|||
23678435|NCT02161562|66202846|FG000|Overall Study|Lost to Follow-up|3|||
23678436|NCT02161562|66202847|FG001|Overall Study|Lost to Follow-up|1|||
23678437|NCT02161562|66202846|FG000|Overall Study|Lack of Efficacy|4|||
23678438|NCT02161562|66202847|FG001|Overall Study|Lack of Efficacy|1|||
23678439|NCT02161562|66202846|FG000|Overall Study|Adverse Event|1|||
23678440|NCT02161562|66202847|FG001|Overall Study|Adverse Event|1|||
23678441|NCT02161562|66202846|FG000|Overall Study|Participant moved back to home country|1|||
23678442|NCT02161562|66202847|FG001|Overall Study|Participant moved back to home country|0|||
23678443|NCT02161562|66202846|FG000|Overall Study|Withdrew due to being out of the country|1|||
23678444|NCT02161562|66202847|FG001|Overall Study|Withdrew due to being out of the country|0|||
23678445|NCT02161562|66202846|FG000|Overall Study|Participant moved out of province|1|||
23678446|NCT02161562|66202847|FG001|Overall Study|Participant moved out of province|0|||
23678447|NCT01465659|66202853|FG000|Completed 1 Cycle of Treatment|Death|0|||
23678448|NCT01465659|66202854|FG001|Completed 1 Cycle of Treatment|Death|1|||
23678449|NCT01465659|66202855|FG002|Completed 1 Cycle of Treatment|Death|0|||
23678450|NCT01465659|66202856|FG003|Completed 1 Cycle of Treatment|Death|0|||
23678451|NCT01465659|66202853|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
23678452|NCT01465659|66202854|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
23678453|NCT01465659|66202855|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
23678454|NCT01465659|66202856|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
23678455|NCT01465659|66202853|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23678456|NCT01465659|66202854|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
23678457|NCT01465659|66202855|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23678458|NCT01465659|66202856|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23678459|NCT01465659|66202853|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
23678460|NCT01465659|66202854|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
23494746|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Death|0|||
23388825|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23388826|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23388827|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
23388828|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
23388829|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
23388830|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
23388831|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388832|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388833|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
23388834|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388835|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23388836|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23678461|NCT01465659|66202855|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
23678462|NCT01465659|66202856|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
23678463|NCT01465659|66202853|FG000|Completed Follow for 1 Year|Death|6|||
23388837|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23388838|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
23678464|NCT01465659|66202854|FG001|Completed Follow for 1 Year|Death|3|||
23678465|NCT01465659|66202855|FG002|Completed Follow for 1 Year|Death|2|||
23678466|NCT01465659|66202856|FG003|Completed Follow for 1 Year|Death|4|||
23678467|NCT00648167|66202857|FG000|Overall Study|Adverse Event|6|||
23678468|NCT00648167|66202857|FG000|Overall Study|unable to swallow tablets|1|||
23678469|NCT02574637|66202861|FG000|Double-blind Period|Adverse Event|1|||
23678470|NCT02574637|66202862|FG001|Double-blind Period|Adverse Event|0|||
23678471|NCT02574637|66202863|FG002|Double-blind Period|Adverse Event|0|||
23678472|NCT02574637|66202864|FG003|Double-blind Period|Adverse Event|0|||
23678473|NCT02574637|66202865|FG004|Double-blind Period|Adverse Event|0|||
23678474|NCT02574637|66202866|FG005|Double-blind Period|Adverse Event|0|||
23678475|NCT02574637|66202867|FG006|Double-blind Period|Adverse Event|0|||
23678476|NCT02574637|66202868|FG007|Double-blind Period|Adverse Event|0|||
23678477|NCT02574637|66202869|FG008|Double-blind Period|Adverse Event|0|||
23678478|NCT02574637|66202870|FG009|Double-blind Period|Adverse Event|0|||
23678479|NCT02574637|66202861|FG000|Double-blind Period|Lack of Efficacy|0|||
23678480|NCT02574637|66202862|FG001|Double-blind Period|Lack of Efficacy|0|||
23678481|NCT02574637|66202863|FG002|Double-blind Period|Lack of Efficacy|2|||
23678482|NCT02574637|66202864|FG003|Double-blind Period|Lack of Efficacy|0|||
23678483|NCT02574637|66202865|FG004|Double-blind Period|Lack of Efficacy|0|||
23678484|NCT02574637|66202866|FG005|Double-blind Period|Lack of Efficacy|0|||
23678485|NCT02574637|66202867|FG006|Double-blind Period|Lack of Efficacy|0|||
23678486|NCT02574637|66202868|FG007|Double-blind Period|Lack of Efficacy|0|||
23678487|NCT02574637|66202869|FG008|Double-blind Period|Lack of Efficacy|0|||
23678488|NCT02574637|66202870|FG009|Double-blind Period|Lack of Efficacy|0|||
23678489|NCT02574637|66202861|FG000|Double-blind Period|Protocol Deviation|1|||
23678490|NCT02574637|66202862|FG001|Double-blind Period|Protocol Deviation|0|||
23678491|NCT02574637|66202863|FG002|Double-blind Period|Protocol Deviation|0|||
23678492|NCT02574637|66202864|FG003|Double-blind Period|Protocol Deviation|0|||
23678493|NCT02574637|66202865|FG004|Double-blind Period|Protocol Deviation|0|||
23678494|NCT02574637|66202866|FG005|Double-blind Period|Protocol Deviation|0|||
23678495|NCT02574637|66202867|FG006|Double-blind Period|Protocol Deviation|0|||
23678496|NCT02574637|66202868|FG007|Double-blind Period|Protocol Deviation|0|||
23678497|NCT02574637|66202869|FG008|Double-blind Period|Protocol Deviation|0|||
23678498|NCT02574637|66202870|FG009|Double-blind Period|Protocol Deviation|0|||
23678499|NCT02574637|66202861|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
23678500|NCT02574637|66202862|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
23678501|NCT02574637|66202863|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
23678502|NCT02574637|66202864|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
23678503|NCT02574637|66202865|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
23388839|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
23388840|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
23388841|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
23388842|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
23388843|NCT04439357|65168835|FG000|Overall Study|Disease Progression|4|||
23678504|NCT02574637|66202866|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
23678505|NCT02574637|66202867|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
23678506|NCT02574637|66202868|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
23678507|NCT02574637|66202869|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
23678508|NCT02574637|66202870|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
23678509|NCT02574637|66202861|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
23678510|NCT02574637|66202862|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
23678511|NCT02574637|66202863|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
23678512|NCT02574637|66202864|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
23678513|NCT02574637|66202865|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
23678514|NCT02574637|66202866|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
23678515|NCT02574637|66202867|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
23678516|NCT02574637|66202868|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
23678517|NCT02574637|66202869|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
23678518|NCT02574637|66202870|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
23678519|NCT02574637|66202861|FG000|Double-blind Period|Reason Not Specified|0|||
23678520|NCT02574637|66202862|FG001|Double-blind Period|Reason Not Specified|0|||
23678521|NCT02574637|66202863|FG002|Double-blind Period|Reason Not Specified|0|||
23678522|NCT02574637|66202864|FG003|Double-blind Period|Reason Not Specified|1|||
23678523|NCT02574637|66202865|FG004|Double-blind Period|Reason Not Specified|0|||
23678524|NCT02574637|66202866|FG005|Double-blind Period|Reason Not Specified|0|||
23678525|NCT02574637|66202867|FG006|Double-blind Period|Reason Not Specified|0|||
23678526|NCT02574637|66202868|FG007|Double-blind Period|Reason Not Specified|0|||
23678527|NCT02574637|66202869|FG008|Double-blind Period|Reason Not Specified|0|||
23678528|NCT02574637|66202870|FG009|Double-blind Period|Reason Not Specified|0|||
23678529|NCT02574637|66202861|FG000|Open-label (OL) Period|Adverse Event|0|||
23678530|NCT02574637|66202862|FG001|Open-label (OL) Period|Adverse Event|0|||
23678531|NCT02574637|66202863|FG002|Open-label (OL) Period|Adverse Event|0|||
23678532|NCT02574637|66202864|FG003|Open-label (OL) Period|Adverse Event|0|||
23678533|NCT02574637|66202865|FG004|Open-label (OL) Period|Adverse Event|0|||
23678534|NCT02574637|66202866|FG005|Open-label (OL) Period|Adverse Event|0|||
23678535|NCT02574637|66202867|FG006|Open-label (OL) Period|Adverse Event|0|||
23678536|NCT02574637|66202868|FG007|Open-label (OL) Period|Adverse Event|0|||
23678537|NCT02574637|66202869|FG008|Open-label (OL) Period|Adverse Event|1|||
23678538|NCT02574637|66202870|FG009|Open-label (OL) Period|Adverse Event|0|||
23678539|NCT02574637|66202861|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
23678540|NCT02574637|66202862|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
23678541|NCT02574637|66202863|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
23678542|NCT02574637|66202864|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
23678543|NCT02574637|66202865|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
23678544|NCT02574637|66202866|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
23678545|NCT02574637|66202867|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
23678546|NCT02574637|66202868|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
23678547|NCT02574637|66202869|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
23678548|NCT02574637|66202870|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
23678549|NCT02574637|66202861|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678550|NCT02574637|66202862|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678551|NCT02574637|66202863|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678552|NCT02574637|66202864|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678553|NCT02574637|66202865|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678554|NCT02574637|66202866|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23678555|NCT02574637|66202867|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
23678556|NCT02574637|66202868|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23678557|NCT02574637|66202869|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23678558|NCT02574637|66202870|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23678559|NCT00700180|66202872|FG000|Overall Study|Death|99|||
23494747|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494748|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23678560|NCT00700180|66202873|FG001|Overall Study|Death|114|||
23678561|NCT00700180|66202872|FG000|Overall Study|Alive on treatment|5|||
23678562|NCT00700180|66202873|FG001|Overall Study|Alive on treatment|3|||
23678563|NCT00700180|66202872|FG000|Overall Study|Alive in follow-up|46|||
23678564|NCT00700180|66202873|FG001|Overall Study|Alive in follow-up|27|||
23678565|NCT00700180|66202872|FG000|Overall Study|Lost to Follow-up|4|||
23678566|NCT00700180|66202873|FG001|Overall Study|Lost to Follow-up|5|||
23678567|NCT00854828|66202874|FG000|Overall Study|Death|1|||
23678568|NCT00854828|66202875|FG001|Overall Study|Death|0|||
23678569|NCT00854828|66202876|FG002|Overall Study|Death|0|||
23678570|NCT00854828|66202877|FG003|Overall Study|Death|0|||
23678571|NCT00854828|66202874|FG000|Overall Study|Withdrawal by Subject|1|||
23678572|NCT00854828|66202875|FG001|Overall Study|Withdrawal by Subject|1|||
23678573|NCT00854828|66202876|FG002|Overall Study|Withdrawal by Subject|0|||
23678574|NCT00854828|66202877|FG003|Overall Study|Withdrawal by Subject|9|||
23678575|NCT00854828|66202874|FG000|Overall Study|Missed 24mo visit|1|||
23678576|NCT00854828|66202875|FG001|Overall Study|Missed 24mo visit|1|||
23678577|NCT00854828|66202876|FG002|Overall Study|Missed 24mo visit|8|||
23678578|NCT00854828|66202877|FG003|Overall Study|Missed 24mo visit|8|||
23678579|NCT01665807|66202885|FG000|Overall Study|Withdrawal by Subject|2|||
23678580|NCT01665807|66202886|FG001|Overall Study|Withdrawal by Subject|0|||
23678581|NCT01665807|66202887|FG002|Overall Study|Withdrawal by Subject|1|||
23678582|NCT01171820|66202888|FG000|Overall Study|Death|3|||
23678583|NCT01171820|66202889|FG001|Overall Study|Death|3|||
23678584|NCT01171820|66202888|FG000|Overall Study|Lost to Follow-up|0|||
23678585|NCT01171820|66202889|FG001|Overall Study|Lost to Follow-up|1|||
23678586|NCT01171820|66202888|FG000|Overall Study|Withdrawal by Subject|2|||
23678587|NCT01171820|66202889|FG001|Overall Study|Withdrawal by Subject|0|||
23678588|NCT01171820|66202888|FG000|Overall Study|Physician Decision|0|||
23678589|NCT01171820|66202889|FG001|Overall Study|Physician Decision|1|||
23678590|NCT01171820|66202888|FG000|Overall Study|1-Year Missed Visit|1|||
23678591|NCT01171820|66202889|FG001|Overall Study|1-Year Missed Visit|1|||
23678592|NCT02508194|66202890|FG000|Overall Study|Death|5|||
23678593|NCT02508194|66202891|FG001|Overall Study|Death|3|||
23678594|NCT02508194|66202890|FG000|Overall Study|Lost to Follow-up|25|||
23678595|NCT02508194|66202891|FG001|Overall Study|Lost to Follow-up|18|||
23678596|NCT02508194|66202890|FG000|Overall Study|Withdrawal by Subject|20|||
23678597|NCT02508194|66202891|FG001|Overall Study|Withdrawal by Subject|18|||
23678598|NCT02508194|66202890|FG000|Overall Study|Error in Randomization|1|||
23678599|NCT02508194|66202891|FG001|Overall Study|Error in Randomization|3|||
23678600|NCT02508194|66202890|FG000|Overall Study|Principal Investigator Decision|1|||
23678601|NCT02508194|66202891|FG001|Overall Study|Principal Investigator Decision|2|||
23678602|NCT01405053|66202892|FG000|Overall Study|Adverse Event|3|||
23678603|NCT01405053|66202893|FG001|Overall Study|Adverse Event|0|||
23678604|NCT01405053|66202892|FG000|Overall Study|Lost to Follow-up|0|||
23678605|NCT01405053|66202893|FG001|Overall Study|Lost to Follow-up|1|||
23678606|NCT01405053|66202892|FG000|Overall Study|Participant choice|2|||
23678607|NCT01405053|66202893|FG001|Overall Study|Participant choice|1|||
23678608|NCT01405053|66202892|FG000|Overall Study|Inadequate therapeutic effect|2|||
23678609|NCT01405053|66202893|FG001|Overall Study|Inadequate therapeutic effect|1|||
23678610|NCT01405053|66202892|FG000|Overall Study|Withdrawal by Subject|3|||
23678611|NCT01405053|66202893|FG001|Overall Study|Withdrawal by Subject|4|||
23678612|NCT01405053|66202892|FG000|Overall Study|Other|0|||
23678613|NCT01405053|66202893|FG001|Overall Study|Other|1|||
23678614|NCT00331409|66202894|FG000|Overall Study|Lack of Efficacy|4|||
23678615|NCT02799069|66202895|FG000|Overall Study|Adverse Event|0|||
23678616|NCT02799069|66202896|FG001|Overall Study|Adverse Event|2|||
23678617|NCT02799069|66202897|FG002|Overall Study|Adverse Event|2|||
23678618|NCT02799069|66202895|FG000|Overall Study|Lack of Efficacy|2|||
23678619|NCT02799069|66202896|FG001|Overall Study|Lack of Efficacy|0|||
23678620|NCT02799069|66202897|FG002|Overall Study|Lack of Efficacy|0|||
23678621|NCT02799069|66202895|FG000|Overall Study|Lost to Follow-up|1|||
23678622|NCT02799069|66202896|FG001|Overall Study|Lost to Follow-up|1|||
23678623|NCT02799069|66202897|FG002|Overall Study|Lost to Follow-up|0|||
23678624|NCT02799069|66202895|FG000|Overall Study|Withdrawal by Subject|4|||
23678625|NCT02799069|66202896|FG001|Overall Study|Withdrawal by Subject|4|||
23678626|NCT02799069|66202897|FG002|Overall Study|Withdrawal by Subject|3|||
23678627|NCT02799069|66202895|FG000|Overall Study|Protocol Violation|1|||
23678628|NCT02799069|66202896|FG001|Overall Study|Protocol Violation|0|||
23678629|NCT02799069|66202897|FG002|Overall Study|Protocol Violation|2|||
23678630|NCT01602341|66202898|FG000|Overall Study|Adverse Event|0|||
23678631|NCT01602341|66202899|FG001|Overall Study|Adverse Event|1|||
23678632|NCT02363478|66202900|FG000|Overall Study|Lost to Follow-up|4|||
23678633|NCT02363478|66202900|FG000|Overall Study|Adverse Event|4|||
23678634|NCT03595280|66202901|FG000|Overall Study|Lost to Follow-up|6|||
23678635|NCT03595280|66202902|FG001|Overall Study|Lost to Follow-up|9|||
23678636|NCT03595280|66202903|FG002|Overall Study|Lost to Follow-up|15|||
23678637|NCT02004873|66202904|FG000|Overall Study|Implant unsuccessful|6|||
23678638|NCT02004873|66202904|FG000|Overall Study|Awaiting 6-month visit|390|||
23678639|NCT02004873|66202904|FG000|Overall Study|Missed 6-month visit|4|||
23678640|NCT02004873|66202904|FG000|Overall Study|Death|23|||
23678641|NCT02004873|66202904|FG000|Overall Study|Withdrawal by Subject|1|||
23678642|NCT04316585|66202905|FG000|Overall Study|Adverse Event|2|||
23678643|NCT04316585|66202906|FG001|Overall Study|Adverse Event|1|||
23678644|NCT04316585|66202905|FG000|Overall Study|Lost to Follow-up|1|||
23678645|NCT04316585|66202906|FG001|Overall Study|Lost to Follow-up|0|||
23678646|NCT04316585|66202905|FG000|Overall Study|Withdrawal by Subject|2|||
23678647|NCT04316585|66202906|FG001|Overall Study|Withdrawal by Subject|3|||
23678648|NCT04316585|66202905|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23678649|NCT04316585|66202906|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
23678650|NCT04316585|66202905|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
23678651|NCT04316585|66202906|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
23678652|NCT02062658|66202907|FG000|Overall Study|Withdrawal by Subject|1|||
23678653|NCT02062658|66202907|FG000|Overall Study|Lack of Efficacy|1|||
23678654|NCT02049944|66202908|FG000|Overall Study|Protocol Violation|2|||
23678655|NCT00584870|66202914|FG000|Overall Study|Adverse Event|4|||
23678656|NCT00584870|66202915|FG001|Overall Study|Adverse Event|3|||
23678657|NCT00584870|66202916|FG002|Overall Study|Adverse Event|2|||
23678658|NCT00584870|66202914|FG000|Overall Study|Lost to Follow-up|4|||
23678659|NCT00584870|66202915|FG001|Overall Study|Lost to Follow-up|1|||
23678660|NCT00584870|66202916|FG002|Overall Study|Lost to Follow-up|1|||
23678661|NCT00584870|66202914|FG000|Overall Study|Lack of Efficacy|7|||
23678662|NCT00584870|66202915|FG001|Overall Study|Lack of Efficacy|14|||
23678663|NCT00584870|66202916|FG002|Overall Study|Lack of Efficacy|8|||
23678664|NCT00584870|66202914|FG000|Overall Study|Withdrawal by Subject|10|||
23678665|NCT00584870|66202915|FG001|Overall Study|Withdrawal by Subject|5|||
23678666|NCT00584870|66202916|FG002|Overall Study|Withdrawal by Subject|3|||
23678667|NCT00584870|66202914|FG000|Overall Study|Protocol Violation|1|||
23388844|NCT00504556|65168836|FG000|Overall Study|Adverse Event|11|||
23678668|NCT00584870|66202915|FG001|Overall Study|Protocol Violation|1|||
23678669|NCT00584870|66202916|FG002|Overall Study|Protocol Violation|2|||
23678670|NCT00584870|66202914|FG000|Overall Study|Did not met entrance criteria|1|||
23678671|NCT00584870|66202915|FG001|Overall Study|Did not met entrance criteria|0|||
23678672|NCT00584870|66202916|FG002|Overall Study|Did not met entrance criteria|0|||
23678673|NCT00584870|66202914|FG000|Overall Study|Other|2|||
23678674|NCT00584870|66202915|FG001|Overall Study|Other|0|||
23678675|NCT00584870|66202916|FG002|Overall Study|Other|0|||
23678676|NCT00584870|66202914|FG000|Overall Study|Randomized but not treated|0|||
23678677|NCT00584870|66202915|FG001|Overall Study|Randomized but not treated|1|||
23678678|NCT00584870|66202916|FG002|Overall Study|Randomized but not treated|2|||
23678679|NCT01430442|66202917|FG000|Overall Study|Subject Withdrew Consent|3|||
23678680|NCT01430442|66202918|FG001|Overall Study|Subject Withdrew Consent|0|||
23678681|NCT01430442|66202919|FG002|Overall Study|Subject Withdrew Consent|1|||
23678682|NCT01430442|66202920|FG003|Overall Study|Subject Withdrew Consent|0|||
23678683|NCT01430442|66202921|FG004|Overall Study|Subject Withdrew Consent|2|||
23678684|NCT01430442|66202922|FG005|Overall Study|Subject Withdrew Consent|1|||
23678685|NCT01430442|66202923|FG006|Overall Study|Subject Withdrew Consent|5|||
23678686|NCT01430442|66202924|FG007|Overall Study|Subject Withdrew Consent|2|||
23678687|NCT01430442|66202917|FG000|Overall Study|Lost to Follow-up|2|||
23678688|NCT01430442|66202918|FG001|Overall Study|Lost to Follow-up|0|||
23678689|NCT01430442|66202919|FG002|Overall Study|Lost to Follow-up|1|||
23678690|NCT01430442|66202920|FG003|Overall Study|Lost to Follow-up|2|||
23678691|NCT01430442|66202921|FG004|Overall Study|Lost to Follow-up|2|||
23678692|NCT01430442|66202922|FG005|Overall Study|Lost to Follow-up|1|||
23678693|NCT01430442|66202923|FG006|Overall Study|Lost to Follow-up|5|||
23678694|NCT01430442|66202924|FG007|Overall Study|Lost to Follow-up|1|||
23678695|NCT01430442|66202917|FG000|Overall Study|Pregnancy|1|||
23678696|NCT01430442|66202918|FG001|Overall Study|Pregnancy|0|||
23678697|NCT01430442|66202919|FG002|Overall Study|Pregnancy|0|||
23678698|NCT01430442|66202920|FG003|Overall Study|Pregnancy|0|||
23678699|NCT01430442|66202921|FG004|Overall Study|Pregnancy|0|||
23678700|NCT01430442|66202922|FG005|Overall Study|Pregnancy|1|||
23678701|NCT01430442|66202923|FG006|Overall Study|Pregnancy|0|||
23678702|NCT01430442|66202924|FG007|Overall Study|Pregnancy|0|||
23678703|NCT01430442|66202917|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
23678704|NCT01430442|66202918|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
23678705|NCT01430442|66202919|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
23678706|NCT01430442|66202920|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
23678707|NCT01430442|66202921|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
23678708|NCT01430442|66202922|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
23678709|NCT01430442|66202923|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
23678710|NCT01430442|66202924|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
23678711|NCT01031446|66202925|FG000|Overall Study|Disease Progression|38|||
23678712|NCT01031446|66202925|FG000|Overall Study|Adverse Event|9|||
23678713|NCT01031446|66202925|FG000|Overall Study|Physician Decision|4|||
23678714|NCT01031446|66202925|FG000|Overall Study|Withdrawal by Subject|3|||
23678715|NCT01031446|66202925|FG000|Overall Study|Still on treatment|1|||
23705654|NCT01234402|66297586|FG002|Overall Study|Withdrawal by Subject|4|||
23705655|NCT01234402|66297584|FG000|Overall Study|Never treated: Death|0|||
23705656|NCT01234402|66297585|FG001|Overall Study|Never treated: Death|0|||
23705657|NCT01234402|66297586|FG002|Overall Study|Never treated: Death|1|||
23705658|NCT01234402|66297584|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
23705659|NCT01234402|66297585|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
23705660|NCT01234402|66297586|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
23705661|NCT01234402|66297584|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
23705662|NCT01234402|66297585|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
23705663|NCT01234402|66297586|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
23705664|NCT04594239|66297587|FG000|Overall Study|Withdrawal by Subject|3|||
23705665|NCT04594239|66297588|FG001|Overall Study|Withdrawal by Subject|4|||
23705666|NCT04594239|66297589|FG002|Overall Study|Withdrawal by Subject|2|||
23705667|NCT04594239|66297590|FG003|Overall Study|Withdrawal by Subject|4|||
23705668|NCT04594239|66297587|FG000|Overall Study|Lost to Follow-up|8|||
23705669|NCT04594239|66297588|FG001|Overall Study|Lost to Follow-up|5|||
23705670|NCT04594239|66297589|FG002|Overall Study|Lost to Follow-up|4|||
23705671|NCT04594239|66297590|FG003|Overall Study|Lost to Follow-up|6|||
23705672|NCT04594239|66297587|FG000|Overall Study|Subject relocated|0|||
23705673|NCT04594239|66297588|FG001|Overall Study|Subject relocated|0|||
23705674|NCT04594239|66297589|FG002|Overall Study|Subject relocated|0|||
23705675|NCT04594239|66297590|FG003|Overall Study|Subject relocated|1|||
23705676|NCT01081873|66297591|FG000|Overall Study|Death|86|||
23705677|NCT01081873|66297591|FG000|Overall Study|Withdrawal by Subject|10|||
23705678|NCT01081873|66297591|FG000|Overall Study|Lost to Follow-up|142|||
23705679|NCT01081873|66297591|FG000|Overall Study|Progression of prostate cancer|13|||
23494749|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23705680|NCT01081873|66297591|FG000|Overall Study|Other|47|||
23705681|NCT00972244|66297592|FG000|Overall Study|Incorrect Enrolment|1|||
23705682|NCT00972244|66297593|FG001|Overall Study|Incorrect Enrolment|0|||
23705683|NCT00972244|66297594|FG002|Overall Study|Incorrect Enrolment|0|||
23705684|NCT00972244|66297595|FG003|Overall Study|Incorrect Enrolment|0|||
23705685|NCT00972244|66297596|FG004|Overall Study|Incorrect Enrolment|0|||
23705686|NCT00972244|66297592|FG000|Overall Study|Adverse Event|0|||
23388845|NCT00504556|65168837|FG001|Overall Study|Adverse Event|11|||
23388846|NCT00504556|65168838|FG002|Overall Study|Adverse Event|14|||
23388847|NCT00504556|65168839|FG003|Overall Study|Adverse Event|13|||
23388848|NCT00504556|65168840|FG004|Overall Study|Adverse Event|5|||
23388849|NCT00504556|65168836|FG000|Overall Study|Death|3|||
23388850|NCT00504556|65168837|FG001|Overall Study|Death|3|||
23388851|NCT00504556|65168838|FG002|Overall Study|Death|1|||
23388852|NCT00504556|65168839|FG003|Overall Study|Death|0|||
23388853|NCT00504556|65168840|FG004|Overall Study|Death|2|||
23388854|NCT00504556|65168836|FG000|Overall Study|Protocol Violation|1|||
23388855|NCT00504556|65168837|FG001|Overall Study|Protocol Violation|3|||
23388856|NCT00504556|65168838|FG002|Overall Study|Protocol Violation|2|||
23388857|NCT00504556|65168839|FG003|Overall Study|Protocol Violation|1|||
23388858|NCT00504556|65168840|FG004|Overall Study|Protocol Violation|2|||
23388859|NCT00504556|65168836|FG000|Overall Study|Lost to Follow-up|0|||
23705687|NCT00972244|66297593|FG001|Overall Study|Adverse Event|1|||
23388860|NCT00504556|65168837|FG001|Overall Study|Lost to Follow-up|0|||
23388861|NCT00504556|65168838|FG002|Overall Study|Lost to Follow-up|1|||
23388862|NCT00504556|65168839|FG003|Overall Study|Lost to Follow-up|1|||
23388863|NCT00504556|65168840|FG004|Overall Study|Lost to Follow-up|1|||
23388864|NCT00504556|65168836|FG000|Overall Study|Withdrawal by Subject|16|||
23388865|NCT00504556|65168837|FG001|Overall Study|Withdrawal by Subject|16|||
23678716|NCT01235962|66205922|FG000|Overall Study|Withdrawal by Subject|20|||
23678717|NCT01235962|66205923|FG001|Overall Study|Withdrawal by Subject|19|||
23678718|NCT01235962|66205924|FG002|Overall Study|Withdrawal by Subject|62|||
23678719|NCT01235962|66205925|FG003|Overall Study|Withdrawal by Subject|49|||
23678720|NCT01235962|66205922|FG000|Overall Study|Lost to Follow-up|21|||
23678721|NCT01235962|66205923|FG001|Overall Study|Lost to Follow-up|16|||
23678722|NCT01235962|66205924|FG002|Overall Study|Lost to Follow-up|47|||
23678723|NCT01235962|66205925|FG003|Overall Study|Lost to Follow-up|32|||
23678724|NCT01235962|66205922|FG000|Overall Study|Physician Decision|5|||
23678725|NCT01235962|66205923|FG001|Overall Study|Physician Decision|0|||
23678726|NCT01235962|66205924|FG002|Overall Study|Physician Decision|9|||
23678727|NCT01235962|66205925|FG003|Overall Study|Physician Decision|5|||
23678728|NCT03902080|66205926|FG000|Overall Study|Adverse Event|17|||
23678729|NCT03902080|66205927|FG001|Overall Study|Adverse Event|15|||
23678730|NCT03902080|66205926|FG000|Overall Study|Withdrawal by Subject|28|||
23678731|NCT03902080|66205927|FG001|Overall Study|Withdrawal by Subject|35|||
23678732|NCT03902080|66205926|FG000|Overall Study|Lost to Follow-up|6|||
23678733|NCT03902080|66205927|FG001|Overall Study|Lost to Follow-up|7|||
23678734|NCT03902080|66205926|FG000|Overall Study|Other|3|||
23678735|NCT03902080|66205927|FG001|Overall Study|Other|5|||
23678736|NCT03902080|66205926|FG000|Overall Study|Non compliance|4|||
23678737|NCT03902080|66205927|FG001|Overall Study|Non compliance|3|||
23678738|NCT03902080|66205926|FG000|Overall Study|Physician Decision|5|||
23678739|NCT03902080|66205927|FG001|Overall Study|Physician Decision|1|||
23678740|NCT03902080|66205926|FG000|Overall Study|Protocol Violation|3|||
23678741|NCT03902080|66205927|FG001|Overall Study|Protocol Violation|3|||
23678742|NCT03902080|66205926|FG000|Overall Study|Lack of Efficacy|1|||
23678743|NCT03902080|66205927|FG001|Overall Study|Lack of Efficacy|3|||
23678744|NCT03902080|66205926|FG000|Overall Study|Withdrawn prior to dosing|0|||
23678745|NCT03902080|66205927|FG001|Overall Study|Withdrawn prior to dosing|1|||
23678746|NCT03056573|66205928|FG000|Overall Study|Death|2|||
23678747|NCT03056573|66205929|FG001|Overall Study|Death|4|||
23678748|NCT03056573|66205928|FG000|Overall Study|Withdrawal by Subject|2|||
23678749|NCT03056573|66205929|FG001|Overall Study|Withdrawal by Subject|0|||
23678750|NCT03056573|66205928|FG000|Overall Study|Lost to Follow-up|1|||
23678751|NCT03056573|66205929|FG001|Overall Study|Lost to Follow-up|1|||
23678752|NCT00578643|66205930|FG000|Overall Study|Death|1|||
23678753|NCT00578643|66205930|FG000|Overall Study|Lost to Follow-up|1|||
23678754|NCT00848120|66205931|FG000|Overall Study|Adverse Event|1|||
23678755|NCT01481896|66205932|FG000|Overall Study|Lost to Follow-up|12|||
23678756|NCT01627860|66205935|FG000|Overall Study|Adverse Event|9|||
23388866|NCT00504556|65168838|FG002|Overall Study|Withdrawal by Subject|7|||
23494750|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
23678757|NCT01627860|66205936|FG001|Overall Study|Adverse Event|4|||
23678758|NCT01627860|66205935|FG000|Overall Study|Withdrawal by Subject|2|||
23678759|NCT01627860|66205936|FG001|Overall Study|Withdrawal by Subject|1|||
23678760|NCT01627860|66205935|FG000|Overall Study|Seizure frequency doubled|0|||
23678761|NCT01627860|66205936|FG001|Overall Study|Seizure frequency doubled|1|||
23678762|NCT01627860|66205935|FG000|Overall Study|Protocol Violation|1|||
23678763|NCT01627860|66205936|FG001|Overall Study|Protocol Violation|0|||
23678764|NCT03603652|66205939|FG000|Overall Study|Death|2|||
23678765|NCT01725750|66205940|FG000|Overall Study|Adverse Event|1|||
23678766|NCT01725750|66205941|FG001|Overall Study|Adverse Event|0|||
23678767|NCT01725750|66205940|FG000|Overall Study|Lost to Follow-up|1|||
23678768|NCT01725750|66205941|FG001|Overall Study|Lost to Follow-up|1|||
23678769|NCT01725750|66205940|FG000|Overall Study|Withdrawal by Subject|0|||
23678770|NCT01725750|66205941|FG001|Overall Study|Withdrawal by Subject|9|||
23678771|NCT02614079|66205942|FG000|Overall Study|Withdrawal by Subject|1|||
23678772|NCT04082663|66205943|FG000|Overall Study|Adverse Event|6|||
23678773|NCT04082663|66205943|FG000|Overall Study|Lost to Follow-up|1|||
23678774|NCT04067518|66205944|FG000|Overall Study|Adverse Event|1|||
23678775|NCT04067518|66205945|FG001|Overall Study|Adverse Event|3|||
23678776|NCT04067518|66205944|FG000|Overall Study|Screen failures|0|||
23678777|NCT04067518|66205945|FG001|Overall Study|Screen failures|1|||
23678778|NCT04067518|66205944|FG000|Overall Study|Enrolled but not treated|0|||
23678779|NCT04067518|66205945|FG001|Overall Study|Enrolled but not treated|1|||
23678780|NCT00332709|66205948|FG000|Overall Study|Adverse Event|11|||
23678781|NCT00332709|66205949|FG001|Overall Study|Adverse Event|14|||
23388867|NCT00504556|65168839|FG003|Overall Study|Withdrawal by Subject|8|||
23388868|NCT00504556|65168840|FG004|Overall Study|Withdrawal by Subject|12|||
23388869|NCT00504556|65168836|FG000|Overall Study|administrative reasons|0|||
23388870|NCT00504556|65168837|FG001|Overall Study|administrative reasons|2|||
23388871|NCT00504556|65168838|FG002|Overall Study|administrative reasons|2|||
23388872|NCT00504556|65168839|FG003|Overall Study|administrative reasons|1|||
23388873|NCT00504556|65168840|FG004|Overall Study|administrative reasons|2|||
23678782|NCT00332709|66205948|FG000|Overall Study|Withdrawal by Subject|2|||
23678783|NCT00332709|66205949|FG001|Overall Study|Withdrawal by Subject|3|||
23678784|NCT00332709|66205948|FG000|Overall Study|Lost to Follow-up|2|||
23678785|NCT00332709|66205949|FG001|Overall Study|Lost to Follow-up|0|||
23678786|NCT00332709|66205948|FG000|Overall Study|Administrative Problems|0|||
23678787|NCT00332709|66205949|FG001|Overall Study|Administrative Problems|3|||
23678788|NCT00332709|66205948|FG000|Overall Study|Abnormal test procedure result|1|||
23678789|NCT00332709|66205949|FG001|Overall Study|Abnormal test procedure result|0|||
23678790|NCT01652287|66205950|FG000|Overall Study|Withdrawal by Subject|2|||
23388874|NCT00504556|65168836|FG000|Overall Study|did not meet entry criteria|2|||
23388875|NCT00504556|65168837|FG001|Overall Study|did not meet entry criteria|0|||
23678791|NCT01652287|66205951|FG001|Overall Study|Withdrawal by Subject|0|||
23678792|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
23678793|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23678794|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23678795|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23678796|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
23678797|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23678798|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23678799|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23678800|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
23678801|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23678802|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23678803|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23678804|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
23678805|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23678806|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23678807|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23678808|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
23388876|NCT00504556|65168838|FG002|Overall Study|did not meet entry criteria|1|||
23494751|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494752|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494753|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494754|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23678809|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23388877|NCT00504556|65168839|FG003|Overall Study|did not meet entry criteria|1|||
23705688|NCT00972244|66297594|FG002|Overall Study|Adverse Event|1|||
23678810|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23678811|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23678812|NCT01360645|66205952|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
23678813|NCT01360645|66205953|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23494755|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494756|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494757|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494758|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494759|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494760|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494761|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494762|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
23494763|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494764|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494765|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494766|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494767|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494768|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494769|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494770|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494771|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494772|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494773|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494774|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
23494775|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494776|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494777|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494778|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494779|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494780|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
23494781|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
23494782|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
23494783|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
23494784|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
23494785|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
23494786|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
23494787|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
23494788|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
23494789|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
23494790|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
23494791|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494792|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494793|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494794|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494795|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494796|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
23494797|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494798|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494799|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494800|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494801|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494802|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494803|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494804|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494805|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494806|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494807|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
23494808|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494809|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494810|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494811|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23705689|NCT00972244|66297595|FG003|Overall Study|Adverse Event|0|||
23678814|NCT01360645|66205954|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23678815|NCT01360645|66205955|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23678816|NCT01360645|66205952|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
23678817|NCT01360645|66205953|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
23678818|NCT01360645|66205954|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
23678819|NCT01360645|66205955|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
23678820|NCT01360645|66205952|FG000|Phase B (6 Weeks)|Adverse Event|0|||
23678821|NCT01360645|66205953|FG001|Phase B (6 Weeks)|Adverse Event|6|||
23678822|NCT01360645|66205954|FG002|Phase B (6 Weeks)|Adverse Event|0|||
23678823|NCT01360645|66205955|FG003|Phase B (6 Weeks)|Adverse Event|0|||
23678824|NCT01360645|66205952|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23678825|NCT01360645|66205953|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
23678826|NCT01360645|66205954|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
23678827|NCT01360645|66205955|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23678828|NCT01360645|66205952|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23678829|NCT01360645|66205953|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
23678830|NCT01360645|66205954|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
23678831|NCT01360645|66205955|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23678832|NCT01360645|66205952|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
23678833|NCT01360645|66205953|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
23678834|NCT01360645|66205954|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
23678835|NCT01360645|66205955|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
23678836|NCT01360645|66205952|FG000|Phase A+|Lost to Follow-up|0|||
23678837|NCT01360645|66205953|FG001|Phase A+|Lost to Follow-up|0|||
23678838|NCT01360645|66205954|FG002|Phase A+|Lost to Follow-up|0|||
23678839|NCT01360645|66205955|FG003|Phase A+|Lost to Follow-up|7|||
23678840|NCT01360645|66205952|FG000|Phase A+|Adverse Event|0|||
23678841|NCT01360645|66205953|FG001|Phase A+|Adverse Event|0|||
23678842|NCT01360645|66205954|FG002|Phase A+|Adverse Event|0|||
23678843|NCT01360645|66205955|FG003|Phase A+|Adverse Event|2|||
23678844|NCT01360645|66205952|FG000|Phase A+|Met Withdrawal Criteria|0|||
23678845|NCT01360645|66205953|FG001|Phase A+|Met Withdrawal Criteria|0|||
23678846|NCT01360645|66205954|FG002|Phase A+|Met Withdrawal Criteria|0|||
23678847|NCT01360645|66205955|FG003|Phase A+|Met Withdrawal Criteria|4|||
23678848|NCT01360645|66205952|FG000|Phase A+|Physician Decision|0|||
23678849|NCT01360645|66205953|FG001|Phase A+|Physician Decision|0|||
23678850|NCT01360645|66205954|FG002|Phase A+|Physician Decision|0|||
23388878|NCT00504556|65168840|FG004|Overall Study|did not meet entry criteria|0|||
23388879|NCT00504556|65168836|FG000|Overall Study|data monitor committee decision|0|||
23388880|NCT00504556|65168837|FG001|Overall Study|data monitor committee decision|0|||
23678851|NCT01360645|66205955|FG003|Phase A+|Physician Decision|2|||
23678852|NCT01360645|66205952|FG000|Phase A+|Withdrawal by Subject|0|||
23678853|NCT01360645|66205953|FG001|Phase A+|Withdrawal by Subject|0|||
23678854|NCT01360645|66205954|FG002|Phase A+|Withdrawal by Subject|0|||
23678855|NCT01360645|66205955|FG003|Phase A+|Withdrawal by Subject|5|||
23678856|NCT01360645|66205952|FG000|Phase A+|Protocol Deviation|0|||
23678857|NCT01360645|66205953|FG001|Phase A+|Protocol Deviation|0|||
23678858|NCT01360645|66205954|FG002|Phase A+|Protocol Deviation|0|||
23678859|NCT01360645|66205955|FG003|Phase A+|Protocol Deviation|4|||
23678860|NCT01688050|66205956|FG000|Overall Study|Death|7|||
23678861|NCT01688050|66205956|FG000|Overall Study|Conversion to open repair|1|||
23494812|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494813|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494814|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23678862|NCT01688050|66205956|FG000|Overall Study|Lost to Follow-up|13|||
23678863|NCT01688050|66205956|FG000|Overall Study|Withdrawal by Subject|10|||
23678864|NCT02445586|66205958|FG000|Overall Study|Death|14|||
23678865|NCT02445586|66205958|FG000|Overall Study|Withdrawal by Subject|13|||
23678866|NCT02445586|66205958|FG000|Overall Study|Disease Progression|10|||
23678867|NCT02445586|66205958|FG000|Overall Study|Protocol Violation|1|||
23678868|NCT02445586|66205958|FG000|Overall Study|Medical Condition|1|||
23678869|NCT00763009|66205959|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
23678870|NCT01818297|66205960|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
23678871|NCT01818297|66205961|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
23678872|NCT01818297|66205960|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
23678873|NCT01818297|66205961|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
23678874|NCT01818297|66205960|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
23678875|NCT01818297|66205961|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
23678876|NCT01592760|66205962|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
23494815|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494816|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494817|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494818|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
23494819|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23678877|NCT01592760|66205963|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
23678878|NCT01592760|66205964|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
23678879|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
23678880|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
23705690|NCT00972244|66297596|FG004|Overall Study|Adverse Event|0|||
23678881|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
23678882|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Death|28|||
23678883|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Death|0|||
23678884|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Death|0|||
23678885|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
23678886|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
23678887|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
23678888|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
23678889|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
23678890|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
23678891|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
23678892|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
23678893|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
23678894|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
23678895|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
23678896|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
23678897|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
23678898|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
23678899|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
23678900|NCT00820755|66205965|FG000|Period 1: Combination Therapy Phase|Other|11|||
23678901|NCT00820755|66205966|FG001|Period 1: Combination Therapy Phase|Other|0|||
23678902|NCT00820755|66205967|FG002|Period 1: Combination Therapy Phase|Other|0|||
23678903|NCT00820755|66205965|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
23678904|NCT00820755|66205966|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
23678905|NCT00820755|66205967|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
23678906|NCT03757988|66205968|FG000|Overall Study|Withdrawal by Subject|1|||
23678907|NCT00130832|66205975|FG000|Overall Study|Adverse Event|1|||
23678908|NCT00130832|66205976|FG001|Overall Study|Adverse Event|1|||
23678909|NCT00130832|66205975|FG000|Overall Study|Lost to Follow-up|1|||
23678910|NCT00130832|66205976|FG001|Overall Study|Lost to Follow-up|2|||
23678911|NCT00130832|66205975|FG000|Overall Study|Protocol Violation|6|||
23678912|NCT00130832|66205976|FG001|Overall Study|Protocol Violation|8|||
23678913|NCT00130832|66205975|FG000|Overall Study|Withdrawal by Subject|6|||
23678914|NCT00130832|66205976|FG001|Overall Study|Withdrawal by Subject|1|||
23678915|NCT00130832|66205975|FG000|Overall Study|Moved|2|||
23678916|NCT00130832|66205976|FG001|Overall Study|Moved|2|||
23678917|NCT00130832|66205975|FG000|Overall Study|Other|0|||
23678918|NCT00130832|66205976|FG001|Overall Study|Other|3|||
23678919|NCT03099707|66205981|FG000|Overall Study|Withdrawal by Subject|0|||
23678920|NCT03099707|66205982|FG001|Overall Study|Withdrawal by Subject|3|||
23678921|NCT03099707|66205981|FG000|Overall Study|Lost to Follow-up|0|||
23678922|NCT03099707|66205982|FG001|Overall Study|Lost to Follow-up|1|||
23678923|NCT01078805|66205991|FG000|Overall Study|Clinically significant abnormal lab|5|||
23678924|NCT01078805|66205991|FG000|Overall Study|Death|134|||
23678925|NCT01078805|66205991|FG000|Overall Study|Lost to Follow-up|676|||
23678926|NCT01078805|66205991|FG000|Overall Study|Physician Decision|169|||
23678927|NCT01078805|66205991|FG000|Overall Study|Serious adverse event|26|||
23678928|NCT01078805|66205991|FG000|Overall Study|Sponsor decision|46|||
23678929|NCT01078805|66205991|FG000|Overall Study|Withdrawal by Subject|739|||
23678930|NCT01078805|66205991|FG000|Overall Study|Other|173|||
23678931|NCT01078805|66205991|FG000|Overall Study|Didn't take study drug|82|||
23678932|NCT03555266|66205992|FG000|Overall Study|Protocol Violation|6|||
23678933|NCT03555266|66205993|FG001|Overall Study|Protocol Violation|4|||
23678934|NCT02078219|66205994|FG000|Overall Study|Other|2|||
23678935|NCT02078219|66205995|FG001|Overall Study|Other|2|||
23678936|NCT02078219|66205996|FG002|Overall Study|Other|3|||
23494820|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23678937|NCT02078219|66205997|FG003|Overall Study|Other|0|||
23678938|NCT02078219|66205998|FG004|Overall Study|Other|1|||
23678939|NCT02078219|66205994|FG000|Overall Study|Withdrawal by Subject|0|||
23678940|NCT02078219|66205995|FG001|Overall Study|Withdrawal by Subject|1|||
23678941|NCT02078219|66205996|FG002|Overall Study|Withdrawal by Subject|0|||
23678942|NCT02078219|66205997|FG003|Overall Study|Withdrawal by Subject|1|||
23678943|NCT02078219|66205998|FG004|Overall Study|Withdrawal by Subject|1|||
23678944|NCT02078219|66205994|FG000|Overall Study|Protocol Violation|0|||
23678945|NCT02078219|66205995|FG001|Overall Study|Protocol Violation|0|||
23678946|NCT02078219|66205996|FG002|Overall Study|Protocol Violation|0|||
23678947|NCT02078219|66205997|FG003|Overall Study|Protocol Violation|1|||
23678948|NCT02078219|66205998|FG004|Overall Study|Protocol Violation|0|||
23678949|NCT02078219|66205994|FG000|Overall Study|Death|0|||
23678950|NCT02078219|66205995|FG001|Overall Study|Death|0|||
23678951|NCT02078219|66205996|FG002|Overall Study|Death|0|||
23678952|NCT02078219|66205997|FG003|Overall Study|Death|1|||
23678953|NCT02078219|66205998|FG004|Overall Study|Death|0|||
23678954|NCT02078219|66205994|FG000|Overall Study|Adverse Event|1|||
23678955|NCT02078219|66205995|FG001|Overall Study|Adverse Event|1|||
23678956|NCT02078219|66205996|FG002|Overall Study|Adverse Event|3|||
23678957|NCT02078219|66205997|FG003|Overall Study|Adverse Event|1|||
23678958|NCT02078219|66205998|FG004|Overall Study|Adverse Event|0|||
23678959|NCT01557166|66206001|FG000|Overall Study|Adverse Event|20|||
23678960|NCT01557166|66206002|FG001|Overall Study|Adverse Event|6|||
23678961|NCT01557166|66206001|FG000|Overall Study|Lack of Efficacy|2|||
23678962|NCT01557166|66206002|FG001|Overall Study|Lack of Efficacy|1|||
23678963|NCT01557166|66206001|FG000|Overall Study|Protocol Violation|8|||
23678964|NCT01557166|66206002|FG001|Overall Study|Protocol Violation|5|||
23678965|NCT01557166|66206001|FG000|Overall Study|Withdrawn consent|12|||
23678966|NCT01557166|66206002|FG001|Overall Study|Withdrawn consent|20|||
23678967|NCT01557166|66206001|FG000|Overall Study|Target dose not tolerated|1|||
23678968|NCT01557166|66206002|FG001|Overall Study|Target dose not tolerated|0|||
23678969|NCT01557166|66206001|FG000|Overall Study|Psychiatric disorder|1|||
23678970|NCT01557166|66206002|FG001|Overall Study|Psychiatric disorder|0|||
23678971|NCT01557166|66206001|FG000|Overall Study|Unclassified|2|||
23678972|NCT01557166|66206002|FG001|Overall Study|Unclassified|5|||
23678973|NCT01565980|66206007|FG000|Overall Study|Death|1|||
23678974|NCT01565980|66206008|FG001|Overall Study|Death|0|||
23678975|NCT01565980|66206007|FG000|Overall Study|Lost to Follow-up|1|||
23494821|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494822|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494823|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494824|NCT03307785|65554999|FG000|Part E: Up to 4.4 Months|Death|0|||
23494825|NCT03307785|65555000|FG001|Part E: Up to 4.4 Months|Death|0|||
23494826|NCT03307785|65555001|FG002|Part E: Up to 4.4 Months|Death|0|||
23494827|NCT03307785|65555002|FG003|Part E: Up to 4.4 Months|Death|0|||
23494828|NCT03307785|65555003|FG004|Part E: Up to 4.4 Months|Death|0|||
23494829|NCT03307785|65555004|FG005|Part E: Up to 4.4 Months|Death|0|||
23494830|NCT03307785|65555005|FG006|Part E: Up to 4.4 Months|Death|1|||
23678976|NCT01565980|66206008|FG001|Overall Study|Lost to Follow-up|0|||
23494831|NCT03307785|65555006|FG007|Part E: Up to 4.4 Months|Death|0|||
23678977|NCT01565980|66206007|FG000|Overall Study|health complications|1|||
23678978|NCT01565980|66206008|FG001|Overall Study|health complications|1|||
23678979|NCT01565980|66206007|FG000|Overall Study|stopped medical treatment|1|||
23678980|NCT01565980|66206008|FG001|Overall Study|stopped medical treatment|0|||
23678981|NCT01565980|66206007|FG000|Overall Study|Withdrawal by Subject|0|||
23678982|NCT01565980|66206008|FG001|Overall Study|Withdrawal by Subject|3|||
23678983|NCT04682405|66206010|FG000|Overall Study|Adverse Event|0|||
23678984|NCT04682405|66206011|FG001|Overall Study|Adverse Event|1|||
23678985|NCT01737931|66206012|FG000|Overall Study|Withdrawal by Subject|0|||
23678986|NCT01737931|66206013|FG001|Overall Study|Withdrawal by Subject|1|||
23678987|NCT01737931|66206014|FG002|Overall Study|Withdrawal by Subject|1|||
23678988|NCT01737931|66206012|FG000|Overall Study|Physician Decision|0|||
23678989|NCT01737931|66206013|FG001|Overall Study|Physician Decision|1|||
23678990|NCT01737931|66206014|FG002|Overall Study|Physician Decision|0|||
23678991|NCT02814565|66206015|FG000|Overall Study|Lack of Efficacy|0|||
23678992|NCT02814565|66206016|FG001|Overall Study|Lack of Efficacy|1|||
23678993|NCT02814565|66206015|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
23678994|NCT02814565|66206016|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
23678995|NCT03887130|66206017|FG000|Overall Study|Progressive disease|23|||
23678996|NCT03887130|66206018|FG001|Overall Study|Progressive disease|14|||
23678997|NCT03887130|66206019|FG002|Overall Study|Progressive disease|7|||
23678998|NCT03887130|66206017|FG000|Overall Study|Protocol Violation|3|||
23678999|NCT03887130|66206018|FG001|Overall Study|Protocol Violation|1|||
23679000|NCT03887130|66206019|FG002|Overall Study|Protocol Violation|2|||
23679001|NCT03887130|66206017|FG000|Overall Study|Drug related toxicity|7|||
23679002|NCT03887130|66206018|FG001|Overall Study|Drug related toxicity|7|||
23679003|NCT03887130|66206019|FG002|Overall Study|Drug related toxicity|13|||
23679004|NCT03887130|66206017|FG000|Overall Study|Non drug related toxicity|3|||
23679005|NCT03887130|66206018|FG001|Overall Study|Non drug related toxicity|0|||
23679006|NCT03887130|66206019|FG002|Overall Study|Non drug related toxicity|0|||
23679007|NCT03887130|66206017|FG000|Overall Study|Death|2|||
23679008|NCT03887130|66206018|FG001|Overall Study|Death|2|||
23679009|NCT03887130|66206019|FG002|Overall Study|Death|1|||
23679010|NCT03887130|66206017|FG000|Overall Study|Withdrawal by Subject|7|||
23679011|NCT03887130|66206018|FG001|Overall Study|Withdrawal by Subject|6|||
23679012|NCT03887130|66206019|FG002|Overall Study|Withdrawal by Subject|11|||
23679013|NCT03887130|66206017|FG000|Overall Study|other reason|6|||
23679014|NCT03887130|66206018|FG001|Overall Study|other reason|20|||
23679015|NCT03887130|66206019|FG002|Overall Study|other reason|17|||
23679016|NCT03183128|66206020|FG000|Overall Study|Adverse Event|1|||
23679017|NCT03183128|66206021|FG001|Overall Study|Adverse Event|2|||
23679018|NCT03183128|66206020|FG000|Overall Study|Withdrawal by Subject|1|||
23679019|NCT03183128|66206021|FG001|Overall Study|Withdrawal by Subject|8|||
23679020|NCT03183128|66206020|FG000|Overall Study|Protocol Violation|2|||
23679021|NCT03183128|66206021|FG001|Overall Study|Protocol Violation|0|||
23679022|NCT03183128|66206020|FG000|Overall Study|Lack of Efficacy|4|||
23679023|NCT03183128|66206021|FG001|Overall Study|Lack of Efficacy|27|||
23679024|NCT03183128|66206020|FG000|Overall Study|Lost to Follow-up|1|||
23679025|NCT03183128|66206021|FG001|Overall Study|Lost to Follow-up|0|||
23679026|NCT03183128|66206020|FG000|Overall Study|Death|2|||
23679027|NCT03183128|66206021|FG001|Overall Study|Death|0|||
23679028|NCT03183128|66206020|FG000|Overall Study|Physician Decision|1|||
23679029|NCT03183128|66206021|FG001|Overall Study|Physician Decision|0|||
23679030|NCT00880256|66206022|FG000|Overall Study|Lost to Follow-up|28|||
23679031|NCT03345472|66206023|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
23679032|NCT03345472|66206023|FG000|Implant to 3 Months|Physician Decision|1|||
23679033|NCT03345472|66206023|FG000|Implant to 3 Months|Adverse Event|1|||
23679034|NCT03345472|66206023|FG000|3 Months to 12 Months|Physician Decision|3|||
23679035|NCT03345472|66206023|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
23679036|NCT03345472|66206023|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
23679037|NCT03345472|66206023|FG000|3 Months to 12 Months|Adverse Event|1|||
23679038|NCT03345472|66206023|FG000|3 Months to 12 Months|Death|1|||
23679039|NCT01337973|66206026|FG000|Overall Study|Lost to Follow-up|2|||
23679040|NCT01337973|66206027|FG001|Overall Study|Lost to Follow-up|4|||
23679041|NCT01337973|66206028|FG002|Overall Study|Lost to Follow-up|3|||
23679042|NCT01337973|66206026|FG000|Overall Study|Death|1|||
23679043|NCT01337973|66206027|FG001|Overall Study|Death|2|||
23679044|NCT01337973|66206028|FG002|Overall Study|Death|1|||
23679045|NCT01337973|66206026|FG000|Overall Study|Withdrawal by Subject|10|||
23679046|NCT01337973|66206027|FG001|Overall Study|Withdrawal by Subject|8|||
23679047|NCT01337973|66206028|FG002|Overall Study|Withdrawal by Subject|4|||
23679048|NCT01337973|66206026|FG000|Overall Study|missing data on primary outcome|3|||
23679049|NCT01337973|66206027|FG001|Overall Study|missing data on primary outcome|1|||
23679050|NCT01337973|66206028|FG002|Overall Study|missing data on primary outcome|3|||
23679051|NCT01116544|66206029|FG000|Overall Study|Protocol Violation|1|||
23679052|NCT01116544|66206030|FG001|Overall Study|Protocol Violation|0|||
23679053|NCT01116544|66206029|FG000|Overall Study|Withdrawal by Subject|1|||
23679054|NCT01116544|66206030|FG001|Overall Study|Withdrawal by Subject|1|||
23679055|NCT03093155|66206031|FG000|Overall Study|Not Eligible|1|||
23679056|NCT03093155|66206032|FG001|Overall Study|Not Eligible|0|||
23679057|NCT03093155|66206031|FG000|Overall Study|Withdrawal by Subject|0|||
23679058|NCT03093155|66206032|FG001|Overall Study|Withdrawal by Subject|1|||
23679059|NCT03261531|66206035|FG000|Overall Study|Withdrawal by Subject|4|||
23494832|NCT03307785|65555007|FG008|Part E: Up to 4.4 Months|Death|0|||
23679060|NCT02292771|66206036|FG000|Overall Study|Withdrawal by Subject|2|||
23679061|NCT02292771|66206037|FG001|Overall Study|Withdrawal by Subject|1|||
23679062|NCT02292771|66206036|FG000|Overall Study|Lost to Follow-up|2|||
23679063|NCT02292771|66206037|FG001|Overall Study|Lost to Follow-up|1|||
23679064|NCT00477165|66206038|FG000|Overall Study|Adverse Event|7|||
23679065|NCT00477165|66206039|FG001|Overall Study|Adverse Event|2|||
23679066|NCT00087646|66206040|FG000|Overall Study|Adverse Event|37|||
23679067|NCT00087646|66206041|FG001|Overall Study|Adverse Event|6|||
23679068|NCT00087646|66206042|FG002|Overall Study|Adverse Event|18|||
23679069|NCT00087646|66206043|FG003|Overall Study|Adverse Event|20|||
23679070|NCT00087646|66206040|FG000|Overall Study|Death|0|||
23679071|NCT00087646|66206041|FG001|Overall Study|Death|1|||
23679072|NCT00087646|66206042|FG002|Overall Study|Death|0|||
23679073|NCT00087646|66206043|FG003|Overall Study|Death|0|||
23679074|NCT00087646|66206040|FG000|Overall Study|Withdrawal by Subject|6|||
23679075|NCT00087646|66206041|FG001|Overall Study|Withdrawal by Subject|1|||
23679076|NCT00087646|66206042|FG002|Overall Study|Withdrawal by Subject|2|||
23679077|NCT00087646|66206043|FG003|Overall Study|Withdrawal by Subject|2|||
23679078|NCT00087646|66206040|FG000|Overall Study|Insufficient therapeutic response|64|||
23679079|NCT00087646|66206041|FG001|Overall Study|Insufficient therapeutic response|24|||
23679080|NCT00087646|66206042|FG002|Overall Study|Insufficient therapeutic response|38|||
23679081|NCT00087646|66206043|FG003|Overall Study|Insufficient therapeutic response|51|||
23679082|NCT00087646|66206040|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
23679083|NCT00087646|66206041|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
23679084|NCT00087646|66206042|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
23679085|NCT00087646|66206043|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
23679086|NCT00087646|66206040|FG000|Overall Study|Failure to Return|5|||
23679087|NCT00087646|66206041|FG001|Overall Study|Failure to Return|2|||
23679088|NCT00087646|66206042|FG002|Overall Study|Failure to Return|2|||
23679089|NCT00087646|66206043|FG003|Overall Study|Failure to Return|3|||
23679090|NCT00087646|66206040|FG000|Overall Study|Administrative/Other|6|||
23679091|NCT00087646|66206041|FG001|Overall Study|Administrative/Other|1|||
23679092|NCT00087646|66206042|FG002|Overall Study|Administrative/Other|1|||
23679093|NCT00087646|66206043|FG003|Overall Study|Administrative/Other|2|||
23679094|NCT00087646|66206040|FG000|Overall Study|Other Protocol Violation|3|||
23679095|NCT00087646|66206041|FG001|Overall Study|Other Protocol Violation|1|||
23679096|NCT00087646|66206042|FG002|Overall Study|Other Protocol Violation|0|||
23679097|NCT00087646|66206043|FG003|Overall Study|Other Protocol Violation|0|||
23679098|NCT00087646|66206040|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23679099|NCT00087646|66206041|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23679100|NCT00087646|66206042|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23679101|NCT00087646|66206043|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
23679102|NCT01827384|66206044|FG000|Overall Study|Switched to alternative treatment|0|||
23679103|NCT01827384|66206045|FG001|Overall Study|Switched to alternative treatment|0|||
23679104|NCT01827384|66206046|FG002|Overall Study|Switched to alternative treatment|0|||
23679105|NCT01827384|66206047|FG003|Overall Study|Switched to alternative treatment|0|||
23679106|NCT01827384|66206048|FG004|Overall Study|Switched to alternative treatment|0|||
23679107|NCT01827384|66206049|FG005|Overall Study|Switched to alternative treatment|0|||
23679108|NCT01827384|66206050|FG006|Overall Study|Switched to alternative treatment|0|||
23679109|NCT01827384|66206051|FG007|Overall Study|Switched to alternative treatment|0|||
23679110|NCT01827384|66206052|FG008|Overall Study|Switched to alternative treatment|0|||
23679111|NCT01827384|66206053|FG009|Overall Study|Switched to alternative treatment|0|||
23679112|NCT01827384|66206054|FG010|Overall Study|Switched to alternative treatment|0|||
23679113|NCT01827384|66206055|FG011|Overall Study|Switched to alternative treatment|0|||
23679114|NCT01827384|66206056|FG012|Overall Study|Switched to alternative treatment|0|||
23679115|NCT01827384|66206057|FG013|Overall Study|Switched to alternative treatment|2|||
23679116|NCT01827384|66206044|FG000|Overall Study|Disease progression before treatment|0|||
23679117|NCT01827384|66206045|FG001|Overall Study|Disease progression before treatment|0|||
23679118|NCT01827384|66206046|FG002|Overall Study|Disease progression before treatment|0|||
23679119|NCT01827384|66206047|FG003|Overall Study|Disease progression before treatment|0|||
23679120|NCT01827384|66206048|FG004|Overall Study|Disease progression before treatment|0|||
23679121|NCT01827384|66206049|FG005|Overall Study|Disease progression before treatment|0|||
23679122|NCT01827384|66206050|FG006|Overall Study|Disease progression before treatment|0|||
23679123|NCT01827384|66206051|FG007|Overall Study|Disease progression before treatment|0|||
23679124|NCT01827384|66206052|FG008|Overall Study|Disease progression before treatment|0|||
23679125|NCT01827384|66206053|FG009|Overall Study|Disease progression before treatment|0|||
23679126|NCT01827384|66206054|FG010|Overall Study|Disease progression before treatment|0|||
23679127|NCT01827384|66206055|FG011|Overall Study|Disease progression before treatment|0|||
23679128|NCT01827384|66206056|FG012|Overall Study|Disease progression before treatment|0|||
23679129|NCT01827384|66206057|FG013|Overall Study|Disease progression before treatment|4|||
23679130|NCT01827384|66206044|FG000|Overall Study|Ineligible|0|||
23679131|NCT01827384|66206045|FG001|Overall Study|Ineligible|0|||
23679132|NCT01827384|66206046|FG002|Overall Study|Ineligible|0|||
23679133|NCT01827384|66206047|FG003|Overall Study|Ineligible|0|||
23679134|NCT01827384|66206048|FG004|Overall Study|Ineligible|0|||
23679135|NCT01827384|66206049|FG005|Overall Study|Ineligible|0|||
23679136|NCT01827384|66206050|FG006|Overall Study|Ineligible|0|||
23679137|NCT01827384|66206051|FG007|Overall Study|Ineligible|0|||
23679138|NCT01827384|66206052|FG008|Overall Study|Ineligible|0|||
23679139|NCT01827384|66206053|FG009|Overall Study|Ineligible|0|||
23679140|NCT01827384|66206054|FG010|Overall Study|Ineligible|0|||
23679141|NCT01827384|66206055|FG011|Overall Study|Ineligible|0|||
23679142|NCT01827384|66206056|FG012|Overall Study|Ineligible|0|||
23679143|NCT01827384|66206057|FG013|Overall Study|Ineligible|19|||
23679144|NCT01827384|66206044|FG000|Overall Study|Participant died before treatment|0|||
23679145|NCT01827384|66206045|FG001|Overall Study|Participant died before treatment|0|||
23679146|NCT01827384|66206046|FG002|Overall Study|Participant died before treatment|0|||
23679147|NCT01827384|66206047|FG003|Overall Study|Participant died before treatment|0|||
23679148|NCT01827384|66206048|FG004|Overall Study|Participant died before treatment|0|||
23679149|NCT01827384|66206049|FG005|Overall Study|Participant died before treatment|0|||
23679150|NCT01827384|66206050|FG006|Overall Study|Participant died before treatment|0|||
23679151|NCT01827384|66206051|FG007|Overall Study|Participant died before treatment|0|||
23679152|NCT01827384|66206052|FG008|Overall Study|Participant died before treatment|0|||
23679153|NCT01827384|66206053|FG009|Overall Study|Participant died before treatment|0|||
23679154|NCT01827384|66206054|FG010|Overall Study|Participant died before treatment|0|||
23679155|NCT01827384|66206055|FG011|Overall Study|Participant died before treatment|0|||
23679156|NCT01827384|66206056|FG012|Overall Study|Participant died before treatment|0|||
23679157|NCT01827384|66206057|FG013|Overall Study|Participant died before treatment|5|||
23679158|NCT01827384|66206044|FG000|Overall Study|Insufficient tumor cells|0|||
23679159|NCT01827384|66206045|FG001|Overall Study|Insufficient tumor cells|0|||
23679160|NCT01827384|66206046|FG002|Overall Study|Insufficient tumor cells|0|||
23679161|NCT01827384|66206047|FG003|Overall Study|Insufficient tumor cells|0|||
23679162|NCT01827384|66206048|FG004|Overall Study|Insufficient tumor cells|0|||
23679163|NCT01827384|66206049|FG005|Overall Study|Insufficient tumor cells|0|||
23679164|NCT01827384|66206050|FG006|Overall Study|Insufficient tumor cells|0|||
23679165|NCT01827384|66206051|FG007|Overall Study|Insufficient tumor cells|0|||
23679166|NCT01827384|66206052|FG008|Overall Study|Insufficient tumor cells|0|||
23679167|NCT01827384|66206053|FG009|Overall Study|Insufficient tumor cells|0|||
23679168|NCT01827384|66206054|FG010|Overall Study|Insufficient tumor cells|0|||
23679169|NCT01827384|66206055|FG011|Overall Study|Insufficient tumor cells|0|||
23679170|NCT01827384|66206056|FG012|Overall Study|Insufficient tumor cells|0|||
23679171|NCT01827384|66206057|FG013|Overall Study|Insufficient tumor cells|13|||
23679172|NCT01827384|66206044|FG000|Overall Study|No actionable mutation|0|||
23679173|NCT01827384|66206045|FG001|Overall Study|No actionable mutation|0|||
23679174|NCT01827384|66206046|FG002|Overall Study|No actionable mutation|0|||
23679175|NCT01827384|66206047|FG003|Overall Study|No actionable mutation|0|||
23679176|NCT01827384|66206048|FG004|Overall Study|No actionable mutation|0|||
23679177|NCT01827384|66206049|FG005|Overall Study|No actionable mutation|0|||
23679178|NCT01827384|66206050|FG006|Overall Study|No actionable mutation|0|||
23679179|NCT01827384|66206051|FG007|Overall Study|No actionable mutation|0|||
23679180|NCT01827384|66206052|FG008|Overall Study|No actionable mutation|0|||
23679181|NCT01827384|66206053|FG009|Overall Study|No actionable mutation|0|||
23679182|NCT01827384|66206054|FG010|Overall Study|No actionable mutation|0|||
23679183|NCT01827384|66206055|FG011|Overall Study|No actionable mutation|0|||
23679184|NCT01827384|66206056|FG012|Overall Study|No actionable mutation|0|||
23679185|NCT01827384|66206057|FG013|Overall Study|No actionable mutation|73|||
23679186|NCT01827384|66206044|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
23679187|NCT01827384|66206045|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
23679188|NCT01827384|66206046|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
23679189|NCT01827384|66206047|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
23679190|NCT01827384|66206048|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
23679191|NCT01827384|66206049|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
23679192|NCT01827384|66206050|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
23679193|NCT01827384|66206051|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
23679194|NCT01827384|66206052|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
23679195|NCT01827384|66206053|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
23679196|NCT01827384|66206054|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
23679197|NCT01827384|66206055|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
23679198|NCT01827384|66206056|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
23679199|NCT01827384|66206057|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
23679200|NCT00559507|66206058|FG000|Overall Study|Not treated, patient ineligible|3|||
23679201|NCT00448708|66206059|FG000|Overall Study|Death|21|||
23679202|NCT00448708|66206060|FG001|Overall Study|Death|17|||
23679203|NCT00448708|66206059|FG000|Overall Study|Withdrawal by Subject|8|||
23679204|NCT00448708|66206060|FG001|Overall Study|Withdrawal by Subject|4|||
23679205|NCT00448708|66206059|FG000|Overall Study|Lost to Follow-up|6|||
23679206|NCT00448708|66206060|FG001|Overall Study|Lost to Follow-up|8|||
23679207|NCT00448708|66206059|FG000|Overall Study|not listed|0|||
23679208|NCT00448708|66206060|FG001|Overall Study|not listed|2|||
23679209|NCT00529958|66206061|FG000|2-Year Follow-up|Lost to Follow-up|1|||
23679210|NCT00529958|66206062|FG001|2-Year Follow-up|Lost to Follow-up|2|||
23679211|NCT00529958|66206063|FG002|2-Year Follow-up|Lost to Follow-up|2|||
23679212|NCT00529958|66206061|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
23679213|NCT00529958|66206062|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
23679214|NCT00529958|66206063|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
23679215|NCT00529958|66206061|FG000|5-Year Follow-up|Lost to Follow-up|2|||
23679216|NCT00529958|66206062|FG001|5-Year Follow-up|Lost to Follow-up|3|||
23388881|NCT00504556|65168838|FG002|Overall Study|data monitor committee decision|0|||
23679217|NCT00529958|66206063|FG002|5-Year Follow-up|Lost to Follow-up|1|||
23679218|NCT00529958|66206061|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
23679219|NCT00529958|66206062|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
23679220|NCT00529958|66206063|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
23679221|NCT02024971|66206066|FG000|Overall Study|Data Not Available|30|||
23679222|NCT02024971|66206066|FG000|Overall Study|Lost to Follow-up|6|||
23679223|NCT01318122|66206071|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23679224|NCT01318122|66206072|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23679225|NCT01318122|66206073|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
23679226|NCT01318122|66206074|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23679227|NCT01318122|66206071|FG000|Enrolled - Long-Term Extension Study|Other|1|||
23679228|NCT01318122|66206072|FG001|Enrolled - Long-Term Extension Study|Other|0|||
23679229|NCT01318122|66206073|FG002|Enrolled - Long-Term Extension Study|Other|0|||
23679230|NCT01318122|66206074|FG003|Enrolled - Long-Term Extension Study|Other|0|||
23679231|NCT01318122|66206071|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
23679232|NCT01318122|66206072|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
23679233|NCT01318122|66206073|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
23679234|NCT01318122|66206074|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
23679235|NCT01318122|66206071|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
23679236|NCT01318122|66206072|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23679237|NCT01318122|66206073|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23679238|NCT01318122|66206074|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23679239|NCT01318122|66206071|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23679240|NCT01318122|66206072|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
23679241|NCT01318122|66206073|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23679242|NCT01318122|66206074|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23679243|NCT01318122|66206071|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23679244|NCT01318122|66206072|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23679245|NCT01318122|66206073|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
23679246|NCT01318122|66206074|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23679247|NCT03446885|66206075|FG000|Overall Study|Lost to Follow-up|1|||
23679248|NCT03446885|66206076|FG001|Overall Study|Lost to Follow-up|0|||
23679249|NCT03446885|66206075|FG000|Overall Study|Did not complete entire visit|1|||
23679250|NCT03446885|66206076|FG001|Overall Study|Did not complete entire visit|0|||
23679251|NCT00070941|66206077|FG000|Overall Study|Adverse Event|10|||
23679252|NCT00070941|66206078|FG001|Overall Study|Adverse Event|8|||
23679253|NCT00070941|66206079|FG002|Overall Study|Adverse Event|4|||
23679254|NCT02787850|66206081|FG000|Overall Study|Withdrawal by Subject|0|||
23679255|NCT02787850|66206082|FG001|Overall Study|Withdrawal by Subject|1|||
23679256|NCT02847598|66206084|FG000|Overall Study|Adverse Event|0|||
23679257|NCT02847598|66206085|FG001|Overall Study|Adverse Event|0|||
23679258|NCT02847598|66206086|FG002|Overall Study|Adverse Event|0|||
23679259|NCT02847598|66206087|FG003|Overall Study|Adverse Event|0|||
23679260|NCT02847598|66206088|FG004|Overall Study|Adverse Event|0|||
23679261|NCT02847598|66206089|FG005|Overall Study|Adverse Event|0|||
23679262|NCT02847598|66206090|FG006|Overall Study|Adverse Event|0|||
23679263|NCT02847598|66206091|FG007|Overall Study|Adverse Event|1|||
23679264|NCT02847598|66206084|FG000|Overall Study|Consent withdrawn|2|||
23679265|NCT02847598|66206085|FG001|Overall Study|Consent withdrawn|0|||
23679266|NCT02847598|66206086|FG002|Overall Study|Consent withdrawn|0|||
23679267|NCT02847598|66206087|FG003|Overall Study|Consent withdrawn|4|||
23679268|NCT02847598|66206088|FG004|Overall Study|Consent withdrawn|3|||
23679269|NCT02847598|66206089|FG005|Overall Study|Consent withdrawn|2|||
23679270|NCT02847598|66206090|FG006|Overall Study|Consent withdrawn|1|||
23679271|NCT02847598|66206091|FG007|Overall Study|Consent withdrawn|3|||
23679272|NCT02847598|66206084|FG000|Overall Study|Death|3|||
23679273|NCT02847598|66206085|FG001|Overall Study|Death|0|||
23679274|NCT02847598|66206086|FG002|Overall Study|Death|0|||
23679275|NCT02847598|66206087|FG003|Overall Study|Death|0|||
23679276|NCT02847598|66206088|FG004|Overall Study|Death|0|||
23679277|NCT02847598|66206089|FG005|Overall Study|Death|0|||
23679278|NCT02847598|66206090|FG006|Overall Study|Death|0|||
23494833|NCT03307785|65555008|FG009|Part E: Up to 4.4 Months|Death|0|||
23679279|NCT02847598|66206091|FG007|Overall Study|Death|0|||
23679280|NCT02847598|66206084|FG000|Overall Study|Lost to Follow-up|0|||
23679281|NCT02847598|66206085|FG001|Overall Study|Lost to Follow-up|0|||
23679282|NCT02847598|66206086|FG002|Overall Study|Lost to Follow-up|0|||
23679283|NCT02847598|66206087|FG003|Overall Study|Lost to Follow-up|0|||
23679284|NCT02847598|66206088|FG004|Overall Study|Lost to Follow-up|0|||
23679285|NCT02847598|66206089|FG005|Overall Study|Lost to Follow-up|1|||
23679286|NCT02847598|66206090|FG006|Overall Study|Lost to Follow-up|1|||
23679287|NCT02847598|66206091|FG007|Overall Study|Lost to Follow-up|0|||
23679288|NCT00440726|66206095|FG000|Phase 1|Dose-Limiting Toxicity|0|||
23679289|NCT00440726|66206096|FG001|Phase 1|Dose-Limiting Toxicity|1|||
23679290|NCT00440726|66206097|FG002|Phase 1|Dose-Limiting Toxicity|0|||
23679291|NCT00440726|66206095|FG000|Phase 1|Physician Decision|1|||
23679292|NCT00440726|66206096|FG001|Phase 1|Physician Decision|0|||
23679293|NCT00440726|66206097|FG002|Phase 1|Physician Decision|0|||
23679294|NCT00440726|66206095|FG000|Phase 2|Death|0|||
23679295|NCT00440726|66206096|FG001|Phase 2|Death|0|||
23679296|NCT00440726|66206097|FG002|Phase 2|Death|1|||
23679297|NCT00440726|66206095|FG000|Phase 2|Adverse Event|0|||
23679298|NCT00440726|66206096|FG001|Phase 2|Adverse Event|0|||
23679299|NCT00440726|66206097|FG002|Phase 2|Adverse Event|1|||
23679300|NCT02026063|66206100|FG000|Overall Study|Physician Decision|0|||
23679301|NCT02026063|66206101|FG001|Overall Study|Physician Decision|10|||
23679302|NCT02026063|66206100|FG000|Overall Study|Noncompliance with Study Drug|1|||
23679303|NCT02026063|66206101|FG001|Overall Study|Noncompliance with Study Drug|1|||
23679304|NCT02026063|66206100|FG000|Overall Study|Withdrawal of Consent|1|||
23679305|NCT02026063|66206101|FG001|Overall Study|Withdrawal of Consent|6|||
23679306|NCT02026063|66206100|FG000|Overall Study|Adverse Event|5|||
23679307|NCT02026063|66206101|FG001|Overall Study|Adverse Event|20|||
23679308|NCT02026063|66206100|FG000|Overall Study|Lack of Efficacy|0|||
23679309|NCT02026063|66206101|FG001|Overall Study|Lack of Efficacy|4|||
23679310|NCT02026063|66206100|FG000|Overall Study|Lost to Follow-up|0|||
23679311|NCT02026063|66206101|FG001|Overall Study|Lost to Follow-up|1|||
23679312|NCT02026063|66206100|FG000|Overall Study|Reason not Specified|2|||
23679313|NCT02026063|66206101|FG001|Overall Study|Reason not Specified|7|||
23679314|NCT03682120|66206102|FG000|Overall Study|Lost to Follow-up|11|||
23388882|NCT00504556|65168839|FG003|Overall Study|data monitor committee decision|100|||
23388883|NCT00504556|65168840|FG004|Overall Study|data monitor committee decision|0|||
23388884|NCT00504556|65168836|FG000|Overall Study|Other|2|||
23388885|NCT00504556|65168837|FG001|Overall Study|Other|2|||
23388886|NCT00504556|65168838|FG002|Overall Study|Other|2|||
23388887|NCT00504556|65168839|FG003|Overall Study|Other|3|||
23388888|NCT00504556|65168840|FG004|Overall Study|Other|0|||
23388889|NCT00504556|65168836|FG000|Overall Study|not in safety analysis set|0|||
23388890|NCT00504556|65168837|FG001|Overall Study|not in safety analysis set|1|||
23388891|NCT00504556|65168838|FG002|Overall Study|not in safety analysis set|1|||
23388892|NCT00504556|65168839|FG003|Overall Study|not in safety analysis set|0|||
23388893|NCT00504556|65168840|FG004|Overall Study|not in safety analysis set|1|||
23388894|NCT02244957|65168841|FG000|Overall Study|Lack of Efficacy|1|||
23388895|NCT02244957|65168842|FG001|Overall Study|Lack of Efficacy|0|||
23388896|NCT01379937|65168846|FG000|Overall Study|Protocol Violation|0|||
23388897|NCT01379937|65168847|FG001|Overall Study|Protocol Violation|0|||
23388898|NCT01379937|65168848|FG002|Overall Study|Protocol Violation|0|||
23388899|NCT01379937|65168849|FG003|Overall Study|Protocol Violation|1|||
23388900|NCT01379937|65168846|FG000|Overall Study|Consent withdrawal|0|||
23388901|NCT01379937|65168847|FG001|Overall Study|Consent withdrawal|1|||
23388902|NCT01379937|65168848|FG002|Overall Study|Consent withdrawal|0|||
23388903|NCT01379937|65168849|FG003|Overall Study|Consent withdrawal|0|||
23388904|NCT01379937|65168846|FG000|Overall Study|Lost to Follow-up|1|||
23388905|NCT01379937|65168847|FG001|Overall Study|Lost to Follow-up|2|||
23494834|NCT03307785|65555009|FG010|Part E: Up to 4.4 Months|Death|0|||
23679315|NCT03682120|66206103|FG001|Overall Study|Lost to Follow-up|4|||
23679316|NCT03682120|66206104|FG002|Overall Study|Lost to Follow-up|5|||
23679317|NCT03682120|66206105|FG003|Overall Study|Lost to Follow-up|2|||
23679318|NCT03682120|66206102|FG000|Overall Study|Physician Decision|1|||
23679319|NCT03682120|66206103|FG001|Overall Study|Physician Decision|0|||
23679320|NCT03682120|66206104|FG002|Overall Study|Physician Decision|0|||
23679321|NCT03682120|66206105|FG003|Overall Study|Physician Decision|0|||
23679322|NCT03682120|66206102|FG000|Overall Study|Withdrawal by Subject|1|||
23679323|NCT03682120|66206103|FG001|Overall Study|Withdrawal by Subject|2|||
23679324|NCT03682120|66206104|FG002|Overall Study|Withdrawal by Subject|3|||
23679325|NCT03682120|66206105|FG003|Overall Study|Withdrawal by Subject|0|||
23679326|NCT03682120|66206102|FG000|Overall Study|Death|0|||
23679327|NCT03682120|66206103|FG001|Overall Study|Death|1|||
23679328|NCT03682120|66206104|FG002|Overall Study|Death|0|||
23679329|NCT03682120|66206105|FG003|Overall Study|Death|0|||
23679330|NCT03682120|66206102|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
23679331|NCT03682120|66206103|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
23679332|NCT03682120|66206104|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
23679333|NCT03682120|66206105|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
23679334|NCT00428597|66206109|FG000|Overall Study|Randomized but not treated|3|||
23679335|NCT00428597|66206110|FG001|Overall Study|Randomized but not treated|3|||
23679336|NCT00428597|66206109|FG000|Overall Study|Objective Progression or Relapse|19|||
23679337|NCT00428597|66206110|FG001|Overall Study|Objective Progression or Relapse|47|||
23679338|NCT00428597|66206109|FG000|Overall Study|Study Terminated by Sponsor|41|||
23679339|NCT00428597|66206110|FG001|Overall Study|Study Terminated by Sponsor|16|||
23679340|NCT00428597|66206109|FG000|Overall Study|Adverse Event|15|||
23679341|NCT00428597|66206110|FG001|Overall Study|Adverse Event|7|||
23679342|NCT00428597|66206109|FG000|Overall Study|Global Deterioration of Health Status|1|||
23679343|NCT00428597|66206110|FG001|Overall Study|Global Deterioration of Health Status|5|||
23679344|NCT00428597|66206109|FG000|Overall Study|Protocol Violation|2|||
23679345|NCT00428597|66206110|FG001|Overall Study|Protocol Violation|1|||
23679346|NCT00428597|66206109|FG000|Overall Study|Withdrawal by Subject|2|||
23679347|NCT00428597|66206110|FG001|Overall Study|Withdrawal by Subject|1|||
23679348|NCT00428597|66206109|FG000|Overall Study|Other|1|||
23679349|NCT00428597|66206110|FG001|Overall Study|Other|1|||
23679350|NCT00428597|66206109|FG000|Overall Study|Lost to Follow-up|0|||
23679351|NCT00428597|66206110|FG001|Overall Study|Lost to Follow-up|1|||
23679352|NCT00428597|66206109|FG000|Overall Study|Pregnancy|1|||
23679353|NCT00428597|66206110|FG001|Overall Study|Pregnancy|0|||
23679354|NCT00428597|66206109|FG000|Overall Study|Death|1|||
23679355|NCT00428597|66206110|FG001|Overall Study|Death|3|||
23679356|NCT00400400|66206114|FG000|Overall Study|Adverse Event|9|||
23679357|NCT00400400|66206115|FG001|Overall Study|Adverse Event|8|||
23679358|NCT00400400|66206114|FG000|Overall Study|Protocol Violation|2|||
23679359|NCT00400400|66206115|FG001|Overall Study|Protocol Violation|0|||
23679360|NCT00400400|66206114|FG000|Overall Study|Withdrawal by Subject|1|||
23679361|NCT00400400|66206115|FG001|Overall Study|Withdrawal by Subject|3|||
23679362|NCT00400400|66206114|FG000|Overall Study|Administrative Problem|1|||
23679363|NCT00400400|66206115|FG001|Overall Study|Administrative Problem|0|||
23679364|NCT00400400|66206114|FG000|Overall Study|Lost to Follow-up|0|||
23679365|NCT00400400|66206115|FG001|Overall Study|Lost to Follow-up|1|||
23679366|NCT00400400|66206114|FG000|Overall Study|Did not receive study drug|1|||
23679367|NCT00400400|66206115|FG001|Overall Study|Did not receive study drug|3|||
23679368|NCT02908880|66206116|FG000|Overall Study|Lost to Follow-up|4|||
23679369|NCT02908880|66206116|FG000|Overall Study|Explantation of the device|1|||
23679370|NCT02908880|66206116|FG000|Overall Study|Withdrawal by Subject|17|||
23679371|NCT02908880|66206116|FG000|Overall Study|Death|5|||
23679372|NCT00132041|66206117|FG000|Baseline|Ineligible|6|||
23679373|NCT00132041|66206117|FG000|3 Months Post Ablation|Transplant|1|||
23679374|NCT00132041|66206117|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
23679375|NCT00132041|66206117|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
23679376|NCT00132041|66206117|FG000|6 Months Post Ablation|Death|2|||
23679377|NCT00132041|66206117|FG000|6 Months Post Ablation|Transplant|6|||
23679378|NCT00132041|66206117|FG000|9 Months Post Ablation|Death|1|||
23679379|NCT00132041|66206117|FG000|9 Months Post Ablation|Transplant|1|||
23679380|NCT00132041|66206117|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
23679381|NCT00132041|66206117|FG000|12 Months Post Ablation|Death|1|||
23679382|NCT00132041|66206117|FG000|12 Months Post Ablation|Transplant|1|||
23679383|NCT00132041|66206117|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
23679384|NCT00132041|66206117|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
23679385|NCT00132041|66206117|FG000|15 Months Post Ablation|Death|1|||
23679386|NCT00132041|66206117|FG000|15 Months Post Ablation|Transplant|5|||
23679387|NCT00132041|66206117|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
23679388|NCT00132041|66206117|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
23679389|NCT00132041|66206117|FG000|18 Months Post Ablation|Transplant|1|||
23679390|NCT00132041|66206117|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
23679391|NCT00132041|66206117|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
23679392|NCT00643994|66206120|FG000|Overall Study|Death|24|||
23679393|NCT00643994|66206120|FG000|Overall Study|Lost to Follow-up|72|||
23679394|NCT00661271|66206125|FG000|Overall Study|Lost to Follow-up|28|||
23679395|NCT00661271|66206126|FG001|Overall Study|Lost to Follow-up|25|||
23679396|NCT01761266|66206129|FG000|Overall Study|Death|415|||
23679397|NCT01761266|66206130|FG001|Overall Study|Death|402|||
23679398|NCT01761266|66206129|FG000|Overall Study|Lost to Follow-up|8|||
23679399|NCT01761266|66206130|FG001|Overall Study|Lost to Follow-up|12|||
23679400|NCT01761266|66206129|FG000|Overall Study|Withdrawal by Subject|14|||
23679401|NCT01761266|66206130|FG001|Overall Study|Withdrawal by Subject|10|||
23679402|NCT01761266|66206129|FG000|Overall Study|Sponsor Decision|41|||
23679403|NCT01761266|66206130|FG001|Overall Study|Sponsor Decision|52|||
23679404|NCT00197054|66206131|FG000|Overall Study|Withdrawal by Subject|9|||
23679405|NCT00197054|66206132|FG001|Overall Study|Withdrawal by Subject|3|||
23679406|NCT00197054|66206133|FG002|Overall Study|Withdrawal by Subject|3|||
23679407|NCT00197054|66206131|FG000|Overall Study|Moved from area|7|||
23679408|NCT00197054|66206132|FG001|Overall Study|Moved from area|14|||
23679409|NCT00197054|66206133|FG002|Overall Study|Moved from area|9|||
23679410|NCT00197054|66206131|FG000|Overall Study|Lost to Follow-up|1|||
23679411|NCT00197054|66206132|FG001|Overall Study|Lost to Follow-up|4|||
23679412|NCT00197054|66206133|FG002|Overall Study|Lost to Follow-up|0|||
23679413|NCT00865020|66206134|FG000|Overall Study|Withdrawal by Subject|22|||
23679414|NCT00865020|66206135|FG001|Overall Study|Withdrawal by Subject|16|||
23679415|NCT00865020|66206134|FG000|Overall Study|Adverse Event|9|||
23679416|NCT00865020|66206135|FG001|Overall Study|Adverse Event|14|||
23679417|NCT00865020|66206134|FG000|Overall Study|Abnormal test procedure result(s)|6|||
23679418|NCT00865020|66206135|FG001|Overall Study|Abnormal test procedure result(s)|8|||
23679419|NCT00865020|66206134|FG000|Overall Study|Lost to Follow-up|6|||
23679420|NCT00865020|66206135|FG001|Overall Study|Lost to Follow-up|4|||
23679421|NCT00865020|66206134|FG000|Overall Study|Protocol deviation|4|||
23679422|NCT00865020|66206135|FG001|Overall Study|Protocol deviation|1|||
23679423|NCT00865020|66206134|FG000|Overall Study|Administrative problems|0|||
23679424|NCT00865020|66206135|FG001|Overall Study|Administrative problems|2|||
23679425|NCT00865020|66206134|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23679426|NCT00865020|66206135|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23679427|NCT00865020|66206134|FG000|Overall Study|Death|0|||
23679428|NCT00865020|66206135|FG001|Overall Study|Death|1|||
23679429|NCT00865020|66206134|FG000|Overall Study|Randomized but discontinued|2|||
23679430|NCT00865020|66206135|FG001|Overall Study|Randomized but discontinued|4|||
23679431|NCT04823949|66206139|FG000|Overall Study|Withdrawal by Subject|0|||
23679432|NCT04823949|66206140|FG001|Overall Study|Withdrawal by Subject|4|||
23679433|NCT04823949|66206139|FG000|Overall Study|Physician Decision|0|||
23679434|NCT04823949|66206140|FG001|Overall Study|Physician Decision|1|||
23679435|NCT00756938|66206145|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
23679436|NCT00756938|66206146|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
23679437|NCT00756938|66206147|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
23679438|NCT00756938|66206148|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
23679439|NCT00756938|66206145|FG000|12-week Base Study|Protocol Violation|0|||
23679440|NCT00756938|66206146|FG001|12-week Base Study|Protocol Violation|0|||
23679441|NCT00756938|66206147|FG002|12-week Base Study|Protocol Violation|1|||
23679442|NCT00756938|66206148|FG003|12-week Base Study|Protocol Violation|0|||
23679443|NCT00756938|66206145|FG000|12-week Base Study|Lost to Follow-up|1|||
23679444|NCT00756938|66206146|FG001|12-week Base Study|Lost to Follow-up|0|||
23679445|NCT00756938|66206147|FG002|12-week Base Study|Lost to Follow-up|0|||
23679446|NCT00756938|66206148|FG003|12-week Base Study|Lost to Follow-up|0|||
23679447|NCT00756938|66206145|FG000|Optional Extension|Lack of Efficacy|0|||
23679448|NCT00756938|66206146|FG001|Optional Extension|Lack of Efficacy|0|||
23679449|NCT00756938|66206147|FG002|Optional Extension|Lack of Efficacy|0|||
23679450|NCT00756938|66206148|FG003|Optional Extension|Lack of Efficacy|1|||
23679451|NCT00756938|66206145|FG000|Optional Extension|End of Study|0|||
23679452|NCT00756938|66206146|FG001|Optional Extension|End of Study|0|||
23679453|NCT00756938|66206147|FG002|Optional Extension|End of Study|0|||
23679454|NCT00756938|66206148|FG003|Optional Extension|End of Study|11|||
23679455|NCT00756938|66206145|FG000|Optional Extension|Protocol-specific criteria met|0|||
23679456|NCT00756938|66206146|FG001|Optional Extension|Protocol-specific criteria met|0|||
23679457|NCT00756938|66206147|FG002|Optional Extension|Protocol-specific criteria met|0|||
23679458|NCT00756938|66206148|FG003|Optional Extension|Protocol-specific criteria met|9|||
23679459|NCT00756938|66206145|FG000|Optional Extension|Physician Decision|0|||
23679460|NCT00756938|66206146|FG001|Optional Extension|Physician Decision|0|||
23679461|NCT00756938|66206147|FG002|Optional Extension|Physician Decision|0|||
23679462|NCT00756938|66206148|FG003|Optional Extension|Physician Decision|3|||
23679463|NCT00756938|66206145|FG000|Optional Extension|Lost to Follow-up|0|||
23679464|NCT00756938|66206146|FG001|Optional Extension|Lost to Follow-up|0|||
23679465|NCT00756938|66206147|FG002|Optional Extension|Lost to Follow-up|0|||
23679466|NCT00756938|66206148|FG003|Optional Extension|Lost to Follow-up|1|||
23679467|NCT00756938|66206145|FG000|Optional Extension|Protocol Violation|0|||
23679468|NCT00756938|66206146|FG001|Optional Extension|Protocol Violation|0|||
23679469|NCT00756938|66206147|FG002|Optional Extension|Protocol Violation|0|||
23679470|NCT00756938|66206148|FG003|Optional Extension|Protocol Violation|1|||
23679471|NCT00756938|66206145|FG000|Optional Extension|Withdrawal by Subject|0|||
23679472|NCT00756938|66206146|FG001|Optional Extension|Withdrawal by Subject|0|||
23679473|NCT00756938|66206147|FG002|Optional Extension|Withdrawal by Subject|0|||
23679474|NCT00756938|66206148|FG003|Optional Extension|Withdrawal by Subject|10|||
23679475|NCT00756938|66206145|FG000|Optional Extension|Adverse Event|0|||
23679476|NCT00756938|66206146|FG001|Optional Extension|Adverse Event|0|||
23679477|NCT00756938|66206147|FG002|Optional Extension|Adverse Event|0|||
23679478|NCT00756938|66206148|FG003|Optional Extension|Adverse Event|1|||
23679479|NCT01613326|66206149|FG000|Overall Study|Adverse Event|7|||
23679480|NCT01613326|66206150|FG001|Overall Study|Adverse Event|5|||
23679481|NCT01613326|66206149|FG000|Overall Study|Withdrawal by Subject|3|||
23679482|NCT01613326|66206150|FG001|Overall Study|Withdrawal by Subject|4|||
23679483|NCT01613326|66206149|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23679484|NCT01613326|66206150|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23679485|NCT01613326|66206149|FG000|Overall Study|inability to use device|1|||
23679486|NCT01613326|66206150|FG001|Overall Study|inability to use device|0|||
23679487|NCT01613326|66206149|FG000|Overall Study|Lack of Efficacy|0|||
23679488|NCT01613326|66206150|FG001|Overall Study|Lack of Efficacy|1|||
23679489|NCT01613326|66206149|FG000|Overall Study|Lost to Follow-up|0|||
23679490|NCT01613326|66206150|FG001|Overall Study|Lost to Follow-up|1|||
23679491|NCT01613326|66206149|FG000|Overall Study|Administrative|0|||
23679492|NCT01613326|66206150|FG001|Overall Study|Administrative|2|||
23679493|NCT01613326|66206149|FG000|Overall Study|Protocol Violation|0|||
23679494|NCT01613326|66206150|FG001|Overall Study|Protocol Violation|1|||
23679495|NCT00379795|66206151|FG000|Overall Study|Death|31|||
23679496|NCT00379795|66206152|FG001|Overall Study|Death|8|||
23679497|NCT00379795|66206153|FG002|Overall Study|Death|6|||
23679498|NCT00379795|66206154|FG003|Overall Study|Death|4|||
23679499|NCT00379795|66206155|FG004|Overall Study|Death|7|||
23679500|NCT00379795|66206151|FG000|Overall Study|Adverse Event|17|||
23679501|NCT00379795|66206152|FG001|Overall Study|Adverse Event|3|||
23679502|NCT00379795|66206153|FG002|Overall Study|Adverse Event|3|||
23679503|NCT00379795|66206154|FG003|Overall Study|Adverse Event|1|||
23679504|NCT00379795|66206155|FG004|Overall Study|Adverse Event|4|||
23679505|NCT00379795|66206151|FG000|Overall Study|Lost to Follow-up|8|||
23679506|NCT00379795|66206152|FG001|Overall Study|Lost to Follow-up|1|||
23679507|NCT00379795|66206153|FG002|Overall Study|Lost to Follow-up|2|||
23679508|NCT00379795|66206154|FG003|Overall Study|Lost to Follow-up|1|||
23679509|NCT00379795|66206155|FG004|Overall Study|Lost to Follow-up|4|||
23679510|NCT00379795|66206151|FG000|Overall Study|Physician Decision|25|||
23679511|NCT00379795|66206152|FG001|Overall Study|Physician Decision|0|||
23679512|NCT00379795|66206153|FG002|Overall Study|Physician Decision|2|||
23679513|NCT00379795|66206154|FG003|Overall Study|Physician Decision|2|||
23679514|NCT00379795|66206155|FG004|Overall Study|Physician Decision|2|||
23679515|NCT00379795|66206151|FG000|Overall Study|Withdrawal by Subject|94|||
23679516|NCT00379795|66206152|FG001|Overall Study|Withdrawal by Subject|11|||
23679517|NCT00379795|66206153|FG002|Overall Study|Withdrawal by Subject|19|||
23679518|NCT00379795|66206154|FG003|Overall Study|Withdrawal by Subject|7|||
23679519|NCT00379795|66206155|FG004|Overall Study|Withdrawal by Subject|14|||
23679520|NCT00379795|66206151|FG000|Overall Study|Subject non-compliance|7|||
23679521|NCT00379795|66206152|FG001|Overall Study|Subject non-compliance|2|||
23679522|NCT00379795|66206153|FG002|Overall Study|Subject non-compliance|0|||
23679523|NCT00379795|66206154|FG003|Overall Study|Subject non-compliance|0|||
23679524|NCT00379795|66206155|FG004|Overall Study|Subject non-compliance|1|||
23679525|NCT00379795|66206151|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
23679526|NCT00379795|66206152|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23679527|NCT00379795|66206153|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23679528|NCT00379795|66206154|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
23679529|NCT00379795|66206155|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23679530|NCT00379795|66206151|FG000|Overall Study|Subjects condition mandated intervention|34|||
23679531|NCT00379795|66206152|FG001|Overall Study|Subjects condition mandated intervention|9|||
23679532|NCT00379795|66206153|FG002|Overall Study|Subjects condition mandated intervention|7|||
23679533|NCT00379795|66206154|FG003|Overall Study|Subjects condition mandated intervention|5|||
23679534|NCT00379795|66206155|FG004|Overall Study|Subjects condition mandated intervention|7|||
23679535|NCT00379795|66206151|FG000|Overall Study|Sponsor's decision|257|||
23679536|NCT00379795|66206152|FG001|Overall Study|Sponsor's decision|17|||
23679537|NCT00379795|66206153|FG002|Overall Study|Sponsor's decision|54|||
23679538|NCT00379795|66206154|FG003|Overall Study|Sponsor's decision|47|||
23679539|NCT00379795|66206155|FG004|Overall Study|Sponsor's decision|10|||
23679540|NCT01791855|66206156|FG000|Overall Study|Adverse Event|0|||
23606114|NCT00614614|65947152|FG004|Booster Vaccination Phase|Adverse Event|0|||
23606115|NCT00614614|65947148|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
23606116|NCT00614614|65947149|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23606117|NCT00614614|65947150|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
23606118|NCT00614614|65947151|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
23606119|NCT00614614|65947152|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
23606120|NCT00614614|65947148|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
23606121|NCT00614614|65947149|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
23606122|NCT00614614|65947150|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
23606123|NCT00614614|65947151|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
23679541|NCT01791855|66206157|FG001|Overall Study|Adverse Event|0|||
23606124|NCT00614614|65947152|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
23606125|NCT00614614|65947148|FG000|Booster Vaccination Phase|Protocol Violation|0|||
23606126|NCT00614614|65947149|FG001|Booster Vaccination Phase|Protocol Violation|0|||
23606127|NCT00614614|65947150|FG002|Booster Vaccination Phase|Protocol Violation|2|||
23679542|NCT01791855|66206158|FG002|Overall Study|Adverse Event|0|||
23679543|NCT01791855|66206159|FG003|Overall Study|Adverse Event|1|||
23679544|NCT01791855|66206156|FG000|Overall Study|Randomized, not treated|0|||
23679545|NCT01791855|66206157|FG001|Overall Study|Randomized, not treated|1|||
23679546|NCT01791855|66206158|FG002|Overall Study|Randomized, not treated|0|||
23679547|NCT01791855|66206159|FG003|Overall Study|Randomized, not treated|0|||
23679548|NCT02239263|66206165|FG000|Overall Study|Protocol Violation|6|||
23679549|NCT00234039|66206168|FG000|Overall Study|Adverse Event|2|||
23679550|NCT00234039|66206168|FG000|Overall Study|Progression/relapse|34|||
23679551|NCT00234039|66206168|FG000|Overall Study|Other - Not Protocol Specified|3|||
23679552|NCT00234039|66206168|FG000|Overall Study|Ineligible|9|||
23679553|NCT00234039|66206168|FG000|Overall Study|No Protocol Treatment Received|2|||
23679554|NCT05048719|66206169|FG000|Overall Study|Withdrawal by Subject|2|||
23679555|NCT05048719|66206170|FG001|Overall Study|Withdrawal by Subject|1|||
23679556|NCT05048719|66206171|FG002|Overall Study|Withdrawal by Subject|3|||
23679557|NCT05048719|66206172|FG003|Overall Study|Withdrawal by Subject|1|||
23679558|NCT05048719|66206173|FG004|Overall Study|Withdrawal by Subject|0|||
23679559|NCT05048719|66206174|FG005|Overall Study|Withdrawal by Subject|2|||
23679560|NCT05048719|66206175|FG006|Overall Study|Withdrawal by Subject|1|||
23679561|NCT05048719|66206176|FG007|Overall Study|Withdrawal by Subject|1|||
23679562|NCT05048719|66206177|FG008|Overall Study|Withdrawal by Subject|0|||
23679563|NCT05048719|66206169|FG000|Overall Study|Death|1|||
23679564|NCT05048719|66206170|FG001|Overall Study|Death|0|||
23679565|NCT05048719|66206171|FG002|Overall Study|Death|0|||
23679566|NCT05048719|66206172|FG003|Overall Study|Death|0|||
23679567|NCT05048719|66206173|FG004|Overall Study|Death|0|||
23388906|NCT01379937|65168848|FG002|Overall Study|Lost to Follow-up|2|||
23388907|NCT01379937|65168849|FG003|Overall Study|Lost to Follow-up|0|||
23388908|NCT01217047|65168852|FG000|Overall Study|Lost to Follow-up|0|||
23388909|NCT01217047|65168853|FG001|Overall Study|Lost to Follow-up|1|||
23388910|NCT01217047|65168854|FG002|Overall Study|Lost to Follow-up|0|||
23388911|NCT01796470|65168855|FG000|Overall Study|Adverse Event|4|||
23388912|NCT01796470|65168856|FG001|Overall Study|Adverse Event|2|||
23388913|NCT01796470|65168857|FG002|Overall Study|Adverse Event|2|||
23388914|NCT01796470|65168858|FG003|Overall Study|Adverse Event|1|||
23388915|NCT01796470|65168859|FG004|Overall Study|Adverse Event|3|||
23388916|NCT01796470|65168855|FG000|Overall Study|Death|2|||
23494835|NCT03307785|65554999|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
23494836|NCT03307785|65555000|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
23494837|NCT03307785|65555001|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
23494838|NCT03307785|65555002|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
23494839|NCT03307785|65555003|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
23494840|NCT03307785|65555004|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
23494841|NCT03307785|65555005|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
23494842|NCT03307785|65555006|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
23679568|NCT05048719|66206174|FG005|Overall Study|Death|0|||
23679569|NCT05048719|66206175|FG006|Overall Study|Death|0|||
23679570|NCT05048719|66206176|FG007|Overall Study|Death|0|||
23679571|NCT05048719|66206177|FG008|Overall Study|Death|0|||
23679572|NCT05048719|66206169|FG000|Overall Study|Adverse Event|0|||
23679573|NCT05048719|66206170|FG001|Overall Study|Adverse Event|1|||
23679574|NCT05048719|66206171|FG002|Overall Study|Adverse Event|2|||
23388917|NCT01796470|65168856|FG001|Overall Study|Death|0|||
23388918|NCT01796470|65168857|FG002|Overall Study|Death|0|||
23494843|NCT03307785|65555007|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
23679575|NCT05048719|66206172|FG003|Overall Study|Adverse Event|0|||
23679576|NCT05048719|66206173|FG004|Overall Study|Adverse Event|1|||
23679577|NCT05048719|66206174|FG005|Overall Study|Adverse Event|0|||
23679578|NCT05048719|66206175|FG006|Overall Study|Adverse Event|0|||
23679579|NCT05048719|66206176|FG007|Overall Study|Adverse Event|0|||
23679580|NCT05048719|66206177|FG008|Overall Study|Adverse Event|0|||
23679581|NCT05048719|66206169|FG000|Overall Study|Lost to Follow-up|0|||
23679582|NCT05048719|66206170|FG001|Overall Study|Lost to Follow-up|0|||
23679583|NCT05048719|66206171|FG002|Overall Study|Lost to Follow-up|1|||
23679584|NCT05048719|66206172|FG003|Overall Study|Lost to Follow-up|3|||
23679585|NCT05048719|66206173|FG004|Overall Study|Lost to Follow-up|1|||
23679586|NCT05048719|66206174|FG005|Overall Study|Lost to Follow-up|1|||
23679587|NCT05048719|66206175|FG006|Overall Study|Lost to Follow-up|1|||
23679588|NCT05048719|66206176|FG007|Overall Study|Lost to Follow-up|1|||
23388919|NCT01796470|65168858|FG003|Overall Study|Death|0|||
23388920|NCT01796470|65168859|FG004|Overall Study|Death|1|||
23679589|NCT05048719|66206177|FG008|Overall Study|Lost to Follow-up|0|||
23679590|NCT05048719|66206169|FG000|Overall Study|Physician Decision|0|||
23679591|NCT05048719|66206170|FG001|Overall Study|Physician Decision|0|||
23388921|NCT01796470|65168855|FG000|Overall Study|Initiated New Therapy|9|||
23388922|NCT01796470|65168856|FG001|Overall Study|Initiated New Therapy|0|||
23388923|NCT01796470|65168857|FG002|Overall Study|Initiated New Therapy|0|||
23494844|NCT03307785|65555008|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
23494845|NCT03307785|65555009|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
23494846|NCT03307785|65554999|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
23494847|NCT03307785|65555000|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
23494848|NCT03307785|65555001|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
23679592|NCT05048719|66206171|FG002|Overall Study|Physician Decision|0|||
23494849|NCT03307785|65555002|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
23494850|NCT03307785|65555003|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
23494851|NCT03307785|65555004|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
23494852|NCT03307785|65555005|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
23494853|NCT03307785|65555006|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
23679593|NCT05048719|66206172|FG003|Overall Study|Physician Decision|0|||
23679594|NCT05048719|66206173|FG004|Overall Study|Physician Decision|0|||
23679595|NCT05048719|66206174|FG005|Overall Study|Physician Decision|0|||
23679596|NCT05048719|66206175|FG006|Overall Study|Physician Decision|0|||
23679597|NCT05048719|66206176|FG007|Overall Study|Physician Decision|1|||
23679598|NCT05048719|66206177|FG008|Overall Study|Physician Decision|1|||
23679599|NCT05048719|66206169|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
23679600|NCT05048719|66206170|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679601|NCT05048719|66206171|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679602|NCT05048719|66206172|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679603|NCT05048719|66206173|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679604|NCT05048719|66206174|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679605|NCT05048719|66206175|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679606|NCT05048719|66206176|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679607|NCT05048719|66206177|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23679608|NCT05048719|66206169|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679609|NCT05048719|66206170|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
23679610|NCT05048719|66206171|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679611|NCT05048719|66206172|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679612|NCT05048719|66206173|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679613|NCT05048719|66206174|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679614|NCT05048719|66206175|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679615|NCT05048719|66206176|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679616|NCT05048719|66206177|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23679617|NCT05048719|66206169|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679618|NCT05048719|66206170|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
23679619|NCT05048719|66206171|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23388924|NCT01796470|65168858|FG003|Overall Study|Initiated New Therapy|0|||
23679620|NCT05048719|66206172|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679621|NCT05048719|66206173|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679622|NCT05048719|66206174|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679623|NCT05048719|66206175|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679624|NCT05048719|66206176|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679625|NCT05048719|66206177|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23679626|NCT05048719|66206169|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679627|NCT05048719|66206170|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679628|NCT05048719|66206171|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679629|NCT05048719|66206172|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
23679630|NCT05048719|66206173|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679631|NCT05048719|66206174|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679632|NCT05048719|66206175|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679633|NCT05048719|66206176|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679634|NCT05048719|66206177|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23679635|NCT05048719|66206169|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679636|NCT05048719|66206170|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679637|NCT05048719|66206171|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679638|NCT05048719|66206172|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679639|NCT05048719|66206173|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679640|NCT05048719|66206174|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
23679641|NCT05048719|66206175|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679642|NCT05048719|66206176|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679643|NCT05048719|66206177|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23679644|NCT02751931|66206178|FG000|Overall Study|Adverse Event|3|||
23679645|NCT02751931|66206179|FG001|Overall Study|Adverse Event|0|||
23679646|NCT02751931|66206178|FG000|Overall Study|Other: Miscelleneous|10|||
23679647|NCT02751931|66206179|FG001|Overall Study|Other: Miscelleneous|8|||
23679648|NCT01469000|66206180|FG000|Overall Study|Withdrawal by Subject|16|||
23679649|NCT01469000|66206181|FG001|Overall Study|Withdrawal by Subject|3|||
23679650|NCT01469000|66206180|FG000|Overall Study|Sponsor Decision|4|||
23679651|NCT01469000|66206181|FG001|Overall Study|Sponsor Decision|1|||
23388925|NCT01796470|65168859|FG004|Overall Study|Initiated New Therapy|2|||
23388926|NCT01796470|65168855|FG000|Overall Study|Lost to Follow-up|0|||
23679652|NCT00605085|66206184|FG000|Overall Study|Withdrawal by Subject|8|||
23679653|NCT00605085|66206185|FG001|Overall Study|Withdrawal by Subject|5|||
23679654|NCT00605085|66206184|FG000|Overall Study|Adverse Event|9|||
23679655|NCT00605085|66206185|FG001|Overall Study|Adverse Event|5|||
23388927|NCT01796470|65168856|FG001|Overall Study|Lost to Follow-up|1|||
23388928|NCT01796470|65168857|FG002|Overall Study|Lost to Follow-up|0|||
23388929|NCT01796470|65168858|FG003|Overall Study|Lost to Follow-up|0|||
23388930|NCT01796470|65168859|FG004|Overall Study|Lost to Follow-up|0|||
23679656|NCT00605085|66206184|FG000|Overall Study|Pregnancy|2|||
23679657|NCT00605085|66206185|FG001|Overall Study|Pregnancy|0|||
23679658|NCT00605085|66206184|FG000|Overall Study|Protocol Violation|3|||
23679659|NCT00605085|66206185|FG001|Overall Study|Protocol Violation|2|||
23679660|NCT00605085|66206184|FG000|Overall Study|Lost to Follow-up|10|||
23679661|NCT00605085|66206185|FG001|Overall Study|Lost to Follow-up|5|||
23679662|NCT00605085|66206184|FG000|Overall Study|administrative reasons|18|||
23679663|NCT00605085|66206185|FG001|Overall Study|administrative reasons|8|||
23679664|NCT02404103|66206186|FG000|Overall Study|Adverse Event|1|||
23679665|NCT02404103|66206187|FG001|Overall Study|Adverse Event|0|||
23679666|NCT02404103|66206186|FG000|Overall Study|Lost to Follow-up|3|||
23679667|NCT02404103|66206187|FG001|Overall Study|Lost to Follow-up|3|||
23679668|NCT01482910|66206188|FG000|Overall Study|Adverse Event|6|||
23679669|NCT01482910|66206189|FG001|Overall Study|Adverse Event|5|||
23679670|NCT01482910|66206188|FG000|Overall Study|Lost to Follow-up|0|||
23679671|NCT01482910|66206189|FG001|Overall Study|Lost to Follow-up|1|||
23679672|NCT01482910|66206188|FG000|Overall Study|Protocol Violation|1|||
23679673|NCT01482910|66206189|FG001|Overall Study|Protocol Violation|1|||
23679674|NCT01482910|66206188|FG000|Overall Study|Withdrawal by Subject|7|||
23679675|NCT01482910|66206189|FG001|Overall Study|Withdrawal by Subject|2|||
23679676|NCT01482910|66206188|FG000|Overall Study|Death|1|||
23679677|NCT01482910|66206189|FG001|Overall Study|Death|0|||
23679678|NCT01282229|66206190|FG000|Overall Study|Protocol Violation|2|||
23679679|NCT03118297|66206193|FG000|Overall Study|Lost to Follow-up|0|||
23679680|NCT03118297|66206194|FG001|Overall Study|Lost to Follow-up|2|||
23679681|NCT01015833|66206202|FG000|Overall Study|Death|1|||
23494854|NCT03307785|65555007|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
23494855|NCT03307785|65555008|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
23494856|NCT03307785|65555009|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
23494857|NCT04553679|65555010|FG000|Overall Study|Withdrawal by Subject|2|||
23494858|NCT04553679|65555011|FG001|Overall Study|Withdrawal by Subject|0|||
23494859|NCT04553679|65555010|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
23494860|NCT04553679|65555011|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
23494861|NCT02171065|65555012|FG000|Overall Study|Withdrawal by Subject|1|||
23494862|NCT02171065|65555013|FG001|Overall Study|Withdrawal by Subject|0|||
23494863|NCT02171065|65555014|FG002|Overall Study|Withdrawal by Subject|0|||
23494864|NCT02171065|65555012|FG000|Overall Study|Lost to Follow-up|0|||
23494865|NCT02171065|65555013|FG001|Overall Study|Lost to Follow-up|0|||
23494866|NCT02171065|65555014|FG002|Overall Study|Lost to Follow-up|1|||
23494867|NCT01890746|65555015|FG000|Overall Study|Death|39|||
23494868|NCT01890746|65555016|FG001|Overall Study|Death|30|||
23494869|NCT01890746|65555015|FG000|Overall Study|Adverse Event|1|||
23494870|NCT01890746|65555016|FG001|Overall Study|Adverse Event|0|||
23494871|NCT01890746|65555015|FG000|Overall Study|Lost to Follow-up|4|||
23494872|NCT01890746|65555016|FG001|Overall Study|Lost to Follow-up|1|||
23494873|NCT01890746|65555015|FG000|Overall Study|Physician Decision|3|||
23494874|NCT01890746|65555016|FG001|Overall Study|Physician Decision|2|||
23494875|NCT01890746|65555015|FG000|Overall Study|Withdrawal by Subject|5|||
23494876|NCT01890746|65555016|FG001|Overall Study|Withdrawal by Subject|8|||
23494877|NCT00085709|65555017|FG000|Overall Study|Adverse Event|8|||
23494878|NCT00085709|65555018|FG001|Overall Study|Adverse Event|0|||
23494879|NCT00085709|65555017|FG000|Overall Study|Death|8|||
23494880|NCT00085709|65555018|FG001|Overall Study|Death|2|||
23494881|NCT00085709|65555017|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23494882|NCT00085709|65555018|FG001|Overall Study|Refusal unrelated to adverse events|2|||
23494883|NCT00085709|65555017|FG000|Overall Study|Progression|3|||
23494884|NCT00085709|65555018|FG001|Overall Study|Progression|4|||
23494885|NCT00085709|65555017|FG000|Overall Study|Not protocol specified|12|||
23494886|NCT00085709|65555018|FG001|Overall Study|Not protocol specified|22|||
23679682|NCT01015833|66206203|FG001|Overall Study|Death|0|||
23679683|NCT01015833|66206202|FG000|Overall Study|Withdrawal by Subject|3|||
23679684|NCT01015833|66206203|FG001|Overall Study|Withdrawal by Subject|2|||
23679685|NCT01015833|66206202|FG000|Overall Study|Adverse Event|0|||
23679686|NCT01015833|66206203|FG001|Overall Study|Adverse Event|1|||
23679687|NCT01015833|66206202|FG000|Overall Study|Physician Decision|2|||
23679688|NCT01015833|66206203|FG001|Overall Study|Physician Decision|0|||
23679689|NCT01015833|66206202|FG000|Overall Study|Symptomatic deterioration|0|||
23679690|NCT01015833|66206203|FG001|Overall Study|Symptomatic deterioration|1|||
23679691|NCT01015833|66206202|FG000|Overall Study|Other|5|||
23679692|NCT01015833|66206203|FG001|Overall Study|Other|1|||
23679693|NCT01015833|66206202|FG000|Overall Study|Motor Vehicle Accidents|1|||
23679694|NCT01015833|66206203|FG001|Overall Study|Motor Vehicle Accidents|0|||
23679695|NCT01015833|66206202|FG000|Overall Study|Did not start treatment|1|||
23494887|NCT00085709|65555017|FG000|Overall Study|Not eligible|19|||
23494888|NCT00085709|65555018|FG001|Overall Study|Not eligible|19|||
23494889|NCT00085709|65555017|FG000|Overall Study|Withdrawal by Subject|2|||
23679696|NCT01015833|66206203|FG001|Overall Study|Did not start treatment|0|||
23494890|NCT00085709|65555018|FG001|Overall Study|Withdrawal by Subject|1|||
23494891|NCT00754065|65555020|FG000|Overall Study|Never received treatment|12|||
23679697|NCT01408147|66206204|FG000|Overall Study|Withdrawal by Subject|0|||
23388931|NCT01796470|65168855|FG000|Overall Study|Physician Decision|5|||
23388932|NCT01796470|65168856|FG001|Overall Study|Physician Decision|4|||
23388933|NCT01796470|65168857|FG002|Overall Study|Physician Decision|1|||
23388934|NCT01796470|65168858|FG003|Overall Study|Physician Decision|0|||
23388935|NCT01796470|65168859|FG004|Overall Study|Physician Decision|1|||
23388936|NCT01796470|65168855|FG000|Overall Study|Progressive Disease|7|||
23388937|NCT01796470|65168856|FG001|Overall Study|Progressive Disease|7|||
23388938|NCT01796470|65168857|FG002|Overall Study|Progressive Disease|3|||
23388939|NCT01796470|65168858|FG003|Overall Study|Progressive Disease|2|||
23388940|NCT01796470|65168859|FG004|Overall Study|Progressive Disease|0|||
23388941|NCT01796470|65168855|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
23388942|NCT01796470|65168856|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
23388943|NCT01796470|65168857|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
23388944|NCT01796470|65168858|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
23388945|NCT01796470|65168859|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
23388946|NCT01796470|65168855|FG000|Overall Study|Withdrawal by Subject|7|||
23388947|NCT01796470|65168856|FG001|Overall Study|Withdrawal by Subject|0|||
23388948|NCT01796470|65168857|FG002|Overall Study|Withdrawal by Subject|0|||
23388949|NCT01796470|65168858|FG003|Overall Study|Withdrawal by Subject|0|||
23388950|NCT01796470|65168859|FG004|Overall Study|Withdrawal by Subject|1|||
23388951|NCT01348490|65168860|FG000|Overall Study|Death|1|||
23388952|NCT01348490|65168860|FG000|Overall Study|Adverse Event|3|||
23388953|NCT01348490|65168860|FG000|Overall Study|Consent withdrawn|7|||
23388954|NCT01348490|65168860|FG000|Overall Study|Disease progression|3|||
23388955|NCT01348490|65168860|FG000|Overall Study|Lost to Follow-up|1|||
23388956|NCT01348490|65168860|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
23388957|NCT01348490|65168860|FG000|Overall Study|Other Unspecified|8|||
23388958|NCT02057666|65168861|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
23388959|NCT02057666|65168862|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
23388960|NCT02057666|65168861|FG000|Double Blind Treatment Period|Poor tolerability|7|||
23388961|NCT02057666|65168862|FG001|Double Blind Treatment Period|Poor tolerability|2|||
23388962|NCT02057666|65168861|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
23388963|NCT02057666|65168862|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
23388964|NCT02057666|65168861|FG000|Double Blind Treatment Period|Physician Decision|1|||
23388965|NCT02057666|65168862|FG001|Double Blind Treatment Period|Physician Decision|0|||
23388966|NCT02057666|65168861|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
23388967|NCT02057666|65168862|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
23388968|NCT02057666|65168861|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
23388969|NCT02057666|65168862|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
23388970|NCT02057666|65168861|FG000|Double Blind Treatment Period|Sponsor's request|70|||
23388971|NCT02057666|65168862|FG001|Double Blind Treatment Period|Sponsor's request|34|||
23388972|NCT02057666|65168861|FG000|Open-Label Treatment Period|Poor tolerability|0|||
23388973|NCT02057666|65168862|FG001|Open-Label Treatment Period|Poor tolerability|1|||
23388974|NCT02057666|65168861|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
23388975|NCT02057666|65168862|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
23388976|NCT02057666|65168861|FG000|Open-Label Treatment Period|Sponsor's request|0|||
23388977|NCT02057666|65168862|FG001|Open-Label Treatment Period|Sponsor's request|4|||
23388978|NCT01539525|65168865|FG000|Overall Study|Lost to Follow-up|19|||
23388979|NCT01539525|65168866|FG001|Overall Study|Lost to Follow-up|12|||
23679698|NCT01408147|66206205|FG001|Overall Study|Withdrawal by Subject|1|||
23679699|NCT00946309|66206206|FG000|Overall Study|Protocol Violation|1|||
23679700|NCT00946309|66206207|FG001|Overall Study|Protocol Violation|0|||
23679701|NCT00946309|66206206|FG000|Overall Study|Lost to Follow-up|0|||
23679702|NCT00946309|66206207|FG001|Overall Study|Lost to Follow-up|1|||
23679703|NCT00946309|66206206|FG000|Overall Study|Procedure cancelled/discontinued|0|||
23679704|NCT00946309|66206207|FG001|Overall Study|Procedure cancelled/discontinued|3|||
23679705|NCT03167073|66206211|FG000|Overall Study|Stillbirth|1|||
23679706|NCT03167073|66206212|FG001|Overall Study|Stillbirth|0|||
23679707|NCT03634800|66206213|FG000|Overall Study|Adverse Event|1|||
23679708|NCT03634800|66206213|FG000|Overall Study|Disease Progression|4|||
23679709|NCT03634800|66206213|FG000|Overall Study|Withdrawal by Subject|1|||
23679710|NCT03686969|66206214|FG000|Overall Study|Study terminated|1|||
23679711|NCT03686969|66206215|FG001|Overall Study|Study terminated|0|||
23679712|NCT01084551|66209916|FG000|Overall Study|Adverse Event|2|||
23679713|NCT01084551|66209917|FG001|Overall Study|Adverse Event|9|||
23679714|NCT01084551|66209918|FG002|Overall Study|Adverse Event|4|||
23679715|NCT01084551|66209916|FG000|Overall Study|Lack of Efficacy|2|||
23679716|NCT01084551|66209917|FG001|Overall Study|Lack of Efficacy|0|||
23679717|NCT01084551|66209918|FG002|Overall Study|Lack of Efficacy|1|||
23679718|NCT01084551|66209916|FG000|Overall Study|Withdrawal by Subject|2|||
23679719|NCT01084551|66209917|FG001|Overall Study|Withdrawal by Subject|1|||
23679720|NCT01084551|66209918|FG002|Overall Study|Withdrawal by Subject|0|||
23679721|NCT01084551|66209916|FG000|Overall Study|Protocol Violation|2|||
23679722|NCT01084551|66209917|FG001|Overall Study|Protocol Violation|4|||
23679723|NCT01084551|66209918|FG002|Overall Study|Protocol Violation|0|||
23679724|NCT01084551|66209916|FG000|Overall Study|Lost to Follow-up|0|||
23679725|NCT01084551|66209917|FG001|Overall Study|Lost to Follow-up|0|||
23679726|NCT01084551|66209918|FG002|Overall Study|Lost to Follow-up|3|||
23679727|NCT01084551|66209916|FG000|Overall Study|Physician Decision|1|||
23679728|NCT01084551|66209917|FG001|Overall Study|Physician Decision|0|||
23679729|NCT01084551|66209918|FG002|Overall Study|Physician Decision|0|||
23679730|NCT02675075|66209920|FG000|Overall Study|Lost to Follow-up|3|||
23679731|NCT02675075|66209921|FG001|Overall Study|Lost to Follow-up|0|||
23679732|NCT02322710|66209922|FG000|Overall Study|No efficacy assessment post-baseline|0|||
23679733|NCT02322710|66209923|FG001|Overall Study|No efficacy assessment post-baseline|1|||
23679734|NCT02322710|66209922|FG000|Overall Study|Protocol Violation|20|||
23679735|NCT02322710|66209923|FG001|Overall Study|Protocol Violation|25|||
23679736|NCT00560755|66209924|FG000|Overall Study|Protocol Violation|15|||
23679737|NCT00560755|66209924|FG000|Overall Study|Withdrawal by Subject|26|||
23679738|NCT00560755|66209924|FG000|Overall Study|Lost to Follow-up|9|||
23679739|NCT00560755|66209924|FG000|Overall Study|Adverse Event|8|||
23679740|NCT00560755|66209924|FG000|Overall Study|Physician Decision|2|||
23679741|NCT00809328|66209925|FG000|Overall Study|Lack of Efficacy|18|||
23679742|NCT00809328|66209925|FG000|Overall Study|Adverse Event|6|||
23679743|NCT00809328|66209925|FG000|Overall Study|Protocol Violation|3|||
23679744|NCT00809328|66209925|FG000|Overall Study|Withdrawal by Subject|2|||
23679745|NCT00491179|66209926|FG000|Overall Study|Adverse Event|5|||
23679746|NCT00491179|66209927|FG001|Overall Study|Adverse Event|1|||
23679747|NCT00491179|66209926|FG000|Overall Study|Withdrawal by Subject|2|||
23679748|NCT00491179|66209927|FG001|Overall Study|Withdrawal by Subject|1|||
23679749|NCT00802360|66209928|FG000|Overall Study|Stimulation failure|4|||
23679750|NCT00802360|66209929|FG001|Overall Study|Stimulation failure|0|||
23679751|NCT00802360|66209930|FG002|Overall Study|Stimulation failure|3|||
23679752|NCT00802360|66209931|FG003|Overall Study|Stimulation failure|3|||
23679753|NCT00802360|66209928|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
23679754|NCT00802360|66209929|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
23679755|NCT00802360|66209930|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
23679756|NCT00802360|66209931|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
23679757|NCT00802360|66209928|FG000|Overall Study|Cycle cancelled|0|||
23679758|NCT00802360|66209929|FG001|Overall Study|Cycle cancelled|1|||
23679759|NCT00802360|66209930|FG002|Overall Study|Cycle cancelled|1|||
23679760|NCT00802360|66209931|FG003|Overall Study|Cycle cancelled|1|||
23679761|NCT00802360|66209928|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23679762|NCT00802360|66209929|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23679763|NCT00802360|66209930|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23679764|NCT00802360|66209931|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
23679765|NCT00802360|66209928|FG000|Overall Study|No positive serum pregnancy|17|||
23679766|NCT00802360|66209929|FG001|Overall Study|No positive serum pregnancy|20|||
23679767|NCT00802360|66209930|FG002|Overall Study|No positive serum pregnancy|14|||
23679768|NCT00802360|66209931|FG003|Overall Study|No positive serum pregnancy|10|||
23388980|NCT01539525|65168867|FG002|Overall Study|Lost to Follow-up|11|||
23388981|NCT01539525|65168865|FG000|Overall Study|Withdrawal by Subject|0|||
23388982|NCT01539525|65168866|FG001|Overall Study|Withdrawal by Subject|3|||
23388983|NCT01539525|65168867|FG002|Overall Study|Withdrawal by Subject|2|||
23388984|NCT01539525|65168865|FG000|Overall Study|Protocol Violation|1|||
23388985|NCT01539525|65168866|FG001|Overall Study|Protocol Violation|1|||
23388986|NCT01539525|65168867|FG002|Overall Study|Protocol Violation|4|||
23388987|NCT02489045|65168869|FG000|Overall Study|unable to collect usable data|53|||
23388988|NCT02489045|65168869|FG000|Follow-up|Lost to Follow-up|10|||
23388989|NCT02766478|65168872|FG000|Overall Study|Withdrawal by Subject|1|||
23388990|NCT02766478|65168873|FG001|Overall Study|Withdrawal by Subject|1|||
23388991|NCT00912509|65168876|FG000|Overall Study|Lost to Follow-up|1|||
23388992|NCT00912509|65168877|FG001|Overall Study|Lost to Follow-up|0|||
23388993|NCT00912509|65168876|FG000|Overall Study|Lack of Efficacy|4|||
23388994|NCT00912509|65168877|FG001|Overall Study|Lack of Efficacy|3|||
23388995|NCT02365064|65168878|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
23388996|NCT02365064|65168879|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
23388997|NCT02365064|65168878|FG000|Overall Study|Withdrawal by Subject|6|||
23388998|NCT02365064|65168879|FG001|Overall Study|Withdrawal by Subject|9|||
23388999|NCT02365064|65168878|FG000|Overall Study|Treatment intolerance|2|||
23389000|NCT02365064|65168879|FG001|Overall Study|Treatment intolerance|4|||
23389001|NCT05122143|65168880|FG000|Overall Study|Adverse Event|1|||
23389002|NCT05122143|65168881|FG001|Overall Study|Adverse Event|0|||
23389003|NCT05122143|65168882|FG002|Overall Study|Adverse Event|0|||
23389004|NCT05122143|65168883|FG003|Overall Study|Adverse Event|0|||
23389005|NCT05122143|65168884|FG004|Overall Study|Adverse Event|1|||
23389006|NCT05122143|65168885|FG005|Overall Study|Adverse Event|0|||
23389007|NCT05122143|65168880|FG000|Overall Study|Protocol non-compliance|0|||
23389008|NCT05122143|65168881|FG001|Overall Study|Protocol non-compliance|0|||
23389009|NCT05122143|65168882|FG002|Overall Study|Protocol non-compliance|1|||
23679769|NCT00802360|66209928|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23679770|NCT00802360|66209929|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23679771|NCT00802360|66209930|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23679772|NCT00802360|66209931|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23679773|NCT00802360|66209928|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
23679774|NCT00802360|66209929|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
23679775|NCT00802360|66209930|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
23679776|NCT00802360|66209931|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
23679777|NCT00802360|66209928|FG000|Overall Study|Other|2|||
23679778|NCT00802360|66209929|FG001|Overall Study|Other|3|||
23679779|NCT00802360|66209930|FG002|Overall Study|Other|6|||
23679780|NCT00802360|66209931|FG003|Overall Study|Other|3|||
23679781|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
23679782|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
23679783|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
23679784|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
23679785|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
23679786|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
23679787|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
23679788|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
23679789|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
23679790|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
23679791|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
23679792|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
23679793|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23679794|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23679795|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23679796|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
23679797|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
23679798|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
23679799|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
23679800|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
23679801|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
23679802|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
23679803|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
23679804|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
23389010|NCT05122143|65168883|FG003|Overall Study|Protocol non-compliance|0|||
23389011|NCT05122143|65168884|FG004|Overall Study|Protocol non-compliance|0|||
23389012|NCT05122143|65168885|FG005|Overall Study|Protocol non-compliance|0|||
23389013|NCT05122143|65168880|FG000|Overall Study|Covid contact|0|||
23389014|NCT05122143|65168881|FG001|Overall Study|Covid contact|0|||
23389015|NCT05122143|65168882|FG002|Overall Study|Covid contact|0|||
23389016|NCT05122143|65168883|FG003|Overall Study|Covid contact|0|||
23679805|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Death|2|||
23679806|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Death|1|||
23679807|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Death|2|||
23679808|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Graft loss|0|||
23679809|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Graft loss|2|||
23679810|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Graft loss|0|||
23679811|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
23679812|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
23679813|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
23679814|NCT01114529|66209932|FG000|Completed Study Medication at Month 24|Missing|2|||
23679815|NCT01114529|66209933|FG001|Completed Study Medication at Month 24|Missing|0|||
23679816|NCT01114529|66209934|FG002|Completed Study Medication at Month 24|Missing|0|||
23679817|NCT01114529|66209932|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
23679818|NCT01114529|66209933|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
23679819|NCT01114529|66209934|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
23679820|NCT01114529|66209932|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
23389017|NCT05122143|65168884|FG004|Overall Study|Covid contact|1|||
23679821|NCT01114529|66209933|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
23679822|NCT01114529|66209934|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
23679823|NCT01114529|66209932|FG000|Completed Study Phase at Month 24|Death|8|||
23679824|NCT01114529|66209933|FG001|Completed Study Phase at Month 24|Death|5|||
23679825|NCT01114529|66209934|FG002|Completed Study Phase at Month 24|Death|4|||
23389018|NCT05122143|65168885|FG005|Overall Study|Covid contact|0|||
23679826|NCT01114529|66209932|FG000|Completed Study Phase at Month 24|Other|2|||
23679827|NCT01114529|66209933|FG001|Completed Study Phase at Month 24|Other|0|||
23679828|NCT01114529|66209934|FG002|Completed Study Phase at Month 24|Other|0|||
23679829|NCT01114529|66209932|FG000|Completed Study Phase at Month 24|Missing|2|||
23679830|NCT01114529|66209933|FG001|Completed Study Phase at Month 24|Missing|0|||
23679831|NCT01114529|66209934|FG002|Completed Study Phase at Month 24|Missing|0|||
23679832|NCT00769119|66209938|FG000|Overall Study|Voluntary discontinuation|0|||
23679833|NCT00769119|66209939|FG001|Overall Study|Voluntary discontinuation|2|||
23679834|NCT00769119|66209938|FG000|Overall Study|Adverse Event|1|||
23679835|NCT00769119|66209939|FG001|Overall Study|Adverse Event|1|||
23679836|NCT00769119|66209938|FG000|Overall Study|Disallowed medication|1|||
23679837|NCT00769119|66209939|FG001|Overall Study|Disallowed medication|0|||
23679838|NCT04162210|66209940|FG000|Overall Study|Lost to Follow-up|4|||
23679839|NCT04162210|66209941|FG001|Overall Study|Lost to Follow-up|1|||
23679840|NCT04162210|66209940|FG000|Overall Study|Withdrawal by Subject|17|||
23679841|NCT04162210|66209941|FG001|Overall Study|Withdrawal by Subject|9|||
23679842|NCT04162210|66209940|FG000|Overall Study|Ongoing|113|||
23679843|NCT04162210|66209941|FG001|Overall Study|Ongoing|59|||
23679844|NCT02723201|66209945|FG000|Second Intervention Period|Protocol Violation|1|||
23679845|NCT02723201|66209946|FG001|Second Intervention Period|Protocol Violation|0|||
23679846|NCT02723201|66209947|FG002|Second Intervention Period|Protocol Violation|0|||
23679847|NCT02723201|66209945|FG000|Second Intervention Period|Adverse Event|1|||
23679848|NCT02723201|66209946|FG001|Second Intervention Period|Adverse Event|0|||
23679849|NCT02723201|66209947|FG002|Second Intervention Period|Adverse Event|0|||
23679850|NCT03433781|66209948|FG000|Overall Study|Progression of Disease|1|||
23679851|NCT03433781|66209949|FG001|Overall Study|Progression of Disease|0|||
23679852|NCT03433781|66209950|FG002|Overall Study|Progression of Disease|0|||
23679853|NCT03433781|66209948|FG000|Overall Study|Physician Decision|0|||
23679854|NCT03433781|66209949|FG001|Overall Study|Physician Decision|1|||
23679855|NCT03433781|66209950|FG002|Overall Study|Physician Decision|0|||
23679856|NCT03430986|66209951|FG000|24-week Control Period|Adverse Event|1|||
23679857|NCT03430986|66209952|FG001|24-week Control Period|Adverse Event|0|||
23679858|NCT03430986|66209951|FG000|24-week Control Period|Lost to Follow-up|2|||
23679859|NCT03430986|66209952|FG001|24-week Control Period|Lost to Follow-up|2|||
23679860|NCT03430986|66209951|FG000|24-week Control Period|Withdrawal by Participant|5|||
23679861|NCT03430986|66209952|FG001|24-week Control Period|Withdrawal by Participant|0|||
23679862|NCT03430986|66209951|FG000|24-week Control Period|Protocol Deviation|0|||
23679863|NCT03430986|66209952|FG001|24-week Control Period|Protocol Deviation|2|||
23679864|NCT03430986|66209951|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
23679865|NCT03430986|66209952|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
23679866|NCT03430986|66209951|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
23679867|NCT03430986|66209952|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
23679868|NCT02354703|66209956|FG000|Overall Study|Withdrawal by Subject|1|||
23679869|NCT02354703|66209957|FG001|Overall Study|Withdrawal by Subject|1|||
23679870|NCT02354703|66209958|FG002|Overall Study|Withdrawal by Subject|1|||
23679871|NCT02354703|66209959|FG003|Overall Study|Withdrawal by Subject|1|||
23679872|NCT02354703|66209956|FG000|Overall Study|Lost to Follow-up|2|||
23679873|NCT02354703|66209957|FG001|Overall Study|Lost to Follow-up|7|||
23679874|NCT02354703|66209958|FG002|Overall Study|Lost to Follow-up|9|||
23679875|NCT02354703|66209959|FG003|Overall Study|Lost to Follow-up|2|||
23679876|NCT02354703|66209956|FG000|Overall Study|Adverse Event|0|||
23679877|NCT02354703|66209957|FG001|Overall Study|Adverse Event|0|||
23679878|NCT02354703|66209958|FG002|Overall Study|Adverse Event|1|||
23679879|NCT02354703|66209959|FG003|Overall Study|Adverse Event|0|||
23679880|NCT02809833|66209967|FG000|Overall Study|Death|3|||
23679881|NCT02809833|66209967|FG000|Overall Study|Intolerance|54|||
23679882|NCT02809833|66209967|FG000|Overall Study|Lack of Efficacy|89|||
23679883|NCT02809833|66209967|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
23679884|NCT02809833|66209967|FG000|Overall Study|Noncompliance|1|||
23679885|NCT02809833|66209967|FG000|Overall Study|Withdrawal by Subject|34|||
23679886|NCT02809833|66209967|FG000|Overall Study|Lost to Follow-up|35|||
23679887|NCT02809833|66209967|FG000|Overall Study|Adverse Event (AE)|24|||
23679888|NCT02809833|66209967|FG000|Overall Study|Other|5|||
23679889|NCT02809833|66209967|FG000|Overall Study|Missing Information|52|||
23679890|NCT03609619|66209968|FG000|Overall Study|Adverse Event|1|||
23679891|NCT03609619|66209969|FG001|Overall Study|Adverse Event|0|||
23679892|NCT03609619|66209968|FG000|Overall Study|Lack of Efficacy|1|||
23679893|NCT03609619|66209969|FG001|Overall Study|Lack of Efficacy|2|||
23679894|NCT03609619|66209968|FG000|Overall Study|Protocol Violation|5|||
23679895|NCT03609619|66209969|FG001|Overall Study|Protocol Violation|0|||
23679896|NCT03609619|66209968|FG000|Overall Study|Withdrawal by Subject|2|||
23679897|NCT03609619|66209969|FG001|Overall Study|Withdrawal by Subject|3|||
23679898|NCT03609619|66209968|FG000|Overall Study|Lost to Follow-up|1|||
23679899|NCT03609619|66209969|FG001|Overall Study|Lost to Follow-up|1|||
23679900|NCT01671345|66209971|FG000|Overall Study|Lost to Follow-up|10|||
23679901|NCT01671345|66209972|FG001|Overall Study|Lost to Follow-up|6|||
23679902|NCT01671345|66209971|FG000|Overall Study|visit with non-participating physician|3|||
23679903|NCT01671345|66209972|FG001|Overall Study|visit with non-participating physician|3|||
23679904|NCT02769624|66209973|FG000|Overall Study|Lost to Follow-up|0|||
23389019|NCT02451007|65168887|FG000|Overall Study|Withdrawal by Subject|4|||
23389020|NCT02451007|65168887|FG000|Overall Study|Adverse Event|1|||
23389021|NCT02451007|65168887|FG000|Overall Study|Disease Progression|2|||
23389022|NCT00803049|65168889|FG000|Overall Study|Adverse Event|21|||
23389023|NCT00803049|65168890|FG001|Overall Study|Adverse Event|33|||
23389024|NCT00803049|65168891|FG002|Overall Study|Adverse Event|13|||
23389025|NCT00803049|65168892|FG003|Overall Study|Adverse Event|27|||
23389026|NCT00803049|65168889|FG000|Overall Study|Lack of Efficacy|10|||
23389027|NCT00803049|65168890|FG001|Overall Study|Lack of Efficacy|19|||
23389028|NCT00803049|65168891|FG002|Overall Study|Lack of Efficacy|6|||
23389029|NCT00803049|65168892|FG003|Overall Study|Lack of Efficacy|13|||
23389030|NCT00803049|65168889|FG000|Overall Study|Lost to Follow-up|0|||
23389031|NCT00803049|65168890|FG001|Overall Study|Lost to Follow-up|2|||
23389032|NCT00803049|65168891|FG002|Overall Study|Lost to Follow-up|0|||
23389033|NCT00803049|65168892|FG003|Overall Study|Lost to Follow-up|3|||
23389034|NCT00803049|65168889|FG000|Overall Study|Death|2|||
23389035|NCT00803049|65168890|FG001|Overall Study|Death|1|||
23389036|NCT00803049|65168891|FG002|Overall Study|Death|0|||
23389037|NCT00803049|65168892|FG003|Overall Study|Death|2|||
23389038|NCT00803049|65168889|FG000|Overall Study|Progressive Disease|6|||
23389039|NCT00803049|65168890|FG001|Overall Study|Progressive Disease|10|||
23389040|NCT00803049|65168891|FG002|Overall Study|Progressive Disease|6|||
23389041|NCT00803049|65168892|FG003|Overall Study|Progressive Disease|6|||
23389042|NCT00803049|65168889|FG000|Overall Study|Withdrawal by Subject|19|||
23389043|NCT00803049|65168890|FG001|Overall Study|Withdrawal by Subject|43|||
23389044|NCT00803049|65168891|FG002|Overall Study|Withdrawal by Subject|16|||
23389045|NCT00803049|65168892|FG003|Overall Study|Withdrawal by Subject|44|||
23389046|NCT00803049|65168889|FG000|Overall Study|Protocol Violation|0|||
23389047|NCT00803049|65168890|FG001|Overall Study|Protocol Violation|1|||
23389048|NCT00803049|65168891|FG002|Overall Study|Protocol Violation|1|||
23389049|NCT00803049|65168892|FG003|Overall Study|Protocol Violation|0|||
23389050|NCT00803049|65168889|FG000|Overall Study|Randomized and Not Treated|0|||
23389051|NCT00803049|65168890|FG001|Overall Study|Randomized and Not Treated|0|||
23389052|NCT00803049|65168891|FG002|Overall Study|Randomized and Not Treated|0|||
23389053|NCT00803049|65168892|FG003|Overall Study|Randomized and Not Treated|2|||
23389054|NCT00803049|65168889|FG000|Overall Study|Other than Specified Above|3|||
23389055|NCT00803049|65168890|FG001|Overall Study|Other than Specified Above|9|||
23389056|NCT00803049|65168891|FG002|Overall Study|Other than Specified Above|2|||
23389057|NCT00803049|65168892|FG003|Overall Study|Other than Specified Above|5|||
23389058|NCT01093534|65168893|FG000|Overall Study|Adverse Event|2|||
23389059|NCT01093534|65168894|FG001|Overall Study|Adverse Event|5|||
23389060|NCT01093534|65168895|FG002|Overall Study|Adverse Event|2|||
23389061|NCT01093534|65168893|FG000|Overall Study|Lack of Efficacy|2|||
23389062|NCT01093534|65168894|FG001|Overall Study|Lack of Efficacy|1|||
23389063|NCT01093534|65168895|FG002|Overall Study|Lack of Efficacy|1|||
23389064|NCT01093534|65168893|FG000|Overall Study|Withdrawal by Subject|5|||
23389065|NCT01093534|65168894|FG001|Overall Study|Withdrawal by Subject|7|||
23389066|NCT01093534|65168895|FG002|Overall Study|Withdrawal by Subject|2|||
23389067|NCT01093534|65168893|FG000|Overall Study|Other|1|||
23389068|NCT01093534|65168894|FG001|Overall Study|Other|3|||
23389069|NCT01093534|65168895|FG002|Overall Study|Other|4|||
23389070|NCT03021005|65168902|FG000|Overall Study|Lost to Follow-up|39|||
23389071|NCT03021005|65168903|FG001|Overall Study|Lost to Follow-up|26|||
23389072|NCT02904265|65168904|FG000|Overall Study|Physician Decision|1|||
23389073|NCT02904265|65168905|FG001|Overall Study|Physician Decision|2|||
23389074|NCT02565186|65168913|FG000|Overall Study|Adverse Event|113|||
23389075|NCT02565186|65168914|FG001|Overall Study|Adverse Event|148|||
23389076|NCT02565186|65168913|FG000|Overall Study|Lost to Follow-up|102|||
23389077|NCT02565186|65168914|FG001|Overall Study|Lost to Follow-up|93|||
23389078|NCT02565186|65168913|FG000|Overall Study|Non-Compliance|57|||
23389079|NCT02565186|65168914|FG001|Overall Study|Non-Compliance|55|||
23389080|NCT02565186|65168913|FG000|Overall Study|Withdrawal by Subject|229|||
23389081|NCT02565186|65168914|FG001|Overall Study|Withdrawal by Subject|214|||
23389082|NCT02565186|65168913|FG000|Overall Study|Physician Decision|18|||
23494892|NCT00754065|65555021|FG001|Overall Study|Never received treatment|2|||
23389083|NCT02565186|65168914|FG001|Overall Study|Physician Decision|16|||
23389084|NCT02565186|65168913|FG000|Overall Study|Sponsor Request|5|||
23494893|NCT00754065|65555020|FG000|Overall Study|Adverse Event|19|||
23494894|NCT00754065|65555021|FG001|Overall Study|Adverse Event|25|||
23494895|NCT00754065|65555020|FG000|Overall Study|Lost to Follow-up|7|||
23494896|NCT00754065|65555021|FG001|Overall Study|Lost to Follow-up|11|||
23494897|NCT00754065|65555020|FG000|Overall Study|Protocol Violation|12|||
23494898|NCT00754065|65555021|FG001|Overall Study|Protocol Violation|10|||
23494899|NCT00754065|65555020|FG000|Overall Study|Withdrawal by Subject|4|||
23494900|NCT00754065|65555021|FG001|Overall Study|Withdrawal by Subject|5|||
23494901|NCT00754065|65555020|FG000|Overall Study|Pregnancy|6|||
23389085|NCT02565186|65168914|FG001|Overall Study|Sponsor Request|9|||
23389086|NCT02565186|65168913|FG000|Overall Study|Missing|1|||
23389087|NCT02565186|65168914|FG001|Overall Study|Missing|0|||
23389088|NCT02565186|65168913|FG000|Overall Study|Did Not Receive Study Drug|55|||
23389089|NCT02565186|65168914|FG001|Overall Study|Did Not Receive Study Drug|86|||
23389090|NCT00421408|65168917|FG000|Overall Study|Lost to Follow-up|30|||
23389091|NCT00421408|65168918|FG001|Overall Study|Lost to Follow-up|20|||
23389092|NCT00421408|65168917|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
23389093|NCT00421408|65168918|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
23389094|NCT01034657|65168921|FG000|Core Phase|Withdrawal by Subject|1|||
23389095|NCT01034657|65168922|FG001|Core Phase|Withdrawal by Subject|0|||
23389096|NCT01034657|65168923|FG002|Core Phase|Withdrawal by Subject|0|||
23389097|NCT01034657|65168921|FG000|Core Phase|Lack of Efficacy|2|||
23389098|NCT01034657|65168922|FG001|Core Phase|Lack of Efficacy|0|||
23389099|NCT01034657|65168923|FG002|Core Phase|Lack of Efficacy|0|||
23389100|NCT01034657|65168921|FG000|Core Phase|Abnormal laboratory value|1|||
23389101|NCT01034657|65168922|FG001|Core Phase|Abnormal laboratory value|0|||
23389102|NCT01034657|65168923|FG002|Core Phase|Abnormal laboratory value|0|||
23389103|NCT01034657|65168921|FG000|Core Phase|Adverse Event|8|||
23389104|NCT01034657|65168922|FG001|Core Phase|Adverse Event|0|||
23389105|NCT01034657|65168923|FG002|Core Phase|Adverse Event|0|||
23389106|NCT01034657|65168921|FG000|Core Phase|Protocol Violation|2|||
23389107|NCT01034657|65168922|FG001|Core Phase|Protocol Violation|0|||
23389108|NCT01034657|65168923|FG002|Core Phase|Protocol Violation|0|||
23389109|NCT01034657|65168921|FG000|Randomized Phase|Withdrawal by Subject|0|||
23389110|NCT01034657|65168922|FG001|Randomized Phase|Withdrawal by Subject|2|||
23389111|NCT01034657|65168923|FG002|Randomized Phase|Withdrawal by Subject|0|||
23389112|NCT01034657|65168921|FG000|Randomized Phase|Lack of Efficacy|5|||
23389113|NCT01034657|65168922|FG001|Randomized Phase|Lack of Efficacy|1|||
23389114|NCT01034657|65168923|FG002|Randomized Phase|Lack of Efficacy|0|||
23389115|NCT01034657|65168921|FG000|Randomized Phase|Abnormal laboratory value|0|||
23389116|NCT01034657|65168922|FG001|Randomized Phase|Abnormal laboratory value|1|||
23389117|NCT01034657|65168923|FG002|Randomized Phase|Abnormal laboratory value|0|||
23389118|NCT01034657|65168921|FG000|Randomized Phase|Adverse Event|0|||
23389119|NCT01034657|65168922|FG001|Randomized Phase|Adverse Event|2|||
23389120|NCT01034657|65168923|FG002|Randomized Phase|Adverse Event|1|||
23389121|NCT00432991|65168928|FG000|Overall Study|Protocol Violation|7|||
23389122|NCT00432991|65168929|FG001|Overall Study|Protocol Violation|12|||
23389123|NCT04691115|65168934|FG000|Overall Study|Withdrawal by Subject|0|||
23389124|NCT04691115|65168935|FG001|Overall Study|Withdrawal by Subject|0|||
23389125|NCT04691115|65168936|FG002|Overall Study|Withdrawal by Subject|0|||
23389126|NCT04691115|65168937|FG003|Overall Study|Withdrawal by Subject|0|||
23389127|NCT04691115|65168938|FG004|Overall Study|Withdrawal by Subject|0|||
23389128|NCT04691115|65168939|FG005|Overall Study|Withdrawal by Subject|1|||
23389129|NCT04691115|65168940|FG006|Overall Study|Withdrawal by Subject|0|||
23389130|NCT04691115|65168941|FG007|Overall Study|Withdrawal by Subject|0|||
23389131|NCT04691115|65168942|FG008|Overall Study|Withdrawal by Subject|0|||
23389132|NCT04691115|65168943|FG009|Overall Study|Withdrawal by Subject|0|||
23389133|NCT04691115|65168944|FG010|Overall Study|Withdrawal by Subject|0|||
23389134|NCT04691115|65168945|FG011|Overall Study|Withdrawal by Subject|0|||
23389135|NCT04691115|65168946|FG012|Overall Study|Withdrawal by Subject|0|||
23389136|NCT04691115|65168947|FG013|Overall Study|Withdrawal by Subject|0|||
23389137|NCT02412436|65168948|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
23389138|NCT02412436|65168948|FG000|Overall Study|Lost to Follow-up|6|||
23389139|NCT02412436|65168948|FG000|Overall Study|Unable to get to clinic|3|||
23389140|NCT02412436|65168948|FG000|Overall Study|Death|1|||
23389141|NCT02412436|65168948|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
23389142|NCT02852005|65168956|FG000|Overall Study|Lost to Follow-up|0|||
23389143|NCT02852005|65168957|FG001|Overall Study|Lost to Follow-up|0|||
23389144|NCT02852005|65168958|FG002|Overall Study|Lost to Follow-up|0|||
23389145|NCT02852005|65168959|FG003|Overall Study|Lost to Follow-up|0|||
23389146|NCT02852005|65168960|FG004|Overall Study|Lost to Follow-up|1|||
23389147|NCT02852005|65168956|FG000|Overall Study|Withdrawal by Subject|1|||
23389148|NCT02852005|65168957|FG001|Overall Study|Withdrawal by Subject|0|||
23389149|NCT02852005|65168958|FG002|Overall Study|Withdrawal by Subject|0|||
23389150|NCT02852005|65168959|FG003|Overall Study|Withdrawal by Subject|0|||
23389151|NCT02852005|65168960|FG004|Overall Study|Withdrawal by Subject|0|||
23389152|NCT00933166|65168961|FG000|Overall Study|Lost to Follow-up|4|||
23389153|NCT00933166|65168961|FG000|Overall Study|Lack of Efficacy|9|||
23389154|NCT00933166|65168961|FG000|Overall Study|Unavailable|4|||
23389155|NCT00933166|65168961|FG000|Overall Study|Withdrawal by Subject|1|||
23389156|NCT01848457|65168965|FG000|Overall Study|Death|1|||
23389157|NCT01848457|65168966|FG001|Overall Study|Death|0|||
23389158|NCT01848457|65168967|FG002|Overall Study|Death|0|||
23389159|NCT01848457|65168968|FG003|Overall Study|Death|0|||
23389160|NCT01682603|65168969|FG000|Overall Study|Lost to Follow-up|3|||
23389161|NCT02965456|65168973|FG000|Overall Study|Lost to Follow-up|40|||
23389162|NCT02965456|65168974|FG001|Overall Study|Lost to Follow-up|18|||
23389163|NCT02965456|65168973|FG000|Overall Study|Subject Request|22|||
23389164|NCT02965456|65168974|FG001|Overall Study|Subject Request|13|||
23389165|NCT02965456|65168973|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
23389166|NCT02965456|65168974|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
23679905|NCT02769624|66209974|FG001|Overall Study|Lost to Follow-up|1|||
23679906|NCT02117687|66209981|FG000|Overall Study|Lost to Follow-up|0|||
23679907|NCT02117687|66209982|FG001|Overall Study|Lost to Follow-up|1|||
23679908|NCT02117687|66209981|FG000|Overall Study|Adverse Event|0|||
23679909|NCT02117687|66209982|FG001|Overall Study|Adverse Event|2|||
23679910|NCT02117687|66209981|FG000|Overall Study|Other Reasons|1|||
23679911|NCT02117687|66209982|FG001|Overall Study|Other Reasons|1|||
23679912|NCT02292212|66209983|FG000|ViE Phase|Withdrawal by Subject|1|||
23679913|NCT02292212|66209983|FG000|ViE Phase|Protocol Violation|2|||
23679914|NCT00821678|66209991|FG000|Overall Study|Withdrawal by Subject|8|||
23679915|NCT00821678|66209992|FG001|Overall Study|Withdrawal by Subject|0|||
23679916|NCT00821678|66209991|FG000|Overall Study|Lost to Follow-up|13|||
23679917|NCT00821678|66209992|FG001|Overall Study|Lost to Follow-up|12|||
23679918|NCT00821678|66209991|FG000|Overall Study|Death|0|||
23679919|NCT00821678|66209992|FG001|Overall Study|Death|2|||
23679920|NCT01926626|66209996|FG000|Overall Study|Withdrawal by Subject|15|||
23679921|NCT01926626|66209996|FG000|Overall Study|Lost to Follow-up|7|||
23679922|NCT00647556|66209997|FG000|Overall Study|Adverse Event|0|||
23679923|NCT00647556|66209998|FG001|Overall Study|Adverse Event|1|||
23679924|NCT00647556|66209997|FG000|Overall Study|Lost to Follow-up|1|||
23679925|NCT00647556|66209998|FG001|Overall Study|Lost to Follow-up|0|||
23679926|NCT00647556|66209997|FG000|Overall Study|Protocol Violation|0|||
23679927|NCT00647556|66209998|FG001|Overall Study|Protocol Violation|1|||
23679928|NCT00647556|66209997|FG000|Overall Study|Withdrawal by Subject|1|||
23679929|NCT00647556|66209998|FG001|Overall Study|Withdrawal by Subject|0|||
23679930|NCT00647556|66209997|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
23679931|NCT00647556|66209998|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
23679932|NCT03313050|66209999|FG000|Stage 2: 12 Months|Adverse Event|0|||
23679933|NCT03313050|66210000|FG001|Stage 2: 12 Months|Adverse Event|0|||
23679934|NCT03313050|66210001|FG002|Stage 2: 12 Months|Adverse Event|0|||
23679935|NCT03313050|66210002|FG003|Stage 2: 12 Months|Adverse Event|1|||
23679936|NCT03313050|66209999|FG000|Stage 2: 12 Months|Death|0|||
23679937|NCT03313050|66210000|FG001|Stage 2: 12 Months|Death|0|||
23679938|NCT03313050|66210001|FG002|Stage 2: 12 Months|Death|3|||
23679939|NCT03313050|66210002|FG003|Stage 2: 12 Months|Death|0|||
23679940|NCT03313050|66209999|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
23679941|NCT03313050|66210000|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
23679942|NCT03313050|66210001|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
23679943|NCT03313050|66210002|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
23679944|NCT03313050|66209999|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23679945|NCT03313050|66210000|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23679946|NCT03313050|66210001|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23679947|NCT03313050|66210002|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
23679948|NCT03313050|66209999|FG000|Stage 2: 12 Months|Protocol deviation|0|||
23679949|NCT03313050|66210000|FG001|Stage 2: 12 Months|Protocol deviation|0|||
23679950|NCT03313050|66210001|FG002|Stage 2: 12 Months|Protocol deviation|7|||
23679951|NCT03313050|66210002|FG003|Stage 2: 12 Months|Protocol deviation|7|||
23679952|NCT03313050|66209999|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
23679953|NCT03313050|66210000|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
23679954|NCT03313050|66210001|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
23679955|NCT03313050|66210002|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
23679956|NCT03313050|66209999|FG000|Stage 2: 12 Months|Other|0|||
23679957|NCT03313050|66210000|FG001|Stage 2: 12 Months|Other|0|||
23679958|NCT03313050|66210001|FG002|Stage 2: 12 Months|Other|0|||
23679959|NCT03313050|66210002|FG003|Stage 2: 12 Months|Other|1|||
23679960|NCT02419508|66210006|FG000|Overall Study|Adverse Event|9|||
23679961|NCT02419508|66210007|FG001|Overall Study|Adverse Event|3|||
23679962|NCT02419508|66210006|FG000|Overall Study|Withdrawal by Subject|1|||
23679963|NCT02419508|66210007|FG001|Overall Study|Withdrawal by Subject|0|||
23679964|NCT02419508|66210006|FG000|Overall Study|Other - Reason not specified|0|||
23679965|NCT02419508|66210007|FG001|Overall Study|Other - Reason not specified|1|||
23679966|NCT01882907|66210013|FG000|Overall Study|Adverse Event|3|||
23679967|NCT01882907|66210014|FG001|Overall Study|Adverse Event|1|||
23679968|NCT01882907|66210013|FG000|Overall Study|Lack of Efficacy|0|||
23679969|NCT01882907|66210014|FG001|Overall Study|Lack of Efficacy|3|||
23679970|NCT01882907|66210013|FG000|Overall Study|Lost to Follow-up|1|||
23679971|NCT01882907|66210014|FG001|Overall Study|Lost to Follow-up|4|||
23679972|NCT01882907|66210013|FG000|Overall Study|Protocol Violation|10|||
23679973|NCT01882907|66210014|FG001|Overall Study|Protocol Violation|14|||
23679974|NCT01882907|66210013|FG000|Overall Study|Withdrawal by Subject|0|||
23679975|NCT01882907|66210014|FG001|Overall Study|Withdrawal by Subject|6|||
23679976|NCT01554579|66210015|FG000|Overall Study|Adverse Event|6|||
23679977|NCT01554579|66210016|FG001|Overall Study|Adverse Event|25|||
23679978|NCT01554579|66210015|FG000|Overall Study|Lack of Efficacy|2|||
23679979|NCT01554579|66210016|FG001|Overall Study|Lack of Efficacy|1|||
23679980|NCT01554579|66210015|FG000|Overall Study|Withdrawal by Subject|2|||
23679981|NCT01554579|66210016|FG001|Overall Study|Withdrawal by Subject|1|||
23679982|NCT04640766|66210017|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
23389167|NCT02965456|65168973|FG000|Overall Study|Adverse Event|3|||
23389168|NCT02965456|65168974|FG001|Overall Study|Adverse Event|0|||
23389169|NCT02965456|65168973|FG000|Overall Study|Noncompliance with Study Drug|1|||
23389170|NCT02965456|65168974|FG001|Overall Study|Noncompliance with Study Drug|1|||
23389171|NCT02965456|65168973|FG000|Overall Study|Worsening Condition|0|||
23389172|NCT02965456|65168974|FG001|Overall Study|Worsening Condition|2|||
23389173|NCT02965456|65168973|FG000|Overall Study|Lack of Efficacy|1|||
23389174|NCT02965456|65168974|FG001|Overall Study|Lack of Efficacy|0|||
23389175|NCT02965456|65168973|FG000|Overall Study|Physician Decision|0|||
23389176|NCT02965456|65168974|FG001|Overall Study|Physician Decision|1|||
23389177|NCT02965456|65168973|FG000|Overall Study|Pregnancy|1|||
23389178|NCT02965456|65168974|FG001|Overall Study|Pregnancy|0|||
23389179|NCT02965456|65168973|FG000|Overall Study|Protocol Violation|0|||
23389180|NCT02965456|65168974|FG001|Overall Study|Protocol Violation|1|||
23389181|NCT02965456|65168973|FG000|Overall Study|Participant ran out of study drug|0|||
23389182|NCT02965456|65168974|FG001|Overall Study|Participant ran out of study drug|1|||
23389183|NCT00527748|65168977|FG000|Overall Study|Other|3|||
23389184|NCT03787212|65168978|FG000|Period 1|Study Termination|2|||
23389185|NCT03787212|65168979|FG001|Period 1|Study Termination|2|||
23389186|NCT03193437|65168980|FG000|Overall Study|Adverse Event|4|||
23389187|NCT03193437|65168980|FG000|Overall Study|Withdrawal by Subject|2|||
23389188|NCT03193437|65168980|FG000|Overall Study|Disease Progression|2|||
23389189|NCT04126174|65171643|FG000|Overall Study|Lost to Follow-up|3|||
23389190|NCT04126174|65171644|FG001|Overall Study|Lost to Follow-up|3|||
23389191|NCT01517178|65171645|FG000|Period 1|Adverse Event|1|||
23389192|NCT01517178|65171646|FG001|Period 1|Adverse Event|2|||
23389193|NCT01517178|65171645|FG000|Period 1|Lack of Efficacy|0|||
23389194|NCT01517178|65171646|FG001|Period 1|Lack of Efficacy|1|||
23389195|NCT01517178|65171645|FG000|Period 1|E.g. study termination|3|||
23389196|NCT01517178|65171646|FG001|Period 1|E.g. study termination|1|||
23389197|NCT01517178|65171645|FG000|Period 1|Withdrawal by Subject|0|||
23389198|NCT01517178|65171646|FG001|Period 1|Withdrawal by Subject|1|||
23389199|NCT01517178|65171645|FG000|Period 2|Adverse Event|1|||
23389200|NCT01517178|65171646|FG001|Period 2|Adverse Event|0|||
23389201|NCT01517178|65171645|FG000|Period 2|Withdrawal by Subject|3|||
23389202|NCT01517178|65171646|FG001|Period 2|Withdrawal by Subject|0|||
23679983|NCT04303000|66210018|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
23679984|NCT04303000|66210019|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
23679985|NCT04303000|66210020|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
23679986|NCT05655377|66210021|FG000|Overall Study|Withdrawal by Subject|2|||
23679987|NCT02479802|66210022|FG000|Overall Study|Lost to Follow-up|1|||
23679988|NCT02479802|66210022|FG000|Overall Study|Adverse Event|1|||
23679989|NCT00130286|66210023|FG000|Overall Study|Withdrawal by Subject|0|||
23679990|NCT00130286|66210024|FG001|Overall Study|Withdrawal by Subject|1|||
23679991|NCT00130286|66210025|FG002|Overall Study|Withdrawal by Subject|2|||
23679992|NCT00130286|66210026|FG003|Overall Study|Withdrawal by Subject|2|||
23679993|NCT00130286|66210023|FG000|Overall Study|Adverse Event|0|||
23679994|NCT00130286|66210024|FG001|Overall Study|Adverse Event|0|||
23679995|NCT00130286|66210025|FG002|Overall Study|Adverse Event|2|||
23679996|NCT00130286|66210026|FG003|Overall Study|Adverse Event|0|||
23679997|NCT00130286|66210023|FG000|Overall Study|Missing lab specimens|0|||
23679998|NCT00130286|66210024|FG001|Overall Study|Missing lab specimens|2|||
23679999|NCT00130286|66210025|FG002|Overall Study|Missing lab specimens|0|||
23680000|NCT00130286|66210026|FG003|Overall Study|Missing lab specimens|0|||
23680001|NCT00463476|66210027|FG000|Overall Study|Withdrawal by Subject|1|||
23680002|NCT00463476|66210028|FG001|Overall Study|Withdrawal by Subject|2|||
23680003|NCT00463476|66210027|FG000|Overall Study|Lost to Follow-up|1|||
23680004|NCT00463476|66210028|FG001|Overall Study|Lost to Follow-up|1|||
23680005|NCT01671280|66210029|FG000|Overall Study|Withdrawal by Subject|2|||
23680006|NCT01988090|66210030|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
23680007|NCT01988090|66210031|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
23680008|NCT01988090|66210030|FG000|Start Treament After Randomization|Protocol Violation|0|||
23680009|NCT01988090|66210031|FG001|Start Treament After Randomization|Protocol Violation|1|||
23680010|NCT01988090|66210030|FG000|Complete Study After Start|Withdrawal by Subject|2|||
23389203|NCT01517178|65171645|FG000|Period 2|E.g. study termination|2|||
23389204|NCT01517178|65171646|FG001|Period 2|E.g. study termination|2|||
23389205|NCT05451329|65171647|FG000|Overall Study|Adverse Event|1|||
23389206|NCT05451329|65171648|FG001|Overall Study|Adverse Event|1|||
23494902|NCT00754065|65555021|FG001|Overall Study|Pregnancy|0|||
23389207|NCT05451329|65171649|FG002|Overall Study|Adverse Event|0|||
23389208|NCT05451329|65171647|FG000|Overall Study|Withdrawal by Subject|1|||
23389209|NCT05451329|65171648|FG001|Overall Study|Withdrawal by Subject|0|||
23389210|NCT05451329|65171649|FG002|Overall Study|Withdrawal by Subject|0|||
23389211|NCT05451329|65171647|FG000|Overall Study|Investigational Product Lot exchange|1|||
23389212|NCT05451329|65171648|FG001|Overall Study|Investigational Product Lot exchange|1|||
23680011|NCT01988090|66210031|FG001|Complete Study After Start|Withdrawal by Subject|0|||
23680012|NCT01988090|66210030|FG000|Complete Study After Start|Protocol Violation|1|||
23680013|NCT01988090|66210031|FG001|Complete Study After Start|Protocol Violation|1|||
23389213|NCT05451329|65171649|FG002|Overall Study|Investigational Product Lot exchange|0|||
23389214|NCT00866775|65171650|FG000|Overall Study|Adverse Event|5|||
23389215|NCT00866775|65171651|FG001|Overall Study|Adverse Event|19|||
23389216|NCT00866775|65171650|FG000|Overall Study|Death|1|||
23389217|NCT00866775|65171651|FG001|Overall Study|Death|0|||
23389218|NCT00866775|65171650|FG000|Overall Study|Lost to Follow-up|0|||
23389219|NCT00866775|65171651|FG001|Overall Study|Lost to Follow-up|4|||
23389220|NCT00866775|65171650|FG000|Overall Study|Physician Decision|0|||
23389221|NCT00866775|65171651|FG001|Overall Study|Physician Decision|3|||
23389222|NCT00866775|65171650|FG000|Overall Study|Protocol Violation|3|||
23389223|NCT00866775|65171651|FG001|Overall Study|Protocol Violation|4|||
23389224|NCT00866775|65171650|FG000|Overall Study|Withdrawal by Subject|4|||
23389225|NCT00866775|65171651|FG001|Overall Study|Withdrawal by Subject|4|||
23389226|NCT00866775|65171650|FG000|Overall Study|met exit criteria|23|||
23389227|NCT00866775|65171651|FG001|Overall Study|met exit criteria|17|||
23389228|NCT00866775|65171650|FG000|Overall Study|discontinued due to communication error|0|||
23389229|NCT00866775|65171651|FG001|Overall Study|discontinued due to communication error|1|||
23389230|NCT01550965|65171652|FG000|Overall Study|Adverse Event|26|||
23389231|NCT01550965|65171652|FG000|Overall Study|Withdrawal by Subject|10|||
23389232|NCT01550965|65171652|FG000|Overall Study|Lost to Follow-up|2|||
23389233|NCT01550965|65171652|FG000|Overall Study|Lack of Efficacy|59|||
23389234|NCT01550965|65171652|FG000|Overall Study|Other|13|||
23389235|NCT03633058|65171653|FG000|Overall Study|Adverse Event|0|||
23389236|NCT03633058|65171654|FG001|Overall Study|Adverse Event|0|||
23389237|NCT03633058|65171655|FG002|Overall Study|Adverse Event|1|||
23389238|NCT03633058|65171656|FG003|Overall Study|Adverse Event|0|||
23389239|NCT00289978|65171657|FG000|Overall Study|Withdrawal by Subject|31|||
23389240|NCT00289978|65171658|FG001|Overall Study|Withdrawal by Subject|17|||
23389241|NCT00289978|65171659|FG002|Overall Study|Withdrawal by Subject|28|||
23389242|NCT00289978|65171657|FG000|Overall Study|Adverse Event|22|||
23389243|NCT00289978|65171658|FG001|Overall Study|Adverse Event|13|||
23389244|NCT00289978|65171659|FG002|Overall Study|Adverse Event|18|||
23389245|NCT00289978|65171657|FG000|Overall Study|Lack of Efficacy|13|||
23389246|NCT00289978|65171658|FG001|Overall Study|Lack of Efficacy|6|||
23389247|NCT00289978|65171659|FG002|Overall Study|Lack of Efficacy|25|||
23389248|NCT00289978|65171657|FG000|Overall Study|Abnormal laboratory value(s)|20|||
23389249|NCT00289978|65171658|FG001|Overall Study|Abnormal laboratory value(s)|9|||
23389250|NCT00289978|65171659|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23389251|NCT00289978|65171657|FG000|Overall Study|Lost to Follow-up|3|||
23389252|NCT00289978|65171658|FG001|Overall Study|Lost to Follow-up|5|||
23389253|NCT00289978|65171659|FG002|Overall Study|Lost to Follow-up|7|||
23389254|NCT00289978|65171657|FG000|Overall Study|Protocol Violation|5|||
23389255|NCT00289978|65171658|FG001|Overall Study|Protocol Violation|5|||
23389256|NCT00289978|65171659|FG002|Overall Study|Protocol Violation|4|||
23389257|NCT00289978|65171657|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23389258|NCT00289978|65171658|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23389259|NCT00289978|65171659|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23389260|NCT00289978|65171657|FG000|Overall Study|Death|1|||
23389261|NCT00289978|65171658|FG001|Overall Study|Death|0|||
23389262|NCT00289978|65171659|FG002|Overall Study|Death|2|||
23389263|NCT00266032|65171663|FG000|Treatment|Adverse Event|42|||
23389264|NCT00266032|65171664|FG001|Treatment|Adverse Event|26|||
23389265|NCT00266032|65171665|FG002|Treatment|Adverse Event|10|||
23389266|NCT00266032|65171663|FG000|Treatment|Lost to Follow-up|19|||
23389267|NCT00266032|65171664|FG001|Treatment|Lost to Follow-up|4|||
23389268|NCT00266032|65171665|FG002|Treatment|Lost to Follow-up|2|||
23389269|NCT00266032|65171663|FG000|Treatment|Pregnancy|3|||
23389270|NCT00266032|65171664|FG001|Treatment|Pregnancy|2|||
23389271|NCT00266032|65171665|FG002|Treatment|Pregnancy|2|||
23389272|NCT00266032|65171663|FG000|Treatment|Protocol Violation|6|||
23389273|NCT00266032|65171664|FG001|Treatment|Protocol Violation|14|||
23389274|NCT00266032|65171665|FG002|Treatment|Protocol Violation|13|||
23389275|NCT00266032|65171663|FG000|Treatment|Withdrawal by Subject|28|||
23389276|NCT00266032|65171664|FG001|Treatment|Withdrawal by Subject|13|||
23389277|NCT00266032|65171665|FG002|Treatment|Withdrawal by Subject|12|||
23389278|NCT00266032|65171663|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
23389279|NCT00266032|65171664|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
23389280|NCT00266032|65171665|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
23389281|NCT00266032|65171663|FG000|Open-label Safety Extension|Adverse Event|5|||
23389282|NCT00266032|65171664|FG001|Open-label Safety Extension|Adverse Event|0|||
23389283|NCT00266032|65171665|FG002|Open-label Safety Extension|Adverse Event|4|||
23389284|NCT00266032|65171663|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
23389285|NCT00266032|65171664|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
23389286|NCT00266032|65171665|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
23389287|NCT00266032|65171663|FG000|Open-label Safety Extension|Pregnancy|4|||
23389288|NCT00266032|65171664|FG001|Open-label Safety Extension|Pregnancy|1|||
23389289|NCT00266032|65171665|FG002|Open-label Safety Extension|Pregnancy|2|||
23389290|NCT00266032|65171663|FG000|Open-label Safety Extension|Protocol Violation|1|||
23389291|NCT00266032|65171664|FG001|Open-label Safety Extension|Protocol Violation|3|||
23389292|NCT00266032|65171665|FG002|Open-label Safety Extension|Protocol Violation|2|||
23389293|NCT00266032|65171663|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
23389294|NCT00266032|65171664|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
23389295|NCT00266032|65171665|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
23389296|NCT00266032|65171663|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
23389297|NCT00266032|65171664|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
23389298|NCT00266032|65171665|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
23389299|NCT00545948|65171666|FG000|Overall Study|Not Treated|1|||
23389300|NCT00545948|65171667|FG001|Overall Study|Not Treated|1|||
23680014|NCT02400255|66210032|FG000|Overall Study|Relapse|4|||
23680015|NCT02400255|66210033|FG001|Overall Study|Relapse|1|||
23680016|NCT02400255|66210034|FG002|Overall Study|Relapse|1|||
23680017|NCT02400255|66210035|FG003|Overall Study|Relapse|2|||
23680018|NCT02400255|66210032|FG000|Overall Study|Adverse Event|6|||
23680019|NCT02400255|66210033|FG001|Overall Study|Adverse Event|3|||
23680020|NCT02400255|66210034|FG002|Overall Study|Adverse Event|0|||
23680021|NCT02400255|66210035|FG003|Overall Study|Adverse Event|0|||
23680022|NCT02400255|66210032|FG000|Overall Study|Physician Decision|6|||
23680023|NCT02400255|66210033|FG001|Overall Study|Physician Decision|0|||
23680024|NCT02400255|66210034|FG002|Overall Study|Physician Decision|0|||
23680025|NCT02400255|66210035|FG003|Overall Study|Physician Decision|0|||
23680026|NCT02400255|66210032|FG000|Overall Study|Loss of insurance|1|||
23680027|NCT02400255|66210033|FG001|Overall Study|Loss of insurance|0|||
23389301|NCT00545948|65171668|FG002|Overall Study|Not Treated|7|||
23389302|NCT05805150|65171672|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
23389303|NCT05805150|65171673|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
23389304|NCT03301415|65171677|FG000|Overall Study|Lost to Follow-up|2|||
23389305|NCT03301415|65171677|FG000|Overall Study|Unable to comply with visit schedule|2|||
23389306|NCT01421459|65171680|FG000|Overall Study|Adverse Event|6|||
23389307|NCT01421459|65171681|FG001|Overall Study|Adverse Event|10|||
23389308|NCT01421459|65171680|FG000|Overall Study|Death|1|||
23389309|NCT01421459|65171681|FG001|Overall Study|Death|1|||
23389310|NCT01421459|65171680|FG000|Overall Study|Lack of Efficacy|1|||
23389311|NCT01421459|65171681|FG001|Overall Study|Lack of Efficacy|2|||
23389312|NCT01421459|65171680|FG000|Overall Study|Lost to Follow-up|8|||
23389313|NCT01421459|65171681|FG001|Overall Study|Lost to Follow-up|9|||
23389314|NCT01421459|65171680|FG000|Overall Study|Physician Decision|9|||
23680028|NCT02400255|66210034|FG002|Overall Study|Loss of insurance|0|||
23680029|NCT02400255|66210035|FG003|Overall Study|Loss of insurance|0|||
23680030|NCT01262976|66210038|FG000|Up to Month 2|Serious Adverse Event|0|||
23680031|NCT01262976|66210039|FG001|Up to Month 2|Serious Adverse Event|0|||
23680032|NCT01262976|66210040|FG002|Up to Month 2|Serious Adverse Event|1|||
23680033|NCT01262976|66210041|FG003|Up to Month 2|Serious Adverse Event|0|||
23680034|NCT01262976|66210042|FG004|Up to Month 2|Serious Adverse Event|0|||
23680035|NCT01262976|66210043|FG005|Up to Month 2|Serious Adverse Event|0|||
23680036|NCT01262976|66210038|FG000|Up to Month 2|Withdrawal by Subject|1|||
23680037|NCT01262976|66210039|FG001|Up to Month 2|Withdrawal by Subject|0|||
23389315|NCT01421459|65171681|FG001|Overall Study|Physician Decision|9|||
23389316|NCT01421459|65171680|FG000|Overall Study|Protocol Violation|8|||
23389317|NCT01421459|65171681|FG001|Overall Study|Protocol Violation|5|||
23389318|NCT01421459|65171680|FG000|Overall Study|Withdrawal by Subject|12|||
23389319|NCT01421459|65171681|FG001|Overall Study|Withdrawal by Subject|16|||
23389320|NCT00392288|65171682|FG000|Overall Study|Adverse Event|17|||
23389321|NCT00392288|65171683|FG001|Overall Study|Adverse Event|7|||
23389322|NCT00392288|65171684|FG002|Overall Study|Adverse Event|8|||
23389323|NCT00392288|65171682|FG000|Overall Study|Lack of Efficacy|8|||
23389324|NCT00392288|65171683|FG001|Overall Study|Lack of Efficacy|5|||
23389325|NCT00392288|65171684|FG002|Overall Study|Lack of Efficacy|3|||
23389326|NCT00392288|65171682|FG000|Overall Study|Protocol Violation|1|||
23389327|NCT00392288|65171683|FG001|Overall Study|Protocol Violation|3|||
23389328|NCT00392288|65171684|FG002|Overall Study|Protocol Violation|1|||
23389329|NCT00392288|65171682|FG000|Overall Study|Lost to Follow-up|1|||
23389330|NCT00392288|65171683|FG001|Overall Study|Lost to Follow-up|1|||
23389331|NCT00392288|65171684|FG002|Overall Study|Lost to Follow-up|1|||
23389332|NCT00392288|65171682|FG000|Overall Study|Withdrawal by Subject|1|||
23389333|NCT00392288|65171683|FG001|Overall Study|Withdrawal by Subject|0|||
23389334|NCT00392288|65171684|FG002|Overall Study|Withdrawal by Subject|2|||
23389335|NCT00392288|65171682|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
23389336|NCT00392288|65171683|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
23389337|NCT00392288|65171684|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
23389338|NCT00392288|65171682|FG000|Overall Study|Other|3|||
23389339|NCT00392288|65171683|FG001|Overall Study|Other|4|||
23389340|NCT00392288|65171684|FG002|Overall Study|Other|1|||
23389341|NCT00003907|65171685|FG000|Overall Study|Adverse Event|2|||
23389342|NCT00003907|65171686|FG001|Overall Study|Adverse Event|11|||
23389343|NCT00003907|65171685|FG000|Overall Study|Death|2|||
23389344|NCT00003907|65171686|FG001|Overall Study|Death|0|||
23389345|NCT00003907|65171685|FG000|Overall Study|Withdrawal by Subject|1|||
23389346|NCT00003907|65171686|FG001|Overall Study|Withdrawal by Subject|3|||
23389347|NCT00003907|65171685|FG000|Overall Study|Progressive disease|4|||
23389348|NCT00003907|65171686|FG001|Overall Study|Progressive disease|4|||
23389349|NCT00003907|65171685|FG000|Overall Study|Complicating disease|1|||
23389350|NCT00003907|65171686|FG001|Overall Study|Complicating disease|0|||
23389351|NCT00003907|65171685|FG000|Overall Study|Other|1|||
23389352|NCT00003907|65171686|FG001|Overall Study|Other|3|||
23389353|NCT00003907|65171685|FG000|Overall Study|ineligible or not treated|2|||
23389354|NCT00003907|65171686|FG001|Overall Study|ineligible or not treated|2|||
23389355|NCT01773889|65171692|FG000|Overall Study|lack of funding|2|||
23389356|NCT01260311|65171693|FG000|Overall Study|Adverse Event|11|||
23389357|NCT01260311|65171693|FG000|Overall Study|Lack of Efficacy|4|||
23389358|NCT01260311|65171693|FG000|Overall Study|Lost to Follow-up|25|||
23389359|NCT01260311|65171693|FG000|Overall Study|Withdrawal by Subject|6|||
23389360|NCT01260311|65171693|FG000|Overall Study|Financial Constraints|77|||
23389361|NCT01260311|65171693|FG000|Overall Study|Gone to Province|2|||
23389362|NCT01260311|65171693|FG000|Overall Study|Medication Stopped|1|||
23389363|NCT01260311|65171693|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
23389364|NCT00461812|65171695|FG000|Overall Study|study terminated|10|||
23389365|NCT02715856|65171696|FG000|Overall Study|Software Issues|12|||
23494903|NCT00754065|65555020|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
23494904|NCT00754065|65555021|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
23389366|NCT02715856|65171697|FG001|Overall Study|Software Issues|7|||
23389367|NCT02715856|65171696|FG000|Overall Study|Death|6|||
23389368|NCT02715856|65171697|FG001|Overall Study|Death|5|||
23389369|NCT02715856|65171696|FG000|Overall Study|Non- Compliant|0|||
23389370|NCT02715856|65171697|FG001|Overall Study|Non- Compliant|40|||
23389371|NCT03382873|65171698|FG000|Overall Study|Lost to Follow-up|9|||
23389372|NCT03382873|65171699|FG001|Overall Study|Lost to Follow-up|10|||
23389373|NCT03382873|65171698|FG000|Overall Study|Withdrawal by Subject|6|||
23494905|NCT00668707|65555029|FG000|Overall Study|Cancer Recurrence|58|||
23389374|NCT03382873|65171699|FG001|Overall Study|Withdrawal by Subject|11|||
23389375|NCT03382873|65171698|FG000|Overall Study|Visit not completed due to pandemic|16|||
23389376|NCT03382873|65171699|FG001|Overall Study|Visit not completed due to pandemic|41|||
23389377|NCT03247673|65171700|FG000|Overall Study|Withdrawal by Subject|1|||
23389378|NCT03247673|65171701|FG001|Overall Study|Withdrawal by Subject|0|||
23389379|NCT03247673|65171702|FG002|Overall Study|Withdrawal by Subject|3|||
23389380|NCT03247673|65171700|FG000|Overall Study|Lost to Follow-up|0|||
23389381|NCT03247673|65171701|FG001|Overall Study|Lost to Follow-up|0|||
23389382|NCT03247673|65171702|FG002|Overall Study|Lost to Follow-up|1|||
23389383|NCT02544763|65171703|FG000|Overall Study|Adverse Event|8|||
23389384|NCT02544763|65171704|FG001|Overall Study|Adverse Event|8|||
23389385|NCT02544763|65171705|FG002|Overall Study|Adverse Event|0|||
23389386|NCT02544763|65171703|FG000|Overall Study|Withdrawn by parent/guardian|1|||
23389387|NCT02544763|65171704|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23389388|NCT02544763|65171705|FG002|Overall Study|Withdrawn by parent/guardian|1|||
23389389|NCT02544763|65171703|FG000|Overall Study|Met withdrawal criteria|0|||
23389390|NCT02544763|65171704|FG001|Overall Study|Met withdrawal criteria|2|||
23389391|NCT02544763|65171705|FG002|Overall Study|Met withdrawal criteria|0|||
23389392|NCT02544763|65171703|FG000|Overall Study|Physician Decision|0|||
23389393|NCT02544763|65171704|FG001|Overall Study|Physician Decision|1|||
23389394|NCT02544763|65171705|FG002|Overall Study|Physician Decision|0|||
23389395|NCT02544763|65171703|FG000|Overall Study|Difficulties taking IMP|1|||
23389396|NCT02544763|65171704|FG001|Overall Study|Difficulties taking IMP|0|||
23389397|NCT02544763|65171705|FG002|Overall Study|Difficulties taking IMP|0|||
23389398|NCT00309946|65171711|FG000|Overall Study|Withdrawal by Subject|1|||
23389399|NCT02336555|65171718|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23389400|NCT02336555|65171719|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23389401|NCT02336555|65171718|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
23389402|NCT02336555|65171719|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
23389403|NCT02336555|65171718|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
23389404|NCT02336555|65171719|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
23389405|NCT01104870|65171720|FG000|Overall Study|Adverse Event|1|||
23389406|NCT01104870|65171721|FG001|Overall Study|Adverse Event|1|||
23389407|NCT01104870|65171722|FG002|Overall Study|Adverse Event|0|||
23389408|NCT01104870|65171720|FG000|Overall Study|Death|0|||
23389409|NCT01104870|65171721|FG001|Overall Study|Death|0|||
23389410|NCT01104870|65171722|FG002|Overall Study|Death|1|||
23389411|NCT01104870|65171720|FG000|Overall Study|Withdrawal by Subject|0|||
23389412|NCT01104870|65171721|FG001|Overall Study|Withdrawal by Subject|0|||
23389413|NCT01104870|65171722|FG002|Overall Study|Withdrawal by Subject|1|||
23389414|NCT05069415|65171725|FG000|Overall Study|Withdrawal by Subject|2|||
23389415|NCT05069415|65171726|FG001|Overall Study|Withdrawal by Subject|0|||
23389416|NCT05069415|65171725|FG000|Overall Study|Adverse Event|2|||
23389417|NCT05069415|65171726|FG001|Overall Study|Adverse Event|0|||
23389418|NCT00480025|65171727|FG000|Overall Study|Protocol Violation|12|||
23389419|NCT00480025|65171728|FG001|Overall Study|Protocol Violation|7|||
23389420|NCT00480025|65171727|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
23389421|NCT00480025|65171728|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
23389422|NCT00480025|65171727|FG000|Overall Study|Disease Progression / Recurrence|449|||
23389423|NCT00480025|65171728|FG001|Overall Study|Disease Progression / Recurrence|224|||
23389424|NCT00480025|65171727|FG000|Overall Study|Adverse Event|44|||
23389425|NCT00480025|65171728|FG001|Overall Study|Adverse Event|12|||
23389426|NCT00480025|65171727|FG000|Overall Study|Other|70|||
23389427|NCT00480025|65171728|FG001|Overall Study|Other|29|||
23389428|NCT00480025|65171727|FG000|Overall Study|SAE including intercurrent illness|76|||
23389429|NCT00480025|65171728|FG001|Overall Study|SAE including intercurrent illness|42|||
23389430|NCT02904096|65171729|FG000|Overall Study|Adverse Event|1|||
23389431|NCT02904096|65171730|FG001|Overall Study|Adverse Event|0|||
23389432|NCT02904096|65171729|FG000|Overall Study|Withdrawal by Subject|4|||
23389433|NCT02904096|65171730|FG001|Overall Study|Withdrawal by Subject|3|||
23389434|NCT02904096|65171729|FG000|Overall Study|Lost to Follow-up|10|||
23389435|NCT02904096|65171730|FG001|Overall Study|Lost to Follow-up|17|||
23389436|NCT02904096|65171729|FG000|Overall Study|Non-compliant|3|||
23389437|NCT02904096|65171730|FG001|Overall Study|Non-compliant|1|||
23389438|NCT02904096|65171729|FG000|Overall Study|Sponsor instructed|1|||
23389439|NCT02904096|65171730|FG001|Overall Study|Sponsor instructed|0|||
23389440|NCT00397046|65171731|FG000|Overall Study|Disease Progression|3|||
23389441|NCT00397046|65171732|FG001|Overall Study|Disease Progression|3|||
23389442|NCT00397046|65171733|FG002|Overall Study|Disease Progression|10|||
23389443|NCT00397046|65171734|FG003|Overall Study|Disease Progression|5|||
23680038|NCT01262976|66210040|FG002|Up to Month 2|Withdrawal by Subject|0|||
23680039|NCT01262976|66210041|FG003|Up to Month 2|Withdrawal by Subject|0|||
23389444|NCT00692237|65171735|FG000|Overall Study|Withdrawal by Subject|1|||
23389445|NCT00692237|65171736|FG001|Overall Study|Withdrawal by Subject|3|||
23389446|NCT00692237|65171735|FG000|Overall Study|Adverse Event|0|||
23389447|NCT00692237|65171736|FG001|Overall Study|Adverse Event|1|||
23389448|NCT02217982|65171737|FG000|Overall Study|Trial discontinued|1|||
23389449|NCT02217982|65171738|FG001|Overall Study|Trial discontinued|0|||
23389450|NCT02217982|65171737|FG000|Overall Study|Adverse Event|0|||
23389451|NCT02217982|65171738|FG001|Overall Study|Adverse Event|1|||
23389452|NCT01027754|65171746|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
23389453|NCT01027754|65171747|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
23389454|NCT01027754|65171746|FG000|Overall Study|Withdrawal by Subject|0|||
23389455|NCT01027754|65171747|FG001|Overall Study|Withdrawal by Subject|5|||
23389456|NCT05524948|65171748|FG000|Overall Study|Withdrawal by Subject|1|||
23389457|NCT05524948|65171749|FG001|Overall Study|Withdrawal by Subject|0|||
23680040|NCT01262976|66210042|FG004|Up to Month 2|Withdrawal by Subject|0|||
23389458|NCT05524948|65171748|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
23389459|NCT05524948|65171749|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
23389460|NCT00773461|65171750|FG000|Overall Study|Adverse Event|1|||
23389461|NCT00773461|65171751|FG001|Overall Study|Adverse Event|3|||
23389462|NCT00773461|65171750|FG000|Overall Study|Withdrawal by Subject|4|||
23389463|NCT00773461|65171751|FG001|Overall Study|Withdrawal by Subject|1|||
23389464|NCT01608308|65171752|FG000|Overall Study|pretreatment medical and billing reasons|0|||
23389465|NCT01608308|65171753|FG001|Overall Study|pretreatment medical and billing reasons|2|||
23389466|NCT01832038|65171756|FG000|Overall Study|Death|5|||
23389467|NCT01832038|65171756|FG000|Overall Study|Adverse Event|50|||
23389468|NCT01832038|65171756|FG000|Overall Study|Lack of Efficacy|81|||
23389469|NCT01832038|65171756|FG000|Overall Study|Protocol Violation|7|||
23389470|NCT01832038|65171756|FG000|Overall Study|Lost to Follow-up|10|||
23389471|NCT01832038|65171756|FG000|Overall Study|Withdrawal by Subject|49|||
23389472|NCT01832038|65171756|FG000|Overall Study|Visit non-compliance|2|||
23389473|NCT01832038|65171756|FG000|Overall Study|Subject refused to return visit|2|||
23389474|NCT01832038|65171756|FG000|Overall Study|Not convenient to come back to site|2|||
23389475|NCT01832038|65171756|FG000|Overall Study|Participant was asked to quit|5|||
23389476|NCT01832038|65171756|FG000|Overall Study|Back home|1|||
23389477|NCT01832038|65171756|FG000|Overall Study|Pregnancy|1|||
23389478|NCT01832038|65171756|FG000|Overall Study|Low compliance|3|||
23389479|NCT01832038|65171756|FG000|Overall Study|Prohibit procedure|2|||
23389480|NCT01832038|65171756|FG000|Overall Study|Not possible to visit the hospital|1|||
23389481|NCT01832038|65171756|FG000|Overall Study|Changes of implementation system|3|||
23389482|NCT01832038|65171756|FG000|Overall Study|Plan to pregnancy|7|||
23389483|NCT01832038|65171756|FG000|Overall Study|Bad mood and has suicidal thought|1|||
23389484|NCT01832038|65171756|FG000|Overall Study|Prohibited concomitant medication|1|||
23389485|NCT01832038|65171756|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
23389486|NCT01832038|65171756|FG000|Overall Study|Subject considered the efficacy was poor|1|||
23389487|NCT01629563|65171757|FG000|Overall Study|Adverse Event|16|||
23389488|NCT01629563|65171758|FG001|Overall Study|Adverse Event|16|||
23389489|NCT01629563|65171757|FG000|Overall Study|Death|2|||
23389490|NCT01629563|65171758|FG001|Overall Study|Death|0|||
23389491|NCT01629563|65171757|FG000|Overall Study|Lack of Efficacy|2|||
23389492|NCT01629563|65171758|FG001|Overall Study|Lack of Efficacy|3|||
23389493|NCT01629563|65171757|FG000|Overall Study|Lost to Follow-up|1|||
23389494|NCT01629563|65171758|FG001|Overall Study|Lost to Follow-up|0|||
23389495|NCT01629563|65171757|FG000|Overall Study|Pregnancy|1|||
23389496|NCT01629563|65171758|FG001|Overall Study|Pregnancy|2|||
23389497|NCT01629563|65171757|FG000|Overall Study|Protocol Violation|0|||
23389498|NCT01629563|65171758|FG001|Overall Study|Protocol Violation|1|||
23389499|NCT01629563|65171757|FG000|Overall Study|Withdrawal by Subject|27|||
23389500|NCT01629563|65171758|FG001|Overall Study|Withdrawal by Subject|20|||
23389501|NCT01629563|65171757|FG000|Overall Study|surgery|0|||
23389502|NCT01629563|65171758|FG001|Overall Study|surgery|3|||
23389503|NCT01629563|65171757|FG000|Overall Study|Lack of return of menses|12|||
23389504|NCT01629563|65171758|FG001|Overall Study|Lack of return of menses|7|||
23389505|NCT01629563|65171757|FG000|Overall Study|Protocol Violation|0|||
23389506|NCT01629563|65171758|FG001|Overall Study|Protocol Violation|1|||
23389507|NCT00903344|65171760|FG000|Overall Study|Pregnancy|2|||
23389508|NCT00903344|65171761|FG001|Overall Study|Pregnancy|3|||
23389509|NCT00903344|65171760|FG000|Overall Study|Lost to Follow-up|3|||
23389510|NCT00903344|65171761|FG001|Overall Study|Lost to Follow-up|0|||
23389511|NCT01248468|65171762|FG000|Overall Study|Administrative problem|1|||
23389512|NCT01248468|65171763|FG001|Overall Study|Administrative problem|0|||
23389513|NCT01248468|65171764|FG002|Overall Study|Administrative problem|0|||
23389514|NCT01248468|65171762|FG000|Overall Study|Lost to Follow-up|9|||
23389515|NCT01248468|65171763|FG001|Overall Study|Lost to Follow-up|12|||
23389516|NCT01248468|65171764|FG002|Overall Study|Lost to Follow-up|4|||
23680041|NCT01262976|66210043|FG005|Up to Month 2|Withdrawal by Subject|0|||
23680042|NCT01262976|66210038|FG000|Up to Month 2|Migrated/moved from study area|0|||
23680043|NCT01262976|66210039|FG001|Up to Month 2|Migrated/moved from study area|1|||
23389517|NCT01248468|65171762|FG000|Overall Study|Pregnancy|1|||
23389518|NCT01248468|65171763|FG001|Overall Study|Pregnancy|0|||
23389519|NCT01248468|65171764|FG002|Overall Study|Pregnancy|0|||
23389520|NCT01248468|65171762|FG000|Overall Study|Withdrawal by Subject|4|||
23389521|NCT01248468|65171763|FG001|Overall Study|Withdrawal by Subject|2|||
23389522|NCT01248468|65171764|FG002|Overall Study|Withdrawal by Subject|0|||
23680044|NCT01262976|66210040|FG002|Up to Month 2|Migrated/moved from study area|0|||
23389523|NCT02093520|65171765|FG000|Overall Study|Not treated|6|||
23389524|NCT02093520|65171766|FG001|Overall Study|Not treated|22|||
23389525|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
23389526|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
23389527|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
23389528|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
23389529|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
23680045|NCT01262976|66210041|FG003|Up to Month 2|Migrated/moved from study area|0|||
23389530|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
23389531|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
23389532|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
23389533|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
23389534|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
23389535|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
23389536|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
23389537|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
23389538|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
23389539|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
23389540|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
23389541|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
23389542|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
23389543|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
23389544|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
23389545|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
23389546|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
23389547|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
23389548|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
23389549|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
23389550|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
23389551|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
23389552|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
23389553|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
23389554|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
23389555|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23389556|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
23389557|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
23389558|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
23389559|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23389560|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23680046|NCT01262976|66210042|FG004|Up to Month 2|Migrated/moved from study area|1|||
23680047|NCT01262976|66210043|FG005|Up to Month 2|Migrated/moved from study area|1|||
23680048|NCT01262976|66210038|FG000|Up to Month 2|Lost to Follow-up|1|||
23680049|NCT01262976|66210039|FG001|Up to Month 2|Lost to Follow-up|0|||
23680050|NCT01262976|66210040|FG002|Up to Month 2|Lost to Follow-up|0|||
23680051|NCT01262976|66210041|FG003|Up to Month 2|Lost to Follow-up|1|||
23680052|NCT01262976|66210042|FG004|Up to Month 2|Lost to Follow-up|1|||
23680053|NCT01262976|66210043|FG005|Up to Month 2|Lost to Follow-up|1|||
23680054|NCT01262976|66210038|FG000|Up to Month 2|Other|1|||
23680055|NCT01262976|66210039|FG001|Up to Month 2|Other|0|||
23680056|NCT01262976|66210040|FG002|Up to Month 2|Other|0|||
23680057|NCT01262976|66210041|FG003|Up to Month 2|Other|1|||
23680058|NCT01262976|66210042|FG004|Up to Month 2|Other|0|||
23680059|NCT01262976|66210043|FG005|Up to Month 2|Other|2|||
23680060|NCT01262976|66210038|FG000|Up to Month 7|Serious Adverse Event|0|||
23680061|NCT01262976|66210039|FG001|Up to Month 7|Serious Adverse Event|0|||
23680062|NCT01262976|66210040|FG002|Up to Month 7|Serious Adverse Event|2|||
23680063|NCT01262976|66210041|FG003|Up to Month 7|Serious Adverse Event|0|||
23680064|NCT01262976|66210042|FG004|Up to Month 7|Serious Adverse Event|0|||
23680065|NCT01262976|66210043|FG005|Up to Month 7|Serious Adverse Event|0|||
23680066|NCT01262976|66210038|FG000|Up to Month 7|Withdrawal by Subject|1|||
23680067|NCT01262976|66210039|FG001|Up to Month 7|Withdrawal by Subject|0|||
23680068|NCT01262976|66210040|FG002|Up to Month 7|Withdrawal by Subject|0|||
23680069|NCT01262976|66210041|FG003|Up to Month 7|Withdrawal by Subject|0|||
23680070|NCT01262976|66210042|FG004|Up to Month 7|Withdrawal by Subject|0|||
23680071|NCT01262976|66210043|FG005|Up to Month 7|Withdrawal by Subject|0|||
23680072|NCT01262976|66210038|FG000|Up to Month 7|Migrated/moved from study area|0|||
23680073|NCT01262976|66210039|FG001|Up to Month 7|Migrated/moved from study area|0|||
23680074|NCT01262976|66210040|FG002|Up to Month 7|Migrated/moved from study area|1|||
23680075|NCT01262976|66210041|FG003|Up to Month 7|Migrated/moved from study area|3|||
23680076|NCT01262976|66210042|FG004|Up to Month 7|Migrated/moved from study area|1|||
23680077|NCT01262976|66210043|FG005|Up to Month 7|Migrated/moved from study area|1|||
23680078|NCT01262976|66210038|FG000|Up to Month 7|Lost to Follow-up|1|||
23680079|NCT01262976|66210039|FG001|Up to Month 7|Lost to Follow-up|0|||
23680080|NCT01262976|66210040|FG002|Up to Month 7|Lost to Follow-up|1|||
23389561|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389562|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23680081|NCT01262976|66210041|FG003|Up to Month 7|Lost to Follow-up|3|||
23680082|NCT01262976|66210042|FG004|Up to Month 7|Lost to Follow-up|1|||
23680083|NCT01262976|66210043|FG005|Up to Month 7|Lost to Follow-up|3|||
23680084|NCT01262976|66210038|FG000|Up to Month 7|Other|3|||
23680085|NCT01262976|66210039|FG001|Up to Month 7|Other|0|||
23680086|NCT01262976|66210040|FG002|Up to Month 7|Other|2|||
23680087|NCT01262976|66210041|FG003|Up to Month 7|Other|0|||
23680088|NCT01262976|66210042|FG004|Up to Month 7|Other|0|||
23680089|NCT01262976|66210043|FG005|Up to Month 7|Other|0|||
23680090|NCT01262976|66210038|FG000|Up to Year 1|Serious Adverse Event|0|||
23680091|NCT01262976|66210039|FG001|Up to Year 1|Serious Adverse Event|0|||
23680092|NCT01262976|66210040|FG002|Up to Year 1|Serious Adverse Event|2|||
23680093|NCT01262976|66210041|FG003|Up to Year 1|Serious Adverse Event|0|||
23680094|NCT01262976|66210042|FG004|Up to Year 1|Serious Adverse Event|0|||
23680095|NCT01262976|66210043|FG005|Up to Year 1|Serious Adverse Event|0|||
23680096|NCT01262976|66210038|FG000|Up to Year 1|Withdrawal by Subject|1|||
23680097|NCT01262976|66210039|FG001|Up to Year 1|Withdrawal by Subject|0|||
23680098|NCT01262976|66210040|FG002|Up to Year 1|Withdrawal by Subject|0|||
23680099|NCT01262976|66210041|FG003|Up to Year 1|Withdrawal by Subject|0|||
23680100|NCT01262976|66210042|FG004|Up to Year 1|Withdrawal by Subject|0|||
23680101|NCT01262976|66210043|FG005|Up to Year 1|Withdrawal by Subject|0|||
23680102|NCT01262976|66210038|FG000|Up to Year 1|Migrated/moved from study area|1|||
23680103|NCT01262976|66210039|FG001|Up to Year 1|Migrated/moved from study area|0|||
23680104|NCT01262976|66210040|FG002|Up to Year 1|Migrated/moved from study area|0|||
23680105|NCT01262976|66210041|FG003|Up to Year 1|Migrated/moved from study area|3|||
23680106|NCT01262976|66210042|FG004|Up to Year 1|Migrated/moved from study area|3|||
23680107|NCT01262976|66210043|FG005|Up to Year 1|Migrated/moved from study area|2|||
23680108|NCT01262976|66210038|FG000|Up to Year 1|Lost to Follow-up|4|||
23680109|NCT01262976|66210039|FG001|Up to Year 1|Lost to Follow-up|0|||
23680110|NCT01262976|66210040|FG002|Up to Year 1|Lost to Follow-up|0|||
23680111|NCT01262976|66210041|FG003|Up to Year 1|Lost to Follow-up|1|||
23680112|NCT01262976|66210042|FG004|Up to Year 1|Lost to Follow-up|6|||
23680113|NCT01262976|66210043|FG005|Up to Year 1|Lost to Follow-up|5|||
23680114|NCT01262976|66210038|FG000|Up to Year 1|Other|3|||
23680115|NCT01262976|66210039|FG001|Up to Year 1|Other|1|||
23680116|NCT01262976|66210040|FG002|Up to Year 1|Other|0|||
23680117|NCT01262976|66210041|FG003|Up to Year 1|Other|0|||
23680118|NCT01262976|66210042|FG004|Up to Year 1|Other|2|||
23680119|NCT01262976|66210043|FG005|Up to Year 1|Other|1|||
23680120|NCT01262976|66210038|FG000|Up to Year 1|Subjects with unknown completion status|0|||
23680121|NCT01262976|66210039|FG001|Up to Year 1|Subjects with unknown completion status|0|||
23680122|NCT01262976|66210040|FG002|Up to Year 1|Subjects with unknown completion status|1|||
23680123|NCT01262976|66210041|FG003|Up to Year 1|Subjects with unknown completion status|0|||
23680124|NCT01262976|66210042|FG004|Up to Year 1|Subjects with unknown completion status|0|||
23680125|NCT01262976|66210043|FG005|Up to Year 1|Subjects with unknown completion status|1|||
23680126|NCT01262976|66210038|FG000|Up to Year 2|Serious Adverse Event|0|||
23680127|NCT01262976|66210039|FG001|Up to Year 2|Serious Adverse Event|0|||
23680128|NCT01262976|66210040|FG002|Up to Year 2|Serious Adverse Event|2|||
23680129|NCT01262976|66210041|FG003|Up to Year 2|Serious Adverse Event|0|||
23680130|NCT01262976|66210042|FG004|Up to Year 2|Serious Adverse Event|0|||
23680131|NCT01262976|66210043|FG005|Up to Year 2|Serious Adverse Event|0|||
23680132|NCT01262976|66210038|FG000|Up to Year 2|Withdrawal by Subject|1|||
23680133|NCT01262976|66210039|FG001|Up to Year 2|Withdrawal by Subject|0|||
23680134|NCT01262976|66210040|FG002|Up to Year 2|Withdrawal by Subject|0|||
23680135|NCT01262976|66210041|FG003|Up to Year 2|Withdrawal by Subject|0|||
23680136|NCT01262976|66210042|FG004|Up to Year 2|Withdrawal by Subject|0|||
23680137|NCT01262976|66210043|FG005|Up to Year 2|Withdrawal by Subject|0|||
23680138|NCT01262976|66210038|FG000|Up to Year 2|Migrated/moved from study area|0|||
23680139|NCT01262976|66210039|FG001|Up to Year 2|Migrated/moved from study area|0|||
23680140|NCT01262976|66210040|FG002|Up to Year 2|Migrated/moved from study area|0|||
23680141|NCT01262976|66210041|FG003|Up to Year 2|Migrated/moved from study area|2|||
23680142|NCT01262976|66210042|FG004|Up to Year 2|Migrated/moved from study area|1|||
23680143|NCT01262976|66210043|FG005|Up to Year 2|Migrated/moved from study area|2|||
23680144|NCT01262976|66210038|FG000|Up to Year 2|Lost to Follow-up|1|||
23680145|NCT01262976|66210039|FG001|Up to Year 2|Lost to Follow-up|1|||
23680146|NCT01262976|66210040|FG002|Up to Year 2|Lost to Follow-up|2|||
23680147|NCT01262976|66210041|FG003|Up to Year 2|Lost to Follow-up|2|||
23680148|NCT01262976|66210042|FG004|Up to Year 2|Lost to Follow-up|3|||
23680149|NCT01262976|66210043|FG005|Up to Year 2|Lost to Follow-up|3|||
23680150|NCT01262976|66210038|FG000|Up to Year 2|Subjects with unknown completion status|0|||
23680151|NCT01262976|66210039|FG001|Up to Year 2|Subjects with unknown completion status|0|||
23680152|NCT01262976|66210040|FG002|Up to Year 2|Subjects with unknown completion status|1|||
23680153|NCT01262976|66210041|FG003|Up to Year 2|Subjects with unknown completion status|0|||
23680154|NCT01262976|66210042|FG004|Up to Year 2|Subjects with unknown completion status|0|||
23680155|NCT01262976|66210043|FG005|Up to Year 2|Subjects with unknown completion status|0|||
23680156|NCT01262976|66210038|FG000|Up to Year 2|Other|3|||
23680157|NCT01262976|66210039|FG001|Up to Year 2|Other|0|||
23680158|NCT01262976|66210040|FG002|Up to Year 2|Other|0|||
23680159|NCT01262976|66210041|FG003|Up to Year 2|Other|0|||
23680160|NCT01262976|66210042|FG004|Up to Year 2|Other|0|||
23680161|NCT01262976|66210043|FG005|Up to Year 2|Other|0|||
23680162|NCT01262976|66210038|FG000|Up to Year 3|Serious Adverse Event|0|||
23680163|NCT01262976|66210039|FG001|Up to Year 3|Serious Adverse Event|0|||
23680164|NCT01262976|66210040|FG002|Up to Year 3|Serious Adverse Event|2|||
23680165|NCT01262976|66210041|FG003|Up to Year 3|Serious Adverse Event|0|||
23680166|NCT01262976|66210042|FG004|Up to Year 3|Serious Adverse Event|0|||
23680167|NCT01262976|66210043|FG005|Up to Year 3|Serious Adverse Event|0|||
23680168|NCT01262976|66210038|FG000|Up to Year 3|Withdrawal by Subject|1|||
23680169|NCT01262976|66210039|FG001|Up to Year 3|Withdrawal by Subject|0|||
23680170|NCT01262976|66210040|FG002|Up to Year 3|Withdrawal by Subject|0|||
23680171|NCT01262976|66210041|FG003|Up to Year 3|Withdrawal by Subject|0|||
23680172|NCT01262976|66210042|FG004|Up to Year 3|Withdrawal by Subject|0|||
23680173|NCT01262976|66210043|FG005|Up to Year 3|Withdrawal by Subject|0|||
23680174|NCT01262976|66210038|FG000|Up to Year 3|Migrated/moved from study area|0|||
23680175|NCT01262976|66210039|FG001|Up to Year 3|Migrated/moved from study area|0|||
23680176|NCT01262976|66210040|FG002|Up to Year 3|Migrated/moved from study area|0|||
23680177|NCT01262976|66210041|FG003|Up to Year 3|Migrated/moved from study area|2|||
23680178|NCT01262976|66210042|FG004|Up to Year 3|Migrated/moved from study area|1|||
23680179|NCT01262976|66210043|FG005|Up to Year 3|Migrated/moved from study area|1|||
23680180|NCT01262976|66210038|FG000|Up to Year 3|Lost to Follow-up|2|||
23680181|NCT01262976|66210039|FG001|Up to Year 3|Lost to Follow-up|2|||
23680182|NCT01262976|66210040|FG002|Up to Year 3|Lost to Follow-up|4|||
23680183|NCT01262976|66210041|FG003|Up to Year 3|Lost to Follow-up|3|||
23680184|NCT01262976|66210042|FG004|Up to Year 3|Lost to Follow-up|1|||
23680185|NCT01262976|66210043|FG005|Up to Year 3|Lost to Follow-up|3|||
23680186|NCT01262976|66210038|FG000|Up to Year 3|Subjects with unknown completion status|0|||
23680187|NCT01262976|66210039|FG001|Up to Year 3|Subjects with unknown completion status|0|||
23680188|NCT01262976|66210040|FG002|Up to Year 3|Subjects with unknown completion status|1|||
23680189|NCT01262976|66210041|FG003|Up to Year 3|Subjects with unknown completion status|0|||
23680190|NCT01262976|66210042|FG004|Up to Year 3|Subjects with unknown completion status|0|||
23680191|NCT01262976|66210043|FG005|Up to Year 3|Subjects with unknown completion status|0|||
23680192|NCT01262976|66210038|FG000|Up to Year 3|Other|3|||
23680193|NCT01262976|66210039|FG001|Up to Year 3|Other|0|||
23680194|NCT01262976|66210040|FG002|Up to Year 3|Other|0|||
23389563|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389564|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
23389565|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389566|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389567|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389568|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
23389569|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389570|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
23389571|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389572|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389573|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389574|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
23389575|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
23389576|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
23389577|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389578|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389579|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389580|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
23389581|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
23389582|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
23389583|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389584|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389585|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389586|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389587|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389588|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
23680195|NCT01262976|66210041|FG003|Up to Year 3|Other|0|||
23680196|NCT01262976|66210042|FG004|Up to Year 3|Other|0|||
23680197|NCT01262976|66210043|FG005|Up to Year 3|Other|0|||
23680198|NCT02631200|66210045|FG000|First Period|Death|1|||
23680199|NCT02631200|66210046|FG001|First Period|Death|2|||
23680200|NCT02631200|66210045|FG000|First Period|Patient ill-health|2|||
23680201|NCT02631200|66210046|FG001|First Period|Patient ill-health|4|||
23680202|NCT02631200|66210045|FG000|First Period|Withdrawal by Subject|4|||
23680203|NCT02631200|66210046|FG001|First Period|Withdrawal by Subject|1|||
23680204|NCT02631200|66210045|FG000|Deferred Period|Death|0|||
23389589|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
23389590|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
23389591|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389592|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389593|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389594|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23680205|NCT02631200|66210046|FG001|Deferred Period|Death|1|||
23680206|NCT02631200|66210045|FG000|Deferred Period|Received kidney transplant|0|||
23389595|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
23389596|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
23389597|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389598|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23680207|NCT02631200|66210046|FG001|Deferred Period|Received kidney transplant|1|||
23680208|NCT02631200|66210045|FG000|Deferred Period|Withdrawal by Subject|0|||
23680209|NCT02631200|66210046|FG001|Deferred Period|Withdrawal by Subject|2|||
23680210|NCT02631200|66210045|FG000|Deferred Period|Lost to Follow-up|0|||
23680211|NCT02631200|66210046|FG001|Deferred Period|Lost to Follow-up|1|||
23680212|NCT02450487|66210047|FG000|Overall Study|Lost to Follow-up|3|||
23680213|NCT02154425|66210048|FG000|Screening Period|Adverse Event|1|||
23680214|NCT02817087|66210051|FG000|Overall Study|Withdrawal by Subject|2|||
23389599|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389600|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389601|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
23389602|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
23389603|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389604|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389605|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389606|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389607|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
23680215|NCT02817087|66210052|FG001|Overall Study|Withdrawal by Subject|0|||
23680216|NCT01407926|66210055|FG000|Overall Study|Lost to Follow-up|55|||
23680217|NCT01439945|66210056|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23680218|NCT01439945|66210057|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23680219|NCT01439945|66210058|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23680220|NCT01439945|66210059|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23680221|NCT01439945|66210056|FG000|Double-Blind Treatment Phase|Ineligible|1|||
23680222|NCT01439945|66210057|FG001|Double-Blind Treatment Phase|Ineligible|2|||
23680223|NCT01439945|66210058|FG002|Double-Blind Treatment Phase|Ineligible|0|||
23680224|NCT01439945|66210059|FG003|Double-Blind Treatment Phase|Ineligible|1|||
23680225|NCT01813890|66210060|FG000|Overall Study|Adverse Event|0|||
23680226|NCT01813890|66210061|FG001|Overall Study|Adverse Event|3|||
23680227|NCT01813890|66210062|FG002|Overall Study|Adverse Event|4|||
23680228|NCT01813890|66210060|FG000|Overall Study|Lack of Efficacy|9|||
23680229|NCT01813890|66210061|FG001|Overall Study|Lack of Efficacy|1|||
23680230|NCT01813890|66210062|FG002|Overall Study|Lack of Efficacy|2|||
23680231|NCT01001702|66210066|FG000|Overall Study|Lost to Follow-up|7|||
23680232|NCT01001702|66210066|FG000|Overall Study|Adverse Event|7|||
23680233|NCT01001702|66210066|FG000|Overall Study|Sponsor Discontinued Study|4|||
23680234|NCT01001702|66210066|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
23680235|NCT01001702|66210066|FG000|Overall Study|Investigator withdrew Subject|10|||
23680236|NCT01001702|66210066|FG000|Overall Study|Withdrawal by Subject|19|||
23680237|NCT01001702|66210066|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
23680238|NCT00486278|66210069|FG000|Overall Study|Adverse Event|5|||
23680239|NCT00486278|66210069|FG000|Overall Study|Withdrawal by Subject|2|||
23680240|NCT00486278|66210069|FG000|Overall Study|Physician Decision|2|||
23680241|NCT02971202|66210072|FG000|Overall Study|Pregnancy|1|||
23680242|NCT02971202|66210073|FG001|Overall Study|Pregnancy|0|||
23680243|NCT02971202|66210074|FG002|Overall Study|Pregnancy|0|||
23389608|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
23389609|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
23389610|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
23389611|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
23389612|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
23389613|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
23389614|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
23389615|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
23389616|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
23389617|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
23389618|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
23389619|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
23389620|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
23680244|NCT02971202|66210072|FG000|Overall Study|screen fail after consent|1|||
23680245|NCT02971202|66210073|FG001|Overall Study|screen fail after consent|0|||
23680246|NCT02971202|66210074|FG002|Overall Study|screen fail after consent|1|||
23680247|NCT00818259|66210075|FG000|Part I|Withdrawal by Subject|1|||
23680248|NCT00818259|66210076|FG001|Part I|Withdrawal by Subject|0|||
23680249|NCT00818259|66210077|FG002|Part I|Withdrawal by Subject|0|||
23680250|NCT00818259|66210078|FG003|Part I|Withdrawal by Subject|0|||
23680251|NCT00818259|66210079|FG004|Part I|Withdrawal by Subject|0|||
23680252|NCT00818259|66210080|FG005|Part I|Withdrawal by Subject|0|||
23680253|NCT00818259|66210081|FG006|Part I|Withdrawal by Subject|0|||
23680254|NCT00818259|66210082|FG007|Part I|Withdrawal by Subject|0|||
23680255|NCT00818259|66210083|FG008|Part I|Withdrawal by Subject|0|||
23680256|NCT00818259|66210075|FG000|Part II|Physician Decision|0|||
23680257|NCT00818259|66210076|FG001|Part II|Physician Decision|0|||
23680258|NCT00818259|66210077|FG002|Part II|Physician Decision|1|||
23680259|NCT00818259|66210078|FG003|Part II|Physician Decision|0|||
23680260|NCT00818259|66210079|FG004|Part II|Physician Decision|0|||
23680261|NCT00818259|66210080|FG005|Part II|Physician Decision|0|||
23680262|NCT00818259|66210081|FG006|Part II|Physician Decision|0|||
23680263|NCT00818259|66210082|FG007|Part II|Physician Decision|0|||
23680264|NCT00818259|66210083|FG008|Part II|Physician Decision|0|||
23680265|NCT00818259|66210075|FG000|Part II|Lack of Efficacy|0|||
23680266|NCT00818259|66210076|FG001|Part II|Lack of Efficacy|0|||
23680267|NCT00818259|66210077|FG002|Part II|Lack of Efficacy|0|||
23680268|NCT00818259|66210078|FG003|Part II|Lack of Efficacy|1|||
23680269|NCT00818259|66210079|FG004|Part II|Lack of Efficacy|0|||
23680270|NCT00818259|66210080|FG005|Part II|Lack of Efficacy|0|||
23680271|NCT00818259|66210081|FG006|Part II|Lack of Efficacy|0|||
23680272|NCT00818259|66210082|FG007|Part II|Lack of Efficacy|0|||
23680273|NCT00818259|66210083|FG008|Part II|Lack of Efficacy|0|||
23680274|NCT00818259|66210075|FG000|Part II|Not Treated|0|||
23680275|NCT00818259|66210076|FG001|Part II|Not Treated|0|||
23680276|NCT00818259|66210077|FG002|Part II|Not Treated|0|||
23680277|NCT00818259|66210078|FG003|Part II|Not Treated|1|||
23680278|NCT00818259|66210079|FG004|Part II|Not Treated|0|||
23680279|NCT00818259|66210080|FG005|Part II|Not Treated|0|||
23680280|NCT00818259|66210081|FG006|Part II|Not Treated|0|||
23680281|NCT00818259|66210082|FG007|Part II|Not Treated|0|||
23680282|NCT00818259|66210083|FG008|Part II|Not Treated|0|||
23680283|NCT00818259|66210075|FG000|Part IV|Physician Decision|0|||
23680284|NCT00818259|66210076|FG001|Part IV|Physician Decision|0|||
23680285|NCT00818259|66210077|FG002|Part IV|Physician Decision|0|||
23680286|NCT00818259|66210078|FG003|Part IV|Physician Decision|0|||
23680287|NCT00818259|66210079|FG004|Part IV|Physician Decision|0|||
23680288|NCT00818259|66210080|FG005|Part IV|Physician Decision|1|||
23680289|NCT00818259|66210081|FG006|Part IV|Physician Decision|0|||
23680290|NCT00818259|66210082|FG007|Part IV|Physician Decision|0|||
23680291|NCT00818259|66210083|FG008|Part IV|Physician Decision|0|||
23680292|NCT00818259|66210075|FG000|Part V|Adverse Event|0|||
23680293|NCT00818259|66210076|FG001|Part V|Adverse Event|0|||
23680294|NCT00818259|66210077|FG002|Part V|Adverse Event|0|||
23680295|NCT00818259|66210078|FG003|Part V|Adverse Event|0|||
23680296|NCT00818259|66210079|FG004|Part V|Adverse Event|0|||
23680297|NCT00818259|66210080|FG005|Part V|Adverse Event|0|||
23680298|NCT00818259|66210081|FG006|Part V|Adverse Event|0|||
23680299|NCT00818259|66210082|FG007|Part V|Adverse Event|1|||
23680300|NCT00818259|66210083|FG008|Part V|Adverse Event|0|||
23680301|NCT00630331|66210084|FG000|Overall Study|Death|2|||
23680302|NCT00630331|66210085|FG001|Overall Study|Death|1|||
23680303|NCT00630331|66210086|FG002|Overall Study|Death|1|||
23680304|NCT00630331|66210084|FG000|Overall Study|Adverse Event|1|||
23680305|NCT00630331|66210085|FG001|Overall Study|Adverse Event|0|||
23680306|NCT00630331|66210086|FG002|Overall Study|Adverse Event|0|||
23389621|NCT02579759|65171774|FG000|Overall Study|Protocol Violation|2|||
23680307|NCT00630331|66210084|FG000|Overall Study|Withdrawal by Subject|12|||
23680308|NCT00630331|66210085|FG001|Overall Study|Withdrawal by Subject|7|||
23680309|NCT00630331|66210086|FG002|Overall Study|Withdrawal by Subject|5|||
23389622|NCT02579759|65171775|FG001|Overall Study|Protocol Violation|0|||
23389623|NCT02579759|65171776|FG002|Overall Study|Protocol Violation|0|||
23389624|NCT02579759|65171774|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
23389625|NCT02579759|65171775|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
23389626|NCT02579759|65171776|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
23680310|NCT00630331|66210084|FG000|Overall Study|Lost to Follow-up|175|||
23680311|NCT00630331|66210085|FG001|Overall Study|Lost to Follow-up|143|||
23389627|NCT02579759|65171774|FG000|Overall Study|BfArM hold|13|||
23389628|NCT02579759|65171775|FG001|Overall Study|BfArM hold|12|||
23389629|NCT02579759|65171776|FG002|Overall Study|BfArM hold|12|||
23389630|NCT02579759|65171774|FG000|Overall Study|Sponsor stopped Dose 2|0|||
23389631|NCT02579759|65171775|FG001|Overall Study|Sponsor stopped Dose 2|41|||
23389632|NCT02579759|65171776|FG002|Overall Study|Sponsor stopped Dose 2|0|||
23389633|NCT02579759|65171774|FG000|Overall Study|Non compliance|0|||
23389634|NCT02579759|65171775|FG001|Overall Study|Non compliance|1|||
23389635|NCT02579759|65171776|FG002|Overall Study|Non compliance|0|||
23389636|NCT02579759|65171774|FG000|Overall Study|Pregnancy|0|||
23389637|NCT02579759|65171775|FG001|Overall Study|Pregnancy|1|||
23389638|NCT02579759|65171776|FG002|Overall Study|Pregnancy|0|||
23389639|NCT02579759|65171774|FG000|Overall Study|Inclusion/exclusion criteria|0|||
23389640|NCT02579759|65171775|FG001|Overall Study|Inclusion/exclusion criteria|0|||
23389641|NCT02579759|65171776|FG002|Overall Study|Inclusion/exclusion criteria|1|||
23389642|NCT02579759|65171774|FG000|Overall Study|Adverse Event|4|||
23389643|NCT02579759|65171775|FG001|Overall Study|Adverse Event|3|||
23389644|NCT02579759|65171776|FG002|Overall Study|Adverse Event|1|||
23389645|NCT02579759|65171774|FG000|Overall Study|Withdrawal by Subject|3|||
23389646|NCT02579759|65171775|FG001|Overall Study|Withdrawal by Subject|3|||
23389647|NCT02579759|65171776|FG002|Overall Study|Withdrawal by Subject|5|||
23389648|NCT02579759|65171774|FG000|Overall Study|Lost to Follow-up|2|||
23389649|NCT02579759|65171775|FG001|Overall Study|Lost to Follow-up|2|||
23389650|NCT02579759|65171776|FG002|Overall Study|Lost to Follow-up|2|||
23389651|NCT00449787|65171777|FG000|Overall Study|Lost to Follow-up|10|||
23389652|NCT00449787|65171778|FG001|Overall Study|Lost to Follow-up|8|||
23389653|NCT00449787|65171777|FG000|Overall Study|Did not require medication|95|||
23389654|NCT00449787|65171778|FG001|Overall Study|Did not require medication|92|||
23389655|NCT01546987|65171779|FG000|Overall Study|Protocol Violation|3|||
23389656|NCT01546987|65171780|FG001|Overall Study|Protocol Violation|4|||
23389657|NCT01309100|65171781|FG000|Overall Study|Protocol Violation|1|||
23389658|NCT01309100|65171781|FG000|Overall Study|Positive Slit lamp finding|1|||
23389659|NCT02038647|65171783|FG000|Overall Study|Progressive Disease|50|||
23389660|NCT02038647|65171784|FG001|Overall Study|Progressive Disease|59|||
23389661|NCT02038647|65171783|FG000|Overall Study|Adverse Event|18|||
23389662|NCT02038647|65171784|FG001|Overall Study|Adverse Event|10|||
23389663|NCT02038647|65171783|FG000|Overall Study|Symptomatic Deterioration|7|||
23389664|NCT02038647|65171784|FG001|Overall Study|Symptomatic Deterioration|7|||
23389665|NCT02038647|65171783|FG000|Overall Study|Withdrawal by Subject|5|||
23389666|NCT02038647|65171784|FG001|Overall Study|Withdrawal by Subject|2|||
23389667|NCT02038647|65171783|FG000|Overall Study|Not Reported|0|||
23389668|NCT02038647|65171784|FG001|Overall Study|Not Reported|1|||
23389669|NCT02038647|65171783|FG000|Overall Study|Ongoing at Datacut|9|||
23389670|NCT02038647|65171784|FG001|Overall Study|Ongoing at Datacut|10|||
23389671|NCT05626686|65171785|FG000|Overall Study|Protocol Violation|3|||
23389672|NCT05626686|65171785|FG000|Overall Study|Withdrawal by Subject|3|||
23389673|NCT00128492|65171791|FG000|Overall Study|AE unrelated to study|2|||
23680312|NCT00630331|66210086|FG002|Overall Study|Lost to Follow-up|170|||
23680313|NCT00630331|66210084|FG000|Overall Study|Inappropriate enrollment|3|||
23389674|NCT00128492|65171792|FG001|Overall Study|AE unrelated to study|9|||
23389675|NCT00128492|65171791|FG000|Overall Study|Study drug intolerance (AE)|2|||
23389676|NCT00128492|65171792|FG001|Overall Study|Study drug intolerance (AE)|8|||
23389677|NCT00128492|65171791|FG000|Overall Study|AE related to study|1|||
23389678|NCT00128492|65171792|FG001|Overall Study|AE related to study|4|||
23389679|NCT00128492|65171791|FG000|Overall Study|Death|1|||
23389680|NCT00128492|65171792|FG001|Overall Study|Death|0|||
23680314|NCT00630331|66210085|FG001|Overall Study|Inappropriate enrollment|6|||
23680315|NCT00630331|66210086|FG002|Overall Study|Inappropriate enrollment|3|||
23680316|NCT00630331|66210084|FG000|Overall Study|Unable to classify|9|||
23680317|NCT00630331|66210085|FG001|Overall Study|Unable to classify|4|||
23680318|NCT00630331|66210086|FG002|Overall Study|Unable to classify|3|||
23680319|NCT00630331|66210084|FG000|Overall Study|Protocol Violation|4|||
23680320|NCT00630331|66210085|FG001|Overall Study|Protocol Violation|5|||
23680321|NCT00630331|66210086|FG002|Overall Study|Protocol Violation|6|||
23680322|NCT01276236|66210087|FG000|Overall Study|Lack of Efficacy|2|||
23680323|NCT01276236|66210087|FG000|Overall Study|Withdrawal by Subject|4|||
23680324|NCT01506882|66210088|FG000|Overall Study|Lack of Efficacy|4|||
23680325|NCT01506882|66210089|FG001|Overall Study|Lack of Efficacy|3|||
23680326|NCT01506882|66210088|FG000|Overall Study|Lost to Follow-up|1|||
23680327|NCT01506882|66210089|FG001|Overall Study|Lost to Follow-up|0|||
23389681|NCT00128492|65171791|FG000|Overall Study|Lost to Follow-up|1|||
23389682|NCT00128492|65171792|FG001|Overall Study|Lost to Follow-up|5|||
23389683|NCT00128492|65171791|FG000|Overall Study|Noncompliance|0|||
23389684|NCT00128492|65171792|FG001|Overall Study|Noncompliance|5|||
23389685|NCT00128492|65171791|FG000|Overall Study|Personal or administrative|10|||
23389686|NCT00128492|65171792|FG001|Overall Study|Personal or administrative|22|||
23389687|NCT00128492|65171791|FG000|Overall Study|Withdrawal by Subject|3|||
23389688|NCT00128492|65171792|FG001|Overall Study|Withdrawal by Subject|5|||
23389689|NCT00128492|65171791|FG000|Overall Study|Pregnancy|0|||
23389690|NCT00128492|65171792|FG001|Overall Study|Pregnancy|1|||
23494906|NCT00668707|65555030|FG001|Overall Study|Cancer Recurrence|58|||
23494907|NCT00668707|65555029|FG000|Overall Study|Withdrawal by Subject|117|||
23494908|NCT00668707|65555030|FG001|Overall Study|Withdrawal by Subject|100|||
23494909|NCT00668707|65555029|FG000|Overall Study|Lost to Follow-up|3|||
23494910|NCT00668707|65555030|FG001|Overall Study|Lost to Follow-up|6|||
23494911|NCT00668707|65555029|FG000|Overall Study|Protocol Violation|10|||
23494912|NCT00668707|65555030|FG001|Overall Study|Protocol Violation|12|||
23494913|NCT00668707|65555029|FG000|Overall Study|Death|11|||
23494914|NCT00668707|65555030|FG001|Overall Study|Death|4|||
23494915|NCT03758443|65555031|FG000|Induction Period|Adverse Event|2|||
23494916|NCT03758443|65555032|FG001|Induction Period|Adverse Event|4|||
23494917|NCT03758443|65555033|FG002|Induction Period|Adverse Event|2|||
23494918|NCT03758443|65555034|FG003|Induction Period|Adverse Event|3|||
23494919|NCT03758443|65555031|FG000|Induction Period|Physician Decision|1|||
23494920|NCT03758443|65555032|FG001|Induction Period|Physician Decision|1|||
23389691|NCT03111108|65171793|FG000|Overall Study|Death|0|||
23389692|NCT03111108|65171794|FG001|Overall Study|Death|1|||
23389693|NCT03111108|65171793|FG000|Overall Study|Withdrawal by Subject|1|||
23494921|NCT03758443|65555033|FG002|Induction Period|Physician Decision|3|||
23494922|NCT03758443|65555034|FG003|Induction Period|Physician Decision|0|||
23494923|NCT03758443|65555031|FG000|Induction Period|Protocol Violation|0|||
23494924|NCT03758443|65555032|FG001|Induction Period|Protocol Violation|0|||
23494925|NCT03758443|65555033|FG002|Induction Period|Protocol Violation|0|||
23494926|NCT03758443|65555034|FG003|Induction Period|Protocol Violation|1|||
23680328|NCT01506882|66210088|FG000|Overall Study|Withdrawal by Subject|9|||
23680329|NCT01506882|66210089|FG001|Overall Study|Withdrawal by Subject|3|||
23680330|NCT01506882|66210088|FG000|Overall Study|SAE, non-fatal|2|||
23389694|NCT03111108|65171794|FG001|Overall Study|Withdrawal by Subject|0|||
23494927|NCT03758443|65555031|FG000|Induction Period|Withdrawal by Subject|3|||
23494928|NCT03758443|65555032|FG001|Induction Period|Withdrawal by Subject|2|||
23494929|NCT03758443|65555033|FG002|Induction Period|Withdrawal by Subject|2|||
23680331|NCT01506882|66210089|FG001|Overall Study|SAE, non-fatal|0|||
23680332|NCT01506882|66210088|FG000|Overall Study|AE, non-serious non-fatal|3|||
23680333|NCT01506882|66210089|FG001|Overall Study|AE, non-serious non-fatal|1|||
23494930|NCT03758443|65555034|FG003|Induction Period|Withdrawal by Subject|4|||
23494931|NCT03758443|65555031|FG000|Extended Induction Period|Adverse Event|1|||
23494932|NCT03758443|65555032|FG001|Extended Induction Period|Adverse Event|1|||
23494933|NCT03758443|65555033|FG002|Extended Induction Period|Adverse Event|0|||
23494934|NCT03758443|65555034|FG003|Extended Induction Period|Adverse Event|1|||
23494935|NCT03758443|65555031|FG000|Extended Induction Period|Lost to Follow-up|1|||
23494936|NCT03758443|65555032|FG001|Extended Induction Period|Lost to Follow-up|0|||
23494937|NCT03758443|65555033|FG002|Extended Induction Period|Lost to Follow-up|0|||
23494938|NCT03758443|65555034|FG003|Extended Induction Period|Lost to Follow-up|0|||
23494939|NCT03758443|65555031|FG000|Extended Induction Period|Physician Decision|2|||
23494940|NCT03758443|65555032|FG001|Extended Induction Period|Physician Decision|1|||
23494941|NCT03758443|65555033|FG002|Extended Induction Period|Physician Decision|2|||
23494942|NCT03758443|65555034|FG003|Extended Induction Period|Physician Decision|2|||
23494943|NCT03758443|65555031|FG000|Extended Induction Period|Protocol Violation|0|||
23494944|NCT03758443|65555032|FG001|Extended Induction Period|Protocol Violation|0|||
23494945|NCT03758443|65555033|FG002|Extended Induction Period|Protocol Violation|0|||
23494946|NCT03758443|65555034|FG003|Extended Induction Period|Protocol Violation|1|||
23494947|NCT03758443|65555031|FG000|Extended Induction Period|Withdrawal by Subject|8|||
23389695|NCT00203242|65171795|FG000|Overall Study|Lost to Follow-up|1|||
23389696|NCT01959919|65171797|FG000|Overall Study|Did not meet the eligibility criteria|2|||
23389697|NCT02741193|65171798|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
23389698|NCT02741193|65171798|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
23389699|NCT02011542|65171800|FG000|Overall Study|Physician Decision|1|||
23389700|NCT04309500|65171801|FG000|Overall Study|Lost to Follow-up|1|||
23389701|NCT04309500|65171802|FG001|Overall Study|Lost to Follow-up|0|||
23389702|NCT04309500|65171803|FG002|Overall Study|Lost to Follow-up|0|||
23389703|NCT04309500|65171804|FG003|Overall Study|Lost to Follow-up|0|||
23389704|NCT02940223|65171805|FG000|Overall Study|Failed Requirement|2|||
23389705|NCT02940223|65171806|FG001|Overall Study|Failed Requirement|0|||
23389706|NCT00004228|65171807|FG000|Overall Study|Adverse Event|0|||
23389707|NCT00004228|65171808|FG001|Overall Study|Adverse Event|1|||
23389708|NCT00004228|65171809|FG002|Overall Study|Adverse Event|0|||
23389709|NCT00004228|65171810|FG003|Overall Study|Adverse Event|0|||
23389710|NCT00004228|65171811|FG004|Overall Study|Adverse Event|1|||
23389711|NCT00004228|65171812|FG005|Overall Study|Adverse Event|0|||
23389712|NCT00004228|65171813|FG006|Overall Study|Adverse Event|0|||
23389713|NCT00004228|65171807|FG000|Overall Study|Death|0|||
23389714|NCT00004228|65171808|FG001|Overall Study|Death|1|||
23389715|NCT00004228|65171809|FG002|Overall Study|Death|2|||
23389716|NCT00004228|65171810|FG003|Overall Study|Death|0|||
23389717|NCT00004228|65171811|FG004|Overall Study|Death|1|||
23389718|NCT00004228|65171812|FG005|Overall Study|Death|0|||
23389719|NCT00004228|65171813|FG006|Overall Study|Death|0|||
23389720|NCT00004228|65171807|FG000|Overall Study|Lack of Efficacy|1|||
23389721|NCT00004228|65171808|FG001|Overall Study|Lack of Efficacy|6|||
23389722|NCT00004228|65171809|FG002|Overall Study|Lack of Efficacy|5|||
23389723|NCT00004228|65171810|FG003|Overall Study|Lack of Efficacy|3|||
23389724|NCT00004228|65171811|FG004|Overall Study|Lack of Efficacy|9|||
23389725|NCT00004228|65171812|FG005|Overall Study|Lack of Efficacy|8|||
23389726|NCT00004228|65171813|FG006|Overall Study|Lack of Efficacy|4|||
23389727|NCT00004228|65171807|FG000|Overall Study|Lost to Follow-up|0|||
23389728|NCT00004228|65171808|FG001|Overall Study|Lost to Follow-up|0|||
23389729|NCT00004228|65171809|FG002|Overall Study|Lost to Follow-up|1|||
23389730|NCT00004228|65171810|FG003|Overall Study|Lost to Follow-up|0|||
23389731|NCT00004228|65171811|FG004|Overall Study|Lost to Follow-up|0|||
23389732|NCT00004228|65171812|FG005|Overall Study|Lost to Follow-up|0|||
23389733|NCT00004228|65171813|FG006|Overall Study|Lost to Follow-up|0|||
23389734|NCT00004228|65171807|FG000|Overall Study|Physician Decision|1|||
23389735|NCT00004228|65171808|FG001|Overall Study|Physician Decision|0|||
23389736|NCT00004228|65171809|FG002|Overall Study|Physician Decision|3|||
23494948|NCT03758443|65555032|FG001|Extended Induction Period|Withdrawal by Subject|1|||
23494949|NCT03758443|65555033|FG002|Extended Induction Period|Withdrawal by Subject|7|||
23494950|NCT03758443|65555034|FG003|Extended Induction Period|Withdrawal by Subject|3|||
23494951|NCT03758443|65555031|FG000|Extended Induction Period|Miscellaneous|1|||
23494952|NCT03758443|65555032|FG001|Extended Induction Period|Miscellaneous|0|||
23494953|NCT03758443|65555033|FG002|Extended Induction Period|Miscellaneous|0|||
23389737|NCT00004228|65171810|FG003|Overall Study|Physician Decision|2|||
23389738|NCT00004228|65171811|FG004|Overall Study|Physician Decision|1|||
23389739|NCT00004228|65171812|FG005|Overall Study|Physician Decision|1|||
23389740|NCT00004228|65171813|FG006|Overall Study|Physician Decision|1|||
23389741|NCT00004228|65171807|FG000|Overall Study|Protocol Violation|0|||
23389742|NCT00004228|65171808|FG001|Overall Study|Protocol Violation|5|||
23389743|NCT00004228|65171809|FG002|Overall Study|Protocol Violation|2|||
23389744|NCT00004228|65171810|FG003|Overall Study|Protocol Violation|1|||
23389745|NCT00004228|65171811|FG004|Overall Study|Protocol Violation|1|||
23494954|NCT03758443|65555034|FG003|Extended Induction Period|Miscellaneous|0|||
23494955|NCT03758443|65555031|FG000|Maintenance Period|Adverse Event|1|||
23494956|NCT03758443|65555032|FG001|Maintenance Period|Adverse Event|2|||
23680334|NCT01506882|66210088|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23680335|NCT01506882|66210089|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23680336|NCT01506882|66210088|FG000|Overall Study|Other Reason|2|||
23680337|NCT01506882|66210089|FG001|Overall Study|Other Reason|0|||
23680338|NCT02549339|66210092|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
23680339|NCT02549339|66210093|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
23389746|NCT00004228|65171812|FG005|Overall Study|Protocol Violation|2|||
23389747|NCT00004228|65171813|FG006|Overall Study|Protocol Violation|0|||
23389748|NCT00004228|65171807|FG000|Overall Study|Withdrawal by Subject|3|||
23389749|NCT00004228|65171808|FG001|Overall Study|Withdrawal by Subject|0|||
23389750|NCT00004228|65171809|FG002|Overall Study|Withdrawal by Subject|1|||
23389751|NCT00004228|65171810|FG003|Overall Study|Withdrawal by Subject|0|||
23389752|NCT00004228|65171811|FG004|Overall Study|Withdrawal by Subject|2|||
23389753|NCT00004228|65171812|FG005|Overall Study|Withdrawal by Subject|1|||
23389754|NCT00004228|65171813|FG006|Overall Study|Withdrawal by Subject|2|||
23389755|NCT00004228|65171807|FG000|Overall Study|Other|0|||
23389756|NCT00004228|65171808|FG001|Overall Study|Other|0|||
23389757|NCT00004228|65171809|FG002|Overall Study|Other|1|||
23389758|NCT00004228|65171810|FG003|Overall Study|Other|0|||
23389759|NCT00004228|65171811|FG004|Overall Study|Other|0|||
23389760|NCT00004228|65171812|FG005|Overall Study|Other|0|||
23389761|NCT00004228|65171813|FG006|Overall Study|Other|0|||
23389762|NCT00004228|65171807|FG000|Overall Study|ineligible|4|||
23494957|NCT03758443|65555033|FG002|Maintenance Period|Adverse Event|0|||
23494958|NCT03758443|65555034|FG003|Maintenance Period|Adverse Event|0|||
23494959|NCT03758443|65555031|FG000|Maintenance Period|Lost to Follow-up|0|||
23494960|NCT03758443|65555032|FG001|Maintenance Period|Lost to Follow-up|0|||
23494961|NCT03758443|65555033|FG002|Maintenance Period|Lost to Follow-up|0|||
23494962|NCT03758443|65555034|FG003|Maintenance Period|Lost to Follow-up|1|||
23494963|NCT03758443|65555031|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
23494964|NCT03758443|65555032|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
23494965|NCT03758443|65555033|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
23494966|NCT03758443|65555034|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
23494967|NCT03758443|65555031|FG000|Maintenance Period|Protocol Violation|0|||
23494968|NCT03758443|65555032|FG001|Maintenance Period|Protocol Violation|1|||
23494969|NCT03758443|65555033|FG002|Maintenance Period|Protocol Violation|0|||
23494970|NCT03758443|65555034|FG003|Maintenance Period|Protocol Violation|0|||
23494971|NCT03758443|65555031|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
23494972|NCT03758443|65555032|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
23389763|NCT00004228|65171808|FG001|Overall Study|ineligible|2|||
23389764|NCT00004228|65171809|FG002|Overall Study|ineligible|4|||
23389765|NCT00004228|65171810|FG003|Overall Study|ineligible|1|||
23389766|NCT00004228|65171811|FG004|Overall Study|ineligible|1|||
23389767|NCT00004228|65171812|FG005|Overall Study|ineligible|2|||
23389768|NCT00004228|65171813|FG006|Overall Study|ineligible|5|||
23389769|NCT03810365|65171816|FG000|Overall Study|Lost to Follow-up|2|||
23389770|NCT03810365|65171817|FG001|Overall Study|Lost to Follow-up|2|||
23389771|NCT03810365|65171816|FG000|Overall Study|Withdrawal by Subject|4|||
23389772|NCT03810365|65171817|FG001|Overall Study|Withdrawal by Subject|5|||
23389773|NCT01044459|65171818|FG000|Overall Study|Withdrawal by Subject|21|||
23389774|NCT01044459|65171819|FG001|Overall Study|Withdrawal by Subject|28|||
23389775|NCT01044459|65171818|FG000|Overall Study|Terminated by Sponsor|22|||
23389776|NCT01044459|65171819|FG001|Overall Study|Terminated by Sponsor|21|||
23389777|NCT01044459|65171818|FG000|Overall Study|Adverse Event|22|||
23389778|NCT01044459|65171819|FG001|Overall Study|Adverse Event|20|||
23389779|NCT01044459|65171818|FG000|Overall Study|Lack of Efficacy|23|||
23389780|NCT01044459|65171819|FG001|Overall Study|Lack of Efficacy|12|||
23389781|NCT01044459|65171818|FG000|Overall Study|Protocol Violation|11|||
23389782|NCT01044459|65171819|FG001|Overall Study|Protocol Violation|16|||
23389783|NCT01044459|65171818|FG000|Overall Study|Other Reason|7|||
23389784|NCT01044459|65171819|FG001|Overall Study|Other Reason|14|||
23389785|NCT01044459|65171818|FG000|Overall Study|COPD exacerbation|9|||
23389786|NCT01044459|65171819|FG001|Overall Study|COPD exacerbation|8|||
23494973|NCT03758443|65555033|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
23494974|NCT03758443|65555034|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
23680340|NCT02549339|66210092|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
23680341|NCT02549339|66210093|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
23680342|NCT02549339|66210092|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
23680343|NCT02549339|66210093|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
23680344|NCT02549339|66210092|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
23680345|NCT02549339|66210093|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
23680346|NCT02549339|66210092|FG000|12-month Follow-up|Lack of Efficacy|0|||
23680347|NCT02549339|66210093|FG001|12-month Follow-up|Lack of Efficacy|2|||
23680348|NCT02549339|66210092|FG000|12-month Follow-up|Withdrawal by Subject|8|||
23680349|NCT02549339|66210093|FG001|12-month Follow-up|Withdrawal by Subject|3|||
23680350|NCT02549339|66210092|FG000|12-month Follow-up|Lost to Follow-up|1|||
23680351|NCT02549339|66210093|FG001|12-month Follow-up|Lost to Follow-up|3|||
23680352|NCT02549339|66210092|FG000|12-month Follow-up|Other|0|||
23680353|NCT02549339|66210093|FG001|12-month Follow-up|Other|3|||
23680354|NCT01960855|66210101|FG000|Overall Study|Subject noncompliant|1|||
23680355|NCT01960855|66210102|FG001|Overall Study|Subject noncompliant|0|||
23494975|NCT03758443|65555031|FG000|Maintenance Period|Withdrawal by Subject|1|||
23494976|NCT03758443|65555032|FG001|Maintenance Period|Withdrawal by Subject|0|||
23680356|NCT01960855|66210103|FG002|Overall Study|Subject noncompliant|0|||
23389787|NCT01044459|65171818|FG000|Overall Study|Lost to Follow-up|18|||
23389788|NCT01044459|65171819|FG001|Overall Study|Lost to Follow-up|12|||
23680357|NCT01960855|66210104|FG003|Overall Study|Subject noncompliant|0|||
23680358|NCT01960855|66210105|FG004|Overall Study|Subject noncompliant|0|||
23680359|NCT01960855|66210101|FG000|Overall Study|Adverse Event|2|||
23389789|NCT00787800|65171820|FG000|Overall Study|Withdrawal by Subject|3|||
23389790|NCT00787800|65171821|FG001|Overall Study|Withdrawal by Subject|5|||
23389791|NCT00787800|65171820|FG000|Overall Study|Death|0|||
23389792|NCT00787800|65171821|FG001|Overall Study|Death|2|||
23389793|NCT03160573|65171822|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
23389794|NCT03160573|65171823|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
23389795|NCT03160573|65171824|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
23389796|NCT03160573|65171825|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
23389797|NCT00124657|65171826|FG000|Overall Study|Toxicity|0|||
23389798|NCT00124657|65171827|FG001|Overall Study|Toxicity|0|||
23389799|NCT00124657|65171828|FG002|Overall Study|Toxicity|1|||
23389800|NCT00124657|65171826|FG000|Overall Study|Non-compliance|1|||
23389801|NCT00124657|65171827|FG001|Overall Study|Non-compliance|0|||
23389802|NCT00124657|65171828|FG002|Overall Study|Non-compliance|4|||
23389803|NCT00124657|65171826|FG000|Overall Study|Progressive disease|14|||
23389804|NCT00124657|65171827|FG001|Overall Study|Progressive disease|5|||
23389805|NCT00124657|65171828|FG002|Overall Study|Progressive disease|27|||
23389806|NCT00124657|65171826|FG000|Overall Study|Intercurrent illness|1|||
23389807|NCT00124657|65171827|FG001|Overall Study|Intercurrent illness|0|||
23389808|NCT00124657|65171828|FG002|Overall Study|Intercurrent illness|0|||
23389809|NCT04204902|65171829|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
23389810|NCT04204902|65171830|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
23389811|NCT04642079|65171833|FG000|Overall Study|Lost to Follow-up|2|||
23389812|NCT04642079|65171834|FG001|Overall Study|Lost to Follow-up|5|||
23680360|NCT01960855|66210102|FG001|Overall Study|Adverse Event|0|||
23389813|NCT04642079|65171835|FG002|Overall Study|Lost to Follow-up|2|||
23389814|NCT04642079|65171836|FG003|Overall Study|Lost to Follow-up|0|||
23389815|NCT04642079|65171833|FG000|Overall Study|Withdrawal by Subject|0|||
23389816|NCT04642079|65171834|FG001|Overall Study|Withdrawal by Subject|4|||
23389817|NCT04642079|65171835|FG002|Overall Study|Withdrawal by Subject|1|||
23389818|NCT04642079|65171836|FG003|Overall Study|Withdrawal by Subject|2|||
23389819|NCT04642079|65171833|FG000|Overall Study|Other|0|||
23389820|NCT04642079|65171834|FG001|Overall Study|Other|0|||
23389821|NCT04642079|65171835|FG002|Overall Study|Other|0|||
23389822|NCT04642079|65171836|FG003|Overall Study|Other|1|||
23389823|NCT04642079|65171833|FG000|Overall Study|No longer met eligibility criteria|1|||
23389824|NCT04642079|65171834|FG001|Overall Study|No longer met eligibility criteria|0|||
23389825|NCT04642079|65171835|FG002|Overall Study|No longer met eligibility criteria|1|||
23389826|NCT04642079|65171836|FG003|Overall Study|No longer met eligibility criteria|1|||
23389827|NCT01687595|65171837|FG000|Overall Study|Withdrawal by Subject|8|||
23680361|NCT01960855|66210103|FG002|Overall Study|Adverse Event|6|||
23680362|NCT01960855|66210104|FG003|Overall Study|Adverse Event|2|||
23680363|NCT01960855|66210105|FG004|Overall Study|Adverse Event|2|||
23680364|NCT01960855|66210101|FG000|Overall Study|Lack of Efficacy|1|||
23680365|NCT01960855|66210102|FG001|Overall Study|Lack of Efficacy|1|||
23680366|NCT01960855|66210103|FG002|Overall Study|Lack of Efficacy|0|||
23680367|NCT01960855|66210104|FG003|Overall Study|Lack of Efficacy|0|||
23680368|NCT01960855|66210105|FG004|Overall Study|Lack of Efficacy|0|||
23680369|NCT01960855|66210101|FG000|Overall Study|Other|2|||
23680370|NCT01960855|66210102|FG001|Overall Study|Other|1|||
23680371|NCT01960855|66210103|FG002|Overall Study|Other|1|||
23680372|NCT01960855|66210104|FG003|Overall Study|Other|1|||
23680373|NCT01960855|66210105|FG004|Overall Study|Other|0|||
23680374|NCT01960855|66210101|FG000|Overall Study|Consent withdrawn by subject|3|||
23680375|NCT01960855|66210102|FG001|Overall Study|Consent withdrawn by subject|1|||
23680376|NCT01960855|66210103|FG002|Overall Study|Consent withdrawn by subject|2|||
23680377|NCT01960855|66210104|FG003|Overall Study|Consent withdrawn by subject|1|||
23680378|NCT01960855|66210105|FG004|Overall Study|Consent withdrawn by subject|1|||
23680379|NCT01960855|66210101|FG000|Overall Study|Lost to Follow-up|2|||
23389828|NCT01687595|65171838|FG001|Overall Study|Withdrawal by Subject|0|||
23389829|NCT01687595|65171837|FG000|Overall Study|Lost to Follow-up|3|||
23389830|NCT01687595|65171838|FG001|Overall Study|Lost to Follow-up|1|||
23389831|NCT01687595|65171837|FG000|Overall Study|Investigator's decision|1|||
23389832|NCT01687595|65171838|FG001|Overall Study|Investigator's decision|0|||
23389833|NCT01687595|65171837|FG000|Overall Study|Sponsor's decision|1|||
23680380|NCT01960855|66210102|FG001|Overall Study|Lost to Follow-up|1|||
23680381|NCT01960855|66210103|FG002|Overall Study|Lost to Follow-up|0|||
23680382|NCT01960855|66210104|FG003|Overall Study|Lost to Follow-up|0|||
23680383|NCT01960855|66210105|FG004|Overall Study|Lost to Follow-up|2|||
23680384|NCT00112905|66210109|FG000|Overall Study|Adverse Event|4|||
23680385|NCT00112905|66210109|FG000|Overall Study|Death|1|||
23680386|NCT00112905|66210109|FG000|Overall Study|Ineligibility|5|||
23389834|NCT01687595|65171838|FG001|Overall Study|Sponsor's decision|0|||
23389835|NCT01687595|65171837|FG000|Overall Study|Noncompliance|1|||
23680387|NCT00112905|66210109|FG000|Overall Study|Alternative treatment|1|||
23680388|NCT00112905|66210109|FG000|Overall Study|performance status was deteiorating|1|||
23389836|NCT01687595|65171838|FG001|Overall Study|Noncompliance|2|||
23389837|NCT01687595|65171837|FG000|Overall Study|Other than specified|56|||
23389838|NCT01687595|65171838|FG001|Overall Study|Other than specified|7|||
23389839|NCT01084135|65171839|FG000|20 Week|Physician Decision|0|||
23389840|NCT01084135|65171840|FG001|20 Week|Physician Decision|1|||
23389841|NCT02595437|65171841|FG000|Triferic Via IV|Withdrawal by Subject|1|||
23389842|NCT02094885|65171842|FG000|Overall Study|Death|1|||
23389843|NCT02094885|65171843|FG001|Overall Study|Death|5|||
23389844|NCT02094885|65171842|FG000|Overall Study|Withdrawn due to age|1|||
23389845|NCT02094885|65171843|FG001|Overall Study|Withdrawn due to age|0|||
23389846|NCT05333965|65171856|FG000|First Intervention|Adverse Event|0|||
23389847|NCT05333965|65171857|FG001|First Intervention|Adverse Event|1|||
23389848|NCT05333965|65171856|FG000|First Intervention|Withdrawal by Subject|0|||
23680389|NCT00352105|66210116|FG000|Overall Study|Death|5|||
23680390|NCT00352105|66210116|FG000|Overall Study|Withdrawal by Subject|5|||
23680391|NCT00352105|66210116|FG000|Overall Study|Lack of Efficacy|9|||
23680392|NCT00352105|66210116|FG000|Overall Study|Adverse Event|19|||
23680393|NCT00352105|66210116|FG000|Overall Study|Protocol Violation|2|||
23680394|NCT00168831|66210117|FG000|Overall Study|Adverse Event|36|||
23680395|NCT00168831|66210118|FG001|Overall Study|Adverse Event|47|||
23494977|NCT03758443|65555033|FG002|Maintenance Period|Withdrawal by Subject|1|||
23494978|NCT03758443|65555034|FG003|Maintenance Period|Withdrawal by Subject|1|||
23680396|NCT00168831|66210119|FG002|Overall Study|Adverse Event|74|||
23680397|NCT00168831|66210117|FG000|Overall Study|Lost to Follow-up|5|||
23680398|NCT00168831|66210118|FG001|Overall Study|Lost to Follow-up|6|||
23680399|NCT00168831|66210119|FG002|Overall Study|Lost to Follow-up|4|||
23680400|NCT00168831|66210117|FG000|Overall Study|Withdrawal by Subject|7|||
23680401|NCT00168831|66210118|FG001|Overall Study|Withdrawal by Subject|14|||
23680402|NCT00168831|66210119|FG002|Overall Study|Withdrawal by Subject|19|||
23680403|NCT00168831|66210117|FG000|Overall Study|Protocol Violation|6|||
23680404|NCT00168831|66210118|FG001|Overall Study|Protocol Violation|11|||
23680405|NCT00168831|66210119|FG002|Overall Study|Protocol Violation|11|||
23680406|NCT00168831|66210117|FG000|Overall Study|Other|6|||
23680407|NCT00168831|66210118|FG001|Overall Study|Other|3|||
23680408|NCT00168831|66210119|FG002|Overall Study|Other|6|||
23680409|NCT01724528|66210120|FG000|Overall Study|Death|3|||
23494979|NCT03758443|65555031|FG000|Maintenance Period|Miscellaneous|0|||
23494980|NCT03758443|65555032|FG001|Maintenance Period|Miscellaneous|0|||
23494981|NCT03758443|65555033|FG002|Maintenance Period|Miscellaneous|1|||
23680410|NCT01724528|66210121|FG001|Overall Study|Death|0|||
23680411|NCT01724528|66210120|FG000|Overall Study|Withdrawal by Subject|0|||
23680412|NCT01724528|66210121|FG001|Overall Study|Withdrawal by Subject|2|||
23680413|NCT01724528|66210120|FG000|Overall Study|Protocol Violation|0|||
23680414|NCT01724528|66210121|FG001|Overall Study|Protocol Violation|1|||
23680415|NCT01724528|66210120|FG000|Overall Study|Patient refused to attend last visit|1|||
23680416|NCT01724528|66210121|FG001|Overall Study|Patient refused to attend last visit|0|||
23680417|NCT01959165|66210122|FG000|Overall Study|Adverse Event|0|||
23680418|NCT01959165|66210123|FG001|Overall Study|Adverse Event|0|||
23680419|NCT01959165|66210124|FG002|Overall Study|Adverse Event|0|||
23680420|NCT01959165|66210125|FG003|Overall Study|Adverse Event|1|||
23680421|NCT01959165|66210122|FG000|Overall Study|Lack of Efficacy|1|||
23680422|NCT01959165|66210123|FG001|Overall Study|Lack of Efficacy|0|||
23680423|NCT01959165|66210124|FG002|Overall Study|Lack of Efficacy|0|||
23680424|NCT01959165|66210125|FG003|Overall Study|Lack of Efficacy|0|||
23680425|NCT01959165|66210122|FG000|Overall Study|overdose|0|||
23680426|NCT01959165|66210123|FG001|Overall Study|overdose|0|||
23680427|NCT01959165|66210124|FG002|Overall Study|overdose|0|||
23680428|NCT01959165|66210125|FG003|Overall Study|overdose|1|||
23680429|NCT01959165|66210122|FG000|Overall Study|Welfare recipient|0|||
23680430|NCT01959165|66210123|FG001|Overall Study|Welfare recipient|1|||
23680431|NCT01959165|66210124|FG002|Overall Study|Welfare recipient|0|||
23680432|NCT01959165|66210125|FG003|Overall Study|Welfare recipient|0|||
23680433|NCT00454805|66210126|FG000|Overall Study|Withdrawal by Subject|9|||
23680434|NCT00454805|66210127|FG001|Overall Study|Withdrawal by Subject|2|||
23680435|NCT00454805|66210126|FG000|Overall Study|Death|0|||
23680436|NCT00454805|66210127|FG001|Overall Study|Death|2|||
23680437|NCT00454805|66210126|FG000|Overall Study|Disease progression|16|||
23680438|NCT00454805|66210127|FG001|Overall Study|Disease progression|19|||
23680439|NCT00454805|66210126|FG000|Overall Study|In order to begin radiotherapy|1|||
23680440|NCT00454805|66210127|FG001|Overall Study|In order to begin radiotherapy|0|||
23680441|NCT01790503|66210128|FG000|Overall Study|Adverse Event|1|||
23680442|NCT01790503|66210129|FG001|Overall Study|Adverse Event|0|||
23680443|NCT01790503|66210130|FG002|Overall Study|Adverse Event|0|||
23680444|NCT01790503|66210131|FG003|Overall Study|Adverse Event|0|||
23680445|NCT01790503|66210132|FG004|Overall Study|Adverse Event|0|||
23680446|NCT01790503|66210133|FG005|Overall Study|Adverse Event|2|||
23680447|NCT01790503|66210134|FG006|Overall Study|Adverse Event|0|||
23680448|NCT01790503|66210135|FG007|Overall Study|Adverse Event|0|||
23680449|NCT01790503|66210136|FG008|Overall Study|Adverse Event|2|||
23680450|NCT01790503|66210137|FG009|Overall Study|Adverse Event|4|||
23680451|NCT01790503|66210138|FG010|Overall Study|Adverse Event|7|||
23680452|NCT01790503|66210128|FG000|Overall Study|Withdrawal by Subject|0|||
23680453|NCT01790503|66210129|FG001|Overall Study|Withdrawal by Subject|0|||
23680454|NCT01790503|66210130|FG002|Overall Study|Withdrawal by Subject|1|||
23680455|NCT01790503|66210131|FG003|Overall Study|Withdrawal by Subject|1|||
23680456|NCT01790503|66210132|FG004|Overall Study|Withdrawal by Subject|1|||
23680457|NCT01790503|66210133|FG005|Overall Study|Withdrawal by Subject|2|||
23680458|NCT01790503|66210134|FG006|Overall Study|Withdrawal by Subject|1|||
23680459|NCT01790503|66210135|FG007|Overall Study|Withdrawal by Subject|0|||
23680460|NCT01790503|66210136|FG008|Overall Study|Withdrawal by Subject|0|||
23680461|NCT01790503|66210137|FG009|Overall Study|Withdrawal by Subject|0|||
23680462|NCT01790503|66210138|FG010|Overall Study|Withdrawal by Subject|1|||
23680463|NCT01790503|66210128|FG000|Overall Study|Disease progression|2|||
23680464|NCT01790503|66210129|FG001|Overall Study|Disease progression|1|||
23680465|NCT01790503|66210130|FG002|Overall Study|Disease progression|0|||
23680466|NCT01790503|66210131|FG003|Overall Study|Disease progression|1|||
23680467|NCT01790503|66210132|FG004|Overall Study|Disease progression|2|||
23680468|NCT01790503|66210133|FG005|Overall Study|Disease progression|1|||
23680469|NCT01790503|66210134|FG006|Overall Study|Disease progression|0|||
23680470|NCT01790503|66210135|FG007|Overall Study|Disease progression|1|||
23680471|NCT01790503|66210136|FG008|Overall Study|Disease progression|0|||
23680472|NCT01790503|66210137|FG009|Overall Study|Disease progression|17|||
23680473|NCT01790503|66210138|FG010|Overall Study|Disease progression|7|||
23680474|NCT01790503|66210128|FG000|Overall Study|Protocol Violation|0|||
23680475|NCT01790503|66210129|FG001|Overall Study|Protocol Violation|0|||
23680476|NCT01790503|66210130|FG002|Overall Study|Protocol Violation|0|||
23680477|NCT01790503|66210131|FG003|Overall Study|Protocol Violation|0|||
23680478|NCT01790503|66210132|FG004|Overall Study|Protocol Violation|0|||
23389849|NCT05333965|65171857|FG001|First Intervention|Withdrawal by Subject|1|||
23389850|NCT02771145|65171858|FG000|Overall Study|Adverse Event|3|||
23389851|NCT02771145|65171858|FG000|Overall Study|Lost to Follow-up|1|||
23389852|NCT04157738|65171861|FG000|Overall Study|Moved out of state|0|||
23389853|NCT04157738|65171862|FG001|Overall Study|Moved out of state|2|||
23389854|NCT04157738|65171861|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
23389855|NCT04157738|65171862|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
23606128|NCT00614614|65947151|FG003|Booster Vaccination Phase|Protocol Violation|3|||
23389857|NCT00564070|65171866|FG000|Overall Study|Lost to Follow-up|9|||
23389858|NCT00564070|65171867|FG001|Overall Study|Lost to Follow-up|7|||
23389859|NCT00564070|65171866|FG000|Overall Study|Worsening depression, referred to care|3|||
23389860|NCT00564070|65171867|FG001|Overall Study|Worsening depression, referred to care|0|||
23389861|NCT00756444|65171874|FG000|Overall Study|Adverse Event|1|||
23389862|NCT00756444|65171875|FG001|Overall Study|Adverse Event|1|||
23389863|NCT00756444|65171874|FG000|Overall Study|Withdrawal by Subject|6|||
23389864|NCT00756444|65171875|FG001|Overall Study|Withdrawal by Subject|8|||
23389865|NCT00756444|65171874|FG000|Overall Study|Lost to Follow-up|0|||
23389866|NCT00756444|65171875|FG001|Overall Study|Lost to Follow-up|1|||
23389867|NCT00756444|65171874|FG000|Overall Study|Death|5|||
23389868|NCT00756444|65171875|FG001|Overall Study|Death|4|||
23389869|NCT00756444|65171874|FG000|Overall Study|Disease Progression|2|||
23389870|NCT00756444|65171875|FG001|Overall Study|Disease Progression|7|||
23389871|NCT00756444|65171874|FG000|Overall Study|Ineligibility Determined|1|||
23389872|NCT00756444|65171875|FG001|Overall Study|Ineligibility Determined|0|||
23389873|NCT02991859|65171876|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389874|NCT02991859|65171877|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
23389875|NCT02991859|65171878|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389876|NCT02991859|65171879|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389877|NCT02991859|65171880|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
23389878|NCT02991859|65171881|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389879|NCT02991859|65171882|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389880|NCT02991859|65171883|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389881|NCT02991859|65171884|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389882|NCT02991859|65171885|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389883|NCT02991859|65171886|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389884|NCT02991859|65171887|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389885|NCT02991859|65171888|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389886|NCT02991859|65171889|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389887|NCT02991859|65171890|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389888|NCT02991859|65171891|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389889|NCT02991859|65171892|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389890|NCT02991859|65171876|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389891|NCT02991859|65171877|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23606129|NCT00614614|65947152|FG004|Booster Vaccination Phase|Protocol Violation|0|||
23606130|NCT00614614|65947148|FG000|Booster Vaccination Phase|Other|0|||
23606131|NCT00614614|65947149|FG001|Booster Vaccination Phase|Other|1|||
23606132|NCT00614614|65947150|FG002|Booster Vaccination Phase|Other|3|||
23606133|NCT00614614|65947151|FG003|Booster Vaccination Phase|Other|2|||
23606134|NCT00614614|65947152|FG004|Booster Vaccination Phase|Other|1|||
23606135|NCT00641537|65947155|FG000|96-week Period|Adverse Event|0|||
23606136|NCT00641537|65947156|FG001|96-week Period|Adverse Event|1|||
23606137|NCT00641537|65947157|FG002|96-week Period|Adverse Event|3|||
23606138|NCT00641537|65947158|FG003|96-week Period|Adverse Event|0|||
23606139|NCT00641537|65947159|FG004|96-week Period|Adverse Event|2|||
23606140|NCT00641537|65947160|FG005|96-week Period|Adverse Event|0|||
23606141|NCT00641537|65947161|FG006|96-week Period|Adverse Event|0|||
23606142|NCT00641537|65947162|FG007|96-week Period|Adverse Event|0|||
23606143|NCT00641537|65947155|FG000|96-week Period|Lost to Follow-up|3|||
23606144|NCT00641537|65947156|FG001|96-week Period|Lost to Follow-up|1|||
23606145|NCT00641537|65947157|FG002|96-week Period|Lost to Follow-up|2|||
23606146|NCT00641537|65947158|FG003|96-week Period|Lost to Follow-up|2|||
23606147|NCT00641537|65947159|FG004|96-week Period|Lost to Follow-up|4|||
23606148|NCT00641537|65947160|FG005|96-week Period|Lost to Follow-up|0|||
23606149|NCT00641537|65947161|FG006|96-week Period|Lost to Follow-up|1|||
23494982|NCT03758443|65555034|FG003|Maintenance Period|Miscellaneous|0|||
23494983|NCT00983437|65555035|FG000|Overall Study|Adverse Event|9|||
23494984|NCT00983437|65555035|FG000|Overall Study|Lack of Efficacy|1|||
23494985|NCT00983437|65555035|FG000|Overall Study|Withdrawal by Subject|8|||
23494986|NCT00983437|65555035|FG000|Overall Study|Noncompliance to Study Procedures|1|||
23494987|NCT00983437|65555035|FG000|Overall Study|Lost to Follow-up|2|||
23494988|NCT00983437|65555035|FG000|Overall Study|Other Reason|26|||
23680479|NCT01790503|66210133|FG005|Overall Study|Protocol Violation|0|||
23680480|NCT01790503|66210134|FG006|Overall Study|Protocol Violation|0|||
23680481|NCT01790503|66210135|FG007|Overall Study|Protocol Violation|0|||
23680482|NCT01790503|66210136|FG008|Overall Study|Protocol Violation|0|||
23680483|NCT01790503|66210137|FG009|Overall Study|Protocol Violation|1|||
23680484|NCT01790503|66210138|FG010|Overall Study|Protocol Violation|0|||
23680485|NCT01790503|66210128|FG000|Overall Study|Physician Decision|0|||
23680486|NCT01790503|66210129|FG001|Overall Study|Physician Decision|0|||
23680487|NCT01790503|66210130|FG002|Overall Study|Physician Decision|0|||
23680488|NCT01790503|66210131|FG003|Overall Study|Physician Decision|0|||
23494989|NCT00287365|65555036|FG000|Overall Study|sample not acquired|13|||
23680489|NCT01790503|66210132|FG004|Overall Study|Physician Decision|0|||
23680490|NCT01790503|66210133|FG005|Overall Study|Physician Decision|0|||
23680491|NCT01790503|66210134|FG006|Overall Study|Physician Decision|0|||
23680492|NCT01790503|66210135|FG007|Overall Study|Physician Decision|0|||
23680493|NCT01790503|66210136|FG008|Overall Study|Physician Decision|0|||
23680494|NCT01790503|66210137|FG009|Overall Study|Physician Decision|1|||
23680495|NCT01790503|66210138|FG010|Overall Study|Physician Decision|1|||
23680496|NCT01790503|66210128|FG000|Overall Study|Death|0|||
23680497|NCT01790503|66210129|FG001|Overall Study|Death|0|||
23680498|NCT01790503|66210130|FG002|Overall Study|Death|0|||
23680499|NCT01790503|66210131|FG003|Overall Study|Death|0|||
23680500|NCT01790503|66210132|FG004|Overall Study|Death|0|||
23680501|NCT01790503|66210133|FG005|Overall Study|Death|0|||
23680502|NCT01790503|66210134|FG006|Overall Study|Death|0|||
23680503|NCT01790503|66210135|FG007|Overall Study|Death|0|||
23680504|NCT01790503|66210136|FG008|Overall Study|Death|0|||
23680505|NCT01790503|66210137|FG009|Overall Study|Death|1|||
23680506|NCT01790503|66210138|FG010|Overall Study|Death|0|||
23680507|NCT01790503|66210128|FG000|Overall Study|Non Compliance|0|||
23680508|NCT01790503|66210129|FG001|Overall Study|Non Compliance|0|||
23680509|NCT01790503|66210130|FG002|Overall Study|Non Compliance|0|||
23680510|NCT01790503|66210131|FG003|Overall Study|Non Compliance|0|||
23680511|NCT01790503|66210132|FG004|Overall Study|Non Compliance|1|||
23680512|NCT01790503|66210133|FG005|Overall Study|Non Compliance|0|||
23680513|NCT01790503|66210134|FG006|Overall Study|Non Compliance|0|||
23680514|NCT01790503|66210135|FG007|Overall Study|Non Compliance|0|||
23680515|NCT01790503|66210136|FG008|Overall Study|Non Compliance|0|||
23680516|NCT01790503|66210137|FG009|Overall Study|Non Compliance|0|||
23680517|NCT01790503|66210138|FG010|Overall Study|Non Compliance|0|||
23494990|NCT01788046|65555037|FG000|Overall Study|Withdrawal by Subject|12|||
23494991|NCT01788046|65555038|FG001|Overall Study|Withdrawal by Subject|12|||
23680518|NCT01790503|66210128|FG000|Overall Study|Other|0|||
23680519|NCT01790503|66210129|FG001|Overall Study|Other|0|||
23680520|NCT01790503|66210130|FG002|Overall Study|Other|0|||
23680521|NCT01790503|66210131|FG003|Overall Study|Other|0|||
23389892|NCT02991859|65171878|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389893|NCT02991859|65171879|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389894|NCT02991859|65171880|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389895|NCT02991859|65171881|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389896|NCT02991859|65171882|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389897|NCT02991859|65171883|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389898|NCT02991859|65171884|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389899|NCT02991859|65171885|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389900|NCT02991859|65171886|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389901|NCT02991859|65171887|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389902|NCT02991859|65171888|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
23389903|NCT02991859|65171889|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
23389904|NCT02991859|65171890|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389905|NCT02991859|65171891|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389906|NCT02991859|65171892|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389907|NCT02991859|65171876|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389908|NCT02991859|65171877|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389909|NCT02991859|65171878|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389910|NCT02991859|65171879|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389911|NCT02991859|65171880|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389912|NCT02991859|65171881|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
23389913|NCT02991859|65171882|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389914|NCT02991859|65171883|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389915|NCT02991859|65171884|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389916|NCT02991859|65171885|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389917|NCT02991859|65171886|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389918|NCT02991859|65171887|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389919|NCT02991859|65171888|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389920|NCT02991859|65171889|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389921|NCT02991859|65171890|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389922|NCT02991859|65171891|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389923|NCT02991859|65171892|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389924|NCT02991859|65171876|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389925|NCT02991859|65171877|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389926|NCT02991859|65171878|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389927|NCT02991859|65171879|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389928|NCT02991859|65171880|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389929|NCT02991859|65171881|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389930|NCT02991859|65171882|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389931|NCT02991859|65171883|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389932|NCT02991859|65171884|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389933|NCT02991859|65171885|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
23389934|NCT02991859|65171886|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389935|NCT02991859|65171887|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389936|NCT02991859|65171888|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389937|NCT02991859|65171889|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389938|NCT02991859|65171890|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389939|NCT02991859|65171891|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389940|NCT02991859|65171892|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389941|NCT02991859|65171876|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389942|NCT02991859|65171877|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389943|NCT02991859|65171878|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389944|NCT02991859|65171879|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389945|NCT02991859|65171880|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389946|NCT02991859|65171881|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389947|NCT02991859|65171882|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389948|NCT02991859|65171883|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389949|NCT02991859|65171884|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
23389950|NCT02991859|65171885|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389951|NCT02991859|65171886|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389952|NCT02991859|65171887|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389953|NCT02991859|65171888|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389954|NCT02991859|65171889|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389955|NCT02991859|65171890|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389956|NCT02991859|65171891|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389957|NCT02991859|65171892|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389958|NCT02554474|65171894|FG000|Overall Study|Protocol Violation|1|||
23680522|NCT01790503|66210132|FG004|Overall Study|Other|1|||
23680523|NCT01790503|66210133|FG005|Overall Study|Other|0|||
23680524|NCT01790503|66210134|FG006|Overall Study|Other|0|||
23680525|NCT01790503|66210135|FG007|Overall Study|Other|0|||
23680526|NCT01790503|66210136|FG008|Overall Study|Other|1|||
23680527|NCT01790503|66210137|FG009|Overall Study|Other|2|||
23680528|NCT01790503|66210138|FG010|Overall Study|Other|0|||
23680529|NCT02411747|66210139|FG000|Overall Study|Withdrawal by Subject|1|||
23680530|NCT02411747|66210140|FG001|Overall Study|Withdrawal by Subject|0|||
23680531|NCT02411747|66210139|FG000|Overall Study|Protocol Violation|2|||
23680532|NCT02411747|66210140|FG001|Overall Study|Protocol Violation|4|||
23389959|NCT02554474|65171895|FG001|Overall Study|Protocol Violation|1|||
23389960|NCT02554474|65171894|FG000|Overall Study|Health issue not related to the study|1|||
23389961|NCT02554474|65171895|FG001|Overall Study|Health issue not related to the study|0|||
23389962|NCT02554474|65171894|FG000|Overall Study|Withdrawal by Subject|1|||
23389963|NCT02554474|65171895|FG001|Overall Study|Withdrawal by Subject|1|||
23389964|NCT02727699|65171896|FG000|Overall Study|Adverse Event|2|||
23389965|NCT02727699|65171897|FG001|Overall Study|Adverse Event|0|||
23389966|NCT02727699|65171896|FG000|Overall Study|Withdrawal by Subject|5|||
23389967|NCT02727699|65171897|FG001|Overall Study|Withdrawal by Subject|3|||
23389968|NCT02727699|65171896|FG000|Overall Study|Protocol Violation|0|||
23389969|NCT02727699|65171897|FG001|Overall Study|Protocol Violation|1|||
23389970|NCT02727699|65171896|FG000|Overall Study|Physician Decision|0|||
23389971|NCT02727699|65171897|FG001|Overall Study|Physician Decision|1|||
23389972|NCT02727699|65171896|FG000|Overall Study|Lost to Follow-up|1|||
23389973|NCT02727699|65171897|FG001|Overall Study|Lost to Follow-up|0|||
23389974|NCT02727699|65171896|FG000|Overall Study|Sponsor Decision|1|||
23389975|NCT02727699|65171897|FG001|Overall Study|Sponsor Decision|0|||
23389976|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
23389977|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
23389978|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
23389979|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
23389980|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
23389981|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
23389982|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
23389983|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
23389984|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
23389985|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
23389986|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
23389987|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
23389988|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
23389989|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
23389990|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
23389991|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
23389992|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
23389993|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
23389994|NCT01755156|65171898|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
23389995|NCT01755156|65171899|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
23389996|NCT01755156|65171898|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
23680533|NCT01467492|66210145|FG000|Overall Study|Withdrawal by Subject|6|||
23680534|NCT01467492|66210146|FG001|Overall Study|Withdrawal by Subject|4|||
23680535|NCT01467492|66210145|FG000|Overall Study|Study Terminated by Sponsor|6|||
23680536|NCT01467492|66210146|FG001|Overall Study|Study Terminated by Sponsor|4|||
23680537|NCT01467492|66210145|FG000|Overall Study|Adverse Event|4|||
23680538|NCT01467492|66210146|FG001|Overall Study|Adverse Event|3|||
23680539|NCT01467492|66210145|FG000|Overall Study|Lost to Follow-up|3|||
23680540|NCT01467492|66210146|FG001|Overall Study|Lost to Follow-up|2|||
23680541|NCT01467492|66210145|FG000|Overall Study|Undefined|2|||
23389997|NCT01755156|65171899|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
23389998|NCT04755231|65171905|FG000|Overall Study|Lost to Follow-up|5|||
23680542|NCT01467492|66210146|FG001|Overall Study|Undefined|0|||
23680543|NCT01467492|66210145|FG000|Overall Study|Enrolled But Not Treated|1|||
23389999|NCT04755231|65171905|FG000|Overall Study|Withdrawal by Subject|5|||
23680544|NCT01467492|66210146|FG001|Overall Study|Enrolled But Not Treated|0|||
23680545|NCT03653390|66210149|FG000|Overall Study|Lost to Follow-up|12|||
23680546|NCT03653390|66210150|FG001|Overall Study|Lost to Follow-up|8|||
23680547|NCT03653390|66210151|FG002|Overall Study|Lost to Follow-up|7|||
23680548|NCT03653390|66210149|FG000|Overall Study|Withdrawal by Subject|6|||
23680549|NCT03653390|66210150|FG001|Overall Study|Withdrawal by Subject|1|||
23680550|NCT03653390|66210151|FG002|Overall Study|Withdrawal by Subject|1|||
23390000|NCT01897896|65171906|FG000|Overall Study|Death|1|||
23390001|NCT01897896|65171907|FG001|Overall Study|Death|0|||
23390002|NCT01897896|65171906|FG000|Overall Study|Adverse Event|11|||
23390003|NCT01897896|65171907|FG001|Overall Study|Adverse Event|1|||
23390004|NCT01897896|65171906|FG000|Overall Study|Lost to Follow-up|1|||
23680551|NCT03653390|66210149|FG000|Overall Study|Death|1|||
23680552|NCT03653390|66210150|FG001|Overall Study|Death|0|||
23680553|NCT03653390|66210151|FG002|Overall Study|Death|0|||
23680554|NCT03653390|66210149|FG000|Overall Study|Paper Survey Lost|1|||
23680555|NCT03653390|66210150|FG001|Overall Study|Paper Survey Lost|0|||
23680556|NCT03653390|66210151|FG002|Overall Study|Paper Survey Lost|0|||
23680557|NCT02624492|66210152|FG000|Overall Study|Adverse Event|2|||
23680558|NCT02624492|66210153|FG001|Overall Study|Adverse Event|2|||
23680559|NCT02624492|66210154|FG002|Overall Study|Adverse Event|2|||
23680560|NCT02624492|66210152|FG000|Overall Study|Progressive disease|0|||
23680561|NCT02624492|66210153|FG001|Overall Study|Progressive disease|2|||
23390005|NCT01897896|65171907|FG001|Overall Study|Lost to Follow-up|0|||
23390006|NCT01897896|65171906|FG000|Overall Study|Non-compliance with study drug dosing|1|||
23680562|NCT02624492|66210154|FG002|Overall Study|Progressive disease|3|||
23680563|NCT01273064|66210164|FG000|Overall Study|Adverse Event|5|||
23680564|NCT01273064|66210165|FG001|Overall Study|Adverse Event|1|||
23680565|NCT01273064|66210166|FG002|Overall Study|Adverse Event|3|||
23680566|NCT01273064|66210167|FG003|Overall Study|Adverse Event|2|||
23680567|NCT01273064|66210168|FG004|Overall Study|Adverse Event|1|||
23680568|NCT01273064|66210164|FG000|Overall Study|Withdrawal by Subject|4|||
23680569|NCT01273064|66210165|FG001|Overall Study|Withdrawal by Subject|2|||
23680570|NCT01273064|66210166|FG002|Overall Study|Withdrawal by Subject|2|||
23680571|NCT01273064|66210167|FG003|Overall Study|Withdrawal by Subject|2|||
23680572|NCT01273064|66210168|FG004|Overall Study|Withdrawal by Subject|0|||
23680573|NCT01273064|66210164|FG000|Overall Study|Study Termination|13|||
23680574|NCT01273064|66210165|FG001|Overall Study|Study Termination|27|||
23680575|NCT01273064|66210166|FG002|Overall Study|Study Termination|26|||
23680576|NCT01273064|66210167|FG003|Overall Study|Study Termination|16|||
23680577|NCT01273064|66210168|FG004|Overall Study|Study Termination|8|||
23680578|NCT01273064|66210164|FG000|Overall Study|Lost to Follow-up|1|||
23680579|NCT01273064|66210165|FG001|Overall Study|Lost to Follow-up|0|||
23680580|NCT01273064|66210166|FG002|Overall Study|Lost to Follow-up|0|||
23680581|NCT01273064|66210167|FG003|Overall Study|Lost to Follow-up|0|||
23680582|NCT01273064|66210168|FG004|Overall Study|Lost to Follow-up|0|||
23680583|NCT01273064|66210164|FG000|Overall Study|Physician Decision|0|||
23680584|NCT01273064|66210165|FG001|Overall Study|Physician Decision|0|||
23680585|NCT01273064|66210166|FG002|Overall Study|Physician Decision|0|||
23680586|NCT01273064|66210167|FG003|Overall Study|Physician Decision|0|||
23680587|NCT01273064|66210168|FG004|Overall Study|Physician Decision|1|||
23680588|NCT01164722|66210169|FG000|Overall Study|Adverse Event|0|||
23680589|NCT01164722|66210170|FG001|Overall Study|Adverse Event|1|||
23680590|NCT01164722|66210169|FG000|Overall Study|Withdrawal by Subject|3|||
23680591|NCT01164722|66210170|FG001|Overall Study|Withdrawal by Subject|4|||
23680592|NCT01164722|66210169|FG000|Overall Study|Lost to Follow-up|3|||
23680593|NCT01164722|66210170|FG001|Overall Study|Lost to Follow-up|6|||
23680594|NCT01164722|66210169|FG000|Overall Study|met protocol criteria for non-treatment|11|||
23680595|NCT01164722|66210170|FG001|Overall Study|met protocol criteria for non-treatment|1|||
23680596|NCT01164722|66210169|FG000|Overall Study|enrolled on other study, concomitant med|1|||
23680597|NCT01164722|66210170|FG001|Overall Study|enrolled on other study, concomitant med|3|||
23680598|NCT00631137|66210172|FG000|Overall Study|Withdrawal by Subject|1|||
23680599|NCT00631137|66210173|FG001|Overall Study|Withdrawal by Subject|0|||
23680600|NCT01014585|66210178|FG000|Overall Study|Adverse Event|0|||
23680601|NCT01014585|66210179|FG001|Overall Study|Adverse Event|2|||
23680602|NCT01014585|66210180|FG002|Overall Study|Adverse Event|0|||
23680603|NCT01014585|66210181|FG003|Overall Study|Adverse Event|3|||
23680604|NCT01014585|66210178|FG000|Overall Study|Withdrawal by Subject|2|||
23680605|NCT01014585|66210179|FG001|Overall Study|Withdrawal by Subject|0|||
23680606|NCT01014585|66210180|FG002|Overall Study|Withdrawal by Subject|1|||
23680607|NCT01014585|66210181|FG003|Overall Study|Withdrawal by Subject|3|||
23680608|NCT01014585|66210178|FG000|Overall Study|Lost to Follow-up|0|||
23680609|NCT01014585|66210179|FG001|Overall Study|Lost to Follow-up|0|||
23680610|NCT01014585|66210180|FG002|Overall Study|Lost to Follow-up|0|||
23680611|NCT01014585|66210181|FG003|Overall Study|Lost to Follow-up|2|||
23680612|NCT01014585|66210178|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
23680613|NCT01014585|66210179|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
23680614|NCT01014585|66210180|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
23680615|NCT01014585|66210181|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
23680616|NCT02058147|66210188|FG000|Overall Study|Randomized but not treated|0|||
23680617|NCT02058147|66210189|FG001|Overall Study|Randomized but not treated|0|||
23680618|NCT02058147|66210190|FG002|Overall Study|Randomized but not treated|1|||
23680619|NCT02058147|66210188|FG000|Overall Study|Adverse Event|12|||
23680620|NCT02058147|66210189|FG001|Overall Study|Adverse Event|9|||
23680621|NCT02058147|66210190|FG002|Overall Study|Adverse Event|21|||
23680622|NCT02058147|66210188|FG000|Overall Study|Lack of Efficacy|1|||
23680623|NCT02058147|66210189|FG001|Overall Study|Lack of Efficacy|0|||
23390007|NCT01897896|65171907|FG001|Overall Study|Non-compliance with study drug dosing|1|||
23390008|NCT01897896|65171906|FG000|Overall Study|Withdrawal by Subject|7|||
23390009|NCT01897896|65171907|FG001|Overall Study|Withdrawal by Subject|1|||
23390010|NCT01897896|65171906|FG000|Overall Study|Require drug that interfere with study|1|||
23390011|NCT01897896|65171907|FG001|Overall Study|Require drug that interfere with study|4|||
23390012|NCT01897896|65171906|FG000|Overall Study|Protocol Violation|1|||
23390013|NCT01897896|65171907|FG001|Overall Study|Protocol Violation|1|||
23390014|NCT01897896|65171906|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
23680624|NCT02058147|66210190|FG002|Overall Study|Lack of Efficacy|3|||
23680625|NCT02058147|66210188|FG000|Overall Study|Poor compliance to protocol|8|||
23680626|NCT02058147|66210189|FG001|Overall Study|Poor compliance to protocol|9|||
23390015|NCT01897896|65171907|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
23680627|NCT02058147|66210190|FG002|Overall Study|Poor compliance to protocol|4|||
23680628|NCT02058147|66210188|FG000|Overall Study|Other than specified|8|||
23680629|NCT02058147|66210189|FG001|Overall Study|Other than specified|9|||
23680630|NCT02058147|66210190|FG002|Overall Study|Other than specified|0|||
23390016|NCT01897896|65171906|FG000|Overall Study|Caregiver can no longer participate|0|||
23390017|NCT01897896|65171907|FG001|Overall Study|Caregiver can no longer participate|2|||
23680631|NCT01651780|66210191|FG000|Overall Study|Physician decision: No 30-day visit|2|||
23680632|NCT01651780|66210192|FG001|Overall Study|Physician decision: No 30-day visit|1|||
23494992|NCT01788046|65555037|FG000|Overall Study|Lost to Follow-up|12|||
23494993|NCT01788046|65555038|FG001|Overall Study|Lost to Follow-up|19|||
23494994|NCT01788046|65555037|FG000|Overall Study|Death|7|||
23494995|NCT01788046|65555038|FG001|Overall Study|Death|5|||
23494996|NCT01788046|65555037|FG000|Overall Study|Protocol Specified Criteria|25|||
23494997|NCT01788046|65555038|FG001|Overall Study|Protocol Specified Criteria|1|||
23494998|NCT00491764|65555039|FG000|Overall Study|Adverse Event|1|||
23494999|NCT00491764|65555040|FG001|Overall Study|Adverse Event|2|||
23495000|NCT00491764|65555041|FG002|Overall Study|Adverse Event|4|||
23495001|NCT00491764|65555042|FG003|Overall Study|Adverse Event|4|||
23495002|NCT00491764|65555043|FG004|Overall Study|Adverse Event|0|||
23495003|NCT00491764|65555044|FG005|Overall Study|Adverse Event|1|||
23495004|NCT00491764|65555039|FG000|Overall Study|Lost to Follow-up|0|||
23495005|NCT00491764|65555040|FG001|Overall Study|Lost to Follow-up|1|||
23495006|NCT00491764|65555041|FG002|Overall Study|Lost to Follow-up|0|||
23495007|NCT00491764|65555042|FG003|Overall Study|Lost to Follow-up|1|||
23495008|NCT00491764|65555043|FG004|Overall Study|Lost to Follow-up|0|||
23495009|NCT00491764|65555044|FG005|Overall Study|Lost to Follow-up|3|||
23495010|NCT00491764|65555039|FG000|Overall Study|Withdrawal by Subject|2|||
23495011|NCT00491764|65555040|FG001|Overall Study|Withdrawal by Subject|3|||
23495012|NCT00491764|65555041|FG002|Overall Study|Withdrawal by Subject|1|||
23495013|NCT00491764|65555042|FG003|Overall Study|Withdrawal by Subject|2|||
23495014|NCT00491764|65555043|FG004|Overall Study|Withdrawal by Subject|2|||
23495015|NCT00491764|65555044|FG005|Overall Study|Withdrawal by Subject|4|||
23495016|NCT00491764|65555039|FG000|Overall Study|Non Compliance with the Protocol|1|||
23495017|NCT00491764|65555040|FG001|Overall Study|Non Compliance with the Protocol|0|||
23495018|NCT00491764|65555041|FG002|Overall Study|Non Compliance with the Protocol|0|||
23495019|NCT00491764|65555042|FG003|Overall Study|Non Compliance with the Protocol|0|||
23495020|NCT00491764|65555043|FG004|Overall Study|Non Compliance with the Protocol|0|||
23495021|NCT00491764|65555044|FG005|Overall Study|Non Compliance with the Protocol|0|||
23495022|NCT00491764|65555039|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
23495023|NCT00491764|65555040|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
23680633|NCT01651780|66210191|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
23680634|NCT01651780|66210192|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
23680635|NCT01651780|66210191|FG000|Overall Study|Withdrawal by Subject|2|||
23680636|NCT01651780|66210192|FG001|Overall Study|Withdrawal by Subject|0|||
23680637|NCT01651780|66210191|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
23680638|NCT01651780|66210192|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23680639|NCT01651780|66210191|FG000|Overall Study|Lost to Follow-up|1|||
23680640|NCT01651780|66210192|FG001|Overall Study|Lost to Follow-up|2|||
23680641|NCT01651780|66210191|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
23680642|NCT01651780|66210192|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
23680643|NCT00257010|66210193|FG000|Overall Study|Lack of Efficacy|11|||
23680644|NCT00257010|66210193|FG000|Overall Study|Lost to Follow-up|53|||
23680645|NCT00257010|66210193|FG000|Overall Study|Withdrawal by Subject|34|||
23680646|NCT00257010|66210193|FG000|Overall Study|Adverse Event|10|||
23680647|NCT00257010|66210193|FG000|Overall Study|various|11|||
23680648|NCT00257010|66210193|FG000|Overall Study|no headache reported|9|||
23680649|NCT03094195|66210194|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
23680650|NCT03094195|66210195|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
23680651|NCT03094195|66210196|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
23680652|NCT03094195|66210197|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23680653|NCT03094195|66210198|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23680654|NCT03094195|66210199|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23680655|NCT03094195|66210200|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23680656|NCT03094195|66210201|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23495024|NCT00491764|65555041|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
23495025|NCT00491764|65555042|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
23495026|NCT00491764|65555043|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
23680657|NCT03094195|66210194|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
23680658|NCT03094195|66210195|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
23680659|NCT03094195|66210196|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
23680660|NCT03094195|66210197|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23680661|NCT03094195|66210198|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23680662|NCT03094195|66210199|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23680663|NCT03094195|66210200|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23680664|NCT03094195|66210201|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23680665|NCT03094195|66210194|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680666|NCT03094195|66210195|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680667|NCT03094195|66210196|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23680668|NCT03094195|66210197|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680669|NCT03094195|66210198|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680670|NCT03094195|66210199|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680671|NCT03094195|66210200|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680672|NCT03094195|66210201|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23680673|NCT03094195|66210194|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680674|NCT03094195|66210195|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
23680675|NCT03094195|66210196|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
23680676|NCT03094195|66210197|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680677|NCT03094195|66210198|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680678|NCT03094195|66210199|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680679|NCT03094195|66210200|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680680|NCT03094195|66210201|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23680681|NCT02944448|66210202|FG000|Overall Study|Adverse Event|37|||
23680682|NCT02944448|66210203|FG001|Overall Study|Adverse Event|6|||
23680683|NCT02944448|66210202|FG000|Overall Study|Lack of Efficacy|8|||
23680684|NCT02944448|66210203|FG001|Overall Study|Lack of Efficacy|5|||
23680685|NCT02944448|66210202|FG000|Overall Study|Lost to Follow-up|3|||
23680686|NCT02944448|66210203|FG001|Overall Study|Lost to Follow-up|1|||
23680687|NCT02944448|66210202|FG000|Overall Study|Protocol Violation|25|||
23680688|NCT02944448|66210203|FG001|Overall Study|Protocol Violation|7|||
23390018|NCT01897896|65171906|FG000|Overall Study|Other than specified|2|||
23390019|NCT01897896|65171907|FG001|Overall Study|Other than specified|1|||
23390020|NCT00993473|65171909|FG000|Overall Study|Adverse Event|0|||
23390021|NCT00993473|65171910|FG001|Overall Study|Adverse Event|2|||
23390022|NCT00993473|65171909|FG000|Overall Study|Protocol Violation|1|||
23390023|NCT00993473|65171910|FG001|Overall Study|Protocol Violation|2|||
23390024|NCT00993473|65171909|FG000|Overall Study|Lost to Follow-up|1|||
23390025|NCT00993473|65171910|FG001|Overall Study|Lost to Follow-up|0|||
23390026|NCT00993473|65171909|FG000|Overall Study|Withdrawal by Subject|1|||
23390027|NCT00993473|65171910|FG001|Overall Study|Withdrawal by Subject|5|||
23390028|NCT00993473|65171909|FG000|Overall Study|Technical problem with CGM device|0|||
23390029|NCT00993473|65171910|FG001|Overall Study|Technical problem with CGM device|1|||
23390030|NCT00993473|65171909|FG000|Overall Study|Family event|1|||
23390031|NCT00993473|65171910|FG001|Overall Study|Family event|0|||
23390032|NCT00617903|65171911|FG000|Overall Study|Withdrawal by Subject|2|||
23390033|NCT00617903|65171912|FG001|Overall Study|Withdrawal by Subject|3|||
23390034|NCT00617903|65171911|FG000|Overall Study|Lost to Follow-up|1|||
23390035|NCT00617903|65171912|FG001|Overall Study|Lost to Follow-up|1|||
23390036|NCT00617903|65171911|FG000|Overall Study|Lack of Efficacy|0|||
23390037|NCT00617903|65171912|FG001|Overall Study|Lack of Efficacy|1|||
23390038|NCT00617903|65171911|FG000|Overall Study|Adverse Event|0|||
23390039|NCT00617903|65171912|FG001|Overall Study|Adverse Event|1|||
23390040|NCT00617903|65171911|FG000|Overall Study|noncompliance|0|||
23390041|NCT00617903|65171912|FG001|Overall Study|noncompliance|1|||
23390042|NCT01633112|65171915|FG000|Overall Study|Lack of Efficacy|1|||
23390043|NCT01633112|65171916|FG001|Overall Study|Lack of Efficacy|6|||
23390044|NCT01633112|65171917|FG002|Overall Study|Lack of Efficacy|13|||
23390045|NCT01633112|65171915|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23390046|NCT01633112|65171916|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23390047|NCT01633112|65171917|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23390048|NCT01633112|65171915|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23390049|NCT01633112|65171916|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23390050|NCT01633112|65171917|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23390051|NCT01633112|65171915|FG000|Overall Study|Administrative problems|1|||
23390052|NCT01633112|65171916|FG001|Overall Study|Administrative problems|2|||
23390053|NCT01633112|65171917|FG002|Overall Study|Administrative problems|5|||
23495027|NCT00491764|65555044|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
23495028|NCT00491764|65555039|FG000|Overall Study|Administrative|1|||
23390054|NCT01633112|65171915|FG000|Overall Study|Adverse Event|16|||
23495029|NCT00491764|65555040|FG001|Overall Study|Administrative|0|||
23680689|NCT02944448|66210202|FG000|Overall Study|Withdrawal by Subject|14|||
23680690|NCT02944448|66210203|FG001|Overall Study|Withdrawal by Subject|4|||
23390055|NCT01633112|65171916|FG001|Overall Study|Adverse Event|18|||
23390056|NCT01633112|65171917|FG002|Overall Study|Adverse Event|20|||
23390057|NCT01633112|65171915|FG000|Overall Study|Lost to Follow-up|7|||
23390058|NCT01633112|65171916|FG001|Overall Study|Lost to Follow-up|19|||
23390059|NCT01633112|65171917|FG002|Overall Study|Lost to Follow-up|6|||
23390060|NCT01633112|65171915|FG000|Overall Study|Protocol Violation|4|||
23390061|NCT01633112|65171916|FG001|Overall Study|Protocol Violation|0|||
23390062|NCT01633112|65171917|FG002|Overall Study|Protocol Violation|2|||
23390063|NCT01633112|65171915|FG000|Overall Study|Subject no longer requires study drug|0|||
23390064|NCT01633112|65171916|FG001|Overall Study|Subject no longer requires study drug|0|||
23390065|NCT01633112|65171917|FG002|Overall Study|Subject no longer requires study drug|1|||
23390066|NCT01633112|65171915|FG000|Overall Study|Withdrawal by Subject|20|||
23390067|NCT01633112|65171916|FG001|Overall Study|Withdrawal by Subject|12|||
23390068|NCT01633112|65171917|FG002|Overall Study|Withdrawal by Subject|41|||
23390069|NCT01633112|65171915|FG000|Overall Study|missing Study Completion CRF|1|||
23390070|NCT01633112|65171916|FG001|Overall Study|missing Study Completion CRF|1|||
23390071|NCT01633112|65171917|FG002|Overall Study|missing Study Completion CRF|4|||
23390072|NCT02605967|65171921|FG000|Overall Study|subject / guardian decision|1|||
23390073|NCT02605967|65171922|FG001|Overall Study|subject / guardian decision|2|||
23390074|NCT02605967|65171921|FG000|Overall Study|Physician Decision|10|||
23390075|NCT02605967|65171922|FG001|Overall Study|Physician Decision|1|||
23390076|NCT02605967|65171921|FG000|Overall Study|Death|4|||
23390077|NCT02605967|65171922|FG001|Overall Study|Death|2|||
23390078|NCT02605967|65171921|FG000|Overall Study|Adverse Event|1|||
23390079|NCT02605967|65171922|FG001|Overall Study|Adverse Event|0|||
23495030|NCT00491764|65555041|FG002|Overall Study|Administrative|2|||
23680691|NCT02944448|66210202|FG000|Overall Study|Sponsor did not supply drug in time|0|||
23390080|NCT02605967|65171921|FG000|Overall Study|progressive disease|66|||
23390081|NCT02605967|65171922|FG001|Overall Study|progressive disease|35|||
23390082|NCT01050218|65171923|FG000|Overall Study|Adverse Event|37|||
23390083|NCT01050218|65171923|FG000|Overall Study|Lack of Efficacy|8|||
23390084|NCT01050218|65171923|FG000|Overall Study|Protocol Violation|3|||
23390085|NCT01050218|65171923|FG000|Overall Study|Withdrawal by Subject|18|||
23390086|NCT01050218|65171923|FG000|Overall Study|Discontinued by sponsor|18|||
23390087|NCT01050218|65171923|FG000|Overall Study|Compliance|2|||
23390088|NCT01050218|65171923|FG000|Overall Study|Failed to return|7|||
23390089|NCT01050218|65171923|FG000|Overall Study|Serious Adverse Event|1|||
23390090|NCT01050218|65171923|FG000|Overall Study|Family emergency|1|||
23390091|NCT02829918|65175133|FG000|Overall Study|Death|2|||
23390092|NCT02829918|65175133|FG000|Overall Study|Withdrawal by Subject|4|||
23390093|NCT02829918|65175133|FG000|Overall Study|Adverse Event|1|||
23680692|NCT02944448|66210203|FG001|Overall Study|Sponsor did not supply drug in time|1|||
23680693|NCT02944448|66210202|FG000|Overall Study|Noncompliant with dosing|1|||
23680694|NCT02944448|66210203|FG001|Overall Study|Noncompliant with dosing|0|||
23680695|NCT02944448|66210202|FG000|Overall Study|Abnormal laboratory values|1|||
23680696|NCT02944448|66210203|FG001|Overall Study|Abnormal laboratory values|0|||
23680697|NCT02183519|66210204|FG000|Overall Study|computer error|3|||
23680698|NCT02183519|66210205|FG001|Overall Study|computer error|0|||
23390094|NCT02829918|65175133|FG000|Overall Study|Progression|1|||
23680699|NCT02183519|66210204|FG000|Overall Study|Did not respond to cough inducter|0|||
23680700|NCT02183519|66210205|FG001|Overall Study|Did not respond to cough inducter|3|||
23390095|NCT00215657|65175136|FG000|Overall Study|Adverse Event|5|||
23390096|NCT00215657|65175137|FG001|Overall Study|Adverse Event|1|||
23680701|NCT05099640|66210206|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
23680702|NCT05099640|66210207|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
23680703|NCT05099640|66210208|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
23680704|NCT05099640|66210206|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
23680705|NCT05099640|66210207|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
23680706|NCT05099640|66210208|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
23680707|NCT05099640|66210206|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
23680708|NCT05099640|66210207|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
23680709|NCT05099640|66210208|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
23680710|NCT05099640|66210206|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
23680711|NCT05099640|66210207|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
23680712|NCT05099640|66210208|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
23680713|NCT05099640|66210206|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
23680714|NCT05099640|66210207|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
23680715|NCT05099640|66210208|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
23680716|NCT05099640|66210206|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
23680717|NCT05099640|66210207|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
23680718|NCT05099640|66210208|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
23680719|NCT00772447|66210209|FG000|Overall Study|Withdrawal by Subject|9|||
23680720|NCT00772447|66210210|FG001|Overall Study|Withdrawal by Subject|5|||
23680721|NCT00772447|66210209|FG000|Overall Study|Physician Decision|4|||
23680722|NCT00772447|66210210|FG001|Overall Study|Physician Decision|8|||
23680723|NCT00772447|66210209|FG000|Overall Study|Lost to Follow-up|2|||
23680724|NCT00772447|66210210|FG001|Overall Study|Lost to Follow-up|4|||
23680725|NCT00772447|66210209|FG000|Overall Study|incorrect enrolment|3|||
23680726|NCT00772447|66210210|FG001|Overall Study|incorrect enrolment|4|||
23680727|NCT00772447|66210209|FG000|Overall Study|Protocol Violation|0|||
23680728|NCT00772447|66210210|FG001|Overall Study|Protocol Violation|1|||
23680729|NCT00772447|66210209|FG000|Overall Study|all others|2|||
23680730|NCT00772447|66210210|FG001|Overall Study|all others|2|||
23680731|NCT01231555|66210218|FG000|Overall Study|Study terminated|8|||
23680732|NCT01231555|66210219|FG001|Overall Study|Study terminated|5|||
23680733|NCT01231555|66210220|FG002|Overall Study|Study terminated|8|||
23680734|NCT01231555|66210218|FG000|Overall Study|Withdrawal by Subject|0|||
23680735|NCT01231555|66210219|FG001|Overall Study|Withdrawal by Subject|2|||
23680736|NCT01231555|66210220|FG002|Overall Study|Withdrawal by Subject|0|||
23680737|NCT05020899|66210222|FG000|8 Week Follow-up|Lost to Follow-up|3|||
23680738|NCT05020899|66210223|FG001|8 Week Follow-up|Lost to Follow-up|6|||
23680739|NCT05020899|66210222|FG000|12 Week Follow-up|Lost to Follow-up|1|||
23680740|NCT05020899|66210223|FG001|12 Week Follow-up|Lost to Follow-up|0|||
23680741|NCT05020899|66210222|FG000|12 Week Follow-up|Death|0|||
23680742|NCT05020899|66210223|FG001|12 Week Follow-up|Death|1|||
23680743|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680744|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680745|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680746|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
23680747|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680748|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
23680749|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680750|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680751|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680752|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680753|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680754|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680755|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680756|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680757|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680758|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680759|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680760|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680761|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680762|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680763|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23390097|NCT00215657|65175138|FG002|Overall Study|Adverse Event|3|||
23390098|NCT00215657|65175139|FG003|Overall Study|Adverse Event|0|||
23390099|NCT00215657|65175140|FG004|Overall Study|Adverse Event|3|||
23390100|NCT00215657|65175141|FG005|Overall Study|Adverse Event|1|||
23390101|NCT00215657|65175142|FG006|Overall Study|Adverse Event|0|||
23390102|NCT00215657|65175143|FG007|Overall Study|Adverse Event|3|||
23390103|NCT00215657|65175136|FG000|Overall Study|Withdrawal by Subject|6|||
23390104|NCT00215657|65175137|FG001|Overall Study|Withdrawal by Subject|3|||
23390105|NCT00215657|65175138|FG002|Overall Study|Withdrawal by Subject|3|||
23390106|NCT00215657|65175139|FG003|Overall Study|Withdrawal by Subject|1|||
23390107|NCT00215657|65175140|FG004|Overall Study|Withdrawal by Subject|6|||
23390108|NCT00215657|65175141|FG005|Overall Study|Withdrawal by Subject|1|||
23390109|NCT00215657|65175142|FG006|Overall Study|Withdrawal by Subject|10|||
23390110|NCT00215657|65175143|FG007|Overall Study|Withdrawal by Subject|3|||
23390111|NCT00215657|65175136|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
23390112|NCT00215657|65175137|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
23390113|NCT00215657|65175138|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
23390114|NCT00215657|65175139|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
23390115|NCT00215657|65175140|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
23390116|NCT00215657|65175141|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
23390117|NCT00215657|65175142|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
23390118|NCT00215657|65175143|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
23390119|NCT00215657|65175136|FG000|Overall Study|Insufficient testosterone response|5|||
23390120|NCT00215657|65175137|FG001|Overall Study|Insufficient testosterone response|4|||
23390121|NCT00215657|65175138|FG002|Overall Study|Insufficient testosterone response|1|||
23390122|NCT00215657|65175139|FG003|Overall Study|Insufficient testosterone response|12|||
23390123|NCT00215657|65175140|FG004|Overall Study|Insufficient testosterone response|8|||
23390124|NCT00215657|65175141|FG005|Overall Study|Insufficient testosterone response|12|||
23390125|NCT00215657|65175142|FG006|Overall Study|Insufficient testosterone response|4|||
23390126|NCT00215657|65175143|FG007|Overall Study|Insufficient testosterone response|7|||
23390127|NCT00215657|65175136|FG000|Overall Study|Other|3|||
23390128|NCT00215657|65175137|FG001|Overall Study|Other|1|||
23680764|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680765|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23680766|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23680767|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
23680768|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23680769|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
23680770|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23680771|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23680772|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23680773|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680774|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680775|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680776|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680777|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680778|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680779|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680780|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23390129|NCT00215657|65175138|FG002|Overall Study|Other|2|||
23390130|NCT00215657|65175139|FG003|Overall Study|Other|3|||
23680781|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680782|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680783|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680784|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680785|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680786|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680787|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680788|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23680789|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23680790|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
23390131|NCT00215657|65175140|FG004|Overall Study|Other|5|||
23390132|NCT00215657|65175141|FG005|Overall Study|Other|4|||
23390133|NCT00215657|65175142|FG006|Overall Study|Other|6|||
23390134|NCT00215657|65175143|FG007|Overall Study|Other|1|||
23390135|NCT01308788|65175144|FG000|2-year Treatment|medication change by treating physician|4|||
23390136|NCT01308788|65175145|FG001|2-year Treatment|medication change by treating physician|11|||
23390137|NCT02003898|65175148|FG000|Overall Study|Death|3|||
23680791|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23390138|NCT02003898|65175148|FG000|Overall Study|Lost to Follow-up|12|||
23390139|NCT02003898|65175148|FG000|Overall Study|Withdrawal by Subject|52|||
23680792|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
23680793|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
23680794|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
23680795|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23495031|NCT00491764|65555042|FG003|Overall Study|Administrative|1|||
23495032|NCT00491764|65555043|FG004|Overall Study|Administrative|0|||
23495033|NCT00491764|65555044|FG005|Overall Study|Administrative|0|||
23680796|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23680797|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680798|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680799|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680800|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680801|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680802|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680803|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680804|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680805|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680806|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23390140|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23390141|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23390142|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23390143|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23390144|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23390145|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23390146|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Other|2|||
23680807|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680808|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680809|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680810|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680811|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23680812|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680813|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680814|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
23680815|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680816|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
23680817|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680818|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680819|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680820|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680821|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680822|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680823|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680824|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680825|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680826|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680827|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680828|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680829|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680830|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680831|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680832|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680833|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680834|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23680835|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
23680836|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680837|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680838|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
23390147|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Other|1|||
23390148|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Other|1|||
23390149|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
23390150|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
23390151|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
23390152|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23390153|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23680839|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680840|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680841|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680842|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680843|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680844|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680845|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23390154|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23390155|NCT04507269|65175152|FG000|Overall Study|Withdrawal by Subject|1|||
23390156|NCT04507269|65175153|FG001|Overall Study|Withdrawal by Subject|1|||
23390157|NCT04507269|65175154|FG002|Overall Study|Withdrawal by Subject|0|||
23390158|NCT04507269|65175155|FG003|Overall Study|Withdrawal by Subject|0|||
23390159|NCT04507269|65175156|FG004|Overall Study|Withdrawal by Subject|0|||
23390160|NCT04507269|65175157|FG005|Overall Study|Withdrawal by Subject|0|||
23390161|NCT04507269|65175152|FG000|Overall Study|Lost to Follow-up|0|||
23680846|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680847|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680848|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680849|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680850|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680851|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680852|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680853|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680854|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680855|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680856|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680857|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23680858|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680859|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680860|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
23680861|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680862|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680863|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680864|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680865|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680866|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680867|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680868|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680869|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680870|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680871|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680872|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680873|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680874|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680875|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680876|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680877|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680878|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680879|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680880|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23680881|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680882|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680883|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
23390162|NCT04507269|65175153|FG001|Overall Study|Lost to Follow-up|0|||
23390163|NCT04507269|65175154|FG002|Overall Study|Lost to Follow-up|0|||
23680884|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680885|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680886|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680887|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680888|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680889|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680890|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680891|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680892|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680893|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680894|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680895|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680896|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680897|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680898|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680899|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23390164|NCT04507269|65175155|FG003|Overall Study|Lost to Follow-up|0|||
23390165|NCT04507269|65175156|FG004|Overall Study|Lost to Follow-up|1|||
23390166|NCT04507269|65175157|FG005|Overall Study|Lost to Follow-up|0|||
23390167|NCT03829683|65175158|FG000|Overall Study|Lost to Follow-up|1|||
23390168|NCT03829683|65175159|FG001|Overall Study|Lost to Follow-up|0|||
23390169|NCT03829683|65175158|FG000|Overall Study|Physician Decision|3|||
23390170|NCT03829683|65175159|FG001|Overall Study|Physician Decision|1|||
23390171|NCT03829683|65175158|FG000|Overall Study|Withdrawal by Subject|0|||
23390172|NCT03829683|65175159|FG001|Overall Study|Withdrawal by Subject|1|||
23390173|NCT03829683|65175158|FG000|Overall Study|Discharge from hospital|1|||
23390174|NCT03829683|65175159|FG001|Overall Study|Discharge from hospital|0|||
23390175|NCT01569763|65175160|FG000|Overall Study|Lack of Efficacy|2|||
23390176|NCT01569763|65175161|FG001|Overall Study|Lack of Efficacy|7|||
23390177|NCT01569763|65175160|FG000|Overall Study|Adverse Event|1|||
23390178|NCT01569763|65175161|FG001|Overall Study|Adverse Event|0|||
23390179|NCT02363283|65175162|FG000|Overall Study|Withdrawal by Subject|1|||
23390180|NCT02363283|65175162|FG000|Overall Study|Not eligible due to transaminitis|1|||
23390181|NCT01592747|65175163|FG000|Overall Study|Loss of Therapeutic Response|107|||
23390182|NCT01592747|65175164|FG001|Overall Study|Loss of Therapeutic Response|108|||
23390183|NCT01592747|65175165|FG002|Overall Study|Loss of Therapeutic Response|100|||
23390184|NCT01592747|65175163|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23495034|NCT00216476|65555051|FG000|Overall Study|Withdrawal by Subject|59|||
23495035|NCT00216476|65555052|FG001|Overall Study|Withdrawal by Subject|72|||
23390185|NCT01592747|65175164|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23390186|NCT01592747|65175165|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
23606150|NCT00641537|65947162|FG007|96-week Period|Lost to Follow-up|0|||
23606151|NCT00641537|65947155|FG000|96-week Period|Protocol Violation|0|||
23606152|NCT00641537|65947156|FG001|96-week Period|Protocol Violation|1|||
23606153|NCT00641537|65947157|FG002|96-week Period|Protocol Violation|0|||
23606154|NCT00641537|65947158|FG003|96-week Period|Protocol Violation|1|||
23606155|NCT00641537|65947159|FG004|96-week Period|Protocol Violation|0|||
23606156|NCT00641537|65947160|FG005|96-week Period|Protocol Violation|1|||
23606157|NCT00641537|65947161|FG006|96-week Period|Protocol Violation|0|||
23606158|NCT00641537|65947162|FG007|96-week Period|Protocol Violation|0|||
23606159|NCT00641537|65947155|FG000|96-week Period|Death|2|||
23606160|NCT00641537|65947156|FG001|96-week Period|Death|0|||
23606161|NCT00641537|65947157|FG002|96-week Period|Death|1|||
23606162|NCT00641537|65947158|FG003|96-week Period|Death|0|||
23606163|NCT00641537|65947159|FG004|96-week Period|Death|0|||
23606164|NCT00641537|65947160|FG005|96-week Period|Death|0|||
23606165|NCT00641537|65947161|FG006|96-week Period|Death|0|||
23606166|NCT00641537|65947162|FG007|96-week Period|Death|0|||
23606167|NCT00641537|65947155|FG000|96-week Period|Other|4|||
23606168|NCT00641537|65947156|FG001|96-week Period|Other|7|||
23606169|NCT00641537|65947157|FG002|96-week Period|Other|14|||
23606170|NCT00641537|65947158|FG003|96-week Period|Other|9|||
23606171|NCT00641537|65947159|FG004|96-week Period|Other|11|||
23606172|NCT00641537|65947160|FG005|96-week Period|Other|6|||
23606173|NCT00641537|65947161|FG006|96-week Period|Other|4|||
23606174|NCT00641537|65947162|FG007|96-week Period|Other|6|||
23606175|NCT00641537|65947155|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606176|NCT00641537|65947156|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606177|NCT00641537|65947157|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606178|NCT00641537|65947158|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
23606179|NCT00641537|65947159|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
23606180|NCT00641537|65947160|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606181|NCT00641537|65947161|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606182|NCT00641537|65947162|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606183|NCT00641537|65947155|FG000|24-Week Supplemental Follow-up Period|Other|0|||
23606184|NCT00641537|65947156|FG001|24-Week Supplemental Follow-up Period|Other|2|||
23606185|NCT00641537|65947157|FG002|24-Week Supplemental Follow-up Period|Other|2|||
23680900|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680901|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680902|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680903|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23680904|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680905|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680906|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680907|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
23680908|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680909|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680910|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680911|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680912|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680913|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680914|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680915|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680916|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680917|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680918|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680919|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680920|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680921|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680922|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680923|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680924|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680925|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680926|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23680927|NCT00896532|66210224|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680928|NCT00896532|66210225|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23680929|NCT00896532|66210226|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680930|NCT00896532|66210227|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23680931|NCT00896532|66210228|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23680932|NCT00896532|66210229|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680933|NCT00896532|66210230|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680934|NCT00896532|66210231|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680935|NCT00896532|66210232|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680936|NCT00896532|66210233|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680937|NCT00896532|66210234|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680938|NCT00896532|66210235|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680939|NCT00896532|66210236|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680940|NCT00896532|66210237|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680941|NCT00896532|66210238|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680942|NCT00896532|66210239|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680943|NCT00896532|66210240|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680944|NCT00896532|66210241|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680945|NCT00896532|66210242|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680946|NCT00896532|66210243|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680947|NCT00896532|66210244|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680948|NCT00896532|66210245|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680949|NCT00896532|66210246|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23680950|NCT00896532|66210224|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680951|NCT00896532|66210225|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680952|NCT00896532|66210226|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680953|NCT00896532|66210227|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680954|NCT00896532|66210228|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680955|NCT00896532|66210229|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680956|NCT00896532|66210230|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680957|NCT00896532|66210231|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680958|NCT00896532|66210232|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
23680959|NCT00896532|66210233|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680960|NCT00896532|66210234|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680961|NCT00896532|66210235|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23495036|NCT00216476|65555053|FG002|Overall Study|Withdrawal by Subject|9|||
23680962|NCT00896532|66210236|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680963|NCT00896532|66210237|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680964|NCT00896532|66210238|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680965|NCT00896532|66210239|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680966|NCT00896532|66210240|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680967|NCT00896532|66210241|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680968|NCT00896532|66210242|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680969|NCT00896532|66210243|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680970|NCT00896532|66210244|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680971|NCT00896532|66210245|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680972|NCT00896532|66210246|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23680973|NCT00896532|66210224|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680974|NCT00896532|66210225|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680975|NCT00896532|66210226|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680976|NCT00896532|66210227|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680977|NCT00896532|66210228|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680978|NCT00896532|66210229|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680979|NCT00896532|66210230|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680980|NCT00896532|66210231|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680981|NCT00896532|66210232|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680982|NCT00896532|66210233|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680983|NCT00896532|66210234|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680984|NCT00896532|66210235|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680985|NCT00896532|66210236|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
23680986|NCT00896532|66210237|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680987|NCT00896532|66210238|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680988|NCT00896532|66210239|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680989|NCT00896532|66210240|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680990|NCT00896532|66210241|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680991|NCT00896532|66210242|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680992|NCT00896532|66210243|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680993|NCT00896532|66210244|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680994|NCT00896532|66210245|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680995|NCT00896532|66210246|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23680996|NCT00896532|66210224|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23680997|NCT00896532|66210225|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23680998|NCT00896532|66210226|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23680999|NCT00896532|66210227|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681000|NCT00896532|66210228|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681001|NCT00896532|66210229|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681002|NCT00896532|66210230|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681003|NCT00896532|66210231|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681004|NCT00896532|66210232|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681005|NCT00896532|66210233|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681006|NCT00896532|66210234|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
23681007|NCT00896532|66210235|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681008|NCT00896532|66210236|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
23681009|NCT00896532|66210237|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681010|NCT00896532|66210238|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681011|NCT00896532|66210239|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681012|NCT00896532|66210240|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681013|NCT00896532|66210241|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681014|NCT00896532|66210242|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681015|NCT00896532|66210243|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681016|NCT00896532|66210244|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681017|NCT00896532|66210245|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681018|NCT00896532|66210246|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23681019|NCT00896532|66210224|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681020|NCT00896532|66210225|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681021|NCT00896532|66210226|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681022|NCT00896532|66210227|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681023|NCT00896532|66210228|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681024|NCT00896532|66210229|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681025|NCT00896532|66210230|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681026|NCT00896532|66210231|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681027|NCT00896532|66210232|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681028|NCT00896532|66210233|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681029|NCT00896532|66210234|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23390187|NCT01592747|65175163|FG000|Overall Study|Adverse Event|1|||
23390188|NCT01592747|65175164|FG001|Overall Study|Adverse Event|0|||
23390189|NCT01592747|65175165|FG002|Overall Study|Adverse Event|0|||
23390190|NCT01592747|65175163|FG000|Overall Study|Protocol Violation|4|||
23390191|NCT01592747|65175164|FG001|Overall Study|Protocol Violation|0|||
23390192|NCT01592747|65175165|FG002|Overall Study|Protocol Violation|4|||
23390193|NCT01592747|65175163|FG000|Overall Study|Lack of Efficacy|0|||
23390194|NCT01592747|65175164|FG001|Overall Study|Lack of Efficacy|1|||
23390195|NCT01592747|65175165|FG002|Overall Study|Lack of Efficacy|0|||
23390196|NCT01592747|65175163|FG000|Overall Study|Withdrawal by Subject|2|||
23390197|NCT01592747|65175164|FG001|Overall Study|Withdrawal by Subject|0|||
23681030|NCT00896532|66210235|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681031|NCT00896532|66210236|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
23681032|NCT00896532|66210237|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
23681033|NCT00896532|66210238|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681034|NCT00896532|66210239|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681035|NCT00896532|66210240|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681036|NCT00896532|66210241|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681037|NCT00896532|66210242|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681038|NCT00896532|66210243|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681039|NCT00896532|66210244|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681040|NCT00896532|66210245|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681041|NCT00896532|66210246|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23681042|NCT00896532|66210224|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
23681043|NCT00896532|66210225|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
23681044|NCT00896532|66210226|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
23681045|NCT00896532|66210227|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
23681046|NCT00896532|66210228|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
23681047|NCT00896532|66210229|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
23681048|NCT00896532|66210230|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
23681049|NCT00896532|66210231|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
23681050|NCT00896532|66210232|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
23681051|NCT00896532|66210233|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
23681052|NCT00896532|66210234|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
23681053|NCT00896532|66210235|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
23681054|NCT00896532|66210236|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
23681055|NCT00896532|66210237|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
23681056|NCT00896532|66210238|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
23681057|NCT00896532|66210239|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
23681058|NCT00896532|66210240|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
23681059|NCT00896532|66210241|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
23681060|NCT00896532|66210242|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
23681061|NCT00896532|66210243|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
23681062|NCT00896532|66210244|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
23681063|NCT00896532|66210245|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
23681064|NCT00896532|66210246|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
23681065|NCT00896532|66210224|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681066|NCT00896532|66210225|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681067|NCT00896532|66210226|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681068|NCT00896532|66210227|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681069|NCT00896532|66210228|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681070|NCT00896532|66210229|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681071|NCT00896532|66210230|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681072|NCT00896532|66210231|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681073|NCT00896532|66210232|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681074|NCT00896532|66210233|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23390198|NCT01592747|65175165|FG002|Overall Study|Withdrawal by Subject|2|||
23390199|NCT01592747|65175163|FG000|Overall Study|Lost to Follow-up|1|||
23390200|NCT01592747|65175164|FG001|Overall Study|Lost to Follow-up|0|||
23390201|NCT01592747|65175165|FG002|Overall Study|Lost to Follow-up|1|||
23390202|NCT01592747|65175163|FG000|Overall Study|Other Reasons|1|||
23390203|NCT01592747|65175164|FG001|Overall Study|Other Reasons|1|||
23390204|NCT01592747|65175165|FG002|Overall Study|Other Reasons|0|||
23390205|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
23390206|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
23681075|NCT00896532|66210234|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681076|NCT00896532|66210235|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681077|NCT00896532|66210236|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681078|NCT00896532|66210237|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681079|NCT00896532|66210238|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681080|NCT00896532|66210239|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
23681081|NCT00896532|66210240|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
23681082|NCT00896532|66210241|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681083|NCT00896532|66210242|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681084|NCT00896532|66210243|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681085|NCT00896532|66210244|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681086|NCT00896532|66210245|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681087|NCT00896532|66210246|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23681088|NCT00896532|66210224|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681089|NCT00896532|66210225|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681090|NCT00896532|66210226|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681091|NCT00896532|66210227|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681092|NCT00896532|66210228|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681093|NCT00896532|66210229|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681094|NCT00896532|66210230|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681095|NCT00896532|66210231|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681096|NCT00896532|66210232|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681097|NCT00896532|66210233|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681098|NCT00896532|66210234|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681099|NCT00896532|66210235|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681100|NCT00896532|66210236|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681101|NCT00896532|66210237|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681102|NCT00896532|66210238|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681103|NCT00896532|66210239|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
23681104|NCT00896532|66210240|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
23681105|NCT00896532|66210241|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
23681106|NCT00896532|66210242|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681107|NCT00896532|66210243|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681108|NCT00896532|66210244|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681109|NCT00896532|66210245|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681110|NCT00896532|66210246|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23681111|NCT00896532|66210224|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681112|NCT00896532|66210225|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681113|NCT00896532|66210226|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681114|NCT00896532|66210227|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681115|NCT00896532|66210228|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681116|NCT00896532|66210229|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681117|NCT00896532|66210230|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681118|NCT00896532|66210231|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681119|NCT00896532|66210232|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681120|NCT00896532|66210233|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23495037|NCT00216476|65555051|FG000|Overall Study|Lost to Follow-up|10|||
23495038|NCT00216476|65555052|FG001|Overall Study|Lost to Follow-up|9|||
23495039|NCT00216476|65555053|FG002|Overall Study|Lost to Follow-up|1|||
23495040|NCT00216476|65555051|FG000|Overall Study|Adverse Event|6|||
23495041|NCT00216476|65555052|FG001|Overall Study|Adverse Event|10|||
23681121|NCT00896532|66210234|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681122|NCT00896532|66210235|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681123|NCT00896532|66210236|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681124|NCT00896532|66210237|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681125|NCT00896532|66210238|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681126|NCT00896532|66210239|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681127|NCT00896532|66210240|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
23681128|NCT00896532|66210241|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681129|NCT00896532|66210242|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681130|NCT00896532|66210243|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23495042|NCT00216476|65555053|FG002|Overall Study|Adverse Event|1|||
23495043|NCT00216476|65555051|FG000|Overall Study|Lack of Efficacy|4|||
23495044|NCT00216476|65555052|FG001|Overall Study|Lack of Efficacy|3|||
23495045|NCT00216476|65555053|FG002|Overall Study|Lack of Efficacy|0|||
23681131|NCT00896532|66210244|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681132|NCT00896532|66210245|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681133|NCT00896532|66210246|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23681134|NCT00896532|66210224|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
23681135|NCT00896532|66210225|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
23681136|NCT00896532|66210226|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
23681137|NCT00896532|66210227|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
23681138|NCT00896532|66210228|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
23681139|NCT00896532|66210229|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
23681140|NCT00896532|66210230|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
23681141|NCT00896532|66210231|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
23681142|NCT00896532|66210232|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
23681143|NCT00896532|66210233|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
23681144|NCT00896532|66210234|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
23681145|NCT00896532|66210235|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
23681146|NCT00896532|66210236|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
23681147|NCT00896532|66210237|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
23681148|NCT00896532|66210238|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
23681149|NCT00896532|66210239|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
23681150|NCT00896532|66210240|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
23681151|NCT00896532|66210241|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
23681152|NCT00896532|66210242|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
23681153|NCT00896532|66210243|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
23681154|NCT00896532|66210244|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
23681155|NCT00896532|66210245|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
23681156|NCT00896532|66210246|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
23681157|NCT00896532|66210224|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681158|NCT00896532|66210225|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681159|NCT00896532|66210226|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681160|NCT00896532|66210227|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681161|NCT00896532|66210228|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681162|NCT00896532|66210229|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681163|NCT00896532|66210230|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681164|NCT00896532|66210231|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681165|NCT00896532|66210232|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681166|NCT00896532|66210233|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681167|NCT00896532|66210234|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681168|NCT00896532|66210235|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681169|NCT00896532|66210236|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681170|NCT00896532|66210237|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681171|NCT00896532|66210238|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681172|NCT00896532|66210239|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681173|NCT00896532|66210240|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
23681174|NCT00896532|66210241|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681175|NCT00896532|66210242|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681176|NCT00896532|66210243|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681177|NCT00896532|66210244|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681178|NCT00896532|66210245|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681179|NCT00896532|66210246|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23681180|NCT00896532|66210224|FG000|Months 48-72: Follow-on Phase|Death|0|||
23681181|NCT00896532|66210225|FG001|Months 48-72: Follow-on Phase|Death|0|||
23681182|NCT00896532|66210226|FG002|Months 48-72: Follow-on Phase|Death|0|||
23681183|NCT00896532|66210227|FG003|Months 48-72: Follow-on Phase|Death|0|||
23681184|NCT00896532|66210228|FG004|Months 48-72: Follow-on Phase|Death|0|||
23681185|NCT00896532|66210229|FG005|Months 48-72: Follow-on Phase|Death|0|||
23681186|NCT00896532|66210230|FG006|Months 48-72: Follow-on Phase|Death|0|||
23681187|NCT00896532|66210231|FG007|Months 48-72: Follow-on Phase|Death|0|||
23681188|NCT00896532|66210232|FG008|Months 48-72: Follow-on Phase|Death|0|||
23681189|NCT00896532|66210233|FG009|Months 48-72: Follow-on Phase|Death|0|||
23390207|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
23390208|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
23681190|NCT00896532|66210234|FG010|Months 48-72: Follow-on Phase|Death|0|||
23681191|NCT00896532|66210235|FG011|Months 48-72: Follow-on Phase|Death|0|||
23681192|NCT00896532|66210236|FG012|Months 48-72: Follow-on Phase|Death|0|||
23681193|NCT00896532|66210237|FG013|Months 48-72: Follow-on Phase|Death|0|||
23390209|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
23681194|NCT00896532|66210238|FG014|Months 48-72: Follow-on Phase|Death|0|||
23681195|NCT00896532|66210239|FG015|Months 48-72: Follow-on Phase|Death|0|||
23681196|NCT00896532|66210240|FG016|Months 48-72: Follow-on Phase|Death|0|||
23681197|NCT00896532|66210241|FG017|Months 48-72: Follow-on Phase|Death|0|||
23681198|NCT00896532|66210242|FG018|Months 48-72: Follow-on Phase|Death|1|||
23681199|NCT00896532|66210243|FG019|Months 48-72: Follow-on Phase|Death|0|||
23681200|NCT00896532|66210244|FG020|Months 48-72: Follow-on Phase|Death|0|||
23681201|NCT00896532|66210245|FG021|Months 48-72: Follow-on Phase|Death|0|||
23681202|NCT00896532|66210246|FG022|Months 48-72: Follow-on Phase|Death|0|||
23681203|NCT00896532|66210224|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681204|NCT00896532|66210225|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681205|NCT00896532|66210226|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681206|NCT00896532|66210227|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681207|NCT00896532|66210228|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681208|NCT00896532|66210229|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681209|NCT00896532|66210230|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681210|NCT00896532|66210231|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681211|NCT00896532|66210232|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681212|NCT00896532|66210233|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681213|NCT00896532|66210234|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681214|NCT00896532|66210235|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681215|NCT00896532|66210236|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681216|NCT00896532|66210237|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681217|NCT00896532|66210238|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681218|NCT00896532|66210239|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681219|NCT00896532|66210240|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681220|NCT00896532|66210241|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681221|NCT00896532|66210242|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681222|NCT00896532|66210243|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681223|NCT00896532|66210244|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681224|NCT00896532|66210245|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
23681225|NCT00896532|66210246|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23681226|NCT00896532|66210224|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681227|NCT00896532|66210225|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681228|NCT00896532|66210226|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681229|NCT00896532|66210227|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681230|NCT00896532|66210228|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681231|NCT00896532|66210229|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681232|NCT00896532|66210230|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681233|NCT00896532|66210231|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681234|NCT00896532|66210232|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681235|NCT00896532|66210233|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681236|NCT00896532|66210234|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681237|NCT00896532|66210235|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681238|NCT00896532|66210236|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681239|NCT00896532|66210237|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681240|NCT00896532|66210238|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681241|NCT00896532|66210239|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681242|NCT00896532|66210240|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681243|NCT00896532|66210241|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681244|NCT00896532|66210242|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681245|NCT00896532|66210243|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681246|NCT00896532|66210244|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681247|NCT00896532|66210245|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
23681248|NCT00896532|66210246|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23681249|NCT01046695|66210247|FG000|Overall Study|Subject had a pacemaker|0|||
23681250|NCT01046695|66210248|FG001|Overall Study|Subject had a pacemaker|1|||
23681251|NCT01046695|66210247|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
23681252|NCT01046695|66210248|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
23681253|NCT00132730|66210249|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
23681254|NCT00132730|66210250|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
23681255|NCT00132730|66210251|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
23681256|NCT00132730|66210252|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
23681257|NCT00132730|66210253|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
23681258|NCT00132730|66210254|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
23495046|NCT00216476|65555051|FG000|Overall Study|Death|2|||
23495047|NCT00216476|65555052|FG001|Overall Study|Death|0|||
23681259|NCT00132730|66210249|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
23681260|NCT00132730|66210250|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
23681261|NCT00132730|66210251|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23681262|NCT00132730|66210252|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23681263|NCT00132730|66210253|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23681264|NCT00132730|66210254|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23681265|NCT00132730|66210249|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
23681266|NCT00132730|66210250|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
23681267|NCT00132730|66210251|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
23681268|NCT00132730|66210252|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
23681269|NCT00132730|66210253|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
23681270|NCT00132730|66210254|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
23681271|NCT00132730|66210249|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23681272|NCT00132730|66210250|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23681273|NCT00132730|66210251|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
23681274|NCT00132730|66210252|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
23681275|NCT00132730|66210253|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23681276|NCT00132730|66210254|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23681277|NCT00132730|66210249|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23681278|NCT00132730|66210250|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23681279|NCT00132730|66210251|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
23681280|NCT00132730|66210252|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
23681281|NCT00132730|66210253|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23681282|NCT00132730|66210254|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23681283|NCT00132730|66210249|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23681284|NCT00132730|66210250|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23681285|NCT00132730|66210251|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23681286|NCT00132730|66210252|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
23681287|NCT00132730|66210253|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23681288|NCT00132730|66210254|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23681289|NCT00132730|66210249|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23681290|NCT00132730|66210250|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23681291|NCT00132730|66210251|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
23681292|NCT00132730|66210252|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
23681293|NCT00132730|66210253|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23681294|NCT00132730|66210254|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23681295|NCT00132730|66210249|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23681296|NCT00132730|66210250|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23681297|NCT00132730|66210251|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23681298|NCT00132730|66210252|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23681299|NCT00132730|66210253|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
23681300|NCT00132730|66210254|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
23681301|NCT00132730|66210249|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23681302|NCT00132730|66210250|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23681303|NCT00132730|66210251|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23681304|NCT00132730|66210252|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23681305|NCT00132730|66210253|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
23681306|NCT00132730|66210254|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23681307|NCT00132730|66210249|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23681308|NCT00132730|66210250|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23681309|NCT00132730|66210251|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23681310|NCT00132730|66210252|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23681311|NCT00132730|66210253|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
23681312|NCT00132730|66210254|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23681313|NCT00132730|66210249|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23681314|NCT00132730|66210250|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23681315|NCT00132730|66210251|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23681316|NCT00132730|66210252|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23681317|NCT00132730|66210253|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
23681318|NCT00132730|66210254|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23681319|NCT00132730|66210249|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23681320|NCT00132730|66210250|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23681321|NCT00132730|66210251|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23681322|NCT00132730|66210252|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23681323|NCT00132730|66210253|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
23681324|NCT00132730|66210254|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
23681325|NCT02429856|66210255|FG000|Overall Study|Death|12|||
23681326|NCT02429856|66210256|FG001|Overall Study|Death|13|||
23681327|NCT02429856|66210255|FG000|Overall Study|Lost to Follow-up|6|||
23681328|NCT02429856|66210256|FG001|Overall Study|Lost to Follow-up|5|||
23681329|NCT02429856|66210255|FG000|Overall Study|Withdrawal by Subject|1|||
23681330|NCT02429856|66210256|FG001|Overall Study|Withdrawal by Subject|1|||
23681331|NCT00675597|66210257|FG000|Overall Study|Withdrawal by Subject|3|||
23681332|NCT00624520|66210258|FG000|Overall Study|Withdrawal by Subject|12|||
23681333|NCT00624520|66210259|FG001|Overall Study|Withdrawal by Subject|7|||
23681334|NCT00624520|66210258|FG000|Overall Study|Death|0|||
23681335|NCT00624520|66210259|FG001|Overall Study|Death|1|||
23681336|NCT00568555|66210262|FG000|Overall Study|Withdrawal by Subject|1|||
23681337|NCT00568555|66210263|FG001|Overall Study|Withdrawal by Subject|1|||
23681338|NCT02542072|66210264|FG000|First Intervention (1 Month)|Adverse Event|1|||
23681339|NCT02542072|66210265|FG001|First Intervention (1 Month)|Adverse Event|1|||
23681340|NCT02542072|66210264|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
23681341|NCT02542072|66210265|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
23681342|NCT02542072|66210264|FG000|First Intervention (1 Month)|Lens discomfort|1|||
23681343|NCT02542072|66210265|FG001|First Intervention (1 Month)|Lens discomfort|2|||
23681344|NCT02542072|66210264|FG000|First Intervention (1 Month)|Protocol Violation|1|||
23681345|NCT02542072|66210265|FG001|First Intervention (1 Month)|Protocol Violation|0|||
23681346|NCT02542072|66210264|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
23681347|NCT02542072|66210265|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
23681348|NCT02542072|66210264|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
23681349|NCT02542072|66210265|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
23681350|NCT05425563|66210266|FG000|Overall Study|Withdrawal by Subject|17|||
23681351|NCT04541004|66210267|FG000|Overall Study|Adverse Event|2|||
23681352|NCT02307682|66210268|FG000|Overall Study|Adverse Event|9|||
23681353|NCT02307682|66210269|FG001|Overall Study|Adverse Event|8|||
23681354|NCT02307682|66210270|FG002|Overall Study|Adverse Event|12|||
23681355|NCT02307682|66210268|FG000|Overall Study|Lack of Efficacy|1|||
23681356|NCT02307682|66210269|FG001|Overall Study|Lack of Efficacy|0|||
23681357|NCT02307682|66210270|FG002|Overall Study|Lack of Efficacy|1|||
23681358|NCT02307682|66210268|FG000|Overall Study|Physician Decision|2|||
23681359|NCT02307682|66210269|FG001|Overall Study|Physician Decision|2|||
23681360|NCT02307682|66210270|FG002|Overall Study|Physician Decision|8|||
23681361|NCT02307682|66210268|FG000|Overall Study|Progressive Disease|1|||
23681362|NCT02307682|66210269|FG001|Overall Study|Progressive Disease|0|||
23681363|NCT02307682|66210270|FG002|Overall Study|Progressive Disease|0|||
23681364|NCT02307682|66210268|FG000|Overall Study|Withdrawal by Subject|26|||
23681365|NCT02307682|66210269|FG001|Overall Study|Withdrawal by Subject|34|||
23681366|NCT02307682|66210270|FG002|Overall Study|Withdrawal by Subject|23|||
23681367|NCT02307682|66210268|FG000|Overall Study|Death|9|||
23681368|NCT02307682|66210269|FG001|Overall Study|Death|7|||
23681369|NCT02307682|66210270|FG002|Overall Study|Death|12|||
23681370|NCT02307682|66210268|FG000|Overall Study|Lost to Follow-up|1|||
23681371|NCT02307682|66210269|FG001|Overall Study|Lost to Follow-up|5|||
23681372|NCT02307682|66210270|FG002|Overall Study|Lost to Follow-up|6|||
23681373|NCT02307682|66210268|FG000|Overall Study|Protocol Deviation|0|||
23681374|NCT02307682|66210269|FG001|Overall Study|Protocol Deviation|0|||
23681375|NCT02307682|66210270|FG002|Overall Study|Protocol Deviation|2|||
23681376|NCT02307682|66210268|FG000|Overall Study|Other|1|||
23681377|NCT02307682|66210269|FG001|Overall Study|Other|1|||
23681378|NCT02307682|66210270|FG002|Overall Study|Other|0|||
23681379|NCT00454779|66210279|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
23681380|NCT00454779|66210280|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
23681381|NCT00454779|66210279|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
23681382|NCT00454779|66210280|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
23681383|NCT00454779|66210279|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
23681384|NCT00454779|66210280|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
23681385|NCT00454779|66210279|FG000|First-line Treatment Phase|Protocol Violation|0|||
23681386|NCT00454779|66210280|FG001|First-line Treatment Phase|Protocol Violation|1|||
23681387|NCT00454779|66210279|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
23681388|NCT00454779|66210280|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
23681389|NCT00454779|66210279|FG000|First-line Treatment Phase|Ongoing|1|||
23681390|NCT00454779|66210280|FG001|First-line Treatment Phase|Ongoing|0|||
23681391|NCT00454779|66210279|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
23681392|NCT00454779|66210280|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
23681393|NCT00454779|66210279|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
23681394|NCT00454779|66210280|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
23681395|NCT00454779|66210279|FG000|Second-line Treatment Phase|Ongoing|0|||
23390210|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
23390211|NCT02144337|65175168|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
23390212|NCT02144337|65175169|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
23390213|NCT02144337|65175168|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
23390214|NCT02144337|65175169|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
23390215|NCT04985682|65175177|FG000|Overall Study|Withdrawal by Subject|1|||
23390216|NCT05346640|65175181|FG000|Overall Study|Lack of Efficacy|2|||
23390217|NCT05346640|65175181|FG000|Overall Study|Lost to Follow-up|14|||
23390218|NCT05346640|65175181|FG000|Overall Study|Protocol Violation|4|||
23390219|NCT05346640|65175181|FG000|Overall Study|Withdrawal by Subject|2|||
23390220|NCT05346640|65175181|FG000|Overall Study|Physiological Complications|3|||
23390221|NCT05346640|65175181|FG000|Overall Study|Other Reason|3|||
23390222|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23681396|NCT00454779|66210280|FG001|Second-line Treatment Phase|Ongoing|1|||
23390223|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390224|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390225|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390226|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390227|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390228|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390229|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390230|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390231|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390232|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Death|2|||
23390233|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Death|1|||
23390234|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Death|3|||
23390235|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Death|1|||
23390236|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Death|2|||
23390237|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Death|3|||
23390238|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Death|3|||
23390239|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Death|0|||
23390240|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Death|0|||
23390241|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Death|0|||
23390242|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390243|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23681397|NCT03575104|66210283|FG000|Overall Study|Adverse Event|4|||
23681398|NCT03575104|66210284|FG001|Overall Study|Adverse Event|3|||
23681399|NCT03575104|66210285|FG002|Overall Study|Adverse Event|4|||
23681400|NCT03575104|66210283|FG000|Overall Study|Withdrawal by Subject|13|||
23681401|NCT03575104|66210284|FG001|Overall Study|Withdrawal by Subject|16|||
23681402|NCT03575104|66210285|FG002|Overall Study|Withdrawal by Subject|11|||
23681403|NCT03575104|66210283|FG000|Overall Study|Other reasons|6|||
23681404|NCT03575104|66210284|FG001|Overall Study|Other reasons|8|||
23681405|NCT03575104|66210285|FG002|Overall Study|Other reasons|6|||
23681406|NCT03575104|66210283|FG000|Overall Study|Lost to Follow-up|1|||
23681407|NCT03575104|66210284|FG001|Overall Study|Lost to Follow-up|2|||
23681408|NCT03575104|66210285|FG002|Overall Study|Lost to Follow-up|1|||
23681409|NCT02542267|66210292|FG000|Overall Study|Withdrawal by Subject|10|||
23681410|NCT02542267|66210292|FG000|Overall Study|Physician Decision|6|||
23681411|NCT02542267|66210292|FG000|Overall Study|Lost to Follow-up|4|||
23681412|NCT02542267|66210292|FG000|Overall Study|Death|13|||
23681413|NCT02542267|66210292|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
23681414|NCT02542267|66210292|FG000|Overall Study|Other|9|||
23681415|NCT03543410|66210295|FG000|Overall Study|Adverse Event|10|||
23681416|NCT03543410|66210296|FG001|Overall Study|Adverse Event|8|||
23681417|NCT03543410|66210297|FG002|Overall Study|Adverse Event|2|||
23681418|NCT03543410|66210295|FG000|Overall Study|Lack of Efficacy|0|||
23681419|NCT03543410|66210296|FG001|Overall Study|Lack of Efficacy|1|||
23681420|NCT03543410|66210297|FG002|Overall Study|Lack of Efficacy|0|||
23681421|NCT03543410|66210295|FG000|Overall Study|Lost to Follow-up|0|||
23681422|NCT03543410|66210296|FG001|Overall Study|Lost to Follow-up|1|||
23495048|NCT00216476|65555053|FG002|Overall Study|Death|0|||
23681423|NCT03543410|66210297|FG002|Overall Study|Lost to Follow-up|0|||
23681424|NCT03543410|66210295|FG000|Overall Study|Withdrawal by Subject|5|||
23681425|NCT03543410|66210296|FG001|Overall Study|Withdrawal by Subject|2|||
23681426|NCT03543410|66210297|FG002|Overall Study|Withdrawal by Subject|8|||
23681427|NCT03543410|66210295|FG000|Overall Study|Protocol Violation|0|||
23681428|NCT03543410|66210296|FG001|Overall Study|Protocol Violation|1|||
23681429|NCT03543410|66210297|FG002|Overall Study|Protocol Violation|0|||
23495049|NCT00216476|65555051|FG000|Overall Study|Pregnancy|0|||
23681430|NCT03543410|66210295|FG000|Overall Study|Due to COVID-19|4|||
23681431|NCT03543410|66210296|FG001|Overall Study|Due to COVID-19|0|||
23390244|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390245|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390246|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390247|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
23390248|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390249|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390250|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390251|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390252|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390253|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390254|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390255|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390256|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390257|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390258|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390259|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
23390260|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
23390261|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
23390262|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
23390263|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
23390264|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
23390265|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
23390266|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
23390267|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
23390268|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
23390269|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
23390270|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
23390271|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
23390272|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390273|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390274|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390275|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390276|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390277|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390278|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390279|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
23390280|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
23390281|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390282|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390283|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390284|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390285|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390286|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390287|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390288|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390289|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390290|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23681432|NCT03543410|66210297|FG002|Overall Study|Due to COVID-19|2|||
23681433|NCT03543410|66210295|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
23681434|NCT03543410|66210296|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
23681435|NCT03543410|66210297|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
23681436|NCT03543410|66210295|FG000|Overall Study|Not Due to COVID-19|2|||
23681437|NCT03543410|66210296|FG001|Overall Study|Not Due to COVID-19|0|||
23681438|NCT03543410|66210297|FG002|Overall Study|Not Due to COVID-19|1|||
23681439|NCT02600507|66210299|FG000|Overall Study|Adverse Event|3|||
23681440|NCT02600507|66210300|FG001|Overall Study|Adverse Event|15|||
23681441|NCT02600507|66210301|FG002|Overall Study|Adverse Event|5|||
23681442|NCT02600507|66210299|FG000|Overall Study|Lack of Efficacy|3|||
23681443|NCT02600507|66210300|FG001|Overall Study|Lack of Efficacy|8|||
23681444|NCT02600507|66210301|FG002|Overall Study|Lack of Efficacy|5|||
23681445|NCT02600507|66210299|FG000|Overall Study|Lost to Follow-up|3|||
23390291|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
23390292|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Death|0|||
23390293|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Death|0|||
23390294|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Death|0|||
23390295|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Death|0|||
23390296|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Death|0|||
23495050|NCT00216476|65555052|FG001|Overall Study|Pregnancy|1|||
23681446|NCT02600507|66210300|FG001|Overall Study|Lost to Follow-up|5|||
23390297|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Death|0|||
23681447|NCT02600507|66210301|FG002|Overall Study|Lost to Follow-up|2|||
23681448|NCT02600507|66210299|FG000|Overall Study|Protocol Violation|12|||
23390298|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Death|0|||
23390299|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Death|4|||
23681449|NCT02600507|66210300|FG001|Overall Study|Protocol Violation|4|||
23681450|NCT02600507|66210301|FG002|Overall Study|Protocol Violation|4|||
23681451|NCT02600507|66210299|FG000|Overall Study|Physician Decision|1|||
23681452|NCT02600507|66210300|FG001|Overall Study|Physician Decision|0|||
23681453|NCT02600507|66210301|FG002|Overall Study|Physician Decision|1|||
23681454|NCT02600507|66210299|FG000|Overall Study|Withdrawal by Subject|7|||
23681455|NCT02600507|66210300|FG001|Overall Study|Withdrawal by Subject|11|||
23681456|NCT02600507|66210301|FG002|Overall Study|Withdrawal by Subject|7|||
23681457|NCT02600507|66210299|FG000|Overall Study|Other|0|||
23681458|NCT02600507|66210300|FG001|Overall Study|Other|1|||
23681459|NCT02600507|66210301|FG002|Overall Study|Other|1|||
23681460|NCT00705263|66210305|FG000|Overall Study|Withdrawal by Subject|2|||
23681461|NCT04957290|66210306|FG000|Overall Study|Progressive disease|3|||
23681462|NCT04957290|66210307|FG001|Overall Study|Progressive disease|3|||
23681463|NCT04957290|66210308|FG002|Overall Study|Progressive disease|2|||
23681464|NCT04957290|66210309|FG003|Overall Study|Progressive disease|0|||
23681465|NCT04957290|66210310|FG004|Overall Study|Progressive disease|0|||
23390300|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Death|8|||
23390301|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Death|10|||
23681466|NCT04957290|66210311|FG005|Overall Study|Progressive disease|0|||
23681467|NCT04957290|66210306|FG000|Overall Study|Withdrawal by Subject|1|||
23681468|NCT04957290|66210307|FG001|Overall Study|Withdrawal by Subject|0|||
23681469|NCT04957290|66210308|FG002|Overall Study|Withdrawal by Subject|1|||
23681470|NCT04957290|66210309|FG003|Overall Study|Withdrawal by Subject|0|||
23681471|NCT04957290|66210310|FG004|Overall Study|Withdrawal by Subject|0|||
23681472|NCT04957290|66210311|FG005|Overall Study|Withdrawal by Subject|0|||
23681473|NCT04957290|66210306|FG000|Overall Study|Death|0|||
23681474|NCT04957290|66210307|FG001|Overall Study|Death|2|||
23681475|NCT04957290|66210308|FG002|Overall Study|Death|1|||
23681476|NCT04957290|66210309|FG003|Overall Study|Death|0|||
23681477|NCT04957290|66210310|FG004|Overall Study|Death|0|||
23681478|NCT04957290|66210311|FG005|Overall Study|Death|0|||
23681479|NCT04957290|66210306|FG000|Overall Study|non compliance with study drug|0|||
23681480|NCT04957290|66210307|FG001|Overall Study|non compliance with study drug|1|||
23681481|NCT04957290|66210308|FG002|Overall Study|non compliance with study drug|0|||
23681482|NCT04957290|66210309|FG003|Overall Study|non compliance with study drug|0|||
23681483|NCT04957290|66210310|FG004|Overall Study|non compliance with study drug|0|||
23681484|NCT04957290|66210311|FG005|Overall Study|non compliance with study drug|0|||
23681485|NCT04957290|66210306|FG000|Overall Study|none specified.|0|||
23681486|NCT04957290|66210307|FG001|Overall Study|none specified.|1|||
23681487|NCT04957290|66210308|FG002|Overall Study|none specified.|2|||
23681488|NCT04957290|66210309|FG003|Overall Study|none specified.|0|||
23681489|NCT04957290|66210310|FG004|Overall Study|none specified.|0|||
23681490|NCT04957290|66210311|FG005|Overall Study|none specified.|0|||
23681491|NCT04957290|66210306|FG000|Overall Study|unacceptable toxicity|0|||
23681492|NCT04957290|66210307|FG001|Overall Study|unacceptable toxicity|0|||
23681493|NCT04957290|66210308|FG002|Overall Study|unacceptable toxicity|1|||
23681494|NCT04957290|66210309|FG003|Overall Study|unacceptable toxicity|0|||
23681495|NCT04957290|66210310|FG004|Overall Study|unacceptable toxicity|0|||
23681496|NCT04957290|66210311|FG005|Overall Study|unacceptable toxicity|0|||
23681497|NCT04957290|66210306|FG000|Overall Study|Adverse Event|0|||
23681498|NCT04957290|66210307|FG001|Overall Study|Adverse Event|0|||
23681499|NCT04957290|66210308|FG002|Overall Study|Adverse Event|1|||
23681500|NCT04957290|66210309|FG003|Overall Study|Adverse Event|0|||
23681501|NCT04957290|66210310|FG004|Overall Study|Adverse Event|0|||
23681502|NCT04957290|66210311|FG005|Overall Study|Adverse Event|0|||
23681503|NCT04957290|66210306|FG000|Overall Study|study terminated by sponsor|0|||
23390302|NCT01335685|65175192|FG000|Overall Study|Study Terminated by Sponsor|2|||
23390303|NCT01335685|65175193|FG001|Overall Study|Study Terminated by Sponsor|1|||
23390304|NCT01335685|65175194|FG002|Overall Study|Study Terminated by Sponsor|1|||
23390305|NCT01335685|65175195|FG003|Overall Study|Study Terminated by Sponsor|10|||
23390306|NCT01335685|65175196|FG004|Overall Study|Study Terminated by Sponsor|0|||
23390307|NCT01335685|65175197|FG005|Overall Study|Study Terminated by Sponsor|4|||
23390308|NCT01335685|65175198|FG006|Overall Study|Study Terminated by Sponsor|2|||
23390309|NCT01335685|65175199|FG007|Overall Study|Study Terminated by Sponsor|3|||
23390310|NCT01335685|65175192|FG000|Overall Study|Withdrawal by Subject|1|||
23390311|NCT01335685|65175193|FG001|Overall Study|Withdrawal by Subject|0|||
23681504|NCT04957290|66210307|FG001|Overall Study|study terminated by sponsor|0|||
23390312|NCT01335685|65175194|FG002|Overall Study|Withdrawal by Subject|0|||
23390313|NCT01335685|65175195|FG003|Overall Study|Withdrawal by Subject|1|||
23681505|NCT04957290|66210308|FG002|Overall Study|study terminated by sponsor|2|||
23681506|NCT04957290|66210309|FG003|Overall Study|study terminated by sponsor|0|||
23681507|NCT04957290|66210310|FG004|Overall Study|study terminated by sponsor|0|||
23681508|NCT04957290|66210311|FG005|Overall Study|study terminated by sponsor|0|||
23681509|NCT00849667|66210312|FG000|Overall Study|Withdrawal by Subject|16|||
23681510|NCT00849667|66210313|FG001|Overall Study|Withdrawal by Subject|33|||
23681511|NCT00849667|66210314|FG002|Overall Study|Withdrawal by Subject|35|||
23681512|NCT00849667|66210312|FG000|Overall Study|Lost to Follow-up|8|||
23681513|NCT00849667|66210313|FG001|Overall Study|Lost to Follow-up|8|||
23681514|NCT00849667|66210314|FG002|Overall Study|Lost to Follow-up|8|||
23681515|NCT00849667|66210312|FG000|Overall Study|Adverse Event|1|||
23681516|NCT00849667|66210313|FG001|Overall Study|Adverse Event|2|||
23681517|NCT00849667|66210314|FG002|Overall Study|Adverse Event|0|||
23681518|NCT00849667|66210312|FG000|Overall Study|Other|18|||
23681519|NCT00849667|66210313|FG001|Overall Study|Other|19|||
23681520|NCT00849667|66210314|FG002|Overall Study|Other|18|||
23681521|NCT00849667|66210312|FG000|Overall Study|Progressive disease|119|||
23681522|NCT00849667|66210313|FG001|Overall Study|Progressive disease|100|||
23681523|NCT00849667|66210314|FG002|Overall Study|Progressive disease|112|||
23681524|NCT00849667|66210312|FG000|Overall Study|Sponsor decision|208|||
23681525|NCT00849667|66210313|FG001|Overall Study|Sponsor decision|204|||
23681526|NCT00849667|66210314|FG002|Overall Study|Sponsor decision|190|||
23681527|NCT00849667|66210312|FG000|Overall Study|Investigator discretion|0|||
23681528|NCT00849667|66210313|FG001|Overall Study|Investigator discretion|0|||
23681529|NCT00849667|66210314|FG002|Overall Study|Investigator discretion|1|||
23681530|NCT00481065|66213786|FG000|Overall Study|Adverse event or death|1|||
23681531|NCT00481065|66213787|FG001|Overall Study|Adverse event or death|1|||
23681532|NCT00481065|66213788|FG002|Overall Study|Adverse event or death|3|||
23681533|NCT00481065|66213789|FG003|Overall Study|Adverse event or death|0|||
23681534|NCT00481065|66213790|FG004|Overall Study|Adverse event or death|2|||
23681535|NCT00481065|66213791|FG005|Overall Study|Adverse event or death|0|||
23681536|NCT00481065|66213792|FG006|Overall Study|Adverse event or death|1|||
23681537|NCT00481065|66213793|FG007|Overall Study|Adverse event or death|1|||
23681538|NCT00481065|66213786|FG000|Overall Study|Withdrawal by Subject|11|||
23681539|NCT00481065|66213787|FG001|Overall Study|Withdrawal by Subject|12|||
23681540|NCT00481065|66213788|FG002|Overall Study|Withdrawal by Subject|7|||
23681541|NCT00481065|66213789|FG003|Overall Study|Withdrawal by Subject|11|||
23681542|NCT00481065|66213790|FG004|Overall Study|Withdrawal by Subject|13|||
23681543|NCT00481065|66213791|FG005|Overall Study|Withdrawal by Subject|12|||
23681544|NCT00481065|66213792|FG006|Overall Study|Withdrawal by Subject|9|||
23681545|NCT00481065|66213793|FG007|Overall Study|Withdrawal by Subject|10|||
23681546|NCT00481065|66213786|FG000|Overall Study|Lost to Follow-up|4|||
23681547|NCT00481065|66213787|FG001|Overall Study|Lost to Follow-up|2|||
23681548|NCT00481065|66213788|FG002|Overall Study|Lost to Follow-up|4|||
23681549|NCT00481065|66213789|FG003|Overall Study|Lost to Follow-up|3|||
23681550|NCT00481065|66213790|FG004|Overall Study|Lost to Follow-up|3|||
23681551|NCT00481065|66213791|FG005|Overall Study|Lost to Follow-up|3|||
23681552|NCT00481065|66213792|FG006|Overall Study|Lost to Follow-up|2|||
23681553|NCT00481065|66213793|FG007|Overall Study|Lost to Follow-up|5|||
23681554|NCT00481065|66213786|FG000|Overall Study|Inappropriate enrollment|4|||
23681555|NCT00481065|66213787|FG001|Overall Study|Inappropriate enrollment|0|||
23681556|NCT00481065|66213788|FG002|Overall Study|Inappropriate enrollment|2|||
23681557|NCT00481065|66213789|FG003|Overall Study|Inappropriate enrollment|0|||
23681558|NCT00481065|66213790|FG004|Overall Study|Inappropriate enrollment|2|||
23681559|NCT00481065|66213791|FG005|Overall Study|Inappropriate enrollment|1|||
23681560|NCT00481065|66213792|FG006|Overall Study|Inappropriate enrollment|0|||
23681561|NCT00481065|66213793|FG007|Overall Study|Inappropriate enrollment|1|||
23681562|NCT00481065|66213786|FG000|Overall Study|Administrative reason|0|||
23681563|NCT00481065|66213787|FG001|Overall Study|Administrative reason|0|||
23681564|NCT00481065|66213788|FG002|Overall Study|Administrative reason|0|||
23681565|NCT00481065|66213789|FG003|Overall Study|Administrative reason|0|||
23681566|NCT00481065|66213790|FG004|Overall Study|Administrative reason|0|||
23681567|NCT00481065|66213791|FG005|Overall Study|Administrative reason|2|||
23681568|NCT00481065|66213792|FG006|Overall Study|Administrative reason|1|||
23681569|NCT00481065|66213793|FG007|Overall Study|Administrative reason|0|||
23681570|NCT00481065|66213786|FG000|Overall Study|Protocol Violation|2|||
23681571|NCT00481065|66213787|FG001|Overall Study|Protocol Violation|1|||
23681572|NCT00481065|66213788|FG002|Overall Study|Protocol Violation|1|||
23681573|NCT00481065|66213789|FG003|Overall Study|Protocol Violation|1|||
23681574|NCT00481065|66213790|FG004|Overall Study|Protocol Violation|2|||
23681575|NCT00481065|66213791|FG005|Overall Study|Protocol Violation|6|||
23681576|NCT00481065|66213792|FG006|Overall Study|Protocol Violation|3|||
23681577|NCT00481065|66213793|FG007|Overall Study|Protocol Violation|2|||
23681578|NCT00481065|66213786|FG000|Overall Study|Unable to classify|0|||
23681579|NCT00481065|66213787|FG001|Overall Study|Unable to classify|1|||
23681580|NCT00481065|66213788|FG002|Overall Study|Unable to classify|2|||
23495051|NCT00216476|65555053|FG002|Overall Study|Pregnancy|1|||
23681581|NCT00481065|66213789|FG003|Overall Study|Unable to classify|0|||
23681582|NCT00481065|66213790|FG004|Overall Study|Unable to classify|1|||
23681583|NCT00481065|66213791|FG005|Overall Study|Unable to classify|0|||
23681584|NCT00481065|66213792|FG006|Overall Study|Unable to classify|0|||
23681585|NCT00481065|66213793|FG007|Overall Study|Unable to classify|0|||
23681586|NCT00930059|66213794|FG000|Overall Study|Death|1|||
23681587|NCT00930059|66213795|FG001|Overall Study|Death|0|||
23681588|NCT00930059|66213794|FG000|Overall Study|Did not meet entrance criteria|1|||
23681589|NCT00930059|66213795|FG001|Overall Study|Did not meet entrance criteria|1|||
23681590|NCT00930059|66213794|FG000|Overall Study|Withdrawal by Subject|3|||
23681591|NCT00930059|66213795|FG001|Overall Study|Withdrawal by Subject|4|||
23681592|NCT00930059|66213794|FG000|Overall Study|Other|1|||
23681593|NCT00930059|66213795|FG001|Overall Study|Other|0|||
23681594|NCT00930059|66213794|FG000|Overall Study|1 site terminated by sponsor|1|||
23681595|NCT00930059|66213795|FG001|Overall Study|1 site terminated by sponsor|1|||
23681596|NCT00930059|66213794|FG000|Overall Study|Adverse Event|1|||
23681597|NCT00930059|66213795|FG001|Overall Study|Adverse Event|6|||
23681598|NCT00469612|66213797|FG000|Overall Study|Study terminated before data collected|2|||
23681599|NCT00469612|66213798|FG001|Overall Study|Study terminated before data collected|0|||
23681600|NCT00860158|66213804|FG000|Overall Study|Study Terminated|1|||
23681601|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
23681602|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
23681603|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|Death|1|||
23681604|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|Death|0|||
23681605|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
23681606|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
23681607|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
23681608|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
23681609|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
23681610|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
23681611|NCT00110994|66213805|FG000|Double-blind (DB) Treatment|other reasons|2|||
23681612|NCT00110994|66213806|FG001|Double-blind (DB) Treatment|other reasons|3|||
23681613|NCT00110994|66213805|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
23681614|NCT00110994|66213806|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
23681615|NCT00110994|66213805|FG000|Active Follow-up|Other reasons|0|||
23681616|NCT00110994|66213806|FG001|Active Follow-up|Other reasons|2|||
23681617|NCT00110994|66213805|FG000|Long Term Follow-up|Death|19|||
23681618|NCT00110994|66213806|FG001|Long Term Follow-up|Death|17|||
23681619|NCT00598975|66213809|FG000|Overall Study|Adverse Event|1|||
23681620|NCT00598975|66213810|FG001|Overall Study|Adverse Event|1|||
23681621|NCT00598975|66213809|FG000|Overall Study|Brain metastases|1|||
23681622|NCT00598975|66213810|FG001|Overall Study|Brain metastases|0|||
23681623|NCT00598975|66213809|FG000|Overall Study|Withdrawal by Subject|1|||
23681624|NCT00598975|66213810|FG001|Overall Study|Withdrawal by Subject|1|||
23681625|NCT00598975|66213809|FG000|Overall Study|Withdrawal of consent|0|||
23681626|NCT00598975|66213810|FG001|Overall Study|Withdrawal of consent|1|||
23681627|NCT00598975|66213809|FG000|Overall Study|Disease progression|8|||
23681628|NCT00598975|66213810|FG001|Overall Study|Disease progression|3|||
23681629|NCT00598975|66213809|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
23681630|NCT00598975|66213810|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
23681631|NCT01072344|66213811|FG000|Overall Study|Relasped-reached end point|7|||
23681632|NCT01072344|66213812|FG001|Overall Study|Relasped-reached end point|12|||
23681633|NCT01072344|66213811|FG000|Overall Study|Protocol Violation|1|||
23681634|NCT01072344|66213812|FG001|Overall Study|Protocol Violation|2|||
23681635|NCT01072344|66213811|FG000|Overall Study|Lost to Follow-up|3|||
23681636|NCT01072344|66213812|FG001|Overall Study|Lost to Follow-up|4|||
23681637|NCT01194440|66213813|FG000|Baseline (First Dose)|Reason not specified|4|||
23681638|NCT01194440|66213813|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
23681639|NCT01194440|66213813|FG000|Baseline (First Dose)|Change in therapy|1|||
23681640|NCT01194440|66213813|FG000|Baseline (First Dose)|Adverse Event|1|||
23681641|NCT01194440|66213813|FG000|6-months (2nd Dose)|Change in therapy|4|||
23681642|NCT00508391|66213814|FG000|First Treatment|Withdrawal by Subject|6|||
23681643|NCT00508391|66213815|FG001|First Treatment|Withdrawal by Subject|3|||
23681644|NCT00508391|66213814|FG000|Second Treatment|Withdrawal by Subject|2|||
23681645|NCT00508391|66213815|FG001|Second Treatment|Withdrawal by Subject|0|||
23681646|NCT04451330|66213816|FG000|Overall Study|Adverse Event|1|||
23681647|NCT04451330|66213817|FG001|Overall Study|Adverse Event|2|||
23681648|NCT04451330|66213816|FG000|Overall Study|Lost to Follow-up|5|||
23681649|NCT04451330|66213817|FG001|Overall Study|Lost to Follow-up|0|||
23681650|NCT04451330|66213816|FG000|Overall Study|Withdrawal by Subject|3|||
23681651|NCT04451330|66213817|FG001|Overall Study|Withdrawal by Subject|1|||
23681652|NCT04451330|66213816|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23681653|NCT04451330|66213817|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23681654|NCT04451330|66213816|FG000|Overall Study|Other than specified|0|||
23681655|NCT04451330|66213817|FG001|Overall Study|Other than specified|1|||
23681656|NCT01925209|66213823|FG000|Treatment Epoch|Physician Decision|1|||
23681657|NCT01925209|66213824|FG001|Treatment Epoch|Physician Decision|0|||
23681658|NCT01925209|66213825|FG002|Treatment Epoch|Physician Decision|0|||
23681659|NCT01925209|66213826|FG003|Treatment Epoch|Physician Decision|0|||
23681660|NCT01925209|66213823|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
23681661|NCT01925209|66213824|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
23681662|NCT01925209|66213825|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
23681663|NCT01925209|66213826|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
23681664|NCT01925209|66213823|FG000|Treatment Epoch|Death|1|||
23681665|NCT01925209|66213824|FG001|Treatment Epoch|Death|0|||
23681666|NCT01925209|66213825|FG002|Treatment Epoch|Death|0|||
23681667|NCT01925209|66213826|FG003|Treatment Epoch|Death|0|||
23681668|NCT01925209|66213823|FG000|Treatment Epoch|Protocol deviation|0|||
23681669|NCT01925209|66213824|FG001|Treatment Epoch|Protocol deviation|0|||
23681670|NCT01925209|66213825|FG002|Treatment Epoch|Protocol deviation|1|||
23681671|NCT01925209|66213826|FG003|Treatment Epoch|Protocol deviation|1|||
23681672|NCT01925209|66213823|FG000|Treatment Epoch|Withdrawal by Subject|4|||
23681673|NCT01925209|66213824|FG001|Treatment Epoch|Withdrawal by Subject|3|||
23681674|NCT01925209|66213825|FG002|Treatment Epoch|Withdrawal by Subject|3|||
23681675|NCT01925209|66213826|FG003|Treatment Epoch|Withdrawal by Subject|2|||
23681676|NCT01925209|66213823|FG000|Treatment Epoch|Adverse Event|3|||
23681677|NCT01925209|66213824|FG001|Treatment Epoch|Adverse Event|5|||
23681678|NCT01925209|66213825|FG002|Treatment Epoch|Adverse Event|3|||
23681679|NCT01925209|66213826|FG003|Treatment Epoch|Adverse Event|1|||
23681680|NCT01925209|66213823|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
23681681|NCT01925209|66213824|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
23681682|NCT01925209|66213825|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
23681683|NCT01925209|66213826|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
23681684|NCT01925209|66213823|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
23681685|NCT01925209|66213824|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
23681686|NCT01925209|66213825|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
23681687|NCT01925209|66213826|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
23681688|NCT01925209|66213823|FG000|Follow-up|Adverse Event|1|||
23681689|NCT01925209|66213824|FG001|Follow-up|Adverse Event|4|||
23681690|NCT01925209|66213825|FG002|Follow-up|Adverse Event|0|||
23681691|NCT01925209|66213826|FG003|Follow-up|Adverse Event|1|||
23681692|NCT01925209|66213823|FG000|Follow-up|Physician Decision|0|||
23681693|NCT01925209|66213824|FG001|Follow-up|Physician Decision|0|||
23681694|NCT01925209|66213825|FG002|Follow-up|Physician Decision|1|||
23681695|NCT01925209|66213826|FG003|Follow-up|Physician Decision|0|||
23681696|NCT01925209|66213823|FG000|Follow-up|Non-compliance with study treatment|0|||
23681697|NCT01925209|66213824|FG001|Follow-up|Non-compliance with study treatment|0|||
23681698|NCT01925209|66213825|FG002|Follow-up|Non-compliance with study treatment|0|||
23681699|NCT01925209|66213826|FG003|Follow-up|Non-compliance with study treatment|1|||
23681700|NCT01925209|66213823|FG000|Follow-up|Withdrawal by Subject|0|||
23681701|NCT01925209|66213824|FG001|Follow-up|Withdrawal by Subject|2|||
23681702|NCT01925209|66213825|FG002|Follow-up|Withdrawal by Subject|0|||
23681703|NCT01925209|66213826|FG003|Follow-up|Withdrawal by Subject|2|||
23681704|NCT03687502|66213829|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
23681705|NCT03687502|66213829|FG000|Overall Study|Lumason not available|1|||
23681706|NCT01885000|66213830|FG000|Overall Study|Adverse Event|1|||
23681707|NCT01885000|66213831|FG001|Overall Study|Adverse Event|0|||
23681708|NCT01885000|66213830|FG000|Overall Study|Withdrawal by Subject|1|||
23681709|NCT01885000|66213831|FG001|Overall Study|Withdrawal by Subject|1|||
23681710|NCT01885000|66213830|FG000|Overall Study|Protocol Violation|0|||
23681711|NCT01885000|66213831|FG001|Overall Study|Protocol Violation|1|||
23681712|NCT00167245|66213832|FG000|Overall Study|Lost to Follow-up|20|||
23681713|NCT00167245|66213833|FG001|Overall Study|Lost to Follow-up|31|||
23681714|NCT00167245|66213832|FG000|Overall Study|Withdrawal by Subject|5|||
23681715|NCT00167245|66213833|FG001|Overall Study|Withdrawal by Subject|8|||
23681716|NCT00167245|66213832|FG000|Overall Study|Incarcerated|3|||
23681717|NCT00167245|66213833|FG001|Overall Study|Incarcerated|2|||
23681718|NCT00167245|66213832|FG000|Overall Study|Drowsy|1|||
23681719|NCT00167245|66213833|FG001|Overall Study|Drowsy|0|||
23681720|NCT03905863|66213834|FG000|Overall Study|Adverse Event|2|||
23681721|NCT03905863|66213835|FG001|Overall Study|Adverse Event|4|||
23681722|NCT03905863|66213834|FG000|Overall Study|Withdrawal by Subject|2|||
23681723|NCT03905863|66213835|FG001|Overall Study|Withdrawal by Subject|2|||
23681724|NCT03905863|66213834|FG000|Overall Study|Physician Decision|0|||
23681725|NCT03905863|66213835|FG001|Overall Study|Physician Decision|3|||
23681726|NCT03905863|66213834|FG000|Overall Study|Lost to Follow-up|1|||
23681727|NCT03905863|66213835|FG001|Overall Study|Lost to Follow-up|0|||
23681728|NCT03905863|66213834|FG000|Overall Study|Protocol Violation|0|||
23681729|NCT03905863|66213835|FG001|Overall Study|Protocol Violation|2|||
23681730|NCT03905863|66213834|FG000|Overall Study|Death|0|||
23681731|NCT03905863|66213835|FG001|Overall Study|Death|1|||
23681732|NCT00094757|66213837|FG000|Overall Study|Adverse Event|11|||
23681733|NCT00094757|66213838|FG001|Overall Study|Adverse Event|9|||
23681734|NCT00094757|66213839|FG002|Overall Study|Adverse Event|6|||
23681735|NCT00094757|66213837|FG000|Overall Study|Lack of Efficacy|11|||
23681736|NCT00094757|66213838|FG001|Overall Study|Lack of Efficacy|15|||
23681737|NCT00094757|66213839|FG002|Overall Study|Lack of Efficacy|8|||
23681738|NCT00094757|66213837|FG000|Overall Study|Lost to Follow-up|3|||
23681739|NCT00094757|66213838|FG001|Overall Study|Lost to Follow-up|5|||
23681740|NCT00094757|66213839|FG002|Overall Study|Lost to Follow-up|6|||
23681741|NCT00094757|66213837|FG000|Overall Study|Patient Moved|2|||
23681742|NCT00094757|66213838|FG001|Overall Study|Patient Moved|1|||
23681743|NCT00094757|66213839|FG002|Overall Study|Patient Moved|1|||
23681744|NCT00094757|66213837|FG000|Overall Study|Protocol Violation|8|||
23681745|NCT00094757|66213838|FG001|Overall Study|Protocol Violation|5|||
23681746|NCT00094757|66213839|FG002|Overall Study|Protocol Violation|3|||
23681747|NCT00094757|66213837|FG000|Overall Study|Withdrawal by Subject|14|||
23681748|NCT00094757|66213838|FG001|Overall Study|Withdrawal by Subject|21|||
23681749|NCT00094757|66213839|FG002|Overall Study|Withdrawal by Subject|5|||
23681750|NCT00094757|66213837|FG000|Overall Study|Other|3|||
23681751|NCT00094757|66213838|FG001|Overall Study|Other|3|||
23681752|NCT00094757|66213839|FG002|Overall Study|Other|1|||
23681753|NCT00094757|66213837|FG000|Overall Study|Protocol specified discontinuation|1|||
23681754|NCT00094757|66213838|FG001|Overall Study|Protocol specified discontinuation|3|||
23681755|NCT00094757|66213839|FG002|Overall Study|Protocol specified discontinuation|0|||
23681756|NCT01916980|66213844|FG000|Overall Study|Adverse Event|4|||
23681757|NCT01916980|66213845|FG001|Overall Study|Adverse Event|2|||
23681758|NCT01916980|66213844|FG000|Overall Study|Lack of Efficacy|2|||
23681759|NCT01916980|66213845|FG001|Overall Study|Lack of Efficacy|2|||
23681760|NCT01916980|66213844|FG000|Overall Study|Withdrawal by Subject|1|||
23681761|NCT01916980|66213845|FG001|Overall Study|Withdrawal by Subject|0|||
23681762|NCT00927368|66213846|FG000|Overall Study|enrollment in another study|1|||
23681763|NCT00927368|66213847|FG001|Overall Study|enrollment in another study|1|||
23681764|NCT00927368|66213848|FG002|Overall Study|enrollment in another study|2|||
23681765|NCT00927368|66213846|FG000|Overall Study|Lost to Follow-up|4|||
23681766|NCT00927368|66213847|FG001|Overall Study|Lost to Follow-up|0|||
23681767|NCT00927368|66213848|FG002|Overall Study|Lost to Follow-up|0|||
23681768|NCT00927368|66213846|FG000|Overall Study|equipment failure|1|||
23681769|NCT00927368|66213847|FG001|Overall Study|equipment failure|0|||
23681770|NCT00927368|66213848|FG002|Overall Study|equipment failure|0|||
23681771|NCT00927368|66213846|FG000|Overall Study|ineligible post randomization|0|||
23681772|NCT00927368|66213847|FG001|Overall Study|ineligible post randomization|3|||
23681773|NCT00927368|66213848|FG002|Overall Study|ineligible post randomization|1|||
23681774|NCT00927368|66213846|FG000|Overall Study|cancellation of surgery|0|||
23681775|NCT00927368|66213847|FG001|Overall Study|cancellation of surgery|1|||
23681776|NCT00927368|66213848|FG002|Overall Study|cancellation of surgery|2|||
23681777|NCT01291017|66213849|FG000|Overall Study|Lost to Follow-up|2|||
23681778|NCT01291017|66213849|FG000|Overall Study|Withdrawal by Subject|3|||
23681779|NCT02149810|66213850|FG000|Overall Study|Physician Decision|1|||
23681780|NCT02149810|66213851|FG001|Overall Study|Physician Decision|2|||
23681781|NCT02149810|66213850|FG000|Overall Study|Lost to Follow-up|2|||
23681782|NCT02149810|66213851|FG001|Overall Study|Lost to Follow-up|1|||
23681783|NCT02149810|66213850|FG000|Overall Study|Withdrawal by Subject|5|||
23681784|NCT02149810|66213851|FG001|Overall Study|Withdrawal by Subject|1|||
23681785|NCT01929135|66213854|FG000|Overall Study|Lost to Follow-up|1|||
23681786|NCT01929135|66213855|FG001|Overall Study|Lost to Follow-up|1|||
23681787|NCT00441545|66213856|FG000|First Intervention|Adverse Event|6|||
23681788|NCT00441545|66213857|FG001|First Intervention|Adverse Event|5|||
23681789|NCT00441545|66213856|FG000|First Intervention|Protocol Violation|2|||
23681790|NCT00441545|66213857|FG001|First Intervention|Protocol Violation|2|||
23681791|NCT00441545|66213856|FG000|First Intervention|Withdrawal by Subject|3|||
23681792|NCT00441545|66213857|FG001|First Intervention|Withdrawal by Subject|3|||
23681793|NCT00441545|66213856|FG000|First Intervention|Kidney transplant|1|||
23681794|NCT00441545|66213857|FG001|First Intervention|Kidney transplant|1|||
23681795|NCT00441545|66213856|FG000|First Intervention|Lack of Efficacy|2|||
23681796|NCT00441545|66213857|FG001|First Intervention|Lack of Efficacy|0|||
23681797|NCT00441545|66213856|FG000|First Intervention|Subject exceeded safety criteria|0|||
23681798|NCT00441545|66213857|FG001|First Intervention|Subject exceeded safety criteria|1|||
23681799|NCT00441545|66213856|FG000|First Intervention|Subject met an exclusionary criteria|1|||
23681800|NCT00441545|66213857|FG001|First Intervention|Subject met an exclusionary criteria|0|||
23681801|NCT00441545|66213856|FG000|First Intervention|Extended hospitalization|1|||
23495052|NCT00216476|65555051|FG000|Overall Study|Other|0|||
23681802|NCT00441545|66213857|FG001|First Intervention|Extended hospitalization|0|||
23681803|NCT00441545|66213856|FG000|First Intervention|Site error|1|||
23681804|NCT00441545|66213857|FG001|First Intervention|Site error|0|||
23681805|NCT00441545|66213856|FG000|First Intervention|Sponsor's request|1|||
23681806|NCT00441545|66213857|FG001|First Intervention|Sponsor's request|0|||
23681807|NCT00441545|66213856|FG000|Second Intervention|Adverse Event|5|||
23681808|NCT00441545|66213857|FG001|Second Intervention|Adverse Event|2|||
23681809|NCT00441545|66213856|FG000|Second Intervention|Protocol Violation|4|||
23681810|NCT00441545|66213857|FG001|Second Intervention|Protocol Violation|1|||
23681811|NCT00441545|66213856|FG000|Second Intervention|Withdrawal by Subject|1|||
23681812|NCT00441545|66213857|FG001|Second Intervention|Withdrawal by Subject|1|||
23681813|NCT00441545|66213856|FG000|Second Intervention|Kidney Transplant|1|||
23681814|NCT00441545|66213857|FG001|Second Intervention|Kidney Transplant|1|||
23681815|NCT00441545|66213856|FG000|Second Intervention|Lack of Efficacy|0|||
23681816|NCT00441545|66213857|FG001|Second Intervention|Lack of Efficacy|1|||
23681817|NCT00441545|66213856|FG000|Second Intervention|Subject exceeded safety criteria|1|||
23681818|NCT00441545|66213857|FG001|Second Intervention|Subject exceeded safety criteria|0|||
23681819|NCT00441545|66213856|FG000|Second Intervention|Subject moved|0|||
23681820|NCT00441545|66213857|FG001|Second Intervention|Subject moved|1|||
23681821|NCT01808612|66213862|FG000|Treatment Period|Adverse Event|8|||
23681822|NCT01808612|66213863|FG001|Treatment Period|Adverse Event|4|||
23681823|NCT01808612|66213864|FG002|Treatment Period|Adverse Event|3|||
23681824|NCT01808612|66213862|FG000|Treatment Period|Lost to Follow-up|2|||
23681825|NCT01808612|66213863|FG001|Treatment Period|Lost to Follow-up|2|||
23681826|NCT01808612|66213864|FG002|Treatment Period|Lost to Follow-up|1|||
23681827|NCT01808612|66213862|FG000|Treatment Period|Protocol Violation|1|||
23681828|NCT01808612|66213863|FG001|Treatment Period|Protocol Violation|0|||
23681829|NCT01808612|66213864|FG002|Treatment Period|Protocol Violation|0|||
23681830|NCT01808612|66213862|FG000|Treatment Period|Withdrawal by Subject|1|||
23681831|NCT01808612|66213863|FG001|Treatment Period|Withdrawal by Subject|0|||
23681832|NCT01808612|66213864|FG002|Treatment Period|Withdrawal by Subject|4|||
23681833|NCT01808612|66213862|FG000|Treatment Period|Physician Decision|1|||
23681834|NCT01808612|66213863|FG001|Treatment Period|Physician Decision|0|||
23681835|NCT01808612|66213864|FG002|Treatment Period|Physician Decision|4|||
23681836|NCT01808612|66213862|FG000|Treatment Period|Sponsor Decision|1|||
23681837|NCT01808612|66213863|FG001|Treatment Period|Sponsor Decision|0|||
23681838|NCT01808612|66213864|FG002|Treatment Period|Sponsor Decision|0|||
23681839|NCT01808612|66213862|FG000|Treatment Period|Lack of Efficacy|1|||
23681840|NCT01808612|66213863|FG001|Treatment Period|Lack of Efficacy|1|||
23681841|NCT01808612|66213864|FG002|Treatment Period|Lack of Efficacy|2|||
23681842|NCT01808612|66213862|FG000|Discontinuation Period|Adverse Event|1|||
23681843|NCT01808612|66213863|FG001|Discontinuation Period|Adverse Event|0|||
23681844|NCT01808612|66213864|FG002|Discontinuation Period|Adverse Event|0|||
23681845|NCT01808612|66213862|FG000|Discontinuation Period|Physician Decision|1|||
23681846|NCT01808612|66213863|FG001|Discontinuation Period|Physician Decision|0|||
23681847|NCT01808612|66213864|FG002|Discontinuation Period|Physician Decision|0|||
23681848|NCT01808612|66213862|FG000|Discontinuation Period|Lost to Follow-up|0|||
23681849|NCT01808612|66213863|FG001|Discontinuation Period|Lost to Follow-up|1|||
23681850|NCT01808612|66213864|FG002|Discontinuation Period|Lost to Follow-up|0|||
23681851|NCT02527707|66213870|FG000|Overall Study|Adverse Event|1|||
23681852|NCT02527707|66213870|FG000|Overall Study|Adverse Event|1|||
23681853|NCT03033745|66213874|FG000|Overall Study|Protocol Violation|0|||
23681854|NCT03033745|66213875|FG001|Overall Study|Protocol Violation|0|||
23681855|NCT03033745|66213876|FG002|Overall Study|Protocol Violation|1|||
23681856|NCT03033745|66213874|FG000|Overall Study|Adverse Event|1|||
23681857|NCT03033745|66213875|FG001|Overall Study|Adverse Event|0|||
23681858|NCT03033745|66213876|FG002|Overall Study|Adverse Event|1|||
23681859|NCT03033745|66213874|FG000|Overall Study|Withdrawal by Subject|0|||
23681860|NCT03033745|66213875|FG001|Overall Study|Withdrawal by Subject|1|||
23681861|NCT03033745|66213876|FG002|Overall Study|Withdrawal by Subject|0|||
23681862|NCT01284114|66213879|FG000|Overall Study|viral infection|1|||
23681863|NCT01284114|66213879|FG000|Overall Study|From the results of ALLTITUDE study|1|||
23681864|NCT01284114|66213879|FG000|Overall Study|Symptomatic hypotension|1|||
23681865|NCT01284114|66213879|FG000|Overall Study|dizziness|1|||
23681866|NCT02222714|66213880|FG000|Overall Study|Death|0|||
23681867|NCT02222714|66213881|FG001|Overall Study|Death|2|||
23681868|NCT02222714|66213882|FG002|Overall Study|Death|3|||
23681869|NCT02222714|66213883|FG003|Overall Study|Death|4|||
23681870|NCT02222714|66213884|FG004|Overall Study|Death|6|||
23681871|NCT02222714|66213880|FG000|Overall Study|Withdrawal by Subject|0|||
23681872|NCT02222714|66213881|FG001|Overall Study|Withdrawal by Subject|0|||
23681873|NCT02222714|66213882|FG002|Overall Study|Withdrawal by Subject|1|||
23681874|NCT02222714|66213883|FG003|Overall Study|Withdrawal by Subject|0|||
23681875|NCT02222714|66213884|FG004|Overall Study|Withdrawal by Subject|1|||
23681876|NCT00956943|66213886|FG000|Overall Study|Lost to Follow-up|9|||
23681877|NCT00956943|66213887|FG001|Overall Study|Lost to Follow-up|10|||
23681878|NCT04276207|66213888|FG000|Period 1|Withdrawal by Subject|0|||
23681879|NCT04276207|66213889|FG001|Period 1|Withdrawal by Subject|1|||
23681880|NCT03158220|66213890|FG000|Overall Study|Screen Failure|0|||
23681881|NCT03158220|66213891|FG001|Overall Study|Screen Failure|1|||
23681882|NCT03158220|66213890|FG000|Overall Study|Withdrawal by Subject|8|||
23681883|NCT03158220|66213891|FG001|Overall Study|Withdrawal by Subject|9|||
23681884|NCT03158220|66213890|FG000|Overall Study|Status unknown|0|||
23681885|NCT03158220|66213891|FG001|Overall Study|Status unknown|1|||
23681886|NCT03158220|66213890|FG000|Overall Study|Lost to Follow-up|8|||
23681887|NCT03158220|66213891|FG001|Overall Study|Lost to Follow-up|5|||
23681888|NCT03158220|66213890|FG000|Overall Study|Physician Decision|1|||
23681889|NCT03158220|66213891|FG001|Overall Study|Physician Decision|0|||
23681890|NCT00542997|66213893|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
23681891|NCT00542997|66213893|FG000|Wash in / Wash Out Period|Adverse Event|3|||
23681892|NCT00542997|66213893|FG000|Efficacy Period|Adverse Event|3|||
23681893|NCT01109940|66213894|FG000|Overall Study|Administrative problems|2|||
23681894|NCT01109940|66213895|FG001|Overall Study|Administrative problems|0|||
23681895|NCT01109940|66213896|FG002|Overall Study|Administrative problems|0|||
23681896|NCT01109940|66213897|FG003|Overall Study|Administrative problems|0|||
23681897|NCT01109940|66213894|FG000|Overall Study|Serious Adverse Event|2|||
23681898|NCT01109940|66213895|FG001|Overall Study|Serious Adverse Event|1|||
23681899|NCT01109940|66213896|FG002|Overall Study|Serious Adverse Event|0|||
23681900|NCT01109940|66213897|FG003|Overall Study|Serious Adverse Event|0|||
23681901|NCT01109940|66213894|FG000|Overall Study|Lost to Follow-up|1|||
23681902|NCT01109940|66213895|FG001|Overall Study|Lost to Follow-up|0|||
23681903|NCT01109940|66213896|FG002|Overall Study|Lost to Follow-up|0|||
23681904|NCT01109940|66213897|FG003|Overall Study|Lost to Follow-up|0|||
23681905|NCT01109940|66213894|FG000|Overall Study|Patient withdrew consent|1|||
23681906|NCT01109940|66213895|FG001|Overall Study|Patient withdrew consent|1|||
23681907|NCT01109940|66213896|FG002|Overall Study|Patient withdrew consent|0|||
23681908|NCT01109940|66213897|FG003|Overall Study|Patient withdrew consent|0|||
23681909|NCT01109940|66213894|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23681910|NCT01109940|66213895|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23681911|NCT01109940|66213896|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23681912|NCT01109940|66213897|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23681913|NCT03118947|66213898|FG000|Overall Study|Adverse Event|7|||
23681914|NCT03118947|66213898|FG000|Overall Study|Death|3|||
23681915|NCT03118947|66213898|FG000|Overall Study|Lack of Efficacy|4|||
23681916|NCT03118947|66213898|FG000|Overall Study|Non-compliance with study drug|1|||
23681917|NCT03118947|66213898|FG000|Overall Study|Protocol Violation|2|||
23681918|NCT03118947|66213898|FG000|Overall Study|Withdrawal by Subject|3|||
23681919|NCT03118947|66213898|FG000|Overall Study|Withdrawal by caregiver|3|||
23681920|NCT03118947|66213898|FG000|Overall Study|Change in patient's living situation|4|||
23681921|NCT03118947|66213898|FG000|Overall Study|Lost to Follow-up|2|||
23681922|NCT04178772|66213901|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
23681923|NCT04178772|66213901|FG000|Overall Study|study terminated early due to COVID-19|7|||
23681924|NCT00996203|66213902|FG000|Overall Study|Adverse Event|3|||
23681925|NCT00996203|66213902|FG000|Overall Study|Lost to Follow-up|1|||
23681926|NCT00996203|66213902|FG000|Overall Study|Lack of Efficacy|1|||
23681927|NCT00996203|66213902|FG000|Overall Study|Protocol Violation|2|||
23681928|NCT02440581|66213903|FG000|Overall Study|Death|0|||
23681929|NCT02440581|66213904|FG001|Overall Study|Death|0|||
23681930|NCT02440581|66213905|FG002|Overall Study|Death|7|||
23681931|NCT02440581|66213906|FG003|Overall Study|Death|5|||
23681932|NCT02440581|66213903|FG000|Overall Study|Transplanted|1|||
23681933|NCT02440581|66213904|FG001|Overall Study|Transplanted|0|||
23681934|NCT02440581|66213905|FG002|Overall Study|Transplanted|3|||
23681935|NCT02440581|66213906|FG003|Overall Study|Transplanted|2|||
23681936|NCT02440581|66213903|FG000|Overall Study|Withdrawal by Subject|4|||
23681937|NCT02440581|66213904|FG001|Overall Study|Withdrawal by Subject|11|||
23681938|NCT02440581|66213905|FG002|Overall Study|Withdrawal by Subject|3|||
23681939|NCT02440581|66213906|FG003|Overall Study|Withdrawal by Subject|7|||
23681940|NCT00553462|66213907|FG000|Overall Study|Adverse Event|4|||
23681941|NCT00553462|66213907|FG000|Overall Study|Progression|4|||
23681942|NCT00553462|66213907|FG000|Overall Study|Withdrawal by Subject|5|||
23681943|NCT00553462|66213907|FG000|Overall Study|Physician Decision|1|||
23681944|NCT01162421|66213910|FG000|Overall Study|Did not receive study drug|2|||
23681945|NCT01162421|66213911|FG001|Overall Study|Did not receive study drug|1|||
23681946|NCT01162421|66213910|FG000|Overall Study|Adverse Event|2|||
23681947|NCT01162421|66213911|FG001|Overall Study|Adverse Event|5|||
23681948|NCT01162421|66213910|FG000|Overall Study|Lost to Follow-up|0|||
23681949|NCT01162421|66213911|FG001|Overall Study|Lost to Follow-up|2|||
23681950|NCT01162421|66213910|FG000|Overall Study|Lack of Efficacy|2|||
23681951|NCT01162421|66213911|FG001|Overall Study|Lack of Efficacy|2|||
23681952|NCT01162421|66213910|FG000|Overall Study|Other|2|||
23681953|NCT01162421|66213911|FG001|Overall Study|Other|3|||
23681954|NCT01662440|66213912|FG000|Overall Study|Adverse Event|1|||
23681955|NCT01662440|66213913|FG001|Overall Study|Adverse Event|0|||
23681956|NCT01662440|66213914|FG002|Overall Study|Adverse Event|0|||
23681957|NCT01662440|66213915|FG003|Overall Study|Adverse Event|1|||
23681958|NCT01662440|66213912|FG000|Overall Study|Death|0|||
23681959|NCT01662440|66213913|FG001|Overall Study|Death|1|||
23390314|NCT01335685|65175196|FG004|Overall Study|Withdrawal by Subject|0|||
23681960|NCT01662440|66213914|FG002|Overall Study|Death|0|||
23681961|NCT01662440|66213915|FG003|Overall Study|Death|0|||
23681962|NCT01662440|66213912|FG000|Overall Study|Lost to Follow-up|2|||
23681963|NCT01662440|66213913|FG001|Overall Study|Lost to Follow-up|2|||
23681964|NCT01662440|66213914|FG002|Overall Study|Lost to Follow-up|4|||
23681965|NCT01662440|66213915|FG003|Overall Study|Lost to Follow-up|1|||
23681966|NCT01662440|66213912|FG000|Overall Study|Subject moved to another country.|0|||
23681967|NCT01662440|66213913|FG001|Overall Study|Subject moved to another country.|1|||
23681968|NCT01662440|66213914|FG002|Overall Study|Subject moved to another country.|0|||
23681969|NCT01662440|66213915|FG003|Overall Study|Subject moved to another country.|0|||
23681970|NCT01662440|66213912|FG000|Overall Study|Protocol Violation|1|||
23681971|NCT01662440|66213913|FG001|Overall Study|Protocol Violation|0|||
23681972|NCT01662440|66213914|FG002|Overall Study|Protocol Violation|0|||
23681973|NCT01662440|66213915|FG003|Overall Study|Protocol Violation|0|||
23681974|NCT01662440|66213912|FG000|Overall Study|Withdrawal by Subject|5|||
23681975|NCT01662440|66213913|FG001|Overall Study|Withdrawal by Subject|2|||
23681976|NCT01662440|66213914|FG002|Overall Study|Withdrawal by Subject|2|||
23681977|NCT01662440|66213915|FG003|Overall Study|Withdrawal by Subject|2|||
23681978|NCT03472560|66213916|FG000|Overall Study|Subject transfer to continuation protocol|0|||
23681979|NCT03472560|66213917|FG001|Overall Study|Subject transfer to continuation protocol|1|||
23681980|NCT03472560|66213916|FG000|Overall Study|Withdrawal by Subject|4|||
23681981|NCT03472560|66213917|FG001|Overall Study|Withdrawal by Subject|0|||
23681982|NCT03472560|66213916|FG000|Overall Study|Progressive disease|24|||
23681983|NCT03472560|66213917|FG001|Overall Study|Progressive disease|8|||
23681984|NCT03472560|66213916|FG000|Overall Study|Physician Decision|1|||
23681985|NCT03472560|66213917|FG001|Overall Study|Physician Decision|0|||
23681986|NCT03472560|66213916|FG000|Overall Study|Death|7|||
23681987|NCT03472560|66213917|FG001|Overall Study|Death|4|||
23681988|NCT03472560|66213916|FG000|Overall Study|Adverse Event|5|||
23681989|NCT03472560|66213917|FG001|Overall Study|Adverse Event|3|||
23681990|NCT03472560|66213916|FG000|Overall Study|Global deterioration of health status|0|||
23681991|NCT03472560|66213917|FG001|Overall Study|Global deterioration of health status|4|||
23681992|NCT02421887|66213918|FG000|Overall Study|Lost to Follow-up|5|||
23681993|NCT02421887|66213919|FG001|Overall Study|Lost to Follow-up|0|||
23681994|NCT02421887|66213918|FG000|Overall Study|Withdrawal by Subject|8|||
23681995|NCT02421887|66213919|FG001|Overall Study|Withdrawal by Subject|5|||
23681996|NCT02421887|66213918|FG000|Overall Study|Physician Decision|2|||
23681997|NCT02421887|66213919|FG001|Overall Study|Physician Decision|4|||
23681998|NCT02421887|66213918|FG000|Overall Study|Adverse Event|2|||
23681999|NCT02421887|66213919|FG001|Overall Study|Adverse Event|0|||
23682000|NCT01327651|66213920|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
23682001|NCT01327651|66213921|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
23682002|NCT01327651|66213922|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
23682003|NCT01327651|66213923|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
23682004|NCT01327651|66213924|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
23682005|NCT01327651|66213925|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
23682006|NCT01327651|66213926|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
23682007|NCT01327651|66213927|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
23682008|NCT01327651|66213928|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
23682009|NCT01327651|66213920|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
23682010|NCT01327651|66213921|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682011|NCT01327651|66213922|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682012|NCT01327651|66213923|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682013|NCT01327651|66213924|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682014|NCT01327651|66213925|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682015|NCT01327651|66213926|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682016|NCT01327651|66213927|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682017|NCT01327651|66213928|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23682018|NCT01327651|66213920|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
23682019|NCT01327651|66213921|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
23682020|NCT01327651|66213922|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
23682021|NCT01327651|66213923|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
23682022|NCT01327651|66213924|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
23682023|NCT01327651|66213925|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
23682024|NCT01327651|66213926|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
23682025|NCT01327651|66213927|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
23682026|NCT01327651|66213928|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
23682027|NCT01327651|66213920|FG000|Post Study Follow-up|Lost to Follow-up|0|||
23682028|NCT01327651|66213921|FG001|Post Study Follow-up|Lost to Follow-up|1|||
23682029|NCT01327651|66213922|FG002|Post Study Follow-up|Lost to Follow-up|1|||
23682030|NCT01327651|66213923|FG003|Post Study Follow-up|Lost to Follow-up|0|||
23682031|NCT01327651|66213924|FG004|Post Study Follow-up|Lost to Follow-up|0|||
23682032|NCT01327651|66213925|FG005|Post Study Follow-up|Lost to Follow-up|0|||
23682033|NCT01327651|66213926|FG006|Post Study Follow-up|Lost to Follow-up|4|||
23682034|NCT01327651|66213927|FG007|Post Study Follow-up|Lost to Follow-up|1|||
23682035|NCT01327651|66213928|FG008|Post Study Follow-up|Lost to Follow-up|2|||
23682036|NCT00939692|66213930|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
23682037|NCT00939692|66213931|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
23682038|NCT00939692|66213930|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
23682039|NCT00939692|66213931|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
23390315|NCT01335685|65175197|FG005|Overall Study|Withdrawal by Subject|0|||
23390316|NCT01335685|65175198|FG006|Overall Study|Withdrawal by Subject|0|||
23390317|NCT01335685|65175199|FG007|Overall Study|Withdrawal by Subject|0|||
23390318|NCT01335685|65175192|FG000|Overall Study|Reason not Specified|0|||
23390319|NCT01335685|65175193|FG001|Overall Study|Reason not Specified|0|||
23390320|NCT01335685|65175194|FG002|Overall Study|Reason not Specified|1|||
23390321|NCT01335685|65175195|FG003|Overall Study|Reason not Specified|0|||
23390322|NCT01335685|65175196|FG004|Overall Study|Reason not Specified|0|||
23390323|NCT01335685|65175197|FG005|Overall Study|Reason not Specified|1|||
23390324|NCT01335685|65175198|FG006|Overall Study|Reason not Specified|0|||
23495053|NCT00216476|65555052|FG001|Overall Study|Other|0|||
23495054|NCT00216476|65555053|FG002|Overall Study|Other|1|||
23495055|NCT00216476|65555051|FG000|Overall Study|Refuses Injection|11|||
23495056|NCT00216476|65555052|FG001|Overall Study|Refuses Injection|0|||
23495057|NCT00216476|65555053|FG002|Overall Study|Refuses Injection|0|||
23495058|NCT00216476|65555051|FG000|Overall Study|No Further Need for Treatment|3|||
23495059|NCT00216476|65555052|FG001|Overall Study|No Further Need for Treatment|4|||
23495060|NCT00216476|65555053|FG002|Overall Study|No Further Need for Treatment|1|||
23682040|NCT01987908|66213937|FG000|Placebo Lead-in Period|Adverse Event|2|||
23682041|NCT01987908|66213938|FG001|Placebo Lead-in Period|Adverse Event|0|||
23682042|NCT01987908|66213939|FG002|Placebo Lead-in Period|Adverse Event|0|||
23390325|NCT01335685|65175199|FG007|Overall Study|Reason not Specified|0|||
23390326|NCT00987935|65175200|FG000|Overall Study|Progressive disease|3|||
23390327|NCT00987935|65175201|FG001|Overall Study|Progressive disease|2|||
23390328|NCT00987935|65175202|FG002|Overall Study|Progressive disease|3|||
23390329|NCT00987935|65175203|FG003|Overall Study|Progressive disease|2|||
23390330|NCT00987935|65175204|FG004|Overall Study|Progressive disease|5|||
23390331|NCT00987935|65175205|FG005|Overall Study|Progressive disease|3|||
23390332|NCT00987935|65175206|FG006|Overall Study|Progressive disease|9|||
23390333|NCT00987935|65175207|FG007|Overall Study|Progressive disease|48|||
23682043|NCT01987908|66213937|FG000|Placebo Lead-in Period|Physician Decision|2|||
23682044|NCT01987908|66213938|FG001|Placebo Lead-in Period|Physician Decision|0|||
23682045|NCT01987908|66213939|FG002|Placebo Lead-in Period|Physician Decision|0|||
23390334|NCT00987935|65175208|FG008|Overall Study|Progressive disease|23|||
23390335|NCT00987935|65175200|FG000|Overall Study|Adverse Event|0|||
23390336|NCT00987935|65175201|FG001|Overall Study|Adverse Event|1|||
23390337|NCT00987935|65175202|FG002|Overall Study|Adverse Event|0|||
23390338|NCT00987935|65175203|FG003|Overall Study|Adverse Event|1|||
23390339|NCT00987935|65175204|FG004|Overall Study|Adverse Event|1|||
23390340|NCT00987935|65175205|FG005|Overall Study|Adverse Event|0|||
23390341|NCT00987935|65175206|FG006|Overall Study|Adverse Event|2|||
23390342|NCT00987935|65175207|FG007|Overall Study|Adverse Event|10|||
23390343|NCT00987935|65175208|FG008|Overall Study|Adverse Event|6|||
23390344|NCT00987935|65175200|FG000|Overall Study|Refused to continue taking trial med.|1|||
23390345|NCT00987935|65175201|FG001|Overall Study|Refused to continue taking trial med.|0|||
23390346|NCT00987935|65175202|FG002|Overall Study|Refused to continue taking trial med.|0|||
23390347|NCT00987935|65175203|FG003|Overall Study|Refused to continue taking trial med.|0|||
23682046|NCT01987908|66213937|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
23682047|NCT01987908|66213938|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
23682048|NCT01987908|66213939|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
23682049|NCT01987908|66213937|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
23390348|NCT00987935|65175204|FG004|Overall Study|Refused to continue taking trial med.|1|||
23390349|NCT00987935|65175205|FG005|Overall Study|Refused to continue taking trial med.|0|||
23390350|NCT00987935|65175206|FG006|Overall Study|Refused to continue taking trial med.|4|||
23390351|NCT00987935|65175207|FG007|Overall Study|Refused to continue taking trial med.|4|||
23390352|NCT00987935|65175208|FG008|Overall Study|Refused to continue taking trial med.|2|||
23390353|NCT00987935|65175200|FG000|Overall Study|Reason other than those specified above|0|||
23390354|NCT00987935|65175201|FG001|Overall Study|Reason other than those specified above|0|||
23682050|NCT01987908|66213938|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
23682051|NCT01987908|66213939|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
23682052|NCT01987908|66213937|FG000|Treatment Period|Adverse Event|0|||
23682053|NCT01987908|66213938|FG001|Treatment Period|Adverse Event|1|||
23682054|NCT01987908|66213939|FG002|Treatment Period|Adverse Event|1|||
23682055|NCT01987908|66213937|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
23390355|NCT00987935|65175202|FG002|Overall Study|Reason other than those specified above|0|||
23390356|NCT00987935|65175203|FG003|Overall Study|Reason other than those specified above|0|||
23390357|NCT00987935|65175204|FG004|Overall Study|Reason other than those specified above|0|||
23390358|NCT00987935|65175205|FG005|Overall Study|Reason other than those specified above|0|||
23390359|NCT00987935|65175206|FG006|Overall Study|Reason other than those specified above|0|||
23495061|NCT00216476|65555051|FG000|Overall Study|Non-compliance|0|||
23495062|NCT00216476|65555052|FG001|Overall Study|Non-compliance|4|||
23682056|NCT01987908|66213938|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
23495063|NCT00216476|65555053|FG002|Overall Study|Non-compliance|1|||
23390360|NCT00987935|65175207|FG007|Overall Study|Reason other than those specified above|0|||
23390361|NCT00987935|65175208|FG008|Overall Study|Reason other than those specified above|1|||
23390362|NCT02272985|65175209|FG000|Overall Study|Withdrawal by Subject|1|||
23390363|NCT02272985|65175209|FG000|Overall Study|hip fracture|1|||
23390364|NCT02272985|65175209|FG000|Overall Study|kidney transplantation|1|||
23390365|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
23390366|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
23390367|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
23390368|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
23390369|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
23390370|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
23390371|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
23390372|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
23390373|NCT00913835|65175211|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
23390374|NCT00913835|65175212|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
23390375|NCT00468546|65175213|FG000|Week 24 Analysis|Lack of Efficacy|83|||
23390376|NCT00468546|65175214|FG001|Week 24 Analysis|Lack of Efficacy|37|||
23495064|NCT00216476|65555051|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
23495065|NCT00216476|65555052|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
23495066|NCT00216476|65555053|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
23495067|NCT00216476|65555051|FG000|Overall Study|Administrative Reasons|1|||
23682057|NCT01987908|66213939|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
23682058|NCT01987908|66213937|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
23682059|NCT01987908|66213938|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
23682060|NCT01987908|66213939|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
23682061|NCT02688647|66213944|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
23682062|NCT02688647|66213945|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
23682063|NCT02688647|66213944|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
23682064|NCT02688647|66213945|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
23682065|NCT02688647|66213944|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
23682066|NCT02688647|66213945|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
23682067|NCT02688647|66213944|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
23682068|NCT02688647|66213945|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
23682069|NCT02688647|66213944|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
23682070|NCT02688647|66213945|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
23390377|NCT00468546|65175213|FG000|Week 24 Analysis|Refused treatment|5|||
23390378|NCT00468546|65175214|FG001|Week 24 Analysis|Refused treatment|5|||
23682071|NCT02688647|66213944|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
23682072|NCT02688647|66213945|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
23682073|NCT02688647|66213944|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
23682074|NCT02688647|66213945|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
23682075|NCT03739528|66213946|FG000|Overall Study|Not treated|8|||
23682076|NCT03739528|66213947|FG001|Overall Study|Not treated|12|||
23682077|NCT03739528|66213946|FG000|Overall Study|Treatment and study discontinued|6|||
23682078|NCT03739528|66213947|FG001|Overall Study|Treatment and study discontinued|2|||
23682079|NCT03739528|66213946|FG000|Overall Study|Treatment discontinued + study completed|1|||
23682080|NCT03739528|66213947|FG001|Overall Study|Treatment discontinued + study completed|3|||
23682081|NCT01679002|66213948|FG000|Overall Study|Adverse Event|1|||
23682082|NCT01679002|66213949|FG001|Overall Study|Adverse Event|1|||
23682083|NCT01679002|66213950|FG002|Overall Study|Adverse Event|0|||
23682084|NCT02324270|66213951|FG000|Overall Study|Withdrawal by Subject|0|||
23682085|NCT02324270|66213952|FG001|Overall Study|Withdrawal by Subject|1|||
23682086|NCT02324270|66213953|FG002|Overall Study|Withdrawal by Subject|0|||
23682087|NCT02324270|66213951|FG000|Overall Study|Lost to Follow-up|4|||
23682088|NCT02324270|66213952|FG001|Overall Study|Lost to Follow-up|3|||
23390379|NCT00468546|65175213|FG000|Week 24 Analysis|Adverse Event|1|||
23390380|NCT00468546|65175214|FG001|Week 24 Analysis|Adverse Event|8|||
23390381|NCT00468546|65175213|FG000|Week 24 Analysis|Failure to return|3|||
23390382|NCT00468546|65175214|FG001|Week 24 Analysis|Failure to return|4|||
23390383|NCT00468546|65175213|FG000|Week 24 Analysis|Rescue therapy|2|||
23390384|NCT00468546|65175214|FG001|Week 24 Analysis|Rescue therapy|0|||
23390385|NCT00468546|65175213|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
23390386|NCT00468546|65175214|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
23390387|NCT00468546|65175213|FG000|Week 24 Analysis|Due to clinical hold|1|||
23390388|NCT00468546|65175214|FG001|Week 24 Analysis|Due to clinical hold|0|||
23390389|NCT00468546|65175213|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
23390390|NCT00468546|65175214|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
23495068|NCT00216476|65555052|FG001|Overall Study|Administrative Reasons|1|||
23682089|NCT02324270|66213953|FG002|Overall Study|Lost to Follow-up|4|||
23682090|NCT02324270|66213951|FG000|Overall Study|Protocol Violation|0|||
23390391|NCT00468546|65175213|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
23390392|NCT00468546|65175214|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
23390393|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
23390394|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
23390395|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Death|1|||
23390396|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Death|0|||
23390397|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
23390398|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
23390399|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
23390400|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
23390401|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
23390402|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
23390403|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
23390404|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
23390405|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
23390406|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
23390407|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Other|17|||
23682091|NCT02324270|66213952|FG001|Overall Study|Protocol Violation|1|||
23682092|NCT02324270|66213953|FG002|Overall Study|Protocol Violation|1|||
23390408|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Other|14|||
23390409|NCT02971137|65175217|FG000|Overall Study|Lost to Follow-up|44|||
23390410|NCT02971137|65175218|FG001|Overall Study|Lost to Follow-up|56|||
23390411|NCT02402907|65175222|FG000|Overall Study|Delivered vaginally|9|||
23390412|NCT02402907|65175223|FG001|Overall Study|Delivered vaginally|3|||
23390413|NCT02402907|65175222|FG000|Overall Study|Delivered outside of Sinai|1|||
23390414|NCT02402907|65175223|FG001|Overall Study|Delivered outside of Sinai|1|||
23390415|NCT02402907|65175222|FG000|Overall Study|Lost to follow up after C-Section|10|||
23390416|NCT02402907|65175223|FG001|Overall Study|Lost to follow up after C-Section|23|||
23390417|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
23390418|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23495069|NCT00216476|65555053|FG002|Overall Study|Administrative Reasons|0|||
23495070|NCT00216476|65555051|FG000|Overall Study|Protocol Deviation|5|||
23495071|NCT00216476|65555052|FG001|Overall Study|Protocol Deviation|1|||
23495072|NCT00216476|65555053|FG002|Overall Study|Protocol Deviation|0|||
23682093|NCT02324270|66213951|FG000|Overall Study|Non Compliance with Study Drug|1|||
23682094|NCT02324270|66213952|FG001|Overall Study|Non Compliance with Study Drug|2|||
23682095|NCT02324270|66213953|FG002|Overall Study|Non Compliance with Study Drug|0|||
23682096|NCT01449708|66213958|FG000|Overall Study|Protocol Violation|0|||
23682097|NCT01449708|66213959|FG001|Overall Study|Protocol Violation|1|||
23682098|NCT01449708|66213958|FG000|Overall Study|surgical complication|1|||
23682099|NCT01449708|66213959|FG001|Overall Study|surgical complication|2|||
23682100|NCT01449708|66213958|FG000|Overall Study|respiratory failure|1|||
23682101|NCT01449708|66213959|FG001|Overall Study|respiratory failure|0|||
23495073|NCT00216476|65555051|FG000|Overall Study|Patient Moved|2|||
23495074|NCT00216476|65555052|FG001|Overall Study|Patient Moved|2|||
23495075|NCT00216476|65555053|FG002|Overall Study|Patient Moved|0|||
23495076|NCT01846104|65555062|FG000|Overall Study|Withdrawal by Subject|1|||
23495077|NCT02959983|65555067|FG000|Overall Study|Protocol Violation|0|||
23495078|NCT02959983|65555068|FG001|Overall Study|Protocol Violation|1|||
23682102|NCT02597062|66213960|FG000|Overall Study|Ineligible|1|||
23682103|NCT00984204|66213961|FG000|Overall Study|Death|1|||
23682104|NCT00984204|66213961|FG000|Overall Study|Lost to Follow-up|4|||
23682105|NCT00984204|66213961|FG000|Overall Study|Lack of Efficacy|10|||
23682106|NCT01299766|66213965|FG000|Overall Study|Death|5|||
23682107|NCT01299766|66213966|FG001|Overall Study|Death|4|||
23682108|NCT01299766|66213965|FG000|Overall Study|Withdrawal by Subject|29|||
23682109|NCT01299766|66213966|FG001|Overall Study|Withdrawal by Subject|19|||
23682110|NCT01442181|66213967|FG000|Overall Study|patient refused surgery|1|||
23682111|NCT01442181|66213968|FG001|Overall Study|patient refused surgery|0|||
23682112|NCT01442181|66213967|FG000|Overall Study|no insurance for surgery|1|||
23390419|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390420|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390421|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390422|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
23390423|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23495079|NCT02959983|65555067|FG000|Overall Study|Lack of Efficacy|0|||
23495080|NCT02959983|65555068|FG001|Overall Study|Lack of Efficacy|1|||
23495081|NCT02959983|65555067|FG000|Overall Study|Lost to Follow-up|12|||
23682113|NCT01442181|66213968|FG001|Overall Study|no insurance for surgery|0|||
23682114|NCT01442181|66213967|FG000|Overall Study|low ejection factor|0|||
23682115|NCT01442181|66213968|FG001|Overall Study|low ejection factor|1|||
23682116|NCT01442181|66213967|FG000|Overall Study|Lost to Follow-up|1|||
23682117|NCT01442181|66213968|FG001|Overall Study|Lost to Follow-up|1|||
23682118|NCT01442181|66213967|FG000|Overall Study|patient in an additional study|1|||
23682119|NCT01442181|66213968|FG001|Overall Study|patient in an additional study|0|||
23390424|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23682120|NCT01442181|66213967|FG000|Overall Study|atrial fibrillation not noted|0|||
23682121|NCT01442181|66213968|FG001|Overall Study|atrial fibrillation not noted|1|||
23682122|NCT03896295|66213973|FG000|Overall Study|Adverse Event|0|||
23682123|NCT03896295|66213974|FG001|Overall Study|Adverse Event|1|||
23682124|NCT03896295|66213973|FG000|Overall Study|COVID-19|7|||
23682125|NCT03896295|66213974|FG001|Overall Study|COVID-19|29|||
23682126|NCT01879410|66213975|FG000|Overall Study|Adverse Event|9|||
23682127|NCT01879410|66213976|FG001|Overall Study|Adverse Event|14|||
23390425|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23390426|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23390427|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
23390428|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390429|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390430|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390431|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390432|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
23390433|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390434|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390435|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390436|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390437|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
23390438|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390439|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390440|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390441|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390442|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
23390443|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390444|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390445|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390446|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390447|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
23495082|NCT02959983|65555068|FG001|Overall Study|Lost to Follow-up|9|||
23495083|NCT02959983|65555067|FG000|Overall Study|Other|1|||
23495084|NCT02959983|65555068|FG001|Overall Study|Other|1|||
23495085|NCT02959983|65555067|FG000|Overall Study|Physician Decision|1|||
23495086|NCT02959983|65555068|FG001|Overall Study|Physician Decision|0|||
23495087|NCT02959983|65555067|FG000|Overall Study|Adverse Event|5|||
23495088|NCT02959983|65555068|FG001|Overall Study|Adverse Event|1|||
23495089|NCT02959983|65555067|FG000|Overall Study|Withdrawal by Subject|7|||
23495090|NCT02959983|65555068|FG001|Overall Study|Withdrawal by Subject|12|||
23495091|NCT00785928|65555069|FG000|Treatment Phase|Adverse Event|1|||
23495092|NCT00785928|65555070|FG001|Treatment Phase|Adverse Event|1|||
23495093|NCT00785928|65555071|FG002|Treatment Phase|Adverse Event|2|||
23495094|NCT00785928|65555072|FG003|Treatment Phase|Adverse Event|0|||
23495095|NCT00785928|65555073|FG004|Treatment Phase|Adverse Event|0|||
23495096|NCT00785928|65555074|FG005|Treatment Phase|Adverse Event|0|||
23495097|NCT00785928|65555075|FG006|Treatment Phase|Adverse Event|2|||
23495098|NCT00785928|65555069|FG000|Treatment Phase|Inadequate Response|0|||
23495099|NCT00785928|65555070|FG001|Treatment Phase|Inadequate Response|1|||
23495100|NCT00785928|65555071|FG002|Treatment Phase|Inadequate Response|0|||
23495101|NCT00785928|65555072|FG003|Treatment Phase|Inadequate Response|0|||
23495102|NCT00785928|65555073|FG004|Treatment Phase|Inadequate Response|0|||
23495103|NCT00785928|65555074|FG005|Treatment Phase|Inadequate Response|0|||
23495104|NCT00785928|65555075|FG006|Treatment Phase|Inadequate Response|0|||
23495105|NCT00785928|65555069|FG000|Treatment Phase|Lack of Efficacy|0|||
23682128|NCT01879410|66213975|FG000|Overall Study|Lack of Efficacy|4|||
23682129|NCT01879410|66213976|FG001|Overall Study|Lack of Efficacy|6|||
23390448|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390449|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390450|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390451|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390452|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
23495106|NCT00785928|65555070|FG001|Treatment Phase|Lack of Efficacy|1|||
23495107|NCT00785928|65555071|FG002|Treatment Phase|Lack of Efficacy|1|||
23390453|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23495108|NCT00785928|65555072|FG003|Treatment Phase|Lack of Efficacy|0|||
23495109|NCT00785928|65555073|FG004|Treatment Phase|Lack of Efficacy|0|||
23495110|NCT00785928|65555074|FG005|Treatment Phase|Lack of Efficacy|0|||
23495111|NCT00785928|65555075|FG006|Treatment Phase|Lack of Efficacy|0|||
23495112|NCT00785928|65555069|FG000|Treatment Phase|Physician Decision|0|||
23495113|NCT00785928|65555070|FG001|Treatment Phase|Physician Decision|0|||
23682130|NCT01879410|66213975|FG000|Overall Study|Protocol Violation|1|||
23495114|NCT00785928|65555071|FG002|Treatment Phase|Physician Decision|0|||
23495115|NCT00785928|65555072|FG003|Treatment Phase|Physician Decision|0|||
23495116|NCT00785928|65555073|FG004|Treatment Phase|Physician Decision|1|||
23495117|NCT00785928|65555074|FG005|Treatment Phase|Physician Decision|0|||
23495118|NCT00785928|65555075|FG006|Treatment Phase|Physician Decision|0|||
23495119|NCT00785928|65555069|FG000|Treatment Phase|Sponsor Decision|1|||
23495120|NCT00785928|65555070|FG001|Treatment Phase|Sponsor Decision|0|||
23495121|NCT00785928|65555071|FG002|Treatment Phase|Sponsor Decision|0|||
23495122|NCT00785928|65555072|FG003|Treatment Phase|Sponsor Decision|0|||
23495123|NCT00785928|65555073|FG004|Treatment Phase|Sponsor Decision|0|||
23495124|NCT00785928|65555074|FG005|Treatment Phase|Sponsor Decision|0|||
23495125|NCT00785928|65555075|FG006|Treatment Phase|Sponsor Decision|1|||
23495126|NCT00785928|65555069|FG000|Treatment Phase|Withdrawal by Subject|1|||
23495127|NCT00785928|65555070|FG001|Treatment Phase|Withdrawal by Subject|2|||
23495128|NCT00785928|65555071|FG002|Treatment Phase|Withdrawal by Subject|0|||
23495129|NCT00785928|65555072|FG003|Treatment Phase|Withdrawal by Subject|0|||
23495130|NCT00785928|65555073|FG004|Treatment Phase|Withdrawal by Subject|1|||
23495131|NCT00785928|65555074|FG005|Treatment Phase|Withdrawal by Subject|0|||
23495132|NCT00785928|65555075|FG006|Treatment Phase|Withdrawal by Subject|0|||
23390454|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23390455|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23495133|NCT02058693|65555077|FG000|Phase 1|Withdrawal by Subject|3|||
23495134|NCT02058693|65555078|FG001|Phase 1|Withdrawal by Subject|2|||
23495135|NCT02058693|65555077|FG000|Phase 1|Adverse Event|0|||
23495136|NCT02058693|65555078|FG001|Phase 1|Adverse Event|1|||
23495137|NCT02058693|65555077|FG000|Phase 1|Lack of Efficacy|1|||
23495138|NCT02058693|65555078|FG001|Phase 1|Lack of Efficacy|0|||
23495139|NCT02058693|65555077|FG000|Phase 1|Physician Decision|1|||
23495140|NCT02058693|65555078|FG001|Phase 1|Physician Decision|1|||
23495141|NCT02058693|65555077|FG000|Phase 2|Withdrawal by Subject|0|||
23495142|NCT02058693|65555078|FG001|Phase 2|Withdrawal by Subject|2|||
23495143|NCT01268150|65555079|FG000|Treatment Phase|Progression of disease|18|||
23495144|NCT01268150|65555079|FG000|Treatment Phase|Adverse Event|3|||
23495145|NCT01268150|65555079|FG000|Treatment Phase|Withdrawal by Subject|3|||
23495146|NCT01268150|65555079|FG000|Treatment Phase|Other|4|||
23495147|NCT01268150|65555079|FG000|Extension Phase|Adverse Event|3|||
23495148|NCT01268150|65555079|FG000|Extension Phase|Disease progression|18|||
23495149|NCT01268150|65555079|FG000|Extension Phase|Other|6|||
23682131|NCT01879410|66213976|FG001|Overall Study|Protocol Violation|7|||
23390456|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23390457|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390458|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390459|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390460|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
23390461|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390462|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23390463|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23390464|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
23390465|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23390466|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23390467|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390468|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
23390469|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390470|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390471|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390472|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390473|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
23390474|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390475|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390476|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390477|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23495150|NCT01193530|65555080|FG000|Overall Study|Withdrawal by Subject|2|||
23495151|NCT01193530|65555081|FG001|Overall Study|Withdrawal by Subject|2|||
23495152|NCT01193530|65555080|FG000|Overall Study|Began Contraindicated Therapy|1|||
23495153|NCT01193530|65555081|FG001|Overall Study|Began Contraindicated Therapy|0|||
23495154|NCT01193530|65555080|FG000|Overall Study|Lost Light Box|0|||
23682132|NCT01879410|66213975|FG000|Overall Study|Lost to Follow-up|2|||
23682133|NCT01879410|66213976|FG001|Overall Study|Lost to Follow-up|1|||
23495155|NCT01193530|65555081|FG001|Overall Study|Lost Light Box|1|||
23495156|NCT01193530|65555080|FG000|Overall Study|Returned home - out of state|0|||
23495157|NCT01193530|65555081|FG001|Overall Study|Returned home - out of state|1|||
23495158|NCT01193530|65555080|FG000|Overall Study|Non-Compliance|0|||
23495159|NCT01193530|65555081|FG001|Overall Study|Non-Compliance|1|||
23495160|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Adverse Event|3|||
23495161|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Adverse Event|0|||
23495162|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
23682134|NCT01879410|66213975|FG000|Overall Study|Withdrawal by Subject|7|||
23682135|NCT01879410|66213976|FG001|Overall Study|Withdrawal by Subject|8|||
23682136|NCT01879410|66213975|FG000|Overall Study|Randomised in Error|1|||
23682137|NCT01879410|66213976|FG001|Overall Study|Randomised in Error|2|||
23682138|NCT01551693|66213977|FG000|Overall Study|Disease Progression|1|||
23682139|NCT01551693|66213978|FG001|Overall Study|Disease Progression|0|||
23682140|NCT01551693|66213977|FG000|Overall Study|Adverse Event|0|||
23682141|NCT01551693|66213978|FG001|Overall Study|Adverse Event|1|||
23682142|NCT01551693|66213977|FG000|Overall Study|Withdrawal by Subject|0|||
23682143|NCT01551693|66213978|FG001|Overall Study|Withdrawal by Subject|1|||
23495163|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
23495164|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
23495165|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
23495166|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Physician Decision|0|||
23495167|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Physician Decision|2|||
23495168|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
23495169|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
23495170|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
23495171|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
23495172|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
23495173|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
23495174|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
23495175|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
23495176|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
23495177|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
23495178|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
23495179|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
23495180|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
23682144|NCT04684420|66213991|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23682145|NCT04684420|66213992|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23390478|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
23495181|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
23390479|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390480|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390481|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390482|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390483|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390484|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
23390485|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390486|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390487|NCT04008069|65175234|FG000|Open-Label Period|Adverse Event|1|||
23390488|NCT04008069|65175235|FG001|Open-Label Period|Adverse Event|0|||
23390489|NCT04008069|65175236|FG002|Open-Label Period|Adverse Event|0|||
23390490|NCT04008069|65175234|FG000|Open-Label Period|Lack of Efficacy|4|||
23390491|NCT04008069|65175235|FG001|Open-Label Period|Lack of Efficacy|0|||
23390492|NCT04008069|65175236|FG002|Open-Label Period|Lack of Efficacy|0|||
23390493|NCT04008069|65175234|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
23390494|NCT04008069|65175235|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
23390495|NCT04008069|65175236|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
23390496|NCT04008069|65175234|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
23390497|NCT04008069|65175235|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
23390498|NCT04008069|65175236|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
23390499|NCT00050011|65175237|FG000|Overall Study|Adverse Event|41|||
23390500|NCT00050011|65175238|FG001|Overall Study|Adverse Event|46|||
23682146|NCT04684420|66213993|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
23682147|NCT04684420|66213994|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
23682148|NCT04684420|66213991|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
23682149|NCT04684420|66213992|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
23682150|NCT04684420|66213993|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
23682151|NCT04684420|66213994|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
23682152|NCT01583179|66213996|FG000|Overall Study|Screen failure|1|||
23682153|NCT01583179|66213997|FG001|Overall Study|Screen failure|2|||
23682154|NCT02367521|66214002|FG000|Overall Study|severe headache after intervention|2|||
23390501|NCT00050011|65175237|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23390502|NCT00050011|65175238|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23390503|NCT00050011|65175237|FG000|Overall Study|Abnormal test procedure results|0|||
23390504|NCT00050011|65175238|FG001|Overall Study|Abnormal test procedure results|1|||
23390505|NCT00050011|65175237|FG000|Overall Study|Lack of Efficacy|16|||
23390506|NCT00050011|65175238|FG001|Overall Study|Lack of Efficacy|21|||
23390507|NCT00050011|65175237|FG000|Overall Study|Participant condition no longer required|1|||
23682155|NCT02367521|66214003|FG001|Overall Study|severe headache after intervention|0|||
23390508|NCT00050011|65175238|FG001|Overall Study|Participant condition no longer required|0|||
23390509|NCT00050011|65175237|FG000|Overall Study|Protocol Violation|4|||
23390510|NCT00050011|65175238|FG001|Overall Study|Protocol Violation|10|||
23390511|NCT00050011|65175237|FG000|Overall Study|Withdrawal by Subject|34|||
23390512|NCT00050011|65175238|FG001|Overall Study|Withdrawal by Subject|26|||
23390513|NCT00050011|65175237|FG000|Overall Study|Lost to Follow-up|7|||
23390514|NCT00050011|65175238|FG001|Overall Study|Lost to Follow-up|9|||
23390515|NCT00050011|65175237|FG000|Overall Study|Administrative problems|10|||
23390516|NCT00050011|65175238|FG001|Overall Study|Administrative problems|6|||
23390517|NCT00050011|65175237|FG000|Overall Study|Death|7|||
23390518|NCT00050011|65175238|FG001|Overall Study|Death|4|||
23390519|NCT00050011|65175237|FG000|Overall Study|Unknown - Reason is missing|0|||
23390520|NCT00050011|65175238|FG001|Overall Study|Unknown - Reason is missing|2|||
23390521|NCT00458705|65175243|FG000|Overall Study|Adverse Event|4|||
23390522|NCT00458705|65175243|FG000|Overall Study|Not Treated|1|||
23390523|NCT03773562|65175247|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
23390524|NCT03773562|65175247|FG000|Overall Study|Lost to Follow-up|10|||
23390525|NCT03773562|65175247|FG000|Overall Study|Withdrawal by Subject|1|||
23390526|NCT00908141|65175248|FG000|Overall Study|Withdrawal by Subject|0|||
23390527|NCT00908141|65175249|FG001|Overall Study|Withdrawal by Subject|1|||
23390528|NCT03052608|65175255|FG000|Treatment Phase|Adverse Event|10|||
23390529|NCT03052608|65175256|FG001|Treatment Phase|Adverse Event|12|||
23390530|NCT03052608|65175255|FG000|Treatment Phase|Death|6|||
23390531|NCT03052608|65175256|FG001|Treatment Phase|Death|4|||
23390532|NCT03052608|65175255|FG000|Treatment Phase|Withdrawal by Subject|4|||
23390533|NCT03052608|65175256|FG001|Treatment Phase|Withdrawal by Subject|12|||
23390534|NCT03052608|65175255|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
23390535|NCT03052608|65175256|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
23682156|NCT02367521|66214002|FG000|Overall Study|unable to find transportation|2|||
23390536|NCT03052608|65175255|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
23390537|NCT03052608|65175256|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
23390538|NCT03052608|65175255|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
23390539|NCT03052608|65175256|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
23495182|NCT02083081|65555086|FG000|Overall Study|Lost to Follow-up|31|||
23495183|NCT02083081|65555087|FG001|Overall Study|Lost to Follow-up|9|||
23495184|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
23495185|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
23495186|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
23495187|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
23495188|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
23495189|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
23495190|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
23495191|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
23495192|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
23495193|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
23495194|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
23495195|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
23495196|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
23682157|NCT02367521|66214003|FG001|Overall Study|unable to find transportation|0|||
23495197|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
23495198|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
23495199|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
23390540|NCT03052608|65175255|FG000|Treatment Phase|Ongoing|103|||
23390541|NCT03052608|65175256|FG001|Treatment Phase|Ongoing|31|||
23390542|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Death|23|||
23390543|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Death|28|||
23390544|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
23390545|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
23390546|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
23390547|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
23390548|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Ongoing|122|||
23390549|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Ongoing|99|||
23390550|NCT04551053|65175257|FG000|Overall Study|Death|9|||
23390551|NCT04551053|65175258|FG001|Overall Study|Death|9|||
23390552|NCT04551053|65175257|FG000|Overall Study|Lost to Follow-up|0|||
23390553|NCT04551053|65175258|FG001|Overall Study|Lost to Follow-up|2|||
23390554|NCT04551053|65175257|FG000|Overall Study|Study Terminated by Sponsor|53|||
23390555|NCT04551053|65175258|FG001|Overall Study|Study Terminated by Sponsor|63|||
23390556|NCT04551053|65175257|FG000|Overall Study|Withdrawal by Subject|12|||
23390557|NCT04551053|65175258|FG001|Overall Study|Withdrawal by Subject|5|||
23390558|NCT04551053|65175257|FG000|Overall Study|Adverse Event|1|||
23390559|NCT04551053|65175258|FG001|Overall Study|Adverse Event|0|||
23390560|NCT04551053|65175257|FG000|Overall Study|Lack of Efficacy|2|||
23390561|NCT04551053|65175258|FG001|Overall Study|Lack of Efficacy|0|||
23390562|NCT04551053|65175257|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
23390563|NCT04551053|65175258|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
23495200|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
23495201|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
23495202|NCT00492531|65555097|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
23495203|NCT00492531|65555098|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
23495204|NCT02124161|65555099|FG000|Overall Study|Other unspecified|0|||
23495205|NCT02124161|65555100|FG001|Overall Study|Other unspecified|1|||
23495206|NCT02124161|65555099|FG000|Overall Study|Death|1|||
23495207|NCT02124161|65555100|FG001|Overall Study|Death|0|||
23495208|NCT02124161|65555099|FG000|Overall Study|Protocol Violation|2|||
23495209|NCT02124161|65555100|FG001|Overall Study|Protocol Violation|1|||
23495210|NCT02124161|65555099|FG000|Overall Study|Withdrawal by Subject|1|||
23495211|NCT02124161|65555100|FG001|Overall Study|Withdrawal by Subject|2|||
23495212|NCT02124161|65555099|FG000|Overall Study|Adverse Event|2|||
23495213|NCT02124161|65555100|FG001|Overall Study|Adverse Event|0|||
23495214|NCT02124161|65555099|FG000|Overall Study|Does not meet entrance criteria|2|||
23495215|NCT02124161|65555100|FG001|Overall Study|Does not meet entrance criteria|3|||
23495216|NCT02124161|65555099|FG000|Overall Study|No longer meets eligibility criteria|5|||
23495217|NCT02124161|65555100|FG001|Overall Study|No longer meets eligibility criteria|4|||
23495218|NCT02124161|65555099|FG000|Overall Study|Lost to Follow-up|3|||
23495219|NCT02124161|65555100|FG001|Overall Study|Lost to Follow-up|4|||
23495220|NCT00892047|65555101|FG000|Overall Study|Adverse Event|2|||
23495221|NCT00892047|65555102|FG001|Overall Study|Adverse Event|2|||
23495222|NCT00892047|65555101|FG000|Overall Study|subject burden|2|||
23495223|NCT00892047|65555102|FG001|Overall Study|subject burden|3|||
23495224|NCT00892047|65555101|FG000|Overall Study|Lack of Efficacy|0|||
23495225|NCT00892047|65555102|FG001|Overall Study|Lack of Efficacy|2|||
23495226|NCT01034631|65555103|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
23495227|NCT01034631|65555104|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
23495228|NCT01034631|65555105|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
23495229|NCT01034631|65555103|FG000|Phase II|Not Evaluable per protocol|0|||
23495230|NCT01034631|65555104|FG001|Phase II|Not Evaluable per protocol|0|||
23495231|NCT01034631|65555105|FG002|Phase II|Not Evaluable per protocol|2|||
23495232|NCT01034631|65555103|FG000|Phase II|Determined Ineligible per protocol|0|||
23495233|NCT01034631|65555104|FG001|Phase II|Determined Ineligible per protocol|1|||
23495234|NCT01034631|65555105|FG002|Phase II|Determined Ineligible per protocol|0|||
23495235|NCT03934684|65555106|FG000|Overall Study|Participants continuing in study|11|||
23495236|NCT03934684|65555107|FG001|Overall Study|Participants continuing in study|4|||
23495237|NCT03934684|65555106|FG000|Overall Study|Discontinuation of carfilzomib|20|||
23390564|NCT04551053|65175257|FG000|Overall Study|Splenapendectomi|1|||
23495238|NCT03934684|65555107|FG001|Overall Study|Discontinuation of carfilzomib|30|||
23495239|NCT03934684|65555106|FG000|Overall Study|Death|2|||
23495240|NCT03934684|65555107|FG001|Overall Study|Death|2|||
23495241|NCT03934684|65555106|FG000|Overall Study|Lost to Follow-up|2|||
23495242|NCT03934684|65555107|FG001|Overall Study|Lost to Follow-up|5|||
23682158|NCT02796755|66214004|FG000|Overall Study|Adverse Event|2|||
23390565|NCT04551053|65175258|FG001|Overall Study|Splenapendectomi|0|||
23390566|NCT04551053|65175257|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
23390567|NCT04551053|65175258|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
23390568|NCT04551053|65175257|FG000|Overall Study|Medical Decision|0|||
23390569|NCT04551053|65175258|FG001|Overall Study|Medical Decision|1|||
23390570|NCT04551053|65175257|FG000|Overall Study|Ongoing|6|||
23390571|NCT04551053|65175258|FG001|Overall Study|Ongoing|4|||
23390572|NCT01916226|65175261|FG000|Overall Study|Adverse Event|1|||
23390573|NCT01916226|65175262|FG001|Overall Study|Adverse Event|0|||
23390574|NCT01916226|65175263|FG002|Overall Study|Adverse Event|1|||
23390575|NCT01916226|65175264|FG003|Overall Study|Adverse Event|1|||
23390576|NCT01916226|65175261|FG000|Overall Study|Lack of Efficacy|0|||
23390577|NCT01916226|65175262|FG001|Overall Study|Lack of Efficacy|0|||
23390578|NCT01916226|65175263|FG002|Overall Study|Lack of Efficacy|2|||
23390579|NCT01916226|65175264|FG003|Overall Study|Lack of Efficacy|1|||
23390580|NCT01916226|65175261|FG000|Overall Study|Protocol Violation|0|||
23390581|NCT01916226|65175262|FG001|Overall Study|Protocol Violation|1|||
23682159|NCT02796755|66214005|FG001|Overall Study|Adverse Event|0|||
23682160|NCT01824979|66214006|FG000|Overall Study|Withdrawal by Subject|5|||
23390582|NCT01916226|65175263|FG002|Overall Study|Protocol Violation|0|||
23390583|NCT01916226|65175264|FG003|Overall Study|Protocol Violation|1|||
23390584|NCT01916226|65175261|FG000|Overall Study|Physician Decision|0|||
23390585|NCT01916226|65175262|FG001|Overall Study|Physician Decision|0|||
23390586|NCT01916226|65175263|FG002|Overall Study|Physician Decision|0|||
23390587|NCT01916226|65175264|FG003|Overall Study|Physician Decision|1|||
23390588|NCT00635050|65175265|FG000|Overall Study|Withdrawal by Subject|1|||
23390589|NCT00720083|65175269|FG000|Overall Study|Ineligible|1|||
23390590|NCT00720083|65175270|FG001|Overall Study|Ineligible|2|||
23390591|NCT03627468|65175271|FG000|Overall Study|Adverse Event|5|||
23390592|NCT03627468|65175272|FG001|Overall Study|Adverse Event|33|||
23390593|NCT03627468|65175271|FG000|Overall Study|Withdrawal by Subject|13|||
23390594|NCT03627468|65175272|FG001|Overall Study|Withdrawal by Subject|23|||
23390595|NCT03627468|65175271|FG000|Overall Study|Physician Decision|1|||
23390596|NCT03627468|65175272|FG001|Overall Study|Physician Decision|0|||
23390597|NCT03627468|65175271|FG000|Overall Study|Protocol Violation|0|||
23390598|NCT03627468|65175272|FG001|Overall Study|Protocol Violation|2|||
23390599|NCT03627468|65175271|FG000|Overall Study|Lost to Follow-up|10|||
23390600|NCT03627468|65175272|FG001|Overall Study|Lost to Follow-up|16|||
23390601|NCT03627468|65175271|FG000|Overall Study|Death|1|||
23390602|NCT03627468|65175272|FG001|Overall Study|Death|0|||
23390603|NCT03627468|65175271|FG000|Overall Study|Pregnancy|1|||
23390604|NCT03627468|65175272|FG001|Overall Study|Pregnancy|1|||
23390605|NCT03627468|65175271|FG000|Overall Study|Lack of Efficacy|0|||
23390606|NCT03627468|65175272|FG001|Overall Study|Lack of Efficacy|2|||
23390607|NCT03627468|65175271|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
23390608|NCT03627468|65175272|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
23390609|NCT01347086|65175295|FG000|Overall Study|failed screening visit|0|||
23390610|NCT01347086|65175296|FG001|Overall Study|failed screening visit|0|||
23390611|NCT01347086|65175297|FG002|Overall Study|failed screening visit|1|||
23390612|NCT01347086|65175298|FG003|Overall Study|failed screening visit|0|||
23390613|NCT01347086|65175299|FG004|Overall Study|failed screening visit|0|||
23390614|NCT01347086|65175300|FG005|Overall Study|failed screening visit|0|||
23390615|NCT01347086|65175301|FG006|Overall Study|failed screening visit|1|||
23390616|NCT01347086|65175302|FG007|Overall Study|failed screening visit|1|||
23390617|NCT01347086|65175303|FG008|Overall Study|failed screening visit|0|||
23390618|NCT01347086|65175304|FG009|Overall Study|failed screening visit|1|||
23390619|NCT01013870|65175305|FG000|Overall Study|Lost to Follow-up|1|||
23390620|NCT01013870|65175306|FG001|Overall Study|Lost to Follow-up|3|||
23390621|NCT01674062|65175307|FG000|Overall Study|Insufficient Therapeutic Response|56|||
23390622|NCT01674062|65175308|FG001|Overall Study|Insufficient Therapeutic Response|26|||
23390623|NCT01674062|65175307|FG000|Overall Study|Other|8|||
23390624|NCT01674062|65175308|FG001|Overall Study|Other|1|||
23390625|NCT01674062|65175307|FG000|Overall Study|Adverse Event|1|||
23390626|NCT01674062|65175308|FG001|Overall Study|Adverse Event|1|||
23390627|NCT01674062|65175307|FG000|Overall Study|Death|0|||
23390628|NCT01674062|65175308|FG001|Overall Study|Death|1|||
23390629|NCT01674062|65175307|FG000|Overall Study|Programming Error|1|||
23390630|NCT01674062|65175308|FG001|Overall Study|Programming Error|0|||
23682161|NCT01824979|66214007|FG001|Overall Study|Withdrawal by Subject|0|||
23390631|NCT02502383|65175320|FG000|Overall Study|Lost to Follow-up|130|||
23390632|NCT02502383|65175321|FG001|Overall Study|Lost to Follow-up|131|||
23390633|NCT02502383|65175320|FG000|Overall Study|Withdrawal by Subject|31|||
23390634|NCT02502383|65175321|FG001|Overall Study|Withdrawal by Subject|24|||
23390635|NCT02410200|65175322|FG000|Overall Study|Adverse Event|2|||
23390636|NCT01903863|65175323|FG000|Overall Study|Physician Decision|2|||
23390637|NCT01903863|65175324|FG001|Overall Study|Physician Decision|0|||
23390638|NCT01472185|65175329|FG000|Overall Study|Randomized but Not Treated|0|||
23390639|NCT01472185|65175330|FG001|Overall Study|Randomized but Not Treated|1|||
23390640|NCT01472185|65175329|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
23390641|NCT01472185|65175330|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
23390642|NCT01472185|65175329|FG000|Overall Study|Hyperglycemia|5|||
23390643|NCT01472185|65175330|FG001|Overall Study|Hyperglycemia|2|||
23390644|NCT01472185|65175329|FG000|Overall Study|Investigator's Discretion|3|||
23390645|NCT01472185|65175330|FG001|Overall Study|Investigator's Discretion|1|||
23390646|NCT01472185|65175329|FG000|Overall Study|Lost to Follow-up|4|||
23390647|NCT01472185|65175330|FG001|Overall Study|Lost to Follow-up|1|||
23390648|NCT01472185|65175329|FG000|Overall Study|Protocol Violation|5|||
23390649|NCT01472185|65175330|FG001|Overall Study|Protocol Violation|1|||
23390650|NCT01472185|65175329|FG000|Overall Study|Subject Noncompliance|8|||
23390651|NCT01472185|65175330|FG001|Overall Study|Subject Noncompliance|15|||
23390652|NCT01472185|65175329|FG000|Overall Study|Subject Withdrew Consent|6|||
23390653|NCT01472185|65175330|FG001|Overall Study|Subject Withdrew Consent|3|||
23390654|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
23390655|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Adverse Event|1|||
23390656|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
23390657|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Physician Decision|1|||
23390658|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
23390659|NCT00088881|65175335|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
23390660|NCT00088881|65175335|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
23390661|NCT00089583|65175337|FG000|Overall Study|Adverse Event|0|||
23390662|NCT00089583|65175338|FG001|Overall Study|Adverse Event|3|||
23682162|NCT01824979|66214006|FG000|Overall Study|Physician Decision|2|||
23682163|NCT01824979|66214007|FG001|Overall Study|Physician Decision|0|||
23682164|NCT01824979|66214006|FG000|Overall Study|Protocol Violation|6|||
23682165|NCT01824979|66214007|FG001|Overall Study|Protocol Violation|13|||
23682166|NCT03786432|66214008|FG000|Overall Study|Screen Failure after consent|1|||
23682167|NCT03786432|66214008|FG000|Overall Study|Lost to Follow-up|4|||
23682168|NCT03786432|66214008|FG000|Overall Study|did not complete 12 month CT scan|1|||
23682169|NCT01528787|66214009|FG000|Overall Study|Withdrawal by Subject|0|||
23682170|NCT01528787|66214010|FG001|Overall Study|Withdrawal by Subject|0|||
23682171|NCT01528787|66214011|FG002|Overall Study|Withdrawal by Subject|0|||
23682172|NCT01528787|66214012|FG003|Overall Study|Withdrawal by Subject|1|||
23682173|NCT01528787|66214009|FG000|Overall Study|Family Emergency|0|||
23682174|NCT01528787|66214010|FG001|Overall Study|Family Emergency|0|||
23682175|NCT01528787|66214011|FG002|Overall Study|Family Emergency|1|||
23682176|NCT01528787|66214012|FG003|Overall Study|Family Emergency|0|||
23682177|NCT01670994|66214016|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
23682178|NCT01670994|66214017|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
23682179|NCT01670994|66214016|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
23682180|NCT01670994|66214017|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
23390663|NCT00089583|65175337|FG000|Overall Study|Insufficient Viral Load Response|5|||
23390664|NCT00089583|65175338|FG001|Overall Study|Insufficient Viral Load Response|5|||
23390665|NCT00089583|65175337|FG000|Overall Study|Withdrawal by Subject|0|||
23390666|NCT00089583|65175338|FG001|Overall Study|Withdrawal by Subject|4|||
23390667|NCT00089583|65175337|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
23682181|NCT01670994|66214016|FG000|Overall Study|Patient experienced DLT|0|||
23682182|NCT01670994|66214017|FG001|Overall Study|Patient experienced DLT|1|||
23682183|NCT02111564|66214018|FG000|Overall Study|Death|109|||
23682184|NCT02111564|66214019|FG001|Overall Study|Death|120|||
23682185|NCT02111564|66214018|FG000|Overall Study|Lost to Follow-up|2|||
23682186|NCT02111564|66214019|FG001|Overall Study|Lost to Follow-up|3|||
23682187|NCT02111564|66214018|FG000|Overall Study|Withdrawal by Subject|20|||
23682188|NCT02111564|66214019|FG001|Overall Study|Withdrawal by Subject|20|||
23682189|NCT02789657|66214020|FG000|Overall Study|Withdrawal by Subject|2|||
23682190|NCT02789657|66214021|FG001|Overall Study|Withdrawal by Subject|0|||
23682191|NCT02789657|66214022|FG002|Overall Study|Withdrawal by Subject|0|||
23682192|NCT02789657|66214023|FG003|Overall Study|Withdrawal by Subject|0|||
23682193|NCT00236080|66214024|FG000|Overall Study|Adverse Event|0|||
23682194|NCT00236080|66214025|FG001|Overall Study|Adverse Event|0|||
23682195|NCT00236080|66214026|FG002|Overall Study|Adverse Event|3|||
23682196|NCT00236080|66214027|FG003|Overall Study|Adverse Event|1|||
23682197|NCT00236080|66214028|FG004|Overall Study|Adverse Event|0|||
23682198|NCT00236080|66214024|FG000|Overall Study|Lost to Follow-up|0|||
23682199|NCT00236080|66214025|FG001|Overall Study|Lost to Follow-up|1|||
23682200|NCT00236080|66214026|FG002|Overall Study|Lost to Follow-up|0|||
23682201|NCT00236080|66214027|FG003|Overall Study|Lost to Follow-up|0|||
23682202|NCT00236080|66214028|FG004|Overall Study|Lost to Follow-up|0|||
23682203|NCT00236080|66214024|FG000|Overall Study|Physician Decision|1|||
23682204|NCT00236080|66214025|FG001|Overall Study|Physician Decision|0|||
23682205|NCT00236080|66214026|FG002|Overall Study|Physician Decision|1|||
23682206|NCT00236080|66214027|FG003|Overall Study|Physician Decision|1|||
23682207|NCT00236080|66214028|FG004|Overall Study|Physician Decision|1|||
23682208|NCT00236080|66214024|FG000|Overall Study|Withdrawal by Subject|1|||
23682209|NCT00236080|66214025|FG001|Overall Study|Withdrawal by Subject|0|||
23682210|NCT00236080|66214026|FG002|Overall Study|Withdrawal by Subject|0|||
23682211|NCT00236080|66214027|FG003|Overall Study|Withdrawal by Subject|0|||
23682212|NCT00236080|66214028|FG004|Overall Study|Withdrawal by Subject|0|||
23682213|NCT00236080|66214024|FG000|Overall Study|Miscellaneous|0|||
23682214|NCT00236080|66214025|FG001|Overall Study|Miscellaneous|0|||
23682215|NCT00236080|66214026|FG002|Overall Study|Miscellaneous|1|||
23682216|NCT00236080|66214027|FG003|Overall Study|Miscellaneous|0|||
23682217|NCT00236080|66214028|FG004|Overall Study|Miscellaneous|0|||
23682218|NCT00544869|66214029|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
23682219|NCT00544869|66214030|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
23682220|NCT00544869|66214031|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
23682221|NCT00544869|66214029|FG000|Overall Study|Adverse Event|6|||
23682222|NCT00544869|66214030|FG001|Overall Study|Adverse Event|1|||
23682223|NCT00544869|66214031|FG002|Overall Study|Adverse Event|0|||
23682224|NCT00544869|66214029|FG000|Overall Study|Lack of Efficacy|1|||
23682225|NCT00544869|66214030|FG001|Overall Study|Lack of Efficacy|1|||
23682226|NCT00544869|66214031|FG002|Overall Study|Lack of Efficacy|0|||
23682227|NCT00544869|66214029|FG000|Overall Study|Physician Decision|2|||
23682228|NCT00544869|66214030|FG001|Overall Study|Physician Decision|0|||
23682229|NCT00544869|66214031|FG002|Overall Study|Physician Decision|0|||
23682230|NCT02425098|66214046|FG000|Overall Study|Lost to Follow-up|7|||
23682231|NCT02425098|66214047|FG001|Overall Study|Lost to Follow-up|7|||
23682232|NCT02425098|66214046|FG000|Overall Study|Withdrawal by Subject|4|||
23682233|NCT02425098|66214047|FG001|Overall Study|Withdrawal by Subject|8|||
23682234|NCT02425098|66214046|FG000|Overall Study|Pregnancy|2|||
23682235|NCT02425098|66214047|FG001|Overall Study|Pregnancy|0|||
23682236|NCT02425098|66214046|FG000|Overall Study|Reason not Specified|0|||
23682237|NCT02425098|66214047|FG001|Overall Study|Reason not Specified|1|||
23682238|NCT03136107|66214053|FG000|Overall Study|Other (Not specified)|1|||
23682239|NCT03446456|66214054|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
23682240|NCT03446456|66214055|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
23682241|NCT03446456|66214054|FG000|Overall Study|Lost to Follow-up|1|||
23682242|NCT03446456|66214055|FG001|Overall Study|Lost to Follow-up|3|||
23682243|NCT03446456|66214054|FG000|Overall Study|Participant failed the toxicology test|1|||
23682244|NCT03446456|66214055|FG001|Overall Study|Participant failed the toxicology test|0|||
23682245|NCT03446456|66214054|FG000|Overall Study|Break down of the experimental equipment|1|||
23682246|NCT03446456|66214055|FG001|Overall Study|Break down of the experimental equipment|0|||
23682247|NCT03898063|66214059|FG000|Overall Study|Withdrawal by Subject|10|||
23682248|NCT03898063|66214060|FG001|Overall Study|Withdrawal by Subject|8|||
23682249|NCT01871090|66214061|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
23682250|NCT01871090|66214062|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
23682251|NCT01871090|66214061|FG000|Overall Study|Interrogation not completed correctly|1|||
23682252|NCT01871090|66214062|FG001|Overall Study|Interrogation not completed correctly|0|||
23682253|NCT01871090|66214061|FG000|Overall Study|Subject Non-Compliance|0|||
23682254|NCT01871090|66214062|FG001|Overall Study|Subject Non-Compliance|1|||
23682255|NCT00713219|66214063|FG000|Overall Study|Death|1|||
23682256|NCT00713219|66214063|FG000|Overall Study|Protocol Violation|1|||
23682257|NCT00382967|66214064|FG000|Overall Study|Protocol Violation|1|||
23682258|NCT00382967|66214065|FG001|Overall Study|Protocol Violation|1|||
23682259|NCT00787787|66214066|FG000|Overall Study|Lack of Efficacy|4|||
23682260|NCT00787787|66214066|FG000|Overall Study|Adverse Event|3|||
23682261|NCT00605267|66214071|FG000|Overall Study|Adverse Event|0|||
23682262|NCT00605267|66214072|FG001|Overall Study|Adverse Event|1|||
23682263|NCT00605267|66214071|FG000|Overall Study|Lack of Efficacy|1|||
23682264|NCT00605267|66214072|FG001|Overall Study|Lack of Efficacy|5|||
23682265|NCT00605267|66214071|FG000|Overall Study|Withdrawal by Subject|2|||
23682266|NCT00605267|66214072|FG001|Overall Study|Withdrawal by Subject|3|||
23682267|NCT00741819|66214080|FG000|Overall Study|Adverse Event|3|||
23682268|NCT00741819|66214080|FG000|Overall Study|Withdrawal by Subject|3|||
23682269|NCT00741819|66214080|FG000|Overall Study|Death|1|||
23682270|NCT00741819|66214080|FG000|Overall Study|Disease progression|1|||
23682271|NCT01163786|66214081|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
23682272|NCT01163786|66214081|FG000|Treatment With Bortezomib|Adverse Event|2|||
23682273|NCT01163786|66214081|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
23682274|NCT03372941|66214083|FG000|Overall Study|Lost to Follow-up|2|||
23682275|NCT03372941|66214084|FG001|Overall Study|Lost to Follow-up|4|||
23682276|NCT01552681|66214085|FG000|Overall Study|Withdrawal by Subject|4|||
23682277|NCT01552681|66214086|FG001|Overall Study|Withdrawal by Subject|0|||
23682278|NCT01552681|66214085|FG000|Overall Study|Physician Decision|1|||
23682279|NCT01552681|66214086|FG001|Overall Study|Physician Decision|0|||
23682280|NCT01552681|66214085|FG000|Overall Study|Subject moved away|0|||
23682281|NCT01552681|66214086|FG001|Overall Study|Subject moved away|1|||
23682282|NCT02009878|66214089|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
23682283|NCT02009878|66214090|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23682284|NCT02009878|66214091|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
23682285|NCT01178138|66214100|FG000|Overall Study|Lost to Follow-up|8|||
23682286|NCT01178138|66214100|FG000|Overall Study|Withdrawal by Subject|7|||
23682287|NCT01178138|66214100|FG000|Overall Study|Physician Decision|8|||
23682288|NCT03624946|66214105|FG000|Overall Study|Lost to Follow-up|0|||
23682289|NCT03624946|66214106|FG001|Overall Study|Lost to Follow-up|1|||
23682290|NCT02654002|66214107|FG000|Overall Study|Adverse Event|0|||
23682291|NCT02654002|66214108|FG001|Overall Study|Adverse Event|0|||
23682292|NCT02654002|66214109|FG002|Overall Study|Adverse Event|0|||
23682293|NCT02654002|66214110|FG003|Overall Study|Adverse Event|0|||
23682294|NCT02654002|66214111|FG004|Overall Study|Adverse Event|0|||
23682295|NCT02654002|66214112|FG005|Overall Study|Adverse Event|0|||
23682296|NCT02654002|66214113|FG006|Overall Study|Adverse Event|1|||
23682297|NCT02654002|66214114|FG007|Overall Study|Adverse Event|0|||
23682298|NCT02654002|66214115|FG008|Overall Study|Adverse Event|0|||
23682299|NCT02654002|66214107|FG000|Overall Study|Withdrew Consent|0|||
23682300|NCT02654002|66214108|FG001|Overall Study|Withdrew Consent|0|||
23682301|NCT02654002|66214109|FG002|Overall Study|Withdrew Consent|0|||
23682302|NCT02654002|66214110|FG003|Overall Study|Withdrew Consent|0|||
23682303|NCT02654002|66214111|FG004|Overall Study|Withdrew Consent|0|||
23682304|NCT02654002|66214112|FG005|Overall Study|Withdrew Consent|1|||
23682305|NCT02654002|66214113|FG006|Overall Study|Withdrew Consent|0|||
23682306|NCT02654002|66214114|FG007|Overall Study|Withdrew Consent|1|||
23682307|NCT02654002|66214115|FG008|Overall Study|Withdrew Consent|0|||
23682308|NCT03064490|66214116|FG000|Overall Study|Physician Decision|5|||
23682309|NCT02848833|66214119|FG000|Overall Study|subject who are duplicated|1|||
23390668|NCT00089583|65175338|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
23390669|NCT00089583|65175337|FG000|Overall Study|Participant Refused Study Medication|0|||
23682310|NCT02848833|66214119|FG000|Overall Study|have not taken the study drug|11|||
23682311|NCT02848833|66214119|FG000|Overall Study|follow-up failure|6|||
23682312|NCT02848833|66214119|FG000|Overall Study|Protocol Violation|119|||
23682313|NCT04439279|66214120|FG000|Overall Study|Adverse Event|7|||
23682314|NCT04439279|66214120|FG000|Overall Study|Death|4|||
23682315|NCT04439279|66214120|FG000|Overall Study|Disease progression|17|||
23682316|NCT04439279|66214120|FG000|Overall Study|Complicating disease|3|||
23682317|NCT04439279|66214120|FG000|Overall Study|Withdrawal by Subject|2|||
23682318|NCT04439279|66214120|FG000|Overall Study|Ineligible|1|||
23682319|NCT04439279|66214120|FG000|Overall Study|Treatment still ongoing|1|||
23682320|NCT01940484|66214124|FG000|Overall Study|Withdrawal by Subject|3|||
23682321|NCT01940484|66214124|FG000|Overall Study|Underwent transplantation|4|||
23682322|NCT01940484|66214124|FG000|Overall Study|Death|2|||
23682323|NCT01940484|66214124|FG000|Overall Study|Adverse Event|1|||
23390670|NCT00089583|65175338|FG001|Overall Study|Participant Refused Study Medication|2|||
23390671|NCT00089583|65175337|FG000|Overall Study|Non-Compliance|0|||
23390672|NCT00089583|65175338|FG001|Overall Study|Non-Compliance|4|||
23390673|NCT00089583|65175337|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
23390674|NCT00089583|65175338|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
23390675|NCT00089583|65175337|FG000|Overall Study|Participant Management Criteria Met|0|||
23390676|NCT00089583|65175338|FG001|Overall Study|Participant Management Criteria Met|1|||
23390677|NCT00089583|65175337|FG000|Overall Study|Reason Not Provided|0|||
23390678|NCT00089583|65175338|FG001|Overall Study|Reason Not Provided|1|||
23390679|NCT00089583|65175337|FG000|Overall Study|Protocol Violation|0|||
23390680|NCT00089583|65175338|FG001|Overall Study|Protocol Violation|3|||
23390681|NCT00089583|65175337|FG000|Overall Study|Principal Investigator Decision|0|||
23390682|NCT00089583|65175338|FG001|Overall Study|Principal Investigator Decision|10|||
23390683|NCT00089583|65175337|FG000|Overall Study|Start of Disallowed Medication|0|||
23390684|NCT00089583|65175338|FG001|Overall Study|Start of Disallowed Medication|1|||
23390685|NCT00089583|65175337|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
23390686|NCT00089583|65175338|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
23390687|NCT00089583|65175337|FG000|Overall Study|Participant Incarcerated|0|||
23390688|NCT00089583|65175338|FG001|Overall Study|Participant Incarcerated|1|||
23390689|NCT04650893|65175339|FG000|Overall Study|Lost to Follow-up|11|||
23390690|NCT04650893|65175340|FG001|Overall Study|Lost to Follow-up|10|||
23390691|NCT04650893|65175341|FG002|Overall Study|Lost to Follow-up|11|||
23390692|NCT00855166|65175342|FG000|Overall Study|Adverse Event|0|||
23390693|NCT00855166|65175343|FG001|Overall Study|Adverse Event|2|||
23390694|NCT00855166|65175342|FG000|Overall Study|Death|0|||
23390695|NCT00855166|65175343|FG001|Overall Study|Death|1|||
23390696|NCT00855166|65175342|FG000|Overall Study|Withdrawal by Subject|1|||
23390697|NCT00855166|65175343|FG001|Overall Study|Withdrawal by Subject|4|||
23390698|NCT00855166|65175342|FG000|Overall Study|Poor/non-compliance|2|||
23390699|NCT00855166|65175343|FG001|Overall Study|Poor/non-compliance|0|||
23390700|NCT00855166|65175342|FG000|Overall Study|Administrative reasons by sponsor|1|||
23390701|NCT00855166|65175343|FG001|Overall Study|Administrative reasons by sponsor|0|||
23390702|NCT00855166|65175342|FG000|Overall Study|Subject no longer meets study criteria|1|||
23390703|NCT00855166|65175343|FG001|Overall Study|Subject no longer meets study criteria|1|||
23390704|NCT02529488|65175344|FG000|Overall Study|Adverse Event|1|||
23390705|NCT02529488|65175344|FG000|Overall Study|Death|3|||
23390706|NCT01908699|65175345|FG000|Overall Study|Adverse Event|8|||
23390707|NCT01908699|65175346|FG001|Overall Study|Adverse Event|12|||
23390708|NCT01908699|65175345|FG000|Overall Study|Lack of Efficacy|2|||
23495243|NCT03934684|65555106|FG000|Overall Study|Withdrawal by Subject|7|||
23495244|NCT03934684|65555107|FG001|Overall Study|Withdrawal by Subject|8|||
23495245|NCT01254292|65555108|FG000|Comparative Phase|Adverse Event|25|||
23495246|NCT01254292|65555109|FG001|Comparative Phase|Adverse Event|25|||
23682324|NCT01957137|66214125|FG000|Randomized Portion|Adverse Event|1|||
23682325|NCT01957137|66214125|FG000|Randomized Portion|Withdrawal by Subject|1|||
23682326|NCT00256295|66214128|FG000|Overall Study|Withdrawal by Subject|3|||
23682327|NCT00256295|66214128|FG000|Overall Study|Death|1|||
23682328|NCT02211261|66214129|FG000|Overall Study|Withdrawal by Subject|0|||
23682329|NCT02211261|66214130|FG001|Overall Study|Withdrawal by Subject|0|||
23682330|NCT02211261|66214131|FG002|Overall Study|Withdrawal by Subject|1|||
23682331|NCT02211261|66214132|FG003|Overall Study|Withdrawal by Subject|0|||
23682332|NCT02211261|66214133|FG004|Overall Study|Withdrawal by Subject|2|||
23682333|NCT02211261|66214134|FG005|Overall Study|Withdrawal by Subject|0|||
23682334|NCT02211261|66214135|FG006|Overall Study|Withdrawal by Subject|0|||
23682335|NCT02211261|66214136|FG007|Overall Study|Withdrawal by Subject|0|||
23682336|NCT02211261|66214137|FG008|Overall Study|Withdrawal by Subject|0|||
23682337|NCT02211261|66214138|FG009|Overall Study|Withdrawal by Subject|0|||
23682338|NCT02211261|66214139|FG010|Overall Study|Withdrawal by Subject|0|||
23682339|NCT02211261|66214129|FG000|Overall Study|Other|0|||
23682340|NCT02211261|66214130|FG001|Overall Study|Other|0|||
23390709|NCT01908699|65175346|FG001|Overall Study|Lack of Efficacy|2|||
23390710|NCT01908699|65175345|FG000|Overall Study|Lost to Follow-up|2|||
23390711|NCT01908699|65175346|FG001|Overall Study|Lost to Follow-up|4|||
23390712|NCT01908699|65175345|FG000|Overall Study|Physician Decision|8|||
23390713|NCT01908699|65175346|FG001|Overall Study|Physician Decision|8|||
23495247|NCT01254292|65555108|FG000|Comparative Phase|Lost to Follow-up|3|||
23495248|NCT01254292|65555109|FG001|Comparative Phase|Lost to Follow-up|21|||
23495249|NCT01254292|65555108|FG000|Comparative Phase|Pregnancy|2|||
23495250|NCT01254292|65555109|FG001|Comparative Phase|Pregnancy|6|||
23495251|NCT01254292|65555108|FG000|Comparative Phase|Withdrawal by Subject|20|||
23390714|NCT01908699|65175345|FG000|Overall Study|Withdrawal by Subject|15|||
23390715|NCT01908699|65175346|FG001|Overall Study|Withdrawal by Subject|10|||
23390716|NCT01908699|65175345|FG000|Overall Study|Pregnancy|0|||
23682341|NCT02211261|66214131|FG002|Overall Study|Other|0|||
23682342|NCT02211261|66214132|FG003|Overall Study|Other|0|||
23682343|NCT02211261|66214133|FG004|Overall Study|Other|0|||
23682344|NCT02211261|66214134|FG005|Overall Study|Other|1|||
23682345|NCT02211261|66214135|FG006|Overall Study|Other|0|||
23682346|NCT02211261|66214136|FG007|Overall Study|Other|0|||
23682347|NCT02211261|66214137|FG008|Overall Study|Other|0|||
23682348|NCT02211261|66214138|FG009|Overall Study|Other|2|||
23682349|NCT02211261|66214139|FG010|Overall Study|Other|0|||
23682350|NCT02211261|66214129|FG000|Overall Study|Lost to Follow-up|0|||
23682351|NCT02211261|66214130|FG001|Overall Study|Lost to Follow-up|0|||
23682352|NCT02211261|66214131|FG002|Overall Study|Lost to Follow-up|0|||
23682353|NCT02211261|66214132|FG003|Overall Study|Lost to Follow-up|0|||
23682354|NCT02211261|66214133|FG004|Overall Study|Lost to Follow-up|0|||
23682355|NCT02211261|66214134|FG005|Overall Study|Lost to Follow-up|0|||
23682356|NCT02211261|66214135|FG006|Overall Study|Lost to Follow-up|0|||
23682357|NCT02211261|66214136|FG007|Overall Study|Lost to Follow-up|1|||
23682358|NCT02211261|66214137|FG008|Overall Study|Lost to Follow-up|0|||
23682359|NCT02211261|66214138|FG009|Overall Study|Lost to Follow-up|0|||
23682360|NCT02211261|66214139|FG010|Overall Study|Lost to Follow-up|0|||
23682361|NCT02899156|66214140|FG000|Overall Study|Death|1|||
23682362|NCT02899156|66214141|FG001|Overall Study|Death|0|||
23682363|NCT02899156|66214140|FG000|Overall Study|Physician Decision|0|||
23682364|NCT02899156|66214141|FG001|Overall Study|Physician Decision|1|||
23682365|NCT00988247|66214142|FG000|Overall Study|Adverse Event|17|||
23682366|NCT00988247|66214143|FG001|Overall Study|Adverse Event|3|||
23682367|NCT00988247|66214142|FG000|Overall Study|Withdrawal by Subject|44|||
23682368|NCT00988247|66214143|FG001|Overall Study|Withdrawal by Subject|13|||
23682369|NCT00988247|66214142|FG000|Overall Study|Pregnancy|1|||
23682370|NCT00988247|66214143|FG001|Overall Study|Pregnancy|2|||
23682371|NCT00988247|66214142|FG000|Overall Study|Lost to Follow-up|11|||
23682372|NCT00988247|66214143|FG001|Overall Study|Lost to Follow-up|2|||
23682373|NCT00988247|66214142|FG000|Overall Study|Protocol Violation|4|||
23682374|NCT00988247|66214143|FG001|Overall Study|Protocol Violation|5|||
23682375|NCT00988247|66214142|FG000|Overall Study|Sponsor requested withdrawal|3|||
23682376|NCT00988247|66214143|FG001|Overall Study|Sponsor requested withdrawal|1|||
23682377|NCT00988247|66214142|FG000|Overall Study|Other|3|||
23682378|NCT00988247|66214143|FG001|Overall Study|Other|0|||
23682379|NCT03336502|66214145|FG000|Overall Study|Physician Decision|0|||
23682380|NCT03336502|66214146|FG001|Overall Study|Physician Decision|1|||
23682381|NCT03336502|66214145|FG000|Overall Study|Prohibited Drugs|1|||
23682382|NCT03336502|66214146|FG001|Overall Study|Prohibited Drugs|1|||
23682383|NCT03336502|66214145|FG000|Overall Study|Death|1|||
23682384|NCT03336502|66214146|FG001|Overall Study|Death|2|||
23682385|NCT03336502|66214145|FG000|Overall Study|Adverse Event|2|||
23682386|NCT03336502|66214146|FG001|Overall Study|Adverse Event|5|||
23682387|NCT00330187|66214147|FG000|Overall Study|Lost to Follow-up|12|||
23682388|NCT00330187|66214148|FG001|Overall Study|Lost to Follow-up|13|||
23682389|NCT00330187|66214149|FG002|Overall Study|Lost to Follow-up|14|||
23682390|NCT00330187|66214150|FG003|Overall Study|Lost to Follow-up|10|||
23682391|NCT00330187|66214147|FG000|Overall Study|Withdrawal by Subject|8|||
23682392|NCT00330187|66214148|FG001|Overall Study|Withdrawal by Subject|5|||
23682393|NCT00330187|66214149|FG002|Overall Study|Withdrawal by Subject|4|||
23682394|NCT00330187|66214150|FG003|Overall Study|Withdrawal by Subject|4|||
23682395|NCT00888238|66214151|FG000|Washout Period After Period 2|Adverse Event|0|||
23682396|NCT00888238|66214152|FG001|Washout Period After Period 2|Adverse Event|0|||
23682397|NCT00888238|66214153|FG002|Washout Period After Period 2|Adverse Event|1|||
23682398|NCT01497262|66214154|FG000|Overall Study|Abnormal Lab Values|4|||
23682399|NCT01497262|66214154|FG000|Overall Study|Abnormal Test Procedure Result|1|||
23682400|NCT01497262|66214154|FG000|Overall Study|Physician Decision|1|||
23682401|NCT01497262|66214154|FG000|Overall Study|Withdrawal by Subject|2|||
23682402|NCT01497262|66214154|FG000|Overall Study|Adverse Event|2|||
23682403|NCT01497262|66214154|FG000|Overall Study|Protocol Violation|1|||
23682404|NCT00264004|66214155|FG000|Overall Study|Adverse Event|2|||
23682405|NCT00264004|66214156|FG001|Overall Study|Adverse Event|3|||
23682406|NCT00264004|66214157|FG002|Overall Study|Adverse Event|6|||
23682407|NCT00264004|66214158|FG003|Overall Study|Adverse Event|4|||
23682408|NCT00264004|66214155|FG000|Overall Study|Withdrawal by Subject|0|||
23682409|NCT00264004|66214156|FG001|Overall Study|Withdrawal by Subject|1|||
23682410|NCT00264004|66214157|FG002|Overall Study|Withdrawal by Subject|2|||
23682411|NCT00264004|66214158|FG003|Overall Study|Withdrawal by Subject|2|||
23682412|NCT00264004|66214155|FG000|Overall Study|Other|2|||
23682413|NCT00264004|66214156|FG001|Overall Study|Other|2|||
23682414|NCT00264004|66214157|FG002|Overall Study|Other|0|||
23682415|NCT00264004|66214158|FG003|Overall Study|Other|3|||
23682416|NCT00264004|66214155|FG000|Overall Study|Development study specific disc. crit.|1|||
23682417|NCT00264004|66214156|FG001|Overall Study|Development study specific disc. crit.|0|||
23682418|NCT00264004|66214157|FG002|Overall Study|Development study specific disc. crit.|1|||
23682419|NCT00264004|66214158|FG003|Overall Study|Development study specific disc. crit.|0|||
23682420|NCT00264004|66214155|FG000|Overall Study|Cond. under inv. worsened|9|||
23682421|NCT00264004|66214156|FG001|Overall Study|Cond. under inv. worsened|5|||
23682422|NCT00264004|66214157|FG002|Overall Study|Cond. under inv. worsened|3|||
23682423|NCT00264004|66214158|FG003|Overall Study|Cond. under inv. worsened|4|||
23682424|NCT00264004|66214155|FG000|Overall Study|Not treated|3|||
23682425|NCT00264004|66214156|FG001|Overall Study|Not treated|0|||
23682426|NCT00264004|66214157|FG002|Overall Study|Not treated|2|||
23682427|NCT00264004|66214158|FG003|Overall Study|Not treated|2|||
23495252|NCT01254292|65555109|FG001|Comparative Phase|Withdrawal by Subject|21|||
23682428|NCT00159432|66214159|FG000|Overall Study|Adverse Event|1|||
23682429|NCT00159432|66214159|FG000|Overall Study|Death|1|||
23682430|NCT00159432|66214159|FG000|Overall Study|Lack of Efficacy|8|||
23682431|NCT04269395|66214160|FG000|Overall Study|Lost to Follow-up|1|||
23682432|NCT04269395|66214161|FG001|Overall Study|Lost to Follow-up|0|||
23682433|NCT04269395|66214160|FG000|Overall Study|Study terminated by Sponsor|13|||
23682434|NCT04269395|66214161|FG001|Overall Study|Study terminated by Sponsor|10|||
23682435|NCT03663166|66214162|FG000|Overall Study|Withdrawal by Subject|1|||
23682436|NCT01214044|66217391|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
23682437|NCT01214044|66217391|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
23682438|NCT01214044|66217391|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
23682439|NCT01214044|66217391|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
23495253|NCT01254292|65555108|FG000|Comparative Phase|Protocol Violation|1|||
23495254|NCT01254292|65555109|FG001|Comparative Phase|Protocol Violation|2|||
23495255|NCT01254292|65555108|FG000|Comparative Phase|Wish for pregnancy|4|||
23495256|NCT01254292|65555109|FG001|Comparative Phase|Wish for pregnancy|6|||
23495257|NCT01254292|65555108|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
23682440|NCT01214044|66217391|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
23682441|NCT01214044|66217391|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
23682442|NCT02901431|66217392|FG000|PK Part|Adverse Event|0|||
23682443|NCT02901431|66217393|FG001|PK Part|Adverse Event|1|||
23682444|NCT02901431|66217394|FG002|PK Part|Adverse Event|0|||
23682445|NCT02901431|66217395|FG003|PK Part|Adverse Event|0|||
23682446|NCT02901431|66217396|FG004|PK Part|Adverse Event|0|||
23682447|NCT02901431|66217397|FG005|PK Part|Adverse Event|0|||
23682448|NCT02901431|66217398|FG006|PK Part|Adverse Event|0|||
23682449|NCT02901431|66217399|FG007|PK Part|Adverse Event|0|||
23495258|NCT01254292|65555109|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
23495259|NCT01254292|65555108|FG000|LCS12 Extension Phase|Adverse Event|9|||
23495260|NCT01254292|65555109|FG001|LCS12 Extension Phase|Adverse Event|0|||
23495261|NCT01254292|65555108|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
23682450|NCT02901431|66217400|FG008|PK Part|Adverse Event|0|||
23682451|NCT02901431|66217401|FG009|PK Part|Adverse Event|0|||
23682452|NCT02901431|66217402|FG010|PK Part|Adverse Event|0|||
23682453|NCT02901431|66217403|FG011|PK Part|Adverse Event|0|||
23682454|NCT02901431|66217404|FG012|PK Part|Adverse Event|0|||
23682455|NCT02901431|66217392|FG000|PK Part|Lost to Follow-up|0|||
23682456|NCT02901431|66217393|FG001|PK Part|Lost to Follow-up|0|||
23682457|NCT02901431|66217394|FG002|PK Part|Lost to Follow-up|1|||
23682458|NCT02901431|66217395|FG003|PK Part|Lost to Follow-up|0|||
23682459|NCT02901431|66217396|FG004|PK Part|Lost to Follow-up|0|||
23682460|NCT02901431|66217397|FG005|PK Part|Lost to Follow-up|0|||
23682461|NCT02901431|66217398|FG006|PK Part|Lost to Follow-up|0|||
23682462|NCT02901431|66217399|FG007|PK Part|Lost to Follow-up|0|||
23682463|NCT02901431|66217400|FG008|PK Part|Lost to Follow-up|0|||
23682464|NCT02901431|66217401|FG009|PK Part|Lost to Follow-up|0|||
23682465|NCT02901431|66217402|FG010|PK Part|Lost to Follow-up|0|||
23682466|NCT02901431|66217403|FG011|PK Part|Lost to Follow-up|0|||
23682467|NCT02901431|66217404|FG012|PK Part|Lost to Follow-up|0|||
23682468|NCT02901431|66217392|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
23682469|NCT02901431|66217393|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682470|NCT02901431|66217394|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682471|NCT02901431|66217395|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682472|NCT02901431|66217396|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682473|NCT02901431|66217397|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682474|NCT02901431|66217398|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682475|NCT02901431|66217399|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682476|NCT02901431|66217400|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23495262|NCT01254292|65555109|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
23682477|NCT02901431|66217401|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682478|NCT02901431|66217402|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682479|NCT02901431|66217403|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682480|NCT02901431|66217404|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23682481|NCT02901431|66217392|FG000|PK Part|Pending dose confirmation|0|||
23682482|NCT02901431|66217393|FG001|PK Part|Pending dose confirmation|1|||
23682483|NCT02901431|66217394|FG002|PK Part|Pending dose confirmation|0|||
23682484|NCT02901431|66217395|FG003|PK Part|Pending dose confirmation|0|||
23682485|NCT02901431|66217396|FG004|PK Part|Pending dose confirmation|0|||
23682486|NCT02901431|66217397|FG005|PK Part|Pending dose confirmation|0|||
23682487|NCT02901431|66217398|FG006|PK Part|Pending dose confirmation|0|||
23682488|NCT02901431|66217399|FG007|PK Part|Pending dose confirmation|0|||
23682489|NCT02901431|66217400|FG008|PK Part|Pending dose confirmation|0|||
23682490|NCT02901431|66217401|FG009|PK Part|Pending dose confirmation|0|||
23390717|NCT01908699|65175346|FG001|Overall Study|Pregnancy|1|||
23390718|NCT01908699|65175345|FG000|Overall Study|Randomized in Error|1|||
23390719|NCT01908699|65175346|FG001|Overall Study|Randomized in Error|0|||
23495263|NCT01254292|65555108|FG000|LCS12 Extension Phase|Other unknown|4|||
23495264|NCT01254292|65555109|FG001|LCS12 Extension Phase|Other unknown|0|||
23495265|NCT01254292|65555108|FG000|LCS12 Extension Phase|Pregnancy|2|||
23495266|NCT01254292|65555109|FG001|LCS12 Extension Phase|Pregnancy|0|||
23495267|NCT01254292|65555108|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
23495268|NCT01254292|65555109|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
23495269|NCT03080454|65555115|FG000|Baseline|Adverse Event|2|||
23682491|NCT02901431|66217402|FG010|PK Part|Pending dose confirmation|0|||
23682492|NCT02901431|66217403|FG011|PK Part|Pending dose confirmation|0|||
23682493|NCT02901431|66217404|FG012|PK Part|Pending dose confirmation|0|||
23682494|NCT02901431|66217392|FG000|PK Part|8 weeks of treatment ran out|2|||
23682495|NCT02901431|66217393|FG001|PK Part|8 weeks of treatment ran out|0|||
23682496|NCT02901431|66217394|FG002|PK Part|8 weeks of treatment ran out|0|||
23682497|NCT02901431|66217395|FG003|PK Part|8 weeks of treatment ran out|0|||
23682498|NCT02901431|66217396|FG004|PK Part|8 weeks of treatment ran out|0|||
23390720|NCT01908699|65175345|FG000|Overall Study|Death|9|||
23682499|NCT02901431|66217397|FG005|PK Part|8 weeks of treatment ran out|0|||
23682500|NCT02901431|66217398|FG006|PK Part|8 weeks of treatment ran out|0|||
23682501|NCT02901431|66217399|FG007|PK Part|8 weeks of treatment ran out|0|||
23682502|NCT02901431|66217400|FG008|PK Part|8 weeks of treatment ran out|0|||
23682503|NCT02901431|66217401|FG009|PK Part|8 weeks of treatment ran out|0|||
23682504|NCT02901431|66217402|FG010|PK Part|8 weeks of treatment ran out|0|||
23682505|NCT02901431|66217403|FG011|PK Part|8 weeks of treatment ran out|0|||
23682506|NCT02901431|66217404|FG012|PK Part|8 weeks of treatment ran out|0|||
23682507|NCT02901431|66217392|FG000|PK Part|Stopped treatment after 8 weeks|1|||
23682508|NCT02901431|66217393|FG001|PK Part|Stopped treatment after 8 weeks|0|||
23682509|NCT02901431|66217394|FG002|PK Part|Stopped treatment after 8 weeks|1|||
23682510|NCT02901431|66217395|FG003|PK Part|Stopped treatment after 8 weeks|0|||
23682511|NCT02901431|66217396|FG004|PK Part|Stopped treatment after 8 weeks|0|||
23682512|NCT02901431|66217397|FG005|PK Part|Stopped treatment after 8 weeks|0|||
23682513|NCT02901431|66217398|FG006|PK Part|Stopped treatment after 8 weeks|0|||
23682514|NCT02901431|66217399|FG007|PK Part|Stopped treatment after 8 weeks|0|||
23682515|NCT02901431|66217400|FG008|PK Part|Stopped treatment after 8 weeks|0|||
23682516|NCT02901431|66217401|FG009|PK Part|Stopped treatment after 8 weeks|0|||
23682517|NCT02901431|66217402|FG010|PK Part|Stopped treatment after 8 weeks|0|||
23682518|NCT02901431|66217403|FG011|PK Part|Stopped treatment after 8 weeks|0|||
23682519|NCT02901431|66217404|FG012|PK Part|Stopped treatment after 8 weeks|0|||
23682520|NCT02901431|66217392|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
23682521|NCT02901431|66217393|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682522|NCT02901431|66217394|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
23682523|NCT02901431|66217395|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682524|NCT02901431|66217396|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682525|NCT02901431|66217397|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23390721|NCT01908699|65175346|FG001|Overall Study|Death|12|||
23390722|NCT01908699|65175345|FG000|Overall Study|Progressive Disease|30|||
23390723|NCT01908699|65175346|FG001|Overall Study|Progressive Disease|29|||
23390724|NCT02799043|65175353|FG000|Overall Study|Adverse Event|0|||
23390725|NCT02799043|65175354|FG001|Overall Study|Adverse Event|1|||
23390726|NCT02799043|65175353|FG000|Overall Study|Death|1|||
23390727|NCT02799043|65175354|FG001|Overall Study|Death|1|||
23390728|NCT02799043|65175353|FG000|Overall Study|Lost to Follow-up|3|||
23390729|NCT02799043|65175354|FG001|Overall Study|Lost to Follow-up|6|||
23390730|NCT02799043|65175353|FG000|Overall Study|Withdrawal by Subject|4|||
23390731|NCT02799043|65175354|FG001|Overall Study|Withdrawal by Subject|4|||
23390732|NCT02799043|65175353|FG000|Overall Study|Moved to different country|0|||
23390733|NCT02799043|65175354|FG001|Overall Study|Moved to different country|1|||
23390734|NCT02799043|65175353|FG000|Overall Study|Trial Screen Failure|1|||
23390735|NCT02799043|65175354|FG001|Overall Study|Trial Screen Failure|0|||
23390736|NCT02799043|65175353|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
23682526|NCT02901431|66217398|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682527|NCT02901431|66217399|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682528|NCT02901431|66217400|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682529|NCT02901431|66217401|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682530|NCT02901431|66217402|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682531|NCT02901431|66217403|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23390737|NCT02799043|65175354|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
23390738|NCT01813357|65175355|FG000|Overall Study|Lost to Follow-up|5|||
23390739|NCT01813357|65175356|FG001|Overall Study|Lost to Follow-up|6|||
23390740|NCT02496156|65175361|FG000|Overall Study|Lost to Follow-up|5|||
23390741|NCT02496156|65175362|FG001|Overall Study|Lost to Follow-up|0|||
23390742|NCT02496156|65175361|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
23390743|NCT02496156|65175362|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
23390744|NCT02255656|65175363|FG000|Overall Study|Adverse Event|11|||
23390745|NCT02255656|65175363|FG000|Overall Study|Poor compliance to protocol|3|||
23390746|NCT02255656|65175363|FG000|Overall Study|Lost to Follow-up|30|||
23390747|NCT02255656|65175363|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
23390748|NCT02255656|65175363|FG000|Overall Study|Other|126|||
23390749|NCT01840163|65175368|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
23495270|NCT03080454|65555115|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
23495271|NCT03080454|65555115|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
23495272|NCT00913380|65555116|FG000|Clinical Outcomes|Lost to Follow-up|6|||
23682532|NCT02901431|66217404|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23682533|NCT02901431|66217392|FG000|PK Part|Discontinued per Sponsor|0|||
23682534|NCT02901431|66217393|FG001|PK Part|Discontinued per Sponsor|3|||
23682535|NCT02901431|66217394|FG002|PK Part|Discontinued per Sponsor|0|||
23682536|NCT02901431|66217395|FG003|PK Part|Discontinued per Sponsor|0|||
23682537|NCT02901431|66217396|FG004|PK Part|Discontinued per Sponsor|0|||
23682538|NCT02901431|66217397|FG005|PK Part|Discontinued per Sponsor|0|||
23682539|NCT02901431|66217398|FG006|PK Part|Discontinued per Sponsor|0|||
23682540|NCT02901431|66217399|FG007|PK Part|Discontinued per Sponsor|0|||
23682541|NCT02901431|66217400|FG008|PK Part|Discontinued per Sponsor|0|||
23390750|NCT01840163|65175369|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
23390751|NCT01840163|65175368|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
23390752|NCT01840163|65175369|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
23682542|NCT02901431|66217401|FG009|PK Part|Discontinued per Sponsor|0|||
23682543|NCT02901431|66217402|FG010|PK Part|Discontinued per Sponsor|0|||
23682544|NCT02901431|66217403|FG011|PK Part|Discontinued per Sponsor|0|||
23682545|NCT02901431|66217404|FG012|PK Part|Discontinued per Sponsor|0|||
23682546|NCT02901431|66217392|FG000|PK Part|Withdrawal by Subject|1|||
23682547|NCT02901431|66217393|FG001|PK Part|Withdrawal by Subject|1|||
23682548|NCT02901431|66217394|FG002|PK Part|Withdrawal by Subject|3|||
23682549|NCT02901431|66217395|FG003|PK Part|Withdrawal by Subject|0|||
23682550|NCT02901431|66217396|FG004|PK Part|Withdrawal by Subject|0|||
23682551|NCT02901431|66217397|FG005|PK Part|Withdrawal by Subject|0|||
23682552|NCT02901431|66217398|FG006|PK Part|Withdrawal by Subject|0|||
23682553|NCT02901431|66217399|FG007|PK Part|Withdrawal by Subject|0|||
23682554|NCT02901431|66217400|FG008|PK Part|Withdrawal by Subject|0|||
23682555|NCT02901431|66217401|FG009|PK Part|Withdrawal by Subject|0|||
23682556|NCT02901431|66217402|FG010|PK Part|Withdrawal by Subject|0|||
23682557|NCT02901431|66217403|FG011|PK Part|Withdrawal by Subject|0|||
23682558|NCT02901431|66217404|FG012|PK Part|Withdrawal by Subject|0|||
23682559|NCT02901431|66217392|FG000|Main Treatment Part|Adverse Event|0|||
23682560|NCT02901431|66217393|FG001|Main Treatment Part|Adverse Event|0|||
23682561|NCT02901431|66217394|FG002|Main Treatment Part|Adverse Event|0|||
23682562|NCT02901431|66217395|FG003|Main Treatment Part|Adverse Event|3|||
23682563|NCT02901431|66217396|FG004|Main Treatment Part|Adverse Event|3|||
23682564|NCT02901431|66217397|FG005|Main Treatment Part|Adverse Event|4|||
23682565|NCT02901431|66217398|FG006|Main Treatment Part|Adverse Event|1|||
23682566|NCT02901431|66217399|FG007|Main Treatment Part|Adverse Event|0|||
23682567|NCT02901431|66217400|FG008|Main Treatment Part|Adverse Event|0|||
23682568|NCT02901431|66217401|FG009|Main Treatment Part|Adverse Event|0|||
23682569|NCT02901431|66217402|FG010|Main Treatment Part|Adverse Event|0|||
23682570|NCT02901431|66217403|FG011|Main Treatment Part|Adverse Event|0|||
23682571|NCT02901431|66217404|FG012|Main Treatment Part|Adverse Event|0|||
23682572|NCT02901431|66217392|FG000|Main Treatment Part|Lack of Efficacy|0|||
23682573|NCT02901431|66217393|FG001|Main Treatment Part|Lack of Efficacy|0|||
23682574|NCT02901431|66217394|FG002|Main Treatment Part|Lack of Efficacy|0|||
23682575|NCT02901431|66217395|FG003|Main Treatment Part|Lack of Efficacy|1|||
23682576|NCT02901431|66217396|FG004|Main Treatment Part|Lack of Efficacy|0|||
23682577|NCT02901431|66217397|FG005|Main Treatment Part|Lack of Efficacy|0|||
23682578|NCT02901431|66217398|FG006|Main Treatment Part|Lack of Efficacy|0|||
23682579|NCT02901431|66217399|FG007|Main Treatment Part|Lack of Efficacy|0|||
23682580|NCT02901431|66217400|FG008|Main Treatment Part|Lack of Efficacy|0|||
23682581|NCT02901431|66217401|FG009|Main Treatment Part|Lack of Efficacy|0|||
23682582|NCT02901431|66217402|FG010|Main Treatment Part|Lack of Efficacy|0|||
23682583|NCT02901431|66217403|FG011|Main Treatment Part|Lack of Efficacy|0|||
23682584|NCT02901431|66217404|FG012|Main Treatment Part|Lack of Efficacy|0|||
23682585|NCT02901431|66217392|FG000|Main Treatment Part|Lost to Follow-up|0|||
23682586|NCT02901431|66217393|FG001|Main Treatment Part|Lost to Follow-up|0|||
23682587|NCT02901431|66217394|FG002|Main Treatment Part|Lost to Follow-up|0|||
23682588|NCT02901431|66217395|FG003|Main Treatment Part|Lost to Follow-up|3|||
23682589|NCT02901431|66217396|FG004|Main Treatment Part|Lost to Follow-up|1|||
23682590|NCT02901431|66217397|FG005|Main Treatment Part|Lost to Follow-up|2|||
23682591|NCT02901431|66217398|FG006|Main Treatment Part|Lost to Follow-up|3|||
23682592|NCT02901431|66217399|FG007|Main Treatment Part|Lost to Follow-up|0|||
23682593|NCT02901431|66217400|FG008|Main Treatment Part|Lost to Follow-up|0|||
23682594|NCT02901431|66217401|FG009|Main Treatment Part|Lost to Follow-up|0|||
23682595|NCT02901431|66217402|FG010|Main Treatment Part|Lost to Follow-up|0|||
23682596|NCT02901431|66217403|FG011|Main Treatment Part|Lost to Follow-up|0|||
23682597|NCT02901431|66217404|FG012|Main Treatment Part|Lost to Follow-up|0|||
23682598|NCT02901431|66217392|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
23682599|NCT02901431|66217393|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
23682600|NCT02901431|66217394|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
23682601|NCT02901431|66217395|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
23682602|NCT02901431|66217396|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
23682603|NCT02901431|66217397|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
23682604|NCT02901431|66217398|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
23682605|NCT02901431|66217399|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
23682606|NCT02901431|66217400|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
23682607|NCT02901431|66217401|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
23682608|NCT02901431|66217402|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
23682609|NCT02901431|66217403|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
23682610|NCT02901431|66217404|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
23682611|NCT02901431|66217392|FG000|Main Treatment Part|Physician Decision|0|||
23682612|NCT02901431|66217393|FG001|Main Treatment Part|Physician Decision|0|||
23682613|NCT02901431|66217394|FG002|Main Treatment Part|Physician Decision|0|||
23682614|NCT02901431|66217395|FG003|Main Treatment Part|Physician Decision|1|||
23390753|NCT01840163|65175368|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
23390754|NCT01840163|65175369|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
23390755|NCT01767857|65175370|FG000|Overall Study|Adverse Event|27|||
23390756|NCT01767857|65175371|FG001|Overall Study|Adverse Event|7|||
23390757|NCT01767857|65175370|FG000|Overall Study|Death|28|||
23390758|NCT01767857|65175371|FG001|Overall Study|Death|13|||
23390759|NCT01767857|65175370|FG000|Overall Study|Lack of Efficacy|299|||
23390760|NCT01767857|65175371|FG001|Overall Study|Lack of Efficacy|151|||
23390761|NCT01767857|65175370|FG000|Overall Study|Lost to Follow-up|1|||
23390762|NCT01767857|65175371|FG001|Overall Study|Lost to Follow-up|1|||
23390763|NCT01767857|65175370|FG000|Overall Study|Withdrawal by Subject|38|||
23390764|NCT01767857|65175371|FG001|Overall Study|Withdrawal by Subject|18|||
23390765|NCT01767857|65175370|FG000|Overall Study|Physician Decision|17|||
23390766|NCT01767857|65175371|FG001|Overall Study|Physician Decision|10|||
23390767|NCT01767857|65175370|FG000|Overall Study|Protocol Terminated|1|||
23390768|NCT01767857|65175371|FG001|Overall Study|Protocol Terminated|0|||
23390769|NCT01767857|65175370|FG000|Overall Study|Randomized But Never Treated|19|||
23390770|NCT01767857|65175371|FG001|Overall Study|Randomized But Never Treated|13|||
23390771|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
23390772|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
23390773|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
23390774|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
23390775|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
23390776|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
23390777|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
23390778|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
23390779|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Other|1|||
23390780|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Other|1|||
23390781|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Other|0|||
23390782|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Other|0|||
23390783|NCT01122680|65175375|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
23682615|NCT02901431|66217396|FG004|Main Treatment Part|Physician Decision|0|||
23682616|NCT02901431|66217397|FG005|Main Treatment Part|Physician Decision|0|||
23682617|NCT02901431|66217398|FG006|Main Treatment Part|Physician Decision|1|||
23682618|NCT02901431|66217399|FG007|Main Treatment Part|Physician Decision|0|||
23682619|NCT02901431|66217400|FG008|Main Treatment Part|Physician Decision|0|||
23682620|NCT02901431|66217401|FG009|Main Treatment Part|Physician Decision|0|||
23682621|NCT02901431|66217402|FG010|Main Treatment Part|Physician Decision|0|||
23682622|NCT02901431|66217403|FG011|Main Treatment Part|Physician Decision|0|||
23682623|NCT02901431|66217404|FG012|Main Treatment Part|Physician Decision|0|||
23390784|NCT01122680|65175376|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
23390785|NCT01122680|65175377|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
23390786|NCT01122680|65175378|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
23390787|NCT01122680|65175375|FG000|Period 2 (4 Weeks)|Other|1|||
23390788|NCT01122680|65175376|FG001|Period 2 (4 Weeks)|Other|0|||
23390789|NCT01122680|65175377|FG002|Period 2 (4 Weeks)|Other|0|||
23390790|NCT01122680|65175378|FG003|Period 2 (4 Weeks)|Other|0|||
23390791|NCT01122680|65175375|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
23390792|NCT01122680|65175376|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
23682624|NCT02901431|66217392|FG000|Main Treatment Part|Withdrawal by Subject|0|||
23682625|NCT02901431|66217393|FG001|Main Treatment Part|Withdrawal by Subject|0|||
23682626|NCT02901431|66217394|FG002|Main Treatment Part|Withdrawal by Subject|0|||
23390793|NCT01122680|65175377|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
23390794|NCT01122680|65175378|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
23390795|NCT01122680|65175375|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390796|NCT01122680|65175376|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
23390797|NCT01122680|65175377|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390798|NCT01122680|65175378|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390799|NCT03186378|65175379|FG000|Overall Study|Lost to Follow-up|1|||
23390800|NCT03186378|65175380|FG001|Overall Study|Lost to Follow-up|0|||
23682627|NCT02901431|66217395|FG003|Main Treatment Part|Withdrawal by Subject|18|||
23682628|NCT02901431|66217396|FG004|Main Treatment Part|Withdrawal by Subject|3|||
23682629|NCT02901431|66217397|FG005|Main Treatment Part|Withdrawal by Subject|5|||
23682630|NCT02901431|66217398|FG006|Main Treatment Part|Withdrawal by Subject|6|||
23390801|NCT00663260|65175381|FG000|Overall Study|Lack of Efficacy|2|||
23682631|NCT02901431|66217399|FG007|Main Treatment Part|Withdrawal by Subject|0|||
23682632|NCT02901431|66217400|FG008|Main Treatment Part|Withdrawal by Subject|0|||
23682633|NCT02901431|66217401|FG009|Main Treatment Part|Withdrawal by Subject|0|||
23682634|NCT02901431|66217402|FG010|Main Treatment Part|Withdrawal by Subject|0|||
23682635|NCT02901431|66217403|FG011|Main Treatment Part|Withdrawal by Subject|0|||
23390802|NCT00663260|65175382|FG001|Overall Study|Lack of Efficacy|0|||
23390803|NCT00663260|65175383|FG002|Overall Study|Lack of Efficacy|0|||
23390804|NCT00663260|65175381|FG000|Overall Study|Adverse Event|12|||
23390805|NCT00663260|65175382|FG001|Overall Study|Adverse Event|7|||
23390806|NCT00663260|65175383|FG002|Overall Study|Adverse Event|6|||
23682636|NCT02901431|66217404|FG012|Main Treatment Part|Withdrawal by Subject|0|||
23682637|NCT02901431|66217392|FG000|Open Label Part|Adverse Event|0|||
23682638|NCT02901431|66217393|FG001|Open Label Part|Adverse Event|0|||
23682639|NCT02901431|66217394|FG002|Open Label Part|Adverse Event|0|||
23682640|NCT02901431|66217395|FG003|Open Label Part|Adverse Event|0|||
23682641|NCT02901431|66217396|FG004|Open Label Part|Adverse Event|0|||
23682642|NCT02901431|66217397|FG005|Open Label Part|Adverse Event|0|||
23682643|NCT02901431|66217398|FG006|Open Label Part|Adverse Event|0|||
23682644|NCT02901431|66217399|FG007|Open Label Part|Adverse Event|0|||
23682645|NCT02901431|66217400|FG008|Open Label Part|Adverse Event|4|||
23682646|NCT02901431|66217401|FG009|Open Label Part|Adverse Event|4|||
23682647|NCT02901431|66217402|FG010|Open Label Part|Adverse Event|0|||
23682648|NCT02901431|66217403|FG011|Open Label Part|Adverse Event|4|||
23682649|NCT02901431|66217404|FG012|Open Label Part|Adverse Event|1|||
23682650|NCT02901431|66217392|FG000|Open Label Part|Lost to Follow-up|0|||
23682651|NCT02901431|66217393|FG001|Open Label Part|Lost to Follow-up|0|||
23682652|NCT02901431|66217394|FG002|Open Label Part|Lost to Follow-up|0|||
23682653|NCT02901431|66217395|FG003|Open Label Part|Lost to Follow-up|0|||
23682654|NCT02901431|66217396|FG004|Open Label Part|Lost to Follow-up|0|||
23682655|NCT02901431|66217397|FG005|Open Label Part|Lost to Follow-up|0|||
23682656|NCT02901431|66217398|FG006|Open Label Part|Lost to Follow-up|0|||
23682657|NCT02901431|66217399|FG007|Open Label Part|Lost to Follow-up|0|||
23682658|NCT02901431|66217400|FG008|Open Label Part|Lost to Follow-up|2|||
23682659|NCT02901431|66217401|FG009|Open Label Part|Lost to Follow-up|2|||
23682660|NCT02901431|66217402|FG010|Open Label Part|Lost to Follow-up|1|||
23682661|NCT02901431|66217403|FG011|Open Label Part|Lost to Follow-up|1|||
23682662|NCT02901431|66217404|FG012|Open Label Part|Lost to Follow-up|1|||
23682663|NCT02901431|66217392|FG000|Open Label Part|Physician Decision|0|||
23682664|NCT02901431|66217393|FG001|Open Label Part|Physician Decision|0|||
23682665|NCT02901431|66217394|FG002|Open Label Part|Physician Decision|0|||
23682666|NCT02901431|66217395|FG003|Open Label Part|Physician Decision|0|||
23682667|NCT02901431|66217396|FG004|Open Label Part|Physician Decision|0|||
23682668|NCT02901431|66217397|FG005|Open Label Part|Physician Decision|0|||
23682669|NCT02901431|66217398|FG006|Open Label Part|Physician Decision|0|||
23682670|NCT02901431|66217399|FG007|Open Label Part|Physician Decision|0|||
23682671|NCT02901431|66217400|FG008|Open Label Part|Physician Decision|1|||
23682672|NCT02901431|66217401|FG009|Open Label Part|Physician Decision|1|||
23682673|NCT02901431|66217402|FG010|Open Label Part|Physician Decision|0|||
23682674|NCT02901431|66217403|FG011|Open Label Part|Physician Decision|0|||
23682675|NCT02901431|66217404|FG012|Open Label Part|Physician Decision|0|||
23682676|NCT02901431|66217392|FG000|Open Label Part|Study Terminated By Sponsor|0|||
23682677|NCT02901431|66217393|FG001|Open Label Part|Study Terminated By Sponsor|0|||
23682678|NCT02901431|66217394|FG002|Open Label Part|Study Terminated By Sponsor|0|||
23682679|NCT02901431|66217395|FG003|Open Label Part|Study Terminated By Sponsor|0|||
23682680|NCT02901431|66217396|FG004|Open Label Part|Study Terminated By Sponsor|0|||
23682681|NCT02901431|66217397|FG005|Open Label Part|Study Terminated By Sponsor|0|||
23682682|NCT02901431|66217398|FG006|Open Label Part|Study Terminated By Sponsor|0|||
23682683|NCT02901431|66217399|FG007|Open Label Part|Study Terminated By Sponsor|0|||
23682684|NCT02901431|66217400|FG008|Open Label Part|Study Terminated By Sponsor|35|||
23682685|NCT02901431|66217401|FG009|Open Label Part|Study Terminated By Sponsor|12|||
23682686|NCT02901431|66217402|FG010|Open Label Part|Study Terminated By Sponsor|21|||
23682687|NCT02901431|66217403|FG011|Open Label Part|Study Terminated By Sponsor|31|||
23682688|NCT02901431|66217404|FG012|Open Label Part|Study Terminated By Sponsor|0|||
23682689|NCT02901431|66217392|FG000|Open Label Part|Withdrawal by Subject|0|||
23682690|NCT02901431|66217393|FG001|Open Label Part|Withdrawal by Subject|0|||
23682691|NCT02901431|66217394|FG002|Open Label Part|Withdrawal by Subject|0|||
23390807|NCT00663260|65175381|FG000|Overall Study|Withdrawal by Subject|3|||
23390808|NCT00663260|65175382|FG001|Overall Study|Withdrawal by Subject|1|||
23682692|NCT02901431|66217395|FG003|Open Label Part|Withdrawal by Subject|0|||
23682693|NCT02901431|66217396|FG004|Open Label Part|Withdrawal by Subject|0|||
23682694|NCT02901431|66217397|FG005|Open Label Part|Withdrawal by Subject|0|||
23682695|NCT02901431|66217398|FG006|Open Label Part|Withdrawal by Subject|0|||
23682696|NCT02901431|66217399|FG007|Open Label Part|Withdrawal by Subject|0|||
23682697|NCT02901431|66217400|FG008|Open Label Part|Withdrawal by Subject|6|||
23390809|NCT00663260|65175383|FG002|Overall Study|Withdrawal by Subject|6|||
23390810|NCT00663260|65175381|FG000|Overall Study|Death|1|||
23682698|NCT02901431|66217401|FG009|Open Label Part|Withdrawal by Subject|5|||
23682699|NCT02901431|66217402|FG010|Open Label Part|Withdrawal by Subject|7|||
23682700|NCT02901431|66217403|FG011|Open Label Part|Withdrawal by Subject|3|||
23682701|NCT02901431|66217404|FG012|Open Label Part|Withdrawal by Subject|1|||
23682702|NCT04436276|66217408|FG000|Overall Study|Adverse Event|0|||
23682703|NCT04436276|66217409|FG001|Overall Study|Adverse Event|0|||
23682704|NCT04436276|66217410|FG002|Overall Study|Adverse Event|0|||
23682705|NCT04436276|66217411|FG003|Overall Study|Adverse Event|0|||
23682706|NCT04436276|66217412|FG004|Overall Study|Adverse Event|0|||
23682707|NCT04436276|66217413|FG005|Overall Study|Adverse Event|0|||
23682708|NCT04436276|66217414|FG006|Overall Study|Adverse Event|0|||
23682709|NCT04436276|66217415|FG007|Overall Study|Adverse Event|0|||
23682710|NCT04436276|66217416|FG008|Overall Study|Adverse Event|0|||
23682711|NCT04436276|66217417|FG009|Overall Study|Adverse Event|0|||
23682712|NCT04436276|66217418|FG010|Overall Study|Adverse Event|0|||
23682713|NCT04436276|66217419|FG011|Overall Study|Adverse Event|0|||
23682714|NCT04436276|66217420|FG012|Overall Study|Adverse Event|0|||
23682715|NCT04436276|66217421|FG013|Overall Study|Adverse Event|0|||
23682716|NCT04436276|66217422|FG014|Overall Study|Adverse Event|0|||
23682717|NCT04436276|66217423|FG015|Overall Study|Adverse Event|0|||
23682718|NCT04436276|66217424|FG016|Overall Study|Adverse Event|1|||
23682719|NCT04436276|66217425|FG017|Overall Study|Adverse Event|0|||
23682720|NCT04436276|66217426|FG018|Overall Study|Adverse Event|0|||
23682721|NCT04436276|66217427|FG019|Overall Study|Adverse Event|0|||
23682722|NCT04436276|66217428|FG020|Overall Study|Adverse Event|0|||
23682723|NCT04436276|66217429|FG021|Overall Study|Adverse Event|0|||
23682724|NCT04436276|66217430|FG022|Overall Study|Adverse Event|0|||
23682725|NCT04436276|66217408|FG000|Overall Study|Death|0|||
23682726|NCT04436276|66217409|FG001|Overall Study|Death|0|||
23682727|NCT04436276|66217410|FG002|Overall Study|Death|0|||
23682728|NCT04436276|66217411|FG003|Overall Study|Death|0|||
23682729|NCT04436276|66217412|FG004|Overall Study|Death|0|||
23682730|NCT04436276|66217413|FG005|Overall Study|Death|0|||
23682731|NCT04436276|66217414|FG006|Overall Study|Death|0|||
23682732|NCT04436276|66217415|FG007|Overall Study|Death|0|||
23682733|NCT04436276|66217416|FG008|Overall Study|Death|0|||
23682734|NCT04436276|66217417|FG009|Overall Study|Death|0|||
23682735|NCT04436276|66217418|FG010|Overall Study|Death|0|||
23682736|NCT04436276|66217419|FG011|Overall Study|Death|0|||
23682737|NCT04436276|66217420|FG012|Overall Study|Death|1|||
23682738|NCT04436276|66217421|FG013|Overall Study|Death|0|||
23682739|NCT04436276|66217422|FG014|Overall Study|Death|1|||
23682740|NCT04436276|66217423|FG015|Overall Study|Death|0|||
23682741|NCT04436276|66217424|FG016|Overall Study|Death|0|||
23682742|NCT04436276|66217425|FG017|Overall Study|Death|0|||
23682743|NCT04436276|66217426|FG018|Overall Study|Death|0|||
23682744|NCT04436276|66217427|FG019|Overall Study|Death|2|||
23682745|NCT04436276|66217428|FG020|Overall Study|Death|0|||
23682746|NCT04436276|66217429|FG021|Overall Study|Death|1|||
23682747|NCT04436276|66217430|FG022|Overall Study|Death|0|||
23682748|NCT04436276|66217408|FG000|Overall Study|Lost to Follow-up|0|||
23682749|NCT04436276|66217409|FG001|Overall Study|Lost to Follow-up|2|||
23682750|NCT04436276|66217410|FG002|Overall Study|Lost to Follow-up|2|||
23682751|NCT04436276|66217411|FG003|Overall Study|Lost to Follow-up|1|||
23682752|NCT04436276|66217412|FG004|Overall Study|Lost to Follow-up|4|||
23682753|NCT04436276|66217413|FG005|Overall Study|Lost to Follow-up|1|||
23682754|NCT04436276|66217414|FG006|Overall Study|Lost to Follow-up|0|||
23682755|NCT04436276|66217415|FG007|Overall Study|Lost to Follow-up|0|||
23682756|NCT04436276|66217416|FG008|Overall Study|Lost to Follow-up|1|||
23682757|NCT04436276|66217417|FG009|Overall Study|Lost to Follow-up|0|||
23682758|NCT04436276|66217418|FG010|Overall Study|Lost to Follow-up|5|||
23682759|NCT04436276|66217419|FG011|Overall Study|Lost to Follow-up|5|||
23682760|NCT04436276|66217420|FG012|Overall Study|Lost to Follow-up|4|||
23682761|NCT04436276|66217421|FG013|Overall Study|Lost to Follow-up|1|||
23682762|NCT04436276|66217422|FG014|Overall Study|Lost to Follow-up|7|||
23682763|NCT04436276|66217423|FG015|Overall Study|Lost to Follow-up|7|||
23682764|NCT04436276|66217424|FG016|Overall Study|Lost to Follow-up|1|||
23682765|NCT04436276|66217425|FG017|Overall Study|Lost to Follow-up|0|||
23682766|NCT04436276|66217426|FG018|Overall Study|Lost to Follow-up|1|||
23682767|NCT04436276|66217427|FG019|Overall Study|Lost to Follow-up|1|||
23682768|NCT04436276|66217428|FG020|Overall Study|Lost to Follow-up|2|||
23682769|NCT04436276|66217429|FG021|Overall Study|Lost to Follow-up|1|||
23682770|NCT04436276|66217430|FG022|Overall Study|Lost to Follow-up|1|||
23682771|NCT04436276|66217408|FG000|Overall Study|Physician Decision|1|||
23682772|NCT04436276|66217409|FG001|Overall Study|Physician Decision|0|||
23682773|NCT04436276|66217410|FG002|Overall Study|Physician Decision|2|||
23682774|NCT04436276|66217411|FG003|Overall Study|Physician Decision|1|||
23682775|NCT04436276|66217412|FG004|Overall Study|Physician Decision|0|||
23682776|NCT04436276|66217413|FG005|Overall Study|Physician Decision|0|||
23682777|NCT04436276|66217414|FG006|Overall Study|Physician Decision|0|||
23682778|NCT04436276|66217415|FG007|Overall Study|Physician Decision|0|||
23682779|NCT04436276|66217416|FG008|Overall Study|Physician Decision|0|||
23682780|NCT04436276|66217417|FG009|Overall Study|Physician Decision|0|||
23682781|NCT04436276|66217418|FG010|Overall Study|Physician Decision|0|||
23682782|NCT04436276|66217419|FG011|Overall Study|Physician Decision|1|||
23682783|NCT04436276|66217420|FG012|Overall Study|Physician Decision|2|||
23682784|NCT04436276|66217421|FG013|Overall Study|Physician Decision|0|||
23682785|NCT04436276|66217422|FG014|Overall Study|Physician Decision|0|||
23682786|NCT04436276|66217423|FG015|Overall Study|Physician Decision|0|||
23682787|NCT04436276|66217424|FG016|Overall Study|Physician Decision|0|||
23682788|NCT04436276|66217425|FG017|Overall Study|Physician Decision|0|||
23682789|NCT04436276|66217426|FG018|Overall Study|Physician Decision|0|||
23682790|NCT04436276|66217427|FG019|Overall Study|Physician Decision|0|||
23682791|NCT04436276|66217428|FG020|Overall Study|Physician Decision|1|||
23682792|NCT04436276|66217429|FG021|Overall Study|Physician Decision|2|||
23682793|NCT04436276|66217430|FG022|Overall Study|Physician Decision|0|||
23682794|NCT04436276|66217408|FG000|Overall Study|Protocol Violation|0|||
23682795|NCT04436276|66217409|FG001|Overall Study|Protocol Violation|0|||
23390811|NCT00663260|65175382|FG001|Overall Study|Death|0|||
23682796|NCT04436276|66217410|FG002|Overall Study|Protocol Violation|0|||
23682797|NCT04436276|66217411|FG003|Overall Study|Protocol Violation|0|||
23682798|NCT04436276|66217412|FG004|Overall Study|Protocol Violation|0|||
23682799|NCT04436276|66217413|FG005|Overall Study|Protocol Violation|0|||
23682800|NCT04436276|66217414|FG006|Overall Study|Protocol Violation|0|||
23682801|NCT04436276|66217415|FG007|Overall Study|Protocol Violation|0|||
23682802|NCT04436276|66217416|FG008|Overall Study|Protocol Violation|0|||
23390812|NCT00663260|65175383|FG002|Overall Study|Death|1|||
23390813|NCT00663260|65175381|FG000|Overall Study|Lost to Follow-up|0|||
23390814|NCT00663260|65175382|FG001|Overall Study|Lost to Follow-up|1|||
23682803|NCT04436276|66217417|FG009|Overall Study|Protocol Violation|0|||
23682804|NCT04436276|66217418|FG010|Overall Study|Protocol Violation|0|||
23682805|NCT04436276|66217419|FG011|Overall Study|Protocol Violation|0|||
23682806|NCT04436276|66217420|FG012|Overall Study|Protocol Violation|0|||
23682807|NCT04436276|66217421|FG013|Overall Study|Protocol Violation|1|||
23682808|NCT04436276|66217422|FG014|Overall Study|Protocol Violation|0|||
23682809|NCT04436276|66217423|FG015|Overall Study|Protocol Violation|1|||
23682810|NCT04436276|66217424|FG016|Overall Study|Protocol Violation|0|||
23682811|NCT04436276|66217425|FG017|Overall Study|Protocol Violation|0|||
23682812|NCT04436276|66217426|FG018|Overall Study|Protocol Violation|0|||
23682813|NCT04436276|66217427|FG019|Overall Study|Protocol Violation|0|||
23682814|NCT04436276|66217428|FG020|Overall Study|Protocol Violation|0|||
23682815|NCT04436276|66217429|FG021|Overall Study|Protocol Violation|0|||
23682816|NCT04436276|66217430|FG022|Overall Study|Protocol Violation|0|||
23682817|NCT04436276|66217408|FG000|Overall Study|Withdrawal by Subject|25|||
23682818|NCT04436276|66217409|FG001|Overall Study|Withdrawal by Subject|22|||
23682819|NCT04436276|66217410|FG002|Overall Study|Withdrawal by Subject|24|||
23682820|NCT04436276|66217411|FG003|Overall Study|Withdrawal by Subject|23|||
23682821|NCT04436276|66217412|FG004|Overall Study|Withdrawal by Subject|14|||
23682822|NCT04436276|66217413|FG005|Overall Study|Withdrawal by Subject|0|||
23682823|NCT04436276|66217414|FG006|Overall Study|Withdrawal by Subject|0|||
23682824|NCT04436276|66217415|FG007|Overall Study|Withdrawal by Subject|1|||
23682825|NCT04436276|66217416|FG008|Overall Study|Withdrawal by Subject|0|||
23682826|NCT04436276|66217417|FG009|Overall Study|Withdrawal by Subject|1|||
23682827|NCT04436276|66217418|FG010|Overall Study|Withdrawal by Subject|17|||
23682828|NCT04436276|66217419|FG011|Overall Study|Withdrawal by Subject|7|||
23682829|NCT04436276|66217420|FG012|Overall Study|Withdrawal by Subject|10|||
23682830|NCT04436276|66217421|FG013|Overall Study|Withdrawal by Subject|6|||
23682831|NCT04436276|66217422|FG014|Overall Study|Withdrawal by Subject|20|||
23682832|NCT04436276|66217423|FG015|Overall Study|Withdrawal by Subject|6|||
23682833|NCT04436276|66217424|FG016|Overall Study|Withdrawal by Subject|11|||
23682834|NCT04436276|66217425|FG017|Overall Study|Withdrawal by Subject|4|||
23682835|NCT04436276|66217426|FG018|Overall Study|Withdrawal by Subject|14|||
23682836|NCT04436276|66217427|FG019|Overall Study|Withdrawal by Subject|24|||
23682837|NCT04436276|66217428|FG020|Overall Study|Withdrawal by Subject|24|||
23682838|NCT04436276|66217429|FG021|Overall Study|Withdrawal by Subject|16|||
23682839|NCT04436276|66217430|FG022|Overall Study|Withdrawal by Subject|14|||
23682840|NCT04436276|66217408|FG000|Overall Study|Other|3|||
23682841|NCT04436276|66217409|FG001|Overall Study|Other|2|||
23682842|NCT04436276|66217410|FG002|Overall Study|Other|5|||
23682843|NCT04436276|66217411|FG003|Overall Study|Other|9|||
23682844|NCT04436276|66217412|FG004|Overall Study|Other|23|||
23682845|NCT04436276|66217413|FG005|Overall Study|Other|1|||
23682846|NCT04436276|66217414|FG006|Overall Study|Other|0|||
23682847|NCT04436276|66217415|FG007|Overall Study|Other|0|||
23682848|NCT04436276|66217416|FG008|Overall Study|Other|0|||
23682849|NCT04436276|66217417|FG009|Overall Study|Other|0|||
23682850|NCT04436276|66217418|FG010|Overall Study|Other|3|||
23682851|NCT04436276|66217419|FG011|Overall Study|Other|1|||
23682852|NCT04436276|66217420|FG012|Overall Study|Other|1|||
23682853|NCT04436276|66217421|FG013|Overall Study|Other|2|||
23682854|NCT04436276|66217422|FG014|Overall Study|Other|3|||
23682855|NCT04436276|66217423|FG015|Overall Study|Other|0|||
23682856|NCT04436276|66217424|FG016|Overall Study|Other|0|||
23682857|NCT04436276|66217425|FG017|Overall Study|Other|6|||
23682858|NCT04436276|66217426|FG018|Overall Study|Other|1|||
23682859|NCT04436276|66217427|FG019|Overall Study|Other|0|||
23390815|NCT00663260|65175383|FG002|Overall Study|Lost to Follow-up|0|||
23390816|NCT00663260|65175381|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
23682860|NCT04436276|66217428|FG020|Overall Study|Other|2|||
23682861|NCT04436276|66217429|FG021|Overall Study|Other|2|||
23682862|NCT04436276|66217430|FG022|Overall Study|Other|60|||
23682863|NCT00927563|66217436|FG000|Overall Study|Lost to Follow-up|1|||
23390817|NCT00663260|65175382|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
23682864|NCT00927563|66217436|FG000|Overall Study|Withdrawal by Subject|1|||
23682865|NCT00059202|66217439|FG000|Overall Study|Withdrawal by Subject|5|||
23682866|NCT00059202|66217440|FG001|Overall Study|Withdrawal by Subject|9|||
23682867|NCT00059202|66217439|FG000|Overall Study|Protocol Violation|1|||
23682868|NCT00059202|66217440|FG001|Overall Study|Protocol Violation|3|||
23682869|NCT00059202|66217439|FG000|Overall Study|drug toxicity|0|||
23682870|NCT00059202|66217440|FG001|Overall Study|drug toxicity|3|||
23682871|NCT03049449|66217441|FG000|Overall Study|Did not receive treatment.|0|||
23682872|NCT03049449|66217442|FG001|Overall Study|Did not receive treatment.|0|||
23682873|NCT03049449|66217443|FG002|Overall Study|Did not receive treatment.|0|||
23682874|NCT03049449|66217444|FG003|Overall Study|Did not receive treatment.|0|||
23682875|NCT03049449|66217445|FG004|Overall Study|Did not receive treatment.|0|||
23682876|NCT03049449|66217446|FG005|Overall Study|Did not receive treatment.|0|||
23682877|NCT03049449|66217447|FG006|Overall Study|Did not receive treatment.|0|||
23682878|NCT03049449|66217448|FG007|Overall Study|Did not receive treatment.|0|||
23682879|NCT03049449|66217449|FG008|Overall Study|Did not receive treatment.|1|||
23682880|NCT03049449|66217450|FG009|Overall Study|Did not receive treatment.|0|||
23682881|NCT03049449|66217441|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
23682882|NCT03049449|66217442|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
23682883|NCT03049449|66217443|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
23682884|NCT03049449|66217444|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
23682885|NCT03049449|66217445|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
23682886|NCT03049449|66217446|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
23682887|NCT03049449|66217447|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
23682888|NCT03049449|66217448|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
23682889|NCT03049449|66217449|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
23682890|NCT03049449|66217450|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
23682891|NCT03049449|66217441|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682892|NCT03049449|66217442|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682893|NCT03049449|66217443|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682894|NCT03049449|66217444|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682895|NCT03049449|66217445|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682896|NCT03049449|66217446|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682897|NCT03049449|66217447|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682898|NCT03049449|66217448|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
23682899|NCT03049449|66217449|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23682900|NCT03049449|66217450|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
23682901|NCT02471716|66217453|FG000|Overall Study|Withdrawal by Subject|0|||
23682902|NCT02471716|66217454|FG001|Overall Study|Withdrawal by Subject|1|||
23682903|NCT02471716|66217455|FG002|Overall Study|Withdrawal by Subject|0|||
23682904|NCT02471716|66217456|FG003|Overall Study|Withdrawal by Subject|2|||
23682905|NCT02471716|66217457|FG004|Overall Study|Withdrawal by Subject|5|||
23682906|NCT02471716|66217453|FG000|Overall Study|Study Terminiated by sponsor|0|||
23682907|NCT02471716|66217454|FG001|Overall Study|Study Terminiated by sponsor|0|||
23682908|NCT02471716|66217455|FG002|Overall Study|Study Terminiated by sponsor|0|||
23682909|NCT02471716|66217456|FG003|Overall Study|Study Terminiated by sponsor|1|||
23682910|NCT02471716|66217457|FG004|Overall Study|Study Terminiated by sponsor|0|||
23682911|NCT02471716|66217453|FG000|Overall Study|Lost to Follow-up|0|||
23682912|NCT02471716|66217454|FG001|Overall Study|Lost to Follow-up|0|||
23682913|NCT02471716|66217455|FG002|Overall Study|Lost to Follow-up|0|||
23682914|NCT02471716|66217456|FG003|Overall Study|Lost to Follow-up|3|||
23682915|NCT02471716|66217457|FG004|Overall Study|Lost to Follow-up|2|||
23682916|NCT02471716|66217453|FG000|Overall Study|Death|0|||
23682917|NCT02471716|66217454|FG001|Overall Study|Death|0|||
23682918|NCT02471716|66217455|FG002|Overall Study|Death|0|||
23682919|NCT02471716|66217456|FG003|Overall Study|Death|1|||
23682920|NCT02471716|66217457|FG004|Overall Study|Death|0|||
23682921|NCT02471716|66217453|FG000|Overall Study|Other|0|||
23682922|NCT02471716|66217454|FG001|Overall Study|Other|0|||
23682923|NCT02471716|66217455|FG002|Overall Study|Other|0|||
23682924|NCT02471716|66217456|FG003|Overall Study|Other|8|||
23682925|NCT02471716|66217457|FG004|Overall Study|Other|9|||
23682926|NCT02090855|66217463|FG000|Overall Study|no evaluable Standard of Truth results|2|||
23682927|NCT01225562|66217464|FG000|Overall Study|Withdrawal by Subject|52|||
23682928|NCT01225562|66217465|FG001|Overall Study|Withdrawal by Subject|50|||
23682929|NCT01225562|66217466|FG002|Overall Study|Withdrawal by Subject|52|||
23682930|NCT01225562|66217464|FG000|Overall Study|Lost to Follow-up|3|||
23682931|NCT01225562|66217465|FG001|Overall Study|Lost to Follow-up|6|||
23682932|NCT01225562|66217466|FG002|Overall Study|Lost to Follow-up|1|||
23682933|NCT03474679|66217469|FG000|Overall Study|Death|7|||
23682934|NCT03474679|66217469|FG000|Overall Study|Withdrawal by Subject|1|||
23390818|NCT00663260|65175383|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
23682935|NCT02605642|66217473|FG000|Overall Study|Other|11|||
23682936|NCT02605642|66217474|FG001|Overall Study|Other|1|||
23682937|NCT02605642|66217473|FG000|Overall Study|Participant non-compliance|2|||
23682938|NCT02605642|66217474|FG001|Overall Study|Participant non-compliance|4|||
23682939|NCT02605642|66217473|FG000|Overall Study|Physician Decision|10|||
23682940|NCT02605642|66217474|FG001|Overall Study|Physician Decision|0|||
23682941|NCT02605642|66217473|FG000|Overall Study|Lost to Follow-up|12|||
23682942|NCT02605642|66217474|FG001|Overall Study|Lost to Follow-up|1|||
23682943|NCT02605642|66217473|FG000|Overall Study|Adverse Event|14|||
23682944|NCT02605642|66217474|FG001|Overall Study|Adverse Event|2|||
23682945|NCT02605642|66217473|FG000|Overall Study|Withdrawal by Subject|23|||
23682946|NCT02605642|66217474|FG001|Overall Study|Withdrawal by Subject|2|||
23682947|NCT02605642|66217473|FG000|Overall Study|Lack of response|24|||
23682948|NCT02605642|66217474|FG001|Overall Study|Lack of response|11|||
23682949|NCT03569202|66217481|FG000|Part 3|Physician Decision|1|||
23682950|NCT03569202|66217482|FG001|Part 3|Physician Decision|0|||
23682951|NCT03569202|66217481|FG000|Part 3|Other|1|||
23682952|NCT03569202|66217482|FG001|Part 3|Other|1|||
23682953|NCT01461044|66217484|FG000|Overall Study|Death|58|||
23682954|NCT01461044|66217485|FG001|Overall Study|Death|35|||
23682955|NCT01461044|66217484|FG000|Overall Study|Lost to Follow-up|12|||
23682956|NCT01461044|66217485|FG001|Overall Study|Lost to Follow-up|5|||
23682957|NCT02771522|66217488|FG000|Overall Study|Lost to Follow-up|3|||
23682958|NCT02771522|66217488|FG000|Overall Study|Withdrawal by Subject|2|||
23682959|NCT02771522|66217488|FG000|Overall Study|No white spot lesions|3|||
23682960|NCT03269344|66217489|FG000|Overall Study|Protocol Violation|4|||
23682961|NCT03269344|66217490|FG001|Overall Study|Protocol Violation|3|||
23682962|NCT01900002|66217491|FG000|Overall Study|Withdrawal by Subject|2|||
23682963|NCT01900002|66217491|FG000|Overall Study|ineligible for Y-90|4|||
23682964|NCT03969875|66217492|FG000|Overall Study|did not receive allocated intervention|3|||
23682965|NCT03969875|66217493|FG001|Overall Study|did not receive allocated intervention|3|||
23682966|NCT03969875|66217494|FG002|Overall Study|did not receive allocated intervention|4|||
23682967|NCT03969875|66217492|FG000|Overall Study|Protocol Violation|4|||
23682968|NCT03969875|66217493|FG001|Overall Study|Protocol Violation|2|||
23682969|NCT03969875|66217494|FG002|Overall Study|Protocol Violation|2|||
23682970|NCT02597855|66217502|FG000|Overall Study|Lost to Follow-up|2|||
23682971|NCT02597855|66217503|FG001|Overall Study|Lost to Follow-up|1|||
23682972|NCT00667576|66217504|FG000|Overall Study|Withdrawal by Subject|1|||
23682973|NCT00667576|66217505|FG001|Overall Study|Withdrawal by Subject|0|||
23682974|NCT00667576|66217506|FG002|Overall Study|Withdrawal by Subject|1|||
23682975|NCT00667576|66217507|FG003|Overall Study|Withdrawal by Subject|1|||
23682976|NCT00667576|66217508|FG004|Overall Study|Withdrawal by Subject|1|||
23682977|NCT00667576|66217504|FG000|Overall Study|Adverse Event|1|||
23682978|NCT00667576|66217505|FG001|Overall Study|Adverse Event|1|||
23682979|NCT00667576|66217506|FG002|Overall Study|Adverse Event|0|||
23682980|NCT00667576|66217507|FG003|Overall Study|Adverse Event|0|||
23682981|NCT00667576|66217508|FG004|Overall Study|Adverse Event|0|||
23682982|NCT00667576|66217504|FG000|Overall Study|Lost to Follow-up|0|||
23682983|NCT00667576|66217505|FG001|Overall Study|Lost to Follow-up|0|||
23682984|NCT00667576|66217506|FG002|Overall Study|Lost to Follow-up|1|||
23682985|NCT00667576|66217507|FG003|Overall Study|Lost to Follow-up|0|||
23682986|NCT00667576|66217508|FG004|Overall Study|Lost to Follow-up|0|||
23682987|NCT00667576|66217504|FG000|Overall Study|Protocol Violation|0|||
23682988|NCT00667576|66217505|FG001|Overall Study|Protocol Violation|0|||
23682989|NCT00667576|66217506|FG002|Overall Study|Protocol Violation|0|||
23390819|NCT02951819|65175384|FG000|Overall Study|Death|9|||
23390820|NCT02951819|65175385|FG001|Overall Study|Death|7|||
23390821|NCT02951819|65175384|FG000|Overall Study|Withdrawal by Subject|3|||
23390822|NCT02951819|65175385|FG001|Overall Study|Withdrawal by Subject|0|||
23390823|NCT02951819|65175384|FG000|Overall Study|Adverse Event|1|||
23390824|NCT02951819|65175385|FG001|Overall Study|Adverse Event|0|||
23390825|NCT02951819|65175384|FG000|Overall Study|Lack of Efficacy|4|||
23390826|NCT02951819|65175385|FG001|Overall Study|Lack of Efficacy|0|||
23390827|NCT02951819|65175384|FG000|Overall Study|Lost to Follow-up|1|||
23682990|NCT00667576|66217507|FG003|Overall Study|Protocol Violation|1|||
23682991|NCT00667576|66217508|FG004|Overall Study|Protocol Violation|0|||
23682992|NCT00667576|66217504|FG000|Overall Study|Physician Decision|0|||
23682993|NCT00667576|66217505|FG001|Overall Study|Physician Decision|0|||
23682994|NCT00667576|66217506|FG002|Overall Study|Physician Decision|0|||
23682995|NCT00667576|66217507|FG003|Overall Study|Physician Decision|1|||
23682996|NCT00667576|66217508|FG004|Overall Study|Physician Decision|0|||
23682997|NCT00667576|66217504|FG000|Overall Study|Missed Visit|0|||
23682998|NCT00667576|66217505|FG001|Overall Study|Missed Visit|0|||
23682999|NCT00667576|66217506|FG002|Overall Study|Missed Visit|0|||
23390828|NCT02951819|65175385|FG001|Overall Study|Lost to Follow-up|0|||
23390829|NCT02951819|65175384|FG000|Overall Study|Progressive Disease|1|||
23390830|NCT02951819|65175385|FG001|Overall Study|Progressive Disease|0|||
23683000|NCT00667576|66217507|FG003|Overall Study|Missed Visit|1|||
23683001|NCT00667576|66217508|FG004|Overall Study|Missed Visit|0|||
23683002|NCT01468311|66217512|FG000|Overall Study|mobilization failure|1|||
23683003|NCT01468311|66217512|FG000|Overall Study|Withdrawal by Subject|1|||
23683004|NCT02546986|66217513|FG000|Treatment Period|Progressive Disease|20|||
23683005|NCT02546986|66217514|FG001|Treatment Period|Progressive Disease|22|||
23683006|NCT02546986|66217513|FG000|Treatment Period|Adverse Event|14|||
23683007|NCT02546986|66217514|FG001|Treatment Period|Adverse Event|6|||
23683008|NCT02546986|66217513|FG000|Treatment Period|Symptomatic Deterioration|4|||
23683009|NCT02546986|66217514|FG001|Treatment Period|Symptomatic Deterioration|3|||
23683010|NCT02546986|66217513|FG000|Treatment Period|Death|3|||
23683011|NCT02546986|66217514|FG001|Treatment Period|Death|4|||
23683012|NCT02546986|66217513|FG000|Treatment Period|Physician Decision|1|||
23683013|NCT02546986|66217514|FG001|Treatment Period|Physician Decision|2|||
23683014|NCT02546986|66217513|FG000|Treatment Period|Protocol Violation|1|||
23683015|NCT02546986|66217514|FG001|Treatment Period|Protocol Violation|0|||
23683016|NCT02546986|66217513|FG000|Treatment Period|Withdrawal by Subject|1|||
23683017|NCT02546986|66217514|FG001|Treatment Period|Withdrawal by Subject|1|||
23683018|NCT02546986|66217513|FG000|Treatment Period|Non-compliance with Study Drug|0|||
23683019|NCT02546986|66217514|FG001|Treatment Period|Non-compliance with Study Drug|1|||
23683020|NCT02546986|66217513|FG000|Treatment Period|Study Terminated by Sponsor|0|||
23683021|NCT02546986|66217514|FG001|Treatment Period|Study Terminated by Sponsor|1|||
23683022|NCT02546986|66217513|FG000|Treatment Period|Miscellaneous|7|||
23683023|NCT02546986|66217514|FG001|Treatment Period|Miscellaneous|9|||
23683024|NCT02546986|66217513|FG000|Survival Follow-Up Phase|Missing Status|3|||
23683025|NCT02546986|66217514|FG001|Survival Follow-Up Phase|Missing Status|5|||
23683026|NCT02546986|66217513|FG000|Survival Follow-Up Phase|Death|18|||
23683027|NCT02546986|66217514|FG001|Survival Follow-Up Phase|Death|12|||
23390831|NCT02951819|65175384|FG000|Overall Study|Other|9|||
23390832|NCT02951819|65175385|FG001|Overall Study|Other|0|||
23390833|NCT01714063|65175386|FG000|Overall Study|Equipment malfunction|2|||
23390834|NCT00500331|65175387|FG000|Overall Study|Adverse Event|0|||
23390835|NCT00500331|65175388|FG001|Overall Study|Adverse Event|2|||
23390836|NCT00500331|65175389|FG002|Overall Study|Adverse Event|0|||
23390837|NCT00500331|65175390|FG003|Overall Study|Adverse Event|1|||
23390838|NCT00500331|65175391|FG004|Overall Study|Adverse Event|2|||
23390839|NCT00500331|65175392|FG005|Overall Study|Adverse Event|2|||
23390840|NCT00500331|65175393|FG006|Overall Study|Adverse Event|0|||
23390841|NCT00500331|65175387|FG000|Overall Study|Lost to Follow-up|1|||
23390842|NCT00500331|65175388|FG001|Overall Study|Lost to Follow-up|1|||
23390843|NCT00500331|65175389|FG002|Overall Study|Lost to Follow-up|1|||
23390844|NCT00500331|65175390|FG003|Overall Study|Lost to Follow-up|2|||
23390845|NCT00500331|65175391|FG004|Overall Study|Lost to Follow-up|1|||
23390846|NCT00500331|65175392|FG005|Overall Study|Lost to Follow-up|0|||
23390847|NCT00500331|65175393|FG006|Overall Study|Lost to Follow-up|0|||
23390848|NCT00500331|65175387|FG000|Overall Study|Protocol Violation|3|||
23390849|NCT00500331|65175388|FG001|Overall Study|Protocol Violation|1|||
23390850|NCT00500331|65175389|FG002|Overall Study|Protocol Violation|1|||
23390851|NCT00500331|65175390|FG003|Overall Study|Protocol Violation|0|||
23390852|NCT00500331|65175391|FG004|Overall Study|Protocol Violation|1|||
23390853|NCT00500331|65175392|FG005|Overall Study|Protocol Violation|1|||
23390854|NCT00500331|65175393|FG006|Overall Study|Protocol Violation|1|||
23390855|NCT00500331|65175387|FG000|Overall Study|Withdrawal by Subject|4|||
23390856|NCT00500331|65175388|FG001|Overall Study|Withdrawal by Subject|0|||
23390857|NCT00500331|65175389|FG002|Overall Study|Withdrawal by Subject|1|||
23390858|NCT00500331|65175390|FG003|Overall Study|Withdrawal by Subject|5|||
23390859|NCT00500331|65175391|FG004|Overall Study|Withdrawal by Subject|0|||
23390860|NCT00500331|65175392|FG005|Overall Study|Withdrawal by Subject|1|||
23390861|NCT00500331|65175393|FG006|Overall Study|Withdrawal by Subject|1|||
23390862|NCT00500331|65175387|FG000|Overall Study|Lack of Efficacy|3|||
23390863|NCT00500331|65175388|FG001|Overall Study|Lack of Efficacy|1|||
23390864|NCT00500331|65175389|FG002|Overall Study|Lack of Efficacy|0|||
23390865|NCT00500331|65175390|FG003|Overall Study|Lack of Efficacy|0|||
23390866|NCT00500331|65175391|FG004|Overall Study|Lack of Efficacy|0|||
23683028|NCT02546986|66217513|FG000|Survival Follow-Up Phase|Alive|13|||
23683029|NCT02546986|66217514|FG001|Survival Follow-Up Phase|Alive|16|||
23683030|NCT02546986|66217513|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
23683031|NCT02546986|66217514|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
23683032|NCT03468309|66217517|FG000|Overall Study|Lost to Follow-up|4|||
23683033|NCT03468309|66217517|FG000|Overall Study|Withdrawal by Subject|2|||
23683034|NCT01622569|66217522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
23683035|NCT01622569|66217523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
23683036|NCT01622569|66217524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
23683037|NCT01622569|66217525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23390867|NCT00500331|65175392|FG005|Overall Study|Lack of Efficacy|0|||
23390868|NCT00500331|65175393|FG006|Overall Study|Lack of Efficacy|0|||
23390869|NCT00500331|65175387|FG000|Overall Study|Liver function test abnormality|0|||
23390870|NCT00500331|65175388|FG001|Overall Study|Liver function test abnormality|0|||
23390871|NCT00500331|65175389|FG002|Overall Study|Liver function test abnormality|1|||
23683038|NCT01622569|66217522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23683039|NCT01622569|66217523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23683040|NCT01622569|66217524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
23683041|NCT01622569|66217525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23683042|NCT01622569|66217522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
23683043|NCT01622569|66217523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23683044|NCT01622569|66217524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
23683045|NCT01622569|66217525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
23683046|NCT01622569|66217522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23683047|NCT01622569|66217523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
23683048|NCT01622569|66217524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23683049|NCT01622569|66217525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
23683050|NCT01622569|66217522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23683051|NCT01622569|66217523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23683052|NCT01622569|66217524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23683053|NCT01622569|66217525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23683054|NCT01622569|66217522|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23683055|NCT01622569|66217523|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
23683056|NCT01622569|66217524|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23683057|NCT01622569|66217525|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23683058|NCT01622569|66217522|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23683059|NCT01622569|66217523|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23683060|NCT01622569|66217524|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
23683061|NCT01622569|66217525|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23683062|NCT01622569|66217522|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23683063|NCT01622569|66217523|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23683064|NCT01622569|66217524|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23683065|NCT01622569|66217525|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
23683066|NCT00110019|66217526|FG000|Overall Study|Lack of Efficacy|253|||
23683067|NCT00110019|66217527|FG001|Overall Study|Lack of Efficacy|285|||
23683068|NCT00110019|66217526|FG000|Overall Study|Adverse Event|61|||
23683069|NCT00110019|66217527|FG001|Overall Study|Adverse Event|40|||
23683070|NCT00110019|66217526|FG000|Overall Study|Death|13|||
23683071|NCT00110019|66217527|FG001|Overall Study|Death|15|||
23683072|NCT00110019|66217526|FG000|Overall Study|Withdrawal by Subject|21|||
23683073|NCT00110019|66217527|FG001|Overall Study|Withdrawal by Subject|9|||
23683074|NCT00110019|66217526|FG000|Overall Study|alternative therapy|5|||
23683075|NCT00110019|66217527|FG001|Overall Study|alternative therapy|1|||
23683076|NCT00110019|66217526|FG000|Overall Study|complicating disease|1|||
23683077|NCT00110019|66217527|FG001|Overall Study|complicating disease|1|||
23683078|NCT00110019|66217526|FG000|Overall Study|symptom deterioration|13|||
23683079|NCT00110019|66217527|FG001|Overall Study|symptom deterioration|16|||
23683080|NCT00110019|66217526|FG000|Overall Study|Not start protocol therapy|17|||
23683081|NCT00110019|66217527|FG001|Overall Study|Not start protocol therapy|16|||
23683082|NCT00110019|66217526|FG000|Overall Study|other reasons|22|||
23683083|NCT00110019|66217527|FG001|Overall Study|other reasons|30|||
23683084|NCT02152345|66217530|FG000|Overall Study|Case Cancellations|2|||
23683085|NCT02152345|66217531|FG001|Overall Study|Case Cancellations|4|||
23683086|NCT02152345|66217530|FG000|Overall Study|Withdrawal by Subject|2|||
23683087|NCT02152345|66217531|FG001|Overall Study|Withdrawal by Subject|1|||
23495273|NCT00913380|65555117|FG001|Clinical Outcomes|Lost to Follow-up|6|||
23495274|NCT01145625|65558751|FG000|Overall Study|Lost to Follow-up|8|||
23495275|NCT01145625|65558752|FG001|Overall Study|Lost to Follow-up|9|||
23495276|NCT01145625|65558751|FG000|Overall Study|Adverse Event|6|||
23495277|NCT01145625|65558752|FG001|Overall Study|Adverse Event|4|||
23683088|NCT03370770|66217532|FG000|Overall Study|Patient was followed in another hospital center|1|||
23683089|NCT03370770|66217532|FG000|Overall Study|Progressive Disease|98|||
23683090|NCT03370770|66217532|FG000|Overall Study|Adverse Event|2|||
23683091|NCT03370770|66217532|FG000|Overall Study|Death|5|||
23683092|NCT01570244|66217534|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
23683093|NCT00559273|66217537|FG000|Correction Period (20 Weeks)|Death|3|||
23683094|NCT00559273|66217538|FG001|Correction Period (20 Weeks)|Death|4|||
23683095|NCT00559273|66217537|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
23683096|NCT00559273|66217538|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
23683097|NCT00559273|66217537|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
23683098|NCT00559273|66217538|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
23683099|NCT00559273|66217537|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
23683100|NCT00559273|66217538|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
23683101|NCT00559273|66217537|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
23683102|NCT00559273|66217538|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
23683103|NCT00559273|66217537|FG000|Evaluation Period (8 Weeks)|Death|1|||
23683104|NCT00559273|66217538|FG001|Evaluation Period (8 Weeks)|Death|3|||
23683105|NCT00559273|66217537|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
23683106|NCT00559273|66217538|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
23683107|NCT00559273|66217537|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
23683108|NCT00559273|66217538|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
23683109|NCT00559273|66217537|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
23683110|NCT00559273|66217538|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
23683111|NCT02159807|66217539|FG000|Overall Study|Adverse Event|0|||
23683112|NCT02159807|66217540|FG001|Overall Study|Adverse Event|0|||
23683113|NCT02159807|66217541|FG002|Overall Study|Adverse Event|1|||
23683114|NCT02159807|66217539|FG000|Overall Study|No CSF|1|||
23683115|NCT02159807|66217540|FG001|Overall Study|No CSF|1|||
23683116|NCT02159807|66217541|FG002|Overall Study|No CSF|1|||
23683117|NCT02159807|66217539|FG000|Overall Study|elevated blood pressure|0|||
23683118|NCT02159807|66217540|FG001|Overall Study|elevated blood pressure|0|||
23683119|NCT02159807|66217541|FG002|Overall Study|elevated blood pressure|1|||
23683120|NCT04187092|66217542|FG000|Overall Study|Lost to Follow-up|1|||
23683121|NCT04187092|66217543|FG001|Overall Study|Lost to Follow-up|1|||
23683122|NCT04187092|66217542|FG000|Overall Study|Withdrawal by Subject|1|||
23683123|NCT04187092|66217543|FG001|Overall Study|Withdrawal by Subject|1|||
23683124|NCT04187092|66217542|FG000|Overall Study|Adverse Event|0|||
23683125|NCT04187092|66217543|FG001|Overall Study|Adverse Event|1|||
23683126|NCT00122135|66217544|FG000|Overall Study|Withdrawal by Subject|3|||
23683127|NCT00122135|66217545|FG001|Overall Study|Withdrawal by Subject|0|||
23683128|NCT02554929|66217546|FG000|Overall Study|Lost to Follow-up|4|||
23683129|NCT02554929|66217547|FG001|Overall Study|Lost to Follow-up|4|||
23683130|NCT02554929|66217546|FG000|Overall Study|Withdrawal by Subject|2|||
23683131|NCT02554929|66217547|FG001|Overall Study|Withdrawal by Subject|8|||
23683132|NCT01354028|66217549|FG000|Overall Study|Physician Decision|0|||
23683133|NCT01354028|66217550|FG001|Overall Study|Physician Decision|2|||
23683134|NCT01354028|66217549|FG000|Overall Study|Discharged before study start|2|||
23683135|NCT01354028|66217550|FG001|Overall Study|Discharged before study start|2|||
23683136|NCT01354028|66217549|FG000|Overall Study|No quiet alert state|0|||
23683137|NCT01354028|66217550|FG001|Overall Study|No quiet alert state|1|||
23683138|NCT03038308|66217551|FG000|Overall Study|Surgical resection|1|||
23683139|NCT03038308|66217551|FG000|Overall Study|Withdrawal by Subject|2|||
23683140|NCT03038308|66217551|FG000|Overall Study|Lost to Follow-up|1|||
23683141|NCT00584233|66217552|FG000|Overall Study|Withdrawal by Subject|5|||
23495278|NCT01145625|65558751|FG000|Overall Study|Protocol Violation|3|||
23495279|NCT01145625|65558752|FG001|Overall Study|Protocol Violation|1|||
23495280|NCT01145625|65558751|FG000|Overall Study|Withdrawal by Subject|7|||
23495281|NCT01145625|65558752|FG001|Overall Study|Withdrawal by Subject|16|||
23495282|NCT01145625|65558751|FG000|Overall Study|Pregnancy|0|||
23495283|NCT01145625|65558752|FG001|Overall Study|Pregnancy|1|||
23495284|NCT04696055|65558753|FG000|Overall Study|Adverse Event|10|||
23495285|NCT04696055|65558754|FG001|Overall Study|Adverse Event|0|||
23495286|NCT04696055|65558753|FG000|Overall Study|Death|2|||
23495287|NCT04696055|65558754|FG001|Overall Study|Death|1|||
23495288|NCT04696055|65558753|FG000|Overall Study|Other|4|||
23495289|NCT04696055|65558754|FG001|Overall Study|Other|0|||
23495290|NCT04696055|65558753|FG000|Overall Study|Physician Decision|1|||
23495291|NCT04696055|65558754|FG001|Overall Study|Physician Decision|0|||
23495292|NCT04696055|65558753|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
23495293|NCT04696055|65558754|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
23683142|NCT00584233|66217552|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
23683143|NCT00655928|66217557|FG000|Overall Study|Withdrawal by Subject|2|||
23683144|NCT00655928|66217558|FG001|Overall Study|Withdrawal by Subject|1|||
23683145|NCT00655928|66217557|FG000|Overall Study|Physician Decision|1|||
23683146|NCT00655928|66217558|FG001|Overall Study|Physician Decision|1|||
23390872|NCT00500331|65175390|FG003|Overall Study|Liver function test abnormality|0|||
23390873|NCT00500331|65175391|FG004|Overall Study|Liver function test abnormality|0|||
23390874|NCT00500331|65175392|FG005|Overall Study|Liver function test abnormality|0|||
23390875|NCT00500331|65175393|FG006|Overall Study|Liver function test abnormality|0|||
23390876|NCT00500331|65175387|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
23390877|NCT00500331|65175388|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
23390878|NCT00500331|65175389|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
23390879|NCT00500331|65175390|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
23390880|NCT00500331|65175391|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
23390881|NCT00500331|65175392|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
23390882|NCT00500331|65175393|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
23390883|NCT00500331|65175387|FG000|Overall Study|Didn't return for continuation of study|1|||
23390884|NCT00500331|65175388|FG001|Overall Study|Didn't return for continuation of study|0|||
23390885|NCT00500331|65175389|FG002|Overall Study|Didn't return for continuation of study|0|||
23390886|NCT00500331|65175390|FG003|Overall Study|Didn't return for continuation of study|0|||
23390887|NCT00500331|65175391|FG004|Overall Study|Didn't return for continuation of study|0|||
23390888|NCT00500331|65175392|FG005|Overall Study|Didn't return for continuation of study|0|||
23390889|NCT00500331|65175393|FG006|Overall Study|Didn't return for continuation of study|0|||
23390890|NCT00500331|65175387|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
23390891|NCT00500331|65175388|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390892|NCT00500331|65175389|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390893|NCT00500331|65175390|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390894|NCT00500331|65175391|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390895|NCT00500331|65175392|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390896|NCT00500331|65175393|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390897|NCT00500331|65175387|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
23390898|NCT00500331|65175388|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
23390899|NCT00500331|65175389|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
23390900|NCT00500331|65175390|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
23390901|NCT00500331|65175391|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
23390902|NCT00500331|65175392|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
23390903|NCT00500331|65175393|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
23390904|NCT00500331|65175387|FG000|Overall Study|Participant was randomized by mistake|1|||
23390905|NCT00500331|65175388|FG001|Overall Study|Participant was randomized by mistake|0|||
23390906|NCT00500331|65175389|FG002|Overall Study|Participant was randomized by mistake|0|||
23390907|NCT00500331|65175390|FG003|Overall Study|Participant was randomized by mistake|0|||
23390908|NCT00500331|65175391|FG004|Overall Study|Participant was randomized by mistake|0|||
23390909|NCT00500331|65175392|FG005|Overall Study|Participant was randomized by mistake|0|||
23390910|NCT00500331|65175393|FG006|Overall Study|Participant was randomized by mistake|0|||
23390911|NCT00500331|65175387|FG000|Overall Study|Diabetologist nurse in the study|0|||
23390912|NCT00500331|65175388|FG001|Overall Study|Diabetologist nurse in the study|0|||
23390913|NCT00500331|65175389|FG002|Overall Study|Diabetologist nurse in the study|1|||
23390914|NCT00500331|65175390|FG003|Overall Study|Diabetologist nurse in the study|0|||
23495294|NCT04696055|65558753|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
23495295|NCT04696055|65558754|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
23495296|NCT04696055|65558753|FG000|Overall Study|Subject Decision|1|||
23495297|NCT04696055|65558754|FG001|Overall Study|Subject Decision|2|||
23683147|NCT03208231|66217562|FG000|Overall Study|Death|1|||
23683148|NCT03208231|66217563|FG001|Overall Study|Death|2|||
23390915|NCT00500331|65175391|FG004|Overall Study|Diabetologist nurse in the study|0|||
23390916|NCT00500331|65175392|FG005|Overall Study|Diabetologist nurse in the study|0|||
23390917|NCT00500331|65175393|FG006|Overall Study|Diabetologist nurse in the study|0|||
23390918|NCT00500331|65175387|FG000|Overall Study|State ban of biological samples export|0|||
23390919|NCT00500331|65175388|FG001|Overall Study|State ban of biological samples export|0|||
23390920|NCT00500331|65175389|FG002|Overall Study|State ban of biological samples export|0|||
23390921|NCT00500331|65175390|FG003|Overall Study|State ban of biological samples export|1|||
23390922|NCT00500331|65175391|FG004|Overall Study|State ban of biological samples export|0|||
23390923|NCT00500331|65175392|FG005|Overall Study|State ban of biological samples export|0|||
23390924|NCT00500331|65175393|FG006|Overall Study|State ban of biological samples export|0|||
23390925|NCT00500331|65175387|FG000|Overall Study|Protocol violated|0|||
23390926|NCT00500331|65175388|FG001|Overall Study|Protocol violated|0|||
23390927|NCT00500331|65175389|FG002|Overall Study|Protocol violated|0|||
23390928|NCT00500331|65175390|FG003|Overall Study|Protocol violated|1|||
23390929|NCT00500331|65175391|FG004|Overall Study|Protocol violated|0|||
23495298|NCT04696055|65558753|FG000|Overall Study|Ongoing with study treatment|13|||
23495299|NCT04696055|65558754|FG001|Overall Study|Ongoing with study treatment|10|||
23495300|NCT03198078|65558756|FG000|Overall Study|Adverse Event|0|||
23495301|NCT03198078|65558757|FG001|Overall Study|Adverse Event|1|||
23495302|NCT03198078|65558758|FG002|Overall Study|Adverse Event|2|||
23495303|NCT03198078|65558756|FG000|Overall Study|Lack of Efficacy|0|||
23495304|NCT03198078|65558757|FG001|Overall Study|Lack of Efficacy|0|||
23495305|NCT03198078|65558758|FG002|Overall Study|Lack of Efficacy|3|||
23495306|NCT03198078|65558756|FG000|Overall Study|Lost to Follow-up|1|||
23390930|NCT00500331|65175392|FG005|Overall Study|Protocol violated|0|||
23390931|NCT00500331|65175393|FG006|Overall Study|Protocol violated|0|||
23390932|NCT03436732|65175394|FG000|Overall Study|Not treated-enrolled in different study|1|||
23390933|NCT03436732|65175395|FG001|Overall Study|Not treated-enrolled in different study|0|||
23390934|NCT03436732|65175394|FG000|Overall Study|Off study after cycle 1|1|||
23390935|NCT03436732|65175395|FG001|Overall Study|Off study after cycle 1|0|||
23390936|NCT03436732|65175394|FG000|Overall Study|Adverse Event|2|||
23390937|NCT03436732|65175395|FG001|Overall Study|Adverse Event|0|||
23390938|NCT03436732|65175394|FG000|Overall Study|Death|0|||
23390939|NCT03436732|65175395|FG001|Overall Study|Death|1|||
23495307|NCT03198078|65558757|FG001|Overall Study|Lost to Follow-up|0|||
23495308|NCT03198078|65558758|FG002|Overall Study|Lost to Follow-up|0|||
23495309|NCT03198078|65558756|FG000|Overall Study|Pregnancy|0|||
23495310|NCT03198078|65558757|FG001|Overall Study|Pregnancy|1|||
23495311|NCT03198078|65558758|FG002|Overall Study|Pregnancy|0|||
23495312|NCT03198078|65558756|FG000|Overall Study|Withdrawal by Subject|1|||
23495313|NCT03198078|65558757|FG001|Overall Study|Withdrawal by Subject|0|||
23495314|NCT03198078|65558758|FG002|Overall Study|Withdrawal by Subject|2|||
23495315|NCT03198078|65558756|FG000|Overall Study|Withdrawal by Caregiver|1|||
23495316|NCT03198078|65558757|FG001|Overall Study|Withdrawal by Caregiver|3|||
23495317|NCT03198078|65558758|FG002|Overall Study|Withdrawal by Caregiver|5|||
23495318|NCT00400764|65558763|FG000|Phase Ib|Adverse Event|1|||
23495319|NCT00400764|65558764|FG001|Phase Ib|Adverse Event|0|||
23495320|NCT00400764|65558765|FG002|Phase Ib|Adverse Event|0|||
23495321|NCT00400764|65558766|FG003|Phase Ib|Adverse Event|0|||
23495322|NCT00400764|65558767|FG004|Phase Ib|Adverse Event|0|||
23495323|NCT00400764|65558763|FG000|Phase Ib|Death|1|||
23495324|NCT00400764|65558764|FG001|Phase Ib|Death|0|||
23495325|NCT00400764|65558765|FG002|Phase Ib|Death|0|||
23495326|NCT00400764|65558766|FG003|Phase Ib|Death|0|||
23495327|NCT00400764|65558767|FG004|Phase Ib|Death|0|||
23495328|NCT00400764|65558763|FG000|Phase Ib|Disease Progression|4|||
23495329|NCT00400764|65558764|FG001|Phase Ib|Disease Progression|4|||
23495330|NCT00400764|65558765|FG002|Phase Ib|Disease Progression|0|||
23495331|NCT00400764|65558766|FG003|Phase Ib|Disease Progression|0|||
23495332|NCT00400764|65558767|FG004|Phase Ib|Disease Progression|0|||
23495333|NCT00400764|65558763|FG000|Phase II|Death|0|||
23495334|NCT00400764|65558764|FG001|Phase II|Death|0|||
23495335|NCT00400764|65558765|FG002|Phase II|Death|1|||
23495336|NCT00400764|65558766|FG003|Phase II|Death|2|||
23495337|NCT00400764|65558767|FG004|Phase II|Death|0|||
23495338|NCT00400764|65558763|FG000|Phase II|Lost to Follow-up|0|||
23390940|NCT02698787|65175396|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
23390941|NCT02698787|65175397|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
23390942|NCT00814983|65175402|FG000|Overall Study|Screen failure|1|||
23390943|NCT00814983|65175403|FG001|Overall Study|Screen failure|0|||
23390944|NCT00814983|65175402|FG000|Overall Study|Withdrawal by Subject|1|||
23390945|NCT00814983|65175403|FG001|Overall Study|Withdrawal by Subject|0|||
23495339|NCT00400764|65558764|FG001|Phase II|Lost to Follow-up|0|||
23495340|NCT00400764|65558765|FG002|Phase II|Lost to Follow-up|1|||
23495341|NCT00400764|65558766|FG003|Phase II|Lost to Follow-up|0|||
23495342|NCT00400764|65558767|FG004|Phase II|Lost to Follow-up|0|||
23495343|NCT00400764|65558763|FG000|Phase II|Physician Decision|0|||
23495344|NCT00400764|65558764|FG001|Phase II|Physician Decision|0|||
23495345|NCT00400764|65558765|FG002|Phase II|Physician Decision|1|||
23390946|NCT00814983|65175402|FG000|Overall Study|Graft failure|1|||
23390947|NCT00814983|65175403|FG001|Overall Study|Graft failure|0|||
23390948|NCT01697501|65175407|FG000|Overall Study|Protocol Violation|2|||
23390949|NCT04629521|65175408|FG000|Overall Study|Death|1|||
23390950|NCT04629521|65175408|FG000|Overall Study|Lost to Follow-up|3|||
23390951|NCT04629521|65175408|FG000|Overall Study|Subject withdrew consent|3|||
23390952|NCT04629521|65175408|FG000|Overall Study|Enrolled in error|1|||
23390953|NCT02462057|65175409|FG000|Overall Study|Left Vitality|32|||
23390954|NCT02462057|65175410|FG001|Overall Study|Left Vitality|27|||
23390955|NCT02462057|65175411|FG002|Overall Study|Left Vitality|23|||
23390956|NCT02462057|65175412|FG003|Overall Study|Left Vitality|35|||
23390957|NCT02462057|65175413|FG004|Overall Study|Left Vitality|33|||
23390958|NCT02462057|65175409|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
23390959|NCT02462057|65175410|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
23390960|NCT02462057|65175411|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
23390961|NCT02462057|65175412|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
23390962|NCT02462057|65175413|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
23390963|NCT01681849|65175414|FG000|Overall Study|Protocol Violation|2|||
23390964|NCT01681849|65175415|FG001|Overall Study|Protocol Violation|0|||
23390965|NCT01681849|65175416|FG002|Overall Study|Protocol Violation|0|||
23390966|NCT01681849|65175414|FG000|Overall Study|Withdrawal by Subject|3|||
23390967|NCT01681849|65175415|FG001|Overall Study|Withdrawal by Subject|5|||
23390968|NCT01681849|65175416|FG002|Overall Study|Withdrawal by Subject|33|||
23390969|NCT01681849|65175414|FG000|Overall Study|Lost to Follow-up|3|||
23390970|NCT01681849|65175415|FG001|Overall Study|Lost to Follow-up|2|||
23390971|NCT01681849|65175416|FG002|Overall Study|Lost to Follow-up|6|||
23390972|NCT01491919|65175417|FG000|Overall Study|Insufficient PK sampling|1|||
23390973|NCT01491919|65175418|FG001|Overall Study|Insufficient PK sampling|2|||
23390974|NCT01491919|65175419|FG002|Overall Study|Insufficient PK sampling|1|||
23390975|NCT04535362|65175420|FG000|Overall Study|Lost to Follow-up|3|||
23390976|NCT04535362|65175421|FG001|Overall Study|Lost to Follow-up|1|||
23390977|NCT00680914|65175422|FG000|Overall Study|Consent withdrawal|6|||
23390978|NCT00680914|65175423|FG001|Overall Study|Consent withdrawal|3|||
23390979|NCT00680914|65175422|FG000|Overall Study|Lost to Follow-up|4|||
23390980|NCT00680914|65175423|FG001|Overall Study|Lost to Follow-up|0|||
23390981|NCT00680914|65175422|FG000|Overall Study|serious adverse event (SAE)|0|||
23390982|NCT00680914|65175423|FG001|Overall Study|serious adverse event (SAE)|1|||
23390983|NCT00530257|65175424|FG000|Overall Study|Lost to Follow-up|1|||
23390984|NCT02105012|65175427|FG000|Overall Study|Withdrawal by Subject|11|||
23390985|NCT02105012|65175427|FG000|Overall Study|Protocol Specified Criteria|9|||
23390986|NCT02105012|65175427|FG000|Overall Study|Lost to Follow-up|4|||
23390987|NCT02105012|65175427|FG000|Overall Study|Protocol Violation|4|||
23390988|NCT02105012|65175427|FG000|Overall Study|Physician Decision|3|||
23390989|NCT02105012|65175427|FG000|Overall Study|Adverse Event|1|||
23390990|NCT02105012|65175427|FG000|Overall Study|Lack of Efficacy|1|||
23390991|NCT03766906|65175428|FG000|Overall Study|Withdrawal by Subject|6|||
23390992|NCT01791205|65175434|FG000|Phase II|Lack of Efficacy|6|||
23390993|NCT01791205|65175435|FG001|Phase II|Lack of Efficacy|0|||
23390994|NCT01791205|65175434|FG000|Phase II|Adverse Event|2|||
23390995|NCT01791205|65175435|FG001|Phase II|Adverse Event|0|||
23390996|NCT01791205|65175434|FG000|Phase II|Safety|1|||
23390997|NCT01791205|65175435|FG001|Phase II|Safety|0|||
23390998|NCT01791205|65175434|FG000|Phase II|Lost to Follow-up|1|||
23390999|NCT01791205|65175435|FG001|Phase II|Lost to Follow-up|0|||
23391000|NCT01791205|65175434|FG000|Phase II|Remission of disease|1|||
23391001|NCT01791205|65175435|FG001|Phase II|Remission of disease|0|||
23683149|NCT03208231|66217562|FG000|Overall Study|Moved and unable to get to clinic|1|||
23683150|NCT03208231|66217563|FG001|Overall Study|Moved and unable to get to clinic|0|||
23391002|NCT01791205|65175434|FG000|Phase II|Physician's decision|1|||
23391003|NCT01791205|65175435|FG001|Phase II|Physician's decision|0|||
23391004|NCT01514422|65175436|FG000|Overall Study|Lost to Follow-up|1|||
23391005|NCT01922895|65175440|FG000|Overall Study|Death|0|||
23391006|NCT01922895|65175441|FG001|Overall Study|Death|1|||
23391007|NCT01922895|65175440|FG000|Overall Study|Withdrawal by Subject|1|||
23391008|NCT01922895|65175441|FG001|Overall Study|Withdrawal by Subject|2|||
23391009|NCT01922895|65175440|FG000|Overall Study|Lost to Follow-up|5|||
23391010|NCT01922895|65175441|FG001|Overall Study|Lost to Follow-up|11|||
23391011|NCT01475825|65175447|FG000|Overall Study|Adverse Event|41|||
23391012|NCT01475825|65175448|FG001|Overall Study|Adverse Event|15|||
23391013|NCT01475825|65175449|FG002|Overall Study|Adverse Event|27|||
23391014|NCT01475825|65175450|FG003|Overall Study|Adverse Event|11|||
23391015|NCT01475825|65175447|FG000|Overall Study|Death|1|||
23391016|NCT01475825|65175448|FG001|Overall Study|Death|0|||
23391017|NCT01475825|65175449|FG002|Overall Study|Death|1|||
23391018|NCT01475825|65175450|FG003|Overall Study|Death|0|||
23391019|NCT01475825|65175447|FG000|Overall Study|Lack of Efficacy|0|||
23391020|NCT01475825|65175448|FG001|Overall Study|Lack of Efficacy|0|||
23391021|NCT01475825|65175449|FG002|Overall Study|Lack of Efficacy|1|||
23391022|NCT01475825|65175450|FG003|Overall Study|Lack of Efficacy|0|||
23391023|NCT01475825|65175447|FG000|Overall Study|Lost to Follow-up|0|||
23391024|NCT01475825|65175448|FG001|Overall Study|Lost to Follow-up|0|||
23391025|NCT01475825|65175449|FG002|Overall Study|Lost to Follow-up|3|||
23391026|NCT01475825|65175450|FG003|Overall Study|Lost to Follow-up|1|||
23391027|NCT01475825|65175447|FG000|Overall Study|Non-compliance with Study Drug|1|||
23391028|NCT01475825|65175448|FG001|Overall Study|Non-compliance with Study Drug|2|||
23391029|NCT01475825|65175449|FG002|Overall Study|Non-compliance with Study Drug|4|||
23391030|NCT01475825|65175450|FG003|Overall Study|Non-compliance with Study Drug|0|||
23391031|NCT01475825|65175447|FG000|Overall Study|Other: Not available|0|||
23391032|NCT01475825|65175448|FG001|Overall Study|Other: Not available|0|||
23391033|NCT01475825|65175449|FG002|Overall Study|Other: Not available|2|||
23683151|NCT03208231|66217562|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
23683152|NCT03208231|66217563|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
23683153|NCT01126580|66217564|FG000|Overall Study|Adverse Event|14|||
23683154|NCT01126580|66217565|FG001|Overall Study|Adverse Event|8|||
23683155|NCT01126580|66217566|FG002|Overall Study|Adverse Event|12|||
23683156|NCT01126580|66217564|FG000|Overall Study|Withdrawal by Subject|11|||
23683157|NCT01126580|66217565|FG001|Overall Study|Withdrawal by Subject|19|||
23683158|NCT01126580|66217566|FG002|Overall Study|Withdrawal by Subject|14|||
23683159|NCT01126580|66217564|FG000|Overall Study|Sponsor Decision|5|||
23683160|NCT01126580|66217565|FG001|Overall Study|Sponsor Decision|4|||
23683161|NCT01126580|66217566|FG002|Overall Study|Sponsor Decision|7|||
23683162|NCT01126580|66217564|FG000|Overall Study|Physician Decision|1|||
23683163|NCT01126580|66217565|FG001|Overall Study|Physician Decision|1|||
23683164|NCT01126580|66217566|FG002|Overall Study|Physician Decision|2|||
23683165|NCT01126580|66217564|FG000|Overall Study|Entry Criteria Not Met|1|||
23683166|NCT01126580|66217565|FG001|Overall Study|Entry Criteria Not Met|1|||
23683167|NCT01126580|66217566|FG002|Overall Study|Entry Criteria Not Met|2|||
23683168|NCT01126580|66217564|FG000|Overall Study|Lack of Efficacy|2|||
23683169|NCT01126580|66217565|FG001|Overall Study|Lack of Efficacy|3|||
23683170|NCT01126580|66217566|FG002|Overall Study|Lack of Efficacy|4|||
23683171|NCT01126580|66217564|FG000|Overall Study|Protocol Violation|0|||
23683172|NCT01126580|66217565|FG001|Overall Study|Protocol Violation|1|||
23683173|NCT01126580|66217566|FG002|Overall Study|Protocol Violation|2|||
23683174|NCT01126580|66217564|FG000|Overall Study|Lost to Follow-up|15|||
23683175|NCT01126580|66217565|FG001|Overall Study|Lost to Follow-up|13|||
23683176|NCT01126580|66217566|FG002|Overall Study|Lost to Follow-up|9|||
23683177|NCT01126580|66217564|FG000|Overall Study|Treatment Non-compliance|0|||
23683178|NCT01126580|66217565|FG001|Overall Study|Treatment Non-compliance|2|||
23683179|NCT01126580|66217566|FG002|Overall Study|Treatment Non-compliance|3|||
23683180|NCT01468987|66217567|FG000|Overall Study|Adverse Event|12|||
23683181|NCT01468987|66217568|FG001|Overall Study|Adverse Event|9|||
23683182|NCT01468987|66217567|FG000|Overall Study|Death|4|||
23683183|NCT01468987|66217568|FG001|Overall Study|Death|1|||
23683184|NCT01468987|66217567|FG000|Overall Study|Lost to Follow-up|10|||
23683185|NCT01468987|66217568|FG001|Overall Study|Lost to Follow-up|5|||
23683186|NCT01468987|66217567|FG000|Overall Study|Protocol Violation|8|||
23683187|NCT01468987|66217568|FG001|Overall Study|Protocol Violation|2|||
23683188|NCT01468987|66217567|FG000|Overall Study|Withdrawal by Subject|28|||
23683189|NCT01468987|66217568|FG001|Overall Study|Withdrawal by Subject|28|||
23683190|NCT01468987|66217567|FG000|Overall Study|Physician Decision|8|||
23683191|NCT01468987|66217568|FG001|Overall Study|Physician Decision|15|||
23391034|NCT01475825|65175450|FG003|Overall Study|Other: Not available|0|||
23683192|NCT01468987|66217567|FG000|Overall Study|Sponsor Decision|1|||
23683193|NCT01468987|66217568|FG001|Overall Study|Sponsor Decision|0|||
23683194|NCT02266433|66217569|FG000|Overall Study|Lost to Follow-up|54|||
23683195|NCT02266433|66217570|FG001|Overall Study|Lost to Follow-up|46|||
23683196|NCT02266433|66217569|FG000|Overall Study|Withdrawal by Subject|5|||
23683197|NCT02266433|66217570|FG001|Overall Study|Withdrawal by Subject|7|||
23683198|NCT01790048|66217572|FG000|Overall Study|Incorrect Age|9|||
23391035|NCT01475825|65175447|FG000|Overall Study|Protocol Violation|1|||
23391036|NCT01475825|65175448|FG001|Overall Study|Protocol Violation|0|||
23391037|NCT01475825|65175449|FG002|Overall Study|Protocol Violation|0|||
23391038|NCT01475825|65175450|FG003|Overall Study|Protocol Violation|0|||
23391039|NCT01475825|65175447|FG000|Overall Study|Physician Decision|0|||
23391040|NCT01475825|65175448|FG001|Overall Study|Physician Decision|1|||
23683199|NCT01790048|66217573|FG001|Overall Study|Incorrect Age|14|||
23683200|NCT01790048|66217572|FG000|Overall Study|data entry error|0|||
23683201|NCT01790048|66217573|FG001|Overall Study|data entry error|1|||
23683202|NCT01790048|66217572|FG000|Overall Study|Other|0|||
23683203|NCT01790048|66217573|FG001|Overall Study|Other|2|||
23683204|NCT01790048|66217572|FG000|Overall Study|SAM at Enrollment|2|||
23683205|NCT01790048|66217573|FG001|Overall Study|SAM at Enrollment|0|||
23391041|NCT01475825|65175449|FG002|Overall Study|Physician Decision|0|||
23391042|NCT01475825|65175450|FG003|Overall Study|Physician Decision|0|||
23683206|NCT01790048|66217572|FG000|Overall Study|Measurement error|1|||
23683207|NCT01790048|66217573|FG001|Overall Study|Measurement error|0|||
23683208|NCT01307033|66217581|FG000|8-week Double-blind Period|Adverse Event|2|||
23391043|NCT01475825|65175447|FG000|Overall Study|Withdrawal by Subject|8|||
23391044|NCT01475825|65175448|FG001|Overall Study|Withdrawal by Subject|3|||
23391045|NCT01475825|65175449|FG002|Overall Study|Withdrawal by Subject|11|||
23495346|NCT00400764|65558766|FG003|Phase II|Physician Decision|1|||
23495347|NCT00400764|65558767|FG004|Phase II|Physician Decision|0|||
23495348|NCT00400764|65558763|FG000|Phase II|Sponsor's decision to terminate|0|||
23495349|NCT00400764|65558764|FG001|Phase II|Sponsor's decision to terminate|0|||
23495350|NCT00400764|65558765|FG002|Phase II|Sponsor's decision to terminate|18|||
23495351|NCT00400764|65558766|FG003|Phase II|Sponsor's decision to terminate|22|||
23495352|NCT00400764|65558767|FG004|Phase II|Sponsor's decision to terminate|11|||
23495353|NCT00400764|65558763|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
23495354|NCT00400764|65558764|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
23495355|NCT00400764|65558765|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
23683209|NCT01307033|66217582|FG001|8-week Double-blind Period|Adverse Event|0|||
23683210|NCT01307033|66217583|FG002|8-week Double-blind Period|Adverse Event|0|||
23683211|NCT01307033|66217584|FG003|8-week Double-blind Period|Adverse Event|0|||
23683212|NCT01307033|66217581|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
23683213|NCT01307033|66217582|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
23683214|NCT01307033|66217583|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
23683215|NCT01307033|66217584|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
23683216|NCT01307033|66217581|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
23683217|NCT01307033|66217582|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
23683218|NCT01307033|66217583|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
23683219|NCT01307033|66217584|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
23683220|NCT01307033|66217581|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23683221|NCT01307033|66217582|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
23683222|NCT01307033|66217583|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23683223|NCT01307033|66217584|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23683224|NCT01307033|66217581|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
23683225|NCT01307033|66217582|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
23683226|NCT01307033|66217583|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
23683227|NCT01307033|66217584|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
23683228|NCT01307033|66217581|FG000|44-week Open-label Extension|Adverse Event|0|||
23683229|NCT01307033|66217582|FG001|44-week Open-label Extension|Adverse Event|0|||
23683230|NCT01307033|66217583|FG002|44-week Open-label Extension|Adverse Event|2|||
23683231|NCT01307033|66217584|FG003|44-week Open-label Extension|Adverse Event|1|||
23683232|NCT01307033|66217581|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
23683233|NCT01307033|66217582|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
23683234|NCT01307033|66217583|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
23683235|NCT01307033|66217584|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
23683236|NCT01307033|66217581|FG000|44-week Open-label Extension|Physician Decision|0|||
23683237|NCT01307033|66217582|FG001|44-week Open-label Extension|Physician Decision|0|||
23683238|NCT01307033|66217583|FG002|44-week Open-label Extension|Physician Decision|1|||
23683239|NCT01307033|66217584|FG003|44-week Open-label Extension|Physician Decision|0|||
23683240|NCT01307033|66217581|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23683241|NCT01307033|66217582|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23683242|NCT01307033|66217583|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23683243|NCT01307033|66217584|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
23683244|NCT01307033|66217581|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
23683245|NCT01307033|66217582|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
23683246|NCT01307033|66217583|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
23683247|NCT01307033|66217584|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
23683248|NCT01307033|66217581|FG000|44-week Open-label Extension|Death|0|||
23391046|NCT01475825|65175450|FG003|Overall Study|Withdrawal by Subject|7|||
23391047|NCT01475825|65175447|FG000|Overall Study|Did not enter OLC|15|||
23391048|NCT01475825|65175448|FG001|Overall Study|Did not enter OLC|11|||
23391049|NCT01475825|65175449|FG002|Overall Study|Did not enter OLC|15|||
23391050|NCT01475825|65175450|FG003|Overall Study|Did not enter OLC|11|||
23391051|NCT03359395|65175451|FG000|First Intervention A / B|Withdrawal by Subject|1|||
23391052|NCT03359395|65175452|FG001|First Intervention A / B|Withdrawal by Subject|0|||
23391053|NCT03359395|65175451|FG000|First Intervention A / B|Lost to Follow-up|2|||
23391054|NCT03359395|65175452|FG001|First Intervention A / B|Lost to Follow-up|3|||
23391055|NCT03359395|65175451|FG000|Second Intervention B/A|Exclusion criteria|0|||
23391056|NCT03359395|65175452|FG001|Second Intervention B/A|Exclusion criteria|1|||
23391057|NCT03359395|65175451|FG000|Second Intervention B/A|Lost to Follow-up|3|||
23495356|NCT00400764|65558766|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
23495357|NCT00400764|65558767|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
23495358|NCT00400764|65558763|FG000|Phase II|Withdrawal by Subject|0|||
23683249|NCT01307033|66217582|FG001|44-week Open-label Extension|Death|0|||
23391058|NCT03359395|65175452|FG001|Second Intervention B/A|Lost to Follow-up|2|||
23683250|NCT01307033|66217583|FG002|44-week Open-label Extension|Death|0|||
23683251|NCT01307033|66217584|FG003|44-week Open-label Extension|Death|1|||
23683252|NCT01573910|66217597|FG000|Overall Study|Adverse Event|4|||
23683253|NCT01573910|66217598|FG001|Overall Study|Adverse Event|4|||
23683254|NCT01573910|66217597|FG000|Overall Study|Lost to Follow-up|2|||
23495359|NCT00400764|65558764|FG001|Phase II|Withdrawal by Subject|0|||
23495360|NCT00400764|65558765|FG002|Phase II|Withdrawal by Subject|1|||
23495361|NCT00400764|65558766|FG003|Phase II|Withdrawal by Subject|1|||
23683255|NCT01573910|66217598|FG001|Overall Study|Lost to Follow-up|1|||
23683256|NCT01573910|66217597|FG000|Overall Study|Withdrawal by Subject|0|||
23683257|NCT01573910|66217598|FG001|Overall Study|Withdrawal by Subject|1|||
23683258|NCT01573910|66217597|FG000|Overall Study|Protocol Violation|3|||
23683259|NCT01573910|66217598|FG001|Overall Study|Protocol Violation|0|||
23683260|NCT01573910|66217597|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
23683261|NCT01573910|66217598|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
23683262|NCT01703000|66217599|FG000|Overall Study|Death|1|||
23683263|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
23683264|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
23495362|NCT00400764|65558767|FG004|Phase II|Withdrawal by Subject|0|||
23495363|NCT02187744|65558768|FG000|Study|Participant refused further follow-up|1|||
23495364|NCT02187744|65558769|FG001|Study|Participant refused further follow-up|0|||
23495365|NCT02187744|65558768|FG000|Study|Other|2|||
23495366|NCT02187744|65558769|FG001|Study|Other|1|||
23495367|NCT02187744|65558768|FG000|Study|Lost to Follow-up|0|||
23495368|NCT02187744|65558769|FG001|Study|Lost to Follow-up|2|||
23495369|NCT02187744|65558768|FG000|Study|Related adverse event, not serious|0|||
23495370|NCT02187744|65558769|FG001|Study|Related adverse event, not serious|2|||
23495371|NCT02187744|65558768|FG000|Study|Death|1|||
23495372|NCT02187744|65558769|FG001|Study|Death|0|||
23495373|NCT02187744|65558768|FG000|Study|Related adverse event, serious non-fatal|0|||
23495374|NCT02187744|65558769|FG001|Study|Related adverse event, serious non-fatal|1|||
23495375|NCT02187744|65558768|FG000|Treatment|Death|1|||
23495376|NCT02187744|65558769|FG001|Treatment|Death|0|||
23495377|NCT02187744|65558768|FG000|Treatment|Related adverse event, serious non-fatal|0|||
23495378|NCT02187744|65558769|FG001|Treatment|Related adverse event, serious non-fatal|1|||
23495379|NCT02187744|65558768|FG000|Treatment|Related adverse event, not serious|0|||
23495380|NCT02187744|65558769|FG001|Treatment|Related adverse event, not serious|2|||
23495381|NCT02187744|65558768|FG000|Treatment|Lost to Follow-up|0|||
23495382|NCT02187744|65558769|FG001|Treatment|Lost to Follow-up|1|||
23495383|NCT02187744|65558768|FG000|Treatment|Other|2|||
23495384|NCT02187744|65558769|FG001|Treatment|Other|0|||
23495385|NCT02187744|65558768|FG000|Treatment|Participant refused continued treatment|1|||
23495386|NCT02187744|65558769|FG001|Treatment|Participant refused continued treatment|1|||
23495387|NCT04032652|65558770|FG000|Overall Study|The study was terminated and the PI has|1|||
23495388|NCT04032652|65558771|FG001|Overall Study|The study was terminated and the PI has|1|||
23495389|NCT03320057|65558773|FG000|Overall Study|Lost to Follow-up|4|||
23495390|NCT03320057|65558774|FG001|Overall Study|Lost to Follow-up|17|||
23495391|NCT03320057|65558773|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
23495392|NCT03320057|65558774|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
23495393|NCT00191269|65558775|FG000|Overall Study|Protocol Violation|0|||
23495394|NCT00191269|65558776|FG001|Overall Study|Protocol Violation|2|||
23495395|NCT00191269|65558775|FG000|Overall Study|Adverse Event|1|||
23495396|NCT00191269|65558776|FG001|Overall Study|Adverse Event|4|||
23495397|NCT00191269|65558775|FG000|Overall Study|Progression of Disease|4|||
23495398|NCT00191269|65558776|FG001|Overall Study|Progression of Disease|42|||
23495399|NCT00191269|65558775|FG000|Overall Study|Lack of Efficacy|1|||
23495400|NCT00191269|65558776|FG001|Overall Study|Lack of Efficacy|5|||
23683265|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
23683266|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23495401|NCT00191269|65558775|FG000|Overall Study|Withdrawal by Subject|0|||
23495402|NCT00191269|65558776|FG001|Overall Study|Withdrawal by Subject|1|||
23683267|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23683268|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23391059|NCT01028560|65175453|FG000|Overall Study|Lack of Efficacy|3|||
23391060|NCT01028560|65175454|FG001|Overall Study|Lack of Efficacy|6|||
23391061|NCT01028560|65175453|FG000|Overall Study|Withdrawal by Subject|7|||
23391062|NCT01028560|65175454|FG001|Overall Study|Withdrawal by Subject|12|||
23391063|NCT00836901|65175455|FG000|First Intervention|Withdrawal by Subject|1|||
23391064|NCT00836901|65175456|FG001|First Intervention|Withdrawal by Subject|0|||
23391065|NCT00911157|65175457|FG000|Overall Study|Adverse Event|4|||
23391066|NCT00911157|65175458|FG001|Overall Study|Adverse Event|1|||
23391067|NCT00911157|65175457|FG000|Overall Study|Withdrawal by Subject|1|||
23391068|NCT00911157|65175458|FG001|Overall Study|Withdrawal by Subject|1|||
23391069|NCT00911157|65175457|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
23391070|NCT00911157|65175458|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
23391071|NCT00911157|65175457|FG000|Overall Study|Need to treat for lung cancer|1|||
23391072|NCT00911157|65175458|FG001|Overall Study|Need to treat for lung cancer|0|||
23391073|NCT02180672|65175459|FG000|Overall Study|Lost to Follow-up|5|||
23391074|NCT02180672|65175460|FG001|Overall Study|Lost to Follow-up|7|||
23391075|NCT00637156|65178459|FG000|Overall Study|Withdrawal by Subject|0|||
23391076|NCT00637156|65178460|FG001|Overall Study|Withdrawal by Subject|7|||
23391077|NCT00637156|65178459|FG000|Overall Study|Death|0|||
23391078|NCT00637156|65178460|FG001|Overall Study|Death|1|||
23391079|NCT00637156|65178459|FG000|Overall Study|Lost to Follow-up|10|||
23391080|NCT00637156|65178460|FG001|Overall Study|Lost to Follow-up|16|||
23391081|NCT02624687|65178465|FG000|Overall Study|Withdrawal by Subject|1|||
23391082|NCT02624687|65178466|FG001|Overall Study|Withdrawal by Subject|1|||
23391083|NCT02624687|65178465|FG000|Overall Study|medical leave from work|0|||
23391084|NCT02624687|65178466|FG001|Overall Study|medical leave from work|1|||
23391085|NCT02231580|65178467|FG000|Overall Study|Adverse Event|5|||
23683269|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23683270|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23683271|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
23683272|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
23683273|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
23683274|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23683275|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23683276|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23683277|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23683278|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23683279|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
23683280|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
23683281|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
23683282|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23683283|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23683284|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23683285|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23683286|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23683287|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
23683288|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
23683289|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23683290|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23683291|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23683292|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23683293|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23683294|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23683295|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
23683296|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
23683297|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
23683298|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23683299|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23683300|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23683301|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23683302|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23683303|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
23683304|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
23683305|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23391086|NCT02231580|65178468|FG001|Overall Study|Adverse Event|0|||
23391087|NCT03701074|65178469|FG000|Overall Study|Physician Decision|1|||
23683306|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23683307|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23683308|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23683309|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23683310|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23683311|NCT01097629|66217600|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
23391088|NCT03701074|65178470|FG001|Overall Study|Physician Decision|0|||
23391089|NCT00023595|65178471|FG000|5 Year Follow up|Lost to Follow-up|2|||
23391090|NCT00023595|65178472|FG001|5 Year Follow up|Lost to Follow-up|2|||
23391091|NCT00023595|65178473|FG002|5 Year Follow up|Lost to Follow-up|1|||
23391092|NCT00023595|65178474|FG003|5 Year Follow up|Lost to Follow-up|7|||
23391093|NCT00023595|65178475|FG004|5 Year Follow up|Lost to Follow-up|3|||
23391094|NCT00023595|65178471|FG000|10 Year Follow up|Lost to Follow-up|12|||
23391095|NCT00023595|65178472|FG001|10 Year Follow up|Lost to Follow-up|10|||
23391096|NCT00023595|65178473|FG002|10 Year Follow up|Lost to Follow-up|3|||
23391097|NCT00023595|65178474|FG003|10 Year Follow up|Lost to Follow-up|0|||
23391098|NCT00023595|65178475|FG004|10 Year Follow up|Lost to Follow-up|0|||
23495403|NCT00191269|65558775|FG000|Overall Study|Pathologic Aggrevation|0|||
23495404|NCT00191269|65558776|FG001|Overall Study|Pathologic Aggrevation|1|||
23495405|NCT00191269|65558775|FG000|Overall Study|Physician Decision|0|||
23495406|NCT00191269|65558776|FG001|Overall Study|Physician Decision|3|||
23495407|NCT00115739|65558779|FG000|Overall Study|Lost to Follow-up|3|||
23495408|NCT04203797|65558787|FG000|Overall Study|Adverse Event|1|||
23495409|NCT04203797|65558788|FG001|Overall Study|Adverse Event|0|||
23495410|NCT04203797|65558787|FG000|Overall Study|Did not complete End of Study follow-up|1|||
23495411|NCT04203797|65558788|FG001|Overall Study|Did not complete End of Study follow-up|0|||
23495412|NCT01696695|65558790|FG000|Overall Study|Disease progression|373|||
23495413|NCT01696695|65558790|FG000|Overall Study|Death|29|||
23495414|NCT01696695|65558790|FG000|Overall Study|Adverse Event|74|||
23683312|NCT01097629|66217601|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
23683313|NCT01097629|66217602|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
23683314|NCT01097629|66217603|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23683315|NCT01097629|66217604|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23683316|NCT01097629|66217605|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23683317|NCT01097629|66217606|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23683318|NCT01097629|66217607|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23683319|NCT01097629|66217600|FG000|DB RO Phase|Withdrawal by Subject|0|||
23683320|NCT01097629|66217601|FG001|DB RO Phase|Withdrawal by Subject|0|||
23683321|NCT01097629|66217602|FG002|DB RO Phase|Withdrawal by Subject|0|||
23683322|NCT01097629|66217603|FG003|DB RO Phase|Withdrawal by Subject|0|||
23683323|NCT01097629|66217604|FG004|DB RO Phase|Withdrawal by Subject|0|||
23683324|NCT01097629|66217605|FG005|DB RO Phase|Withdrawal by Subject|0|||
23683325|NCT01097629|66217606|FG006|DB RO Phase|Withdrawal by Subject|0|||
23683326|NCT01097629|66217607|FG007|DB RO Phase|Withdrawal by Subject|1|||
23683327|NCT01097629|66217600|FG000|DB RO Phase|Protocol Violation|0|||
23683328|NCT01097629|66217601|FG001|DB RO Phase|Protocol Violation|0|||
23683329|NCT01097629|66217602|FG002|DB RO Phase|Protocol Violation|0|||
23683330|NCT01097629|66217603|FG003|DB RO Phase|Protocol Violation|1|||
23683331|NCT01097629|66217604|FG004|DB RO Phase|Protocol Violation|0|||
23683332|NCT01097629|66217605|FG005|DB RO Phase|Protocol Violation|1|||
23683333|NCT01097629|66217606|FG006|DB RO Phase|Protocol Violation|1|||
23683334|NCT01097629|66217607|FG007|DB RO Phase|Protocol Violation|0|||
23683335|NCT01097629|66217600|FG000|DB RO Phase|Lost to Follow-up|0|||
23683336|NCT01097629|66217601|FG001|DB RO Phase|Lost to Follow-up|0|||
23683337|NCT01097629|66217602|FG002|DB RO Phase|Lost to Follow-up|0|||
23683338|NCT01097629|66217603|FG003|DB RO Phase|Lost to Follow-up|0|||
23683339|NCT01097629|66217604|FG004|DB RO Phase|Lost to Follow-up|0|||
23683340|NCT01097629|66217605|FG005|DB RO Phase|Lost to Follow-up|0|||
23683341|NCT01097629|66217606|FG006|DB RO Phase|Lost to Follow-up|2|||
23683342|NCT01097629|66217607|FG007|DB RO Phase|Lost to Follow-up|0|||
23683343|NCT00045032|66217608|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
23683344|NCT00045032|66217609|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
23683345|NCT00045032|66217610|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
23683346|NCT00045032|66217608|FG000|Overall Study|Death|22|||
23683347|NCT00045032|66217609|FG001|Overall Study|Death|24|||
23683348|NCT00045032|66217610|FG002|Overall Study|Death|17|||
23683349|NCT00045032|66217608|FG000|Overall Study|Insufficient Therapeutic Response|542|||
23683350|NCT00045032|66217609|FG001|Overall Study|Insufficient Therapeutic Response|437|||
23683351|NCT00045032|66217610|FG002|Overall Study|Insufficient Therapeutic Response|445|||
23495415|NCT01696695|65558790|FG000|Overall Study|Withdrawal by Subject|92|||
23683352|NCT00045032|66217608|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
23391099|NCT01149460|65178479|FG000|Overall Study|Withdrawal by Subject|0|||
23683353|NCT00045032|66217609|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
23391100|NCT01149460|65178480|FG001|Overall Study|Withdrawal by Subject|2|||
23495416|NCT01696695|65558790|FG000|Overall Study|Lost to Follow-up|48|||
23495417|NCT01696695|65558790|FG000|Overall Study|Other|74|||
23495418|NCT01696695|65558790|FG000|Overall Study|Major Protocol Violation|192|||
23495419|NCT01950169|65558791|FG000|Overall Study|Withdrawal by Subject|2|||
23495420|NCT01950169|65558792|FG001|Overall Study|Withdrawal by Subject|8|||
23495421|NCT01950169|65558793|FG002|Overall Study|Withdrawal by Subject|1|||
23495422|NCT01950169|65558791|FG000|Overall Study|Death|1|||
23495423|NCT01950169|65558792|FG001|Overall Study|Death|0|||
23495424|NCT01950169|65558793|FG002|Overall Study|Death|0|||
23495425|NCT02158975|65558794|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
23495426|NCT03641339|65558795|FG000|Overall Study|Physician Decision|1|||
23495427|NCT03641339|65558796|FG001|Overall Study|Physician Decision|0|||
23495428|NCT03641339|65558797|FG002|Overall Study|Physician Decision|0|||
23495429|NCT03641339|65558798|FG003|Overall Study|Physician Decision|0|||
23495430|NCT03641339|65558799|FG004|Overall Study|Physician Decision|0|||
23495431|NCT03641339|65558800|FG005|Overall Study|Physician Decision|0|||
23495432|NCT03641339|65558795|FG000|Overall Study|Withdrawal by Subject|0|||
23495433|NCT03641339|65558796|FG001|Overall Study|Withdrawal by Subject|2|||
23495434|NCT03641339|65558797|FG002|Overall Study|Withdrawal by Subject|0|||
23495435|NCT03641339|65558798|FG003|Overall Study|Withdrawal by Subject|2|||
23495436|NCT03641339|65558799|FG004|Overall Study|Withdrawal by Subject|0|||
23495437|NCT03641339|65558800|FG005|Overall Study|Withdrawal by Subject|1|||
23495438|NCT01739309|65558802|FG000|Overall Study|Adverse Event|1|||
23495439|NCT01739309|65558802|FG000|Overall Study|Withdrawal by Subject|1|||
23495440|NCT01449539|65558806|FG000|Overall Study|Withdrawal by Subject|3|||
23495441|NCT01449539|65558806|FG000|Overall Study|Toxicity not study related|1|||
23495442|NCT00516074|65558808|FG000|Overall Study|Adverse Event|0|||
23495443|NCT00516074|65558809|FG001|Overall Study|Adverse Event|1|||
23495444|NCT00516074|65558808|FG000|Overall Study|Subject Decision|4|||
23495445|NCT00516074|65558809|FG001|Overall Study|Subject Decision|2|||
23495446|NCT00516074|65558808|FG000|Overall Study|Loss of Glucose Control|2|||
23683354|NCT00045032|66217610|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
23683355|NCT00045032|66217608|FG000|Overall Study|Other Protocol Violation|2|||
23683356|NCT00045032|66217609|FG001|Overall Study|Other Protocol Violation|0|||
23683357|NCT00045032|66217610|FG002|Overall Study|Other Protocol Violation|1|||
23683358|NCT00045032|66217608|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
23683359|NCT00045032|66217609|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
23683360|NCT00045032|66217610|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
23391101|NCT01299961|65178481|FG000|Overall Study|Adverse Event|3|||
23391102|NCT01299961|65178481|FG000|Overall Study|Lack of Efficacy|2|||
23391103|NCT01299961|65178481|FG000|Overall Study|Lost to Follow-up|1|||
23391104|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
23391105|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
23391106|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
23391107|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
23391108|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
23391109|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
23391110|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
23391111|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
23391112|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
23391113|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
23391114|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
23495447|NCT00516074|65558809|FG001|Overall Study|Loss of Glucose Control|0|||
23495448|NCT05306977|65558814|FG000|Overall Study|Withdrawal by Subject|1|||
23495449|NCT04057365|65558820|FG000|Overall Study|Withdrawal by Subject|2|||
23683361|NCT00045032|66217608|FG000|Overall Study|Failure to Return|57|||
23683362|NCT00045032|66217609|FG001|Overall Study|Failure to Return|62|||
23683363|NCT00045032|66217610|FG002|Overall Study|Failure to Return|61|||
23683364|NCT00045032|66217608|FG000|Overall Study|Other|93|||
23683365|NCT00045032|66217609|FG001|Overall Study|Other|84|||
23683366|NCT00045032|66217610|FG002|Overall Study|Other|105|||
23683367|NCT00675025|66217611|FG000|Overall Study|Study Terminated by Sponsor|38|||
23683368|NCT00675025|66217612|FG001|Overall Study|Study Terminated by Sponsor|42|||
23683369|NCT00675025|66217611|FG000|Overall Study|Adverse Event|6|||
23683370|NCT00675025|66217612|FG001|Overall Study|Adverse Event|11|||
23495450|NCT04057365|65558821|FG001|Overall Study|Withdrawal by Subject|0|||
23495451|NCT04545385|65558822|FG000|Overall Study|Withdrawal by Subject|2|||
23495452|NCT04545385|65558823|FG001|Overall Study|Withdrawal by Subject|0|||
23495453|NCT04545385|65558822|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
23495454|NCT04545385|65558823|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
23495455|NCT04545385|65558822|FG000|Overall Study|Study termination|10|||
23495456|NCT04545385|65558823|FG001|Overall Study|Study termination|10|||
23495457|NCT04545385|65558822|FG000|Overall Study|Sponsor decision|2|||
23683371|NCT00675025|66217611|FG000|Overall Study|Lost to Follow-up|6|||
23683372|NCT00675025|66217612|FG001|Overall Study|Lost to Follow-up|4|||
23683373|NCT00675025|66217611|FG000|Overall Study|Withdrawal by Subject|4|||
23683374|NCT00675025|66217612|FG001|Overall Study|Withdrawal by Subject|6|||
23683375|NCT02629159|66217613|FG000|Overall Study|Adverse Event|17|||
23683376|NCT02629159|66217614|FG001|Overall Study|Adverse Event|20|||
23683377|NCT02629159|66217615|FG002|Overall Study|Adverse Event|22|||
23683378|NCT02629159|66217613|FG000|Overall Study|Withdrawal by Subject|22|||
23683379|NCT02629159|66217614|FG001|Overall Study|Withdrawal by Subject|11|||
23683380|NCT02629159|66217615|FG002|Overall Study|Withdrawal by Subject|15|||
23683381|NCT02629159|66217613|FG000|Overall Study|Lost to Follow-up|7|||
23683382|NCT02629159|66217614|FG001|Overall Study|Lost to Follow-up|4|||
23683383|NCT02629159|66217615|FG002|Overall Study|Lost to Follow-up|5|||
23683384|NCT02629159|66217613|FG000|Overall Study|Lack of Efficacy|4|||
23683385|NCT02629159|66217614|FG001|Overall Study|Lack of Efficacy|0|||
23683386|NCT02629159|66217615|FG002|Overall Study|Lack of Efficacy|1|||
23683387|NCT02629159|66217613|FG000|Overall Study|Other|6|||
23683388|NCT02629159|66217614|FG001|Overall Study|Other|4|||
23683389|NCT02629159|66217615|FG002|Overall Study|Other|8|||
23683390|NCT04373460|66217622|FG000|Overall Study|Did not receive tranfusion|18|||
23683391|NCT04373460|66217623|FG001|Overall Study|Did not receive tranfusion|26|||
23683392|NCT03665038|66217624|FG000|Overall Study|Lost to Follow-up|0|||
23683393|NCT03665038|66217625|FG001|Overall Study|Lost to Follow-up|0|||
23683394|NCT03665038|66217626|FG002|Overall Study|Lost to Follow-up|1|||
23683395|NCT02690194|66217627|FG000|Overall Study|Withdrawal by Subject|1|||
23495458|NCT04545385|65558823|FG001|Overall Study|Sponsor decision|2|||
23495459|NCT04545385|65558822|FG000|Overall Study|Other than specified|1|||
23495460|NCT04545385|65558823|FG001|Overall Study|Other than specified|0|||
23495461|NCT00246753|65558824|FG000|Overall Study|Withdrawal by Subject|2|||
23683396|NCT02690194|66217628|FG001|Overall Study|Withdrawal by Subject|4|||
23683397|NCT02690194|66217629|FG002|Overall Study|Withdrawal by Subject|0|||
23683398|NCT00395967|66217637|FG000|Treatment Period|Failed Mobilization|1|||
23683399|NCT00395967|66217637|FG000|Follow-up Period|Death|1|||
23683400|NCT00395967|66217637|FG000|Follow-up Period|Lost to Follow-up|1|||
23683401|NCT04270760|66217638|FG000|Overall Study|Withdrawal by Subject|0|||
23683402|NCT04270760|66217639|FG001|Overall Study|Withdrawal by Subject|1|||
23683403|NCT04270760|66217640|FG002|Overall Study|Withdrawal by Subject|3|||
23683404|NCT04270760|66217641|FG003|Overall Study|Withdrawal by Subject|0|||
23683405|NCT04270760|66217642|FG004|Overall Study|Withdrawal by Subject|0|||
23683406|NCT04270760|66217638|FG000|Overall Study|Lost to Follow-up|1|||
23683407|NCT04270760|66217639|FG001|Overall Study|Lost to Follow-up|2|||
23683408|NCT04270760|66217640|FG002|Overall Study|Lost to Follow-up|1|||
23683409|NCT04270760|66217641|FG003|Overall Study|Lost to Follow-up|0|||
23683410|NCT04270760|66217642|FG004|Overall Study|Lost to Follow-up|0|||
23683411|NCT04270760|66217638|FG000|Overall Study|Death|0|||
23683412|NCT04270760|66217639|FG001|Overall Study|Death|0|||
23683413|NCT04270760|66217640|FG002|Overall Study|Death|0|||
23683414|NCT04270760|66217641|FG003|Overall Study|Death|0|||
23683415|NCT04270760|66217642|FG004|Overall Study|Death|1|||
23683416|NCT03072160|66217643|FG000|Overall Study|Adverse Event|3|||
23683417|NCT03072160|66217644|FG001|Overall Study|Adverse Event|1|||
23683418|NCT03072160|66217643|FG000|Overall Study|Refused further treatment|6|||
23683419|NCT03072160|66217644|FG001|Overall Study|Refused further treatment|1|||
23683420|NCT03072160|66217643|FG000|Overall Study|Physician Decision|1|||
23683421|NCT03072160|66217644|FG001|Overall Study|Physician Decision|0|||
23683422|NCT03072160|66217643|FG000|Overall Study|Disease progression on study|1|||
23683423|NCT03072160|66217644|FG001|Overall Study|Disease progression on study|1|||
23683424|NCT03072160|66217643|FG000|Overall Study|No contact|0|||
23683425|NCT03072160|66217644|FG001|Overall Study|No contact|1|||
23683426|NCT00709956|66217651|FG000|Overall Study|Withdrawal by Subject|1|||
23683427|NCT00709956|66217652|FG001|Overall Study|Withdrawal by Subject|1|||
23683428|NCT00709956|66217651|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
23683429|NCT00709956|66217652|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
23683430|NCT00621504|66217653|FG000|Overall Study|Adverse Event|1|||
23683431|NCT00621504|66217654|FG001|Overall Study|Adverse Event|3|||
23683432|NCT00621504|66217653|FG000|Overall Study|At the request of sponsor/investigator|1|||
23683433|NCT00621504|66217654|FG001|Overall Study|At the request of sponsor/investigator|0|||
23683434|NCT00621504|66217653|FG000|Overall Study|Withdrew consent|9|||
23683435|NCT00621504|66217654|FG001|Overall Study|Withdrew consent|6|||
23683436|NCT00621504|66217653|FG000|Overall Study|Lost to Follow-up|8|||
23683437|NCT00621504|66217654|FG001|Overall Study|Lost to Follow-up|10|||
23683438|NCT00621504|66217653|FG000|Overall Study|Other|1|||
23683439|NCT00621504|66217654|FG001|Overall Study|Other|0|||
23683440|NCT00621504|66217653|FG000|Overall Study|Death|6|||
23495462|NCT00246753|65558824|FG000|Overall Study|Physician Decision|2|||
23683441|NCT00621504|66217654|FG001|Overall Study|Death|6|||
23683442|NCT02949128|66217655|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
23683443|NCT02949128|66217655|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
23683444|NCT02949128|66217655|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
23683445|NCT02949128|66217655|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
23683446|NCT02949128|66217655|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
23683447|NCT02949128|66217655|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
23683448|NCT02949128|66217655|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
23683449|NCT02949128|66217655|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
23683450|NCT02949128|66217655|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
23683451|NCT02949128|66217655|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
23683452|NCT01752023|66217656|FG000|Overall Study|Physician Decision|2|||
23683453|NCT01752023|66217657|FG001|Overall Study|Physician Decision|1|||
23683454|NCT01451645|66217660|FG000|Overall Study|Protocol Violation|1|||
23683455|NCT01451645|66217661|FG001|Overall Study|Protocol Violation|0|||
23683456|NCT01451645|66217660|FG000|Overall Study|Adverse Event|0|||
23683457|NCT01451645|66217661|FG001|Overall Study|Adverse Event|3|||
23683458|NCT01451645|66217660|FG000|Overall Study|Withdrawal by Subject|4|||
23391115|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
23391116|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
23391117|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
23495463|NCT00246753|65558824|FG000|Overall Study|Adverse Event|2|||
23495464|NCT00246753|65558824|FG000|Overall Study|Unacceptable toxicity|2|||
23495465|NCT00319501|65558825|FG000|Double-blind Period|Withdrawal by Subject|0|||
23495466|NCT00319501|65558826|FG001|Double-blind Period|Withdrawal by Subject|3|||
23495467|NCT00319501|65558825|FG000|Double-blind Period|Sponsor Request|1|||
23495468|NCT00319501|65558826|FG001|Double-blind Period|Sponsor Request|0|||
23495469|NCT00319501|65558825|FG000|Double-blind Period|Did not receive treatment|42|||
23495470|NCT00319501|65558826|FG001|Double-blind Period|Did not receive treatment|29|||
23495471|NCT00319501|65558825|FG000|Open-label Period|Adverse Event|5|||
23495472|NCT00319501|65558826|FG001|Open-label Period|Adverse Event|0|||
23495473|NCT00319501|65558825|FG000|Open-label Period|Protocol Violation|6|||
23495474|NCT00319501|65558826|FG001|Open-label Period|Protocol Violation|0|||
23495475|NCT00319501|65558825|FG000|Open-label Period|Withdrawal by Subject|38|||
23495476|NCT00319501|65558826|FG001|Open-label Period|Withdrawal by Subject|0|||
23495477|NCT00319501|65558825|FG000|Open-label Period|Principal Investigator decision|6|||
23495478|NCT00319501|65558826|FG001|Open-label Period|Principal Investigator decision|0|||
23495479|NCT00319501|65558825|FG000|Open-label Period|Sponsor request|12|||
23495480|NCT00319501|65558826|FG001|Open-label Period|Sponsor request|0|||
23495481|NCT00319501|65558825|FG000|Open-label Period|Lost to Follow-up|5|||
23495482|NCT00319501|65558826|FG001|Open-label Period|Lost to Follow-up|0|||
23495483|NCT00319501|65558825|FG000|Open-label Period|Did not receive treatment|33|||
23495484|NCT00319501|65558826|FG001|Open-label Period|Did not receive treatment|0|||
23495485|NCT00319501|65558825|FG000|Open-label Period|Other|11|||
23391118|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
23391119|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
23495486|NCT00319501|65558826|FG001|Open-label Period|Other|0|||
23495487|NCT00319501|65558825|FG000|Open-label Extension Period|Adverse Event|2|||
23495488|NCT00319501|65558826|FG001|Open-label Extension Period|Adverse Event|0|||
23495489|NCT00319501|65558825|FG000|Open-label Extension Period|Did not receive treatment|18|||
23495490|NCT00319501|65558826|FG001|Open-label Extension Period|Did not receive treatment|0|||
23495491|NCT00319501|65558825|FG000|Open-label Extension Period|Other|1|||
23495492|NCT00319501|65558826|FG001|Open-label Extension Period|Other|0|||
23495493|NCT00319501|65558825|FG000|Open-label Extension Period|Principal investigator decision|2|||
23495494|NCT00319501|65558826|FG001|Open-label Extension Period|Principal investigator decision|0|||
23495495|NCT00319501|65558825|FG000|Open-label Extension Period|Sponsor request|26|||
23495496|NCT00319501|65558826|FG001|Open-label Extension Period|Sponsor request|0|||
23683459|NCT01451645|66217661|FG001|Overall Study|Withdrawal by Subject|2|||
23683460|NCT01451645|66217660|FG000|Overall Study|Lost to Follow-up|4|||
23683461|NCT01451645|66217661|FG001|Overall Study|Lost to Follow-up|3|||
23683462|NCT00531960|66217662|FG000|Overall Study|Adverse Event|5|||
23683463|NCT00531960|66217663|FG001|Overall Study|Adverse Event|4|||
23683464|NCT00531960|66217662|FG000|Overall Study|Death|3|||
23683465|NCT00531960|66217663|FG001|Overall Study|Death|2|||
23391120|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
23391121|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
23683466|NCT00531960|66217662|FG000|Overall Study|Lack of Efficacy|42|||
23683467|NCT00531960|66217663|FG001|Overall Study|Lack of Efficacy|41|||
23683468|NCT00531960|66217662|FG000|Overall Study|Violation of Selection Criteria|2|||
23683469|NCT00531960|66217663|FG001|Overall Study|Violation of Selection Criteria|0|||
23683470|NCT00531960|66217662|FG000|Overall Study|Refused Treatment|5|||
23683471|NCT00531960|66217663|FG001|Overall Study|Refused Treatment|6|||
23683472|NCT00531960|66217662|FG000|Overall Study|Other|4|||
23683473|NCT00531960|66217663|FG001|Overall Study|Other|10|||
23683474|NCT00552110|66217668|FG000|Overall Study|Serious or Life-Threatening AE|0|||
23495497|NCT00319501|65558825|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
23495498|NCT00319501|65558826|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
23495499|NCT02083965|65558827|FG000|Treatment Period|Other|1|||
23495500|NCT02083965|65558828|FG001|Treatment Period|Other|0|||
23495501|NCT01414608|65558829|FG000|Overall Study|Ineligible|5|||
23495502|NCT01414608|65558830|FG001|Overall Study|Ineligible|2|||
23495503|NCT00615108|65558836|FG000|Overall Study|Adverse Event|122|||
23495504|NCT00615108|65558836|FG000|Overall Study|Other|370|||
23495505|NCT00615108|65558836|FG000|Overall Study|Lost to Follow-up|15|||
23391122|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
23391123|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
23391124|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
23391125|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
23391126|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
23391127|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
23495506|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
23495507|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
23495508|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
23495509|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
23495510|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
23495511|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
23495512|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Death|6|||
23495513|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Death|0|||
23495514|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Death|0|||
23495515|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
23495516|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
23495517|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
23495518|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
23495519|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
23495520|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
23495521|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
23495522|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
23495523|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
23495524|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Other|5|||
23495525|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Other|0|||
23495526|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Other|0|||
23495527|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
23495528|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
23495529|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
23495530|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Other|0|||
23495531|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Other|1|||
23495532|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Other|1|||
23495533|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
23495534|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
23495535|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
23495536|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
23495537|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
23495538|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
23495539|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
23495540|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
23495541|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
23495542|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
23495543|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
23495544|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
23495545|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Death|0|||
23495546|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Death|6|||
23495547|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Death|11|||
23495548|NCT03855228|65558845|FG000|Overall Study|Adverse Event|2|||
23495549|NCT03855228|65558846|FG001|Overall Study|Adverse Event|4|||
23495550|NCT03855228|65558847|FG002|Overall Study|Adverse Event|4|||
23495551|NCT03855228|65558848|FG003|Overall Study|Adverse Event|8|||
23495552|NCT03855228|65558845|FG000|Overall Study|Treatment Failure|1|||
23495553|NCT03855228|65558846|FG001|Overall Study|Treatment Failure|2|||
23495554|NCT03855228|65558847|FG002|Overall Study|Treatment Failure|1|||
23495555|NCT03855228|65558848|FG003|Overall Study|Treatment Failure|8|||
23495556|NCT03855228|65558845|FG000|Overall Study|Lost to Follow-up|0|||
23495557|NCT03855228|65558846|FG001|Overall Study|Lost to Follow-up|0|||
23495558|NCT03855228|65558847|FG002|Overall Study|Lost to Follow-up|0|||
23495559|NCT03855228|65558848|FG003|Overall Study|Lost to Follow-up|1|||
23495560|NCT03855228|65558845|FG000|Overall Study|Protocol Violation|0|||
23495561|NCT03855228|65558846|FG001|Overall Study|Protocol Violation|1|||
23495562|NCT03855228|65558847|FG002|Overall Study|Protocol Violation|2|||
23495563|NCT03855228|65558848|FG003|Overall Study|Protocol Violation|1|||
23495564|NCT03855228|65558845|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
23495565|NCT03855228|65558846|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
23495566|NCT03855228|65558847|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
23495567|NCT03855228|65558848|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
23495568|NCT00408629|65558852|FG000|Overall Study|Adverse Event|13|||
23495569|NCT00408629|65558853|FG001|Overall Study|Adverse Event|27|||
23495570|NCT00408629|65558852|FG000|Overall Study|Withdrawal by Subject|8|||
23495571|NCT00408629|65558853|FG001|Overall Study|Withdrawal by Subject|4|||
23495572|NCT00408629|65558852|FG000|Overall Study|Lost to Follow-up|1|||
23495573|NCT00408629|65558853|FG001|Overall Study|Lost to Follow-up|1|||
23495574|NCT00408629|65558852|FG000|Overall Study|Lack of Efficacy|63|||
23495575|NCT00408629|65558853|FG001|Overall Study|Lack of Efficacy|73|||
23495576|NCT00408629|65558852|FG000|Overall Study|Protocol Violation|1|||
23495577|NCT00408629|65558853|FG001|Overall Study|Protocol Violation|5|||
23495578|NCT00408629|65558852|FG000|Overall Study|Miscellaneous|11|||
23495579|NCT00408629|65558853|FG001|Overall Study|Miscellaneous|15|||
23495580|NCT00586625|65558854|FG000|Overall Study|Adverse Event|6|||
23495581|NCT00586625|65558855|FG001|Overall Study|Adverse Event|6|||
23495582|NCT00586625|65558854|FG000|Overall Study|Protocol Violation|3|||
23495583|NCT00586625|65558855|FG001|Overall Study|Protocol Violation|0|||
23495584|NCT00586625|65558854|FG000|Overall Study|Withdrawal by Subject|32|||
23495585|NCT00586625|65558855|FG001|Overall Study|Withdrawal by Subject|10|||
23495586|NCT00586625|65558854|FG000|Overall Study|Subject non-compliance|0|||
23495587|NCT00586625|65558855|FG001|Overall Study|Subject non-compliance|1|||
23495588|NCT00586625|65558854|FG000|Overall Study|Subject unable to return for visit|2|||
23495589|NCT00586625|65558855|FG001|Overall Study|Subject unable to return for visit|0|||
23495590|NCT00866788|65558858|FG000|Overall Study|Adverse Event|0|||
23495591|NCT00866788|65558859|FG001|Overall Study|Adverse Event|2|||
23495592|NCT00866788|65558860|FG002|Overall Study|Adverse Event|0|||
23495593|NCT00866788|65558861|FG003|Overall Study|Adverse Event|1|||
23495594|NCT00866788|65558858|FG000|Overall Study|Lost to Follow-up|1|||
23495595|NCT00866788|65558859|FG001|Overall Study|Lost to Follow-up|1|||
23495596|NCT00866788|65558860|FG002|Overall Study|Lost to Follow-up|0|||
23495597|NCT00866788|65558861|FG003|Overall Study|Lost to Follow-up|2|||
23495598|NCT00866788|65558858|FG000|Overall Study|Withdrawal by Subject|2|||
23495599|NCT00866788|65558859|FG001|Overall Study|Withdrawal by Subject|1|||
23495600|NCT00866788|65558860|FG002|Overall Study|Withdrawal by Subject|0|||
23495601|NCT00866788|65558861|FG003|Overall Study|Withdrawal by Subject|1|||
23495602|NCT00866788|65558858|FG000|Overall Study|Pregnancy|0|||
23495603|NCT00866788|65558859|FG001|Overall Study|Pregnancy|1|||
23495604|NCT00866788|65558860|FG002|Overall Study|Pregnancy|0|||
23495605|NCT00866788|65558861|FG003|Overall Study|Pregnancy|0|||
23495606|NCT00866788|65558858|FG000|Overall Study|Disease progression|3|||
23495607|NCT00866788|65558859|FG001|Overall Study|Disease progression|1|||
23495608|NCT00866788|65558860|FG002|Overall Study|Disease progression|1|||
23495609|NCT00866788|65558861|FG003|Overall Study|Disease progression|0|||
23495610|NCT00866788|65558858|FG000|Overall Study|Physician Decision|0|||
23495611|NCT00866788|65558859|FG001|Overall Study|Physician Decision|0|||
23495612|NCT00866788|65558860|FG002|Overall Study|Physician Decision|1|||
23495613|NCT00866788|65558861|FG003|Overall Study|Physician Decision|1|||
23495614|NCT02002091|65558862|FG000|Screening|Lost to Follow-up|10|||
23495615|NCT02002091|65558863|FG001|Screening|Lost to Follow-up|12|||
23495616|NCT02002091|65558862|FG000|Screening|Death|3|||
23495617|NCT02002091|65558863|FG001|Screening|Death|2|||
23495618|NCT01235689|65558864|FG000|Overall Study|Adverse Event|12|||
23495619|NCT01235689|65558865|FG001|Overall Study|Adverse Event|16|||
23495620|NCT01235689|65558864|FG000|Overall Study|Lack of Efficacy|12|||
23495621|NCT01235689|65558865|FG001|Overall Study|Lack of Efficacy|5|||
23495622|NCT01235689|65558864|FG000|Overall Study|Withdrawal by Subject|3|||
23495623|NCT01235689|65558865|FG001|Overall Study|Withdrawal by Subject|4|||
23495624|NCT01235689|65558864|FG000|Overall Study|Lost to Follow-up|1|||
23495625|NCT01235689|65558865|FG001|Overall Study|Lost to Follow-up|2|||
23495626|NCT01235689|65558864|FG000|Overall Study|Miscellaneous|1|||
23495627|NCT01235689|65558865|FG001|Overall Study|Miscellaneous|5|||
23495628|NCT00508755|65558868|FG000|Overall Study|Withdrawal by Subject|1|||
23495629|NCT03583697|65558869|FG000|Overall Study|Withdrawal by Subject|0|||
23495630|NCT03583697|65558870|FG001|Overall Study|Withdrawal by Subject|0|||
23495631|NCT03583697|65558871|FG002|Overall Study|Withdrawal by Subject|1|||
23495632|NCT03583697|65558869|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
23495633|NCT03583697|65558870|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
23495634|NCT03583697|65558871|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
23495635|NCT00799383|65558872|FG000|Overall Study|Protocol Violation|1|||
23495636|NCT00799383|65558873|FG001|Overall Study|Protocol Violation|1|||
23495637|NCT00799383|65558872|FG000|Overall Study|Adverse Event|0|||
23495638|NCT00799383|65558873|FG001|Overall Study|Adverse Event|1|||
23495639|NCT00799383|65558872|FG000|Overall Study|Lost to Follow-up|1|||
23495640|NCT00799383|65558873|FG001|Overall Study|Lost to Follow-up|2|||
23495641|NCT00799383|65558872|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
23495642|NCT00799383|65558873|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
23495643|NCT00799383|65558872|FG000|Overall Study|Withdrawal by Subject|0|||
23495644|NCT00799383|65558873|FG001|Overall Study|Withdrawal by Subject|1|||
23495645|NCT00398411|65558874|FG000|Overall Study|Death|0|||
23495646|NCT00398411|65558875|FG001|Overall Study|Death|1|||
23495647|NCT01849783|65558878|FG000|Overall Study|Adverse Event|5|||
23495648|NCT01849783|65558878|FG000|Overall Study|Death|2|||
23495649|NCT01849783|65558878|FG000|Overall Study|Physician Decision|1|||
23495650|NCT01849783|65558878|FG000|Overall Study|Withdrawal by Subject|1|||
23495651|NCT01849783|65558878|FG000|Overall Study|Unable to comply|2|||
23495652|NCT01849783|65558878|FG000|Overall Study|Disease progression|11|||
23495653|NCT02008318|65558879|FG000|Overall Study|Adverse Event|4|||
23495654|NCT02008318|65558880|FG001|Overall Study|Adverse Event|0|||
23495655|NCT02008318|65558879|FG000|Overall Study|Physician Decision|2|||
23495656|NCT02008318|65558880|FG001|Overall Study|Physician Decision|0|||
23495657|NCT02008318|65558879|FG000|Overall Study|Progressive Disease|2|||
23495658|NCT02008318|65558880|FG001|Overall Study|Progressive Disease|0|||
23495659|NCT02008318|65558879|FG000|Overall Study|Protocol Violation|1|||
23495660|NCT02008318|65558880|FG001|Overall Study|Protocol Violation|1|||
23495661|NCT02008318|65558879|FG000|Overall Study|Withdrawal by Subject|3|||
23495662|NCT02008318|65558880|FG001|Overall Study|Withdrawal by Subject|0|||
23495663|NCT02728596|65558881|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23495664|NCT02728596|65558882|FG001|Overall Study|Refusal unrelated to adverse event|6|||
23495665|NCT02728596|65558883|FG002|Overall Study|Refusal unrelated to adverse event|7|||
23495666|NCT02728596|65558884|FG003|Overall Study|Refusal unrelated to adverse event|7|||
23495667|NCT02728596|65558881|FG000|Overall Study|Death|44|||
23495668|NCT02728596|65558882|FG001|Overall Study|Death|42|||
23495669|NCT02728596|65558883|FG002|Overall Study|Death|123|||
23495670|NCT02728596|65558884|FG003|Overall Study|Death|68|||
23495671|NCT02248701|65558887|FG000|Overall Study|Withdrawal by Subject|2|||
23495672|NCT02248701|65558888|FG001|Overall Study|Withdrawal by Subject|1|||
23495673|NCT02248701|65558887|FG000|Overall Study|Physician Decision|0|||
23495674|NCT02248701|65558888|FG001|Overall Study|Physician Decision|1|||
23495675|NCT02248701|65558887|FG000|Overall Study|Adverse Event|1|||
23495676|NCT02248701|65558888|FG001|Overall Study|Adverse Event|0|||
23495677|NCT02248701|65558887|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
23495678|NCT02248701|65558888|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
23495679|NCT00392015|65558891|FG000|Overall Study|Lost to Follow-up|2|||
23495680|NCT00392015|65558892|FG001|Overall Study|Lost to Follow-up|0|||
23495681|NCT00392015|65558893|FG002|Overall Study|Lost to Follow-up|2|||
23495682|NCT00392015|65558894|FG003|Overall Study|Lost to Follow-up|1|||
23495683|NCT00392015|65558895|FG004|Overall Study|Lost to Follow-up|1|||
23495684|NCT00392015|65558896|FG005|Overall Study|Lost to Follow-up|0|||
23495685|NCT00392015|65558891|FG000|Overall Study|Withdrawal by Subject|0|||
23495686|NCT00392015|65558892|FG001|Overall Study|Withdrawal by Subject|0|||
23495687|NCT00392015|65558893|FG002|Overall Study|Withdrawal by Subject|2|||
23495688|NCT00392015|65558894|FG003|Overall Study|Withdrawal by Subject|0|||
23495689|NCT00392015|65558895|FG004|Overall Study|Withdrawal by Subject|0|||
23495690|NCT00392015|65558896|FG005|Overall Study|Withdrawal by Subject|0|||
23495691|NCT00392015|65558891|FG000|Overall Study|Adverse Event|0|||
23495692|NCT00392015|65558892|FG001|Overall Study|Adverse Event|0|||
23495693|NCT00392015|65558893|FG002|Overall Study|Adverse Event|0|||
23495694|NCT00392015|65558894|FG003|Overall Study|Adverse Event|0|||
23495695|NCT00392015|65558895|FG004|Overall Study|Adverse Event|1|||
23495696|NCT00392015|65558896|FG005|Overall Study|Adverse Event|0|||
23495697|NCT00392015|65558891|FG000|Overall Study|Previous trial recipient|0|||
23495698|NCT00392015|65558892|FG001|Overall Study|Previous trial recipient|0|||
23495699|NCT00392015|65558893|FG002|Overall Study|Previous trial recipient|0|||
23495700|NCT00392015|65558894|FG003|Overall Study|Previous trial recipient|0|||
23683475|NCT00552110|66217669|FG001|Overall Study|Serious or Life-Threatening AE|0|||
23683476|NCT00552110|66217670|FG002|Overall Study|Serious or Life-Threatening AE|1|||
23683477|NCT00552110|66217671|FG003|Overall Study|Serious or Life-Threatening AE|0|||
23683478|NCT00552110|66217672|FG004|Overall Study|Serious or Life-Threatening AE|0|||
23495701|NCT00392015|65558895|FG004|Overall Study|Previous trial recipient|1|||
23495702|NCT00392015|65558896|FG005|Overall Study|Previous trial recipient|0|||
23495703|NCT01522248|65558899|FG000|Overall Study|Lost to Follow-up|1|||
23495704|NCT01522248|65558900|FG001|Overall Study|Lost to Follow-up|0|||
23495705|NCT01031381|65558901|FG000|Overall Study|Physician Decision|3|||
23495706|NCT01031381|65558901|FG000|Overall Study|Withdrawal by Subject|6|||
23495707|NCT01816074|65558902|FG000|Phase 1|Time commitment issues|0|||
23495708|NCT01816074|65558903|FG001|Phase 1|Time commitment issues|0|||
23495709|NCT01816074|65558904|FG002|Phase 1|Time commitment issues|1|||
23495710|NCT01816074|65558905|FG003|Phase 1|Time commitment issues|0|||
23683479|NCT00552110|66217668|FG000|Overall Study|Lack of Efficacy|1|||
23495711|NCT01816074|65558902|FG000|Phase 2|Time commitment Issues|0|||
23683480|NCT00552110|66217669|FG001|Overall Study|Lack of Efficacy|0|||
23495712|NCT01816074|65558903|FG001|Phase 2|Time commitment Issues|2|||
23495713|NCT01816074|65558904|FG002|Phase 2|Time commitment Issues|0|||
23495714|NCT01816074|65558905|FG003|Phase 2|Time commitment Issues|0|||
23495715|NCT01816074|65558902|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
23495716|NCT01816074|65558903|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495717|NCT01816074|65558904|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495718|NCT01816074|65558905|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495719|NCT01816074|65558902|FG000|Phase 2|Physician Decision|0|||
23495720|NCT01816074|65558903|FG001|Phase 2|Physician Decision|0|||
23495721|NCT01816074|65558904|FG002|Phase 2|Physician Decision|0|||
23495722|NCT01816074|65558905|FG003|Phase 2|Physician Decision|1|||
23495723|NCT01816074|65558902|FG000|Phase 2|Withdrawal by Subject|1|||
23495724|NCT01816074|65558903|FG001|Phase 2|Withdrawal by Subject|0|||
23495725|NCT01816074|65558904|FG002|Phase 2|Withdrawal by Subject|0|||
23495726|NCT01816074|65558905|FG003|Phase 2|Withdrawal by Subject|0|||
23495727|NCT00676338|65558906|FG000|Overall Study|Adverse Event|6|||
23495728|NCT00676338|65558907|FG001|Overall Study|Adverse Event|6|||
23495729|NCT00676338|65558908|FG002|Overall Study|Adverse Event|5|||
23495730|NCT00676338|65558909|FG003|Overall Study|Adverse Event|1|||
23495731|NCT00676338|65558906|FG000|Overall Study|Lost to Follow-up|4|||
23495732|NCT00676338|65558907|FG001|Overall Study|Lost to Follow-up|1|||
23683481|NCT00552110|66217670|FG002|Overall Study|Lack of Efficacy|0|||
23683482|NCT00552110|66217671|FG003|Overall Study|Lack of Efficacy|1|||
23683483|NCT00552110|66217672|FG004|Overall Study|Lack of Efficacy|4|||
23683484|NCT00552110|66217668|FG000|Overall Study|Withdrawal by Subject|0|||
23683485|NCT00552110|66217669|FG001|Overall Study|Withdrawal by Subject|2|||
23683486|NCT00552110|66217670|FG002|Overall Study|Withdrawal by Subject|0|||
23683487|NCT00552110|66217671|FG003|Overall Study|Withdrawal by Subject|3|||
23683488|NCT00552110|66217672|FG004|Overall Study|Withdrawal by Subject|2|||
23683489|NCT00552110|66217668|FG000|Overall Study|Lost to Follow-up|0|||
23683490|NCT00552110|66217669|FG001|Overall Study|Lost to Follow-up|0|||
23683491|NCT00552110|66217670|FG002|Overall Study|Lost to Follow-up|0|||
23683492|NCT00552110|66217671|FG003|Overall Study|Lost to Follow-up|1|||
23683493|NCT00552110|66217672|FG004|Overall Study|Lost to Follow-up|1|||
23683494|NCT00552110|66217668|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
23683495|NCT00552110|66217669|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
23683496|NCT00552110|66217670|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
23683497|NCT00552110|66217671|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
23683498|NCT00552110|66217672|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
23683499|NCT00552110|66217668|FG000|Overall Study|Withdrawn per Sponsor|0|||
23683500|NCT00552110|66217669|FG001|Overall Study|Withdrawn per Sponsor|1|||
23683501|NCT00552110|66217670|FG002|Overall Study|Withdrawn per Sponsor|0|||
23683502|NCT00552110|66217671|FG003|Overall Study|Withdrawn per Sponsor|0|||
23683503|NCT00552110|66217672|FG004|Overall Study|Withdrawn per Sponsor|1|||
23683504|NCT00552110|66217668|FG000|Overall Study|Use of Prohibited Medication|1|||
23683505|NCT00552110|66217669|FG001|Overall Study|Use of Prohibited Medication|1|||
23683506|NCT00552110|66217670|FG002|Overall Study|Use of Prohibited Medication|0|||
23683507|NCT00552110|66217671|FG003|Overall Study|Use of Prohibited Medication|0|||
23683508|NCT00552110|66217672|FG004|Overall Study|Use of Prohibited Medication|0|||
23683509|NCT00552110|66217668|FG000|Overall Study|Delay of Study due to Relabeling|0|||
23683510|NCT00552110|66217669|FG001|Overall Study|Delay of Study due to Relabeling|0|||
23683511|NCT00552110|66217670|FG002|Overall Study|Delay of Study due to Relabeling|0|||
23683512|NCT00552110|66217671|FG003|Overall Study|Delay of Study due to Relabeling|1|||
23683513|NCT00552110|66217672|FG004|Overall Study|Delay of Study due to Relabeling|0|||
23683514|NCT00552110|66217668|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
23683515|NCT00552110|66217669|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
23683516|NCT00552110|66217670|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
23683517|NCT00552110|66217671|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
23683518|NCT00552110|66217672|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
23683519|NCT00552110|66217668|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
23683520|NCT00552110|66217669|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
23683521|NCT00552110|66217670|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
23683522|NCT00552110|66217671|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
23683523|NCT00552110|66217672|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
23495733|NCT00676338|65558908|FG002|Overall Study|Lost to Follow-up|3|||
23495734|NCT00676338|65558909|FG003|Overall Study|Lost to Follow-up|4|||
23495735|NCT00676338|65558906|FG000|Overall Study|Physician Decision|3|||
23495736|NCT00676338|65558907|FG001|Overall Study|Physician Decision|3|||
23495737|NCT00676338|65558908|FG002|Overall Study|Physician Decision|2|||
23683524|NCT03029832|66217673|FG000|Overall Study|Safety Follow-Up Completed|2|||
23683525|NCT03029832|66217674|FG001|Overall Study|Safety Follow-Up Completed|0|||
23495738|NCT00676338|65558909|FG003|Overall Study|Physician Decision|3|||
23683526|NCT03029832|66217673|FG000|Overall Study|Death due to Disease Progression|1|||
23495739|NCT00676338|65558906|FG000|Overall Study|Protocol Violation|5|||
23683527|NCT03029832|66217674|FG001|Overall Study|Death due to Disease Progression|0|||
23683528|NCT03029832|66217673|FG000|Overall Study|Study Terminated By Sponsor|1|||
23683529|NCT03029832|66217674|FG001|Overall Study|Study Terminated By Sponsor|1|||
23683530|NCT01756274|66217675|FG000|Overall Study|Protocol Violation|2|||
23683531|NCT01756274|66217675|FG000|Overall Study|Laboratory error|1|||
23683532|NCT01869348|66217676|FG000|Overall Study|Withdrawal by Subject|1|||
23683533|NCT01869348|66217677|FG001|Overall Study|Withdrawal by Subject|1|||
23683534|NCT01934140|66217678|FG000|Persistence Phase (Year 6-10)|Other|24|||
23683535|NCT01934140|66217679|FG001|Persistence Phase (Year 6-10)|Other|6|||
23683536|NCT01934140|66217678|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
23683537|NCT01934140|66217679|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
23683538|NCT01934140|66217678|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
23683539|NCT01934140|66217679|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
23683540|NCT01934140|66217678|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
23683541|NCT01934140|66217679|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
23683542|NCT01934140|66217678|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
23683543|NCT01934140|66217679|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
23683544|NCT01934140|66217678|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
23683545|NCT01934140|66217679|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
23683546|NCT01934140|66217678|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
23683547|NCT01934140|66217679|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
23683548|NCT01934140|66217678|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
23683549|NCT01934140|66217679|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
23683550|NCT01220414|66217680|FG000|Overall Study|Withdrawal by Subject|1|||
23683551|NCT01220414|66217681|FG001|Overall Study|Withdrawal by Subject|0|||
23683552|NCT01220414|66217682|FG002|Overall Study|Withdrawal by Subject|0|||
23683553|NCT01220414|66217683|FG003|Overall Study|Withdrawal by Subject|1|||
23683554|NCT00654498|66217684|FG000|Overall Study|Not Treated|1|||
23683555|NCT00654498|66217685|FG001|Overall Study|Not Treated|0|||
23683556|NCT00654498|66217684|FG000|Overall Study|Adverse Event|6|||
23683557|NCT00654498|66217685|FG001|Overall Study|Adverse Event|1|||
23683558|NCT00654498|66217684|FG000|Overall Study|Protocol Violation|1|||
23683559|NCT00654498|66217685|FG001|Overall Study|Protocol Violation|1|||
23683560|NCT00654498|66217684|FG000|Overall Study|Lost to Follow-up|1|||
23683561|NCT00654498|66217685|FG001|Overall Study|Lost to Follow-up|5|||
23683562|NCT00654498|66217684|FG000|Overall Study|Withdrawal by Subject|1|||
23683563|NCT00654498|66217685|FG001|Overall Study|Withdrawal by Subject|0|||
23683564|NCT00654498|66217684|FG000|Overall Study|Other reason not defined above|4|||
23683565|NCT00654498|66217685|FG001|Overall Study|Other reason not defined above|5|||
23683566|NCT01709331|66217686|FG000|Overall Study|Adverse Event|1|||
23683567|NCT01444300|66217690|FG000|Overall Study|Adverse Event|4|||
23683568|NCT01444300|66217691|FG001|Overall Study|Adverse Event|0|||
23683569|NCT04698525|66217692|FG000|Overall Study|Lost to Follow-up|1|||
23683570|NCT04698525|66217693|FG001|Overall Study|Lost to Follow-up|2|||
23683571|NCT04698525|66217692|FG000|Overall Study|Three suffered of Covid-19|2|||
23683572|NCT04698525|66217693|FG001|Overall Study|Three suffered of Covid-19|1|||
23683573|NCT03308188|66217703|FG000|Overall Study|Withdrawal by Subject|0|||
23683574|NCT03308188|66217704|FG001|Overall Study|Withdrawal by Subject|3|||
23683575|NCT03308188|66217703|FG000|Overall Study|Death|0|||
23683576|NCT03308188|66217704|FG001|Overall Study|Death|1|||
23683577|NCT00179959|66217705|FG000|Overall Study|Lost to Follow-up|3|||
23391128|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
23391129|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
23391130|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
23391131|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
23391132|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
23391133|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
23391134|NCT03093415|65178482|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
23391135|NCT03093415|65178483|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
23391136|NCT03093415|65178484|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
23391137|NCT02402647|65178489|FG000|Overall Study|Lost to Follow-up|13|||
23391138|NCT02402647|65178490|FG001|Overall Study|Lost to Follow-up|7|||
23391139|NCT02402647|65178489|FG000|Overall Study|Protocol Violation|1|||
23391140|NCT02402647|65178490|FG001|Overall Study|Protocol Violation|1|||
23683578|NCT00179959|66217706|FG001|Overall Study|Lost to Follow-up|1|||
23683579|NCT00179959|66217705|FG000|Overall Study|Withdrawal by Subject|3|||
23683580|NCT00179959|66217706|FG001|Overall Study|Withdrawal by Subject|2|||
23683581|NCT00947531|66217707|FG000|Overall Study|Withdrawal by Subject|10|||
23683582|NCT00947531|66217708|FG001|Overall Study|Withdrawal by Subject|7|||
23683583|NCT00947531|66217707|FG000|Overall Study|Administrative Reason|0|||
23683584|NCT00947531|66217708|FG001|Overall Study|Administrative Reason|1|||
23683585|NCT00947531|66217707|FG000|Overall Study|Adverse Event|2|||
23683586|NCT00947531|66217708|FG001|Overall Study|Adverse Event|2|||
23683587|NCT00947531|66217707|FG000|Overall Study|Lack of Efficacy|1|||
23683588|NCT00947531|66217708|FG001|Overall Study|Lack of Efficacy|0|||
23683589|NCT00947531|66217707|FG000|Overall Study|Other|1|||
23683590|NCT00947531|66217708|FG001|Overall Study|Other|1|||
23683591|NCT01773421|66217711|FG000|Treatment Phase|Other|0|||
23683592|NCT01773421|66217712|FG001|Treatment Phase|Other|0|||
23683593|NCT01773421|66217713|FG002|Treatment Phase|Other|2|||
23683594|NCT01773421|66217714|FG003|Treatment Phase|Other|0|||
23683595|NCT01773421|66217715|FG004|Treatment Phase|Other|0|||
23683596|NCT01773421|66217716|FG005|Treatment Phase|Other|0|||
23683597|NCT01773421|66217717|FG006|Treatment Phase|Other|0|||
23683598|NCT01773421|66217711|FG000|Treatment Phase|Adverse Event|0|||
23683599|NCT01773421|66217712|FG001|Treatment Phase|Adverse Event|0|||
23683600|NCT01773421|66217713|FG002|Treatment Phase|Adverse Event|3|||
23683601|NCT01773421|66217714|FG003|Treatment Phase|Adverse Event|1|||
23683602|NCT01773421|66217715|FG004|Treatment Phase|Adverse Event|0|||
23683603|NCT01773421|66217716|FG005|Treatment Phase|Adverse Event|0|||
23683604|NCT01773421|66217717|FG006|Treatment Phase|Adverse Event|0|||
23683605|NCT01773421|66217711|FG000|Treatment Phase|Withdrawal by Subject|0|||
23391141|NCT02402647|65178489|FG000|Overall Study|scheduled and timed out|2|||
23391142|NCT02402647|65178490|FG001|Overall Study|scheduled and timed out|1|||
23391143|NCT02402647|65178489|FG000|Overall Study|medical illness|2|||
23391144|NCT02402647|65178490|FG001|Overall Study|medical illness|4|||
23391145|NCT02402647|65178489|FG000|Overall Study|Moved|2|||
23391146|NCT02402647|65178490|FG001|Overall Study|Moved|0|||
23391147|NCT02402647|65178489|FG000|Overall Study|loved one illness|1|||
23391148|NCT02402647|65178490|FG001|Overall Study|loved one illness|0|||
23391149|NCT02402647|65178489|FG000|Overall Study|deceased preexisting condition|2|||
23391150|NCT02402647|65178490|FG001|Overall Study|deceased preexisting condition|0|||
23391151|NCT02402647|65178489|FG000|Overall Study|Other|2|||
23391152|NCT02402647|65178490|FG001|Overall Study|Other|1|||
23391153|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
23391154|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391155|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391156|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391157|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391158|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
23391159|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391160|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
23391161|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391162|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
23391163|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391164|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391165|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391166|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391167|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
23391168|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391169|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391170|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391171|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391172|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391173|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391174|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
23391175|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391176|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391177|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391178|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23683606|NCT01773421|66217712|FG001|Treatment Phase|Withdrawal by Subject|0|||
23683607|NCT01773421|66217713|FG002|Treatment Phase|Withdrawal by Subject|1|||
23683608|NCT01773421|66217714|FG003|Treatment Phase|Withdrawal by Subject|1|||
23683609|NCT01773421|66217715|FG004|Treatment Phase|Withdrawal by Subject|0|||
23683610|NCT01773421|66217716|FG005|Treatment Phase|Withdrawal by Subject|0|||
23391179|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
23391180|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23402832|NCT02185534|65220020|FG003|First Washout Period|Protocol Violation|0|||
23683611|NCT01773421|66217717|FG006|Treatment Phase|Withdrawal by Subject|0|||
23683612|NCT01773421|66217711|FG000|Extension Phase|Other|0|||
23683613|NCT01773421|66217712|FG001|Extension Phase|Other|0|||
23683614|NCT01773421|66217713|FG002|Extension Phase|Other|0|||
23683615|NCT01773421|66217714|FG003|Extension Phase|Other|0|||
23683616|NCT01773421|66217715|FG004|Extension Phase|Other|1|||
23683617|NCT01773421|66217716|FG005|Extension Phase|Other|2|||
23683618|NCT01773421|66217717|FG006|Extension Phase|Other|0|||
23683619|NCT01773421|66217711|FG000|Extension Phase|Adverse Event|0|||
23683620|NCT01773421|66217712|FG001|Extension Phase|Adverse Event|0|||
23683621|NCT01773421|66217713|FG002|Extension Phase|Adverse Event|0|||
23683622|NCT01773421|66217714|FG003|Extension Phase|Adverse Event|0|||
23683623|NCT01773421|66217715|FG004|Extension Phase|Adverse Event|2|||
23683624|NCT01773421|66217716|FG005|Extension Phase|Adverse Event|0|||
23683625|NCT01773421|66217717|FG006|Extension Phase|Adverse Event|0|||
23683626|NCT01176916|66217718|FG000|Overall Study|Adverse Event|61|||
23683627|NCT01176916|66217718|FG000|Overall Study|Death|1|||
23683628|NCT01176916|66217718|FG000|Overall Study|Lost to Follow-up|15|||
23683629|NCT01176916|66217718|FG000|Overall Study|Objective progression or relapse|17|||
23683630|NCT01176916|66217718|FG000|Overall Study|Protocol Violation|24|||
23683631|NCT01176916|66217718|FG000|Overall Study|Withdrawal by Subject|37|||
23683632|NCT01176916|66217718|FG000|Overall Study|Other|6|||
23683633|NCT01176916|66217718|FG000|Overall Study|Withdrawal prior to Treatment|6|||
23391181|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391182|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
23391183|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391184|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391185|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391186|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391187|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391188|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391189|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391190|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391191|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391192|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391193|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
23391194|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
23391195|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391196|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391197|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391198|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391199|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391200|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391201|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391202|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
23391203|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391204|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
23391205|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391206|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391207|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391208|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391209|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391210|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391211|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391212|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391213|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391214|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391215|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391216|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
23391217|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
23391218|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391219|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391220|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391221|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391222|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391223|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391224|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391225|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391226|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
23391227|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23683634|NCT02911688|66217719|FG000|Washout|Lost to Follow-up|1|||
23683635|NCT02911688|66217720|FG001|Washout|Lost to Follow-up|1|||
23683636|NCT02911688|66217719|FG000|Washout|Withdrawal by Subject|0|||
23391228|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391229|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391230|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
23391231|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
23391232|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391233|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391234|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391235|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391236|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391237|NCT03977155|65178498|FG000|Overall Study|Adverse Event|3|||
23391238|NCT03977155|65178499|FG001|Overall Study|Adverse Event|0|||
23391239|NCT03977155|65178500|FG002|Overall Study|Adverse Event|0|||
23391240|NCT03977155|65178498|FG000|Overall Study|Lost to Follow-up|0|||
23391241|NCT03977155|65178499|FG001|Overall Study|Lost to Follow-up|1|||
23391242|NCT03977155|65178500|FG002|Overall Study|Lost to Follow-up|0|||
23391243|NCT03977155|65178498|FG000|Overall Study|Withdrawal by Subject|1|||
23391244|NCT03977155|65178499|FG001|Overall Study|Withdrawal by Subject|1|||
23391245|NCT03977155|65178500|FG002|Overall Study|Withdrawal by Subject|2|||
23391246|NCT03977155|65178498|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
23391247|NCT03977155|65178499|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
23391248|NCT03977155|65178500|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
23391249|NCT02202577|65178501|FG000|Overall Study|Lost to Follow-up|6|||
23391250|NCT02202577|65178502|FG001|Overall Study|Lost to Follow-up|16|||
23391251|NCT02202577|65178501|FG000|Overall Study|Protocol Violation|7|||
23391252|NCT02202577|65178502|FG001|Overall Study|Protocol Violation|3|||
23391253|NCT00605657|65178505|FG000|Overall Study|Adverse Event|1|||
23391254|NCT00605657|65178505|FG000|Overall Study|Protocol Violation|1|||
23391255|NCT05185453|65178506|FG000|Overall Study|Lost to Follow-up|13|||
23391256|NCT05185453|65178507|FG001|Overall Study|Lost to Follow-up|3|||
23391257|NCT02254460|65178508|FG000|Overall Study|Adverse Event|1|||
23391258|NCT02254460|65178509|FG001|Overall Study|Adverse Event|0|||
23391259|NCT01882829|65178510|FG000|Overall Study|Adverse Event|4|||
23391260|NCT01882829|65178510|FG000|Overall Study|Protocol Violation|1|||
23391261|NCT01882829|65178510|FG000|Overall Study|Withdrawal by Subject|1|||
23391262|NCT03921528|65178511|FG000|Overall Study|Withdrawal by Subject|0|||
23391263|NCT03921528|65178512|FG001|Overall Study|Withdrawal by Subject|1|||
23391264|NCT03921528|65178513|FG002|Overall Study|Withdrawal by Subject|0|||
23391265|NCT03921528|65178514|FG003|Overall Study|Withdrawal by Subject|0|||
23391266|NCT03921528|65178515|FG004|Overall Study|Withdrawal by Subject|0|||
23391267|NCT00456365|65178518|FG000|Overall Study|Lost to Follow-up|1|||
23391268|NCT00456365|65178519|FG001|Overall Study|Lost to Follow-up|3|||
23391269|NCT00456365|65178518|FG000|Overall Study|Withdrawal by Subject|4|||
23391270|NCT00456365|65178519|FG001|Overall Study|Withdrawal by Subject|7|||
23391271|NCT00456365|65178518|FG000|Overall Study|Pregnancy|1|||
23391272|NCT00456365|65178519|FG001|Overall Study|Pregnancy|1|||
23495740|NCT00676338|65558907|FG001|Overall Study|Protocol Violation|9|||
23495741|NCT00676338|65558908|FG002|Overall Study|Protocol Violation|2|||
23495742|NCT00676338|65558909|FG003|Overall Study|Protocol Violation|5|||
23495743|NCT00676338|65558906|FG000|Overall Study|Withdrawal by Subject|17|||
23495744|NCT00676338|65558907|FG001|Overall Study|Withdrawal by Subject|9|||
23495745|NCT00676338|65558908|FG002|Overall Study|Withdrawal by Subject|12|||
23495746|NCT00676338|65558909|FG003|Overall Study|Withdrawal by Subject|6|||
23683637|NCT02911688|66217720|FG001|Washout|Withdrawal by Subject|1|||
23683638|NCT01524991|66217723|FG000|Overall Study|Adverse Event|12|||
23683639|NCT01524991|66217723|FG000|Overall Study|Death|1|||
23683640|NCT01524991|66217723|FG000|Overall Study|Disease ProgressionDu|17|||
23683641|NCT01524991|66217723|FG000|Overall Study|Other complicating disease|1|||
23683642|NCT01524991|66217723|FG000|Overall Study|Withdrawal by Subject|2|||
23683643|NCT01524991|66217723|FG000|Overall Study|Symptomatic Deterioration|1|||
23683644|NCT00944034|66221004|FG000|Overall Study|Inappropriate enrollment|0|||
23683645|NCT00944034|66221005|FG001|Overall Study|Inappropriate enrollment|1|||
23683646|NCT00944034|66221006|FG002|Overall Study|Inappropriate enrollment|0|||
23683647|NCT00944034|66221007|FG003|Overall Study|Inappropriate enrollment|1|||
23683648|NCT00944034|66221008|FG004|Overall Study|Inappropriate enrollment|2|||
23683649|NCT00944034|66221009|FG005|Overall Study|Inappropriate enrollment|1|||
23683650|NCT00944034|66221010|FG006|Overall Study|Inappropriate enrollment|0|||
23683651|NCT00944034|66221011|FG007|Overall Study|Inappropriate enrollment|0|||
23683652|NCT00944034|66221012|FG008|Overall Study|Inappropriate enrollment|1|||
23683653|NCT00944034|66221013|FG009|Overall Study|Inappropriate enrollment|1|||
23683654|NCT00944034|66221014|FG010|Overall Study|Inappropriate enrollment|0|||
23683655|NCT00944034|66221015|FG011|Overall Study|Inappropriate enrollment|0|||
23683656|NCT00944034|66221004|FG000|Overall Study|Withdrawal by Subject|3|||
23683657|NCT00944034|66221005|FG001|Overall Study|Withdrawal by Subject|2|||
23683658|NCT00944034|66221006|FG002|Overall Study|Withdrawal by Subject|6|||
23683659|NCT00944034|66221007|FG003|Overall Study|Withdrawal by Subject|2|||
23683660|NCT00944034|66221008|FG004|Overall Study|Withdrawal by Subject|5|||
23683661|NCT00944034|66221009|FG005|Overall Study|Withdrawal by Subject|8|||
23683662|NCT00944034|66221010|FG006|Overall Study|Withdrawal by Subject|2|||
23683663|NCT00944034|66221011|FG007|Overall Study|Withdrawal by Subject|2|||
23683664|NCT00944034|66221012|FG008|Overall Study|Withdrawal by Subject|3|||
23683665|NCT00944034|66221013|FG009|Overall Study|Withdrawal by Subject|4|||
23683666|NCT00944034|66221014|FG010|Overall Study|Withdrawal by Subject|0|||
23683667|NCT00944034|66221015|FG011|Overall Study|Withdrawal by Subject|4|||
23683668|NCT00944034|66221004|FG000|Overall Study|Lost to Follow-up|0|||
23683669|NCT00944034|66221005|FG001|Overall Study|Lost to Follow-up|4|||
23683670|NCT00944034|66221006|FG002|Overall Study|Lost to Follow-up|2|||
23683671|NCT00944034|66221007|FG003|Overall Study|Lost to Follow-up|0|||
23683672|NCT00944034|66221008|FG004|Overall Study|Lost to Follow-up|5|||
23683673|NCT00944034|66221009|FG005|Overall Study|Lost to Follow-up|7|||
23683674|NCT00944034|66221010|FG006|Overall Study|Lost to Follow-up|0|||
23683675|NCT00944034|66221011|FG007|Overall Study|Lost to Follow-up|1|||
23683676|NCT00944034|66221012|FG008|Overall Study|Lost to Follow-up|5|||
23683677|NCT00944034|66221013|FG009|Overall Study|Lost to Follow-up|1|||
23683678|NCT00944034|66221014|FG010|Overall Study|Lost to Follow-up|1|||
23683679|NCT00944034|66221015|FG011|Overall Study|Lost to Follow-up|0|||
23683680|NCT00944034|66221004|FG000|Overall Study|Death|0|||
23683681|NCT00944034|66221005|FG001|Overall Study|Death|0|||
23683682|NCT00944034|66221006|FG002|Overall Study|Death|1|||
23683683|NCT00944034|66221007|FG003|Overall Study|Death|0|||
23683684|NCT00944034|66221008|FG004|Overall Study|Death|0|||
23683685|NCT00944034|66221009|FG005|Overall Study|Death|0|||
23683686|NCT00944034|66221010|FG006|Overall Study|Death|0|||
23683687|NCT00944034|66221011|FG007|Overall Study|Death|0|||
23683688|NCT00944034|66221012|FG008|Overall Study|Death|0|||
23683689|NCT00944034|66221013|FG009|Overall Study|Death|0|||
23683690|NCT00944034|66221014|FG010|Overall Study|Death|0|||
23683691|NCT00944034|66221015|FG011|Overall Study|Death|0|||
23683692|NCT00944034|66221004|FG000|Overall Study|Protocol Violation|2|||
23683693|NCT00944034|66221005|FG001|Overall Study|Protocol Violation|0|||
23683694|NCT00944034|66221006|FG002|Overall Study|Protocol Violation|0|||
23683695|NCT00944034|66221007|FG003|Overall Study|Protocol Violation|1|||
23683696|NCT00944034|66221008|FG004|Overall Study|Protocol Violation|2|||
23683697|NCT00944034|66221009|FG005|Overall Study|Protocol Violation|3|||
23683698|NCT00944034|66221010|FG006|Overall Study|Protocol Violation|0|||
23683699|NCT00944034|66221011|FG007|Overall Study|Protocol Violation|1|||
23683700|NCT00944034|66221012|FG008|Overall Study|Protocol Violation|1|||
23683701|NCT00944034|66221013|FG009|Overall Study|Protocol Violation|4|||
23683702|NCT00944034|66221014|FG010|Overall Study|Protocol Violation|0|||
23683703|NCT00944034|66221015|FG011|Overall Study|Protocol Violation|0|||
23683704|NCT00944034|66221004|FG000|Overall Study|Unable to classify|0|||
23683705|NCT00944034|66221005|FG001|Overall Study|Unable to classify|0|||
23683706|NCT00944034|66221006|FG002|Overall Study|Unable to classify|0|||
23683707|NCT00944034|66221007|FG003|Overall Study|Unable to classify|0|||
23683708|NCT00944034|66221008|FG004|Overall Study|Unable to classify|0|||
23683709|NCT00944034|66221009|FG005|Overall Study|Unable to classify|1|||
23683710|NCT00944034|66221010|FG006|Overall Study|Unable to classify|1|||
23683711|NCT00944034|66221011|FG007|Overall Study|Unable to classify|1|||
23683712|NCT00944034|66221012|FG008|Overall Study|Unable to classify|0|||
23683713|NCT00944034|66221013|FG009|Overall Study|Unable to classify|0|||
23683714|NCT00944034|66221014|FG010|Overall Study|Unable to classify|0|||
23683715|NCT00944034|66221015|FG011|Overall Study|Unable to classify|0|||
23683716|NCT00944034|66221004|FG000|Overall Study|Administrative reason|0|||
23683717|NCT00944034|66221005|FG001|Overall Study|Administrative reason|0|||
23683718|NCT00944034|66221006|FG002|Overall Study|Administrative reason|0|||
23683719|NCT00944034|66221007|FG003|Overall Study|Administrative reason|0|||
23683720|NCT00944034|66221008|FG004|Overall Study|Administrative reason|0|||
23683721|NCT00944034|66221009|FG005|Overall Study|Administrative reason|0|||
23683722|NCT00944034|66221010|FG006|Overall Study|Administrative reason|1|||
23683723|NCT00944034|66221011|FG007|Overall Study|Administrative reason|0|||
23683724|NCT00944034|66221012|FG008|Overall Study|Administrative reason|0|||
23683725|NCT00944034|66221013|FG009|Overall Study|Administrative reason|0|||
23683726|NCT00944034|66221014|FG010|Overall Study|Administrative reason|0|||
23683727|NCT00944034|66221015|FG011|Overall Study|Administrative reason|0|||
23683728|NCT02908516|66221016|FG000|Overall Study|Study Terminated|3|||
23683729|NCT02908516|66221017|FG001|Overall Study|Study Terminated|3|||
23683730|NCT02494596|66221018|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23683731|NCT02494596|66221019|FG001|Overall Study|Insufficient Therapeutic Response|3|||
23683732|NCT02494596|66221020|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23683733|NCT02494596|66221018|FG000|Overall Study|Adverse Event|0|||
23683734|NCT02494596|66221019|FG001|Overall Study|Adverse Event|1|||
23683735|NCT02494596|66221020|FG002|Overall Study|Adverse Event|0|||
23683736|NCT02494596|66221018|FG000|Overall Study|Refused Treatment|0|||
23683737|NCT02494596|66221019|FG001|Overall Study|Refused Treatment|1|||
23683738|NCT02494596|66221020|FG002|Overall Study|Refused Treatment|0|||
23683739|NCT02435914|66221024|FG000|Overall Study|Ocular Adverse Event|1|||
23683740|NCT02435914|66221025|FG001|Overall Study|Ocular Adverse Event|0|||
23683741|NCT02435914|66221026|FG002|Overall Study|Ocular Adverse Event|0|||
23683742|NCT02435914|66221027|FG003|Overall Study|Ocular Adverse Event|0|||
23683743|NCT02435914|66221024|FG000|Overall Study|Withdrawal by Subject|0|||
23683744|NCT02435914|66221025|FG001|Overall Study|Withdrawal by Subject|1|||
23391273|NCT00456365|65178518|FG000|Overall Study|oncologic diagnosis|1|||
23683745|NCT02435914|66221026|FG002|Overall Study|Withdrawal by Subject|0|||
23683746|NCT02435914|66221027|FG003|Overall Study|Withdrawal by Subject|0|||
23683747|NCT02435914|66221024|FG000|Overall Study|Other Miscellaneous Reason|0|||
23683748|NCT02435914|66221025|FG001|Overall Study|Other Miscellaneous Reason|0|||
23683749|NCT02435914|66221026|FG002|Overall Study|Other Miscellaneous Reason|1|||
23683750|NCT02435914|66221027|FG003|Overall Study|Other Miscellaneous Reason|0|||
23683751|NCT01961115|66221030|FG000|Overall Study|Disease Progression|1|||
23683752|NCT01961115|66221031|FG001|Overall Study|Disease Progression|0|||
23683753|NCT01961115|66221032|FG002|Overall Study|Disease Progression|3|||
23683754|NCT01961115|66221030|FG000|Overall Study|Adverse Event|1|||
23683755|NCT01961115|66221031|FG001|Overall Study|Adverse Event|0|||
23683756|NCT01961115|66221032|FG002|Overall Study|Adverse Event|1|||
23683757|NCT02700984|66221037|FG000|Overall Study|Death|2|||
23683758|NCT02700984|66221038|FG001|Overall Study|Death|1|||
23683759|NCT02700984|66221037|FG000|Overall Study|Lost to Follow-up|2|||
23683760|NCT02700984|66221038|FG001|Overall Study|Lost to Follow-up|1|||
23683761|NCT02700984|66221037|FG000|Overall Study|Physician Decision|0|||
23683762|NCT02700984|66221038|FG001|Overall Study|Physician Decision|1|||
23683763|NCT02700984|66221037|FG000|Overall Study|Withdrawal by Subject|8|||
23683764|NCT02700984|66221038|FG001|Overall Study|Withdrawal by Subject|9|||
23683765|NCT02700984|66221037|FG000|Overall Study|Reason not specified|3|||
23683766|NCT02700984|66221038|FG001|Overall Study|Reason not specified|2|||
23683767|NCT00699348|66221043|FG000|Overall Study|Death|6|||
23391274|NCT00456365|65178519|FG001|Overall Study|oncologic diagnosis|1|||
23391275|NCT02679274|65178520|FG000|Overall Study|Withdrawal by Subject|1|||
23391276|NCT02679274|65178521|FG001|Overall Study|Withdrawal by Subject|0|||
23391277|NCT01730729|65178527|FG000|Overall Study|Adverse Event|1|||
23391278|NCT01730729|65178527|FG000|Overall Study|Death|1|||
23391279|NCT01730729|65178527|FG000|Overall Study|Progressive Disease|12|||
23391280|NCT00959049|65178534|FG000|Overall Study|Adverse Event|1|||
23391281|NCT00959049|65178535|FG001|Overall Study|Adverse Event|0|||
23391282|NCT00959049|65178536|FG002|Overall Study|Adverse Event|0|||
23495747|NCT00676338|65558906|FG000|Overall Study|Entry Criteria Not Met|0|||
23495748|NCT00676338|65558907|FG001|Overall Study|Entry Criteria Not Met|2|||
23495749|NCT00676338|65558908|FG002|Overall Study|Entry Criteria Not Met|1|||
23495750|NCT00676338|65558909|FG003|Overall Study|Entry Criteria Not Met|1|||
23495751|NCT00676338|65558906|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495752|NCT00676338|65558907|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495753|NCT00676338|65558908|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
23495754|NCT00676338|65558909|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495755|NCT00622284|65558910|FG000|Overall Study|Lack of Efficacy|45|||
23495756|NCT00622284|65558911|FG001|Overall Study|Lack of Efficacy|15|||
23495757|NCT00622284|65558910|FG000|Overall Study|Adverse Event|61|||
23495758|NCT00622284|65558911|FG001|Overall Study|Adverse Event|90|||
23495759|NCT00622284|65558910|FG000|Overall Study|Protocol Violation|12|||
23495760|NCT00622284|65558911|FG001|Overall Study|Protocol Violation|5|||
23495761|NCT00622284|65558910|FG000|Overall Study|Lost to Follow-up|11|||
23495762|NCT00622284|65558911|FG001|Overall Study|Lost to Follow-up|13|||
23495763|NCT00622284|65558910|FG000|Overall Study|Withdrawal by Subject|27|||
23495764|NCT00622284|65558911|FG001|Overall Study|Withdrawal by Subject|24|||
23495765|NCT00622284|65558910|FG000|Overall Study|Other reason (not specified)|33|||
23495766|NCT00622284|65558911|FG001|Overall Study|Other reason (not specified)|24|||
23495767|NCT03095612|65558912|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495768|NCT03095612|65558913|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
23495769|NCT03095612|65558914|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23683768|NCT00699348|66221043|FG000|Overall Study|Adverse Event|15|||
23683769|NCT00699348|66221043|FG000|Overall Study|Withdrawal by Subject|11|||
23683770|NCT00699348|66221043|FG000|Overall Study|Protocol Violation|10|||
23683771|NCT00699348|66221043|FG000|Overall Study|Lack of Efficacy|8|||
23683772|NCT00699348|66221043|FG000|Overall Study|Failure to return|1|||
23683773|NCT00699348|66221043|FG000|Overall Study|Blood transfusion|24|||
23683774|NCT00699348|66221043|FG000|Overall Study|Renal transplantation|10|||
23391283|NCT00959049|65178537|FG003|Overall Study|Adverse Event|0|||
23683775|NCT00699348|66221043|FG000|Overall Study|Other|5|||
23683776|NCT01523873|66221044|FG000|Overall Study|Protocol Violation|422|||
23683777|NCT00404092|66221045|FG000|Overall Study|Death|1|||
23683778|NCT00404092|66221046|FG001|Overall Study|Death|0|||
23683779|NCT00404092|66221047|FG002|Overall Study|Death|0|||
23683780|NCT00404092|66221048|FG003|Overall Study|Death|0|||
23683781|NCT00404092|66221045|FG000|Overall Study|Adverse Event|0|||
23683782|NCT00404092|66221046|FG001|Overall Study|Adverse Event|0|||
23683783|NCT00404092|66221047|FG002|Overall Study|Adverse Event|1|||
23683784|NCT00404092|66221048|FG003|Overall Study|Adverse Event|0|||
23683785|NCT01707030|66221049|FG000|Overall Study|Death|1|||
23683786|NCT01707030|66221050|FG001|Overall Study|Death|1|||
23683787|NCT01707030|66221049|FG000|Overall Study|Withdrawal by Subject|2|||
23683788|NCT01707030|66221050|FG001|Overall Study|Withdrawal by Subject|3|||
23683789|NCT01707030|66221049|FG000|Overall Study|Lost to Follow-up|8|||
23683790|NCT01707030|66221050|FG001|Overall Study|Lost to Follow-up|13|||
23683791|NCT02663895|66221051|FG000|Overall Study|Adverse Event|3|||
23683792|NCT02663895|66221051|FG000|Overall Study|Physician Decision|2|||
23683793|NCT02663895|66221051|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
23683794|NCT02663895|66221051|FG000|Overall Study|Withdrawal by Subject|1|||
23683795|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
23683796|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
23683797|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
23683798|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23683799|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23683800|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23683801|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
23683802|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
23683803|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
23683804|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23683805|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23683806|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23683807|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
23683808|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
23683809|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
23683810|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23683811|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23683812|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23683813|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
23683814|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23683815|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23683816|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23683817|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23683818|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23683819|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
23683820|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
23683821|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
23683822|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23683823|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23683824|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23683825|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
23683826|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
23683827|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
23495770|NCT03095612|65558915|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495771|NCT03095612|65558916|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23683828|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23683829|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23683830|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23683831|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
23495772|NCT03095612|65558917|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495773|NCT03095612|65558918|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23683832|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
23683833|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
23683834|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
23683835|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
23683836|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
23683837|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
23683838|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
23683839|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
23683840|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23683841|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23683842|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23683843|NCT01707992|66221056|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
23683844|NCT01707992|66221057|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
23683845|NCT01707992|66221058|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
23683846|NCT01707992|66221059|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23683847|NCT01707992|66221060|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23683848|NCT01707992|66221061|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23683849|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
23683850|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
23683851|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
23683852|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
23683853|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
23683854|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
23683855|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23683856|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23683857|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23683858|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
23683859|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
23683860|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
23683861|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23683862|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23683863|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23683864|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
23683865|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
23683866|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
23683867|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
23683868|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
23683869|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
23683870|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
23683871|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
23683872|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
23683873|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23683874|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23683875|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23683876|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
23683877|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
23683878|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
23683879|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Death|0|||
23683880|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Death|0|||
23683881|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Death|0|||
23683882|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Death|2|||
23683883|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Death|0|||
23683884|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Death|0|||
23683885|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
23683886|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
23683887|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
23683888|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
23683889|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
23683890|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
23683891|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
23683892|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
23683893|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
23683894|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
23683895|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
23683896|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
23683897|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23683898|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23683899|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23683900|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
23683901|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
23683902|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
23683903|NCT01707992|66221056|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23683904|NCT01707992|66221057|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23683905|NCT01707992|66221058|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23683906|NCT01707992|66221059|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23683907|NCT01707992|66221060|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
23683908|NCT01707992|66221061|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23683909|NCT01552057|66221072|FG000|Overall Study|Adverse Event|14|||
23683910|NCT01552057|66221073|FG001|Overall Study|Adverse Event|15|||
23683911|NCT01552057|66221072|FG000|Overall Study|Lack of Efficacy|8|||
23683912|NCT01552057|66221073|FG001|Overall Study|Lack of Efficacy|23|||
23683913|NCT01552057|66221072|FG000|Overall Study|Withdrawal by Subject|5|||
23683914|NCT01552057|66221073|FG001|Overall Study|Withdrawal by Subject|8|||
23683915|NCT01552057|66221072|FG000|Overall Study|Entry Criteria Not Met|2|||
23683916|NCT01552057|66221073|FG001|Overall Study|Entry Criteria Not Met|2|||
23683917|NCT01552057|66221072|FG000|Overall Study|Physician Decision|1|||
23683918|NCT01552057|66221073|FG001|Overall Study|Physician Decision|0|||
23683919|NCT02327260|66221078|FG000|Overall Study|Lost to Follow-up|2|||
23683920|NCT02327260|66221079|FG001|Overall Study|Lost to Follow-up|3|||
23683921|NCT02327260|66221080|FG002|Overall Study|Lost to Follow-up|2|||
23683922|NCT02327260|66221078|FG000|Overall Study|invalid phone number|1|||
23683923|NCT02327260|66221079|FG001|Overall Study|invalid phone number|1|||
23683924|NCT02327260|66221080|FG002|Overall Study|invalid phone number|0|||
23683925|NCT02327260|66221078|FG000|Overall Study|non-adherence to protocol|2|||
23683926|NCT02327260|66221079|FG001|Overall Study|non-adherence to protocol|0|||
23683927|NCT02327260|66221080|FG002|Overall Study|non-adherence to protocol|0|||
23683928|NCT02327260|66221078|FG000|Overall Study|cognitive concerns|1|||
23683929|NCT02327260|66221079|FG001|Overall Study|cognitive concerns|0|||
23683930|NCT02327260|66221080|FG002|Overall Study|cognitive concerns|0|||
23683931|NCT01254669|66221081|FG000|Overall Study|Withdrawal by Subject|0|||
23683932|NCT01254669|66221082|FG001|Overall Study|Withdrawal by Subject|1|||
23683933|NCT01254669|66221081|FG000|Overall Study|time constraint|2|||
23683934|NCT01254669|66221082|FG001|Overall Study|time constraint|2|||
23683935|NCT01254669|66221081|FG000|Overall Study|called to clinic during intervention|1|||
23683936|NCT01254669|66221082|FG001|Overall Study|called to clinic during intervention|1|||
23683937|NCT04897867|66221083|FG000|Overall Study|Withdrawal of Consent|1|||
23683938|NCT04897867|66221083|FG000|Overall Study|Pregnancy|1|||
23683939|NCT04897867|66221083|FG000|Overall Study|Lost to Follow-up|7|||
23683940|NCT04897867|66221083|FG000|Overall Study|Reason not Specified|2|||
23683941|NCT02886702|66221084|FG000|Overall Study|Other|4|||
23683942|NCT02886702|66221085|FG001|Overall Study|Other|3|||
23683943|NCT02886702|66221086|FG002|Overall Study|Other|9|||
23683944|NCT02886702|66221084|FG000|Overall Study|Withdrawal by Subject|24|||
23683945|NCT02886702|66221085|FG001|Overall Study|Withdrawal by Subject|18|||
23683946|NCT02886702|66221086|FG002|Overall Study|Withdrawal by Subject|22|||
23683947|NCT02886702|66221084|FG000|Overall Study|Significant Worsening of Condition|0|||
23683948|NCT02886702|66221085|FG001|Overall Study|Significant Worsening of Condition|1|||
23683949|NCT02886702|66221086|FG002|Overall Study|Significant Worsening of Condition|0|||
23683950|NCT02886702|66221084|FG000|Overall Study|Protocol Violation|2|||
23683951|NCT02886702|66221085|FG001|Overall Study|Protocol Violation|2|||
23683952|NCT02886702|66221086|FG002|Overall Study|Protocol Violation|1|||
23683953|NCT02886702|66221084|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23683954|NCT02886702|66221085|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23683955|NCT02886702|66221086|FG002|Overall Study|Non-Compliance With Study Drug|4|||
23683956|NCT02886702|66221084|FG000|Overall Study|Lost to Follow-up|11|||
23683957|NCT02886702|66221085|FG001|Overall Study|Lost to Follow-up|13|||
23683958|NCT02886702|66221086|FG002|Overall Study|Lost to Follow-up|8|||
23683959|NCT02886702|66221084|FG000|Overall Study|Lack of Efficacy|3|||
23683960|NCT02886702|66221085|FG001|Overall Study|Lack of Efficacy|4|||
23683961|NCT02886702|66221086|FG002|Overall Study|Lack of Efficacy|5|||
23683962|NCT02886702|66221084|FG000|Overall Study|Adverse Event|4|||
23683963|NCT02886702|66221085|FG001|Overall Study|Adverse Event|9|||
23683964|NCT02886702|66221086|FG002|Overall Study|Adverse Event|3|||
23683965|NCT02886702|66221084|FG000|Overall Study|Administrative Reasons|0|||
23683966|NCT02886702|66221085|FG001|Overall Study|Administrative Reasons|0|||
23683967|NCT02886702|66221086|FG002|Overall Study|Administrative Reasons|1|||
23391284|NCT00959049|65178538|FG004|Overall Study|Adverse Event|0|||
23683968|NCT01658514|66221087|FG000|Overall Study|Protocol Violation|1|||
23683969|NCT01658514|66221088|FG001|Overall Study|Protocol Violation|0|||
23683970|NCT01658514|66221089|FG002|Overall Study|Protocol Violation|2|||
23683971|NCT00700804|66221090|FG000|Overall Study|Withdrawal by Subject|1|||
23683972|NCT00700804|66221091|FG001|Overall Study|Withdrawal by Subject|2|||
23683973|NCT00700804|66221090|FG000|Overall Study|Protocol Violation|1|||
23683974|NCT00700804|66221091|FG001|Overall Study|Protocol Violation|1|||
23683975|NCT00700804|66221090|FG000|Overall Study|Loose Stools|1|||
23683976|NCT00700804|66221091|FG001|Overall Study|Loose Stools|1|||
23683977|NCT01553149|66221092|FG000|Overall Study|Adverse Event|0|||
23683978|NCT01553149|66221093|FG001|Overall Study|Adverse Event|9|||
23495774|NCT00809354|65558920|FG000|Overall Study|Adverse Event|32|||
23683979|NCT01553149|66221092|FG000|Overall Study|Physician Decision|5|||
23683980|NCT01553149|66221093|FG001|Overall Study|Physician Decision|10|||
23683981|NCT01553149|66221092|FG000|Overall Study|Ineligible|0|||
23683982|NCT01553149|66221093|FG001|Overall Study|Ineligible|1|||
23683983|NCT02804763|66221099|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
23683984|NCT02804763|66221100|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23683985|NCT02804763|66221101|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23683986|NCT02804763|66221102|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23683987|NCT02804763|66221099|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
23683988|NCT02804763|66221100|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
23683989|NCT02804763|66221101|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
23683990|NCT02804763|66221102|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
23683991|NCT02804763|66221099|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23683992|NCT02804763|66221100|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
23683993|NCT02804763|66221101|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23683994|NCT02804763|66221102|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23683995|NCT02804763|66221099|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
23683996|NCT02804763|66221100|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
23683997|NCT02804763|66221101|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
23683998|NCT02804763|66221102|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
23683999|NCT02804763|66221099|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
23684000|NCT02804763|66221100|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
23684001|NCT02804763|66221101|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
23684002|NCT02804763|66221102|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
23391285|NCT00959049|65178539|FG005|Overall Study|Adverse Event|0|||
23391286|NCT00959049|65178534|FG000|Overall Study|Lost to Follow-up|17|||
23391287|NCT00959049|65178535|FG001|Overall Study|Lost to Follow-up|5|||
23391288|NCT00959049|65178536|FG002|Overall Study|Lost to Follow-up|1|||
23391289|NCT00959049|65178537|FG003|Overall Study|Lost to Follow-up|10|||
23391290|NCT00959049|65178538|FG004|Overall Study|Lost to Follow-up|9|||
23391291|NCT00959049|65178539|FG005|Overall Study|Lost to Follow-up|1|||
23391292|NCT00959049|65178534|FG000|Overall Study|Contraindicated medication|0|||
23391293|NCT00959049|65178535|FG001|Overall Study|Contraindicated medication|0|||
23391294|NCT00959049|65178536|FG002|Overall Study|Contraindicated medication|0|||
23391295|NCT00959049|65178537|FG003|Overall Study|Contraindicated medication|1|||
23391296|NCT00959049|65178538|FG004|Overall Study|Contraindicated medication|0|||
23391297|NCT00959049|65178539|FG005|Overall Study|Contraindicated medication|0|||
23391298|NCT00959049|65178534|FG000|Overall Study|Withdrawal by Subject|0|||
23391299|NCT00959049|65178535|FG001|Overall Study|Withdrawal by Subject|2|||
23391300|NCT00959049|65178536|FG002|Overall Study|Withdrawal by Subject|0|||
23391301|NCT00959049|65178537|FG003|Overall Study|Withdrawal by Subject|0|||
23391302|NCT00959049|65178538|FG004|Overall Study|Withdrawal by Subject|0|||
23391303|NCT00959049|65178539|FG005|Overall Study|Withdrawal by Subject|0|||
23391304|NCT03647137|65178540|FG000|Overall Study|Scan Limitation|2|||
23391305|NCT03647137|65178541|FG001|Overall Study|Scan Limitation|1|||
23391306|NCT03647137|65178542|FG002|Overall Study|Scan Limitation|1|||
23391307|NCT03647137|65178543|FG003|Overall Study|Scan Limitation|2|||
23391308|NCT04976855|65178550|FG000|Part I|Withdrawal by Subject|0|||
23391309|NCT04976855|65178551|FG001|Part I|Withdrawal by Subject|1|||
23391310|NCT04976855|65178552|FG002|Part I|Withdrawal by Subject|0|||
23391311|NCT04976855|65178553|FG003|Part I|Withdrawal by Subject|0|||
23391312|NCT04976855|65178554|FG004|Part I|Withdrawal by Subject|0|||
23391313|NCT04976855|65178555|FG005|Part I|Withdrawal by Subject|0|||
23391314|NCT04976855|65178556|FG006|Part I|Withdrawal by Subject|0|||
23391315|NCT04976855|65178550|FG000|Part II|Adverse Event|0|||
23391316|NCT04976855|65178551|FG001|Part II|Adverse Event|0|||
23391317|NCT04976855|65178552|FG002|Part II|Adverse Event|0|||
23391318|NCT04976855|65178553|FG003|Part II|Adverse Event|1|||
23391319|NCT04976855|65178554|FG004|Part II|Adverse Event|0|||
23391320|NCT04976855|65178555|FG005|Part II|Adverse Event|0|||
23391321|NCT04976855|65178556|FG006|Part II|Adverse Event|0|||
23391322|NCT04976855|65178550|FG000|Part II|Withdrawal by Subject|0|||
23391323|NCT04976855|65178551|FG001|Part II|Withdrawal by Subject|0|||
23391324|NCT04976855|65178552|FG002|Part II|Withdrawal by Subject|0|||
23391325|NCT04976855|65178553|FG003|Part II|Withdrawal by Subject|0|||
23391326|NCT04976855|65178554|FG004|Part II|Withdrawal by Subject|1|||
23684003|NCT02804763|66221099|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23684004|NCT02804763|66221100|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
23391327|NCT04976855|65178555|FG005|Part II|Withdrawal by Subject|0|||
23391328|NCT04976855|65178556|FG006|Part II|Withdrawal by Subject|0|||
23391329|NCT04976855|65178550|FG000|Part II|Lost to Follow-up|0|||
23391330|NCT04976855|65178551|FG001|Part II|Lost to Follow-up|0|||
23391331|NCT04976855|65178552|FG002|Part II|Lost to Follow-up|0|||
23391332|NCT04976855|65178553|FG003|Part II|Lost to Follow-up|0|||
23684005|NCT02804763|66221101|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23684006|NCT02804763|66221102|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23684007|NCT02487108|66221103|FG000|Overall Study|Adverse Event|1|||
23684008|NCT02487108|66221104|FG001|Overall Study|Adverse Event|6|||
23684009|NCT02487108|66221105|FG002|Overall Study|Adverse Event|12|||
23684010|NCT02487108|66221106|FG003|Overall Study|Adverse Event|6|||
23684011|NCT02487108|66221103|FG000|Overall Study|Withdrawal by Subject|8|||
23684012|NCT02487108|66221104|FG001|Overall Study|Withdrawal by Subject|5|||
23684013|NCT02487108|66221105|FG002|Overall Study|Withdrawal by Subject|5|||
23684014|NCT02487108|66221106|FG003|Overall Study|Withdrawal by Subject|0|||
23684015|NCT02487108|66221103|FG000|Overall Study|Non-compliance to study medication|3|||
23684016|NCT02487108|66221104|FG001|Overall Study|Non-compliance to study medication|2|||
23684017|NCT02487108|66221105|FG002|Overall Study|Non-compliance to study medication|5|||
23684018|NCT02487108|66221106|FG003|Overall Study|Non-compliance to study medication|4|||
23684019|NCT02487108|66221103|FG000|Overall Study|Protocol Violation|1|||
23684020|NCT02487108|66221104|FG001|Overall Study|Protocol Violation|1|||
23684021|NCT02487108|66221105|FG002|Overall Study|Protocol Violation|2|||
23684022|NCT02487108|66221106|FG003|Overall Study|Protocol Violation|0|||
23684023|NCT02487108|66221103|FG000|Overall Study|Non-compliance to study procedures|0|||
23684024|NCT02487108|66221104|FG001|Overall Study|Non-compliance to study procedures|0|||
23684025|NCT02487108|66221105|FG002|Overall Study|Non-compliance to study procedures|0|||
23684026|NCT02487108|66221106|FG003|Overall Study|Non-compliance to study procedures|1|||
23684027|NCT02487108|66221103|FG000|Overall Study|Other than specified|3|||
23684028|NCT02487108|66221104|FG001|Overall Study|Other than specified|2|||
23684029|NCT02487108|66221105|FG002|Overall Study|Other than specified|2|||
23684030|NCT02487108|66221106|FG003|Overall Study|Other than specified|0|||
23684031|NCT00977470|66221107|FG000|Overall Study|Lack of Efficacy|32|||
23684032|NCT00977470|66221108|FG001|Overall Study|Lack of Efficacy|30|||
23684033|NCT00977470|66221107|FG000|Overall Study|Physician Decision|2|||
23684034|NCT00977470|66221108|FG001|Overall Study|Physician Decision|0|||
23684035|NCT00977470|66221107|FG000|Overall Study|Adverse Event|1|||
23684036|NCT00977470|66221108|FG001|Overall Study|Adverse Event|2|||
23684037|NCT00977470|66221107|FG000|Overall Study|Protocol Violation|1|||
23684038|NCT00977470|66221108|FG001|Overall Study|Protocol Violation|0|||
23684039|NCT00977470|66221107|FG000|Overall Study|Withdrawal by Subject|0|||
23684040|NCT00977470|66221108|FG001|Overall Study|Withdrawal by Subject|2|||
23684041|NCT00977470|66221107|FG000|Overall Study|Death|0|||
23684042|NCT00977470|66221108|FG001|Overall Study|Death|2|||
23684043|NCT00977470|66221107|FG000|Overall Study|clinical decline|0|||
23684044|NCT00977470|66221108|FG001|Overall Study|clinical decline|1|||
23684045|NCT00977470|66221107|FG000|Overall Study|prolonged recovery post-surgery|0|||
23684046|NCT00977470|66221108|FG001|Overall Study|prolonged recovery post-surgery|1|||
23684047|NCT00977470|66221107|FG000|Overall Study|Still on-study|2|||
23684048|NCT00977470|66221108|FG001|Overall Study|Still on-study|0|||
23684049|NCT04173741|66221112|FG000|Overall Study|IVC measurement cannot be done|1|||
23684050|NCT04173741|66221113|FG001|Overall Study|IVC measurement cannot be done|1|||
23684051|NCT05032950|66221122|FG000|Overall Study|Adverse Event|0|||
23684052|NCT05032950|66221123|FG001|Overall Study|Adverse Event|0|||
23684053|NCT05032950|66221124|FG002|Overall Study|Adverse Event|1|||
23684054|NCT05032950|66221125|FG003|Overall Study|Adverse Event|1|||
23391333|NCT04976855|65178554|FG004|Part II|Lost to Follow-up|0|||
23391334|NCT04976855|65178555|FG005|Part II|Lost to Follow-up|1|||
23391335|NCT04976855|65178556|FG006|Part II|Lost to Follow-up|0|||
23684055|NCT05032950|66221126|FG004|Overall Study|Adverse Event|0|||
23684056|NCT05032950|66221127|FG005|Overall Study|Adverse Event|0|||
23684057|NCT00709202|66221128|FG000|Overall Study|Withdrawal by Subject|6|||
23684058|NCT00709202|66221129|FG001|Overall Study|Withdrawal by Subject|6|||
23684059|NCT01731002|66221130|FG000|Overall Study|Adverse Event|0|||
23684060|NCT01731002|66221131|FG001|Overall Study|Adverse Event|2|||
23684061|NCT01731002|66221132|FG002|Overall Study|Adverse Event|2|||
23684062|NCT01731002|66221130|FG000|Overall Study|Non-Compliant|0|||
23684063|NCT01731002|66221131|FG001|Overall Study|Non-Compliant|1|||
23684064|NCT01731002|66221132|FG002|Overall Study|Non-Compliant|0|||
23684065|NCT01731002|66221130|FG000|Overall Study|Lost to Follow-up|1|||
23684066|NCT01731002|66221131|FG001|Overall Study|Lost to Follow-up|0|||
23684067|NCT01731002|66221132|FG002|Overall Study|Lost to Follow-up|0|||
23684068|NCT01731002|66221130|FG000|Overall Study|Test Agent Discontinuation|0|||
23684069|NCT01731002|66221131|FG001|Overall Study|Test Agent Discontinuation|1|||
23684070|NCT01731002|66221132|FG002|Overall Study|Test Agent Discontinuation|0|||
23684071|NCT01731002|66221130|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
23684072|NCT01731002|66221131|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
23684073|NCT01731002|66221132|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
23684074|NCT01731002|66221130|FG000|Overall Study|Elevated IOP|1|||
23684075|NCT01731002|66221131|FG001|Overall Study|Elevated IOP|0|||
23684076|NCT01731002|66221132|FG002|Overall Study|Elevated IOP|0|||
23684077|NCT01731002|66221130|FG000|Overall Study|Inappropriate use of study medications|0|||
23495775|NCT00809354|65558921|FG001|Overall Study|Adverse Event|45|||
23684078|NCT01731002|66221131|FG001|Overall Study|Inappropriate use of study medications|0|||
23684079|NCT01731002|66221132|FG002|Overall Study|Inappropriate use of study medications|1|||
23684080|NCT00891202|66221134|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
23684081|NCT00891202|66221135|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23684082|NCT00891202|66221136|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23684083|NCT00891202|66221137|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23684084|NCT00891202|66221134|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23684085|NCT00891202|66221135|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23684086|NCT00891202|66221136|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
23684087|NCT00891202|66221137|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23684088|NCT00891202|66221134|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23684089|NCT00891202|66221135|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23684090|NCT00891202|66221136|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
23684091|NCT00891202|66221137|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23684092|NCT00891202|66221134|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
23684093|NCT00891202|66221135|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
23684094|NCT00891202|66221136|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
23684095|NCT00891202|66221137|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
23684096|NCT03619213|66221138|FG000|Overall Study|Lost to Follow-up|2|||
23684097|NCT03619213|66221139|FG001|Overall Study|Lost to Follow-up|1|||
23684098|NCT03619213|66221138|FG000|Overall Study|Withdrawal by Subject|8|||
23684099|NCT03619213|66221139|FG001|Overall Study|Withdrawal by Subject|10|||
23684100|NCT03828487|66221140|FG000|Overall Study|Physician Decision|1|||
23684101|NCT00434967|66221141|FG000|Overall Study|Adverse Event|2|||
23684102|NCT00434967|66221142|FG001|Overall Study|Adverse Event|4|||
23684103|NCT00434967|66221143|FG002|Overall Study|Adverse Event|3|||
23684104|NCT00434967|66221144|FG003|Overall Study|Adverse Event|3|||
23684105|NCT00434967|66221141|FG000|Overall Study|Lost to Follow-up|0|||
23684106|NCT00434967|66221142|FG001|Overall Study|Lost to Follow-up|0|||
23684107|NCT00434967|66221143|FG002|Overall Study|Lost to Follow-up|1|||
23684108|NCT00434967|66221144|FG003|Overall Study|Lost to Follow-up|0|||
23684109|NCT00434967|66221141|FG000|Overall Study|Withdrawal by Subject|2|||
23684110|NCT00434967|66221142|FG001|Overall Study|Withdrawal by Subject|2|||
23684111|NCT00434967|66221143|FG002|Overall Study|Withdrawal by Subject|4|||
23684112|NCT00434967|66221144|FG003|Overall Study|Withdrawal by Subject|6|||
23684113|NCT00434967|66221141|FG000|Overall Study|Randomized in error|0|||
23684114|NCT00434967|66221142|FG001|Overall Study|Randomized in error|0|||
23684115|NCT00434967|66221143|FG002|Overall Study|Randomized in error|0|||
23684116|NCT00434967|66221144|FG003|Overall Study|Randomized in error|1|||
23684117|NCT00434967|66221141|FG000|Overall Study|Protocol Violation|0|||
23684118|NCT00434967|66221142|FG001|Overall Study|Protocol Violation|1|||
23684119|NCT00434967|66221143|FG002|Overall Study|Protocol Violation|0|||
23684120|NCT00434967|66221144|FG003|Overall Study|Protocol Violation|1|||
23684121|NCT00434967|66221141|FG000|Overall Study|Physician Decision|1|||
23684122|NCT00434967|66221142|FG001|Overall Study|Physician Decision|1|||
23684123|NCT00434967|66221143|FG002|Overall Study|Physician Decision|1|||
23684124|NCT00434967|66221144|FG003|Overall Study|Physician Decision|0|||
23684125|NCT00434967|66221141|FG000|Overall Study|Patient Disposition Challenges|2|||
23684126|NCT00434967|66221142|FG001|Overall Study|Patient Disposition Challenges|0|||
23684127|NCT00434967|66221143|FG002|Overall Study|Patient Disposition Challenges|0|||
23684128|NCT00434967|66221144|FG003|Overall Study|Patient Disposition Challenges|3|||
23684129|NCT01384292|66221146|FG000|Part B|Severe non-compliance to protocol|1|||
23684130|NCT01384292|66221147|FG001|Part B|Severe non-compliance to protocol|0|||
23684131|NCT01384292|66221148|FG002|Part B|Severe non-compliance to protocol|0|||
23684132|NCT01818726|66221152|FG000|Overall Study|Administrative reasons|5|||
23684133|NCT01818726|66221153|FG001|Overall Study|Administrative reasons|1|||
23684134|NCT01818726|66221152|FG000|Overall Study|Withdrawal by Subject|0|||
23684135|NCT01818726|66221153|FG001|Overall Study|Withdrawal by Subject|1|||
23684136|NCT01818726|66221152|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
23684137|NCT01818726|66221153|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
23684138|NCT00200850|66221154|FG000|Overall Study|relocation|1|||
23684139|NCT00200850|66221155|FG001|Overall Study|relocation|0|||
23684140|NCT00200850|66221156|FG002|Overall Study|relocation|1|||
23684141|NCT00200850|66221154|FG000|Overall Study|too busy|1|||
23684142|NCT00200850|66221155|FG001|Overall Study|too busy|0|||
23684143|NCT00200850|66221156|FG002|Overall Study|too busy|0|||
23684144|NCT00200850|66221154|FG000|Overall Study|Pregnancy|0|||
23684145|NCT00200850|66221155|FG001|Overall Study|Pregnancy|0|||
23684146|NCT00200850|66221156|FG002|Overall Study|Pregnancy|1|||
23684147|NCT00200850|66221154|FG000|Overall Study|Poor adherence|0|||
23684148|NCT00200850|66221155|FG001|Overall Study|Poor adherence|0|||
23684149|NCT00200850|66221156|FG002|Overall Study|Poor adherence|1|||
23684150|NCT00200850|66221154|FG000|Overall Study|optic neuritis|0|||
23684151|NCT00200850|66221155|FG001|Overall Study|optic neuritis|0|||
23684152|NCT00200850|66221156|FG002|Overall Study|optic neuritis|1|||
23684153|NCT00200850|66221154|FG000|Overall Study|Adverse Event|1|||
23684154|NCT00200850|66221155|FG001|Overall Study|Adverse Event|1|||
23684155|NCT00200850|66221156|FG002|Overall Study|Adverse Event|2|||
23495776|NCT00809354|65558922|FG002|Overall Study|Adverse Event|37|||
23495777|NCT00809354|65558923|FG003|Overall Study|Adverse Event|53|||
23495778|NCT00809354|65558924|FG004|Overall Study|Adverse Event|26|||
23495779|NCT00809354|65558925|FG005|Overall Study|Adverse Event|33|||
23495780|NCT00809354|65558926|FG006|Overall Study|Adverse Event|44|||
23495781|NCT00809354|65558927|FG007|Overall Study|Adverse Event|40|||
23495782|NCT00809354|65558928|FG008|Overall Study|Adverse Event|46|||
23495783|NCT00809354|65558929|FG009|Overall Study|Adverse Event|26|||
23495784|NCT00809354|65558920|FG000|Overall Study|Lack of Efficacy|23|||
23495785|NCT00809354|65558921|FG001|Overall Study|Lack of Efficacy|23|||
23495786|NCT00809354|65558922|FG002|Overall Study|Lack of Efficacy|22|||
23495787|NCT00809354|65558923|FG003|Overall Study|Lack of Efficacy|15|||
23684156|NCT02320487|66221157|FG000|Overall Study|Reason not Specified|1|||
23684157|NCT02320487|66221157|FG000|Overall Study|Physician Decision|5|||
23684158|NCT02320487|66221157|FG000|Overall Study|Withdrawal by Subject|1|||
23684159|NCT02320487|66221157|FG000|Overall Study|Death|3|||
23684160|NCT02320487|66221157|FG000|Overall Study|Adverse Event|11|||
23684161|NCT00483327|66221158|FG000|Overall Study|Adverse Event|1|||
23684162|NCT00483327|66221158|FG000|Overall Study|Withdrawal by Subject|3|||
23684163|NCT00483327|66221158|FG000|Overall Study|Lost to Follow-up|4|||
23684164|NCT00483327|66221158|FG000|Overall Study|Patient Non Compliance|2|||
23684165|NCT01961544|66221159|FG000|Overall Study|Protocol Violation|1|||
23684166|NCT01961544|66221159|FG000|Overall Study|Withdrawal by Subject|7|||
23684167|NCT01961544|66221159|FG000|Overall Study|Adverse Event|1|||
23684168|NCT01961544|66221159|FG000|Overall Study|Physician Decision|2|||
23684169|NCT01961544|66221159|FG000|Overall Study|Poor Tolerance|1|||
23684170|NCT01961544|66221159|FG000|Overall Study|Aggravation of Steral Pain|1|||
23684171|NCT02700451|66221160|FG000|Overall Study|Protocol Violation|2|||
23684172|NCT02700451|66221161|FG001|Overall Study|Protocol Violation|2|||
23684173|NCT02700451|66221162|FG002|Overall Study|Protocol Violation|3|||
23684174|NCT02700451|66221160|FG000|Overall Study|Discontinued intervention|14|||
23684175|NCT02700451|66221161|FG001|Overall Study|Discontinued intervention|15|||
23684176|NCT02700451|66221162|FG002|Overall Study|Discontinued intervention|14|||
23684177|NCT00805740|66221171|FG000|Overall Study|Death|7|||
23684178|NCT00805740|66221172|FG001|Overall Study|Death|4|||
23684179|NCT00805740|66221171|FG000|Overall Study|Withdrawal by Subject|1|||
23684180|NCT00805740|66221172|FG001|Overall Study|Withdrawal by Subject|0|||
23684181|NCT00805740|66221171|FG000|Overall Study|Lost to Follow-up|1|||
23684182|NCT00805740|66221172|FG001|Overall Study|Lost to Follow-up|0|||
23684183|NCT00805740|66221171|FG000|Overall Study|Randomized, but not treated|2|||
23684184|NCT00805740|66221172|FG001|Overall Study|Randomized, but not treated|0|||
23684185|NCT02304926|66221177|FG000|Overall Study|Lost to Follow-up|2|||
23684186|NCT02304926|66221178|FG001|Overall Study|Lost to Follow-up|1|||
23684187|NCT01227967|66221182|FG000|Overall Study|Protocol Violation|3|||
23684188|NCT01227967|66221183|FG001|Overall Study|Protocol Violation|1|||
23684189|NCT01227967|66221182|FG000|Overall Study|Death|0|||
23684190|NCT01227967|66221183|FG001|Overall Study|Death|1|||
23684191|NCT01227967|66221182|FG000|Overall Study|Lost to Follow-up|8|||
23684192|NCT01227967|66221183|FG001|Overall Study|Lost to Follow-up|3|||
23391336|NCT00661687|65178557|FG000|Overall Study|Study related symptoms and complaints|5|||
23391337|NCT00661687|65178557|FG000|Overall Study|Positive slit lamp findings|4|||
23391338|NCT00661687|65178557|FG000|Overall Study|Inability to maintain wearing schedule|3|||
23391339|NCT00661687|65178557|FG000|Overall Study|Physician Decision|1|||
23391340|NCT00661687|65178557|FG000|Overall Study|Adverse Event|2|||
23391341|NCT00662038|65178558|FG000|Overall Study|Reason not specified|3|||
23391342|NCT00662038|65178558|FG000|Overall Study|Withdrawn consent|22|||
23391343|NCT00662038|65178558|FG000|Overall Study|Withdrawal by Subject|83|||
23495788|NCT00809354|65558924|FG004|Overall Study|Lack of Efficacy|40|||
23495789|NCT00809354|65558925|FG005|Overall Study|Lack of Efficacy|19|||
23495790|NCT00809354|65558926|FG006|Overall Study|Lack of Efficacy|21|||
23495791|NCT00809354|65558927|FG007|Overall Study|Lack of Efficacy|15|||
23684193|NCT01227967|66221182|FG000|Overall Study|Withdrawal by Subject|4|||
23684194|NCT01227967|66221183|FG001|Overall Study|Withdrawal by Subject|3|||
23684195|NCT01227967|66221182|FG000|Overall Study|Physician Decision|0|||
23684196|NCT01227967|66221183|FG001|Overall Study|Physician Decision|1|||
23684197|NCT01227967|66221182|FG000|Overall Study|Never Started Treatment|0|||
23684198|NCT01227967|66221183|FG001|Overall Study|Never Started Treatment|4|||
23684199|NCT01227967|66221182|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
23684200|NCT01227967|66221183|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
23684201|NCT01290887|66221184|FG000|Overall Study|Adverse Event|6|||
23684202|NCT01290887|66221185|FG001|Overall Study|Adverse Event|11|||
23684203|NCT01290887|66221184|FG000|Overall Study|Lack of Efficacy|4|||
23684204|NCT01290887|66221185|FG001|Overall Study|Lack of Efficacy|5|||
23684205|NCT01290887|66221184|FG000|Overall Study|Withdrawal by Subject|26|||
23684206|NCT01290887|66221185|FG001|Overall Study|Withdrawal by Subject|32|||
23495792|NCT00809354|65558928|FG008|Overall Study|Lack of Efficacy|18|||
23684207|NCT01290887|66221184|FG000|Overall Study|Protocol Violation|2|||
23684208|NCT01290887|66221185|FG001|Overall Study|Protocol Violation|1|||
23684209|NCT01290887|66221184|FG000|Overall Study|Lost to Follow-up|4|||
23684210|NCT01290887|66221185|FG001|Overall Study|Lost to Follow-up|4|||
23684211|NCT01290887|66221184|FG000|Overall Study|Non-compliance to study procedures|0|||
23684212|NCT01290887|66221185|FG001|Overall Study|Non-compliance to study procedures|1|||
23684213|NCT01290887|66221184|FG000|Overall Study|Non-compliance to study medications|1|||
23684214|NCT01290887|66221185|FG001|Overall Study|Non-compliance to study medications|0|||
23684215|NCT01290887|66221184|FG000|Overall Study|Sponsor closure of study|420|||
23684216|NCT01290887|66221185|FG001|Overall Study|Sponsor closure of study|476|||
23684217|NCT01290887|66221184|FG000|Overall Study|Other|3|||
23684218|NCT01290887|66221185|FG001|Overall Study|Other|6|||
23684219|NCT02582658|66221186|FG000|Overall Study|Failure to Return|10|||
23684220|NCT02582658|66221186|FG000|Overall Study|Insufficient Virological Response|2|||
23684221|NCT02582658|66221186|FG000|Overall Study|Withdrawn Consent|1|||
23684222|NCT02582658|66221186|FG000|Overall Study|Death|1|||
23684223|NCT02582658|66221186|FG000|Overall Study|Not further specified|11|||
23684224|NCT03283085|66221187|FG000|Overall Study|Adverse Event|18|||
23684225|NCT03283085|66221188|FG001|Overall Study|Adverse Event|3|||
23684226|NCT03283085|66221189|FG002|Overall Study|Adverse Event|13|||
23684227|NCT03283085|66221190|FG003|Overall Study|Adverse Event|0|||
23684228|NCT03283085|66221191|FG004|Overall Study|Adverse Event|0|||
23684229|NCT03283085|66221192|FG005|Overall Study|Adverse Event|5|||
23684230|NCT03283085|66221187|FG000|Overall Study|Death|0|||
23684231|NCT03283085|66221188|FG001|Overall Study|Death|0|||
23684232|NCT03283085|66221189|FG002|Overall Study|Death|3|||
23684233|NCT03283085|66221190|FG003|Overall Study|Death|1|||
23684234|NCT03283085|66221191|FG004|Overall Study|Death|0|||
23684235|NCT03283085|66221192|FG005|Overall Study|Death|0|||
23391344|NCT00662038|65178558|FG000|Overall Study|Sponsor decision|1|||
23391345|NCT00662038|65178558|FG000|Overall Study|Physician Decision|19|||
23391346|NCT00662038|65178558|FG000|Overall Study|Lung transplantation|44|||
23391347|NCT00662038|65178558|FG000|Overall Study|Lost to Follow-up|1|||
23391348|NCT00662038|65178558|FG000|Overall Study|Death|95|||
23391349|NCT00662038|65178558|FG000|Overall Study|Adverse Event|358|||
23391350|NCT00662038|65178558|FG000|Overall Study|Continued treatment|5|||
23391351|NCT00979407|65178561|FG000|Overall Study|Withdrawal by Subject|3|||
23391352|NCT00979407|65178562|FG001|Overall Study|Withdrawal by Subject|4|||
23391353|NCT00979407|65178561|FG000|Overall Study|Lost to Follow-up|3|||
23495793|NCT00809354|65558929|FG009|Overall Study|Lack of Efficacy|38|||
23495794|NCT00809354|65558920|FG000|Overall Study|Lost to Follow-up|10|||
23495795|NCT00809354|65558921|FG001|Overall Study|Lost to Follow-up|11|||
23495796|NCT00809354|65558922|FG002|Overall Study|Lost to Follow-up|8|||
23495797|NCT00809354|65558923|FG003|Overall Study|Lost to Follow-up|13|||
23495798|NCT00809354|65558924|FG004|Overall Study|Lost to Follow-up|6|||
23495799|NCT00809354|65558925|FG005|Overall Study|Lost to Follow-up|2|||
23495800|NCT00809354|65558926|FG006|Overall Study|Lost to Follow-up|0|||
23495801|NCT00809354|65558927|FG007|Overall Study|Lost to Follow-up|5|||
23495802|NCT00809354|65558928|FG008|Overall Study|Lost to Follow-up|4|||
23495803|NCT00809354|65558929|FG009|Overall Study|Lost to Follow-up|0|||
23495804|NCT00809354|65558920|FG000|Overall Study|Protocol Violation|7|||
23495805|NCT00809354|65558921|FG001|Overall Study|Protocol Violation|14|||
23495806|NCT00809354|65558922|FG002|Overall Study|Protocol Violation|14|||
23495807|NCT00809354|65558923|FG003|Overall Study|Protocol Violation|12|||
23495808|NCT00809354|65558924|FG004|Overall Study|Protocol Violation|14|||
23495809|NCT00809354|65558925|FG005|Overall Study|Protocol Violation|6|||
23391354|NCT00979407|65178562|FG001|Overall Study|Lost to Follow-up|3|||
23391355|NCT00322218|65178563|FG000|Overall Study|Death|3|||
23391356|NCT00322218|65178564|FG001|Overall Study|Death|6|||
23391357|NCT00879398|65178570|FG000|Overall Study|Visit Stop|399|||
23391358|NCT00879398|65178570|FG000|Overall Study|Lack of Efficacy|64|||
23391359|NCT00879398|65178570|FG000|Overall Study|Adverse Event|41|||
23495810|NCT00809354|65558926|FG006|Overall Study|Protocol Violation|4|||
23495811|NCT00809354|65558927|FG007|Overall Study|Protocol Violation|6|||
23495812|NCT00809354|65558928|FG008|Overall Study|Protocol Violation|9|||
23495813|NCT00809354|65558929|FG009|Overall Study|Protocol Violation|3|||
23684236|NCT03283085|66221187|FG000|Overall Study|Withdrawal by Subject|42|||
23684237|NCT03283085|66221188|FG001|Overall Study|Withdrawal by Subject|21|||
23684238|NCT03283085|66221189|FG002|Overall Study|Withdrawal by Subject|66|||
23684239|NCT03283085|66221190|FG003|Overall Study|Withdrawal by Subject|3|||
23684240|NCT03283085|66221191|FG004|Overall Study|Withdrawal by Subject|3|||
23684241|NCT03283085|66221192|FG005|Overall Study|Withdrawal by Subject|5|||
23684242|NCT03283085|66221187|FG000|Overall Study|Physician Decision|14|||
23684243|NCT03283085|66221188|FG001|Overall Study|Physician Decision|8|||
23391360|NCT00879398|65178570|FG000|Overall Study|Other Reasons|171|||
23391361|NCT03757715|65178571|FG000|Overall Study|Lost to Follow-up|4|||
23391362|NCT03757715|65178572|FG001|Overall Study|Lost to Follow-up|9|||
23495814|NCT00809354|65558920|FG000|Overall Study|Withdrawal by Subject|32|||
23684244|NCT03283085|66221189|FG002|Overall Study|Physician Decision|19|||
23684245|NCT03283085|66221190|FG003|Overall Study|Physician Decision|0|||
23495815|NCT00809354|65558921|FG001|Overall Study|Withdrawal by Subject|27|||
23495816|NCT00809354|65558922|FG002|Overall Study|Withdrawal by Subject|31|||
23495817|NCT00809354|65558923|FG003|Overall Study|Withdrawal by Subject|33|||
23495818|NCT00809354|65558924|FG004|Overall Study|Withdrawal by Subject|34|||
23495819|NCT00809354|65558925|FG005|Overall Study|Withdrawal by Subject|29|||
23495820|NCT00809354|65558926|FG006|Overall Study|Withdrawal by Subject|27|||
23495821|NCT00809354|65558927|FG007|Overall Study|Withdrawal by Subject|19|||
23684246|NCT03283085|66221191|FG004|Overall Study|Physician Decision|0|||
23684247|NCT03283085|66221192|FG005|Overall Study|Physician Decision|2|||
23684248|NCT03283085|66221187|FG000|Overall Study|Site Terminated by Sponsor|1|||
23684249|NCT03283085|66221188|FG001|Overall Study|Site Terminated by Sponsor|0|||
23684250|NCT03283085|66221189|FG002|Overall Study|Site Terminated by Sponsor|3|||
23684251|NCT03283085|66221190|FG003|Overall Study|Site Terminated by Sponsor|0|||
23684252|NCT03283085|66221191|FG004|Overall Study|Site Terminated by Sponsor|0|||
23684253|NCT03283085|66221192|FG005|Overall Study|Site Terminated by Sponsor|0|||
23684254|NCT03283085|66221187|FG000|Overall Study|Lost to Follow-up|2|||
23684255|NCT03283085|66221188|FG001|Overall Study|Lost to Follow-up|0|||
23684256|NCT03283085|66221189|FG002|Overall Study|Lost to Follow-up|2|||
23684257|NCT03283085|66221190|FG003|Overall Study|Lost to Follow-up|0|||
23684258|NCT03283085|66221191|FG004|Overall Study|Lost to Follow-up|0|||
23684259|NCT03283085|66221192|FG005|Overall Study|Lost to Follow-up|1|||
23684260|NCT03283085|66221187|FG000|Overall Study|Pregnancy|0|||
23684261|NCT03283085|66221188|FG001|Overall Study|Pregnancy|0|||
23684262|NCT03283085|66221189|FG002|Overall Study|Pregnancy|1|||
23684263|NCT03283085|66221190|FG003|Overall Study|Pregnancy|0|||
23684264|NCT03283085|66221191|FG004|Overall Study|Pregnancy|0|||
23684265|NCT03283085|66221192|FG005|Overall Study|Pregnancy|0|||
23684266|NCT03283085|66221187|FG000|Overall Study|Lack of Efficacy|12|||
23684267|NCT03283085|66221188|FG001|Overall Study|Lack of Efficacy|6|||
23684268|NCT03283085|66221189|FG002|Overall Study|Lack of Efficacy|24|||
23684269|NCT03283085|66221190|FG003|Overall Study|Lack of Efficacy|1|||
23684270|NCT03283085|66221191|FG004|Overall Study|Lack of Efficacy|1|||
23684271|NCT03283085|66221192|FG005|Overall Study|Lack of Efficacy|0|||
23684272|NCT03283085|66221187|FG000|Overall Study|Reason not Specified|0|||
23684273|NCT03283085|66221188|FG001|Overall Study|Reason not Specified|4|||
23684274|NCT03283085|66221189|FG002|Overall Study|Reason not Specified|8|||
23684275|NCT03283085|66221190|FG003|Overall Study|Reason not Specified|0|||
23684276|NCT03283085|66221191|FG004|Overall Study|Reason not Specified|0|||
23684277|NCT03283085|66221192|FG005|Overall Study|Reason not Specified|1|||
23495822|NCT00809354|65558928|FG008|Overall Study|Withdrawal by Subject|18|||
23495823|NCT00809354|65558929|FG009|Overall Study|Withdrawal by Subject|20|||
23684278|NCT02720757|66221194|FG000|Overall Study|Other reason|5|||
23684279|NCT02720757|66221194|FG000|Overall Study|Loss of contact|4|||
23684280|NCT02720757|66221194|FG000|Overall Study|Informed consent withdrawal|1|||
23684281|NCT02720757|66221194|FG000|Overall Study|Patients wish to withdraw|2|||
23391363|NCT03757715|65178571|FG000|Overall Study|Withdrawal by Subject|1|||
23391364|NCT03757715|65178572|FG001|Overall Study|Withdrawal by Subject|1|||
23391365|NCT01772693|65178573|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
23391366|NCT01772693|65178574|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
23391367|NCT01772693|65178573|FG000|Overall Study|Withdrawal by Subject|2|||
23391368|NCT01772693|65178574|FG001|Overall Study|Withdrawal by Subject|0|||
23391369|NCT01772693|65178573|FG000|Overall Study|Alternative Treatment|2|||
23391370|NCT01772693|65178574|FG001|Overall Study|Alternative Treatment|0|||
23391371|NCT00382863|65178575|FG000|Overall Study|Death|9|||
23391372|NCT00382863|65178576|FG001|Overall Study|Death|9|||
23391373|NCT00382863|65178575|FG000|Overall Study|Lost to Follow-up|1|||
23391374|NCT00382863|65178576|FG001|Overall Study|Lost to Follow-up|2|||
23391375|NCT00382863|65178575|FG000|Overall Study|Withdrawal by Subject|5|||
23391376|NCT00382863|65178576|FG001|Overall Study|Withdrawal by Subject|25|||
23391377|NCT03449147|65178577|FG000|52-week Treatment Period|Death|0|||
23391378|NCT03449147|65178578|FG001|52-week Treatment Period|Death|1|||
23391379|NCT03449147|65178579|FG002|52-week Treatment Period|Death|0|||
23391380|NCT03449147|65178577|FG000|52-week Treatment Period|Lost to Follow-up|6|||
23391381|NCT03449147|65178578|FG001|52-week Treatment Period|Lost to Follow-up|2|||
23495824|NCT00809354|65558920|FG000|Overall Study|Other|10|||
23495825|NCT00809354|65558921|FG001|Overall Study|Other|2|||
23495826|NCT00809354|65558922|FG002|Overall Study|Other|7|||
23495827|NCT00809354|65558923|FG003|Overall Study|Other|10|||
23495828|NCT00809354|65558924|FG004|Overall Study|Other|5|||
23495829|NCT00809354|65558925|FG005|Overall Study|Other|3|||
23495830|NCT00809354|65558926|FG006|Overall Study|Other|2|||
23495831|NCT00809354|65558927|FG007|Overall Study|Other|3|||
23495832|NCT00809354|65558928|FG008|Overall Study|Other|4|||
23495833|NCT00809354|65558929|FG009|Overall Study|Other|3|||
23495834|NCT00809354|65558920|FG000|Overall Study|Study terminated by sponsor|138|||
23495835|NCT00809354|65558921|FG001|Overall Study|Study terminated by sponsor|134|||
23495836|NCT00809354|65558922|FG002|Overall Study|Study terminated by sponsor|129|||
23495837|NCT00809354|65558923|FG003|Overall Study|Study terminated by sponsor|120|||
23495838|NCT00809354|65558924|FG004|Overall Study|Study terminated by sponsor|126|||
23495839|NCT00809354|65558925|FG005|Overall Study|Study terminated by sponsor|133|||
23684282|NCT02720757|66221194|FG000|Overall Study|Missing|3|||
23391382|NCT03449147|65178579|FG002|52-week Treatment Period|Lost to Follow-up|5|||
23391383|NCT03449147|65178577|FG000|52-week Treatment Period|Other|0|||
23391384|NCT03449147|65178578|FG001|52-week Treatment Period|Other|1|||
23391385|NCT03449147|65178579|FG002|52-week Treatment Period|Other|2|||
23391386|NCT03449147|65178577|FG000|52-week Treatment Period|Physician Decision|1|||
23391387|NCT03449147|65178578|FG001|52-week Treatment Period|Physician Decision|0|||
23391388|NCT03449147|65178579|FG002|52-week Treatment Period|Physician Decision|3|||
23391389|NCT03449147|65178577|FG000|52-week Treatment Period|Screen Failure|1|||
23391390|NCT03449147|65178578|FG001|52-week Treatment Period|Screen Failure|2|||
23391391|NCT03449147|65178579|FG002|52-week Treatment Period|Screen Failure|0|||
23391392|NCT03449147|65178577|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
23391393|NCT03449147|65178578|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
23391394|NCT03449147|65178579|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
23391395|NCT03449147|65178577|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
23391396|NCT03449147|65178578|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
23391397|NCT03449147|65178579|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
23391398|NCT03449147|65178577|FG000|12-Week Off-Treatment Durability Period|Other|0|||
23391399|NCT03449147|65178578|FG001|12-Week Off-Treatment Durability Period|Other|1|||
23391400|NCT03449147|65178579|FG002|12-Week Off-Treatment Durability Period|Other|0|||
23391401|NCT00944645|65178584|FG000|Period 2|Adverse Event|1|||
23391402|NCT00944645|65178585|FG001|Period 2|Adverse Event|0|||
23391403|NCT00944645|65178584|FG000|Period 2|Lost to Follow-up|0|||
23391404|NCT00944645|65178585|FG001|Period 2|Lost to Follow-up|3|||
23391405|NCT00944645|65178584|FG000|Period 2|Withdrawal by Subject|7|||
23391406|NCT00944645|65178585|FG001|Period 2|Withdrawal by Subject|6|||
23391407|NCT01926509|65178586|FG000|Overall Study|vital sign met discontinuation criteria|1|||
23391408|NCT01926509|65178587|FG001|Overall Study|vital sign met discontinuation criteria|0|||
23391409|NCT01926509|65178588|FG002|Overall Study|vital sign met discontinuation criteria|0|||
23391410|NCT01926509|65178589|FG003|Overall Study|vital sign met discontinuation criteria|0|||
23391411|NCT03034044|65178595|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
23495840|NCT00809354|65558926|FG006|Overall Study|Study terminated by sponsor|124|||
23495841|NCT00809354|65558927|FG007|Overall Study|Study terminated by sponsor|148|||
23684283|NCT02720757|66221194|FG000|Overall Study|General exclusion|3|||
23684284|NCT00364182|66221199|FG000|First Intervention|Secondary prophylaxis|1|||
23391412|NCT00563316|65178598|FG000|Overall Study|Adverse Event|2|||
23391413|NCT00563316|65178598|FG000|Overall Study|Physician Decision|1|||
23391414|NCT00563316|65178598|FG000|Overall Study|Lost to Follow-up|2|||
23495842|NCT00809354|65558928|FG008|Overall Study|Study terminated by sponsor|127|||
23495843|NCT00809354|65558929|FG009|Overall Study|Study terminated by sponsor|135|||
23495844|NCT00809354|65558920|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23391415|NCT00563316|65178598|FG000|Overall Study|Death|1|||
23391416|NCT00563316|65178598|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
23391417|NCT00563316|65178598|FG000|Overall Study|Other|1|||
23391418|NCT02757963|65178599|FG000|Overall Study|Adverse Event|3|||
23391419|NCT02757963|65178599|FG000|Overall Study|Reached Stopping Criteria|1054|||
23391420|NCT02757963|65178599|FG000|Overall Study|Lost to Follow-up|5|||
23391421|NCT02757963|65178599|FG000|Overall Study|Physician Decision|1|||
23391422|NCT02757963|65178599|FG000|Overall Study|Withdrawal by Subject|34|||
23391423|NCT02414841|65178600|FG000|Overall Study|Withdrawal by Subject|7|||
23391424|NCT02414841|65178601|FG001|Overall Study|Withdrawal by Subject|5|||
23391425|NCT02414841|65178600|FG000|Overall Study|Lost to Follow-up|13|||
23684285|NCT00364182|66221200|FG001|First Intervention|Secondary prophylaxis|0|||
23684286|NCT00364182|66221201|FG002|First Intervention|Secondary prophylaxis|0|||
23684287|NCT00364182|66221199|FG000|First Intervention|Withdrawal by Subject|2|||
23684288|NCT00364182|66221200|FG001|First Intervention|Withdrawal by Subject|0|||
23684289|NCT00364182|66221201|FG002|First Intervention|Withdrawal by Subject|0|||
23684290|NCT00364182|66221199|FG000|Second Intervention|non-compliance|0|||
23684291|NCT00364182|66221200|FG001|Second Intervention|non-compliance|1|||
23684292|NCT00364182|66221201|FG002|Second Intervention|non-compliance|1|||
23684293|NCT00364182|66221199|FG000|Second Intervention|Protocol Violation|0|||
23684294|NCT00364182|66221200|FG001|Second Intervention|Protocol Violation|1|||
23684295|NCT00364182|66221201|FG002|Second Intervention|Protocol Violation|0|||
23684296|NCT00364182|66221199|FG000|Second Intervention|Adverse Event|0|||
23684297|NCT00364182|66221200|FG001|Second Intervention|Adverse Event|0|||
23684298|NCT00364182|66221201|FG002|Second Intervention|Adverse Event|1|||
23684299|NCT00364182|66221199|FG000|Third Intervention|non-compliance|0|||
23684300|NCT00364182|66221200|FG001|Third Intervention|non-compliance|1|||
23684301|NCT00364182|66221201|FG002|Third Intervention|non-compliance|0|||
23684302|NCT00364182|66221199|FG000|Third Intervention|Lost to Follow-up|0|||
23684303|NCT00364182|66221200|FG001|Third Intervention|Lost to Follow-up|0|||
23684304|NCT00364182|66221201|FG002|Third Intervention|Lost to Follow-up|1|||
23684305|NCT03075163|66221202|FG000|Overall Study|not eligible for treatment limb|138|||
23684306|NCT03075163|66221203|FG001|Overall Study|not eligible for treatment limb|138|||
23684307|NCT01446809|66221204|FG000|Overall Study|Adverse Event|0|||
23684308|NCT01446809|66221205|FG001|Overall Study|Adverse Event|0|||
23684309|NCT01446809|66221206|FG002|Overall Study|Adverse Event|1|||
23684310|NCT01446809|66221204|FG000|Overall Study|Failure to complete study procedures|0|||
23684311|NCT01446809|66221205|FG001|Overall Study|Failure to complete study procedures|0|||
23684312|NCT01446809|66221206|FG002|Overall Study|Failure to complete study procedures|1|||
23684313|NCT03064763|66221207|FG000|Overall Study|Lost to Follow-up|1|||
23684314|NCT03064763|66221207|FG000|Overall Study|Death|8|||
23684315|NCT04698629|66221208|FG000|Overall Study|Adverse Event|1|||
23684316|NCT01275222|66221212|FG000|Phase l by Treatment|Adverse Event|1|||
23684317|NCT01275222|66221213|FG001|Phase l by Treatment|Adverse Event|4|||
23684318|NCT01275222|66221214|FG002|Phase l by Treatment|Adverse Event|2|||
23684319|NCT01275222|66221215|FG003|Phase l by Treatment|Adverse Event|3|||
23684320|NCT01275222|66221216|FG004|Phase l by Treatment|Adverse Event|0|||
23684321|NCT01275222|66221217|FG005|Phase l by Treatment|Adverse Event|0|||
23684322|NCT01275222|66221212|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23684323|NCT01275222|66221213|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23684324|NCT01275222|66221214|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
23684325|NCT01275222|66221215|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23684326|NCT01275222|66221216|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23684327|NCT01275222|66221217|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23684328|NCT01275222|66221212|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23684329|NCT01275222|66221213|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23684330|NCT01275222|66221214|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23684331|NCT01275222|66221215|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
23391426|NCT02414841|65178601|FG001|Overall Study|Lost to Follow-up|6|||
23391427|NCT02414841|65178600|FG000|Overall Study|Death|17|||
23391428|NCT02414841|65178601|FG001|Overall Study|Death|14|||
23684332|NCT01275222|66221216|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23684333|NCT01275222|66221217|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23684334|NCT01275222|66221212|FG000|Phase l by Treatment|Disease progression|12|||
23684335|NCT01275222|66221213|FG001|Phase l by Treatment|Disease progression|8|||
23684336|NCT01275222|66221214|FG002|Phase l by Treatment|Disease progression|2|||
23684337|NCT01275222|66221215|FG003|Phase l by Treatment|Disease progression|5|||
23684338|NCT01275222|66221216|FG004|Phase l by Treatment|Disease progression|0|||
23684339|NCT01275222|66221217|FG005|Phase l by Treatment|Disease progression|0|||
23684340|NCT01275222|66221212|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
23684341|NCT01275222|66221213|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
23684342|NCT01275222|66221214|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
23684343|NCT01275222|66221215|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
23684344|NCT01275222|66221216|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
23684345|NCT01275222|66221217|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
23684346|NCT01275222|66221212|FG000|Phase l by Treatment|Death|0|||
23391429|NCT02414841|65178600|FG000|Overall Study|Received a Kidney Transplant|13|||
23391430|NCT02414841|65178601|FG001|Overall Study|Received a Kidney Transplant|4|||
23391431|NCT02414841|65178600|FG000|Overall Study|Randomized But Not Treated|6|||
23391432|NCT02414841|65178601|FG001|Overall Study|Randomized But Not Treated|4|||
23391433|NCT00185614|65178602|FG000|Inter-treatment Period|Physician Decision|1|||
23391434|NCT00185614|65178602|FG000|Inter-treatment Period|Relapse|2|||
23391435|NCT00185614|65178602|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
23391436|NCT03906071|65178607|FG000|Overall Study|Death|180|||
23391437|NCT03906071|65178608|FG001|Overall Study|Death|185|||
23391438|NCT03906071|65178607|FG000|Overall Study|Lost to Follow-up|3|||
23391439|NCT03906071|65178608|FG001|Overall Study|Lost to Follow-up|3|||
23391440|NCT03906071|65178607|FG000|Overall Study|Withdrawal by Subject|15|||
23391441|NCT03906071|65178608|FG001|Overall Study|Withdrawal by Subject|27|||
23391442|NCT03906071|65178607|FG000|Overall Study|Other|2|||
23391443|NCT03906071|65178608|FG001|Overall Study|Other|1|||
23495845|NCT00809354|65558921|FG001|Overall Study|Withdrawn due to pregnancy|1|||
23495846|NCT00809354|65558922|FG002|Overall Study|Withdrawn due to pregnancy|0|||
23495847|NCT00809354|65558923|FG003|Overall Study|Withdrawn due to pregnancy|0|||
23495848|NCT00809354|65558924|FG004|Overall Study|Withdrawn due to pregnancy|0|||
23495849|NCT00809354|65558925|FG005|Overall Study|Withdrawn due to pregnancy|0|||
23495850|NCT00809354|65558926|FG006|Overall Study|Withdrawn due to pregnancy|0|||
23495851|NCT00809354|65558927|FG007|Overall Study|Withdrawn due to pregnancy|0|||
23495852|NCT00809354|65558928|FG008|Overall Study|Withdrawn due to pregnancy|0|||
23495853|NCT00809354|65558929|FG009|Overall Study|Withdrawn due to pregnancy|0|||
23495854|NCT00809354|65558920|FG000|Overall Study|Randomized but not Treated|3|||
23495855|NCT00809354|65558921|FG001|Overall Study|Randomized but not Treated|1|||
23495856|NCT00809354|65558922|FG002|Overall Study|Randomized but not Treated|6|||
23495857|NCT00809354|65558923|FG003|Overall Study|Randomized but not Treated|0|||
23495858|NCT00809354|65558924|FG004|Overall Study|Randomized but not Treated|5|||
23495859|NCT00809354|65558925|FG005|Overall Study|Randomized but not Treated|0|||
23495860|NCT00809354|65558926|FG006|Overall Study|Randomized but not Treated|1|||
23495861|NCT00809354|65558927|FG007|Overall Study|Randomized but not Treated|1|||
23495862|NCT00809354|65558928|FG008|Overall Study|Randomized but not Treated|2|||
23495863|NCT00809354|65558929|FG009|Overall Study|Randomized but not Treated|1|||
23495864|NCT00809354|65558920|FG000|Overall Study|Death|0|||
23495865|NCT00809354|65558921|FG001|Overall Study|Death|0|||
23495866|NCT00809354|65558922|FG002|Overall Study|Death|0|||
23495867|NCT00809354|65558923|FG003|Overall Study|Death|0|||
23495868|NCT00809354|65558924|FG004|Overall Study|Death|0|||
23684347|NCT01275222|66221213|FG001|Phase l by Treatment|Death|1|||
23684348|NCT01275222|66221214|FG002|Phase l by Treatment|Death|0|||
23684349|NCT01275222|66221215|FG003|Phase l by Treatment|Death|1|||
23684350|NCT01275222|66221216|FG004|Phase l by Treatment|Death|0|||
23684351|NCT01275222|66221217|FG005|Phase l by Treatment|Death|0|||
23684352|NCT01275222|66221212|FG000|Phase ll by Stratum|Adverse Event|0|||
23684353|NCT01275222|66221213|FG001|Phase ll by Stratum|Adverse Event|0|||
23391444|NCT04887285|65178614|FG000|Overall Study|Lost to Follow-up|0|||
23391445|NCT04887285|65178615|FG001|Overall Study|Lost to Follow-up|2|||
23391446|NCT04887285|65178616|FG002|Overall Study|Lost to Follow-up|3|||
23684354|NCT01275222|66221214|FG002|Phase ll by Stratum|Adverse Event|0|||
23684355|NCT01275222|66221215|FG003|Phase ll by Stratum|Adverse Event|0|||
23684356|NCT01275222|66221216|FG004|Phase ll by Stratum|Adverse Event|2|||
23684357|NCT01275222|66221217|FG005|Phase ll by Stratum|Adverse Event|10|||
23684358|NCT01275222|66221212|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
23684359|NCT01275222|66221213|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
23684360|NCT01275222|66221214|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
23684361|NCT01275222|66221215|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
23684362|NCT01275222|66221216|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
23684363|NCT01275222|66221217|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
23684364|NCT01275222|66221212|FG000|Phase ll by Stratum|Disease progression|0|||
23684365|NCT01275222|66221213|FG001|Phase ll by Stratum|Disease progression|0|||
23684366|NCT01275222|66221214|FG002|Phase ll by Stratum|Disease progression|0|||
23684367|NCT01275222|66221215|FG003|Phase ll by Stratum|Disease progression|0|||
23684368|NCT01275222|66221216|FG004|Phase ll by Stratum|Disease progression|23|||
23684369|NCT01275222|66221217|FG005|Phase ll by Stratum|Disease progression|31|||
23684370|NCT01275222|66221212|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
23684371|NCT01275222|66221213|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
23684372|NCT01275222|66221214|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
23684373|NCT01275222|66221215|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
23684374|NCT01275222|66221216|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
23684375|NCT01275222|66221217|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
23684376|NCT01275222|66221212|FG000|Phase ll by Stratum|Death|0|||
23684377|NCT01275222|66221213|FG001|Phase ll by Stratum|Death|0|||
23684378|NCT01275222|66221214|FG002|Phase ll by Stratum|Death|0|||
23684379|NCT01275222|66221215|FG003|Phase ll by Stratum|Death|0|||
23684380|NCT01275222|66221216|FG004|Phase ll by Stratum|Death|1|||
23684381|NCT01275222|66221217|FG005|Phase ll by Stratum|Death|1|||
23684382|NCT03588741|66221218|FG000|Overall Study|Withdrawal by Subject|1|||
23495869|NCT00809354|65558925|FG005|Overall Study|Death|0|||
23684383|NCT00619957|66221219|FG000|Month 24 Double-Blind|Adverse Event|9|||
23684384|NCT00619957|66221220|FG001|Month 24 Double-Blind|Adverse Event|7|||
23684385|NCT00619957|66221219|FG000|Month 24 Double-Blind|Protocol Violation|1|||
23684386|NCT00619957|66221220|FG001|Month 24 Double-Blind|Protocol Violation|0|||
23684387|NCT00619957|66221219|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
23684388|NCT00619957|66221220|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
23684389|NCT00619957|66221219|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
23684390|NCT00619957|66221220|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
23684391|NCT00619957|66221219|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
23684392|NCT00619957|66221220|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
23684393|NCT00619957|66221219|FG000|Month 48 Open-Label|Adverse Event|4|||
23684394|NCT00619957|66221220|FG001|Month 48 Open-Label|Adverse Event|4|||
23684395|NCT00619957|66221219|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
23684396|NCT00619957|66221220|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
23684397|NCT00619957|66221219|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
23684398|NCT00619957|66221220|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
23391447|NCT04641975|65178623|FG000|Overall Study|Protocol Violation|1|||
23391448|NCT04641975|65178624|FG001|Overall Study|Protocol Violation|2|||
23391449|NCT04641975|65178625|FG002|Overall Study|Protocol Violation|0|||
23391450|NCT04641975|65178626|FG003|Overall Study|Protocol Violation|0|||
23391451|NCT04641975|65178623|FG000|Overall Study|Adverse Event|0|||
23391452|NCT04641975|65178624|FG001|Overall Study|Adverse Event|0|||
23391453|NCT04641975|65178625|FG002|Overall Study|Adverse Event|1|||
23391454|NCT04641975|65178626|FG003|Overall Study|Adverse Event|1|||
23391455|NCT04641975|65178623|FG000|Overall Study|Withdrawal by Subject|1|||
23391456|NCT04641975|65178624|FG001|Overall Study|Withdrawal by Subject|0|||
23391457|NCT04641975|65178625|FG002|Overall Study|Withdrawal by Subject|0|||
23391458|NCT04641975|65178626|FG003|Overall Study|Withdrawal by Subject|0|||
23391459|NCT01487161|65178633|FG000|Overall Study|Adverse Event|1|||
23391460|NCT01487161|65178634|FG001|Overall Study|Adverse Event|0|||
23391461|NCT01487161|65178635|FG002|Overall Study|Adverse Event|0|||
23391462|NCT01487161|65178636|FG003|Overall Study|Adverse Event|0|||
23495870|NCT00809354|65558926|FG006|Overall Study|Death|0|||
23684399|NCT02908100|66221223|FG000|Overall Study|Adverse Event|7|||
23684400|NCT02908100|66221224|FG001|Overall Study|Adverse Event|6|||
23684401|NCT02908100|66221225|FG002|Overall Study|Adverse Event|9|||
23684402|NCT02908100|66221223|FG000|Overall Study|Death|2|||
23684403|NCT02908100|66221224|FG001|Overall Study|Death|0|||
23684404|NCT02908100|66221225|FG002|Overall Study|Death|0|||
23684405|NCT02908100|66221223|FG000|Overall Study|Lack of Efficacy|2|||
23391463|NCT01487161|65178633|FG000|Overall Study|Withdrawal by Subject|1|||
23391464|NCT01487161|65178634|FG001|Overall Study|Withdrawal by Subject|1|||
23391465|NCT01487161|65178635|FG002|Overall Study|Withdrawal by Subject|1|||
23495871|NCT00809354|65558927|FG007|Overall Study|Death|1|||
23684406|NCT02908100|66221224|FG001|Overall Study|Lack of Efficacy|3|||
23684407|NCT02908100|66221225|FG002|Overall Study|Lack of Efficacy|3|||
23684408|NCT02908100|66221223|FG000|Overall Study|Lost to Follow-up|0|||
23684409|NCT02908100|66221224|FG001|Overall Study|Lost to Follow-up|1|||
23684410|NCT02908100|66221225|FG002|Overall Study|Lost to Follow-up|2|||
23684411|NCT02908100|66221223|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23684412|NCT02908100|66221224|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23684413|NCT02908100|66221225|FG002|Overall Study|Non-Compliance With Study Drug|2|||
23684414|NCT02908100|66221223|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
23684415|NCT02908100|66221224|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
23684416|NCT02908100|66221225|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
23684417|NCT02908100|66221223|FG000|Overall Study|Physician Decision|0|||
23684418|NCT02908100|66221224|FG001|Overall Study|Physician Decision|1|||
23684419|NCT02908100|66221225|FG002|Overall Study|Physician Decision|0|||
23684420|NCT02908100|66221223|FG000|Overall Study|Pregnancy|1|||
23684421|NCT02908100|66221224|FG001|Overall Study|Pregnancy|2|||
23684422|NCT02908100|66221225|FG002|Overall Study|Pregnancy|0|||
23684423|NCT02908100|66221223|FG000|Overall Study|Withdrawal by Subject|8|||
23684424|NCT02908100|66221224|FG001|Overall Study|Withdrawal by Subject|7|||
23684425|NCT02908100|66221225|FG002|Overall Study|Withdrawal by Subject|5|||
23684426|NCT02908100|66221223|FG000|Overall Study|Randomised in Error|1|||
23684427|NCT02908100|66221224|FG001|Overall Study|Randomised in Error|0|||
23684428|NCT02908100|66221225|FG002|Overall Study|Randomised in Error|0|||
23684429|NCT01412957|66221226|FG000|Overall Study|Withdrawal by Subject|6|||
23684430|NCT01412957|66221227|FG001|Overall Study|Withdrawal by Subject|22|||
23684431|NCT01412957|66221226|FG000|Overall Study|Lost to Follow-up|7|||
23684432|NCT01412957|66221227|FG001|Overall Study|Lost to Follow-up|2|||
23684433|NCT01412957|66221226|FG000|Overall Study|Death|136|||
23684434|NCT01412957|66221227|FG001|Overall Study|Death|133|||
23684435|NCT02604264|66221228|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
23684436|NCT02604264|66221229|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
23684437|NCT01279057|66221230|FG000|Overall Study|Adverse Event|1|||
23684438|NCT01279057|66221231|FG001|Overall Study|Adverse Event|0|||
23684439|NCT01279057|66221232|FG002|Overall Study|Adverse Event|1|||
23684440|NCT01279057|66221230|FG000|Overall Study|Insufficient therapeutic response|0|||
23684441|NCT01279057|66221231|FG001|Overall Study|Insufficient therapeutic response|0|||
23684442|NCT01279057|66221232|FG002|Overall Study|Insufficient therapeutic response|1|||
23684443|NCT01279057|66221230|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23684444|NCT01279057|66221231|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
23684445|NCT01279057|66221232|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23684446|NCT01279057|66221230|FG000|Overall Study|Withdrew consent|2|||
23684447|NCT01279057|66221231|FG001|Overall Study|Withdrew consent|0|||
23684448|NCT01279057|66221232|FG002|Overall Study|Withdrew consent|1|||
23684449|NCT01279057|66221230|FG000|Overall Study|Pregnancy|0|||
23684450|NCT01279057|66221231|FG001|Overall Study|Pregnancy|1|||
23684451|NCT01279057|66221232|FG002|Overall Study|Pregnancy|0|||
23684452|NCT01279057|66221230|FG000|Overall Study|Other|3|||
23684453|NCT01279057|66221231|FG001|Overall Study|Other|3|||
23684454|NCT01279057|66221232|FG002|Overall Study|Other|0|||
23684455|NCT03882424|66221233|FG000|Overall Study|Lost to Follow-up|3|||
23684456|NCT03882424|66221234|FG001|Overall Study|Lost to Follow-up|0|||
23684457|NCT03882424|66221235|FG002|Overall Study|Lost to Follow-up|0|||
23684458|NCT03882424|66221233|FG000|Overall Study|schedule conflict|1|||
23391466|NCT01487161|65178636|FG003|Overall Study|Withdrawal by Subject|2|||
23391467|NCT01487161|65178633|FG000|Overall Study|missing data|0|||
23684459|NCT03882424|66221234|FG001|Overall Study|schedule conflict|0|||
23684460|NCT03882424|66221235|FG002|Overall Study|schedule conflict|0|||
23684461|NCT00490542|66221242|FG000|Overall Study|Lost to Follow-up|3|||
23684462|NCT00490542|66221243|FG001|Overall Study|Lost to Follow-up|0|||
23684463|NCT00490542|66221242|FG000|Overall Study|Adverse Event|3|||
23684464|NCT00490542|66221243|FG001|Overall Study|Adverse Event|3|||
23684465|NCT00490542|66221242|FG000|Overall Study|Lack of Efficacy|1|||
23684466|NCT00490542|66221243|FG001|Overall Study|Lack of Efficacy|1|||
23684467|NCT01662648|66221245|FG000|Overall Study|Death|1|||
23684468|NCT01662648|66221246|FG001|Overall Study|Death|3|||
23391468|NCT01487161|65178634|FG001|Overall Study|missing data|1|||
23391469|NCT01487161|65178635|FG002|Overall Study|missing data|0|||
23391470|NCT01487161|65178636|FG003|Overall Study|missing data|0|||
23391471|NCT02264821|65178637|FG000|Overall Study|Protocol Violation|1|||
23391472|NCT02264821|65178638|FG001|Overall Study|Protocol Violation|3|||
23391473|NCT02264821|65178639|FG002|Overall Study|Protocol Violation|6|||
23391474|NCT02367885|65178642|FG000|Overall Study|Lost to Follow-up|1|||
23684469|NCT01662648|66221245|FG000|Overall Study|Adverse Event|40|||
23684470|NCT01662648|66221246|FG001|Overall Study|Adverse Event|37|||
23684471|NCT01662648|66221245|FG000|Overall Study|Lack of Efficacy|17|||
23684472|NCT01662648|66221246|FG001|Overall Study|Lack of Efficacy|16|||
23684473|NCT01662648|66221245|FG000|Overall Study|Participant ineligible to continue trial|1|||
23684474|NCT01662648|66221246|FG001|Overall Study|Participant ineligible to continue trial|1|||
23684475|NCT01662648|66221245|FG000|Overall Study|Lost to Follow-up|24|||
23391475|NCT02367885|65178643|FG001|Overall Study|Lost to Follow-up|0|||
23391476|NCT02367885|65178644|FG002|Overall Study|Lost to Follow-up|0|||
23684476|NCT01662648|66221246|FG001|Overall Study|Lost to Follow-up|36|||
23684477|NCT01662648|66221245|FG000|Overall Study|Withdrawal by Subject|36|||
23684478|NCT01662648|66221246|FG001|Overall Study|Withdrawal by Subject|53|||
23684479|NCT01662648|66221245|FG000|Overall Study|Participant non-compliant|16|||
23684480|NCT01662648|66221246|FG001|Overall Study|Participant non-compliant|20|||
23684481|NCT01662648|66221245|FG000|Overall Study|Other|8|||
23684482|NCT01662648|66221246|FG001|Overall Study|Other|11|||
23684483|NCT01662648|66221245|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
23684484|NCT01662648|66221246|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
23684485|NCT01662648|66221245|FG000|Overall Study|LOE and other reason unspecified|1|||
23684486|NCT01662648|66221246|FG001|Overall Study|LOE and other reason unspecified|0|||
23684487|NCT01662648|66221245|FG000|Overall Study|LOE and Participant non-compliant|0|||
23684488|NCT01662648|66221246|FG001|Overall Study|LOE and Participant non-compliant|1|||
23684489|NCT01032629|66221247|FG000|Overall Study|Closed Site|21|||
23684490|NCT01032629|66221248|FG001|Overall Study|Closed Site|18|||
23684491|NCT01032629|66221249|FG002|Overall Study|Closed Site|16|||
23684492|NCT01032629|66221247|FG000|Overall Study|Withdrawal by Subject|50|||
23391477|NCT02367885|65178642|FG000|Overall Study|Withdrawal by Subject|1|||
23391478|NCT02367885|65178643|FG001|Overall Study|Withdrawal by Subject|0|||
23391479|NCT02367885|65178644|FG002|Overall Study|Withdrawal by Subject|0|||
23391480|NCT03766399|65178645|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391481|NCT03766399|65178646|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391482|NCT03766399|65178647|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391483|NCT03766399|65178648|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391484|NCT03766399|65178649|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391485|NCT03766399|65178650|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391486|NCT03766399|65178651|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391487|NCT03766399|65178652|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391488|NCT03766399|65178653|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391489|NCT03766399|65178654|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391490|NCT03766399|65178655|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391491|NCT03766399|65178656|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391492|NCT03766399|65178657|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391493|NCT03766399|65178658|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
23391494|NCT03766399|65178659|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391495|NCT03766399|65178660|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391496|NCT03766399|65178661|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391497|NCT03766399|65178662|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391498|NCT02298946|65178665|FG000|Overall Study|Did not receive treatment|2|||
23391499|NCT02298946|65178666|FG001|Overall Study|Did not receive treatment|0|||
23495872|NCT00809354|65558928|FG008|Overall Study|Death|0|||
23495873|NCT00809354|65558929|FG009|Overall Study|Death|0|||
23495874|NCT02762578|65558930|FG000|Overall Study|Adverse Event|1|||
23495875|NCT02762578|65558931|FG001|Overall Study|Adverse Event|6|||
23495876|NCT02762578|65558930|FG000|Overall Study|Protocol Violation|4|||
23495877|NCT02762578|65558931|FG001|Overall Study|Protocol Violation|2|||
23495878|NCT02762578|65558930|FG000|Overall Study|Withdrawal by Subject|4|||
23495879|NCT02762578|65558931|FG001|Overall Study|Withdrawal by Subject|2|||
23495880|NCT02762578|65558930|FG000|Overall Study|Unclassified|6|||
23495881|NCT02762578|65558931|FG001|Overall Study|Unclassified|0|||
23495882|NCT00781274|65558933|FG000|Overall Study|Withdrawal by Subject|2|||
23495883|NCT01201785|65558942|FG000|Overall Study|Lost to Follow-up|16|||
23495884|NCT00289016|65558943|FG000|Overall Study|Disease Progression|29|||
23495885|NCT00289016|65558943|FG000|Overall Study|Death|2|||
23495886|NCT00289016|65558943|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
23495887|NCT00289016|65558943|FG000|Overall Study|Withdrawal by Subject|2|||
23495888|NCT00289016|65558943|FG000|Overall Study|Adverse Event|1|||
23495889|NCT00289016|65558943|FG000|Overall Study|Other|1|||
23495890|NCT01218113|65558947|FG000|Overall Study|Withdrawal by Subject|1|||
23684493|NCT01032629|66221248|FG001|Overall Study|Withdrawal by Subject|36|||
23684494|NCT01032629|66221249|FG002|Overall Study|Withdrawal by Subject|35|||
23684495|NCT01032629|66221247|FG000|Overall Study|Lost to Follow-up|74|||
23684496|NCT01032629|66221248|FG001|Overall Study|Lost to Follow-up|47|||
23684497|NCT01032629|66221249|FG002|Overall Study|Lost to Follow-up|37|||
23684498|NCT02397473|66221254|FG000|Treatment Phase|Adverse Event|1|||
23391500|NCT02298946|65178665|FG000|Overall Study|Unevaluable|2|||
23684499|NCT02397473|66221255|FG001|Treatment Phase|Adverse Event|2|||
23684500|NCT02397473|66221254|FG000|Treatment Phase|Lack of Efficacy|8|||
23495891|NCT01218113|65558948|FG001|Overall Study|Withdrawal by Subject|0|||
23495892|NCT01218113|65558949|FG002|Overall Study|Withdrawal by Subject|1|||
23495893|NCT01218113|65558947|FG000|Overall Study|Lost to Follow-up|4|||
23495894|NCT01218113|65558948|FG001|Overall Study|Lost to Follow-up|1|||
23684501|NCT02397473|66221255|FG001|Treatment Phase|Lack of Efficacy|1|||
23684502|NCT02397473|66221254|FG000|Treatment Phase|Lost to Follow-up|1|||
23684503|NCT02397473|66221255|FG001|Treatment Phase|Lost to Follow-up|0|||
23391501|NCT02298946|65178666|FG001|Overall Study|Unevaluable|1|||
23495895|NCT01218113|65558949|FG002|Overall Study|Lost to Follow-up|4|||
23684504|NCT02397473|66221254|FG000|Treatment Phase|Withdrawal by Subject|2|||
23391502|NCT02457546|65178667|FG000|Overall Study|Other reasons|4|||
23391503|NCT02457546|65178668|FG001|Overall Study|Other reasons|1|||
23391504|NCT02457546|65178667|FG000|Overall Study|Refused to complete study/procedures|1|||
23391505|NCT02457546|65178668|FG001|Overall Study|Refused to complete study/procedures|1|||
23391506|NCT02457546|65178667|FG000|Overall Study|Lost to Follow-up|4|||
23391507|NCT02457546|65178668|FG001|Overall Study|Lost to Follow-up|1|||
23391508|NCT02457546|65178667|FG000|Overall Study|Adverse Event|0|||
23391509|NCT02457546|65178668|FG001|Overall Study|Adverse Event|1|||
23391510|NCT01428713|65178669|FG000|Overall Study|Non-compliance|2|||
23391511|NCT01428713|65178670|FG001|Overall Study|Non-compliance|2|||
23391512|NCT01428713|65178669|FG000|Overall Study|Withdrawal by Subject|1|||
23391513|NCT01428713|65178670|FG001|Overall Study|Withdrawal by Subject|1|||
23391514|NCT01428713|65178669|FG000|Overall Study|Adverse Event|0|||
23391515|NCT01428713|65178670|FG001|Overall Study|Adverse Event|2|||
23391516|NCT02913326|65178671|FG000|Overall Study|Reason not listed|0|||
23391517|NCT02913326|65178672|FG001|Overall Study|Reason not listed|1|||
23391518|NCT02913326|65178671|FG000|Overall Study|Lost to Follow-up|0|||
23391519|NCT02913326|65178672|FG001|Overall Study|Lost to Follow-up|1|||
23391520|NCT02913326|65178671|FG000|Overall Study|Adverse Event|1|||
23391521|NCT02913326|65178672|FG001|Overall Study|Adverse Event|0|||
23391522|NCT01213251|65178673|FG000|Overall Study|Death|2|||
23495896|NCT01218113|65558947|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
23495897|NCT01218113|65558948|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
23495898|NCT01218113|65558949|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
23495899|NCT01893203|65558950|FG000|Overall Study|Withdrawal by Subject|1|||
23495900|NCT01387932|65558951|FG000|Randomized and Treated|Physician Decision|3|||
23495901|NCT01387932|65558952|FG001|Randomized and Treated|Physician Decision|2|||
23495902|NCT01387932|65558951|FG000|Randomized and Treated|Withdrawal by Subject|4|||
23495903|NCT01387932|65558952|FG001|Randomized and Treated|Withdrawal by Subject|2|||
23495904|NCT01387932|65558951|FG000|Survival Follow-up|Liver Transplant|24|||
23495905|NCT01387932|65558952|FG001|Survival Follow-up|Liver Transplant|28|||
23495906|NCT01387932|65558951|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
23495907|NCT01387932|65558952|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
23495908|NCT01387932|65558951|FG000|Survival Follow-up|Withdrawal by Subject|2|||
23495909|NCT01387932|65558952|FG001|Survival Follow-up|Withdrawal by Subject|4|||
23495910|NCT01387932|65558951|FG000|Survival Follow-up|Lost to Follow-up|6|||
23495911|NCT01387932|65558952|FG001|Survival Follow-up|Lost to Follow-up|5|||
23495912|NCT01797731|65558953|FG000|Overall Study|Didn't have proper radiographs required|3|||
23684505|NCT02397473|66221255|FG001|Treatment Phase|Withdrawal by Subject|1|||
23684506|NCT02397473|66221254|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
23684507|NCT02397473|66221255|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
23684508|NCT02397473|66221254|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
23684509|NCT02397473|66221255|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
23684510|NCT02397473|66221254|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
23684511|NCT02397473|66221255|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23684512|NCT02397473|66221254|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
23684513|NCT02397473|66221255|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
23684514|NCT02397473|66221254|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23684515|NCT02397473|66221255|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23684516|NCT04426695|66221259|FG000|Overall Study|Death|2|||
23684517|NCT04426695|66221260|FG001|Overall Study|Death|0|||
23684518|NCT04426695|66221261|FG002|Overall Study|Death|1|||
23684519|NCT04426695|66221262|FG003|Overall Study|Death|27|||
23684520|NCT04426695|66221263|FG004|Overall Study|Death|25|||
23684521|NCT04426695|66221264|FG005|Overall Study|Death|21|||
23684522|NCT04426695|66221265|FG006|Overall Study|Death|42|||
23684523|NCT04426695|66221266|FG007|Overall Study|Death|23|||
23684524|NCT04426695|66221267|FG008|Overall Study|Death|37|||
23391523|NCT01213251|65178674|FG001|Overall Study|Death|1|||
23391524|NCT01213251|65178675|FG002|Overall Study|Death|2|||
23391525|NCT01213251|65178673|FG000|Overall Study|Exit|3|||
23684525|NCT04426695|66221268|FG009|Overall Study|Death|14|||
23684526|NCT04426695|66221269|FG010|Overall Study|Death|8|||
23684527|NCT04426695|66221270|FG011|Overall Study|Death|7|||
23684528|NCT04426695|66221271|FG012|Overall Study|Death|13|||
23495913|NCT01797731|65558954|FG001|Overall Study|Didn't have proper radiographs required|3|||
23495914|NCT03846804|65558955|FG000|Overall Study|Refused blood draw|1|||
23495915|NCT03846804|65558955|FG000|Overall Study|Protocol Violation|1|||
23495916|NCT02598960|65558957|FG000|Treatment Period|Disease Progression|4|||
23495917|NCT02598960|65558958|FG001|Treatment Period|Disease Progression|4|||
23391526|NCT01213251|65178674|FG001|Overall Study|Exit|2|||
23391527|NCT01213251|65178675|FG002|Overall Study|Exit|8|||
23391528|NCT01213251|65178673|FG000|Overall Study|Protocol Violation|1|||
23391529|NCT01213251|65178674|FG001|Overall Study|Protocol Violation|1|||
23684529|NCT04426695|66221272|FG013|Overall Study|Death|25|||
23684530|NCT04426695|66221273|FG014|Overall Study|Death|19|||
23684531|NCT04426695|66221274|FG015|Overall Study|Death|7|||
23684532|NCT04426695|66221275|FG016|Overall Study|Death|8|||
23684533|NCT04426695|66221276|FG017|Overall Study|Death|4|||
23684534|NCT04426695|66221259|FG000|Overall Study|Lost to Follow-up|2|||
23684535|NCT04426695|66221260|FG001|Overall Study|Lost to Follow-up|4|||
23684536|NCT04426695|66221261|FG002|Overall Study|Lost to Follow-up|1|||
23684537|NCT04426695|66221262|FG003|Overall Study|Lost to Follow-up|19|||
23684538|NCT04426695|66221263|FG004|Overall Study|Lost to Follow-up|10|||
23684539|NCT04426695|66221264|FG005|Overall Study|Lost to Follow-up|14|||
23684540|NCT04426695|66221265|FG006|Overall Study|Lost to Follow-up|5|||
23684541|NCT04426695|66221266|FG007|Overall Study|Lost to Follow-up|14|||
23684542|NCT04426695|66221267|FG008|Overall Study|Lost to Follow-up|10|||
23684543|NCT04426695|66221268|FG009|Overall Study|Lost to Follow-up|11|||
23684544|NCT04426695|66221269|FG010|Overall Study|Lost to Follow-up|12|||
23684545|NCT04426695|66221270|FG011|Overall Study|Lost to Follow-up|6|||
23684546|NCT04426695|66221271|FG012|Overall Study|Lost to Follow-up|2|||
23684547|NCT04426695|66221272|FG013|Overall Study|Lost to Follow-up|2|||
23684548|NCT04426695|66221273|FG014|Overall Study|Lost to Follow-up|2|||
23684549|NCT04426695|66221274|FG015|Overall Study|Lost to Follow-up|0|||
23684550|NCT04426695|66221275|FG016|Overall Study|Lost to Follow-up|0|||
23684551|NCT04426695|66221276|FG017|Overall Study|Lost to Follow-up|0|||
23684552|NCT04426695|66221259|FG000|Overall Study|Participant Decision|1|||
23684553|NCT04426695|66221260|FG001|Overall Study|Participant Decision|2|||
23684554|NCT04426695|66221261|FG002|Overall Study|Participant Decision|2|||
23684555|NCT04426695|66221262|FG003|Overall Study|Participant Decision|12|||
23684556|NCT04426695|66221263|FG004|Overall Study|Participant Decision|18|||
23684557|NCT04426695|66221264|FG005|Overall Study|Participant Decision|22|||
23684558|NCT04426695|66221265|FG006|Overall Study|Participant Decision|13|||
23684559|NCT04426695|66221266|FG007|Overall Study|Participant Decision|13|||
23684560|NCT04426695|66221267|FG008|Overall Study|Participant Decision|10|||
23684561|NCT04426695|66221268|FG009|Overall Study|Participant Decision|15|||
23684562|NCT04426695|66221269|FG010|Overall Study|Participant Decision|16|||
23684563|NCT04426695|66221270|FG011|Overall Study|Participant Decision|17|||
23684564|NCT04426695|66221271|FG012|Overall Study|Participant Decision|2|||
23684565|NCT04426695|66221272|FG013|Overall Study|Participant Decision|1|||
23684566|NCT04426695|66221273|FG014|Overall Study|Participant Decision|2|||
23684567|NCT04426695|66221274|FG015|Overall Study|Participant Decision|0|||
23684568|NCT04426695|66221275|FG016|Overall Study|Participant Decision|0|||
23684569|NCT04426695|66221276|FG017|Overall Study|Participant Decision|0|||
23684570|NCT04426695|66221259|FG000|Overall Study|Adverse Event|0|||
23684571|NCT04426695|66221260|FG001|Overall Study|Adverse Event|0|||
23684572|NCT04426695|66221261|FG002|Overall Study|Adverse Event|0|||
23684573|NCT04426695|66221262|FG003|Overall Study|Adverse Event|0|||
23684574|NCT04426695|66221263|FG004|Overall Study|Adverse Event|0|||
23684575|NCT04426695|66221264|FG005|Overall Study|Adverse Event|0|||
23684576|NCT04426695|66221265|FG006|Overall Study|Adverse Event|0|||
23684577|NCT04426695|66221266|FG007|Overall Study|Adverse Event|1|||
23684578|NCT04426695|66221267|FG008|Overall Study|Adverse Event|0|||
23684579|NCT04426695|66221268|FG009|Overall Study|Adverse Event|0|||
23684580|NCT04426695|66221269|FG010|Overall Study|Adverse Event|1|||
23684581|NCT04426695|66221270|FG011|Overall Study|Adverse Event|1|||
23684582|NCT04426695|66221271|FG012|Overall Study|Adverse Event|0|||
23684583|NCT04426695|66221272|FG013|Overall Study|Adverse Event|0|||
23684584|NCT04426695|66221273|FG014|Overall Study|Adverse Event|0|||
23684585|NCT04426695|66221274|FG015|Overall Study|Adverse Event|0|||
23684586|NCT04426695|66221275|FG016|Overall Study|Adverse Event|0|||
23684587|NCT04426695|66221276|FG017|Overall Study|Adverse Event|0|||
23684588|NCT04426695|66221259|FG000|Overall Study|Sponsor Request|0|||
23684589|NCT04426695|66221260|FG001|Overall Study|Sponsor Request|0|||
23684590|NCT04426695|66221261|FG002|Overall Study|Sponsor Request|0|||
23684591|NCT04426695|66221262|FG003|Overall Study|Sponsor Request|0|||
23684592|NCT04426695|66221263|FG004|Overall Study|Sponsor Request|0|||
23684593|NCT04426695|66221264|FG005|Overall Study|Sponsor Request|0|||
23684594|NCT04426695|66221265|FG006|Overall Study|Sponsor Request|1|||
23684595|NCT04426695|66221266|FG007|Overall Study|Sponsor Request|0|||
23684596|NCT04426695|66221267|FG008|Overall Study|Sponsor Request|0|||
23684597|NCT04426695|66221268|FG009|Overall Study|Sponsor Request|0|||
23684598|NCT04426695|66221269|FG010|Overall Study|Sponsor Request|0|||
23684599|NCT04426695|66221270|FG011|Overall Study|Sponsor Request|0|||
23684600|NCT04426695|66221271|FG012|Overall Study|Sponsor Request|0|||
23684601|NCT04426695|66221272|FG013|Overall Study|Sponsor Request|0|||
23684602|NCT04426695|66221273|FG014|Overall Study|Sponsor Request|0|||
23684603|NCT04426695|66221274|FG015|Overall Study|Sponsor Request|0|||
23684604|NCT04426695|66221275|FG016|Overall Study|Sponsor Request|0|||
23684605|NCT04426695|66221276|FG017|Overall Study|Sponsor Request|0|||
23391530|NCT01213251|65178675|FG002|Overall Study|Protocol Violation|0|||
23684606|NCT04426695|66221259|FG000|Overall Study|Physician Decision|0|||
23684607|NCT04426695|66221260|FG001|Overall Study|Physician Decision|0|||
23684608|NCT04426695|66221261|FG002|Overall Study|Physician Decision|0|||
23684609|NCT04426695|66221262|FG003|Overall Study|Physician Decision|0|||
23684610|NCT04426695|66221263|FG004|Overall Study|Physician Decision|0|||
23684611|NCT04426695|66221264|FG005|Overall Study|Physician Decision|0|||
23684612|NCT04426695|66221265|FG006|Overall Study|Physician Decision|0|||
23684613|NCT04426695|66221266|FG007|Overall Study|Physician Decision|0|||
23684614|NCT04426695|66221267|FG008|Overall Study|Physician Decision|0|||
23684615|NCT04426695|66221268|FG009|Overall Study|Physician Decision|1|||
23684616|NCT04426695|66221269|FG010|Overall Study|Physician Decision|0|||
23684617|NCT04426695|66221270|FG011|Overall Study|Physician Decision|0|||
23684618|NCT04426695|66221271|FG012|Overall Study|Physician Decision|1|||
23684619|NCT04426695|66221272|FG013|Overall Study|Physician Decision|0|||
23684620|NCT04426695|66221273|FG014|Overall Study|Physician Decision|0|||
23684621|NCT04426695|66221274|FG015|Overall Study|Physician Decision|0|||
23684622|NCT04426695|66221275|FG016|Overall Study|Physician Decision|0|||
23684623|NCT04426695|66221276|FG017|Overall Study|Physician Decision|0|||
23684624|NCT04426695|66221259|FG000|Overall Study|Randomized but Never Treated|3|||
23684625|NCT04426695|66221260|FG001|Overall Study|Randomized but Never Treated|1|||
23684626|NCT04426695|66221261|FG002|Overall Study|Randomized but Never Treated|0|||
23684627|NCT04426695|66221262|FG003|Overall Study|Randomized but Never Treated|4|||
23684628|NCT04426695|66221263|FG004|Overall Study|Randomized but Never Treated|5|||
23684629|NCT04426695|66221264|FG005|Overall Study|Randomized but Never Treated|5|||
23684630|NCT04426695|66221265|FG006|Overall Study|Randomized but Never Treated|4|||
23684631|NCT04426695|66221266|FG007|Overall Study|Randomized but Never Treated|6|||
23684632|NCT04426695|66221267|FG008|Overall Study|Randomized but Never Treated|6|||
23684633|NCT04426695|66221268|FG009|Overall Study|Randomized but Never Treated|3|||
23684634|NCT04426695|66221269|FG010|Overall Study|Randomized but Never Treated|3|||
23684635|NCT04426695|66221270|FG011|Overall Study|Randomized but Never Treated|6|||
23684636|NCT04426695|66221271|FG012|Overall Study|Randomized but Never Treated|1|||
23684637|NCT04426695|66221272|FG013|Overall Study|Randomized but Never Treated|2|||
23684638|NCT04426695|66221273|FG014|Overall Study|Randomized but Never Treated|0|||
23684639|NCT04426695|66221274|FG015|Overall Study|Randomized but Never Treated|0|||
23684640|NCT04426695|66221275|FG016|Overall Study|Randomized but Never Treated|0|||
23684641|NCT04426695|66221276|FG017|Overall Study|Randomized but Never Treated|0|||
23684642|NCT02495948|66221280|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
23684643|NCT02495948|66221281|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
23684644|NCT02495948|66221280|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
23684645|NCT02495948|66221281|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
23684646|NCT01268293|66221283|FG000|Overall Study|Disease progression|7|||
23684647|NCT01268293|66221283|FG000|Overall Study|Adverse Event|1|||
23684648|NCT01268293|66221283|FG000|Overall Study|Subject choice|1|||
23684649|NCT02522767|66221286|FG000|Double-blind|Withdrawal by Subject|8|||
23684650|NCT02522767|66221287|FG001|Double-blind|Withdrawal by Subject|11|||
23684651|NCT02522767|66221286|FG000|Double-blind|Lost to Follow-up|1|||
23684652|NCT02522767|66221287|FG001|Double-blind|Lost to Follow-up|0|||
23684653|NCT02522767|66221286|FG000|Double-blind|Adverse Event|1|||
23684654|NCT02522767|66221287|FG001|Double-blind|Adverse Event|10|||
23684655|NCT02522767|66221286|FG000|Double-blind|Protocol Violation|0|||
23684656|NCT02522767|66221287|FG001|Double-blind|Protocol Violation|1|||
23684657|NCT02522767|66221286|FG000|Double-blind|Lack of Efficacy|0|||
23684658|NCT02522767|66221287|FG001|Double-blind|Lack of Efficacy|2|||
23684659|NCT02522767|66221286|FG000|Double-blind|Protocol Deviation|1|||
23684660|NCT02522767|66221287|FG001|Double-blind|Protocol Deviation|0|||
23684661|NCT02522767|66221286|FG000|Open-label|Withdrawal by Subject|2|||
23684662|NCT02522767|66221287|FG001|Open-label|Withdrawal by Subject|3|||
23684663|NCT02522767|66221286|FG000|Open-label|Lost to Follow-up|0|||
23684664|NCT02522767|66221287|FG001|Open-label|Lost to Follow-up|1|||
23684665|NCT02522767|66221286|FG000|Open-label|Adverse Event|2|||
23684666|NCT02522767|66221287|FG001|Open-label|Adverse Event|1|||
23684667|NCT02522767|66221286|FG000|Open-label|Lack of Efficacy|1|||
23684668|NCT02522767|66221287|FG001|Open-label|Lack of Efficacy|1|||
23684669|NCT02522767|66221286|FG000|Open-label|Protocol Violation|0|||
23684670|NCT02522767|66221287|FG001|Open-label|Protocol Violation|1|||
23684671|NCT00804687|66221289|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
23684672|NCT00804687|66221290|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
23684673|NCT00804687|66221291|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
23391531|NCT01213251|65178673|FG000|Overall Study|Missed 18-Month Follow-up|0|||
23684674|NCT00804687|66221292|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
23684675|NCT00804687|66221293|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
23684676|NCT00804687|66221294|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
23684677|NCT00804687|66221289|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
23684678|NCT00804687|66221290|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
23684679|NCT00804687|66221291|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
23684680|NCT00804687|66221292|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
23684681|NCT00804687|66221293|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
23684682|NCT00804687|66221294|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
23684683|NCT00804687|66221289|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
23684684|NCT00804687|66221290|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
23684685|NCT00804687|66221291|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
23684686|NCT00804687|66221292|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
23684687|NCT00804687|66221293|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
23684688|NCT00804687|66221294|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
23684689|NCT00804687|66221289|FG000|Period 5: Treatment Period|Positive drug test|1|||
23684690|NCT00804687|66221290|FG001|Period 5: Treatment Period|Positive drug test|0|||
23684691|NCT00804687|66221291|FG002|Period 5: Treatment Period|Positive drug test|0|||
23684692|NCT00804687|66221292|FG003|Period 5: Treatment Period|Positive drug test|0|||
23684693|NCT00804687|66221293|FG004|Period 5: Treatment Period|Positive drug test|0|||
23684694|NCT00804687|66221294|FG005|Period 5: Treatment Period|Positive drug test|0|||
23684695|NCT00450580|66221295|FG000|Overall Study|Adverse Event|5|||
23684696|NCT00450580|66221296|FG001|Overall Study|Adverse Event|7|||
23684697|NCT00450580|66221295|FG000|Overall Study|Lost to Follow-up|4|||
23684698|NCT00450580|66221296|FG001|Overall Study|Lost to Follow-up|5|||
23684699|NCT00450580|66221295|FG000|Overall Study|Withdrawal by Subject|2|||
23684700|NCT00450580|66221296|FG001|Overall Study|Withdrawal by Subject|2|||
23684701|NCT00450580|66221295|FG000|Overall Study|Protocol Violation|1|||
23684702|NCT00450580|66221296|FG001|Overall Study|Protocol Violation|1|||
23684703|NCT00450580|66221295|FG000|Overall Study|Protocol-defined virologic failure|1|||
23684704|NCT00450580|66221296|FG001|Overall Study|Protocol-defined virologic failure|0|||
23684705|NCT00450580|66221295|FG000|Overall Study|Could not comply with scheduled visits|1|||
23684706|NCT00450580|66221296|FG001|Overall Study|Could not comply with scheduled visits|0|||
23684707|NCT00450580|66221295|FG000|Overall Study|Patient went to Brazil|1|||
23684708|NCT00450580|66221296|FG001|Overall Study|Patient went to Brazil|0|||
23684709|NCT00450580|66221295|FG000|Overall Study|Patient could not swallow Norvir|1|||
23684710|NCT00450580|66221296|FG001|Overall Study|Patient could not swallow Norvir|0|||
23684711|NCT00450580|66221295|FG000|Overall Study|Withdrawal due to pregnancy|0|||
23684712|NCT00450580|66221296|FG001|Overall Study|Withdrawal due to pregnancy|1|||
23684713|NCT02613208|66221297|FG000|Overall Study|Withdrawal by Subject|1|||
23684714|NCT02613208|66221297|FG000|Overall Study|Change of address|2|||
23684715|NCT02613208|66221297|FG000|Overall Study|Physician Decision|2|||
23684716|NCT02613208|66221297|FG000|Overall Study|Lost to Follow-up|5|||
23684717|NCT02613208|66221297|FG000|Overall Study|Death|37|||
23684718|NCT00755079|66221305|FG000|Overall Study|Lost to Follow-up|1|||
23684719|NCT00755079|66221306|FG001|Overall Study|Lost to Follow-up|3|||
23684720|NCT00755079|66221305|FG000|Overall Study|Adverse Event|0|||
23684721|NCT00755079|66221306|FG001|Overall Study|Adverse Event|1|||
23684722|NCT00755079|66221305|FG000|Overall Study|Withdrawal by Subject|0|||
23684723|NCT00755079|66221306|FG001|Overall Study|Withdrawal by Subject|2|||
23684724|NCT01795547|66221308|FG000|Overall Study|Adverse Event|16|||
23684725|NCT01795547|66221309|FG001|Overall Study|Adverse Event|27|||
23684726|NCT01795547|66221308|FG000|Overall Study|Lack of Efficacy|8|||
23684727|NCT01795547|66221309|FG001|Overall Study|Lack of Efficacy|3|||
23684728|NCT01795547|66221308|FG000|Overall Study|Protocol Violation|6|||
23684729|NCT01795547|66221309|FG001|Overall Study|Protocol Violation|4|||
23684730|NCT01795547|66221308|FG000|Overall Study|Lost to Follow-up|2|||
23684731|NCT01795547|66221309|FG001|Overall Study|Lost to Follow-up|5|||
23684732|NCT01795547|66221308|FG000|Overall Study|Withdrawal of consent|7|||
23684733|NCT01795547|66221309|FG001|Overall Study|Withdrawal of consent|12|||
23684734|NCT01795547|66221308|FG000|Overall Study|Not Treated|4|||
23684735|NCT01795547|66221309|FG001|Overall Study|Not Treated|10|||
23684736|NCT01795547|66221308|FG000|Overall Study|Non-compliance with IMP|1|||
23684737|NCT01795547|66221309|FG001|Overall Study|Non-compliance with IMP|1|||
23684738|NCT01795547|66221308|FG000|Overall Study|Others|4|||
23684739|NCT01795547|66221309|FG001|Overall Study|Others|1|||
23684740|NCT01795547|66221308|FG000|Overall Study|Not stated|0|||
23684741|NCT01795547|66221309|FG001|Overall Study|Not stated|1|||
23684742|NCT04258579|66221310|FG000|Overall Study|Withdrawal by Subject|7|||
23684743|NCT04258579|66221310|FG000|Overall Study|Lost to Follow-up|3|||
23684744|NCT04258579|66221310|FG000|Overall Study|Protocol Violation|2|||
23684745|NCT04258579|66221310|FG000|Overall Study|Adverse Event|1|||
23684746|NCT01505894|66221311|FG000|Overall Study|Adverse Event|1|||
23684747|NCT01505894|66221312|FG001|Overall Study|Adverse Event|0|||
23684748|NCT01505894|66221313|FG002|Overall Study|Adverse Event|0|||
23684749|NCT01505894|66221314|FG003|Overall Study|Adverse Event|0|||
23684750|NCT01505894|66221315|FG004|Overall Study|Adverse Event|0|||
23684751|NCT01505894|66221316|FG005|Overall Study|Adverse Event|0|||
23684752|NCT01505894|66221317|FG006|Overall Study|Adverse Event|0|||
23684753|NCT01505894|66221318|FG007|Overall Study|Adverse Event|0|||
23684754|NCT01505894|66221319|FG008|Overall Study|Adverse Event|0|||
23684755|NCT01505894|66221311|FG000|Overall Study|Other than specified|0|||
23684756|NCT01505894|66221312|FG001|Overall Study|Other than specified|0|||
23684757|NCT01505894|66221313|FG002|Overall Study|Other than specified|0|||
23684758|NCT01505894|66221314|FG003|Overall Study|Other than specified|0|||
23684759|NCT01505894|66221315|FG004|Overall Study|Other than specified|1|||
23684760|NCT01505894|66221316|FG005|Overall Study|Other than specified|0|||
23684761|NCT01505894|66221317|FG006|Overall Study|Other than specified|0|||
23684762|NCT01505894|66221318|FG007|Overall Study|Other than specified|0|||
23684763|NCT01505894|66221319|FG008|Overall Study|Other than specified|0|||
23684764|NCT00556426|66221326|FG000|Overall Study|Withdrawal by Subject|3|||
23684765|NCT00556426|66221326|FG000|Overall Study|Death|6|||
23684766|NCT01256177|66221327|FG000|Overall Study|Withdrawal by Subject|23|||
23684767|NCT01256177|66221328|FG001|Overall Study|Withdrawal by Subject|22|||
23684768|NCT01256177|66221327|FG000|Overall Study|Lost to Follow-up|2|||
23684769|NCT01256177|66221328|FG001|Overall Study|Lost to Follow-up|2|||
23684770|NCT01256177|66221327|FG000|Overall Study|Adverse Event|8|||
23684771|NCT01256177|66221328|FG001|Overall Study|Adverse Event|9|||
23684772|NCT01256177|66221327|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23684773|NCT01256177|66221328|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23684774|NCT01256177|66221327|FG000|Overall Study|Condition under Investigation Worsened|1|||
23684775|NCT01256177|66221328|FG001|Overall Study|Condition under Investigation Worsened|0|||
23684776|NCT01256177|66221327|FG000|Overall Study|Lack of Efficacy|11|||
23684777|NCT01256177|66221328|FG001|Overall Study|Lack of Efficacy|2|||
23684778|NCT01256177|66221327|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
23684779|NCT01256177|66221328|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
23684780|NCT01262625|66221334|FG000|Overall Study|Administrative Error|1|||
23684781|NCT01262625|66221335|FG001|Overall Study|Administrative Error|1|||
23684782|NCT01262625|66221334|FG000|Overall Study|Site Closed|1|||
23684783|NCT01262625|66221335|FG001|Overall Study|Site Closed|0|||
23684784|NCT00546364|66225296|FG000|Overall Study|Disease progression|5|||
23684785|NCT00546364|66225297|FG001|Overall Study|Disease progression|11|||
23684786|NCT00546364|66225298|FG002|Overall Study|Disease progression|8|||
23684787|NCT00546364|66225296|FG000|Overall Study|Completed and off treatment|1|||
23684788|NCT00546364|66225297|FG001|Overall Study|Completed and off treatment|0|||
23684789|NCT00546364|66225298|FG002|Overall Study|Completed and off treatment|2|||
23684790|NCT00546364|66225296|FG000|Overall Study|Administrative reason by sponsor|1|||
23684791|NCT00546364|66225297|FG001|Overall Study|Administrative reason by sponsor|0|||
23684792|NCT00546364|66225298|FG002|Overall Study|Administrative reason by sponsor|0|||
23684793|NCT00546364|66225296|FG000|Overall Study|Poor compliance/noncompliance|0|||
23684794|NCT00546364|66225297|FG001|Overall Study|Poor compliance/noncompliance|0|||
23684795|NCT00546364|66225298|FG002|Overall Study|Poor compliance/noncompliance|1|||
23684796|NCT00546364|66225296|FG000|Overall Study|No longer meets study criteria|1|||
23684797|NCT00546364|66225297|FG001|Overall Study|No longer meets study criteria|1|||
23684798|NCT00546364|66225298|FG002|Overall Study|No longer meets study criteria|0|||
23684799|NCT00546364|66225296|FG000|Overall Study|Withdrawal by Subject|5|||
23684800|NCT00546364|66225297|FG001|Overall Study|Withdrawal by Subject|6|||
23684801|NCT00546364|66225298|FG002|Overall Study|Withdrawal by Subject|3|||
23684802|NCT00546364|66225296|FG000|Overall Study|Prior taxotere|1|||
23684803|NCT00546364|66225297|FG001|Overall Study|Prior taxotere|0|||
23684804|NCT00546364|66225298|FG002|Overall Study|Prior taxotere|0|||
23684805|NCT00546364|66225296|FG000|Overall Study|Mixed response|1|||
23684806|NCT00546364|66225297|FG001|Overall Study|Mixed response|0|||
23684807|NCT00546364|66225298|FG002|Overall Study|Mixed response|0|||
23684808|NCT00546364|66225296|FG000|Overall Study|Palliative treatment|1|||
23684809|NCT00546364|66225297|FG001|Overall Study|Palliative treatment|0|||
23684810|NCT00546364|66225298|FG002|Overall Study|Palliative treatment|1|||
23684811|NCT00546364|66225296|FG000|Overall Study|Target lesions resected|1|||
23684812|NCT00546364|66225297|FG001|Overall Study|Target lesions resected|0|||
23684813|NCT00546364|66225298|FG002|Overall Study|Target lesions resected|0|||
23684814|NCT00546364|66225296|FG000|Overall Study|Physician Decision|0|||
23684815|NCT00546364|66225297|FG001|Overall Study|Physician Decision|0|||
23684816|NCT00546364|66225298|FG002|Overall Study|Physician Decision|1|||
23684817|NCT00546364|66225296|FG000|Overall Study|Sponsor decision|0|||
23684818|NCT00546364|66225297|FG001|Overall Study|Sponsor decision|0|||
23684819|NCT00546364|66225298|FG002|Overall Study|Sponsor decision|1|||
23684820|NCT01728779|66225302|FG000|Overall Study|Withdrawal by Subject|1|||
23684821|NCT00792298|66225303|FG000|Treatment Period 1|Adverse Event|0|||
23684822|NCT00792298|66225304|FG001|Treatment Period 1|Adverse Event|1|||
23684823|NCT00792298|66225305|FG002|Treatment Period 1|Adverse Event|0|||
23684824|NCT00792298|66225306|FG003|Treatment Period 1|Adverse Event|1|||
23684825|NCT00792298|66225307|FG004|Treatment Period 1|Adverse Event|0|||
23684826|NCT00792298|66225308|FG005|Treatment Period 1|Adverse Event|1|||
23684827|NCT00792298|66225309|FG006|Treatment Period 1|Adverse Event|1|||
23684828|NCT00792298|66225310|FG007|Treatment Period 1|Adverse Event|0|||
23684829|NCT00792298|66225303|FG000|Treatment Period 1|Lack of Efficacy|0|||
23684830|NCT00792298|66225304|FG001|Treatment Period 1|Lack of Efficacy|0|||
23684831|NCT00792298|66225305|FG002|Treatment Period 1|Lack of Efficacy|1|||
23684832|NCT00792298|66225306|FG003|Treatment Period 1|Lack of Efficacy|0|||
23684833|NCT00792298|66225307|FG004|Treatment Period 1|Lack of Efficacy|0|||
23684834|NCT00792298|66225308|FG005|Treatment Period 1|Lack of Efficacy|0|||
23684835|NCT00792298|66225309|FG006|Treatment Period 1|Lack of Efficacy|0|||
23684836|NCT00792298|66225310|FG007|Treatment Period 1|Lack of Efficacy|0|||
23684837|NCT00792298|66225303|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23684838|NCT00792298|66225304|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23684839|NCT00792298|66225305|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23684840|NCT00792298|66225306|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23684841|NCT00792298|66225307|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23684842|NCT00792298|66225308|FG005|Treatment Period 1|Withdrawal by Subject|2|||
23684843|NCT00792298|66225309|FG006|Treatment Period 1|Withdrawal by Subject|1|||
23684844|NCT00792298|66225310|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23684845|NCT00792298|66225303|FG000|Treatment Period 1|Lost to Follow-up|0|||
23684846|NCT00792298|66225304|FG001|Treatment Period 1|Lost to Follow-up|0|||
23684847|NCT00792298|66225305|FG002|Treatment Period 1|Lost to Follow-up|0|||
23684848|NCT00792298|66225306|FG003|Treatment Period 1|Lost to Follow-up|0|||
23684849|NCT00792298|66225307|FG004|Treatment Period 1|Lost to Follow-up|0|||
23684850|NCT00792298|66225308|FG005|Treatment Period 1|Lost to Follow-up|0|||
23684851|NCT00792298|66225309|FG006|Treatment Period 1|Lost to Follow-up|1|||
23684852|NCT00792298|66225310|FG007|Treatment Period 1|Lost to Follow-up|0|||
23684853|NCT00792298|66225303|FG000|Treatment Period 1|Physician Decision|0|||
23684854|NCT00792298|66225304|FG001|Treatment Period 1|Physician Decision|0|||
23684855|NCT00792298|66225305|FG002|Treatment Period 1|Physician Decision|0|||
23684856|NCT00792298|66225306|FG003|Treatment Period 1|Physician Decision|1|||
23684857|NCT00792298|66225307|FG004|Treatment Period 1|Physician Decision|0|||
23684858|NCT00792298|66225308|FG005|Treatment Period 1|Physician Decision|0|||
23684859|NCT00792298|66225309|FG006|Treatment Period 1|Physician Decision|1|||
23684860|NCT00792298|66225310|FG007|Treatment Period 1|Physician Decision|0|||
23684861|NCT00792298|66225303|FG000|Treatment Period 1|Protocol Violation|0|||
23684862|NCT00792298|66225304|FG001|Treatment Period 1|Protocol Violation|0|||
23684863|NCT00792298|66225305|FG002|Treatment Period 1|Protocol Violation|0|||
23684864|NCT00792298|66225306|FG003|Treatment Period 1|Protocol Violation|0|||
23684865|NCT00792298|66225307|FG004|Treatment Period 1|Protocol Violation|0|||
23684866|NCT00792298|66225308|FG005|Treatment Period 1|Protocol Violation|0|||
23684867|NCT00792298|66225309|FG006|Treatment Period 1|Protocol Violation|0|||
23684868|NCT00792298|66225310|FG007|Treatment Period 1|Protocol Violation|1|||
23684869|NCT00792298|66225303|FG000|Washout|Adverse Event|0|||
23684870|NCT00792298|66225304|FG001|Washout|Adverse Event|0|||
23684871|NCT00792298|66225305|FG002|Washout|Adverse Event|0|||
23684872|NCT00792298|66225306|FG003|Washout|Adverse Event|0|||
23684873|NCT00792298|66225307|FG004|Washout|Adverse Event|0|||
23684874|NCT00792298|66225308|FG005|Washout|Adverse Event|1|||
23684875|NCT00792298|66225309|FG006|Washout|Adverse Event|0|||
23684876|NCT00792298|66225310|FG007|Washout|Adverse Event|0|||
23684877|NCT00792298|66225303|FG000|Washout|Withdrawal by Subject|0|||
23684878|NCT00792298|66225304|FG001|Washout|Withdrawal by Subject|0|||
23684879|NCT00792298|66225305|FG002|Washout|Withdrawal by Subject|1|||
23684880|NCT00792298|66225306|FG003|Washout|Withdrawal by Subject|0|||
23684881|NCT00792298|66225307|FG004|Washout|Withdrawal by Subject|0|||
23684882|NCT00792298|66225308|FG005|Washout|Withdrawal by Subject|1|||
23684883|NCT00792298|66225309|FG006|Washout|Withdrawal by Subject|0|||
23684884|NCT00792298|66225310|FG007|Washout|Withdrawal by Subject|0|||
23684885|NCT00792298|66225303|FG000|Treatment Period 2|Lack of Efficacy|0|||
23684886|NCT00792298|66225304|FG001|Treatment Period 2|Lack of Efficacy|0|||
23684887|NCT00792298|66225305|FG002|Treatment Period 2|Lack of Efficacy|0|||
23684888|NCT00792298|66225306|FG003|Treatment Period 2|Lack of Efficacy|0|||
23684889|NCT00792298|66225307|FG004|Treatment Period 2|Lack of Efficacy|1|||
23684890|NCT00792298|66225308|FG005|Treatment Period 2|Lack of Efficacy|0|||
23684891|NCT00792298|66225309|FG006|Treatment Period 2|Lack of Efficacy|0|||
23684892|NCT00792298|66225310|FG007|Treatment Period 2|Lack of Efficacy|0|||
23684893|NCT00792298|66225303|FG000|Treatment Period 2|Physician Decision|0|||
23684894|NCT00792298|66225304|FG001|Treatment Period 2|Physician Decision|0|||
23684895|NCT00792298|66225305|FG002|Treatment Period 2|Physician Decision|0|||
23684896|NCT00792298|66225306|FG003|Treatment Period 2|Physician Decision|0|||
23684897|NCT00792298|66225307|FG004|Treatment Period 2|Physician Decision|0|||
23684898|NCT00792298|66225308|FG005|Treatment Period 2|Physician Decision|0|||
23684899|NCT00792298|66225309|FG006|Treatment Period 2|Physician Decision|1|||
23684900|NCT00792298|66225310|FG007|Treatment Period 2|Physician Decision|0|||
23684901|NCT00792298|66225303|FG000|Treatment Period 2|Pregnancy|0|||
23684902|NCT00792298|66225304|FG001|Treatment Period 2|Pregnancy|0|||
23684903|NCT00792298|66225305|FG002|Treatment Period 2|Pregnancy|1|||
23684904|NCT00792298|66225306|FG003|Treatment Period 2|Pregnancy|0|||
23684905|NCT00792298|66225307|FG004|Treatment Period 2|Pregnancy|0|||
23684906|NCT00792298|66225308|FG005|Treatment Period 2|Pregnancy|0|||
23684907|NCT00792298|66225309|FG006|Treatment Period 2|Pregnancy|0|||
23684908|NCT00792298|66225310|FG007|Treatment Period 2|Pregnancy|0|||
23684909|NCT00792298|66225303|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23684910|NCT00792298|66225304|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23684911|NCT00792298|66225305|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23684912|NCT00792298|66225306|FG003|Treatment Period 2|Withdrawal by Subject|2|||
23684913|NCT00792298|66225307|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23684914|NCT00792298|66225308|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23684915|NCT00792298|66225309|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23684916|NCT00792298|66225310|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23684917|NCT00214461|66225311|FG000|Overall Study|Adverse Event|0|||
23684918|NCT00214461|66225312|FG001|Overall Study|Adverse Event|0|||
23684919|NCT00214461|66225313|FG002|Overall Study|Adverse Event|1|||
23684920|NCT00214461|66225314|FG003|Overall Study|Adverse Event|1|||
23684921|NCT00214461|66225311|FG000|Overall Study|Withdrawal by Subject|0|||
23684922|NCT00214461|66225312|FG001|Overall Study|Withdrawal by Subject|0|||
23684923|NCT00214461|66225313|FG002|Overall Study|Withdrawal by Subject|1|||
23684924|NCT00214461|66225314|FG003|Overall Study|Withdrawal by Subject|0|||
23684925|NCT04167345|66225316|FG000|Overall Study|Other|1|||
23684926|NCT04167345|66225317|FG001|Overall Study|Other|1|||
23684927|NCT04167345|66225318|FG002|Overall Study|Other|0|||
23684928|NCT04167345|66225319|FG003|Overall Study|Other|0|||
23684929|NCT04167345|66225320|FG004|Overall Study|Other|0|||
23684930|NCT00189462|66225323|FG000|Overall Study|Lack of Efficacy|5|||
23684931|NCT00189462|66225324|FG001|Overall Study|Lack of Efficacy|1|||
23684932|NCT00189462|66225323|FG000|Overall Study|Lost to Follow-up|18|||
23684933|NCT00189462|66225324|FG001|Overall Study|Lost to Follow-up|20|||
23684934|NCT00473876|66225327|FG000|Overall Study|Lost to Follow-up|3|||
23684935|NCT00473876|66225328|FG001|Overall Study|Lost to Follow-up|1|||
23684936|NCT02507349|66225334|FG000|Overall Study|Death|12|||
23684937|NCT02507349|66225335|FG001|Overall Study|Death|16|||
23684938|NCT02507349|66225334|FG000|Overall Study|Withdrawal by Subject|1|||
23684939|NCT02507349|66225335|FG001|Overall Study|Withdrawal by Subject|1|||
23684940|NCT02507349|66225334|FG000|Overall Study|Lost to Follow-up|174|||
23684941|NCT02507349|66225335|FG001|Overall Study|Lost to Follow-up|144|||
23684942|NCT01299727|66225336|FG000|Overall Study|Withdrawal by Subject|1|||
23684943|NCT01299727|66225337|FG001|Overall Study|Withdrawal by Subject|0|||
23684944|NCT01299727|66225338|FG002|Overall Study|Withdrawal by Subject|0|||
23684945|NCT01299727|66225336|FG000|Overall Study|Adverse Event|0|||
23684946|NCT01299727|66225337|FG001|Overall Study|Adverse Event|0|||
23684947|NCT01299727|66225338|FG002|Overall Study|Adverse Event|1|||
23684948|NCT01299727|66225336|FG000|Overall Study|Completed the Treatment Period|3|||
23684949|NCT01299727|66225337|FG001|Overall Study|Completed the Treatment Period|4|||
23684950|NCT01299727|66225338|FG002|Overall Study|Completed the Treatment Period|3|||
23684951|NCT02983604|66225339|FG000|Overall Study|Enrolled but not Treated|0|||
23684952|NCT02983604|66225340|FG001|Overall Study|Enrolled but not Treated|0|||
23684953|NCT02983604|66225341|FG002|Overall Study|Enrolled but not Treated|1|||
23684954|NCT02983604|66225342|FG003|Overall Study|Enrolled but not Treated|0|||
23684955|NCT01614964|66225345|FG000|Overall Study|Withdrawal by Subject|2|||
23684956|NCT01614964|66225346|FG001|Overall Study|Withdrawal by Subject|0|||
23684957|NCT01614964|66225345|FG000|Overall Study|Lost to Follow-up|3|||
23684958|NCT01614964|66225346|FG001|Overall Study|Lost to Follow-up|0|||
23684959|NCT01769105|66225356|FG000|First Intervention|Protocol Violation|2|||
23684960|NCT01769105|66225357|FG001|First Intervention|Protocol Violation|2|||
23684961|NCT01769105|66225356|FG000|Cross-over|Lost to Follow-up|5|||
23684962|NCT01769105|66225357|FG001|Cross-over|Lost to Follow-up|0|||
23684963|NCT00206726|66225358|FG000|Overall Study|Delayed recovery of blood counts|1|||
23684964|NCT00206726|66225358|FG000|Overall Study|Progressive disease or relapsed disease|18|||
23684965|NCT00206726|66225358|FG000|Overall Study|Placed on new protocol|1|||
23684966|NCT00206726|66225358|FG000|Overall Study|Bone marrow transplant|1|||
23684967|NCT00206726|66225358|FG000|Overall Study|Adverse Event|17|||
23684968|NCT00206726|66225358|FG000|Overall Study|Death|4|||
23684969|NCT00206726|66225358|FG000|Overall Study|Protocol Violation|1|||
23684970|NCT00206726|66225358|FG000|Overall Study|Withdrawal by Subject|8|||
23391532|NCT01213251|65178674|FG001|Overall Study|Missed 18-Month Follow-up|0|||
23391533|NCT01213251|65178675|FG002|Overall Study|Missed 18-Month Follow-up|1|||
23684971|NCT00542191|66225359|FG000|Overall Study|Death|3|||
23684972|NCT01817790|66225362|FG000|Overall Study|Adverse Event|0|||
23684973|NCT01817790|66225363|FG001|Overall Study|Adverse Event|2|||
23684974|NCT01817790|66225362|FG000|Overall Study|Lost to Follow-up|0|||
23684975|NCT01817790|66225363|FG001|Overall Study|Lost to Follow-up|1|||
23684976|NCT01817790|66225362|FG000|Overall Study|Protocol Violation|2|||
23684977|NCT01817790|66225363|FG001|Overall Study|Protocol Violation|1|||
23684978|NCT01817790|66225362|FG000|Overall Study|Withdrawal by Subject|1|||
23684979|NCT01817790|66225363|FG001|Overall Study|Withdrawal by Subject|3|||
23684980|NCT01817790|66225362|FG000|Overall Study|Other: Could not attend appointment|1|||
23684981|NCT01817790|66225363|FG001|Overall Study|Other: Could not attend appointment|1|||
23684982|NCT01445535|66225370|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23684983|NCT01445535|66225371|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23684984|NCT01445535|66225372|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23391534|NCT00488293|65178676|FG000|Overall Study|Lost to Follow-up|28|||
23391535|NCT00488293|65178677|FG001|Overall Study|Lost to Follow-up|25|||
23391536|NCT00488293|65178676|FG000|Overall Study|Withdrawal by Subject|5|||
23391537|NCT00488293|65178677|FG001|Overall Study|Withdrawal by Subject|3|||
23391538|NCT00488293|65178676|FG000|Overall Study|Death|2|||
23391539|NCT00488293|65178677|FG001|Overall Study|Death|1|||
23391540|NCT00488293|65178676|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
23391541|NCT00488293|65178677|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
23391542|NCT03510715|65178678|FG000|Overall Study|Adverse Event|1|||
23391543|NCT03510715|65178679|FG001|Overall Study|Adverse Event|0|||
23684985|NCT01445535|66225373|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
23684986|NCT01445535|66225370|FG000|Overall Study|Disease progression|1|||
23684987|NCT01445535|66225371|FG001|Overall Study|Disease progression|0|||
23684988|NCT01445535|66225372|FG002|Overall Study|Disease progression|1|||
23684989|NCT01445535|66225373|FG003|Overall Study|Disease progression|0|||
23684990|NCT01445535|66225370|FG000|Overall Study|PI discretion|0|||
23684991|NCT01445535|66225371|FG001|Overall Study|PI discretion|0|||
23684992|NCT01445535|66225372|FG002|Overall Study|PI discretion|0|||
23684993|NCT01445535|66225373|FG003|Overall Study|PI discretion|1|||
23684994|NCT00855439|66225374|FG000|Overall Study|Withdrawal by Subject|2|||
23684995|NCT00855439|66225375|FG001|Overall Study|Withdrawal by Subject|0|||
23684996|NCT00855439|66225374|FG000|Overall Study|Pregnancy|1|||
23684997|NCT00855439|66225375|FG001|Overall Study|Pregnancy|0|||
23684998|NCT00684177|66225376|FG000|Overall Study|Adverse Event|4|||
23684999|NCT00684177|66225377|FG001|Overall Study|Adverse Event|3|||
23685000|NCT00684177|66225376|FG000|Overall Study|Lack of Efficacy|10|||
23685001|NCT00684177|66225377|FG001|Overall Study|Lack of Efficacy|15|||
23685002|NCT00684177|66225376|FG000|Overall Study|Protocol Violation|1|||
23685003|NCT00684177|66225377|FG001|Overall Study|Protocol Violation|0|||
23685004|NCT00684177|66225376|FG000|Overall Study|Lost to Follow-up|2|||
23685005|NCT00684177|66225377|FG001|Overall Study|Lost to Follow-up|1|||
23685006|NCT00684177|66225376|FG000|Overall Study|Physician Decision|2|||
23685007|NCT00684177|66225377|FG001|Overall Study|Physician Decision|0|||
23685008|NCT00684177|66225376|FG000|Overall Study|Withdrawal by Subject|1|||
23685009|NCT00684177|66225377|FG001|Overall Study|Withdrawal by Subject|2|||
23685010|NCT00684177|66225376|FG000|Overall Study|Other|1|||
23685011|NCT00684177|66225377|FG001|Overall Study|Other|2|||
23685012|NCT01777763|66225378|FG000|Overall Study|Adverse Event|2|||
23685013|NCT01777763|66225379|FG001|Overall Study|Adverse Event|32|||
23685014|NCT01777763|66225378|FG000|Overall Study|Protocol Violation|1|||
23685015|NCT01777763|66225379|FG001|Overall Study|Protocol Violation|7|||
23685016|NCT01777763|66225378|FG000|Overall Study|Withdrawal by Subject|0|||
23685017|NCT01777763|66225379|FG001|Overall Study|Withdrawal by Subject|2|||
23685018|NCT01777763|66225378|FG000|Overall Study|Treatment Failure|1|||
23685019|NCT01777763|66225379|FG001|Overall Study|Treatment Failure|6|||
23685020|NCT00862251|66225381|FG000|Overall Study|Adverse Event|8|||
23685021|NCT00862251|66225382|FG001|Overall Study|Adverse Event|3|||
23685022|NCT00862251|66225383|FG002|Overall Study|Adverse Event|1|||
23685023|NCT00862251|66225381|FG000|Overall Study|Lost to Follow-up|0|||
23685024|NCT00862251|66225382|FG001|Overall Study|Lost to Follow-up|0|||
23685025|NCT00862251|66225383|FG002|Overall Study|Lost to Follow-up|1|||
23685026|NCT00862251|66225381|FG000|Overall Study|Protocol Violation|2|||
23685027|NCT00862251|66225382|FG001|Overall Study|Protocol Violation|0|||
23685028|NCT00862251|66225383|FG002|Overall Study|Protocol Violation|1|||
23685029|NCT00862251|66225381|FG000|Overall Study|Withdrawal by Subject|9|||
23685030|NCT00862251|66225382|FG001|Overall Study|Withdrawal by Subject|2|||
23685031|NCT00862251|66225383|FG002|Overall Study|Withdrawal by Subject|6|||
23685032|NCT04223609|66225385|FG000|Overall Study|Adverse Event|0|||
23685033|NCT04223609|66225386|FG001|Overall Study|Adverse Event|1|||
23685034|NCT04223609|66225385|FG000|Overall Study|Missed last visit|0|||
23685035|NCT04223609|66225386|FG001|Overall Study|Missed last visit|1|||
23685036|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Adverse Event|21|||
23685037|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Adverse Event|6|||
23495918|NCT02598960|65558959|FG002|Treatment Period|Disease Progression|4|||
23685038|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
23685039|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
23685040|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
23685041|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
23685042|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
23685043|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
23685044|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Physician Decision|0|||
23685045|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Physician Decision|3|||
23685046|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
23685047|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
23685048|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
23685049|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
23685050|NCT00510276|66225389|FG000|Acute Double-Blind Phase|Subject Decision|26|||
23685051|NCT00510276|66225390|FG001|Acute Double-Blind Phase|Subject Decision|28|||
23685052|NCT00510276|66225389|FG000|Extension Open-Label Phase|Adverse Event|9|||
23685053|NCT00510276|66225390|FG001|Extension Open-Label Phase|Adverse Event|18|||
23685054|NCT00510276|66225389|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
23685055|NCT00510276|66225390|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
23685056|NCT00510276|66225389|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
23685057|NCT00510276|66225390|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
23685058|NCT00510276|66225389|FG000|Extension Open-Label Phase|Physician Decision|2|||
23685059|NCT00510276|66225390|FG001|Extension Open-Label Phase|Physician Decision|3|||
23685060|NCT00510276|66225389|FG000|Extension Open-Label Phase|Protocol Violation|0|||
23685061|NCT00510276|66225390|FG001|Extension Open-Label Phase|Protocol Violation|1|||
23685062|NCT00510276|66225389|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
23685063|NCT00510276|66225390|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
23685064|NCT00510276|66225389|FG000|Extension Open-Label Phase|Subject Decision|7|||
23685065|NCT00510276|66225390|FG001|Extension Open-Label Phase|Subject Decision|9|||
23685066|NCT01552902|66225396|FG000|Overall Study|Adverse Event|1|||
23685067|NCT01552902|66225397|FG001|Overall Study|Adverse Event|15|||
23685068|NCT01552902|66225398|FG002|Overall Study|Adverse Event|14|||
23685069|NCT01552902|66225396|FG000|Overall Study|Protocol Violation|3|||
23685070|NCT01552902|66225397|FG001|Overall Study|Protocol Violation|3|||
23685071|NCT01552902|66225398|FG002|Overall Study|Protocol Violation|3|||
23685072|NCT01552902|66225396|FG000|Overall Study|Lack of Efficacy|4|||
23685073|NCT01552902|66225397|FG001|Overall Study|Lack of Efficacy|3|||
23685074|NCT01552902|66225398|FG002|Overall Study|Lack of Efficacy|1|||
23685075|NCT01552902|66225396|FG000|Overall Study|Withdrawal by Subject|1|||
23685076|NCT01552902|66225397|FG001|Overall Study|Withdrawal by Subject|9|||
23685077|NCT01552902|66225398|FG002|Overall Study|Withdrawal by Subject|6|||
23685078|NCT01552902|66225396|FG000|Overall Study|Lost to Follow-up|1|||
23685079|NCT01552902|66225397|FG001|Overall Study|Lost to Follow-up|3|||
23685080|NCT01552902|66225398|FG002|Overall Study|Lost to Follow-up|6|||
23685081|NCT01552902|66225396|FG000|Overall Study|Other|3|||
23685082|NCT01552902|66225397|FG001|Overall Study|Other|4|||
23685083|NCT01552902|66225398|FG002|Overall Study|Other|3|||
23685084|NCT03529409|66225401|FG000|Randomized|Lost to Follow-up|0|||
23685085|NCT03529409|66225402|FG001|Randomized|Lost to Follow-up|0|||
23685086|NCT03529409|66225403|FG002|Randomized|Lost to Follow-up|4|||
23685087|NCT03529409|66225401|FG000|Randomized|Excluded|0|||
23685088|NCT03529409|66225402|FG001|Randomized|Excluded|0|||
23685089|NCT03529409|66225403|FG002|Randomized|Excluded|1|||
23685090|NCT03529409|66225401|FG000|Post-treatment Assessment|Death|1|||
23685091|NCT03529409|66225402|FG001|Post-treatment Assessment|Death|0|||
23685092|NCT03529409|66225403|FG002|Post-treatment Assessment|Death|0|||
23685093|NCT03529409|66225401|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
23685094|NCT03529409|66225402|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
23685095|NCT03529409|66225403|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
23685096|NCT03529409|66225401|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
23685097|NCT03529409|66225402|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
23685098|NCT03529409|66225403|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
23685099|NCT03529409|66225401|FG000|Follow-up Assessment|Death|1|||
23685100|NCT03529409|66225402|FG001|Follow-up Assessment|Death|0|||
23685101|NCT03529409|66225403|FG002|Follow-up Assessment|Death|0|||
23685102|NCT03529409|66225401|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
23685103|NCT03529409|66225402|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
23685104|NCT03529409|66225403|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
23685105|NCT01412229|66225405|FG000|Overall Study|Physician Decision|1|||
23685106|NCT00582556|66225406|FG000|Overall Study|Withdrawal by Subject|0|||
23685107|NCT00582556|66225407|FG001|Overall Study|Withdrawal by Subject|1|||
23685108|NCT00582556|66225408|FG002|Overall Study|Withdrawal by Subject|1|||
23685109|NCT00582556|66225406|FG000|Overall Study|Physician Decision|0|||
23685110|NCT00582556|66225407|FG001|Overall Study|Physician Decision|0|||
23685111|NCT00582556|66225408|FG002|Overall Study|Physician Decision|1|||
23685112|NCT00934102|66225414|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
23685113|NCT00934102|66225415|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
23685114|NCT00934102|66225416|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
23685115|NCT00388947|66225421|FG000|Overall Study|Protocol Violation|47|||
23685116|NCT02162862|66225422|FG000|Overall Study|Lost to Follow-up|0|||
23685117|NCT02162862|66225423|FG001|Overall Study|Lost to Follow-up|11|||
23685118|NCT02162862|66225424|FG002|Overall Study|Lost to Follow-up|0|||
23685119|NCT02162862|66225422|FG000|Overall Study|Subject did not feel the med was needed|0|||
23685120|NCT02162862|66225423|FG001|Overall Study|Subject did not feel the med was needed|0|||
23685121|NCT02162862|66225424|FG002|Overall Study|Subject did not feel the med was needed|4|||
23685122|NCT02203149|66225425|FG000|Part 1|Adverse Event|0|||
23685123|NCT02203149|66225426|FG001|Part 1|Adverse Event|1|||
23685124|NCT02203149|66225427|FG002|Part 1|Adverse Event|0|||
23685125|NCT02203149|66225428|FG003|Part 1|Adverse Event|0|||
23685126|NCT02203149|66225429|FG004|Part 1|Adverse Event|0|||
23685127|NCT02203149|66225425|FG000|Part 2|Death|0|||
23685128|NCT02203149|66225426|FG001|Part 2|Death|0|||
23685129|NCT02203149|66225427|FG002|Part 2|Death|1|||
23685130|NCT02203149|66225428|FG003|Part 2|Death|1|||
23685131|NCT02203149|66225429|FG004|Part 2|Death|0|||
23685132|NCT02203149|66225425|FG000|Part 2|Withdrawal by Subject|0|||
23685133|NCT02203149|66225426|FG001|Part 2|Withdrawal by Subject|0|||
23685134|NCT02203149|66225427|FG002|Part 2|Withdrawal by Subject|0|||
23685135|NCT02203149|66225428|FG003|Part 2|Withdrawal by Subject|1|||
23685136|NCT02203149|66225429|FG004|Part 2|Withdrawal by Subject|0|||
23685137|NCT02203149|66225425|FG000|Part 2|Adverse Event|0|||
23685138|NCT02203149|66225426|FG001|Part 2|Adverse Event|0|||
23685139|NCT02203149|66225427|FG002|Part 2|Adverse Event|0|||
23685140|NCT02203149|66225428|FG003|Part 2|Adverse Event|1|||
23685141|NCT02203149|66225429|FG004|Part 2|Adverse Event|1|||
23685142|NCT02772757|66225430|FG000|Overall Study|Withdrawal by Subject|1|||
23685143|NCT02772757|66225431|FG001|Overall Study|Withdrawal by Subject|0|||
23685144|NCT02772757|66225432|FG002|Overall Study|Withdrawal by Subject|1|||
23685145|NCT02772757|66225430|FG000|Overall Study|Protocol Violation|0|||
23685146|NCT02772757|66225431|FG001|Overall Study|Protocol Violation|0|||
23685147|NCT02772757|66225432|FG002|Overall Study|Protocol Violation|1|||
23685148|NCT02772757|66225430|FG000|Overall Study|Physician Decision|0|||
23685149|NCT02772757|66225431|FG001|Overall Study|Physician Decision|3|||
23685150|NCT02772757|66225432|FG002|Overall Study|Physician Decision|3|||
23685151|NCT03157531|66225433|FG000|Overall Study|Death|2|||
23685152|NCT03157531|66225433|FG000|Overall Study|Lost to Follow-up|4|||
23685153|NCT02468648|66225434|FG000|Overall Study|Death|1|||
23685154|NCT00808444|66225435|FG000|Overall Study|Withdrawal by Subject|1|||
23685155|NCT00808444|66225436|FG001|Overall Study|Withdrawal by Subject|0|||
23685156|NCT00808444|66225435|FG000|Overall Study|Lost to Follow-up|0|||
23685157|NCT00808444|66225436|FG001|Overall Study|Lost to Follow-up|1|||
23685158|NCT02690701|66225437|FG000|Treatment Period 1|Adverse Event|2|||
23685159|NCT02690701|66225438|FG001|Treatment Period 1|Adverse Event|2|||
23685160|NCT02690701|66225437|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23685161|NCT02690701|66225438|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23685162|NCT02690701|66225437|FG000|Treatment Period 2|Adverse Event|2|||
23685163|NCT02690701|66225438|FG001|Treatment Period 2|Adverse Event|0|||
23685164|NCT02690701|66225437|FG000|Treatment Period 2|Lack of Efficacy|1|||
23685165|NCT02690701|66225438|FG001|Treatment Period 2|Lack of Efficacy|0|||
23685166|NCT02690701|66225437|FG000|Treatment Period 2|Lost to Follow-up|0|||
23685167|NCT02690701|66225438|FG001|Treatment Period 2|Lost to Follow-up|2|||
23685168|NCT02690701|66225437|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23685169|NCT02690701|66225438|FG001|Treatment Period 2|Withdrawal by Subject|2|||
23685170|NCT02690701|66225437|FG000|Treatment Period 2|Protocol Violation|0|||
23685171|NCT02690701|66225438|FG001|Treatment Period 2|Protocol Violation|1|||
23685172|NCT01431287|66225441|FG000|Overall Study|not treated|0|||
23685173|NCT01431287|66225442|FG001|Overall Study|not treated|0|||
23685174|NCT01431287|66225443|FG002|Overall Study|not treated|1|||
23685175|NCT01431287|66225444|FG003|Overall Study|not treated|0|||
23685176|NCT01431287|66225445|FG004|Overall Study|not treated|0|||
23685177|NCT01431287|66225441|FG000|Overall Study|Adverse Event|59|||
23685178|NCT01431287|66225442|FG001|Overall Study|Adverse Event|57|||
23685179|NCT01431287|66225443|FG002|Overall Study|Adverse Event|53|||
23685180|NCT01431287|66225444|FG003|Overall Study|Adverse Event|33|||
23685181|NCT01431287|66225445|FG004|Overall Study|Adverse Event|41|||
23685182|NCT01431287|66225441|FG000|Overall Study|Non compliant with protocol|6|||
23685183|NCT01431287|66225442|FG001|Overall Study|Non compliant with protocol|6|||
23685184|NCT01431287|66225443|FG002|Overall Study|Non compliant with protocol|5|||
23685185|NCT01431287|66225444|FG003|Overall Study|Non compliant with protocol|6|||
23685186|NCT01431287|66225445|FG004|Overall Study|Non compliant with protocol|5|||
23685187|NCT01431287|66225441|FG000|Overall Study|Lost to Follow-up|0|||
23685188|NCT01431287|66225442|FG001|Overall Study|Lost to Follow-up|3|||
23685189|NCT01431287|66225443|FG002|Overall Study|Lost to Follow-up|2|||
23685190|NCT01431287|66225444|FG003|Overall Study|Lost to Follow-up|3|||
23685191|NCT01431287|66225445|FG004|Overall Study|Lost to Follow-up|1|||
23685192|NCT01431287|66225441|FG000|Overall Study|Consent withdrawn not due to AE|29|||
23685193|NCT01431287|66225442|FG001|Overall Study|Consent withdrawn not due to AE|30|||
23685194|NCT01431287|66225443|FG002|Overall Study|Consent withdrawn not due to AE|34|||
23685195|NCT01431287|66225444|FG003|Overall Study|Consent withdrawn not due to AE|19|||
23685196|NCT01431287|66225445|FG004|Overall Study|Consent withdrawn not due to AE|29|||
23685197|NCT01431287|66225441|FG000|Overall Study|not stated above|4|||
23685198|NCT01431287|66225442|FG001|Overall Study|not stated above|2|||
23685199|NCT01431287|66225443|FG002|Overall Study|not stated above|2|||
23685200|NCT01431287|66225444|FG003|Overall Study|not stated above|2|||
23685201|NCT01431287|66225445|FG004|Overall Study|not stated above|1|||
23685202|NCT02731742|66225446|FG000|Overall Study|Death|1|||
23685203|NCT02731742|66225447|FG001|Overall Study|Death|2|||
23685204|NCT02731742|66225448|FG002|Overall Study|Death|5|||
23685205|NCT02731742|66225449|FG003|Overall Study|Death|0|||
23685206|NCT02731742|66225446|FG000|Overall Study|Physician Decision|0|||
23685207|NCT02731742|66225447|FG001|Overall Study|Physician Decision|0|||
23685208|NCT02731742|66225448|FG002|Overall Study|Physician Decision|0|||
23685209|NCT02731742|66225449|FG003|Overall Study|Physician Decision|1|||
23685210|NCT02731742|66225446|FG000|Overall Study|Study Terminated by Sponsor|2|||
23685211|NCT02731742|66225447|FG001|Overall Study|Study Terminated by Sponsor|1|||
23685212|NCT02731742|66225448|FG002|Overall Study|Study Terminated by Sponsor|1|||
23685213|NCT02731742|66225449|FG003|Overall Study|Study Terminated by Sponsor|1|||
23685214|NCT02939131|66225453|FG000|Overall Study|Unable to get to clinic|6|||
23685215|NCT02939131|66225454|FG001|Overall Study|Unable to get to clinic|4|||
23685216|NCT02939131|66225453|FG000|Overall Study|Lost to Follow-up|2|||
23685217|NCT02939131|66225454|FG001|Overall Study|Lost to Follow-up|4|||
23685218|NCT02939131|66225453|FG000|Overall Study|severe debilitation|1|||
23685219|NCT02939131|66225454|FG001|Overall Study|severe debilitation|0|||
23685220|NCT02939131|66225453|FG000|Overall Study|Other|0|||
23685221|NCT02939131|66225454|FG001|Overall Study|Other|1|||
23685222|NCT02939131|66225453|FG000|Overall Study|not willing to adhere to protocol|2|||
23685223|NCT02939131|66225454|FG001|Overall Study|not willing to adhere to protocol|0|||
23685224|NCT00611247|66225455|FG000|Overall Study|Death|1|||
23685225|NCT00611247|66225456|FG001|Overall Study|Death|5|||
23685226|NCT00611247|66225455|FG000|Overall Study|Lack of Efficacy|1|||
23685227|NCT00611247|66225456|FG001|Overall Study|Lack of Efficacy|16|||
23685228|NCT02472847|66225461|FG000|Overall Study|Withdrawal by Subject|1|||
23685229|NCT02472847|66225462|FG001|Overall Study|Withdrawal by Subject|5|||
23685230|NCT00454207|66225463|FG000|Overall Study|Adverse Event|3|||
23685231|NCT00454207|66225464|FG001|Overall Study|Adverse Event|1|||
23685232|NCT00454207|66225463|FG000|Overall Study|Lack of Efficacy|1|||
23685233|NCT00454207|66225464|FG001|Overall Study|Lack of Efficacy|0|||
23685234|NCT00454207|66225463|FG000|Overall Study|Protocol Violation|0|||
23391544|NCT00721110|65178681|FG000|Overall Study|Ultram use|1|||
23391545|NCT00721110|65178682|FG001|Overall Study|Ultram use|0|||
23391546|NCT00721110|65178683|FG002|Overall Study|Ultram use|0|||
23391547|NCT00721110|65178684|FG003|Overall Study|Ultram use|0|||
23391548|NCT00721110|65178681|FG000|Overall Study|vertical incision|0|||
23391549|NCT00721110|65178682|FG001|Overall Study|vertical incision|0|||
23391550|NCT00721110|65178683|FG002|Overall Study|vertical incision|1|||
23391551|NCT00721110|65178684|FG003|Overall Study|vertical incision|0|||
23391552|NCT01443026|65178685|FG000|Overall Study|Physician Decision|1|||
23391553|NCT01443026|65178686|FG001|Overall Study|Physician Decision|0|||
23391554|NCT01443026|65178685|FG000|Overall Study|Death|0|||
23391555|NCT01443026|65178686|FG001|Overall Study|Death|1|||
23391556|NCT01443026|65178685|FG000|Overall Study|Withdrawal by Subject|0|||
23391557|NCT01443026|65178686|FG001|Overall Study|Withdrawal by Subject|3|||
23391558|NCT01443026|65178685|FG000|Overall Study|Lost to Follow-up|2|||
23391559|NCT01443026|65178686|FG001|Overall Study|Lost to Follow-up|1|||
23495919|NCT02598960|65558960|FG003|Treatment Period|Disease Progression|6|||
23495920|NCT02598960|65558961|FG004|Treatment Period|Disease Progression|8|||
23391560|NCT00489359|65178687|FG000|Overall Study|Death|0|||
23391561|NCT00489359|65178688|FG001|Overall Study|Death|2|||
23495921|NCT02598960|65558962|FG005|Treatment Period|Disease Progression|2|||
23391562|NCT00489359|65178687|FG000|Overall Study|Progressive Disease|5|||
23685235|NCT00454207|66225464|FG001|Overall Study|Protocol Violation|1|||
23391563|NCT00489359|65178688|FG001|Overall Study|Progressive Disease|6|||
23685236|NCT00331760|66225466|FG000|Overall Study|Ineligible / no protocol treatment|15|||
23685237|NCT00331760|66225467|FG001|Overall Study|Ineligible / no protocol treatment|8|||
23685238|NCT00403260|66225468|FG000|Overall Study|Adverse Event|5|||
23685239|NCT00403260|66225469|FG001|Overall Study|Adverse Event|4|||
23685240|NCT00403260|66225468|FG000|Overall Study|Withdrawal by Subject|5|||
23391564|NCT00489359|65178687|FG000|Overall Study|Lost to Follow-up|1|||
23391565|NCT00489359|65178688|FG001|Overall Study|Lost to Follow-up|0|||
23391566|NCT00489359|65178687|FG000|Overall Study|Withdrawal by Subject|1|||
23391567|NCT00489359|65178688|FG001|Overall Study|Withdrawal by Subject|5|||
23391568|NCT00489359|65178687|FG000|Overall Study|Adverse Event|0|||
23391569|NCT00489359|65178688|FG001|Overall Study|Adverse Event|16|||
23391570|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23391571|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
23391572|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23391573|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
23391574|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
23391575|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
23391576|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
23391577|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
23391578|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
23391579|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391580|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391581|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
23391582|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23391583|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391584|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23685241|NCT00403260|66225469|FG001|Overall Study|Withdrawal by Subject|6|||
23685242|NCT00403260|66225468|FG000|Overall Study|Lost to Follow-up|49|||
23685243|NCT00403260|66225469|FG001|Overall Study|Lost to Follow-up|25|||
23685244|NCT00403260|66225468|FG000|Overall Study|Re-appearance of P. falciparum|34|||
23685245|NCT00403260|66225469|FG001|Overall Study|Re-appearance of P. falciparum|25|||
23685246|NCT00403260|66225468|FG000|Overall Study|P. vivax infection|26|||
23685247|NCT00403260|66225469|FG001|Overall Study|P. vivax infection|4|||
23685248|NCT00403260|66225468|FG000|Overall Study|Mixed infection with P. vivax|2|||
23685249|NCT00403260|66225469|FG001|Overall Study|Mixed infection with P. vivax|0|||
23685250|NCT00403260|66225468|FG000|Overall Study|Mixed infection with P. falciparum|1|||
23685251|NCT00403260|66225469|FG001|Overall Study|Mixed infection with P. falciparum|0|||
23685252|NCT00403260|66225468|FG000|Overall Study|P. vivax infection at screening|1|||
23685253|NCT00403260|66225469|FG001|Overall Study|P. vivax infection at screening|0|||
23685254|NCT00403260|66225468|FG000|Overall Study|P. ovale infection|1|||
23685255|NCT00403260|66225469|FG001|Overall Study|P. ovale infection|0|||
23685256|NCT00403260|66225468|FG000|Overall Study|Gametocyte re-appearance|1|||
23685257|NCT00403260|66225469|FG001|Overall Study|Gametocyte re-appearance|1|||
23685258|NCT00403260|66225468|FG000|Overall Study|Withdrawn from study accidentally|0|||
23685259|NCT00403260|66225469|FG001|Overall Study|Withdrawn from study accidentally|1|||
23685260|NCT01246206|66225470|FG000|Overall Study|Patient did not receive study regiments.|1|||
23685261|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
23685262|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
23685263|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
23685264|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
23685265|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
23685266|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
23685267|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
23685268|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
23685269|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23685270|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23685271|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23685272|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
23685273|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
23685274|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23685275|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23685276|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
23685277|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
23685278|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
23685279|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23685280|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23685281|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
23685282|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23685283|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23685284|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23685285|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23685286|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
23391585|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23685287|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
23685288|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
23685289|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
23685290|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
23685291|NCT05195528|66225472|FG000|Placebo-controlled Treatment Period|Other|0|||
23685292|NCT05195528|66225473|FG001|Placebo-controlled Treatment Period|Other|0|||
23685293|NCT05195528|66225474|FG002|Placebo-controlled Treatment Period|Other|1|||
23685294|NCT05195528|66225475|FG003|Placebo-controlled Treatment Period|Other|0|||
23685295|NCT05195528|66225476|FG004|Placebo-controlled Treatment Period|Other|0|||
23685296|NCT05195528|66225472|FG000|Extension Period|PTE or AE or SAE|0|||
23685297|NCT05195528|66225473|FG001|Extension Period|PTE or AE or SAE|4|||
23685298|NCT05195528|66225474|FG002|Extension Period|PTE or AE or SAE|5|||
23685299|NCT05195528|66225475|FG003|Extension Period|PTE or AE or SAE|4|||
23685300|NCT05195528|66225476|FG004|Extension Period|PTE or AE or SAE|4|||
23685301|NCT05195528|66225472|FG000|Extension Period|Protocol Violation|0|||
23685302|NCT05195528|66225473|FG001|Extension Period|Protocol Violation|2|||
23685303|NCT05195528|66225474|FG002|Extension Period|Protocol Violation|1|||
23685304|NCT05195528|66225475|FG003|Extension Period|Protocol Violation|0|||
23685305|NCT05195528|66225476|FG004|Extension Period|Protocol Violation|1|||
23685306|NCT05195528|66225472|FG000|Extension Period|Lost to Follow-up|0|||
23685307|NCT05195528|66225473|FG001|Extension Period|Lost to Follow-up|6|||
23685308|NCT05195528|66225474|FG002|Extension Period|Lost to Follow-up|13|||
23685309|NCT05195528|66225475|FG003|Extension Period|Lost to Follow-up|3|||
23685310|NCT05195528|66225476|FG004|Extension Period|Lost to Follow-up|7|||
23685311|NCT05195528|66225472|FG000|Extension Period|Withdrawal by Subject|0|||
23685312|NCT05195528|66225473|FG001|Extension Period|Withdrawal by Subject|12|||
23685313|NCT05195528|66225474|FG002|Extension Period|Withdrawal by Subject|9|||
23685314|NCT05195528|66225475|FG003|Extension Period|Withdrawal by Subject|6|||
23685315|NCT05195528|66225476|FG004|Extension Period|Withdrawal by Subject|5|||
23685316|NCT05195528|66225472|FG000|Extension Period|Lack of Efficacy|0|||
23685317|NCT05195528|66225473|FG001|Extension Period|Lack of Efficacy|3|||
23685318|NCT05195528|66225474|FG002|Extension Period|Lack of Efficacy|0|||
23685319|NCT05195528|66225475|FG003|Extension Period|Lack of Efficacy|0|||
23685320|NCT05195528|66225476|FG004|Extension Period|Lack of Efficacy|2|||
23685321|NCT05195528|66225472|FG000|Extension Period|Not Treated|0|||
23685322|NCT05195528|66225473|FG001|Extension Period|Not Treated|0|||
23685323|NCT05195528|66225474|FG002|Extension Period|Not Treated|2|||
23685324|NCT05195528|66225475|FG003|Extension Period|Not Treated|3|||
23685325|NCT05195528|66225476|FG004|Extension Period|Not Treated|0|||
23685326|NCT05195528|66225472|FG000|Extension Period|Other|0|||
23685327|NCT05195528|66225473|FG001|Extension Period|Other|1|||
23685328|NCT05195528|66225474|FG002|Extension Period|Other|1|||
23391586|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391587|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23391588|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391589|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391590|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391591|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391592|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391593|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
23495922|NCT02598960|65558963|FG006|Treatment Period|Disease Progression|2|||
23495923|NCT02598960|65558964|FG007|Treatment Period|Disease Progression|3|||
23495924|NCT02598960|65558965|FG008|Treatment Period|Disease Progression|7|||
23495925|NCT02598960|65558966|FG009|Treatment Period|Disease Progression|9|||
23495926|NCT02598960|65558967|FG010|Treatment Period|Disease Progression|7|||
23495927|NCT02598960|65558968|FG011|Treatment Period|Disease Progression|143|||
23495928|NCT02598960|65558969|FG012|Treatment Period|Disease Progression|23|||
23495929|NCT02598960|65558957|FG000|Treatment Period|Study drug toxicity|0|||
23495930|NCT02598960|65558958|FG001|Treatment Period|Study drug toxicity|0|||
23495931|NCT02598960|65558959|FG002|Treatment Period|Study drug toxicity|0|||
23685329|NCT05195528|66225475|FG003|Extension Period|Other|0|||
23685330|NCT05195528|66225476|FG004|Extension Period|Other|0|||
23685331|NCT02620020|66225479|FG000|Overall Study|Adverse Event|8|||
23685332|NCT02620020|66225480|FG001|Overall Study|Adverse Event|4|||
23495932|NCT02598960|65558960|FG003|Treatment Period|Study drug toxicity|0|||
23495933|NCT02598960|65558961|FG004|Treatment Period|Study drug toxicity|0|||
23685333|NCT02620020|66225481|FG002|Overall Study|Adverse Event|3|||
23685334|NCT02620020|66225482|FG003|Overall Study|Adverse Event|5|||
23685335|NCT02620020|66225479|FG000|Overall Study|Lost to Follow-up|4|||
23685336|NCT02620020|66225480|FG001|Overall Study|Lost to Follow-up|8|||
23685337|NCT02620020|66225481|FG002|Overall Study|Lost to Follow-up|1|||
23685338|NCT02620020|66225482|FG003|Overall Study|Lost to Follow-up|4|||
23685339|NCT02620020|66225479|FG000|Overall Study|Physician Decision|7|||
23685340|NCT02620020|66225480|FG001|Overall Study|Physician Decision|4|||
23685341|NCT02620020|66225481|FG002|Overall Study|Physician Decision|3|||
23391594|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23495934|NCT02598960|65558962|FG005|Treatment Period|Study drug toxicity|0|||
23495935|NCT02598960|65558963|FG006|Treatment Period|Study drug toxicity|0|||
23495936|NCT02598960|65558964|FG007|Treatment Period|Study drug toxicity|0|||
23391595|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391596|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391597|NCT02150863|65178711|FG000|Overall Study|Lost to Follow-up|0|||
23391598|NCT02150863|65178712|FG001|Overall Study|Lost to Follow-up|1|||
23391599|NCT02150863|65178713|FG002|Overall Study|Lost to Follow-up|0|||
23391600|NCT03791060|65178714|FG000|Overall Study|Withdrawal by Subject|1|||
23391601|NCT01027351|65178715|FG000|Overall Study|Withdrawal by Subject|1|||
23391602|NCT01027351|65178716|FG001|Overall Study|Withdrawal by Subject|0|||
23391603|NCT01027351|65178717|FG002|Overall Study|Withdrawal by Subject|1|||
23391604|NCT01027351|65178718|FG003|Overall Study|Withdrawal by Subject|0|||
23495937|NCT02598960|65558965|FG008|Treatment Period|Study drug toxicity|0|||
23495938|NCT02598960|65558966|FG009|Treatment Period|Study drug toxicity|1|||
23391605|NCT01027351|65178719|FG004|Overall Study|Withdrawal by Subject|3|||
23391606|NCT01027351|65178720|FG005|Overall Study|Withdrawal by Subject|5|||
23391607|NCT01027351|65178715|FG000|Overall Study|Lost to Follow-up|1|||
23391608|NCT01027351|65178716|FG001|Overall Study|Lost to Follow-up|1|||
23391609|NCT01027351|65178717|FG002|Overall Study|Lost to Follow-up|0|||
23391610|NCT01027351|65178718|FG003|Overall Study|Lost to Follow-up|1|||
23391611|NCT01027351|65178719|FG004|Overall Study|Lost to Follow-up|6|||
23391612|NCT01027351|65178720|FG005|Overall Study|Lost to Follow-up|0|||
23391613|NCT01027351|65178715|FG000|Overall Study|Inappropriate enrollment|0|||
23391614|NCT01027351|65178716|FG001|Overall Study|Inappropriate enrollment|0|||
23391615|NCT01027351|65178717|FG002|Overall Study|Inappropriate enrollment|0|||
23391616|NCT01027351|65178718|FG003|Overall Study|Inappropriate enrollment|0|||
23391617|NCT01027351|65178719|FG004|Overall Study|Inappropriate enrollment|1|||
23391618|NCT01027351|65178720|FG005|Overall Study|Inappropriate enrollment|0|||
23391619|NCT01027351|65178715|FG000|Overall Study|Protocol Violation|1|||
23391620|NCT01027351|65178716|FG001|Overall Study|Protocol Violation|0|||
23391621|NCT01027351|65178717|FG002|Overall Study|Protocol Violation|0|||
23391622|NCT01027351|65178718|FG003|Overall Study|Protocol Violation|1|||
23495939|NCT02598960|65558967|FG010|Treatment Period|Study drug toxicity|0|||
23495940|NCT02598960|65558968|FG011|Treatment Period|Study drug toxicity|3|||
23495941|NCT02598960|65558969|FG012|Treatment Period|Study drug toxicity|0|||
23685342|NCT02620020|66225482|FG003|Overall Study|Physician Decision|4|||
23685343|NCT02620020|66225479|FG000|Overall Study|Protocol Violation|5|||
23685344|NCT02620020|66225480|FG001|Overall Study|Protocol Violation|2|||
23685345|NCT02620020|66225481|FG002|Overall Study|Protocol Violation|1|||
23685346|NCT02620020|66225482|FG003|Overall Study|Protocol Violation|1|||
23685347|NCT02620020|66225479|FG000|Overall Study|Withdrawal by Subject|20|||
23495942|NCT02598960|65558957|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
23495943|NCT02598960|65558958|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
23685348|NCT02620020|66225480|FG001|Overall Study|Withdrawal by Subject|16|||
23685349|NCT02620020|66225481|FG002|Overall Study|Withdrawal by Subject|17|||
23685350|NCT02620020|66225482|FG003|Overall Study|Withdrawal by Subject|12|||
23685351|NCT02620020|66225479|FG000|Overall Study|Death|0|||
23685352|NCT02620020|66225480|FG001|Overall Study|Death|1|||
23685353|NCT02620020|66225481|FG002|Overall Study|Death|0|||
23685354|NCT02620020|66225482|FG003|Overall Study|Death|0|||
23685355|NCT01289015|66225483|FG000|Overall Study|Protocol Violation|12|||
23685356|NCT01289015|66225484|FG001|Overall Study|Protocol Violation|9|||
23685357|NCT01289015|66225483|FG000|Overall Study|Adverse Event|3|||
23685358|NCT01289015|66225484|FG001|Overall Study|Adverse Event|0|||
23685359|NCT01289015|66225483|FG000|Overall Study|Lost to Follow-up|33|||
23685360|NCT01289015|66225484|FG001|Overall Study|Lost to Follow-up|17|||
23685361|NCT01289015|66225483|FG000|Overall Study|Withdrawal by Subject|17|||
23685362|NCT01289015|66225484|FG001|Overall Study|Withdrawal by Subject|8|||
23685363|NCT01289015|66225483|FG000|Overall Study|Disease progression|1|||
23685364|NCT01289015|66225484|FG001|Overall Study|Disease progression|0|||
23685365|NCT01289015|66225483|FG000|Overall Study|Negative baseline culture and others|33|||
23685366|NCT01289015|66225484|FG001|Overall Study|Negative baseline culture and others|20|||
23685367|NCT01955707|66225485|FG000|Overall Study|Adverse Event|1|||
23685368|NCT01955707|66225486|FG001|Overall Study|Adverse Event|2|||
23685369|NCT01955707|66225485|FG000|Overall Study|Lost to Follow-up|2|||
23685370|NCT01955707|66225486|FG001|Overall Study|Lost to Follow-up|1|||
23685371|NCT01955707|66225485|FG000|Overall Study|Withdrawal by Subject|0|||
23685372|NCT01955707|66225486|FG001|Overall Study|Withdrawal by Subject|3|||
23495944|NCT02598960|65558959|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
23685373|NCT01955707|66225485|FG000|Overall Study|Death|13|||
23495945|NCT02598960|65558960|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
23495946|NCT02598960|65558961|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
23685374|NCT01955707|66225486|FG001|Overall Study|Death|14|||
23391623|NCT01027351|65178719|FG004|Overall Study|Protocol Violation|1|||
23391624|NCT01027351|65178720|FG005|Overall Study|Protocol Violation|0|||
23391625|NCT02067156|65178727|FG000|Overall Study|Lost to Follow-up|4|||
23685375|NCT01955707|66225485|FG000|Overall Study|Other|4|||
23685376|NCT01955707|66225486|FG001|Overall Study|Other|2|||
23685377|NCT03219164|66225487|FG000|Overall Study|Study Terminated by Sponsor|16|||
23685378|NCT03219164|66225488|FG001|Overall Study|Study Terminated by Sponsor|12|||
23685379|NCT03219164|66225487|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
23685380|NCT03219164|66225488|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
23495947|NCT02598960|65558962|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
23495948|NCT02598960|65558963|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
23495949|NCT02598960|65558964|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
23495950|NCT02598960|65558965|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
23495951|NCT02598960|65558966|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
23495952|NCT02598960|65558967|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
23495953|NCT02598960|65558968|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
23495954|NCT02598960|65558969|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
23495955|NCT02598960|65558957|FG000|Treatment Period|participant request to discontinue|0|||
23495956|NCT02598960|65558958|FG001|Treatment Period|participant request to discontinue|1|||
23495957|NCT02598960|65558959|FG002|Treatment Period|participant request to discontinue|0|||
23495958|NCT02598960|65558960|FG003|Treatment Period|participant request to discontinue|0|||
23495959|NCT02598960|65558961|FG004|Treatment Period|participant request to discontinue|1|||
23685381|NCT03219164|66225487|FG000|Overall Study|Lost to Follow-up|1|||
23685382|NCT03219164|66225488|FG001|Overall Study|Lost to Follow-up|1|||
23685383|NCT03219164|66225487|FG000|Overall Study|Adverse Event|1|||
23685384|NCT03219164|66225488|FG001|Overall Study|Adverse Event|0|||
23685385|NCT03219164|66225487|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23685386|NCT03219164|66225488|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23685387|NCT03219164|66225487|FG000|Overall Study|Protocol Violation|0|||
23685388|NCT03219164|66225488|FG001|Overall Study|Protocol Violation|1|||
23685389|NCT03219164|66225487|FG000|Overall Study|Withdrew Assent|1|||
23685390|NCT03219164|66225488|FG001|Overall Study|Withdrew Assent|0|||
23685391|NCT05340504|66225489|FG000|Overall Study|Withdrawal by Subject|1|||
23685392|NCT05340504|66225490|FG001|Overall Study|Withdrawal by Subject|0|||
23685393|NCT00348140|66225491|FG000|Overall Study|Adverse Event|46|||
23685394|NCT00348140|66225492|FG001|Overall Study|Adverse Event|49|||
23495960|NCT02598960|65558962|FG005|Treatment Period|participant request to discontinue|0|||
23685395|NCT00348140|66225493|FG002|Overall Study|Adverse Event|78|||
23685396|NCT00348140|66225491|FG000|Overall Study|Lost to Follow-up|4|||
23495961|NCT02598960|65558963|FG006|Treatment Period|participant request to discontinue|0|||
23495962|NCT02598960|65558964|FG007|Treatment Period|participant request to discontinue|0|||
23495963|NCT02598960|65558965|FG008|Treatment Period|participant request to discontinue|0|||
23685397|NCT00348140|66225492|FG001|Overall Study|Lost to Follow-up|4|||
23685398|NCT00348140|66225493|FG002|Overall Study|Lost to Follow-up|4|||
23685399|NCT00348140|66225491|FG000|Overall Study|Protocol Violation|12|||
23685400|NCT00348140|66225492|FG001|Overall Study|Protocol Violation|13|||
23685401|NCT00348140|66225493|FG002|Overall Study|Protocol Violation|14|||
23685402|NCT00348140|66225491|FG000|Overall Study|Withdrawal by Subject|32|||
23685403|NCT00348140|66225492|FG001|Overall Study|Withdrawal by Subject|40|||
23685404|NCT00348140|66225493|FG002|Overall Study|Withdrawal by Subject|40|||
23685405|NCT00348140|66225491|FG000|Overall Study|Non-compliance|8|||
23391626|NCT01416831|65178730|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
23391627|NCT01416831|65178731|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
23391628|NCT04620668|65178750|FG000|Overall Study|Withdrawal by Subject|2|||
23391629|NCT04620668|65178751|FG001|Overall Study|Withdrawal by Subject|0|||
23391630|NCT04620668|65178750|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
23391631|NCT04620668|65178751|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
23391632|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: missing data|2|||
23391633|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: missing data|0|||
23391634|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
23391635|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
23391636|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
23391637|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
23391638|NCT03460704|65178752|FG000|Overall Study|Withdrawal by Subject|11|||
23391639|NCT03460704|65178753|FG001|Overall Study|Withdrawal by Subject|14|||
23391640|NCT03460704|65178752|FG000|Overall Study|Study terminated by the Sponsor|29|||
23391641|NCT03460704|65178753|FG001|Overall Study|Study terminated by the Sponsor|19|||
23391642|NCT03460704|65178752|FG000|Overall Study|Adverse Event|10|||
23391643|NCT03460704|65178753|FG001|Overall Study|Adverse Event|5|||
23391644|NCT03460704|65178752|FG000|Overall Study|Death|3|||
23391645|NCT03460704|65178753|FG001|Overall Study|Death|2|||
23391646|NCT03460704|65178752|FG000|Overall Study|Non-Compliance with Study Drug|3|||
23391647|NCT03460704|65178753|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23391648|NCT03460704|65178752|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23391649|NCT03460704|65178753|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
23391650|NCT03460704|65178752|FG000|Overall Study|Other|2|||
23391651|NCT03460704|65178753|FG001|Overall Study|Other|1|||
23391652|NCT03412591|65178754|FG000|Overall Study|Withdrawal by Subject|1|||
23391653|NCT03412591|65178755|FG001|Overall Study|Withdrawal by Subject|8|||
23391654|NCT03412591|65178754|FG000|Overall Study|Adverse Event|0|||
23391655|NCT03412591|65178755|FG001|Overall Study|Adverse Event|1|||
23391656|NCT03163667|65178756|FG000|Overall Study|Death|15|||
23391657|NCT03163667|65178757|FG001|Overall Study|Death|27|||
23391658|NCT03163667|65178756|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
23391659|NCT03163667|65178757|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
23391660|NCT02743221|65180804|FG000|Overall Study|Progressive disease|29|||
23391661|NCT02743221|65180805|FG001|Overall Study|Progressive disease|38|||
23391662|NCT02743221|65180804|FG000|Overall Study|Adverse Event|17|||
23391663|NCT02743221|65180805|FG001|Overall Study|Adverse Event|14|||
23391664|NCT02743221|65180804|FG000|Overall Study|non medical reason|8|||
23391665|NCT02743221|65180805|FG001|Overall Study|non medical reason|2|||
23391666|NCT02743221|65180804|FG000|Overall Study|Physician Decision|2|||
23391667|NCT02743221|65180805|FG001|Overall Study|Physician Decision|5|||
23391668|NCT02743221|65180804|FG000|Overall Study|Patient not eligible, not treated|0|||
23391669|NCT02743221|65180805|FG001|Overall Study|Patient not eligible, not treated|1|||
23606186|NCT00641537|65947158|FG003|24-Week Supplemental Follow-up Period|Other|1|||
23606187|NCT00641537|65947159|FG004|24-Week Supplemental Follow-up Period|Other|3|||
23606188|NCT00641537|65947160|FG005|24-Week Supplemental Follow-up Period|Other|0|||
23606189|NCT00641537|65947161|FG006|24-Week Supplemental Follow-up Period|Other|1|||
23606190|NCT00641537|65947162|FG007|24-Week Supplemental Follow-up Period|Other|1|||
23606191|NCT00704340|65947164|FG000|Overall Study|Lost to Follow-up|2|||
23606192|NCT00704340|65947165|FG001|Overall Study|Lost to Follow-up|1|||
23606193|NCT00704340|65947164|FG000|Overall Study|Death|0|||
23606194|NCT00704340|65947165|FG001|Overall Study|Death|1|||
23606195|NCT01009645|65947166|FG000|Overall Study|Lost to Follow-up|2|||
23391680|NCT01506726|65180810|FG000|Overall Study|Adverse Event|1|||
23391681|NCT01506726|65180811|FG001|Overall Study|Adverse Event|2|||
23495964|NCT02598960|65558966|FG009|Treatment Period|participant request to discontinue|0|||
23495965|NCT02598960|65558967|FG010|Treatment Period|participant request to discontinue|1|||
23495966|NCT02598960|65558968|FG011|Treatment Period|participant request to discontinue|4|||
23495967|NCT02598960|65558969|FG012|Treatment Period|participant request to discontinue|0|||
23685406|NCT00348140|66225492|FG001|Overall Study|Non-compliance|13|||
23685407|NCT00348140|66225493|FG002|Overall Study|Non-compliance|5|||
23391682|NCT03345550|65180812|FG000|Overall Study|Withdrawal by Subject|1|||
23391683|NCT03345550|65180813|FG001|Overall Study|Withdrawal by Subject|0|||
23391684|NCT03345550|65180812|FG000|Overall Study|Lost to Follow-up|4|||
23391685|NCT03345550|65180813|FG001|Overall Study|Lost to Follow-up|5|||
23391686|NCT03312543|65180816|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
23391687|NCT03312543|65180817|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
23391688|NCT03312543|65180816|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
23391689|NCT03312543|65180817|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
23391690|NCT03312543|65180816|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
23391691|NCT03312543|65180817|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
23391692|NCT03312543|65180816|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
23391693|NCT03312543|65180817|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
23391694|NCT03312543|65180816|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
23391695|NCT03312543|65180817|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
23391696|NCT03312543|65180816|FG000|Regression (Week 12 to Week 24)|Death|0|||
23391697|NCT03312543|65180817|FG001|Regression (Week 12 to Week 24)|Death|1|||
23391698|NCT02034565|65180818|FG000|Overall Study|Adverse Event|1|||
23495968|NCT02598960|65558957|FG000|Treatment Period|participant withdrew consent|0|||
23495969|NCT02598960|65558958|FG001|Treatment Period|participant withdrew consent|0|||
23685408|NCT00348140|66225491|FG000|Overall Study|Participant at risk due to study drug|2|||
23391699|NCT02034565|65180819|FG001|Overall Study|Adverse Event|0|||
23391700|NCT00493285|65180826|FG000|Overall Study|Lost to Follow-up|0|||
23391701|NCT00493285|65180827|FG001|Overall Study|Lost to Follow-up|0|||
23391702|NCT00493285|65180828|FG002|Overall Study|Lost to Follow-up|0|||
23391703|NCT00493285|65180829|FG003|Overall Study|Lost to Follow-up|0|||
23391704|NCT00493285|65180830|FG004|Overall Study|Lost to Follow-up|1|||
23391705|NCT00493285|65180831|FG005|Overall Study|Lost to Follow-up|0|||
23391706|NCT03502200|65180832|FG000|Overall Study|Adverse Event|1|||
23391707|NCT03502200|65180833|FG001|Overall Study|Adverse Event|0|||
23391708|NCT03502200|65180832|FG000|Overall Study|Lost to Follow-up|36|||
23391709|NCT03502200|65180833|FG001|Overall Study|Lost to Follow-up|38|||
23391710|NCT03502200|65180832|FG000|Overall Study|Study Team Decision|1|||
23391711|NCT03502200|65180833|FG001|Overall Study|Study Team Decision|1|||
23391712|NCT03502200|65180832|FG000|Overall Study|Withdrawal by Subject|5|||
23391713|NCT03502200|65180833|FG001|Overall Study|Withdrawal by Subject|7|||
23391714|NCT03502200|65180832|FG000|Overall Study|Death|0|||
23391715|NCT03502200|65180833|FG001|Overall Study|Death|2|||
23391716|NCT01767987|65180834|FG000|Overall Study|Physician Decision|4|||
23391717|NCT01767987|65180835|FG001|Overall Study|Physician Decision|1|||
23495970|NCT02598960|65558959|FG002|Treatment Period|participant withdrew consent|0|||
23495971|NCT02598960|65558960|FG003|Treatment Period|participant withdrew consent|0|||
23495972|NCT02598960|65558961|FG004|Treatment Period|participant withdrew consent|0|||
23495973|NCT02598960|65558962|FG005|Treatment Period|participant withdrew consent|0|||
23495974|NCT02598960|65558963|FG006|Treatment Period|participant withdrew consent|0|||
23495975|NCT02598960|65558964|FG007|Treatment Period|participant withdrew consent|0|||
23685409|NCT00348140|66225492|FG001|Overall Study|Participant at risk due to study drug|0|||
23685410|NCT00348140|66225493|FG002|Overall Study|Participant at risk due to study drug|0|||
23685411|NCT00348140|66225491|FG000|Overall Study|Conditional medication increased dose|1|||
23685412|NCT00348140|66225492|FG001|Overall Study|Conditional medication increased dose|0|||
23685413|NCT00348140|66225493|FG002|Overall Study|Conditional medication increased dose|0|||
23685414|NCT00348140|66225491|FG000|Overall Study|Caregiver related|4|||
23495976|NCT02598960|65558965|FG008|Treatment Period|participant withdrew consent|0|||
23495977|NCT02598960|65558966|FG009|Treatment Period|participant withdrew consent|0|||
23495978|NCT02598960|65558967|FG010|Treatment Period|participant withdrew consent|0|||
23495979|NCT02598960|65558968|FG011|Treatment Period|participant withdrew consent|3|||
23495980|NCT02598960|65558969|FG012|Treatment Period|participant withdrew consent|0|||
23495981|NCT02598960|65558957|FG000|Treatment Period|No longer meets study criteria|0|||
23495982|NCT02598960|65558958|FG001|Treatment Period|No longer meets study criteria|0|||
23495983|NCT02598960|65558959|FG002|Treatment Period|No longer meets study criteria|0|||
23495984|NCT02598960|65558960|FG003|Treatment Period|No longer meets study criteria|0|||
23495985|NCT02598960|65558961|FG004|Treatment Period|No longer meets study criteria|0|||
23495986|NCT02598960|65558962|FG005|Treatment Period|No longer meets study criteria|0|||
23495987|NCT02598960|65558963|FG006|Treatment Period|No longer meets study criteria|0|||
23685415|NCT00348140|66225492|FG001|Overall Study|Caregiver related|7|||
23685416|NCT00348140|66225493|FG002|Overall Study|Caregiver related|3|||
23685417|NCT00348140|66225491|FG000|Overall Study|Participant hospitalised|3|||
23685418|NCT00348140|66225492|FG001|Overall Study|Participant hospitalised|0|||
23391718|NCT01381679|65180836|FG000|Overall Study|Adverse Event|3|||
23391719|NCT01381679|65180836|FG000|Overall Study|Lost to Follow-up|885|||
23391720|NCT03559530|65180838|FG000|Overall Study|non-location of medical records|44|||
23391721|NCT03559530|65180839|FG001|Overall Study|non-location of medical records|0|||
23391722|NCT03559530|65180838|FG000|Overall Study|culture results not considered for treat|29|||
23391723|NCT03559530|65180839|FG001|Overall Study|culture results not considered for treat|0|||
23391724|NCT03559530|65180838|FG000|Overall Study|duplicate cases|8|||
23391725|NCT03559530|65180839|FG001|Overall Study|duplicate cases|0|||
23685419|NCT00348140|66225493|FG002|Overall Study|Participant hospitalised|0|||
23685420|NCT00348140|66225491|FG000|Overall Study|Efficacy related|1|||
23685421|NCT00348140|66225492|FG001|Overall Study|Efficacy related|1|||
23685422|NCT00348140|66225493|FG002|Overall Study|Efficacy related|0|||
23685423|NCT00348140|66225491|FG000|Overall Study|Administration related|3|||
23685424|NCT00348140|66225492|FG001|Overall Study|Administration related|1|||
23685425|NCT00348140|66225493|FG002|Overall Study|Administration related|1|||
23685426|NCT00348140|66225491|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
23685427|NCT00348140|66225492|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
23685428|NCT00348140|66225493|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
23685429|NCT00348140|66225491|FG000|Overall Study|Participant unwell|1|||
23685430|NCT00348140|66225492|FG001|Overall Study|Participant unwell|0|||
23685431|NCT00348140|66225493|FG002|Overall Study|Participant unwell|0|||
23685432|NCT00348140|66225491|FG000|Overall Study|Screen failure|1|||
23685433|NCT00348140|66225492|FG001|Overall Study|Screen failure|0|||
23685434|NCT00348140|66225493|FG002|Overall Study|Screen failure|0|||
23685435|NCT00348140|66225491|FG000|Overall Study|Investigator decided to discontinue|4|||
23685436|NCT00348140|66225492|FG001|Overall Study|Investigator decided to discontinue|1|||
23685437|NCT00348140|66225493|FG002|Overall Study|Investigator decided to discontinue|4|||
23685438|NCT00348140|66225491|FG000|Overall Study|Decided to discontinue on their own|1|||
23685439|NCT00348140|66225492|FG001|Overall Study|Decided to discontinue on their own|4|||
23685440|NCT00348140|66225493|FG002|Overall Study|Decided to discontinue on their own|1|||
23685441|NCT00348140|66225491|FG000|Overall Study|Use of prohibited drug|1|||
23685442|NCT00348140|66225492|FG001|Overall Study|Use of prohibited drug|0|||
23685443|NCT00348140|66225493|FG002|Overall Study|Use of prohibited drug|2|||
23685444|NCT00348140|66225491|FG000|Overall Study|Disease progression|1|||
23685445|NCT00348140|66225492|FG001|Overall Study|Disease progression|2|||
23685446|NCT00348140|66225493|FG002|Overall Study|Disease progression|5|||
23685447|NCT00348140|66225491|FG000|Overall Study|Increased risk of cardiac infarction|0|||
23685448|NCT00348140|66225492|FG001|Overall Study|Increased risk of cardiac infarction|1|||
23685449|NCT00348140|66225493|FG002|Overall Study|Increased risk of cardiac infarction|0|||
23685450|NCT00348140|66225491|FG000|Overall Study|Serious adverse event|0|||
23685451|NCT00348140|66225492|FG001|Overall Study|Serious adverse event|1|||
23685452|NCT00348140|66225493|FG002|Overall Study|Serious adverse event|0|||
23685453|NCT00348140|66225491|FG000|Overall Study|Abnormal ECG|0|||
23685454|NCT00348140|66225492|FG001|Overall Study|Abnormal ECG|1|||
23685455|NCT00348140|66225493|FG002|Overall Study|Abnormal ECG|3|||
23685456|NCT00348140|66225491|FG000|Overall Study|Participant died|0|||
23685457|NCT00348140|66225492|FG001|Overall Study|Participant died|1|||
23685458|NCT00348140|66225493|FG002|Overall Study|Participant died|0|||
23685459|NCT00348140|66225491|FG000|Overall Study|Exclusion criteria met|0|||
23685460|NCT00348140|66225492|FG001|Overall Study|Exclusion criteria met|0|||
23685461|NCT00348140|66225493|FG002|Overall Study|Exclusion criteria met|1|||
23685462|NCT00348140|66225491|FG000|Overall Study|Memory declined|0|||
23685463|NCT00348140|66225492|FG001|Overall Study|Memory declined|0|||
23685464|NCT00348140|66225493|FG002|Overall Study|Memory declined|1|||
23685465|NCT00793793|66225494|FG000|Overall Study|Adverse Event|0|||
23685466|NCT00793793|66225495|FG001|Overall Study|Adverse Event|0|||
23685467|NCT00793793|66225496|FG002|Overall Study|Adverse Event|1|||
23685468|NCT00793793|66225497|FG003|Overall Study|Adverse Event|1|||
23391726|NCT03559530|65180838|FG000|Overall Study|other species of Acinetobacte|7|||
23391727|NCT03559530|65180839|FG001|Overall Study|other species of Acinetobacte|0|||
23391728|NCT03559530|65180838|FG000|Overall Study|contamination / colonization|3|||
23391729|NCT03559530|65180839|FG001|Overall Study|contamination / colonization|0|||
23391730|NCT00539500|65180840|FG000|Overall Study|Disease Progression|1|||
23391731|NCT00539500|65180840|FG000|Overall Study|Lost to Follow-up|2|||
23391732|NCT01557569|65180845|FG000|Overall Study|Adverse Event|2|||
23391733|NCT01557569|65180846|FG001|Overall Study|Adverse Event|0|||
23391734|NCT01557569|65180845|FG000|Overall Study|high blood pressure|0|||
23391735|NCT01557569|65180846|FG001|Overall Study|high blood pressure|1|||
23391736|NCT01557569|65180845|FG000|Overall Study|Withdrawal by Subject|3|||
23391737|NCT01557569|65180846|FG001|Overall Study|Withdrawal by Subject|5|||
23391738|NCT01557569|65180845|FG000|Overall Study|noncompliance with rules of residential|0|||
23391739|NCT01557569|65180846|FG001|Overall Study|noncompliance with rules of residential|1|||
23391740|NCT03777020|65180847|FG000|Overall Study|Withdrawal by Subject|4|||
23391741|NCT03777020|65180848|FG001|Overall Study|Withdrawal by Subject|4|||
23391742|NCT03777020|65180847|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
23391743|NCT03777020|65180848|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
23391744|NCT03847519|65180849|FG000|Overall Study|Death|5|||
23391745|NCT03847519|65180850|FG001|Overall Study|Death|8|||
23391746|NCT03847519|65180851|FG002|Overall Study|Death|1|||
23391747|NCT03847519|65180849|FG000|Overall Study|Lost to Follow-up|1|||
23391748|NCT03847519|65180850|FG001|Overall Study|Lost to Follow-up|2|||
23391749|NCT03847519|65180851|FG002|Overall Study|Lost to Follow-up|0|||
23391750|NCT03847519|65180849|FG000|Overall Study|Study Terminated by Sponsor|0|||
23391751|NCT03847519|65180850|FG001|Overall Study|Study Terminated by Sponsor|3|||
23391752|NCT03847519|65180851|FG002|Overall Study|Study Terminated by Sponsor|2|||
23391753|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
23391754|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
23391755|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
23391756|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
23391757|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
23391758|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
23391759|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
23391760|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
23391761|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
23391762|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
23391763|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391764|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391765|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391766|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391767|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391768|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391769|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23685469|NCT00793793|66225498|FG004|Overall Study|Adverse Event|0|||
23685470|NCT00793793|66225499|FG005|Overall Study|Adverse Event|1|||
23685471|NCT00793793|66225500|FG006|Overall Study|Adverse Event|2|||
23685472|NCT00793793|66225501|FG007|Overall Study|Adverse Event|0|||
23685473|NCT00793793|66225502|FG008|Overall Study|Adverse Event|0|||
23685474|NCT00793793|66225503|FG009|Overall Study|Adverse Event|0|||
23685475|NCT00793793|66225504|FG010|Overall Study|Adverse Event|0|||
23685476|NCT00793793|66225505|FG011|Overall Study|Adverse Event|2|||
23685477|NCT00793793|66225494|FG000|Overall Study|Protocol Violation|0|||
23685478|NCT00793793|66225495|FG001|Overall Study|Protocol Violation|0|||
23685479|NCT00793793|66225496|FG002|Overall Study|Protocol Violation|0|||
23685480|NCT00793793|66225497|FG003|Overall Study|Protocol Violation|1|||
23685481|NCT00793793|66225498|FG004|Overall Study|Protocol Violation|0|||
23685482|NCT00793793|66225499|FG005|Overall Study|Protocol Violation|0|||
23685483|NCT00793793|66225500|FG006|Overall Study|Protocol Violation|0|||
23685484|NCT00793793|66225501|FG007|Overall Study|Protocol Violation|0|||
23685485|NCT00793793|66225502|FG008|Overall Study|Protocol Violation|0|||
23685486|NCT00793793|66225503|FG009|Overall Study|Protocol Violation|0|||
23685487|NCT00793793|66225504|FG010|Overall Study|Protocol Violation|0|||
23685488|NCT00793793|66225505|FG011|Overall Study|Protocol Violation|0|||
23685489|NCT00793793|66225494|FG000|Overall Study|Lost to Follow-up|0|||
23685490|NCT00793793|66225495|FG001|Overall Study|Lost to Follow-up|0|||
23685491|NCT00793793|66225496|FG002|Overall Study|Lost to Follow-up|1|||
23685492|NCT00793793|66225497|FG003|Overall Study|Lost to Follow-up|0|||
23685493|NCT00793793|66225498|FG004|Overall Study|Lost to Follow-up|0|||
23685494|NCT00793793|66225499|FG005|Overall Study|Lost to Follow-up|0|||
23391770|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
23685495|NCT00793793|66225500|FG006|Overall Study|Lost to Follow-up|0|||
23685496|NCT00793793|66225501|FG007|Overall Study|Lost to Follow-up|0|||
23391771|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391772|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23606196|NCT01009645|65947167|FG001|Overall Study|Lost to Follow-up|8|||
23685497|NCT00793793|66225502|FG008|Overall Study|Lost to Follow-up|1|||
23685498|NCT00793793|66225503|FG009|Overall Study|Lost to Follow-up|3|||
23391773|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391774|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391775|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391776|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391777|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391778|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
23391779|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391780|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391781|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391782|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391783|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391784|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391785|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391786|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391787|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391788|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391789|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
23391790|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391791|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
23391792|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391793|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391794|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391795|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391796|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391797|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391798|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391799|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391800|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
23391801|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391802|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391803|NCT01946880|65180862|FG000|Overall Study|Lost to Follow-up|1|||
23391804|NCT01946880|65180863|FG001|Overall Study|Lost to Follow-up|0|||
23391805|NCT01946880|65180862|FG000|Overall Study|Physician Decision|1|||
23391806|NCT01946880|65180863|FG001|Overall Study|Physician Decision|1|||
23685499|NCT00793793|66225504|FG010|Overall Study|Lost to Follow-up|1|||
23685500|NCT00793793|66225505|FG011|Overall Study|Lost to Follow-up|0|||
23685501|NCT00793793|66225494|FG000|Overall Study|Withdrawal by Subject|0|||
23685502|NCT00793793|66225495|FG001|Overall Study|Withdrawal by Subject|0|||
23685503|NCT00793793|66225496|FG002|Overall Study|Withdrawal by Subject|0|||
23685504|NCT00793793|66225497|FG003|Overall Study|Withdrawal by Subject|0|||
23685505|NCT00793793|66225498|FG004|Overall Study|Withdrawal by Subject|1|||
23685506|NCT00793793|66225499|FG005|Overall Study|Withdrawal by Subject|0|||
23685507|NCT00793793|66225500|FG006|Overall Study|Withdrawal by Subject|0|||
23685508|NCT00793793|66225501|FG007|Overall Study|Withdrawal by Subject|0|||
23685509|NCT00793793|66225502|FG008|Overall Study|Withdrawal by Subject|1|||
23685510|NCT00793793|66225503|FG009|Overall Study|Withdrawal by Subject|0|||
23685511|NCT00793793|66225504|FG010|Overall Study|Withdrawal by Subject|0|||
23685512|NCT00793793|66225505|FG011|Overall Study|Withdrawal by Subject|0|||
23685513|NCT00793793|66225494|FG000|Overall Study|reason not specified|0|||
23685514|NCT00793793|66225495|FG001|Overall Study|reason not specified|1|||
23685515|NCT00793793|66225496|FG002|Overall Study|reason not specified|0|||
23685516|NCT00793793|66225497|FG003|Overall Study|reason not specified|1|||
23685517|NCT00793793|66225498|FG004|Overall Study|reason not specified|1|||
23685518|NCT00793793|66225499|FG005|Overall Study|reason not specified|1|||
23685519|NCT00793793|66225500|FG006|Overall Study|reason not specified|2|||
23685520|NCT00793793|66225501|FG007|Overall Study|reason not specified|0|||
23685521|NCT00793793|66225502|FG008|Overall Study|reason not specified|7|||
23685522|NCT00793793|66225503|FG009|Overall Study|reason not specified|6|||
23685523|NCT00793793|66225504|FG010|Overall Study|reason not specified|2|||
23685524|NCT00793793|66225505|FG011|Overall Study|reason not specified|4|||
23685525|NCT00618748|66225506|FG000|Overall Study|Adverse Event|4|||
23685526|NCT00618748|66225507|FG001|Overall Study|Adverse Event|3|||
23685527|NCT00618748|66225508|FG002|Overall Study|Adverse Event|8|||
23685528|NCT00618748|66225506|FG000|Overall Study|Physician Decision|3|||
23685529|NCT00618748|66225507|FG001|Overall Study|Physician Decision|1|||
23685530|NCT00618748|66225508|FG002|Overall Study|Physician Decision|1|||
23685531|NCT00618748|66225506|FG000|Overall Study|Withdrawal by Subject|4|||
23685532|NCT00618748|66225507|FG001|Overall Study|Withdrawal by Subject|1|||
23685533|NCT00618748|66225508|FG002|Overall Study|Withdrawal by Subject|5|||
23685534|NCT03502330|66225509|FG000|Overall Study|Adverse Event|2|||
23391807|NCT01946880|65180862|FG000|Overall Study|Withdrawal by Subject|3|||
23391808|NCT01946880|65180863|FG001|Overall Study|Withdrawal by Subject|2|||
23391809|NCT01946880|65180862|FG000|Overall Study|Met Primary Endpoint|1|||
23391810|NCT01946880|65180863|FG001|Overall Study|Met Primary Endpoint|0|||
23685535|NCT03502330|66225510|FG001|Overall Study|Adverse Event|1|||
23685536|NCT03502330|66225511|FG002|Overall Study|Adverse Event|0|||
23685537|NCT03502330|66225512|FG003|Overall Study|Adverse Event|0|||
23391811|NCT01946880|65180862|FG000|Overall Study|Personal and Family Issues|1|||
23391812|NCT01946880|65180863|FG001|Overall Study|Personal and Family Issues|0|||
23391813|NCT05752487|65180864|FG000|Overall Study|Randomized, not treated|9|||
23391814|NCT05752487|65180864|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
23495988|NCT02598960|65558964|FG007|Treatment Period|No longer meets study criteria|0|||
23495989|NCT02598960|65558965|FG008|Treatment Period|No longer meets study criteria|0|||
23495990|NCT02598960|65558966|FG009|Treatment Period|No longer meets study criteria|0|||
23685538|NCT03502330|66225513|FG004|Overall Study|Adverse Event|1|||
23685539|NCT03502330|66225514|FG005|Overall Study|Adverse Event|0|||
23685540|NCT03502330|66225515|FG006|Overall Study|Adverse Event|1|||
23685541|NCT03502330|66225516|FG007|Overall Study|Adverse Event|1|||
23685542|NCT03502330|66225517|FG008|Overall Study|Adverse Event|0|||
23685543|NCT03502330|66225509|FG000|Overall Study|Lack of Efficacy|1|||
23685544|NCT03502330|66225510|FG001|Overall Study|Lack of Efficacy|5|||
23685545|NCT03502330|66225511|FG002|Overall Study|Lack of Efficacy|3|||
23685546|NCT03502330|66225512|FG003|Overall Study|Lack of Efficacy|5|||
23685547|NCT03502330|66225513|FG004|Overall Study|Lack of Efficacy|1|||
23685548|NCT03502330|66225514|FG005|Overall Study|Lack of Efficacy|5|||
23685549|NCT03502330|66225515|FG006|Overall Study|Lack of Efficacy|5|||
23685550|NCT03502330|66225516|FG007|Overall Study|Lack of Efficacy|6|||
23685551|NCT03502330|66225517|FG008|Overall Study|Lack of Efficacy|0|||
23685552|NCT03502330|66225509|FG000|Overall Study|Physician Decision|0|||
23685553|NCT03502330|66225510|FG001|Overall Study|Physician Decision|0|||
23685554|NCT03502330|66225511|FG002|Overall Study|Physician Decision|0|||
23685555|NCT03502330|66225512|FG003|Overall Study|Physician Decision|0|||
23685556|NCT03502330|66225513|FG004|Overall Study|Physician Decision|1|||
23685557|NCT03502330|66225514|FG005|Overall Study|Physician Decision|0|||
23685558|NCT03502330|66225515|FG006|Overall Study|Physician Decision|0|||
23685559|NCT03502330|66225516|FG007|Overall Study|Physician Decision|0|||
23685560|NCT03502330|66225517|FG008|Overall Study|Physician Decision|0|||
23685561|NCT03502330|66225509|FG000|Overall Study|Withdrawal by Subject|0|||
23685562|NCT03502330|66225510|FG001|Overall Study|Withdrawal by Subject|0|||
23685563|NCT03502330|66225511|FG002|Overall Study|Withdrawal by Subject|0|||
23685564|NCT03502330|66225512|FG003|Overall Study|Withdrawal by Subject|0|||
23685565|NCT03502330|66225513|FG004|Overall Study|Withdrawal by Subject|0|||
23685566|NCT03502330|66225514|FG005|Overall Study|Withdrawal by Subject|1|||
23685567|NCT03502330|66225515|FG006|Overall Study|Withdrawal by Subject|0|||
23685568|NCT03502330|66225516|FG007|Overall Study|Withdrawal by Subject|1|||
23685569|NCT03502330|66225517|FG008|Overall Study|Withdrawal by Subject|0|||
23685570|NCT03502330|66225509|FG000|Overall Study|Death|0|||
23685571|NCT03502330|66225510|FG001|Overall Study|Death|0|||
23685572|NCT03502330|66225511|FG002|Overall Study|Death|0|||
23685573|NCT03502330|66225512|FG003|Overall Study|Death|0|||
23685574|NCT03502330|66225513|FG004|Overall Study|Death|0|||
23685575|NCT03502330|66225514|FG005|Overall Study|Death|0|||
23685576|NCT03502330|66225515|FG006|Overall Study|Death|2|||
23495991|NCT02598960|65558967|FG010|Treatment Period|No longer meets study criteria|0|||
23495992|NCT02598960|65558968|FG011|Treatment Period|No longer meets study criteria|1|||
23495993|NCT02598960|65558969|FG012|Treatment Period|No longer meets study criteria|0|||
23495994|NCT02598960|65558957|FG000|Treatment Period|Other Reasons|0|||
23495995|NCT02598960|65558958|FG001|Treatment Period|Other Reasons|0|||
23495996|NCT02598960|65558959|FG002|Treatment Period|Other Reasons|0|||
23495997|NCT02598960|65558960|FG003|Treatment Period|Other Reasons|0|||
23495998|NCT02598960|65558961|FG004|Treatment Period|Other Reasons|0|||
23495999|NCT02598960|65558962|FG005|Treatment Period|Other Reasons|0|||
23496000|NCT02598960|65558963|FG006|Treatment Period|Other Reasons|0|||
23496001|NCT02598960|65558964|FG007|Treatment Period|Other Reasons|0|||
23496002|NCT02598960|65558965|FG008|Treatment Period|Other Reasons|0|||
23496003|NCT02598960|65558966|FG009|Treatment Period|Other Reasons|0|||
23685577|NCT03502330|66225516|FG007|Overall Study|Death|0|||
23685578|NCT03502330|66225517|FG008|Overall Study|Death|0|||
23685579|NCT00441792|66225518|FG000|Overall Study|Lost to Follow-up|0|||
23685580|NCT00441792|66225519|FG001|Overall Study|Lost to Follow-up|2|||
23685581|NCT01672957|66225521|FG000|Overall Study|Protocol Violation|48|||
23496004|NCT02598960|65558967|FG010|Treatment Period|Other Reasons|0|||
23685582|NCT01672957|66225521|FG000|Overall Study|Death|2|||
23496005|NCT02598960|65558968|FG011|Treatment Period|Other Reasons|0|||
23685583|NCT01672957|66225521|FG000|Overall Study|ICF Signed After Transplantation|5|||
23685584|NCT03093402|66225522|FG000|Overall Study|Lost to Follow-up|1|||
23685585|NCT03093402|66225523|FG001|Overall Study|Lost to Follow-up|0|||
23685586|NCT03093402|66225524|FG002|Overall Study|Lost to Follow-up|0|||
23685587|NCT03093402|66225525|FG003|Overall Study|Lost to Follow-up|0|||
23496006|NCT02598960|65558969|FG012|Treatment Period|Other Reasons|1|||
23496007|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|Death|1|||
23496008|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|Death|0|||
23685588|NCT03093402|66225522|FG000|Overall Study|Withdrawal by Subject|3|||
23391815|NCT05752487|65180864|FG000|Overall Study|Withdrawal by Subject|2|||
23391816|NCT05752487|65180864|FG000|Overall Study|Ongoing|137|||
23391817|NCT00833703|65180865|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
23391818|NCT00833703|65180866|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
23391819|NCT05543174|65180867|FG000|Overall Study|Ongoing|7|||
23391820|NCT02967692|65180868|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
23496009|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|Death|0|||
23685589|NCT03093402|66225523|FG001|Overall Study|Withdrawal by Subject|3|||
23685590|NCT03093402|66225524|FG002|Overall Study|Withdrawal by Subject|0|||
23685591|NCT03093402|66225525|FG003|Overall Study|Withdrawal by Subject|1|||
23685592|NCT03093402|66225522|FG000|Overall Study|Withdrew prior to dosing|2|||
23685593|NCT03093402|66225523|FG001|Overall Study|Withdrew prior to dosing|1|||
23685594|NCT03093402|66225524|FG002|Overall Study|Withdrew prior to dosing|2|||
23685595|NCT03093402|66225525|FG003|Overall Study|Withdrew prior to dosing|3|||
23685596|NCT03093402|66225522|FG000|Overall Study|Ineligible for study|1|||
23685597|NCT03093402|66225523|FG001|Overall Study|Ineligible for study|0|||
23685598|NCT03093402|66225524|FG002|Overall Study|Ineligible for study|0|||
23685599|NCT03093402|66225525|FG003|Overall Study|Ineligible for study|0|||
23685600|NCT03093402|66225522|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
23685601|NCT03093402|66225523|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
23685602|NCT03093402|66225524|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
23685603|NCT03093402|66225525|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
23685604|NCT00054132|66225526|FG000|Overall Study|Not Treated|1|||
23685605|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685606|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23685607|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685608|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685609|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685610|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
23685611|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23685612|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23685613|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23685614|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
23685615|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23685616|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23685617|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685618|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23685619|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23685620|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23685621|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23685622|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23685623|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23685624|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
23685625|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685626|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685627|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685628|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23685629|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685630|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23685631|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
23685632|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23685633|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23685634|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23685635|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
23685636|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
23685637|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
23685638|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
23685639|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
23685640|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23685641|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
23685642|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
23685643|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
23685644|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23391821|NCT02967692|65180869|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
23496010|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|Death|0|||
23685645|NCT00289913|66225528|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
23685646|NCT00289913|66225529|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685647|NCT00289913|66225530|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
23685648|NCT00289913|66225531|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685649|NCT00289913|66225532|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685650|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685651|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685652|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23685653|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685654|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685655|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
23685656|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
23685657|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
23685658|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
23685659|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
23685660|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23685661|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
23685662|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23685663|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23685664|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23685665|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
23685666|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23685667|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
23685668|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685669|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685670|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23685671|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685672|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23685673|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685674|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685675|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23685676|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23685677|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
23685678|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23685679|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23685680|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
23685681|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
23685682|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
23685683|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
23685684|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
23685685|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23685686|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
23685687|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
23685688|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23685689|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23685690|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
23685691|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23685692|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23685693|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23685694|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23685695|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23685696|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23685697|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23685698|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23685699|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
23685700|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23685701|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23685702|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23685703|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23685704|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
23685705|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23685706|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23685707|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23685708|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23685709|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
23685710|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23685711|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23685712|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23685713|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23685714|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
23685715|NCT00289913|66225528|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23685716|NCT00289913|66225529|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23685717|NCT00289913|66225530|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23685718|NCT00289913|66225531|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23685719|NCT00289913|66225532|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
23685720|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685721|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23685722|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685723|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685724|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23685725|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
23685726|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
23685727|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
23685728|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
23685729|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
23685730|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685731|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685732|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685733|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
23685734|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23685735|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685736|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685737|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685738|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23685739|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23685740|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
23685741|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
23685742|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
23685743|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
23685744|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
23685745|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23685746|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
23685747|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
23685748|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23685749|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23685750|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23685751|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23606197|NCT01009645|65947168|FG002|Overall Study|Lost to Follow-up|4|||
23606198|NCT01009645|65947169|FG003|Overall Study|Lost to Follow-up|5|||
23606199|NCT01867307|65947170|FG000|Overall Study|Protocol Violation|2|||
23606200|NCT01867307|65947171|FG001|Overall Study|Protocol Violation|0|||
23606201|NCT01867307|65947170|FG000|Overall Study|Other Adverse Event|1|||
23606202|NCT01867307|65947171|FG001|Overall Study|Other Adverse Event|3|||
23606203|NCT01536093|65947172|FG000|Overall Study|Death|1|||
23606204|NCT01536093|65947173|FG001|Overall Study|Death|2|||
23606205|NCT01536093|65947172|FG000|Overall Study|absence of maternal colostrum|2|||
23606206|NCT01536093|65947173|FG001|Overall Study|absence of maternal colostrum|0|||
23606207|NCT01536093|65947172|FG000|Overall Study|Withdrawal by Subject|0|||
23606208|NCT01536093|65947173|FG001|Overall Study|Withdrawal by Subject|1|||
23606209|NCT00985088|65947178|FG000|Overall Study|Serious Adverse Event|1|||
23606210|NCT00985088|65947179|FG001|Overall Study|Serious Adverse Event|1|||
23606211|NCT00985088|65947180|FG002|Overall Study|Serious Adverse Event|0|||
23685752|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23685753|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23685754|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
23685755|NCT00289913|66225528|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685756|NCT00289913|66225529|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
23685757|NCT00289913|66225530|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685758|NCT00289913|66225531|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685759|NCT00289913|66225532|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23685760|NCT00331006|66225533|FG000|Screening Phase|Withdrawal by Subject|1|||
23685761|NCT00331006|66225533|FG000|Screening Phase|enrollment halted|1|||
23685762|NCT00331006|66225533|FG000|Screening Phase|Lost to Follow-up|1|||
23685763|NCT00331006|66225533|FG000|Screening Phase|Ineligible for treatment phase|4|||
23685764|NCT00331006|66225533|FG000|Treatment Phase|Withdrawal by Subject|1|||
23685765|NCT00331006|66225533|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
23685766|NCT00331006|66225533|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
23685767|NCT01661790|66225534|FG000|Overall Study|Lost to Follow-up|0|||
23685768|NCT01661790|66225535|FG001|Overall Study|Lost to Follow-up|2|||
23685769|NCT01324830|66225540|FG000|Overall Study|Progressive Disease|3|||
23685770|NCT01324830|66225541|FG001|Overall Study|Progressive Disease|2|||
23685771|NCT01324830|66225542|FG002|Overall Study|Progressive Disease|3|||
23685772|NCT01324830|66225543|FG003|Overall Study|Progressive Disease|3|||
23685773|NCT01324830|66225544|FG004|Overall Study|Progressive Disease|6|||
23685774|NCT01324830|66225545|FG005|Overall Study|Progressive Disease|6|||
23685775|NCT01324830|66225546|FG006|Overall Study|Progressive Disease|3|||
23685776|NCT01324830|66225547|FG007|Overall Study|Progressive Disease|3|||
23391822|NCT02967692|65180870|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
23391823|NCT02967692|65180871|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
23391824|NCT02967692|65180868|FG000|Overall Study|Progressive disease|3|||
23391825|NCT02967692|65180869|FG001|Overall Study|Progressive disease|15|||
23391826|NCT02967692|65180870|FG002|Overall Study|Progressive disease|99|||
23391827|NCT02967692|65180871|FG003|Overall Study|Progressive disease|128|||
23391828|NCT02967692|65180868|FG000|Overall Study|Subject/guardian decision|1|||
23391829|NCT02967692|65180869|FG001|Overall Study|Subject/guardian decision|1|||
23391830|NCT02967692|65180870|FG002|Overall Study|Subject/guardian decision|6|||
23391831|NCT02967692|65180871|FG003|Overall Study|Subject/guardian decision|13|||
23391832|NCT02967692|65180868|FG000|Overall Study|Death|0|||
23391833|NCT02967692|65180869|FG001|Overall Study|Death|1|||
23391834|NCT02967692|65180870|FG002|Overall Study|Death|10|||
23391835|NCT02967692|65180871|FG003|Overall Study|Death|9|||
23391836|NCT02967692|65180868|FG000|Overall Study|Protocol deviation|1|||
23391837|NCT02967692|65180869|FG001|Overall Study|Protocol deviation|0|||
23391838|NCT02967692|65180870|FG002|Overall Study|Protocol deviation|1|||
23606212|NCT00985088|65947181|FG003|Overall Study|Serious Adverse Event|0|||
23606213|NCT00985088|65947182|FG004|Overall Study|Serious Adverse Event|0|||
23606214|NCT00985088|65947183|FG005|Overall Study|Serious Adverse Event|0|||
23606215|NCT00985088|65947184|FG006|Overall Study|Serious Adverse Event|0|||
23606216|NCT00985088|65947185|FG007|Overall Study|Serious Adverse Event|1|||
23606217|NCT00985088|65947178|FG000|Overall Study|Adverse Event|0|||
23606218|NCT00985088|65947179|FG001|Overall Study|Adverse Event|0|||
23606219|NCT00985088|65947180|FG002|Overall Study|Adverse Event|1|||
23606220|NCT00985088|65947181|FG003|Overall Study|Adverse Event|0|||
23606221|NCT00985088|65947182|FG004|Overall Study|Adverse Event|0|||
23606222|NCT00985088|65947183|FG005|Overall Study|Adverse Event|0|||
23606223|NCT00985088|65947184|FG006|Overall Study|Adverse Event|0|||
23606224|NCT00985088|65947185|FG007|Overall Study|Adverse Event|0|||
23606225|NCT00985088|65947178|FG000|Overall Study|Withdrawal by Subject|4|||
23606226|NCT00985088|65947179|FG001|Overall Study|Withdrawal by Subject|0|||
23606227|NCT00985088|65947180|FG002|Overall Study|Withdrawal by Subject|0|||
23606228|NCT00985088|65947181|FG003|Overall Study|Withdrawal by Subject|1|||
23606229|NCT00985088|65947182|FG004|Overall Study|Withdrawal by Subject|3|||
23606230|NCT00985088|65947183|FG005|Overall Study|Withdrawal by Subject|2|||
23606231|NCT00985088|65947184|FG006|Overall Study|Withdrawal by Subject|1|||
23606232|NCT00985088|65947185|FG007|Overall Study|Withdrawal by Subject|2|||
23606233|NCT00985088|65947178|FG000|Overall Study|Migrated/moved from study area|0|||
23606234|NCT00985088|65947179|FG001|Overall Study|Migrated/moved from study area|0|||
23606235|NCT00985088|65947180|FG002|Overall Study|Migrated/moved from study area|1|||
23606236|NCT00985088|65947181|FG003|Overall Study|Migrated/moved from study area|0|||
23606237|NCT00985088|65947182|FG004|Overall Study|Migrated/moved from study area|0|||
23606238|NCT00985088|65947183|FG005|Overall Study|Migrated/moved from study area|0|||
23606239|NCT00985088|65947184|FG006|Overall Study|Migrated/moved from study area|0|||
23606240|NCT00985088|65947185|FG007|Overall Study|Migrated/moved from study area|1|||
23606241|NCT00985088|65947178|FG000|Overall Study|Lost to Follow-up|6|||
23606242|NCT00985088|65947179|FG001|Overall Study|Lost to Follow-up|1|||
23606243|NCT00985088|65947180|FG002|Overall Study|Lost to Follow-up|2|||
23606244|NCT00985088|65947181|FG003|Overall Study|Lost to Follow-up|6|||
23606245|NCT00985088|65947182|FG004|Overall Study|Lost to Follow-up|6|||
23606246|NCT00985088|65947183|FG005|Overall Study|Lost to Follow-up|5|||
23606247|NCT00985088|65947184|FG006|Overall Study|Lost to Follow-up|3|||
23606248|NCT00985088|65947185|FG007|Overall Study|Lost to Follow-up|2|||
23606249|NCT03692871|65947186|FG000|Overall Study|Death|1|||
23606250|NCT03692871|65947187|FG001|Overall Study|Death|1|||
23685777|NCT01324830|66225548|FG008|Overall Study|Progressive Disease|3|||
23685778|NCT01324830|66225549|FG009|Overall Study|Progressive Disease|6|||
23685779|NCT01324830|66225550|FG010|Overall Study|Progressive Disease|2|||
23685780|NCT01324830|66225551|FG011|Overall Study|Progressive Disease|1|||
23685781|NCT01324830|66225552|FG012|Overall Study|Progressive Disease|1|||
23685782|NCT01324830|66225553|FG013|Overall Study|Progressive Disease|1|||
23685783|NCT01324830|66225554|FG014|Overall Study|Progressive Disease|1|||
23685784|NCT01324830|66225555|FG015|Overall Study|Progressive Disease|3|||
23685785|NCT01324830|66225556|FG016|Overall Study|Progressive Disease|2|||
23685786|NCT01324830|66225557|FG017|Overall Study|Progressive Disease|3|||
23685787|NCT01324830|66225558|FG018|Overall Study|Progressive Disease|4|||
23685788|NCT01324830|66225540|FG000|Overall Study|Dose limiting toxicity|0|||
23685789|NCT01324830|66225541|FG001|Overall Study|Dose limiting toxicity|0|||
23685790|NCT01324830|66225542|FG002|Overall Study|Dose limiting toxicity|0|||
23685791|NCT01324830|66225543|FG003|Overall Study|Dose limiting toxicity|0|||
23685792|NCT01324830|66225544|FG004|Overall Study|Dose limiting toxicity|1|||
23685793|NCT01324830|66225545|FG005|Overall Study|Dose limiting toxicity|0|||
23685794|NCT01324830|66225546|FG006|Overall Study|Dose limiting toxicity|0|||
23685795|NCT01324830|66225547|FG007|Overall Study|Dose limiting toxicity|0|||
23685796|NCT01324830|66225548|FG008|Overall Study|Dose limiting toxicity|0|||
23685797|NCT01324830|66225549|FG009|Overall Study|Dose limiting toxicity|0|||
23685798|NCT01324830|66225550|FG010|Overall Study|Dose limiting toxicity|0|||
23685799|NCT01324830|66225551|FG011|Overall Study|Dose limiting toxicity|0|||
23685800|NCT01324830|66225552|FG012|Overall Study|Dose limiting toxicity|0|||
23685801|NCT01324830|66225553|FG013|Overall Study|Dose limiting toxicity|0|||
23685802|NCT01324830|66225554|FG014|Overall Study|Dose limiting toxicity|0|||
23685803|NCT01324830|66225555|FG015|Overall Study|Dose limiting toxicity|0|||
23685804|NCT01324830|66225556|FG016|Overall Study|Dose limiting toxicity|1|||
23685805|NCT01324830|66225557|FG017|Overall Study|Dose limiting toxicity|1|||
23685806|NCT01324830|66225558|FG018|Overall Study|Dose limiting toxicity|1|||
23685807|NCT01324830|66225540|FG000|Overall Study|Reason not mentioned above|0|||
23685808|NCT01324830|66225541|FG001|Overall Study|Reason not mentioned above|0|||
23685809|NCT01324830|66225542|FG002|Overall Study|Reason not mentioned above|0|||
23685810|NCT01324830|66225543|FG003|Overall Study|Reason not mentioned above|0|||
23685811|NCT01324830|66225544|FG004|Overall Study|Reason not mentioned above|0|||
23685812|NCT01324830|66225545|FG005|Overall Study|Reason not mentioned above|0|||
23685813|NCT01324830|66225546|FG006|Overall Study|Reason not mentioned above|0|||
23685814|NCT01324830|66225547|FG007|Overall Study|Reason not mentioned above|0|||
23685815|NCT01324830|66225548|FG008|Overall Study|Reason not mentioned above|0|||
23685816|NCT01324830|66225549|FG009|Overall Study|Reason not mentioned above|0|||
23685817|NCT01324830|66225550|FG010|Overall Study|Reason not mentioned above|0|||
23685818|NCT01324830|66225551|FG011|Overall Study|Reason not mentioned above|0|||
23685819|NCT01324830|66225552|FG012|Overall Study|Reason not mentioned above|0|||
23685820|NCT01324830|66225553|FG013|Overall Study|Reason not mentioned above|0|||
23685821|NCT01324830|66225554|FG014|Overall Study|Reason not mentioned above|0|||
23685822|NCT01324830|66225555|FG015|Overall Study|Reason not mentioned above|0|||
23685823|NCT01324830|66225556|FG016|Overall Study|Reason not mentioned above|0|||
23685824|NCT01324830|66225557|FG017|Overall Study|Reason not mentioned above|1|||
23685825|NCT01324830|66225558|FG018|Overall Study|Reason not mentioned above|0|||
23685826|NCT01324830|66225540|FG000|Overall Study|Adverse Event, serious fatal|0|||
23685827|NCT01324830|66225541|FG001|Overall Study|Adverse Event, serious fatal|1|||
23685828|NCT01324830|66225542|FG002|Overall Study|Adverse Event, serious fatal|0|||
23685829|NCT01324830|66225543|FG003|Overall Study|Adverse Event, serious fatal|0|||
23685830|NCT01324830|66225544|FG004|Overall Study|Adverse Event, serious fatal|0|||
23685831|NCT01324830|66225545|FG005|Overall Study|Adverse Event, serious fatal|0|||
23685832|NCT01324830|66225546|FG006|Overall Study|Adverse Event, serious fatal|0|||
23685833|NCT01324830|66225547|FG007|Overall Study|Adverse Event, serious fatal|0|||
23685834|NCT01324830|66225548|FG008|Overall Study|Adverse Event, serious fatal|0|||
23685835|NCT01324830|66225549|FG009|Overall Study|Adverse Event, serious fatal|0|||
23685836|NCT01324830|66225550|FG010|Overall Study|Adverse Event, serious fatal|0|||
23685837|NCT01324830|66225551|FG011|Overall Study|Adverse Event, serious fatal|0|||
23391839|NCT02967692|65180871|FG003|Overall Study|Protocol deviation|1|||
23391840|NCT02967692|65180868|FG000|Overall Study|Lost to Follow-up|0|||
23391841|NCT02967692|65180869|FG001|Overall Study|Lost to Follow-up|0|||
23391842|NCT02967692|65180870|FG002|Overall Study|Lost to Follow-up|1|||
23391843|NCT02967692|65180871|FG003|Overall Study|Lost to Follow-up|0|||
23496011|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|Death|0|||
23685838|NCT01324830|66225552|FG012|Overall Study|Adverse Event, serious fatal|0|||
23685839|NCT01324830|66225553|FG013|Overall Study|Adverse Event, serious fatal|0|||
23685840|NCT01324830|66225554|FG014|Overall Study|Adverse Event, serious fatal|0|||
23685841|NCT01324830|66225555|FG015|Overall Study|Adverse Event, serious fatal|0|||
23685842|NCT01324830|66225556|FG016|Overall Study|Adverse Event, serious fatal|0|||
23685843|NCT01324830|66225557|FG017|Overall Study|Adverse Event, serious fatal|0|||
23685844|NCT01324830|66225558|FG018|Overall Study|Adverse Event, serious fatal|0|||
23391844|NCT02967692|65180868|FG000|Overall Study|Physician Decision|0|||
23391845|NCT02967692|65180869|FG001|Overall Study|Physician Decision|0|||
23391846|NCT02967692|65180870|FG002|Overall Study|Physician Decision|13|||
23391847|NCT02967692|65180871|FG003|Overall Study|Physician Decision|9|||
23391848|NCT02967692|65180868|FG000|Overall Study|Adverse Event|1|||
23391849|NCT02967692|65180869|FG001|Overall Study|Adverse Event|9|||
23391850|NCT02967692|65180870|FG002|Overall Study|Adverse Event|51|||
23391851|NCT02967692|65180871|FG003|Overall Study|Adverse Event|23|||
23685845|NCT01324830|66225540|FG000|Overall Study|Adverse Event, non-fatal|0|||
23685846|NCT01324830|66225541|FG001|Overall Study|Adverse Event, non-fatal|0|||
23685847|NCT01324830|66225542|FG002|Overall Study|Adverse Event, non-fatal|0|||
23685848|NCT01324830|66225543|FG003|Overall Study|Adverse Event, non-fatal|0|||
23685849|NCT01324830|66225544|FG004|Overall Study|Adverse Event, non-fatal|0|||
23685850|NCT01324830|66225545|FG005|Overall Study|Adverse Event, non-fatal|0|||
23685851|NCT01324830|66225546|FG006|Overall Study|Adverse Event, non-fatal|0|||
23685852|NCT01324830|66225547|FG007|Overall Study|Adverse Event, non-fatal|0|||
23685853|NCT01324830|66225548|FG008|Overall Study|Adverse Event, non-fatal|2|||
23391852|NCT02758626|65180872|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
23391853|NCT02758626|65180873|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
23391854|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
23391855|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
23391856|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
23391857|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
23391858|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
23391859|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
23391860|NCT03443401|65180874|FG000|Overall Study|Lost to Follow-up|13|||
23391861|NCT03443401|65180874|FG000|Overall Study|Influential outlier|1|||
23391862|NCT02457793|65180884|FG000|Overall Study|Reason not specified|0|||
23391863|NCT02457793|65180885|FG001|Overall Study|Reason not specified|0|||
23391864|NCT02457793|65180886|FG002|Overall Study|Reason not specified|0|||
23391865|NCT02457793|65180887|FG003|Overall Study|Reason not specified|1|||
23391866|NCT02457793|65180888|FG004|Overall Study|Reason not specified|1|||
23391867|NCT02457793|65180889|FG005|Overall Study|Reason not specified|1|||
23391868|NCT02457793|65180884|FG000|Overall Study|Withdrawal by Subject|0|||
23391869|NCT02457793|65180885|FG001|Overall Study|Withdrawal by Subject|4|||
23391870|NCT02457793|65180886|FG002|Overall Study|Withdrawal by Subject|2|||
23391871|NCT02457793|65180887|FG003|Overall Study|Withdrawal by Subject|2|||
23391872|NCT02457793|65180888|FG004|Overall Study|Withdrawal by Subject|2|||
23391873|NCT02457793|65180889|FG005|Overall Study|Withdrawal by Subject|2|||
23391874|NCT02457793|65180884|FG000|Overall Study|Adverse Event|0|||
23391875|NCT02457793|65180885|FG001|Overall Study|Adverse Event|0|||
23391876|NCT02457793|65180886|FG002|Overall Study|Adverse Event|0|||
23391877|NCT02457793|65180887|FG003|Overall Study|Adverse Event|1|||
23391878|NCT02457793|65180888|FG004|Overall Study|Adverse Event|0|||
23391879|NCT02457793|65180889|FG005|Overall Study|Adverse Event|0|||
23391880|NCT02457793|65180884|FG000|Overall Study|Physician Decision|1|||
23391881|NCT02457793|65180885|FG001|Overall Study|Physician Decision|0|||
23391882|NCT02457793|65180886|FG002|Overall Study|Physician Decision|1|||
23391883|NCT02457793|65180887|FG003|Overall Study|Physician Decision|1|||
23391884|NCT02457793|65180888|FG004|Overall Study|Physician Decision|1|||
23391885|NCT02457793|65180889|FG005|Overall Study|Physician Decision|3|||
23391886|NCT01889251|65180891|FG000|Overall Study|Adverse Event|1|||
23391887|NCT01889251|65180892|FG001|Overall Study|Adverse Event|0|||
23391888|NCT02395627|65180899|FG000|Overall Study|Withdrawal by Subject|0|||
23391889|NCT02395627|65180900|FG001|Overall Study|Withdrawal by Subject|2|||
23391890|NCT02395627|65180901|FG002|Overall Study|Withdrawal by Subject|0|||
23391891|NCT02395627|65180899|FG000|Overall Study|Did not receive pembrolizumab|3|||
23391892|NCT02395627|65180900|FG001|Overall Study|Did not receive pembrolizumab|1|||
23391893|NCT02395627|65180901|FG002|Overall Study|Did not receive pembrolizumab|0|||
23391894|NCT03439072|65180902|FG000|Overall Study|Withdrawal by Subject|2|||
23391895|NCT03439072|65180903|FG001|Overall Study|Withdrawal by Subject|3|||
23391896|NCT03439072|65180902|FG000|Overall Study|Physician Decision|0|||
23391897|NCT03439072|65180903|FG001|Overall Study|Physician Decision|1|||
23391898|NCT04349098|65180904|FG000|Overall Study|Death|16|||
23391899|NCT04349098|65180905|FG001|Overall Study|Death|8|||
23391900|NCT04349098|65180904|FG000|Overall Study|Lost to Follow-up|11|||
23391901|NCT04349098|65180905|FG001|Overall Study|Lost to Follow-up|8|||
23391902|NCT04349098|65180904|FG000|Overall Study|Withdrawal by Subject|8|||
23391903|NCT04349098|65180905|FG001|Overall Study|Withdrawal by Subject|5|||
23391904|NCT04349098|65180904|FG000|Overall Study|Other|3|||
23391905|NCT04349098|65180905|FG001|Overall Study|Other|5|||
23391906|NCT02014103|65180907|FG000|Overall Study|Protocol Violation|7|||
23391907|NCT02014103|65180908|FG001|Overall Study|Protocol Violation|7|||
23391908|NCT02014103|65180907|FG000|Overall Study|Adverse Event|1|||
23391909|NCT02014103|65180908|FG001|Overall Study|Adverse Event|0|||
23391910|NCT02014103|65180907|FG000|Overall Study|Lost venous access|1|||
23685854|NCT01324830|66225549|FG009|Overall Study|Adverse Event, non-fatal|0|||
23685855|NCT01324830|66225550|FG010|Overall Study|Adverse Event, non-fatal|1|||
23685856|NCT01324830|66225551|FG011|Overall Study|Adverse Event, non-fatal|0|||
23685857|NCT01324830|66225552|FG012|Overall Study|Adverse Event, non-fatal|0|||
23685858|NCT01324830|66225553|FG013|Overall Study|Adverse Event, non-fatal|0|||
23685859|NCT01324830|66225554|FG014|Overall Study|Adverse Event, non-fatal|0|||
23685860|NCT01324830|66225555|FG015|Overall Study|Adverse Event, non-fatal|0|||
23685861|NCT01324830|66225556|FG016|Overall Study|Adverse Event, non-fatal|0|||
23685862|NCT01324830|66225557|FG017|Overall Study|Adverse Event, non-fatal|1|||
23685863|NCT01324830|66225558|FG018|Overall Study|Adverse Event, non-fatal|0|||
23685864|NCT01324830|66225540|FG000|Overall Study|Withdrawal by Subject|0|||
23685865|NCT01324830|66225541|FG001|Overall Study|Withdrawal by Subject|0|||
23685866|NCT01324830|66225542|FG002|Overall Study|Withdrawal by Subject|0|||
23685867|NCT01324830|66225543|FG003|Overall Study|Withdrawal by Subject|0|||
23685868|NCT01324830|66225544|FG004|Overall Study|Withdrawal by Subject|0|||
23685869|NCT01324830|66225545|FG005|Overall Study|Withdrawal by Subject|1|||
23685870|NCT01324830|66225546|FG006|Overall Study|Withdrawal by Subject|0|||
23685871|NCT01324830|66225547|FG007|Overall Study|Withdrawal by Subject|0|||
23685872|NCT01324830|66225548|FG008|Overall Study|Withdrawal by Subject|0|||
23685873|NCT01324830|66225549|FG009|Overall Study|Withdrawal by Subject|0|||
23685874|NCT01324830|66225550|FG010|Overall Study|Withdrawal by Subject|1|||
23685875|NCT01324830|66225551|FG011|Overall Study|Withdrawal by Subject|0|||
23685876|NCT01324830|66225552|FG012|Overall Study|Withdrawal by Subject|0|||
23685877|NCT01324830|66225553|FG013|Overall Study|Withdrawal by Subject|0|||
23685878|NCT01324830|66225554|FG014|Overall Study|Withdrawal by Subject|0|||
23685879|NCT01324830|66225555|FG015|Overall Study|Withdrawal by Subject|0|||
23685880|NCT01324830|66225556|FG016|Overall Study|Withdrawal by Subject|0|||
23685881|NCT01324830|66225557|FG017|Overall Study|Withdrawal by Subject|0|||
23685882|NCT01324830|66225558|FG018|Overall Study|Withdrawal by Subject|1|||
23685883|NCT04336163|66225559|FG000|Overall Study|Lost to Follow-up|55|||
23685884|NCT04336163|66225560|FG001|Overall Study|Lost to Follow-up|0|||
23685885|NCT01147497|66225561|FG000|Overall Study|failed insertion|2|||
23685886|NCT01147497|66225562|FG001|Overall Study|failed insertion|0|||
23685887|NCT00771472|66225564|FG000|Overall Study|Physician Decision|2|||
23685888|NCT00771472|66225565|FG001|Overall Study|Physician Decision|3|||
23685889|NCT00771472|66225564|FG000|Overall Study|Progressive Disease|3|||
23685890|NCT00771472|66225565|FG001|Overall Study|Progressive Disease|1|||
23685891|NCT00771472|66225564|FG000|Overall Study|Protocol Violation|1|||
23685892|NCT00771472|66225565|FG001|Overall Study|Protocol Violation|0|||
23685893|NCT02305563|66225567|FG000|Treatment Period|Disease progression|0|||
23685894|NCT02305563|66225568|FG001|Treatment Period|Disease progression|0|||
23685895|NCT02305563|66225569|FG002|Treatment Period|Disease progression|15|||
23685896|NCT02305563|66225570|FG003|Treatment Period|Disease progression|6|||
23685897|NCT02305563|66225571|FG004|Treatment Period|Disease progression|6|||
23685898|NCT02305563|66225567|FG000|Treatment Period|Study drug toxicity|0|||
23685899|NCT02305563|66225568|FG001|Treatment Period|Study drug toxicity|0|||
23685900|NCT02305563|66225569|FG002|Treatment Period|Study drug toxicity|0|||
23685901|NCT02305563|66225570|FG003|Treatment Period|Study drug toxicity|1|||
23685902|NCT02305563|66225571|FG004|Treatment Period|Study drug toxicity|2|||
23685903|NCT02305563|66225567|FG000|Treatment Period|Death|0|||
23685904|NCT02305563|66225568|FG001|Treatment Period|Death|0|||
23685905|NCT02305563|66225569|FG002|Treatment Period|Death|1|||
23685906|NCT02305563|66225570|FG003|Treatment Period|Death|2|||
23685907|NCT02305563|66225571|FG004|Treatment Period|Death|1|||
23685908|NCT02305563|66225567|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
23685909|NCT02305563|66225568|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
23685910|NCT02305563|66225569|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
23685911|NCT02305563|66225570|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
23685912|NCT02305563|66225571|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
23685913|NCT02305563|66225567|FG000|Treatment Period|Participant request to stop therapy|0|||
23685914|NCT02305563|66225568|FG001|Treatment Period|Participant request to stop therapy|2|||
23685915|NCT02305563|66225569|FG002|Treatment Period|Participant request to stop therapy|0|||
23391911|NCT02014103|65180908|FG001|Overall Study|Lost venous access|0|||
23391912|NCT02014103|65180907|FG000|Overall Study|Withdrawal by Subject|0|||
23391913|NCT02014103|65180908|FG001|Overall Study|Withdrawal by Subject|2|||
23391914|NCT00835042|65180911|FG000|First Intervention|Withdrawal by Subject|3|||
23391915|NCT00835042|65180912|FG001|First Intervention|Withdrawal by Subject|0|||
23685916|NCT02305563|66225570|FG003|Treatment Period|Participant request to stop therapy|1|||
23685917|NCT02305563|66225571|FG004|Treatment Period|Participant request to stop therapy|0|||
23685918|NCT02305563|66225567|FG000|Treatment Period|Participant withdrew consent|0|||
23685919|NCT02305563|66225568|FG001|Treatment Period|Participant withdrew consent|0|||
23685920|NCT02305563|66225569|FG002|Treatment Period|Participant withdrew consent|1|||
23685921|NCT02305563|66225570|FG003|Treatment Period|Participant withdrew consent|1|||
23685922|NCT02305563|66225571|FG004|Treatment Period|Participant withdrew consent|1|||
23685923|NCT02305563|66225567|FG000|Treatment Period|Maximum clinical benefit|0|||
23685924|NCT02305563|66225568|FG001|Treatment Period|Maximum clinical benefit|0|||
23685925|NCT02305563|66225569|FG002|Treatment Period|Maximum clinical benefit|0|||
23685926|NCT02305563|66225570|FG003|Treatment Period|Maximum clinical benefit|0|||
23685927|NCT02305563|66225571|FG004|Treatment Period|Maximum clinical benefit|1|||
23685928|NCT02305563|66225567|FG000|Treatment Period|Poor/non-compliance|0|||
23685929|NCT02305563|66225568|FG001|Treatment Period|Poor/non-compliance|0|||
23685930|NCT02305563|66225569|FG002|Treatment Period|Poor/non-compliance|0|||
23685931|NCT02305563|66225570|FG003|Treatment Period|Poor/non-compliance|0|||
23685932|NCT02305563|66225571|FG004|Treatment Period|Poor/non-compliance|1|||
23685933|NCT02305563|66225567|FG000|Treatment Period|Administrative reason by Sponsor|0|||
23685934|NCT02305563|66225568|FG001|Treatment Period|Administrative reason by Sponsor|0|||
23685935|NCT02305563|66225569|FG002|Treatment Period|Administrative reason by Sponsor|0|||
23685936|NCT02305563|66225570|FG003|Treatment Period|Administrative reason by Sponsor|0|||
23685937|NCT02305563|66225571|FG004|Treatment Period|Administrative reason by Sponsor|1|||
23685938|NCT02305563|66225567|FG000|Treatment Period|other reason|2|||
23685939|NCT02305563|66225568|FG001|Treatment Period|other reason|0|||
23685940|NCT02305563|66225569|FG002|Treatment Period|other reason|2|||
23685941|NCT02305563|66225570|FG003|Treatment Period|other reason|2|||
23685942|NCT02305563|66225571|FG004|Treatment Period|other reason|1|||
23685943|NCT02305563|66225567|FG000|Treatment Period|Randomized but not treated|0|||
23685944|NCT02305563|66225568|FG001|Treatment Period|Randomized but not treated|0|||
23685945|NCT02305563|66225569|FG002|Treatment Period|Randomized but not treated|0|||
23685946|NCT02305563|66225570|FG003|Treatment Period|Randomized but not treated|0|||
23685947|NCT02305563|66225571|FG004|Treatment Period|Randomized but not treated|2|||
23685948|NCT02305563|66225567|FG000|Treatment Period|added ULO, then disease progression|0|||
23685949|NCT02305563|66225568|FG001|Treatment Period|added ULO, then disease progression|0|||
23685950|NCT02305563|66225569|FG002|Treatment Period|added ULO, then disease progression|0|||
23685951|NCT02305563|66225570|FG003|Treatment Period|added ULO, then disease progression|0|||
23685952|NCT02305563|66225571|FG004|Treatment Period|added ULO, then disease progression|4|||
23685953|NCT02305563|66225567|FG000|Treatment Period|added ULO; then other reason|0|||
23685954|NCT02305563|66225568|FG001|Treatment Period|added ULO; then other reason|0|||
23685955|NCT02305563|66225569|FG002|Treatment Period|added ULO; then other reason|0|||
23685956|NCT02305563|66225570|FG003|Treatment Period|added ULO; then other reason|0|||
23685957|NCT02305563|66225571|FG004|Treatment Period|added ULO; then other reason|1|||
23685958|NCT02305563|66225567|FG000|Treatment Period|added ULO, then request to stop|0|||
23685959|NCT02305563|66225568|FG001|Treatment Period|added ULO, then request to stop|0|||
23685960|NCT02305563|66225569|FG002|Treatment Period|added ULO, then request to stop|0|||
23685961|NCT02305563|66225570|FG003|Treatment Period|added ULO, then request to stop|0|||
23685962|NCT02305563|66225571|FG004|Treatment Period|added ULO, then request to stop|1|||
23685963|NCT02305563|66225567|FG000|Follow-up Period|Death|0|||
23685964|NCT02305563|66225568|FG001|Follow-up Period|Death|0|||
23685965|NCT02305563|66225569|FG002|Follow-up Period|Death|5|||
23685966|NCT02305563|66225570|FG003|Follow-up Period|Death|4|||
23685967|NCT02305563|66225571|FG004|Follow-up Period|Death|7|||
23685968|NCT02305563|66225567|FG000|Follow-up Period|Participant withdrew consent|0|||
23685969|NCT02305563|66225568|FG001|Follow-up Period|Participant withdrew consent|0|||
23685970|NCT02305563|66225569|FG002|Follow-up Period|Participant withdrew consent|2|||
23685971|NCT02305563|66225570|FG003|Follow-up Period|Participant withdrew consent|1|||
23685972|NCT02305563|66225571|FG004|Follow-up Period|Participant withdrew consent|0|||
23685973|NCT02305563|66225567|FG000|Follow-up Period|other reason|0|||
23685974|NCT02305563|66225568|FG001|Follow-up Period|other reason|0|||
23685975|NCT02305563|66225569|FG002|Follow-up Period|other reason|0|||
23685976|NCT02305563|66225570|FG003|Follow-up Period|other reason|0|||
23685977|NCT02305563|66225571|FG004|Follow-up Period|other reason|1|||
23685978|NCT02305563|66225567|FG000|Follow-up Period|Followup no longer required per protocol|3|||
23685979|NCT02305563|66225568|FG001|Follow-up Period|Followup no longer required per protocol|3|||
23685980|NCT02305563|66225569|FG002|Follow-up Period|Followup no longer required per protocol|4|||
23685981|NCT02305563|66225570|FG003|Follow-up Period|Followup no longer required per protocol|1|||
23685982|NCT02305563|66225571|FG004|Follow-up Period|Followup no longer required per protocol|4|||
23685983|NCT00961961|66225572|FG000|Phase I|Withdrawal by Subject|7|||
23685984|NCT00961961|66225573|FG001|Phase I|Withdrawal by Subject|0|||
23685985|NCT00961961|66225574|FG002|Phase I|Withdrawal by Subject|0|||
23685986|NCT00961961|66225575|FG003|Phase I|Withdrawal by Subject|0|||
23685987|NCT00961961|66225572|FG000|Phase I|Lost to Follow-up|10|||
23685988|NCT00961961|66225573|FG001|Phase I|Lost to Follow-up|0|||
23685989|NCT00961961|66225574|FG002|Phase I|Lost to Follow-up|0|||
23685990|NCT00961961|66225575|FG003|Phase I|Lost to Follow-up|0|||
23685991|NCT00961961|66225572|FG000|Phase I|Lack of Efficacy|94|||
23685992|NCT00961961|66225573|FG001|Phase I|Lack of Efficacy|0|||
23685993|NCT00961961|66225574|FG002|Phase I|Lack of Efficacy|0|||
23685994|NCT00961961|66225575|FG003|Phase I|Lack of Efficacy|0|||
23685995|NCT00961961|66225572|FG000|Phase I|Adverse Event|7|||
23685996|NCT00961961|66225573|FG001|Phase I|Adverse Event|0|||
23685997|NCT00961961|66225574|FG002|Phase I|Adverse Event|0|||
23685998|NCT00961961|66225575|FG003|Phase I|Adverse Event|0|||
23685999|NCT00961961|66225572|FG000|Phase I|Physician Decision|8|||
23686000|NCT00961961|66225573|FG001|Phase I|Physician Decision|0|||
23686001|NCT00961961|66225574|FG002|Phase I|Physician Decision|0|||
23686002|NCT00961961|66225575|FG003|Phase I|Physician Decision|0|||
23686003|NCT00961961|66225572|FG000|Phase II|Lost to Follow-up|0|||
23686004|NCT00961961|66225573|FG001|Phase II|Lost to Follow-up|0|||
23686005|NCT00961961|66225574|FG002|Phase II|Lost to Follow-up|10|||
23686006|NCT00961961|66225575|FG003|Phase II|Lost to Follow-up|7|||
23686007|NCT00961961|66225572|FG000|Phase II|Adverse Event|0|||
23686008|NCT00961961|66225573|FG001|Phase II|Adverse Event|0|||
23391916|NCT00835042|65180911|FG000|First Intervention|Adverse Event|1|||
23391917|NCT00835042|65180912|FG001|First Intervention|Adverse Event|2|||
23391918|NCT00835042|65180911|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
23391919|NCT00835042|65180912|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
23391920|NCT00642759|65180918|FG000|Overall Study|Protocol Violation|1|||
23391921|NCT03400787|65180919|FG000|Overall Study|Lost to Follow-up|1|||
23391922|NCT03400787|65180920|FG001|Overall Study|Lost to Follow-up|0|||
23391923|NCT03400787|65180919|FG000|Overall Study|Death|1|||
23391924|NCT03400787|65180920|FG001|Overall Study|Death|0|||
23391925|NCT03400787|65180919|FG000|Overall Study|Protocol Violation|0|||
23391926|NCT03400787|65180920|FG001|Overall Study|Protocol Violation|2|||
23391927|NCT03400787|65180919|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
23391928|NCT03400787|65180920|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
23391929|NCT04115293|65180921|FG000|Overall Study|Adverse Event|0|||
23391930|NCT04115293|65180922|FG001|Overall Study|Adverse Event|2|||
23391931|NCT04115293|65180921|FG000|Overall Study|Withdrawal by Subject|2|||
23391932|NCT04115293|65180922|FG001|Overall Study|Withdrawal by Subject|1|||
23391933|NCT04115293|65180921|FG000|Overall Study|Physician Decision|1|||
23391934|NCT04115293|65180922|FG001|Overall Study|Physician Decision|0|||
23391935|NCT04115293|65180921|FG000|Overall Study|Death|1|||
23496012|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|Death|0|||
23686009|NCT00961961|66225574|FG002|Phase II|Adverse Event|0|||
23686010|NCT00961961|66225575|FG003|Phase II|Adverse Event|1|||
23686011|NCT00961961|66225572|FG000|Phase II|Physician Decision|0|||
23686012|NCT00961961|66225573|FG001|Phase II|Physician Decision|0|||
23686013|NCT00961961|66225574|FG002|Phase II|Physician Decision|1|||
23686014|NCT00961961|66225575|FG003|Phase II|Physician Decision|0|||
23686015|NCT00961961|66225572|FG000|Phase II|Withdrawal by Subject|0|||
23686016|NCT00961961|66225573|FG001|Phase II|Withdrawal by Subject|0|||
23686017|NCT00961961|66225574|FG002|Phase II|Withdrawal by Subject|1|||
23686018|NCT00961961|66225575|FG003|Phase II|Withdrawal by Subject|0|||
23686019|NCT01409928|66225579|FG000|Overall Study|Physician Decision|12|||
23686020|NCT01628926|66225583|FG000|Overall Study|Adverse Event|13|||
23686021|NCT01628926|66225584|FG001|Overall Study|Adverse Event|11|||
23686022|NCT01628926|66225585|FG002|Overall Study|Adverse Event|9|||
23686023|NCT01628926|66225583|FG000|Overall Study|Lack of Efficacy|2|||
23686024|NCT01628926|66225584|FG001|Overall Study|Lack of Efficacy|1|||
23686025|NCT01628926|66225585|FG002|Overall Study|Lack of Efficacy|5|||
23686026|NCT01628926|66225583|FG000|Overall Study|Withdrawal by Subject|6|||
23686027|NCT01628926|66225584|FG001|Overall Study|Withdrawal by Subject|4|||
23686028|NCT01628926|66225585|FG002|Overall Study|Withdrawal by Subject|2|||
23686029|NCT01628926|66225583|FG000|Overall Study|Protocol Violation|0|||
23686030|NCT01628926|66225584|FG001|Overall Study|Protocol Violation|1|||
23686031|NCT01628926|66225585|FG002|Overall Study|Protocol Violation|0|||
23686032|NCT01628926|66225583|FG000|Overall Study|Discontinuation criteria|3|||
23686033|NCT01628926|66225584|FG001|Overall Study|Discontinuation criteria|4|||
23686034|NCT01628926|66225585|FG002|Overall Study|Discontinuation criteria|0|||
23686035|NCT01628926|66225583|FG000|Overall Study|Physician Decision|2|||
23686036|NCT01628926|66225584|FG001|Overall Study|Physician Decision|2|||
23686037|NCT01628926|66225585|FG002|Overall Study|Physician Decision|1|||
23686038|NCT03437447|66225588|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23686039|NCT03437447|66225589|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23686040|NCT03437447|66225590|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23686041|NCT00840827|66225591|FG000|Overall Study|Adverse Event|1|||
23686042|NCT00840827|66225591|FG000|Overall Study|Lack of Efficacy|4|||
23686043|NCT00840827|66225591|FG000|Overall Study|Physician Decision|1|||
23686044|NCT01756456|66225592|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23686045|NCT01756456|66225593|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23686046|NCT01756456|66225594|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23686047|NCT01756456|66225595|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23391936|NCT04115293|65180922|FG001|Overall Study|Death|1|||
23391937|NCT00980798|65180926|FG000|Overall Study|Adverse Event|7|||
23391938|NCT00980798|65180927|FG001|Overall Study|Adverse Event|36|||
23391939|NCT00980798|65180926|FG000|Overall Study|Lack of Efficacy|16|||
23496013|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|Death|0|||
23686048|NCT01756456|66225596|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23391940|NCT00980798|65180927|FG001|Overall Study|Lack of Efficacy|5|||
23391941|NCT00980798|65180926|FG000|Overall Study|Lost to Follow-up|0|||
23391942|NCT00980798|65180927|FG001|Overall Study|Lost to Follow-up|1|||
23391943|NCT00980798|65180926|FG000|Overall Study|Physician Decision|2|||
23686049|NCT01756456|66225597|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23686050|NCT01756456|66225592|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23686051|NCT01756456|66225593|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23686052|NCT01756456|66225594|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23686053|NCT01756456|66225595|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
23686054|NCT01756456|66225596|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
23686055|NCT01756456|66225597|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23686056|NCT01756456|66225592|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23686057|NCT01756456|66225593|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
23686058|NCT01756456|66225594|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23686059|NCT01756456|66225595|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23686060|NCT01756456|66225596|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23686061|NCT01756456|66225597|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23686062|NCT01756456|66225592|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
23686063|NCT01756456|66225593|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
23686064|NCT01756456|66225594|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
23686065|NCT01756456|66225595|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
23686066|NCT01756456|66225596|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
23686067|NCT01756456|66225597|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
23391944|NCT00980798|65180927|FG001|Overall Study|Physician Decision|1|||
23686068|NCT01756456|66225592|FG000|Treatment Period: Phase I/II|Other causes|0|||
23686069|NCT01756456|66225593|FG001|Treatment Period: Phase I/II|Other causes|0|||
23391945|NCT00980798|65180926|FG000|Overall Study|Withdrawal by Subject|8|||
23391946|NCT00980798|65180927|FG001|Overall Study|Withdrawal by Subject|11|||
23391947|NCT00980798|65180926|FG000|Overall Study|Other|0|||
23391948|NCT00980798|65180927|FG001|Overall Study|Other|1|||
23391949|NCT03794544|65180928|FG000|Overall Study|Withdrawal by Subject|1|||
23391950|NCT03794544|65180929|FG001|Overall Study|Withdrawal by Subject|1|||
23391951|NCT03794544|65180930|FG002|Overall Study|Withdrawal by Subject|0|||
23391952|NCT03794544|65180931|FG003|Overall Study|Withdrawal by Subject|0|||
23391953|NCT03794544|65180928|FG000|Overall Study|Death|0|||
23391954|NCT03794544|65180929|FG001|Overall Study|Death|0|||
23391955|NCT03794544|65180930|FG002|Overall Study|Death|0|||
23391956|NCT03794544|65180931|FG003|Overall Study|Death|1|||
23391957|NCT03794544|65180928|FG000|Overall Study|Lost to Follow-up|0|||
23391958|NCT03794544|65180929|FG001|Overall Study|Lost to Follow-up|1|||
23686070|NCT01756456|66225594|FG002|Treatment Period: Phase I/II|Other causes|0|||
23686071|NCT01756456|66225595|FG003|Treatment Period: Phase I/II|Other causes|1|||
23686072|NCT01756456|66225596|FG004|Treatment Period: Phase I/II|Other causes|2|||
23686073|NCT01756456|66225597|FG005|Treatment Period: Phase I/II|Other causes|2|||
23686074|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
23686075|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
23686076|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
23686077|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
23686078|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
23686079|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
23686080|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23686081|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
23686082|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23686083|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23686084|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23391959|NCT03794544|65180930|FG002|Overall Study|Lost to Follow-up|1|||
23686085|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23686086|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23686087|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23391960|NCT03794544|65180931|FG003|Overall Study|Lost to Follow-up|0|||
23391961|NCT03794544|65180928|FG000|Overall Study|Other|0|||
23391962|NCT03794544|65180929|FG001|Overall Study|Other|1|||
23391963|NCT03794544|65180930|FG002|Overall Study|Other|0|||
23391964|NCT03794544|65180931|FG003|Overall Study|Other|0|||
23391965|NCT02249949|65180932|FG000|Overall Study|Cancelled prior to treatment|2|||
23391966|NCT03101267|65180934|FG000|Primary Study Period|Withdrawal by Subject|1|||
23686088|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23686089|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23391967|NCT03101267|65180935|FG001|Primary Study Period|Withdrawal by Subject|2|||
23391968|NCT03101267|65180936|FG002|Primary Study Period|Withdrawal by Subject|3|||
23391969|NCT03101267|65180934|FG000|Primary Study Period|Miscellaneous|2|||
23391970|NCT03101267|65180935|FG001|Primary Study Period|Miscellaneous|0|||
23496014|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|Death|0|||
23496015|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|Death|0|||
23391971|NCT03101267|65180936|FG002|Primary Study Period|Miscellaneous|0|||
23391972|NCT03004183|65180944|FG000|Overall Study|Adverse Event|7|||
23391973|NCT03004183|65180944|FG000|Overall Study|Lost to Follow-up|1|||
23391974|NCT03004183|65180944|FG000|Overall Study|Physician Decision|40|||
23391975|NCT03004183|65180944|FG000|Overall Study|Withdrawal by Subject|1|||
23391976|NCT03004183|65180944|FG000|Overall Study|COVID-19|1|||
23391977|NCT00267488|65180950|FG000|Overall Study|Sponsor Terminated Study|9|||
23391978|NCT00267488|65180950|FG000|Overall Study|Protocol Violation|1|||
23391979|NCT00267488|65180950|FG000|Overall Study|Other (Disease Progression)|1|||
23391980|NCT01904279|65180952|FG000|Overall Study|Lack of Efficacy|2|||
23391981|NCT01904279|65180953|FG001|Overall Study|Lack of Efficacy|3|||
23391982|NCT01904279|65180952|FG000|Overall Study|Withdrawal by Subject|1|||
23391983|NCT01904279|65180953|FG001|Overall Study|Withdrawal by Subject|0|||
23391984|NCT03474107|65180954|FG000|Overall Study|Adverse Event|42|||
23391985|NCT03474107|65180955|FG001|Overall Study|Adverse Event|46|||
23391986|NCT03474107|65180954|FG000|Overall Study|Death|2|||
23391987|NCT03474107|65180955|FG001|Overall Study|Death|2|||
23391988|NCT03474107|65180954|FG000|Overall Study|Lost to Follow-up|0|||
23391989|NCT03474107|65180955|FG001|Overall Study|Lost to Follow-up|1|||
23391990|NCT03474107|65180954|FG000|Overall Study|Progressive Disease|177|||
23391991|NCT03474107|65180955|FG001|Overall Study|Progressive Disease|180|||
23391992|NCT03474107|65180954|FG000|Overall Study|Protocol Violation|1|||
23391993|NCT03474107|65180955|FG001|Overall Study|Protocol Violation|1|||
23391994|NCT03474107|65180954|FG000|Overall Study|Withdrawal by Subject|15|||
23391995|NCT03474107|65180955|FG001|Overall Study|Withdrawal by Subject|27|||
23391996|NCT03474107|65180954|FG000|Overall Study|Physician Decision|7|||
23391997|NCT03474107|65180955|FG001|Overall Study|Physician Decision|22|||
23391998|NCT03474107|65180954|FG000|Overall Study|Miscellaneous|1|||
23391999|NCT03474107|65180955|FG001|Overall Study|Miscellaneous|6|||
23392000|NCT02607722|65182652|FG000|Overall Study|No data reliability|1|||
23392001|NCT02607722|65182652|FG000|Overall Study|no patient visit|18|||
23392002|NCT02607722|65182652|FG000|Overall Study|missing info in CRF|13|||
23392003|NCT02607722|65182652|FG000|Overall Study|Withdrawal by Subject|616|||
23392004|NCT02607722|65182652|FG000|Overall Study|Lost to Follow-up|312|||
23392005|NCT02607722|65182652|FG000|Overall Study|Improved|22|||
23392006|NCT02607722|65182652|FG000|Overall Study|Lack of Efficacy|316|||
23496016|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|Death|1|||
23496017|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|Death|0|||
23496018|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|Death|11|||
23496019|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|Death|2|||
23496020|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496021|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496022|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496023|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496024|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496025|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496026|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496027|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
23686090|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23686091|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
23686092|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
23686093|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
23392007|NCT02607722|65182652|FG000|Overall Study|Adverse Event|2553|||
23392008|NCT02607722|65182652|FG000|Overall Study|Not treated|1|||
23392009|NCT02607722|65182652|FG000|Overall Study|No CRF collected|138|||
23392010|NCT02607722|65182652|FG000|Overall Study|without CRF|4225|||
23686094|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
23392011|NCT02607722|65182652|FG000|Overall Study|Physician Decision|367|||
23392012|NCT03880019|65182655|FG000|Overall Study|Competing disease|1|||
23392013|NCT04034927|65182661|FG000|Overall Study|Adverse Event|4|||
23392014|NCT04034927|65182662|FG001|Overall Study|Adverse Event|9|||
23686095|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
23686096|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
23686097|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
23686098|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23686099|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23686100|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
23686101|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
23686102|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23686103|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
23686104|NCT01756456|66225592|FG000|Follow Up Period Phase I/II|Other causes|0|||
23686105|NCT01756456|66225593|FG001|Follow Up Period Phase I/II|Other causes|0|||
23686106|NCT01756456|66225594|FG002|Follow Up Period Phase I/II|Other causes|0|||
23686107|NCT01756456|66225595|FG003|Follow Up Period Phase I/II|Other causes|1|||
23686108|NCT01756456|66225596|FG004|Follow Up Period Phase I/II|Other causes|3|||
23686109|NCT01756456|66225597|FG005|Follow Up Period Phase I/II|Other causes|5|||
23686110|NCT01727258|66225598|FG000|Overall Study|Adverse Event|0|||
23392015|NCT04034927|65182661|FG000|Overall Study|Death|0|||
23392016|NCT04034927|65182662|FG001|Overall Study|Death|1|||
23392017|NCT04034927|65182661|FG000|Overall Study|Withdrawal by Subject|0|||
23392018|NCT04034927|65182662|FG001|Overall Study|Withdrawal by Subject|3|||
23496028|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
23686111|NCT01727258|66225599|FG001|Overall Study|Adverse Event|2|||
23686112|NCT01727258|66225600|FG002|Overall Study|Adverse Event|0|||
23686113|NCT01727258|66225598|FG000|Overall Study|Noncompliance with Study Drug|0|||
23686114|NCT01727258|66225599|FG001|Overall Study|Noncompliance with Study Drug|0|||
23686115|NCT01727258|66225600|FG002|Overall Study|Noncompliance with Study Drug|1|||
23686116|NCT01727258|66225598|FG000|Overall Study|Withdrawal by Subject|1|||
23686117|NCT01727258|66225599|FG001|Overall Study|Withdrawal by Subject|1|||
23686118|NCT01727258|66225600|FG002|Overall Study|Withdrawal by Subject|0|||
23686119|NCT01727258|66225598|FG000|Overall Study|Lost to Follow-up|1|||
23686120|NCT01727258|66225599|FG001|Overall Study|Lost to Follow-up|0|||
23392019|NCT04034927|65182661|FG000|Overall Study|Still on Treatment|2|||
23392020|NCT04034927|65182662|FG001|Overall Study|Still on Treatment|1|||
23392021|NCT04034927|65182661|FG000|Overall Study|Other|1|||
23392022|NCT04034927|65182662|FG001|Overall Study|Other|1|||
23392023|NCT03038672|65182667|FG000|Initial Treatment|Unacceptable chemistry|0|||
23392024|NCT03038672|65182668|FG001|Initial Treatment|Unacceptable chemistry|1|||
23392025|NCT03038672|65182667|FG000|Initial Treatment|Progression prior to treatment|1|||
23686121|NCT01727258|66225600|FG002|Overall Study|Lost to Follow-up|0|||
23686122|NCT00486902|66225601|FG000|Overall Study|Withdrawal by Subject|1|||
23686123|NCT00486902|66225602|FG001|Overall Study|Withdrawal by Subject|2|||
23686124|NCT00486902|66225601|FG000|Overall Study|decision for postpartum tubal ligation|3|||
23686125|NCT00486902|66225602|FG001|Overall Study|decision for postpartum tubal ligation|1|||
23392026|NCT03038672|65182668|FG001|Initial Treatment|Progression prior to treatment|0|||
23392027|NCT03038672|65182667|FG000|Initial Treatment|No treatment per protocol|1|||
23392028|NCT03038672|65182668|FG001|Initial Treatment|No treatment per protocol|0|||
23392029|NCT02088554|65182671|FG000|Overall Study|Exited before procedure|130|||
23392030|NCT02088554|65182671|FG000|Overall Study|Attempted but not implanted|31|||
23392031|NCT02088554|65182671|FG000|Overall Study|Implant not attempted|19|||
23392032|NCT02088554|65182671|FG000|Overall Study|Pending next visit|532|||
23392033|NCT02088554|65182671|FG000|Overall Study|Death|170|||
23392034|NCT02088554|65182671|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
23392035|NCT02088554|65182671|FG000|Overall Study|Lost to Follow-up|23|||
23392036|NCT02088554|65182671|FG000|Overall Study|Explanted|32|||
23392037|NCT02088554|65182671|FG000|Overall Study|Any other reason not covered by previous categories|11|||
23392038|NCT05418426|65182679|FG000|Overall Study|Adverse Event|0|||
23392039|NCT05418426|65182680|FG001|Overall Study|Adverse Event|1|||
23392040|NCT05418426|65182681|FG002|Overall Study|Adverse Event|0|||
23392041|NCT05418426|65182679|FG000|Overall Study|Withdrawal by Subject|0|||
23392042|NCT05418426|65182680|FG001|Overall Study|Withdrawal by Subject|1|||
23392043|NCT05418426|65182681|FG002|Overall Study|Withdrawal by Subject|0|||
23392044|NCT05418426|65182679|FG000|Overall Study|Protocol Violation|0|||
23392045|NCT05418426|65182680|FG001|Overall Study|Protocol Violation|0|||
23392046|NCT05418426|65182681|FG002|Overall Study|Protocol Violation|1|||
23392047|NCT03338790|65182694|FG000|Overall Study|Disease Progression|65|||
23392048|NCT03338790|65182695|FG001|Overall Study|Disease Progression|43|||
23392049|NCT03338790|65182696|FG002|Overall Study|Disease Progression|50|||
23392050|NCT03338790|65182697|FG003|Overall Study|Disease Progression|37|||
23392051|NCT03338790|65182694|FG000|Overall Study|Study Drug Toxicity|9|||
23392052|NCT03338790|65182695|FG001|Overall Study|Study Drug Toxicity|8|||
23392053|NCT03338790|65182696|FG002|Overall Study|Study Drug Toxicity|15|||
23392054|NCT03338790|65182697|FG003|Overall Study|Study Drug Toxicity|0|||
23392055|NCT03338790|65182694|FG000|Overall Study|Death|1|||
23392056|NCT03338790|65182695|FG001|Overall Study|Death|1|||
23392057|NCT03338790|65182696|FG002|Overall Study|Death|1|||
23392058|NCT03338790|65182697|FG003|Overall Study|Death|0|||
23392059|NCT03338790|65182694|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392060|NCT03338790|65182695|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392061|NCT03338790|65182696|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
23392062|NCT03338790|65182697|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392063|NCT03338790|65182694|FG000|Overall Study|Participant request to discontinue study treatment|3|||
23392064|NCT03338790|65182695|FG001|Overall Study|Participant request to discontinue study treatment|3|||
23392065|NCT03338790|65182696|FG002|Overall Study|Participant request to discontinue study treatment|2|||
23392066|NCT03338790|65182697|FG003|Overall Study|Participant request to discontinue study treatment|1|||
23392067|NCT03338790|65182694|FG000|Overall Study|Poor/non-compliance|0|||
23392068|NCT03338790|65182695|FG001|Overall Study|Poor/non-compliance|1|||
23392069|NCT03338790|65182696|FG002|Overall Study|Poor/non-compliance|0|||
23392070|NCT03338790|65182697|FG003|Overall Study|Poor/non-compliance|0|||
23392071|NCT03338790|65182694|FG000|Overall Study|Participant withdrew consent|1|||
23392072|NCT03338790|65182695|FG001|Overall Study|Participant withdrew consent|0|||
23392073|NCT03338790|65182696|FG002|Overall Study|Participant withdrew consent|1|||
23392074|NCT03338790|65182697|FG003|Overall Study|Participant withdrew consent|1|||
23392075|NCT03338790|65182694|FG000|Overall Study|Other reasons|0|||
23392076|NCT03338790|65182695|FG001|Overall Study|Other reasons|5|||
23392077|NCT03338790|65182696|FG002|Overall Study|Other reasons|0|||
23392078|NCT03338790|65182697|FG003|Overall Study|Other reasons|2|||
23392079|NCT03338790|65182694|FG000|Overall Study|Not reported|0|||
23392080|NCT03338790|65182695|FG001|Overall Study|Not reported|0|||
23392081|NCT03338790|65182696|FG002|Overall Study|Not reported|1|||
23392082|NCT03338790|65182697|FG003|Overall Study|Not reported|0|||
23392083|NCT03338790|65182694|FG000|Overall Study|Completed treatment period|1|||
23392084|NCT03338790|65182695|FG001|Overall Study|Completed treatment period|2|||
23392085|NCT03338790|65182696|FG002|Overall Study|Completed treatment period|0|||
23392086|NCT03338790|65182697|FG003|Overall Study|Completed treatment period|0|||
23392087|NCT02507934|65182698|FG000|Overall Study|Lost to Follow-up|2|||
23392088|NCT02507934|65182699|FG001|Overall Study|Lost to Follow-up|0|||
23392089|NCT02507934|65182698|FG000|Overall Study|Withdrawal by Subject|2|||
23392090|NCT02507934|65182699|FG001|Overall Study|Withdrawal by Subject|0|||
23392091|NCT05473715|65182700|FG000|Overall Study|Trial terminate|2|||
23392092|NCT05473715|65182701|FG001|Overall Study|Trial terminate|1|||
23392093|NCT05878067|65182706|FG000|Overall Study|Lost to Follow-up|2|||
23392094|NCT04730271|65182707|FG000|Overall Study|Adverse Event|0|||
23392095|NCT04730271|65182708|FG001|Overall Study|Adverse Event|2|||
23392096|NCT04730271|65182707|FG000|Overall Study|Withdrawal by Subject|1|||
23392097|NCT04730271|65182708|FG001|Overall Study|Withdrawal by Subject|1|||
23392098|NCT04730271|65182707|FG000|Overall Study|Protocol Violation|7|||
23392099|NCT04730271|65182708|FG001|Overall Study|Protocol Violation|13|||
23392100|NCT04730271|65182707|FG000|Overall Study|Lost to Follow-up|3|||
23392101|NCT04730271|65182708|FG001|Overall Study|Lost to Follow-up|3|||
23392102|NCT04730271|65182707|FG000|Overall Study|Death|1|||
23392103|NCT04730271|65182708|FG001|Overall Study|Death|0|||
23392104|NCT06582732|65182710|FG000|Initial Study Period|Adverse Event|0|||
23392105|NCT06582732|65182711|FG001|Initial Study Period|Adverse Event|0|||
23392106|NCT06582732|65182712|FG002|Initial Study Period|Adverse Event|0|||
23392107|NCT06582732|65182713|FG003|Initial Study Period|Adverse Event|2|||
23392108|NCT06582732|65182714|FG004|Initial Study Period|Adverse Event|0|||
23392109|NCT06582732|65182715|FG005|Initial Study Period|Adverse Event|0|||
23392110|NCT06582732|65182716|FG006|Initial Study Period|Adverse Event|0|||
23392111|NCT06582732|65182710|FG000|Initial Study Period|Death|1|||
23392112|NCT06582732|65182711|FG001|Initial Study Period|Death|0|||
23392113|NCT06582732|65182712|FG002|Initial Study Period|Death|0|||
23392114|NCT06582732|65182713|FG003|Initial Study Period|Death|0|||
23392115|NCT06582732|65182714|FG004|Initial Study Period|Death|1|||
23392116|NCT06582732|65182715|FG005|Initial Study Period|Death|0|||
23392117|NCT06582732|65182716|FG006|Initial Study Period|Death|0|||
23392118|NCT06582732|65182710|FG000|Initial Study Period|Lost to Follow-up|0|||
23392119|NCT06582732|65182711|FG001|Initial Study Period|Lost to Follow-up|0|||
23392120|NCT06582732|65182712|FG002|Initial Study Period|Lost to Follow-up|2|||
23392121|NCT06582732|65182713|FG003|Initial Study Period|Lost to Follow-up|0|||
23392122|NCT06582732|65182714|FG004|Initial Study Period|Lost to Follow-up|0|||
23392123|NCT06582732|65182715|FG005|Initial Study Period|Lost to Follow-up|0|||
23392124|NCT06582732|65182716|FG006|Initial Study Period|Lost to Follow-up|0|||
23392125|NCT06582732|65182710|FG000|Initial Study Period|Withdrawal by Subject|0|||
23392126|NCT06582732|65182711|FG001|Initial Study Period|Withdrawal by Subject|1|||
23392127|NCT06582732|65182712|FG002|Initial Study Period|Withdrawal by Subject|0|||
23392128|NCT06582732|65182713|FG003|Initial Study Period|Withdrawal by Subject|1|||
23392129|NCT06582732|65182714|FG004|Initial Study Period|Withdrawal by Subject|3|||
23392130|NCT06582732|65182715|FG005|Initial Study Period|Withdrawal by Subject|1|||
23392131|NCT06582732|65182716|FG006|Initial Study Period|Withdrawal by Subject|2|||
23392132|NCT06582732|65182710|FG000|Initial Study Period|Moved Away|0|||
23392133|NCT06582732|65182711|FG001|Initial Study Period|Moved Away|0|||
23392134|NCT06582732|65182712|FG002|Initial Study Period|Moved Away|0|||
23392135|NCT06582732|65182713|FG003|Initial Study Period|Moved Away|0|||
23392136|NCT06582732|65182714|FG004|Initial Study Period|Moved Away|1|||
23392137|NCT06582732|65182715|FG005|Initial Study Period|Moved Away|0|||
23392138|NCT06582732|65182716|FG006|Initial Study Period|Moved Away|0|||
23392139|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392140|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
23392141|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392142|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392143|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
23392144|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23392145|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23392146|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
23392147|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
23392148|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
23392149|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23392150|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23392151|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392152|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23392153|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392154|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392155|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392156|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
23392157|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392158|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392159|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
23392160|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392161|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392162|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392163|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23392164|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23392165|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
23392166|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
23392167|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23392168|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23392169|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
23392170|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
23392171|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Death|0|||
23392172|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Death|0|||
23392173|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Death|1|||
23392174|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Death|0|||
23392175|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392176|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392177|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
23392178|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392179|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
23686126|NCT00486902|66225601|FG000|Overall Study|spinal anesthetic protocal violation|1|||
23686127|NCT00486902|66225602|FG001|Overall Study|spinal anesthetic protocal violation|1|||
23686128|NCT00486902|66225601|FG000|Overall Study|Did not meet inclusion criteria|1|||
23686129|NCT00486902|66225602|FG001|Overall Study|Did not meet inclusion criteria|0|||
23686130|NCT00486902|66225601|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
23686131|NCT00486902|66225602|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
23686132|NCT00151892|66225603|FG000|Overall Study|Lack of Efficacy|50|||
23686133|NCT00151892|66225604|FG001|Overall Study|Lack of Efficacy|57|||
23686134|NCT00151892|66225603|FG000|Overall Study|Patient request|10|||
23686135|NCT00151892|66225604|FG001|Overall Study|Patient request|7|||
23686136|NCT00151892|66225603|FG000|Overall Study|Lost to Follow-up|5|||
23686137|NCT00151892|66225604|FG001|Overall Study|Lost to Follow-up|10|||
23686138|NCT00151892|66225603|FG000|Overall Study|Adverse Event|6|||
23686139|NCT00151892|66225604|FG001|Overall Study|Adverse Event|3|||
23686140|NCT00151892|66225603|FG000|Overall Study|Protocol Violation|3|||
23686141|NCT00151892|66225604|FG001|Overall Study|Protocol Violation|3|||
23686142|NCT00151892|66225603|FG000|Overall Study|Non-compliance|0|||
23686143|NCT00151892|66225604|FG001|Overall Study|Non-compliance|1|||
23686144|NCT00151892|66225603|FG000|Overall Study|Pregnancy|0|||
23686145|NCT00151892|66225604|FG001|Overall Study|Pregnancy|1|||
23686146|NCT00151892|66225603|FG000|Overall Study|Did not return for a visit|1|||
23686147|NCT00151892|66225604|FG001|Overall Study|Did not return for a visit|0|||
23686148|NCT00151892|66225603|FG000|Overall Study|Used prohibited corticosteroids|1|||
23686149|NCT00151892|66225604|FG001|Overall Study|Used prohibited corticosteroids|0|||
23686150|NCT00151892|66225603|FG000|Overall Study|Lack of study medication at center|0|||
23686151|NCT00151892|66225604|FG001|Overall Study|Lack of study medication at center|1|||
23686152|NCT03838484|66225607|FG000|Overall Study|Lost to Follow-up|0|||
23686153|NCT03838484|66225608|FG001|Overall Study|Lost to Follow-up|1|||
23686154|NCT03838484|66225609|FG002|Overall Study|Lost to Follow-up|0|||
23686155|NCT03838484|66225610|FG003|Overall Study|Lost to Follow-up|0|||
23686156|NCT01107444|66225611|FG000|Overall Study|Withdrawal by Subject|8|||
23686157|NCT01107444|66225612|FG001|Overall Study|Withdrawal by Subject|12|||
23686158|NCT01107444|66225611|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
23686159|NCT01107444|66225612|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
23392180|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
23686160|NCT01354132|66225613|FG000|Randomization|Physician Decision|1|||
23392181|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
23392182|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
23392183|NCT02595879|65182722|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
23392184|NCT02595879|65182723|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
23392185|NCT02168439|65182725|FG000|Overall Study|Protocol Violation|0|||
23392186|NCT02168439|65182726|FG001|Overall Study|Protocol Violation|2|||
23392187|NCT02562235|65182727|FG000|Overall Study|Adverse Event|3|||
23392188|NCT03579719|65182729|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
23392189|NCT00552279|65182730|FG000|Overall Study|Adverse Event|0|||
23392190|NCT00552279|65182731|FG001|Overall Study|Adverse Event|1|||
23392191|NCT00552279|65182730|FG000|Overall Study|Withdrawal by Subject|12|||
23392192|NCT00552279|65182731|FG001|Overall Study|Withdrawal by Subject|1|||
23392193|NCT00552279|65182730|FG000|Overall Study|Lost to Follow-up|1|||
23392194|NCT00552279|65182731|FG001|Overall Study|Lost to Follow-up|0|||
23392195|NCT00552279|65182730|FG000|Overall Study|Other|1|||
23392196|NCT00552279|65182731|FG001|Overall Study|Other|1|||
23392197|NCT03878602|65182732|FG000|Overall Study|cord blood donation|7|||
23392198|NCT03878602|65182733|FG001|Overall Study|cord blood donation|1|||
23606251|NCT03692871|65947186|FG000|Overall Study|Lost to Follow-up|24|||
23392199|NCT03878602|65182732|FG000|Overall Study|incomplete data collection|2|||
23606252|NCT03692871|65947187|FG001|Overall Study|Lost to Follow-up|9|||
23606253|NCT03692871|65947186|FG000|Overall Study|Physician Decision|22|||
23606254|NCT03692871|65947187|FG001|Overall Study|Physician Decision|7|||
23606255|NCT03692871|65947186|FG000|Overall Study|Protocol Deviation|1|||
23606256|NCT03692871|65947187|FG001|Overall Study|Protocol Deviation|0|||
23606257|NCT03692871|65947186|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
23606258|NCT03692871|65947187|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
23606259|NCT02671266|65947188|FG000|Overall Study|Withdrawal by Subject|1|||
23606260|NCT02671266|65947189|FG001|Overall Study|Withdrawal by Subject|1|||
23606261|NCT03019289|65947190|FG000|Overall Study|Adverse Event|1|||
23606262|NCT03019289|65947191|FG001|Overall Study|Adverse Event|0|||
23606263|NCT03019289|65947192|FG002|Overall Study|Adverse Event|0|||
23606264|NCT03019289|65947193|FG003|Overall Study|Adverse Event|0|||
23606265|NCT03019289|65947194|FG004|Overall Study|Adverse Event|0|||
23606266|NCT03019289|65947195|FG005|Overall Study|Adverse Event|0|||
23686161|NCT01354132|66225614|FG001|Randomization|Physician Decision|0|||
23686162|NCT01354132|66225613|FG000|Randomization|Withdrawal by Subject|0|||
23686163|NCT01354132|66225614|FG001|Randomization|Withdrawal by Subject|1|||
23686164|NCT01354132|66225613|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
23686165|NCT01354132|66225614|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
23686166|NCT01354132|66225613|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
23686167|NCT01354132|66225614|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
23686168|NCT01354132|66225613|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
23686169|NCT01354132|66225614|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
23686170|NCT00828464|66225615|FG000|Overall Study|Withdrawal by Subject|1|||
23686171|NCT03041311|66225622|FG000|Overall Study|Death|39|||
23686172|NCT03041311|66225623|FG001|Overall Study|Death|42|||
23686173|NCT03041311|66225622|FG000|Overall Study|Lost to Follow-up|0|||
23686174|NCT03041311|66225623|FG001|Overall Study|Lost to Follow-up|1|||
23686175|NCT03041311|66225622|FG000|Overall Study|Withdrawal by Subject|8|||
23686176|NCT03041311|66225623|FG001|Overall Study|Withdrawal by Subject|5|||
23686177|NCT03041311|66225622|FG000|Overall Study|Sponsor Terminated Study|2|||
23686178|NCT03041311|66225623|FG001|Overall Study|Sponsor Terminated Study|4|||
23686179|NCT03041311|66225622|FG000|Overall Study|Disease Progression|3|||
23686180|NCT03041311|66225623|FG001|Overall Study|Disease Progression|1|||
23686181|NCT03041311|66225622|FG000|Overall Study|Randomized in error, did not receive drug|2|||
23686182|NCT03041311|66225623|FG001|Overall Study|Randomized in error, did not receive drug|0|||
23686183|NCT04025632|66225624|FG000|Overall Study|Adverse Event|1|||
23686184|NCT04025632|66225625|FG001|Overall Study|Adverse Event|1|||
23686185|NCT04025632|66225624|FG000|Overall Study|Withdrawal by Subject|1|||
23686186|NCT04025632|66225625|FG001|Overall Study|Withdrawal by Subject|1|||
23686187|NCT04025632|66225624|FG000|Overall Study|Study Terminated by Sponsor|10|||
23686188|NCT04025632|66225625|FG001|Overall Study|Study Terminated by Sponsor|9|||
23686189|NCT04025632|66225624|FG000|Overall Study|Physician Decision|3|||
23686190|NCT04025632|66225625|FG001|Overall Study|Physician Decision|1|||
23686191|NCT03480802|66225626|FG000|Overall Study|Lost to Follow-up|5|||
23686192|NCT03480802|66225627|FG001|Overall Study|Lost to Follow-up|1|||
23686193|NCT03480802|66225626|FG000|Overall Study|Withdrawal by Subject|2|||
23686194|NCT03480802|66225627|FG001|Overall Study|Withdrawal by Subject|1|||
23496029|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496030|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496031|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
23496032|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496033|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
23496034|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
23496035|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
23496036|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
23496037|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
23496038|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
23496039|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
23496040|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
23496041|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
23496042|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
23496043|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
23496044|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
23496045|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
23496046|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496047|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496048|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23686195|NCT03480802|66225626|FG000|Overall Study|Relocated|0|||
23686196|NCT03480802|66225627|FG001|Overall Study|Relocated|1|||
23686197|NCT03770403|66225628|FG000|Overall Study|Adverse Event|8|||
23686198|NCT03770403|66225628|FG000|Overall Study|Death|5|||
23686199|NCT03770403|66225628|FG000|Overall Study|Physician Decision|1|||
23686200|NCT03770403|66225628|FG000|Overall Study|Sponsor decision|1|||
23686201|NCT03770403|66225628|FG000|Overall Study|Study terminated by Sponsor|1|||
23686202|NCT03770403|66225628|FG000|Overall Study|Withdrawal by Subject|13|||
23686203|NCT03770403|66225628|FG000|Overall Study|Other|88|||
23686204|NCT04041375|66225629|FG000|Intervention Phase|Withdrawal by Subject|2|||
23686205|NCT04041375|66225630|FG001|Intervention Phase|Withdrawal by Subject|2|||
23686206|NCT04041375|66225629|FG000|Follow-up Phase|Death|2|||
23686207|NCT04041375|66225630|FG001|Follow-up Phase|Death|0|||
23686208|NCT04041375|66225629|FG000|Follow-up Phase|Lost to Follow-up|2|||
23686209|NCT04041375|66225630|FG001|Follow-up Phase|Lost to Follow-up|1|||
23686210|NCT04041375|66225629|FG000|Follow-up Phase|Too ill|3|||
23686211|NCT04041375|66225630|FG001|Follow-up Phase|Too ill|0|||
23496049|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496050|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496051|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496052|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496053|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496054|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496055|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496056|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496057|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
23496058|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496059|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
23496060|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
23496061|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
23496062|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
23496063|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
23496064|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
23496065|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
23496066|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
23496067|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
23496068|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
23496069|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
23496070|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
23496071|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
23496072|NCT01622231|65558970|FG000|Overall Study|Physician Decision|1|||
23496073|NCT01622231|65558970|FG000|Overall Study|Withdrawal by Subject|1|||
23496074|NCT01980940|65558972|FG000|Overall Study|Protocol Violation|0|||
23496075|NCT01980940|65558973|FG001|Overall Study|Protocol Violation|0|||
23496076|NCT01980940|65558974|FG002|Overall Study|Protocol Violation|0|||
23496077|NCT01980940|65558975|FG003|Overall Study|Protocol Violation|0|||
23496078|NCT01980940|65558976|FG004|Overall Study|Protocol Violation|0|||
23496079|NCT01980940|65558977|FG005|Overall Study|Protocol Violation|2|||
23496080|NCT01980940|65558978|FG006|Overall Study|Protocol Violation|0|||
23496081|NCT01980940|65558979|FG007|Overall Study|Protocol Violation|0|||
23496082|NCT01719783|65558982|FG000|Dose 2|Physician Decision|1|||
23496083|NCT01719783|65558983|FG001|Dose 2|Physician Decision|0|||
23496084|NCT00385762|65558986|FG000|Overall Study|Adverse Event|1|||
23496085|NCT00385762|65558986|FG000|Overall Study|Lost to Follow-up|1|||
23496086|NCT00434954|65558988|FG000|Overall Study|Adverse Event|17|||
23496087|NCT00434954|65558989|FG001|Overall Study|Adverse Event|2|||
23496088|NCT00434954|65558988|FG000|Overall Study|Entry criteria not met|14|||
23496089|NCT00434954|65558989|FG001|Overall Study|Entry criteria not met|16|||
23496090|NCT00434954|65558988|FG000|Overall Study|Lost to Follow-up|0|||
23496091|NCT00434954|65558989|FG001|Overall Study|Lost to Follow-up|1|||
23496092|NCT00434954|65558988|FG000|Overall Study|Physician Decision|6|||
23496093|NCT00434954|65558989|FG001|Overall Study|Physician Decision|3|||
23496094|NCT00434954|65558988|FG000|Overall Study|Protocol Violation|36|||
23496095|NCT00434954|65558989|FG001|Overall Study|Protocol Violation|27|||
23496096|NCT00434954|65558988|FG000|Overall Study|Sponsor decision|1|||
23496097|NCT00434954|65558989|FG001|Overall Study|Sponsor decision|0|||
23496098|NCT00434954|65558988|FG000|Overall Study|Subject decision|8|||
23496099|NCT00434954|65558989|FG001|Overall Study|Subject decision|22|||
23496100|NCT01611155|65558995|FG000|Overall Study|Adverse Event|1|||
23496101|NCT01611155|65558996|FG001|Overall Study|Adverse Event|1|||
23496102|NCT01611155|65558995|FG000|Overall Study|Refused further treatment|6|||
23496103|NCT01611155|65558996|FG001|Overall Study|Refused further treatment|4|||
23496104|NCT01611155|65558995|FG000|Overall Study|Disease progression|1|||
23496105|NCT01611155|65558996|FG001|Overall Study|Disease progression|0|||
23496106|NCT01611155|65558995|FG000|Overall Study|Withdrawal by Subject|1|||
23496107|NCT01611155|65558996|FG001|Overall Study|Withdrawal by Subject|0|||
23496108|NCT01611155|65558995|FG000|Overall Study|Alternative treatment|0|||
23496109|NCT01611155|65558996|FG001|Overall Study|Alternative treatment|1|||
23496110|NCT01611155|65558995|FG000|Overall Study|Ineligible patient|0|||
23496111|NCT01611155|65558996|FG001|Overall Study|Ineligible patient|1|||
23496112|NCT00761631|65558999|FG000|Overall Study|Parent/legal guardian request|8|||
23496113|NCT00761631|65559000|FG001|Overall Study|Parent/legal guardian request|3|||
23496114|NCT00761631|65559001|FG002|Overall Study|Parent/legal guardian request|8|||
23496115|NCT00761631|65559002|FG003|Overall Study|Parent/legal guardian request|0|||
23496116|NCT00761631|65559003|FG004|Overall Study|Parent/legal guardian request|5|||
23496117|NCT00761631|65559004|FG005|Overall Study|Parent/legal guardian request|0|||
23496118|NCT00761631|65558999|FG000|Overall Study|Lost to Follow-up|2|||
23496119|NCT00761631|65559000|FG001|Overall Study|Lost to Follow-up|4|||
23496120|NCT00761631|65559001|FG002|Overall Study|Lost to Follow-up|7|||
23496121|NCT00761631|65559002|FG003|Overall Study|Lost to Follow-up|1|||
23496122|NCT00761631|65559003|FG004|Overall Study|Lost to Follow-up|6|||
23496123|NCT00761631|65559004|FG005|Overall Study|Lost to Follow-up|1|||
23496124|NCT00761631|65558999|FG000|Overall Study|Protocol Violation|2|||
23496125|NCT00761631|65559000|FG001|Overall Study|Protocol Violation|0|||
23496126|NCT00761631|65559001|FG002|Overall Study|Protocol Violation|0|||
23496127|NCT00761631|65559002|FG003|Overall Study|Protocol Violation|1|||
23496128|NCT00761631|65559003|FG004|Overall Study|Protocol Violation|5|||
23496129|NCT00761631|65559004|FG005|Overall Study|Protocol Violation|1|||
23496130|NCT00761631|65558999|FG000|Overall Study|Randomized, not treated|1|||
23496131|NCT00761631|65559000|FG001|Overall Study|Randomized, not treated|0|||
23496132|NCT00761631|65559001|FG002|Overall Study|Randomized, not treated|0|||
23496133|NCT00761631|65559002|FG003|Overall Study|Randomized, not treated|0|||
23496134|NCT00761631|65559003|FG004|Overall Study|Randomized, not treated|0|||
23496135|NCT00761631|65559004|FG005|Overall Study|Randomized, not treated|0|||
23496136|NCT00761631|65558999|FG000|Overall Study|Failed to return|1|||
23496137|NCT00761631|65559000|FG001|Overall Study|Failed to return|0|||
23496138|NCT00761631|65559001|FG002|Overall Study|Failed to return|1|||
23496139|NCT00761631|65559002|FG003|Overall Study|Failed to return|1|||
23496140|NCT00761631|65559003|FG004|Overall Study|Failed to return|5|||
23496141|NCT00761631|65559004|FG005|Overall Study|Failed to return|2|||
23496142|NCT00761631|65558999|FG000|Overall Study|Physician Decision|1|||
23496143|NCT00761631|65559000|FG001|Overall Study|Physician Decision|0|||
23496144|NCT00761631|65559001|FG002|Overall Study|Physician Decision|0|||
23496145|NCT00761631|65559002|FG003|Overall Study|Physician Decision|0|||
23496146|NCT00761631|65559003|FG004|Overall Study|Physician Decision|0|||
23496147|NCT00761631|65559004|FG005|Overall Study|Physician Decision|0|||
23496148|NCT00761631|65558999|FG000|Overall Study|Other|0|||
23496149|NCT00761631|65559000|FG001|Overall Study|Other|0|||
23496150|NCT00761631|65559001|FG002|Overall Study|Other|0|||
23496151|NCT00761631|65559002|FG003|Overall Study|Other|0|||
23496152|NCT00761631|65559003|FG004|Overall Study|Other|1|||
23496153|NCT00761631|65559004|FG005|Overall Study|Other|1|||
23496154|NCT05350410|65559005|FG000|Overall Study|Withdrawal by Subject|1|||
23496155|NCT01976338|65559006|FG000|Overall Study|Physician Decision|0|||
23496156|NCT01976338|65559007|FG001|Overall Study|Physician Decision|1|||
23496157|NCT01976338|65559006|FG000|Overall Study|Lost to Follow-up|3|||
23496158|NCT01976338|65559007|FG001|Overall Study|Lost to Follow-up|0|||
23496159|NCT01976338|65559006|FG000|Overall Study|Withdrawal by Subject|5|||
23496160|NCT01976338|65559007|FG001|Overall Study|Withdrawal by Subject|2|||
23496161|NCT01976338|65559006|FG000|Overall Study|Adverse Event|5|||
23496162|NCT01976338|65559007|FG001|Overall Study|Adverse Event|1|||
23496163|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
23496164|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
23496165|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
23686212|NCT02497001|66225631|FG000|Overall Study|Lost to Follow-up|10|||
23686213|NCT02497001|66225632|FG001|Overall Study|Lost to Follow-up|2|||
23686214|NCT02497001|66225633|FG002|Overall Study|Lost to Follow-up|0|||
23686215|NCT02497001|66225634|FG003|Overall Study|Lost to Follow-up|2|||
23686216|NCT02497001|66225631|FG000|Overall Study|Adverse Event|28|||
23686217|NCT02497001|66225632|FG001|Overall Study|Adverse Event|30|||
23686218|NCT02497001|66225633|FG002|Overall Study|Adverse Event|11|||
23686219|NCT02497001|66225634|FG003|Overall Study|Adverse Event|11|||
23686220|NCT02497001|66225631|FG000|Overall Study|Withdrawal by Subject|14|||
23686221|NCT02497001|66225632|FG001|Overall Study|Withdrawal by Subject|37|||
23686222|NCT02497001|66225633|FG002|Overall Study|Withdrawal by Subject|19|||
23686223|NCT02497001|66225634|FG003|Overall Study|Withdrawal by Subject|15|||
23686224|NCT02497001|66225631|FG000|Overall Study|Physician Decision|5|||
23392200|NCT03878602|65182733|FG001|Overall Study|incomplete data collection|0|||
23402833|NCT02185534|65220021|FG004|First Washout Period|Protocol Violation|0|||
23496166|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
23496167|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496168|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496169|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496170|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23686225|NCT02497001|66225632|FG001|Overall Study|Physician Decision|11|||
23686226|NCT02497001|66225633|FG002|Overall Study|Physician Decision|5|||
23686227|NCT02497001|66225634|FG003|Overall Study|Physician Decision|1|||
23686228|NCT02497001|66225631|FG000|Overall Study|subjects that were not treated|1|||
23686229|NCT02497001|66225632|FG001|Overall Study|subjects that were not treated|2|||
23686230|NCT02497001|66225633|FG002|Overall Study|subjects that were not treated|2|||
23402834|NCT02185534|65220022|FG005|First Washout Period|Protocol Violation|1|||
23402835|NCT04245709|65220023|FG000|Overall Study|Adverse Event|13|||
23402836|NCT04245709|65220023|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
23402837|NCT03782064|65220024|FG000|Overall Study|Lack of Efficacy|2|||
23402838|NCT03782064|65220024|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
23402839|NCT02927795|65220025|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
23402840|NCT02927795|65220025|FG000|Overall Study|Not Treated|4|||
23496171|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496172|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496173|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496174|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496175|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
23496176|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
23496177|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
23496178|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496179|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496180|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496181|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496182|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496183|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496184|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496185|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496186|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496187|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
23496188|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
23496189|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496190|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496191|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496192|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496193|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496194|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496195|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496196|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496197|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496198|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496199|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
23496200|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
23496201|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
23496202|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
23496203|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
23496204|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
23496205|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
23496206|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
23496207|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
23496208|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
23496209|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
23496210|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
23496211|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496212|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496213|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496214|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496215|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496216|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
23496217|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496218|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496219|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496220|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496221|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
23496222|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
23496223|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496224|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496225|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496226|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496227|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496228|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
23496229|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
23496230|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
23496231|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496232|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23392201|NCT04152200|65182736|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
23496233|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496234|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496235|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496236|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496237|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496238|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496239|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496240|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
23496241|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496242|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496243|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496244|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496245|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496246|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496247|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
23496248|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
23392202|NCT04152200|65182737|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
23392203|NCT00855335|65182738|FG000|Overall Study|Lost to Follow-up|0|||
23392204|NCT00855335|65182739|FG001|Overall Study|Lost to Follow-up|0|||
23392205|NCT00855335|65182740|FG002|Overall Study|Lost to Follow-up|3|||
23392206|NCT00855335|65182741|FG003|Overall Study|Lost to Follow-up|1|||
23392207|NCT00855335|65182742|FG004|Overall Study|Lost to Follow-up|0|||
23392208|NCT00855335|65182738|FG000|Overall Study|Withdrawal by Subject|0|||
23392209|NCT00855335|65182739|FG001|Overall Study|Withdrawal by Subject|0|||
23392210|NCT00855335|65182740|FG002|Overall Study|Withdrawal by Subject|0|||
23392211|NCT00855335|65182741|FG003|Overall Study|Withdrawal by Subject|1|||
23392212|NCT00855335|65182742|FG004|Overall Study|Withdrawal by Subject|0|||
23392213|NCT00855335|65182738|FG000|Overall Study|Adverse Event|2|||
23392214|NCT00855335|65182739|FG001|Overall Study|Adverse Event|0|||
23392215|NCT00855335|65182740|FG002|Overall Study|Adverse Event|0|||
23392216|NCT00855335|65182741|FG003|Overall Study|Adverse Event|0|||
23392217|NCT00855335|65182742|FG004|Overall Study|Adverse Event|0|||
23392218|NCT00855335|65182738|FG000|Overall Study|Physician Decision|1|||
23392219|NCT00855335|65182739|FG001|Overall Study|Physician Decision|1|||
23392220|NCT00855335|65182740|FG002|Overall Study|Physician Decision|0|||
23392221|NCT00855335|65182741|FG003|Overall Study|Physician Decision|0|||
23392222|NCT00855335|65182742|FG004|Overall Study|Physician Decision|0|||
23392223|NCT00855335|65182738|FG000|Overall Study|Other|2|||
23392224|NCT00855335|65182739|FG001|Overall Study|Other|1|||
23392225|NCT00855335|65182740|FG002|Overall Study|Other|2|||
23392226|NCT00855335|65182741|FG003|Overall Study|Other|5|||
23392227|NCT00855335|65182742|FG004|Overall Study|Other|1|||
23392228|NCT03896581|65182743|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
23392229|NCT03896581|65182744|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
23392230|NCT03896581|65182743|FG000|Overall Study|Withdrawal by Subject|4|||
23392231|NCT03896581|65182744|FG001|Overall Study|Withdrawal by Subject|1|||
23392232|NCT03896581|65182743|FG000|Overall Study|Lost to Follow-up|1|||
23392233|NCT03896581|65182744|FG001|Overall Study|Lost to Follow-up|0|||
23392234|NCT03896581|65182743|FG000|Overall Study|Lack of Efficacy|2|||
23392235|NCT03896581|65182744|FG001|Overall Study|Lack of Efficacy|1|||
23392236|NCT03896581|65182743|FG000|Overall Study|Adverse event, non-fatal|0|||
23392237|NCT03896581|65182744|FG001|Overall Study|Adverse event, non-fatal|2|||
23392238|NCT03404960|65182745|FG000|Overall Study|Adverse Event|0|||
23392239|NCT03404960|65182746|FG001|Overall Study|Adverse Event|2|||
23392240|NCT03404960|65182745|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
23392241|NCT03404960|65182746|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
23392242|NCT03404960|65182745|FG000|Overall Study|Bowel obstruction|0|||
23392243|NCT03404960|65182746|FG001|Overall Study|Bowel obstruction|1|||
23392244|NCT03404960|65182745|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
23392245|NCT03404960|65182746|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
23392246|NCT02657343|65182747|FG000|Overall Study|Death|0|||
23392247|NCT02657343|65182748|FG001|Overall Study|Death|2|||
23392248|NCT02657343|65182749|FG002|Overall Study|Death|0|||
23392249|NCT02657343|65182750|FG003|Overall Study|Death|0|||
23392250|NCT02657343|65182751|FG004|Overall Study|Death|0|||
23392251|NCT02657343|65182752|FG005|Overall Study|Death|0|||
23392252|NCT02657343|65182747|FG000|Overall Study|Patient went to hospice|1|||
23392253|NCT02657343|65182748|FG001|Overall Study|Patient went to hospice|0|||
23392254|NCT02657343|65182749|FG002|Overall Study|Patient went to hospice|0|||
23392255|NCT02657343|65182750|FG003|Overall Study|Patient went to hospice|0|||
23392256|NCT02657343|65182751|FG004|Overall Study|Patient went to hospice|0|||
23392257|NCT02657343|65182752|FG005|Overall Study|Patient went to hospice|0|||
23392258|NCT02657343|65182747|FG000|Overall Study|Withdrawal by Subject|0|||
23392259|NCT02657343|65182748|FG001|Overall Study|Withdrawal by Subject|0|||
23392260|NCT02657343|65182749|FG002|Overall Study|Withdrawal by Subject|0|||
23392261|NCT02657343|65182750|FG003|Overall Study|Withdrawal by Subject|0|||
23496249|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
23496250|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
23496251|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
23496252|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
23392262|NCT02657343|65182751|FG004|Overall Study|Withdrawal by Subject|1|||
23392263|NCT02657343|65182752|FG005|Overall Study|Withdrawal by Subject|0|||
23392264|NCT01197300|65182762|FG000|Overall Study|Lost to Follow-up|0|||
23392265|NCT01197300|65182763|FG001|Overall Study|Lost to Follow-up|1|||
23392266|NCT01197300|65182762|FG000|Overall Study|Protocol Violation|0|||
23392267|NCT01197300|65182763|FG001|Overall Study|Protocol Violation|1|||
23392268|NCT02284893|65182766|FG000|26 Week (Short Term)|Adverse Event|1|||
23392269|NCT02284893|65182767|FG001|26 Week (Short Term)|Adverse Event|9|||
23392270|NCT02284893|65182766|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
23392271|NCT02284893|65182767|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
23392272|NCT02284893|65182766|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
23392273|NCT02284893|65182767|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
23686231|NCT02497001|66225634|FG003|Overall Study|subjects that were not treated|1|||
23686232|NCT02497001|66225631|FG000|Overall Study|Major Protocol Deviation|3|||
23686233|NCT02497001|66225632|FG001|Overall Study|Major Protocol Deviation|4|||
23686234|NCT02497001|66225633|FG002|Overall Study|Major Protocol Deviation|4|||
23686235|NCT02497001|66225634|FG003|Overall Study|Major Protocol Deviation|4|||
23686236|NCT02497001|66225631|FG000|Overall Study|Lack of Efficacy|10|||
23392274|NCT02284893|65182766|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
23392275|NCT02284893|65182767|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
23392276|NCT02284893|65182766|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
23392277|NCT02284893|65182767|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
23392278|NCT02284893|65182766|FG000|26 Week (Short Term)|Other|1|||
23392279|NCT02284893|65182767|FG001|26 Week (Short Term)|Other|1|||
23392280|NCT02284893|65182766|FG000|52 Week (Long Term)|Adverse Event|3|||
23392281|NCT02284893|65182767|FG001|52 Week (Long Term)|Adverse Event|1|||
23392282|NCT02284893|65182766|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
23392283|NCT02284893|65182767|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
23392284|NCT02284893|65182766|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
23392285|NCT02284893|65182767|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
23392286|NCT02284893|65182766|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
23392287|NCT02284893|65182767|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
23392288|NCT02284893|65182766|FG000|52 Week (Long Term)|Non-Compliance|2|||
23392289|NCT02284893|65182767|FG001|52 Week (Long Term)|Non-Compliance|3|||
23392290|NCT03537508|65182768|FG000|Overall Study|Adverse Event|2|||
23392291|NCT03537508|65182769|FG001|Overall Study|Adverse Event|1|||
23392292|NCT03537508|65182768|FG000|Overall Study|Protocol Violation|65|||
23392293|NCT03537508|65182769|FG001|Overall Study|Protocol Violation|48|||
23392294|NCT03537508|65182768|FG000|Overall Study|Lost to Follow-up|86|||
23392295|NCT03537508|65182769|FG001|Overall Study|Lost to Follow-up|60|||
23392296|NCT03537508|65182768|FG000|Overall Study|Withdrawal by parent/guardian|263|||
23392297|NCT03537508|65182769|FG001|Overall Study|Withdrawal by parent/guardian|149|||
23392298|NCT02720094|65182774|FG000|Overall Study|Scheduled exit visit/end of study|2|||
23392299|NCT02720094|65182775|FG001|Overall Study|Scheduled exit visit/end of study|1|||
23392300|NCT02720094|65182774|FG000|Overall Study|Death|4|||
23392301|NCT02720094|65182775|FG001|Overall Study|Death|7|||
23392302|NCT02720094|65182774|FG000|Overall Study|Withdrawal by Subject|55|||
23392303|NCT02720094|65182775|FG001|Overall Study|Withdrawal by Subject|56|||
23392304|NCT02720094|65182774|FG000|Overall Study|Lost to Follow-up|2|||
23496253|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
23496254|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
23496255|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
23496256|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
23392305|NCT02720094|65182775|FG001|Overall Study|Lost to Follow-up|7|||
23392306|NCT02720094|65182774|FG000|Overall Study|Physician Decision|1|||
23392307|NCT02720094|65182775|FG001|Overall Study|Physician Decision|3|||
23392308|NCT02720094|65182774|FG000|Overall Study|Inappropriate enrollment|1|||
23392309|NCT02720094|65182775|FG001|Overall Study|Inappropriate enrollment|3|||
23392310|NCT02720094|65182774|FG000|Overall Study|Ongoing|2210|||
23392311|NCT02720094|65182775|FG001|Overall Study|Ongoing|2203|||
23392312|NCT02720094|65182774|FG000|Overall Study|Relocation|1|||
23392313|NCT02720094|65182775|FG001|Overall Study|Relocation|1|||
23392314|NCT02302222|65182776|FG000|Overall Study|Physician Decision|0|||
23392315|NCT02302222|65182777|FG001|Overall Study|Physician Decision|4|||
23496257|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
23496258|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
23496259|NCT03519178|65559026|FG000|PF-06873600 Treatment|Adverse Event|0|||
23496260|NCT03519178|65559027|FG001|PF-06873600 Treatment|Adverse Event|0|||
23496261|NCT03519178|65559028|FG002|PF-06873600 Treatment|Adverse Event|0|||
23496262|NCT03519178|65559029|FG003|PF-06873600 Treatment|Adverse Event|0|||
23496263|NCT03519178|65559030|FG004|PF-06873600 Treatment|Adverse Event|0|||
23686237|NCT02497001|66225632|FG001|Overall Study|Lack of Efficacy|16|||
23392316|NCT02302222|65182776|FG000|Overall Study|Lost to Follow-up|1|||
23392317|NCT02302222|65182777|FG001|Overall Study|Lost to Follow-up|0|||
23392318|NCT02302222|65182776|FG000|Overall Study|Treatment discontinued before day 5|0|||
23686238|NCT02497001|66225633|FG002|Overall Study|Lack of Efficacy|6|||
23392319|NCT02302222|65182777|FG001|Overall Study|Treatment discontinued before day 5|1|||
23496264|NCT03519178|65559031|FG005|PF-06873600 Treatment|Adverse Event|0|||
23392320|NCT02302222|65182776|FG000|Overall Study|Withdrawn prior to any treatment|0|||
23392321|NCT02302222|65182777|FG001|Overall Study|Withdrawn prior to any treatment|1|||
23392322|NCT04909801|65182778|FG000|Overall Study|Lack of Efficacy|2|||
23496265|NCT03519178|65559032|FG006|PF-06873600 Treatment|Adverse Event|0|||
23496266|NCT03519178|65559033|FG007|PF-06873600 Treatment|Adverse Event|2|||
23496267|NCT03519178|65559034|FG008|PF-06873600 Treatment|Adverse Event|1|||
23496268|NCT03519178|65559035|FG009|PF-06873600 Treatment|Adverse Event|0|||
23496269|NCT03519178|65559036|FG010|PF-06873600 Treatment|Adverse Event|0|||
23496270|NCT03519178|65559037|FG011|PF-06873600 Treatment|Adverse Event|0|||
23496271|NCT03519178|65559038|FG012|PF-06873600 Treatment|Adverse Event|1|||
23496272|NCT03519178|65559039|FG013|PF-06873600 Treatment|Adverse Event|3|||
23496273|NCT03519178|65559040|FG014|PF-06873600 Treatment|Adverse Event|2|||
23496274|NCT03519178|65559026|FG000|PF-06873600 Treatment|Death|0|||
23496275|NCT03519178|65559027|FG001|PF-06873600 Treatment|Death|0|||
23496276|NCT03519178|65559028|FG002|PF-06873600 Treatment|Death|0|||
23496277|NCT03519178|65559029|FG003|PF-06873600 Treatment|Death|0|||
23496278|NCT03519178|65559030|FG004|PF-06873600 Treatment|Death|0|||
23496279|NCT03519178|65559031|FG005|PF-06873600 Treatment|Death|0|||
23496280|NCT03519178|65559032|FG006|PF-06873600 Treatment|Death|0|||
23496281|NCT03519178|65559033|FG007|PF-06873600 Treatment|Death|0|||
23496282|NCT03519178|65559034|FG008|PF-06873600 Treatment|Death|1|||
23496283|NCT03519178|65559035|FG009|PF-06873600 Treatment|Death|1|||
23496284|NCT03519178|65559036|FG010|PF-06873600 Treatment|Death|0|||
23496285|NCT03519178|65559037|FG011|PF-06873600 Treatment|Death|0|||
23496286|NCT03519178|65559038|FG012|PF-06873600 Treatment|Death|0|||
23496287|NCT03519178|65559039|FG013|PF-06873600 Treatment|Death|0|||
23496288|NCT03519178|65559040|FG014|PF-06873600 Treatment|Death|1|||
23496289|NCT03519178|65559026|FG000|PF-06873600 Treatment|Physician Decision|0|||
23496290|NCT03519178|65559027|FG001|PF-06873600 Treatment|Physician Decision|0|||
23496291|NCT03519178|65559028|FG002|PF-06873600 Treatment|Physician Decision|0|||
23496292|NCT03519178|65559029|FG003|PF-06873600 Treatment|Physician Decision|0|||
23496293|NCT03519178|65559030|FG004|PF-06873600 Treatment|Physician Decision|0|||
23496294|NCT03519178|65559031|FG005|PF-06873600 Treatment|Physician Decision|0|||
23496295|NCT03519178|65559032|FG006|PF-06873600 Treatment|Physician Decision|0|||
23496296|NCT03519178|65559033|FG007|PF-06873600 Treatment|Physician Decision|1|||
23496297|NCT03519178|65559034|FG008|PF-06873600 Treatment|Physician Decision|0|||
23496298|NCT03519178|65559035|FG009|PF-06873600 Treatment|Physician Decision|0|||
23496299|NCT03519178|65559036|FG010|PF-06873600 Treatment|Physician Decision|1|||
23496300|NCT03519178|65559037|FG011|PF-06873600 Treatment|Physician Decision|0|||
23496301|NCT03519178|65559038|FG012|PF-06873600 Treatment|Physician Decision|0|||
23496302|NCT03519178|65559039|FG013|PF-06873600 Treatment|Physician Decision|4|||
23496303|NCT03519178|65559040|FG014|PF-06873600 Treatment|Physician Decision|1|||
23496304|NCT03519178|65559026|FG000|PF-06873600 Treatment|Progressive disease|1|||
23496305|NCT03519178|65559027|FG001|PF-06873600 Treatment|Progressive disease|1|||
23496306|NCT03519178|65559028|FG002|PF-06873600 Treatment|Progressive disease|1|||
23496307|NCT03519178|65559029|FG003|PF-06873600 Treatment|Progressive disease|1|||
23496308|NCT03519178|65559030|FG004|PF-06873600 Treatment|Progressive disease|6|||
23496309|NCT03519178|65559031|FG005|PF-06873600 Treatment|Progressive disease|7|||
23496310|NCT03519178|65559032|FG006|PF-06873600 Treatment|Progressive disease|3|||
23496311|NCT03519178|65559033|FG007|PF-06873600 Treatment|Progressive disease|7|||
23496312|NCT03519178|65559034|FG008|PF-06873600 Treatment|Progressive disease|3|||
23496313|NCT03519178|65559035|FG009|PF-06873600 Treatment|Progressive disease|5|||
23496314|NCT03519178|65559036|FG010|PF-06873600 Treatment|Progressive disease|4|||
23496315|NCT03519178|65559037|FG011|PF-06873600 Treatment|Progressive disease|3|||
23496316|NCT03519178|65559038|FG012|PF-06873600 Treatment|Progressive disease|4|||
23496317|NCT03519178|65559039|FG013|PF-06873600 Treatment|Progressive disease|28|||
23496318|NCT03519178|65559040|FG014|PF-06873600 Treatment|Progressive disease|7|||
23496319|NCT03519178|65559026|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496320|NCT03519178|65559027|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496321|NCT03519178|65559028|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496322|NCT03519178|65559029|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496323|NCT03519178|65559030|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496324|NCT03519178|65559031|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496325|NCT03519178|65559032|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496326|NCT03519178|65559033|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496327|NCT03519178|65559034|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
23686239|NCT02497001|66225634|FG003|Overall Study|Lack of Efficacy|6|||
23496328|NCT03519178|65559035|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496329|NCT03519178|65559036|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496330|NCT03519178|65559037|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496331|NCT03519178|65559038|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496332|NCT03519178|65559039|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496333|NCT03519178|65559040|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496334|NCT03519178|65559026|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
23496335|NCT03519178|65559027|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
23496336|NCT03519178|65559028|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
23606267|NCT03019289|65947196|FG006|Overall Study|Adverse Event|0|||
23686240|NCT02497001|66225631|FG000|Overall Study|Protocol Violation|3|||
23496337|NCT03519178|65559029|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
23496338|NCT03519178|65559030|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
23496339|NCT03519178|65559031|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
23496340|NCT03519178|65559032|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
23496341|NCT03519178|65559033|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
23496342|NCT03519178|65559034|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
23496343|NCT03519178|65559035|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
23496344|NCT03519178|65559036|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
23496345|NCT03519178|65559037|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
23496346|NCT03519178|65559038|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
23496347|NCT03519178|65559039|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
23496348|NCT03519178|65559040|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
23496349|NCT03519178|65559026|FG000|PF-06873600 Treatment|Refused further treatment|0|||
23496350|NCT03519178|65559027|FG001|PF-06873600 Treatment|Refused further treatment|1|||
23496351|NCT03519178|65559028|FG002|PF-06873600 Treatment|Refused further treatment|0|||
23496352|NCT03519178|65559029|FG003|PF-06873600 Treatment|Refused further treatment|0|||
23496353|NCT03519178|65559030|FG004|PF-06873600 Treatment|Refused further treatment|1|||
23496354|NCT03519178|65559031|FG005|PF-06873600 Treatment|Refused further treatment|0|||
23496355|NCT03519178|65559032|FG006|PF-06873600 Treatment|Refused further treatment|0|||
23496356|NCT03519178|65559033|FG007|PF-06873600 Treatment|Refused further treatment|0|||
23496357|NCT03519178|65559034|FG008|PF-06873600 Treatment|Refused further treatment|0|||
23496358|NCT03519178|65559035|FG009|PF-06873600 Treatment|Refused further treatment|0|||
23496359|NCT03519178|65559036|FG010|PF-06873600 Treatment|Refused further treatment|0|||
23496360|NCT03519178|65559037|FG011|PF-06873600 Treatment|Refused further treatment|0|||
23496361|NCT03519178|65559038|FG012|PF-06873600 Treatment|Refused further treatment|0|||
23496362|NCT03519178|65559039|FG013|PF-06873600 Treatment|Refused further treatment|0|||
23496363|NCT03519178|65559040|FG014|PF-06873600 Treatment|Refused further treatment|1|||
23496364|NCT03519178|65559026|FG000|PF-06873600 Treatment|Other|0|||
23496365|NCT03519178|65559027|FG001|PF-06873600 Treatment|Other|0|||
23496366|NCT03519178|65559028|FG002|PF-06873600 Treatment|Other|0|||
23496367|NCT03519178|65559029|FG003|PF-06873600 Treatment|Other|0|||
23496368|NCT03519178|65559030|FG004|PF-06873600 Treatment|Other|0|||
23496369|NCT03519178|65559031|FG005|PF-06873600 Treatment|Other|0|||
23496370|NCT03519178|65559032|FG006|PF-06873600 Treatment|Other|0|||
23496371|NCT03519178|65559033|FG007|PF-06873600 Treatment|Other|0|||
23496372|NCT03519178|65559034|FG008|PF-06873600 Treatment|Other|1|||
23496373|NCT03519178|65559035|FG009|PF-06873600 Treatment|Other|0|||
23496374|NCT03519178|65559036|FG010|PF-06873600 Treatment|Other|0|||
23496375|NCT03519178|65559037|FG011|PF-06873600 Treatment|Other|0|||
23496376|NCT03519178|65559038|FG012|PF-06873600 Treatment|Other|0|||
23496377|NCT03519178|65559039|FG013|PF-06873600 Treatment|Other|1|||
23496378|NCT03519178|65559040|FG014|PF-06873600 Treatment|Other|3|||
23496379|NCT03519178|65559026|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
23496380|NCT03519178|65559027|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
23496381|NCT03519178|65559028|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
23496382|NCT03519178|65559029|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
23496383|NCT03519178|65559030|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
23496384|NCT03519178|65559031|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
23496385|NCT03519178|65559032|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
23496386|NCT03519178|65559033|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
23496387|NCT03519178|65559034|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
23496388|NCT03519178|65559035|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
23496389|NCT03519178|65559036|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
23686241|NCT02497001|66225632|FG001|Overall Study|Protocol Violation|1|||
23392323|NCT04909801|65182779|FG001|Overall Study|Lack of Efficacy|1|||
23392324|NCT04909801|65182778|FG000|Overall Study|Adverse Event|1|||
23392325|NCT04909801|65182779|FG001|Overall Study|Adverse Event|2|||
23392326|NCT04909801|65182778|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23392327|NCT04909801|65182779|FG001|Overall Study|Participant request to discontinue study treatment|2|||
23392328|NCT04909801|65182778|FG000|Overall Study|Withdrawal by Subject|2|||
23392329|NCT04909801|65182779|FG001|Overall Study|Withdrawal by Subject|1|||
23392330|NCT04909801|65182778|FG000|Overall Study|other reasons|1|||
23496390|NCT03519178|65559037|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
23496391|NCT03519178|65559038|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
23496392|NCT03519178|65559039|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
23496393|NCT03519178|65559040|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
23496394|NCT03519178|65559026|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496395|NCT03519178|65559027|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496396|NCT03519178|65559028|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496397|NCT03519178|65559029|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
23392331|NCT04909801|65182779|FG001|Overall Study|other reasons|1|||
23496398|NCT03519178|65559030|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496399|NCT03519178|65559031|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496400|NCT03519178|65559032|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496401|NCT03519178|65559033|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496402|NCT03519178|65559034|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496403|NCT03519178|65559035|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496404|NCT03519178|65559036|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
23392332|NCT04918771|65182781|FG000|Overall Study|Withdrawal by Subject|4|||
23392333|NCT04918771|65182782|FG001|Overall Study|Withdrawal by Subject|5|||
23392334|NCT04918771|65182781|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
23392335|NCT04918771|65182782|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
23392336|NCT04893811|65182783|FG000|Vaccination Phase|Death|1|||
23392337|NCT04893811|65182784|FG001|Vaccination Phase|Death|0|||
23392338|NCT04893811|65182783|FG000|Vaccination Phase|Lost to Follow-up|1|||
23392339|NCT04893811|65182784|FG001|Vaccination Phase|Lost to Follow-up|1|||
23392340|NCT04893811|65182783|FG000|Vaccination Phase|Protocol Violation|2|||
23392341|NCT04893811|65182784|FG001|Vaccination Phase|Protocol Violation|0|||
23392342|NCT04893811|65182783|FG000|Vaccination Phase|Withdrawal by Subject|2|||
23392343|NCT04893811|65182784|FG001|Vaccination Phase|Withdrawal by Subject|1|||
23392344|NCT04893811|65182783|FG000|Vaccination Phase|Other|0|||
23392345|NCT04893811|65182784|FG001|Vaccination Phase|Other|1|||
23392346|NCT04893811|65182783|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
23392347|NCT04893811|65182784|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
23392348|NCT04893811|65182783|FG000|Follow-up Phase|Lost to Follow-up|0|||
23392349|NCT04893811|65182784|FG001|Follow-up Phase|Lost to Follow-up|1|||
23392350|NCT03374254|65182785|FG000|Overall Study|Death|5|||
23392351|NCT03374254|65182786|FG001|Overall Study|Death|16|||
23392352|NCT03374254|65182787|FG002|Overall Study|Death|13|||
23392353|NCT03374254|65182788|FG003|Overall Study|Death|11|||
23392354|NCT03374254|65182789|FG004|Overall Study|Death|9|||
23392355|NCT03374254|65182790|FG005|Overall Study|Death|12|||
23392356|NCT03374254|65182791|FG006|Overall Study|Death|11|||
23392357|NCT03374254|65182792|FG007|Overall Study|Death|6|||
23392358|NCT03374254|65182793|FG008|Overall Study|Death|7|||
23392359|NCT03374254|65182785|FG000|Overall Study|Lost to Follow-up|0|||
23392360|NCT03374254|65182786|FG001|Overall Study|Lost to Follow-up|0|||
23392361|NCT03374254|65182787|FG002|Overall Study|Lost to Follow-up|0|||
23392362|NCT03374254|65182788|FG003|Overall Study|Lost to Follow-up|0|||
23392363|NCT03374254|65182789|FG004|Overall Study|Lost to Follow-up|0|||
23392364|NCT03374254|65182790|FG005|Overall Study|Lost to Follow-up|0|||
23392365|NCT03374254|65182791|FG006|Overall Study|Lost to Follow-up|2|||
23392366|NCT03374254|65182792|FG007|Overall Study|Lost to Follow-up|0|||
23392367|NCT03374254|65182793|FG008|Overall Study|Lost to Follow-up|0|||
23392368|NCT03374254|65182785|FG000|Overall Study|Sponsor Decision|1|||
23392369|NCT03374254|65182786|FG001|Overall Study|Sponsor Decision|0|||
23392370|NCT03374254|65182787|FG002|Overall Study|Sponsor Decision|2|||
23392371|NCT03374254|65182788|FG003|Overall Study|Sponsor Decision|3|||
23496405|NCT03519178|65559037|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496406|NCT03519178|65559038|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496407|NCT03519178|65559039|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
23496408|NCT03519178|65559040|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
23496409|NCT03519178|65559026|FG000|PF-06873600 Treatment|Ongoing|0|||
23496410|NCT03519178|65559027|FG001|PF-06873600 Treatment|Ongoing|0|||
23496411|NCT03519178|65559028|FG002|PF-06873600 Treatment|Ongoing|0|||
23392372|NCT03374254|65182789|FG004|Overall Study|Sponsor Decision|2|||
23392373|NCT03374254|65182790|FG005|Overall Study|Sponsor Decision|3|||
23392374|NCT03374254|65182791|FG006|Overall Study|Sponsor Decision|3|||
23392375|NCT03374254|65182792|FG007|Overall Study|Sponsor Decision|3|||
23392376|NCT03374254|65182793|FG008|Overall Study|Sponsor Decision|4|||
23392377|NCT03374254|65182785|FG000|Overall Study|Withdrawal by Subject|0|||
23392378|NCT03374254|65182786|FG001|Overall Study|Withdrawal by Subject|0|||
23392379|NCT03374254|65182787|FG002|Overall Study|Withdrawal by Subject|0|||
23392380|NCT03374254|65182788|FG003|Overall Study|Withdrawal by Subject|2|||
23392381|NCT03374254|65182789|FG004|Overall Study|Withdrawal by Subject|0|||
23392382|NCT03374254|65182790|FG005|Overall Study|Withdrawal by Subject|1|||
23392383|NCT03374254|65182791|FG006|Overall Study|Withdrawal by Subject|0|||
23392384|NCT03374254|65182792|FG007|Overall Study|Withdrawal by Subject|0|||
23392385|NCT03374254|65182793|FG008|Overall Study|Withdrawal by Subject|0|||
23392386|NCT05852340|65182795|FG000|Period 5|Not completing the meal|0|||
23392387|NCT05852340|65182796|FG001|Period 5|Not completing the meal|1|||
23392388|NCT05852340|65182797|FG002|Period 5|Not completing the meal|0|||
23392389|NCT05852340|65182798|FG003|Period 5|Not completing the meal|0|||
23392390|NCT05852340|65182795|FG000|Period 5|Adverse Event|0|||
23392391|NCT05852340|65182796|FG001|Period 5|Adverse Event|0|||
23496412|NCT03519178|65559029|FG003|PF-06873600 Treatment|Ongoing|0|||
23392392|NCT05852340|65182797|FG002|Period 5|Adverse Event|0|||
23392393|NCT05852340|65182798|FG003|Period 5|Adverse Event|1|||
23392394|NCT00605189|65182799|FG000|Overall Study|Adverse Event|1|||
23392395|NCT00605189|65182800|FG001|Overall Study|Adverse Event|0|||
23392396|NCT00605189|65182801|FG002|Overall Study|Adverse Event|0|||
23392397|NCT00605189|65182799|FG000|Overall Study|Other|2|||
23392398|NCT00605189|65182800|FG001|Overall Study|Other|2|||
23392399|NCT00605189|65182801|FG002|Overall Study|Other|0|||
23392400|NCT01698905|65182802|FG000|Overall Study|Adverse Event|4|||
23392401|NCT01698905|65182802|FG000|Overall Study|Physician Decision|2|||
23392402|NCT01698905|65182802|FG000|Overall Study|Pregnancy|1|||
23392403|NCT01698905|65182802|FG000|Overall Study|Protocol Violation|1|||
23392404|NCT01698905|65182802|FG000|Overall Study|Subject/guardian decision|2|||
23392405|NCT01698905|65182802|FG000|Overall Study|Death|1|||
23392406|NCT04770285|65184678|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
23392407|NCT04770285|65184679|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
23392408|NCT04770285|65184678|FG000|Overall Study|Lack of Efficacy|0|||
23392409|NCT04770285|65184679|FG001|Overall Study|Lack of Efficacy|1|||
23392410|NCT04770285|65184678|FG000|Overall Study|Lost to Follow-up|11|||
23392411|NCT04770285|65184679|FG001|Overall Study|Lost to Follow-up|8|||
23392412|NCT04770285|65184678|FG000|Overall Study|Protocol Deviation|6|||
23392413|NCT04770285|65184679|FG001|Overall Study|Protocol Deviation|6|||
23392414|NCT04770285|65184678|FG000|Overall Study|Technical Problem|0|||
23392415|NCT04770285|65184679|FG001|Overall Study|Technical Problem|1|||
23392416|NCT04770285|65184678|FG000|Overall Study|Withdrawal by Subject|9|||
23392417|NCT04770285|65184679|FG001|Overall Study|Withdrawal by Subject|8|||
23392418|NCT04770285|65184678|FG000|Overall Study|Reason Not Specified|0|||
23392419|NCT04770285|65184679|FG001|Overall Study|Reason Not Specified|1|||
23392420|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Adverse Event|5|||
23392421|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Adverse Event|0|||
23392422|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
23392423|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
23392424|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
23392425|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
23392426|NCT02960893|65184682|FG000|Extension Phase (48-week)|Adverse Event|2|||
23392427|NCT02960893|65184683|FG001|Extension Phase (48-week)|Adverse Event|3|||
23392428|NCT02960893|65184682|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
23392429|NCT02960893|65184683|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
23392430|NCT02960893|65184682|FG000|Extension Phase (48-week)|Other Reason|2|||
23392431|NCT02960893|65184683|FG001|Extension Phase (48-week)|Other Reason|1|||
23392432|NCT02960893|65184682|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
23392433|NCT02960893|65184683|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
23392434|NCT02960893|65184682|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
23392435|NCT02960893|65184683|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
23392436|NCT05130281|65184688|FG000|Overall Study|Withdrawal by Subject|0|||
23392437|NCT05130281|65184689|FG001|Overall Study|Withdrawal by Subject|0|||
23392438|NCT05130281|65184690|FG002|Overall Study|Withdrawal by Subject|1|||
23392439|NCT04487080|65184691|FG000|Overall Study|Withdrawal by Subject|19|||
23392440|NCT04487080|65184692|FG001|Overall Study|Withdrawal by Subject|18|||
23392441|NCT04487080|65184693|FG002|Overall Study|Withdrawal by Subject|13|||
23392442|NCT04487080|65184691|FG000|Overall Study|Lost to Follow-up|3|||
23392443|NCT04487080|65184692|FG001|Overall Study|Lost to Follow-up|1|||
23392444|NCT04487080|65184693|FG002|Overall Study|Lost to Follow-up|0|||
23392445|NCT04487080|65184691|FG000|Overall Study|Ongoing|313|||
23392446|NCT04487080|65184692|FG001|Overall Study|Ongoing|297|||
23392447|NCT04487080|65184693|FG002|Overall Study|Ongoing|149|||
23392448|NCT03738228|65184694|FG000|Overall Study|Never received study treatment|2|||
23392449|NCT03738228|65184695|FG001|Overall Study|Never received study treatment|2|||
23392450|NCT02592863|65184698|FG000|Overall Study|Withdrawal by Subject|2|||
23392451|NCT02592863|65184699|FG001|Overall Study|Withdrawal by Subject|2|||
23392452|NCT02592863|65184698|FG000|Overall Study|Lost to Follow-up|1|||
23392453|NCT02592863|65184699|FG001|Overall Study|Lost to Follow-up|1|||
23392454|NCT02097225|65184700|FG000|Dose Level 4|Adverse Event|0|||
23392455|NCT02097225|65184701|FG001|Dose Level 4|Adverse Event|0|||
23392456|NCT02097225|65184702|FG002|Dose Level 4|Adverse Event|0|||
23392457|NCT02097225|65184703|FG003|Dose Level 4|Adverse Event|0|||
23392458|NCT02097225|65184704|FG004|Dose Level 4|Adverse Event|1|||
23392459|NCT05602727|65184705|FG000|Overall Study|Physician Decision|0|||
23496413|NCT03519178|65559030|FG004|PF-06873600 Treatment|Ongoing|0|||
23392460|NCT05602727|65184706|FG001|Overall Study|Physician Decision|1|||
23392461|NCT05602727|65184707|FG002|Overall Study|Physician Decision|0|||
23392462|NCT05602727|65184705|FG000|Overall Study|Randomized by mistake without study medication|1|||
23392463|NCT05602727|65184706|FG001|Overall Study|Randomized by mistake without study medication|0|||
23392464|NCT05602727|65184707|FG002|Overall Study|Randomized by mistake without study medication|0|||
23392465|NCT05602727|65184705|FG000|Overall Study|Study termination by Sponsor|18|||
23392466|NCT05602727|65184706|FG001|Overall Study|Study termination by Sponsor|15|||
23392467|NCT05602727|65184707|FG002|Overall Study|Study termination by Sponsor|19|||
23392468|NCT05602727|65184705|FG000|Overall Study|Withdrawal by Subject|2|||
23392469|NCT05602727|65184706|FG001|Overall Study|Withdrawal by Subject|1|||
23392470|NCT05602727|65184707|FG002|Overall Study|Withdrawal by Subject|1|||
23392471|NCT05602727|65184705|FG000|Overall Study|Various reasons|1|||
23392472|NCT05602727|65184706|FG001|Overall Study|Various reasons|6|||
23392473|NCT05602727|65184707|FG002|Overall Study|Various reasons|1|||
23686242|NCT02497001|66225633|FG002|Overall Study|Protocol Violation|3|||
23686243|NCT02497001|66225634|FG003|Overall Study|Protocol Violation|1|||
23686244|NCT00880750|66225636|FG000|First Intervention|Adverse Event|1|||
23686245|NCT00880750|66225637|FG001|First Intervention|Adverse Event|0|||
23392478|NCT05837481|65184710|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
23392479|NCT05837481|65184711|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
23392480|NCT03228537|65184712|FG000|Neoadjuvant|Adverse Event|2|||
23392481|NCT03228537|65184712|FG000|Neoadjuvant|Progression/Relapse|4|||
23392482|NCT03228537|65184712|FG000|Neoadjuvant|Death|1|||
23392483|NCT03228537|65184712|FG000|Surgery|Death|1|||
23392484|NCT03228537|65184712|FG000|Surgery|Other - Not Protocol Specified|2|||
23392485|NCT03228537|65184712|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
23392486|NCT03228537|65184712|FG000|Maintenance|Progression/Relapse|10|||
23392487|NCT04134936|65184716|FG000|Overall Study|Adverse Event|3|||
23392488|NCT04134936|65184717|FG001|Overall Study|Adverse Event|2|||
23392489|NCT04134936|65184716|FG000|Overall Study|Withdrawal by Subject|2|||
23392490|NCT04134936|65184717|FG001|Overall Study|Withdrawal by Subject|3|||
23686246|NCT00880750|66225636|FG000|First Intervention|Unable to collect urine|4|||
23686247|NCT00880750|66225637|FG001|First Intervention|Unable to collect urine|0|||
23686248|NCT00880750|66225636|FG000|First Intervention|Non-compliance with meals|0|||
23392491|NCT04134936|65184716|FG000|Overall Study|Physician Decision|0|||
23392492|NCT04134936|65184717|FG001|Overall Study|Physician Decision|1|||
23392493|NCT04134936|65184716|FG000|Overall Study|Progressive disease, joined another trial|1|||
23392494|NCT04134936|65184717|FG001|Overall Study|Progressive disease, joined another trial|0|||
23392495|NCT04134936|65184716|FG000|Overall Study|Progressive disease|1|||
23392496|NCT04134936|65184717|FG001|Overall Study|Progressive disease|0|||
23392497|NCT01065454|65184718|FG000|Treatment|Adverse Event|7|||
23392498|NCT01065454|65184719|FG001|Treatment|Adverse Event|4|||
23392499|NCT01065454|65184720|FG002|Treatment|Adverse Event|3|||
23392500|NCT01065454|65184721|FG003|Treatment|Adverse Event|6|||
23392501|NCT01065454|65184718|FG000|Treatment|Death|1|||
23392502|NCT01065454|65184719|FG001|Treatment|Death|0|||
23392503|NCT01065454|65184720|FG002|Treatment|Death|0|||
23392504|NCT01065454|65184721|FG003|Treatment|Death|0|||
23392505|NCT01065454|65184718|FG000|Treatment|Non-compliance|1|||
23392506|NCT01065454|65184719|FG001|Treatment|Non-compliance|0|||
23392507|NCT01065454|65184720|FG002|Treatment|Non-compliance|0|||
23392508|NCT01065454|65184721|FG003|Treatment|Non-compliance|1|||
23392509|NCT01065454|65184718|FG000|Treatment|Protocol Decision|0|||
23392510|NCT01065454|65184719|FG001|Treatment|Protocol Decision|0|||
23392511|NCT01065454|65184720|FG002|Treatment|Protocol Decision|3|||
23392512|NCT01065454|65184721|FG003|Treatment|Protocol Decision|2|||
23392513|NCT01065454|65184718|FG000|Treatment|Protocol Violation|1|||
23392514|NCT01065454|65184719|FG001|Treatment|Protocol Violation|0|||
23392515|NCT01065454|65184720|FG002|Treatment|Protocol Violation|1|||
23392516|NCT01065454|65184721|FG003|Treatment|Protocol Violation|0|||
23392517|NCT01065454|65184718|FG000|Treatment|Withdrawal by Subject|3|||
23392518|NCT01065454|65184719|FG001|Treatment|Withdrawal by Subject|1|||
23392519|NCT01065454|65184720|FG002|Treatment|Withdrawal by Subject|2|||
23392520|NCT01065454|65184721|FG003|Treatment|Withdrawal by Subject|3|||
23392521|NCT01065454|65184718|FG000|Follow up|Adverse Event|1|||
23392522|NCT01065454|65184719|FG001|Follow up|Adverse Event|0|||
23392523|NCT01065454|65184720|FG002|Follow up|Adverse Event|0|||
23392524|NCT01065454|65184721|FG003|Follow up|Adverse Event|1|||
23392525|NCT01065454|65184718|FG000|Follow up|Death|0|||
23392526|NCT01065454|65184719|FG001|Follow up|Death|1|||
23392527|NCT01065454|65184720|FG002|Follow up|Death|1|||
23392528|NCT01065454|65184721|FG003|Follow up|Death|0|||
23392529|NCT01065454|65184718|FG000|Follow up|Lost to Follow-up|0|||
23392530|NCT01065454|65184719|FG001|Follow up|Lost to Follow-up|0|||
23392531|NCT01065454|65184720|FG002|Follow up|Lost to Follow-up|0|||
23392532|NCT01065454|65184721|FG003|Follow up|Lost to Follow-up|1|||
23392533|NCT01065454|65184718|FG000|Follow up|Progressive disease|0|||
23392534|NCT01065454|65184719|FG001|Follow up|Progressive disease|0|||
23392535|NCT01065454|65184720|FG002|Follow up|Progressive disease|0|||
23392536|NCT01065454|65184721|FG003|Follow up|Progressive disease|1|||
23392537|NCT01065454|65184718|FG000|Follow up|Withdrawal by Subject|1|||
23392538|NCT01065454|65184719|FG001|Follow up|Withdrawal by Subject|1|||
23392539|NCT01065454|65184720|FG002|Follow up|Withdrawal by Subject|1|||
23496414|NCT03519178|65559031|FG005|PF-06873600 Treatment|Ongoing|0|||
23392540|NCT01065454|65184721|FG003|Follow up|Withdrawal by Subject|0|||
23392541|NCT01065454|65184718|FG000|Follow up|study ongoing|37|||
23392542|NCT01065454|65184719|FG001|Follow up|study ongoing|22|||
23392543|NCT01065454|65184720|FG002|Follow up|study ongoing|15|||
23496415|NCT03519178|65559032|FG006|PF-06873600 Treatment|Ongoing|0|||
23496416|NCT03519178|65559033|FG007|PF-06873600 Treatment|Ongoing|0|||
23496417|NCT03519178|65559034|FG008|PF-06873600 Treatment|Ongoing|0|||
23496418|NCT03519178|65559035|FG009|PF-06873600 Treatment|Ongoing|0|||
23496419|NCT03519178|65559036|FG010|PF-06873600 Treatment|Ongoing|0|||
23392544|NCT01065454|65184721|FG003|Follow up|study ongoing|41|||
23392545|NCT04116489|65184722|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
23392546|NCT04116489|65184722|FG000|Overall Study|Withdrawal by Subject|1|||
23392547|NCT04197583|65184724|FG000|Overall Study|Study Stent Replacement|34|||
23392548|NCT04197583|65184725|FG001|Overall Study|Study Stent Replacement|8|||
23392549|NCT04197583|65184724|FG000|Overall Study|Lost to Follow-up|14|||
23392550|NCT04197583|65184725|FG001|Overall Study|Lost to Follow-up|3|||
23392551|NCT04197583|65184724|FG000|Overall Study|Death|3|||
23392552|NCT04197583|65184725|FG001|Overall Study|Death|0|||
23392553|NCT04197583|65184724|FG000|Overall Study|Physician Decision|1|||
23392554|NCT04197583|65184725|FG001|Overall Study|Physician Decision|0|||
23392555|NCT04197583|65184724|FG000|Overall Study|Withdrawal by Subject|1|||
23392556|NCT04197583|65184725|FG001|Overall Study|Withdrawal by Subject|1|||
23392557|NCT04197583|65184724|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
23392558|NCT04197583|65184725|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
23392559|NCT04197583|65184724|FG000|Overall Study|Screen Failure|0|||
23392560|NCT04197583|65184725|FG001|Overall Study|Screen Failure|20|||
23392561|NCT01587196|65184726|FG000|Overall Study|Lost to Follow-up|50|||
23392562|NCT01587196|65184726|FG000|Overall Study|Withdrawal by Subject|4|||
23392563|NCT01380080|65184729|FG000|Overall Study|Death|36|||
23392564|NCT01380080|65184730|FG001|Overall Study|Death|44|||
23392565|NCT01380080|65184729|FG000|Overall Study|Site is closing|28|||
23392566|NCT01380080|65184730|FG001|Overall Study|Site is closing|31|||
23392567|NCT01380080|65184729|FG000|Overall Study|Not able to get to clinic|7|||
23392568|NCT01380080|65184730|FG001|Overall Study|Not able to get to clinic|1|||
23392569|NCT01380080|65184729|FG000|Overall Study|Not willing to adhere to requirements|6|||
23392570|NCT01380080|65184730|FG001|Overall Study|Not willing to adhere to requirements|2|||
23392571|NCT01380080|65184729|FG000|Overall Study|Withdrawal by Subject|5|||
23392572|NCT01380080|65184730|FG001|Overall Study|Withdrawal by Subject|2|||
23686249|NCT00880750|66225637|FG001|First Intervention|Non-compliance with meals|1|||
23686250|NCT00880750|66225636|FG000|First Intervention|Withdrawal by Subject|2|||
23496420|NCT03519178|65559037|FG011|PF-06873600 Treatment|Ongoing|0|||
23496421|NCT03519178|65559038|FG012|PF-06873600 Treatment|Ongoing|0|||
23496422|NCT03519178|65559039|FG013|PF-06873600 Treatment|Ongoing|1|||
23496423|NCT03519178|65559040|FG014|PF-06873600 Treatment|Ongoing|6|||
23496424|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496425|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496426|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496427|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496428|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496429|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496430|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496431|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496432|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496433|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496434|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496435|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496436|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496437|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
23496438|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496439|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Death|0|||
23496440|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Death|0|||
23496441|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Death|0|||
23496442|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Death|0|||
23496443|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Death|0|||
23686251|NCT00880750|66225637|FG001|First Intervention|Withdrawal by Subject|0|||
23686252|NCT00880750|66225636|FG000|First Intervention|Lost to Follow-up|2|||
23686253|NCT00880750|66225637|FG001|First Intervention|Lost to Follow-up|0|||
23686254|NCT00880750|66225636|FG000|Second Intervention|Withdrawal by Subject|2|||
23392573|NCT01380080|65184729|FG000|Overall Study|Lost to Follow-up|3|||
23392574|NCT01380080|65184730|FG001|Overall Study|Lost to Follow-up|3|||
23392575|NCT04144517|65184734|FG000|Overall Study|Physician Decision|0|||
23392576|NCT04144517|65184735|FG001|Overall Study|Physician Decision|1|||
23392577|NCT04144517|65184734|FG000|Overall Study|Other|2|||
23392578|NCT04144517|65184735|FG001|Overall Study|Other|2|||
23496444|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Death|0|||
23496445|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Death|0|||
23496446|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Death|0|||
23496447|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Death|0|||
23496448|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Death|1|||
23686255|NCT00880750|66225637|FG001|Second Intervention|Withdrawal by Subject|2|||
23392579|NCT04144517|65184734|FG000|Overall Study|Death|6|||
23392580|NCT04144517|65184735|FG001|Overall Study|Death|3|||
23392581|NCT02763566|65184738|FG000|Overall Study|Lost to Follow-up|1|||
23392582|NCT02763566|65184739|FG001|Overall Study|Lost to Follow-up|4|||
23392583|NCT02763566|65184740|FG002|Overall Study|Lost to Follow-up|0|||
23392584|NCT02763566|65184741|FG003|Overall Study|Lost to Follow-up|1|||
23392585|NCT02763566|65184738|FG000|Overall Study|On study treatment at study conclusion|114|||
23392586|NCT02763566|65184739|FG001|Overall Study|On study treatment at study conclusion|34|||
23392587|NCT02763566|65184740|FG002|Overall Study|On study treatment at study conclusion|54|||
23392588|NCT02763566|65184741|FG003|Overall Study|On study treatment at study conclusion|13|||
23392589|NCT02763566|65184738|FG000|Overall Study|Withdrawal by Subject|3|||
23392590|NCT02763566|65184739|FG001|Overall Study|Withdrawal by Subject|1|||
23392591|NCT02763566|65184740|FG002|Overall Study|Withdrawal by Subject|0|||
23392592|NCT02763566|65184741|FG003|Overall Study|Withdrawal by Subject|0|||
23392593|NCT02879695|65184750|FG000|Overall Study|Did not start study treatment|2|||
23392594|NCT02879695|65184751|FG001|Overall Study|Did not start study treatment|0|||
23392595|NCT02879695|65184752|FG002|Overall Study|Did not start study treatment|3|||
23392596|NCT02879695|65184753|FG003|Overall Study|Did not start study treatment|0|||
23392597|NCT00847730|65184754|FG000|Overall Study|Multiple interruptions in therapy|8|||
23392598|NCT02420314|65184757|FG000|Overall Study|Withdrawal by Subject|1|||
23392599|NCT02420314|65184757|FG000|Overall Study|Protocol Violation|1|||
23392600|NCT03913130|65184758|FG000|Overall Study|Sponsor Decision|1|||
23392601|NCT03952559|65184763|FG000|Double Blind Treatment Period|Adverse Event|0|||
23392602|NCT03952559|65184764|FG001|Double Blind Treatment Period|Adverse Event|2|||
23392603|NCT03952559|65184765|FG002|Double Blind Treatment Period|Adverse Event|1|||
23392604|NCT03952559|65184766|FG003|Double Blind Treatment Period|Adverse Event|0|||
23392605|NCT03952559|65184767|FG004|Double Blind Treatment Period|Adverse Event|1|||
23392606|NCT03952559|65184763|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
23392607|NCT03952559|65184764|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
23392608|NCT03952559|65184765|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
23392609|NCT03952559|65184766|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
23392610|NCT03952559|65184767|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23392611|NCT03952559|65184763|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
23392612|NCT03952559|65184764|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23392613|NCT03952559|65184765|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
23392614|NCT03952559|65184766|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
23392615|NCT03952559|65184767|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23392616|NCT03952559|65184763|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
23392617|NCT03952559|65184764|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
23392618|NCT03952559|65184765|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
23392619|NCT03952559|65184766|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
23392620|NCT03952559|65184767|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
23392621|NCT04347538|65184768|FG000|Overall Study|Lost to Follow-up|4|||
23392622|NCT04347538|65184769|FG001|Overall Study|Lost to Follow-up|5|||
23392623|NCT04347538|65184770|FG002|Overall Study|Lost to Follow-up|7|||
23392624|NCT02367040|65184771|FG000|Overall Study|Lost to Follow-up|1|||
23392625|NCT02367040|65184772|FG001|Overall Study|Lost to Follow-up|1|||
23392626|NCT02367040|65184771|FG000|Overall Study|Lack of Efficacy|1|||
23392627|NCT02367040|65184772|FG001|Overall Study|Lack of Efficacy|0|||
23392628|NCT02367040|65184771|FG000|Overall Study|Additional primary malignancy|0|||
23392629|NCT02367040|65184772|FG001|Overall Study|Additional primary malignancy|1|||
23392630|NCT02367040|65184771|FG000|Overall Study|AE not associated with clinical disease progression|114|||
23392631|NCT02367040|65184772|FG001|Overall Study|AE not associated with clinical disease progression|11|||
23392632|NCT02367040|65184771|FG000|Overall Study|AE associated with clinical disease progression|1|||
23392633|NCT02367040|65184772|FG001|Overall Study|AE associated with clinical disease progression|3|||
23392634|NCT02367040|65184771|FG000|Overall Study|Physician Decision|2|||
23392635|NCT02367040|65184772|FG001|Overall Study|Physician Decision|8|||
23392636|NCT02367040|65184771|FG000|Overall Study|Non-compliance with study drug|1|||
23392637|NCT02367040|65184772|FG001|Overall Study|Non-compliance with study drug|0|||
23392638|NCT02367040|65184771|FG000|Overall Study|Failure to meet continuation criteria|1|||
23392639|NCT02367040|65184772|FG001|Overall Study|Failure to meet continuation criteria|0|||
23392640|NCT02367040|65184771|FG000|Overall Study|Switching to other therapy|2|||
23392641|NCT02367040|65184772|FG001|Overall Study|Switching to other therapy|0|||
23392642|NCT02367040|65184771|FG000|Overall Study|Withdrawal by Subject|46|||
23392643|NCT02367040|65184772|FG001|Overall Study|Withdrawal by Subject|16|||
23392644|NCT02367040|65184771|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
23392645|NCT02367040|65184772|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
23392646|NCT02367040|65184771|FG000|Overall Study|Patient decision|39|||
23392647|NCT02367040|65184772|FG001|Overall Study|Patient decision|14|||
23392648|NCT02367040|65184771|FG000|Overall Study|Required procedure failed|1|||
23392649|NCT02367040|65184772|FG001|Overall Study|Required procedure failed|0|||
23392650|NCT02367040|65184771|FG000|Overall Study|Randomized by mistake with study treatment|1|||
23392651|NCT02367040|65184772|FG001|Overall Study|Randomized by mistake with study treatment|0|||
23392652|NCT02367040|65184771|FG000|Overall Study|Protocol Violation|1|||
23392653|NCT02367040|65184772|FG001|Overall Study|Protocol Violation|0|||
23392654|NCT02367040|65184771|FG000|Overall Study|Progressive disease - radiological progression|51|||
23392655|NCT02367040|65184772|FG001|Overall Study|Progressive disease - radiological progression|78|||
23496449|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Death|0|||
23496450|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Death|0|||
23496451|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Death|0|||
23496452|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Death|0|||
23496453|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Death|1|||
23496454|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496455|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496456|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496457|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496458|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496459|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496460|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496461|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496462|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496463|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496464|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496465|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23686256|NCT00880750|66225636|FG000|Second Intervention|Protocol Violation|1|||
23686257|NCT00880750|66225637|FG001|Second Intervention|Protocol Violation|0|||
23496466|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496467|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496468|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
23496469|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496470|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496471|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496472|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496473|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496474|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496475|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23686258|NCT00880750|66225636|FG000|Second Intervention|Unable to collect urine|1|||
23686259|NCT00880750|66225637|FG001|Second Intervention|Unable to collect urine|0|||
23686260|NCT01023789|66225638|FG000|3 - Year Visit|Death|29|||
23686261|NCT01023789|66225638|FG000|3 - Year Visit|Withdrawal of consent|1|||
23686262|NCT01023789|66225638|FG000|3 - Year Visit|Lost to Follow-up|13|||
23686263|NCT00727402|66225642|FG000|Overall Study|Physician Decision|116|||
23686264|NCT01708057|66228382|FG000|Overall Study|Withdrawal due to study termination.|1|||
23686265|NCT01708057|66228383|FG001|Overall Study|Withdrawal due to study termination.|1|||
23686266|NCT01708057|66228384|FG002|Overall Study|Withdrawal due to study termination.|1|||
23686267|NCT01267955|66228385|FG000|Stage 1 (6 Months)|Death|3|||
23686268|NCT01267955|66228385|FG000|Stage 2 (6 Months)|Death|5|||
23686269|NCT01267955|66228385|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
23686270|NCT04003610|66228386|FG000|Overall Study|Lost to Follow-up|0|||
23686271|NCT04003610|66228387|FG001|Overall Study|Lost to Follow-up|1|||
23686272|NCT04003610|66228388|FG002|Overall Study|Lost to Follow-up|0|||
23686273|NCT04003610|66228386|FG000|Overall Study|Death|0|||
23686274|NCT04003610|66228387|FG001|Overall Study|Death|0|||
23686275|NCT04003610|66228388|FG002|Overall Study|Death|3|||
23686276|NCT04003610|66228386|FG000|Overall Study|Study Terminated by Sponsor|0|||
23686277|NCT04003610|66228387|FG001|Overall Study|Study Terminated by Sponsor|0|||
23686278|NCT04003610|66228388|FG002|Overall Study|Study Terminated by Sponsor|3|||
23686279|NCT03367871|66228393|FG000|Overall Study|Lost to Follow-up|1|||
23686280|NCT00474240|66228394|FG000|Overall Study|Withdrawal by Subject|1|||
23686281|NCT00474240|66228395|FG001|Overall Study|Withdrawal by Subject|1|||
23686282|NCT00474240|66228396|FG002|Overall Study|Withdrawal by Subject|0|||
23686283|NCT00474240|66228397|FG003|Overall Study|Withdrawal by Subject|2|||
23686284|NCT00474240|66228398|FG004|Overall Study|Withdrawal by Subject|3|||
23686285|NCT00474240|66228399|FG005|Overall Study|Withdrawal by Subject|1|||
23686286|NCT00474240|66228394|FG000|Overall Study|Adverse Event|0|||
23392656|NCT02367040|65184771|FG000|Overall Study|Progressive disease - clinical progression|6|||
23392657|NCT02367040|65184772|FG001|Overall Study|Progressive disease - clinical progression|6|||
23686287|NCT00474240|66228395|FG001|Overall Study|Adverse Event|0|||
23686288|NCT00474240|66228396|FG002|Overall Study|Adverse Event|9|||
23392658|NCT02367040|65184771|FG000|Overall Study|Drug not administered|3|||
23686289|NCT00474240|66228397|FG003|Overall Study|Adverse Event|14|||
23686290|NCT00474240|66228398|FG004|Overall Study|Adverse Event|5|||
23686291|NCT00474240|66228399|FG005|Overall Study|Adverse Event|16|||
23686292|NCT00474240|66228394|FG000|Overall Study|Removed due to lab value|0|||
23686293|NCT00474240|66228395|FG001|Overall Study|Removed due to lab value|0|||
23686294|NCT00474240|66228396|FG002|Overall Study|Removed due to lab value|0|||
23686295|NCT00474240|66228397|FG003|Overall Study|Removed due to lab value|0|||
23686296|NCT00474240|66228398|FG004|Overall Study|Removed due to lab value|0|||
23686297|NCT00474240|66228399|FG005|Overall Study|Removed due to lab value|1|||
23686298|NCT00974220|66228400|FG000|Treatment Period 1|Adverse Event|2|||
23686299|NCT00974220|66228401|FG001|Treatment Period 1|Adverse Event|1|||
23686300|NCT00974220|66228400|FG000|Treatment Period 1|noncompliant subjects|0|||
23686301|NCT00974220|66228401|FG001|Treatment Period 1|noncompliant subjects|1|||
23686302|NCT00420511|66228402|FG000|Overall Study|Adverse Event|1|||
23686303|NCT00420511|66228403|FG001|Overall Study|Adverse Event|1|||
23686304|NCT00420511|66228402|FG000|Overall Study|Lost to Follow-up|1|||
23686305|NCT00420511|66228403|FG001|Overall Study|Lost to Follow-up|0|||
23686306|NCT00619502|66228404|FG000|Overall Study|Lost to Follow-up|8|||
23686307|NCT00619502|66228405|FG001|Overall Study|Lost to Follow-up|10|||
23686308|NCT02347631|66228409|FG000|First Intervention (2 Months)|Adverse Event|1|||
23686309|NCT02347631|66228410|FG001|First Intervention (2 Months)|Adverse Event|1|||
23686310|NCT02347631|66228409|FG000|First Intervention (2 Months)|Pregnancy|1|||
23686311|NCT02347631|66228410|FG001|First Intervention (2 Months)|Pregnancy|0|||
23496476|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23686312|NCT02347631|66228409|FG000|First Intervention (2 Months)|Moved out of area|0|||
23686313|NCT02347631|66228410|FG001|First Intervention (2 Months)|Moved out of area|2|||
23686314|NCT02347631|66228409|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
23686315|NCT02347631|66228410|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
23686316|NCT02347631|66228409|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
23686317|NCT02347631|66228410|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
23686318|NCT02347631|66228409|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
23686319|NCT02347631|66228410|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
23686320|NCT02347631|66228409|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
23686321|NCT02347631|66228410|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
23686322|NCT02347631|66228409|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
23686323|NCT02347631|66228410|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
23686324|NCT04134494|66228411|FG000|Overall Study|Lost to Follow-up|2|||
23606268|NCT03019289|65947197|FG007|Overall Study|Adverse Event|0|||
23606269|NCT03019289|65947198|FG008|Overall Study|Adverse Event|1|||
23606270|NCT03019289|65947190|FG000|Overall Study|Other|1|||
23496477|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496478|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496479|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496480|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496481|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496482|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
23496483|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
23496484|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496485|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496486|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496487|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496488|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496489|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496490|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496491|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496492|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496493|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
23496494|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496495|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496496|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496497|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
23496498|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
23496499|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496500|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496501|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496502|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496503|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496504|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496505|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23606271|NCT03019289|65947191|FG001|Overall Study|Other|0|||
23606272|NCT03019289|65947192|FG002|Overall Study|Other|0|||
23606273|NCT03019289|65947193|FG003|Overall Study|Other|0|||
23606274|NCT03019289|65947194|FG004|Overall Study|Other|0|||
23686325|NCT00773279|66228412|FG000|Period 1|Adverse Event|2|||
23392659|NCT02367040|65184772|FG001|Overall Study|Drug not administered|2|||
23392660|NCT02367040|65184771|FG000|Overall Study|Progressive disease|0|||
23496506|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496507|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496508|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496509|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496510|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496511|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496512|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
23496513|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
23606275|NCT03019289|65947195|FG005|Overall Study|Other|0|||
23606276|NCT03019289|65947196|FG006|Overall Study|Other|0|||
23392661|NCT02367040|65184772|FG001|Overall Study|Progressive disease|1|||
23392662|NCT02367040|65184771|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
23392663|NCT02367040|65184772|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
23392664|NCT02367040|65184771|FG000|Overall Study|Death|2|||
23392665|NCT02367040|65184772|FG001|Overall Study|Death|0|||
23392666|NCT03770286|65184773|FG000|Overall Study|Lost to Follow-up|6|||
23392667|NCT03770286|65184774|FG001|Overall Study|Lost to Follow-up|4|||
23392668|NCT03770286|65184775|FG002|Overall Study|Lost to Follow-up|3|||
23392669|NCT03770286|65184773|FG000|Overall Study|Protocol Violation|1|||
23392670|NCT03770286|65184774|FG001|Overall Study|Protocol Violation|0|||
23392671|NCT03770286|65184775|FG002|Overall Study|Protocol Violation|2|||
23392672|NCT04573881|65184776|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
23392673|NCT01969058|65184777|FG000|Overall Study|Withdrawal by Subject|2|||
23392674|NCT01969058|65184778|FG001|Overall Study|Withdrawal by Subject|0|||
23392675|NCT01969058|65184777|FG000|Overall Study|Adverse Event|1|||
23392676|NCT01969058|65184778|FG001|Overall Study|Adverse Event|0|||
23392677|NCT03735121|65184779|FG000|Overall Study|Death|3|||
23392678|NCT03735121|65184780|FG001|Overall Study|Death|6|||
23392679|NCT03735121|65184781|FG002|Overall Study|Death|8|||
23392680|NCT03735121|65184782|FG003|Overall Study|Death|37|||
23392681|NCT03735121|65184783|FG004|Overall Study|Death|86|||
23392682|NCT03735121|65184779|FG000|Overall Study|Withdrawal by Subject|1|||
23392683|NCT03735121|65184780|FG001|Overall Study|Withdrawal by Subject|1|||
23392684|NCT03735121|65184781|FG002|Overall Study|Withdrawal by Subject|3|||
23392685|NCT03735121|65184782|FG003|Overall Study|Withdrawal by Subject|4|||
23392686|NCT03735121|65184783|FG004|Overall Study|Withdrawal by Subject|2|||
23392687|NCT03735121|65184779|FG000|Overall Study|Progressive Disease|0|||
23392688|NCT03735121|65184780|FG001|Overall Study|Progressive Disease|0|||
23392689|NCT03735121|65184781|FG002|Overall Study|Progressive Disease|1|||
23392690|NCT03735121|65184782|FG003|Overall Study|Progressive Disease|0|||
23392691|NCT03735121|65184783|FG004|Overall Study|Progressive Disease|0|||
23392692|NCT03735121|65184779|FG000|Overall Study|Lost to Follow-up|0|||
23392693|NCT03735121|65184780|FG001|Overall Study|Lost to Follow-up|0|||
23392694|NCT03735121|65184781|FG002|Overall Study|Lost to Follow-up|0|||
23392695|NCT03735121|65184782|FG003|Overall Study|Lost to Follow-up|0|||
23392696|NCT03735121|65184783|FG004|Overall Study|Lost to Follow-up|1|||
23392697|NCT03735121|65184779|FG000|Overall Study|Ongoing|3|||
23392698|NCT03735121|65184780|FG001|Overall Study|Ongoing|3|||
23392699|NCT03735121|65184781|FG002|Overall Study|Ongoing|26|||
23392700|NCT03735121|65184782|FG003|Overall Study|Ongoing|83|||
23392701|NCT03735121|65184783|FG004|Overall Study|Ongoing|158|||
23392702|NCT02135133|65184785|FG000|Overall Study|Adverse Event|10|||
23392703|NCT02135133|65184785|FG000|Overall Study|regulatory mandate|5|||
23392704|NCT03822468|65184786|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
23392705|NCT03822468|65184787|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
23392706|NCT03822468|65184786|FG000|Treatment Period|Progressive disease|50|||
23392707|NCT03822468|65184787|FG001|Treatment Period|Progressive disease|51|||
23392708|NCT03822468|65184786|FG000|Treatment Period|Adverse Event|16|||
23392709|NCT03822468|65184787|FG001|Treatment Period|Adverse Event|18|||
23392710|NCT03822468|65184786|FG000|Treatment Period|Patient decision|4|||
23392711|NCT03822468|65184787|FG001|Treatment Period|Patient decision|5|||
23392712|NCT03822468|65184786|FG000|Treatment Period|Physician Decision|4|||
23392713|NCT03822468|65184787|FG001|Treatment Period|Physician Decision|5|||
23392714|NCT03822468|65184786|FG000|Treatment Period|Protocol deviation|2|||
23606277|NCT03019289|65947197|FG007|Overall Study|Other|0|||
23686326|NCT00773279|66228413|FG001|Period 1|Adverse Event|1|||
23686327|NCT00773279|66228412|FG000|Period 1|Lack of Efficacy|0|||
23392715|NCT03822468|65184787|FG001|Treatment Period|Protocol deviation|1|||
23392716|NCT03822468|65184786|FG000|Treatment Period|Death|1|||
23392717|NCT03822468|65184787|FG001|Treatment Period|Death|1|||
23392718|NCT03822468|65184786|FG000|Treatment Period|Lost to Follow-up|1|||
23392719|NCT03822468|65184787|FG001|Treatment Period|Lost to Follow-up|0|||
23392720|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
23402841|NCT01349673|65220031|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
23392721|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
23392722|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23392723|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23392724|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
23392725|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
23392726|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Death|1|||
23392727|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Death|0|||
23392728|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23392729|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23392730|NCT06351371|65184788|FG000|Overall Study|Mutation Status Not Confirmed|9|||
23392731|NCT06351371|65184788|FG000|Overall Study|Ineligible|1|||
23496514|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496515|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496516|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496517|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496518|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496519|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496520|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496521|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496522|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496523|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
23496524|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496525|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496526|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496527|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
23496528|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
23496529|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496530|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496531|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496532|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496533|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496534|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496535|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496536|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496537|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496538|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
23496539|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496540|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496541|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496542|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
23496543|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496544|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496545|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496546|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496547|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496548|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496549|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496550|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496551|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496552|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496553|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496554|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496555|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496556|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496557|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496558|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
23496559|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Other|0|||
23496560|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Other|0|||
23686328|NCT00773279|66228413|FG001|Period 1|Lack of Efficacy|2|||
23686329|NCT00773279|66228412|FG000|Period 1|Unclassified|5|||
23392732|NCT06351371|65184788|FG000|Overall Study|Adverse Event|4|||
23392733|NCT06351371|65184788|FG000|Overall Study|Death|1|||
23496561|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Other|0|||
23496562|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Other|0|||
23496563|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Other|0|||
23496564|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Other|0|||
23496565|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Other|0|||
23496566|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Other|0|||
23496567|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Other|0|||
23496568|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Other|0|||
23496569|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Other|0|||
23496570|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Other|0|||
23496571|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Other|0|||
23496572|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Other|1|||
23496573|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Other|3|||
23496574|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496575|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496576|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496577|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496578|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496579|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496580|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496581|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496582|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496583|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496584|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496585|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496586|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496587|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
23496588|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
23496589|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
23496590|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
23496591|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
23496592|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
23392734|NCT06351371|65184788|FG000|Overall Study|Disease progression|14|||
23392735|NCT06351371|65184788|FG000|Overall Study|Withdrawal by Subject|3|||
23392736|NCT06351371|65184788|FG000|Overall Study|Physician Decision|3|||
23392737|NCT01107496|65184789|FG000|Overall Study|Adverse Event|1|||
23392738|NCT01107496|65184790|FG001|Overall Study|Adverse Event|0|||
23392739|NCT01107496|65184789|FG000|Overall Study|Lack of Efficacy|1|||
23392740|NCT01107496|65184790|FG001|Overall Study|Lack of Efficacy|0|||
23392741|NCT01107496|65184789|FG000|Overall Study|Protocol Violation|0|||
23496593|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
23496594|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
23496595|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
23496596|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
23496597|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
23496598|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
23496599|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
23496600|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
23496601|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
23496602|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
23496603|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
23496604|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
23496605|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
23496606|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
23496607|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
23496608|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
23496609|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
23392742|NCT01107496|65184790|FG001|Overall Study|Protocol Violation|1|||
23392743|NCT01107496|65184789|FG000|Overall Study|Lost to Follow-up|0|||
23392744|NCT01107496|65184790|FG001|Overall Study|Lost to Follow-up|1|||
23392745|NCT03518060|65184793|FG000|Overall Study|Death|1|||
23392746|NCT03518060|65184793|FG000|Overall Study|Poor adherence|1|||
23392747|NCT03518060|65184793|FG000|Overall Study|Withdrawal of informed consent|2|||
23392748|NCT03518060|65184793|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
23392749|NCT03518060|65184793|FG000|Overall Study|Physician Decision|7|||
23392750|NCT03518060|65184793|FG000|Overall Study|Adverse drug reactions|23|||
23392751|NCT03518060|65184793|FG000|Overall Study|Withdrawal by Subject|25|||
23392752|NCT03518060|65184793|FG000|Overall Study|Lost to Follow-up|13|||
23392753|NCT05810597|65184802|FG000|Period 1|Adverse Event|2|||
23392754|NCT05810597|65184803|FG001|Period 1|Adverse Event|0|||
23392755|NCT05810597|65184802|FG000|Period 1|Physician Decision|1|||
23392756|NCT05810597|65184803|FG001|Period 1|Physician Decision|0|||
23392757|NCT04756531|65184804|FG000|Overall Study|Adverse Event|0|||
23392758|NCT04756531|65184805|FG001|Overall Study|Adverse Event|0|||
23392759|NCT04756531|65184806|FG002|Overall Study|Adverse Event|0|||
23392760|NCT04756531|65184807|FG003|Overall Study|Adverse Event|0|||
23392761|NCT04756531|65184808|FG004|Overall Study|Adverse Event|1|||
23392762|NCT04756531|65184809|FG005|Overall Study|Adverse Event|0|||
23392763|NCT04756531|65184810|FG006|Overall Study|Adverse Event|0|||
23392764|NCT04756531|65184811|FG007|Overall Study|Adverse Event|0|||
23392765|NCT04756531|65184812|FG008|Overall Study|Adverse Event|0|||
23392766|NCT04756531|65184813|FG009|Overall Study|Adverse Event|0|||
23392767|NCT04756531|65184814|FG010|Overall Study|Adverse Event|0|||
23392768|NCT04756531|65184815|FG011|Overall Study|Adverse Event|0|||
23392769|NCT04756531|65184816|FG012|Overall Study|Adverse Event|0|||
23392770|NCT04756531|65184817|FG013|Overall Study|Adverse Event|0|||
23392771|NCT04756531|65184818|FG014|Overall Study|Adverse Event|0|||
23392772|NCT04756531|65184819|FG015|Overall Study|Adverse Event|0|||
23392773|NCT04756531|65184820|FG016|Overall Study|Adverse Event|0|||
23392774|NCT04756531|65184821|FG017|Overall Study|Adverse Event|0|||
23392775|NCT04756531|65184804|FG000|Overall Study|Withdrawal by Subject|0|||
23392776|NCT04756531|65184805|FG001|Overall Study|Withdrawal by Subject|0|||
23392777|NCT04756531|65184806|FG002|Overall Study|Withdrawal by Subject|0|||
23392778|NCT04756531|65184807|FG003|Overall Study|Withdrawal by Subject|0|||
23392779|NCT04756531|65184808|FG004|Overall Study|Withdrawal by Subject|0|||
23392780|NCT04756531|65184809|FG005|Overall Study|Withdrawal by Subject|0|||
23392781|NCT04756531|65184810|FG006|Overall Study|Withdrawal by Subject|1|||
23392782|NCT04756531|65184811|FG007|Overall Study|Withdrawal by Subject|0|||
23392783|NCT04756531|65184812|FG008|Overall Study|Withdrawal by Subject|0|||
23392784|NCT04756531|65184813|FG009|Overall Study|Withdrawal by Subject|0|||
23392785|NCT04756531|65184814|FG010|Overall Study|Withdrawal by Subject|0|||
23392786|NCT04756531|65184815|FG011|Overall Study|Withdrawal by Subject|0|||
23392787|NCT04756531|65184816|FG012|Overall Study|Withdrawal by Subject|0|||
23392788|NCT04756531|65184817|FG013|Overall Study|Withdrawal by Subject|0|||
23392789|NCT04756531|65184818|FG014|Overall Study|Withdrawal by Subject|0|||
23392790|NCT04756531|65184819|FG015|Overall Study|Withdrawal by Subject|0|||
23392791|NCT04756531|65184820|FG016|Overall Study|Withdrawal by Subject|0|||
23392792|NCT04756531|65184821|FG017|Overall Study|Withdrawal by Subject|0|||
23392793|NCT04035486|65184826|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
23392794|NCT04035486|65184827|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
23392795|NCT04035486|65184828|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
23496610|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
23392796|NCT04035486|65184829|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
23392797|NCT04035486|65184826|FG000|Overall Study|Death|6|||
23392798|NCT04035486|65184827|FG001|Overall Study|Death|3|||
23392799|NCT04035486|65184828|FG002|Overall Study|Death|70|||
23392800|NCT04035486|65184829|FG003|Overall Study|Death|77|||
23496611|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
23496612|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
23496613|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
23496614|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
23496615|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
23496616|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
23496617|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
23496618|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
23496619|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496620|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496621|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496622|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496623|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496624|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496625|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496626|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496627|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496628|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496629|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
23496630|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496631|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496632|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496633|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496634|NCT03519178|65559026|FG000|Follow-Up|Death|0|||
23496635|NCT03519178|65559027|FG001|Follow-Up|Death|0|||
23496636|NCT03519178|65559028|FG002|Follow-Up|Death|1|||
23496637|NCT03519178|65559029|FG003|Follow-Up|Death|0|||
23496638|NCT03519178|65559030|FG004|Follow-Up|Death|0|||
23496639|NCT03519178|65559031|FG005|Follow-Up|Death|0|||
23496640|NCT03519178|65559032|FG006|Follow-Up|Death|0|||
23496641|NCT03519178|65559033|FG007|Follow-Up|Death|0|||
23496642|NCT03519178|65559034|FG008|Follow-Up|Death|3|||
23496643|NCT03519178|65559035|FG009|Follow-Up|Death|1|||
23496644|NCT03519178|65559036|FG010|Follow-Up|Death|0|||
23496645|NCT03519178|65559037|FG011|Follow-Up|Death|0|||
23496646|NCT03519178|65559038|FG012|Follow-Up|Death|2|||
23496647|NCT03519178|65559039|FG013|Follow-Up|Death|0|||
23496648|NCT03519178|65559040|FG014|Follow-Up|Death|0|||
23496649|NCT03519178|65559026|FG000|Follow-Up|Lost to Follow-up|0|||
23496650|NCT03519178|65559027|FG001|Follow-Up|Lost to Follow-up|0|||
23496651|NCT03519178|65559028|FG002|Follow-Up|Lost to Follow-up|0|||
23496652|NCT03519178|65559029|FG003|Follow-Up|Lost to Follow-up|0|||
23496653|NCT03519178|65559030|FG004|Follow-Up|Lost to Follow-up|0|||
23496654|NCT03519178|65559031|FG005|Follow-Up|Lost to Follow-up|3|||
23496655|NCT03519178|65559032|FG006|Follow-Up|Lost to Follow-up|1|||
23496656|NCT03519178|65559033|FG007|Follow-Up|Lost to Follow-up|4|||
23496657|NCT03519178|65559034|FG008|Follow-Up|Lost to Follow-up|1|||
23496658|NCT03519178|65559035|FG009|Follow-Up|Lost to Follow-up|0|||
23496659|NCT03519178|65559036|FG010|Follow-Up|Lost to Follow-up|0|||
23496660|NCT03519178|65559037|FG011|Follow-Up|Lost to Follow-up|0|||
23496661|NCT03519178|65559038|FG012|Follow-Up|Lost to Follow-up|0|||
23496662|NCT03519178|65559039|FG013|Follow-Up|Lost to Follow-up|0|||
23496663|NCT03519178|65559040|FG014|Follow-Up|Lost to Follow-up|0|||
23496664|NCT03519178|65559026|FG000|Follow-Up|Withdrawal by Subject|1|||
23496665|NCT03519178|65559027|FG001|Follow-Up|Withdrawal by Subject|2|||
23496666|NCT03519178|65559028|FG002|Follow-Up|Withdrawal by Subject|2|||
23496667|NCT03519178|65559029|FG003|Follow-Up|Withdrawal by Subject|3|||
23496668|NCT03519178|65559030|FG004|Follow-Up|Withdrawal by Subject|5|||
23496669|NCT03519178|65559031|FG005|Follow-Up|Withdrawal by Subject|1|||
23496670|NCT03519178|65559032|FG006|Follow-Up|Withdrawal by Subject|2|||
23496671|NCT03519178|65559033|FG007|Follow-Up|Withdrawal by Subject|6|||
23496672|NCT03519178|65559034|FG008|Follow-Up|Withdrawal by Subject|5|||
23496673|NCT03519178|65559035|FG009|Follow-Up|Withdrawal by Subject|2|||
23496674|NCT03519178|65559036|FG010|Follow-Up|Withdrawal by Subject|3|||
23496675|NCT03519178|65559037|FG011|Follow-Up|Withdrawal by Subject|5|||
23686330|NCT00773279|66228413|FG001|Period 1|Unclassified|1|||
23686331|NCT00773279|66228412|FG000|Period 2|Adverse Event|0|||
23392801|NCT04035486|65184826|FG000|Overall Study|Screen Failure|0|||
23496676|NCT03519178|65559038|FG012|Follow-Up|Withdrawal by Subject|2|||
23496677|NCT03519178|65559039|FG013|Follow-Up|Withdrawal by Subject|0|||
23496678|NCT03519178|65559040|FG014|Follow-Up|Withdrawal by Subject|0|||
23496679|NCT03519178|65559026|FG000|Follow-Up|Other|0|||
23496680|NCT03519178|65559027|FG001|Follow-Up|Other|0|||
23496681|NCT03519178|65559028|FG002|Follow-Up|Other|0|||
23496682|NCT03519178|65559029|FG003|Follow-Up|Other|0|||
23686332|NCT00773279|66228413|FG001|Period 2|Adverse Event|1|||
23496683|NCT03519178|65559030|FG004|Follow-Up|Other|0|||
23496684|NCT03519178|65559031|FG005|Follow-Up|Other|0|||
23496685|NCT03519178|65559032|FG006|Follow-Up|Other|0|||
23496686|NCT03519178|65559033|FG007|Follow-Up|Other|1|||
23496687|NCT03519178|65559034|FG008|Follow-Up|Other|0|||
23496688|NCT03519178|65559035|FG009|Follow-Up|Other|0|||
23496689|NCT03519178|65559036|FG010|Follow-Up|Other|0|||
23496690|NCT03519178|65559037|FG011|Follow-Up|Other|0|||
23496691|NCT03519178|65559038|FG012|Follow-Up|Other|0|||
23496692|NCT03519178|65559039|FG013|Follow-Up|Other|0|||
23496693|NCT03519178|65559040|FG014|Follow-Up|Other|0|||
23496694|NCT03519178|65559026|FG000|Long-term Follow-up|Death|0|||
23496695|NCT03519178|65559027|FG001|Long-term Follow-up|Death|0|||
23496696|NCT03519178|65559028|FG002|Long-term Follow-up|Death|0|||
23496697|NCT03519178|65559029|FG003|Long-term Follow-up|Death|0|||
23392802|NCT04035486|65184827|FG001|Overall Study|Screen Failure|0|||
23392803|NCT04035486|65184828|FG002|Overall Study|Screen Failure|1|||
23392804|NCT04035486|65184829|FG003|Overall Study|Screen Failure|1|||
23392805|NCT04035486|65184826|FG000|Overall Study|Withdrawal by Subject|1|||
23496698|NCT03519178|65559030|FG004|Long-term Follow-up|Death|0|||
23496699|NCT03519178|65559031|FG005|Long-term Follow-up|Death|0|||
23496700|NCT03519178|65559032|FG006|Long-term Follow-up|Death|0|||
23496701|NCT03519178|65559033|FG007|Long-term Follow-up|Death|0|||
23496702|NCT03519178|65559034|FG008|Long-term Follow-up|Death|0|||
23496703|NCT03519178|65559035|FG009|Long-term Follow-up|Death|0|||
23496704|NCT03519178|65559036|FG010|Long-term Follow-up|Death|0|||
23496705|NCT03519178|65559037|FG011|Long-term Follow-up|Death|0|||
23496706|NCT03519178|65559038|FG012|Long-term Follow-up|Death|0|||
23496707|NCT03519178|65559039|FG013|Long-term Follow-up|Death|4|||
23496708|NCT03519178|65559040|FG014|Long-term Follow-up|Death|4|||
23496709|NCT03519178|65559026|FG000|Long-term Follow-up|Lost to Follow-up|0|||
23496710|NCT03519178|65559027|FG001|Long-term Follow-up|Lost to Follow-up|0|||
23496711|NCT03519178|65559028|FG002|Long-term Follow-up|Lost to Follow-up|0|||
23496712|NCT03519178|65559029|FG003|Long-term Follow-up|Lost to Follow-up|0|||
23496713|NCT03519178|65559030|FG004|Long-term Follow-up|Lost to Follow-up|0|||
23496714|NCT03519178|65559031|FG005|Long-term Follow-up|Lost to Follow-up|0|||
23496715|NCT03519178|65559032|FG006|Long-term Follow-up|Lost to Follow-up|0|||
23496716|NCT03519178|65559033|FG007|Long-term Follow-up|Lost to Follow-up|0|||
23496717|NCT03519178|65559034|FG008|Long-term Follow-up|Lost to Follow-up|0|||
23496718|NCT03519178|65559035|FG009|Long-term Follow-up|Lost to Follow-up|0|||
23496719|NCT03519178|65559036|FG010|Long-term Follow-up|Lost to Follow-up|0|||
23496720|NCT03519178|65559037|FG011|Long-term Follow-up|Lost to Follow-up|0|||
23496721|NCT03519178|65559038|FG012|Long-term Follow-up|Lost to Follow-up|0|||
23496722|NCT03519178|65559039|FG013|Long-term Follow-up|Lost to Follow-up|1|||
23496723|NCT03519178|65559040|FG014|Long-term Follow-up|Lost to Follow-up|1|||
23496724|NCT03519178|65559026|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
23496725|NCT03519178|65559027|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
23496726|NCT03519178|65559028|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
23496727|NCT03519178|65559029|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
23496728|NCT03519178|65559030|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
23496729|NCT03519178|65559031|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
23496730|NCT03519178|65559032|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
23496731|NCT03519178|65559033|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
23496732|NCT03519178|65559034|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
23496733|NCT03519178|65559035|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
23496734|NCT03519178|65559036|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
23496735|NCT03519178|65559037|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
23686333|NCT00773279|66228412|FG000|Period 2|Lack of Efficacy|1|||
23686334|NCT00773279|66228413|FG001|Period 2|Lack of Efficacy|0|||
23686335|NCT00773279|66228412|FG000|Period 2|Protocol Violation|0|||
23686336|NCT00773279|66228413|FG001|Period 2|Protocol Violation|3|||
23686337|NCT00773279|66228412|FG000|Period 2|Unclassified|2|||
23686338|NCT00773279|66228413|FG001|Period 2|Unclassified|2|||
23686339|NCT00127127|66228422|FG000|Overall Study|Adverse Event|0|||
23496736|NCT03519178|65559038|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
23686340|NCT00127127|66228423|FG001|Overall Study|Adverse Event|2|||
23686341|NCT00127127|66228424|FG002|Overall Study|Adverse Event|0|||
23496737|NCT03519178|65559039|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
23496738|NCT03519178|65559040|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
23496739|NCT03519178|65559026|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
23496740|NCT03519178|65559027|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
23496741|NCT03519178|65559028|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
23496742|NCT03519178|65559029|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
23496743|NCT03519178|65559030|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
23496744|NCT03519178|65559031|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
23496745|NCT03519178|65559032|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
23496746|NCT03519178|65559033|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
23496747|NCT03519178|65559034|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
23496748|NCT03519178|65559035|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
23606278|NCT03019289|65947198|FG008|Overall Study|Other|0|||
23392806|NCT04035486|65184827|FG001|Overall Study|Withdrawal by Subject|1|||
23392807|NCT04035486|65184828|FG002|Overall Study|Withdrawal by Subject|11|||
23392808|NCT04035486|65184829|FG003|Overall Study|Withdrawal by Subject|9|||
23392809|NCT01355627|65184830|FG000|Overall Study|Request By the Patient to Discontinue|5|||
23392810|NCT01355627|65184831|FG001|Overall Study|Request By the Patient to Discontinue|7|||
23392811|NCT01355627|65184830|FG000|Overall Study|Lost to Follow-up|8|||
23392812|NCT01355627|65184831|FG001|Overall Study|Lost to Follow-up|7|||
23392813|NCT01355627|65184830|FG000|Overall Study|Fatal Adverse Event|19|||
23392814|NCT01355627|65184831|FG001|Overall Study|Fatal Adverse Event|23|||
23392815|NCT01355627|65184830|FG000|Overall Study|Other|1|||
23392816|NCT01355627|65184831|FG001|Overall Study|Other|1|||
23392817|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
23392818|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
23392819|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
23392820|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
23392821|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
23392822|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
23392823|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
23392824|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
23392825|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
23392826|NCT01854775|65184832|FG000|Extension Phase|Pregnancy|3|||
23392827|NCT01854775|65184833|FG001|Extension Phase|Pregnancy|0|||
23392828|NCT01854775|65184834|FG002|Extension Phase|Pregnancy|0|||
23392829|NCT01854775|65184832|FG000|Extension Phase|Investigator's Discretion|1|||
23392830|NCT01854775|65184833|FG001|Extension Phase|Investigator's Discretion|0|||
23392831|NCT01854775|65184834|FG002|Extension Phase|Investigator's Discretion|0|||
23392832|NCT01854775|65184832|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
23392833|NCT01854775|65184833|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
23392834|NCT01854775|65184834|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
23392835|NCT01854775|65184832|FG000|Extension Phase|Lost to Follow-up|2|||
23392836|NCT01854775|65184833|FG001|Extension Phase|Lost to Follow-up|0|||
23392837|NCT01854775|65184834|FG002|Extension Phase|Lost to Follow-up|0|||
23392838|NCT01854775|65184832|FG000|Extension Phase|Still on Study|32|||
23392839|NCT01854775|65184833|FG001|Extension Phase|Still on Study|47|||
23392840|NCT01854775|65184834|FG002|Extension Phase|Still on Study|18|||
23392841|NCT05305651|65184835|FG000|Overall Study|Death|1|||
23392842|NCT05305651|65184835|FG000|Overall Study|Withdrawal by Subject|4|||
23392843|NCT05305651|65184835|FG000|Overall Study|Lost to Follow-up|4|||
23392844|NCT02721732|65184836|FG000|Overall Study|Adverse Event|2|||
23392845|NCT02721732|65184837|FG001|Overall Study|Adverse Event|0|||
23392846|NCT02721732|65184838|FG002|Overall Study|Adverse Event|2|||
23392847|NCT02721732|65184839|FG003|Overall Study|Adverse Event|0|||
23392848|NCT02721732|65184840|FG004|Overall Study|Adverse Event|1|||
23392849|NCT02721732|65184841|FG005|Overall Study|Adverse Event|0|||
23392850|NCT02721732|65184842|FG006|Overall Study|Adverse Event|1|||
23392851|NCT02721732|65184843|FG007|Overall Study|Adverse Event|0|||
23392852|NCT02721732|65184844|FG008|Overall Study|Adverse Event|1|||
23392853|NCT02721732|65184845|FG009|Overall Study|Adverse Event|1|||
23392854|NCT02721732|65184836|FG000|Overall Study|Death|0|||
23392855|NCT02721732|65184837|FG001|Overall Study|Death|0|||
23392856|NCT02721732|65184838|FG002|Overall Study|Death|0|||
23392857|NCT02721732|65184839|FG003|Overall Study|Death|0|||
23392858|NCT02721732|65184840|FG004|Overall Study|Death|1|||
23392859|NCT02721732|65184841|FG005|Overall Study|Death|0|||
23392860|NCT02721732|65184842|FG006|Overall Study|Death|1|||
23392861|NCT02721732|65184843|FG007|Overall Study|Death|0|||
23392862|NCT02721732|65184844|FG008|Overall Study|Death|0|||
23392863|NCT02721732|65184845|FG009|Overall Study|Death|1|||
23392864|NCT02721732|65184836|FG000|Overall Study|Lack of Efficacy|12|||
23392865|NCT02721732|65184837|FG001|Overall Study|Lack of Efficacy|11|||
23392866|NCT02721732|65184838|FG002|Overall Study|Lack of Efficacy|18|||
23496749|NCT03519178|65559036|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
23392867|NCT02721732|65184839|FG003|Overall Study|Lack of Efficacy|5|||
23392868|NCT02721732|65184840|FG004|Overall Study|Lack of Efficacy|21|||
23392869|NCT02721732|65184841|FG005|Overall Study|Lack of Efficacy|2|||
23392870|NCT02721732|65184842|FG006|Overall Study|Lack of Efficacy|8|||
23392871|NCT02721732|65184843|FG007|Overall Study|Lack of Efficacy|11|||
23392872|NCT02721732|65184844|FG008|Overall Study|Lack of Efficacy|10|||
23392873|NCT02721732|65184845|FG009|Overall Study|Lack of Efficacy|20|||
23392874|NCT02721732|65184836|FG000|Overall Study|Physician Decision|0|||
23392875|NCT02721732|65184837|FG001|Overall Study|Physician Decision|0|||
23392876|NCT02721732|65184838|FG002|Overall Study|Physician Decision|1|||
23392877|NCT02721732|65184839|FG003|Overall Study|Physician Decision|0|||
23392878|NCT02721732|65184840|FG004|Overall Study|Physician Decision|0|||
23392879|NCT02721732|65184841|FG005|Overall Study|Physician Decision|0|||
23392880|NCT02721732|65184842|FG006|Overall Study|Physician Decision|0|||
23392881|NCT02721732|65184843|FG007|Overall Study|Physician Decision|0|||
23392882|NCT02721732|65184844|FG008|Overall Study|Physician Decision|0|||
23392883|NCT02721732|65184845|FG009|Overall Study|Physician Decision|0|||
23392884|NCT02721732|65184836|FG000|Overall Study|Withdrawal by Subject|1|||
23392885|NCT02721732|65184837|FG001|Overall Study|Withdrawal by Subject|0|||
23392886|NCT02721732|65184838|FG002|Overall Study|Withdrawal by Subject|0|||
23392887|NCT02721732|65184839|FG003|Overall Study|Withdrawal by Subject|0|||
23392888|NCT02721732|65184840|FG004|Overall Study|Withdrawal by Subject|3|||
23392889|NCT02721732|65184841|FG005|Overall Study|Withdrawal by Subject|0|||
23392890|NCT02721732|65184842|FG006|Overall Study|Withdrawal by Subject|1|||
23392891|NCT02721732|65184843|FG007|Overall Study|Withdrawal by Subject|1|||
23392892|NCT02721732|65184844|FG008|Overall Study|Withdrawal by Subject|0|||
23392893|NCT02721732|65184845|FG009|Overall Study|Withdrawal by Subject|1|||
23392894|NCT02721732|65184836|FG000|Overall Study|Participant Choice|1|||
23392895|NCT02721732|65184837|FG001|Overall Study|Participant Choice|0|||
23392896|NCT02721732|65184838|FG002|Overall Study|Participant Choice|0|||
23392897|NCT02721732|65184839|FG003|Overall Study|Participant Choice|0|||
23392898|NCT02721732|65184840|FG004|Overall Study|Participant Choice|0|||
23392899|NCT02721732|65184841|FG005|Overall Study|Participant Choice|0|||
23392900|NCT02721732|65184842|FG006|Overall Study|Participant Choice|0|||
23392901|NCT02721732|65184843|FG007|Overall Study|Participant Choice|0|||
23392902|NCT02721732|65184844|FG008|Overall Study|Participant Choice|0|||
23392903|NCT02721732|65184845|FG009|Overall Study|Participant Choice|1|||
23392904|NCT02721732|65184836|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392905|NCT02721732|65184837|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392906|NCT02721732|65184838|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
23392907|NCT02721732|65184839|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392908|NCT02721732|65184840|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392909|NCT02721732|65184841|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392910|NCT02721732|65184842|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392911|NCT02721732|65184843|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23686342|NCT00127127|66228425|FG003|Overall Study|Adverse Event|1|||
23686343|NCT00127127|66228422|FG000|Overall Study|Lack of Efficacy|1|||
23686344|NCT00127127|66228423|FG001|Overall Study|Lack of Efficacy|3|||
23686345|NCT00127127|66228424|FG002|Overall Study|Lack of Efficacy|0|||
23686346|NCT00127127|66228425|FG003|Overall Study|Lack of Efficacy|2|||
23686347|NCT01070329|66228426|FG000|Overall Study|Adverse Event|13|||
23686348|NCT01070329|66228427|FG001|Overall Study|Adverse Event|10|||
23686349|NCT01070329|66228426|FG000|Overall Study|Lost to Follow-up|22|||
23686350|NCT01070329|66228427|FG001|Overall Study|Lost to Follow-up|12|||
23686351|NCT01070329|66228426|FG000|Overall Study|Withdrawal by Subject|9|||
23686352|NCT01070329|66228427|FG001|Overall Study|Withdrawal by Subject|11|||
23686353|NCT01070329|66228426|FG000|Overall Study|Protocol Violation|3|||
23686354|NCT01070329|66228427|FG001|Overall Study|Protocol Violation|8|||
23686355|NCT01070329|66228426|FG000|Overall Study|Lack of Efficacy|2|||
23686356|NCT01070329|66228427|FG001|Overall Study|Lack of Efficacy|6|||
23686357|NCT01070329|66228426|FG000|Overall Study|Physician Decision|2|||
23686358|NCT01070329|66228427|FG001|Overall Study|Physician Decision|1|||
23686359|NCT01070329|66228426|FG000|Overall Study|Entry Criteria Not Met|1|||
23686360|NCT01070329|66228427|FG001|Overall Study|Entry Criteria Not Met|0|||
23686361|NCT01070329|66228426|FG000|Overall Study|Sponsor Decision|0|||
23686362|NCT01070329|66228427|FG001|Overall Study|Sponsor Decision|1|||
23686363|NCT00442598|66228428|FG000|Overall Study|Adverse Event|1|||
23686364|NCT00442598|66228429|FG001|Overall Study|Adverse Event|0|||
23686365|NCT00442598|66228430|FG002|Overall Study|Adverse Event|0|||
23686366|NCT00442598|66228428|FG000|Overall Study|Tumor progression|3|||
23686367|NCT00442598|66228429|FG001|Overall Study|Tumor progression|4|||
23686368|NCT00442598|66228430|FG002|Overall Study|Tumor progression|0|||
23686369|NCT00442598|66228428|FG000|Overall Study|Clinical deterioration|1|||
23686370|NCT00442598|66228429|FG001|Overall Study|Clinical deterioration|2|||
23686371|NCT00442598|66228430|FG002|Overall Study|Clinical deterioration|0|||
23686372|NCT00442598|66228428|FG000|Overall Study|CA125 progression|0|||
23686373|NCT00442598|66228429|FG001|Overall Study|CA125 progression|1|||
23686374|NCT00442598|66228430|FG002|Overall Study|CA125 progression|0|||
23686375|NCT00442598|66228428|FG000|Overall Study|Reduced creatinine clearance|1|||
23686376|NCT00442598|66228429|FG001|Overall Study|Reduced creatinine clearance|0|||
23686377|NCT00442598|66228430|FG002|Overall Study|Reduced creatinine clearance|0|||
23686378|NCT00442598|66228428|FG000|Overall Study|Death|0|||
23496750|NCT03519178|65559037|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
23686379|NCT00442598|66228429|FG001|Overall Study|Death|1|||
23686380|NCT00442598|66228430|FG002|Overall Study|Death|0|||
23686381|NCT00501228|66228431|FG000|Overall Study|Withdrawal by Subject|1|||
23686382|NCT02586805|66228432|FG000|Overall Study|Withdrawal by Subject|3|||
23686383|NCT02586805|66228433|FG001|Overall Study|Withdrawal by Subject|1|||
23686384|NCT02586805|66228434|FG002|Overall Study|Withdrawal by Subject|1|||
23686385|NCT02586805|66228435|FG003|Overall Study|Withdrawal by Subject|2|||
23686386|NCT02586805|66228432|FG000|Overall Study|Adverse Event|2|||
23686387|NCT02586805|66228433|FG001|Overall Study|Adverse Event|0|||
23686388|NCT02586805|66228434|FG002|Overall Study|Adverse Event|1|||
23686389|NCT02586805|66228435|FG003|Overall Study|Adverse Event|0|||
23686390|NCT02586805|66228432|FG000|Overall Study|Lost to Follow-up|0|||
23686391|NCT02586805|66228433|FG001|Overall Study|Lost to Follow-up|0|||
23686392|NCT02586805|66228434|FG002|Overall Study|Lost to Follow-up|1|||
23686393|NCT02586805|66228435|FG003|Overall Study|Lost to Follow-up|0|||
23686394|NCT02586805|66228432|FG000|Overall Study|Physician Decision|1|||
23686395|NCT02586805|66228433|FG001|Overall Study|Physician Decision|0|||
23686396|NCT02586805|66228434|FG002|Overall Study|Physician Decision|0|||
23686397|NCT02586805|66228435|FG003|Overall Study|Physician Decision|0|||
23686398|NCT02393209|66228436|FG000|Overall Study|Study Terminated by Sponsor|1|||
23686399|NCT02393209|66228437|FG001|Overall Study|Study Terminated by Sponsor|1|||
23686400|NCT02393209|66228438|FG002|Overall Study|Study Terminated by Sponsor|0|||
23686401|NCT02393209|66228439|FG003|Overall Study|Study Terminated by Sponsor|0|||
23686402|NCT02393209|66228436|FG000|Overall Study|Withdrawal by Patient|1|||
23686403|NCT02393209|66228437|FG001|Overall Study|Withdrawal by Patient|0|||
23686404|NCT02393209|66228438|FG002|Overall Study|Withdrawal by Patient|0|||
23686405|NCT02393209|66228439|FG003|Overall Study|Withdrawal by Patient|0|||
23686406|NCT02393209|66228436|FG000|Overall Study|Death|2|||
23686407|NCT02393209|66228437|FG001|Overall Study|Death|2|||
23686408|NCT02393209|66228438|FG002|Overall Study|Death|0|||
23686409|NCT02393209|66228439|FG003|Overall Study|Death|0|||
23686410|NCT02393209|66228436|FG000|Overall Study|Death due to Disease Progression|2|||
23686411|NCT02393209|66228437|FG001|Overall Study|Death due to Disease Progression|2|||
23686412|NCT02393209|66228438|FG002|Overall Study|Death due to Disease Progression|0|||
23686413|NCT02393209|66228439|FG003|Overall Study|Death due to Disease Progression|0|||
23686414|NCT02393209|66228436|FG000|Overall Study|Death from Legionella Infection|0|||
23686415|NCT02393209|66228437|FG001|Overall Study|Death from Legionella Infection|1|||
23686416|NCT02393209|66228438|FG002|Overall Study|Death from Legionella Infection|0|||
23686417|NCT02393209|66228439|FG003|Overall Study|Death from Legionella Infection|0|||
23686418|NCT02393209|66228436|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
23686419|NCT02393209|66228437|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
23686420|NCT02393209|66228438|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
23686421|NCT02393209|66228439|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
23686422|NCT02393209|66228436|FG000|Overall Study|Lost to Follow-up|0|||
23686423|NCT02393209|66228437|FG001|Overall Study|Lost to Follow-up|1|||
23686424|NCT02393209|66228438|FG002|Overall Study|Lost to Follow-up|0|||
23686425|NCT02393209|66228439|FG003|Overall Study|Lost to Follow-up|0|||
23686426|NCT02029976|66228440|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
23686427|NCT02029976|66228441|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
23686428|NCT02029976|66228440|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
23686429|NCT02029976|66228441|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
23686430|NCT02029976|66228440|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
23686431|NCT02029976|66228441|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
23686432|NCT02029976|66228440|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
23686433|NCT02029976|66228441|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
23686434|NCT01053429|66228442|FG000|Overall Study|Adverse Event|64|||
23686435|NCT01053429|66228442|FG000|Overall Study|Other|309|||
23686436|NCT01285349|66228443|FG000|Overall Study|Lost to Follow-up|27|||
23686437|NCT01285349|66228444|FG001|Overall Study|Lost to Follow-up|20|||
23686438|NCT01285349|66228445|FG002|Overall Study|Lost to Follow-up|27|||
23686439|NCT00924703|66228446|FG000|Overall Study|Withdrawal by Subject|11|||
23686440|NCT00924703|66228446|FG000|Overall Study|Physician Decision|5|||
23686441|NCT00924703|66228446|FG000|Overall Study|Lost to Follow-up|3|||
23686442|NCT00924703|66228446|FG000|Overall Study|Adverse Event|2|||
23686443|NCT00924703|66228446|FG000|Overall Study|Withdrawal by Sponsor|1|||
23686444|NCT03403400|66228449|FG000|Overall Study|Lost to Follow-up|1|||
23686445|NCT03403400|66228450|FG001|Overall Study|Lost to Follow-up|0|||
23686446|NCT03403400|66228451|FG002|Overall Study|Lost to Follow-up|1|||
23686447|NCT03403400|66228449|FG000|Overall Study|Hospitalization|1|||
23686448|NCT03403400|66228450|FG001|Overall Study|Hospitalization|0|||
23686449|NCT03403400|66228451|FG002|Overall Study|Hospitalization|0|||
23686450|NCT03403400|66228449|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
23686451|NCT03403400|66228450|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
23686452|NCT03403400|66228451|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
23686453|NCT00355264|66228452|FG000|Extension (Variable Duration)|Adverse Event|1|||
23686454|NCT00355264|66228452|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
23686455|NCT03168867|66228454|FG000|Overall Study|Withdrawal by Subject|1|||
23686456|NCT03168867|66228455|FG001|Overall Study|Withdrawal by Subject|5|||
23686457|NCT01413958|66228456|FG000|Overall Study|Lost to Follow-up|0|||
23686458|NCT01413958|66228457|FG001|Overall Study|Lost to Follow-up|1|||
23686459|NCT00345605|66228458|FG000|Arm 1|Adverse Event|0|||
23686460|NCT00345605|66228459|FG001|Arm 1|Adverse Event|1|||
23686461|NCT00345605|66228458|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
23686462|NCT00345605|66228459|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
23686463|NCT01805180|66228462|FG000|Lead-in Donor Phase|screen failure|1|||
23686464|NCT01805180|66228463|FG001|Lead-in Donor Phase|screen failure|0|||
23686465|NCT01805180|66228464|FG002|Lead-in Donor Phase|screen failure|0|||
23686466|NCT00699192|66228465|FG000|Overall Study|Missing|1|||
23686467|NCT00699192|66228466|FG001|Overall Study|Missing|1|||
23686468|NCT00699192|66228467|FG002|Overall Study|Missing|1|||
23686469|NCT00699192|66228465|FG000|Overall Study|Adverse Event|9|||
23686470|NCT00699192|66228466|FG001|Overall Study|Adverse Event|4|||
23686471|NCT00699192|66228467|FG002|Overall Study|Adverse Event|3|||
23686472|NCT00699192|66228465|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23686473|NCT00699192|66228466|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23686474|NCT00699192|66228467|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23686475|NCT00699192|66228465|FG000|Overall Study|Lack of Efficacy|0|||
23686476|NCT00699192|66228466|FG001|Overall Study|Lack of Efficacy|0|||
23686477|NCT00699192|66228467|FG002|Overall Study|Lack of Efficacy|1|||
23686478|NCT00699192|66228465|FG000|Overall Study|Withdrawal by Subject|3|||
23686479|NCT00699192|66228466|FG001|Overall Study|Withdrawal by Subject|2|||
23686480|NCT00699192|66228467|FG002|Overall Study|Withdrawal by Subject|4|||
23686481|NCT00699192|66228465|FG000|Overall Study|Administrative problems|1|||
23686482|NCT00699192|66228466|FG001|Overall Study|Administrative problems|3|||
23686483|NCT00699192|66228467|FG002|Overall Study|Administrative problems|1|||
23686484|NCT00699192|66228465|FG000|Overall Study|Protocol Violation|2|||
23686485|NCT00699192|66228466|FG001|Overall Study|Protocol Violation|2|||
23686486|NCT00699192|66228467|FG002|Overall Study|Protocol Violation|0|||
23686487|NCT04007159|66228468|FG000|Induction Phase|(missed study visits)|16|||
23686488|NCT04007159|66228468|FG000|Induction Phase|Withdrawal by Subject|4|||
23686489|NCT04007159|66228468|FG000|Induction Phase|Adverse Event|2|||
23686490|NCT04007159|66228468|FG000|Challenge Phase|missed study visits|3|||
23686491|NCT02251912|66228470|FG000|Overall Study|Withdrawal by Subject|2|||
23686492|NCT02251912|66228471|FG001|Overall Study|Withdrawal by Subject|3|||
23686493|NCT02251912|66228470|FG000|Overall Study|Adverse Event|0|||
23686494|NCT02251912|66228471|FG001|Overall Study|Adverse Event|2|||
23686495|NCT00688909|66228472|FG000|Overall Study|Adverse Event|28|||
23686496|NCT00688909|66228472|FG000|Overall Study|Patient withdrew consent|2|||
23686497|NCT00688909|66228472|FG000|Overall Study|Administrative problems|1|||
23686498|NCT00688909|66228472|FG000|Overall Study|Protocol Violation|2|||
23686499|NCT00430755|66228476|FG000|Overall Study|Withdrawal by Subject|53|||
23686500|NCT02502864|66228477|FG000|Overall Study|Withdrawal by Subject|1|||
23686501|NCT02116621|66228480|FG000|Baseline|Withdrawal by Subject|0|||
23686502|NCT02116621|66228481|FG001|Baseline|Withdrawal by Subject|4|||
23686503|NCT02116621|66228480|FG000|Three Month Follow-up|Death|1|||
23686504|NCT02116621|66228481|FG001|Three Month Follow-up|Death|1|||
23686505|NCT02116621|66228480|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
23496751|NCT03519178|65559038|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
23496752|NCT03519178|65559039|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
23496753|NCT03519178|65559040|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
23496754|NCT03519178|65559026|FG000|Long-term Follow-up|Other|0|||
23496755|NCT03519178|65559027|FG001|Long-term Follow-up|Other|0|||
23496756|NCT03519178|65559028|FG002|Long-term Follow-up|Other|0|||
23496757|NCT03519178|65559029|FG003|Long-term Follow-up|Other|0|||
23496758|NCT03519178|65559030|FG004|Long-term Follow-up|Other|0|||
23496759|NCT03519178|65559031|FG005|Long-term Follow-up|Other|0|||
23496760|NCT03519178|65559032|FG006|Long-term Follow-up|Other|0|||
23496761|NCT03519178|65559033|FG007|Long-term Follow-up|Other|0|||
23496762|NCT03519178|65559034|FG008|Long-term Follow-up|Other|0|||
23496763|NCT03519178|65559035|FG009|Long-term Follow-up|Other|0|||
23496764|NCT03519178|65559036|FG010|Long-term Follow-up|Other|0|||
23496765|NCT03519178|65559037|FG011|Long-term Follow-up|Other|0|||
23496766|NCT03519178|65559038|FG012|Long-term Follow-up|Other|0|||
23496767|NCT03519178|65559039|FG013|Long-term Follow-up|Other|0|||
23496768|NCT03519178|65559040|FG014|Long-term Follow-up|Other|1|||
23496769|NCT03519178|65559026|FG000|Long-term Follow-up|Ongoing|0|||
23496770|NCT03519178|65559027|FG001|Long-term Follow-up|Ongoing|0|||
23496771|NCT03519178|65559028|FG002|Long-term Follow-up|Ongoing|0|||
23496772|NCT03519178|65559029|FG003|Long-term Follow-up|Ongoing|0|||
23496773|NCT03519178|65559030|FG004|Long-term Follow-up|Ongoing|0|||
23496774|NCT03519178|65559031|FG005|Long-term Follow-up|Ongoing|0|||
23496775|NCT03519178|65559032|FG006|Long-term Follow-up|Ongoing|0|||
23496776|NCT03519178|65559033|FG007|Long-term Follow-up|Ongoing|0|||
23496777|NCT03519178|65559034|FG008|Long-term Follow-up|Ongoing|0|||
23496778|NCT03519178|65559035|FG009|Long-term Follow-up|Ongoing|0|||
23496779|NCT03519178|65559036|FG010|Long-term Follow-up|Ongoing|0|||
23686506|NCT02116621|66228481|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
23686507|NCT02116621|66228480|FG000|Three Month Follow-up|Lost to Follow-up|0|||
23686508|NCT02116621|66228481|FG001|Three Month Follow-up|Lost to Follow-up|1|||
23686509|NCT02116621|66228480|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
23686510|NCT02116621|66228481|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
23686511|NCT02116621|66228480|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
23686512|NCT02116621|66228481|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
23686513|NCT02116621|66228480|FG000|Six Month Follow-up|Lost to Follow-up|2|||
23496780|NCT03519178|65559037|FG011|Long-term Follow-up|Ongoing|0|||
23496781|NCT03519178|65559038|FG012|Long-term Follow-up|Ongoing|0|||
23496782|NCT03519178|65559039|FG013|Long-term Follow-up|Ongoing|1|||
23496783|NCT03519178|65559040|FG014|Long-term Follow-up|Ongoing|0|||
23496784|NCT03685123|65562464|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
23496785|NCT03685123|65562465|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
23496786|NCT03685123|65562466|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
23496787|NCT03685123|65562464|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
23496788|NCT03685123|65562465|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
23496789|NCT03685123|65562466|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
23496790|NCT03685123|65562464|FG000|Weight Loss Phase|Lost to Follow-up|1|||
23496791|NCT03685123|65562465|FG001|Weight Loss Phase|Lost to Follow-up|0|||
23496792|NCT03685123|65562466|FG002|Weight Loss Phase|Lost to Follow-up|0|||
23496793|NCT03685123|65562464|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
23496794|NCT03685123|65562465|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
23496795|NCT03685123|65562466|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
23496796|NCT03685123|65562464|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
23496797|NCT03685123|65562465|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
23496798|NCT03685123|65562466|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
23496799|NCT03685123|65562464|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
23496800|NCT03685123|65562465|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
23496801|NCT03685123|65562466|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
23496802|NCT03724032|65562470|FG000|Overall Study|Physician Decision|1|||
23496803|NCT03724032|65562471|FG001|Overall Study|Physician Decision|0|||
23496804|NCT03724032|65562472|FG002|Overall Study|Physician Decision|0|||
23496805|NCT03724032|65562470|FG000|Overall Study|Protocol Violation|2|||
23496806|NCT03724032|65562471|FG001|Overall Study|Protocol Violation|2|||
23496807|NCT03724032|65562472|FG002|Overall Study|Protocol Violation|1|||
23496808|NCT01548287|65562474|FG000|Screening|No reason provided|0|||
23496809|NCT01548287|65562475|FG001|Screening|No reason provided|0|||
23496810|NCT01548287|65562476|FG002|Screening|No reason provided|0|||
23496811|NCT01548287|65562477|FG003|Screening|No reason provided|0|||
23496812|NCT01548287|65562478|FG004|Screening|No reason provided|9|||
23496813|NCT01548287|65562474|FG000|Screening|Did not meet eligibility criteria|0|||
23496814|NCT01548287|65562475|FG001|Screening|Did not meet eligibility criteria|0|||
23496815|NCT01548287|65562476|FG002|Screening|Did not meet eligibility criteria|0|||
23496816|NCT01548287|65562477|FG003|Screening|Did not meet eligibility criteria|0|||
23496817|NCT01548287|65562478|FG004|Screening|Did not meet eligibility criteria|74|||
23496818|NCT01548287|65562474|FG000|Randomized Period|Did not meet inclusion criteria|0|||
23496819|NCT01548287|65562475|FG001|Randomized Period|Did not meet inclusion criteria|0|||
23496820|NCT01548287|65562476|FG002|Randomized Period|Did not meet inclusion criteria|2|||
23496821|NCT01548287|65562477|FG003|Randomized Period|Did not meet inclusion criteria|0|||
23496822|NCT01548287|65562478|FG004|Randomized Period|Did not meet inclusion criteria|0|||
23496823|NCT01548287|65562474|FG000|Randomized Period|Adverse Event|0|||
23496824|NCT01548287|65562475|FG001|Randomized Period|Adverse Event|2|||
23496825|NCT01548287|65562476|FG002|Randomized Period|Adverse Event|5|||
23496826|NCT01548287|65562477|FG003|Randomized Period|Adverse Event|0|||
23496827|NCT01548287|65562478|FG004|Randomized Period|Adverse Event|0|||
23496828|NCT02229383|65562479|FG000|Overall Study|Adverse Event|7|||
23496829|NCT02229383|65562480|FG001|Overall Study|Adverse Event|4|||
23496830|NCT02229383|65562479|FG000|Overall Study|Death|0|||
23496831|NCT02229383|65562480|FG001|Overall Study|Death|1|||
23496832|NCT02229383|65562479|FG000|Overall Study|Lost to Follow-up|5|||
23496833|NCT02229383|65562480|FG001|Overall Study|Lost to Follow-up|3|||
23496834|NCT02229383|65562479|FG000|Overall Study|Withdrawal by Subject|4|||
23496835|NCT02229383|65562480|FG001|Overall Study|Withdrawal by Subject|6|||
23496836|NCT02229383|65562479|FG000|Overall Study|Did not receive treatment|1|||
23496837|NCT02229383|65562480|FG001|Overall Study|Did not receive treatment|0|||
23496838|NCT02229383|65562479|FG000|Overall Study|Other|3|||
23496839|NCT02229383|65562480|FG001|Overall Study|Other|8|||
23496840|NCT05213481|65562481|FG000|Overall Study|Adverse Event|3|||
23496841|NCT05213481|65562481|FG000|Overall Study|Lost to Follow-up|1|||
23496842|NCT00894166|65562484|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
23686514|NCT02116621|66228481|FG001|Six Month Follow-up|Lost to Follow-up|1|||
23496843|NCT00894166|65562485|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
23496844|NCT00894166|65562486|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
23496845|NCT00894166|65562487|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
23496846|NCT00894166|65562488|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
23496847|NCT00894166|65562489|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
23496848|NCT00894166|65562490|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
23496849|NCT00894166|65562491|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
23496850|NCT00894166|65562484|FG000|Overall Study|Death|0|||
23496851|NCT00894166|65562485|FG001|Overall Study|Death|0|||
23496852|NCT00894166|65562486|FG002|Overall Study|Death|0|||
23496853|NCT00894166|65562487|FG003|Overall Study|Death|1|||
23496854|NCT00894166|65562488|FG004|Overall Study|Death|0|||
23496855|NCT00894166|65562489|FG005|Overall Study|Death|0|||
23496856|NCT00894166|65562490|FG006|Overall Study|Death|0|||
23496857|NCT00894166|65562491|FG007|Overall Study|Death|0|||
23496858|NCT02217878|65562494|FG000|Overall Study|required morphine due to chest pain|1|||
23496859|NCT02217878|65562495|FG001|Overall Study|required morphine due to chest pain|2|||
23496860|NCT02217878|65562494|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
23496861|NCT02217878|65562495|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
23496862|NCT00880542|65562499|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
23496863|NCT00880542|65562499|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
23496864|NCT00880542|65562499|FG000|REP: Surgical Resection|progressive disease|1|||
23496865|NCT01651039|65562500|FG000|Overall Study|Non-evaluables|5|||
23496866|NCT01651039|65562500|FG000|Overall Study|Physician Decision|2|||
23496867|NCT01651039|65562500|FG000|Overall Study|Withdrawal by Subject|1|||
23496868|NCT01651039|65562500|FG000|Overall Study|Progressive Disease|22|||
23496869|NCT03673046|65562501|FG000|Overall Study|Adverse Event|1|||
23496870|NCT03673046|65562502|FG001|Overall Study|Adverse Event|1|||
23496871|NCT03673046|65562501|FG000|Overall Study|Withdrawal by Subject|8|||
23496872|NCT03673046|65562502|FG001|Overall Study|Withdrawal by Subject|2|||
23496873|NCT00446251|65562506|FG000|Overall Study|On-study Transplants|2|||
23496874|NCT00446251|65562506|FG000|Overall Study|Rituximab Infusion Reaction|2|||
23496875|NCT00446251|65562506|FG000|Overall Study|Lost to Follow-up|1|||
23496876|NCT03087643|65562507|FG000|Overall Study|Withdrawal by Subject|2|||
23496877|NCT03087643|65562508|FG001|Overall Study|Withdrawal by Subject|4|||
23496878|NCT03087643|65562507|FG000|Overall Study|Death|2|||
23496879|NCT03087643|65562508|FG001|Overall Study|Death|2|||
23496880|NCT04674644|65562509|FG000|Overall Study|with missing data|37|||
23496881|NCT02699593|65562510|FG000|Period 1|Unsatisfactory Visual Response|0|||
23496882|NCT02699593|65562511|FG001|Period 1|Unsatisfactory Visual Response|1|||
23496883|NCT02699593|65562510|FG000|Period 1|Torn Contact Len|4|||
23496884|NCT02699593|65562511|FG001|Period 1|Torn Contact Len|3|||
23496885|NCT02699593|65562510|FG000|Period 1|Protocol Violation|0|||
23496886|NCT02699593|65562511|FG001|Period 1|Protocol Violation|1|||
23496887|NCT02699593|65562510|FG000|Period 1|Withdrawal by Subject|0|||
23496888|NCT02699593|65562511|FG001|Period 1|Withdrawal by Subject|1|||
23496889|NCT02699593|65562510|FG000|Period 1|Adverse Event|1|||
23496890|NCT02699593|65562511|FG001|Period 1|Adverse Event|1|||
23496891|NCT02699593|65562510|FG000|Period 2|Adverse Event|1|||
23496892|NCT02699593|65562511|FG001|Period 2|Adverse Event|1|||
23496893|NCT02699593|65562510|FG000|Period 2|Lost Contact Lens|0|||
23496894|NCT02699593|65562511|FG001|Period 2|Lost Contact Lens|1|||
23496895|NCT02699593|65562510|FG000|Period 2|Torn Contact Lens|1|||
23496896|NCT02699593|65562511|FG001|Period 2|Torn Contact Lens|0|||
23496897|NCT00150709|65562514|FG000|Overall Study|Protocol Violation|7|||
23496898|NCT00150709|65562515|FG001|Overall Study|Protocol Violation|8|||
23496899|NCT00150709|65562516|FG002|Overall Study|Protocol Violation|3|||
23496900|NCT00150709|65562517|FG003|Overall Study|Protocol Violation|1|||
23496901|NCT00150709|65562514|FG000|Overall Study|Adverse Event|8|||
23496902|NCT00150709|65562515|FG001|Overall Study|Adverse Event|2|||
23496903|NCT00150709|65562516|FG002|Overall Study|Adverse Event|2|||
23496904|NCT00150709|65562517|FG003|Overall Study|Adverse Event|3|||
23686515|NCT02116621|66228480|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
23686516|NCT02116621|66228481|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
23686517|NCT02116621|66228480|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
23686518|NCT02116621|66228481|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
23686519|NCT02116621|66228480|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
23686520|NCT02116621|66228481|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
23686521|NCT02116621|66228480|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
23686522|NCT02116621|66228481|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
23686523|NCT02116621|66228480|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
23496905|NCT00150709|65562514|FG000|Overall Study|Lack of Efficacy|6|||
23686524|NCT02116621|66228481|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
23686525|NCT00680836|66228482|FG000|Overall Study|Withdrawal by Subject|3|||
23686526|NCT00680836|66228483|FG001|Overall Study|Withdrawal by Subject|0|||
23686527|NCT00680836|66228482|FG000|Overall Study|Lost to Follow-up|3|||
23686528|NCT00680836|66228483|FG001|Overall Study|Lost to Follow-up|1|||
23686529|NCT00680836|66228482|FG000|Overall Study|Physician Decision|2|||
23686530|NCT00680836|66228483|FG001|Overall Study|Physician Decision|1|||
23496906|NCT00150709|65562515|FG001|Overall Study|Lack of Efficacy|11|||
23496907|NCT00150709|65562516|FG002|Overall Study|Lack of Efficacy|9|||
23496908|NCT00150709|65562517|FG003|Overall Study|Lack of Efficacy|0|||
23496909|NCT00150709|65562514|FG000|Overall Study|Withdrawal by Subject|7|||
23496910|NCT00150709|65562515|FG001|Overall Study|Withdrawal by Subject|10|||
23496911|NCT00150709|65562516|FG002|Overall Study|Withdrawal by Subject|5|||
23496912|NCT00150709|65562517|FG003|Overall Study|Withdrawal by Subject|0|||
23496913|NCT00150709|65562514|FG000|Overall Study|Lost to Follow-up|3|||
23496914|NCT00150709|65562515|FG001|Overall Study|Lost to Follow-up|2|||
23686531|NCT03772327|66228484|FG000|Overall Study|Lost to Follow-up|3|||
23496915|NCT00150709|65562516|FG002|Overall Study|Lost to Follow-up|0|||
23496916|NCT00150709|65562517|FG003|Overall Study|Lost to Follow-up|0|||
23496917|NCT00150709|65562514|FG000|Overall Study|Sponsor decision|0|||
23496918|NCT00150709|65562515|FG001|Overall Study|Sponsor decision|0|||
23496919|NCT00150709|65562516|FG002|Overall Study|Sponsor decision|0|||
23496920|NCT00150709|65562517|FG003|Overall Study|Sponsor decision|1|||
23496921|NCT00150709|65562514|FG000|Overall Study|Site/Investigator discontinued the study|5|||
23496922|NCT00150709|65562515|FG001|Overall Study|Site/Investigator discontinued the study|5|||
23496923|NCT00150709|65562516|FG002|Overall Study|Site/Investigator discontinued the study|2|||
23496924|NCT00150709|65562517|FG003|Overall Study|Site/Investigator discontinued the study|0|||
23496925|NCT00150709|65562514|FG000|Overall Study|Decision of parent(s)|1|||
23496926|NCT00150709|65562515|FG001|Overall Study|Decision of parent(s)|2|||
23496927|NCT00150709|65562516|FG002|Overall Study|Decision of parent(s)|0|||
23496928|NCT00150709|65562517|FG003|Overall Study|Decision of parent(s)|0|||
23496929|NCT00150709|65562514|FG000|Overall Study|Decision of parent(s) and investigator|3|||
23496930|NCT00150709|65562515|FG001|Overall Study|Decision of parent(s) and investigator|0|||
23496931|NCT00150709|65562516|FG002|Overall Study|Decision of parent(s) and investigator|0|||
23496932|NCT00150709|65562517|FG003|Overall Study|Decision of parent(s) and investigator|0|||
23496933|NCT00150709|65562514|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
23496934|NCT00150709|65562515|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
23496935|NCT00150709|65562516|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
23496936|NCT00150709|65562517|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
23496937|NCT00150709|65562514|FG000|Overall Study|Investigator decision|1|||
23496938|NCT00150709|65562515|FG001|Overall Study|Investigator decision|0|||
23496939|NCT00150709|65562516|FG002|Overall Study|Investigator decision|0|||
23496940|NCT00150709|65562517|FG003|Overall Study|Investigator decision|1|||
23496941|NCT00150709|65562514|FG000|Overall Study|Subject relocated|2|||
23496942|NCT00150709|65562515|FG001|Overall Study|Subject relocated|2|||
23496943|NCT00150709|65562516|FG002|Overall Study|Subject relocated|1|||
23496944|NCT00150709|65562517|FG003|Overall Study|Subject relocated|0|||
23496945|NCT00150709|65562514|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
23496946|NCT00150709|65562515|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
23496947|NCT00150709|65562516|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
23496948|NCT00150709|65562517|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
23496949|NCT00150709|65562514|FG000|Overall Study|Convenience|0|||
23496950|NCT00150709|65562515|FG001|Overall Study|Convenience|1|||
23496951|NCT00150709|65562516|FG002|Overall Study|Convenience|0|||
23496952|NCT00150709|65562517|FG003|Overall Study|Convenience|0|||
23496953|NCT00150709|65562514|FG000|Overall Study|Subject entered new drug study|0|||
23496954|NCT00150709|65562515|FG001|Overall Study|Subject entered new drug study|1|||
23496955|NCT00150709|65562516|FG002|Overall Study|Subject entered new drug study|0|||
23496956|NCT00150709|65562517|FG003|Overall Study|Subject entered new drug study|0|||
23496957|NCT00150709|65562514|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
23496958|NCT00150709|65562515|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
23496959|NCT00150709|65562516|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
23496960|NCT00150709|65562517|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
23496961|NCT00150709|65562514|FG000|Overall Study|Lack of ease of swallowing|0|||
23496962|NCT00150709|65562515|FG001|Overall Study|Lack of ease of swallowing|1|||
23496963|NCT00150709|65562516|FG002|Overall Study|Lack of ease of swallowing|0|||
23496964|NCT00150709|65562517|FG003|Overall Study|Lack of ease of swallowing|0|||
23496965|NCT03342963|65562518|FG000|Overall Study|Adverse Event|1|||
23496966|NCT03342963|65562519|FG001|Overall Study|Adverse Event|2|||
23496967|NCT03342963|65562520|FG002|Overall Study|Adverse Event|0|||
23496968|NCT03342963|65562521|FG003|Overall Study|Adverse Event|0|||
23496969|NCT03342963|65562518|FG000|Overall Study|Withdrawal by Subject|1|||
23496970|NCT03342963|65562519|FG001|Overall Study|Withdrawal by Subject|0|||
23496971|NCT03342963|65562520|FG002|Overall Study|Withdrawal by Subject|0|||
23496972|NCT03342963|65562521|FG003|Overall Study|Withdrawal by Subject|0|||
23496973|NCT01453361|65562522|FG000|Overall Study|Disease Progression|6|||
23496974|NCT01453361|65562522|FG000|Overall Study|Screen-Failures|10|||
23496975|NCT00957580|65562523|FG000|Overall Study|Ongoing at data cut-off|0|||
23496976|NCT00957580|65562524|FG001|Overall Study|Ongoing at data cut-off|1|||
23686532|NCT03772327|66228485|FG001|Overall Study|Lost to Follow-up|4|||
23496977|NCT00957580|65562525|FG002|Overall Study|Ongoing at data cut-off|0|||
23496978|NCT00957580|65562523|FG000|Overall Study|Enrolled but not treated|0|||
23496979|NCT00957580|65562524|FG001|Overall Study|Enrolled but not treated|1|||
23496980|NCT00957580|65562525|FG002|Overall Study|Enrolled but not treated|0|||
23496981|NCT00621582|65562526|FG000|Overall Study|Adverse Event|7|||
23496982|NCT00621582|65562526|FG000|Overall Study|Protocol Violation|57|||
23496983|NCT00621582|65562526|FG000|Overall Study|Lost to Follow-up|24|||
23496984|NCT00621582|65562526|FG000|Overall Study|issues not identified by investigators|18|||
23496985|NCT00457301|65562527|FG000|Overall Study|Withdrawal by Subject|3|||
23686533|NCT03772327|66228484|FG000|Overall Study|Withdrawal by Subject|2|||
23686534|NCT03772327|66228485|FG001|Overall Study|Withdrawal by Subject|3|||
23686535|NCT03822884|66228488|FG000|Overall Study|Withdrawal by Subject|0|||
23686536|NCT03822884|66228489|FG001|Overall Study|Withdrawal by Subject|0|||
23686537|NCT03822884|66228490|FG002|Overall Study|Withdrawal by Subject|0|||
23686538|NCT03822884|66228491|FG003|Overall Study|Withdrawal by Subject|0|||
23686539|NCT03822884|66228492|FG004|Overall Study|Withdrawal by Subject|1|||
23686540|NCT03822884|66228493|FG005|Overall Study|Withdrawal by Subject|0|||
23686541|NCT01993888|66228494|FG000|Overall Study|Death|1|||
23686542|NCT01993888|66228495|FG001|Overall Study|Death|1|||
23686543|NCT01993888|66228494|FG000|Overall Study|Lost to Follow-up|1|||
23686544|NCT01993888|66228495|FG001|Overall Study|Lost to Follow-up|1|||
23686545|NCT01993888|66228494|FG000|Overall Study|Withdrawal by Subject|0|||
23686546|NCT01993888|66228495|FG001|Overall Study|Withdrawal by Subject|1|||
23686547|NCT00670007|66228496|FG000|Overall Study|Drug abuse|1|||
23686548|NCT00670007|66228496|FG000|Overall Study|Lung transplant|1|||
23686549|NCT00670007|66228496|FG000|Overall Study|Travel/Vacation|1|||
23686550|NCT00670007|66228496|FG000|Overall Study|Adverse event, serious fatal|1|||
23686551|NCT00670007|66228496|FG000|Overall Study|Adverse Event|1|||
23686552|NCT00670007|66228496|FG000|Overall Study|Withdrawal by Subject|4|||
23392912|NCT02721732|65184844|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392913|NCT02721732|65184845|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392914|NCT02721732|65184836|FG000|Overall Study|Progression and withdrew consent|1|||
23392915|NCT02721732|65184837|FG001|Overall Study|Progression and withdrew consent|1|||
23392916|NCT02721732|65184838|FG002|Overall Study|Progression and withdrew consent|0|||
23392917|NCT02721732|65184839|FG003|Overall Study|Progression and withdrew consent|0|||
23392918|NCT02721732|65184840|FG004|Overall Study|Progression and withdrew consent|0|||
23392919|NCT02721732|65184841|FG005|Overall Study|Progression and withdrew consent|0|||
23392920|NCT02721732|65184842|FG006|Overall Study|Progression and withdrew consent|0|||
23392921|NCT02721732|65184843|FG007|Overall Study|Progression and withdrew consent|0|||
23392922|NCT02721732|65184844|FG008|Overall Study|Progression and withdrew consent|0|||
23392923|NCT02721732|65184845|FG009|Overall Study|Progression and withdrew consent|1|||
23392924|NCT02721732|65184836|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
23392925|NCT02721732|65184837|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
23392926|NCT02721732|65184838|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
23392927|NCT02721732|65184839|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
23392928|NCT02721732|65184840|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
23392929|NCT02721732|65184841|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
23392930|NCT02721732|65184842|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
23392931|NCT02721732|65184843|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
23392932|NCT02721732|65184844|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
23392933|NCT02721732|65184845|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
23392934|NCT02096354|65184846|FG000|Overall Study|Physician Decision|4|||
23392935|NCT02096354|65184847|FG001|Overall Study|Physician Decision|5|||
23392936|NCT02096354|65184848|FG002|Overall Study|Physician Decision|0|||
23392937|NCT02096354|65184846|FG000|Overall Study|Withdrawal by Subject|3|||
23392938|NCT02096354|65184847|FG001|Overall Study|Withdrawal by Subject|1|||
23392939|NCT02096354|65184848|FG002|Overall Study|Withdrawal by Subject|0|||
23392940|NCT02096354|65184846|FG000|Overall Study|Adverse Event|7|||
23392941|NCT02096354|65184847|FG001|Overall Study|Adverse Event|4|||
23392942|NCT02096354|65184848|FG002|Overall Study|Adverse Event|0|||
23392943|NCT02096354|65184846|FG000|Overall Study|Ineligible|0|||
23392944|NCT02096354|65184847|FG001|Overall Study|Ineligible|0|||
23392945|NCT02096354|65184848|FG002|Overall Study|Ineligible|11|||
23392946|NCT00645658|65184854|FG000|Overall Study|Withdrawal by Subject|1|||
23392947|NCT00645658|65184855|FG001|Overall Study|Withdrawal by Subject|0|||
23392948|NCT00645658|65184854|FG000|Overall Study|Did not complete all assesments|0|||
23392949|NCT00645658|65184855|FG001|Overall Study|Did not complete all assesments|2|||
23392950|NCT03569891|65184856|FG000|Lead-in|Ineligible during lead-in|8|||
23392951|NCT03569891|65184856|FG000|Lead-in|Withdrawal by Subject|3|||
23392952|NCT03569891|65184856|FG000|Lead-in|Risks related to COVID-19|2|||
23392953|NCT03569891|65184856|FG000|AMT-061|Adverse Event|1|||
23392954|NCT03423979|65184857|FG000|Overall Study|Death|1|||
23392955|NCT03692052|65184860|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
23392956|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
23392957|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
23392958|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
23392959|NCT01500135|65184871|FG000|Overall Study|Withdrawal of Consent|4|||
23392960|NCT01500135|65184872|FG001|Overall Study|Withdrawal of Consent|0|||
23686553|NCT00950170|66228499|FG000|Overall Study|Parent/Legal Guardian Request|1|||
23686554|NCT00950170|66228499|FG000|Overall Study|Adverse Event|2|||
23686555|NCT00950170|66228499|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23686556|NCT02382133|66228510|FG000|Overall Study|Death|22|||
23686557|NCT02382133|66228510|FG000|Overall Study|transfer out of ICU|4|||
23686558|NCT02382133|66228510|FG000|Overall Study|Physician Decision|2|||
23496986|NCT00457301|65562528|FG001|Overall Study|Withdrawal by Subject|3|||
23496987|NCT00457301|65562527|FG000|Overall Study|Censored out of the study|15|||
23496988|NCT00457301|65562528|FG001|Overall Study|Censored out of the study|14|||
23496989|NCT00457301|65562527|FG000|Overall Study|Death|5|||
23496990|NCT00457301|65562528|FG001|Overall Study|Death|7|||
23496991|NCT03000569|65562529|FG000|Overall Study|Withdrawal by Subject|1|||
23496992|NCT03000569|65562530|FG001|Overall Study|Withdrawal by Subject|0|||
23496993|NCT00165984|65562531|FG000|Overall Study|Death|15|||
23496994|NCT02059408|65562532|FG000|Overall Study|Did not get tested|0|||
23496995|NCT02059408|65562533|FG001|Overall Study|Did not get tested|330|||
23496996|NCT02059408|65562534|FG002|Overall Study|Did not get tested|358|||
23496997|NCT01706146|65562535|FG000|Overall Study|Withdrawal by Subject|1|||
23496998|NCT01706146|65562535|FG000|Overall Study|Adverse Event|3|||
23496999|NCT01706146|65562535|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
23497000|NCT02202980|65562539|FG000|Overall Study|Lack of Efficacy|1|||
23497001|NCT02202980|65562540|FG001|Overall Study|Lack of Efficacy|0|||
23497002|NCT02202980|65562541|FG002|Overall Study|Lack of Efficacy|7|||
23497003|NCT02202980|65562542|FG003|Overall Study|Lack of Efficacy|0|||
23497004|NCT02202980|65562543|FG004|Overall Study|Lack of Efficacy|3|||
23497005|NCT02202980|65562544|FG005|Overall Study|Lack of Efficacy|1|||
23497006|NCT02202980|65562545|FG006|Overall Study|Lack of Efficacy|11|||
23497007|NCT02202980|65562546|FG007|Overall Study|Lack of Efficacy|2|||
23497008|NCT02202980|65562547|FG008|Overall Study|Lack of Efficacy|2|||
23497009|NCT02202980|65562548|FG009|Overall Study|Lack of Efficacy|0|||
23497010|NCT02202980|65562549|FG010|Overall Study|Lack of Efficacy|0|||
23497011|NCT02202980|65562550|FG011|Overall Study|Lack of Efficacy|3|||
23497012|NCT02202980|65562551|FG012|Overall Study|Lack of Efficacy|10|||
23497013|NCT02202980|65562552|FG013|Overall Study|Lack of Efficacy|0|||
23497014|NCT02202980|65562539|FG000|Overall Study|Protocol Violation|0|||
23497015|NCT02202980|65562540|FG001|Overall Study|Protocol Violation|0|||
23497016|NCT02202980|65562541|FG002|Overall Study|Protocol Violation|0|||
23497017|NCT02202980|65562542|FG003|Overall Study|Protocol Violation|3|||
23497018|NCT02202980|65562543|FG004|Overall Study|Protocol Violation|3|||
23497019|NCT02202980|65562544|FG005|Overall Study|Protocol Violation|0|||
23497020|NCT02202980|65562545|FG006|Overall Study|Protocol Violation|0|||
23497021|NCT02202980|65562546|FG007|Overall Study|Protocol Violation|0|||
23497022|NCT02202980|65562547|FG008|Overall Study|Protocol Violation|0|||
23497023|NCT02202980|65562548|FG009|Overall Study|Protocol Violation|0|||
23497024|NCT02202980|65562549|FG010|Overall Study|Protocol Violation|0|||
23497025|NCT02202980|65562550|FG011|Overall Study|Protocol Violation|0|||
23497026|NCT02202980|65562551|FG012|Overall Study|Protocol Violation|0|||
23497027|NCT02202980|65562552|FG013|Overall Study|Protocol Violation|0|||
23497028|NCT02202980|65562539|FG000|Overall Study|Lost to Follow-up|0|||
23497029|NCT02202980|65562540|FG001|Overall Study|Lost to Follow-up|1|||
23497030|NCT02202980|65562541|FG002|Overall Study|Lost to Follow-up|1|||
23497031|NCT02202980|65562542|FG003|Overall Study|Lost to Follow-up|1|||
23497032|NCT02202980|65562543|FG004|Overall Study|Lost to Follow-up|0|||
23497033|NCT02202980|65562544|FG005|Overall Study|Lost to Follow-up|0|||
23497034|NCT02202980|65562545|FG006|Overall Study|Lost to Follow-up|0|||
23497035|NCT02202980|65562546|FG007|Overall Study|Lost to Follow-up|1|||
23497036|NCT02202980|65562547|FG008|Overall Study|Lost to Follow-up|1|||
23497037|NCT02202980|65562548|FG009|Overall Study|Lost to Follow-up|0|||
23497038|NCT02202980|65562549|FG010|Overall Study|Lost to Follow-up|0|||
23497039|NCT02202980|65562550|FG011|Overall Study|Lost to Follow-up|0|||
23497040|NCT02202980|65562551|FG012|Overall Study|Lost to Follow-up|1|||
23497041|NCT02202980|65562552|FG013|Overall Study|Lost to Follow-up|0|||
23497042|NCT02202980|65562539|FG000|Overall Study|Withdrew Consent|0|||
23497043|NCT02202980|65562540|FG001|Overall Study|Withdrew Consent|1|||
23497044|NCT02202980|65562541|FG002|Overall Study|Withdrew Consent|2|||
23497045|NCT02202980|65562542|FG003|Overall Study|Withdrew Consent|0|||
23497046|NCT02202980|65562543|FG004|Overall Study|Withdrew Consent|0|||
23497047|NCT02202980|65562544|FG005|Overall Study|Withdrew Consent|0|||
23497048|NCT02202980|65562545|FG006|Overall Study|Withdrew Consent|0|||
23497049|NCT02202980|65562546|FG007|Overall Study|Withdrew Consent|0|||
23497050|NCT02202980|65562547|FG008|Overall Study|Withdrew Consent|1|||
23497051|NCT02202980|65562548|FG009|Overall Study|Withdrew Consent|0|||
23497052|NCT02202980|65562549|FG010|Overall Study|Withdrew Consent|0|||
23497053|NCT02202980|65562550|FG011|Overall Study|Withdrew Consent|0|||
23497054|NCT02202980|65562551|FG012|Overall Study|Withdrew Consent|0|||
23497055|NCT02202980|65562552|FG013|Overall Study|Withdrew Consent|0|||
23497056|NCT00736944|65562557|FG000|Induction|Death|1|||
23497057|NCT00736944|65562557|FG000|Definitive Treatment|Physician Decision|1|||
23497058|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
23497059|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
23497060|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
23497061|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
23497062|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
23497063|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
23392961|NCT01500135|65184871|FG000|Overall Study|Lost to Follow-up|6|||
23497064|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
23497065|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
23497066|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
23497067|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
23497068|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
23497069|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
23497070|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
23497071|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
23497072|NCT00044083|65562559|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
23497073|NCT00044083|65562560|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
23497074|NCT00044083|65562559|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
23497075|NCT00044083|65562560|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
23497076|NCT00044083|65562559|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
23497077|NCT00044083|65562560|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
23497078|NCT01330030|65562564|FG000|Overall Study|Lost to Follow-up|16|||
23497079|NCT01330030|65562565|FG001|Overall Study|Lost to Follow-up|17|||
23497080|NCT03113071|65562568|FG000|Overall Study|Withdrawal by Subject|1|||
23497081|NCT03113071|65562569|FG001|Overall Study|Withdrawal by Subject|0|||
23497082|NCT01409434|65562570|FG000|Overall Study|Protocol Violation|4|||
23497083|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
23497084|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
23497085|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
23497086|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
23497087|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
23497088|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
23497089|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
23497090|NCT00369707|65562571|FG000|Follow up for 2 Years After Treatment|Death|1|||
23497091|NCT00369707|65562571|FG000|Follow up for 2 Years After Treatment|Other|2|||
23497092|NCT02564796|65562574|FG000|Overall Study|Physician Decision|2|||
23497093|NCT02564796|65562575|FG001|Overall Study|Physician Decision|2|||
23497094|NCT01558739|65562576|FG000|Overall Study|Adverse Event|7|||
23497095|NCT01558739|65562576|FG000|Overall Study|Withdrawal by Subject|2|||
23497096|NCT01558739|65562576|FG000|Overall Study|Death|3|||
23497097|NCT01558739|65562576|FG000|Overall Study|Disease Progression|4|||
23497098|NCT01558739|65562576|FG000|Overall Study|Protocol Violation|1|||
23497099|NCT03068455|65562579|FG000|Pre-treatment Period|Disease progression|0|||
23497100|NCT03068455|65562580|FG001|Pre-treatment Period|Disease progression|1|||
23497101|NCT03068455|65562579|FG000|Pre-treatment Period|Participant withdrew consent|1|||
23497102|NCT03068455|65562580|FG001|Pre-treatment Period|Participant withdrew consent|1|||
23497103|NCT03068455|65562579|FG000|Pre-treatment Period|Poor/non-compliance|0|||
23497104|NCT03068455|65562580|FG001|Pre-treatment Period|Poor/non-compliance|1|||
23497105|NCT03068455|65562579|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
23497106|NCT03068455|65562580|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
23497107|NCT03068455|65562579|FG000|Pre-treatment Period|Not reported|2|||
23497108|NCT03068455|65562580|FG001|Pre-treatment Period|Not reported|1|||
23497109|NCT03068455|65562579|FG000|Treatment Period|Disease progression|166|||
23497110|NCT03068455|65562580|FG001|Treatment Period|Disease progression|208|||
23497111|NCT03068455|65562579|FG000|Treatment Period|Study drug toxicity|317|||
23497112|NCT03068455|65562580|FG001|Treatment Period|Study drug toxicity|104|||
23497113|NCT03068455|65562579|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
23497114|NCT03068455|65562580|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
23497115|NCT03068455|65562579|FG000|Treatment Period|Participant request to stop therapy|33|||
23497116|NCT03068455|65562580|FG001|Treatment Period|Participant request to stop therapy|20|||
23497117|NCT03068455|65562579|FG000|Treatment Period|Participant withdrew consent|5|||
23497118|NCT03068455|65562580|FG001|Treatment Period|Participant withdrew consent|10|||
23497119|NCT03068455|65562579|FG000|Treatment Period|Poor/non-compliance|3|||
23497120|NCT03068455|65562580|FG001|Treatment Period|Poor/non-compliance|0|||
23497121|NCT03068455|65562579|FG000|Treatment Period|Participant no longer meets study criteria|1|||
23497122|NCT03068455|65562580|FG001|Treatment Period|Participant no longer meets study criteria|3|||
23497123|NCT03068455|65562579|FG000|Treatment Period|Other reasons|12|||
23497124|NCT03068455|65562580|FG001|Treatment Period|Other reasons|4|||
23497125|NCT03344796|65562582|FG000|Overall Study|Lost to Follow-up|0|||
23686559|NCT02382133|66228510|FG000|Overall Study|arterial catheter loss|4|||
23497126|NCT03344796|65562583|FG001|Overall Study|Lost to Follow-up|0|||
23497127|NCT03344796|65562584|FG002|Overall Study|Lost to Follow-up|0|||
23497128|NCT03344796|65562585|FG003|Overall Study|Lost to Follow-up|0|||
23497129|NCT03344796|65562586|FG004|Overall Study|Lost to Follow-up|0|||
23497130|NCT03344796|65562587|FG005|Overall Study|Lost to Follow-up|2|||
23497131|NCT00851630|65562594|FG000|Overall Study|Death|2|||
23497132|NCT00851630|65562595|FG001|Overall Study|Death|1|||
23497133|NCT00851630|65562594|FG000|Overall Study|Clinical failure|0|||
23497134|NCT00851630|65562595|FG001|Overall Study|Clinical failure|1|||
23497135|NCT00751933|65562596|FG000|Overall Study|Withdrawal by Subject|0|||
23497136|NCT00751933|65562597|FG001|Overall Study|Withdrawal by Subject|1|||
23497137|NCT00751933|65562598|FG002|Overall Study|Withdrawal by Subject|0|||
23497138|NCT00751933|65562599|FG003|Overall Study|Withdrawal by Subject|0|||
23497139|NCT00751933|65562596|FG000|Overall Study|Physician Decision|0|||
23497140|NCT00751933|65562597|FG001|Overall Study|Physician Decision|0|||
23497141|NCT00751933|65562598|FG002|Overall Study|Physician Decision|1|||
23497142|NCT00751933|65562599|FG003|Overall Study|Physician Decision|1|||
23497143|NCT05085730|65562600|FG000|Overall Study|Withdrawal by Subject|4|||
23497144|NCT05085730|65562600|FG000|Overall Study|Physician Decision|1|||
23497145|NCT01488370|65562605|FG000|Overall Study|Protocol Violation|0|||
23497146|NCT01488370|65562606|FG001|Overall Study|Protocol Violation|1|||
23497147|NCT01488370|65562607|FG002|Overall Study|Protocol Violation|1|||
23497148|NCT00306189|65562609|FG000|Overall Study|Physician Decision|0|||
23497149|NCT00306189|65562610|FG001|Overall Study|Physician Decision|0|||
23497150|NCT00306189|65562611|FG002|Overall Study|Physician Decision|0|||
23497151|NCT00306189|65562612|FG003|Overall Study|Physician Decision|1|||
23497152|NCT00306189|65562609|FG000|Overall Study|Adverse Event|3|||
23497153|NCT00306189|65562610|FG001|Overall Study|Adverse Event|3|||
23497154|NCT00306189|65562611|FG002|Overall Study|Adverse Event|2|||
23497155|NCT00306189|65562612|FG003|Overall Study|Adverse Event|2|||
23497156|NCT00306189|65562609|FG000|Overall Study|Withdrawal by Subject|4|||
23497157|NCT00306189|65562610|FG001|Overall Study|Withdrawal by Subject|2|||
23686560|NCT02382133|66228510|FG000|Overall Study|pressure injury both sites|1|||
23686561|NCT01193686|66228511|FG000|Overall Study|Withdrawal by Subject|4|||
23686562|NCT01193686|66228512|FG001|Overall Study|Withdrawal by Subject|1|||
23686563|NCT01193686|66228511|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
23686564|NCT01193686|66228512|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
23686565|NCT02932267|66228513|FG000|Overall Study|Withdrawal by Subject|3|||
23686566|NCT02932267|66228513|FG000|Overall Study|Lost to Follow-up|4|||
23686567|NCT02932267|66228513|FG000|Overall Study|Pregnancy|1|||
23686568|NCT02965378|66228516|FG000|Overall Study|Progression|16|||
23686569|NCT02965378|66228517|FG001|Overall Study|Progression|4|||
23686570|NCT02965378|66228516|FG000|Overall Study|Adverse Event|5|||
23686571|NCT02965378|66228517|FG001|Overall Study|Adverse Event|2|||
23686572|NCT02965378|66228516|FG000|Overall Study|Death|2|||
23686573|NCT02965378|66228517|FG001|Overall Study|Death|0|||
23686574|NCT02965378|66228516|FG000|Overall Study|Refusal|2|||
23686575|NCT02965378|66228517|FG001|Overall Study|Refusal|1|||
23686576|NCT02965378|66228516|FG000|Overall Study|Not protocol specified|0|||
23686577|NCT02965378|66228517|FG001|Overall Study|Not protocol specified|2|||
23686578|NCT02959814|66228522|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
23686579|NCT02959814|66228522|FG000|Overall Study|Excluded based on anatomical criteria|2|||
23686580|NCT02959814|66228522|FG000|Overall Study|Protocol Violation|7|||
23686581|NCT02959814|66228522|FG000|Overall Study|FFR not measured|2|||
23686582|NCT02959814|66228522|FG000|Overall Study|In-procedure QFR not computed|6|||
23686583|NCT02959814|66228522|FG000|Overall Study|Excluded by FFR core-lab|24|||
23686584|NCT00981526|66228523|FG000|Overall Study|Withdrawal by Subject|0|||
23686585|NCT00981526|66228524|FG001|Overall Study|Withdrawal by Subject|2|||
23686586|NCT00981526|66228523|FG000|Overall Study|Physician Decision|4|||
23686587|NCT00981526|66228524|FG001|Overall Study|Physician Decision|4|||
23686588|NCT03539432|66228527|FG000|Overall Study|Lost to Follow-up|0|||
23686589|NCT03539432|66228528|FG001|Overall Study|Lost to Follow-up|1|||
23686590|NCT03823391|66228531|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
23686591|NCT03823391|66228532|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
23686592|NCT03823391|66228531|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
23686593|NCT03823391|66228532|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
23686594|NCT04574999|66228536|FG000|Overall Study|Adverse Event|1|||
23686595|NCT04574999|66228537|FG001|Overall Study|Adverse Event|0|||
23686596|NCT04574999|66228536|FG000|Overall Study|Lack of Efficacy|2|||
23686597|NCT04574999|66228537|FG001|Overall Study|Lack of Efficacy|3|||
23686598|NCT04574999|66228536|FG000|Overall Study|Protocol Violation|1|||
23686599|NCT04574999|66228537|FG001|Overall Study|Protocol Violation|0|||
23686600|NCT04574999|66228536|FG000|Overall Study|Withdrawal by Subject|2|||
23497158|NCT00306189|65562611|FG002|Overall Study|Withdrawal by Subject|8|||
23497159|NCT00306189|65562612|FG003|Overall Study|Withdrawal by Subject|1|||
23497160|NCT00306189|65562609|FG000|Overall Study|Ineligibility determined|1|||
23497161|NCT00306189|65562610|FG001|Overall Study|Ineligibility determined|1|||
23497162|NCT00306189|65562611|FG002|Overall Study|Ineligibility determined|1|||
23497163|NCT00306189|65562612|FG003|Overall Study|Ineligibility determined|1|||
23497164|NCT00306189|65562609|FG000|Overall Study|Other|1|||
23497165|NCT00306189|65562610|FG001|Overall Study|Other|0|||
23686601|NCT04574999|66228537|FG001|Overall Study|Withdrawal by Subject|2|||
23686602|NCT04574999|66228536|FG000|Overall Study|Lost to Follow-up|1|||
23686603|NCT04574999|66228537|FG001|Overall Study|Lost to Follow-up|0|||
23686604|NCT04574999|66228536|FG000|Overall Study|Personal problems|1|||
23686605|NCT04574999|66228537|FG001|Overall Study|Personal problems|0|||
23497166|NCT00306189|65562611|FG002|Overall Study|Other|0|||
23686606|NCT04574999|66228536|FG000|Overall Study|Previous planned surgery|1|||
23686607|NCT04574999|66228537|FG001|Overall Study|Previous planned surgery|0|||
23686608|NCT01763164|66228538|FG000|Treatment Phase|Participant/Guardian decision|26|||
23686609|NCT01763164|66228539|FG001|Treatment Phase|Participant/Guardian decision|14|||
23686610|NCT01763164|66228538|FG000|Treatment Phase|Protocol Violation|1|||
23686611|NCT01763164|66228539|FG001|Treatment Phase|Protocol Violation|1|||
23686612|NCT01763164|66228538|FG000|Treatment Phase|Progressive Disease|142|||
23686613|NCT01763164|66228539|FG001|Treatment Phase|Progressive Disease|76|||
23392962|NCT01500135|65184872|FG001|Overall Study|Lost to Follow-up|4|||
23392963|NCT01500135|65184871|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
23392964|NCT01500135|65184872|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
23392965|NCT01500135|65184871|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
23392966|NCT01500135|65184872|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
23392967|NCT01500135|65184871|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
23392968|NCT01500135|65184872|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
23392969|NCT01500135|65184871|FG000|Overall Study|Participant was a Safety Concern|1|||
23392970|NCT01500135|65184872|FG001|Overall Study|Participant was a Safety Concern|0|||
23392971|NCT01500135|65184871|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
23392972|NCT01500135|65184872|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
23392973|NCT03274466|65184873|FG000|Overall Study|Withdrawal by Subject|7|||
23392974|NCT03274466|65184874|FG001|Overall Study|Withdrawal by Subject|3|||
23392975|NCT03274466|65184873|FG000|Overall Study|Protocol Specified Withdrawal|5|||
23392976|NCT03274466|65184874|FG001|Overall Study|Protocol Specified Withdrawal|11|||
23392977|NCT03274466|65184873|FG000|Overall Study|Lost to Follow-up|5|||
23392978|NCT03274466|65184874|FG001|Overall Study|Lost to Follow-up|7|||
23392979|NCT03274466|65184873|FG000|Overall Study|Subject Non-compliance|0|||
23392980|NCT03274466|65184874|FG001|Overall Study|Subject Non-compliance|1|||
23392981|NCT03274466|65184873|FG000|Overall Study|Adverse Event|3|||
23392982|NCT03274466|65184874|FG001|Overall Study|Adverse Event|3|||
23392983|NCT03274466|65184873|FG000|Overall Study|Physician Decision|0|||
23392984|NCT03274466|65184874|FG001|Overall Study|Physician Decision|1|||
23392985|NCT03274466|65184873|FG000|Overall Study|Protocol Violation|3|||
23392986|NCT03274466|65184874|FG001|Overall Study|Protocol Violation|3|||
23392987|NCT01979185|65184875|FG000|Period 2|Other|0|||
23392988|NCT01979185|65184876|FG001|Period 2|Other|1|||
23392989|NCT01911260|65184877|FG000|Supplementation Period|transference or evasion of school|7|||
23392990|NCT01911260|65184878|FG001|Supplementation Period|transference or evasion of school|9|||
23392991|NCT01911260|65184879|FG002|Supplementation Period|transference or evasion of school|7|||
23392992|NCT01911260|65184880|FG003|Supplementation Period|transference or evasion of school|6|||
23392993|NCT01911260|65184877|FG000|Supplementation Period|Adverse Event|2|||
23392994|NCT01911260|65184878|FG001|Supplementation Period|Adverse Event|0|||
23392995|NCT01911260|65184879|FG002|Supplementation Period|Adverse Event|1|||
23392996|NCT01911260|65184880|FG003|Supplementation Period|Adverse Event|0|||
23392997|NCT01911260|65184877|FG000|Supplementation Period|refused to receive supplement|1|||
23392998|NCT01911260|65184878|FG001|Supplementation Period|refused to receive supplement|0|||
23392999|NCT01911260|65184879|FG002|Supplementation Period|refused to receive supplement|1|||
23393000|NCT01911260|65184880|FG003|Supplementation Period|refused to receive supplement|0|||
23393001|NCT01911260|65184877|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
23393002|NCT01911260|65184878|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
23393003|NCT01911260|65184879|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
23393004|NCT01911260|65184880|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
23393005|NCT01911260|65184877|FG000|Follow-up Period|transference or evasion of school|13|||
23393006|NCT01911260|65184878|FG001|Follow-up Period|transference or evasion of school|20|||
23393007|NCT01911260|65184879|FG002|Follow-up Period|transference or evasion of school|15|||
23393008|NCT01911260|65184880|FG003|Follow-up Period|transference or evasion of school|12|||
23393009|NCT03997383|65186711|FG000|Double-blind Treatment Period|Adverse Event|4|||
23393010|NCT03997383|65186712|FG001|Double-blind Treatment Period|Adverse Event|3|||
23393011|NCT03997383|65186711|FG000|Double-blind Treatment Period|Death|4|||
23393012|NCT03997383|65186712|FG001|Double-blind Treatment Period|Death|4|||
23393013|NCT03997383|65186711|FG000|Double-blind Treatment Period|Physician Decision|2|||
23393014|NCT03997383|65186712|FG001|Double-blind Treatment Period|Physician Decision|0|||
23393015|NCT03997383|65186711|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
23393016|NCT03997383|65186712|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
23393017|NCT03997383|65186711|FG000|Open-label Extension Period|Ongoing|148|||
23393018|NCT03997383|65186712|FG001|Open-label Extension Period|Ongoing|151|||
23393019|NCT03997383|65186711|FG000|Open-label Extension Period|Adverse Event|4|||
23393020|NCT03997383|65186712|FG001|Open-label Extension Period|Adverse Event|1|||
23393021|NCT03997383|65186711|FG000|Open-label Extension Period|Death|8|||
23393022|NCT03997383|65186712|FG001|Open-label Extension Period|Death|9|||
23393023|NCT03997383|65186711|FG000|Open-label Extension Period|Physician Decision|1|||
23497167|NCT00306189|65562612|FG003|Overall Study|Other|0|||
23497168|NCT03948581|65562617|FG000|Overall Study|Lost to Follow-up|0|||
23497169|NCT03948581|65562618|FG001|Overall Study|Lost to Follow-up|1|||
23497170|NCT01649804|65562622|FG000|Overall Study|Administrative/Other|8|||
23497171|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
23497172|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
23497173|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
23497174|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
23497175|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
23497176|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
23497177|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
23497178|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
23497179|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
23497180|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497181|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497182|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497183|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497184|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497185|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497186|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497187|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
23497188|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497189|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497190|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497191|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497192|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497193|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497194|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497195|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
23497196|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497197|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497198|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497199|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497200|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497201|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497202|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497203|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
23497204|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497205|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497206|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497207|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497208|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497209|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497210|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497211|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
23497212|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497213|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497214|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497215|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497216|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497217|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497218|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497219|NCT00533897|65562627|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497220|NCT00533897|65562628|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
23686614|NCT01763164|66228538|FG000|Treatment Phase|Physician Decision|24|||
23686615|NCT01763164|66228539|FG001|Treatment Phase|Physician Decision|13|||
23686616|NCT01763164|66228538|FG000|Treatment Phase|Death|10|||
23686617|NCT01763164|66228539|FG001|Treatment Phase|Death|1|||
23686618|NCT01763164|66228538|FG000|Treatment Phase|Adverse Event|66|||
23686619|NCT01763164|66228539|FG001|Treatment Phase|Adverse Event|8|||
23686620|NCT01763164|66228538|FG000|Treatment Phase|Randomized but not Treated|0|||
23686621|NCT01763164|66228539|FG001|Treatment Phase|Randomized but not Treated|19|||
23686622|NCT01763164|66228538|FG000|Treatment Phase|Other|0|||
23686623|NCT01763164|66228539|FG001|Treatment Phase|Other|1|||
23686624|NCT01763164|66228538|FG000|Follow up Phase|New therapy for study indication|12|||
23686625|NCT01763164|66228539|FG001|Follow up Phase|New therapy for study indication|3|||
23393024|NCT03997383|65186712|FG001|Open-label Extension Period|Physician Decision|1|||
23393025|NCT03997383|65186711|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
23393026|NCT03997383|65186712|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
23497221|NCT00533897|65562629|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
23686626|NCT01763164|66228538|FG000|Follow up Phase|Death|21|||
23686627|NCT01763164|66228539|FG001|Follow up Phase|Death|4|||
23497222|NCT00533897|65562630|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497223|NCT00533897|65562631|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497224|NCT00533897|65562632|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497225|NCT00533897|65562633|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497226|NCT00533897|65562634|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497227|NCT00533897|65562627|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497228|NCT00533897|65562628|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497229|NCT00533897|65562629|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
23497230|NCT00533897|65562630|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497231|NCT00533897|65562631|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497232|NCT00533897|65562632|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497233|NCT00533897|65562633|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497234|NCT00533897|65562634|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497235|NCT00533897|65562627|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497236|NCT00533897|65562628|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497237|NCT00533897|65562629|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497238|NCT00533897|65562630|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497239|NCT00533897|65562631|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497240|NCT00533897|65562632|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
23497241|NCT00533897|65562633|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497242|NCT00533897|65562634|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497243|NCT00533897|65562627|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497244|NCT00533897|65562628|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497245|NCT00533897|65562629|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497246|NCT00533897|65562630|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497247|NCT00533897|65562631|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497248|NCT00533897|65562632|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
23497249|NCT00533897|65562633|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497250|NCT00533897|65562634|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497251|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497252|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497253|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497254|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497255|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497256|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497257|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
23497258|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
23497259|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Death|0|||
23497260|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Death|0|||
23497261|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Death|0|||
23497262|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Death|0|||
23497263|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Death|0|||
23497264|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Death|0|||
23497265|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Death|1|||
23497266|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Death|3|||
23497267|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497268|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497269|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497270|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497271|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497272|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497273|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
23497274|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
23497275|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497276|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497277|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497278|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497279|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497280|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497281|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
23497282|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497283|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Adverse Event|0|||
23497284|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Adverse Event|0|||
23497285|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Adverse Event|0|||
23497286|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Adverse Event|0|||
23497287|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Adverse Event|0|||
23497288|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Adverse Event|0|||
23497289|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Adverse Event|2|||
23497290|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Adverse Event|5|||
23497291|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Pregnancy|0|||
23497292|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Pregnancy|0|||
23497293|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Pregnancy|0|||
23497294|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Pregnancy|0|||
23497295|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Pregnancy|0|||
23497296|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Pregnancy|0|||
23497297|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Pregnancy|0|||
23497298|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Pregnancy|2|||
23497299|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497300|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497301|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497302|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497303|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497304|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497305|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
23497306|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
23497307|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Other|0|||
23497308|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Other|0|||
23497309|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Other|0|||
23497310|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Other|0|||
23497311|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Other|0|||
23497312|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Other|0|||
23497313|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Other|1|||
23497314|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Other|6|||
23497315|NCT01930123|65562635|FG000|Overall Study|Adverse Event|1|||
23497316|NCT01930123|65562636|FG001|Overall Study|Adverse Event|0|||
23497317|NCT01930123|65562635|FG000|Overall Study|Physician Decision|21|||
23497318|NCT01930123|65562636|FG001|Overall Study|Physician Decision|8|||
23497319|NCT01930123|65562635|FG000|Overall Study|Withdrawal by Subject|1|||
23497320|NCT01930123|65562636|FG001|Overall Study|Withdrawal by Subject|0|||
23497321|NCT02015754|65562645|FG000|Overall Study|Disease progression|5|||
23686628|NCT01763164|66228538|FG000|Follow up Phase|Subject/guardian decision|9|||
23686629|NCT01763164|66228539|FG001|Follow up Phase|Subject/guardian decision|2|||
23686630|NCT01763164|66228538|FG000|Follow up Phase|Progressive disease|127|||
23686631|NCT01763164|66228539|FG001|Follow up Phase|Progressive disease|62|||
23686632|NCT01763164|66228538|FG000|Follow up Phase|Physician Decision|10|||
23686633|NCT01763164|66228539|FG001|Follow up Phase|Physician Decision|3|||
23686634|NCT01763164|66228538|FG000|Follow up Phase|Lost to Follow-up|1|||
23686635|NCT01763164|66228539|FG001|Follow up Phase|Lost to Follow-up|0|||
23686636|NCT01763164|66228538|FG000|Follow up Phase|Adverse Event|17|||
23686637|NCT01763164|66228539|FG001|Follow up Phase|Adverse Event|1|||
23686638|NCT01392183|66228543|FG000|First Drug Administration|Adverse Event|3|||
23686639|NCT01392183|66228544|FG001|First Drug Administration|Adverse Event|2|||
23686640|NCT01392183|66228543|FG000|First Drug Administration|Death|1|||
23686641|NCT01392183|66228544|FG001|First Drug Administration|Death|0|||
23686642|NCT01392183|66228543|FG000|First Drug Administration|Withdrawal by Subject|10|||
23686643|NCT01392183|66228544|FG001|First Drug Administration|Withdrawal by Subject|17|||
23686644|NCT00461175|66228545|FG000|Overall Study|Protocol Violation|522|||
23686645|NCT00461175|66228546|FG001|Overall Study|Protocol Violation|365|||
23686646|NCT00548548|66228550|FG000|Overall Study|Death|345|||
23686647|NCT00548548|66228551|FG001|Overall Study|Death|348|||
23686648|NCT00548548|66228550|FG000|Overall Study|Lost to Follow-up|17|||
23686649|NCT00548548|66228551|FG001|Overall Study|Lost to Follow-up|18|||
23686650|NCT03968419|66228552|FG000|Treatment Period|Adverse Event|0|||
23686651|NCT03968419|66228553|FG001|Treatment Period|Adverse Event|0|||
23686652|NCT03968419|66228554|FG002|Treatment Period|Adverse Event|1|||
23686653|NCT03968419|66228552|FG000|Safety Follow-up Period|Death|3|||
23686654|NCT03968419|66228553|FG001|Safety Follow-up Period|Death|2|||
23686655|NCT03968419|66228554|FG002|Safety Follow-up Period|Death|1|||
23686656|NCT03968419|66228552|FG000|Safety Follow-up Period|Subject Decision|2|||
23686657|NCT03968419|66228553|FG001|Safety Follow-up Period|Subject Decision|1|||
23686658|NCT03968419|66228554|FG002|Safety Follow-up Period|Subject Decision|0|||
23497322|NCT02015754|65562645|FG000|Overall Study|Change in treatment modality|5|||
23497323|NCT02015754|65562645|FG000|Overall Study|Lost to Follow-up|1|||
23686659|NCT00833092|66228555|FG000|Overall Study|Withdrawal by Subject|2|||
23497324|NCT04515394|65562657|FG000|Overall Study|Participant did not receive treatment|1|||
23497325|NCT00094172|65562660|FG000|Overall Study|Adverse Event|0|||
23497326|NCT00094172|65562661|FG001|Overall Study|Adverse Event|1|||
23497327|NCT00094172|65562660|FG000|Overall Study|Lost to Follow-up|2|||
23497328|NCT00094172|65562661|FG001|Overall Study|Lost to Follow-up|0|||
23686660|NCT00833092|66228556|FG001|Overall Study|Withdrawal by Subject|3|||
23686661|NCT00833092|66228555|FG000|Overall Study|Protocol Violation|2|||
23686662|NCT00833092|66228556|FG001|Overall Study|Protocol Violation|1|||
23686663|NCT00833092|66228555|FG000|Overall Study|Diarrhea|0|||
23686664|NCT00833092|66228556|FG001|Overall Study|Diarrhea|2|||
23686665|NCT00833092|66228555|FG000|Overall Study|constipation|0|||
23686666|NCT00833092|66228556|FG001|Overall Study|constipation|1|||
23686667|NCT00480857|66228558|FG000|Overall Study|Lack of Efficacy|2|||
23686668|NCT03160560|66228559|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
23686669|NCT03160560|66228560|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23686670|NCT03160560|66228561|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23686671|NCT03160560|66228562|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23686672|NCT03160560|66228559|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23686673|NCT03160560|66228560|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23686674|NCT03160560|66228561|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23686675|NCT03160560|66228562|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23686676|NCT03192904|66228564|FG000|Overall Study|Physician Decision|3|||
23686677|NCT03192904|66228565|FG001|Overall Study|Physician Decision|1|||
23686678|NCT03192904|66228564|FG000|Overall Study|Lost to Follow-up|0|||
23686679|NCT03192904|66228565|FG001|Overall Study|Lost to Follow-up|1|||
23686680|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
23686681|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23686682|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23686683|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23686684|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23686685|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
23393027|NCT03997383|65186711|FG000|Open-label Extension Period|Reason Not Specified|2|||
23686686|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23686687|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
23686688|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
23686689|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23686690|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23686691|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
23686692|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
23686693|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
23686694|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23686695|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23686696|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23686697|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
23686698|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
23686699|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
23686700|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
23686701|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
23686702|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
23686703|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
23686704|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
23686705|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
23686706|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
23686707|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
23686708|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
23686709|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
23686710|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
23686711|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
23686712|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
23686713|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
23686714|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
23686715|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
23393028|NCT03997383|65186712|FG001|Open-label Extension Period|Reason Not Specified|0|||
23393029|NCT02185768|65186713|FG000|Overall Study|Patients were not treated|2|||
23393030|NCT01356940|65186715|FG000|First Intervention (28 Days)|Adverse Event|1|||
23393031|NCT01356940|65186716|FG001|First Intervention (28 Days)|Adverse Event|0|||
23393032|NCT01356940|65186715|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
23393033|NCT01356940|65186716|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
23393034|NCT03599713|65186719|FG000|Overall Study|Death|26|||
23393035|NCT03599713|65186720|FG001|Overall Study|Death|3|||
23393036|NCT03599713|65186719|FG000|Overall Study|Withdrawal by Subject|6|||
23393037|NCT03599713|65186720|FG001|Overall Study|Withdrawal by Subject|0|||
23393038|NCT03599713|65186719|FG000|Overall Study|Ongoing|69|||
23393039|NCT03599713|65186720|FG001|Overall Study|Ongoing|3|||
23393040|NCT00432965|65186721|FG000|Overall Study|Lost to Follow-up|22|||
23393041|NCT00432965|65186722|FG001|Overall Study|Lost to Follow-up|19|||
23393042|NCT00432965|65186721|FG000|Overall Study|Withdrawal by Subject|13|||
23393043|NCT00432965|65186722|FG001|Overall Study|Withdrawal by Subject|13|||
23686716|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
23393044|NCT00432965|65186721|FG000|Overall Study|Physician Decision|14|||
23393045|NCT00432965|65186722|FG001|Overall Study|Physician Decision|13|||
23393046|NCT00432965|65186721|FG000|Overall Study|Lack of Efficacy|8|||
23393047|NCT00432965|65186722|FG001|Overall Study|Lack of Efficacy|13|||
23393048|NCT00432965|65186721|FG000|Overall Study|Non-compliance|7|||
23393049|NCT00432965|65186722|FG001|Overall Study|Non-compliance|0|||
23393050|NCT00432965|65186721|FG000|Overall Study|Adverse Event|22|||
23393051|NCT00432965|65186722|FG001|Overall Study|Adverse Event|19|||
23393052|NCT00432965|65186721|FG000|Overall Study|Death|3|||
23393053|NCT00432965|65186722|FG001|Overall Study|Death|4|||
23393054|NCT00432965|65186721|FG000|Overall Study|Exclusionary Methods|1|||
23393055|NCT00432965|65186722|FG001|Overall Study|Exclusionary Methods|2|||
23393056|NCT00432965|65186721|FG000|Overall Study|Incomplete Data|4|||
23393057|NCT00432965|65186722|FG001|Overall Study|Incomplete Data|3|||
23393058|NCT00425555|65186723|FG000|Overall Study|Withdrawal by Subject|11|||
23393059|NCT00425555|65186724|FG001|Overall Study|Withdrawal by Subject|8|||
23393060|NCT00425555|65186723|FG000|Overall Study|Lost to Follow-up|0|||
23393061|NCT00425555|65186724|FG001|Overall Study|Lost to Follow-up|1|||
23393062|NCT00425555|65186723|FG000|Overall Study|Administrative problems|3|||
23393063|NCT00425555|65186724|FG001|Overall Study|Administrative problems|0|||
23393064|NCT00425555|65186723|FG000|Overall Study|Death|1|||
23393065|NCT00425555|65186724|FG001|Overall Study|Death|2|||
23393066|NCT00425555|65186723|FG000|Overall Study|New cancer therapy|2|||
23393067|NCT00425555|65186724|FG001|Overall Study|New cancer therapy|1|||
23393068|NCT00425555|65186723|FG000|Overall Study|Disease progression|36|||
23393069|NCT00425555|65186724|FG001|Overall Study|Disease progression|33|||
23393070|NCT00425555|65186723|FG000|Overall Study|Adverse Event|25|||
23393071|NCT00425555|65186724|FG001|Overall Study|Adverse Event|15|||
23686717|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
23686718|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
23686719|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
23686720|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
23686721|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
23686722|NCT00100048|66228571|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23686723|NCT00100048|66228572|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23686724|NCT00100048|66228573|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23686725|NCT00100048|66228574|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
23686726|NCT00100048|66228575|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23686727|NCT00100048|66228576|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23686728|NCT02853760|66228578|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
23686729|NCT02853760|66228579|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
23686730|NCT02853760|66228580|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
23686731|NCT02853760|66228581|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
23686732|NCT02853760|66228582|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
23686733|NCT02853760|66228583|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
23686734|NCT04343651|66228584|FG000|Overall Study|Physician Decision|2|||
23686735|NCT04343651|66228585|FG001|Overall Study|Physician Decision|1|||
23686736|NCT04343651|66228584|FG000|Overall Study|Lost to Follow-up|2|||
23686737|NCT04343651|66228585|FG001|Overall Study|Lost to Follow-up|1|||
23686738|NCT04343651|66228584|FG000|Overall Study|Protocol Violation|4|||
23686739|NCT04343651|66228585|FG001|Overall Study|Protocol Violation|6|||
23686740|NCT04343651|66228584|FG000|Overall Study|Missing|3|||
23686741|NCT04343651|66228585|FG001|Overall Study|Missing|9|||
23686742|NCT04343651|66228584|FG000|Overall Study|Withdrawal by Subject|0|||
23686743|NCT04343651|66228585|FG001|Overall Study|Withdrawal by Subject|4|||
23686744|NCT04343651|66228584|FG000|Overall Study|Death|0|||
23686745|NCT04343651|66228585|FG001|Overall Study|Death|1|||
23686746|NCT04343651|66228584|FG000|Overall Study|Did not start treatment|1|||
23686747|NCT04343651|66228585|FG001|Overall Study|Did not start treatment|1|||
23686748|NCT04343651|66228584|FG000|Overall Study|Patient did not complete visits 3-6|0|||
23686749|NCT04343651|66228585|FG001|Overall Study|Patient did not complete visits 3-6|1|||
23686750|NCT04325503|66228586|FG000|Overall Study|Withdrawal by Subject|1|||
23686751|NCT04325503|66228586|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
23686752|NCT02115308|66228587|FG000|Overall Study|Safety Screening|2|||
23393072|NCT00425555|65186723|FG000|Overall Study|Protocol Violation|1|||
23393073|NCT00425555|65186724|FG001|Overall Study|Protocol Violation|0|||
23686753|NCT02115308|66228588|FG001|Overall Study|Safety Screening|2|||
23393074|NCT05270863|65186725|FG000|Visit 2 First Intervention|Randomization error|0|||
23393075|NCT05270863|65186726|FG001|Visit 2 First Intervention|Randomization error|0|||
23393076|NCT05270863|65186727|FG002|Visit 2 First Intervention|Randomization error|0|||
23393077|NCT05270863|65186728|FG003|Visit 2 First Intervention|Randomization error|1|||
23393078|NCT05270863|65186729|FG004|Visit 2 First Intervention|Randomization error|0|||
23686754|NCT01243268|66228589|FG000|Overall Study|Lost to Follow-up|4|||
23686755|NCT01243268|66228589|FG000|Overall Study|Protocol Violation|51|||
23686756|NCT01243268|66228589|FG000|Overall Study|Deviation with contract date|7|||
23686757|NCT01243268|66228589|FG000|Overall Study|Duplicate subject|2|||
23686758|NCT02118792|66228591|FG000|Overall Study|Withdrawal by Subject|6|||
23686759|NCT02118792|66228592|FG001|Overall Study|Withdrawal by Subject|3|||
23686760|NCT02118792|66228591|FG000|Overall Study|Lost to Follow-up|4|||
23686761|NCT02118792|66228592|FG001|Overall Study|Lost to Follow-up|4|||
23686762|NCT02118792|66228591|FG000|Overall Study|Adverse Event|5|||
23686763|NCT02118792|66228592|FG001|Overall Study|Adverse Event|4|||
23686764|NCT02118792|66228591|FG000|Overall Study|Withdrawal by parent/guardian|14|||
23686765|NCT02118792|66228592|FG001|Overall Study|Withdrawal by parent/guardian|20|||
23686766|NCT02118792|66228591|FG000|Overall Study|Other|1|||
23686767|NCT02118792|66228592|FG001|Overall Study|Other|6|||
23686768|NCT02118792|66228591|FG000|Overall Study|Randomised but not treated|1|||
23686769|NCT02118792|66228592|FG001|Overall Study|Randomised but not treated|0|||
23686770|NCT05172544|66228593|FG000|Overall Study|Withdrawal by Subject|1|||
23686771|NCT05172544|66228594|FG001|Overall Study|Withdrawal by Subject|0|||
23686772|NCT05172544|66228595|FG002|Overall Study|Withdrawal by Subject|0|||
23686773|NCT05172544|66228593|FG000|Overall Study|Physician Decision|0|||
23686774|NCT05172544|66228594|FG001|Overall Study|Physician Decision|0|||
23686775|NCT05172544|66228595|FG002|Overall Study|Physician Decision|1|||
23686776|NCT01976806|66228596|FG000|Overall Study|Lost to Follow-up|1|||
23686777|NCT01976806|66228597|FG001|Overall Study|Lost to Follow-up|4|||
23686778|NCT01976806|66228596|FG000|Overall Study|Adverse Event|1|||
23686779|NCT01976806|66228597|FG001|Overall Study|Adverse Event|1|||
23686780|NCT01976806|66228596|FG000|Overall Study|Withdrawal by Subject|1|||
23686781|NCT01976806|66228597|FG001|Overall Study|Withdrawal by Subject|1|||
23686782|NCT01587989|66228598|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
23686783|NCT01587989|66228599|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
23686784|NCT01587989|66228600|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
23686785|NCT01587989|66228598|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
23686786|NCT01587989|66228599|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
23686787|NCT01587989|66228600|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
23686788|NCT01587989|66228598|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
23686789|NCT01587989|66228599|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
23686790|NCT01587989|66228600|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
23686791|NCT01587989|66228598|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
23686792|NCT01587989|66228599|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
23686793|NCT01587989|66228600|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
23686794|NCT01587989|66228598|FG000|Randomized Study Treatment|Screening failure|0|||
23686795|NCT01587989|66228599|FG001|Randomized Study Treatment|Screening failure|1|||
23686796|NCT01587989|66228600|FG002|Randomized Study Treatment|Screening failure|0|||
23686797|NCT01587989|66228598|FG000|Randomized Study Treatment|Physician Decision|0|||
23686798|NCT01587989|66228599|FG001|Randomized Study Treatment|Physician Decision|0|||
23686799|NCT01587989|66228600|FG002|Randomized Study Treatment|Physician Decision|1|||
23686800|NCT00103012|66228601|FG000|Overall Study|Withdrawal by Subject|2|||
23686801|NCT00103012|66228602|FG001|Overall Study|Withdrawal by Subject|1|||
23686802|NCT00103012|66228603|FG002|Overall Study|Withdrawal by Subject|2|||
23686803|NCT00103012|66228601|FG000|Overall Study|Pregnancy|1|||
23686804|NCT00103012|66228602|FG001|Overall Study|Pregnancy|0|||
23686805|NCT00103012|66228603|FG002|Overall Study|Pregnancy|0|||
23686806|NCT00103012|66228601|FG000|Overall Study|Adverse Event|0|||
23686807|NCT00103012|66228602|FG001|Overall Study|Adverse Event|0|||
23686808|NCT00103012|66228603|FG002|Overall Study|Adverse Event|1|||
23686809|NCT00103012|66228601|FG000|Overall Study|Subject non-compliant with medications|0|||
23686810|NCT00103012|66228602|FG001|Overall Study|Subject non-compliant with medications|0|||
23686811|NCT00103012|66228603|FG002|Overall Study|Subject non-compliant with medications|1|||
23686812|NCT00365989|66228604|FG000|Overall Study|Withdrawal by Subject|1|||
23686813|NCT00365989|66228604|FG000|Overall Study|Non-compliance|1|||
23686814|NCT02357420|66228605|FG000|Overall Study|Adverse Event|3|||
23686815|NCT02357420|66228606|FG001|Overall Study|Adverse Event|3|||
23686816|NCT02357420|66228607|FG002|Overall Study|Adverse Event|8|||
23686817|NCT02357420|66228608|FG003|Overall Study|Adverse Event|9|||
23686818|NCT02357420|66228605|FG000|Overall Study|Investigator Decision|1|||
23686819|NCT02357420|66228606|FG001|Overall Study|Investigator Decision|0|||
23686820|NCT02357420|66228607|FG002|Overall Study|Investigator Decision|0|||
23686821|NCT02357420|66228608|FG003|Overall Study|Investigator Decision|0|||
23686822|NCT02357420|66228605|FG000|Overall Study|Prohibited Medication|1|||
23686823|NCT02357420|66228606|FG001|Overall Study|Prohibited Medication|1|||
23686824|NCT02357420|66228607|FG002|Overall Study|Prohibited Medication|0|||
23686825|NCT02357420|66228608|FG003|Overall Study|Prohibited Medication|0|||
23686826|NCT02357420|66228605|FG000|Overall Study|Protocol Non-compliance|0|||
23686827|NCT02357420|66228606|FG001|Overall Study|Protocol Non-compliance|0|||
23686828|NCT02357420|66228607|FG002|Overall Study|Protocol Non-compliance|0|||
23686829|NCT02357420|66228608|FG003|Overall Study|Protocol Non-compliance|1|||
23686830|NCT02357420|66228605|FG000|Overall Study|Withdrawn Consent|4|||
23686831|NCT02357420|66228606|FG001|Overall Study|Withdrawn Consent|8|||
23686832|NCT02357420|66228607|FG002|Overall Study|Withdrawn Consent|6|||
23686833|NCT02357420|66228608|FG003|Overall Study|Withdrawn Consent|6|||
23686834|NCT02357420|66228605|FG000|Overall Study|Lost to Follow-up|3|||
23686835|NCT02357420|66228606|FG001|Overall Study|Lost to Follow-up|0|||
23686836|NCT02357420|66228607|FG002|Overall Study|Lost to Follow-up|2|||
23686837|NCT02357420|66228608|FG003|Overall Study|Lost to Follow-up|3|||
23686838|NCT02689492|66228611|FG000|Overall Study|Lost to Follow-up|61|||
23686839|NCT02689492|66228611|FG000|Overall Study|Withdrawal by Subject|11|||
23686840|NCT02689492|66228611|FG000|Overall Study|Death|9|||
23686841|NCT02689492|66228611|FG000|Overall Study|Physician Decision|2|||
23686842|NCT02689492|66228611|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
23686843|NCT02689492|66228611|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
23686844|NCT02689492|66228611|FG000|Overall Study|Other than listed|1|||
23686845|NCT03486392|66228612|FG000|Overall Study|Lost to Follow-up|0|||
23686846|NCT03486392|66228613|FG001|Overall Study|Lost to Follow-up|0|||
23686847|NCT03486392|66228614|FG002|Overall Study|Lost to Follow-up|8|||
23686848|NCT03486392|66228615|FG003|Overall Study|Lost to Follow-up|5|||
23686849|NCT03486392|66228616|FG004|Overall Study|Lost to Follow-up|2|||
23686850|NCT03486392|66228612|FG000|Overall Study|Withdrawal by Subject|3|||
23686851|NCT03486392|66228613|FG001|Overall Study|Withdrawal by Subject|0|||
23686852|NCT03486392|66228614|FG002|Overall Study|Withdrawal by Subject|6|||
23686853|NCT03486392|66228615|FG003|Overall Study|Withdrawal by Subject|4|||
23686854|NCT03486392|66228616|FG004|Overall Study|Withdrawal by Subject|1|||
23686855|NCT03486392|66228612|FG000|Overall Study|Death|0|||
23686856|NCT03486392|66228613|FG001|Overall Study|Death|0|||
23686857|NCT03486392|66228614|FG002|Overall Study|Death|0|||
23686858|NCT03486392|66228615|FG003|Overall Study|Death|0|||
23686859|NCT03486392|66228616|FG004|Overall Study|Death|1|||
23686860|NCT00929240|66228617|FG000|Initial Treatment Phase|Adverse Event|31|||
23686861|NCT00929240|66228618|FG001|Initial Treatment Phase|Adverse Event|0|||
23686862|NCT00929240|66228619|FG002|Initial Treatment Phase|Adverse Event|0|||
23686863|NCT00929240|66228617|FG000|Initial Treatment Phase|Disease progression|41|||
23686864|NCT00929240|66228618|FG001|Initial Treatment Phase|Disease progression|0|||
23686865|NCT00929240|66228619|FG002|Initial Treatment Phase|Disease progression|0|||
23686866|NCT00929240|66228617|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
23686867|NCT00929240|66228618|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
23686868|NCT00929240|66228619|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
23686869|NCT00929240|66228617|FG000|Initial Treatment Phase|Protocol Violation|5|||
23686870|NCT00929240|66228618|FG001|Initial Treatment Phase|Protocol Violation|0|||
23686871|NCT00929240|66228619|FG002|Initial Treatment Phase|Protocol Violation|0|||
23686872|NCT00929240|66228617|FG000|Initial Treatment Phase|Death|2|||
23686873|NCT00929240|66228618|FG001|Initial Treatment Phase|Death|0|||
23686874|NCT00929240|66228619|FG002|Initial Treatment Phase|Death|0|||
23686875|NCT00929240|66228617|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
23686876|NCT00929240|66228618|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
23686877|NCT00929240|66228619|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
23686878|NCT00929240|66228617|FG000|Initial Treatment Phase|Physician Decision|4|||
23686879|NCT00929240|66228618|FG001|Initial Treatment Phase|Physician Decision|0|||
23686880|NCT00929240|66228619|FG002|Initial Treatment Phase|Physician Decision|0|||
23686881|NCT00929240|66228617|FG000|Maintenance Phase|Disease progression|0|||
23686882|NCT00929240|66228618|FG001|Maintenance Phase|Disease progression|73|||
23686883|NCT00929240|66228619|FG002|Maintenance Phase|Disease progression|60|||
23686884|NCT00929240|66228617|FG000|Maintenance Phase|Adverse Event|0|||
23686885|NCT00929240|66228618|FG001|Maintenance Phase|Adverse Event|9|||
23686886|NCT00929240|66228619|FG002|Maintenance Phase|Adverse Event|12|||
23686887|NCT00929240|66228617|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23686888|NCT00929240|66228618|FG001|Maintenance Phase|Withdrawal by Subject|2|||
23686889|NCT00929240|66228619|FG002|Maintenance Phase|Withdrawal by Subject|6|||
23686890|NCT00929240|66228617|FG000|Maintenance Phase|Protocol Violation|0|||
23686891|NCT00929240|66228618|FG001|Maintenance Phase|Protocol Violation|1|||
23686892|NCT00929240|66228619|FG002|Maintenance Phase|Protocol Violation|0|||
23686893|NCT00929240|66228617|FG000|Maintenance Phase|Health authority/Study termination|0|||
23686894|NCT00929240|66228618|FG001|Maintenance Phase|Health authority/Study termination|1|||
23686895|NCT00929240|66228619|FG002|Maintenance Phase|Health authority/Study termination|2|||
23686896|NCT00929240|66228617|FG000|Maintenance Phase|Physician Decision|0|||
23686897|NCT00929240|66228618|FG001|Maintenance Phase|Physician Decision|2|||
23686898|NCT00929240|66228619|FG002|Maintenance Phase|Physician Decision|1|||
23686899|NCT00929240|66228617|FG000|Maintenance Phase|Change of treatment|0|||
23686900|NCT00929240|66228618|FG001|Maintenance Phase|Change of treatment|4|||
23686901|NCT00929240|66228619|FG002|Maintenance Phase|Change of treatment|0|||
23686902|NCT00929240|66228617|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
23686903|NCT00929240|66228618|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
23686904|NCT00929240|66228619|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
23686905|NCT00929240|66228617|FG000|Maintenance Phase|Participant not treated|0|||
23686906|NCT00929240|66228618|FG001|Maintenance Phase|Participant not treated|2|||
23686907|NCT00929240|66228619|FG002|Maintenance Phase|Participant not treated|0|||
23686908|NCT00868790|66228624|FG000|Period 1|Adverse Event|1|||
23686909|NCT00868790|66228625|FG001|Period 1|Adverse Event|0|||
23686910|NCT00868790|66228626|FG002|Period 1|Adverse Event|0|||
23686911|NCT00868790|66228627|FG003|Period 1|Adverse Event|0|||
23686912|NCT00868790|66228628|FG004|Period 1|Adverse Event|0|||
23686913|NCT00868790|66228629|FG005|Period 1|Adverse Event|0|||
23497329|NCT00094172|65562660|FG000|Overall Study|Protocol Violation|0|||
23497330|NCT00094172|65562661|FG001|Overall Study|Protocol Violation|1|||
23497331|NCT00094172|65562660|FG000|Overall Study|Withdrawal by Subject|10|||
23497332|NCT00094172|65562661|FG001|Overall Study|Withdrawal by Subject|5|||
23497333|NCT00094172|65562660|FG000|Overall Study|Primary endpoint met.|1|||
23497334|NCT00094172|65562661|FG001|Overall Study|Primary endpoint met.|0|||
23497335|NCT00094172|65562660|FG000|Overall Study|Started other MS therapy due to disease|1|||
23497336|NCT00094172|65562661|FG001|Overall Study|Started other MS therapy due to disease|0|||
23497337|NCT04478266|65562662|FG000|Overall Study|Adverse Event|20|||
23497338|NCT04478266|65562663|FG001|Overall Study|Adverse Event|21|||
23497339|NCT04478266|65562662|FG000|Overall Study|Progressive disease|146|||
23497340|NCT04478266|65562663|FG001|Overall Study|Progressive disease|168|||
23497341|NCT04478266|65562662|FG000|Overall Study|Poor compliance to protocol|1|||
23497342|NCT04478266|65562663|FG001|Overall Study|Poor compliance to protocol|0|||
23497343|NCT04478266|65562662|FG000|Overall Study|Withdrawal by Subject|19|||
23497344|NCT04478266|65562663|FG001|Overall Study|Withdrawal by Subject|16|||
23497345|NCT04478266|65562662|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
23497346|NCT04478266|65562663|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
23497347|NCT04478266|65562662|FG000|Overall Study|Study terminated by sponsor|33|||
23497348|NCT04478266|65562663|FG001|Overall Study|Study terminated by sponsor|35|||
23497349|NCT04478266|65562662|FG000|Overall Study|Other: unspecified|5|||
23497350|NCT04478266|65562663|FG001|Overall Study|Other: unspecified|7|||
23497351|NCT04478266|65562662|FG000|Overall Study|Randomized but not treated|1|||
23497352|NCT04478266|65562663|FG001|Overall Study|Randomized but not treated|1|||
23686914|NCT00868790|66228630|FG006|Period 1|Adverse Event|0|||
23393079|NCT05270863|65186730|FG005|Visit 2 First Intervention|Randomization error|0|||
23393080|NCT05270863|65186725|FG000|First Washout|Withdrawal by Subject|0|||
23393081|NCT05270863|65186726|FG001|First Washout|Withdrawal by Subject|0|||
23393082|NCT05270863|65186727|FG002|First Washout|Withdrawal by Subject|0|||
23393083|NCT05270863|65186728|FG003|First Washout|Withdrawal by Subject|0|||
23393084|NCT05270863|65186729|FG004|First Washout|Withdrawal by Subject|1|||
23393085|NCT05270863|65186730|FG005|First Washout|Withdrawal by Subject|1|||
23393086|NCT05270863|65186725|FG000|First Washout|Lost to Follow-up|0|||
23393087|NCT05270863|65186726|FG001|First Washout|Lost to Follow-up|0|||
23393088|NCT05270863|65186727|FG002|First Washout|Lost to Follow-up|0|||
23393089|NCT05270863|65186728|FG003|First Washout|Lost to Follow-up|0|||
23393090|NCT05270863|65186729|FG004|First Washout|Lost to Follow-up|0|||
23393091|NCT05270863|65186730|FG005|First Washout|Lost to Follow-up|1|||
23393092|NCT05270863|65186725|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
23393093|NCT05270863|65186726|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393094|NCT05270863|65186727|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
23393095|NCT05270863|65186728|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393096|NCT05270863|65186729|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393097|NCT05270863|65186730|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393098|NCT05270863|65186725|FG000|Second Washout|Withdrawal by Subject|1|||
23393099|NCT05270863|65186726|FG001|Second Washout|Withdrawal by Subject|1|||
23393100|NCT05270863|65186727|FG002|Second Washout|Withdrawal by Subject|0|||
23393101|NCT05270863|65186728|FG003|Second Washout|Withdrawal by Subject|0|||
23393102|NCT05270863|65186729|FG004|Second Washout|Withdrawal by Subject|0|||
23393103|NCT05270863|65186730|FG005|Second Washout|Withdrawal by Subject|0|||
23393104|NCT05270863|65186725|FG000|Second Washout|Lost to Follow-up|0|||
23393105|NCT05270863|65186726|FG001|Second Washout|Lost to Follow-up|0|||
23393106|NCT05270863|65186727|FG002|Second Washout|Lost to Follow-up|0|||
23393107|NCT05270863|65186728|FG003|Second Washout|Lost to Follow-up|1|||
23393108|NCT05270863|65186729|FG004|Second Washout|Lost to Follow-up|0|||
23393109|NCT05270863|65186730|FG005|Second Washout|Lost to Follow-up|0|||
23393110|NCT00939185|65186732|FG000|Overall Study|Adverse Event|3|||
23393111|NCT00939185|65186732|FG000|Overall Study|Lack of Efficacy|1|||
23393112|NCT00939185|65186732|FG000|Overall Study|Lost to Follow-up|6|||
23393113|NCT00939185|65186732|FG000|Overall Study|Other|3|||
23393114|NCT00939185|65186732|FG000|Overall Study|Withdrawal by Subject|2|||
23393115|NCT00939185|65186732|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
23393116|NCT04100018|65186733|FG000|Pre-Treatment Period|Not Reported|0|||
23497353|NCT00365508|65562664|FG000|Overall Study|Lost to Follow-up|139|||
23497354|NCT00365508|65562665|FG001|Overall Study|Lost to Follow-up|154|||
23393117|NCT04100018|65186734|FG001|Pre-Treatment Period|Not Reported|4|||
23497355|NCT01788228|65562666|FG000|Overall Study|Migrated/moved from study area|1|||
23497356|NCT01788228|65562667|FG001|Overall Study|Migrated/moved from study area|0|||
23497357|NCT03840174|65562668|FG000|Overall Study|Withdrawal by Subject|1|||
23497358|NCT03840174|65562669|FG001|Overall Study|Withdrawal by Subject|0|||
23497359|NCT03840174|65562670|FG002|Overall Study|Withdrawal by Subject|0|||
23497360|NCT03840174|65562671|FG003|Overall Study|Withdrawal by Subject|0|||
23497361|NCT01387789|65562672|FG000|Overall Study|Adverse Event|5|||
23497362|NCT01387789|65562672|FG000|Overall Study|Lack of Efficacy|2|||
23497363|NCT01387789|65562672|FG000|Overall Study|Lost to Follow-up|1|||
23497364|NCT01773733|65562673|FG000|Overall Study|Adverse Event|3286|||
23497365|NCT01773733|65562674|FG001|Overall Study|Adverse Event|540|||
23497366|NCT01773733|65562673|FG000|Overall Study|Pregnancy|28|||
23497367|NCT01773733|65562674|FG001|Overall Study|Pregnancy|0|||
23497368|NCT01773733|65562673|FG000|Overall Study|Other different categories of not compl|55415|||
23497369|NCT01773733|65562674|FG001|Overall Study|Other different categories of not compl|7781|||
23497370|NCT01890473|65562675|FG000|Overall Study|Lost to Follow-up|1|||
23497371|NCT01890473|65562676|FG001|Overall Study|Lost to Follow-up|0|||
23497372|NCT01890473|65562675|FG000|Overall Study|Poor/non-compliance|1|||
23497373|NCT01890473|65562676|FG001|Overall Study|Poor/non-compliance|0|||
23497374|NCT00282412|65562677|FG000|Overall Study|Death|2|||
23497375|NCT01197560|65562678|FG000|Overall Study|Adverse Event|6|||
23497376|NCT01197560|65562679|FG001|Overall Study|Adverse Event|8|||
23497377|NCT01197560|65562678|FG000|Overall Study|Death|3|||
23497378|NCT01197560|65562679|FG001|Overall Study|Death|5|||
23497379|NCT01197560|65562678|FG000|Overall Study|Withdrawal by Subject|1|||
23497380|NCT01197560|65562679|FG001|Overall Study|Withdrawal by Subject|1|||
23393118|NCT04100018|65186733|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
23393119|NCT04100018|65186734|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
23393120|NCT04100018|65186733|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
23393121|NCT04100018|65186734|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
23393122|NCT04100018|65186733|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
23393123|NCT04100018|65186734|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23393124|NCT04100018|65186733|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23393125|NCT04100018|65186734|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
23393126|NCT04100018|65186733|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
23393127|NCT04100018|65186734|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
23393128|NCT04100018|65186733|FG000|Treatment Period|Other Reason|18|||
23393129|NCT04100018|65186734|FG001|Treatment Period|Other Reason|29|||
23393130|NCT04100018|65186733|FG000|Treatment Period|Completed treatment as per protocol|0|||
23393131|NCT04100018|65186734|FG001|Treatment Period|Completed treatment as per protocol|1|||
23393132|NCT04100018|65186733|FG000|Treatment Period|Maximum clinical benefit|3|||
23393133|NCT04100018|65186734|FG001|Treatment Period|Maximum clinical benefit|0|||
23393134|NCT04100018|65186733|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
23393135|NCT04100018|65186734|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
23393136|NCT04100018|65186733|FG000|Treatment Period|Study drug toxicity|67|||
23393137|NCT04100018|65186734|FG001|Treatment Period|Study drug toxicity|28|||
23393138|NCT04100018|65186733|FG000|Treatment Period|Disease Progression|269|||
23393139|NCT04100018|65186734|FG001|Treatment Period|Disease Progression|318|||
23393140|NCT04100018|65186733|FG000|Treatment Period|Administrative reasons by sponsor|1|||
23393141|NCT04100018|65186734|FG001|Treatment Period|Administrative reasons by sponsor|1|||
23393142|NCT04100018|65186733|FG000|Treatment Period|Poor/Non-Compliance|1|||
23393143|NCT04100018|65186734|FG001|Treatment Period|Poor/Non-Compliance|0|||
23393144|NCT04100018|65186733|FG000|Treatment Period|Lost to Follow-up|2|||
23393145|NCT04100018|65186734|FG001|Treatment Period|Lost to Follow-up|2|||
23393146|NCT04100018|65186733|FG000|Treatment Period|Death|14|||
23393147|NCT04100018|65186734|FG001|Treatment Period|Death|11|||
23393148|NCT04100018|65186733|FG000|Treatment Period|Participant withdrew consent|8|||
23393149|NCT04100018|65186734|FG001|Treatment Period|Participant withdrew consent|10|||
23393150|NCT04100018|65186733|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
23393151|NCT04100018|65186734|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
23393152|NCT04100018|65186733|FG000|Treatment Period|Adverse Event|12|||
23393153|NCT04100018|65186734|FG001|Treatment Period|Adverse Event|6|||
23393154|NCT04100018|65186733|FG000|Treatment Period|Lack of Efficacy|4|||
23393155|NCT04100018|65186734|FG001|Treatment Period|Lack of Efficacy|2|||
23393156|NCT01400412|65186735|FG000|Overall Study|Lost to Follow-up|4|||
23393157|NCT01400412|65186736|FG001|Overall Study|Lost to Follow-up|7|||
23393158|NCT01400412|65186735|FG000|Overall Study|Withdrawal by Subject|3|||
23393159|NCT01400412|65186736|FG001|Overall Study|Withdrawal by Subject|4|||
23497381|NCT01197560|65562678|FG000|Overall Study|Disease progression|40|||
23497382|NCT01197560|65562679|FG001|Overall Study|Disease progression|35|||
23497383|NCT01197560|65562678|FG000|Overall Study|Miscellaneous|4|||
23393160|NCT01400412|65186735|FG000|Overall Study|Unable to complete|3|||
23393161|NCT01400412|65186736|FG001|Overall Study|Unable to complete|3|||
23497384|NCT01197560|65562679|FG001|Overall Study|Miscellaneous|3|||
23497385|NCT01197560|65562678|FG000|Overall Study|Missing|0|||
23497386|NCT01197560|65562679|FG001|Overall Study|Missing|1|||
23497387|NCT01817530|65562680|FG000|Overall Study|Exclusionary Medication Received|0|||
23497388|NCT01817530|65562681|FG001|Overall Study|Exclusionary Medication Received|0|||
23497389|NCT01817530|65562682|FG002|Overall Study|Exclusionary Medication Received|0|||
23497390|NCT01817530|65562683|FG003|Overall Study|Exclusionary Medication Received|0|||
23497391|NCT01817530|65562684|FG004|Overall Study|Exclusionary Medication Received|1|||
23497392|NCT01817530|65562685|FG005|Overall Study|Exclusionary Medication Received|0|||
23497393|NCT01817530|65562686|FG006|Overall Study|Exclusionary Medication Received|0|||
23497394|NCT01817530|65562687|FG007|Overall Study|Exclusionary Medication Received|0|||
23497395|NCT01817530|65562680|FG000|Overall Study|Adverse Event|6|||
23497396|NCT01817530|65562681|FG001|Overall Study|Adverse Event|3|||
23497397|NCT01817530|65562682|FG002|Overall Study|Adverse Event|2|||
23497398|NCT01817530|65562683|FG003|Overall Study|Adverse Event|5|||
23497399|NCT01817530|65562684|FG004|Overall Study|Adverse Event|0|||
23497400|NCT01817530|65562685|FG005|Overall Study|Adverse Event|10|||
23497401|NCT01817530|65562686|FG006|Overall Study|Adverse Event|5|||
23497402|NCT01817530|65562687|FG007|Overall Study|Adverse Event|8|||
23497403|NCT01817530|65562680|FG000|Overall Study|Subject Noncompliant|3|||
23497404|NCT01817530|65562681|FG001|Overall Study|Subject Noncompliant|1|||
23497405|NCT01817530|65562682|FG002|Overall Study|Subject Noncompliant|0|||
23497406|NCT01817530|65562683|FG003|Overall Study|Subject Noncompliant|4|||
23497407|NCT01817530|65562684|FG004|Overall Study|Subject Noncompliant|0|||
23497408|NCT01817530|65562685|FG005|Overall Study|Subject Noncompliant|1|||
23497409|NCT01817530|65562686|FG006|Overall Study|Subject Noncompliant|1|||
23497410|NCT01817530|65562687|FG007|Overall Study|Subject Noncompliant|1|||
23497411|NCT01817530|65562680|FG000|Overall Study|Lack of Efficacy|1|||
23497412|NCT01817530|65562681|FG001|Overall Study|Lack of Efficacy|0|||
23497413|NCT01817530|65562682|FG002|Overall Study|Lack of Efficacy|0|||
23497414|NCT01817530|65562683|FG003|Overall Study|Lack of Efficacy|0|||
23393162|NCT01400412|65186735|FG000|Overall Study|Never started study treatment|0|||
23393163|NCT01400412|65186736|FG001|Overall Study|Never started study treatment|3|||
23393164|NCT03331354|65186740|FG000|Overall Study|Withdrawal by Subject|1|||
23393165|NCT03331354|65186741|FG001|Overall Study|Withdrawal by Subject|3|||
23393166|NCT03331354|65186740|FG000|Overall Study|Lost to Follow-up|3|||
23393167|NCT03331354|65186741|FG001|Overall Study|Lost to Follow-up|3|||
23393168|NCT03331354|65186740|FG000|Overall Study|Found employment before initiated active intervention|0|||
23393169|NCT03331354|65186741|FG001|Overall Study|Found employment before initiated active intervention|4|||
23393170|NCT03557931|65186742|FG000|Overall Study|Adverse Event|4|||
23393171|NCT03557931|65186743|FG001|Overall Study|Adverse Event|6|||
23393172|NCT03557931|65186744|FG002|Overall Study|Adverse Event|1|||
23393173|NCT03557931|65186742|FG000|Overall Study|Lost to Follow-up|4|||
23393174|NCT03557931|65186743|FG001|Overall Study|Lost to Follow-up|4|||
23393175|NCT03557931|65186744|FG002|Overall Study|Lost to Follow-up|1|||
23393176|NCT03557931|65186742|FG000|Overall Study|Protocol Violation|1|||
23393177|NCT03557931|65186743|FG001|Overall Study|Protocol Violation|4|||
23393178|NCT03557931|65186744|FG002|Overall Study|Protocol Violation|1|||
23393179|NCT03557931|65186742|FG000|Overall Study|Withdrawal by Subject|14|||
23393180|NCT03557931|65186743|FG001|Overall Study|Withdrawal by Subject|0|||
23393181|NCT03557931|65186744|FG002|Overall Study|Withdrawal by Subject|7|||
23393182|NCT03557931|65186742|FG000|Overall Study|Miscellaneous|8|||
23393183|NCT03557931|65186743|FG001|Overall Study|Miscellaneous|5|||
23393184|NCT03557931|65186744|FG002|Overall Study|Miscellaneous|3|||
23393185|NCT00112385|65186745|FG000|Overall Study|Lost to Follow-up|1|||
23393186|NCT00112385|65186746|FG001|Overall Study|Lost to Follow-up|0|||
23393187|NCT00112385|65186745|FG000|Overall Study|Withdrawal by Subject|0|||
23393188|NCT00112385|65186746|FG001|Overall Study|Withdrawal by Subject|1|||
23393189|NCT03384966|65186747|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
23393190|NCT03384966|65186748|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
23393191|NCT03384966|65186749|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
23393192|NCT03384966|65186747|FG000|Follow-up Period|Adverse Event|1|||
23393193|NCT03384966|65186748|FG001|Follow-up Period|Adverse Event|0|||
23393194|NCT03384966|65186749|FG002|Follow-up Period|Adverse Event|0|||
23393195|NCT01585025|65186754|FG000|Overall Study|Withdrawal by Subject|0|||
23393196|NCT01585025|65186755|FG001|Overall Study|Withdrawal by Subject|3|||
23393197|NCT01585025|65186756|FG002|Overall Study|Withdrawal by Subject|4|||
23497415|NCT01817530|65562684|FG004|Overall Study|Lack of Efficacy|0|||
23497416|NCT01817530|65562685|FG005|Overall Study|Lack of Efficacy|1|||
23497417|NCT01817530|65562686|FG006|Overall Study|Lack of Efficacy|0|||
23497418|NCT01817530|65562687|FG007|Overall Study|Lack of Efficacy|1|||
23393198|NCT01649869|65186759|FG000|Overall Study|Family member illness|1|||
23393199|NCT01649869|65186760|FG001|Overall Study|Family member illness|0|||
23393200|NCT01649869|65186759|FG000|Overall Study|Required treatment outside protocol|1|||
23393201|NCT01649869|65186760|FG001|Overall Study|Required treatment outside protocol|0|||
23497419|NCT01817530|65562680|FG000|Overall Study|Pregnancy|0|||
23497420|NCT01817530|65562681|FG001|Overall Study|Pregnancy|0|||
23497421|NCT01817530|65562682|FG002|Overall Study|Pregnancy|0|||
23497422|NCT01817530|65562683|FG003|Overall Study|Pregnancy|0|||
23497423|NCT01817530|65562684|FG004|Overall Study|Pregnancy|0|||
23497424|NCT01817530|65562685|FG005|Overall Study|Pregnancy|1|||
23497425|NCT01817530|65562686|FG006|Overall Study|Pregnancy|0|||
23497426|NCT01817530|65562687|FG007|Overall Study|Pregnancy|0|||
23497427|NCT01817530|65562680|FG000|Overall Study|Other|0|||
23497428|NCT01817530|65562681|FG001|Overall Study|Other|1|||
23497429|NCT01817530|65562682|FG002|Overall Study|Other|0|||
23497430|NCT01817530|65562683|FG003|Overall Study|Other|0|||
23497431|NCT01817530|65562684|FG004|Overall Study|Other|1|||
23497432|NCT01817530|65562685|FG005|Overall Study|Other|0|||
23497433|NCT01817530|65562686|FG006|Overall Study|Other|5|||
23497434|NCT01817530|65562687|FG007|Overall Study|Other|0|||
23497435|NCT01817530|65562680|FG000|Overall Study|Surgery or Invasive Intervention|1|||
23497436|NCT01817530|65562681|FG001|Overall Study|Surgery or Invasive Intervention|0|||
23497437|NCT01817530|65562682|FG002|Overall Study|Surgery or Invasive Intervention|0|||
23497438|NCT01817530|65562683|FG003|Overall Study|Surgery or Invasive Intervention|0|||
23497439|NCT01817530|65562684|FG004|Overall Study|Surgery or Invasive Intervention|1|||
23497440|NCT01817530|65562685|FG005|Overall Study|Surgery or Invasive Intervention|1|||
23497441|NCT01817530|65562686|FG006|Overall Study|Surgery or Invasive Intervention|1|||
23497442|NCT01817530|65562687|FG007|Overall Study|Surgery or Invasive Intervention|0|||
23497443|NCT01817530|65562680|FG000|Overall Study|Consent Withdrawn by Subject|3|||
23497444|NCT01817530|65562681|FG001|Overall Study|Consent Withdrawn by Subject|4|||
23497445|NCT01817530|65562682|FG002|Overall Study|Consent Withdrawn by Subject|7|||
23497446|NCT01817530|65562683|FG003|Overall Study|Consent Withdrawn by Subject|3|||
23497447|NCT01817530|65562684|FG004|Overall Study|Consent Withdrawn by Subject|5|||
23497448|NCT01817530|65562685|FG005|Overall Study|Consent Withdrawn by Subject|3|||
23497449|NCT01817530|65562686|FG006|Overall Study|Consent Withdrawn by Subject|3|||
23497450|NCT01817530|65562687|FG007|Overall Study|Consent Withdrawn by Subject|10|||
23497451|NCT01817530|65562680|FG000|Overall Study|Lost to Follow-up|1|||
23497452|NCT01817530|65562681|FG001|Overall Study|Lost to Follow-up|4|||
23497453|NCT01817530|65562682|FG002|Overall Study|Lost to Follow-up|2|||
23497454|NCT01817530|65562683|FG003|Overall Study|Lost to Follow-up|1|||
23497455|NCT01817530|65562684|FG004|Overall Study|Lost to Follow-up|3|||
23497456|NCT01817530|65562685|FG005|Overall Study|Lost to Follow-up|2|||
23497457|NCT01817530|65562686|FG006|Overall Study|Lost to Follow-up|8|||
23497458|NCT01817530|65562687|FG007|Overall Study|Lost to Follow-up|4|||
23497459|NCT00560105|65562690|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
23497460|NCT00560105|65562691|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
23686915|NCT00868790|66228631|FG007|Period 1|Adverse Event|3|||
23686916|NCT00868790|66228632|FG008|Period 1|Adverse Event|1|||
23686917|NCT00868790|66228633|FG009|Period 1|Adverse Event|0|||
23686918|NCT00868790|66228634|FG010|Period 1|Adverse Event|0|||
23686919|NCT00868790|66228635|FG011|Period 1|Adverse Event|0|||
23393202|NCT01649869|65186759|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
23393203|NCT01649869|65186760|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
23393204|NCT01422382|65186761|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
23393205|NCT03232567|65186762|FG000|Overall Study|Withdrawal by Subject|0|||
23393206|NCT03232567|65186763|FG001|Overall Study|Withdrawal by Subject|1|||
23393207|NCT03232567|65186764|FG002|Overall Study|Withdrawal by Subject|0|||
23393208|NCT03232567|65186765|FG003|Overall Study|Withdrawal by Subject|0|||
23393209|NCT03636022|65186770|FG000|Overall Study|Withdrawal by Subject|1|||
23393210|NCT03636022|65186771|FG001|Overall Study|Withdrawal by Subject|3|||
23393211|NCT03802396|65186773|FG000|Overall Study|Withdrawal by Subject|2|||
23393212|NCT03802396|65186774|FG001|Overall Study|Withdrawal by Subject|0|||
23393213|NCT03802396|65186773|FG000|Overall Study|Surgery Cancelled|1|||
23393214|NCT03802396|65186774|FG001|Overall Study|Surgery Cancelled|0|||
23393215|NCT01088906|65186777|FG000|Overall Study|Inclusion error|1|||
23393216|NCT01088906|65186777|FG000|Overall Study|Did not receive study treatment|3|||
23393217|NCT01088906|65186777|FG000|Overall Study|Missing data|1|||
23393218|NCT00492050|65186778|FG000|Overall Study|Adverse Event|1|||
23393219|NCT00492050|65186778|FG000|Overall Study|Lack of Efficacy|1|||
23393220|NCT00492050|65186778|FG000|Overall Study|Withdrawal by Subject|3|||
23393221|NCT00492050|65186778|FG000|Overall Study|Unable to collect SCT|2|||
23497461|NCT00478231|65562692|FG000|Overall Study|Death|7|||
23497462|NCT00478231|65562692|FG000|Overall Study|Lack of Efficacy|47|||
23497463|NCT00478231|65562692|FG000|Overall Study|Lost to Follow-up|7|||
23686920|NCT00868790|66228636|FG012|Period 1|Adverse Event|0|||
23686921|NCT00868790|66228637|FG013|Period 1|Adverse Event|1|||
23686922|NCT00868790|66228624|FG000|Period 1|Protocol Violation|1|||
23393222|NCT00492050|65186778|FG000|Overall Study|Progressive Disease|2|||
23393223|NCT01052779|65186779|FG000|Overall Study|Adverse Event|1|||
23393224|NCT01052779|65186780|FG001|Overall Study|Adverse Event|4|||
23497464|NCT00478231|65562692|FG000|Overall Study|Withdrawal by Subject|6|||
23497465|NCT00478231|65562692|FG000|Overall Study|Other|9|||
23497466|NCT00478231|65562692|FG000|Overall Study|Adverse Event|5|||
23686923|NCT00868790|66228625|FG001|Period 1|Protocol Violation|0|||
23393225|NCT01052779|65186779|FG000|Overall Study|Withdrawal by Subject|1|||
23393226|NCT01052779|65186780|FG001|Overall Study|Withdrawal by Subject|2|||
23393227|NCT01052779|65186779|FG000|Overall Study|Other-Protocol Violation|1|||
23393228|NCT01052779|65186780|FG001|Overall Study|Other-Protocol Violation|1|||
23393229|NCT01052779|65186779|FG000|Overall Study|Other-Surgery|0|||
23393230|NCT01052779|65186780|FG001|Overall Study|Other-Surgery|2|||
23393231|NCT01052779|65186779|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
23393232|NCT01052779|65186780|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
23393233|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
23393234|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
23393235|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
23393236|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
23393237|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
23393238|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
23497467|NCT00478231|65562692|FG000|Overall Study|Randomized, not treated|3|||
23497468|NCT00850343|65562693|FG000|Overall Study|Withdrawal by Subject|11|||
23497469|NCT00850343|65562694|FG001|Overall Study|Withdrawal by Subject|0|||
23497470|NCT00850343|65562695|FG002|Overall Study|Withdrawal by Subject|3|||
23497471|NCT00850343|65562696|FG003|Overall Study|Withdrawal by Subject|2|||
23497472|NCT00850343|65562693|FG000|Overall Study|Adverse Event|15|||
23497473|NCT00850343|65562694|FG001|Overall Study|Adverse Event|2|||
23497474|NCT00850343|65562695|FG002|Overall Study|Adverse Event|6|||
23497475|NCT00850343|65562696|FG003|Overall Study|Adverse Event|6|||
23497476|NCT00850343|65562693|FG000|Overall Study|Pregnancy|0|||
23497477|NCT00850343|65562694|FG001|Overall Study|Pregnancy|0|||
23497478|NCT00850343|65562695|FG002|Overall Study|Pregnancy|0|||
23497479|NCT00850343|65562696|FG003|Overall Study|Pregnancy|1|||
23497480|NCT00850343|65562693|FG000|Overall Study|Lack of Efficacy|17|||
23497481|NCT00850343|65562694|FG001|Overall Study|Lack of Efficacy|0|||
23497482|NCT00850343|65562695|FG002|Overall Study|Lack of Efficacy|3|||
23497483|NCT00850343|65562696|FG003|Overall Study|Lack of Efficacy|2|||
23497484|NCT00850343|65562693|FG000|Overall Study|Non-compliance with Study Procedures|1|||
23497485|NCT00850343|65562694|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23497486|NCT00850343|65562695|FG002|Overall Study|Non-compliance with Study Procedures|1|||
23497487|NCT00850343|65562696|FG003|Overall Study|Non-compliance with Study Procedures|1|||
23497488|NCT00850343|65562693|FG000|Overall Study|Physician Decision|2|||
23497489|NCT00850343|65562694|FG001|Overall Study|Physician Decision|1|||
23497490|NCT00850343|65562695|FG002|Overall Study|Physician Decision|1|||
23497491|NCT00850343|65562696|FG003|Overall Study|Physician Decision|1|||
23497492|NCT00231842|65562697|FG000|Overall Study|Withdrawal by Subject|3|||
23497493|NCT00231842|65562697|FG000|Overall Study|Did not complete the last 3 cycle|8|||
23497494|NCT03780543|65562698|FG000|Overall Study|Adverse Event|1|||
23497495|NCT03780543|65562699|FG001|Overall Study|Adverse Event|0|||
23497496|NCT03780543|65562700|FG002|Overall Study|Adverse Event|2|||
23497497|NCT03780543|65562698|FG000|Overall Study|Lost to Follow-up|2|||
23497498|NCT03780543|65562699|FG001|Overall Study|Lost to Follow-up|0|||
23497499|NCT03780543|65562700|FG002|Overall Study|Lost to Follow-up|1|||
23393239|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
23393240|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
23393241|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
23393242|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
23393243|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
23393244|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
23393245|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
23393246|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
23393247|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
23393248|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
23393249|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
23393250|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
23393251|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
23393252|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
23393253|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
23393254|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
23393255|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
23497500|NCT03780543|65562698|FG000|Overall Study|Study terminated by Sponsor|8|||
23497501|NCT03780543|65562699|FG001|Overall Study|Study terminated by Sponsor|7|||
23497502|NCT03780543|65562700|FG002|Overall Study|Study terminated by Sponsor|13|||
23497503|NCT03780543|65562698|FG000|Overall Study|Withdrawal by Subject|1|||
23393256|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
23393257|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
23497504|NCT03780543|65562699|FG001|Overall Study|Withdrawal by Subject|8|||
23497505|NCT03780543|65562700|FG002|Overall Study|Withdrawal by Subject|1|||
23497506|NCT03780543|65562698|FG000|Overall Study|Noncompliance with study drug|1|||
23497507|NCT03780543|65562699|FG001|Overall Study|Noncompliance with study drug|0|||
23497508|NCT03780543|65562700|FG002|Overall Study|Noncompliance with study drug|0|||
23393258|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
23393259|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
23393260|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
23497509|NCT00705289|65562704|FG000|Overall Study|Subject or treating physician's choice|131|||
23497510|NCT00259610|65562705|FG000|Overall Study|Withdrawal by Subject|33|||
23497511|NCT00259610|65562706|FG001|Overall Study|Withdrawal by Subject|25|||
23497512|NCT00259610|65562707|FG002|Overall Study|Withdrawal by Subject|29|||
23497513|NCT00259610|65562708|FG003|Overall Study|Withdrawal by Subject|19|||
23497514|NCT00259610|65562705|FG000|Overall Study|Lost to Follow-up|19|||
23497515|NCT00259610|65562706|FG001|Overall Study|Lost to Follow-up|8|||
23497516|NCT00259610|65562707|FG002|Overall Study|Lost to Follow-up|18|||
23686924|NCT00868790|66228626|FG002|Period 1|Protocol Violation|0|||
23686925|NCT00868790|66228627|FG003|Period 1|Protocol Violation|0|||
23686926|NCT00868790|66228628|FG004|Period 1|Protocol Violation|0|||
23686927|NCT00868790|66228629|FG005|Period 1|Protocol Violation|0|||
23686928|NCT00868790|66228630|FG006|Period 1|Protocol Violation|0|||
23686929|NCT00868790|66228631|FG007|Period 1|Protocol Violation|0|||
23686930|NCT00868790|66228632|FG008|Period 1|Protocol Violation|0|||
23686931|NCT00868790|66228633|FG009|Period 1|Protocol Violation|0|||
23686932|NCT00868790|66228634|FG010|Period 1|Protocol Violation|0|||
23686933|NCT00868790|66228635|FG011|Period 1|Protocol Violation|0|||
23686934|NCT00868790|66228636|FG012|Period 1|Protocol Violation|0|||
23497517|NCT00259610|65562708|FG003|Overall Study|Lost to Follow-up|15|||
23497518|NCT00259610|65562705|FG000|Overall Study|Physician Decision|6|||
23497519|NCT00259610|65562706|FG001|Overall Study|Physician Decision|4|||
23686935|NCT00868790|66228637|FG013|Period 1|Protocol Violation|0|||
23686936|NCT00868790|66228624|FG000|Period 1|Withdrawal by Subject|0|||
23686937|NCT00868790|66228625|FG001|Period 1|Withdrawal by Subject|1|||
23686938|NCT00868790|66228626|FG002|Period 1|Withdrawal by Subject|0|||
23686939|NCT00868790|66228627|FG003|Period 1|Withdrawal by Subject|0|||
23393261|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
23393262|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
23393263|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
23393264|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
23393265|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
23393266|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
23393267|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
23393268|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
23393269|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
23393270|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
23393271|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
23393272|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
23393273|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
23393274|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
23393275|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
23393276|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
23686940|NCT00868790|66228628|FG004|Period 1|Withdrawal by Subject|0|||
23686941|NCT00868790|66228629|FG005|Period 1|Withdrawal by Subject|0|||
23686942|NCT00868790|66228630|FG006|Period 1|Withdrawal by Subject|0|||
23686943|NCT00868790|66228631|FG007|Period 1|Withdrawal by Subject|0|||
23686944|NCT00868790|66228632|FG008|Period 1|Withdrawal by Subject|0|||
23686945|NCT00868790|66228633|FG009|Period 1|Withdrawal by Subject|0|||
23686946|NCT00868790|66228634|FG010|Period 1|Withdrawal by Subject|0|||
23686947|NCT00868790|66228635|FG011|Period 1|Withdrawal by Subject|0|||
23686948|NCT00868790|66228636|FG012|Period 1|Withdrawal by Subject|0|||
23686949|NCT00868790|66228637|FG013|Period 1|Withdrawal by Subject|1|||
23686950|NCT00868790|66228624|FG000|Period 1|Abnormal Triglycerides|0|||
23686951|NCT00868790|66228625|FG001|Period 1|Abnormal Triglycerides|0|||
23686952|NCT00868790|66228626|FG002|Period 1|Abnormal Triglycerides|0|||
23686953|NCT00868790|66228627|FG003|Period 1|Abnormal Triglycerides|0|||
23686954|NCT00868790|66228628|FG004|Period 1|Abnormal Triglycerides|1|||
23686955|NCT00868790|66228629|FG005|Period 1|Abnormal Triglycerides|0|||
23686956|NCT00868790|66228630|FG006|Period 1|Abnormal Triglycerides|0|||
23686957|NCT00868790|66228631|FG007|Period 1|Abnormal Triglycerides|0|||
23686958|NCT00868790|66228632|FG008|Period 1|Abnormal Triglycerides|0|||
23686959|NCT00868790|66228633|FG009|Period 1|Abnormal Triglycerides|0|||
23686960|NCT00868790|66228634|FG010|Period 1|Abnormal Triglycerides|0|||
23686961|NCT00868790|66228635|FG011|Period 1|Abnormal Triglycerides|0|||
23686962|NCT00868790|66228636|FG012|Period 1|Abnormal Triglycerides|0|||
23686963|NCT00868790|66228637|FG013|Period 1|Abnormal Triglycerides|0|||
23686964|NCT00868790|66228624|FG000|Period 1|Lost to Follow-up|0|||
23497520|NCT00259610|65562707|FG002|Overall Study|Physician Decision|7|||
23497521|NCT00259610|65562708|FG003|Overall Study|Physician Decision|2|||
23497522|NCT00259610|65562705|FG000|Overall Study|Death|1|||
23497523|NCT00259610|65562706|FG001|Overall Study|Death|1|||
23497524|NCT00259610|65562707|FG002|Overall Study|Death|2|||
23497525|NCT00259610|65562708|FG003|Overall Study|Death|0|||
23497526|NCT00259610|65562705|FG000|Overall Study|non medical reason|6|||
23497527|NCT00259610|65562706|FG001|Overall Study|non medical reason|2|||
23686965|NCT00868790|66228625|FG001|Period 1|Lost to Follow-up|0|||
23686966|NCT00868790|66228626|FG002|Period 1|Lost to Follow-up|0|||
23686967|NCT00868790|66228627|FG003|Period 1|Lost to Follow-up|0|||
23686968|NCT00868790|66228628|FG004|Period 1|Lost to Follow-up|0|||
23686969|NCT00868790|66228629|FG005|Period 1|Lost to Follow-up|1|||
23686970|NCT00868790|66228630|FG006|Period 1|Lost to Follow-up|0|||
23686971|NCT00868790|66228631|FG007|Period 1|Lost to Follow-up|0|||
23497528|NCT00259610|65562707|FG002|Overall Study|non medical reason|10|||
23686972|NCT00868790|66228632|FG008|Period 1|Lost to Follow-up|0|||
23686973|NCT00868790|66228633|FG009|Period 1|Lost to Follow-up|0|||
23686974|NCT00868790|66228634|FG010|Period 1|Lost to Follow-up|0|||
23686975|NCT00868790|66228635|FG011|Period 1|Lost to Follow-up|0|||
23686976|NCT00868790|66228636|FG012|Period 1|Lost to Follow-up|0|||
23686977|NCT00868790|66228637|FG013|Period 1|Lost to Follow-up|0|||
23686978|NCT00868790|66228624|FG000|Period 2|Adverse Event|0|||
23686979|NCT00868790|66228625|FG001|Period 2|Adverse Event|0|||
23686980|NCT00868790|66228626|FG002|Period 2|Adverse Event|0|||
23686981|NCT00868790|66228627|FG003|Period 2|Adverse Event|0|||
23686982|NCT00868790|66228628|FG004|Period 2|Adverse Event|0|||
23686983|NCT00868790|66228629|FG005|Period 2|Adverse Event|0|||
23686984|NCT00868790|66228630|FG006|Period 2|Adverse Event|0|||
23686985|NCT00868790|66228631|FG007|Period 2|Adverse Event|0|||
23686986|NCT00868790|66228632|FG008|Period 2|Adverse Event|1|||
23686987|NCT00868790|66228633|FG009|Period 2|Adverse Event|0|||
23686988|NCT00868790|66228634|FG010|Period 2|Adverse Event|0|||
23686989|NCT00868790|66228635|FG011|Period 2|Adverse Event|0|||
23686990|NCT00868790|66228636|FG012|Period 2|Adverse Event|0|||
23497529|NCT00259610|65562708|FG003|Overall Study|non medical reason|3|||
23497530|NCT00259610|65562705|FG000|Overall Study|Adverse Event|3|||
23497531|NCT00259610|65562706|FG001|Overall Study|Adverse Event|4|||
23497532|NCT00259610|65562707|FG002|Overall Study|Adverse Event|5|||
23497533|NCT00259610|65562708|FG003|Overall Study|Adverse Event|2|||
23497534|NCT00259610|65562705|FG000|Overall Study|Serious Adverse Event|8|||
23497535|NCT00259610|65562706|FG001|Overall Study|Serious Adverse Event|2|||
23497536|NCT00259610|65562707|FG002|Overall Study|Serious Adverse Event|2|||
23497537|NCT00259610|65562708|FG003|Overall Study|Serious Adverse Event|2|||
23497538|NCT04289623|65562710|FG000|Wave 1 Emails|Email was not delivered|268|||
23497539|NCT04289623|65562711|FG001|Wave 1 Emails|Email was not delivered|257|||
23497540|NCT04289623|65562712|FG002|Wave 1 Emails|Email was not delivered|0|||
23497541|NCT04289623|65562713|FG003|Wave 1 Emails|Email was not delivered|0|||
23497542|NCT04289623|65562714|FG004|Wave 1 Emails|Email was not delivered|0|||
23497543|NCT04289623|65562715|FG005|Wave 1 Emails|Email was not delivered|0|||
23497544|NCT00939640|65562716|FG000|Overall Study|Physician Decision|1|||
23497545|NCT02693119|65562719|FG000|Open-Label Period|Withdrawal by Subject|0|||
23497546|NCT02693119|65562720|FG001|Open-Label Period|Withdrawal by Subject|1|||
23686991|NCT00868790|66228637|FG013|Period 2|Adverse Event|0|||
23686992|NCT00868790|66228624|FG000|Period 2|Lost to Follow-up|0|||
23686993|NCT00868790|66228625|FG001|Period 2|Lost to Follow-up|1|||
23686994|NCT00868790|66228626|FG002|Period 2|Lost to Follow-up|0|||
23686995|NCT00868790|66228627|FG003|Period 2|Lost to Follow-up|0|||
23393277|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
23393278|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
23393279|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
23393280|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
23393281|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
23393282|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
23393283|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
23393284|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
23393285|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
23393286|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
23393287|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
23393288|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
23393289|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
23393290|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
23393291|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
23393292|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
23393293|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
23393294|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
23393295|NCT00581919|65186786|FG000|Overall Study|Adverse Event|8|||
23393296|NCT00581919|65186786|FG000|Overall Study|Death|1|||
23393297|NCT00581919|65186786|FG000|Overall Study|Disease Progression|10|||
23393298|NCT00581919|65186786|FG000|Overall Study|Physician Decision|1|||
23393299|NCT00581919|65186786|FG000|Overall Study|Other Complicating Disease|1|||
23393300|NCT00581919|65186786|FG000|Overall Study|Started Non-Protocol Therapy|2|||
23393301|NCT00581919|65186786|FG000|Overall Study|Withdrawal by Subject|1|||
23393302|NCT05788991|65186787|FG000|Overall Study|Not treated with study medication|1|||
23393303|NCT05788991|65186788|FG001|Overall Study|Not treated with study medication|3|||
23393304|NCT05788991|65186787|FG000|Overall Study|Withdrawal by Subject|1|||
23393305|NCT05788991|65186788|FG001|Overall Study|Withdrawal by Subject|0|||
23393306|NCT05788991|65186787|FG000|Overall Study|Lack of Efficacy|0|||
23393307|NCT05788991|65186788|FG001|Overall Study|Lack of Efficacy|1|||
23393308|NCT05788991|65186787|FG000|Overall Study|Protocol Violation|1|||
23393309|NCT05788991|65186788|FG001|Overall Study|Protocol Violation|2|||
23393310|NCT03189719|65186789|FG000|Overall Study|Death|325|||
23393311|NCT03189719|65186790|FG001|Overall Study|Death|361|||
23393312|NCT03189719|65186789|FG000|Overall Study|Physician Decision|1|||
23393313|NCT03189719|65186790|FG001|Overall Study|Physician Decision|0|||
23393314|NCT03189719|65186789|FG000|Overall Study|Sponsor Decision|40|||
23497547|NCT00573183|65562723|FG000|Overall Study|Lost to Follow-up|52|||
23497548|NCT00573183|65562724|FG001|Overall Study|Lost to Follow-up|50|||
23686996|NCT00868790|66228628|FG004|Period 2|Lost to Follow-up|0|||
23393315|NCT03189719|65186790|FG001|Overall Study|Sponsor Decision|12|||
23686997|NCT00868790|66228629|FG005|Period 2|Lost to Follow-up|1|||
23686998|NCT00868790|66228630|FG006|Period 2|Lost to Follow-up|0|||
23497549|NCT00573183|65562723|FG000|Overall Study|Withdrawal by Subject|8|||
23497550|NCT00573183|65562724|FG001|Overall Study|Withdrawal by Subject|2|||
23497551|NCT00573183|65562723|FG000|Overall Study|Death|0|||
23497552|NCT00573183|65562724|FG001|Overall Study|Death|1|||
23497553|NCT00573183|65562723|FG000|Overall Study|Adverse Event|2|||
23497554|NCT00573183|65562724|FG001|Overall Study|Adverse Event|0|||
23497555|NCT00573183|65562723|FG000|Overall Study|Incarceration|5|||
23497556|NCT00573183|65562724|FG001|Overall Study|Incarceration|8|||
23497557|NCT00573183|65562723|FG000|Overall Study|Other|5|||
23497558|NCT00573183|65562724|FG001|Overall Study|Other|2|||
23497559|NCT00293033|65562725|FG000|Open-label Titration Period|Adverse Event|10|||
23497560|NCT00293033|65562725|FG000|Open-label Titration Period|Death|3|||
23497561|NCT00293033|65562725|FG000|Open-label Titration Period|Lack of Efficacy|5|||
23497562|NCT00293033|65562725|FG000|Open-label Titration Period|Protocol Violation|2|||
23497563|NCT00293033|65562725|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
23497564|NCT00293033|65562725|FG000|Open-label Titration Period|Noncompliance and other|27|||
23497565|NCT00293033|65562725|FG000|Double-blind Treatment Period|Adverse Event|3|||
23497566|NCT00293033|65562725|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23497567|NCT00293033|65562725|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
23497568|NCT00293033|65562725|FG000|Double-blind Treatment Period|Noncompliance|4|||
23497569|NCT01443078|65562726|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
23497570|NCT01443078|65562726|FG000|Overall Study|Withdrawal by Subject|1|||
23497571|NCT01443078|65562726|FG000|Overall Study|Patient had brain mets|1|||
23497572|NCT00799422|65562734|FG000|First Week of Wear|Lost to Follow-up|0|||
23497573|NCT00799422|65562735|FG001|First Week of Wear|Lost to Follow-up|0|||
23497574|NCT00799422|65562736|FG002|First Week of Wear|Lost to Follow-up|1|||
23497575|NCT00799422|65562737|FG003|First Week of Wear|Lost to Follow-up|0|||
23497576|NCT00799422|65562738|FG004|First Week of Wear|Lost to Follow-up|0|||
23497577|NCT00799422|65562739|FG005|First Week of Wear|Lost to Follow-up|0|||
23497578|NCT00799422|65562734|FG000|First Week of Wear|Adverse Event|0|||
23497579|NCT00799422|65562735|FG001|First Week of Wear|Adverse Event|0|||
23497580|NCT00799422|65562736|FG002|First Week of Wear|Adverse Event|0|||
23497581|NCT00799422|65562737|FG003|First Week of Wear|Adverse Event|1|||
23497582|NCT00799422|65562738|FG004|First Week of Wear|Adverse Event|0|||
23497583|NCT00799422|65562739|FG005|First Week of Wear|Adverse Event|0|||
23497584|NCT01790932|65562740|FG000|Overall Study|Disease Progression|41|||
23497585|NCT01790932|65562740|FG000|Overall Study|Adverse Event|7|||
23497586|NCT01790932|65562740|FG000|Overall Study|Physician Decision|1|||
23497587|NCT01790932|65562740|FG000|Overall Study|Withdrawal by Subject|1|||
23497588|NCT02336373|65562741|FG000|Overall Study|Protocol closed early|4|||
23497589|NCT02336373|65562741|FG000|Overall Study|Physician Decision|14|||
23497590|NCT03750955|65562743|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
23497591|NCT03750955|65562744|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
23497592|NCT03750955|65562743|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
23497593|NCT03750955|65562744|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
23497594|NCT00644228|65562745|FG000|Randomization & Eligibility|Ineligible|31|||
23497595|NCT00644228|65562746|FG001|Randomization & Eligibility|Ineligible|21|||
23497596|NCT00644228|65562745|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
23497597|NCT00644228|65562746|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
23497598|NCT00644228|65562745|FG000|Randomization & Eligibility|Invalid Consent|0|||
23497599|NCT00644228|65562746|FG001|Randomization & Eligibility|Invalid Consent|1|||
23497600|NCT00644228|65562745|FG000|Induction Therapy|Adverse Event|22|||
23497601|NCT00644228|65562746|FG001|Induction Therapy|Adverse Event|55|||
23497602|NCT00644228|65562745|FG000|Induction Therapy|Withdrawal by Subject|10|||
23497603|NCT00644228|65562746|FG001|Induction Therapy|Withdrawal by Subject|3|||
23497604|NCT00644228|65562745|FG000|Induction Therapy|Progression/Relapse|24|||
23497605|NCT00644228|65562746|FG001|Induction Therapy|Progression/Relapse|12|||
23497606|NCT00644228|65562745|FG000|Induction Therapy|Death|3|||
23497607|NCT00644228|65562746|FG001|Induction Therapy|Death|7|||
23497608|NCT00644228|65562745|FG000|Induction Therapy|Not Protocol-Specified|24|||
23497609|NCT00644228|65562746|FG001|Induction Therapy|Not Protocol-Specified|28|||
23497610|NCT00644228|65562745|FG000|Maintenance|Adverse Event|27|||
23497611|NCT00644228|65562746|FG001|Maintenance|Adverse Event|31|||
23686999|NCT00868790|66228631|FG007|Period 2|Lost to Follow-up|0|||
23687000|NCT00868790|66228632|FG008|Period 2|Lost to Follow-up|0|||
23687001|NCT00868790|66228633|FG009|Period 2|Lost to Follow-up|0|||
23497612|NCT00644228|65562745|FG000|Maintenance|Withdrawal by Subject|6|||
23497613|NCT00644228|65562746|FG001|Maintenance|Withdrawal by Subject|4|||
23497614|NCT00644228|65562745|FG000|Maintenance|Progression/Relapse|67|||
23497615|NCT00644228|65562746|FG001|Maintenance|Progression/Relapse|42|||
23497616|NCT00644228|65562745|FG000|Maintenance|Death|3|||
23497617|NCT00644228|65562746|FG001|Maintenance|Death|3|||
23497618|NCT00644228|65562745|FG000|Maintenance|Not Protocol-Specified|14|||
23497619|NCT00644228|65562746|FG001|Maintenance|Not Protocol-Specified|15|||
23497620|NCT00644228|65562745|FG000|Maintenance|On Treatment|26|||
23497621|NCT00644228|65562746|FG001|Maintenance|On Treatment|40|||
23497622|NCT04528732|65562750|FG000|Overall Study|Death|1|||
23497623|NCT04528732|65562751|FG001|Overall Study|Death|0|||
23497624|NCT04528732|65562752|FG002|Overall Study|Death|1|||
23497625|NCT04528732|65562750|FG000|Overall Study|Lost to Follow-up|0|||
23497626|NCT04528732|65562751|FG001|Overall Study|Lost to Follow-up|1|||
23497627|NCT04528732|65562752|FG002|Overall Study|Lost to Follow-up|2|||
23497628|NCT03817879|65562756|FG000|Overall Study|Drop out|5|||
23497629|NCT03817879|65562757|FG001|Overall Study|Drop out|12|||
23497630|NCT03817879|65562756|FG000|Overall Study|Withdrawal by Subject|0|||
23497631|NCT03817879|65562757|FG001|Overall Study|Withdrawal by Subject|1|||
23497632|NCT03606512|65562758|FG000|Overall Study|Lost to Follow-up|0|||
23497633|NCT03606512|65562759|FG001|Overall Study|Lost to Follow-up|1|||
23497634|NCT03606512|65562758|FG000|Overall Study|'moved from study area|0|||
23497635|NCT03606512|65562759|FG001|Overall Study|'moved from study area|1|||
23497636|NCT03334539|65566143|FG000|Overall Study|Adverse Event|3|||
23497637|NCT03334539|65566144|FG001|Overall Study|Adverse Event|5|||
23497638|NCT03334539|65566145|FG002|Overall Study|Adverse Event|0|||
23497639|NCT03334539|65566143|FG000|Overall Study|Withdrawal by Subject|0|||
23497640|NCT03334539|65566144|FG001|Overall Study|Withdrawal by Subject|1|||
23497641|NCT03334539|65566145|FG002|Overall Study|Withdrawal by Subject|1|||
23497642|NCT03334539|65566143|FG000|Overall Study|Administrative Reasons|1|||
23497643|NCT03334539|65566144|FG001|Overall Study|Administrative Reasons|0|||
23497644|NCT03334539|65566145|FG002|Overall Study|Administrative Reasons|0|||
23497645|NCT03334539|65566143|FG000|Overall Study|Hypertension Not Controlled|0|||
23497646|NCT03334539|65566144|FG001|Overall Study|Hypertension Not Controlled|1|||
23497647|NCT03334539|65566145|FG002|Overall Study|Hypertension Not Controlled|0|||
23497648|NCT00816595|65566146|FG000|Overall Study|Withdrawal by Subject|2|||
23497649|NCT00816595|65566147|FG001|Overall Study|Withdrawal by Subject|0|||
23497650|NCT01602120|65566148|FG000|Overall Study|Adverse Event|3|||
23497651|NCT01602120|65566149|FG001|Overall Study|Adverse Event|6|||
23497652|NCT01602120|65566150|FG002|Overall Study|Adverse Event|0|||
23497653|NCT01602120|65566151|FG003|Overall Study|Adverse Event|2|||
23497654|NCT01602120|65566148|FG000|Overall Study|Death|0|||
23497655|NCT01602120|65566149|FG001|Overall Study|Death|4|||
23497656|NCT01602120|65566150|FG002|Overall Study|Death|0|||
23497657|NCT01602120|65566151|FG003|Overall Study|Death|0|||
23497658|NCT01602120|65566148|FG000|Overall Study|Lost to Follow-up|0|||
23497659|NCT01602120|65566149|FG001|Overall Study|Lost to Follow-up|1|||
23497660|NCT01602120|65566150|FG002|Overall Study|Lost to Follow-up|0|||
23497661|NCT01602120|65566151|FG003|Overall Study|Lost to Follow-up|1|||
23497662|NCT01602120|65566148|FG000|Overall Study|Protocol Violation|1|||
23497663|NCT01602120|65566149|FG001|Overall Study|Protocol Violation|1|||
23497664|NCT01602120|65566150|FG002|Overall Study|Protocol Violation|0|||
23497665|NCT01602120|65566151|FG003|Overall Study|Protocol Violation|0|||
23497666|NCT01602120|65566148|FG000|Overall Study|Non-compliance|0|||
23497667|NCT01602120|65566149|FG001|Overall Study|Non-compliance|3|||
23497668|NCT01602120|65566150|FG002|Overall Study|Non-compliance|0|||
23497669|NCT01602120|65566151|FG003|Overall Study|Non-compliance|1|||
23497670|NCT01602120|65566148|FG000|Overall Study|Withdrawal by Subject|8|||
23497671|NCT01602120|65566149|FG001|Overall Study|Withdrawal by Subject|17|||
23497672|NCT01602120|65566150|FG002|Overall Study|Withdrawal by Subject|0|||
23497673|NCT01602120|65566151|FG003|Overall Study|Withdrawal by Subject|3|||
23497674|NCT01602120|65566148|FG000|Overall Study|Study Terminated by Sponsor|12|||
23497675|NCT01602120|65566149|FG001|Overall Study|Study Terminated by Sponsor|24|||
23497676|NCT01602120|65566150|FG002|Overall Study|Study Terminated by Sponsor|17|||
23497677|NCT01602120|65566151|FG003|Overall Study|Study Terminated by Sponsor|44|||
23497678|NCT01602120|65566148|FG000|Overall Study|Physician Decision|2|||
23497679|NCT01602120|65566149|FG001|Overall Study|Physician Decision|3|||
23497680|NCT01602120|65566150|FG002|Overall Study|Physician Decision|0|||
23497681|NCT01602120|65566151|FG003|Overall Study|Physician Decision|0|||
23497682|NCT01602120|65566148|FG000|Overall Study|Unspecified Reason|3|||
23497683|NCT01602120|65566149|FG001|Overall Study|Unspecified Reason|1|||
23497684|NCT01602120|65566150|FG002|Overall Study|Unspecified Reason|0|||
23497685|NCT01602120|65566151|FG003|Overall Study|Unspecified Reason|2|||
23497686|NCT00289133|65566152|FG000|Overall Study|Non-study device implanted|12|||
23497687|NCT00289133|65566153|FG001|Overall Study|Non-study device implanted|0|||
23497688|NCT00289133|65566152|FG000|Overall Study|Protocol Violation|32|||
23497689|NCT00289133|65566153|FG001|Overall Study|Protocol Violation|38|||
23497690|NCT00289133|65566152|FG000|Overall Study|Withdrawal by Subject|9|||
23497691|NCT00289133|65566153|FG001|Overall Study|Withdrawal by Subject|10|||
23497692|NCT00289133|65566152|FG000|Overall Study|Death|5|||
23497693|NCT00289133|65566153|FG001|Overall Study|Death|10|||
23497694|NCT00289133|65566152|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
23497695|NCT00289133|65566153|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
23497696|NCT00289133|65566152|FG000|Overall Study|Physician Decision|41|||
23497697|NCT00289133|65566153|FG001|Overall Study|Physician Decision|45|||
23497698|NCT00289133|65566152|FG000|Overall Study|Revision|8|||
23497699|NCT00289133|65566153|FG001|Overall Study|Revision|6|||
23497700|NCT00289133|65566152|FG000|Overall Study|Lost to Follow-up|92|||
23497701|NCT00289133|65566153|FG001|Overall Study|Lost to Follow-up|115|||
23497702|NCT00412542|65566162|FG000|Overall Study|Withdrawal by Subject|0|||
23497703|NCT00412542|65566163|FG001|Overall Study|Withdrawal by Subject|2|||
23497704|NCT00412542|65566162|FG000|Overall Study|Not Eligible|0|||
23497705|NCT00412542|65566163|FG001|Overall Study|Not Eligible|1|||
23497706|NCT01534962|65566164|FG000|Overall Study|Randomized but did not start treatment|2|||
23497707|NCT01534962|65566165|FG001|Overall Study|Randomized but did not start treatment|0|||
23497708|NCT01534962|65566166|FG002|Overall Study|Randomized but did not start treatment|0|||
23497709|NCT01534962|65566167|FG003|Overall Study|Randomized but did not start treatment|1|||
23393316|NCT03189719|65186789|FG000|Overall Study|Withdrawal by Subject|7|||
23393317|NCT03189719|65186790|FG001|Overall Study|Withdrawal by Subject|3|||
23393318|NCT03884101|65186791|FG000|Overall Study|Participant Ongoing in Study|202|||
23393319|NCT03884101|65186792|FG001|Overall Study|Participant Ongoing in Study|186|||
23393320|NCT03884101|65186791|FG000|Overall Study|Death|212|||
23393321|NCT03884101|65186792|FG001|Overall Study|Death|224|||
23393322|NCT03884101|65186791|FG000|Overall Study|Lost to Follow-up|0|||
23393323|NCT03884101|65186792|FG001|Overall Study|Lost to Follow-up|1|||
23393324|NCT03884101|65186791|FG000|Overall Study|Withdrawal by Subject|6|||
23393325|NCT03884101|65186792|FG001|Overall Study|Withdrawal by Subject|11|||
23393326|NCT02310321|65186806|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
23393327|NCT02310321|65186807|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393328|NCT02310321|65186808|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393329|NCT02310321|65186806|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
23393330|NCT02310321|65186807|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393331|NCT02310321|65186808|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393332|NCT02310321|65186806|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
23497710|NCT01534962|65566164|FG000|Overall Study|Discontinued at AF recurrence|35|||
23497711|NCT01534962|65566165|FG001|Overall Study|Discontinued at AF recurrence|26|||
23497712|NCT01534962|65566166|FG002|Overall Study|Discontinued at AF recurrence|24|||
23497713|NCT01534962|65566167|FG003|Overall Study|Discontinued at AF recurrence|31|||
23497714|NCT00091442|65566168|FG000|Overall Study|Progressive Disease|220|||
23497715|NCT00091442|65566169|FG001|Overall Study|Progressive Disease|189|||
23497716|NCT00091442|65566168|FG000|Overall Study|Physician Decision|61|||
23497717|NCT00091442|65566169|FG001|Overall Study|Physician Decision|58|||
23497718|NCT00091442|65566168|FG000|Overall Study|Withdrawal by Subject|38|||
23497719|NCT00091442|65566169|FG001|Overall Study|Withdrawal by Subject|46|||
23497720|NCT00091442|65566168|FG000|Overall Study|Adverse Event|29|||
23497721|NCT00091442|65566169|FG001|Overall Study|Adverse Event|48|||
23687002|NCT00868790|66228634|FG010|Period 2|Lost to Follow-up|0|||
23687003|NCT00868790|66228635|FG011|Period 2|Lost to Follow-up|0|||
23687004|NCT00868790|66228636|FG012|Period 2|Lost to Follow-up|0|||
23687005|NCT00868790|66228637|FG013|Period 2|Lost to Follow-up|0|||
23687006|NCT00868790|66228624|FG000|Period 2|Withdrawal by Subject|0|||
23687007|NCT00868790|66228625|FG001|Period 2|Withdrawal by Subject|0|||
23687008|NCT00868790|66228626|FG002|Period 2|Withdrawal by Subject|0|||
23687009|NCT00868790|66228627|FG003|Period 2|Withdrawal by Subject|0|||
23393333|NCT02310321|65186807|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393334|NCT02310321|65186808|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23497722|NCT00091442|65566168|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
23497723|NCT00091442|65566169|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
23497724|NCT00091442|65566168|FG000|Overall Study|Death|9|||
23497725|NCT00091442|65566169|FG001|Overall Study|Death|7|||
23497726|NCT00091442|65566168|FG000|Overall Study|Lost to Follow-up|1|||
23497727|NCT00091442|65566169|FG001|Overall Study|Lost to Follow-up|3|||
23497728|NCT00091442|65566168|FG000|Overall Study|Other|2|||
23497729|NCT00091442|65566169|FG001|Overall Study|Other|6|||
23497730|NCT01889238|65566172|FG000|Overall Study|Treatment ongoing|9|||
23497731|NCT04431453|65566173|FG000|Overall Study|Withdrew Consent|0|||
23497732|NCT04431453|65566174|FG001|Overall Study|Withdrew Consent|1|||
23497733|NCT04431453|65566175|FG002|Overall Study|Withdrew Consent|0|||
23497734|NCT04431453|65566176|FG003|Overall Study|Withdrew Consent|2|||
23497735|NCT04431453|65566177|FG004|Overall Study|Withdrew Consent|0|||
23497736|NCT04431453|65566178|FG005|Overall Study|Withdrew Consent|0|||
23497737|NCT04431453|65566179|FG006|Overall Study|Withdrew Consent|0|||
23497738|NCT04431453|65566180|FG007|Overall Study|Withdrew Consent|0|||
23497739|NCT04431453|65566173|FG000|Overall Study|Death|1|||
23393335|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
23497740|NCT04431453|65566174|FG001|Overall Study|Death|0|||
23497741|NCT04431453|65566175|FG002|Overall Study|Death|0|||
23497742|NCT04431453|65566176|FG003|Overall Study|Death|0|||
23497743|NCT04431453|65566177|FG004|Overall Study|Death|0|||
23497744|NCT04431453|65566178|FG005|Overall Study|Death|0|||
23687010|NCT00868790|66228628|FG004|Period 2|Withdrawal by Subject|0|||
23497745|NCT04431453|65566179|FG006|Overall Study|Death|0|||
23497746|NCT04431453|65566180|FG007|Overall Study|Death|1|||
23393336|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
23497747|NCT04431453|65566173|FG000|Overall Study|Lost to Follow-up|0|||
23687011|NCT00868790|66228629|FG005|Period 2|Withdrawal by Subject|0|||
23497748|NCT04431453|65566174|FG001|Overall Study|Lost to Follow-up|0|||
23497749|NCT04431453|65566175|FG002|Overall Study|Lost to Follow-up|1|||
23497750|NCT04431453|65566176|FG003|Overall Study|Lost to Follow-up|1|||
23497751|NCT04431453|65566177|FG004|Overall Study|Lost to Follow-up|0|||
23497752|NCT04431453|65566178|FG005|Overall Study|Lost to Follow-up|0|||
23497753|NCT04431453|65566179|FG006|Overall Study|Lost to Follow-up|0|||
23497754|NCT04431453|65566180|FG007|Overall Study|Lost to Follow-up|0|||
23497755|NCT04431453|65566173|FG000|Overall Study|Enrolled but Never Treated|0|||
23497756|NCT04431453|65566174|FG001|Overall Study|Enrolled but Never Treated|0|||
23497757|NCT04431453|65566175|FG002|Overall Study|Enrolled but Never Treated|0|||
23497758|NCT04431453|65566176|FG003|Overall Study|Enrolled but Never Treated|0|||
23497759|NCT04431453|65566177|FG004|Overall Study|Enrolled but Never Treated|1|||
23497760|NCT04431453|65566178|FG005|Overall Study|Enrolled but Never Treated|0|||
23497761|NCT04431453|65566179|FG006|Overall Study|Enrolled but Never Treated|0|||
23497762|NCT04431453|65566180|FG007|Overall Study|Enrolled but Never Treated|0|||
23497763|NCT03689530|65566181|FG000|Overall Study|Withdrawal by Subject|53|||
23497764|NCT03689530|65566182|FG001|Overall Study|Withdrawal by Subject|16|||
23497765|NCT01083485|65566184|FG000|Overall Study|Adverse Event|0|||
23497766|NCT01083485|65566185|FG001|Overall Study|Adverse Event|1|||
23497767|NCT01083485|65566184|FG000|Overall Study|Protocol Violation|1|||
23497768|NCT01083485|65566185|FG001|Overall Study|Protocol Violation|0|||
23497769|NCT01083485|65566184|FG000|Overall Study|Withdrawal by Subject|5|||
23497770|NCT01083485|65566185|FG001|Overall Study|Withdrawal by Subject|2|||
23497771|NCT01083485|65566184|FG000|Overall Study|Other|1|||
23497772|NCT01083485|65566185|FG001|Overall Study|Other|0|||
23497773|NCT00843856|65566187|FG000|Overall Study|Lost to Follow-up|1|||
23497774|NCT00843856|65566188|FG001|Overall Study|Lost to Follow-up|2|||
23497775|NCT04138810|65566189|FG000|Overall Study|Withdrawal by Subject|0|||
23497776|NCT04138810|65566190|FG001|Overall Study|Withdrawal by Subject|1|||
23497777|NCT04138810|65566189|FG000|Overall Study|Subject cancelled surgery|1|||
23497778|NCT04138810|65566190|FG001|Overall Study|Subject cancelled surgery|0|||
23497779|NCT00493025|65566191|FG000|Overall Study|Physician Decision|19|||
23497780|NCT02369016|65566194|FG000|Overall Study|AE associated with clinical disease progression|2|||
23497781|NCT02369016|65566195|FG001|Overall Study|AE associated with clinical disease progression|1|||
23497782|NCT02369016|65566194|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
23497783|NCT02369016|65566195|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
23497784|NCT02369016|65566194|FG000|Overall Study|Progressive disease - clinical progression|1|||
23497785|NCT02369016|65566195|FG001|Overall Study|Progressive disease - clinical progression|4|||
23497786|NCT02369016|65566194|FG000|Overall Study|withdrawal by patient|4|||
23497787|NCT02369016|65566195|FG001|Overall Study|withdrawal by patient|0|||
23497788|NCT02369016|65566194|FG000|Overall Study|Progressive disease - radiological progression|6|||
23497789|NCT02369016|65566195|FG001|Overall Study|Progressive disease - radiological progression|2|||
23497790|NCT02378961|65566197|FG000|Overall Study|Lack of Efficacy|4|||
23497791|NCT02378961|65566198|FG001|Overall Study|Lack of Efficacy|2|||
23497792|NCT02378961|65566199|FG002|Overall Study|Lack of Efficacy|0|||
23497793|NCT02378961|65566200|FG003|Overall Study|Lack of Efficacy|1|||
23497794|NCT02378961|65566197|FG000|Overall Study|Death|0|||
23497795|NCT02378961|65566198|FG001|Overall Study|Death|0|||
23497796|NCT02378961|65566199|FG002|Overall Study|Death|1|||
23497797|NCT02378961|65566200|FG003|Overall Study|Death|0|||
23497798|NCT01189604|65566201|FG000|Overall Study|Impossible to visit|0|||
23497799|NCT01189604|65566202|FG001|Overall Study|Impossible to visit|0|||
23497800|NCT01189604|65566203|FG002|Overall Study|Impossible to visit|0|||
23497801|NCT01189604|65566204|FG003|Overall Study|Impossible to visit|0|||
23497802|NCT01189604|65566205|FG004|Overall Study|Impossible to visit|0|||
23497803|NCT01189604|65566206|FG005|Overall Study|Impossible to visit|1|||
23497804|NCT01189604|65566207|FG006|Overall Study|Impossible to visit|0|||
23497805|NCT01189604|65566201|FG000|Overall Study|Adverse Event|0|||
23497806|NCT01189604|65566202|FG001|Overall Study|Adverse Event|1|||
23497807|NCT01189604|65566203|FG002|Overall Study|Adverse Event|0|||
23497808|NCT01189604|65566204|FG003|Overall Study|Adverse Event|0|||
23497809|NCT01189604|65566205|FG004|Overall Study|Adverse Event|2|||
23497810|NCT01189604|65566206|FG005|Overall Study|Adverse Event|0|||
23497811|NCT01189604|65566207|FG006|Overall Study|Adverse Event|1|||
23497812|NCT01189604|65566201|FG000|Overall Study|Withdrawal by Subject|1|||
23497813|NCT01189604|65566202|FG001|Overall Study|Withdrawal by Subject|0|||
23497814|NCT01189604|65566203|FG002|Overall Study|Withdrawal by Subject|0|||
23497815|NCT01189604|65566204|FG003|Overall Study|Withdrawal by Subject|0|||
23497816|NCT01189604|65566205|FG004|Overall Study|Withdrawal by Subject|0|||
23497817|NCT01189604|65566206|FG005|Overall Study|Withdrawal by Subject|0|||
23497818|NCT01189604|65566207|FG006|Overall Study|Withdrawal by Subject|0|||
23497819|NCT00675948|65566208|FG000|Overall Study|Adverse Event|23|||
23497820|NCT00675948|65566209|FG001|Overall Study|Adverse Event|1|||
23497821|NCT00675948|65566208|FG000|Overall Study|Lack of Efficacy|3|||
23497822|NCT00675948|65566209|FG001|Overall Study|Lack of Efficacy|0|||
23497823|NCT00675948|65566208|FG000|Overall Study|Withdrawal by Subject|7|||
23497824|NCT00675948|65566209|FG001|Overall Study|Withdrawal by Subject|0|||
23497825|NCT00675948|65566208|FG000|Overall Study|Lost to Follow-up|2|||
23497826|NCT00675948|65566209|FG001|Overall Study|Lost to Follow-up|0|||
23497827|NCT00675948|65566208|FG000|Overall Study|Protocol Violation|1|||
23497828|NCT00675948|65566209|FG001|Overall Study|Protocol Violation|0|||
23497829|NCT00675948|65566208|FG000|Overall Study|Pain under control|1|||
23497830|NCT00675948|65566209|FG001|Overall Study|Pain under control|0|||
23497831|NCT00675948|65566208|FG000|Overall Study|Sponsor decision|0|||
23497832|NCT00675948|65566209|FG001|Overall Study|Sponsor decision|1|||
23497833|NCT00675948|65566208|FG000|Overall Study|Patient died|1|||
23497834|NCT00675948|65566209|FG001|Overall Study|Patient died|0|||
23497835|NCT00675948|65566208|FG000|Overall Study|Patient unable to comply with diaries|1|||
23497836|NCT00675948|65566209|FG001|Overall Study|Patient unable to comply with diaries|0|||
23497837|NCT00675948|65566208|FG000|Overall Study|Patient feels unable to take medication|0|||
23497838|NCT00675948|65566209|FG001|Overall Study|Patient feels unable to take medication|1|||
23497839|NCT02339285|65566211|FG000|Overall Study|Withdrawal by Subject|0|||
23497840|NCT02339285|65566212|FG001|Overall Study|Withdrawal by Subject|1|||
23497841|NCT02339285|65566213|FG002|Overall Study|Withdrawal by Subject|1|||
23497842|NCT02339285|65566211|FG000|Overall Study|Lost to Follow-up|1|||
23497843|NCT02339285|65566212|FG001|Overall Study|Lost to Follow-up|1|||
23497844|NCT02339285|65566213|FG002|Overall Study|Lost to Follow-up|1|||
23497845|NCT02339285|65566211|FG000|Overall Study|Protocol Deviation|0|||
23497846|NCT02339285|65566212|FG001|Overall Study|Protocol Deviation|1|||
23497847|NCT02339285|65566213|FG002|Overall Study|Protocol Deviation|0|||
23497848|NCT04502433|65566214|FG000|Overall Study|Death|2|||
23497849|NCT04502433|65566215|FG001|Overall Study|Death|4|||
23497850|NCT04502433|65566214|FG000|Overall Study|Lost to Follow-up|1|||
23497851|NCT04502433|65566215|FG001|Overall Study|Lost to Follow-up|0|||
23497852|NCT04502433|65566214|FG000|Overall Study|Physician Decision|0|||
23497853|NCT04502433|65566215|FG001|Overall Study|Physician Decision|1|||
23497854|NCT05439941|65566216|FG000|Overall Study|Lack of Efficacy|8|||
23497855|NCT05439941|65566217|FG001|Overall Study|Lack of Efficacy|5|||
23497856|NCT05439941|65566218|FG002|Overall Study|Lack of Efficacy|3|||
23497857|NCT05439941|65566216|FG000|Overall Study|Treatment Failure|0|||
23497858|NCT05439941|65566217|FG001|Overall Study|Treatment Failure|1|||
23497859|NCT05439941|65566218|FG002|Overall Study|Treatment Failure|0|||
23497860|NCT05439941|65566216|FG000|Overall Study|Adverse Event|1|||
23497861|NCT05439941|65566217|FG001|Overall Study|Adverse Event|3|||
23497862|NCT05439941|65566218|FG002|Overall Study|Adverse Event|0|||
23497863|NCT05439941|65566216|FG000|Overall Study|Adverse Event - Parent Study|1|||
23497864|NCT05439941|65566217|FG001|Overall Study|Adverse Event - Parent Study|0|||
23497865|NCT05439941|65566218|FG002|Overall Study|Adverse Event - Parent Study|0|||
23497866|NCT05439941|65566216|FG000|Overall Study|Pregnancy|1|||
23497867|NCT05439941|65566217|FG001|Overall Study|Pregnancy|0|||
23497868|NCT05439941|65566218|FG002|Overall Study|Pregnancy|0|||
23497869|NCT05439941|65566216|FG000|Overall Study|Withdrawal by Subject|9|||
23497870|NCT05439941|65566217|FG001|Overall Study|Withdrawal by Subject|6|||
23497871|NCT05439941|65566218|FG002|Overall Study|Withdrawal by Subject|10|||
23497872|NCT05439941|65566216|FG000|Overall Study|Non-Compliance|1|||
23497873|NCT05439941|65566217|FG001|Overall Study|Non-Compliance|1|||
23497874|NCT05439941|65566218|FG002|Overall Study|Non-Compliance|1|||
23497875|NCT05439941|65566216|FG000|Overall Study|Lost to Follow-up|2|||
23497876|NCT05439941|65566217|FG001|Overall Study|Lost to Follow-up|2|||
23497877|NCT05439941|65566218|FG002|Overall Study|Lost to Follow-up|0|||
23497878|NCT05439941|65566216|FG000|Overall Study|Physician Decision|1|||
23497879|NCT05439941|65566217|FG001|Overall Study|Physician Decision|0|||
23497880|NCT05439941|65566218|FG002|Overall Study|Physician Decision|0|||
23497881|NCT05439941|65566216|FG000|Overall Study|Trial Termination by Sponsor|78|||
23497882|NCT05439941|65566217|FG001|Overall Study|Trial Termination by Sponsor|83|||
23497883|NCT05439941|65566218|FG002|Overall Study|Trial Termination by Sponsor|65|||
23497884|NCT05439941|65566216|FG000|Overall Study|Other than Reasons Listed|2|||
23497885|NCT05439941|65566217|FG001|Overall Study|Other than Reasons Listed|1|||
23497886|NCT05439941|65566218|FG002|Overall Study|Other than Reasons Listed|0|||
23497887|NCT04401423|65566223|FG000|Overall Study|Withdrawal by Subject|3|||
23497888|NCT04401423|65566224|FG001|Overall Study|Withdrawal by Subject|1|||
23497889|NCT04401423|65566223|FG000|Overall Study|Physician Decision|2|||
23497890|NCT04401423|65566224|FG001|Overall Study|Physician Decision|1|||
23497891|NCT00087607|65566225|FG000|Overall Study|Adverse Event|14|||
23497892|NCT00087607|65566226|FG001|Overall Study|Adverse Event|24|||
23497893|NCT00087607|65566225|FG000|Overall Study|Death|0|||
23497894|NCT00087607|65566226|FG001|Overall Study|Death|1|||
23497895|NCT00087607|65566225|FG000|Overall Study|Insufficient Therapeutic Response|53|||
23497896|NCT00087607|65566226|FG001|Overall Study|Insufficient Therapeutic Response|42|||
23497897|NCT00087607|65566225|FG000|Overall Study|Failure to return|21|||
23497898|NCT00087607|65566226|FG001|Overall Study|Failure to return|17|||
23497899|NCT00087607|65566225|FG000|Overall Study|Withdrew Consent|12|||
23497900|NCT00087607|65566226|FG001|Overall Study|Withdrew Consent|16|||
23497901|NCT00087607|65566225|FG000|Overall Study|Administrative|12|||
23497902|NCT00087607|65566226|FG001|Overall Study|Administrative|12|||
23497903|NCT00087607|65566225|FG000|Overall Study|Refused Treatment|5|||
23497904|NCT00087607|65566226|FG001|Overall Study|Refused Treatment|7|||
23497905|NCT00087607|65566225|FG000|Overall Study|Other Protocol Violation|5|||
23497906|NCT00087607|65566226|FG001|Overall Study|Other Protocol Violation|2|||
23497907|NCT00087607|65566225|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23497908|NCT00087607|65566226|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23497909|NCT00134082|65566227|FG000|Overall Study|Adverse Event|2|||
23497910|NCT00134082|65566227|FG000|Overall Study|Death|1|||
23497911|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
23497912|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
23497913|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
23497914|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
23497915|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
23497916|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
23497917|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
23497918|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
23497919|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
23497920|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
23497921|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
23497922|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
23497923|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
23497924|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
23497925|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
23497926|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
23497927|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
23497928|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
23497929|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
23497930|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
23497931|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
23497932|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
23497933|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
23687012|NCT00868790|66228630|FG006|Period 2|Withdrawal by Subject|0|||
23687013|NCT00868790|66228631|FG007|Period 2|Withdrawal by Subject|0|||
23393337|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
23393338|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393339|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
23393340|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393341|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
23393342|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
23393343|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
23393344|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
23393345|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
23393346|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
23393347|NCT02310321|65186806|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
23393348|NCT02310321|65186807|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
23393349|NCT02310321|65186808|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
23393350|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
23393351|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
23393352|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
23687014|NCT00868790|66228632|FG008|Period 2|Withdrawal by Subject|1|||
23687015|NCT00868790|66228633|FG009|Period 2|Withdrawal by Subject|0|||
23687016|NCT00868790|66228634|FG010|Period 2|Withdrawal by Subject|0|||
23687017|NCT00868790|66228635|FG011|Period 2|Withdrawal by Subject|0|||
23687018|NCT00868790|66228636|FG012|Period 2|Withdrawal by Subject|0|||
23687019|NCT00868790|66228637|FG013|Period 2|Withdrawal by Subject|1|||
23687020|NCT00868790|66228624|FG000|Period 3|Adverse Event|0|||
23687021|NCT00868790|66228625|FG001|Period 3|Adverse Event|0|||
23393353|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
23393354|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
23393355|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
23393356|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
23393357|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
23687022|NCT00868790|66228626|FG002|Period 3|Adverse Event|0|||
23497934|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
23497935|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
23497936|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
23497937|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
23497938|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
23497939|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
23497940|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
23687023|NCT00868790|66228627|FG003|Period 3|Adverse Event|0|||
23393358|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
23393359|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
23393360|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
23497941|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
23497942|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
23497943|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
23497944|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
23497945|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
23497946|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
23393361|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
23393362|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
23393363|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
23393364|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
23393365|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
23497947|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
23497948|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
23497949|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
23497950|NCT03386448|65566233|FG000|Overall Study|Adverse Event|0|||
23497951|NCT03386448|65566234|FG001|Overall Study|Adverse Event|2|||
23497952|NCT00702923|65566235|FG000|Overall Study|Adverse Event|1|||
23497953|NCT03988088|65566236|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497954|NCT03988088|65566237|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
23497955|NCT03988088|65566238|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497956|NCT03988088|65566239|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497957|NCT03988088|65566236|FG000|Open-Label Addendum|Lost to Follow-up|0|||
23497958|NCT03988088|65566237|FG001|Open-Label Addendum|Lost to Follow-up|0|||
23497959|NCT03988088|65566238|FG002|Open-Label Addendum|Lost to Follow-up|1|||
23497960|NCT03988088|65566239|FG003|Open-Label Addendum|Lost to Follow-up|0|||
23497961|NCT02130297|65566240|FG000|Overall Study|Lost to Follow-up|4|||
23497962|NCT00334958|65566244|FG000|Overall Study|Medication Noncompliance|0|||
23497963|NCT00334958|65566245|FG001|Overall Study|Medication Noncompliance|3|||
23497964|NCT00334958|65566244|FG000|Overall Study|Protocol Violation|2|||
23497965|NCT00334958|65566245|FG001|Overall Study|Protocol Violation|2|||
23497966|NCT00334958|65566244|FG000|Overall Study|Request of the investigator or sponsor|0|||
23497967|NCT00334958|65566245|FG001|Overall Study|Request of the investigator or sponsor|1|||
23497968|NCT00334958|65566244|FG000|Overall Study|Withdrawal by Subject|7|||
23497969|NCT00334958|65566245|FG001|Overall Study|Withdrawal by Subject|4|||
23497970|NCT00334958|65566244|FG000|Overall Study|Adverse Event|27|||
23497971|NCT00334958|65566245|FG001|Overall Study|Adverse Event|12|||
23497972|NCT00334958|65566244|FG000|Overall Study|Other|1|||
23497973|NCT00334958|65566245|FG001|Overall Study|Other|2|||
23497974|NCT01543958|65566246|FG000|Overall Study|Loss to follow-up|3|||
23497975|NCT01543958|65566246|FG000|Overall Study|ART initiation|1|||
23497976|NCT01065597|65566247|FG000|Overall Study|Adverse Event|1|||
23497977|NCT01972568|65566248|FG000|Overall Study|Other events|3|||
23497978|NCT01972568|65566249|FG001|Overall Study|Other events|0|||
23497979|NCT01972568|65566250|FG002|Overall Study|Other events|0|||
23497980|NCT01972568|65566248|FG000|Overall Study|Lack of Efficacy|0|||
23497981|NCT01972568|65566249|FG001|Overall Study|Lack of Efficacy|1|||
23497982|NCT01972568|65566250|FG002|Overall Study|Lack of Efficacy|2|||
23497983|NCT01972568|65566248|FG000|Overall Study|Protocol Violation|1|||
23497984|NCT01972568|65566249|FG001|Overall Study|Protocol Violation|2|||
23497985|NCT01972568|65566250|FG002|Overall Study|Protocol Violation|2|||
23497986|NCT01972568|65566248|FG000|Overall Study|Withdrawal by Subject|6|||
23497987|NCT01972568|65566249|FG001|Overall Study|Withdrawal by Subject|3|||
23497988|NCT01972568|65566250|FG002|Overall Study|Withdrawal by Subject|7|||
23393366|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
23497989|NCT01972568|65566248|FG000|Overall Study|Lost to Follow-up|1|||
23497990|NCT01972568|65566249|FG001|Overall Study|Lost to Follow-up|0|||
23687024|NCT00868790|66228628|FG004|Period 3|Adverse Event|0|||
23687025|NCT00868790|66228629|FG005|Period 3|Adverse Event|0|||
23497991|NCT01972568|65566250|FG002|Overall Study|Lost to Follow-up|0|||
23497992|NCT01972568|65566248|FG000|Overall Study|Adverse Event|5|||
23497993|NCT01972568|65566249|FG001|Overall Study|Adverse Event|6|||
23497994|NCT01972568|65566250|FG002|Overall Study|Adverse Event|5|||
23497995|NCT03719586|65566255|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
23497996|NCT03719586|65566256|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
23497997|NCT03719586|65566257|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
23497998|NCT03719586|65566258|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
23497999|NCT03137537|65566259|FG000|Overall Study|Adverse Event|0|||
23498000|NCT03137537|65566260|FG001|Overall Study|Adverse Event|1|||
23687026|NCT00868790|66228630|FG006|Period 3|Adverse Event|0|||
23687027|NCT00868790|66228631|FG007|Period 3|Adverse Event|0|||
23687028|NCT00868790|66228632|FG008|Period 3|Adverse Event|0|||
23687029|NCT00868790|66228633|FG009|Period 3|Adverse Event|1|||
23687030|NCT00868790|66228634|FG010|Period 3|Adverse Event|0|||
23687031|NCT00868790|66228635|FG011|Period 3|Adverse Event|0|||
23687032|NCT00868790|66228636|FG012|Period 3|Adverse Event|0|||
23687033|NCT00868790|66228637|FG013|Period 3|Adverse Event|0|||
23687034|NCT00868790|66228624|FG000|Period 3|Protocol Violation|0|||
23687035|NCT00868790|66228625|FG001|Period 3|Protocol Violation|0|||
23687036|NCT00868790|66228626|FG002|Period 3|Protocol Violation|0|||
23687037|NCT00868790|66228627|FG003|Period 3|Protocol Violation|0|||
23687038|NCT00868790|66228628|FG004|Period 3|Protocol Violation|0|||
23687039|NCT00868790|66228629|FG005|Period 3|Protocol Violation|0|||
23687040|NCT00868790|66228630|FG006|Period 3|Protocol Violation|0|||
23687041|NCT00868790|66228631|FG007|Period 3|Protocol Violation|0|||
23687042|NCT00868790|66228632|FG008|Period 3|Protocol Violation|0|||
23687043|NCT00868790|66228633|FG009|Period 3|Protocol Violation|0|||
23687044|NCT00868790|66228634|FG010|Period 3|Protocol Violation|1|||
23393367|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
23393368|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
23393369|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
23393370|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
23393371|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
23393372|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
23393373|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
23393374|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
23393375|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
23393376|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
23393377|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
23393378|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
23393379|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
23498001|NCT00075218|65566263|FG000|Double-Blind Treatment|Adverse Event|23|||
23498002|NCT00075218|65566264|FG001|Double-Blind Treatment|Adverse Event|4|||
23498003|NCT00075218|65566265|FG002|Double-Blind Treatment|Adverse Event|0|||
23498004|NCT00075218|65566263|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
23687045|NCT00868790|66228635|FG011|Period 3|Protocol Violation|0|||
23687046|NCT00868790|66228636|FG012|Period 3|Protocol Violation|0|||
23687047|NCT00868790|66228637|FG013|Period 3|Protocol Violation|0|||
23687048|NCT00868790|66228624|FG000|Period 3|Study Terminated by Sponsor|0|||
23687049|NCT00868790|66228625|FG001|Period 3|Study Terminated by Sponsor|0|||
23687050|NCT00868790|66228626|FG002|Period 3|Study Terminated by Sponsor|0|||
23687051|NCT00868790|66228627|FG003|Period 3|Study Terminated by Sponsor|1|||
23687052|NCT00868790|66228628|FG004|Period 3|Study Terminated by Sponsor|0|||
23687053|NCT00868790|66228629|FG005|Period 3|Study Terminated by Sponsor|0|||
23687054|NCT00868790|66228630|FG006|Period 3|Study Terminated by Sponsor|0|||
23687055|NCT00868790|66228631|FG007|Period 3|Study Terminated by Sponsor|0|||
23687056|NCT00868790|66228632|FG008|Period 3|Study Terminated by Sponsor|0|||
23687057|NCT00868790|66228633|FG009|Period 3|Study Terminated by Sponsor|0|||
23687058|NCT00868790|66228634|FG010|Period 3|Study Terminated by Sponsor|0|||
23687059|NCT00868790|66228635|FG011|Period 3|Study Terminated by Sponsor|0|||
23498005|NCT00075218|65566264|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
23498006|NCT00075218|65566265|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
23498007|NCT00075218|65566263|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
23498008|NCT00075218|65566264|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
23498009|NCT00075218|65566265|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
23498010|NCT00075218|65566263|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
23498011|NCT00075218|65566264|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
23498012|NCT00075218|65566265|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
23498013|NCT00075218|65566263|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
23498014|NCT00075218|65566264|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
23498015|NCT00075218|65566265|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
23498016|NCT00075218|65566263|FG000|Double-Blind Treatment|No study medication taken|2|||
23498017|NCT00075218|65566264|FG001|Double-Blind Treatment|No study medication taken|0|||
23498018|NCT00075218|65566265|FG002|Double-Blind Treatment|No study medication taken|0|||
23498019|NCT00075218|65566263|FG000|Open-Label Treatment|Lack of Efficacy|0|||
23498020|NCT00075218|65566264|FG001|Open-Label Treatment|Lack of Efficacy|0|||
23687060|NCT00868790|66228636|FG012|Period 3|Study Terminated by Sponsor|0|||
23687061|NCT00868790|66228637|FG013|Period 3|Study Terminated by Sponsor|0|||
23687062|NCT00868790|66228624|FG000|Period 4|Adverse Event|0|||
23687063|NCT00868790|66228625|FG001|Period 4|Adverse Event|0|||
23687064|NCT00868790|66228626|FG002|Period 4|Adverse Event|0|||
23687065|NCT00868790|66228627|FG003|Period 4|Adverse Event|0|||
23687066|NCT00868790|66228628|FG004|Period 4|Adverse Event|0|||
23687067|NCT00868790|66228629|FG005|Period 4|Adverse Event|0|||
23687068|NCT00868790|66228630|FG006|Period 4|Adverse Event|0|||
23687069|NCT00868790|66228631|FG007|Period 4|Adverse Event|1|||
23687070|NCT00868790|66228632|FG008|Period 4|Adverse Event|0|||
23687071|NCT00868790|66228633|FG009|Period 4|Adverse Event|0|||
23687072|NCT00868790|66228634|FG010|Period 4|Adverse Event|1|||
23687073|NCT00868790|66228635|FG011|Period 4|Adverse Event|0|||
23687074|NCT00868790|66228636|FG012|Period 4|Adverse Event|1|||
23687075|NCT00868790|66228637|FG013|Period 4|Adverse Event|0|||
23687076|NCT00868790|66228624|FG000|Period 4|Lost to Follow-up|0|||
23687077|NCT00868790|66228625|FG001|Period 4|Lost to Follow-up|0|||
23687078|NCT00868790|66228626|FG002|Period 4|Lost to Follow-up|0|||
23687079|NCT00868790|66228627|FG003|Period 4|Lost to Follow-up|0|||
23687080|NCT00868790|66228628|FG004|Period 4|Lost to Follow-up|0|||
23687081|NCT00868790|66228629|FG005|Period 4|Lost to Follow-up|0|||
23687082|NCT00868790|66228630|FG006|Period 4|Lost to Follow-up|0|||
23687083|NCT00868790|66228631|FG007|Period 4|Lost to Follow-up|1|||
23498021|NCT00075218|65566265|FG002|Open-Label Treatment|Lack of Efficacy|174|||
23498022|NCT00075218|65566263|FG000|Open-Label Treatment|Adverse Event|0|||
23498023|NCT00075218|65566264|FG001|Open-Label Treatment|Adverse Event|0|||
23498024|NCT00075218|65566265|FG002|Open-Label Treatment|Adverse Event|51|||
23498025|NCT00075218|65566263|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
23498026|NCT00075218|65566264|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23498027|NCT00075218|65566265|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
23498028|NCT00075218|65566263|FG000|Open-Label Treatment|Decision of Sponsor|0|||
23498029|NCT00075218|65566264|FG001|Open-Label Treatment|Decision of Sponsor|0|||
23498030|NCT00075218|65566265|FG002|Open-Label Treatment|Decision of Sponsor|8|||
23498031|NCT00075218|65566263|FG000|Open-Label Treatment|Protocol Violation|0|||
23498032|NCT00075218|65566264|FG001|Open-Label Treatment|Protocol Violation|0|||
23498033|NCT00075218|65566265|FG002|Open-Label Treatment|Protocol Violation|1|||
23687084|NCT00868790|66228632|FG008|Period 4|Lost to Follow-up|0|||
23687085|NCT00868790|66228633|FG009|Period 4|Lost to Follow-up|0|||
23687086|NCT00868790|66228634|FG010|Period 4|Lost to Follow-up|0|||
23687087|NCT00868790|66228635|FG011|Period 4|Lost to Follow-up|0|||
23687088|NCT00868790|66228636|FG012|Period 4|Lost to Follow-up|0|||
23687089|NCT00868790|66228637|FG013|Period 4|Lost to Follow-up|0|||
23498034|NCT00075218|65566263|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
23498035|NCT00075218|65566264|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
23687090|NCT00868790|66228624|FG000|Period 4|Study Terminated by Sponsor|2|||
23687091|NCT00868790|66228625|FG001|Period 4|Study Terminated by Sponsor|0|||
23687092|NCT00868790|66228626|FG002|Period 4|Study Terminated by Sponsor|0|||
23687093|NCT00868790|66228627|FG003|Period 4|Study Terminated by Sponsor|0|||
23687094|NCT00868790|66228628|FG004|Period 4|Study Terminated by Sponsor|0|||
23687095|NCT00868790|66228629|FG005|Period 4|Study Terminated by Sponsor|0|||
23498036|NCT00075218|65566265|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
23498037|NCT00142298|65566266|FG000|Overall Study|Adverse Event|10|||
23498038|NCT00142298|65566267|FG001|Overall Study|Adverse Event|10|||
23498039|NCT00142298|65566268|FG002|Overall Study|Adverse Event|1|||
23498040|NCT00142298|65566269|FG003|Overall Study|Adverse Event|5|||
23498041|NCT00142298|65566270|FG004|Overall Study|Adverse Event|2|||
23687096|NCT00868790|66228630|FG006|Period 4|Study Terminated by Sponsor|0|||
23687097|NCT00868790|66228631|FG007|Period 4|Study Terminated by Sponsor|1|||
23687098|NCT00868790|66228632|FG008|Period 4|Study Terminated by Sponsor|2|||
23687099|NCT00868790|66228633|FG009|Period 4|Study Terminated by Sponsor|0|||
23687100|NCT00868790|66228634|FG010|Period 4|Study Terminated by Sponsor|2|||
23498042|NCT00142298|65566271|FG005|Overall Study|Adverse Event|2|||
23498043|NCT00142298|65566272|FG006|Overall Study|Adverse Event|0|||
23498044|NCT00142298|65566273|FG007|Overall Study|Adverse Event|0|||
23498045|NCT00142298|65566274|FG008|Overall Study|Adverse Event|0|||
23498046|NCT00142298|65566275|FG009|Overall Study|Adverse Event|0|||
23498047|NCT00142298|65566266|FG000|Overall Study|Clinical disease progression|1|||
23687101|NCT00868790|66228635|FG011|Period 4|Study Terminated by Sponsor|1|||
23687102|NCT00868790|66228636|FG012|Period 4|Study Terminated by Sponsor|0|||
23687103|NCT00868790|66228637|FG013|Period 4|Study Terminated by Sponsor|1|||
23687104|NCT00868790|66228624|FG000|Period 4|Abnormal ALT/AST|0|||
23687105|NCT00868790|66228625|FG001|Period 4|Abnormal ALT/AST|0|||
23687106|NCT00868790|66228626|FG002|Period 4|Abnormal ALT/AST|1|||
23687107|NCT00868790|66228627|FG003|Period 4|Abnormal ALT/AST|0|||
23687108|NCT00868790|66228628|FG004|Period 4|Abnormal ALT/AST|0|||
23687109|NCT00868790|66228629|FG005|Period 4|Abnormal ALT/AST|0|||
23687110|NCT00868790|66228630|FG006|Period 4|Abnormal ALT/AST|0|||
23687111|NCT00868790|66228631|FG007|Period 4|Abnormal ALT/AST|0|||
23687112|NCT00868790|66228632|FG008|Period 4|Abnormal ALT/AST|0|||
23687113|NCT00868790|66228633|FG009|Period 4|Abnormal ALT/AST|0|||
23687114|NCT00868790|66228634|FG010|Period 4|Abnormal ALT/AST|0|||
23687115|NCT00868790|66228635|FG011|Period 4|Abnormal ALT/AST|0|||
23687116|NCT00868790|66228636|FG012|Period 4|Abnormal ALT/AST|0|||
23687117|NCT00868790|66228637|FG013|Period 4|Abnormal ALT/AST|0|||
23687118|NCT00868790|66228624|FG000|Post-study|Withdrawal by Subject|0|||
23687119|NCT00868790|66228625|FG001|Post-study|Withdrawal by Subject|0|||
23687120|NCT00868790|66228626|FG002|Post-study|Withdrawal by Subject|0|||
23687121|NCT00868790|66228627|FG003|Post-study|Withdrawal by Subject|0|||
23687122|NCT00868790|66228628|FG004|Post-study|Withdrawal by Subject|1|||
23687123|NCT00868790|66228629|FG005|Post-study|Withdrawal by Subject|0|||
23687124|NCT00868790|66228630|FG006|Post-study|Withdrawal by Subject|0|||
23687125|NCT00868790|66228631|FG007|Post-study|Withdrawal by Subject|0|||
23687126|NCT00868790|66228632|FG008|Post-study|Withdrawal by Subject|0|||
23498048|NCT00142298|65566267|FG001|Overall Study|Clinical disease progression|0|||
23498049|NCT00142298|65566268|FG002|Overall Study|Clinical disease progression|0|||
23498050|NCT00142298|65566269|FG003|Overall Study|Clinical disease progression|0|||
23498051|NCT00142298|65566270|FG004|Overall Study|Clinical disease progression|0|||
23498052|NCT00142298|65566271|FG005|Overall Study|Clinical disease progression|0|||
23498053|NCT00142298|65566272|FG006|Overall Study|Clinical disease progression|0|||
23498054|NCT00142298|65566273|FG007|Overall Study|Clinical disease progression|0|||
23498055|NCT00142298|65566274|FG008|Overall Study|Clinical disease progression|0|||
23498056|NCT00142298|65566275|FG009|Overall Study|Clinical disease progression|0|||
23498057|NCT00142298|65566266|FG000|Overall Study|Death|1|||
23498058|NCT00142298|65566267|FG001|Overall Study|Death|1|||
23498059|NCT00142298|65566268|FG002|Overall Study|Death|1|||
23498060|NCT00142298|65566269|FG003|Overall Study|Death|0|||
23498061|NCT00142298|65566270|FG004|Overall Study|Death|0|||
23498062|NCT00142298|65566271|FG005|Overall Study|Death|6|||
23498063|NCT00142298|65566272|FG006|Overall Study|Death|0|||
23498064|NCT00142298|65566273|FG007|Overall Study|Death|0|||
23498065|NCT00142298|65566274|FG008|Overall Study|Death|0|||
23498066|NCT00142298|65566275|FG009|Overall Study|Death|0|||
23498067|NCT00142298|65566266|FG000|Overall Study|Lack of Efficacy|44|||
23498068|NCT00142298|65566267|FG001|Overall Study|Lack of Efficacy|62|||
23498069|NCT00142298|65566268|FG002|Overall Study|Lack of Efficacy|9|||
23498070|NCT00142298|65566269|FG003|Overall Study|Lack of Efficacy|12|||
23498071|NCT00142298|65566270|FG004|Overall Study|Lack of Efficacy|1|||
23498072|NCT00142298|65566271|FG005|Overall Study|Lack of Efficacy|0|||
23687127|NCT00868790|66228633|FG009|Post-study|Withdrawal by Subject|0|||
23687128|NCT00868790|66228634|FG010|Post-study|Withdrawal by Subject|0|||
23687129|NCT00868790|66228635|FG011|Post-study|Withdrawal by Subject|0|||
23498073|NCT00142298|65566272|FG006|Overall Study|Lack of Efficacy|0|||
23687130|NCT00868790|66228636|FG012|Post-study|Withdrawal by Subject|0|||
23687131|NCT00868790|66228637|FG013|Post-study|Withdrawal by Subject|0|||
23498074|NCT00142298|65566273|FG007|Overall Study|Lack of Efficacy|1|||
23498075|NCT00142298|65566274|FG008|Overall Study|Lack of Efficacy|0|||
23498076|NCT00142298|65566275|FG009|Overall Study|Lack of Efficacy|0|||
23498077|NCT00142298|65566266|FG000|Overall Study|Non-compliance|15|||
23687132|NCT00868790|66228624|FG000|Post-study|Excluded Medication|0|||
23498078|NCT00142298|65566267|FG001|Overall Study|Non-compliance|13|||
23498079|NCT00142298|65566268|FG002|Overall Study|Non-compliance|0|||
23498080|NCT00142298|65566269|FG003|Overall Study|Non-compliance|6|||
23498081|NCT00142298|65566270|FG004|Overall Study|Non-compliance|1|||
23498082|NCT00142298|65566271|FG005|Overall Study|Non-compliance|0|||
23498083|NCT00142298|65566272|FG006|Overall Study|Non-compliance|0|||
23498084|NCT00142298|65566273|FG007|Overall Study|Non-compliance|3|||
23498085|NCT00142298|65566274|FG008|Overall Study|Non-compliance|3|||
23393380|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
23393381|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
23393382|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
23393383|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
23393384|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
23393385|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
23393386|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
23393387|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
23393388|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
23393389|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
23393390|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
23393391|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
23393392|NCT05309291|65186811|FG000|Overall Study|Adverse Event|0|||
23393393|NCT05309291|65186812|FG001|Overall Study|Adverse Event|1|||
23393394|NCT01435356|65186814|FG000|Overall Study|Adverse Event|2|||
23393395|NCT01435356|65186815|FG001|Overall Study|Adverse Event|0|||
23393396|NCT01435356|65186814|FG000|Overall Study|Disease progression/recurrence|17|||
23393397|NCT01435356|65186815|FG001|Overall Study|Disease progression/recurrence|10|||
23393398|NCT01435356|65186814|FG000|Overall Study|Protocol Violation|0|||
23393399|NCT01435356|65186815|FG001|Overall Study|Protocol Violation|1|||
23393400|NCT01435356|65186814|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
23393401|NCT01435356|65186815|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
23393402|NCT01435356|65186814|FG000|Overall Study|Withdrawal by Subject|1|||
23393403|NCT01435356|65186815|FG001|Overall Study|Withdrawal by Subject|1|||
23393404|NCT01435356|65186814|FG000|Overall Study|Facial palsy|1|||
23393405|NCT01435356|65186815|FG001|Overall Study|Facial palsy|0|||
23393406|NCT01435356|65186814|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
23393407|NCT01435356|65186815|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
23393408|NCT01435356|65186814|FG000|Overall Study|Physician Decision|1|||
23393409|NCT01435356|65186815|FG001|Overall Study|Physician Decision|0|||
23393410|NCT01435356|65186814|FG000|Overall Study|Patient decision|3|||
23393411|NCT01435356|65186815|FG001|Overall Study|Patient decision|0|||
23393412|NCT01435356|65186814|FG000|Overall Study|Patient moved to another city|1|||
23393413|NCT01435356|65186815|FG001|Overall Study|Patient moved to another city|1|||
23393414|NCT00734032|65186816|FG000|Overall Study|Adverse Event|0|||
23393415|NCT00734032|65186817|FG001|Overall Study|Adverse Event|1|||
23393416|NCT00734032|65186818|FG002|Overall Study|Adverse Event|0|||
23393417|NCT00734032|65186819|FG003|Overall Study|Adverse Event|0|||
23393418|NCT02776735|65186824|FG000|Overall Study|Adverse Event|0|||
23393419|NCT02776735|65186825|FG001|Overall Study|Adverse Event|0|||
23393420|NCT02776735|65186826|FG002|Overall Study|Adverse Event|0|||
23393421|NCT02776735|65186827|FG003|Overall Study|Adverse Event|1|||
23393422|NCT02776735|65186828|FG004|Overall Study|Adverse Event|0|||
23393423|NCT02776735|65186829|FG005|Overall Study|Adverse Event|1|||
23393424|NCT02776735|65186824|FG000|Overall Study|Lost to Follow-up|0|||
23393425|NCT02776735|65186825|FG001|Overall Study|Lost to Follow-up|0|||
23393426|NCT02776735|65186826|FG002|Overall Study|Lost to Follow-up|0|||
23393427|NCT02776735|65186827|FG003|Overall Study|Lost to Follow-up|1|||
23393428|NCT02776735|65186828|FG004|Overall Study|Lost to Follow-up|0|||
23393429|NCT02776735|65186829|FG005|Overall Study|Lost to Follow-up|0|||
23393430|NCT02776735|65186824|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23393431|NCT02776735|65186825|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23393432|NCT02776735|65186826|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23393433|NCT02776735|65186827|FG003|Overall Study|Withdrawal by parent/guardian|2|||
23393434|NCT02776735|65186828|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23393435|NCT02776735|65186829|FG005|Overall Study|Withdrawal by parent/guardian|0|||
23393436|NCT02776735|65186824|FG000|Overall Study|Withdrawal by Subject|1|||
23393437|NCT02776735|65186825|FG001|Overall Study|Withdrawal by Subject|0|||
23393438|NCT02776735|65186826|FG002|Overall Study|Withdrawal by Subject|0|||
23393439|NCT02776735|65186827|FG003|Overall Study|Withdrawal by Subject|0|||
23393440|NCT02776735|65186828|FG004|Overall Study|Withdrawal by Subject|0|||
23393441|NCT02776735|65186829|FG005|Overall Study|Withdrawal by Subject|1|||
23498086|NCT00142298|65566275|FG009|Overall Study|Non-compliance|0|||
23498087|NCT00142298|65566266|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
23393442|NCT02776735|65186824|FG000|Overall Study|Other|0|||
23393443|NCT02776735|65186825|FG001|Overall Study|Other|0|||
23498088|NCT00142298|65566267|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
23498089|NCT00142298|65566268|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
23498090|NCT00142298|65566269|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
23498091|NCT00142298|65566270|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
23498092|NCT00142298|65566271|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
23498093|NCT00142298|65566272|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
23498094|NCT00142298|65566273|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
23498095|NCT00142298|65566274|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
23498096|NCT00142298|65566275|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
23498097|NCT00142298|65566266|FG000|Overall Study|Pregnancy|4|||
23498098|NCT00142298|65566267|FG001|Overall Study|Pregnancy|4|||
23498099|NCT00142298|65566268|FG002|Overall Study|Pregnancy|2|||
23498100|NCT00142298|65566269|FG003|Overall Study|Pregnancy|3|||
23498101|NCT00142298|65566270|FG004|Overall Study|Pregnancy|0|||
23498102|NCT00142298|65566271|FG005|Overall Study|Pregnancy|0|||
23498103|NCT00142298|65566272|FG006|Overall Study|Pregnancy|0|||
23498104|NCT00142298|65566273|FG007|Overall Study|Pregnancy|0|||
23498105|NCT00142298|65566274|FG008|Overall Study|Pregnancy|1|||
23498106|NCT00142298|65566275|FG009|Overall Study|Pregnancy|0|||
23498107|NCT00142298|65566266|FG000|Overall Study|Virologic breakthrough|19|||
23498108|NCT00142298|65566267|FG001|Overall Study|Virologic breakthrough|23|||
23498109|NCT00142298|65566268|FG002|Overall Study|Virologic breakthrough|9|||
23498110|NCT00142298|65566269|FG003|Overall Study|Virologic breakthrough|7|||
23498111|NCT00142298|65566270|FG004|Overall Study|Virologic breakthrough|2|||
23498112|NCT00142298|65566271|FG005|Overall Study|Virologic breakthrough|3|||
23498113|NCT00142298|65566272|FG006|Overall Study|Virologic breakthrough|3|||
23498114|NCT00142298|65566273|FG007|Overall Study|Virologic breakthrough|0|||
23498115|NCT00142298|65566274|FG008|Overall Study|Virologic breakthrough|0|||
23498116|NCT00142298|65566275|FG009|Overall Study|Virologic breakthrough|0|||
23498117|NCT00142298|65566266|FG000|Overall Study|Other- not specified|0|||
23498118|NCT00142298|65566267|FG001|Overall Study|Other- not specified|3|||
23498119|NCT00142298|65566268|FG002|Overall Study|Other- not specified|0|||
23498120|NCT00142298|65566269|FG003|Overall Study|Other- not specified|1|||
23498121|NCT00142298|65566270|FG004|Overall Study|Other- not specified|0|||
23393444|NCT02776735|65186826|FG002|Overall Study|Other|3|||
23498122|NCT00142298|65566271|FG005|Overall Study|Other- not specified|0|||
23498123|NCT00142298|65566272|FG006|Overall Study|Other- not specified|0|||
23498124|NCT00142298|65566273|FG007|Overall Study|Other- not specified|0|||
23498125|NCT00142298|65566274|FG008|Overall Study|Other- not specified|0|||
23498126|NCT00142298|65566275|FG009|Overall Study|Other- not specified|0|||
23498127|NCT00142298|65566266|FG000|Overall Study|Lost to Follow-up|0|||
23498128|NCT00142298|65566267|FG001|Overall Study|Lost to Follow-up|0|||
23498129|NCT00142298|65566268|FG002|Overall Study|Lost to Follow-up|0|||
23687133|NCT00868790|66228625|FG001|Post-study|Excluded Medication|0|||
23687134|NCT00868790|66228626|FG002|Post-study|Excluded Medication|0|||
23687135|NCT00868790|66228627|FG003|Post-study|Excluded Medication|0|||
23687136|NCT00868790|66228628|FG004|Post-study|Excluded Medication|0|||
23687137|NCT00868790|66228629|FG005|Post-study|Excluded Medication|0|||
23687138|NCT00868790|66228630|FG006|Post-study|Excluded Medication|0|||
23687139|NCT00868790|66228631|FG007|Post-study|Excluded Medication|2|||
23687140|NCT00868790|66228632|FG008|Post-study|Excluded Medication|0|||
23498130|NCT00142298|65566269|FG003|Overall Study|Lost to Follow-up|0|||
23498131|NCT00142298|65566270|FG004|Overall Study|Lost to Follow-up|0|||
23498132|NCT00142298|65566271|FG005|Overall Study|Lost to Follow-up|0|||
23498133|NCT00142298|65566272|FG006|Overall Study|Lost to Follow-up|2|||
23498134|NCT00142298|65566273|FG007|Overall Study|Lost to Follow-up|0|||
23498135|NCT00142298|65566274|FG008|Overall Study|Lost to Follow-up|0|||
23498136|NCT00142298|65566275|FG009|Overall Study|Lost to Follow-up|0|||
23498137|NCT00142298|65566266|FG000|Overall Study|Treatment Failure|0|||
23498138|NCT00142298|65566267|FG001|Overall Study|Treatment Failure|0|||
23687141|NCT00868790|66228633|FG009|Post-study|Excluded Medication|1|||
23498139|NCT00142298|65566268|FG002|Overall Study|Treatment Failure|0|||
23498140|NCT00142298|65566269|FG003|Overall Study|Treatment Failure|0|||
23498141|NCT00142298|65566270|FG004|Overall Study|Treatment Failure|0|||
23498142|NCT00142298|65566271|FG005|Overall Study|Treatment Failure|2|||
23498143|NCT00142298|65566272|FG006|Overall Study|Treatment Failure|2|||
23498144|NCT00142298|65566273|FG007|Overall Study|Treatment Failure|0|||
23498145|NCT00142298|65566274|FG008|Overall Study|Treatment Failure|0|||
23498146|NCT00142298|65566275|FG009|Overall Study|Treatment Failure|0|||
23498147|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
23498148|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
23498149|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
23498150|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
23498151|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
23498152|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
23498153|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
23498154|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
23498155|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
23498156|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
23498157|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
23498158|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
23498159|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
23498160|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
23498161|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
23498162|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
23498163|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
23498164|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
23498165|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
23498166|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
23498167|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
23498168|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
23498169|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
23498170|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
23498171|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
23498172|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
23498173|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
23498174|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
23498175|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
23498176|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
23498177|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
23498178|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498179|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498180|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498181|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498182|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
23498183|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
23498184|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
23498185|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
23498186|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
23498187|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
23498188|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
23498189|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
23498190|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
23498191|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
23498192|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
23498193|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
23498194|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
23498195|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
23498196|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
23498197|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
23498198|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
23498199|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
23498200|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
23498201|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
23498202|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
23498203|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
23498204|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
23498205|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
23498206|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
23498207|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
23498208|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
23498209|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
23498210|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
23498211|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
23498212|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
23498213|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
23687142|NCT00868790|66228634|FG010|Post-study|Excluded Medication|0|||
23498214|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
23687143|NCT00868790|66228635|FG011|Post-study|Excluded Medication|0|||
23687144|NCT00868790|66228636|FG012|Post-study|Excluded Medication|0|||
23687145|NCT00868790|66228637|FG013|Post-study|Excluded Medication|0|||
23687146|NCT01889602|66228639|FG000|First Intervention|Adverse Event|1|||
23687147|NCT01889602|66228640|FG001|First Intervention|Adverse Event|1|||
23687148|NCT01889602|66228641|FG002|First Intervention|Adverse Event|1|||
23687149|NCT01889602|66228639|FG000|First Intervention|Protocol Violation|0|||
23687150|NCT01889602|66228640|FG001|First Intervention|Protocol Violation|1|||
23687151|NCT01889602|66228641|FG002|First Intervention|Protocol Violation|1|||
23687152|NCT01889602|66228639|FG000|First Intervention|Study ending|0|||
23687153|NCT01889602|66228640|FG001|First Intervention|Study ending|1|||
23498215|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
23498216|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
23498217|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
23498218|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498219|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498220|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498221|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498222|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
23498223|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
23498224|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
23498225|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
23498226|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
23498227|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498228|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
23498229|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498230|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498231|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498232|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23498233|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
23498234|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
23498235|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23687154|NCT01889602|66228641|FG002|First Intervention|Study ending|0|||
23687155|NCT01889602|66228639|FG000|Second Intervention|Adverse Event|0|||
23687156|NCT01889602|66228640|FG001|Second Intervention|Adverse Event|0|||
23687157|NCT01889602|66228641|FG002|Second Intervention|Adverse Event|1|||
23687158|NCT01889602|66228639|FG000|Second Intervention|Study ending|1|||
23687159|NCT01889602|66228640|FG001|Second Intervention|Study ending|0|||
23687160|NCT01889602|66228641|FG002|Second Intervention|Study ending|0|||
23687161|NCT01889602|66228639|FG000|Second Intervention|Withdrawal by Subject|0|||
23687162|NCT01889602|66228640|FG001|Second Intervention|Withdrawal by Subject|0|||
23687163|NCT01889602|66228641|FG002|Second Intervention|Withdrawal by Subject|1|||
23687164|NCT01889602|66228639|FG000|Third Intervention|Protocol Violation|1|||
23687165|NCT01889602|66228640|FG001|Third Intervention|Protocol Violation|0|||
23687166|NCT01889602|66228641|FG002|Third Intervention|Protocol Violation|0|||
23687167|NCT01889602|66228639|FG000|Third Intervention|Withdrawal by Subject|2|||
23687168|NCT01889602|66228640|FG001|Third Intervention|Withdrawal by Subject|2|||
23687169|NCT01889602|66228641|FG002|Third Intervention|Withdrawal by Subject|0|||
23687170|NCT03377634|66228643|FG000|Study Period|Adverse Event|1|||
23687171|NCT03377634|66228644|FG001|Study Period|Adverse Event|0|||
23687172|NCT03377634|66228643|FG000|Study Period|Withdrawal by Subject|1|||
23687173|NCT03377634|66228644|FG001|Study Period|Withdrawal by Subject|0|||
23687174|NCT02076165|66228645|FG000|Overall Study|Lost to Follow-up|7|||
23687175|NCT02076165|66228646|FG001|Overall Study|Lost to Follow-up|5|||
23687176|NCT02076165|66228645|FG000|Overall Study|Refused follow-up assessment|1|||
23687177|NCT02076165|66228646|FG001|Overall Study|Refused follow-up assessment|1|||
23687178|NCT02197377|66228648|FG000|Overall Study|Insertion Failure|0|||
23687179|NCT02197377|66228649|FG001|Overall Study|Insertion Failure|3|||
23687180|NCT00669617|66228650|FG000|Period 1|Withdrawal by Subject|0|||
23687181|NCT00669617|66228651|FG001|Period 1|Withdrawal by Subject|0|||
23687182|NCT00669617|66228652|FG002|Period 1|Withdrawal by Subject|1|||
23687183|NCT00669617|66228653|FG003|Period 1|Withdrawal by Subject|0|||
23687184|NCT00669617|66228654|FG004|Period 1|Withdrawal by Subject|0|||
23687185|NCT00669617|66228650|FG000|Period 1|Protocol Deviation|0|||
23687186|NCT00669617|66228651|FG001|Period 1|Protocol Deviation|0|||
23687187|NCT00669617|66228652|FG002|Period 1|Protocol Deviation|0|||
23687188|NCT00669617|66228653|FG003|Period 1|Protocol Deviation|0|||
23687189|NCT00669617|66228654|FG004|Period 1|Protocol Deviation|1|||
23687190|NCT00669617|66228650|FG000|Period 3|Lost to Follow-up|1|||
23687191|NCT00669617|66228651|FG001|Period 3|Lost to Follow-up|0|||
23687192|NCT00669617|66228652|FG002|Period 3|Lost to Follow-up|0|||
23687193|NCT00669617|66228653|FG003|Period 3|Lost to Follow-up|0|||
23498236|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23498237|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
23498238|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498239|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498240|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498241|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498242|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498243|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498244|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498245|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
23498246|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
23498247|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
23498248|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498249|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498250|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
23498251|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498252|NCT02004522|65566281|FG000|Overall Study|Adverse Event|55|||
23498253|NCT02004522|65566282|FG001|Overall Study|Adverse Event|6|||
23498254|NCT02004522|65566281|FG000|Overall Study|Withdrawal by Subject|13|||
23498255|NCT02004522|65566282|FG001|Overall Study|Withdrawal by Subject|7|||
23498256|NCT02004522|65566281|FG000|Overall Study|Death|12|||
23498257|NCT02004522|65566282|FG001|Overall Study|Death|3|||
23498258|NCT02004522|65566281|FG000|Overall Study|Physician Decision|3|||
23498259|NCT02004522|65566282|FG001|Overall Study|Physician Decision|4|||
23498260|NCT02004522|65566281|FG000|Overall Study|Protocol Violation|1|||
23498261|NCT02004522|65566282|FG001|Overall Study|Protocol Violation|0|||
23498262|NCT02004522|65566281|FG000|Overall Study|Other is reason listed by PI|4|||
23498263|NCT02004522|65566282|FG001|Overall Study|Other is reason listed by PI|1|||
23498264|NCT02004522|65566281|FG000|Overall Study|Never Dosed|2|||
23498265|NCT02004522|65566282|FG001|Overall Study|Never Dosed|4|||
23498266|NCT02004522|65566281|FG000|Overall Study|Disease Progression|35|||
23687194|NCT00669617|66228654|FG004|Period 3|Lost to Follow-up|0|||
23393445|NCT02776735|65186827|FG003|Overall Study|Other|0|||
23687195|NCT03182738|66228655|FG000|Overall Study|Lost to Follow-up|9|||
23393446|NCT02776735|65186828|FG004|Overall Study|Other|0|||
23393447|NCT02776735|65186829|FG005|Overall Study|Other|0|||
23393448|NCT05293717|65186830|FG000|Overall Study|Physician Decision|1|||
23393449|NCT02321514|65186843|FG000|Overall Study|Death|15|||
23393450|NCT02321514|65186843|FG000|Overall Study|Missed Visit|7|||
23393451|NCT02321514|65186843|FG000|Overall Study|Study Exit|3|||
23393452|NCT03379870|65186855|FG000|Overall Study|Lost to Follow-up|1|||
23393453|NCT03379870|65186856|FG001|Overall Study|Lost to Follow-up|0|||
23393454|NCT03379870|65186855|FG000|Overall Study|Protocol Violation|1|||
23393455|NCT03379870|65186856|FG001|Overall Study|Protocol Violation|1|||
23393456|NCT03814044|65186859|FG000|Overall Study|Protocol deviation|1|||
23393457|NCT03559556|65186860|FG000|Overall Study|Withdrawal by Subject|1|||
23393458|NCT01450631|65186861|FG000|Overall Study|Lost to Follow-up|2|||
23393459|NCT01450631|65186862|FG001|Overall Study|Lost to Follow-up|4|||
23393460|NCT01450631|65186861|FG000|Overall Study|Withdrawal by Subject|1|||
23393461|NCT01450631|65186862|FG001|Overall Study|Withdrawal by Subject|0|||
23393462|NCT02730169|65186863|FG000|Overall Study|Protocol Violation|1|||
23393463|NCT02730169|65186864|FG001|Overall Study|Protocol Violation|0|||
23393464|NCT02730169|65186865|FG002|Overall Study|Protocol Violation|0|||
23393465|NCT02730169|65186866|FG003|Overall Study|Protocol Violation|1|||
23393466|NCT02730169|65186863|FG000|Overall Study|Adverse Event|2|||
23393467|NCT02730169|65186864|FG001|Overall Study|Adverse Event|3|||
23393468|NCT02730169|65186865|FG002|Overall Study|Adverse Event|3|||
23393469|NCT02730169|65186866|FG003|Overall Study|Adverse Event|0|||
23393470|NCT02730169|65186863|FG000|Overall Study|Adverse Event of Special Interest|0|||
23393471|NCT02730169|65186864|FG001|Overall Study|Adverse Event of Special Interest|1|||
23393472|NCT02730169|65186865|FG002|Overall Study|Adverse Event of Special Interest|2|||
23393473|NCT02730169|65186866|FG003|Overall Study|Adverse Event of Special Interest|0|||
23393474|NCT02730169|65186863|FG000|Overall Study|Withdrawal by Subject|6|||
23393475|NCT02730169|65186864|FG001|Overall Study|Withdrawal by Subject|11|||
23393476|NCT02730169|65186865|FG002|Overall Study|Withdrawal by Subject|6|||
23393477|NCT02730169|65186866|FG003|Overall Study|Withdrawal by Subject|8|||
23393478|NCT02730169|65186863|FG000|Overall Study|Lost to Follow-up|5|||
23393479|NCT02730169|65186864|FG001|Overall Study|Lost to Follow-up|6|||
23498267|NCT02004522|65566282|FG001|Overall Study|Disease Progression|31|||
23498268|NCT02004522|65566281|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
23498269|NCT02004522|65566282|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
23498270|NCT01854658|65566283|FG000|Overall Study|Protocol Violation|6|||
23498271|NCT01854658|65566284|FG001|Overall Study|Protocol Violation|2|||
23498272|NCT01854658|65566285|FG002|Overall Study|Protocol Violation|2|||
23687196|NCT03182738|66228656|FG001|Overall Study|Lost to Follow-up|3|||
23687197|NCT03182738|66228655|FG000|Overall Study|Pregnancy|0|||
23393480|NCT02730169|65186865|FG002|Overall Study|Lost to Follow-up|5|||
23393481|NCT02730169|65186866|FG003|Overall Study|Lost to Follow-up|6|||
23393482|NCT02730169|65186863|FG000|Overall Study|Other|0|||
23393483|NCT02730169|65186864|FG001|Overall Study|Other|0|||
23393484|NCT02730169|65186865|FG002|Overall Study|Other|1|||
23393485|NCT02730169|65186866|FG003|Overall Study|Other|1|||
23393486|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
23393487|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393488|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393489|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393490|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23393491|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23687198|NCT03182738|66228656|FG001|Overall Study|Pregnancy|1|||
23687199|NCT03182738|66228655|FG000|Overall Study|Withdrawal by Subject|0|||
23687200|NCT03182738|66228656|FG001|Overall Study|Withdrawal by Subject|1|||
23393492|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23393493|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23393494|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
23393495|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
23393496|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
23393497|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
23393498|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393499|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
23393500|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393501|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393502|NCT05375929|65186870|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
23393503|NCT05375929|65186871|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393504|NCT05375929|65186872|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393505|NCT05375929|65186873|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393506|NCT05375929|65186870|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23498273|NCT01854658|65566286|FG003|Overall Study|Protocol Violation|1|||
23498274|NCT01854658|65566283|FG000|Overall Study|Physician Decision|7|||
23498275|NCT01854658|65566284|FG001|Overall Study|Physician Decision|5|||
23498276|NCT01854658|65566285|FG002|Overall Study|Physician Decision|2|||
23498277|NCT01854658|65566286|FG003|Overall Study|Physician Decision|4|||
23498278|NCT01854658|65566283|FG000|Overall Study|Lost to Follow-up|8|||
23498279|NCT01854658|65566284|FG001|Overall Study|Lost to Follow-up|9|||
23498280|NCT01854658|65566285|FG002|Overall Study|Lost to Follow-up|8|||
23498281|NCT01854658|65566286|FG003|Overall Study|Lost to Follow-up|4|||
23393507|NCT05375929|65186871|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
23393508|NCT05375929|65186872|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23393509|NCT05375929|65186873|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23393510|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393511|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393512|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393513|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
23393514|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393515|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393516|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
23393517|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393518|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393519|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393520|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
23393521|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393522|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393523|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393524|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
23393525|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393526|NCT00835549|65186874|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
23393527|NCT00835549|65186875|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23393528|NCT02781558|65186885|FG000|Overall Study|Lost to Follow-up|2|||
23498282|NCT01854658|65566283|FG000|Overall Study|Withdrawal by Subject|28|||
23498283|NCT01854658|65566284|FG001|Overall Study|Withdrawal by Subject|21|||
23498284|NCT01854658|65566285|FG002|Overall Study|Withdrawal by Subject|29|||
23498285|NCT01854658|65566286|FG003|Overall Study|Withdrawal by Subject|15|||
23498286|NCT01854658|65566283|FG000|Overall Study|Protocol-specified criteria|15|||
23498287|NCT01854658|65566284|FG001|Overall Study|Protocol-specified criteria|15|||
23498288|NCT01854658|65566285|FG002|Overall Study|Protocol-specified criteria|10|||
23687201|NCT01596257|66228658|FG000|Overall Study|Inadequate Collection|23|||
23687202|NCT01596257|66228659|FG001|Overall Study|Inadequate Collection|19|||
23498289|NCT01854658|65566286|FG003|Overall Study|Protocol-specified criteria|7|||
23498290|NCT01854658|65566283|FG000|Overall Study|Lack of Efficacy|3|||
23498291|NCT01854658|65566284|FG001|Overall Study|Lack of Efficacy|8|||
23498292|NCT01854658|65566285|FG002|Overall Study|Lack of Efficacy|4|||
23687203|NCT00158184|66228660|FG000|Overall Study|personal issues|3|||
23687204|NCT00158184|66228661|FG001|Overall Study|personal issues|1|||
23687205|NCT00158184|66228660|FG000|Overall Study|failed for follow unit/study rules|2|||
23687206|NCT00158184|66228661|FG001|Overall Study|failed for follow unit/study rules|0|||
23687207|NCT00158184|66228660|FG000|Overall Study|Adverse Event|1|||
23687208|NCT00158184|66228661|FG001|Overall Study|Adverse Event|1|||
23687209|NCT01400932|66228662|FG000|Overall Study|Adverse Event|10|||
23687210|NCT01400932|66228663|FG001|Overall Study|Adverse Event|5|||
23687211|NCT01400932|66228662|FG000|Overall Study|Lack of Efficacy|0|||
23687212|NCT01400932|66228663|FG001|Overall Study|Lack of Efficacy|3|||
23687213|NCT01400932|66228662|FG000|Overall Study|Withdrawal by Subject|2|||
23687214|NCT01400932|66228663|FG001|Overall Study|Withdrawal by Subject|6|||
23687215|NCT01400932|66228662|FG000|Overall Study|Lost to Follow-up|1|||
23687216|NCT01400932|66228663|FG001|Overall Study|Lost to Follow-up|0|||
23687217|NCT01400932|66228662|FG000|Overall Study|Protocol Deviation|0|||
23687218|NCT01400932|66228663|FG001|Overall Study|Protocol Deviation|1|||
23687219|NCT01400932|66228662|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23687220|NCT01400932|66228663|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23687221|NCT02661594|66228664|FG000|Overall Study|Protocol Violation|1|||
23687222|NCT02661594|66228665|FG001|Overall Study|Protocol Violation|0|||
23687223|NCT02661594|66228666|FG002|Overall Study|Protocol Violation|1|||
23687224|NCT02661594|66228667|FG003|Overall Study|Protocol Violation|0|||
23687225|NCT00723957|66228668|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23687226|NCT00723957|66228669|FG001|Overall Study|Adverse event unrelated to study drug|4|||
23687227|NCT00723957|66228668|FG000|Overall Study|Death|3|||
23687228|NCT00723957|66228669|FG001|Overall Study|Death|4|||
23687229|NCT00723957|66228668|FG000|Overall Study|Disease progression|27|||
23687230|NCT00723957|66228669|FG001|Overall Study|Disease progression|25|||
23687231|NCT00723957|66228668|FG000|Overall Study|Maximum clinical benefit|4|||
23687232|NCT00723957|66228669|FG001|Overall Study|Maximum clinical benefit|5|||
23687233|NCT00723957|66228668|FG000|Overall Study|Investigator decision|1|||
23687234|NCT00723957|66228669|FG001|Overall Study|Investigator decision|1|||
23687235|NCT00723957|66228668|FG000|Overall Study|Study drug toxicity|4|||
23393529|NCT02781558|65186886|FG001|Overall Study|Lost to Follow-up|2|||
23393530|NCT02781558|65186885|FG000|Overall Study|Adverse Event|1|||
23393531|NCT02781558|65186886|FG001|Overall Study|Adverse Event|0|||
23393532|NCT04938427|65186887|FG000|Overall Study|Adverse Event|5|||
23393533|NCT04938427|65186888|FG001|Overall Study|Adverse Event|19|||
23393534|NCT04938427|65186887|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23393535|NCT04938427|65186888|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23393536|NCT04938427|65186887|FG000|Overall Study|Withdrawal by Subject|1|||
23393537|NCT04938427|65186888|FG001|Overall Study|Withdrawal by Subject|0|||
23393538|NCT04938427|65186887|FG000|Overall Study|Reason Not Specified|2|||
23393539|NCT04938427|65186888|FG001|Overall Study|Reason Not Specified|1|||
23393540|NCT02697448|65186891|FG000|Overall Study|Protocol Violation|2|||
23393541|NCT02697448|65186892|FG001|Overall Study|Protocol Violation|4|||
23393542|NCT02697448|65186891|FG000|Overall Study|Clinical concerns during ablation|1|||
23393543|NCT02697448|65186892|FG001|Overall Study|Clinical concerns during ablation|1|||
23393544|NCT02697448|65186891|FG000|Overall Study|No data collected|2|||
23393545|NCT02697448|65186892|FG001|Overall Study|No data collected|0|||
23393546|NCT03900650|65186894|FG000|Overall Study|Withdrawal by Subject|1|||
23393547|NCT03900650|65186895|FG001|Overall Study|Withdrawal by Subject|1|||
23393548|NCT03900650|65186896|FG002|Overall Study|Withdrawal by Subject|0|||
23393549|NCT03900650|65186897|FG003|Overall Study|Withdrawal by Subject|0|||
23393550|NCT03900650|65186894|FG000|Overall Study|Withdrawn by staff|1|||
23393551|NCT03900650|65186895|FG001|Overall Study|Withdrawn by staff|0|||
23393552|NCT03900650|65186896|FG002|Overall Study|Withdrawn by staff|0|||
23393553|NCT03900650|65186897|FG003|Overall Study|Withdrawn by staff|0|||
23687236|NCT00723957|66228669|FG001|Overall Study|Study drug toxicity|6|||
23687237|NCT00723957|66228668|FG000|Overall Study|Withdrawal by Subject|7|||
23687238|NCT00723957|66228669|FG001|Overall Study|Withdrawal by Subject|5|||
23687239|NCT00723957|66228668|FG000|Overall Study|Reason not analyzed|1|||
23393562|NCT03729609|65186907|FG000|Overall Study|Protocol Violation|1|||
23393563|NCT01166646|65186910|FG000|Overall Study|Protocol Violation|0|||
23393564|NCT01166646|65186911|FG001|Overall Study|Protocol Violation|1|||
23393565|NCT01166646|65186910|FG000|Overall Study|Adverse Event|1|||
23498293|NCT01854658|65566286|FG003|Overall Study|Lack of Efficacy|7|||
23498294|NCT01854658|65566283|FG000|Overall Study|Adverse Event|21|||
23498295|NCT01854658|65566284|FG001|Overall Study|Adverse Event|14|||
23498296|NCT01854658|65566285|FG002|Overall Study|Adverse Event|23|||
23498297|NCT01854658|65566286|FG003|Overall Study|Adverse Event|19|||
23498298|NCT01854658|65566283|FG000|Overall Study|Administrative reasons|5|||
23498299|NCT01854658|65566284|FG001|Overall Study|Administrative reasons|1|||
23498300|NCT01854658|65566285|FG002|Overall Study|Administrative reasons|2|||
23498301|NCT01854658|65566286|FG003|Overall Study|Administrative reasons|2|||
23498302|NCT00934089|65566289|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
23498303|NCT00934089|65566290|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
23498304|NCT00934089|65566289|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
23498305|NCT00934089|65566290|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
23498306|NCT02021773|65566291|FG000|Overall Study|Adverse Event|1|||
23498307|NCT02021773|65566292|FG001|Overall Study|Adverse Event|4|||
23498308|NCT02021773|65566293|FG002|Overall Study|Adverse Event|3|||
23498309|NCT02021773|65566291|FG000|Overall Study|Lack of Efficacy|2|||
23498310|NCT02021773|65566292|FG001|Overall Study|Lack of Efficacy|2|||
23498311|NCT02021773|65566293|FG002|Overall Study|Lack of Efficacy|2|||
23498312|NCT02021773|65566291|FG000|Overall Study|Protocol Violation|2|||
23498313|NCT02021773|65566292|FG001|Overall Study|Protocol Violation|3|||
23498314|NCT02021773|65566293|FG002|Overall Study|Protocol Violation|1|||
23498315|NCT02021773|65566291|FG000|Overall Study|Withdrawal by Subject|3|||
23498316|NCT02021773|65566292|FG001|Overall Study|Withdrawal by Subject|4|||
23498317|NCT02021773|65566293|FG002|Overall Study|Withdrawal by Subject|5|||
23498318|NCT02021773|65566291|FG000|Overall Study|Lost to Follow-up|1|||
23498319|NCT02021773|65566292|FG001|Overall Study|Lost to Follow-up|3|||
23498320|NCT02021773|65566293|FG002|Overall Study|Lost to Follow-up|0|||
23498321|NCT02021773|65566291|FG000|Overall Study|Reason not specified|3|||
23498322|NCT02021773|65566292|FG001|Overall Study|Reason not specified|0|||
23498323|NCT02021773|65566293|FG002|Overall Study|Reason not specified|0|||
23498324|NCT00178633|65566294|FG000|Overall Study|Lost to Follow-up|6|||
23498325|NCT01702961|65566300|FG000|Overall Study|Additional treatment|3|||
23498326|NCT01702961|65566300|FG000|Overall Study|Progressive disease|5|||
23498327|NCT01702961|65566300|FG000|Overall Study|Relapse|20|||
23498328|NCT01702961|65566300|FG000|Overall Study|Death|6|||
23498329|NCT01702961|65566300|FG000|Overall Study|Lost to Follow-up|2|||
23498330|NCT01702961|65566300|FG000|Overall Study|Ongoing|11|||
23498331|NCT04377620|65566303|FG000|Overall Study|Death|42|||
23498332|NCT04377620|65566304|FG001|Overall Study|Death|48|||
23498333|NCT04377620|65566305|FG002|Overall Study|Death|36|||
23498334|NCT04377620|65566303|FG000|Overall Study|Withdrawal by Subject|0|||
23498335|NCT04377620|65566304|FG001|Overall Study|Withdrawal by Subject|2|||
23498336|NCT04377620|65566305|FG002|Overall Study|Withdrawal by Subject|0|||
23498337|NCT00437983|65566308|FG000|Overall Study|Adverse Event|6|||
23498338|NCT00437983|65566309|FG001|Overall Study|Adverse Event|6|||
23498339|NCT00437983|65566308|FG000|Overall Study|Protocol Violation|2|||
23498340|NCT00437983|65566309|FG001|Overall Study|Protocol Violation|1|||
23498341|NCT00437983|65566308|FG000|Overall Study|Withdrawal by Subject|5|||
23498342|NCT00437983|65566309|FG001|Overall Study|Withdrawal by Subject|6|||
23498343|NCT00926328|65566312|FG000|Overall Study|Lost to Follow-up|12|||
23498344|NCT00926328|65566313|FG001|Overall Study|Lost to Follow-up|14|||
23498345|NCT00003473|65566315|FG000|Overall Study|Three patients were not evaluable.|3|||
23498346|NCT01999868|65566316|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
23498347|NCT01999868|65566317|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
23498348|NCT01999868|65566318|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
23498349|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
23498350|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
23498351|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
23498352|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
23498353|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
23498354|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
23498355|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
23498356|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
23498357|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
23498358|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
23498359|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
23498360|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
23687240|NCT00723957|66228669|FG001|Overall Study|Reason not analyzed|0|||
23687241|NCT00723957|66228668|FG000|Overall Study|Never received treatment|3|||
23393566|NCT01166646|65186911|FG001|Overall Study|Adverse Event|0|||
23498361|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
23498362|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
23498363|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
23498364|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
23498365|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
23498366|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
23498367|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
23687242|NCT00723957|66228669|FG001|Overall Study|Never received treatment|3|||
23393567|NCT01992757|65189343|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
23687243|NCT00424398|66228672|FG000|Overall Study|Withdrawal by Subject|2|||
23498368|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
23498369|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
23498370|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
23498371|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
23498372|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
23498373|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
23498374|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
23498375|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
23498376|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
23393568|NCT05261126|65189344|FG000|Overall Study|Death|0|||
23393569|NCT05261126|65189345|FG001|Overall Study|Death|0|||
23393570|NCT05261126|65189346|FG002|Overall Study|Death|1|||
23393571|NCT05261126|65189347|FG003|Overall Study|Death|0|||
23393572|NCT05261126|65189348|FG004|Overall Study|Death|0|||
23393573|NCT05261126|65189344|FG000|Overall Study|Lost to Follow-up|0|||
23393574|NCT05261126|65189345|FG001|Overall Study|Lost to Follow-up|0|||
23393575|NCT05261126|65189346|FG002|Overall Study|Lost to Follow-up|0|||
23393576|NCT05261126|65189347|FG003|Overall Study|Lost to Follow-up|0|||
23393577|NCT05261126|65189348|FG004|Overall Study|Lost to Follow-up|1|||
23393578|NCT05261126|65189344|FG000|Overall Study|Physician Decision|1|||
23393579|NCT05261126|65189345|FG001|Overall Study|Physician Decision|0|||
23393580|NCT05261126|65189346|FG002|Overall Study|Physician Decision|0|||
23393581|NCT05261126|65189347|FG003|Overall Study|Physician Decision|0|||
23393582|NCT05261126|65189348|FG004|Overall Study|Physician Decision|0|||
23393583|NCT05261126|65189344|FG000|Overall Study|Screen Failure|0|||
23393584|NCT05261126|65189345|FG001|Overall Study|Screen Failure|0|||
23393585|NCT05261126|65189346|FG002|Overall Study|Screen Failure|0|||
23393586|NCT05261126|65189347|FG003|Overall Study|Screen Failure|0|||
23393587|NCT05261126|65189348|FG004|Overall Study|Screen Failure|1|||
23393588|NCT05261126|65189344|FG000|Overall Study|Withdrawal by Subject|1|||
23393589|NCT05261126|65189345|FG001|Overall Study|Withdrawal by Subject|0|||
23393590|NCT05261126|65189346|FG002|Overall Study|Withdrawal by Subject|1|||
23393591|NCT05261126|65189347|FG003|Overall Study|Withdrawal by Subject|1|||
23393592|NCT05261126|65189348|FG004|Overall Study|Withdrawal by Subject|0|||
23393593|NCT05261126|65189344|FG000|Overall Study|Not Recorded|0|||
23393594|NCT05261126|65189345|FG001|Overall Study|Not Recorded|0|||
23393595|NCT05261126|65189346|FG002|Overall Study|Not Recorded|0|||
23393596|NCT05261126|65189347|FG003|Overall Study|Not Recorded|1|||
23393597|NCT05261126|65189348|FG004|Overall Study|Not Recorded|0|||
23393598|NCT02496000|65189352|FG000|Overall Study|Withdrawal by Subject|1|||
23393599|NCT02496000|65189353|FG001|Overall Study|Withdrawal by Subject|2|||
23393600|NCT02496000|65189354|FG002|Overall Study|Withdrawal by Subject|0|||
23393601|NCT02496000|65189352|FG000|Overall Study|Lost to Follow-up|1|||
23393602|NCT02496000|65189353|FG001|Overall Study|Lost to Follow-up|0|||
23393603|NCT02496000|65189354|FG002|Overall Study|Lost to Follow-up|1|||
23393604|NCT02496000|65189352|FG000|Overall Study|Protocol Violation|0|||
23393605|NCT02496000|65189353|FG001|Overall Study|Protocol Violation|0|||
23393606|NCT02496000|65189354|FG002|Overall Study|Protocol Violation|1|||
23393607|NCT02496000|65189352|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
23393608|NCT02496000|65189353|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
23393609|NCT02496000|65189354|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
23393610|NCT02496000|65189352|FG000|Overall Study|undetermined|0|||
23393611|NCT02496000|65189353|FG001|Overall Study|undetermined|1|||
23393612|NCT02496000|65189354|FG002|Overall Study|undetermined|0|||
23393613|NCT02734004|65189355|FG000|Overall Study|Death|36|||
23393614|NCT02734004|65189356|FG001|Overall Study|Death|24|||
23498377|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
23498378|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
23393615|NCT02734004|65189357|FG002|Overall Study|Death|26|||
23393616|NCT02734004|65189358|FG003|Overall Study|Death|35|||
23393617|NCT02734004|65189359|FG004|Overall Study|Death|13|||
23393618|NCT02734004|65189360|FG005|Overall Study|Death|17|||
23393619|NCT02734004|65189361|FG006|Overall Study|Death|20|||
23393620|NCT02734004|65189355|FG000|Overall Study|Lost to Follow-up|1|||
23393621|NCT02734004|65189356|FG001|Overall Study|Lost to Follow-up|1|||
23393622|NCT02734004|65189357|FG002|Overall Study|Lost to Follow-up|0|||
23393623|NCT02734004|65189358|FG003|Overall Study|Lost to Follow-up|0|||
23393624|NCT02734004|65189359|FG004|Overall Study|Lost to Follow-up|1|||
23393625|NCT02734004|65189360|FG005|Overall Study|Lost to Follow-up|0|||
23393626|NCT02734004|65189361|FG006|Overall Study|Lost to Follow-up|0|||
23393627|NCT02734004|65189355|FG000|Overall Study|Withdrawal by Subject|3|||
23393628|NCT02734004|65189356|FG001|Overall Study|Withdrawal by Subject|1|||
23393629|NCT02734004|65189357|FG002|Overall Study|Withdrawal by Subject|1|||
23393630|NCT02734004|65189358|FG003|Overall Study|Withdrawal by Subject|1|||
23393631|NCT02734004|65189359|FG004|Overall Study|Withdrawal by Subject|3|||
23393632|NCT02734004|65189360|FG005|Overall Study|Withdrawal by Subject|0|||
23393633|NCT02734004|65189361|FG006|Overall Study|Withdrawal by Subject|2|||
23498379|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
23498380|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
23498381|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
23498382|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
23498383|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
23498384|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
23498385|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
23498386|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
23498387|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
23498388|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
23498389|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
23687244|NCT00424398|66228673|FG001|Overall Study|Withdrawal by Subject|1|||
23687245|NCT00424398|66228674|FG002|Overall Study|Withdrawal by Subject|0|||
23687246|NCT00424398|66228672|FG000|Overall Study|Subject met exclusion criteria|1|||
23687247|NCT00424398|66228673|FG001|Overall Study|Subject met exclusion criteria|0|||
23687248|NCT00424398|66228674|FG002|Overall Study|Subject met exclusion criteria|0|||
23687249|NCT00600171|66228676|FG000|Overall Study|Adverse Event|0|||
23687250|NCT00600171|66228677|FG001|Overall Study|Adverse Event|1|||
23687251|NCT00600171|66228678|FG002|Overall Study|Adverse Event|0|||
23687252|NCT00600171|66228679|FG003|Overall Study|Adverse Event|0|||
23687253|NCT00600171|66228680|FG004|Overall Study|Adverse Event|1|||
23687254|NCT00600171|66228681|FG005|Overall Study|Adverse Event|0|||
23393634|NCT02734004|65189355|FG000|Overall Study|Other|0|||
23393635|NCT02734004|65189356|FG001|Overall Study|Other|8|||
23393636|NCT02734004|65189357|FG002|Overall Study|Other|7|||
23393637|NCT02734004|65189358|FG003|Overall Study|Other|4|||
23687255|NCT00600171|66228676|FG000|Overall Study|Lack of Efficacy|9|||
23687256|NCT00600171|66228677|FG001|Overall Study|Lack of Efficacy|12|||
23687257|NCT00600171|66228678|FG002|Overall Study|Lack of Efficacy|3|||
23687258|NCT00600171|66228679|FG003|Overall Study|Lack of Efficacy|5|||
23687259|NCT00600171|66228680|FG004|Overall Study|Lack of Efficacy|4|||
23687260|NCT00600171|66228681|FG005|Overall Study|Lack of Efficacy|0|||
23687261|NCT00600171|66228676|FG000|Overall Study|Protocol Violation|1|||
23687262|NCT00600171|66228677|FG001|Overall Study|Protocol Violation|2|||
23687263|NCT00600171|66228678|FG002|Overall Study|Protocol Violation|0|||
23687264|NCT00600171|66228679|FG003|Overall Study|Protocol Violation|1|||
23687265|NCT00600171|66228680|FG004|Overall Study|Protocol Violation|0|||
23687266|NCT00600171|66228681|FG005|Overall Study|Protocol Violation|0|||
23687267|NCT00600171|66228676|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23687268|NCT00600171|66228677|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23687269|NCT00600171|66228678|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
23687270|NCT00600171|66228679|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23687271|NCT00600171|66228680|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23687272|NCT00600171|66228681|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23687273|NCT00600171|66228676|FG000|Overall Study|Withdrawal by Subject|3|||
23687274|NCT00600171|66228677|FG001|Overall Study|Withdrawal by Subject|0|||
23687275|NCT00600171|66228678|FG002|Overall Study|Withdrawal by Subject|0|||
23687276|NCT00600171|66228679|FG003|Overall Study|Withdrawal by Subject|1|||
23687277|NCT00600171|66228680|FG004|Overall Study|Withdrawal by Subject|1|||
23687278|NCT00600171|66228681|FG005|Overall Study|Withdrawal by Subject|1|||
23687279|NCT00600171|66228676|FG000|Overall Study|Physician Decision|0|||
23687280|NCT00600171|66228677|FG001|Overall Study|Physician Decision|1|||
23687281|NCT00600171|66228678|FG002|Overall Study|Physician Decision|0|||
23687282|NCT00600171|66228679|FG003|Overall Study|Physician Decision|1|||
23687283|NCT00600171|66228680|FG004|Overall Study|Physician Decision|0|||
23687284|NCT00600171|66228681|FG005|Overall Study|Physician Decision|2|||
23687285|NCT00600171|66228676|FG000|Overall Study|Lost to Follow-up|0|||
23687286|NCT00600171|66228677|FG001|Overall Study|Lost to Follow-up|0|||
23687287|NCT00600171|66228678|FG002|Overall Study|Lost to Follow-up|0|||
23687288|NCT00600171|66228679|FG003|Overall Study|Lost to Follow-up|1|||
23687289|NCT00600171|66228680|FG004|Overall Study|Lost to Follow-up|0|||
23687290|NCT00600171|66228681|FG005|Overall Study|Lost to Follow-up|0|||
23687291|NCT01838044|66228682|FG000|Overall Study|Adverse Event|4|||
23687292|NCT01838044|66228683|FG001|Overall Study|Adverse Event|6|||
23687293|NCT01838044|66228682|FG000|Overall Study|Protocol Violation|3|||
23687294|NCT01838044|66228683|FG001|Overall Study|Protocol Violation|3|||
23687295|NCT01838044|66228682|FG000|Overall Study|Withdrawal by Subject|0|||
23687296|NCT01838044|66228683|FG001|Overall Study|Withdrawal by Subject|2|||
23687297|NCT01838044|66228682|FG000|Overall Study|Insufficient clinical response|1|||
23687298|NCT01838044|66228683|FG001|Overall Study|Insufficient clinical response|2|||
23393638|NCT02734004|65189359|FG004|Overall Study|Other|34|||
23393639|NCT02734004|65189360|FG005|Overall Study|Other|14|||
23498390|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
23687299|NCT01838044|66228682|FG000|Overall Study|Medication error without associated AE|0|||
23687300|NCT01838044|66228683|FG001|Overall Study|Medication error without associated AE|1|||
23687301|NCT01838044|66228682|FG000|Overall Study|Lost to Follow-up|0|||
23687302|NCT01838044|66228683|FG001|Overall Study|Lost to Follow-up|2|||
23687303|NCT01934504|66228684|FG000|Overall Study|Protocol Deviation|0|||
23687304|NCT01934504|66228685|FG001|Overall Study|Protocol Deviation|0|||
23687305|NCT01934504|66228686|FG002|Overall Study|Protocol Deviation|0|||
23687306|NCT01934504|66228687|FG003|Overall Study|Protocol Deviation|2|||
23687307|NCT01934504|66228684|FG000|Overall Study|Study Terminated by Sponsor|1|||
23687308|NCT01934504|66228685|FG001|Overall Study|Study Terminated by Sponsor|0|||
23687309|NCT01934504|66228686|FG002|Overall Study|Study Terminated by Sponsor|5|||
23687310|NCT01934504|66228687|FG003|Overall Study|Study Terminated by Sponsor|5|||
23687311|NCT02581995|66232846|FG000|Overall Study|Unspecified other|3|||
23687312|NCT02581995|66232846|FG000|Overall Study|Adverse Event|6|||
23687313|NCT02581995|66232846|FG000|Overall Study|Lost to Follow-up|5|||
23687314|NCT02581995|66232846|FG000|Overall Study|Withdrawal by participant|12|||
23687315|NCT02581995|66232846|FG000|Overall Study|Physician Decision|1|||
23687316|NCT02581995|66232846|FG000|Overall Study|Death|4|||
23687317|NCT00733902|66232847|FG000|Overall Study|Death|0|||
23687318|NCT00733902|66232848|FG001|Overall Study|Death|0|||
23687319|NCT00733902|66232849|FG002|Overall Study|Death|0|||
23687320|NCT00733902|66232850|FG003|Overall Study|Death|1|||
23687321|NCT00733902|66232847|FG000|Overall Study|Adverse Event|3|||
23687322|NCT00733902|66232848|FG001|Overall Study|Adverse Event|4|||
23687323|NCT00733902|66232849|FG002|Overall Study|Adverse Event|7|||
23393640|NCT02734004|65189361|FG006|Overall Study|Other|10|||
23393641|NCT01313676|65189370|FG000|Overall Study|Adverse Event|395|||
23393642|NCT01313676|65189371|FG001|Overall Study|Adverse Event|365|||
23393643|NCT01313676|65189372|FG002|Overall Study|Adverse Event|372|||
23393644|NCT01313676|65189373|FG003|Overall Study|Adverse Event|333|||
23687324|NCT00733902|66232850|FG003|Overall Study|Adverse Event|11|||
23687325|NCT00733902|66232847|FG000|Overall Study|Lack of Efficacy|56|||
23687326|NCT00733902|66232848|FG001|Overall Study|Lack of Efficacy|21|||
23687327|NCT00733902|66232849|FG002|Overall Study|Lack of Efficacy|34|||
23687328|NCT00733902|66232850|FG003|Overall Study|Lack of Efficacy|23|||
23687329|NCT00733902|66232847|FG000|Overall Study|Protocol Violation|4|||
23687330|NCT00733902|66232848|FG001|Overall Study|Protocol Violation|6|||
23687331|NCT00733902|66232849|FG002|Overall Study|Protocol Violation|3|||
23687332|NCT00733902|66232850|FG003|Overall Study|Protocol Violation|3|||
23687333|NCT00733902|66232847|FG000|Overall Study|Withdrawal by Subject|10|||
23687334|NCT00733902|66232848|FG001|Overall Study|Withdrawal by Subject|5|||
23687335|NCT00733902|66232849|FG002|Overall Study|Withdrawal by Subject|4|||
23687336|NCT00733902|66232850|FG003|Overall Study|Withdrawal by Subject|16|||
23687337|NCT00733902|66232847|FG000|Overall Study|Entered extension study|89|||
23687338|NCT00733902|66232848|FG001|Overall Study|Entered extension study|124|||
23687339|NCT00733902|66232849|FG002|Overall Study|Entered extension study|111|||
23687340|NCT00733902|66232850|FG003|Overall Study|Entered extension study|109|||
23687341|NCT00733902|66232847|FG000|Overall Study|Randomized but not treated|2|||
23687342|NCT00733902|66232848|FG001|Overall Study|Randomized but not treated|2|||
23687343|NCT00733902|66232849|FG002|Overall Study|Randomized but not treated|2|||
23687344|NCT00733902|66232850|FG003|Overall Study|Randomized but not treated|1|||
23687345|NCT00888355|66232855|FG000|Overall Study|Adverse Event|10|||
23687346|NCT00888355|66232856|FG001|Overall Study|Adverse Event|0|||
23687347|NCT00888355|66232857|FG002|Overall Study|Adverse Event|3|||
23687348|NCT00888355|66232858|FG003|Overall Study|Adverse Event|3|||
23687349|NCT00888355|66232855|FG000|Overall Study|Lack of Efficacy|9|||
23687350|NCT00888355|66232856|FG001|Overall Study|Lack of Efficacy|2|||
23687351|NCT00888355|66232857|FG002|Overall Study|Lack of Efficacy|5|||
23687352|NCT00888355|66232858|FG003|Overall Study|Lack of Efficacy|2|||
23687353|NCT00888355|66232855|FG000|Overall Study|Lost to Follow-up|0|||
23687354|NCT00888355|66232856|FG001|Overall Study|Lost to Follow-up|2|||
23687355|NCT00888355|66232857|FG002|Overall Study|Lost to Follow-up|2|||
23687356|NCT00888355|66232858|FG003|Overall Study|Lost to Follow-up|0|||
23687357|NCT00888355|66232855|FG000|Overall Study|Protocol Violation|3|||
23687358|NCT00888355|66232856|FG001|Overall Study|Protocol Violation|2|||
23687359|NCT00888355|66232857|FG002|Overall Study|Protocol Violation|1|||
23687360|NCT00888355|66232858|FG003|Overall Study|Protocol Violation|2|||
23687361|NCT00888355|66232855|FG000|Overall Study|Withdrawal by Subject|0|||
23687362|NCT00888355|66232856|FG001|Overall Study|Withdrawal by Subject|3|||
23687363|NCT00888355|66232857|FG002|Overall Study|Withdrawal by Subject|1|||
23687364|NCT00888355|66232858|FG003|Overall Study|Withdrawal by Subject|3|||
23687365|NCT02318784|66232859|FG000|Overall Study|Adverse Event|13|||
23498391|NCT03385564|65566319|FG000|Overall Study|Adverse Event|0|||
23687366|NCT02318784|66232859|FG000|Overall Study|Death|2|||
23687367|NCT02318784|66232859|FG000|Overall Study|Progressive Disease|37|||
23393645|NCT01313676|65189370|FG000|Overall Study|Lack of Efficacy|98|||
23687368|NCT02318784|66232859|FG000|Overall Study|Withdrawal by Subject|10|||
23687369|NCT01355289|66232861|FG000|Core Study|Adverse Event, Non-Fatal|1|||
23687370|NCT01355289|66232862|FG001|Core Study|Adverse Event, Non-Fatal|0|||
23687371|NCT01355289|66232863|FG002|Core Study|Adverse Event, Non-Fatal|0|||
23687372|NCT01355289|66232864|FG003|Core Study|Adverse Event, Non-Fatal|0|||
23687373|NCT01355289|66232865|FG004|Core Study|Adverse Event, Non-Fatal|0|||
23498392|NCT03385564|65566320|FG001|Overall Study|Adverse Event|0|||
23498393|NCT03385564|65566321|FG002|Overall Study|Adverse Event|3|||
23498394|NCT03385564|65566322|FG003|Overall Study|Adverse Event|3|||
23498395|NCT03385564|65566319|FG000|Overall Study|Other than listed|0|||
23498396|NCT03385564|65566320|FG001|Overall Study|Other than listed|0|||
23498397|NCT03385564|65566321|FG002|Overall Study|Other than listed|0|||
23498398|NCT03385564|65566322|FG003|Overall Study|Other than listed|5|||
23498399|NCT03385564|65566319|FG000|Overall Study|Withdrawal by Subject|0|||
23498400|NCT03385564|65566320|FG001|Overall Study|Withdrawal by Subject|1|||
23498401|NCT03385564|65566321|FG002|Overall Study|Withdrawal by Subject|1|||
23498402|NCT03385564|65566322|FG003|Overall Study|Withdrawal by Subject|0|||
23498403|NCT03385564|65566319|FG000|Overall Study|Lack of Efficacy|0|||
23498404|NCT03385564|65566320|FG001|Overall Study|Lack of Efficacy|0|||
23498405|NCT03385564|65566321|FG002|Overall Study|Lack of Efficacy|0|||
23498406|NCT03385564|65566322|FG003|Overall Study|Lack of Efficacy|1|||
23498407|NCT03385564|65566319|FG000|Overall Study|Death|0|||
23498408|NCT03385564|65566320|FG001|Overall Study|Death|0|||
23498409|NCT03385564|65566321|FG002|Overall Study|Death|1|||
23498410|NCT03385564|65566322|FG003|Overall Study|Death|0|||
23498411|NCT00428792|65566323|FG000|Overall Study|Lack of Efficacy|1|||
23498412|NCT00428792|65566324|FG001|Overall Study|Lack of Efficacy|3|||
23498413|NCT00428792|65566323|FG000|Overall Study|Lost to Follow-up|0|||
23498414|NCT00428792|65566324|FG001|Overall Study|Lost to Follow-up|1|||
23498415|NCT00191139|65566325|FG000|Overall Study|Adverse Event|2|||
23498416|NCT00191139|65566326|FG001|Overall Study|Adverse Event|6|||
23498417|NCT00191139|65566325|FG000|Overall Study|Death|2|||
23498418|NCT00191139|65566326|FG001|Overall Study|Death|0|||
23498419|NCT00191139|65566325|FG000|Overall Study|Withdrawal by Subject|0|||
23498420|NCT00191139|65566326|FG001|Overall Study|Withdrawal by Subject|3|||
23498421|NCT00191139|65566325|FG000|Overall Study|Disease Progression|0|||
23498422|NCT00191139|65566326|FG001|Overall Study|Disease Progression|1|||
23498423|NCT00191139|65566325|FG000|Overall Study|Other|1|||
23498424|NCT00191139|65566326|FG001|Overall Study|Other|2|||
23498425|NCT01539538|65566329|FG000|Overall Study|Adverse Event|13|||
23498426|NCT01539538|65566330|FG001|Overall Study|Adverse Event|18|||
23498427|NCT01539538|65566329|FG000|Overall Study|Lack of Efficacy|13|||
23498428|NCT01539538|65566330|FG001|Overall Study|Lack of Efficacy|16|||
23498429|NCT01539538|65566329|FG000|Overall Study|Withdrawal by Subject|2|||
23498430|NCT01539538|65566330|FG001|Overall Study|Withdrawal by Subject|3|||
23498431|NCT01539538|65566329|FG000|Overall Study|PCA no longer required or PCA problem|3|||
23498432|NCT01539538|65566330|FG001|Overall Study|PCA no longer required or PCA problem|7|||
23498433|NCT00371826|65566333|FG000|Core Phase (12 Months)|Adverse Event|15|||
23498434|NCT00371826|65566334|FG001|Core Phase (12 Months)|Adverse Event|4|||
23498435|NCT00371826|65566335|FG002|Core Phase (12 Months)|Adverse Event|9|||
23498436|NCT00371826|65566333|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
23498437|NCT00371826|65566334|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
23498438|NCT00371826|65566335|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
23498439|NCT00371826|65566333|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
23498440|NCT00371826|65566334|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
23498441|NCT00371826|65566335|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
23498442|NCT00371826|65566333|FG000|Core Phase (12 Months)|Protocol Violation|1|||
23498443|NCT00371826|65566334|FG001|Core Phase (12 Months)|Protocol Violation|0|||
23498444|NCT00371826|65566335|FG002|Core Phase (12 Months)|Protocol Violation|1|||
23498445|NCT00371826|65566333|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
23498446|NCT00371826|65566334|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
23498447|NCT00371826|65566335|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
23498448|NCT00371826|65566333|FG000|Core Phase (12 Months)|Administrative problems|1|||
23687374|NCT01355289|66232861|FG000|Core Study|Inadequate Therapeutic Effect|0|||
23687375|NCT01355289|66232862|FG001|Core Study|Inadequate Therapeutic Effect|0|||
23687376|NCT01355289|66232863|FG002|Core Study|Inadequate Therapeutic Effect|0|||
23498449|NCT00371826|65566334|FG001|Core Phase (12 Months)|Administrative problems|0|||
23498450|NCT00371826|65566335|FG002|Core Phase (12 Months)|Administrative problems|8|||
23498451|NCT00371826|65566333|FG000|Core Phase (12 Months)|Graft Loss|0|||
23498452|NCT00371826|65566334|FG001|Core Phase (12 Months)|Graft Loss|1|||
23498453|NCT00371826|65566335|FG002|Core Phase (12 Months)|Graft Loss|0|||
23498454|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Adverse Event|4|||
23498455|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Adverse Event|5|||
23498456|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Adverse Event|0|||
23498457|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
23498458|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
23498459|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
23498460|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
23498461|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
23687377|NCT01355289|66232864|FG003|Core Study|Inadequate Therapeutic Effect|1|||
23687378|NCT01355289|66232865|FG004|Core Study|Inadequate Therapeutic Effect|0|||
23687379|NCT01355289|66232861|FG000|Core Study|Other|0|||
23687380|NCT01355289|66232862|FG001|Core Study|Other|0|||
23687381|NCT01355289|66232863|FG002|Core Study|Other|0|||
23687382|NCT01355289|66232864|FG003|Core Study|Other|1|||
23687383|NCT01355289|66232865|FG004|Core Study|Other|0|||
23687384|NCT01355289|66232861|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
23687385|NCT01355289|66232862|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
23687386|NCT01355289|66232863|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
23687387|NCT01355289|66232864|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
23687388|NCT01355289|66232865|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
23687389|NCT01355289|66232861|FG000|Open Label Extension|Lost to Follow-up|0|||
23687390|NCT01355289|66232862|FG001|Open Label Extension|Lost to Follow-up|0|||
23687391|NCT01355289|66232863|FG002|Open Label Extension|Lost to Follow-up|0|||
23687392|NCT01355289|66232864|FG003|Open Label Extension|Lost to Follow-up|0|||
23687393|NCT01355289|66232865|FG004|Open Label Extension|Lost to Follow-up|1|||
23687394|NCT01355289|66232861|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
23687395|NCT01355289|66232862|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
23687396|NCT01355289|66232863|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
23687397|NCT01355289|66232864|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
23687398|NCT01355289|66232865|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
23687399|NCT01355289|66232861|FG000|Open Label Extension|Other|0|||
23687400|NCT01355289|66232862|FG001|Open Label Extension|Other|0|||
23687401|NCT01355289|66232863|FG002|Open Label Extension|Other|0|||
23687402|NCT01355289|66232864|FG003|Open Label Extension|Other|0|||
23687403|NCT01355289|66232865|FG004|Open Label Extension|Other|3|||
23687404|NCT03244059|66232866|FG000|Specific Aim 1|Physician Decision|1|||
23687405|NCT03244059|66232867|FG001|Specific Aim 1|Physician Decision|0|||
23687406|NCT03244059|66232866|FG000|Specific Aim 2|Physician Decision|1|||
23687407|NCT03244059|66232867|FG001|Specific Aim 2|Physician Decision|0|||
23687408|NCT01562028|66232869|FG000|Overall Study|Withdrawal by Subject|1|||
23687409|NCT01562028|66232870|FG001|Overall Study|Withdrawal by Subject|1|||
23687410|NCT01562028|66232869|FG000|Overall Study|Lost to Follow-up|2|||
23687411|NCT01562028|66232870|FG001|Overall Study|Lost to Follow-up|1|||
23687412|NCT02210780|66232871|FG000|Overall Study|Adverse Event|0|||
23687413|NCT02210780|66232872|FG001|Overall Study|Adverse Event|5|||
23687414|NCT02210780|66232871|FG000|Overall Study|Lost to Follow-up|2|||
23687415|NCT02210780|66232872|FG001|Overall Study|Lost to Follow-up|1|||
23687416|NCT02210780|66232871|FG000|Overall Study|Withdrawal by Subject|1|||
23687417|NCT02210780|66232872|FG001|Overall Study|Withdrawal by Subject|1|||
23687418|NCT02210780|66232871|FG000|Overall Study|Physician Decision|1|||
23687419|NCT02210780|66232872|FG001|Overall Study|Physician Decision|0|||
23687420|NCT02210780|66232871|FG000|Overall Study|Protocol Violation|1|||
23687421|NCT02210780|66232872|FG001|Overall Study|Protocol Violation|0|||
23687422|NCT02210780|66232871|FG000|Overall Study|Other than specified above|0|||
23687423|NCT02210780|66232872|FG001|Overall Study|Other than specified above|1|||
23687424|NCT00749190|66232873|FG000|Overall Study|Adverse Event|0|||
23687425|NCT00749190|66232874|FG001|Overall Study|Adverse Event|2|||
23687426|NCT00749190|66232875|FG002|Overall Study|Adverse Event|0|||
23687427|NCT00749190|66232876|FG003|Overall Study|Adverse Event|4|||
23687428|NCT00749190|66232877|FG004|Overall Study|Adverse Event|0|||
23687429|NCT00749190|66232878|FG005|Overall Study|Adverse Event|3|||
23687430|NCT00749190|66232879|FG006|Overall Study|Adverse Event|0|||
23687431|NCT00749190|66232873|FG000|Overall Study|Lack of Efficacy|3|||
23687432|NCT00749190|66232874|FG001|Overall Study|Lack of Efficacy|1|||
23687433|NCT00749190|66232875|FG002|Overall Study|Lack of Efficacy|1|||
23687434|NCT00749190|66232876|FG003|Overall Study|Lack of Efficacy|0|||
23687435|NCT00749190|66232877|FG004|Overall Study|Lack of Efficacy|0|||
23687436|NCT00749190|66232878|FG005|Overall Study|Lack of Efficacy|1|||
23687437|NCT00749190|66232879|FG006|Overall Study|Lack of Efficacy|0|||
23687438|NCT00749190|66232873|FG000|Overall Study|Withdrawal by Subject|2|||
23687439|NCT00749190|66232874|FG001|Overall Study|Withdrawal by Subject|1|||
23687440|NCT00749190|66232875|FG002|Overall Study|Withdrawal by Subject|0|||
23687441|NCT00749190|66232876|FG003|Overall Study|Withdrawal by Subject|0|||
23687442|NCT00749190|66232877|FG004|Overall Study|Withdrawal by Subject|0|||
23687443|NCT00749190|66232878|FG005|Overall Study|Withdrawal by Subject|1|||
23687444|NCT00749190|66232879|FG006|Overall Study|Withdrawal by Subject|0|||
23687445|NCT00749190|66232873|FG000|Overall Study|Protocol Violation|0|||
23687446|NCT00749190|66232874|FG001|Overall Study|Protocol Violation|1|||
23687447|NCT00749190|66232875|FG002|Overall Study|Protocol Violation|0|||
23687448|NCT00749190|66232876|FG003|Overall Study|Protocol Violation|0|||
23687449|NCT00749190|66232877|FG004|Overall Study|Protocol Violation|0|||
23393646|NCT01313676|65189371|FG001|Overall Study|Lack of Efficacy|90|||
23687450|NCT00749190|66232878|FG005|Overall Study|Protocol Violation|0|||
23687451|NCT00749190|66232879|FG006|Overall Study|Protocol Violation|1|||
23687452|NCT00749190|66232873|FG000|Overall Study|Other reason not defined above|0|||
23687453|NCT00749190|66232874|FG001|Overall Study|Other reason not defined above|0|||
23687454|NCT00749190|66232875|FG002|Overall Study|Other reason not defined above|0|||
23687455|NCT00749190|66232876|FG003|Overall Study|Other reason not defined above|1|||
23687456|NCT00749190|66232877|FG004|Overall Study|Other reason not defined above|0|||
23687457|NCT00749190|66232878|FG005|Overall Study|Other reason not defined above|0|||
23687458|NCT00749190|66232879|FG006|Overall Study|Other reason not defined above|0|||
23687459|NCT00943683|66232884|FG000|Overall Study|Adverse Event|3|||
23687460|NCT00943683|66232885|FG001|Overall Study|Adverse Event|3|||
23687461|NCT00943683|66232884|FG000|Overall Study|Lost to Follow-up|1|||
23687462|NCT00943683|66232885|FG001|Overall Study|Lost to Follow-up|1|||
23687463|NCT00943683|66232884|FG000|Overall Study|Protocol Violation|1|||
23687464|NCT00943683|66232885|FG001|Overall Study|Protocol Violation|2|||
23687465|NCT00943683|66232884|FG000|Overall Study|Withdrawal by Subject|1|||
23687466|NCT00943683|66232885|FG001|Overall Study|Withdrawal by Subject|0|||
23687467|NCT00943683|66232884|FG000|Overall Study|Patient Moved|1|||
23687468|NCT00943683|66232885|FG001|Overall Study|Patient Moved|0|||
23687469|NCT00828451|66232898|FG000|Overall Study|Death|2|||
23687470|NCT00828451|66232898|FG000|Overall Study|Lack of intravenous line|7|||
23687471|NCT00828451|66232898|FG000|Overall Study|Withdrawal by Subject|1|||
23687472|NCT00828451|66232898|FG000|Overall Study|Deterioration in clinical status|1|||
23687473|NCT01624194|66232900|FG000|Overall Study|Lost to Follow-up|1|||
23687474|NCT01624194|66232901|FG001|Overall Study|Lost to Follow-up|0|||
23687475|NCT01624194|66232900|FG000|Overall Study|Withdrawal by Subject|1|||
23687476|NCT01624194|66232901|FG001|Overall Study|Withdrawal by Subject|0|||
23687477|NCT01445171|66232902|FG000|Overall Study|Lost to Follow-up|11|||
23687478|NCT01445171|66232902|FG000|Overall Study|Withdrawal by Subject|16|||
23687479|NCT01445171|66232902|FG000|Overall Study|Death|51|||
23687480|NCT01445171|66232902|FG000|Overall Study|Subjects declined to return for followup|9|||
23687481|NCT01445171|66232902|FG000|Overall Study|Consented but did not receive device|8|||
23687482|NCT01361711|66232904|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
23687483|NCT01361711|66232904|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
23687484|NCT01361711|66232904|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
23687485|NCT01361711|66232904|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
23687486|NCT01361711|66232904|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
23687487|NCT01361711|66232904|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
23687488|NCT01361711|66232904|FG000|Completed Week 18 of Treatment|Other|9|||
23687489|NCT01361711|66232904|FG000|10 Year Follow-up|Still in follow-up|22|||
23687490|NCT01361711|66232904|FG000|10 Year Follow-up|Death|7|||
23687491|NCT01361711|66232904|FG000|10 Year Follow-up|Developed new cancer|1|||
23687492|NCT01361711|66232904|FG000|10 Year Follow-up|Lost to Follow-up|2|||
23687493|NCT01361711|66232904|FG000|10 Year Follow-up|New treatment started|6|||
23687494|NCT01361711|66232904|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
23687495|NCT01361711|66232904|FG000|10 Year Follow-up|Progressive Disease|1|||
23687496|NCT01111604|66232905|FG000|Overall Study|Lost to Follow-up|0|||
23687497|NCT01111604|66232906|FG001|Overall Study|Lost to Follow-up|0|||
23687498|NCT01111604|66232907|FG002|Overall Study|Lost to Follow-up|1|||
23687499|NCT01111604|66232905|FG000|Overall Study|Withdrew Consent|3|||
23687500|NCT01111604|66232906|FG001|Overall Study|Withdrew Consent|0|||
23687501|NCT01111604|66232907|FG002|Overall Study|Withdrew Consent|2|||
23687502|NCT01111604|66232905|FG000|Overall Study|Withdrawal by Subject|2|||
23687503|NCT01111604|66232906|FG001|Overall Study|Withdrawal by Subject|0|||
23687504|NCT01111604|66232907|FG002|Overall Study|Withdrawal by Subject|0|||
23687505|NCT01111604|66232905|FG000|Overall Study|Death|1|||
23687506|NCT01111604|66232906|FG001|Overall Study|Death|0|||
23687507|NCT01111604|66232907|FG002|Overall Study|Death|0|||
23687508|NCT01111604|66232905|FG000|Overall Study|Met Exclusion Criteria|2|||
23687509|NCT01111604|66232906|FG001|Overall Study|Met Exclusion Criteria|0|||
23687510|NCT01111604|66232907|FG002|Overall Study|Met Exclusion Criteria|0|||
23687511|NCT00712348|66232908|FG000|Overall Study|Withdrawal by Subject|1|||
23687512|NCT00891735|66232911|FG000|Overall Study|Adverse Event|2|||
23687513|NCT00891735|66232912|FG001|Overall Study|Adverse Event|0|||
23687514|NCT00891735|66232913|FG002|Overall Study|Adverse Event|2|||
23687515|NCT00891735|66232914|FG003|Overall Study|Adverse Event|0|||
23687516|NCT00891735|66232911|FG000|Overall Study|Death|8|||
23687517|NCT00891735|66232912|FG001|Overall Study|Death|5|||
23687518|NCT00891735|66232913|FG002|Overall Study|Death|4|||
23687519|NCT00891735|66232914|FG003|Overall Study|Death|5|||
23687520|NCT00891735|66232911|FG000|Overall Study|Lost to Follow-up|2|||
23687521|NCT00891735|66232912|FG001|Overall Study|Lost to Follow-up|2|||
23687522|NCT00891735|66232913|FG002|Overall Study|Lost to Follow-up|2|||
23687523|NCT00891735|66232914|FG003|Overall Study|Lost to Follow-up|2|||
23687524|NCT00891735|66232911|FG000|Overall Study|Physician's decision to withdraw patient|1|||
23687525|NCT00891735|66232912|FG001|Overall Study|Physician's decision to withdraw patient|0|||
23687526|NCT00891735|66232913|FG002|Overall Study|Physician's decision to withdraw patient|0|||
23687527|NCT00891735|66232914|FG003|Overall Study|Physician's decision to withdraw patient|0|||
23687528|NCT00891735|66232911|FG000|Overall Study|Patient's decision to withdraw|4|||
23687529|NCT00891735|66232912|FG001|Overall Study|Patient's decision to withdraw|9|||
23687530|NCT00891735|66232913|FG002|Overall Study|Patient's decision to withdraw|4|||
23687531|NCT00891735|66232914|FG003|Overall Study|Patient's decision to withdraw|8|||
23687532|NCT01145560|66232917|FG000|Overall Study|Withdrawal by Subject|2|||
23687533|NCT01145560|66232918|FG001|Overall Study|Withdrawal by Subject|1|||
23687534|NCT01145560|66232919|FG002|Overall Study|Withdrawal by Subject|0|||
23687535|NCT01145560|66232917|FG000|Overall Study|Lost to Follow-up|1|||
23687536|NCT01145560|66232918|FG001|Overall Study|Lost to Follow-up|1|||
23687537|NCT01145560|66232919|FG002|Overall Study|Lost to Follow-up|1|||
23687538|NCT01145560|66232917|FG000|Overall Study|No study drug by 24h after organ failure|1|||
23687539|NCT01145560|66232918|FG001|Overall Study|No study drug by 24h after organ failure|0|||
23687540|NCT01145560|66232919|FG002|Overall Study|No study drug by 24h after organ failure|0|||
23687541|NCT01145560|66232917|FG000|Overall Study|Accidental unblinding of study treatment|0|||
23687542|NCT01145560|66232918|FG001|Overall Study|Accidental unblinding of study treatment|1|||
23687543|NCT01145560|66232919|FG002|Overall Study|Accidental unblinding of study treatment|0|||
23687544|NCT01145560|66232917|FG000|Overall Study|False insurance information|0|||
23687545|NCT01145560|66232918|FG001|Overall Study|False insurance information|1|||
23687546|NCT01145560|66232919|FG002|Overall Study|False insurance information|0|||
23687547|NCT01145560|66232917|FG000|Overall Study|Withdrawal of therapy|0|||
23687548|NCT01145560|66232918|FG001|Overall Study|Withdrawal of therapy|0|||
23687549|NCT01145560|66232919|FG002|Overall Study|Withdrawal of therapy|1|||
23687550|NCT01264939|66232933|FG000|Overall Study|Adverse Event|1|||
23687551|NCT01264939|66232934|FG001|Overall Study|Adverse Event|3|||
23687552|NCT01264939|66232933|FG000|Overall Study|Lost to Follow-up|0|||
23687553|NCT01264939|66232934|FG001|Overall Study|Lost to Follow-up|3|||
23687554|NCT01264939|66232933|FG000|Overall Study|Physician Decision|1|||
23687555|NCT01264939|66232934|FG001|Overall Study|Physician Decision|1|||
23687556|NCT01264939|66232933|FG000|Overall Study|Patient/Guardian Decision|8|||
23687557|NCT01264939|66232934|FG001|Overall Study|Patient/Guardian Decision|10|||
23687558|NCT01264939|66232933|FG000|Overall Study|Disease Progression|8|||
23687559|NCT01264939|66232934|FG001|Overall Study|Disease Progression|11|||
23687560|NCT02928952|66232935|FG000|Overall Study|Lost to Follow-up|5|||
23687561|NCT02928952|66232936|FG001|Overall Study|Lost to Follow-up|5|||
23687562|NCT02928952|66232935|FG000|Overall Study|Withdrawal by Subject|5|||
23687563|NCT02928952|66232936|FG001|Overall Study|Withdrawal by Subject|1|||
23687564|NCT02928952|66232935|FG000|Overall Study|Physician Decision|0|||
23687565|NCT02928952|66232936|FG001|Overall Study|Physician Decision|1|||
23687566|NCT01499290|66232937|FG000|Overall Study|Withdrawal by Subject|22|||
23687567|NCT01499290|66232938|FG001|Overall Study|Withdrawal by Subject|15|||
23687568|NCT01499290|66232937|FG000|Overall Study|Not specified in study report|11|||
23687569|NCT01499290|66232938|FG001|Overall Study|Not specified in study report|5|||
23687570|NCT01499290|66232937|FG000|Overall Study|Condition improved/subject recovered|1|||
23687571|NCT01499290|66232938|FG001|Overall Study|Condition improved/subject recovered|0|||
23687572|NCT01499290|66232937|FG000|Overall Study|Lack of Efficacy|7|||
23687573|NCT01499290|66232938|FG001|Overall Study|Lack of Efficacy|8|||
23687574|NCT01499290|66232937|FG000|Overall Study|Adverse Event|14|||
23687575|NCT01499290|66232938|FG001|Overall Study|Adverse Event|7|||
23687576|NCT00768222|66232939|FG000|Overall Study|Lost to Follow-up|1|||
23687577|NCT00768222|66232940|FG001|Overall Study|Lost to Follow-up|1|||
23687578|NCT00768222|66232939|FG000|Overall Study|Withdrawal by Subject|3|||
23687579|NCT00768222|66232940|FG001|Overall Study|Withdrawal by Subject|1|||
23687580|NCT00768222|66232939|FG000|Overall Study|Protocol Violation|0|||
23687581|NCT00768222|66232940|FG001|Overall Study|Protocol Violation|2|||
23687582|NCT01642212|66232943|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
23687583|NCT01642212|66232944|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23687584|NCT01642212|66232945|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23687585|NCT01642212|66232946|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23687586|NCT01642212|66232947|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23687587|NCT01642212|66232943|FG000|Double-blind Treatment|Other|0|||
23687588|NCT01642212|66232944|FG001|Double-blind Treatment|Other|2|||
23687589|NCT01642212|66232945|FG002|Double-blind Treatment|Other|1|||
23687590|NCT01642212|66232946|FG003|Double-blind Treatment|Other|0|||
23687591|NCT01642212|66232947|FG004|Double-blind Treatment|Other|0|||
23687592|NCT01642212|66232943|FG000|Double-blind Treatment|Non-compliance|0|||
23687593|NCT01642212|66232944|FG001|Double-blind Treatment|Non-compliance|1|||
23687594|NCT01642212|66232945|FG002|Double-blind Treatment|Non-compliance|0|||
23687595|NCT01642212|66232946|FG003|Double-blind Treatment|Non-compliance|0|||
23687596|NCT01642212|66232947|FG004|Double-blind Treatment|Non-compliance|0|||
23687597|NCT01642212|66232943|FG000|Double-blind Treatment|Adverse Event|0|||
23687598|NCT01642212|66232944|FG001|Double-blind Treatment|Adverse Event|0|||
23687599|NCT01642212|66232945|FG002|Double-blind Treatment|Adverse Event|1|||
23687600|NCT01642212|66232946|FG003|Double-blind Treatment|Adverse Event|0|||
23687601|NCT01642212|66232947|FG004|Double-blind Treatment|Adverse Event|0|||
23687602|NCT01642212|66232943|FG000|Open-label Extension|Adverse Event|0|||
23687603|NCT01642212|66232944|FG001|Open-label Extension|Adverse Event|0|||
23687604|NCT01642212|66232945|FG002|Open-label Extension|Adverse Event|0|||
23687605|NCT01642212|66232946|FG003|Open-label Extension|Adverse Event|3|||
23687606|NCT01642212|66232947|FG004|Open-label Extension|Adverse Event|0|||
23687607|NCT01642212|66232943|FG000|Open-label Extension|Sponsor Decision|0|||
23687608|NCT01642212|66232944|FG001|Open-label Extension|Sponsor Decision|0|||
23687609|NCT01642212|66232945|FG002|Open-label Extension|Sponsor Decision|0|||
23687610|NCT01642212|66232946|FG003|Open-label Extension|Sponsor Decision|7|||
23687611|NCT01642212|66232947|FG004|Open-label Extension|Sponsor Decision|4|||
23687612|NCT01642212|66232943|FG000|Open-label Extension|Consent Withdrawn|0|||
23687613|NCT01642212|66232944|FG001|Open-label Extension|Consent Withdrawn|0|||
23687614|NCT01642212|66232945|FG002|Open-label Extension|Consent Withdrawn|0|||
23687615|NCT01642212|66232946|FG003|Open-label Extension|Consent Withdrawn|0|||
23687616|NCT01642212|66232947|FG004|Open-label Extension|Consent Withdrawn|2|||
23687617|NCT01642212|66232943|FG000|Open-label Extension|Lost to Follow-up|0|||
23687618|NCT01642212|66232944|FG001|Open-label Extension|Lost to Follow-up|0|||
23687619|NCT01642212|66232945|FG002|Open-label Extension|Lost to Follow-up|0|||
23687620|NCT01642212|66232946|FG003|Open-label Extension|Lost to Follow-up|0|||
23687621|NCT01642212|66232947|FG004|Open-label Extension|Lost to Follow-up|1|||
23687622|NCT01642212|66232943|FG000|Open-label Extension|Other|0|||
23687623|NCT01642212|66232944|FG001|Open-label Extension|Other|0|||
23687624|NCT01642212|66232945|FG002|Open-label Extension|Other|0|||
23687625|NCT01642212|66232946|FG003|Open-label Extension|Other|0|||
23687626|NCT01642212|66232947|FG004|Open-label Extension|Other|1|||
23687627|NCT01946178|66232958|FG000|Overall Study|Pregnancy|1|||
23687628|NCT01946178|66232958|FG000|Overall Study|Lost to Follow-up|1|||
23687629|NCT00666562|66232961|FG000|Overall Study|Withdrawal by Subject|0|||
23687630|NCT00666562|66232962|FG001|Overall Study|Withdrawal by Subject|1|||
23687631|NCT00666562|66232963|FG002|Overall Study|Withdrawal by Subject|0|||
23687632|NCT00666562|66232961|FG000|Overall Study|Concomitant Medication|0|||
23687633|NCT00666562|66232962|FG001|Overall Study|Concomitant Medication|1|||
23687634|NCT00666562|66232963|FG002|Overall Study|Concomitant Medication|0|||
23687635|NCT01147809|66232964|FG000|Phase I (168 Days)|Adverse Event|0|||
23687636|NCT01147809|66232965|FG001|Phase I (168 Days)|Adverse Event|0|||
23687637|NCT01147809|66232966|FG002|Phase I (168 Days)|Adverse Event|0|||
23687638|NCT01147809|66232967|FG003|Phase I (168 Days)|Adverse Event|1|||
23687639|NCT01147809|66232968|FG004|Phase I (168 Days)|Adverse Event|0|||
23687640|NCT01147809|66232969|FG005|Phase I (168 Days)|Adverse Event|0|||
23687641|NCT01147809|66232964|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
23687642|NCT01147809|66232965|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
23687643|NCT01147809|66232966|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
23687644|NCT01147809|66232967|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
23687645|NCT01147809|66232968|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
23687646|NCT01147809|66232969|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
23687647|NCT01147809|66232964|FG000|Phase I (168 Days)|Physician Decision|0|||
23687648|NCT01147809|66232965|FG001|Phase I (168 Days)|Physician Decision|1|||
23687649|NCT01147809|66232966|FG002|Phase I (168 Days)|Physician Decision|2|||
23687650|NCT01147809|66232967|FG003|Phase I (168 Days)|Physician Decision|0|||
23687651|NCT01147809|66232968|FG004|Phase I (168 Days)|Physician Decision|0|||
23687652|NCT01147809|66232969|FG005|Phase I (168 Days)|Physician Decision|0|||
23687653|NCT01147809|66232964|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
23687654|NCT01147809|66232965|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
23687655|NCT01147809|66232966|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
23687656|NCT01147809|66232967|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
23687657|NCT01147809|66232968|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
23687658|NCT01147809|66232969|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
23687659|NCT01147809|66232964|FG000|Phase II (168 Days)|Adverse Event|0|||
23687660|NCT01147809|66232965|FG001|Phase II (168 Days)|Adverse Event|0|||
23687661|NCT01147809|66232966|FG002|Phase II (168 Days)|Adverse Event|0|||
23687662|NCT01147809|66232967|FG003|Phase II (168 Days)|Adverse Event|0|||
23687663|NCT01147809|66232968|FG004|Phase II (168 Days)|Adverse Event|3|||
23687664|NCT01147809|66232969|FG005|Phase II (168 Days)|Adverse Event|6|||
23687665|NCT01147809|66232964|FG000|Phase II (168 Days)|Protocol Violation|0|||
23687666|NCT01147809|66232965|FG001|Phase II (168 Days)|Protocol Violation|0|||
23687667|NCT01147809|66232966|FG002|Phase II (168 Days)|Protocol Violation|0|||
23687668|NCT01147809|66232967|FG003|Phase II (168 Days)|Protocol Violation|0|||
23393647|NCT01313676|65189372|FG002|Overall Study|Lack of Efficacy|65|||
23687669|NCT01147809|66232968|FG004|Phase II (168 Days)|Protocol Violation|0|||
23687670|NCT01147809|66232969|FG005|Phase II (168 Days)|Protocol Violation|1|||
23687671|NCT01147809|66232964|FG000|Phase II (168 Days)|Physician Decision|0|||
23687672|NCT01147809|66232965|FG001|Phase II (168 Days)|Physician Decision|0|||
23687673|NCT01147809|66232966|FG002|Phase II (168 Days)|Physician Decision|0|||
23393648|NCT01313676|65189373|FG003|Overall Study|Lack of Efficacy|46|||
23687674|NCT01147809|66232967|FG003|Phase II (168 Days)|Physician Decision|0|||
23393649|NCT01313676|65189370|FG000|Overall Study|Protocol Violation|37|||
23687675|NCT01147809|66232968|FG004|Phase II (168 Days)|Physician Decision|5|||
23393650|NCT01313676|65189371|FG001|Overall Study|Protocol Violation|44|||
23687676|NCT01147809|66232969|FG005|Phase II (168 Days)|Physician Decision|11|||
23687677|NCT01147809|66232964|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
23687678|NCT01147809|66232965|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
23687679|NCT01147809|66232966|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
23687680|NCT01147809|66232967|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
23687681|NCT01147809|66232968|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
23687682|NCT01147809|66232969|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
23687683|NCT01147809|66232964|FG000|Phase II (168 Days)|Ongoing|0|||
23687684|NCT01147809|66232965|FG001|Phase II (168 Days)|Ongoing|0|||
23687685|NCT01147809|66232966|FG002|Phase II (168 Days)|Ongoing|0|||
23687686|NCT01147809|66232967|FG003|Phase II (168 Days)|Ongoing|0|||
23687687|NCT01147809|66232968|FG004|Phase II (168 Days)|Ongoing|1|||
23687688|NCT01147809|66232969|FG005|Phase II (168 Days)|Ongoing|0|||
23687689|NCT00603239|66232972|FG000|Overall Study|Adverse Event|4|||
23687690|NCT00603239|66232973|FG001|Overall Study|Adverse Event|1|||
23687691|NCT00603239|66232972|FG000|Overall Study|Entry criteria not met|0|||
23687692|NCT00603239|66232973|FG001|Overall Study|Entry criteria not met|1|||
23687693|NCT00603239|66232972|FG000|Overall Study|Loss of glucose control|3|||
23687694|NCT00603239|66232973|FG001|Overall Study|Loss of glucose control|0|||
23687695|NCT00603239|66232972|FG000|Overall Study|Lost to Follow-up|2|||
23687696|NCT00603239|66232973|FG001|Overall Study|Lost to Follow-up|1|||
23687697|NCT00603239|66232972|FG000|Overall Study|Physician Decision|2|||
23687698|NCT00603239|66232973|FG001|Overall Study|Physician Decision|0|||
23687699|NCT00603239|66232972|FG000|Overall Study|Protocol Violation|2|||
23687700|NCT00603239|66232973|FG001|Overall Study|Protocol Violation|0|||
23687701|NCT00603239|66232972|FG000|Overall Study|Subject decision|2|||
23687702|NCT00603239|66232973|FG001|Overall Study|Subject decision|1|||
23687703|NCT00928070|66232974|FG000|Overall Study|Lost to Follow-up|1|||
23687704|NCT00928070|66232975|FG001|Overall Study|Lost to Follow-up|2|||
23687705|NCT00928070|66232974|FG000|Overall Study|Withdrawal by Subject|10|||
23687706|NCT00928070|66232975|FG001|Overall Study|Withdrawal by Subject|3|||
23687707|NCT00928070|66232974|FG000|Overall Study|Adverse Event|14|||
23687708|NCT00928070|66232975|FG001|Overall Study|Adverse Event|26|||
23687709|NCT00928070|66232974|FG000|Overall Study|Lack of Efficacy|9|||
23687710|NCT00928070|66232975|FG001|Overall Study|Lack of Efficacy|5|||
23687711|NCT00928070|66232974|FG000|Overall Study|Did not meet entrance criteria|16|||
23687712|NCT00928070|66232975|FG001|Overall Study|Did not meet entrance criteria|9|||
23687713|NCT00928070|66232974|FG000|Overall Study|Protocol Violation|6|||
23687714|NCT00928070|66232975|FG001|Overall Study|Protocol Violation|5|||
23687715|NCT00928070|66232974|FG000|Overall Study|Randomized but not treated|2|||
23687716|NCT00928070|66232975|FG001|Overall Study|Randomized but not treated|2|||
23687717|NCT00928070|66232974|FG000|Overall Study|Other|5|||
23687718|NCT00928070|66232975|FG001|Overall Study|Other|5|||
23687719|NCT01822561|66232976|FG000|Overall Study|Withdrawal by Subject|2|||
23687720|NCT04525703|66232977|FG000|Overall Study|Lost to Follow-up|6|||
23687721|NCT04525703|66232978|FG001|Overall Study|Lost to Follow-up|15|||
23687722|NCT04525703|66232979|FG002|Overall Study|Lost to Follow-up|8|||
23687723|NCT01412879|66232980|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
23687724|NCT01412879|66232981|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
23687725|NCT01412879|66232982|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
23687726|NCT01412879|66232980|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
23687727|NCT01412879|66232981|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
23687728|NCT01412879|66232982|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
23687729|NCT01412879|66232980|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
23687730|NCT01412879|66232981|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
23687731|NCT01412879|66232982|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
23687732|NCT01412879|66232980|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
23687733|NCT01412879|66232981|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
23687734|NCT01412879|66232982|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
23687735|NCT01412879|66232980|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
23687736|NCT01412879|66232981|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
23687737|NCT01412879|66232982|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
23687738|NCT03502187|66232983|FG000|Overall Study|Withdrawal by Subject|4|||
23687739|NCT03502187|66232984|FG001|Overall Study|Withdrawal by Subject|3|||
23687740|NCT03502187|66232985|FG002|Overall Study|Withdrawal by Subject|3|||
23687741|NCT03502187|66232983|FG000|Overall Study|Lost to Follow-up|5|||
23687742|NCT03502187|66232984|FG001|Overall Study|Lost to Follow-up|4|||
23687743|NCT03502187|66232985|FG002|Overall Study|Lost to Follow-up|5|||
23687744|NCT01228747|66232986|FG000|Overall Study|Adverse Event|8|||
23687745|NCT01228747|66232987|FG001|Overall Study|Adverse Event|4|||
23393651|NCT01313676|65189372|FG002|Overall Study|Protocol Violation|46|||
23687746|NCT01228747|66232986|FG000|Overall Study|Lack of Efficacy|40|||
23687747|NCT01228747|66232987|FG001|Overall Study|Lack of Efficacy|27|||
23393652|NCT01313676|65189373|FG003|Overall Study|Protocol Violation|44|||
23393653|NCT01313676|65189370|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
23393654|NCT01313676|65189371|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
23687748|NCT01228747|66232986|FG000|Overall Study|Protocol Violation|6|||
23687749|NCT01228747|66232987|FG001|Overall Study|Protocol Violation|5|||
23687750|NCT01228747|66232986|FG000|Overall Study|Lost to Follow-up|4|||
23687751|NCT01228747|66232987|FG001|Overall Study|Lost to Follow-up|3|||
23687752|NCT01228747|66232986|FG000|Overall Study|Withdrawal by Subject|5|||
23687753|NCT01228747|66232987|FG001|Overall Study|Withdrawal by Subject|1|||
23687754|NCT01228747|66232986|FG000|Overall Study|Other Reason|2|||
23687755|NCT01228747|66232987|FG001|Overall Study|Other Reason|5|||
23687756|NCT00716976|66232988|FG000|Overall Study|Adverse Event|2|||
23687757|NCT00716976|66232989|FG001|Overall Study|Adverse Event|0|||
23687758|NCT00716976|66232988|FG000|Overall Study|Death|1|||
23687759|NCT00716976|66232989|FG001|Overall Study|Death|0|||
23687760|NCT00716976|66232988|FG000|Overall Study|Physician Decision|2|||
23687761|NCT00716976|66232989|FG001|Overall Study|Physician Decision|2|||
23687762|NCT00716976|66232988|FG000|Overall Study|Withdrawal by Subject|5|||
23687763|NCT00716976|66232989|FG001|Overall Study|Withdrawal by Subject|1|||
23687764|NCT00716976|66232988|FG000|Overall Study|Premature discontinuation cisplatin|5|||
23687765|NCT00716976|66232989|FG001|Overall Study|Premature discontinuation cisplatin|4|||
23687766|NCT00716976|66232988|FG000|Overall Study|Radiation during protocol|1|||
23687767|NCT00716976|66232989|FG001|Overall Study|Radiation during protocol|0|||
23687768|NCT00716976|66232988|FG000|Overall Study|Ineligibles|4|||
23687769|NCT00716976|66232989|FG001|Overall Study|Ineligibles|2|||
23687770|NCT01151137|66232990|FG000|Overall Study|Death|15|||
23687771|NCT01151137|66232991|FG001|Overall Study|Death|27|||
23687772|NCT01151137|66232990|FG000|Overall Study|Lost to Follow-up|1|||
23687773|NCT01151137|66232991|FG001|Overall Study|Lost to Follow-up|1|||
23687774|NCT02945657|66232992|FG000|Overall Study|Adverse Event|1|||
23687775|NCT02945657|66232992|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23687776|NCT00275561|66232993|FG000|Overall Study|Withdrawal by Subject|0|||
23687777|NCT00275561|66232994|FG001|Overall Study|Withdrawal by Subject|1|||
23687778|NCT00275561|66232993|FG000|Overall Study|Travel|1|||
23687779|NCT00275561|66232994|FG001|Overall Study|Travel|1|||
23687780|NCT00275561|66232993|FG000|Overall Study|Scheduling|1|||
23687781|NCT00275561|66232994|FG001|Overall Study|Scheduling|2|||
23687782|NCT00275561|66232993|FG000|Overall Study|Family Issues|0|||
23687783|NCT00275561|66232994|FG001|Overall Study|Family Issues|2|||
23687784|NCT02370121|66232995|FG000|Overall Study|Lost to Follow-up|1|||
23687785|NCT02370121|66232996|FG001|Overall Study|Lost to Follow-up|1|||
23687786|NCT01427309|66232997|FG000|Overall Study|Lost to Follow-up|130|||
23687787|NCT01427309|66232998|FG001|Overall Study|Lost to Follow-up|145|||
23687788|NCT01427309|66232999|FG002|Overall Study|Lost to Follow-up|122|||
23687789|NCT01427309|66233000|FG003|Overall Study|Lost to Follow-up|135|||
23687790|NCT01427309|66232997|FG000|Overall Study|Protocol Violation|42|||
23687791|NCT01427309|66232998|FG001|Overall Study|Protocol Violation|69|||
23687792|NCT01427309|66232999|FG002|Overall Study|Protocol Violation|125|||
23687793|NCT01427309|66233000|FG003|Overall Study|Protocol Violation|124|||
23687794|NCT01427309|66232997|FG000|Overall Study|Adverse Event|0|||
23687795|NCT01427309|66232998|FG001|Overall Study|Adverse Event|0|||
23687796|NCT01427309|66232999|FG002|Overall Study|Adverse Event|3|||
23687797|NCT01427309|66233000|FG003|Overall Study|Adverse Event|1|||
23687798|NCT01427309|66232997|FG000|Overall Study|Serious adverse event|52|||
23687799|NCT01427309|66232998|FG001|Overall Study|Serious adverse event|45|||
23687800|NCT01427309|66232999|FG002|Overall Study|Serious adverse event|50|||
23687801|NCT01427309|66233000|FG003|Overall Study|Serious adverse event|61|||
23687802|NCT01427309|66232997|FG000|Overall Study|Withdrawal by Subject|148|||
23687803|NCT01427309|66232998|FG001|Overall Study|Withdrawal by Subject|148|||
23687804|NCT01427309|66232999|FG002|Overall Study|Withdrawal by Subject|61|||
23687805|NCT01427309|66233000|FG003|Overall Study|Withdrawal by Subject|55|||
23687806|NCT01157117|66233003|FG000|Overall Study|Dosing Symptoms|0|||
23687807|NCT01157117|66233004|FG001|Overall Study|Dosing Symptoms|4|||
23687808|NCT01157117|66233005|FG002|Overall Study|Dosing Symptoms|0|||
23687809|NCT01157117|66233003|FG000|Overall Study|Withdrawal by Subject|4|||
23687810|NCT01157117|66233004|FG001|Overall Study|Withdrawal by Subject|1|||
23687811|NCT01157117|66233005|FG002|Overall Study|Withdrawal by Subject|1|||
23687812|NCT01157117|66233003|FG000|Overall Study|Lack of Efficacy|1|||
23687813|NCT01157117|66233004|FG001|Overall Study|Lack of Efficacy|1|||
23687814|NCT01157117|66233005|FG002|Overall Study|Lack of Efficacy|0|||
23687815|NCT01157117|66233003|FG000|Overall Study|Lost to Follow-up|0|||
23687816|NCT01157117|66233004|FG001|Overall Study|Lost to Follow-up|0|||
23687817|NCT01157117|66233005|FG002|Overall Study|Lost to Follow-up|1|||
23687818|NCT01157117|66233003|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
23687819|NCT01157117|66233004|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
23687820|NCT01157117|66233005|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
23687821|NCT01287104|66233006|FG000|Overall Study|Patient developed progressive disease|1|||
23687822|NCT01287104|66233007|FG001|Overall Study|Patient developed progressive disease|1|||
23687823|NCT01287104|66233008|FG002|Overall Study|Patient developed progressive disease|3|||
23687824|NCT01287104|66233009|FG003|Overall Study|Patient developed progressive disease|2|||
23687825|NCT01287104|66233006|FG000|Overall Study|Donor anaphylaxis|0|||
23687826|NCT01287104|66233007|FG001|Overall Study|Donor anaphylaxis|1|||
23687827|NCT01287104|66233008|FG002|Overall Study|Donor anaphylaxis|0|||
23687828|NCT01287104|66233009|FG003|Overall Study|Donor anaphylaxis|1|||
23687829|NCT01287104|66233006|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
23687830|NCT01287104|66233007|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
23687831|NCT01287104|66233008|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
23687832|NCT01287104|66233009|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
23687833|NCT01287104|66233006|FG000|Overall Study|Low donor chimerism|0|||
23687834|NCT01287104|66233007|FG001|Overall Study|Low donor chimerism|1|||
23687835|NCT01287104|66233008|FG002|Overall Study|Low donor chimerism|0|||
23687836|NCT01287104|66233009|FG003|Overall Study|Low donor chimerism|0|||
23687837|NCT01287104|66233006|FG000|Overall Study|NK cells did not meet release criteria|0|||
23687838|NCT01287104|66233007|FG001|Overall Study|NK cells did not meet release criteria|1|||
23687839|NCT01287104|66233008|FG002|Overall Study|NK cells did not meet release criteria|0|||
23687840|NCT01287104|66233009|FG003|Overall Study|NK cells did not meet release criteria|0|||
23687841|NCT00191854|66233015|FG000|Overall Study|Death|26|||
23687842|NCT00191854|66233016|FG001|Overall Study|Death|23|||
23687843|NCT00191854|66233017|FG002|Overall Study|Death|29|||
23393655|NCT01313676|65189372|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
23393656|NCT01313676|65189373|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
23393657|NCT01313676|65189370|FG000|Overall Study|Study Closed/terminated|7|||
23393658|NCT01313676|65189371|FG001|Overall Study|Study Closed/terminated|6|||
23393659|NCT01313676|65189372|FG002|Overall Study|Study Closed/terminated|9|||
23393660|NCT01313676|65189373|FG003|Overall Study|Study Closed/terminated|9|||
23393661|NCT01313676|65189370|FG000|Overall Study|Lost to Follow-up|0|||
23393662|NCT01313676|65189371|FG001|Overall Study|Lost to Follow-up|0|||
23393663|NCT01313676|65189372|FG002|Overall Study|Lost to Follow-up|1|||
23393664|NCT01313676|65189373|FG003|Overall Study|Lost to Follow-up|0|||
23393665|NCT01313676|65189370|FG000|Overall Study|Physician Decision|53|||
23393666|NCT01313676|65189371|FG001|Overall Study|Physician Decision|64|||
23393667|NCT01313676|65189372|FG002|Overall Study|Physician Decision|62|||
23393668|NCT01313676|65189373|FG003|Overall Study|Physician Decision|48|||
23393669|NCT01313676|65189370|FG000|Overall Study|Decision by Participant or Proxy|643|||
23393670|NCT01313676|65189371|FG001|Overall Study|Decision by Participant or Proxy|527|||
23393671|NCT01313676|65189372|FG002|Overall Study|Decision by Participant or Proxy|515|||
23393672|NCT01313676|65189373|FG003|Overall Study|Decision by Participant or Proxy|492|||
23393673|NCT01313676|65189370|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
23393674|NCT01313676|65189371|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
23393675|NCT01313676|65189372|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
23393676|NCT01313676|65189373|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
23393677|NCT01313676|65189370|FG000|Overall Study|Investigator Site Closed|12|||
23393678|NCT01313676|65189371|FG001|Overall Study|Investigator Site Closed|11|||
23393679|NCT01313676|65189372|FG002|Overall Study|Investigator Site Closed|15|||
23393680|NCT01313676|65189373|FG003|Overall Study|Investigator Site Closed|10|||
23393681|NCT01313676|65189370|FG000|Overall Study|Missing|1|||
23393682|NCT01313676|65189371|FG001|Overall Study|Missing|1|||
23393683|NCT01313676|65189372|FG002|Overall Study|Missing|1|||
23393684|NCT01313676|65189373|FG003|Overall Study|Missing|0|||
23393685|NCT01554904|65189374|FG000|Overall Study|Withdrawal by Subject|3|||
23393686|NCT01554904|65189374|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
23393687|NCT00137449|65189377|FG000|Overall Study|Disease Progression|8|||
23393688|NCT00137449|65189378|FG001|Overall Study|Disease Progression|13|||
23393689|NCT00137449|65189377|FG000|Overall Study|Death|4|||
23393690|NCT00137449|65189378|FG001|Overall Study|Death|3|||
23393691|NCT00137449|65189377|FG000|Overall Study|Adverse Event|3|||
23393692|NCT00137449|65189378|FG001|Overall Study|Adverse Event|1|||
23393693|NCT00137449|65189377|FG000|Overall Study|Withdrawal by Subject|1|||
23393694|NCT00137449|65189378|FG001|Overall Study|Withdrawal by Subject|1|||
23393695|NCT00567580|65189383|FG000|Overall Study|Protocol Violation|28|||
23393696|NCT00567580|65189384|FG001|Overall Study|Protocol Violation|24|||
23393697|NCT00567580|65189385|FG002|Overall Study|Protocol Violation|24|||
23393698|NCT00835354|65189388|FG000|First Intervention|Adverse Event|0|||
23393699|NCT00835354|65189389|FG001|First Intervention|Adverse Event|1|||
23393700|NCT02251041|65189394|FG000|Overall Study|Did not receive intervention|15|||
23393701|NCT02251041|65189395|FG001|Overall Study|Did not receive intervention|4|||
23393702|NCT02276040|65189396|FG000|Overall Study|Physician Decision|15|||
23393703|NCT02022202|65189403|FG000|Overall Study|Withdrawal by Subject|2|||
23393704|NCT02022202|65189403|FG000|Overall Study|Disease Progression|3|||
23393705|NCT02022202|65189403|FG000|Overall Study|Desire go to immediately to surgery|3|||
23393706|NCT03204812|65189404|FG000|Overall Study|Adverse Event|3|||
23393707|NCT00526799|65189410|FG000|Overall Study|Withdrawal by Subject|1|||
23393708|NCT00526799|65189411|FG001|Overall Study|Withdrawal by Subject|0|||
23393709|NCT00526799|65189410|FG000|Overall Study|Intercurrent Complicating Disease|0|||
23393710|NCT00526799|65189411|FG001|Overall Study|Intercurrent Complicating Disease|1|||
23687844|NCT00191854|66233015|FG000|Overall Study|Lost to Follow-up|7|||
23687845|NCT00191854|66233016|FG001|Overall Study|Lost to Follow-up|5|||
23393711|NCT01661595|65189413|FG000|Phase 1: Week 0-4|Adverse Event|1|||
23393712|NCT01661595|65189414|FG001|Phase 1: Week 0-4|Adverse Event|0|||
23393713|NCT01661595|65189415|FG002|Phase 1: Week 0-4|Adverse Event|0|||
23393714|NCT01661595|65189416|FG003|Phase 1: Week 0-4|Adverse Event|0|||
23393715|NCT01661595|65189413|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
23393716|NCT01661595|65189414|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
23393717|NCT01661595|65189415|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
23393718|NCT01661595|65189416|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
23393719|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393720|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393721|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
23393722|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
23393723|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393724|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
23393725|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
23393726|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393727|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393728|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
23393729|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393730|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393731|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393732|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
23393733|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
23393734|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
23393735|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393736|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393737|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
23393738|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
23393739|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
23393740|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
23393741|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
23393742|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
23393743|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
23393744|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
23393745|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
23393746|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
23687846|NCT00191854|66233017|FG002|Overall Study|Lost to Follow-up|5|||
23687847|NCT00191854|66233015|FG000|Overall Study|Withdrawal by Subject|4|||
23687848|NCT00191854|66233016|FG001|Overall Study|Withdrawal by Subject|2|||
23687849|NCT00191854|66233017|FG002|Overall Study|Withdrawal by Subject|3|||
23687850|NCT00191854|66233015|FG000|Overall Study|Sponsor Decision|0|||
23687851|NCT00191854|66233016|FG001|Overall Study|Sponsor Decision|0|||
23687852|NCT00191854|66233017|FG002|Overall Study|Sponsor Decision|1|||
23687853|NCT00191854|66233015|FG000|Overall Study|Screen Failure|0|||
23687854|NCT00191854|66233016|FG001|Overall Study|Screen Failure|0|||
23687855|NCT00191854|66233017|FG002|Overall Study|Screen Failure|1|||
23687856|NCT03068715|66233018|FG000|Overall Study|No longer met inclusion criteria|1|||
23687857|NCT03068715|66233019|FG001|Overall Study|No longer met inclusion criteria|0|||
23687858|NCT02485717|66233024|FG000|Overall Study|Lost to Follow-up|6|||
23687859|NCT02485717|66233025|FG001|Overall Study|Lost to Follow-up|0|||
23687860|NCT02485717|66233026|FG002|Overall Study|Lost to Follow-up|0|||
23687861|NCT02485717|66233024|FG000|Overall Study|Withdrawal by Subject|0|||
23687862|NCT02485717|66233025|FG001|Overall Study|Withdrawal by Subject|0|||
23687863|NCT02485717|66233026|FG002|Overall Study|Withdrawal by Subject|1|||
23687864|NCT02485717|66233024|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
23393747|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
23393748|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
23393749|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
23393750|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393751|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
23393752|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
23393753|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393754|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393755|NCT03332056|65189429|FG000|Overall Study|Incomplete questionnaires|8|||
23393756|NCT03332056|65189430|FG001|Overall Study|Incomplete questionnaires|9|||
23393757|NCT03332056|65189429|FG000|Overall Study|Passed stone prior to surgery date|1|||
23393758|NCT03332056|65189430|FG001|Overall Study|Passed stone prior to surgery date|0|||
23393759|NCT03332056|65189429|FG000|Overall Study|Did not require a ureteral stent|0|||
23393760|NCT03332056|65189430|FG001|Overall Study|Did not require a ureteral stent|1|||
23687865|NCT02485717|66233025|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
23393761|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
23393762|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
23393763|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
23393764|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
23393765|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
23393766|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
23393767|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
23393768|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
23393769|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
23393770|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
23393771|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
23393772|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
23393773|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
23393774|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
23393775|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
23393776|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
23393777|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
23393778|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
23393779|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
23393780|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
23393781|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
23393782|NCT00511199|65189437|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
23393783|NCT00511199|65189438|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
23393784|NCT00511199|65189437|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
23393785|NCT00511199|65189438|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
23393786|NCT00511199|65189437|FG000|Overall Study|Withdrawal of Informed Consent|19|||
23393787|NCT00511199|65189438|FG001|Overall Study|Withdrawal of Informed Consent|4|||
23393788|NCT00511199|65189437|FG000|Overall Study|Pregnancy|6|||
23393789|NCT00511199|65189438|FG001|Overall Study|Pregnancy|3|||
23393790|NCT00511199|65189437|FG000|Overall Study|Pregnancy Wish|16|||
23393791|NCT00511199|65189438|FG001|Overall Study|Pregnancy Wish|8|||
23393792|NCT00511199|65189437|FG000|Overall Study|Lost to Follow-up|40|||
23393793|NCT00511199|65189438|FG001|Overall Study|Lost to Follow-up|17|||
23687866|NCT02485717|66233026|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
23687867|NCT02485717|66233024|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
23687868|NCT02485717|66233025|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
23687869|NCT02485717|66233026|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
23687870|NCT01929083|66233028|FG000|Intervention 1|Lost to Follow-up|2|||
23687871|NCT01929083|66233029|FG001|Intervention 1|Lost to Follow-up|0|||
23687872|NCT01929083|66233028|FG000|Intervention 1|Nonadherent to study medications|1|||
23687873|NCT01929083|66233029|FG001|Intervention 1|Nonadherent to study medications|0|||
23687874|NCT01929083|66233028|FG000|Intervention 2|Adverse Event|0|||
23687875|NCT01929083|66233029|FG001|Intervention 2|Adverse Event|1|||
23687876|NCT03124459|66233030|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23687877|NCT03124459|66233031|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23687878|NCT03124459|66233032|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23687879|NCT03124459|66233033|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23687880|NCT03124459|66233034|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
23687881|NCT03124459|66233035|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23687882|NCT03124459|66233030|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23687883|NCT03124459|66233031|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23687884|NCT03124459|66233032|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23687885|NCT03124459|66233033|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23687886|NCT03124459|66233034|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
23687887|NCT03124459|66233035|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23687888|NCT03124459|66233030|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23687889|NCT03124459|66233031|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23687890|NCT03124459|66233032|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23687891|NCT03124459|66233033|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
23687892|NCT03124459|66233034|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
23687893|NCT03124459|66233035|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23687894|NCT03124459|66233030|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23687895|NCT03124459|66233031|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23687896|NCT03124459|66233032|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23687897|NCT03124459|66233033|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
23687898|NCT03124459|66233034|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
23687899|NCT03124459|66233035|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23687900|NCT03124459|66233030|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23393794|NCT00511199|65189437|FG000|Overall Study|Other Reason|78|||
23393795|NCT00511199|65189438|FG001|Overall Study|Other Reason|37|||
23393796|NCT03440411|65189444|FG000|Overall Study|Adverse Event|0|||
23393797|NCT03440411|65189445|FG001|Overall Study|Adverse Event|0|||
23393798|NCT03440411|65189446|FG002|Overall Study|Adverse Event|1|||
23393799|NCT03440411|65189447|FG003|Overall Study|Adverse Event|0|||
23393800|NCT03440411|65189444|FG000|Overall Study|PD|2|||
23393801|NCT03440411|65189445|FG001|Overall Study|PD|1|||
23393802|NCT03440411|65189446|FG002|Overall Study|PD|1|||
23687901|NCT03124459|66233031|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23687902|NCT03124459|66233032|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23687903|NCT03124459|66233033|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23393803|NCT03440411|65189447|FG003|Overall Study|PD|1|||
23393804|NCT03440411|65189444|FG000|Overall Study|Withdrawal by Subject|1|||
23393805|NCT03440411|65189445|FG001|Overall Study|Withdrawal by Subject|0|||
23393806|NCT03440411|65189446|FG002|Overall Study|Withdrawal by Subject|0|||
23393807|NCT03440411|65189447|FG003|Overall Study|Withdrawal by Subject|0|||
23393808|NCT03440411|65189444|FG000|Overall Study|Closed study by sponsor|0|||
23687904|NCT03124459|66233034|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23687905|NCT03124459|66233035|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
23687906|NCT03124459|66233030|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23687907|NCT03124459|66233031|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23687908|NCT03124459|66233032|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23687909|NCT03124459|66233033|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23687910|NCT03124459|66233034|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23687911|NCT03124459|66233035|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
23687912|NCT00781365|66233036|FG000|Overall Study|Withdrawal by Subject|13|||
23687913|NCT00781365|66233037|FG001|Overall Study|Withdrawal by Subject|8|||
23687914|NCT00781365|66233036|FG000|Overall Study|Did Not Attend Visit|20|||
23687915|NCT00781365|66233037|FG001|Overall Study|Did Not Attend Visit|28|||
23687916|NCT00781365|66233036|FG000|Overall Study|Language barrier|1|||
23687917|NCT00781365|66233037|FG001|Overall Study|Language barrier|0|||
23687918|NCT04026568|66233039|FG000|Overall Study|study terminated|0|||
23687919|NCT04026568|66233040|FG001|Overall Study|study terminated|1|||
23687920|NCT00609622|66233044|FG000|Overall Study|Adverse Event|14|||
23687921|NCT00609622|66233045|FG001|Overall Study|Adverse Event|10|||
23687922|NCT00609622|66233044|FG000|Overall Study|Withdrawal by Subject|4|||
23687923|NCT00609622|66233045|FG001|Overall Study|Withdrawal by Subject|20|||
23687924|NCT00609622|66233044|FG000|Overall Study|Death|1|||
23687925|NCT00609622|66233045|FG001|Overall Study|Death|4|||
23687926|NCT00609622|66233044|FG000|Overall Study|Protocol Violation|1|||
23687927|NCT00609622|66233045|FG001|Overall Study|Protocol Violation|1|||
23687928|NCT00609622|66233044|FG000|Overall Study|Objective progression or relapse|47|||
23687929|NCT00609622|66233045|FG001|Overall Study|Objective progression or relapse|41|||
23687930|NCT00609622|66233044|FG000|Overall Study|Study terminated by sponsor|16|||
23687931|NCT00609622|66233045|FG001|Overall Study|Study terminated by sponsor|3|||
23687932|NCT00609622|66233044|FG000|Overall Study|Other|7|||
23687933|NCT00609622|66233045|FG001|Overall Study|Other|14|||
23687934|NCT00609622|66233044|FG000|Overall Study|Global deterioration of health status|6|||
23687935|NCT00609622|66233045|FG001|Overall Study|Global deterioration of health status|2|||
23687936|NCT00960076|66233046|FG000|Overall Study|Adverse Event|1|||
23687937|NCT00960076|66233047|FG001|Overall Study|Adverse Event|7|||
23687938|NCT00960076|66233046|FG000|Overall Study|No longer met study criteria|1|||
23687939|NCT00960076|66233047|FG001|Overall Study|No longer met study criteria|5|||
23687940|NCT00960076|66233046|FG000|Overall Study|Withdrawal by Subject|1|||
23687941|NCT00960076|66233047|FG001|Overall Study|Withdrawal by Subject|2|||
23687942|NCT00960076|66233046|FG000|Overall Study|Lost to Follow-up|3|||
23687943|NCT00960076|66233047|FG001|Overall Study|Lost to Follow-up|3|||
23687944|NCT00960076|66233046|FG000|Overall Study|Severe non-compliance to protocol|1|||
23687945|NCT00960076|66233047|FG001|Overall Study|Severe non-compliance to protocol|2|||
23687946|NCT00960076|66233046|FG000|Overall Study|Hyperglycemia|1|||
23687947|NCT00960076|66233047|FG001|Overall Study|Hyperglycemia|5|||
23687948|NCT00960076|66233046|FG000|Overall Study|Did not attend the termination visit|0|||
23393809|NCT03440411|65189445|FG001|Overall Study|Closed study by sponsor|0|||
23687949|NCT00960076|66233047|FG001|Overall Study|Did not attend the termination visit|1|||
23687950|NCT00623831|66233050|FG000|Overall Study|Withdrawal by Subject|1|||
23687951|NCT00623831|66233051|FG001|Overall Study|Withdrawal by Subject|0|||
23687952|NCT00623831|66233050|FG000|Overall Study|Progressive Disease|0|||
23687953|NCT00623831|66233051|FG001|Overall Study|Progressive Disease|1|||
23687954|NCT01802281|66233052|FG000|Overall Study|Death|1|||
23687955|NCT01802281|66233053|FG001|Overall Study|Death|2|||
23393810|NCT03440411|65189446|FG002|Overall Study|Closed study by sponsor|0|||
23393811|NCT03440411|65189447|FG003|Overall Study|Closed study by sponsor|1|||
23393812|NCT03787615|65189449|FG000|Overall Study|Withdrawal by Subject|2|||
23687956|NCT01802281|66233052|FG000|Overall Study|Withdrawal by Subject|2|||
23687957|NCT01802281|66233053|FG001|Overall Study|Withdrawal by Subject|1|||
23687958|NCT01802281|66233052|FG000|Overall Study|Ineligible|5|||
23687959|NCT01802281|66233053|FG001|Overall Study|Ineligible|3|||
23687960|NCT02786901|66233056|FG000|Overall Study|Adverse Event|1|||
23687961|NCT02786901|66233057|FG001|Overall Study|Adverse Event|1|||
23687962|NCT02786901|66233058|FG002|Overall Study|Adverse Event|2|||
23687963|NCT02786901|66233056|FG000|Overall Study|Physician Decision|1|||
23687964|NCT02786901|66233057|FG001|Overall Study|Physician Decision|0|||
23687965|NCT02786901|66233058|FG002|Overall Study|Physician Decision|0|||
23687966|NCT02786901|66233056|FG000|Overall Study|Rescue Therapy Use|71|||
23393813|NCT03787615|65189449|FG000|Overall Study|Lost to Follow-up|2|||
23393814|NCT03468998|65189453|FG000|Overall Study|Withdrawal by Subject|1|||
23393815|NCT03468998|65189454|FG001|Overall Study|Withdrawal by Subject|1|||
23393816|NCT03468998|65189455|FG002|Overall Study|Withdrawal by Subject|0|||
23393817|NCT03468998|65189456|FG003|Overall Study|Withdrawal by Subject|4|||
23393818|NCT03468998|65189457|FG004|Overall Study|Withdrawal by Subject|1|||
23393819|NCT03468998|65189458|FG005|Overall Study|Withdrawal by Subject|0|||
23393820|NCT02943473|65189459|FG000|Overall Study|enrolled but not dosed|1|||
23393821|NCT02943473|65189459|FG000|Overall Study|screen failure|1|||
23393822|NCT02943473|65189459|FG000|Overall Study|Physician Decision|4|||
23393823|NCT05360784|65189460|FG000|Overall Study|Discontinued|25|||
23393824|NCT05360784|65189461|FG001|Overall Study|Discontinued|11|||
23393825|NCT05538728|65189462|FG000|Overall Study|Withdrawal by Subject|1|||
23393826|NCT05538728|65189463|FG001|Overall Study|Withdrawal by Subject|1|||
23393827|NCT04890509|65189464|FG000|Overall Study|Death|4|||
23393828|NCT04890509|65189465|FG001|Overall Study|Death|4|||
23393829|NCT00553254|65189474|FG000|Overall Study|Death|3|||
23393830|NCT00553254|65189475|FG001|Overall Study|Death|6|||
23393831|NCT00553254|65189476|FG002|Overall Study|Death|25|||
23393832|NCT00553254|65189474|FG000|Overall Study|Lost to Follow-up|0|||
23393833|NCT00553254|65189475|FG001|Overall Study|Lost to Follow-up|0|||
23393834|NCT00553254|65189476|FG002|Overall Study|Lost to Follow-up|2|||
23393835|NCT00553254|65189474|FG000|Overall Study|Withdrawal by Subject|2|||
23393836|NCT00553254|65189475|FG001|Overall Study|Withdrawal by Subject|0|||
23393837|NCT00553254|65189476|FG002|Overall Study|Withdrawal by Subject|2|||
23393838|NCT00553254|65189474|FG000|Overall Study|Study terminated by Sponsor|0|||
23393839|NCT00553254|65189475|FG001|Overall Study|Study terminated by Sponsor|0|||
23393840|NCT00553254|65189476|FG002|Overall Study|Study terminated by Sponsor|1|||
23393841|NCT00553254|65189474|FG000|Overall Study|Other|1|||
23393842|NCT00553254|65189475|FG001|Overall Study|Other|0|||
23393843|NCT00553254|65189476|FG002|Overall Study|Other|13|||
23393844|NCT03257657|65189479|FG000|Overall Study|Lost to Follow-up|0|||
23393845|NCT03257657|65189480|FG001|Overall Study|Lost to Follow-up|3|||
23393846|NCT03257657|65189479|FG000|Overall Study|Withdrawn|0|||
23393847|NCT03257657|65189480|FG001|Overall Study|Withdrawn|1|||
23393848|NCT03257657|65189479|FG000|Overall Study|Noted not eligible right after enrolled|0|||
23393849|NCT03257657|65189480|FG001|Overall Study|Noted not eligible right after enrolled|1|||
23393850|NCT03058952|65189482|FG000|Overall Study|Adverse Event|1|||
23393851|NCT03058952|65189483|FG001|Overall Study|Adverse Event|0|||
23393852|NCT03058952|65189482|FG000|Overall Study|Lost to Follow-up|15|||
23393853|NCT03058952|65189483|FG001|Overall Study|Lost to Follow-up|15|||
23393854|NCT03058952|65189482|FG000|Overall Study|Withdrawal by Subject|7|||
23393855|NCT03058952|65189483|FG001|Overall Study|Withdrawal by Subject|11|||
23393856|NCT00415636|65189484|FG000|Overall Study|Symptomatic deterioration|1|||
23393857|NCT00415636|65189485|FG001|Overall Study|Symptomatic deterioration|0|||
23393858|NCT00415636|65189486|FG002|Overall Study|Symptomatic deterioration|1|||
23393859|NCT00415636|65189487|FG003|Overall Study|Symptomatic deterioration|2|||
23393860|NCT00415636|65189488|FG004|Overall Study|Symptomatic deterioration|0|||
23393861|NCT00415636|65189489|FG005|Overall Study|Symptomatic deterioration|1|||
23393862|NCT00415636|65189484|FG000|Overall Study|Adverse Event|0|||
23393863|NCT00415636|65189485|FG001|Overall Study|Adverse Event|0|||
23393864|NCT00415636|65189486|FG002|Overall Study|Adverse Event|0|||
23393865|NCT00415636|65189487|FG003|Overall Study|Adverse Event|1|||
23393866|NCT00415636|65189488|FG004|Overall Study|Adverse Event|1|||
23687967|NCT02786901|66233057|FG001|Overall Study|Rescue Therapy Use|49|||
23393867|NCT00415636|65189489|FG005|Overall Study|Adverse Event|0|||
23393868|NCT00415636|65189484|FG000|Overall Study|Withdrawal by Subject|0|||
23393869|NCT00415636|65189485|FG001|Overall Study|Withdrawal by Subject|0|||
23687968|NCT02786901|66233058|FG002|Overall Study|Rescue Therapy Use|33|||
23687969|NCT02786901|66233056|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
23687970|NCT02786901|66233057|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
23687971|NCT02786901|66233058|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
23393870|NCT00415636|65189486|FG002|Overall Study|Withdrawal by Subject|0|||
23393871|NCT00415636|65189487|FG003|Overall Study|Withdrawal by Subject|0|||
23393872|NCT00415636|65189488|FG004|Overall Study|Withdrawal by Subject|1|||
23393873|NCT00415636|65189489|FG005|Overall Study|Withdrawal by Subject|0|||
23687972|NCT02786901|66233056|FG000|Overall Study|Disallowed medication|1|||
23687973|NCT02786901|66233057|FG001|Overall Study|Disallowed medication|1|||
23687974|NCT02786901|66233058|FG002|Overall Study|Disallowed medication|0|||
23393874|NCT00415636|65189484|FG000|Overall Study|Disease progression|0|||
23393875|NCT00415636|65189485|FG001|Overall Study|Disease progression|0|||
23393876|NCT00415636|65189486|FG002|Overall Study|Disease progression|0|||
23393877|NCT00415636|65189487|FG003|Overall Study|Disease progression|3|||
23393878|NCT00415636|65189488|FG004|Overall Study|Disease progression|0|||
23393879|NCT00415636|65189489|FG005|Overall Study|Disease progression|1|||
23393880|NCT02014467|65189490|FG000|Overall Study|Adverse Event|4|||
23393881|NCT02014467|65189491|FG001|Overall Study|Adverse Event|0|||
23393882|NCT02014467|65189490|FG000|Overall Study|Protocol Violation|3|||
23393883|NCT02014467|65189491|FG001|Overall Study|Protocol Violation|0|||
23393884|NCT02014467|65189490|FG000|Overall Study|Physician Decision|2|||
23393885|NCT02014467|65189491|FG001|Overall Study|Physician Decision|3|||
23393886|NCT02014467|65189490|FG000|Overall Study|Withdrawal by Subject|16|||
23393887|NCT02014467|65189491|FG001|Overall Study|Withdrawal by Subject|4|||
23393888|NCT00522379|65189492|FG000|Overall Study|Adverse Event|12|||
23393889|NCT00522379|65189493|FG001|Overall Study|Adverse Event|15|||
23393890|NCT00522379|65189494|FG002|Overall Study|Adverse Event|12|||
23393891|NCT00522379|65189495|FG003|Overall Study|Adverse Event|5|||
23393892|NCT00522379|65189496|FG004|Overall Study|Adverse Event|17|||
23393893|NCT00522379|65189492|FG000|Overall Study|Lack of Efficacy|3|||
23393894|NCT00522379|65189493|FG001|Overall Study|Lack of Efficacy|0|||
23393895|NCT00522379|65189494|FG002|Overall Study|Lack of Efficacy|2|||
23393896|NCT00522379|65189495|FG003|Overall Study|Lack of Efficacy|2|||
23393897|NCT00522379|65189496|FG004|Overall Study|Lack of Efficacy|7|||
23393898|NCT00522379|65189492|FG000|Overall Study|Withdrawal by Subject|2|||
23393899|NCT00522379|65189493|FG001|Overall Study|Withdrawal by Subject|3|||
23393900|NCT00522379|65189494|FG002|Overall Study|Withdrawal by Subject|1|||
23393901|NCT00522379|65189495|FG003|Overall Study|Withdrawal by Subject|2|||
23393902|NCT00522379|65189496|FG004|Overall Study|Withdrawal by Subject|0|||
23393903|NCT00522379|65189492|FG000|Overall Study|Protocol Violation|1|||
23393904|NCT00522379|65189493|FG001|Overall Study|Protocol Violation|1|||
23393905|NCT00522379|65189494|FG002|Overall Study|Protocol Violation|2|||
23393906|NCT00522379|65189495|FG003|Overall Study|Protocol Violation|0|||
23393907|NCT00522379|65189496|FG004|Overall Study|Protocol Violation|0|||
23687975|NCT02786901|66233056|FG000|Overall Study|Randomized in error|2|||
23687976|NCT02786901|66233057|FG001|Overall Study|Randomized in error|0|||
23687977|NCT02786901|66233058|FG002|Overall Study|Randomized in error|1|||
23687978|NCT01169779|66233059|FG000|Overall Study|Adverse Event|3|||
23687979|NCT01169779|66233060|FG001|Overall Study|Adverse Event|11|||
23687980|NCT01169779|66233059|FG000|Overall Study|Lack of Efficacy|1|||
23687981|NCT01169779|66233060|FG001|Overall Study|Lack of Efficacy|0|||
23687982|NCT01169779|66233059|FG000|Overall Study|Protocol Violation|1|||
23687983|NCT01169779|66233060|FG001|Overall Study|Protocol Violation|1|||
23687984|NCT01169779|66233059|FG000|Overall Study|Withdrawal by Subject|3|||
23687985|NCT01169779|66233060|FG001|Overall Study|Withdrawal by Subject|2|||
23687986|NCT01169779|66233059|FG000|Overall Study|Familial and personal reasons|3|||
23687987|NCT01169779|66233060|FG001|Overall Study|Familial and personal reasons|3|||
23687988|NCT01309737|66233061|FG000|Week 0 to 16|Death|1|||
23687989|NCT01309737|66233062|FG001|Week 0 to 16|Death|0|||
23687990|NCT01309737|66233063|FG002|Week 0 to 16|Death|1|||
23687991|NCT01309737|66233064|FG003|Week 0 to 16|Death|0|||
23687992|NCT01309737|66233065|FG004|Week 0 to 16|Death|0|||
23687993|NCT01309737|66233061|FG000|Week 0 to 16|Adverse Event|11|||
23687994|NCT01309737|66233062|FG001|Week 0 to 16|Adverse Event|10|||
23687995|NCT01309737|66233063|FG002|Week 0 to 16|Adverse Event|5|||
23687996|NCT01309737|66233064|FG003|Week 0 to 16|Adverse Event|0|||
23687997|NCT01309737|66233065|FG004|Week 0 to 16|Adverse Event|0|||
23687998|NCT01309737|66233061|FG000|Week 0 to 16|Lack of Efficacy|15|||
23687999|NCT01309737|66233062|FG001|Week 0 to 16|Lack of Efficacy|2|||
23688000|NCT01309737|66233063|FG002|Week 0 to 16|Lack of Efficacy|24|||
23688001|NCT01309737|66233064|FG003|Week 0 to 16|Lack of Efficacy|0|||
23688002|NCT01309737|66233065|FG004|Week 0 to 16|Lack of Efficacy|0|||
23688003|NCT01309737|66233061|FG000|Week 0 to 16|Lost to Follow-up|7|||
23688004|NCT01309737|66233062|FG001|Week 0 to 16|Lost to Follow-up|8|||
23688005|NCT01309737|66233063|FG002|Week 0 to 16|Lost to Follow-up|3|||
23688006|NCT01309737|66233064|FG003|Week 0 to 16|Lost to Follow-up|0|||
23688007|NCT01309737|66233065|FG004|Week 0 to 16|Lost to Follow-up|0|||
23688008|NCT01309737|66233061|FG000|Week 0 to 16|Withdrawal by Subject|7|||
23688009|NCT01309737|66233062|FG001|Week 0 to 16|Withdrawal by Subject|6|||
23393908|NCT00522379|65189492|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
23393909|NCT00522379|65189493|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
23393910|NCT00522379|65189494|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
23688010|NCT01309737|66233063|FG002|Week 0 to 16|Withdrawal by Subject|7|||
23393911|NCT00522379|65189495|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
23393912|NCT00522379|65189496|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
23393913|NCT00522379|65189492|FG000|Overall Study|Lost to Follow-up|1|||
23688011|NCT01309737|66233064|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23688012|NCT01309737|66233065|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23688013|NCT01309737|66233061|FG000|Week 0 to 16|Other|10|||
23393914|NCT00522379|65189493|FG001|Overall Study|Lost to Follow-up|0|||
23688014|NCT01309737|66233062|FG001|Week 0 to 16|Other|14|||
23688015|NCT01309737|66233063|FG002|Week 0 to 16|Other|4|||
23688016|NCT01309737|66233064|FG003|Week 0 to 16|Other|0|||
23688017|NCT01309737|66233065|FG004|Week 0 to 16|Other|0|||
23688018|NCT01309737|66233061|FG000|Week 0 to 16|Randomized, but not treated|1|||
23688019|NCT01309737|66233062|FG001|Week 0 to 16|Randomized, but not treated|0|||
23688020|NCT01309737|66233063|FG002|Week 0 to 16|Randomized, but not treated|0|||
23688021|NCT01309737|66233064|FG003|Week 0 to 16|Randomized, but not treated|0|||
23688022|NCT01309737|66233065|FG004|Week 0 to 16|Randomized, but not treated|0|||
23688023|NCT01309737|66233061|FG000|Week 16 to 52|Death|0|||
23688024|NCT01309737|66233062|FG001|Week 16 to 52|Death|0|||
23688025|NCT01309737|66233063|FG002|Week 16 to 52|Death|0|||
23688026|NCT01309737|66233064|FG003|Week 16 to 52|Death|0|||
23688027|NCT01309737|66233065|FG004|Week 16 to 52|Death|1|||
23688028|NCT01309737|66233061|FG000|Week 16 to 52|Adverse Event|7|||
23688029|NCT01309737|66233062|FG001|Week 16 to 52|Adverse Event|7|||
23688030|NCT01309737|66233063|FG002|Week 16 to 52|Adverse Event|0|||
23688031|NCT01309737|66233064|FG003|Week 16 to 52|Adverse Event|6|||
23688032|NCT01309737|66233065|FG004|Week 16 to 52|Adverse Event|5|||
23688033|NCT01309737|66233061|FG000|Week 16 to 52|Lack of Efficacy|107|||
23688034|NCT01309737|66233062|FG001|Week 16 to 52|Lack of Efficacy|76|||
23688035|NCT01309737|66233063|FG002|Week 16 to 52|Lack of Efficacy|0|||
23688036|NCT01309737|66233064|FG003|Week 16 to 52|Lack of Efficacy|25|||
23688037|NCT01309737|66233065|FG004|Week 16 to 52|Lack of Efficacy|21|||
23688038|NCT01309737|66233061|FG000|Week 16 to 52|Lost to Follow-up|4|||
23688039|NCT01309737|66233062|FG001|Week 16 to 52|Lost to Follow-up|2|||
23688040|NCT01309737|66233063|FG002|Week 16 to 52|Lost to Follow-up|0|||
23688041|NCT01309737|66233064|FG003|Week 16 to 52|Lost to Follow-up|1|||
23688042|NCT01309737|66233065|FG004|Week 16 to 52|Lost to Follow-up|4|||
23688043|NCT01309737|66233061|FG000|Week 16 to 52|Withdrawal by Subject|5|||
23688044|NCT01309737|66233062|FG001|Week 16 to 52|Withdrawal by Subject|6|||
23688045|NCT01309737|66233063|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23688046|NCT01309737|66233064|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23688047|NCT01309737|66233065|FG004|Week 16 to 52|Withdrawal by Subject|2|||
23688048|NCT01309737|66233061|FG000|Week 16 to 52|Other|10|||
23688049|NCT01309737|66233062|FG001|Week 16 to 52|Other|12|||
23688050|NCT01309737|66233063|FG002|Week 16 to 52|Other|0|||
23688051|NCT01309737|66233064|FG003|Week 16 to 52|Other|2|||
23688052|NCT01309737|66233065|FG004|Week 16 to 52|Other|0|||
23688053|NCT00484315|66233074|FG000|12-Month Clinical Follow-up|Death|6|||
23688054|NCT00484315|66233075|FG001|12-Month Clinical Follow-up|Death|2|||
23688055|NCT00484315|66233074|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
23688056|NCT00484315|66233075|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
23688057|NCT00484315|66233074|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
23688058|NCT00484315|66233075|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
23688059|NCT00484315|66233074|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
23688060|NCT00484315|66233075|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
23688061|NCT00484315|66233074|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
23688062|NCT00484315|66233075|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
23688063|NCT00484315|66233074|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
23688064|NCT00484315|66233075|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
23688065|NCT00484315|66233074|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
23688066|NCT00484315|66233075|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
23688067|NCT01535235|66233076|FG000|Overall Study|Adverse Event|1|||
23688068|NCT01535235|66233077|FG001|Overall Study|Adverse Event|0|||
23688069|NCT02970929|66233078|FG000|Overall Study|Adverse Event|18|||
23688070|NCT02970929|66233078|FG000|Overall Study|Lack of Efficacy|8|||
23688071|NCT02970929|66233078|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
23688072|NCT02970929|66233078|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
23688073|NCT02970929|66233078|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
23688074|NCT02970929|66233078|FG000|Overall Study|LOST TO FOLLOWUP|6|||
23688075|NCT02970929|66233078|FG000|Overall Study|MOVED OUT OF STATE|1|||
23688076|NCT02970929|66233078|FG000|Overall Study|Withdrawal by Subject|16|||
23688077|NCT00642642|66233079|FG000|Treatment & Follow Up|Adverse Event|2|||
23688078|NCT00642642|66233079|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
23688079|NCT00642642|66233079|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
23688080|NCT01948830|66233088|FG000|Overall Study|Physician Decision|1|||
23688081|NCT01948830|66233089|FG001|Overall Study|Physician Decision|3|||
23688082|NCT01948830|66233088|FG000|Overall Study|Protocol deviation|1|||
23688083|NCT01948830|66233089|FG001|Overall Study|Protocol deviation|2|||
23393915|NCT00522379|65189494|FG002|Overall Study|Lost to Follow-up|4|||
23688084|NCT01948830|66233088|FG000|Overall Study|Lost to Follow-up|5|||
23688085|NCT01948830|66233089|FG001|Overall Study|Lost to Follow-up|4|||
23688086|NCT01948830|66233088|FG000|Overall Study|Withdrawal by Subject|14|||
23688087|NCT01948830|66233089|FG001|Overall Study|Withdrawal by Subject|17|||
23688088|NCT01948830|66233088|FG000|Overall Study|Adverse Event|9|||
23688089|NCT01948830|66233089|FG001|Overall Study|Adverse Event|2|||
23688090|NCT01948830|66233088|FG000|Overall Study|Death|3|||
23688091|NCT01948830|66233089|FG001|Overall Study|Death|4|||
23688092|NCT01381094|66233090|FG000|Overall Study|Adverse Event|1|||
23688093|NCT01381094|66233091|FG001|Overall Study|Adverse Event|2|||
23688094|NCT01381094|66233092|FG002|Overall Study|Adverse Event|0|||
23688095|NCT01381094|66233093|FG003|Overall Study|Adverse Event|1|||
23688096|NCT01381094|66233094|FG004|Overall Study|Adverse Event|0|||
23688097|NCT01381094|66233090|FG000|Overall Study|Lost to Follow-up|0|||
23688098|NCT01381094|66233091|FG001|Overall Study|Lost to Follow-up|0|||
23688099|NCT01381094|66233092|FG002|Overall Study|Lost to Follow-up|0|||
23688100|NCT01381094|66233093|FG003|Overall Study|Lost to Follow-up|0|||
23688101|NCT01381094|66233094|FG004|Overall Study|Lost to Follow-up|1|||
23688102|NCT01381094|66233090|FG000|Overall Study|Withdrawal of informed consent|0|||
23688103|NCT01381094|66233091|FG001|Overall Study|Withdrawal of informed consent|1|||
23688104|NCT01381094|66233092|FG002|Overall Study|Withdrawal of informed consent|0|||
23688105|NCT01381094|66233093|FG003|Overall Study|Withdrawal of informed consent|0|||
23688106|NCT01381094|66233094|FG004|Overall Study|Withdrawal of informed consent|0|||
23688107|NCT01381094|66233090|FG000|Overall Study|Participant given Aranesp injection|1|||
23688108|NCT01381094|66233091|FG001|Overall Study|Participant given Aranesp injection|0|||
23688109|NCT01381094|66233092|FG002|Overall Study|Participant given Aranesp injection|0|||
23688110|NCT01381094|66233093|FG003|Overall Study|Participant given Aranesp injection|0|||
23688111|NCT01381094|66233094|FG004|Overall Study|Participant given Aranesp injection|0|||
23688112|NCT01276288|66233095|FG000|Overall Study|Adverse Event|1|||
23688113|NCT01276288|66233096|FG001|Overall Study|Adverse Event|1|||
23688114|NCT01276288|66233097|FG002|Overall Study|Adverse Event|0|||
23688115|NCT01276288|66233098|FG003|Overall Study|Adverse Event|0|||
23688116|NCT01276288|66233095|FG000|Overall Study|not treated|1|||
23688117|NCT01276288|66233096|FG001|Overall Study|not treated|0|||
23688118|NCT01276288|66233097|FG002|Overall Study|not treated|0|||
23688119|NCT01276288|66233098|FG003|Overall Study|not treated|0|||
23688120|NCT00195650|66233099|FG000|Overall Study|Adverse Event|194|||
23688121|NCT00195650|66233099|FG000|Overall Study|Lack of Efficacy|99|||
23688122|NCT00195650|66233099|FG000|Overall Study|Withdrawal by Subject|67|||
23688123|NCT00195650|66233099|FG000|Overall Study|Lost to Follow-up|44|||
23688124|NCT00195650|66233099|FG000|Overall Study|Death|23|||
23688125|NCT00195650|66233099|FG000|Overall Study|Protocol Violation|15|||
23688126|NCT00195650|66233099|FG000|Overall Study|Administrative reasons|83|||
23688127|NCT01859403|66233100|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
23688128|NCT01859403|66233101|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
23688129|NCT01859403|66233100|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
23688130|NCT01859403|66233101|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
23688131|NCT01859403|66233100|FG000|Primary Endpoint Measure|Physician Decision|0|||
23688132|NCT01859403|66233101|FG001|Primary Endpoint Measure|Physician Decision|1|||
23688133|NCT01859403|66233100|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
23688134|NCT01859403|66233101|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
23688135|NCT00496366|66233102|FG000|Overall Study|Death|1|||
23688136|NCT03636906|66233105|FG000|Overall Study|Adverse Event|0|||
23688137|NCT03636906|66233106|FG001|Overall Study|Adverse Event|0|||
23688138|NCT03636906|66233107|FG002|Overall Study|Adverse Event|1|||
23688139|NCT03636906|66233105|FG000|Overall Study|Lost to Follow-up|1|||
23688140|NCT03636906|66233106|FG001|Overall Study|Lost to Follow-up|0|||
23688141|NCT03636906|66233107|FG002|Overall Study|Lost to Follow-up|0|||
23688142|NCT03636906|66233105|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
23688143|NCT03636906|66233106|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
23688144|NCT03636906|66233107|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
23688145|NCT03636906|66233105|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23688146|NCT03636906|66233106|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23688147|NCT03636906|66233107|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
23688148|NCT03636906|66233105|FG000|Overall Study|Other|0|||
23688149|NCT03636906|66233106|FG001|Overall Study|Other|0|||
23688150|NCT03636906|66233107|FG002|Overall Study|Other|1|||
23688151|NCT01335971|66233108|FG000|Overall Study|Withdrawal by Subject|1|||
23688152|NCT01335971|66233109|FG001|Overall Study|Withdrawal by Subject|0|||
23688153|NCT01335971|66233110|FG002|Overall Study|Withdrawal by Subject|0|||
23688154|NCT01335971|66233108|FG000|Overall Study|Did not complete bronchoscopy|1|||
23688155|NCT01335971|66233109|FG001|Overall Study|Did not complete bronchoscopy|1|||
23688156|NCT01335971|66233110|FG002|Overall Study|Did not complete bronchoscopy|1|||
23688157|NCT02337387|66233113|FG000|Overall Study|Adverse Event|0|||
23688158|NCT02337387|66233114|FG001|Overall Study|Adverse Event|1|||
23688159|NCT02337387|66233115|FG002|Overall Study|Adverse Event|0|||
23688160|NCT02337387|66233116|FG003|Overall Study|Adverse Event|0|||
23393916|NCT00522379|65189495|FG003|Overall Study|Lost to Follow-up|2|||
23688161|NCT02337387|66233113|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
23688162|NCT02337387|66233114|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
23688163|NCT02337387|66233115|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
23688164|NCT02337387|66233116|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
23688165|NCT05499520|66233117|FG000|Overall Study|Lost to Follow-up|0|||
23688166|NCT05499520|66233118|FG001|Overall Study|Lost to Follow-up|0|||
23688167|NCT05499520|66233119|FG002|Overall Study|Lost to Follow-up|38|||
23688168|NCT05499520|66233120|FG003|Overall Study|Lost to Follow-up|41|||
23688169|NCT05499520|66233121|FG004|Overall Study|Lost to Follow-up|46|||
23688170|NCT05499520|66233122|FG005|Overall Study|Lost to Follow-up|0|||
23688171|NCT05499520|66233123|FG006|Overall Study|Lost to Follow-up|31|||
23688172|NCT05499520|66233124|FG007|Overall Study|Lost to Follow-up|45|||
23688173|NCT05499520|66233125|FG008|Overall Study|Lost to Follow-up|42|||
23688174|NCT05499520|66233126|FG009|Overall Study|Lost to Follow-up|0|||
23688175|NCT05499520|66233127|FG010|Overall Study|Lost to Follow-up|0|||
23688176|NCT05499520|66233128|FG011|Overall Study|Lost to Follow-up|37|||
23688177|NCT05499520|66233129|FG012|Overall Study|Lost to Follow-up|53|||
23688178|NCT05499520|66233130|FG013|Overall Study|Lost to Follow-up|49|||
23688179|NCT05499520|66233131|FG014|Overall Study|Lost to Follow-up|0|||
23688180|NCT05499520|66233132|FG015|Overall Study|Lost to Follow-up|36|||
23688181|NCT05499520|66233133|FG016|Overall Study|Lost to Follow-up|58|||
23688182|NCT05499520|66233134|FG017|Overall Study|Lost to Follow-up|53|||
23688183|NCT03403192|66233137|FG000|Overall Study|Lost to Follow-up|1|||
23688184|NCT03403192|66233138|FG001|Overall Study|Lost to Follow-up|2|||
23688185|NCT03403192|66233139|FG002|Overall Study|Lost to Follow-up|0|||
23688186|NCT03403192|66233140|FG003|Overall Study|Lost to Follow-up|0|||
23688187|NCT03403192|66233137|FG000|Overall Study|Unable to respond|0|||
23688188|NCT03403192|66233138|FG001|Overall Study|Unable to respond|1|||
23688189|NCT03403192|66233139|FG002|Overall Study|Unable to respond|0|||
23688190|NCT03403192|66233140|FG003|Overall Study|Unable to respond|0|||
23688191|NCT03403192|66233137|FG000|Overall Study|Incomplete|3|||
23688192|NCT03403192|66233138|FG001|Overall Study|Incomplete|1|||
23688193|NCT03403192|66233139|FG002|Overall Study|Incomplete|3|||
23688194|NCT03403192|66233140|FG003|Overall Study|Incomplete|6|||
23688195|NCT02344576|66233141|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
23688196|NCT02344576|66233142|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
23688197|NCT02344576|66233143|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
23688198|NCT02344576|66233144|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
23688199|NCT02344576|66233141|FG000|1-Month Follow-Up|Death|13|||
23688200|NCT02344576|66233142|FG001|1-Month Follow-Up|Death|8|||
23688201|NCT02344576|66233143|FG002|1-Month Follow-Up|Death|0|||
23688202|NCT02344576|66233144|FG003|1-Month Follow-Up|Death|0|||
23688203|NCT02344576|66233141|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
23688204|NCT02344576|66233142|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
23688205|NCT02344576|66233143|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
23688206|NCT02344576|66233144|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
23688207|NCT02344576|66233141|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
23688208|NCT02344576|66233142|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
23688209|NCT02344576|66233143|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
23688210|NCT02344576|66233144|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
23688211|NCT02344576|66233141|FG000|6-Month Follow-Up|Death|14|||
23688212|NCT02344576|66233142|FG001|6-Month Follow-Up|Death|14|||
23688213|NCT02344576|66233143|FG002|6-Month Follow-Up|Death|0|||
23688214|NCT02344576|66233144|FG003|6-Month Follow-Up|Death|0|||
23688215|NCT02344576|66233141|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
23688216|NCT02344576|66233142|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
23688217|NCT02344576|66233143|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
23688218|NCT02344576|66233144|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
23688219|NCT02344576|66233141|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
23688220|NCT02344576|66233142|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
23688221|NCT02344576|66233143|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
23688222|NCT02344576|66233144|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
23688223|NCT03371355|66233145|FG000|Overall Study|Investigator judgment|0|||
23688224|NCT03371355|66233146|FG001|Overall Study|Investigator judgment|0|||
23688225|NCT03371355|66233147|FG002|Overall Study|Investigator judgment|1|||
23688226|NCT03371355|66233148|FG003|Overall Study|Investigator judgment|1|||
23688227|NCT03371355|66233145|FG000|Overall Study|Voluntary withdrawal|1|||
23688228|NCT03371355|66233146|FG001|Overall Study|Voluntary withdrawal|0|||
23688229|NCT03371355|66233147|FG002|Overall Study|Voluntary withdrawal|1|||
23688230|NCT03371355|66233148|FG003|Overall Study|Voluntary withdrawal|2|||
23688231|NCT03371355|66233145|FG000|Overall Study|Adverse Event|0|||
23688232|NCT03371355|66233146|FG001|Overall Study|Adverse Event|1|||
23688233|NCT03371355|66233147|FG002|Overall Study|Adverse Event|2|||
23688234|NCT03371355|66233148|FG003|Overall Study|Adverse Event|3|||
23688235|NCT03371355|66233145|FG000|Overall Study|Reason not Specified|0|||
23688236|NCT03371355|66233146|FG001|Overall Study|Reason not Specified|1|||
23688237|NCT03371355|66233147|FG002|Overall Study|Reason not Specified|0|||
23688238|NCT03371355|66233148|FG003|Overall Study|Reason not Specified|1|||
23688239|NCT01700829|66233149|FG000|Overall Study|Withdrawal by Subject|1|||
23688240|NCT01700829|66233150|FG001|Overall Study|Withdrawal by Subject|1|||
23688241|NCT00316264|66233154|FG000|Overall Study|Lost to Follow-up|0|||
23688242|NCT00316264|66233155|FG001|Overall Study|Lost to Follow-up|1|||
23688243|NCT00316264|66233156|FG002|Overall Study|Lost to Follow-up|0|||
23688244|NCT00316264|66233154|FG000|Overall Study|Withdrawal of Consent|3|||
23688245|NCT00316264|66233155|FG001|Overall Study|Withdrawal of Consent|5|||
23688246|NCT00316264|66233156|FG002|Overall Study|Withdrawal of Consent|6|||
23688247|NCT00316264|66233154|FG000|Overall Study|Death|2|||
23688248|NCT00316264|66233155|FG001|Overall Study|Death|0|||
23688249|NCT00316264|66233156|FG002|Overall Study|Death|0|||
23688250|NCT00316264|66233154|FG000|Overall Study|Other|1|||
23688251|NCT00316264|66233155|FG001|Overall Study|Other|1|||
23688252|NCT00316264|66233156|FG002|Overall Study|Other|0|||
23688253|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
23688254|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
23688255|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
23688256|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
23688257|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
23688258|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
23688259|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
23688260|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
23688261|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
23688262|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
23688263|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
23688264|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
23688265|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
23688266|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
23688267|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
23688268|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
23688269|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
23688270|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
23688271|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
23688272|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
23688273|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
23688274|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
23688275|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
23688276|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
23688277|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
23688278|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
23688279|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
23688280|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
23688281|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23688282|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
23688283|NCT00849017|66233157|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
23688284|NCT00849017|66233158|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
23688285|NCT00849017|66233159|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
23688286|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
23688287|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
23688288|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
23688289|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23688290|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
23688291|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
23688292|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
23688293|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
23688294|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
23688295|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
23688296|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
23688297|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
23688298|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
23688299|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
23688300|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
23688301|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
23688302|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
23688303|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
23688304|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
23688305|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
23688306|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
23688307|NCT00849017|66233157|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
23393917|NCT00522379|65189496|FG004|Overall Study|Lost to Follow-up|2|||
23393918|NCT00522379|65189492|FG000|Overall Study|Randomization error|0|||
23393919|NCT00522379|65189493|FG001|Overall Study|Randomization error|0|||
23688308|NCT00849017|66233158|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
23688309|NCT00849017|66233159|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
23688310|NCT01850615|66233161|FG000|Overall Study|Protocol Violation|4|||
23688311|NCT01850615|66233162|FG001|Overall Study|Protocol Violation|1|||
23688312|NCT01850615|66233161|FG000|Overall Study|Adverse Event|2|||
23688313|NCT01850615|66233162|FG001|Overall Study|Adverse Event|1|||
23688314|NCT01850615|66233161|FG000|Overall Study|Withdrawal by Subject|3|||
23688315|NCT01850615|66233162|FG001|Overall Study|Withdrawal by Subject|1|||
23688316|NCT01850615|66233161|FG000|Overall Study|Lost to Follow-up|0|||
23688317|NCT01850615|66233162|FG001|Overall Study|Lost to Follow-up|1|||
23688318|NCT01850615|66233161|FG000|Overall Study|Unclassified|0|||
23688319|NCT01850615|66233162|FG001|Overall Study|Unclassified|1|||
23688320|NCT04401267|66233163|FG000|Overall Study|Death|0|||
23688321|NCT04401267|66233164|FG001|Overall Study|Death|1|||
23688322|NCT04401267|66233163|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
23688323|NCT04401267|66233164|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
23688324|NCT04401267|66233163|FG000|Overall Study|Found to be Ineligible|1|||
23688325|NCT04401267|66233164|FG001|Overall Study|Found to be Ineligible|0|||
23688326|NCT00522392|66233165|FG000|Overall Study|Disease progression|0|||
23688327|NCT00522392|66233166|FG001|Overall Study|Disease progression|3|||
23688328|NCT00522392|66233165|FG000|Overall Study|Adverse Event|7|||
23688329|NCT00522392|66233166|FG001|Overall Study|Adverse Event|7|||
23688330|NCT00522392|66233165|FG000|Overall Study|Withdrawal by Subject|1|||
23688331|NCT00522392|66233166|FG001|Overall Study|Withdrawal by Subject|1|||
23688332|NCT00522392|66233165|FG000|Overall Study|Physician Decision|0|||
23688333|NCT00522392|66233166|FG001|Overall Study|Physician Decision|1|||
23688334|NCT00522392|66233165|FG000|Overall Study|Non-compliance|0|||
23688335|NCT00522392|66233166|FG001|Overall Study|Non-compliance|1|||
23688336|NCT00706628|66233167|FG000|Overall Study|Other Adverse Event|16|||
23688337|NCT00706628|66233168|FG001|Overall Study|Other Adverse Event|5|||
23688338|NCT00706628|66233169|FG002|Overall Study|Other Adverse Event|5|||
23688339|NCT00706628|66233170|FG003|Overall Study|Other Adverse Event|2|||
23688340|NCT00706628|66233167|FG000|Overall Study|Non compliant with protocol|0|||
23688341|NCT00706628|66233168|FG001|Overall Study|Non compliant with protocol|1|||
23688342|NCT00706628|66233169|FG002|Overall Study|Non compliant with protocol|0|||
23688343|NCT00706628|66233170|FG003|Overall Study|Non compliant with protocol|0|||
23688344|NCT00706628|66233167|FG000|Overall Study|Consent withdrawn|6|||
23688345|NCT00706628|66233168|FG001|Overall Study|Consent withdrawn|1|||
23688346|NCT00706628|66233169|FG002|Overall Study|Consent withdrawn|3|||
23688347|NCT00706628|66233170|FG003|Overall Study|Consent withdrawn|0|||
23688348|NCT00706628|66233167|FG000|Overall Study|Progressive disease|20|||
23688349|NCT00706628|66233168|FG001|Overall Study|Progressive disease|13|||
23688350|NCT00706628|66233169|FG002|Overall Study|Progressive disease|8|||
23688351|NCT00706628|66233170|FG003|Overall Study|Progressive disease|1|||
23688352|NCT00706628|66233167|FG000|Overall Study|Other than those stated above|4|||
23688353|NCT00706628|66233168|FG001|Overall Study|Other than those stated above|0|||
23688354|NCT00706628|66233169|FG002|Overall Study|Other than those stated above|0|||
23688355|NCT00706628|66233170|FG003|Overall Study|Other than those stated above|0|||
23688356|NCT00706628|66233167|FG000|Overall Study|Not treated|1|||
23688357|NCT00706628|66233168|FG001|Overall Study|Not treated|1|||
23688358|NCT00706628|66233169|FG002|Overall Study|Not treated|0|||
23688359|NCT00706628|66233170|FG003|Overall Study|Not treated|0|||
23688360|NCT01147926|66233171|FG000|Overall Study|Subject Withdrew Consent|9|||
23688361|NCT01147926|66233172|FG001|Overall Study|Subject Withdrew Consent|10|||
23688362|NCT01147926|66233171|FG000|Overall Study|Adverse Event|7|||
23688363|NCT01147926|66233172|FG001|Overall Study|Adverse Event|6|||
23688364|NCT01147926|66233171|FG000|Overall Study|Subject Non-Compliant|5|||
23688365|NCT01147926|66233172|FG001|Overall Study|Subject Non-Compliant|4|||
23688366|NCT01147926|66233171|FG000|Overall Study|Principal investigator left hospital|1|||
23688367|NCT01147926|66233172|FG001|Overall Study|Principal investigator left hospital|3|||
23688368|NCT01147926|66233171|FG000|Overall Study|Selection criteria not met|3|||
23688369|NCT01147926|66233172|FG001|Overall Study|Selection criteria not met|1|||
23688370|NCT01147926|66233171|FG000|Overall Study|Lost to Follow-up|0|||
23688371|NCT01147926|66233172|FG001|Overall Study|Lost to Follow-up|2|||
23688372|NCT01147926|66233171|FG000|Overall Study|Sponsor's Decision|0|||
23688373|NCT01147926|66233172|FG001|Overall Study|Sponsor's Decision|1|||
23688374|NCT01147926|66233171|FG000|Overall Study|Lack of Efficacy|1|||
23688375|NCT01147926|66233172|FG001|Overall Study|Lack of Efficacy|0|||
23688376|NCT01147926|66233171|FG000|Overall Study|Too busy, no time for study|1|||
23688377|NCT01147926|66233172|FG001|Overall Study|Too busy, no time for study|0|||
23688378|NCT01147926|66233171|FG000|Overall Study|Went on holiday|0|||
23688379|NCT01147926|66233172|FG001|Overall Study|Went on holiday|1|||
23688380|NCT01147926|66233171|FG000|Overall Study|Colonoscopy result|0|||
23688381|NCT01147926|66233172|FG001|Overall Study|Colonoscopy result|1|||
23688382|NCT00389207|66233173|FG000|Overall Study|Adverse Event|26|||
23688383|NCT00389207|66233174|FG001|Overall Study|Adverse Event|32|||
23688384|NCT00389207|66233175|FG002|Overall Study|Adverse Event|10|||
23688385|NCT00389207|66233173|FG000|Overall Study|Protocol Violation|3|||
23688386|NCT00389207|66233174|FG001|Overall Study|Protocol Violation|1|||
23688387|NCT00389207|66233175|FG002|Overall Study|Protocol Violation|4|||
23688388|NCT00389207|66233173|FG000|Overall Study|Lost to Follow-up|12|||
23688389|NCT00389207|66233174|FG001|Overall Study|Lost to Follow-up|9|||
23688390|NCT00389207|66233175|FG002|Overall Study|Lost to Follow-up|7|||
23688391|NCT00389207|66233173|FG000|Overall Study|Withdrawal by Subject|5|||
23688392|NCT00389207|66233174|FG001|Overall Study|Withdrawal by Subject|7|||
23688393|NCT00389207|66233175|FG002|Overall Study|Withdrawal by Subject|11|||
23688394|NCT00389207|66233173|FG000|Overall Study|Other|17|||
23688395|NCT00389207|66233174|FG001|Overall Study|Other|23|||
23688396|NCT00389207|66233175|FG002|Overall Study|Other|9|||
23688397|NCT01237951|66233176|FG000|Overall Study|Death|1|||
23688398|NCT00374556|66233177|FG000|Overall Study|Lost to Follow-up|1|||
23688399|NCT00374556|66233178|FG001|Overall Study|Lost to Follow-up|0|||
23688400|NCT00374556|66233177|FG000|Overall Study|Removed at baseline due to medical cond|0|||
23688401|NCT00374556|66233178|FG001|Overall Study|Removed at baseline due to medical cond|1|||
23688402|NCT02949830|66233182|FG000|Overall Study|Adverse Event|1|||
23688403|NCT02949830|66233182|FG000|Overall Study|Withdrawal by Subject|1|||
23688404|NCT01128387|66233183|FG000|Overall Study|Physician Decision|0|||
23688405|NCT01128387|66233184|FG001|Overall Study|Physician Decision|1|||
23688406|NCT03812510|66233186|FG000|Overall Study|Lost to Follow-up|39|||
23688407|NCT03812510|66233186|FG000|Overall Study|Withdrawal by Subject|42|||
23688408|NCT03812510|66233186|FG000|Overall Study|Physician Decision|2|||
23688409|NCT03812510|66233186|FG000|Overall Study|Study Terminated by Sponsor|9|||
23688410|NCT03812510|66233186|FG000|Overall Study|Did Not Start Study Medication|55|||
23688411|NCT03812510|66233186|FG000|Overall Study|Adverse Event|5|||
23688412|NCT00008385|66233189|FG000|Overall Study|Off treatment reasons not reported|79|||
23688413|NCT00008385|66233190|FG001|Overall Study|Off treatment reasons not reported|70|||
23688414|NCT00008385|66233189|FG000|Overall Study|Progressive disease|52|||
23688415|NCT00008385|66233190|FG001|Overall Study|Progressive disease|117|||
23688416|NCT00008385|66233189|FG000|Overall Study|Adverse Event|8|||
23688417|NCT00008385|66233190|FG001|Overall Study|Adverse Event|20|||
23688418|NCT00008385|66233189|FG000|Overall Study|Death|12|||
23688419|NCT00008385|66233190|FG001|Overall Study|Death|18|||
23688420|NCT00008385|66233189|FG000|Overall Study|Withdrawal by Subject|67|||
23688421|NCT00008385|66233190|FG001|Overall Study|Withdrawal by Subject|157|||
23688422|NCT00008385|66233189|FG000|Overall Study|Start non-protocol therapy|3|||
23688423|NCT00008385|66233190|FG001|Overall Study|Start non-protocol therapy|1|||
23688424|NCT00008385|66233189|FG000|Overall Study|Other complicating disease|17|||
23688425|NCT00008385|66233190|FG001|Overall Study|Other complicating disease|30|||
23688426|NCT00008385|66233189|FG000|Overall Study|Maximum dose reached|0|||
23688427|NCT00008385|66233190|FG001|Overall Study|Maximum dose reached|2|||
23688428|NCT00008385|66233189|FG000|Overall Study|Other|105|||
23688429|NCT00008385|66233190|FG001|Overall Study|Other|212|||
23688430|NCT00008385|66233189|FG000|Overall Study|Not start protocol therapy|44|||
23688431|NCT00008385|66233190|FG001|Overall Study|Not start protocol therapy|175|||
23688432|NCT01990261|66233194|FG000|Overall Study|Death Before Treatment Start|2|||
23688433|NCT01990261|66233194|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
23688434|NCT01990261|66233194|FG000|Overall Study|Death From other Causes|1|||
23688435|NCT01990261|66233194|FG000|Overall Study|Disease Progression (PD)|8|||
23688436|NCT01990261|66233194|FG000|Overall Study|PD Before Treatment Start|1|||
23688437|NCT01990261|66233194|FG000|Overall Study|Dossier not Approved|1|||
23393920|NCT00522379|65189494|FG002|Overall Study|Randomization error|0|||
23393921|NCT00522379|65189495|FG003|Overall Study|Randomization error|0|||
23393922|NCT00522379|65189496|FG004|Overall Study|Randomization error|1|||
23393923|NCT00522379|65189492|FG000|Overall Study|Dispensing error|1|||
23393924|NCT00522379|65189493|FG001|Overall Study|Dispensing error|0|||
23393925|NCT00522379|65189494|FG002|Overall Study|Dispensing error|0|||
23393926|NCT00522379|65189495|FG003|Overall Study|Dispensing error|1|||
23393927|NCT00522379|65189496|FG004|Overall Study|Dispensing error|0|||
23393928|NCT00522379|65189492|FG000|Overall Study|Subject Moved|1|||
23393929|NCT00522379|65189493|FG001|Overall Study|Subject Moved|1|||
23393930|NCT00522379|65189494|FG002|Overall Study|Subject Moved|0|||
23393931|NCT00522379|65189495|FG003|Overall Study|Subject Moved|0|||
23393932|NCT00522379|65189496|FG004|Overall Study|Subject Moved|0|||
23393933|NCT00522379|65189492|FG000|Overall Study|Sponsor Request|0|||
23393934|NCT00522379|65189493|FG001|Overall Study|Sponsor Request|1|||
23393935|NCT00522379|65189494|FG002|Overall Study|Sponsor Request|0|||
23393936|NCT00522379|65189495|FG003|Overall Study|Sponsor Request|0|||
23393937|NCT00522379|65189496|FG004|Overall Study|Sponsor Request|0|||
23393938|NCT00522379|65189492|FG000|Overall Study|Family Problem|0|||
23393939|NCT00522379|65189493|FG001|Overall Study|Family Problem|0|||
23688438|NCT01990261|66233194|FG000|Overall Study|Lost to Follow-up|2|||
23688439|NCT01705691|66233195|FG000|Overall Study|Death|1|||
23688440|NCT01705691|66233196|FG001|Overall Study|Death|2|||
23688441|NCT01705691|66233195|FG000|Overall Study|Withdrawal by Subject|1|||
23688442|NCT01705691|66233196|FG001|Overall Study|Withdrawal by Subject|2|||
23393940|NCT00522379|65189494|FG002|Overall Study|Family Problem|1|||
23393941|NCT00522379|65189495|FG003|Overall Study|Family Problem|0|||
23393942|NCT00522379|65189496|FG004|Overall Study|Family Problem|0|||
23688443|NCT01705691|66233195|FG000|Overall Study|Lost to Follow-up|1|||
23688444|NCT01705691|66233196|FG001|Overall Study|Lost to Follow-up|1|||
23688445|NCT01705691|66233195|FG000|Overall Study|Other|0|||
23688446|NCT01705691|66233196|FG001|Overall Study|Other|1|||
23688447|NCT02582671|66233201|FG000|Overall Study|Failure to return|1|||
23688448|NCT02582671|66233201|FG000|Overall Study|Other, not specified|1|||
23688449|NCT00355121|66233202|FG000|Overall Study|Did not receive study vaccine|1|||
23688450|NCT00355121|66233203|FG001|Overall Study|Did not receive study vaccine|0|||
23688451|NCT00355121|66233204|FG002|Overall Study|Did not receive study vaccine|1|||
23688452|NCT00355121|66233202|FG000|Overall Study|Adverse Event|0|||
23688453|NCT00355121|66233203|FG001|Overall Study|Adverse Event|1|||
23688454|NCT00355121|66233204|FG002|Overall Study|Adverse Event|0|||
23688455|NCT00355121|66233202|FG000|Overall Study|Protocol Violation|7|||
23688456|NCT00355121|66233203|FG001|Overall Study|Protocol Violation|9|||
23688457|NCT00355121|66233204|FG002|Overall Study|Protocol Violation|1|||
23688458|NCT00355121|66233202|FG000|Overall Study|Lost to Follow-up|4|||
23688459|NCT00355121|66233203|FG001|Overall Study|Lost to Follow-up|7|||
23688460|NCT00355121|66233204|FG002|Overall Study|Lost to Follow-up|1|||
23688461|NCT00355121|66233202|FG000|Overall Study|Withdrawal by Subject|9|||
23688462|NCT00355121|66233203|FG001|Overall Study|Withdrawal by Subject|10|||
23688463|NCT00355121|66233204|FG002|Overall Study|Withdrawal by Subject|2|||
23688464|NCT00355121|66233202|FG000|Overall Study|Serious adverse events|0|||
23688465|NCT00355121|66233203|FG001|Overall Study|Serious adverse events|2|||
23688466|NCT00355121|66233204|FG002|Overall Study|Serious adverse events|0|||
23688467|NCT00846742|66237030|FG000|Overall Study|Withdrawal by Subject|1|||
23688468|NCT01891643|66237035|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23688469|NCT01891643|66237036|FG001|Overall Study|Adverse event unrelated to study drug|5|||
23688470|NCT01891643|66237035|FG000|Overall Study|Disease Progression|4|||
23688471|NCT01891643|66237036|FG001|Overall Study|Disease Progression|3|||
23688472|NCT01891643|66237035|FG000|Overall Study|Study Drug Toxicity|3|||
23688473|NCT01891643|66237036|FG001|Overall Study|Study Drug Toxicity|0|||
23688474|NCT01891643|66237035|FG000|Overall Study|Maximum Clinical Benefit|0|||
23688475|NCT01891643|66237036|FG001|Overall Study|Maximum Clinical Benefit|1|||
23688476|NCT01891643|66237035|FG000|Overall Study|Poor/Non-compliance|0|||
23688477|NCT01891643|66237036|FG001|Overall Study|Poor/Non-compliance|1|||
23688478|NCT01891643|66237035|FG000|Overall Study|Participant request to discontinue|1|||
23688479|NCT01891643|66237036|FG001|Overall Study|Participant request to discontinue|0|||
23688480|NCT00282243|66237042|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
23688481|NCT00282243|66237042|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
23688482|NCT00282243|66237042|FG000|Extension Treatment Period|Adverse Event|15|||
23688483|NCT00282243|66237042|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
23688484|NCT00282243|66237042|FG000|Extension Treatment Period|Non-compliance|2|||
23688485|NCT00282243|66237042|FG000|Extension Treatment Period|Physician Decision|1|||
23688486|NCT02034123|66237043|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688487|NCT02034123|66237044|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688488|NCT02034123|66237045|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688489|NCT02034123|66237046|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688490|NCT02034123|66237047|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23688491|NCT02034123|66237048|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688492|NCT02034123|66237049|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688493|NCT02034123|66237050|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23688494|NCT02034123|66237051|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23688495|NCT02034123|66237052|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688496|NCT02034123|66237053|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688497|NCT02034123|66237054|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688498|NCT02034123|66237055|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688499|NCT02034123|66237056|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688500|NCT02034123|66237057|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688501|NCT02034123|66237058|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688502|NCT02034123|66237059|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688503|NCT02034123|66237060|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23688504|NCT02034123|66237043|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688505|NCT02034123|66237044|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688506|NCT02034123|66237045|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688507|NCT02034123|66237046|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
23688508|NCT02034123|66237047|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688509|NCT02034123|66237048|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688510|NCT02034123|66237049|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688511|NCT02034123|66237050|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23393943|NCT00522379|65189492|FG000|Overall Study|Site Closed|0|||
23393944|NCT00522379|65189493|FG001|Overall Study|Site Closed|0|||
23393945|NCT00522379|65189494|FG002|Overall Study|Site Closed|0|||
23688512|NCT02034123|66237051|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688513|NCT02034123|66237052|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688514|NCT02034123|66237053|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688515|NCT02034123|66237054|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688516|NCT02034123|66237055|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688517|NCT02034123|66237056|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688518|NCT02034123|66237057|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688519|NCT02034123|66237058|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688520|NCT02034123|66237059|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688521|NCT02034123|66237060|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23688522|NCT02034123|66237043|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688523|NCT02034123|66237044|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688524|NCT02034123|66237045|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688525|NCT02034123|66237046|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688526|NCT02034123|66237047|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688527|NCT02034123|66237048|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688528|NCT02034123|66237049|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688529|NCT02034123|66237050|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688530|NCT02034123|66237051|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
23688531|NCT02034123|66237052|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688532|NCT02034123|66237053|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688533|NCT02034123|66237054|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688534|NCT02034123|66237055|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688535|NCT02034123|66237056|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688536|NCT02034123|66237057|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688537|NCT02034123|66237058|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688538|NCT02034123|66237059|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688539|NCT02034123|66237060|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23688540|NCT02034123|66237043|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688541|NCT02034123|66237044|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688542|NCT02034123|66237045|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688543|NCT02034123|66237046|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
23688544|NCT02034123|66237047|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
23688545|NCT02034123|66237048|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688546|NCT02034123|66237049|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688547|NCT02034123|66237050|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688548|NCT02034123|66237051|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688549|NCT02034123|66237052|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688550|NCT02034123|66237053|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688551|NCT02034123|66237054|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688552|NCT02034123|66237055|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688553|NCT02034123|66237056|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688554|NCT02034123|66237057|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688555|NCT02034123|66237058|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688556|NCT02034123|66237059|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23393946|NCT00522379|65189495|FG003|Overall Study|Site Closed|1|||
23393947|NCT00522379|65189496|FG004|Overall Study|Site Closed|0|||
23393948|NCT00522379|65189492|FG000|Overall Study|Subject Withdrawal|0|||
23393949|NCT00522379|65189493|FG001|Overall Study|Subject Withdrawal|0|||
23393950|NCT00522379|65189494|FG002|Overall Study|Subject Withdrawal|0|||
23393951|NCT00522379|65189495|FG003|Overall Study|Subject Withdrawal|1|||
23393952|NCT00522379|65189496|FG004|Overall Study|Subject Withdrawal|0|||
23393953|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
23393954|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
23393955|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
23393956|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
23393957|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393958|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393959|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
23393960|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393961|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23688557|NCT02034123|66237060|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23688558|NCT01892722|66237061|FG000|Overall Study|Protocol deviation|0|||
23393962|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23393963|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
23393964|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23393965|NCT04237584|65189497|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
23393966|NCT04237584|65189498|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
23393967|NCT04237584|65189499|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
23393968|NCT04237584|65189500|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
23393969|NCT04237584|65189497|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393970|NCT04237584|65189498|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393971|NCT04237584|65189499|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
23393972|NCT04237584|65189500|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393973|NCT00759395|65189509|FG000|Overall Study|Adverse Event|1|||
23393974|NCT00759395|65189510|FG001|Overall Study|Adverse Event|0|||
23393975|NCT00759395|65189509|FG000|Overall Study|Withdrawal by Subject|1|||
23393976|NCT00759395|65189510|FG001|Overall Study|Withdrawal by Subject|0|||
23393977|NCT00759395|65189509|FG000|Overall Study|Lack of Efficacy|0|||
23393978|NCT00759395|65189510|FG001|Overall Study|Lack of Efficacy|2|||
23393979|NCT03553836|65189511|FG000|Overall Study|Ongoing in Study|460|||
23393980|NCT03553836|65189512|FG001|Overall Study|Ongoing in Study|459|||
23393981|NCT03553836|65189511|FG000|Overall Study|Withdrawal by Subject|9|||
23393982|NCT03553836|65189512|FG001|Overall Study|Withdrawal by Subject|10|||
23393983|NCT03553836|65189511|FG000|Overall Study|Lost to Follow-up|1|||
23393984|NCT03553836|65189512|FG001|Overall Study|Lost to Follow-up|3|||
23393985|NCT03553836|65189511|FG000|Overall Study|Death|17|||
23393986|NCT03553836|65189512|FG001|Overall Study|Death|17|||
23393987|NCT03681678|65189513|FG000|Overall Study|Lost to Follow-up|20|||
23393988|NCT00835367|65189515|FG000|Washout|Adverse Event|2|||
23393989|NCT00835367|65189516|FG001|Washout|Adverse Event|0|||
23393990|NCT00835367|65189515|FG000|Washout|Withdrawal by Subject|1|||
23393991|NCT00835367|65189516|FG001|Washout|Withdrawal by Subject|0|||
23393992|NCT00835367|65189515|FG000|Second Intervention|Adverse Event|1|||
23393993|NCT00835367|65189516|FG001|Second Intervention|Adverse Event|1|||
23393994|NCT05166902|65189517|FG000|First Intervention|Lost to Follow-up|0|||
23393995|NCT05166902|65189518|FG001|First Intervention|Lost to Follow-up|1|||
23393996|NCT03682367|65189521|FG000|Overall Study|Protocol Violation|2|||
23393997|NCT03682367|65189522|FG001|Overall Study|Protocol Violation|1|||
23393998|NCT03682367|65189521|FG000|Overall Study|Closed Study Early|0|||
23393999|NCT03682367|65189522|FG001|Overall Study|Closed Study Early|3|||
23394000|NCT00863304|65189523|FG000|Overall Study|Adverse Event|10|||
23394001|NCT00863304|65189524|FG001|Overall Study|Adverse Event|4|||
23394002|NCT00863304|65189525|FG002|Overall Study|Adverse Event|14|||
23394003|NCT00863304|65189526|FG003|Overall Study|Adverse Event|16|||
23394004|NCT00863304|65189523|FG000|Overall Study|Lost to Follow-up|1|||
23394005|NCT00863304|65189524|FG001|Overall Study|Lost to Follow-up|5|||
23394006|NCT00863304|65189525|FG002|Overall Study|Lost to Follow-up|4|||
23394007|NCT00863304|65189526|FG003|Overall Study|Lost to Follow-up|2|||
23394008|NCT00863304|65189523|FG000|Overall Study|Lack of Efficacy|57|||
23394009|NCT00863304|65189524|FG001|Overall Study|Lack of Efficacy|26|||
23394010|NCT00863304|65189525|FG002|Overall Study|Lack of Efficacy|30|||
23394011|NCT00863304|65189526|FG003|Overall Study|Lack of Efficacy|28|||
23394012|NCT00863304|65189523|FG000|Overall Study|Withdrawal by Subject|19|||
23394013|NCT00863304|65189524|FG001|Overall Study|Withdrawal by Subject|14|||
23394014|NCT00863304|65189525|FG002|Overall Study|Withdrawal by Subject|20|||
23394015|NCT00863304|65189526|FG003|Overall Study|Withdrawal by Subject|18|||
23394016|NCT00863304|65189523|FG000|Overall Study|Other|1|||
23688559|NCT01892722|66237062|FG001|Overall Study|Protocol deviation|1|||
23688560|NCT01892722|66237061|FG000|Overall Study|Administrative problems|0|||
23688561|NCT01892722|66237062|FG001|Overall Study|Administrative problems|1|||
23688562|NCT01892722|66237061|FG000|Overall Study|Patient/guardian decision|0|||
23394017|NCT00863304|65189524|FG001|Overall Study|Other|0|||
23394018|NCT00863304|65189525|FG002|Overall Study|Other|0|||
23394019|NCT00863304|65189526|FG003|Overall Study|Other|1|||
23394020|NCT00863304|65189523|FG000|Overall Study|Protocol Violation|2|||
23394021|NCT00863304|65189524|FG001|Overall Study|Protocol Violation|6|||
23394022|NCT00863304|65189525|FG002|Overall Study|Protocol Violation|2|||
23394023|NCT00863304|65189526|FG003|Overall Study|Protocol Violation|0|||
23394024|NCT00863304|65189523|FG000|Overall Study|Randomized, but not Treated|3|||
23394025|NCT00863304|65189524|FG001|Overall Study|Randomized, but not Treated|1|||
23394026|NCT00863304|65189525|FG002|Overall Study|Randomized, but not Treated|4|||
23394027|NCT00863304|65189526|FG003|Overall Study|Randomized, but not Treated|1|||
23394028|NCT00863304|65189523|FG000|Overall Study|Entered extension study|101|||
23394029|NCT00863304|65189524|FG001|Overall Study|Entered extension study|129|||
23394030|NCT00863304|65189525|FG002|Overall Study|Entered extension study|113|||
23394031|NCT00863304|65189526|FG003|Overall Study|Entered extension study|125|||
23394032|NCT04164901|65189527|FG000|Overall Study|Withdrawal by Subject|4|||
23394033|NCT04164901|65189528|FG001|Overall Study|Withdrawal by Subject|4|||
23394034|NCT00581100|65189532|FG000|Overall Study|Death|1|||
23394035|NCT00581100|65189533|FG001|Overall Study|Death|0|||
23394036|NCT00581100|65189532|FG000|Overall Study|Adverse Event|2|||
23394037|NCT00581100|65189533|FG001|Overall Study|Adverse Event|1|||
23394038|NCT00581100|65189532|FG000|Overall Study|Withdrawal by Subject|1|||
23394039|NCT00581100|65189533|FG001|Overall Study|Withdrawal by Subject|4|||
23394040|NCT00581100|65189532|FG000|Overall Study|Other|3|||
23394041|NCT00581100|65189533|FG001|Overall Study|Other|0|||
23394042|NCT00323622|65189534|FG000|Overall Study|Other|30|||
23394043|NCT00323622|65189535|FG001|Overall Study|Other|91|||
23394044|NCT00323622|65189536|FG002|Overall Study|Other|4|||
23394045|NCT00323622|65189537|FG003|Overall Study|Other|12|||
23394046|NCT00323622|65189538|FG004|Overall Study|Other|32|||
23394047|NCT00323622|65189539|FG005|Overall Study|Other|74|||
23394048|NCT00323622|65189540|FG006|Overall Study|Other|5|||
23394049|NCT00323622|65189541|FG007|Overall Study|Other|13|||
23394050|NCT00323622|65189534|FG000|Overall Study|Death|1|||
23394051|NCT00323622|65189535|FG001|Overall Study|Death|1|||
23394052|NCT00323622|65189536|FG002|Overall Study|Death|0|||
23394053|NCT00323622|65189537|FG003|Overall Study|Death|0|||
23688563|NCT01892722|66237062|FG001|Overall Study|Patient/guardian decision|2|||
23688564|NCT01892722|66237061|FG000|Overall Study|Physician Decision|1|||
23688565|NCT01892722|66237062|FG001|Overall Study|Physician Decision|2|||
23688566|NCT01892722|66237061|FG000|Overall Study|Adverse Event|3|||
23688567|NCT01892722|66237062|FG001|Overall Study|Adverse Event|2|||
23688568|NCT01892722|66237061|FG000|Overall Study|Lack of Efficacy|0|||
23688569|NCT01892722|66237062|FG001|Overall Study|Lack of Efficacy|7|||
23688570|NCT01892722|66237061|FG000|Overall Study|Withdrawal by Subject|3|||
23688571|NCT01892722|66237062|FG001|Overall Study|Withdrawal by Subject|5|||
23688572|NCT01475734|66237063|FG000|Overall Study|Withdrawal by Subject|1|||
23688573|NCT01475734|66237064|FG001|Overall Study|Withdrawal by Subject|0|||
23688574|NCT01475734|66237063|FG000|Overall Study|Protocol Violation|1|||
23688575|NCT01475734|66237064|FG001|Overall Study|Protocol Violation|0|||
23688576|NCT01475734|66237063|FG000|Overall Study|Physician Decision|0|||
23688577|NCT01475734|66237064|FG001|Overall Study|Physician Decision|1|||
23688578|NCT00398112|66237069|FG000|Overall Study|Adverse Event|4|||
23688579|NCT00398112|66237069|FG000|Overall Study|Disease progression|9|||
23688580|NCT00398112|66237069|FG000|Overall Study|Alternative treatment|1|||
23688581|NCT00398112|66237069|FG000|Overall Study|Withdrawal by Subject|3|||
23688582|NCT00398112|66237069|FG000|Overall Study|Death|1|||
23688583|NCT04672083|66237070|FG000|Overall Study|Lost to Follow-up|1|||
23688584|NCT04672083|66237071|FG001|Overall Study|Lost to Follow-up|0|||
23394054|NCT00323622|65189538|FG004|Overall Study|Death|7|||
23394055|NCT00323622|65189539|FG005|Overall Study|Death|0|||
23394056|NCT00323622|65189540|FG006|Overall Study|Death|0|||
23394057|NCT00323622|65189541|FG007|Overall Study|Death|2|||
23394058|NCT03556891|65189543|FG000|Overall Study|Adverse Event|4|||
23394059|NCT03556891|65189543|FG000|Overall Study|MRI Need|3|||
23394060|NCT03556891|65189543|FG000|Overall Study|Device Failure|1|||
23394061|NCT03556891|65189543|FG000|Overall Study|Death|1|||
23394062|NCT03556891|65189543|FG000|Overall Study|Lost to Follow-up|1|||
23394063|NCT03556891|65189543|FG000|Overall Study|Missing at random|1|||
23394064|NCT03556891|65189543|FG000|Overall Study|Missing due to COVID|1|||
23394065|NCT03556891|65189543|FG000|Overall Study|Protocol Violation|1|||
23688585|NCT04672083|66237072|FG002|Overall Study|Lost to Follow-up|0|||
23688586|NCT04672083|66237073|FG003|Overall Study|Lost to Follow-up|0|||
23688587|NCT04672083|66237074|FG004|Overall Study|Lost to Follow-up|0|||
23688588|NCT02209506|66237075|FG000|Overall Study|Withdrawal by Subject|0|||
23688589|NCT02209506|66237076|FG001|Overall Study|Withdrawal by Subject|0|||
23688590|NCT02209506|66237077|FG002|Overall Study|Withdrawal by Subject|0|||
23688591|NCT02209506|66237078|FG003|Overall Study|Withdrawal by Subject|0|||
23688592|NCT02209506|66237079|FG004|Overall Study|Withdrawal by Subject|1|||
23688593|NCT02921425|66237080|FG000|Overall Study|Protocol Violation|9|||
23688594|NCT00591734|66237081|FG000|Overall Study|Lack of Efficacy|35|||
23688595|NCT00591734|66237081|FG000|Overall Study|Adverse Event|5|||
23688596|NCT00591734|66237081|FG000|Overall Study|Physician Decision|5|||
23688597|NCT00591734|66237081|FG000|Overall Study|Intercurrent Illness|8|||
23688598|NCT00809133|66237082|FG000|Overall Study|Progressive disease|2|||
23688599|NCT00809133|66237083|FG001|Overall Study|Progressive disease|5|||
23688600|NCT00809133|66237084|FG002|Overall Study|Progressive disease|5|||
23688601|NCT00809133|66237085|FG003|Overall Study|Progressive disease|3|||
23394066|NCT03524157|65189551|FG000|Overall Study|cytology not readable|0|||
23394067|NCT03524157|65189552|FG001|Overall Study|cytology not readable|0|||
23394068|NCT03524157|65189553|FG002|Overall Study|cytology not readable|1|||
23394069|NCT00656370|65189557|FG000|Overall Study|Screen Failures|7|||
23394070|NCT00656370|65189557|FG000|Overall Study|Alternates|3|||
23394071|NCT01437189|65189558|FG000|Overall Study|Adverse Event|3|||
23394072|NCT01437189|65189558|FG000|Overall Study|Lack of Efficacy|4|||
23394073|NCT01437189|65189558|FG000|Overall Study|Withdrawal by Subject|8|||
23394074|NCT01702298|65189560|FG000|Overall Study|Withdrawal by Subject|1|||
23394075|NCT02706392|65189561|FG000|Overall Study|Death|1|||
23394076|NCT02706392|65189562|FG001|Overall Study|Death|0|||
23394077|NCT02706392|65189563|FG002|Overall Study|Death|2|||
23394078|NCT02706392|65189564|FG003|Overall Study|Death|2|||
23394079|NCT02706392|65189565|FG004|Overall Study|Death|5|||
23394080|NCT02706392|65189566|FG005|Overall Study|Death|2|||
23394081|NCT00867035|65189567|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
23394082|NCT00867035|65189568|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
23394083|NCT00867035|65189567|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
23688602|NCT00809133|66237086|FG004|Overall Study|Progressive disease|4|||
23688603|NCT00809133|66237087|FG005|Overall Study|Progressive disease|1|||
23688604|NCT00809133|66237088|FG006|Overall Study|Progressive disease|3|||
23688605|NCT00809133|66237089|FG007|Overall Study|Progressive disease|3|||
23688606|NCT00809133|66237090|FG008|Overall Study|Progressive disease|3|||
23688607|NCT00809133|66237091|FG009|Overall Study|Progressive disease|9|||
23688608|NCT00809133|66237092|FG010|Overall Study|Progressive disease|5|||
23688609|NCT00809133|66237093|FG011|Overall Study|Progressive disease|7|||
23394084|NCT00867035|65189568|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
23394085|NCT03514134|65189569|FG000|Overall Study|Lost to Follow-up|0|||
23394086|NCT03514134|65189570|FG001|Overall Study|Lost to Follow-up|1|||
23394087|NCT01405196|65189571|FG000|Overall Study|Study Terminated by Sponsor|0|||
23394088|NCT01405196|65189572|FG001|Overall Study|Study Terminated by Sponsor|0|||
23498462|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
23498463|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
23498464|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
23498465|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
23498466|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Administrative problems|0|||
23498467|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Administrative problems|0|||
23498468|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Administrative problems|2|||
23498469|NCT00709761|65566336|FG000|Overall Study|Withdrawal by Subject|8|||
23498470|NCT00709761|65566336|FG000|Overall Study|study closed/terminated|17|||
23498471|NCT00709761|65566336|FG000|Overall Study|Lost to Follow-up|2|||
23498472|NCT05209360|65566337|FG000|Overall Study|Withdrawal by Subject|0|||
23498473|NCT05209360|65566338|FG001|Overall Study|Withdrawal by Subject|0|||
23498474|NCT05209360|65566339|FG002|Overall Study|Withdrawal by Subject|1|||
23498475|NCT05209360|65566340|FG003|Overall Study|Withdrawal by Subject|0|||
23498476|NCT05209360|65566341|FG004|Overall Study|Withdrawal by Subject|0|||
23498477|NCT05209360|65566342|FG005|Overall Study|Withdrawal by Subject|0|||
23498478|NCT01686828|65566343|FG000|Overall Study|Physician Decision|1|||
23498479|NCT01686828|65566344|FG001|Overall Study|Physician Decision|0|||
23498480|NCT01686828|65566345|FG002|Overall Study|Physician Decision|0|||
23498481|NCT01686828|65566346|FG003|Overall Study|Physician Decision|0|||
23498482|NCT01686828|65566343|FG000|Overall Study|New Job|0|||
23498483|NCT01686828|65566344|FG001|Overall Study|New Job|1|||
23498484|NCT01686828|65566345|FG002|Overall Study|New Job|0|||
23498485|NCT01686828|65566346|FG003|Overall Study|New Job|0|||
23498486|NCT01686828|65566343|FG000|Overall Study|Weight Loss|0|||
23498487|NCT01686828|65566344|FG001|Overall Study|Weight Loss|0|||
23498488|NCT01686828|65566345|FG002|Overall Study|Weight Loss|1|||
23498489|NCT01686828|65566346|FG003|Overall Study|Weight Loss|0|||
23498490|NCT00036270|65566348|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
23498491|NCT00036270|65566349|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
23498492|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
23498493|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
23498494|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
23498495|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
23498496|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
23498497|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
23498498|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Other|277|||
23498499|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Other|288|||
23498500|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
23498501|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
23498502|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
23498503|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
23498504|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
23498505|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
23688610|NCT00809133|66237094|FG012|Overall Study|Progressive disease|5|||
23688611|NCT00809133|66237095|FG013|Overall Study|Progressive disease|4|||
23498506|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
23498507|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
23688612|NCT00809133|66237082|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23394089|NCT01405196|65189573|FG002|Overall Study|Study Terminated by Sponsor|9|||
23394090|NCT01405196|65189574|FG003|Overall Study|Study Terminated by Sponsor|0|||
23394091|NCT01405196|65189571|FG000|Overall Study|Other|2|||
23394092|NCT01405196|65189572|FG001|Overall Study|Other|2|||
23394093|NCT01405196|65189573|FG002|Overall Study|Other|5|||
23688613|NCT00809133|66237083|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23394094|NCT01405196|65189574|FG003|Overall Study|Other|0|||
23394095|NCT01405196|65189571|FG000|Overall Study|Withdrawal by Subject|4|||
23394096|NCT01405196|65189572|FG001|Overall Study|Withdrawal by Subject|6|||
23394097|NCT01405196|65189573|FG002|Overall Study|Withdrawal by Subject|3|||
23394098|NCT01405196|65189574|FG003|Overall Study|Withdrawal by Subject|6|||
23394099|NCT01405196|65189571|FG000|Overall Study|Adverse Event|2|||
23394100|NCT01405196|65189572|FG001|Overall Study|Adverse Event|2|||
23394101|NCT01405196|65189573|FG002|Overall Study|Adverse Event|0|||
23394102|NCT01405196|65189574|FG003|Overall Study|Adverse Event|2|||
23394103|NCT01405196|65189571|FG000|Overall Study|Death|1|||
23394104|NCT01405196|65189572|FG001|Overall Study|Death|0|||
23688614|NCT00809133|66237084|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688615|NCT00809133|66237085|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688616|NCT00809133|66237086|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688617|NCT00809133|66237087|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23688618|NCT00809133|66237088|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23688619|NCT00809133|66237089|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23688620|NCT00809133|66237090|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688621|NCT00809133|66237091|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688622|NCT00809133|66237092|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688623|NCT00809133|66237093|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688624|NCT00809133|66237094|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23688625|NCT00809133|66237095|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23688626|NCT00809133|66237082|FG000|Overall Study|Other adverse event|1|||
23688627|NCT00809133|66237083|FG001|Overall Study|Other adverse event|1|||
23688628|NCT00809133|66237084|FG002|Overall Study|Other adverse event|1|||
23688629|NCT00809133|66237085|FG003|Overall Study|Other adverse event|0|||
23688630|NCT00809133|66237086|FG004|Overall Study|Other adverse event|0|||
23688631|NCT00809133|66237087|FG005|Overall Study|Other adverse event|3|||
23688632|NCT00809133|66237088|FG006|Overall Study|Other adverse event|2|||
23688633|NCT00809133|66237089|FG007|Overall Study|Other adverse event|4|||
23688634|NCT00809133|66237090|FG008|Overall Study|Other adverse event|0|||
23688635|NCT00809133|66237091|FG009|Overall Study|Other adverse event|0|||
23688636|NCT00809133|66237092|FG010|Overall Study|Other adverse event|1|||
23688637|NCT00809133|66237093|FG011|Overall Study|Other adverse event|1|||
23688638|NCT00809133|66237094|FG012|Overall Study|Other adverse event|0|||
23688639|NCT00809133|66237095|FG013|Overall Study|Other adverse event|1|||
23688640|NCT00809133|66237082|FG000|Overall Study|Lost to Follow-up|0|||
23688641|NCT00809133|66237083|FG001|Overall Study|Lost to Follow-up|0|||
23688642|NCT00809133|66237084|FG002|Overall Study|Lost to Follow-up|0|||
23688643|NCT00809133|66237085|FG003|Overall Study|Lost to Follow-up|0|||
23688644|NCT00809133|66237086|FG004|Overall Study|Lost to Follow-up|0|||
23688645|NCT00809133|66237087|FG005|Overall Study|Lost to Follow-up|1|||
23688646|NCT00809133|66237088|FG006|Overall Study|Lost to Follow-up|0|||
23688647|NCT00809133|66237089|FG007|Overall Study|Lost to Follow-up|0|||
23688648|NCT00809133|66237090|FG008|Overall Study|Lost to Follow-up|0|||
23688649|NCT00809133|66237091|FG009|Overall Study|Lost to Follow-up|0|||
23688650|NCT00809133|66237092|FG010|Overall Study|Lost to Follow-up|0|||
23688651|NCT00809133|66237093|FG011|Overall Study|Lost to Follow-up|0|||
23688652|NCT00809133|66237094|FG012|Overall Study|Lost to Follow-up|0|||
23688653|NCT00809133|66237095|FG013|Overall Study|Lost to Follow-up|0|||
23688654|NCT00809133|66237082|FG000|Overall Study|Consent withdrawn|0|||
23688655|NCT00809133|66237083|FG001|Overall Study|Consent withdrawn|0|||
23688656|NCT00809133|66237084|FG002|Overall Study|Consent withdrawn|0|||
23688657|NCT00809133|66237085|FG003|Overall Study|Consent withdrawn|0|||
23688658|NCT00809133|66237086|FG004|Overall Study|Consent withdrawn|1|||
23688659|NCT00809133|66237087|FG005|Overall Study|Consent withdrawn|0|||
23688660|NCT00809133|66237088|FG006|Overall Study|Consent withdrawn|0|||
23688661|NCT00809133|66237089|FG007|Overall Study|Consent withdrawn|0|||
23688662|NCT00809133|66237090|FG008|Overall Study|Consent withdrawn|0|||
23688663|NCT00809133|66237091|FG009|Overall Study|Consent withdrawn|0|||
23688664|NCT00809133|66237092|FG010|Overall Study|Consent withdrawn|0|||
23688665|NCT00809133|66237093|FG011|Overall Study|Consent withdrawn|0|||
23688666|NCT00809133|66237094|FG012|Overall Study|Consent withdrawn|0|||
23688667|NCT00809133|66237095|FG013|Overall Study|Consent withdrawn|0|||
23688668|NCT00809133|66237082|FG000|Overall Study|Other not mentioned above|0|||
23688669|NCT00809133|66237083|FG001|Overall Study|Other not mentioned above|1|||
23688670|NCT00809133|66237084|FG002|Overall Study|Other not mentioned above|0|||
23688671|NCT00809133|66237085|FG003|Overall Study|Other not mentioned above|0|||
23688672|NCT00809133|66237086|FG004|Overall Study|Other not mentioned above|0|||
23688673|NCT00809133|66237087|FG005|Overall Study|Other not mentioned above|1|||
23688674|NCT00809133|66237088|FG006|Overall Study|Other not mentioned above|0|||
23688675|NCT00809133|66237089|FG007|Overall Study|Other not mentioned above|0|||
23394105|NCT01405196|65189573|FG002|Overall Study|Death|3|||
23394106|NCT01405196|65189574|FG003|Overall Study|Death|0|||
23394107|NCT01405196|65189571|FG000|Overall Study|Lost to Follow-up|2|||
23394108|NCT01405196|65189572|FG001|Overall Study|Lost to Follow-up|2|||
23688676|NCT00809133|66237090|FG008|Overall Study|Other not mentioned above|0|||
23688677|NCT00809133|66237091|FG009|Overall Study|Other not mentioned above|0|||
23688678|NCT00809133|66237092|FG010|Overall Study|Other not mentioned above|0|||
23688679|NCT00809133|66237093|FG011|Overall Study|Other not mentioned above|0|||
23688680|NCT00809133|66237094|FG012|Overall Study|Other not mentioned above|0|||
23688681|NCT00809133|66237095|FG013|Overall Study|Other not mentioned above|0|||
23688682|NCT00260208|66237096|FG000|Overall Study|Subject withdrew consent|11|||
23688683|NCT00260208|66237097|FG001|Overall Study|Subject withdrew consent|7|||
23688684|NCT00260208|66237096|FG000|Overall Study|Lost to Follow-up|6|||
23688685|NCT00260208|66237097|FG001|Overall Study|Lost to Follow-up|1|||
23688686|NCT00260208|66237096|FG000|Overall Study|Death|12|||
23688687|NCT00260208|66237097|FG001|Overall Study|Death|10|||
23688688|NCT00260208|66237096|FG000|Overall Study|Missing|18|||
23688689|NCT00260208|66237097|FG001|Overall Study|Missing|16|||
23688690|NCT00832819|66237100|FG000|Overall Study|Adverse Event|0|||
23688691|NCT00832819|66237101|FG001|Overall Study|Adverse Event|1|||
23688692|NCT00832819|66237102|FG002|Overall Study|Adverse Event|0|||
23688693|NCT00832819|66237100|FG000|Overall Study|Protocol Violation|0|||
23688694|NCT00832819|66237101|FG001|Overall Study|Protocol Violation|0|||
23394109|NCT01405196|65189573|FG002|Overall Study|Lost to Follow-up|3|||
23394110|NCT01405196|65189574|FG003|Overall Study|Lost to Follow-up|1|||
23394111|NCT00480532|65189575|FG000|Overall Study|Withdrawal by Subject|2|||
23394112|NCT00480532|65189576|FG001|Overall Study|Withdrawal by Subject|4|||
23394113|NCT00480532|65189577|FG002|Overall Study|Withdrawal by Subject|3|||
23394114|NCT00480532|65189578|FG003|Overall Study|Withdrawal by Subject|1|||
23394115|NCT00480532|65189575|FG000|Overall Study|Protocol Violation|0|||
23688695|NCT00832819|66237102|FG002|Overall Study|Protocol Violation|1|||
23688696|NCT00087438|66237105|FG000|Overall Study|Ineligible / No protocol treatment|4|||
23688697|NCT03715465|66237106|FG000|Overall Study|Withdrawal by Subject|1|||
23688698|NCT03715465|66237107|FG001|Overall Study|Withdrawal by Subject|2|||
23688699|NCT01238120|66237108|FG000|Overall Study|Withdrawal by Subject|4|||
23688700|NCT01238120|66237109|FG001|Overall Study|Withdrawal by Subject|1|||
23688701|NCT01238120|66237110|FG002|Overall Study|Withdrawal by Subject|2|||
23688702|NCT01238120|66237111|FG003|Overall Study|Withdrawal by Subject|5|||
23688703|NCT01238120|66237108|FG000|Overall Study|Lost to Follow-up|2|||
23688704|NCT01238120|66237109|FG001|Overall Study|Lost to Follow-up|0|||
23688705|NCT01238120|66237110|FG002|Overall Study|Lost to Follow-up|1|||
23688706|NCT01238120|66237111|FG003|Overall Study|Lost to Follow-up|1|||
23688707|NCT01238120|66237108|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
23688708|NCT01238120|66237109|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
23688709|NCT01238120|66237110|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
23688710|NCT01238120|66237111|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
23394116|NCT00480532|65189576|FG001|Overall Study|Protocol Violation|0|||
23394117|NCT00480532|65189577|FG002|Overall Study|Protocol Violation|1|||
23394118|NCT00480532|65189578|FG003|Overall Study|Protocol Violation|0|||
23688711|NCT00693706|66237112|FG000|Overall Study|Protocol Violation|0|||
23688712|NCT00693706|66237113|FG001|Overall Study|Protocol Violation|1|||
23688713|NCT00686543|66237114|FG000|Overall Study|Adverse Event|9|||
23688714|NCT00686543|66237115|FG001|Overall Study|Adverse Event|1|||
23688715|NCT00686543|66237116|FG002|Overall Study|Adverse Event|3|||
23688716|NCT00686543|66237117|FG003|Overall Study|Adverse Event|2|||
23688717|NCT00686543|66237114|FG000|Overall Study|Withdrawal by Subject|2|||
23688718|NCT00686543|66237115|FG001|Overall Study|Withdrawal by Subject|0|||
23688719|NCT00686543|66237116|FG002|Overall Study|Withdrawal by Subject|0|||
23688720|NCT00686543|66237117|FG003|Overall Study|Withdrawal by Subject|0|||
23688721|NCT00686543|66237114|FG000|Overall Study|Protocol Violation|3|||
23688722|NCT00686543|66237115|FG001|Overall Study|Protocol Violation|0|||
23688723|NCT00686543|66237116|FG002|Overall Study|Protocol Violation|2|||
23688724|NCT00686543|66237117|FG003|Overall Study|Protocol Violation|1|||
23688725|NCT02722044|66237120|FG000|Overall Study|Adverse Event|2|||
23688726|NCT02722044|66237120|FG000|Overall Study|Physician Decision|1|||
23688727|NCT02722044|66237120|FG000|Overall Study|Withdrawal by Subject|1|||
23688728|NCT02722044|66237120|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
23688729|NCT05300087|66237121|FG000|Overall Study|Withdrawal by Subject|0|||
23688730|NCT05300087|66237122|FG001|Overall Study|Withdrawal by Subject|1|||
23688731|NCT03542682|66237128|FG000|Overall Study|COVID-19 Protocol|0|||
23688732|NCT03542682|66237129|FG001|Overall Study|COVID-19 Protocol|1|||
23688733|NCT01245673|66237132|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
23688734|NCT00778830|66237135|FG000|Overall Study|Ongoing at data cut-off|0|||
23688735|NCT00778830|66237136|FG001|Overall Study|Ongoing at data cut-off|1|||
23688736|NCT01511445|66237137|FG000|Overall Study|Lost to Follow-up|3|||
23688737|NCT01511445|66237138|FG001|Overall Study|Lost to Follow-up|1|||
23688738|NCT01511445|66237137|FG000|Overall Study|Protocol Violation|1|||
23688739|NCT01511445|66237138|FG001|Overall Study|Protocol Violation|3|||
23688740|NCT01511445|66237137|FG000|Overall Study|Protocol Violation|1|||
23394119|NCT01174563|65189579|FG000|Overall Study|Progressive Disease|45|||
23394120|NCT01174563|65189579|FG000|Overall Study|Death|5|||
23394121|NCT01174563|65189579|FG000|Overall Study|Investigator's Discretion|5|||
23688741|NCT01511445|66237138|FG001|Overall Study|Protocol Violation|0|||
23688742|NCT01485614|66237141|FG000|Randomization|Not Treated|1|||
23688743|NCT01485614|66237142|FG001|Randomization|Not Treated|0|||
23688744|NCT01485614|66237143|FG002|Randomization|Not Treated|0|||
23688745|NCT01485614|66237144|FG003|Randomization|Not Treated|0|||
23688746|NCT01485614|66237141|FG000|Weeks 0-20|Lost to Follow-up|2|||
23688747|NCT01485614|66237142|FG001|Weeks 0-20|Lost to Follow-up|0|||
23688748|NCT01485614|66237143|FG002|Weeks 0-20|Lost to Follow-up|0|||
23688749|NCT01485614|66237144|FG003|Weeks 0-20|Lost to Follow-up|0|||
23688750|NCT01485614|66237141|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
23688751|NCT01485614|66237142|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
23688752|NCT01485614|66237143|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
23688753|NCT01485614|66237144|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
23498508|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
23688754|NCT01485614|66237141|FG000|Weeks 0-20|Withdrawal by Subject|3|||
23688755|NCT01485614|66237142|FG001|Weeks 0-20|Withdrawal by Subject|2|||
23688756|NCT01485614|66237143|FG002|Weeks 0-20|Withdrawal by Subject|1|||
23688757|NCT01485614|66237144|FG003|Weeks 0-20|Withdrawal by Subject|0|||
23688758|NCT01485614|66237141|FG000|Weeks 20-54|Lost to Follow-up|4|||
23688759|NCT01485614|66237142|FG001|Weeks 20-54|Lost to Follow-up|3|||
23688760|NCT01485614|66237143|FG002|Weeks 20-54|Lost to Follow-up|1|||
23688761|NCT01485614|66237144|FG003|Weeks 20-54|Lost to Follow-up|0|||
23688762|NCT01485614|66237141|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
23688763|NCT01485614|66237142|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
23688764|NCT01485614|66237143|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
23688765|NCT01485614|66237144|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
23688766|NCT01485614|66237141|FG000|Weeks 20-54|Withdrawal by Subject|5|||
23688767|NCT01485614|66237142|FG001|Weeks 20-54|Withdrawal by Subject|3|||
23688768|NCT01485614|66237143|FG002|Weeks 20-54|Withdrawal by Subject|0|||
23688769|NCT01485614|66237144|FG003|Weeks 20-54|Withdrawal by Subject|0|||
23688770|NCT04348851|66237148|FG000|Post-Test 1|Withdrawal by Subject|0|||
23688771|NCT04348851|66237149|FG001|Post-Test 1|Withdrawal by Subject|1|||
23688772|NCT04348851|66237150|FG002|Post-Test 1|Withdrawal by Subject|0|||
23688773|NCT04348851|66237151|FG003|Post-Test 1|Withdrawal by Subject|0|||
23688774|NCT04348851|66237148|FG000|Post-Test 1|Lost to Follow-up|0|||
23688775|NCT04348851|66237149|FG001|Post-Test 1|Lost to Follow-up|1|||
23688776|NCT04348851|66237150|FG002|Post-Test 1|Lost to Follow-up|0|||
23688777|NCT04348851|66237151|FG003|Post-Test 1|Lost to Follow-up|0|||
23688778|NCT04348851|66237148|FG000|Post-Test 2|Stroke survivor death|0|||
23688779|NCT04348851|66237149|FG001|Post-Test 2|Stroke survivor death|1|||
23688780|NCT04348851|66237150|FG002|Post-Test 2|Stroke survivor death|0|||
23688781|NCT04348851|66237151|FG003|Post-Test 2|Stroke survivor death|1|||
23688782|NCT01389245|66237152|FG000|Overall Study|Protocol Violation|10|||
23688783|NCT01389245|66237152|FG000|Overall Study|Lost to Follow-up|3|||
23688784|NCT01389245|66237152|FG000|Overall Study|Withdrawal by Subject|2|||
23688785|NCT00702143|66237155|FG000|Overall Study|Lost to Follow-up|0|||
23688786|NCT00702143|66237156|FG001|Overall Study|Lost to Follow-up|0|||
23688787|NCT00702143|66237157|FG002|Overall Study|Lost to Follow-up|1|||
23688788|NCT01551745|66237158|FG000|Overall Study|Withdrawal by Subject|1|||
23688789|NCT01551745|66237158|FG000|Overall Study|Disease Progression|2|||
23688790|NCT00270894|66237159|FG000|Overall Study|Adverse Event|1|||
23688791|NCT00270894|66237159|FG000|Overall Study|Withdrawal by Subject|1|||
23688792|NCT02054702|66237162|FG000|Overall Study|Lost to Follow-up|3|||
23688793|NCT02054702|66237163|FG001|Overall Study|Lost to Follow-up|5|||
23688794|NCT02054702|66237162|FG000|Overall Study|Adverse Event|3|||
23688795|NCT02054702|66237163|FG001|Overall Study|Adverse Event|1|||
23688796|NCT02054702|66237162|FG000|Overall Study|Met Withdrawal Criteria|4|||
23688797|NCT02054702|66237163|FG001|Overall Study|Met Withdrawal Criteria|1|||
23688798|NCT02054702|66237162|FG000|Overall Study|Physician Decision|0|||
23688799|NCT02054702|66237163|FG001|Overall Study|Physician Decision|1|||
23498509|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
23688800|NCT02054702|66237162|FG000|Overall Study|Withdrawal by Subject|14|||
23688801|NCT02054702|66237163|FG001|Overall Study|Withdrawal by Subject|4|||
23688802|NCT00254566|66237164|FG000|Overall Study|Death|1|||
23688803|NCT00254566|66237165|FG001|Overall Study|Death|0|||
23688804|NCT00254566|66237164|FG000|Overall Study|Adverse Event|5|||
23688805|NCT00254566|66237165|FG001|Overall Study|Adverse Event|4|||
23688806|NCT00254566|66237164|FG000|Overall Study|Lack of Efficacy|12|||
23688807|NCT00254566|66237165|FG001|Overall Study|Lack of Efficacy|9|||
23688808|NCT00254566|66237164|FG000|Overall Study|Other|1|||
23688809|NCT00254566|66237165|FG001|Overall Study|Other|5|||
23688810|NCT00254566|66237164|FG000|Overall Study|Withdrawal by Subject|5|||
23688811|NCT00254566|66237165|FG001|Overall Study|Withdrawal by Subject|6|||
23688812|NCT00254566|66237164|FG000|Overall Study|Lost to Follow-up|7|||
23688813|NCT00254566|66237165|FG001|Overall Study|Lost to Follow-up|2|||
23688814|NCT02698189|66237166|FG000|Overall Study|Physician Decision|3|||
23688815|NCT02698189|66237167|FG001|Overall Study|Physician Decision|0|||
23688816|NCT02698189|66237166|FG000|Overall Study|Progressive disease|0|||
23688817|NCT02698189|66237167|FG001|Overall Study|Progressive disease|5|||
23688818|NCT02698189|66237166|FG000|Overall Study|Study terminated by sponsor|0|||
23394122|NCT01174563|65189579|FG000|Overall Study|Participant Withdrew Consent|3|||
23394123|NCT01174563|65189579|FG000|Overall Study|Rash Adverse Event|1|||
23394124|NCT01174563|65189579|FG000|Overall Study|Sponsor's decision|1|||
23606279|NCT01916109|65947199|FG000|Overall Study|Withdrawal by Subject|1|||
23606280|NCT04748341|65947201|FG000|Overall Study|Lost to Follow-up|1|||
23606281|NCT04748341|65947202|FG001|Overall Study|Lost to Follow-up|1|||
23606282|NCT02060487|65947203|FG000|Overall Study|Other|1|||
23606283|NCT02060487|65947204|FG001|Overall Study|Other|2|||
23606284|NCT02060487|65947205|FG002|Overall Study|Other|1|||
23606285|NCT02060487|65947203|FG000|Overall Study|Lack of Efficacy|0|||
23606286|NCT02060487|65947204|FG001|Overall Study|Lack of Efficacy|1|||
23606287|NCT02060487|65947205|FG002|Overall Study|Lack of Efficacy|0|||
23606288|NCT02060487|65947203|FG000|Overall Study|Withdrawal by Subject|3|||
23606289|NCT02060487|65947204|FG001|Overall Study|Withdrawal by Subject|10|||
23606290|NCT02060487|65947205|FG002|Overall Study|Withdrawal by Subject|4|||
23394137|NCT02971163|65189588|FG000|Overall Study|Lost to Follow-up|4|||
23394138|NCT02971163|65189589|FG001|Overall Study|Lost to Follow-up|2|||
23394139|NCT03110562|65189591|FG000|Initial Treatment Period|Disease Progression|1|||
23394140|NCT03110562|65189592|FG001|Initial Treatment Period|Disease Progression|1|||
23394141|NCT03110562|65189593|FG002|Initial Treatment Period|Disease Progression|0|||
23394142|NCT03110562|65189594|FG003|Initial Treatment Period|Disease Progression|0|||
23394143|NCT03110562|65189591|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
23394144|NCT03110562|65189592|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
23394145|NCT03110562|65189593|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
23394146|NCT03110562|65189594|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
23394147|NCT03110562|65189591|FG000|Initial Treatment Period|Adverse Event|1|||
23394148|NCT03110562|65189592|FG001|Initial Treatment Period|Adverse Event|0|||
23394149|NCT03110562|65189593|FG002|Initial Treatment Period|Adverse Event|0|||
23394150|NCT03110562|65189594|FG003|Initial Treatment Period|Adverse Event|0|||
23394151|NCT03110562|65189591|FG000|Initial Treatment Period|Death|74|||
23394152|NCT03110562|65189592|FG001|Initial Treatment Period|Death|82|||
23394153|NCT03110562|65189593|FG002|Initial Treatment Period|Death|0|||
23394154|NCT03110562|65189594|FG003|Initial Treatment Period|Death|0|||
23394155|NCT03110562|65189591|FG000|Initial Treatment Period|Lost to Follow-up|13|||
23394156|NCT03110562|65189592|FG001|Initial Treatment Period|Lost to Follow-up|8|||
23394157|NCT03110562|65189593|FG002|Initial Treatment Period|Lost to Follow-up|0|||
23394158|NCT03110562|65189594|FG003|Initial Treatment Period|Lost to Follow-up|0|||
23394159|NCT03110562|65189591|FG000|Initial Treatment Period|Protocol Deviation|1|||
23394160|NCT03110562|65189592|FG001|Initial Treatment Period|Protocol Deviation|0|||
23394161|NCT03110562|65189593|FG002|Initial Treatment Period|Protocol Deviation|0|||
23394162|NCT03110562|65189594|FG003|Initial Treatment Period|Protocol Deviation|0|||
23394163|NCT03110562|65189591|FG000|Initial Treatment Period|Physician Decision|2|||
23394164|NCT03110562|65189592|FG001|Initial Treatment Period|Physician Decision|1|||
23688819|NCT02698189|66237167|FG001|Overall Study|Study terminated by sponsor|1|||
23688820|NCT04800315|66237173|FG000|Randomization|Did not receive study treatment|1|||
23688821|NCT04800315|66237174|FG001|Randomization|Did not receive study treatment|0|||
23394165|NCT03110562|65189593|FG002|Initial Treatment Period|Physician Decision|0|||
23394166|NCT03110562|65189594|FG003|Initial Treatment Period|Physician Decision|0|||
23688822|NCT04800315|66237175|FG002|Randomization|Did not receive study treatment|0|||
23688823|NCT04800315|66237176|FG003|Randomization|Did not receive study treatment|0|||
23688824|NCT04800315|66237173|FG000|Treatment Period|Adverse Event|4|||
23688825|NCT04800315|66237174|FG001|Treatment Period|Adverse Event|2|||
23688826|NCT04800315|66237175|FG002|Treatment Period|Adverse Event|1|||
23688827|NCT04800315|66237176|FG003|Treatment Period|Adverse Event|2|||
23688828|NCT04800315|66237173|FG000|Treatment Period|Lack of Efficacy|1|||
23688829|NCT04800315|66237174|FG001|Treatment Period|Lack of Efficacy|0|||
23688830|NCT04800315|66237175|FG002|Treatment Period|Lack of Efficacy|0|||
23688831|NCT04800315|66237176|FG003|Treatment Period|Lack of Efficacy|3|||
23688832|NCT04800315|66237173|FG000|Treatment Period|Lost to Follow-up|0|||
23688833|NCT04800315|66237174|FG001|Treatment Period|Lost to Follow-up|1|||
23394167|NCT03110562|65189591|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
23394168|NCT03110562|65189592|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
23394169|NCT03110562|65189593|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
23688834|NCT04800315|66237175|FG002|Treatment Period|Lost to Follow-up|2|||
23688835|NCT04800315|66237176|FG003|Treatment Period|Lost to Follow-up|2|||
23688836|NCT04800315|66237173|FG000|Treatment Period|Withdrawal by participant|0|||
23688837|NCT04800315|66237174|FG001|Treatment Period|Withdrawal by participant|0|||
23688838|NCT04800315|66237175|FG002|Treatment Period|Withdrawal by participant|0|||
23688839|NCT04800315|66237176|FG003|Treatment Period|Withdrawal by participant|4|||
23394170|NCT03110562|65189594|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
23394171|NCT03110562|65189591|FG000|Initial Treatment Period|Other|5|||
23394172|NCT03110562|65189592|FG001|Initial Treatment Period|Other|4|||
23394173|NCT03110562|65189593|FG002|Initial Treatment Period|Other|0|||
23394174|NCT03110562|65189594|FG003|Initial Treatment Period|Other|0|||
23688840|NCT04800315|66237173|FG000|Treatment Period|Other Reasons|0|||
23688841|NCT04800315|66237174|FG001|Treatment Period|Other Reasons|2|||
23688842|NCT04800315|66237175|FG002|Treatment Period|Other Reasons|0|||
23688843|NCT04800315|66237176|FG003|Treatment Period|Other Reasons|1|||
23688844|NCT00486603|66237181|FG000|Overall Study|Withdrawal by Subject|1|||
23688845|NCT00486603|66237182|FG001|Overall Study|Withdrawal by Subject|0|||
23688846|NCT00486603|66237183|FG002|Overall Study|Withdrawal by Subject|0|||
23688847|NCT00486603|66237184|FG003|Overall Study|Withdrawal by Subject|0|||
23688848|NCT00486603|66237185|FG004|Overall Study|Withdrawal by Subject|0|||
23688849|NCT00486603|66237181|FG000|Overall Study|Physician Decision|0|||
23688850|NCT00486603|66237182|FG001|Overall Study|Physician Decision|1|||
23688851|NCT00486603|66237183|FG002|Overall Study|Physician Decision|0|||
23688852|NCT00486603|66237184|FG003|Overall Study|Physician Decision|0|||
23688853|NCT00486603|66237185|FG004|Overall Study|Physician Decision|0|||
23688854|NCT00432237|66237186|FG000|Overall Study|Adverse Event|0|||
23688855|NCT00432237|66237187|FG001|Overall Study|Adverse Event|0|||
23688856|NCT00432237|66237188|FG002|Overall Study|Adverse Event|0|||
23688857|NCT00432237|66237189|FG003|Overall Study|Adverse Event|1|||
23688858|NCT00432237|66237186|FG000|Overall Study|Lack of Efficacy|0|||
23688859|NCT00432237|66237187|FG001|Overall Study|Lack of Efficacy|0|||
23688860|NCT00432237|66237188|FG002|Overall Study|Lack of Efficacy|0|||
23688861|NCT00432237|66237189|FG003|Overall Study|Lack of Efficacy|1|||
23688862|NCT00432237|66237186|FG000|Overall Study|Lost to Follow-up|10|||
23688863|NCT00432237|66237187|FG001|Overall Study|Lost to Follow-up|10|||
23688864|NCT00432237|66237188|FG002|Overall Study|Lost to Follow-up|18|||
23688865|NCT00432237|66237189|FG003|Overall Study|Lost to Follow-up|18|||
23688866|NCT00432237|66237186|FG000|Overall Study|Physician Decision|1|||
23688867|NCT00432237|66237187|FG001|Overall Study|Physician Decision|3|||
23688868|NCT00432237|66237188|FG002|Overall Study|Physician Decision|2|||
23688869|NCT00432237|66237189|FG003|Overall Study|Physician Decision|1|||
23688870|NCT00432237|66237186|FG000|Overall Study|Pregnancy|0|||
23688871|NCT00432237|66237187|FG001|Overall Study|Pregnancy|1|||
23688872|NCT00432237|66237188|FG002|Overall Study|Pregnancy|0|||
23688873|NCT00432237|66237189|FG003|Overall Study|Pregnancy|0|||
23688874|NCT00432237|66237186|FG000|Overall Study|Protocol Violation|13|||
23688875|NCT00432237|66237187|FG001|Overall Study|Protocol Violation|10|||
23688876|NCT00432237|66237188|FG002|Overall Study|Protocol Violation|11|||
23688877|NCT00432237|66237189|FG003|Overall Study|Protocol Violation|8|||
23688878|NCT00432237|66237186|FG000|Overall Study|Withdrawal by Subject|5|||
23688879|NCT00432237|66237187|FG001|Overall Study|Withdrawal by Subject|6|||
23688880|NCT00432237|66237188|FG002|Overall Study|Withdrawal by Subject|9|||
23688881|NCT00432237|66237189|FG003|Overall Study|Withdrawal by Subject|11|||
23688882|NCT00432237|66237186|FG000|Overall Study|Lack of Qualifying Event|38|||
23688883|NCT00432237|66237187|FG001|Overall Study|Lack of Qualifying Event|71|||
23688884|NCT00432237|66237188|FG002|Overall Study|Lack of Qualifying Event|69|||
23688885|NCT00432237|66237189|FG003|Overall Study|Lack of Qualifying Event|84|||
23688886|NCT04125680|66237190|FG000|Overall Study|Lost to Follow-up|15|||
23688887|NCT01950819|66237191|FG000|Overall Study|Graft Loss|35|||
23688888|NCT01950819|66237192|FG001|Overall Study|Graft Loss|30|||
23688889|NCT01950819|66237191|FG000|Overall Study|Death|29|||
23688890|NCT01950819|66237192|FG001|Overall Study|Death|34|||
23688891|NCT01950819|66237191|FG000|Overall Study|Subject / Gardian decision|54|||
23688892|NCT01950819|66237192|FG001|Overall Study|Subject / Gardian decision|51|||
23688893|NCT01950819|66237191|FG000|Overall Study|technical problems|2|||
23688894|NCT01950819|66237192|FG001|Overall Study|technical problems|0|||
23688895|NCT01950819|66237191|FG000|Overall Study|Pregnancy|0|||
23688896|NCT01950819|66237192|FG001|Overall Study|Pregnancy|2|||
23688897|NCT01950819|66237191|FG000|Overall Study|Lost to Follow-up|9|||
23688898|NCT01950819|66237192|FG001|Overall Study|Lost to Follow-up|17|||
23688899|NCT00619229|66237193|FG000|Overall Study|Withdrawal by Subject|1|||
23688900|NCT00619229|66237194|FG001|Overall Study|Withdrawal by Subject|1|||
23688901|NCT00619229|66237193|FG000|Overall Study|Lost to Follow-up|1|||
23688902|NCT00619229|66237194|FG001|Overall Study|Lost to Follow-up|0|||
23688903|NCT00619229|66237193|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
23688904|NCT00619229|66237194|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
23688905|NCT00619229|66237193|FG000|Overall Study|Investigator planned Cataract Operation|1|||
23394175|NCT03110562|65189591|FG000|Initial Treatment Period|Randomized but never treated|0|||
23394176|NCT03110562|65189592|FG001|Initial Treatment Period|Randomized but never treated|3|||
23688906|NCT00619229|66237194|FG001|Overall Study|Investigator planned Cataract Operation|0|||
23688907|NCT02388295|66237195|FG000|Dose Escalation Week 1|Adverse Event|1|||
23688908|NCT02388295|66237196|FG001|Dose Escalation Week 1|Adverse Event|2|||
23688909|NCT02388295|66237197|FG002|Dose Escalation Week 1|Adverse Event|1|||
23688910|NCT02388295|66237195|FG000|Dose Escalation Week 1|Determined not eligible|1|||
23688911|NCT02388295|66237196|FG001|Dose Escalation Week 1|Determined not eligible|1|||
23688912|NCT02388295|66237197|FG002|Dose Escalation Week 1|Determined not eligible|1|||
23688913|NCT02388295|66237195|FG000|Dose Escalation Week 2|Protocol Violation|0|||
23688914|NCT02388295|66237196|FG001|Dose Escalation Week 2|Protocol Violation|1|||
23688915|NCT02388295|66237197|FG002|Dose Escalation Week 2|Protocol Violation|0|||
23688916|NCT02388295|66237195|FG000|Dose Escalation Week 2|Determined not eligible|1|||
23688917|NCT02388295|66237196|FG001|Dose Escalation Week 2|Determined not eligible|1|||
23688918|NCT02388295|66237197|FG002|Dose Escalation Week 2|Determined not eligible|1|||
23688919|NCT02388295|66237195|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
23688920|NCT02388295|66237196|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
23688921|NCT02388295|66237197|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
23688922|NCT00500266|66237203|FG000|Overall Study|Death|3|||
23688923|NCT00500266|66237203|FG000|Overall Study|Lost to Follow-up|3|||
23688924|NCT00500266|66237203|FG000|Overall Study|Withdrawal by Subject|3|||
23688925|NCT00500266|66237203|FG000|Overall Study|Assigned, not treated|4|||
23688926|NCT01491178|66237213|FG000|Overall Study|Adverse Event|1016|||
23688927|NCT01491178|66237213|FG000|Overall Study|Improvement of NVAF|210|||
23688928|NCT01491178|66237213|FG000|Overall Study|To conduct invasive treatment|59|||
23688929|NCT01491178|66237213|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
23688930|NCT01491178|66237213|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
23688931|NCT01491178|66237213|FG000|Overall Study|To take a contraindication|20|||
23688932|NCT01491178|66237213|FG000|Overall Study|Other than specified above|657|||
23688933|NCT03133767|66237214|FG000|Overall Study|Lost to Follow-up|38|||
23688934|NCT03133767|66237215|FG001|Overall Study|Lost to Follow-up|24|||
23688935|NCT03133767|66237214|FG000|Overall Study|Protocol Violation|0|||
23688936|NCT03133767|66237215|FG001|Overall Study|Protocol Violation|1|||
23688937|NCT00376961|66237216|FG000|Initial Registration|Adverse Event|1|||
23688938|NCT00376961|66237217|FG001|Initial Registration|Adverse Event|0|||
23688939|NCT00376961|66237216|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
23688940|NCT00376961|66237217|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23688941|NCT00376961|66237216|FG000|Initial Registration|Progression/relapse|1|||
23688942|NCT00376961|66237217|FG001|Initial Registration|Progression/relapse|0|||
23688943|NCT00376961|66237216|FG000|Initial Registration|Ineligible|3|||
23688944|NCT00376961|66237217|FG001|Initial Registration|Ineligible|0|||
23688945|NCT00376961|66237216|FG000|Maintenance|Adverse Event|0|||
23688946|NCT00376961|66237217|FG001|Maintenance|Adverse Event|1|||
23688947|NCT00376961|66237216|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
23688948|NCT00376961|66237217|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
23688949|NCT00376961|66237216|FG000|Maintenance|Progression/relapse|0|||
23688950|NCT00376961|66237217|FG001|Maintenance|Progression/relapse|18|||
23688951|NCT00376961|66237216|FG000|Maintenance|Ineligible|0|||
23688952|NCT00376961|66237217|FG001|Maintenance|Ineligible|3|||
23688953|NCT00502840|66237218|FG000|Overall Study|Adverse Event|5|||
23688954|NCT00502840|66237218|FG000|Overall Study|Additional or changed therapy|48|||
23688955|NCT00502840|66237218|FG000|Overall Study|Lack of Efficacy|11|||
23688956|NCT00502840|66237218|FG000|Overall Study|Protocol Violation|4|||
23688957|NCT00502840|66237218|FG000|Overall Study|Withdrawal by Subject|5|||
23688958|NCT00502840|66237218|FG000|Overall Study|Lost to Follow-up|6|||
23688959|NCT00502840|66237218|FG000|Overall Study|Administrative problems|1|||
23688960|NCT00502840|66237218|FG000|Overall Study|Other|20|||
23688961|NCT01341457|66237235|FG000|Overall Study|Adverse Event|2|||
23688962|NCT01341457|66237236|FG001|Overall Study|Adverse Event|0|||
23688963|NCT00393718|66237237|FG000|Overall Study|Adverse Event|20|||
23688964|NCT00393718|66237238|FG001|Overall Study|Adverse Event|8|||
23688965|NCT00393718|66237237|FG000|Overall Study|Protocol Violation|1|||
23688966|NCT00393718|66237238|FG001|Overall Study|Protocol Violation|2|||
23688967|NCT00393718|66237237|FG000|Overall Study|Lack of Efficacy|10|||
23688968|NCT00393718|66237238|FG001|Overall Study|Lack of Efficacy|9|||
23688969|NCT00393718|66237237|FG000|Overall Study|Hypoglycaemia|3|||
23688970|NCT00393718|66237238|FG001|Overall Study|Hypoglycaemia|2|||
23688971|NCT00393718|66237237|FG000|Overall Study|Subject decision|5|||
23688972|NCT00393718|66237238|FG001|Overall Study|Subject decision|0|||
23688973|NCT00393718|66237237|FG000|Overall Study|Withdrawal of consent|2|||
23688974|NCT00393718|66237238|FG001|Overall Study|Withdrawal of consent|1|||
23688975|NCT00393718|66237237|FG000|Overall Study|Missed measurement|1|||
23688976|NCT00393718|66237238|FG001|Overall Study|Missed measurement|0|||
23688977|NCT00393718|66237237|FG000|Overall Study|Move|1|||
23688978|NCT00393718|66237238|FG001|Overall Study|Move|0|||
23688979|NCT02013544|66237239|FG000|Overall Study|Adverse Event|5|||
23688980|NCT02013544|66237240|FG001|Overall Study|Adverse Event|5|||
23688981|NCT02013544|66237239|FG000|Overall Study|Lost to Follow-up|2|||
23688982|NCT02013544|66237240|FG001|Overall Study|Lost to Follow-up|3|||
23688983|NCT02013544|66237239|FG000|Overall Study|Withdrawal by Subject|2|||
23688984|NCT02013544|66237240|FG001|Overall Study|Withdrawal by Subject|8|||
23688985|NCT02013544|66237239|FG000|Overall Study|Physician Decision|0|||
23688986|NCT02013544|66237240|FG001|Overall Study|Physician Decision|1|||
23688987|NCT02013544|66237239|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
23688988|NCT02013544|66237240|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
23688989|NCT00246259|66237242|FG000|Overall Study|Other|3|||
23688990|NCT00246259|66237243|FG001|Overall Study|Other|3|||
23688991|NCT00246259|66237242|FG000|Overall Study|Not stable by Week 18|2|||
23688992|NCT00246259|66237243|FG001|Overall Study|Not stable by Week 18|1|||
23688993|NCT00246259|66237242|FG000|Overall Study|Participant non-compliant|4|||
23688994|NCT00246259|66237243|FG001|Overall Study|Participant non-compliant|9|||
23688995|NCT00246259|66237242|FG000|Overall Study|Lack of Efficacy|2|||
23688996|NCT00246259|66237243|FG001|Overall Study|Lack of Efficacy|2|||
23688997|NCT00246259|66237242|FG000|Overall Study|Investigator withdrew participant|2|||
23688998|NCT00246259|66237243|FG001|Overall Study|Investigator withdrew participant|0|||
23688999|NCT00246259|66237242|FG000|Overall Study|Adverse Event|5|||
23689000|NCT00246259|66237243|FG001|Overall Study|Adverse Event|0|||
23689001|NCT00246259|66237242|FG000|Overall Study|Lost to Follow-up|3|||
23689002|NCT00246259|66237243|FG001|Overall Study|Lost to Follow-up|4|||
23689003|NCT00246259|66237242|FG000|Overall Study|Withdrawal by Subject|5|||
23689004|NCT00246259|66237243|FG001|Overall Study|Withdrawal by Subject|1|||
23689005|NCT00246259|66237242|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
23689006|NCT00246259|66237243|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
23689007|NCT03304522|66237253|FG000|Overall Study|Adverse Event|0|||
23689008|NCT03304522|66237254|FG001|Overall Study|Adverse Event|4|||
23689009|NCT03304522|66237253|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23689010|NCT03304522|66237254|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23689011|NCT03304522|66237253|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
23689012|NCT03304522|66237254|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
23689013|NCT03304522|66237253|FG000|Overall Study|Other|0|||
23689014|NCT03304522|66237254|FG001|Overall Study|Other|1|||
23689015|NCT05148884|66237255|FG000|Overall Study|Withdrawal by Subject|3|||
23689016|NCT05148884|66237256|FG001|Overall Study|Withdrawal by Subject|0|||
23689017|NCT05148884|66237255|FG000|Overall Study|Deep brain stimulation operation|0|||
23689018|NCT05148884|66237256|FG001|Overall Study|Deep brain stimulation operation|1|||
23689019|NCT03521791|66237258|FG000|Overall Study|Protocol Violation|7|||
23689020|NCT03521791|66237259|FG001|Overall Study|Protocol Violation|17|||
23689021|NCT02764541|66237263|FG000|Overall Study|Withdrawal by Subject|0|||
23689022|NCT02764541|66237264|FG001|Overall Study|Withdrawal by Subject|0|||
23689023|NCT02764541|66237265|FG002|Overall Study|Withdrawal by Subject|0|||
23689024|NCT02764541|66237266|FG003|Overall Study|Withdrawal by Subject|0|||
23689025|NCT02764541|66237267|FG004|Overall Study|Withdrawal by Subject|1|||
23689026|NCT02764541|66237268|FG005|Overall Study|Withdrawal by Subject|1|||
23689027|NCT02764541|66237269|FG006|Overall Study|Withdrawal by Subject|0|||
23689028|NCT02764541|66237270|FG007|Overall Study|Withdrawal by Subject|1|||
23689029|NCT02764541|66237263|FG000|Overall Study|Adverse Event|1|||
23689030|NCT02764541|66237264|FG001|Overall Study|Adverse Event|0|||
23689031|NCT02764541|66237265|FG002|Overall Study|Adverse Event|0|||
23689032|NCT02764541|66237266|FG003|Overall Study|Adverse Event|0|||
23689033|NCT02764541|66237267|FG004|Overall Study|Adverse Event|0|||
23689034|NCT02764541|66237268|FG005|Overall Study|Adverse Event|0|||
23689035|NCT02764541|66237269|FG006|Overall Study|Adverse Event|1|||
23689036|NCT02764541|66237270|FG007|Overall Study|Adverse Event|0|||
23689037|NCT02764541|66237263|FG000|Overall Study|Metastasis|1|||
23689038|NCT02764541|66237264|FG001|Overall Study|Metastasis|0|||
23689039|NCT02764541|66237265|FG002|Overall Study|Metastasis|0|||
23689040|NCT02764541|66237266|FG003|Overall Study|Metastasis|0|||
23689041|NCT02764541|66237267|FG004|Overall Study|Metastasis|0|||
23689042|NCT02764541|66237268|FG005|Overall Study|Metastasis|0|||
23689043|NCT02764541|66237269|FG006|Overall Study|Metastasis|0|||
23689044|NCT02764541|66237270|FG007|Overall Study|Metastasis|0|||
23689045|NCT02764541|66237263|FG000|Overall Study|Disease progression|1|||
23689046|NCT02764541|66237264|FG001|Overall Study|Disease progression|1|||
23689047|NCT02764541|66237265|FG002|Overall Study|Disease progression|0|||
23689048|NCT02764541|66237266|FG003|Overall Study|Disease progression|0|||
23689049|NCT02764541|66237267|FG004|Overall Study|Disease progression|0|||
23689050|NCT02764541|66237268|FG005|Overall Study|Disease progression|0|||
23689051|NCT02764541|66237269|FG006|Overall Study|Disease progression|0|||
23689052|NCT02764541|66237270|FG007|Overall Study|Disease progression|1|||
23689053|NCT02764541|66237263|FG000|Overall Study|Protocol Violation|0|||
23689054|NCT02764541|66237264|FG001|Overall Study|Protocol Violation|0|||
23689055|NCT02764541|66237265|FG002|Overall Study|Protocol Violation|0|||
23689056|NCT02764541|66237266|FG003|Overall Study|Protocol Violation|1|||
23689057|NCT02764541|66237267|FG004|Overall Study|Protocol Violation|0|||
23689058|NCT02764541|66237268|FG005|Overall Study|Protocol Violation|1|||
23689059|NCT02764541|66237269|FG006|Overall Study|Protocol Violation|0|||
23689060|NCT02764541|66237270|FG007|Overall Study|Protocol Violation|0|||
23689061|NCT02764541|66237263|FG000|Overall Study|Physician Decision|0|||
23689062|NCT02764541|66237264|FG001|Overall Study|Physician Decision|0|||
23689063|NCT02764541|66237265|FG002|Overall Study|Physician Decision|0|||
23689064|NCT02764541|66237266|FG003|Overall Study|Physician Decision|1|||
23689065|NCT02764541|66237267|FG004|Overall Study|Physician Decision|0|||
23689066|NCT02764541|66237268|FG005|Overall Study|Physician Decision|0|||
23689067|NCT02764541|66237269|FG006|Overall Study|Physician Decision|0|||
23689068|NCT02764541|66237270|FG007|Overall Study|Physician Decision|1|||
23689069|NCT02764541|66237263|FG000|Overall Study|Three Cycles completed before surgery|0|||
23689070|NCT02764541|66237264|FG001|Overall Study|Three Cycles completed before surgery|0|||
23689071|NCT02764541|66237265|FG002|Overall Study|Three Cycles completed before surgery|0|||
23689072|NCT02764541|66237266|FG003|Overall Study|Three Cycles completed before surgery|1|||
23689073|NCT02764541|66237267|FG004|Overall Study|Three Cycles completed before surgery|0|||
23689074|NCT02764541|66237268|FG005|Overall Study|Three Cycles completed before surgery|0|||
23689075|NCT02764541|66237269|FG006|Overall Study|Three Cycles completed before surgery|0|||
23689076|NCT02764541|66237270|FG007|Overall Study|Three Cycles completed before surgery|0|||
23394177|NCT03110562|65189593|FG002|Initial Treatment Period|Randomized but never treated|0|||
23394178|NCT03110562|65189594|FG003|Initial Treatment Period|Randomized but never treated|0|||
23394179|NCT03110562|65189591|FG000|Crossover Period|Disease Progression|0|||
23394180|NCT03110562|65189592|FG001|Crossover Period|Disease Progression|0|||
23689077|NCT02764541|66237263|FG000|Overall Study|Patient Compliance|0|||
23689078|NCT02764541|66237264|FG001|Overall Study|Patient Compliance|0|||
23689079|NCT02764541|66237265|FG002|Overall Study|Patient Compliance|1|||
23689080|NCT02764541|66237266|FG003|Overall Study|Patient Compliance|0|||
23689081|NCT02764541|66237267|FG004|Overall Study|Patient Compliance|0|||
23689082|NCT02764541|66237268|FG005|Overall Study|Patient Compliance|0|||
23689083|NCT02764541|66237269|FG006|Overall Study|Patient Compliance|0|||
23689084|NCT02764541|66237270|FG007|Overall Study|Patient Compliance|0|||
23394181|NCT03110562|65189593|FG002|Crossover Period|Disease Progression|1|||
23394182|NCT03110562|65189594|FG003|Crossover Period|Disease Progression|0|||
23394183|NCT03110562|65189591|FG000|Crossover Period|Withdrawal by Subject|0|||
23394184|NCT03110562|65189592|FG001|Crossover Period|Withdrawal by Subject|0|||
23394185|NCT03110562|65189593|FG002|Crossover Period|Withdrawal by Subject|8|||
23394186|NCT03110562|65189594|FG003|Crossover Period|Withdrawal by Subject|6|||
23394187|NCT03110562|65189591|FG000|Crossover Period|Death|0|||
23394188|NCT03110562|65189592|FG001|Crossover Period|Death|0|||
23689085|NCT02764541|66237263|FG000|Overall Study|Death|0|||
23689086|NCT02764541|66237264|FG001|Overall Study|Death|0|||
23689087|NCT02764541|66237265|FG002|Overall Study|Death|0|||
23689088|NCT02764541|66237266|FG003|Overall Study|Death|0|||
23689089|NCT02764541|66237267|FG004|Overall Study|Death|0|||
23689090|NCT02764541|66237268|FG005|Overall Study|Death|0|||
23689091|NCT02764541|66237269|FG006|Overall Study|Death|1|||
23689092|NCT02764541|66237270|FG007|Overall Study|Death|0|||
23689093|NCT02764541|66237263|FG000|Overall Study|Insurance reasons|0|||
23689094|NCT02764541|66237264|FG001|Overall Study|Insurance reasons|0|||
23689095|NCT02764541|66237265|FG002|Overall Study|Insurance reasons|0|||
23689096|NCT02764541|66237266|FG003|Overall Study|Insurance reasons|0|||
23689097|NCT02764541|66237267|FG004|Overall Study|Insurance reasons|0|||
23689098|NCT02764541|66237268|FG005|Overall Study|Insurance reasons|0|||
23689099|NCT02764541|66237269|FG006|Overall Study|Insurance reasons|1|||
23689100|NCT02764541|66237270|FG007|Overall Study|Insurance reasons|0|||
23689101|NCT01914679|66237271|FG000|Overall Study|Lack of Efficacy|1|||
23689102|NCT01914679|66237271|FG000|Overall Study|Sponsor terminated study|4|||
23689103|NCT04439903|66237273|FG000|Overall Study|Withdrawal by Subject|2|||
23689104|NCT04439903|66237273|FG000|Overall Study|Screen Failure|1|||
23689105|NCT01097044|66237275|FG000|Overall Study|Withdrawal by Subject|4|||
23689106|NCT01097044|66237276|FG001|Overall Study|Withdrawal by Subject|4|||
23689107|NCT01097044|66237275|FG000|Overall Study|Lost to Follow-up|1|||
23689108|NCT01097044|66237276|FG001|Overall Study|Lost to Follow-up|0|||
23689109|NCT01097044|66237275|FG000|Overall Study|Withdrawal by Sponsor|0|||
23689110|NCT01097044|66237276|FG001|Overall Study|Withdrawal by Sponsor|1|||
23689111|NCT02292849|66237280|FG000|Overall Study|Lost to Follow-up|0|||
23689112|NCT02292849|66237281|FG001|Overall Study|Lost to Follow-up|2|||
23689113|NCT02292849|66237282|FG002|Overall Study|Lost to Follow-up|2|||
23689114|NCT02292849|66237280|FG000|Overall Study|Physician Decision|4|||
23689115|NCT02292849|66237281|FG001|Overall Study|Physician Decision|0|||
23689116|NCT02292849|66237282|FG002|Overall Study|Physician Decision|0|||
23689117|NCT00607048|66237284|FG000|Overall Study|Adverse Event|0|||
23689118|NCT00607048|66237285|FG001|Overall Study|Adverse Event|1|||
23689119|NCT00607048|66237286|FG002|Overall Study|Adverse Event|0|||
23689120|NCT00607048|66237287|FG003|Overall Study|Adverse Event|0|||
23689121|NCT00607048|66237288|FG004|Overall Study|Adverse Event|4|||
23689122|NCT00607048|66237289|FG005|Overall Study|Adverse Event|0|||
23689123|NCT00607048|66237284|FG000|Overall Study|Global deterioration of health|1|||
23689124|NCT00607048|66237285|FG001|Overall Study|Global deterioration of health|0|||
23689125|NCT00607048|66237286|FG002|Overall Study|Global deterioration of health|0|||
23689126|NCT00607048|66237287|FG003|Overall Study|Global deterioration of health|0|||
23689127|NCT00607048|66237288|FG004|Overall Study|Global deterioration of health|0|||
23689128|NCT00607048|66237289|FG005|Overall Study|Global deterioration of health|0|||
23689129|NCT00607048|66237284|FG000|Overall Study|Objective disease progression - relapse|1|||
23689130|NCT00607048|66237285|FG001|Overall Study|Objective disease progression - relapse|2|||
23689131|NCT00607048|66237286|FG002|Overall Study|Objective disease progression - relapse|4|||
23689132|NCT00607048|66237287|FG003|Overall Study|Objective disease progression - relapse|2|||
23689133|NCT00607048|66237288|FG004|Overall Study|Objective disease progression - relapse|2|||
23394189|NCT03110562|65189593|FG002|Crossover Period|Death|37|||
23394190|NCT03110562|65189594|FG003|Crossover Period|Death|3|||
23394191|NCT03110562|65189591|FG000|Crossover Period|Lost to Follow-up|0|||
23689134|NCT00607048|66237289|FG005|Overall Study|Objective disease progression - relapse|2|||
23689135|NCT00607048|66237284|FG000|Overall Study|Withdrawal by Subject|0|||
23689136|NCT00607048|66237285|FG001|Overall Study|Withdrawal by Subject|0|||
23689137|NCT00607048|66237286|FG002|Overall Study|Withdrawal by Subject|0|||
23689138|NCT00607048|66237287|FG003|Overall Study|Withdrawal by Subject|1|||
23689139|NCT00607048|66237288|FG004|Overall Study|Withdrawal by Subject|0|||
23689140|NCT00607048|66237289|FG005|Overall Study|Withdrawal by Subject|2|||
23689141|NCT00607048|66237284|FG000|Overall Study|Other|1|||
23689142|NCT00607048|66237285|FG001|Overall Study|Other|1|||
23689143|NCT00607048|66237286|FG002|Overall Study|Other|0|||
23689144|NCT00607048|66237287|FG003|Overall Study|Other|0|||
23689145|NCT00607048|66237288|FG004|Overall Study|Other|0|||
23689146|NCT00607048|66237289|FG005|Overall Study|Other|1|||
23689147|NCT01075178|66237290|FG000|Subject Matching|eligible but not matched|130|||
23689148|NCT01075178|66237291|FG001|Subject Matching|eligible but not matched|403|||
23689149|NCT01075178|66237290|FG000|Subject Chart Review|died before chart review period|0|||
23689150|NCT01075178|66237291|FG001|Subject Chart Review|died before chart review period|2|||
23689151|NCT01075178|66237290|FG000|Subject Chart Review|no data collected due to site closure|3|||
23689152|NCT01075178|66237291|FG001|Subject Chart Review|no data collected due to site closure|4|||
23689153|NCT01075178|66237290|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
23689154|NCT01075178|66237291|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
23689155|NCT02207907|66237292|FG000|Overall Study|Lost to Follow-up|3|||
23689156|NCT02207907|66237293|FG001|Overall Study|Lost to Follow-up|1|||
23689157|NCT02207907|66237292|FG000|Overall Study|Withdrawal by Subject|5|||
23689158|NCT02207907|66237293|FG001|Overall Study|Withdrawal by Subject|6|||
23689159|NCT02207907|66237292|FG000|Overall Study|Did not meet study criteria|3|||
23689160|NCT02207907|66237293|FG001|Overall Study|Did not meet study criteria|0|||
23689161|NCT02207907|66237292|FG000|Overall Study|Pregnancy|0|||
23689162|NCT02207907|66237293|FG001|Overall Study|Pregnancy|1|||
23689163|NCT02909153|66237295|FG000|Overall Study|Withdrawal by Subject|0|||
23689164|NCT02909153|66237296|FG001|Overall Study|Withdrawal by Subject|1|||
23689165|NCT02909153|66237297|FG002|Overall Study|Withdrawal by Subject|0|||
23689166|NCT02909153|66237298|FG003|Overall Study|Withdrawal by Subject|0|||
23689167|NCT02909153|66237299|FG004|Overall Study|Withdrawal by Subject|0|||
23689168|NCT03440944|66237300|FG000|Overall Study|Physician Decision|1|||
23689169|NCT03440944|66237301|FG001|Overall Study|Physician Decision|0|||
23689170|NCT03440944|66237300|FG000|Overall Study|No Acceptable Vasculature|0|||
23689171|NCT03440944|66237301|FG001|Overall Study|No Acceptable Vasculature|1|||
23689172|NCT01974817|66237302|FG000|Overall Study|Death|4|||
23689173|NCT01974817|66237302|FG000|Overall Study|Lost to Follow-up|2|||
23689174|NCT01974817|66237302|FG000|Overall Study|Protocol Violation|2|||
23689175|NCT04826900|66237303|FG000|Overall Study|Family factor|1|||
23689176|NCT04826900|66237304|FG001|Overall Study|Family factor|1|||
23689177|NCT00811252|66237306|FG000|Overall Study|Adverse Event|6|||
23689178|NCT00811252|66237307|FG001|Overall Study|Adverse Event|10|||
23689179|NCT00811252|66237308|FG002|Overall Study|Adverse Event|15|||
23689180|NCT00811252|66237306|FG000|Overall Study|Lack of Efficacy|7|||
23689181|NCT00811252|66237307|FG001|Overall Study|Lack of Efficacy|2|||
23689182|NCT00811252|66237308|FG002|Overall Study|Lack of Efficacy|0|||
23689183|NCT00811252|66237306|FG000|Overall Study|Protocol Violation|3|||
23689184|NCT00811252|66237307|FG001|Overall Study|Protocol Violation|3|||
23689185|NCT00811252|66237308|FG002|Overall Study|Protocol Violation|2|||
23689186|NCT00811252|66237306|FG000|Overall Study|Withdrawal of Consent|1|||
23689187|NCT00811252|66237307|FG001|Overall Study|Withdrawal of Consent|2|||
23689188|NCT00811252|66237308|FG002|Overall Study|Withdrawal of Consent|2|||
23689189|NCT00811252|66237306|FG000|Overall Study|Lost to Follow-up|0|||
23689190|NCT00811252|66237307|FG001|Overall Study|Lost to Follow-up|0|||
23689191|NCT00811252|66237308|FG002|Overall Study|Lost to Follow-up|2|||
23689192|NCT00811252|66237306|FG000|Overall Study|Administrative or Other Reasons|0|||
23689193|NCT00811252|66237307|FG001|Overall Study|Administrative or Other Reasons|3|||
23689194|NCT00811252|66237308|FG002|Overall Study|Administrative or Other Reasons|2|||
23689195|NCT00238264|66237311|FG000|Overall Study|Death|7|||
23689196|NCT00238264|66237311|FG000|Overall Study|Lost to Follow-up|18|||
23689197|NCT00238264|66237311|FG000|Overall Study|Withdrawal by Subject|4|||
23689198|NCT00238264|66237311|FG000|Overall Study|Ineligible|7|||
23689199|NCT03617705|66237319|FG000|Overall Study|Withdrawal by Subject|2|||
23689200|NCT03617705|66237319|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
23689201|NCT03617705|66237319|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
23689202|NCT02601573|66237320|FG000|Overall Study|Lost to Follow-up|0|||
23689203|NCT02601573|66237321|FG001|Overall Study|Lost to Follow-up|3|||
23689204|NCT02601573|66237322|FG002|Overall Study|Lost to Follow-up|1|||
23689205|NCT02601573|66237323|FG003|Overall Study|Lost to Follow-up|0|||
23689206|NCT02601573|66237324|FG004|Overall Study|Lost to Follow-up|2|||
23689207|NCT02601573|66237320|FG000|Overall Study|Withdrawal by Subject|0|||
23689208|NCT02601573|66237321|FG001|Overall Study|Withdrawal by Subject|1|||
23689209|NCT02601573|66237322|FG002|Overall Study|Withdrawal by Subject|0|||
23689210|NCT02601573|66237323|FG003|Overall Study|Withdrawal by Subject|1|||
23689211|NCT02601573|66237324|FG004|Overall Study|Withdrawal by Subject|0|||
23689212|NCT00935883|66237325|FG000|Treatment Period|Physician Decision|1|||
23689213|NCT00935883|66237326|FG001|Treatment Period|Physician Decision|0|||
23689214|NCT00935883|66237325|FG000|Treatment Period|Withdrawal by Subject|0|||
23689215|NCT00935883|66237326|FG001|Treatment Period|Withdrawal by Subject|2|||
23689216|NCT01591330|66237333|FG000|Period 1|Adverse Event|1|||
23689217|NCT01591330|66237334|FG001|Period 1|Adverse Event|0|||
23689218|NCT01591330|66237335|FG002|Period 1|Adverse Event|0|||
23689219|NCT01591330|66237336|FG003|Period 1|Adverse Event|0|||
23689220|NCT01591330|66237333|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
23689221|NCT01591330|66237334|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23689222|NCT01591330|66237335|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23689223|NCT01591330|66237336|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23689224|NCT01591330|66237333|FG000|Period 2|Adverse Event|1|||
23689225|NCT01591330|66237334|FG001|Period 2|Adverse Event|0|||
23689226|NCT01591330|66237335|FG002|Period 2|Adverse Event|0|||
23689227|NCT01591330|66237336|FG003|Period 2|Adverse Event|0|||
23689228|NCT01454076|66237342|FG000|Overall Study|Other|2|||
23689229|NCT01454076|66237343|FG001|Overall Study|Other|0|||
23689230|NCT01454076|66237344|FG002|Overall Study|Other|0|||
23689231|NCT01454076|66237345|FG003|Overall Study|Other|1|||
23689232|NCT01454076|66237346|FG004|Overall Study|Other|2|||
23689233|NCT01454076|66237342|FG000|Overall Study|Withdrawal by Subject|3|||
23394192|NCT03110562|65189592|FG001|Crossover Period|Lost to Follow-up|0|||
23689234|NCT01454076|66237343|FG001|Overall Study|Withdrawal by Subject|4|||
23689235|NCT01454076|66237344|FG002|Overall Study|Withdrawal by Subject|2|||
23689236|NCT01454076|66237345|FG003|Overall Study|Withdrawal by Subject|1|||
23689237|NCT01454076|66237346|FG004|Overall Study|Withdrawal by Subject|2|||
23689238|NCT01454076|66237342|FG000|Overall Study|Adverse Event|8|||
23689239|NCT01454076|66237343|FG001|Overall Study|Adverse Event|2|||
23689240|NCT01454076|66237344|FG002|Overall Study|Adverse Event|7|||
23689241|NCT01454076|66237345|FG003|Overall Study|Adverse Event|0|||
23689242|NCT01454076|66237346|FG004|Overall Study|Adverse Event|2|||
23689243|NCT02966314|66237347|FG000|Overall Study|Lost to Follow-up|1|||
23689244|NCT02966314|66237348|FG001|Overall Study|Lost to Follow-up|0|||
23689245|NCT01085682|66237349|FG000|Overall Study|Withdrawal by Subject|25|||
23689246|NCT01085682|66237350|FG001|Overall Study|Withdrawal by Subject|25|||
23689247|NCT00384956|66237351|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
23689248|NCT03195894|66237355|FG000|Overall Study|"An example is Started other treatment."|4|||
23689249|NCT03195894|66237356|FG001|Overall Study|"An example is Started other treatment."|5|||
23689250|NCT03195894|66237355|FG000|Overall Study|Withdrawal by Subject|15|||
23689251|NCT03195894|66237356|FG001|Overall Study|Withdrawal by Subject|4|||
23689252|NCT03195894|66237355|FG000|Overall Study|Lost to Follow-up|14|||
23689253|NCT03195894|66237356|FG001|Overall Study|Lost to Follow-up|19|||
23689254|NCT04317690|66237357|FG000|Overall Study|did not have complete information for primary outcome|0|||
23689255|NCT04317690|66237358|FG001|Overall Study|did not have complete information for primary outcome|4|||
23689256|NCT04317690|66237359|FG002|Overall Study|did not have complete information for primary outcome|0|||
23689257|NCT04317690|66237360|FG003|Overall Study|did not have complete information for primary outcome|2|||
23689258|NCT04317690|66237361|FG004|Overall Study|did not have complete information for primary outcome|0|||
23689259|NCT02185521|66237362|FG000|Overall Study|Withdrawal by Subject|1|||
23689260|NCT02185521|66237362|FG000|Overall Study|Protocol Violation|1|||
23689261|NCT02006576|66237363|FG000|Overall Study|Withdrawal by Subject|4|||
23689262|NCT02006576|66237364|FG001|Overall Study|Withdrawal by Subject|6|||
23689263|NCT02006576|66237365|FG002|Overall Study|Withdrawal by Subject|2|||
23689264|NCT02006576|66237363|FG000|Overall Study|Death|0|||
23689265|NCT02006576|66237364|FG001|Overall Study|Death|0|||
23689266|NCT02006576|66237365|FG002|Overall Study|Death|1|||
23689267|NCT02006576|66237363|FG000|Overall Study|Lost to Follow-up|1|||
23689268|NCT02006576|66237364|FG001|Overall Study|Lost to Follow-up|0|||
23689269|NCT02006576|66237365|FG002|Overall Study|Lost to Follow-up|1|||
23689270|NCT02006576|66237363|FG000|Overall Study|Screen Failure, too sick, other|13|||
23689271|NCT02006576|66237364|FG001|Overall Study|Screen Failure, too sick, other|1|||
23689272|NCT02006576|66237365|FG002|Overall Study|Screen Failure, too sick, other|13|||
23689273|NCT00883493|66237366|FG000|Overall Study|Adverse Event|11|||
23689274|NCT00883493|66237367|FG001|Overall Study|Adverse Event|12|||
23394193|NCT03110562|65189593|FG002|Crossover Period|Lost to Follow-up|0|||
23689275|NCT00883493|66237366|FG000|Overall Study|Lack of Efficacy|4|||
23689276|NCT00883493|66237367|FG001|Overall Study|Lack of Efficacy|3|||
23689277|NCT00883493|66237366|FG000|Overall Study|Lost to Follow-up|7|||
23689278|NCT00883493|66237367|FG001|Overall Study|Lost to Follow-up|6|||
23689279|NCT00883493|66237366|FG000|Overall Study|Withdrawal by Subject|11|||
23689280|NCT00883493|66237367|FG001|Overall Study|Withdrawal by Subject|20|||
23689281|NCT00883493|66237366|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
23689282|NCT00883493|66237367|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
23689283|NCT00883493|66237366|FG000|Overall Study|Study specific disc. criteria|2|||
23689284|NCT00883493|66237367|FG001|Overall Study|Study specific disc. criteria|0|||
23689285|NCT00883493|66237366|FG000|Overall Study|Other|5|||
23689286|NCT00883493|66237367|FG001|Overall Study|Other|3|||
23689287|NCT01244737|66237369|FG000|Overall Study|Physician Decision|2|||
23689288|NCT01244737|66237370|FG001|Overall Study|Physician Decision|18|||
23689289|NCT01244737|66237371|FG002|Overall Study|Physician Decision|5|||
23689290|NCT01244737|66237369|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
23689291|NCT01244737|66237370|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
23689292|NCT01244737|66237371|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
23689293|NCT01244737|66237369|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
23689294|NCT01244737|66237370|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
23689295|NCT01244737|66237371|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
23689296|NCT01244737|66237369|FG000|Overall Study|MIB immunopathology results not available|3|||
23689297|NCT01244737|66237370|FG001|Overall Study|MIB immunopathology results not available|2|||
23689298|NCT01244737|66237371|FG002|Overall Study|MIB immunopathology results not available|0|||
23689299|NCT01244737|66237369|FG000|Overall Study|PET data failure|0|||
23689300|NCT01244737|66237370|FG001|Overall Study|PET data failure|1|||
23689301|NCT01244737|66237371|FG002|Overall Study|PET data failure|0|||
23689302|NCT01244737|66237369|FG000|Overall Study|Withdrawal by Subject|0|||
23689303|NCT01244737|66237370|FG001|Overall Study|Withdrawal by Subject|0|||
23689304|NCT01244737|66237371|FG002|Overall Study|Withdrawal by Subject|1|||
23689305|NCT01287754|66240373|FG000|Overall Study|Death|2|||
23689306|NCT01287754|66240374|FG001|Overall Study|Death|12|||
23689307|NCT01287754|66240373|FG000|Overall Study|Lost to Follow-up|1|||
23689308|NCT01287754|66240374|FG001|Overall Study|Lost to Follow-up|6|||
23689309|NCT01287754|66240373|FG000|Overall Study|Protocol Violation|0|||
23689310|NCT01287754|66240374|FG001|Overall Study|Protocol Violation|3|||
23689311|NCT02041962|66240375|FG000|Overall Study|Lost Aetna Coverage|43|||
23689312|NCT02041962|66240376|FG001|Overall Study|Lost Aetna Coverage|40|||
23689313|NCT02041962|66240375|FG000|Overall Study|Death|1|||
23689314|NCT02041962|66240376|FG001|Overall Study|Death|1|||
23689315|NCT02041962|66240375|FG000|Overall Study|Lost to Follow-up|37|||
23689316|NCT02041962|66240376|FG001|Overall Study|Lost to Follow-up|32|||
23689317|NCT02041962|66240375|FG000|Overall Study|Withdrawal by Subject|0|||
23689318|NCT02041962|66240376|FG001|Overall Study|Withdrawal by Subject|11|||
23689319|NCT01607892|66240383|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
23689320|NCT01607892|66240384|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
23689321|NCT01607892|66240385|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
23689322|NCT01607892|66240386|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
23689323|NCT01607892|66240387|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
23689324|NCT01607892|66240383|FG000|Overall Study|Death|4|||
23689325|NCT01607892|66240384|FG001|Overall Study|Death|2|||
23689326|NCT01607892|66240385|FG002|Overall Study|Death|8|||
23689327|NCT01607892|66240386|FG003|Overall Study|Death|10|||
23689328|NCT01607892|66240387|FG004|Overall Study|Death|3|||
23689329|NCT01607892|66240383|FG000|Overall Study|Investigator discretion|2|||
23689330|NCT01607892|66240384|FG001|Overall Study|Investigator discretion|4|||
23689331|NCT01607892|66240385|FG002|Overall Study|Investigator discretion|4|||
23689332|NCT01607892|66240386|FG003|Overall Study|Investigator discretion|8|||
23689333|NCT01607892|66240387|FG004|Overall Study|Investigator discretion|0|||
23689334|NCT01607892|66240383|FG000|Overall Study|Other treatments became available|1|||
23689335|NCT01607892|66240384|FG001|Overall Study|Other treatments became available|1|||
23689336|NCT01607892|66240385|FG002|Overall Study|Other treatments became available|0|||
23689337|NCT01607892|66240386|FG003|Overall Study|Other treatments became available|0|||
23689338|NCT01607892|66240387|FG004|Overall Study|Other treatments became available|2|||
23689339|NCT01607892|66240383|FG000|Overall Study|Intercurrent illness|1|||
23689340|NCT01607892|66240384|FG001|Overall Study|Intercurrent illness|0|||
23689341|NCT01607892|66240385|FG002|Overall Study|Intercurrent illness|0|||
23689342|NCT01607892|66240386|FG003|Overall Study|Intercurrent illness|3|||
23689343|NCT01607892|66240387|FG004|Overall Study|Intercurrent illness|0|||
23689344|NCT01607892|66240383|FG000|Overall Study|Non-Compliance with study procedures|0|||
23689345|NCT01607892|66240384|FG001|Overall Study|Non-Compliance with study procedures|0|||
23689346|NCT01607892|66240385|FG002|Overall Study|Non-Compliance with study procedures|1|||
23689347|NCT01607892|66240386|FG003|Overall Study|Non-Compliance with study procedures|0|||
23689348|NCT01607892|66240387|FG004|Overall Study|Non-Compliance with study procedures|0|||
23689349|NCT01607892|66240383|FG000|Overall Study|Consent withdrawn by participant|9|||
23689350|NCT01607892|66240384|FG001|Overall Study|Consent withdrawn by participant|4|||
23689351|NCT01607892|66240385|FG002|Overall Study|Consent withdrawn by participant|24|||
23689352|NCT01607892|66240386|FG003|Overall Study|Consent withdrawn by participant|14|||
23689353|NCT01607892|66240387|FG004|Overall Study|Consent withdrawn by participant|4|||
23689354|NCT01607892|66240383|FG000|Overall Study|Disease progression|38|||
23689355|NCT01607892|66240384|FG001|Overall Study|Disease progression|13|||
23689356|NCT01607892|66240385|FG002|Overall Study|Disease progression|37|||
23689357|NCT01607892|66240386|FG003|Overall Study|Disease progression|57|||
23689358|NCT01607892|66240387|FG004|Overall Study|Disease progression|9|||
23689359|NCT01607892|66240383|FG000|Overall Study|Incidence or severity of Adverse events|3|||
23689360|NCT01607892|66240384|FG001|Overall Study|Incidence or severity of Adverse events|3|||
23689361|NCT01607892|66240385|FG002|Overall Study|Incidence or severity of Adverse events|7|||
23689362|NCT01607892|66240386|FG003|Overall Study|Incidence or severity of Adverse events|2|||
23689363|NCT01607892|66240387|FG004|Overall Study|Incidence or severity of Adverse events|6|||
23689364|NCT04398732|66240388|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
23689365|NCT02665689|66240394|FG000|Overall Study|Adverse Event|1|||
23689366|NCT02665689|66240395|FG001|Overall Study|Adverse Event|0|||
23689367|NCT02665689|66240394|FG000|Overall Study|Trial termination|1|||
23689368|NCT02665689|66240395|FG001|Overall Study|Trial termination|1|||
23689369|NCT02665689|66240394|FG000|Overall Study|Lost to Follow-up|0|||
23689370|NCT02665689|66240395|FG001|Overall Study|Lost to Follow-up|1|||
23689371|NCT01686568|66240396|FG000|Main Study|Withdrawal by Subject|1|||
23689372|NCT01686568|66240397|FG001|Main Study|Withdrawal by Subject|3|||
23689373|NCT01686568|66240396|FG000|Main Study|Noncompliance with protocol|0|||
23689374|NCT01686568|66240397|FG001|Main Study|Noncompliance with protocol|1|||
23689375|NCT01686568|66240396|FG000|Main Study|Liver enzymes above range of exclusion|1|||
23689376|NCT01686568|66240397|FG001|Main Study|Liver enzymes above range of exclusion|0|||
23689377|NCT01686568|66240396|FG000|Sub-Study|Not consented for sub-study|2|||
23689378|NCT01686568|66240397|FG001|Sub-Study|Not consented for sub-study|2|||
23689379|NCT01059448|66240401|FG000|Overall Study|Adverse Event|1|||
23689380|NCT01059448|66240402|FG001|Overall Study|Adverse Event|3|||
23689381|NCT01059448|66240403|FG002|Overall Study|Adverse Event|0|||
23689382|NCT01059448|66240404|FG003|Overall Study|Adverse Event|1|||
23689383|NCT01059448|66240401|FG000|Overall Study|Withdrawal by Subject|2|||
23689384|NCT01059448|66240402|FG001|Overall Study|Withdrawal by Subject|0|||
23689385|NCT01059448|66240403|FG002|Overall Study|Withdrawal by Subject|2|||
23689386|NCT01059448|66240404|FG003|Overall Study|Withdrawal by Subject|4|||
23689387|NCT01059448|66240401|FG000|Overall Study|Disease Progression|2|||
23689388|NCT01059448|66240402|FG001|Overall Study|Disease Progression|1|||
23689389|NCT01059448|66240403|FG002|Overall Study|Disease Progression|4|||
23689390|NCT01059448|66240404|FG003|Overall Study|Disease Progression|2|||
23689391|NCT01059448|66240401|FG000|Overall Study|Administrative Decision|43|||
23689392|NCT01059448|66240402|FG001|Overall Study|Administrative Decision|49|||
23689393|NCT01059448|66240403|FG002|Overall Study|Administrative Decision|45|||
23689394|NCT01059448|66240404|FG003|Overall Study|Administrative Decision|46|||
23689395|NCT01059448|66240401|FG000|Overall Study|Lost to Follow-up|0|||
23689396|NCT01059448|66240402|FG001|Overall Study|Lost to Follow-up|0|||
23689397|NCT01059448|66240403|FG002|Overall Study|Lost to Follow-up|2|||
23689398|NCT01059448|66240404|FG003|Overall Study|Lost to Follow-up|0|||
23689399|NCT01059448|66240401|FG000|Overall Study|Death|0|||
23689400|NCT01059448|66240402|FG001|Overall Study|Death|1|||
23689401|NCT01059448|66240403|FG002|Overall Study|Death|0|||
23689402|NCT01059448|66240404|FG003|Overall Study|Death|0|||
23689403|NCT01059448|66240401|FG000|Overall Study|Other|1|||
23689404|NCT01059448|66240402|FG001|Overall Study|Other|1|||
23689405|NCT01059448|66240403|FG002|Overall Study|Other|0|||
23689406|NCT01059448|66240404|FG003|Overall Study|Other|1|||
23689407|NCT01650805|66240409|FG000|Overall Study|Withdrawal by Subject|1|||
23689408|NCT01650805|66240410|FG001|Overall Study|Withdrawal by Subject|0|||
23689409|NCT02338843|66240412|FG000|Overall Study|Adverse Event|2|||
23689410|NCT02338843|66240413|FG001|Overall Study|Adverse Event|1|||
23689411|NCT02338843|66240412|FG000|Overall Study|Death|40|||
23689412|NCT02338843|66240413|FG001|Overall Study|Death|53|||
23689413|NCT02338843|66240412|FG000|Overall Study|Physician Decision|1|||
23689414|NCT02338843|66240413|FG001|Overall Study|Physician Decision|0|||
23689415|NCT02338843|66240412|FG000|Overall Study|Withdrawal by Subject|0|||
23689416|NCT02338843|66240413|FG001|Overall Study|Withdrawal by Subject|2|||
23689417|NCT02338843|66240412|FG000|Overall Study|Subject Recovered|0|||
23689418|NCT02338843|66240413|FG001|Overall Study|Subject Recovered|2|||
23689419|NCT02338843|66240412|FG000|Overall Study|Discontinued prior to randomizat|1|||
23689420|NCT02338843|66240413|FG001|Overall Study|Discontinued prior to randomizat|0|||
23689421|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23689422|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23689423|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
23689424|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689425|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689426|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689427|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689428|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689429|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23689430|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
23689431|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23689432|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23689433|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689434|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689435|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689436|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689437|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689438|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23689439|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
23689440|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23689441|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
23689442|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689443|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689444|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689445|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689446|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689447|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23689448|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689449|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689450|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
23689451|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689452|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689453|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689454|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689455|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689456|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23689457|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
23689458|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23689459|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
23689460|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689461|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689462|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689463|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689464|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689465|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23689466|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23689467|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689468|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689469|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689470|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689471|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689472|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689473|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689474|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23689475|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
23689476|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
23689477|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689478|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689479|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689480|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689481|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689482|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689483|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23689484|NCT01307423|66240421|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689485|NCT01307423|66240422|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
23689486|NCT01307423|66240423|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
23689487|NCT01307423|66240424|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689488|NCT01307423|66240425|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689489|NCT01307423|66240426|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689490|NCT01307423|66240427|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689491|NCT01307423|66240428|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689492|NCT01307423|66240429|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23689493|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23689494|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
23394194|NCT03110562|65189594|FG003|Crossover Period|Lost to Follow-up|1|||
23394195|NCT03110562|65189591|FG000|Crossover Period|Other|0|||
23689495|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23689496|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23689497|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23689498|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23689499|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23689500|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23689501|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23689502|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23689503|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
23689504|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
23689505|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
23689506|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
23689507|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23689508|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23606291|NCT02060487|65947203|FG000|Overall Study|Study Terminated By Sponsor|87|||
23606292|NCT02060487|65947204|FG001|Overall Study|Study Terminated By Sponsor|89|||
23606293|NCT02060487|65947205|FG002|Overall Study|Study Terminated By Sponsor|100|||
23606294|NCT02060487|65947203|FG000|Overall Study|Randomized in error|1|||
23606295|NCT02060487|65947204|FG001|Overall Study|Randomized in error|0|||
23606296|NCT02060487|65947205|FG002|Overall Study|Randomized in error|0|||
23606297|NCT02060487|65947203|FG000|Overall Study|Protocol Violation|0|||
23606298|NCT02060487|65947204|FG001|Overall Study|Protocol Violation|1|||
23606299|NCT02060487|65947205|FG002|Overall Study|Protocol Violation|1|||
23606300|NCT02060487|65947203|FG000|Overall Study|Lost to Follow-up|3|||
23606301|NCT02060487|65947204|FG001|Overall Study|Lost to Follow-up|0|||
23606302|NCT02060487|65947205|FG002|Overall Study|Lost to Follow-up|2|||
23606303|NCT02060487|65947203|FG000|Overall Study|Death|34|||
23606304|NCT02060487|65947204|FG001|Overall Study|Death|25|||
23689509|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23689510|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23689511|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689512|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689513|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689514|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689515|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689516|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
23689517|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689518|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689519|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23689520|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23689521|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
23689522|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
23689523|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23689524|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23689525|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
23689526|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
23689527|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23689528|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23689529|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689530|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689531|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689532|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
23689533|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689534|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689535|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689536|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689537|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23689538|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
23689539|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
23689540|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
23689541|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
23689542|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
23689543|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
23689544|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
23689545|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
23689546|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
23689547|NCT01307423|66240421|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23606305|NCT02060487|65947205|FG002|Overall Study|Death|19|||
23606306|NCT02060487|65947203|FG000|Overall Study|Adverse Event|0|||
23689548|NCT01307423|66240422|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689549|NCT01307423|66240423|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689550|NCT01307423|66240424|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689551|NCT01307423|66240425|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689552|NCT01307423|66240426|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
23689553|NCT01307423|66240427|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689554|NCT01307423|66240428|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689555|NCT01307423|66240429|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23689556|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23689557|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
23689558|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
23689559|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23689560|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23689561|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23689562|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23689563|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
23689564|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
23689565|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23689566|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
23689567|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
23689568|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23689569|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23689570|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23689571|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23689572|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
23689573|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
23689574|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689575|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689576|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
23689577|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689578|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689579|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689580|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689581|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689582|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23689583|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23689584|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
23689585|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
23689586|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23689587|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23689588|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23689589|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23689590|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
23689591|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
23689592|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689593|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23689594|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689595|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689596|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689597|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689598|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23689599|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23689600|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23689601|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23689602|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
23689603|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23689604|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23689605|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23689606|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23689607|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23689608|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
23689609|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
23689610|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23689611|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23689612|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
23689613|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23394196|NCT03110562|65189592|FG001|Crossover Period|Other|0|||
23394197|NCT03110562|65189593|FG002|Crossover Period|Other|1|||
23689614|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23689615|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23689616|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23689617|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
23689618|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23689619|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689620|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
23689621|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
23689622|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689623|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689624|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689625|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689626|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689627|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23689628|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23689629|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
23689630|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
23689631|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23689632|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23689633|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23689634|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23689635|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
23689636|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
23689637|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23689638|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
23689639|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
23689640|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23689641|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23689642|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23689643|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23689644|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23689645|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23689646|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689647|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23689648|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689649|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689650|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689651|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689652|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689653|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23689654|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23689655|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689656|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
23689657|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689658|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689659|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689660|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689661|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689662|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689663|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23689664|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689665|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23689666|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689667|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689668|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689669|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689670|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689671|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23689672|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23689673|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23689674|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
23689675|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23689676|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23689677|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23689678|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23689679|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23394198|NCT03110562|65189594|FG003|Crossover Period|Other|1|||
23606307|NCT02060487|65947204|FG001|Overall Study|Adverse Event|0|||
23689680|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
23689681|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23689682|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689683|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689684|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
23689685|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689686|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689687|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689688|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689689|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689690|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23689691|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689692|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689693|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23394199|NCT03110562|65189591|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
23394200|NCT03110562|65189592|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
23394201|NCT03110562|65189593|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
23394202|NCT03110562|65189594|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
23394203|NCT02467270|65189596|FG000|Overall Study|Participants Never Treated|0|||
23394204|NCT02467270|65189597|FG001|Overall Study|Participants Never Treated|1|||
23394205|NCT02467270|65189598|FG002|Overall Study|Participants Never Treated|0|||
23394206|NCT02467270|65189596|FG000|Overall Study|Ongoing|50|||
23394207|NCT02467270|65189597|FG001|Overall Study|Ongoing|41|||
23394208|NCT02467270|65189598|FG002|Overall Study|Ongoing|43|||
23394209|NCT02467270|65189596|FG000|Overall Study|Adverse Event|16|||
23394210|NCT02467270|65189597|FG001|Overall Study|Adverse Event|15|||
23394211|NCT02467270|65189598|FG002|Overall Study|Adverse Event|14|||
23394212|NCT02467270|65189596|FG000|Overall Study|Progressive Disease|7|||
23394213|NCT02467270|65189597|FG001|Overall Study|Progressive Disease|7|||
23394214|NCT02467270|65189598|FG002|Overall Study|Progressive Disease|4|||
23394215|NCT02467270|65189596|FG000|Overall Study|Death|2|||
23394216|NCT02467270|65189597|FG001|Overall Study|Death|0|||
23394217|NCT02467270|65189598|FG002|Overall Study|Death|2|||
23394218|NCT02467270|65189596|FG000|Overall Study|Lack of Efficacy|12|||
23394219|NCT02467270|65189597|FG001|Overall Study|Lack of Efficacy|18|||
23394220|NCT02467270|65189598|FG002|Overall Study|Lack of Efficacy|23|||
23394221|NCT02467270|65189596|FG000|Overall Study|Non-compliance With Study Drug|0|||
23394222|NCT02467270|65189597|FG001|Overall Study|Non-compliance With Study Drug|2|||
23394223|NCT02467270|65189598|FG002|Overall Study|Non-compliance With Study Drug|1|||
23394224|NCT02467270|65189596|FG000|Overall Study|Lost to Follow-up|2|||
23394225|NCT02467270|65189597|FG001|Overall Study|Lost to Follow-up|1|||
23394226|NCT02467270|65189598|FG002|Overall Study|Lost to Follow-up|0|||
23394227|NCT02467270|65189596|FG000|Overall Study|Pregnancy|0|||
23394228|NCT02467270|65189597|FG001|Overall Study|Pregnancy|1|||
23394229|NCT02467270|65189598|FG002|Overall Study|Pregnancy|0|||
23394230|NCT02467270|65189596|FG000|Overall Study|Physician Decision|0|||
23394231|NCT02467270|65189597|FG001|Overall Study|Physician Decision|4|||
23394232|NCT02467270|65189598|FG002|Overall Study|Physician Decision|1|||
23394233|NCT02467270|65189596|FG000|Overall Study|Withdrawal by Subject|4|||
23394234|NCT02467270|65189597|FG001|Overall Study|Withdrawal by Subject|3|||
23394235|NCT02467270|65189598|FG002|Overall Study|Withdrawal by Subject|5|||
23394236|NCT02467270|65189596|FG000|Overall Study|Reason not Specified|1|||
23394237|NCT02467270|65189597|FG001|Overall Study|Reason not Specified|2|||
23394238|NCT02467270|65189598|FG002|Overall Study|Reason not Specified|1|||
23394239|NCT04110145|65189602|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394240|NCT04110145|65189603|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394241|NCT04110145|65189604|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394242|NCT04110145|65189605|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
23394243|NCT04110145|65189606|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394244|NCT02263547|65189609|FG000|Overall Study|Adverse Event|1|||
23394245|NCT02263547|65189609|FG000|Overall Study|Lost to Follow-up|2|||
23394246|NCT01969409|65192555|FG000|Overall Study|Death|2|||
23394247|NCT01969409|65192556|FG001|Overall Study|Death|2|||
23394248|NCT01969409|65192555|FG000|Overall Study|Transplant|1|||
23689694|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689695|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689696|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689697|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23394249|NCT01969409|65192556|FG001|Overall Study|Transplant|1|||
23394250|NCT01969409|65192555|FG000|Overall Study|Withdrawal by Subject|0|||
23394251|NCT01969409|65192556|FG001|Overall Study|Withdrawal by Subject|1|||
23394252|NCT01948427|65192559|FG000|Overall Study|Serious Adverse Event|3|||
23394253|NCT01948427|65192560|FG001|Overall Study|Serious Adverse Event|0|||
23394254|NCT01948427|65192561|FG002|Overall Study|Serious Adverse Event|0|||
23689698|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23689699|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23689700|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689701|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23689702|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23689703|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689704|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689705|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689706|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689707|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23689708|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23689709|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689710|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
23689711|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
23689712|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689713|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689714|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689715|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689716|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689717|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23689718|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689719|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
23689720|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
23689721|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689722|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689723|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689724|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689725|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23689726|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23689727|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689728|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
23689729|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689730|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689731|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689732|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689733|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689734|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689735|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23689736|NCT01307423|66240421|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23689737|NCT01307423|66240422|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23689738|NCT01307423|66240423|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
23689739|NCT01307423|66240424|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23689740|NCT01307423|66240425|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23689741|NCT01307423|66240426|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23689742|NCT01307423|66240427|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23394255|NCT01948427|65192562|FG003|Overall Study|Serious Adverse Event|0|||
23394256|NCT01948427|65192563|FG004|Overall Study|Serious Adverse Event|1|||
23689743|NCT01307423|66240428|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
23689744|NCT01307423|66240429|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
23689745|NCT00476086|66240430|FG000|Overall Study|Alternative therapy|1|||
23689746|NCT00476086|66240430|FG000|Overall Study|Progressive Disease|4|||
23689747|NCT01573442|66240431|FG000|Overall Study|Cancels|9|||
23689748|NCT01573442|66240432|FG001|Overall Study|Cancels|10|||
23689749|NCT01254344|66240438|FG000|Overall Study|Adverse Event|2|||
23689750|NCT01254344|66240439|FG001|Overall Study|Adverse Event|5|||
23689751|NCT01254344|66240438|FG000|Overall Study|Physician Decision|7|||
23689752|NCT01254344|66240439|FG001|Overall Study|Physician Decision|4|||
23689753|NCT01254344|66240438|FG000|Overall Study|Protocol Violation|1|||
23689754|NCT01254344|66240439|FG001|Overall Study|Protocol Violation|4|||
23394257|NCT01948427|65192559|FG000|Overall Study|Investigator Request|0|||
23394258|NCT01948427|65192560|FG001|Overall Study|Investigator Request|8|||
23394259|NCT01948427|65192561|FG002|Overall Study|Investigator Request|0|||
23394260|NCT01948427|65192562|FG003|Overall Study|Investigator Request|0|||
23689755|NCT01254344|66240438|FG000|Overall Study|Withdrawal by Subject|3|||
23689756|NCT01254344|66240439|FG001|Overall Study|Withdrawal by Subject|6|||
23689757|NCT01748071|66240441|FG000|Overall Study|Adverse Event|2|||
23689758|NCT01748071|66240442|FG001|Overall Study|Adverse Event|2|||
23689759|NCT01748071|66240443|FG002|Overall Study|Adverse Event|0|||
23689760|NCT00635102|66240444|FG000|Overall Study|Withdrawal by Subject|7|||
23689761|NCT00635102|66240445|FG001|Overall Study|Withdrawal by Subject|8|||
23689762|NCT00469079|66240446|FG000|Overall Study|Lack of Efficacy|3|||
23394261|NCT01948427|65192563|FG004|Overall Study|Investigator Request|6|||
23689763|NCT00469079|66240447|FG001|Overall Study|Lack of Efficacy|8|||
23689764|NCT00469079|66240448|FG002|Overall Study|Lack of Efficacy|5|||
23689765|NCT00469079|66240446|FG000|Overall Study|Adverse Event|1|||
23689766|NCT00469079|66240447|FG001|Overall Study|Adverse Event|3|||
23689767|NCT00469079|66240448|FG002|Overall Study|Adverse Event|2|||
23689768|NCT00469079|66240446|FG000|Overall Study|Lost to Follow-up|4|||
23689769|NCT00469079|66240447|FG001|Overall Study|Lost to Follow-up|8|||
23689770|NCT00469079|66240448|FG002|Overall Study|Lost to Follow-up|10|||
23689771|NCT00469079|66240446|FG000|Overall Study|Withdrawal by Subject|1|||
23689772|NCT00469079|66240447|FG001|Overall Study|Withdrawal by Subject|2|||
23689773|NCT00469079|66240448|FG002|Overall Study|Withdrawal by Subject|2|||
23689774|NCT00469079|66240446|FG000|Overall Study|Ineligible|0|||
23689775|NCT00469079|66240447|FG001|Overall Study|Ineligible|1|||
23689776|NCT00469079|66240448|FG002|Overall Study|Ineligible|0|||
23689777|NCT00737529|66240454|FG000|Overall Study|Disease Progression|95|||
23689778|NCT00737529|66240454|FG000|Overall Study|Adverse Event|24|||
23689779|NCT00737529|66240454|FG000|Overall Study|Withdrawal by Subject|5|||
23689780|NCT00737529|66240454|FG000|Overall Study|Death|4|||
23689781|NCT00737529|66240454|FG000|Overall Study|Protocol Violation|1|||
23689782|NCT00737529|66240454|FG000|Overall Study|Other|4|||
23689783|NCT00752986|66240460|FG000|Overall Study|Withdrawal by Subject|2|||
23689784|NCT00752986|66240461|FG001|Overall Study|Withdrawal by Subject|1|||
23689785|NCT00752986|66240462|FG002|Overall Study|Withdrawal by Subject|2|||
23689786|NCT00752986|66240460|FG000|Overall Study|Protocol Violation|3|||
23689787|NCT00752986|66240461|FG001|Overall Study|Protocol Violation|0|||
23689788|NCT00752986|66240462|FG002|Overall Study|Protocol Violation|0|||
23689789|NCT00684814|66240468|FG000|Washout Period of 7 Days|Adverse Event|1|||
23689790|NCT00684814|66240469|FG001|Washout Period of 7 Days|Adverse Event|2|||
23689791|NCT00684814|66240468|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23689792|NCT00684814|66240469|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23689793|NCT00684814|66240468|FG000|Second Intervention|Adverse Event|1|||
23689794|NCT00684814|66240469|FG001|Second Intervention|Adverse Event|0|||
23689795|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
23689796|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
23689797|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
23689798|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
23689799|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
23689800|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23689801|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23689802|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23689803|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23689804|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
23689805|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23689806|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23689807|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23689808|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
23689809|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23689810|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
23689811|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
23689812|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
23689813|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
23689814|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
23689815|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
23689816|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
23689817|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
23689818|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
23689819|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
23689820|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
23689821|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23689822|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23689823|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
23689824|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23689825|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23689826|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
23689827|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23689828|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23498510|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
23689829|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
23689830|NCT00785577|66240470|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23689831|NCT00785577|66240471|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
23689832|NCT00785577|66240472|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23689833|NCT00785577|66240473|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23498511|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
23394262|NCT01948427|65192559|FG000|Overall Study|Lost to Follow-up|1|||
23394263|NCT01948427|65192560|FG001|Overall Study|Lost to Follow-up|0|||
23394264|NCT01948427|65192561|FG002|Overall Study|Lost to Follow-up|0|||
23394265|NCT01948427|65192562|FG003|Overall Study|Lost to Follow-up|0|||
23394266|NCT01948427|65192563|FG004|Overall Study|Lost to Follow-up|4|||
23394267|NCT01948427|65192559|FG000|Overall Study|Withdrawal by Subject|2|||
23394268|NCT01948427|65192560|FG001|Overall Study|Withdrawal by Subject|0|||
23394269|NCT01948427|65192561|FG002|Overall Study|Withdrawal by Subject|0|||
23689834|NCT00785577|66240474|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
23689835|NCT00785577|66240470|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23689836|NCT00785577|66240471|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23689837|NCT00785577|66240472|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23689838|NCT00785577|66240473|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
23689839|NCT00785577|66240474|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23689840|NCT00785577|66240470|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
23689841|NCT00785577|66240471|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
23689842|NCT00785577|66240472|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
23689843|NCT00785577|66240473|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
23689844|NCT00785577|66240474|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
23689845|NCT01276821|66240486|FG000|Overall Study|Protocol Violation|0|||
23689846|NCT01276821|66240487|FG001|Overall Study|Protocol Violation|1|||
23689847|NCT00104871|66240490|FG000|Overall Study|Not evaluable|1|||
23689848|NCT03596164|66240491|FG000|Overall Study|Adverse Event|0|||
23689849|NCT03596164|66240492|FG001|Overall Study|Adverse Event|1|||
23689850|NCT03596164|66240491|FG000|Overall Study|Death|1|||
23689851|NCT03596164|66240492|FG001|Overall Study|Death|0|||
23689852|NCT00541307|66240493|FG000|Overall Study|Death|5|||
23689853|NCT00541307|66240493|FG000|Overall Study|Physician Decision|3|||
23689854|NCT00541307|66240493|FG000|Overall Study|Withdrawal by Subject|6|||
23689855|NCT00541307|66240493|FG000|Overall Study|Lost to Follow-up|4|||
23689856|NCT00541307|66240493|FG000|Overall Study|Subject returned early (outside window)|1|||
23689857|NCT00541307|66240493|FG000|Overall Study|Surgical Bypass|5|||
23689858|NCT04964258|66240494|FG000|Overall Study|Lost to Follow-up|1|||
23689859|NCT04964258|66240495|FG001|Overall Study|Lost to Follow-up|0|||
23394270|NCT01948427|65192562|FG003|Overall Study|Withdrawal by Subject|0|||
23689860|NCT04964258|66240496|FG002|Overall Study|Lost to Follow-up|0|||
23689861|NCT04964258|66240497|FG003|Overall Study|Lost to Follow-up|0|||
23689862|NCT04964258|66240498|FG004|Overall Study|Lost to Follow-up|0|||
23689863|NCT04964258|66240499|FG005|Overall Study|Lost to Follow-up|1|||
23394271|NCT01948427|65192563|FG004|Overall Study|Withdrawal by Subject|1|||
23394272|NCT01948427|65192559|FG000|Overall Study|Other, Not Specified|1|||
23394273|NCT01948427|65192560|FG001|Overall Study|Other, Not Specified|9|||
23394274|NCT01948427|65192561|FG002|Overall Study|Other, Not Specified|0|||
23394275|NCT01948427|65192562|FG003|Overall Study|Other, Not Specified|0|||
23394276|NCT01948427|65192563|FG004|Overall Study|Other, Not Specified|2|||
23394277|NCT03639935|65192566|FG000|Overall Study|Death|3|||
23394278|NCT03639935|65192566|FG000|Overall Study|Adverse Event|1|||
23394279|NCT02038036|65192567|FG000|Core Study|Adverse Event|7|||
23394280|NCT02038036|65192568|FG001|Core Study|Adverse Event|7|||
23394281|NCT02038036|65192567|FG000|Core Study|Death|1|||
23394282|NCT02038036|65192568|FG001|Core Study|Death|1|||
23394283|NCT02038036|65192567|FG000|Core Study|Disease progression|2|||
23689864|NCT04964258|66240500|FG006|Overall Study|Lost to Follow-up|0|||
23689865|NCT04964258|66240501|FG007|Overall Study|Lost to Follow-up|0|||
23689866|NCT04964258|66240502|FG008|Overall Study|Lost to Follow-up|0|||
23689867|NCT04964258|66240503|FG009|Overall Study|Lost to Follow-up|0|||
23689868|NCT04964258|66240504|FG010|Overall Study|Lost to Follow-up|0|||
23689869|NCT03358472|66240506|FG000|Overall Study|Death|6|||
23689870|NCT03358472|66240507|FG001|Overall Study|Death|3|||
23689871|NCT03358472|66240508|FG002|Overall Study|Death|10|||
23689872|NCT03358472|66240506|FG000|Overall Study|Physician Decision|0|||
23689873|NCT03358472|66240507|FG001|Overall Study|Physician Decision|1|||
23689874|NCT03358472|66240508|FG002|Overall Study|Physician Decision|0|||
23394284|NCT02038036|65192568|FG001|Core Study|Disease progression|2|||
23498512|NCT01365052|65566350|FG000|Overall Study|Adverse Event|4|||
23689875|NCT03358472|66240506|FG000|Overall Study|Withdrawal by Subject|0|||
23689876|NCT03358472|66240507|FG001|Overall Study|Withdrawal by Subject|0|||
23689877|NCT03358472|66240508|FG002|Overall Study|Withdrawal by Subject|1|||
23689878|NCT03358472|66240506|FG000|Overall Study|On-going at clinical cut off date|9|||
23689879|NCT03358472|66240507|FG001|Overall Study|On-going at clinical cut off date|6|||
23689880|NCT03358472|66240508|FG002|Overall Study|On-going at clinical cut off date|5|||
23394285|NCT02038036|65192567|FG000|Core Study|Lost to Follow-up|0|||
23394286|NCT02038036|65192568|FG001|Core Study|Lost to Follow-up|1|||
23689881|NCT00925600|66240509|FG000|Overall Study|Withdrawal by Subject|16|||
23689882|NCT00925600|66240510|FG001|Overall Study|Withdrawal by Subject|14|||
23394287|NCT02038036|65192567|FG000|Core Study|Physician Decision|2|||
23394288|NCT02038036|65192568|FG001|Core Study|Physician Decision|1|||
23394289|NCT02038036|65192567|FG000|Core Study|Subject/guardian decision|0|||
23689883|NCT00925600|66240509|FG000|Overall Study|Death|4|||
23689884|NCT00925600|66240510|FG001|Overall Study|Death|3|||
23689885|NCT00925600|66240509|FG000|Overall Study|Lost to Follow-up|2|||
23689886|NCT00925600|66240510|FG001|Overall Study|Lost to Follow-up|2|||
23689887|NCT00925600|66240509|FG000|Overall Study|Disease Progression|1|||
23689888|NCT00925600|66240510|FG001|Overall Study|Disease Progression|3|||
23689889|NCT00925600|66240509|FG000|Overall Study|Administrative Decision|1|||
23689890|NCT00925600|66240510|FG001|Overall Study|Administrative Decision|1|||
23689891|NCT00925600|66240509|FG000|Overall Study|Noncompliance|2|||
23689892|NCT00925600|66240510|FG001|Overall Study|Noncompliance|0|||
23689893|NCT00925600|66240509|FG000|Overall Study|Ineligibility Determined|2|||
23689894|NCT00925600|66240510|FG001|Overall Study|Ineligibility Determined|0|||
23689895|NCT00925600|66240509|FG000|Overall Study|Protocol Deviation|0|||
23689896|NCT00925600|66240510|FG001|Overall Study|Protocol Deviation|1|||
23689897|NCT00925600|66240509|FG000|Overall Study|Requirement for Alternative Therapy|0|||
23689898|NCT00925600|66240510|FG001|Overall Study|Requirement for Alternative Therapy|1|||
23689899|NCT00925600|66240509|FG000|Overall Study|Other|3|||
23689900|NCT00925600|66240510|FG001|Overall Study|Other|1|||
23689901|NCT00925600|66240509|FG000|Overall Study|Adverse Event|1|||
23689902|NCT00925600|66240510|FG001|Overall Study|Adverse Event|2|||
23689903|NCT02658448|66240511|FG000|Overall Study|Lost to Follow-up|1|||
23689904|NCT00749203|66240512|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
23689905|NCT00749203|66240513|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
23689906|NCT00749203|66240512|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
23689907|NCT00749203|66240513|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
23689908|NCT00749203|66240512|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
23689909|NCT00749203|66240513|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
23689910|NCT00749203|66240512|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
23689911|NCT00749203|66240513|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
23689912|NCT00749203|66240512|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
23689913|NCT00749203|66240513|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
23689914|NCT00749203|66240512|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
23689915|NCT00749203|66240513|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
23689916|NCT04426630|66240515|FG000|Overall Study|Death|4|||
23689917|NCT04426630|66240515|FG000|Overall Study|Lost to Follow-up|2|||
23689918|NCT03514914|66240516|FG000|Overall Study|Death|3|||
23689919|NCT03514914|66240517|FG001|Overall Study|Death|3|||
23689920|NCT03514914|66240516|FG000|Overall Study|Lost to Follow-up|117|||
23689921|NCT03514914|66240517|FG001|Overall Study|Lost to Follow-up|89|||
23689922|NCT00618722|66240518|FG000|Overall Study|Refusal of Treatment|0|||
23689923|NCT00618722|66240519|FG001|Overall Study|Refusal of Treatment|0|||
23689924|NCT00618722|66240520|FG002|Overall Study|Refusal of Treatment|1|||
23689925|NCT00618722|66240521|FG003|Overall Study|Refusal of Treatment|0|||
23689926|NCT00618722|66240518|FG000|Overall Study|Patient Request|1|||
23689927|NCT00618722|66240519|FG001|Overall Study|Patient Request|1|||
23689928|NCT00618722|66240520|FG002|Overall Study|Patient Request|1|||
23689929|NCT00618722|66240521|FG003|Overall Study|Patient Request|1|||
23689930|NCT00618722|66240518|FG000|Overall Study|Inability to Complete Study Procedure|0|||
23689931|NCT00618722|66240519|FG001|Overall Study|Inability to Complete Study Procedure|1|||
23689932|NCT00618722|66240520|FG002|Overall Study|Inability to Complete Study Procedure|0|||
23689933|NCT00618722|66240521|FG003|Overall Study|Inability to Complete Study Procedure|0|||
23689934|NCT00618722|66240518|FG000|Overall Study|Lost to Follow-up|2|||
23689935|NCT00618722|66240519|FG001|Overall Study|Lost to Follow-up|0|||
23689936|NCT00618722|66240520|FG002|Overall Study|Lost to Follow-up|0|||
23689937|NCT00618722|66240521|FG003|Overall Study|Lost to Follow-up|2|||
23689938|NCT00618722|66240518|FG000|Overall Study|Miscellaneous Reasons|0|||
23689939|NCT00618722|66240519|FG001|Overall Study|Miscellaneous Reasons|0|||
23689940|NCT00618722|66240520|FG002|Overall Study|Miscellaneous Reasons|1|||
23689941|NCT00618722|66240521|FG003|Overall Study|Miscellaneous Reasons|1|||
23689942|NCT00332202|66240522|FG000|Overall Study|Adverse Event|72|||
23689943|NCT00332202|66240523|FG001|Overall Study|Adverse Event|28|||
23689944|NCT00332202|66240522|FG000|Overall Study|Lost to Follow-up|2|||
23689945|NCT00332202|66240523|FG001|Overall Study|Lost to Follow-up|1|||
23689946|NCT00332202|66240522|FG000|Overall Study|Physician Decision|6|||
23689947|NCT00332202|66240523|FG001|Overall Study|Physician Decision|8|||
23689948|NCT00332202|66240522|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
23689949|NCT00332202|66240523|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
23689950|NCT00332202|66240522|FG000|Overall Study|Protocol Violation|7|||
23689951|NCT00332202|66240523|FG001|Overall Study|Protocol Violation|2|||
23689952|NCT00332202|66240522|FG000|Overall Study|Sponsor Decision|1|||
23689953|NCT00332202|66240523|FG001|Overall Study|Sponsor Decision|2|||
23689954|NCT00332202|66240522|FG000|Overall Study|Withdrawal by Subject|36|||
23689955|NCT00332202|66240523|FG001|Overall Study|Withdrawal by Subject|17|||
23689956|NCT00332202|66240522|FG000|Overall Study|Progressive Disease|106|||
23689957|NCT00332202|66240523|FG001|Overall Study|Progressive Disease|60|||
23689958|NCT00332202|66240522|FG000|Overall Study|Death|5|||
23689959|NCT00332202|66240523|FG001|Overall Study|Death|2|||
23689960|NCT01856114|66240524|FG000|Overall Study|Withdrawal by Subject|1|||
23689961|NCT01856114|66240525|FG001|Overall Study|Withdrawal by Subject|0|||
23689962|NCT01856114|66240524|FG000|Overall Study|Adverse Event|1|||
23689963|NCT01856114|66240525|FG001|Overall Study|Adverse Event|0|||
23689964|NCT02770807|66240529|FG000|Overall Study|Adverse Event|3|||
23689965|NCT02770807|66240530|FG001|Overall Study|Adverse Event|3|||
23689966|NCT02770807|66240531|FG002|Overall Study|Adverse Event|1|||
23689967|NCT02770807|66240529|FG000|Overall Study|Withdrawal by Subject|7|||
23689968|NCT02770807|66240530|FG001|Overall Study|Withdrawal by Subject|3|||
23689969|NCT02770807|66240531|FG002|Overall Study|Withdrawal by Subject|4|||
23689970|NCT02770807|66240529|FG000|Overall Study|Other|0|||
23689971|NCT02770807|66240530|FG001|Overall Study|Other|1|||
23689972|NCT02770807|66240531|FG002|Overall Study|Other|0|||
23689973|NCT02770807|66240529|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
23689974|NCT02770807|66240530|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
23689975|NCT02770807|66240531|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
23689976|NCT02770807|66240529|FG000|Overall Study|Physician Decision|0|||
23689977|NCT02770807|66240530|FG001|Overall Study|Physician Decision|0|||
23689978|NCT02770807|66240531|FG002|Overall Study|Physician Decision|1|||
23689979|NCT02706938|66240534|FG000|First Period, 6 Weeks|Adverse Event|8|||
23689980|NCT02706938|66240535|FG001|First Period, 6 Weeks|Adverse Event|0|||
23689981|NCT02706938|66240534|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
23689982|NCT02706938|66240535|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
23689983|NCT02706938|66240534|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
23689984|NCT02706938|66240535|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
23689985|NCT02706938|66240534|FG000|Second Period, 6 Weeks|Adverse Event|0|||
23689986|NCT02706938|66240535|FG001|Second Period, 6 Weeks|Adverse Event|7|||
23689987|NCT02706938|66240534|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
23689988|NCT02706938|66240535|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
23689989|NCT01390389|66240538|FG000|Overall Study|Withdrawal by Subject|2|||
23689990|NCT01390389|66240539|FG001|Overall Study|Withdrawal by Subject|0|||
23689991|NCT01390389|66240538|FG000|Overall Study|Screen Fail|2|||
23689992|NCT01390389|66240539|FG001|Overall Study|Screen Fail|1|||
23689993|NCT00885365|66240545|FG000|4 Weeks ON Treatment|Adverse Event|2|||
23689994|NCT00885365|66240546|FG001|4 Weeks ON Treatment|Adverse Event|4|||
23689995|NCT00885365|66240545|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
23689996|NCT00885365|66240546|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
23689997|NCT00885365|66240545|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
23689998|NCT00885365|66240546|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
23689999|NCT00768560|66240547|FG000|Intervention Set 1|Adverse Event|0|||
23690000|NCT00768560|66240548|FG001|Intervention Set 1|Adverse Event|1|||
23690001|NCT00768560|66240549|FG002|Intervention Set 1|Adverse Event|0|||
23690002|NCT00768560|66240550|FG003|Intervention Set 1|Adverse Event|0|||
23690003|NCT00768560|66240551|FG004|Intervention Set 1|Adverse Event|0|||
23690004|NCT00768560|66240552|FG005|Intervention Set 1|Adverse Event|0|||
23690005|NCT02318095|66240556|FG000|Overall Study|Adverse Event|1|||
23690006|NCT02599402|66240557|FG000|Overall Study|Disease progression|153|||
23690007|NCT02599402|66240557|FG000|Overall Study|Study drug toxicity|201|||
23394290|NCT02038036|65192568|FG001|Core Study|Subject/guardian decision|1|||
23394291|NCT02038036|65192567|FG000|Core Study|Withdrawal by Subject|3|||
23394292|NCT02038036|65192568|FG001|Core Study|Withdrawal by Subject|1|||
23394293|NCT02038036|65192567|FG000|Crossover Period|Withdrawal by Subject|0|||
23394294|NCT02038036|65192568|FG001|Crossover Period|Withdrawal by Subject|3|||
23394295|NCT02038036|65192567|FG000|Crossover Period|Adverse Event|0|||
23394296|NCT02038036|65192568|FG001|Crossover Period|Adverse Event|9|||
23394297|NCT02038036|65192567|FG000|Crossover Period|Death|0|||
23394298|NCT02038036|65192568|FG001|Crossover Period|Death|2|||
23394299|NCT02038036|65192567|FG000|Crossover Period|Disease progression|0|||
23394300|NCT02038036|65192568|FG001|Crossover Period|Disease progression|3|||
23394301|NCT02038036|65192567|FG000|Crossover Period|Lost to Follow-up|0|||
23394302|NCT02038036|65192568|FG001|Crossover Period|Lost to Follow-up|1|||
23394303|NCT02038036|65192567|FG000|Crossover Period|Physician Decision|0|||
23394304|NCT02038036|65192568|FG001|Crossover Period|Physician Decision|2|||
23394305|NCT00836706|65192571|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
23394306|NCT00836706|65192572|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23690008|NCT02599402|66240557|FG000|Overall Study|Death|26|||
23690009|NCT02599402|66240557|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
23690010|NCT02599402|66240557|FG000|Overall Study|Participant request to discontinue study treatment|13|||
23690011|NCT02599402|66240557|FG000|Overall Study|Participant withdrew consent|5|||
23690012|NCT02599402|66240557|FG000|Overall Study|Lost to Follow-up|1|||
23690013|NCT02599402|66240557|FG000|Overall Study|Maximum Clinical Benefit|7|||
23690014|NCT02599402|66240557|FG000|Overall Study|Poor/non-compliance|1|||
23690015|NCT02599402|66240557|FG000|Overall Study|Pregnancy|1|||
23690016|NCT02599402|66240557|FG000|Overall Study|Participant no longer met study criteria|7|||
23690017|NCT02599402|66240557|FG000|Overall Study|Other Reasons|95|||
23690018|NCT00947349|66240559|FG000|Triple Treatment Combination Period|Adverse Event|0|||
23690019|NCT00947349|66240560|FG001|Triple Treatment Combination Period|Adverse Event|1|||
23394307|NCT00113373|65192573|FG000|Overall Study|Ineligible: wrong primary|1|||
23394308|NCT00113373|65192573|FG000|Overall Study|Ineligible: second primary|1|||
23394309|NCT00113373|65192573|FG000|Overall Study|Never Treated|1|||
23394310|NCT02919618|65192590|FG000|Overall Study|Death|1|||
23690020|NCT00947349|66240561|FG002|Triple Treatment Combination Period|Adverse Event|0|||
23690021|NCT00947349|66240562|FG003|Triple Treatment Combination Period|Adverse Event|0|||
23690022|NCT00947349|66240559|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
23690023|NCT00947349|66240560|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
23690024|NCT00947349|66240561|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
23690025|NCT00947349|66240562|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
23690026|NCT00947349|66240559|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
23690027|NCT00947349|66240560|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
23690028|NCT00947349|66240561|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
23690029|NCT00947349|66240562|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
23690030|NCT00947349|66240559|FG000|Overall Study Standard of Care|Other|0|||
23690031|NCT00947349|66240560|FG001|Overall Study Standard of Care|Other|0|||
23690032|NCT00947349|66240561|FG002|Overall Study Standard of Care|Other|0|||
23690033|NCT00947349|66240562|FG003|Overall Study Standard of Care|Other|1|||
23690034|NCT01478958|66240563|FG000|Overall Study|Withdrawal by Subject|1|||
23690035|NCT01478958|66240564|FG001|Overall Study|Withdrawal by Subject|1|||
23690036|NCT01478958|66240565|FG002|Overall Study|Withdrawal by Subject|1|||
23690037|NCT01478958|66240563|FG000|Overall Study|Weight loss|1|||
23690038|NCT01478958|66240564|FG001|Overall Study|Weight loss|0|||
23690039|NCT01478958|66240565|FG002|Overall Study|Weight loss|0|||
23690040|NCT01478958|66240563|FG000|Overall Study|Re-located|0|||
23690041|NCT01478958|66240564|FG001|Overall Study|Re-located|1|||
23690042|NCT01478958|66240565|FG002|Overall Study|Re-located|0|||
23690043|NCT01478958|66240563|FG000|Overall Study|Unable to comply|0|||
23690044|NCT01478958|66240564|FG001|Overall Study|Unable to comply|0|||
23690045|NCT01478958|66240565|FG002|Overall Study|Unable to comply|2|||
23690046|NCT00900796|66240567|FG000|Phase 1|Lacked sufficient information|4|||
23690047|NCT00900796|66240567|FG000|Phase 1|Missing information at Week 16|7|||
23690048|NCT00900796|66240567|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
23690049|NCT00900796|66240567|FG000|Phase 2|Lost to Follow-up|5|||
23690050|NCT01262898|66240568|FG000|Overall Study|Protocol Violation|1|||
23690051|NCT01262898|66240569|FG001|Overall Study|Protocol Violation|1|||
23690052|NCT01262898|66240570|FG002|Overall Study|Protocol Violation|0|||
23690053|NCT01262898|66240571|FG003|Overall Study|Protocol Violation|0|||
23690054|NCT01262898|66240568|FG000|Overall Study|Lost to Follow-up|1|||
23394311|NCT03131479|65192591|FG000|Overall Study|Adverse Event|0|||
23394312|NCT03131479|65192592|FG001|Overall Study|Adverse Event|0|||
23394313|NCT03131479|65192593|FG002|Overall Study|Adverse Event|1|||
23690055|NCT01262898|66240569|FG001|Overall Study|Lost to Follow-up|0|||
23690056|NCT01262898|66240570|FG002|Overall Study|Lost to Follow-up|0|||
23690057|NCT01262898|66240571|FG003|Overall Study|Lost to Follow-up|0|||
23690058|NCT01262898|66240568|FG000|Overall Study|Withdrawal by Subject|1|||
23690059|NCT01262898|66240569|FG001|Overall Study|Withdrawal by Subject|1|||
23690060|NCT01262898|66240570|FG002|Overall Study|Withdrawal by Subject|0|||
23690061|NCT01262898|66240571|FG003|Overall Study|Withdrawal by Subject|0|||
23690062|NCT02537678|66240572|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
23690063|NCT02537678|66240573|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
23690064|NCT02537678|66240572|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
23690065|NCT02537678|66240573|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
23690066|NCT02537678|66240572|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
23690067|NCT02537678|66240573|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
23690068|NCT02537678|66240572|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
23690069|NCT02537678|66240573|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
23690070|NCT02537678|66240572|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
23690071|NCT02537678|66240573|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
23690072|NCT02537678|66240572|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
23690073|NCT02537678|66240573|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
23690074|NCT02537678|66240572|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
23690075|NCT02537678|66240573|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
23690076|NCT04429022|66240574|FG000|Overall Study|Protocol Violation|18|||
23690077|NCT04429022|66240575|FG001|Overall Study|Protocol Violation|1|||
23690078|NCT01973283|66240576|FG000|Overall Study|Lost to Follow-up|4|||
23690079|NCT00628355|66240578|FG000|Overall Study|Withdrawal by Subject|1|||
23690080|NCT00628355|66240579|FG001|Overall Study|Withdrawal by Subject|1|||
23394314|NCT03131479|65192594|FG003|Overall Study|Adverse Event|1|||
23690081|NCT01028352|66240581|FG000|Overall Study|Ineligible due to baseline average pain|5|||
23394315|NCT03131479|65192595|FG004|Overall Study|Adverse Event|0|||
23394316|NCT03131479|65192591|FG000|Overall Study|Subject/Guardian Decision|0|||
23690082|NCT01028352|66240581|FG000|Overall Study|Withdrawal by Subject|1|||
23690083|NCT02272790|66240582|FG000|Overall Study|Physician Decision|0|||
23690084|NCT02272790|66240583|FG001|Overall Study|Physician Decision|1|||
23690085|NCT02272790|66240584|FG002|Overall Study|Physician Decision|0|||
23690086|NCT02272790|66240585|FG003|Overall Study|Physician Decision|0|||
23690087|NCT02272790|66240586|FG004|Overall Study|Physician Decision|0|||
23690088|NCT02272790|66240587|FG005|Overall Study|Physician Decision|0|||
23690089|NCT01120626|66240591|FG000|Overall Study|Withdrawal by Subject|1|||
23690090|NCT01120626|66240592|FG001|Overall Study|Withdrawal by Subject|0|||
23690091|NCT00432809|66240599|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
23690092|NCT00432809|66240600|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
23690093|NCT00432809|66240601|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
23690094|NCT00432809|66240599|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
23690095|NCT00432809|66240600|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
23690096|NCT00432809|66240601|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
23690097|NCT00222105|66240604|FG000|Overall Study|Removed due to wrong diagnosis|1|||
23690098|NCT00222105|66240604|FG000|Overall Study|Withdrawal by Subject|1|||
23690099|NCT00222105|66240604|FG000|Overall Study|Adverse Event|8|||
23690100|NCT00222105|66240604|FG000|Overall Study|Treatment delays|2|||
23690101|NCT00222105|66240604|FG000|Overall Study|Death|2|||
23690102|NCT02500537|66240612|FG000|Overall Study|Death|2|||
23690103|NCT02500537|66240613|FG001|Overall Study|Death|0|||
23690104|NCT02500537|66240612|FG000|Overall Study|Lost to Follow-up|0|||
23690105|NCT02500537|66240613|FG001|Overall Study|Lost to Follow-up|1|||
23690106|NCT02500537|66240612|FG000|Overall Study|Withdrawal by Subject|1|||
23690107|NCT02500537|66240613|FG001|Overall Study|Withdrawal by Subject|0|||
23690108|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
23690109|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
23690110|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
23690111|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
23690112|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
23690113|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
23690114|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
23690115|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
23690116|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
23690117|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
23690118|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
23690119|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
23690120|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
23690121|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
23690122|NCT00446030|66240614|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
23690123|NCT00446030|66240615|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
23690124|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
23690125|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
23690126|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
23690127|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
23690128|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
23690129|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
23690130|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
23690131|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
23690132|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
23690133|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
23690134|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
23690135|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
23690136|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
23690137|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
23690138|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
23690139|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
23690140|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
23690141|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
23690142|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
23690143|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
23690144|NCT00446030|66240614|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
23690145|NCT00446030|66240615|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
23690146|NCT02504541|66240620|FG000|Overall Study|Adverse Event|4|||
23690147|NCT02504541|66240620|FG000|Overall Study|Withdrawal by Subject|4|||
23690148|NCT02504541|66240620|FG000|Overall Study|Lost to Follow-up|1|||
23394317|NCT03131479|65192592|FG001|Overall Study|Subject/Guardian Decision|0|||
23394318|NCT03131479|65192593|FG002|Overall Study|Subject/Guardian Decision|0|||
23394319|NCT03131479|65192594|FG003|Overall Study|Subject/Guardian Decision|1|||
23690149|NCT02504541|66240620|FG000|Overall Study|Met Stopping Criteria|1|||
23690150|NCT02504541|66240620|FG000|Overall Study|Protocol Violation|2|||
23690151|NCT02504541|66240620|FG000|Overall Study|Termination by Sponsor|1|||
23690152|NCT02504541|66240620|FG000|Overall Study|Other|2|||
23690153|NCT02504541|66240620|FG000|Overall Study|Multiple|5|||
23394320|NCT03131479|65192595|FG004|Overall Study|Subject/Guardian Decision|0|||
23394321|NCT01538199|65192596|FG000|Overall Study|Lost to Follow-up|1|||
23394322|NCT01538199|65192597|FG001|Overall Study|Lost to Follow-up|2|||
23394323|NCT01538199|65192598|FG002|Overall Study|Lost to Follow-up|1|||
23394324|NCT01538199|65192599|FG003|Overall Study|Lost to Follow-up|0|||
23394325|NCT01538199|65192596|FG000|Overall Study|participant did not have time|1|||
23394326|NCT01538199|65192597|FG001|Overall Study|participant did not have time|0|||
23394327|NCT01538199|65192598|FG002|Overall Study|participant did not have time|0|||
23394328|NCT01538199|65192599|FG003|Overall Study|participant did not have time|2|||
23394329|NCT01538199|65192596|FG000|Overall Study|Lack of Efficacy|0|||
23690154|NCT01021007|66240627|FG000|Overall Study|Lost to Follow-up|1|||
23690155|NCT01021007|66240628|FG001|Overall Study|Lost to Follow-up|1|||
23690156|NCT01021007|66240627|FG000|Overall Study|Adverse Event|1|||
23690157|NCT01021007|66240628|FG001|Overall Study|Adverse Event|3|||
23690158|NCT02360098|66240629|FG000|Overall Study|Physician Decision|7|||
23690159|NCT01925703|66240630|FG000|Overall Study|Physician Decision|1|||
23690160|NCT01925703|66240630|FG000|Overall Study|Lost to Follow-up|2|||
23690161|NCT01925703|66240630|FG000|Overall Study|Discharge prior to full iron repletion|1|||
23690162|NCT00927485|66243815|FG000|Overall Study|Adverse Event|4|||
23690163|NCT00927485|66243816|FG001|Overall Study|Adverse Event|2|||
23690164|NCT00927485|66243815|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
23690165|NCT00927485|66243816|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
23690166|NCT03293654|66243817|FG000|Overall Study|Lost to Follow-up|0|||
23690167|NCT03293654|66243818|FG001|Overall Study|Lost to Follow-up|1|||
23690168|NCT03293654|66243819|FG002|Overall Study|Lost to Follow-up|0|||
23690169|NCT00816036|66243820|FG000|Overall Study|Death|47|||
23690170|NCT00816036|66243821|FG001|Overall Study|Death|28|||
23690171|NCT00816036|66243820|FG000|Overall Study|Lost to Follow-up|75|||
23690172|NCT00816036|66243821|FG001|Overall Study|Lost to Follow-up|57|||
23690173|NCT00816036|66243820|FG000|Overall Study|Withdrawal by Subject|54|||
23690174|NCT00816036|66243821|FG001|Overall Study|Withdrawal by Subject|23|||
23690175|NCT00870688|66243824|FG000|Overall Study|Lost to Follow-up|2|||
23690176|NCT00870688|66243824|FG000|Overall Study|Death, Unrelated|1|||
23690177|NCT00870688|66243824|FG000|Overall Study|Granules in the Stools|1|||
23690178|NCT00190775|66243825|FG000|Overall Study|Adverse Event|57|||
23690179|NCT00190775|66243826|FG001|Overall Study|Adverse Event|22|||
23690180|NCT00190775|66243825|FG000|Overall Study|Satisfactory Response|1|||
23690181|NCT00190775|66243826|FG001|Overall Study|Satisfactory Response|0|||
23690182|NCT00190775|66243825|FG000|Overall Study|Lack of Efficacy|28|||
23690183|NCT00190775|66243826|FG001|Overall Study|Lack of Efficacy|32|||
23690184|NCT00190775|66243825|FG000|Overall Study|Lost to Follow-up|31|||
23690185|NCT00190775|66243826|FG001|Overall Study|Lost to Follow-up|23|||
23690186|NCT00190775|66243825|FG000|Overall Study|Participant Moved|0|||
23690187|NCT00190775|66243826|FG001|Overall Study|Participant Moved|1|||
23690188|NCT00190775|66243825|FG000|Overall Study|Withdrawal by Subject|24|||
23690189|NCT00190775|66243826|FG001|Overall Study|Withdrawal by Subject|13|||
23690190|NCT00190775|66243825|FG000|Overall Study|Sponsor Decision|1|||
23690191|NCT00190775|66243826|FG001|Overall Study|Sponsor Decision|0|||
23394330|NCT01538199|65192597|FG001|Overall Study|Lack of Efficacy|1|||
23394331|NCT01538199|65192598|FG002|Overall Study|Lack of Efficacy|0|||
23690192|NCT00190775|66243825|FG000|Overall Study|Physician Decision|3|||
23690193|NCT00190775|66243826|FG001|Overall Study|Physician Decision|0|||
23690194|NCT00190775|66243825|FG000|Overall Study|Noncompliance|3|||
23690195|NCT00190775|66243826|FG001|Overall Study|Noncompliance|5|||
23690196|NCT00190775|66243825|FG000|Overall Study|Protocol Violation|0|||
23690197|NCT00190775|66243826|FG001|Overall Study|Protocol Violation|1|||
23690198|NCT00190775|66243825|FG000|Overall Study|Exclusion Criteria Met|1|||
23690199|NCT00190775|66243826|FG001|Overall Study|Exclusion Criteria Met|3|||
23690200|NCT01931865|66243827|FG000|Overall Study|Lost to Follow-up|2|||
23690201|NCT01931865|66243827|FG000|Overall Study|Withdrawal by Subject|2|||
23690202|NCT00629083|66243828|FG000|Overall Study|Adverse Event|0|||
23690203|NCT00629083|66243829|FG001|Overall Study|Adverse Event|2|||
23690204|NCT00629083|66243828|FG000|Overall Study|Lack of Efficacy|3|||
23690205|NCT00629083|66243829|FG001|Overall Study|Lack of Efficacy|1|||
23690206|NCT00629083|66243828|FG000|Overall Study|Withdrawal by Subject|10|||
23690207|NCT00629083|66243829|FG001|Overall Study|Withdrawal by Subject|2|||
23394332|NCT01538199|65192599|FG003|Overall Study|Lack of Efficacy|0|||
23394333|NCT03132467|65192600|FG000|Overall Study|Adverse Event|2|||
23498513|NCT01365052|65566351|FG001|Overall Study|Adverse Event|4|||
23690208|NCT00629083|66243828|FG000|Overall Study|Lost to Follow-up|12|||
23690209|NCT00629083|66243829|FG001|Overall Study|Lost to Follow-up|8|||
23690210|NCT00629083|66243828|FG000|Overall Study|Moved out of country/state|2|||
23690211|NCT00629083|66243829|FG001|Overall Study|Moved out of country/state|1|||
23690212|NCT00629083|66243828|FG000|Overall Study|Refused to return for 12 month visit|1|||
23498514|NCT00005044|65566352|FG000|Overall Study|Protocol Violation|37|||
23690213|NCT00629083|66243829|FG001|Overall Study|Refused to return for 12 month visit|0|||
23690214|NCT03567187|66243830|FG000|Overall Study|Lost to Follow-up|18|||
23690215|NCT04927312|66243831|FG000|Overall Study|Adverse Event|1|||
23690216|NCT04927312|66243831|FG000|Overall Study|Death|1|||
23690217|NCT04927312|66243831|FG000|Overall Study|Withdrawal by Subject|1|||
23690218|NCT04927312|66243831|FG000|Overall Study|Other|1|||
23690219|NCT03459040|66243832|FG000|Overall Study|Death|8|||
23690220|NCT03459040|66243832|FG000|Overall Study|Withdrawal by Subject|1|||
23690221|NCT00162773|66243835|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
23690222|NCT02835495|66243837|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
23690223|NCT02835495|66243838|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
23690224|NCT02835495|66243837|FG000|Overall Study|Declined in-person follow-up visit|4|||
23690225|NCT02835495|66243838|FG001|Overall Study|Declined in-person follow-up visit|2|||
23690226|NCT05292755|66243843|FG000|Overall Study|Lost to Follow-up|5|||
23690227|NCT05292755|66243844|FG001|Overall Study|Lost to Follow-up|9|||
23690228|NCT03668223|66243845|FG000|Overall Study|Death|10|||
23690229|NCT03668223|66243846|FG001|Overall Study|Death|5|||
23690230|NCT03668223|66243845|FG000|Overall Study|Lost to Follow-up|12|||
23690231|NCT03668223|66243846|FG001|Overall Study|Lost to Follow-up|12|||
23690232|NCT03668223|66243845|FG000|Overall Study|Withdrawal by Subject|8|||
23690233|NCT03668223|66243846|FG001|Overall Study|Withdrawal by Subject|3|||
23690234|NCT02635204|66243864|FG000|Overall Study|Adverse Event|1|||
23690235|NCT02635204|66243865|FG001|Overall Study|Adverse Event|0|||
23690236|NCT02635204|66243864|FG000|Overall Study|Lost to Follow-up|1|||
23690237|NCT02635204|66243865|FG001|Overall Study|Lost to Follow-up|1|||
23690238|NCT01009294|66243871|FG000|Overall Study|Study discontinued by Sponsor|6|||
23690239|NCT05369806|66243872|FG000|Overall Study|Lost to Follow-up|1|||
23690240|NCT00049127|66243877|FG000|Overall Study|Withdrawal by Subject|0|||
23690241|NCT00049127|66243878|FG001|Overall Study|Withdrawal by Subject|0|||
23690242|NCT00049127|66243879|FG002|Overall Study|Withdrawal by Subject|1|||
23690243|NCT00049127|66243880|FG003|Overall Study|Withdrawal by Subject|0|||
23690244|NCT00049127|66243881|FG004|Overall Study|Withdrawal by Subject|0|||
23690245|NCT01903876|66243886|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
23690246|NCT01903876|66243887|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
23690247|NCT01903876|66243886|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
23690248|NCT01903876|66243887|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
23690249|NCT02612909|66243888|FG000|Phase 2|Withdrawal by Subject|2|||
23690250|NCT02612909|66243889|FG001|Phase 2|Withdrawal by Subject|5|||
23690251|NCT02612909|66243890|FG002|Phase 2|Withdrawal by Subject|0|||
23690252|NCT02612909|66243891|FG003|Phase 2|Withdrawal by Subject|0|||
23690253|NCT02612909|66243892|FG004|Phase 2|Withdrawal by Subject|0|||
23690254|NCT02612909|66243888|FG000|Phase 2|Pregnancy|0|||
23690255|NCT02612909|66243889|FG001|Phase 2|Pregnancy|0|||
23690256|NCT02612909|66243890|FG002|Phase 2|Pregnancy|1|||
23690257|NCT02612909|66243891|FG003|Phase 2|Pregnancy|0|||
23690258|NCT02612909|66243892|FG004|Phase 2|Pregnancy|0|||
23690259|NCT02612909|66243888|FG000|Phase 3|Withdrawal by Subject|0|||
23690260|NCT02612909|66243889|FG001|Phase 3|Withdrawal by Subject|0|||
23690261|NCT02612909|66243890|FG002|Phase 3|Withdrawal by Subject|0|||
23690262|NCT02612909|66243891|FG003|Phase 3|Withdrawal by Subject|1|||
23690263|NCT02612909|66243892|FG004|Phase 3|Withdrawal by Subject|0|||
23690264|NCT00942162|66243901|FG000|Overall Study|Death|45|||
23690265|NCT00942162|66243902|FG001|Overall Study|Death|35|||
23690266|NCT00942162|66243903|FG002|Overall Study|Death|0|||
23690267|NCT00942162|66243901|FG000|Overall Study|Withdrawal by Subject|7|||
23690268|NCT00942162|66243902|FG001|Overall Study|Withdrawal by Subject|2|||
23690269|NCT00942162|66243903|FG002|Overall Study|Withdrawal by Subject|0|||
23690270|NCT00942162|66243901|FG000|Overall Study|Lost to Follow-up|4|||
23690271|NCT00942162|66243902|FG001|Overall Study|Lost to Follow-up|0|||
23690272|NCT00942162|66243903|FG002|Overall Study|Lost to Follow-up|0|||
23690273|NCT00942162|66243901|FG000|Overall Study|Other|14|||
23690274|NCT00942162|66243902|FG001|Overall Study|Other|13|||
23690275|NCT00942162|66243903|FG002|Overall Study|Other|2|||
23690276|NCT01217606|66243904|FG000|Initial Treatment Phase|Other Reasons|0|||
23690277|NCT01217606|66243905|FG001|Initial Treatment Phase|Other Reasons|2|||
23690278|NCT01217606|66243904|FG000|Initial Treatment Phase|Protocol Violation|3|||
23690279|NCT01217606|66243905|FG001|Initial Treatment Phase|Protocol Violation|2|||
23690280|NCT01217606|66243904|FG000|Initial Treatment Phase|Personal Reasons|0|||
23690281|NCT01217606|66243905|FG001|Initial Treatment Phase|Personal Reasons|2|||
23690282|NCT01217606|66243904|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
23690283|NCT01217606|66243905|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
23690284|NCT01217606|66243904|FG000|Initial Treatment Phase|Adverse Event|10|||
23690285|NCT01217606|66243905|FG001|Initial Treatment Phase|Adverse Event|6|||
23690286|NCT01217606|66243904|FG000|9-Month Masked Extension|Adverse Event|3|||
23690287|NCT01217606|66243905|FG001|9-Month Masked Extension|Adverse Event|6|||
23690288|NCT01217606|66243904|FG000|9-Month Masked Extension|Other Reasons|4|||
23690289|NCT01217606|66243905|FG001|9-Month Masked Extension|Other Reasons|4|||
23690290|NCT01217606|66243904|FG000|9-Month Masked Extension|Personal Reasons|2|||
23690291|NCT01217606|66243905|FG001|9-Month Masked Extension|Personal Reasons|1|||
23690292|NCT01217606|66243904|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
23690293|NCT01217606|66243905|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
23690294|NCT01217606|66243904|FG000|9-Month Masked Extension|Pregnancy|1|||
23690295|NCT01217606|66243905|FG001|9-Month Masked Extension|Pregnancy|0|||
23690296|NCT01217606|66243904|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
23690297|NCT01217606|66243905|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
23690298|NCT00613626|66243906|FG000|Overall Study|Ineligible|0|||
23690299|NCT00613626|66243907|FG001|Overall Study|Ineligible|1|||
23394334|NCT03132467|65192600|FG000|Overall Study|Withdrawal by Subject|2|||
23394335|NCT00668642|65192601|FG000|First Off-cycle|Cancer progression|1|||
23394336|NCT00668642|65192602|FG001|First Off-cycle|Cancer progression|0|||
23394337|NCT00668642|65192601|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
23394338|NCT00668642|65192602|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
23394339|NCT02314923|65192603|FG000|Overall Study|Death|0|||
23394340|NCT02314923|65192604|FG001|Overall Study|Death|0|||
23394341|NCT02314923|65192605|FG002|Overall Study|Death|0|||
23394342|NCT02314923|65192606|FG003|Overall Study|Death|1|||
23394343|NCT02314923|65192607|FG004|Overall Study|Death|0|||
23394344|NCT02314923|65192608|FG005|Overall Study|Death|0|||
23690300|NCT00613626|66243908|FG002|Overall Study|Ineligible|0|||
23690301|NCT00098787|66243915|FG000|Overall Study|Never started treatment|3|||
23690302|NCT00098787|66243916|FG001|Overall Study|Never started treatment|2|||
23690303|NCT00098787|66243917|FG002|Overall Study|Never started treatment|1|||
23690304|NCT00098787|66243915|FG000|Overall Study|Ineligible|9|||
23690305|NCT00098787|66243916|FG001|Overall Study|Ineligible|7|||
23690306|NCT00098787|66243917|FG002|Overall Study|Ineligible|3|||
23690307|NCT00098787|66243915|FG000|Overall Study|Disease progression|28|||
23690308|NCT00098787|66243916|FG001|Overall Study|Disease progression|17|||
23690309|NCT00098787|66243917|FG002|Overall Study|Disease progression|23|||
23690310|NCT00098787|66243915|FG000|Overall Study|Adverse Event|8|||
23690311|NCT00098787|66243916|FG001|Overall Study|Adverse Event|17|||
23690312|NCT00098787|66243917|FG002|Overall Study|Adverse Event|8|||
23690313|NCT00098787|66243915|FG000|Overall Study|Death|6|||
23690314|NCT00098787|66243916|FG001|Overall Study|Death|1|||
23690315|NCT00098787|66243917|FG002|Overall Study|Death|0|||
23690316|NCT00098787|66243915|FG000|Overall Study|Withdrawal by Subject|4|||
23690317|NCT00098787|66243916|FG001|Overall Study|Withdrawal by Subject|12|||
23690318|NCT00098787|66243917|FG002|Overall Study|Withdrawal by Subject|6|||
23690319|NCT00098787|66243915|FG000|Overall Study|Alternative therapy|8|||
23690320|NCT00098787|66243916|FG001|Overall Study|Alternative therapy|13|||
23690321|NCT00098787|66243917|FG002|Overall Study|Alternative therapy|13|||
23690322|NCT00098787|66243915|FG000|Overall Study|Other|7|||
23690323|NCT00098787|66243916|FG001|Overall Study|Other|6|||
23690324|NCT00098787|66243917|FG002|Overall Study|Other|9|||
23690325|NCT03874234|66243918|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690326|NCT03874234|66243919|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690327|NCT03874234|66243920|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690328|NCT03874234|66243921|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
23690329|NCT03874234|66243922|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690330|NCT03874234|66243923|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690331|NCT03874234|66243924|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690332|NCT03874234|66243925|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690333|NCT03874234|66243926|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690334|NCT03874234|66243927|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690335|NCT03874234|66243928|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690336|NCT03874234|66243929|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690337|NCT03874234|66243930|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23690338|NCT03874234|66243918|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
23690339|NCT03874234|66243919|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690340|NCT03874234|66243920|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690341|NCT03874234|66243921|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690342|NCT03874234|66243922|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23394345|NCT02314923|65192609|FG006|Overall Study|Death|0|||
23394346|NCT02314923|65192610|FG007|Overall Study|Death|0|||
23690343|NCT03874234|66243923|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690344|NCT03874234|66243924|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690345|NCT03874234|66243925|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690346|NCT03874234|66243926|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690347|NCT03874234|66243927|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690348|NCT03874234|66243928|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690349|NCT03874234|66243929|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23394347|NCT02314923|65192611|FG008|Overall Study|Death|0|||
23394348|NCT02314923|65192612|FG009|Overall Study|Death|0|||
23394349|NCT02314923|65192603|FG000|Overall Study|Lost to Follow-up|2|||
23690350|NCT03874234|66243930|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23690351|NCT03874234|66243918|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690352|NCT03874234|66243919|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690353|NCT03874234|66243920|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690354|NCT03874234|66243921|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
23690355|NCT03874234|66243922|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690356|NCT03874234|66243923|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690357|NCT03874234|66243924|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690358|NCT03874234|66243925|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690359|NCT03874234|66243926|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690360|NCT03874234|66243927|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690361|NCT03874234|66243928|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690362|NCT03874234|66243929|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690363|NCT03874234|66243930|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23690364|NCT03874234|66243918|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690365|NCT03874234|66243919|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690366|NCT03874234|66243920|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690367|NCT03874234|66243921|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690368|NCT03874234|66243922|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
23690369|NCT03874234|66243923|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690370|NCT03874234|66243924|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690371|NCT03874234|66243925|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690372|NCT03874234|66243926|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690373|NCT03874234|66243927|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690374|NCT03874234|66243928|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690375|NCT03874234|66243929|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690376|NCT03874234|66243930|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23690377|NCT03874234|66243918|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690378|NCT03874234|66243919|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690379|NCT03874234|66243920|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690380|NCT03874234|66243921|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690381|NCT03874234|66243922|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690382|NCT03874234|66243923|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690383|NCT03874234|66243924|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690384|NCT03874234|66243925|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
23690385|NCT03874234|66243926|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690386|NCT03874234|66243927|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690387|NCT03874234|66243928|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690388|NCT03874234|66243929|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690389|NCT03874234|66243930|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23690390|NCT03874234|66243918|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690391|NCT03874234|66243919|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690392|NCT03874234|66243920|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690393|NCT03874234|66243921|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690394|NCT03874234|66243922|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
23690395|NCT03874234|66243923|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
23690396|NCT03874234|66243924|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690397|NCT03874234|66243925|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690398|NCT03874234|66243926|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690399|NCT03874234|66243927|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690400|NCT03874234|66243928|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690401|NCT03874234|66243929|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690402|NCT03874234|66243930|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23690403|NCT03874234|66243918|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690404|NCT03874234|66243919|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23394350|NCT02314923|65192604|FG001|Overall Study|Lost to Follow-up|3|||
23394351|NCT02314923|65192605|FG002|Overall Study|Lost to Follow-up|1|||
23690405|NCT03874234|66243920|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690406|NCT03874234|66243921|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690407|NCT03874234|66243922|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690408|NCT03874234|66243923|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690409|NCT03874234|66243924|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
23690410|NCT03874234|66243925|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690411|NCT03874234|66243926|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690412|NCT03874234|66243927|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690413|NCT03874234|66243928|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690414|NCT03874234|66243929|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690415|NCT03874234|66243930|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23690416|NCT03874234|66243918|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690417|NCT03874234|66243919|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690418|NCT03874234|66243920|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690419|NCT03874234|66243921|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690420|NCT03874234|66243922|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
23690421|NCT03874234|66243923|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690422|NCT03874234|66243924|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690423|NCT03874234|66243925|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690424|NCT03874234|66243926|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690425|NCT03874234|66243927|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690426|NCT03874234|66243928|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690427|NCT03874234|66243929|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690428|NCT03874234|66243930|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23690429|NCT01624142|66243931|FG000|Overall Study|Withdrawal by Subject|14|||
23690430|NCT01624142|66243932|FG001|Overall Study|Withdrawal by Subject|4|||
23394352|NCT02314923|65192606|FG003|Overall Study|Lost to Follow-up|0|||
23394353|NCT02314923|65192607|FG004|Overall Study|Lost to Follow-up|0|||
23394354|NCT02314923|65192608|FG005|Overall Study|Lost to Follow-up|0|||
23394355|NCT02314923|65192609|FG006|Overall Study|Lost to Follow-up|3|||
23690431|NCT01624142|66243931|FG000|Overall Study|Death|3|||
23690432|NCT01624142|66243932|FG001|Overall Study|Death|6|||
23690433|NCT01624142|66243931|FG000|Overall Study|Study Closure|12|||
23690434|NCT01624142|66243932|FG001|Overall Study|Study Closure|6|||
23690435|NCT01624142|66243931|FG000|Overall Study|Lost to Follow-up|2|||
23690436|NCT01624142|66243932|FG001|Overall Study|Lost to Follow-up|0|||
23690437|NCT01624142|66243931|FG000|Overall Study|Other|1|||
23690438|NCT01624142|66243932|FG001|Overall Study|Other|0|||
23690439|NCT03487445|66243933|FG000|Randomization|Not treated for administrative reasons|1|||
23690440|NCT03487445|66243934|FG001|Randomization|Not treated for administrative reasons|0|||
23690441|NCT04052139|66243936|FG000|Overall Study|Lost to Follow-up|2|||
23690442|NCT04052139|66243937|FG001|Overall Study|Lost to Follow-up|0|||
23690443|NCT04052139|66243938|FG002|Overall Study|Lost to Follow-up|0|||
23690444|NCT04052139|66243936|FG000|Overall Study|Withdrawal by Subject|1|||
23690445|NCT04052139|66243937|FG001|Overall Study|Withdrawal by Subject|0|||
23690446|NCT04052139|66243938|FG002|Overall Study|Withdrawal by Subject|0|||
23690447|NCT03022422|66243939|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
23690448|NCT03022422|66243940|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
23690449|NCT03022422|66243941|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
23690450|NCT03022422|66243942|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
23690451|NCT03022422|66243943|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
23690452|NCT03022422|66243944|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
23690453|NCT00002850|66243960|FG000|Overall Study|Death|4|||
23690454|NCT00002850|66243961|FG001|Overall Study|Death|1|||
23690455|NCT00002850|66243962|FG002|Overall Study|Death|3|||
23394356|NCT02314923|65192610|FG007|Overall Study|Lost to Follow-up|4|||
23394357|NCT02314923|65192611|FG008|Overall Study|Lost to Follow-up|2|||
23394358|NCT02314923|65192612|FG009|Overall Study|Lost to Follow-up|0|||
23394359|NCT02314923|65192603|FG000|Overall Study|Withdrawal by Subject|0|||
23394360|NCT02314923|65192604|FG001|Overall Study|Withdrawal by Subject|0|||
23394361|NCT02314923|65192605|FG002|Overall Study|Withdrawal by Subject|1|||
23394362|NCT02314923|65192606|FG003|Overall Study|Withdrawal by Subject|0|||
23394363|NCT02314923|65192607|FG004|Overall Study|Withdrawal by Subject|1|||
23394364|NCT02314923|65192608|FG005|Overall Study|Withdrawal by Subject|0|||
23394365|NCT02314923|65192609|FG006|Overall Study|Withdrawal by Subject|1|||
23394366|NCT02314923|65192610|FG007|Overall Study|Withdrawal by Subject|0|||
23394367|NCT02314923|65192611|FG008|Overall Study|Withdrawal by Subject|0|||
23394368|NCT02314923|65192612|FG009|Overall Study|Withdrawal by Subject|0|||
23394369|NCT02314923|65192603|FG000|Overall Study|Physician Decision|0|||
23394370|NCT02314923|65192604|FG001|Overall Study|Physician Decision|1|||
23394371|NCT02314923|65192605|FG002|Overall Study|Physician Decision|0|||
23394372|NCT02314923|65192606|FG003|Overall Study|Physician Decision|0|||
23394373|NCT02314923|65192607|FG004|Overall Study|Physician Decision|0|||
23394374|NCT02314923|65192608|FG005|Overall Study|Physician Decision|0|||
23394375|NCT02314923|65192609|FG006|Overall Study|Physician Decision|0|||
23394376|NCT02314923|65192610|FG007|Overall Study|Physician Decision|0|||
23394377|NCT02314923|65192611|FG008|Overall Study|Physician Decision|0|||
23394378|NCT02314923|65192612|FG009|Overall Study|Physician Decision|0|||
23394379|NCT02314923|65192603|FG000|Overall Study|Participant unavailable|0|||
23394380|NCT02314923|65192604|FG001|Overall Study|Participant unavailable|0|||
23394381|NCT02314923|65192605|FG002|Overall Study|Participant unavailable|0|||
23394382|NCT02314923|65192606|FG003|Overall Study|Participant unavailable|0|||
23394383|NCT02314923|65192607|FG004|Overall Study|Participant unavailable|0|||
23394384|NCT02314923|65192608|FG005|Overall Study|Participant unavailable|1|||
23394385|NCT02314923|65192609|FG006|Overall Study|Participant unavailable|0|||
23690456|NCT00002850|66243960|FG000|Overall Study|Protocol Violation|1|||
23690457|NCT00002850|66243961|FG001|Overall Study|Protocol Violation|0|||
23690458|NCT00002850|66243962|FG002|Overall Study|Protocol Violation|1|||
23690459|NCT00002850|66243960|FG000|Overall Study|Withdrawal by Subject|0|||
23690460|NCT00002850|66243961|FG001|Overall Study|Withdrawal by Subject|1|||
23690461|NCT00002850|66243962|FG002|Overall Study|Withdrawal by Subject|0|||
23690462|NCT03832387|66243963|FG000|Overall Study|Protocol Violation|2|||
23690463|NCT03832387|66243964|FG001|Overall Study|Protocol Violation|6|||
23690464|NCT03832387|66243963|FG000|Overall Study|EXCLUSION CRITERIA|3|||
23690465|NCT03832387|66243964|FG001|Overall Study|EXCLUSION CRITERIA|1|||
23690466|NCT02048904|66243965|FG000|Overall Study|Withdrawal by Subject|7|||
23690467|NCT02048904|66243965|FG000|Overall Study|Physician Decision|70|||
23690468|NCT01171612|66243967|FG000|Overall Study|Lost to Follow-up|51|||
23690469|NCT02031679|66243968|FG000|Overall Study|Protocol Violation|0|||
23690470|NCT02031679|66243969|FG001|Overall Study|Protocol Violation|1|||
23690471|NCT02031679|66243968|FG000|Overall Study|Lack of Efficacy|0|||
23690472|NCT02031679|66243969|FG001|Overall Study|Lack of Efficacy|1|||
23690473|NCT01486264|66243972|FG000|Overall Study|Death|1|||
23690474|NCT01486264|66243973|FG001|Overall Study|Death|1|||
23690475|NCT01486264|66243972|FG000|Overall Study|Adverse Event|3|||
23690476|NCT01486264|66243973|FG001|Overall Study|Adverse Event|3|||
23690477|NCT01486264|66243972|FG000|Overall Study|Lack of Efficacy|6|||
23690478|NCT01486264|66243973|FG001|Overall Study|Lack of Efficacy|10|||
23690479|NCT01486264|66243972|FG000|Overall Study|Withdrawal by Subject|7|||
23690480|NCT01486264|66243973|FG001|Overall Study|Withdrawal by Subject|18|||
23690481|NCT01486264|66243972|FG000|Overall Study|Physician Decision|1|||
23690482|NCT01486264|66243973|FG001|Overall Study|Physician Decision|1|||
23690483|NCT01486264|66243972|FG000|Overall Study|Protocol Violation|3|||
23690484|NCT01486264|66243973|FG001|Overall Study|Protocol Violation|0|||
23690485|NCT01486264|66243972|FG000|Overall Study|Lost to Follow-up|3|||
23690486|NCT01486264|66243973|FG001|Overall Study|Lost to Follow-up|2|||
23690487|NCT01486264|66243972|FG000|Overall Study|Other|5|||
23690488|NCT01486264|66243973|FG001|Overall Study|Other|11|||
23690489|NCT01486264|66243972|FG000|Overall Study|Not treated|0|||
23690490|NCT01486264|66243973|FG001|Overall Study|Not treated|1|||
23690491|NCT04488822|66243974|FG000|Overall Study|Adverse Event|8|||
23690492|NCT04488822|66243974|FG000|Overall Study|Withdrawal by Subject|1|||
23690493|NCT03138564|66243975|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
23690494|NCT03138564|66243976|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
23690495|NCT03138564|66243975|FG000|Overall Study|Lost to Follow-up|16|||
23394386|NCT02314923|65192610|FG007|Overall Study|Participant unavailable|0|||
23394387|NCT02314923|65192611|FG008|Overall Study|Participant unavailable|0|||
23394388|NCT02314923|65192612|FG009|Overall Study|Participant unavailable|0|||
23394389|NCT02314923|65192603|FG000|Overall Study|Screen failure|0|||
23394390|NCT02314923|65192604|FG001|Overall Study|Screen failure|0|||
23394391|NCT02314923|65192605|FG002|Overall Study|Screen failure|0|||
23394392|NCT02314923|65192606|FG003|Overall Study|Screen failure|0|||
23394393|NCT02314923|65192607|FG004|Overall Study|Screen failure|0|||
23394394|NCT02314923|65192608|FG005|Overall Study|Screen failure|0|||
23394395|NCT02314923|65192609|FG006|Overall Study|Screen failure|1|||
23394396|NCT02314923|65192610|FG007|Overall Study|Screen failure|0|||
23394397|NCT02314923|65192611|FG008|Overall Study|Screen failure|0|||
23394398|NCT02314923|65192612|FG009|Overall Study|Screen failure|0|||
23394399|NCT02314923|65192603|FG000|Overall Study|Participant relocation|1|||
23394400|NCT02314923|65192604|FG001|Overall Study|Participant relocation|0|||
23394401|NCT02314923|65192605|FG002|Overall Study|Participant relocation|0|||
23394402|NCT02314923|65192606|FG003|Overall Study|Participant relocation|0|||
23690496|NCT03138564|66243976|FG001|Overall Study|Lost to Follow-up|2|||
23690497|NCT03138564|66243975|FG000|Overall Study|Withdrawal by Subject|48|||
23690498|NCT03138564|66243976|FG001|Overall Study|Withdrawal by Subject|4|||
23690499|NCT03138564|66243975|FG000|Overall Study|No longer met eligibility criteria|2|||
23690500|NCT03138564|66243976|FG001|Overall Study|No longer met eligibility criteria|0|||
23690501|NCT03138564|66243975|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
23690502|NCT03138564|66243976|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
23690503|NCT03138564|66243975|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
23394403|NCT02314923|65192607|FG004|Overall Study|Participant relocation|0|||
23394404|NCT02314923|65192608|FG005|Overall Study|Participant relocation|0|||
23394405|NCT02314923|65192609|FG006|Overall Study|Participant relocation|0|||
23394406|NCT02314923|65192610|FG007|Overall Study|Participant relocation|1|||
23394407|NCT02314923|65192611|FG008|Overall Study|Participant relocation|0|||
23690504|NCT03138564|66243976|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
23690505|NCT03138564|66243975|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
23690506|NCT03138564|66243976|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
23690507|NCT03138564|66243975|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
23690508|NCT03138564|66243976|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
23690509|NCT03584009|66243985|FG000|Overall Study|Death|25|||
23690510|NCT03584009|66243986|FG001|Overall Study|Death|18|||
23690511|NCT03584009|66243985|FG000|Overall Study|Lost to Follow-up|0|||
23690512|NCT03584009|66243986|FG001|Overall Study|Lost to Follow-up|1|||
23690513|NCT03584009|66243985|FG000|Overall Study|Physician Decision|1|||
23690514|NCT03584009|66243986|FG001|Overall Study|Physician Decision|1|||
23690515|NCT03584009|66243985|FG000|Overall Study|Study Terminated by Sponsor|22|||
23394408|NCT02314923|65192612|FG009|Overall Study|Participant relocation|0|||
23394409|NCT01394185|65192613|FG000|Overall Study|Withdrawal by Subject|2|||
23394410|NCT01394185|65192614|FG001|Overall Study|Withdrawal by Subject|0|||
23394411|NCT01394185|65192615|FG002|Overall Study|Withdrawal by Subject|0|||
23394412|NCT01394185|65192616|FG003|Overall Study|Withdrawal by Subject|0|||
23394413|NCT01394185|65192617|FG004|Overall Study|Withdrawal by Subject|1|||
23394414|NCT01394185|65192618|FG005|Overall Study|Withdrawal by Subject|0|||
23394415|NCT01394185|65192613|FG000|Overall Study|Change in protocol|3|||
23394416|NCT01394185|65192614|FG001|Overall Study|Change in protocol|0|||
23690516|NCT03584009|66243986|FG001|Overall Study|Study Terminated by Sponsor|30|||
23690517|NCT03584009|66243985|FG000|Overall Study|Withdrawal by Subject|3|||
23690518|NCT03584009|66243986|FG001|Overall Study|Withdrawal by Subject|2|||
23690519|NCT03851510|66243987|FG000|Overall Study|Screen Fail|1|||
23690520|NCT03851510|66243987|FG000|Overall Study|Adverse Event|1|||
23690521|NCT03851510|66243987|FG000|Overall Study|Withdrawal by Subject|1|||
23690522|NCT01717638|66243990|FG000|Overall Study|Lost to Follow-up|0|||
23394417|NCT01394185|65192615|FG002|Overall Study|Change in protocol|0|||
23394418|NCT01394185|65192616|FG003|Overall Study|Change in protocol|0|||
23394419|NCT01394185|65192617|FG004|Overall Study|Change in protocol|3|||
23394420|NCT01394185|65192618|FG005|Overall Study|Change in protocol|0|||
23394421|NCT01394185|65192613|FG000|Overall Study|Protocol Violation|1|||
23394422|NCT01394185|65192614|FG001|Overall Study|Protocol Violation|0|||
23394423|NCT01394185|65192615|FG002|Overall Study|Protocol Violation|0|||
23394424|NCT01394185|65192616|FG003|Overall Study|Protocol Violation|1|||
23394425|NCT01394185|65192617|FG004|Overall Study|Protocol Violation|0|||
23394426|NCT01394185|65192618|FG005|Overall Study|Protocol Violation|1|||
23394427|NCT04576455|65192619|FG000|Overall Study|Ongoing in the Study|122|||
23394428|NCT04576455|65192620|FG001|Overall Study|Ongoing in the Study|135|||
23690523|NCT01717638|66243991|FG001|Overall Study|Lost to Follow-up|0|||
23690524|NCT01717638|66243992|FG002|Overall Study|Lost to Follow-up|0|||
23690525|NCT01717638|66243993|FG003|Overall Study|Lost to Follow-up|0|||
23690526|NCT01717638|66243994|FG004|Overall Study|Lost to Follow-up|0|||
23690527|NCT01717638|66243995|FG005|Overall Study|Lost to Follow-up|1|||
23690528|NCT01717638|66243996|FG006|Overall Study|Lost to Follow-up|0|||
23394429|NCT04576455|65192619|FG000|Overall Study|Death|18|||
23394430|NCT04576455|65192620|FG001|Overall Study|Death|12|||
23394431|NCT04576455|65192619|FG000|Overall Study|Lost to Follow-up|1|||
23394432|NCT04576455|65192620|FG001|Overall Study|Lost to Follow-up|0|||
23394433|NCT04576455|65192619|FG000|Overall Study|Withdrawal by Subject|10|||
23394434|NCT04576455|65192620|FG001|Overall Study|Withdrawal by Subject|5|||
23394435|NCT02495883|65192621|FG000|Overall Study|Excessive head motion|1|||
23394436|NCT02495883|65192622|FG001|Overall Study|Excessive head motion|0|||
23394437|NCT01344356|65192624|FG000|Overall Study|Physician Decision|0|||
23394438|NCT01344356|65192625|FG001|Overall Study|Physician Decision|3|||
23394439|NCT01344356|65192624|FG000|Overall Study|Lost to Follow-up|0|||
23394440|NCT01344356|65192625|FG001|Overall Study|Lost to Follow-up|6|||
23394441|NCT03312114|65192628|FG000|Overall Study|All the five enrolled dropped out of the|5|||
23394442|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Adverse Event|3|||
23394443|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Adverse Event|0|||
23690529|NCT01717638|66243997|FG007|Overall Study|Lost to Follow-up|0|||
23690530|NCT01717638|66243998|FG008|Overall Study|Lost to Follow-up|0|||
23690531|NCT01717638|66243999|FG009|Overall Study|Lost to Follow-up|0|||
23394444|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Adverse Event|0|||
23394445|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
23394446|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
23394447|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
23394448|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
23394449|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
23394450|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
23394451|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
23394452|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
23690532|NCT01717638|66244000|FG010|Overall Study|Lost to Follow-up|0|||
23690533|NCT01717638|66244001|FG011|Overall Study|Lost to Follow-up|0|||
23394453|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
23498515|NCT00005044|65566353|FG001|Overall Study|Protocol Violation|46|||
23690534|NCT01717638|66244002|FG012|Overall Study|Lost to Follow-up|0|||
23690535|NCT01717638|66243990|FG000|Overall Study|Father in hospital|0|||
23690536|NCT01717638|66243991|FG001|Overall Study|Father in hospital|0|||
23690537|NCT01717638|66243992|FG002|Overall Study|Father in hospital|0|||
23690538|NCT01717638|66243993|FG003|Overall Study|Father in hospital|0|||
23690539|NCT01717638|66243994|FG004|Overall Study|Father in hospital|0|||
23690540|NCT01717638|66243995|FG005|Overall Study|Father in hospital|0|||
23690541|NCT01717638|66243996|FG006|Overall Study|Father in hospital|0|||
23690542|NCT01717638|66243997|FG007|Overall Study|Father in hospital|0|||
23690543|NCT01717638|66243998|FG008|Overall Study|Father in hospital|0|||
23690544|NCT01717638|66243999|FG009|Overall Study|Father in hospital|0|||
23690545|NCT01717638|66244000|FG010|Overall Study|Father in hospital|0|||
23690546|NCT01717638|66244001|FG011|Overall Study|Father in hospital|0|||
23690547|NCT01717638|66244002|FG012|Overall Study|Father in hospital|1|||
23690548|NCT01717638|66243990|FG000|Overall Study|Withdrawal by Subject|0|||
23690549|NCT01717638|66243991|FG001|Overall Study|Withdrawal by Subject|1|||
23690550|NCT01717638|66243992|FG002|Overall Study|Withdrawal by Subject|1|||
23690551|NCT01717638|66243993|FG003|Overall Study|Withdrawal by Subject|0|||
23690552|NCT01717638|66243994|FG004|Overall Study|Withdrawal by Subject|1|||
23690553|NCT01717638|66243995|FG005|Overall Study|Withdrawal by Subject|0|||
23690554|NCT01717638|66243996|FG006|Overall Study|Withdrawal by Subject|2|||
23690555|NCT01717638|66243997|FG007|Overall Study|Withdrawal by Subject|1|||
23690556|NCT01717638|66243998|FG008|Overall Study|Withdrawal by Subject|2|||
23690557|NCT01717638|66243999|FG009|Overall Study|Withdrawal by Subject|1|||
23690558|NCT01717638|66244000|FG010|Overall Study|Withdrawal by Subject|0|||
23690559|NCT01717638|66244001|FG011|Overall Study|Withdrawal by Subject|0|||
23690560|NCT01717638|66244002|FG012|Overall Study|Withdrawal by Subject|18|||
23690561|NCT03258814|66244003|FG000|Overall Study|Early Termination|4|||
23690562|NCT03258814|66244004|FG001|Overall Study|Early Termination|3|||
23690563|NCT03258814|66244005|FG002|Overall Study|Early Termination|10|||
23690564|NCT04725682|66244006|FG000|Overall Study|Withdrawal by Subject|7|||
23690565|NCT04725682|66244007|FG001|Overall Study|Withdrawal by Subject|5|||
23690566|NCT04725682|66244006|FG000|Overall Study|Failed to comply with the requirements|2|||
23394454|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
23606308|NCT02060487|65947205|FG002|Overall Study|Adverse Event|1|||
23690567|NCT04725682|66244007|FG001|Overall Study|Failed to comply with the requirements|1|||
23690568|NCT04725682|66244006|FG000|Overall Study|Adverse Event|1|||
23690569|NCT04725682|66244007|FG001|Overall Study|Adverse Event|1|||
23690570|NCT04725682|66244006|FG000|Overall Study|Death|0|||
23690571|NCT04725682|66244007|FG001|Overall Study|Death|1|||
23690572|NCT00817414|66244011|FG000|Overall Study|Adverse Event|1|||
23690573|NCT00817414|66244012|FG001|Overall Study|Adverse Event|1|||
23690574|NCT00817414|66244013|FG002|Overall Study|Adverse Event|1|||
23690575|NCT00817414|66244014|FG003|Overall Study|Adverse Event|0|||
23690576|NCT00817414|66244015|FG004|Overall Study|Adverse Event|0|||
23690577|NCT00817414|66244011|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
23690578|NCT00817414|66244012|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
23606309|NCT00089609|65947207|FG000|Overall Study|Withdrawal by Subject|3|||
23606310|NCT00089609|65947208|FG001|Overall Study|Withdrawal by Subject|1|||
23606311|NCT05445557|65947209|FG000|Double Blind Part|Lost to Follow-up|1|||
23606312|NCT01005602|65947210|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
23606313|NCT01005602|65947211|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
23606314|NCT00088166|65947212|FG000|Overall Study|Adverse Event|11|||
23606315|NCT00088166|65947213|FG001|Overall Study|Adverse Event|9|||
23606316|NCT00088166|65947212|FG000|Overall Study|Death|3|||
23606317|NCT00088166|65947213|FG001|Overall Study|Death|1|||
23606318|NCT00088166|65947212|FG000|Overall Study|Lost to Follow-up|0|||
23606319|NCT00088166|65947213|FG001|Overall Study|Lost to Follow-up|1|||
23606320|NCT00088166|65947212|FG000|Overall Study|Physician Decision|4|||
23606321|NCT00088166|65947213|FG001|Overall Study|Physician Decision|1|||
23606322|NCT00088166|65947212|FG000|Overall Study|Protocol Violation|1|||
23606323|NCT00088166|65947213|FG001|Overall Study|Protocol Violation|5|||
23606324|NCT00088166|65947212|FG000|Overall Study|Patient deterioration|29|||
23606325|NCT00088166|65947213|FG001|Overall Study|Patient deterioration|39|||
23606326|NCT00088166|65947212|FG000|Overall Study|Withdrawal by Subject|5|||
23606327|NCT00088166|65947213|FG001|Overall Study|Withdrawal by Subject|5|||
23606328|NCT03265132|65947214|FG000|Overall Study|Adverse Event|0|||
23606329|NCT03265132|65947215|FG001|Overall Study|Adverse Event|1|||
23606330|NCT03265132|65947214|FG000|Overall Study|Lack of Efficacy|0|||
23606331|NCT03265132|65947215|FG001|Overall Study|Lack of Efficacy|2|||
23606332|NCT03265132|65947214|FG000|Overall Study|Progressive disease|0|||
23606333|NCT03265132|65947215|FG001|Overall Study|Progressive disease|2|||
23606334|NCT03265132|65947214|FG000|Overall Study|Withdrawal by Subject|0|||
23606335|NCT03265132|65947215|FG001|Overall Study|Withdrawal by Subject|1|||
23606336|NCT02332824|65947216|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
23606337|NCT02332824|65947217|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23606338|NCT02332824|65947218|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23606339|NCT02332824|65947219|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23606340|NCT02332824|65947220|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
23690579|NCT00817414|66244013|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
23690580|NCT00817414|66244014|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
23690581|NCT00817414|66244015|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
23690582|NCT00817414|66244011|FG000|Overall Study|Withdrawal by Subject|1|||
23690583|NCT00817414|66244012|FG001|Overall Study|Withdrawal by Subject|1|||
23394455|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
23394456|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
23690584|NCT00817414|66244013|FG002|Overall Study|Withdrawal by Subject|0|||
23690585|NCT00817414|66244014|FG003|Overall Study|Withdrawal by Subject|0|||
23690586|NCT00817414|66244015|FG004|Overall Study|Withdrawal by Subject|0|||
23690587|NCT00817414|66244011|FG000|Overall Study|Lost to Follow-up|0|||
23690588|NCT00817414|66244012|FG001|Overall Study|Lost to Follow-up|0|||
23394457|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
23690589|NCT00817414|66244013|FG002|Overall Study|Lost to Follow-up|1|||
23690590|NCT00817414|66244014|FG003|Overall Study|Lost to Follow-up|1|||
23690591|NCT00817414|66244015|FG004|Overall Study|Lost to Follow-up|1|||
23690592|NCT00817414|66244011|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23394458|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
23394459|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
23394460|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23394461|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23394462|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Adverse Event|14|||
23394463|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
23690593|NCT00817414|66244012|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23690594|NCT00817414|66244013|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23690595|NCT00817414|66244014|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
23690596|NCT00817414|66244015|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23690597|NCT00817414|66244011|FG000|Overall Study|Protocol Violation|0|||
23690598|NCT00817414|66244012|FG001|Overall Study|Protocol Violation|0|||
23690599|NCT00817414|66244013|FG002|Overall Study|Protocol Violation|0|||
23690600|NCT00817414|66244014|FG003|Overall Study|Protocol Violation|0|||
23690601|NCT00817414|66244015|FG004|Overall Study|Protocol Violation|1|||
23690602|NCT03245814|66244016|FG000|Overall Study|Lost to Follow-up|5|||
23690603|NCT03245814|66244017|FG001|Overall Study|Lost to Follow-up|8|||
23690604|NCT03245814|66244016|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
23690605|NCT03245814|66244017|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
23690606|NCT02443402|66244018|FG000|Overall Study|Withdrawal by Subject|3|||
23690607|NCT02443402|66244019|FG001|Overall Study|Withdrawal by Subject|1|||
23690608|NCT02443402|66244018|FG000|Overall Study|Screen Failure|1|||
23690609|NCT02443402|66244019|FG001|Overall Study|Screen Failure|2|||
23690610|NCT00140855|66244023|FG000|Overall Study|Progressive disease|2|||
23690611|NCT03430310|66244024|FG000|Overall Study|Protocol Violation|2|||
23690612|NCT03430310|66244025|FG001|Overall Study|Protocol Violation|0|||
23690613|NCT03430310|66244024|FG000|Overall Study|Withdrawal by Subject|3|||
23394464|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
23394465|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
23690614|NCT03430310|66244025|FG001|Overall Study|Withdrawal by Subject|2|||
23690615|NCT03430310|66244024|FG000|Overall Study|COVID shutdown March 2020|0|||
23690616|NCT03430310|66244025|FG001|Overall Study|COVID shutdown March 2020|1|||
23690617|NCT00097539|66244026|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
23690618|NCT00097539|66244027|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
23690619|NCT00097539|66244028|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
23690620|NCT00097539|66244029|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
23690621|NCT00097539|66244030|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
23690622|NCT00097539|66244031|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
23690623|NCT00097539|66244032|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
23690624|NCT00097539|66244026|FG000|Overall Study|Withdrawal by Subject|925|||
23690625|NCT00097539|66244027|FG001|Overall Study|Withdrawal by Subject|323|||
23690626|NCT00097539|66244028|FG002|Overall Study|Withdrawal by Subject|346|||
23690627|NCT00097539|66244029|FG003|Overall Study|Withdrawal by Subject|217|||
23394466|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23394467|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23690628|NCT00097539|66244030|FG004|Overall Study|Withdrawal by Subject|68|||
23690629|NCT00097539|66244031|FG005|Overall Study|Withdrawal by Subject|229|||
23690630|NCT00097539|66244032|FG006|Overall Study|Withdrawal by Subject|3|||
23690631|NCT00097539|66244026|FG000|Overall Study|Participant Non-compliant|2140|||
23690632|NCT00097539|66244027|FG001|Overall Study|Participant Non-compliant|567|||
23690633|NCT00097539|66244028|FG002|Overall Study|Participant Non-compliant|1067|||
23690634|NCT00097539|66244029|FG003|Overall Study|Participant Non-compliant|353|||
23690635|NCT00097539|66244030|FG004|Overall Study|Participant Non-compliant|136|||
23690636|NCT00097539|66244031|FG005|Overall Study|Participant Non-compliant|543|||
23394468|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
23394469|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
23394470|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
23394471|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
23394472|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
23394473|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
23394474|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
23394475|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
23394476|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
23394477|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
23394478|NCT00518180|65192633|FG000|Overall Study|Withdrawal by Subject|29|||
23394479|NCT00518180|65192634|FG001|Overall Study|Withdrawal by Subject|30|||
23394480|NCT00518180|65192635|FG002|Overall Study|Withdrawal by Subject|42|||
23394481|NCT00518180|65192633|FG000|Overall Study|Lost to Follow-up|30|||
23394482|NCT00518180|65192634|FG001|Overall Study|Lost to Follow-up|28|||
23690637|NCT00097539|66244032|FG006|Overall Study|Participant Non-compliant|18|||
23690638|NCT00097539|66244026|FG000|Overall Study|Lack of Efficacy|249|||
23690639|NCT00097539|66244027|FG001|Overall Study|Lack of Efficacy|122|||
23690640|NCT00097539|66244028|FG002|Overall Study|Lack of Efficacy|202|||
23690641|NCT00097539|66244029|FG003|Overall Study|Lack of Efficacy|105|||
23690642|NCT00097539|66244030|FG004|Overall Study|Lack of Efficacy|45|||
23690643|NCT00097539|66244031|FG005|Overall Study|Lack of Efficacy|228|||
23690644|NCT00097539|66244032|FG006|Overall Study|Lack of Efficacy|5|||
23690645|NCT00097539|66244026|FG000|Overall Study|Adverse Event|78|||
23690646|NCT00097539|66244027|FG001|Overall Study|Adverse Event|133|||
23690647|NCT00097539|66244028|FG002|Overall Study|Adverse Event|37|||
23690648|NCT00097539|66244029|FG003|Overall Study|Adverse Event|27|||
23690649|NCT00097539|66244030|FG004|Overall Study|Adverse Event|30|||
23690650|NCT00097539|66244031|FG005|Overall Study|Adverse Event|59|||
23690651|NCT00097539|66244032|FG006|Overall Study|Adverse Event|1|||
23690652|NCT00097539|66244026|FG000|Overall Study|Death|2|||
23690653|NCT00097539|66244027|FG001|Overall Study|Death|7|||
23690654|NCT00097539|66244028|FG002|Overall Study|Death|0|||
23690655|NCT00097539|66244029|FG003|Overall Study|Death|0|||
23690656|NCT00097539|66244030|FG004|Overall Study|Death|1|||
23690657|NCT00097539|66244031|FG005|Overall Study|Death|3|||
23690658|NCT00097539|66244032|FG006|Overall Study|Death|0|||
23690659|NCT00097539|66244026|FG000|Overall Study|Reasons Other Than Above|3602|||
23690660|NCT00097539|66244027|FG001|Overall Study|Reasons Other Than Above|1382|||
23690661|NCT00097539|66244028|FG002|Overall Study|Reasons Other Than Above|1757|||
23690662|NCT00097539|66244029|FG003|Overall Study|Reasons Other Than Above|692|||
23690663|NCT00097539|66244030|FG004|Overall Study|Reasons Other Than Above|361|||
23690664|NCT00097539|66244031|FG005|Overall Study|Reasons Other Than Above|1244|||
23690665|NCT00097539|66244032|FG006|Overall Study|Reasons Other Than Above|34|||
23690666|NCT00097539|66244026|FG000|Overall Study|Reason not Specified|111|||
23690667|NCT00097539|66244027|FG001|Overall Study|Reason not Specified|49|||
23690668|NCT00097539|66244028|FG002|Overall Study|Reason not Specified|53|||
23690669|NCT00097539|66244029|FG003|Overall Study|Reason not Specified|21|||
23690670|NCT00097539|66244030|FG004|Overall Study|Reason not Specified|11|||
23690671|NCT00097539|66244031|FG005|Overall Study|Reason not Specified|40|||
23690672|NCT00097539|66244032|FG006|Overall Study|Reason not Specified|2|||
23394483|NCT00518180|65192635|FG002|Overall Study|Lost to Follow-up|34|||
23394484|NCT00518180|65192633|FG000|Overall Study|Administrative reason|0|||
23394485|NCT00518180|65192634|FG001|Overall Study|Administrative reason|2|||
23498516|NCT00005044|65566352|FG000|Overall Study|Withdrawal by Subject|1|||
23498517|NCT00005044|65566353|FG001|Overall Study|Withdrawal by Subject|5|||
23498518|NCT00005044|65566352|FG000|Overall Study|No protocol treatment|0|||
23498519|NCT00005044|65566353|FG001|Overall Study|No protocol treatment|1|||
23498520|NCT00293215|65566354|FG000|Overall Study|Progressive disease|3|||
23498521|NCT00293215|65566355|FG001|Overall Study|Progressive disease|1|||
23498522|NCT00293215|65566354|FG000|Overall Study|Adverse Event|2|||
23498523|NCT00293215|65566355|FG001|Overall Study|Adverse Event|2|||
23498524|NCT04066023|65566358|FG000|Overall Study|Adverse Event|0|||
23498525|NCT04066023|65566359|FG001|Overall Study|Adverse Event|0|||
23690673|NCT00851903|66244033|FG000|Overall Study|Withdrawal by Subject|2|||
23690674|NCT03263091|66244034|FG000|OL Component|Withdrawal by Subject|1|||
23690675|NCT03263091|66244035|FG001|OL Component|Withdrawal by Subject|1|||
23690676|NCT03263091|66244036|FG002|OL Component|Withdrawal by Subject|0|||
23690677|NCT03263091|66244037|FG003|OL Component|Withdrawal by Subject|0|||
23690678|NCT03263091|66244038|FG004|OL Component|Withdrawal by Subject|0|||
23394486|NCT00518180|65192635|FG002|Overall Study|Administrative reason|2|||
23394487|NCT00518180|65192633|FG000|Overall Study|Protocol Violation|5|||
23498526|NCT04066023|65566360|FG002|Overall Study|Adverse Event|1|||
23498527|NCT04066023|65566358|FG000|Overall Study|Sponsor decision|3|||
23498528|NCT04066023|65566359|FG001|Overall Study|Sponsor decision|6|||
23498529|NCT04066023|65566360|FG002|Overall Study|Sponsor decision|2|||
23690679|NCT03263091|66244039|FG005|OL Component|Withdrawal by Subject|0|||
23690680|NCT03263091|66244034|FG000|OL Component|Physician Decision|0|||
23690681|NCT03263091|66244035|FG001|OL Component|Physician Decision|1|||
23690682|NCT03263091|66244036|FG002|OL Component|Physician Decision|2|||
23690683|NCT03263091|66244037|FG003|OL Component|Physician Decision|0|||
23690684|NCT03263091|66244038|FG004|OL Component|Physician Decision|0|||
23690685|NCT03263091|66244039|FG005|OL Component|Physician Decision|0|||
23690686|NCT03263091|66244034|FG000|OL Component|Death|1|||
23690687|NCT03263091|66244035|FG001|OL Component|Death|0|||
23690688|NCT03263091|66244036|FG002|OL Component|Death|0|||
23690689|NCT03263091|66244037|FG003|OL Component|Death|0|||
23690690|NCT03263091|66244038|FG004|OL Component|Death|0|||
23690691|NCT03263091|66244039|FG005|OL Component|Death|0|||
23690692|NCT03263091|66244034|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
23690693|NCT03263091|66244035|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
23690694|NCT03263091|66244036|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
23690695|NCT03263091|66244037|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
23690696|NCT03263091|66244038|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
23690697|NCT03263091|66244039|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
23690698|NCT03263091|66244034|FG000|OL High-EPO Component|Physician Decision|0|||
23690699|NCT03263091|66244035|FG001|OL High-EPO Component|Physician Decision|0|||
23690700|NCT03263091|66244036|FG002|OL High-EPO Component|Physician Decision|0|||
23690701|NCT03263091|66244037|FG003|OL High-EPO Component|Physician Decision|1|||
23690702|NCT03263091|66244038|FG004|OL High-EPO Component|Physician Decision|0|||
23690703|NCT03263091|66244039|FG005|OL High-EPO Component|Physician Decision|0|||
23690704|NCT03263091|66244034|FG000|OL High-EPO Component|Death|0|||
23690705|NCT03263091|66244035|FG001|OL High-EPO Component|Death|0|||
23690706|NCT03263091|66244036|FG002|OL High-EPO Component|Death|0|||
23690707|NCT03263091|66244037|FG003|OL High-EPO Component|Death|3|||
23690708|NCT03263091|66244038|FG004|OL High-EPO Component|Death|0|||
23690709|NCT03263091|66244039|FG005|OL High-EPO Component|Death|0|||
23690710|NCT03263091|66244034|FG000|DB Component|Withdrawal by Subject|0|||
23690711|NCT03263091|66244035|FG001|DB Component|Withdrawal by Subject|0|||
23690712|NCT03263091|66244036|FG002|DB Component|Withdrawal by Subject|0|||
23690713|NCT03263091|66244037|FG003|DB Component|Withdrawal by Subject|0|||
23690714|NCT03263091|66244038|FG004|DB Component|Withdrawal by Subject|22|||
23690715|NCT03263091|66244039|FG005|DB Component|Withdrawal by Subject|8|||
23690716|NCT03263091|66244034|FG000|DB Component|Physician Decision|0|||
23690717|NCT03263091|66244035|FG001|DB Component|Physician Decision|0|||
23690718|NCT03263091|66244036|FG002|DB Component|Physician Decision|0|||
23690719|NCT03263091|66244037|FG003|DB Component|Physician Decision|0|||
23690720|NCT03263091|66244038|FG004|DB Component|Physician Decision|3|||
23690721|NCT03263091|66244039|FG005|DB Component|Physician Decision|1|||
23690722|NCT03263091|66244034|FG000|DB Component|Adverse Event|0|||
23690723|NCT03263091|66244035|FG001|DB Component|Adverse Event|0|||
23690724|NCT03263091|66244036|FG002|DB Component|Adverse Event|0|||
23690725|NCT03263091|66244037|FG003|DB Component|Adverse Event|0|||
23690726|NCT03263091|66244038|FG004|DB Component|Adverse Event|2|||
23690727|NCT03263091|66244039|FG005|DB Component|Adverse Event|1|||
23690728|NCT03263091|66244034|FG000|DB Component|Lost to Follow-up|0|||
23690729|NCT03263091|66244035|FG001|DB Component|Lost to Follow-up|0|||
23690730|NCT03263091|66244036|FG002|DB Component|Lost to Follow-up|0|||
23690731|NCT03263091|66244037|FG003|DB Component|Lost to Follow-up|0|||
23690732|NCT03263091|66244038|FG004|DB Component|Lost to Follow-up|2|||
23690733|NCT03263091|66244039|FG005|DB Component|Lost to Follow-up|1|||
23690734|NCT03263091|66244034|FG000|DB Component|Death|0|||
23690735|NCT03263091|66244035|FG001|DB Component|Death|0|||
23690736|NCT03263091|66244036|FG002|DB Component|Death|0|||
23690737|NCT03263091|66244037|FG003|DB Component|Death|0|||
23690738|NCT03263091|66244038|FG004|DB Component|Death|7|||
23690739|NCT03263091|66244039|FG005|DB Component|Death|4|||
23690740|NCT03263091|66244034|FG000|DB Component|Other than specified|0|||
23690741|NCT03263091|66244035|FG001|DB Component|Other than specified|0|||
23690742|NCT03263091|66244036|FG002|DB Component|Other than specified|0|||
23690743|NCT03263091|66244037|FG003|DB Component|Other than specified|0|||
23690744|NCT03263091|66244038|FG004|DB Component|Other than specified|8|||
23690745|NCT03263091|66244039|FG005|DB Component|Other than specified|6|||
23690746|NCT02318602|66244040|FG000|Overall Study|Adverse Event|0|||
23690747|NCT02318602|66244041|FG001|Overall Study|Adverse Event|1|||
23690748|NCT02318602|66244042|FG002|Overall Study|Adverse Event|1|||
23690749|NCT02318602|66244040|FG000|Overall Study|Withdrawal by Subject|0|||
23690750|NCT02318602|66244041|FG001|Overall Study|Withdrawal by Subject|3|||
23690751|NCT02318602|66244042|FG002|Overall Study|Withdrawal by Subject|0|||
23690752|NCT02318602|66244040|FG000|Overall Study|Death|1|||
23690753|NCT02318602|66244041|FG001|Overall Study|Death|0|||
23690754|NCT02318602|66244042|FG002|Overall Study|Death|0|||
23690755|NCT02318602|66244040|FG000|Overall Study|Guardian decision to withdraw|0|||
23690756|NCT02318602|66244041|FG001|Overall Study|Guardian decision to withdraw|0|||
23690757|NCT02318602|66244042|FG002|Overall Study|Guardian decision to withdraw|1|||
23690758|NCT03417440|66244043|FG000|Overall Study|Lost to Follow-up|0|||
23690759|NCT03417440|66244044|FG001|Overall Study|Lost to Follow-up|1|||
23690760|NCT03417440|66244045|FG002|Overall Study|Lost to Follow-up|0|||
23690761|NCT03417440|66244046|FG003|Overall Study|Lost to Follow-up|0|||
23690762|NCT03417440|66244047|FG004|Overall Study|Lost to Follow-up|1|||
23690763|NCT03417440|66244048|FG005|Overall Study|Lost to Follow-up|0|||
23690764|NCT03417440|66244049|FG006|Overall Study|Lost to Follow-up|0|||
23690765|NCT03417440|66244050|FG007|Overall Study|Lost to Follow-up|0|||
23690766|NCT03417440|66244043|FG000|Overall Study|Withdrawal by Subject|2|||
23690767|NCT03417440|66244044|FG001|Overall Study|Withdrawal by Subject|0|||
23690768|NCT03417440|66244045|FG002|Overall Study|Withdrawal by Subject|2|||
23690769|NCT03417440|66244046|FG003|Overall Study|Withdrawal by Subject|1|||
23690770|NCT03417440|66244047|FG004|Overall Study|Withdrawal by Subject|1|||
23690771|NCT03417440|66244048|FG005|Overall Study|Withdrawal by Subject|0|||
23690772|NCT03417440|66244049|FG006|Overall Study|Withdrawal by Subject|0|||
23690773|NCT03417440|66244050|FG007|Overall Study|Withdrawal by Subject|1|||
23690774|NCT02498821|66244051|FG000|Overall Study|Screen failure|3|||
23690775|NCT02498821|66244052|FG001|Overall Study|Screen failure|5|||
23690776|NCT02333227|66244053|FG000|Overall Study|Lost to Follow-up|137|||
23690777|NCT02333227|66244054|FG001|Overall Study|Lost to Follow-up|106|||
23690778|NCT02333227|66244053|FG000|Overall Study|Pregnancy Interrupted|42|||
23690779|NCT02333227|66244054|FG001|Overall Study|Pregnancy Interrupted|89|||
23690780|NCT02333227|66244053|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
23690781|NCT02333227|66244054|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
23690782|NCT04538664|66244055|FG000|Overall Study|Withdrawal by Subject|5|||
23690783|NCT04538664|66244056|FG001|Overall Study|Withdrawal by Subject|9|||
23690784|NCT04538664|66244055|FG000|Overall Study|Lost to Follow-up|2|||
23690785|NCT04538664|66244056|FG001|Overall Study|Lost to Follow-up|1|||
23690786|NCT04538664|66244055|FG000|Overall Study|Ongoing|106|||
23690787|NCT04538664|66244056|FG001|Overall Study|Ongoing|115|||
23690788|NCT03213665|66244057|FG000|Overall Study|Adverse Event|1|||
23690789|NCT03213665|66244057|FG000|Overall Study|Physician Decision|2|||
23690790|NCT03213665|66244057|FG000|Overall Study|Withdrawal by Subject|3|||
23690791|NCT03213665|66244057|FG000|Overall Study|Progressive Disease|13|||
23690792|NCT03593915|66244058|FG000|Overall Study|Adverse Event|0|||
23690793|NCT03593915|66244059|FG001|Overall Study|Adverse Event|0|||
23690794|NCT03593915|66244060|FG002|Overall Study|Adverse Event|0|||
23394488|NCT00518180|65192634|FG001|Overall Study|Protocol Violation|7|||
23394489|NCT00518180|65192635|FG002|Overall Study|Protocol Violation|4|||
23394490|NCT00518180|65192633|FG000|Overall Study|Unable to classify|0|||
23394491|NCT00518180|65192634|FG001|Overall Study|Unable to classify|2|||
23394492|NCT00518180|65192635|FG002|Overall Study|Unable to classify|0|||
23394493|NCT00518180|65192633|FG000|Overall Study|Adverse Event|1|||
23394494|NCT00518180|65192634|FG001|Overall Study|Adverse Event|0|||
23394495|NCT00518180|65192635|FG002|Overall Study|Adverse Event|0|||
23690795|NCT03593915|66244061|FG003|Overall Study|Adverse Event|1|||
23690796|NCT03593915|66244062|FG004|Overall Study|Adverse Event|0|||
23690797|NCT03593915|66244063|FG005|Overall Study|Adverse Event|0|||
23690798|NCT03593915|66244058|FG000|Overall Study|Physician Decision|0|||
23690799|NCT03593915|66244059|FG001|Overall Study|Physician Decision|0|||
23690800|NCT03593915|66244060|FG002|Overall Study|Physician Decision|0|||
23690801|NCT03593915|66244061|FG003|Overall Study|Physician Decision|0|||
23690802|NCT03593915|66244062|FG004|Overall Study|Physician Decision|0|||
23690803|NCT03593915|66244063|FG005|Overall Study|Physician Decision|1|||
23690804|NCT00283387|66244064|FG000|First Intervention|Subject non-compliant|1|||
23690805|NCT00283387|66244065|FG001|First Intervention|Subject non-compliant|1|||
23690806|NCT00283387|66244064|FG000|First Intervention|Withdrawal by Subject|0|||
23690807|NCT00283387|66244065|FG001|First Intervention|Withdrawal by Subject|1|||
23690808|NCT03885284|66244075|FG000|Overall Study|Disease Progression|1|||
23690809|NCT03885284|66244076|FG001|Overall Study|Disease Progression|3|||
23690810|NCT03885284|66244075|FG000|Overall Study|Physician Decision|0|||
23690811|NCT03885284|66244076|FG001|Overall Study|Physician Decision|1|||
23690812|NCT04197713|66244083|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
23690813|NCT04197713|66244084|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
23690814|NCT02978222|66244085|FG000|Overall Study|Withdrawal by Subject|2|||
23690815|NCT02978222|66244086|FG001|Overall Study|Withdrawal by Subject|2|||
23394496|NCT00862940|65192636|FG000|Overall Study|Adverse Event|15|||
23394497|NCT00862940|65192637|FG001|Overall Study|Adverse Event|12|||
23394498|NCT00862940|65192636|FG000|Overall Study|Lack of Efficacy|1|||
23394499|NCT00862940|65192637|FG001|Overall Study|Lack of Efficacy|3|||
23690816|NCT02978222|66244085|FG000|Overall Study|Physician Decision|2|||
23690817|NCT02978222|66244086|FG001|Overall Study|Physician Decision|0|||
23690818|NCT02978222|66244085|FG000|Overall Study|Adverse Event|0|||
23690819|NCT02978222|66244086|FG001|Overall Study|Adverse Event|1|||
23690820|NCT02978222|66244085|FG000|Overall Study|Death|1|||
23690821|NCT02978222|66244086|FG001|Overall Study|Death|0|||
23690822|NCT02978222|66244085|FG000|Overall Study|Disease Progression|32|||
23690823|NCT02978222|66244086|FG001|Overall Study|Disease Progression|32|||
23690824|NCT02978222|66244085|FG000|Overall Study|Early Study Termination|24|||
23690825|NCT02978222|66244086|FG001|Overall Study|Early Study Termination|21|||
23690826|NCT00601900|66244087|FG000|Overall Study|Withdrawal by Subject|0|||
23690827|NCT00601900|66244088|FG001|Overall Study|Withdrawal by Subject|3|||
23690828|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
23690829|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
23690830|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23690831|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23394500|NCT00862940|65192636|FG000|Overall Study|Protocol Violation|2|||
23394501|NCT00862940|65192637|FG001|Overall Study|Protocol Violation|5|||
23394502|NCT00862940|65192636|FG000|Overall Study|Withdrawal by Subject|4|||
23394503|NCT00862940|65192637|FG001|Overall Study|Withdrawal by Subject|6|||
23394504|NCT00862940|65192636|FG000|Overall Study|Non-compliance|4|||
23394505|NCT00862940|65192637|FG001|Overall Study|Non-compliance|0|||
23394506|NCT00862940|65192636|FG000|Overall Study|Lost to Follow-up|0|||
23394507|NCT00862940|65192637|FG001|Overall Study|Lost to Follow-up|1|||
23394508|NCT00862940|65192636|FG000|Overall Study|Administrative or other reason(s)|4|||
23394509|NCT00862940|65192637|FG001|Overall Study|Administrative or other reason(s)|3|||
23690832|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23690833|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
23690834|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
23690835|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23690836|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23690837|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23394510|NCT04581395|65192640|FG000|Overall Study|Protocol Violation|4|||
23394511|NCT04581395|65192641|FG001|Overall Study|Protocol Violation|3|||
23394512|NCT04581395|65192642|FG002|Overall Study|Protocol Violation|2|||
23394513|NCT04581395|65192640|FG000|Overall Study|Physician Decision|0|||
23394514|NCT04581395|65192641|FG001|Overall Study|Physician Decision|1|||
23394515|NCT04581395|65192642|FG002|Overall Study|Physician Decision|0|||
23394516|NCT03014089|65192648|FG000|Overall Study|Withdrawal by Subject|0|||
23394517|NCT03014089|65192649|FG001|Overall Study|Withdrawal by Subject|1|||
23690838|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
23690839|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23690840|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23690841|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23690842|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23690843|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
23690844|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23690845|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23690846|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23690847|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23690848|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Death|0|||
23690849|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Death|1|||
23690850|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Death|0|||
23690851|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Death|0|||
23690852|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Death|0|||
23690853|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23690854|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
23690855|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23690856|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23690857|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23690858|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
23690859|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23690860|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23690861|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23690862|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23394518|NCT03014089|65192650|FG002|Overall Study|Withdrawal by Subject|1|||
23394519|NCT03014089|65192651|FG003|Overall Study|Withdrawal by Subject|1|||
23394520|NCT03014089|65192648|FG000|Overall Study|Lost to Follow-up|1|||
23394521|NCT03014089|65192649|FG001|Overall Study|Lost to Follow-up|0|||
23394522|NCT03014089|65192650|FG002|Overall Study|Lost to Follow-up|0|||
23394523|NCT03014089|65192651|FG003|Overall Study|Lost to Follow-up|0|||
23498530|NCT04066023|65566358|FG000|Overall Study|Physician Decision|0|||
23394524|NCT03014089|65192648|FG000|Overall Study|Adverse Event|1|||
23394525|NCT03014089|65192649|FG001|Overall Study|Adverse Event|0|||
23394526|NCT03014089|65192650|FG002|Overall Study|Adverse Event|1|||
23394527|NCT03014089|65192651|FG003|Overall Study|Adverse Event|0|||
23394528|NCT02801578|65192654|FG000|Overall Study|Adverse Event|2|||
23690863|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
23690864|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23690865|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23690866|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23690867|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23690868|NCT05087030|66244089|FG000|Main Period (Week 0 to Week 52)|Other|1|||
23690869|NCT05087030|66244090|FG001|Main Period (Week 0 to Week 52)|Other|2|||
23690870|NCT05087030|66244091|FG002|Main Period (Week 0 to Week 52)|Other|0|||
23690871|NCT05087030|66244092|FG003|Main Period (Week 0 to Week 52)|Other|0|||
23690872|NCT05087030|66244093|FG004|Main Period (Week 0 to Week 52)|Other|0|||
23690873|NCT05087030|66244089|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23690874|NCT05087030|66244090|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23690875|NCT05087030|66244091|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23690876|NCT05087030|66244092|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23690877|NCT05087030|66244093|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
23690878|NCT00317044|66244095|FG000|Overall Study|Protocol Violation|28|||
23394529|NCT00397540|65192655|FG000|Overall Study|short follow-up duration < 12 months|1|||
23394530|NCT00397540|65192656|FG001|Overall Study|short follow-up duration < 12 months|0|||
23394531|NCT04442269|65192659|FG000|Overall Study|Adverse Event|1|||
23394532|NCT04442269|65192660|FG001|Overall Study|Adverse Event|0|||
23394533|NCT04442269|65192659|FG000|Overall Study|Death|0|||
23394534|NCT04442269|65192660|FG001|Overall Study|Death|1|||
23394535|NCT04442269|65192659|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
23394536|NCT04442269|65192660|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
23394537|NCT04442269|65192659|FG000|Overall Study|Lost to Follow-up|1|||
23394538|NCT04442269|65192660|FG001|Overall Study|Lost to Follow-up|0|||
23394539|NCT04442269|65192659|FG000|Overall Study|Withdrawal by Subject|3|||
23394540|NCT04442269|65192660|FG001|Overall Study|Withdrawal by Subject|2|||
23394541|NCT04442269|65192659|FG000|Overall Study|Protocol Deviation|0|||
23394542|NCT04442269|65192660|FG001|Overall Study|Protocol Deviation|1|||
23394543|NCT04442269|65192659|FG000|Overall Study|Travel Limitations|1|||
23394544|NCT04442269|65192660|FG001|Overall Study|Travel Limitations|1|||
23394545|NCT01514357|65192665|FG000|Overall Study|Screen failure|2|||
23394546|NCT01514357|65192666|FG001|Overall Study|Screen failure|0|||
23394547|NCT01514357|65192665|FG000|Overall Study|Withdrawal by Subject|2|||
23394548|NCT01514357|65192666|FG001|Overall Study|Withdrawal by Subject|0|||
23394549|NCT00830336|65192671|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23394550|NCT00830336|65192672|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
23690879|NCT00317044|66244096|FG001|Overall Study|Protocol Violation|22|||
23690880|NCT00317044|66244097|FG002|Overall Study|Protocol Violation|20|||
23690881|NCT00317044|66244095|FG000|Overall Study|Adverse Event|4|||
23690882|NCT00317044|66244096|FG001|Overall Study|Adverse Event|7|||
23690883|NCT00317044|66244097|FG002|Overall Study|Adverse Event|4|||
23690884|NCT00317044|66244095|FG000|Overall Study|Withdrawal by Subject|10|||
23690885|NCT00317044|66244096|FG001|Overall Study|Withdrawal by Subject|7|||
23690886|NCT00317044|66244097|FG002|Overall Study|Withdrawal by Subject|12|||
23690887|NCT00317044|66244095|FG000|Overall Study|Lost to Follow-up|0|||
23690888|NCT00317044|66244096|FG001|Overall Study|Lost to Follow-up|2|||
23690889|NCT00317044|66244097|FG002|Overall Study|Lost to Follow-up|3|||
23690890|NCT00317044|66244095|FG000|Overall Study|Multiple Reasons|6|||
23690891|NCT00317044|66244096|FG001|Overall Study|Multiple Reasons|2|||
23690892|NCT00317044|66244097|FG002|Overall Study|Multiple Reasons|6|||
23690893|NCT00110305|66244101|FG000|Overall Study|Adverse Event|46|||
23690894|NCT00110305|66244102|FG001|Overall Study|Adverse Event|13|||
23394551|NCT00071032|65192673|FG000|Overall Study|Lost to Follow-up|1|||
23394552|NCT00071032|65192674|FG001|Overall Study|Lost to Follow-up|1|||
23394553|NCT00071032|65192673|FG000|Overall Study|Withdrawal by Subject|8|||
23394554|NCT00071032|65192674|FG001|Overall Study|Withdrawal by Subject|6|||
23394555|NCT00071032|65192673|FG000|Overall Study|Missing Primary Outcome|0|||
23690895|NCT00110305|66244101|FG000|Overall Study|Sponsors Decision|1|||
23690896|NCT00110305|66244102|FG001|Overall Study|Sponsors Decision|0|||
23690897|NCT00110305|66244101|FG000|Overall Study|Subject Non-Compliant|9|||
23690898|NCT00110305|66244102|FG001|Overall Study|Subject Non-Compliant|2|||
23690899|NCT00110305|66244101|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23690900|NCT00110305|66244102|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
23690901|NCT00110305|66244101|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
23690902|NCT00110305|66244102|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
23690903|NCT00110305|66244101|FG000|Overall Study|Protocol Violation|0|||
23394556|NCT00071032|65192674|FG001|Overall Study|Missing Primary Outcome|1|||
23394557|NCT03773484|65192676|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
23394558|NCT03289039|65192684|FG000|Overall Study|Withdrawal by Subject|0|||
23394559|NCT03289039|65192685|FG001|Overall Study|Withdrawal by Subject|1|||
23394560|NCT03289039|65192684|FG000|Overall Study|Became ineligible prior to treatment start|0|||
23690904|NCT00110305|66244102|FG001|Overall Study|Protocol Violation|1|||
23394561|NCT03289039|65192685|FG001|Overall Study|Became ineligible prior to treatment start|1|||
23690905|NCT00110305|66244101|FG000|Overall Study|Withdrawal by Subject|7|||
23690906|NCT00110305|66244102|FG001|Overall Study|Withdrawal by Subject|7|||
23690907|NCT00110305|66244101|FG000|Overall Study|Lost to Follow-up|20|||
23690908|NCT00110305|66244102|FG001|Overall Study|Lost to Follow-up|3|||
23690909|NCT00110305|66244101|FG000|Overall Study|Other|8|||
23690910|NCT00110305|66244102|FG001|Overall Study|Other|2|||
23690911|NCT03106779|66244103|FG000|Overall Study|Lack of Efficacy|33|||
23394562|NCT03289039|65192684|FG000|Overall Study|progressed before treatment start|1|||
23394563|NCT03289039|65192685|FG001|Overall Study|progressed before treatment start|0|||
23394564|NCT00095576|65192688|FG000|Overall Study|Adverse Event|5|||
23394565|NCT00095576|65192689|FG001|Overall Study|Adverse Event|3|||
23394566|NCT00095576|65192688|FG000|Overall Study|Lost to Follow-up|233|||
23394567|NCT00095576|65192689|FG001|Overall Study|Lost to Follow-up|229|||
23394568|NCT00095576|65192688|FG000|Overall Study|Protocol Violation|1|||
23394569|NCT00095576|65192689|FG001|Overall Study|Protocol Violation|0|||
23394570|NCT00095576|65192688|FG000|Overall Study|Withdrawal by Subject|34|||
23394571|NCT00095576|65192689|FG001|Overall Study|Withdrawal by Subject|47|||
23394572|NCT00095576|65192688|FG000|Overall Study|Option to switch to a rollover study|1097|||
23394573|NCT00095576|65192689|FG001|Overall Study|Option to switch to a rollover study|1099|||
23690912|NCT03106779|66244104|FG001|Overall Study|Lack of Efficacy|24|||
23690913|NCT03106779|66244103|FG000|Overall Study|Adverse Event|8|||
23690914|NCT03106779|66244104|FG001|Overall Study|Adverse Event|16|||
23394574|NCT00095576|65192688|FG000|Overall Study|Site terminated|75|||
23690915|NCT03106779|66244103|FG000|Overall Study|Physician Decision|10|||
23690916|NCT03106779|66244104|FG001|Overall Study|Physician Decision|6|||
23690917|NCT03106779|66244103|FG000|Overall Study|Patient/guardian decision|4|||
23690918|NCT03106779|66244104|FG001|Overall Study|Patient/guardian decision|3|||
23690919|NCT03106779|66244103|FG000|Overall Study|Progressive disease|1|||
23690920|NCT03106779|66244104|FG001|Overall Study|Progressive disease|3|||
23690921|NCT03106779|66244103|FG000|Overall Study|Lost to Follow-up|1|||
23394575|NCT00095576|65192689|FG001|Overall Study|Site terminated|67|||
23394576|NCT00095576|65192688|FG000|Overall Study|Subject moved|30|||
23394577|NCT00095576|65192689|FG001|Overall Study|Subject moved|36|||
23394578|NCT00643279|65192692|FG000|Overall Study|Death|13|||
23394579|NCT00643279|65192693|FG001|Overall Study|Death|11|||
23394580|NCT00643279|65192692|FG000|Overall Study|Withdrawal by Subject|3|||
23394581|NCT00643279|65192693|FG001|Overall Study|Withdrawal by Subject|0|||
23394582|NCT00643279|65192692|FG000|Overall Study|Lost to Follow-up|0|||
23394583|NCT00643279|65192693|FG001|Overall Study|Lost to Follow-up|1|||
23394584|NCT00643279|65192692|FG000|Overall Study|Physician Decision|0|||
23394585|NCT00643279|65192693|FG001|Overall Study|Physician Decision|1|||
23394586|NCT02296125|65192698|FG000|Overall Study|Withdrawal by Subject|18|||
23394587|NCT02296125|65192699|FG001|Overall Study|Withdrawal by Subject|8|||
23394588|NCT02296125|65192700|FG002|Overall Study|Withdrawal by Subject|6|||
23394589|NCT02296125|65192701|FG003|Overall Study|Withdrawal by Subject|2|||
23394590|NCT02296125|65192698|FG000|Overall Study|Adverse Event|41|||
23690922|NCT03106779|66244104|FG001|Overall Study|Lost to Follow-up|2|||
23690923|NCT03106779|66244103|FG000|Overall Study|Death|1|||
23690924|NCT03106779|66244104|FG001|Overall Study|Death|0|||
23690925|NCT03106779|66244103|FG000|Overall Study|Protocol Violation|1|||
23690926|NCT03106779|66244104|FG001|Overall Study|Protocol Violation|0|||
23690927|NCT03106779|66244103|FG000|Overall Study|Not treated|1|||
23690928|NCT03106779|66244104|FG001|Overall Study|Not treated|0|||
23690929|NCT05593432|66244105|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
23690930|NCT05593432|66244106|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
23690931|NCT05593432|66244107|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
23690932|NCT05593432|66244108|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
23690933|NCT05593432|66244105|FG000|16-Week OLE Period|Lack of Efficacy|0|||
23690934|NCT05593432|66244106|FG001|16-Week OLE Period|Lack of Efficacy|0|||
23690935|NCT05593432|66244107|FG002|16-Week OLE Period|Lack of Efficacy|0|||
23394591|NCT02296125|65192699|FG001|Overall Study|Adverse Event|52|||
23394592|NCT02296125|65192700|FG002|Overall Study|Adverse Event|9|||
23394593|NCT02296125|65192701|FG003|Overall Study|Adverse Event|4|||
23394594|NCT02296125|65192698|FG000|Overall Study|Severe non-compliance to protocol|0|||
23394595|NCT02296125|65192699|FG001|Overall Study|Severe non-compliance to protocol|1|||
23394596|NCT02296125|65192700|FG002|Overall Study|Severe non-compliance to protocol|0|||
23394597|NCT02296125|65192701|FG003|Overall Study|Severe non-compliance to protocol|0|||
23394598|NCT02296125|65192698|FG000|Overall Study|Condition under investigation worsened|153|||
23394599|NCT02296125|65192699|FG001|Overall Study|Condition under investigation worsened|199|||
23394600|NCT02296125|65192700|FG002|Overall Study|Condition under investigation worsened|39|||
23690936|NCT05593432|66244108|FG003|16-Week OLE Period|Lack of Efficacy|1|||
23690937|NCT05593432|66244105|FG000|16-Week OLE Period|Lost to Follow-up|0|||
23690938|NCT05593432|66244106|FG001|16-Week OLE Period|Lost to Follow-up|0|||
23394601|NCT02296125|65192701|FG003|Overall Study|Condition under investigation worsened|56|||
23394602|NCT02296125|65192698|FG000|Overall Study|Any reason not specifically recorded|6|||
23690939|NCT05593432|66244107|FG002|16-Week OLE Period|Lost to Follow-up|1|||
23394603|NCT02296125|65192699|FG001|Overall Study|Any reason not specifically recorded|4|||
23394604|NCT02296125|65192700|FG002|Overall Study|Any reason not specifically recorded|2|||
23394605|NCT02296125|65192701|FG003|Overall Study|Any reason not specifically recorded|0|||
23394606|NCT02743962|65192709|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
23394607|NCT02743962|65192710|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
23394608|NCT00329420|65192715|FG000|Re-induction Phase|Lack of Efficacy|0|||
23394609|NCT00329420|65192716|FG001|Re-induction Phase|Lack of Efficacy|1|||
23394610|NCT00329420|65192717|FG002|Re-induction Phase|Lack of Efficacy|0|||
23394611|NCT00329420|65192715|FG000|Re-induction Phase|Withdrawal of Consent|0|||
23394612|NCT00329420|65192716|FG001|Re-induction Phase|Withdrawal of Consent|0|||
23394613|NCT00329420|65192717|FG002|Re-induction Phase|Withdrawal of Consent|1|||
23394614|NCT00329420|65192715|FG000|Re-induction Phase|Did not respond to re-induction|6|||
23394615|NCT00329420|65192716|FG001|Re-induction Phase|Did not respond to re-induction|5|||
23394616|NCT00329420|65192717|FG002|Re-induction Phase|Did not respond to re-induction|7|||
23394617|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
23394618|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
23394619|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
23394620|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
23394621|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
23394622|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
23394623|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
23394624|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
23394625|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
23394626|NCT02526290|65192718|FG000|Overall Study|Adverse Event|3|||
23394627|NCT02526290|65192718|FG000|Overall Study|Withdrawal by Subject|4|||
23394628|NCT02526290|65192718|FG000|Overall Study|Physician Decision|1|||
23394629|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23690940|NCT05593432|66244108|FG003|16-Week OLE Period|Lost to Follow-up|2|||
23690941|NCT05593432|66244105|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
23690942|NCT05593432|66244106|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
23690943|NCT05593432|66244107|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
23690944|NCT05593432|66244108|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
23690945|NCT02432807|66244110|FG000|Overall Study|Adverse Event|0|||
23690946|NCT02432807|66244111|FG001|Overall Study|Adverse Event|2|||
23690947|NCT02432807|66244110|FG000|Overall Study|Lost to Follow-up|1|||
23690948|NCT02432807|66244111|FG001|Overall Study|Lost to Follow-up|0|||
23690949|NCT02432807|66244110|FG000|Overall Study|Withdrawal by Subject|1|||
23690950|NCT02432807|66244111|FG001|Overall Study|Withdrawal by Subject|1|||
23690951|NCT02432807|66244110|FG000|Overall Study|Other|1|||
23690952|NCT02432807|66244111|FG001|Overall Study|Other|1|||
23394630|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
23394631|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394632|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
23394633|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
23394634|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
23394635|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
23394636|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394637|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394638|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23690953|NCT03311126|66244112|FG000|Induction|Death|1|||
23690954|NCT03311126|66244112|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
23690955|NCT03570892|66244115|FG000|Overall Study|Death|51|||
23690956|NCT03570892|66244116|FG001|Overall Study|Death|45|||
23690957|NCT03570892|66244115|FG000|Overall Study|Subject decision|5|||
23690958|NCT03570892|66244116|FG001|Overall Study|Subject decision|3|||
23690959|NCT03570892|66244115|FG000|Overall Study|Protocol Violation|1|||
23690960|NCT03570892|66244116|FG001|Overall Study|Protocol Violation|4|||
23690961|NCT03570892|66244115|FG000|Overall Study|Physician Decision|0|||
23690962|NCT03570892|66244116|FG001|Overall Study|Physician Decision|2|||
23690963|NCT03814746|66244117|FG000|Overall Study|Participant decision|9|||
23690964|NCT03814746|66244118|FG001|Overall Study|Participant decision|6|||
23690965|NCT03814746|66244119|FG002|Overall Study|Participant decision|15|||
23690966|NCT03814746|66244117|FG000|Overall Study|Physician Decision|2|||
23690967|NCT03814746|66244118|FG001|Overall Study|Physician Decision|2|||
23690968|NCT03814746|66244119|FG002|Overall Study|Physician Decision|4|||
23690969|NCT03814746|66244117|FG000|Overall Study|Death|2|||
23690970|NCT03814746|66244118|FG001|Overall Study|Death|2|||
23394639|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394640|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23690971|NCT03814746|66244119|FG002|Overall Study|Death|2|||
23690972|NCT03814746|66244117|FG000|Overall Study|Adverse Event|2|||
23690973|NCT03814746|66244118|FG001|Overall Study|Adverse Event|2|||
23690974|NCT03814746|66244119|FG002|Overall Study|Adverse Event|1|||
23690975|NCT03814746|66244117|FG000|Overall Study|Lost to Follow-up|2|||
23690976|NCT03814746|66244118|FG001|Overall Study|Lost to Follow-up|1|||
23690977|NCT03814746|66244119|FG002|Overall Study|Lost to Follow-up|2|||
23690978|NCT03814746|66244117|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23690979|NCT03814746|66244118|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23690980|NCT03814746|66244119|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23690981|NCT03814746|66244117|FG000|Overall Study|Pregnancy|0|||
23690982|NCT03814746|66244118|FG001|Overall Study|Pregnancy|1|||
23690983|NCT03814746|66244119|FG002|Overall Study|Pregnancy|1|||
23690984|NCT03814746|66244117|FG000|Overall Study|Protocol Violation|1|||
23690985|NCT03814746|66244118|FG001|Overall Study|Protocol Violation|0|||
23690986|NCT03814746|66244119|FG002|Overall Study|Protocol Violation|0|||
23690987|NCT01386385|66244120|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
23690988|NCT01386385|66244121|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690989|NCT01386385|66244122|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690990|NCT01386385|66244123|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690991|NCT01386385|66244124|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690992|NCT01386385|66244125|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690993|NCT01386385|66244126|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690994|NCT01386385|66244127|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23690995|NCT01386385|66244120|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
23690996|NCT01386385|66244121|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23690997|NCT01386385|66244122|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23690998|NCT01386385|66244123|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23690999|NCT01386385|66244124|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23691000|NCT01386385|66244125|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23691001|NCT01386385|66244126|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23691002|NCT01386385|66244127|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23691003|NCT01386385|66244120|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691004|NCT01386385|66244121|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691005|NCT01386385|66244122|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
23691006|NCT01386385|66244123|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691007|NCT01386385|66244124|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691008|NCT01386385|66244125|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691009|NCT01386385|66244126|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691010|NCT01386385|66244127|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23691011|NCT01386385|66244120|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691012|NCT01386385|66244121|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691013|NCT01386385|66244122|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691014|NCT01386385|66244123|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691015|NCT01386385|66244124|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
23691016|NCT01386385|66244125|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691017|NCT01386385|66244126|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691018|NCT01386385|66244127|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23691019|NCT01386385|66244120|FG000|Phase II Concurrent CRT|Adverse Event|0|||
23691020|NCT01386385|66244121|FG001|Phase II Concurrent CRT|Adverse Event|0|||
23691021|NCT01386385|66244122|FG002|Phase II Concurrent CRT|Adverse Event|0|||
23691022|NCT01386385|66244123|FG003|Phase II Concurrent CRT|Adverse Event|0|||
23691023|NCT01386385|66244124|FG004|Phase II Concurrent CRT|Adverse Event|0|||
23691024|NCT01386385|66244125|FG005|Phase II Concurrent CRT|Adverse Event|0|||
23691025|NCT01386385|66244126|FG006|Phase II Concurrent CRT|Adverse Event|3|||
23691026|NCT01386385|66244127|FG007|Phase II Concurrent CRT|Adverse Event|3|||
23691027|NCT01386385|66244120|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691028|NCT01386385|66244121|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691029|NCT01386385|66244122|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691030|NCT01386385|66244123|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691031|NCT01386385|66244124|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691032|NCT01386385|66244125|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691033|NCT01386385|66244126|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
23691034|NCT01386385|66244127|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23691035|NCT01386385|66244120|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
23691036|NCT01386385|66244121|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
23691037|NCT01386385|66244122|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
23394641|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23691038|NCT01386385|66244123|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
23691039|NCT01386385|66244124|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
23691040|NCT01386385|66244125|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
23691041|NCT01386385|66244126|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
23691042|NCT01386385|66244127|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
23691043|NCT01386385|66244120|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691044|NCT01386385|66244121|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691045|NCT01386385|66244122|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691046|NCT01386385|66244123|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691047|NCT01386385|66244124|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691048|NCT01386385|66244125|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691049|NCT01386385|66244126|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
23691050|NCT01386385|66244127|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23691051|NCT01386385|66244120|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
23691052|NCT01386385|66244121|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
23691053|NCT01386385|66244122|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
23691054|NCT01386385|66244123|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
23691055|NCT01386385|66244124|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
23394642|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23691056|NCT01386385|66244125|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
23691057|NCT01386385|66244126|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
23691058|NCT01386385|66244127|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
23691059|NCT01064648|66246972|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
23691060|NCT01064648|66246973|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
23691061|NCT01064648|66246974|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
23691062|NCT01064648|66246975|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
23691063|NCT01064648|66246972|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
23691064|NCT01064648|66246973|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23691065|NCT01064648|66246974|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23691066|NCT01064648|66246975|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23691067|NCT01064648|66246972|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23691068|NCT01064648|66246973|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
23691069|NCT01064648|66246974|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23691070|NCT01064648|66246975|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23691071|NCT01064648|66246972|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23691072|NCT01064648|66246973|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
23691073|NCT01064648|66246974|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23691074|NCT01064648|66246975|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23691075|NCT01064648|66246972|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
23691076|NCT01064648|66246973|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
23691077|NCT01064648|66246974|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
23691078|NCT01064648|66246975|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
23691079|NCT01064648|66246972|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23691080|NCT01064648|66246973|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
23691081|NCT01064648|66246974|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23691082|NCT01064648|66246975|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23691083|NCT01064648|66246972|FG000|Phase II|Adverse Event|0|||
23691084|NCT01064648|66246973|FG001|Phase II|Adverse Event|0|||
23691085|NCT01064648|66246974|FG002|Phase II|Adverse Event|15|||
23691086|NCT01064648|66246975|FG003|Phase II|Adverse Event|8|||
23691087|NCT01064648|66246972|FG000|Phase II|Death|0|||
23691088|NCT01064648|66246973|FG001|Phase II|Death|0|||
23691089|NCT01064648|66246974|FG002|Phase II|Death|4|||
23691090|NCT01064648|66246975|FG003|Phase II|Death|5|||
23394643|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23691091|NCT01064648|66246972|FG000|Phase II|Withdrawal by Subject|0|||
23691092|NCT01064648|66246973|FG001|Phase II|Withdrawal by Subject|0|||
23691093|NCT01064648|66246974|FG002|Phase II|Withdrawal by Subject|2|||
23691094|NCT01064648|66246975|FG003|Phase II|Withdrawal by Subject|5|||
23691095|NCT01064648|66246972|FG000|Phase II|Progression|0|||
23691096|NCT01064648|66246973|FG001|Phase II|Progression|0|||
23691097|NCT01064648|66246974|FG002|Phase II|Progression|21|||
23691098|NCT01064648|66246975|FG003|Phase II|Progression|27|||
23691099|NCT01064648|66246972|FG000|Phase II|Non-protocol specified|0|||
23691100|NCT01064648|66246973|FG001|Phase II|Non-protocol specified|0|||
23691101|NCT01064648|66246974|FG002|Phase II|Non-protocol specified|5|||
23691102|NCT01064648|66246975|FG003|Phase II|Non-protocol specified|3|||
23691103|NCT01064648|66246972|FG000|Phase II|Under Review|0|||
23691104|NCT01064648|66246973|FG001|Phase II|Under Review|0|||
23691105|NCT01064648|66246974|FG002|Phase II|Under Review|2|||
23691106|NCT01064648|66246975|FG003|Phase II|Under Review|0|||
23394644|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23691107|NCT02112448|66246976|FG000|Overall Study|lab values precluding use of ketorolac|2|||
23691108|NCT02112448|66246977|FG001|Overall Study|lab values precluding use of ketorolac|2|||
23691109|NCT02112448|66246976|FG000|Overall Study|Protocol Violation|1|||
23691110|NCT02112448|66246977|FG001|Overall Study|Protocol Violation|2|||
23691111|NCT02112448|66246976|FG000|Overall Study|Physician Decision|4|||
23691112|NCT02112448|66246977|FG001|Overall Study|Physician Decision|6|||
23691113|NCT02112448|66246976|FG000|Overall Study|required heparin so could not use ketoro|1|||
23691114|NCT02112448|66246977|FG001|Overall Study|required heparin so could not use ketoro|0|||
23691115|NCT03277196|66246978|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
23691116|NCT03277196|66246978|FG000|Overall Study|Lost to Follow-up|3|||
23691117|NCT03277196|66246978|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23691118|NCT03277196|66246978|FG000|Overall Study|Other|2|||
23691119|NCT03323749|66246979|FG000|Double-blind Period|Lost to Follow-up|4|||
23691120|NCT03323749|66246980|FG001|Double-blind Period|Lost to Follow-up|5|||
23691121|NCT03323749|66246979|FG000|Double-blind Period|Adverse Event|3|||
23691122|NCT03323749|66246980|FG001|Double-blind Period|Adverse Event|1|||
23691123|NCT03323749|66246979|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
23691124|NCT03323749|66246980|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
23691125|NCT03323749|66246979|FG000|Open-Label Period|Adverse Event|3|||
23691126|NCT03323749|66246980|FG001|Open-Label Period|Adverse Event|10|||
23691127|NCT03323749|66246979|FG000|Open-Label Period|Withdrawal by Subject|7|||
23691128|NCT03323749|66246980|FG001|Open-Label Period|Withdrawal by Subject|5|||
23691129|NCT01829048|66246981|FG000|Overall Study|Withdrawal by Subject|0|||
23691130|NCT01829048|66246982|FG001|Overall Study|Withdrawal by Subject|0|||
23691131|NCT01829048|66246983|FG002|Overall Study|Withdrawal by Subject|0|||
23691132|NCT01829048|66246984|FG003|Overall Study|Withdrawal by Subject|2|||
23691133|NCT01829048|66246985|FG004|Overall Study|Withdrawal by Subject|0|||
23691134|NCT00845429|66246986|FG000|Overall Study|Protocol Violation|5|||
23691135|NCT00845429|66246987|FG001|Overall Study|Protocol Violation|4|||
23691136|NCT00845429|66246988|FG002|Overall Study|Protocol Violation|7|||
23691137|NCT00845429|66246986|FG000|Overall Study|Lost to Follow-up|7|||
23691138|NCT00845429|66246987|FG001|Overall Study|Lost to Follow-up|9|||
23691139|NCT00845429|66246988|FG002|Overall Study|Lost to Follow-up|10|||
23691140|NCT00845429|66246986|FG000|Overall Study|Withdrawal by Subject|2|||
23691141|NCT00845429|66246987|FG001|Overall Study|Withdrawal by Subject|2|||
23691142|NCT00845429|66246988|FG002|Overall Study|Withdrawal by Subject|2|||
23691143|NCT00845429|66246986|FG000|Overall Study|Serious adverse event|0|||
23691144|NCT00845429|66246987|FG001|Overall Study|Serious adverse event|0|||
23691145|NCT00845429|66246988|FG002|Overall Study|Serious adverse event|1|||
23691146|NCT03180736|66246990|FG000|Overall Study|Adverse Event|3|||
23691147|NCT03180736|66246991|FG001|Overall Study|Adverse Event|4|||
23691148|NCT03180736|66246990|FG000|Overall Study|Death|10|||
23691149|NCT03180736|66246991|FG001|Overall Study|Death|7|||
23691150|NCT03180736|66246990|FG000|Overall Study|Withdrawal by Subject|5|||
23691151|NCT03180736|66246991|FG001|Overall Study|Withdrawal by Subject|12|||
23691152|NCT03180736|66246990|FG000|Overall Study|Lost to Follow-up|1|||
23691153|NCT03180736|66246991|FG001|Overall Study|Lost to Follow-up|0|||
23691154|NCT03180736|66246990|FG000|Overall Study|Lack of Efficacy|66|||
23691155|NCT03180736|66246991|FG001|Overall Study|Lack of Efficacy|87|||
23691156|NCT03180736|66246990|FG000|Overall Study|Physician Decision|4|||
23691157|NCT03180736|66246991|FG001|Overall Study|Physician Decision|7|||
23691158|NCT03180736|66246990|FG000|Overall Study|randomized but not treated|2|||
23691159|NCT03180736|66246991|FG001|Overall Study|randomized but not treated|3|||
23691160|NCT01974323|66246992|FG000|Overall Study|Other Reasons|25|||
23691161|NCT01974323|66246993|FG001|Overall Study|Other Reasons|28|||
23691162|NCT01974323|66246992|FG000|Overall Study|Protocol Violation|2|||
23691163|NCT01974323|66246993|FG001|Overall Study|Protocol Violation|2|||
23691164|NCT01974323|66246992|FG000|Overall Study|Personal Reasons|15|||
23691165|NCT01974323|66246993|FG001|Overall Study|Personal Reasons|19|||
23691166|NCT01974323|66246992|FG000|Overall Study|Lost to Follow-up|45|||
23691167|NCT01974323|66246993|FG001|Overall Study|Lost to Follow-up|40|||
23691168|NCT01974323|66246992|FG000|Overall Study|Pregnancy|2|||
23691169|NCT01974323|66246993|FG001|Overall Study|Pregnancy|1|||
23691170|NCT01974323|66246992|FG000|Overall Study|Lack of Efficacy|1|||
23691171|NCT01974323|66246993|FG001|Overall Study|Lack of Efficacy|1|||
23691172|NCT01974323|66246992|FG000|Overall Study|Adverse Event|2|||
23691173|NCT01974323|66246993|FG001|Overall Study|Adverse Event|2|||
23691174|NCT00886938|66246999|FG000|Overall Study|Adverse Event|1|||
23691175|NCT00886938|66246999|FG000|Overall Study|Withdrawal by Subject|1|||
23691176|NCT04091217|66247000|FG000|Overall Study|Lost to Follow-up|2|||
23691177|NCT04513158|66247001|FG000|Overall Study|Screen Failure|1|||
23691178|NCT03191786|66247002|FG000|Overall Study|Death|236|||
23691179|NCT03191786|66247003|FG001|Overall Study|Death|127|||
23691180|NCT03191786|66247002|FG000|Overall Study|Lost to Follow-up|9|||
23691181|NCT03191786|66247003|FG001|Overall Study|Lost to Follow-up|3|||
23691182|NCT03191786|66247002|FG000|Overall Study|Physician Decision|1|||
23691183|NCT03191786|66247003|FG001|Overall Study|Physician Decision|0|||
23691184|NCT03191786|66247002|FG000|Overall Study|Moved to Post Trial Access Program|30|||
23691185|NCT03191786|66247003|FG001|Overall Study|Moved to Post Trial Access Program|5|||
23691186|NCT03191786|66247002|FG000|Overall Study|Withdrawal by Subject|26|||
23691187|NCT03191786|66247003|FG001|Overall Study|Withdrawal by Subject|16|||
23691188|NCT00813748|66247004|FG000|Skin Test Substudy|Physician Decision|0|||
23691189|NCT00813748|66247005|FG001|Skin Test Substudy|Physician Decision|1|||
23691190|NCT05089708|66247007|FG000|Overall Study|Lost to Follow-up|9|||
23691191|NCT05089708|66247008|FG001|Overall Study|Lost to Follow-up|7|||
23691192|NCT05089708|66247007|FG000|Overall Study|Withdrawal by Subject|3|||
23691193|NCT05089708|66247008|FG001|Overall Study|Withdrawal by Subject|1|||
23691194|NCT05089708|66247007|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
23691195|NCT05089708|66247008|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
23691196|NCT05089708|66247007|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
23691197|NCT05089708|66247008|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
23691198|NCT05900115|66247009|FG000|Overall Study|Lost to Follow-up|129|||
23691199|NCT05900115|66247010|FG001|Overall Study|Lost to Follow-up|98|||
23691200|NCT00503399|66247014|FG000|Overall Study|Death|2|||
23691201|NCT00503399|66247015|FG001|Overall Study|Death|1|||
23691202|NCT00503399|66247014|FG000|Overall Study|Protocol Violation|1|||
23691203|NCT00503399|66247015|FG001|Overall Study|Protocol Violation|0|||
23691204|NCT00503399|66247014|FG000|Overall Study|Withdrawal by Subject|4|||
23691205|NCT00503399|66247015|FG001|Overall Study|Withdrawal by Subject|2|||
23691206|NCT00503399|66247014|FG000|Overall Study|Adverse Event|0|||
23691207|NCT00503399|66247015|FG001|Overall Study|Adverse Event|3|||
23691208|NCT00503399|66247014|FG000|Overall Study|Lost to Follow-up|0|||
23691209|NCT00503399|66247015|FG001|Overall Study|Lost to Follow-up|2|||
23691210|NCT00860470|66247016|FG000|Overall Study|Death|6|||
23691211|NCT00860470|66247017|FG001|Overall Study|Death|10|||
23691212|NCT00860470|66247016|FG000|Overall Study|Moved away|8|||
23691213|NCT00860470|66247017|FG001|Overall Study|Moved away|10|||
23691214|NCT00860470|66247016|FG000|Overall Study|Lost to Follow-up|34|||
23691215|NCT00860470|66247017|FG001|Overall Study|Lost to Follow-up|39|||
23691216|NCT02725788|66247018|FG000|Overall Study|Lost to Follow-up|1|||
23394645|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
23394646|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
23394647|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
23394648|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
23394649|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
23394650|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
23394651|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
23394652|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
23394653|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
23394654|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
23394655|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
23394656|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
23691217|NCT02725788|66247019|FG001|Overall Study|Lost to Follow-up|1|||
23691218|NCT02725788|66247018|FG000|Overall Study|Protocol Violation|0|||
23691219|NCT02725788|66247019|FG001|Overall Study|Protocol Violation|1|||
23691220|NCT03367156|66247020|FG000|Overall Study|Lack of interest|3|||
23691221|NCT03367156|66247021|FG001|Overall Study|Lack of interest|1|||
23691222|NCT03367156|66247020|FG000|Overall Study|Death|2|||
23691223|NCT03367156|66247021|FG001|Overall Study|Death|0|||
23691224|NCT03367156|66247020|FG000|Overall Study|Lost to Follow-up|2|||
23691225|NCT03367156|66247021|FG001|Overall Study|Lost to Follow-up|1|||
23691226|NCT03367156|66247020|FG000|Overall Study|Became ineligible|1|||
23691227|NCT03367156|66247021|FG001|Overall Study|Became ineligible|2|||
23691228|NCT03367156|66247020|FG000|Overall Study|Hospitalization|1|||
23691229|NCT03367156|66247021|FG001|Overall Study|Hospitalization|0|||
23691230|NCT03367156|66247020|FG000|Overall Study|Concerned about Treatment|11|||
23691231|NCT03367156|66247021|FG001|Overall Study|Concerned about Treatment|3|||
23691232|NCT03367156|66247020|FG000|Overall Study|Started new treatment|4|||
23691233|NCT03367156|66247021|FG001|Overall Study|Started new treatment|1|||
23691234|NCT01299025|66247022|FG000|Overall Study|Withdrawal by Subject|2|||
23691235|NCT01299025|66247023|FG001|Overall Study|Withdrawal by Subject|1|||
23691236|NCT01299025|66247022|FG000|Overall Study|Lost to Follow-up|1|||
23691237|NCT01299025|66247023|FG001|Overall Study|Lost to Follow-up|0|||
23691238|NCT01672892|66247024|FG000|Overall Study|Protocol Violation|7|||
23691239|NCT01672892|66247025|FG001|Overall Study|Protocol Violation|3|||
23691240|NCT03717922|66247026|FG000|Overall Study|Lost to Follow-up|2|||
23691241|NCT03717922|66247027|FG001|Overall Study|Lost to Follow-up|2|||
23691242|NCT01662999|66247029|FG000|Period 3|Withdrawal by Subject|0|||
23691243|NCT01662999|66247030|FG001|Period 3|Withdrawal by Subject|1|||
23691244|NCT01662999|66247031|FG002|Period 3|Withdrawal by Subject|0|||
23691245|NCT01662999|66247032|FG003|Period 3|Withdrawal by Subject|0|||
23691246|NCT01662999|66247033|FG004|Period 3|Withdrawal by Subject|0|||
23691247|NCT01662999|66247034|FG005|Period 3|Withdrawal by Subject|0|||
23691248|NCT02040142|66247035|FG000|Overall Study|Lost to Follow-up|5|||
23691249|NCT02040142|66247035|FG000|Overall Study|Death|17|||
23691250|NCT02040142|66247035|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
23691251|NCT05139030|66247036|FG000|Overall Study|Withdrawal by Subject|1|||
23691252|NCT05139030|66247037|FG001|Overall Study|Withdrawal by Subject|3|||
23394657|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
23394658|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
23691253|NCT05139030|66247036|FG000|Overall Study|Adverse Event|0|||
23691254|NCT05139030|66247037|FG001|Overall Study|Adverse Event|1|||
23691255|NCT05139030|66247036|FG000|Overall Study|Failure to meet continuation criteria|0|||
23691256|NCT05139030|66247037|FG001|Overall Study|Failure to meet continuation criteria|1|||
23691257|NCT02143414|66247038|FG000|Induction|Adverse Event|1|||
23691258|NCT02143414|66247039|FG001|Induction|Adverse Event|2|||
23691259|NCT02143414|66247038|FG000|Induction|Death|1|||
23691260|NCT02143414|66247039|FG001|Induction|Death|2|||
23691261|NCT02143414|66247038|FG000|Induction|Patient refusal|1|||
23691262|NCT02143414|66247039|FG001|Induction|Patient refusal|1|||
23691263|NCT02143414|66247038|FG000|Induction|Refractory|1|||
23691264|NCT02143414|66247039|FG001|Induction|Refractory|0|||
23691265|NCT02143414|66247038|FG000|Induction|Began alternative treatment|1|||
23691266|NCT02143414|66247039|FG001|Induction|Began alternative treatment|0|||
23691267|NCT02143414|66247038|FG000|Induction|Ineligible for postremission|5|||
23691268|NCT02143414|66247039|FG001|Induction|Ineligible for postremission|1|||
23691269|NCT02143414|66247038|FG000|Post-remission|Adverse Event|0|||
23691270|NCT02143414|66247039|FG001|Post-remission|Adverse Event|2|||
23691271|NCT02143414|66247038|FG000|Post-remission|Disease progression/relapse|5|||
23691272|NCT02143414|66247039|FG001|Post-remission|Disease progression/relapse|0|||
23691273|NCT02143414|66247038|FG000|Maintenance|Adverse Event|4|||
23691274|NCT02143414|66247039|FG001|Maintenance|Adverse Event|6|||
23691275|NCT02143414|66247038|FG000|Maintenance|Disease progression/relapse|3|||
23691276|NCT02143414|66247039|FG001|Maintenance|Disease progression/relapse|2|||
23691277|NCT02143414|66247038|FG000|Maintenance|Patient refusal|2|||
23691278|NCT02143414|66247039|FG001|Maintenance|Patient refusal|1|||
23691279|NCT02143414|66247038|FG000|Maintenance|Physician Decision|1|||
23691280|NCT02143414|66247039|FG001|Maintenance|Physician Decision|0|||
23691281|NCT02143414|66247038|FG000|Maintenance|Death|0|||
23691282|NCT02143414|66247039|FG001|Maintenance|Death|1|||
23691283|NCT02143414|66247038|FG000|Maintenance|On protocol treatment|0|||
23691284|NCT02143414|66247039|FG001|Maintenance|On protocol treatment|6|||
23691285|NCT00327444|66247043|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
23691286|NCT00327444|66247044|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
23691287|NCT00327444|66247043|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
23691288|NCT00327444|66247044|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
23691289|NCT00327444|66247043|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
23691290|NCT00327444|66247044|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
23691291|NCT00327444|66247043|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
23691292|NCT00327444|66247044|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
23691293|NCT00327444|66247043|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
23691294|NCT00327444|66247044|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
23691295|NCT00327444|66247043|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
23691296|NCT00327444|66247044|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
23691297|NCT00327444|66247043|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
23691298|NCT00327444|66247044|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
23691299|NCT00327444|66247043|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
23691300|NCT00327444|66247044|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
23691301|NCT04178590|66247045|FG000|Overall Study|Pregnancy|1|||
23691302|NCT04178590|66247045|FG000|Overall Study|Lost to Follow-up|1|||
23691303|NCT02317510|66247046|FG000|Overall Study|Adverse Event|0|||
23691304|NCT02317510|66247047|FG001|Overall Study|Adverse Event|1|||
23691305|NCT04433117|66247048|FG000|Overall Study|Withdrawal by Subject|1|||
23691306|NCT04433117|66247049|FG001|Overall Study|Withdrawal by Subject|0|||
23691307|NCT01725165|66247051|FG000|Overall Study|Death|11|||
23691308|NCT01725165|66247052|FG001|Overall Study|Death|18|||
23691309|NCT02886715|66247053|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23691310|NCT02886715|66247054|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23691311|NCT02886715|66247055|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23691312|NCT02886715|66247053|FG000|Overall Study|Adverse Event|4|||
23691313|NCT02886715|66247054|FG001|Overall Study|Adverse Event|2|||
23691314|NCT02886715|66247055|FG002|Overall Study|Adverse Event|0|||
23691315|NCT02886715|66247053|FG000|Overall Study|Lack of Efficacy|0|||
23691316|NCT02886715|66247054|FG001|Overall Study|Lack of Efficacy|2|||
23691317|NCT02886715|66247055|FG002|Overall Study|Lack of Efficacy|1|||
23394659|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
23394660|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
23691318|NCT02886715|66247053|FG000|Overall Study|Lost to Follow-up|29|||
23691319|NCT02886715|66247054|FG001|Overall Study|Lost to Follow-up|26|||
23691320|NCT02886715|66247055|FG002|Overall Study|Lost to Follow-up|10|||
23394661|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
23691321|NCT02886715|66247053|FG000|Overall Study|Pregnancy|1|||
23691322|NCT02886715|66247054|FG001|Overall Study|Pregnancy|1|||
23691323|NCT02886715|66247055|FG002|Overall Study|Pregnancy|1|||
23691324|NCT02886715|66247053|FG000|Overall Study|Protocol Violation|3|||
23691325|NCT02886715|66247054|FG001|Overall Study|Protocol Violation|2|||
23691326|NCT02886715|66247055|FG002|Overall Study|Protocol Violation|1|||
23691327|NCT02886715|66247053|FG000|Overall Study|Withdrawal by Subject|20|||
23691328|NCT02886715|66247054|FG001|Overall Study|Withdrawal by Subject|18|||
23691329|NCT02886715|66247055|FG002|Overall Study|Withdrawal by Subject|5|||
23691330|NCT02886715|66247053|FG000|Overall Study|missing|7|||
23691331|NCT02886715|66247054|FG001|Overall Study|missing|2|||
23691332|NCT02886715|66247055|FG002|Overall Study|missing|2|||
23691333|NCT04246047|66247056|FG000|Overall Study|Death|50|||
23691334|NCT04246047|66247057|FG001|Overall Study|Death|77|||
23691335|NCT04246047|66247056|FG000|Overall Study|Lost to Follow-up|1|||
23691336|NCT04246047|66247057|FG001|Overall Study|Lost to Follow-up|3|||
23691337|NCT04246047|66247056|FG000|Overall Study|Physician Decision|4|||
23691338|NCT04246047|66247057|FG001|Overall Study|Physician Decision|10|||
23691339|NCT04246047|66247056|FG000|Overall Study|Withdrawal by Subject|19|||
23691340|NCT04246047|66247057|FG001|Overall Study|Withdrawal by Subject|26|||
23691341|NCT04246047|66247056|FG000|Overall Study|Ongoing|169|||
23691342|NCT04246047|66247057|FG001|Overall Study|Ongoing|135|||
23691343|NCT01877655|66247059|FG000|Overall Study|Death|57|||
23691344|NCT01877655|66247060|FG001|Overall Study|Death|52|||
23691345|NCT01877655|66247059|FG000|Overall Study|Withdrawal by Subject|18|||
23691346|NCT01877655|66247060|FG001|Overall Study|Withdrawal by Subject|26|||
23691347|NCT01877655|66247059|FG000|Overall Study|Physician Decision|11|||
23691348|NCT01877655|66247060|FG001|Overall Study|Physician Decision|10|||
23691349|NCT01877655|66247059|FG000|Overall Study|Miscellaneous|4|||
23691350|NCT01877655|66247060|FG001|Overall Study|Miscellaneous|4|||
23691351|NCT01877655|66247059|FG000|Overall Study|Randomized but Never Received Drug|8|||
23691352|NCT01877655|66247060|FG001|Overall Study|Randomized but Never Received Drug|5|||
23691353|NCT03748641|66247061|FG000|Overall Study|Ongoing|155|||
23691354|NCT03748641|66247062|FG001|Overall Study|Ongoing|148|||
23691355|NCT03748641|66247063|FG002|Overall Study|Ongoing|66|||
23691356|NCT03748641|66247064|FG003|Overall Study|Ongoing|79|||
23691357|NCT03748641|66247065|FG004|Overall Study|Ongoing|84|||
23691358|NCT03748641|66247061|FG000|Overall Study|Death|54|||
23691359|NCT03748641|66247062|FG001|Overall Study|Death|59|||
23691360|NCT03748641|66247063|FG002|Overall Study|Death|51|||
23691361|NCT03748641|66247064|FG003|Overall Study|Death|42|||
23691362|NCT03748641|66247065|FG004|Overall Study|Death|9|||
23691363|NCT03748641|66247061|FG000|Overall Study|Lost to Follow-up|0|||
23691364|NCT03748641|66247062|FG001|Overall Study|Lost to Follow-up|2|||
23691365|NCT03748641|66247063|FG002|Overall Study|Lost to Follow-up|1|||
23691366|NCT03748641|66247064|FG003|Overall Study|Lost to Follow-up|0|||
23394662|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
23394663|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394664|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23691367|NCT03748641|66247065|FG004|Overall Study|Lost to Follow-up|0|||
23691368|NCT03748641|66247061|FG000|Overall Study|Withdrawal by Subject|3|||
23691369|NCT03748641|66247062|FG001|Overall Study|Withdrawal by Subject|2|||
23691370|NCT03748641|66247063|FG002|Overall Study|Withdrawal by Subject|5|||
23691371|NCT03748641|66247064|FG003|Overall Study|Withdrawal by Subject|3|||
23691372|NCT03748641|66247065|FG004|Overall Study|Withdrawal by Subject|2|||
23691373|NCT03842709|66247066|FG000|Overall Study|Withdrawal by Subject|3|||
23691374|NCT03842709|66247067|FG001|Overall Study|Withdrawal by Subject|3|||
23691375|NCT03842709|66247066|FG000|Overall Study|Lost to Follow-up|1|||
23691376|NCT03842709|66247067|FG001|Overall Study|Lost to Follow-up|0|||
23691377|NCT02936752|66247068|FG000|Overall Study|Death|2|||
23691378|NCT02936752|66247069|FG001|Overall Study|Death|1|||
23691379|NCT02936752|66247068|FG000|Overall Study|Physician Decision|4|||
23691380|NCT02936752|66247069|FG001|Overall Study|Physician Decision|0|||
23691381|NCT02936752|66247068|FG000|Overall Study|Withdrawal by Subject|0|||
23691382|NCT02936752|66247069|FG001|Overall Study|Withdrawal by Subject|2|||
23691383|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
23691384|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
23691385|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
23691386|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
23691387|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
23691388|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23691389|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23691390|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23691391|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
23691392|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23691393|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23691394|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23691395|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
23691396|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23691397|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23394665|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23691398|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23691399|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
23691400|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23691401|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23691402|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23691403|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
23691404|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23691405|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23691406|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23691407|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
23691408|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23691409|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23691410|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23691411|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
23691412|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23691413|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23691414|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23691415|NCT03818035|66247076|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
23691416|NCT03818035|66247077|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
23691417|NCT03818035|66247078|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
23691418|NCT03818035|66247079|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
23691419|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23691420|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23691421|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23691422|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
23691423|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
23691424|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
23691425|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
23691426|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
23691427|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23394666|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394667|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394668|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394669|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394670|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394671|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394672|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394673|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394674|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394675|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394676|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394677|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
23394678|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394679|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
23394680|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394681|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394682|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394683|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394684|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394685|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394686|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394687|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394688|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394689|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394690|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394691|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394692|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394693|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394694|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23691428|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23394695|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394696|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
23394697|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394698|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394699|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
23394700|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394701|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394702|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394703|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394704|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23691429|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23691430|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
23691431|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
23394705|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394706|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394707|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394708|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394709|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394710|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394711|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
23394712|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394713|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394714|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394715|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394716|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394717|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394718|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394719|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394720|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394721|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394722|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23691432|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
23691433|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
23691434|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
23691435|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
23691436|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
23394723|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394724|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394725|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394726|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394727|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394728|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394729|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394730|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23691437|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
23394731|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394732|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394733|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394734|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394735|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394736|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394737|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394738|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394739|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394740|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394741|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
23394742|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
23394743|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
23394744|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
23394745|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
23394746|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
23394747|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
23394748|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
23394749|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
23394750|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
23394751|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
23394752|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
23394753|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
23394754|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
23394755|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
23394756|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
23394757|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394758|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394759|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394760|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394761|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
23394762|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394763|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23498531|NCT04066023|65566359|FG001|Overall Study|Physician Decision|0|||
23691438|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
23394764|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394765|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394766|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394767|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394768|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394769|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394770|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394771|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394772|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394773|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394774|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394775|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23691439|NCT03818035|66247076|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
23691440|NCT03818035|66247077|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
23691441|NCT03818035|66247078|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
23691442|NCT03818035|66247079|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
23691443|NCT01670500|66247080|FG000|Overall Study|Withdrawal by Subject|1|||
23691444|NCT01670500|66247081|FG001|Overall Study|Withdrawal by Subject|0|||
23691445|NCT05113940|66247082|FG000|Part A (18 Days)|Adverse Event|0|||
23394776|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394777|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394778|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394779|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394780|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394781|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394782|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
23394783|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394784|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394785|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
23394786|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23691446|NCT05113940|66247083|FG001|Part A (18 Days)|Adverse Event|0|||
23691447|NCT05113940|66247084|FG002|Part A (18 Days)|Adverse Event|1|||
23691448|NCT05113940|66247085|FG003|Part A (18 Days)|Adverse Event|1|||
23691449|NCT05113940|66247086|FG004|Part A (18 Days)|Adverse Event|1|||
23691450|NCT05113940|66247087|FG005|Part A (18 Days)|Adverse Event|0|||
23691451|NCT05113940|66247088|FG006|Part A (18 Days)|Adverse Event|0|||
23691452|NCT05113940|66247089|FG007|Part A (18 Days)|Adverse Event|0|||
23691453|NCT05113940|66247090|FG008|Part A (18 Days)|Adverse Event|0|||
23691454|NCT05113940|66247091|FG009|Part A (18 Days)|Adverse Event|0|||
23691455|NCT05113940|66247092|FG010|Part A (18 Days)|Adverse Event|0|||
23691456|NCT05113940|66247093|FG011|Part A (18 Days)|Adverse Event|2|||
23691457|NCT05113940|66247094|FG012|Part A (18 Days)|Adverse Event|0|||
23691458|NCT05113940|66247095|FG013|Part A (18 Days)|Adverse Event|0|||
23691459|NCT05113940|66247096|FG014|Part A (18 Days)|Adverse Event|0|||
23691460|NCT05113940|66247082|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691461|NCT05113940|66247083|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691462|NCT05113940|66247084|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691463|NCT05113940|66247085|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691464|NCT05113940|66247086|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691465|NCT05113940|66247087|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691466|NCT05113940|66247088|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691467|NCT05113940|66247089|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691468|NCT05113940|66247090|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691469|NCT05113940|66247091|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691470|NCT05113940|66247092|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691471|NCT05113940|66247093|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691472|NCT05113940|66247094|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691473|NCT05113940|66247095|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
23691474|NCT05113940|66247096|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
23691475|NCT05817045|66247097|FG000|Overall Study|Protocol Violation|0|||
23691476|NCT05817045|66247098|FG001|Overall Study|Protocol Violation|3|||
23691477|NCT05817045|66247097|FG000|Overall Study|Withdrawal by Subject|10|||
23691478|NCT05817045|66247098|FG001|Overall Study|Withdrawal by Subject|7|||
23691479|NCT05817045|66247097|FG000|Overall Study|Physician Decision|3|||
23691480|NCT05817045|66247098|FG001|Overall Study|Physician Decision|0|||
23691481|NCT05817045|66247097|FG000|Overall Study|Lost to Follow-up|0|||
23691482|NCT05817045|66247098|FG001|Overall Study|Lost to Follow-up|1|||
23691483|NCT05817045|66247097|FG000|Overall Study|Device Deficiency|1|||
23691484|NCT05817045|66247098|FG001|Overall Study|Device Deficiency|0|||
23691485|NCT05817045|66247097|FG000|Overall Study|System Error|1|||
23691486|NCT05817045|66247098|FG001|Overall Study|System Error|0|||
23691487|NCT03517436|66247100|FG000|Overall Study|Death|3|||
23394787|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394788|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
23691488|NCT03517436|66247100|FG000|Overall Study|Withdrawal by Subject|4|||
23691489|NCT03517436|66247100|FG000|Overall Study|Did not receive study valve.|1|||
23691490|NCT01275677|66247106|FG000|Overall Study|Not at risk for recurrence.|1|||
23691491|NCT01275677|66247107|FG001|Overall Study|Not at risk for recurrence.|1|||
23691492|NCT01275677|66247106|FG000|Overall Study|No follow-up|26|||
23691493|NCT01275677|66247107|FG001|Overall Study|No follow-up|37|||
23691494|NCT01275677|66247106|FG000|Overall Study|No clinical follow up.|1|||
23691495|NCT01275677|66247107|FG001|Overall Study|No clinical follow up.|4|||
23691496|NCT04925570|66247113|FG000|Overall Study|Protocol Violation|24|||
23691497|NCT04925570|66247114|FG001|Overall Study|Protocol Violation|30|||
23691498|NCT04925570|66247113|FG000|Overall Study|Withdrawal by Subject|0|||
23691499|NCT04925570|66247114|FG001|Overall Study|Withdrawal by Subject|2|||
23691500|NCT03615222|66247117|FG000|Overall Study|Ineligible|26|||
23691501|NCT03615222|66247117|FG000|Overall Study|Withdrawal by Subject|7|||
23691502|NCT03615222|66247117|FG000|Overall Study|Death|1|||
23691503|NCT03095703|66247118|FG000|Overall Study|Withdrawal by Subject|1|||
23691504|NCT04358458|66247119|FG000|Overall Study|Death|1|||
23691505|NCT04358458|66247120|FG001|Overall Study|Death|1|||
23691506|NCT04358458|66247121|FG002|Overall Study|Death|3|||
23691507|NCT04358458|66247122|FG003|Overall Study|Death|8|||
23691508|NCT04358458|66247123|FG004|Overall Study|Death|1|||
23691509|NCT04358458|66247124|FG005|Overall Study|Death|6|||
23691510|NCT04358458|66247125|FG006|Overall Study|Death|2|||
23691511|NCT04358458|66247126|FG007|Overall Study|Death|3|||
23691512|NCT04358458|66247119|FG000|Overall Study|Lost to Follow-up|0|||
23691513|NCT04358458|66247120|FG001|Overall Study|Lost to Follow-up|0|||
23691514|NCT04358458|66247121|FG002|Overall Study|Lost to Follow-up|0|||
23691515|NCT04358458|66247122|FG003|Overall Study|Lost to Follow-up|0|||
23691516|NCT04358458|66247123|FG004|Overall Study|Lost to Follow-up|0|||
23691517|NCT04358458|66247124|FG005|Overall Study|Lost to Follow-up|0|||
23691518|NCT04358458|66247125|FG006|Overall Study|Lost to Follow-up|0|||
23691519|NCT04358458|66247126|FG007|Overall Study|Lost to Follow-up|1|||
23691520|NCT04358458|66247119|FG000|Overall Study|Site is closing study participation|0|||
23691521|NCT04358458|66247120|FG001|Overall Study|Site is closing study participation|0|||
23691522|NCT04358458|66247121|FG002|Overall Study|Site is closing study participation|0|||
23691523|NCT04358458|66247122|FG003|Overall Study|Site is closing study participation|1|||
23691524|NCT04358458|66247123|FG004|Overall Study|Site is closing study participation|0|||
23691525|NCT04358458|66247124|FG005|Overall Study|Site is closing study participation|0|||
23691526|NCT04358458|66247125|FG006|Overall Study|Site is closing study participation|0|||
23691527|NCT04358458|66247126|FG007|Overall Study|Site is closing study participation|0|||
23691528|NCT04358458|66247119|FG000|Overall Study|Sponsor request|2|||
23691529|NCT04358458|66247120|FG001|Overall Study|Sponsor request|3|||
23691530|NCT04358458|66247121|FG002|Overall Study|Sponsor request|3|||
23691531|NCT04358458|66247122|FG003|Overall Study|Sponsor request|0|||
23691532|NCT04358458|66247123|FG004|Overall Study|Sponsor request|2|||
23691533|NCT04358458|66247124|FG005|Overall Study|Sponsor request|3|||
23691534|NCT04358458|66247125|FG006|Overall Study|Sponsor request|1|||
23691535|NCT04358458|66247126|FG007|Overall Study|Sponsor request|1|||
23691536|NCT04358458|66247119|FG000|Overall Study|Withdrawal by Subject|0|||
23691537|NCT04358458|66247120|FG001|Overall Study|Withdrawal by Subject|0|||
23691538|NCT04358458|66247121|FG002|Overall Study|Withdrawal by Subject|1|||
23691539|NCT04358458|66247122|FG003|Overall Study|Withdrawal by Subject|1|||
23691540|NCT04358458|66247123|FG004|Overall Study|Withdrawal by Subject|0|||
23691541|NCT04358458|66247124|FG005|Overall Study|Withdrawal by Subject|1|||
23691542|NCT04358458|66247125|FG006|Overall Study|Withdrawal by Subject|0|||
23691543|NCT04358458|66247126|FG007|Overall Study|Withdrawal by Subject|1|||
23691544|NCT02761057|66247127|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
23691545|NCT02761057|66247128|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
23691546|NCT02761057|66247129|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
23691547|NCT02761057|66247130|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
23691548|NCT02761057|66247127|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
23691549|NCT02761057|66247128|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
23691550|NCT02761057|66247129|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
23691551|NCT02761057|66247130|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
23691552|NCT02761057|66247127|FG000|Overall Study|Currently On Study Treatment|0|||
23691553|NCT02761057|66247128|FG001|Overall Study|Currently On Study Treatment|3|||
23691554|NCT02761057|66247129|FG002|Overall Study|Currently On Study Treatment|0|||
23691555|NCT02761057|66247130|FG003|Overall Study|Currently On Study Treatment|0|||
23691556|NCT02761057|66247127|FG000|Overall Study|Adverse Event|11|||
23691557|NCT02761057|66247128|FG001|Overall Study|Adverse Event|9|||
23691558|NCT02761057|66247129|FG002|Overall Study|Adverse Event|5|||
23691559|NCT02761057|66247130|FG003|Overall Study|Adverse Event|3|||
23691560|NCT02761057|66247127|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
23691561|NCT02761057|66247128|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
23691562|NCT02761057|66247129|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
23691563|NCT02761057|66247130|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
23691564|NCT02761057|66247127|FG000|Overall Study|Progression/Relapse|29|||
23691565|NCT02761057|66247128|FG001|Overall Study|Progression/Relapse|27|||
23691566|NCT02761057|66247129|FG002|Overall Study|Progression/Relapse|20|||
23691567|NCT02761057|66247130|FG003|Overall Study|Progression/Relapse|23|||
23691568|NCT02761057|66247127|FG000|Overall Study|Death|2|||
23691569|NCT02761057|66247128|FG001|Overall Study|Death|2|||
23691570|NCT02761057|66247129|FG002|Overall Study|Death|1|||
23691571|NCT02761057|66247130|FG003|Overall Study|Death|1|||
23691572|NCT02761057|66247127|FG000|Overall Study|Other - Not Protocol Specified|2|||
23691573|NCT02761057|66247128|FG001|Overall Study|Other - Not Protocol Specified|1|||
23691574|NCT02761057|66247129|FG002|Overall Study|Other - Not Protocol Specified|2|||
23691575|NCT02761057|66247130|FG003|Overall Study|Other - Not Protocol Specified|0|||
23691576|NCT05047523|66247131|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23691577|NCT05047523|66247132|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23691578|NCT05047523|66247133|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
23691579|NCT05047523|66247134|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23691580|NCT05047523|66247135|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23691581|NCT05047523|66247136|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23394789|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394790|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394791|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394792|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394793|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394794|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394795|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394796|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394797|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
23394798|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
23394799|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394800|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
23394801|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394802|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
23394803|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394804|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
23394805|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394806|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394807|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394808|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23691582|NCT05047523|66247131|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23691583|NCT05047523|66247132|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
23394809|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394810|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394811|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394812|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394813|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23691584|NCT05047523|66247133|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23691585|NCT05047523|66247134|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23691586|NCT05047523|66247135|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23691587|NCT05047523|66247136|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23691588|NCT05047523|66247131|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
23691589|NCT05047523|66247132|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
23691590|NCT05047523|66247133|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
23691591|NCT05047523|66247134|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
23691592|NCT05047523|66247135|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
23691593|NCT05047523|66247136|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
23691594|NCT05047523|66247131|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
23691595|NCT05047523|66247132|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23691596|NCT05047523|66247133|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23691597|NCT05047523|66247134|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23691598|NCT05047523|66247135|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23691599|NCT05047523|66247136|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23691600|NCT05047523|66247131|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23691601|NCT05047523|66247132|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23691602|NCT05047523|66247133|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23394814|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
23394815|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23691603|NCT05047523|66247134|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23691604|NCT05047523|66247135|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
23691605|NCT05047523|66247136|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
23691606|NCT05047523|66247131|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
23691607|NCT05047523|66247132|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
23691608|NCT05047523|66247133|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
23691609|NCT05047523|66247134|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
23691610|NCT05047523|66247135|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
23691611|NCT05047523|66247136|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
23691612|NCT03293680|66247137|FG000|Overall Study|Death|1|||
23691613|NCT03293680|66247137|FG000|Overall Study|Did not meet inclusion criteria|8|||
23691614|NCT04963231|66247138|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
23691615|NCT04963231|66247139|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
23691616|NCT04963231|66247140|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
23691617|NCT04963231|66247138|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
23691618|NCT04963231|66247139|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
23691619|NCT04963231|66247140|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
23691620|NCT04963231|66247138|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
23691621|NCT04963231|66247139|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
23691622|NCT04963231|66247140|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
23691623|NCT04963231|66247138|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
23394816|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394817|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394818|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394819|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394820|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
23394821|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394822|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394823|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394824|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394825|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394826|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394827|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394828|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394829|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394830|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394831|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394832|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
23394833|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
23394834|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
23394835|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
23394836|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
23394837|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
23394838|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
23394839|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
23394840|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
23394841|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
23394842|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
23394843|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
23394844|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
23394845|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
23394846|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
23394847|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
23394848|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
23394849|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
23394850|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
23394851|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
23394852|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
23394853|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394854|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394855|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394856|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394857|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394858|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394859|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394860|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394861|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394862|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23691624|NCT04963231|66247139|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
23498532|NCT04066023|65566360|FG002|Overall Study|Physician Decision|1|||
23394863|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394864|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394865|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394866|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
23394867|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394868|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394869|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394870|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394871|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394872|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394873|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394874|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394875|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394876|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394877|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394878|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394879|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394880|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394881|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394882|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
23394883|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23691625|NCT04963231|66247140|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
23691626|NCT04963231|66247138|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
23691627|NCT04963231|66247139|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
23691628|NCT04963231|66247140|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
23691629|NCT04963231|66247138|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
23691630|NCT04963231|66247139|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
23691631|NCT04963231|66247140|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
23691632|NCT04963231|66247138|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
23691633|NCT04963231|66247139|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
23691634|NCT04963231|66247140|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
23691635|NCT03871491|66247143|FG000|Overall Study|Withdrawal by Subject|14|||
23691636|NCT03871491|66247144|FG001|Overall Study|Withdrawal by Subject|14|||
23691637|NCT03871491|66247145|FG002|Overall Study|Withdrawal by Subject|14|||
23691638|NCT03871491|66247146|FG003|Overall Study|Withdrawal by Subject|14|||
23394884|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394885|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394886|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394887|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394888|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394889|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394890|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394891|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394892|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23691639|NCT03871491|66247143|FG000|Overall Study|Physician Decision|0|||
23691640|NCT03871491|66247144|FG001|Overall Study|Physician Decision|0|||
23691641|NCT03871491|66247145|FG002|Overall Study|Physician Decision|1|||
23691642|NCT03871491|66247146|FG003|Overall Study|Physician Decision|1|||
23691643|NCT03871491|66247143|FG000|Overall Study|Lost to Follow-up|50|||
23691644|NCT03871491|66247144|FG001|Overall Study|Lost to Follow-up|15|||
23691645|NCT03871491|66247145|FG002|Overall Study|Lost to Follow-up|36|||
23691646|NCT03871491|66247146|FG003|Overall Study|Lost to Follow-up|11|||
23691647|NCT05847881|66247147|FG000|Overall Study|Principal Investigator Decision|8|||
23691648|NCT05847881|66247147|FG000|Overall Study|Withdrawal by Subject|2|||
23691649|NCT02642042|66247152|FG000|Overall Study|Adverse Event|22|||
23691650|NCT02642042|66247152|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23691651|NCT02642042|66247152|FG000|Overall Study|Progression/Relapse|28|||
23691652|NCT02642042|66247152|FG000|Overall Study|Death|1|||
23691653|NCT02642042|66247152|FG000|Overall Study|Not Protocol Specified|2|||
23691654|NCT04996797|66247153|FG000|Overall Study|Adverse Event|0|||
23691655|NCT04996797|66247154|FG001|Overall Study|Adverse Event|2|||
23691656|NCT04996797|66247155|FG002|Overall Study|Adverse Event|0|||
23691657|NCT04996797|66247156|FG003|Overall Study|Adverse Event|1|||
23691658|NCT04996797|66247153|FG000|Overall Study|Lack of Efficacy|0|||
23691659|NCT04996797|66247154|FG001|Overall Study|Lack of Efficacy|2|||
23691660|NCT04996797|66247155|FG002|Overall Study|Lack of Efficacy|0|||
23691661|NCT04996797|66247156|FG003|Overall Study|Lack of Efficacy|0|||
23691662|NCT04996797|66247153|FG000|Overall Study|Prohibited Medication|0|||
23691663|NCT04996797|66247154|FG001|Overall Study|Prohibited Medication|1|||
23691664|NCT04996797|66247155|FG002|Overall Study|Prohibited Medication|0|||
23691665|NCT04996797|66247156|FG003|Overall Study|Prohibited Medication|0|||
23691666|NCT04996797|66247153|FG000|Overall Study|Ongoing|68|||
23691667|NCT04996797|66247154|FG001|Overall Study|Ongoing|60|||
23691668|NCT04996797|66247155|FG002|Overall Study|Ongoing|22|||
23691669|NCT04996797|66247156|FG003|Overall Study|Ongoing|20|||
23691670|NCT04996797|66247153|FG000|Overall Study|Withdrawal by Subject|0|||
23691671|NCT04996797|66247154|FG001|Overall Study|Withdrawal by Subject|2|||
23691672|NCT04996797|66247155|FG002|Overall Study|Withdrawal by Subject|0|||
23691673|NCT04996797|66247156|FG003|Overall Study|Withdrawal by Subject|0|||
23691674|NCT01526148|66247157|FG000|Overall Study|Adverse Event|6|||
23691675|NCT01526148|66247158|FG001|Overall Study|Adverse Event|5|||
23691676|NCT01526148|66247157|FG000|Overall Study|Lost to Follow-up|3|||
23691677|NCT01526148|66247158|FG001|Overall Study|Lost to Follow-up|6|||
23691678|NCT01526148|66247157|FG000|Overall Study|Withdrawal by Subject|2|||
23691679|NCT01526148|66247158|FG001|Overall Study|Withdrawal by Subject|0|||
23691680|NCT01526148|66247157|FG000|Overall Study|Unstable Medical Condition|1|||
23691681|NCT01526148|66247158|FG001|Overall Study|Unstable Medical Condition|0|||
23691682|NCT01526148|66247157|FG000|Overall Study|Unable to discontinue concomitant med|1|||
23691683|NCT01526148|66247158|FG001|Overall Study|Unable to discontinue concomitant med|0|||
23691684|NCT01526148|66247157|FG000|Overall Study|Moved out of state|1|||
23691685|NCT01526148|66247158|FG001|Overall Study|Moved out of state|0|||
23691686|NCT01526148|66247157|FG000|Overall Study|Incarcerated|0|||
23691687|NCT01526148|66247158|FG001|Overall Study|Incarcerated|2|||
23691688|NCT00592683|66247161|FG000|Overall Study|Found ineligible|0|||
23691689|NCT00592683|66247162|FG001|Overall Study|Found ineligible|1|||
23691690|NCT00592683|66247161|FG000|Overall Study|Withdrawal by Subject|1|||
23691691|NCT00592683|66247162|FG001|Overall Study|Withdrawal by Subject|0|||
23691692|NCT00592683|66247161|FG000|Overall Study|Adverse Event|0|||
23691693|NCT00592683|66247162|FG001|Overall Study|Adverse Event|2|||
23394893|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394894|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
23394895|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394896|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394897|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394898|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394899|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394900|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394901|NCT00654732|65192743|FG000|Overall Study|Adverse Event|4|||
23394902|NCT00654732|65192744|FG001|Overall Study|Adverse Event|6|||
23394903|NCT00851084|65192745|FG000|Overall Study|Randomized but not treated|1|||
23394904|NCT00851084|65192746|FG001|Overall Study|Randomized but not treated|0|||
23394905|NCT00851084|65192745|FG000|Overall Study|Adverse Event|26|||
23394906|NCT00851084|65192746|FG001|Overall Study|Adverse Event|36|||
23394907|NCT00851084|65192745|FG000|Overall Study|Disease progression|52|||
23394908|NCT00851084|65192746|FG001|Overall Study|Disease progression|47|||
23691694|NCT00592683|66247161|FG000|Overall Study|Protocol Violation|1|||
23691695|NCT00592683|66247162|FG001|Overall Study|Protocol Violation|0|||
23691696|NCT00592683|66247161|FG000|Overall Study|Study drug expired|1|||
23691697|NCT00592683|66247162|FG001|Overall Study|Study drug expired|0|||
23691698|NCT00592683|66247161|FG000|Overall Study|Other|1|||
23691699|NCT00592683|66247162|FG001|Overall Study|Other|0|||
23691700|NCT00592683|66247161|FG000|Overall Study|Lost to Follow-up|0|||
23691701|NCT00592683|66247162|FG001|Overall Study|Lost to Follow-up|1|||
23691702|NCT02424149|66247163|FG000|Overall Study|surgery cancelled|2|||
23691703|NCT02424149|66247164|FG001|Overall Study|surgery cancelled|0|||
23691704|NCT02424149|66247163|FG000|Overall Study|Withdrawal by Subject|0|||
23691705|NCT02424149|66247164|FG001|Overall Study|Withdrawal by Subject|1|||
23691706|NCT01739595|66247165|FG000|Overall Study|Adverse Event|3|||
23394909|NCT00851084|65192745|FG000|Overall Study|Poor compliance to protocol|1|||
23394910|NCT00851084|65192746|FG001|Overall Study|Poor compliance to protocol|1|||
23394911|NCT00851084|65192745|FG000|Overall Study|Physician Decision|13|||
23691707|NCT01739595|66247166|FG001|Overall Study|Adverse Event|0|||
23691708|NCT01739595|66247167|FG002|Overall Study|Adverse Event|0|||
23691709|NCT01739595|66247165|FG000|Overall Study|Lost to Follow-up|2|||
23691710|NCT01739595|66247166|FG001|Overall Study|Lost to Follow-up|0|||
23691711|NCT01739595|66247167|FG002|Overall Study|Lost to Follow-up|0|||
23394912|NCT00851084|65192746|FG001|Overall Study|Physician Decision|14|||
23691712|NCT01739595|66247165|FG000|Overall Study|Withdrawal by Subject|2|||
23691713|NCT01739595|66247166|FG001|Overall Study|Withdrawal by Subject|1|||
23691714|NCT01739595|66247167|FG002|Overall Study|Withdrawal by Subject|2|||
23691715|NCT01739595|66247165|FG000|Overall Study|Eligibility issue|3|||
23691716|NCT01739595|66247166|FG001|Overall Study|Eligibility issue|0|||
23691717|NCT01739595|66247167|FG002|Overall Study|Eligibility issue|0|||
23691718|NCT01739595|66247165|FG000|Overall Study|Protocol Violation|1|||
23691719|NCT01739595|66247166|FG001|Overall Study|Protocol Violation|0|||
23691720|NCT01739595|66247167|FG002|Overall Study|Protocol Violation|0|||
23691721|NCT01739595|66247165|FG000|Overall Study|Lab assessment|1|||
23691722|NCT01739595|66247166|FG001|Overall Study|Lab assessment|0|||
23691723|NCT01739595|66247167|FG002|Overall Study|Lab assessment|0|||
23691724|NCT01739595|66247165|FG000|Overall Study|Drug discrepancy|1|||
23691725|NCT01739595|66247166|FG001|Overall Study|Drug discrepancy|0|||
23691726|NCT01739595|66247167|FG002|Overall Study|Drug discrepancy|0|||
23691727|NCT03545282|66247168|FG000|Overall Study|Lost to Follow-up|15|||
23691728|NCT03545282|66247169|FG001|Overall Study|Lost to Follow-up|10|||
23691729|NCT03545282|66247168|FG000|Overall Study|Withdrawal by Subject|2|||
23691730|NCT03545282|66247169|FG001|Overall Study|Withdrawal by Subject|2|||
23691731|NCT03233048|66247175|FG000|Overall Study|Withdrawal by Subject|1|||
23691732|NCT01360996|66247179|FG000|Overall Study|Withdrawal by Subject|4|||
23691733|NCT01360996|66247180|FG001|Overall Study|Withdrawal by Subject|3|||
23691734|NCT01360996|66247181|FG002|Overall Study|Withdrawal by Subject|2|||
23691735|NCT01360996|66247179|FG000|Overall Study|Noncompliant|2|||
23691736|NCT01360996|66247180|FG001|Overall Study|Noncompliant|0|||
23691737|NCT01360996|66247181|FG002|Overall Study|Noncompliant|0|||
23691738|NCT02951052|66247183|FG000|Overall Study|Adverse Event|13|||
23691739|NCT02951052|66247184|FG001|Overall Study|Adverse Event|5|||
23691740|NCT02951052|66247183|FG000|Overall Study|Withdrawal by Subject|1|||
23691741|NCT02951052|66247184|FG001|Overall Study|Withdrawal by Subject|5|||
23691742|NCT02951052|66247183|FG000|Overall Study|Physician Decision|2|||
23691743|NCT02951052|66247184|FG001|Overall Study|Physician Decision|0|||
23691744|NCT02951052|66247183|FG000|Overall Study|Lost to Follow-up|1|||
23691745|NCT02951052|66247184|FG001|Overall Study|Lost to Follow-up|1|||
23691746|NCT02951052|66247183|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
23691747|NCT02951052|66247184|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
23691748|NCT02951052|66247183|FG000|Overall Study|Protocol Violation|5|||
23691749|NCT02951052|66247184|FG001|Overall Study|Protocol Violation|3|||
23691750|NCT02951052|66247183|FG000|Overall Study|Lack of Efficacy|3|||
23691751|NCT02951052|66247184|FG001|Overall Study|Lack of Efficacy|4|||
23691752|NCT02951052|66247183|FG000|Overall Study|Ongoing|1|||
23691753|NCT02951052|66247184|FG001|Overall Study|Ongoing|0|||
23691754|NCT01503021|66247187|FG000|Overall Study|Adverse Event|7|||
23691755|NCT01503021|66247188|FG001|Overall Study|Adverse Event|6|||
23691756|NCT01503021|66247187|FG000|Overall Study|Death|0|||
23691757|NCT01503021|66247188|FG001|Overall Study|Death|2|||
23691758|NCT01503021|66247187|FG000|Overall Study|Lost to Follow-up|2|||
23691759|NCT01503021|66247188|FG001|Overall Study|Lost to Follow-up|0|||
23691760|NCT01503021|66247187|FG000|Overall Study|Physician Decision|3|||
23691761|NCT01503021|66247188|FG001|Overall Study|Physician Decision|0|||
23691762|NCT01503021|66247187|FG000|Overall Study|Protocol Violation|1|||
23691763|NCT01503021|66247188|FG001|Overall Study|Protocol Violation|3|||
23691764|NCT01503021|66247187|FG000|Overall Study|Withdrawal by Subject|9|||
23691765|NCT01503021|66247188|FG001|Overall Study|Withdrawal by Subject|8|||
23691766|NCT01503021|66247187|FG000|Overall Study|Moved, received transplant, etc.|5|||
23691767|NCT01503021|66247188|FG001|Overall Study|Moved, received transplant, etc.|7|||
23691768|NCT02224664|66247189|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
23691769|NCT02224664|66247190|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23691770|NCT02224664|66247191|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23691771|NCT02224664|66247192|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23691772|NCT02224664|66247193|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23691773|NCT02224664|66247189|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
23691774|NCT02224664|66247190|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
23691775|NCT02224664|66247191|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
23691776|NCT02224664|66247192|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
23691777|NCT02224664|66247193|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
23691778|NCT02224664|66247189|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23691779|NCT02224664|66247190|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23691780|NCT02224664|66247191|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23691781|NCT02224664|66247192|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
23691782|NCT02224664|66247193|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
23691783|NCT00917384|66247194|FG000|Overall Study|Lost to Follow-up|4|||
23691784|NCT00917384|66247195|FG001|Overall Study|Lost to Follow-up|2|||
23691785|NCT00917384|66247194|FG000|Overall Study|Withdrawal by Subject|10|||
23691786|NCT00917384|66247195|FG001|Overall Study|Withdrawal by Subject|2|||
23394913|NCT00851084|65192745|FG000|Overall Study|Consent withdrawn|0|||
23394914|NCT00851084|65192746|FG001|Overall Study|Consent withdrawn|2|||
23394915|NCT00851084|65192745|FG000|Overall Study|Withdrawal by Subject|11|||
23691787|NCT03830281|66247199|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
23691788|NCT03830281|66247200|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
23691789|NCT03830281|66247199|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
23691790|NCT03830281|66247200|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
23691791|NCT03830281|66247199|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
23691792|NCT03830281|66247200|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
23691793|NCT03830281|66247199|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
23691794|NCT03830281|66247200|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
23691795|NCT03830281|66247199|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
23691796|NCT03830281|66247200|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
23394916|NCT00851084|65192746|FG001|Overall Study|Withdrawal by Subject|12|||
23394917|NCT00851084|65192745|FG000|Overall Study|Metastatic surgery|6|||
23394918|NCT00851084|65192746|FG001|Overall Study|Metastatic surgery|6|||
23394919|NCT00851084|65192745|FG000|Overall Study|Other|7|||
23394920|NCT00851084|65192746|FG001|Overall Study|Other|1|||
23394921|NCT01651208|65192751|FG000|Overall Study|Lost to Follow-up|14|||
23691797|NCT03830281|66247199|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
23691798|NCT03830281|66247200|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
23691799|NCT03830281|66247199|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
23691800|NCT03830281|66247200|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
23691801|NCT03830281|66247199|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
23691802|NCT03830281|66247200|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
23691803|NCT03830281|66247199|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
23691804|NCT03830281|66247200|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
23691805|NCT02091440|66247212|FG000|Overall Study|Death|2|||
23691806|NCT03406962|66247213|FG000|Overall Study|Death|2|||
23691807|NCT03406962|66247213|FG000|Overall Study|Adverse Event|1|||
23691808|NCT02111811|66247214|FG000|Treatment Phase|Lost to Follow-up|22|||
23691809|NCT02111811|66247215|FG001|Treatment Phase|Lost to Follow-up|18|||
23691810|NCT02111811|66247214|FG000|Treatment Phase|Death|2|||
23691811|NCT02111811|66247215|FG001|Treatment Phase|Death|0|||
23691812|NCT02111811|66247214|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
23691813|NCT02111811|66247215|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
23691814|NCT02111811|66247214|FG000|Follow up Period (Aim 2)|Death|2|||
23691815|NCT02111811|66247215|FG001|Follow up Period (Aim 2)|Death|0|||
23691816|NCT03455543|66247216|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
23691817|NCT03455543|66247217|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
23691818|NCT03455543|66247218|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
23691819|NCT03455543|66247216|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
23691820|NCT03455543|66247217|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
23691821|NCT03455543|66247218|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
23691822|NCT03455543|66247216|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
23691823|NCT03455543|66247217|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
23691824|NCT03455543|66247218|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
23691825|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
23691826|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
23691827|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
23691828|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
23691829|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
23691830|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
23691831|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
23691832|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
23691833|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
23691834|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
23691835|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
23691836|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
23691837|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
23691838|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
23394922|NCT01651208|65192752|FG001|Overall Study|Lost to Follow-up|16|||
23394923|NCT00829868|65192755|FG000|Washout|Physician Decision|1|||
23394924|NCT00829868|65192756|FG001|Washout|Physician Decision|0|||
23394925|NCT03242434|65192757|FG000|Overall Study|Death|0|||
23394926|NCT03242434|65192758|FG001|Overall Study|Death|2|||
23691839|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
23691840|NCT03455543|66247216|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
23691841|NCT03455543|66247217|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
23394927|NCT01358734|65192759|FG000|Overall Study|Adverse Event|4|||
23394928|NCT01358734|65192760|FG001|Overall Study|Adverse Event|7|||
23691842|NCT03455543|66247218|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
23691843|NCT00957853|66247221|FG000|Overall Study|Withdrawal by Subject|1|||
23691844|NCT00957853|66247222|FG001|Overall Study|Withdrawal by Subject|0|||
23691845|NCT00957853|66247223|FG002|Overall Study|Withdrawal by Subject|0|||
23691846|NCT05299892|66247224|FG000|Overall Study|Withdrawal by Subject|2|||
23394929|NCT01358734|65192761|FG002|Overall Study|Adverse Event|3|||
23394930|NCT01358734|65192759|FG000|Overall Study|Lack of Efficacy|0|||
23691847|NCT02782715|66247225|FG000|Overall Study|Withdrawal by Subject|1|||
23691848|NCT00278629|66250731|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
23691849|NCT00509106|66250732|FG000|Overall Study|Adverse Event|3|||
23691850|NCT00509106|66250733|FG001|Overall Study|Adverse Event|2|||
23691851|NCT00509106|66250732|FG000|Overall Study|Noncompliance|0|||
23691852|NCT00509106|66250733|FG001|Overall Study|Noncompliance|1|||
23691853|NCT00509106|66250732|FG000|Overall Study|At the request of sponsor/investigator|1|||
23691854|NCT00509106|66250733|FG001|Overall Study|At the request of sponsor/investigator|2|||
23691855|NCT00509106|66250732|FG000|Overall Study|Withdrew consent|4|||
23691856|NCT00509106|66250733|FG001|Overall Study|Withdrew consent|8|||
23691857|NCT00509106|66250732|FG000|Overall Study|Lost to Follow-up|16|||
23691858|NCT00509106|66250733|FG001|Overall Study|Lost to Follow-up|10|||
23691859|NCT00509106|66250732|FG000|Overall Study|Other|1|||
23691860|NCT00509106|66250733|FG001|Overall Study|Other|0|||
23691861|NCT00509106|66250732|FG000|Overall Study|Death|6|||
23691862|NCT00509106|66250733|FG001|Overall Study|Death|6|||
23691863|NCT00586690|66250734|FG000|Overall Study|Death|2|||
23691864|NCT00586690|66250735|FG001|Overall Study|Death|0|||
23691865|NCT00586690|66250734|FG000|Overall Study|Disease Progression|10|||
23691866|NCT00586690|66250735|FG001|Overall Study|Disease Progression|0|||
23691867|NCT00586690|66250734|FG000|Overall Study|Adverse Event|1|||
23691868|NCT00586690|66250735|FG001|Overall Study|Adverse Event|0|||
23691869|NCT00586690|66250734|FG000|Overall Study|Lack of Efficacy|2|||
23691870|NCT00586690|66250735|FG001|Overall Study|Lack of Efficacy|0|||
23691871|NCT00586690|66250734|FG000|Overall Study|Lab can't accommodate|1|||
23691872|NCT00586690|66250735|FG001|Overall Study|Lab can't accommodate|0|||
23691873|NCT00813995|66250736|FG000|Overall Study|Clinical adverse event|9|||
23691874|NCT00813995|66250737|FG001|Overall Study|Clinical adverse event|3|||
23691875|NCT00813995|66250736|FG000|Overall Study|Laboratory adverse event|0|||
23691876|NCT00813995|66250737|FG001|Overall Study|Laboratory adverse event|2|||
23691877|NCT00813995|66250736|FG000|Overall Study|Lack of Efficacy|1|||
23691878|NCT00813995|66250737|FG001|Overall Study|Lack of Efficacy|0|||
23691879|NCT00813995|66250736|FG000|Overall Study|Lost to Follow-up|4|||
23691880|NCT00813995|66250737|FG001|Overall Study|Lost to Follow-up|2|||
23691881|NCT00813995|66250736|FG000|Overall Study|Other reason|2|||
23691882|NCT00813995|66250737|FG001|Overall Study|Other reason|2|||
23691883|NCT00813995|66250736|FG000|Overall Study|Protocol Violation|3|||
23691884|NCT00813995|66250737|FG001|Overall Study|Protocol Violation|2|||
23691885|NCT00813995|66250736|FG000|Overall Study|Subject moved|4|||
23691886|NCT00813995|66250737|FG001|Overall Study|Subject moved|0|||
23691887|NCT00813995|66250736|FG000|Overall Study|Withdrawal by Subject|0|||
23691888|NCT00813995|66250737|FG001|Overall Study|Withdrawal by Subject|5|||
23691889|NCT01794780|66250738|FG000|Overall Study|Adverse Event|0|||
23691890|NCT01794780|66250739|FG001|Overall Study|Adverse Event|1|||
23691891|NCT01794780|66250740|FG002|Overall Study|Adverse Event|2|||
23691892|NCT01794780|66250741|FG003|Overall Study|Adverse Event|0|||
23691893|NCT01794780|66250742|FG004|Overall Study|Adverse Event|0|||
23691894|NCT01794780|66250743|FG005|Overall Study|Adverse Event|0|||
23691895|NCT01794780|66250744|FG006|Overall Study|Adverse Event|0|||
23691896|NCT01794780|66250745|FG007|Overall Study|Adverse Event|0|||
23691897|NCT01794780|66250738|FG000|Overall Study|Death|0|||
23691898|NCT01794780|66250739|FG001|Overall Study|Death|2|||
23691899|NCT01794780|66250740|FG002|Overall Study|Death|14|||
23691900|NCT01794780|66250741|FG003|Overall Study|Death|1|||
23691901|NCT01794780|66250742|FG004|Overall Study|Death|0|||
23691902|NCT01794780|66250743|FG005|Overall Study|Death|9|||
23691903|NCT01794780|66250744|FG006|Overall Study|Death|4|||
23691904|NCT01794780|66250745|FG007|Overall Study|Death|0|||
23691905|NCT01794780|66250738|FG000|Overall Study|Lost to Follow-up|10|||
23691906|NCT01794780|66250739|FG001|Overall Study|Lost to Follow-up|64|||
23394931|NCT01358734|65192760|FG001|Overall Study|Lack of Efficacy|1|||
23394932|NCT01358734|65192761|FG002|Overall Study|Lack of Efficacy|3|||
23394933|NCT01358734|65192759|FG000|Overall Study|Withdrawal by Subject|1|||
23394934|NCT01358734|65192760|FG001|Overall Study|Withdrawal by Subject|6|||
23394935|NCT01358734|65192761|FG002|Overall Study|Withdrawal by Subject|3|||
23691907|NCT01794780|66250740|FG002|Overall Study|Lost to Follow-up|165|||
23691908|NCT01794780|66250741|FG003|Overall Study|Lost to Follow-up|53|||
23691909|NCT01794780|66250742|FG004|Overall Study|Lost to Follow-up|2|||
23691910|NCT01794780|66250743|FG005|Overall Study|Lost to Follow-up|99|||
23691911|NCT01794780|66250744|FG006|Overall Study|Lost to Follow-up|30|||
23394936|NCT01358734|65192759|FG000|Overall Study|Death|3|||
23394937|NCT01358734|65192760|FG001|Overall Study|Death|7|||
23691912|NCT01794780|66250745|FG007|Overall Study|Lost to Follow-up|5|||
23691913|NCT01794780|66250738|FG000|Overall Study|Withdrew informed consent|7|||
23691914|NCT01794780|66250739|FG001|Overall Study|Withdrew informed consent|17|||
23691915|NCT01794780|66250740|FG002|Overall Study|Withdrew informed consent|36|||
23691916|NCT01794780|66250741|FG003|Overall Study|Withdrew informed consent|9|||
23691917|NCT01794780|66250742|FG004|Overall Study|Withdrew informed consent|0|||
23691918|NCT01794780|66250743|FG005|Overall Study|Withdrew informed consent|48|||
23691919|NCT01794780|66250744|FG006|Overall Study|Withdrew informed consent|4|||
23394938|NCT01358734|65192761|FG002|Overall Study|Death|2|||
23394939|NCT01358734|65192759|FG000|Overall Study|Progressive Disease|5|||
23394940|NCT01358734|65192760|FG001|Overall Study|Progressive Disease|13|||
23394941|NCT01358734|65192761|FG002|Overall Study|Progressive Disease|16|||
23394942|NCT01358734|65192759|FG000|Overall Study|Non-compliance with study drug|0|||
23394943|NCT01358734|65192760|FG001|Overall Study|Non-compliance with study drug|0|||
23394944|NCT01358734|65192761|FG002|Overall Study|Non-compliance with study drug|1|||
23394945|NCT01358734|65192759|FG000|Overall Study|Other|2|||
23394946|NCT01358734|65192760|FG001|Overall Study|Other|5|||
23394947|NCT01358734|65192761|FG002|Overall Study|Other|4|||
23394948|NCT01358734|65192759|FG000|Overall Study|Protocol Violation|0|||
23394949|NCT01358734|65192760|FG001|Overall Study|Protocol Violation|0|||
23394950|NCT01358734|65192761|FG002|Overall Study|Protocol Violation|2|||
23394951|NCT02448381|65192763|FG000|Overall Study|Adverse Event|2|||
23394952|NCT02448381|65192764|FG001|Overall Study|Adverse Event|0|||
23394953|NCT02448381|65192763|FG000|Overall Study|Lost to Follow-up|16|||
23394954|NCT02448381|65192764|FG001|Overall Study|Lost to Follow-up|9|||
23394955|NCT02448381|65192763|FG000|Overall Study|Physician Decision|1|||
23394956|NCT02448381|65192764|FG001|Overall Study|Physician Decision|1|||
23394957|NCT02448381|65192763|FG000|Overall Study|Pregnancy|1|||
23394958|NCT02448381|65192764|FG001|Overall Study|Pregnancy|0|||
23394959|NCT02448381|65192763|FG000|Overall Study|Withdrawal by Subject|13|||
23394960|NCT02448381|65192764|FG001|Overall Study|Withdrawal by Subject|9|||
23394961|NCT02448381|65192763|FG000|Overall Study|Noncompliance with Study Procedures|2|||
23394962|NCT02448381|65192764|FG001|Overall Study|Noncompliance with Study Procedures|0|||
23394963|NCT00982280|65192767|FG000|Observation Period|Not eligible to be dosed|19|||
23394964|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
23394965|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
23394966|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
23394967|NCT00982280|65192767|FG000|Maintenance Period|Adverse Event|1|||
23394968|NCT03078868|65192768|FG000|Overall Study|Physician Decision|3|||
23394969|NCT04123704|65192769|FG000|Overall Study|Disease progression|2|||
23394970|NCT00321932|65192770|FG000|Overall Study|Death|3|||
23394971|NCT00321932|65192771|FG001|Overall Study|Death|6|||
23691920|NCT01794780|66250745|FG007|Overall Study|Withdrew informed consent|3|||
23394972|NCT00321932|65192770|FG000|Overall Study|Withdrawal by Subject|3|||
23394973|NCT00321932|65192771|FG001|Overall Study|Withdrawal by Subject|6|||
23394974|NCT00321932|65192770|FG000|Overall Study|Early relapse|2|||
23394975|NCT00321932|65192771|FG001|Overall Study|Early relapse|8|||
23394976|NCT00321932|65192770|FG000|Overall Study|Missing data|2|||
23394977|NCT00321932|65192771|FG001|Overall Study|Missing data|1|||
23394978|NCT03427619|65192772|FG000|Overall Study|Physician Decision|3|||
23394979|NCT03427619|65192772|FG000|Overall Study|Withdrawal by Subject|4|||
23394980|NCT03427619|65192772|FG000|Overall Study|Lost to Follow-up|5|||
23394981|NCT03427619|65192772|FG000|Overall Study|Administrative|4|||
23394982|NCT03427619|65192772|FG000|Overall Study|Other|2|||
23394983|NCT03427619|65192772|FG000|Overall Study|Unknown or Missing Completion Status|48|||
23394984|NCT02552225|65192773|FG000|Overall Study|Withdrawal by Subject|1|||
23394985|NCT02552225|65192774|FG001|Overall Study|Withdrawal by Subject|0|||
23394986|NCT03033784|65192775|FG000|Overall Study|Anxiety related to MRI scanner|0|||
23394987|NCT03033784|65192776|FG001|Overall Study|Anxiety related to MRI scanner|1|||
23394988|NCT03033784|65192777|FG002|Overall Study|Anxiety related to MRI scanner|0|||
23394989|NCT03033784|65192778|FG003|Overall Study|Anxiety related to MRI scanner|0|||
23394990|NCT03033784|65192779|FG004|Overall Study|Anxiety related to MRI scanner|0|||
23394991|NCT03033784|65192780|FG005|Overall Study|Anxiety related to MRI scanner|0|||
23394992|NCT03033784|65192781|FG006|Overall Study|Anxiety related to MRI scanner|0|||
23394993|NCT03033784|65192782|FG007|Overall Study|Anxiety related to MRI scanner|0|||
23394994|NCT03033784|65192783|FG008|Overall Study|Anxiety related to MRI scanner|0|||
23394995|NCT03033784|65192784|FG009|Overall Study|Anxiety related to MRI scanner|0|||
23394996|NCT03033784|65192785|FG010|Overall Study|Anxiety related to MRI scanner|0|||
23394997|NCT03033784|65192786|FG011|Overall Study|Anxiety related to MRI scanner|0|||
23394998|NCT03033784|65192787|FG012|Overall Study|Anxiety related to MRI scanner|0|||
23394999|NCT03033784|65192775|FG000|Overall Study|Withdrawal by Subject|0|||
23395000|NCT03033784|65192776|FG001|Overall Study|Withdrawal by Subject|0|||
23395001|NCT03033784|65192777|FG002|Overall Study|Withdrawal by Subject|0|||
23395002|NCT03033784|65192778|FG003|Overall Study|Withdrawal by Subject|0|||
23395003|NCT03033784|65192779|FG004|Overall Study|Withdrawal by Subject|0|||
23395004|NCT03033784|65192780|FG005|Overall Study|Withdrawal by Subject|0|||
23395005|NCT03033784|65192781|FG006|Overall Study|Withdrawal by Subject|0|||
23395006|NCT03033784|65192782|FG007|Overall Study|Withdrawal by Subject|0|||
23395007|NCT03033784|65192783|FG008|Overall Study|Withdrawal by Subject|0|||
23395008|NCT03033784|65192784|FG009|Overall Study|Withdrawal by Subject|0|||
23395009|NCT03033784|65192785|FG010|Overall Study|Withdrawal by Subject|0|||
23395010|NCT03033784|65192786|FG011|Overall Study|Withdrawal by Subject|0|||
23395011|NCT03033784|65192787|FG012|Overall Study|Withdrawal by Subject|2|||
23395012|NCT03456076|65192788|FG000|Overall Study|Withdrawal by Subject|5|||
23395013|NCT03456076|65192789|FG001|Overall Study|Withdrawal by Subject|9|||
23395014|NCT03456076|65192788|FG000|Overall Study|Protocol deviation|0|||
23395015|NCT03456076|65192789|FG001|Overall Study|Protocol deviation|1|||
23395016|NCT03456076|65192788|FG000|Overall Study|Lost to Follow-up|0|||
23395017|NCT03456076|65192789|FG001|Overall Study|Lost to Follow-up|1|||
23395018|NCT03456076|65192788|FG000|Overall Study|Death|2|||
23395019|NCT03456076|65192789|FG001|Overall Study|Death|5|||
23395020|NCT03456076|65192788|FG000|Overall Study|Study ongoing|123|||
23395021|NCT03456076|65192789|FG001|Overall Study|Study ongoing|111|||
23395022|NCT00730327|65192790|FG000|Overall Study|Lost to Follow-up|14|||
23395023|NCT00730327|65192791|FG001|Overall Study|Lost to Follow-up|16|||
23395024|NCT00730327|65192790|FG000|Overall Study|Adverse Event|8|||
23395025|NCT00730327|65192791|FG001|Overall Study|Adverse Event|1|||
23395026|NCT00730327|65192790|FG000|Overall Study|Withdrawal by Subject|3|||
23395027|NCT00730327|65192791|FG001|Overall Study|Withdrawal by Subject|13|||
23395028|NCT00730327|65192790|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
23395029|NCT00730327|65192791|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
23395030|NCT03895372|65192792|FG000|Investigational Treatment Period|Adverse Event|1|||
23395031|NCT03895372|65192793|FG001|Investigational Treatment Period|Adverse Event|0|||
23691921|NCT01794780|66250738|FG000|Overall Study|Other|0|||
23691922|NCT01794780|66250739|FG001|Overall Study|Other|12|||
23691923|NCT01794780|66250740|FG002|Overall Study|Other|25|||
23691924|NCT01794780|66250741|FG003|Overall Study|Other|20|||
23691925|NCT01794780|66250742|FG004|Overall Study|Other|1|||
23691926|NCT01794780|66250743|FG005|Overall Study|Other|24|||
23691927|NCT01794780|66250744|FG006|Overall Study|Other|4|||
23691928|NCT01794780|66250745|FG007|Overall Study|Other|1|||
23691929|NCT00892437|66250746|FG000|Randomized Phase|Randomized but not treated|6|||
23691930|NCT00892437|66250747|FG001|Randomized Phase|Randomized but not treated|0|||
23691931|NCT00892437|66250746|FG000|Randomized Phase|Adverse Event|2|||
23691932|NCT00892437|66250747|FG001|Randomized Phase|Adverse Event|2|||
23691933|NCT00892437|66250746|FG000|Randomized Phase|Lost to Follow-up|1|||
23691934|NCT00892437|66250747|FG001|Randomized Phase|Lost to Follow-up|3|||
23691935|NCT00892437|66250746|FG000|Randomized Phase|Investigator's Discretion|1|||
23691936|NCT00892437|66250747|FG001|Randomized Phase|Investigator's Discretion|0|||
23691937|NCT00892437|66250746|FG000|Randomized Phase|Withdrew Consent|1|||
23691938|NCT00892437|66250747|FG001|Randomized Phase|Withdrew Consent|0|||
23691939|NCT00892437|66250746|FG000|Open-Label Extension Phase|Adverse Event|4|||
23691940|NCT00892437|66250747|FG001|Open-Label Extension Phase|Adverse Event|2|||
23691941|NCT00892437|66250746|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
23691942|NCT00892437|66250747|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
23691943|NCT00892437|66250746|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
23691944|NCT00892437|66250747|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23691945|NCT00892437|66250746|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
23691946|NCT00892437|66250747|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23691947|NCT00892437|66250746|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
23691948|NCT00892437|66250747|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
23395032|NCT03895372|65192794|FG002|Investigational Treatment Period|Adverse Event|0|||
23395033|NCT03895372|65192795|FG003|Investigational Treatment Period|Adverse Event|0|||
23395034|NCT03895372|65192796|FG004|Investigational Treatment Period|Adverse Event|0|||
23395035|NCT03895372|65192797|FG005|Investigational Treatment Period|Adverse Event|0|||
23395036|NCT03895372|65192798|FG006|Investigational Treatment Period|Adverse Event|4|||
23395037|NCT03895372|65192799|FG007|Investigational Treatment Period|Adverse Event|3|||
23395038|NCT03895372|65192792|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
23395039|NCT03895372|65192793|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
23395040|NCT03895372|65192794|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
23395041|NCT03895372|65192795|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
23691949|NCT01137435|66250748|FG000|Overall Study|Lost to Follow-up|24|||
23691950|NCT01137435|66250748|FG000|Overall Study|Off label usage|4|||
23691951|NCT00688688|66250750|FG000|Overall Study|Eligibility criterion not met|7|||
23691952|NCT00688688|66250751|FG001|Overall Study|Eligibility criterion not met|7|||
23691953|NCT00688688|66250752|FG002|Overall Study|Eligibility criterion not met|10|||
23691954|NCT00688688|66250750|FG000|Overall Study|Adverse Event|52|||
23395042|NCT03895372|65192796|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
23395043|NCT03895372|65192797|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
23395044|NCT03895372|65192798|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
23395045|NCT03895372|65192799|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
23395046|NCT03895372|65192792|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
23691955|NCT00688688|66250751|FG001|Overall Study|Adverse Event|51|||
23691956|NCT00688688|66250752|FG002|Overall Study|Adverse Event|50|||
23691957|NCT00688688|66250750|FG000|Overall Study|Lack of Efficacy|34|||
23691958|NCT00688688|66250751|FG001|Overall Study|Lack of Efficacy|25|||
23691959|NCT00688688|66250752|FG002|Overall Study|Lack of Efficacy|45|||
23691960|NCT00688688|66250750|FG000|Overall Study|Withdrawal by Subject|66|||
23691961|NCT00688688|66250751|FG001|Overall Study|Withdrawal by Subject|75|||
23691962|NCT00688688|66250752|FG002|Overall Study|Withdrawal by Subject|65|||
23691963|NCT00688688|66250750|FG000|Overall Study|Lost to Follow-up|14|||
23691964|NCT00688688|66250751|FG001|Overall Study|Lost to Follow-up|7|||
23691965|NCT00688688|66250752|FG002|Overall Study|Lost to Follow-up|7|||
23691966|NCT00688688|66250750|FG000|Overall Study|Protocol Violation|6|||
23691967|NCT00688688|66250751|FG001|Overall Study|Protocol Violation|9|||
23691968|NCT00688688|66250752|FG002|Overall Study|Protocol Violation|11|||
23691969|NCT00688688|66250750|FG000|Overall Study|Randomized but never received study drug|1|||
23691970|NCT00688688|66250751|FG001|Overall Study|Randomized but never received study drug|0|||
23691971|NCT00688688|66250752|FG002|Overall Study|Randomized but never received study drug|0|||
23691972|NCT00688688|66250750|FG000|Overall Study|Non-compliance with study procedures|5|||
23691973|NCT00688688|66250751|FG001|Overall Study|Non-compliance with study procedures|3|||
23691974|NCT00688688|66250752|FG002|Overall Study|Non-compliance with study procedures|4|||
23691975|NCT00688688|66250750|FG000|Overall Study|Taking exclusionary medications|1|||
23691976|NCT00688688|66250751|FG001|Overall Study|Taking exclusionary medications|0|||
23691977|NCT00688688|66250752|FG002|Overall Study|Taking exclusionary medications|0|||
23691978|NCT00688688|66250750|FG000|Overall Study|Site closure|0|||
23691979|NCT00688688|66250751|FG001|Overall Study|Site closure|1|||
23691980|NCT00688688|66250752|FG002|Overall Study|Site closure|0|||
23691981|NCT00688688|66250750|FG000|Overall Study|Violation of exclusion criterion|0|||
23691982|NCT00688688|66250751|FG001|Overall Study|Violation of exclusion criterion|1|||
23691983|NCT00688688|66250752|FG002|Overall Study|Violation of exclusion criterion|0|||
23691984|NCT03015532|66250753|FG000|Overall Study|Adverse Event|0|||
23691985|NCT03015532|66250754|FG001|Overall Study|Adverse Event|0|||
23691986|NCT03015532|66250755|FG002|Overall Study|Adverse Event|0|||
23691987|NCT03015532|66250756|FG003|Overall Study|Adverse Event|0|||
23691988|NCT03015532|66250757|FG004|Overall Study|Adverse Event|0|||
23691989|NCT03015532|66250758|FG005|Overall Study|Adverse Event|2|||
23691990|NCT03015532|66250759|FG006|Overall Study|Adverse Event|1|||
23691991|NCT03015532|66250760|FG007|Overall Study|Adverse Event|0|||
23691992|NCT03015532|66250753|FG000|Overall Study|Withdrawal by Subject|0|||
23691993|NCT03015532|66250754|FG001|Overall Study|Withdrawal by Subject|0|||
23691994|NCT03015532|66250755|FG002|Overall Study|Withdrawal by Subject|0|||
23691995|NCT03015532|66250756|FG003|Overall Study|Withdrawal by Subject|0|||
23395047|NCT03895372|65192793|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
23691996|NCT03015532|66250757|FG004|Overall Study|Withdrawal by Subject|0|||
23691997|NCT03015532|66250758|FG005|Overall Study|Withdrawal by Subject|0|||
23691998|NCT03015532|66250759|FG006|Overall Study|Withdrawal by Subject|1|||
23691999|NCT03015532|66250760|FG007|Overall Study|Withdrawal by Subject|0|||
23395048|NCT03895372|65192794|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
23395049|NCT03895372|65192795|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
23395050|NCT03895372|65192796|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
23692000|NCT02704429|66250761|FG000|Part A: 24 Weeks|Adverse Event|3|||
23692001|NCT02704429|66250762|FG001|Part A: 24 Weeks|Adverse Event|0|||
23692002|NCT02704429|66250761|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
23692003|NCT02704429|66250762|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
23692004|NCT01982630|66250763|FG000|Overall Study|Adverse Event|2|||
23692005|NCT01982630|66250764|FG001|Overall Study|Adverse Event|0|||
23692006|NCT01982630|66250765|FG002|Overall Study|Adverse Event|1|||
23692007|NCT01982630|66250766|FG003|Overall Study|Adverse Event|0|||
23692008|NCT01982630|66250767|FG004|Overall Study|Adverse Event|1|||
23692009|NCT01982630|66250768|FG005|Overall Study|Adverse Event|2|||
23395051|NCT03895372|65192797|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
23395052|NCT03895372|65192798|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
23692010|NCT01982630|66250769|FG006|Overall Study|Adverse Event|1|||
23692011|NCT01982630|66250770|FG007|Overall Study|Adverse Event|0|||
23692012|NCT01982630|66250763|FG000|Overall Study|Physician Decision|1|||
23692013|NCT01982630|66250764|FG001|Overall Study|Physician Decision|0|||
23692014|NCT01982630|66250765|FG002|Overall Study|Physician Decision|2|||
23692015|NCT01982630|66250766|FG003|Overall Study|Physician Decision|1|||
23692016|NCT01982630|66250767|FG004|Overall Study|Physician Decision|2|||
23692017|NCT01982630|66250768|FG005|Overall Study|Physician Decision|0|||
23395053|NCT03895372|65192799|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
23395054|NCT03895372|65192792|FG000|Investigational Treatment Period|Other|0|||
23395055|NCT03895372|65192793|FG001|Investigational Treatment Period|Other|0|||
23692018|NCT01982630|66250769|FG006|Overall Study|Physician Decision|0|||
23692019|NCT01982630|66250770|FG007|Overall Study|Physician Decision|0|||
23692020|NCT01982630|66250763|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692021|NCT01982630|66250764|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692022|NCT01982630|66250765|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
23692023|NCT01982630|66250766|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692024|NCT01982630|66250767|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692025|NCT01982630|66250768|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692026|NCT01982630|66250769|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692027|NCT01982630|66250770|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23692028|NCT01982630|66250763|FG000|Overall Study|Withdrawal by Subject|0|||
23692029|NCT01982630|66250764|FG001|Overall Study|Withdrawal by Subject|0|||
23395056|NCT03895372|65192794|FG002|Investigational Treatment Period|Other|0|||
23395057|NCT03895372|65192795|FG003|Investigational Treatment Period|Other|0|||
23395058|NCT03895372|65192796|FG004|Investigational Treatment Period|Other|0|||
23395059|NCT03895372|65192797|FG005|Investigational Treatment Period|Other|1|||
23395060|NCT03895372|65192798|FG006|Investigational Treatment Period|Other|0|||
23395061|NCT03895372|65192799|FG007|Investigational Treatment Period|Other|2|||
23395062|NCT03895372|65192792|FG000|Investigational Treatment Period|Protocol Violation|0|||
23395063|NCT03895372|65192793|FG001|Investigational Treatment Period|Protocol Violation|0|||
23692030|NCT01982630|66250765|FG002|Overall Study|Withdrawal by Subject|0|||
23692031|NCT01982630|66250766|FG003|Overall Study|Withdrawal by Subject|0|||
23692032|NCT01982630|66250767|FG004|Overall Study|Withdrawal by Subject|0|||
23692033|NCT01982630|66250768|FG005|Overall Study|Withdrawal by Subject|1|||
23692034|NCT01982630|66250769|FG006|Overall Study|Withdrawal by Subject|0|||
23692035|NCT01982630|66250770|FG007|Overall Study|Withdrawal by Subject|0|||
23692036|NCT03116113|66250771|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23692037|NCT03116113|66250772|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23692038|NCT03116113|66250773|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23395064|NCT03895372|65192794|FG002|Investigational Treatment Period|Protocol Violation|0|||
23692039|NCT03116113|66250774|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23395065|NCT03895372|65192795|FG003|Investigational Treatment Period|Protocol Violation|1|||
23395066|NCT03895372|65192796|FG004|Investigational Treatment Period|Protocol Violation|0|||
23395067|NCT03895372|65192797|FG005|Investigational Treatment Period|Protocol Violation|0|||
23395068|NCT03895372|65192798|FG006|Investigational Treatment Period|Protocol Violation|0|||
23395069|NCT03895372|65192799|FG007|Investigational Treatment Period|Protocol Violation|0|||
23395070|NCT03895372|65192792|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
23395071|NCT03895372|65192793|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
23395072|NCT03895372|65192794|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
23606341|NCT02332824|65947221|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
23606342|NCT02332824|65947216|FG000|Overall Study|Voluntary Withdrawal|1|||
23606343|NCT02332824|65947217|FG001|Overall Study|Voluntary Withdrawal|0|||
23606344|NCT02332824|65947218|FG002|Overall Study|Voluntary Withdrawal|0|||
23606345|NCT02332824|65947219|FG003|Overall Study|Voluntary Withdrawal|0|||
23606346|NCT02332824|65947220|FG004|Overall Study|Voluntary Withdrawal|0|||
23606347|NCT02332824|65947221|FG005|Overall Study|Voluntary Withdrawal|0|||
23606348|NCT02332824|65947216|FG000|Overall Study|Inconvenient schedule|1|||
23606349|NCT02332824|65947217|FG001|Overall Study|Inconvenient schedule|1|||
23606350|NCT02332824|65947218|FG002|Overall Study|Inconvenient schedule|0|||
23606351|NCT02332824|65947219|FG003|Overall Study|Inconvenient schedule|0|||
23606352|NCT02332824|65947220|FG004|Overall Study|Inconvenient schedule|0|||
23606353|NCT02332824|65947221|FG005|Overall Study|Inconvenient schedule|0|||
23606354|NCT02332824|65947216|FG000|Overall Study|Transfer|0|||
23606355|NCT02332824|65947217|FG001|Overall Study|Transfer|0|||
23606356|NCT02332824|65947218|FG002|Overall Study|Transfer|1|||
23606357|NCT02332824|65947219|FG003|Overall Study|Transfer|1|||
23606358|NCT02332824|65947220|FG004|Overall Study|Transfer|0|||
23606359|NCT02332824|65947221|FG005|Overall Study|Transfer|0|||
23606360|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
23606361|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
23606362|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Death|2|||
23606363|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
23606364|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
23606365|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
23606366|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
23606367|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Death|1|||
23606368|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
23606369|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
23606370|NCT02833948|65947223|FG000|Overall Study|Death|2|||
23606371|NCT02833948|65947224|FG001|Overall Study|Death|3|||
23606372|NCT02833948|65947223|FG000|Overall Study|were not scanned|8|||
23606373|NCT02833948|65947224|FG001|Overall Study|were not scanned|13|||
23606374|NCT02833948|65947223|FG000|Overall Study|scans could not be evaluated|5|||
23606375|NCT02833948|65947224|FG001|Overall Study|scans could not be evaluated|2|||
23606376|NCT00659373|65947232|FG000|Overall Study|Withdrawal by Subject|3|||
23606377|NCT00659373|65947233|FG001|Overall Study|Withdrawal by Subject|5|||
23606378|NCT00659373|65947232|FG000|Overall Study|Assessment Missed|2|||
23606379|NCT00659373|65947233|FG001|Overall Study|Assessment Missed|2|||
23606380|NCT02958553|65947235|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
23606381|NCT02958553|65947235|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
23606382|NCT00551421|65947236|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
23606383|NCT02309892|65947237|FG000|Overall Study|Physician Decision|1|||
23692040|NCT03116113|66250775|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23692041|NCT03116113|66250776|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23692042|NCT03116113|66250777|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23692043|NCT03116113|66250778|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
23692044|NCT03116113|66250779|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
23692045|NCT04321343|66250780|FG000|Overall Study|Adverse Event|0|||
23692046|NCT04321343|66250781|FG001|Overall Study|Adverse Event|0|||
23692047|NCT04321343|66250782|FG002|Overall Study|Adverse Event|1|||
23692048|NCT04321343|66250783|FG003|Overall Study|Adverse Event|0|||
23692049|NCT04321343|66250780|FG000|Overall Study|Death|0|||
23692050|NCT04321343|66250781|FG001|Overall Study|Death|0|||
23692051|NCT04321343|66250782|FG002|Overall Study|Death|0|||
23692052|NCT04321343|66250783|FG003|Overall Study|Death|1|||
23692053|NCT04321343|66250780|FG000|Overall Study|Pregnancy|1|||
23692054|NCT04321343|66250781|FG001|Overall Study|Pregnancy|0|||
23692055|NCT04321343|66250782|FG002|Overall Study|Pregnancy|0|||
23692056|NCT04321343|66250783|FG003|Overall Study|Pregnancy|0|||
23692057|NCT04321343|66250780|FG000|Overall Study|Protocol Violation|1|||
23692058|NCT04321343|66250781|FG001|Overall Study|Protocol Violation|1|||
23692059|NCT04321343|66250782|FG002|Overall Study|Protocol Violation|1|||
23692060|NCT04321343|66250783|FG003|Overall Study|Protocol Violation|1|||
23692061|NCT04321343|66250780|FG000|Overall Study|Withdrawal by Subject|0|||
23692062|NCT04321343|66250781|FG001|Overall Study|Withdrawal by Subject|6|||
23692063|NCT04321343|66250782|FG002|Overall Study|Withdrawal by Subject|0|||
23692064|NCT04321343|66250783|FG003|Overall Study|Withdrawal by Subject|2|||
23692065|NCT04321343|66250780|FG000|Overall Study|Lost to Follow-up|2|||
23692066|NCT04321343|66250781|FG001|Overall Study|Lost to Follow-up|2|||
23692067|NCT04321343|66250782|FG002|Overall Study|Lost to Follow-up|1|||
23692068|NCT04321343|66250783|FG003|Overall Study|Lost to Follow-up|3|||
23692069|NCT00466505|66250784|FG000|Overall Study|disease progression|13|||
23692070|NCT00466505|66250784|FG000|Overall Study|Adverse Event|4|||
23692071|NCT00473694|66250785|FG000|Overall Study|Adverse Event|0|||
23692072|NCT00473694|66250786|FG001|Overall Study|Adverse Event|1|||
23692073|NCT00473694|66250787|FG002|Overall Study|Adverse Event|0|||
23692074|NCT00473694|66250788|FG003|Overall Study|Adverse Event|0|||
23692075|NCT00473694|66250785|FG000|Overall Study|Participants did not receive treatment|11|||
23692076|NCT00473694|66250786|FG001|Overall Study|Participants did not receive treatment|3|||
23692077|NCT00473694|66250787|FG002|Overall Study|Participants did not receive treatment|5|||
23692078|NCT00473694|66250788|FG003|Overall Study|Participants did not receive treatment|6|||
23692079|NCT00473694|66250785|FG000|Overall Study|Lost to Follow-up|0|||
23692080|NCT00473694|66250786|FG001|Overall Study|Lost to Follow-up|0|||
23692081|NCT00473694|66250787|FG002|Overall Study|Lost to Follow-up|0|||
23692082|NCT00473694|66250788|FG003|Overall Study|Lost to Follow-up|1|||
23692083|NCT02717507|66250793|FG000|Overall Study|Lost to Follow-up|5|||
23692084|NCT02717507|66250794|FG001|Overall Study|Lost to Follow-up|8|||
23692085|NCT02717507|66250793|FG000|Overall Study|Pregnancy|1|||
23692086|NCT02717507|66250794|FG001|Overall Study|Pregnancy|1|||
23692087|NCT02717507|66250793|FG000|Overall Study|Protocol Violation|2|||
23692088|NCT02717507|66250794|FG001|Overall Study|Protocol Violation|2|||
23692089|NCT02717507|66250793|FG000|Overall Study|Withdrawal by Subject|20|||
23692090|NCT02717507|66250794|FG001|Overall Study|Withdrawal by Subject|20|||
23692091|NCT02717507|66250793|FG000|Overall Study|Relapse|1|||
23692092|NCT02717507|66250794|FG001|Overall Study|Relapse|1|||
23692093|NCT02717507|66250793|FG000|Overall Study|Cardiac Event|2|||
23692094|NCT02717507|66250794|FG001|Overall Study|Cardiac Event|6|||
23692095|NCT01123889|66250800|FG000|Overall Study|Lost to Follow-up|3|||
23692096|NCT01123889|66250801|FG001|Overall Study|Lost to Follow-up|1|||
23692097|NCT00195351|66250802|FG000|Overall Study|Lost to Follow-up|9|||
23692098|NCT00195351|66250803|FG001|Overall Study|Lost to Follow-up|9|||
23692099|NCT00195351|66250802|FG000|Overall Study|Withdrawal by Subject|6|||
23692100|NCT00195351|66250803|FG001|Overall Study|Withdrawal by Subject|3|||
23692101|NCT00195351|66250802|FG000|Overall Study|Protocol Deviation|3|||
23692102|NCT00195351|66250803|FG001|Overall Study|Protocol Deviation|2|||
23692103|NCT00195351|66250802|FG000|Overall Study|Death|3|||
23692104|NCT00195351|66250803|FG001|Overall Study|Death|1|||
23692105|NCT00195351|66250802|FG000|Overall Study|Lack of Efficacy|0|||
23692106|NCT00195351|66250803|FG001|Overall Study|Lack of Efficacy|1|||
23692107|NCT02498652|66250804|FG000|Overall Study|Protocol Violation|0|||
23692108|NCT02498652|66250805|FG001|Overall Study|Protocol Violation|1|||
23692109|NCT01154101|66250806|FG000|Overall Study|Adverse Event|0|||
23692110|NCT01154101|66250807|FG001|Overall Study|Adverse Event|2|||
23692111|NCT01154101|66250808|FG002|Overall Study|Adverse Event|1|||
23692112|NCT01154101|66250809|FG003|Overall Study|Adverse Event|1|||
23692113|NCT01154101|66250810|FG004|Overall Study|Adverse Event|0|||
23692114|NCT01154101|66250806|FG000|Overall Study|Lost to Follow-up|0|||
23692115|NCT01154101|66250807|FG001|Overall Study|Lost to Follow-up|1|||
23692116|NCT01154101|66250808|FG002|Overall Study|Lost to Follow-up|0|||
23692117|NCT01154101|66250809|FG003|Overall Study|Lost to Follow-up|1|||
23692118|NCT01154101|66250810|FG004|Overall Study|Lost to Follow-up|0|||
23692119|NCT01154101|66250806|FG000|Overall Study|Withdrawal by Subject|0|||
23692120|NCT01154101|66250807|FG001|Overall Study|Withdrawal by Subject|1|||
23692121|NCT01154101|66250808|FG002|Overall Study|Withdrawal by Subject|2|||
23692122|NCT01154101|66250809|FG003|Overall Study|Withdrawal by Subject|0|||
23692123|NCT01154101|66250810|FG004|Overall Study|Withdrawal by Subject|1|||
23692124|NCT03240081|66250813|FG000|Overall Study|Withdrawal by Subject|0|||
23692125|NCT03240081|66250814|FG001|Overall Study|Withdrawal by Subject|2|||
23692126|NCT03240081|66250813|FG000|Overall Study|Lost to Follow-up|0|||
23692127|NCT03240081|66250814|FG001|Overall Study|Lost to Follow-up|1|||
23692128|NCT00986349|66250818|FG000|Overall Study|Unsuccessful implant procedure|3|||
23692129|NCT00986349|66250818|FG000|Overall Study|Adverse Event|2|||
23692130|NCT00986349|66250818|FG000|Overall Study|Physician Decision|1|||
23692131|NCT00986349|66250818|FG000|Overall Study|device migration|1|||
23692132|NCT04030195|66250821|FG000|Overall Study|Withdrawal by Subject|2|||
23692133|NCT04030195|66250822|FG001|Overall Study|Withdrawal by Subject|0|||
23692134|NCT04030195|66250823|FG002|Overall Study|Withdrawal by Subject|0|||
23692135|NCT03427073|66250828|FG000|Overall Study|Disease Progression|1|||
23692136|NCT03427073|66250829|FG001|Overall Study|Disease Progression|1|||
23692137|NCT03427073|66250830|FG002|Overall Study|Disease Progression|1|||
23692138|NCT03427073|66250831|FG003|Overall Study|Disease Progression|3|||
23692139|NCT03427073|66250832|FG004|Overall Study|Disease Progression|3|||
23692140|NCT03427073|66250833|FG005|Overall Study|Disease Progression|4|||
23692141|NCT03427073|66250834|FG006|Overall Study|Disease Progression|2|||
23692142|NCT03427073|66250835|FG007|Overall Study|Disease Progression|3|||
23692143|NCT03427073|66250828|FG000|Overall Study|Physician Decision|0|||
23692144|NCT03427073|66250829|FG001|Overall Study|Physician Decision|0|||
23692145|NCT03427073|66250830|FG002|Overall Study|Physician Decision|0|||
23692146|NCT03427073|66250831|FG003|Overall Study|Physician Decision|0|||
23692147|NCT03427073|66250832|FG004|Overall Study|Physician Decision|0|||
23692148|NCT03427073|66250833|FG005|Overall Study|Physician Decision|0|||
23692149|NCT03427073|66250834|FG006|Overall Study|Physician Decision|1|||
23692150|NCT03427073|66250835|FG007|Overall Study|Physician Decision|1|||
23692151|NCT01333189|66250836|FG000|Overall Study|Time constraints|1|||
23692152|NCT01333189|66250837|FG001|Overall Study|Time constraints|0|||
23692153|NCT01333189|66250836|FG000|Overall Study|Adverse Event|1|||
23692154|NCT01333189|66250837|FG001|Overall Study|Adverse Event|0|||
23692155|NCT01333189|66250836|FG000|Overall Study|Transportation difficulties|0|||
23692156|NCT01333189|66250837|FG001|Overall Study|Transportation difficulties|1|||
23692157|NCT01333189|66250836|FG000|Overall Study|Moved from region|0|||
23692158|NCT01333189|66250837|FG001|Overall Study|Moved from region|1|||
23692159|NCT01856673|66250838|FG000|Overall Study|Withdrawal by Subject|44|||
23692160|NCT01856673|66250839|FG001|Overall Study|Withdrawal by Subject|50|||
23692161|NCT01856673|66250840|FG002|Overall Study|Withdrawal by Subject|33|||
23692162|NCT01856673|66250838|FG000|Overall Study|Lost to Follow-up|31|||
23692163|NCT01856673|66250839|FG001|Overall Study|Lost to Follow-up|34|||
23692164|NCT01856673|66250840|FG002|Overall Study|Lost to Follow-up|0|||
23692165|NCT01856673|66250838|FG000|Overall Study|Unknown reasons|9|||
23692166|NCT01856673|66250839|FG001|Overall Study|Unknown reasons|0|||
23692167|NCT01856673|66250840|FG002|Overall Study|Unknown reasons|0|||
23692168|NCT01856673|66250838|FG000|Overall Study|Psychologist decision|1|||
23692169|NCT01856673|66250839|FG001|Overall Study|Psychologist decision|0|||
23692170|NCT01856673|66250840|FG002|Overall Study|Psychologist decision|0|||
23692171|NCT01856673|66250838|FG000|Overall Study|Paperwork errors|8|||
23692172|NCT01856673|66250839|FG001|Overall Study|Paperwork errors|0|||
23692173|NCT01856673|66250840|FG002|Overall Study|Paperwork errors|0|||
23692174|NCT01856673|66250838|FG000|Overall Study|Death|1|||
23692175|NCT01856673|66250839|FG001|Overall Study|Death|1|||
23692176|NCT01856673|66250840|FG002|Overall Study|Death|0|||
23692177|NCT01856673|66250838|FG000|Overall Study|Protocol Violation|1|||
23692178|NCT01856673|66250839|FG001|Overall Study|Protocol Violation|0|||
23692179|NCT01856673|66250840|FG002|Overall Study|Protocol Violation|1|||
23692180|NCT02732951|66250841|FG000|Overall Study|Other than listed|1|||
23692181|NCT02732951|66250842|FG001|Overall Study|Other than listed|0|||
23692182|NCT02732951|66250841|FG000|Overall Study|Lost to Follow-up|0|||
23692183|NCT02732951|66250842|FG001|Overall Study|Lost to Follow-up|1|||
23692184|NCT02732951|66250841|FG000|Overall Study|Adverse Event|4|||
23692185|NCT02732951|66250842|FG001|Overall Study|Adverse Event|4|||
23692186|NCT02732951|66250841|FG000|Overall Study|Protocol Violation|0|||
23692187|NCT02732951|66250842|FG001|Overall Study|Protocol Violation|1|||
23692188|NCT01937312|66250843|FG000|Overall Study|Adverse Event|10|||
23692189|NCT01937312|66250844|FG001|Overall Study|Adverse Event|1|||
23692190|NCT01937312|66250843|FG000|Overall Study|Lack of Efficacy|0|||
23692191|NCT01937312|66250844|FG001|Overall Study|Lack of Efficacy|1|||
23692192|NCT01937312|66250843|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
23692193|NCT01937312|66250844|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
23692194|NCT00826748|66250850|FG000|Overall Study|Withdrawal by Subject|0|||
23692195|NCT00826748|66250851|FG001|Overall Study|Withdrawal by Subject|0|||
23692196|NCT00826748|66250852|FG002|Overall Study|Withdrawal by Subject|2|||
23692197|NCT00826748|66250850|FG000|Overall Study|Physician Decision|0|||
23692198|NCT00826748|66250851|FG001|Overall Study|Physician Decision|0|||
23692199|NCT00826748|66250852|FG002|Overall Study|Physician Decision|1|||
23692200|NCT00826748|66250850|FG000|Overall Study|Samples Did Not pass QC|0|||
23692201|NCT00826748|66250851|FG001|Overall Study|Samples Did Not pass QC|0|||
23692202|NCT00826748|66250852|FG002|Overall Study|Samples Did Not pass QC|1|||
23692203|NCT01193335|66250855|FG000|After Infant Series|Lost to Follow-up|1|||
23692204|NCT01193335|66250856|FG001|After Infant Series|Lost to Follow-up|2|||
23692205|NCT01193335|66250855|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
23692206|NCT01193335|66250856|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
23692207|NCT01193335|66250855|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
23692208|NCT01193335|66250856|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
23692209|NCT01193335|66250855|FG000|1-Year Follow-up|Lost to Follow-up|4|||
23692210|NCT01193335|66250856|FG001|1-Year Follow-up|Lost to Follow-up|0|||
23395073|NCT03895372|65192795|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
23395074|NCT03895372|65192796|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
23395075|NCT03895372|65192797|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
23692211|NCT01193335|66250855|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
23692212|NCT01193335|66250856|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
23692213|NCT01193335|66250855|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
23692214|NCT01193335|66250856|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
23692215|NCT02698410|66250861|FG000|Overall Study|Adverse Event|2|||
23692216|NCT02698410|66250861|FG000|Overall Study|Withdrawal by Subject|1|||
23692217|NCT02698410|66250861|FG000|Overall Study|Other|1|||
23692218|NCT00942409|66250863|FG000|Overall Study|Lack of Efficacy|1|||
23692219|NCT00942409|66250863|FG000|Overall Study|study drug unavailable|2|||
23692220|NCT01440101|66250864|FG000|Overall Study|Adverse Event|2|||
23692221|NCT01440101|66250865|FG001|Overall Study|Adverse Event|0|||
23692222|NCT01440101|66250866|FG002|Overall Study|Adverse Event|0|||
23692223|NCT01440101|66250864|FG000|Overall Study|Withdrawal by Subject|0|||
23692224|NCT01440101|66250865|FG001|Overall Study|Withdrawal by Subject|3|||
23692225|NCT01440101|66250866|FG002|Overall Study|Withdrawal by Subject|1|||
23692226|NCT01440101|66250864|FG000|Overall Study|Other|0|||
23692227|NCT01440101|66250865|FG001|Overall Study|Other|1|||
23692228|NCT01440101|66250866|FG002|Overall Study|Other|0|||
23692229|NCT00659438|66250869|FG000|Overall Study|Withdrawal by Subject|2|||
23692230|NCT00659438|66250870|FG001|Overall Study|Withdrawal by Subject|2|||
23692231|NCT00659438|66250869|FG000|Overall Study|Death|11|||
23692232|NCT00659438|66250870|FG001|Overall Study|Death|6|||
23692233|NCT00659438|66250869|FG000|Overall Study|Lost to Follow-up|1|||
23692234|NCT00659438|66250870|FG001|Overall Study|Lost to Follow-up|0|||
23692235|NCT02500550|66250877|FG000|Overall Study|Death|7|||
23692236|NCT03065530|66250879|FG000|Overall Study|Lack of Efficacy|1|||
23692237|NCT03065530|66250880|FG001|Overall Study|Lack of Efficacy|1|||
23692238|NCT03065530|66250881|FG002|Overall Study|Lack of Efficacy|0|||
23692239|NCT03065530|66250882|FG003|Overall Study|Lack of Efficacy|1|||
23692240|NCT03065530|66250879|FG000|Overall Study|Protocol Violation|1|||
23692241|NCT03065530|66250880|FG001|Overall Study|Protocol Violation|0|||
23692242|NCT03065530|66250881|FG002|Overall Study|Protocol Violation|1|||
23692243|NCT03065530|66250882|FG003|Overall Study|Protocol Violation|1|||
23692244|NCT02032524|66250888|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
23692245|NCT02032524|66250889|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
23692246|NCT02032524|66250890|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
23692247|NCT02032524|66250891|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
23692248|NCT02032524|66250892|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
23692249|NCT02032524|66250893|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
23692250|NCT02032524|66250888|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23692251|NCT02032524|66250889|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23692252|NCT02032524|66250890|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23692253|NCT02032524|66250891|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
23692254|NCT02032524|66250892|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23692255|NCT02032524|66250893|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
23692256|NCT02032524|66250888|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
23692257|NCT02032524|66250889|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
23692258|NCT02032524|66250890|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
23692259|NCT02032524|66250891|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
23692260|NCT02032524|66250892|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
23692261|NCT02032524|66250893|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
23692262|NCT02032524|66250888|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23692263|NCT02032524|66250889|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
23692264|NCT02032524|66250890|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23692265|NCT02032524|66250891|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23692266|NCT02032524|66250892|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
23692267|NCT02032524|66250893|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23692268|NCT02032524|66250888|FG000|Period 2: LTS13769 Study|Other|0|||
23692269|NCT02032524|66250889|FG001|Period 2: LTS13769 Study|Other|0|||
23692270|NCT02032524|66250890|FG002|Period 2: LTS13769 Study|Other|0|||
23692271|NCT02032524|66250891|FG003|Period 2: LTS13769 Study|Other|0|||
23692272|NCT02032524|66250892|FG004|Period 2: LTS13769 Study|Other|0|||
23692273|NCT02032524|66250893|FG005|Period 2: LTS13769 Study|Other|1|||
23692274|NCT03075839|66250894|FG000|Overall Study|Lost to Follow-up|4|||
23692275|NCT03853694|66250895|FG000|Overall Study|Protocol Violation|3|||
23692276|NCT03853694|66250896|FG001|Overall Study|Protocol Violation|5|||
23692277|NCT03853694|66250897|FG002|Overall Study|Protocol Violation|3|||
23692278|NCT03853694|66250895|FG000|Overall Study|Delivered early|0|||
23692279|NCT03853694|66250896|FG001|Overall Study|Delivered early|1|||
23692280|NCT03853694|66250897|FG002|Overall Study|Delivered early|0|||
23692281|NCT03853694|66250895|FG000|Overall Study|not suitable to proceed|0|||
23692282|NCT03853694|66250896|FG001|Overall Study|not suitable to proceed|1|||
23692283|NCT03853694|66250897|FG002|Overall Study|not suitable to proceed|0|||
23692284|NCT03853694|66250895|FG000|Overall Study|difficult surgery|0|||
23692285|NCT03853694|66250896|FG001|Overall Study|difficult surgery|0|||
23692286|NCT03853694|66250897|FG002|Overall Study|difficult surgery|1|||
23692287|NCT03853694|66250895|FG000|Overall Study|Lost to Follow-up|0|||
23692288|NCT03853694|66250896|FG001|Overall Study|Lost to Follow-up|1|||
23395076|NCT03895372|65192798|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
23395077|NCT03895372|65192799|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
23395078|NCT03895372|65192792|FG000|Extension Treatment Period|Adverse Event|0|||
23395079|NCT03895372|65192793|FG001|Extension Treatment Period|Adverse Event|1|||
23395080|NCT03895372|65192794|FG002|Extension Treatment Period|Adverse Event|0|||
23395081|NCT03895372|65192795|FG003|Extension Treatment Period|Adverse Event|1|||
23395082|NCT03895372|65192796|FG004|Extension Treatment Period|Adverse Event|0|||
23395083|NCT03895372|65192797|FG005|Extension Treatment Period|Adverse Event|0|||
23395084|NCT03895372|65192798|FG006|Extension Treatment Period|Adverse Event|3|||
23395085|NCT03895372|65192799|FG007|Extension Treatment Period|Adverse Event|3|||
23395086|NCT03895372|65192792|FG000|Extension Treatment Period|Other|1|||
23395087|NCT03895372|65192793|FG001|Extension Treatment Period|Other|3|||
23395088|NCT03895372|65192794|FG002|Extension Treatment Period|Other|0|||
23395089|NCT03895372|65192795|FG003|Extension Treatment Period|Other|0|||
23395090|NCT03895372|65192796|FG004|Extension Treatment Period|Other|1|||
23395091|NCT03895372|65192797|FG005|Extension Treatment Period|Other|0|||
23395092|NCT03895372|65192798|FG006|Extension Treatment Period|Other|0|||
23395093|NCT03895372|65192799|FG007|Extension Treatment Period|Other|2|||
23395094|NCT03895372|65192792|FG000|Extension Treatment Period|Pregnancy|0|||
23395095|NCT03895372|65192793|FG001|Extension Treatment Period|Pregnancy|0|||
23395096|NCT03895372|65192794|FG002|Extension Treatment Period|Pregnancy|0|||
23395097|NCT03895372|65192795|FG003|Extension Treatment Period|Pregnancy|0|||
23395098|NCT03895372|65192796|FG004|Extension Treatment Period|Pregnancy|1|||
23395099|NCT03895372|65192797|FG005|Extension Treatment Period|Pregnancy|0|||
23395100|NCT03895372|65192798|FG006|Extension Treatment Period|Pregnancy|0|||
23395101|NCT03895372|65192799|FG007|Extension Treatment Period|Pregnancy|0|||
23395102|NCT03895372|65192792|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
23395103|NCT03895372|65192793|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
23395104|NCT03895372|65192794|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23395105|NCT03895372|65192795|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
23395106|NCT03895372|65192796|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
23395107|NCT03895372|65192797|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
23395108|NCT03895372|65192798|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
23395109|NCT03895372|65192799|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
23692289|NCT03853694|66250897|FG002|Overall Study|Lost to Follow-up|0|||
23395110|NCT02989857|65192801|FG000|Randomization Phase|Not Treated|3|||
23692290|NCT03853694|66250895|FG000|Overall Study|Withdrawal by Subject|0|||
23692291|NCT03853694|66250896|FG001|Overall Study|Withdrawal by Subject|1|||
23692292|NCT03853694|66250897|FG002|Overall Study|Withdrawal by Subject|0|||
23692293|NCT00742781|66250898|FG000|Overall Study|Withdrawal by Subject|3|||
23692294|NCT00630032|66250899|FG000|Overall Study|Death|55|||
23395111|NCT02989857|65192802|FG001|Randomization Phase|Not Treated|2|||
23498533|NCT04066023|65566358|FG000|Overall Study|Lost to Follow-up|0|||
23692295|NCT00630032|66250900|FG001|Overall Study|Death|49|||
23692296|NCT00630032|66250899|FG000|Overall Study|Withdrawal by Subject|3|||
23692297|NCT00630032|66250900|FG001|Overall Study|Withdrawal by Subject|2|||
23692298|NCT00630032|66250899|FG000|Overall Study|Lost to Follow-up|18|||
23692299|NCT00630032|66250900|FG001|Overall Study|Lost to Follow-up|31|||
23692300|NCT00630032|66250899|FG000|Overall Study|Protocol Violation|1|||
23692301|NCT00630032|66250900|FG001|Overall Study|Protocol Violation|0|||
23692302|NCT00630032|66250899|FG000|Overall Study|Patient has moved|1|||
23395112|NCT02989857|65192803|FG002|Randomization Phase|Not Treated|0|||
23395113|NCT03552029|65192804|FG000|Overall Study|Death|3|||
23395114|NCT03552029|65192805|FG001|Overall Study|Death|0|||
23692303|NCT00630032|66250900|FG001|Overall Study|Patient has moved|1|||
23692304|NCT00630032|66250899|FG000|Overall Study|Disease progression|1|||
23692305|NCT00630032|66250900|FG001|Overall Study|Disease progression|1|||
23692306|NCT00630032|66250899|FG000|Overall Study|End of monitoring in US centers|11|||
23692307|NCT00630032|66250900|FG001|Overall Study|End of monitoring in US centers|11|||
23692308|NCT00488631|66250901|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
23692309|NCT00488631|66250902|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
23692310|NCT00488631|66250903|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
23692311|NCT00488631|66250904|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
23692312|NCT00488631|66250905|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
23692313|NCT00488631|66250906|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
23692314|NCT00488631|66250907|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
23692315|NCT00488631|66250908|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
23692316|NCT00488631|66250909|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
23692317|NCT00488631|66250910|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
23692318|NCT00488631|66250901|FG000|Double Blind Period (Week 0-54)|Death|0|||
23692319|NCT00488631|66250902|FG001|Double Blind Period (Week 0-54)|Death|0|||
23692320|NCT00488631|66250903|FG002|Double Blind Period (Week 0-54)|Death|0|||
23692321|NCT00488631|66250904|FG003|Double Blind Period (Week 0-54)|Death|0|||
23692322|NCT00488631|66250905|FG004|Double Blind Period (Week 0-54)|Death|0|||
23692323|NCT00488631|66250906|FG005|Double Blind Period (Week 0-54)|Death|1|||
23692324|NCT00488631|66250907|FG006|Double Blind Period (Week 0-54)|Death|0|||
23692325|NCT00488631|66250908|FG007|Double Blind Period (Week 0-54)|Death|0|||
23692326|NCT00488631|66250909|FG008|Double Blind Period (Week 0-54)|Death|0|||
23692327|NCT00488631|66250910|FG009|Double Blind Period (Week 0-54)|Death|0|||
23692328|NCT00488631|66250901|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
23692329|NCT00488631|66250902|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
23692330|NCT00488631|66250903|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
23692331|NCT00488631|66250904|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
23395115|NCT03552029|65192804|FG000|Overall Study|Adverse Event|1|||
23498534|NCT04066023|65566359|FG001|Overall Study|Lost to Follow-up|1|||
23692332|NCT00488631|66250905|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
23692333|NCT00488631|66250906|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
23692334|NCT00488631|66250907|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23692335|NCT00488631|66250908|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23692336|NCT00488631|66250909|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23692337|NCT00488631|66250910|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23692338|NCT00488631|66250901|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
23692339|NCT00488631|66250902|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
23692340|NCT00488631|66250903|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
23692341|NCT00488631|66250904|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23692342|NCT00488631|66250905|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
23692343|NCT00488631|66250906|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
23692344|NCT00488631|66250907|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23692345|NCT00488631|66250908|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23692346|NCT00488631|66250909|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23692347|NCT00488631|66250910|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23692348|NCT00488631|66250901|FG000|Double Blind Period (Week 0-54)|Other|6|||
23692349|NCT00488631|66250902|FG001|Double Blind Period (Week 0-54)|Other|12|||
23692350|NCT00488631|66250903|FG002|Double Blind Period (Week 0-54)|Other|10|||
23692351|NCT00488631|66250904|FG003|Double Blind Period (Week 0-54)|Other|11|||
23692352|NCT00488631|66250905|FG004|Double Blind Period (Week 0-54)|Other|14|||
23692353|NCT00488631|66250906|FG005|Double Blind Period (Week 0-54)|Other|34|||
23692354|NCT00488631|66250907|FG006|Double Blind Period (Week 0-54)|Other|0|||
23692355|NCT00488631|66250908|FG007|Double Blind Period (Week 0-54)|Other|0|||
23692356|NCT00488631|66250909|FG008|Double Blind Period (Week 0-54)|Other|0|||
23692357|NCT00488631|66250910|FG009|Double Blind Period (Week 0-54)|Other|0|||
23692358|NCT00488631|66250901|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692359|NCT00488631|66250902|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692360|NCT00488631|66250903|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692361|NCT00488631|66250904|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692362|NCT00488631|66250905|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692363|NCT00488631|66250906|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692364|NCT00488631|66250907|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
23692365|NCT00488631|66250908|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
23692366|NCT00488631|66250909|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
23692367|NCT00488631|66250910|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23692368|NCT00488631|66250901|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
23692369|NCT00488631|66250902|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
23692370|NCT00488631|66250903|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
23692371|NCT00488631|66250904|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
23692372|NCT00488631|66250905|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
23692373|NCT00488631|66250906|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
23692374|NCT00488631|66250907|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
23692375|NCT00488631|66250908|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
23692376|NCT00488631|66250909|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
23692377|NCT00488631|66250910|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
23692378|NCT00488631|66250901|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23692379|NCT00488631|66250902|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23692380|NCT00488631|66250903|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23692381|NCT00488631|66250904|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23692382|NCT00488631|66250905|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23692383|NCT00488631|66250906|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23395116|NCT03552029|65192805|FG001|Overall Study|Adverse Event|0|||
23395117|NCT03552029|65192804|FG000|Overall Study|Lack of Efficacy|0|||
23692384|NCT00488631|66250907|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
23692385|NCT00488631|66250908|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
23692386|NCT00488631|66250909|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
23395118|NCT03552029|65192805|FG001|Overall Study|Lack of Efficacy|2|||
23395119|NCT03552029|65192804|FG000|Overall Study|Physician Decision|0|||
23395120|NCT03552029|65192805|FG001|Overall Study|Physician Decision|1|||
23395121|NCT03552029|65192804|FG000|Overall Study|Study terminated by Sponsor|0|||
23395122|NCT03552029|65192805|FG001|Overall Study|Study terminated by Sponsor|1|||
23395123|NCT03552029|65192804|FG000|Overall Study|Other|0|||
23692387|NCT00488631|66250910|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
23395124|NCT03552029|65192805|FG001|Overall Study|Other|2|||
23395125|NCT00829244|65192806|FG000|Overall Study|Adverse Event|1|||
23395126|NCT00829244|65192807|FG001|Overall Study|Adverse Event|3|||
23395127|NCT00829244|65192806|FG000|Overall Study|Protocol Violation|1|||
23395128|NCT00829244|65192807|FG001|Overall Study|Protocol Violation|0|||
23395129|NCT00829244|65192806|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
23395130|NCT00829244|65192807|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
23395131|NCT00829244|65192806|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
23395132|NCT00829244|65192807|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
23395133|NCT00829244|65192806|FG000|Overall Study|No fertilization|2|||
23395134|NCT00829244|65192807|FG001|Overall Study|No fertilization|2|||
23395135|NCT00829244|65192806|FG000|Overall Study|All embryos discarded|0|||
23395136|NCT00829244|65192807|FG001|Overall Study|All embryos discarded|3|||
23395137|NCT00829244|65192806|FG000|Overall Study|No embryo cleavage|0|||
23395138|NCT00829244|65192807|FG001|Overall Study|No embryo cleavage|2|||
23395139|NCT00105066|65192816|FG000|Overall Study|Adverse Event|2|||
23395140|NCT00105066|65192817|FG001|Overall Study|Adverse Event|5|||
23395141|NCT00936936|65192818|FG000|Overall Study|Adverse Event|7|||
23395142|NCT00936936|65192819|FG001|Overall Study|Adverse Event|1|||
23395143|NCT00936936|65192818|FG000|Overall Study|Disease Progression|2|||
23395144|NCT00936936|65192819|FG001|Overall Study|Disease Progression|2|||
23395145|NCT00936936|65192818|FG000|Overall Study|Unrelated|3|||
23395146|NCT00936936|65192819|FG001|Overall Study|Unrelated|1|||
23395147|NCT02213926|65192822|FG000|Overall Study|Death|59|||
23395148|NCT02213926|65192822|FG000|Overall Study|Withdrawal by Subject|10|||
23395149|NCT02213926|65192822|FG000|Overall Study|study terminated by sponsor|51|||
23395150|NCT02213926|65192822|FG000|Overall Study|Lost to Follow-up|3|||
23395151|NCT02213926|65192822|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
23395152|NCT04016714|65192825|FG000|Overall Study|Death|1|||
23395153|NCT04016714|65192826|FG001|Overall Study|Death|0|||
23395154|NCT04016714|65192825|FG000|Overall Study|Lost to Follow-up|3|||
23395155|NCT04016714|65192826|FG001|Overall Study|Lost to Follow-up|1|||
23395156|NCT04016714|65192825|FG000|Overall Study|Physician Decision|3|||
23395157|NCT04016714|65192826|FG001|Overall Study|Physician Decision|3|||
23395158|NCT04016714|65192825|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
23395159|NCT04016714|65192826|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
23395160|NCT00381641|65192827|FG000|Overall Study|Withdrawal by Subject|0|||
23395161|NCT00381641|65192828|FG001|Overall Study|Withdrawal by Subject|2|||
23395162|NCT00835172|65192832|FG000|Washout|Protocol Violation|0|||
23395163|NCT00835172|65192833|FG001|Washout|Protocol Violation|1|||
23395164|NCT00618787|65192836|FG000|Overall Study|Adverse Event|0|||
23395165|NCT00618787|65192837|FG001|Overall Study|Adverse Event|1|||
23395166|NCT00618787|65192836|FG000|Overall Study|Withdrawal by Subject|2|||
23395167|NCT00618787|65192837|FG001|Overall Study|Withdrawal by Subject|1|||
23395168|NCT00618787|65192836|FG000|Overall Study|Lost to Follow-up|1|||
23395169|NCT00618787|65192837|FG001|Overall Study|Lost to Follow-up|0|||
23395170|NCT03802916|65192841|FG000|Overall Study|Adverse Event|0|||
23395171|NCT03802916|65192842|FG001|Overall Study|Adverse Event|1|||
23395172|NCT03802916|65192841|FG000|Overall Study|Withdrawal by Subject|0|||
23395173|NCT03802916|65192842|FG001|Overall Study|Withdrawal by Subject|1|||
23395174|NCT00457626|65192849|FG000|Overall Study|Adverse Event|3|||
23395175|NCT00457626|65192849|FG000|Overall Study|Administrative Problems|2|||
23498535|NCT04066023|65566360|FG002|Overall Study|Lost to Follow-up|1|||
23692388|NCT00488631|66250901|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692389|NCT00488631|66250902|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692390|NCT00488631|66250903|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692391|NCT00488631|66250904|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692392|NCT00488631|66250905|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692393|NCT00488631|66250906|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692394|NCT00488631|66250907|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
23692395|NCT00488631|66250908|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23692396|NCT00488631|66250909|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
23692397|NCT00488631|66250910|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23395176|NCT00457626|65192849|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
23395177|NCT00652834|65192850|FG000|Overall Study|Withdrawal by Subject|3|||
23395178|NCT00652834|65192850|FG000|Overall Study|Lost to Follow-up|2|||
23395179|NCT03685149|65192852|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
23395180|NCT03685149|65192853|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
23395181|NCT03685149|65192852|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23395182|NCT03685149|65192853|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23395183|NCT03685149|65192852|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
23395184|NCT03685149|65192853|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
23395185|NCT02374255|65192854|FG000|Overall Study|Withdrawal by Subject|2|||
23395186|NCT02374255|65192855|FG001|Overall Study|Withdrawal by Subject|0|||
23395187|NCT02374255|65192856|FG002|Overall Study|Withdrawal by Subject|0|||
23395188|NCT02374255|65192857|FG003|Overall Study|Withdrawal by Subject|0|||
23498536|NCT04066023|65566358|FG000|Overall Study|Noncompliance|0|||
23395189|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Adverse Event|6|||
23395190|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Adverse Event|15|||
23692398|NCT00488631|66250901|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692399|NCT00488631|66250902|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692400|NCT00488631|66250903|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692401|NCT00488631|66250904|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692402|NCT00488631|66250905|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692403|NCT00488631|66250906|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23692404|NCT00488631|66250907|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
23692405|NCT00488631|66250908|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
23692406|NCT00488631|66250909|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
23692407|NCT00488631|66250910|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23395191|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Adverse Event|0|||
23395192|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Death|0|||
23395193|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Death|2|||
23395194|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Death|0|||
23395195|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
23395196|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
23395197|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
23395198|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
23395199|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
23395200|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
23395201|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Physician Decision|1|||
23395202|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Physician Decision|1|||
23395203|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Physician Decision|0|||
23395204|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
23395205|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
23395206|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
23395207|NCT02921256|65192863|FG000|Arm Ib v Arm III|Adverse Event|9|||
23395208|NCT02921256|65192864|FG001|Arm Ib v Arm III|Adverse Event|0|||
23395209|NCT02921256|65192865|FG002|Arm Ib v Arm III|Adverse Event|4|||
23395210|NCT02921256|65192863|FG000|Arm Ib v Arm III|Death|1|||
23395211|NCT02921256|65192864|FG001|Arm Ib v Arm III|Death|0|||
23395212|NCT02921256|65192865|FG002|Arm Ib v Arm III|Death|1|||
23395213|NCT02921256|65192863|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
23395214|NCT02921256|65192864|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
23692408|NCT01564784|66250911|FG000|Overall Study|Other|1|||
23692409|NCT01564784|66250912|FG001|Overall Study|Other|0|||
23692410|NCT01564784|66250911|FG000|Overall Study|Subject refused further follow-up|1|||
23692411|NCT01564784|66250912|FG001|Overall Study|Subject refused further follow-up|6|||
23692412|NCT01564784|66250911|FG000|Overall Study|Lost to Follow-up|1|||
23692413|NCT01564784|66250912|FG001|Overall Study|Lost to Follow-up|1|||
23692414|NCT01564784|66250911|FG000|Overall Study|Death|131|||
23692415|NCT01564784|66250912|FG001|Overall Study|Death|126|||
23692416|NCT00075881|66250916|FG000|Overall Study|Lack of Efficacy|18|||
23692417|NCT00075881|66250916|FG000|Overall Study|Adverse Event|7|||
23692418|NCT00075881|66250916|FG000|Overall Study|Death|1|||
23692419|NCT00075881|66250916|FG000|Overall Study|Withdrawal by Subject|2|||
23692420|NCT00075881|66250916|FG000|Overall Study|Protocol Violation|4|||
23692421|NCT00075881|66250916|FG000|Overall Study|other complicating disease|3|||
23692422|NCT00075881|66250916|FG000|Overall Study|other|4|||
23692423|NCT00075881|66250916|FG000|Overall Study|missing data|2|||
23692424|NCT00075881|66250916|FG000|Overall Study|Ineligible|1|||
23692425|NCT00075881|66250916|FG000|Overall Study|never start protocol therapy|1|||
23692426|NCT01073943|66250925|FG000|Overall Study|Withdrawal by Subject|8|||
23692427|NCT01073943|66250926|FG001|Overall Study|Withdrawal by Subject|2|||
23692428|NCT01073943|66250925|FG000|Overall Study|Protocol Violation|2|||
23692429|NCT01073943|66250926|FG001|Overall Study|Protocol Violation|1|||
23395215|NCT02921256|65192865|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
23395216|NCT02921256|65192863|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
23395217|NCT02921256|65192864|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
23395218|NCT02921256|65192865|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
23395219|NCT02921256|65192863|FG000|Arm Ib v Arm III|Physician Decision|4|||
23395220|NCT02921256|65192864|FG001|Arm Ib v Arm III|Physician Decision|0|||
23395221|NCT02921256|65192865|FG002|Arm Ib v Arm III|Physician Decision|1|||
23692430|NCT01073943|66250925|FG000|Overall Study|Adverse Event|1|||
23692431|NCT01073943|66250926|FG001|Overall Study|Adverse Event|1|||
23395222|NCT02921256|65192863|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
23395223|NCT02921256|65192864|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
23395224|NCT02921256|65192865|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
23395225|NCT02014376|65192866|FG000|Overall Study|Adverse Event|1|||
23395226|NCT02014376|65192867|FG001|Overall Study|Adverse Event|1|||
23395227|NCT02014376|65192868|FG002|Overall Study|Adverse Event|0|||
23395228|NCT02014376|65192866|FG000|Overall Study|Lost to Follow-up|2|||
23395229|NCT02014376|65192867|FG001|Overall Study|Lost to Follow-up|0|||
23692432|NCT01073943|66250925|FG000|Overall Study|Lost to Follow-up|0|||
23692433|NCT01073943|66250926|FG001|Overall Study|Lost to Follow-up|2|||
23692434|NCT01073943|66250925|FG000|Overall Study|Power outage; colonoscopy not done|1|||
23692435|NCT01073943|66250926|FG001|Overall Study|Power outage; colonoscopy not done|0|||
23692436|NCT01073943|66250925|FG000|Overall Study|Subject forgot|0|||
23692437|NCT01073943|66250926|FG001|Overall Study|Subject forgot|1|||
23692438|NCT01073943|66250925|FG000|Overall Study|Unable to return for follow-up|0|||
23692439|NCT01073943|66250926|FG001|Overall Study|Unable to return for follow-up|1|||
23692440|NCT01073943|66250925|FG000|Overall Study|Could not tolerate prep|1|||
23692441|NCT01073943|66250926|FG001|Overall Study|Could not tolerate prep|0|||
23692442|NCT03263806|66250929|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
23692443|NCT03263806|66250930|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
23692444|NCT03263806|66250929|FG000|Overall Study|Withdrawal by Subject|0|||
23692445|NCT03263806|66250930|FG001|Overall Study|Withdrawal by Subject|1|||
23692446|NCT03263806|66250929|FG000|Overall Study|Study Termination|5|||
23692447|NCT03263806|66250930|FG001|Overall Study|Study Termination|6|||
23692448|NCT05502289|66250931|FG000|Period 1|Out Of Window|1|||
23692449|NCT05502289|66250932|FG001|Period 1|Out Of Window|0|||
23692450|NCT00775021|66250935|FG000|First Intervention|Lost to Follow-up|1|||
23692451|NCT00775021|66250936|FG001|First Intervention|Lost to Follow-up|0|||
23692452|NCT00775021|66250935|FG000|Second Intervention|Adverse Event|0|||
23692453|NCT00775021|66250936|FG001|Second Intervention|Adverse Event|1|||
23692454|NCT01697345|66250937|FG000|Overall Study|Withdrawal by Subject|1|||
23692455|NCT02649634|66250938|FG000|Overall Study|Withdrawal by Subject|3|||
23692456|NCT02649634|66250939|FG001|Overall Study|Withdrawal by Subject|5|||
23692457|NCT02649634|66250938|FG000|Overall Study|Lost to Follow-up|0|||
23692458|NCT02649634|66250939|FG001|Overall Study|Lost to Follow-up|1|||
23692459|NCT04112914|66250940|FG000|Overall Study|Lost to Follow-up|13|||
23692460|NCT04112914|66250941|FG001|Overall Study|Lost to Follow-up|9|||
23692461|NCT04112914|66250940|FG000|Overall Study|Withdrawal by Subject|1|||
23692462|NCT04112914|66250941|FG001|Overall Study|Withdrawal by Subject|0|||
23692463|NCT03022461|66250942|FG000|Overall Study|Death|3|||
23692464|NCT01682044|66250943|FG000|Overall Study|Death|1|||
23692465|NCT01682044|66250943|FG000|Overall Study|Progression|3|||
23692466|NCT02900092|66250944|FG000|Overall Study|Adverse Event|1|||
23692467|NCT02088034|66250945|FG000|Overall Study|Lost to Follow-up|1|||
23692468|NCT02088034|66250946|FG001|Overall Study|Lost to Follow-up|1|||
23692469|NCT02088034|66250947|FG002|Overall Study|Lost to Follow-up|0|||
23692470|NCT02088034|66250945|FG000|Overall Study|Pregnancy|2|||
23692471|NCT02088034|66250946|FG001|Overall Study|Pregnancy|1|||
23692472|NCT02088034|66250947|FG002|Overall Study|Pregnancy|2|||
23692473|NCT00587223|66250948|FG000|Overall Study|Adverse Event|1|||
23692474|NCT00609609|66250950|FG000|Overall Study|Withdrawal by Subject|2|||
23692475|NCT00609609|66250951|FG001|Overall Study|Withdrawal by Subject|0|||
23692476|NCT00609609|66250950|FG000|Overall Study|Progression|4|||
23692477|NCT00609609|66250951|FG001|Overall Study|Progression|2|||
23692478|NCT02240706|66250952|FG000|Overall Study|Lack of Efficacy|2|||
23692479|NCT02240706|66250953|FG001|Overall Study|Lack of Efficacy|2|||
23692480|NCT02240706|66250954|FG002|Overall Study|Lack of Efficacy|2|||
23692481|NCT02240706|66250955|FG003|Overall Study|Lack of Efficacy|2|||
23692482|NCT02240706|66250956|FG004|Overall Study|Lack of Efficacy|5|||
23692483|NCT02240706|66250957|FG005|Overall Study|Lack of Efficacy|0|||
23692484|NCT02240706|66250958|FG006|Overall Study|Lack of Efficacy|0|||
23395230|NCT02014376|65192868|FG002|Overall Study|Lost to Follow-up|0|||
23395231|NCT00829998|65192872|FG000|Washout|Adverse Event|0|||
23395232|NCT00829998|65192873|FG001|Washout|Adverse Event|1|||
23395233|NCT03360344|65192874|FG000|Overall Study|Withdrawal by Subject|0|||
23395234|NCT03360344|65192875|FG001|Overall Study|Withdrawal by Subject|1|||
23395235|NCT03360344|65192876|FG002|Overall Study|Withdrawal by Subject|1|||
23395236|NCT01107886|65195577|FG000|Overall Study|Lost to Follow-up|15|||
23395237|NCT01107886|65195578|FG001|Overall Study|Lost to Follow-up|13|||
23395238|NCT01107886|65195577|FG000|Overall Study|Withdrawal by Subject|180|||
23395239|NCT01107886|65195578|FG001|Overall Study|Withdrawal by Subject|196|||
23395240|NCT01107886|65195577|FG000|Overall Study|Administrative withdrawal of consent|7|||
23395241|NCT01107886|65195578|FG001|Overall Study|Administrative withdrawal of consent|5|||
23692485|NCT02240706|66250952|FG000|Overall Study|Adverse Event|1|||
23692486|NCT02240706|66250953|FG001|Overall Study|Adverse Event|0|||
23692487|NCT02240706|66250954|FG002|Overall Study|Adverse Event|1|||
23692488|NCT02240706|66250955|FG003|Overall Study|Adverse Event|0|||
23692489|NCT02240706|66250956|FG004|Overall Study|Adverse Event|2|||
23692490|NCT02240706|66250957|FG005|Overall Study|Adverse Event|0|||
23692491|NCT02240706|66250958|FG006|Overall Study|Adverse Event|0|||
23692492|NCT02240706|66250952|FG000|Overall Study|Progressive disease|0|||
23395242|NCT04507204|65195582|FG000|Overall Study|Adverse Event|8|||
23395243|NCT04507204|65195583|FG001|Overall Study|Adverse Event|13|||
23692493|NCT02240706|66250953|FG001|Overall Study|Progressive disease|0|||
23692494|NCT02240706|66250954|FG002|Overall Study|Progressive disease|0|||
23395244|NCT04507204|65195582|FG000|Overall Study|Death|0|||
23395245|NCT04507204|65195583|FG001|Overall Study|Death|1|||
23692495|NCT02240706|66250955|FG003|Overall Study|Progressive disease|0|||
23692496|NCT02240706|66250956|FG004|Overall Study|Progressive disease|1|||
23692497|NCT02240706|66250957|FG005|Overall Study|Progressive disease|0|||
23692498|NCT02240706|66250958|FG006|Overall Study|Progressive disease|0|||
23692499|NCT02240706|66250952|FG000|Overall Study|Dose limiting toxicity|0|||
23692500|NCT02240706|66250953|FG001|Overall Study|Dose limiting toxicity|0|||
23692501|NCT02240706|66250954|FG002|Overall Study|Dose limiting toxicity|0|||
23692502|NCT02240706|66250955|FG003|Overall Study|Dose limiting toxicity|0|||
23692503|NCT02240706|66250956|FG004|Overall Study|Dose limiting toxicity|1|||
23692504|NCT02240706|66250957|FG005|Overall Study|Dose limiting toxicity|0|||
23692505|NCT02240706|66250958|FG006|Overall Study|Dose limiting toxicity|0|||
23692506|NCT02240706|66250952|FG000|Overall Study|Refused to continue taking medication|0|||
23692507|NCT02240706|66250953|FG001|Overall Study|Refused to continue taking medication|1|||
23692508|NCT02240706|66250954|FG002|Overall Study|Refused to continue taking medication|3|||
23692509|NCT02240706|66250955|FG003|Overall Study|Refused to continue taking medication|1|||
23692510|NCT02240706|66250956|FG004|Overall Study|Refused to continue taking medication|2|||
23692511|NCT02240706|66250957|FG005|Overall Study|Refused to continue taking medication|0|||
23692512|NCT02240706|66250958|FG006|Overall Study|Refused to continue taking medication|0|||
23692513|NCT02240706|66250952|FG000|Overall Study|Insurance billing concerns|0|||
23692514|NCT02240706|66250953|FG001|Overall Study|Insurance billing concerns|0|||
23692515|NCT02240706|66250954|FG002|Overall Study|Insurance billing concerns|0|||
23692516|NCT02240706|66250955|FG003|Overall Study|Insurance billing concerns|1|||
23692517|NCT02240706|66250956|FG004|Overall Study|Insurance billing concerns|0|||
23692518|NCT02240706|66250957|FG005|Overall Study|Insurance billing concerns|0|||
23692519|NCT02240706|66250958|FG006|Overall Study|Insurance billing concerns|0|||
23692520|NCT03926143|66250959|FG000|Overall Study|Physician Decision|3|||
23692521|NCT03926143|66250959|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
23692522|NCT03926143|66250959|FG000|Overall Study|Adverse Event|2|||
23692523|NCT03926143|66250959|FG000|Overall Study|Progressive disease|3|||
23692524|NCT00200057|66250960|FG000|Overall Study|Lack of Efficacy|3|||
23692525|NCT00200057|66250960|FG000|Overall Study|Exited due to terminal illness of PI|2|||
23692526|NCT00200057|66250960|FG000|Overall Study|Withdrawal by Subject|1|||
23692527|NCT00200057|66250960|FG000|Overall Study|Change in medical condition|1|||
23692528|NCT00200057|66250960|FG000|Overall Study|Infection|1|||
23692529|NCT00200057|66250960|FG000|Overall Study|Death|1|||
23692530|NCT01295125|66250961|FG000|Overall Study|Study stopped prematurely|9|||
23692531|NCT03301857|66250962|FG000|Overall Study|Death|0|||
23692532|NCT03301857|66250963|FG001|Overall Study|Death|2|||
23692533|NCT03301857|66250962|FG000|Overall Study|Lost to Follow-up|4|||
23692534|NCT03301857|66250963|FG001|Overall Study|Lost to Follow-up|2|||
23692535|NCT03301857|66250962|FG000|Overall Study|Decision by Sponsor|6|||
23692536|NCT03301857|66250963|FG001|Overall Study|Decision by Sponsor|0|||
23692537|NCT03301857|66250962|FG000|Overall Study|Withdrawal by Subject|12|||
23692538|NCT03301857|66250963|FG001|Overall Study|Withdrawal by Subject|4|||
23692539|NCT03312218|66250964|FG000|Overall Study|Never signed in to access the app|54|||
23692540|NCT03312218|66250965|FG001|Overall Study|Never signed in to access the app|58|||
23692541|NCT05408858|66250966|FG000|Overall Study|no longer met eligibility criteria|1|||
23692542|NCT01733329|66250972|FG000|Overall Study|Protocol Violation|1|||
23692543|NCT01733329|66250973|FG001|Overall Study|Protocol Violation|1|||
23692544|NCT01733329|66250972|FG000|Overall Study|Uterine artery injury|1|||
23692545|NCT01733329|66250973|FG001|Overall Study|Uterine artery injury|0|||
23692546|NCT03633331|66250974|FG000|Overall Study|Withdrawal by Subject|1|||
23692547|NCT01122927|66250975|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
23692548|NCT01122927|66250976|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
23692549|NCT01122927|66250975|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
23692550|NCT01122927|66250976|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23692551|NCT01122927|66250975|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
23692552|NCT01122927|66250976|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
23692553|NCT01122927|66250975|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
23692554|NCT01122927|66250976|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23692555|NCT01122927|66250975|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
23692556|NCT01122927|66250976|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
23692557|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
23692558|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
23692559|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
23692560|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
23692561|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
23692562|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
23692563|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
23692564|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
23692565|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
23692566|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
23395246|NCT04507204|65195582|FG000|Overall Study|Lost to Follow-up|15|||
23395247|NCT04507204|65195583|FG001|Overall Study|Lost to Follow-up|14|||
23395248|NCT04507204|65195582|FG000|Overall Study|Poor Compliance with Protocol|2|||
23395249|NCT04507204|65195583|FG001|Overall Study|Poor Compliance with Protocol|4|||
23395250|NCT04507204|65195582|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
23395251|NCT04507204|65195583|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
23395252|NCT04507204|65195582|FG000|Overall Study|Withdrawal of Patient Consent|21|||
23395253|NCT04507204|65195583|FG001|Overall Study|Withdrawal of Patient Consent|13|||
23395254|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
23395255|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395256|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395257|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395258|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395259|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395260|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395261|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
23395262|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
23395263|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
23395264|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
23395265|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
23395266|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
23395267|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
23692567|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
23692568|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
23692569|NCT01122927|66250975|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
23692570|NCT01122927|66250976|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
23395268|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
23395269|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
23395270|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
23395271|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
23395272|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
23395273|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
23395274|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
23395275|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
23395276|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
23395277|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
23395278|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
23395279|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
23395280|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
23395281|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
23395282|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
23395283|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
23395284|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
23395285|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
23395286|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
23395287|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
23395288|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
23395289|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
23395290|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
23395291|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
23395292|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
23395293|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
23395294|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
23395295|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
23395296|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
23395297|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395298|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395299|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395300|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395301|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395302|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395303|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395304|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
23395305|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395306|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23498537|NCT04066023|65566359|FG001|Overall Study|Noncompliance|1|||
23498538|NCT04066023|65566360|FG002|Overall Study|Noncompliance|1|||
23498539|NCT01313858|65566361|FG000|Overall Study|Premature Treatment Termination|251|||
23498540|NCT01313858|65566362|FG001|Overall Study|Premature Treatment Termination|219|||
23692571|NCT02868892|66250977|FG000|Overall Study|Investigator left site and no follow-up|6|||
23692572|NCT03716726|66250978|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
23692573|NCT03716726|66250979|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
23692574|NCT03716726|66250978|FG000|12 Months Followup|Lost to Follow-up|10|||
23692575|NCT03716726|66250979|FG001|12 Months Followup|Lost to Follow-up|17|||
23692576|NCT02209766|66250981|FG000|Overall Study|Withdrawal by Subject|0|||
23692577|NCT02209766|66250982|FG001|Overall Study|Withdrawal by Subject|0|||
23692578|NCT02209766|66250983|FG002|Overall Study|Withdrawal by Subject|0|||
23692579|NCT02209766|66250984|FG003|Overall Study|Withdrawal by Subject|1|||
23692580|NCT02209766|66250985|FG004|Overall Study|Withdrawal by Subject|0|||
23692581|NCT02579603|66250986|FG000|Overall Study|Not treated|1|||
23692582|NCT02579603|66250987|FG001|Overall Study|Not treated|0|||
23692583|NCT02579603|66250986|FG000|Overall Study|Adverse Event|2|||
23692584|NCT02579603|66250987|FG001|Overall Study|Adverse Event|2|||
23692585|NCT02579603|66250986|FG000|Overall Study|Other than stated|1|||
23692586|NCT02579603|66250987|FG001|Overall Study|Other than stated|0|||
23692587|NCT03401749|66250988|FG000|Overall Study|Lost to Follow-up|20|||
23692588|NCT03401749|66250989|FG001|Overall Study|Lost to Follow-up|16|||
23692589|NCT03401749|66250990|FG002|Overall Study|Lost to Follow-up|26|||
23692590|NCT01173653|66250991|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
23692591|NCT01173653|66250992|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
23692592|NCT01076179|66250993|FG000|Overall Study|Withdrawal by Subject|1|||
23692593|NCT03019549|66250997|FG000|Washout|DId not meet genotype criteria|11|||
23692594|NCT03019549|66250997|FG000|Period 2|Adverse Event|2|||
23692595|NCT03019549|66250997|FG000|Period 2|Physician Decision|2|||
23692596|NCT03019549|66250997|FG000|Period 2|Withdrawal by Subject|1|||
23692597|NCT00561353|66251000|FG000|Overall Study|Subject reached a virologic endpoint|2|||
23692598|NCT00561353|66251001|FG001|Overall Study|Subject reached a virologic endpoint|1|||
23692599|NCT00561353|66251002|FG002|Overall Study|Subject reached a virologic endpoint|1|||
23692600|NCT00561353|66251003|FG003|Overall Study|Subject reached a virologic endpoint|4|||
23692601|NCT00561353|66251004|FG004|Overall Study|Subject reached a virologic endpoint|1|||
23692602|NCT00561353|66251005|FG005|Overall Study|Subject reached a virologic endpoint|3|||
23692603|NCT00561353|66251006|FG006|Overall Study|Subject reached a virologic endpoint|4|||
23692604|NCT00561353|66251007|FG007|Overall Study|Subject reached a virologic endpoint|4|||
23692605|NCT00561353|66251008|FG008|Overall Study|Subject reached a virologic endpoint|5|||
23692606|NCT00561353|66251009|FG009|Overall Study|Subject reached a virologic endpoint|0|||
23692607|NCT00561353|66251000|FG000|Overall Study|Subject ineligible to continue the trial|0|||
23692608|NCT00561353|66251001|FG001|Overall Study|Subject ineligible to continue the trial|0|||
23692609|NCT00561353|66251002|FG002|Overall Study|Subject ineligible to continue the trial|0|||
23692610|NCT00561353|66251003|FG003|Overall Study|Subject ineligible to continue the trial|0|||
23692611|NCT00561353|66251004|FG004|Overall Study|Subject ineligible to continue the trial|0|||
23692612|NCT00561353|66251005|FG005|Overall Study|Subject ineligible to continue the trial|1|||
23692613|NCT00561353|66251006|FG006|Overall Study|Subject ineligible to continue the trial|1|||
23692614|NCT00561353|66251007|FG007|Overall Study|Subject ineligible to continue the trial|0|||
23692615|NCT00561353|66251008|FG008|Overall Study|Subject ineligible to continue the trial|2|||
23692616|NCT00561353|66251009|FG009|Overall Study|Subject ineligible to continue the trial|1|||
23692617|NCT00561353|66251000|FG000|Overall Study|Other|1|||
23692618|NCT00561353|66251001|FG001|Overall Study|Other|0|||
23692619|NCT00561353|66251002|FG002|Overall Study|Other|1|||
23692620|NCT00561353|66251003|FG003|Overall Study|Other|0|||
23692621|NCT00561353|66251004|FG004|Overall Study|Other|0|||
23692622|NCT00561353|66251005|FG005|Overall Study|Other|2|||
23395307|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395308|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395309|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395310|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Death on study|0|||
23395311|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Death on study|0|||
23395312|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Death on study|0|||
23395313|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Death on study|1|||
23395314|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Death on study|0|||
23395315|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Death on study|0|||
23395316|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Death on study|0|||
23395317|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
23395318|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
23395319|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
23498541|NCT01313858|65566363|FG002|Overall Study|Premature Treatment Termination|191|||
23498542|NCT01313858|65566361|FG000|Overall Study|Lost to Follow-up|35|||
23692623|NCT00561353|66251006|FG006|Overall Study|Other|0|||
23692624|NCT00561353|66251007|FG007|Overall Study|Other|0|||
23692625|NCT00561353|66251008|FG008|Overall Study|Other|0|||
23692626|NCT00561353|66251009|FG009|Overall Study|Other|0|||
23692627|NCT00561353|66251000|FG000|Overall Study|Adverse Event|0|||
23692628|NCT00561353|66251001|FG001|Overall Study|Adverse Event|0|||
23692629|NCT00561353|66251002|FG002|Overall Study|Adverse Event|0|||
23692630|NCT00561353|66251003|FG003|Overall Study|Adverse Event|2|||
23692631|NCT00561353|66251004|FG004|Overall Study|Adverse Event|0|||
23692632|NCT00561353|66251005|FG005|Overall Study|Adverse Event|0|||
23692633|NCT00561353|66251006|FG006|Overall Study|Adverse Event|1|||
23692634|NCT00561353|66251007|FG007|Overall Study|Adverse Event|0|||
23692635|NCT00561353|66251008|FG008|Overall Study|Adverse Event|0|||
23692636|NCT00561353|66251009|FG009|Overall Study|Adverse Event|1|||
23692637|NCT00561353|66251000|FG000|Overall Study|Lost to Follow-up|2|||
23692638|NCT00561353|66251001|FG001|Overall Study|Lost to Follow-up|0|||
23692639|NCT00561353|66251002|FG002|Overall Study|Lost to Follow-up|1|||
23692640|NCT00561353|66251003|FG003|Overall Study|Lost to Follow-up|0|||
23692641|NCT00561353|66251004|FG004|Overall Study|Lost to Follow-up|0|||
23692642|NCT00561353|66251005|FG005|Overall Study|Lost to Follow-up|0|||
23692643|NCT00561353|66251006|FG006|Overall Study|Lost to Follow-up|0|||
23692644|NCT00561353|66251007|FG007|Overall Study|Lost to Follow-up|0|||
23692645|NCT00561353|66251008|FG008|Overall Study|Lost to Follow-up|0|||
23692646|NCT00561353|66251009|FG009|Overall Study|Lost to Follow-up|0|||
23692647|NCT00561353|66251000|FG000|Overall Study|Withdrawal by Subject|0|||
23692648|NCT00561353|66251001|FG001|Overall Study|Withdrawal by Subject|2|||
23692649|NCT00561353|66251002|FG002|Overall Study|Withdrawal by Subject|0|||
23692650|NCT00561353|66251003|FG003|Overall Study|Withdrawal by Subject|0|||
23692651|NCT00561353|66251004|FG004|Overall Study|Withdrawal by Subject|0|||
23692652|NCT00561353|66251005|FG005|Overall Study|Withdrawal by Subject|0|||
23692653|NCT00561353|66251006|FG006|Overall Study|Withdrawal by Subject|0|||
23692654|NCT00561353|66251007|FG007|Overall Study|Withdrawal by Subject|0|||
23692655|NCT00561353|66251008|FG008|Overall Study|Withdrawal by Subject|0|||
23692656|NCT00561353|66251009|FG009|Overall Study|Withdrawal by Subject|0|||
23692657|NCT01938625|66251013|FG000|Overall Study|Withdrawal by Subject|0|||
23692658|NCT01938625|66251014|FG001|Overall Study|Withdrawal by Subject|1|||
23692659|NCT01938625|66251013|FG000|Overall Study|Adverse Event|0|||
23692660|NCT01938625|66251014|FG001|Overall Study|Adverse Event|1|||
23692661|NCT02582515|66251020|FG000|Overall Study|Withdrawal by Subject|0|||
23692662|NCT02582515|66251021|FG001|Overall Study|Withdrawal by Subject|1|||
23692663|NCT03815175|66251022|FG000|Overall Study|Subject Lost to Follow-up|6|||
23692664|NCT03815175|66251022|FG000|Overall Study|Subject Withdrew Consent|48|||
23692665|NCT03815175|66251022|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
23692666|NCT03815175|66251022|FG000|Overall Study|Death|86|||
23692667|NCT03815175|66251022|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
23692668|NCT03815175|66251022|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
23692669|NCT03815175|66251022|FG000|Overall Study|Other Status Change Reason|1|||
23692670|NCT03815175|66251022|FG000|Overall Study|Missed Visit|12|||
23692671|NCT01719757|66251023|FG000|Overall Study|Adverse Event|38|||
23692672|NCT01719757|66251023|FG000|Overall Study|Withdrawal by Subject|15|||
23692673|NCT01719757|66251023|FG000|Overall Study|Lost to Follow-up|20|||
23692674|NCT01719757|66251023|FG000|Overall Study|Protocol Violation|1|||
23692675|NCT01719757|66251023|FG000|Overall Study|well controlled pain|27|||
23692676|NCT01773473|66251027|FG000|Overall Study|Adverse Event|3|||
23692677|NCT01773473|66251028|FG001|Overall Study|Adverse Event|2|||
23692678|NCT01773473|66251027|FG000|Overall Study|Protocol Violation|0|||
23692679|NCT01773473|66251028|FG001|Overall Study|Protocol Violation|4|||
23692680|NCT01773473|66251027|FG000|Overall Study|Physician Decision|3|||
23692681|NCT01773473|66251028|FG001|Overall Study|Physician Decision|5|||
23692682|NCT01773473|66251027|FG000|Overall Study|Sponsor Decision|2|||
23692683|NCT01773473|66251028|FG001|Overall Study|Sponsor Decision|0|||
23692684|NCT01773473|66251027|FG000|Overall Study|Lack of Efficacy|0|||
23692685|NCT01773473|66251028|FG001|Overall Study|Lack of Efficacy|1|||
23692686|NCT01773473|66251027|FG000|Overall Study|Non-Compliance with study drug|1|||
23692687|NCT01773473|66251028|FG001|Overall Study|Non-Compliance with study drug|4|||
23692688|NCT01773473|66251027|FG000|Overall Study|Withdrawal by Subject|5|||
23692689|NCT01773473|66251028|FG001|Overall Study|Withdrawal by Subject|3|||
23692690|NCT01773473|66251027|FG000|Overall Study|Lost to Follow-up|2|||
23692691|NCT01773473|66251028|FG001|Overall Study|Lost to Follow-up|0|||
23692692|NCT01241786|66251029|FG000|Overall Study|Lack of Efficacy|5|||
23692693|NCT00023322|66251030|FG000|Overall Study|Lost to Follow-up|1|||
23692694|NCT01750918|66251031|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
23692695|NCT01750918|66251032|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
23692696|NCT01750918|66251033|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
23692697|NCT01750918|66251034|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
23692698|NCT01750918|66251035|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
23692699|NCT01750918|66251036|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
23692700|NCT01750918|66251037|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
23692701|NCT01750918|66251038|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
23692702|NCT01750918|66251031|FG000|Overall Study|Lost to Follow-up|0|||
23692703|NCT01750918|66251032|FG001|Overall Study|Lost to Follow-up|0|||
23395320|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
23395321|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
23395322|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
23395323|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
23395324|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395325|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395326|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395327|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395328|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
23395329|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395330|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395331|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
23395332|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
23395333|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
23395334|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
23395335|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
23395336|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
23395337|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
23395338|NCT00688740|65195594|FG000|Overall Study|Adverse Event|45|||
23395339|NCT00688740|65195595|FG001|Overall Study|Adverse Event|8|||
23395340|NCT00688740|65195594|FG000|Overall Study|Death|2|||
23395341|NCT00688740|65195595|FG001|Overall Study|Death|2|||
23395342|NCT00688740|65195594|FG000|Overall Study|Lost to Follow-up|0|||
23395343|NCT00688740|65195595|FG001|Overall Study|Lost to Follow-up|1|||
23395344|NCT00688740|65195594|FG000|Overall Study|Consent Withdrawn|17|||
23395345|NCT00688740|65195595|FG001|Overall Study|Consent Withdrawn|17|||
23395346|NCT00688740|65195594|FG000|Overall Study|Breast Cancer Relapse|1|||
23395347|NCT00688740|65195595|FG001|Overall Study|Breast Cancer Relapse|4|||
23395348|NCT00688740|65195594|FG000|Overall Study|Violation of Inclusion Criteria|1|||
23395349|NCT00688740|65195595|FG001|Overall Study|Violation of Inclusion Criteria|3|||
23395350|NCT01121757|65195596|FG000|First Drug|Death|1|||
23395351|NCT01121757|65195597|FG001|First Drug|Death|0|||
23395352|NCT01121757|65195596|FG000|First Drug|Disease Progression|0|||
23395353|NCT01121757|65195597|FG001|First Drug|Disease Progression|2|||
23395354|NCT01121757|65195596|FG000|Combination|Physician Decision|0|||
23395355|NCT01121757|65195597|FG001|Combination|Physician Decision|1|||
23395356|NCT01121757|65195596|FG000|Combination|Disease Progression|2|||
23395357|NCT01121757|65195597|FG001|Combination|Disease Progression|0|||
23395358|NCT00163189|65195599|FG000|Overall Study|Other|6|||
23395359|NCT00163189|65195599|FG000|Overall Study|Lost to Follow-up|1|||
23395360|NCT00163189|65195599|FG000|Overall Study|Protocol Violation|2|||
23395361|NCT00163189|65195599|FG000|Overall Study|Death|3|||
23395362|NCT00163189|65195599|FG000|Overall Study|Adverse Event|6|||
23395363|NCT00163189|65195599|FG000|Overall Study|Lack of Efficacy|7|||
23395364|NCT00163189|65195599|FG000|Overall Study|Study terminated by sponsor|11|||
23395365|NCT00163189|65195599|FG000|Overall Study|Withdrawal by Subject|11|||
23395366|NCT00163189|65195599|FG000|Overall Study|Did not meet continuation criterion|16|||
23395367|NCT02629861|65195601|FG000|Overall Study|Adverse Event|7|||
23692704|NCT01750918|66251033|FG002|Overall Study|Lost to Follow-up|2|||
23692705|NCT01750918|66251034|FG003|Overall Study|Lost to Follow-up|2|||
23692706|NCT01750918|66251035|FG004|Overall Study|Lost to Follow-up|0|||
23692707|NCT01750918|66251036|FG005|Overall Study|Lost to Follow-up|0|||
23692708|NCT01750918|66251037|FG006|Overall Study|Lost to Follow-up|0|||
23692709|NCT01750918|66251038|FG007|Overall Study|Lost to Follow-up|1|||
23692710|NCT01750918|66251031|FG000|Overall Study|Withdrawal by Subject|0|||
23692711|NCT01750918|66251032|FG001|Overall Study|Withdrawal by Subject|0|||
23395368|NCT02629861|65195602|FG001|Overall Study|Adverse Event|5|||
23395369|NCT02629861|65195603|FG002|Overall Study|Adverse Event|4|||
23395370|NCT02629861|65195601|FG000|Overall Study|Withdrawal by Subject|5|||
23395371|NCT02629861|65195602|FG001|Overall Study|Withdrawal by Subject|8|||
23395372|NCT02629861|65195603|FG002|Overall Study|Withdrawal by Subject|13|||
23395373|NCT02629861|65195601|FG000|Overall Study|Protocol Violation|2|||
23395374|NCT02629861|65195602|FG001|Overall Study|Protocol Violation|3|||
23395375|NCT02629861|65195603|FG002|Overall Study|Protocol Violation|7|||
23692712|NCT01750918|66251033|FG002|Overall Study|Withdrawal by Subject|1|||
23692713|NCT01750918|66251034|FG003|Overall Study|Withdrawal by Subject|2|||
23395376|NCT02629861|65195601|FG000|Overall Study|Lost to Follow-up|12|||
23395377|NCT02629861|65195602|FG001|Overall Study|Lost to Follow-up|9|||
23395378|NCT02629861|65195603|FG002|Overall Study|Lost to Follow-up|4|||
23395379|NCT02629861|65195601|FG000|Overall Study|Other|1|||
23395380|NCT02629861|65195602|FG001|Overall Study|Other|1|||
23395381|NCT02629861|65195603|FG002|Overall Study|Other|0|||
23395382|NCT02629861|65195601|FG000|Overall Study|Pregnancy|2|||
23395383|NCT02629861|65195602|FG001|Overall Study|Pregnancy|1|||
23395384|NCT02629861|65195603|FG002|Overall Study|Pregnancy|0|||
23395385|NCT02546323|65195611|FG000|Overall Study|Withdrawal by Subject|36|||
23692714|NCT01750918|66251035|FG004|Overall Study|Withdrawal by Subject|1|||
23395386|NCT02546323|65195612|FG001|Overall Study|Withdrawal by Subject|33|||
23395387|NCT02546323|65195611|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
23395388|NCT02546323|65195612|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
23395389|NCT02546323|65195611|FG000|Overall Study|Adverse Event|17|||
23395390|NCT02546323|65195612|FG001|Overall Study|Adverse Event|11|||
23395391|NCT02546323|65195611|FG000|Overall Study|Patient Specific Reasons|1|||
23395392|NCT02546323|65195612|FG001|Overall Study|Patient Specific Reasons|2|||
23395393|NCT02546323|65195611|FG000|Overall Study|Lost to Follow-up|2|||
23395394|NCT02546323|65195612|FG001|Overall Study|Lost to Follow-up|3|||
23395395|NCT02546323|65195611|FG000|Overall Study|Non-compliance with Study Drug|2|||
23395396|NCT02546323|65195612|FG001|Overall Study|Non-compliance with Study Drug|2|||
23395397|NCT02546323|65195611|FG000|Overall Study|Met Withdrawal Criteria|2|||
23395398|NCT02546323|65195612|FG001|Overall Study|Met Withdrawal Criteria|14|||
23395399|NCT02993263|65195615|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
23395400|NCT00567502|65195616|FG000|Overall Study|Lost to Follow-up|91|||
23395401|NCT00567502|65195617|FG001|Overall Study|Lost to Follow-up|14|||
23395402|NCT00567502|65195618|FG002|Overall Study|Lost to Follow-up|351|||
23395403|NCT00567502|65195619|FG003|Overall Study|Lost to Follow-up|2|||
23395404|NCT00567502|65195616|FG000|Overall Study|Death|65|||
23395405|NCT00567502|65195617|FG001|Overall Study|Death|16|||
23395406|NCT00567502|65195618|FG002|Overall Study|Death|360|||
23395407|NCT00567502|65195619|FG003|Overall Study|Death|5|||
23395408|NCT00567502|65195616|FG000|Overall Study|Other|64|||
23395409|NCT00567502|65195617|FG001|Overall Study|Other|2|||
23395410|NCT00567502|65195618|FG002|Overall Study|Other|134|||
23395411|NCT00567502|65195619|FG003|Overall Study|Other|6|||
23395412|NCT00567502|65195616|FG000|Overall Study|Participant request|12|||
23395413|NCT00567502|65195617|FG001|Overall Study|Participant request|1|||
23395414|NCT00567502|65195618|FG002|Overall Study|Participant request|33|||
23395415|NCT00567502|65195619|FG003|Overall Study|Participant request|1|||
23395416|NCT00567502|65195616|FG000|Overall Study|Sponsor request|9|||
23395417|NCT00567502|65195617|FG001|Overall Study|Sponsor request|0|||
23395418|NCT00567502|65195618|FG002|Overall Study|Sponsor request|30|||
23395419|NCT00567502|65195619|FG003|Overall Study|Sponsor request|1|||
23395420|NCT00567502|65195616|FG000|Overall Study|Never Initiated Treatment|0|||
23395421|NCT00567502|65195617|FG001|Overall Study|Never Initiated Treatment|0|||
23395422|NCT00567502|65195618|FG002|Overall Study|Never Initiated Treatment|0|||
23395423|NCT00567502|65195619|FG003|Overall Study|Never Initiated Treatment|72|||
23395424|NCT01148771|65195620|FG000|Washout Period|Withdrawal by Subject|0|||
23395425|NCT01148771|65195621|FG001|Washout Period|Withdrawal by Subject|1|||
23395426|NCT03122184|65195622|FG000|Overall Study|Lost to Follow-up|4|||
23395427|NCT03122184|65195623|FG001|Overall Study|Lost to Follow-up|6|||
23395428|NCT03122184|65195622|FG000|Overall Study|Withdrawal by Subject|3|||
23395429|NCT03122184|65195623|FG001|Overall Study|Withdrawal by Subject|0|||
23395430|NCT03122184|65195622|FG000|Overall Study|Terminated due to cognitive problem|1|||
23395431|NCT03122184|65195623|FG001|Overall Study|Terminated due to cognitive problem|0|||
23395432|NCT00404248|65195624|FG000|Overall Study|pts declining status|0|||
23395433|NCT00404248|65195625|FG001|Overall Study|pts declining status|1|||
23395434|NCT00404248|65195626|FG002|Overall Study|pts declining status|0|||
23395435|NCT00404248|65195627|FG003|Overall Study|pts declining status|0|||
23395436|NCT00404248|65195628|FG004|Overall Study|pts declining status|0|||
23395437|NCT00404248|65195629|FG005|Overall Study|pts declining status|0|||
23395438|NCT00404248|65195630|FG006|Overall Study|pts declining status|0|||
23395439|NCT00404248|65195631|FG007|Overall Study|pts declining status|0|||
23395440|NCT00404248|65195632|FG008|Overall Study|pts declining status|0|||
23395441|NCT03391882|65195635|FG000|Study Overall|Adverse Event|3|||
23395442|NCT03391882|65195636|FG001|Study Overall|Adverse Event|6|||
23692715|NCT01750918|66251036|FG005|Overall Study|Withdrawal by Subject|1|||
23692716|NCT01750918|66251037|FG006|Overall Study|Withdrawal by Subject|2|||
23692717|NCT01750918|66251038|FG007|Overall Study|Withdrawal by Subject|2|||
23692718|NCT02468193|66251040|FG000|Overall Study|Adverse Event|4|||
23395443|NCT03391882|65195637|FG002|Study Overall|Adverse Event|1|||
23395444|NCT03391882|65195638|FG003|Study Overall|Adverse Event|1|||
23395445|NCT03391882|65195639|FG004|Study Overall|Adverse Event|3|||
23395446|NCT03391882|65195640|FG005|Study Overall|Adverse Event|1|||
23395447|NCT03391882|65195635|FG000|Study Overall|Lack of Efficacy|13|||
23395448|NCT03391882|65195636|FG001|Study Overall|Lack of Efficacy|9|||
23395449|NCT03391882|65195637|FG002|Study Overall|Lack of Efficacy|0|||
23395450|NCT03391882|65195638|FG003|Study Overall|Lack of Efficacy|0|||
23395451|NCT03391882|65195639|FG004|Study Overall|Lack of Efficacy|0|||
23395452|NCT03391882|65195640|FG005|Study Overall|Lack of Efficacy|0|||
23395453|NCT03391882|65195635|FG000|Study Overall|Withdrawal by Subject|3|||
23692719|NCT02468193|66251040|FG000|Overall Study|Subject/ Guardian decision|2|||
23395454|NCT03391882|65195636|FG001|Study Overall|Withdrawal by Subject|3|||
23395455|NCT03391882|65195637|FG002|Study Overall|Withdrawal by Subject|2|||
23395456|NCT03391882|65195638|FG003|Study Overall|Withdrawal by Subject|2|||
23395457|NCT03391882|65195639|FG004|Study Overall|Withdrawal by Subject|1|||
23395458|NCT03391882|65195640|FG005|Study Overall|Withdrawal by Subject|3|||
23692720|NCT02111369|66251041|FG000|Overall Study|Lost to Follow-up|2|||
23692721|NCT02111369|66251041|FG000|Overall Study|Withdrawal by Subject|1|||
23692722|NCT04285723|66251045|FG000|Overall Study|Subject decision|1|||
23692723|NCT04285723|66251046|FG001|Overall Study|Subject decision|2|||
23692724|NCT04285723|66251045|FG000|Overall Study|Physician Decision|1|||
23692725|NCT04285723|66251046|FG001|Overall Study|Physician Decision|0|||
23692726|NCT04285723|66251045|FG000|Overall Study|No efficiency|1|||
23692727|NCT04285723|66251046|FG001|Overall Study|No efficiency|0|||
23692728|NCT03040024|66254249|FG000|Overall Study|Adverse Event|0|||
23692729|NCT03040024|66254250|FG001|Overall Study|Adverse Event|1|||
23692730|NCT03040024|66254251|FG002|Overall Study|Adverse Event|0|||
23692731|NCT03040024|66254249|FG000|Overall Study|Death|0|||
23692732|NCT03040024|66254250|FG001|Overall Study|Death|1|||
23692733|NCT03040024|66254251|FG002|Overall Study|Death|0|||
23692734|NCT03040024|66254249|FG000|Overall Study|Physician Decision|0|||
23692735|NCT03040024|66254250|FG001|Overall Study|Physician Decision|0|||
23692736|NCT03040024|66254251|FG002|Overall Study|Physician Decision|1|||
23692737|NCT01531725|66254252|FG000|Overall Study|Protocol Violation|5|||
23692738|NCT01826214|66254257|FG000|Overall Study|Adverse Event|7|||
23692739|NCT01826214|66254258|FG001|Overall Study|Adverse Event|6|||
23692740|NCT01826214|66254257|FG000|Overall Study|Death|3|||
23692741|NCT01826214|66254258|FG001|Overall Study|Death|1|||
23692742|NCT01826214|66254257|FG000|Overall Study|Lost to Follow-up|1|||
23692743|NCT01826214|66254258|FG001|Overall Study|Lost to Follow-up|0|||
23692744|NCT01826214|66254257|FG000|Overall Study|Physician Decision|0|||
23692745|NCT01826214|66254258|FG001|Overall Study|Physician Decision|2|||
23692746|NCT01826214|66254257|FG000|Overall Study|Progressive disease|22|||
23692747|NCT01826214|66254258|FG001|Overall Study|Progressive disease|21|||
23692748|NCT01826214|66254257|FG000|Overall Study|Study terminated by Sponsor|0|||
23692749|NCT01826214|66254258|FG001|Overall Study|Study terminated by Sponsor|1|||
23692750|NCT01826214|66254257|FG000|Overall Study|Subject/guardian decision|2|||
23692751|NCT01826214|66254258|FG001|Overall Study|Subject/guardian decision|3|||
23395459|NCT03391882|65195635|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23498543|NCT01313858|65566362|FG001|Overall Study|Lost to Follow-up|51|||
23498544|NCT01313858|65566363|FG002|Overall Study|Lost to Follow-up|47|||
23692752|NCT00844883|66254262|FG000|Overall Study|Bridged to liver transplant|3|||
23692753|NCT00844883|66254262|FG000|Overall Study|Bridged to resection|1|||
23692754|NCT00840463|66254270|FG000|Overall Study|Adverse Event|1|||
23692755|NCT00840463|66254271|FG001|Overall Study|Adverse Event|0|||
23692756|NCT00847613|66254272|FG000|Overall Study|Ongoing at cut-off date|250|||
23692757|NCT00847613|66254273|FG001|Overall Study|Ongoing at cut-off date|265|||
23692758|NCT00847613|66254274|FG002|Overall Study|Ongoing at cut-off date|64|||
23692759|NCT00847613|66254275|FG003|Overall Study|Ongoing at cut-off date|64|||
23692760|NCT00847613|66254272|FG000|Overall Study|Death|1|||
23692761|NCT00847613|66254273|FG001|Overall Study|Death|1|||
23692762|NCT00847613|66254274|FG002|Overall Study|Death|0|||
23692763|NCT00847613|66254275|FG003|Overall Study|Death|0|||
23692764|NCT00847613|66254272|FG000|Overall Study|Adverse Event|36|||
23692765|NCT00847613|66254273|FG001|Overall Study|Adverse Event|26|||
23692766|NCT00847613|66254274|FG002|Overall Study|Adverse Event|5|||
23692767|NCT00847613|66254275|FG003|Overall Study|Adverse Event|6|||
23692768|NCT00847613|66254272|FG000|Overall Study|Lack of Efficacy|7|||
23692769|NCT00847613|66254273|FG001|Overall Study|Lack of Efficacy|3|||
23692770|NCT00847613|66254274|FG002|Overall Study|Lack of Efficacy|3|||
23692771|NCT00847613|66254275|FG003|Overall Study|Lack of Efficacy|1|||
23692772|NCT00847613|66254272|FG000|Overall Study|Study terminated by Sponsor|1|||
23692773|NCT00847613|66254273|FG001|Overall Study|Study terminated by Sponsor|0|||
23692774|NCT00847613|66254274|FG002|Overall Study|Study terminated by Sponsor|2|||
23692775|NCT00847613|66254275|FG003|Overall Study|Study terminated by Sponsor|1|||
23692776|NCT00847613|66254272|FG000|Overall Study|Lost to Follow-up|5|||
23692777|NCT00847613|66254273|FG001|Overall Study|Lost to Follow-up|0|||
23692778|NCT00847613|66254274|FG002|Overall Study|Lost to Follow-up|0|||
23692779|NCT00847613|66254275|FG003|Overall Study|Lost to Follow-up|3|||
23692780|NCT00847613|66254272|FG000|Overall Study|Protocol Violation|6|||
23692781|NCT00847613|66254273|FG001|Overall Study|Protocol Violation|6|||
23692782|NCT00847613|66254274|FG002|Overall Study|Protocol Violation|3|||
23692783|NCT00847613|66254275|FG003|Overall Study|Protocol Violation|1|||
23692784|NCT00847613|66254272|FG000|Overall Study|Pregnancy|1|||
23692785|NCT00847613|66254273|FG001|Overall Study|Pregnancy|1|||
23692786|NCT00847613|66254274|FG002|Overall Study|Pregnancy|0|||
23692787|NCT00847613|66254275|FG003|Overall Study|Pregnancy|0|||
23692788|NCT00847613|66254272|FG000|Overall Study|Site closure|1|||
23692789|NCT00847613|66254273|FG001|Overall Study|Site closure|0|||
23692790|NCT00847613|66254274|FG002|Overall Study|Site closure|0|||
23692791|NCT00847613|66254275|FG003|Overall Study|Site closure|1|||
23692792|NCT00847613|66254272|FG000|Overall Study|Withdrawal by Subject|8|||
23692793|NCT00847613|66254273|FG001|Overall Study|Withdrawal by Subject|11|||
23692794|NCT00847613|66254274|FG002|Overall Study|Withdrawal by Subject|2|||
23692795|NCT00847613|66254275|FG003|Overall Study|Withdrawal by Subject|2|||
23692796|NCT00847613|66254272|FG000|Overall Study|Participant moved|4|||
23692797|NCT00847613|66254273|FG001|Overall Study|Participant moved|1|||
23692798|NCT00847613|66254274|FG002|Overall Study|Participant moved|0|||
23692799|NCT00847613|66254275|FG003|Overall Study|Participant moved|0|||
23692800|NCT00847613|66254272|FG000|Overall Study|Sponsor request|0|||
23692801|NCT00847613|66254273|FG001|Overall Study|Sponsor request|1|||
23692802|NCT00847613|66254274|FG002|Overall Study|Sponsor request|0|||
23692803|NCT00847613|66254275|FG003|Overall Study|Sponsor request|0|||
23692804|NCT00847613|66254272|FG000|Overall Study|Randomized, but not treated|0|||
23692805|NCT00847613|66254273|FG001|Overall Study|Randomized, but not treated|3|||
23692806|NCT00847613|66254274|FG002|Overall Study|Randomized, but not treated|0|||
23692807|NCT00847613|66254275|FG003|Overall Study|Randomized, but not treated|0|||
23692808|NCT00847613|66254272|FG000|Overall Study|Other|1|||
23692809|NCT00847613|66254273|FG001|Overall Study|Other|1|||
23692810|NCT00847613|66254274|FG002|Overall Study|Other|2|||
23692811|NCT00847613|66254275|FG003|Overall Study|Other|0|||
23692812|NCT00826514|66254277|FG000|Overall Study|Adverse Event|1|||
23692813|NCT00826514|66254278|FG001|Overall Study|Adverse Event|1|||
23692814|NCT00826514|66254277|FG000|Overall Study|Lack of Efficacy|0|||
23692815|NCT00826514|66254278|FG001|Overall Study|Lack of Efficacy|1|||
23692816|NCT00826514|66254277|FG000|Overall Study|Withdrawal by Subject|2|||
23692817|NCT00826514|66254278|FG001|Overall Study|Withdrawal by Subject|3|||
23692818|NCT02017444|66254279|FG000|Overall Study|Physician Decision|1|||
23692819|NCT02017444|66254280|FG001|Overall Study|Physician Decision|0|||
23395460|NCT03391882|65195636|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
23395461|NCT03391882|65195637|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395462|NCT03391882|65195638|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395463|NCT03391882|65195639|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23692820|NCT02017444|66254279|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
23692821|NCT02017444|66254280|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
23692822|NCT00538681|66254281|FG000|Overall Study|Progressive Disease|7|||
23692823|NCT00538681|66254282|FG001|Overall Study|Progressive Disease|0|||
23692824|NCT00538681|66254283|FG002|Overall Study|Progressive Disease|1|||
23692825|NCT00538681|66254284|FG003|Overall Study|Progressive Disease|0|||
23692826|NCT00538681|66254281|FG000|Overall Study|Sponsor Decision|1|||
23692827|NCT00538681|66254282|FG001|Overall Study|Sponsor Decision|3|||
23692828|NCT00538681|66254283|FG002|Overall Study|Sponsor Decision|8|||
23692829|NCT00538681|66254284|FG003|Overall Study|Sponsor Decision|9|||
23692830|NCT00538681|66254281|FG000|Overall Study|Adverse Event|1|||
23692831|NCT00538681|66254282|FG001|Overall Study|Adverse Event|1|||
23692832|NCT00538681|66254283|FG002|Overall Study|Adverse Event|1|||
23692833|NCT00538681|66254284|FG003|Overall Study|Adverse Event|0|||
23692834|NCT00538681|66254281|FG000|Overall Study|Death|0|||
23692835|NCT00538681|66254282|FG001|Overall Study|Death|0|||
23692836|NCT00538681|66254283|FG002|Overall Study|Death|1|||
23692837|NCT00538681|66254284|FG003|Overall Study|Death|1|||
23692838|NCT00538681|66254281|FG000|Overall Study|Investigator Decision|0|||
23692839|NCT00538681|66254282|FG001|Overall Study|Investigator Decision|0|||
23692840|NCT00538681|66254283|FG002|Overall Study|Investigator Decision|0|||
23692841|NCT00538681|66254284|FG003|Overall Study|Investigator Decision|1|||
23692842|NCT00144170|66254285|FG000|Overall Study|Adverse Event|84|||
23692843|NCT00144170|66254286|FG001|Overall Study|Adverse Event|41|||
23692844|NCT00144170|66254285|FG000|Overall Study|Protocol Violation|23|||
23692845|NCT00144170|66254286|FG001|Overall Study|Protocol Violation|16|||
23692846|NCT00144170|66254285|FG000|Overall Study|Lost to Follow-up|5|||
23395464|NCT03391882|65195640|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395465|NCT03391882|65195635|FG000|Study Overall|Protocol Violation|1|||
23395466|NCT03391882|65195636|FG001|Study Overall|Protocol Violation|0|||
23395467|NCT03391882|65195637|FG002|Study Overall|Protocol Violation|0|||
23395468|NCT03391882|65195638|FG003|Study Overall|Protocol Violation|0|||
23395469|NCT03391882|65195639|FG004|Study Overall|Protocol Violation|0|||
23395470|NCT03391882|65195640|FG005|Study Overall|Protocol Violation|0|||
23395471|NCT03391882|65195635|FG000|Part A - Titration Phase|Adverse Event|3|||
23395472|NCT03391882|65195636|FG001|Part A - Titration Phase|Adverse Event|6|||
23395473|NCT03391882|65195637|FG002|Part A - Titration Phase|Adverse Event|0|||
23395474|NCT03391882|65195638|FG003|Part A - Titration Phase|Adverse Event|0|||
23498545|NCT00389597|65566364|FG000|Overall Study|Lost to Follow-up|8|||
23498546|NCT00389597|65566365|FG001|Overall Study|Lost to Follow-up|6|||
23692847|NCT00144170|66254286|FG001|Overall Study|Lost to Follow-up|10|||
23395475|NCT03391882|65195639|FG004|Part A - Titration Phase|Adverse Event|0|||
23395476|NCT03391882|65195640|FG005|Part A - Titration Phase|Adverse Event|0|||
23692848|NCT00144170|66254285|FG000|Overall Study|Withdrawal by Subject|29|||
23692849|NCT00144170|66254286|FG001|Overall Study|Withdrawal by Subject|13|||
23692850|NCT00144170|66254285|FG000|Overall Study|Other reason not defined above|211|||
23692851|NCT00144170|66254286|FG001|Overall Study|Other reason not defined above|316|||
23395477|NCT03391882|65195635|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
23395478|NCT03391882|65195636|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
23498547|NCT00389597|65566366|FG002|Overall Study|Lost to Follow-up|4|||
23692852|NCT00784758|66254287|FG000|Overall Study|Withdrawal by Subject|3|||
23395479|NCT03391882|65195637|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
23395480|NCT03391882|65195638|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
23395481|NCT03391882|65195639|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
23395482|NCT03391882|65195640|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
23395483|NCT03391882|65195635|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
23395484|NCT03391882|65195636|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
23395485|NCT03391882|65195637|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
23395486|NCT03391882|65195638|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
23395487|NCT03391882|65195639|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
23692853|NCT00784758|66254288|FG001|Overall Study|Withdrawal by Subject|0|||
23692854|NCT00784758|66254287|FG000|Overall Study|Adverse Event|1|||
23692855|NCT00784758|66254288|FG001|Overall Study|Adverse Event|0|||
23692856|NCT01844076|66254294|FG000|Overall Study|Adverse Event|1|||
23692857|NCT01844076|66254295|FG001|Overall Study|Adverse Event|0|||
23692858|NCT01844076|66254296|FG002|Overall Study|Adverse Event|0|||
23692859|NCT01844076|66254297|FG003|Overall Study|Adverse Event|0|||
23692860|NCT01844076|66254294|FG000|Overall Study|Withdrawal by Subject|1|||
23692861|NCT01844076|66254295|FG001|Overall Study|Withdrawal by Subject|0|||
23692862|NCT01844076|66254296|FG002|Overall Study|Withdrawal by Subject|0|||
23692863|NCT01844076|66254297|FG003|Overall Study|Withdrawal by Subject|0|||
23692864|NCT02561156|66254305|FG000|Part 2|Adverse Event|0|||
23692865|NCT02561156|66254306|FG001|Part 2|Adverse Event|0|||
23692866|NCT02561156|66254307|FG002|Part 2|Adverse Event|0|||
23692867|NCT02561156|66254308|FG003|Part 2|Adverse Event|0|||
23692868|NCT02561156|66254309|FG004|Part 2|Adverse Event|0|||
23692869|NCT02561156|66254310|FG005|Part 2|Adverse Event|0|||
23692870|NCT02561156|66254311|FG006|Part 2|Adverse Event|0|||
23692871|NCT02561156|66254312|FG007|Part 2|Adverse Event|0|||
23692872|NCT02561156|66254313|FG008|Part 2|Adverse Event|0|||
23395488|NCT03391882|65195640|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
23692873|NCT02561156|66254314|FG009|Part 2|Adverse Event|0|||
23692874|NCT02561156|66254315|FG010|Part 2|Adverse Event|0|||
23692875|NCT02561156|66254316|FG011|Part 2|Adverse Event|1|||
23692876|NCT02561156|66254317|FG012|Part 2|Adverse Event|0|||
23692877|NCT00004980|66254323|FG000|Overall Study|Withdrawal by Subject|1|||
23692878|NCT00004980|66254324|FG001|Overall Study|Withdrawal by Subject|0|||
23395489|NCT03391882|65195635|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395490|NCT03391882|65195636|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
23692879|NCT00004980|66254323|FG000|Overall Study|memory difficulties|1|||
23692880|NCT00004980|66254324|FG001|Overall Study|memory difficulties|1|||
23692881|NCT00004980|66254323|FG000|Overall Study|Physician Decision|0|||
23395491|NCT03391882|65195637|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395492|NCT03391882|65195638|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395493|NCT03391882|65195639|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395494|NCT03391882|65195640|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395495|NCT03391882|65195635|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
23395496|NCT03391882|65195636|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
23395497|NCT03391882|65195637|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395498|NCT03391882|65195638|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395499|NCT03391882|65195639|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395500|NCT03391882|65195640|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395501|NCT03391882|65195635|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
23395502|NCT03391882|65195636|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
23395503|NCT03391882|65195637|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
23395504|NCT03391882|65195638|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
23395505|NCT03391882|65195639|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
23395506|NCT03391882|65195640|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
23395507|NCT03391882|65195635|FG000|Part B - Treatment Phase|Adverse Event|0|||
23395508|NCT03391882|65195636|FG001|Part B - Treatment Phase|Adverse Event|0|||
23395509|NCT03391882|65195637|FG002|Part B - Treatment Phase|Adverse Event|1|||
23395510|NCT03391882|65195638|FG003|Part B - Treatment Phase|Adverse Event|1|||
23395511|NCT03391882|65195639|FG004|Part B - Treatment Phase|Adverse Event|3|||
23395512|NCT03391882|65195640|FG005|Part B - Treatment Phase|Adverse Event|1|||
23395513|NCT03391882|65195635|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
23692882|NCT00004980|66254324|FG001|Overall Study|Physician Decision|1|||
23692883|NCT00201201|66254326|FG000|Overall Study|Death|0|||
23395514|NCT03391882|65195636|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
23395515|NCT03391882|65195637|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
23692884|NCT00201201|66254327|FG001|Overall Study|Death|2|||
23692885|NCT00201201|66254326|FG000|Overall Study|Withdrawal by Subject|5|||
23692886|NCT00201201|66254327|FG001|Overall Study|Withdrawal by Subject|5|||
23692887|NCT02902809|66254338|FG000|Overall Study|Discontinuation of asthma program|28|||
23692888|NCT00998738|66254339|FG000|Overall Study|Uknown|1|||
23692889|NCT02863848|66254340|FG000|Overall Study|Lost to Follow-up|1|||
23692890|NCT02863848|66254341|FG001|Overall Study|Lost to Follow-up|1|||
23692891|NCT02863848|66254340|FG000|Overall Study|Protocol Violation|1|||
23395516|NCT03391882|65195638|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
23395517|NCT03391882|65195639|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
23692892|NCT02863848|66254341|FG001|Overall Study|Protocol Violation|2|||
23692893|NCT03577990|66254343|FG000|Overall Study|Lost to Follow-up|4|||
23692894|NCT03577990|66254344|FG001|Overall Study|Lost to Follow-up|6|||
23692895|NCT03577990|66254343|FG000|Overall Study|Withdrawal by Subject|4|||
23692896|NCT03577990|66254344|FG001|Overall Study|Withdrawal by Subject|7|||
23692897|NCT00754390|66254345|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
23692898|NCT00754390|66254345|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
23692899|NCT00754390|66254345|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
23692900|NCT00754390|66254345|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
23692901|NCT04919564|66254349|FG000|Overall Study|Lost to Follow-up|1|||
23692902|NCT04919564|66254350|FG001|Overall Study|Lost to Follow-up|0|||
23692903|NCT04919564|66254349|FG000|Overall Study|Physician Decision|1|||
23692904|NCT04919564|66254350|FG001|Overall Study|Physician Decision|1|||
23692905|NCT00686127|66254353|FG000|Overall Study|Withdrawal by Subject|14|||
23692906|NCT00686127|66254354|FG001|Overall Study|Withdrawal by Subject|6|||
23692907|NCT03215277|66254355|FG000|Overall Study|Adverse Event|2|||
23692908|NCT03215277|66254356|FG001|Overall Study|Adverse Event|3|||
23692909|NCT03215277|66254355|FG000|Overall Study|Death|1|||
23692910|NCT03215277|66254356|FG001|Overall Study|Death|0|||
23692911|NCT03215277|66254355|FG000|Overall Study|Lost to Follow-up|0|||
23692912|NCT03215277|66254356|FG001|Overall Study|Lost to Follow-up|1|||
23692913|NCT03215277|66254355|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
23692914|NCT03215277|66254356|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
23692915|NCT00356915|66254358|FG000|Overall Study|Non compliance|1|||
23692916|NCT00356915|66254359|FG001|Overall Study|Non compliance|2|||
23692917|NCT00356915|66254360|FG002|Overall Study|Non compliance|1|||
23692918|NCT00356915|66254358|FG000|Overall Study|Protocol Violation|2|||
23692919|NCT00356915|66254359|FG001|Overall Study|Protocol Violation|3|||
23692920|NCT00356915|66254360|FG002|Overall Study|Protocol Violation|2|||
23692921|NCT00356915|66254358|FG000|Overall Study|Withdrawal by Subject|14|||
23692922|NCT00356915|66254359|FG001|Overall Study|Withdrawal by Subject|14|||
23692923|NCT00356915|66254360|FG002|Overall Study|Withdrawal by Subject|10|||
23692924|NCT00356915|66254358|FG000|Overall Study|Lack of Efficacy|0|||
23692925|NCT00356915|66254359|FG001|Overall Study|Lack of Efficacy|0|||
23692926|NCT00356915|66254360|FG002|Overall Study|Lack of Efficacy|3|||
23692927|NCT00356915|66254358|FG000|Overall Study|Lost to Follow-up|27|||
23692928|NCT00356915|66254359|FG001|Overall Study|Lost to Follow-up|34|||
23692929|NCT00356915|66254360|FG002|Overall Study|Lost to Follow-up|14|||
23395518|NCT03391882|65195640|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
23692930|NCT00356915|66254358|FG000|Overall Study|Administrative Decision|0|||
23692931|NCT00356915|66254359|FG001|Overall Study|Administrative Decision|0|||
23692932|NCT00356915|66254360|FG002|Overall Study|Administrative Decision|1|||
23692933|NCT00356915|66254358|FG000|Overall Study|Physician Decision|0|||
23692934|NCT00356915|66254359|FG001|Overall Study|Physician Decision|2|||
23692935|NCT00356915|66254360|FG002|Overall Study|Physician Decision|0|||
23692936|NCT00356915|66254358|FG000|Overall Study|Adverse Event|21|||
23692937|NCT00356915|66254359|FG001|Overall Study|Adverse Event|31|||
23692938|NCT00356915|66254360|FG002|Overall Study|Adverse Event|8|||
23692939|NCT00356915|66254358|FG000|Overall Study|Miscellaneous reasons|11|||
23692940|NCT00356915|66254359|FG001|Overall Study|Miscellaneous reasons|8|||
23692941|NCT00356915|66254360|FG002|Overall Study|Miscellaneous reasons|3|||
23692942|NCT00472303|66254361|FG000|Titration Phase|Adverse Event|22|||
23692943|NCT00472303|66254362|FG001|Titration Phase|Adverse Event|12|||
23692944|NCT00472303|66254363|FG002|Titration Phase|Adverse Event|0|||
23692945|NCT00472303|66254361|FG000|Titration Phase|Death|4|||
23692946|NCT00472303|66254362|FG001|Titration Phase|Death|2|||
23692947|NCT00472303|66254363|FG002|Titration Phase|Death|0|||
23692948|NCT00472303|66254361|FG000|Titration Phase|Lack of Efficacy|10|||
23692949|NCT00472303|66254362|FG001|Titration Phase|Lack of Efficacy|0|||
23692950|NCT00472303|66254363|FG002|Titration Phase|Lack of Efficacy|0|||
23692951|NCT00472303|66254361|FG000|Titration Phase|Withdrawal by Subject|16|||
23395519|NCT02257684|65195641|FG000|Overall Study|Adverse Event|2|||
23395520|NCT02257684|65195641|FG000|Overall Study|Lack of Efficacy|1|||
23395521|NCT02257684|65195641|FG000|Overall Study|Sponsor's Decision|1|||
23395522|NCT04549454|65195642|FG000|T1 to T2|Lost to Follow-up|22|||
23395523|NCT04549454|65195643|FG001|T1 to T2|Lost to Follow-up|26|||
23692952|NCT00472303|66254362|FG001|Titration Phase|Withdrawal by Subject|13|||
23692953|NCT00472303|66254363|FG002|Titration Phase|Withdrawal by Subject|0|||
23692954|NCT00472303|66254361|FG000|Titration Phase|Trial Medication non-compliant|4|||
23395524|NCT04549454|65195642|FG000|T1 to T3|Lost to Follow-up|31|||
23692955|NCT00472303|66254362|FG001|Titration Phase|Trial Medication non-compliant|1|||
23692956|NCT00472303|66254363|FG002|Titration Phase|Trial Medication non-compliant|0|||
23692957|NCT00472303|66254361|FG000|Titration Phase|Other|3|||
23692958|NCT00472303|66254362|FG001|Titration Phase|Other|1|||
23692959|NCT00472303|66254363|FG002|Titration Phase|Other|0|||
23692960|NCT00472303|66254361|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
23692961|NCT00472303|66254362|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
23692962|NCT00472303|66254363|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
23692963|NCT00472303|66254361|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
23692964|NCT00472303|66254362|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
23692965|NCT00472303|66254363|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
23692966|NCT00472303|66254361|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
23692967|NCT00472303|66254362|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
23692968|NCT00472303|66254363|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
23692969|NCT00472303|66254361|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
23692970|NCT00472303|66254362|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
23692971|NCT00472303|66254363|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
23692972|NCT00472303|66254361|FG000|Discontinuations After Titration Phase|Other|5|||
23692973|NCT00472303|66254362|FG001|Discontinuations After Titration Phase|Other|0|||
23692974|NCT00472303|66254363|FG002|Discontinuations After Titration Phase|Other|0|||
23692975|NCT00472303|66254361|FG000|Maintenance Phase|Adverse Event|5|||
23692976|NCT00472303|66254362|FG001|Maintenance Phase|Adverse Event|6|||
23692977|NCT00472303|66254363|FG002|Maintenance Phase|Adverse Event|6|||
23692978|NCT00472303|66254361|FG000|Maintenance Phase|Death|3|||
23692979|NCT00472303|66254362|FG001|Maintenance Phase|Death|0|||
23692980|NCT00472303|66254363|FG002|Maintenance Phase|Death|2|||
23692981|NCT00472303|66254361|FG000|Maintenance Phase|Lack of Efficacy|2|||
23692982|NCT00472303|66254362|FG001|Maintenance Phase|Lack of Efficacy|2|||
23692983|NCT00472303|66254363|FG002|Maintenance Phase|Lack of Efficacy|4|||
23692984|NCT00472303|66254361|FG000|Maintenance Phase|Withdrawal by Subject|6|||
23692985|NCT00472303|66254362|FG001|Maintenance Phase|Withdrawal by Subject|7|||
23692986|NCT00472303|66254363|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23692987|NCT00472303|66254361|FG000|Maintenance Phase|Trial medication non-compliant|0|||
23692988|NCT00472303|66254362|FG001|Maintenance Phase|Trial medication non-compliant|0|||
23692989|NCT00472303|66254363|FG002|Maintenance Phase|Trial medication non-compliant|1|||
23692990|NCT00472303|66254361|FG000|Maintenance Phase|Resolution of pain|0|||
23692991|NCT00472303|66254362|FG001|Maintenance Phase|Resolution of pain|0|||
23692992|NCT00472303|66254363|FG002|Maintenance Phase|Resolution of pain|1|||
23692993|NCT00472303|66254361|FG000|Maintenance Phase|Other|1|||
23692994|NCT00472303|66254362|FG001|Maintenance Phase|Other|1|||
23692995|NCT00472303|66254363|FG002|Maintenance Phase|Other|0|||
23692996|NCT02104180|66254364|FG000|Overall Study|Protocol Violation|1|||
23692997|NCT02104180|66254365|FG001|Overall Study|Protocol Violation|0|||
23692998|NCT01748760|66254370|FG000|Overall Study|Withdrawal by Subject|1|||
23692999|NCT01748760|66254371|FG001|Overall Study|Withdrawal by Subject|1|||
23693000|NCT01748760|66254370|FG000|Overall Study|Lost to Follow-up|5|||
23693001|NCT01748760|66254371|FG001|Overall Study|Lost to Follow-up|1|||
23693002|NCT01901224|66254376|FG000|Overall Study|study was not funded and terminated|2|||
23693003|NCT00805207|66254377|FG000|Overall Study|Protocol Violation|0|||
23693004|NCT00805207|66254378|FG001|Overall Study|Protocol Violation|0|||
23693005|NCT00805207|66254379|FG002|Overall Study|Protocol Violation|1|||
23693006|NCT00805207|66254380|FG003|Overall Study|Protocol Violation|0|||
23693007|NCT00805207|66254381|FG004|Overall Study|Protocol Violation|0|||
23693008|NCT00805207|66254382|FG005|Overall Study|Protocol Violation|0|||
23693009|NCT00805207|66254383|FG006|Overall Study|Protocol Violation|0|||
23693010|NCT00805207|66254384|FG007|Overall Study|Protocol Violation|0|||
23693011|NCT00805207|66254385|FG008|Overall Study|Protocol Violation|0|||
23693012|NCT00805207|66254377|FG000|Overall Study|Physician Decision|0|||
23693013|NCT00805207|66254378|FG001|Overall Study|Physician Decision|1|||
23693014|NCT00805207|66254379|FG002|Overall Study|Physician Decision|0|||
23693015|NCT00805207|66254380|FG003|Overall Study|Physician Decision|0|||
23693016|NCT00805207|66254381|FG004|Overall Study|Physician Decision|0|||
23693017|NCT00805207|66254382|FG005|Overall Study|Physician Decision|1|||
23693018|NCT00805207|66254383|FG006|Overall Study|Physician Decision|0|||
23693019|NCT00805207|66254384|FG007|Overall Study|Physician Decision|0|||
23693020|NCT00805207|66254385|FG008|Overall Study|Physician Decision|0|||
23693021|NCT00805207|66254377|FG000|Overall Study|Withdrawal by Subject|0|||
23693022|NCT00805207|66254378|FG001|Overall Study|Withdrawal by Subject|1|||
23693023|NCT00805207|66254379|FG002|Overall Study|Withdrawal by Subject|0|||
23693024|NCT00805207|66254380|FG003|Overall Study|Withdrawal by Subject|0|||
23693025|NCT00805207|66254381|FG004|Overall Study|Withdrawal by Subject|1|||
23693026|NCT00805207|66254382|FG005|Overall Study|Withdrawal by Subject|2|||
23693027|NCT00805207|66254383|FG006|Overall Study|Withdrawal by Subject|0|||
23693028|NCT00805207|66254384|FG007|Overall Study|Withdrawal by Subject|0|||
23693029|NCT00805207|66254385|FG008|Overall Study|Withdrawal by Subject|0|||
23693030|NCT02251743|66254386|FG000|Overall Study|Withdrawal by Subject|1|||
23693031|NCT02251743|66254387|FG001|Overall Study|Withdrawal by Subject|1|||
23693032|NCT01676116|66254388|FG000|Overall Study|Withdrawal criteria|2|||
23693033|NCT01676116|66254389|FG001|Overall Study|Withdrawal criteria|14|||
23693034|NCT01676116|66254388|FG000|Overall Study|Adverse Event|1|||
23693035|NCT01676116|66254389|FG001|Overall Study|Adverse Event|2|||
23693036|NCT01676116|66254388|FG000|Overall Study|Unclassified|4|||
23693037|NCT01676116|66254389|FG001|Overall Study|Unclassified|10|||
23693038|NCT01676116|66254388|FG000|Overall Study|Protocol Violation|9|||
23693039|NCT01676116|66254389|FG001|Overall Study|Protocol Violation|3|||
23693040|NCT01331161|66254390|FG000|Overall Study|Physician Decision|1|||
23693041|NCT01331161|66254391|FG001|Overall Study|Physician Decision|0|||
23693042|NCT01331161|66254390|FG000|Overall Study|Lost to Follow-up|0|||
23693043|NCT01331161|66254391|FG001|Overall Study|Lost to Follow-up|1|||
23693044|NCT01331161|66254390|FG000|Overall Study|Pregnancy|0|||
23693045|NCT01331161|66254391|FG001|Overall Study|Pregnancy|1|||
23693046|NCT00761215|66254392|FG000|Overall Study|Randomized but didn't receive drug|1|||
23693047|NCT00761215|66254393|FG001|Overall Study|Randomized but didn't receive drug|1|||
23693048|NCT00761215|66254394|FG002|Overall Study|Randomized but didn't receive drug|2|||
23693049|NCT00761215|66254392|FG000|Overall Study|Lost to Follow-up|6|||
23693050|NCT00761215|66254393|FG001|Overall Study|Lost to Follow-up|3|||
23693051|NCT00761215|66254394|FG002|Overall Study|Lost to Follow-up|6|||
23693052|NCT00761215|66254392|FG000|Overall Study|Withdrawal by Subject|1|||
23693053|NCT00761215|66254393|FG001|Overall Study|Withdrawal by Subject|0|||
23693054|NCT00761215|66254394|FG002|Overall Study|Withdrawal by Subject|0|||
23693055|NCT00761215|66254392|FG000|Overall Study|Bacteremia|1|||
23693056|NCT00761215|66254393|FG001|Overall Study|Bacteremia|0|||
23693057|NCT00761215|66254394|FG002|Overall Study|Bacteremia|0|||
23693058|NCT01287117|66254403|FG000|Overall Study|Adverse Event|2|||
23693059|NCT01287117|66254404|FG001|Overall Study|Adverse Event|1|||
23693060|NCT01287117|66254405|FG002|Overall Study|Adverse Event|1|||
23693061|NCT01287117|66254406|FG003|Overall Study|Adverse Event|1|||
23693062|NCT01287117|66254403|FG000|Overall Study|Lost to Follow-up|1|||
23693063|NCT01287117|66254404|FG001|Overall Study|Lost to Follow-up|1|||
23693064|NCT01287117|66254405|FG002|Overall Study|Lost to Follow-up|0|||
23395525|NCT04549454|65195643|FG001|T1 to T3|Lost to Follow-up|36|||
23395526|NCT00779909|65195646|FG000|Overall Study|Lost to Follow-up|1|||
23395527|NCT00779909|65195647|FG001|Overall Study|Lost to Follow-up|0|||
23395528|NCT00779909|65195648|FG002|Overall Study|Lost to Follow-up|0|||
23395529|NCT00779909|65195649|FG003|Overall Study|Lost to Follow-up|1|||
23395530|NCT00779909|65195646|FG000|Overall Study|Withdrawal by Subject|0|||
23395531|NCT00779909|65195647|FG001|Overall Study|Withdrawal by Subject|1|||
23395532|NCT00779909|65195648|FG002|Overall Study|Withdrawal by Subject|0|||
23395533|NCT00779909|65195649|FG003|Overall Study|Withdrawal by Subject|0|||
23395534|NCT00565747|65195654|FG000|Overall Study|No embryo transfer|67|||
23395535|NCT00565747|65195655|FG001|Overall Study|No embryo transfer|73|||
23395536|NCT00800735|65195658|FG000|Overall Study|Administrative/Other|2|||
23395537|NCT00800735|65195658|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23395538|NCT00800735|65195658|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
23395539|NCT00800735|65195658|FG000|Overall Study|Withdrew Consent|3|||
23395540|NCT04282148|65195660|FG000|Overall Study|Death|1|||
23395541|NCT04282148|65195660|FG000|Overall Study|Withdrawal by Subject|1|||
23395542|NCT04282148|65195660|FG000|Overall Study|Physician Decision|1|||
23395543|NCT00209131|65195662|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
23395544|NCT00209131|65195663|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
23693065|NCT01287117|66254406|FG003|Overall Study|Lost to Follow-up|0|||
23693066|NCT01287117|66254403|FG000|Overall Study|Physician Decision|0|||
23693067|NCT01287117|66254404|FG001|Overall Study|Physician Decision|1|||
23693068|NCT01287117|66254405|FG002|Overall Study|Physician Decision|1|||
23693069|NCT01287117|66254406|FG003|Overall Study|Physician Decision|1|||
23693070|NCT01287117|66254403|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
23693071|NCT01287117|66254404|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
23693072|NCT01287117|66254405|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
23693073|NCT01287117|66254406|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
23693074|NCT01287117|66254403|FG000|Overall Study|Disease Progression|10|||
23395545|NCT00760552|65195664|FG000|Overall Study|Death|2|||
23395546|NCT00760552|65195665|FG001|Overall Study|Death|0|||
23395547|NCT00760552|65195664|FG000|Overall Study|Lost to Follow-up|11|||
23395548|NCT00760552|65195665|FG001|Overall Study|Lost to Follow-up|10|||
23395549|NCT03612570|65195666|FG000|Overall Study|Lost to Follow-up|1|||
23693075|NCT01287117|66254404|FG001|Overall Study|Disease Progression|5|||
23693076|NCT01287117|66254405|FG002|Overall Study|Disease Progression|6|||
23693077|NCT01287117|66254406|FG003|Overall Study|Disease Progression|5|||
23693078|NCT00308620|66254409|FG000|Overall Study|Death|1|||
23693079|NCT00308620|66254410|FG001|Overall Study|Death|1|||
23395550|NCT04064905|65195667|FG000|Overall Study|Lost to Follow-up|0|||
23395551|NCT04064905|65195668|FG001|Overall Study|Lost to Follow-up|3|||
23395552|NCT04064905|65195669|FG002|Overall Study|Lost to Follow-up|1|||
23498548|NCT00389597|65566367|FG003|Overall Study|Lost to Follow-up|6|||
23606384|NCT02309892|65947238|FG001|Overall Study|Physician Decision|0|||
23395553|NCT04064905|65195670|FG003|Overall Study|Lost to Follow-up|4|||
23395554|NCT04064905|65195671|FG004|Overall Study|Lost to Follow-up|2|||
23693080|NCT00308620|66254411|FG002|Overall Study|Death|0|||
23693081|NCT00308620|66254409|FG000|Overall Study|Lost to Follow-up|0|||
23693082|NCT00308620|66254410|FG001|Overall Study|Lost to Follow-up|0|||
23693083|NCT00308620|66254411|FG002|Overall Study|Lost to Follow-up|1|||
23693084|NCT02638012|66254416|FG000|Overall Study|Lost to Follow-up|1|||
23693085|NCT04938648|66254417|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
23395555|NCT00666263|65195672|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
23395556|NCT00666263|65195673|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
23395557|NCT00666263|65195672|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
23395558|NCT00666263|65195673|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
23395559|NCT00666263|65195672|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
23395560|NCT00666263|65195673|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
23395561|NCT01285102|65195674|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
23395562|NCT01972659|65195675|FG000|Overall Study|Protocol Violation|2|||
23395563|NCT01972659|65195676|FG001|Overall Study|Protocol Violation|2|||
23395564|NCT01972659|65195675|FG000|Overall Study|problems realted to acceleromyograph|2|||
23395565|NCT01972659|65195676|FG001|Overall Study|problems realted to acceleromyograph|1|||
23395566|NCT01928433|65195690|FG000|Overall Study|Adverse Event|5|||
23395567|NCT01928433|65195691|FG001|Overall Study|Adverse Event|2|||
23395568|NCT01928433|65195692|FG002|Overall Study|Adverse Event|5|||
23498549|NCT03338010|65566373|FG000|Overall Study|Withdrawal by Subject|14|||
23498550|NCT03338010|65566374|FG001|Overall Study|Withdrawal by Subject|8|||
23498551|NCT03338010|65566373|FG000|Overall Study|Lost to Follow-up|4|||
23498552|NCT03338010|65566374|FG001|Overall Study|Lost to Follow-up|2|||
23498553|NCT03338010|65566373|FG000|Overall Study|Adverse Event|3|||
23498554|NCT03338010|65566374|FG001|Overall Study|Adverse Event|2|||
23498555|NCT03338010|65566373|FG000|Overall Study|Physician Decision|2|||
23498556|NCT03338010|65566374|FG001|Overall Study|Physician Decision|2|||
23498557|NCT03338010|65566373|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23498558|NCT03338010|65566374|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23498559|NCT03338010|65566373|FG000|Overall Study|Protocol Violation|0|||
23498560|NCT03338010|65566374|FG001|Overall Study|Protocol Violation|1|||
23498561|NCT02899299|65566375|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
23498562|NCT02899299|65566376|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
23498563|NCT02899299|65566375|FG000|Pre-treatment|Participant withdrew consent|1|||
23498564|NCT02899299|65566376|FG001|Pre-treatment|Participant withdrew consent|11|||
23498565|NCT02899299|65566375|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
23498566|NCT02899299|65566376|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
23498567|NCT02899299|65566375|FG000|Pre-treatment|Not reported|0|||
23498568|NCT02899299|65566376|FG001|Pre-treatment|Not reported|1|||
23498569|NCT02899299|65566375|FG000|Treatment|Disease Progression|182|||
23498570|NCT02899299|65566376|FG001|Treatment|Disease Progression|43|||
23498571|NCT02899299|65566375|FG000|Treatment|Study Drug Toxicity|60|||
23498572|NCT02899299|65566376|FG001|Treatment|Study Drug Toxicity|24|||
23498573|NCT02899299|65566375|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
23498574|NCT02899299|65566376|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
23498575|NCT02899299|65566375|FG000|Treatment|Participant request to discontinue Study treatment|4|||
23498576|NCT02899299|65566376|FG001|Treatment|Participant request to discontinue Study treatment|10|||
23498577|NCT02899299|65566375|FG000|Treatment|Participant withdrew consent|6|||
23498578|NCT02899299|65566376|FG001|Treatment|Participant withdrew consent|3|||
23498579|NCT02899299|65566375|FG000|Treatment|Lost to Follow-up|0|||
23693086|NCT04938648|66254418|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
23693087|NCT04938648|66254417|FG000|Overall Study|Patient too ill|0|||
23693088|NCT04938648|66254418|FG001|Overall Study|Patient too ill|1|||
23693089|NCT04938648|66254417|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
23693090|NCT04938648|66254418|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
23693091|NCT04938648|66254417|FG000|Overall Study|Patient did not have memory problems|1|||
23693092|NCT04938648|66254418|FG001|Overall Study|Patient did not have memory problems|1|||
23693093|NCT04938648|66254417|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
23693094|NCT04938648|66254418|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
23693095|NCT04938648|66254417|FG000|Overall Study|Care partner could not be reached|0|||
23693096|NCT04938648|66254418|FG001|Overall Study|Care partner could not be reached|1|||
23395569|NCT01928433|65195690|FG000|Overall Study|Protocol Violation|0|||
23395570|NCT01928433|65195691|FG001|Overall Study|Protocol Violation|0|||
23395571|NCT01928433|65195692|FG002|Overall Study|Protocol Violation|2|||
23498580|NCT02899299|65566376|FG001|Treatment|Lost to Follow-up|2|||
23498581|NCT02899299|65566375|FG000|Treatment|Maximum Clinical Benefit|11|||
23498582|NCT02899299|65566376|FG001|Treatment|Maximum Clinical Benefit|2|||
23498583|NCT02899299|65566375|FG000|Treatment|Poor/Non-compliance|1|||
23498584|NCT02899299|65566376|FG001|Treatment|Poor/Non-compliance|0|||
23395572|NCT01928433|65195690|FG000|Overall Study|Lack of Efficacy|5|||
23395573|NCT01928433|65195691|FG001|Overall Study|Lack of Efficacy|4|||
23395574|NCT01928433|65195692|FG002|Overall Study|Lack of Efficacy|4|||
23498585|NCT02899299|65566375|FG000|Treatment|Participant no longer meets Study criteria|4|||
23498586|NCT02899299|65566376|FG001|Treatment|Participant no longer meets Study criteria|0|||
23606385|NCT02309892|65947239|FG002|Overall Study|Physician Decision|0|||
23395575|NCT01928433|65195690|FG000|Overall Study|Withdrawal by Subject|0|||
23395576|NCT01928433|65195691|FG001|Overall Study|Withdrawal by Subject|4|||
23395577|NCT01928433|65195692|FG002|Overall Study|Withdrawal by Subject|0|||
23395578|NCT01928433|65195690|FG000|Overall Study|Negative screening urine culture|7|||
23395579|NCT01928433|65195691|FG001|Overall Study|Negative screening urine culture|6|||
23395580|NCT01928433|65195692|FG002|Overall Study|Negative screening urine culture|10|||
23395581|NCT01928433|65195690|FG000|Overall Study|Lost to Follow-up|0|||
23395582|NCT01928433|65195691|FG001|Overall Study|Lost to Follow-up|2|||
23395583|NCT01928433|65195692|FG002|Overall Study|Lost to Follow-up|3|||
23395584|NCT01928433|65195690|FG000|Overall Study|Other reasons|3|||
23395585|NCT01928433|65195691|FG001|Overall Study|Other reasons|3|||
23395586|NCT01928433|65195692|FG002|Overall Study|Other reasons|4|||
23395587|NCT01155050|65195693|FG000|Overall Study|Lost to Follow-up|15|||
23395588|NCT01155050|65195694|FG001|Overall Study|Lost to Follow-up|20|||
23395589|NCT01155050|65195695|FG002|Overall Study|Lost to Follow-up|19|||
23395590|NCT01155050|65195696|FG003|Overall Study|Lost to Follow-up|22|||
23395591|NCT00505687|65195697|FG000|Overall Study|Important protocol violation|2|||
23395592|NCT00505687|65195697|FG000|Overall Study|Lack of Efficacy|15|||
23395593|NCT00505687|65195697|FG000|Overall Study|Adverse Event|48|||
23395594|NCT00505687|65195697|FG000|Overall Study|Subject withdrew consent|15|||
23395595|NCT00505687|65195697|FG000|Overall Study|Lost to Follow-up|1|||
23395596|NCT00505687|65195697|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
23395597|NCT00505687|65195697|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
23395598|NCT00505687|65195697|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
23395599|NCT00505687|65195697|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
23395600|NCT00505687|65195697|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
23395601|NCT00505687|65195697|FG000|Overall Study|Other: Disease Progression|1|||
23395602|NCT00505687|65195697|FG000|Overall Study|Other: As Per Sponsor|8|||
23395603|NCT02853136|65195698|FG000|Wash-out|Adverse Event|0|||
23395604|NCT02853136|65195699|FG001|Wash-out|Adverse Event|0|||
23395605|NCT02853136|65195700|FG002|Wash-out|Adverse Event|0|||
23395606|NCT02853136|65195701|FG003|Wash-out|Adverse Event|1|||
23395607|NCT00443456|65195704|FG000|Overall Study|Adverse Event|16|||
23395608|NCT00443456|65195704|FG000|Overall Study|Move|1|||
23395609|NCT00443456|65195704|FG000|Overall Study|Withdrawal by Subject|1|||
23395610|NCT02796651|65195706|FG000|Overall Study|Adverse Event|6|||
23395611|NCT02796651|65195706|FG000|Overall Study|Lost to Follow-up|1|||
23395612|NCT02796651|65195706|FG000|Overall Study|Withdrawal by Subject|4|||
23395613|NCT02796651|65195706|FG000|Overall Study|Protocol Violation|4|||
23693097|NCT04938648|66254417|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
23693098|NCT04938648|66254418|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
23693099|NCT04938648|66254417|FG000|Overall Study|Withdrawal by Subject|2|||
23693100|NCT04938648|66254418|FG001|Overall Study|Withdrawal by Subject|1|||
23693101|NCT00730236|66254421|FG000|Overall Study|Adverse Event|4|||
23693102|NCT00730236|66254421|FG000|Overall Study|Withdrawal by Subject|1|||
23693103|NCT00730236|66254421|FG000|Overall Study|Non-compliance|1|||
23693104|NCT01966731|66254422|FG000|Overall Study|Death|2|||
23693105|NCT01966731|66254422|FG000|Overall Study|Lost to Follow-up|1|||
23693106|NCT01966731|66254422|FG000|Overall Study|Physician Decision|2|||
23693107|NCT01966731|66254422|FG000|Overall Study|Follow up is not complete|600|||
23693108|NCT01966731|66254422|FG000|Overall Study|Screening Failure|29|||
23693109|NCT01966731|66254422|FG000|Overall Study|Found to be ineligible|1|||
23693110|NCT02120417|66254423|FG000|Overall Study|Death|5|||
23693111|NCT02120417|66254424|FG001|Overall Study|Death|1|||
23395614|NCT02796651|65195706|FG000|Overall Study|Lack of Efficacy|1|||
23395615|NCT02796651|65195706|FG000|Overall Study|Other|10|||
23395616|NCT00427700|65195707|FG000|Overall Study|Lost to Follow-up|2|||
23395617|NCT00427700|65195708|FG001|Overall Study|Lost to Follow-up|5|||
23395618|NCT00427700|65195707|FG000|Overall Study|no induction of menses|1|||
23395619|NCT00427700|65195708|FG001|Overall Study|no induction of menses|4|||
23395620|NCT00427700|65195707|FG000|Overall Study|Pregnancy|0|||
23395621|NCT00427700|65195708|FG001|Overall Study|Pregnancy|2|||
23395622|NCT03801525|65195709|FG000|Overall Study|Adverse Event|17|||
23693112|NCT02120417|66254423|FG000|Overall Study|Adverse Event|3|||
23693113|NCT02120417|66254424|FG001|Overall Study|Adverse Event|9|||
23693114|NCT02120417|66254423|FG000|Overall Study|Participant decision|4|||
23693115|NCT02120417|66254424|FG001|Overall Study|Participant decision|4|||
23693116|NCT02120417|66254423|FG000|Overall Study|Disease progression|41|||
23693117|NCT02120417|66254424|FG001|Overall Study|Disease progression|45|||
23693118|NCT02120417|66254423|FG000|Overall Study|Noncompliance with study treatment|0|||
23395623|NCT03801525|65195710|FG001|Overall Study|Adverse Event|1|||
23395624|NCT03801525|65195711|FG002|Overall Study|Adverse Event|0|||
23395625|NCT03801525|65195709|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
23395626|NCT03801525|65195710|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
23395627|NCT03801525|65195711|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
23395628|NCT03801525|65195709|FG000|Overall Study|Death|29|||
23395629|NCT03801525|65195710|FG001|Overall Study|Death|1|||
23395630|NCT03801525|65195711|FG002|Overall Study|Death|4|||
23395631|NCT03801525|65195709|FG000|Overall Study|Disease Progression|6|||
23395632|NCT03801525|65195710|FG001|Overall Study|Disease Progression|0|||
23395633|NCT03801525|65195711|FG002|Overall Study|Disease Progression|1|||
23395634|NCT03801525|65195709|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
23395635|NCT03801525|65195710|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
23395636|NCT03801525|65195711|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
23395637|NCT03801525|65195709|FG000|Overall Study|Investigator Decision|18|||
23395638|NCT03801525|65195710|FG001|Overall Study|Investigator Decision|1|||
23395639|NCT03801525|65195711|FG002|Overall Study|Investigator Decision|0|||
23395640|NCT03801525|65195709|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
23395641|NCT03801525|65195710|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
23395642|NCT03801525|65195711|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
23395643|NCT03801525|65195709|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
23395644|NCT03801525|65195710|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
23395645|NCT03801525|65195711|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
23395646|NCT03801525|65195709|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
23395647|NCT03801525|65195710|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
23395648|NCT03801525|65195711|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
23395649|NCT03801525|65195709|FG000|Overall Study|Withdrawal of Subject Consent|38|||
23395650|NCT03801525|65195710|FG001|Overall Study|Withdrawal of Subject Consent|2|||
23395651|NCT03801525|65195711|FG002|Overall Study|Withdrawal of Subject Consent|1|||
23395652|NCT03801525|65195709|FG000|Overall Study|Reason not Specified|4|||
23395653|NCT03801525|65195710|FG001|Overall Study|Reason not Specified|0|||
23395654|NCT03801525|65195711|FG002|Overall Study|Reason not Specified|4|||
23395655|NCT01188967|65195712|FG000|Overall Study|Withdrawal by Subject|1|||
23395656|NCT01188967|65195713|FG001|Overall Study|Withdrawal by Subject|1|||
23395657|NCT01188967|65195712|FG000|Overall Study|Physician Decision|1|||
23395658|NCT01188967|65195713|FG001|Overall Study|Physician Decision|1|||
23395659|NCT01188967|65195712|FG000|Overall Study|Lost to Follow-up|3|||
23395660|NCT01188967|65195713|FG001|Overall Study|Lost to Follow-up|2|||
23395661|NCT00654355|65195716|FG000|Overall Study|Lost to Follow-up|2|||
23395662|NCT00654355|65195717|FG001|Overall Study|Lost to Follow-up|2|||
23395663|NCT01168596|65195720|FG000|Overall Study|Withdrawal by Subject|3|||
23395664|NCT01168596|65195721|FG001|Overall Study|Withdrawal by Subject|1|||
23395665|NCT02106832|65195722|FG000|Overall Study|Adverse Event|1|||
23395666|NCT02106832|65195723|FG001|Overall Study|Adverse Event|2|||
23395667|NCT02106832|65195724|FG002|Overall Study|Adverse Event|3|||
23395668|NCT02106832|65195725|FG003|Overall Study|Adverse Event|0|||
23395669|NCT02106832|65195722|FG000|Overall Study|Death|4|||
23395670|NCT02106832|65195723|FG001|Overall Study|Death|4|||
23395671|NCT02106832|65195724|FG002|Overall Study|Death|1|||
23395672|NCT02106832|65195725|FG003|Overall Study|Death|4|||
23395673|NCT02106832|65195722|FG000|Overall Study|Deterioration of general conditions|0|||
23395674|NCT02106832|65195723|FG001|Overall Study|Deterioration of general conditions|0|||
23395675|NCT02106832|65195724|FG002|Overall Study|Deterioration of general conditions|1|||
23395676|NCT02106832|65195725|FG003|Overall Study|Deterioration of general conditions|0|||
23395677|NCT02106832|65195722|FG000|Overall Study|Lost to Follow-up|0|||
23395678|NCT02106832|65195723|FG001|Overall Study|Lost to Follow-up|1|||
23395679|NCT02106832|65195724|FG002|Overall Study|Lost to Follow-up|1|||
23395680|NCT02106832|65195725|FG003|Overall Study|Lost to Follow-up|3|||
23395681|NCT02106832|65195722|FG000|Overall Study|Physician Decision|1|||
23395682|NCT02106832|65195723|FG001|Overall Study|Physician Decision|0|||
23395683|NCT02106832|65195724|FG002|Overall Study|Physician Decision|0|||
23395684|NCT02106832|65195725|FG003|Overall Study|Physician Decision|0|||
23395685|NCT02106832|65195722|FG000|Overall Study|Protocol Violation|0|||
23395686|NCT02106832|65195723|FG001|Overall Study|Protocol Violation|0|||
23395687|NCT02106832|65195724|FG002|Overall Study|Protocol Violation|0|||
23395688|NCT02106832|65195725|FG003|Overall Study|Protocol Violation|1|||
23395689|NCT02106832|65195722|FG000|Overall Study|Withdrawal by Subject|17|||
23395690|NCT02106832|65195723|FG001|Overall Study|Withdrawal by Subject|17|||
23395691|NCT02106832|65195724|FG002|Overall Study|Withdrawal by Subject|10|||
23395692|NCT02106832|65195725|FG003|Overall Study|Withdrawal by Subject|7|||
23395693|NCT02106832|65195722|FG000|Overall Study|Technical problems|0|||
23395694|NCT02106832|65195723|FG001|Overall Study|Technical problems|1|||
23395695|NCT02106832|65195724|FG002|Overall Study|Technical problems|0|||
23395696|NCT02106832|65195725|FG003|Overall Study|Technical problems|0|||
23395697|NCT02090764|65195726|FG000|Overall Study|Adverse Event|1|||
23395698|NCT02090764|65195727|FG001|Overall Study|Adverse Event|3|||
23395699|NCT02090764|65195726|FG000|Overall Study|Lack of Efficacy|0|||
23395700|NCT02090764|65195727|FG001|Overall Study|Lack of Efficacy|13|||
23395701|NCT02090764|65195726|FG000|Overall Study|Withdrawal by Subject|2|||
23395702|NCT02090764|65195727|FG001|Overall Study|Withdrawal by Subject|1|||
23395703|NCT02090764|65195726|FG000|Overall Study|Intercurrent illness and other|1|||
23606386|NCT02309892|65947240|FG003|Overall Study|Physician Decision|0|||
23395704|NCT02090764|65195727|FG001|Overall Study|Intercurrent illness and other|1|||
23395705|NCT02090764|65195726|FG000|Overall Study|Lost to Follow-up|2|||
23395706|NCT02090764|65195727|FG001|Overall Study|Lost to Follow-up|2|||
23395707|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
23395708|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
23395709|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
23395710|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
23395711|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
23395712|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
23395713|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
23395714|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
23395715|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
23395716|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
23395717|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395718|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395719|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
23395720|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
23395721|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
23395722|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
23395723|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
23395724|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
23395725|NCT05014919|65195728|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
23395726|NCT05014919|65195729|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
23395727|NCT05014919|65195730|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
23395728|NCT05014919|65195728|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395729|NCT05014919|65195729|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
23395730|NCT05014919|65195730|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
23395731|NCT00129974|65195731|FG000|Overall Study|Other|1|||
23395732|NCT01537432|65195734|FG000|Overall Study|Lost to Follow-up|3|||
23395733|NCT01537432|65195735|FG001|Overall Study|Lost to Follow-up|1|||
23395734|NCT01537432|65195734|FG000|Overall Study|Withdrawal by Subject|0|||
23395735|NCT01537432|65195735|FG001|Overall Study|Withdrawal by Subject|1|||
23395736|NCT01537432|65195734|FG000|Overall Study|Administrative problems|1|||
23693119|NCT02120417|66254424|FG001|Overall Study|Noncompliance with study treatment|2|||
23693120|NCT02120417|66254423|FG000|Overall Study|Physician Decision|2|||
23693121|NCT02120417|66254424|FG001|Overall Study|Physician Decision|3|||
23693122|NCT02120417|66254423|FG000|Overall Study|Other unspecified|5|||
23693123|NCT02120417|66254424|FG001|Overall Study|Other unspecified|4|||
23693124|NCT01325493|66254425|FG000|Overall Study|Protocol Violation|0|||
23693125|NCT01325493|66254426|FG001|Overall Study|Protocol Violation|1|||
23693126|NCT01325493|66254425|FG000|Overall Study|loss of neuromonitoring signals|0|||
23693127|NCT01325493|66254426|FG001|Overall Study|loss of neuromonitoring signals|2|||
23693128|NCT01325493|66254425|FG000|Overall Study|Allergy|1|||
23693129|NCT01325493|66254426|FG001|Overall Study|Allergy|0|||
23693130|NCT02609399|66254427|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
23693131|NCT02609399|66254428|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
23693132|NCT02609399|66254427|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
23693133|NCT02609399|66254428|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
23693134|NCT02609399|66254427|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
23693135|NCT02609399|66254428|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
23693136|NCT00364793|66254429|FG000|Overall Study|Adverse Event|2|||
23693137|NCT00364793|66254430|FG001|Overall Study|Adverse Event|0|||
23693138|NCT00364793|66254431|FG002|Overall Study|Adverse Event|0|||
23693139|NCT00364793|66254432|FG003|Overall Study|Adverse Event|0|||
23693140|NCT00364793|66254429|FG000|Overall Study|Death|1|||
23693141|NCT00364793|66254430|FG001|Overall Study|Death|0|||
23693142|NCT00364793|66254431|FG002|Overall Study|Death|1|||
23693143|NCT00364793|66254432|FG003|Overall Study|Death|0|||
23693144|NCT00364793|66254429|FG000|Overall Study|Lack of Efficacy|3|||
23693145|NCT00364793|66254430|FG001|Overall Study|Lack of Efficacy|3|||
23693146|NCT00364793|66254431|FG002|Overall Study|Lack of Efficacy|1|||
23693147|NCT00364793|66254432|FG003|Overall Study|Lack of Efficacy|1|||
23693148|NCT00364793|66254429|FG000|Overall Study|Lost to Follow-up|1|||
23693149|NCT00364793|66254430|FG001|Overall Study|Lost to Follow-up|0|||
23693150|NCT00364793|66254431|FG002|Overall Study|Lost to Follow-up|2|||
23693151|NCT00364793|66254432|FG003|Overall Study|Lost to Follow-up|0|||
23693152|NCT00364793|66254429|FG000|Overall Study|Poor or non-compliance|1|||
23693153|NCT00364793|66254430|FG001|Overall Study|Poor or non-compliance|1|||
23395737|NCT01537432|65195735|FG001|Overall Study|Administrative problems|0|||
23693154|NCT00364793|66254431|FG002|Overall Study|Poor or non-compliance|0|||
23693155|NCT00364793|66254432|FG003|Overall Study|Poor or non-compliance|1|||
23693156|NCT00364793|66254429|FG000|Overall Study|No longer meets criteria|0|||
23395738|NCT01537432|65195734|FG000|Overall Study|Adverse Event|1|||
23693157|NCT00364793|66254430|FG001|Overall Study|No longer meets criteria|0|||
23693158|NCT00364793|66254431|FG002|Overall Study|No longer meets criteria|0|||
23395739|NCT01537432|65195735|FG001|Overall Study|Adverse Event|0|||
23395740|NCT01537432|65195734|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23395741|NCT01537432|65195735|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23395742|NCT03498716|65195736|FG000|Overall Study|Withdrawal by Subject|88|||
23395743|NCT03498716|65195737|FG001|Overall Study|Withdrawal by Subject|73|||
23395744|NCT03498716|65195736|FG000|Overall Study|Study Terminated By Sponsor|933|||
23395745|NCT03498716|65195737|FG001|Overall Study|Study Terminated By Sponsor|927|||
23395746|NCT03498716|65195736|FG000|Overall Study|Lost to Follow-up|15|||
23395747|NCT03498716|65195737|FG001|Overall Study|Lost to Follow-up|26|||
23395748|NCT03498716|65195736|FG000|Overall Study|Disease Relapse|0|||
23395749|NCT03498716|65195737|FG001|Overall Study|Disease Relapse|1|||
23395750|NCT03498716|65195736|FG000|Overall Study|Death|58|||
23395751|NCT03498716|65195737|FG001|Overall Study|Death|72|||
23395752|NCT03498716|65195736|FG000|Overall Study|Physician Decision|4|||
23395753|NCT03498716|65195737|FG001|Overall Study|Physician Decision|2|||
23395754|NCT04617860|65195741|FG000|Overall Study|Adverse Event|0|||
23395755|NCT04617860|65195742|FG001|Overall Study|Adverse Event|2|||
23395756|NCT04617860|65195743|FG002|Overall Study|Adverse Event|2|||
23395757|NCT04617860|65195741|FG000|Overall Study|Withdrawal by Subject|0|||
23395758|NCT04617860|65195742|FG001|Overall Study|Withdrawal by Subject|0|||
23395759|NCT04617860|65195743|FG002|Overall Study|Withdrawal by Subject|2|||
23395760|NCT04617860|65195741|FG000|Overall Study|Physician Decision|0|||
23395761|NCT04617860|65195742|FG001|Overall Study|Physician Decision|1|||
23395762|NCT04617860|65195743|FG002|Overall Study|Physician Decision|0|||
23395763|NCT04617860|65195741|FG000|Overall Study|Sponsor Decision|0|||
23395764|NCT04617860|65195742|FG001|Overall Study|Sponsor Decision|3|||
23395765|NCT04617860|65195743|FG002|Overall Study|Sponsor Decision|1|||
23395766|NCT04617860|65195741|FG000|Overall Study|Termination of Study by Sponsor|8|||
23395767|NCT04617860|65195742|FG001|Overall Study|Termination of Study by Sponsor|4|||
23395768|NCT04617860|65195743|FG002|Overall Study|Termination of Study by Sponsor|13|||
23395769|NCT01448616|65195756|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
23395770|NCT01448616|65195757|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395771|NCT01448616|65195758|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395772|NCT01448616|65195759|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395773|NCT01448616|65195756|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
23395774|NCT01448616|65195757|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23693159|NCT00364793|66254432|FG003|Overall Study|No longer meets criteria|1|||
23693160|NCT00364793|66254429|FG000|Overall Study|Withdrawal by Subject|0|||
23693161|NCT00364793|66254430|FG001|Overall Study|Withdrawal by Subject|1|||
23693162|NCT00364793|66254431|FG002|Overall Study|Withdrawal by Subject|0|||
23395775|NCT01448616|65195758|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23395776|NCT01448616|65195759|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23395777|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
23395778|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
23395779|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
23395780|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
23498587|NCT02899299|65566375|FG000|Treatment|Administrative reason by Sponsor|2|||
23693163|NCT00364793|66254432|FG003|Overall Study|Withdrawal by Subject|0|||
23693164|NCT05127486|66254433|FG000|Overall Study|Adverse Event|2|||
23693165|NCT05127486|66254434|FG001|Overall Study|Adverse Event|4|||
23693166|NCT05127486|66254433|FG000|Overall Study|Lack of Efficacy|1|||
23693167|NCT05127486|66254434|FG001|Overall Study|Lack of Efficacy|0|||
23693168|NCT05127486|66254433|FG000|Overall Study|Pregnancy|0|||
23693169|NCT05127486|66254434|FG001|Overall Study|Pregnancy|1|||
23693170|NCT05127486|66254433|FG000|Overall Study|Physician Decision|4|||
23693171|NCT05127486|66254434|FG001|Overall Study|Physician Decision|1|||
23693172|NCT05127486|66254433|FG000|Overall Study|Withdrawal by Subject|14|||
23693173|NCT05127486|66254434|FG001|Overall Study|Withdrawal by Subject|13|||
23498588|NCT02899299|65566376|FG001|Treatment|Administrative reason by Sponsor|0|||
23498589|NCT02899299|65566375|FG000|Treatment|Other reasons|12|||
23693174|NCT05127486|66254433|FG000|Overall Study|Lost to Follow-up|5|||
23693175|NCT05127486|66254434|FG001|Overall Study|Lost to Follow-up|8|||
23693176|NCT01548638|66254440|FG000|Overall Study|Protocol Violation|3|||
23693177|NCT01548638|66254440|FG000|Overall Study|Withdrawal by Subject|1|||
23693178|NCT01896232|66254441|FG000|Overall Study|Death|6|||
23395781|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
23395782|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
23395783|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
23395784|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
23395785|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
23395786|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
23498590|NCT02899299|65566376|FG001|Treatment|Other reasons|2|||
23693179|NCT01896232|66254442|FG001|Overall Study|Death|10|||
23693180|NCT01896232|66254441|FG000|Overall Study|Withdrawal by Subject|32|||
23693181|NCT01896232|66254442|FG001|Overall Study|Withdrawal by Subject|31|||
23693182|NCT01896232|66254441|FG000|Overall Study|Sponsor Decision|2|||
23693183|NCT01896232|66254442|FG001|Overall Study|Sponsor Decision|0|||
23693184|NCT01896232|66254441|FG000|Overall Study|Lost to Follow-up|9|||
23693185|NCT01896232|66254442|FG001|Overall Study|Lost to Follow-up|12|||
23693186|NCT04840667|66254445|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
23693187|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
23693188|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
23693189|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
23693190|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
23693191|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
23693192|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
23693193|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Personal issues|2|||
23693194|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Personal issues|0|||
23693195|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Personal issues|0|||
23693196|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Too busy|7|||
23693197|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Too busy|1|||
23693198|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Too busy|0|||
23693199|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Pain|2|||
23693200|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Pain|0|||
23693201|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Pain|0|||
23693202|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Moved|1|||
23693203|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Moved|0|||
23693204|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Moved|0|||
23693205|NCT00594399|66254446|FG000|Initial 3 Month Counseling|Family illness|1|||
23395787|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
23395788|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
23395789|NCT02371889|65195760|FG000|Overall Study|Adverse medication effect|11|||
23395790|NCT02371889|65195761|FG001|Overall Study|Adverse medication effect|2|||
23395791|NCT02371889|65195760|FG000|Overall Study|Lost to Follow-up|6|||
23395792|NCT02371889|65195761|FG001|Overall Study|Lost to Follow-up|5|||
23395793|NCT02371889|65195760|FG000|Overall Study|Personal time constraints|2|||
23395794|NCT02371889|65195761|FG001|Overall Study|Personal time constraints|4|||
23395795|NCT02371889|65195760|FG000|Overall Study|Lack of Efficacy|0|||
23395796|NCT02371889|65195761|FG001|Overall Study|Lack of Efficacy|2|||
23395797|NCT02371889|65195760|FG000|Overall Study|Relapse|0|||
23395798|NCT02371889|65195761|FG001|Overall Study|Relapse|1|||
23395799|NCT03309202|65195762|FG000|Overall Study|Lost to Follow-up|1|||
23395800|NCT03309202|65195763|FG001|Overall Study|Lost to Follow-up|0|||
23395801|NCT03309202|65195764|FG002|Overall Study|Lost to Follow-up|0|||
23395802|NCT03309202|65195765|FG003|Overall Study|Lost to Follow-up|0|||
23693206|NCT00594399|66254447|FG001|Initial 3 Month Counseling|Family illness|0|||
23693207|NCT00594399|66254448|FG002|Initial 3 Month Counseling|Family illness|0|||
23693208|NCT00594399|66254446|FG000|Rerandomization Arm 1 Only|Death|2|||
23693209|NCT00594399|66254447|FG001|Rerandomization Arm 1 Only|Death|1|||
23693210|NCT00594399|66254448|FG002|Rerandomization Arm 1 Only|Death|0|||
23693211|NCT00594399|66254446|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
23693212|NCT00594399|66254447|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
23693213|NCT00594399|66254448|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
23606387|NCT02309892|65947241|FG004|Overall Study|Physician Decision|0|||
23606388|NCT02309892|65947242|FG005|Overall Study|Physician Decision|0|||
23606389|NCT02309892|65947243|FG006|Overall Study|Physician Decision|0|||
23606390|NCT02309892|65947237|FG000|Overall Study|Adverse Event|1|||
23606391|NCT02309892|65947238|FG001|Overall Study|Adverse Event|0|||
23606392|NCT02309892|65947239|FG002|Overall Study|Adverse Event|1|||
23606393|NCT02309892|65947240|FG003|Overall Study|Adverse Event|0|||
23606394|NCT02309892|65947241|FG004|Overall Study|Adverse Event|0|||
23606395|NCT02309892|65947242|FG005|Overall Study|Adverse Event|0|||
23606396|NCT02309892|65947243|FG006|Overall Study|Adverse Event|0|||
23606397|NCT02309892|65947237|FG000|Overall Study|Progressive Disease|0|||
23606398|NCT02309892|65947238|FG001|Overall Study|Progressive Disease|1|||
23606399|NCT02309892|65947239|FG002|Overall Study|Progressive Disease|0|||
23606400|NCT02309892|65947240|FG003|Overall Study|Progressive Disease|0|||
23606401|NCT02309892|65947241|FG004|Overall Study|Progressive Disease|1|||
23606402|NCT02309892|65947242|FG005|Overall Study|Progressive Disease|0|||
23606403|NCT02309892|65947243|FG006|Overall Study|Progressive Disease|0|||
23606404|NCT02309892|65947237|FG000|Overall Study|Death|0|||
23606405|NCT02309892|65947238|FG001|Overall Study|Death|0|||
23606406|NCT02309892|65947239|FG002|Overall Study|Death|0|||
23606407|NCT02309892|65947240|FG003|Overall Study|Death|0|||
23606408|NCT02309892|65947241|FG004|Overall Study|Death|0|||
23606409|NCT02309892|65947242|FG005|Overall Study|Death|1|||
23395803|NCT04129398|65195771|FG000|Overall Study|Physician Decision|2|||
23395804|NCT00954447|65195772|FG000|Overall Study|Adverse Event|33|||
23395805|NCT00954447|65195773|FG001|Overall Study|Adverse Event|25|||
23395806|NCT00954447|65195772|FG000|Overall Study|Lack of Efficacy|17|||
23395807|NCT00954447|65195773|FG001|Overall Study|Lack of Efficacy|3|||
23693214|NCT00670111|66254450|FG000|Enrollment to One Month|Testing Failure|0|||
23693215|NCT00670111|66254451|FG001|Enrollment to One Month|Testing Failure|0|||
23693216|NCT00670111|66254452|FG002|Enrollment to One Month|Testing Failure|13|||
23693217|NCT00670111|66254450|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
23693218|NCT00670111|66254451|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
23693219|NCT00670111|66254452|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
23693220|NCT00670111|66254450|FG000|Enrollment to One Month|Physician Decision|1|||
23693221|NCT00670111|66254451|FG001|Enrollment to One Month|Physician Decision|0|||
23693222|NCT00670111|66254452|FG002|Enrollment to One Month|Physician Decision|0|||
23693223|NCT01051739|66254453|FG000|Overall Study|Death|3|||
23693224|NCT01051739|66254454|FG001|Overall Study|Death|3|||
23693225|NCT01051739|66254453|FG000|Overall Study|Withdrawal by Subject|25|||
23693226|NCT01051739|66254454|FG001|Overall Study|Withdrawal by Subject|10|||
23693227|NCT00963807|66254455|FG000|Overall Study|Physician Decision|2|||
23693228|NCT00963807|66254455|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
23693229|NCT00963807|66254455|FG000|Overall Study|Disease progression|15|||
23693230|NCT01772134|66254461|FG000|Overall Study|Adverse Event|6|||
23693231|NCT01772134|66254462|FG001|Overall Study|Adverse Event|5|||
23693232|NCT01772134|66254463|FG002|Overall Study|Adverse Event|10|||
23693233|NCT01772134|66254461|FG000|Overall Study|Withdrew Consent|3|||
23693234|NCT01772134|66254462|FG001|Overall Study|Withdrew Consent|1|||
23693235|NCT01772134|66254463|FG002|Overall Study|Withdrew Consent|5|||
23693236|NCT01772134|66254461|FG000|Overall Study|Lost to Follow-up|2|||
23693237|NCT01772134|66254462|FG001|Overall Study|Lost to Follow-up|0|||
23693238|NCT01772134|66254463|FG002|Overall Study|Lost to Follow-up|0|||
23693239|NCT01772134|66254461|FG000|Overall Study|Protocol Deviation|4|||
23693240|NCT01772134|66254462|FG001|Overall Study|Protocol Deviation|3|||
23693241|NCT01772134|66254463|FG002|Overall Study|Protocol Deviation|3|||
23693242|NCT01772134|66254461|FG000|Overall Study|Lack of Efficacy|11|||
23693243|NCT01772134|66254462|FG001|Overall Study|Lack of Efficacy|5|||
23693244|NCT01772134|66254463|FG002|Overall Study|Lack of Efficacy|3|||
23693245|NCT01772134|66254461|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
23693246|NCT01772134|66254462|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23693247|NCT01772134|66254463|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
23693248|NCT01772134|66254461|FG000|Overall Study|Randomized Study Medication Not Received|2|||
23693249|NCT01772134|66254462|FG001|Overall Study|Randomized Study Medication Not Received|0|||
23693250|NCT01772134|66254463|FG002|Overall Study|Randomized Study Medication Not Received|1|||
23693251|NCT05029622|66254465|FG000|Overall Study|Lost to Follow-up|1|||
23693252|NCT03212261|66254468|FG000|Overall Study|Became ineligible d/t tech|2|||
23693253|NCT03212261|66254468|FG000|Overall Study|Tech Trouble- No first study visit|1|||
23693254|NCT03212261|66254468|FG000|Overall Study|Lost to Follow-up|7|||
23693255|NCT03212261|66254468|FG000|Overall Study|Family Emergency|1|||
23693256|NCT03212261|66254468|FG000|Overall Study|Too busy/ No time|5|||
23693257|NCT00636818|66254469|FG000|Overall Study|Adverse Event|1|||
23693258|NCT00636818|66254469|FG000|Overall Study|Lost to Follow-up|2|||
23693259|NCT00636818|66254469|FG000|Overall Study|Entry Criteria Exclusion|3|||
23693260|NCT00636818|66254469|FG000|Overall Study|Protocol Violation|1|||
23693261|NCT00636818|66254469|FG000|Overall Study|Withdrawal by Subject|4|||
23693262|NCT00524303|66254470|FG000|Overall Study|Lost to Follow-up|6|||
23693263|NCT00524303|66254471|FG001|Overall Study|Lost to Follow-up|0|||
23693264|NCT00524303|66254472|FG002|Overall Study|Lost to Follow-up|3|||
23693265|NCT00524303|66254470|FG000|Overall Study|Protocol Violation|0|||
23693266|NCT00524303|66254471|FG001|Overall Study|Protocol Violation|1|||
23693267|NCT00524303|66254472|FG002|Overall Study|Protocol Violation|1|||
23693268|NCT00524303|66254470|FG000|Overall Study|Withdrawal by Subject|3|||
23693269|NCT00524303|66254471|FG001|Overall Study|Withdrawal by Subject|0|||
23693270|NCT00524303|66254472|FG002|Overall Study|Withdrawal by Subject|4|||
23693271|NCT00524303|66254470|FG000|Overall Study|Death|0|||
23693272|NCT00524303|66254471|FG001|Overall Study|Death|2|||
23693273|NCT00524303|66254472|FG002|Overall Study|Death|3|||
23693274|NCT00524303|66254470|FG000|Overall Study|Adverse Event|1|||
23395808|NCT00954447|65195772|FG000|Overall Study|Protocol Violation|5|||
23395809|NCT00954447|65195773|FG001|Overall Study|Protocol Violation|7|||
23498591|NCT02899299|65566375|FG000|Treatment|Not reported|7|||
23693275|NCT00524303|66254471|FG001|Overall Study|Adverse Event|2|||
23693276|NCT00524303|66254472|FG002|Overall Study|Adverse Event|3|||
23693277|NCT00524303|66254470|FG000|Overall Study|Did not Complete Study Dosing|1|||
23693278|NCT00524303|66254471|FG001|Overall Study|Did not Complete Study Dosing|0|||
23498592|NCT02899299|65566376|FG001|Treatment|Not reported|0|||
23498593|NCT01332331|65566377|FG000|Overall Study|Lost to Follow-up|0|||
23498594|NCT01332331|65566378|FG001|Overall Study|Lost to Follow-up|1|||
23693279|NCT00524303|66254472|FG002|Overall Study|Did not Complete Study Dosing|0|||
23693280|NCT00524303|66254470|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
23693281|NCT00524303|66254471|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
23693282|NCT00524303|66254472|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
23693283|NCT00524303|66254470|FG000|Overall Study|Disease Progression|0|||
23693284|NCT00524303|66254471|FG001|Overall Study|Disease Progression|4|||
23693285|NCT00524303|66254472|FG002|Overall Study|Disease Progression|1|||
23693286|NCT00524303|66254470|FG000|Overall Study|Disease Recurrence|0|||
23693287|NCT00524303|66254471|FG001|Overall Study|Disease Recurrence|1|||
23693288|NCT00524303|66254472|FG002|Overall Study|Disease Recurrence|0|||
23693289|NCT00524303|66254470|FG000|Overall Study|Sponsor Request|0|||
23693290|NCT00524303|66254471|FG001|Overall Study|Sponsor Request|0|||
23693291|NCT00524303|66254472|FG002|Overall Study|Sponsor Request|1|||
23693292|NCT00524303|66254470|FG000|Overall Study|Physician Decision|0|||
23693293|NCT00524303|66254471|FG001|Overall Study|Physician Decision|0|||
23693294|NCT00524303|66254472|FG002|Overall Study|Physician Decision|1|||
23693295|NCT00524303|66254470|FG000|Overall Study|Completed 5 years|0|||
23693296|NCT00524303|66254471|FG001|Overall Study|Completed 5 years|0|||
23693297|NCT00524303|66254472|FG002|Overall Study|Completed 5 years|1|||
23693298|NCT00532259|66254477|FG000|Overall Study|Withdrawal by Subject|2|||
23693299|NCT00532259|66254477|FG000|Overall Study|Adverse Event|1|||
23693300|NCT00532259|66254477|FG000|Overall Study|Death|1|||
23693301|NCT00532259|66254477|FG000|Overall Study|Lack of Efficacy|21|||
23693302|NCT00532259|66254477|FG000|Overall Study|Lost to Follow-up|3|||
23693303|NCT00532259|66254477|FG000|Overall Study|Physician Decision|3|||
23693304|NCT00532259|66254477|FG000|Overall Study|Protocol Violation|1|||
23693305|NCT04734873|66254479|FG000|Overall Study|Lost to Follow-up|1|||
23693306|NCT04734873|66254480|FG001|Overall Study|Lost to Follow-up|3|||
23693307|NCT04734873|66254481|FG002|Overall Study|Lost to Follow-up|2|||
23693308|NCT04734873|66254479|FG000|Overall Study|Randomized but not dosed|1|||
23693309|NCT04734873|66254480|FG001|Overall Study|Randomized but not dosed|0|||
23693310|NCT04734873|66254481|FG002|Overall Study|Randomized but not dosed|1|||
23693311|NCT02623361|66254482|FG000|Overall Study|Protocol Violation|0|||
23693312|NCT02623361|66254483|FG001|Overall Study|Protocol Violation|1|||
23693313|NCT02623361|66254482|FG000|Overall Study|Withdrawal by Subject|0|||
23693314|NCT02623361|66254483|FG001|Overall Study|Withdrawal by Subject|1|||
23693315|NCT00504257|66254484|FG000|Overall Study|Withdrawal by Subject|2|||
23693316|NCT00504257|66254484|FG000|Overall Study|ineligible histology|2|||
23693317|NCT01252966|66254486|FG000|Overall Study|Lost to Follow-up|16|||
23693318|NCT01252966|66254487|FG001|Overall Study|Lost to Follow-up|10|||
23693319|NCT01252966|66254486|FG000|Overall Study|Withdrawal by Subject|7|||
23693320|NCT01252966|66254487|FG001|Overall Study|Withdrawal by Subject|3|||
23395810|NCT00954447|65195772|FG000|Overall Study|Lost to Follow-up|8|||
23395811|NCT00954447|65195773|FG001|Overall Study|Lost to Follow-up|14|||
23395812|NCT00954447|65195772|FG000|Overall Study|Withdrawal by Subject|26|||
23395813|NCT00954447|65195773|FG001|Overall Study|Withdrawal by Subject|21|||
23395814|NCT00954447|65195772|FG000|Overall Study|Other|21|||
23395815|NCT00954447|65195773|FG001|Overall Study|Other|18|||
23395816|NCT03038087|65195774|FG000|Overall Study|lost data|1|||
23395817|NCT04103450|65195778|FG000|Overall Study|Adverse Event|4|||
23395818|NCT04103450|65195779|FG001|Overall Study|Adverse Event|2|||
23395819|NCT04103450|65195778|FG000|Overall Study|Lack of Efficacy|3|||
23395820|NCT04103450|65195779|FG001|Overall Study|Lack of Efficacy|0|||
23395821|NCT04103450|65195778|FG000|Overall Study|Withdrawal by Subject|5|||
23395822|NCT04103450|65195779|FG001|Overall Study|Withdrawal by Subject|3|||
23395823|NCT04103450|65195778|FG000|Overall Study|Lost to Follow-up|1|||
23395824|NCT04103450|65195779|FG001|Overall Study|Lost to Follow-up|2|||
23395825|NCT04103450|65195778|FG000|Overall Study|Physician Decision|1|||
23395826|NCT04103450|65195779|FG001|Overall Study|Physician Decision|2|||
23395827|NCT04103450|65195778|FG000|Overall Study|Protocol Violation|1|||
23395828|NCT04103450|65195779|FG001|Overall Study|Protocol Violation|0|||
23693321|NCT01967225|66254490|FG000|Overall Study|Adverse Event|3|||
23693322|NCT01967225|66254491|FG001|Overall Study|Adverse Event|1|||
23693323|NCT01967225|66254490|FG000|Overall Study|Withdrawal by Subject|2|||
23693324|NCT01967225|66254491|FG001|Overall Study|Withdrawal by Subject|1|||
23693325|NCT01967225|66254490|FG000|Overall Study|Lack of Efficacy|1|||
23693326|NCT01967225|66254491|FG001|Overall Study|Lack of Efficacy|1|||
23693327|NCT01967225|66254490|FG000|Overall Study|Switching to other therapy|2|||
23693328|NCT01967225|66254491|FG001|Overall Study|Switching to other therapy|0|||
23693329|NCT01967225|66254490|FG000|Overall Study|Protocol driven decision point|1|||
23395829|NCT04103450|65195778|FG000|Overall Study|Other|1|||
23395830|NCT04103450|65195779|FG001|Overall Study|Other|1|||
23395831|NCT01153516|65195780|FG000|Overall Study|Both subjects refused surgery|2|||
23395832|NCT01153516|65195781|FG001|Overall Study|Both subjects refused surgery|0|||
23395833|NCT01156844|65195782|FG000|Overall Study|Adverse Event|0|||
23693330|NCT01967225|66254491|FG001|Overall Study|Protocol driven decision point|0|||
23693331|NCT01967225|66254490|FG000|Overall Study|Logistical difficulties|1|||
23693332|NCT01967225|66254491|FG001|Overall Study|Logistical difficulties|0|||
23693333|NCT01967225|66254490|FG000|Overall Study|Protocol Violation|2|||
23693334|NCT01967225|66254491|FG001|Overall Study|Protocol Violation|0|||
23693335|NCT02499952|66254492|FG000|Overall Study|Lost to Follow-up|1|||
23693336|NCT02499952|66254492|FG000|Overall Study|Death|9|||
23693337|NCT00215150|66254493|FG000|Open Label Phase|Lost to Follow-up|7|||
23693338|NCT00215150|66254493|FG000|Open Label Phase|Withdrawal by Subject|1|||
23693339|NCT00215150|66254493|FG000|Open Label Phase|Did not complete a post base visit|13|||
23693340|NCT00215150|66254493|FG000|Open Label Phase|Did not meet randomization criteria|9|||
23693341|NCT00215150|66254493|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
23693342|NCT00215150|66254493|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
23693343|NCT00215150|66254493|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
23693344|NCT02286102|66254495|FG000|Overall Study|Screen Failure|1|||
23693345|NCT02286102|66254496|FG001|Overall Study|Screen Failure|1|||
23693346|NCT00996840|66254497|FG000|Overall Study|Adverse Event|0|||
23693347|NCT00996840|66254498|FG001|Overall Study|Adverse Event|1|||
23693348|NCT00996840|66254499|FG002|Overall Study|Adverse Event|0|||
23693349|NCT00996840|66254500|FG003|Overall Study|Adverse Event|0|||
23693350|NCT00996840|66254501|FG004|Overall Study|Adverse Event|0|||
23693351|NCT00996840|66254497|FG000|Overall Study|Physician Decision|0|||
23693352|NCT00996840|66254498|FG001|Overall Study|Physician Decision|0|||
23693353|NCT00996840|66254499|FG002|Overall Study|Physician Decision|1|||
23693354|NCT00996840|66254500|FG003|Overall Study|Physician Decision|1|||
23693355|NCT00996840|66254501|FG004|Overall Study|Physician Decision|2|||
23693356|NCT00996840|66254497|FG000|Overall Study|Withdrawal by Subject|1|||
23693357|NCT00996840|66254498|FG001|Overall Study|Withdrawal by Subject|1|||
23693358|NCT00996840|66254499|FG002|Overall Study|Withdrawal by Subject|0|||
23693359|NCT00996840|66254500|FG003|Overall Study|Withdrawal by Subject|0|||
23693360|NCT00996840|66254501|FG004|Overall Study|Withdrawal by Subject|0|||
23693361|NCT01071070|66254504|FG000|Overall Study|Adverse Event|0|||
23693362|NCT01071070|66254505|FG001|Overall Study|Adverse Event|3|||
23693363|NCT01071070|66254504|FG000|Overall Study|Withdrawal by Subject|1|||
23693364|NCT01071070|66254505|FG001|Overall Study|Withdrawal by Subject|0|||
23693365|NCT01071070|66254504|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
23693366|NCT01071070|66254505|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
23693367|NCT01071070|66254504|FG000|Overall Study|Hypercalcemia|1|||
23693368|NCT01071070|66254505|FG001|Overall Study|Hypercalcemia|0|||
23693369|NCT01025635|66254506|FG000|Overall Study|Withdrawal by Subject|6|||
23693370|NCT01025635|66254507|FG001|Overall Study|Withdrawal by Subject|7|||
23693371|NCT01025635|66254506|FG000|Overall Study|Protocol Violation|4|||
23693372|NCT01025635|66254507|FG001|Overall Study|Protocol Violation|2|||
23693373|NCT01025635|66254506|FG000|Overall Study|Lack of Efficacy|0|||
23693374|NCT01025635|66254507|FG001|Overall Study|Lack of Efficacy|1|||
23693375|NCT01025635|66254506|FG000|Overall Study|Lost to Follow-up|9|||
23693376|NCT01025635|66254507|FG001|Overall Study|Lost to Follow-up|13|||
23693377|NCT01025635|66254506|FG000|Overall Study|Reason not known|4|||
23693378|NCT01025635|66254507|FG001|Overall Study|Reason not known|2|||
23693379|NCT02286960|66254508|FG000|Overall Study|Lost to Follow-up|3|||
23693380|NCT02286960|66254509|FG001|Overall Study|Lost to Follow-up|3|||
23693381|NCT01633060|66254510|FG000|Randomization Phase|Protocol deviation|1|||
23693382|NCT01633060|66254511|FG001|Randomization Phase|Protocol deviation|2|||
23693383|NCT01633060|66254510|FG000|Randomization Phase|Technical problem|0|||
23693384|NCT01633060|66254511|FG001|Randomization Phase|Technical problem|1|||
23693385|NCT01633060|66254510|FG000|Treatment Phase|Adverse Event|24|||
23693386|NCT01633060|66254511|FG001|Treatment Phase|Adverse Event|3|||
23693387|NCT01633060|66254510|FG000|Treatment Phase|Lost to Follow-up|1|||
23693388|NCT01633060|66254511|FG001|Treatment Phase|Lost to Follow-up|0|||
23693389|NCT01633060|66254510|FG000|Treatment Phase|Physician Decision|16|||
23693390|NCT01633060|66254511|FG001|Treatment Phase|Physician Decision|7|||
23693391|NCT01633060|66254510|FG000|Treatment Phase|Progressive Disease|210|||
23693392|NCT01633060|66254511|FG001|Treatment Phase|Progressive Disease|120|||
23693393|NCT01633060|66254510|FG000|Treatment Phase|Protocol Deviation|1|||
23693394|NCT01633060|66254511|FG001|Treatment Phase|Protocol Deviation|0|||
23693395|NCT01633060|66254510|FG000|Treatment Phase|Study Terminated by sponsor|7|||
23693396|NCT01633060|66254511|FG001|Treatment Phase|Study Terminated by sponsor|3|||
23693397|NCT01633060|66254510|FG000|Treatment Phase|Subject/guardian decision|25|||
23693398|NCT01633060|66254511|FG001|Treatment Phase|Subject/guardian decision|4|||
23498595|NCT01332331|65566377|FG000|Overall Study|Adverse Event|1|||
23693399|NCT01633060|66254510|FG000|Treatment Phase|Death|4|||
23693400|NCT01633060|66254511|FG001|Treatment Phase|Death|3|||
23693401|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
23693402|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23693403|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
23693404|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
23693405|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
23693406|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
23693407|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
23693408|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
23693409|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23693410|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23693411|NCT01633060|66254510|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
23693412|NCT01633060|66254511|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
23693413|NCT02986373|66254512|FG000|Overall Study|Adverse Event|4|||
23693414|NCT02986373|66254512|FG000|Overall Study|Lost to Follow-up|1|||
23693415|NCT02986373|66254512|FG000|Overall Study|Withdrawal by Subject|10|||
23693416|NCT02986373|66254512|FG000|Overall Study|Other|24|||
23693417|NCT04329949|66254513|FG000|Overall Study|Death|36|||
23693418|NCT04329949|66254513|FG000|Overall Study|Withdrawal by Subject|4|||
23693419|NCT04329949|66254513|FG000|Overall Study|Termination of study by sponsor|3|||
23693420|NCT01357239|66254516|FG000|Stratum: All Patients|Adverse Event|0|||
23693421|NCT01357239|66254517|FG001|Stratum: All Patients|Adverse Event|0|||
23693422|NCT01357239|66254518|FG002|Stratum: All Patients|Adverse Event|1|||
23693423|NCT01357239|66254519|FG003|Stratum: All Patients|Adverse Event|1|||
23693424|NCT01357239|66254516|FG000|Stratum: All Patients|Subject withdrew consent|0|||
23693425|NCT01357239|66254517|FG001|Stratum: All Patients|Subject withdrew consent|0|||
23693426|NCT01357239|66254518|FG002|Stratum: All Patients|Subject withdrew consent|1|||
23693427|NCT01357239|66254519|FG003|Stratum: All Patients|Subject withdrew consent|1|||
23693428|NCT01357239|66254516|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
23693429|NCT01357239|66254517|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
23693430|NCT01357239|66254518|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
23693431|NCT01357239|66254519|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
23693432|NCT01357239|66254516|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
23693433|NCT01357239|66254517|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
23693434|NCT01357239|66254518|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
23693435|NCT01357239|66254519|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
23693436|NCT01357239|66254516|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
23693437|NCT01357239|66254517|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
23693438|NCT01357239|66254518|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
23693439|NCT01357239|66254519|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
23693440|NCT00824564|66254520|FG000|Overall Study|Lost to Follow-up|5|||
23693441|NCT00824564|66254521|FG001|Overall Study|Lost to Follow-up|7|||
23693442|NCT00824564|66254520|FG000|Overall Study|Withdrawal by Subject|1|||
23693443|NCT00824564|66254521|FG001|Overall Study|Withdrawal by Subject|1|||
23693444|NCT00824564|66254520|FG000|Overall Study|Other|1|||
23693445|NCT00824564|66254521|FG001|Overall Study|Other|2|||
23693446|NCT00824564|66254520|FG000|Overall Study|Randomized, but not treated|1|||
23693447|NCT00824564|66254521|FG001|Overall Study|Randomized, but not treated|0|||
23693448|NCT00658333|66254522|FG000|Overall Study|Adverse Event|2|||
23693449|NCT00658333|66254523|FG001|Overall Study|Adverse Event|1|||
23693450|NCT02299934|66254524|FG000|Overall Study|Termination of study|13|||
23693451|NCT00391976|66254528|FG000|Overall Study|Adverse Event|0|||
23693452|NCT00391976|66254529|FG001|Overall Study|Adverse Event|0|||
23693453|NCT00391976|66254530|FG002|Overall Study|Adverse Event|1|||
23693454|NCT00391976|66254528|FG000|Overall Study|Withdrawal of consent|0|||
23693455|NCT00391976|66254529|FG001|Overall Study|Withdrawal of consent|1|||
23693456|NCT00391976|66254530|FG002|Overall Study|Withdrawal of consent|1|||
23693457|NCT00391976|66254528|FG000|Overall Study|Lost to Follow-up|1|||
23693458|NCT00391976|66254529|FG001|Overall Study|Lost to Follow-up|2|||
23693459|NCT00391976|66254530|FG002|Overall Study|Lost to Follow-up|0|||
23693460|NCT00391976|66254528|FG000|Overall Study|Inappropriate enrollment|1|||
23693461|NCT00391976|66254529|FG001|Overall Study|Inappropriate enrollment|1|||
23693462|NCT00391976|66254530|FG002|Overall Study|Inappropriate enrollment|0|||
23693463|NCT00391976|66254528|FG000|Overall Study|Protocol deviation/violation|4|||
23693464|NCT00391976|66254529|FG001|Overall Study|Protocol deviation/violation|2|||
23693465|NCT00391976|66254530|FG002|Overall Study|Protocol deviation/violation|1|||
23693466|NCT00391976|66254528|FG000|Overall Study|Recurrence/no eradication of infection|21|||
23693467|NCT00391976|66254529|FG001|Overall Study|Recurrence/no eradication of infection|19|||
23693468|NCT00391976|66254530|FG002|Overall Study|Recurrence/no eradication of infection|0|||
23693469|NCT00391976|66254528|FG000|Overall Study|Unable to classify|0|||
23693470|NCT00391976|66254529|FG001|Overall Study|Unable to classify|0|||
23693471|NCT00391976|66254530|FG002|Overall Study|Unable to classify|1|||
23693472|NCT00391976|66254528|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
23693473|NCT00391976|66254529|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
23693474|NCT00391976|66254530|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
23693475|NCT02919306|66254531|FG000|Overall Study|Withdrawal by Subject|1|||
23693476|NCT02919306|66254532|FG001|Overall Study|Withdrawal by Subject|0|||
23693477|NCT02919306|66254531|FG000|Overall Study|Protocol Violation|1|||
23693478|NCT02919306|66254532|FG001|Overall Study|Protocol Violation|0|||
23693479|NCT02580058|66254533|FG000|Overall Study|Adverse Event|16|||
23693480|NCT02580058|66254534|FG001|Overall Study|Adverse Event|30|||
23693481|NCT02580058|66254535|FG002|Overall Study|Adverse Event|20|||
23693482|NCT02580058|66254533|FG000|Overall Study|Death|4|||
23693483|NCT02580058|66254534|FG001|Overall Study|Death|4|||
23693484|NCT02580058|66254535|FG002|Overall Study|Death|5|||
23693485|NCT02580058|66254533|FG000|Overall Study|Physician Decision|1|||
23693486|NCT02580058|66254534|FG001|Overall Study|Physician Decision|3|||
23693487|NCT02580058|66254535|FG002|Overall Study|Physician Decision|11|||
23693488|NCT02580058|66254533|FG000|Overall Study|Other|5|||
23693489|NCT02580058|66254534|FG001|Overall Study|Other|1|||
23693490|NCT02580058|66254535|FG002|Overall Study|Other|3|||
23693491|NCT02580058|66254533|FG000|Overall Study|Withdrawal by Subject|4|||
23693492|NCT02580058|66254534|FG001|Overall Study|Withdrawal by Subject|7|||
23693493|NCT02580058|66254535|FG002|Overall Study|Withdrawal by Subject|31|||
23693494|NCT02580058|66254533|FG000|Overall Study|Global Deterioration of Health Status|19|||
23693495|NCT02580058|66254534|FG001|Overall Study|Global Deterioration of Health Status|18|||
23693496|NCT02580058|66254535|FG002|Overall Study|Global Deterioration of Health Status|24|||
23693497|NCT02580058|66254533|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
23693498|NCT02580058|66254534|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23693499|NCT02580058|66254535|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
23693500|NCT02580058|66254533|FG000|Overall Study|Progressive Disease|137|||
23693501|NCT02580058|66254534|FG001|Overall Study|Progressive Disease|125|||
23693502|NCT02580058|66254535|FG002|Overall Study|Progressive Disease|94|||
23693503|NCT02580058|66254533|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23693504|NCT02580058|66254534|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23693505|NCT02580058|66254535|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23693506|NCT01059812|66254538|FG000|Overall Study|Adverse Event|9|||
23693507|NCT01059812|66254539|FG001|Overall Study|Adverse Event|5|||
23693508|NCT01059812|66254538|FG000|Overall Study|Lack of Efficacy|2|||
23693509|NCT01059812|66254539|FG001|Overall Study|Lack of Efficacy|2|||
23693510|NCT01059812|66254538|FG000|Overall Study|Protocol Violation|3|||
23693511|NCT01059812|66254539|FG001|Overall Study|Protocol Violation|1|||
23498596|NCT01332331|65566378|FG001|Overall Study|Adverse Event|1|||
23693512|NCT01059812|66254538|FG000|Overall Study|Withdrawal Criteria|9|||
23693513|NCT01059812|66254539|FG001|Overall Study|Withdrawal Criteria|4|||
23693514|NCT01059812|66254538|FG000|Overall Study|Unclassified|14|||
23693515|NCT01059812|66254539|FG001|Overall Study|Unclassified|4|||
23693516|NCT00206518|66254542|FG000|Overall Study|Lack of Efficacy|6|||
23693517|NCT00206518|66254543|FG001|Overall Study|Lack of Efficacy|4|||
23693518|NCT00206518|66254542|FG000|Overall Study|Adverse Event|2|||
23693519|NCT00206518|66254543|FG001|Overall Study|Adverse Event|1|||
23693520|NCT00206518|66254542|FG000|Overall Study|Physician Decision|1|||
23693521|NCT00206518|66254543|FG001|Overall Study|Physician Decision|0|||
23693522|NCT00206518|66254542|FG000|Overall Study|Protocol Violation|1|||
23693523|NCT00206518|66254543|FG001|Overall Study|Protocol Violation|1|||
23693524|NCT00793585|66257119|FG000|Overall Study|Adverse Event|1|||
23693525|NCT00793585|66257120|FG001|Overall Study|Adverse Event|1|||
23693526|NCT00793585|66257119|FG000|Overall Study|Protocol Violation|1|||
23693527|NCT00793585|66257120|FG001|Overall Study|Protocol Violation|2|||
23693528|NCT01687673|66257123|FG000|Overall Study|Physician Decision|1|||
23693529|NCT03846947|66257126|FG000|Overall Study|technical issues with imaging sequence|2|||
23693530|NCT05309083|66257131|FG000|Overall Study|Withdrawal by Subject|2|||
23693531|NCT00519077|66257132|FG000|Overall Study|Death|6|||
23693532|NCT00519077|66257132|FG000|Overall Study|Other|2|||
23693533|NCT00553787|66257133|FG000|Overall Study|Adverse Event|34|||
23693534|NCT00553787|66257134|FG001|Overall Study|Adverse Event|21|||
23693535|NCT00553787|66257135|FG002|Overall Study|Adverse Event|67|||
23693536|NCT00553787|66257133|FG000|Overall Study|Lost to Follow-up|132|||
23693537|NCT00553787|66257134|FG001|Overall Study|Lost to Follow-up|44|||
23693538|NCT00553787|66257135|FG002|Overall Study|Lost to Follow-up|78|||
23693539|NCT00553787|66257133|FG000|Overall Study|Withdrawal by Subject|151|||
23693540|NCT00553787|66257134|FG001|Overall Study|Withdrawal by Subject|40|||
23693541|NCT00553787|66257135|FG002|Overall Study|Withdrawal by Subject|83|||
23693542|NCT00553787|66257133|FG000|Overall Study|Lack of Efficacy|31|||
23693543|NCT00553787|66257134|FG001|Overall Study|Lack of Efficacy|1|||
23693544|NCT00553787|66257135|FG002|Overall Study|Lack of Efficacy|3|||
23693545|NCT00553787|66257133|FG000|Overall Study|Pregnancy|0|||
23693546|NCT00553787|66257134|FG001|Overall Study|Pregnancy|1|||
23693547|NCT00553787|66257135|FG002|Overall Study|Pregnancy|2|||
23693548|NCT00553787|66257133|FG000|Overall Study|non compliance|4|||
23395834|NCT01156844|65195783|FG001|Overall Study|Adverse Event|0|||
23395835|NCT01156844|65195784|FG002|Overall Study|Adverse Event|1|||
23395836|NCT01156844|65195785|FG003|Overall Study|Adverse Event|1|||
23395837|NCT01156844|65195782|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23395838|NCT01156844|65195783|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23395839|NCT01156844|65195784|FG002|Overall Study|Abnormal test procedure result(s)|2|||
23395840|NCT01156844|65195785|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23395841|NCT01156844|65195782|FG000|Overall Study|Withdrawal by Subject|0|||
23693549|NCT00553787|66257134|FG001|Overall Study|non compliance|0|||
23693550|NCT00553787|66257135|FG002|Overall Study|non compliance|11|||
23693551|NCT00553787|66257133|FG000|Overall Study|Requirement for restricted medication|8|||
23693552|NCT00553787|66257134|FG001|Overall Study|Requirement for restricted medication|7|||
23395842|NCT01156844|65195783|FG001|Overall Study|Withdrawal by Subject|0|||
23498597|NCT01332331|65566377|FG000|Overall Study|Physician Decision|1|||
23693553|NCT00553787|66257135|FG002|Overall Study|Requirement for restricted medication|5|||
23693554|NCT00553787|66257133|FG000|Overall Study|Other|18|||
23693555|NCT00553787|66257134|FG001|Overall Study|Other|10|||
23693556|NCT00553787|66257135|FG002|Overall Study|Other|13|||
23693557|NCT01919307|66257136|FG000|Overall Study|Withdrawal by Subject|9|||
23693558|NCT01451515|66257137|FG000|Overall Study|Death|0|||
23693559|NCT01451515|66257138|FG001|Overall Study|Death|1|||
23395843|NCT01156844|65195784|FG002|Overall Study|Withdrawal by Subject|2|||
23395844|NCT01156844|65195785|FG003|Overall Study|Withdrawal by Subject|2|||
23693560|NCT01451515|66257139|FG002|Overall Study|Death|0|||
23693561|NCT01451515|66257137|FG000|Overall Study|Withdrawal by Subject|0|||
23693562|NCT01451515|66257138|FG001|Overall Study|Withdrawal by Subject|1|||
23693563|NCT01451515|66257139|FG002|Overall Study|Withdrawal by Subject|0|||
23693564|NCT01451515|66257137|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
23693565|NCT01451515|66257138|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
23693566|NCT01451515|66257139|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
23693567|NCT01451515|66257137|FG000|Overall Study|Relapse (except CNS)|1|||
23693568|NCT01451515|66257138|FG001|Overall Study|Relapse (except CNS)|1|||
23693569|NCT01451515|66257139|FG002|Overall Study|Relapse (except CNS)|0|||
23693570|NCT02452359|66257140|FG000|Overall Study|Adverse Event|1|||
23693571|NCT02452359|66257140|FG000|Overall Study|Lost to Follow-up|15|||
23693572|NCT02452359|66257140|FG000|Overall Study|Pregnancy|1|||
23693573|NCT02452359|66257140|FG000|Overall Study|Withdrawal by Subject|4|||
23693574|NCT01389128|66257141|FG000|Overall Study|Fetal distress|1|||
23693575|NCT01389128|66257142|FG001|Overall Study|Fetal distress|0|||
23693576|NCT01389128|66257141|FG000|Overall Study|Cervix dilation stop|1|||
23693577|NCT01389128|66257142|FG001|Overall Study|Cervix dilation stop|2|||
23693578|NCT01389128|66257141|FG000|Overall Study|Rapid labor evolution|3|||
23693579|NCT01389128|66257142|FG001|Overall Study|Rapid labor evolution|2|||
23693580|NCT01389128|66257141|FG000|Overall Study|Intolerance to procedure|0|||
23693581|NCT01389128|66257142|FG001|Overall Study|Intolerance to procedure|2|||
23693582|NCT03486314|66257146|FG000|Part A|Adverse Event|1|||
23693583|NCT03486314|66257147|FG001|Part A|Adverse Event|0|||
23693584|NCT03486314|66257148|FG002|Part A|Adverse Event|0|||
23395845|NCT01156844|65195782|FG000|Overall Study|Lost to Follow-up|0|||
23395846|NCT01156844|65195783|FG001|Overall Study|Lost to Follow-up|0|||
23395847|NCT01156844|65195784|FG002|Overall Study|Lost to Follow-up|1|||
23395848|NCT01156844|65195785|FG003|Overall Study|Lost to Follow-up|0|||
23395849|NCT01156844|65195782|FG000|Overall Study|Administrative problems|0|||
23395850|NCT01156844|65195783|FG001|Overall Study|Administrative problems|1|||
23395851|NCT01156844|65195784|FG002|Overall Study|Administrative problems|0|||
23395852|NCT01156844|65195785|FG003|Overall Study|Administrative problems|1|||
23395853|NCT01156844|65195782|FG000|Overall Study|Protocol deviation|2|||
23395854|NCT01156844|65195783|FG001|Overall Study|Protocol deviation|0|||
23395855|NCT01156844|65195784|FG002|Overall Study|Protocol deviation|0|||
23395856|NCT01156844|65195785|FG003|Overall Study|Protocol deviation|0|||
23395857|NCT01605097|65195786|FG000|Overall Study|Protocol Violation|1|||
23395858|NCT02746809|65195788|FG000|Enrollment|Inclusion Exclusion not met|9|||
23395859|NCT02746809|65195788|FG000|Enrollment|Withdrawal by Subject|1|||
23395860|NCT02746809|65195788|FG000|Enrollment|Expected Enrollment Met|2|||
23395861|NCT02746809|65195788|FG000|Procedure|Death|1|||
23395862|NCT02746809|65195788|FG000|1-Month|Death|5|||
23395863|NCT02746809|65195788|FG000|6-Month|Death|2|||
23395864|NCT02746809|65195788|FG000|6-Month|Withdrawal by Subject|1|||
23395865|NCT02746809|65195788|FG000|12-Month|Death|3|||
23395866|NCT02746809|65195788|FG000|12-Month|Withdrawal by Subject|2|||
23395867|NCT02746809|65195788|FG000|24-Month|Death|1|||
23395868|NCT02746809|65195788|FG000|24-Month|Withdrawal by Subject|1|||
23395869|NCT02746809|65195788|FG000|36-Month|Death|8|||
23395870|NCT02746809|65195788|FG000|36-Month|Withdrawal by Subject|1|||
23395871|NCT02746809|65195788|FG000|48-Month|Death|7|||
23395872|NCT02746809|65195788|FG000|48-Month|Withdrawal by Subject|1|||
23693585|NCT03486314|66257146|FG000|Part A|Symptomatic Deterioration|2|||
23693586|NCT03486314|66257147|FG001|Part A|Symptomatic Deterioration|0|||
23693587|NCT03486314|66257148|FG002|Part A|Symptomatic Deterioration|0|||
23693588|NCT02489630|66257151|FG000|Overall Study|Oversedation|1|||
23693589|NCT02489630|66257152|FG001|Overall Study|Oversedation|1|||
23693590|NCT02489630|66257151|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
23693591|NCT02489630|66257152|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
23693592|NCT03478683|66257155|FG000|Overall Study|Adverse Event|5|||
23395873|NCT02746809|65195788|FG000|60-Month|Death|1|||
23395874|NCT02746809|65195788|FG000|60-Month|Lost to Follow-up|2|||
23395875|NCT01217892|65195791|FG000|Overall Study|Adverse Event|1|||
23395876|NCT01217892|65195792|FG001|Overall Study|Adverse Event|1|||
23395877|NCT01217892|65195793|FG002|Overall Study|Adverse Event|1|||
23395878|NCT01217892|65195794|FG003|Overall Study|Adverse Event|0|||
23395879|NCT01217892|65195791|FG000|Overall Study|Withdrawal by Subject|0|||
23395880|NCT01217892|65195792|FG001|Overall Study|Withdrawal by Subject|2|||
23395881|NCT01217892|65195793|FG002|Overall Study|Withdrawal by Subject|1|||
23395882|NCT01217892|65195794|FG003|Overall Study|Withdrawal by Subject|0|||
23395883|NCT01217892|65195791|FG000|Overall Study|Lab value|1|||
23395884|NCT01217892|65195792|FG001|Overall Study|Lab value|0|||
23395885|NCT01217892|65195793|FG002|Overall Study|Lab value|1|||
23395886|NCT01217892|65195794|FG003|Overall Study|Lab value|0|||
23395887|NCT01217892|65195791|FG000|Overall Study|Subject no longer meets study criteria|5|||
23395888|NCT01217892|65195792|FG001|Overall Study|Subject no longer meets study criteria|2|||
23395889|NCT01217892|65195793|FG002|Overall Study|Subject no longer meets study criteria|4|||
23395890|NCT01217892|65195794|FG003|Overall Study|Subject no longer meets study criteria|8|||
23395891|NCT01217892|65195791|FG000|Overall Study|Incorrect enrollment|0|||
23395892|NCT01217892|65195792|FG001|Overall Study|Incorrect enrollment|1|||
23395893|NCT01217892|65195793|FG002|Overall Study|Incorrect enrollment|1|||
23395894|NCT01217892|65195794|FG003|Overall Study|Incorrect enrollment|0|||
23395895|NCT01217892|65195791|FG000|Overall Study|Poor/Non-Compliance|0|||
23395896|NCT01217892|65195792|FG001|Overall Study|Poor/Non-Compliance|0|||
23395897|NCT01217892|65195793|FG002|Overall Study|Poor/Non-Compliance|1|||
23395898|NCT01217892|65195794|FG003|Overall Study|Poor/Non-Compliance|0|||
23395899|NCT00437073|65195806|FG000|Overall Study|Sponsor Terminated Study|1|||
23395900|NCT00437073|65195807|FG001|Overall Study|Sponsor Terminated Study|0|||
23395901|NCT00437073|65195806|FG000|Overall Study|Physician Decision|0|||
23395902|NCT00437073|65195807|FG001|Overall Study|Physician Decision|1|||
23395903|NCT02997202|65195814|FG000|Overall Study|Miscellaneous|2|||
23395904|NCT02997202|65195815|FG001|Overall Study|Miscellaneous|2|||
23395905|NCT02997202|65195814|FG000|Overall Study|Withdrawal by Subject|8|||
23395906|NCT02997202|65195815|FG001|Overall Study|Withdrawal by Subject|12|||
23395907|NCT02997202|65195814|FG000|Overall Study|Lost to Follow-up|5|||
23395908|NCT02997202|65195815|FG001|Overall Study|Lost to Follow-up|3|||
23395909|NCT02997202|65195814|FG000|Overall Study|Death|41|||
23395910|NCT02997202|65195815|FG001|Overall Study|Death|45|||
23395911|NCT02439957|65195818|FG000|Overall Study|Study Terminated|3|||
23395912|NCT02439957|65195819|FG001|Overall Study|Study Terminated|3|||
23395913|NCT01817777|65195820|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
23395914|NCT01817777|65195821|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
23395915|NCT01817777|65195822|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
23395916|NCT01817777|65195820|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
23395917|NCT01817777|65195821|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
23395918|NCT01817777|65195822|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
23395919|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
23395920|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
23395921|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
23395922|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
23395923|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
23395924|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
23395925|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
23693593|NCT03478683|66257156|FG001|Overall Study|Adverse Event|3|||
23693594|NCT03478683|66257155|FG000|Overall Study|Lost to Follow-up|0|||
23693595|NCT03478683|66257156|FG001|Overall Study|Lost to Follow-up|5|||
23693596|NCT03478683|66257155|FG000|Overall Study|Physician Decision|1|||
23693597|NCT03478683|66257156|FG001|Overall Study|Physician Decision|3|||
23693598|NCT03478683|66257155|FG000|Overall Study|Withdrawal by Subject|7|||
23693599|NCT03478683|66257156|FG001|Overall Study|Withdrawal by Subject|7|||
23693600|NCT01985321|66257157|FG000|Overall Study|Protocol Violation|4|||
23693601|NCT01985321|66257158|FG001|Overall Study|Protocol Violation|3|||
23693602|NCT01985321|66257157|FG000|Overall Study|Withdrawal by Subject|1|||
23693603|NCT01985321|66257158|FG001|Overall Study|Withdrawal by Subject|0|||
23693604|NCT01985321|66257157|FG000|Overall Study|Lost to Follow-up|5|||
23693605|NCT01985321|66257158|FG001|Overall Study|Lost to Follow-up|2|||
23693606|NCT01985321|66257157|FG000|Overall Study|Subject treated wrong type of sore|1|||
23693607|NCT01985321|66257158|FG001|Overall Study|Subject treated wrong type of sore|0|||
23693608|NCT01242111|66257164|FG000|Overall Study|Adverse Event|1|||
23693609|NCT01242111|66257164|FG000|Overall Study|Withdrawal by Subject|1|||
23395926|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
23395927|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
23395928|NCT00363298|65195823|FG000|First Study Week|Lack of Efficacy|6|||
23395929|NCT00363298|65195824|FG001|First Study Week|Lack of Efficacy|5|||
23395930|NCT00363298|65195823|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
23395931|NCT00363298|65195824|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
23395932|NCT01634152|65195825|FG000|Overall Study|Adverse Event|2|||
23395933|NCT01634152|65195826|FG001|Overall Study|Adverse Event|0|||
23395934|NCT01634152|65195827|FG002|Overall Study|Adverse Event|2|||
23395935|NCT01634152|65195825|FG000|Overall Study|Consent withdrawn not due to AE|1|||
23395936|NCT01634152|65195826|FG001|Overall Study|Consent withdrawn not due to AE|0|||
23395937|NCT01634152|65195827|FG002|Overall Study|Consent withdrawn not due to AE|1|||
23395938|NCT01634152|65195825|FG000|Overall Study|Not treated|0|||
23693610|NCT01242111|66257164|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
23693611|NCT00847561|66257171|FG000|Overall Study|Withdrawal by Subject|4|||
23693612|NCT00847561|66257172|FG001|Overall Study|Withdrawal by Subject|3|||
23693613|NCT00847561|66257171|FG000|Overall Study|Unable to schedule|9|||
23693614|NCT00847561|66257172|FG001|Overall Study|Unable to schedule|1|||
23693615|NCT00957372|66257179|FG000|PART I|Lost to Follow-up|0|||
23693616|NCT00957372|66257180|FG001|PART I|Lost to Follow-up|0|||
23693617|NCT00957372|66257181|FG002|PART I|Lost to Follow-up|1|||
23693618|NCT00957372|66257182|FG003|PART I|Lost to Follow-up|0|||
23693619|NCT00957372|66257179|FG000|PART II|Withdrawal by Subject|0|||
23693620|NCT00957372|66257180|FG001|PART II|Withdrawal by Subject|0|||
23693621|NCT00957372|66257181|FG002|PART II|Withdrawal by Subject|0|||
23693622|NCT00957372|66257182|FG003|PART II|Withdrawal by Subject|8|||
23693623|NCT00957372|66257179|FG000|PART II|Physician Decision|0|||
23693624|NCT00957372|66257180|FG001|PART II|Physician Decision|0|||
23693625|NCT00957372|66257181|FG002|PART II|Physician Decision|0|||
23693626|NCT00957372|66257182|FG003|PART II|Physician Decision|1|||
23693627|NCT00957372|66257179|FG000|PART II|Pregnancy|0|||
23693628|NCT00957372|66257180|FG001|PART II|Pregnancy|0|||
23693629|NCT00957372|66257181|FG002|PART II|Pregnancy|0|||
23693630|NCT00957372|66257182|FG003|PART II|Pregnancy|1|||
23693631|NCT00957372|66257179|FG000|PART II|Not Know|0|||
23693632|NCT00957372|66257180|FG001|PART II|Not Know|0|||
23693633|NCT00957372|66257181|FG002|PART II|Not Know|0|||
23693634|NCT00957372|66257182|FG003|PART II|Not Know|20|||
23693635|NCT00957372|66257179|FG000|PART II|Adverse Event|0|||
23693636|NCT00957372|66257180|FG001|PART II|Adverse Event|0|||
23693637|NCT00957372|66257181|FG002|PART II|Adverse Event|0|||
23693638|NCT00957372|66257182|FG003|PART II|Adverse Event|10|||
23693639|NCT00957372|66257179|FG000|PART II|Patient non-compliance|0|||
23693640|NCT00957372|66257180|FG001|PART II|Patient non-compliance|0|||
23693641|NCT00957372|66257181|FG002|PART II|Patient non-compliance|0|||
23693642|NCT00957372|66257182|FG003|PART II|Patient non-compliance|4|||
23693643|NCT02015819|66257183|FG000|Overall Study|Rickham catheter was misaligned|0|||
23693644|NCT02015819|66257184|FG001|Overall Study|Rickham catheter was misaligned|0|||
23693645|NCT02015819|66257185|FG002|Overall Study|Rickham catheter was misaligned|0|||
23693646|NCT02015819|66257186|FG003|Overall Study|Rickham catheter was misaligned|1|||
23693647|NCT01006356|66257187|FG000|Overall Study|Adverse Event|6|||
23693648|NCT01006356|66257187|FG000|Overall Study|Physician Decision|1|||
23693649|NCT01006356|66257187|FG000|Overall Study|Paticipants did not cooperate|6|||
23693650|NCT01006356|66257187|FG000|Overall Study|Withdrawal by Subject|1|||
23693651|NCT01006356|66257187|FG000|Overall Study|Choice by participants|2|||
23693652|NCT01006356|66257187|FG000|Overall Study|Protocol Violation|3|||
23693653|NCT01006356|66257187|FG000|Overall Study|Other|23|||
23693654|NCT05480514|66257197|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
23693655|NCT05480514|66257198|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
23693656|NCT05480514|66257197|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
23693657|NCT05480514|66257198|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
23693658|NCT05480514|66257197|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
23693659|NCT05480514|66257198|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
23693660|NCT05480514|66257197|FG000|Period 1|Covid-19 Related|1|||
23693661|NCT05480514|66257198|FG001|Period 1|Covid-19 Related|0|||
23693662|NCT05480514|66257197|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
23693663|NCT05480514|66257198|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
23693664|NCT01926886|66257199|FG000|Overall Study|Administrative/other|1|||
23693665|NCT01926886|66257200|FG001|Overall Study|Administrative/other|0|||
23693666|NCT01926886|66257199|FG000|Overall Study|Adverse event/intercurrent illness|4|||
23693667|NCT01926886|66257200|FG001|Overall Study|Adverse event/intercurrent illness|0|||
23693668|NCT01926886|66257199|FG000|Overall Study|Disease progression/recurrence|4|||
23693669|NCT01926886|66257200|FG001|Overall Study|Disease progression/recurrence|0|||
23693670|NCT01926886|66257199|FG000|Overall Study|Withdrawal by Subject|15|||
23693671|NCT01926886|66257200|FG001|Overall Study|Withdrawal by Subject|0|||
23498598|NCT01332331|65566378|FG001|Overall Study|Physician Decision|0|||
23693672|NCT01926886|66257199|FG000|Overall Study|Failure to return|3|||
23693673|NCT01926886|66257200|FG001|Overall Study|Failure to return|0|||
23693674|NCT01926886|66257199|FG000|Overall Study|Recurrence of disease|1|||
23693675|NCT01926886|66257200|FG001|Overall Study|Recurrence of disease|0|||
23693676|NCT01926886|66257199|FG000|Overall Study|Progression of disease|2|||
23693677|NCT01926886|66257200|FG001|Overall Study|Progression of disease|0|||
23693678|NCT01926886|66257199|FG000|Overall Study|Death|1|||
23693679|NCT01926886|66257200|FG001|Overall Study|Death|0|||
23693680|NCT01926886|66257199|FG000|Overall Study|Did not cooperate|1|||
23693681|NCT01926886|66257200|FG001|Overall Study|Did not cooperate|0|||
23693682|NCT00756002|66257208|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23395939|NCT01634152|65195826|FG001|Overall Study|Not treated|1|||
23693683|NCT00756002|66257209|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23498599|NCT01681472|65566380|FG000|Overall Study|Adverse Event|0|||
23498600|NCT01681472|65566381|FG001|Overall Study|Adverse Event|1|||
23498601|NCT01681472|65566382|FG002|Overall Study|Adverse Event|0|||
23693684|NCT00756002|66257208|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23693685|NCT00756002|66257209|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23693686|NCT00756002|66257208|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23693687|NCT00756002|66257209|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23693688|NCT00756002|66257208|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
23693689|NCT00756002|66257209|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
23693690|NCT00756002|66257208|FG000|Double-Blind Treatment Period|Other|2|||
23693691|NCT00756002|66257209|FG001|Double-Blind Treatment Period|Other|2|||
23693692|NCT04538950|66257215|FG000|Overall Study|Pulmonary Issues|2|||
23693693|NCT04538950|66257215|FG000|Overall Study|illness|2|||
23693694|NCT03794986|66257216|FG000|Overall Study|0 Sessions Attended|34|||
23693695|NCT03794986|66257217|FG001|Overall Study|0 Sessions Attended|37|||
23693696|NCT03794986|66257216|FG000|Overall Study|Withdrawal by Subject|4|||
23693697|NCT03794986|66257217|FG001|Overall Study|Withdrawal by Subject|6|||
23693698|NCT03794986|66257216|FG000|Overall Study|Protocol Violation|1|||
23693699|NCT03794986|66257217|FG001|Overall Study|Protocol Violation|0|||
23693700|NCT01158950|66257221|FG000|1st Intervention (1 Day)|Physician Decision|1|||
23693701|NCT01158950|66257222|FG001|1st Intervention (1 Day)|Physician Decision|2|||
23693702|NCT02626338|66257223|FG000|Overall Study|Lack of Efficacy|3|||
23693703|NCT02626338|66257224|FG001|Overall Study|Lack of Efficacy|2|||
23693704|NCT02626338|66257225|FG002|Overall Study|Lack of Efficacy|0|||
23693705|NCT01524289|66257228|FG000|Overall Study|Lost to Follow-up|0|||
23693706|NCT01524289|66257229|FG001|Overall Study|Lost to Follow-up|1|||
23693707|NCT01524289|66257228|FG000|Overall Study|Physician Decision|1|||
23693708|NCT01524289|66257229|FG001|Overall Study|Physician Decision|0|||
23693709|NCT01524289|66257228|FG000|Overall Study|Protocol Violation|5|||
23693710|NCT01524289|66257229|FG001|Overall Study|Protocol Violation|1|||
23693711|NCT01524289|66257228|FG000|Overall Study|Withdrawal by Subject|11|||
23693712|NCT01524289|66257229|FG001|Overall Study|Withdrawal by Subject|7|||
23693713|NCT01524289|66257228|FG000|Overall Study|Adverse Event|12|||
23693714|NCT01524289|66257229|FG001|Overall Study|Adverse Event|5|||
23693715|NCT01524289|66257228|FG000|Overall Study|Did not take study medication|1|||
23693716|NCT01524289|66257229|FG001|Overall Study|Did not take study medication|0|||
23693717|NCT02981472|66257230|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
23693718|NCT02981472|66257231|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
23693719|NCT02981472|66257230|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23693720|NCT02981472|66257231|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23693721|NCT02981472|66257230|FG000|Treatment Period|Adverse Event|6|||
23693722|NCT02981472|66257231|FG001|Treatment Period|Adverse Event|1|||
23693723|NCT02981472|66257230|FG000|Treatment Period|Participant withdrew consent|1|||
23395940|NCT01634152|65195827|FG002|Overall Study|Not treated|0|||
23395941|NCT01634152|65195825|FG000|Overall Study|Other reason not defined above|1|||
23693724|NCT02981472|66257231|FG001|Treatment Period|Participant withdrew consent|0|||
23693725|NCT02981472|66257230|FG000|Treatment Period|Lost to Follow-up|0|||
23693726|NCT02981472|66257231|FG001|Treatment Period|Lost to Follow-up|1|||
23693727|NCT00853905|66257232|FG000|Overall Study|Lost to Follow-up|1|||
23693728|NCT00853905|66257233|FG001|Overall Study|Lost to Follow-up|3|||
23693729|NCT00853905|66257232|FG000|Overall Study|Withdrawal by Subject|0|||
23693730|NCT00853905|66257233|FG001|Overall Study|Withdrawal by Subject|1|||
23693731|NCT00853905|66257232|FG000|Overall Study|never had surgery|1|||
23693732|NCT00853905|66257233|FG001|Overall Study|never had surgery|0|||
23693733|NCT01282814|66257234|FG000|First Intervention|Emesis During Dosing Interval|0|||
23395942|NCT01634152|65195826|FG001|Overall Study|Other reason not defined above|0|||
23395943|NCT01634152|65195827|FG002|Overall Study|Other reason not defined above|1|||
23693734|NCT01282814|66257235|FG001|First Intervention|Emesis During Dosing Interval|3|||
23693735|NCT01282814|66257234|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
23693736|NCT01282814|66257235|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23693737|NCT01845025|66257236|FG000|Overall Study|Adverse Event|6|||
23693738|NCT01845025|66257237|FG001|Overall Study|Adverse Event|3|||
23693739|NCT01845025|66257236|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23693740|NCT01845025|66257237|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23693741|NCT01845025|66257236|FG000|Overall Study|Withdrawal by Subject|48|||
23693742|NCT01845025|66257237|FG001|Overall Study|Withdrawal by Subject|44|||
23693743|NCT01845025|66257236|FG000|Overall Study|Lost to Follow-up|13|||
23693744|NCT01845025|66257237|FG001|Overall Study|Lost to Follow-up|13|||
23693745|NCT01845025|66257236|FG000|Overall Study|Administrative problems|8|||
23693746|NCT01845025|66257237|FG001|Overall Study|Administrative problems|8|||
23693747|NCT01845025|66257236|FG000|Overall Study|Death|2|||
23693748|NCT01845025|66257237|FG001|Overall Study|Death|0|||
23693749|NCT01845025|66257236|FG000|Overall Study|Protocol deviation|3|||
23693750|NCT01845025|66257237|FG001|Overall Study|Protocol deviation|6|||
23693751|NCT01845025|66257236|FG000|Overall Study|Missing|1|||
23693752|NCT01845025|66257237|FG001|Overall Study|Missing|1|||
23693753|NCT01450540|66257241|FG000|Overall Study|Withdrawal by Subject|19|||
23693754|NCT01450540|66257242|FG001|Overall Study|Withdrawal by Subject|13|||
23693755|NCT01450540|66257241|FG000|Overall Study|protocol deviation|3|||
23395944|NCT00754572|65195828|FG000|Overall Study|Adverse Event|19|||
23693756|NCT01450540|66257242|FG001|Overall Study|protocol deviation|23|||
23693757|NCT00440401|66257243|FG000|Overall Study|Adverse Event|2|||
23693758|NCT00440401|66257244|FG001|Overall Study|Adverse Event|1|||
23693759|NCT00440401|66257243|FG000|Overall Study|Other|2|||
23693760|NCT00440401|66257244|FG001|Overall Study|Other|5|||
23693761|NCT00546351|66257245|FG000|Overall Study|Adverse Event|76|||
23693762|NCT00546351|66257245|FG000|Overall Study|Lack of Efficacy|15|||
23693763|NCT00546351|66257245|FG000|Overall Study|Withdrawal by Subject|109|||
23693764|NCT00546351|66257245|FG000|Overall Study|Lost to Follow-up|9|||
23693765|NCT00546351|66257245|FG000|Overall Study|Protocol Deviation|1|||
23693766|NCT00546351|66257245|FG000|Overall Study|Unsatisfactory compliance|9|||
23693767|NCT00546351|66257245|FG000|Overall Study|Other reasons for premature termination|17|||
23693768|NCT00613314|66257255|FG000|Overall Study|Adverse Event|5|||
23693769|NCT00613314|66257255|FG000|Overall Study|Protocol Violation|14|||
23693770|NCT00613314|66257255|FG000|Overall Study|Lost to Follow-up|46|||
23693771|NCT00613314|66257255|FG000|Overall Study|Other reason not defined above|90|||
23693772|NCT03443024|66257256|FG000|Overall Study|Adverse Event|2|||
23693773|NCT03443024|66257257|FG001|Overall Study|Adverse Event|4|||
23693774|NCT03443024|66257258|FG002|Overall Study|Adverse Event|3|||
23693775|NCT03443024|66257259|FG003|Overall Study|Adverse Event|1|||
23693776|NCT03443024|66257256|FG000|Overall Study|Lost to Follow-up|9|||
23693777|NCT03443024|66257257|FG001|Overall Study|Lost to Follow-up|9|||
23693778|NCT03443024|66257258|FG002|Overall Study|Lost to Follow-up|7|||
23693779|NCT03443024|66257259|FG003|Overall Study|Lost to Follow-up|5|||
23693780|NCT03443024|66257256|FG000|Overall Study|Withdrawal by Subject|8|||
23693781|NCT03443024|66257257|FG001|Overall Study|Withdrawal by Subject|15|||
23693782|NCT03443024|66257258|FG002|Overall Study|Withdrawal by Subject|9|||
23693783|NCT03443024|66257259|FG003|Overall Study|Withdrawal by Subject|23|||
23693784|NCT03443024|66257256|FG000|Overall Study|Physician Decision|1|||
23693785|NCT03443024|66257257|FG001|Overall Study|Physician Decision|2|||
23693786|NCT03443024|66257258|FG002|Overall Study|Physician Decision|0|||
23693787|NCT03443024|66257259|FG003|Overall Study|Physician Decision|1|||
23693788|NCT03443024|66257256|FG000|Overall Study|Sponsor Decision|1|||
23693789|NCT03443024|66257257|FG001|Overall Study|Sponsor Decision|1|||
23693790|NCT03443024|66257258|FG002|Overall Study|Sponsor Decision|0|||
23693791|NCT03443024|66257259|FG003|Overall Study|Sponsor Decision|0|||
23693792|NCT03443024|66257256|FG000|Overall Study|Protocol Deviation|0|||
23693793|NCT03443024|66257257|FG001|Overall Study|Protocol Deviation|0|||
23693794|NCT03443024|66257258|FG002|Overall Study|Protocol Deviation|0|||
23693795|NCT03443024|66257259|FG003|Overall Study|Protocol Deviation|2|||
23693796|NCT03167619|66257260|FG000|Overall Study|Death|11|||
23693797|NCT03167619|66257261|FG001|Overall Study|Death|8|||
23693798|NCT03167619|66257260|FG000|Overall Study|Withdrawal by Subject|1|||
23693799|NCT03167619|66257261|FG001|Overall Study|Withdrawal by Subject|2|||
23693800|NCT03167619|66257260|FG000|Overall Study|Physician Decision|0|||
23693801|NCT03167619|66257261|FG001|Overall Study|Physician Decision|1|||
23693802|NCT01676961|66257262|FG000|Overall Study|Death|3|||
23693803|NCT01676961|66257262|FG000|Overall Study|Lost to Follow-up|1|||
23693804|NCT01676961|66257262|FG000|Overall Study|Withdrawal by Subject|1|||
23693805|NCT01645930|66257264|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
23693806|NCT01645930|66257264|FG000|Overall Study|Progressive Disease|12|||
23693807|NCT01645930|66257264|FG000|Overall Study|Adverse Event|4|||
23693808|NCT01645930|66257264|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
23693809|NCT01645930|66257264|FG000|Overall Study|Withdrawal by Participant|2|||
23693810|NCT01645930|66257264|FG000|Overall Study|Reason not Defined|1|||
23693811|NCT02707757|66257265|FG000|Overall Study|Protocol Violation|3|||
23693812|NCT02707757|66257266|FG001|Overall Study|Protocol Violation|2|||
23395945|NCT00754572|65195828|FG000|Overall Study|Other|39|||
23395946|NCT00754572|65195828|FG000|Overall Study|Protocol Violation|3|||
23395947|NCT00754572|65195828|FG000|Overall Study|Withdrawal by Subject|3|||
23693813|NCT02707757|66257265|FG000|Overall Study|Withdrawal by Subject|2|||
23693814|NCT02707757|66257266|FG001|Overall Study|Withdrawal by Subject|0|||
23693815|NCT02707757|66257265|FG000|Overall Study|Death|0|||
23693816|NCT02707757|66257266|FG001|Overall Study|Death|1|||
23693817|NCT02707757|66257265|FG000|Overall Study|Adverse Event|6|||
23693818|NCT02707757|66257266|FG001|Overall Study|Adverse Event|4|||
23693819|NCT02707757|66257265|FG000|Overall Study|Renal transplant/elective operation|1|||
23693820|NCT02707757|66257266|FG001|Overall Study|Renal transplant/elective operation|5|||
23693821|NCT00231478|66257269|FG000|Overall Study|Protocol Violation|3|||
23693822|NCT00231478|66257270|FG001|Overall Study|Protocol Violation|2|||
23693823|NCT00231478|66257269|FG000|Overall Study|Refused Treatment|1|||
23693824|NCT00231478|66257270|FG001|Overall Study|Refused Treatment|1|||
23693825|NCT00231478|66257269|FG000|Overall Study|Withdrawal by Subject|1|||
23693826|NCT00231478|66257270|FG001|Overall Study|Withdrawal by Subject|0|||
23395948|NCT00754572|65195828|FG000|Overall Study|Lack of Efficacy|2|||
23693827|NCT00231478|66257269|FG000|Overall Study|Adverse Event|0|||
23693828|NCT00231478|66257270|FG001|Overall Study|Adverse Event|1|||
23693829|NCT00231478|66257269|FG000|Overall Study|Administrative|3|||
23693830|NCT00231478|66257270|FG001|Overall Study|Administrative|2|||
23693831|NCT00104104|66257271|FG000|Overall Study|Adverse Event|8|||
23693832|NCT00104104|66257272|FG001|Overall Study|Adverse Event|8|||
23693833|NCT00104104|66257271|FG000|Overall Study|Abnormal laboratory value(s)|20|||
23693834|NCT00104104|66257272|FG001|Overall Study|Abnormal laboratory value(s)|14|||
23693835|NCT00104104|66257271|FG000|Overall Study|Lack of Efficacy|0|||
23693836|NCT00104104|66257272|FG001|Overall Study|Lack of Efficacy|3|||
23693837|NCT00104104|66257271|FG000|Overall Study|Condition no longer requires study drug|7|||
23693838|NCT00104104|66257272|FG001|Overall Study|Condition no longer requires study drug|4|||
23693839|NCT00104104|66257271|FG000|Overall Study|Protocol Violation|5|||
23693840|NCT00104104|66257272|FG001|Overall Study|Protocol Violation|2|||
23693841|NCT00104104|66257271|FG000|Overall Study|Withdrawal by Subject|11|||
23693842|NCT00104104|66257272|FG001|Overall Study|Withdrawal by Subject|15|||
23693843|NCT00104104|66257271|FG000|Overall Study|Lost to Follow-up|3|||
23693844|NCT00104104|66257272|FG001|Overall Study|Lost to Follow-up|7|||
23693845|NCT00104104|66257271|FG000|Overall Study|Administrative problems|12|||
23693846|NCT00104104|66257272|FG001|Overall Study|Administrative problems|13|||
23693847|NCT00104104|66257271|FG000|Overall Study|Death|9|||
23693848|NCT00104104|66257272|FG001|Overall Study|Death|6|||
23693849|NCT02519231|66257273|FG000|Overall Study|Lost to Follow-up|2|||
23693850|NCT02519231|66257274|FG001|Overall Study|Lost to Follow-up|5|||
23693851|NCT02519231|66257273|FG000|Overall Study|Withdrawal by Subject|0|||
23693852|NCT02519231|66257274|FG001|Overall Study|Withdrawal by Subject|1|||
23693853|NCT04375878|66257275|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
23693854|NCT04375878|66257276|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
23693855|NCT04375878|66257277|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23693856|NCT04375878|66257278|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23693857|NCT04375878|66257279|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23693858|NCT04375878|66257280|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23693859|NCT04375878|66257275|FG000|Crossover First and Second Interventions|Adverse Event|0|||
23693860|NCT04375878|66257276|FG001|Crossover First and Second Interventions|Adverse Event|0|||
23693861|NCT04375878|66257277|FG002|Crossover First and Second Interventions|Adverse Event|1|||
23693862|NCT04375878|66257278|FG003|Crossover First and Second Interventions|Adverse Event|0|||
23693863|NCT04375878|66257279|FG004|Crossover First and Second Interventions|Adverse Event|0|||
23693864|NCT04375878|66257280|FG005|Crossover First and Second Interventions|Adverse Event|0|||
23693865|NCT04375878|66257275|FG000|Extension Phase|Withdrawal by Subject|0|||
23693866|NCT04375878|66257276|FG001|Extension Phase|Withdrawal by Subject|0|||
23693867|NCT04375878|66257277|FG002|Extension Phase|Withdrawal by Subject|0|||
23693868|NCT04375878|66257278|FG003|Extension Phase|Withdrawal by Subject|0|||
23693869|NCT04375878|66257279|FG004|Extension Phase|Withdrawal by Subject|1|||
23693870|NCT04375878|66257280|FG005|Extension Phase|Withdrawal by Subject|0|||
23693871|NCT00095121|66257284|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
23693872|NCT00095121|66257285|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
23693873|NCT00095121|66257284|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
23693874|NCT00095121|66257285|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
23693875|NCT01096667|66257294|FG000|Overall Study|Lost to Follow-up|1|||
23693876|NCT01096667|66257295|FG001|Overall Study|Lost to Follow-up|1|||
23693877|NCT01096667|66257296|FG002|Overall Study|Lost to Follow-up|1|||
23693878|NCT01096667|66257297|FG003|Overall Study|Lost to Follow-up|0|||
23693879|NCT01096667|66257298|FG004|Overall Study|Lost to Follow-up|0|||
23693880|NCT01096667|66257294|FG000|Overall Study|Withdrawal by Subject|1|||
23693881|NCT01096667|66257295|FG001|Overall Study|Withdrawal by Subject|0|||
23693882|NCT01096667|66257296|FG002|Overall Study|Withdrawal by Subject|0|||
23693883|NCT01096667|66257297|FG003|Overall Study|Withdrawal by Subject|1|||
23693884|NCT01096667|66257298|FG004|Overall Study|Withdrawal by Subject|0|||
23693885|NCT01096667|66257294|FG000|Overall Study|Reason not available|0|||
23693886|NCT01096667|66257295|FG001|Overall Study|Reason not available|1|||
23693887|NCT01096667|66257296|FG002|Overall Study|Reason not available|1|||
23693888|NCT01096667|66257297|FG003|Overall Study|Reason not available|1|||
23693889|NCT01096667|66257298|FG004|Overall Study|Reason not available|0|||
23693890|NCT01096667|66257294|FG000|Overall Study|Protocol Violation|0|||
23693891|NCT01096667|66257295|FG001|Overall Study|Protocol Violation|0|||
23693892|NCT01096667|66257296|FG002|Overall Study|Protocol Violation|0|||
23693893|NCT01096667|66257297|FG003|Overall Study|Protocol Violation|1|||
23693894|NCT01096667|66257298|FG004|Overall Study|Protocol Violation|0|||
23693895|NCT01096667|66257294|FG000|Overall Study|Not treated|1|||
23693896|NCT01096667|66257295|FG001|Overall Study|Not treated|0|||
23693897|NCT01096667|66257296|FG002|Overall Study|Not treated|0|||
23693898|NCT01096667|66257297|FG003|Overall Study|Not treated|0|||
23395949|NCT00754572|65195828|FG000|Overall Study|Death|1|||
23693899|NCT01096667|66257298|FG004|Overall Study|Not treated|0|||
23693900|NCT00377962|66257299|FG000|Core Study: 0-12 Months|Adverse Event|18|||
23693901|NCT00377962|66257300|FG001|Core Study: 0-12 Months|Adverse Event|2|||
23693902|NCT00377962|66257299|FG000|Core Study: 0-12 Months|Death|3|||
23693903|NCT00377962|66257300|FG001|Core Study: 0-12 Months|Death|0|||
23693904|NCT00377962|66257299|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
23693905|NCT00377962|66257300|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
23693906|NCT00377962|66257299|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
23693907|NCT00377962|66257300|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
23693908|NCT00377962|66257299|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
23693909|NCT00377962|66257300|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
23693910|NCT00377962|66257299|FG000|Extension Study: 12-24 Months|Death|1|||
23693911|NCT00377962|66257300|FG001|Extension Study: 12-24 Months|Death|1|||
23693912|NCT00377962|66257299|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
23693913|NCT00377962|66257300|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
23693914|NCT00377962|66257299|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
23693915|NCT00377962|66257300|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
23693916|NCT00377962|66257299|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
23693917|NCT00377962|66257300|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
23693918|NCT02240628|66257301|FG000|Overall Study|Physician Decision|6|||
23693919|NCT02240628|66257302|FG001|Overall Study|Physician Decision|5|||
23693920|NCT03952650|66257303|FG000|Overall Study|TRAVEL|0|||
23693921|NCT03952650|66257304|FG001|Overall Study|TRAVEL|4|||
23693922|NCT03952650|66257305|FG002|Overall Study|TRAVEL|0|||
23693923|NCT03952650|66257306|FG003|Overall Study|TRAVEL|4|||
23693924|NCT03952650|66257307|FG004|Overall Study|TRAVEL|0|||
23693925|NCT03952650|66257308|FG005|Overall Study|TRAVEL|3|||
23693926|NCT03952650|66257309|FG006|Overall Study|TRAVEL|2|||
23693927|NCT03952650|66257303|FG000|Overall Study|Withdrawal by Subject|0|||
23693928|NCT03952650|66257304|FG001|Overall Study|Withdrawal by Subject|2|||
23693929|NCT03952650|66257305|FG002|Overall Study|Withdrawal by Subject|0|||
23693930|NCT03952650|66257306|FG003|Overall Study|Withdrawal by Subject|3|||
23693931|NCT03952650|66257307|FG004|Overall Study|Withdrawal by Subject|0|||
23693932|NCT03952650|66257308|FG005|Overall Study|Withdrawal by Subject|1|||
23693933|NCT03952650|66257309|FG006|Overall Study|Withdrawal by Subject|1|||
23693934|NCT03952650|66257303|FG000|Overall Study|Lost to Follow-up|0|||
23693935|NCT03952650|66257304|FG001|Overall Study|Lost to Follow-up|1|||
23693936|NCT03952650|66257305|FG002|Overall Study|Lost to Follow-up|0|||
23693937|NCT03952650|66257306|FG003|Overall Study|Lost to Follow-up|0|||
23693938|NCT03952650|66257307|FG004|Overall Study|Lost to Follow-up|0|||
23693939|NCT03952650|66257308|FG005|Overall Study|Lost to Follow-up|1|||
23693940|NCT03952650|66257309|FG006|Overall Study|Lost to Follow-up|1|||
23693941|NCT03952650|66257303|FG000|Overall Study|Received wrong vaccine and travelled|0|||
23693942|NCT03952650|66257304|FG001|Overall Study|Received wrong vaccine and travelled|0|||
23693943|NCT03952650|66257305|FG002|Overall Study|Received wrong vaccine and travelled|0|||
23693944|NCT03952650|66257306|FG003|Overall Study|Received wrong vaccine and travelled|0|||
23693945|NCT03952650|66257307|FG004|Overall Study|Received wrong vaccine and travelled|0|||
23693946|NCT03952650|66257308|FG005|Overall Study|Received wrong vaccine and travelled|1|||
23693947|NCT03952650|66257309|FG006|Overall Study|Received wrong vaccine and travelled|0|||
23693948|NCT03952650|66257303|FG000|Overall Study|Unable to make study visit|0|||
23693949|NCT03952650|66257304|FG001|Overall Study|Unable to make study visit|0|||
23693950|NCT03952650|66257305|FG002|Overall Study|Unable to make study visit|0|||
23693951|NCT03952650|66257306|FG003|Overall Study|Unable to make study visit|0|||
23693952|NCT03952650|66257307|FG004|Overall Study|Unable to make study visit|0|||
23693953|NCT03952650|66257308|FG005|Overall Study|Unable to make study visit|1|||
23693954|NCT03952650|66257309|FG006|Overall Study|Unable to make study visit|0|||
23693955|NCT03497689|66257310|FG000|Overall Study|Adverse Event|2|||
23693956|NCT03497689|66257310|FG000|Overall Study|Death|1|||
23693957|NCT03497689|66257310|FG000|Overall Study|Physician Decision|1|||
23693958|NCT03497689|66257310|FG000|Overall Study|Withdrawal by Subject|1|||
23693959|NCT03497689|66257310|FG000|Overall Study|Protocol Violation|2|||
23693960|NCT00995371|66257311|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
23693961|NCT00995371|66257312|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
23693962|NCT00465569|66257313|FG000|Overall Study|persistent eczema during dose escalation|1|||
23693963|NCT00465569|66257314|FG001|Overall Study|persistent eczema during dose escalation|0|||
23693964|NCT04655586|66257316|FG000|Overall Study|Physician Decision|1|||
23693965|NCT04655586|66257317|FG001|Overall Study|Physician Decision|3|||
23693966|NCT04655586|66257318|FG002|Overall Study|Physician Decision|4|||
23693967|NCT04655586|66257316|FG000|Overall Study|Withdrawal by Subject|1|||
23693968|NCT04655586|66257317|FG001|Overall Study|Withdrawal by Subject|3|||
23693969|NCT04655586|66257318|FG002|Overall Study|Withdrawal by Subject|1|||
23693970|NCT00408681|66257319|FG000|Overall Study|Lack of Efficacy|2|||
23693971|NCT00408681|66257319|FG000|Overall Study|Adverse Event|7|||
23693972|NCT01450137|66257333|FG000|Up to Week 12|Adverse Event|2|||
23693973|NCT01450137|66257334|FG001|Up to Week 12|Adverse Event|1|||
23693974|NCT01450137|66257333|FG000|Up to Week 12|Withdrawal by Subject|0|||
23693975|NCT01450137|66257334|FG001|Up to Week 12|Withdrawal by Subject|2|||
23693976|NCT01450137|66257333|FG000|Week 12 to Study End|Death|0|||
23693977|NCT01450137|66257334|FG001|Week 12 to Study End|Death|1|||
23693978|NCT01450137|66257333|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
23693979|NCT01450137|66257334|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
23693980|NCT03185130|66257335|FG000|Overall Study|Withdrawal by Subject|0|||
23693981|NCT03185130|66257336|FG001|Overall Study|Withdrawal by Subject|2|||
23693982|NCT01584024|66257337|FG000|Overall Study|Lost to Follow-up|10|||
23693983|NCT01584024|66257337|FG000|Overall Study|Withdrawal by Subject|3|||
23693984|NCT02397655|66257338|FG000|Overall Study|data not completed|1301|||
23693985|NCT02629393|66257340|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
23693986|NCT02629393|66257340|FG000|Overall Study|Physician Decision|1|||
23693987|NCT05370157|66257345|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
23693988|NCT05370157|66257346|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
23693989|NCT05370157|66257345|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
23693990|NCT05370157|66257346|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
23693991|NCT00638846|66257347|FG000|Overall Study|Adverse Event|0|||
23693992|NCT00638846|66257348|FG001|Overall Study|Adverse Event|1|||
23693993|NCT00638846|66257347|FG000|Overall Study|Lost to Follow-up|3|||
23693994|NCT00638846|66257348|FG001|Overall Study|Lost to Follow-up|2|||
23693995|NCT00638846|66257347|FG000|Overall Study|lens issue|1|||
23693996|NCT00638846|66257348|FG001|Overall Study|lens issue|3|||
23693997|NCT00117312|66257349|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
23693998|NCT00117312|66257350|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
23693999|NCT00117312|66257351|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
23694000|NCT00117312|66257352|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
23694001|NCT00117312|66257349|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
23694002|NCT00117312|66257350|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
23694003|NCT00117312|66257351|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
23694004|NCT00117312|66257352|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
23694005|NCT00117312|66257349|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
23694006|NCT00117312|66257350|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
23694007|NCT00117312|66257351|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
23694008|NCT00117312|66257352|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
23694009|NCT00117312|66257349|FG000|Overall Study|Other|0|||
23694010|NCT00117312|66257350|FG001|Overall Study|Other|1|||
23694011|NCT00117312|66257351|FG002|Overall Study|Other|3|||
23694012|NCT00117312|66257352|FG003|Overall Study|Other|1|||
23694013|NCT00117312|66257349|FG000|Overall Study|Patient choice|0|||
23694014|NCT00117312|66257350|FG001|Overall Study|Patient choice|0|||
23694015|NCT00117312|66257351|FG002|Overall Study|Patient choice|2|||
23694016|NCT00117312|66257352|FG003|Overall Study|Patient choice|1|||
23694017|NCT00117312|66257349|FG000|Overall Study|Adverse Event|0|||
23694018|NCT00117312|66257350|FG001|Overall Study|Adverse Event|2|||
23694019|NCT00117312|66257351|FG002|Overall Study|Adverse Event|0|||
23694020|NCT00117312|66257352|FG003|Overall Study|Adverse Event|0|||
23694021|NCT00117312|66257349|FG000|Overall Study|Protocol Violation|0|||
23694022|NCT00117312|66257350|FG001|Overall Study|Protocol Violation|1|||
23694023|NCT00117312|66257351|FG002|Overall Study|Protocol Violation|3|||
23694024|NCT00117312|66257352|FG003|Overall Study|Protocol Violation|0|||
23694025|NCT00117312|66257349|FG000|Overall Study|PSA decrease <=50%|0|||
23694026|NCT00117312|66257350|FG001|Overall Study|PSA decrease <=50%|2|||
23694027|NCT00117312|66257351|FG002|Overall Study|PSA decrease <=50%|2|||
23694028|NCT00117312|66257352|FG003|Overall Study|PSA decrease <=50%|4|||
23694029|NCT00117312|66257349|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
23694030|NCT00117312|66257350|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
23694031|NCT00117312|66257351|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
23694032|NCT00117312|66257352|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
23694033|NCT00117312|66257349|FG000|Overall Study|Hepatic abnormality|0|||
23694034|NCT00117312|66257350|FG001|Overall Study|Hepatic abnormality|1|||
23694035|NCT00117312|66257351|FG002|Overall Study|Hepatic abnormality|0|||
23694036|NCT00117312|66257352|FG003|Overall Study|Hepatic abnormality|1|||
23694037|NCT00117312|66257349|FG000|Overall Study|Withdrawal by Subject|0|||
23694038|NCT00117312|66257350|FG001|Overall Study|Withdrawal by Subject|2|||
23694039|NCT00117312|66257351|FG002|Overall Study|Withdrawal by Subject|0|||
23694040|NCT00117312|66257352|FG003|Overall Study|Withdrawal by Subject|0|||
23694041|NCT02453841|66257353|FG000|Overall Study|Protocol Violation|1|||
23694042|NCT02453841|66257353|FG000|Overall Study|Unable to obtain blood samples|2|||
23694043|NCT02300129|66257354|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23694044|NCT02300129|66257355|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
23694045|NCT02300129|66257356|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23694046|NCT02300129|66257357|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23694047|NCT02300129|66257354|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23694048|NCT02300129|66257355|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23694049|NCT02300129|66257356|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23694050|NCT02300129|66257357|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
23694051|NCT02300129|66257354|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
23694052|NCT02300129|66257355|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23694053|NCT02300129|66257356|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23694054|NCT02300129|66257357|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23694055|NCT02158533|66257358|FG000|Stage 1|Adverse Event|6|||
23694056|NCT02158533|66257359|FG001|Stage 1|Adverse Event|4|||
23694057|NCT02158533|66257360|FG002|Stage 1|Adverse Event|7|||
23694058|NCT02158533|66257361|FG003|Stage 1|Adverse Event|0|||
23694059|NCT02158533|66257362|FG004|Stage 1|Adverse Event|0|||
23694060|NCT02158533|66257363|FG005|Stage 1|Adverse Event|0|||
23694061|NCT02158533|66257358|FG000|Stage 1|Withdrawal by Subject|3|||
23694062|NCT02158533|66257359|FG001|Stage 1|Withdrawal by Subject|2|||
23694063|NCT02158533|66257360|FG002|Stage 1|Withdrawal by Subject|1|||
23694064|NCT02158533|66257361|FG003|Stage 1|Withdrawal by Subject|0|||
23694065|NCT02158533|66257362|FG004|Stage 1|Withdrawal by Subject|0|||
23694066|NCT02158533|66257363|FG005|Stage 1|Withdrawal by Subject|0|||
23694067|NCT02158533|66257358|FG000|Stage 1|Lack of Efficacy|1|||
23694068|NCT02158533|66257359|FG001|Stage 1|Lack of Efficacy|0|||
23694069|NCT02158533|66257360|FG002|Stage 1|Lack of Efficacy|0|||
23694070|NCT02158533|66257361|FG003|Stage 1|Lack of Efficacy|0|||
23694071|NCT02158533|66257362|FG004|Stage 1|Lack of Efficacy|0|||
23694072|NCT02158533|66257363|FG005|Stage 1|Lack of Efficacy|0|||
23694073|NCT02158533|66257358|FG000|Stage 1|Lost to Follow-up|3|||
23694074|NCT02158533|66257359|FG001|Stage 1|Lost to Follow-up|1|||
23694075|NCT02158533|66257360|FG002|Stage 1|Lost to Follow-up|0|||
23694076|NCT02158533|66257361|FG003|Stage 1|Lost to Follow-up|0|||
23694077|NCT02158533|66257362|FG004|Stage 1|Lost to Follow-up|0|||
23694078|NCT02158533|66257363|FG005|Stage 1|Lost to Follow-up|0|||
23694079|NCT02158533|66257358|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
23694080|NCT02158533|66257359|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
23694081|NCT02158533|66257360|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
23694082|NCT02158533|66257361|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
23694083|NCT02158533|66257362|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
23694084|NCT02158533|66257363|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
23694085|NCT02158533|66257358|FG000|Stage 1|Non-compliance with study visits|1|||
23694086|NCT02158533|66257359|FG001|Stage 1|Non-compliance with study visits|0|||
23694087|NCT02158533|66257360|FG002|Stage 1|Non-compliance with study visits|0|||
23694088|NCT02158533|66257361|FG003|Stage 1|Non-compliance with study visits|0|||
23694089|NCT02158533|66257362|FG004|Stage 1|Non-compliance with study visits|0|||
23694090|NCT02158533|66257363|FG005|Stage 1|Non-compliance with study visits|0|||
23694091|NCT02158533|66257358|FG000|Stage 2|Adverse Event|0|||
23694092|NCT02158533|66257359|FG001|Stage 2|Adverse Event|0|||
23694093|NCT02158533|66257360|FG002|Stage 2|Adverse Event|0|||
23694094|NCT02158533|66257361|FG003|Stage 2|Adverse Event|0|||
23694095|NCT02158533|66257362|FG004|Stage 2|Adverse Event|0|||
23694096|NCT02158533|66257363|FG005|Stage 2|Adverse Event|1|||
23694097|NCT02158533|66257358|FG000|Stage 2|Lack of Efficacy|0|||
23694098|NCT02158533|66257359|FG001|Stage 2|Lack of Efficacy|0|||
23694099|NCT02158533|66257360|FG002|Stage 2|Lack of Efficacy|0|||
23694100|NCT02158533|66257361|FG003|Stage 2|Lack of Efficacy|0|||
23694101|NCT02158533|66257362|FG004|Stage 2|Lack of Efficacy|1|||
23694102|NCT02158533|66257363|FG005|Stage 2|Lack of Efficacy|0|||
23694103|NCT02158533|66257358|FG000|Stage 2|Lost to Follow-up|0|||
23694104|NCT02158533|66257359|FG001|Stage 2|Lost to Follow-up|0|||
23694105|NCT02158533|66257360|FG002|Stage 2|Lost to Follow-up|0|||
23694106|NCT02158533|66257361|FG003|Stage 2|Lost to Follow-up|1|||
23694107|NCT02158533|66257362|FG004|Stage 2|Lost to Follow-up|1|||
23694108|NCT02158533|66257363|FG005|Stage 2|Lost to Follow-up|2|||
23694109|NCT02158533|66257358|FG000|Stage 2|Withdrawal by Subject|0|||
23694110|NCT02158533|66257359|FG001|Stage 2|Withdrawal by Subject|0|||
23694111|NCT02158533|66257360|FG002|Stage 2|Withdrawal by Subject|0|||
23694112|NCT02158533|66257361|FG003|Stage 2|Withdrawal by Subject|0|||
23694113|NCT02158533|66257362|FG004|Stage 2|Withdrawal by Subject|1|||
23694114|NCT02158533|66257363|FG005|Stage 2|Withdrawal by Subject|2|||
23694115|NCT02158533|66257358|FG000|Stage 2|Physician Decision|0|||
23694116|NCT02158533|66257359|FG001|Stage 2|Physician Decision|0|||
23694117|NCT02158533|66257360|FG002|Stage 2|Physician Decision|0|||
23694118|NCT02158533|66257361|FG003|Stage 2|Physician Decision|0|||
23694119|NCT02158533|66257362|FG004|Stage 2|Physician Decision|1|||
23694120|NCT02158533|66257363|FG005|Stage 2|Physician Decision|0|||
23694121|NCT02158533|66257358|FG000|Stage 2|Pregnancy|0|||
23694122|NCT02158533|66257359|FG001|Stage 2|Pregnancy|0|||
23694123|NCT02158533|66257360|FG002|Stage 2|Pregnancy|0|||
23395950|NCT00754572|65195828|FG000|Overall Study|Administrative Reason|3|||
23694124|NCT02158533|66257361|FG003|Stage 2|Pregnancy|1|||
23395951|NCT00754572|65195828|FG000|Overall Study|Lost to Follow-up|1|||
23395952|NCT01542788|65195829|FG000|Overall Study|Randomized but Not Treated|2|||
23694125|NCT02158533|66257362|FG004|Stage 2|Pregnancy|0|||
23694126|NCT02158533|66257363|FG005|Stage 2|Pregnancy|0|||
23694127|NCT02158533|66257358|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
23694128|NCT02158533|66257359|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
23694129|NCT02158533|66257360|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
23694130|NCT02158533|66257361|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
23694131|NCT02158533|66257362|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
23694132|NCT02158533|66257363|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
23694133|NCT02158533|66257358|FG000|Stage 2|Non-adherence with study visits|0|||
23694134|NCT02158533|66257359|FG001|Stage 2|Non-adherence with study visits|0|||
23694135|NCT02158533|66257360|FG002|Stage 2|Non-adherence with study visits|0|||
23694136|NCT02158533|66257361|FG003|Stage 2|Non-adherence with study visits|0|||
23694137|NCT02158533|66257362|FG004|Stage 2|Non-adherence with study visits|0|||
23694138|NCT02158533|66257363|FG005|Stage 2|Non-adherence with study visits|1|||
23694139|NCT04430348|66257367|FG000|Overall Study|Death|3|||
23694140|NCT04430348|66257368|FG001|Overall Study|Death|2|||
23694141|NCT04430348|66257369|FG002|Overall Study|Death|2|||
23694142|NCT04430348|66257370|FG003|Overall Study|Death|2|||
23694143|NCT04430348|66257371|FG004|Overall Study|Death|2|||
23694144|NCT04430348|66257372|FG005|Overall Study|Death|3|||
23694145|NCT04430348|66257367|FG000|Overall Study|Lost to Follow-up|0|||
23694146|NCT04430348|66257368|FG001|Overall Study|Lost to Follow-up|0|||
23694147|NCT04430348|66257369|FG002|Overall Study|Lost to Follow-up|0|||
23694148|NCT04430348|66257370|FG003|Overall Study|Lost to Follow-up|1|||
23694149|NCT04430348|66257371|FG004|Overall Study|Lost to Follow-up|0|||
23694150|NCT04430348|66257372|FG005|Overall Study|Lost to Follow-up|0|||
23694151|NCT04430348|66257367|FG000|Overall Study|Adverse Event|0|||
23694152|NCT04430348|66257368|FG001|Overall Study|Adverse Event|0|||
23694153|NCT04430348|66257369|FG002|Overall Study|Adverse Event|0|||
23694154|NCT04430348|66257370|FG003|Overall Study|Adverse Event|0|||
23694155|NCT04430348|66257371|FG004|Overall Study|Adverse Event|0|||
23694156|NCT04430348|66257372|FG005|Overall Study|Adverse Event|1|||
23694157|NCT04430348|66257367|FG000|Overall Study|Withdrawal by Subject|0|||
23694158|NCT04430348|66257368|FG001|Overall Study|Withdrawal by Subject|1|||
23694159|NCT04430348|66257369|FG002|Overall Study|Withdrawal by Subject|0|||
23694160|NCT04430348|66257370|FG003|Overall Study|Withdrawal by Subject|0|||
23694161|NCT04430348|66257371|FG004|Overall Study|Withdrawal by Subject|0|||
23694162|NCT04430348|66257372|FG005|Overall Study|Withdrawal by Subject|1|||
23694163|NCT04430348|66257367|FG000|Overall Study|Study Terminated by Sponsor|0|||
23694164|NCT04430348|66257368|FG001|Overall Study|Study Terminated by Sponsor|0|||
23694165|NCT04430348|66257369|FG002|Overall Study|Study Terminated by Sponsor|2|||
23694166|NCT04430348|66257370|FG003|Overall Study|Study Terminated by Sponsor|0|||
23395953|NCT01542788|65195830|FG001|Overall Study|Randomized but Not Treated|0|||
23395954|NCT01542788|65195829|FG000|Overall Study|Lack of Efficacy|41|||
23694167|NCT04430348|66257371|FG004|Overall Study|Study Terminated by Sponsor|1|||
23694168|NCT04430348|66257372|FG005|Overall Study|Study Terminated by Sponsor|1|||
23694169|NCT00500071|66257380|FG000|Screening and Washout Phase|Protocol Violation|1|||
23694170|NCT00500071|66257380|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
23694171|NCT00500071|66257380|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
23694172|NCT00500071|66257380|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
23694173|NCT00500071|66257380|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
23694174|NCT00500071|66257380|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
23694175|NCT00500071|66257380|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
23694176|NCT01040832|66257381|FG000|Overall Study|Adverse Event|4|||
23694177|NCT01040832|66257382|FG001|Overall Study|Adverse Event|5|||
23694178|NCT01040832|66257381|FG000|Overall Study|Death|4|||
23694179|NCT01040832|66257382|FG001|Overall Study|Death|6|||
23694180|NCT01040832|66257381|FG000|Overall Study|Withdrawal by Subject|2|||
23694181|NCT01040832|66257382|FG001|Overall Study|Withdrawal by Subject|3|||
23395955|NCT01542788|65195830|FG001|Overall Study|Lack of Efficacy|71|||
23395956|NCT01542788|65195829|FG000|Overall Study|Lost to Follow-up|5|||
23395957|NCT01542788|65195830|FG001|Overall Study|Lost to Follow-up|0|||
23395958|NCT01542788|65195829|FG000|Overall Study|Death|3|||
23395959|NCT01542788|65195830|FG001|Overall Study|Death|0|||
23395960|NCT01542788|65195829|FG000|Overall Study|Protocol Violation|2|||
23395961|NCT01542788|65195830|FG001|Overall Study|Protocol Violation|0|||
23395962|NCT01542788|65195829|FG000|Overall Study|Physician Decision|1|||
23395963|NCT01542788|65195830|FG001|Overall Study|Physician Decision|0|||
23395964|NCT01542788|65195829|FG000|Overall Study|Withdrawal by Subject|1|||
23498602|NCT01681472|65566383|FG003|Overall Study|Adverse Event|0|||
23498603|NCT00717093|65566387|FG000|Overall Study|Adverse Event|19|||
23694182|NCT01040832|66257381|FG000|Overall Study|Progressive disease|32|||
23694183|NCT01040832|66257382|FG001|Overall Study|Progressive disease|17|||
23694184|NCT01040832|66257381|FG000|Overall Study|Symptomatic deterioration|2|||
23694185|NCT01040832|66257382|FG001|Overall Study|Symptomatic deterioration|5|||
23694186|NCT01040832|66257381|FG000|Overall Study|Other|2|||
23694187|NCT01040832|66257382|FG001|Overall Study|Other|1|||
23395965|NCT01542788|65195830|FG001|Overall Study|Withdrawal by Subject|0|||
23395966|NCT04992273|65195833|FG000|Overall Study|Lost to Follow-up|0|||
23395967|NCT04992273|65195834|FG001|Overall Study|Lost to Follow-up|1|||
23395968|NCT04724837|65195840|FG000|Overall Study|Other|4|||
23395969|NCT04724837|65195841|FG001|Overall Study|Other|16|||
23694188|NCT01480180|66257386|FG000|Main Phase|Withdrawal criteria|12|||
23694189|NCT01480180|66257387|FG001|Main Phase|Withdrawal criteria|1|||
23694190|NCT01480180|66257388|FG002|Main Phase|Withdrawal criteria|0|||
23395970|NCT04724837|65195842|FG002|Overall Study|Other|0|||
23395971|NCT04724837|65195840|FG000|Overall Study|Withdrawal by Subject|2|||
23395972|NCT04724837|65195841|FG001|Overall Study|Withdrawal by Subject|9|||
23395973|NCT04724837|65195842|FG002|Overall Study|Withdrawal by Subject|9|||
23395974|NCT04724837|65195840|FG000|Overall Study|Adverse Event|2|||
23395975|NCT04724837|65195841|FG001|Overall Study|Adverse Event|7|||
23395976|NCT04724837|65195842|FG002|Overall Study|Adverse Event|4|||
23395977|NCT04724837|65195840|FG000|Overall Study|Lost to Follow-up|0|||
23395978|NCT04724837|65195841|FG001|Overall Study|Lost to Follow-up|1|||
23395979|NCT04724837|65195842|FG002|Overall Study|Lost to Follow-up|3|||
23395980|NCT04724837|65195840|FG000|Overall Study|Physician Decision|1|||
23395981|NCT04724837|65195841|FG001|Overall Study|Physician Decision|2|||
23395982|NCT04724837|65195842|FG002|Overall Study|Physician Decision|0|||
23694191|NCT01480180|66257389|FG003|Main Phase|Withdrawal criteria|0|||
23694192|NCT01480180|66257390|FG004|Main Phase|Withdrawal criteria|0|||
23694193|NCT01480180|66257391|FG005|Main Phase|Withdrawal criteria|0|||
23694194|NCT01480180|66257386|FG000|Main Phase|Lack of Efficacy|1|||
23694195|NCT01480180|66257387|FG001|Main Phase|Lack of Efficacy|0|||
23694196|NCT01480180|66257388|FG002|Main Phase|Lack of Efficacy|0|||
23694197|NCT01480180|66257389|FG003|Main Phase|Lack of Efficacy|0|||
23694198|NCT01480180|66257390|FG004|Main Phase|Lack of Efficacy|0|||
23694199|NCT01480180|66257391|FG005|Main Phase|Lack of Efficacy|0|||
23694200|NCT01480180|66257386|FG000|Main Phase|Non-compliance|3|||
23694201|NCT01480180|66257387|FG001|Main Phase|Non-compliance|0|||
23694202|NCT01480180|66257388|FG002|Main Phase|Non-compliance|0|||
23694203|NCT01480180|66257389|FG003|Main Phase|Non-compliance|0|||
23694204|NCT01480180|66257390|FG004|Main Phase|Non-compliance|0|||
23694205|NCT01480180|66257391|FG005|Main Phase|Non-compliance|0|||
23694206|NCT01480180|66257386|FG000|Main Phase|Unclassified|3|||
23694207|NCT01480180|66257387|FG001|Main Phase|Unclassified|0|||
23694208|NCT01480180|66257388|FG002|Main Phase|Unclassified|0|||
23694209|NCT01480180|66257389|FG003|Main Phase|Unclassified|0|||
23395983|NCT04724837|65195840|FG000|Overall Study|Death|0|||
23395984|NCT04724837|65195841|FG001|Overall Study|Death|0|||
23395985|NCT04724837|65195842|FG002|Overall Study|Death|1|||
23395986|NCT04724837|65195840|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23395987|NCT04724837|65195841|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
23395988|NCT04724837|65195842|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
23395989|NCT04724837|65195840|FG000|Overall Study|Study Terminated by Sponsor|0|||
23395990|NCT04724837|65195841|FG001|Overall Study|Study Terminated by Sponsor|1|||
23395991|NCT04724837|65195842|FG002|Overall Study|Study Terminated by Sponsor|0|||
23395992|NCT03958331|65195844|FG000|Overall Study|Withdrawal by Subject|3|||
23395993|NCT03958331|65195845|FG001|Overall Study|Withdrawal by Subject|1|||
23395994|NCT03958331|65195846|FG002|Overall Study|Withdrawal by Subject|5|||
23395995|NCT03958331|65195844|FG000|Overall Study|Weaned from medicine|2|||
23395996|NCT03958331|65195845|FG001|Overall Study|Weaned from medicine|0|||
23395997|NCT03958331|65195846|FG002|Overall Study|Weaned from medicine|0|||
23395998|NCT03958331|65195844|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
23395999|NCT03958331|65195845|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
23396000|NCT03958331|65195846|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
23396001|NCT03032484|65195847|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
23396002|NCT03032484|65195848|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
23396003|NCT03032484|65195847|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
23396004|NCT03032484|65195848|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
23396005|NCT03386773|65195849|FG000|Overall Study|Lost to Follow-up|24|||
23396006|NCT03386773|65195850|FG001|Overall Study|Lost to Follow-up|33|||
23396007|NCT03386773|65195849|FG000|Overall Study|Withdrawal by Subject|3|||
23396008|NCT03386773|65195850|FG001|Overall Study|Withdrawal by Subject|2|||
23396009|NCT00347269|65195851|FG000|Overall Study|Lost to Follow-up|74|||
23396010|NCT00347269|65195852|FG001|Overall Study|Lost to Follow-up|65|||
23396011|NCT00347269|65195851|FG000|Overall Study|Withdrawal by Subject|18|||
23498604|NCT00717093|65566388|FG001|Overall Study|Adverse Event|9|||
23694210|NCT01480180|66257390|FG004|Main Phase|Unclassified|0|||
23396012|NCT00347269|65195852|FG001|Overall Study|Withdrawal by Subject|38|||
23396013|NCT00347269|65195851|FG000|Overall Study|Death|2|||
23396014|NCT00347269|65195852|FG001|Overall Study|Death|3|||
23396015|NCT01344226|65195853|FG000|Overall Study|Protocol Violation|2|||
23396016|NCT01344226|65195853|FG000|Overall Study|Withdrawal by Subject|3|||
23396017|NCT01344226|65195853|FG000|Overall Study|Lack of Efficacy|3|||
23396018|NCT02216526|65195854|FG000|Overall Study|Adverse Event|1|||
23498605|NCT00717093|65566387|FG000|Overall Study|Lack of Efficacy|3|||
23498606|NCT00717093|65566388|FG001|Overall Study|Lack of Efficacy|13|||
23498607|NCT00717093|65566387|FG000|Overall Study|Lost to Follow-up|9|||
23396019|NCT02216526|65195855|FG001|Overall Study|Adverse Event|1|||
23396020|NCT02216526|65195856|FG002|Overall Study|Adverse Event|0|||
23396021|NCT02216526|65195854|FG000|Overall Study|Death|0|||
23694211|NCT01480180|66257391|FG005|Main Phase|Unclassified|0|||
23694212|NCT01480180|66257386|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
23694213|NCT01480180|66257387|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
23694214|NCT01480180|66257388|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
23694215|NCT01480180|66257389|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
23694216|NCT01480180|66257390|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
23694217|NCT01480180|66257391|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
23694218|NCT01480180|66257386|FG000|Extension Phase, Part 1|Unclassified|0|||
23694219|NCT01480180|66257387|FG001|Extension Phase, Part 1|Unclassified|0|||
23694220|NCT01480180|66257388|FG002|Extension Phase, Part 1|Unclassified|1|||
23694221|NCT01480180|66257389|FG003|Extension Phase, Part 1|Unclassified|0|||
23694222|NCT01480180|66257390|FG004|Extension Phase, Part 1|Unclassified|0|||
23694223|NCT01480180|66257391|FG005|Extension Phase, Part 1|Unclassified|0|||
23694224|NCT01480180|66257386|FG000|Extension Phase, Part 1|Adverse Event|0|||
23694225|NCT01480180|66257387|FG001|Extension Phase, Part 1|Adverse Event|0|||
23694226|NCT01480180|66257388|FG002|Extension Phase, Part 1|Adverse Event|4|||
23694227|NCT01480180|66257389|FG003|Extension Phase, Part 1|Adverse Event|1|||
23694228|NCT01480180|66257390|FG004|Extension Phase, Part 1|Adverse Event|0|||
23694229|NCT01480180|66257391|FG005|Extension Phase, Part 1|Adverse Event|0|||
23694230|NCT01480180|66257386|FG000|Extension Phase, Part 1|Change of treatment|0|||
23694231|NCT01480180|66257387|FG001|Extension Phase, Part 1|Change of treatment|0|||
23694232|NCT01480180|66257388|FG002|Extension Phase, Part 1|Change of treatment|0|||
23694233|NCT01480180|66257389|FG003|Extension Phase, Part 1|Change of treatment|9|||
23694234|NCT01480180|66257390|FG004|Extension Phase, Part 1|Change of treatment|0|||
23694235|NCT01480180|66257391|FG005|Extension Phase, Part 1|Change of treatment|0|||
23694236|NCT01480180|66257386|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
23694237|NCT01480180|66257387|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
23694238|NCT01480180|66257388|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
23694239|NCT01480180|66257389|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
23694240|NCT01480180|66257390|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
23694241|NCT01480180|66257391|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
23694242|NCT01480180|66257386|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
23694243|NCT01480180|66257387|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
23694244|NCT01480180|66257388|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
23694245|NCT01480180|66257389|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
23694246|NCT01480180|66257390|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
23694247|NCT01480180|66257391|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
23694248|NCT01480180|66257386|FG000|Extension Phase, Part 2|Unclassified|0|||
23694249|NCT01480180|66257387|FG001|Extension Phase, Part 2|Unclassified|0|||
23694250|NCT01480180|66257388|FG002|Extension Phase, Part 2|Unclassified|3|||
23694251|NCT01480180|66257389|FG003|Extension Phase, Part 2|Unclassified|1|||
23694252|NCT01480180|66257390|FG004|Extension Phase, Part 2|Unclassified|1|||
23694253|NCT01480180|66257391|FG005|Extension Phase, Part 2|Unclassified|0|||
23694254|NCT01981187|66257392|FG000|Overall Study|Participant/guardian decision|2|||
23694255|NCT01981187|66257392|FG000|Overall Study|Physician Decision|1|||
23694256|NCT01981187|66257392|FG000|Overall Study|Disease progression|2|||
23694257|NCT01981187|66257392|FG000|Overall Study|Adverse Event|7|||
23694258|NCT00174941|66257398|FG000|Overall Study|Adverse Event|1|||
23694259|NCT00174941|66257399|FG001|Overall Study|Adverse Event|10|||
23694260|NCT00174941|66257400|FG002|Overall Study|Adverse Event|2|||
23694261|NCT00174941|66257401|FG003|Overall Study|Adverse Event|13|||
23694262|NCT00174941|66257398|FG000|Overall Study|Protocol Violation|0|||
23694263|NCT00174941|66257399|FG001|Overall Study|Protocol Violation|1|||
23694264|NCT00174941|66257400|FG002|Overall Study|Protocol Violation|0|||
23694265|NCT00174941|66257401|FG003|Overall Study|Protocol Violation|1|||
23694266|NCT00174941|66257398|FG000|Overall Study|Lost to Follow-up|0|||
23694267|NCT00174941|66257399|FG001|Overall Study|Lost to Follow-up|3|||
23694268|NCT00174941|66257400|FG002|Overall Study|Lost to Follow-up|2|||
23396022|NCT02216526|65195855|FG001|Overall Study|Death|1|||
23396023|NCT02216526|65195856|FG002|Overall Study|Death|3|||
23396024|NCT02216526|65195854|FG000|Overall Study|Protocol Violation|2|||
23694269|NCT00174941|66257401|FG003|Overall Study|Lost to Follow-up|5|||
23694270|NCT00174941|66257398|FG000|Overall Study|Personal Reason(s)|0|||
23694271|NCT00174941|66257399|FG001|Overall Study|Personal Reason(s)|14|||
23694272|NCT00174941|66257400|FG002|Overall Study|Personal Reason(s)|8|||
23694273|NCT00174941|66257401|FG003|Overall Study|Personal Reason(s)|22|||
23694274|NCT00174941|66257398|FG000|Overall Study|Gout Flare|0|||
23694275|NCT00174941|66257399|FG001|Overall Study|Gout Flare|4|||
23694276|NCT00174941|66257400|FG002|Overall Study|Gout Flare|4|||
23694277|NCT00174941|66257401|FG003|Overall Study|Gout Flare|8|||
23694278|NCT00174941|66257398|FG000|Overall Study|Reason Not Specified|1|||
23694279|NCT00174941|66257399|FG001|Overall Study|Reason Not Specified|6|||
23694280|NCT00174941|66257400|FG002|Overall Study|Reason Not Specified|2|||
23694281|NCT00174941|66257401|FG003|Overall Study|Reason Not Specified|9|||
23694282|NCT00491530|66257402|FG000|Overall Study|Adverse Event|6|||
23694283|NCT00491530|66257403|FG001|Overall Study|Adverse Event|1|||
23694284|NCT00491530|66257404|FG002|Overall Study|Adverse Event|2|||
23396025|NCT02216526|65195855|FG001|Overall Study|Protocol Violation|0|||
23694285|NCT00491530|66257402|FG000|Overall Study|Withdrawal by Subject|3|||
23694286|NCT00491530|66257403|FG001|Overall Study|Withdrawal by Subject|0|||
23694287|NCT00491530|66257404|FG002|Overall Study|Withdrawal by Subject|0|||
23694288|NCT00491530|66257402|FG000|Overall Study|Lost to Follow-up|3|||
23694289|NCT00491530|66257403|FG001|Overall Study|Lost to Follow-up|2|||
23694290|NCT00491530|66257404|FG002|Overall Study|Lost to Follow-up|2|||
23694291|NCT00491530|66257402|FG000|Overall Study|Lack of Efficacy|0|||
23694292|NCT00491530|66257403|FG001|Overall Study|Lack of Efficacy|1|||
23694293|NCT00491530|66257404|FG002|Overall Study|Lack of Efficacy|0|||
23694294|NCT00491530|66257402|FG000|Overall Study|Investigator Discretion|0|||
23694295|NCT00491530|66257403|FG001|Overall Study|Investigator Discretion|1|||
23694296|NCT00491530|66257404|FG002|Overall Study|Investigator Discretion|0|||
23694297|NCT00491530|66257402|FG000|Overall Study|Patient Request|0|||
23694298|NCT00491530|66257403|FG001|Overall Study|Patient Request|1|||
23694299|NCT00491530|66257404|FG002|Overall Study|Patient Request|0|||
23694300|NCT00491530|66257402|FG000|Overall Study|Use of Prohibited Medication|0|||
23694301|NCT00491530|66257403|FG001|Overall Study|Use of Prohibited Medication|0|||
23694302|NCT00491530|66257404|FG002|Overall Study|Use of Prohibited Medication|1|||
23694303|NCT02201940|66257405|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
23694304|NCT02201940|66257406|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
23694305|NCT02201940|66257405|FG000|Overall Study|Lack of Efficacy|2|||
23694306|NCT02201940|66257406|FG001|Overall Study|Lack of Efficacy|113|||
23694307|NCT02201940|66257405|FG000|Overall Study|Lost to Follow-up|5|||
23694308|NCT02201940|66257406|FG001|Overall Study|Lost to Follow-up|0|||
23694309|NCT02201940|66257405|FG000|Overall Study|Withdrew Consent|2|||
23694310|NCT02201940|66257406|FG001|Overall Study|Withdrew Consent|1|||
23694311|NCT02201940|66257405|FG000|Overall Study|Investigator's Discretion|1|||
23694312|NCT02201940|66257406|FG001|Overall Study|Investigator's Discretion|1|||
23694313|NCT02201940|66257405|FG000|Overall Study|Death|1|||
23694314|NCT02201940|66257406|FG001|Overall Study|Death|0|||
23694315|NCT02201940|66257405|FG000|Overall Study|Adverse Event|0|||
23694316|NCT02201940|66257406|FG001|Overall Study|Adverse Event|1|||
23396026|NCT02216526|65195856|FG002|Overall Study|Protocol Violation|2|||
23396027|NCT02216526|65195854|FG000|Overall Study|Hospitalization|2|||
23396028|NCT02216526|65195855|FG001|Overall Study|Hospitalization|1|||
23396029|NCT02216526|65195856|FG002|Overall Study|Hospitalization|3|||
23396030|NCT01722669|65195861|FG000|Overall Study|Withdrawal by Subject|0|||
23396031|NCT01722669|65195862|FG001|Overall Study|Withdrawal by Subject|0|||
23396032|NCT01722669|65195863|FG002|Overall Study|Withdrawal by Subject|0|||
23396033|NCT01722669|65195864|FG003|Overall Study|Withdrawal by Subject|0|||
23396034|NCT01722669|65195865|FG004|Overall Study|Withdrawal by Subject|0|||
23396035|NCT01722669|65195866|FG005|Overall Study|Withdrawal by Subject|2|||
23396036|NCT00770679|65195867|FG000|Overall Study|Lost to Follow-up|3|||
23396037|NCT00770679|65195867|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
23396038|NCT01959932|65195868|FG000|Overall Study|Withdrawal by Subject|1|||
23396039|NCT01959932|65195869|FG001|Overall Study|Withdrawal by Subject|0|||
23396040|NCT01959932|65195870|FG002|Overall Study|Withdrawal by Subject|0|||
23396041|NCT03610048|65195871|FG000|Overall Study|Study terminated by sponsor|84|||
23396042|NCT03610048|65195871|FG000|Overall Study|Adverse Event|32|||
23396043|NCT03610048|65195871|FG000|Overall Study|Withdrawal by Subject|31|||
23396044|NCT03610048|65195871|FG000|Overall Study|Lost to Follow-up|8|||
23396045|NCT03610048|65195871|FG000|Overall Study|Other|4|||
23396046|NCT03610048|65195871|FG000|Overall Study|Physician Decision|1|||
23396047|NCT03610048|65195871|FG000|Overall Study|Pregnancy|1|||
23396048|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Adverse Event|20|||
23396049|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Adverse Event|10|||
23396050|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Adverse Event|5|||
23396051|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Adverse Event|0|||
23396052|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Adverse Event|0|||
23694317|NCT01273818|66257407|FG000|Overall Study|Physician Decision|13|||
23694318|NCT01273818|66257408|FG001|Overall Study|Physician Decision|2|||
23694319|NCT01273818|66257409|FG002|Overall Study|Physician Decision|9|||
23396053|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Adverse Event|0|||
23396054|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Adverse Event|0|||
23694320|NCT04272606|66257414|FG000|Overall Study|Protocol Violation|1|||
23694321|NCT04272606|66257415|FG001|Overall Study|Protocol Violation|1|||
23694322|NCT04272606|66257414|FG000|Overall Study|Physician Decision|0|||
23694323|NCT04272606|66257415|FG001|Overall Study|Physician Decision|1|||
23694324|NCT05421754|66257416|FG000|Overall Study|Technical issue with sensor|1|||
23694325|NCT00479466|66257417|FG000|Overall Study|Adverse Event|5|||
23694326|NCT00479466|66257418|FG001|Overall Study|Adverse Event|1|||
23396055|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Adverse Event|0|||
23396056|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Adverse Event|0|||
23396057|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Adverse Event|0|||
23396058|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Adverse Event|0|||
23396059|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Adverse Event|0|||
23694327|NCT00479466|66257419|FG002|Overall Study|Adverse Event|0|||
23694328|NCT00479466|66257420|FG003|Overall Study|Adverse Event|1|||
23396060|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396061|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396062|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
23396063|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396064|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396065|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396066|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396067|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396068|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396069|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396070|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396071|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396072|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
23694329|NCT00479466|66257421|FG004|Overall Study|Adverse Event|2|||
23694330|NCT00479466|66257422|FG005|Overall Study|Adverse Event|0|||
23694331|NCT00479466|66257417|FG000|Overall Study|Hyperglycemia|0|||
23694332|NCT00479466|66257418|FG001|Overall Study|Hyperglycemia|0|||
23694333|NCT00479466|66257419|FG002|Overall Study|Hyperglycemia|0|||
23694334|NCT00479466|66257420|FG003|Overall Study|Hyperglycemia|0|||
23694335|NCT00479466|66257421|FG004|Overall Study|Hyperglycemia|0|||
23694336|NCT00479466|66257422|FG005|Overall Study|Hyperglycemia|1|||
23694337|NCT00479466|66257417|FG000|Overall Study|Lack of Efficacy|2|||
23694338|NCT00479466|66257418|FG001|Overall Study|Lack of Efficacy|0|||
23694339|NCT00479466|66257419|FG002|Overall Study|Lack of Efficacy|1|||
23694340|NCT00479466|66257420|FG003|Overall Study|Lack of Efficacy|0|||
23694341|NCT00479466|66257421|FG004|Overall Study|Lack of Efficacy|0|||
23694342|NCT00479466|66257422|FG005|Overall Study|Lack of Efficacy|0|||
23694343|NCT00479466|66257417|FG000|Overall Study|Lost to Follow-up|0|||
23694344|NCT00479466|66257418|FG001|Overall Study|Lost to Follow-up|1|||
23694345|NCT00479466|66257419|FG002|Overall Study|Lost to Follow-up|1|||
23694346|NCT00479466|66257420|FG003|Overall Study|Lost to Follow-up|0|||
23694347|NCT00479466|66257421|FG004|Overall Study|Lost to Follow-up|2|||
23694348|NCT00479466|66257422|FG005|Overall Study|Lost to Follow-up|2|||
23694349|NCT00479466|66257417|FG000|Overall Study|Physician Decision|2|||
23694350|NCT00479466|66257418|FG001|Overall Study|Physician Decision|1|||
23694351|NCT00479466|66257419|FG002|Overall Study|Physician Decision|1|||
23694352|NCT00479466|66257420|FG003|Overall Study|Physician Decision|0|||
23694353|NCT00479466|66257421|FG004|Overall Study|Physician Decision|0|||
23694354|NCT00479466|66257422|FG005|Overall Study|Physician Decision|0|||
23694355|NCT00479466|66257417|FG000|Overall Study|Pregnancy|0|||
23694356|NCT00479466|66257418|FG001|Overall Study|Pregnancy|0|||
23694357|NCT00479466|66257419|FG002|Overall Study|Pregnancy|0|||
23694358|NCT00479466|66257420|FG003|Overall Study|Pregnancy|0|||
23694359|NCT00479466|66257421|FG004|Overall Study|Pregnancy|1|||
23694360|NCT00479466|66257422|FG005|Overall Study|Pregnancy|0|||
23694361|NCT00479466|66257417|FG000|Overall Study|Protocol Violation|1|||
23694362|NCT00479466|66257418|FG001|Overall Study|Protocol Violation|0|||
23694363|NCT00479466|66257419|FG002|Overall Study|Protocol Violation|0|||
23694364|NCT00479466|66257420|FG003|Overall Study|Protocol Violation|0|||
23694365|NCT00479466|66257421|FG004|Overall Study|Protocol Violation|0|||
23694366|NCT00479466|66257422|FG005|Overall Study|Protocol Violation|0|||
23694367|NCT00479466|66257417|FG000|Overall Study|Withdrawal by Subject|3|||
23396073|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
23396074|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
23396075|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
23396076|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
23396077|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
23396078|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
23396079|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
23396080|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
23498608|NCT00717093|65566388|FG001|Overall Study|Lost to Follow-up|6|||
23498609|NCT00717093|65566387|FG000|Overall Study|Withdrawal by Subject|12|||
23694368|NCT00479466|66257418|FG001|Overall Study|Withdrawal by Subject|5|||
23694369|NCT00479466|66257419|FG002|Overall Study|Withdrawal by Subject|0|||
23694370|NCT00479466|66257420|FG003|Overall Study|Withdrawal by Subject|2|||
23694371|NCT00479466|66257421|FG004|Overall Study|Withdrawal by Subject|3|||
23694372|NCT00479466|66257422|FG005|Overall Study|Withdrawal by Subject|1|||
23694373|NCT00871858|66257426|FG000|Overall Study|Protocol Violation|3|||
23694374|NCT00871858|66257427|FG001|Overall Study|Protocol Violation|4|||
23694375|NCT00871858|66257426|FG000|Overall Study|Adverse Event|1|||
23694376|NCT00871858|66257427|FG001|Overall Study|Adverse Event|1|||
23694377|NCT00871858|66257426|FG000|Overall Study|Withdrawal by Subject|1|||
23396081|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
23396082|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
23694378|NCT00871858|66257427|FG001|Overall Study|Withdrawal by Subject|1|||
23694379|NCT00871858|66257426|FG000|Overall Study|Lost to Follow-up|0|||
23396083|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
23396084|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
23694380|NCT00871858|66257427|FG001|Overall Study|Lost to Follow-up|1|||
23694381|NCT01061008|66257428|FG000|Overall Study|Badiocephalic fistula failed|3|||
23694382|NCT01061008|66257429|FG001|Overall Study|Badiocephalic fistula failed|2|||
23694383|NCT01061008|66257428|FG000|Overall Study|Death|1|||
23694384|NCT01061008|66257429|FG001|Overall Study|Death|0|||
23694385|NCT01061008|66257428|FG000|Overall Study|Withdrawal by Subject|1|||
23694386|NCT01061008|66257429|FG001|Overall Study|Withdrawal by Subject|3|||
23694387|NCT01061008|66257428|FG000|Overall Study|Unable to exercise following surgery|1|||
23694388|NCT01061008|66257429|FG001|Overall Study|Unable to exercise following surgery|0|||
23694389|NCT01061008|66257428|FG000|Overall Study|Adverse Event|0|||
23694390|NCT01061008|66257429|FG001|Overall Study|Adverse Event|1|||
23694391|NCT03227861|66260261|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
23694392|NCT03227861|66260261|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
23694393|NCT03227861|66260261|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
23694394|NCT03227861|66260261|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
23694395|NCT03227861|66260261|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
23396085|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
23396086|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
23396087|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
23396088|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
23396089|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
23396090|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
23396091|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
23396092|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
23694396|NCT03227861|66260261|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
23694397|NCT03227861|66260261|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
23694398|NCT03227861|66260261|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
23694399|NCT03227861|66260261|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
23694400|NCT03227861|66260261|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
23694401|NCT02493751|66260263|FG000|Overall Study|Withdrawal by Subject|2|||
23694402|NCT02493751|66260264|FG001|Overall Study|Withdrawal by Subject|8|||
23694403|NCT02493751|66260263|FG000|Overall Study|Death|6|||
23694404|NCT02493751|66260264|FG001|Overall Study|Death|13|||
23694405|NCT02493751|66260263|FG000|Overall Study|Lost to Follow-up|2|||
23396093|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
23396094|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
23396095|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
23396096|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Other|50|||
23396097|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Other|38|||
23396098|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Other|24|||
23396099|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Other|0|||
23694406|NCT02493751|66260264|FG001|Overall Study|Lost to Follow-up|3|||
23694407|NCT02493751|66260263|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
23694408|NCT02493751|66260264|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
23694409|NCT01318902|66260267|FG000|Overall Study|Symptomatic Deterioration|0|||
23694410|NCT01318902|66260268|FG001|Overall Study|Symptomatic Deterioration|1|||
23694411|NCT01318902|66260269|FG002|Overall Study|Symptomatic Deterioration|1|||
23694412|NCT01318902|66260270|FG003|Overall Study|Symptomatic Deterioration|2|||
23694413|NCT01318902|66260267|FG000|Overall Study|Withdrawal by Patient|0|||
23694414|NCT01318902|66260268|FG001|Overall Study|Withdrawal by Patient|1|||
23694415|NCT01318902|66260269|FG002|Overall Study|Withdrawal by Patient|0|||
23694416|NCT01318902|66260270|FG003|Overall Study|Withdrawal by Patient|3|||
23694417|NCT01318902|66260267|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23694418|NCT01318902|66260268|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23694419|NCT01318902|66260269|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23694420|NCT01318902|66260270|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
23694421|NCT01318902|66260267|FG000|Overall Study|Adverse Event|0|||
23694422|NCT01318902|66260268|FG001|Overall Study|Adverse Event|1|||
23694423|NCT01318902|66260269|FG002|Overall Study|Adverse Event|0|||
23694424|NCT01318902|66260270|FG003|Overall Study|Adverse Event|0|||
23694425|NCT01318902|66260267|FG000|Overall Study|Terminated by Sponsor|0|||
23694426|NCT01318902|66260268|FG001|Overall Study|Terminated by Sponsor|0|||
23694427|NCT01318902|66260269|FG002|Overall Study|Terminated by Sponsor|1|||
23694428|NCT01318902|66260270|FG003|Overall Study|Terminated by Sponsor|0|||
23396100|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Other|0|||
23396101|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Other|0|||
23694429|NCT02723630|66260273|FG000|Intervention Period 1|Adverse Event|1|||
23694430|NCT02723630|66260274|FG001|Intervention Period 1|Adverse Event|0|||
23396102|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Other|0|||
23396103|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Other|0|||
23694431|NCT02723630|66260275|FG002|Intervention Period 1|Adverse Event|0|||
23694432|NCT02723630|66260276|FG003|Intervention Period 1|Adverse Event|0|||
23694433|NCT02723630|66260277|FG004|Intervention Period 1|Adverse Event|0|||
23694434|NCT02723630|66260278|FG005|Intervention Period 1|Adverse Event|0|||
23694435|NCT02723630|66260273|FG000|Intervention Period 3|consumption of restricted item|0|||
23694436|NCT02723630|66260274|FG001|Intervention Period 3|consumption of restricted item|1|||
23694437|NCT02723630|66260275|FG002|Intervention Period 3|consumption of restricted item|0|||
23694438|NCT02723630|66260276|FG003|Intervention Period 3|consumption of restricted item|0|||
23694439|NCT02723630|66260277|FG004|Intervention Period 3|consumption of restricted item|0|||
23694440|NCT02723630|66260278|FG005|Intervention Period 3|consumption of restricted item|0|||
23694441|NCT00618956|66260280|FG000|Overall Study|Adverse Event|10|||
23694442|NCT00618956|66260281|FG001|Overall Study|Adverse Event|34|||
23694443|NCT00618956|66260280|FG000|Overall Study|Lack of Efficacy|2|||
23694444|NCT00618956|66260281|FG001|Overall Study|Lack of Efficacy|1|||
23694445|NCT00618956|66260280|FG000|Overall Study|Withdrawal by Subject|5|||
23694446|NCT00618956|66260281|FG001|Overall Study|Withdrawal by Subject|7|||
23694447|NCT00618956|66260280|FG000|Overall Study|Lost to Follow-up|4|||
23694448|NCT00618956|66260281|FG001|Overall Study|Lost to Follow-up|5|||
23694449|NCT00618956|66260280|FG000|Overall Study|Protocol Violation|2|||
23694450|NCT00618956|66260281|FG001|Overall Study|Protocol Violation|2|||
23694451|NCT00618956|66260280|FG000|Overall Study|did not meet criteria, non-compliance|2|||
23396104|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Other|0|||
23396105|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Other|0|||
23396106|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Other|0|||
23396107|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Other|0|||
23396108|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396109|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396110|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396111|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
23396112|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
23396113|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
23396114|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396115|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396116|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396117|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396118|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396119|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396120|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Death|0|||
23396121|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Death|0|||
23396122|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Death|0|||
23396123|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Death|0|||
23396124|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Death|1|||
23396125|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Death|0|||
23396126|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Death|0|||
23396127|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Death|0|||
23396128|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Death|0|||
23396129|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Death|0|||
23396130|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Death|0|||
23396131|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Death|0|||
23396132|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396133|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396134|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396135|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
23396136|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396137|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396138|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396139|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396140|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396141|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396142|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396143|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396144|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
23498610|NCT00717093|65566388|FG001|Overall Study|Withdrawal by Subject|19|||
23694452|NCT00618956|66260281|FG001|Overall Study|did not meet criteria, non-compliance|1|||
23694453|NCT01208181|66260282|FG000|Part 1|Withdrawal by Subject|11|||
23694454|NCT01208181|66260283|FG001|Part 1|Withdrawal by Subject|10|||
23694455|NCT01208181|66260284|FG002|Part 1|Withdrawal by Subject|0|||
23694456|NCT01208181|66260285|FG003|Part 1|Withdrawal by Subject|0|||
23396145|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396146|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396147|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396148|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396149|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
23396150|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
23498611|NCT00717093|65566387|FG000|Overall Study|Other|0|||
23498612|NCT00717093|65566388|FG001|Overall Study|Other|1|||
23396151|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396152|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396153|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396154|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396155|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396156|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Other|0|||
23396157|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Other|0|||
23396158|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Other|0|||
23694457|NCT01208181|66260286|FG004|Part 1|Withdrawal by Subject|0|||
23694458|NCT01208181|66260282|FG000|Part 1|Technical problem|5|||
23694459|NCT01208181|66260283|FG001|Part 1|Technical problem|0|||
23694460|NCT01208181|66260284|FG002|Part 1|Technical problem|0|||
23694461|NCT01208181|66260285|FG003|Part 1|Technical problem|0|||
23694462|NCT01208181|66260286|FG004|Part 1|Technical problem|0|||
23694463|NCT01208181|66260282|FG000|Part 1|Protocol Violation|10|||
23694464|NCT01208181|66260283|FG001|Part 1|Protocol Violation|5|||
23694465|NCT01208181|66260284|FG002|Part 1|Protocol Violation|0|||
23694466|NCT01208181|66260285|FG003|Part 1|Protocol Violation|0|||
23694467|NCT01208181|66260286|FG004|Part 1|Protocol Violation|0|||
23694468|NCT01208181|66260282|FG000|Part 1|Physician Decision|4|||
23694469|NCT01208181|66260283|FG001|Part 1|Physician Decision|0|||
23694470|NCT01208181|66260284|FG002|Part 1|Physician Decision|0|||
23694471|NCT01208181|66260285|FG003|Part 1|Physician Decision|0|||
23694472|NCT01208181|66260286|FG004|Part 1|Physician Decision|0|||
23694473|NCT01208181|66260282|FG000|Part 1|Non-compliance with study drug|1|||
23694474|NCT01208181|66260283|FG001|Part 1|Non-compliance with study drug|1|||
23694475|NCT01208181|66260284|FG002|Part 1|Non-compliance with study drug|0|||
23694476|NCT01208181|66260285|FG003|Part 1|Non-compliance with study drug|0|||
23694477|NCT01208181|66260286|FG004|Part 1|Non-compliance with study drug|0|||
23694478|NCT01208181|66260282|FG000|Part 1|Lost to Follow-up|5|||
23694479|NCT01208181|66260283|FG001|Part 1|Lost to Follow-up|3|||
23694480|NCT01208181|66260284|FG002|Part 1|Lost to Follow-up|0|||
23694481|NCT01208181|66260285|FG003|Part 1|Lost to Follow-up|0|||
23694482|NCT01208181|66260286|FG004|Part 1|Lost to Follow-up|1|||
23694483|NCT01208181|66260282|FG000|Part 1|Lack of Efficacy|37|||
23694484|NCT01208181|66260283|FG001|Part 1|Lack of Efficacy|12|||
23694485|NCT01208181|66260284|FG002|Part 1|Lack of Efficacy|0|||
23694486|NCT01208181|66260285|FG003|Part 1|Lack of Efficacy|0|||
23694487|NCT01208181|66260286|FG004|Part 1|Lack of Efficacy|17|||
23694488|NCT01208181|66260282|FG000|Part 1|Adverse Event|26|||
23694489|NCT01208181|66260283|FG001|Part 1|Adverse Event|24|||
23694490|NCT01208181|66260284|FG002|Part 1|Adverse Event|0|||
23694491|NCT01208181|66260285|FG003|Part 1|Adverse Event|0|||
23694492|NCT01208181|66260286|FG004|Part 1|Adverse Event|4|||
23694493|NCT01208181|66260282|FG000|Part 2|Adverse Event|0|||
23694494|NCT01208181|66260283|FG001|Part 2|Adverse Event|0|||
23694495|NCT01208181|66260284|FG002|Part 2|Adverse Event|6|||
23694496|NCT01208181|66260285|FG003|Part 2|Adverse Event|7|||
23694497|NCT01208181|66260286|FG004|Part 2|Adverse Event|0|||
23694498|NCT01208181|66260282|FG000|Part 2|Withdrawal by Subject|0|||
23694499|NCT01208181|66260283|FG001|Part 2|Withdrawal by Subject|0|||
23694500|NCT01208181|66260284|FG002|Part 2|Withdrawal by Subject|1|||
23694501|NCT01208181|66260285|FG003|Part 2|Withdrawal by Subject|1|||
23694502|NCT01208181|66260286|FG004|Part 2|Withdrawal by Subject|0|||
23694503|NCT01208181|66260282|FG000|Part 2|Protocol Violation|0|||
23694504|NCT01208181|66260283|FG001|Part 2|Protocol Violation|0|||
23694505|NCT01208181|66260284|FG002|Part 2|Protocol Violation|1|||
23694506|NCT01208181|66260285|FG003|Part 2|Protocol Violation|0|||
23694507|NCT01208181|66260286|FG004|Part 2|Protocol Violation|0|||
23694508|NCT01208181|66260282|FG000|Part 2|Physician Decision|0|||
23694509|NCT01208181|66260283|FG001|Part 2|Physician Decision|0|||
23694510|NCT01208181|66260284|FG002|Part 2|Physician Decision|1|||
23694511|NCT01208181|66260285|FG003|Part 2|Physician Decision|2|||
23694512|NCT01208181|66260286|FG004|Part 2|Physician Decision|0|||
23396159|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Other|15|||
23396160|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Other|20|||
23396161|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Other|44|||
23694513|NCT01208181|66260282|FG000|Part 2|Non-compliance with study drug|0|||
23694514|NCT01208181|66260283|FG001|Part 2|Non-compliance with study drug|0|||
23694515|NCT01208181|66260284|FG002|Part 2|Non-compliance with study drug|1|||
23694516|NCT01208181|66260285|FG003|Part 2|Non-compliance with study drug|1|||
23694517|NCT01208181|66260286|FG004|Part 2|Non-compliance with study drug|0|||
23694518|NCT01208181|66260282|FG000|Part 2|Lost to Follow-up|0|||
23694519|NCT01208181|66260283|FG001|Part 2|Lost to Follow-up|0|||
23694520|NCT01208181|66260284|FG002|Part 2|Lost to Follow-up|1|||
23694521|NCT01208181|66260285|FG003|Part 2|Lost to Follow-up|2|||
23694522|NCT01208181|66260286|FG004|Part 2|Lost to Follow-up|0|||
23694523|NCT01208181|66260282|FG000|Part 2|Lack of Efficacy|0|||
23694524|NCT01208181|66260283|FG001|Part 2|Lack of Efficacy|0|||
23396162|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Other|0|||
23694525|NCT01208181|66260284|FG002|Part 2|Lack of Efficacy|5|||
23694526|NCT01208181|66260285|FG003|Part 2|Lack of Efficacy|7|||
23694527|NCT01208181|66260286|FG004|Part 2|Lack of Efficacy|0|||
23694528|NCT03088605|66260289|FG000|Overall Study|Withdrawal by Subject|1|||
23694529|NCT03088605|66260290|FG001|Overall Study|Withdrawal by Subject|0|||
23694530|NCT02128490|66260291|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23694531|NCT02128490|66260292|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23694532|NCT02128490|66260293|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23694533|NCT02128490|66260294|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23694534|NCT02128490|66260295|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23694535|NCT02128490|66260291|FG000|Overall Study|Major Protocol Deviation|1|||
23694536|NCT02128490|66260292|FG001|Overall Study|Major Protocol Deviation|2|||
23694537|NCT02128490|66260293|FG002|Overall Study|Major Protocol Deviation|0|||
23694538|NCT02128490|66260294|FG003|Overall Study|Major Protocol Deviation|2|||
23694539|NCT02128490|66260295|FG004|Overall Study|Major Protocol Deviation|2|||
23694540|NCT02128490|66260291|FG000|Overall Study|Lost to Follow-up|0|||
23694541|NCT02128490|66260292|FG001|Overall Study|Lost to Follow-up|0|||
23694542|NCT02128490|66260293|FG002|Overall Study|Lost to Follow-up|1|||
23694543|NCT02128490|66260294|FG003|Overall Study|Lost to Follow-up|1|||
23694544|NCT02128490|66260295|FG004|Overall Study|Lost to Follow-up|1|||
23694545|NCT02128490|66260291|FG000|Overall Study|Voluntary Withdrawal|3|||
23694546|NCT02128490|66260292|FG001|Overall Study|Voluntary Withdrawal|3|||
23694547|NCT02128490|66260293|FG002|Overall Study|Voluntary Withdrawal|1|||
23694548|NCT02128490|66260294|FG003|Overall Study|Voluntary Withdrawal|1|||
23694549|NCT02128490|66260295|FG004|Overall Study|Voluntary Withdrawal|2|||
23694550|NCT02128490|66260291|FG000|Overall Study|Lack of Efficacy|0|||
23694551|NCT02128490|66260292|FG001|Overall Study|Lack of Efficacy|1|||
23694552|NCT02128490|66260293|FG002|Overall Study|Lack of Efficacy|0|||
23694553|NCT02128490|66260294|FG003|Overall Study|Lack of Efficacy|0|||
23694554|NCT02128490|66260295|FG004|Overall Study|Lack of Efficacy|0|||
23694555|NCT02128490|66260291|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23694556|NCT02128490|66260292|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23396163|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Other|0|||
23396164|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Other|0|||
23396165|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Other|0|||
23396166|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Other|0|||
23396167|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Other|0|||
23396168|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396169|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396170|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396171|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396172|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396173|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396174|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396175|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
23396176|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396177|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396178|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396179|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396180|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396181|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396182|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396183|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396184|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396185|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396186|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396187|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396188|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
23396189|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396190|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396191|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396192|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396193|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396194|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396195|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396196|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23694557|NCT02128490|66260293|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23694558|NCT02128490|66260294|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23694559|NCT02128490|66260295|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
23694560|NCT02128490|66260291|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23694561|NCT02128490|66260292|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23694562|NCT02128490|66260293|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23694563|NCT02128490|66260294|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23694564|NCT02128490|66260295|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23694565|NCT00883753|66260296|FG000|Overall Study|Adverse Event|37|||
23694566|NCT00883753|66260296|FG000|Overall Study|Death|2|||
23694567|NCT00883753|66260296|FG000|Overall Study|Insufficient therapeutic response|16|||
23694568|NCT00883753|66260296|FG000|Overall Study|Lost to Follow-up|4|||
23694569|NCT00883753|66260296|FG000|Overall Study|Violation of selection criteria at entry|7|||
23694570|NCT00883753|66260296|FG000|Overall Study|Protocol Violation|2|||
23694571|NCT00883753|66260296|FG000|Overall Study|Refused treatment|4|||
23694572|NCT00883753|66260296|FG000|Overall Study|Withdrew consent|10|||
23694573|NCT00883753|66260296|FG000|Overall Study|Investigator's decision|17|||
23694574|NCT00883753|66260296|FG000|Overall Study|Administrative/Other|8|||
23694575|NCT04651777|66260299|FG000|Overall Study|Adverse Event|1|||
23694576|NCT04651777|66260299|FG000|Overall Study|Withdrawal by Subject|2|||
23694577|NCT01380093|66260302|FG000|Naloxone Challenge Phase|Screen failures|21|||
23694578|NCT01380093|66260303|FG001|Naloxone Challenge Phase|Screen failures|0|||
23694579|NCT01380093|66260304|FG002|Naloxone Challenge Phase|Screen failures|0|||
23694580|NCT01380093|66260305|FG003|Naloxone Challenge Phase|Screen failures|0|||
23694581|NCT01380093|66260306|FG004|Naloxone Challenge Phase|Screen failures|0|||
23694582|NCT01380093|66260307|FG005|Naloxone Challenge Phase|Screen failures|0|||
23694583|NCT01380093|66260308|FG006|Naloxone Challenge Phase|Screen failures|0|||
23694584|NCT01380093|66260309|FG007|Naloxone Challenge Phase|Screen failures|0|||
23694585|NCT01380093|66260310|FG008|Naloxone Challenge Phase|Screen failures|0|||
23694586|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694587|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
23694588|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694589|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694590|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694591|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694592|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694593|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694594|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23694595|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694596|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
23694597|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
23694598|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694599|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694600|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694601|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694602|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694603|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23694604|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694605|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
23694606|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694607|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694608|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694609|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694610|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694611|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694612|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23694613|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694614|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
23694615|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
23694616|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694617|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694618|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694619|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694620|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694621|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23694622|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694623|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
23694624|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
23694625|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694626|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694627|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694628|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694629|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694630|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23694631|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
23498613|NCT00717093|65566387|FG000|Overall Study|Randomized but not treated|1|||
23694632|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694633|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
23694634|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694635|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694636|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694637|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694638|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694639|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
23694640|NCT01380093|66260302|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694641|NCT01380093|66260303|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694642|NCT01380093|66260304|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
23694643|NCT01380093|66260305|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694644|NCT01380093|66260306|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694645|NCT01380093|66260307|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694646|NCT01380093|66260308|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694647|NCT01380093|66260309|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694648|NCT01380093|66260310|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23694649|NCT01380093|66260302|FG000|Treatment Phase: Second Intervention|Other|0|||
23694650|NCT01380093|66260303|FG001|Treatment Phase: Second Intervention|Other|0|||
23694651|NCT01380093|66260304|FG002|Treatment Phase: Second Intervention|Other|0|||
23694652|NCT01380093|66260305|FG003|Treatment Phase: Second Intervention|Other|1|||
23694653|NCT01380093|66260306|FG004|Treatment Phase: Second Intervention|Other|0|||
23694654|NCT01380093|66260307|FG005|Treatment Phase: Second Intervention|Other|0|||
23694655|NCT01380093|66260308|FG006|Treatment Phase: Second Intervention|Other|0|||
23694656|NCT01380093|66260309|FG007|Treatment Phase: Second Intervention|Other|0|||
23694657|NCT01380093|66260310|FG008|Treatment Phase: Second Intervention|Other|0|||
23694658|NCT01380093|66260302|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
23694659|NCT01380093|66260303|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
23694660|NCT01380093|66260304|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
23694661|NCT01380093|66260305|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
23694662|NCT01380093|66260306|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
23694663|NCT01380093|66260307|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
23694664|NCT01380093|66260308|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
23694665|NCT01380093|66260309|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
23694666|NCT01380093|66260310|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
23694667|NCT01380093|66260302|FG000|Treatment Phase: Third Intervention|Other|0|||
23694668|NCT01380093|66260303|FG001|Treatment Phase: Third Intervention|Other|0|||
23694669|NCT01380093|66260304|FG002|Treatment Phase: Third Intervention|Other|0|||
23694670|NCT01380093|66260305|FG003|Treatment Phase: Third Intervention|Other|0|||
23694671|NCT01380093|66260306|FG004|Treatment Phase: Third Intervention|Other|0|||
23694672|NCT01380093|66260307|FG005|Treatment Phase: Third Intervention|Other|0|||
23694673|NCT01380093|66260308|FG006|Treatment Phase: Third Intervention|Other|0|||
23694674|NCT01380093|66260309|FG007|Treatment Phase: Third Intervention|Other|0|||
23694675|NCT01380093|66260310|FG008|Treatment Phase: Third Intervention|Other|1|||
23694676|NCT00542815|66260311|FG000|Overall Study|Adverse Event|19|||
23694677|NCT00542815|66260312|FG001|Overall Study|Adverse Event|6|||
23694678|NCT00542815|66260313|FG002|Overall Study|Adverse Event|9|||
23694679|NCT00542815|66260311|FG000|Overall Study|Death|10|||
23694680|NCT00542815|66260312|FG001|Overall Study|Death|7|||
23694681|NCT00542815|66260313|FG002|Overall Study|Death|3|||
23694682|NCT00542815|66260311|FG000|Overall Study|Lack of Efficacy|9|||
23694683|NCT00542815|66260312|FG001|Overall Study|Lack of Efficacy|2|||
23694684|NCT00542815|66260313|FG002|Overall Study|Lack of Efficacy|0|||
23694685|NCT00542815|66260311|FG000|Overall Study|Physician Decision|2|||
23694686|NCT00542815|66260312|FG001|Overall Study|Physician Decision|1|||
23694687|NCT00542815|66260313|FG002|Overall Study|Physician Decision|0|||
23694688|NCT00542815|66260311|FG000|Overall Study|Protocol Violation|1|||
23694689|NCT00542815|66260312|FG001|Overall Study|Protocol Violation|1|||
23694690|NCT00542815|66260313|FG002|Overall Study|Protocol Violation|2|||
23694691|NCT00542815|66260311|FG000|Overall Study|Withdrawal by Subject|41|||
23694692|NCT00542815|66260312|FG001|Overall Study|Withdrawal by Subject|5|||
23694693|NCT00542815|66260313|FG002|Overall Study|Withdrawal by Subject|8|||
23694694|NCT00542815|66260311|FG000|Overall Study|Other reasons|24|||
23694695|NCT00542815|66260312|FG001|Overall Study|Other reasons|10|||
23498614|NCT00717093|65566388|FG001|Overall Study|Randomized but not treated|0|||
23498615|NCT00986830|65566391|FG000|Overall Study|Death|1|||
23694696|NCT00542815|66260313|FG002|Overall Study|Other reasons|10|||
23694697|NCT01416181|66260314|FG000|Part 1|Other|10|||
23498616|NCT00986830|65566391|FG000|Overall Study|Lost to Follow-up|1|||
23694698|NCT01416181|66260315|FG001|Part 1|Other|24|||
23694699|NCT01416181|66260314|FG000|Part 1|Death|0|||
23694700|NCT01416181|66260315|FG001|Part 1|Death|1|||
23694701|NCT01416181|66260314|FG000|Part 1|Investigator Decision|7|||
23694702|NCT01416181|66260315|FG001|Part 1|Investigator Decision|6|||
23396197|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396198|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
23396199|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
23396200|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
23396201|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396202|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396203|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396204|NCT00725985|65198880|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396205|NCT00725985|65198881|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396206|NCT00725985|65198882|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396207|NCT00725985|65198883|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396208|NCT00725985|65198884|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396209|NCT00725985|65198885|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396210|NCT00725985|65198886|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396211|NCT00725985|65198887|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396212|NCT00725985|65198888|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396213|NCT00725985|65198889|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
23396214|NCT00725985|65198890|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
23396215|NCT00725985|65198891|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
23396216|NCT01230060|65198892|FG000|Overall Study|Withdrawal by Subject|1|||
23396217|NCT02457065|65198893|FG000|Overall Study|Lost to Follow-up|9|||
23396218|NCT02457065|65198894|FG001|Overall Study|Lost to Follow-up|11|||
23396219|NCT02112656|65198900|FG000|Overall Study|Death|78|||
23396220|NCT02112656|65198901|FG001|Overall Study|Death|82|||
23396221|NCT02112656|65198900|FG000|Overall Study|Withdrawal by Subject|9|||
23396222|NCT02112656|65198901|FG001|Overall Study|Withdrawal by Subject|11|||
23396223|NCT02112656|65198900|FG000|Overall Study|Lost to Follow-up|2|||
23396224|NCT02112656|65198901|FG001|Overall Study|Lost to Follow-up|4|||
23396225|NCT02112656|65198900|FG000|Overall Study|Noncompliance|1|||
23396226|NCT02112656|65198901|FG001|Overall Study|Noncompliance|2|||
23396227|NCT00791648|65198902|FG000|Overall Study|Physician Decision|0|||
23396228|NCT00791648|65198903|FG001|Overall Study|Physician Decision|1|||
23396229|NCT00791648|65198902|FG000|Overall Study|Withdrawal by Subject|0|||
23396230|NCT00791648|65198903|FG001|Overall Study|Withdrawal by Subject|1|||
23396231|NCT02278003|65198904|FG000|Overall Study|Withdrawal by Subject|11|||
23396232|NCT02278003|65198905|FG001|Overall Study|Withdrawal by Subject|0|||
23396233|NCT02278003|65198904|FG000|Overall Study|Not Treated|1|||
23396234|NCT02278003|65198905|FG001|Overall Study|Not Treated|0|||
23396235|NCT02278003|65198904|FG000|Overall Study|Recognition task improperly completed|7|||
23396236|NCT02278003|65198905|FG001|Overall Study|Recognition task improperly completed|0|||
23396237|NCT02284191|65198910|FG000|Overall Study|Withdrawal by Subject|1|||
23396238|NCT02284191|65198911|FG001|Overall Study|Withdrawal by Subject|3|||
23396239|NCT02284191|65198910|FG000|Overall Study|Lost to Follow-up|1|||
23396240|NCT02284191|65198911|FG001|Overall Study|Lost to Follow-up|0|||
23396241|NCT02724839|65198912|FG000|Overall Study|Withdrawal by Subject|1|||
23396242|NCT02724839|65198913|FG001|Overall Study|Withdrawal by Subject|1|||
23396243|NCT02724839|65198914|FG002|Overall Study|Withdrawal by Subject|0|||
23396244|NCT02724839|65198912|FG000|Overall Study|Lost to Follow-up|0|||
23396245|NCT02724839|65198913|FG001|Overall Study|Lost to Follow-up|3|||
23396246|NCT02724839|65198914|FG002|Overall Study|Lost to Follow-up|2|||
23396247|NCT02724839|65198912|FG000|Overall Study|Physician Decision|0|||
23396248|NCT02724839|65198913|FG001|Overall Study|Physician Decision|0|||
23396249|NCT02724839|65198914|FG002|Overall Study|Physician Decision|3|||
23396250|NCT01038323|65198915|FG000|Overall Study|Withdrawal by Subject|3|||
23396251|NCT01038323|65198916|FG001|Overall Study|Withdrawal by Subject|2|||
23396252|NCT01038323|65198917|FG002|Overall Study|Withdrawal by Subject|4|||
23396253|NCT03674281|65198918|FG000|Overall Study|screen failure|2|||
23396254|NCT03674281|65198919|FG001|Overall Study|screen failure|0|||
23396255|NCT03674281|65198920|FG002|Overall Study|screen failure|0|||
23396256|NCT03674281|65198918|FG000|Overall Study|Withdrawal by Subject|1|||
23396257|NCT03674281|65198919|FG001|Overall Study|Withdrawal by Subject|3|||
23396258|NCT03674281|65198920|FG002|Overall Study|Withdrawal by Subject|3|||
23396259|NCT02271880|65198921|FG000|Overall Study|Premature discontinuation of study|3|||
23396260|NCT02271880|65198922|FG001|Overall Study|Premature discontinuation of study|4|||
23396261|NCT03707821|65198923|FG000|Overall Study|Protocol Violation|0|||
23396262|NCT03707821|65198924|FG001|Overall Study|Protocol Violation|1|||
23396263|NCT03707821|65198923|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23396264|NCT03707821|65198924|FG001|Overall Study|Unsatisfactory Visual Response|0|||
23396265|NCT03707821|65198923|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
23396266|NCT03707821|65198924|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
23396267|NCT02006927|65198925|FG000|Overall Study|Adverse Event|2|||
23396268|NCT02006927|65198925|FG000|Overall Study|Withdrawal by Subject|1|||
23396269|NCT02390076|65198926|FG000|Overall Study|Lost to Follow-up|2|||
23396270|NCT02390076|65198927|FG001|Overall Study|Lost to Follow-up|1|||
23396271|NCT02390076|65198928|FG002|Overall Study|Lost to Follow-up|4|||
23396272|NCT01728246|65198929|FG000|Overall Study|Participant needed rescue medication|1|||
23694703|NCT01416181|66260314|FG000|Part 1|Withdrawal by Subject|74|||
23694704|NCT01416181|66260315|FG001|Part 1|Withdrawal by Subject|48|||
23694705|NCT01416181|66260314|FG000|Part 1|Lack of Efficacy|16|||
23694706|NCT01416181|66260315|FG001|Part 1|Lack of Efficacy|8|||
23694707|NCT01416181|66260314|FG000|Part 1|Lost to Follow-up|1|||
23694708|NCT01416181|66260315|FG001|Part 1|Lost to Follow-up|1|||
23694709|NCT01416181|66260314|FG000|Part 1|Adverse Event|15|||
23694710|NCT01416181|66260315|FG001|Part 1|Adverse Event|18|||
23694711|NCT01416181|66260314|FG000|Part 1|Ongoing in Follow-Up|14|||
23694712|NCT01416181|66260315|FG001|Part 1|Ongoing in Follow-Up|8|||
23694713|NCT01416181|66260314|FG000|Part 2|Adverse Event|11|||
23694714|NCT01416181|66260315|FG001|Part 2|Adverse Event|4|||
23694715|NCT01416181|66260314|FG000|Part 2|Other|234|||
23694716|NCT01416181|66260315|FG001|Part 2|Other|267|||
23694717|NCT01416181|66260314|FG000|Part 2|Investigator Decision|6|||
23694718|NCT01416181|66260315|FG001|Part 2|Investigator Decision|7|||
23694719|NCT01416181|66260314|FG000|Part 2|Withdrawal by Subject|14|||
23694720|NCT01416181|66260315|FG001|Part 2|Withdrawal by Subject|5|||
23694721|NCT01416181|66260314|FG000|Part 2|Lack of Efficacy|4|||
23694722|NCT01416181|66260315|FG001|Part 2|Lack of Efficacy|1|||
23694723|NCT01416181|66260314|FG000|Part 2|Lost to Follow-up|2|||
23694724|NCT01416181|66260315|FG001|Part 2|Lost to Follow-up|2|||
23694725|NCT00641147|66260316|FG000|Completed 4 Months.|Physician Decision|1|||
23694726|NCT00641147|66260317|FG001|Completed 4 Months.|Physician Decision|0|||
23694727|NCT00641147|66260316|FG000|Completed 4 Months.|Adverse Event|1|||
23694728|NCT00641147|66260317|FG001|Completed 4 Months.|Adverse Event|0|||
23694729|NCT00641147|66260316|FG000|Completed 8 Months.|Physician Decision|2|||
23694730|NCT00641147|66260317|FG001|Completed 8 Months.|Physician Decision|1|||
23694731|NCT00641147|66260316|FG000|Completed 8 Months.|non compliance|1|||
23694732|NCT00641147|66260317|FG001|Completed 8 Months.|non compliance|0|||
23694733|NCT00641147|66260316|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
23694734|NCT00641147|66260317|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
23694735|NCT00641147|66260316|FG000|Completed 12 Months.|Physician Decision|1|||
23694736|NCT00641147|66260317|FG001|Completed 12 Months.|Physician Decision|1|||
23694737|NCT00641147|66260316|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
23694738|NCT00641147|66260317|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
23694739|NCT00641147|66260316|FG000|Completed 16 Months.|Physician Decision|1|||
23694740|NCT00641147|66260317|FG001|Completed 16 Months.|Physician Decision|0|||
23694741|NCT00641147|66260316|FG000|Completed 16 Months.|Lost to Follow-up|1|||
23694742|NCT00641147|66260317|FG001|Completed 16 Months.|Lost to Follow-up|0|||
23694743|NCT01157169|66260318|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
23694744|NCT01157169|66260319|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
23694745|NCT01157169|66260318|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
23694746|NCT01157169|66260319|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
23694747|NCT02109029|66260320|FG000|Part B|Adverse Event|0|||
23694748|NCT02109029|66260321|FG001|Part B|Adverse Event|0|||
23694749|NCT02109029|66260322|FG002|Part B|Adverse Event|0|||
23694750|NCT02109029|66260323|FG003|Part B|Adverse Event|0|||
23694751|NCT02109029|66260324|FG004|Part B|Adverse Event|1|||
23694752|NCT02109029|66260325|FG005|Part B|Adverse Event|1|||
23694753|NCT00149214|66260326|FG000|Overall Study|Adverse Event|12|||
23694754|NCT00149214|66260327|FG001|Overall Study|Adverse Event|9|||
23694755|NCT00149214|66260326|FG000|Overall Study|Withdrawal by Subject|4|||
23694756|NCT00149214|66260327|FG001|Overall Study|Withdrawal by Subject|1|||
23694757|NCT00149214|66260326|FG000|Overall Study|Physician Decision|3|||
23694758|NCT00149214|66260327|FG001|Overall Study|Physician Decision|3|||
23694759|NCT00149214|66260326|FG000|Overall Study|Sponsor Decision|0|||
23694760|NCT00149214|66260327|FG001|Overall Study|Sponsor Decision|1|||
23694761|NCT00149214|66260326|FG000|Overall Study|Progressive Disease|7|||
23694762|NCT00149214|66260327|FG001|Overall Study|Progressive Disease|3|||
23396273|NCT01728246|65198930|FG001|Overall Study|Participant needed rescue medication|5|||
23396274|NCT01728246|65198929|FG000|Overall Study|Protocol Violation|1|||
23396275|NCT01728246|65198930|FG001|Overall Study|Protocol Violation|0|||
23694763|NCT01444391|66260329|FG000|Overall Study|Death|1|||
23694764|NCT02285010|66260338|FG000|Overall Study|not abdominal hysterectomy|2|||
23396276|NCT01728246|65198929|FG000|Overall Study|Withdrawal by Subject|2|||
23396277|NCT01728246|65198930|FG001|Overall Study|Withdrawal by Subject|3|||
23694765|NCT02285010|66260339|FG001|Overall Study|not abdominal hysterectomy|0|||
23694766|NCT02285010|66260338|FG000|Overall Study|Not spinal anesthesia|3|||
23694767|NCT02285010|66260339|FG001|Overall Study|Not spinal anesthesia|1|||
23694768|NCT01174784|66260345|FG000|Overall Study|Screen fails|4|||
23694769|NCT02517515|66260346|FG000|Overall Study|Adverse Event|0|||
23694770|NCT02517515|66260347|FG001|Overall Study|Adverse Event|1|||
23694771|NCT02517515|66260346|FG000|Overall Study|Withdrew Consent|0|||
23694772|NCT02517515|66260347|FG001|Overall Study|Withdrew Consent|1|||
23694773|NCT02517515|66260346|FG000|Overall Study|Lost to Follow-up|1|||
23694774|NCT02517515|66260347|FG001|Overall Study|Lost to Follow-up|0|||
23694775|NCT02517515|66260346|FG000|Overall Study|Other|1|||
23694776|NCT02517515|66260347|FG001|Overall Study|Other|0|||
23694777|NCT00363415|66260356|FG000|Overall Study|Progressive Disease|196|||
23396278|NCT01728246|65198929|FG000|Overall Study|Lost to Follow-up|23|||
23396279|NCT01728246|65198930|FG001|Overall Study|Lost to Follow-up|22|||
23396280|NCT01728246|65198929|FG000|Overall Study|Lack of Efficacy|1|||
23396281|NCT01728246|65198930|FG001|Overall Study|Lack of Efficacy|1|||
23396282|NCT01728246|65198929|FG000|Overall Study|Adverse Event|8|||
23396283|NCT01728246|65198930|FG001|Overall Study|Adverse Event|5|||
23396284|NCT01365455|65198932|FG000|Induction Period|Adverse Event|5|||
23396285|NCT01365455|65198933|FG001|Induction Period|Adverse Event|3|||
23396286|NCT01365455|65198934|FG002|Induction Period|Adverse Event|4|||
23396287|NCT01365455|65198935|FG003|Induction Period|Adverse Event|0|||
23396288|NCT01365455|65198936|FG004|Induction Period|Adverse Event|0|||
23396289|NCT01365455|65198932|FG000|Induction Period|Lack of Efficacy|1|||
23396290|NCT01365455|65198933|FG001|Induction Period|Lack of Efficacy|1|||
23694778|NCT00363415|66260357|FG001|Overall Study|Progressive Disease|107|||
23694779|NCT00363415|66260356|FG000|Overall Study|Sponsor Decision|67|||
23694780|NCT00363415|66260357|FG001|Overall Study|Sponsor Decision|31|||
23694781|NCT00363415|66260356|FG000|Overall Study|Death|32|||
23694782|NCT00363415|66260357|FG001|Overall Study|Death|29|||
23694783|NCT00363415|66260356|FG000|Overall Study|Adverse Event|24|||
23694784|NCT00363415|66260357|FG001|Overall Study|Adverse Event|15|||
23694785|NCT00363415|66260356|FG000|Overall Study|Physician Decision|18|||
23694786|NCT00363415|66260357|FG001|Overall Study|Physician Decision|35|||
23694787|NCT00363415|66260356|FG000|Overall Study|Entry Criteria Not Met|11|||
23694788|NCT00363415|66260357|FG001|Overall Study|Entry Criteria Not Met|10|||
23694789|NCT00363415|66260356|FG000|Overall Study|Withdrawal by Subject|9|||
23694790|NCT00363415|66260357|FG001|Overall Study|Withdrawal by Subject|15|||
23694791|NCT00363415|66260356|FG000|Overall Study|Lost to Follow-up|3|||
23694792|NCT00363415|66260357|FG001|Overall Study|Lost to Follow-up|3|||
23694793|NCT00363415|66260356|FG000|Overall Study|Protocol Violation|1|||
23694794|NCT00363415|66260357|FG001|Overall Study|Protocol Violation|4|||
23694795|NCT02873221|66260358|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23694796|NCT02873221|66260359|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
23694797|NCT02873221|66260360|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
23694798|NCT02873221|66260358|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
23694799|NCT02873221|66260359|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
23694800|NCT02873221|66260360|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
23694801|NCT02873221|66260358|FG000|Treatment Period|Protocol Violation|2|||
23694802|NCT02873221|66260359|FG001|Treatment Period|Protocol Violation|5|||
23694803|NCT02873221|66260360|FG002|Treatment Period|Protocol Violation|8|||
23694804|NCT02873221|66260358|FG000|Treatment Period|Pregnancy|4|||
23694805|NCT02873221|66260359|FG001|Treatment Period|Pregnancy|6|||
23694806|NCT02873221|66260360|FG002|Treatment Period|Pregnancy|3|||
23694807|NCT02873221|66260358|FG000|Treatment Period|Lack of Qualifying Event|0|||
23694808|NCT02873221|66260359|FG001|Treatment Period|Lack of Qualifying Event|3|||
23694809|NCT02873221|66260360|FG002|Treatment Period|Lack of Qualifying Event|1|||
23694810|NCT02873221|66260358|FG000|Treatment Period|Withdrawal of Consent|52|||
23694811|NCT02873221|66260359|FG001|Treatment Period|Withdrawal of Consent|51|||
23694812|NCT02873221|66260360|FG002|Treatment Period|Withdrawal of Consent|41|||
23694813|NCT02873221|66260358|FG000|Treatment Period|Lack of Efficacy|0|||
23694814|NCT02873221|66260359|FG001|Treatment Period|Lack of Efficacy|17|||
23694815|NCT02873221|66260360|FG002|Treatment Period|Lack of Efficacy|12|||
23694816|NCT02873221|66260358|FG000|Treatment Period|Adverse Event|4|||
23694817|NCT02873221|66260359|FG001|Treatment Period|Adverse Event|9|||
23694818|NCT02873221|66260360|FG002|Treatment Period|Adverse Event|11|||
23694819|NCT02873221|66260358|FG000|Treatment Period|Lost to Follow-up|26|||
23694820|NCT02873221|66260359|FG001|Treatment Period|Lost to Follow-up|30|||
23396291|NCT01365455|65198934|FG002|Induction Period|Lack of Efficacy|0|||
23396292|NCT01365455|65198935|FG003|Induction Period|Lack of Efficacy|0|||
23396293|NCT01365455|65198936|FG004|Induction Period|Lack of Efficacy|0|||
23396294|NCT01365455|65198932|FG000|Induction Period|Pregnancy|0|||
23694821|NCT02873221|66260360|FG002|Treatment Period|Lost to Follow-up|26|||
23694822|NCT02873221|66260358|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23694823|NCT02873221|66260359|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
23694824|NCT02873221|66260360|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23694825|NCT02873221|66260358|FG000|Safety Follow-up Period|Protocol Violation|0|||
23694826|NCT02873221|66260359|FG001|Safety Follow-up Period|Protocol Violation|0|||
23694827|NCT02873221|66260360|FG002|Safety Follow-up Period|Protocol Violation|1|||
23694828|NCT02873221|66260358|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
23694829|NCT02873221|66260359|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
23694830|NCT02873221|66260360|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
23694831|NCT02873221|66260358|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
23694832|NCT02873221|66260359|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
23694833|NCT02873221|66260360|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
23694834|NCT03825042|66260361|FG000|Overall Study|Adverse Event|1|||
23694835|NCT03825042|66260362|FG001|Overall Study|Adverse Event|0|||
23694836|NCT03825042|66260361|FG000|Overall Study|Withdrawal by Subject|1|||
23694837|NCT03825042|66260362|FG001|Overall Study|Withdrawal by Subject|0|||
23694838|NCT02591615|66260367|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23694839|NCT02591615|66260368|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23694840|NCT02591615|66260369|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
23396295|NCT01365455|65198933|FG001|Induction Period|Pregnancy|1|||
23396296|NCT01365455|65198934|FG002|Induction Period|Pregnancy|0|||
23396297|NCT01365455|65198935|FG003|Induction Period|Pregnancy|0|||
23396298|NCT01365455|65198936|FG004|Induction Period|Pregnancy|0|||
23694841|NCT02591615|66260370|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23694842|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23694843|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
23694844|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23694845|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23694846|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
23694847|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
23694848|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
23694849|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
23694850|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
23694851|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
23694852|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
23694853|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
23694854|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
23694855|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
23694856|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
23694857|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
23694858|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23694859|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
23694860|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23694861|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23694862|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
23694863|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
23694864|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
23694865|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
23694866|NCT02591615|66260367|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
23694867|NCT02591615|66260368|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23694868|NCT02591615|66260369|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23694869|NCT02591615|66260370|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23396299|NCT01365455|65198932|FG000|Induction Period|Protocol deviation|0|||
23396300|NCT01365455|65198933|FG001|Induction Period|Protocol deviation|1|||
23396301|NCT01365455|65198934|FG002|Induction Period|Protocol deviation|1|||
23396302|NCT01365455|65198935|FG003|Induction Period|Protocol deviation|0|||
23396303|NCT01365455|65198936|FG004|Induction Period|Protocol deviation|0|||
23396304|NCT01365455|65198932|FG000|Induction Period|Subject/guardian decision|9|||
23396305|NCT01365455|65198933|FG001|Induction Period|Subject/guardian decision|1|||
23396306|NCT01365455|65198934|FG002|Induction Period|Subject/guardian decision|8|||
23396307|NCT01365455|65198935|FG003|Induction Period|Subject/guardian decision|0|||
23396308|NCT01365455|65198936|FG004|Induction Period|Subject/guardian decision|0|||
23396309|NCT01365455|65198932|FG000|Induction Period|Lost to Follow-up|0|||
23396310|NCT01365455|65198933|FG001|Induction Period|Lost to Follow-up|0|||
23396311|NCT01365455|65198934|FG002|Induction Period|Lost to Follow-up|3|||
23396312|NCT01365455|65198935|FG003|Induction Period|Lost to Follow-up|0|||
23396313|NCT01365455|65198936|FG004|Induction Period|Lost to Follow-up|0|||
23396314|NCT01365455|65198932|FG000|Maintenance Period|Adverse Event|12|||
23396315|NCT01365455|65198933|FG001|Maintenance Period|Adverse Event|5|||
23396316|NCT01365455|65198934|FG002|Maintenance Period|Adverse Event|1|||
23396317|NCT01365455|65198935|FG003|Maintenance Period|Adverse Event|2|||
23498617|NCT00986830|65566391|FG000|Overall Study|Lack of Efficacy|1|||
23694870|NCT02591615|66260367|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
23694871|NCT02591615|66260368|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
23396318|NCT01365455|65198936|FG004|Maintenance Period|Adverse Event|4|||
23396319|NCT01365455|65198932|FG000|Maintenance Period|Lack of Efficacy|10|||
23396320|NCT01365455|65198933|FG001|Maintenance Period|Lack of Efficacy|2|||
23396321|NCT01365455|65198934|FG002|Maintenance Period|Lack of Efficacy|0|||
23396322|NCT01365455|65198935|FG003|Maintenance Period|Lack of Efficacy|2|||
23396323|NCT01365455|65198936|FG004|Maintenance Period|Lack of Efficacy|2|||
23396324|NCT01365455|65198932|FG000|Maintenance Period|Lost to Follow-up|2|||
23396325|NCT01365455|65198933|FG001|Maintenance Period|Lost to Follow-up|4|||
23396326|NCT01365455|65198934|FG002|Maintenance Period|Lost to Follow-up|0|||
23396327|NCT01365455|65198935|FG003|Maintenance Period|Lost to Follow-up|0|||
23396328|NCT01365455|65198936|FG004|Maintenance Period|Lost to Follow-up|3|||
23396329|NCT01365455|65198932|FG000|Maintenance Period|Non-compliance with study treatment|0|||
23396330|NCT01365455|65198933|FG001|Maintenance Period|Non-compliance with study treatment|0|||
23694872|NCT02591615|66260369|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
23694873|NCT02591615|66260370|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
23694874|NCT02591615|66260367|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
23694875|NCT02591615|66260368|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
23694876|NCT02591615|66260369|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
23694877|NCT02591615|66260370|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
23694878|NCT02591615|66260367|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
23694879|NCT02591615|66260368|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
23694880|NCT02591615|66260369|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
23694881|NCT02591615|66260370|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
23694882|NCT02591615|66260367|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23694883|NCT02591615|66260368|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23694884|NCT02591615|66260369|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
23694885|NCT02591615|66260370|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23694886|NCT02591615|66260367|FG000|Maintenance MK-3475|Adverse Event|0|||
23694887|NCT02591615|66260368|FG001|Maintenance MK-3475|Adverse Event|3|||
23694888|NCT02591615|66260369|FG002|Maintenance MK-3475|Adverse Event|1|||
23694889|NCT02591615|66260370|FG003|Maintenance MK-3475|Adverse Event|2|||
23694890|NCT02591615|66260367|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
23694891|NCT02591615|66260368|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
23694892|NCT02591615|66260369|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
23694893|NCT02591615|66260370|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
23694894|NCT02591615|66260367|FG000|Maintenance MK-3475|Death|0|||
23694895|NCT02591615|66260368|FG001|Maintenance MK-3475|Death|1|||
23694896|NCT02591615|66260369|FG002|Maintenance MK-3475|Death|1|||
23694897|NCT02591615|66260370|FG003|Maintenance MK-3475|Death|0|||
23694898|NCT02591615|66260367|FG000|Maintenance MK-3475|Physician discretion|0|||
23694899|NCT02591615|66260368|FG001|Maintenance MK-3475|Physician discretion|0|||
23694900|NCT02591615|66260369|FG002|Maintenance MK-3475|Physician discretion|1|||
23694901|NCT02591615|66260370|FG003|Maintenance MK-3475|Physician discretion|0|||
23694902|NCT02591615|66260367|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
23694903|NCT02591615|66260368|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
23694904|NCT02591615|66260369|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
23694905|NCT02591615|66260370|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
23694906|NCT02591615|66260367|FG000|Maintenance MK-3475|In active treatment|2|||
23694907|NCT02591615|66260368|FG001|Maintenance MK-3475|In active treatment|0|||
23694908|NCT02591615|66260369|FG002|Maintenance MK-3475|In active treatment|0|||
23694909|NCT02591615|66260370|FG003|Maintenance MK-3475|In active treatment|1|||
23694910|NCT01259466|66260371|FG000|Overall Study|Withdrawal by Subject|1|||
23694911|NCT01259466|66260372|FG001|Overall Study|Withdrawal by Subject|9|||
23694912|NCT01609933|66260379|FG000|Overall Study|Adverse Event|1|||
23694913|NCT01609933|66260379|FG000|Overall Study|Withdrawal by Subject|3|||
23694914|NCT00820040|66260380|FG000|Overall Study|Death|1|||
23694915|NCT00820040|66260380|FG000|Overall Study|Sponsor terminated study|1|||
23694916|NCT00820040|66260380|FG000|Overall Study|Screen failure|1|||
23694917|NCT01415440|66260381|FG000|Overall Study|Lost to Follow-up|0|||
23694918|NCT01415440|66260382|FG001|Overall Study|Lost to Follow-up|1|||
23694919|NCT01415440|66260383|FG002|Overall Study|Lost to Follow-up|2|||
23694920|NCT01415440|66260381|FG000|Overall Study|Physician Decision|3|||
23694921|NCT01415440|66260382|FG001|Overall Study|Physician Decision|0|||
23396331|NCT01365455|65198934|FG002|Maintenance Period|Non-compliance with study treatment|0|||
23396332|NCT01365455|65198935|FG003|Maintenance Period|Non-compliance with study treatment|1|||
23396333|NCT01365455|65198936|FG004|Maintenance Period|Non-compliance with study treatment|0|||
23396334|NCT01365455|65198932|FG000|Maintenance Period|Physician Decision|0|||
23396335|NCT01365455|65198933|FG001|Maintenance Period|Physician Decision|1|||
23498618|NCT00986830|65566391|FG000|Overall Study|Unable to access sinus with device|5|||
23694922|NCT01415440|66260383|FG002|Overall Study|Physician Decision|0|||
23694923|NCT01415440|66260381|FG000|Overall Study|Withdrawal by Subject|1|||
23694924|NCT01415440|66260382|FG001|Overall Study|Withdrawal by Subject|0|||
23396336|NCT01365455|65198934|FG002|Maintenance Period|Physician Decision|0|||
23396337|NCT01365455|65198935|FG003|Maintenance Period|Physician Decision|0|||
23694925|NCT01415440|66260383|FG002|Overall Study|Withdrawal by Subject|0|||
23694926|NCT02273973|66260384|FG000|Overall Study|Adverse Event|4|||
23694927|NCT02273973|66260385|FG001|Overall Study|Adverse Event|0|||
23694928|NCT02273973|66260384|FG000|Overall Study|Withdrawal by Subject|2|||
23694929|NCT02273973|66260385|FG001|Overall Study|Withdrawal by Subject|3|||
23694930|NCT02273973|66260384|FG000|Overall Study|Death|1|||
23694931|NCT02273973|66260385|FG001|Overall Study|Death|0|||
23694932|NCT02273973|66260384|FG000|Overall Study|Non-compliance|1|||
23694933|NCT02273973|66260385|FG001|Overall Study|Non-compliance|0|||
23694934|NCT02273973|66260384|FG000|Overall Study|Protocol Violation|1|||
23694935|NCT02273973|66260385|FG001|Overall Study|Protocol Violation|0|||
23694936|NCT02273973|66260384|FG000|Overall Study|Progression of disease|0|||
23694937|NCT02273973|66260385|FG001|Overall Study|Progression of disease|2|||
23694938|NCT02273973|66260384|FG000|Overall Study|Lost to Follow-up|0|||
23396338|NCT01365455|65198936|FG004|Maintenance Period|Physician Decision|1|||
23396339|NCT01365455|65198932|FG000|Maintenance Period|Pregnancy|0|||
23396340|NCT01365455|65198933|FG001|Maintenance Period|Pregnancy|4|||
23396341|NCT01365455|65198934|FG002|Maintenance Period|Pregnancy|0|||
23396342|NCT01365455|65198935|FG003|Maintenance Period|Pregnancy|0|||
23396343|NCT01365455|65198936|FG004|Maintenance Period|Pregnancy|2|||
23396344|NCT01365455|65198932|FG000|Maintenance Period|Protocol deviation|1|||
23396345|NCT01365455|65198933|FG001|Maintenance Period|Protocol deviation|1|||
23396346|NCT01365455|65198934|FG002|Maintenance Period|Protocol deviation|0|||
23396347|NCT01365455|65198935|FG003|Maintenance Period|Protocol deviation|0|||
23396348|NCT01365455|65198936|FG004|Maintenance Period|Protocol deviation|0|||
23396349|NCT01365455|65198932|FG000|Maintenance Period|Subject/guardian decision|4|||
23396350|NCT01365455|65198933|FG001|Maintenance Period|Subject/guardian decision|6|||
23396351|NCT01365455|65198934|FG002|Maintenance Period|Subject/guardian decision|2|||
23396352|NCT01365455|65198935|FG003|Maintenance Period|Subject/guardian decision|4|||
23396353|NCT01365455|65198936|FG004|Maintenance Period|Subject/guardian decision|1|||
23396354|NCT03663582|65198937|FG000|Overall Study|Physician Decision|1|||
23396355|NCT00431964|65198938|FG000|Overall Study|Adverse Event|1|||
23396356|NCT00431964|65198939|FG001|Overall Study|Adverse Event|0|||
23396357|NCT00431964|65198938|FG000|Overall Study|Lost to Follow-up|1|||
23396358|NCT00431964|65198939|FG001|Overall Study|Lost to Follow-up|2|||
23396359|NCT00431964|65198938|FG000|Overall Study|Physician Decision|2|||
23396360|NCT00431964|65198939|FG001|Overall Study|Physician Decision|2|||
23396361|NCT00431964|65198938|FG000|Overall Study|Withdrawal by Subject|2|||
23396362|NCT00431964|65198939|FG001|Overall Study|Withdrawal by Subject|1|||
23396363|NCT00431964|65198938|FG000|Overall Study|Parental Consent Withdrawn|0|||
23396364|NCT00431964|65198939|FG001|Overall Study|Parental Consent Withdrawn|2|||
23396365|NCT00431964|65198938|FG000|Overall Study|Due to Unstable Health|0|||
23694939|NCT02273973|66260385|FG001|Overall Study|Lost to Follow-up|1|||
23396366|NCT00431964|65198939|FG001|Overall Study|Due to Unstable Health|1|||
23396367|NCT00789555|65198943|FG000|Overall Study|Protocol Amendment|78|||
23396368|NCT00789555|65198944|FG001|Overall Study|Protocol Amendment|76|||
23396369|NCT00789555|65198945|FG002|Overall Study|Protocol Amendment|80|||
23396370|NCT00789555|65198943|FG000|Overall Study|Adverse Event|17|||
23396371|NCT00789555|65198944|FG001|Overall Study|Adverse Event|7|||
23396372|NCT00789555|65198945|FG002|Overall Study|Adverse Event|10|||
23396373|NCT00789555|65198943|FG000|Overall Study|Lost to Follow-up|9|||
23396374|NCT00789555|65198944|FG001|Overall Study|Lost to Follow-up|10|||
23396375|NCT00789555|65198945|FG002|Overall Study|Lost to Follow-up|18|||
23396376|NCT00789555|65198943|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
23396377|NCT00789555|65198944|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
23396378|NCT00789555|65198945|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
23396379|NCT00789555|65198943|FG000|Overall Study|Treatment failure|11|||
23396380|NCT00789555|65198944|FG001|Overall Study|Treatment failure|8|||
23396381|NCT00789555|65198945|FG002|Overall Study|Treatment failure|12|||
23396382|NCT00789555|65198943|FG000|Overall Study|Protocol Violation|6|||
23396383|NCT00789555|65198944|FG001|Overall Study|Protocol Violation|9|||
23396384|NCT00789555|65198945|FG002|Overall Study|Protocol Violation|13|||
23396385|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
23396386|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
23396387|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
23396388|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396389|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396390|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23694940|NCT02273973|66260384|FG000|Overall Study|Physician Decision|0|||
23694941|NCT02273973|66260385|FG001|Overall Study|Physician Decision|1|||
23694942|NCT02273973|66260384|FG000|Overall Study|Reason not specified|0|||
23694943|NCT02273973|66260385|FG001|Overall Study|Reason not specified|1|||
23694944|NCT03658889|66260388|FG000|Overall Study|Protocol Violation|2|||
23694945|NCT03658889|66260389|FG001|Overall Study|Protocol Violation|0|||
23694946|NCT00467649|66260390|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
23694947|NCT00467649|66260391|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
23694948|NCT00467649|66260392|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
23694949|NCT00467649|66260393|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
23694950|NCT00467649|66260394|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
23694951|NCT00467649|66260395|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
23694952|NCT00467649|66260390|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
23694953|NCT00467649|66260391|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
23694954|NCT00467649|66260392|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
23694955|NCT00467649|66260393|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
23694956|NCT00467649|66260394|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
23694957|NCT00467649|66260395|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
23694958|NCT00467649|66260390|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
23694959|NCT00467649|66260391|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
23694960|NCT00467649|66260392|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23694961|NCT00467649|66260393|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23694962|NCT00467649|66260394|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23694963|NCT00467649|66260395|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23694964|NCT00467649|66260390|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
23694965|NCT00467649|66260391|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
23694966|NCT00467649|66260392|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23694967|NCT00467649|66260393|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23694968|NCT00467649|66260394|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23694969|NCT00467649|66260395|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23694970|NCT00467649|66260390|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23694971|NCT00467649|66260391|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23694972|NCT00467649|66260392|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23694973|NCT00467649|66260393|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
23694974|NCT00467649|66260394|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23694975|NCT00467649|66260395|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23694976|NCT00467649|66260390|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23694977|NCT00467649|66260391|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23694978|NCT00467649|66260392|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23694979|NCT00467649|66260393|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
23694980|NCT00467649|66260394|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23694981|NCT00467649|66260395|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23694982|NCT00467649|66260390|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23694983|NCT00467649|66260391|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23694984|NCT00467649|66260392|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23694985|NCT00467649|66260393|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23694986|NCT00467649|66260394|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23694987|NCT00467649|66260395|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
23694988|NCT02243176|66260396|FG000|Overall Study|Other reason|1|||
23694989|NCT02243176|66260397|FG001|Overall Study|Other reason|2|||
23694990|NCT02243176|66260396|FG000|Overall Study|protocol specified withdrawal critera|1|||
23694991|NCT02243176|66260397|FG001|Overall Study|protocol specified withdrawal critera|3|||
23396391|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396392|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396393|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396394|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396395|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396396|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396397|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396398|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396399|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396400|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396401|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23396402|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23396403|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23694992|NCT02243176|66260396|FG000|Overall Study|Protocol Violation|2|||
23694993|NCT02243176|66260397|FG001|Overall Study|Protocol Violation|1|||
23694994|NCT02243176|66260396|FG000|Overall Study|Withdrawal by Subject|8|||
23694995|NCT02243176|66260397|FG001|Overall Study|Withdrawal by Subject|7|||
23396404|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396405|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396406|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396407|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396408|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396409|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396410|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396411|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396412|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396413|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396414|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396415|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396416|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396417|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396418|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396419|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396420|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
23396421|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396422|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396423|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396424|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396425|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23694996|NCT02243176|66260396|FG000|Overall Study|Adverse Event|2|||
23694997|NCT02243176|66260397|FG001|Overall Study|Adverse Event|2|||
23694998|NCT02403206|66260400|FG000|Overall Study|Lost to Follow-up|4|||
23694999|NCT02403206|66260401|FG001|Overall Study|Lost to Follow-up|3|||
23695000|NCT02403206|66260400|FG000|Overall Study|Physician Decision|2|||
23695001|NCT02403206|66260401|FG001|Overall Study|Physician Decision|0|||
23695002|NCT02403206|66260400|FG000|Overall Study|Withdrawal by Subject|3|||
23695003|NCT02403206|66260401|FG001|Overall Study|Withdrawal by Subject|3|||
23695004|NCT02403206|66260400|FG000|Overall Study|Reason not given|2|||
23695005|NCT02403206|66260401|FG001|Overall Study|Reason not given|4|||
23695006|NCT01887912|66260416|FG000|Overall Study|Serious adverse event|400|||
23695007|NCT01887912|66260417|FG001|Overall Study|Serious adverse event|198|||
23695008|NCT01887912|66260416|FG000|Overall Study|Other Adverse Event|34|||
23695009|NCT01887912|66260417|FG001|Overall Study|Other Adverse Event|15|||
23695010|NCT01887912|66260416|FG000|Overall Study|Protocol Violation|67|||
23695011|NCT01887912|66260417|FG001|Overall Study|Protocol Violation|37|||
23695012|NCT01887912|66260416|FG000|Overall Study|Lost to Follow-up|163|||
23695013|NCT01887912|66260417|FG001|Overall Study|Lost to Follow-up|74|||
23695014|NCT01887912|66260416|FG000|Overall Study|Withdrawal by Subject|606|||
23695015|NCT01887912|66260417|FG001|Overall Study|Withdrawal by Subject|349|||
23695016|NCT01887912|66260416|FG000|Overall Study|Other|122|||
23695017|NCT01887912|66260417|FG001|Overall Study|Other|58|||
23695018|NCT00224016|66260418|FG000|Titration Period|Withdrawal by Subject|0|||
23695019|NCT00224016|66260419|FG001|Titration Period|Withdrawal by Subject|1|||
23695020|NCT00224016|66260418|FG000|Titration Period|Lost to Follow-up|1|||
23695021|NCT00224016|66260419|FG001|Titration Period|Lost to Follow-up|0|||
23695022|NCT00224016|66260418|FG000|Maintenance Period|Withdrawal by Subject|2|||
23695023|NCT00224016|66260419|FG001|Maintenance Period|Withdrawal by Subject|0|||
23695024|NCT00224016|66260418|FG000|Maintenance Period|Lost to Follow-up|0|||
23695025|NCT00224016|66260419|FG001|Maintenance Period|Lost to Follow-up|1|||
23695026|NCT00772967|66260420|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
23695027|NCT00772967|66260421|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
23695028|NCT00772967|66260422|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
23695029|NCT00772967|66260423|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
23695030|NCT00772967|66260424|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
23695031|NCT00772967|66260425|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
23695032|NCT00772967|66260420|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23695033|NCT00772967|66260421|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
23695034|NCT00772967|66260422|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23695035|NCT00772967|66260423|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23695036|NCT00772967|66260424|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23695037|NCT00772967|66260425|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23695038|NCT00772967|66260420|FG000|Crossover Treatment 3|Adverse Event|0|||
23695039|NCT00772967|66260421|FG001|Crossover Treatment 3|Adverse Event|0|||
23695040|NCT00772967|66260422|FG002|Crossover Treatment 3|Adverse Event|0|||
23695041|NCT00772967|66260423|FG003|Crossover Treatment 3|Adverse Event|0|||
23396426|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396427|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396428|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396429|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23695042|NCT00772967|66260424|FG004|Crossover Treatment 3|Adverse Event|1|||
23695043|NCT00772967|66260425|FG005|Crossover Treatment 3|Adverse Event|0|||
23695044|NCT03826914|66260426|FG000|Overall Study|Withdrawal by Subject|1|||
23695045|NCT03826914|66260427|FG001|Overall Study|Withdrawal by Subject|1|||
23695046|NCT00815308|66260428|FG000|Overall Study|Adverse Event|4|||
23695047|NCT00815308|66260428|FG000|Overall Study|Withdrawal by Subject|0|||
23695048|NCT00815308|66260428|FG000|Overall Study|Protocol Violation|6|||
23695049|NCT03476239|66260432|FG000|Overall Study|Withdrawal by Subject|10|||
23695050|NCT03476239|66260432|FG000|Overall Study|Death|80|||
23695051|NCT03476239|66260432|FG000|Overall Study|Lost to Follow-up|8|||
23695052|NCT01121406|66260433|FG000|Overall Study|Progressive disease RECIST|44|||
23695053|NCT01121406|66260434|FG001|Overall Study|Progressive disease RECIST|28|||
23695054|NCT01121406|66260433|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
23695055|NCT01121406|66260434|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
23695056|NCT01121406|66260433|FG000|Overall Study|Other AE|3|||
23695057|NCT01121406|66260434|FG001|Overall Study|Other AE|10|||
23695058|NCT01121406|66260433|FG000|Overall Study|Non-compliant with protocol|0|||
23695059|NCT01121406|66260434|FG001|Overall Study|Non-compliant with protocol|2|||
23695060|NCT01121406|66260433|FG000|Overall Study|Lost to Follow-up|0|||
23695061|NCT01121406|66260434|FG001|Overall Study|Lost to Follow-up|1|||
23695062|NCT01121406|66260433|FG000|Overall Study|Refused continuation of study med.|1|||
23695063|NCT01121406|66260434|FG001|Overall Study|Refused continuation of study med.|2|||
23695064|NCT01121406|66260433|FG000|Overall Study|Reason other than specified above|2|||
23695065|NCT01121406|66260434|FG001|Overall Study|Reason other than specified above|6|||
23695066|NCT01121406|66260433|FG000|Overall Study|Not treated|1|||
23695067|NCT01121406|66260434|FG001|Overall Study|Not treated|0|||
23695068|NCT01025336|66260436|FG000|Overall Study|Protocol Violation|0|||
23695069|NCT01025336|66260437|FG001|Overall Study|Protocol Violation|0|||
23695070|NCT01025336|66260438|FG002|Overall Study|Protocol Violation|0|||
23695071|NCT01025336|66260439|FG003|Overall Study|Protocol Violation|2|||
23695072|NCT01025336|66260440|FG004|Overall Study|Protocol Violation|0|||
23695073|NCT01901328|66260444|FG000|Overall Study|Lost to Follow-up|1|||
23695074|NCT01901328|66260445|FG001|Overall Study|Lost to Follow-up|0|||
23695075|NCT01901328|66260444|FG000|Overall Study|Physician Decision|0|||
23695076|NCT01901328|66260445|FG001|Overall Study|Physician Decision|1|||
23695077|NCT01901328|66260444|FG000|Overall Study|Protocol Violation|1|||
23695078|NCT01901328|66260445|FG001|Overall Study|Protocol Violation|1|||
23695079|NCT01901328|66260444|FG000|Overall Study|Study Terminated by Sponsor|19|||
23695080|NCT01901328|66260445|FG001|Overall Study|Study Terminated by Sponsor|16|||
23695081|NCT01901328|66260444|FG000|Overall Study|Withdrawal by Subject|1|||
23695082|NCT01901328|66260445|FG001|Overall Study|Withdrawal by Subject|2|||
23695083|NCT01901328|66260444|FG000|Overall Study|Lack of Efficacy|0|||
23695084|NCT01901328|66260445|FG001|Overall Study|Lack of Efficacy|1|||
23695085|NCT00376688|66260446|FG000|Overall Study|Adverse Event|3|||
23695086|NCT00376688|66260446|FG000|Overall Study|Death|1|||
23695087|NCT00707577|66260448|FG000|Overall Study|Withdrawal by Subject|3|||
23695088|NCT00707577|66260449|FG001|Overall Study|Withdrawal by Subject|2|||
23695089|NCT00707577|66260448|FG000|Overall Study|Lost to Follow-up|34|||
23695090|NCT00707577|66260449|FG001|Overall Study|Lost to Follow-up|25|||
23695091|NCT00707577|66260448|FG000|Overall Study|Left employment|13|||
23695092|NCT00707577|66260449|FG001|Overall Study|Left employment|10|||
23695093|NCT00707577|66260448|FG000|Overall Study|Pregnancy|4|||
23695094|NCT00707577|66260449|FG001|Overall Study|Pregnancy|1|||
23695095|NCT00117338|66260450|FG000|Overall Study|Adverse Event|0|||
23695096|NCT00117338|66260451|FG001|Overall Study|Adverse Event|1|||
23695097|NCT00117338|66260450|FG000|Overall Study|Protocol Violation|3|||
23695098|NCT00117338|66260451|FG001|Overall Study|Protocol Violation|2|||
23695099|NCT00117338|66260450|FG000|Overall Study|Withdrawal by Subject|1|||
23695100|NCT00117338|66260451|FG001|Overall Study|Withdrawal by Subject|0|||
23695101|NCT00117338|66260450|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
23695102|NCT00117338|66260451|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
23695103|NCT00117338|66260450|FG000|Overall Study|Lack of Efficacy|0|||
23396430|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396431|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396432|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23695104|NCT00117338|66260451|FG001|Overall Study|Lack of Efficacy|1|||
23695105|NCT02124798|66260452|FG000|Overall Study|Adverse Event|3|||
23695106|NCT02124798|66260452|FG000|Overall Study|Lost to Follow-up|1|||
23695107|NCT03518840|66260453|FG000|Overall Study|Lost to Follow-up|6|||
23695108|NCT00201851|66260454|FG000|Overall Study|Lost to Follow-up|2|||
23695109|NCT00201851|66260455|FG001|Overall Study|Lost to Follow-up|1|||
23695110|NCT00201851|66260456|FG002|Overall Study|Lost to Follow-up|0|||
23695111|NCT00201851|66260454|FG000|Overall Study|Ineligible post enrollment|6|||
23396433|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23695112|NCT00201851|66260455|FG001|Overall Study|Ineligible post enrollment|1|||
23695113|NCT00201851|66260456|FG002|Overall Study|Ineligible post enrollment|1|||
23695114|NCT01507246|66260457|FG000|Overall Study|Required different surgical procedures|2|||
23695115|NCT01507246|66260458|FG001|Overall Study|Required different surgical procedures|1|||
23695116|NCT02053246|66260459|FG000|Overall Study|Withdrawal by Subject|3|||
23695117|NCT02053246|66260459|FG000|Overall Study|Physician Decision|1|||
23695118|NCT03414359|66260460|FG000|Overall Study|Lack of Efficacy|1|||
23695119|NCT03414359|66260461|FG001|Overall Study|Lack of Efficacy|1|||
23695120|NCT03414359|66260460|FG000|Overall Study|Protocol Violation|0|||
23695121|NCT03414359|66260461|FG001|Overall Study|Protocol Violation|1|||
23695122|NCT00814710|66260462|FG000|Overall Study|Adverse Event|1|||
23695123|NCT00814710|66260463|FG001|Overall Study|Adverse Event|0|||
23695124|NCT00814710|66260462|FG000|Overall Study|Lost to Follow-up|7|||
23695125|NCT00814710|66260463|FG001|Overall Study|Lost to Follow-up|3|||
23695126|NCT01845077|66260466|FG000|Washout Period|Lost to Follow-up|0|||
23695127|NCT01845077|66260467|FG001|Washout Period|Lost to Follow-up|1|||
23695128|NCT01845077|66260468|FG002|Washout Period|Lost to Follow-up|0|||
23695129|NCT01845077|66260469|FG003|Washout Period|Lost to Follow-up|1|||
23695130|NCT01845077|66260470|FG004|Washout Period|Lost to Follow-up|0|||
23695131|NCT01845077|66260471|FG005|Washout Period|Lost to Follow-up|1|||
23695132|NCT01845077|66260466|FG000|Washout Period|Adverse Event|1|||
23695133|NCT01845077|66260467|FG001|Washout Period|Adverse Event|0|||
23695134|NCT01845077|66260468|FG002|Washout Period|Adverse Event|0|||
23695135|NCT01845077|66260469|FG003|Washout Period|Adverse Event|0|||
23695136|NCT01845077|66260470|FG004|Washout Period|Adverse Event|0|||
23695137|NCT01845077|66260471|FG005|Washout Period|Adverse Event|0|||
23695138|NCT01845077|66260466|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
23695139|NCT01845077|66260467|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
23695140|NCT01845077|66260468|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
23695141|NCT01845077|66260469|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
23695142|NCT01845077|66260470|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
23695143|NCT01845077|66260471|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
23695144|NCT01845077|66260466|FG000|Washout Period|Protocol Violation|0|||
23695145|NCT01845077|66260467|FG001|Washout Period|Protocol Violation|0|||
23695146|NCT01845077|66260468|FG002|Washout Period|Protocol Violation|0|||
23695147|NCT01845077|66260469|FG003|Washout Period|Protocol Violation|1|||
23695148|NCT01845077|66260470|FG004|Washout Period|Protocol Violation|1|||
23695149|NCT01845077|66260471|FG005|Washout Period|Protocol Violation|0|||
23695150|NCT00824421|66260473|FG000|Overall Study|Adverse Event|6|||
23695151|NCT00824421|66260474|FG001|Overall Study|Adverse Event|6|||
23695152|NCT00824421|66260475|FG002|Overall Study|Adverse Event|6|||
23695153|NCT00824421|66260473|FG000|Overall Study|Death|0|||
23695154|NCT00824421|66260474|FG001|Overall Study|Death|1|||
23695155|NCT00824421|66260475|FG002|Overall Study|Death|0|||
23695156|NCT00824421|66260473|FG000|Overall Study|Lack of Efficacy|5|||
23695157|NCT00824421|66260474|FG001|Overall Study|Lack of Efficacy|7|||
23695158|NCT00824421|66260475|FG002|Overall Study|Lack of Efficacy|4|||
23695159|NCT00824421|66260473|FG000|Overall Study|Lost to Follow-up|2|||
23396434|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396435|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
23396436|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396437|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396438|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396439|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396440|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396441|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396442|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396443|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396444|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396445|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396446|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396447|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396448|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396449|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23695160|NCT00824421|66260474|FG001|Overall Study|Lost to Follow-up|3|||
23695161|NCT00824421|66260475|FG002|Overall Study|Lost to Follow-up|0|||
23695162|NCT00824421|66260473|FG000|Overall Study|Pregnancy|1|||
23695163|NCT00824421|66260474|FG001|Overall Study|Pregnancy|0|||
23695164|NCT00824421|66260475|FG002|Overall Study|Pregnancy|1|||
23695165|NCT00824421|66260473|FG000|Overall Study|Withdrawal by Subject|2|||
23695166|NCT00824421|66260474|FG001|Overall Study|Withdrawal by Subject|3|||
23695167|NCT00824421|66260475|FG002|Overall Study|Withdrawal by Subject|3|||
23396450|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23695168|NCT00824421|66260473|FG000|Overall Study|Randomized but not Treated|1|||
23695169|NCT00824421|66260474|FG001|Overall Study|Randomized but not Treated|1|||
23695170|NCT00824421|66260475|FG002|Overall Study|Randomized but not Treated|0|||
23695171|NCT00824421|66260473|FG000|Overall Study|Other|0|||
23695172|NCT00824421|66260474|FG001|Overall Study|Other|1|||
23695173|NCT00824421|66260475|FG002|Overall Study|Other|0|||
23695174|NCT02767570|66260476|FG000|Overall Study|Lost to Follow-up|3|||
23695175|NCT02767570|66260477|FG001|Overall Study|Lost to Follow-up|0|||
23695176|NCT02767570|66260476|FG000|Overall Study|COVID shutdown|2|||
23695177|NCT02767570|66260477|FG001|Overall Study|COVID shutdown|5|||
23695178|NCT02767570|66260476|FG000|Overall Study|Increased pain|2|||
23695179|NCT02767570|66260477|FG001|Overall Study|Increased pain|0|||
23695180|NCT02767570|66260476|FG000|Overall Study|Withdrawal by Subject|1|||
23695181|NCT02767570|66260477|FG001|Overall Study|Withdrawal by Subject|3|||
23695182|NCT02767570|66260476|FG000|Overall Study|Unrelated medical issue|1|||
23695183|NCT02767570|66260477|FG001|Overall Study|Unrelated medical issue|1|||
23695184|NCT02767570|66260476|FG000|Overall Study|Received intra-articular injection|0|||
23695185|NCT02767570|66260477|FG001|Overall Study|Received intra-articular injection|1|||
23695186|NCT00949650|66260480|FG000|Overall Study|Progressive disease|188|||
23695187|NCT00949650|66260481|FG001|Overall Study|Progressive disease|19|||
23695188|NCT00949650|66260480|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
23695189|NCT00949650|66260481|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
23695190|NCT00949650|66260480|FG000|Overall Study|Other Adverse Event (AE)|28|||
23695191|NCT00949650|66260481|FG001|Overall Study|Other Adverse Event (AE)|17|||
23695192|NCT00949650|66260480|FG000|Overall Study|Protocol Violation|1|||
23695193|NCT00949650|66260481|FG001|Overall Study|Protocol Violation|4|||
23695194|NCT00949650|66260480|FG000|Overall Study|Refusal to continue medication|7|||
23695195|NCT00949650|66260481|FG001|Overall Study|Refusal to continue medication|11|||
23695196|NCT00949650|66260480|FG000|Overall Study|Not treated|1|||
23695197|NCT00949650|66260481|FG001|Overall Study|Not treated|4|||
23695198|NCT00949650|66260480|FG000|Overall Study|Other not specified above|5|||
23695199|NCT00949650|66260481|FG001|Overall Study|Other not specified above|0|||
23695200|NCT02559505|66260482|FG000|Overall Study|Lost to Follow-up|23|||
23695201|NCT02559505|66260483|FG001|Overall Study|Lost to Follow-up|20|||
23695202|NCT02559505|66260482|FG000|Overall Study|Withdrawal by Subject|4|||
23695203|NCT02559505|66260483|FG001|Overall Study|Withdrawal by Subject|2|||
23695204|NCT00095303|66260485|FG000|Main Study|Lost to Follow-up|91|||
23695205|NCT00095303|66260486|FG001|Main Study|Lost to Follow-up|87|||
23695206|NCT00095303|66260485|FG000|Follow Up Study|Lost to Follow-up|59|||
23695207|NCT00095303|66260486|FG001|Follow Up Study|Lost to Follow-up|58|||
23695208|NCT01499576|66260487|FG000|Overall Study|Physician Decision|12|||
23695209|NCT01499576|66260487|FG000|Overall Study|Withdrawal by Subject|9|||
23695210|NCT02522377|66260488|FG000|Overall Study|Withdrawal by Subject|1|||
23695211|NCT02522377|66260489|FG001|Overall Study|Withdrawal by Subject|0|||
23695212|NCT02522377|66260488|FG000|Overall Study|Remission Achieved|3|||
23695213|NCT02522377|66260489|FG001|Overall Study|Remission Achieved|0|||
23695214|NCT04331899|66260492|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
23695215|NCT04331899|66260493|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
23695216|NCT02469246|66260494|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
23695217|NCT02469246|66260495|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
23695218|NCT02469246|66260494|FG000|Double-Blind Phase|Adverse Event|12|||
23695219|NCT02469246|66260495|FG001|Double-Blind Phase|Adverse Event|9|||
23396451|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396452|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
23396453|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396454|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396455|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396456|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396457|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396458|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396459|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396460|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396461|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396462|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396463|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396464|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396465|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396466|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396467|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396468|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
23695220|NCT02469246|66260494|FG000|Double-Blind Phase|Death|2|||
23396469|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396470|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23498619|NCT00945893|65566392|FG000|Overall Study|Lost to Follow-up|2|||
23498620|NCT00945893|65566393|FG001|Overall Study|Lost to Follow-up|8|||
23695221|NCT02469246|66260495|FG001|Double-Blind Phase|Death|0|||
23695222|NCT02469246|66260494|FG000|Double-Blind Phase|Lack of Efficacy|2|||
23396471|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23695223|NCT02469246|66260495|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23695224|NCT02469246|66260494|FG000|Double-Blind Phase|Investigator's Discretion|8|||
23695225|NCT02469246|66260495|FG001|Double-Blind Phase|Investigator's Discretion|8|||
23695226|NCT02469246|66260494|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23695227|NCT02469246|66260495|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23695228|NCT02469246|66260494|FG000|Double-Blind Phase|Protocol Violation|1|||
23396472|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23695229|NCT02469246|66260495|FG001|Double-Blind Phase|Protocol Violation|1|||
23695230|NCT02469246|66260494|FG000|Double-Blind Phase|Withdrew Consent|25|||
23695231|NCT02469246|66260495|FG001|Double-Blind Phase|Withdrew Consent|25|||
23695232|NCT02469246|66260494|FG000|Double-Blind Phase|Lost to Follow-up|9|||
23695233|NCT02469246|66260495|FG001|Double-Blind Phase|Lost to Follow-up|5|||
23695234|NCT03368859|66260505|FG000|Overall Study|Withdrew Consent|5|||
23695235|NCT03368859|66260506|FG001|Overall Study|Withdrew Consent|4|||
23695236|NCT03368859|66260505|FG000|Overall Study|Death|12|||
23695237|NCT03368859|66260506|FG001|Overall Study|Death|6|||
23695238|NCT03368859|66260505|FG000|Overall Study|Study terminated by Sponsor|18|||
23695239|NCT03368859|66260506|FG001|Overall Study|Study terminated by Sponsor|23|||
23695240|NCT03368859|66260505|FG000|Overall Study|Other|1|||
23695241|NCT03368859|66260506|FG001|Overall Study|Other|1|||
23695242|NCT02371629|66260507|FG000|Overall Study|Patient decision|14|||
23695243|NCT02371629|66260508|FG001|Overall Study|Patient decision|10|||
23695244|NCT02371629|66260507|FG000|Overall Study|Adverse Event|8|||
23695245|NCT02371629|66260508|FG001|Overall Study|Adverse Event|8|||
23695246|NCT02371629|66260507|FG000|Overall Study|Physician Decision|2|||
23695247|NCT02371629|66260508|FG001|Overall Study|Physician Decision|3|||
23695248|NCT02371629|66260507|FG000|Overall Study|Death|1|||
23695249|NCT02371629|66260508|FG001|Overall Study|Death|1|||
23695250|NCT02371629|66260507|FG000|Overall Study|Noncompliance with study treatment|1|||
23695251|NCT02371629|66260508|FG001|Overall Study|Noncompliance with study treatment|0|||
23695252|NCT02371629|66260507|FG000|Overall Study|Lack of Efficacy|0|||
23695253|NCT02371629|66260508|FG001|Overall Study|Lack of Efficacy|2|||
23695254|NCT02371629|66260507|FG000|Overall Study|Protocol deviation|0|||
23695255|NCT02371629|66260508|FG001|Overall Study|Protocol deviation|1|||
23695256|NCT00850499|66260509|FG000|Overall Study|Adverse Event|3|||
23695257|NCT00850499|66260510|FG001|Overall Study|Adverse Event|1|||
23695258|NCT00850499|66260509|FG000|Overall Study|Lack of Efficacy|0|||
23695259|NCT00850499|66260510|FG001|Overall Study|Lack of Efficacy|1|||
23695260|NCT00907738|66260520|FG000|Overall Study|Adverse Event|2|||
23695261|NCT00907738|66260521|FG001|Overall Study|Adverse Event|0|||
23695262|NCT00907738|66260522|FG002|Overall Study|Adverse Event|1|||
23695263|NCT00907738|66260523|FG003|Overall Study|Adverse Event|0|||
23695264|NCT00907738|66260524|FG004|Overall Study|Adverse Event|0|||
23695265|NCT00907738|66260520|FG000|Overall Study|not specified or withdrew consent|3|||
23695266|NCT00907738|66260521|FG001|Overall Study|not specified or withdrew consent|0|||
23695267|NCT00907738|66260522|FG002|Overall Study|not specified or withdrew consent|0|||
23695268|NCT00907738|66260523|FG003|Overall Study|not specified or withdrew consent|0|||
23695269|NCT00907738|66260524|FG004|Overall Study|not specified or withdrew consent|0|||
23695270|NCT00907738|66260520|FG000|Overall Study|Disease progression|8|||
23695271|NCT00907738|66260521|FG001|Overall Study|Disease progression|1|||
23695272|NCT00907738|66260522|FG002|Overall Study|Disease progression|6|||
23695273|NCT00907738|66260523|FG003|Overall Study|Disease progression|4|||
23695274|NCT00907738|66260524|FG004|Overall Study|Disease progression|2|||
23695275|NCT02795156|66260525|FG000|Overall Study|Progressive Disease|22|||
23695276|NCT02795156|66260526|FG001|Overall Study|Progressive Disease|7|||
23695277|NCT02795156|66260527|FG002|Overall Study|Progressive Disease|34|||
23695278|NCT02795156|66260528|FG003|Overall Study|Progressive Disease|7|||
23695279|NCT02795156|66260525|FG000|Overall Study|Adverse Event|13|||
23695280|NCT02795156|66260526|FG001|Overall Study|Adverse Event|2|||
23695281|NCT02795156|66260527|FG002|Overall Study|Adverse Event|3|||
23396473|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396474|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396475|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396476|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396477|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396478|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396479|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396480|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396481|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396482|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396483|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23606410|NCT02309892|65947243|FG006|Overall Study|Death|0|||
23606411|NCT03345407|65947244|FG000|Overall Study|Withdrawal by Subject|11|||
23606412|NCT03345407|65947245|FG001|Overall Study|Withdrawal by Subject|1|||
23606413|NCT03345407|65947246|FG002|Overall Study|Withdrawal by Subject|5|||
23606414|NCT03345407|65947247|FG003|Overall Study|Withdrawal by Subject|6|||
23606415|NCT03345407|65947248|FG004|Overall Study|Withdrawal by Subject|3|||
23606416|NCT03345407|65947249|FG005|Overall Study|Withdrawal by Subject|6|||
23606417|NCT03345407|65947250|FG006|Overall Study|Withdrawal by Subject|16|||
23606418|NCT03345407|65947244|FG000|Overall Study|Physician Decision|3|||
23606419|NCT03345407|65947245|FG001|Overall Study|Physician Decision|1|||
23606420|NCT03345407|65947246|FG002|Overall Study|Physician Decision|0|||
23606421|NCT03345407|65947247|FG003|Overall Study|Physician Decision|0|||
23606422|NCT03345407|65947248|FG004|Overall Study|Physician Decision|1|||
23396484|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396485|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396486|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396487|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
23396488|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
23396489|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
23396490|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
23396491|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396492|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396493|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396494|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396495|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396496|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396497|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396498|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396499|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396500|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396501|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396502|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
23396503|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396504|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396505|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396506|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
23396507|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396508|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396509|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396510|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396511|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396512|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396513|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396514|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396515|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396516|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396517|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396518|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396519|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
23396520|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
23396521|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
23396522|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
23396523|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396524|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396525|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396526|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396527|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396528|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396529|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396530|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396531|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396532|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396533|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
23396534|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396535|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396536|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396537|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396538|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396539|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396540|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396541|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396542|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396543|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396544|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396545|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396546|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396547|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396548|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23402842|NCT01349673|65220031|FG000|Overall Study|No Longer Qualified For Study|1|||
23498621|NCT00945893|65566392|FG000|Overall Study|Withdrawal of consent|1|||
23695282|NCT02795156|66260528|FG003|Overall Study|Adverse Event|2|||
23695283|NCT02795156|66260525|FG000|Overall Study|Death|1|||
23695284|NCT02795156|66260526|FG001|Overall Study|Death|1|||
23695285|NCT02795156|66260527|FG002|Overall Study|Death|1|||
23695286|NCT02795156|66260528|FG003|Overall Study|Death|0|||
23695287|NCT02795156|66260525|FG000|Overall Study|Physician Decision|1|||
23695288|NCT02795156|66260526|FG001|Overall Study|Physician Decision|0|||
23695289|NCT02795156|66260527|FG002|Overall Study|Physician Decision|1|||
23695290|NCT02795156|66260528|FG003|Overall Study|Physician Decision|0|||
23695291|NCT02795156|66260525|FG000|Overall Study|Withdrawal by Subject|2|||
23695292|NCT02795156|66260526|FG001|Overall Study|Withdrawal by Subject|0|||
23695293|NCT02795156|66260527|FG002|Overall Study|Withdrawal by Subject|3|||
23695294|NCT02795156|66260528|FG003|Overall Study|Withdrawal by Subject|0|||
23695295|NCT00064701|66260531|FG000|One Year Post-transplant|Did not receive study drug|7|||
23695296|NCT00064701|66260532|FG001|One Year Post-transplant|Did not receive study drug|12|||
23695297|NCT00064701|66260533|FG002|One Year Post-transplant|Did not receive study drug|11|||
23695298|NCT00064701|66260531|FG000|One Year Post-transplant|Adverse Event|23|||
23695299|NCT00064701|66260532|FG001|One Year Post-transplant|Adverse Event|19|||
23695300|NCT00064701|66260533|FG002|One Year Post-transplant|Adverse Event|37|||
23695301|NCT00064701|66260531|FG000|One Year Post-transplant|Rejection|0|||
23695302|NCT00064701|66260532|FG001|One Year Post-transplant|Rejection|1|||
23695303|NCT00064701|66260533|FG002|One Year Post-transplant|Rejection|16|||
23695304|NCT00064701|66260531|FG000|One Year Post-transplant|Non-compliance|4|||
23695305|NCT00064701|66260532|FG001|One Year Post-transplant|Non-compliance|2|||
23695306|NCT00064701|66260533|FG002|One Year Post-transplant|Non-compliance|5|||
23695307|NCT00064701|66260531|FG000|One Year Post-transplant|Graft Failure|3|||
23695308|NCT00064701|66260532|FG001|One Year Post-transplant|Graft Failure|2|||
23695309|NCT00064701|66260533|FG002|One Year Post-transplant|Graft Failure|1|||
23695310|NCT00064701|66260531|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
23695311|NCT00064701|66260532|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
23695312|NCT00064701|66260533|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
23695313|NCT00064701|66260531|FG000|One Year Post-transplant|Lost to Follow-up|1|||
23695314|NCT00064701|66260532|FG001|One Year Post-transplant|Lost to Follow-up|0|||
23695315|NCT00064701|66260533|FG002|One Year Post-transplant|Lost to Follow-up|0|||
23695316|NCT00064701|66260531|FG000|One Year Post-transplant|Converted to rapamycin|1|||
23695317|NCT00064701|66260532|FG001|One Year Post-transplant|Converted to rapamycin|0|||
23695318|NCT00064701|66260533|FG002|One Year Post-transplant|Converted to rapamycin|0|||
23695319|NCT00064701|66260531|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
23695320|NCT00064701|66260532|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
23695321|NCT00064701|66260533|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
23695322|NCT00064701|66260531|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
23695323|NCT00064701|66260532|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
23695324|NCT00064701|66260533|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
23695325|NCT00064701|66260531|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
23695326|NCT00064701|66260532|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
23695327|NCT00064701|66260533|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
23695328|NCT00064701|66260531|FG000|One Year Post-transplant|Poor absorption|0|||
23695329|NCT00064701|66260532|FG001|One Year Post-transplant|Poor absorption|1|||
23695330|NCT00064701|66260533|FG002|One Year Post-transplant|Poor absorption|0|||
23695331|NCT00064701|66260531|FG000|One Year Post-transplant|Pancreas transplant|0|||
23695332|NCT00064701|66260532|FG001|One Year Post-transplant|Pancreas transplant|0|||
23695333|NCT00064701|66260533|FG002|One Year Post-transplant|Pancreas transplant|1|||
23695334|NCT00064701|66260531|FG000|Clinical Continuation Phase|Adverse Event|12|||
23695335|NCT00064701|66260532|FG001|Clinical Continuation Phase|Adverse Event|21|||
23695336|NCT00064701|66260533|FG002|Clinical Continuation Phase|Adverse Event|14|||
23695337|NCT00064701|66260531|FG000|Clinical Continuation Phase|Non-compliance|8|||
23695338|NCT00064701|66260532|FG001|Clinical Continuation Phase|Non-compliance|6|||
23695339|NCT00064701|66260533|FG002|Clinical Continuation Phase|Non-compliance|7|||
23695340|NCT00064701|66260531|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
23695341|NCT00064701|66260532|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
23695342|NCT00064701|66260533|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
23695343|NCT00064701|66260531|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
23695344|NCT00064701|66260532|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
23695345|NCT00064701|66260533|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
23695346|NCT00064701|66260531|FG000|Clinical Continuation Phase|Graft Failure|5|||
23402843|NCT01349673|65220031|FG000|Overall Study|Site Closure|10|||
23695347|NCT00064701|66260532|FG001|Clinical Continuation Phase|Graft Failure|5|||
23695348|NCT00064701|66260533|FG002|Clinical Continuation Phase|Graft Failure|2|||
23695349|NCT00064701|66260531|FG000|Clinical Continuation Phase|Rejection|1|||
23695350|NCT00064701|66260532|FG001|Clinical Continuation Phase|Rejection|2|||
23695351|NCT00064701|66260533|FG002|Clinical Continuation Phase|Rejection|2|||
23695352|NCT00064701|66260531|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
23695353|NCT00064701|66260532|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
23396549|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396550|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396551|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
23396552|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396553|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396554|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396555|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396556|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396557|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396558|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396559|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396560|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396561|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396562|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396563|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396564|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396565|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396566|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396567|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396568|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396569|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396570|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396571|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396572|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396573|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396574|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396575|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396576|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396577|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396578|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396579|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396580|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396581|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396582|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396583|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396584|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
23606423|NCT03345407|65947249|FG005|Overall Study|Physician Decision|2|||
23396585|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396586|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396587|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396588|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396589|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396590|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396591|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396592|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396593|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396594|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396595|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396596|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396597|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396598|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396599|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396600|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396601|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
23396602|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396603|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396604|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396605|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396606|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396607|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396608|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396609|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396610|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396611|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396612|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396613|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23606424|NCT03345407|65947250|FG006|Overall Study|Physician Decision|3|||
23695354|NCT00064701|66260533|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
23695355|NCT00064701|66260531|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
23695356|NCT00064701|66260532|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
23695357|NCT00064701|66260533|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
23695358|NCT00064701|66260531|FG000|Clinical Continuation Phase|Physician Decision|1|||
23695359|NCT00064701|66260532|FG001|Clinical Continuation Phase|Physician Decision|3|||
23695360|NCT00064701|66260533|FG002|Clinical Continuation Phase|Physician Decision|0|||
23695361|NCT00064701|66260531|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
23695362|NCT00064701|66260532|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
23695363|NCT00064701|66260533|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
23695364|NCT00064701|66260531|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
23695365|NCT00064701|66260532|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
23695366|NCT00064701|66260533|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
23695367|NCT00064701|66260531|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
23695368|NCT00064701|66260532|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
23695369|NCT00064701|66260533|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
23695370|NCT00064701|66260531|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
23695371|NCT00064701|66260532|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
23695372|NCT00064701|66260533|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
23695373|NCT00064701|66260531|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
23695374|NCT00064701|66260532|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
23695375|NCT00064701|66260533|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
23695376|NCT00064701|66260531|FG000|Clinical Continuation Phase|Patient opted out|0|||
23695377|NCT00064701|66260532|FG001|Clinical Continuation Phase|Patient opted out|0|||
23695378|NCT00064701|66260533|FG002|Clinical Continuation Phase|Patient opted out|1|||
23695379|NCT01491945|66260537|FG000|Overall Study|Death|30|||
23695380|NCT01491945|66260537|FG000|Overall Study|Withdrwan/LTF|16|||
23695381|NCT01491945|66260537|FG000|Overall Study|Conversion|4|||
23695382|NCT01491945|66260537|FG000|Overall Study|Missed Visit|1|||
23695383|NCT00465738|66260538|FG000|Overall Study|Lost to Follow-up|2|||
23695384|NCT00465738|66260539|FG001|Overall Study|Lost to Follow-up|0|||
23695385|NCT00465738|66260538|FG000|Overall Study|Adverse Event|0|||
23695386|NCT00465738|66260539|FG001|Overall Study|Adverse Event|1|||
23695387|NCT00465738|66260538|FG000|Overall Study|Withdrawal by Subject|2|||
23695388|NCT00465738|66260539|FG001|Overall Study|Withdrawal by Subject|0|||
23695389|NCT00465738|66260538|FG000|Overall Study|Other|2|||
23695390|NCT00465738|66260539|FG001|Overall Study|Other|5|||
23695391|NCT02799381|66260544|FG000|Overall Study|Withdrew consent|3|||
23695392|NCT02799381|66260545|FG001|Overall Study|Withdrew consent|2|||
23695393|NCT02799381|66260544|FG000|Overall Study|Adverse Event|0|||
23695394|NCT02799381|66260545|FG001|Overall Study|Adverse Event|1|||
23695395|NCT02799381|66260544|FG000|Overall Study|Participant did not take any study drug|1|||
23695396|NCT02799381|66260545|FG001|Overall Study|Participant did not take any study drug|0|||
23695397|NCT00090285|66260547|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
23695398|NCT00090285|66260548|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
23695399|NCT00090285|66260549|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23695400|NCT00090285|66260550|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23695401|NCT00090285|66260551|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23695402|NCT00090285|66260552|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23695403|NCT00090285|66260547|FG000|Base Study Vaccination Period|Adverse Event|2|||
23695404|NCT00090285|66260548|FG001|Base Study Vaccination Period|Adverse Event|4|||
23695405|NCT00090285|66260549|FG002|Base Study Vaccination Period|Adverse Event|0|||
23695406|NCT00090285|66260550|FG003|Base Study Vaccination Period|Adverse Event|0|||
23695407|NCT00090285|66260551|FG004|Base Study Vaccination Period|Adverse Event|0|||
23695408|NCT00090285|66260552|FG005|Base Study Vaccination Period|Adverse Event|0|||
23695409|NCT00090285|66260547|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
23695410|NCT00090285|66260548|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
23695411|NCT00090285|66260549|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23695412|NCT00090285|66260550|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23695413|NCT00090285|66260551|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23695414|NCT00090285|66260552|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
23695415|NCT00090285|66260547|FG000|Base Study Vaccination Period|Protocol Violation|2|||
23695416|NCT00090285|66260548|FG001|Base Study Vaccination Period|Protocol Violation|3|||
23695417|NCT00090285|66260549|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23695418|NCT00090285|66260550|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23695419|NCT00090285|66260551|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23695420|NCT00090285|66260552|FG005|Base Study Vaccination Period|Protocol Violation|0|||
23695421|NCT00090285|66260547|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
23695422|NCT00090285|66260548|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
23695423|NCT00090285|66260549|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23695424|NCT00090285|66260550|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23695425|NCT00090285|66260551|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23695426|NCT00090285|66260552|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
23695427|NCT00090285|66260547|FG000|Base Study Vaccination Period|Uncooperative|2|||
23695428|NCT00090285|66260548|FG001|Base Study Vaccination Period|Uncooperative|2|||
23695429|NCT00090285|66260549|FG002|Base Study Vaccination Period|Uncooperative|0|||
23695430|NCT00090285|66260550|FG003|Base Study Vaccination Period|Uncooperative|0|||
23695431|NCT00090285|66260551|FG004|Base Study Vaccination Period|Uncooperative|0|||
23695432|NCT00090285|66260552|FG005|Base Study Vaccination Period|Uncooperative|0|||
23695433|NCT00090285|66260547|FG000|Base Study Vaccination Period|Moved|20|||
23695434|NCT00090285|66260548|FG001|Base Study Vaccination Period|Moved|21|||
23695435|NCT00090285|66260549|FG002|Base Study Vaccination Period|Moved|0|||
23695436|NCT00090285|66260550|FG003|Base Study Vaccination Period|Moved|0|||
23695437|NCT00090285|66260551|FG004|Base Study Vaccination Period|Moved|0|||
23695438|NCT00090285|66260552|FG005|Base Study Vaccination Period|Moved|0|||
23695439|NCT00090285|66260547|FG000|Base Study Vaccination Period|Site Terminated|1|||
23695440|NCT00090285|66260548|FG001|Base Study Vaccination Period|Site Terminated|0|||
23695441|NCT00090285|66260549|FG002|Base Study Vaccination Period|Site Terminated|0|||
23695442|NCT00090285|66260550|FG003|Base Study Vaccination Period|Site Terminated|0|||
23695443|NCT00090285|66260551|FG004|Base Study Vaccination Period|Site Terminated|0|||
23695444|NCT00090285|66260552|FG005|Base Study Vaccination Period|Site Terminated|0|||
23695445|NCT00090285|66260547|FG000|Base Study Vaccination Period|Other|2|||
23695446|NCT00090285|66260548|FG001|Base Study Vaccination Period|Other|2|||
23695447|NCT00090285|66260549|FG002|Base Study Vaccination Period|Other|0|||
23695448|NCT00090285|66260550|FG003|Base Study Vaccination Period|Other|0|||
23695449|NCT00090285|66260551|FG004|Base Study Vaccination Period|Other|0|||
23695450|NCT00090285|66260552|FG005|Base Study Vaccination Period|Other|0|||
23695451|NCT00090285|66260547|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
23695452|NCT00090285|66260548|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
23695453|NCT00090285|66260549|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
23695454|NCT00090285|66260550|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
23695455|NCT00090285|66260551|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
23695456|NCT00090285|66260552|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
23695457|NCT00090285|66260547|FG000|Base Study Vaccination Period|HIV positive|1|||
23695458|NCT00090285|66260548|FG001|Base Study Vaccination Period|HIV positive|1|||
23695459|NCT00090285|66260549|FG002|Base Study Vaccination Period|HIV positive|0|||
23695460|NCT00090285|66260550|FG003|Base Study Vaccination Period|HIV positive|0|||
23695461|NCT00090285|66260551|FG004|Base Study Vaccination Period|HIV positive|0|||
23695462|NCT00090285|66260552|FG005|Base Study Vaccination Period|HIV positive|0|||
23695463|NCT00090285|66260547|FG000|Base Study Follow-up Period|Adverse Event|3|||
23695464|NCT00090285|66260548|FG001|Base Study Follow-up Period|Adverse Event|10|||
23695465|NCT00090285|66260549|FG002|Base Study Follow-up Period|Adverse Event|0|||
23695466|NCT00090285|66260550|FG003|Base Study Follow-up Period|Adverse Event|0|||
23695467|NCT00090285|66260551|FG004|Base Study Follow-up Period|Adverse Event|0|||
23695468|NCT00090285|66260552|FG005|Base Study Follow-up Period|Adverse Event|0|||
23695469|NCT00090285|66260547|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
23695470|NCT00090285|66260548|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
23695471|NCT00090285|66260549|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
23695472|NCT00090285|66260550|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
23695473|NCT00090285|66260551|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23695474|NCT00090285|66260552|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
23695475|NCT00090285|66260547|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
23695476|NCT00090285|66260548|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
23695477|NCT00090285|66260549|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23695478|NCT00090285|66260550|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23695479|NCT00090285|66260551|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23695480|NCT00090285|66260552|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
23695481|NCT00090285|66260547|FG000|Base Study Follow-up Period|Moved|41|||
23695482|NCT00090285|66260548|FG001|Base Study Follow-up Period|Moved|36|||
23695483|NCT00090285|66260549|FG002|Base Study Follow-up Period|Moved|0|||
23695484|NCT00090285|66260550|FG003|Base Study Follow-up Period|Moved|0|||
23695485|NCT00090285|66260551|FG004|Base Study Follow-up Period|Moved|0|||
23695486|NCT00090285|66260552|FG005|Base Study Follow-up Period|Moved|0|||
23695487|NCT00090285|66260547|FG000|Base Study Follow-up Period|Other|2|||
23695488|NCT00090285|66260548|FG001|Base Study Follow-up Period|Other|0|||
23695489|NCT00090285|66260549|FG002|Base Study Follow-up Period|Other|0|||
23695490|NCT00090285|66260550|FG003|Base Study Follow-up Period|Other|0|||
23396614|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396615|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396616|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396617|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396618|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
23396619|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396620|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396621|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396622|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396623|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23695491|NCT00090285|66260551|FG004|Base Study Follow-up Period|Other|0|||
23695492|NCT00090285|66260552|FG005|Base Study Follow-up Period|Other|0|||
23695493|NCT00090285|66260547|FG000|Base Study Follow-up Period|Protocol Violation|1|||
23695494|NCT00090285|66260548|FG001|Base Study Follow-up Period|Protocol Violation|0|||
23695495|NCT00090285|66260549|FG002|Base Study Follow-up Period|Protocol Violation|0|||
23695496|NCT00090285|66260550|FG003|Base Study Follow-up Period|Protocol Violation|0|||
23396624|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396625|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396626|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396627|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396628|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396629|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396630|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396631|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396632|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396633|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396634|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
23396635|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396636|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396637|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396638|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396639|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396640|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396641|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396642|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396643|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396644|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396645|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23695497|NCT00090285|66260551|FG004|Base Study Follow-up Period|Protocol Violation|0|||
23695498|NCT00090285|66260552|FG005|Base Study Follow-up Period|Protocol Violation|0|||
23695499|NCT00090285|66260547|FG000|Base Study Follow-up Period|Uncooperative|3|||
23695500|NCT00090285|66260548|FG001|Base Study Follow-up Period|Uncooperative|4|||
23695501|NCT00090285|66260549|FG002|Base Study Follow-up Period|Uncooperative|0|||
23695502|NCT00090285|66260550|FG003|Base Study Follow-up Period|Uncooperative|0|||
23695503|NCT00090285|66260551|FG004|Base Study Follow-up Period|Uncooperative|0|||
23695504|NCT00090285|66260552|FG005|Base Study Follow-up Period|Uncooperative|0|||
23695505|NCT00090285|66260547|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
23695506|NCT00090285|66260548|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
23695507|NCT00090285|66260549|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
23695508|NCT00090285|66260550|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
23695509|NCT00090285|66260551|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
23695510|NCT00090285|66260552|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
23695511|NCT00090285|66260547|FG000|Extension 1|Adverse Event|0|||
23695512|NCT00090285|66260548|FG001|Extension 1|Adverse Event|0|||
23695513|NCT00090285|66260549|FG002|Extension 1|Adverse Event|2|||
23695514|NCT00090285|66260550|FG003|Extension 1|Adverse Event|0|||
23695515|NCT00090285|66260551|FG004|Extension 1|Adverse Event|0|||
23695516|NCT00090285|66260552|FG005|Extension 1|Adverse Event|0|||
23695517|NCT00090285|66260547|FG000|Extension 1|Lost to Follow-up|0|||
23695518|NCT00090285|66260548|FG001|Extension 1|Lost to Follow-up|0|||
23695519|NCT00090285|66260549|FG002|Extension 1|Lost to Follow-up|35|||
23695520|NCT00090285|66260550|FG003|Extension 1|Lost to Follow-up|0|||
23695521|NCT00090285|66260551|FG004|Extension 1|Lost to Follow-up|0|||
23695522|NCT00090285|66260552|FG005|Extension 1|Lost to Follow-up|0|||
23695523|NCT00090285|66260547|FG000|Extension 1|Withdrawal by Subject|0|||
23695524|NCT00090285|66260548|FG001|Extension 1|Withdrawal by Subject|0|||
23695525|NCT00090285|66260549|FG002|Extension 1|Withdrawal by Subject|13|||
23695526|NCT00090285|66260550|FG003|Extension 1|Withdrawal by Subject|1|||
23695527|NCT00090285|66260551|FG004|Extension 1|Withdrawal by Subject|0|||
23695528|NCT00090285|66260552|FG005|Extension 1|Withdrawal by Subject|0|||
23695529|NCT00090285|66260547|FG000|Extension 1|Other|0|||
23695530|NCT00090285|66260548|FG001|Extension 1|Other|0|||
23695531|NCT00090285|66260549|FG002|Extension 1|Other|4|||
23695532|NCT00090285|66260550|FG003|Extension 1|Other|0|||
23695533|NCT00090285|66260551|FG004|Extension 1|Other|0|||
23695534|NCT00090285|66260552|FG005|Extension 1|Other|0|||
23695535|NCT00090285|66260547|FG000|Extension 1|Moved|0|||
23695536|NCT00090285|66260548|FG001|Extension 1|Moved|0|||
23396646|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396647|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396648|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396649|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23498622|NCT00945893|65566393|FG001|Overall Study|Withdrawal of consent|2|||
23498623|NCT02296320|65566394|FG000|Overall Study|Withdrawal by Subject|4|||
23498624|NCT02296320|65566395|FG001|Overall Study|Withdrawal by Subject|0|||
23695537|NCT00090285|66260549|FG002|Extension 1|Moved|3|||
23695538|NCT00090285|66260550|FG003|Extension 1|Moved|0|||
23695539|NCT00090285|66260551|FG004|Extension 1|Moved|0|||
23695540|NCT00090285|66260552|FG005|Extension 1|Moved|0|||
23695541|NCT00090285|66260547|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
23695542|NCT00090285|66260548|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
23695543|NCT00090285|66260549|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
23695544|NCT00090285|66260550|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
23695545|NCT00090285|66260551|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
23695546|NCT00090285|66260552|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
23695547|NCT00090285|66260547|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23396650|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396651|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
23396652|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23695548|NCT00090285|66260548|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23695549|NCT00090285|66260549|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23695550|NCT00090285|66260550|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23695551|NCT00090285|66260551|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
23695552|NCT00090285|66260552|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
23695553|NCT00090285|66260547|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23695554|NCT00090285|66260548|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23695555|NCT00090285|66260549|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23695556|NCT00090285|66260550|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23695557|NCT00090285|66260551|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
23695558|NCT00090285|66260552|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
23396653|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396654|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396655|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396656|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396657|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396658|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396659|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396660|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396661|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396662|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396663|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396664|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396665|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396666|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396667|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
23396668|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396669|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396670|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396671|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396672|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396673|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396674|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396675|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396676|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396677|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396678|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396679|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396680|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396681|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396682|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396683|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
23396684|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396685|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396686|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396687|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396688|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396689|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396690|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396691|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396692|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396693|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396694|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396695|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396696|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396697|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396698|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396699|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
23396700|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396701|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396702|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396703|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396704|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396705|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23695559|NCT00090285|66260547|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
23396706|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396707|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23695560|NCT00090285|66260548|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
23695561|NCT00090285|66260549|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
23695562|NCT00090285|66260550|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
23695563|NCT00090285|66260551|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
23695564|NCT00090285|66260552|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
23695565|NCT00501852|66263576|FG000|Overall Study|Adverse Event|3|||
23695566|NCT00501852|66263576|FG000|Overall Study|Withdrawal by Subject|2|||
23695567|NCT02750410|66263577|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23695568|NCT02750410|66263578|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23695569|NCT02750410|66263577|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23695570|NCT02750410|66263578|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23396708|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396709|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396710|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396711|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396712|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396713|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396714|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396715|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
23396716|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396717|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396718|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396719|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396720|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396721|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396722|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396723|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396724|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23695571|NCT02750410|66263577|FG000|Open-Label Extension Period|Adverse Event|5|||
23695572|NCT02750410|66263578|FG001|Open-Label Extension Period|Adverse Event|3|||
23695573|NCT02750410|66263577|FG000|Open-Label Extension Period|Protocol Violation|0|||
23695574|NCT02750410|66263578|FG001|Open-Label Extension Period|Protocol Violation|1|||
23695575|NCT02750410|66263577|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
23695576|NCT02750410|66263578|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
23695577|NCT01088412|66263579|FG000|Overall Study|Adverse Event|38|||
23695578|NCT01088412|66263580|FG001|Overall Study|Adverse Event|0|||
23695579|NCT01088412|66263581|FG002|Overall Study|Adverse Event|0|||
23695580|NCT01088412|66263579|FG000|Overall Study|Death|42|||
23695581|NCT01088412|66263580|FG001|Overall Study|Death|6|||
23695582|NCT01088412|66263581|FG002|Overall Study|Death|0|||
23695583|NCT01088412|66263579|FG000|Overall Study|Other Reason per Case Report Form|2089|||
23695584|NCT01088412|66263580|FG001|Overall Study|Other Reason per Case Report Form|103|||
23396725|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396726|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396727|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396728|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396729|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396730|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396731|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
23396732|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396733|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396734|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396735|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396736|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396737|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396738|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396739|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396740|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396741|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23695585|NCT01088412|66263581|FG002|Overall Study|Other Reason per Case Report Form|9|||
23695586|NCT01088412|66263579|FG000|Overall Study|Withdrawal by Subject|1761|||
23695587|NCT01088412|66263580|FG001|Overall Study|Withdrawal by Subject|25|||
23695588|NCT01088412|66263581|FG002|Overall Study|Withdrawal by Subject|1|||
23396742|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396743|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396744|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396745|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396746|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396747|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
23396748|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396749|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396750|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396751|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396752|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396753|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396754|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396755|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396756|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396757|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396758|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396759|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396760|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396761|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396762|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396763|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
23396764|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396765|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23695589|NCT01088412|66263579|FG000|Overall Study|Received Another GH Product|79|||
23695590|NCT01088412|66263580|FG001|Overall Study|Received Another GH Product|0|||
23695591|NCT01088412|66263581|FG002|Overall Study|Received Another GH Product|0|||
23695592|NCT01088412|66263579|FG000|Overall Study|Participant Moved|601|||
23695593|NCT01088412|66263580|FG001|Overall Study|Participant Moved|21|||
23695594|NCT01088412|66263581|FG002|Overall Study|Participant Moved|2|||
23695595|NCT01088412|66263579|FG000|Overall Study|Physician Decision|1041|||
23695596|NCT01088412|66263580|FG001|Overall Study|Physician Decision|8|||
23695597|NCT01088412|66263581|FG002|Overall Study|Physician Decision|4|||
23695598|NCT01088412|66263579|FG000|Overall Study|Sponsor Decision|4467|||
23695599|NCT01088412|66263580|FG001|Overall Study|Sponsor Decision|79|||
23695600|NCT01088412|66263581|FG002|Overall Study|Sponsor Decision|23|||
23695601|NCT01088412|66263579|FG000|Overall Study|Third Party Required to Change Brand|487|||
23695602|NCT01088412|66263580|FG001|Overall Study|Third Party Required to Change Brand|0|||
23695603|NCT01088412|66263581|FG002|Overall Study|Third Party Required to Change Brand|0|||
23695604|NCT01088412|66263579|FG000|Overall Study|Lost to Follow-up|3052|||
23695605|NCT01088412|66263580|FG001|Overall Study|Lost to Follow-up|130|||
23695606|NCT01088412|66263581|FG002|Overall Study|Lost to Follow-up|11|||
23695607|NCT01088412|66263579|FG000|Overall Study|Study Summary Not Completed|4360|||
23695608|NCT01088412|66263580|FG001|Overall Study|Study Summary Not Completed|64|||
23695609|NCT01088412|66263581|FG002|Overall Study|Study Summary Not Completed|22|||
23695610|NCT04024228|66263584|FG000|Overall Study|Adverse Event|1|||
23695611|NCT04024228|66263585|FG001|Overall Study|Adverse Event|0|||
23695612|NCT04024228|66263584|FG000|Overall Study|Protocol Deviation|0|||
23695613|NCT04024228|66263585|FG001|Overall Study|Protocol Deviation|2|||
23695614|NCT04024228|66263584|FG000|Overall Study|Withdrawal by Subject|3|||
23695615|NCT04024228|66263585|FG001|Overall Study|Withdrawal by Subject|4|||
23695616|NCT03671369|66263589|FG000|Overall Study|Other|1|||
23695617|NCT03671369|66263589|FG000|Overall Study|Withdrawal by Subject|289|||
23695618|NCT03671369|66263589|FG000|Overall Study|Not willing to be vaccinated|1|||
23695619|NCT05372315|66263590|FG000|Overall Study|Withdrawal by Subject|1|||
23695620|NCT05372315|66263591|FG001|Overall Study|Withdrawal by Subject|0|||
23695621|NCT02263365|66263592|FG000|Overall Study|Physician Decision|22|||
23695622|NCT02263365|66263593|FG001|Overall Study|Physician Decision|18|||
23695623|NCT02179398|66263599|FG000|Overall Study|Lack of obligatory data|3|||
23695624|NCT02179398|66263600|FG001|Overall Study|Lack of obligatory data|3|||
23695625|NCT02179398|66263599|FG000|Overall Study|Lost to Follow-up|0|||
23695626|NCT02179398|66263600|FG001|Overall Study|Lost to Follow-up|1|||
23695627|NCT01089725|66263601|FG000|Overall Study|Adverse Event|1|||
23695628|NCT01089725|66263602|FG001|Overall Study|Adverse Event|1|||
23695629|NCT01089725|66263603|FG002|Overall Study|Adverse Event|0|||
23695630|NCT01089725|66263604|FG003|Overall Study|Adverse Event|0|||
23695631|NCT01089725|66263605|FG004|Overall Study|Adverse Event|2|||
23695632|NCT01089725|66263601|FG000|Overall Study|Lack of Efficacy|4|||
23695633|NCT01089725|66263602|FG001|Overall Study|Lack of Efficacy|3|||
23695634|NCT01089725|66263603|FG002|Overall Study|Lack of Efficacy|1|||
23695635|NCT01089725|66263604|FG003|Overall Study|Lack of Efficacy|0|||
23695636|NCT01089725|66263605|FG004|Overall Study|Lack of Efficacy|4|||
23396766|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396767|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396768|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23695637|NCT01089725|66263601|FG000|Overall Study|Lost to Follow-up|2|||
23695638|NCT01089725|66263602|FG001|Overall Study|Lost to Follow-up|2|||
23695639|NCT01089725|66263603|FG002|Overall Study|Lost to Follow-up|0|||
23695640|NCT01089725|66263604|FG003|Overall Study|Lost to Follow-up|3|||
23695641|NCT01089725|66263605|FG004|Overall Study|Lost to Follow-up|0|||
23695642|NCT01089725|66263601|FG000|Overall Study|Protocol Violation|0|||
23695643|NCT01089725|66263602|FG001|Overall Study|Protocol Violation|0|||
23695644|NCT01089725|66263603|FG002|Overall Study|Protocol Violation|1|||
23695645|NCT01089725|66263604|FG003|Overall Study|Protocol Violation|1|||
23695646|NCT01089725|66263605|FG004|Overall Study|Protocol Violation|0|||
23695647|NCT01089725|66263601|FG000|Overall Study|Withdrawal by Subject|5|||
23695648|NCT01089725|66263602|FG001|Overall Study|Withdrawal by Subject|5|||
23695649|NCT01089725|66263603|FG002|Overall Study|Withdrawal by Subject|4|||
23695650|NCT01089725|66263604|FG003|Overall Study|Withdrawal by Subject|5|||
23695651|NCT01089725|66263605|FG004|Overall Study|Withdrawal by Subject|4|||
23695652|NCT01089725|66263601|FG000|Overall Study|Study Terminated by Sponsor|51|||
23695653|NCT01089725|66263602|FG001|Overall Study|Study Terminated by Sponsor|56|||
23695654|NCT01089725|66263603|FG002|Overall Study|Study Terminated by Sponsor|53|||
23695655|NCT01089725|66263604|FG003|Overall Study|Study Terminated by Sponsor|68|||
23695656|NCT01089725|66263605|FG004|Overall Study|Study Terminated by Sponsor|68|||
23695657|NCT01089725|66263601|FG000|Overall Study|Randomized, but not treated|0|||
23695658|NCT01089725|66263602|FG001|Overall Study|Randomized, but not treated|1|||
23695659|NCT01089725|66263603|FG002|Overall Study|Randomized, but not treated|2|||
23695660|NCT01089725|66263604|FG003|Overall Study|Randomized, but not treated|1|||
23695661|NCT01089725|66263605|FG004|Overall Study|Randomized, but not treated|2|||
23396769|NCT02891226|65198950|FG000|Follow-up Period|Withdrawal by Subject|0|||
23396770|NCT02891226|65198951|FG001|Follow-up Period|Withdrawal by Subject|0|||
23396771|NCT02891226|65198952|FG002|Follow-up Period|Withdrawal by Subject|0|||
23695662|NCT01089725|66263601|FG000|Overall Study|Other|3|||
23695663|NCT01089725|66263602|FG001|Overall Study|Other|0|||
23695664|NCT01089725|66263603|FG002|Overall Study|Other|0|||
23695665|NCT01089725|66263604|FG003|Overall Study|Other|1|||
23695666|NCT01089725|66263605|FG004|Overall Study|Other|0|||
23695667|NCT00849212|66263606|FG000|Overall Study|Lack of Efficacy|1|||
23695668|NCT00849212|66263606|FG000|Overall Study|Withdrawal by Subject|3|||
23695669|NCT00849212|66263606|FG000|Overall Study|Adverse Event|2|||
23695670|NCT00849212|66263606|FG000|Overall Study|Miscellaneous|1|||
23695671|NCT01849848|66263607|FG000|Overall Study|Physician Decision|1|||
23396772|NCT02891226|65198953|FG003|Follow-up Period|Withdrawal by Subject|0|||
23396773|NCT02891226|65198954|FG004|Follow-up Period|Withdrawal by Subject|0|||
23396774|NCT02891226|65198955|FG005|Follow-up Period|Withdrawal by Subject|0|||
23695672|NCT01849848|66263607|FG000|Overall Study|Progression of the primary disease|3|||
23695673|NCT02955186|66263610|FG000|Overall Study|Withdrawal by Subject|6|||
23695674|NCT02955186|66263611|FG001|Overall Study|Withdrawal by Subject|2|||
23695675|NCT02955186|66263610|FG000|Overall Study|Protocol Violation|1|||
23695676|NCT02955186|66263611|FG001|Overall Study|Protocol Violation|0|||
23695677|NCT02138110|66263612|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
23695678|NCT02138110|66263612|FG000|Overall Scaffold Implantation|Death|3|||
23695679|NCT00728416|66263615|FG000|Overall Study|Adverse Event|1|||
23695680|NCT00728416|66263616|FG001|Overall Study|Adverse Event|1|||
23695681|NCT00728416|66263615|FG000|Overall Study|Treatment Failure|0|||
23695682|NCT00728416|66263616|FG001|Overall Study|Treatment Failure|1|||
23695683|NCT00728416|66263615|FG000|Overall Study|Withdrawal by Subject|1|||
23695684|NCT00728416|66263616|FG001|Overall Study|Withdrawal by Subject|0|||
23695685|NCT02190591|66263617|FG000|Overall Study|Withdrawal by Subject|1|||
23695686|NCT02190591|66263618|FG001|Overall Study|Withdrawal by Subject|8|||
23695687|NCT02190591|66263617|FG000|Overall Study|Protocol Violation|1|||
23695688|NCT02190591|66263618|FG001|Overall Study|Protocol Violation|0|||
23695689|NCT02190591|66263617|FG000|Overall Study|did not use peanut ball as instructed|0|||
23695690|NCT02190591|66263618|FG001|Overall Study|did not use peanut ball as instructed|2|||
23695691|NCT02190591|66263617|FG000|Overall Study|face presentation so she was ineligible|0|||
23695692|NCT02190591|66263618|FG001|Overall Study|face presentation so she was ineligible|1|||
23695693|NCT03241173|66263620|FG000|Overall Study|Death|3|||
23396775|NCT02891226|65198956|FG006|Follow-up Period|Withdrawal by Subject|0|||
23396776|NCT02891226|65198957|FG007|Follow-up Period|Withdrawal by Subject|0|||
23396777|NCT02891226|65198958|FG008|Follow-up Period|Withdrawal by Subject|0|||
23396778|NCT02891226|65198959|FG009|Follow-up Period|Withdrawal by Subject|0|||
23396779|NCT02891226|65198960|FG010|Follow-up Period|Withdrawal by Subject|0|||
23396780|NCT02891226|65198961|FG011|Follow-up Period|Withdrawal by Subject|1|||
23396781|NCT02891226|65198962|FG012|Follow-up Period|Withdrawal by Subject|0|||
23396782|NCT02891226|65198963|FG013|Follow-up Period|Withdrawal by Subject|0|||
23396783|NCT02891226|65198964|FG014|Follow-up Period|Withdrawal by Subject|1|||
23396784|NCT02891226|65198965|FG015|Follow-up Period|Withdrawal by Subject|1|||
23396785|NCT00815633|65198966|FG000|Overall Study|study terminated|1|||
23396786|NCT00787150|65198967|FG000|Overall Study|Adverse Event|4|||
23396787|NCT00787150|65198968|FG001|Overall Study|Adverse Event|4|||
23396788|NCT00787150|65198969|FG002|Overall Study|Adverse Event|4|||
23695694|NCT03241173|66263621|FG001|Overall Study|Death|2|||
23695695|NCT03241173|66263622|FG002|Overall Study|Death|4|||
23695696|NCT03241173|66263623|FG003|Overall Study|Death|4|||
23695697|NCT03241173|66263624|FG004|Overall Study|Death|2|||
23695698|NCT03241173|66263625|FG005|Overall Study|Death|2|||
23695699|NCT03241173|66263626|FG006|Overall Study|Death|3|||
23695700|NCT03241173|66263627|FG007|Overall Study|Death|1|||
23695701|NCT03241173|66263628|FG008|Overall Study|Death|0|||
23695702|NCT03241173|66263629|FG009|Overall Study|Death|5|||
23695703|NCT03241173|66263630|FG010|Overall Study|Death|4|||
23695704|NCT03241173|66263631|FG011|Overall Study|Death|3|||
23695705|NCT03241173|66263632|FG012|Overall Study|Death|0|||
23396789|NCT00787150|65198967|FG000|Overall Study|Physician Decision|1|||
23396790|NCT00787150|65198968|FG001|Overall Study|Physician Decision|2|||
23695706|NCT03241173|66263633|FG013|Overall Study|Death|0|||
23695707|NCT03241173|66263634|FG014|Overall Study|Death|0|||
23396791|NCT00787150|65198969|FG002|Overall Study|Physician Decision|1|||
23396792|NCT00787150|65198967|FG000|Overall Study|Withdrawal by Subject|2|||
23396793|NCT00787150|65198968|FG001|Overall Study|Withdrawal by Subject|1|||
23396794|NCT00787150|65198969|FG002|Overall Study|Withdrawal by Subject|0|||
23396795|NCT00787150|65198967|FG000|Overall Study|Dosing incorrect study durg|2|||
23396796|NCT00787150|65198968|FG001|Overall Study|Dosing incorrect study durg|0|||
23396797|NCT00787150|65198969|FG002|Overall Study|Dosing incorrect study durg|0|||
23396798|NCT04618471|65198970|FG000|Overall Study|Screen Failure|62|||
23396799|NCT04618471|65198970|FG000|Overall Study|Withdrawal by Subject|6|||
23396800|NCT04618471|65198970|FG000|Overall Study|Physician Decision|2|||
23396801|NCT04618471|65198970|FG000|Overall Study|Lost to Follow-up|1|||
23695708|NCT03241173|66263620|FG000|Overall Study|Withdrawal by Subject|0|||
23695709|NCT03241173|66263621|FG001|Overall Study|Withdrawal by Subject|0|||
23695710|NCT03241173|66263622|FG002|Overall Study|Withdrawal by Subject|1|||
23695711|NCT03241173|66263623|FG003|Overall Study|Withdrawal by Subject|0|||
23695712|NCT03241173|66263624|FG004|Overall Study|Withdrawal by Subject|0|||
23695713|NCT03241173|66263625|FG005|Overall Study|Withdrawal by Subject|1|||
23695714|NCT03241173|66263626|FG006|Overall Study|Withdrawal by Subject|0|||
23396802|NCT04618471|65198970|FG000|Overall Study|Various other reasons|2|||
23396803|NCT04618471|65198970|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
23695715|NCT03241173|66263627|FG007|Overall Study|Withdrawal by Subject|0|||
23396804|NCT01998477|65198971|FG000|Overall Study|Lost to Follow-up|4|||
23396805|NCT01998477|65198972|FG001|Overall Study|Lost to Follow-up|5|||
23396806|NCT01998477|65198971|FG000|Overall Study|Withdrawal by Subject|6|||
23396807|NCT01998477|65198972|FG001|Overall Study|Withdrawal by Subject|0|||
23396808|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
23396809|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
23396810|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
23396811|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
23396812|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
23396813|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
23396814|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
23396815|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
23396816|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
23396817|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
23396818|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
23396819|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
23396820|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
23396821|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
23695716|NCT03241173|66263628|FG008|Overall Study|Withdrawal by Subject|0|||
23695717|NCT03241173|66263629|FG009|Overall Study|Withdrawal by Subject|0|||
23695718|NCT03241173|66263630|FG010|Overall Study|Withdrawal by Subject|0|||
23695719|NCT03241173|66263631|FG011|Overall Study|Withdrawal by Subject|0|||
23695720|NCT03241173|66263632|FG012|Overall Study|Withdrawal by Subject|0|||
23695721|NCT03241173|66263633|FG013|Overall Study|Withdrawal by Subject|0|||
23695722|NCT03241173|66263634|FG014|Overall Study|Withdrawal by Subject|0|||
23695723|NCT03241173|66263620|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23695724|NCT03241173|66263621|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23695725|NCT03241173|66263622|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23396822|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
23396823|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
23396824|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
23396825|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
23396826|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
23396827|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
23396828|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
23396829|NCT01432444|65198973|FG000|Treatment Phase|Lost to Follow-up|0|||
23396830|NCT01432444|65198974|FG001|Treatment Phase|Lost to Follow-up|33|||
23695726|NCT03241173|66263623|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23695727|NCT03241173|66263624|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23695728|NCT03241173|66263625|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23695729|NCT03241173|66263626|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23695730|NCT03241173|66263627|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23695731|NCT03241173|66263628|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23695732|NCT03241173|66263629|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23695733|NCT03241173|66263630|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23695734|NCT03241173|66263631|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
23695735|NCT03241173|66263632|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23695736|NCT03241173|66263633|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23695737|NCT03241173|66263634|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23695738|NCT03241173|66263620|FG000|Overall Study|Lost to Follow-up|0|||
23695739|NCT03241173|66263621|FG001|Overall Study|Lost to Follow-up|0|||
23695740|NCT03241173|66263622|FG002|Overall Study|Lost to Follow-up|0|||
23396831|NCT01432444|65198975|FG002|Treatment Phase|Lost to Follow-up|0|||
23396832|NCT01432444|65198973|FG000|Treatment Phase|Adverse Event|0|||
23396833|NCT01432444|65198974|FG001|Treatment Phase|Adverse Event|37|||
23396834|NCT01432444|65198975|FG002|Treatment Phase|Adverse Event|0|||
23396835|NCT01432444|65198973|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
23498625|NCT02296320|65566396|FG002|Overall Study|Withdrawal by Subject|2|||
23498626|NCT02296320|65566394|FG000|Overall Study|Death|24|||
23396836|NCT01432444|65198974|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
23396837|NCT01432444|65198975|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
23498627|NCT02296320|65566395|FG001|Overall Study|Death|3|||
23695741|NCT03241173|66263623|FG003|Overall Study|Lost to Follow-up|0|||
23695742|NCT03241173|66263624|FG004|Overall Study|Lost to Follow-up|1|||
23695743|NCT03241173|66263625|FG005|Overall Study|Lost to Follow-up|0|||
23695744|NCT03241173|66263626|FG006|Overall Study|Lost to Follow-up|0|||
23695745|NCT03241173|66263627|FG007|Overall Study|Lost to Follow-up|0|||
23695746|NCT03241173|66263628|FG008|Overall Study|Lost to Follow-up|0|||
23695747|NCT03241173|66263629|FG009|Overall Study|Lost to Follow-up|1|||
23695748|NCT03241173|66263630|FG010|Overall Study|Lost to Follow-up|0|||
23695749|NCT03241173|66263631|FG011|Overall Study|Lost to Follow-up|0|||
23695750|NCT03241173|66263632|FG012|Overall Study|Lost to Follow-up|0|||
23695751|NCT03241173|66263633|FG013|Overall Study|Lost to Follow-up|0|||
23695752|NCT03241173|66263634|FG014|Overall Study|Lost to Follow-up|0|||
23695753|NCT03461289|66263635|FG000|Overall Study|Death|1|||
23695754|NCT00891657|66263638|FG000|Overall Study|Withdrawal by Subject|1|||
23695755|NCT00891657|66263639|FG001|Overall Study|Withdrawal by Subject|1|||
23695756|NCT04075604|66263644|FG000|Overall Study|Adverse Event|0|||
23695757|NCT04075604|66263645|FG001|Overall Study|Adverse Event|0|||
23695758|NCT04075604|66263646|FG002|Overall Study|Adverse Event|3|||
23695759|NCT04075604|66263644|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23695760|NCT04075604|66263645|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23695761|NCT04075604|66263646|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23695762|NCT04075604|66263644|FG000|Overall Study|Participant withdrew consent|0|||
23695763|NCT04075604|66263645|FG001|Overall Study|Participant withdrew consent|0|||
23695764|NCT04075604|66263646|FG002|Overall Study|Participant withdrew consent|1|||
23695765|NCT04075604|66263644|FG000|Overall Study|Other reasons|1|||
23695766|NCT04075604|66263645|FG001|Overall Study|Other reasons|0|||
23695767|NCT04075604|66263646|FG002|Overall Study|Other reasons|0|||
23695768|NCT04075604|66263644|FG000|Overall Study|Disease progression|0|||
23695769|NCT04075604|66263645|FG001|Overall Study|Disease progression|1|||
23695770|NCT04075604|66263646|FG002|Overall Study|Disease progression|0|||
23695771|NCT04075604|66263644|FG000|Overall Study|Study drug toxicity|0|||
23695772|NCT04075604|66263645|FG001|Overall Study|Study drug toxicity|5|||
23695773|NCT04075604|66263646|FG002|Overall Study|Study drug toxicity|1|||
23695774|NCT01165229|66263647|FG000|Overall Study|Serious Adverse Event|456|||
23695775|NCT01165229|66263648|FG001|Overall Study|Serious Adverse Event|487|||
23695776|NCT01165229|66263647|FG000|Overall Study|Non-Serious Adverse Event|47|||
23695777|NCT01165229|66263648|FG001|Overall Study|Non-Serious Adverse Event|15|||
23695778|NCT01165229|66263647|FG000|Overall Study|Protocol Violation|6|||
23695779|NCT01165229|66263648|FG001|Overall Study|Protocol Violation|8|||
23695780|NCT01165229|66263647|FG000|Overall Study|Withdrawal by Subject|387|||
23695781|NCT01165229|66263648|FG001|Overall Study|Withdrawal by Subject|396|||
23695782|NCT01165229|66263647|FG000|Overall Study|Migrated/moved from study area|51|||
23695783|NCT01165229|66263648|FG001|Overall Study|Migrated/moved from study area|46|||
23695784|NCT01165229|66263647|FG000|Overall Study|Lost to Follow-up|123|||
23396838|NCT01432444|65198973|FG000|Treatment Phase|Physician Decision|0|||
23396839|NCT01432444|65198974|FG001|Treatment Phase|Physician Decision|5|||
23396840|NCT01432444|65198975|FG002|Treatment Phase|Physician Decision|0|||
23396841|NCT01432444|65198973|FG000|Treatment Phase|Withdrawal by Subject|0|||
23396842|NCT01432444|65198974|FG001|Treatment Phase|Withdrawal by Subject|41|||
23396843|NCT01432444|65198975|FG002|Treatment Phase|Withdrawal by Subject|0|||
23396844|NCT01432444|65198973|FG000|Treatment Phase|Protocol Deviation|0|||
23396845|NCT01432444|65198974|FG001|Treatment Phase|Protocol Deviation|3|||
23396846|NCT01432444|65198975|FG002|Treatment Phase|Protocol Deviation|0|||
23396847|NCT01432444|65198973|FG000|Treatment Phase|Lack of Efficacy|0|||
23396848|NCT01432444|65198974|FG001|Treatment Phase|Lack of Efficacy|10|||
23396849|NCT01432444|65198975|FG002|Treatment Phase|Lack of Efficacy|0|||
23396850|NCT01432444|65198973|FG000|Extension Phase|Lost to Follow-up|0|||
23396851|NCT01432444|65198974|FG001|Extension Phase|Lost to Follow-up|0|||
23396852|NCT01432444|65198975|FG002|Extension Phase|Lost to Follow-up|17|||
23396853|NCT01432444|65198973|FG000|Extension Phase|Adverse Event|0|||
23396854|NCT01432444|65198974|FG001|Extension Phase|Adverse Event|0|||
23396855|NCT01432444|65198975|FG002|Extension Phase|Adverse Event|10|||
23396856|NCT01432444|65198973|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
23396857|NCT01432444|65198974|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
23396858|NCT01432444|65198975|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
23396859|NCT01432444|65198973|FG000|Extension Phase|Met Withdrawal Criteria|0|||
23396860|NCT01432444|65198974|FG001|Extension Phase|Met Withdrawal Criteria|0|||
23396861|NCT01432444|65198975|FG002|Extension Phase|Met Withdrawal Criteria|144|||
23695785|NCT01165229|66263648|FG001|Overall Study|Lost to Follow-up|133|||
23695786|NCT01165229|66263647|FG000|Overall Study|Suspected HZ Episode|2|||
23695787|NCT01165229|66263648|FG001|Overall Study|Suspected HZ Episode|2|||
23396862|NCT01432444|65198973|FG000|Extension Phase|Physician Decision|0|||
23396863|NCT01432444|65198974|FG001|Extension Phase|Physician Decision|0|||
23396864|NCT01432444|65198975|FG002|Extension Phase|Physician Decision|1|||
23695788|NCT01165229|66263647|FG000|Overall Study|No reason from the subject|108|||
23396865|NCT01432444|65198973|FG000|Extension Phase|Withdrawal by Subject|0|||
23396866|NCT01432444|65198974|FG001|Extension Phase|Withdrawal by Subject|0|||
23396867|NCT01432444|65198975|FG002|Extension Phase|Withdrawal by Subject|13|||
23396868|NCT00543985|65198976|FG000|Overall Study|Withdrawal by Subject|4|||
23396869|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
23396870|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
23396871|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
23396872|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
23396873|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
23396874|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
23396875|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
23396876|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
23396877|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
23396878|NCT03069716|65198977|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23396879|NCT03069716|65198978|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23396880|NCT03069716|65198979|FG002|Randomized Treatment|Withdrawal by Subject|0|||
23396881|NCT00949533|65198980|FG000|Overall Study|Lost to Follow-up|0|||
23396882|NCT00949533|65198981|FG001|Overall Study|Lost to Follow-up|1|||
23396883|NCT00841815|65198984|FG000|Washout|Withdrawal by Subject|0|||
23396884|NCT00841815|65198985|FG001|Washout|Withdrawal by Subject|1|||
23396885|NCT03950856|65198986|FG000|Overall Study|Death|1|||
23396886|NCT03950856|65198987|FG001|Overall Study|Death|2|||
23396887|NCT03950856|65198988|FG002|Overall Study|Death|0|||
23396888|NCT03950856|65198989|FG003|Overall Study|Death|0|||
23396889|NCT03950856|65198986|FG000|Overall Study|Lost to Follow-up|5|||
23396890|NCT03950856|65198987|FG001|Overall Study|Lost to Follow-up|6|||
23695789|NCT01165229|66263648|FG001|Overall Study|No reason from the subject|102|||
23695790|NCT01165229|66263647|FG000|Overall Study|Unknown completion status|0|||
23695791|NCT01165229|66263648|FG001|Overall Study|Unknown completion status|1|||
23695792|NCT00506389|66263649|FG000|In-treatment Period|Other|3|||
23695793|NCT00506389|66263650|FG001|In-treatment Period|Other|3|||
23695794|NCT00506389|66263651|FG002|In-treatment Period|Other|4|||
23695795|NCT00506389|66263649|FG000|In-treatment Period|Lost to Follow-up|0|||
23396891|NCT03950856|65198988|FG002|Overall Study|Lost to Follow-up|8|||
23396892|NCT03950856|65198989|FG003|Overall Study|Lost to Follow-up|2|||
23695796|NCT00506389|66263650|FG001|In-treatment Period|Lost to Follow-up|0|||
23695797|NCT00506389|66263651|FG002|In-treatment Period|Lost to Follow-up|1|||
23695798|NCT00506389|66263649|FG000|In-treatment Period|Lack of compliance|1|||
23695799|NCT00506389|66263650|FG001|In-treatment Period|Lack of compliance|0|||
23695800|NCT00506389|66263651|FG002|In-treatment Period|Lack of compliance|0|||
23695801|NCT00506389|66263649|FG000|In-treatment Period|Reasons not related to trial|4|||
23695802|NCT00506389|66263650|FG001|In-treatment Period|Reasons not related to trial|1|||
23695803|NCT00506389|66263651|FG002|In-treatment Period|Reasons not related to trial|0|||
23695804|NCT00506389|66263649|FG000|In-treatment Period|Withdrawal by Subject|3|||
23695805|NCT00506389|66263650|FG001|In-treatment Period|Withdrawal by Subject|3|||
23695806|NCT00506389|66263651|FG002|In-treatment Period|Withdrawal by Subject|4|||
23695807|NCT00506389|66263649|FG000|In-treatment Period|Lack of Efficacy|0|||
23695808|NCT00506389|66263650|FG001|In-treatment Period|Lack of Efficacy|2|||
23695809|NCT00506389|66263651|FG002|In-treatment Period|Lack of Efficacy|0|||
23695810|NCT00506389|66263649|FG000|In-treatment Period|Adverse Event|11|||
23695811|NCT00506389|66263650|FG001|In-treatment Period|Adverse Event|5|||
23695812|NCT00506389|66263651|FG002|In-treatment Period|Adverse Event|2|||
23695813|NCT00506389|66263649|FG000|In-treatment Period|Randomized but not treated|4|||
23695814|NCT00506389|66263650|FG001|In-treatment Period|Randomized but not treated|1|||
23695815|NCT00506389|66263651|FG002|In-treatment Period|Randomized but not treated|1|||
23695816|NCT01756157|66263652|FG000|First Intervention Period|Withdrawal by Subject|1|||
23695817|NCT01756157|66263653|FG001|First Intervention Period|Withdrawal by Subject|0|||
23695818|NCT01756157|66263652|FG000|First Intervention Period|Lost to Follow-up|0|||
23695819|NCT01756157|66263653|FG001|First Intervention Period|Lost to Follow-up|2|||
23695820|NCT00942708|66263654|FG000|Overall Study|Withdrawal by Subject|1|||
23695821|NCT02259231|66263659|FG000|Overall Study|Adverse Event|1|||
23695822|NCT02259231|66263660|FG001|Overall Study|Adverse Event|1|||
23695823|NCT02259231|66263661|FG002|Overall Study|Adverse Event|2|||
23695824|NCT02259231|66263662|FG003|Overall Study|Adverse Event|0|||
23695825|NCT02259231|66263663|FG004|Overall Study|Adverse Event|0|||
23695826|NCT02259231|66263664|FG005|Overall Study|Adverse Event|0|||
23695827|NCT02259231|66263665|FG006|Overall Study|Adverse Event|0|||
23396893|NCT03950856|65198986|FG000|Overall Study|Protocol Violation|2|||
23695828|NCT02259231|66263659|FG000|Overall Study|Progressive Disease|4|||
23695829|NCT02259231|66263660|FG001|Overall Study|Progressive Disease|5|||
23695830|NCT02259231|66263661|FG002|Overall Study|Progressive Disease|4|||
23396894|NCT03950856|65198987|FG001|Overall Study|Protocol Violation|0|||
23396895|NCT03950856|65198988|FG002|Overall Study|Protocol Violation|0|||
23396896|NCT03950856|65198989|FG003|Overall Study|Protocol Violation|1|||
23695831|NCT02259231|66263662|FG003|Overall Study|Progressive Disease|5|||
23695832|NCT02259231|66263663|FG004|Overall Study|Progressive Disease|4|||
23695833|NCT02259231|66263664|FG005|Overall Study|Progressive Disease|5|||
23695834|NCT02259231|66263665|FG006|Overall Study|Progressive Disease|4|||
23695835|NCT02259231|66263659|FG000|Overall Study|Sponsor termination of study|1|||
23396897|NCT03950856|65198986|FG000|Overall Study|Withdrawal by Subject|4|||
23396898|NCT03950856|65198987|FG001|Overall Study|Withdrawal by Subject|1|||
23396899|NCT03950856|65198988|FG002|Overall Study|Withdrawal by Subject|3|||
23396900|NCT03950856|65198989|FG003|Overall Study|Withdrawal by Subject|1|||
23396901|NCT03950856|65198986|FG000|Overall Study|Unable to phone|7|||
23396902|NCT03950856|65198987|FG001|Overall Study|Unable to phone|6|||
23396903|NCT03950856|65198988|FG002|Overall Study|Unable to phone|7|||
23396904|NCT03950856|65198989|FG003|Overall Study|Unable to phone|2|||
23396905|NCT02259114|65198990|FG000|Overall Study|Progressive Disease|14|||
23396906|NCT02259114|65198991|FG001|Overall Study|Progressive Disease|2|||
23396907|NCT02259114|65198992|FG002|Overall Study|Progressive Disease|10|||
23396908|NCT02259114|65198993|FG003|Overall Study|Progressive Disease|2|||
23396909|NCT02259114|65198994|FG004|Overall Study|Progressive Disease|5|||
23396910|NCT02259114|65198990|FG000|Overall Study|Adverse Event|2|||
23396911|NCT02259114|65198991|FG001|Overall Study|Adverse Event|1|||
23396912|NCT02259114|65198992|FG002|Overall Study|Adverse Event|0|||
23396913|NCT02259114|65198993|FG003|Overall Study|Adverse Event|0|||
23396914|NCT02259114|65198994|FG004|Overall Study|Adverse Event|1|||
23396915|NCT02259114|65198990|FG000|Overall Study|Death|3|||
23396916|NCT02259114|65198991|FG001|Overall Study|Death|0|||
23396917|NCT02259114|65198992|FG002|Overall Study|Death|1|||
23396918|NCT02259114|65198993|FG003|Overall Study|Death|0|||
23396919|NCT02259114|65198994|FG004|Overall Study|Death|0|||
23396920|NCT02259114|65198990|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396921|NCT02259114|65198991|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396922|NCT02259114|65198992|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
23396923|NCT02259114|65198993|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396924|NCT02259114|65198994|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396925|NCT02259114|65198990|FG000|Overall Study|Withdrawal by Subject|0|||
23396926|NCT02259114|65198991|FG001|Overall Study|Withdrawal by Subject|0|||
23396927|NCT02259114|65198992|FG002|Overall Study|Withdrawal by Subject|1|||
23396928|NCT02259114|65198993|FG003|Overall Study|Withdrawal by Subject|1|||
23396929|NCT02259114|65198994|FG004|Overall Study|Withdrawal by Subject|0|||
23396930|NCT02259114|65198990|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
23396931|NCT02259114|65198991|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
23396932|NCT02259114|65198992|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396933|NCT02259114|65198993|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396934|NCT02259114|65198994|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396935|NCT02259114|65198990|FG000|Overall Study|Not Treated|1|||
23396936|NCT02259114|65198991|FG001|Overall Study|Not Treated|0|||
23396937|NCT02259114|65198992|FG002|Overall Study|Not Treated|0|||
23396938|NCT02259114|65198993|FG003|Overall Study|Not Treated|0|||
23396939|NCT02259114|65198994|FG004|Overall Study|Not Treated|0|||
23396940|NCT04540367|65199002|FG000|Overall Study|Withdrawal by Subject|0|||
23396941|NCT04540367|65199003|FG001|Overall Study|Withdrawal by Subject|0|||
23396942|NCT04540367|65199004|FG002|Overall Study|Withdrawal by Subject|0|||
23396943|NCT04540367|65199005|FG003|Overall Study|Withdrawal by Subject|2|||
23396944|NCT04540367|65199002|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
23396945|NCT04540367|65199003|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
23396946|NCT04540367|65199004|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
23396947|NCT04540367|65199005|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
23695836|NCT02259231|66263660|FG001|Overall Study|Sponsor termination of study|0|||
23695837|NCT02259231|66263661|FG002|Overall Study|Sponsor termination of study|0|||
23396948|NCT04540367|65199002|FG000|Overall Study|Adverse Event|0|||
23396949|NCT04540367|65199003|FG001|Overall Study|Adverse Event|0|||
23695838|NCT02259231|66263662|FG003|Overall Study|Sponsor termination of study|1|||
23695839|NCT02259231|66263663|FG004|Overall Study|Sponsor termination of study|2|||
23695840|NCT02259231|66263664|FG005|Overall Study|Sponsor termination of study|1|||
23695841|NCT02259231|66263665|FG006|Overall Study|Sponsor termination of study|1|||
23695842|NCT00003641|66263666|FG000|Overall Study|Withdrawal by Subject|0|||
23396950|NCT04540367|65199004|FG002|Overall Study|Adverse Event|1|||
23695843|NCT00003641|66263667|FG001|Overall Study|Withdrawal by Subject|100|||
23695844|NCT00003641|66263666|FG000|Overall Study|Adverse Event|0|||
23396951|NCT04540367|65199005|FG003|Overall Study|Adverse Event|1|||
23396952|NCT00967499|65199008|FG000|Overall Study|Adverse Event|0|||
23396953|NCT00967499|65199009|FG001|Overall Study|Adverse Event|1|||
23396954|NCT00967499|65199008|FG000|Overall Study|Protocol Violation|1|||
23396955|NCT00967499|65199009|FG001|Overall Study|Protocol Violation|0|||
23396956|NCT00967499|65199008|FG000|Overall Study|Sponsor Decision|1|||
23396957|NCT00967499|65199009|FG001|Overall Study|Sponsor Decision|0|||
23396958|NCT00967499|65199008|FG000|Overall Study|Randomized but not treated|63|||
23396959|NCT00967499|65199009|FG001|Overall Study|Randomized but not treated|59|||
23396960|NCT02757430|65199010|FG000|Overall Study|Physician Decision|6|||
23396961|NCT02757430|65199010|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
23695845|NCT00003641|66263667|FG001|Overall Study|Adverse Event|38|||
23396962|NCT02757430|65199010|FG000|Overall Study|No informed consent|1|||
23396963|NCT02757430|65199010|FG000|Overall Study|No procedure performed|2|||
23396964|NCT00485173|65199024|FG000|Overall Study|Death|4|||
23396965|NCT00485173|65199025|FG001|Overall Study|Death|3|||
23396966|NCT00485173|65199024|FG000|Overall Study|Lost to Follow-up|32|||
23396967|NCT00485173|65199025|FG001|Overall Study|Lost to Follow-up|61|||
23396968|NCT03402841|65199027|FG000|Overall Study|Withdrawal by Subject|3|||
23396969|NCT03402841|65199027|FG000|Overall Study|Lost to Follow-up|2|||
23396970|NCT03402841|65199027|FG000|Overall Study|Death|146|||
23396971|NCT01734902|65199029|FG000|Overall Study|Other than listed|0|||
23396972|NCT01734902|65199030|FG001|Overall Study|Other than listed|2|||
23396973|NCT02511106|65199031|FG000|Overall Study|Lost to Follow-up|6|||
23396974|NCT02511106|65199032|FG001|Overall Study|Lost to Follow-up|4|||
23396975|NCT02511106|65199031|FG000|Overall Study|Withdrawal by Subject|24|||
23396976|NCT02511106|65199032|FG001|Overall Study|Withdrawal by Subject|21|||
23396977|NCT02511106|65199031|FG000|Overall Study|Death|42|||
23396978|NCT02511106|65199032|FG001|Overall Study|Death|82|||
23396979|NCT02511106|65199031|FG000|Overall Study|Ongoing study at data cut-off|3|||
23396980|NCT02511106|65199032|FG001|Overall Study|Ongoing study at data cut-off|2|||
23396981|NCT02511106|65199031|FG000|Overall Study|Without specified reason|3|||
23396982|NCT02511106|65199032|FG001|Overall Study|Without specified reason|0|||
23396983|NCT04614324|65199035|FG000|Overall Study|Lost to Follow-up|3|||
23396984|NCT04614324|65199035|FG000|Overall Study|Physician Decision|1|||
23396985|NCT04614324|65199035|FG000|Overall Study|Withdrawal by Subject|2|||
23396986|NCT04614324|65199035|FG000|Overall Study|Remaining in Follow up|123|||
23396987|NCT00776230|65199038|FG000|Overall Study|Lost to Follow-up|2|||
23396988|NCT00776230|65199039|FG001|Overall Study|Lost to Follow-up|1|||
23396989|NCT00776230|65199040|FG002|Overall Study|Lost to Follow-up|5|||
23396990|NCT00776230|65199038|FG000|Overall Study|Not vaccinated at Day 0|1|||
23396991|NCT00776230|65199039|FG001|Overall Study|Not vaccinated at Day 0|0|||
23396992|NCT00776230|65199040|FG002|Overall Study|Not vaccinated at Day 0|0|||
23396993|NCT00776230|65199038|FG000|Overall Study|Withdrawal by Subject|0|||
23396994|NCT00776230|65199039|FG001|Overall Study|Withdrawal by Subject|1|||
23396995|NCT00776230|65199040|FG002|Overall Study|Withdrawal by Subject|0|||
23695846|NCT00003641|66263666|FG000|Overall Study|Disease progression|0|||
23498628|NCT02296320|65566396|FG002|Overall Study|Death|27|||
23498629|NCT02296320|65566394|FG000|Overall Study|Lost to Follow-up|5|||
23695847|NCT00003641|66263667|FG001|Overall Study|Disease progression|2|||
23695848|NCT00003641|66263666|FG000|Overall Study|Unknown/missing|0|||
23695849|NCT00003641|66263667|FG001|Overall Study|Unknown/missing|22|||
23695850|NCT00003641|66263666|FG000|Overall Study|Should not receive interferon therapy|2|||
23695851|NCT00003641|66263667|FG001|Overall Study|Should not receive interferon therapy|0|||
23695852|NCT00003641|66263666|FG000|Overall Study|Never started interferon|567|||
23695853|NCT00003641|66263667|FG001|Overall Study|Never started interferon|12|||
23695854|NCT03894540|66263675|FG000|Overall Study|Adverse Event|0|||
23695855|NCT03894540|66263676|FG001|Overall Study|Adverse Event|0|||
23695856|NCT03894540|66263677|FG002|Overall Study|Adverse Event|0|||
23695857|NCT03894540|66263678|FG003|Overall Study|Adverse Event|0|||
23695858|NCT03894540|66263679|FG004|Overall Study|Adverse Event|1|||
23695859|NCT03894540|66263680|FG005|Overall Study|Adverse Event|0|||
23695860|NCT03894540|66263675|FG000|Overall Study|Withdrawal by Subject|0|||
23695861|NCT03894540|66263676|FG001|Overall Study|Withdrawal by Subject|0|||
23396996|NCT00776230|65199038|FG000|Overall Study|Subject missed Visit 4|0|||
23396997|NCT00776230|65199039|FG001|Overall Study|Subject missed Visit 4|1|||
23396998|NCT00776230|65199040|FG002|Overall Study|Subject missed Visit 4|0|||
23396999|NCT04138056|65199043|FG000|Primary Study|Lost to Follow-up|3|||
23397000|NCT04138056|65199044|FG001|Primary Study|Lost to Follow-up|4|||
23397001|NCT04138056|65199045|FG002|Primary Study|Lost to Follow-up|1|||
23397002|NCT04138056|65199046|FG003|Primary Study|Lost to Follow-up|1|||
23397003|NCT04138056|65199047|FG004|Primary Study|Lost to Follow-up|4|||
23397004|NCT04138056|65199043|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
23397005|NCT04138056|65199044|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
23397006|NCT04138056|65199045|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
23397007|NCT04138056|65199046|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
23397008|NCT04138056|65199047|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
23498630|NCT02296320|65566395|FG001|Overall Study|Lost to Follow-up|2|||
23695862|NCT03894540|66263677|FG002|Overall Study|Withdrawal by Subject|0|||
23695863|NCT03894540|66263678|FG003|Overall Study|Withdrawal by Subject|0|||
23695864|NCT03894540|66263679|FG004|Overall Study|Withdrawal by Subject|1|||
23695865|NCT03894540|66263680|FG005|Overall Study|Withdrawal by Subject|0|||
23397009|NCT04138056|65199043|FG000|Extension Study|Lost to Follow-up|1|||
23397010|NCT04138056|65199044|FG001|Extension Study|Lost to Follow-up|2|||
23397011|NCT04138056|65199045|FG002|Extension Study|Lost to Follow-up|1|||
23397012|NCT04138056|65199046|FG003|Extension Study|Lost to Follow-up|0|||
23397013|NCT04138056|65199047|FG004|Extension Study|Lost to Follow-up|1|||
23498631|NCT02296320|65566396|FG002|Overall Study|Lost to Follow-up|7|||
23397014|NCT03485157|65199048|FG000|Double Blind Phase|Lost to Follow-up|4|||
23695866|NCT03894540|66263675|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
23695867|NCT03894540|66263676|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
23695868|NCT03894540|66263677|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
23695869|NCT03894540|66263678|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
23695870|NCT03894540|66263679|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
23397015|NCT03485157|65199049|FG001|Double Blind Phase|Lost to Follow-up|4|||
23397016|NCT03485157|65199048|FG000|Double Blind Phase|Adverse Event|2|||
23397017|NCT03485157|65199049|FG001|Double Blind Phase|Adverse Event|1|||
23397018|NCT03485157|65199048|FG000|Double Blind Phase|Withdrawal by Subject|6|||
23397019|NCT03485157|65199049|FG001|Double Blind Phase|Withdrawal by Subject|9|||
23397020|NCT03485157|65199048|FG000|Double Blind Phase|Removal by PI|3|||
23397021|NCT03485157|65199049|FG001|Double Blind Phase|Removal by PI|7|||
23397022|NCT03485157|65199048|FG000|Open Label Phase|Lost to Follow-up|1|||
23397023|NCT03485157|65199049|FG001|Open Label Phase|Lost to Follow-up|2|||
23397024|NCT03485157|65199048|FG000|Open Label Phase|Adverse Event|0|||
23397025|NCT03485157|65199049|FG001|Open Label Phase|Adverse Event|1|||
23397026|NCT03485157|65199048|FG000|Open Label Phase|Withdrawal by Subject|1|||
23397027|NCT03485157|65199049|FG001|Open Label Phase|Withdrawal by Subject|2|||
23397028|NCT03485157|65199048|FG000|Open Label Phase|Removal by PI|2|||
23397029|NCT03485157|65199049|FG001|Open Label Phase|Removal by PI|0|||
23397030|NCT00523978|65199054|FG000|Overall Study|Withdrawal by Subject|3|||
23397031|NCT00523978|65199055|FG001|Overall Study|Withdrawal by Subject|7|||
23695871|NCT03894540|66263680|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
23695872|NCT03894540|66263675|FG000|Overall Study|Progressive Disease Clinical|1|||
23695873|NCT03894540|66263676|FG001|Overall Study|Progressive Disease Clinical|1|||
23695874|NCT03894540|66263677|FG002|Overall Study|Progressive Disease Clinical|0|||
23695875|NCT03894540|66263678|FG003|Overall Study|Progressive Disease Clinical|1|||
23695876|NCT03894540|66263679|FG004|Overall Study|Progressive Disease Clinical|5|||
23695877|NCT03894540|66263680|FG005|Overall Study|Progressive Disease Clinical|1|||
23695878|NCT03894540|66263675|FG000|Overall Study|Study termination by sponsor|0|||
23695879|NCT03894540|66263676|FG001|Overall Study|Study termination by sponsor|0|||
23695880|NCT03894540|66263677|FG002|Overall Study|Study termination by sponsor|0|||
23695881|NCT03894540|66263678|FG003|Overall Study|Study termination by sponsor|0|||
23695882|NCT03894540|66263679|FG004|Overall Study|Study termination by sponsor|2|||
23695883|NCT03894540|66263680|FG005|Overall Study|Study termination by sponsor|0|||
23695884|NCT00685178|66263681|FG000|Overall Study|Adverse Event|1|||
23695885|NCT00685178|66263682|FG001|Overall Study|Adverse Event|5|||
23695886|NCT00685178|66263683|FG002|Overall Study|Adverse Event|2|||
23695887|NCT00685178|66263684|FG003|Overall Study|Adverse Event|4|||
23695888|NCT00685178|66263681|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
23695889|NCT00685178|66263682|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
23695890|NCT00685178|66263683|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
23695891|NCT00685178|66263684|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
23397032|NCT00523978|65199054|FG000|Overall Study|Screen Failures|5|||
23397033|NCT00523978|65199055|FG001|Overall Study|Screen Failures|1|||
23397034|NCT00523978|65199054|FG000|Overall Study|Death|1|||
23397035|NCT00523978|65199055|FG001|Overall Study|Death|0|||
23397036|NCT02037529|65199056|FG000|Overall Study|Withdrawal by Subject|1|||
23397037|NCT02037529|65199057|FG001|Overall Study|Withdrawal by Subject|3|||
23397038|NCT02037529|65199056|FG000|Overall Study|Adverse Event|0|||
23397039|NCT02037529|65199057|FG001|Overall Study|Adverse Event|1|||
23397040|NCT00027560|65199060|FG000|Overall Study|Withdrawal by Subject|1|||
23397041|NCT00619866|65199061|FG000|Weeks 1 - 12|Adverse Event|0|||
23397042|NCT00619866|65199062|FG001|Weeks 1 - 12|Adverse Event|1|||
23397043|NCT00619866|65199063|FG002|Weeks 1 - 12|Adverse Event|2|||
23397044|NCT00619866|65199064|FG003|Weeks 1 - 12|Adverse Event|0|||
23397045|NCT00619866|65199065|FG004|Weeks 1 - 12|Adverse Event|0|||
23397046|NCT00619866|65199061|FG000|Weeks 1 - 12|Non-compliance|0|||
23397047|NCT00619866|65199062|FG001|Weeks 1 - 12|Non-compliance|0|||
23397048|NCT00619866|65199063|FG002|Weeks 1 - 12|Non-compliance|1|||
23498632|NCT02296320|65566394|FG000|Overall Study|Not treated|2|||
23498633|NCT02296320|65566395|FG001|Overall Study|Not treated|0|||
23498634|NCT02296320|65566396|FG002|Overall Study|Not treated|0|||
23397049|NCT00619866|65199064|FG003|Weeks 1 - 12|Non-compliance|0|||
23397050|NCT00619866|65199065|FG004|Weeks 1 - 12|Non-compliance|0|||
23397051|NCT00619866|65199061|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
23397052|NCT00619866|65199062|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
23397053|NCT00619866|65199063|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
23397054|NCT00619866|65199064|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
23397055|NCT00619866|65199065|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
23397056|NCT00619866|65199061|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
23498635|NCT02296320|65566394|FG000|Overall Study|Not - specified|0|||
23695892|NCT00685178|66263681|FG000|Overall Study|voluntary study discharge|4|||
23695893|NCT00685178|66263682|FG001|Overall Study|voluntary study discharge|5|||
23695894|NCT00685178|66263683|FG002|Overall Study|voluntary study discharge|1|||
23695895|NCT00685178|66263684|FG003|Overall Study|voluntary study discharge|1|||
23695896|NCT00685178|66263681|FG000|Overall Study|incarcerated|1|||
23695897|NCT00685178|66263682|FG001|Overall Study|incarcerated|3|||
23695898|NCT00685178|66263683|FG002|Overall Study|incarcerated|7|||
23695899|NCT00685178|66263684|FG003|Overall Study|incarcerated|0|||
23695900|NCT00685178|66263681|FG000|Overall Study|administrative (disciplinary) discharge|0|||
23695901|NCT00685178|66263682|FG001|Overall Study|administrative (disciplinary) discharge|1|||
23695902|NCT00685178|66263683|FG002|Overall Study|administrative (disciplinary) discharge|0|||
23695903|NCT00685178|66263684|FG003|Overall Study|administrative (disciplinary) discharge|2|||
23695904|NCT00685178|66263681|FG000|Overall Study|Pregnancy|0|||
23695905|NCT00685178|66263682|FG001|Overall Study|Pregnancy|0|||
23695906|NCT00685178|66263683|FG002|Overall Study|Pregnancy|0|||
23695907|NCT00685178|66263684|FG003|Overall Study|Pregnancy|1|||
23695908|NCT01635933|66263690|FG000|Overall Study|Adverse Event|1|||
23695909|NCT01635933|66263691|FG001|Overall Study|Adverse Event|0|||
23695910|NCT01635933|66263690|FG000|Overall Study|Lost to Follow-up|0|||
23695911|NCT01635933|66263691|FG001|Overall Study|Lost to Follow-up|5|||
23695912|NCT01635933|66263690|FG000|Overall Study|Subject decision|1|||
23695913|NCT01635933|66263691|FG001|Overall Study|Subject decision|1|||
23695914|NCT01635933|66263690|FG000|Overall Study|Noncompliance|0|||
23695915|NCT01635933|66263691|FG001|Overall Study|Noncompliance|1|||
23695916|NCT01635933|66263690|FG000|Overall Study|No longer had transportation|0|||
23695917|NCT01635933|66263691|FG001|Overall Study|No longer had transportation|1|||
23695918|NCT04083222|66263692|FG000|Overall Study|Voluntary Withdrawal|0|||
23695919|NCT04083222|66263693|FG001|Overall Study|Voluntary Withdrawal|1|||
23695920|NCT04083222|66263692|FG000|Overall Study|Reason not Specified|0|||
23695921|NCT04083222|66263693|FG001|Overall Study|Reason not Specified|1|||
23695922|NCT03941548|66263701|FG000|Overall Study|Adverse Event|0|||
23695923|NCT03941548|66263702|FG001|Overall Study|Adverse Event|1|||
23695924|NCT03941548|66263701|FG000|Overall Study|Lost to Follow-up|0|||
23695925|NCT03941548|66263702|FG001|Overall Study|Lost to Follow-up|1|||
23695926|NCT03941548|66263701|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
23695927|NCT03941548|66263702|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
23695928|NCT00793104|66263705|FG000|Overall Study|Lost to Follow-up|1|||
23695929|NCT02424539|66263706|FG000|Overall Study|Adverse Event|0|||
23695930|NCT02424539|66263707|FG001|Overall Study|Adverse Event|0|||
23695931|NCT02424539|66263708|FG002|Overall Study|Adverse Event|1|||
23695932|NCT02424539|66263706|FG000|Overall Study|Physician Decision|0|||
23695933|NCT02424539|66263707|FG001|Overall Study|Physician Decision|0|||
23695934|NCT02424539|66263708|FG002|Overall Study|Physician Decision|1|||
23695935|NCT02424539|66263706|FG000|Overall Study|Withdrawal by Subject|3|||
23695936|NCT02424539|66263707|FG001|Overall Study|Withdrawal by Subject|1|||
23695937|NCT02424539|66263708|FG002|Overall Study|Withdrawal by Subject|0|||
23695938|NCT02424539|66263706|FG000|Overall Study|Other: Reached stopping criteria|11|||
23695939|NCT02424539|66263707|FG001|Overall Study|Other: Reached stopping criteria|7|||
23695940|NCT02424539|66263708|FG002|Overall Study|Other: Reached stopping criteria|6|||
23695941|NCT00492921|66263709|FG000|Overall Study|Death|1|||
23695942|NCT00492921|66263710|FG001|Overall Study|Death|0|||
23695943|NCT00492921|66263711|FG002|Overall Study|Death|1|||
23695944|NCT03429556|66263712|FG000|Overall Study|Lost to Follow-up|0|||
23695945|NCT03429556|66263713|FG001|Overall Study|Lost to Follow-up|1|||
23695946|NCT03429556|66263714|FG002|Overall Study|Lost to Follow-up|0|||
23695947|NCT03429556|66263715|FG003|Overall Study|Lost to Follow-up|0|||
23695948|NCT03067311|66263720|FG000|Overall Study|Lost to Follow-up|1|||
23695949|NCT03067311|66263721|FG001|Overall Study|Lost to Follow-up|1|||
23695950|NCT03067311|66263720|FG000|Overall Study|Moved away|1|||
23695951|NCT03067311|66263721|FG001|Overall Study|Moved away|1|||
23695952|NCT03060577|66263725|FG000|Overall Study|Withdrawal by Subject|25|||
23695953|NCT03060577|66263726|FG001|Overall Study|Withdrawal by Subject|5|||
23695954|NCT03060577|66263725|FG000|Overall Study|Physician Decision|4|||
23695955|NCT03060577|66263726|FG001|Overall Study|Physician Decision|3|||
23695956|NCT03060577|66263725|FG000|Overall Study|Lost to Follow-up|3|||
23695957|NCT03060577|66263726|FG001|Overall Study|Lost to Follow-up|0|||
23695958|NCT03060577|66263725|FG000|Overall Study|Death|7|||
23695959|NCT03060577|66263726|FG001|Overall Study|Death|1|||
23695960|NCT03060577|66263725|FG000|Overall Study|Adverse Event|9|||
23695961|NCT03060577|66263726|FG001|Overall Study|Adverse Event|1|||
23695962|NCT03060577|66263725|FG000|Overall Study|Inclusion/Exclusion|1|||
23695963|NCT03060577|66263726|FG001|Overall Study|Inclusion/Exclusion|0|||
23695964|NCT03060577|66263725|FG000|Overall Study|Other|8|||
23695965|NCT03060577|66263726|FG001|Overall Study|Other|2|||
23695966|NCT04332419|66263728|FG000|Overall Study|Withdrawal by Subject|1|||
23695967|NCT01520922|66263731|FG000|Treatment Phase|Physician Decision|2|||
23695968|NCT01520922|66263732|FG001|Treatment Phase|Physician Decision|1|||
23695969|NCT01520922|66263731|FG000|Treatment Phase|Progression|0|||
23695970|NCT01520922|66263732|FG001|Treatment Phase|Progression|2|||
23695971|NCT01520922|66263731|FG000|Treatment Phase|Adverse Event|3|||
23695972|NCT01520922|66263732|FG001|Treatment Phase|Adverse Event|5|||
23695973|NCT01520922|66263731|FG000|Follow up|Lost to Follow-up|0|||
23695974|NCT01520922|66263732|FG001|Follow up|Lost to Follow-up|1|||
23695975|NCT01520922|66263731|FG000|Survival Follow-up|Withdrawal by Subject|1|||
23695976|NCT01520922|66263732|FG001|Survival Follow-up|Withdrawal by Subject|0|||
23695977|NCT01570491|66263735|FG000|Overall Study|Lost to Follow-up|3|||
23695978|NCT01570491|66263736|FG001|Overall Study|Lost to Follow-up|1|||
23695979|NCT01570491|66263735|FG000|Overall Study|treatment: not given or discontinued|2|||
23695980|NCT01570491|66263736|FG001|Overall Study|treatment: not given or discontinued|0|||
23695981|NCT02714205|66263737|FG000|Overall Study|Cannot tolerate medication|1|||
23695982|NCT02714205|66263738|FG001|Overall Study|Cannot tolerate medication|0|||
23695983|NCT02714205|66263737|FG000|Overall Study|Adverse Event|2|||
23695984|NCT02714205|66263738|FG001|Overall Study|Adverse Event|0|||
23695985|NCT02714205|66263737|FG000|Overall Study|Too busy|1|||
23695986|NCT02714205|66263738|FG001|Overall Study|Too busy|0|||
23695987|NCT02714205|66263737|FG000|Overall Study|Incomplete outcome data|0|||
23695988|NCT02714205|66263738|FG001|Overall Study|Incomplete outcome data|1|||
23695989|NCT00947154|66263740|FG000|Overall Study|Lost to Follow-up|1|||
23695990|NCT01457339|66263741|FG000|Period 3 (100 mg)|Adverse Event|0|||
23695991|NCT01457339|66263742|FG001|Period 3 (100 mg)|Adverse Event|1|||
23695992|NCT01457339|66263741|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
23695993|NCT01457339|66263742|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
23695994|NCT01457339|66263741|FG000|Period 6 (250 mg)|Family Emergency|1|||
23695995|NCT01457339|66263742|FG001|Period 6 (250 mg)|Family Emergency|0|||
23695996|NCT01457339|66263741|FG000|Period 6 (250 mg)|Personal appointment|0|||
23695997|NCT01457339|66263742|FG001|Period 6 (250 mg)|Personal appointment|1|||
23695998|NCT00971321|66263744|FG000|Up to Month 7|Withdrawal by Subject|1|||
23695999|NCT00971321|66263745|FG001|Up to Month 7|Withdrawal by Subject|0|||
23696000|NCT00971321|66263744|FG000|Up to Month 7|Migrated/moved from study area|3|||
23696001|NCT00971321|66263745|FG001|Up to Month 7|Migrated/moved from study area|2|||
23696002|NCT00971321|66263744|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
23696003|NCT00971321|66263745|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
23696004|NCT00971321|66263744|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
23696005|NCT00971321|66263745|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
23696006|NCT00971321|66263744|FG000|Up to Month 11-12|Lost to Follow-up|1|||
23696007|NCT00971321|66263745|FG001|Up to Month 11-12|Lost to Follow-up|0|||
23696008|NCT00852930|66263746|FG000|Overall Study|Withdrawal by Subject|1|||
23696009|NCT00852930|66263747|FG001|Overall Study|Withdrawal by Subject|1|||
23696010|NCT00852930|66263748|FG002|Overall Study|Withdrawal by Subject|1|||
23696011|NCT00852930|66263746|FG000|Overall Study|Physician Decision|0|||
23696012|NCT00852930|66263747|FG001|Overall Study|Physician Decision|0|||
23696013|NCT00852930|66263748|FG002|Overall Study|Physician Decision|1|||
23696014|NCT01821963|66263750|FG000|Overall Study|Adverse Event|1|||
23696015|NCT00283712|66263752|FG000|Overall Study|Death|0|||
23696016|NCT00283712|66263753|FG001|Overall Study|Death|1|||
23696017|NCT00673673|66263754|FG000|Overall Study|Progressive disease|27|||
23696018|NCT00673673|66263754|FG000|Overall Study|Adverse Event|4|||
23696019|NCT00673673|66263754|FG000|Overall Study|Withdrawal by Subject|3|||
23696020|NCT00673673|66263754|FG000|Overall Study|Investigators' discretion|2|||
23696021|NCT00550238|66263755|FG000|Overall Study|Adverse Event|88|||
23696022|NCT00550238|66263755|FG000|Overall Study|Death|34|||
23696023|NCT00550238|66263755|FG000|Overall Study|Disease progression|46|||
23696024|NCT00550238|66263755|FG000|Overall Study|Withdrawal by Subject|167|||
23696025|NCT00550238|66263755|FG000|Overall Study|Physician Decision|31|||
23696026|NCT00550238|66263755|FG000|Overall Study|Patient noncompliance|25|||
23696027|NCT00550238|66263755|FG000|Overall Study|Lost to Follow-up|13|||
23696028|NCT00550238|66263755|FG000|Overall Study|Sponsor decision|55|||
23696029|NCT00964795|66263756|FG000|Overall Study|Withdrawal by Subject|79|||
23696030|NCT00964795|66263756|FG000|Overall Study|Adverse Event|12|||
23696031|NCT00964795|66263756|FG000|Overall Study|Death|14|||
23696032|NCT00964795|66263756|FG000|Overall Study|Lost to Follow-up|7|||
23696033|NCT00964795|66263756|FG000|Overall Study|Termination of Study by Sponsor|169|||
23696034|NCT00964795|66263756|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
23696035|NCT00964795|66263756|FG000|Overall Study|Other|23|||
23696036|NCT00969618|66263759|FG000|Overall Study|Adverse Event|29|||
23696037|NCT00969618|66263759|FG000|Overall Study|Entry Criteria Not Met|3|||
23696038|NCT00969618|66263759|FG000|Overall Study|Lack of Efficacy|2|||
23696039|NCT00969618|66263759|FG000|Overall Study|Lost to Follow-up|7|||
23696040|NCT00969618|66263759|FG000|Overall Study|Physician Decision|1|||
23696041|NCT00969618|66263759|FG000|Overall Study|Protocol Violation|9|||
23696042|NCT00969618|66263759|FG000|Overall Study|Withdrawal by Subject|27|||
23696043|NCT02032875|66263761|FG000|Treatment Period|Adverse Event|1|||
23696044|NCT02032875|66263762|FG001|Treatment Period|Adverse Event|0|||
23696045|NCT02032875|66263761|FG000|Treatment Period|Liver transplant, No extension needed|0|||
23696046|NCT02032875|66263762|FG001|Treatment Period|Liver transplant, No extension needed|1|||
23696047|NCT02032875|66263761|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
23696048|NCT02032875|66263762|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
23696049|NCT02032875|66263761|FG000|Follow-up Period|Death|0|||
23696050|NCT02032875|66263762|FG001|Follow-up Period|Death|1|||
23696051|NCT02032875|66263761|FG000|Follow-up Period|Virologic Relapse|3|||
23696052|NCT02032875|66263762|FG001|Follow-up Period|Virologic Relapse|10|||
23696053|NCT01707147|66263769|FG000|Overall Study|Administered Trajenta prior to contract|5|||
23397057|NCT00619866|65199062|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
23397058|NCT00619866|65199063|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
23397059|NCT00619866|65199064|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
23397060|NCT00619866|65199065|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
23397061|NCT00619866|65199061|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
23397062|NCT00619866|65199062|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
23397063|NCT00619866|65199063|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
23397064|NCT00619866|65199064|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
23397065|NCT00619866|65199065|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
23397066|NCT00619866|65199061|FG000|Weeks 1 - 12|Sponsor Decision|0|||
23397067|NCT00619866|65199062|FG001|Weeks 1 - 12|Sponsor Decision|1|||
23397068|NCT00619866|65199063|FG002|Weeks 1 - 12|Sponsor Decision|0|||
23397069|NCT00619866|65199064|FG003|Weeks 1 - 12|Sponsor Decision|0|||
23696054|NCT01707147|66263769|FG000|Overall Study|Patients who have not taken Trajenta|1|||
23696055|NCT01707147|66263769|FG000|Overall Study|Follow-up failure|17|||
23696056|NCT01707147|66263769|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
23696057|NCT02725177|66263777|FG000|Overall Study|Physician Decision|4|||
23696058|NCT02725177|66263777|FG000|Overall Study|Adverse Event|1|||
23696059|NCT00474253|66263778|FG000|Overall Study|Withdrew consent|2|||
23696060|NCT00474253|66263779|FG001|Overall Study|Withdrew consent|0|||
23696061|NCT00474253|66263778|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
23696062|NCT00474253|66263779|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
23696063|NCT00474253|66263778|FG000|Overall Study|Lost to Follow-up|1|||
23696064|NCT00474253|66263779|FG001|Overall Study|Lost to Follow-up|0|||
23696065|NCT00474253|66263778|FG000|Overall Study|Discharged prior to study completion|0|||
23696066|NCT00474253|66263779|FG001|Overall Study|Discharged prior to study completion|1|||
23696067|NCT02345161|66263784|FG000|Overall Study|Withdrawal by Subject|25|||
23696068|NCT02345161|66263785|FG001|Overall Study|Withdrawal by Subject|33|||
23696069|NCT02345161|66263784|FG000|Overall Study|Adverse Event|16|||
23696070|NCT02345161|66263785|FG001|Overall Study|Adverse Event|19|||
23397070|NCT00619866|65199065|FG004|Weeks 1 - 12|Sponsor Decision|0|||
23397071|NCT00619866|65199061|FG000|Weeks 13 - 24|Adverse Event|0|||
23397072|NCT00619866|65199062|FG001|Weeks 13 - 24|Adverse Event|0|||
23397073|NCT00619866|65199063|FG002|Weeks 13 - 24|Adverse Event|2|||
23397074|NCT00619866|65199064|FG003|Weeks 13 - 24|Adverse Event|1|||
23397075|NCT00619866|65199065|FG004|Weeks 13 - 24|Adverse Event|0|||
23397076|NCT00619866|65199061|FG000|Weeks 13 - 24|Protocol Deviation|0|||
23397077|NCT00619866|65199062|FG001|Weeks 13 - 24|Protocol Deviation|0|||
23397078|NCT00619866|65199063|FG002|Weeks 13 - 24|Protocol Deviation|0|||
23397079|NCT00619866|65199064|FG003|Weeks 13 - 24|Protocol Deviation|1|||
23397080|NCT00619866|65199065|FG004|Weeks 13 - 24|Protocol Deviation|0|||
23397081|NCT00619866|65199061|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
23397082|NCT00619866|65199062|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
23397083|NCT00619866|65199063|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
23397084|NCT00619866|65199064|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
23397085|NCT00619866|65199065|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
23397086|NCT00619866|65199061|FG000|Weeks 13 - 24|Non-compliance|0|||
23397087|NCT00619866|65199062|FG001|Weeks 13 - 24|Non-compliance|1|||
23397088|NCT00619866|65199063|FG002|Weeks 13 - 24|Non-compliance|1|||
23397089|NCT00619866|65199064|FG003|Weeks 13 - 24|Non-compliance|0|||
23397090|NCT00619866|65199065|FG004|Weeks 13 - 24|Non-compliance|0|||
23397091|NCT00619866|65199061|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
23397092|NCT00619866|65199062|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
23397093|NCT00619866|65199063|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
23397094|NCT00619866|65199064|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
23397095|NCT00619866|65199065|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
23397096|NCT00474903|65199066|FG000|Overall Study|Protocol Violation|1|||
23397097|NCT00474903|65199067|FG001|Overall Study|Protocol Violation|5|||
23397098|NCT00474903|65199068|FG002|Overall Study|Protocol Violation|2|||
23397099|NCT01073293|65199071|FG000|Overall Study|Lost to Follow-up|0|||
23696071|NCT02345161|66263784|FG000|Overall Study|Physician Decision|4|||
23696072|NCT02345161|66263785|FG001|Overall Study|Physician Decision|4|||
23397100|NCT01073293|65199072|FG001|Overall Study|Lost to Follow-up|1|||
23397101|NCT01073293|65199071|FG000|Overall Study|Withdrawal by Subject|5|||
23397102|NCT01073293|65199072|FG001|Overall Study|Withdrawal by Subject|10|||
23397103|NCT02367456|65199073|FG000|Overall Study|Death|8|||
23397104|NCT02367456|65199074|FG001|Overall Study|Death|24|||
23397105|NCT02367456|65199075|FG002|Overall Study|Death|17|||
23397106|NCT02367456|65199073|FG000|Overall Study|Lost to Follow-up|1|||
23397107|NCT02367456|65199074|FG001|Overall Study|Lost to Follow-up|3|||
23696073|NCT02345161|66263784|FG000|Overall Study|Lost to Follow-up|0|||
23696074|NCT02345161|66263785|FG001|Overall Study|Lost to Follow-up|1|||
23696075|NCT00624338|66263786|FG000|Overall Study|Adverse Event|14|||
23696076|NCT00624338|66263787|FG001|Overall Study|Adverse Event|14|||
23696077|NCT00624338|66263788|FG002|Overall Study|Adverse Event|18|||
23696078|NCT00624338|66263786|FG000|Overall Study|Lost to Follow-up|1|||
23696079|NCT00624338|66263787|FG001|Overall Study|Lost to Follow-up|0|||
23696080|NCT00624338|66263788|FG002|Overall Study|Lost to Follow-up|0|||
23696081|NCT00624338|66263786|FG000|Overall Study|Lack of Efficacy|11|||
23696082|NCT00624338|66263787|FG001|Overall Study|Lack of Efficacy|3|||
23696083|NCT00624338|66263788|FG002|Overall Study|Lack of Efficacy|14|||
23696084|NCT00624338|66263786|FG000|Overall Study|Protocol Violation|3|||
23696085|NCT00624338|66263787|FG001|Overall Study|Protocol Violation|3|||
23696086|NCT00624338|66263788|FG002|Overall Study|Protocol Violation|2|||
23696087|NCT00624338|66263786|FG000|Overall Study|Death|0|||
23696088|NCT00624338|66263787|FG001|Overall Study|Death|2|||
23696089|NCT00624338|66263788|FG002|Overall Study|Death|0|||
23696090|NCT00624338|66263786|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
23696091|NCT00624338|66263787|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
23696092|NCT00624338|66263788|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
23696093|NCT00624338|66263786|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
23696094|NCT00624338|66263787|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
23696095|NCT00624338|66263788|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
23696096|NCT00624338|66263786|FG000|Overall Study|Other|15|||
23696097|NCT00624338|66263787|FG001|Overall Study|Other|5|||
23696098|NCT00624338|66263788|FG002|Overall Study|Other|9|||
23696099|NCT00624338|66263786|FG000|Overall Study|Randomized but not treated|2|||
23696100|NCT00624338|66263787|FG001|Overall Study|Randomized but not treated|1|||
23696101|NCT00624338|66263788|FG002|Overall Study|Randomized but not treated|3|||
23696102|NCT00091793|66263791|FG000|Overall Study|Adverse Event|1|||
23696103|NCT00091793|66263792|FG001|Overall Study|Adverse Event|2|||
23696104|NCT00091793|66263791|FG000|Overall Study|Withdrawal by Subject|10|||
23696105|NCT00091793|66263792|FG001|Overall Study|Withdrawal by Subject|15|||
23696106|NCT00091793|66263791|FG000|Overall Study|Ineligibility determined|2|||
23696107|NCT00091793|66263792|FG001|Overall Study|Ineligibility determined|0|||
23696108|NCT00091793|66263791|FG000|Overall Study|Lost to Follow-up|7|||
23696109|NCT00091793|66263792|FG001|Overall Study|Lost to Follow-up|5|||
23696110|NCT00091793|66263791|FG000|Overall Study|Noncompliance|2|||
23696111|NCT00091793|66263792|FG001|Overall Study|Noncompliance|0|||
23696112|NCT00091793|66263791|FG000|Overall Study|Other|2|||
23696113|NCT00091793|66263792|FG001|Overall Study|Other|0|||
23696114|NCT03133481|66263793|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
23696115|NCT03133481|66263794|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
23696116|NCT01041573|66263798|FG000|Overall Study|Withdrawal by Subject|2|||
23696117|NCT01041573|66263799|FG001|Overall Study|Withdrawal by Subject|5|||
23696118|NCT01041573|66263800|FG002|Overall Study|Withdrawal by Subject|2|||
23696119|NCT01041573|66263801|FG003|Overall Study|Withdrawal by Subject|0|||
23696120|NCT01041573|66263798|FG000|Overall Study|Death|1|||
23696121|NCT01041573|66263799|FG001|Overall Study|Death|0|||
23696122|NCT01041573|66263800|FG002|Overall Study|Death|0|||
23696123|NCT01041573|66263801|FG003|Overall Study|Death|0|||
23696124|NCT01041573|66263798|FG000|Overall Study|Lost to Follow-up|0|||
23696125|NCT01041573|66263799|FG001|Overall Study|Lost to Follow-up|1|||
23696126|NCT01041573|66263800|FG002|Overall Study|Lost to Follow-up|2|||
23696127|NCT01041573|66263801|FG003|Overall Study|Lost to Follow-up|1|||
23696128|NCT01041573|66263798|FG000|Overall Study|Adverse Event|0|||
23696129|NCT01041573|66263799|FG001|Overall Study|Adverse Event|2|||
23696130|NCT01041573|66263800|FG002|Overall Study|Adverse Event|0|||
23696131|NCT01041573|66263801|FG003|Overall Study|Adverse Event|0|||
23696132|NCT01041573|66263798|FG000|Overall Study|relocation|1|||
23696133|NCT01041573|66263799|FG001|Overall Study|relocation|4|||
23696134|NCT01041573|66263800|FG002|Overall Study|relocation|3|||
23696135|NCT01041573|66263801|FG003|Overall Study|relocation|1|||
23696136|NCT01041573|66263798|FG000|Overall Study|further blood extraction|0|||
23498636|NCT02296320|65566395|FG001|Overall Study|Not - specified|0|||
23696137|NCT01041573|66263799|FG001|Overall Study|further blood extraction|1|||
23696138|NCT01041573|66263800|FG002|Overall Study|further blood extraction|0|||
23696139|NCT01041573|66263801|FG003|Overall Study|further blood extraction|0|||
23696140|NCT01041573|66263798|FG000|Overall Study|positive to anti-HCV|1|||
23696141|NCT01041573|66263799|FG001|Overall Study|positive to anti-HCV|0|||
23696142|NCT01041573|66263800|FG002|Overall Study|positive to anti-HCV|0|||
23696143|NCT01041573|66263801|FG003|Overall Study|positive to anti-HCV|0|||
23696144|NCT00072189|66263802|FG000|Overall Study|Withdrawal by Subject|1|||
23696145|NCT04786210|66263803|FG000|Overall Study|Lost to Follow-up|2|||
23696146|NCT04786210|66263803|FG000|Overall Study|Withdrawal by Subject|4|||
23696147|NCT03607682|66263806|FG000|Overall Study|Withdrawal by Subject|1|||
23696148|NCT03607682|66263806|FG000|Overall Study|Disease progression|1|||
23696149|NCT04382651|66263813|FG000|Overall Study|Death|26|||
23696150|NCT04382651|66263814|FG001|Overall Study|Death|23|||
23696151|NCT04382651|66263813|FG000|Overall Study|Lost to Follow-up|3|||
23696152|NCT04382651|66263814|FG001|Overall Study|Lost to Follow-up|4|||
23696153|NCT04382651|66263813|FG000|Overall Study|Withdrawal by Subject|2|||
23397108|NCT02367456|65199075|FG002|Overall Study|Lost to Follow-up|1|||
23397109|NCT02367456|65199073|FG000|Overall Study|Other reason|3|||
23397110|NCT02367456|65199074|FG001|Overall Study|Other reason|3|||
23397111|NCT02367456|65199075|FG002|Overall Study|Other reason|9|||
23397112|NCT02367456|65199073|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
23397113|NCT02367456|65199074|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
23397114|NCT02367456|65199075|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
23397115|NCT01936831|65199084|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23696154|NCT04382651|66263814|FG001|Overall Study|Withdrawal by Subject|0|||
23696155|NCT04382651|66263813|FG000|Overall Study|Physician Decision|0|||
23696156|NCT04382651|66263814|FG001|Overall Study|Physician Decision|1|||
23696157|NCT01824602|66263815|FG000|Overall Study|Withdrawal by Subject|0|||
23696158|NCT01824602|66263816|FG001|Overall Study|Withdrawal by Subject|0|||
23696159|NCT01824602|66263817|FG002|Overall Study|Withdrawal by Subject|1|||
23696160|NCT01824602|66263818|FG003|Overall Study|Withdrawal by Subject|2|||
23696161|NCT01824602|66263815|FG000|Overall Study|Patient non-compliance|0|||
23696162|NCT01824602|66263816|FG001|Overall Study|Patient non-compliance|0|||
23696163|NCT01824602|66263817|FG002|Overall Study|Patient non-compliance|1|||
23696164|NCT01824602|66263818|FG003|Overall Study|Patient non-compliance|0|||
23696165|NCT01824602|66263815|FG000|Overall Study|Adverse Event|1|||
23397116|NCT01936831|65199085|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397117|NCT01936831|65199086|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397118|NCT01936831|65199087|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397119|NCT01936831|65199088|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23498637|NCT02296320|65566396|FG002|Overall Study|Not - specified|1|||
23498638|NCT03607487|65566401|FG000|Overall Study|Withdrawal by Subject|2|||
23498639|NCT03607487|65566402|FG001|Overall Study|Withdrawal by Subject|0|||
23498640|NCT03607487|65566403|FG002|Overall Study|Withdrawal by Subject|0|||
23696166|NCT01824602|66263816|FG001|Overall Study|Adverse Event|0|||
23696167|NCT01824602|66263817|FG002|Overall Study|Adverse Event|2|||
23696168|NCT01824602|66263818|FG003|Overall Study|Adverse Event|2|||
23696169|NCT01824602|66263815|FG000|Overall Study|Treatment failure|0|||
23696170|NCT01824602|66263816|FG001|Overall Study|Treatment failure|0|||
23696171|NCT01824602|66263817|FG002|Overall Study|Treatment failure|0|||
23696172|NCT01824602|66263818|FG003|Overall Study|Treatment failure|1|||
23696173|NCT01618656|66263830|FG000|Overall Study|Withdrawal by Subject|7|||
23696174|NCT01618656|66263831|FG001|Overall Study|Withdrawal by Subject|3|||
23696175|NCT01618656|66263830|FG000|Overall Study|Physician Decision|1|||
23696176|NCT01618656|66263831|FG001|Overall Study|Physician Decision|1|||
23696177|NCT03937986|66263832|FG000|Overall Study|COVID-19 Pandemic|1|||
23696178|NCT01736683|66263833|FG000|Overall Study|Disease Relapse|0|||
23696179|NCT01736683|66263834|FG001|Overall Study|Disease Relapse|0|||
23696180|NCT01736683|66263835|FG002|Overall Study|Disease Relapse|2|||
23696181|NCT01736683|66263836|FG003|Overall Study|Disease Relapse|1|||
23696182|NCT01736683|66263837|FG004|Overall Study|Disease Relapse|0|||
23696183|NCT01736683|66263833|FG000|Overall Study|Adverse Event|0|||
23696184|NCT01736683|66263834|FG001|Overall Study|Adverse Event|2|||
23696185|NCT01736683|66263835|FG002|Overall Study|Adverse Event|2|||
23696186|NCT01736683|66263836|FG003|Overall Study|Adverse Event|3|||
23696187|NCT01736683|66263837|FG004|Overall Study|Adverse Event|2|||
23696188|NCT01736683|66263833|FG000|Overall Study|Withdrawal by Subject|0|||
23696189|NCT01736683|66263834|FG001|Overall Study|Withdrawal by Subject|0|||
23696190|NCT01736683|66263835|FG002|Overall Study|Withdrawal by Subject|3|||
23696191|NCT01736683|66263836|FG003|Overall Study|Withdrawal by Subject|1|||
23696192|NCT01736683|66263837|FG004|Overall Study|Withdrawal by Subject|1|||
23696193|NCT01736683|66263833|FG000|Overall Study|Lack of Therapeutic Effect|7|||
23696194|NCT01736683|66263834|FG001|Overall Study|Lack of Therapeutic Effect|4|||
23696195|NCT01736683|66263835|FG002|Overall Study|Lack of Therapeutic Effect|13|||
23696196|NCT01736683|66263836|FG003|Overall Study|Lack of Therapeutic Effect|20|||
23696197|NCT01736683|66263837|FG004|Overall Study|Lack of Therapeutic Effect|1|||
23696198|NCT01736683|66263833|FG000|Overall Study|Progressive Disease|0|||
23696199|NCT01736683|66263834|FG001|Overall Study|Progressive Disease|0|||
23397120|NCT01936831|65199089|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
23696200|NCT01736683|66263835|FG002|Overall Study|Progressive Disease|0|||
23696201|NCT01736683|66263836|FG003|Overall Study|Progressive Disease|1|||
23498641|NCT03607487|65566404|FG003|Overall Study|Withdrawal by Subject|1|||
23498642|NCT00724932|65566409|FG000|Overall Study|Lost to Follow-up|1|||
23498643|NCT00724932|65566410|FG001|Overall Study|Lost to Follow-up|0|||
23696202|NCT01736683|66263837|FG004|Overall Study|Progressive Disease|0|||
23696203|NCT01736683|66263833|FG000|Overall Study|Other|0|||
23696204|NCT01736683|66263834|FG001|Overall Study|Other|0|||
23696205|NCT01736683|66263835|FG002|Overall Study|Other|1|||
23696206|NCT01736683|66263836|FG003|Overall Study|Other|9|||
23696207|NCT01736683|66263837|FG004|Overall Study|Other|1|||
23696208|NCT00858832|66263838|FG000|Overall Study|became ineligible: delivered vaginally|1|||
23696209|NCT00858832|66263839|FG001|Overall Study|became ineligible: delivered vaginally|0|||
23696210|NCT00858832|66263838|FG000|Overall Study|Adverse Event|0|||
23696211|NCT00858832|66263839|FG001|Overall Study|Adverse Event|1|||
23696212|NCT00035815|66263840|FG000|Overall Study|Withdrawal by Subject|17|||
23696213|NCT00035815|66263841|FG001|Overall Study|Withdrawal by Subject|11|||
23696214|NCT03575468|66263845|FG000|Overall Study|Withdrawal by Subject|3|||
23696215|NCT03575468|66263846|FG001|Overall Study|Withdrawal by Subject|0|||
23696216|NCT03575468|66263845|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
23696217|NCT03575468|66263846|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
23696218|NCT03575468|66263845|FG000|Overall Study|Lost to Follow-up|13|||
23696219|NCT03575468|66263846|FG001|Overall Study|Lost to Follow-up|17|||
23696220|NCT02515669|66263847|FG000|228 Week Open-Label Phase|Other|0|||
23696221|NCT02515669|66263848|FG001|228 Week Open-Label Phase|Other|0|||
23696222|NCT02515669|66263849|FG002|228 Week Open-Label Phase|Other|1|||
23696223|NCT02515669|66263850|FG003|228 Week Open-Label Phase|Other|4|||
23696224|NCT02515669|66263847|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
23696225|NCT02515669|66263848|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
23696226|NCT02515669|66263849|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
23696227|NCT02515669|66263850|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
23696228|NCT02515669|66263847|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
23696229|NCT02515669|66263848|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
23696230|NCT02515669|66263849|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
23696231|NCT02515669|66263850|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
23696232|NCT02515669|66263847|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
23696233|NCT02515669|66263848|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
23696234|NCT02515669|66263849|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
23696235|NCT02515669|66263850|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
23696236|NCT02515669|66263847|FG000|228 Week Open-Label Phase|Missing|0|||
23696237|NCT02515669|66263848|FG001|228 Week Open-Label Phase|Missing|2|||
23696238|NCT02515669|66263849|FG002|228 Week Open-Label Phase|Missing|2|||
23696239|NCT02515669|66263850|FG003|228 Week Open-Label Phase|Missing|2|||
23696240|NCT03228186|66263853|FG000|Overall Study|Patient never started treatment|1|||
23696241|NCT00686205|66263854|FG000|Overall Study|Protocol Violation|127|||
23696242|NCT00686205|66263855|FG001|Overall Study|Protocol Violation|0|||
23696243|NCT00686205|66263854|FG000|Overall Study|Withdrawal by Subject|2|||
23696244|NCT00686205|66263855|FG001|Overall Study|Withdrawal by Subject|0|||
23696245|NCT00686205|66263854|FG000|Overall Study|Specimen handling procedure altered|5878|||
23696246|NCT00686205|66263855|FG001|Overall Study|Specimen handling procedure altered|0|||
23696247|NCT00686205|66263854|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
23696248|NCT00686205|66263855|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
23696249|NCT02522481|66263856|FG000|Overall Study|discontinued|1|||
23696250|NCT02522481|66263856|FG000|Overall Study|Not dosed|2|||
23696251|NCT00753922|66263857|FG000|Overall Study|Lost to Follow-up|155|||
23696252|NCT00753922|66263858|FG001|Overall Study|Lost to Follow-up|24|||
23696253|NCT00753922|66263859|FG002|Overall Study|Lost to Follow-up|28|||
23696254|NCT00753922|66263860|FG003|Overall Study|Lost to Follow-up|5|||
23696255|NCT00753922|66263857|FG000|Overall Study|Withdrawal by Subject|9|||
23696256|NCT00753922|66263858|FG001|Overall Study|Withdrawal by Subject|11|||
23696257|NCT00753922|66263859|FG002|Overall Study|Withdrawal by Subject|4|||
23696258|NCT00753922|66263860|FG003|Overall Study|Withdrawal by Subject|2|||
23696259|NCT00753922|66263857|FG000|Overall Study|Patient Non-compliance|55|||
23696260|NCT00753922|66263858|FG001|Overall Study|Patient Non-compliance|22|||
23696261|NCT00753922|66263859|FG002|Overall Study|Patient Non-compliance|14|||
23696262|NCT00753922|66263860|FG003|Overall Study|Patient Non-compliance|11|||
23696263|NCT00753922|66263857|FG000|Overall Study|Patients Not Completing Visit|11|||
23696264|NCT00753922|66263858|FG001|Overall Study|Patients Not Completing Visit|0|||
23696265|NCT00753922|66263859|FG002|Overall Study|Patients Not Completing Visit|1|||
23696266|NCT00753922|66263860|FG003|Overall Study|Patients Not Completing Visit|0|||
23696267|NCT00753922|66263857|FG000|Overall Study|Death|2|||
23696268|NCT00753922|66263858|FG001|Overall Study|Death|23|||
23696269|NCT00753922|66263859|FG002|Overall Study|Death|2|||
23696270|NCT00753922|66263860|FG003|Overall Study|Death|1|||
23696271|NCT00753922|66263857|FG000|Overall Study|Discontinuation Due to Explantation|14|||
23696272|NCT00753922|66263858|FG001|Overall Study|Discontinuation Due to Explantation|14|||
23696273|NCT00753922|66263859|FG002|Overall Study|Discontinuation Due to Explantation|14|||
23696274|NCT00753922|66263860|FG003|Overall Study|Discontinuation Due to Explantation|4|||
23696275|NCT01614457|66263861|FG000|Overall Study|Non-Compliance|1|||
23696276|NCT01614457|66263862|FG001|Overall Study|Non-Compliance|0|||
23696277|NCT01614457|66263861|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
23696278|NCT01614457|66263862|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
23696279|NCT01326962|66266531|FG000|Overall Study|Adverse Event|1|||
23696280|NCT01326962|66266531|FG000|Overall Study|Withdrawal by Subject|1|||
23696281|NCT01326962|66266531|FG000|Overall Study|Lost to Follow-up|3|||
23696282|NCT01326962|66266531|FG000|Overall Study|Other|2|||
23696283|NCT00642616|66266540|FG000|Overall Study|Adverse Event|2|||
23696284|NCT00642616|66266541|FG001|Overall Study|Adverse Event|0|||
23696285|NCT00642616|66266542|FG002|Overall Study|Adverse Event|1|||
23696286|NCT00642616|66266543|FG003|Overall Study|Adverse Event|0|||
23696287|NCT00642616|66266540|FG000|Overall Study|Study Terminated by Sponsor|7|||
23696288|NCT00642616|66266541|FG001|Overall Study|Study Terminated by Sponsor|6|||
23696289|NCT00642616|66266542|FG002|Overall Study|Study Terminated by Sponsor|4|||
23696290|NCT00642616|66266543|FG003|Overall Study|Study Terminated by Sponsor|5|||
23696291|NCT00642616|66266540|FG000|Overall Study|Withdrawal by Subject|0|||
23696292|NCT00642616|66266541|FG001|Overall Study|Withdrawal by Subject|1|||
23696293|NCT00642616|66266542|FG002|Overall Study|Withdrawal by Subject|1|||
23696294|NCT00642616|66266543|FG003|Overall Study|Withdrawal by Subject|1|||
23696295|NCT00642616|66266540|FG000|Overall Study|Protocol Violation|0|||
23696296|NCT00642616|66266541|FG001|Overall Study|Protocol Violation|0|||
23696297|NCT00642616|66266542|FG002|Overall Study|Protocol Violation|2|||
23696298|NCT00642616|66266543|FG003|Overall Study|Protocol Violation|0|||
23696299|NCT00642616|66266540|FG000|Overall Study|Physician Decision|0|||
23696300|NCT00642616|66266541|FG001|Overall Study|Physician Decision|0|||
23696301|NCT00642616|66266542|FG002|Overall Study|Physician Decision|1|||
23696302|NCT00642616|66266543|FG003|Overall Study|Physician Decision|1|||
23696303|NCT01426386|66266546|FG000|Overall Study|Adverse Event|0|||
23696304|NCT01426386|66266547|FG001|Overall Study|Adverse Event|1|||
23696305|NCT01426386|66266548|FG002|Overall Study|Adverse Event|0|||
23696306|NCT01426386|66266549|FG003|Overall Study|Adverse Event|0|||
23696307|NCT01426386|66266550|FG004|Overall Study|Adverse Event|0|||
23696308|NCT01426386|66266551|FG005|Overall Study|Adverse Event|0|||
23696309|NCT01426386|66266546|FG000|Overall Study|Did not attend scheduled visit|1|||
23696310|NCT01426386|66266547|FG001|Overall Study|Did not attend scheduled visit|4|||
23696311|NCT01426386|66266548|FG002|Overall Study|Did not attend scheduled visit|0|||
23696312|NCT01426386|66266549|FG003|Overall Study|Did not attend scheduled visit|0|||
23696313|NCT01426386|66266550|FG004|Overall Study|Did not attend scheduled visit|2|||
23696314|NCT01426386|66266551|FG005|Overall Study|Did not attend scheduled visit|1|||
23696315|NCT01426386|66266546|FG000|Overall Study|Poor response|2|||
23696316|NCT01426386|66266547|FG001|Overall Study|Poor response|1|||
23696317|NCT01426386|66266548|FG002|Overall Study|Poor response|2|||
23696318|NCT01426386|66266549|FG003|Overall Study|Poor response|0|||
23696319|NCT01426386|66266550|FG004|Overall Study|Poor response|1|||
23696320|NCT01426386|66266551|FG005|Overall Study|Poor response|0|||
23696321|NCT01426386|66266546|FG000|Overall Study|Personal reasons|0|||
23696322|NCT01426386|66266547|FG001|Overall Study|Personal reasons|0|||
23696323|NCT01426386|66266548|FG002|Overall Study|Personal reasons|0|||
23696324|NCT01426386|66266549|FG003|Overall Study|Personal reasons|0|||
23696325|NCT01426386|66266550|FG004|Overall Study|Personal reasons|1|||
23696326|NCT01426386|66266551|FG005|Overall Study|Personal reasons|0|||
23696327|NCT01522651|66266555|FG000|Overall Study|Adverse Event|3|||
23696328|NCT01522651|66266556|FG001|Overall Study|Adverse Event|4|||
23696329|NCT01522651|66266557|FG002|Overall Study|Adverse Event|4|||
23696330|NCT01522651|66266558|FG003|Overall Study|Adverse Event|5|||
23696331|NCT01522651|66266559|FG004|Overall Study|Adverse Event|4|||
23696332|NCT01522651|66266555|FG000|Overall Study|Cardioversion|1|||
23696333|NCT01522651|66266556|FG001|Overall Study|Cardioversion|0|||
23696334|NCT01522651|66266557|FG002|Overall Study|Cardioversion|0|||
23696335|NCT01522651|66266558|FG003|Overall Study|Cardioversion|0|||
23696336|NCT01522651|66266559|FG004|Overall Study|Cardioversion|0|||
23696337|NCT01522651|66266555|FG000|Overall Study|Device Malfunction|0|||
23696338|NCT01522651|66266556|FG001|Overall Study|Device Malfunction|1|||
23696339|NCT01522651|66266557|FG002|Overall Study|Device Malfunction|0|||
23696340|NCT01522651|66266558|FG003|Overall Study|Device Malfunction|0|||
23696341|NCT01522651|66266559|FG004|Overall Study|Device Malfunction|0|||
23696342|NCT01522651|66266555|FG000|Overall Study|Investigator's Discretion|0|||
23696343|NCT01522651|66266556|FG001|Overall Study|Investigator's Discretion|1|||
23696344|NCT01522651|66266557|FG002|Overall Study|Investigator's Discretion|0|||
23696345|NCT01522651|66266558|FG003|Overall Study|Investigator's Discretion|0|||
23397121|NCT01936831|65199090|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397122|NCT01936831|65199091|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397123|NCT01936831|65199092|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23696346|NCT01522651|66266559|FG004|Overall Study|Investigator's Discretion|0|||
23696347|NCT01522651|66266555|FG000|Overall Study|Protocol Violation|3|||
23696348|NCT01522651|66266556|FG001|Overall Study|Protocol Violation|0|||
23696349|NCT01522651|66266557|FG002|Overall Study|Protocol Violation|0|||
23696350|NCT01522651|66266558|FG003|Overall Study|Protocol Violation|0|||
23696351|NCT01522651|66266559|FG004|Overall Study|Protocol Violation|0|||
23696352|NCT01522651|66266555|FG000|Overall Study|Reason Not Specified|0|||
23696353|NCT01522651|66266556|FG001|Overall Study|Reason Not Specified|0|||
23696354|NCT01522651|66266557|FG002|Overall Study|Reason Not Specified|0|||
23696355|NCT01522651|66266558|FG003|Overall Study|Reason Not Specified|1|||
23696356|NCT01522651|66266559|FG004|Overall Study|Reason Not Specified|0|||
23696357|NCT01522651|66266555|FG000|Overall Study|Participant Non-Compliance|1|||
23696358|NCT01522651|66266556|FG001|Overall Study|Participant Non-Compliance|0|||
23696359|NCT01522651|66266557|FG002|Overall Study|Participant Non-Compliance|0|||
23696360|NCT01522651|66266558|FG003|Overall Study|Participant Non-Compliance|0|||
23696361|NCT01522651|66266559|FG004|Overall Study|Participant Non-Compliance|0|||
23696362|NCT01522651|66266555|FG000|Overall Study|Withdrew Consent|1|||
23696363|NCT01522651|66266556|FG001|Overall Study|Withdrew Consent|1|||
23696364|NCT01522651|66266557|FG002|Overall Study|Withdrew Consent|0|||
23696365|NCT01522651|66266558|FG003|Overall Study|Withdrew Consent|1|||
23696366|NCT01522651|66266559|FG004|Overall Study|Withdrew Consent|1|||
23696367|NCT01522651|66266555|FG000|Overall Study|Randomized but Never Treated|0|||
23696368|NCT01522651|66266556|FG001|Overall Study|Randomized but Never Treated|1|||
23696369|NCT01522651|66266557|FG002|Overall Study|Randomized but Never Treated|0|||
23696370|NCT01522651|66266558|FG003|Overall Study|Randomized but Never Treated|1|||
23696371|NCT01522651|66266559|FG004|Overall Study|Randomized but Never Treated|1|||
23696372|NCT01508676|66266562|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
23696373|NCT01508676|66266563|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
23696374|NCT01508676|66266562|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
23696375|NCT01508676|66266563|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
23696376|NCT01508676|66266562|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
23696377|NCT01508676|66266563|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
23696378|NCT01508676|66266562|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
23696379|NCT01508676|66266563|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
23696380|NCT01508676|66266562|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
23696381|NCT01508676|66266563|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
23696382|NCT00650585|66266565|FG000|Overall Study|Lost to Follow-up|505|||
23696383|NCT00650585|66266566|FG001|Overall Study|Lost to Follow-up|482|||
23696384|NCT00650585|66266565|FG000|Overall Study|No parental consent|935|||
23696385|NCT00650585|66266566|FG001|Overall Study|No parental consent|866|||
23696386|NCT00650585|66266565|FG000|Overall Study|Excluded/ruled ineligible|357|||
23696387|NCT00650585|66266566|FG001|Overall Study|Excluded/ruled ineligible|129|||
23696388|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Adverse Event|12|||
23696389|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Adverse Event|3|||
23696390|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Adverse Event|4|||
23696391|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Adverse Event|2|||
23696392|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
23696393|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
23696394|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
23696395|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
23696396|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
23696397|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
23696398|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
23696399|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
23696400|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
23696401|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
23696402|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
23696403|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
23696404|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
23696405|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
23696406|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
23696407|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
23696408|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
23696409|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
23696410|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
23696411|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
23696412|NCT02436239|66266572|FG000|Open-Lable Treatment Period|Other Reason|1|||
23696413|NCT02436239|66266573|FG001|Open-Lable Treatment Period|Other Reason|1|||
23696414|NCT02436239|66266574|FG002|Open-Lable Treatment Period|Other Reason|0|||
23696415|NCT02436239|66266575|FG003|Open-Lable Treatment Period|Other Reason|0|||
23696416|NCT02436239|66266572|FG000|Down-Taper Period|Withdrawal by Subject|4|||
23696417|NCT02436239|66266573|FG001|Down-Taper Period|Withdrawal by Subject|4|||
23696418|NCT02436239|66266574|FG002|Down-Taper Period|Withdrawal by Subject|1|||
23696419|NCT02436239|66266575|FG003|Down-Taper Period|Withdrawal by Subject|2|||
23696420|NCT03750838|66266577|FG000|Overall Study|Lost to Follow-up|10|||
23696421|NCT03750838|66266578|FG001|Overall Study|Lost to Follow-up|6|||
23696422|NCT03634072|66266585|FG000|Overall Study|Early termination of overall study|1|||
23696423|NCT03634072|66266586|FG001|Overall Study|Early termination of overall study|0|||
23696424|NCT00069121|66266600|FG000|Overall Study|Death|286|||
23696425|NCT00069121|66266601|FG001|Overall Study|Death|242|||
23696426|NCT00069121|66266600|FG000|Overall Study|Withdrawal by Subject|18|||
23696427|NCT00069121|66266601|FG001|Overall Study|Withdrawal by Subject|20|||
23696428|NCT00069121|66266600|FG000|Overall Study|Lost to Follow-up|63|||
23696429|NCT00069121|66266601|FG001|Overall Study|Lost to Follow-up|63|||
23696430|NCT03694522|66266602|FG000|Overall Study|Withdrawal by Subject|8|||
23696431|NCT03694522|66266603|FG001|Overall Study|Withdrawal by Subject|10|||
23696432|NCT03694522|66266602|FG000|Overall Study|Physician Decision|53|||
23696433|NCT03694522|66266603|FG001|Overall Study|Physician Decision|54|||
23696434|NCT03694522|66266602|FG000|Overall Study|Other|1|||
23696435|NCT03694522|66266603|FG001|Overall Study|Other|1|||
23696436|NCT03694522|66266602|FG000|Overall Study|Lost to Follow-up|0|||
23696437|NCT03694522|66266603|FG001|Overall Study|Lost to Follow-up|1|||
23696438|NCT04723537|66266606|FG000|Overall Study|Withdrawal by Subject|3|||
23696439|NCT04723537|66266607|FG001|Overall Study|Withdrawal by Subject|0|||
23696440|NCT04723537|66266608|FG002|Overall Study|Withdrawal by Subject|0|||
23696441|NCT04723537|66266606|FG000|Overall Study|Physician Decision|0|||
23696442|NCT04723537|66266607|FG001|Overall Study|Physician Decision|0|||
23696443|NCT04723537|66266608|FG002|Overall Study|Physician Decision|1|||
23696444|NCT04723537|66266606|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23696445|NCT04723537|66266607|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23696446|NCT04723537|66266608|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23696447|NCT00414440|66266609|FG000|Core Period|Withdrawal by Subject|70|||
23696448|NCT00414440|66266610|FG001|Core Period|Withdrawal by Subject|32|||
23696449|NCT00414440|66266609|FG000|Extension Period|Lost to Follow-up|44|||
23696450|NCT00414440|66266610|FG001|Extension Period|Lost to Follow-up|52|||
23696451|NCT00414440|66266609|FG000|Extension Period|Did not consent to continue follow up|61|||
23696452|NCT00414440|66266610|FG001|Extension Period|Did not consent to continue follow up|54|||
23696453|NCT00414440|66266609|FG000|Extension Period|Other|1|||
23696454|NCT00414440|66266610|FG001|Extension Period|Other|1|||
23696455|NCT00414440|66266609|FG000|Extension Period|Administrative|16|||
23696456|NCT00414440|66266610|FG001|Extension Period|Administrative|16|||
23696457|NCT00414440|66266609|FG000|Extension Period|Death|1|||
23696458|NCT00414440|66266610|FG001|Extension Period|Death|2|||
23696459|NCT00414440|66266609|FG000|Extension Period|Withdrawal by Subject|9|||
23696460|NCT00414440|66266610|FG001|Extension Period|Withdrawal by Subject|7|||
23696461|NCT00414440|66266609|FG000|Extension Period|Not included in follow up period|18|||
23696462|NCT00414440|66266610|FG001|Extension Period|Not included in follow up period|8|||
23696463|NCT03952130|66266613|FG000|Overall Study|Adverse Event|0|||
23696464|NCT03952130|66266614|FG001|Overall Study|Adverse Event|1|||
23696465|NCT03952130|66266613|FG000|Overall Study|Lost to Follow-up|1|||
23696466|NCT03952130|66266614|FG001|Overall Study|Lost to Follow-up|0|||
23696467|NCT03952130|66266613|FG000|Overall Study|Withdrawal by Subject|1|||
23696468|NCT03952130|66266614|FG001|Overall Study|Withdrawal by Subject|5|||
23696469|NCT01634243|66266615|FG000|Overall Study|Adverse Event|5|||
23696470|NCT01634243|66266616|FG001|Overall Study|Adverse Event|5|||
23696471|NCT01634243|66266615|FG000|Overall Study|Lack of Efficacy|1|||
23696472|NCT01634243|66266616|FG001|Overall Study|Lack of Efficacy|0|||
23696473|NCT01269125|66266617|FG000|Overall Study|Adverse Event|3|||
23696474|NCT01269125|66266618|FG001|Overall Study|Adverse Event|5|||
23696475|NCT01269125|66266619|FG002|Overall Study|Adverse Event|0|||
23696476|NCT01269125|66266617|FG000|Overall Study|Lost to Follow-up|4|||
23696477|NCT01269125|66266618|FG001|Overall Study|Lost to Follow-up|0|||
23696478|NCT01269125|66266619|FG002|Overall Study|Lost to Follow-up|0|||
23696479|NCT02024464|66266620|FG000|Overall Study|Discontinued|5|||
23696480|NCT02024464|66266621|FG001|Overall Study|Discontinued|4|||
23696481|NCT02024464|66266620|FG000|Overall Study|Missed Visits|1|||
23696482|NCT02024464|66266621|FG001|Overall Study|Missed Visits|0|||
23696483|NCT02024464|66266620|FG000|Overall Study|Lost to Follow-up|4|||
23696484|NCT02024464|66266621|FG001|Overall Study|Lost to Follow-up|7|||
23696485|NCT00393458|66266624|FG000|Overall Study|Adverse Event|35|||
23696486|NCT00393458|66266625|FG001|Overall Study|Adverse Event|24|||
23696487|NCT00393458|66266626|FG002|Overall Study|Adverse Event|40|||
23696488|NCT00393458|66266627|FG003|Overall Study|Adverse Event|35|||
23696489|NCT00393458|66266624|FG000|Overall Study|Subject withdrew consent|27|||
23696490|NCT00393458|66266625|FG001|Overall Study|Subject withdrew consent|40|||
23696491|NCT00393458|66266626|FG002|Overall Study|Subject withdrew consent|33|||
23696492|NCT00393458|66266627|FG003|Overall Study|Subject withdrew consent|50|||
23696493|NCT00393458|66266624|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
23696494|NCT00393458|66266625|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
23696495|NCT00393458|66266626|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
23696496|NCT00393458|66266627|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
23696497|NCT00393458|66266624|FG000|Overall Study|Protocol deviation|11|||
23696498|NCT00393458|66266625|FG001|Overall Study|Protocol deviation|11|||
23696499|NCT00393458|66266626|FG002|Overall Study|Protocol deviation|11|||
23696500|NCT00393458|66266627|FG003|Overall Study|Protocol deviation|10|||
23696501|NCT00393458|66266624|FG000|Overall Study|Administrative problems|7|||
23696502|NCT00393458|66266625|FG001|Overall Study|Administrative problems|8|||
23696503|NCT00393458|66266626|FG002|Overall Study|Administrative problems|5|||
23696504|NCT00393458|66266627|FG003|Overall Study|Administrative problems|2|||
23696505|NCT00393458|66266624|FG000|Overall Study|Lost to Follow-up|5|||
23696506|NCT00393458|66266625|FG001|Overall Study|Lost to Follow-up|6|||
23696507|NCT00393458|66266626|FG002|Overall Study|Lost to Follow-up|5|||
23696508|NCT00393458|66266627|FG003|Overall Study|Lost to Follow-up|3|||
23696509|NCT00393458|66266624|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23696510|NCT00393458|66266625|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23696511|NCT00393458|66266626|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23696512|NCT00393458|66266627|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23696513|NCT00393458|66266624|FG000|Overall Study|Death|1|||
23397124|NCT02489279|65199093|FG000|Overall Study|Lost to Follow-up|12|||
23397125|NCT02489279|65199094|FG001|Overall Study|Lost to Follow-up|10|||
23397126|NCT02297516|65199095|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
23397127|NCT02297516|65199096|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
23696514|NCT00393458|66266625|FG001|Overall Study|Death|1|||
23696515|NCT00393458|66266626|FG002|Overall Study|Death|5|||
23696516|NCT00393458|66266627|FG003|Overall Study|Death|5|||
23696517|NCT00393458|66266624|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23696518|NCT00393458|66266625|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23696519|NCT00393458|66266626|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23696520|NCT00393458|66266627|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23696521|NCT00393458|66266624|FG000|Overall Study|Subject no longer requires study drug|0|||
23696522|NCT00393458|66266625|FG001|Overall Study|Subject no longer requires study drug|1|||
23696523|NCT00393458|66266626|FG002|Overall Study|Subject no longer requires study drug|0|||
23696524|NCT00393458|66266627|FG003|Overall Study|Subject no longer requires study drug|0|||
23696525|NCT03976401|66266631|FG000|Overall Study|Adverse Event|2|||
23696526|NCT03976401|66266632|FG001|Overall Study|Adverse Event|0|||
23696527|NCT03976401|66266633|FG002|Overall Study|Adverse Event|4|||
23696528|NCT03976401|66266634|FG003|Overall Study|Adverse Event|1|||
23696529|NCT03976401|66266635|FG004|Overall Study|Adverse Event|1|||
23696530|NCT03976401|66266636|FG005|Overall Study|Adverse Event|0|||
23696531|NCT03976401|66266631|FG000|Overall Study|Withdrawal by Subject|0|||
23696532|NCT03976401|66266632|FG001|Overall Study|Withdrawal by Subject|1|||
23696533|NCT03976401|66266633|FG002|Overall Study|Withdrawal by Subject|0|||
23696534|NCT03976401|66266634|FG003|Overall Study|Withdrawal by Subject|0|||
23696535|NCT03976401|66266635|FG004|Overall Study|Withdrawal by Subject|0|||
23696536|NCT03976401|66266636|FG005|Overall Study|Withdrawal by Subject|1|||
23696537|NCT03976401|66266631|FG000|Overall Study|Physician Decision|0|||
23696538|NCT03976401|66266632|FG001|Overall Study|Physician Decision|0|||
23696539|NCT03976401|66266633|FG002|Overall Study|Physician Decision|1|||
23696540|NCT03976401|66266634|FG003|Overall Study|Physician Decision|0|||
23696541|NCT03976401|66266635|FG004|Overall Study|Physician Decision|0|||
23696542|NCT03976401|66266636|FG005|Overall Study|Physician Decision|0|||
23696543|NCT03976401|66266631|FG000|Overall Study|Lost to Follow-up|1|||
23696544|NCT03976401|66266632|FG001|Overall Study|Lost to Follow-up|2|||
23696545|NCT03976401|66266633|FG002|Overall Study|Lost to Follow-up|0|||
23696546|NCT03976401|66266634|FG003|Overall Study|Lost to Follow-up|0|||
23696547|NCT03976401|66266635|FG004|Overall Study|Lost to Follow-up|0|||
23696548|NCT03976401|66266636|FG005|Overall Study|Lost to Follow-up|0|||
23696549|NCT03976401|66266631|FG000|Overall Study|Protocol Violation|0|||
23696550|NCT03976401|66266632|FG001|Overall Study|Protocol Violation|1|||
23696551|NCT03976401|66266633|FG002|Overall Study|Protocol Violation|0|||
23696552|NCT03976401|66266634|FG003|Overall Study|Protocol Violation|0|||
23696553|NCT03976401|66266635|FG004|Overall Study|Protocol Violation|0|||
23696554|NCT03976401|66266636|FG005|Overall Study|Protocol Violation|0|||
23696555|NCT03976401|66266631|FG000|Overall Study|Withdrew Consent|0|||
23696556|NCT03976401|66266632|FG001|Overall Study|Withdrew Consent|0|||
23696557|NCT03976401|66266633|FG002|Overall Study|Withdrew Consent|0|||
23696558|NCT03976401|66266634|FG003|Overall Study|Withdrew Consent|1|||
23696559|NCT03976401|66266635|FG004|Overall Study|Withdrew Consent|0|||
23696560|NCT03976401|66266636|FG005|Overall Study|Withdrew Consent|0|||
23696561|NCT01342640|66266637|FG000|Overall Study|Adverse Event|3|||
23696562|NCT01342640|66266637|FG000|Overall Study|Protocol Violation|16|||
23397128|NCT02297516|65199095|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
23397129|NCT02297516|65199096|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
23397130|NCT02297516|65199095|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
23397131|NCT02297516|65199096|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
23397132|NCT00399529|65199097|FG000|Overall Study|Off Study Prior to Treatment|2|||
23397133|NCT05201807|65199098|FG000|Overall Study|Adverse Event|1|||
23397134|NCT05201807|65199098|FG000|Overall Study|COVID-19 Related|1|||
23397135|NCT02164864|65199101|FG000|Overall Study|Trial disease worsening|7|||
23397136|NCT02164864|65199102|FG001|Overall Study|Trial disease worsening|5|||
23397137|NCT02164864|65199103|FG002|Overall Study|Trial disease worsening|1|||
23397138|NCT02164864|65199101|FG000|Overall Study|Other pre-existing disease worsening|6|||
23397139|NCT02164864|65199102|FG001|Overall Study|Other pre-existing disease worsening|4|||
23397140|NCT02164864|65199103|FG002|Overall Study|Other pre-existing disease worsening|9|||
23498644|NCT00724932|65566409|FG000|Overall Study|Not treated|4|||
23696563|NCT01342640|66266637|FG000|Overall Study|Lost to Follow-up|21|||
23696564|NCT01342640|66266637|FG000|Overall Study|Other|1|||
23696565|NCT01887210|66266639|FG000|Overall Study|Withdrawal by Subject|1|||
23696566|NCT01887210|66266640|FG001|Overall Study|Withdrawal by Subject|3|||
23696567|NCT01887210|66266639|FG000|Overall Study|Lost to Follow-up|0|||
23696568|NCT01887210|66266640|FG001|Overall Study|Lost to Follow-up|1|||
23696569|NCT02333331|66266641|FG000|Overall Study|Adverse Event|1|||
23696570|NCT02333331|66266642|FG001|Overall Study|Adverse Event|0|||
23696571|NCT02333331|66266643|FG002|Overall Study|Adverse Event|4|||
23696572|NCT02333331|66266644|FG003|Overall Study|Adverse Event|1|||
23696573|NCT02333331|66266641|FG000|Overall Study|Death|0|||
23696574|NCT02333331|66266642|FG001|Overall Study|Death|0|||
23696575|NCT02333331|66266643|FG002|Overall Study|Death|2|||
23696576|NCT02333331|66266644|FG003|Overall Study|Death|0|||
23397141|NCT02164864|65199101|FG000|Overall Study|Other Adverse Event (AE)|52|||
23397142|NCT02164864|65199102|FG001|Overall Study|Other Adverse Event (AE)|32|||
23397143|NCT02164864|65199103|FG002|Overall Study|Other Adverse Event (AE)|49|||
23397144|NCT02164864|65199101|FG000|Overall Study|Protocol Violation|2|||
23696577|NCT02333331|66266641|FG000|Overall Study|Lost to Follow-up|0|||
23696578|NCT02333331|66266642|FG001|Overall Study|Lost to Follow-up|0|||
23696579|NCT02333331|66266643|FG002|Overall Study|Lost to Follow-up|1|||
23696580|NCT02333331|66266644|FG003|Overall Study|Lost to Follow-up|0|||
23696581|NCT02333331|66266641|FG000|Overall Study|Physician Decision|0|||
23696582|NCT02333331|66266642|FG001|Overall Study|Physician Decision|1|||
23696583|NCT02333331|66266643|FG002|Overall Study|Physician Decision|0|||
23696584|NCT02333331|66266644|FG003|Overall Study|Physician Decision|0|||
23696585|NCT02333331|66266641|FG000|Overall Study|Protocol Deviation|0|||
23696586|NCT02333331|66266642|FG001|Overall Study|Protocol Deviation|3|||
23696587|NCT02333331|66266643|FG002|Overall Study|Protocol Deviation|2|||
23696588|NCT02333331|66266644|FG003|Overall Study|Protocol Deviation|1|||
23696589|NCT02333331|66266641|FG000|Overall Study|Patient/Guardian Decision|1|||
23696590|NCT02333331|66266642|FG001|Overall Study|Patient/Guardian Decision|2|||
23696591|NCT02333331|66266643|FG002|Overall Study|Patient/Guardian Decision|9|||
23696592|NCT02333331|66266644|FG003|Overall Study|Patient/Guardian Decision|1|||
23696593|NCT00866294|66266648|FG000|Overall Study|Adverse Event|12|||
23696594|NCT00866294|66266649|FG001|Overall Study|Adverse Event|13|||
23696595|NCT00866294|66266650|FG002|Overall Study|Adverse Event|9|||
23696596|NCT00866294|66266648|FG000|Overall Study|Lack of Efficacy|7|||
23696597|NCT00866294|66266649|FG001|Overall Study|Lack of Efficacy|1|||
23696598|NCT00866294|66266650|FG002|Overall Study|Lack of Efficacy|0|||
23696599|NCT00866294|66266648|FG000|Overall Study|Protocol Violation|2|||
23696600|NCT00866294|66266649|FG001|Overall Study|Protocol Violation|0|||
23696601|NCT00866294|66266650|FG002|Overall Study|Protocol Violation|0|||
23696602|NCT00866294|66266648|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
23696603|NCT00866294|66266649|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23696604|NCT00866294|66266650|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23696605|NCT00866294|66266648|FG000|Overall Study|Lost to Follow-up|1|||
23696606|NCT00866294|66266649|FG001|Overall Study|Lost to Follow-up|3|||
23696607|NCT00866294|66266650|FG002|Overall Study|Lost to Follow-up|0|||
23696608|NCT00866294|66266648|FG000|Overall Study|Physician Decision|6|||
23696609|NCT00866294|66266649|FG001|Overall Study|Physician Decision|2|||
23696610|NCT00866294|66266650|FG002|Overall Study|Physician Decision|1|||
23696611|NCT00538733|66266651|FG000|Overall Study|Adverse Event|8|||
23696612|NCT00538733|66266651|FG000|Overall Study|Death|1|||
23696613|NCT00538733|66266651|FG000|Overall Study|declined to participate|2|||
23696614|NCT00538733|66266651|FG000|Overall Study|still on therapy|1|||
23696615|NCT01172288|66266652|FG000|Overall Study|Adverse Event|1|||
23696616|NCT01172288|66266653|FG001|Overall Study|Adverse Event|0|||
23696617|NCT01172288|66266652|FG000|Overall Study|Protocol Violation|0|||
23696618|NCT01172288|66266653|FG001|Overall Study|Protocol Violation|1|||
23696619|NCT02903511|66266654|FG000|Overall Study|Withdrawal by Subject|1|||
23397145|NCT02164864|65199102|FG001|Overall Study|Protocol Violation|4|||
23397146|NCT02164864|65199103|FG002|Overall Study|Protocol Violation|1|||
23397147|NCT02164864|65199101|FG000|Overall Study|Lost to Follow-up|4|||
23696620|NCT02903511|66266655|FG001|Overall Study|Withdrawal by Subject|0|||
23696621|NCT02903511|66266654|FG000|Overall Study|Lost to Follow-up|3|||
23696622|NCT02903511|66266655|FG001|Overall Study|Lost to Follow-up|2|||
23696623|NCT00530712|66266656|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
23696624|NCT00530712|66266656|FG000|30 Day Follow-up Visit|Missed Visit|5|||
23696625|NCT00530712|66266656|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
23696626|NCT00530712|66266656|FG000|6 Month Follow-up Visit|Missed Visit|3|||
23696627|NCT00530712|66266656|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
23696628|NCT00530712|66266656|FG000|6 Month Follow-up Visit|Death|2|||
23696629|NCT00530712|66266656|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
23397148|NCT02164864|65199102|FG001|Overall Study|Lost to Follow-up|3|||
23696630|NCT00530712|66266656|FG000|12 Month Follow-up Visit|Missed Visit|3|||
23397149|NCT02164864|65199103|FG002|Overall Study|Lost to Follow-up|2|||
23696631|NCT00530712|66266656|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
23397150|NCT02164864|65199101|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
23696632|NCT00530712|66266656|FG000|12 Month Follow-up Visit|Death|9|||
23696633|NCT01899144|66266657|FG000|Treatment Period 2|Other|1|||
23696634|NCT01899144|66266657|FG000|Treatment Period 3|Other|2|||
23696635|NCT01899144|66266657|FG000|Treatment Period 5|Other|1|||
23696636|NCT01720667|66266658|FG000|Overall Study|Adverse Event|1|||
23696637|NCT01720667|66266659|FG001|Overall Study|Adverse Event|1|||
23696638|NCT01720667|66266658|FG000|Overall Study|Withdrawal by Subject|3|||
23696639|NCT01720667|66266659|FG001|Overall Study|Withdrawal by Subject|0|||
23696640|NCT03494725|66266665|FG000|Overall Study|Withdrawal by Subject|0|||
23696641|NCT03494725|66266666|FG001|Overall Study|Withdrawal by Subject|2|||
23696642|NCT03494725|66266665|FG000|Overall Study|Antibiotic use|1|||
23696643|NCT03494725|66266666|FG001|Overall Study|Antibiotic use|0|||
23397151|NCT02164864|65199102|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
23397152|NCT02164864|65199103|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
23397153|NCT02164864|65199101|FG000|Overall Study|Other than stated|3|||
23397154|NCT02164864|65199102|FG001|Overall Study|Other than stated|4|||
23397155|NCT02164864|65199103|FG002|Overall Study|Other than stated|14|||
23696644|NCT02873715|66266667|FG000|Overall Study|Lost to Follow-up|84|||
23696645|NCT02873715|66266668|FG001|Overall Study|Lost to Follow-up|94|||
23696646|NCT02873715|66266667|FG000|Overall Study|Withdrawal by Subject|7|||
23696647|NCT02873715|66266668|FG001|Overall Study|Withdrawal by Subject|26|||
23696648|NCT01300286|66266671|FG000|Overall Study|did not get dosed|1|||
23696649|NCT00510692|66266675|FG000|Overall Study|Adverse Event|1|||
23696650|NCT00510692|66266676|FG001|Overall Study|Adverse Event|3|||
23696651|NCT00510692|66266675|FG000|Overall Study|Withdrawal by Subject|1|||
23696652|NCT00510692|66266676|FG001|Overall Study|Withdrawal by Subject|0|||
23696653|NCT01919411|66266677|FG000|Overall Study|Lost to Follow-up|2|||
23696654|NCT01919411|66266678|FG001|Overall Study|Lost to Follow-up|4|||
23696655|NCT01919411|66266677|FG000|Overall Study|Physician Decision|1|||
23696656|NCT01919411|66266678|FG001|Overall Study|Physician Decision|0|||
23696657|NCT01919411|66266677|FG000|Overall Study|Protocol Violation|2|||
23696658|NCT01919411|66266678|FG001|Overall Study|Protocol Violation|1|||
23696659|NCT01416610|66266679|FG000|Overall Study|Adverse Event|4|||
23696660|NCT01416610|66266679|FG000|Overall Study|Adverse Event -Patient decision|3|||
23696661|NCT01416610|66266679|FG000|Overall Study|Lack of Efficacy|4|||
23696662|NCT01416610|66266679|FG000|Overall Study|No reason given|5|||
23696663|NCT01416610|66266679|FG000|Overall Study|Withdrawal by Subject|13|||
23696664|NCT01416610|66266679|FG000|Overall Study|Lost to Follow-up|7|||
23696665|NCT01416610|66266679|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
23696666|NCT00744055|66266681|FG000|Overall Study|Withdrawal by Subject|6|||
23696667|NCT00744055|66266682|FG001|Overall Study|Withdrawal by Subject|9|||
23696668|NCT00744055|66266681|FG000|Overall Study|Lack of Efficacy|0|||
23696669|NCT00744055|66266682|FG001|Overall Study|Lack of Efficacy|1|||
23696670|NCT00744055|66266681|FG000|Overall Study|Physician Decision|0|||
23696671|NCT00744055|66266682|FG001|Overall Study|Physician Decision|2|||
23696672|NCT00744055|66266681|FG000|Overall Study|Protocol Violation|1|||
23696673|NCT00744055|66266682|FG001|Overall Study|Protocol Violation|1|||
23696674|NCT00744055|66266681|FG000|Overall Study|Lost to Follow-up|0|||
23696675|NCT00744055|66266682|FG001|Overall Study|Lost to Follow-up|1|||
23696676|NCT02786537|66266689|FG000|As Randomized|Adverse Event|0|||
23696677|NCT02786537|66266690|FG001|As Randomized|Adverse Event|11|||
23696678|NCT02786537|66266691|FG002|As Randomized|Adverse Event|0|||
23696679|NCT02786537|66266692|FG003|As Randomized|Adverse Event|4|||
23696680|NCT02786537|66266693|FG004|As Randomized|Adverse Event|6|||
23696681|NCT02786537|66266694|FG005|As Randomized|Adverse Event|2|||
23696682|NCT02786537|66266689|FG000|As Randomized|Lack of Efficacy|0|||
23696683|NCT02786537|66266690|FG001|As Randomized|Lack of Efficacy|0|||
23696684|NCT02786537|66266691|FG002|As Randomized|Lack of Efficacy|0|||
23696685|NCT02786537|66266692|FG003|As Randomized|Lack of Efficacy|1|||
23696686|NCT02786537|66266693|FG004|As Randomized|Lack of Efficacy|0|||
23696687|NCT02786537|66266694|FG005|As Randomized|Lack of Efficacy|0|||
23696688|NCT02786537|66266689|FG000|As Randomized|Withdrawal by Subject|1|||
23696689|NCT02786537|66266690|FG001|As Randomized|Withdrawal by Subject|2|||
23696690|NCT02786537|66266691|FG002|As Randomized|Withdrawal by Subject|0|||
23696691|NCT02786537|66266692|FG003|As Randomized|Withdrawal by Subject|1|||
23696692|NCT02786537|66266693|FG004|As Randomized|Withdrawal by Subject|1|||
23696693|NCT02786537|66266694|FG005|As Randomized|Withdrawal by Subject|0|||
23696694|NCT02786537|66266689|FG000|As Randomized|Death|0|||
23696695|NCT02786537|66266690|FG001|As Randomized|Death|2|||
23397156|NCT02317627|65199106|FG000|Overall Study|Withdrawal by Subject|0|||
23397157|NCT02317627|65199107|FG001|Overall Study|Withdrawal by Subject|1|||
23397158|NCT02317627|65199108|FG002|Overall Study|Withdrawal by Subject|1|||
23397159|NCT02317627|65199106|FG000|Overall Study|Lost to Follow-up|2|||
23696696|NCT02786537|66266691|FG002|As Randomized|Death|0|||
23696697|NCT02786537|66266692|FG003|As Randomized|Death|3|||
23696698|NCT02786537|66266693|FG004|As Randomized|Death|1|||
23696699|NCT02786537|66266694|FG005|As Randomized|Death|0|||
23696700|NCT02786537|66266689|FG000|As Randomized|Non-compliance with study drug|1|||
23696701|NCT02786537|66266690|FG001|As Randomized|Non-compliance with study drug|11|||
23696702|NCT02786537|66266691|FG002|As Randomized|Non-compliance with study drug|0|||
23696703|NCT02786537|66266692|FG003|As Randomized|Non-compliance with study drug|1|||
23397160|NCT02317627|65199107|FG001|Overall Study|Lost to Follow-up|0|||
23696704|NCT02786537|66266693|FG004|As Randomized|Non-compliance with study drug|0|||
23696705|NCT02786537|66266694|FG005|As Randomized|Non-compliance with study drug|1|||
23696706|NCT02786537|66266689|FG000|As Randomized|Lost to treatment follow-up|4|||
23696707|NCT02786537|66266690|FG001|As Randomized|Lost to treatment follow-up|32|||
23696708|NCT02786537|66266691|FG002|As Randomized|Lost to treatment follow-up|0|||
23696709|NCT02786537|66266692|FG003|As Randomized|Lost to treatment follow-up|24|||
23696710|NCT02786537|66266693|FG004|As Randomized|Lost to treatment follow-up|4|||
23696711|NCT02786537|66266694|FG005|As Randomized|Lost to treatment follow-up|4|||
23696712|NCT02786537|66266689|FG000|As Randomized|Incarceration|0|||
23696713|NCT02786537|66266690|FG001|As Randomized|Incarceration|1|||
23696714|NCT02786537|66266691|FG002|As Randomized|Incarceration|0|||
23696715|NCT02786537|66266692|FG003|As Randomized|Incarceration|0|||
23696716|NCT02786537|66266693|FG004|As Randomized|Incarceration|0|||
23696717|NCT02786537|66266694|FG005|As Randomized|Incarceration|0|||
23696718|NCT02786537|66266689|FG000|As Randomized|Opiate Dependency Relapse|0|||
23696719|NCT02786537|66266690|FG001|As Randomized|Opiate Dependency Relapse|1|||
23696720|NCT02786537|66266691|FG002|As Randomized|Opiate Dependency Relapse|0|||
23696721|NCT02786537|66266692|FG003|As Randomized|Opiate Dependency Relapse|0|||
23696722|NCT02786537|66266693|FG004|As Randomized|Opiate Dependency Relapse|0|||
23696723|NCT02786537|66266694|FG005|As Randomized|Opiate Dependency Relapse|0|||
23696724|NCT02786537|66266689|FG000|As Randomized|HCV drugs stolen from pt|0|||
23696725|NCT02786537|66266690|FG001|As Randomized|HCV drugs stolen from pt|1|||
23696726|NCT02786537|66266691|FG002|As Randomized|HCV drugs stolen from pt|0|||
23696727|NCT02786537|66266692|FG003|As Randomized|HCV drugs stolen from pt|0|||
23696728|NCT02786537|66266693|FG004|As Randomized|HCV drugs stolen from pt|0|||
23696729|NCT02786537|66266694|FG005|As Randomized|HCV drugs stolen from pt|0|||
23696730|NCT02786537|66266689|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
23696731|NCT02786537|66266690|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
23696732|NCT02786537|66266691|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
23397161|NCT02317627|65199108|FG002|Overall Study|Lost to Follow-up|0|||
23397162|NCT02317627|65199106|FG000|Overall Study|Stopped by Investigator|0|||
23397163|NCT02317627|65199107|FG001|Overall Study|Stopped by Investigator|1|||
23397164|NCT02317627|65199108|FG002|Overall Study|Stopped by Investigator|0|||
23397165|NCT02317627|65199106|FG000|Overall Study|Adverse Event|0|||
23397166|NCT02317627|65199107|FG001|Overall Study|Adverse Event|2|||
23397167|NCT02317627|65199108|FG002|Overall Study|Adverse Event|3|||
23397168|NCT02317627|65199106|FG000|Overall Study|Non-compliance with study drug|0|||
23397169|NCT02317627|65199107|FG001|Overall Study|Non-compliance with study drug|1|||
23397170|NCT02317627|65199108|FG002|Overall Study|Non-compliance with study drug|0|||
23397171|NCT01475721|65199109|FG000|Overall Study|Death|3|||
23397172|NCT01475721|65199110|FG001|Overall Study|Death|6|||
23397173|NCT01475721|65199109|FG000|Overall Study|Withdrawal by Subject|8|||
23397174|NCT01475721|65199110|FG001|Overall Study|Withdrawal by Subject|8|||
23397175|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
23397176|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
23397177|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
23397178|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
23397179|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
23397180|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
23397181|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
23397182|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
23397183|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
23397184|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
23397185|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
23397186|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397187|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397188|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397189|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
23397190|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397191|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397192|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397193|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397194|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397195|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397196|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397197|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397198|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397199|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
23696733|NCT02786537|66266692|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
23696734|NCT02786537|66266693|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
23696735|NCT02786537|66266694|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
23397200|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23696736|NCT02786537|66266689|FG000|As Randomized|Subject lost insurance|0|||
23397201|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397202|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397203|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397204|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397205|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397206|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397207|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397208|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
23397209|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
23397210|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397211|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23696737|NCT02786537|66266690|FG001|As Randomized|Subject lost insurance|0|||
23696738|NCT02786537|66266691|FG002|As Randomized|Subject lost insurance|0|||
23696739|NCT02786537|66266692|FG003|As Randomized|Subject lost insurance|1|||
23696740|NCT02786537|66266693|FG004|As Randomized|Subject lost insurance|0|||
23696741|NCT02786537|66266694|FG005|As Randomized|Subject lost insurance|0|||
23696742|NCT02786537|66266689|FG000|As Treated|Adverse Event|0|||
23696743|NCT02786537|66266690|FG001|As Treated|Adverse Event|11|||
23696744|NCT02786537|66266691|FG002|As Treated|Adverse Event|0|||
23696745|NCT02786537|66266692|FG003|As Treated|Adverse Event|4|||
23696746|NCT02786537|66266693|FG004|As Treated|Adverse Event|6|||
23696747|NCT02786537|66266694|FG005|As Treated|Adverse Event|2|||
23696748|NCT02786537|66266689|FG000|As Treated|Death|0|||
23696749|NCT02786537|66266690|FG001|As Treated|Death|2|||
23696750|NCT02786537|66266691|FG002|As Treated|Death|0|||
23696751|NCT02786537|66266692|FG003|As Treated|Death|3|||
23696752|NCT02786537|66266693|FG004|As Treated|Death|1|||
23696753|NCT02786537|66266694|FG005|As Treated|Death|0|||
23696754|NCT02786537|66266689|FG000|As Treated|Lack of Efficacy|0|||
23696755|NCT02786537|66266690|FG001|As Treated|Lack of Efficacy|0|||
23696756|NCT02786537|66266691|FG002|As Treated|Lack of Efficacy|0|||
23696757|NCT02786537|66266692|FG003|As Treated|Lack of Efficacy|1|||
23696758|NCT02786537|66266693|FG004|As Treated|Lack of Efficacy|0|||
23696759|NCT02786537|66266694|FG005|As Treated|Lack of Efficacy|0|||
23696760|NCT02786537|66266689|FG000|As Treated|Lost to Follow-up|4|||
23696761|NCT02786537|66266690|FG001|As Treated|Lost to Follow-up|32|||
23696762|NCT02786537|66266691|FG002|As Treated|Lost to Follow-up|0|||
23397212|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397213|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397214|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397215|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397216|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23696763|NCT02786537|66266692|FG003|As Treated|Lost to Follow-up|25|||
23696764|NCT02786537|66266693|FG004|As Treated|Lost to Follow-up|4|||
23696765|NCT02786537|66266694|FG005|As Treated|Lost to Follow-up|4|||
23696766|NCT02786537|66266689|FG000|As Treated|Non-compliance with study drug|1|||
23696767|NCT02786537|66266690|FG001|As Treated|Non-compliance with study drug|11|||
23696768|NCT02786537|66266691|FG002|As Treated|Non-compliance with study drug|0|||
23696769|NCT02786537|66266692|FG003|As Treated|Non-compliance with study drug|1|||
23696770|NCT02786537|66266693|FG004|As Treated|Non-compliance with study drug|0|||
23696771|NCT02786537|66266694|FG005|As Treated|Non-compliance with study drug|1|||
23696772|NCT02786537|66266689|FG000|As Treated|Lost insurance|0|||
23696773|NCT02786537|66266690|FG001|As Treated|Lost insurance|0|||
23696774|NCT02786537|66266691|FG002|As Treated|Lost insurance|0|||
23696775|NCT02786537|66266692|FG003|As Treated|Lost insurance|1|||
23696776|NCT02786537|66266693|FG004|As Treated|Lost insurance|0|||
23696777|NCT02786537|66266694|FG005|As Treated|Lost insurance|0|||
23696778|NCT02786537|66266689|FG000|As Treated|Withdrawal by Subject|1|||
23696779|NCT02786537|66266690|FG001|As Treated|Withdrawal by Subject|2|||
23696780|NCT02786537|66266691|FG002|As Treated|Withdrawal by Subject|0|||
23696781|NCT02786537|66266692|FG003|As Treated|Withdrawal by Subject|0|||
23696782|NCT02786537|66266693|FG004|As Treated|Withdrawal by Subject|1|||
23696783|NCT02786537|66266694|FG005|As Treated|Withdrawal by Subject|0|||
23696784|NCT02786537|66266689|FG000|As Treated|Incarceration|0|||
23696785|NCT02786537|66266690|FG001|As Treated|Incarceration|1|||
23696786|NCT02786537|66266691|FG002|As Treated|Incarceration|0|||
23696787|NCT02786537|66266692|FG003|As Treated|Incarceration|0|||
23696788|NCT02786537|66266693|FG004|As Treated|Incarceration|0|||
23696789|NCT02786537|66266694|FG005|As Treated|Incarceration|0|||
23696790|NCT02786537|66266689|FG000|As Treated|Opiate dependency relapse|0|||
23696791|NCT02786537|66266690|FG001|As Treated|Opiate dependency relapse|1|||
23696792|NCT02786537|66266691|FG002|As Treated|Opiate dependency relapse|0|||
23696793|NCT02786537|66266692|FG003|As Treated|Opiate dependency relapse|0|||
23696794|NCT02786537|66266693|FG004|As Treated|Opiate dependency relapse|0|||
23696795|NCT02786537|66266694|FG005|As Treated|Opiate dependency relapse|0|||
23696796|NCT02786537|66266689|FG000|As Treated|Drugs stolen from patient|0|||
23696797|NCT02786537|66266690|FG001|As Treated|Drugs stolen from patient|1|||
23696798|NCT02786537|66266691|FG002|As Treated|Drugs stolen from patient|0|||
23696799|NCT02786537|66266692|FG003|As Treated|Drugs stolen from patient|0|||
23696800|NCT02786537|66266693|FG004|As Treated|Drugs stolen from patient|0|||
23696801|NCT02786537|66266694|FG005|As Treated|Drugs stolen from patient|0|||
23696802|NCT02786537|66266689|FG000|As Treated|Advised to stop tx after loss of meds|0|||
23696803|NCT02786537|66266690|FG001|As Treated|Advised to stop tx after loss of meds|1|||
23696804|NCT02786537|66266691|FG002|As Treated|Advised to stop tx after loss of meds|0|||
23696805|NCT02786537|66266692|FG003|As Treated|Advised to stop tx after loss of meds|0|||
23696806|NCT02786537|66266693|FG004|As Treated|Advised to stop tx after loss of meds|0|||
23696807|NCT02786537|66266694|FG005|As Treated|Advised to stop tx after loss of meds|0|||
23696808|NCT00545818|66266699|FG000|Overall Study|Protocol Violation|1|||
23696809|NCT00545818|66266700|FG001|Overall Study|Protocol Violation|0|||
23696810|NCT00545818|66266699|FG000|Overall Study|Adverse Event|1|||
23696811|NCT00545818|66266700|FG001|Overall Study|Adverse Event|1|||
23696812|NCT00545818|66266699|FG000|Overall Study|Lost to Follow-up|1|||
23696813|NCT00545818|66266700|FG001|Overall Study|Lost to Follow-up|6|||
23696814|NCT01024244|66266701|FG000|Overall Study|Adverse Event|1|||
23397217|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397218|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397219|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397220|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397221|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397222|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397223|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397224|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397225|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397226|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397227|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397228|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397229|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397230|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397231|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397232|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397233|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397234|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397235|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
23397236|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397237|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397238|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
23397239|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397240|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397241|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397242|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397243|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23498645|NCT00724932|65566410|FG001|Overall Study|Not treated|3|||
23498646|NCT02538029|65566422|FG000|Overall Study|unable to complete cognitive assessments|1|||
23696815|NCT01024244|66266702|FG001|Overall Study|Adverse Event|2|||
23696816|NCT01024244|66266703|FG002|Overall Study|Adverse Event|0|||
23696817|NCT01024244|66266704|FG003|Overall Study|Adverse Event|1|||
23696818|NCT01024244|66266705|FG004|Overall Study|Adverse Event|2|||
23696819|NCT01024244|66266701|FG000|Overall Study|Entry Criteria Not Met|0|||
23696820|NCT01024244|66266702|FG001|Overall Study|Entry Criteria Not Met|1|||
23696821|NCT01024244|66266703|FG002|Overall Study|Entry Criteria Not Met|0|||
23696822|NCT01024244|66266704|FG003|Overall Study|Entry Criteria Not Met|0|||
23696823|NCT01024244|66266705|FG004|Overall Study|Entry Criteria Not Met|0|||
23696824|NCT01024244|66266701|FG000|Overall Study|Lack of Efficacy|1|||
23696825|NCT01024244|66266702|FG001|Overall Study|Lack of Efficacy|0|||
23696826|NCT01024244|66266703|FG002|Overall Study|Lack of Efficacy|0|||
23696827|NCT01024244|66266704|FG003|Overall Study|Lack of Efficacy|0|||
23696828|NCT01024244|66266705|FG004|Overall Study|Lack of Efficacy|0|||
23397244|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397245|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397246|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23606425|NCT03345407|65947244|FG000|Overall Study|Lost to Follow-up|2|||
23696829|NCT01024244|66266701|FG000|Overall Study|Protocol Violation|1|||
23696830|NCT01024244|66266702|FG001|Overall Study|Protocol Violation|0|||
23696831|NCT01024244|66266703|FG002|Overall Study|Protocol Violation|0|||
23696832|NCT01024244|66266704|FG003|Overall Study|Protocol Violation|0|||
23696833|NCT01024244|66266705|FG004|Overall Study|Protocol Violation|2|||
23696834|NCT01024244|66266701|FG000|Overall Study|Sponsor Decision|14|||
23696835|NCT01024244|66266702|FG001|Overall Study|Sponsor Decision|7|||
23696836|NCT01024244|66266703|FG002|Overall Study|Sponsor Decision|14|||
23696837|NCT01024244|66266704|FG003|Overall Study|Sponsor Decision|12|||
23696838|NCT01024244|66266705|FG004|Overall Study|Sponsor Decision|10|||
23696839|NCT01024244|66266701|FG000|Overall Study|Withdrawal by Subject|0|||
23696840|NCT01024244|66266702|FG001|Overall Study|Withdrawal by Subject|1|||
23696841|NCT01024244|66266703|FG002|Overall Study|Withdrawal by Subject|0|||
23696842|NCT01024244|66266704|FG003|Overall Study|Withdrawal by Subject|0|||
23696843|NCT01024244|66266705|FG004|Overall Study|Withdrawal by Subject|0|||
23696844|NCT00881205|66266708|FG000|Overall Study|Adverse Event|8|||
23696845|NCT00881205|66266709|FG001|Overall Study|Adverse Event|3|||
23696846|NCT00881205|66266708|FG000|Overall Study|Withdrawal by Subject|1|||
23696847|NCT00881205|66266709|FG001|Overall Study|Withdrawal by Subject|2|||
23696848|NCT00881205|66266708|FG000|Overall Study|Lost to Follow-up|0|||
23696849|NCT00881205|66266709|FG001|Overall Study|Lost to Follow-up|1|||
23696850|NCT00881205|66266708|FG000|Overall Study|Administrative problems|1|||
23696851|NCT00881205|66266709|FG001|Overall Study|Administrative problems|1|||
23696852|NCT00881205|66266708|FG000|Overall Study|Condition no longer requires drug|1|||
23696853|NCT00881205|66266709|FG001|Overall Study|Condition no longer requires drug|0|||
23696854|NCT00783289|66266710|FG000|Overall Study|Protocol Violation|0|||
23696855|NCT00783289|66266711|FG001|Overall Study|Protocol Violation|1|||
23696856|NCT00783289|66266712|FG002|Overall Study|Protocol Violation|0|||
23696857|NCT00783289|66266713|FG003|Overall Study|Protocol Violation|0|||
23696858|NCT00447421|66266714|FG000|Overall Study|Lack of Efficacy|1|||
23696859|NCT00447421|66266714|FG000|Overall Study|Adverse Event|3|||
23696860|NCT00447421|66266714|FG000|Overall Study|Sponsor Decision|2|||
23696861|NCT00652093|66266715|FG000|Overall Study|Withdrawal by Subject|0|||
23696862|NCT00652093|66266716|FG001|Overall Study|Withdrawal by Subject|0|||
23696863|NCT00652093|66266717|FG002|Overall Study|Withdrawal by Subject|1|||
23696864|NCT00652093|66266718|FG003|Overall Study|Withdrawal by Subject|0|||
23696865|NCT00652093|66266719|FG004|Overall Study|Withdrawal by Subject|1|||
23696866|NCT00652093|66266720|FG005|Overall Study|Withdrawal by Subject|0|||
23696867|NCT00652093|66266715|FG000|Overall Study|Physician Decision|0|||
23696868|NCT00652093|66266716|FG001|Overall Study|Physician Decision|0|||
23696869|NCT00652093|66266717|FG002|Overall Study|Physician Decision|0|||
23696870|NCT00652093|66266718|FG003|Overall Study|Physician Decision|0|||
23696871|NCT00652093|66266719|FG004|Overall Study|Physician Decision|1|||
23696872|NCT00652093|66266720|FG005|Overall Study|Physician Decision|0|||
23696873|NCT02082184|66266727|FG000|Overall Study|Adverse Event|1|||
23696874|NCT02082184|66266728|FG001|Overall Study|Adverse Event|0|||
23696875|NCT02082184|66266727|FG000|Overall Study|Medical diagnosis|1|||
23696876|NCT02082184|66266728|FG001|Overall Study|Medical diagnosis|2|||
23696877|NCT02082184|66266727|FG000|Overall Study|Device associated symptoms|5|||
23696878|NCT02082184|66266728|FG001|Overall Study|Device associated symptoms|0|||
23696879|NCT02082184|66266727|FG000|Overall Study|Withdrawal by Subject|3|||
23696880|NCT02082184|66266728|FG001|Overall Study|Withdrawal by Subject|2|||
23696881|NCT02082184|66266727|FG000|Overall Study|Protocol Violation|0|||
23696882|NCT02082184|66266728|FG001|Overall Study|Protocol Violation|6|||
23696883|NCT02082184|66266727|FG000|Overall Study|Lost to Follow-up|0|||
23696884|NCT02082184|66266728|FG001|Overall Study|Lost to Follow-up|2|||
23696885|NCT02082184|66266727|FG000|Overall Study|Subject non-compliance|0|||
23696886|NCT02082184|66266728|FG001|Overall Study|Subject non-compliance|1|||
23696887|NCT04090164|66266729|FG000|Overall Study|incomplete data on file|245|||
23696888|NCT04090164|66266730|FG001|Overall Study|incomplete data on file|0|||
23696889|NCT01716169|66266734|FG000|Overall Study|Adverse Event|1|||
23696890|NCT01716169|66266734|FG000|Overall Study|Lost to Follow-up|1|||
23696891|NCT01716169|66266734|FG000|Overall Study|Withdrawal by Subject|1|||
23696892|NCT01716169|66266734|FG000|Overall Study|inconsistent dressing application|1|||
23696893|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
23498647|NCT02538029|65566423|FG001|Overall Study|unable to complete cognitive assessments|0|||
23696894|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
23696895|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
23696896|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
23696897|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
23696898|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
23696899|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23696900|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23696901|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
23696902|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
23696903|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
23696904|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
23696905|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
23696906|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
23696907|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
23696908|NCT01330381|66266735|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23696909|NCT01330381|66266736|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23696910|NCT01330381|66266737|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23397247|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397248|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397249|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
23397250|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397251|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397252|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397253|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397254|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397255|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397256|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397257|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397258|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397259|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
23397260|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
23397261|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23606426|NCT03345407|65947245|FG001|Overall Study|Lost to Follow-up|0|||
23606427|NCT03345407|65947246|FG002|Overall Study|Lost to Follow-up|1|||
23606428|NCT03345407|65947247|FG003|Overall Study|Lost to Follow-up|0|||
23606429|NCT03345407|65947248|FG004|Overall Study|Lost to Follow-up|1|||
23606430|NCT03345407|65947249|FG005|Overall Study|Lost to Follow-up|2|||
23606431|NCT03345407|65947250|FG006|Overall Study|Lost to Follow-up|3|||
23606432|NCT03345407|65947244|FG000|Overall Study|Protocol-defined stopping criteria|9|||
23606433|NCT03345407|65947245|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23606434|NCT03345407|65947246|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23606435|NCT03345407|65947247|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23606436|NCT03345407|65947248|FG004|Overall Study|Protocol-defined stopping criteria|2|||
23606437|NCT03345407|65947249|FG005|Overall Study|Protocol-defined stopping criteria|1|||
23606438|NCT03345407|65947250|FG006|Overall Study|Protocol-defined stopping criteria|1|||
23606439|NCT03345407|65947244|FG000|Overall Study|Protocol Violation|2|||
23606440|NCT03345407|65947245|FG001|Overall Study|Protocol Violation|0|||
23606441|NCT03345407|65947246|FG002|Overall Study|Protocol Violation|0|||
23606442|NCT03345407|65947247|FG003|Overall Study|Protocol Violation|0|||
23606443|NCT03345407|65947248|FG004|Overall Study|Protocol Violation|1|||
23606444|NCT03345407|65947249|FG005|Overall Study|Protocol Violation|0|||
23606445|NCT03345407|65947250|FG006|Overall Study|Protocol Violation|3|||
23606446|NCT03345407|65947244|FG000|Overall Study|Lack of Efficacy|1|||
23606447|NCT03345407|65947245|FG001|Overall Study|Lack of Efficacy|1|||
23606448|NCT03345407|65947246|FG002|Overall Study|Lack of Efficacy|1|||
23606449|NCT03345407|65947247|FG003|Overall Study|Lack of Efficacy|1|||
23606450|NCT03345407|65947248|FG004|Overall Study|Lack of Efficacy|1|||
23606451|NCT03345407|65947249|FG005|Overall Study|Lack of Efficacy|0|||
23606452|NCT03345407|65947250|FG006|Overall Study|Lack of Efficacy|3|||
23606453|NCT03345407|65947244|FG000|Overall Study|Adverse Event|4|||
23606454|NCT03345407|65947245|FG001|Overall Study|Adverse Event|0|||
23606455|NCT03345407|65947246|FG002|Overall Study|Adverse Event|5|||
23606456|NCT03345407|65947247|FG003|Overall Study|Adverse Event|4|||
23606457|NCT03345407|65947248|FG004|Overall Study|Adverse Event|6|||
23606458|NCT03345407|65947249|FG005|Overall Study|Adverse Event|5|||
23606459|NCT03345407|65947250|FG006|Overall Study|Adverse Event|16|||
23606460|NCT00624377|65947251|FG000|Overall Study|Lost to Follow-up|355|||
23606461|NCT00624377|65947251|FG000|Overall Study|Withdrawal by Subject|100|||
23606462|NCT00624377|65947251|FG000|Overall Study|Adverse Event|14|||
23606463|NCT00624377|65947251|FG000|Overall Study|Other|91|||
23606464|NCT00624377|65947251|FG000|Overall Study|Non-evaluable population|84|||
23606465|NCT01777932|65947254|FG000|Overall Study|Disease progression|136|||
23606466|NCT01777932|65947254|FG000|Overall Study|Death|3|||
23606467|NCT01777932|65947254|FG000|Overall Study|Adverse Event|34|||
23606468|NCT01777932|65947254|FG000|Overall Study|Lost to Follow-up|3|||
23606469|NCT01777932|65947254|FG000|Overall Study|Investigator decision|10|||
23606470|NCT01777932|65947254|FG000|Overall Study|Reimbursement limit|9|||
23606471|NCT01777932|65947254|FG000|Overall Study|Patient refused further treatment|10|||
23606472|NCT00378898|65947257|FG000|Overall Study|Withdrawal by Subject|10|||
23606473|NCT00378898|65947258|FG001|Overall Study|Withdrawal by Subject|5|||
23606474|NCT00378898|65947257|FG000|Overall Study|Protocol Violation|1|||
23606475|NCT00378898|65947258|FG001|Overall Study|Protocol Violation|1|||
23606476|NCT02446015|65947259|FG000|Overall Study|Adverse Event|0|||
23606477|NCT02446015|65947260|FG001|Overall Study|Adverse Event|1|||
23397262|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23696911|NCT01330381|66266735|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
23696912|NCT01330381|66266736|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
23696913|NCT01330381|66266737|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
23696914|NCT01330381|66266735|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
23696915|NCT01330381|66266736|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
23696916|NCT01330381|66266737|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
23696917|NCT01330381|66266735|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
23696918|NCT01330381|66266736|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
23696919|NCT01330381|66266737|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
23696920|NCT01330381|66266735|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
23696921|NCT01330381|66266736|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
23696922|NCT01330381|66266737|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
23696923|NCT01713348|66266738|FG000|Overall Study|Withdrawal by Subject|3|||
23696924|NCT01713348|66266739|FG001|Overall Study|Withdrawal by Subject|2|||
23696925|NCT01713348|66266740|FG002|Overall Study|Withdrawal by Subject|2|||
23696926|NCT01713348|66266741|FG003|Overall Study|Withdrawal by Subject|0|||
23696927|NCT01713348|66266738|FG000|Overall Study|Lost to Follow-up|1|||
23696928|NCT01713348|66266739|FG001|Overall Study|Lost to Follow-up|0|||
23696929|NCT01713348|66266740|FG002|Overall Study|Lost to Follow-up|0|||
23696930|NCT01713348|66266741|FG003|Overall Study|Lost to Follow-up|0|||
23696931|NCT03114969|66266748|FG000|Overall Study|Lost to Follow-up|0|||
23696932|NCT03114969|66266749|FG001|Overall Study|Lost to Follow-up|0|||
23696933|NCT03114969|66266750|FG002|Overall Study|Lost to Follow-up|3|||
23696934|NCT03114969|66266751|FG003|Overall Study|Lost to Follow-up|2|||
23696935|NCT03114969|66266752|FG004|Overall Study|Lost to Follow-up|0|||
23696936|NCT03114969|66266753|FG005|Overall Study|Lost to Follow-up|0|||
23696937|NCT03114969|66266754|FG006|Overall Study|Lost to Follow-up|0|||
23696938|NCT03114969|66266755|FG007|Overall Study|Lost to Follow-up|0|||
23696939|NCT03114969|66266756|FG008|Overall Study|Lost to Follow-up|0|||
23696940|NCT03114969|66266748|FG000|Overall Study|Adverse Event|0|||
23696941|NCT03114969|66266749|FG001|Overall Study|Adverse Event|0|||
23696942|NCT03114969|66266750|FG002|Overall Study|Adverse Event|1|||
23696943|NCT03114969|66266751|FG003|Overall Study|Adverse Event|0|||
23696944|NCT03114969|66266752|FG004|Overall Study|Adverse Event|0|||
23696945|NCT03114969|66266753|FG005|Overall Study|Adverse Event|1|||
23696946|NCT03114969|66266754|FG006|Overall Study|Adverse Event|1|||
23696947|NCT03114969|66266755|FG007|Overall Study|Adverse Event|0|||
23696948|NCT03114969|66266756|FG008|Overall Study|Adverse Event|2|||
23696949|NCT01787591|66266757|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23696950|NCT01787591|66266758|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23696951|NCT01787591|66266759|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23696952|NCT01787591|66266760|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
23696953|NCT02234622|66266761|FG000|Overall Study|Withdrawal by Subject|16|||
23696954|NCT02234622|66266762|FG001|Overall Study|Withdrawal by Subject|22|||
23696955|NCT02234622|66266761|FG000|Overall Study|Lost to Follow-up|27|||
23696956|NCT02234622|66266762|FG001|Overall Study|Lost to Follow-up|14|||
23696957|NCT00144300|66266763|FG000|Overall Study|Adverse Event|18|||
23696958|NCT00144300|66266764|FG001|Overall Study|Adverse Event|16|||
23696959|NCT00144300|66266763|FG000|Overall Study|Protocol Violation|1|||
23696960|NCT00144300|66266764|FG001|Overall Study|Protocol Violation|3|||
23696961|NCT00144300|66266763|FG000|Overall Study|Lost to Follow-up|3|||
23696962|NCT00144300|66266764|FG001|Overall Study|Lost to Follow-up|0|||
23696963|NCT00144300|66266763|FG000|Overall Study|Withdrawal by Subject|6|||
23696964|NCT00144300|66266764|FG001|Overall Study|Withdrawal by Subject|6|||
23696965|NCT00144300|66266763|FG000|Overall Study|Other reason (not specified)|1|||
23696966|NCT00144300|66266764|FG001|Overall Study|Other reason (not specified)|3|||
23696967|NCT04407507|66266765|FG000|Overall Study|Withdrawal by Subject|0|||
23696968|NCT04407507|66266766|FG001|Overall Study|Withdrawal by Subject|1|||
23696969|NCT01009463|66266767|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
23696970|NCT01009463|66266768|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23696971|NCT01009463|66266769|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23397263|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397264|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23696972|NCT01009463|66266770|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23696973|NCT01009463|66266771|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23696974|NCT01009463|66266767|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
23696975|NCT01009463|66266768|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
23397265|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23696976|NCT01009463|66266769|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
23696977|NCT01009463|66266770|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
23696978|NCT01009463|66266771|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
23696979|NCT01009463|66266767|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
23696980|NCT01009463|66266768|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23696981|NCT01009463|66266769|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23696982|NCT01009463|66266770|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23696983|NCT01009463|66266771|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23696984|NCT01009463|66266767|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
23696985|NCT01009463|66266768|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
23696986|NCT01009463|66266769|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
23696987|NCT01009463|66266770|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
23696988|NCT01009463|66266771|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
23696989|NCT01009463|66266767|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
23696990|NCT01009463|66266768|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23696991|NCT01009463|66266769|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23696992|NCT01009463|66266770|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23696993|NCT01009463|66266771|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23696994|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
23696995|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
23696996|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
23696997|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
23696998|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
23696999|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23697000|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
23697001|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
23697002|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
23697003|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
23697004|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23697005|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
23697006|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
23697007|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
23697008|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
23697009|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
23697010|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23697011|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23697012|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23697013|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23697014|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23697015|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
23697016|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
23697017|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23697018|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
23697019|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23397266|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397267|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397268|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397269|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397270|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397271|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397272|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
23397273|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
23397274|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397275|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397276|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397277|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397278|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397279|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397280|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397281|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397282|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397283|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
23697020|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
23697021|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23397284|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23697022|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23397285|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397286|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397287|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397288|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397289|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397290|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397291|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397292|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397293|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397294|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397295|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
23397296|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397297|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397298|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397299|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397300|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397301|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397302|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397303|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397304|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397305|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
23397306|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
23397307|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397308|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397309|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397310|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397311|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397312|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397313|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397314|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397315|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397316|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
23397317|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397318|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23697023|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23397319|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397320|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397321|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397322|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397323|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23697024|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23697025|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
23697026|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
23697027|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23697028|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
23397324|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397325|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397326|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397327|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
23397328|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
23397329|NCT04573972|65199122|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
23397330|NCT04573972|65199123|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
23397331|NCT00928668|65199130|FG000|Overall Study|Adverse Event|1|||
23397332|NCT00928668|65199131|FG001|Overall Study|Adverse Event|0|||
23397333|NCT00928668|65199132|FG002|Overall Study|Adverse Event|0|||
23397334|NCT00928668|65199133|FG003|Overall Study|Adverse Event|0|||
23397335|NCT00928668|65199134|FG004|Overall Study|Adverse Event|0|||
23697029|NCT01009463|66266767|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
23697030|NCT01009463|66266768|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
23697031|NCT01009463|66266769|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
23697032|NCT01009463|66266770|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
23697033|NCT01009463|66266771|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
23697034|NCT03199911|66266775|FG000|Overall Study|Lost to Follow-up|5|||
23697035|NCT03199911|66266776|FG001|Overall Study|Lost to Follow-up|5|||
23397336|NCT00928668|65199130|FG000|Overall Study|Protocol Violation|0|||
23397337|NCT00928668|65199131|FG001|Overall Study|Protocol Violation|0|||
23697036|NCT03199911|66266775|FG000|Overall Study|Did not proceed with surgery|2|||
23697037|NCT03199911|66266776|FG001|Overall Study|Did not proceed with surgery|1|||
23697038|NCT00893789|66266780|FG000|Overall Study|Withdrawal by Subject|3|||
23697039|NCT00893789|66266781|FG001|Overall Study|Withdrawal by Subject|1|||
23697040|NCT00893789|66266782|FG002|Overall Study|Withdrawal by Subject|3|||
23697041|NCT00893789|66266783|FG003|Overall Study|Withdrawal by Subject|1|||
23697042|NCT00893789|66266780|FG000|Overall Study|Noncompliance With Study Drug|1|||
23697043|NCT00893789|66266781|FG001|Overall Study|Noncompliance With Study Drug|0|||
23697044|NCT00893789|66266782|FG002|Overall Study|Noncompliance With Study Drug|1|||
23697045|NCT00893789|66266783|FG003|Overall Study|Noncompliance With Study Drug|2|||
23697046|NCT00893789|66266780|FG000|Overall Study|Noncompliance With Study Procedures|1|||
23697047|NCT00893789|66266781|FG001|Overall Study|Noncompliance With Study Procedures|0|||
23697048|NCT00893789|66266782|FG002|Overall Study|Noncompliance With Study Procedures|0|||
23697049|NCT00893789|66266783|FG003|Overall Study|Noncompliance With Study Procedures|0|||
23697050|NCT00893789|66266780|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
23697051|NCT00893789|66266781|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
23697052|NCT00893789|66266782|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
23697053|NCT00893789|66266783|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
23697054|NCT00893789|66266780|FG000|Overall Study|Adverse Event|0|||
23697055|NCT00893789|66266781|FG001|Overall Study|Adverse Event|2|||
23697056|NCT00893789|66266782|FG002|Overall Study|Adverse Event|1|||
23697057|NCT00893789|66266783|FG003|Overall Study|Adverse Event|5|||
23697058|NCT00893789|66266780|FG000|Overall Study|Protocol Violation|0|||
23697059|NCT00893789|66266781|FG001|Overall Study|Protocol Violation|1|||
23697060|NCT00893789|66266782|FG002|Overall Study|Protocol Violation|1|||
23697061|NCT00893789|66266783|FG003|Overall Study|Protocol Violation|4|||
23697062|NCT00893789|66266780|FG000|Overall Study|Lost to Follow-up|0|||
23697063|NCT00893789|66266781|FG001|Overall Study|Lost to Follow-up|0|||
23697064|NCT00893789|66266782|FG002|Overall Study|Lost to Follow-up|0|||
23697065|NCT00893789|66266783|FG003|Overall Study|Lost to Follow-up|1|||
23697066|NCT01821677|66266787|FG000|Overall Study|Adverse Event|4|||
23697067|NCT01821677|66266788|FG001|Overall Study|Adverse Event|6|||
23697068|NCT01821677|66266789|FG002|Overall Study|Adverse Event|5|||
23697069|NCT01821677|66266787|FG000|Overall Study|Physician Decision|1|||
23697070|NCT01821677|66266788|FG001|Overall Study|Physician Decision|4|||
23697071|NCT01821677|66266789|FG002|Overall Study|Physician Decision|1|||
23697072|NCT01821677|66266787|FG000|Overall Study|Non-compliance|0|||
23697073|NCT01821677|66266788|FG001|Overall Study|Non-compliance|1|||
23697074|NCT01821677|66266789|FG002|Overall Study|Non-compliance|2|||
23697075|NCT01821677|66266787|FG000|Overall Study|Lost to Follow-up|2|||
23697076|NCT01821677|66266788|FG001|Overall Study|Lost to Follow-up|1|||
23697077|NCT01821677|66266789|FG002|Overall Study|Lost to Follow-up|3|||
23697078|NCT01821677|66266787|FG000|Overall Study|Protocol Violation|0|||
23697079|NCT01821677|66266788|FG001|Overall Study|Protocol Violation|0|||
23697080|NCT01821677|66266789|FG002|Overall Study|Protocol Violation|2|||
23697081|NCT01821677|66266787|FG000|Overall Study|Withdrawal by Subject|7|||
23697082|NCT01821677|66266788|FG001|Overall Study|Withdrawal by Subject|3|||
23697083|NCT01821677|66266789|FG002|Overall Study|Withdrawal by Subject|2|||
23697084|NCT01821677|66266787|FG000|Overall Study|Other|9|||
23697085|NCT01821677|66266788|FG001|Overall Study|Other|0|||
23697086|NCT01821677|66266789|FG002|Overall Study|Other|0|||
23397338|NCT00928668|65199132|FG002|Overall Study|Protocol Violation|0|||
23397339|NCT00928668|65199133|FG003|Overall Study|Protocol Violation|0|||
23397340|NCT00928668|65199134|FG004|Overall Study|Protocol Violation|1|||
23397341|NCT00928668|65199130|FG000|Overall Study|Withdrawal by Subject|0|||
23397342|NCT00928668|65199131|FG001|Overall Study|Withdrawal by Subject|1|||
23397343|NCT00928668|65199132|FG002|Overall Study|Withdrawal by Subject|1|||
23397344|NCT00928668|65199133|FG003|Overall Study|Withdrawal by Subject|0|||
23397345|NCT00928668|65199134|FG004|Overall Study|Withdrawal by Subject|0|||
23397346|NCT00928668|65199130|FG000|Overall Study|Other reasons not listed above|0|||
23397347|NCT00928668|65199131|FG001|Overall Study|Other reasons not listed above|0|||
23498648|NCT02538029|65566424|FG002|Overall Study|unable to complete cognitive assessments|1|||
23697087|NCT00231062|66266790|FG000|Overall Study|Physician Decision|6|||
23697088|NCT00922935|66266799|FG000|Overall Study|Protocol Violation|0|||
23697089|NCT00922935|66266800|FG001|Overall Study|Protocol Violation|3|||
23697090|NCT00922935|66266801|FG002|Overall Study|Protocol Violation|0|||
23697091|NCT00922935|66266799|FG000|Overall Study|Physician Decision|1|||
23697092|NCT00922935|66266800|FG001|Overall Study|Physician Decision|1|||
23697093|NCT00922935|66266801|FG002|Overall Study|Physician Decision|0|||
23697094|NCT00922935|66266799|FG000|Overall Study|Lost to Follow-up|0|||
23697095|NCT00922935|66266800|FG001|Overall Study|Lost to Follow-up|1|||
23697096|NCT00922935|66266801|FG002|Overall Study|Lost to Follow-up|0|||
23697097|NCT04101422|66266802|FG000|Overall Study|Ineligible|1|||
23697098|NCT04101422|66266803|FG001|Overall Study|Ineligible|0|||
23697099|NCT04101422|66266804|FG002|Overall Study|Ineligible|9|||
23397348|NCT00928668|65199132|FG002|Overall Study|Other reasons not listed above|0|||
23397349|NCT00928668|65199133|FG003|Overall Study|Other reasons not listed above|1|||
23697100|NCT04101422|66266805|FG003|Overall Study|Ineligible|0|||
23397350|NCT00928668|65199134|FG004|Overall Study|Other reasons not listed above|0|||
23397351|NCT01085214|65199135|FG000|Overall Study|Alternate treatment required|1|||
23397352|NCT02327169|65199136|FG000|Overall Study|Progressive Disease|1|||
23397353|NCT02327169|65199137|FG001|Overall Study|Progressive Disease|3|||
23397354|NCT02327169|65199138|FG002|Overall Study|Progressive Disease|4|||
23397355|NCT02327169|65199139|FG003|Overall Study|Progressive Disease|3|||
23397356|NCT02327169|65199140|FG004|Overall Study|Progressive Disease|4|||
23397357|NCT02327169|65199141|FG005|Overall Study|Progressive Disease|3|||
23397358|NCT02327169|65199142|FG006|Overall Study|Progressive Disease|3|||
23397359|NCT02327169|65199143|FG007|Overall Study|Progressive Disease|3|||
23397360|NCT02327169|65199144|FG008|Overall Study|Progressive Disease|4|||
23397361|NCT02327169|65199145|FG009|Overall Study|Progressive Disease|4|||
23397362|NCT02327169|65199146|FG010|Overall Study|Progressive Disease|4|||
23397363|NCT02327169|65199147|FG011|Overall Study|Progressive Disease|3|||
23397364|NCT02327169|65199148|FG012|Overall Study|Progressive Disease|1|||
23397365|NCT02327169|65199149|FG013|Overall Study|Progressive Disease|3|||
23397366|NCT02327169|65199150|FG014|Overall Study|Progressive Disease|3|||
23397367|NCT02327169|65199136|FG000|Overall Study|Adverse Event|2|||
23397368|NCT02327169|65199137|FG001|Overall Study|Adverse Event|0|||
23397369|NCT02327169|65199138|FG002|Overall Study|Adverse Event|1|||
23397370|NCT02327169|65199139|FG003|Overall Study|Adverse Event|0|||
23697101|NCT04101422|66266802|FG000|Overall Study|Withdrawal by Subject|0|||
23697102|NCT04101422|66266803|FG001|Overall Study|Withdrawal by Subject|0|||
23697103|NCT04101422|66266804|FG002|Overall Study|Withdrawal by Subject|1|||
23697104|NCT04101422|66266805|FG003|Overall Study|Withdrawal by Subject|0|||
23697105|NCT04101422|66266802|FG000|Overall Study|Not attending to the stimuli|0|||
23697106|NCT04101422|66266803|FG001|Overall Study|Not attending to the stimuli|0|||
23697107|NCT04101422|66266804|FG002|Overall Study|Not attending to the stimuli|4|||
23697108|NCT04101422|66266805|FG003|Overall Study|Not attending to the stimuli|0|||
23697109|NCT04101422|66266802|FG000|Overall Study|Did not download app|0|||
23697110|NCT04101422|66266803|FG001|Overall Study|Did not download app|0|||
23697111|NCT04101422|66266804|FG002|Overall Study|Did not download app|0|||
23697112|NCT04101422|66266805|FG003|Overall Study|Did not download app|17|||
23697113|NCT04101422|66266802|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23697114|NCT04101422|66266803|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23697115|NCT04101422|66266804|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23697116|NCT04101422|66266805|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
23697117|NCT03598777|66266806|FG000|Overall Study|Study Terminated by Sponsor|3|||
23697118|NCT03598777|66266807|FG001|Overall Study|Study Terminated by Sponsor|0|||
23697119|NCT03598777|66266808|FG002|Overall Study|Study Terminated by Sponsor|0|||
23697120|NCT03598777|66266809|FG003|Overall Study|Study Terminated by Sponsor|0|||
23697121|NCT03598777|66266810|FG004|Overall Study|Study Terminated by Sponsor|15|||
23697122|NCT03598777|66266806|FG000|Overall Study|Withdrawal by Subject|1|||
23697123|NCT03598777|66266807|FG001|Overall Study|Withdrawal by Subject|1|||
23697124|NCT03598777|66266808|FG002|Overall Study|Withdrawal by Subject|0|||
23697125|NCT03598777|66266809|FG003|Overall Study|Withdrawal by Subject|0|||
23697126|NCT03598777|66266810|FG004|Overall Study|Withdrawal by Subject|0|||
23697127|NCT03598777|66266806|FG000|Overall Study|Adverse Event|1|||
23697128|NCT03598777|66266807|FG001|Overall Study|Adverse Event|0|||
23697129|NCT03598777|66266808|FG002|Overall Study|Adverse Event|0|||
23697130|NCT03598777|66266809|FG003|Overall Study|Adverse Event|0|||
23697131|NCT03598777|66266810|FG004|Overall Study|Adverse Event|0|||
23697132|NCT03598777|66266806|FG000|Overall Study|Lost to Follow-up|1|||
23697133|NCT03598777|66266807|FG001|Overall Study|Lost to Follow-up|0|||
23697134|NCT03598777|66266808|FG002|Overall Study|Lost to Follow-up|0|||
23697135|NCT03598777|66266809|FG003|Overall Study|Lost to Follow-up|0|||
23697136|NCT03598777|66266810|FG004|Overall Study|Lost to Follow-up|0|||
23697137|NCT00377299|66266811|FG000|Overall Study|Lost to Follow-up|14|||
23697138|NCT00377299|66266812|FG001|Overall Study|Lost to Follow-up|19|||
23697139|NCT00377299|66266811|FG000|Overall Study|Adverse Event|0|||
23697140|NCT00377299|66266812|FG001|Overall Study|Adverse Event|1|||
23697141|NCT00377299|66266811|FG000|Overall Study|Withdrawal by Subject|5|||
23697142|NCT00377299|66266812|FG001|Overall Study|Withdrawal by Subject|4|||
23697143|NCT01362322|66266814|FG000|Overall Study|Withdrawal by Subject|3|||
23697144|NCT01362322|66266815|FG001|Overall Study|Withdrawal by Subject|1|||
23697145|NCT01362322|66266814|FG000|Overall Study|Lost to Follow-up|2|||
23697146|NCT01362322|66266815|FG001|Overall Study|Lost to Follow-up|6|||
23397371|NCT02327169|65199140|FG004|Overall Study|Adverse Event|1|||
23397372|NCT02327169|65199141|FG005|Overall Study|Adverse Event|0|||
23697147|NCT02990338|66266819|FG000|Overall Study|Ongoing|30|||
23697148|NCT02990338|66266820|FG001|Overall Study|Ongoing|36|||
23397373|NCT02327169|65199142|FG006|Overall Study|Adverse Event|0|||
23397374|NCT02327169|65199143|FG007|Overall Study|Adverse Event|0|||
23397375|NCT02327169|65199144|FG008|Overall Study|Adverse Event|0|||
23397376|NCT02327169|65199145|FG009|Overall Study|Adverse Event|2|||
23697149|NCT02973815|66266821|FG000|Post Intervention|Death|1|||
23697150|NCT02973815|66266822|FG001|Post Intervention|Death|0|||
23697151|NCT02973815|66266821|FG000|Post Intervention|Lost to Follow-up|7|||
23697152|NCT02973815|66266822|FG001|Post Intervention|Lost to Follow-up|24|||
23697153|NCT02973815|66266821|FG000|Follow-up|Lost to Follow-up|2|||
23697154|NCT02973815|66266822|FG001|Follow-up|Lost to Follow-up|0|||
23697155|NCT01164501|66266826|FG000|Overall Study|Not treated|2|||
23697156|NCT01164501|66266827|FG001|Overall Study|Not treated|0|||
23697157|NCT01164501|66266828|FG002|Overall Study|Not treated|1|||
23697158|NCT01164501|66266826|FG000|Overall Study|Adverse Event|18|||
23697159|NCT01164501|66266827|FG001|Overall Study|Adverse Event|4|||
23697160|NCT01164501|66266828|FG002|Overall Study|Adverse Event|21|||
23697161|NCT01164501|66266826|FG000|Overall Study|Lack of Efficacy|0|||
23697162|NCT01164501|66266827|FG001|Overall Study|Lack of Efficacy|0|||
23697163|NCT01164501|66266828|FG002|Overall Study|Lack of Efficacy|1|||
23697164|NCT01164501|66266826|FG000|Overall Study|Non compliant with protocol|1|||
23697165|NCT01164501|66266827|FG001|Overall Study|Non compliant with protocol|1|||
23697166|NCT01164501|66266828|FG002|Overall Study|Non compliant with protocol|4|||
23697167|NCT01164501|66266826|FG000|Overall Study|Lost to Follow-up|3|||
23697168|NCT01164501|66266827|FG001|Overall Study|Lost to Follow-up|0|||
23697169|NCT01164501|66266828|FG002|Overall Study|Lost to Follow-up|3|||
23697170|NCT01164501|66266826|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
23697171|NCT01164501|66266827|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
23697172|NCT01164501|66266828|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
23697173|NCT01164501|66266826|FG000|Overall Study|Other reason not defined above|9|||
23697174|NCT01164501|66266827|FG001|Overall Study|Other reason not defined above|1|||
23697175|NCT01164501|66266828|FG002|Overall Study|Other reason not defined above|4|||
23697176|NCT04419506|66266829|FG000|Overall Study|Adverse Event|0|||
23697177|NCT04419506|66266830|FG001|Overall Study|Adverse Event|10|||
23697178|NCT04419506|66266831|FG002|Overall Study|Adverse Event|0|||
23697179|NCT04419506|66266832|FG003|Overall Study|Adverse Event|3|||
23697180|NCT04419506|66266829|FG000|Overall Study|Withdrawal by Subject|0|||
23697181|NCT04419506|66266830|FG001|Overall Study|Withdrawal by Subject|0|||
23697182|NCT04419506|66266831|FG002|Overall Study|Withdrawal by Subject|0|||
23697183|NCT04419506|66266832|FG003|Overall Study|Withdrawal by Subject|1|||
23697184|NCT04419506|66266829|FG000|Overall Study|poor-compliance|0|||
23697185|NCT04419506|66266830|FG001|Overall Study|poor-compliance|0|||
23697186|NCT04419506|66266831|FG002|Overall Study|poor-compliance|0|||
23697187|NCT04419506|66266832|FG003|Overall Study|poor-compliance|1|||
23697188|NCT01200511|66270328|FG000|Overall Study|Lost to Follow-up|3|||
23697189|NCT01200511|66270328|FG000|Overall Study|Withdrawal by Subject|1|||
23697190|NCT01200511|66270328|FG000|Overall Study|Adverse Event|1|||
23697191|NCT01903434|66270329|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
23697192|NCT01903434|66270330|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
23697193|NCT01903434|66270329|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
23697194|NCT01903434|66270330|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
23697195|NCT00637728|66270331|FG000|Double-blind Phase|Adverse Event|1|||
23697196|NCT00637728|66270332|FG001|Double-blind Phase|Adverse Event|0|||
23697197|NCT00637728|66270333|FG002|Double-blind Phase|Adverse Event|0|||
23697198|NCT00637728|66270331|FG000|Double-blind Phase|Non-compliance|2|||
23697199|NCT00637728|66270332|FG001|Double-blind Phase|Non-compliance|0|||
23697200|NCT00637728|66270333|FG002|Double-blind Phase|Non-compliance|0|||
23697201|NCT00637728|66270331|FG000|Double-blind Phase|Study Discontinued|1|||
23697202|NCT00637728|66270332|FG001|Double-blind Phase|Study Discontinued|1|||
23697203|NCT00637728|66270333|FG002|Double-blind Phase|Study Discontinued|0|||
23697204|NCT01645280|66270338|FG000|Overall Study|Death|0|||
23697205|NCT01645280|66270339|FG001|Overall Study|Death|1|||
23697206|NCT01645280|66270340|FG002|Overall Study|Death|0|||
23697207|NCT01645280|66270341|FG003|Overall Study|Death|0|||
23697208|NCT01645280|66270342|FG004|Overall Study|Death|0|||
23697209|NCT01645280|66270338|FG000|Overall Study|Withdrawal by Subject|4|||
23697210|NCT01645280|66270339|FG001|Overall Study|Withdrawal by Subject|0|||
23697211|NCT01645280|66270340|FG002|Overall Study|Withdrawal by Subject|2|||
23697212|NCT01645280|66270341|FG003|Overall Study|Withdrawal by Subject|4|||
23697213|NCT01645280|66270342|FG004|Overall Study|Withdrawal by Subject|5|||
23697214|NCT01645280|66270338|FG000|Overall Study|Lost to Follow-up|0|||
23697215|NCT01645280|66270339|FG001|Overall Study|Lost to Follow-up|0|||
23697216|NCT01645280|66270340|FG002|Overall Study|Lost to Follow-up|0|||
23697217|NCT01645280|66270341|FG003|Overall Study|Lost to Follow-up|2|||
23697218|NCT01645280|66270342|FG004|Overall Study|Lost to Follow-up|1|||
23697219|NCT01645280|66270338|FG000|Overall Study|Other|1|||
23697220|NCT01645280|66270339|FG001|Overall Study|Other|1|||
23697221|NCT01645280|66270340|FG002|Overall Study|Other|2|||
23697222|NCT01645280|66270341|FG003|Overall Study|Other|0|||
23697223|NCT01645280|66270342|FG004|Overall Study|Other|0|||
23697224|NCT01645280|66270338|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
23697225|NCT01645280|66270339|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
23697226|NCT01645280|66270340|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
23697227|NCT01645280|66270341|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
23697228|NCT01645280|66270342|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
23697229|NCT02385123|66270343|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
23697230|NCT00875420|66270344|FG000|Overall Study|Adverse Event|0|||
23697231|NCT00875420|66270345|FG001|Overall Study|Adverse Event|1|||
23697232|NCT00875420|66270346|FG002|Overall Study|Adverse Event|1|||
23697233|NCT00875420|66270347|FG003|Overall Study|Adverse Event|0|||
23697234|NCT00875420|66270348|FG004|Overall Study|Adverse Event|0|||
23697235|NCT00875420|66270344|FG000|Overall Study|Inability to complete study procedures|1|||
23697236|NCT00875420|66270345|FG001|Overall Study|Inability to complete study procedures|0|||
23697237|NCT00875420|66270346|FG002|Overall Study|Inability to complete study procedures|1|||
23697238|NCT00875420|66270347|FG003|Overall Study|Inability to complete study procedures|1|||
23697239|NCT00875420|66270348|FG004|Overall Study|Inability to complete study procedures|1|||
23697240|NCT00875420|66270344|FG000|Overall Study|Lost to Follow-up|1|||
23697241|NCT00875420|66270345|FG001|Overall Study|Lost to Follow-up|0|||
23697242|NCT00875420|66270346|FG002|Overall Study|Lost to Follow-up|0|||
23697243|NCT00875420|66270347|FG003|Overall Study|Lost to Follow-up|0|||
23697244|NCT00875420|66270348|FG004|Overall Study|Lost to Follow-up|0|||
23697245|NCT00875420|66270344|FG000|Overall Study|Personal reason|0|||
23697246|NCT00875420|66270345|FG001|Overall Study|Personal reason|0|||
23697247|NCT00875420|66270346|FG002|Overall Study|Personal reason|0|||
23697248|NCT00875420|66270347|FG003|Overall Study|Personal reason|0|||
23697249|NCT00875420|66270348|FG004|Overall Study|Personal reason|1|||
23697250|NCT00875420|66270344|FG000|Overall Study|Prohibited medication|0|||
23697251|NCT00875420|66270345|FG001|Overall Study|Prohibited medication|0|||
23697252|NCT00875420|66270346|FG002|Overall Study|Prohibited medication|0|||
23697253|NCT00875420|66270347|FG003|Overall Study|Prohibited medication|1|||
23697254|NCT00875420|66270348|FG004|Overall Study|Prohibited medication|0|||
23697255|NCT00875420|66270344|FG000|Overall Study|Sponsor decision|0|||
23697256|NCT00875420|66270345|FG001|Overall Study|Sponsor decision|1|||
23697257|NCT00875420|66270346|FG002|Overall Study|Sponsor decision|0|||
23697258|NCT00875420|66270347|FG003|Overall Study|Sponsor decision|0|||
23697259|NCT00875420|66270348|FG004|Overall Study|Sponsor decision|0|||
23697260|NCT00875420|66270344|FG000|Overall Study|Withdrawal by Subject|0|||
23697261|NCT00875420|66270345|FG001|Overall Study|Withdrawal by Subject|0|||
23697262|NCT00875420|66270346|FG002|Overall Study|Withdrawal by Subject|1|||
23697263|NCT00875420|66270347|FG003|Overall Study|Withdrawal by Subject|0|||
23697264|NCT00875420|66270348|FG004|Overall Study|Withdrawal by Subject|0|||
23697265|NCT00336492|66270353|FG000|Overall Study|Adverse Event|4|||
23697266|NCT00336492|66270354|FG001|Overall Study|Adverse Event|3|||
23697267|NCT00336492|66270355|FG002|Overall Study|Adverse Event|6|||
23697268|NCT00336492|66270353|FG000|Overall Study|Lack of Efficacy|6|||
23697269|NCT00336492|66270354|FG001|Overall Study|Lack of Efficacy|1|||
23697270|NCT00336492|66270355|FG002|Overall Study|Lack of Efficacy|4|||
23697271|NCT00336492|66270353|FG000|Overall Study|Other|5|||
23697272|NCT00336492|66270354|FG001|Overall Study|Other|0|||
23697273|NCT00336492|66270355|FG002|Overall Study|Other|1|||
23697274|NCT00552305|66270359|FG000|Overall Study|Adverse Event|43|||
23697275|NCT00552305|66270359|FG000|Overall Study|Lack of Efficacy|120|||
23397377|NCT02327169|65199146|FG010|Overall Study|Adverse Event|0|||
23397378|NCT02327169|65199147|FG011|Overall Study|Adverse Event|3|||
23397379|NCT02327169|65199148|FG012|Overall Study|Adverse Event|0|||
23397380|NCT02327169|65199149|FG013|Overall Study|Adverse Event|2|||
23397381|NCT02327169|65199150|FG014|Overall Study|Adverse Event|1|||
23397382|NCT02327169|65199136|FG000|Overall Study|Symptomatic Deterioration|0|||
23397383|NCT02327169|65199137|FG001|Overall Study|Symptomatic Deterioration|0|||
23397384|NCT02327169|65199138|FG002|Overall Study|Symptomatic Deterioration|1|||
23397385|NCT02327169|65199139|FG003|Overall Study|Symptomatic Deterioration|0|||
23397386|NCT02327169|65199140|FG004|Overall Study|Symptomatic Deterioration|1|||
23397387|NCT02327169|65199141|FG005|Overall Study|Symptomatic Deterioration|1|||
23397388|NCT02327169|65199142|FG006|Overall Study|Symptomatic Deterioration|0|||
23397389|NCT02327169|65199143|FG007|Overall Study|Symptomatic Deterioration|0|||
23397390|NCT02327169|65199144|FG008|Overall Study|Symptomatic Deterioration|2|||
23397391|NCT02327169|65199145|FG009|Overall Study|Symptomatic Deterioration|1|||
23397392|NCT02327169|65199146|FG010|Overall Study|Symptomatic Deterioration|0|||
23397393|NCT02327169|65199147|FG011|Overall Study|Symptomatic Deterioration|0|||
23397394|NCT02327169|65199148|FG012|Overall Study|Symptomatic Deterioration|0|||
23397395|NCT02327169|65199149|FG013|Overall Study|Symptomatic Deterioration|2|||
23397396|NCT02327169|65199150|FG014|Overall Study|Symptomatic Deterioration|1|||
23397397|NCT02327169|65199136|FG000|Overall Study|Reason Not Specified|0|||
23697276|NCT00552305|66270359|FG000|Overall Study|Lost to Follow-up|4|||
23697277|NCT00552305|66270359|FG000|Overall Study|Protocol Violation|3|||
23697278|NCT00552305|66270359|FG000|Overall Study|Withdrawal by Subject|44|||
23697279|NCT00552305|66270359|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
23397398|NCT02327169|65199137|FG001|Overall Study|Reason Not Specified|0|||
23397399|NCT02327169|65199138|FG002|Overall Study|Reason Not Specified|1|||
23397400|NCT02327169|65199139|FG003|Overall Study|Reason Not Specified|0|||
23697280|NCT00552305|66270359|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
23697281|NCT00552305|66270359|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
23697282|NCT00552305|66270359|FG000|Overall Study|Unsatisfactory compliance|11|||
23697283|NCT00552305|66270359|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
23697284|NCT00552305|66270359|FG000|Overall Study|AE/Other: prohibited drug required|1|||
23697285|NCT00552305|66270359|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
23697286|NCT00552305|66270359|FG000|Overall Study|Other: Site closed|4|||
23697287|NCT00552305|66270359|FG000|Overall Study|Other: Personal problems|1|||
23697288|NCT00552305|66270359|FG000|Overall Study|Other: Unable to attend visits|1|||
23697289|NCT00552305|66270359|FG000|Overall Study|Other: Subject underwent surgery|4|||
23697290|NCT00552305|66270359|FG000|Overall Study|Other: Subject became pregnant|1|||
23697291|NCT00552305|66270359|FG000|Overall Study|Other: Health problems, not drug related|1|||
23697292|NCT00552305|66270359|FG000|Overall Study|Other: Subject moved from area|2|||
23697293|NCT00552305|66270359|FG000|Overall Study|Other: Subject incarcerated|1|||
23697294|NCT00552305|66270359|FG000|Overall Study|Other: Subject went to rehab|1|||
23697295|NCT02089737|66270365|FG000|Overall Study|Survey form not completed|5|||
23697296|NCT02089737|66270365|FG000|Overall Study|Not treated|1|||
23697297|NCT00933335|66270373|FG000|Overall Study|Lost to Follow-up|1|||
23697298|NCT00933335|66270374|FG001|Overall Study|Lost to Follow-up|3|||
23697299|NCT00933335|66270373|FG000|Overall Study|Withdrawal by Subject|0|||
23697300|NCT00933335|66270374|FG001|Overall Study|Withdrawal by Subject|1|||
23697301|NCT00933335|66270373|FG000|Overall Study|Progressive Disease|0|||
23697302|NCT00933335|66270374|FG001|Overall Study|Progressive Disease|11|||
23397401|NCT02327169|65199140|FG004|Overall Study|Reason Not Specified|0|||
23397402|NCT02327169|65199141|FG005|Overall Study|Reason Not Specified|0|||
23397403|NCT02327169|65199142|FG006|Overall Study|Reason Not Specified|0|||
23397404|NCT02327169|65199143|FG007|Overall Study|Reason Not Specified|0|||
23397405|NCT02327169|65199144|FG008|Overall Study|Reason Not Specified|0|||
23397406|NCT02327169|65199145|FG009|Overall Study|Reason Not Specified|1|||
23397407|NCT02327169|65199146|FG010|Overall Study|Reason Not Specified|2|||
23397408|NCT02327169|65199147|FG011|Overall Study|Reason Not Specified|1|||
23397409|NCT02327169|65199148|FG012|Overall Study|Reason Not Specified|0|||
23397410|NCT02327169|65199149|FG013|Overall Study|Reason Not Specified|0|||
23397411|NCT02327169|65199150|FG014|Overall Study|Reason Not Specified|2|||
23397412|NCT02327169|65199136|FG000|Overall Study|Withdrawal by Subject|1|||
23397413|NCT02327169|65199137|FG001|Overall Study|Withdrawal by Subject|0|||
23397414|NCT02327169|65199138|FG002|Overall Study|Withdrawal by Subject|0|||
23397415|NCT02327169|65199139|FG003|Overall Study|Withdrawal by Subject|0|||
23397416|NCT02327169|65199140|FG004|Overall Study|Withdrawal by Subject|1|||
23397417|NCT02327169|65199141|FG005|Overall Study|Withdrawal by Subject|0|||
23397418|NCT02327169|65199142|FG006|Overall Study|Withdrawal by Subject|0|||
23397419|NCT02327169|65199143|FG007|Overall Study|Withdrawal by Subject|1|||
23397420|NCT02327169|65199144|FG008|Overall Study|Withdrawal by Subject|0|||
23397421|NCT02327169|65199145|FG009|Overall Study|Withdrawal by Subject|0|||
23397422|NCT02327169|65199146|FG010|Overall Study|Withdrawal by Subject|0|||
23397423|NCT02327169|65199147|FG011|Overall Study|Withdrawal by Subject|0|||
23397424|NCT02327169|65199148|FG012|Overall Study|Withdrawal by Subject|0|||
23397425|NCT02327169|65199149|FG013|Overall Study|Withdrawal by Subject|0|||
23397426|NCT02327169|65199150|FG014|Overall Study|Withdrawal by Subject|3|||
23397427|NCT02327169|65199136|FG000|Overall Study|Lost to Follow-up|0|||
23397428|NCT02327169|65199137|FG001|Overall Study|Lost to Follow-up|0|||
23397429|NCT02327169|65199138|FG002|Overall Study|Lost to Follow-up|0|||
23397430|NCT02327169|65199139|FG003|Overall Study|Lost to Follow-up|0|||
23397431|NCT02327169|65199140|FG004|Overall Study|Lost to Follow-up|1|||
23397432|NCT02327169|65199141|FG005|Overall Study|Lost to Follow-up|0|||
23397433|NCT02327169|65199142|FG006|Overall Study|Lost to Follow-up|0|||
23397434|NCT02327169|65199143|FG007|Overall Study|Lost to Follow-up|0|||
23397435|NCT02327169|65199144|FG008|Overall Study|Lost to Follow-up|0|||
23397436|NCT02327169|65199145|FG009|Overall Study|Lost to Follow-up|0|||
23397437|NCT02327169|65199146|FG010|Overall Study|Lost to Follow-up|0|||
23397438|NCT02327169|65199147|FG011|Overall Study|Lost to Follow-up|0|||
23397439|NCT02327169|65199148|FG012|Overall Study|Lost to Follow-up|0|||
23397440|NCT02327169|65199149|FG013|Overall Study|Lost to Follow-up|0|||
23397441|NCT02327169|65199150|FG014|Overall Study|Lost to Follow-up|0|||
23397442|NCT02191618|65199151|FG000|Overall Study|Withdrawal by Subject|3|||
23397443|NCT02191618|65199151|FG000|Overall Study|Missed Visit|4|||
23697303|NCT00933335|66270373|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
23697304|NCT00933335|66270374|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
23697305|NCT00933335|66270373|FG000|Overall Study|Co-morbid Illness|1|||
23697306|NCT00933335|66270374|FG001|Overall Study|Co-morbid Illness|0|||
23697307|NCT00663858|66270377|FG000|Overall Study|Adverse Event|9|||
23697308|NCT00663858|66270378|FG001|Overall Study|Adverse Event|1|||
23697309|NCT00663858|66270379|FG002|Overall Study|Adverse Event|6|||
23397444|NCT02415556|65199152|FG000|Overall Study|Adverse Event|3|||
23397445|NCT02415556|65199153|FG001|Overall Study|Adverse Event|4|||
23397446|NCT02415556|65199154|FG002|Overall Study|Adverse Event|2|||
23697310|NCT00663858|66270377|FG000|Overall Study|Lack of Efficacy|5|||
23697311|NCT00663858|66270378|FG001|Overall Study|Lack of Efficacy|1|||
23697312|NCT00663858|66270379|FG002|Overall Study|Lack of Efficacy|3|||
23697313|NCT00663858|66270377|FG000|Overall Study|Withdrawal by Subject|7|||
23697314|NCT00663858|66270378|FG001|Overall Study|Withdrawal by Subject|3|||
23697315|NCT00663858|66270379|FG002|Overall Study|Withdrawal by Subject|3|||
23697316|NCT00663858|66270377|FG000|Overall Study|Protocol Violation|5|||
23697317|NCT00663858|66270378|FG001|Overall Study|Protocol Violation|3|||
23697318|NCT00663858|66270379|FG002|Overall Study|Protocol Violation|4|||
23697319|NCT00663858|66270377|FG000|Overall Study|Other|8|||
23697320|NCT00663858|66270378|FG001|Overall Study|Other|2|||
23697321|NCT00663858|66270379|FG002|Overall Study|Other|4|||
23697322|NCT02369510|66270380|FG000|Overall Study|Spilled Medication|1|||
23697323|NCT02369510|66270381|FG001|Overall Study|Spilled Medication|2|||
23697324|NCT02369510|66270382|FG002|Overall Study|Spilled Medication|1|||
23697325|NCT02369510|66270380|FG000|Overall Study|Epidural Activation|1|||
23697326|NCT02369510|66270381|FG001|Overall Study|Epidural Activation|1|||
23697327|NCT02369510|66270382|FG002|Overall Study|Epidural Activation|5|||
23697328|NCT02675517|66270383|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
23697329|NCT02675517|66270383|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
23697330|NCT00482001|66270390|FG000|Overall Study|Protocol Violation|1|||
23697331|NCT00482001|66270391|FG001|Overall Study|Protocol Violation|1|||
23697332|NCT04814823|66270392|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
23697333|NCT00306891|66270393|FG000|Part A|Withdrawal by Subject|1|||
23697334|NCT00306891|66270394|FG001|Part A|Withdrawal by Subject|1|||
23697335|NCT00306891|66270395|FG002|Part A|Withdrawal by Subject|0|||
23397447|NCT02415556|65199155|FG003|Overall Study|Adverse Event|4|||
23397448|NCT02415556|65199152|FG000|Overall Study|Lost to Follow-up|4|||
23397449|NCT02415556|65199153|FG001|Overall Study|Lost to Follow-up|5|||
23397450|NCT02415556|65199154|FG002|Overall Study|Lost to Follow-up|4|||
23397451|NCT02415556|65199155|FG003|Overall Study|Lost to Follow-up|1|||
23397452|NCT02415556|65199152|FG000|Overall Study|Withdrawal by Subject|13|||
23397453|NCT02415556|65199153|FG001|Overall Study|Withdrawal by Subject|4|||
23397454|NCT02415556|65199154|FG002|Overall Study|Withdrawal by Subject|14|||
23397455|NCT02415556|65199155|FG003|Overall Study|Withdrawal by Subject|12|||
23397456|NCT02415556|65199152|FG000|Overall Study|Physician Decision|1|||
23397457|NCT02415556|65199153|FG001|Overall Study|Physician Decision|3|||
23397458|NCT02415556|65199154|FG002|Overall Study|Physician Decision|1|||
23397459|NCT02415556|65199155|FG003|Overall Study|Physician Decision|2|||
23397460|NCT02415556|65199152|FG000|Overall Study|Censored - study completion|4|||
23397461|NCT02415556|65199153|FG001|Overall Study|Censored - study completion|5|||
23397462|NCT02415556|65199154|FG002|Overall Study|Censored - study completion|1|||
23397463|NCT02415556|65199155|FG003|Overall Study|Censored - study completion|0|||
23397464|NCT02415556|65199152|FG000|Overall Study|Family-related issues|0|||
23397465|NCT02415556|65199153|FG001|Overall Study|Family-related issues|0|||
23397466|NCT02415556|65199154|FG002|Overall Study|Family-related issues|0|||
23397467|NCT02415556|65199155|FG003|Overall Study|Family-related issues|1|||
23397468|NCT00332696|65199156|FG000|Overall Study|Death|24|||
23397469|NCT00332696|65199157|FG001|Overall Study|Death|14|||
23397470|NCT00332696|65199156|FG000|Overall Study|Insufficient therapeutic effect|4|||
23397471|NCT00332696|65199157|FG001|Overall Study|Insufficient therapeutic effect|11|||
23397472|NCT00332696|65199156|FG000|Overall Study|Adverse Event|1|||
23397473|NCT00332696|65199157|FG001|Overall Study|Adverse Event|2|||
23397474|NCT00332696|65199156|FG000|Overall Study|Condition does not justify treatment|0|||
23397475|NCT00332696|65199157|FG001|Overall Study|Condition does not justify treatment|2|||
23697336|NCT00306891|66270396|FG003|Part A|Withdrawal by Subject|0|||
23697337|NCT00306891|66270393|FG000|Part A|Condition under investigation worsened|2|||
23697338|NCT00306891|66270394|FG001|Part A|Condition under investigation worsened|2|||
23697339|NCT00306891|66270395|FG002|Part A|Condition under investigation worsened|0|||
23697340|NCT00306891|66270396|FG003|Part A|Condition under investigation worsened|0|||
23697341|NCT00306891|66270393|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23697342|NCT00306891|66270394|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
23697343|NCT00306891|66270395|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23397476|NCT00332696|65199156|FG000|Overall Study|Lost to Follow-up|0|||
23397477|NCT00332696|65199157|FG001|Overall Study|Lost to Follow-up|1|||
23397478|NCT00332696|65199156|FG000|Overall Study|Withdrawal by Subject|1|||
23397479|NCT00332696|65199157|FG001|Overall Study|Withdrawal by Subject|0|||
23697344|NCT00306891|66270396|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23697345|NCT00306891|66270393|FG000|Part A|Partial bowel obstruction|1|||
23397480|NCT01570387|65199160|FG000|Overall Study|Adverse Event|1|||
23498649|NCT01146665|65566427|FG000|Overall Study|Withdrawal by Subject|10|||
23697346|NCT00306891|66270394|FG001|Part A|Partial bowel obstruction|0|||
23697347|NCT00306891|66270395|FG002|Part A|Partial bowel obstruction|0|||
23697348|NCT00306891|66270396|FG003|Part A|Partial bowel obstruction|0|||
23697349|NCT00306891|66270393|FG000|Part A|Reaccumul. of ascites following drainage|0|||
23697350|NCT00306891|66270394|FG001|Part A|Reaccumul. of ascites following drainage|1|||
23397481|NCT01570387|65199161|FG001|Overall Study|Adverse Event|0|||
23697351|NCT00306891|66270395|FG002|Part A|Reaccumul. of ascites following drainage|0|||
23697352|NCT00306891|66270396|FG003|Part A|Reaccumul. of ascites following drainage|0|||
23697353|NCT00306891|66270393|FG000|Part A|Suspicion of second malignancy|0|||
23697354|NCT00306891|66270394|FG001|Part A|Suspicion of second malignancy|1|||
23697355|NCT00306891|66270395|FG002|Part A|Suspicion of second malignancy|0|||
23697356|NCT00306891|66270396|FG003|Part A|Suspicion of second malignancy|0|||
23697357|NCT00306891|66270393|FG000|Part A|QTC interval outwith elig. criteria|1|||
23697358|NCT00306891|66270394|FG001|Part A|QTC interval outwith elig. criteria|0|||
23697359|NCT00306891|66270395|FG002|Part A|QTC interval outwith elig. criteria|0|||
23697360|NCT00306891|66270396|FG003|Part A|QTC interval outwith elig. criteria|0|||
23697361|NCT00306891|66270393|FG000|Part B|Death|0|||
23697362|NCT00306891|66270394|FG001|Part B|Death|0|||
23697363|NCT00306891|66270395|FG002|Part B|Death|1|||
23697364|NCT00306891|66270396|FG003|Part B|Death|2|||
23697365|NCT00306891|66270393|FG000|Part B|Adverse Event|0|||
23697366|NCT00306891|66270394|FG001|Part B|Adverse Event|0|||
23697367|NCT00306891|66270395|FG002|Part B|Adverse Event|5|||
23697368|NCT00306891|66270396|FG003|Part B|Adverse Event|5|||
23697369|NCT00306891|66270393|FG000|Part B|Withdrawal by Subject|0|||
23697370|NCT00306891|66270394|FG001|Part B|Withdrawal by Subject|0|||
23697371|NCT00306891|66270395|FG002|Part B|Withdrawal by Subject|3|||
23697372|NCT00306891|66270396|FG003|Part B|Withdrawal by Subject|1|||
23697373|NCT00306891|66270393|FG000|Part B|Condition under investigation worsened|0|||
23697374|NCT00306891|66270394|FG001|Part B|Condition under investigation worsened|0|||
23697375|NCT00306891|66270395|FG002|Part B|Condition under investigation worsened|2|||
23697376|NCT00306891|66270396|FG003|Part B|Condition under investigation worsened|8|||
23697377|NCT00306891|66270393|FG000|Part B|Development of study specific disc crit.|0|||
23697378|NCT00306891|66270394|FG001|Part B|Development of study specific disc crit.|0|||
23697379|NCT00306891|66270395|FG002|Part B|Development of study specific disc crit.|0|||
23697380|NCT00306891|66270396|FG003|Part B|Development of study specific disc crit.|1|||
23697381|NCT00872898|66270399|FG000|Part Two - Double Blind|Adverse Event|4|||
23697382|NCT00872898|66270400|FG001|Part Two - Double Blind|Adverse Event|3|||
23697383|NCT00872898|66270399|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
23697384|NCT00872898|66270400|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
23697385|NCT00872898|66270399|FG000|Part Two - Double Blind|Protocol Violation|1|||
23697386|NCT00872898|66270400|FG001|Part Two - Double Blind|Protocol Violation|0|||
23697387|NCT00872898|66270399|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
23697388|NCT00872898|66270400|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
23697389|NCT00872898|66270399|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
23697390|NCT00872898|66270400|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
23697391|NCT00872898|66270399|FG000|Part Two - Double Blind|Other reasons|2|||
23697392|NCT00872898|66270400|FG001|Part Two - Double Blind|Other reasons|0|||
23697393|NCT01056107|66270401|FG000|Overall Study|Withdrawal by Subject|0|||
23697394|NCT01056107|66270402|FG001|Overall Study|Withdrawal by Subject|1|||
23697395|NCT01056107|66270403|FG002|Overall Study|Withdrawal by Subject|3|||
23697396|NCT01056107|66270404|FG003|Overall Study|Withdrawal by Subject|0|||
23697397|NCT02144220|66270405|FG000|Overall Study|technology incompatibility|9|||
23697398|NCT02144220|66270405|FG000|Overall Study|Lack of Efficacy|4|||
23397482|NCT01570387|65199162|FG002|Overall Study|Adverse Event|0|||
23397483|NCT01570387|65199163|FG003|Overall Study|Adverse Event|0|||
23397484|NCT01570387|65199160|FG000|Overall Study|Death|0|||
23397485|NCT01570387|65199161|FG001|Overall Study|Death|0|||
23397486|NCT01570387|65199162|FG002|Overall Study|Death|0|||
23397487|NCT01570387|65199163|FG003|Overall Study|Death|1|||
23498650|NCT01146665|65566428|FG001|Overall Study|Withdrawal by Subject|16|||
23697399|NCT02144220|66270405|FG000|Overall Study|Physician Decision|3|||
23697400|NCT02144220|66270405|FG000|Overall Study|Withdrawal by Subject|2|||
23697401|NCT02144220|66270405|FG000|Overall Study|Protocol Violation|1|||
23697402|NCT01024465|66270408|FG000|Overall Study|Adverse Event|2|||
23697403|NCT01024465|66270408|FG000|Overall Study|Physician Decision|1|||
23697404|NCT00443560|66270411|FG000|Overall Study|No intrathecal dose|58|||
23697405|NCT00443560|66270412|FG001|Overall Study|No intrathecal dose|26|||
23697406|NCT00443560|66270411|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
23697407|NCT00443560|66270412|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
23697408|NCT00091390|66270413|FG000|Overall Study|Protocol Violation|1|||
23697409|NCT00091390|66270413|FG000|Overall Study|No protocol treatment|3|||
23697410|NCT02342171|66270415|FG000|Overall Study|Death|4|||
23697411|NCT02342171|66270416|FG001|Overall Study|Death|87|||
23697412|NCT02342171|66270415|FG000|Overall Study|Received favipiravir|10|||
23697413|NCT02342171|66270416|FG001|Overall Study|Received favipiravir|0|||
23697414|NCT02342171|66270415|FG000|Overall Study|Missing cycle treshold value|1|||
23697415|NCT02342171|66270416|FG001|Overall Study|Missing cycle treshold value|0|||
23697416|NCT02342171|66270415|FG000|Overall Study|Unknown outcome|0|||
23697417|NCT02342171|66270416|FG001|Overall Study|Unknown outcome|1|||
23697418|NCT02342171|66270415|FG000|Overall Study|Missing age data|0|||
23397488|NCT01570387|65199160|FG000|Overall Study|Withdrawal by Subject|0|||
23397489|NCT01570387|65199161|FG001|Overall Study|Withdrawal by Subject|0|||
23397490|NCT01570387|65199162|FG002|Overall Study|Withdrawal by Subject|0|||
23397491|NCT01570387|65199163|FG003|Overall Study|Withdrawal by Subject|1|||
23397492|NCT03931330|65199164|FG000|Overall Study|Physician Decision|1|||
23397493|NCT04068922|65199165|FG000|Overall Study|Lost to Follow-up|5|||
23397494|NCT04068922|65199165|FG000|Overall Study|Withdrawal by Subject|7|||
23397495|NCT04068922|65199165|FG000|Overall Study|Adverse Event|1|||
23397496|NCT00856557|65199166|FG000|Overall Study|No patients with contextual flags|12|||
23498651|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23697419|NCT02342171|66270416|FG001|Overall Study|Missing age data|1|||
23697420|NCT03216265|66270417|FG000|Overall Study|Adverse Event|2|||
23697421|NCT03216265|66270418|FG001|Overall Study|Adverse Event|0|||
23697422|NCT03216265|66270419|FG002|Overall Study|Adverse Event|2|||
23697423|NCT03216265|66270417|FG000|Overall Study|Lost to Follow-up|0|||
23697424|NCT03216265|66270418|FG001|Overall Study|Lost to Follow-up|1|||
23697425|NCT03216265|66270419|FG002|Overall Study|Lost to Follow-up|0|||
23697426|NCT03216265|66270417|FG000|Overall Study|Withdrawal by Subject|0|||
23697427|NCT03216265|66270418|FG001|Overall Study|Withdrawal by Subject|0|||
23697428|NCT03216265|66270419|FG002|Overall Study|Withdrawal by Subject|1|||
23697429|NCT01458340|66270423|FG000|Overall Study|Adverse Event|5|||
23697430|NCT01458340|66270424|FG001|Overall Study|Adverse Event|4|||
23697431|NCT01458340|66270425|FG002|Overall Study|Adverse Event|2|||
23697432|NCT01458340|66270423|FG000|Overall Study|Lost to Follow-up|3|||
23697433|NCT01458340|66270424|FG001|Overall Study|Lost to Follow-up|3|||
23697434|NCT01458340|66270425|FG002|Overall Study|Lost to Follow-up|10|||
23697435|NCT01458340|66270423|FG000|Overall Study|Miscellaneous|0|||
23697436|NCT01458340|66270424|FG001|Overall Study|Miscellaneous|1|||
23697437|NCT01458340|66270425|FG002|Overall Study|Miscellaneous|0|||
23697438|NCT01458340|66270423|FG000|Overall Study|Physician Decision|1|||
23697439|NCT01458340|66270424|FG001|Overall Study|Physician Decision|1|||
23697440|NCT01458340|66270425|FG002|Overall Study|Physician Decision|2|||
23697441|NCT01458340|66270423|FG000|Overall Study|Protocol Violation|6|||
23697442|NCT01458340|66270424|FG001|Overall Study|Protocol Violation|6|||
23697443|NCT01458340|66270425|FG002|Overall Study|Protocol Violation|5|||
23697444|NCT01458340|66270423|FG000|Overall Study|Withdrawal by Subject|12|||
23697445|NCT01458340|66270424|FG001|Overall Study|Withdrawal by Subject|6|||
23697446|NCT01458340|66270425|FG002|Overall Study|Withdrawal by Subject|4|||
23697447|NCT02859415|66270427|FG000|Overall Study|Physician Decision|1|||
23697448|NCT02859415|66270428|FG001|Overall Study|Physician Decision|0|||
23697449|NCT02859415|66270427|FG000|Overall Study|Off treatment due to cardiac event|0|||
23697450|NCT02859415|66270428|FG001|Overall Study|Off treatment due to cardiac event|1|||
23697451|NCT03894904|66270430|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
23697452|NCT03894904|66270431|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
23697453|NCT03894904|66270430|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
23697454|NCT03894904|66270431|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
23697455|NCT02795767|66270442|FG000|Overall Study|Received Commercial Emicizumab|1|||
23697456|NCT02795767|66270443|FG001|Overall Study|Received Commercial Emicizumab|0|||
23697457|NCT02795767|66270444|FG002|Overall Study|Received Commercial Emicizumab|0|||
23697458|NCT02388776|66270450|FG000|Overall Study|Death|1|||
23697459|NCT02388776|66270450|FG000|Overall Study|Lost to Follow-up|1|||
23697460|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
23697461|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
23697462|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Death|0|||
23697463|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Death|4|||
23697464|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
23697465|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
23697466|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
23697467|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
23697468|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
23697469|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
23697470|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
23697471|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
23697472|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
23697473|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
23697474|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Other|4|||
23697475|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Other|3|||
23697476|NCT03517722|66270457|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
23697477|NCT03517722|66270458|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
23697478|NCT03517722|66270457|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
23697479|NCT03517722|66270458|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
23697480|NCT03517722|66270457|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
23397497|NCT00856557|65199167|FG001|Overall Study|No patients with contextual flags|16|||
23397498|NCT01133847|65203239|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
23697481|NCT03517722|66270458|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
23697482|NCT03517722|66270457|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
23697483|NCT03517722|66270458|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
23697484|NCT03517722|66270457|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
23697485|NCT03517722|66270458|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
23697486|NCT02614794|66270461|FG000|Overall Study|Death|258|||
23697487|NCT02614794|66270462|FG001|Overall Study|Death|151|||
23697488|NCT02614794|66270461|FG000|Overall Study|Study closure by Sponsor|119|||
23697489|NCT02614794|66270462|FG001|Overall Study|Study closure by Sponsor|45|||
23697490|NCT02614794|66270461|FG000|Overall Study|Withdrawal by Subject|24|||
23697491|NCT02614794|66270462|FG001|Overall Study|Withdrawal by Subject|5|||
23697492|NCT02614794|66270461|FG000|Overall Study|Lost to Follow-up|7|||
23697493|NCT02614794|66270462|FG001|Overall Study|Lost to Follow-up|0|||
23697494|NCT02614794|66270461|FG000|Overall Study|Physician Decision|1|||
23697495|NCT02614794|66270462|FG001|Overall Study|Physician Decision|1|||
23697496|NCT02614794|66270461|FG000|Overall Study|Hospital closure|1|||
23697497|NCT02614794|66270462|FG001|Overall Study|Hospital closure|0|||
23697498|NCT03090737|66270465|FG000|Overall Study|Other reasons|1|||
23697499|NCT03090737|66270465|FG000|Overall Study|Completed treatment as per protocol|17|||
23697500|NCT03090737|66270465|FG000|Overall Study|Maximum clinical benefit|2|||
23697501|NCT03090737|66270465|FG000|Overall Study|Adverse event unrelated to study drug|7|||
23697502|NCT03090737|66270465|FG000|Overall Study|Study drug toxicity|4|||
23697503|NCT03090737|66270465|FG000|Overall Study|Disease progression|98|||
23697504|NCT01183858|66270466|FG000|Overall Study|Death not related to Progressive Disease|5|||
23697505|NCT01183858|66270467|FG001|Overall Study|Death not related to Progressive Disease|6|||
23697506|NCT01183858|66270466|FG000|Overall Study|Adverse Event|14|||
23697507|NCT01183858|66270467|FG001|Overall Study|Adverse Event|11|||
23697508|NCT01183858|66270466|FG000|Overall Study|Investigator's Decision|0|||
23697509|NCT01183858|66270467|FG001|Overall Study|Investigator's Decision|3|||
23697510|NCT01183858|66270466|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23697511|NCT01183858|66270467|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23697512|NCT01183858|66270466|FG000|Overall Study|Refused Treatment|1|||
23697513|NCT01183858|66270467|FG001|Overall Study|Refused Treatment|4|||
23697514|NCT01183858|66270466|FG000|Overall Study|Withdrew Consent|4|||
23697515|NCT01183858|66270467|FG001|Overall Study|Withdrew Consent|4|||
23697516|NCT01183858|66270466|FG000|Overall Study|Discontinued Smoking|3|||
23697517|NCT01183858|66270467|FG001|Overall Study|Discontinued Smoking|1|||
23697518|NCT01183858|66270466|FG000|Overall Study|Protocol Violation|1|||
23697519|NCT01183858|66270467|FG001|Overall Study|Protocol Violation|0|||
23697520|NCT01183858|66270466|FG000|Overall Study|Administrative/Other|6|||
23697521|NCT01183858|66270467|FG001|Overall Study|Administrative/Other|6|||
23697522|NCT01183858|66270466|FG000|Overall Study|Progressive Disease|112|||
23697523|NCT01183858|66270467|FG001|Overall Study|Progressive Disease|115|||
23697524|NCT01183858|66270466|FG000|Overall Study|Death related to Progressive Disease|4|||
23697525|NCT01183858|66270467|FG001|Overall Study|Death related to Progressive Disease|5|||
23697526|NCT01183858|66270466|FG000|Overall Study|Lost to Follow-up|1|||
23697527|NCT01183858|66270467|FG001|Overall Study|Lost to Follow-up|1|||
23697528|NCT04799782|66270474|FG000|Washout|Physician Decision|2|||
23697529|NCT04799782|66270475|FG001|Washout|Physician Decision|0|||
23697530|NCT04799782|66270474|FG000|Washout|Withdrawal by Subject|0|||
23697531|NCT04799782|66270475|FG001|Washout|Withdrawal by Subject|2|||
23697532|NCT04799782|66270474|FG000|Washout|Lost to Follow-up|0|||
23697533|NCT04799782|66270475|FG001|Washout|Lost to Follow-up|1|||
23697534|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Adverse Event|37|||
23697535|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Adverse Event|0|||
23697536|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Adverse Event|0|||
23697537|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Adverse Event|0|||
23697538|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Death|2|||
23697539|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Death|0|||
23697540|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Death|0|||
23397499|NCT01133847|65203240|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
23498652|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23697541|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Death|0|||
23697542|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
23697543|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
23697544|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
23697545|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
23697546|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
23697547|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
23697548|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
23697549|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
23697550|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
23697551|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
23697552|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
23697553|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
23697554|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
23397500|NCT01133847|65203241|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
23397501|NCT01133847|65203239|FG000|Follow-Up Phase|Lost to Follow-up|1|||
23397502|NCT01133847|65203240|FG001|Follow-Up Phase|Lost to Follow-up|3|||
23397503|NCT01133847|65203241|FG002|Follow-Up Phase|Lost to Follow-up|7|||
23397504|NCT00133705|65203245|FG000|Overall Study|Withdrawal by Subject|2|||
23397505|NCT00133705|65203246|FG001|Overall Study|Withdrawal by Subject|3|||
23397506|NCT04976777|65203247|FG000|Overall Study|COVID-19 Infection|1|||
23397507|NCT04976777|65203248|FG001|Overall Study|COVID-19 Infection|0|||
23397508|NCT00478257|65203249|FG000|Overall Study|Withdrawal by Subject|8|||
23397509|NCT00478257|65203250|FG001|Overall Study|Withdrawal by Subject|3|||
23397510|NCT00573768|65203251|FG000|Overall Study|Adverse Event|1|||
23397511|NCT00573768|65203252|FG001|Overall Study|Adverse Event|1|||
23397512|NCT00573768|65203253|FG002|Overall Study|Adverse Event|2|||
23397513|NCT00573768|65203251|FG000|Overall Study|Protocol Violation|1|||
23397514|NCT00573768|65203252|FG001|Overall Study|Protocol Violation|0|||
23397515|NCT00573768|65203253|FG002|Overall Study|Protocol Violation|1|||
23397516|NCT00573768|65203251|FG000|Overall Study|Withdrawal by Subject|0|||
23397517|NCT00573768|65203252|FG001|Overall Study|Withdrawal by Subject|1|||
23397518|NCT00573768|65203253|FG002|Overall Study|Withdrawal by Subject|0|||
23397519|NCT00573768|65203251|FG000|Overall Study|Lost to Follow-up|0|||
23397520|NCT00573768|65203252|FG001|Overall Study|Lost to Follow-up|0|||
23397521|NCT00573768|65203253|FG002|Overall Study|Lost to Follow-up|1|||
23397522|NCT01055028|65203256|FG000|Screening|Screen Failure|1|||
23397523|NCT01055028|65203257|FG001|Screening|Screen Failure|1|||
23397524|NCT01055028|65203256|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
23397525|NCT01055028|65203257|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
23397526|NCT01055028|65203256|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
23397527|NCT01055028|65203257|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
23397528|NCT01055028|65203256|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
23397529|NCT01055028|65203257|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
23397530|NCT03341936|65203258|FG000|Overall Study|Ineligible|1|||
23397531|NCT03341936|65203258|FG000|Overall Study|Disease Progression|2|||
23397532|NCT03341936|65203258|FG000|Overall Study|Withdrew Consent|4|||
23397533|NCT03341936|65203258|FG000|Overall Study|Non-Compliance|1|||
23397534|NCT03341936|65203258|FG000|Overall Study|Physician Decision|1|||
23397535|NCT03341936|65203258|FG000|Overall Study|Withdrawal by Subject|1|||
23397536|NCT03341936|65203258|FG000|Overall Study|Other|1|||
23397537|NCT01047540|65203264|FG000|Overall Study|Protocol Violation|1|||
23397538|NCT01047540|65203265|FG001|Overall Study|Protocol Violation|0|||
23397539|NCT01047540|65203266|FG002|Overall Study|Protocol Violation|0|||
23397540|NCT01047540|65203267|FG003|Overall Study|Protocol Violation|0|||
23397541|NCT01047540|65203268|FG004|Overall Study|Protocol Violation|0|||
23397542|NCT01047540|65203264|FG000|Overall Study|Lost to Follow-up|1|||
23397543|NCT01047540|65203265|FG001|Overall Study|Lost to Follow-up|0|||
23397544|NCT01047540|65203266|FG002|Overall Study|Lost to Follow-up|0|||
23397545|NCT01047540|65203267|FG003|Overall Study|Lost to Follow-up|0|||
23397546|NCT01047540|65203268|FG004|Overall Study|Lost to Follow-up|0|||
23397547|NCT01047540|65203264|FG000|Overall Study|Withdrawal by Subject|1|||
23397548|NCT01047540|65203265|FG001|Overall Study|Withdrawal by Subject|0|||
23397549|NCT01047540|65203266|FG002|Overall Study|Withdrawal by Subject|3|||
23397550|NCT01047540|65203267|FG003|Overall Study|Withdrawal by Subject|0|||
23397551|NCT01047540|65203268|FG004|Overall Study|Withdrawal by Subject|1|||
23397552|NCT01047540|65203264|FG000|Overall Study|Pregnancy|1|||
23397553|NCT01047540|65203265|FG001|Overall Study|Pregnancy|0|||
23397554|NCT01047540|65203266|FG002|Overall Study|Pregnancy|0|||
23697555|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23697556|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23697557|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23697558|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Physician Decision|4|||
23697559|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Physician Decision|0|||
23697560|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Physician Decision|0|||
23697561|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Physician Decision|0|||
23697562|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Pregnancy|1|||
23397555|NCT01047540|65203267|FG003|Overall Study|Pregnancy|0|||
23397556|NCT01047540|65203268|FG004|Overall Study|Pregnancy|0|||
23397557|NCT01047540|65203264|FG000|Overall Study|Adverse Event|1|||
23397558|NCT01047540|65203265|FG001|Overall Study|Adverse Event|0|||
23397559|NCT01047540|65203266|FG002|Overall Study|Adverse Event|0|||
23397560|NCT01047540|65203267|FG003|Overall Study|Adverse Event|0|||
23697563|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Pregnancy|0|||
23397561|NCT01047540|65203268|FG004|Overall Study|Adverse Event|0|||
23397562|NCT04749914|65203269|FG000|Period 1|Adverse Event|1|||
23397563|NCT04749914|65203270|FG001|Period 1|Adverse Event|0|||
23397564|NCT04749914|65203271|FG002|Period 1|Adverse Event|0|||
23397565|NCT04749914|65203272|FG003|Period 1|Adverse Event|0|||
23397566|NCT04749914|65203269|FG000|Period 1|Withdrawal by Subject|1|||
23397567|NCT04749914|65203270|FG001|Period 1|Withdrawal by Subject|0|||
23397568|NCT04749914|65203271|FG002|Period 1|Withdrawal by Subject|1|||
23397569|NCT04749914|65203272|FG003|Period 1|Withdrawal by Subject|0|||
23397570|NCT04856527|65203273|FG000|Overall Study|Unable to complete experimental task|2|||
23397571|NCT04856527|65203274|FG001|Overall Study|Unable to complete experimental task|0|||
23397572|NCT02670473|65203275|FG000|Overall Study|Withdrawal by Subject|1|||
23397573|NCT01209767|65203279|FG000|Overall Study|Withdrawal by Subject|1|||
23397574|NCT01209767|65203279|FG000|Overall Study|Lost to Follow-up|3|||
23397575|NCT00016354|65203280|FG000|Overall Study|Lack of Efficacy|0|||
23397576|NCT00016354|65203281|FG001|Overall Study|Lack of Efficacy|0|||
23397577|NCT00016354|65203282|FG002|Overall Study|Lack of Efficacy|0|||
23397578|NCT00016354|65203283|FG003|Overall Study|Lack of Efficacy|0|||
23397579|NCT00016354|65203284|FG004|Overall Study|Lack of Efficacy|0|||
23397580|NCT00016354|65203285|FG005|Overall Study|Lack of Efficacy|0|||
23397581|NCT00016354|65203286|FG006|Overall Study|Lack of Efficacy|0|||
23397582|NCT00016354|65203287|FG007|Overall Study|Lack of Efficacy|1|||
23397583|NCT02081586|65203288|FG000|Overall Study|Lost to Follow-up|0|||
23397584|NCT02081586|65203289|FG001|Overall Study|Lost to Follow-up|1|||
23397585|NCT02081586|65203290|FG002|Overall Study|Lost to Follow-up|0|||
23397586|NCT02081586|65203291|FG003|Overall Study|Lost to Follow-up|1|||
23397587|NCT02081586|65203288|FG000|Overall Study|Head injury not related to study|0|||
23397588|NCT02081586|65203289|FG001|Overall Study|Head injury not related to study|0|||
23397589|NCT02081586|65203290|FG002|Overall Study|Head injury not related to study|1|||
23397590|NCT02081586|65203291|FG003|Overall Study|Head injury not related to study|0|||
23397591|NCT02735200|65203292|FG000|Overall Study|Lost to Follow-up|0|||
23397592|NCT02735200|65203293|FG001|Overall Study|Lost to Follow-up|5|||
23397593|NCT02735200|65203292|FG000|Overall Study|Withdrawal by Subject|8|||
23397594|NCT02735200|65203293|FG001|Overall Study|Withdrawal by Subject|0|||
23397595|NCT01280968|65203298|FG000|Overall Study|Lost to Follow-up|8|||
23397596|NCT01280968|65203299|FG001|Overall Study|Lost to Follow-up|2|||
23397597|NCT01280968|65203298|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
23397598|NCT01280968|65203299|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
23397599|NCT01280968|65203298|FG000|Overall Study|Commuting Problems|2|||
23397600|NCT01280968|65203299|FG001|Overall Study|Commuting Problems|0|||
23397601|NCT01280968|65203298|FG000|Overall Study|Anxiety|2|||
23397602|NCT01280968|65203299|FG001|Overall Study|Anxiety|0|||
23397603|NCT01280968|65203298|FG000|Overall Study|Adverse Event|1|||
23397604|NCT01280968|65203299|FG001|Overall Study|Adverse Event|0|||
23397605|NCT01280968|65203298|FG000|Overall Study|Scheduling Conflicts|1|||
23397606|NCT01280968|65203299|FG001|Overall Study|Scheduling Conflicts|1|||
23397607|NCT01280968|65203298|FG000|Overall Study|Pre-existing Neurological Condition|1|||
23397608|NCT01280968|65203299|FG001|Overall Study|Pre-existing Neurological Condition|0|||
23397609|NCT01280968|65203298|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
23397610|NCT01280968|65203299|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
23397611|NCT04507763|65203300|FG000|Overall Study|Participants did not meet entrance criteria|201|||
23397612|NCT01853280|65203303|FG000|Overall Study|Lack of Efficacy|2|||
23397613|NCT01853280|65203304|FG001|Overall Study|Lack of Efficacy|2|||
23397614|NCT01853280|65203303|FG000|Overall Study|Lost to Follow-up|0|||
23397615|NCT01853280|65203304|FG001|Overall Study|Lost to Follow-up|1|||
23397616|NCT01853280|65203303|FG000|Overall Study|Physician Decision|0|||
23397617|NCT01853280|65203304|FG001|Overall Study|Physician Decision|1|||
23397618|NCT01853280|65203303|FG000|Overall Study|Withdrawal by Subject|0|||
23397619|NCT01853280|65203304|FG001|Overall Study|Withdrawal by Subject|1|||
23397620|NCT01853280|65203303|FG000|Overall Study|Ineligible|0|||
23397621|NCT01853280|65203304|FG001|Overall Study|Ineligible|1|||
23397622|NCT00492557|65203305|FG000|Overall Study|Subject request|12|||
23397623|NCT00492557|65203306|FG001|Overall Study|Subject request|11|||
23397624|NCT00492557|65203305|FG000|Overall Study|Protocol Violation|7|||
23397625|NCT00492557|65203306|FG001|Overall Study|Protocol Violation|8|||
23397626|NCT00492557|65203305|FG000|Overall Study|Other|2|||
23397627|NCT00492557|65203306|FG001|Overall Study|Other|2|||
23397628|NCT00492557|65203305|FG000|Overall Study|Death|1|||
23397629|NCT00492557|65203306|FG001|Overall Study|Death|1|||
23397630|NCT00492557|65203305|FG000|Overall Study|Adverse Event|1|||
23397631|NCT00492557|65203306|FG001|Overall Study|Adverse Event|0|||
23397632|NCT00492557|65203305|FG000|Overall Study|Failed to return|1|||
23397633|NCT00492557|65203306|FG001|Overall Study|Failed to return|0|||
23397634|NCT00492557|65203305|FG000|Overall Study|Lost to Follow-up|0|||
23397635|NCT00492557|65203306|FG001|Overall Study|Lost to Follow-up|1|||
23397636|NCT02806414|65203307|FG000|Overall Study|Lost to Follow-up|2|||
23397637|NCT01152437|65203308|FG000|Overall Study|Other Adverse Event|8|||
23397638|NCT01152437|65203309|FG001|Overall Study|Other Adverse Event|1|||
23397639|NCT01152437|65203310|FG002|Overall Study|Other Adverse Event|7|||
23397640|NCT01152437|65203308|FG000|Overall Study|Not treated|0|||
23397641|NCT01152437|65203309|FG001|Overall Study|Not treated|1|||
23397642|NCT01152437|65203310|FG002|Overall Study|Not treated|2|||
23397643|NCT01152437|65203308|FG000|Overall Study|Progressive disease|27|||
23397644|NCT01152437|65203309|FG001|Overall Study|Progressive disease|13|||
23397645|NCT01152437|65203310|FG002|Overall Study|Progressive disease|32|||
23397646|NCT01152437|65203308|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
23397647|NCT01152437|65203309|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
23397648|NCT01152437|65203310|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
23397649|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
23397650|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
23397651|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
23397652|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
23397653|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
23397654|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
23397655|NCT03435380|65203313|FG000|Overall Study|Death|1|||
23397656|NCT03435380|65203314|FG001|Overall Study|Death|2|||
23397657|NCT03435380|65203315|FG002|Overall Study|Death|1|||
23397658|NCT03435380|65203313|FG000|Overall Study|Lost to Follow-up|12|||
23397659|NCT03435380|65203314|FG001|Overall Study|Lost to Follow-up|8|||
23397660|NCT03435380|65203315|FG002|Overall Study|Lost to Follow-up|6|||
23397661|NCT03435380|65203313|FG000|Overall Study|Physician Decision|1|||
23397662|NCT03435380|65203314|FG001|Overall Study|Physician Decision|0|||
23397663|NCT03435380|65203315|FG002|Overall Study|Physician Decision|0|||
23397664|NCT03435380|65203313|FG000|Overall Study|Withdrawal by Subject|0|||
23397665|NCT03435380|65203314|FG001|Overall Study|Withdrawal by Subject|1|||
23397666|NCT03435380|65203315|FG002|Overall Study|Withdrawal by Subject|1|||
23397667|NCT03435380|65203313|FG000|Overall Study|Ineligible|0|||
23397668|NCT03435380|65203314|FG001|Overall Study|Ineligible|1|||
23397669|NCT03435380|65203315|FG002|Overall Study|Ineligible|1|||
23397670|NCT00104884|65203319|FG000|Overall Study|Disease progression|4|||
23397671|NCT04388826|65203320|FG000|Overall Study|Lost to Follow-up|3|||
23397672|NCT04388826|65203321|FG001|Overall Study|Lost to Follow-up|2|||
23397673|NCT04388826|65203320|FG000|Overall Study|Adverse Event|1|||
23397674|NCT04388826|65203321|FG001|Overall Study|Adverse Event|0|||
23397675|NCT00462826|65203322|FG000|Overall Study|Ineligible - second primary|1|||
23397676|NCT00462826|65203322|FG000|Overall Study|Ineligible - wrong cell type|1|||
23397677|NCT00462826|65203322|FG000|Overall Study|Ineligible - wrong primary|2|||
23397678|NCT00462826|65203322|FG000|Overall Study|Never treated|1|||
23397679|NCT00557440|65203323|FG000|Treatment Period 1|Adverse Event|0|||
23397680|NCT00557440|65203324|FG001|Treatment Period 1|Adverse Event|0|||
23397681|NCT00557440|65203325|FG002|Treatment Period 1|Adverse Event|1|||
23397682|NCT04704193|65203329|FG000|Overall Study|Withdrawal by Subject|1|||
23397683|NCT00889005|65203330|FG000|Overall Study|Lost to Follow-up|4|||
23397684|NCT00889005|65203331|FG001|Overall Study|Lost to Follow-up|2|||
23397685|NCT00889005|65203330|FG000|Overall Study|Withdrawal by Subject|4|||
23397686|NCT00889005|65203331|FG001|Overall Study|Withdrawal by Subject|0|||
23397687|NCT02157610|65203338|FG000|Overall Study|Death|4|||
23397688|NCT02157610|65203339|FG001|Overall Study|Death|4|||
23397689|NCT00718315|65203344|FG000|Overall Study|Adverse Event|1|||
23397690|NCT00718315|65203345|FG001|Overall Study|Adverse Event|2|||
23397691|NCT00718315|65203346|FG002|Overall Study|Adverse Event|3|||
23397692|NCT00718315|65203344|FG000|Overall Study|Death|6|||
23397693|NCT00718315|65203345|FG001|Overall Study|Death|6|||
23397694|NCT00718315|65203346|FG002|Overall Study|Death|5|||
23397695|NCT00718315|65203344|FG000|Overall Study|Lost to Follow-up|2|||
23397696|NCT00718315|65203345|FG001|Overall Study|Lost to Follow-up|3|||
23397697|NCT00718315|65203346|FG002|Overall Study|Lost to Follow-up|4|||
23397698|NCT00718315|65203344|FG000|Overall Study|Protocol Violation|5|||
23397699|NCT00718315|65203345|FG001|Overall Study|Protocol Violation|5|||
23397700|NCT00718315|65203346|FG002|Overall Study|Protocol Violation|3|||
23397701|NCT00718315|65203344|FG000|Overall Study|Erlotinib dose decreased|4|||
23397702|NCT00718315|65203345|FG001|Overall Study|Erlotinib dose decreased|3|||
23397703|NCT00718315|65203346|FG002|Overall Study|Erlotinib dose decreased|1|||
23397704|NCT00718315|65203344|FG000|Overall Study|Use of Minocyclin|1|||
23397705|NCT00718315|65203345|FG001|Overall Study|Use of Minocyclin|1|||
23397706|NCT00718315|65203346|FG002|Overall Study|Use of Minocyclin|1|||
23397707|NCT00718315|65203344|FG000|Overall Study|Disease progression|0|||
23498653|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23498654|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
23397708|NCT00718315|65203345|FG001|Overall Study|Disease progression|1|||
23397709|NCT00718315|65203346|FG002|Overall Study|Disease progression|1|||
23498655|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23397710|NCT00718315|65203344|FG000|Overall Study|Other|0|||
23397711|NCT00718315|65203345|FG001|Overall Study|Other|0|||
23397712|NCT00718315|65203346|FG002|Overall Study|Other|1|||
23397713|NCT00718315|65203344|FG000|Overall Study|Use of ATB and Corticoids|0|||
23397714|NCT00718315|65203345|FG001|Overall Study|Use of ATB and Corticoids|1|||
23397715|NCT00718315|65203346|FG002|Overall Study|Use of ATB and Corticoids|2|||
23397716|NCT02684461|65203347|FG000|Overall Study|Adverse Event|1|||
23397717|NCT02684461|65203348|FG001|Overall Study|Adverse Event|0|||
23397718|NCT02684461|65203349|FG002|Overall Study|Adverse Event|0|||
23397719|NCT02684461|65203347|FG000|Overall Study|Lack of Efficacy|1|||
23397720|NCT02684461|65203348|FG001|Overall Study|Lack of Efficacy|2|||
23397721|NCT02684461|65203349|FG002|Overall Study|Lack of Efficacy|0|||
23397722|NCT02154061|65203353|FG000|Overall Study|Pregnancy|1|||
23397723|NCT02154061|65203354|FG001|Overall Study|Pregnancy|0|||
23397724|NCT02154061|65203353|FG000|Overall Study|enrolled but not vaccinated|1|||
23397725|NCT02154061|65203354|FG001|Overall Study|enrolled but not vaccinated|0|||
23397726|NCT04023487|65203355|FG000|Overall Study|Lost to Follow-up|5|||
23397727|NCT04023487|65203356|FG001|Overall Study|Lost to Follow-up|4|||
23397728|NCT04023487|65203355|FG000|Overall Study|Pregnancy|1|||
23397729|NCT04023487|65203356|FG001|Overall Study|Pregnancy|2|||
23397730|NCT04023487|65203355|FG000|Overall Study|Withdrawal by Subject|4|||
23397731|NCT04023487|65203356|FG001|Overall Study|Withdrawal by Subject|5|||
23397732|NCT04023487|65203355|FG000|Overall Study|Partially completed testing|8|||
23397733|NCT04023487|65203356|FG001|Overall Study|Partially completed testing|4|||
23397734|NCT01784029|65203361|FG000|Overall Study|Lost to Follow-up|19|||
23397735|NCT01784029|65203362|FG001|Overall Study|Lost to Follow-up|20|||
23697564|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Pregnancy|0|||
23397736|NCT01784029|65203363|FG002|Overall Study|Lost to Follow-up|22|||
23397737|NCT01994876|65203375|FG000|Test Period 1|Withdrawal by Subject|0|||
23397738|NCT01994876|65203376|FG001|Test Period 1|Withdrawal by Subject|1|||
23397739|NCT01994876|65203375|FG000|Test Period 1|Adverse Event|0|||
23397740|NCT01994876|65203376|FG001|Test Period 1|Adverse Event|1|||
23397741|NCT01994876|65203375|FG000|Test Period 2|Adverse Event|1|||
23397742|NCT01994876|65203376|FG001|Test Period 2|Adverse Event|0|||
23397743|NCT01994876|65203375|FG000|Test Period 2|Protocol Violation|0|||
23397744|NCT01994876|65203376|FG001|Test Period 2|Protocol Violation|1|||
23397745|NCT01198587|65203377|FG000|Overall Study|Lost to Follow-up|8|||
23397746|NCT01198587|65203378|FG001|Overall Study|Lost to Follow-up|0|||
23397747|NCT01198587|65203379|FG002|Overall Study|Lost to Follow-up|9|||
23397748|NCT01198587|65203380|FG003|Overall Study|Lost to Follow-up|0|||
23397749|NCT01246960|65203383|FG000|Overall Study|Lost to Follow-up|3|||
23397750|NCT01246960|65203384|FG001|Overall Study|Lost to Follow-up|1|||
23397751|NCT01246960|65203383|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
23397752|NCT01246960|65203384|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
23397753|NCT02604511|65203385|FG000|Overall Study|Adverse Event|3|||
23397754|NCT02604511|65203385|FG000|Overall Study|Disease Progression|4|||
23397755|NCT02604511|65203385|FG000|Overall Study|Withdrawal by Subject|3|||
23397756|NCT02604511|65203385|FG000|Overall Study|Participant ineligible|1|||
23397757|NCT02604511|65203385|FG000|Overall Study|Intercurrent illness|1|||
23397758|NCT04570384|65203386|FG000|Overall Study|Adverse Event|2|||
23397759|NCT04570384|65203387|FG001|Overall Study|Adverse Event|1|||
23397760|NCT04570384|65203386|FG000|Overall Study|Death|2|||
23397761|NCT04570384|65203387|FG001|Overall Study|Death|5|||
23397762|NCT04570384|65203386|FG000|Overall Study|Lost to Follow-up|1|||
23397763|NCT04570384|65203387|FG001|Overall Study|Lost to Follow-up|0|||
23397764|NCT04570384|65203386|FG000|Overall Study|Other|1|||
23397765|NCT04570384|65203387|FG001|Overall Study|Other|0|||
23397766|NCT04570384|65203386|FG000|Overall Study|Protocol Violation|0|||
23397767|NCT04570384|65203387|FG001|Overall Study|Protocol Violation|1|||
23697565|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Pregnancy|0|||
23397768|NCT04570384|65203386|FG000|Overall Study|Sponsor Decision|1|||
23397769|NCT04570384|65203387|FG001|Overall Study|Sponsor Decision|0|||
23697566|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
23697567|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
23697568|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
23697569|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
23697570|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
23697571|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
23697572|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
23697573|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
23697574|NCT01855789|66270479|FG000|1) Baseline up to Week 24|Other|4|||
23697575|NCT01855789|66270480|FG001|1) Baseline up to Week 24|Other|0|||
23697576|NCT01855789|66270481|FG002|1) Baseline up to Week 24|Other|0|||
23397770|NCT04570384|65203386|FG000|Overall Study|Withdrawal by Subject|4|||
23397771|NCT04570384|65203387|FG001|Overall Study|Withdrawal by Subject|2|||
23397772|NCT01832727|65203388|FG000|Overall Study|Adverse Event|4|||
23397773|NCT01832727|65203389|FG001|Overall Study|Adverse Event|6|||
23697577|NCT01855789|66270482|FG003|1) Baseline up to Week 24|Other|0|||
23397774|NCT01832727|65203390|FG002|Overall Study|Adverse Event|1|||
23397775|NCT01832727|65203391|FG003|Overall Study|Adverse Event|0|||
23397776|NCT01832727|65203392|FG004|Overall Study|Adverse Event|1|||
23397777|NCT01832727|65203393|FG005|Overall Study|Adverse Event|1|||
23397778|NCT01832727|65203394|FG006|Overall Study|Adverse Event|2|||
23397779|NCT01832727|65203395|FG007|Overall Study|Adverse Event|1|||
23397780|NCT01832727|65203396|FG008|Overall Study|Adverse Event|9|||
23397781|NCT01832727|65203388|FG000|Overall Study|Disease progression|3|||
23397782|NCT01832727|65203389|FG001|Overall Study|Disease progression|0|||
23397783|NCT01832727|65203390|FG002|Overall Study|Disease progression|2|||
23397784|NCT01832727|65203391|FG003|Overall Study|Disease progression|1|||
23397785|NCT01832727|65203392|FG004|Overall Study|Disease progression|3|||
23397786|NCT01832727|65203393|FG005|Overall Study|Disease progression|3|||
23397787|NCT01832727|65203394|FG006|Overall Study|Disease progression|6|||
23397788|NCT01832727|65203395|FG007|Overall Study|Disease progression|2|||
23397789|NCT01832727|65203396|FG008|Overall Study|Disease progression|7|||
23397790|NCT01832727|65203388|FG000|Overall Study|Lost to Follow-up|0|||
23397791|NCT01832727|65203389|FG001|Overall Study|Lost to Follow-up|0|||
23397792|NCT01832727|65203390|FG002|Overall Study|Lost to Follow-up|0|||
23397793|NCT01832727|65203391|FG003|Overall Study|Lost to Follow-up|1|||
23397794|NCT01832727|65203392|FG004|Overall Study|Lost to Follow-up|0|||
23397795|NCT01832727|65203393|FG005|Overall Study|Lost to Follow-up|0|||
23697578|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
23697579|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
23697580|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
23697581|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
23697582|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23697583|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23697584|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23697585|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
23697586|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
23697587|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
23697588|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
23697589|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
23697590|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
23697591|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
23697592|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
23697593|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
23697594|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
23697595|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
23697596|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
23697597|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
23697598|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
23697599|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
23697600|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
23697601|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
23697602|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
23697603|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
23697604|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
23697605|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
23697606|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
23697607|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
23397796|NCT01832727|65203394|FG006|Overall Study|Lost to Follow-up|0|||
23397797|NCT01832727|65203395|FG007|Overall Study|Lost to Follow-up|0|||
23397798|NCT01832727|65203396|FG008|Overall Study|Lost to Follow-up|0|||
23397799|NCT01832727|65203388|FG000|Overall Study|Physician Decision|1|||
23397800|NCT01832727|65203389|FG001|Overall Study|Physician Decision|0|||
23397801|NCT01832727|65203390|FG002|Overall Study|Physician Decision|0|||
23397802|NCT01832727|65203391|FG003|Overall Study|Physician Decision|1|||
23397803|NCT01832727|65203392|FG004|Overall Study|Physician Decision|0|||
23397804|NCT01832727|65203393|FG005|Overall Study|Physician Decision|1|||
23397805|NCT01832727|65203394|FG006|Overall Study|Physician Decision|0|||
23397806|NCT01832727|65203395|FG007|Overall Study|Physician Decision|0|||
23397807|NCT01832727|65203396|FG008|Overall Study|Physician Decision|0|||
23397808|NCT01832727|65203388|FG000|Overall Study|Withdrawal by Subject|1|||
23397809|NCT01832727|65203389|FG001|Overall Study|Withdrawal by Subject|1|||
23397810|NCT01832727|65203390|FG002|Overall Study|Withdrawal by Subject|0|||
23397811|NCT01832727|65203391|FG003|Overall Study|Withdrawal by Subject|1|||
23397812|NCT01832727|65203392|FG004|Overall Study|Withdrawal by Subject|0|||
23397813|NCT01832727|65203393|FG005|Overall Study|Withdrawal by Subject|1|||
23397814|NCT01832727|65203394|FG006|Overall Study|Withdrawal by Subject|0|||
23397815|NCT01832727|65203395|FG007|Overall Study|Withdrawal by Subject|2|||
23397816|NCT01832727|65203396|FG008|Overall Study|Withdrawal by Subject|1|||
23397817|NCT01832727|65203388|FG000|Overall Study|Study terminated by sponsor|0|||
23397818|NCT01832727|65203389|FG001|Overall Study|Study terminated by sponsor|0|||
23697608|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
23697609|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
23397819|NCT01832727|65203390|FG002|Overall Study|Study terminated by sponsor|0|||
23397820|NCT01832727|65203391|FG003|Overall Study|Study terminated by sponsor|0|||
23397821|NCT01832727|65203392|FG004|Overall Study|Study terminated by sponsor|0|||
23397822|NCT01832727|65203393|FG005|Overall Study|Study terminated by sponsor|0|||
23397823|NCT01832727|65203394|FG006|Overall Study|Study terminated by sponsor|0|||
23397824|NCT01832727|65203395|FG007|Overall Study|Study terminated by sponsor|1|||
23397825|NCT01832727|65203396|FG008|Overall Study|Study terminated by sponsor|1|||
23397826|NCT03235050|65203397|FG000|Overall Study|Adverse Event|0|||
23697610|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
23697611|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
23697612|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
23697613|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
23397827|NCT03235050|65203398|FG001|Overall Study|Adverse Event|0|||
23397828|NCT03235050|65203399|FG002|Overall Study|Adverse Event|1|||
23397829|NCT03235050|65203400|FG003|Overall Study|Adverse Event|4|||
23397830|NCT03235050|65203401|FG004|Overall Study|Adverse Event|1|||
23397831|NCT03235050|65203397|FG000|Overall Study|Death|0|||
23397832|NCT03235050|65203398|FG001|Overall Study|Death|0|||
23397833|NCT03235050|65203399|FG002|Overall Study|Death|0|||
23397834|NCT03235050|65203400|FG003|Overall Study|Death|2|||
23397835|NCT03235050|65203401|FG004|Overall Study|Death|1|||
23397836|NCT03235050|65203397|FG000|Overall Study|Lost to Follow-up|1|||
23397837|NCT03235050|65203398|FG001|Overall Study|Lost to Follow-up|2|||
23397838|NCT03235050|65203399|FG002|Overall Study|Lost to Follow-up|1|||
23397839|NCT03235050|65203400|FG003|Overall Study|Lost to Follow-up|2|||
23397840|NCT03235050|65203401|FG004|Overall Study|Lost to Follow-up|0|||
23397841|NCT03235050|65203397|FG000|Overall Study|Withdrawal by Subject|3|||
23397842|NCT03235050|65203398|FG001|Overall Study|Withdrawal by Subject|2|||
23397843|NCT03235050|65203399|FG002|Overall Study|Withdrawal by Subject|2|||
23397844|NCT03235050|65203400|FG003|Overall Study|Withdrawal by Subject|5|||
23397845|NCT03235050|65203401|FG004|Overall Study|Withdrawal by Subject|7|||
23397846|NCT03235050|65203397|FG000|Overall Study|Other reasons|0|||
23397847|NCT03235050|65203398|FG001|Overall Study|Other reasons|1|||
23397848|NCT03235050|65203399|FG002|Overall Study|Other reasons|0|||
23397849|NCT03235050|65203400|FG003|Overall Study|Other reasons|1|||
23397850|NCT03235050|65203401|FG004|Overall Study|Other reasons|2|||
23397851|NCT04436744|65203406|FG000|Overall Study|Adverse Event|1|||
23397852|NCT04436744|65203407|FG001|Overall Study|Adverse Event|1|||
23397853|NCT04436744|65203406|FG000|Overall Study|Death|1|||
23397854|NCT04436744|65203407|FG001|Overall Study|Death|0|||
23397855|NCT04436744|65203406|FG000|Overall Study|Lost to Follow-up|0|||
23397856|NCT04436744|65203407|FG001|Overall Study|Lost to Follow-up|2|||
23697614|NCT01855789|66270479|FG000|2) Week 24 up to End of Study|Other|0|||
23697615|NCT01855789|66270480|FG001|2) Week 24 up to End of Study|Other|0|||
23697616|NCT01855789|66270481|FG002|2) Week 24 up to End of Study|Other|0|||
23697617|NCT01855789|66270482|FG003|2) Week 24 up to End of Study|Other|1|||
23697618|NCT02021812|66270483|FG000|Overall Study|Death|8|||
23697619|NCT02021812|66270483|FG000|Overall Study|Withdrawal by Subject|3|||
23697620|NCT02021812|66270483|FG000|Overall Study|Lost to Follow-up|2|||
23697621|NCT02021812|66270483|FG000|Overall Study|Refuse to return, COVD 19|2|||
23697622|NCT01171521|66270487|FG000|Overall Study|Lost to Follow-up|5|||
23697623|NCT01171521|66270487|FG000|Overall Study|screen failure|1|||
23697624|NCT00542828|66270488|FG000|Overall Study|Physician Decision|1|||
23697625|NCT00542828|66270488|FG000|Overall Study|Need for Prohibited Treatment|3|||
23697626|NCT00542828|66270488|FG000|Overall Study|Study Prematurely Discontinued|7|||
23697627|NCT00542828|66270488|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
23697628|NCT02961764|66270489|FG000|Overall Study|Protocol Violation|0|||
23697629|NCT02961764|66270490|FG001|Overall Study|Protocol Violation|1|||
23697630|NCT02961764|66270489|FG000|Overall Study|Death|2|||
23397857|NCT04436744|65203406|FG000|Overall Study|Physician Decision|0|||
23397858|NCT04436744|65203407|FG001|Overall Study|Physician Decision|1|||
23397859|NCT04436744|65203406|FG000|Overall Study|Progressive Disease|0|||
23397860|NCT04436744|65203407|FG001|Overall Study|Progressive Disease|4|||
23397861|NCT04436744|65203406|FG000|Overall Study|Protocol Deviation|1|||
23397862|NCT04436744|65203407|FG001|Overall Study|Protocol Deviation|1|||
23397863|NCT04436744|65203406|FG000|Overall Study|Withdrawal by Subject|1|||
23397864|NCT04436744|65203407|FG001|Overall Study|Withdrawal by Subject|2|||
23397865|NCT02704208|65203408|FG000|Overall Study|Lost to Follow-up|42|||
23397866|NCT02704208|65203409|FG001|Overall Study|Lost to Follow-up|37|||
23397867|NCT01677988|65203410|FG000|Overall Study|Lack of Efficacy|2|||
23697631|NCT02961764|66270490|FG001|Overall Study|Death|0|||
23397868|NCT04476784|65203414|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
23397869|NCT04476784|65203415|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
23397870|NCT02437318|65203416|FG000|Overall Study|Progressive disease|173|||
23397871|NCT02437318|65203417|FG001|Overall Study|Progressive disease|208|||
23697632|NCT02961764|66270489|FG000|Overall Study|Lost to Follow-up|35|||
23697633|NCT02961764|66270490|FG001|Overall Study|Lost to Follow-up|24|||
23697634|NCT02961764|66270489|FG000|Overall Study|Withdrawal by Subject|2|||
23397872|NCT02437318|65203416|FG000|Overall Study|Subject/guardian decision|22|||
23397873|NCT02437318|65203417|FG001|Overall Study|Subject/guardian decision|10|||
23397874|NCT02437318|65203416|FG000|Overall Study|Physician Decision|11|||
23397875|NCT02437318|65203417|FG001|Overall Study|Physician Decision|10|||
23397876|NCT02437318|65203416|FG000|Overall Study|Adverse Event|14|||
23397877|NCT02437318|65203417|FG001|Overall Study|Adverse Event|3|||
23697635|NCT02961764|66270490|FG001|Overall Study|Withdrawal by Subject|0|||
23397878|NCT02437318|65203416|FG000|Overall Study|Death|4|||
23397879|NCT02437318|65203417|FG001|Overall Study|Death|4|||
23397880|NCT02437318|65203416|FG000|Overall Study|Protocol Violation|5|||
23397881|NCT02437318|65203417|FG001|Overall Study|Protocol Violation|6|||
23397882|NCT02437318|65203416|FG000|Overall Study|Untreated|0|||
23397883|NCT02437318|65203417|FG001|Overall Study|Untreated|1|||
23397884|NCT00448448|65203419|FG000|Overall Study|Withdrawal by Subject|13|||
23397885|NCT00448448|65203420|FG001|Overall Study|Withdrawal by Subject|2|||
23397886|NCT00448448|65203419|FG000|Overall Study|On protocol when study ended|83|||
23397887|NCT00448448|65203420|FG001|Overall Study|On protocol when study ended|36|||
23397888|NCT00448448|65203419|FG000|Overall Study|Lost to Follow-up|2|||
23397889|NCT00448448|65203420|FG001|Overall Study|Lost to Follow-up|1|||
23397890|NCT00448448|65203419|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
23397891|NCT00448448|65203420|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
23397892|NCT00448448|65203419|FG000|Overall Study|Signed consent lost|0|||
23397893|NCT00448448|65203420|FG001|Overall Study|Signed consent lost|1|||
23397894|NCT02378480|65203421|FG000|Overall Study|Physician Decision|1|||
23397895|NCT02378480|65203422|FG001|Overall Study|Physician Decision|1|||
23397896|NCT02378480|65203421|FG000|Overall Study|Death|1|||
23397897|NCT02378480|65203422|FG001|Overall Study|Death|2|||
23397898|NCT02378480|65203421|FG000|Overall Study|Randomized, but Not Treated|6|||
23397899|NCT02378480|65203422|FG001|Overall Study|Randomized, but Not Treated|4|||
23397900|NCT02378480|65203421|FG000|Overall Study|Adverse Event|0|||
23397901|NCT02378480|65203422|FG001|Overall Study|Adverse Event|1|||
23397902|NCT02378480|65203421|FG000|Overall Study|Missed EOT/PTE Visit|1|||
23397903|NCT02378480|65203422|FG001|Overall Study|Missed EOT/PTE Visit|2|||
23397904|NCT02378480|65203421|FG000|Overall Study|Withdrawal by Subject|9|||
23397905|NCT02378480|65203422|FG001|Overall Study|Withdrawal by Subject|4|||
23397906|NCT02378480|65203421|FG000|Overall Study|Lost to Follow-up|10|||
23397907|NCT02378480|65203422|FG001|Overall Study|Lost to Follow-up|18|||
23697636|NCT02031146|66270493|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23697637|NCT02031146|66270494|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23697638|NCT02031146|66270495|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23697639|NCT02031146|66270496|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
23697640|NCT02031146|66270497|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
23697641|NCT02031146|66270498|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
23697642|NCT02031146|66270499|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
23697643|NCT01348919|66270502|FG000|Overall Study|Adverse Event|3|||
23697644|NCT01348919|66270503|FG001|Overall Study|Adverse Event|1|||
23697645|NCT01348919|66270504|FG002|Overall Study|Adverse Event|0|||
23697646|NCT01348919|66270502|FG000|Overall Study|Withdrawal by Subject|0|||
23697647|NCT01348919|66270503|FG001|Overall Study|Withdrawal by Subject|1|||
23697648|NCT01348919|66270504|FG002|Overall Study|Withdrawal by Subject|0|||
23697649|NCT01348919|66270502|FG000|Overall Study|Disease progression|0|||
23697650|NCT01348919|66270503|FG001|Overall Study|Disease progression|1|||
23697651|NCT01348919|66270504|FG002|Overall Study|Disease progression|1|||
23697652|NCT04601272|66270505|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
23697653|NCT04601272|66270506|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
23697654|NCT04601272|66270507|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
23697655|NCT03705494|66270509|FG000|Overall Study|Lost to Follow-up|2|||
23697656|NCT03705494|66270510|FG001|Overall Study|Lost to Follow-up|1|||
23697657|NCT03705494|66270509|FG000|Overall Study|Withdrawal by Subject|5|||
23697658|NCT03705494|66270510|FG001|Overall Study|Withdrawal by Subject|2|||
23697659|NCT04334148|66270511|FG000|Overall Study|positive nasal swab at baseline|0|||
23697660|NCT04334148|66270512|FG001|Overall Study|positive nasal swab at baseline|1|||
23697661|NCT03270085|66270513|FG000|Overall Study|Withdrawal by Subject|1|||
23697662|NCT03270085|66270514|FG001|Overall Study|Withdrawal by Subject|0|||
23697663|NCT05253807|66270515|FG000|Overall Study|Death|1|||
23697664|NCT05253807|66270516|FG001|Overall Study|Death|4|||
23697665|NCT05253807|66270515|FG000|Overall Study|Withdrawal by Subject|1|||
23697666|NCT05253807|66270516|FG001|Overall Study|Withdrawal by Subject|0|||
23697667|NCT05253807|66270515|FG000|Overall Study|Study Terminated by Sponsor|1|||
23697668|NCT05253807|66270516|FG001|Overall Study|Study Terminated by Sponsor|1|||
23697669|NCT03280550|66270519|FG000|Overall Study|Withdrawal by Subject|2|||
23697670|NCT03280550|66270520|FG001|Overall Study|Withdrawal by Subject|2|||
23697671|NCT03280550|66270519|FG000|Overall Study|Physician Decision|0|||
23697672|NCT03280550|66270520|FG001|Overall Study|Physician Decision|1|||
23697673|NCT00375934|66270522|FG000|Overall Study|Adverse Event|1|||
23697674|NCT00375934|66270523|FG001|Overall Study|Adverse Event|1|||
23697675|NCT00375934|66270522|FG000|Overall Study|Withdrawal by Subject|2|||
23397908|NCT02441218|65203425|FG000|Overall Study|Death|503|||
23397909|NCT02441218|65203426|FG001|Overall Study|Death|553|||
23397910|NCT02441218|65203425|FG000|Overall Study|Withdrawal by Subject|73|||
23397911|NCT02441218|65203426|FG001|Overall Study|Withdrawal by Subject|58|||
23697676|NCT00375934|66270523|FG001|Overall Study|Withdrawal by Subject|2|||
23397912|NCT02441218|65203425|FG000|Overall Study|Lost to Follow-up|2|||
23697677|NCT00375934|66270522|FG000|Overall Study|Lack of Efficacy|0|||
23697678|NCT00375934|66270523|FG001|Overall Study|Lack of Efficacy|2|||
23697679|NCT00375934|66270522|FG000|Overall Study|Physician Decision|0|||
23697680|NCT00375934|66270523|FG001|Overall Study|Physician Decision|1|||
23697681|NCT02362412|66270524|FG000|Treatment Period III|Lost to Follow-up|0|||
23697682|NCT02362412|66270525|FG001|Treatment Period III|Lost to Follow-up|1|||
23697683|NCT00564629|66270529|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
23697684|NCT00564629|66270530|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
23697685|NCT04021862|66270531|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23697686|NCT04021862|66270532|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
23697687|NCT04021862|66270533|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23697688|NCT04021862|66270534|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23697689|NCT04021862|66270535|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23697690|NCT04021862|66270536|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23697691|NCT04021862|66270531|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
23397913|NCT02441218|65203426|FG001|Overall Study|Lost to Follow-up|1|||
23397914|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
23397915|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
23397916|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
23397917|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
23397918|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
23397919|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
23697692|NCT04021862|66270532|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23697693|NCT04021862|66270533|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23697694|NCT04021862|66270534|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23697695|NCT04021862|66270535|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23697696|NCT04021862|66270536|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23697697|NCT04021862|66270531|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23697698|NCT04021862|66270532|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23697699|NCT04021862|66270533|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
23697700|NCT04021862|66270534|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23697701|NCT04021862|66270535|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23697702|NCT04021862|66270536|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23697703|NCT04021862|66270531|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
23697704|NCT04021862|66270532|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
23697705|NCT04021862|66270533|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
23697706|NCT04021862|66270534|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
23397920|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
23397921|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
23397922|NCT01373281|65203427|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
23397923|NCT01373281|65203428|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
23397924|NCT01373281|65203427|FG000|Surveillance Expansion Period|Protocol Violation|9|||
23397925|NCT01373281|65203428|FG001|Surveillance Expansion Period|Protocol Violation|1|||
23397926|NCT01373281|65203427|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
23397927|NCT01373281|65203428|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
23397928|NCT01373281|65203427|FG000|Surveillance Expansion Period|Serious adverse event|3|||
23397929|NCT01373281|65203428|FG001|Surveillance Expansion Period|Serious adverse event|4|||
23397930|NCT02133573|65203434|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
23397931|NCT02133573|65203435|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
23397932|NCT02133573|65203434|FG000|Overall Study|Child Deaths|3|||
23397933|NCT02133573|65203435|FG001|Overall Study|Child Deaths|5|||
23397934|NCT02133573|65203434|FG000|Overall Study|Child Declined Follow Ups|2|||
23397935|NCT02133573|65203435|FG001|Overall Study|Child Declined Follow Ups|1|||
23397936|NCT02133573|65203434|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
23397937|NCT02133573|65203435|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
23397938|NCT01693367|65203438|FG000|Overall Study|Withdrawal by Subject|1|||
23397939|NCT01693367|65203439|FG001|Overall Study|Withdrawal by Subject|1|||
23397940|NCT01693367|65203438|FG000|Overall Study|Physician Decision|0|||
23397941|NCT01693367|65203439|FG001|Overall Study|Physician Decision|1|||
23397942|NCT00582907|65203440|FG000|1st Course|Withdrawal by Subject|1|||
23397943|NCT00582907|65203441|FG001|1st Course|Withdrawal by Subject|0|||
23697707|NCT04021862|66270535|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
23697708|NCT04021862|66270536|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
23397944|NCT00582907|65203442|FG002|1st Course|Withdrawal by Subject|0|||
23397945|NCT00582907|65203443|FG003|1st Course|Withdrawal by Subject|0|||
23697709|NCT04021862|66270531|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23397946|NCT00582907|65203440|FG000|1st Course|Lost to Follow-up|0|||
23397947|NCT00582907|65203441|FG001|1st Course|Lost to Follow-up|0|||
23397948|NCT00582907|65203442|FG002|1st Course|Lost to Follow-up|0|||
23397949|NCT00582907|65203443|FG003|1st Course|Lost to Follow-up|1|||
23697710|NCT04021862|66270532|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23697711|NCT04021862|66270533|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23697712|NCT04021862|66270534|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
23697713|NCT04021862|66270535|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23697714|NCT04021862|66270536|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23697715|NCT01663740|66270545|FG000|Overall Study|Lost to Follow-up|1|||
23697716|NCT01663740|66270546|FG001|Overall Study|Lost to Follow-up|4|||
23697717|NCT01663740|66270545|FG000|Overall Study|Other|9|||
23697718|NCT01663740|66270546|FG001|Overall Study|Other|2|||
23697719|NCT01663740|66270545|FG000|Overall Study|Inclusion/Exclusion not met|1|||
23697720|NCT01663740|66270546|FG001|Overall Study|Inclusion/Exclusion not met|0|||
23697721|NCT01663740|66270545|FG000|Overall Study|Death|0|||
23697722|NCT01663740|66270546|FG001|Overall Study|Death|1|||
23697723|NCT01663740|66270545|FG000|Overall Study|Withdrawal by Subject|2|||
23697724|NCT01663740|66270546|FG001|Overall Study|Withdrawal by Subject|1|||
23697725|NCT01663740|66270545|FG000|Overall Study|No end of study status|3|||
23697726|NCT01663740|66270546|FG001|Overall Study|No end of study status|0|||
23697727|NCT02586207|66270547|FG000|Overall Study|Physician Decision|1|||
23697728|NCT02586207|66270547|FG000|Overall Study|Withdrawal by Subject|1|||
23697729|NCT04172831|66270548|FG000|Overall Study|Adverse Event|21|||
23697730|NCT04172831|66270549|FG001|Overall Study|Adverse Event|9|||
23697731|NCT04172831|66270548|FG000|Overall Study|Lack of Efficacy|2|||
23697732|NCT04172831|66270549|FG001|Overall Study|Lack of Efficacy|8|||
23697733|NCT04172831|66270548|FG000|Overall Study|Physician Decision|0|||
23697734|NCT04172831|66270549|FG001|Overall Study|Physician Decision|1|||
23697735|NCT04172831|66270548|FG000|Overall Study|Withdrawal by Subject|12|||
23697736|NCT04172831|66270549|FG001|Overall Study|Withdrawal by Subject|11|||
23697737|NCT04172831|66270548|FG000|Overall Study|Lost to Follow-up|4|||
23697738|NCT04172831|66270549|FG001|Overall Study|Lost to Follow-up|9|||
23697739|NCT04172831|66270548|FG000|Overall Study|COVID-19 related crisis|3|||
23697740|NCT04172831|66270549|FG001|Overall Study|COVID-19 related crisis|3|||
23697741|NCT04172831|66270548|FG000|Overall Study|Subject non-compliance|1|||
23697742|NCT04172831|66270549|FG001|Overall Study|Subject non-compliance|1|||
23697743|NCT04172831|66270548|FG000|Overall Study|Family emergency|1|||
23697744|NCT04172831|66270549|FG001|Overall Study|Family emergency|0|||
23697745|NCT00621023|66270550|FG000|Overall Study|Death|5|||
23697746|NCT00621023|66270550|FG000|Overall Study|Follow up discontinued|1|||
23697747|NCT02613572|66270551|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
23697748|NCT02613572|66270552|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
23697749|NCT02613572|66270553|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
23697750|NCT02613572|66270551|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
23697751|NCT02613572|66270552|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
23697752|NCT02613572|66270553|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
23697753|NCT03000452|66270554|FG000|Treatment Period|Death|1|||
23697754|NCT03000452|66270554|FG000|Treatment Period|Progressive Disease (PD)|14|||
23697755|NCT03000452|66270554|FG000|Treatment Period|Physician Decision|1|||
23697756|NCT03000452|66270554|FG000|Treatment Period|Miscellaneous|2|||
23697757|NCT03000452|66270554|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
23697758|NCT03000452|66270554|FG000|Follow-Up Period|Death|3|||
23697759|NCT03000452|66270554|FG000|Follow-Up Period|Withdrawal by Subject|3|||
23697760|NCT01873950|66270555|FG000|Period 5|Withdrawal by Subject|0|||
23697761|NCT01873950|66270556|FG001|Period 5|Withdrawal by Subject|0|||
23697762|NCT01873950|66270557|FG002|Period 5|Withdrawal by Subject|0|||
23697763|NCT01873950|66270558|FG003|Period 5|Withdrawal by Subject|1|||
23697764|NCT01873950|66270559|FG004|Period 5|Withdrawal by Subject|0|||
23697765|NCT02224846|66270560|FG000|Period 1 (Month 3)|Adverse Event|2|||
23697766|NCT02224846|66270561|FG001|Period 1 (Month 3)|Adverse Event|1|||
23697767|NCT02224846|66270560|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
23697768|NCT02224846|66270561|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
23697769|NCT02224846|66270560|FG000|Period 1 (Month 3)|Protocol Violation|4|||
23697770|NCT02224846|66270561|FG001|Period 1 (Month 3)|Protocol Violation|8|||
23697771|NCT02224846|66270560|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
23697772|NCT02224846|66270561|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
23697773|NCT02224846|66270560|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
23697774|NCT02224846|66270561|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
23697775|NCT02224846|66270560|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
23498656|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23498657|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23697776|NCT02224846|66270561|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
23697777|NCT02224846|66270560|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
23697778|NCT02224846|66270561|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
23697779|NCT02224846|66270560|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
23697780|NCT02224846|66270561|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
23697781|NCT02224846|66270560|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
23697782|NCT02224846|66270561|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
23397950|NCT00582907|65203440|FG000|2nd Course|Lack of Efficacy|1|||
23697783|NCT02224846|66270560|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
23697784|NCT02224846|66270561|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
23697785|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
23697786|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
23697787|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
23697788|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
23697789|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
23697790|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
23697791|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
23697792|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
23697793|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
23697794|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
23697795|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
23697796|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
23697797|NCT02224846|66270560|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
23697798|NCT02224846|66270561|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
23697799|NCT00404768|66270571|FG000|Part A and B|Withdrawn due to labor progression|1|||
23697800|NCT00404768|66270572|FG001|Part A and B|Withdrawn due to labor progression|0|||
23697801|NCT00404768|66270573|FG002|Part A and B|Withdrawn due to labor progression|0|||
23697802|NCT00404768|66270574|FG003|Part A and B|Withdrawn due to labor progression|0|||
23697803|NCT00404768|66270571|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
23697804|NCT00404768|66270572|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
23697805|NCT00404768|66270573|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
23697806|NCT00404768|66270574|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
23697807|NCT00404768|66270571|FG000|Part C|Adverse Event|0|||
23697808|NCT00404768|66270572|FG001|Part C|Adverse Event|0|||
23697809|NCT00404768|66270573|FG002|Part C|Adverse Event|0|||
23697810|NCT00404768|66270574|FG003|Part C|Adverse Event|3|||
23697811|NCT00404768|66270571|FG000|Part C|Lost to Follow-up|0|||
23697812|NCT00404768|66270572|FG001|Part C|Lost to Follow-up|0|||
23697813|NCT00404768|66270573|FG002|Part C|Lost to Follow-up|3|||
23697814|NCT00404768|66270574|FG003|Part C|Lost to Follow-up|1|||
23697815|NCT00404768|66270571|FG000|Part C|Withdrawal by Subject|0|||
23697816|NCT00404768|66270572|FG001|Part C|Withdrawal by Subject|0|||
23397951|NCT00582907|65203441|FG001|2nd Course|Lack of Efficacy|0|||
23397952|NCT00582907|65203442|FG002|2nd Course|Lack of Efficacy|0|||
23397953|NCT00582907|65203443|FG003|2nd Course|Lack of Efficacy|0|||
23397954|NCT04290624|65203444|FG000|Overall Study|Adverse Event|1|||
23697817|NCT00404768|66270573|FG002|Part C|Withdrawal by Subject|2|||
23697818|NCT00404768|66270574|FG003|Part C|Withdrawal by Subject|1|||
23697819|NCT00404768|66270571|FG000|Part C|Early withdrawal from study medication|0|||
23697820|NCT00404768|66270572|FG001|Part C|Early withdrawal from study medication|0|||
23697821|NCT00404768|66270573|FG002|Part C|Early withdrawal from study medication|1|||
23697822|NCT00404768|66270574|FG003|Part C|Early withdrawal from study medication|0|||
23697823|NCT00404768|66270571|FG000|Part C|Participant did not respond to therapy|0|||
23697824|NCT00404768|66270572|FG001|Part C|Participant did not respond to therapy|0|||
23697825|NCT00404768|66270573|FG002|Part C|Participant did not respond to therapy|1|||
23697826|NCT00404768|66270574|FG003|Part C|Participant did not respond to therapy|1|||
23697827|NCT00404768|66270571|FG000|Part C|Physician withdrew the study medication|0|||
23697828|NCT00404768|66270572|FG001|Part C|Physician withdrew the study medication|0|||
23697829|NCT00404768|66270573|FG002|Part C|Physician withdrew the study medication|1|||
23697830|NCT00404768|66270574|FG003|Part C|Physician withdrew the study medication|0|||
23697831|NCT00404768|66270571|FG000|Part C|Participant delivered baby|0|||
23697832|NCT00404768|66270572|FG001|Part C|Participant delivered baby|0|||
23697833|NCT00404768|66270573|FG002|Part C|Participant delivered baby|0|||
23697834|NCT00404768|66270574|FG003|Part C|Participant delivered baby|1|||
23697835|NCT00404768|66270571|FG000|Part C|Unsatisfactory uterine response to IP|0|||
23397955|NCT04290624|65203445|FG001|Overall Study|Adverse Event|0|||
23397956|NCT00833690|65203446|FG000|Overall Study|Withdrawal by Subject|1|||
23397957|NCT00833690|65203447|FG001|Overall Study|Withdrawal by Subject|0|||
23397958|NCT00833690|65203448|FG002|Overall Study|Withdrawal by Subject|0|||
23397959|NCT00833690|65203446|FG000|Overall Study|Discontinued study drug|3|||
23397960|NCT00833690|65203447|FG001|Overall Study|Discontinued study drug|2|||
23397961|NCT00833690|65203448|FG002|Overall Study|Discontinued study drug|0|||
23397962|NCT00127855|65203453|FG000|Primary Vaccination Course|Adverse Event|0|||
23397963|NCT00127855|65203454|FG001|Primary Vaccination Course|Adverse Event|0|||
23697836|NCT00404768|66270572|FG001|Part C|Unsatisfactory uterine response to IP|0|||
23697837|NCT00404768|66270573|FG002|Part C|Unsatisfactory uterine response to IP|0|||
23697838|NCT00404768|66270574|FG003|Part C|Unsatisfactory uterine response to IP|1|||
23697839|NCT00404768|66270571|FG000|Part C|Active labor|0|||
23697840|NCT00404768|66270572|FG001|Part C|Active labor|0|||
23397964|NCT00127855|65203455|FG002|Primary Vaccination Course|Adverse Event|1|||
23697841|NCT00404768|66270573|FG002|Part C|Active labor|0|||
23697842|NCT00404768|66270574|FG003|Part C|Active labor|1|||
23697843|NCT00404768|66270571|FG000|Part C|Lack of Efficacy|0|||
23697844|NCT00404768|66270572|FG001|Part C|Lack of Efficacy|0|||
23697845|NCT00404768|66270573|FG002|Part C|Lack of Efficacy|0|||
23697846|NCT00404768|66270574|FG003|Part C|Lack of Efficacy|2|||
23397965|NCT00127855|65203456|FG003|Primary Vaccination Course|Adverse Event|0|||
23397966|NCT00127855|65203457|FG004|Primary Vaccination Course|Adverse Event|0|||
23697847|NCT00404768|66270571|FG000|Part C|Treatment failure|0|||
23697848|NCT00404768|66270572|FG001|Part C|Treatment failure|0|||
23697849|NCT00404768|66270573|FG002|Part C|Treatment failure|0|||
23697850|NCT00404768|66270574|FG003|Part C|Treatment failure|1|||
23697851|NCT00404768|66270571|FG000|Part C|Investigator discretion|0|||
23697852|NCT00404768|66270572|FG001|Part C|Investigator discretion|0|||
23697853|NCT00404768|66270573|FG002|Part C|Investigator discretion|0|||
23697854|NCT00404768|66270574|FG003|Part C|Investigator discretion|1|||
23697855|NCT00404768|66270571|FG000|Part C|Researcher suspended study medication|0|||
23697856|NCT00404768|66270572|FG001|Part C|Researcher suspended study medication|0|||
23697857|NCT00404768|66270573|FG002|Part C|Researcher suspended study medication|0|||
23697858|NCT00404768|66270574|FG003|Part C|Researcher suspended study medication|1|||
23697859|NCT00857246|66270577|FG000|Induction Regimen|Adverse Event|1|||
23697860|NCT00857246|66270577|FG000|Induction Regimen|disease-related complications|1|||
23697861|NCT00857246|66270577|FG000|Induction Regimen|Withdrawal by Subject|1|||
23697862|NCT00857246|66270577|FG000|Surgery (Curative)|disease progression|6|||
23697863|NCT00857246|66270577|FG000|ChemoRT|Withdrawal by Subject|1|||
23697864|NCT00857246|66270577|FG000|ChemoRT|Adverse Event|2|||
23697865|NCT01927562|66270578|FG000|Overall Study|Lost to Follow-up|30|||
23697866|NCT01927562|66270578|FG000|Overall Study|Withdrawal by Subject|3|||
23697867|NCT01927562|66270578|FG000|Overall Study|Physician Decision|5|||
23697868|NCT00417612|66270579|FG000|Overall Study|Errant diagnosis|0|||
23697869|NCT00417612|66270580|FG001|Overall Study|Errant diagnosis|1|||
23697870|NCT00417612|66270579|FG000|Overall Study|Adverse Event|2|||
23697871|NCT00417612|66270580|FG001|Overall Study|Adverse Event|0|||
23697872|NCT00417612|66270579|FG000|Overall Study|Protocol Violation|0|||
23697873|NCT00417612|66270580|FG001|Overall Study|Protocol Violation|2|||
23697874|NCT00417612|66270579|FG000|Overall Study|Lost to Follow-up|1|||
23697875|NCT00417612|66270580|FG001|Overall Study|Lost to Follow-up|0|||
23697876|NCT00519532|66270587|FG000|Overall Study|Adverse Event|11|||
23697877|NCT00519532|66270587|FG000|Overall Study|Withdrawal by Subject|5|||
23697878|NCT00519532|66270587|FG000|Overall Study|Lost to Follow-up|2|||
23697879|NCT04952389|66270588|FG000|Overall Study|Withdrawal by Subject|8|||
23697880|NCT04952389|66270589|FG001|Overall Study|Withdrawal by Subject|4|||
23697881|NCT01507545|66270596|FG000|Overall Study|Withdrawal by Subject|6|||
23697882|NCT01507545|66270597|FG001|Overall Study|Withdrawal by Subject|2|||
23697883|NCT01507545|66270596|FG000|Overall Study|Lost to Follow-up|1|||
23697884|NCT01507545|66270597|FG001|Overall Study|Lost to Follow-up|0|||
23697885|NCT01507545|66270596|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
23697886|NCT01507545|66270597|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
23697887|NCT01507545|66270596|FG000|Overall Study|Progressive disease|60|||
23697888|NCT01507545|66270597|FG001|Overall Study|Progressive disease|27|||
23697889|NCT01507545|66270596|FG000|Overall Study|Other|6|||
23697890|NCT01507545|66270597|FG001|Overall Study|Other|4|||
23697891|NCT02640612|66270602|FG000|Overall Study|Adverse Event|6|||
23697892|NCT02640612|66270603|FG001|Overall Study|Adverse Event|7|||
23697893|NCT02640612|66270604|FG002|Overall Study|Adverse Event|2|||
23697894|NCT02640612|66270602|FG000|Overall Study|Death|1|||
23697895|NCT02640612|66270603|FG001|Overall Study|Death|0|||
23697896|NCT02640612|66270604|FG002|Overall Study|Death|0|||
23697897|NCT02640612|66270602|FG000|Overall Study|Withdrawal by Subject|10|||
23697898|NCT02640612|66270603|FG001|Overall Study|Withdrawal by Subject|3|||
23697899|NCT02640612|66270604|FG002|Overall Study|Withdrawal by Subject|3|||
23697900|NCT02640612|66270602|FG000|Overall Study|Lost to Follow-up|4|||
23697901|NCT02640612|66270603|FG001|Overall Study|Lost to Follow-up|1|||
23697902|NCT02640612|66270604|FG002|Overall Study|Lost to Follow-up|1|||
23697903|NCT02640612|66270602|FG000|Overall Study|Protocol Violation|0|||
23697904|NCT02640612|66270603|FG001|Overall Study|Protocol Violation|2|||
23697905|NCT02640612|66270604|FG002|Overall Study|Protocol Violation|0|||
23697906|NCT02640612|66270602|FG000|Overall Study|Lack of Efficacy|1|||
23397967|NCT00127855|65203453|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
23397968|NCT00127855|65203454|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
23397969|NCT00127855|65203455|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
23697907|NCT02640612|66270603|FG001|Overall Study|Lack of Efficacy|1|||
23697908|NCT02640612|66270604|FG002|Overall Study|Lack of Efficacy|0|||
23697909|NCT02792777|66270606|FG000|Overall Study|Withdrawal by Subject|2|||
23397970|NCT00127855|65203456|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
23697910|NCT02792777|66270607|FG001|Overall Study|Withdrawal by Subject|0|||
23397971|NCT00127855|65203457|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
23697911|NCT02792777|66270606|FG000|Overall Study|Recording malfunction|2|||
23697912|NCT02792777|66270607|FG001|Overall Study|Recording malfunction|0|||
23697913|NCT02792777|66270606|FG000|Overall Study|Later determined to be ineligible|2|||
23697914|NCT02792777|66270607|FG001|Overall Study|Later determined to be ineligible|0|||
23697915|NCT02792777|66270606|FG000|Overall Study|Participant interviewed twice|1|||
23697916|NCT02792777|66270607|FG001|Overall Study|Participant interviewed twice|0|||
23697917|NCT02413255|66270616|FG000|Overall Study|Voluntary Withdrawal|0|||
23697918|NCT02413255|66270617|FG001|Overall Study|Voluntary Withdrawal|0|||
23697919|NCT02413255|66270618|FG002|Overall Study|Voluntary Withdrawal|0|||
23697920|NCT02413255|66270619|FG003|Overall Study|Voluntary Withdrawal|0|||
23697921|NCT02413255|66270620|FG004|Overall Study|Voluntary Withdrawal|0|||
23697922|NCT02413255|66270621|FG005|Overall Study|Voluntary Withdrawal|0|||
23697923|NCT02413255|66270622|FG006|Overall Study|Voluntary Withdrawal|0|||
23697924|NCT02413255|66270623|FG007|Overall Study|Voluntary Withdrawal|0|||
23697925|NCT02413255|66270624|FG008|Overall Study|Voluntary Withdrawal|0|||
23697926|NCT02413255|66270625|FG009|Overall Study|Voluntary Withdrawal|0|||
23697927|NCT02413255|66270626|FG010|Overall Study|Voluntary Withdrawal|0|||
23697928|NCT02413255|66270627|FG011|Overall Study|Voluntary Withdrawal|0|||
23697929|NCT02413255|66270628|FG012|Overall Study|Voluntary Withdrawal|0|||
23697930|NCT02413255|66270629|FG013|Overall Study|Voluntary Withdrawal|0|||
23697931|NCT02413255|66270630|FG014|Overall Study|Voluntary Withdrawal|1|||
23697932|NCT02413255|66270631|FG015|Overall Study|Voluntary Withdrawal|0|||
23697933|NCT02413255|66270632|FG016|Overall Study|Voluntary Withdrawal|0|||
23697934|NCT00984659|66270633|FG000|2-week Run-in Period|Adverse Event|8|||
23697935|NCT00984659|66270634|FG001|2-week Run-in Period|Adverse Event|0|||
23697936|NCT00984659|66270635|FG002|2-week Run-in Period|Adverse Event|0|||
23397972|NCT00127855|65203453|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
23397973|NCT00127855|65203454|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
23697937|NCT00984659|66270636|FG003|2-week Run-in Period|Adverse Event|0|||
23697938|NCT00984659|66270633|FG000|2-week Run-in Period|Protocol Violation|5|||
23697939|NCT00984659|66270634|FG001|2-week Run-in Period|Protocol Violation|0|||
23697940|NCT00984659|66270635|FG002|2-week Run-in Period|Protocol Violation|0|||
23697941|NCT00984659|66270636|FG003|2-week Run-in Period|Protocol Violation|0|||
23697942|NCT00984659|66270633|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
23697943|NCT00984659|66270634|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
23697944|NCT00984659|66270635|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
23697945|NCT00984659|66270636|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
23697946|NCT00984659|66270633|FG000|2-week Run-in Period|Lost to Follow-up|3|||
23697947|NCT00984659|66270634|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23697948|NCT00984659|66270635|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23697949|NCT00984659|66270636|FG003|2-week Run-in Period|Lost to Follow-up|0|||
23697950|NCT00984659|66270633|FG000|2-week Run-in Period|Physician Decision|10|||
23697951|NCT00984659|66270634|FG001|2-week Run-in Period|Physician Decision|0|||
23397974|NCT00127855|65203455|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
23397975|NCT00127855|65203456|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
23397976|NCT00127855|65203457|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
23697952|NCT00984659|66270635|FG002|2-week Run-in Period|Physician Decision|0|||
23697953|NCT00984659|66270636|FG003|2-week Run-in Period|Physician Decision|0|||
23697954|NCT00984659|66270633|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
23697955|NCT00984659|66270634|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23697956|NCT00984659|66270635|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23697957|NCT00984659|66270636|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
23697958|NCT00984659|66270633|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
23697959|NCT00984659|66270634|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23697960|NCT00984659|66270635|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23697961|NCT00984659|66270636|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23697962|NCT00984659|66270633|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
23697963|NCT00984659|66270634|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
23697964|NCT00984659|66270635|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
23697965|NCT00984659|66270636|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
23697966|NCT00984659|66270633|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
23697967|NCT00984659|66270634|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
23697968|NCT00984659|66270635|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
23697969|NCT00984659|66270636|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
23697970|NCT00984659|66270633|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
23697971|NCT00984659|66270634|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
23697972|NCT00984659|66270635|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
23697973|NCT00984659|66270636|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
23397977|NCT00127855|65203453|FG000|Primary Vaccination Course|Other|0|||
23397978|NCT00127855|65203454|FG001|Primary Vaccination Course|Other|0|||
23697974|NCT00984659|66270633|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23697975|NCT00984659|66270634|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23697976|NCT00984659|66270635|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
23697977|NCT00984659|66270636|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23697978|NCT00984659|66270633|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23397979|NCT00127855|65203455|FG002|Primary Vaccination Course|Other|0|||
23397980|NCT00127855|65203456|FG003|Primary Vaccination Course|Other|0|||
23697979|NCT00984659|66270634|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
23697980|NCT00984659|66270635|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
23697981|NCT00984659|66270636|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
23697982|NCT01486238|66270637|FG000|Overall Study|Death|0|||
23697983|NCT01486238|66270638|FG001|Overall Study|Death|2|||
23697984|NCT01486238|66270637|FG000|Overall Study|Withdrawal by Subject|2|||
23697985|NCT01486238|66270638|FG001|Overall Study|Withdrawal by Subject|1|||
23697986|NCT01486238|66270637|FG000|Overall Study|Lost to Follow-up|0|||
23697987|NCT01486238|66270638|FG001|Overall Study|Lost to Follow-up|3|||
23697988|NCT01070303|66270641|FG000|Overall Study|Adverse Event|39|||
23697989|NCT01070303|66270641|FG000|Overall Study|Withdrawal by Subject|20|||
23697990|NCT01070303|66270641|FG000|Overall Study|Lost to Follow-up|9|||
23697991|NCT01070303|66270641|FG000|Overall Study|Protocol Violation|0|||
23697992|NCT01070303|66270641|FG000|Overall Study|Lack of Efficacy|2|||
23697993|NCT01070303|66270641|FG000|Overall Study|Administrative Reason|1|||
23697994|NCT01070303|66270641|FG000|Overall Study|Other|18|||
23697995|NCT00196937|66270642|FG000|Overall Study|Serious Adverse Event|1|||
23697996|NCT00196937|66270643|FG001|Overall Study|Serious Adverse Event|0|||
23697997|NCT00196937|66270644|FG002|Overall Study|Serious Adverse Event|0|||
23697998|NCT00196937|66270642|FG000|Overall Study|Non-serious adverse event|1|||
23697999|NCT00196937|66270643|FG001|Overall Study|Non-serious adverse event|1|||
23698000|NCT00196937|66270644|FG002|Overall Study|Non-serious adverse event|1|||
23698001|NCT00196937|66270642|FG000|Overall Study|Withdrawal by Subject|0|||
23698002|NCT00196937|66270643|FG001|Overall Study|Withdrawal by Subject|0|||
23698003|NCT00196937|66270644|FG002|Overall Study|Withdrawal by Subject|2|||
23698004|NCT00196937|66270642|FG000|Overall Study|Lost to Follow-up|4|||
23698005|NCT00196937|66270643|FG001|Overall Study|Lost to Follow-up|3|||
23698006|NCT00196937|66270644|FG002|Overall Study|Lost to Follow-up|3|||
23698007|NCT00196937|66270642|FG000|Overall Study|Other|3|||
23698008|NCT00196937|66270643|FG001|Overall Study|Other|1|||
23698009|NCT00196937|66270644|FG002|Overall Study|Other|1|||
23698010|NCT00537745|66270647|FG000|Overall Study|Did not meet eligibility criteria|2|||
23698011|NCT00537745|66270647|FG000|Overall Study|Withdrawal by Subject|2|||
23698012|NCT00537745|66270647|FG000|Overall Study|Subject unable to provide Interlock info|1|||
23698013|NCT01050062|66270648|FG000|Overall Study|Adverse Event|75|||
23698014|NCT01050062|66270649|FG001|Overall Study|Adverse Event|22|||
23698015|NCT01050062|66270648|FG000|Overall Study|Lost to Follow-up|83|||
23698016|NCT01050062|66270649|FG001|Overall Study|Lost to Follow-up|35|||
23698017|NCT01050062|66270648|FG000|Overall Study|Lack of Efficacy|22|||
23698018|NCT01050062|66270649|FG001|Overall Study|Lack of Efficacy|35|||
23698019|NCT01050062|66270648|FG000|Overall Study|Physician Decision|74|||
23698020|NCT01050062|66270649|FG001|Overall Study|Physician Decision|9|||
23698021|NCT01050062|66270648|FG000|Overall Study|Others|17|||
23698022|NCT01050062|66270649|FG001|Overall Study|Others|11|||
23698023|NCT02332915|66270650|FG000|Overall Study|Moved out of region|3|||
23698024|NCT02332915|66270651|FG001|Overall Study|Moved out of region|0|||
23698025|NCT02332915|66270650|FG000|Overall Study|Unrelated illness|1|||
23698026|NCT02332915|66270651|FG001|Overall Study|Unrelated illness|1|||
23698027|NCT02332915|66270650|FG000|Overall Study|Travel distance prohibitive|0|||
23698028|NCT02332915|66270651|FG001|Overall Study|Travel distance prohibitive|1|||
23698029|NCT02332915|66270650|FG000|Overall Study|did not meet inclusion criteria|2|||
23698030|NCT02332915|66270651|FG001|Overall Study|did not meet inclusion criteria|4|||
23698031|NCT05590403|66270652|FG000|Overall Study|Lost to Follow-up|3|||
23698032|NCT05590403|66270653|FG001|Overall Study|Lost to Follow-up|0|||
23698033|NCT05590403|66270654|FG002|Overall Study|Lost to Follow-up|2|||
23698034|NCT05590403|66270655|FG003|Overall Study|Lost to Follow-up|0|||
23698035|NCT05590403|66270656|FG004|Overall Study|Lost to Follow-up|0|||
23698036|NCT05590403|66270652|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23698037|NCT05590403|66270653|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
23698038|NCT05590403|66270654|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23698039|NCT05590403|66270655|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
23698040|NCT05590403|66270656|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23698041|NCT03242759|66270659|FG000|Overall Study|Adverse Event|5|||
23698042|NCT03242759|66270660|FG001|Overall Study|Adverse Event|1|||
23698043|NCT03242759|66270659|FG000|Overall Study|Withdrawal by Subject|4|||
23397981|NCT00127855|65203457|FG004|Primary Vaccination Course|Other|1|||
23698044|NCT03242759|66270660|FG001|Overall Study|Withdrawal by Subject|3|||
23698045|NCT03242759|66270659|FG000|Overall Study|Lost to Follow-up|3|||
23397982|NCT01849276|65203459|FG000|Followed for Survival for 5 Years|Death|1|||
23698046|NCT03242759|66270660|FG001|Overall Study|Lost to Follow-up|1|||
23698047|NCT03242759|66270659|FG000|Overall Study|Administrative problems|1|||
23698048|NCT03242759|66270660|FG001|Overall Study|Administrative problems|1|||
23698049|NCT03242759|66270659|FG000|Overall Study|Death|22|||
23698050|NCT03242759|66270660|FG001|Overall Study|Death|0|||
23698051|NCT03242759|66270659|FG000|Overall Study|Change visit schedule|0|||
23698052|NCT03242759|66270660|FG001|Overall Study|Change visit schedule|1|||
23698053|NCT01952015|66270663|FG000|Induction|Protocol Violation|1|||
23698054|NCT01952015|66270663|FG000|Maintenance|Adverse Event|2|||
23698055|NCT01952015|66270663|FG000|Treatment Period 3|Physician Decision|9|||
23698056|NCT00537823|66270668|FG000|Overall Study|Adverse Event|2|||
23698057|NCT00537823|66270669|FG001|Overall Study|Adverse Event|0|||
23698058|NCT00184054|66270670|FG000|Overall Study|Adverse Event|1|||
23698059|NCT04238663|66273597|FG000|Overall Study|Lost to Follow-up|0|||
23698060|NCT04238663|66273598|FG001|Overall Study|Lost to Follow-up|1|||
23698061|NCT04238663|66273599|FG002|Overall Study|Lost to Follow-up|0|||
23698062|NCT00227877|66273607|FG000|Pre-visit Assessment|Technical difficulties|7|||
23698063|NCT00227877|66273608|FG001|Pre-visit Assessment|Technical difficulties|3|||
23698064|NCT00227877|66273609|FG002|Pre-visit Assessment|Technical difficulties|0|||
23698065|NCT00227877|66273610|FG003|Pre-visit Assessment|Technical difficulties|0|||
23698066|NCT00227877|66273607|FG000|Post-visit Checklist|Lost to Follow-up|24|||
23698067|NCT00227877|66273608|FG001|Post-visit Checklist|Lost to Follow-up|13|||
23698068|NCT00227877|66273609|FG002|Post-visit Checklist|Lost to Follow-up|1|||
23698069|NCT00227877|66273610|FG003|Post-visit Checklist|Lost to Follow-up|0|||
23698070|NCT00227877|66273607|FG000|3-months Follow-up|Completed late|135|||
23698071|NCT00227877|66273608|FG001|3-months Follow-up|Completed late|128|||
23698072|NCT00227877|66273609|FG002|3-months Follow-up|Completed late|34|||
23698073|NCT00227877|66273610|FG003|3-months Follow-up|Completed late|8|||
23698074|NCT00227877|66273607|FG000|3-months Follow-up|Lost to Follow-up|178|||
23698075|NCT00227877|66273608|FG001|3-months Follow-up|Lost to Follow-up|139|||
23698076|NCT00227877|66273609|FG002|3-months Follow-up|Lost to Follow-up|18|||
23698077|NCT00227877|66273610|FG003|3-months Follow-up|Lost to Follow-up|13|||
23698078|NCT00227877|66273607|FG000|12-months Follow-up|Completed late|78|||
23698079|NCT00227877|66273608|FG001|12-months Follow-up|Completed late|74|||
23698080|NCT00227877|66273609|FG002|12-months Follow-up|Completed late|1|||
23698081|NCT00227877|66273610|FG003|12-months Follow-up|Completed late|0|||
23698082|NCT00227877|66273607|FG000|12-months Follow-up|Lost to Follow-up|232|||
23698083|NCT00227877|66273608|FG001|12-months Follow-up|Lost to Follow-up|189|||
23698084|NCT00227877|66273609|FG002|12-months Follow-up|Lost to Follow-up|30|||
23698085|NCT00227877|66273610|FG003|12-months Follow-up|Lost to Follow-up|26|||
23698086|NCT03176966|66273611|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
23698087|NCT03176966|66273612|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
23698088|NCT03176966|66273611|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
23698089|NCT03176966|66273612|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
23698090|NCT03176966|66273611|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
23698091|NCT03176966|66273612|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
23698092|NCT03176966|66273611|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
23698093|NCT03176966|66273612|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
23698094|NCT03176966|66273611|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
23698095|NCT03176966|66273612|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
23698096|NCT03176966|66273611|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
23698097|NCT03176966|66273612|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
23698098|NCT03176966|66273611|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
23698099|NCT03176966|66273612|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
23698100|NCT01853228|66273613|FG000|Phase 1|Lack of Efficacy|8|||
23698101|NCT01853228|66273614|FG001|Phase 1|Lack of Efficacy|0|||
23698102|NCT01853228|66273613|FG000|Phase 1|Other|1|||
23698103|NCT01853228|66273614|FG001|Phase 1|Other|0|||
23698104|NCT01853228|66273613|FG000|Phase 2|Physician Decision|0|||
23698105|NCT01853228|66273614|FG001|Phase 2|Physician Decision|1|||
23698106|NCT01853228|66273613|FG000|Phase 2|Proceed To Transplant|0|||
23698107|NCT01853228|66273614|FG001|Phase 2|Proceed To Transplant|3|||
23698108|NCT01853228|66273613|FG000|Phase 2|Lack of Efficacy|0|||
23698109|NCT01853228|66273614|FG001|Phase 2|Lack of Efficacy|4|||
23698110|NCT03964415|66273615|FG000|Overall Study|Sponsor's decision|1563|||
23698111|NCT03964415|66273616|FG001|Overall Study|Sponsor's decision|1528|||
23698112|NCT03964415|66273615|FG000|Overall Study|Lost to Follow-up|139|||
23698113|NCT03964415|66273616|FG001|Overall Study|Lost to Follow-up|146|||
23698114|NCT03964415|66273615|FG000|Overall Study|Withdrawal by Subject|68|||
23698115|NCT03964415|66273616|FG001|Overall Study|Withdrawal by Subject|72|||
23698116|NCT03964415|66273615|FG000|Overall Study|Physician Decision|34|||
23698117|NCT03964415|66273616|FG001|Overall Study|Physician Decision|48|||
23698118|NCT03964415|66273615|FG000|Overall Study|Adverse Event|3|||
23698119|NCT03964415|66273616|FG001|Overall Study|Adverse Event|0|||
23397983|NCT01849276|65203459|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
23698120|NCT03964415|66273615|FG000|Overall Study|Death|4|||
23698121|NCT03964415|66273616|FG001|Overall Study|Death|6|||
23698122|NCT03964415|66273615|FG000|Overall Study|Protocol Violation|1|||
23698123|NCT03964415|66273616|FG001|Overall Study|Protocol Violation|4|||
23698124|NCT03964415|66273615|FG000|Overall Study|Other|35|||
23698125|NCT03964415|66273616|FG001|Overall Study|Other|38|||
23698126|NCT03964415|66273615|FG000|Overall Study|Randomized but not treated|6|||
23698127|NCT03964415|66273616|FG001|Overall Study|Randomized but not treated|7|||
23698128|NCT02400346|66273617|FG000|Overall Study|Adverse Event|24|||
23698129|NCT02400346|66273617|FG000|Overall Study|Lack of Efficacy|9|||
23698130|NCT02400346|66273617|FG000|Overall Study|Non-compliance with IMP|1|||
23698131|NCT02400346|66273617|FG000|Overall Study|Withdrawal by Subject|7|||
23698132|NCT02400346|66273617|FG000|Overall Study|Administrative or other reason(s)|2|||
23698133|NCT02400346|66273617|FG000|Overall Study|Lost to Follow-up|1|||
23698134|NCT01001494|66273618|FG000|Overall Study|Adverse Event|8|||
23698135|NCT01001494|66273619|FG001|Overall Study|Adverse Event|4|||
23698136|NCT01001494|66273620|FG002|Overall Study|Adverse Event|6|||
23698137|NCT01001494|66273618|FG000|Overall Study|Protocol Violation|0|||
23698138|NCT01001494|66273619|FG001|Overall Study|Protocol Violation|1|||
23698139|NCT01001494|66273620|FG002|Overall Study|Protocol Violation|1|||
23698140|NCT01001494|66273618|FG000|Overall Study|Lost to Follow-up|2|||
23698141|NCT01001494|66273619|FG001|Overall Study|Lost to Follow-up|0|||
23698142|NCT01001494|66273620|FG002|Overall Study|Lost to Follow-up|1|||
23698143|NCT01001494|66273618|FG000|Overall Study|Withdrawal by Subject|9|||
23698144|NCT01001494|66273619|FG001|Overall Study|Withdrawal by Subject|7|||
23698145|NCT01001494|66273620|FG002|Overall Study|Withdrawal by Subject|17|||
23698146|NCT01001494|66273618|FG000|Overall Study|COPD exacerbation|3|||
23698147|NCT01001494|66273619|FG001|Overall Study|COPD exacerbation|4|||
23698148|NCT01001494|66273620|FG002|Overall Study|COPD exacerbation|5|||
23698149|NCT01001494|66273618|FG000|Overall Study|Lack of Efficacy|2|||
23698150|NCT01001494|66273619|FG001|Overall Study|Lack of Efficacy|0|||
23698151|NCT01001494|66273620|FG002|Overall Study|Lack of Efficacy|8|||
23698152|NCT01001494|66273618|FG000|Overall Study|Other|0|||
23698153|NCT01001494|66273619|FG001|Overall Study|Other|1|||
23698154|NCT01001494|66273620|FG002|Overall Study|Other|3|||
23698155|NCT02399475|66273622|FG000|Overall Study|Physician Decision|1|||
23698156|NCT02399475|66273623|FG001|Overall Study|Physician Decision|0|||
23698157|NCT02239094|66273624|FG000|Overall Study|Withdrawal by Subject|1|||
23698158|NCT02239094|66273624|FG000|Overall Study|Remitted before started|1|||
23698159|NCT00916721|66273625|FG000|Overall Study|Lost to Follow-up|0|||
23698160|NCT00916721|66273626|FG001|Overall Study|Lost to Follow-up|1|||
23698161|NCT00916721|66273625|FG000|Overall Study|Adverse Event|6|||
23698162|NCT00916721|66273626|FG001|Overall Study|Adverse Event|3|||
23698163|NCT00916721|66273625|FG000|Overall Study|Withdrawal by Subject|2|||
23698164|NCT00916721|66273626|FG001|Overall Study|Withdrawal by Subject|2|||
23698165|NCT00916721|66273625|FG000|Overall Study|Protocol Violation|2|||
23698166|NCT00916721|66273626|FG001|Overall Study|Protocol Violation|4|||
23698167|NCT05165394|66273627|FG000|Overall Study|Withdrawal by Subject|5|||
23698168|NCT05165394|66273628|FG001|Overall Study|Withdrawal by Subject|1|||
23698169|NCT05165394|66273627|FG000|Overall Study|Lost to Follow-up|1|||
23698170|NCT05165394|66273628|FG001|Overall Study|Lost to Follow-up|2|||
23698171|NCT05165394|66273627|FG000|Overall Study|Other Than Specified|0|||
23698172|NCT05165394|66273628|FG001|Overall Study|Other Than Specified|1|||
23698173|NCT02908477|66273629|FG000|Overall Study|Withdrawal by Subject|8|||
23698174|NCT02908477|66273630|FG001|Overall Study|Withdrawal by Subject|28|||
23698175|NCT00955110|66273631|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
23698176|NCT00955110|66273631|FG000|Treatment Phase|Adverse Event|2|||
23698177|NCT00955110|66273631|FG000|Treatment Phase|Administrative reasons|2|||
23698178|NCT00955110|66273631|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
23698179|NCT00955110|66273631|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
23698180|NCT00611130|66273636|FG000|Overall Study|Lost to Follow-up|25|||
23698181|NCT00611130|66273637|FG001|Overall Study|Lost to Follow-up|29|||
23698182|NCT00611130|66273636|FG000|Overall Study|Protocol noncompliance|7|||
23698183|NCT00611130|66273637|FG001|Overall Study|Protocol noncompliance|6|||
23698184|NCT00611130|66273636|FG000|Overall Study|Withdrawal by Subject|6|||
23698185|NCT00611130|66273637|FG001|Overall Study|Withdrawal by Subject|5|||
23698186|NCT00611130|66273636|FG000|Overall Study|Other|5|||
23698187|NCT00611130|66273637|FG001|Overall Study|Other|4|||
23698188|NCT00611130|66273636|FG000|Overall Study|Incarceration|3|||
23698189|NCT00611130|66273637|FG001|Overall Study|Incarceration|2|||
23698190|NCT00611130|66273636|FG000|Overall Study|Administrative|1|||
23397984|NCT03383666|65203460|FG000|Overall Study|Withdrawal by Subject|2|||
23698191|NCT00611130|66273637|FG001|Overall Study|Administrative|1|||
23698192|NCT00611130|66273636|FG000|Overall Study|Adverse Event|1|||
23698193|NCT00611130|66273637|FG001|Overall Study|Adverse Event|0|||
23397985|NCT03383666|65203460|FG000|Overall Study|Lost to Follow-up|2|||
23698194|NCT00611130|66273636|FG000|Overall Study|Death|1|||
23698195|NCT00611130|66273637|FG001|Overall Study|Death|0|||
23698196|NCT00719810|66273638|FG000|Overall Study|Adverse Event|0|||
23698197|NCT00719810|66273639|FG001|Overall Study|Adverse Event|2|||
23698198|NCT00719810|66273640|FG002|Overall Study|Adverse Event|3|||
23698199|NCT00719810|66273638|FG000|Overall Study|Lost to Follow-up|2|||
23698200|NCT00719810|66273639|FG001|Overall Study|Lost to Follow-up|0|||
23698201|NCT00719810|66273640|FG002|Overall Study|Lost to Follow-up|3|||
23698202|NCT00719810|66273638|FG000|Overall Study|Physician Decision|0|||
23698203|NCT00719810|66273639|FG001|Overall Study|Physician Decision|1|||
23698204|NCT00719810|66273640|FG002|Overall Study|Physician Decision|0|||
23698205|NCT00719810|66273638|FG000|Overall Study|Withdrawal by Subject|1|||
23698206|NCT00719810|66273639|FG001|Overall Study|Withdrawal by Subject|1|||
23698207|NCT00719810|66273640|FG002|Overall Study|Withdrawal by Subject|2|||
23698208|NCT01396525|66273641|FG000|Overall Study|Withdrawal by Subject|8|||
23698209|NCT01396525|66273641|FG000|Overall Study|Death|14|||
23698210|NCT01396525|66273641|FG000|Overall Study|Lost to Follow-up|4|||
23698211|NCT01272180|66273647|FG000|Overall Study|Adverse Event|0|||
23698212|NCT01272180|66273648|FG001|Overall Study|Adverse Event|0|||
23698213|NCT01272180|66273649|FG002|Overall Study|Adverse Event|1|||
23698214|NCT01272180|66273650|FG003|Overall Study|Adverse Event|0|||
23698215|NCT01272180|66273647|FG000|Overall Study|Withdrawal by Subject|2|||
23698216|NCT01272180|66273648|FG001|Overall Study|Withdrawal by Subject|6|||
23698217|NCT01272180|66273649|FG002|Overall Study|Withdrawal by Subject|3|||
23698218|NCT01272180|66273650|FG003|Overall Study|Withdrawal by Subject|2|||
23698219|NCT01272180|66273647|FG000|Overall Study|Lost to Follow-up|15|||
23698220|NCT01272180|66273648|FG001|Overall Study|Lost to Follow-up|14|||
23397986|NCT01561976|65203461|FG000|Period 1|Adverse Event|0|||
23397987|NCT01561976|65203462|FG001|Period 1|Adverse Event|0|||
23397988|NCT01561976|65203463|FG002|Period 1|Adverse Event|1|||
23397989|NCT01561976|65203464|FG003|Period 1|Adverse Event|0|||
23397990|NCT01561976|65203465|FG004|Period 1|Adverse Event|0|||
23397991|NCT01561976|65203466|FG005|Period 1|Adverse Event|0|||
23397992|NCT01561976|65203461|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23397993|NCT01561976|65203462|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
23397994|NCT01561976|65203463|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23397995|NCT01561976|65203464|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
23397996|NCT01561976|65203465|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
23397997|NCT01561976|65203466|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
23397998|NCT01561976|65203461|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23397999|NCT01561976|65203462|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398000|NCT01561976|65203463|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398001|NCT01561976|65203464|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398002|NCT01561976|65203465|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398003|NCT01561976|65203466|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23398004|NCT01561976|65203461|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
23398005|NCT01561976|65203462|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
23398006|NCT01561976|65203463|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
23398007|NCT01561976|65203464|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
23398008|NCT01561976|65203465|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
23698221|NCT01272180|66273649|FG002|Overall Study|Lost to Follow-up|8|||
23698222|NCT01272180|66273650|FG003|Overall Study|Lost to Follow-up|10|||
23698223|NCT01272180|66273647|FG000|Overall Study|Inappropriate enrollment|0|||
23698224|NCT01272180|66273648|FG001|Overall Study|Inappropriate enrollment|0|||
23698225|NCT01272180|66273649|FG002|Overall Study|Inappropriate enrollment|1|||
23698226|NCT01272180|66273650|FG003|Overall Study|Inappropriate enrollment|1|||
23698227|NCT01272180|66273647|FG000|Overall Study|Protocol Violation|0|||
23698228|NCT01272180|66273648|FG001|Overall Study|Protocol Violation|1|||
23698229|NCT01272180|66273649|FG002|Overall Study|Protocol Violation|0|||
23698230|NCT01272180|66273650|FG003|Overall Study|Protocol Violation|1|||
23698231|NCT01651260|66273651|FG000|Overall Study|unable to apply product|3|||
23698232|NCT00882713|66273653|FG000|Overall Study|Adverse Event|2|||
23698233|NCT00882713|66273653|FG000|Overall Study|Death|3|||
23698234|NCT00882713|66273653|FG000|Overall Study|Administrative reasons|4|||
23698235|NCT00882713|66273653|FG000|Overall Study|refused treatment/withdrew consent|4|||
23698236|NCT00882713|66273653|FG000|Overall Study|Blood transfusion|2|||
23698237|NCT00882713|66273653|FG000|Overall Study|Insufficient therapeutic response|3|||
23698238|NCT00882713|66273653|FG000|Overall Study|Failure to return|2|||
23698239|NCT00882713|66273653|FG000|Overall Study|Other - Reasons|2|||
23698240|NCT00309777|66273654|FG000|Overall Study|Adverse Event|13|||
23698241|NCT00309777|66273655|FG001|Overall Study|Adverse Event|2|||
23698242|NCT00309777|66273656|FG002|Overall Study|Adverse Event|8|||
23698243|NCT00309777|66273657|FG003|Overall Study|Adverse Event|1|||
23698244|NCT00309777|66273654|FG000|Overall Study|Protocol Violation|4|||
23698245|NCT00309777|66273655|FG001|Overall Study|Protocol Violation|1|||
23398009|NCT01561976|65203466|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
23398010|NCT00575666|65203467|FG000|Overall Study|Withdrawal by Subject|3|||
23398011|NCT00575666|65203468|FG001|Overall Study|Withdrawal by Subject|2|||
23698246|NCT00309777|66273656|FG002|Overall Study|Protocol Violation|3|||
23698247|NCT00309777|66273657|FG003|Overall Study|Protocol Violation|1|||
23698248|NCT00309777|66273654|FG000|Overall Study|Withdrawal by Subject|6|||
23698249|NCT00309777|66273655|FG001|Overall Study|Withdrawal by Subject|5|||
23698250|NCT00309777|66273656|FG002|Overall Study|Withdrawal by Subject|7|||
23698251|NCT00309777|66273657|FG003|Overall Study|Withdrawal by Subject|2|||
23698252|NCT00309777|66273654|FG000|Overall Study|Lost to Follow-up|0|||
23698253|NCT00309777|66273655|FG001|Overall Study|Lost to Follow-up|0|||
23698254|NCT00309777|66273656|FG002|Overall Study|Lost to Follow-up|1|||
23698255|NCT00309777|66273657|FG003|Overall Study|Lost to Follow-up|0|||
23698256|NCT00309777|66273654|FG000|Overall Study|Death|0|||
23698257|NCT00309777|66273655|FG001|Overall Study|Death|1|||
23698258|NCT00309777|66273656|FG002|Overall Study|Death|0|||
23698259|NCT00309777|66273657|FG003|Overall Study|Death|0|||
23698260|NCT01364467|66273658|FG000|Overall Study|Lost to Follow-up|1|||
23698261|NCT01364467|66273659|FG001|Overall Study|Lost to Follow-up|2|||
23698262|NCT02441803|66273662|FG000|Overall Study|Physician Decision|0|||
23698263|NCT02441803|66273663|FG001|Overall Study|Physician Decision|2|||
23698264|NCT02441803|66273664|FG002|Overall Study|Physician Decision|2|||
23698265|NCT03103750|66273668|FG000|Overall Study|Adverse Event|1|||
23698266|NCT03103750|66273669|FG001|Overall Study|Adverse Event|0|||
23698267|NCT03103750|66273668|FG000|Overall Study|Lost to Follow-up|1|||
23698268|NCT03103750|66273669|FG001|Overall Study|Lost to Follow-up|0|||
23698269|NCT03103750|66273668|FG000|Overall Study|PET Equipment Related|2|||
23698270|NCT03103750|66273669|FG001|Overall Study|PET Equipment Related|2|||
23698271|NCT00667277|66273670|FG000|Overall Study|Withdrawal by Subject|2|||
23698272|NCT00839098|66273671|FG000|Overall Study|Withdrawal by Subject|2|||
23698273|NCT00839098|66273672|FG001|Overall Study|Withdrawal by Subject|1|||
23698274|NCT00839098|66273673|FG002|Overall Study|Withdrawal by Subject|7|||
23398012|NCT00575666|65203467|FG000|Overall Study|Physician Decision|1|||
23398013|NCT00575666|65203468|FG001|Overall Study|Physician Decision|1|||
23398014|NCT02519842|65203469|FG000|Base Study: Cycle 1|Screening Failure|1|||
23698275|NCT01933672|66273674|FG000|Metformin Run-in Period|Adverse Event|1|||
23698276|NCT01933672|66273675|FG001|Metformin Run-in Period|Adverse Event|0|||
23398015|NCT02519842|65203470|FG001|Base Study: Cycle 1|Screening Failure|1|||
23398016|NCT02519842|65203471|FG002|Base Study: Cycle 1|Screening Failure|0|||
23398017|NCT02519842|65203469|FG000|Base Study: Cycle 1|Adverse Event|1|||
23398018|NCT02519842|65203470|FG001|Base Study: Cycle 1|Adverse Event|0|||
23398019|NCT02519842|65203471|FG002|Base Study: Cycle 1|Adverse Event|0|||
23398020|NCT02519842|65203469|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
23398021|NCT02519842|65203470|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
23398022|NCT02519842|65203471|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
23398023|NCT02519842|65203469|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
23398024|NCT02519842|65203470|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
23398025|NCT02519842|65203471|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
23398026|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
23398027|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
23398028|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
23398029|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
23398030|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
23398031|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
23398032|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23398033|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23398034|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
23398035|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
23398036|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
23398037|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
23398038|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Death|0|||
23398039|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Death|0|||
23398040|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Death|1|||
23398041|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
23398042|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
23398043|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
23398044|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
23398045|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
23398046|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
23398047|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
23398048|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
23398049|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
23398050|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
23398051|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
23398052|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
23398053|NCT02287610|65203472|FG000|Overall Study|Lost to Follow-up|3|||
23698277|NCT01933672|66273676|FG002|Metformin Run-in Period|Adverse Event|0|||
23698278|NCT01933672|66273677|FG003|Metformin Run-in Period|Adverse Event|0|||
23398054|NCT02287610|65203472|FG000|Overall Study|Withdrawal by Subject|8|||
23398055|NCT02287610|65203472|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
23398056|NCT04466891|65203474|FG000|Overall Study|Death|52|||
23698279|NCT01933672|66273678|FG004|Metformin Run-in Period|Adverse Event|0|||
23698280|NCT01933672|66273679|FG005|Metformin Run-in Period|Adverse Event|0|||
23698281|NCT01933672|66273680|FG006|Metformin Run-in Period|Adverse Event|0|||
23698282|NCT01933672|66273674|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
23698283|NCT01933672|66273675|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698284|NCT01933672|66273676|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698285|NCT01933672|66273677|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698286|NCT01933672|66273678|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698287|NCT01933672|66273679|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698288|NCT01933672|66273680|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23698289|NCT01933672|66273674|FG000|Metformin Run-in Period|Other|5|||
23398057|NCT04466891|65203475|FG001|Overall Study|Death|5|||
23398058|NCT04466891|65203474|FG000|Overall Study|Withdrawal by Subject|8|||
23398059|NCT04466891|65203475|FG001|Overall Study|Withdrawal by Subject|1|||
23398060|NCT00419744|65203476|FG000|Overall Study|Adverse Event|39|||
23398061|NCT00419744|65203477|FG001|Overall Study|Adverse Event|40|||
23698290|NCT01933672|66273675|FG001|Metformin Run-in Period|Other|0|||
23698291|NCT01933672|66273676|FG002|Metformin Run-in Period|Other|0|||
23698292|NCT01933672|66273677|FG003|Metformin Run-in Period|Other|0|||
23698293|NCT01933672|66273678|FG004|Metformin Run-in Period|Other|0|||
23698294|NCT01933672|66273679|FG005|Metformin Run-in Period|Other|0|||
23698295|NCT01933672|66273680|FG006|Metformin Run-in Period|Other|0|||
23698296|NCT01933672|66273674|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698297|NCT01933672|66273675|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698298|NCT01933672|66273676|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698299|NCT01933672|66273677|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698300|NCT01933672|66273678|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
23698301|NCT01933672|66273679|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698302|NCT01933672|66273680|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698303|NCT01933672|66273674|FG000|First Intervention Period (12-16 Days)|Other|0|||
23698304|NCT01933672|66273675|FG001|First Intervention Period (12-16 Days)|Other|0|||
23698305|NCT01933672|66273676|FG002|First Intervention Period (12-16 Days)|Other|1|||
23698306|NCT01933672|66273677|FG003|First Intervention Period (12-16 Days)|Other|0|||
23698307|NCT01933672|66273678|FG004|First Intervention Period (12-16 Days)|Other|0|||
23698308|NCT01933672|66273679|FG005|First Intervention Period (12-16 Days)|Other|1|||
23698309|NCT01933672|66273680|FG006|First Intervention Period (12-16 Days)|Other|0|||
23698310|NCT01933672|66273674|FG000|Second Intervention Period (12-16 Days)|Other|0|||
23698311|NCT01933672|66273675|FG001|Second Intervention Period (12-16 Days)|Other|1|||
23698312|NCT01933672|66273676|FG002|Second Intervention Period (12-16 Days)|Other|1|||
23698313|NCT01933672|66273677|FG003|Second Intervention Period (12-16 Days)|Other|0|||
23698314|NCT01933672|66273678|FG004|Second Intervention Period (12-16 Days)|Other|0|||
23698315|NCT01933672|66273679|FG005|Second Intervention Period (12-16 Days)|Other|0|||
23698316|NCT01933672|66273680|FG006|Second Intervention Period (12-16 Days)|Other|0|||
23698317|NCT01933672|66273674|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698318|NCT01933672|66273675|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698319|NCT01933672|66273676|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698320|NCT01933672|66273677|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
23698321|NCT01933672|66273678|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698322|NCT01933672|66273679|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698323|NCT01933672|66273680|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23698324|NCT01933672|66273674|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698325|NCT01933672|66273675|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
23698326|NCT01933672|66273676|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698327|NCT01933672|66273677|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698328|NCT01933672|66273678|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698329|NCT01933672|66273679|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698330|NCT01933672|66273680|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23698331|NCT02203838|66273681|FG000|Overall Study|Lack of Efficacy|7|||
23698332|NCT02203838|66273682|FG001|Overall Study|Lack of Efficacy|0|||
23698333|NCT02203838|66273683|FG002|Overall Study|Lack of Efficacy|1|||
23698334|NCT02203838|66273684|FG003|Overall Study|Lack of Efficacy|1|||
23698335|NCT02203838|66273681|FG000|Overall Study|Adverse Event|46|||
23698336|NCT02203838|66273682|FG001|Overall Study|Adverse Event|6|||
23698337|NCT02203838|66273683|FG002|Overall Study|Adverse Event|3|||
23698338|NCT02203838|66273684|FG003|Overall Study|Adverse Event|2|||
23698339|NCT02203838|66273681|FG000|Overall Study|Lost to Follow-up|39|||
23698340|NCT02203838|66273682|FG001|Overall Study|Lost to Follow-up|3|||
23698341|NCT02203838|66273683|FG002|Overall Study|Lost to Follow-up|2|||
23698342|NCT02203838|66273684|FG003|Overall Study|Lost to Follow-up|1|||
23698343|NCT02203838|66273681|FG000|Overall Study|Protocol Violation|7|||
23698344|NCT02203838|66273682|FG001|Overall Study|Protocol Violation|3|||
23398062|NCT00419744|65203478|FG002|Overall Study|Adverse Event|50|||
23398063|NCT00419744|65203476|FG000|Overall Study|Withdrawal by Subject|45|||
23398064|NCT00419744|65203477|FG001|Overall Study|Withdrawal by Subject|49|||
23698345|NCT02203838|66273683|FG002|Overall Study|Protocol Violation|0|||
23698346|NCT02203838|66273684|FG003|Overall Study|Protocol Violation|0|||
23698347|NCT02203838|66273681|FG000|Overall Study|Withdrawal by Subject|83|||
23698348|NCT02203838|66273682|FG001|Overall Study|Withdrawal by Subject|10|||
23698349|NCT02203838|66273683|FG002|Overall Study|Withdrawal by Subject|8|||
23698350|NCT02203838|66273684|FG003|Overall Study|Withdrawal by Subject|11|||
23698351|NCT02203838|66273681|FG000|Overall Study|Physician Decision|27|||
23698352|NCT02203838|66273682|FG001|Overall Study|Physician Decision|0|||
23398065|NCT00419744|65203478|FG002|Overall Study|Withdrawal by Subject|52|||
23398066|NCT00419744|65203476|FG000|Overall Study|Lost to Follow-up|8|||
23398067|NCT00419744|65203477|FG001|Overall Study|Lost to Follow-up|10|||
23398068|NCT00419744|65203478|FG002|Overall Study|Lost to Follow-up|6|||
23398069|NCT00419744|65203476|FG000|Overall Study|Protocol Violation|4|||
23398070|NCT00419744|65203477|FG001|Overall Study|Protocol Violation|7|||
23398071|NCT00419744|65203478|FG002|Overall Study|Protocol Violation|8|||
23398072|NCT00419744|65203476|FG000|Overall Study|Randomized in error|9|||
23398073|NCT00419744|65203477|FG001|Overall Study|Randomized in error|6|||
23398074|NCT00419744|65203478|FG002|Overall Study|Randomized in error|7|||
23398075|NCT00419744|65203476|FG000|Overall Study|Moving out of state|2|||
23398076|NCT00419744|65203477|FG001|Overall Study|Moving out of state|0|||
23398077|NCT00419744|65203478|FG002|Overall Study|Moving out of state|1|||
23398078|NCT00419744|65203476|FG000|Overall Study|Physician Decision|10|||
23398079|NCT00419744|65203477|FG001|Overall Study|Physician Decision|5|||
23398080|NCT00419744|65203478|FG002|Overall Study|Physician Decision|6|||
23398081|NCT00419744|65203476|FG000|Overall Study|Spirometry mouthpiece issues|0|||
23398082|NCT00419744|65203477|FG001|Overall Study|Spirometry mouthpiece issues|1|||
23398083|NCT00419744|65203478|FG002|Overall Study|Spirometry mouthpiece issues|2|||
23398084|NCT00419744|65203476|FG000|Overall Study|Incorrect medication kit dispensed|0|||
23398085|NCT00419744|65203477|FG001|Overall Study|Incorrect medication kit dispensed|0|||
23398086|NCT00419744|65203478|FG002|Overall Study|Incorrect medication kit dispensed|1|||
23398087|NCT00557193|65203479|FG000|Induction|Adverse Event|2|||
23398088|NCT00557193|65203480|FG001|Induction|Adverse Event|0|||
23398089|NCT00557193|65203481|FG002|Induction|Adverse Event|0|||
23398090|NCT00557193|65203482|FG003|Induction|Adverse Event|0|||
23398091|NCT00557193|65203483|FG004|Induction|Adverse Event|0|||
23398092|NCT00557193|65203484|FG005|Induction|Adverse Event|0|||
23698353|NCT02203838|66273683|FG002|Overall Study|Physician Decision|2|||
23698354|NCT02203838|66273684|FG003|Overall Study|Physician Decision|3|||
23698355|NCT02203838|66273681|FG000|Overall Study|Other|1|||
23698356|NCT02203838|66273682|FG001|Overall Study|Other|0|||
23698357|NCT02203838|66273683|FG002|Overall Study|Other|0|||
23698358|NCT02203838|66273684|FG003|Overall Study|Other|0|||
23698359|NCT02749370|66273685|FG000|Overall Study|Withdrawal by Subject|11|||
23698360|NCT02749370|66273685|FG000|Overall Study|Lost to Follow-up|3|||
23698361|NCT03472534|66273688|FG000|Overall Study|Withdrawal by Subject|9|||
23698362|NCT03472534|66273688|FG000|Overall Study|Adverse Event|2|||
23698363|NCT00312377|66273689|FG000|Overall Study|Death|403|||
23698364|NCT00312377|66273690|FG001|Overall Study|Death|418|||
23698365|NCT00312377|66273689|FG000|Overall Study|Withdrawal by Subject|23|||
23698366|NCT00312377|66273690|FG001|Overall Study|Withdrawal by Subject|30|||
23698367|NCT00312377|66273689|FG000|Overall Study|Lost to Follow-up|9|||
23698368|NCT00312377|66273690|FG001|Overall Study|Lost to Follow-up|12|||
23698369|NCT00312377|66273689|FG000|Overall Study|Non-compliance|0|||
23698370|NCT00312377|66273690|FG001|Overall Study|Non-compliance|2|||
23698371|NCT00312377|66273689|FG000|Overall Study|Randomised but never received treatment|6|||
23698372|NCT00312377|66273690|FG001|Overall Study|Randomised but never received treatment|6|||
23698373|NCT00312377|66273689|FG000|Overall Study|Discontinue treatment survival follow up|202|||
23398093|NCT00557193|65203479|FG000|Induction|Death|6|||
23398094|NCT00557193|65203480|FG001|Induction|Death|0|||
23398095|NCT00557193|65203481|FG002|Induction|Death|0|||
23398096|NCT00557193|65203482|FG003|Induction|Death|0|||
23398097|NCT00557193|65203483|FG004|Induction|Death|0|||
23398098|NCT00557193|65203484|FG005|Induction|Death|0|||
23398099|NCT00557193|65203479|FG000|Induction|Physician Decision|3|||
23398100|NCT00557193|65203480|FG001|Induction|Physician Decision|0|||
23398101|NCT00557193|65203481|FG002|Induction|Physician Decision|0|||
23398102|NCT00557193|65203482|FG003|Induction|Physician Decision|0|||
23398103|NCT00557193|65203483|FG004|Induction|Physician Decision|0|||
23398104|NCT00557193|65203484|FG005|Induction|Physician Decision|0|||
23398105|NCT00557193|65203479|FG000|Induction|Withdrawal by Subject|1|||
23398106|NCT00557193|65203480|FG001|Induction|Withdrawal by Subject|0|||
23398107|NCT00557193|65203481|FG002|Induction|Withdrawal by Subject|0|||
23698374|NCT00312377|66273690|FG001|Overall Study|Discontinue treatment survival follow up|200|||
23698375|NCT00312377|66273689|FG000|Overall Study|Site ended participation in study|1|||
23698376|NCT00312377|66273690|FG001|Overall Study|Site ended participation in study|0|||
23698377|NCT04530825|66273691|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
23698378|NCT04530825|66273692|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
23698379|NCT04530825|66273693|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
23698380|NCT04530825|66273694|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
23698381|NCT04530825|66273691|FG000|Overall Study|Did not complete follow-up|3|||
23698382|NCT04530825|66273692|FG001|Overall Study|Did not complete follow-up|0|||
23698383|NCT04530825|66273693|FG002|Overall Study|Did not complete follow-up|0|||
23698384|NCT04530825|66273694|FG003|Overall Study|Did not complete follow-up|0|||
23698385|NCT04542291|66273695|FG000|Overall Study|Adverse Event|1|||
23698386|NCT04542291|66273695|FG000|Overall Study|Physician Decision|2|||
23698387|NCT01863758|66273696|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
23698388|NCT01863758|66273696|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
23698389|NCT00487279|66273697|FG000|Overall Study|Death|1|||
23698390|NCT00487279|66273698|FG001|Overall Study|Death|0|||
23698391|NCT00487279|66273697|FG000|Overall Study|Withdrawal by Subject|0|||
23698392|NCT00487279|66273698|FG001|Overall Study|Withdrawal by Subject|2|||
23698393|NCT02732912|66273699|FG000|Overall Study|Discharged before night|2|||
23698394|NCT02732912|66273700|FG001|Overall Study|Discharged before night|6|||
23398108|NCT00557193|65203482|FG003|Induction|Withdrawal by Subject|0|||
23398109|NCT00557193|65203483|FG004|Induction|Withdrawal by Subject|0|||
23398110|NCT00557193|65203484|FG005|Induction|Withdrawal by Subject|0|||
23398111|NCT00557193|65203479|FG000|Induction|Refusal of Further Protocol Therapy|2|||
23398112|NCT00557193|65203480|FG001|Induction|Refusal of Further Protocol Therapy|0|||
23698395|NCT02732912|66273699|FG000|Overall Study|Incomplete completion of questionnaire|2|||
23398113|NCT00557193|65203481|FG002|Induction|Refusal of Further Protocol Therapy|0|||
23398114|NCT00557193|65203482|FG003|Induction|Refusal of Further Protocol Therapy|0|||
23398115|NCT00557193|65203483|FG004|Induction|Refusal of Further Protocol Therapy|0|||
23698396|NCT02732912|66273700|FG001|Overall Study|Incomplete completion of questionnaire|3|||
23698397|NCT02732912|66273699|FG000|Overall Study|No outcome; discharged or refused|6|||
23698398|NCT02732912|66273700|FG001|Overall Study|No outcome; discharged or refused|9|||
23698399|NCT01302769|66273705|FG000|Overall Study|Lost to Follow-up|1|||
23398116|NCT00557193|65203484|FG005|Induction|Refusal of Further Protocol Therapy|0|||
23398117|NCT00557193|65203479|FG000|Induction|Ineligible|8|||
23398118|NCT00557193|65203480|FG001|Induction|Ineligible|0|||
23398119|NCT00557193|65203481|FG002|Induction|Ineligible|0|||
23398120|NCT00557193|65203482|FG003|Induction|Ineligible|0|||
23398121|NCT00557193|65203483|FG004|Induction|Ineligible|0|||
23398122|NCT00557193|65203484|FG005|Induction|Ineligible|0|||
23398123|NCT00557193|65203479|FG000|Induction|Inevaluable for post Induction|2|||
23398124|NCT00557193|65203480|FG001|Induction|Inevaluable for post Induction|0|||
23398125|NCT00557193|65203481|FG002|Induction|Inevaluable for post Induction|0|||
23398126|NCT00557193|65203482|FG003|Induction|Inevaluable for post Induction|0|||
23398127|NCT00557193|65203483|FG004|Induction|Inevaluable for post Induction|0|||
23398128|NCT00557193|65203484|FG005|Induction|Inevaluable for post Induction|0|||
23398129|NCT00557193|65203479|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
23398130|NCT00557193|65203480|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398131|NCT00557193|65203481|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398132|NCT00557193|65203482|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398133|NCT00557193|65203483|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398134|NCT00557193|65203484|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398135|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23398136|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
23398137|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
23398138|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
23398139|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23398140|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
23398141|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
23398142|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
23398143|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
23398144|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
23398145|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
23398146|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
23398147|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23398148|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
23398149|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
23398150|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
23398151|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
23398152|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
23398153|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
23398154|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
23398155|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
23698400|NCT01302769|66273706|FG001|Overall Study|Lost to Follow-up|1|||
23698401|NCT01943539|66273707|FG000|Overall Study|Non-compliance with at-home intervention|4|||
23698402|NCT01943539|66273708|FG001|Overall Study|Non-compliance with at-home intervention|0|||
23698403|NCT01260181|66273709|FG000|Overall Study|Decision of Investigator|1|||
23398156|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
23398157|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
23398158|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
23398159|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
23398160|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
23398161|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
23398162|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
23398163|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
23398164|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
23398165|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398166|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398167|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
23398168|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398169|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398170|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23698404|NCT00514449|66273712|FG000|Overall Study|Withdrawal by Subject|1|||
23698405|NCT00514449|66273713|FG001|Overall Study|Withdrawal by Subject|2|||
23698406|NCT00514449|66273712|FG000|Overall Study|Protocol Violation|1|||
23698407|NCT00514449|66273713|FG001|Overall Study|Protocol Violation|2|||
23398171|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23498658|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23498659|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498660|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
23498661|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498662|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498663|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498664|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498665|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498666|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
23498667|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498668|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498669|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
23498670|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498671|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498672|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498673|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498674|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498675|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Other|0|||
23498676|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Other|0|||
23498677|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Other|1|||
23498678|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Other|1|||
23498679|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Other|2|||
23498680|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Other|0|||
23498681|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Other|0|||
23498682|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Other|0|||
23498683|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498684|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498685|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498686|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498687|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
23498688|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
23698408|NCT00514449|66273712|FG000|Overall Study|Lost to Follow-up|1|||
23698409|NCT00514449|66273713|FG001|Overall Study|Lost to Follow-up|0|||
23698410|NCT04579393|66273714|FG000|Overall Study|Withdrawal by Subject|2|||
23698411|NCT04579393|66273715|FG001|Overall Study|Withdrawal by Subject|2|||
23698412|NCT04579393|66273714|FG000|Overall Study|Death|1|||
23698413|NCT04579393|66273715|FG001|Overall Study|Death|3|||
23698414|NCT01650779|66273716|FG000|Overall Study|Withdrawal by Subject|1|||
23698415|NCT00726323|66273718|FG000|Overall Study|Withdrawal by Subject|3|||
23698416|NCT00726323|66273719|FG001|Overall Study|Withdrawal by Subject|1|||
23698417|NCT00726323|66273718|FG000|Overall Study|Physician Decision|1|||
23698418|NCT00726323|66273719|FG001|Overall Study|Physician Decision|0|||
23698419|NCT00726323|66273718|FG000|Overall Study|Progressive disease|23|||
23698420|NCT00726323|66273719|FG001|Overall Study|Progressive disease|16|||
23698421|NCT00726323|66273718|FG000|Overall Study|Clinical progression|0|||
23698422|NCT00726323|66273719|FG001|Overall Study|Clinical progression|3|||
23698423|NCT00726323|66273718|FG000|Overall Study|Adverse Event|9|||
23698424|NCT00726323|66273719|FG001|Overall Study|Adverse Event|9|||
23698425|NCT00726323|66273718|FG000|Overall Study|Death|1|||
23698426|NCT00726323|66273719|FG001|Overall Study|Death|0|||
23698427|NCT00726323|66273718|FG000|Overall Study|Participant wished to discontinue|0|||
23698428|NCT00726323|66273719|FG001|Overall Study|Participant wished to discontinue|1|||
23698429|NCT00726323|66273718|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
23698430|NCT00726323|66273719|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
23698431|NCT01632878|66273722|FG000|Screening|Physician Decision|268|||
23698432|NCT01632878|66273722|FG000|Treatment|Lost to Follow-up|41|||
23698433|NCT01632878|66273722|FG000|Treatment|Withdrawal by Subject|36|||
23698434|NCT01632878|66273722|FG000|Treatment|Physician Decision|34|||
23698435|NCT01632878|66273722|FG000|Treatment|missing information|4|||
23698436|NCT01632878|66273722|FG000|Treatment|no information on study completion|43|||
23698437|NCT00734929|66273728|FG000|Overall Study|Lost to Follow-up|1|||
23698438|NCT00734929|66273729|FG001|Overall Study|Lost to Follow-up|2|||
23398172|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398173|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
23398174|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398175|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398176|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398177|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398178|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398179|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
23398180|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398181|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398182|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
23398183|NCT03837509|65203489|FG000|Phase 1|Death|5|||
23398184|NCT03837509|65203490|FG001|Phase 1|Death|2|||
23398185|NCT03837509|65203491|FG002|Phase 1|Death|0|||
23398186|NCT03837509|65203492|FG003|Phase 1|Death|0|||
23398187|NCT03837509|65203493|FG004|Phase 1|Death|0|||
23698439|NCT00734929|66273728|FG000|Overall Study|No intervention/ screen fail|5|||
23698440|NCT00734929|66273729|FG001|Overall Study|No intervention/ screen fail|3|||
23398188|NCT03837509|65203489|FG000|Phase 2|Death|0|||
23398189|NCT03837509|65203490|FG001|Phase 2|Death|0|||
23398190|NCT03837509|65203491|FG002|Phase 2|Death|0|||
23398191|NCT03837509|65203492|FG003|Phase 2|Death|1|||
23398192|NCT03837509|65203493|FG004|Phase 2|Death|1|||
23398193|NCT03937479|65203496|FG000|Overall Study|Adverse Event|2|||
23398194|NCT03937479|65203497|FG001|Overall Study|Adverse Event|3|||
23398195|NCT03937479|65203498|FG002|Overall Study|Adverse Event|0|||
23398196|NCT03937479|65203499|FG003|Overall Study|Adverse Event|0|||
23398197|NCT03937479|65203500|FG004|Overall Study|Adverse Event|1|||
23398198|NCT03937479|65203496|FG000|Overall Study|Withdrawal by Subject|3|||
23398199|NCT03937479|65203497|FG001|Overall Study|Withdrawal by Subject|5|||
23398200|NCT03937479|65203498|FG002|Overall Study|Withdrawal by Subject|2|||
23398201|NCT03937479|65203499|FG003|Overall Study|Withdrawal by Subject|2|||
23398202|NCT03937479|65203500|FG004|Overall Study|Withdrawal by Subject|1|||
23398203|NCT03937479|65203496|FG000|Overall Study|Protocol Violation|5|||
23398204|NCT03937479|65203497|FG001|Overall Study|Protocol Violation|6|||
23398205|NCT03937479|65203498|FG002|Overall Study|Protocol Violation|4|||
23398206|NCT03937479|65203499|FG003|Overall Study|Protocol Violation|3|||
23398207|NCT03937479|65203500|FG004|Overall Study|Protocol Violation|2|||
23398208|NCT03937479|65203496|FG000|Overall Study|Lost to Follow-up|0|||
23398209|NCT03937479|65203497|FG001|Overall Study|Lost to Follow-up|1|||
23398210|NCT03937479|65203498|FG002|Overall Study|Lost to Follow-up|0|||
23398211|NCT03937479|65203499|FG003|Overall Study|Lost to Follow-up|1|||
23398212|NCT03937479|65203500|FG004|Overall Study|Lost to Follow-up|0|||
23398213|NCT03937479|65203496|FG000|Overall Study|Physician Decision|0|||
23398214|NCT03937479|65203497|FG001|Overall Study|Physician Decision|0|||
23398215|NCT03937479|65203498|FG002|Overall Study|Physician Decision|1|||
23398216|NCT03937479|65203499|FG003|Overall Study|Physician Decision|0|||
23398217|NCT03937479|65203500|FG004|Overall Study|Physician Decision|1|||
23398218|NCT03038620|65203501|FG000|Overall Study|Lost to Follow-up|18|||
23398219|NCT03038620|65203502|FG001|Overall Study|Lost to Follow-up|23|||
23398220|NCT03038620|65203501|FG000|Overall Study|Withdrawal by Subject|0|||
23398221|NCT03038620|65203502|FG001|Overall Study|Withdrawal by Subject|15|||
23398222|NCT03038620|65203501|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
23698441|NCT02426086|66273731|FG000|Overall Study|Death|33|||
23698442|NCT02426086|66273732|FG001|Overall Study|Death|36|||
23398223|NCT03038620|65203502|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
23398224|NCT04567524|65203503|FG000|Overall Study|Adverse Event|1|||
23398225|NCT04567524|65203504|FG001|Overall Study|Adverse Event|1|||
23398226|NCT04567524|65203505|FG002|Overall Study|Adverse Event|0|||
23398227|NCT04567524|65203506|FG003|Overall Study|Adverse Event|0|||
23398228|NCT04567524|65203503|FG000|Overall Study|Withdrawal by Subject|2|||
23398229|NCT04567524|65203504|FG001|Overall Study|Withdrawal by Subject|0|||
23398230|NCT04567524|65203505|FG002|Overall Study|Withdrawal by Subject|0|||
23398231|NCT04567524|65203506|FG003|Overall Study|Withdrawal by Subject|1|||
23398232|NCT00622726|65203507|FG000|March, 2008 to August, 2010|Death|5|||
23398233|NCT00622726|65203508|FG001|March, 2008 to August, 2010|Death|2|||
23398234|NCT00622726|65203507|FG000|August, 2010 to April, 2013|Death|1|||
23398235|NCT00622726|65203508|FG001|August, 2010 to April, 2013|Death|5|||
23398236|NCT00907621|65203510|FG000|Overall Study|Lost to Follow-up|6|||
23398237|NCT00907621|65203511|FG001|Overall Study|Lost to Follow-up|3|||
23398238|NCT00907621|65203510|FG000|Overall Study|intercurrent febrile illness|1|||
23398239|NCT00907621|65203511|FG001|Overall Study|intercurrent febrile illness|1|||
23498689|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
23698443|NCT02426086|66273731|FG000|Overall Study|Lost to Follow-up|2|||
23698444|NCT02426086|66273732|FG001|Overall Study|Lost to Follow-up|0|||
23698445|NCT02426086|66273731|FG000|Overall Study|Study Terminated by Sponsor|5|||
23698446|NCT02426086|66273732|FG001|Overall Study|Study Terminated by Sponsor|14|||
23698447|NCT02426086|66273731|FG000|Overall Study|Withdrawal by Subject|8|||
23698448|NCT02426086|66273732|FG001|Overall Study|Withdrawal by Subject|9|||
23698449|NCT00519623|66273739|FG000|Overall Study|Adverse Event|1|||
23698450|NCT02760602|66273740|FG000|Overall Study|Withdrawal by Subject|1|||
23698451|NCT02760602|66273741|FG001|Overall Study|Withdrawal by Subject|0|||
23698452|NCT02760602|66273740|FG000|Overall Study|Terminated by sponsor|12|||
23698453|NCT02760602|66273741|FG001|Overall Study|Terminated by sponsor|13|||
23698454|NCT03334214|66273742|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23698455|NCT03334214|66273743|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23698456|NCT03334214|66273742|FG000|Overall Study|Withdrawal by Subject|0|||
23698457|NCT03334214|66273743|FG001|Overall Study|Withdrawal by Subject|1|||
23698458|NCT03334214|66273742|FG000|Overall Study|Other|1|||
23698459|NCT03334214|66273743|FG001|Overall Study|Other|0|||
23698460|NCT00945191|66273746|FG000|Overall Study|Did not achieve a complete response|18|||
23698461|NCT00945191|66273746|FG000|Overall Study|Participant relocated to another state|1|||
23698462|NCT00945191|66273746|FG000|Overall Study|Disease progression|3|||
23698463|NCT00945191|66273746|FG000|Overall Study|Serious adverse event or adverse event|1|||
23698464|NCT00945191|66273746|FG000|Overall Study|Investigator's discretion|1|||
23698465|NCT00265941|66273752|FG000|Overall Study|Protocol Violation|22|||
23698466|NCT00265941|66273753|FG001|Overall Study|Protocol Violation|25|||
23698467|NCT00265941|66273752|FG000|Overall Study|Lost to Follow-up|1|||
23698468|NCT00265941|66273753|FG001|Overall Study|Lost to Follow-up|1|||
23698469|NCT00751881|66273754|FG000|Core Treatment Period|Not treated|1|||
23698470|NCT00751881|66273755|FG001|Core Treatment Period|Not treated|1|||
23698471|NCT00751881|66273756|FG002|Core Treatment Period|Not treated|2|||
23698472|NCT00751881|66273754|FG000|Core Treatment Period|Adverse Event|26|||
23698473|NCT00751881|66273755|FG001|Core Treatment Period|Adverse Event|54|||
23698474|NCT00751881|66273756|FG002|Core Treatment Period|Adverse Event|58|||
23698475|NCT00751881|66273754|FG000|Core Treatment Period|Lack of Efficacy|37|||
23698476|NCT00751881|66273755|FG001|Core Treatment Period|Lack of Efficacy|30|||
23698477|NCT00751881|66273756|FG002|Core Treatment Period|Lack of Efficacy|20|||
23698478|NCT00751881|66273754|FG000|Core Treatment Period|Poor compliance to protocol|15|||
23698479|NCT00751881|66273755|FG001|Core Treatment Period|Poor compliance to protocol|3|||
23698480|NCT00751881|66273756|FG002|Core Treatment Period|Poor compliance to protocol|4|||
23698481|NCT00751881|66273754|FG000|Core Treatment Period|Lost to Follow-up|6|||
23698482|NCT00751881|66273755|FG001|Core Treatment Period|Lost to Follow-up|4|||
23698483|NCT00751881|66273756|FG002|Core Treatment Period|Lost to Follow-up|3|||
23698484|NCT00751881|66273754|FG000|Core Treatment Period|Other: protocol deviation|3|||
23698485|NCT00751881|66273755|FG001|Core Treatment Period|Other: protocol deviation|3|||
23698486|NCT00751881|66273756|FG002|Core Treatment Period|Other: protocol deviation|7|||
23698487|NCT00751881|66273754|FG000|Core Treatment Period|Other: wish to parent|5|||
23698488|NCT00751881|66273755|FG001|Core Treatment Period|Other: wish to parent|7|||
23698489|NCT00751881|66273756|FG002|Core Treatment Period|Other: wish to parent|4|||
23698490|NCT00751881|66273754|FG000|Core Treatment Period|Other: personal/family constraints|6|||
23698491|NCT00751881|66273755|FG001|Core Treatment Period|Other: personal/family constraints|7|||
23698492|NCT00751881|66273756|FG002|Core Treatment Period|Other: personal/family constraints|10|||
23698493|NCT00751881|66273754|FG000|Core Treatment Period|Other: MS treatment change|6|||
23698494|NCT00751881|66273755|FG001|Core Treatment Period|Other: MS treatment change|4|||
23698495|NCT00751881|66273756|FG002|Core Treatment Period|Other: MS treatment change|4|||
23698496|NCT00751881|66273754|FG000|Core Treatment Period|Other: tolerability complaints|2|||
23698497|NCT00751881|66273755|FG001|Core Treatment Period|Other: tolerability complaints|0|||
23698498|NCT00751881|66273756|FG002|Core Treatment Period|Other: tolerability complaints|0|||
23698499|NCT00751881|66273754|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
23698500|NCT00751881|66273755|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
23698501|NCT00751881|66273756|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
23698502|NCT00751881|66273754|FG000|Extension Study Period|Adverse Event|18|||
23398240|NCT04339062|65203512|FG000|Overall Study|Death|0|||
23398241|NCT04339062|65203513|FG001|Overall Study|Death|1|||
23398242|NCT00876447|65203514|FG000|Overall Study|Other miscellaneous reasons|3|||
23698503|NCT00751881|66273755|FG001|Extension Study Period|Adverse Event|20|||
23698504|NCT00751881|66273756|FG002|Extension Study Period|Adverse Event|21|||
23698505|NCT00751881|66273754|FG000|Extension Study Period|Lack of Efficacy|14|||
23698506|NCT00751881|66273755|FG001|Extension Study Period|Lack of Efficacy|10|||
23698507|NCT00751881|66273756|FG002|Extension Study Period|Lack of Efficacy|20|||
23698508|NCT00751881|66273754|FG000|Extension Study Period|Lost to Follow-up|4|||
23698509|NCT00751881|66273755|FG001|Extension Study Period|Lost to Follow-up|9|||
23698510|NCT00751881|66273756|FG002|Extension Study Period|Lost to Follow-up|6|||
23698511|NCT00751881|66273754|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
23698512|NCT00751881|66273755|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
23698513|NCT00751881|66273756|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
23698514|NCT00751881|66273754|FG000|Extension Study Period|Other than specified above|26|||
23698515|NCT00751881|66273755|FG001|Extension Study Period|Other than specified above|30|||
23698516|NCT00751881|66273756|FG002|Extension Study Period|Other than specified above|18|||
23698517|NCT03141307|66273757|FG000|In-Hospital|Withdrawal by Subject|0|||
23698518|NCT03141307|66273758|FG001|In-Hospital|Withdrawal by Subject|2|||
23698519|NCT03141307|66273757|FG000|In-Hospital|Protocol Violation|4|||
23698520|NCT03141307|66273758|FG001|In-Hospital|Protocol Violation|0|||
23698521|NCT03141307|66273757|FG000|Follow-Up|Lost to Follow-up|97|||
23698522|NCT03141307|66273758|FG001|Follow-Up|Lost to Follow-up|54|||
23698523|NCT01770353|66273759|FG000|Overall Study|Progressive disease|2|||
23698524|NCT01770353|66273760|FG001|Overall Study|Progressive disease|1|||
23698525|NCT01770353|66273759|FG000|Overall Study|Adverse Event|0|||
23698526|NCT01770353|66273760|FG001|Overall Study|Adverse Event|1|||
23698527|NCT01770353|66273759|FG000|Overall Study|Protocol Violation|1|||
23698528|NCT01770353|66273760|FG001|Overall Study|Protocol Violation|0|||
23698529|NCT01770353|66273759|FG000|Overall Study|Physician Decision|0|||
23698530|NCT01770353|66273760|FG001|Overall Study|Physician Decision|3|||
23698531|NCT01770353|66273759|FG000|Overall Study|Clinical deterioration|3|||
23698532|NCT01770353|66273760|FG001|Overall Study|Clinical deterioration|6|||
23698533|NCT01770353|66273759|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
23698534|NCT01770353|66273760|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
23698535|NCT00593112|66273761|FG000|Overall Study|Scan Anxiety|3|||
23698536|NCT00593112|66273762|FG001|Overall Study|Scan Anxiety|0|||
23698537|NCT00593112|66273761|FG000|Overall Study|Abnormal Scan|1|||
23698538|NCT00593112|66273762|FG001|Overall Study|Abnormal Scan|0|||
23698539|NCT00593112|66273761|FG000|Overall Study|Unreadable Scan|1|||
23698540|NCT00593112|66273762|FG001|Overall Study|Unreadable Scan|0|||
23698541|NCT00593112|66273761|FG000|Overall Study|Withdrawal by Subject|5|||
23698542|NCT00593112|66273762|FG001|Overall Study|Withdrawal by Subject|0|||
23698543|NCT00784784|66273769|FG000|Overall Study|Withdrawal by Subject|2|||
23698544|NCT00784784|66273770|FG001|Overall Study|Withdrawal by Subject|2|||
23698545|NCT04770155|66273780|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698546|NCT04770155|66273781|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698547|NCT04770155|66273782|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698548|NCT04770155|66273783|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698549|NCT04770155|66273784|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698550|NCT04770155|66273785|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698551|NCT04770155|66273786|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698552|NCT04770155|66273787|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23698553|NCT04275310|66273788|FG000|Overall Study|Non-randomized due to running out of funding|4|||
23698554|NCT04275310|66273789|FG001|Overall Study|Non-randomized due to running out of funding|0|||
23698555|NCT00570739|66273792|FG000|Overall Study|Adverse Event|8|||
23698556|NCT00570739|66273793|FG001|Overall Study|Adverse Event|6|||
23698557|NCT00570739|66273794|FG002|Overall Study|Adverse Event|2|||
23698558|NCT00570739|66273795|FG003|Overall Study|Adverse Event|2|||
23698559|NCT00570739|66273792|FG000|Overall Study|Lost to Follow-up|4|||
23698560|NCT00570739|66273793|FG001|Overall Study|Lost to Follow-up|5|||
23698561|NCT00570739|66273794|FG002|Overall Study|Lost to Follow-up|4|||
23698562|NCT00570739|66273795|FG003|Overall Study|Lost to Follow-up|1|||
23698563|NCT00570739|66273792|FG000|Overall Study|Physician Decision|1|||
23698564|NCT00570739|66273793|FG001|Overall Study|Physician Decision|1|||
23698565|NCT00570739|66273794|FG002|Overall Study|Physician Decision|0|||
23698566|NCT00570739|66273795|FG003|Overall Study|Physician Decision|0|||
23698567|NCT00570739|66273792|FG000|Overall Study|Withdrawal by Subject|7|||
23698568|NCT00570739|66273793|FG001|Overall Study|Withdrawal by Subject|7|||
23698569|NCT00570739|66273794|FG002|Overall Study|Withdrawal by Subject|3|||
23698570|NCT00570739|66273795|FG003|Overall Study|Withdrawal by Subject|5|||
23698571|NCT00570739|66273792|FG000|Overall Study|Required restricted medication|0|||
23398243|NCT00876447|65203515|FG001|Overall Study|Other miscellaneous reasons|8|||
23698572|NCT00570739|66273793|FG001|Overall Study|Required restricted medication|0|||
23698573|NCT00570739|66273794|FG002|Overall Study|Required restricted medication|1|||
23698574|NCT00570739|66273795|FG003|Overall Study|Required restricted medication|0|||
23698575|NCT00570739|66273792|FG000|Overall Study|Met discontinuation criteria|1|||
23698576|NCT00570739|66273793|FG001|Overall Study|Met discontinuation criteria|0|||
23698577|NCT00570739|66273794|FG002|Overall Study|Met discontinuation criteria|1|||
23698578|NCT00570739|66273795|FG003|Overall Study|Met discontinuation criteria|1|||
23698579|NCT00570739|66273792|FG000|Overall Study|Other|0|||
23698580|NCT00570739|66273793|FG001|Overall Study|Other|2|||
23698581|NCT00570739|66273794|FG002|Overall Study|Other|5|||
23698582|NCT00570739|66273795|FG003|Overall Study|Other|3|||
23698583|NCT03988751|66273796|FG000|Overall Study|Withdrawal by Subject|1|||
23698584|NCT03988751|66273797|FG001|Overall Study|Withdrawal by Subject|0|||
23698585|NCT03988751|66273796|FG000|Overall Study|Protocol Violation|0|||
23698586|NCT03988751|66273797|FG001|Overall Study|Protocol Violation|1|||
23698587|NCT02119104|66273800|FG000|Overall Study|Protocol Violation|16|||
23698588|NCT02117050|66273808|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
23698589|NCT00790296|66273809|FG000|Overall Study|Did not meet study eligibility criteria|1|||
23698590|NCT00790296|66273810|FG001|Overall Study|Did not meet study eligibility criteria|1|||
23698591|NCT00790296|66273809|FG000|Overall Study|Adverse Event|0|||
23698592|NCT00790296|66273810|FG001|Overall Study|Adverse Event|1|||
23698593|NCT01541254|66273811|FG000|Overall Study|Withdrawal by Subject|1|||
23698594|NCT01541254|66273811|FG000|Overall Study|excluded - metal allergy|1|||
23698595|NCT01541254|66273811|FG000|Overall Study|enrolled after study closed|1|||
23698596|NCT01541254|66273811|FG000|Overall Study|GI bleed prior to procedure|1|||
23698597|NCT01541254|66273811|FG000|Overall Study|stent not required|1|||
23698598|NCT01541254|66273811|FG000|Overall Study|alternate stent used|1|||
23698599|NCT04156646|66273812|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
23698600|NCT04156646|66273813|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
23698601|NCT03043365|66273816|FG000|Weeks 0 to Week 8|Adverse Event|1|||
23698602|NCT03043365|66273817|FG001|Weeks 0 to Week 8|Adverse Event|3|||
23698603|NCT03043365|66273816|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
23698604|NCT03043365|66273817|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
23698605|NCT03043365|66273816|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
23698606|NCT03043365|66273817|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
23698607|NCT02492711|66273818|FG000|Overall Study|Adverse Event|9|||
23698608|NCT02492711|66273819|FG001|Overall Study|Adverse Event|9|||
23698609|NCT02492711|66273820|FG002|Overall Study|Adverse Event|2|||
23698610|NCT02492711|66273818|FG000|Overall Study|Death|3|||
23698611|NCT02492711|66273819|FG001|Overall Study|Death|3|||
23698612|NCT02492711|66273820|FG002|Overall Study|Death|0|||
23698613|NCT02492711|66273818|FG000|Overall Study|Withdrawal by Subject|10|||
23698614|NCT02492711|66273819|FG001|Overall Study|Withdrawal by Subject|16|||
23698615|NCT02492711|66273820|FG002|Overall Study|Withdrawal by Subject|5|||
23698616|NCT02492711|66273818|FG000|Overall Study|Physician Decision|10|||
23698617|NCT02492711|66273819|FG001|Overall Study|Physician Decision|6|||
23698618|NCT02492711|66273820|FG002|Overall Study|Physician Decision|4|||
23698619|NCT02492711|66273818|FG000|Overall Study|Lost to Follow-up|0|||
23698620|NCT02492711|66273819|FG001|Overall Study|Lost to Follow-up|0|||
23698621|NCT02492711|66273820|FG002|Overall Study|Lost to Follow-up|1|||
23698622|NCT02492711|66273818|FG000|Overall Study|study treatment delay|2|||
23698623|NCT02492711|66273819|FG001|Overall Study|study treatment delay|1|||
23698624|NCT02492711|66273820|FG002|Overall Study|study treatment delay|0|||
23698625|NCT02492711|66273818|FG000|Overall Study|change in chemotherapy|0|||
23698626|NCT02492711|66273819|FG001|Overall Study|change in chemotherapy|1|||
23698627|NCT02492711|66273820|FG002|Overall Study|change in chemotherapy|0|||
23698628|NCT02492711|66273818|FG000|Overall Study|never treated|2|||
23698629|NCT02492711|66273819|FG001|Overall Study|never treated|4|||
23698630|NCT02492711|66273820|FG002|Overall Study|never treated|0|||
23698631|NCT02492711|66273818|FG000|Overall Study|Other|0|||
23698632|NCT02492711|66273819|FG001|Overall Study|Other|0|||
23698633|NCT02492711|66273820|FG002|Overall Study|Other|1|||
23698634|NCT02746679|66273821|FG000|Overall Study|Lost to Follow-up|4|||
23698635|NCT02746679|66273822|FG001|Overall Study|Lost to Follow-up|6|||
23698636|NCT01118143|66273823|FG000|Overall Study|Withdrawal by Subject|2|||
23698637|NCT01118143|66273824|FG001|Overall Study|Withdrawal by Subject|5|||
23698638|NCT03366844|66273825|FG000|Overall Study|Physician Decision|1|||
23698639|NCT03366844|66273825|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
23698640|NCT00399802|66273827|FG000|Overall Study|Adverse Event|0|||
23698641|NCT00399802|66273828|FG001|Overall Study|Adverse Event|2|||
23698642|NCT00399802|66273827|FG000|Overall Study|Participant discontinued by mistake|0|||
23698643|NCT00399802|66273828|FG001|Overall Study|Participant discontinued by mistake|1|||
23698644|NCT01589094|66273831|FG000|Overall Study|Did not receive treatment|2|||
23698645|NCT01749735|66273832|FG000|Overall Study|Withdrawal by Subject|1|||
23698646|NCT01749735|66273833|FG001|Overall Study|Withdrawal by Subject|0|||
23698647|NCT00942877|66273839|FG000|Overall Study|Refused further treatment|1|||
23698648|NCT00942877|66273840|FG001|Overall Study|Refused further treatment|1|||
23698649|NCT00942877|66273839|FG000|Overall Study|Patient was not treated|1|||
23698650|NCT00942877|66273840|FG001|Overall Study|Patient was not treated|0|||
23698651|NCT00942877|66273839|FG000|Overall Study|Adverse Event|1|||
23698652|NCT00942877|66273840|FG001|Overall Study|Adverse Event|0|||
23698653|NCT00942877|66273839|FG000|Overall Study|Progressive disease|42|||
23398244|NCT00876447|65203514|FG000|Overall Study|Site closure|19|||
23398245|NCT00876447|65203515|FG001|Overall Study|Site closure|14|||
23698654|NCT00942877|66273840|FG001|Overall Study|Progressive disease|3|||
23698655|NCT00909090|66273842|FG000|Overall Study|Lost to Follow-up|17|||
23698656|NCT00909090|66273843|FG001|Overall Study|Lost to Follow-up|17|||
23698657|NCT02465034|66273844|FG000|Overall Study|Withdrawal by Subject|1|||
23698658|NCT02465034|66273845|FG001|Overall Study|Withdrawal by Subject|1|||
23698659|NCT02465034|66273844|FG000|Overall Study|Screen fail|2|||
23698660|NCT02465034|66273845|FG001|Overall Study|Screen fail|0|||
23698661|NCT02465034|66273844|FG000|Overall Study|Could not be scheduled for study visit|0|||
23698662|NCT02465034|66273845|FG001|Overall Study|Could not be scheduled for study visit|5|||
23698663|NCT01478347|66273854|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
23698664|NCT01478347|66273854|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
23698665|NCT01478347|66273854|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
23698666|NCT02504892|66273862|FG000|Overall Study|Adverse event-pneumonitis|2|||
23698667|NCT02606877|66273863|FG000|Overall Study|Adverse Event|3|||
23698668|NCT02606877|66273864|FG001|Overall Study|Adverse Event|0|||
23698669|NCT02606877|66273863|FG000|Overall Study|Non-compliance with protocol|0|||
23698670|NCT02606877|66273864|FG001|Overall Study|Non-compliance with protocol|1|||
23698671|NCT02606877|66273863|FG000|Overall Study|Other than listed above|1|||
23698672|NCT02606877|66273864|FG001|Overall Study|Other than listed above|0|||
23698673|NCT01184989|66273870|FG000|Overall Study|Adverse Event|11|||
23398246|NCT00876447|65203514|FG000|Overall Study|Protocol Violation|9|||
23398247|NCT00876447|65203515|FG001|Overall Study|Protocol Violation|3|||
23398248|NCT00876447|65203514|FG000|Overall Study|Personal reasons|30|||
23398249|NCT00876447|65203515|FG001|Overall Study|Personal reasons|28|||
23398250|NCT00876447|65203514|FG000|Overall Study|Lost to Follow-up|6|||
23398251|NCT00876447|65203515|FG001|Overall Study|Lost to Follow-up|15|||
23398252|NCT00876447|65203514|FG000|Overall Study|Pregnancy|4|||
23398253|NCT00876447|65203515|FG001|Overall Study|Pregnancy|2|||
23398254|NCT00876447|65203514|FG000|Overall Study|Lack of Efficacy|5|||
23398255|NCT00876447|65203515|FG001|Overall Study|Lack of Efficacy|3|||
23398256|NCT00876447|65203514|FG000|Overall Study|Adverse Event|4|||
23398257|NCT00876447|65203515|FG001|Overall Study|Adverse Event|8|||
23398258|NCT04881760|65203516|FG000|Overall Study|Adverse Event|0|||
23398259|NCT04881760|65203517|FG001|Overall Study|Adverse Event|1|||
23398260|NCT04881760|65203518|FG002|Overall Study|Adverse Event|1|||
23398261|NCT04881760|65203519|FG003|Overall Study|Adverse Event|0|||
23398262|NCT04881760|65203520|FG004|Overall Study|Adverse Event|1|||
23398263|NCT04881760|65203521|FG005|Overall Study|Adverse Event|1|||
23398264|NCT04881760|65203522|FG006|Overall Study|Adverse Event|2|||
23398265|NCT04881760|65203516|FG000|Overall Study|Death|0|||
23398266|NCT04881760|65203517|FG001|Overall Study|Death|0|||
23398267|NCT04881760|65203518|FG002|Overall Study|Death|0|||
23398268|NCT04881760|65203519|FG003|Overall Study|Death|1|||
23398269|NCT04881760|65203520|FG004|Overall Study|Death|0|||
23398270|NCT04881760|65203521|FG005|Overall Study|Death|0|||
23398271|NCT04881760|65203522|FG006|Overall Study|Death|0|||
23398272|NCT04881760|65203516|FG000|Overall Study|Lost to Follow-up|5|||
23398273|NCT04881760|65203517|FG001|Overall Study|Lost to Follow-up|7|||
23398274|NCT04881760|65203518|FG002|Overall Study|Lost to Follow-up|5|||
23398275|NCT04881760|65203519|FG003|Overall Study|Lost to Follow-up|1|||
23398276|NCT04881760|65203520|FG004|Overall Study|Lost to Follow-up|2|||
23398277|NCT04881760|65203521|FG005|Overall Study|Lost to Follow-up|4|||
23398278|NCT04881760|65203522|FG006|Overall Study|Lost to Follow-up|4|||
23398279|NCT04881760|65203516|FG000|Overall Study|Withdrawal by Subject|13|||
23398280|NCT04881760|65203517|FG001|Overall Study|Withdrawal by Subject|1|||
23398281|NCT04881760|65203518|FG002|Overall Study|Withdrawal by Subject|1|||
23698674|NCT01184989|66273870|FG000|Overall Study|Withdrawal by Subject|1|||
23398282|NCT04881760|65203519|FG003|Overall Study|Withdrawal by Subject|4|||
23698675|NCT02213198|66273872|FG000|Baseline|No show for intake|7|||
23698676|NCT02213198|66273873|FG001|Baseline|No show for intake|9|||
23698677|NCT02213198|66273872|FG000|Baseline|Withdrawal by Subject|34|||
23698678|NCT02213198|66273873|FG001|Baseline|Withdrawal by Subject|11|||
23698679|NCT02213198|66273872|FG000|Baseline|transferred out of clinic|7|||
23398283|NCT04881760|65203520|FG004|Overall Study|Withdrawal by Subject|2|||
23398284|NCT04881760|65203521|FG005|Overall Study|Withdrawal by Subject|1|||
23398285|NCT04881760|65203522|FG006|Overall Study|Withdrawal by Subject|2|||
23398286|NCT04881760|65203516|FG000|Overall Study|Randomized but Never Treated|0|||
23398287|NCT04881760|65203517|FG001|Overall Study|Randomized but Never Treated|0|||
23398288|NCT04881760|65203518|FG002|Overall Study|Randomized but Never Treated|0|||
23398289|NCT04881760|65203519|FG003|Overall Study|Randomized but Never Treated|1|||
23698680|NCT02213198|66273873|FG001|Baseline|transferred out of clinic|9|||
23698681|NCT02213198|66273872|FG000|Baseline|Lost to Follow-up|40|||
23698682|NCT02213198|66273873|FG001|Baseline|Lost to Follow-up|21|||
23698683|NCT02213198|66273872|FG000|Baseline|incarcerated,violent|0|||
23698684|NCT02213198|66273873|FG001|Baseline|incarcerated,violent|1|||
23698685|NCT02213198|66273872|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
23698686|NCT02213198|66273873|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
23698687|NCT02213198|66273872|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
23698688|NCT02213198|66273873|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
23698689|NCT02213198|66273872|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
23698690|NCT02213198|66273873|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
23698691|NCT02213198|66273872|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
23698692|NCT02213198|66273873|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
23698693|NCT02213198|66273872|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
23698694|NCT02213198|66273873|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
23698695|NCT02213198|66273872|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
23698696|NCT02213198|66273873|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
23698697|NCT03704051|66276615|FG000|Overall Study|Withdrawal by Subject|4|||
23698698|NCT03704051|66276616|FG001|Overall Study|Withdrawal by Subject|0|||
23698699|NCT00592501|66276617|FG000|Overall Study|Withdrawal by Subject|1|||
23698700|NCT00592501|66276617|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
23698701|NCT00590681|66276618|FG000|Overall Study|Withdrawal by Subject|7|||
23698702|NCT00590681|66276618|FG000|Overall Study|Adverse Event|8|||
23698703|NCT00590681|66276618|FG000|Overall Study|Death|3|||
23698704|NCT00590681|66276618|FG000|Overall Study|Lost to Follow-up|1|||
23698705|NCT00590681|66276618|FG000|Overall Study|disease progression|1|||
23698706|NCT02532543|66276621|FG000|Overall Study|Lost to Follow-up|0|||
23698707|NCT02532543|66276622|FG001|Overall Study|Lost to Follow-up|0|||
23698708|NCT02532543|66276623|FG002|Overall Study|Lost to Follow-up|1|||
23398290|NCT04881760|65203520|FG004|Overall Study|Randomized but Never Treated|0|||
23398291|NCT04881760|65203521|FG005|Overall Study|Randomized but Never Treated|0|||
23398292|NCT04881760|65203522|FG006|Overall Study|Randomized but Never Treated|0|||
23398293|NCT04881760|65203516|FG000|Overall Study|Inadvertent Enrollment|2|||
23398294|NCT04881760|65203517|FG001|Overall Study|Inadvertent Enrollment|0|||
23398295|NCT04881760|65203518|FG002|Overall Study|Inadvertent Enrollment|0|||
23398296|NCT04881760|65203519|FG003|Overall Study|Inadvertent Enrollment|0|||
23398297|NCT04881760|65203520|FG004|Overall Study|Inadvertent Enrollment|0|||
23398298|NCT04881760|65203521|FG005|Overall Study|Inadvertent Enrollment|0|||
23398299|NCT04881760|65203522|FG006|Overall Study|Inadvertent Enrollment|0|||
23398300|NCT04881760|65203516|FG000|Overall Study|Site Closure|0|||
23398301|NCT04881760|65203517|FG001|Overall Study|Site Closure|0|||
23398302|NCT04881760|65203518|FG002|Overall Study|Site Closure|0|||
23398303|NCT04881760|65203519|FG003|Overall Study|Site Closure|1|||
23398304|NCT04881760|65203520|FG004|Overall Study|Site Closure|0|||
23398305|NCT04881760|65203521|FG005|Overall Study|Site Closure|0|||
23398306|NCT04881760|65203522|FG006|Overall Study|Site Closure|0|||
23398307|NCT00183248|65203523|FG000|Overall Study|Lost to Follow-up|0|||
23398308|NCT00183248|65203524|FG001|Overall Study|Lost to Follow-up|1|||
23398309|NCT00183248|65203523|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
23398310|NCT00183248|65203524|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
23398311|NCT04047446|65203526|FG000|Overall Study|Physician Decision|1|||
23398312|NCT04047446|65203527|FG001|Overall Study|Physician Decision|0|||
23398313|NCT00189423|65203530|FG000|Overall Study|Death|746|||
23398314|NCT00189423|65203531|FG001|Overall Study|Death|747|||
23398315|NCT00189423|65203530|FG000|Overall Study|Withdrawal by Subject|9|||
23398316|NCT00189423|65203531|FG001|Overall Study|Withdrawal by Subject|9|||
23698709|NCT02532543|66276624|FG003|Overall Study|Lost to Follow-up|0|||
23398317|NCT00189423|65203530|FG000|Overall Study|Lost to Follow-up|10|||
23398318|NCT00189423|65203531|FG001|Overall Study|Lost to Follow-up|10|||
23398319|NCT00402987|65203534|FG000|Overall Study|Lack of Efficacy|0|||
23398320|NCT00402987|65203535|FG001|Overall Study|Lack of Efficacy|0|||
23698710|NCT00739297|66276625|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
23698711|NCT00739297|66276626|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
23698712|NCT00739297|66276627|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
23698713|NCT00739297|66276628|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
23698714|NCT00739297|66276629|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
23398321|NCT00402987|65203536|FG002|Overall Study|Lack of Efficacy|1|||
23398322|NCT00402987|65203537|FG003|Overall Study|Lack of Efficacy|0|||
23398323|NCT01696643|65203538|FG000|Overall Study|Adverse Event|15|||
23398324|NCT01696643|65203539|FG001|Overall Study|Adverse Event|7|||
23698715|NCT00739297|66276630|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
23698716|NCT00739297|66276631|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
23698717|NCT00739297|66276625|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23698718|NCT00739297|66276626|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23698719|NCT00739297|66276627|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23698720|NCT00739297|66276628|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23698721|NCT00739297|66276629|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23698722|NCT00739297|66276630|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
23698723|NCT00739297|66276631|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
23698724|NCT03237845|66276632|FG000|Overall Study|Adverse Event|0|||
23698725|NCT03237845|66276633|FG001|Overall Study|Adverse Event|1|||
23698726|NCT03237845|66276632|FG000|Overall Study|Lost to Follow-up|13|||
23698727|NCT03237845|66276633|FG001|Overall Study|Lost to Follow-up|10|||
23698728|NCT03237845|66276632|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
23698729|NCT03237845|66276633|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
23698730|NCT03237845|66276632|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23698731|NCT03237845|66276633|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
23698732|NCT03237845|66276632|FG000|Overall Study|Physician Decision|1|||
23698733|NCT03237845|66276633|FG001|Overall Study|Physician Decision|2|||
23698734|NCT03237845|66276632|FG000|Overall Study|Pregnancy|1|||
23698735|NCT03237845|66276633|FG001|Overall Study|Pregnancy|0|||
23698736|NCT03237845|66276632|FG000|Overall Study|Protocol Deviation|0|||
23698737|NCT03237845|66276633|FG001|Overall Study|Protocol Deviation|1|||
23698738|NCT03237845|66276632|FG000|Overall Study|Technical Problems|8|||
23698739|NCT03237845|66276633|FG001|Overall Study|Technical Problems|1|||
23698740|NCT03237845|66276632|FG000|Overall Study|Withdrawal by Subject|3|||
23698741|NCT03237845|66276633|FG001|Overall Study|Withdrawal by Subject|3|||
23698742|NCT03237845|66276632|FG000|Overall Study|Other Reasons|4|||
23698743|NCT03237845|66276633|FG001|Overall Study|Other Reasons|0|||
23698744|NCT00751101|66276634|FG000|Overall Study|Withdrawal by Subject|1|||
23698745|NCT00751101|66276635|FG001|Overall Study|Withdrawal by Subject|0|||
23698746|NCT00751101|66276634|FG000|Overall Study|No HFS / Never Started Patch/|0|||
23698747|NCT00751101|66276635|FG001|Overall Study|No HFS / Never Started Patch/|4|||
23698748|NCT00751101|66276634|FG000|Overall Study|Never began capecitabine|1|||
23698749|NCT00751101|66276635|FG001|Overall Study|Never began capecitabine|0|||
23698750|NCT00751101|66276634|FG000|Overall Study|Physician Decision|0|||
23698751|NCT00751101|66276635|FG001|Overall Study|Physician Decision|1|||
23698752|NCT00425438|66276639|FG000|Overall Study|Termination by Sponsor|25|||
23698753|NCT00425438|66276640|FG001|Overall Study|Termination by Sponsor|27|||
23698754|NCT02616029|66276641|FG000|Overall Study|Adverse Event|1|||
23698755|NCT02616029|66276642|FG001|Overall Study|Adverse Event|0|||
23698756|NCT02616029|66276641|FG000|Overall Study|Death|0|||
23698757|NCT02616029|66276642|FG001|Overall Study|Death|1|||
23698758|NCT02616029|66276641|FG000|Overall Study|Protocol Violation|1|||
23698759|NCT02616029|66276642|FG001|Overall Study|Protocol Violation|0|||
23698760|NCT02616029|66276641|FG000|Overall Study|Withdrew Consent|1|||
23698761|NCT02616029|66276642|FG001|Overall Study|Withdrew Consent|0|||
23698762|NCT02616029|66276641|FG000|Overall Study|Enrolled and Never Treated|1|||
23698763|NCT02616029|66276642|FG001|Overall Study|Enrolled and Never Treated|1|||
23698764|NCT00779038|66276643|FG000|Overall Study|Study Prematurely Terminated|13|||
23698765|NCT01277289|66276644|FG000|Overall Study|fragile vein|1|||
23698766|NCT01277289|66276645|FG001|Overall Study|fragile vein|0|||
23698767|NCT01277289|66276644|FG000|Overall Study|Physician Decision|1|||
23698768|NCT01277289|66276645|FG001|Overall Study|Physician Decision|0|||
23698769|NCT01277289|66276644|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
23398325|NCT01696643|65203538|FG000|Overall Study|Death|1|||
23698770|NCT01277289|66276645|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
23698771|NCT01277289|66276644|FG000|Overall Study|Protocol Violation|1|||
23698772|NCT01277289|66276645|FG001|Overall Study|Protocol Violation|1|||
23698773|NCT01277289|66276644|FG000|Overall Study|Adverse Event|2|||
23698774|NCT01277289|66276645|FG001|Overall Study|Adverse Event|1|||
23698775|NCT01277289|66276644|FG000|Overall Study|consent withdrawn|1|||
23698776|NCT01277289|66276645|FG001|Overall Study|consent withdrawn|1|||
23698777|NCT01277289|66276644|FG000|Overall Study|premature closure of the study|4|||
23698778|NCT01277289|66276645|FG001|Overall Study|premature closure of the study|2|||
23698779|NCT05091060|66276653|FG000|Overall Study|Lost to Follow-up|1|||
23698780|NCT02940886|66276654|FG000|Overall Study|Adverse Event|7|||
23698781|NCT02940886|66276655|FG001|Overall Study|Adverse Event|3|||
23398326|NCT01696643|65203539|FG001|Overall Study|Death|2|||
23398327|NCT01696643|65203538|FG000|Overall Study|Lack of Efficacy|3|||
23698782|NCT02940886|66276654|FG000|Overall Study|Protocol Violation|0|||
23698783|NCT02940886|66276655|FG001|Overall Study|Protocol Violation|2|||
23698784|NCT02940886|66276654|FG000|Overall Study|Withdrawal by Subject|28|||
23698785|NCT02940886|66276655|FG001|Overall Study|Withdrawal by Subject|20|||
23698786|NCT02940886|66276654|FG000|Overall Study|Death|1|||
23698787|NCT02940886|66276655|FG001|Overall Study|Death|0|||
23698788|NCT02940886|66276654|FG000|Overall Study|Lack of Efficacy|1|||
23698789|NCT02940886|66276655|FG001|Overall Study|Lack of Efficacy|0|||
23698790|NCT02940886|66276654|FG000|Overall Study|Lost to Follow-up|49|||
23698791|NCT02940886|66276655|FG001|Overall Study|Lost to Follow-up|21|||
23698792|NCT02940886|66276654|FG000|Overall Study|Physician Decision|9|||
23698793|NCT02940886|66276655|FG001|Overall Study|Physician Decision|4|||
23698794|NCT02940886|66276654|FG000|Overall Study|Sponsor decision|0|||
23698795|NCT02940886|66276655|FG001|Overall Study|Sponsor decision|1|||
23698796|NCT02940886|66276654|FG000|Overall Study|No treatment|7|||
23698797|NCT02940886|66276655|FG001|Overall Study|No treatment|2|||
23698798|NCT02940886|66276654|FG000|Overall Study|Enrolment error|0|||
23698799|NCT02940886|66276655|FG001|Overall Study|Enrolment error|1|||
23698800|NCT02747043|66276659|FG000|Overall Study|Other|1|||
23698801|NCT02747043|66276660|FG001|Overall Study|Other|1|||
23698802|NCT02747043|66276659|FG000|Overall Study|Adverse Event|3|||
23698803|NCT02747043|66276660|FG001|Overall Study|Adverse Event|1|||
23698804|NCT02747043|66276659|FG000|Overall Study|Withdrawal by Subject|1|||
23698805|NCT02747043|66276660|FG001|Overall Study|Withdrawal by Subject|1|||
23698806|NCT02747043|66276659|FG000|Overall Study|Physician Decision|1|||
23698807|NCT02747043|66276660|FG001|Overall Study|Physician Decision|1|||
23698808|NCT02747043|66276659|FG000|Overall Study|Protocol Violation|0|||
23698809|NCT02747043|66276660|FG001|Overall Study|Protocol Violation|1|||
23698810|NCT02747043|66276659|FG000|Overall Study|Disease progression|4|||
23698811|NCT02747043|66276660|FG001|Overall Study|Disease progression|0|||
23698812|NCT01988012|66276662|FG000|Overall Study|Adverse Event|5|||
23698813|NCT01988012|66276662|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23698814|NCT01988012|66276662|FG000|Overall Study|Patient Withdrawal of Consent|4|||
23698815|NCT01988012|66276662|FG000|Overall Study|Lost to Follow-up|1|||
23698816|NCT01988012|66276662|FG000|Overall Study|Physician Decision|1|||
23698817|NCT01988012|66276662|FG000|Overall Study|Protocol Violation|1|||
23698818|NCT02241512|66276663|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
23698819|NCT02241512|66276664|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
23698820|NCT02805907|66276665|FG000|Overall Study|Lost to Follow-up|3|||
23698821|NCT02805907|66276666|FG001|Overall Study|Lost to Follow-up|3|||
23698822|NCT00450866|66276669|FG000|Overall Study|Adverse Event|0|||
23698823|NCT00450866|66276670|FG001|Overall Study|Adverse Event|1|||
23698824|NCT00450866|66276669|FG000|Overall Study|Withdrawal by Subject|5|||
23698825|NCT00450866|66276670|FG001|Overall Study|Withdrawal by Subject|2|||
23698826|NCT00450866|66276669|FG000|Overall Study|Death|1|||
23698827|NCT00450866|66276670|FG001|Overall Study|Death|0|||
23698828|NCT00450866|66276669|FG000|Overall Study|Physician Decision|1|||
23698829|NCT00450866|66276670|FG001|Overall Study|Physician Decision|0|||
23698830|NCT01056523|66276673|FG000|Overall Study|Death|1|||
23698831|NCT01056523|66276674|FG001|Overall Study|Death|0|||
23698832|NCT01056523|66276675|FG002|Overall Study|Death|2|||
23698833|NCT01056523|66276676|FG003|Overall Study|Death|3|||
23698834|NCT01056523|66276677|FG004|Overall Study|Death|0|||
23698835|NCT01056523|66276678|FG005|Overall Study|Death|0|||
23698836|NCT01056523|66276679|FG006|Overall Study|Death|1|||
23698837|NCT03321929|66276684|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
23698838|NCT01264965|66276685|FG000|Overall Study|Withdrawal by Subject|10|||
23698839|NCT01595646|66276687|FG000|Overall Study|Withdrawal by Subject|1|||
23698840|NCT01595646|66276688|FG001|Overall Study|Withdrawal by Subject|0|||
23698841|NCT01595646|66276689|FG002|Overall Study|Withdrawal by Subject|0|||
23698842|NCT02760407|66276693|FG000|Overall Study|Death|2|||
23698843|NCT02760407|66276694|FG001|Overall Study|Death|3|||
23698844|NCT02760407|66276695|FG002|Overall Study|Death|1|||
23698845|NCT02760407|66276696|FG003|Overall Study|Death|1|||
23698846|NCT02760407|66276693|FG000|Overall Study|Lost to Follow-up|1|||
23698847|NCT02760407|66276694|FG001|Overall Study|Lost to Follow-up|7|||
23698848|NCT02760407|66276695|FG002|Overall Study|Lost to Follow-up|4|||
23698849|NCT02760407|66276696|FG003|Overall Study|Lost to Follow-up|6|||
23698850|NCT02760407|66276693|FG000|Overall Study|Withdrawal by Subject|25|||
23698851|NCT02760407|66276694|FG001|Overall Study|Withdrawal by Subject|31|||
23698852|NCT02760407|66276695|FG002|Overall Study|Withdrawal by Subject|37|||
23698853|NCT02760407|66276696|FG003|Overall Study|Withdrawal by Subject|25|||
23698854|NCT02760407|66276693|FG000|Overall Study|Violation of Eligibility criteria|0|||
23698855|NCT02760407|66276694|FG001|Overall Study|Violation of Eligibility criteria|0|||
23698856|NCT02760407|66276695|FG002|Overall Study|Violation of Eligibility criteria|1|||
23698857|NCT02760407|66276696|FG003|Overall Study|Violation of Eligibility criteria|1|||
23698858|NCT02760407|66276693|FG000|Overall Study|Personal reasons|0|||
23698859|NCT02760407|66276694|FG001|Overall Study|Personal reasons|0|||
23698860|NCT02760407|66276695|FG002|Overall Study|Personal reasons|0|||
23698861|NCT02760407|66276696|FG003|Overall Study|Personal reasons|1|||
23698862|NCT02760407|66276693|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
23698863|NCT02760407|66276694|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23698864|NCT02760407|66276695|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23698865|NCT02760407|66276696|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23398328|NCT01696643|65203539|FG001|Overall Study|Lack of Efficacy|0|||
23698866|NCT02760407|66276693|FG000|Overall Study|Use of prohibited Medication|0|||
23698867|NCT02760407|66276694|FG001|Overall Study|Use of prohibited Medication|0|||
23698868|NCT02760407|66276695|FG002|Overall Study|Use of prohibited Medication|1|||
23698869|NCT02760407|66276696|FG003|Overall Study|Use of prohibited Medication|0|||
23698870|NCT02760407|66276693|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23698871|NCT02760407|66276694|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23698872|NCT02760407|66276695|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
23698873|NCT02760407|66276696|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23698874|NCT02760407|66276693|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
23698875|NCT02760407|66276694|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23698876|NCT02760407|66276695|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23698877|NCT02760407|66276696|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23698878|NCT02760407|66276693|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
23698879|NCT02760407|66276694|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
23698880|NCT02760407|66276695|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
23698881|NCT02760407|66276696|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
23398329|NCT01696643|65203538|FG000|Overall Study|Lost to Follow-up|67|||
23398330|NCT01696643|65203539|FG001|Overall Study|Lost to Follow-up|67|||
23398331|NCT01696643|65203538|FG000|Overall Study|Physician Decision|3|||
23498690|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
23698882|NCT02760407|66276693|FG000|Overall Study|Inadequately Enrolled|0|||
23698883|NCT02760407|66276694|FG001|Overall Study|Inadequately Enrolled|0|||
23698884|NCT02760407|66276695|FG002|Overall Study|Inadequately Enrolled|0|||
23698885|NCT02760407|66276696|FG003|Overall Study|Inadequately Enrolled|1|||
23698886|NCT02760407|66276693|FG000|Overall Study|Withdrawal By PI's Decision|0|||
23698887|NCT02760407|66276694|FG001|Overall Study|Withdrawal By PI's Decision|1|||
23698888|NCT02760407|66276695|FG002|Overall Study|Withdrawal By PI's Decision|0|||
23698889|NCT02760407|66276696|FG003|Overall Study|Withdrawal By PI's Decision|0|||
23698890|NCT02760407|66276693|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
23698891|NCT02760407|66276694|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
23698892|NCT02760407|66276695|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
23698893|NCT02760407|66276696|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
23698894|NCT02760407|66276693|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23698895|NCT02760407|66276694|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23698896|NCT02760407|66276695|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
23698897|NCT02760407|66276696|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23698898|NCT02760407|66276693|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
23698899|NCT02760407|66276694|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23698900|NCT02760407|66276695|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23698901|NCT02760407|66276696|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23698902|NCT02760407|66276693|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
23698903|NCT02760407|66276694|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
23698904|NCT02760407|66276695|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
23698905|NCT02760407|66276696|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
23698906|NCT02760407|66276693|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
23698907|NCT02760407|66276694|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23698908|NCT02760407|66276695|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23698909|NCT02760407|66276696|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23698910|NCT02760407|66276693|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
23698911|NCT02760407|66276694|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23698912|NCT02760407|66276695|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23698913|NCT02760407|66276696|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23398332|NCT01696643|65203539|FG001|Overall Study|Physician Decision|2|||
23698914|NCT02760407|66276693|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
23698915|NCT02760407|66276694|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
23698916|NCT02760407|66276695|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
23698917|NCT02760407|66276696|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
23698918|NCT02760407|66276693|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
23698919|NCT02760407|66276694|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23698920|NCT02760407|66276695|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23698921|NCT02760407|66276696|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23698922|NCT02760407|66276693|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
23698923|NCT02760407|66276694|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
23698924|NCT02760407|66276695|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
23698925|NCT02760407|66276696|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
23698926|NCT01408537|66276697|FG000|Overall Study|Withdrawal by Subject|2|||
23698927|NCT01408537|66276697|FG000|Overall Study|Protocol Violation|3|||
23698928|NCT01408537|66276697|FG000|Overall Study|Lost to Follow-up|3|||
23698929|NCT04498910|66276698|FG000|Overall Study|Lost to Follow-up|0|||
23698930|NCT04498910|66276699|FG001|Overall Study|Lost to Follow-up|1|||
23698931|NCT04498910|66276698|FG000|Overall Study|Withdrawal by Subject|2|||
23698932|NCT04498910|66276699|FG001|Overall Study|Withdrawal by Subject|1|||
23698933|NCT04498910|66276698|FG000|Overall Study|Adverse Event|1|||
23698934|NCT04498910|66276699|FG001|Overall Study|Adverse Event|0|||
23698935|NCT02601001|66276700|FG000|Dosing Period 2|Adverse Event|0|||
23698936|NCT02601001|66276701|FG001|Dosing Period 2|Adverse Event|0|||
23698937|NCT02601001|66276702|FG002|Dosing Period 2|Adverse Event|0|||
23398333|NCT01696643|65203538|FG000|Overall Study|Pregnancy|0|||
23398334|NCT01696643|65203539|FG001|Overall Study|Pregnancy|1|||
23398335|NCT01696643|65203538|FG000|Overall Study|Protocol Violation|7|||
23398336|NCT01696643|65203539|FG001|Overall Study|Protocol Violation|7|||
23398337|NCT01696643|65203538|FG000|Overall Study|Study Terminated by Sponsor|286|||
23398338|NCT01696643|65203539|FG001|Overall Study|Study Terminated by Sponsor|294|||
23398339|NCT01696643|65203538|FG000|Overall Study|Withdrawal by Subject|142|||
23398340|NCT01696643|65203539|FG001|Overall Study|Withdrawal by Subject|149|||
23398341|NCT01696643|65203538|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
23398342|NCT01696643|65203539|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
23398343|NCT01696643|65203538|FG000|Overall Study|Site Error|2|||
23398344|NCT01696643|65203539|FG001|Overall Study|Site Error|1|||
23698938|NCT02601001|66276703|FG003|Dosing Period 2|Adverse Event|0|||
23698939|NCT02601001|66276704|FG004|Dosing Period 2|Adverse Event|0|||
23698940|NCT02601001|66276705|FG005|Dosing Period 2|Adverse Event|0|||
23698941|NCT02601001|66276706|FG006|Dosing Period 2|Adverse Event|1|||
23698942|NCT01494038|66276707|FG000|Overall Study|Protocol Violation|1|||
23698943|NCT01494038|66276708|FG001|Overall Study|Protocol Violation|1|||
23698944|NCT01494038|66276707|FG000|Overall Study|Lost to Follow-up|18|||
23698945|NCT01494038|66276708|FG001|Overall Study|Lost to Follow-up|20|||
23698946|NCT01494038|66276707|FG000|Overall Study|Withdrawal by Subject|44|||
23698947|NCT01494038|66276708|FG001|Overall Study|Withdrawal by Subject|34|||
23698948|NCT01494038|66276707|FG000|Overall Study|Not able to get to clinic|21|||
23398345|NCT01696643|65203538|FG000|Overall Study|Participant Incarcerated|0|||
23398346|NCT01696643|65203539|FG001|Overall Study|Participant Incarcerated|1|||
23398347|NCT01696643|65203538|FG000|Overall Study|Medical Monitor Decision|0|||
23398348|NCT01696643|65203539|FG001|Overall Study|Medical Monitor Decision|2|||
23398349|NCT01696643|65203538|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
23398350|NCT01696643|65203539|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
23398351|NCT00508482|65203541|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
23698949|NCT01494038|66276708|FG001|Overall Study|Not able to get to clinic|15|||
23698950|NCT01494038|66276707|FG000|Overall Study|Not willing to adhere to reqs|2|||
23698951|NCT01494038|66276708|FG001|Overall Study|Not willing to adhere to reqs|9|||
23698952|NCT01494038|66276707|FG000|Overall Study|Death|2|||
23698953|NCT01494038|66276708|FG001|Overall Study|Death|4|||
23698954|NCT00077623|66276709|FG000|Overall Study|Adverse Event|1|||
23698955|NCT00077623|66276710|FG001|Overall Study|Adverse Event|0|||
23698956|NCT00077623|66276711|FG002|Overall Study|Adverse Event|1|||
23698957|NCT00077623|66276709|FG000|Overall Study|Withdrawal by Subject|2|||
23698958|NCT00077623|66276710|FG001|Overall Study|Withdrawal by Subject|10|||
23698959|NCT00077623|66276711|FG002|Overall Study|Withdrawal by Subject|1|||
23698960|NCT00077623|66276709|FG000|Overall Study|Other-Non safety reason|18|||
23698961|NCT00077623|66276710|FG001|Overall Study|Other-Non safety reason|15|||
23698962|NCT00077623|66276711|FG002|Overall Study|Other-Non safety reason|19|||
23398352|NCT00508482|65203542|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
23398353|NCT00508482|65203543|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
23398354|NCT00508482|65203541|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
23398355|NCT00508482|65203542|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
23698963|NCT00077623|66276709|FG000|Overall Study|Insufficient therapeutic response|2|||
23698964|NCT00077623|66276710|FG001|Overall Study|Insufficient therapeutic response|0|||
23698965|NCT00077623|66276711|FG002|Overall Study|Insufficient therapeutic response|0|||
23698966|NCT00077623|66276709|FG000|Overall Study|Death|12|||
23698967|NCT00077623|66276710|FG001|Overall Study|Death|18|||
23698968|NCT00077623|66276711|FG002|Overall Study|Death|11|||
23698969|NCT00077623|66276709|FG000|Overall Study|Failure to return|1|||
23698970|NCT00077623|66276710|FG001|Overall Study|Failure to return|0|||
23698971|NCT00077623|66276711|FG002|Overall Study|Failure to return|0|||
23698972|NCT01597193|66276715|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
23698973|NCT01597193|66276716|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
23398356|NCT00508482|65203543|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
23398357|NCT00508482|65203541|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
23398358|NCT00508482|65203542|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
23398359|NCT00508482|65203543|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
23398360|NCT03283241|65203544|FG000|Overall Study|Adverse Event|4|||
23398361|NCT03283241|65203545|FG001|Overall Study|Adverse Event|1|||
23398362|NCT03283241|65203544|FG000|Overall Study|Withdrawal by Subject|0|||
23398363|NCT03283241|65203545|FG001|Overall Study|Withdrawal by Subject|1|||
23398364|NCT03283241|65203544|FG000|Overall Study|Subject relocated to Finland|0|||
23398365|NCT03283241|65203545|FG001|Overall Study|Subject relocated to Finland|1|||
23398366|NCT01602484|65203546|FG000|Overall Study|Airway issues unrelated to study|0|||
23698974|NCT01597193|66276717|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23698975|NCT01597193|66276718|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23698976|NCT01597193|66276719|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23698977|NCT01597193|66276720|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23698978|NCT01597193|66276721|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23698979|NCT01597193|66276715|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23698980|NCT01597193|66276716|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23698981|NCT01597193|66276717|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23698982|NCT01597193|66276718|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
23698983|NCT01597193|66276719|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
23698984|NCT01597193|66276720|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
23698985|NCT01597193|66276721|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23698986|NCT01597193|66276715|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
23698987|NCT01597193|66276716|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
23698988|NCT01597193|66276717|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
23698989|NCT01597193|66276718|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
23698990|NCT01597193|66276719|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
23698991|NCT01597193|66276720|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
23698992|NCT01597193|66276721|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
23698993|NCT01597193|66276715|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23698994|NCT01597193|66276716|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23698995|NCT01597193|66276717|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23698996|NCT01597193|66276718|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23698997|NCT01597193|66276719|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23698998|NCT01597193|66276720|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
23698999|NCT01597193|66276721|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23699000|NCT01597193|66276715|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23699001|NCT01597193|66276716|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23699002|NCT01597193|66276717|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23699003|NCT01597193|66276718|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
23699004|NCT01597193|66276719|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23699005|NCT01597193|66276720|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
23699006|NCT01597193|66276721|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23699007|NCT01797432|66276722|FG000|Overall Study|Lost to Follow-up|1|||
23699008|NCT01797432|66276722|FG000|Overall Study|Adverse Event|1|||
23699009|NCT01797432|66276722|FG000|Overall Study|Withdrawal by Subject|1|||
23699010|NCT01797432|66276722|FG000|Overall Study|lived too far from study site|1|||
23699011|NCT01594476|66276723|FG000|Overall Study|Protocol Violation|1|||
23699012|NCT01594476|66276724|FG001|Overall Study|Protocol Violation|3|||
23699013|NCT02927171|66276726|FG000|Overall Study|Lost to Follow-up|0|||
23699014|NCT02927171|66276727|FG001|Overall Study|Lost to Follow-up|1|||
23699015|NCT03090191|66276729|FG000|Overall Study|Adverse Event|90|||
23699016|NCT03090191|66276730|FG001|Overall Study|Adverse Event|72|||
23699017|NCT03090191|66276729|FG000|Overall Study|Death|365|||
23699018|NCT03090191|66276730|FG001|Overall Study|Death|358|||
23398367|NCT01602484|65203547|FG001|Overall Study|Airway issues unrelated to study|1|||
23398368|NCT02561962|65203548|FG000|Overall Study|Withdrawal by Subject|1|||
23398369|NCT02561962|65203549|FG001|Overall Study|Withdrawal by Subject|0|||
23398370|NCT02561962|65203550|FG002|Overall Study|Withdrawal by Subject|0|||
23699019|NCT03090191|66276729|FG000|Overall Study|Lost to Follow-up|382|||
23699020|NCT03090191|66276730|FG001|Overall Study|Lost to Follow-up|394|||
23699021|NCT03090191|66276729|FG000|Overall Study|Physician Decision|77|||
23699022|NCT03090191|66276730|FG001|Overall Study|Physician Decision|66|||
23699023|NCT03090191|66276729|FG000|Overall Study|Protocol Violation|43|||
23699024|NCT03090191|66276730|FG001|Overall Study|Protocol Violation|52|||
23699025|NCT03090191|66276729|FG000|Overall Study|Withdrawal by Subject|2160|||
23699026|NCT03090191|66276730|FG001|Overall Study|Withdrawal by Subject|2133|||
23699027|NCT03090191|66276729|FG000|Overall Study|Site terminated|7|||
23699028|NCT03090191|66276730|FG001|Overall Study|Site terminated|8|||
23699029|NCT03090191|66276729|FG000|Overall Study|Other|66|||
23699030|NCT03090191|66276730|FG001|Overall Study|Other|60|||
23699031|NCT03090191|66276729|FG000|Overall Study|Withdrawn before any study vaccination|43|||
23699032|NCT03090191|66276730|FG001|Overall Study|Withdrawn before any study vaccination|52|||
23699033|NCT03126227|66276733|FG000|Overall Study|Adverse Event|43|||
23699034|NCT03126227|66276734|FG001|Overall Study|Adverse Event|4|||
23699035|NCT03126227|66276733|FG000|Overall Study|Death|0|||
23699036|NCT03126227|66276734|FG001|Overall Study|Death|1|||
23699037|NCT03126227|66276733|FG000|Overall Study|Lost to Follow-up|0|||
23699038|NCT03126227|66276734|FG001|Overall Study|Lost to Follow-up|1|||
23699039|NCT03126227|66276733|FG000|Overall Study|Physician Decision|2|||
23699040|NCT03126227|66276734|FG001|Overall Study|Physician Decision|0|||
23699041|NCT03126227|66276733|FG000|Overall Study|Protocol Violation|1|||
23699042|NCT03126227|66276734|FG001|Overall Study|Protocol Violation|0|||
23699043|NCT03126227|66276733|FG000|Overall Study|Withdrawal by Subject|19|||
23699044|NCT03126227|66276734|FG001|Overall Study|Withdrawal by Subject|3|||
23699045|NCT03126227|66276733|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
23699046|NCT03126227|66276734|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
23699047|NCT03126227|66276733|FG000|Overall Study|Lack of dosing compliance|2|||
23699048|NCT03126227|66276734|FG001|Overall Study|Lack of dosing compliance|0|||
23699049|NCT03126227|66276733|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
23699050|NCT03126227|66276734|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
23699051|NCT03126227|66276733|FG000|Overall Study|Scheduling conflict|1|||
23699052|NCT03126227|66276734|FG001|Overall Study|Scheduling conflict|0|||
23699053|NCT01413178|66276735|FG000|Overall Study|Toxicity|1|||
23699054|NCT01413178|66276736|FG001|Overall Study|Toxicity|0|||
23699055|NCT01413178|66276735|FG000|Overall Study|Ineligible|0|||
23699056|NCT01413178|66276736|FG001|Overall Study|Ineligible|2|||
23699057|NCT00500149|66276737|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
23699058|NCT00500149|66276738|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
23699059|NCT00500149|66276737|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
23699060|NCT00500149|66276738|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
23699061|NCT00500149|66276737|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
23699062|NCT00500149|66276738|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
23699063|NCT00500149|66276737|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
23699064|NCT00500149|66276738|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
23699065|NCT00500149|66276737|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
23699066|NCT00500149|66276738|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
23699067|NCT00500149|66276737|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
23699068|NCT00500149|66276738|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
23699069|NCT00500149|66276737|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
23699070|NCT00500149|66276738|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
23699071|NCT01696877|66276740|FG000|Overall Study|Adverse Event|0|||
23699072|NCT01696877|66276741|FG001|Overall Study|Adverse Event|1|||
23699073|NCT01165203|66276742|FG000|Active Phase|Serious Adverse Event|1|||
23699074|NCT01165203|66276743|FG001|Active Phase|Serious Adverse Event|0|||
23699075|NCT01165203|66276742|FG000|Active Phase|Withdrawal by Subject|2|||
23699076|NCT01165203|66276743|FG001|Active Phase|Withdrawal by Subject|1|||
23699077|NCT01165203|66276742|FG000|Active Phase|Migrated/moved from study area|0|||
23699078|NCT01165203|66276743|FG001|Active Phase|Migrated/moved from study area|1|||
23699079|NCT01165203|66276742|FG000|Active Phase|Lost to Follow-up|2|||
23699080|NCT01165203|66276743|FG001|Active Phase|Lost to Follow-up|0|||
23699081|NCT01165203|66276742|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
23699082|NCT01165203|66276743|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
23699083|NCT01165203|66276742|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
23699084|NCT01165203|66276743|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
23699085|NCT01165203|66276742|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
23398371|NCT02561962|65203551|FG003|Overall Study|Withdrawal by Subject|0|||
23398372|NCT02561962|65203552|FG004|Overall Study|Withdrawal by Subject|1|||
23398373|NCT02561962|65203553|FG005|Overall Study|Withdrawal by Subject|1|||
23699086|NCT01165203|66276743|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
23699087|NCT01165203|66276742|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
23699088|NCT01165203|66276743|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
23398374|NCT02561962|65203554|FG006|Overall Study|Withdrawal by Subject|2|||
23398375|NCT02561962|65203555|FG007|Overall Study|Withdrawal by Subject|1|||
23398376|NCT02561962|65203556|FG008|Overall Study|Withdrawal by Subject|0|||
23398377|NCT02561962|65203548|FG000|Overall Study|Decision by sponsor|0|||
23398378|NCT02561962|65203549|FG001|Overall Study|Decision by sponsor|0|||
23398379|NCT02561962|65203550|FG002|Overall Study|Decision by sponsor|0|||
23699089|NCT01165203|66276742|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
23699090|NCT01165203|66276743|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
23699091|NCT01062399|66276744|FG000|Overall Study|Protocol Violation|0|||
23699092|NCT01062399|66276745|FG001|Overall Study|Protocol Violation|1|||
23699093|NCT01062399|66276746|FG002|Overall Study|Protocol Violation|0|||
23699094|NCT01062399|66276747|FG003|Overall Study|Protocol Violation|6|||
23699095|NCT01062399|66276748|FG004|Overall Study|Protocol Violation|4|||
23699096|NCT05372575|66276752|FG000|Overall Study|Protocol Violation|7|||
23699097|NCT05372575|66276753|FG001|Overall Study|Protocol Violation|16|||
23699098|NCT01052012|66276755|FG000|Overall Study|Not treated|2|||
23699099|NCT01052012|66276756|FG001|Overall Study|Not treated|5|||
23699100|NCT01052012|66276757|FG002|Overall Study|Not treated|0|||
23699101|NCT01052012|66276758|FG003|Overall Study|Not treated|0|||
23699102|NCT01052012|66276759|FG004|Overall Study|Not treated|11|||
23699103|NCT01052012|66276760|FG005|Overall Study|Not treated|8|||
23699104|NCT01052012|66276755|FG000|Overall Study|Adverse Event|1|||
23699105|NCT01052012|66276756|FG001|Overall Study|Adverse Event|0|||
23699106|NCT01052012|66276757|FG002|Overall Study|Adverse Event|0|||
23699107|NCT01052012|66276758|FG003|Overall Study|Adverse Event|1|||
23699108|NCT01052012|66276759|FG004|Overall Study|Adverse Event|0|||
23699109|NCT01052012|66276760|FG005|Overall Study|Adverse Event|0|||
23699110|NCT01052012|66276755|FG000|Overall Study|Lost to Follow-up|0|||
23699111|NCT01052012|66276756|FG001|Overall Study|Lost to Follow-up|0|||
23699112|NCT01052012|66276757|FG002|Overall Study|Lost to Follow-up|0|||
23699113|NCT01052012|66276758|FG003|Overall Study|Lost to Follow-up|0|||
23699114|NCT01052012|66276759|FG004|Overall Study|Lost to Follow-up|1|||
23699115|NCT01052012|66276760|FG005|Overall Study|Lost to Follow-up|0|||
23398380|NCT02561962|65203551|FG003|Overall Study|Decision by sponsor|0|||
23398381|NCT02561962|65203552|FG004|Overall Study|Decision by sponsor|1|||
23699116|NCT01052012|66276755|FG000|Overall Study|Withdrawal by Subject|1|||
23699117|NCT01052012|66276756|FG001|Overall Study|Withdrawal by Subject|1|||
23699118|NCT01052012|66276757|FG002|Overall Study|Withdrawal by Subject|0|||
23398382|NCT02561962|65203553|FG005|Overall Study|Decision by sponsor|1|||
23398383|NCT02561962|65203554|FG006|Overall Study|Decision by sponsor|0|||
23398384|NCT02561962|65203555|FG007|Overall Study|Decision by sponsor|3|||
23398385|NCT02561962|65203556|FG008|Overall Study|Decision by sponsor|0|||
23398386|NCT02561962|65203548|FG000|Overall Study|Lost to Follow-up|0|||
23398387|NCT02561962|65203549|FG001|Overall Study|Lost to Follow-up|0|||
23699119|NCT01052012|66276758|FG003|Overall Study|Withdrawal by Subject|0|||
23699120|NCT01052012|66276759|FG004|Overall Study|Withdrawal by Subject|3|||
23699121|NCT01052012|66276760|FG005|Overall Study|Withdrawal by Subject|1|||
23699122|NCT01052012|66276755|FG000|Overall Study|Physician Decision|0|||
23699123|NCT01052012|66276756|FG001|Overall Study|Physician Decision|0|||
23699124|NCT01052012|66276757|FG002|Overall Study|Physician Decision|0|||
23699125|NCT01052012|66276758|FG003|Overall Study|Physician Decision|0|||
23398388|NCT02561962|65203550|FG002|Overall Study|Lost to Follow-up|0|||
23398389|NCT02561962|65203551|FG003|Overall Study|Lost to Follow-up|0|||
23398390|NCT02561962|65203552|FG004|Overall Study|Lost to Follow-up|0|||
23398391|NCT02561962|65203553|FG005|Overall Study|Lost to Follow-up|1|||
23398392|NCT02561962|65203554|FG006|Overall Study|Lost to Follow-up|0|||
23398393|NCT02561962|65203555|FG007|Overall Study|Lost to Follow-up|0|||
23398394|NCT02561962|65203556|FG008|Overall Study|Lost to Follow-up|0|||
23398395|NCT01463033|65203557|FG000|Overall Study|Lost to Follow-up|4|||
23398396|NCT01463033|65203558|FG001|Overall Study|Lost to Follow-up|4|||
23398397|NCT01463033|65203557|FG000|Overall Study|Death|3|||
23398398|NCT01463033|65203558|FG001|Overall Study|Death|2|||
23398399|NCT00337168|65203563|FG000|Overall Study|Death|5|||
23398400|NCT00337168|65203563|FG000|Overall Study|Not protocol specified|2|||
23398401|NCT00337168|65203563|FG000|Overall Study|Did not start therapy|1|||
23398402|NCT01170663|65203564|FG000|Overall Study|Lost to Follow-up|3|||
23398403|NCT01170663|65203565|FG001|Overall Study|Lost to Follow-up|9|||
23398404|NCT01170663|65203564|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
23699126|NCT01052012|66276759|FG004|Overall Study|Physician Decision|0|||
23699127|NCT01052012|66276760|FG005|Overall Study|Physician Decision|1|||
23699128|NCT01052012|66276755|FG000|Overall Study|Other|0|||
23699129|NCT01052012|66276756|FG001|Overall Study|Other|0|||
23398405|NCT01170663|65203565|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
23699130|NCT01052012|66276757|FG002|Overall Study|Other|0|||
23699131|NCT01052012|66276758|FG003|Overall Study|Other|0|||
23699132|NCT01052012|66276759|FG004|Overall Study|Other|1|||
23398406|NCT00542178|65203566|FG000|Overall Study|did not complete year 4 follow-up|75|||
23699133|NCT01052012|66276760|FG005|Overall Study|Other|0|||
23699134|NCT01319929|66276761|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
23699135|NCT01319929|66276762|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
23699136|NCT01319929|66276761|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
23699137|NCT01319929|66276762|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
23699138|NCT01319929|66276761|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
23699139|NCT01319929|66276762|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
23699140|NCT01319929|66276761|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
23699141|NCT01319929|66276762|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
23699142|NCT01319929|66276761|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
23699143|NCT01319929|66276762|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
23699144|NCT03396471|66276767|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
23699145|NCT03396471|66276767|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
23699146|NCT03396471|66276767|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
23699147|NCT03396471|66276767|FG000|Study Treatment - Up to 22 Months|Death|2|||
23699148|NCT03396471|66276767|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
23699149|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|Death|9|||
23699150|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
23699151|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
23699152|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|study terminated|1|||
23699153|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
23699154|NCT03396471|66276767|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
23699155|NCT01096550|66276768|FG000|Overall Study|discontinued site|10|||
23699156|NCT01096550|66276769|FG001|Overall Study|discontinued site|11|||
23699157|NCT01096550|66276768|FG000|Overall Study|non-regular treatment track at clinic|1|||
23699158|NCT01096550|66276769|FG001|Overall Study|non-regular treatment track at clinic|1|||
23699159|NCT01096550|66276768|FG000|Overall Study|clinic readmission|1|||
23699160|NCT01096550|66276769|FG001|Overall Study|clinic readmission|1|||
23699161|NCT01096550|66276768|FG000|Overall Study|Withdrawal by Subject|0|||
23699162|NCT01096550|66276769|FG001|Overall Study|Withdrawal by Subject|1|||
23699163|NCT01096550|66276768|FG000|Overall Study|non-African American participant|13|||
23699164|NCT01096550|66276769|FG001|Overall Study|non-African American participant|6|||
23699165|NCT01096550|66276768|FG000|Overall Study|Lost to Follow-up|12|||
23699166|NCT01096550|66276769|FG001|Overall Study|Lost to Follow-up|9|||
23699167|NCT00001259|66276772|FG000|Study 2|Adverse Event|0|||
23699168|NCT00001259|66276773|FG001|Study 2|Adverse Event|0|||
23699169|NCT00001259|66276774|FG002|Study 2|Adverse Event|0|||
23699170|NCT00001259|66276775|FG003|Study 2|Adverse Event|0|||
23699171|NCT00001259|66276776|FG004|Study 2|Adverse Event|2|||
23699172|NCT00001259|66276777|FG005|Study 2|Adverse Event|0|||
23699173|NCT00001259|66276778|FG006|Study 2|Adverse Event|0|||
23699174|NCT00390780|66276779|FG000|Overall Study|Not completed|10|||
23699175|NCT00390780|66276780|FG001|Overall Study|Not completed|4|||
23699176|NCT00390780|66276779|FG000|Overall Study|Protocol Violation|6|||
23699177|NCT00390780|66276780|FG001|Overall Study|Protocol Violation|4|||
23699178|NCT00390780|66276779|FG000|Overall Study|Lost to Follow-up|3|||
23699179|NCT00390780|66276780|FG001|Overall Study|Lost to Follow-up|6|||
23699180|NCT00390780|66276779|FG000|Overall Study|Adverse Event|2|||
23699181|NCT00390780|66276780|FG001|Overall Study|Adverse Event|3|||
23699182|NCT00390780|66276779|FG000|Overall Study|Death|1|||
23699183|NCT00390780|66276780|FG001|Overall Study|Death|3|||
23699184|NCT00390780|66276779|FG000|Overall Study|Withdrawal by Subject|1|||
23699185|NCT00390780|66276780|FG001|Overall Study|Withdrawal by Subject|2|||
23699186|NCT00390780|66276779|FG000|Overall Study|Inclusion criteria not satisfied|0|||
23699187|NCT00390780|66276780|FG001|Overall Study|Inclusion criteria not satisfied|2|||
23699188|NCT00390780|66276779|FG000|Overall Study|Lost to follow up and other reasons|0|||
23699189|NCT00390780|66276780|FG001|Overall Study|Lost to follow up and other reasons|1|||
23699190|NCT00390780|66276779|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
23699191|NCT00390780|66276780|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
23699192|NCT00390780|66276779|FG000|Overall Study|SAE, death|0|||
23699193|NCT00390780|66276780|FG001|Overall Study|SAE, death|1|||
23699194|NCT02335450|66276783|FG000|Overall Study|Pregnancy|1|||
23699195|NCT01781026|66276784|FG000|Overall Study|Lack of Efficacy|2|||
23699196|NCT01161524|66276789|FG000|Core Study (23 Weeks)|Adverse Event|3|||
23699197|NCT01161524|66276790|FG001|Core Study (23 Weeks)|Adverse Event|0|||
23398407|NCT00542178|65203567|FG001|Overall Study|did not complete year 4 follow-up|80|||
23699198|NCT01161524|66276791|FG002|Core Study (23 Weeks)|Adverse Event|0|||
23699199|NCT01161524|66276789|FG000|Core Study (23 Weeks)|Other|1|||
23699200|NCT01161524|66276790|FG001|Core Study (23 Weeks)|Other|0|||
23699201|NCT01161524|66276791|FG002|Core Study (23 Weeks)|Other|0|||
23699202|NCT01161524|66276789|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
23699203|NCT01161524|66276790|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
23699204|NCT01161524|66276791|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
23699205|NCT01161524|66276789|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
23699206|NCT01161524|66276790|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
23699207|NCT01161524|66276791|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
23699208|NCT01161524|66276789|FG000|Core Study (23 Weeks)|Subject Choice|3|||
23398408|NCT00542178|65203568|FG002|Overall Study|did not complete year 4 follow-up|74|||
23498691|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
23699209|NCT01161524|66276790|FG001|Core Study (23 Weeks)|Subject Choice|2|||
23699210|NCT01161524|66276791|FG002|Core Study (23 Weeks)|Subject Choice|0|||
23699211|NCT01161524|66276789|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
23699212|NCT01161524|66276790|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
23699213|NCT01161524|66276791|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
23699214|NCT01161524|66276789|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
23699215|NCT01161524|66276790|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
23699216|NCT01161524|66276791|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
23699217|NCT01161524|66276789|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
23699218|NCT01161524|66276790|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
23699219|NCT01161524|66276791|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
23699220|NCT01161524|66276789|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
23699221|NCT01161524|66276790|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
23699222|NCT01161524|66276791|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
23699223|NCT01161524|66276789|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
23699224|NCT01161524|66276790|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
23699225|NCT01161524|66276791|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
23699226|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
23699227|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
23699228|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
23699229|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
23699230|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
23699231|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
23699232|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
23699233|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
23699234|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
23699235|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
23699236|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
23699237|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
23699238|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
23699239|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
23398409|NCT00542178|65203569|FG003|Overall Study|did not complete year 4 follow-up|62|||
23398410|NCT00542178|65203570|FG004|Overall Study|did not complete year 4 follow-up|64|||
23398411|NCT00542178|65203571|FG005|Overall Study|did not complete year 4 follow-up|89|||
23398412|NCT00542178|65203572|FG006|Overall Study|did not complete year 4 follow-up|87|||
23398413|NCT00542178|65203573|FG007|Overall Study|did not complete year 4 follow-up|85|||
23398414|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|0|||
23398415|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|1|||
23398416|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|1|||
23398417|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|0|||
23398418|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|1|||
23398419|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|0|||
23398420|NCT00444106|65203576|FG000|Overall Study|Lost to Follow-up|2|||
23398421|NCT00444106|65203577|FG001|Overall Study|Lost to Follow-up|1|||
23398422|NCT00444106|65203578|FG002|Overall Study|Lost to Follow-up|0|||
23398423|NCT00444106|65203576|FG000|Overall Study|Abnormal Test Procedure Results|0|||
23398424|NCT00444106|65203577|FG001|Overall Study|Abnormal Test Procedure Results|0|||
23398425|NCT00444106|65203578|FG002|Overall Study|Abnormal Test Procedure Results|1|||
23398426|NCT00806585|65203587|FG000|Overall Study|Study terminated by Sponsor|0|||
23398427|NCT00806585|65203588|FG001|Overall Study|Study terminated by Sponsor|0|||
23398428|NCT00806585|65203589|FG002|Overall Study|Study terminated by Sponsor|1|||
23398429|NCT00806585|65203590|FG003|Overall Study|Study terminated by Sponsor|2|||
23398430|NCT00806585|65203591|FG004|Overall Study|Study terminated by Sponsor|0|||
23398431|NCT00806585|65203587|FG000|Overall Study|Protocol Violation|3|||
23398432|NCT00806585|65203588|FG001|Overall Study|Protocol Violation|1|||
23398433|NCT00806585|65203589|FG002|Overall Study|Protocol Violation|2|||
23398434|NCT00806585|65203590|FG003|Overall Study|Protocol Violation|0|||
23398435|NCT00806585|65203591|FG004|Overall Study|Protocol Violation|0|||
23398436|NCT00806585|65203587|FG000|Overall Study|Physician Decision|0|||
23398437|NCT00806585|65203588|FG001|Overall Study|Physician Decision|2|||
23398438|NCT00806585|65203589|FG002|Overall Study|Physician Decision|3|||
23398439|NCT00806585|65203590|FG003|Overall Study|Physician Decision|0|||
23398440|NCT00806585|65203591|FG004|Overall Study|Physician Decision|1|||
23398441|NCT00806585|65203587|FG000|Overall Study|Lost to Follow-up|2|||
23398442|NCT00806585|65203588|FG001|Overall Study|Lost to Follow-up|1|||
23398443|NCT00806585|65203589|FG002|Overall Study|Lost to Follow-up|2|||
23398444|NCT00806585|65203590|FG003|Overall Study|Lost to Follow-up|2|||
23398445|NCT00806585|65203591|FG004|Overall Study|Lost to Follow-up|5|||
23498692|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
23699240|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
23699241|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
23699242|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
23699243|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
23699244|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Death|0|||
23699245|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Death|1|||
23699246|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Death|0|||
23699247|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
23699248|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
23699249|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
23699250|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
23699251|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
23398446|NCT00806585|65203587|FG000|Overall Study|Lack of Efficacy|1|||
23699252|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
23699253|NCT00430781|66276792|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
23699254|NCT00430781|66276793|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
23699255|NCT00430781|66276794|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
23699256|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
23699257|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
23398447|NCT00806585|65203588|FG001|Overall Study|Lack of Efficacy|0|||
23398448|NCT00806585|65203589|FG002|Overall Study|Lack of Efficacy|0|||
23398449|NCT00806585|65203590|FG003|Overall Study|Lack of Efficacy|0|||
23398450|NCT00806585|65203591|FG004|Overall Study|Lack of Efficacy|0|||
23398451|NCT00806585|65203587|FG000|Overall Study|Adverse Event|1|||
23398452|NCT00806585|65203588|FG001|Overall Study|Adverse Event|5|||
23398453|NCT00806585|65203589|FG002|Overall Study|Adverse Event|3|||
23398454|NCT00806585|65203590|FG003|Overall Study|Adverse Event|4|||
23398455|NCT00806585|65203591|FG004|Overall Study|Adverse Event|2|||
23398456|NCT00806585|65203587|FG000|Overall Study|Withdrawal by Subject|10|||
23398457|NCT00806585|65203588|FG001|Overall Study|Withdrawal by Subject|8|||
23398458|NCT00806585|65203589|FG002|Overall Study|Withdrawal by Subject|9|||
23398459|NCT00806585|65203590|FG003|Overall Study|Withdrawal by Subject|3|||
23398460|NCT00806585|65203591|FG004|Overall Study|Withdrawal by Subject|11|||
23398461|NCT00806585|65203587|FG000|Overall Study|Completion status unknown|15|||
23398462|NCT00806585|65203588|FG001|Overall Study|Completion status unknown|14|||
23398463|NCT00806585|65203589|FG002|Overall Study|Completion status unknown|12|||
23398464|NCT00806585|65203590|FG003|Overall Study|Completion status unknown|4|||
23398465|NCT00806585|65203591|FG004|Overall Study|Completion status unknown|12|||
23398466|NCT02835690|65203604|FG000|Overall Study|Death|12|||
23398467|NCT02835690|65203605|FG001|Overall Study|Death|11|||
23398468|NCT02835690|65203606|FG002|Overall Study|Death|13|||
23398469|NCT02835690|65203604|FG000|Overall Study|Transferred to Extension Study|2|||
23699258|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
23699259|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
23699260|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
23699261|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
23699262|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
23699263|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
23699264|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
23699265|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
23699266|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
23699267|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
23699268|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Other|0|||
23699269|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Other|1|||
23699270|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Other|0|||
23699271|NCT00430781|66276792|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
23699272|NCT00430781|66276793|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
23699273|NCT00430781|66276794|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
23398470|NCT02835690|65203605|FG001|Overall Study|Transferred to Extension Study|2|||
23398471|NCT02835690|65203606|FG002|Overall Study|Transferred to Extension Study|1|||
23398472|NCT02835690|65203604|FG000|Overall Study|Did Not Continue on Extension Study|0|||
23699274|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
23699275|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
23398473|NCT02835690|65203605|FG001|Overall Study|Did Not Continue on Extension Study|0|||
23398474|NCT02835690|65203606|FG002|Overall Study|Did Not Continue on Extension Study|1|||
23398475|NCT02835690|65203604|FG000|Overall Study|Not Treated|0|||
23398476|NCT02835690|65203605|FG001|Overall Study|Not Treated|2|||
23398477|NCT02835690|65203606|FG002|Overall Study|Not Treated|0|||
23398478|NCT00902330|65203607|FG000|Overall Study|Too overwhelmed by treatment|2|||
23398479|NCT00902330|65203608|FG001|Overall Study|Too overwhelmed by treatment|5|||
23398480|NCT00902330|65203607|FG000|Overall Study|Adverse Event|1|||
23398481|NCT00902330|65203608|FG001|Overall Study|Adverse Event|0|||
23699276|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
23699277|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
23699278|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
23699279|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
23699280|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
23699281|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
23699282|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
23699283|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
23699284|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
23699285|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
23699286|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
23699287|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
23699288|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
23699289|NCT00430781|66276792|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
23699290|NCT00430781|66276793|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
23699291|NCT00430781|66276794|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
23699292|NCT00370149|66276795|FG000|Overall Study|Physician Decision|16|||
23699293|NCT00370149|66276796|FG001|Overall Study|Physician Decision|16|||
23699294|NCT00370149|66276795|FG000|Overall Study|Protocol Violation|1|||
23699295|NCT00370149|66276796|FG001|Overall Study|Protocol Violation|0|||
23699296|NCT00370149|66276795|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
23699297|NCT00370149|66276796|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
23699298|NCT00370149|66276795|FG000|Overall Study|Pre-existing infection|0|||
23699299|NCT00370149|66276796|FG001|Overall Study|Pre-existing infection|1|||
23699300|NCT00370149|66276795|FG000|Overall Study|Antibiotic coated dressing placed|0|||
23699301|NCT00370149|66276796|FG001|Overall Study|Antibiotic coated dressing placed|1|||
23699302|NCT04222725|66276803|FG000|Overall Study|Adverse Event|0|||
23699303|NCT04222725|66276804|FG001|Overall Study|Adverse Event|1|||
23699304|NCT04222725|66276805|FG002|Overall Study|Adverse Event|0|||
23699305|NCT04222725|66276806|FG003|Overall Study|Adverse Event|0|||
23699306|NCT00474630|66276811|FG000|Overall Study|Adverse Event|98|||
23699307|NCT00474630|66276812|FG001|Overall Study|Adverse Event|26|||
23699308|NCT00474630|66276811|FG000|Overall Study|Lost to Follow-up|22|||
23699309|NCT00474630|66276812|FG001|Overall Study|Lost to Follow-up|15|||
23699310|NCT00474630|66276811|FG000|Overall Study|Withdrawal by Subject|21|||
23699311|NCT00474630|66276812|FG001|Overall Study|Withdrawal by Subject|15|||
23699312|NCT00474630|66276811|FG000|Overall Study|Protocol Violation|3|||
23699313|NCT00474630|66276812|FG001|Overall Study|Protocol Violation|4|||
23699314|NCT00474630|66276811|FG000|Overall Study|Lack of Efficacy|5|||
23699315|NCT00474630|66276812|FG001|Overall Study|Lack of Efficacy|6|||
23699316|NCT00474630|66276811|FG000|Overall Study|Drug noncompliance, other|11|||
23699317|NCT00474630|66276812|FG001|Overall Study|Drug noncompliance, other|4|||
23699318|NCT00537940|66276817|FG000|Overall Study|Adverse Event|20|||
23699319|NCT00537940|66276818|FG001|Overall Study|Adverse Event|19|||
23699320|NCT00537940|66276817|FG000|Overall Study|Lack of Efficacy|8|||
23699321|NCT00537940|66276818|FG001|Overall Study|Lack of Efficacy|16|||
23699322|NCT00537940|66276817|FG000|Overall Study|Lost to Follow-up|23|||
23699323|NCT00537940|66276818|FG001|Overall Study|Lost to Follow-up|29|||
23699324|NCT00537940|66276817|FG000|Overall Study|Withdrawal by Subject|113|||
23699325|NCT00537940|66276818|FG001|Overall Study|Withdrawal by Subject|95|||
23699326|NCT00537940|66276817|FG000|Overall Study|Protocol Violation|6|||
23699327|NCT00537940|66276818|FG001|Overall Study|Protocol Violation|4|||
23699328|NCT00537940|66276817|FG000|Overall Study|Pregnancy|1|||
23699329|NCT00537940|66276818|FG001|Overall Study|Pregnancy|1|||
23699330|NCT00537940|66276817|FG000|Overall Study|Study terminated by sponsor|2|||
23699331|NCT00537940|66276818|FG001|Overall Study|Study terminated by sponsor|3|||
23699332|NCT00537940|66276817|FG000|Overall Study|Other|10|||
23699333|NCT00537940|66276818|FG001|Overall Study|Other|12|||
23699334|NCT00098345|66276819|FG000|Overall Study|Adverse Event|7|||
23699335|NCT00098345|66276819|FG000|Overall Study|Withdrawal by Subject|2|||
23699336|NCT00098345|66276819|FG000|Overall Study|progression|4|||
23699337|NCT02698423|66276820|FG000|Overall Study|Lost to Follow-up|19|||
23699338|NCT02698423|66276821|FG001|Overall Study|Lost to Follow-up|24|||
23699339|NCT03184701|66276822|FG000|Overall Study|Death|3|||
23699340|NCT03184701|66276822|FG000|Overall Study|Physician Decision|3|||
23699341|NCT03184701|66276822|FG000|Overall Study|Withdrawal by Subject|6|||
23699342|NCT03184701|66276822|FG000|Overall Study|Lost to Follow-up|5|||
23699343|NCT01208662|66276825|FG000|Induction and Consolidation|Disease Progression|23|||
23699344|NCT01208662|66276826|FG001|Induction and Consolidation|Disease Progression|13|||
23699345|NCT01208662|66276827|FG002|Induction and Consolidation|Disease Progression|0|||
23699346|NCT01208662|66276825|FG000|Induction and Consolidation|Adverse Event|16|||
23699347|NCT01208662|66276826|FG001|Induction and Consolidation|Adverse Event|18|||
23699348|NCT01208662|66276827|FG002|Induction and Consolidation|Adverse Event|2|||
23699349|NCT01208662|66276825|FG000|Induction and Consolidation|MD or Participant Decision|16|||
23699350|NCT01208662|66276826|FG001|Induction and Consolidation|MD or Participant Decision|34|||
23699351|NCT01208662|66276827|FG002|Induction and Consolidation|MD or Participant Decision|4|||
23699352|NCT01208662|66276825|FG000|Induction and Consolidation|Death|1|||
23699353|NCT01208662|66276826|FG001|Induction and Consolidation|Death|3|||
23699354|NCT01208662|66276827|FG002|Induction and Consolidation|Death|1|||
23699355|NCT01208662|66276825|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
23699356|NCT01208662|66276826|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
23699357|NCT01208662|66276827|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
23699358|NCT01208662|66276825|FG000|Maintenance|Disease Progression|156|||
23699359|NCT01208662|66276826|FG001|Maintenance|Disease Progression|102|||
23699360|NCT01208662|66276827|FG002|Maintenance|Disease Progression|0|||
23699361|NCT01208662|66276825|FG000|Maintenance|Adverse Event|12|||
23699362|NCT01208662|66276826|FG001|Maintenance|Adverse Event|28|||
23699363|NCT01208662|66276827|FG002|Maintenance|Adverse Event|0|||
23699364|NCT01208662|66276825|FG000|Maintenance|MD or Participant Decision|24|||
23699365|NCT01208662|66276826|FG001|Maintenance|MD or Participant Decision|36|||
23699366|NCT01208662|66276827|FG002|Maintenance|MD or Participant Decision|0|||
23699367|NCT01208662|66276825|FG000|Maintenance|Death|0|||
23699368|NCT01208662|66276826|FG001|Maintenance|Death|3|||
23699369|NCT01208662|66276827|FG002|Maintenance|Death|0|||
23699370|NCT01208662|66276825|FG000|Maintenance|Discontinued for other reasons|21|||
23699371|NCT01208662|66276826|FG001|Maintenance|Discontinued for other reasons|31|||
23699372|NCT01208662|66276827|FG002|Maintenance|Discontinued for other reasons|0|||
23699373|NCT01208662|66276825|FG000|Maintenance|Still on Treatment|78|||
23699374|NCT01208662|66276826|FG001|Maintenance|Still on Treatment|89|||
23699375|NCT01208662|66276827|FG002|Maintenance|Still on Treatment|0|||
23699376|NCT00426751|66276828|FG000|Overall Study|Adverse Event|8|||
23699377|NCT00426751|66276829|FG001|Overall Study|Adverse Event|1|||
23699378|NCT00426751|66276828|FG000|Overall Study|Lost to Follow-up|7|||
23699379|NCT00426751|66276829|FG001|Overall Study|Lost to Follow-up|6|||
23699380|NCT00426751|66276828|FG000|Overall Study|Consent Withdrawn|0|||
23699381|NCT00426751|66276829|FG001|Overall Study|Consent Withdrawn|1|||
23699382|NCT00426751|66276828|FG000|Overall Study|Other Reasons|7|||
23699383|NCT00426751|66276829|FG001|Overall Study|Other Reasons|12|||
23699384|NCT02296840|66276830|FG000|Overall Study|Adverse Event|1|||
23699385|NCT02296840|66276831|FG001|Overall Study|Adverse Event|1|||
23699386|NCT02296840|66276830|FG000|Overall Study|Protocol Violation|2|||
23699387|NCT02296840|66276831|FG001|Overall Study|Protocol Violation|1|||
23699388|NCT02296840|66276830|FG000|Overall Study|Lost to Follow-up|6|||
23699389|NCT02296840|66276831|FG001|Overall Study|Lost to Follow-up|17|||
23699390|NCT00455858|66276832|FG000|Overall Study|Lost to Follow-up|2|||
23699391|NCT00455858|66276832|FG000|Overall Study|Protocol Violation|1|||
23699392|NCT00455858|66276832|FG000|Overall Study|Lack of Efficacy|1|||
23699393|NCT00455858|66276832|FG000|Overall Study|Well controlled FPG without insulin|1|||
23699394|NCT00455858|66276832|FG000|Overall Study|Withdrawal|1|||
23699395|NCT00573131|66276835|FG000|Overall Study|Withdrawal by Subject|10|||
23699396|NCT00573131|66276836|FG001|Overall Study|Withdrawal by Subject|8|||
23699397|NCT01469052|66276841|FG000|Overall Study|Adverse Event|2|||
23699398|NCT01469052|66276842|FG001|Overall Study|Adverse Event|3|||
23699399|NCT01469052|66276843|FG002|Overall Study|Adverse Event|0|||
23699400|NCT01469052|66276844|FG003|Overall Study|Adverse Event|2|||
23699401|NCT01469052|66276845|FG004|Overall Study|Adverse Event|0|||
23699402|NCT01469052|66276846|FG005|Overall Study|Adverse Event|1|||
23398482|NCT00902330|65203607|FG000|Overall Study|No post baseline data|1|||
23398483|NCT00902330|65203608|FG001|Overall Study|No post baseline data|0|||
23398484|NCT00160563|65203609|FG000|Overall Study|Adverse Event|1|||
23398485|NCT00160563|65203610|FG001|Overall Study|Adverse Event|1|||
23398486|NCT00160563|65203611|FG002|Overall Study|Adverse Event|1|||
23398487|NCT00160563|65203609|FG000|Overall Study|Lost to Follow-up|1|||
23398488|NCT00160563|65203610|FG001|Overall Study|Lost to Follow-up|1|||
23398489|NCT00160563|65203611|FG002|Overall Study|Lost to Follow-up|2|||
23398490|NCT00160563|65203609|FG000|Overall Study|Protocol Violation|0|||
23398491|NCT00160563|65203610|FG001|Overall Study|Protocol Violation|0|||
23699403|NCT01469052|66276841|FG000|Overall Study|Progressive disease|3|||
23699404|NCT01469052|66276842|FG001|Overall Study|Progressive disease|0|||
23398492|NCT00160563|65203611|FG002|Overall Study|Protocol Violation|3|||
23398493|NCT00160563|65203609|FG000|Overall Study|Withdrawal by Subject|1|||
23398494|NCT00160563|65203610|FG001|Overall Study|Withdrawal by Subject|2|||
23398495|NCT00160563|65203611|FG002|Overall Study|Withdrawal by Subject|3|||
23699405|NCT01469052|66276843|FG002|Overall Study|Progressive disease|5|||
23699406|NCT01469052|66276844|FG003|Overall Study|Progressive disease|3|||
23699407|NCT01469052|66276845|FG004|Overall Study|Progressive disease|7|||
23699408|NCT01469052|66276846|FG005|Overall Study|Progressive disease|2|||
23699409|NCT01469052|66276841|FG000|Overall Study|Lack of Efficacy|0|||
23699410|NCT01469052|66276842|FG001|Overall Study|Lack of Efficacy|0|||
23699411|NCT01469052|66276843|FG002|Overall Study|Lack of Efficacy|0|||
23699412|NCT01469052|66276844|FG003|Overall Study|Lack of Efficacy|0|||
23699413|NCT01469052|66276845|FG004|Overall Study|Lack of Efficacy|0|||
23699414|NCT01469052|66276846|FG005|Overall Study|Lack of Efficacy|2|||
23398496|NCT00160563|65203609|FG000|Overall Study|Other (listed in the study report)|48|||
23398497|NCT00160563|65203610|FG001|Overall Study|Other (listed in the study report)|40|||
23398498|NCT00160563|65203611|FG002|Overall Study|Other (listed in the study report)|81|||
23398499|NCT00160563|65203609|FG000|Overall Study|Missing reason|0|||
23699415|NCT01469052|66276841|FG000|Overall Study|Moved to rollover protocol|1|||
23699416|NCT01469052|66276842|FG001|Overall Study|Moved to rollover protocol|0|||
23699417|NCT01469052|66276843|FG002|Overall Study|Moved to rollover protocol|1|||
23699418|NCT01469052|66276844|FG003|Overall Study|Moved to rollover protocol|0|||
23699419|NCT01469052|66276845|FG004|Overall Study|Moved to rollover protocol|0|||
23699420|NCT01469052|66276846|FG005|Overall Study|Moved to rollover protocol|1|||
23699421|NCT01469052|66276841|FG000|Overall Study|Other|0|||
23699422|NCT01469052|66276842|FG001|Overall Study|Other|1|||
23699423|NCT01469052|66276843|FG002|Overall Study|Other|0|||
23699424|NCT01469052|66276844|FG003|Overall Study|Other|0|||
23699425|NCT01469052|66276845|FG004|Overall Study|Other|1|||
23699426|NCT01469052|66276846|FG005|Overall Study|Other|0|||
23699427|NCT01266148|66276855|FG000|Overall Study|Adverse Event|2|||
23699428|NCT01266148|66276856|FG001|Overall Study|Adverse Event|0|||
23699429|NCT01266148|66276855|FG000|Overall Study|Ongoing rejection|1|||
23699430|NCT01266148|66276856|FG001|Overall Study|Ongoing rejection|0|||
23699431|NCT01266148|66276855|FG000|Overall Study|2 2R rejections|1|||
23699432|NCT01266148|66276856|FG001|Overall Study|2 2R rejections|0|||
23699433|NCT01266148|66276855|FG000|Overall Study|Death|2|||
23699434|NCT01266148|66276856|FG001|Overall Study|Death|3|||
23699435|NCT01266148|66276855|FG000|Overall Study|missing mGFR value + AE|1|||
23699436|NCT01266148|66276856|FG001|Overall Study|missing mGFR value + AE|0|||
23699437|NCT01713036|66276858|FG000|Overall Study|Death|1|||
23699438|NCT00374907|66276859|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
23699439|NCT00374907|66276860|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
23699440|NCT00374907|66276859|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
23699441|NCT00374907|66276860|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
23699442|NCT00374907|66276859|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
23699443|NCT00374907|66276860|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
23699444|NCT00374907|66276859|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
23699445|NCT00374907|66276860|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
23699446|NCT00374907|66276859|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
23398500|NCT00160563|65203610|FG001|Overall Study|Missing reason|1|||
23398501|NCT00160563|65203611|FG002|Overall Study|Missing reason|0|||
23398502|NCT04622592|65203612|FG000|Overall Study|Death|0|||
23398503|NCT04622592|65203613|FG001|Overall Study|Death|0|||
23398504|NCT04622592|65203614|FG002|Overall Study|Death|1|||
23398505|NCT04622592|65203615|FG003|Overall Study|Death|0|||
23398506|NCT04622592|65203616|FG004|Overall Study|Death|0|||
23398507|NCT04622592|65203617|FG005|Overall Study|Death|0|||
23398508|NCT04622592|65203618|FG006|Overall Study|Death|0|||
23398509|NCT04622592|65203619|FG007|Overall Study|Death|1|||
23398510|NCT04622592|65203612|FG000|Overall Study|Lost to Follow-up|0|||
23398511|NCT04622592|65203613|FG001|Overall Study|Lost to Follow-up|0|||
23398512|NCT04622592|65203614|FG002|Overall Study|Lost to Follow-up|0|||
23498693|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
23498694|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
23498695|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
23498696|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
23498697|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
23498698|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
23498699|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498700|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498701|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498702|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498703|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498704|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498705|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498706|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23699447|NCT00374907|66276860|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
23699448|NCT03700892|66276861|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
23699449|NCT03700892|66276862|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
23699450|NCT03700892|66276863|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
23398513|NCT04622592|65203615|FG003|Overall Study|Lost to Follow-up|3|||
23398514|NCT04622592|65203616|FG004|Overall Study|Lost to Follow-up|1|||
23398515|NCT04622592|65203617|FG005|Overall Study|Lost to Follow-up|0|||
23398516|NCT04622592|65203618|FG006|Overall Study|Lost to Follow-up|2|||
23699451|NCT00803244|66276864|FG000|Overall Study|Adverse Event|1|||
23398517|NCT04622592|65203619|FG007|Overall Study|Lost to Follow-up|2|||
23498707|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498708|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
23498709|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23699452|NCT00803244|66276865|FG001|Overall Study|Adverse Event|2|||
23699453|NCT00803244|66276864|FG000|Overall Study|Withdrawal by Subject|2|||
23699454|NCT00803244|66276865|FG001|Overall Study|Withdrawal by Subject|3|||
23699455|NCT00803244|66276864|FG000|Overall Study|Any other reason not above-mentioned|4|||
23699456|NCT00803244|66276865|FG001|Overall Study|Any other reason not above-mentioned|10|||
23699457|NCT00864227|66276866|FG000|Overall Study|Withdrawal by Subject|1|||
23699458|NCT00864227|66276866|FG000|Overall Study|Disease Relapse/Progression|3|||
23699459|NCT02284906|66276867|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23699460|NCT02284906|66276868|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23699461|NCT02284906|66276869|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23699462|NCT02284906|66276867|FG000|Overall Study|Major Protocol Deviation|0|||
23699463|NCT02284906|66276868|FG001|Overall Study|Major Protocol Deviation|1|||
23699464|NCT02284906|66276869|FG002|Overall Study|Major Protocol Deviation|0|||
23699465|NCT02284906|66276867|FG000|Overall Study|Voluntary Withdrawal|2|||
23699466|NCT02284906|66276868|FG001|Overall Study|Voluntary Withdrawal|4|||
23699467|NCT02284906|66276869|FG002|Overall Study|Voluntary Withdrawal|5|||
23699468|NCT02284906|66276867|FG000|Overall Study|Study Termination|0|||
23699469|NCT02284906|66276868|FG001|Overall Study|Study Termination|11|||
23699470|NCT02284906|66276869|FG002|Overall Study|Study Termination|14|||
23699471|NCT02284906|66276867|FG000|Overall Study|Reason not Specified|1|||
23699472|NCT02284906|66276868|FG001|Overall Study|Reason not Specified|1|||
23498710|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498711|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498712|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23699473|NCT02284906|66276869|FG002|Overall Study|Reason not Specified|0|||
23699474|NCT01422304|66276870|FG000|Overall Study|Adverse Event|0|||
23699475|NCT01422304|66276871|FG001|Overall Study|Adverse Event|1|||
23699476|NCT01422304|66276870|FG000|Overall Study|Lost to Follow-up|14|||
23699477|NCT01422304|66276871|FG001|Overall Study|Lost to Follow-up|20|||
23699478|NCT01422304|66276870|FG000|Overall Study|Never Entered Follow-up|2|||
23699479|NCT01422304|66276871|FG001|Overall Study|Never Entered Follow-up|1|||
23699480|NCT01422304|66276870|FG000|Overall Study|Protocol Violation|1|||
23699481|NCT01422304|66276871|FG001|Overall Study|Protocol Violation|0|||
23699482|NCT01422304|66276870|FG000|Overall Study|Withdrawal by Subject|4|||
23699483|NCT01422304|66276871|FG001|Overall Study|Withdrawal by Subject|2|||
23699484|NCT01422304|66276870|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23699485|NCT01422304|66276871|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
23699486|NCT01422304|66276870|FG000|Overall Study|Not Treated|3|||
23699487|NCT01422304|66276871|FG001|Overall Study|Not Treated|11|||
23699488|NCT01751646|66276872|FG000|Overall Study|Lost to Follow-up|5|||
23699489|NCT01751646|66276873|FG001|Overall Study|Lost to Follow-up|1|||
23699490|NCT01751646|66276872|FG000|Overall Study|Withdrawal by Subject|0|||
23498713|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498714|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498715|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Other|0|||
23498716|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Other|1|||
23498717|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Other|1|||
23498718|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Other|0|||
23498719|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Other|0|||
23699491|NCT01751646|66276873|FG001|Overall Study|Withdrawal by Subject|4|||
23699492|NCT01751646|66276872|FG000|Overall Study|Starting hormone therapy|1|||
23699493|NCT01751646|66276873|FG001|Overall Study|Starting hormone therapy|0|||
23699494|NCT01751646|66276872|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
23699495|NCT01751646|66276873|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
23699496|NCT01751646|66276872|FG000|Overall Study|Inadvertent enrollment|1|||
23699497|NCT01751646|66276873|FG001|Overall Study|Inadvertent enrollment|1|||
23699498|NCT01751646|66276872|FG000|Overall Study|Moved out of the area|1|||
23699499|NCT01751646|66276873|FG001|Overall Study|Moved out of the area|5|||
23699500|NCT01751646|66276872|FG000|Overall Study|Inability to attend required visits|0|||
23699501|NCT01751646|66276873|FG001|Overall Study|Inability to attend required visits|1|||
23699502|NCT01751646|66276872|FG000|Overall Study|Off study due to multiple obligations|0|||
23699503|NCT01751646|66276873|FG001|Overall Study|Off study due to multiple obligations|1|||
23498720|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Other|0|||
23498721|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Other|0|||
23498722|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Other|0|||
23498723|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498724|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498725|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23699504|NCT01751646|66276872|FG000|Overall Study|Fails to comply with study requirements|0|||
23498726|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498727|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498728|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498729|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
23498730|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498731|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498732|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498733|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498734|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498735|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498736|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498737|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
23498738|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498739|NCT00199875|65566437|FG000|Overall Study|Withdrawal by Subject|0|||
23498740|NCT00199875|65566438|FG001|Overall Study|Withdrawal by Subject|0|||
23498741|NCT00199875|65566439|FG002|Overall Study|Withdrawal by Subject|0|||
23498742|NCT00199875|65566440|FG003|Overall Study|Withdrawal by Subject|0|||
23498743|NCT00199875|65566441|FG004|Overall Study|Withdrawal by Subject|1|||
23498744|NCT01500031|65566442|FG000|Overall Study|Death|1|||
23498745|NCT01500031|65566442|FG000|Overall Study|Withdrawal by Subject|4|||
23699505|NCT01751646|66276873|FG001|Overall Study|Fails to comply with study requirements|1|||
23699506|NCT01751646|66276872|FG000|Overall Study|Childcare issues|1|||
23699507|NCT01751646|66276873|FG001|Overall Study|Childcare issues|1|||
23699508|NCT02275026|66276878|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
23699509|NCT02275026|66276878|FG000|Overall Study|Withdrawal by Subject|4|||
23699510|NCT02275026|66276878|FG000|Overall Study|Ineligible due to medical history|13|||
23699511|NCT02275026|66276878|FG000|Overall Study|MRI malfunction precluded testing|1|||
23699512|NCT02275026|66276878|FG000|Overall Study|Ineligible after MRI findings|1|||
23699513|NCT02275026|66276878|FG000|Overall Study|Lost to Follow-up|2|||
23699514|NCT02275026|66276878|FG000|Overall Study|Scanner failure|1|||
23699515|NCT01013883|66276879|FG000|Overall Study|Lost to Follow-up|2|||
23699516|NCT01013883|66276880|FG001|Overall Study|Lost to Follow-up|2|||
23699517|NCT01334125|66276885|FG000|Overall Study|Lost to Follow-up|3|||
23699518|NCT01334125|66276886|FG001|Overall Study|Lost to Follow-up|3|||
23699519|NCT02046564|66276887|FG000|Overall Study|Adverse Event|6|||
23699520|NCT02046564|66276888|FG001|Overall Study|Adverse Event|3|||
23699521|NCT02046564|66276887|FG000|Overall Study|Physician Decision|0|||
23699522|NCT02046564|66276888|FG001|Overall Study|Physician Decision|1|||
23699523|NCT02046564|66276887|FG000|Overall Study|Protocol Violation|3|||
23699524|NCT02046564|66276888|FG001|Overall Study|Protocol Violation|1|||
23699525|NCT02046564|66276887|FG000|Overall Study|Withdrawal by Subject|4|||
23699526|NCT02046564|66276888|FG001|Overall Study|Withdrawal by Subject|10|||
23699527|NCT02046564|66276887|FG000|Overall Study|Subject met withdrawal criteria|2|||
23699528|NCT02046564|66276888|FG001|Overall Study|Subject met withdrawal criteria|5|||
23699529|NCT02062151|66276889|FG000|Overall Study|screen failure|1|||
23699530|NCT03662334|66276894|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
23699531|NCT03662334|66276895|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
23699532|NCT01588197|66280419|FG000|Overall Study|Lack of Efficacy|0|||
23699533|NCT01588197|66280420|FG001|Overall Study|Lack of Efficacy|1|||
23699534|NCT01588197|66280419|FG000|Overall Study|No MRI|1|||
23699535|NCT01588197|66280420|FG001|Overall Study|No MRI|0|||
23699536|NCT04705597|66280430|FG000|Overall Study|Death|16|||
23699537|NCT04705597|66280431|FG001|Overall Study|Death|9|||
23699538|NCT04705597|66280430|FG000|Overall Study|Lost to Follow-up|1|||
23699539|NCT04705597|66280431|FG001|Overall Study|Lost to Follow-up|0|||
23699540|NCT04705597|66280430|FG000|Overall Study|Withdrawal by Subject|1|||
23699541|NCT04705597|66280431|FG001|Overall Study|Withdrawal by Subject|2|||
23699542|NCT02116972|66280437|FG000|Overall Study|Adverse Event|4|||
23699543|NCT02116972|66280438|FG001|Overall Study|Adverse Event|4|||
23699544|NCT02116972|66280439|FG002|Overall Study|Adverse Event|1|||
23699545|NCT02116972|66280437|FG000|Overall Study|Withdrawal by Subject|1|||
23699546|NCT02116972|66280438|FG001|Overall Study|Withdrawal by Subject|1|||
23699547|NCT02116972|66280439|FG002|Overall Study|Withdrawal by Subject|5|||
23498746|NCT01020981|65566443|FG000|Overall Study|Did not return mailed survey|74|||
23498747|NCT01020981|65566444|FG001|Overall Study|Did not return mailed survey|58|||
23498748|NCT01020981|65566443|FG000|Overall Study|Survey returned undeliverable|8|||
23498749|NCT01020981|65566444|FG001|Overall Study|Survey returned undeliverable|32|||
23498750|NCT01020981|65566443|FG000|Overall Study|Participant declined to complete survey|2|||
23498751|NCT01020981|65566444|FG001|Overall Study|Participant declined to complete survey|0|||
23699548|NCT02116972|66280437|FG000|Overall Study|Protocol Violation|1|||
23398518|NCT04622592|65203612|FG000|Overall Study|Physician Decision|0|||
23498752|NCT01180985|65566445|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
23699549|NCT02116972|66280438|FG001|Overall Study|Protocol Violation|0|||
23699550|NCT02116972|66280439|FG002|Overall Study|Protocol Violation|1|||
23699551|NCT02116972|66280437|FG000|Overall Study|Lost to Follow-up|4|||
23699552|NCT02116972|66280438|FG001|Overall Study|Lost to Follow-up|3|||
23699553|NCT02116972|66280439|FG002|Overall Study|Lost to Follow-up|1|||
23699554|NCT02116972|66280437|FG000|Overall Study|Lack of Efficacy|6|||
23699555|NCT02116972|66280438|FG001|Overall Study|Lack of Efficacy|6|||
23699556|NCT02116972|66280439|FG002|Overall Study|Lack of Efficacy|5|||
23699557|NCT02116972|66280437|FG000|Overall Study|scheduling conflicts and relocation|3|||
23699558|NCT02116972|66280438|FG001|Overall Study|scheduling conflicts and relocation|3|||
23699559|NCT02116972|66280439|FG002|Overall Study|scheduling conflicts and relocation|6|||
23699560|NCT02225223|66280443|FG000|Overall Study|Death|10|||
23699561|NCT02225223|66280444|FG001|Overall Study|Death|1|||
23699562|NCT02225223|66280443|FG000|Overall Study|Lost to Follow-up|5|||
23699563|NCT02225223|66280444|FG001|Overall Study|Lost to Follow-up|0|||
23699564|NCT02225223|66280443|FG000|Overall Study|Other|1|||
23699565|NCT02225223|66280444|FG001|Overall Study|Other|2|||
23699566|NCT02225223|66280443|FG000|Overall Study|Physician Decision|1|||
23699567|NCT02225223|66280444|FG001|Overall Study|Physician Decision|0|||
23699568|NCT02225223|66280443|FG000|Overall Study|Withdrawal by Subject|2|||
23699569|NCT02225223|66280444|FG001|Overall Study|Withdrawal by Subject|2|||
23699570|NCT00723840|66280445|FG000|Overall Study|Lost to Follow-up|2|||
23699571|NCT00723840|66280445|FG000|Overall Study|Failure to return|18|||
23699572|NCT00723840|66280445|FG000|Overall Study|Withdrawal by Subject|55|||
23699573|NCT00723840|66280445|FG000|Overall Study|Serious Adverse Events|3|||
23498753|NCT01180985|65566446|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
23498754|NCT00415168|65566448|FG000|Overall Study|Death|26|||
23498755|NCT00415168|65566448|FG000|Overall Study|Lost to Follow-up|3|||
23498756|NCT00415168|65566448|FG000|Overall Study|Physician Decision|13|||
23498757|NCT00415168|65566448|FG000|Overall Study|Sponsor Decision|4|||
23498758|NCT00415168|65566448|FG000|Overall Study|Withdrawal by Subject|6|||
23498759|NCT02465515|65566449|FG000|Overall Study|Investigator site closed|4|||
23498760|NCT02465515|65566450|FG001|Overall Study|Investigator site closed|5|||
23498761|NCT02465515|65566449|FG000|Overall Study|Withdrawal by Subject|74|||
23498762|NCT02465515|65566450|FG001|Overall Study|Withdrawal by Subject|43|||
23498763|NCT02465515|65566449|FG000|Overall Study|Physician Decision|8|||
23498764|NCT02465515|65566450|FG001|Overall Study|Physician Decision|12|||
23498765|NCT02465515|65566449|FG000|Overall Study|Lost to Follow-up|68|||
23498766|NCT02465515|65566450|FG001|Overall Study|Lost to Follow-up|51|||
23498767|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
23498768|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
23498769|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
23498770|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
23498771|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
23498772|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
23498773|NCT01964430|65566451|FG000|Treatment Period|Adverse Event|71|||
23699574|NCT00723840|66280445|FG000|Overall Study|Other Medical Event|2|||
23699575|NCT00723840|66280445|FG000|Overall Study|Unspecified reason|2|||
23699576|NCT02421120|66280449|FG000|Overall Study|Adverse Event|1|||
23699577|NCT01753518|66280450|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
23699578|NCT01753518|66280451|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
23699579|NCT01753518|66280450|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
23699580|NCT01753518|66280451|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
23699581|NCT01753518|66280450|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
23699582|NCT01753518|66280451|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
23699583|NCT01753518|66280450|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
23699584|NCT01753518|66280451|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
23699585|NCT00829166|66280452|FG000|Overall Study|Death|305|||
23699586|NCT00829166|66280453|FG001|Overall Study|Death|333|||
23699587|NCT00829166|66280452|FG000|Overall Study|Lost to Follow-up|5|||
23699588|NCT00829166|66280453|FG001|Overall Study|Lost to Follow-up|4|||
23699589|NCT00829166|66280452|FG000|Overall Study|Physician's Decision|4|||
23699590|NCT00829166|66280453|FG001|Overall Study|Physician's Decision|3|||
23699591|NCT00829166|66280452|FG000|Overall Study|Subject's Decision|41|||
23699592|NCT00829166|66280453|FG001|Overall Study|Subject's Decision|55|||
23699593|NCT00829166|66280452|FG000|Overall Study|Sponsor's Decision|137|||
23699594|NCT00829166|66280453|FG001|Overall Study|Sponsor's Decision|98|||
23699595|NCT00829166|66280452|FG000|Overall Study|Reason Not Specified|3|||
23699596|NCT00829166|66280453|FG001|Overall Study|Reason Not Specified|3|||
23699597|NCT00081289|66280454|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
23699598|NCT00081289|66280455|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
23699599|NCT00081289|66280454|FG000|Overall Study|Ineligible / no protocol treatment|3|||
23699600|NCT00081289|66280455|FG001|Overall Study|Ineligible / no protocol treatment|4|||
23699601|NCT01070550|66280461|FG000|Overall Study|Adverse Event|43|||
23498774|NCT01964430|65566452|FG001|Treatment Period|Adverse Event|37|||
23498775|NCT01964430|65566451|FG000|Treatment Period|Withdrawal by Subject|36|||
23498776|NCT01964430|65566452|FG001|Treatment Period|Withdrawal by Subject|27|||
23498777|NCT01964430|65566451|FG000|Treatment Period|Death|1|||
23699602|NCT01070550|66280462|FG001|Overall Study|Adverse Event|1|||
23699603|NCT01070550|66280463|FG002|Overall Study|Adverse Event|3|||
23699604|NCT01070550|66280464|FG003|Overall Study|Adverse Event|0|||
23699605|NCT01070550|66280465|FG004|Overall Study|Adverse Event|0|||
23699606|NCT01070550|66280466|FG005|Overall Study|Adverse Event|0|||
23699607|NCT01070550|66280461|FG000|Overall Study|Death|20|||
23699608|NCT01070550|66280462|FG001|Overall Study|Death|4|||
23699609|NCT01070550|66280463|FG002|Overall Study|Death|3|||
23699610|NCT01070550|66280464|FG003|Overall Study|Death|0|||
23699611|NCT01070550|66280465|FG004|Overall Study|Death|0|||
23699612|NCT01070550|66280466|FG005|Overall Study|Death|0|||
23699613|NCT01070550|66280461|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
23699614|NCT01070550|66280462|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23699615|NCT01070550|66280463|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23699616|NCT01070550|66280464|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23699617|NCT01070550|66280465|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23699618|NCT01070550|66280466|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23699619|NCT01070550|66280461|FG000|Overall Study|Early termination|3|||
23699620|NCT01070550|66280462|FG001|Overall Study|Early termination|0|||
23699621|NCT01070550|66280463|FG002|Overall Study|Early termination|0|||
23699622|NCT01070550|66280464|FG003|Overall Study|Early termination|0|||
23699623|NCT01070550|66280465|FG004|Overall Study|Early termination|0|||
23699624|NCT01070550|66280466|FG005|Overall Study|Early termination|0|||
23699625|NCT01070550|66280461|FG000|Overall Study|Failed to return|450|||
23699626|NCT01070550|66280462|FG001|Overall Study|Failed to return|33|||
23699627|NCT01070550|66280463|FG002|Overall Study|Failed to return|144|||
23699628|NCT01070550|66280464|FG003|Overall Study|Failed to return|40|||
23699629|NCT01070550|66280465|FG004|Overall Study|Failed to return|1|||
23699630|NCT01070550|66280466|FG005|Overall Study|Failed to return|2|||
23699631|NCT01070550|66280461|FG000|Overall Study|Incomplete treatment|2|||
23699632|NCT01070550|66280462|FG001|Overall Study|Incomplete treatment|0|||
23699633|NCT01070550|66280463|FG002|Overall Study|Incomplete treatment|0|||
23699634|NCT01070550|66280464|FG003|Overall Study|Incomplete treatment|0|||
23699635|NCT01070550|66280465|FG004|Overall Study|Incomplete treatment|0|||
23699636|NCT01070550|66280466|FG005|Overall Study|Incomplete treatment|0|||
23699637|NCT01070550|66280461|FG000|Overall Study|Lab test not done|22|||
23699638|NCT01070550|66280462|FG001|Overall Study|Lab test not done|3|||
23699639|NCT01070550|66280463|FG002|Overall Study|Lab test not done|4|||
23699640|NCT01070550|66280464|FG003|Overall Study|Lab test not done|1|||
23699641|NCT01070550|66280465|FG004|Overall Study|Lab test not done|0|||
23699642|NCT01070550|66280466|FG005|Overall Study|Lab test not done|1|||
23699643|NCT01070550|66280461|FG000|Overall Study|Lack of Efficacy|65|||
23699644|NCT01070550|66280462|FG001|Overall Study|Lack of Efficacy|1|||
23699645|NCT01070550|66280463|FG002|Overall Study|Lack of Efficacy|5|||
23699646|NCT01070550|66280464|FG003|Overall Study|Lack of Efficacy|5|||
23699647|NCT01070550|66280465|FG004|Overall Study|Lack of Efficacy|0|||
23699648|NCT01070550|66280466|FG005|Overall Study|Lack of Efficacy|1|||
23699649|NCT01070550|66280461|FG000|Overall Study|Miscellaneous|12|||
23699650|NCT01070550|66280462|FG001|Overall Study|Miscellaneous|2|||
23699651|NCT01070550|66280463|FG002|Overall Study|Miscellaneous|3|||
23699652|NCT01070550|66280464|FG003|Overall Study|Miscellaneous|1|||
23699653|NCT01070550|66280465|FG004|Overall Study|Miscellaneous|0|||
23699654|NCT01070550|66280466|FG005|Overall Study|Miscellaneous|0|||
23699655|NCT01070550|66280461|FG000|Overall Study|New treatment started|3|||
23699656|NCT01070550|66280462|FG001|Overall Study|New treatment started|1|||
23699657|NCT01070550|66280463|FG002|Overall Study|New treatment started|0|||
23699658|NCT01070550|66280464|FG003|Overall Study|New treatment started|2|||
23699659|NCT01070550|66280465|FG004|Overall Study|New treatment started|0|||
23699660|NCT01070550|66280466|FG005|Overall Study|New treatment started|0|||
23699661|NCT01070550|66280461|FG000|Overall Study|Non-responders|493|||
23699662|NCT01070550|66280462|FG001|Overall Study|Non-responders|4|||
23699663|NCT01070550|66280463|FG002|Overall Study|Non-responders|21|||
23699664|NCT01070550|66280464|FG003|Overall Study|Non-responders|20|||
23699665|NCT01070550|66280465|FG004|Overall Study|Non-responders|0|||
23699666|NCT01070550|66280466|FG005|Overall Study|Non-responders|2|||
23699667|NCT01070550|66280461|FG000|Overall Study|Not categorized|33|||
23699668|NCT01070550|66280462|FG001|Overall Study|Not categorized|2|||
23498778|NCT01964430|65566452|FG001|Treatment Period|Death|3|||
23699669|NCT01070550|66280463|FG002|Overall Study|Not categorized|6|||
23699670|NCT01070550|66280464|FG003|Overall Study|Not categorized|1|||
23699671|NCT01070550|66280465|FG004|Overall Study|Not categorized|0|||
23699672|NCT01070550|66280466|FG005|Overall Study|Not categorized|1|||
23699673|NCT01070550|66280461|FG000|Overall Study|Protocol Violation|15|||
23699674|NCT01070550|66280462|FG001|Overall Study|Protocol Violation|1|||
23699675|NCT01070550|66280463|FG002|Overall Study|Protocol Violation|1|||
23699676|NCT01070550|66280464|FG003|Overall Study|Protocol Violation|1|||
23699677|NCT01070550|66280465|FG004|Overall Study|Protocol Violation|0|||
23699678|NCT01070550|66280466|FG005|Overall Study|Protocol Violation|0|||
23699679|NCT01070550|66280461|FG000|Overall Study|Relapse|44|||
23699680|NCT01070550|66280462|FG001|Overall Study|Relapse|5|||
23699681|NCT01070550|66280463|FG002|Overall Study|Relapse|14|||
23699682|NCT01070550|66280464|FG003|Overall Study|Relapse|4|||
23699683|NCT01070550|66280465|FG004|Overall Study|Relapse|0|||
23699684|NCT01070550|66280466|FG005|Overall Study|Relapse|0|||
23699685|NCT01070550|66280461|FG000|Overall Study|Result not available|3|||
23699686|NCT01070550|66280462|FG001|Overall Study|Result not available|1|||
23699687|NCT01070550|66280463|FG002|Overall Study|Result not available|3|||
23699688|NCT01070550|66280464|FG003|Overall Study|Result not available|0|||
23699689|NCT01070550|66280465|FG004|Overall Study|Result not available|0|||
23699690|NCT01070550|66280466|FG005|Overall Study|Result not available|0|||
23699691|NCT01070550|66280461|FG000|Overall Study|Screen failure|1|||
23699692|NCT01070550|66280462|FG001|Overall Study|Screen failure|0|||
23699693|NCT01070550|66280463|FG002|Overall Study|Screen failure|0|||
23699694|NCT01070550|66280464|FG003|Overall Study|Screen failure|0|||
23699695|NCT01070550|66280465|FG004|Overall Study|Screen failure|0|||
23699696|NCT01070550|66280466|FG005|Overall Study|Screen failure|0|||
23699697|NCT01070550|66280461|FG000|Overall Study|Sponsor decision|1|||
23699698|NCT01070550|66280462|FG001|Overall Study|Sponsor decision|0|||
23699699|NCT01070550|66280463|FG002|Overall Study|Sponsor decision|0|||
23699700|NCT01070550|66280464|FG003|Overall Study|Sponsor decision|0|||
23699701|NCT01070550|66280465|FG004|Overall Study|Sponsor decision|0|||
23699702|NCT01070550|66280466|FG005|Overall Study|Sponsor decision|0|||
23699703|NCT01070550|66280461|FG000|Overall Study|Treatment duration shortened|1|||
23699704|NCT01070550|66280462|FG001|Overall Study|Treatment duration shortened|0|||
23699705|NCT01070550|66280463|FG002|Overall Study|Treatment duration shortened|0|||
23699706|NCT01070550|66280464|FG003|Overall Study|Treatment duration shortened|0|||
23699707|NCT01070550|66280465|FG004|Overall Study|Treatment duration shortened|0|||
23699708|NCT01070550|66280466|FG005|Overall Study|Treatment duration shortened|0|||
23699709|NCT01070550|66280461|FG000|Overall Study|Treatment interrupted|7|||
23699710|NCT01070550|66280462|FG001|Overall Study|Treatment interrupted|0|||
23699711|NCT01070550|66280463|FG002|Overall Study|Treatment interrupted|1|||
23699712|NCT01070550|66280464|FG003|Overall Study|Treatment interrupted|1|||
23699713|NCT01070550|66280465|FG004|Overall Study|Treatment interrupted|0|||
23699714|NCT01070550|66280466|FG005|Overall Study|Treatment interrupted|0|||
23498779|NCT01964430|65566451|FG000|Treatment Period|Protocol Deviation|0|||
23498780|NCT01964430|65566452|FG001|Treatment Period|Protocol Deviation|1|||
23498781|NCT01964430|65566451|FG000|Treatment Period|Physician Decision|5|||
23498782|NCT01964430|65566452|FG001|Treatment Period|Physician Decision|4|||
23498783|NCT01964430|65566451|FG000|Treatment Period|Disease Relapse|28|||
23498784|NCT01964430|65566452|FG001|Treatment Period|Disease Relapse|38|||
23498785|NCT01964430|65566451|FG000|Treatment Period|Other reasons|1|||
23498786|NCT01964430|65566452|FG001|Treatment Period|Other reasons|3|||
23498787|NCT01999114|65566453|FG000|Overall Study|Adverse Event|8|||
23699715|NCT01070550|66280461|FG000|Overall Study|Treatment not started|14|||
23699716|NCT01070550|66280462|FG001|Overall Study|Treatment not started|2|||
23699717|NCT01070550|66280463|FG002|Overall Study|Treatment not started|4|||
23699718|NCT01070550|66280464|FG003|Overall Study|Treatment not started|0|||
23699719|NCT01070550|66280465|FG004|Overall Study|Treatment not started|0|||
23699720|NCT01070550|66280466|FG005|Overall Study|Treatment not started|0|||
23699721|NCT01070550|66280461|FG000|Overall Study|Treatment restarted|0|||
23699722|NCT01070550|66280462|FG001|Overall Study|Treatment restarted|1|||
23699723|NCT01070550|66280463|FG002|Overall Study|Treatment restarted|0|||
23699724|NCT01070550|66280464|FG003|Overall Study|Treatment restarted|0|||
23699725|NCT01070550|66280465|FG004|Overall Study|Treatment restarted|0|||
23699726|NCT01070550|66280466|FG005|Overall Study|Treatment restarted|0|||
23699727|NCT01070550|66280461|FG000|Overall Study|Treatment stopped|3|||
23699728|NCT01070550|66280462|FG001|Overall Study|Treatment stopped|0|||
23699729|NCT01070550|66280463|FG002|Overall Study|Treatment stopped|0|||
23699730|NCT01070550|66280464|FG003|Overall Study|Treatment stopped|0|||
23699731|NCT01070550|66280465|FG004|Overall Study|Treatment stopped|0|||
23699732|NCT01070550|66280466|FG005|Overall Study|Treatment stopped|0|||
23699733|NCT01070550|66280461|FG000|Overall Study|Treatment unavailable|1|||
23699734|NCT01070550|66280462|FG001|Overall Study|Treatment unavailable|0|||
23699735|NCT01070550|66280463|FG002|Overall Study|Treatment unavailable|0|||
23699736|NCT01070550|66280464|FG003|Overall Study|Treatment unavailable|0|||
23498788|NCT01999114|65566454|FG001|Overall Study|Adverse Event|7|||
23498789|NCT01999114|65566455|FG002|Overall Study|Adverse Event|2|||
23498790|NCT01999114|65566456|FG003|Overall Study|Adverse Event|2|||
23498791|NCT01999114|65566457|FG004|Overall Study|Adverse Event|1|||
23699737|NCT01070550|66280465|FG004|Overall Study|Treatment unavailable|0|||
23699738|NCT01070550|66280466|FG005|Overall Study|Treatment unavailable|0|||
23699739|NCT01070550|66280461|FG000|Overall Study|Treatment was stopped early|7|||
23699740|NCT01070550|66280462|FG001|Overall Study|Treatment was stopped early|0|||
23699741|NCT01070550|66280463|FG002|Overall Study|Treatment was stopped early|0|||
23699742|NCT01070550|66280464|FG003|Overall Study|Treatment was stopped early|0|||
23699743|NCT01070550|66280465|FG004|Overall Study|Treatment was stopped early|0|||
23699744|NCT01070550|66280466|FG005|Overall Study|Treatment was stopped early|0|||
23699745|NCT01070550|66280461|FG000|Overall Study|Other|5|||
23699746|NCT01070550|66280462|FG001|Overall Study|Other|0|||
23699747|NCT01070550|66280463|FG002|Overall Study|Other|0|||
23699748|NCT01070550|66280464|FG003|Overall Study|Other|1|||
23699749|NCT01070550|66280465|FG004|Overall Study|Other|0|||
23699750|NCT01070550|66280466|FG005|Overall Study|Other|0|||
23699751|NCT01070550|66280461|FG000|Overall Study|Withdrawal by Subject|35|||
23699752|NCT01070550|66280462|FG001|Overall Study|Withdrawal by Subject|0|||
23699753|NCT01070550|66280463|FG002|Overall Study|Withdrawal by Subject|3|||
23699754|NCT01070550|66280464|FG003|Overall Study|Withdrawal by Subject|0|||
23699755|NCT01070550|66280465|FG004|Overall Study|Withdrawal by Subject|0|||
23699756|NCT01070550|66280466|FG005|Overall Study|Withdrawal by Subject|0|||
23699757|NCT01996319|66280472|FG000|Overall Study|Protocol Violation|1|||
23699758|NCT01996319|66280473|FG001|Overall Study|Protocol Violation|0|||
23699759|NCT01996319|66280472|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
23699760|NCT01996319|66280473|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
23699761|NCT01996319|66280472|FG000|Overall Study|Adverse Event|2|||
23699762|NCT01996319|66280473|FG001|Overall Study|Adverse Event|2|||
23699763|NCT00914628|66280474|FG000|Overall Study|Death|35|||
23699764|NCT00914628|66280475|FG001|Overall Study|Death|17|||
23699765|NCT00914628|66280474|FG000|Overall Study|Medical decision|4|||
23699766|NCT00914628|66280475|FG001|Overall Study|Medical decision|0|||
23699767|NCT00914628|66280474|FG000|Overall Study|Protocol Violation|1|||
23699768|NCT00914628|66280475|FG001|Overall Study|Protocol Violation|0|||
23699769|NCT00914628|66280474|FG000|Overall Study|Lack of Efficacy|1|||
23498792|NCT01999114|65566453|FG000|Overall Study|Withdrawal by Subject|0|||
23498793|NCT01999114|65566454|FG001|Overall Study|Withdrawal by Subject|0|||
23498794|NCT01999114|65566455|FG002|Overall Study|Withdrawal by Subject|1|||
23498795|NCT01999114|65566456|FG003|Overall Study|Withdrawal by Subject|0|||
23498796|NCT01999114|65566457|FG004|Overall Study|Withdrawal by Subject|1|||
23498797|NCT01999114|65566453|FG000|Overall Study|Lost to Follow-up|0|||
23498798|NCT01999114|65566454|FG001|Overall Study|Lost to Follow-up|0|||
23498799|NCT01999114|65566455|FG002|Overall Study|Lost to Follow-up|1|||
23498800|NCT01999114|65566456|FG003|Overall Study|Lost to Follow-up|0|||
23498801|NCT01999114|65566457|FG004|Overall Study|Lost to Follow-up|0|||
23498802|NCT01999114|65566453|FG000|Overall Study|Administrative|0|||
23498803|NCT01999114|65566454|FG001|Overall Study|Administrative|0|||
23498804|NCT01999114|65566455|FG002|Overall Study|Administrative|1|||
23498805|NCT01999114|65566456|FG003|Overall Study|Administrative|1|||
23498806|NCT01999114|65566457|FG004|Overall Study|Administrative|2|||
23498807|NCT01604408|65566460|FG000|Treatment Period 1|Protocol Violation|0|||
23498808|NCT01604408|65566461|FG001|Treatment Period 1|Protocol Violation|1|||
23498809|NCT01604408|65566460|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23498810|NCT01604408|65566461|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23498811|NCT01604408|65566460|FG000|Treatment Period 2|Protocol Violation|1|||
23498812|NCT01604408|65566461|FG001|Treatment Period 2|Protocol Violation|0|||
23498813|NCT01604408|65566460|FG000|Treatment Period 2|Adverse Event|0|||
23498814|NCT01604408|65566461|FG001|Treatment Period 2|Adverse Event|1|||
23498815|NCT01604408|65566460|FG000|Treatment Period 3|Protocol Violation|1|||
23498816|NCT01604408|65566461|FG001|Treatment Period 3|Protocol Violation|1|||
23498817|NCT01604408|65566460|FG000|Treatment Period 3|Adverse Event|0|||
23498818|NCT01604408|65566461|FG001|Treatment Period 3|Adverse Event|3|||
23498819|NCT01604408|65566460|FG000|Treatment Period 3|Withdrawal by Subject|3|||
23498820|NCT01604408|65566461|FG001|Treatment Period 3|Withdrawal by Subject|1|||
23498821|NCT01604408|65566460|FG000|Treatment Period 3|Sponsor Decision|1|||
23498822|NCT01604408|65566461|FG001|Treatment Period 3|Sponsor Decision|0|||
23498823|NCT01604408|65566460|FG000|Treatment Period 4|Death|1|||
23498824|NCT01604408|65566461|FG001|Treatment Period 4|Death|0|||
23498825|NCT01604408|65566460|FG000|Treatment Period 4|Withdrawal by Subject|2|||
23699770|NCT00914628|66280475|FG001|Overall Study|Lack of Efficacy|0|||
23699771|NCT00914628|66280474|FG000|Overall Study|non-randomized|1|||
23699772|NCT00914628|66280475|FG001|Overall Study|non-randomized|0|||
23699773|NCT00914628|66280474|FG000|Overall Study|Relapse|1|||
23699774|NCT00914628|66280475|FG001|Overall Study|Relapse|2|||
23699775|NCT00914628|66280474|FG000|Overall Study|Study terminated by Sponsor|14|||
23699776|NCT00914628|66280475|FG001|Overall Study|Study terminated by Sponsor|8|||
23699777|NCT00914628|66280474|FG000|Overall Study|Patients who did not receive a single dose|7|||
23699778|NCT00914628|66280475|FG001|Overall Study|Patients who did not receive a single dose|1|||
23498826|NCT01604408|65566461|FG001|Treatment Period 4|Withdrawal by Subject|1|||
23498827|NCT01604408|65566460|FG000|Treatment Period 4|Adverse Event|0|||
23699779|NCT00418886|66280476|FG000|Overall Study|discontinue treatment survival follow up|90|||
23498828|NCT01604408|65566461|FG001|Treatment Period 4|Adverse Event|1|||
23498829|NCT01604408|65566460|FG000|Treatment Period 5|Adverse Event|4|||
23699780|NCT00418886|66280477|FG001|Overall Study|discontinue treatment survival follow up|91|||
23699781|NCT00418886|66280476|FG000|Overall Study|Death|122|||
23699782|NCT00418886|66280477|FG001|Overall Study|Death|147|||
23699783|NCT00418886|66280476|FG000|Overall Study|Withdrawal by Subject|9|||
23498830|NCT01604408|65566461|FG001|Treatment Period 5|Adverse Event|0|||
23498831|NCT01604408|65566460|FG000|Treatment Period 6|Lost to Follow-up|0|||
23498832|NCT01604408|65566461|FG001|Treatment Period 6|Lost to Follow-up|1|||
23699784|NCT00418886|66280477|FG001|Overall Study|Withdrawal by Subject|10|||
23699785|NCT00418886|66280476|FG000|Overall Study|Lost to Follow-up|4|||
23699786|NCT00418886|66280477|FG001|Overall Study|Lost to Follow-up|6|||
23699787|NCT00418886|66280476|FG000|Overall Study|withdrawn due to other reason|1|||
23699788|NCT00418886|66280477|FG001|Overall Study|withdrawn due to other reason|0|||
23699789|NCT00418886|66280476|FG000|Overall Study|randomised but no treatment received|0|||
23699790|NCT00418886|66280477|FG001|Overall Study|randomised but no treatment received|1|||
23699791|NCT01937130|66280478|FG000|Overall Study|Withdrawal by Subject|0|||
23699792|NCT01937130|66280479|FG001|Overall Study|Withdrawal by Subject|0|||
23699793|NCT01937130|66280480|FG002|Overall Study|Withdrawal by Subject|0|||
23699794|NCT01937130|66280481|FG003|Overall Study|Withdrawal by Subject|1|||
23699795|NCT01937130|66280478|FG000|Overall Study|Adverse Event|0|||
23699796|NCT01937130|66280479|FG001|Overall Study|Adverse Event|1|||
23699797|NCT01937130|66280480|FG002|Overall Study|Adverse Event|0|||
23699798|NCT01937130|66280481|FG003|Overall Study|Adverse Event|1|||
23699799|NCT01937130|66280478|FG000|Overall Study|Death|1|||
23699800|NCT01937130|66280479|FG001|Overall Study|Death|1|||
23699801|NCT01937130|66280480|FG002|Overall Study|Death|1|||
23699802|NCT01937130|66280481|FG003|Overall Study|Death|0|||
23699803|NCT01937130|66280478|FG000|Overall Study|Lost to Follow-up|2|||
23699804|NCT01937130|66280479|FG001|Overall Study|Lost to Follow-up|0|||
23699805|NCT01937130|66280480|FG002|Overall Study|Lost to Follow-up|2|||
23699806|NCT01937130|66280481|FG003|Overall Study|Lost to Follow-up|0|||
23699807|NCT01937130|66280478|FG000|Overall Study|Physician Decision|0|||
23699808|NCT01937130|66280479|FG001|Overall Study|Physician Decision|1|||
23699809|NCT01937130|66280480|FG002|Overall Study|Physician Decision|0|||
23699810|NCT01937130|66280481|FG003|Overall Study|Physician Decision|0|||
23699811|NCT01937130|66280478|FG000|Overall Study|Patients unable to swallow|0|||
23699812|NCT01937130|66280479|FG001|Overall Study|Patients unable to swallow|1|||
23699813|NCT01937130|66280480|FG002|Overall Study|Patients unable to swallow|0|||
23699814|NCT01937130|66280481|FG003|Overall Study|Patients unable to swallow|0|||
23699815|NCT01937130|66280478|FG000|Overall Study|Patient lost to FU due to death|2|||
23699816|NCT01937130|66280479|FG001|Overall Study|Patient lost to FU due to death|0|||
23699817|NCT01937130|66280480|FG002|Overall Study|Patient lost to FU due to death|0|||
23699818|NCT01937130|66280481|FG003|Overall Study|Patient lost to FU due to death|0|||
23699819|NCT01022853|66280484|FG000|Overall Study|Progressive disease|2|||
23699820|NCT01022853|66280485|FG001|Overall Study|Progressive disease|3|||
23699821|NCT01022853|66280486|FG002|Overall Study|Progressive disease|11|||
23699822|NCT01022853|66280487|FG003|Overall Study|Progressive disease|7|||
23699823|NCT01022853|66280488|FG004|Overall Study|Progressive disease|1|||
23699824|NCT01022853|66280484|FG000|Overall Study|Dose-limiting toxicity|0|||
23699825|NCT01022853|66280485|FG001|Overall Study|Dose-limiting toxicity|0|||
23699826|NCT01022853|66280486|FG002|Overall Study|Dose-limiting toxicity|0|||
23699827|NCT01022853|66280487|FG003|Overall Study|Dose-limiting toxicity|0|||
23699828|NCT01022853|66280488|FG004|Overall Study|Dose-limiting toxicity|1|||
23699829|NCT01022853|66280484|FG000|Overall Study|Withdrawal by Subject|0|||
23699830|NCT01022853|66280485|FG001|Overall Study|Withdrawal by Subject|1|||
23699831|NCT01022853|66280486|FG002|Overall Study|Withdrawal by Subject|1|||
23699832|NCT01022853|66280487|FG003|Overall Study|Withdrawal by Subject|1|||
23699833|NCT01022853|66280488|FG004|Overall Study|Withdrawal by Subject|0|||
23699834|NCT01022853|66280484|FG000|Overall Study|Other not stated above|1|||
23699835|NCT01022853|66280485|FG001|Overall Study|Other not stated above|0|||
23699836|NCT01022853|66280486|FG002|Overall Study|Other not stated above|1|||
23699837|NCT01022853|66280487|FG003|Overall Study|Other not stated above|0|||
23699838|NCT01022853|66280488|FG004|Overall Study|Other not stated above|0|||
23699839|NCT02229864|66280489|FG000|Overall Study|Death|2|||
23699840|NCT02229864|66280489|FG000|Overall Study|Lost to Follow-up|1|||
23699841|NCT04220866|66280491|FG000|Overall Study|Death|4|||
23699842|NCT04220866|66280492|FG001|Overall Study|Death|5|||
23699843|NCT04220866|66280491|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
23498833|NCT01604408|65566460|FG000|Treatment Period 6|Adverse Event|2|||
23498834|NCT01604408|65566461|FG001|Treatment Period 6|Adverse Event|0|||
23498835|NCT01604408|65566460|FG000|Treatment Period 6|Sponsor decision|0|||
23498836|NCT01604408|65566461|FG001|Treatment Period 6|Sponsor decision|1|||
23498837|NCT01604408|65566460|FG000|Observation Period|Adverse Event|1|||
23498838|NCT01604408|65566461|FG001|Observation Period|Adverse Event|1|||
23498839|NCT01604408|65566460|FG000|Observation Period|Withdrawal by Subject|0|||
23699844|NCT04220866|66280492|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
23498840|NCT01604408|65566461|FG001|Observation Period|Withdrawal by Subject|2|||
23699845|NCT04220866|66280491|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
23699846|NCT04220866|66280492|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
23699847|NCT04220866|66280491|FG000|Overall Study|Withdrawal by Subject|0|||
23699848|NCT04220866|66280492|FG001|Overall Study|Withdrawal by Subject|1|||
23699849|NCT02717546|66280495|FG000|Overall Study|Lost to Follow-up|12|||
23699850|NCT01070784|66280496|FG000|Overall Study|Withdrawal by Subject|6|||
23699851|NCT01070784|66280497|FG001|Overall Study|Withdrawal by Subject|9|||
23699852|NCT01070784|66280496|FG000|Overall Study|Adverse Event|14|||
23699853|NCT01070784|66280497|FG001|Overall Study|Adverse Event|9|||
23699854|NCT00053846|66280499|FG000|Overall Study|Changed mind|8|||
23699855|NCT00053846|66280500|FG001|Overall Study|Changed mind|13|||
23699856|NCT00053846|66280499|FG000|Overall Study|Became too ill|8|||
23498841|NCT01921387|65566462|FG000|Overall Study|Adverse Event|1|||
23498842|NCT02628938|65566463|FG000|Overall Study|Did not attend the follow up recall|2|||
23699857|NCT00053846|66280500|FG001|Overall Study|Became too ill|7|||
23699858|NCT00053846|66280499|FG000|Overall Study|Expired|5|||
23699859|NCT00053846|66280500|FG001|Overall Study|Expired|0|||
23699860|NCT00053846|66280499|FG000|Overall Study|Became ineligible|3|||
23699861|NCT00053846|66280500|FG001|Overall Study|Became ineligible|1|||
23699862|NCT00053846|66280499|FG000|Overall Study|Did not return data|1|||
23699863|NCT00053846|66280500|FG001|Overall Study|Did not return data|2|||
23699864|NCT00053846|66280499|FG000|Overall Study|Quit due to side effects|1|||
23699865|NCT00053846|66280500|FG001|Overall Study|Quit due to side effects|3|||
23699866|NCT00053846|66280499|FG000|Overall Study|Pills too large|0|||
23699867|NCT00053846|66280500|FG001|Overall Study|Pills too large|1|||
23699868|NCT01276847|66280501|FG000|Overall Study|Withdrawal by Subject|1|||
23699869|NCT01276847|66280502|FG001|Overall Study|Withdrawal by Subject|0|||
23498843|NCT02628938|65566464|FG001|Overall Study|Did not attend the follow up recall|2|||
23498844|NCT02628938|65566465|FG002|Overall Study|Did not attend the follow up recall|1|||
23498845|NCT02628938|65566463|FG000|Overall Study|Failure to comply with the instructions|3|||
23498846|NCT02628938|65566464|FG001|Overall Study|Failure to comply with the instructions|0|||
23498847|NCT02628938|65566465|FG002|Overall Study|Failure to comply with the instructions|3|||
23498848|NCT00450255|65566468|FG000|Overall Study|Prior RFA ablation of liver|1|||
23498849|NCT00806351|65566469|FG000|Overall Study|Death|5|||
23498850|NCT00806351|65566470|FG001|Overall Study|Death|4|||
23498851|NCT03307967|65566472|FG000|Overall Study|Lost to Follow-up|4|||
23498852|NCT01441180|65566474|FG000|Overall Study|Lost to Follow-up|1|||
23498853|NCT01441180|65566475|FG001|Overall Study|Lost to Follow-up|1|||
23498854|NCT01441180|65566476|FG002|Overall Study|Lost to Follow-up|1|||
23498855|NCT01441180|65566474|FG000|Overall Study|Discontinued|0|||
23498856|NCT01441180|65566475|FG001|Overall Study|Discontinued|0|||
23498857|NCT01441180|65566476|FG002|Overall Study|Discontinued|2|||
23498858|NCT01945281|65566478|FG000|Overall Study|Adverse Event|1|||
23498859|NCT01945281|65566479|FG001|Overall Study|Adverse Event|0|||
23498860|NCT01945281|65566478|FG000|Overall Study|Death|3|||
23498861|NCT01945281|65566479|FG001|Overall Study|Death|3|||
23498862|NCT01945281|65566478|FG000|Overall Study|Physician Decision|1|||
23498863|NCT01945281|65566479|FG001|Overall Study|Physician Decision|1|||
23498864|NCT01945281|65566478|FG000|Overall Study|Technical Problems|1|||
23498865|NCT01945281|65566479|FG001|Overall Study|Technical Problems|0|||
23498866|NCT00395304|65566481|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23498867|NCT00395304|65566482|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23498868|NCT00395304|65566483|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23498869|NCT00395304|65566484|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23498870|NCT00395304|65566485|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23498871|NCT00395304|65566486|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23498872|NCT00395304|65566481|FG000|Treatment Period 1|Lost to Follow-up|1|||
23498873|NCT00395304|65566482|FG001|Treatment Period 1|Lost to Follow-up|0|||
23498874|NCT00395304|65566483|FG002|Treatment Period 1|Lost to Follow-up|0|||
23498875|NCT00395304|65566484|FG003|Treatment Period 1|Lost to Follow-up|1|||
23498876|NCT00395304|65566485|FG004|Treatment Period 1|Lost to Follow-up|0|||
23498877|NCT00395304|65566486|FG005|Treatment Period 1|Lost to Follow-up|1|||
23498878|NCT00395304|65566481|FG000|Treatment Period 1|Physician Decision|0|||
23498879|NCT00395304|65566482|FG001|Treatment Period 1|Physician Decision|1|||
23498880|NCT00395304|65566483|FG002|Treatment Period 1|Physician Decision|0|||
23498881|NCT00395304|65566484|FG003|Treatment Period 1|Physician Decision|0|||
23498882|NCT00395304|65566485|FG004|Treatment Period 1|Physician Decision|0|||
23498883|NCT00395304|65566486|FG005|Treatment Period 1|Physician Decision|0|||
23498884|NCT00395304|65566481|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23498885|NCT00395304|65566482|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23498886|NCT00395304|65566483|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23498887|NCT00395304|65566484|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23498888|NCT00395304|65566485|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23498889|NCT00395304|65566486|FG005|Treatment Period 2|Withdrawal by Subject|2|||
23498890|NCT00395304|65566481|FG000|Treatment Period 2|Lost to Follow-up|0|||
23498891|NCT00395304|65566482|FG001|Treatment Period 2|Lost to Follow-up|3|||
23498892|NCT00395304|65566483|FG002|Treatment Period 2|Lost to Follow-up|0|||
23498893|NCT00395304|65566484|FG003|Treatment Period 2|Lost to Follow-up|0|||
23498894|NCT00395304|65566485|FG004|Treatment Period 2|Lost to Follow-up|0|||
23699870|NCT01276847|66280503|FG002|Overall Study|Withdrawal by Subject|0|||
23699871|NCT03408873|66280507|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
23699872|NCT03408873|66280507|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
23699873|NCT03408873|66280507|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
23498895|NCT00395304|65566486|FG005|Treatment Period 2|Lost to Follow-up|0|||
23498896|NCT00395304|65566481|FG000|Treatment Period 2|Physician Decision|0|||
23498897|NCT00395304|65566482|FG001|Treatment Period 2|Physician Decision|0|||
23498898|NCT00395304|65566483|FG002|Treatment Period 2|Physician Decision|1|||
23498899|NCT00395304|65566484|FG003|Treatment Period 2|Physician Decision|0|||
23498900|NCT00395304|65566485|FG004|Treatment Period 2|Physician Decision|0|||
23498901|NCT00395304|65566486|FG005|Treatment Period 2|Physician Decision|0|||
23498902|NCT00395304|65566481|FG000|Treatment Period 2|Other|0|||
23498903|NCT00395304|65566482|FG001|Treatment Period 2|Other|1|||
23498904|NCT00395304|65566483|FG002|Treatment Period 2|Other|0|||
23498905|NCT00395304|65566484|FG003|Treatment Period 2|Other|0|||
23498906|NCT00395304|65566485|FG004|Treatment Period 2|Other|0|||
23498907|NCT00395304|65566486|FG005|Treatment Period 2|Other|0|||
23498908|NCT00395304|65566481|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23498909|NCT00395304|65566482|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23498910|NCT00395304|65566483|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23498911|NCT00395304|65566484|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23498912|NCT00395304|65566485|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23498913|NCT00395304|65566486|FG005|Treatment Period 3|Withdrawal by Subject|1|||
23498914|NCT00395304|65566481|FG000|Treatment Period 3|Lost to Follow-up|1|||
23498915|NCT00395304|65566482|FG001|Treatment Period 3|Lost to Follow-up|1|||
23498916|NCT00395304|65566483|FG002|Treatment Period 3|Lost to Follow-up|0|||
23498917|NCT00395304|65566484|FG003|Treatment Period 3|Lost to Follow-up|0|||
23498918|NCT00395304|65566485|FG004|Treatment Period 3|Lost to Follow-up|0|||
23498919|NCT00395304|65566486|FG005|Treatment Period 3|Lost to Follow-up|0|||
23498920|NCT00395304|65566481|FG000|Treatment Period 3|Physician Decision|0|||
23498921|NCT00395304|65566482|FG001|Treatment Period 3|Physician Decision|1|||
23498922|NCT00395304|65566483|FG002|Treatment Period 3|Physician Decision|0|||
23498923|NCT00395304|65566484|FG003|Treatment Period 3|Physician Decision|0|||
23498924|NCT00395304|65566485|FG004|Treatment Period 3|Physician Decision|0|||
23498925|NCT00395304|65566486|FG005|Treatment Period 3|Physician Decision|0|||
23498926|NCT00395304|65566481|FG000|Treatment Period 3|Other|0|||
23498927|NCT00395304|65566482|FG001|Treatment Period 3|Other|0|||
23498928|NCT00395304|65566483|FG002|Treatment Period 3|Other|0|||
23498929|NCT00395304|65566484|FG003|Treatment Period 3|Other|1|||
23498930|NCT00395304|65566485|FG004|Treatment Period 3|Other|0|||
23498931|NCT00395304|65566486|FG005|Treatment Period 3|Other|0|||
23498932|NCT00825682|65566487|FG000|Overall Study|personal reasons/ inconvenience|13|||
23498933|NCT00825682|65566488|FG001|Overall Study|personal reasons/ inconvenience|5|||
23498934|NCT00496470|65569733|FG000|Overall Study|Adverse Event|8|||
23498935|NCT00496470|65569734|FG001|Overall Study|Adverse Event|10|||
23498936|NCT00496470|65569733|FG000|Overall Study|Withdrawal by Subject|5|||
23498937|NCT00496470|65569734|FG001|Overall Study|Withdrawal by Subject|12|||
23498938|NCT00496470|65569733|FG000|Overall Study|Incorrectly enrolled|13|||
23498939|NCT00496470|65569734|FG001|Overall Study|Incorrectly enrolled|5|||
23498940|NCT00496470|65569733|FG000|Overall Study|Other reason|0|||
23498941|NCT00496470|65569734|FG001|Overall Study|Other reason|2|||
23498942|NCT00531934|65569737|FG000|Overall Study|Adverse Event|4|||
23498943|NCT00531934|65569738|FG001|Overall Study|Adverse Event|8|||
23498944|NCT00531934|65569737|FG000|Overall Study|Progression|52|||
23498945|NCT00531934|65569738|FG001|Overall Study|Progression|42|||
23498946|NCT00531934|65569737|FG000|Overall Study|Death|7|||
23498947|NCT00531934|65569738|FG001|Overall Study|Death|10|||
23498948|NCT00531934|65569737|FG000|Overall Study|Withdrawal by Subject|1|||
23498949|NCT00531934|65569738|FG001|Overall Study|Withdrawal by Subject|1|||
23498950|NCT00531934|65569737|FG000|Overall Study|Other|2|||
23498951|NCT00531934|65569738|FG001|Overall Study|Other|2|||
23498952|NCT01768286|65569747|FG000|Overall Study|Randomized But Not Treated|0|||
23498953|NCT01768286|65569748|FG001|Overall Study|Randomized But Not Treated|0|||
23498954|NCT01768286|65569749|FG002|Overall Study|Randomized But Not Treated|1|||
23498955|NCT01768286|65569750|FG003|Overall Study|Randomized But Not Treated|0|||
23498956|NCT01768286|65569747|FG000|Overall Study|Lack of Efficacy|7|||
23498957|NCT01768286|65569748|FG001|Overall Study|Lack of Efficacy|4|||
23498958|NCT01768286|65569749|FG002|Overall Study|Lack of Efficacy|0|||
23498959|NCT01768286|65569750|FG003|Overall Study|Lack of Efficacy|1|||
23498960|NCT01768286|65569747|FG000|Overall Study|Withdrew Consent|0|||
23498961|NCT01768286|65569748|FG001|Overall Study|Withdrew Consent|0|||
23498962|NCT01768286|65569749|FG002|Overall Study|Withdrew Consent|1|||
23498963|NCT01768286|65569750|FG003|Overall Study|Withdrew Consent|0|||
23498964|NCT00518687|65569751|FG000|Overall Study|Adverse Event|201|||
23699874|NCT03408873|66280507|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
23498965|NCT00518687|65569752|FG001|Overall Study|Adverse Event|177|||
23498966|NCT00518687|65569751|FG000|Overall Study|Lost to Follow-up|144|||
23498967|NCT00518687|65569752|FG001|Overall Study|Lost to Follow-up|155|||
23498968|NCT00518687|65569751|FG000|Overall Study|Physician Decision|42|||
23498969|NCT00518687|65569752|FG001|Overall Study|Physician Decision|48|||
23498970|NCT00518687|65569751|FG000|Overall Study|Progressive disease|2|||
23498971|NCT00518687|65569752|FG001|Overall Study|Progressive disease|2|||
23498972|NCT00518687|65569751|FG000|Overall Study|Protocol Violation|8|||
23498973|NCT00518687|65569752|FG001|Overall Study|Protocol Violation|10|||
23498974|NCT00518687|65569751|FG000|Overall Study|Study terminated by sponsor|930|||
23498975|NCT00518687|65569752|FG001|Overall Study|Study terminated by sponsor|918|||
23498976|NCT00518687|65569751|FG000|Overall Study|Withdrawal by Subject|110|||
23498977|NCT00518687|65569752|FG001|Overall Study|Withdrawal by Subject|110|||
23498978|NCT00915278|65569753|FG000|Overall Study|Death|1|||
23498979|NCT00915278|65569754|FG001|Overall Study|Death|0|||
23498980|NCT00915278|65569755|FG002|Overall Study|Death|0|||
23498981|NCT00915278|65569756|FG003|Overall Study|Death|0|||
23498982|NCT00915278|65569757|FG004|Overall Study|Death|0|||
23498983|NCT00915278|65569758|FG005|Overall Study|Death|0|||
23498984|NCT00915278|65569753|FG000|Overall Study|Lost to Follow-up|0|||
23498985|NCT00915278|65569754|FG001|Overall Study|Lost to Follow-up|1|||
23498986|NCT00915278|65569755|FG002|Overall Study|Lost to Follow-up|0|||
23498987|NCT00915278|65569756|FG003|Overall Study|Lost to Follow-up|0|||
23498988|NCT00915278|65569757|FG004|Overall Study|Lost to Follow-up|0|||
23498989|NCT00915278|65569758|FG005|Overall Study|Lost to Follow-up|0|||
23498990|NCT00915278|65569753|FG000|Overall Study|Withdrawal by Subject|0|||
23498991|NCT00915278|65569754|FG001|Overall Study|Withdrawal by Subject|1|||
23498992|NCT00915278|65569755|FG002|Overall Study|Withdrawal by Subject|0|||
23498993|NCT00915278|65569756|FG003|Overall Study|Withdrawal by Subject|0|||
23498994|NCT00915278|65569757|FG004|Overall Study|Withdrawal by Subject|1|||
23498995|NCT00915278|65569758|FG005|Overall Study|Withdrawal by Subject|4|||
23498996|NCT00915278|65569753|FG000|Overall Study|Adverse Event|4|||
23498997|NCT00915278|65569754|FG001|Overall Study|Adverse Event|1|||
23498998|NCT00915278|65569755|FG002|Overall Study|Adverse Event|0|||
23498999|NCT00915278|65569756|FG003|Overall Study|Adverse Event|0|||
23499000|NCT00915278|65569757|FG004|Overall Study|Adverse Event|0|||
23499001|NCT00915278|65569758|FG005|Overall Study|Adverse Event|0|||
23499002|NCT00915278|65569753|FG000|Overall Study|Progressive disease/clinical progression|0|||
23499003|NCT00915278|65569754|FG001|Overall Study|Progressive disease/clinical progression|0|||
23499004|NCT00915278|65569755|FG002|Overall Study|Progressive disease/clinical progression|0|||
23499005|NCT00915278|65569756|FG003|Overall Study|Progressive disease/clinical progression|3|||
23499006|NCT00915278|65569757|FG004|Overall Study|Progressive disease/clinical progression|1|||
23499007|NCT00915278|65569758|FG005|Overall Study|Progressive disease/clinical progression|2|||
23499008|NCT00915278|65569753|FG000|Overall Study|Infusion related AEs|0|||
23499009|NCT00915278|65569754|FG001|Overall Study|Infusion related AEs|0|||
23499010|NCT00915278|65569755|FG002|Overall Study|Infusion related AEs|0|||
23499011|NCT00915278|65569756|FG003|Overall Study|Infusion related AEs|0|||
23499012|NCT00915278|65569757|FG004|Overall Study|Infusion related AEs|0|||
23499013|NCT00915278|65569758|FG005|Overall Study|Infusion related AEs|2|||
23499014|NCT00915278|65569753|FG000|Overall Study|Admission to hospice|0|||
23499015|NCT00915278|65569754|FG001|Overall Study|Admission to hospice|0|||
23499016|NCT00915278|65569755|FG002|Overall Study|Admission to hospice|1|||
23499017|NCT00915278|65569756|FG003|Overall Study|Admission to hospice|0|||
23499018|NCT00915278|65569757|FG004|Overall Study|Admission to hospice|0|||
23499019|NCT00915278|65569758|FG005|Overall Study|Admission to hospice|0|||
23499020|NCT00530946|65569762|FG000|Overall Study|Adverse Event|1|||
23499021|NCT00530946|65569763|FG001|Overall Study|Adverse Event|2|||
23499022|NCT00530946|65569764|FG002|Overall Study|Adverse Event|1|||
23499023|NCT00530946|65569765|FG003|Overall Study|Adverse Event|1|||
23499024|NCT00530946|65569762|FG000|Overall Study|Protocol Violation|0|||
23499025|NCT00530946|65569763|FG001|Overall Study|Protocol Violation|0|||
23499026|NCT00530946|65569764|FG002|Overall Study|Protocol Violation|0|||
23499027|NCT00530946|65569765|FG003|Overall Study|Protocol Violation|1|||
23499028|NCT00530946|65569762|FG000|Overall Study|Noncompliance|1|||
23499029|NCT00530946|65569763|FG001|Overall Study|Noncompliance|0|||
23499030|NCT00530946|65569764|FG002|Overall Study|Noncompliance|0|||
23499031|NCT00530946|65569765|FG003|Overall Study|Noncompliance|0|||
23499032|NCT05399641|65569766|FG000|Overall Study|Adverse Event|0|||
23499033|NCT05399641|65569767|FG001|Overall Study|Adverse Event|1|||
23499034|NCT05399641|65569768|FG002|Overall Study|Adverse Event|1|||
23499035|NCT05399641|65569766|FG000|Overall Study|Lost to Follow-up|1|||
23499036|NCT05399641|65569767|FG001|Overall Study|Lost to Follow-up|2|||
23499037|NCT05399641|65569768|FG002|Overall Study|Lost to Follow-up|2|||
23499038|NCT05399641|65569766|FG000|Overall Study|Physician Decision|1|||
23499039|NCT05399641|65569767|FG001|Overall Study|Physician Decision|3|||
23499040|NCT05399641|65569768|FG002|Overall Study|Physician Decision|3|||
23499041|NCT05399641|65569766|FG000|Overall Study|Withdrawal by Subject|4|||
23499042|NCT05399641|65569767|FG001|Overall Study|Withdrawal by Subject|11|||
23499043|NCT05399641|65569768|FG002|Overall Study|Withdrawal by Subject|7|||
23499044|NCT05399641|65569766|FG000|Overall Study|Reason not defined|3|||
23499045|NCT05399641|65569767|FG001|Overall Study|Reason not defined|5|||
23499046|NCT05399641|65569768|FG002|Overall Study|Reason not defined|6|||
23499047|NCT03334630|65569770|FG000|Overall Study|Withdrawal by Subject|7|||
23499048|NCT03334630|65569771|FG001|Overall Study|Withdrawal by Subject|7|||
23499049|NCT03334630|65569770|FG000|Overall Study|Lost to Follow-up|3|||
23499050|NCT03334630|65569771|FG001|Overall Study|Lost to Follow-up|1|||
23499051|NCT03334630|65569770|FG000|Overall Study|Adverse Event|0|||
23499052|NCT03334630|65569771|FG001|Overall Study|Adverse Event|1|||
23499053|NCT03334630|65569770|FG000|Overall Study|Physician Decision|1|||
23499054|NCT03334630|65569771|FG001|Overall Study|Physician Decision|1|||
23499055|NCT03334630|65569770|FG000|Overall Study|Enrollment closed|2|||
23499056|NCT03334630|65569771|FG001|Overall Study|Enrollment closed|1|||
23499057|NCT03334630|65569770|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
23499058|NCT03334630|65569771|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
23499059|NCT03334630|65569770|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
23499060|NCT03334630|65569771|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
23499061|NCT00660699|65569772|FG000|Overall Study|Withdrawal by Subject|2|||
23499062|NCT00570765|65569773|FG000|DB Phase|Withdrawal by Subject|1|||
23499063|NCT00570765|65569774|FG001|DB Phase|Withdrawal by Subject|0|||
23499064|NCT00570765|65569775|FG002|DB Phase|Withdrawal by Subject|0|||
23499065|NCT00570765|65569776|FG003|DB Phase|Withdrawal by Subject|0|||
23499066|NCT00570765|65569773|FG000|DB Phase|Protocol Violation|0|||
23499067|NCT00570765|65569774|FG001|DB Phase|Protocol Violation|1|||
23499068|NCT00570765|65569775|FG002|DB Phase|Protocol Violation|0|||
23499069|NCT00570765|65569776|FG003|DB Phase|Protocol Violation|0|||
23499070|NCT00570765|65569773|FG000|DB Phase|Adverse Event|3|||
23499071|NCT00570765|65569774|FG001|DB Phase|Adverse Event|6|||
23499072|NCT00570765|65569775|FG002|DB Phase|Adverse Event|0|||
23499073|NCT00570765|65569776|FG003|DB Phase|Adverse Event|0|||
23499074|NCT00570765|65569773|FG000|DB Phase|Did Not Receive Study Drug|0|||
23499075|NCT00570765|65569774|FG001|DB Phase|Did Not Receive Study Drug|0|||
23499076|NCT00570765|65569775|FG002|DB Phase|Did Not Receive Study Drug|1|||
23499077|NCT00570765|65569776|FG003|DB Phase|Did Not Receive Study Drug|0|||
23499078|NCT00570765|65569773|FG000|LTSE Phase|Withdrawal by Subject|0|||
23499079|NCT00570765|65569774|FG001|LTSE Phase|Withdrawal by Subject|0|||
23499080|NCT00570765|65569775|FG002|LTSE Phase|Withdrawal by Subject|0|||
23499081|NCT00570765|65569776|FG003|LTSE Phase|Withdrawal by Subject|1|||
23499082|NCT00570765|65569773|FG000|LTSE Phase|Adverse Event|0|||
23499083|NCT00570765|65569774|FG001|LTSE Phase|Adverse Event|0|||
23499084|NCT00570765|65569775|FG002|LTSE Phase|Adverse Event|0|||
23499085|NCT00570765|65569776|FG003|LTSE Phase|Adverse Event|7|||
23499086|NCT00570765|65569773|FG000|LTSE Phase|Physician Decision|0|||
23499087|NCT00570765|65569774|FG001|LTSE Phase|Physician Decision|0|||
23499088|NCT00570765|65569775|FG002|LTSE Phase|Physician Decision|0|||
23499089|NCT00570765|65569776|FG003|LTSE Phase|Physician Decision|4|||
23499090|NCT02362269|65569777|FG000|Overall Study|Moved|1|||
23499091|NCT02362269|65569778|FG001|Overall Study|Moved|0|||
23499092|NCT02362269|65569777|FG000|Overall Study|Lost to Follow-up|0|||
23499093|NCT02362269|65569778|FG001|Overall Study|Lost to Follow-up|6|||
23499094|NCT00762229|65569781|FG000|Overall Study|Lost to Follow-up|1|||
23499095|NCT00762229|65569782|FG001|Overall Study|Lost to Follow-up|1|||
23499096|NCT00762229|65569781|FG000|Overall Study|did not recveive intervention|0|||
23499097|NCT00762229|65569782|FG001|Overall Study|did not recveive intervention|1|||
23499098|NCT01683383|65569784|FG000|Overall Study|Infant was not transported|1|||
23499099|NCT01683383|65569785|FG001|Overall Study|Infant was not transported|0|||
23499100|NCT00001880|65569790|FG000|Overall Study|Death|14|||
23499101|NCT01393301|65569796|FG000|Overall Study|Lost to Follow-up|5|||
23499102|NCT01393301|65569797|FG001|Overall Study|Lost to Follow-up|3|||
23499103|NCT01393301|65569796|FG000|Overall Study|Withdrawal by Subject|2|||
23499104|NCT01393301|65569797|FG001|Overall Study|Withdrawal by Subject|0|||
23499105|NCT01393301|65569796|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
23499106|NCT01393301|65569797|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
23499107|NCT03741062|65569800|FG000|Overall Study|Protocol Violation|1|||
23499108|NCT03741062|65569801|FG001|Overall Study|Protocol Violation|0|||
23499109|NCT05248867|65569802|FG000|Double-blind Period|Lost to Follow-up|0|||
23499110|NCT05248867|65569803|FG001|Double-blind Period|Lost to Follow-up|3|||
23499111|NCT05248867|65569804|FG002|Double-blind Period|Lost to Follow-up|0|||
23499112|NCT05248867|65569805|FG003|Double-blind Period|Lost to Follow-up|0|||
23499113|NCT05248867|65569806|FG004|Double-blind Period|Lost to Follow-up|0|||
23499114|NCT05248867|65569807|FG005|Double-blind Period|Lost to Follow-up|0|||
23499115|NCT05248867|65569802|FG000|Double-blind Period|Withdrawal by Subject|5|||
23699875|NCT03408873|66280507|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
23499116|NCT05248867|65569803|FG001|Double-blind Period|Withdrawal by Subject|14|||
23499117|NCT05248867|65569804|FG002|Double-blind Period|Withdrawal by Subject|0|||
23499118|NCT05248867|65569805|FG003|Double-blind Period|Withdrawal by Subject|0|||
23699876|NCT03408873|66280507|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
23499119|NCT05248867|65569806|FG004|Double-blind Period|Withdrawal by Subject|0|||
23499120|NCT05248867|65569807|FG005|Double-blind Period|Withdrawal by Subject|0|||
23499121|NCT05248867|65569802|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499122|NCT05248867|65569803|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
23499123|NCT05248867|65569804|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499124|NCT05248867|65569805|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499125|NCT05248867|65569806|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499126|NCT05248867|65569807|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499127|NCT05248867|65569802|FG000|Double-blind Period|Other, not specified|3|||
23499128|NCT05248867|65569803|FG001|Double-blind Period|Other, not specified|8|||
23499129|NCT05248867|65569804|FG002|Double-blind Period|Other, not specified|0|||
23499130|NCT05248867|65569805|FG003|Double-blind Period|Other, not specified|0|||
23499131|NCT05248867|65569806|FG004|Double-blind Period|Other, not specified|0|||
23499132|NCT05248867|65569807|FG005|Double-blind Period|Other, not specified|0|||
23499133|NCT05248867|65569802|FG000|Open-label Period|Withdrawal by Subject|0|||
23499134|NCT05248867|65569803|FG001|Open-label Period|Withdrawal by Subject|0|||
23499135|NCT05248867|65569804|FG002|Open-label Period|Withdrawal by Subject|3|||
23499136|NCT05248867|65569805|FG003|Open-label Period|Withdrawal by Subject|1|||
23499137|NCT05248867|65569806|FG004|Open-label Period|Withdrawal by Subject|7|||
23499138|NCT05248867|65569807|FG005|Open-label Period|Withdrawal by Subject|9|||
23499139|NCT05248867|65569802|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499140|NCT05248867|65569803|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499141|NCT05248867|65569804|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499142|NCT05248867|65569805|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
23499143|NCT05248867|65569806|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499144|NCT05248867|65569807|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499145|NCT05248867|65569802|FG000|Open-label Period|Lost to Follow-up|0|||
23499146|NCT05248867|65569803|FG001|Open-label Period|Lost to Follow-up|0|||
23499147|NCT05248867|65569804|FG002|Open-label Period|Lost to Follow-up|0|||
23499148|NCT05248867|65569805|FG003|Open-label Period|Lost to Follow-up|0|||
23499149|NCT05248867|65569806|FG004|Open-label Period|Lost to Follow-up|5|||
23499150|NCT05248867|65569807|FG005|Open-label Period|Lost to Follow-up|2|||
23499151|NCT05248867|65569802|FG000|Open-label Period|COVID-19 Infection|0|||
23499152|NCT05248867|65569803|FG001|Open-label Period|COVID-19 Infection|0|||
23499153|NCT05248867|65569804|FG002|Open-label Period|COVID-19 Infection|0|||
23499154|NCT05248867|65569805|FG003|Open-label Period|COVID-19 Infection|0|||
23499155|NCT05248867|65569806|FG004|Open-label Period|COVID-19 Infection|1|||
23499156|NCT05248867|65569807|FG005|Open-label Period|COVID-19 Infection|0|||
23499157|NCT05248867|65569802|FG000|Open-label Period|Other, not specified|0|||
23499158|NCT05248867|65569803|FG001|Open-label Period|Other, not specified|0|||
23499159|NCT05248867|65569804|FG002|Open-label Period|Other, not specified|0|||
23499160|NCT05248867|65569805|FG003|Open-label Period|Other, not specified|0|||
23499161|NCT05248867|65569806|FG004|Open-label Period|Other, not specified|4|||
23499162|NCT05248867|65569807|FG005|Open-label Period|Other, not specified|0|||
23499163|NCT02582983|65569809|FG000|Overall Study|Death|3|||
23499164|NCT02582983|65569809|FG000|Overall Study|Withdrawal by Subject|2|||
23499165|NCT02582983|65569809|FG000|Overall Study|Adverse Event|1|||
23499166|NCT02339584|65569810|FG000|Overall Study|Adverse Event|11|||
23499167|NCT02339584|65569811|FG001|Overall Study|Adverse Event|7|||
23499168|NCT02339584|65569810|FG000|Overall Study|Lack of Efficacy|0|||
23499169|NCT02339584|65569811|FG001|Overall Study|Lack of Efficacy|1|||
23499170|NCT02339584|65569810|FG000|Overall Study|Physician Decision|1|||
23499171|NCT02339584|65569811|FG001|Overall Study|Physician Decision|2|||
23499172|NCT02339584|65569810|FG000|Overall Study|Protocol Violation|1|||
23499173|NCT02339584|65569811|FG001|Overall Study|Protocol Violation|1|||
23499174|NCT02339584|65569810|FG000|Overall Study|Withdrawal by Subject|2|||
23499175|NCT02339584|65569811|FG001|Overall Study|Withdrawal by Subject|4|||
23499176|NCT03478657|65569816|FG000|Overall Study|Withdrawal by Subject|0|||
23499177|NCT03478657|65569817|FG001|Overall Study|Withdrawal by Subject|1|||
23499178|NCT00868608|65569818|FG000|Overall Study|Withdrawal by Subject|3|||
23499179|NCT00868608|65569819|FG001|Overall Study|Withdrawal by Subject|1|||
23499180|NCT00868608|65569820|FG002|Overall Study|Withdrawal by Subject|0|||
23499181|NCT00868608|65569818|FG000|Overall Study|Lost to Follow-up|3|||
23499182|NCT00868608|65569819|FG001|Overall Study|Lost to Follow-up|0|||
23499183|NCT00868608|65569820|FG002|Overall Study|Lost to Follow-up|1|||
23499184|NCT00868608|65569818|FG000|Overall Study|Death|16|||
23499185|NCT00868608|65569819|FG001|Overall Study|Death|2|||
23499186|NCT00868608|65569820|FG002|Overall Study|Death|4|||
23499187|NCT00868608|65569818|FG000|Overall Study|Other - Unspecified|1|||
23499188|NCT00868608|65569819|FG001|Overall Study|Other - Unspecified|0|||
23499189|NCT00868608|65569820|FG002|Overall Study|Other - Unspecified|0|||
23499190|NCT01909674|65569821|FG000|Overall Study|Withdrawal by Subject|5|||
23499191|NCT01909674|65569822|FG001|Overall Study|Withdrawal by Subject|2|||
23499192|NCT01926015|65569823|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23499193|NCT01926015|65569824|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23499194|NCT01926015|65569823|FG000|Overall Study|Randomized not treated|2|||
23499195|NCT01926015|65569824|FG001|Overall Study|Randomized not treated|0|||
23499196|NCT03345914|65569825|FG000|Overall Study|Transition to another study at week 16|80|||
23499197|NCT03345914|65569826|FG001|Overall Study|Transition to another study at week 16|86|||
23499198|NCT03345914|65569827|FG002|Overall Study|Transition to another study at week 16|78|||
23499199|NCT03345914|65569825|FG000|Overall Study|Transition to OLE during follow-up|37|||
23398519|NCT04622592|65203613|FG001|Overall Study|Physician Decision|0|||
23398520|NCT04622592|65203614|FG002|Overall Study|Physician Decision|0|||
23398521|NCT04622592|65203615|FG003|Overall Study|Physician Decision|0|||
23398522|NCT04622592|65203616|FG004|Overall Study|Physician Decision|1|||
23398523|NCT04622592|65203617|FG005|Overall Study|Physician Decision|0|||
23398524|NCT04622592|65203618|FG006|Overall Study|Physician Decision|0|||
23398525|NCT04622592|65203619|FG007|Overall Study|Physician Decision|0|||
23398526|NCT04622592|65203612|FG000|Overall Study|Withdrawal by Subject|1|||
23398527|NCT04622592|65203613|FG001|Overall Study|Withdrawal by Subject|0|||
23398528|NCT04622592|65203614|FG002|Overall Study|Withdrawal by Subject|2|||
23398529|NCT04622592|65203615|FG003|Overall Study|Withdrawal by Subject|0|||
23398530|NCT04622592|65203616|FG004|Overall Study|Withdrawal by Subject|0|||
23398531|NCT04622592|65203617|FG005|Overall Study|Withdrawal by Subject|0|||
23398532|NCT04622592|65203618|FG006|Overall Study|Withdrawal by Subject|1|||
23398533|NCT04622592|65203619|FG007|Overall Study|Withdrawal by Subject|4|||
23398534|NCT04622592|65203612|FG000|Overall Study|Other than specified above|0|||
23398535|NCT04622592|65203613|FG001|Overall Study|Other than specified above|0|||
23398536|NCT04622592|65203614|FG002|Overall Study|Other than specified above|1|||
23398537|NCT04622592|65203615|FG003|Overall Study|Other than specified above|0|||
23398538|NCT04622592|65203616|FG004|Overall Study|Other than specified above|0|||
23398539|NCT04622592|65203617|FG005|Overall Study|Other than specified above|0|||
23398540|NCT04622592|65203618|FG006|Overall Study|Other than specified above|0|||
23398541|NCT04622592|65203619|FG007|Overall Study|Other than specified above|0|||
23398542|NCT03673176|65207081|FG000|Overall Study|Death prior to intervention|1|||
23398543|NCT03673176|65207081|FG000|Overall Study|Death following intervention|3|||
23398544|NCT03673176|65207081|FG000|Overall Study|Withdrawal by Subject|1|||
23398545|NCT00370292|65207082|FG000|Overall Study|Disease Progression|4|||
23398546|NCT00370292|65207082|FG000|Overall Study|Adverse Event|7|||
23398547|NCT00370292|65207082|FG000|Overall Study|Physician Decision|2|||
23398548|NCT00256126|65207083|FG000|Overall Study|Adverse Event|1|||
23398549|NCT00256126|65207084|FG001|Overall Study|Adverse Event|0|||
23398550|NCT00256126|65207083|FG000|Overall Study|Other|1|||
23398551|NCT00256126|65207084|FG001|Overall Study|Other|2|||
23398552|NCT01276704|65207085|FG000|Overall Study|Lost to Follow-up|2|||
23398553|NCT01276704|65207086|FG001|Overall Study|Lost to Follow-up|3|||
23398554|NCT01276704|65207085|FG000|Overall Study|Non-compliant|2|||
23398555|NCT01276704|65207086|FG001|Overall Study|Non-compliant|2|||
23398556|NCT01276704|65207085|FG000|Overall Study|Withdrawal by Subject|7|||
23398557|NCT01276704|65207086|FG001|Overall Study|Withdrawal by Subject|1|||
23398558|NCT01276704|65207085|FG000|Overall Study|Physician Decision|3|||
23398559|NCT01276704|65207086|FG001|Overall Study|Physician Decision|5|||
23398560|NCT03247829|65207087|FG000|Overall Study|Death|3|||
23398561|NCT03247829|65207088|FG001|Overall Study|Death|4|||
23398562|NCT03247829|65207087|FG000|Overall Study|Enter Hospice Care|1|||
23398563|NCT03247829|65207088|FG001|Overall Study|Enter Hospice Care|0|||
23398564|NCT03247829|65207087|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
23398565|NCT03247829|65207088|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
23398566|NCT03247829|65207087|FG000|Overall Study|LVAD Explant|1|||
23398567|NCT03247829|65207088|FG001|Overall Study|LVAD Explant|1|||
23398568|NCT03247829|65207087|FG000|Overall Study|Transplant|1|||
23398569|NCT03247829|65207088|FG001|Overall Study|Transplant|1|||
23398570|NCT01767909|65207089|FG000|Overall Study|Withdrawal by Subject|4|||
23398571|NCT01767909|65207090|FG001|Overall Study|Withdrawal by Subject|7|||
23398572|NCT01767909|65207089|FG000|Overall Study|Adverse Event|3|||
23398573|NCT01767909|65207090|FG001|Overall Study|Adverse Event|1|||
23398574|NCT01767909|65207089|FG000|Overall Study|Withdrawal by Study Partner|3|||
23398575|NCT01767909|65207090|FG001|Overall Study|Withdrawal by Study Partner|1|||
23398576|NCT01767909|65207089|FG000|Overall Study|Non-Compliance|2|||
23398577|NCT01767909|65207090|FG001|Overall Study|Non-Compliance|0|||
23398578|NCT01767909|65207089|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23398579|NCT01767909|65207090|FG001|Overall Study|Perceived Lack of Efficacy|0|||
23398580|NCT01767909|65207089|FG000|Overall Study|Investigator Recommendation|0|||
23398581|NCT01767909|65207090|FG001|Overall Study|Investigator Recommendation|1|||
23398582|NCT01767909|65207089|FG000|Overall Study|Lost to Follow-up|0|||
23398583|NCT01767909|65207090|FG001|Overall Study|Lost to Follow-up|1|||
23398584|NCT01767909|65207089|FG000|Overall Study|LP uncessessful|0|||
23398585|NCT01767909|65207090|FG001|Overall Study|LP uncessessful|1|||
23398586|NCT00399035|65207091|FG000|Overall Study|Death|289|||
23398587|NCT00399035|65207092|FG001|Overall Study|Death|141|||
23398588|NCT00399035|65207093|FG002|Overall Study|Death|234|||
23398589|NCT00399035|65207091|FG000|Overall Study|Lost to Follow-up|2|||
23398590|NCT00399035|65207092|FG001|Overall Study|Lost to Follow-up|1|||
23398591|NCT00399035|65207093|FG002|Overall Study|Lost to Follow-up|5|||
23398592|NCT00399035|65207091|FG000|Overall Study|Withdrawal by Subject|19|||
23398593|NCT00399035|65207092|FG001|Overall Study|Withdrawal by Subject|15|||
23499200|NCT03345914|65569826|FG001|Overall Study|Transition to OLE during follow-up|33|||
23499201|NCT03345914|65569827|FG002|Overall Study|Transition to OLE during follow-up|39|||
23499202|NCT03345914|65569825|FG000|Overall Study|Physician Decision|0|||
23499203|NCT03345914|65569826|FG001|Overall Study|Physician Decision|1|||
23499204|NCT03345914|65569827|FG002|Overall Study|Physician Decision|1|||
23499205|NCT03345914|65569825|FG000|Overall Study|Withdrawal by Subject|5|||
23499206|NCT03345914|65569826|FG001|Overall Study|Withdrawal by Subject|1|||
23499207|NCT03345914|65569827|FG002|Overall Study|Withdrawal by Subject|2|||
23499208|NCT03345914|65569825|FG000|Overall Study|Other|1|||
23499209|NCT03345914|65569826|FG001|Overall Study|Other|1|||
23499210|NCT03345914|65569827|FG002|Overall Study|Other|1|||
23499211|NCT03345914|65569825|FG000|Overall Study|Ongoing|0|||
23499212|NCT03345914|65569826|FG001|Overall Study|Ongoing|0|||
23499213|NCT03345914|65569827|FG002|Overall Study|Ongoing|1|||
23499214|NCT00345839|65569828|FG000|Overall Study|Withdrawal by Subject|91|||
23499215|NCT00345839|65569829|FG001|Overall Study|Withdrawal by Subject|98|||
23499216|NCT00345839|65569828|FG000|Overall Study|Lost to Follow-up|58|||
23499217|NCT00345839|65569829|FG001|Overall Study|Lost to Follow-up|61|||
23499218|NCT01218243|65569832|FG000|Overall Study|Lack of Efficacy|1|||
23499219|NCT01218243|65569833|FG001|Overall Study|Lack of Efficacy|1|||
23499220|NCT01218243|65569832|FG000|Overall Study|Lost to Follow-up|3|||
23499221|NCT01218243|65569833|FG001|Overall Study|Lost to Follow-up|3|||
23499222|NCT01218243|65569832|FG000|Overall Study|Protocol Violation|5|||
23499223|NCT01218243|65569833|FG001|Overall Study|Protocol Violation|10|||
23499224|NCT01201850|65569836|FG000|Overall Study|Tumor progression|4|||
23499225|NCT01896050|65569837|FG000|Overall Study|Adverse Event|37|||
23499226|NCT01896050|65569838|FG001|Overall Study|Adverse Event|2|||
23499227|NCT01896050|65569837|FG000|Overall Study|Death|1|||
23499228|NCT01896050|65569838|FG001|Overall Study|Death|0|||
23499229|NCT02099708|65569840|FG000|Overall Study|Data Not Available|30|||
23499230|NCT02099708|65569840|FG000|Overall Study|Lost to Follow-up|141|||
23499231|NCT02099708|65569840|FG000|Overall Study|Other|29|||
23499232|NCT02091960|65569841|FG000|Overall Study|Death|7|||
23499233|NCT02091960|65569841|FG000|Overall Study|Withdrawal by Subject|1|||
23499234|NCT02091960|65569841|FG000|Overall Study|Miscellaneous Reasons|31|||
23499235|NCT02091960|65569841|FG000|Overall Study|On Study at Data Cut-off|12|||
23499236|NCT02571777|65569842|FG000|Overall Study|Subject/guardian decision|34|||
23499237|NCT02571777|65569843|FG001|Overall Study|Subject/guardian decision|26|||
23499238|NCT02571777|65569844|FG002|Overall Study|Subject/guardian decision|26|||
23499239|NCT02571777|65569845|FG003|Overall Study|Subject/guardian decision|25|||
23499240|NCT02571777|65569846|FG004|Overall Study|Subject/guardian decision|27|||
23499241|NCT02571777|65569842|FG000|Overall Study|Protocol Deviation|2|||
23499242|NCT02571777|65569843|FG001|Overall Study|Protocol Deviation|3|||
23499243|NCT02571777|65569844|FG002|Overall Study|Protocol Deviation|4|||
23499244|NCT02571777|65569845|FG003|Overall Study|Protocol Deviation|8|||
23499245|NCT02571777|65569846|FG004|Overall Study|Protocol Deviation|4|||
23499246|NCT02571777|65569842|FG000|Overall Study|Death|1|||
23499247|NCT02571777|65569843|FG001|Overall Study|Death|1|||
23499248|NCT02571777|65569844|FG002|Overall Study|Death|4|||
23499249|NCT02571777|65569845|FG003|Overall Study|Death|0|||
23499250|NCT02571777|65569846|FG004|Overall Study|Death|0|||
23499251|NCT02571777|65569842|FG000|Overall Study|Lost to Follow-up|1|||
23499252|NCT02571777|65569843|FG001|Overall Study|Lost to Follow-up|1|||
23499253|NCT02571777|65569844|FG002|Overall Study|Lost to Follow-up|2|||
23499254|NCT02571777|65569845|FG003|Overall Study|Lost to Follow-up|0|||
23499255|NCT02571777|65569846|FG004|Overall Study|Lost to Follow-up|1|||
23499256|NCT02571777|65569842|FG000|Overall Study|Physician Decision|1|||
23499257|NCT02571777|65569843|FG001|Overall Study|Physician Decision|7|||
23499258|NCT02571777|65569844|FG002|Overall Study|Physician Decision|5|||
23499259|NCT02571777|65569845|FG003|Overall Study|Physician Decision|2|||
23499260|NCT02571777|65569846|FG004|Overall Study|Physician Decision|4|||
23499261|NCT02571777|65569842|FG000|Overall Study|Pregnancy|0|||
23499262|NCT02571777|65569843|FG001|Overall Study|Pregnancy|0|||
23499263|NCT02571777|65569844|FG002|Overall Study|Pregnancy|0|||
23499264|NCT02571777|65569845|FG003|Overall Study|Pregnancy|2|||
23699877|NCT00970294|66280510|FG000|Overall Study|Physician Decision|4|||
23499265|NCT02571777|65569846|FG004|Overall Study|Pregnancy|0|||
23499266|NCT02570074|65569847|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
23499267|NCT02570074|65569848|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
23499268|NCT02925923|65569850|FG000|Overall Study|blood samples hemolyzed|0|||
23499269|NCT02925923|65569851|FG001|Overall Study|blood samples hemolyzed|2|||
23499270|NCT03228433|65569853|FG000|Overall Study|Lost to Follow-up|1|||
23499271|NCT03228433|65569854|FG001|Overall Study|Lost to Follow-up|0|||
23499272|NCT03228433|65569855|FG002|Overall Study|Lost to Follow-up|0|||
23499273|NCT03228433|65569856|FG003|Overall Study|Lost to Follow-up|0|||
23499274|NCT03228433|65569857|FG004|Overall Study|Lost to Follow-up|0|||
23499275|NCT03228433|65569858|FG005|Overall Study|Lost to Follow-up|0|||
23499276|NCT03228433|65569853|FG000|Overall Study|Positive alcohol test|0|||
23499277|NCT03228433|65569854|FG001|Overall Study|Positive alcohol test|0|||
23499278|NCT03228433|65569855|FG002|Overall Study|Positive alcohol test|0|||
23499279|NCT03228433|65569856|FG003|Overall Study|Positive alcohol test|1|||
23499280|NCT03228433|65569857|FG004|Overall Study|Positive alcohol test|0|||
23499281|NCT03228433|65569858|FG005|Overall Study|Positive alcohol test|0|||
23499282|NCT03600818|65569862|FG000|Overall Study|Adverse Event|4|||
23499283|NCT03600818|65569863|FG001|Overall Study|Adverse Event|7|||
23499284|NCT03600818|65569862|FG000|Overall Study|Lack of Efficacy|9|||
23499285|NCT03600818|65569863|FG001|Overall Study|Lack of Efficacy|4|||
23499286|NCT03600818|65569862|FG000|Overall Study|Withdrawal by Subject|4|||
23499287|NCT03600818|65569863|FG001|Overall Study|Withdrawal by Subject|3|||
23499288|NCT03600818|65569862|FG000|Overall Study|Other-unspecified|5|||
23499289|NCT03600818|65569863|FG001|Overall Study|Other-unspecified|3|||
23499290|NCT03600818|65569862|FG000|Overall Study|Randomized and not treated|0|||
23499291|NCT03600818|65569863|FG001|Overall Study|Randomized and not treated|1|||
23499292|NCT02850965|65569867|FG000|Overall Study|Other than listed|3|||
23499293|NCT02850965|65569868|FG001|Overall Study|Other than listed|4|||
23499294|NCT02850965|65569867|FG000|Overall Study|Protocol Violation|0|||
23499295|NCT02850965|65569868|FG001|Overall Study|Protocol Violation|2|||
23499296|NCT02850965|65569867|FG000|Overall Study|Lost to Follow-up|5|||
23499297|NCT02850965|65569868|FG001|Overall Study|Lost to Follow-up|3|||
23499298|NCT02850965|65569867|FG000|Overall Study|Lack of Efficacy|4|||
23499299|NCT02850965|65569868|FG001|Overall Study|Lack of Efficacy|8|||
23499300|NCT02850965|65569867|FG000|Overall Study|Adverse Event|3|||
23499301|NCT02850965|65569868|FG001|Overall Study|Adverse Event|2|||
23499302|NCT02850965|65569867|FG000|Overall Study|Withdrawal by Subject|3|||
23499303|NCT02850965|65569868|FG001|Overall Study|Withdrawal by Subject|4|||
23499304|NCT02850965|65569867|FG000|Overall Study|Physician Decision|0|||
23499305|NCT02850965|65569868|FG001|Overall Study|Physician Decision|1|||
23499306|NCT02850965|65569867|FG000|Overall Study|Randomized but not treated|0|||
23499307|NCT02850965|65569868|FG001|Overall Study|Randomized but not treated|1|||
23499308|NCT03758066|65569869|FG000|Overall Study|Lost to Follow-up|14|||
23499309|NCT02572401|65569876|FG000|Overall Study|Lost to Follow-up|5|||
23499310|NCT02572401|65569877|FG001|Overall Study|Lost to Follow-up|8|||
23499311|NCT02572401|65569878|FG002|Overall Study|Lost to Follow-up|9|||
23499312|NCT02572401|65569879|FG003|Overall Study|Lost to Follow-up|9|||
23499313|NCT02572401|65569876|FG000|Overall Study|Death|0|||
23499314|NCT02572401|65569877|FG001|Overall Study|Death|0|||
23499315|NCT02572401|65569878|FG002|Overall Study|Death|0|||
23499316|NCT02572401|65569879|FG003|Overall Study|Death|1|||
23499317|NCT00847379|65569885|FG000|Overall Study|Study terminated by Sponsor|59|||
23499318|NCT00847379|65569886|FG001|Overall Study|Study terminated by Sponsor|57|||
23499319|NCT00847379|65569887|FG002|Overall Study|Study terminated by Sponsor|57|||
23499320|NCT00242216|65569890|FG000|Overall Study|Lost to Follow-up|12|||
23499321|NCT00242216|65569891|FG001|Overall Study|Lost to Follow-up|17|||
23499322|NCT00242216|65569890|FG000|Overall Study|Death|4|||
23499323|NCT00242216|65569891|FG001|Overall Study|Death|2|||
23499324|NCT00242216|65569890|FG000|Overall Study|Lack of Efficacy|1|||
23499325|NCT00242216|65569891|FG001|Overall Study|Lack of Efficacy|2|||
23499326|NCT00242216|65569890|FG000|Overall Study|no medicaiton dispensed|1|||
23499327|NCT00242216|65569891|FG001|Overall Study|no medicaiton dispensed|1|||
23499328|NCT01217801|65569892|FG000|Period 1|Protocol Violation|1|||
23499329|NCT01217801|65569893|FG001|Period 1|Protocol Violation|1|||
23499330|NCT01217801|65569892|FG000|Period 1|Withdrawal by Subject|0|||
23499331|NCT01217801|65569893|FG001|Period 1|Withdrawal by Subject|1|||
23499332|NCT01233258|65569897|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499333|NCT01233258|65569898|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499334|NCT01233258|65569899|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499335|NCT01233258|65569900|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
23499336|NCT01233258|65569901|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499337|NCT01233258|65569902|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
23499338|NCT01233258|65569897|FG000|First Intervention (6 Months)|Protocol Violation|0|||
23499339|NCT01233258|65569898|FG001|First Intervention (6 Months)|Protocol Violation|0|||
23499340|NCT01233258|65569899|FG002|First Intervention (6 Months)|Protocol Violation|1|||
23699878|NCT00970294|66280510|FG000|Overall Study|Withdrawal by Subject|1|||
23699879|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
23499341|NCT01233258|65569900|FG003|First Intervention (6 Months)|Protocol Violation|0|||
23499342|NCT01233258|65569901|FG004|First Intervention (6 Months)|Protocol Violation|0|||
23499343|NCT01233258|65569902|FG005|First Intervention (6 Months)|Protocol Violation|0|||
23499344|NCT01233258|65569897|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
23499345|NCT01233258|65569898|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
23699880|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
23499346|NCT01233258|65569899|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499347|NCT01233258|65569900|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499348|NCT01233258|65569901|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
23699881|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
23699882|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
23499349|NCT01233258|65569902|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499350|NCT00696800|65569909|FG000|Overall Study|Adverse Event|16|||
23499351|NCT00696800|65569910|FG001|Overall Study|Adverse Event|3|||
23499352|NCT00696800|65569909|FG000|Overall Study|Insufficient compliance with medication|2|||
23499353|NCT00696800|65569910|FG001|Overall Study|Insufficient compliance with medication|1|||
23499354|NCT00696800|65569909|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
23499355|NCT00696800|65569910|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
23499356|NCT00696800|65569909|FG000|Overall Study|Insufficient ovarian response|4|||
23499357|NCT00696800|65569910|FG001|Overall Study|Insufficient ovarian response|1|||
23499358|NCT00696800|65569909|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
23499359|NCT00696800|65569910|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
23499360|NCT00696800|65569909|FG000|Overall Study|Too high ovarian response|6|||
23499361|NCT00696800|65569910|FG001|Overall Study|Too high ovarian response|1|||
23499362|NCT00696800|65569909|FG000|Overall Study|No/too few/bad quality oocytes|4|||
23499363|NCT00696800|65569910|FG001|Overall Study|No/too few/bad quality oocytes|3|||
23499364|NCT00696800|65569909|FG000|Overall Study|No/abnormal fertilization|11|||
23499365|NCT00696800|65569910|FG001|Overall Study|No/abnormal fertilization|13|||
23499366|NCT00696800|65569909|FG000|Overall Study|No/too few/bad quality embryos|24|||
23499367|NCT00696800|65569910|FG001|Overall Study|No/too few/bad quality embryos|18|||
23499368|NCT00696800|65569909|FG000|Overall Study|Other Reasons|5|||
23499369|NCT00696800|65569910|FG001|Overall Study|Other Reasons|3|||
23499370|NCT00696800|65569909|FG000|Overall Study|Not treated|1|||
23499371|NCT00696800|65569910|FG001|Overall Study|Not treated|2|||
23499372|NCT02422303|65569915|FG000|Overall Study|Lost to Follow-up|1|||
23499373|NCT02422303|65569916|FG001|Overall Study|Lost to Follow-up|1|||
23499374|NCT01970397|65569917|FG000|Overall Study|Adverse Event|0|||
23499375|NCT01970397|65569918|FG001|Overall Study|Adverse Event|1|||
23499376|NCT01970397|65569917|FG000|Overall Study|Lost to Follow-up|0|||
23499377|NCT01970397|65569918|FG001|Overall Study|Lost to Follow-up|1|||
23499378|NCT01970397|65569917|FG000|Overall Study|Personal Reasons|1|||
23499379|NCT01970397|65569918|FG001|Overall Study|Personal Reasons|2|||
23499380|NCT01970397|65569917|FG000|Overall Study|Protocol Violation|1|||
23499381|NCT01970397|65569918|FG001|Overall Study|Protocol Violation|1|||
23499382|NCT02610725|65569919|FG000|Overall Study|Lost to Follow-up|197|||
23499383|NCT02610725|65569919|FG000|Overall Study|self-reported contraindication|9|||
23499384|NCT03408483|65569920|FG000|Overall Study|Physician Decision|3|||
23499385|NCT03408483|65569921|FG001|Overall Study|Physician Decision|3|||
23499386|NCT03408483|65569920|FG000|Overall Study|Lost to Follow-up|3|||
23499387|NCT03408483|65569921|FG001|Overall Study|Lost to Follow-up|0|||
23499388|NCT01397162|65569924|FG000|Overall Study|Adverse Event|4|||
23499389|NCT01397162|65569925|FG001|Overall Study|Adverse Event|0|||
23499390|NCT01397162|65569926|FG002|Overall Study|Adverse Event|0|||
23499391|NCT01397162|65569927|FG003|Overall Study|Adverse Event|0|||
23499392|NCT01397162|65569928|FG004|Overall Study|Adverse Event|0|||
23499393|NCT01397162|65569924|FG000|Overall Study|Not yet defined|3|||
23499394|NCT01397162|65569925|FG001|Overall Study|Not yet defined|4|||
23499395|NCT01397162|65569926|FG002|Overall Study|Not yet defined|3|||
23499396|NCT01397162|65569927|FG003|Overall Study|Not yet defined|5|||
23499397|NCT01397162|65569928|FG004|Overall Study|Not yet defined|3|||
23499398|NCT01397890|65569938|FG000|Overall Study|Withdrawal by Subject|7|||
23499399|NCT01397890|65569939|FG001|Overall Study|Withdrawal by Subject|11|||
23499400|NCT01397890|65569938|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
23499401|NCT01397890|65569939|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
23499402|NCT01397890|65569938|FG000|Overall Study|Death|2|||
23499403|NCT01397890|65569939|FG001|Overall Study|Death|3|||
23499404|NCT01397890|65569938|FG000|Overall Study|Lost to Follow-up|1|||
23499405|NCT01397890|65569939|FG001|Overall Study|Lost to Follow-up|4|||
23499406|NCT01397890|65569938|FG000|Overall Study|Condition under Investigation Worsened|1|||
23499407|NCT01397890|65569939|FG001|Overall Study|Condition under Investigation Worsened|3|||
23499408|NCT01397890|65569938|FG000|Overall Study|Adverse Event|1|||
23499409|NCT01397890|65569939|FG001|Overall Study|Adverse Event|2|||
23499410|NCT01397890|65569938|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
23499411|NCT01397890|65569939|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
23499412|NCT01397890|65569938|FG000|Overall Study|Others|2|||
23499413|NCT01397890|65569939|FG001|Overall Study|Others|1|||
23499414|NCT01402011|65569940|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
23499415|NCT01402011|65569941|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
23499416|NCT01402011|65569942|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
23499417|NCT01402011|65569940|FG000|Active Treatment Period|Withdrawal by Subject|1|||
23499418|NCT01402011|65569941|FG001|Active Treatment Period|Withdrawal by Subject|3|||
23499419|NCT01402011|65569942|FG002|Active Treatment Period|Withdrawal by Subject|0|||
23499420|NCT01402011|65569940|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
23499421|NCT01402011|65569941|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
23499422|NCT01402011|65569942|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
23499423|NCT02657369|65569943|FG000|Overall Study|Death|27|||
23499424|NCT02657369|65569943|FG000|Overall Study|Study terminated by sponsor|7|||
23499425|NCT02605824|65569946|FG000|Overall Study|Physician Decision|1|||
23499426|NCT02605824|65569947|FG001|Overall Study|Physician Decision|0|||
23499427|NCT02993757|65569950|FG000|Overall Study|Non compliance with the protocol|155|||
23499428|NCT02993757|65569951|FG001|Overall Study|Non compliance with the protocol|170|||
23499429|NCT02993757|65569950|FG000|Overall Study|Lost to Follow-up|1|||
23499430|NCT02993757|65569951|FG001|Overall Study|Lost to Follow-up|0|||
23499431|NCT02993757|65569950|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
23499432|NCT02993757|65569951|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
23499433|NCT03797014|65569954|FG000|Overall Study|Withdrawal by Subject|1|||
23499434|NCT03797014|65569954|FG000|Overall Study|Lost to Follow-up|1|||
23499435|NCT03797014|65569954|FG000|Overall Study|Protocol Violation|1|||
23499436|NCT04390191|65569957|FG000|Overall Study|Withdrawal by Subject|1|||
23499437|NCT04390191|65569958|FG001|Overall Study|Withdrawal by Subject|0|||
23499438|NCT01999179|65569961|FG000|Overall Study|Adverse Event|1|||
23499439|NCT01999179|65569961|FG000|Overall Study|Lost to Follow-up|1|||
23499440|NCT01999179|65569961|FG000|Overall Study|Change in Therapy|3|||
23499441|NCT01999179|65569961|FG000|Overall Study|New catheter|2|||
23499442|NCT01300650|65569964|FG000|Overall Study|Adverse Event|1|||
23499443|NCT02083783|65569965|FG000|Overall Study|Withdrawal by Subject|1|||
23499444|NCT02083783|65569966|FG001|Overall Study|Withdrawal by Subject|0|||
23499445|NCT00674362|65569967|FG000|Double Blind|Adverse Event|6|||
23499446|NCT00674362|65569968|FG001|Double Blind|Adverse Event|6|||
23499447|NCT00674362|65569967|FG000|Double Blind|Lack of Efficacy|2|||
23499448|NCT00674362|65569968|FG001|Double Blind|Lack of Efficacy|6|||
23499449|NCT00674362|65569967|FG000|Double Blind|Loss of efficacy|0|||
23499450|NCT00674362|65569968|FG001|Double Blind|Loss of efficacy|1|||
23499451|NCT00674362|65569967|FG000|Double Blind|Withdrawal by Subject|4|||
23499452|NCT00674362|65569968|FG001|Double Blind|Withdrawal by Subject|3|||
23499453|NCT00674362|65569967|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
23499454|NCT00674362|65569968|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
23499455|NCT00674362|65569967|FG000|Double Blind|Other: Surgery|0|||
23499456|NCT00674362|65569968|FG001|Double Blind|Other: Surgery|1|||
23499457|NCT00674362|65569967|FG000|Open Label|Adverse Event|1|||
23499458|NCT00674362|65569968|FG001|Open Label|Adverse Event|0|||
23499459|NCT00674362|65569967|FG000|Open Label|Other: Subject moved to extension study|1|||
23499460|NCT00674362|65569968|FG001|Open Label|Other: Subject moved to extension study|0|||
23499461|NCT00639678|65569969|FG000|Overall Study|Withdrawal by Subject|3|||
23499462|NCT00639678|65569970|FG001|Overall Study|Withdrawal by Subject|0|||
23499463|NCT00639678|65569971|FG002|Overall Study|Withdrawal by Subject|4|||
23499464|NCT00639678|65569972|FG003|Overall Study|Withdrawal by Subject|0|||
23499465|NCT00639678|65569969|FG000|Overall Study|Lost to Follow-up|1|||
23499466|NCT00639678|65569970|FG001|Overall Study|Lost to Follow-up|0|||
23499467|NCT00639678|65569971|FG002|Overall Study|Lost to Follow-up|6|||
23499468|NCT00639678|65569972|FG003|Overall Study|Lost to Follow-up|0|||
23499469|NCT00639678|65569969|FG000|Overall Study|Adverse Event|0|||
23499470|NCT00639678|65569970|FG001|Overall Study|Adverse Event|1|||
23499471|NCT00639678|65569971|FG002|Overall Study|Adverse Event|0|||
23499472|NCT00639678|65569972|FG003|Overall Study|Adverse Event|0|||
23499473|NCT00639678|65569969|FG000|Overall Study|Lack of Compliance|0|||
23499474|NCT00639678|65569970|FG001|Overall Study|Lack of Compliance|0|||
23499475|NCT00639678|65569971|FG002|Overall Study|Lack of Compliance|1|||
23499476|NCT00639678|65569972|FG003|Overall Study|Lack of Compliance|0|||
23499477|NCT00622401|65569973|FG000|Overall Study|Disease progression prior to treatment|3|||
23499478|NCT00622401|65569974|FG001|Overall Study|Disease progression prior to treatment|2|||
23499479|NCT00622401|65569975|FG002|Overall Study|Disease progression prior to treatment|0|||
23499480|NCT00404235|65569978|FG000|Overall Study|Withdrawal by Subject|1|||
23499481|NCT00404235|65569979|FG001|Overall Study|Withdrawal by Subject|2|||
23499482|NCT00911547|65569982|FG000|Overall Study|Adverse Event|8|||
23499483|NCT00911547|65569983|FG001|Overall Study|Adverse Event|27|||
23499484|NCT00911547|65569984|FG002|Overall Study|Adverse Event|11|||
23499485|NCT00911547|65569985|FG003|Overall Study|Adverse Event|6|||
23499486|NCT00911547|65569982|FG000|Overall Study|Lost to Follow-up|0|||
23499487|NCT00911547|65569983|FG001|Overall Study|Lost to Follow-up|0|||
23499488|NCT00911547|65569984|FG002|Overall Study|Lost to Follow-up|2|||
23499489|NCT00911547|65569985|FG003|Overall Study|Lost to Follow-up|1|||
23499490|NCT00911547|65569982|FG000|Overall Study|Protocol Violation|0|||
23699883|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
23699884|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23499491|NCT00911547|65569983|FG001|Overall Study|Protocol Violation|5|||
23499492|NCT00911547|65569984|FG002|Overall Study|Protocol Violation|5|||
23499493|NCT00911547|65569985|FG003|Overall Study|Protocol Violation|1|||
23499494|NCT00911547|65569982|FG000|Overall Study|Withdrawal by Subject|3|||
23499495|NCT00911547|65569983|FG001|Overall Study|Withdrawal by Subject|10|||
23499496|NCT00911547|65569984|FG002|Overall Study|Withdrawal by Subject|4|||
23499497|NCT00911547|65569985|FG003|Overall Study|Withdrawal by Subject|8|||
23499498|NCT01253408|65569988|FG000|Overall Study|Adverse Event|0|||
23499499|NCT01253408|65569989|FG001|Overall Study|Adverse Event|1|||
23499500|NCT01253408|65569990|FG002|Overall Study|Adverse Event|0|||
23499501|NCT00316719|65569991|FG000|Overall Study|Adverse Event|0|||
23499502|NCT00316719|65569992|FG001|Overall Study|Adverse Event|6|||
23499503|NCT00316719|65569991|FG000|Overall Study|Consent withdrawn|2|||
23499504|NCT00316719|65569992|FG001|Overall Study|Consent withdrawn|0|||
23499505|NCT01552694|65569995|FG000|Overall Study|Lost to Follow-up|0|||
23499506|NCT01552694|65569996|FG001|Overall Study|Lost to Follow-up|1|||
23499507|NCT01552694|65569995|FG000|Overall Study|Protocol Violation|0|||
23499508|NCT01552694|65569996|FG001|Overall Study|Protocol Violation|1|||
23499509|NCT01466153|65569997|FG000|Overall Study|Disease Progression|2|||
23499510|NCT01466153|65569998|FG001|Overall Study|Disease Progression|2|||
23499511|NCT01466153|65569999|FG002|Overall Study|Disease Progression|0|||
23499512|NCT01466153|65569997|FG000|Overall Study|Adverse Event|14|||
23499513|NCT01466153|65569998|FG001|Overall Study|Adverse Event|13|||
23499514|NCT01466153|65569999|FG002|Overall Study|Adverse Event|17|||
23499515|NCT01466153|65569997|FG000|Overall Study|Withdrawal of Consent|2|||
23499516|NCT01466153|65569998|FG001|Overall Study|Withdrawal of Consent|0|||
23499517|NCT01466153|65569999|FG002|Overall Study|Withdrawal of Consent|0|||
23499518|NCT01466153|65569997|FG000|Overall Study|Investigator Discretion|3|||
23499519|NCT01466153|65569998|FG001|Overall Study|Investigator Discretion|2|||
23499520|NCT01466153|65569999|FG002|Overall Study|Investigator Discretion|2|||
23499521|NCT01466153|65569997|FG000|Overall Study|Randomized-Not Treated|2|||
23499522|NCT01466153|65569998|FG001|Overall Study|Randomized-Not Treated|3|||
23499523|NCT01466153|65569999|FG002|Overall Study|Randomized-Not Treated|4|||
23499524|NCT01466153|65569997|FG000|Overall Study|Other-Unspecified|6|||
23499525|NCT01466153|65569998|FG001|Overall Study|Other-Unspecified|4|||
23499526|NCT01466153|65569999|FG002|Overall Study|Other-Unspecified|2|||
23499527|NCT03469934|65570000|FG000|Overall Study|Withdrawal by Subject|0|||
23499528|NCT03469934|65570001|FG001|Overall Study|Withdrawal by Subject|1|||
23499529|NCT01203098|65570003|FG000|Overall Study|Adverse Event|3|||
23499530|NCT01203098|65570004|FG001|Overall Study|Adverse Event|1|||
23499531|NCT01203098|65570005|FG002|Overall Study|Adverse Event|7|||
23499532|NCT01203098|65570003|FG000|Overall Study|Lost to Follow-up|0|||
23499533|NCT01203098|65570004|FG001|Overall Study|Lost to Follow-up|0|||
23499534|NCT01203098|65570005|FG002|Overall Study|Lost to Follow-up|1|||
23499535|NCT01203098|65570003|FG000|Overall Study|Physician Decision|2|||
23499536|NCT01203098|65570004|FG001|Overall Study|Physician Decision|2|||
23499537|NCT01203098|65570005|FG002|Overall Study|Physician Decision|0|||
23499538|NCT01203098|65570003|FG000|Overall Study|Withdrawal by Subject|1|||
23499539|NCT01203098|65570004|FG001|Overall Study|Withdrawal by Subject|1|||
23499540|NCT01203098|65570005|FG002|Overall Study|Withdrawal by Subject|3|||
23499541|NCT00968201|65570008|FG000|Base Study - (Period II)|Adverse Event|8|||
23499542|NCT00968201|65570009|FG001|Base Study - (Period II)|Adverse Event|0|||
23499543|NCT00968201|65570010|FG002|Base Study - (Period II)|Adverse Event|16|||
23499544|NCT00968201|65570008|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
23499545|NCT00968201|65570009|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
23499546|NCT00968201|65570010|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
23499547|NCT00968201|65570008|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
23499548|NCT00968201|65570009|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
23499549|NCT00968201|65570010|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
23499550|NCT00968201|65570008|FG000|Base Study - (Period II)|Protocol Violation|12|||
23499551|NCT00968201|65570009|FG001|Base Study - (Period II)|Protocol Violation|0|||
23499552|NCT00968201|65570010|FG002|Base Study - (Period II)|Protocol Violation|12|||
23499553|NCT00968201|65570008|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
23499554|NCT00968201|65570009|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
23499555|NCT00968201|65570010|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
23499556|NCT00968201|65570008|FG000|Base Study - (Period II)|Site Error|0|||
23499557|NCT00968201|65570009|FG001|Base Study - (Period II)|Site Error|0|||
23499558|NCT00968201|65570010|FG002|Base Study - (Period II)|Site Error|1|||
23499559|NCT00968201|65570008|FG000|Extension Study - (Period III)|Adverse Event|0|||
23499560|NCT00968201|65570009|FG001|Extension Study - (Period III)|Adverse Event|5|||
23499561|NCT00968201|65570010|FG002|Extension Study - (Period III)|Adverse Event|22|||
23499562|NCT00968201|65570008|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
23499563|NCT00968201|65570009|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
23499564|NCT00968201|65570010|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
23499565|NCT00968201|65570008|FG000|Extension Study - (Period III)|Protocol Violation|0|||
23499566|NCT00968201|65570009|FG001|Extension Study - (Period III)|Protocol Violation|17|||
23499567|NCT00968201|65570010|FG002|Extension Study - (Period III)|Protocol Violation|14|||
23499568|NCT00968201|65570008|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
23499569|NCT00968201|65570009|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
23499570|NCT00968201|65570010|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
23499571|NCT00968201|65570008|FG000|Extension Study - (Period III)|Patient Relocated|0|||
23499572|NCT00968201|65570009|FG001|Extension Study - (Period III)|Patient Relocated|1|||
23499573|NCT00968201|65570010|FG002|Extension Study - (Period III)|Patient Relocated|1|||
23499574|NCT00968201|65570008|FG000|Extension Study - (Period III)|Noncompliance|0|||
23499575|NCT00968201|65570009|FG001|Extension Study - (Period III)|Noncompliance|0|||
23499576|NCT00968201|65570010|FG002|Extension Study - (Period III)|Noncompliance|3|||
23499577|NCT00968201|65570008|FG000|Extension Study - (Period III)|Other|0|||
23499578|NCT00968201|65570009|FG001|Extension Study - (Period III)|Other|0|||
23499579|NCT00968201|65570010|FG002|Extension Study - (Period III)|Other|2|||
23499580|NCT00968201|65570008|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
23499581|NCT00968201|65570009|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
23499582|NCT00968201|65570010|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
23499583|NCT00040365|65570011|FG000|Overall Study|Death|1|||
23499584|NCT00040365|65570011|FG000|Overall Study|Progressive disease|7|||
23499585|NCT00040365|65570011|FG000|Overall Study|Lost to Follow-up|3|||
23499586|NCT00003487|65570012|FG000|Overall Study|Not evaluable|2|||
23499587|NCT04092582|65573142|FG000|Overall Study|Death|1|||
23499588|NCT04092582|65573143|FG001|Overall Study|Death|1|||
23499589|NCT04092582|65573142|FG000|Overall Study|Withdrawal by Subject|4|||
23499590|NCT04092582|65573143|FG001|Overall Study|Withdrawal by Subject|1|||
23499591|NCT04092582|65573142|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
23499592|NCT04092582|65573143|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
23499593|NCT01781975|65573144|FG000|Overall Study|Death|1|||
23499594|NCT01781975|65573145|FG001|Overall Study|Death|0|||
23499595|NCT01781975|65573144|FG000|Overall Study|Withdrawal by Subject|1|||
23499596|NCT01781975|65573145|FG001|Overall Study|Withdrawal by Subject|1|||
23499597|NCT03128411|65573146|FG000|Treatment Phase|Adverse Event|21|||
23499598|NCT03128411|65573146|FG000|Treatment Phase|Physician Decision|1|||
23499599|NCT03128411|65573146|FG000|Treatment Phase|Other|2|||
23499600|NCT03128411|65573146|FG000|Long Term Follow-up Phase|Death|2|||
23499601|NCT02639065|65573147|FG000|Study Treatment|Disease Progression|13|||
23499602|NCT02639065|65573147|FG000|Study Treatment|Adverse Event|9|||
23499603|NCT02639065|65573147|FG000|Study Treatment|Withdrawal by Subject|1|||
23499604|NCT02639065|65573147|FG000|Follow up|Subject refused to follow up|1|||
23499605|NCT02639065|65573147|FG000|Follow up|Symptomatic Deterioration|2|||
23398594|NCT00399035|65207093|FG002|Overall Study|Withdrawal by Subject|12|||
23398595|NCT00399035|65207091|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
23398596|NCT00399035|65207092|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
23398597|NCT00399035|65207093|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
23398598|NCT00399035|65207091|FG000|Overall Study|Severe non-compliance with protocol|2|||
23398599|NCT00399035|65207092|FG001|Overall Study|Severe non-compliance with protocol|1|||
23398600|NCT00399035|65207093|FG002|Overall Study|Severe non-compliance with protocol|0|||
23398601|NCT00940602|65207094|FG000|Overall Study|Administrative problems|1|||
23398602|NCT00940602|65207095|FG001|Overall Study|Administrative problems|1|||
23398603|NCT00940602|65207094|FG000|Overall Study|Patient/guardian decision|13|||
23398604|NCT00940602|65207095|FG001|Overall Study|Patient/guardian decision|28|||
23398605|NCT00940602|65207094|FG000|Overall Study|Physician Decision|8|||
23398606|NCT00940602|65207095|FG001|Overall Study|Physician Decision|5|||
23398607|NCT00940602|65207094|FG000|Overall Study|Pregnancy|1|||
23398608|NCT00940602|65207095|FG001|Overall Study|Pregnancy|0|||
23398609|NCT00940602|65207094|FG000|Overall Study|Protocol Deviation (untreated)|1|||
23398610|NCT00940602|65207095|FG001|Overall Study|Protocol Deviation (untreated)|0|||
23398611|NCT00940602|65207094|FG000|Overall Study|Disease progression|8|||
23398612|NCT00940602|65207095|FG001|Overall Study|Disease progression|2|||
23398613|NCT00940602|65207094|FG000|Overall Study|Death|38|||
23398614|NCT00940602|65207095|FG001|Overall Study|Death|19|||
23398615|NCT00940602|65207094|FG000|Overall Study|Lost to Follow-up|3|||
23398616|NCT00940602|65207095|FG001|Overall Study|Lost to Follow-up|1|||
23398617|NCT00940602|65207094|FG000|Overall Study|Patient withdrew consent|26|||
23398618|NCT00940602|65207095|FG001|Overall Study|Patient withdrew consent|13|||
23398619|NCT00940602|65207094|FG000|Overall Study|Adverse Event|7|||
23398620|NCT00940602|65207095|FG001|Overall Study|Adverse Event|2|||
23398621|NCT00940602|65207094|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
23398622|NCT00940602|65207095|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
23398623|NCT01593917|65207098|FG000|Overall Study|Death|67|||
23398624|NCT01593917|65207098|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
23398625|NCT01593917|65207098|FG000|Overall Study|Withdrawal by Subject|23|||
23398626|NCT01593917|65207098|FG000|Overall Study|Lost to Follow-up|12|||
23398627|NCT01593917|65207098|FG000|Overall Study|Protocol Violation|5|||
23398628|NCT01593917|65207098|FG000|Overall Study|Physician Decision|3|||
23398629|NCT01729039|65207102|FG000|Overall Study|disqualified|2|||
23398630|NCT01729039|65207103|FG001|Overall Study|disqualified|5|||
23499606|NCT02639065|65573147|FG000|Follow up|Death|2|||
23499607|NCT02639065|65573147|FG000|Follow up|Study Terminated|1|||
23499608|NCT02639065|65573147|FG000|Follow up|Disease Progression|3|||
23499609|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
23499610|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
23398631|NCT01729039|65207102|FG000|Overall Study|Withdrawal by Subject|8|||
23398632|NCT01729039|65207103|FG001|Overall Study|Withdrawal by Subject|7|||
23398633|NCT02660229|65207106|FG000|Overall Study|Adverse Event|2|||
23398634|NCT02660229|65207107|FG001|Overall Study|Adverse Event|0|||
23398635|NCT02660229|65207106|FG000|Overall Study|Withdrawal by Subject|0|||
23398636|NCT02660229|65207107|FG001|Overall Study|Withdrawal by Subject|1|||
23398637|NCT03412929|65207108|FG000|Overall Study|Protocol Violation|3|||
23398638|NCT04577781|65207109|FG000|Overall Study|Adverse Event|2|||
23398639|NCT04577781|65207110|FG001|Overall Study|Adverse Event|2|||
23398640|NCT04577781|65207109|FG000|Overall Study|Physician Decision|1|||
23398641|NCT04577781|65207110|FG001|Overall Study|Physician Decision|0|||
23398642|NCT00366457|65207111|FG000|Overall Study|never began study therapy|2|||
23398643|NCT03243084|65207112|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
23398644|NCT03243084|65207113|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
23398645|NCT00744861|65207117|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
23398646|NCT00744861|65207118|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
23398647|NCT00744861|65207119|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
23398648|NCT00744861|65207120|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
23398649|NCT00744861|65207117|FG000|Feasibility Stage 1|Pregnancy|0|||
23398650|NCT00744861|65207118|FG001|Feasibility Stage 1|Pregnancy|1|||
23398651|NCT00744861|65207119|FG002|Feasibility Stage 1|Pregnancy|0|||
23398652|NCT00744861|65207120|FG003|Feasibility Stage 1|Pregnancy|0|||
23398653|NCT00744861|65207117|FG000|Pivotal Stage 2|Adverse Event|0|||
23398654|NCT00744861|65207118|FG001|Pivotal Stage 2|Adverse Event|0|||
23398655|NCT00744861|65207119|FG002|Pivotal Stage 2|Adverse Event|6|||
23398656|NCT00744861|65207120|FG003|Pivotal Stage 2|Adverse Event|11|||
23398657|NCT00744861|65207117|FG000|Pivotal Stage 2|Death|0|||
23398658|NCT00744861|65207118|FG001|Pivotal Stage 2|Death|0|||
23398659|NCT00744861|65207119|FG002|Pivotal Stage 2|Death|0|||
23398660|NCT00744861|65207120|FG003|Pivotal Stage 2|Death|1|||
23398661|NCT00744861|65207117|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
23398662|NCT00744861|65207118|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
23398663|NCT00744861|65207119|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
23398664|NCT00744861|65207120|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
23398665|NCT00744861|65207117|FG000|Pivotal Stage 2|Physician Decision|0|||
23398666|NCT00744861|65207118|FG001|Pivotal Stage 2|Physician Decision|0|||
23398667|NCT00744861|65207119|FG002|Pivotal Stage 2|Physician Decision|3|||
23398668|NCT00744861|65207120|FG003|Pivotal Stage 2|Physician Decision|1|||
23398669|NCT00744861|65207117|FG000|Pivotal Stage 2|Protocol Violation|0|||
23398670|NCT00744861|65207118|FG001|Pivotal Stage 2|Protocol Violation|0|||
23398671|NCT00744861|65207119|FG002|Pivotal Stage 2|Protocol Violation|0|||
23398672|NCT00744861|65207120|FG003|Pivotal Stage 2|Protocol Violation|1|||
23398673|NCT00744861|65207117|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
23398674|NCT00744861|65207118|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
23398675|NCT00744861|65207119|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
23398676|NCT00744861|65207120|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
23398677|NCT00744861|65207117|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
23398678|NCT00744861|65207118|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
23398679|NCT00744861|65207119|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
23398680|NCT00744861|65207120|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
23398681|NCT02862574|65207124|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23398682|NCT02862574|65207125|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23398683|NCT02862574|65207126|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23398684|NCT02862574|65207124|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
23398685|NCT02862574|65207125|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
23398686|NCT02862574|65207126|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
23398687|NCT02862574|65207124|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
23499611|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
23499612|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
23499613|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499614|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499615|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499616|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499617|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499618|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499619|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499620|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
23499621|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
23398688|NCT02862574|65207125|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
23398689|NCT02862574|65207126|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
23398690|NCT01816984|65207127|FG000|Overall Study|declining health status|1|||
23398691|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Death|2|||
23499622|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
23499623|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
23499624|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499625|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499626|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499627|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499628|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499629|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499630|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499631|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
23499632|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
23499633|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
23499634|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
23499635|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499636|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499637|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499638|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499639|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499640|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499641|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499642|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499643|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499644|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499645|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
23499646|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499647|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499648|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499649|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499650|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499651|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499652|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499653|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
23499654|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
23499655|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
23499656|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
23499657|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499658|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499659|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499660|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499661|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499662|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499663|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499664|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
23499665|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
23499666|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
23499667|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
23499668|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499669|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499670|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499671|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499672|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499673|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499674|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499675|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
23499676|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
23499677|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
23499678|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
23499679|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499680|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499681|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499682|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499683|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23699885|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23499684|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499685|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499686|NCT01847274|65573154|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499687|NCT01847274|65573155|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499688|NCT01847274|65573156|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499689|NCT01847274|65573157|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499690|NCT01847274|65573158|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499691|NCT01847274|65573159|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
23499692|NCT01847274|65573160|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499693|NCT01847274|65573161|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499694|NCT01847274|65573162|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499695|NCT01847274|65573163|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499696|NCT01847274|65573164|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499697|NCT01847274|65573154|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499698|NCT01847274|65573155|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499699|NCT01847274|65573156|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499700|NCT01847274|65573157|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499701|NCT01847274|65573158|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
23499702|NCT01847274|65573159|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499703|NCT01847274|65573160|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499704|NCT01847274|65573161|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499705|NCT01847274|65573162|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499706|NCT01847274|65573163|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499707|NCT01847274|65573164|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499708|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499709|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499710|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499711|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499712|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499713|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499714|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
23499715|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499716|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499717|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499718|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499719|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499720|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499721|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499722|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499723|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499724|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499725|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
23499726|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499727|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499728|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499729|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499730|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499731|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499732|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499733|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499734|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499735|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499736|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
23499737|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499738|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499739|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499740|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499741|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499742|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499743|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23699886|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23699887|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
23699888|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
23699889|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
23499744|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499745|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499746|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499747|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499748|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
23499749|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
23499750|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
23499751|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
23499752|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499753|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499754|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499755|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499756|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499757|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499758|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499759|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
23499760|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499761|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
23499762|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499763|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499764|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499765|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499766|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499767|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499768|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499769|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499770|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
23499771|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499772|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
23499773|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
23499774|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499775|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499776|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499777|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499778|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499779|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499780|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499781|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499782|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499783|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
23499784|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499785|NCT00190671|65573168|FG000|Overall Study|Satisfactory Response|4|||
23499786|NCT00190671|65573169|FG001|Overall Study|Satisfactory Response|7|||
23499787|NCT00190671|65573168|FG000|Overall Study|Lack of Efficacy|19|||
23499788|NCT00190671|65573169|FG001|Overall Study|Lack of Efficacy|24|||
23499789|NCT00190671|65573168|FG000|Overall Study|Death from Study Disease|1|||
23499790|NCT00190671|65573169|FG001|Overall Study|Death from Study Disease|1|||
23499791|NCT00190671|65573168|FG000|Overall Study|Adverse Event|3|||
23499792|NCT00190671|65573169|FG001|Overall Study|Adverse Event|2|||
23499793|NCT00190671|65573168|FG000|Overall Study|Clinical Relapse|0|||
23499794|NCT00190671|65573169|FG001|Overall Study|Clinical Relapse|1|||
23499795|NCT00190671|65573168|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
23499796|NCT00190671|65573169|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
23499797|NCT00190671|65573168|FG000|Overall Study|Death from Other Causes|0|||
23499798|NCT00190671|65573169|FG001|Overall Study|Death from Other Causes|2|||
23499799|NCT00190671|65573168|FG000|Overall Study|Protocol Violation|0|||
23499800|NCT00190671|65573169|FG001|Overall Study|Protocol Violation|1|||
23499801|NCT00190671|65573168|FG000|Overall Study|Withdrawal by Subject|0|||
23499802|NCT00190671|65573169|FG001|Overall Study|Withdrawal by Subject|2|||
23499803|NCT03727230|65573170|FG000|Overall Study|Lost to Follow-up|12|||
23398692|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
23398693|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
23398694|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Physician Decision|1|||
23398695|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
23398696|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
23499804|NCT00126191|65573176|FG000|Overall Study|Physician Decision|0|||
23499805|NCT00126191|65573177|FG001|Overall Study|Physician Decision|1|||
23499806|NCT00126191|65573176|FG000|Overall Study|Death|0|||
23499807|NCT00126191|65573177|FG001|Overall Study|Death|1|||
23499808|NCT00378378|65573178|FG000|Overall Study|Withdrawal by Subject|0|||
23499809|NCT00378378|65573179|FG001|Overall Study|Withdrawal by Subject|1|||
23499810|NCT00378378|65573180|FG002|Overall Study|Withdrawal by Subject|0|||
23499811|NCT00378378|65573178|FG000|Overall Study|Treatment Failure|0|||
23499812|NCT00378378|65573179|FG001|Overall Study|Treatment Failure|0|||
23499813|NCT00378378|65573180|FG002|Overall Study|Treatment Failure|1|||
23499814|NCT00378378|65573178|FG000|Overall Study|Non-compliance with protocol|0|||
23499815|NCT00378378|65573179|FG001|Overall Study|Non-compliance with protocol|0|||
23499816|NCT00378378|65573180|FG002|Overall Study|Non-compliance with protocol|1|||
23499817|NCT00074152|65573181|FG000|Overall Study|Death|21|||
23499818|NCT00074152|65573182|FG001|Overall Study|Death|9|||
23499819|NCT00074152|65573181|FG000|Overall Study|Lack of Efficacy|34|||
23499820|NCT00074152|65573182|FG001|Overall Study|Lack of Efficacy|24|||
23499821|NCT04545060|65573183|FG000|Overall Study|Adverse Event|0|||
23499822|NCT04545060|65573184|FG001|Overall Study|Adverse Event|1|||
23499823|NCT04545060|65573183|FG000|Overall Study|Death|0|||
23499824|NCT04545060|65573184|FG001|Overall Study|Death|5|||
23499825|NCT04545060|65573183|FG000|Overall Study|Lost to Follow-up|10|||
23499826|NCT04545060|65573184|FG001|Overall Study|Lost to Follow-up|13|||
23499827|NCT04545060|65573183|FG000|Overall Study|Physician Decision|3|||
23499828|NCT04545060|65573184|FG001|Overall Study|Physician Decision|0|||
23499829|NCT04545060|65573183|FG000|Overall Study|Withdrawal by Subject|17|||
23499830|NCT04545060|65573184|FG001|Overall Study|Withdrawal by Subject|22|||
23499831|NCT03166735|65573185|FG000|Overall Study|Not Treated|1|||
23499832|NCT03166735|65573186|FG001|Overall Study|Not Treated|0|||
23499833|NCT03166735|65573187|FG002|Overall Study|Not Treated|0|||
23499834|NCT03166735|65573188|FG003|Overall Study|Not Treated|0|||
23499835|NCT03166735|65573189|FG004|Overall Study|Not Treated|0|||
23499836|NCT03166735|65573185|FG000|Overall Study|follow-up not completed as planned|0|||
23499837|NCT03166735|65573186|FG001|Overall Study|follow-up not completed as planned|1|||
23499838|NCT03166735|65573187|FG002|Overall Study|follow-up not completed as planned|1|||
23499839|NCT03166735|65573188|FG003|Overall Study|follow-up not completed as planned|0|||
23499840|NCT03166735|65573189|FG004|Overall Study|follow-up not completed as planned|1|||
23499841|NCT03166735|65573185|FG000|Overall Study|Withdrawal by Subject|0|||
23499842|NCT03166735|65573186|FG001|Overall Study|Withdrawal by Subject|0|||
23499843|NCT03166735|65573187|FG002|Overall Study|Withdrawal by Subject|1|||
23499844|NCT03166735|65573188|FG003|Overall Study|Withdrawal by Subject|1|||
23499845|NCT03166735|65573189|FG004|Overall Study|Withdrawal by Subject|2|||
23499846|NCT03166735|65573185|FG000|Overall Study|Lost to Follow-up|0|||
23499847|NCT03166735|65573186|FG001|Overall Study|Lost to Follow-up|2|||
23499848|NCT03166735|65573187|FG002|Overall Study|Lost to Follow-up|1|||
23499849|NCT03166735|65573188|FG003|Overall Study|Lost to Follow-up|0|||
23499850|NCT03166735|65573189|FG004|Overall Study|Lost to Follow-up|1|||
23499851|NCT01727297|65573190|FG000|Overall Study|Death|13|||
23499852|NCT01727297|65573191|FG001|Overall Study|Death|0|||
23499853|NCT01727297|65573190|FG000|Overall Study|Protocol Violation|1|||
23499854|NCT01727297|65573191|FG001|Overall Study|Protocol Violation|10|||
23499855|NCT01727297|65573190|FG000|Overall Study|Adverse Event|3|||
23499856|NCT01727297|65573191|FG001|Overall Study|Adverse Event|1|||
23499857|NCT01727297|65573190|FG000|Overall Study|Lost to Follow-up|11|||
23499858|NCT01727297|65573191|FG001|Overall Study|Lost to Follow-up|0|||
23499859|NCT01727297|65573190|FG000|Overall Study|Withdrawal by Subject|26|||
23499860|NCT01727297|65573191|FG001|Overall Study|Withdrawal by Subject|27|||
23499861|NCT01727297|65573190|FG000|Overall Study|Physician Decision|19|||
23499862|NCT01727297|65573191|FG001|Overall Study|Physician Decision|5|||
23499863|NCT01727297|65573190|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
23499864|NCT01727297|65573191|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
23499865|NCT00880009|65573192|FG000|Overall Study|Study terminated by sponsor|14|||
23499866|NCT00880009|65573192|FG000|Overall Study|Withdrawal by Subject|1|||
23699890|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
23499867|NCT00880009|65573192|FG000|Overall Study|Protocol Violation|1|||
23499868|NCT03322631|65573193|FG000|Overall Study|Withdrawal by Subject|0|||
23499869|NCT03322631|65573194|FG001|Overall Study|Withdrawal by Subject|1|||
23499870|NCT03322631|65573195|FG002|Overall Study|Withdrawal by Subject|0|||
23499871|NCT03322631|65573196|FG003|Overall Study|Withdrawal by Subject|0|||
23499872|NCT03322631|65573193|FG000|Overall Study|Adverse Event|0|||
23499873|NCT03322631|65573194|FG001|Overall Study|Adverse Event|0|||
23499874|NCT03322631|65573195|FG002|Overall Study|Adverse Event|1|||
23499875|NCT03322631|65573196|FG003|Overall Study|Adverse Event|0|||
23499876|NCT00282984|65573197|FG000|Overall Study|Death|2|||
23499877|NCT00282984|65573198|FG001|Overall Study|Death|5|||
23499878|NCT00282984|65573197|FG000|Overall Study|Adverse Event|8|||
23499879|NCT00282984|65573198|FG001|Overall Study|Adverse Event|5|||
23499880|NCT00282984|65573197|FG000|Overall Study|Lack of Efficacy|0|||
23499881|NCT00282984|65573198|FG001|Overall Study|Lack of Efficacy|2|||
23499882|NCT00282984|65573197|FG000|Overall Study|Lost to Follow-up|14|||
23499883|NCT00282984|65573198|FG001|Overall Study|Lost to Follow-up|10|||
23499884|NCT00282984|65573197|FG000|Overall Study|Withdrawal by Participant|22|||
23499885|NCT00282984|65573198|FG001|Overall Study|Withdrawal by Participant|34|||
23499886|NCT00282984|65573197|FG000|Overall Study|Participant stopped study medication|2|||
23499887|NCT00282984|65573198|FG001|Overall Study|Participant stopped study medication|2|||
23499888|NCT00282984|65573197|FG000|Overall Study|Participant only allowed phone follow-up|0|||
23499889|NCT00282984|65573198|FG001|Overall Study|Participant only allowed phone follow-up|1|||
23499890|NCT00282984|65573197|FG000|Overall Study|Participant used antipsychosis meds|0|||
23499891|NCT00282984|65573198|FG001|Overall Study|Participant used antipsychosis meds|1|||
23499892|NCT00282984|65573197|FG000|Overall Study|lack of motivation|1|||
23499893|NCT00282984|65573198|FG001|Overall Study|lack of motivation|0|||
23499894|NCT00282984|65573197|FG000|Overall Study|in prison|0|||
23499895|NCT00282984|65573198|FG001|Overall Study|in prison|1|||
23499896|NCT00282984|65573197|FG000|Overall Study|Protocol Violation|2|||
23499897|NCT00282984|65573198|FG001|Overall Study|Protocol Violation|0|||
23499898|NCT02527161|65573199|FG000|Overall Study|Failed MRI|52|||
23499899|NCT02527161|65573199|FG000|Overall Study|Withdrawal by Subject|19|||
23499900|NCT02527161|65573199|FG000|Overall Study|Delay in or unfit for surgery|16|||
23499901|NCT02527161|65573199|FG000|Overall Study|MRI contraindication|6|||
23499902|NCT02527161|65573199|FG000|Overall Study|Consent violation|4|||
23499903|NCT02527161|65573199|FG000|Overall Study|Only Recruited to Part A|27|||
23499904|NCT02527161|65573199|FG000|Overall Study|Physician Decision|1|||
23499905|NCT02527161|65573199|FG000|Overall Study|Adverse Event|1|||
23499906|NCT02527161|65573199|FG000|Overall Study|Lost to Follow-up|6|||
23499907|NCT02166905|65573202|FG000|Overall Study|Withdrawal by Subject|1|||
23499908|NCT02166905|65573203|FG001|Overall Study|Withdrawal by Subject|0|||
23499909|NCT02166905|65573204|FG002|Overall Study|Withdrawal by Subject|0|||
23499910|NCT02166905|65573205|FG003|Overall Study|Withdrawal by Subject|0|||
23499911|NCT02969369|65573206|FG000|Study|Adverse Event|1|||
23499912|NCT02969369|65573207|FG001|Study|Adverse Event|6|||
23499913|NCT02969369|65573206|FG000|Study|Lack of Efficacy|0|||
23499914|NCT02969369|65573207|FG001|Study|Lack of Efficacy|1|||
23499915|NCT02969369|65573206|FG000|Study|Lost to Follow-up|0|||
23499916|NCT02969369|65573207|FG001|Study|Lost to Follow-up|1|||
23499917|NCT02969369|65573206|FG000|Study|Withdrawal by Subject|3|||
23499918|NCT02969369|65573207|FG001|Study|Withdrawal by Subject|5|||
23499919|NCT02969369|65573206|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
23499920|NCT02969369|65573207|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
23499921|NCT02969369|65573206|FG000|Double-blind Period|Adverse Event|1|||
23499922|NCT02969369|65573207|FG001|Double-blind Period|Adverse Event|5|||
23499923|NCT02969369|65573206|FG000|Double-blind Period|Lost to Follow-up|0|||
23499924|NCT02969369|65573207|FG001|Double-blind Period|Lost to Follow-up|1|||
23499925|NCT02969369|65573206|FG000|Double-blind Period|Withdrawal by Subject|2|||
23499926|NCT02969369|65573207|FG001|Double-blind Period|Withdrawal by Subject|3|||
23499927|NCT02969369|65573206|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
23499928|NCT02969369|65573207|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
23499929|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
23499930|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
23499931|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
23499932|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
23499933|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
23499934|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
23499935|NCT01637272|65573208|FG000|Overall Study|Adverse Event|6|||
23499936|NCT01637272|65573208|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23499937|NCT01637272|65573208|FG000|Overall Study|Withdrawal by Subject|3|||
23499938|NCT01637272|65573208|FG000|Overall Study|Lost to Follow-up|2|||
23499939|NCT01637272|65573208|FG000|Overall Study|completed core, did not enter ext. phase|4|||
23499940|NCT01637272|65573208|FG000|Overall Study|Administrative problems|1|||
23499941|NCT01637272|65573208|FG000|Overall Study|Protocol Violation|2|||
23499942|NCT01496612|65573209|FG000|1st Intervention|Adverse Event|1|||
23499943|NCT01496612|65573210|FG001|1st Intervention|Adverse Event|0|||
23499944|NCT01496612|65573209|FG000|1st Intervention|Withdrawal by Subject|1|||
23499945|NCT01496612|65573210|FG001|1st Intervention|Withdrawal by Subject|0|||
23499946|NCT01269463|65573212|FG000|First Intervention|Withdrawal by Subject|1|||
23499947|NCT01269463|65573213|FG001|First Intervention|Withdrawal by Subject|0|||
23499948|NCT01269463|65573212|FG000|First Intervention|Adverse Event|1|||
23499949|NCT01269463|65573213|FG001|First Intervention|Adverse Event|0|||
23499950|NCT01269463|65573212|FG000|First Intervention|Lack of Efficacy|0|||
23499951|NCT01269463|65573213|FG001|First Intervention|Lack of Efficacy|1|||
23499952|NCT01269463|65573212|FG000|First Intervention|Physician Decision|0|||
23499953|NCT01269463|65573213|FG001|First Intervention|Physician Decision|1|||
23499954|NCT01787331|65573214|FG000|Overall Study|Physician Decision|1|||
23499955|NCT01787331|65573214|FG000|Overall Study|Withdrawal by Subject|1|||
23499956|NCT00261807|65573220|FG000|Overall Study|Lost to Follow-up|2|||
23499957|NCT00261807|65573220|FG000|Overall Study|Adverse Event|2|||
23499958|NCT00261807|65573220|FG000|Overall Study|Death|1|||
23499959|NCT00261807|65573220|FG000|Overall Study|Protocol Violation|2|||
23499960|NCT00129272|65573230|FG000|Overall Study|Lost to Follow-up|12|||
23499961|NCT00129272|65573231|FG001|Overall Study|Lost to Follow-up|11|||
23499962|NCT00129272|65573230|FG000|Overall Study|Withdrawal by Subject|5|||
23499963|NCT00129272|65573231|FG001|Overall Study|Withdrawal by Subject|11|||
23499964|NCT01348165|65573232|FG000|Overall Study|Adverse Event|0|||
23499965|NCT01348165|65573233|FG001|Overall Study|Adverse Event|0|||
23499966|NCT01348165|65573234|FG002|Overall Study|Adverse Event|0|||
23499967|NCT01348165|65573235|FG003|Overall Study|Adverse Event|0|||
23499968|NCT01348165|65573236|FG004|Overall Study|Adverse Event|0|||
23499969|NCT01348165|65573237|FG005|Overall Study|Adverse Event|0|||
23499970|NCT01348165|65573238|FG006|Overall Study|Adverse Event|1|||
23499971|NCT02302807|65573239|FG000|Overall Study|Withdrawal by Subject|28|||
23499972|NCT02302807|65573240|FG001|Overall Study|Withdrawal by Subject|11|||
23499973|NCT02302807|65573239|FG000|Overall Study|Lost to Follow-up|4|||
23499974|NCT02302807|65573240|FG001|Overall Study|Lost to Follow-up|6|||
23499975|NCT02302807|65573239|FG000|Overall Study|Death|397|||
23499976|NCT02302807|65573240|FG001|Overall Study|Death|385|||
23499977|NCT02302807|65573239|FG000|Overall Study|Study Terminated By Sponsor|35|||
23499978|NCT02302807|65573240|FG001|Overall Study|Study Terminated By Sponsor|64|||
23499979|NCT02302807|65573239|FG000|Overall Study|Physician Decision|0|||
23499980|NCT02302807|65573240|FG001|Overall Study|Physician Decision|1|||
23499981|NCT00300274|65573241|FG000|Overall Study|Withdrawal by Subject|12|||
23499982|NCT00300274|65573242|FG001|Overall Study|Withdrawal by Subject|3|||
23499983|NCT00300274|65573243|FG002|Overall Study|Withdrawal by Subject|14|||
23499984|NCT00300274|65573241|FG000|Overall Study|Lost to Follow-up|3|||
23499985|NCT00300274|65573242|FG001|Overall Study|Lost to Follow-up|4|||
23499986|NCT00300274|65573243|FG002|Overall Study|Lost to Follow-up|5|||
23499987|NCT00300274|65573241|FG000|Overall Study|Death|31|||
23499988|NCT00300274|65573242|FG001|Overall Study|Death|20|||
23499989|NCT00300274|65573243|FG002|Overall Study|Death|25|||
23499990|NCT00300274|65573241|FG000|Overall Study|Re-transplant|0|||
23499991|NCT00300274|65573242|FG001|Overall Study|Re-transplant|0|||
23499992|NCT00300274|65573243|FG002|Overall Study|Re-transplant|1|||
23499993|NCT02200211|65573244|FG000|Overall Study|Lost to Follow-up|7|||
23499994|NCT02200211|65573245|FG001|Overall Study|Lost to Follow-up|7|||
23499995|NCT02200211|65573246|FG002|Overall Study|Lost to Follow-up|1|||
23499996|NCT02200211|65573247|FG003|Overall Study|Lost to Follow-up|2|||
23499997|NCT02200211|65573244|FG000|Overall Study|Withdrawal by Subject|1|||
23499998|NCT02200211|65573245|FG001|Overall Study|Withdrawal by Subject|0|||
23499999|NCT02200211|65573246|FG002|Overall Study|Withdrawal by Subject|0|||
23500000|NCT02200211|65573247|FG003|Overall Study|Withdrawal by Subject|0|||
23500001|NCT01786668|65573250|FG000|Overall Study|Adverse Event|0|||
23500002|NCT01786668|65573251|FG001|Overall Study|Adverse Event|1|||
23500003|NCT01786668|65573252|FG002|Overall Study|Adverse Event|1|||
23500004|NCT01786668|65573253|FG003|Overall Study|Adverse Event|2|||
23500005|NCT01786668|65573250|FG000|Overall Study|Withdrawal by Subject|0|||
23500006|NCT01786668|65573251|FG001|Overall Study|Withdrawal by Subject|0|||
23500007|NCT01786668|65573252|FG002|Overall Study|Withdrawal by Subject|3|||
23500008|NCT01786668|65573253|FG003|Overall Study|Withdrawal by Subject|1|||
23500009|NCT01786668|65573250|FG000|Overall Study|Pregnancy|0|||
23500010|NCT01786668|65573251|FG001|Overall Study|Pregnancy|0|||
23500011|NCT01786668|65573252|FG002|Overall Study|Pregnancy|0|||
23500012|NCT01786668|65573253|FG003|Overall Study|Pregnancy|1|||
23500013|NCT01786668|65573250|FG000|Overall Study|Lost to Follow-up|1|||
23500014|NCT01786668|65573251|FG001|Overall Study|Lost to Follow-up|0|||
23500015|NCT01786668|65573252|FG002|Overall Study|Lost to Follow-up|1|||
23500016|NCT01786668|65573253|FG003|Overall Study|Lost to Follow-up|0|||
23500017|NCT00221403|65573254|FG000|Overall Study|Protocol Violation|1|||
23500018|NCT00221403|65573255|FG001|Overall Study|Protocol Violation|0|||
23500019|NCT00221403|65573256|FG002|Overall Study|Protocol Violation|0|||
23500020|NCT00221403|65573254|FG000|Overall Study|Physician Decision|1|||
23500021|NCT00221403|65573255|FG001|Overall Study|Physician Decision|0|||
23500022|NCT00221403|65573256|FG002|Overall Study|Physician Decision|0|||
23500023|NCT00221403|65573254|FG000|Overall Study|Withdrawal by Subject|0|||
23500024|NCT00221403|65573255|FG001|Overall Study|Withdrawal by Subject|3|||
23500025|NCT00221403|65573256|FG002|Overall Study|Withdrawal by Subject|0|||
23500026|NCT00221403|65573254|FG000|Overall Study|Lack of Efficacy|0|||
23500027|NCT00221403|65573255|FG001|Overall Study|Lack of Efficacy|1|||
23500028|NCT00221403|65573256|FG002|Overall Study|Lack of Efficacy|0|||
23500029|NCT00221403|65573254|FG000|Overall Study|Adverse Event|0|||
23500030|NCT00221403|65573255|FG001|Overall Study|Adverse Event|1|||
23500031|NCT00221403|65573256|FG002|Overall Study|Adverse Event|0|||
23500032|NCT03230097|65573257|FG000|Overall Study|Adverse Event|2|||
23500033|NCT03230097|65573258|FG001|Overall Study|Adverse Event|1|||
23500034|NCT03230097|65573257|FG000|Overall Study|non-compliance|0|||
23500035|NCT03230097|65573258|FG001|Overall Study|non-compliance|1|||
23500036|NCT03230097|65573257|FG000|Overall Study|Lost to Follow-up|2|||
23500037|NCT03230097|65573258|FG001|Overall Study|Lost to Follow-up|4|||
23500038|NCT03230097|65573257|FG000|Overall Study|Withdrawal by Subject|7|||
23500039|NCT03230097|65573258|FG001|Overall Study|Withdrawal by Subject|3|||
23500040|NCT03230097|65573257|FG000|Overall Study|Trial termination|4|||
23500041|NCT03230097|65573258|FG001|Overall Study|Trial termination|5|||
23500042|NCT03230097|65573257|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
23500043|NCT03230097|65573258|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
23500044|NCT03230097|65573257|FG000|Overall Study|outcome event|0|||
23500045|NCT03230097|65573258|FG001|Overall Study|outcome event|1|||
23500046|NCT00299104|65573261|FG000|Treatment Period|Adverse Event|14|||
23500047|NCT00299104|65573262|FG001|Treatment Period|Adverse Event|9|||
23500048|NCT00299104|65573263|FG002|Treatment Period|Adverse Event|7|||
23500049|NCT00299104|65573261|FG000|Treatment Period|Death|1|||
23500050|NCT00299104|65573262|FG001|Treatment Period|Death|1|||
23500051|NCT00299104|65573263|FG002|Treatment Period|Death|1|||
23500052|NCT00299104|65573261|FG000|Treatment Period|Insufficient therapeutic response|34|||
23500053|NCT00299104|65573262|FG001|Treatment Period|Insufficient therapeutic response|13|||
23500054|NCT00299104|65573263|FG002|Treatment Period|Insufficient therapeutic response|8|||
23500055|NCT00299104|65573261|FG000|Treatment Period|Failure to return|9|||
23500056|NCT00299104|65573262|FG001|Treatment Period|Failure to return|8|||
23500057|NCT00299104|65573263|FG002|Treatment Period|Failure to return|8|||
23500058|NCT00299104|65573261|FG000|Treatment Period|Violation of selection criteria|1|||
23500059|NCT00299104|65573262|FG001|Treatment Period|Violation of selection criteria|2|||
23500060|NCT00299104|65573263|FG002|Treatment Period|Violation of selection criteria|0|||
23500061|NCT00299104|65573261|FG000|Treatment Period|Protocol Violation|1|||
23500062|NCT00299104|65573262|FG001|Treatment Period|Protocol Violation|1|||
23500063|NCT00299104|65573263|FG002|Treatment Period|Protocol Violation|0|||
23500064|NCT00299104|65573261|FG000|Treatment Period|Refused treatment|9|||
23500065|NCT00299104|65573262|FG001|Treatment Period|Refused treatment|2|||
23500066|NCT00299104|65573263|FG002|Treatment Period|Refused treatment|2|||
23500067|NCT00299104|65573261|FG000|Treatment Period|Withdrew consent|14|||
23500068|NCT00299104|65573262|FG001|Treatment Period|Withdrew consent|19|||
23500069|NCT00299104|65573263|FG002|Treatment Period|Withdrew consent|9|||
23500070|NCT00299104|65573261|FG000|Treatment Period|Administrative reasons|106|||
23500071|NCT00299104|65573262|FG001|Treatment Period|Administrative reasons|120|||
23500072|NCT00299104|65573263|FG002|Treatment Period|Administrative reasons|137|||
23500073|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Death|3|||
23500074|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Death|2|||
23500075|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Death|1|||
23500076|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
23500077|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
23500078|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
23500079|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
23500080|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
23500081|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
23500082|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
23500083|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
23500084|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
23500085|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
23500086|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
23500087|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
23500088|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500089|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500090|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500091|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
23500092|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
23500093|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
23500094|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
23500095|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
23500096|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
23500097|NCT01273597|65573264|FG000|Overall Study|Adverse Event|5|||
23500098|NCT01273597|65573264|FG000|Overall Study|Underwent Kidney Transplantation|2|||
23500099|NCT01273597|65573264|FG000|Overall Study|Reason Not Reported|1|||
23500100|NCT01281865|65573265|FG000|Overall Study|Adverse Event|1|||
23500101|NCT01281865|65573266|FG001|Overall Study|Adverse Event|1|||
23500102|NCT01281865|65573265|FG000|Overall Study|Withdrawal by Subject|1|||
23500103|NCT01281865|65573266|FG001|Overall Study|Withdrawal by Subject|0|||
23500104|NCT01281865|65573265|FG000|Overall Study|Lack of Efficacy|1|||
23500105|NCT01281865|65573266|FG001|Overall Study|Lack of Efficacy|0|||
23500106|NCT00259649|65573267|FG000|Overall Study|Lost to Follow-up|7|||
23500107|NCT00259649|65573267|FG000|Overall Study|irregular menses|3|||
23500108|NCT03602482|65573269|FG000|Overall Study|Withdrawal by Subject|6|||
23500109|NCT03602482|65573270|FG001|Overall Study|Withdrawal by Subject|7|||
23500110|NCT03602482|65573271|FG002|Overall Study|Withdrawal by Subject|0|||
23500111|NCT03602482|65573272|FG003|Overall Study|Withdrawal by Subject|0|||
23500112|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
23500113|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
23500114|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
23500115|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Other|2|||
23500116|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Other|0|||
23500117|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Other|0|||
23500118|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Death|1|||
23500119|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Death|0|||
23500120|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Death|0|||
23500121|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
23500122|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
23500123|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
23500124|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Death|3|||
23500125|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Death|2|||
23500126|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Death|4|||
23500127|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
23500128|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
23500129|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
23500130|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
23500131|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
23500132|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
23500133|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Other|5|||
23500134|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Other|4|||
23500135|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Other|2|||
23500136|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
23500137|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
23500138|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
23500139|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
23500140|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
23500141|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
23500142|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
23500143|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
23500144|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
23500145|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
23500146|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
23500147|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
23500148|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Death|3|||
23500149|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Death|0|||
23500150|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Death|0|||
23500151|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
23500152|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
23500153|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
23500154|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Other|2|||
23500155|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Other|0|||
23500156|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Other|1|||
23500157|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
23500158|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
23500159|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
23500160|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
23500161|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
23500162|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
23500163|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Death|0|||
23500164|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Death|2|||
23500165|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Death|1|||
23500166|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
23500167|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
23500168|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
23500169|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
23500170|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
23500171|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
23500172|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
23500173|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
23500174|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
23500175|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Other|0|||
23500176|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Other|1|||
23500177|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Other|1|||
23500178|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
23500179|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
23500180|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
23500181|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
23500182|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
23500183|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
23500184|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
23500185|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
23500186|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
23500187|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
23500188|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
23500189|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
23500190|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
23500191|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
23500192|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
23500193|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
23500194|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
23500195|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
23500196|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
23500197|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
23500198|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
23500199|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
23500200|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
23500201|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
23500202|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
23500203|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
23500204|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
23500205|NCT04523220|65573279|FG000|Main Treatment Period|Physician Decision|1|||
23500206|NCT04523220|65573280|FG001|Main Treatment Period|Physician Decision|1|||
23500207|NCT04523220|65573281|FG002|Main Treatment Period|Physician Decision|0|||
23500208|NCT04523220|65573279|FG000|Main Treatment Period|Other|5|||
23500209|NCT04523220|65573280|FG001|Main Treatment Period|Other|2|||
23500210|NCT04523220|65573281|FG002|Main Treatment Period|Other|4|||
23500211|NCT04523220|65573279|FG000|Main Treatment Period|Subject Decision|5|||
23500212|NCT04523220|65573280|FG001|Main Treatment Period|Subject Decision|7|||
23500213|NCT04523220|65573281|FG002|Main Treatment Period|Subject Decision|3|||
23500214|NCT04523220|65573279|FG000|Main Treatment Period|Death|5|||
23500215|NCT04523220|65573280|FG001|Main Treatment Period|Death|11|||
23500216|NCT04523220|65573281|FG002|Main Treatment Period|Death|4|||
23500217|NCT04523220|65573279|FG000|Main Treatment Period|Adverse Event|11|||
23500218|NCT04523220|65573280|FG001|Main Treatment Period|Adverse Event|9|||
23500219|NCT04523220|65573281|FG002|Main Treatment Period|Adverse Event|9|||
23500220|NCT04523220|65573279|FG000|Main Treatment Period|Withdrawal by Subject|3|||
23500221|NCT04523220|65573280|FG001|Main Treatment Period|Withdrawal by Subject|3|||
23500222|NCT04523220|65573281|FG002|Main Treatment Period|Withdrawal by Subject|4|||
23500223|NCT04523220|65573279|FG000|Main Treatment Period|Study drug never adminstered|10|||
23500224|NCT04523220|65573280|FG001|Main Treatment Period|Study drug never adminstered|3|||
23500225|NCT04523220|65573281|FG002|Main Treatment Period|Study drug never adminstered|5|||
23500226|NCT04523220|65573279|FG000|Extension Treatment Period|Physician Decision|1|||
23500227|NCT04523220|65573280|FG001|Extension Treatment Period|Physician Decision|0|||
23500228|NCT04523220|65573281|FG002|Extension Treatment Period|Physician Decision|3|||
23500229|NCT04523220|65573279|FG000|Extension Treatment Period|Other|2|||
23500230|NCT04523220|65573280|FG001|Extension Treatment Period|Other|6|||
23500231|NCT04523220|65573281|FG002|Extension Treatment Period|Other|6|||
23500232|NCT04523220|65573279|FG000|Extension Treatment Period|Subject Decision|5|||
23500233|NCT04523220|65573280|FG001|Extension Treatment Period|Subject Decision|2|||
23500234|NCT04523220|65573281|FG002|Extension Treatment Period|Subject Decision|4|||
23500235|NCT04523220|65573279|FG000|Extension Treatment Period|Death|6|||
23500236|NCT04523220|65573280|FG001|Extension Treatment Period|Death|4|||
23500237|NCT04523220|65573281|FG002|Extension Treatment Period|Death|7|||
23500238|NCT04523220|65573279|FG000|Extension Treatment Period|Adverse Event|6|||
23500239|NCT04523220|65573280|FG001|Extension Treatment Period|Adverse Event|7|||
23500240|NCT04523220|65573281|FG002|Extension Treatment Period|Adverse Event|9|||
23500241|NCT04523220|65573279|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23500242|NCT04523220|65573280|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
23500243|NCT04523220|65573281|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
23500244|NCT04523220|65573279|FG000|Extension Treatment Period|Study drug never administered|0|||
23500245|NCT04523220|65573280|FG001|Extension Treatment Period|Study drug never administered|1|||
23500246|NCT04523220|65573281|FG002|Extension Treatment Period|Study drug never administered|0|||
23500247|NCT01876420|65573282|FG000|Overall Study|Missed 30 day visit|1|||
23500248|NCT00114530|65573285|FG000|Overall Study|Death|3|||
23500249|NCT00114530|65573286|FG001|Overall Study|Death|11|||
23500250|NCT00114530|65573285|FG000|Overall Study|Lost to Follow-up|1|||
23500251|NCT00114530|65573286|FG001|Overall Study|Lost to Follow-up|1|||
23500252|NCT00114530|65573285|FG000|Overall Study|Physician Decision|1|||
23500253|NCT00114530|65573286|FG001|Overall Study|Physician Decision|1|||
23500254|NCT00114530|65573285|FG000|Overall Study|Withdrawal by Subject|2|||
23500255|NCT00114530|65573286|FG001|Overall Study|Withdrawal by Subject|6|||
23500256|NCT00114530|65573285|FG000|Overall Study|Breast Cancer|1|||
23500257|NCT00114530|65573286|FG001|Overall Study|Breast Cancer|0|||
23500258|NCT00114530|65573285|FG000|Overall Study|Subject decision after endpoint failure|0|||
23500259|NCT00114530|65573286|FG001|Overall Study|Subject decision after endpoint failure|1|||
23500260|NCT00114530|65573285|FG000|Overall Study|Ineligible|1|||
23500261|NCT00114530|65573286|FG001|Overall Study|Ineligible|0|||
23500262|NCT01392443|65573287|FG000|Overall Study|Disease progression|30|||
23500263|NCT01392443|65573287|FG000|Overall Study|Adverse Event|24|||
23500264|NCT01392443|65573287|FG000|Overall Study|Death|7|||
23500265|NCT01392443|65573287|FG000|Overall Study|Withdrawal by Subject|5|||
23500266|NCT01392443|65573287|FG000|Overall Study|Lost to Follow-up|1|||
23500267|NCT01392443|65573287|FG000|Overall Study|Protocol Violation|1|||
23500268|NCT03298867|65573288|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
23500269|NCT03298867|65573289|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
23500270|NCT03298867|65573288|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
23500271|NCT03298867|65573289|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
23500272|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
23500273|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
23500274|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
23500275|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
23500276|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
23500277|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
23500278|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
23500279|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
23500280|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
23500281|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
23500282|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
23500283|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
23500284|NCT03298867|65573288|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
23500285|NCT03298867|65573289|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
23500286|NCT02795832|65573290|FG000|Overall Study|Adverse Event|0|||
23500287|NCT02795832|65573291|FG001|Overall Study|Adverse Event|0|||
23500288|NCT02795832|65573292|FG002|Overall Study|Adverse Event|0|||
23500289|NCT02795832|65573293|FG003|Overall Study|Adverse Event|0|||
23500290|NCT02795832|65573294|FG004|Overall Study|Adverse Event|0|||
23500291|NCT02795832|65573295|FG005|Overall Study|Adverse Event|3|||
23500292|NCT01133522|65573298|FG000|Overall Study|Withdrawal by Subject|0|||
23500293|NCT01133522|65573299|FG001|Overall Study|Withdrawal by Subject|1|||
23500294|NCT01133522|65573300|FG002|Overall Study|Withdrawal by Subject|0|||
23500295|NCT01133522|65573301|FG003|Overall Study|Withdrawal by Subject|1|||
23500296|NCT01133522|65573302|FG004|Overall Study|Withdrawal by Subject|0|||
23500297|NCT01133522|65573303|FG005|Overall Study|Withdrawal by Subject|0|||
23500298|NCT01133522|65573304|FG006|Overall Study|Withdrawal by Subject|0|||
23500299|NCT01133522|65573305|FG007|Overall Study|Withdrawal by Subject|0|||
23500300|NCT01133522|65573306|FG008|Overall Study|Withdrawal by Subject|0|||
23500301|NCT01133522|65573307|FG009|Overall Study|Withdrawal by Subject|0|||
23500302|NCT01133522|65573298|FG000|Overall Study|Physician Decision|0|||
23500303|NCT01133522|65573299|FG001|Overall Study|Physician Decision|0|||
23500304|NCT01133522|65573300|FG002|Overall Study|Physician Decision|0|||
23500305|NCT01133522|65573301|FG003|Overall Study|Physician Decision|0|||
23500306|NCT01133522|65573302|FG004|Overall Study|Physician Decision|1|||
23500307|NCT01133522|65573303|FG005|Overall Study|Physician Decision|0|||
23500308|NCT01133522|65573304|FG006|Overall Study|Physician Decision|0|||
23500309|NCT01133522|65573305|FG007|Overall Study|Physician Decision|0|||
23500310|NCT01133522|65573306|FG008|Overall Study|Physician Decision|0|||
23500311|NCT01133522|65573307|FG009|Overall Study|Physician Decision|0|||
23500312|NCT03478930|65573314|FG000|Overall Study|Adverse Event|0|||
23500313|NCT03478930|65573315|FG001|Overall Study|Adverse Event|1|||
23699891|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23500314|NCT03478930|65573314|FG000|Overall Study|Lack of Efficacy|3|||
23500315|NCT03478930|65573315|FG001|Overall Study|Lack of Efficacy|3|||
23699892|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23500316|NCT03478930|65573314|FG000|Overall Study|Withdrawal by Subject|6|||
23500317|NCT03478930|65573315|FG001|Overall Study|Withdrawal by Subject|5|||
23500318|NCT00672646|65573316|FG000|Overall Study|Lost to Follow-up|0|||
23500319|NCT00672646|65573317|FG001|Overall Study|Lost to Follow-up|1|||
23500320|NCT00672646|65573318|FG002|Overall Study|Lost to Follow-up|2|||
23500321|NCT00672646|65573316|FG000|Overall Study|Withdrawal by Subject|0|||
23500322|NCT00672646|65573317|FG001|Overall Study|Withdrawal by Subject|0|||
23500323|NCT00672646|65573318|FG002|Overall Study|Withdrawal by Subject|1|||
23500324|NCT00814164|65573319|FG000|Overall Study|Progression|7|||
23500325|NCT00814164|65573319|FG000|Overall Study|not stated|7|||
23500326|NCT00814164|65573319|FG000|Overall Study|Death|5|||
23500327|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
23500328|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500329|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
23500330|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500331|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500332|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500333|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500334|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500335|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500336|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
23500337|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
23500338|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
23500339|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500340|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500341|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500342|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500343|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500344|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500345|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500346|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
23500347|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500348|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500349|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500350|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500351|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500352|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500353|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500354|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
23500355|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500356|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500357|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500358|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500359|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500360|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500361|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500362|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500363|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500364|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
23500365|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
23500366|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
23500367|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
23500368|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
23500369|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500370|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500371|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500372|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500373|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500374|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
23500375|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500376|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500377|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500378|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500379|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500380|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500381|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500382|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
23500383|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
23500384|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
23500385|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
23500386|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
23500387|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500388|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500389|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500390|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500391|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500392|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500393|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500394|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500395|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500396|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500397|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500398|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500399|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500400|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500401|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500402|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500403|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500404|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500405|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
23500406|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500407|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500408|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500409|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500410|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500411|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
23500412|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500413|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500414|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
23500415|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500416|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500417|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
23500418|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
23500419|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
23500420|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
23500421|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
23500422|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
23500423|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
23500424|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
23500425|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
23500426|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500427|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500428|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500429|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500430|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500431|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500432|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500433|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
23500434|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
23500435|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500436|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500437|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500438|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500439|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500440|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500441|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500442|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
23500443|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
23500444|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500445|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500446|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500447|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500448|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500449|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500450|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500451|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
23500452|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500453|NCT02985957|65573330|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500454|NCT02985957|65573331|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500455|NCT02985957|65573332|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500456|NCT02985957|65573333|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500457|NCT02985957|65573334|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23500458|NCT02985957|65573335|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500459|NCT02985957|65573336|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500460|NCT02985957|65573330|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23500461|NCT02985957|65573331|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23500462|NCT02985957|65573332|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
23500463|NCT02985957|65573333|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
23500464|NCT02985957|65573334|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
23500465|NCT02985957|65573335|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
23500466|NCT02985957|65573336|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
23500467|NCT02985957|65573330|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500468|NCT02985957|65573331|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500469|NCT02985957|65573332|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500470|NCT02985957|65573333|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500471|NCT02985957|65573334|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500472|NCT02985957|65573335|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500473|NCT02985957|65573336|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23500474|NCT02985957|65573330|FG000|Treatment Period|Death|0|||
23500475|NCT02985957|65573331|FG001|Treatment Period|Death|0|||
23500476|NCT02985957|65573332|FG002|Treatment Period|Death|0|||
23500477|NCT02985957|65573333|FG003|Treatment Period|Death|0|||
23500478|NCT02985957|65573334|FG004|Treatment Period|Death|1|||
23500479|NCT02985957|65573335|FG005|Treatment Period|Death|0|||
23500480|NCT02985957|65573336|FG006|Treatment Period|Death|0|||
23500481|NCT02985957|65573330|FG000|Treatment Period|Participant withdrew consent|0|||
23500482|NCT02985957|65573331|FG001|Treatment Period|Participant withdrew consent|0|||
23500483|NCT02985957|65573332|FG002|Treatment Period|Participant withdrew consent|0|||
23500484|NCT02985957|65573333|FG003|Treatment Period|Participant withdrew consent|1|||
23500485|NCT02985957|65573334|FG004|Treatment Period|Participant withdrew consent|3|||
23500486|NCT02985957|65573335|FG005|Treatment Period|Participant withdrew consent|0|||
23500487|NCT02985957|65573336|FG006|Treatment Period|Participant withdrew consent|1|||
23500488|NCT02985957|65573330|FG000|Treatment Period|Lost to Follow-up|0|||
23500489|NCT02985957|65573331|FG001|Treatment Period|Lost to Follow-up|0|||
23500490|NCT02985957|65573332|FG002|Treatment Period|Lost to Follow-up|0|||
23500491|NCT02985957|65573333|FG003|Treatment Period|Lost to Follow-up|0|||
23500492|NCT02985957|65573334|FG004|Treatment Period|Lost to Follow-up|1|||
23500493|NCT02985957|65573335|FG005|Treatment Period|Lost to Follow-up|0|||
23500494|NCT02985957|65573336|FG006|Treatment Period|Lost to Follow-up|0|||
23500495|NCT02985957|65573330|FG000|Treatment Period|Other reasons|0|||
23500496|NCT02985957|65573331|FG001|Treatment Period|Other reasons|0|||
23500497|NCT02985957|65573332|FG002|Treatment Period|Other reasons|1|||
23500498|NCT02985957|65573333|FG003|Treatment Period|Other reasons|3|||
23500499|NCT02985957|65573334|FG004|Treatment Period|Other reasons|6|||
23500500|NCT02985957|65573335|FG005|Treatment Period|Other reasons|0|||
23500501|NCT02985957|65573336|FG006|Treatment Period|Other reasons|1|||
23500502|NCT02985957|65573330|FG000|Treatment Period|Not reported|0|||
23500503|NCT02985957|65573331|FG001|Treatment Period|Not reported|1|||
23500504|NCT02985957|65573332|FG002|Treatment Period|Not reported|2|||
23500505|NCT02985957|65573333|FG003|Treatment Period|Not reported|5|||
23500506|NCT02985957|65573334|FG004|Treatment Period|Not reported|0|||
23500507|NCT02985957|65573335|FG005|Treatment Period|Not reported|0|||
23500508|NCT02985957|65573336|FG006|Treatment Period|Not reported|0|||
23500509|NCT02985957|65573330|FG000|Treatment Period|Maximum clinical benefit|0|||
23500510|NCT02985957|65573331|FG001|Treatment Period|Maximum clinical benefit|0|||
23500511|NCT02985957|65573332|FG002|Treatment Period|Maximum clinical benefit|1|||
23500512|NCT02985957|65573333|FG003|Treatment Period|Maximum clinical benefit|1|||
23500513|NCT02985957|65573334|FG004|Treatment Period|Maximum clinical benefit|0|||
23500514|NCT02985957|65573335|FG005|Treatment Period|Maximum clinical benefit|0|||
23500515|NCT02985957|65573336|FG006|Treatment Period|Maximum clinical benefit|2|||
23500516|NCT02985957|65573330|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
23500517|NCT02985957|65573331|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
23500518|NCT02985957|65573332|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
23500519|NCT02985957|65573333|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
23500520|NCT02985957|65573334|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
23500521|NCT02985957|65573335|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
23500522|NCT02985957|65573336|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
23500523|NCT02985957|65573330|FG000|Treatment Period|Study drug toxicity|1|||
23500524|NCT02985957|65573331|FG001|Treatment Period|Study drug toxicity|23|||
23500525|NCT02985957|65573332|FG002|Treatment Period|Study drug toxicity|20|||
23500526|NCT02985957|65573333|FG003|Treatment Period|Study drug toxicity|11|||
23500527|NCT02985957|65573334|FG004|Treatment Period|Study drug toxicity|19|||
23500528|NCT02985957|65573335|FG005|Treatment Period|Study drug toxicity|3|||
23500529|NCT02985957|65573336|FG006|Treatment Period|Study drug toxicity|5|||
23500530|NCT02985957|65573330|FG000|Treatment Period|Disease progression|0|||
23500531|NCT02985957|65573331|FG001|Treatment Period|Disease progression|16|||
23500532|NCT02985957|65573332|FG002|Treatment Period|Disease progression|20|||
23500533|NCT02985957|65573333|FG003|Treatment Period|Disease progression|39|||
23500534|NCT02985957|65573334|FG004|Treatment Period|Disease progression|29|||
23500535|NCT02985957|65573335|FG005|Treatment Period|Disease progression|11|||
23500536|NCT02985957|65573336|FG006|Treatment Period|Disease progression|28|||
23500537|NCT02985957|65573330|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
23500538|NCT02985957|65573331|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
23500539|NCT02985957|65573332|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
23500540|NCT02985957|65573333|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
23500541|NCT02985957|65573334|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
23500542|NCT02985957|65573335|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
23500543|NCT02985957|65573336|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
23500544|NCT02985957|65573330|FG000|Treatment Period|Poor/Non-Compliance|0|||
23500545|NCT02985957|65573331|FG001|Treatment Period|Poor/Non-Compliance|0|||
23500546|NCT02985957|65573332|FG002|Treatment Period|Poor/Non-Compliance|0|||
23500547|NCT02985957|65573333|FG003|Treatment Period|Poor/Non-Compliance|0|||
23500548|NCT02985957|65573334|FG004|Treatment Period|Poor/Non-Compliance|1|||
23500549|NCT02985957|65573335|FG005|Treatment Period|Poor/Non-Compliance|1|||
23500550|NCT02985957|65573336|FG006|Treatment Period|Poor/Non-Compliance|0|||
23500551|NCT02985957|65573330|FG000|Treatment Period|Continuing in Treatment Period|0|||
23500552|NCT02985957|65573331|FG001|Treatment Period|Continuing in Treatment Period|1|||
23500553|NCT02985957|65573332|FG002|Treatment Period|Continuing in Treatment Period|0|||
23500554|NCT02985957|65573333|FG003|Treatment Period|Continuing in Treatment Period|4|||
23500555|NCT02985957|65573334|FG004|Treatment Period|Continuing in Treatment Period|4|||
23500556|NCT02985957|65573335|FG005|Treatment Period|Continuing in Treatment Period|0|||
23500557|NCT02985957|65573336|FG006|Treatment Period|Continuing in Treatment Period|0|||
23500558|NCT01318993|65573338|FG000|Overall Study|Adverse Event|53|||
23500559|NCT01318993|65573338|FG000|Overall Study|Lack of Efficacy|121|||
23500560|NCT01318993|65573338|FG000|Overall Study|Protocol Violation|3|||
23500561|NCT01318993|65573338|FG000|Overall Study|Protocol based stopping criteria|6|||
23500562|NCT01318993|65573338|FG000|Overall Study|Study closed or terminated|174|||
23500563|NCT01318993|65573338|FG000|Overall Study|Lost to Follow-up|4|||
23500564|NCT01318993|65573338|FG000|Overall Study|Physician Decision|13|||
23500565|NCT01318993|65573338|FG000|Overall Study|Withdrawal by Subject|24|||
23500566|NCT02747875|65573339|FG000|Overall Study|Physician Decision|1|||
23500567|NCT02747875|65573340|FG001|Overall Study|Physician Decision|0|||
23500568|NCT02747875|65573339|FG000|Overall Study|Adverse Event|0|||
23500569|NCT02747875|65573340|FG001|Overall Study|Adverse Event|1|||
23500570|NCT01606800|65573343|FG000|Overall Study|Adverse Event|3|||
23500571|NCT01606800|65573344|FG001|Overall Study|Adverse Event|1|||
23500572|NCT01606800|65573343|FG000|Overall Study|Participant withdrew consent|0|||
23500573|NCT01606800|65573344|FG001|Overall Study|Participant withdrew consent|1|||
23500574|NCT01606800|65573343|FG000|Overall Study|Missing completion status|2|||
23500575|NCT01606800|65573344|FG001|Overall Study|Missing completion status|0|||
23500576|NCT00679432|65573345|FG000|Overall Study|Adverse Event|5|||
23500577|NCT00679432|65573346|FG001|Overall Study|Adverse Event|6|||
23500578|NCT00679432|65573347|FG002|Overall Study|Adverse Event|10|||
23500579|NCT00679432|65573348|FG003|Overall Study|Adverse Event|7|||
23500580|NCT00679432|65573345|FG000|Overall Study|Protocol Violation|1|||
23500581|NCT00679432|65573346|FG001|Overall Study|Protocol Violation|1|||
23500582|NCT00679432|65573347|FG002|Overall Study|Protocol Violation|2|||
23500583|NCT00679432|65573348|FG003|Overall Study|Protocol Violation|1|||
23500584|NCT00679432|65573345|FG000|Overall Study|Withdrawal by Subject|8|||
23500585|NCT00679432|65573346|FG001|Overall Study|Withdrawal by Subject|11|||
23500586|NCT00679432|65573347|FG002|Overall Study|Withdrawal by Subject|10|||
23500587|NCT00679432|65573348|FG003|Overall Study|Withdrawal by Subject|9|||
23500588|NCT00679432|65573345|FG000|Overall Study|Lost to Follow-up|1|||
23500589|NCT00679432|65573346|FG001|Overall Study|Lost to Follow-up|5|||
23500590|NCT00679432|65573347|FG002|Overall Study|Lost to Follow-up|4|||
23500591|NCT00679432|65573348|FG003|Overall Study|Lost to Follow-up|2|||
23500592|NCT00679432|65573345|FG000|Overall Study|Physician Decision|3|||
23500593|NCT00679432|65573346|FG001|Overall Study|Physician Decision|2|||
23500594|NCT00679432|65573347|FG002|Overall Study|Physician Decision|2|||
23500595|NCT00679432|65573348|FG003|Overall Study|Physician Decision|2|||
23500596|NCT00679432|65573345|FG000|Overall Study|Sponsor decision|1|||
23500597|NCT00679432|65573346|FG001|Overall Study|Sponsor decision|0|||
23500598|NCT00679432|65573347|FG002|Overall Study|Sponsor decision|0|||
23500599|NCT00679432|65573348|FG003|Overall Study|Sponsor decision|0|||
23500600|NCT00679432|65573345|FG000|Overall Study|Lack of Efficacy|13|||
23500601|NCT00679432|65573346|FG001|Overall Study|Lack of Efficacy|9|||
23500602|NCT00679432|65573347|FG002|Overall Study|Lack of Efficacy|14|||
23500603|NCT00679432|65573348|FG003|Overall Study|Lack of Efficacy|8|||
23500604|NCT00679432|65573345|FG000|Overall Study|Infectious colitis, normal histology|5|||
23500605|NCT00679432|65573346|FG001|Overall Study|Infectious colitis, normal histology|4|||
23500606|NCT00679432|65573347|FG002|Overall Study|Infectious colitis, normal histology|8|||
23500607|NCT00679432|65573348|FG003|Overall Study|Infectious colitis, normal histology|3|||
23500608|NCT00679432|65573345|FG000|Overall Study|Randomization error, return to prior Rx|0|||
23398697|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Adverse Event|2|||
23500609|NCT00679432|65573346|FG001|Overall Study|Randomization error, return to prior Rx|0|||
23500610|NCT00679432|65573347|FG002|Overall Study|Randomization error, return to prior Rx|3|||
23500611|NCT00679432|65573348|FG003|Overall Study|Randomization error, return to prior Rx|0|||
23500612|NCT02742441|65573349|FG000|Overall Study|Lost to Follow-up|4|||
23500613|NCT02742441|65573350|FG001|Overall Study|Lost to Follow-up|4|||
23500614|NCT02742441|65573349|FG000|Overall Study|Withdrawal by Subject|2|||
23500615|NCT02742441|65573350|FG001|Overall Study|Withdrawal by Subject|2|||
23500616|NCT02742441|65573349|FG000|Overall Study|Adverse Event|0|||
23500617|NCT02742441|65573350|FG001|Overall Study|Adverse Event|2|||
23500618|NCT04094883|65573353|FG000|Overall Study|Withdrawal by Subject|1|||
23500619|NCT00705484|65573360|FG000|Overall Study|Adverse Event|28|||
23500620|NCT00705484|65573361|FG001|Overall Study|Adverse Event|27|||
23500621|NCT00705484|65573360|FG000|Overall Study|Lost to Follow-up|169|||
23500622|NCT00705484|65573361|FG001|Overall Study|Lost to Follow-up|250|||
23500623|NCT00705484|65573360|FG000|Overall Study|Withdrawal by Subject|96|||
23500624|NCT00705484|65573361|FG001|Overall Study|Withdrawal by Subject|72|||
23500625|NCT00705484|65573360|FG000|Overall Study|Administrative|89|||
23500626|NCT00705484|65573361|FG001|Overall Study|Administrative|59|||
23500627|NCT00401531|65573363|FG000|Overall Study|Adverse Event|2|||
23500628|NCT00401531|65573364|FG001|Overall Study|Adverse Event|0|||
23500629|NCT00401531|65573363|FG000|Overall Study|Protocol Violation|3|||
23500630|NCT00401531|65573364|FG001|Overall Study|Protocol Violation|7|||
23500631|NCT00401531|65573363|FG000|Overall Study|Lost to Follow-up|1|||
23500632|NCT00401531|65573364|FG001|Overall Study|Lost to Follow-up|1|||
23500633|NCT00401531|65573363|FG000|Overall Study|Withdrawal by Subject|3|||
23500634|NCT00401531|65573364|FG001|Overall Study|Withdrawal by Subject|2|||
23500635|NCT00996307|65573365|FG000|Overall Study|Adverse Event|0|||
23500636|NCT00996307|65573366|FG001|Overall Study|Adverse Event|1|||
23500637|NCT00996307|65573367|FG002|Overall Study|Adverse Event|0|||
23500638|NCT00996307|65573368|FG003|Overall Study|Adverse Event|0|||
23500639|NCT00996307|65573365|FG000|Overall Study|Withdrawal by Subject|3|||
23500640|NCT00996307|65573366|FG001|Overall Study|Withdrawal by Subject|2|||
23500641|NCT00996307|65573367|FG002|Overall Study|Withdrawal by Subject|5|||
23500642|NCT00996307|65573368|FG003|Overall Study|Withdrawal by Subject|5|||
23500643|NCT00996307|65573365|FG000|Overall Study|Lost to Follow-up|13|||
23500644|NCT00996307|65573366|FG001|Overall Study|Lost to Follow-up|13|||
23500645|NCT00996307|65573367|FG002|Overall Study|Lost to Follow-up|7|||
23500646|NCT00996307|65573368|FG003|Overall Study|Lost to Follow-up|15|||
23500647|NCT00996307|65573365|FG000|Overall Study|Administrative reason|0|||
23500648|NCT00996307|65573366|FG001|Overall Study|Administrative reason|1|||
23500649|NCT00996307|65573367|FG002|Overall Study|Administrative reason|0|||
23500650|NCT00996307|65573368|FG003|Overall Study|Administrative reason|0|||
23699893|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
23699894|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23398698|NCT00786422|65207137|FG000|Follow-up Period|Death|1|||
23398699|NCT00786422|65207137|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
23398700|NCT03639610|65207141|FG000|Overall Study|Adverse Event|7|||
23398701|NCT03639610|65207142|FG001|Overall Study|Adverse Event|1|||
23398702|NCT03639610|65207143|FG002|Overall Study|Adverse Event|0|||
23398703|NCT03639610|65207141|FG000|Overall Study|Physician Decision|3|||
23398704|NCT03639610|65207142|FG001|Overall Study|Physician Decision|1|||
23398705|NCT03639610|65207143|FG002|Overall Study|Physician Decision|0|||
23398706|NCT03639610|65207141|FG000|Overall Study|Disease progression|8|||
23398707|NCT03639610|65207142|FG001|Overall Study|Disease progression|5|||
23398708|NCT03639610|65207143|FG002|Overall Study|Disease progression|3|||
23398709|NCT03639610|65207141|FG000|Overall Study|Study terminated by sponsor|2|||
23398710|NCT03639610|65207142|FG001|Overall Study|Study terminated by sponsor|1|||
23398711|NCT03639610|65207143|FG002|Overall Study|Study terminated by sponsor|1|||
23398712|NCT03639610|65207141|FG000|Overall Study|Patient request to stop treatment|1|||
23398713|NCT03639610|65207142|FG001|Overall Study|Patient request to stop treatment|2|||
23398714|NCT03639610|65207143|FG002|Overall Study|Patient request to stop treatment|0|||
23398715|NCT01215851|65207144|FG000|Treatment Period|Adverse Event|1|||
23398716|NCT01215851|65207145|FG001|Treatment Period|Adverse Event|1|||
23398717|NCT01215851|65207146|FG002|Treatment Period|Adverse Event|1|||
23398718|NCT01215851|65207147|FG003|Treatment Period|Adverse Event|3|||
23398719|NCT01215851|65207148|FG004|Treatment Period|Adverse Event|0|||
23398720|NCT01215851|65207149|FG005|Treatment Period|Adverse Event|1|||
23398721|NCT01215851|65207144|FG000|Follow up Period|Lost to Follow-up|0|||
23398722|NCT01215851|65207145|FG001|Follow up Period|Lost to Follow-up|0|||
23500651|NCT00996307|65573365|FG000|Overall Study|Unable to classify|4|||
23500652|NCT00996307|65573366|FG001|Overall Study|Unable to classify|0|||
23500653|NCT00996307|65573367|FG002|Overall Study|Unable to classify|2|||
23500654|NCT00996307|65573368|FG003|Overall Study|Unable to classify|1|||
23500655|NCT00453063|65573371|FG000|Overall Study|Adverse Event|1|||
23500656|NCT00453063|65573372|FG001|Overall Study|Adverse Event|2|||
23500657|NCT00453063|65573371|FG000|Overall Study|Withdrawal by Subject|1|||
23500658|NCT00453063|65573372|FG001|Overall Study|Withdrawal by Subject|1|||
23500659|NCT00453063|65573371|FG000|Overall Study|Protocol Violation|1|||
23500660|NCT00453063|65573372|FG001|Overall Study|Protocol Violation|0|||
23500661|NCT00443261|65573373|FG000|Overall Study|Death|1|||
23500662|NCT02590003|65573385|FG000|Overall Study|Death|1|||
23500663|NCT02590003|65573386|FG001|Overall Study|Death|2|||
23500664|NCT01064310|65573387|FG000|Period 1|Adverse Event|7|||
23500665|NCT01064310|65573388|FG001|Period 1|Adverse Event|10|||
23500666|NCT01064310|65573389|FG002|Period 1|Adverse Event|0|||
23500667|NCT01064310|65573387|FG000|Period 1|Physician Decision|1|||
23500668|NCT01064310|65573388|FG001|Period 1|Physician Decision|0|||
23500669|NCT01064310|65573389|FG002|Period 1|Physician Decision|0|||
23500670|NCT01064310|65573387|FG000|Period 1|Withdrawal by Subject|2|||
23500671|NCT01064310|65573388|FG001|Period 1|Withdrawal by Subject|2|||
23500672|NCT01064310|65573389|FG002|Period 1|Withdrawal by Subject|0|||
23500673|NCT01064310|65573387|FG000|Period 1|Lack of Efficacy|3|||
23500674|NCT01064310|65573388|FG001|Period 1|Lack of Efficacy|5|||
23500675|NCT01064310|65573389|FG002|Period 1|Lack of Efficacy|0|||
23500676|NCT01064310|65573387|FG000|Period 1|Entered Open-label Period|1|||
23500677|NCT01064310|65573388|FG001|Period 1|Entered Open-label Period|1|||
23500678|NCT01064310|65573389|FG002|Period 1|Entered Open-label Period|0|||
23500679|NCT01064310|65573387|FG000|Period 2|Adverse Event|2|||
23500680|NCT01064310|65573388|FG001|Period 2|Adverse Event|1|||
23500681|NCT01064310|65573389|FG002|Period 2|Adverse Event|0|||
23500682|NCT01064310|65573387|FG000|Period 2|Physician Decision|0|||
23500683|NCT01064310|65573388|FG001|Period 2|Physician Decision|1|||
23500684|NCT01064310|65573389|FG002|Period 2|Physician Decision|0|||
23500685|NCT01064310|65573387|FG000|Period 2|Entered Open-label Period|1|||
23500686|NCT01064310|65573388|FG001|Period 2|Entered Open-label Period|0|||
23500687|NCT01064310|65573389|FG002|Period 2|Entered Open-label Period|0|||
23500688|NCT01064310|65573387|FG000|Period 2|Lack of Efficacy|1|||
23500689|NCT01064310|65573388|FG001|Period 2|Lack of Efficacy|4|||
23500690|NCT01064310|65573389|FG002|Period 2|Lack of Efficacy|0|||
23500691|NCT01064310|65573387|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
23500692|NCT01064310|65573388|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
23500693|NCT01064310|65573389|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
23500694|NCT01064310|65573387|FG000|Open Label Pazopinib|Adverse Event|0|||
23500695|NCT01064310|65573388|FG001|Open Label Pazopinib|Adverse Event|0|||
23500696|NCT01064310|65573389|FG002|Open Label Pazopinib|Adverse Event|12|||
23500697|NCT01064310|65573387|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
23500698|NCT01064310|65573388|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
23500699|NCT01064310|65573389|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
23500700|NCT01064310|65573387|FG000|Open Label Pazopinib|Physician Decision|0|||
23500701|NCT01064310|65573388|FG001|Open Label Pazopinib|Physician Decision|0|||
23500702|NCT01064310|65573389|FG002|Open Label Pazopinib|Physician Decision|20|||
23500703|NCT02571075|65573399|FG000|Overall Study|Lost to Follow-up|20|||
23500704|NCT02571075|65573400|FG001|Overall Study|Lost to Follow-up|24|||
23500705|NCT04749615|65573405|FG000|Overall Study|Lost to Follow-up|6|||
23500706|NCT04749615|65573406|FG001|Overall Study|Lost to Follow-up|10|||
23500707|NCT04502693|65573407|FG000|Overall Study|Adverse Event|7|||
23500708|NCT04502693|65573408|FG001|Overall Study|Adverse Event|6|||
23500709|NCT04502693|65573409|FG002|Overall Study|Adverse Event|11|||
23500710|NCT04502693|65573410|FG003|Overall Study|Adverse Event|1|||
23500711|NCT04502693|65573407|FG000|Overall Study|Lost to Follow-up|32|||
23500712|NCT04502693|65573408|FG001|Overall Study|Lost to Follow-up|36|||
23500713|NCT04502693|65573409|FG002|Overall Study|Lost to Follow-up|69|||
23500714|NCT04502693|65573410|FG003|Overall Study|Lost to Follow-up|4|||
23500715|NCT04502693|65573407|FG000|Overall Study|Protocol Violation|8|||
23500716|NCT04502693|65573408|FG001|Overall Study|Protocol Violation|8|||
23500717|NCT04502693|65573409|FG002|Overall Study|Protocol Violation|16|||
23500718|NCT04502693|65573410|FG003|Overall Study|Protocol Violation|1|||
23500719|NCT04502693|65573407|FG000|Overall Study|Withdrawal by Subject|46|||
23500720|NCT04502693|65573408|FG001|Overall Study|Withdrawal by Subject|38|||
23500721|NCT04502693|65573409|FG002|Overall Study|Withdrawal by Subject|54|||
23500722|NCT04502693|65573410|FG003|Overall Study|Withdrawal by Subject|7|||
23500723|NCT04502693|65573407|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
23500724|NCT04502693|65573408|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
23500725|NCT04502693|65573409|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
23500726|NCT04502693|65573410|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23500727|NCT04502693|65573407|FG000|Overall Study|Other|1|||
23500728|NCT04502693|65573408|FG001|Overall Study|Other|0|||
23500729|NCT04502693|65573409|FG002|Overall Study|Other|1|||
23500730|NCT04502693|65573410|FG003|Overall Study|Other|1|||
23500731|NCT00538291|65573411|FG000|Overall Study|Adverse Event|2|||
23500732|NCT00538291|65573411|FG000|Overall Study|Withdrawal by Subject|1|||
23500733|NCT04930965|65573412|FG000|Overall Study|Lost to Follow-up|7|||
23500734|NCT04930965|65573413|FG001|Overall Study|Lost to Follow-up|5|||
23500735|NCT02763462|65573414|FG000|Overall Study|Protocol Violation|6|||
23500736|NCT02030041|65573420|FG000|Overall Study|Withdrawal by Subject|2|||
23500737|NCT02030041|65573421|FG001|Overall Study|Withdrawal by Subject|2|||
23500738|NCT02030041|65573422|FG002|Overall Study|Withdrawal by Subject|1|||
23500739|NCT03681405|65573426|FG000|Overall Study|Found to be ineligible after randomized|1|||
23500740|NCT03681405|65573427|FG001|Overall Study|Found to be ineligible after randomized|0|||
23500741|NCT03302234|65573434|FG000|Overall Study|Death|191|||
23500742|NCT03302234|65573435|FG001|Overall Study|Death|192|||
23500743|NCT03302234|65573434|FG000|Overall Study|Withdrawal by Subject|2|||
23500744|NCT03302234|65573435|FG001|Overall Study|Withdrawal by Subject|2|||
23500745|NCT03302234|65573434|FG000|Overall Study|Sponsor Decision|90|||
23500746|NCT03302234|65573435|FG001|Overall Study|Sponsor Decision|89|||
23500747|NCT03302234|65573434|FG000|Overall Study|Laryngeal carcinoma|0|||
23500748|NCT03302234|65573435|FG001|Overall Study|Laryngeal carcinoma|1|||
23500749|NCT03302234|65573434|FG000|Overall Study|Not Reported|1|||
23500750|NCT03302234|65573435|FG001|Overall Study|Not Reported|0|||
23500751|NCT00762385|65573436|FG000|First Intervention|Lens Issue|1|||
23500752|NCT00762385|65573437|FG001|First Intervention|Lens Issue|1|||
23500753|NCT00762385|65573436|FG000|First Intervention|Lost to Follow-up|0|||
23500754|NCT00762385|65573437|FG001|First Intervention|Lost to Follow-up|2|||
23500755|NCT00762385|65573436|FG000|First Intervention|Ineligible|1|||
23500756|NCT00762385|65573437|FG001|First Intervention|Ineligible|0|||
23500757|NCT00762385|65573436|FG000|First Intervention|Protocol Violation|0|||
23500758|NCT00762385|65573437|FG001|First Intervention|Protocol Violation|1|||
23500759|NCT00762385|65573436|FG000|Second Intervention|Protocol Violation|3|||
23500760|NCT00762385|65573437|FG001|Second Intervention|Protocol Violation|3|||
23500761|NCT01364649|65573438|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
23500762|NCT01364649|65573439|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
23500763|NCT01364649|65573438|FG000|Overall Study|Lack of Efficacy|6|||
23500764|NCT01364649|65573439|FG001|Overall Study|Lack of Efficacy|0|||
23500765|NCT01364649|65573438|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
23500766|NCT01364649|65573439|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
23500767|NCT01364649|65573438|FG000|Overall Study|Protocol Deviations|4|||
23500768|NCT01364649|65573439|FG001|Overall Study|Protocol Deviations|8|||
23500769|NCT01364649|65573438|FG000|Overall Study|Withdrawal of Consent|9|||
23500770|NCT01364649|65573439|FG001|Overall Study|Withdrawal of Consent|7|||
23500771|NCT01364649|65573438|FG000|Overall Study|Lost to Follow-up|12|||
23500772|NCT01364649|65573439|FG001|Overall Study|Lost to Follow-up|13|||
23500773|NCT01364649|65573438|FG000|Overall Study|Other|4|||
23500774|NCT01364649|65573439|FG001|Overall Study|Other|1|||
23500775|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
23500776|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
23500777|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500778|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500779|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500780|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500781|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
23500782|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
23500783|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500784|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500785|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500786|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500787|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
23500788|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
23500789|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500790|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500791|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500792|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500793|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
23500794|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
23500795|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500796|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500797|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500798|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500799|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
23500800|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
23500801|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500802|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500803|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23699895|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23699896|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23699897|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23699898|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23699899|NCT01894516|66280511|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23699900|NCT01894516|66280512|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23699901|NCT01894516|66280513|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
23699902|NCT01894516|66280514|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23699903|NCT01894516|66280511|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
23699904|NCT01894516|66280512|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23699905|NCT01894516|66280513|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23699906|NCT01894516|66280514|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23699907|NCT01894516|66280511|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23699908|NCT01894516|66280512|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23699909|NCT01894516|66280513|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
23699910|NCT01894516|66280514|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23699911|NCT04590937|66280520|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
23699912|NCT01963117|66280521|FG000|Overall Study|Death|1|||
23699913|NCT04333433|66280522|FG000|Overall Study|Withdrawal by Subject|6|||
23699914|NCT04333433|66280523|FG001|Overall Study|Withdrawal by Subject|3|||
23699915|NCT04333433|66280522|FG000|Overall Study|Death|3|||
23699916|NCT04333433|66280523|FG001|Overall Study|Death|0|||
23699917|NCT04333433|66280522|FG000|Overall Study|Lost to Follow-up|6|||
23699918|NCT04333433|66280523|FG001|Overall Study|Lost to Follow-up|1|||
23699919|NCT04333433|66280522|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
23699920|NCT04333433|66280523|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
23699921|NCT02702193|66280524|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
23699922|NCT02702193|66280525|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
23699923|NCT02702193|66280524|FG000|4 Month Follow up|Withdrawal by Subject|1|||
23699924|NCT02702193|66280525|FG001|4 Month Follow up|Withdrawal by Subject|0|||
23699925|NCT02702193|66280524|FG000|4 Month Follow up|Lost to Follow-up|17|||
23699926|NCT02702193|66280525|FG001|4 Month Follow up|Lost to Follow-up|18|||
23699927|NCT02702193|66280524|FG000|8 Month Follow up|Withdrawal by Subject|1|||
23699928|NCT02702193|66280525|FG001|8 Month Follow up|Withdrawal by Subject|0|||
23699929|NCT02702193|66280524|FG000|8 Month Follow up|Lost to Follow-up|14|||
23699930|NCT02702193|66280525|FG001|8 Month Follow up|Lost to Follow-up|18|||
23699931|NCT02702193|66280524|FG000|12 Month Follow up|Withdrawal by Subject|1|||
23699932|NCT02702193|66280525|FG001|12 Month Follow up|Withdrawal by Subject|0|||
23699933|NCT02702193|66280524|FG000|12 Month Follow up|Lost to Follow-up|16|||
23699934|NCT02702193|66280525|FG001|12 Month Follow up|Lost to Follow-up|18|||
23699935|NCT01981122|66280526|FG000|Overall Study|Withdrawal by Subject|0|||
23699936|NCT01981122|66280527|FG001|Overall Study|Withdrawal by Subject|2|||
23699937|NCT01981122|66280526|FG000|Overall Study|Protocol Violation|0|||
23699938|NCT01981122|66280527|FG001|Overall Study|Protocol Violation|1|||
23699939|NCT01981122|66280526|FG000|Overall Study|Lost to Follow-up|0|||
23699940|NCT01981122|66280527|FG001|Overall Study|Lost to Follow-up|1|||
23699941|NCT01981122|66280526|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
23699942|NCT01981122|66280527|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
23699943|NCT01981122|66280526|FG000|Overall Study|Death|14|||
23699944|NCT01981122|66280527|FG001|Overall Study|Death|15|||
23699945|NCT00521339|66280533|FG000|Treatment Phase|Adverse Event|2|||
23699946|NCT00521339|66280534|FG001|Treatment Phase|Adverse Event|0|||
23699947|NCT00521339|66280535|FG002|Treatment Phase|Adverse Event|0|||
23699948|NCT00521339|66280533|FG000|Treatment Phase|Intolerability to study drug|2|||
23699949|NCT00521339|66280534|FG001|Treatment Phase|Intolerability to study drug|0|||
23699950|NCT00521339|66280535|FG002|Treatment Phase|Intolerability to study drug|0|||
23699951|NCT00521339|66280533|FG000|Treatment Phase|Lack of Efficacy|3|||
23699952|NCT00521339|66280534|FG001|Treatment Phase|Lack of Efficacy|0|||
23699953|NCT00521339|66280535|FG002|Treatment Phase|Lack of Efficacy|0|||
23699954|NCT00521339|66280533|FG000|Treatment Phase|Withdrawal by Subject|3|||
23699955|NCT00521339|66280534|FG001|Treatment Phase|Withdrawal by Subject|0|||
23699956|NCT00521339|66280535|FG002|Treatment Phase|Withdrawal by Subject|0|||
23699957|NCT00521339|66280533|FG000|Treatment Phase|Lost to Follow-up|1|||
23699958|NCT00521339|66280534|FG001|Treatment Phase|Lost to Follow-up|0|||
23699959|NCT00521339|66280535|FG002|Treatment Phase|Lost to Follow-up|0|||
23699960|NCT00521339|66280533|FG000|Treatment Phase|Protocol Violation|1|||
23699961|NCT00521339|66280534|FG001|Treatment Phase|Protocol Violation|0|||
23699962|NCT00521339|66280535|FG002|Treatment Phase|Protocol Violation|0|||
23699963|NCT00521339|66280533|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
23699964|NCT00521339|66280534|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
23699965|NCT00521339|66280535|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
23500804|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500805|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500806|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
23500807|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500808|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500809|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500810|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500811|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Other|0|||
23500812|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Other|1|||
23500813|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Other|0|||
23500814|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Other|0|||
23500815|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Other|0|||
23500816|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Other|0|||
23500817|NCT00843024|65573440|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
23500818|NCT00843024|65573441|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
23500819|NCT00843024|65573442|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
23500820|NCT00843024|65573443|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
23500821|NCT00843024|65573444|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
23500822|NCT00843024|65573445|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
23500823|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23500824|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23500825|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
23500826|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500827|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500828|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500829|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500830|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500831|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500832|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23500833|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500834|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
23500835|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23500836|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
23500837|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
23500838|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
23500839|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
23500840|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
23500841|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Physician Decision|0|||
23500842|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Physician Decision|0|||
23500843|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Physician Decision|0|||
23500844|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Physician Decision|3|||
23500845|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Physician Decision|1|||
23500846|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Physician Decision|1|||
23500847|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23500848|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23500849|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23500850|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Adverse Event|0|||
23500851|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Adverse Event|1|||
23500852|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Adverse Event|1|||
23500853|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500854|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500855|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500856|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500857|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
23500858|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500859|NCT01081678|65576435|FG000|Overall Study|Ineligibility Determined|0|||
23500860|NCT01081678|65576436|FG001|Overall Study|Ineligibility Determined|0|||
23500861|NCT01081678|65576437|FG002|Overall Study|Ineligibility Determined|1|||
23500862|NCT01081678|65576438|FG003|Overall Study|Ineligibility Determined|1|||
23500863|NCT01081678|65576435|FG000|Overall Study|Noncompliance|3|||
23500864|NCT01081678|65576436|FG001|Overall Study|Noncompliance|4|||
23500865|NCT01081678|65576437|FG002|Overall Study|Noncompliance|5|||
23500866|NCT01081678|65576438|FG003|Overall Study|Noncompliance|2|||
23500867|NCT01081678|65576435|FG000|Overall Study|Adverse Event|2|||
23500868|NCT01081678|65576436|FG001|Overall Study|Adverse Event|1|||
23500869|NCT01081678|65576437|FG002|Overall Study|Adverse Event|2|||
23500870|NCT01081678|65576438|FG003|Overall Study|Adverse Event|2|||
23500871|NCT01081678|65576435|FG000|Overall Study|Withdrawal by Subject|15|||
23500872|NCT01081678|65576436|FG001|Overall Study|Withdrawal by Subject|7|||
23500873|NCT01081678|65576437|FG002|Overall Study|Withdrawal by Subject|17|||
23500874|NCT01081678|65576438|FG003|Overall Study|Withdrawal by Subject|14|||
23500875|NCT01081678|65576435|FG000|Overall Study|Administrative Decision|1|||
23500876|NCT01081678|65576436|FG001|Overall Study|Administrative Decision|0|||
23500877|NCT01081678|65576437|FG002|Overall Study|Administrative Decision|0|||
23500878|NCT01081678|65576438|FG003|Overall Study|Administrative Decision|1|||
23500879|NCT01081678|65576435|FG000|Overall Study|Lost to Follow-up|4|||
23500880|NCT01081678|65576436|FG001|Overall Study|Lost to Follow-up|1|||
23500881|NCT01081678|65576437|FG002|Overall Study|Lost to Follow-up|4|||
23500882|NCT01081678|65576438|FG003|Overall Study|Lost to Follow-up|3|||
23500883|NCT01081678|65576435|FG000|Overall Study|Death|2|||
23500884|NCT01081678|65576436|FG001|Overall Study|Death|2|||
23500885|NCT01081678|65576437|FG002|Overall Study|Death|2|||
23500886|NCT01081678|65576438|FG003|Overall Study|Death|6|||
23500887|NCT01081678|65576435|FG000|Overall Study|Other|0|||
23500888|NCT01081678|65576436|FG001|Overall Study|Other|1|||
23500889|NCT01081678|65576437|FG002|Overall Study|Other|0|||
23500890|NCT01081678|65576438|FG003|Overall Study|Other|0|||
23500891|NCT00939770|65576442|FG000|Overall Study|Adverse Event|1|||
23500892|NCT00939770|65576443|FG001|Overall Study|Adverse Event|1|||
23500893|NCT00939770|65576444|FG002|Overall Study|Adverse Event|0|||
23500894|NCT00939770|65576445|FG003|Overall Study|Adverse Event|0|||
23500895|NCT00939770|65576446|FG004|Overall Study|Adverse Event|6|||
23500896|NCT00939770|65576447|FG005|Overall Study|Adverse Event|2|||
23500897|NCT00939770|65576448|FG006|Overall Study|Adverse Event|1|||
23500898|NCT00939770|65576449|FG007|Overall Study|Adverse Event|1|||
23500899|NCT00939770|65576442|FG000|Overall Study|Lack of Efficacy|4|||
23500900|NCT00939770|65576443|FG001|Overall Study|Lack of Efficacy|6|||
23500901|NCT00939770|65576444|FG002|Overall Study|Lack of Efficacy|13|||
23500902|NCT00939770|65576445|FG003|Overall Study|Lack of Efficacy|9|||
23500903|NCT00939770|65576446|FG004|Overall Study|Lack of Efficacy|16|||
23500904|NCT00939770|65576447|FG005|Overall Study|Lack of Efficacy|8|||
23500905|NCT00939770|65576448|FG006|Overall Study|Lack of Efficacy|11|||
23500906|NCT00939770|65576449|FG007|Overall Study|Lack of Efficacy|1|||
23500907|NCT00939770|65576442|FG000|Overall Study|Lost to Follow-up|0|||
23500908|NCT00939770|65576443|FG001|Overall Study|Lost to Follow-up|0|||
23500909|NCT00939770|65576444|FG002|Overall Study|Lost to Follow-up|0|||
23500910|NCT00939770|65576445|FG003|Overall Study|Lost to Follow-up|0|||
23500911|NCT00939770|65576446|FG004|Overall Study|Lost to Follow-up|1|||
23500912|NCT00939770|65576447|FG005|Overall Study|Lost to Follow-up|0|||
23500913|NCT00939770|65576448|FG006|Overall Study|Lost to Follow-up|0|||
23500914|NCT00939770|65576449|FG007|Overall Study|Lost to Follow-up|0|||
23500915|NCT00939770|65576442|FG000|Overall Study|Physician Decision|0|||
23500916|NCT00939770|65576443|FG001|Overall Study|Physician Decision|0|||
23500917|NCT00939770|65576444|FG002|Overall Study|Physician Decision|2|||
23500918|NCT00939770|65576445|FG003|Overall Study|Physician Decision|0|||
23500919|NCT00939770|65576446|FG004|Overall Study|Physician Decision|7|||
23500920|NCT00939770|65576447|FG005|Overall Study|Physician Decision|1|||
23500921|NCT00939770|65576448|FG006|Overall Study|Physician Decision|0|||
23500922|NCT00939770|65576449|FG007|Overall Study|Physician Decision|6|||
23500923|NCT00939770|65576442|FG000|Overall Study|Protocol Violation|0|||
23500924|NCT00939770|65576443|FG001|Overall Study|Protocol Violation|0|||
23500925|NCT00939770|65576444|FG002|Overall Study|Protocol Violation|0|||
23500926|NCT00939770|65576445|FG003|Overall Study|Protocol Violation|0|||
23500927|NCT00939770|65576446|FG004|Overall Study|Protocol Violation|1|||
23500928|NCT00939770|65576447|FG005|Overall Study|Protocol Violation|0|||
23500929|NCT00939770|65576448|FG006|Overall Study|Protocol Violation|0|||
23500930|NCT00939770|65576449|FG007|Overall Study|Protocol Violation|0|||
23500931|NCT00939770|65576442|FG000|Overall Study|Withdrawal by Subject|0|||
23500932|NCT00939770|65576443|FG001|Overall Study|Withdrawal by Subject|1|||
23500933|NCT00939770|65576444|FG002|Overall Study|Withdrawal by Subject|5|||
23500934|NCT00939770|65576445|FG003|Overall Study|Withdrawal by Subject|2|||
23500935|NCT00939770|65576446|FG004|Overall Study|Withdrawal by Subject|6|||
23500936|NCT00939770|65576447|FG005|Overall Study|Withdrawal by Subject|0|||
23500937|NCT00939770|65576448|FG006|Overall Study|Withdrawal by Subject|2|||
23500938|NCT00939770|65576449|FG007|Overall Study|Withdrawal by Subject|2|||
23500939|NCT02591290|65576452|FG000|Overall Study|Withdrawal by Subject|2|||
23500940|NCT02784431|65576463|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
23500941|NCT02784431|65576463|FG000|Overall Study|Early Study Termination|19|||
23500942|NCT03733470|65576466|FG000|Overall Study|PI Decision|1|||
23500943|NCT03733470|65576467|FG001|Overall Study|PI Decision|1|||
23500944|NCT05229406|65576469|FG000|Overall Study|Withdrawal by Subject|1|||
23500945|NCT05229406|65576470|FG001|Overall Study|Withdrawal by Subject|2|||
23500946|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
23500947|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
23500948|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
23500949|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
23500950|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
23500951|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
23500952|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
23699966|NCT00521339|66280533|FG000|Treatment Extension Phase|Death|0|||
23500953|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
23500954|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
23500955|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
23500956|NCT03943147|65576477|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
23500957|NCT03943147|65576478|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
23500958|NCT02151110|65576479|FG000|Overall Study|Withdrawal by Subject|0|||
23500959|NCT02151110|65576480|FG001|Overall Study|Withdrawal by Subject|0|||
23500960|NCT02151110|65576481|FG002|Overall Study|Withdrawal by Subject|0|||
23500961|NCT02151110|65576482|FG003|Overall Study|Withdrawal by Subject|0|||
23500962|NCT02151110|65576483|FG004|Overall Study|Withdrawal by Subject|0|||
23500963|NCT02151110|65576484|FG005|Overall Study|Withdrawal by Subject|0|||
23500964|NCT02151110|65576485|FG006|Overall Study|Withdrawal by Subject|0|||
23500965|NCT02151110|65576486|FG007|Overall Study|Withdrawal by Subject|1|||
23500966|NCT02151110|65576479|FG000|Overall Study|Lost to Follow-up|0|||
23500967|NCT02151110|65576480|FG001|Overall Study|Lost to Follow-up|0|||
23500968|NCT02151110|65576481|FG002|Overall Study|Lost to Follow-up|0|||
23500969|NCT02151110|65576482|FG003|Overall Study|Lost to Follow-up|0|||
23500970|NCT02151110|65576483|FG004|Overall Study|Lost to Follow-up|0|||
23500971|NCT02151110|65576484|FG005|Overall Study|Lost to Follow-up|0|||
23500972|NCT02151110|65576485|FG006|Overall Study|Lost to Follow-up|0|||
23500973|NCT02151110|65576486|FG007|Overall Study|Lost to Follow-up|2|||
23500974|NCT01896102|65576487|FG000|Overall Study|Death|1|||
23500975|NCT01896102|65576487|FG000|Overall Study|Participant to receive allogenic transplant|2|||
23500976|NCT00566995|65576488|FG000|Overall Study|Toxicity|4|||
23500977|NCT00566995|65576488|FG000|Overall Study|Withdrew consent|3|||
23500978|NCT01084083|65576489|FG000|Overall Study|Adverse Event|5|||
23500979|NCT01084083|65576489|FG000|Overall Study|Death|1|||
23500980|NCT01084083|65576489|FG000|Overall Study|Withdrawal by Subject|2|||
23500981|NCT01084083|65576489|FG000|Overall Study|Complicating disease|1|||
23500982|NCT01084083|65576489|FG000|Overall Study|Other|2|||
23500983|NCT01084083|65576489|FG000|Overall Study|Never started assigned therapy|1|||
23500984|NCT02915016|65576490|FG000|Overall Study|Lost to Follow-up|4|||
23500985|NCT02915016|65576491|FG001|Overall Study|Lost to Follow-up|2|||
23500986|NCT02915016|65576492|FG002|Overall Study|Lost to Follow-up|5|||
23500987|NCT02915016|65576493|FG003|Overall Study|Lost to Follow-up|3|||
23500988|NCT02915016|65576494|FG004|Overall Study|Lost to Follow-up|5|||
23500989|NCT02915016|65576495|FG005|Overall Study|Lost to Follow-up|2|||
23500990|NCT02915016|65576496|FG006|Overall Study|Lost to Follow-up|8|||
23500991|NCT02915016|65576497|FG007|Overall Study|Lost to Follow-up|2|||
23500992|NCT02915016|65576490|FG000|Overall Study|Physician Decision|0|||
23500993|NCT02915016|65576491|FG001|Overall Study|Physician Decision|0|||
23500994|NCT02915016|65576492|FG002|Overall Study|Physician Decision|1|||
23500995|NCT02915016|65576493|FG003|Overall Study|Physician Decision|0|||
23500996|NCT02915016|65576494|FG004|Overall Study|Physician Decision|0|||
23500997|NCT02915016|65576495|FG005|Overall Study|Physician Decision|1|||
23500998|NCT02915016|65576496|FG006|Overall Study|Physician Decision|2|||
23500999|NCT02915016|65576497|FG007|Overall Study|Physician Decision|0|||
23501000|NCT02915016|65576490|FG000|Overall Study|Withdrawal by Subject|2|||
23501001|NCT02915016|65576491|FG001|Overall Study|Withdrawal by Subject|0|||
23501002|NCT02915016|65576492|FG002|Overall Study|Withdrawal by Subject|1|||
23501003|NCT02915016|65576493|FG003|Overall Study|Withdrawal by Subject|0|||
23501004|NCT02915016|65576494|FG004|Overall Study|Withdrawal by Subject|1|||
23501005|NCT02915016|65576495|FG005|Overall Study|Withdrawal by Subject|3|||
23501006|NCT02915016|65576496|FG006|Overall Study|Withdrawal by Subject|1|||
23501007|NCT02915016|65576497|FG007|Overall Study|Withdrawal by Subject|1|||
23501008|NCT02915016|65576490|FG000|Overall Study|Elected not to continue|0|||
23501009|NCT02915016|65576491|FG001|Overall Study|Elected not to continue|0|||
23501010|NCT02915016|65576492|FG002|Overall Study|Elected not to continue|0|||
23501011|NCT02915016|65576493|FG003|Overall Study|Elected not to continue|1|||
23501012|NCT02915016|65576494|FG004|Overall Study|Elected not to continue|0|||
23501013|NCT02915016|65576495|FG005|Overall Study|Elected not to continue|0|||
23501014|NCT02915016|65576496|FG006|Overall Study|Elected not to continue|1|||
23501015|NCT02915016|65576497|FG007|Overall Study|Elected not to continue|0|||
23501016|NCT02915016|65576490|FG000|Overall Study|HIV infection|1|||
23501017|NCT02915016|65576491|FG001|Overall Study|HIV infection|1|||
23501018|NCT02915016|65576492|FG002|Overall Study|HIV infection|1|||
23501019|NCT02915016|65576493|FG003|Overall Study|HIV infection|0|||
23501020|NCT02915016|65576494|FG004|Overall Study|HIV infection|1|||
23398723|NCT01215851|65207146|FG002|Follow up Period|Lost to Follow-up|0|||
23501021|NCT02915016|65576495|FG005|Overall Study|HIV infection|0|||
23501022|NCT02915016|65576496|FG006|Overall Study|HIV infection|0|||
23501023|NCT02915016|65576497|FG007|Overall Study|HIV infection|0|||
23501024|NCT02915016|65576490|FG000|Overall Study|Participant unable to adhere|0|||
23501025|NCT02915016|65576491|FG001|Overall Study|Participant unable to adhere|0|||
23501026|NCT02915016|65576492|FG002|Overall Study|Participant unable to adhere|0|||
23501027|NCT02915016|65576493|FG003|Overall Study|Participant unable to adhere|0|||
23501028|NCT02915016|65576494|FG004|Overall Study|Participant unable to adhere|0|||
23501029|NCT02915016|65576495|FG005|Overall Study|Participant unable to adhere|0|||
23501030|NCT02915016|65576496|FG006|Overall Study|Participant unable to adhere|0|||
23501031|NCT02915016|65576497|FG007|Overall Study|Participant unable to adhere|1|||
23501032|NCT01866293|65576501|FG000|Overall Study|Adverse Event|2|||
23501033|NCT02192359|65576502|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501034|NCT02192359|65576503|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501035|NCT02192359|65576504|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
23501036|NCT02192359|65576505|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501037|NCT02192359|65576502|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
23501038|NCT02192359|65576503|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501039|NCT02192359|65576504|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501040|NCT02192359|65576505|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501041|NCT02192359|65576502|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501042|NCT02192359|65576503|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501043|NCT02192359|65576504|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501044|NCT02192359|65576505|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
23501045|NCT01546883|65576508|FG000|Overall Study|Withdrawal by Subject|3|||
23501046|NCT01546883|65576508|FG000|Overall Study|Adverse Event|4|||
23501047|NCT01546883|65576508|FG000|Overall Study|Lost to Follow-up|2|||
23501048|NCT01546883|65576508|FG000|Overall Study|early closure of study|2|||
23501049|NCT01546883|65576508|FG000|Overall Study|other unrelated illness|1|||
23501050|NCT01578187|65576509|FG000|Usability Phase|Withdrawal by Subject|1|||
23501051|NCT01350492|65576510|FG000|Intervention|Lost to Follow-up|2|||
23501052|NCT01350492|65576511|FG001|Intervention|Lost to Follow-up|5|||
23501053|NCT01350492|65576510|FG000|Intervention|Withdrawal by Subject|3|||
23501054|NCT01350492|65576511|FG001|Intervention|Withdrawal by Subject|1|||
23501055|NCT01350492|65576510|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
23501056|NCT01350492|65576511|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
23501057|NCT01350492|65576510|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
23501058|NCT01350492|65576511|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
23501059|NCT04786990|65576513|FG000|Overall Study|Withdrawal by Subject|1|||
23501060|NCT04786990|65576513|FG000|Overall Study|Adverse Event|1|||
23501061|NCT04786990|65576513|FG000|Overall Study|Lost to Follow-up|1|||
23501062|NCT04786990|65576513|FG000|Overall Study|Noncompliance|1|||
23501063|NCT04786990|65576513|FG000|Overall Study|Unable to complete site visits|1|||
23501064|NCT04786990|65576513|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23501065|NCT03725852|65576516|FG000|Overall Study|Death|1|||
23501066|NCT03725852|65576517|FG001|Overall Study|Death|0|||
23501067|NCT03725852|65576516|FG000|Overall Study|Withdrawal by Subject|1|||
23501068|NCT03725852|65576517|FG001|Overall Study|Withdrawal by Subject|0|||
23501069|NCT03725852|65576516|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
23501070|NCT03725852|65576517|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
23398724|NCT01215851|65207147|FG003|Follow up Period|Lost to Follow-up|0|||
23398725|NCT01215851|65207148|FG004|Follow up Period|Lost to Follow-up|0|||
23398726|NCT01215851|65207149|FG005|Follow up Period|Lost to Follow-up|1|||
23398727|NCT00673920|65207150|FG000|Baseline up to Week 48|Withdrew consent|1|||
23398728|NCT00673920|65207151|FG001|Baseline up to Week 48|Withdrew consent|0|||
23398729|NCT00673920|65207152|FG002|Baseline up to Week 48|Withdrew consent|2|||
23398730|NCT00673920|65207153|FG003|Baseline up to Week 48|Withdrew consent|0|||
23398731|NCT00673920|65207154|FG004|Baseline up to Week 48|Withdrew consent|0|||
23398732|NCT00673920|65207155|FG005|Baseline up to Week 48|Withdrew consent|0|||
23398733|NCT00673920|65207156|FG006|Baseline up to Week 48|Withdrew consent|0|||
23398734|NCT00673920|65207157|FG007|Baseline up to Week 48|Withdrew consent|0|||
23398735|NCT00673920|65207150|FG000|Baseline up to Week 48|Refused treatment|1|||
23398736|NCT00673920|65207151|FG001|Baseline up to Week 48|Refused treatment|0|||
23398737|NCT00673920|65207152|FG002|Baseline up to Week 48|Refused treatment|0|||
23398738|NCT00673920|65207153|FG003|Baseline up to Week 48|Refused treatment|0|||
23398739|NCT00673920|65207154|FG004|Baseline up to Week 48|Refused treatment|0|||
23398740|NCT00673920|65207155|FG005|Baseline up to Week 48|Refused treatment|0|||
23398741|NCT00673920|65207156|FG006|Baseline up to Week 48|Refused treatment|0|||
23398742|NCT00673920|65207157|FG007|Baseline up to Week 48|Refused treatment|0|||
23398743|NCT00673920|65207150|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
23398744|NCT00673920|65207151|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
23398745|NCT00673920|65207152|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398746|NCT00673920|65207153|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398747|NCT00673920|65207154|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398748|NCT00673920|65207155|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398749|NCT00673920|65207156|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
23501071|NCT00845858|65576519|FG000|Overall Study|Withdrawal by Subject|5|||
23501072|NCT00845858|65576520|FG001|Overall Study|Withdrawal by Subject|1|||
23501073|NCT00845858|65576521|FG002|Overall Study|Withdrawal by Subject|1|||
23501074|NCT00845858|65576519|FG000|Overall Study|Adverse Event|3|||
23501075|NCT00845858|65576520|FG001|Overall Study|Adverse Event|8|||
23501076|NCT00845858|65576521|FG002|Overall Study|Adverse Event|4|||
23501077|NCT00845858|65576519|FG000|Overall Study|Protocol Violation|0|||
23501078|NCT00845858|65576520|FG001|Overall Study|Protocol Violation|0|||
23501079|NCT00845858|65576521|FG002|Overall Study|Protocol Violation|1|||
23501080|NCT00845858|65576519|FG000|Overall Study|not eligible|0|||
23501081|NCT00845858|65576520|FG001|Overall Study|not eligible|3|||
23501082|NCT00845858|65576521|FG002|Overall Study|not eligible|2|||
23501083|NCT00824720|65576522|FG000|Overall Study|failed plug insertion|3|||
23501084|NCT00824720|65576523|FG001|Overall Study|failed plug insertion|1|||
23501085|NCT00824720|65576524|FG002|Overall Study|failed plug insertion|0|||
23501086|NCT00824720|65576522|FG000|Overall Study|Protocol Violation|0|||
23501087|NCT00824720|65576523|FG001|Overall Study|Protocol Violation|0|||
23501088|NCT00824720|65576524|FG002|Overall Study|Protocol Violation|1|||
23501089|NCT02725710|65576527|FG000|Overall Study|Lost to Follow-up|1|||
23501090|NCT02725710|65576528|FG001|Overall Study|Lost to Follow-up|0|||
23501091|NCT00458211|65576529|FG000|Overall Study|Lack of Efficacy|12|||
23501092|NCT00458211|65576529|FG000|Overall Study|Withdrawal by Subject|2|||
23501093|NCT00458211|65576529|FG000|Overall Study|Protocol Violation|2|||
23501094|NCT00361569|65576535|FG000|Overall Study|Protocol Violation|3|||
23501095|NCT00361569|65576536|FG001|Overall Study|Protocol Violation|2|||
23501096|NCT00361569|65576537|FG002|Overall Study|Protocol Violation|4|||
23501097|NCT00361569|65576538|FG003|Overall Study|Protocol Violation|2|||
23501098|NCT00361569|65576535|FG000|Overall Study|Withdrawal by Subject|2|||
23501099|NCT00361569|65576536|FG001|Overall Study|Withdrawal by Subject|1|||
23501100|NCT00361569|65576537|FG002|Overall Study|Withdrawal by Subject|9|||
23501101|NCT00361569|65576538|FG003|Overall Study|Withdrawal by Subject|14|||
23501102|NCT00361569|65576535|FG000|Overall Study|Adverse Event|3|||
23501103|NCT00361569|65576536|FG001|Overall Study|Adverse Event|5|||
23501104|NCT00361569|65576537|FG002|Overall Study|Adverse Event|2|||
23501105|NCT00361569|65576538|FG003|Overall Study|Adverse Event|2|||
23501106|NCT00361569|65576535|FG000|Overall Study|Lost to Follow-up|2|||
23501107|NCT00361569|65576536|FG001|Overall Study|Lost to Follow-up|3|||
23501108|NCT00361569|65576537|FG002|Overall Study|Lost to Follow-up|3|||
23501109|NCT00361569|65576538|FG003|Overall Study|Lost to Follow-up|2|||
23501110|NCT00361569|65576535|FG000|Overall Study|Not specified by investigator|2|||
23501111|NCT00361569|65576536|FG001|Overall Study|Not specified by investigator|0|||
23501112|NCT00361569|65576537|FG002|Overall Study|Not specified by investigator|0|||
23501113|NCT00361569|65576538|FG003|Overall Study|Not specified by investigator|1|||
23501114|NCT01606007|65576539|FG000|Overall Study|Reason 'Other' in the protocol|0|||
23501115|NCT01606007|65576540|FG001|Overall Study|Reason 'Other' in the protocol|1|||
23501116|NCT01606007|65576541|FG002|Overall Study|Reason 'Other' in the protocol|1|||
23501117|NCT01606007|65576539|FG000|Overall Study|Pregnancy|0|||
23501118|NCT01606007|65576540|FG001|Overall Study|Pregnancy|1|||
23501119|NCT01606007|65576541|FG002|Overall Study|Pregnancy|1|||
23501120|NCT01606007|65576539|FG000|Overall Study|Withdrawal by Subject|8|||
23501121|NCT01606007|65576540|FG001|Overall Study|Withdrawal by Subject|6|||
23501122|NCT01606007|65576541|FG002|Overall Study|Withdrawal by Subject|1|||
23501123|NCT01606007|65576539|FG000|Overall Study|Adverse Event|0|||
23501124|NCT01606007|65576540|FG001|Overall Study|Adverse Event|1|||
23501125|NCT01606007|65576541|FG002|Overall Study|Adverse Event|1|||
23501126|NCT01606007|65576539|FG000|Overall Study|discontinue study treatment|0|||
23501127|NCT01606007|65576540|FG001|Overall Study|discontinue study treatment|2|||
23501128|NCT01606007|65576541|FG002|Overall Study|discontinue study treatment|1|||
23501129|NCT01606007|65576539|FG000|Overall Study|Lost to Follow-up|6|||
23501130|NCT01606007|65576540|FG001|Overall Study|Lost to Follow-up|8|||
23501131|NCT01606007|65576541|FG002|Overall Study|Lost to Follow-up|5|||
23501132|NCT01606007|65576539|FG000|Overall Study|Poor/Non-compliance|1|||
23501133|NCT01606007|65576540|FG001|Overall Study|Poor/Non-compliance|0|||
23501134|NCT01606007|65576541|FG002|Overall Study|Poor/Non-compliance|0|||
23501135|NCT00851747|65576542|FG000|Overall Study|Physician Decision|6|||
23501136|NCT00851747|65576543|FG001|Overall Study|Physician Decision|6|||
23501137|NCT00851747|65576544|FG002|Overall Study|Physician Decision|6|||
23501138|NCT02100514|65576545|FG000|Treatment Period|Adverse Event|0|||
23501139|NCT02100514|65576546|FG001|Treatment Period|Adverse Event|5|||
23501140|NCT02100514|65576547|FG002|Treatment Period|Adverse Event|0|||
23501141|NCT02100514|65576548|FG003|Treatment Period|Adverse Event|0|||
23501142|NCT02100514|65576549|FG004|Treatment Period|Adverse Event|0|||
23501143|NCT02100514|65576545|FG000|Treatment Period|Death|2|||
23501144|NCT02100514|65576546|FG001|Treatment Period|Death|2|||
23501145|NCT02100514|65576547|FG002|Treatment Period|Death|0|||
23501146|NCT02100514|65576548|FG003|Treatment Period|Death|0|||
23501147|NCT02100514|65576549|FG004|Treatment Period|Death|0|||
23501148|NCT02100514|65576545|FG000|Treatment Period|Lost to Follow-up|5|||
23501149|NCT02100514|65576546|FG001|Treatment Period|Lost to Follow-up|17|||
23501150|NCT02100514|65576547|FG002|Treatment Period|Lost to Follow-up|0|||
23501151|NCT02100514|65576548|FG003|Treatment Period|Lost to Follow-up|0|||
23501152|NCT02100514|65576549|FG004|Treatment Period|Lost to Follow-up|0|||
23501153|NCT02100514|65576545|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501154|NCT02100514|65576546|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
23501155|NCT02100514|65576547|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501156|NCT02100514|65576548|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501157|NCT02100514|65576549|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501158|NCT02100514|65576545|FG000|Treatment Period|Protocol Violation|1|||
23501159|NCT02100514|65576546|FG001|Treatment Period|Protocol Violation|1|||
23501160|NCT02100514|65576547|FG002|Treatment Period|Protocol Violation|0|||
23501161|NCT02100514|65576548|FG003|Treatment Period|Protocol Violation|0|||
23501162|NCT02100514|65576549|FG004|Treatment Period|Protocol Violation|0|||
23501163|NCT02100514|65576545|FG000|Treatment Period|Withdrawal by Subject|12|||
23501164|NCT02100514|65576546|FG001|Treatment Period|Withdrawal by Subject|37|||
23501165|NCT02100514|65576547|FG002|Treatment Period|Withdrawal by Subject|0|||
23501166|NCT02100514|65576548|FG003|Treatment Period|Withdrawal by Subject|0|||
23501167|NCT02100514|65576549|FG004|Treatment Period|Withdrawal by Subject|0|||
23501168|NCT02100514|65576545|FG000|Treatment Period|Other|9|||
23501169|NCT02100514|65576546|FG001|Treatment Period|Other|11|||
23501170|NCT02100514|65576547|FG002|Treatment Period|Other|0|||
23501171|NCT02100514|65576548|FG003|Treatment Period|Other|0|||
23501172|NCT02100514|65576549|FG004|Treatment Period|Other|0|||
23501173|NCT02100514|65576545|FG000|Extension Period|Withdrew consent|0|||
23501174|NCT02100514|65576546|FG001|Extension Period|Withdrew consent|0|||
23501175|NCT02100514|65576547|FG002|Extension Period|Withdrew consent|2|||
23501176|NCT02100514|65576548|FG003|Extension Period|Withdrew consent|0|||
23501177|NCT02100514|65576549|FG004|Extension Period|Withdrew consent|0|||
23501178|NCT01962896|65576558|FG000|Overall Study|Lack of Efficacy|4|||
23501179|NCT01325584|65576561|FG000|Overall Study|Death|1|||
23501180|NCT01370356|65576563|FG000|Overall Study|Death|1|||
23501181|NCT01370356|65576564|FG001|Overall Study|Death|0|||
23501182|NCT01370356|65576563|FG000|Overall Study|Lack of Efficacy|6|||
23501183|NCT01370356|65576564|FG001|Overall Study|Lack of Efficacy|28|||
23501184|NCT01370356|65576563|FG000|Overall Study|Lost to Follow-up|76|||
23501185|NCT01370356|65576564|FG001|Overall Study|Lost to Follow-up|81|||
23501186|NCT01370356|65576563|FG000|Overall Study|Withdrawal by Subject|54|||
23501187|NCT01370356|65576564|FG001|Overall Study|Withdrawal by Subject|59|||
23398750|NCT00673920|65207157|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398751|NCT00673920|65207150|FG000|Baseline up to Week 48|Protocol Violation|0|||
23398752|NCT00673920|65207151|FG001|Baseline up to Week 48|Protocol Violation|0|||
23398753|NCT00673920|65207152|FG002|Baseline up to Week 48|Protocol Violation|1|||
23398754|NCT00673920|65207153|FG003|Baseline up to Week 48|Protocol Violation|0|||
23398755|NCT00673920|65207154|FG004|Baseline up to Week 48|Protocol Violation|0|||
23398756|NCT00673920|65207155|FG005|Baseline up to Week 48|Protocol Violation|0|||
23398757|NCT00673920|65207156|FG006|Baseline up to Week 48|Protocol Violation|0|||
23398758|NCT00673920|65207157|FG007|Baseline up to Week 48|Protocol Violation|0|||
23398759|NCT00673920|65207150|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398760|NCT00673920|65207151|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398761|NCT00673920|65207152|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
23398762|NCT00673920|65207153|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398763|NCT00673920|65207154|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398764|NCT00673920|65207155|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398765|NCT00673920|65207156|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398766|NCT00673920|65207157|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398767|NCT00673920|65207150|FG000|Baseline up to Week 48|Administrative/Other|0|||
23398768|NCT00673920|65207151|FG001|Baseline up to Week 48|Administrative/Other|1|||
23398769|NCT00673920|65207152|FG002|Baseline up to Week 48|Administrative/Other|2|||
23398770|NCT00673920|65207153|FG003|Baseline up to Week 48|Administrative/Other|0|||
23398771|NCT00673920|65207154|FG004|Baseline up to Week 48|Administrative/Other|0|||
23398772|NCT00673920|65207155|FG005|Baseline up to Week 48|Administrative/Other|0|||
23398773|NCT00673920|65207156|FG006|Baseline up to Week 48|Administrative/Other|0|||
23398774|NCT00673920|65207157|FG007|Baseline up to Week 48|Administrative/Other|0|||
23398775|NCT00673920|65207150|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398776|NCT00673920|65207151|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
23398777|NCT00673920|65207152|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
23398778|NCT00673920|65207153|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398779|NCT00673920|65207154|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398780|NCT00673920|65207155|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398781|NCT00673920|65207156|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398782|NCT00673920|65207157|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398783|NCT00673920|65207150|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23501188|NCT01370356|65576563|FG000|Overall Study|Reason not specified|39|||
23501189|NCT01370356|65576564|FG001|Overall Study|Reason not specified|43|||
23501190|NCT01370356|65576563|FG000|Overall Study|Protocol Violation|3|||
23501191|NCT01370356|65576564|FG001|Overall Study|Protocol Violation|3|||
23501192|NCT01370356|65576563|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
23501193|NCT01370356|65576564|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
23501194|NCT01370356|65576563|FG000|Overall Study|AE Not Related to Study Drug|1|||
23501195|NCT01370356|65576564|FG001|Overall Study|AE Not Related to Study Drug|4|||
23501196|NCT02516163|65576565|FG000|Overall Study|Withdrawal by Subject|1|||
23501197|NCT02516163|65576565|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
23501198|NCT02516163|65576565|FG000|Overall Study|Unfit/delay in surgery|3|||
23501199|NCT02516163|65576565|FG000|Overall Study|Use of incorrect measurement technique|5|||
23501200|NCT02516163|65576565|FG000|Overall Study|Data not recorded|2|||
23501201|NCT02516163|65576565|FG000|Overall Study|MRI contraindication exclusion|6|||
23501202|NCT02400333|65576566|FG000|Overall Study|Withdrawal by Subject|0|||
23501203|NCT02400333|65576567|FG001|Overall Study|Withdrawal by Subject|1|||
23501204|NCT02400333|65576568|FG002|Overall Study|Withdrawal by Subject|0|||
23501205|NCT02400333|65576569|FG003|Overall Study|Withdrawal by Subject|1|||
23501206|NCT02400333|65576566|FG000|Overall Study|Protocol Violation|1|||
23501207|NCT02400333|65576567|FG001|Overall Study|Protocol Violation|0|||
23501208|NCT02400333|65576568|FG002|Overall Study|Protocol Violation|2|||
23501209|NCT02400333|65576569|FG003|Overall Study|Protocol Violation|1|||
23501210|NCT01091974|65576585|FG000|Overall Study|Did not start intervention|3|||
23501211|NCT01091974|65576586|FG001|Overall Study|Did not start intervention|1|||
23501212|NCT01091974|65576587|FG002|Overall Study|Did not start intervention|3|||
23501213|NCT01091974|65576588|FG003|Overall Study|Did not start intervention|1|||
23501214|NCT01091974|65576585|FG000|Overall Study|resumed sleep medication|0|||
23501215|NCT01091974|65576586|FG001|Overall Study|resumed sleep medication|0|||
23501216|NCT01091974|65576587|FG002|Overall Study|resumed sleep medication|1|||
23501217|NCT01091974|65576588|FG003|Overall Study|resumed sleep medication|2|||
23501218|NCT01091974|65576585|FG000|Overall Study|Withdrawal by Subject|1|||
23501219|NCT01091974|65576586|FG001|Overall Study|Withdrawal by Subject|3|||
23501220|NCT01091974|65576587|FG002|Overall Study|Withdrawal by Subject|2|||
23501221|NCT01091974|65576588|FG003|Overall Study|Withdrawal by Subject|2|||
23501222|NCT01091974|65576585|FG000|Overall Study|side-effects|1|||
23501223|NCT01091974|65576586|FG001|Overall Study|side-effects|1|||
23501224|NCT01091974|65576587|FG002|Overall Study|side-effects|0|||
23501225|NCT01091974|65576588|FG003|Overall Study|side-effects|2|||
23501226|NCT00289783|65576589|FG000|Primary Phase|Adverse Event|10|||
23501227|NCT00289783|65576590|FG001|Primary Phase|Adverse Event|1|||
23501228|NCT00289783|65576589|FG000|Primary Phase|Protocol Violation|27|||
23501229|NCT00289783|65576590|FG001|Primary Phase|Protocol Violation|6|||
23501230|NCT00289783|65576589|FG000|Primary Phase|Withdrawal by Subject|93|||
23501231|NCT00289783|65576590|FG001|Primary Phase|Withdrawal by Subject|40|||
23501232|NCT00289783|65576589|FG000|Primary Phase|Lost to Follow-up|60|||
23501233|NCT00289783|65576590|FG001|Primary Phase|Lost to Follow-up|14|||
23501234|NCT00289783|65576589|FG000|Primary Phase|Migration from the study area|26|||
23501235|NCT00289783|65576590|FG001|Primary Phase|Migration from the study area|10|||
23501236|NCT00289783|65576589|FG000|Primary Phase|Other|32|||
23501237|NCT00289783|65576590|FG001|Primary Phase|Other|12|||
23501238|NCT00289783|65576589|FG000|Fourth Dose Phase|Adverse Event|1|||
23501239|NCT00289783|65576590|FG001|Fourth Dose Phase|Adverse Event|0|||
23501240|NCT00289783|65576589|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
23501241|NCT00289783|65576590|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
23501242|NCT00289783|65576589|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
23501243|NCT00289783|65576590|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
23501244|NCT00289783|65576589|FG000|Fourth Dose Phase|Migration from the study area|1|||
23501245|NCT00289783|65576590|FG001|Fourth Dose Phase|Migration from the study area|1|||
23501246|NCT00289783|65576589|FG000|Fourth Dose Phase|Other|22|||
23501247|NCT00289783|65576590|FG001|Fourth Dose Phase|Other|10|||
23501248|NCT01049308|65576595|FG000|Pill Counts|Withdrawal by Subject|83|||
23501249|NCT00205881|65576596|FG000|Overall Study|Withdrawal by Subject|16|||
23501250|NCT00844896|65576597|FG000|Overall Study|Lost to Follow-up|12|||
23501251|NCT00844896|65576598|FG001|Overall Study|Lost to Follow-up|16|||
23501252|NCT00844896|65576597|FG000|Overall Study|Parents did not have time to complete|0|||
23501253|NCT00844896|65576598|FG001|Overall Study|Parents did not have time to complete|1|||
23501254|NCT02195583|65576599|FG000|Overall Study|Lost to Follow-up|1|||
23501255|NCT02195583|65576599|FG000|Overall Study|Withdrawal by Subject|4|||
23501256|NCT02195583|65576599|FG000|Overall Study|Adverse Event|2|||
23501257|NCT02195583|65576599|FG000|Overall Study|Other Reason|2|||
23501258|NCT03616600|65576600|FG000|Overall Study|Withdrawal by Subject|1|||
23501259|NCT03616600|65576601|FG001|Overall Study|Withdrawal by Subject|0|||
23501260|NCT00319553|65576604|FG000|Overall Study|Protocol Violation|1|||
23501261|NCT00319553|65576605|FG001|Overall Study|Protocol Violation|2|||
23501262|NCT00319553|65576604|FG000|Overall Study|Lost to Follow-up|2|||
23501263|NCT00319553|65576605|FG001|Overall Study|Lost to Follow-up|1|||
23501264|NCT00319553|65576604|FG000|Overall Study|Withdrawal by Subject|1|||
23501265|NCT00319553|65576605|FG001|Overall Study|Withdrawal by Subject|1|||
23501266|NCT00211510|65576606|FG000|Overall Study|Physician Decision|3|||
23501267|NCT00211510|65576607|FG001|Overall Study|Physician Decision|1|||
23501268|NCT00211510|65576606|FG000|Overall Study|Withdrawal by Subject|3|||
23501269|NCT00211510|65576607|FG001|Overall Study|Withdrawal by Subject|1|||
23501270|NCT01256008|65576608|FG000|Overall Study|Lost to Follow-up|6|||
23501271|NCT01256008|65576609|FG001|Overall Study|Lost to Follow-up|4|||
23501272|NCT01256008|65576610|FG002|Overall Study|Lost to Follow-up|11|||
23501273|NCT01256008|65576608|FG000|Overall Study|Withdrawal by Subject|2|||
23501274|NCT01256008|65576609|FG001|Overall Study|Withdrawal by Subject|3|||
23501275|NCT01256008|65576610|FG002|Overall Study|Withdrawal by Subject|10|||
23501276|NCT01774968|65576612|FG000|Overall Study|Adverse Event|4|||
23501277|NCT01774968|65576613|FG001|Overall Study|Adverse Event|4|||
23501278|NCT01774968|65576612|FG000|Overall Study|Death|0|||
23501279|NCT01774968|65576613|FG001|Overall Study|Death|1|||
23501280|NCT01774968|65576612|FG000|Overall Study|Lost to Follow-up|1|||
23501281|NCT01774968|65576613|FG001|Overall Study|Lost to Follow-up|3|||
23501282|NCT01774968|65576612|FG000|Overall Study|Physician Decision|5|||
23501283|NCT01774968|65576613|FG001|Overall Study|Physician Decision|1|||
23501284|NCT01774968|65576612|FG000|Overall Study|Protocol Violation|14|||
23501285|NCT01774968|65576613|FG001|Overall Study|Protocol Violation|13|||
23501286|NCT01774968|65576612|FG000|Overall Study|Sponsor Decision|0|||
23501287|NCT01774968|65576613|FG001|Overall Study|Sponsor Decision|2|||
23501288|NCT01774968|65576612|FG000|Overall Study|Withdrawal by Subject|6|||
23501289|NCT01774968|65576613|FG001|Overall Study|Withdrawal by Subject|11|||
23501290|NCT03173313|65576614|FG000|Overall Study|Lost to Follow-up|2|||
23501291|NCT03173313|65576615|FG001|Overall Study|Lost to Follow-up|3|||
23501292|NCT03173313|65576614|FG000|Overall Study|Withdrawal by Subject|0|||
23501293|NCT03173313|65576615|FG001|Overall Study|Withdrawal by Subject|1|||
23501294|NCT03173313|65576614|FG000|Overall Study|Death|5|||
23501295|NCT03173313|65576615|FG001|Overall Study|Death|0|||
23501296|NCT03173313|65576614|FG000|Overall Study|Physician Decision|1|||
23501297|NCT03173313|65576615|FG001|Overall Study|Physician Decision|0|||
23501298|NCT03173313|65576614|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
23501299|NCT03173313|65576615|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
23501300|NCT03173313|65576614|FG000|Overall Study|Bone Fracture|1|||
23501301|NCT03173313|65576615|FG001|Overall Study|Bone Fracture|0|||
23501302|NCT01416272|65576616|FG000|Overall Study|Unacceptable distance visual acuity|2|||
23501303|NCT01416272|65576616|FG000|Overall Study|Lost to Follow-up|1|||
23501304|NCT01416272|65576616|FG000|Overall Study|Study related complaints|1|||
23501305|NCT04112784|65576617|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
23501306|NCT04112784|65576617|FG000|Overall Study|Screen Failures|4|||
23501307|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501308|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501309|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501310|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501311|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501312|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501313|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501314|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501315|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501316|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501317|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501318|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501319|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501320|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501321|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501322|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
23501323|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
23501324|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
23501325|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501326|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501327|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501328|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501329|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501330|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501331|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501332|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501333|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501334|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501335|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501336|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501337|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501338|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
23699967|NCT00521339|66280534|FG001|Treatment Extension Phase|Death|0|||
23501339|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501340|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
23501341|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501342|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501343|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501344|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501345|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501346|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501347|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501348|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501349|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501350|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501351|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501352|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501353|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
23501354|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501355|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501356|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501357|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501358|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501359|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501360|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501361|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501362|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501363|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501364|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501365|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501366|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501367|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501368|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501369|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501370|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501371|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
23501372|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501373|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501374|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501375|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501376|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501377|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501378|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501379|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501380|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501381|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501382|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501383|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501384|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501385|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
23501386|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501387|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501388|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501389|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501390|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501391|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501392|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501393|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501394|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501395|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501396|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501397|NCT01737697|65576620|FG000|Subacute Phase|Adverse Event|0|||
23501398|NCT01737697|65576621|FG001|Subacute Phase|Adverse Event|0|||
23501399|NCT01737697|65576622|FG002|Subacute Phase|Adverse Event|0|||
23501400|NCT01737697|65576623|FG003|Subacute Phase|Adverse Event|0|||
23501401|NCT01737697|65576624|FG004|Subacute Phase|Adverse Event|0|||
23501402|NCT01737697|65576625|FG005|Subacute Phase|Adverse Event|1|||
23501403|NCT01737697|65576626|FG006|Subacute Phase|Adverse Event|1|||
23501404|NCT01737697|65576627|FG007|Subacute Phase|Adverse Event|1|||
23501405|NCT01737697|65576628|FG008|Subacute Phase|Adverse Event|1|||
23501406|NCT01737697|65576629|FG009|Subacute Phase|Adverse Event|1|||
23501407|NCT01737697|65576630|FG010|Subacute Phase|Adverse Event|4|||
23501408|NCT01737697|65576631|FG011|Subacute Phase|Adverse Event|1|||
23501409|NCT01737697|65576632|FG012|Subacute Phase|Adverse Event|1|||
23501410|NCT01737697|65576633|FG013|Subacute Phase|Adverse Event|0|||
23501411|NCT01737697|65576634|FG014|Subacute Phase|Adverse Event|0|||
23501412|NCT01737697|65576620|FG000|Subacute Phase|Withdrawal by Subject|0|||
23501413|NCT01737697|65576621|FG001|Subacute Phase|Withdrawal by Subject|0|||
23501414|NCT01737697|65576622|FG002|Subacute Phase|Withdrawal by Subject|0|||
23501415|NCT01737697|65576623|FG003|Subacute Phase|Withdrawal by Subject|0|||
23501416|NCT01737697|65576624|FG004|Subacute Phase|Withdrawal by Subject|0|||
23501417|NCT01737697|65576625|FG005|Subacute Phase|Withdrawal by Subject|1|||
23501418|NCT01737697|65576626|FG006|Subacute Phase|Withdrawal by Subject|0|||
23501419|NCT01737697|65576627|FG007|Subacute Phase|Withdrawal by Subject|2|||
23501420|NCT01737697|65576628|FG008|Subacute Phase|Withdrawal by Subject|0|||
23501421|NCT01737697|65576629|FG009|Subacute Phase|Withdrawal by Subject|1|||
23501422|NCT01737697|65576630|FG010|Subacute Phase|Withdrawal by Subject|0|||
23501423|NCT01737697|65576631|FG011|Subacute Phase|Withdrawal by Subject|1|||
23501424|NCT01737697|65576632|FG012|Subacute Phase|Withdrawal by Subject|1|||
23501425|NCT01737697|65576633|FG013|Subacute Phase|Withdrawal by Subject|1|||
23501426|NCT01737697|65576634|FG014|Subacute Phase|Withdrawal by Subject|0|||
23501427|NCT01737697|65576620|FG000|Subacute Phase|Lost to Follow-up|0|||
23501428|NCT01737697|65576621|FG001|Subacute Phase|Lost to Follow-up|0|||
23501429|NCT01737697|65576622|FG002|Subacute Phase|Lost to Follow-up|0|||
23501430|NCT01737697|65576623|FG003|Subacute Phase|Lost to Follow-up|0|||
23501431|NCT01737697|65576624|FG004|Subacute Phase|Lost to Follow-up|0|||
23501432|NCT01737697|65576625|FG005|Subacute Phase|Lost to Follow-up|0|||
23501433|NCT01737697|65576626|FG006|Subacute Phase|Lost to Follow-up|0|||
23501434|NCT01737697|65576627|FG007|Subacute Phase|Lost to Follow-up|0|||
23501435|NCT01737697|65576628|FG008|Subacute Phase|Lost to Follow-up|0|||
23501436|NCT01737697|65576629|FG009|Subacute Phase|Lost to Follow-up|0|||
23501437|NCT01737697|65576630|FG010|Subacute Phase|Lost to Follow-up|0|||
23501438|NCT01737697|65576631|FG011|Subacute Phase|Lost to Follow-up|0|||
23501439|NCT01737697|65576632|FG012|Subacute Phase|Lost to Follow-up|0|||
23501440|NCT01737697|65576633|FG013|Subacute Phase|Lost to Follow-up|0|||
23501441|NCT01737697|65576634|FG014|Subacute Phase|Lost to Follow-up|1|||
23501442|NCT01737697|65576620|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
23501443|NCT01737697|65576621|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
23501444|NCT01737697|65576622|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
23501445|NCT01737697|65576623|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
23501446|NCT01737697|65576624|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
23501447|NCT01737697|65576625|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
23501448|NCT01737697|65576626|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
23501449|NCT01737697|65576627|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
23501450|NCT01737697|65576628|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
23501451|NCT01737697|65576629|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
23398784|NCT00673920|65207151|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398785|NCT00673920|65207152|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398786|NCT00673920|65207153|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398787|NCT00673920|65207154|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398788|NCT00673920|65207155|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398789|NCT00673920|65207156|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
23398790|NCT00673920|65207157|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398791|NCT00673920|65207150|FG000|Week 24 to Week 48|Failure to return|0|||
23398792|NCT00673920|65207151|FG001|Week 24 to Week 48|Failure to return|0|||
23398793|NCT00673920|65207152|FG002|Week 24 to Week 48|Failure to return|0|||
23398794|NCT00673920|65207153|FG003|Week 24 to Week 48|Failure to return|0|||
23398795|NCT00673920|65207154|FG004|Week 24 to Week 48|Failure to return|0|||
23398796|NCT00673920|65207155|FG005|Week 24 to Week 48|Failure to return|1|||
23398797|NCT00673920|65207156|FG006|Week 24 to Week 48|Failure to return|0|||
23398798|NCT00673920|65207157|FG007|Week 24 to Week 48|Failure to return|0|||
23398799|NCT00673920|65207150|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398800|NCT00673920|65207151|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398801|NCT00673920|65207152|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398802|NCT00673920|65207153|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398803|NCT00673920|65207154|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398804|NCT00673920|65207155|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
23398805|NCT00673920|65207156|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398806|NCT00673920|65207157|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398807|NCT00673920|65207150|FG000|Week 24 to Week 48|Death|0|||
23398808|NCT00673920|65207151|FG001|Week 24 to Week 48|Death|0|||
23398809|NCT00673920|65207152|FG002|Week 24 to Week 48|Death|0|||
23398810|NCT00673920|65207153|FG003|Week 24 to Week 48|Death|0|||
23398811|NCT00673920|65207154|FG004|Week 24 to Week 48|Death|0|||
23398812|NCT00673920|65207155|FG005|Week 24 to Week 48|Death|1|||
23398813|NCT00673920|65207156|FG006|Week 24 to Week 48|Death|0|||
23398814|NCT00673920|65207157|FG007|Week 24 to Week 48|Death|0|||
23398815|NCT00673920|65207150|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
23398816|NCT00673920|65207151|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
23501452|NCT01737697|65576630|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
23501453|NCT01737697|65576631|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
23501454|NCT01737697|65576632|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
23501455|NCT01737697|65576633|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
23501456|NCT01737697|65576634|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
23501457|NCT01737697|65576620|FG000|Subacute Phase|Protocol Violation|0|||
23501458|NCT01737697|65576621|FG001|Subacute Phase|Protocol Violation|0|||
23501459|NCT01737697|65576622|FG002|Subacute Phase|Protocol Violation|0|||
23501460|NCT01737697|65576623|FG003|Subacute Phase|Protocol Violation|0|||
23501461|NCT01737697|65576624|FG004|Subacute Phase|Protocol Violation|0|||
23501462|NCT01737697|65576625|FG005|Subacute Phase|Protocol Violation|1|||
23501463|NCT01737697|65576626|FG006|Subacute Phase|Protocol Violation|0|||
23501464|NCT01737697|65576627|FG007|Subacute Phase|Protocol Violation|0|||
23501465|NCT01737697|65576628|FG008|Subacute Phase|Protocol Violation|0|||
23501466|NCT01737697|65576629|FG009|Subacute Phase|Protocol Violation|0|||
23501467|NCT01737697|65576630|FG010|Subacute Phase|Protocol Violation|1|||
23501468|NCT01737697|65576631|FG011|Subacute Phase|Protocol Violation|0|||
23501469|NCT01737697|65576632|FG012|Subacute Phase|Protocol Violation|0|||
23501470|NCT01737697|65576633|FG013|Subacute Phase|Protocol Violation|0|||
23501471|NCT01737697|65576634|FG014|Subacute Phase|Protocol Violation|0|||
23501472|NCT01737697|65576620|FG000|Subacute Phase|Physician Decision|0|||
23501473|NCT01737697|65576621|FG001|Subacute Phase|Physician Decision|0|||
23501474|NCT01737697|65576622|FG002|Subacute Phase|Physician Decision|0|||
23501475|NCT01737697|65576623|FG003|Subacute Phase|Physician Decision|0|||
23501476|NCT01737697|65576624|FG004|Subacute Phase|Physician Decision|0|||
23501477|NCT01737697|65576625|FG005|Subacute Phase|Physician Decision|0|||
23501478|NCT01737697|65576626|FG006|Subacute Phase|Physician Decision|0|||
23501479|NCT01737697|65576627|FG007|Subacute Phase|Physician Decision|0|||
23501480|NCT01737697|65576628|FG008|Subacute Phase|Physician Decision|1|||
23501481|NCT01737697|65576629|FG009|Subacute Phase|Physician Decision|0|||
23501482|NCT01737697|65576630|FG010|Subacute Phase|Physician Decision|0|||
23501483|NCT01737697|65576631|FG011|Subacute Phase|Physician Decision|0|||
23501484|NCT01737697|65576632|FG012|Subacute Phase|Physician Decision|0|||
23501485|NCT01737697|65576633|FG013|Subacute Phase|Physician Decision|0|||
23501486|NCT01737697|65576634|FG014|Subacute Phase|Physician Decision|0|||
23501487|NCT01737697|65576620|FG000|Subacute Phase|Death|0|||
23501488|NCT01737697|65576621|FG001|Subacute Phase|Death|0|||
23501489|NCT01737697|65576622|FG002|Subacute Phase|Death|0|||
23501490|NCT01737697|65576623|FG003|Subacute Phase|Death|0|||
23501491|NCT01737697|65576624|FG004|Subacute Phase|Death|0|||
23501492|NCT01737697|65576625|FG005|Subacute Phase|Death|0|||
23501493|NCT01737697|65576626|FG006|Subacute Phase|Death|0|||
23501494|NCT01737697|65576627|FG007|Subacute Phase|Death|0|||
23501495|NCT01737697|65576628|FG008|Subacute Phase|Death|0|||
23501496|NCT01737697|65576629|FG009|Subacute Phase|Death|0|||
23501497|NCT01737697|65576630|FG010|Subacute Phase|Death|1|||
23501498|NCT01737697|65576631|FG011|Subacute Phase|Death|0|||
23501499|NCT01737697|65576632|FG012|Subacute Phase|Death|0|||
23501500|NCT01737697|65576633|FG013|Subacute Phase|Death|0|||
23501501|NCT01737697|65576634|FG014|Subacute Phase|Death|0|||
23501502|NCT00558558|65576635|FG000|Overall Study|Unable to swallow|1|||
23501503|NCT00558558|65576635|FG000|Overall Study|Withdrawal by Subject|1|||
23501504|NCT00558558|65576635|FG000|Overall Study|Lack of Efficacy|4|||
23501505|NCT00279305|65576636|FG000|Overall Study|Pregnancy|1|||
23501506|NCT00279305|65576637|FG001|Overall Study|Pregnancy|0|||
23501507|NCT00279305|65576636|FG000|Overall Study|Withdrawal by Subject|2|||
23501508|NCT00279305|65576637|FG001|Overall Study|Withdrawal by Subject|0|||
23501509|NCT00279305|65576636|FG000|Overall Study|Dificulting establishing IV|1|||
23501510|NCT00279305|65576637|FG001|Overall Study|Dificulting establishing IV|0|||
23501511|NCT00279305|65576636|FG000|Overall Study|FDA Safety Alert|4|||
23501512|NCT00279305|65576637|FG001|Overall Study|FDA Safety Alert|1|||
23501513|NCT01546207|65576640|FG000|Overall Study|Death|1|||
23501514|NCT02695329|65576641|FG000|Overall Study|Adverse Event|1|||
23501515|NCT02695329|65576642|FG001|Overall Study|Adverse Event|0|||
23501516|NCT02695329|65576641|FG000|Overall Study|Poor X-ray quality for measurement|4|||
23501517|NCT02695329|65576642|FG001|Overall Study|Poor X-ray quality for measurement|5|||
23501518|NCT01169493|65576643|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501519|NCT01169493|65576644|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
23501520|NCT01169493|65576645|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
23699968|NCT00521339|66280535|FG002|Treatment Extension Phase|Death|1|||
23501521|NCT01169493|65576646|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501522|NCT01169493|65576647|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501523|NCT01169493|65576648|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
23501524|NCT01169493|65576643|FG000|Period 3 (6 Months)|Adverse Event|0|||
23501525|NCT01169493|65576644|FG001|Period 3 (6 Months)|Adverse Event|1|||
23501526|NCT01169493|65576645|FG002|Period 3 (6 Months)|Adverse Event|0|||
23501527|NCT01169493|65576646|FG003|Period 3 (6 Months)|Adverse Event|0|||
23501528|NCT01169493|65576647|FG004|Period 3 (6 Months)|Adverse Event|0|||
23501529|NCT01169493|65576648|FG005|Period 3 (6 Months)|Adverse Event|0|||
23501530|NCT01169493|65576643|FG000|Period 3 (6 Months)|Physician Decision|0|||
23501531|NCT01169493|65576644|FG001|Period 3 (6 Months)|Physician Decision|1|||
23501532|NCT01169493|65576645|FG002|Period 3 (6 Months)|Physician Decision|1|||
23501533|NCT01169493|65576646|FG003|Period 3 (6 Months)|Physician Decision|0|||
23501534|NCT01169493|65576647|FG004|Period 3 (6 Months)|Physician Decision|0|||
23501535|NCT01169493|65576648|FG005|Period 3 (6 Months)|Physician Decision|0|||
23501536|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
23501537|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
23501538|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
23501539|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
23501540|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
23501541|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
23501542|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
23501543|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
23501544|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
23501545|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
23501546|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
23501547|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
23501548|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
23501549|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
23501550|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
23501551|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Other|1|||
23501552|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Other|1|||
23501553|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Other|0|||
23501554|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
23501555|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
23501556|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
23501557|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
23501558|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
23501559|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
23501560|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
23501561|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
23501562|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
23501563|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
23501564|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
23501565|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
23501566|NCT02854631|65576654|FG000|Overall Study|Adverse Event|1|||
23501567|NCT02854631|65576655|FG001|Overall Study|Adverse Event|2|||
23501568|NCT02854631|65576654|FG000|Overall Study|Withdrew Consent|3|||
23501569|NCT02854631|65576655|FG001|Overall Study|Withdrew Consent|2|||
23501570|NCT02854631|65576654|FG000|Overall Study|Investigator's Discretion|2|||
23501571|NCT02854631|65576655|FG001|Overall Study|Investigator's Discretion|0|||
23501572|NCT02854631|65576654|FG000|Overall Study|Death|12|||
23501573|NCT02854631|65576655|FG001|Overall Study|Death|8|||
23501574|NCT02854631|65576654|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
23501575|NCT02854631|65576655|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
23501576|NCT02854631|65576654|FG000|Overall Study|Protocol Violation|0|||
23501577|NCT02854631|65576655|FG001|Overall Study|Protocol Violation|1|||
23501578|NCT02854631|65576654|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
23501579|NCT02854631|65576655|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
23501580|NCT02854631|65576654|FG000|Overall Study|Lost to Follow-up|4|||
23501581|NCT02854631|65576655|FG001|Overall Study|Lost to Follow-up|2|||
23501582|NCT01010061|65576656|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
23501583|NCT01010061|65576657|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
23501584|NCT01010061|65576656|FG000|Overall Study|Disease Progression|2|||
23501585|NCT01010061|65576657|FG001|Overall Study|Disease Progression|8|||
23501586|NCT01010061|65576656|FG000|Overall Study|Withdrew Consent|5|||
23501587|NCT01010061|65576657|FG001|Overall Study|Withdrew Consent|1|||
23501588|NCT01010061|65576656|FG000|Overall Study|Death|3|||
23501589|NCT01010061|65576657|FG001|Overall Study|Death|6|||
23501590|NCT01010061|65576656|FG000|Overall Study|Administrative/Other|0|||
23501591|NCT01010061|65576657|FG001|Overall Study|Administrative/Other|1|||
23501592|NCT01010061|65576656|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
23501593|NCT01010061|65576657|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23501594|NCT01010061|65576656|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23501595|NCT01010061|65576657|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23501596|NCT01010061|65576656|FG000|Overall Study|Violation of Selection Criteria|0|||
23501597|NCT01010061|65576657|FG001|Overall Study|Violation of Selection Criteria|1|||
23501598|NCT01010061|65576656|FG000|Overall Study|Did Not Receive Treatment|2|||
23501599|NCT01010061|65576657|FG001|Overall Study|Did Not Receive Treatment|2|||
23501600|NCT02469298|65576669|FG000|Overall Study|Protocol Violation|0|||
23501601|NCT02469298|65576670|FG001|Overall Study|Protocol Violation|1|||
23501602|NCT02469298|65576671|FG002|Overall Study|Protocol Violation|1|||
23501603|NCT02469298|65576672|FG003|Overall Study|Protocol Violation|0|||
23501604|NCT02469298|65576669|FG000|Overall Study|Lost to Follow-up|1|||
23501605|NCT02469298|65576670|FG001|Overall Study|Lost to Follow-up|0|||
23501606|NCT02469298|65576671|FG002|Overall Study|Lost to Follow-up|1|||
23501607|NCT02469298|65576672|FG003|Overall Study|Lost to Follow-up|0|||
23501608|NCT02469298|65576669|FG000|Overall Study|Physician Decision|0|||
23501609|NCT02469298|65576670|FG001|Overall Study|Physician Decision|0|||
23501610|NCT02469298|65576671|FG002|Overall Study|Physician Decision|0|||
23501611|NCT02469298|65576672|FG003|Overall Study|Physician Decision|1|||
23501612|NCT02469298|65576669|FG000|Overall Study|Withdrawal by Subject|0|||
23501613|NCT02469298|65576670|FG001|Overall Study|Withdrawal by Subject|0|||
23501614|NCT02469298|65576671|FG002|Overall Study|Withdrawal by Subject|0|||
23501615|NCT02469298|65576672|FG003|Overall Study|Withdrawal by Subject|1|||
23501616|NCT01389817|65576673|FG000|Overall Study|Physician Decision|1|||
23501617|NCT01389817|65576674|FG001|Overall Study|Physician Decision|0|||
23501618|NCT01389817|65576673|FG000|Overall Study|Lost to Follow-up|1|||
23501619|NCT01389817|65576674|FG001|Overall Study|Lost to Follow-up|0|||
23501620|NCT01389817|65576673|FG000|Overall Study|Withdrawal by Subject|2|||
23501621|NCT01389817|65576674|FG001|Overall Study|Withdrawal by Subject|0|||
23501622|NCT05570500|65576676|FG000|Overall Study|Lost to Follow-up|7|||
23501623|NCT05570500|65576677|FG001|Overall Study|Lost to Follow-up|5|||
23501624|NCT00481078|65576680|FG000|Overall Study|Progression of disease|11|||
23501625|NCT00481078|65576681|FG001|Overall Study|Progression of disease|11|||
23501626|NCT00481078|65576680|FG000|Overall Study|Adverse Event|15|||
23501627|NCT00481078|65576681|FG001|Overall Study|Adverse Event|3|||
23501628|NCT00481078|65576680|FG000|Overall Study|Death|5|||
23501629|NCT00481078|65576681|FG001|Overall Study|Death|3|||
23501630|NCT00481078|65576680|FG000|Overall Study|Intercurrent illness|1|||
23501631|NCT00481078|65576681|FG001|Overall Study|Intercurrent illness|0|||
23501632|NCT00481078|65576680|FG000|Overall Study|Withdrawal by Subject|7|||
23501633|NCT00481078|65576681|FG001|Overall Study|Withdrawal by Subject|1|||
23501634|NCT00481078|65576680|FG000|Overall Study|Information not available|1|||
23501635|NCT00481078|65576681|FG001|Overall Study|Information not available|0|||
23501636|NCT00481078|65576680|FG000|Overall Study|Received other treatment|2|||
23501637|NCT00481078|65576681|FG001|Overall Study|Received other treatment|1|||
23501638|NCT00481078|65576680|FG000|Overall Study|Brain metastasis|0|||
23501639|NCT00481078|65576681|FG001|Overall Study|Brain metastasis|1|||
23501640|NCT00713323|65576682|FG000|Overall Study|Adverse Event|75|||
23501641|NCT00713323|65576682|FG000|Overall Study|Withdrawal by Subject|15|||
23501642|NCT00713323|65576682|FG000|Overall Study|Lost to Follow-up|11|||
23501643|NCT00713323|65576682|FG000|Overall Study|Lack of Efficacy|36|||
23501644|NCT00713323|65576682|FG000|Overall Study|Low creatine clearance at screening|1|||
23501645|NCT00713323|65576682|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
23501646|NCT00713323|65576682|FG000|Overall Study|Surgery cured allodynic pain|1|||
23501647|NCT00713323|65576682|FG000|Overall Study|Pain free|1|||
23501648|NCT00713323|65576682|FG000|Overall Study|Non-compliance|1|||
23501649|NCT00713323|65576682|FG000|Overall Study|Pain resolved|1|||
23501650|NCT00713323|65576682|FG000|Overall Study|Subject travelling to USA|1|||
23501651|NCT00713323|65576682|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
23501652|NCT00713323|65576682|FG000|Overall Study|Treatment that may interact with Sativex|1|||
23501653|NCT02021331|65576685|FG000|Overall Study|Adverse Event|0|||
23501654|NCT02021331|65576686|FG001|Overall Study|Adverse Event|2|||
23501655|NCT01513343|65576691|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
23501656|NCT01513343|65576692|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
23501657|NCT01513343|65576691|FG000|Post Data Collection|Dropped/withdrew from study|7|||
23501658|NCT01513343|65576692|FG001|Post Data Collection|Dropped/withdrew from study|1|||
23501659|NCT01513343|65576691|FG000|Post Data Collection|Lost to Follow-up|10|||
23501660|NCT01513343|65576692|FG001|Post Data Collection|Lost to Follow-up|23|||
23501661|NCT01513343|65576691|FG000|6-month Follow-up|Lost to Follow-up|28|||
23501662|NCT01513343|65576692|FG001|6-month Follow-up|Lost to Follow-up|17|||
23501663|NCT01513343|65576691|FG000|12-month Follow-up|Lost to Follow-up|10|||
23501664|NCT01513343|65576692|FG001|12-month Follow-up|Lost to Follow-up|3|||
23501665|NCT04661839|65576693|FG000|Overall Study|Not Treated|0|||
23501666|NCT04661839|65576694|FG001|Overall Study|Not Treated|0|||
23501667|NCT04661839|65576695|FG002|Overall Study|Not Treated|1|||
23501668|NCT04661839|65576696|FG003|Overall Study|Not Treated|0|||
23501669|NCT04661839|65576693|FG000|Overall Study|Lost to Follow-up|1|||
23501670|NCT04661839|65576694|FG001|Overall Study|Lost to Follow-up|0|||
23501671|NCT04661839|65576695|FG002|Overall Study|Lost to Follow-up|0|||
23501672|NCT04661839|65576696|FG003|Overall Study|Lost to Follow-up|1|||
23501673|NCT04752475|65576701|FG000|Overall Study|Withdrawal by Subject|1|||
23501674|NCT04752475|65576702|FG001|Overall Study|Withdrawal by Subject|1|||
23501675|NCT01858389|65576704|FG000|Overall Study|Death|1|||
23501676|NCT01858389|65576705|FG001|Overall Study|Death|3|||
23501677|NCT01858389|65576704|FG000|Overall Study|Study terminated by sponsor|0|||
23501678|NCT01858389|65576705|FG001|Overall Study|Study terminated by sponsor|2|||
23501679|NCT01858389|65576704|FG000|Overall Study|Withdrawal by Subject|0|||
23501680|NCT01858389|65576705|FG001|Overall Study|Withdrawal by Subject|1|||
23501681|NCT01858389|65576704|FG000|Overall Study|Progressive disease|10|||
23501682|NCT01858389|65576705|FG001|Overall Study|Progressive disease|11|||
23501683|NCT01858389|65576704|FG000|Overall Study|Other|2|||
23501684|NCT01858389|65576705|FG001|Overall Study|Other|4|||
23501685|NCT01858389|65576704|FG000|Overall Study|Adverse Event|3|||
23501686|NCT01858389|65576705|FG001|Overall Study|Adverse Event|1|||
23501687|NCT01858389|65576704|FG000|Overall Study|Did not receive treatment|0|||
23501688|NCT01858389|65576705|FG001|Overall Study|Did not receive treatment|3|||
23501689|NCT00640601|65576709|FG000|Overall Study|Adverse Event|43|||
23501690|NCT00640601|65576709|FG000|Overall Study|Withdrawal by Subject|20|||
23501691|NCT00640601|65576709|FG000|Overall Study|Protocol Violation|6|||
23501692|NCT00640601|65576709|FG000|Overall Study|Lack of Efficacy|16|||
23501693|NCT00640601|65576709|FG000|Overall Study|Lost to Follow-up|9|||
23501694|NCT00640601|65576709|FG000|Overall Study|Physician Decision|8|||
23501695|NCT00640601|65576709|FG000|Overall Study|treatment naive, combination therapy|10|||
23501696|NCT02321800|65576712|FG000|Overall Study|Withdrawal by Subject|3|||
23501697|NCT02321800|65576713|FG001|Overall Study|Withdrawal by Subject|3|||
23501698|NCT02321800|65576712|FG000|Overall Study|Death|1|||
23501699|NCT02321800|65576713|FG001|Overall Study|Death|0|||
23501700|NCT02321800|65576712|FG000|Overall Study|Protocol Violation|1|||
23501701|NCT02321800|65576713|FG001|Overall Study|Protocol Violation|0|||
23501702|NCT02321800|65576712|FG000|Overall Study|Lost to Follow-up|10|||
23501703|NCT02321800|65576713|FG001|Overall Study|Lost to Follow-up|4|||
23501704|NCT02321800|65576712|FG000|Overall Study|Adverse Event|2|||
23501705|NCT02321800|65576713|FG001|Overall Study|Adverse Event|3|||
23501706|NCT02321800|65576712|FG000|Overall Study|Other, Miscellaneous|3|||
23501707|NCT02321800|65576713|FG001|Overall Study|Other, Miscellaneous|1|||
23501708|NCT02059395|65576714|FG000|Overall Study|Lost to Follow-up|2|||
23501709|NCT02059395|65576715|FG001|Overall Study|Lost to Follow-up|4|||
23501710|NCT01708161|65576716|FG000|Overall Study|Adverse Event|1|||
23501711|NCT01708161|65576717|FG001|Overall Study|Adverse Event|3|||
23501712|NCT01708161|65576718|FG002|Overall Study|Adverse Event|4|||
23501713|NCT01708161|65576719|FG003|Overall Study|Adverse Event|2|||
23501714|NCT01708161|65576720|FG004|Overall Study|Adverse Event|3|||
23501715|NCT01708161|65576721|FG005|Overall Study|Adverse Event|0|||
23501716|NCT01708161|65576716|FG000|Overall Study|Death|0|||
23501717|NCT01708161|65576717|FG001|Overall Study|Death|0|||
23501718|NCT01708161|65576718|FG002|Overall Study|Death|0|||
23501719|NCT01708161|65576719|FG003|Overall Study|Death|1|||
23501720|NCT01708161|65576720|FG004|Overall Study|Death|0|||
23501721|NCT01708161|65576721|FG005|Overall Study|Death|1|||
23501722|NCT01708161|65576716|FG000|Overall Study|Withdrawal by Subject|0|||
23501723|NCT01708161|65576717|FG001|Overall Study|Withdrawal by Subject|1|||
23501724|NCT01708161|65576718|FG002|Overall Study|Withdrawal by Subject|1|||
23501725|NCT01708161|65576719|FG003|Overall Study|Withdrawal by Subject|0|||
23501726|NCT01708161|65576720|FG004|Overall Study|Withdrawal by Subject|0|||
23501727|NCT01708161|65576721|FG005|Overall Study|Withdrawal by Subject|0|||
23501728|NCT01708161|65576716|FG000|Overall Study|Administrative problems|0|||
23501729|NCT01708161|65576717|FG001|Overall Study|Administrative problems|1|||
23501730|NCT01708161|65576718|FG002|Overall Study|Administrative problems|0|||
23501731|NCT01708161|65576719|FG003|Overall Study|Administrative problems|0|||
23501732|NCT01708161|65576720|FG004|Overall Study|Administrative problems|0|||
23501733|NCT01708161|65576721|FG005|Overall Study|Administrative problems|0|||
23501734|NCT01708161|65576716|FG000|Overall Study|Disease progression|3|||
23501735|NCT01708161|65576717|FG001|Overall Study|Disease progression|5|||
23501736|NCT01708161|65576718|FG002|Overall Study|Disease progression|5|||
23501737|NCT01708161|65576719|FG003|Overall Study|Disease progression|13|||
23501738|NCT01708161|65576720|FG004|Overall Study|Disease progression|3|||
23501739|NCT01708161|65576721|FG005|Overall Study|Disease progression|0|||
23501740|NCT03868124|65576722|FG000|Overall Study|Withdrawal by Subject|4|||
23501741|NCT03868124|65576723|FG001|Overall Study|Withdrawal by Subject|0|||
23501742|NCT03868124|65576724|FG002|Overall Study|Withdrawal by Subject|1|||
23501743|NCT03868124|65576722|FG000|Overall Study|Physician Decision|1|||
23501744|NCT03868124|65576723|FG001|Overall Study|Physician Decision|0|||
23501745|NCT03868124|65576724|FG002|Overall Study|Physician Decision|1|||
23501746|NCT03868124|65576722|FG000|Overall Study|Lost to Follow-up|1|||
23501747|NCT03868124|65576723|FG001|Overall Study|Lost to Follow-up|1|||
23501748|NCT03868124|65576724|FG002|Overall Study|Lost to Follow-up|2|||
23501749|NCT03868124|65576722|FG000|Overall Study|Death|1|||
23501750|NCT03868124|65576723|FG001|Overall Study|Death|1|||
23501751|NCT03868124|65576724|FG002|Overall Study|Death|2|||
23501752|NCT03868124|65576722|FG000|Overall Study|Adverse Event|0|||
23501753|NCT03868124|65576723|FG001|Overall Study|Adverse Event|0|||
23501754|NCT03868124|65576724|FG002|Overall Study|Adverse Event|3|||
23501755|NCT03868124|65576722|FG000|Overall Study|Explanted|2|||
23501756|NCT03868124|65576723|FG001|Overall Study|Explanted|1|||
23501757|NCT03868124|65576724|FG002|Overall Study|Explanted|0|||
23501758|NCT03868124|65576722|FG000|Overall Study|Ongoing in study|176|||
23501759|NCT03868124|65576723|FG001|Overall Study|Ongoing in study|180|||
23501760|NCT03868124|65576724|FG002|Overall Study|Ongoing in study|183|||
23501761|NCT01782222|65576725|FG000|Overall Study|Adverse Event|4|||
23501762|NCT01782222|65576726|FG001|Overall Study|Adverse Event|5|||
23501763|NCT01782222|65576727|FG002|Overall Study|Adverse Event|3|||
23501764|NCT01782222|65576725|FG000|Overall Study|Lack of Efficacy|2|||
23501765|NCT01782222|65576726|FG001|Overall Study|Lack of Efficacy|1|||
23501766|NCT01782222|65576727|FG002|Overall Study|Lack of Efficacy|0|||
23501767|NCT01782222|65576725|FG000|Overall Study|Protocol Violation|1|||
23501768|NCT01782222|65576726|FG001|Overall Study|Protocol Violation|0|||
23501769|NCT01782222|65576727|FG002|Overall Study|Protocol Violation|0|||
23501770|NCT01782222|65576725|FG000|Overall Study|Withdrawal by Subject|1|||
23501771|NCT01782222|65576726|FG001|Overall Study|Withdrawal by Subject|4|||
23501772|NCT01782222|65576727|FG002|Overall Study|Withdrawal by Subject|1|||
23501773|NCT01782222|65576725|FG000|Overall Study|Moved to other state|0|||
23501774|NCT01782222|65576726|FG001|Overall Study|Moved to other state|1|||
23501775|NCT01782222|65576727|FG002|Overall Study|Moved to other state|0|||
23501776|NCT00923156|65576728|FG000|Overall Study|Adverse Event|0|||
23501777|NCT00923156|65576729|FG001|Overall Study|Adverse Event|2|||
23501778|NCT00923156|65576730|FG002|Overall Study|Adverse Event|1|||
23501779|NCT00923156|65576728|FG000|Overall Study|Abnormal laboratory values|0|||
23501780|NCT00923156|65576729|FG001|Overall Study|Abnormal laboratory values|0|||
23501781|NCT00923156|65576730|FG002|Overall Study|Abnormal laboratory values|1|||
23501782|NCT00923156|65576728|FG000|Overall Study|Withdrawal by Subject|0|||
23501783|NCT00923156|65576729|FG001|Overall Study|Withdrawal by Subject|1|||
23501784|NCT00923156|65576730|FG002|Overall Study|Withdrawal by Subject|0|||
23501785|NCT00923156|65576728|FG000|Overall Study|Death|0|||
23501786|NCT00923156|65576729|FG001|Overall Study|Death|1|||
23501787|NCT00923156|65576730|FG002|Overall Study|Death|0|||
23501788|NCT00923156|65576728|FG000|Overall Study|Lack of Efficacy|0|||
23501789|NCT00923156|65576729|FG001|Overall Study|Lack of Efficacy|0|||
23501790|NCT00923156|65576730|FG002|Overall Study|Lack of Efficacy|1|||
23501791|NCT00873015|65576731|FG000|Overall Study|Withdrawal by Subject|0|||
23501792|NCT00873015|65576732|FG001|Overall Study|Withdrawal by Subject|1|||
23501793|NCT00873015|65576733|FG002|Overall Study|Withdrawal by Subject|0|||
23501794|NCT00873015|65576734|FG003|Overall Study|Withdrawal by Subject|0|||
23606478|NCT02446015|65947259|FG000|Overall Study|Withdrawal by Subject|1|||
23606479|NCT02446015|65947260|FG001|Overall Study|Withdrawal by Subject|0|||
23606480|NCT03052517|65947261|FG000|Overall Study|Study Terminated By Sponsor|928|||
23606481|NCT03052517|65947262|FG001|Overall Study|Study Terminated By Sponsor|938|||
23606482|NCT03052517|65947263|FG002|Overall Study|Study Terminated By Sponsor|296|||
23606483|NCT03052517|65947261|FG000|Overall Study|Subject/Guardian Decision|50|||
23606484|NCT03052517|65947262|FG001|Overall Study|Subject/Guardian Decision|45|||
23606485|NCT03052517|65947263|FG002|Overall Study|Subject/Guardian Decision|22|||
23606486|NCT03052517|65947261|FG000|Overall Study|Lack of Efficacy|23|||
23606487|NCT03052517|65947262|FG001|Overall Study|Lack of Efficacy|14|||
23606488|NCT03052517|65947263|FG002|Overall Study|Lack of Efficacy|7|||
23606489|NCT03052517|65947261|FG000|Overall Study|Adverse Event|6|||
23606490|NCT03052517|65947262|FG001|Overall Study|Adverse Event|5|||
23606491|NCT03052517|65947263|FG002|Overall Study|Adverse Event|0|||
23606492|NCT03052517|65947261|FG000|Overall Study|Physician Decision|4|||
23606493|NCT03052517|65947262|FG001|Overall Study|Physician Decision|5|||
23606494|NCT03052517|65947263|FG002|Overall Study|Physician Decision|1|||
23606495|NCT03052517|65947261|FG000|Overall Study|Death|3|||
23606496|NCT03052517|65947262|FG001|Overall Study|Death|0|||
23606497|NCT03052517|65947263|FG002|Overall Study|Death|1|||
23606498|NCT03052517|65947261|FG000|Overall Study|Lost to Follow-up|2|||
23606499|NCT03052517|65947262|FG001|Overall Study|Lost to Follow-up|4|||
23606500|NCT03052517|65947263|FG002|Overall Study|Lost to Follow-up|0|||
23606501|NCT03052517|65947261|FG000|Overall Study|Pregnancy|1|||
23606502|NCT03052517|65947262|FG001|Overall Study|Pregnancy|0|||
23606503|NCT03052517|65947263|FG002|Overall Study|Pregnancy|1|||
23606504|NCT03052517|65947261|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23606505|NCT03052517|65947262|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
23606506|NCT03052517|65947263|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
23606507|NCT03052517|65947261|FG000|Overall Study|Technical Problems|0|||
23606508|NCT03052517|65947262|FG001|Overall Study|Technical Problems|1|||
23606509|NCT03052517|65947263|FG002|Overall Study|Technical Problems|0|||
23606510|NCT00657709|65947266|FG000|Overall Study|AE or Death|7|||
23606511|NCT00657709|65947267|FG001|Overall Study|AE or Death|7|||
23606512|NCT00657709|65947268|FG002|Overall Study|AE or Death|6|||
23606513|NCT00657709|65947269|FG003|Overall Study|AE or Death|7|||
23606514|NCT00657709|65947270|FG004|Overall Study|AE or Death|1|||
23606515|NCT00657709|65947266|FG000|Overall Study|Withdrawal by Subject|7|||
23606516|NCT00657709|65947267|FG001|Overall Study|Withdrawal by Subject|15|||
23606517|NCT00657709|65947268|FG002|Overall Study|Withdrawal by Subject|15|||
23606518|NCT00657709|65947269|FG003|Overall Study|Withdrawal by Subject|5|||
23606519|NCT00657709|65947270|FG004|Overall Study|Withdrawal by Subject|9|||
23606520|NCT00657709|65947266|FG000|Overall Study|Lost to Follow-up|9|||
23606521|NCT00657709|65947267|FG001|Overall Study|Lost to Follow-up|9|||
23606522|NCT00657709|65947268|FG002|Overall Study|Lost to Follow-up|7|||
23501795|NCT02256631|65580043|FG000|Overall Study|Lost to Follow-up|1|||
23501796|NCT02256631|65580044|FG001|Overall Study|Lost to Follow-up|1|||
23501797|NCT02256631|65580045|FG002|Overall Study|Lost to Follow-up|0|||
23501798|NCT02256631|65580046|FG003|Overall Study|Lost to Follow-up|2|||
23501799|NCT02256631|65580047|FG004|Overall Study|Lost to Follow-up|0|||
23501800|NCT02256631|65580048|FG005|Overall Study|Lost to Follow-up|4|||
23501801|NCT02256631|65580049|FG006|Overall Study|Lost to Follow-up|1|||
23501802|NCT02256631|65580043|FG000|Overall Study|Withdrawal by Subject|0|||
23501803|NCT02256631|65580044|FG001|Overall Study|Withdrawal by Subject|0|||
23501804|NCT02256631|65580045|FG002|Overall Study|Withdrawal by Subject|0|||
23501805|NCT02256631|65580046|FG003|Overall Study|Withdrawal by Subject|1|||
23501806|NCT02256631|65580047|FG004|Overall Study|Withdrawal by Subject|1|||
23501807|NCT02256631|65580048|FG005|Overall Study|Withdrawal by Subject|0|||
23501808|NCT02256631|65580049|FG006|Overall Study|Withdrawal by Subject|1|||
23501809|NCT02256631|65580043|FG000|Overall Study|Unable to get to clinic|0|||
23501810|NCT02256631|65580044|FG001|Overall Study|Unable to get to clinic|2|||
23501811|NCT02256631|65580045|FG002|Overall Study|Unable to get to clinic|0|||
23501812|NCT02256631|65580046|FG003|Overall Study|Unable to get to clinic|1|||
23501813|NCT02256631|65580047|FG004|Overall Study|Unable to get to clinic|0|||
23501814|NCT02256631|65580048|FG005|Overall Study|Unable to get to clinic|1|||
23501815|NCT02256631|65580049|FG006|Overall Study|Unable to get to clinic|2|||
23501816|NCT00039130|65580050|FG000|Overall Study|Adverse Event|11|||
23501817|NCT00039130|65580050|FG000|Overall Study|Death|9|||
23501818|NCT00039130|65580050|FG000|Overall Study|Withdrawal by Subject|3|||
23501819|NCT00039130|65580050|FG000|Overall Study|Progression|2|||
23501820|NCT00039130|65580050|FG000|Overall Study|Subsequent treatment|2|||
23501821|NCT00039130|65580050|FG000|Overall Study|Physician Decision|3|||
23501822|NCT03845985|65580053|FG000|Overall Study|Lost to Follow-up|2|||
23501823|NCT03845985|65580054|FG001|Overall Study|Lost to Follow-up|1|||
23501824|NCT03845985|65580053|FG000|Overall Study|Physician Decision|1|||
23501825|NCT03845985|65580054|FG001|Overall Study|Physician Decision|0|||
23501826|NCT03845985|65580053|FG000|Overall Study|Withdrawal by Subject|4|||
23501827|NCT03845985|65580054|FG001|Overall Study|Withdrawal by Subject|1|||
23501828|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501829|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
23501830|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501831|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501832|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501833|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501834|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501835|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501836|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501837|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501838|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501839|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501840|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
23501841|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
23501842|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
23501843|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
23501844|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
23501845|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
23501846|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
23501847|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
23501848|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
23501849|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
23501850|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
23501851|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
23501852|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
23501853|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
23501854|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
23501855|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
23501856|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
23501857|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
23501858|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
23501859|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
23501860|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
23501861|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
23501862|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
23501863|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
23501864|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501865|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501866|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501867|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501868|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
23501869|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501870|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501871|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501872|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501873|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501874|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
23501875|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501876|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
23501877|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
23501878|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
23501879|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
23501880|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
23501881|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
23501882|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
23501883|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
23501884|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
23501885|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
23501886|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
23501887|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
23501888|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
23501889|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
23501890|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
23501891|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
23501892|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
23501893|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
23501894|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
23501895|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
23501896|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
23501897|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
23501898|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
23501899|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
23501900|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Death|0|||
23501901|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Death|0|||
23501902|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Death|0|||
23501903|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Death|0|||
23501904|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Death|1|||
23501905|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Death|1|||
23501906|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Death|3|||
23501907|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Death|1|||
23501908|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Death|1|||
23501909|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Death|5|||
23501910|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Death|2|||
23501911|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Death|2|||
23501912|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Other|0|||
23501913|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Other|0|||
23501914|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Other|0|||
23501915|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Other|0|||
23501916|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Other|10|||
23501917|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Other|3|||
23501918|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Other|2|||
23501919|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Other|0|||
23501920|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Other|10|||
23501921|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Other|5|||
23501922|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Other|1|||
23501923|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Other|7|||
23501924|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501925|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501926|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501927|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501928|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
23501929|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501930|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501931|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501932|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501933|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501934|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501935|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501936|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501937|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501938|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501939|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501940|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
23501941|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501942|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23606523|NCT00657709|65947269|FG003|Overall Study|Lost to Follow-up|1|||
23501943|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501944|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501945|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501946|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501947|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501948|NCT02165215|65580074|FG000|Induction Phase|Adverse Event|1|||
23501949|NCT02165215|65580075|FG001|Induction Phase|Adverse Event|0|||
23501950|NCT02165215|65580076|FG002|Induction Phase|Adverse Event|0|||
23501951|NCT02165215|65580074|FG000|Induction Phase|Withdrawal by Subject|10|||
23501952|NCT02165215|65580075|FG001|Induction Phase|Withdrawal by Subject|0|||
23501953|NCT02165215|65580076|FG002|Induction Phase|Withdrawal by Subject|0|||
23501954|NCT02165215|65580074|FG000|Induction Phase|Protocol Violation|1|||
23501955|NCT02165215|65580075|FG001|Induction Phase|Protocol Violation|0|||
23501956|NCT02165215|65580076|FG002|Induction Phase|Protocol Violation|0|||
23501957|NCT02165215|65580074|FG000|Induction Phase|Physician Decision|1|||
23501958|NCT02165215|65580075|FG001|Induction Phase|Physician Decision|0|||
23501959|NCT02165215|65580076|FG002|Induction Phase|Physician Decision|0|||
23501960|NCT02165215|65580074|FG000|Induction Phase|Lack of Efficacy|2|||
23501961|NCT02165215|65580075|FG001|Induction Phase|Lack of Efficacy|0|||
23501962|NCT02165215|65580076|FG002|Induction Phase|Lack of Efficacy|0|||
23501963|NCT02165215|65580074|FG000|Induction Phase|Non-Compliance|2|||
23501964|NCT02165215|65580075|FG001|Induction Phase|Non-Compliance|0|||
23501965|NCT02165215|65580076|FG002|Induction Phase|Non-Compliance|0|||
23501966|NCT02165215|65580074|FG000|Induction Phase|Lost to Follow-up|6|||
23501967|NCT02165215|65580075|FG001|Induction Phase|Lost to Follow-up|0|||
23501968|NCT02165215|65580076|FG002|Induction Phase|Lost to Follow-up|0|||
23501969|NCT02165215|65580074|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23501970|NCT02165215|65580075|FG001|Maintenance Phase|Withdrawal by Subject|7|||
23501971|NCT02165215|65580076|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23501972|NCT02165215|65580074|FG000|Maintenance Phase|Multiple reasons|0|||
23501973|NCT02165215|65580075|FG001|Maintenance Phase|Multiple reasons|2|||
23501974|NCT02165215|65580076|FG002|Maintenance Phase|Multiple reasons|1|||
23501975|NCT02165215|65580074|FG000|Maintenance Phase|Lost to Follow-up|0|||
23501976|NCT02165215|65580075|FG001|Maintenance Phase|Lost to Follow-up|2|||
23501977|NCT02165215|65580076|FG002|Maintenance Phase|Lost to Follow-up|0|||
23501978|NCT02165215|65580074|FG000|Maintenance Phase|Adverse Event|0|||
23501979|NCT02165215|65580075|FG001|Maintenance Phase|Adverse Event|1|||
23501980|NCT02165215|65580076|FG002|Maintenance Phase|Adverse Event|1|||
23501981|NCT00660309|65580080|FG000|Overall Study|Adverse Event|2|||
23501982|NCT00660309|65580081|FG001|Overall Study|Adverse Event|0|||
23501983|NCT00660309|65580080|FG000|Overall Study|Withdrawal by Subject|0|||
23501984|NCT00660309|65580081|FG001|Overall Study|Withdrawal by Subject|3|||
23501985|NCT02619175|65580082|FG000|Overall Study|Withdrawal by Subject|1|||
23501986|NCT02619175|65580083|FG001|Overall Study|Withdrawal by Subject|0|||
23501987|NCT02619175|65580082|FG000|Overall Study|foot pain|1|||
23501988|NCT02619175|65580083|FG001|Overall Study|foot pain|0|||
23501989|NCT03167411|65580084|FG000|Overall Study|Adverse Event|0|||
23501990|NCT03167411|65580085|FG001|Overall Study|Adverse Event|1|||
23501991|NCT02853604|65580094|FG000|Overall Study|Withdrawal by Subject|12|||
23501992|NCT02853604|65580095|FG001|Overall Study|Withdrawal by Subject|35|||
23501993|NCT02853604|65580094|FG000|Overall Study|Lost to Follow-up|4|||
23501994|NCT02853604|65580095|FG001|Overall Study|Lost to Follow-up|8|||
23501995|NCT02853604|65580094|FG000|Overall Study|Death|1|||
23501996|NCT02853604|65580095|FG001|Overall Study|Death|5|||
23501997|NCT02853604|65580094|FG000|Overall Study|Miscellaneous|11|||
23501998|NCT02853604|65580095|FG001|Overall Study|Miscellaneous|2|||
23501999|NCT02853604|65580094|FG000|Overall Study|Progressive Disease|0|||
23502000|NCT02853604|65580095|FG001|Overall Study|Progressive Disease|2|||
23502001|NCT01032837|65580098|FG000|Overall Study|Adverse event/internal illness|0|||
23502002|NCT01032837|65580099|FG001|Overall Study|Adverse event/internal illness|1|||
23502003|NCT01032837|65580100|FG002|Overall Study|Adverse event/internal illness|0|||
23502004|NCT01032837|65580101|FG003|Overall Study|Adverse event/internal illness|1|||
23502005|NCT01032837|65580098|FG000|Overall Study|Withdrew consent|0|||
23502006|NCT01032837|65580099|FG001|Overall Study|Withdrew consent|2|||
23502007|NCT01032837|65580100|FG002|Overall Study|Withdrew consent|0|||
23502008|NCT01032837|65580101|FG003|Overall Study|Withdrew consent|1|||
23502009|NCT01032837|65580098|FG000|Overall Study|Failed to return|0|||
23502010|NCT01032837|65580099|FG001|Overall Study|Failed to return|0|||
23502011|NCT01032837|65580100|FG002|Overall Study|Failed to return|1|||
23502012|NCT01032837|65580101|FG003|Overall Study|Failed to return|0|||
23502013|NCT01032837|65580098|FG000|Overall Study|Refused treatment|0|||
23502014|NCT01032837|65580099|FG001|Overall Study|Refused treatment|0|||
23502015|NCT01032837|65580100|FG002|Overall Study|Refused treatment|0|||
23502016|NCT01032837|65580101|FG003|Overall Study|Refused treatment|1|||
23502017|NCT00582166|65580102|FG000|Overall Study|Death|1|||
23502018|NCT00582166|65580102|FG000|Overall Study|Ineligible pathology|1|||
23502019|NCT00288054|65580103|FG000|Overall Study|Protocol Violation|2|||
23502020|NCT00288054|65580103|FG000|Overall Study|Lack of Efficacy|16|||
23502021|NCT00288054|65580103|FG000|Overall Study|Adverse Event|3|||
23502022|NCT00288054|65580103|FG000|Overall Study|Withdrawal by Subject|1|||
23502023|NCT00288054|65580103|FG000|Overall Study|Not protocol specified|2|||
23502024|NCT01471171|65580106|FG000|Treatment Period 1|Adverse Event|4|||
23502025|NCT01471171|65580107|FG001|Treatment Period 1|Adverse Event|1|||
23502026|NCT01471171|65580106|FG000|Treatment Period 2|Adverse Event|1|||
23699969|NCT02401256|66280536|FG000|Overall Study|Adverse Event|5|||
23699970|NCT02401256|66280536|FG000|Overall Study|Withdrawal by Subject|12|||
23699971|NCT00273858|66280537|FG000|Overall Study|Not completed 24 month observation time|334|||
23699972|NCT00273858|66280537|FG000|Overall Study|Lost to Follow-up|101|||
23699973|NCT00273858|66280537|FG000|Overall Study|Withdrawal by Subject|21|||
23699974|NCT00273858|66280537|FG000|Overall Study|Adverse Event|81|||
23699975|NCT00719732|66280538|FG000|Overall Study|Lost to Follow-up|20|||
23699976|NCT00719732|66280538|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
23699977|NCT00719732|66280538|FG000|Overall Study|Illness not associated with device|1|||
23699978|NCT01095250|66280542|FG000|Overall Study|administrative reasons|8|||
23699979|NCT01095250|66280543|FG001|Overall Study|administrative reasons|10|||
23699980|NCT01095250|66280544|FG002|Overall Study|administrative reasons|7|||
23699981|NCT01095250|66280545|FG003|Overall Study|administrative reasons|5|||
23699982|NCT01095250|66280542|FG000|Overall Study|Withdrawal by Subject|0|||
23699983|NCT01095250|66280543|FG001|Overall Study|Withdrawal by Subject|0|||
23699984|NCT01095250|66280544|FG002|Overall Study|Withdrawal by Subject|1|||
23398817|NCT00673920|65207152|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
23398818|NCT00673920|65207153|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
23398819|NCT00673920|65207154|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
23398820|NCT00673920|65207155|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
23398821|NCT00673920|65207156|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
23398822|NCT00673920|65207157|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
23398823|NCT01645176|65207158|FG000|Overall Study|Lack of Efficacy|4|||
23398824|NCT01645176|65207158|FG000|Overall Study|did not complete final MRI|1|||
23398825|NCT03342560|65207159|FG000|Overall Study|Lost to Follow-up|2|||
23398826|NCT01664624|65207163|FG000|Overall Study|Adverse Event|0|||
23398827|NCT01664624|65207164|FG001|Overall Study|Adverse Event|1|||
23398828|NCT01664624|65207165|FG002|Overall Study|Adverse Event|0|||
23398829|NCT01664624|65207166|FG003|Overall Study|Adverse Event|0|||
23398830|NCT04490278|65207170|FG000|Overall Study|Lost to Follow-up|6|||
23398831|NCT01346176|65207179|FG000|Recruited|Protocol Violation|1|||
23398832|NCT01346176|65207180|FG001|Recruited|Protocol Violation|0|||
23398833|NCT01346176|65207181|FG002|Recruited|Protocol Violation|0|||
23398834|NCT01346176|65207179|FG000|Completed Advance Directive|Death|3|||
23398835|NCT01346176|65207180|FG001|Completed Advance Directive|Death|2|||
23398836|NCT01346176|65207181|FG002|Completed Advance Directive|Death|2|||
23398837|NCT01346176|65207179|FG000|Completed Advance Directive|Became Ineligible|3|||
23398838|NCT01346176|65207180|FG001|Completed Advance Directive|Became Ineligible|0|||
23398839|NCT01346176|65207181|FG002|Completed Advance Directive|Became Ineligible|1|||
23398840|NCT01346176|65207179|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
23398841|NCT01346176|65207180|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
23398842|NCT01346176|65207181|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
23398843|NCT01346176|65207179|FG000|Completed Satisfaction Survey|Death|3|||
23398844|NCT01346176|65207180|FG001|Completed Satisfaction Survey|Death|0|||
23398845|NCT01346176|65207181|FG002|Completed Satisfaction Survey|Death|2|||
23398846|NCT01346176|65207179|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
23398847|NCT01346176|65207180|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
23398848|NCT01346176|65207181|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
23398849|NCT01263119|65207182|FG000|Period 1|Protocol Violation|2|||
23398850|NCT01263119|65207182|FG000|Period 2|Adverse Event|2|||
23398851|NCT03586973|65207183|FG000|Overall Study|Death|15|||
23398852|NCT03586973|65207184|FG001|Overall Study|Death|8|||
23398853|NCT03586973|65207183|FG000|Overall Study|Site Terminated by Sponsor|3|||
23398854|NCT03586973|65207184|FG001|Overall Study|Site Terminated by Sponsor|6|||
23398855|NCT03586973|65207183|FG000|Overall Study|Withdrawal by Subject|1|||
23398856|NCT03586973|65207184|FG001|Overall Study|Withdrawal by Subject|0|||
23398857|NCT03586973|65207183|FG000|Overall Study|Lost to Follow-up|1|||
23398858|NCT03586973|65207184|FG001|Overall Study|Lost to Follow-up|0|||
23398859|NCT00335829|65207185|FG000|Overall Study|Withdrawal by Subject|1|||
23398860|NCT00335829|65207185|FG000|Overall Study|Lost to Follow-up|1|||
23398861|NCT00335829|65207185|FG000|Overall Study|Adverse Event|1|||
23398862|NCT03580044|65207186|FG000|Overall Study|Death|2|||
23398863|NCT03580044|65207187|FG001|Overall Study|Death|1|||
23398864|NCT03580044|65207186|FG000|Overall Study|Withdrawal by Subject|1|||
23398865|NCT03580044|65207187|FG001|Overall Study|Withdrawal by Subject|1|||
23398866|NCT03139448|65207188|FG000|Overall Study|Lack of Efficacy|6|||
23398867|NCT03139448|65207189|FG001|Overall Study|Lack of Efficacy|7|||
23398868|NCT03139448|65207188|FG000|Overall Study|Location of procedure changed|2|||
23398869|NCT03139448|65207189|FG001|Overall Study|Location of procedure changed|8|||
23398870|NCT03139448|65207188|FG000|Overall Study|Withdrawal by Subject|3|||
23699985|NCT01095250|66280545|FG003|Overall Study|Withdrawal by Subject|0|||
23699986|NCT02375698|66280546|FG000|Overall Study|Withdrawal by Subject|0|||
23699987|NCT02375698|66280547|FG001|Overall Study|Withdrawal by Subject|2|||
23699988|NCT02375698|66280546|FG000|Overall Study|Physician Decision|2|||
23699989|NCT02375698|66280547|FG001|Overall Study|Physician Decision|0|||
23699990|NCT01582282|66280548|FG000|Overall Study|Adverse Event|1|||
23699991|NCT01582282|66280549|FG001|Overall Study|Adverse Event|1|||
23699992|NCT01582282|66280550|FG002|Overall Study|Adverse Event|0|||
23699993|NCT01582282|66280548|FG000|Overall Study|Lost to Follow-up|1|||
23699994|NCT01582282|66280549|FG001|Overall Study|Lost to Follow-up|0|||
23699995|NCT01582282|66280550|FG002|Overall Study|Lost to Follow-up|0|||
23699996|NCT01582282|66280548|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
23502027|NCT01471171|65580107|FG001|Treatment Period 2|Adverse Event|0|||
23502028|NCT03486223|65580114|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
23502029|NCT03486223|65580115|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
23502030|NCT01929343|65580118|FG000|Overall Study|Physician Decision|0|||
23502031|NCT01929343|65580119|FG001|Overall Study|Physician Decision|2|||
23502032|NCT01929343|65580120|FG002|Overall Study|Physician Decision|0|||
23502033|NCT01929343|65580118|FG000|Overall Study|Withdrawal by Subject|1|||
23502034|NCT01929343|65580119|FG001|Overall Study|Withdrawal by Subject|0|||
23502035|NCT01929343|65580120|FG002|Overall Study|Withdrawal by Subject|0|||
23502036|NCT00393029|65580123|FG000|Overall Study|Not treated|0|||
23502037|NCT00393029|65580124|FG001|Overall Study|Not treated|1|||
23502038|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
23502039|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
23502040|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
23502041|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
23502042|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
23699997|NCT01582282|66280549|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
23699998|NCT01582282|66280550|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
23699999|NCT01518192|66280551|FG000|Overall Study|Lost to Follow-up|29|||
23700000|NCT01518192|66280552|FG001|Overall Study|Lost to Follow-up|26|||
23700001|NCT01518192|66280553|FG002|Overall Study|Lost to Follow-up|35|||
23700002|NCT01188798|66280554|FG000|Overall Study|Death|0|||
23700003|NCT01188798|66280555|FG001|Overall Study|Death|1|||
23700004|NCT01188798|66280554|FG000|Overall Study|Required additional transplant|1|||
23700005|NCT01188798|66280555|FG001|Overall Study|Required additional transplant|1|||
23700006|NCT01188798|66280554|FG000|Overall Study|Protocol closure|1|||
23700007|NCT01188798|66280555|FG001|Overall Study|Protocol closure|1|||
23700008|NCT02345434|66280558|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
23700009|NCT02345434|66280559|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
23700010|NCT01544595|66280562|FG000|Status at Week 68|Adverse Event|3|||
23502043|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502044|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
23700011|NCT01544595|66280563|FG001|Status at Week 68|Adverse Event|2|||
23700012|NCT01544595|66280564|FG002|Status at Week 68|Adverse Event|1|||
23700013|NCT01544595|66280565|FG003|Status at Week 68|Adverse Event|0|||
23700014|NCT01544595|66280566|FG004|Status at Week 68|Adverse Event|0|||
23700015|NCT01544595|66280567|FG005|Status at Week 68|Adverse Event|0|||
23700016|NCT01544595|66280562|FG000|Status at Week 68|Lack of Efficacy|1|||
23700017|NCT01544595|66280563|FG001|Status at Week 68|Lack of Efficacy|0|||
23700018|NCT01544595|66280564|FG002|Status at Week 68|Lack of Efficacy|0|||
23700019|NCT01544595|66280565|FG003|Status at Week 68|Lack of Efficacy|0|||
23700020|NCT01544595|66280566|FG004|Status at Week 68|Lack of Efficacy|0|||
23700021|NCT01544595|66280567|FG005|Status at Week 68|Lack of Efficacy|0|||
23700022|NCT01544595|66280562|FG000|Status at Week 68|Lost to Follow-up|1|||
23700023|NCT01544595|66280563|FG001|Status at Week 68|Lost to Follow-up|1|||
23700024|NCT01544595|66280564|FG002|Status at Week 68|Lost to Follow-up|0|||
23700025|NCT01544595|66280565|FG003|Status at Week 68|Lost to Follow-up|0|||
23700026|NCT01544595|66280566|FG004|Status at Week 68|Lost to Follow-up|0|||
23700027|NCT01544595|66280567|FG005|Status at Week 68|Lost to Follow-up|0|||
23700028|NCT01544595|66280562|FG000|Status at Week 68|Non-compliance with study treatment|1|||
23700029|NCT01544595|66280563|FG001|Status at Week 68|Non-compliance with study treatment|0|||
23700030|NCT01544595|66280564|FG002|Status at Week 68|Non-compliance with study treatment|0|||
23700031|NCT01544595|66280565|FG003|Status at Week 68|Non-compliance with study treatment|1|||
23700032|NCT01544595|66280566|FG004|Status at Week 68|Non-compliance with study treatment|0|||
23700033|NCT01544595|66280567|FG005|Status at Week 68|Non-compliance with study treatment|0|||
23700034|NCT01544595|66280562|FG000|Status at Week 68|Protocol Violation|2|||
23700035|NCT01544595|66280563|FG001|Status at Week 68|Protocol Violation|0|||
23700036|NCT01544595|66280564|FG002|Status at Week 68|Protocol Violation|1|||
23700037|NCT01544595|66280565|FG003|Status at Week 68|Protocol Violation|1|||
23502045|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
23700038|NCT01544595|66280566|FG004|Status at Week 68|Protocol Violation|0|||
23700039|NCT01544595|66280567|FG005|Status at Week 68|Protocol Violation|0|||
23398871|NCT03139448|65207189|FG001|Overall Study|Withdrawal by Subject|6|||
23398872|NCT03139448|65207188|FG000|Overall Study|Screen fail|1|||
23398873|NCT03139448|65207189|FG001|Overall Study|Screen fail|3|||
23398874|NCT03139448|65207188|FG000|Overall Study|Physician Decision|0|||
23398875|NCT03139448|65207189|FG001|Overall Study|Physician Decision|2|||
23398876|NCT00320606|65207190|FG000|Overall Study|Adverse Event|1|||
23398877|NCT00320606|65207190|FG000|Overall Study|Protocol Violation|1|||
23398878|NCT00320606|65207190|FG000|Overall Study|Withdrawal by Subject|1|||
23398879|NCT01917318|65207191|FG000|First Treatment|Withdrawal by Subject|0|||
23398880|NCT01917318|65207192|FG001|First Treatment|Withdrawal by Subject|1|||
23398881|NCT02095106|65207193|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23398882|NCT02095106|65207194|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23398883|NCT02234362|65207195|FG000|Overall Study|Not eligible after first screening visit|17|||
23398884|NCT02234362|65207195|FG000|Overall Study|Lost to Follow-up|6|||
23398885|NCT02234362|65207195|FG000|Overall Study|Withdrawal by Subject|3|||
23398886|NCT00529633|65207200|FG000|Overall Study|Withdrawal by Subject|1|||
23398887|NCT00529633|65207201|FG001|Overall Study|Withdrawal by Subject|1|||
23398888|NCT01464879|65207202|FG000|Overall Study|Physician Decision|1|||
23398889|NCT01464879|65207202|FG000|Overall Study|Non-compliance|1|||
23398890|NCT01900665|65207207|FG000|Placebo Controlled Period|Death|9|||
23398891|NCT01900665|65207208|FG001|Placebo Controlled Period|Death|16|||
23398892|NCT01900665|65207207|FG000|Placebo Controlled Period|Adverse Event|48|||
23398893|NCT01900665|65207208|FG001|Placebo Controlled Period|Adverse Event|39|||
23398894|NCT01900665|65207207|FG000|Placebo Controlled Period|Protocol Violation|1|||
23398895|NCT01900665|65207208|FG001|Placebo Controlled Period|Protocol Violation|7|||
23398896|NCT01900665|65207207|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
23398897|NCT01900665|65207208|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
23398898|NCT01900665|65207207|FG000|Placebo Controlled Period|Physician Decision|11|||
23502046|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502047|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502048|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
23502049|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
23502050|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
23502051|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
23502052|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
23502053|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
23502054|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
23502055|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
23502056|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
23502057|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
23502058|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502059|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502060|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
23502061|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502062|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502063|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502064|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502065|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
23502066|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502067|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502068|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
23502069|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502070|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502071|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502072|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502073|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502074|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
23700040|NCT01544595|66280562|FG000|Status at Week 68|Technical problems|1|||
23700041|NCT01544595|66280563|FG001|Status at Week 68|Technical problems|0|||
23700042|NCT01544595|66280564|FG002|Status at Week 68|Technical problems|0|||
23700043|NCT01544595|66280565|FG003|Status at Week 68|Technical problems|1|||
23700044|NCT01544595|66280566|FG004|Status at Week 68|Technical problems|0|||
23700045|NCT01544595|66280567|FG005|Status at Week 68|Technical problems|0|||
23398899|NCT01900665|65207208|FG001|Placebo Controlled Period|Physician Decision|7|||
23398900|NCT01900665|65207207|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
23398901|NCT01900665|65207208|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
23700046|NCT01544595|66280562|FG000|Status at Week 68|Withdrawal by Subject|0|||
23700047|NCT01544595|66280563|FG001|Status at Week 68|Withdrawal by Subject|1|||
23700048|NCT01544595|66280564|FG002|Status at Week 68|Withdrawal by Subject|1|||
23398902|NCT01900665|65207207|FG000|Placebo Controlled Period|Caregiver Decision|33|||
23700049|NCT01544595|66280565|FG003|Status at Week 68|Withdrawal by Subject|2|||
23700050|NCT01544595|66280566|FG004|Status at Week 68|Withdrawal by Subject|0|||
23700051|NCT01544595|66280567|FG005|Status at Week 68|Withdrawal by Subject|0|||
23700052|NCT01544595|66280562|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
23700053|NCT01544595|66280563|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
23700054|NCT01544595|66280564|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
23700055|NCT01544595|66280565|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
23700056|NCT01544595|66280566|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
23700057|NCT01544595|66280567|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
23700058|NCT01544595|66280562|FG000|Status at Week 156|Withdrawal by Subject|9|||
23700059|NCT01544595|66280563|FG001|Status at Week 156|Withdrawal by Subject|10|||
23700060|NCT01544595|66280564|FG002|Status at Week 156|Withdrawal by Subject|4|||
23700061|NCT01544595|66280565|FG003|Status at Week 156|Withdrawal by Subject|9|||
23700062|NCT01544595|66280566|FG004|Status at Week 156|Withdrawal by Subject|20|||
23700063|NCT01544595|66280567|FG005|Status at Week 156|Withdrawal by Subject|6|||
23700064|NCT01544595|66280562|FG000|Status at Week 156|Adverse Event|9|||
23700065|NCT01544595|66280563|FG001|Status at Week 156|Adverse Event|11|||
23700066|NCT01544595|66280564|FG002|Status at Week 156|Adverse Event|1|||
23700067|NCT01544595|66280565|FG003|Status at Week 156|Adverse Event|3|||
23700068|NCT01544595|66280566|FG004|Status at Week 156|Adverse Event|4|||
23700069|NCT01544595|66280567|FG005|Status at Week 156|Adverse Event|2|||
23700070|NCT01544595|66280562|FG000|Status at Week 156|Lost to Follow-up|4|||
23700071|NCT01544595|66280563|FG001|Status at Week 156|Lost to Follow-up|4|||
23700072|NCT01544595|66280564|FG002|Status at Week 156|Lost to Follow-up|0|||
23700073|NCT01544595|66280565|FG003|Status at Week 156|Lost to Follow-up|1|||
23700074|NCT01544595|66280566|FG004|Status at Week 156|Lost to Follow-up|4|||
23700075|NCT01544595|66280567|FG005|Status at Week 156|Lost to Follow-up|1|||
23700076|NCT01544595|66280562|FG000|Status at Week 156|Non-compliance with study treatement|0|||
23700077|NCT01544595|66280563|FG001|Status at Week 156|Non-compliance with study treatement|1|||
23700078|NCT01544595|66280564|FG002|Status at Week 156|Non-compliance with study treatement|0|||
23700079|NCT01544595|66280565|FG003|Status at Week 156|Non-compliance with study treatement|1|||
23700080|NCT01544595|66280566|FG004|Status at Week 156|Non-compliance with study treatement|0|||
23700081|NCT01544595|66280567|FG005|Status at Week 156|Non-compliance with study treatement|1|||
23700082|NCT01544595|66280562|FG000|Status at Week 156|Physician Decision|0|||
23700083|NCT01544595|66280563|FG001|Status at Week 156|Physician Decision|3|||
23700084|NCT01544595|66280564|FG002|Status at Week 156|Physician Decision|1|||
23700085|NCT01544595|66280565|FG003|Status at Week 156|Physician Decision|0|||
23700086|NCT01544595|66280566|FG004|Status at Week 156|Physician Decision|0|||
23700087|NCT01544595|66280567|FG005|Status at Week 156|Physician Decision|0|||
23700088|NCT01544595|66280562|FG000|Status at Week 156|Pregnancy|2|||
23700089|NCT01544595|66280563|FG001|Status at Week 156|Pregnancy|3|||
23700090|NCT01544595|66280564|FG002|Status at Week 156|Pregnancy|0|||
23700091|NCT01544595|66280565|FG003|Status at Week 156|Pregnancy|0|||
23700092|NCT01544595|66280566|FG004|Status at Week 156|Pregnancy|0|||
23700093|NCT01544595|66280567|FG005|Status at Week 156|Pregnancy|0|||
23700094|NCT01544595|66280562|FG000|Status at Week 156|Protocol Violation|3|||
23700095|NCT01544595|66280563|FG001|Status at Week 156|Protocol Violation|1|||
23700096|NCT01544595|66280564|FG002|Status at Week 156|Protocol Violation|2|||
23700097|NCT01544595|66280565|FG003|Status at Week 156|Protocol Violation|2|||
23700098|NCT01544595|66280566|FG004|Status at Week 156|Protocol Violation|0|||
23700099|NCT01544595|66280567|FG005|Status at Week 156|Protocol Violation|0|||
23700100|NCT01544595|66280562|FG000|Status at Week 156|Technical problems|3|||
23700101|NCT01544595|66280563|FG001|Status at Week 156|Technical problems|1|||
23700102|NCT01544595|66280564|FG002|Status at Week 156|Technical problems|0|||
23700103|NCT01544595|66280565|FG003|Status at Week 156|Technical problems|1|||
23700104|NCT01544595|66280566|FG004|Status at Week 156|Technical problems|0|||
23700105|NCT01544595|66280567|FG005|Status at Week 156|Technical problems|0|||
23700106|NCT01544595|66280562|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
23700107|NCT01544595|66280563|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
23700108|NCT01544595|66280564|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
23700109|NCT01544595|66280565|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
23700110|NCT01544595|66280566|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
23700111|NCT01544595|66280567|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
23700112|NCT01544595|66280562|FG000|Status at Week 156|Lack of Efficacy|1|||
23700113|NCT01544595|66280563|FG001|Status at Week 156|Lack of Efficacy|0|||
23700114|NCT01544595|66280564|FG002|Status at Week 156|Lack of Efficacy|1|||
23700115|NCT01544595|66280565|FG003|Status at Week 156|Lack of Efficacy|4|||
23700116|NCT01544595|66280566|FG004|Status at Week 156|Lack of Efficacy|10|||
23700117|NCT01544595|66280567|FG005|Status at Week 156|Lack of Efficacy|5|||
23700118|NCT01512368|66280570|FG000|Overall Study|Protocol Violation|3|||
23700119|NCT05301322|66280577|FG000|Overall Study|Adverse Event|7|||
23700120|NCT05301322|66280578|FG001|Overall Study|Adverse Event|3|||
23700121|NCT05301322|66280577|FG000|Overall Study|Death|0|||
23700122|NCT05301322|66280578|FG001|Overall Study|Death|1|||
23700123|NCT05301322|66280577|FG000|Overall Study|Lost to Follow-up|2|||
23700124|NCT05301322|66280578|FG001|Overall Study|Lost to Follow-up|1|||
23700125|NCT05301322|66280577|FG000|Overall Study|Protocol Violation|3|||
23700126|NCT05301322|66280578|FG001|Overall Study|Protocol Violation|1|||
23700127|NCT05301322|66280577|FG000|Overall Study|Withdrawal by Subject|3|||
23700128|NCT05301322|66280578|FG001|Overall Study|Withdrawal by Subject|0|||
23700129|NCT05301322|66280577|FG000|Overall Study|Other|4|||
23700130|NCT05301322|66280578|FG001|Overall Study|Other|0|||
23700131|NCT01671085|66280586|FG000|Overall Study|Withdrawal by Subject|1|||
23700132|NCT01671085|66280587|FG001|Overall Study|Withdrawal by Subject|0|||
23700133|NCT00443430|66280588|FG000|Overall Study|Lack of Efficacy|3|||
23700134|NCT00443430|66280589|FG001|Overall Study|Lack of Efficacy|3|||
23700135|NCT00443430|66280588|FG000|Overall Study|Adverse Event|1|||
23700136|NCT00443430|66280589|FG001|Overall Study|Adverse Event|1|||
23700137|NCT00893113|66280590|FG000|Overall Study|Lost to Follow-up|4|||
23700138|NCT00893113|66280591|FG001|Overall Study|Lost to Follow-up|8|||
23700139|NCT00893113|66280590|FG000|Overall Study|Early Termination|1|||
23700140|NCT00893113|66280591|FG001|Overall Study|Early Termination|1|||
23700141|NCT00893113|66280590|FG000|Overall Study|Withdrew Consent|8|||
23700142|NCT00893113|66280591|FG001|Overall Study|Withdrew Consent|7|||
23700143|NCT02452970|66280592|FG000|Overall Study|Adverse Event|1|||
23700144|NCT00436215|66280593|FG000|Overall Study|Refused further treatment|3|||
23700145|NCT00436215|66280593|FG000|Overall Study|Small bowel obstruction|1|||
23700146|NCT02341014|66280596|FG000|Overall Study|Adverse Event|0|||
23700147|NCT02341014|66280597|FG001|Overall Study|Adverse Event|1|||
23700148|NCT02341014|66280598|FG002|Overall Study|Adverse Event|0|||
23700149|NCT02341014|66280599|FG003|Overall Study|Adverse Event|0|||
23700150|NCT02341014|66280600|FG004|Overall Study|Adverse Event|2|||
23700151|NCT04283461|66280601|FG000|Overall Study|Enrolled in separate trial|0|||
23502075|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502076|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502077|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502078|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502079|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
23502080|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502081|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502082|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
23502083|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502084|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502085|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
23502086|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502087|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502088|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
23502089|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
23502090|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
23502091|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
23502092|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
23502093|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502094|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
23502095|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502096|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502097|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502098|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502099|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502100|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502101|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
23502102|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502103|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502104|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502105|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
23502106|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502107|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502108|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Change of location|0|||
23502109|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Change of location|0|||
23700152|NCT04283461|66280602|FG001|Overall Study|Enrolled in separate trial|0|||
23700153|NCT04283461|66280603|FG002|Overall Study|Enrolled in separate trial|8|||
23700154|NCT04283461|66280604|FG003|Overall Study|Enrolled in separate trial|13|||
23700155|NCT04283461|66280605|FG004|Overall Study|Enrolled in separate trial|12|||
23700156|NCT04283461|66280606|FG005|Overall Study|Enrolled in separate trial|0|||
23700157|NCT04283461|66280607|FG006|Overall Study|Enrolled in separate trial|0|||
23700158|NCT04283461|66280608|FG007|Overall Study|Enrolled in separate trial|8|||
23700159|NCT04283461|66280609|FG008|Overall Study|Enrolled in separate trial|0|||
23700160|NCT04283461|66280610|FG009|Overall Study|Enrolled in separate trial|0|||
23700161|NCT04283461|66280611|FG010|Overall Study|Enrolled in separate trial|0|||
23700162|NCT04283461|66280612|FG011|Overall Study|Enrolled in separate trial|7|||
23700163|NCT04283461|66280613|FG012|Overall Study|Enrolled in separate trial|0|||
23700164|NCT04329923|66280614|FG000|Overall Study|Withdrawal by Subject|1|||
23700165|NCT04329923|66280615|FG001|Overall Study|Withdrawal by Subject|4|||
23700166|NCT04329923|66280616|FG002|Overall Study|Withdrawal by Subject|1|||
23700167|NCT04329923|66280617|FG003|Overall Study|Withdrawal by Subject|1|||
23700168|NCT04329923|66280618|FG004|Overall Study|Withdrawal by Subject|1|||
23700169|NCT04329923|66280619|FG005|Overall Study|Withdrawal by Subject|1|||
23700170|NCT04329923|66280614|FG000|Overall Study|early termination of study|0|||
23700171|NCT04329923|66280615|FG001|Overall Study|early termination of study|0|||
23700172|NCT04329923|66280616|FG002|Overall Study|early termination of study|0|||
23700173|NCT04329923|66280617|FG003|Overall Study|early termination of study|0|||
23700174|NCT04329923|66280618|FG004|Overall Study|early termination of study|1|||
23700175|NCT04329923|66280619|FG005|Overall Study|early termination of study|2|||
23700176|NCT04329923|66280614|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23700177|NCT04329923|66280615|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23700178|NCT04329923|66280616|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23700179|NCT04329923|66280617|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23700180|NCT04329923|66280618|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23700181|NCT04329923|66280619|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
23700182|NCT01671488|66280620|FG000|Overall Study|Withdrawal by Subject|1|||
23700183|NCT02749721|66280621|FG000|Screening|Withdrawal by Subject|1|||
23700184|NCT02749721|66280621|FG000|Screening|Lost to Follow-up|2|||
23700185|NCT02749721|66280621|FG000|Screening|Protocol Violation|3|||
23700186|NCT02749721|66280621|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
23700187|NCT02749721|66280621|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
23700188|NCT03635190|66280622|FG000|Overall Study|Lost to Follow-up|4|||
23700189|NCT03635190|66280622|FG000|Overall Study|Death|3|||
23700190|NCT03635190|66280622|FG000|Overall Study|Withdrawal by Subject|1|||
23700191|NCT03635190|66280622|FG000|Overall Study|Patient moved and did not return for follow up|1|||
23700192|NCT02114203|66280623|FG000|Overall Study|Adverse Event|0|||
23700193|NCT02114203|66280624|FG001|Overall Study|Adverse Event|1|||
23700194|NCT02114203|66280625|FG002|Overall Study|Adverse Event|0|||
23700195|NCT02114203|66280623|FG000|Overall Study|Withdrawal by Subject|0|||
23700196|NCT02114203|66280624|FG001|Overall Study|Withdrawal by Subject|1|||
23700197|NCT02114203|66280625|FG002|Overall Study|Withdrawal by Subject|0|||
23700198|NCT01743027|66280627|FG000|Overall Study|Adverse Event|2|||
23700199|NCT01743027|66280628|FG001|Overall Study|Adverse Event|0|||
23700200|NCT01743027|66280629|FG002|Overall Study|Adverse Event|0|||
23700201|NCT01743027|66280630|FG003|Overall Study|Adverse Event|0|||
23700202|NCT01743027|66280627|FG000|Overall Study|Lost to Follow-up|0|||
23700203|NCT01743027|66280628|FG001|Overall Study|Lost to Follow-up|0|||
23700204|NCT01743027|66280629|FG002|Overall Study|Lost to Follow-up|2|||
23700205|NCT01743027|66280630|FG003|Overall Study|Lost to Follow-up|0|||
23700206|NCT01743027|66280627|FG000|Overall Study|Progressive Disease|1|||
23700207|NCT01743027|66280628|FG001|Overall Study|Progressive Disease|4|||
23700208|NCT01743027|66280629|FG002|Overall Study|Progressive Disease|3|||
23700209|NCT01743027|66280630|FG003|Overall Study|Progressive Disease|0|||
23700210|NCT01743027|66280627|FG000|Overall Study|Protocol Violation|1|||
23700211|NCT01743027|66280628|FG001|Overall Study|Protocol Violation|1|||
23700212|NCT01743027|66280629|FG002|Overall Study|Protocol Violation|1|||
23700213|NCT01743027|66280630|FG003|Overall Study|Protocol Violation|0|||
23700214|NCT01743027|66280627|FG000|Overall Study|Withdrawal by Subject|1|||
23700215|NCT01743027|66280628|FG001|Overall Study|Withdrawal by Subject|0|||
23700216|NCT01743027|66280629|FG002|Overall Study|Withdrawal by Subject|3|||
23700217|NCT01743027|66280630|FG003|Overall Study|Withdrawal by Subject|1|||
23700218|NCT03290300|66280631|FG000|Overall Study|Lost to Follow-up|3|||
23700219|NCT00394914|66280636|FG000|Treatment Period|Adverse Event|0|||
23700220|NCT00394914|66280637|FG001|Treatment Period|Adverse Event|3|||
23700221|NCT00394914|66280638|FG002|Treatment Period|Adverse Event|1|||
23700222|NCT00394914|66280636|FG000|Treatment Period|Lost to Follow-up|0|||
23700223|NCT00394914|66280637|FG001|Treatment Period|Lost to Follow-up|1|||
23700224|NCT00394914|66280638|FG002|Treatment Period|Lost to Follow-up|0|||
23700225|NCT00394914|66280636|FG000|Treatment Period|Withdrawal by Subject|0|||
23700226|NCT00394914|66280637|FG001|Treatment Period|Withdrawal by Subject|2|||
23700227|NCT00394914|66280638|FG002|Treatment Period|Withdrawal by Subject|2|||
23700228|NCT00394914|66280636|FG000|Treatment Period|Noncompliance with protocol|0|||
23700229|NCT00394914|66280637|FG001|Treatment Period|Noncompliance with protocol|3|||
23700230|NCT00394914|66280638|FG002|Treatment Period|Noncompliance with protocol|2|||
23700231|NCT00394914|66280636|FG000|Treatment Period|Did not meet protocol eligibility|0|||
23700232|NCT00394914|66280637|FG001|Treatment Period|Did not meet protocol eligibility|1|||
23700233|NCT00394914|66280638|FG002|Treatment Period|Did not meet protocol eligibility|1|||
23700234|NCT00401973|66280644|FG000|Overall Study|Adverse Event|2|||
23700235|NCT00401973|66280645|FG001|Overall Study|Adverse Event|8|||
23700236|NCT00401973|66280646|FG002|Overall Study|Adverse Event|4|||
23700237|NCT00401973|66280644|FG000|Overall Study|Clinical Relapse|0|||
23700238|NCT00401973|66280645|FG001|Overall Study|Clinical Relapse|1|||
23700239|NCT00401973|66280646|FG002|Overall Study|Clinical Relapse|1|||
23700240|NCT00401973|66280644|FG000|Overall Study|Lack of Efficacy|0|||
23700241|NCT00401973|66280645|FG001|Overall Study|Lack of Efficacy|0|||
23700242|NCT00401973|66280646|FG002|Overall Study|Lack of Efficacy|3|||
23700243|NCT00401973|66280644|FG000|Overall Study|Lost to Follow-up|2|||
23700244|NCT00401973|66280645|FG001|Overall Study|Lost to Follow-up|2|||
23700245|NCT00401973|66280646|FG002|Overall Study|Lost to Follow-up|2|||
23700246|NCT00401973|66280644|FG000|Overall Study|Physician Decision|2|||
23700247|NCT00401973|66280645|FG001|Overall Study|Physician Decision|0|||
23700248|NCT00401973|66280646|FG002|Overall Study|Physician Decision|1|||
23700249|NCT00401973|66280644|FG000|Overall Study|Protocol Violation|1|||
23700250|NCT00401973|66280645|FG001|Overall Study|Protocol Violation|2|||
23700251|NCT00401973|66280646|FG002|Overall Study|Protocol Violation|3|||
23700252|NCT00401973|66280644|FG000|Overall Study|Sponsor Decision|0|||
23700253|NCT00401973|66280645|FG001|Overall Study|Sponsor Decision|1|||
23700254|NCT00401973|66280646|FG002|Overall Study|Sponsor Decision|0|||
23700255|NCT00401973|66280644|FG000|Overall Study|Withdrawal by Subject|4|||
23700256|NCT00401973|66280645|FG001|Overall Study|Withdrawal by Subject|12|||
23700257|NCT00401973|66280646|FG002|Overall Study|Withdrawal by Subject|9|||
23700258|NCT00616239|66280647|FG000|Overall Study|Withdrawal by Subject|2|||
23700259|NCT01978912|66280654|FG000|Overall Study|Adverse Event|0|||
23700260|NCT01978912|66280655|FG001|Overall Study|Adverse Event|1|||
23700261|NCT01978912|66280656|FG002|Overall Study|Adverse Event|0|||
23700262|NCT01978912|66280657|FG003|Overall Study|Adverse Event|0|||
23700263|NCT01978912|66280654|FG000|Overall Study|Lost to Follow-up|1|||
23700264|NCT01978912|66280655|FG001|Overall Study|Lost to Follow-up|1|||
23700265|NCT01978912|66280656|FG002|Overall Study|Lost to Follow-up|0|||
23700266|NCT01978912|66280657|FG003|Overall Study|Lost to Follow-up|1|||
23700267|NCT01978912|66280654|FG000|Overall Study|Withdrawal by Subject|1|||
23700268|NCT01978912|66280655|FG001|Overall Study|Withdrawal by Subject|0|||
23700269|NCT01978912|66280656|FG002|Overall Study|Withdrawal by Subject|2|||
23700270|NCT01978912|66280657|FG003|Overall Study|Withdrawal by Subject|2|||
23700271|NCT01978912|66280654|FG000|Overall Study|Lumbar Surgery|1|||
23700272|NCT01978912|66280655|FG001|Overall Study|Lumbar Surgery|0|||
23700273|NCT01978912|66280656|FG002|Overall Study|Lumbar Surgery|1|||
23700274|NCT01978912|66280657|FG003|Overall Study|Lumbar Surgery|0|||
23700275|NCT01978912|66280654|FG000|Overall Study|Intradiscal Steroid Injection|0|||
23700276|NCT01978912|66280655|FG001|Overall Study|Intradiscal Steroid Injection|1|||
23700277|NCT01978912|66280656|FG002|Overall Study|Intradiscal Steroid Injection|0|||
23700278|NCT01978912|66280657|FG003|Overall Study|Intradiscal Steroid Injection|0|||
23700279|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
23700280|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
23700281|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
23700282|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
23700283|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
23700284|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
23700285|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
23700286|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
23700287|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
23700288|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
23700289|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
23700290|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
23700291|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
23700292|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
23700293|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
23700294|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
23700295|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
23606524|NCT00657709|65947270|FG004|Overall Study|Lost to Follow-up|21|||
23606525|NCT00657709|65947266|FG000|Overall Study|Protocol Violation|0|||
23606526|NCT00657709|65947267|FG001|Overall Study|Protocol Violation|2|||
23606527|NCT00657709|65947268|FG002|Overall Study|Protocol Violation|0|||
23700296|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
23700297|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
23700298|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
23700299|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
23700300|NCT00092547|66280658|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
23700301|NCT00092547|66280659|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
23606528|NCT00657709|65947269|FG003|Overall Study|Protocol Violation|1|||
23700302|NCT00092547|66280660|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
23700303|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
23700304|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
23700305|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
23700306|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
23700307|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
23700308|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
23700309|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
23700310|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
23700311|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
23700312|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
23700313|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
23700314|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
23700315|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
23700316|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
23700317|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
23700318|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
23700319|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
23700320|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
23700321|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
23700322|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
23700323|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
23700324|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
23700325|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
23700326|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
23700327|NCT00092547|66280658|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
23700328|NCT00092547|66280659|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
23700329|NCT00092547|66280660|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
23700330|NCT00092547|66280658|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
23700331|NCT00092547|66280659|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
23700332|NCT00092547|66280660|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
23700333|NCT00092547|66280658|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
23700334|NCT00092547|66280659|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
23700335|NCT00092547|66280660|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
23700336|NCT00092547|66280658|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
23700337|NCT00092547|66280659|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
23700338|NCT00092547|66280660|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
23700339|NCT00092547|66280658|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
23700340|NCT00092547|66280659|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
23700341|NCT00092547|66280660|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
23700342|NCT00258154|66280664|FG000|Overall Study|Adverse Event|1|||
23700343|NCT00258154|66280665|FG001|Overall Study|Adverse Event|0|||
23700344|NCT00258154|66280664|FG000|Overall Study|Lost to Follow-up|0|||
23700345|NCT00258154|66280665|FG001|Overall Study|Lost to Follow-up|1|||
23700346|NCT00258154|66280664|FG000|Overall Study|Protocol Violation|2|||
23700347|NCT00258154|66280665|FG001|Overall Study|Protocol Violation|1|||
23700348|NCT00258154|66280664|FG000|Overall Study|Withdrawal by Subject|3|||
23700349|NCT00258154|66280665|FG001|Overall Study|Withdrawal by Subject|4|||
23700350|NCT00258154|66280664|FG000|Overall Study|Patient Moved|3|||
23700351|NCT00258154|66280665|FG001|Overall Study|Patient Moved|1|||
23700352|NCT00546819|66280666|FG000|Overall Study|Adverse Event|2|||
23700353|NCT00546819|66280667|FG001|Overall Study|Adverse Event|3|||
23700354|NCT00546819|66280666|FG000|Overall Study|Lost to Follow-up|2|||
23700355|NCT00546819|66280667|FG001|Overall Study|Lost to Follow-up|1|||
23700356|NCT00546819|66280666|FG000|Overall Study|Withdrawal by Subject|4|||
23700357|NCT00546819|66280667|FG001|Overall Study|Withdrawal by Subject|2|||
23700358|NCT00576693|66280674|FG000|Overall Study|Lost to Follow-up|7|||
23700359|NCT00576693|66280675|FG001|Overall Study|Lost to Follow-up|11|||
23700360|NCT00576693|66280674|FG000|Overall Study|Withdrawal by Subject|3|||
23700361|NCT00576693|66280675|FG001|Overall Study|Withdrawal by Subject|13|||
23700362|NCT04370028|66280676|FG000|Overall Study|Withdrawal by Subject|695|||
23700363|NCT04370028|66280676|FG000|Overall Study|Protocol Violation|9|||
23700364|NCT04370028|66280676|FG000|Overall Study|Adverse Event|3|||
23700365|NCT00224107|66280677|FG000|Overall Study|Adverse Event|20|||
23700366|NCT00224107|66280678|FG001|Overall Study|Adverse Event|6|||
23700367|NCT00224107|66280677|FG000|Overall Study|Protocol Violation|2|||
23700368|NCT00224107|66280678|FG001|Overall Study|Protocol Violation|3|||
23700369|NCT00224107|66280677|FG000|Overall Study|Withdrawal by Subject|1|||
23700370|NCT00224107|66280678|FG001|Overall Study|Withdrawal by Subject|4|||
23700371|NCT00224107|66280677|FG000|Overall Study|Lack of Efficacy|2|||
23700372|NCT00224107|66280678|FG001|Overall Study|Lack of Efficacy|0|||
23700373|NCT00224107|66280677|FG000|Overall Study|Lost to Follow-up|4|||
23700374|NCT00224107|66280678|FG001|Overall Study|Lost to Follow-up|0|||
23700375|NCT00224107|66280677|FG000|Overall Study|Physician Decision|1|||
23700376|NCT00224107|66280678|FG001|Overall Study|Physician Decision|0|||
23700377|NCT00224107|66280677|FG000|Overall Study|Other|1|||
23700378|NCT00224107|66280678|FG001|Overall Study|Other|1|||
23700379|NCT01780389|66280694|FG000|Overall Study|Adverse Event|1|||
23700380|NCT00469014|66280700|FG000|Initial Phase Randomization|Disease Progression|0|||
23700381|NCT00469014|66280701|FG001|Initial Phase Randomization|Disease Progression|1|||
23700382|NCT00469014|66280702|FG002|Initial Phase Randomization|Disease Progression|1|||
23700383|NCT00469014|66280703|FG003|Initial Phase Randomization|Disease Progression|0|||
23700384|NCT00469014|66280700|FG000|Initial Phase Randomization|No Response|1|||
23700385|NCT00469014|66280701|FG001|Initial Phase Randomization|No Response|0|||
23700386|NCT00469014|66280702|FG002|Initial Phase Randomization|No Response|0|||
23700387|NCT00469014|66280703|FG003|Initial Phase Randomization|No Response|1|||
23700388|NCT00469014|66280700|FG000|Adaptive Randomization|Not Evaluable|1|||
23700389|NCT00469014|66280701|FG001|Adaptive Randomization|Not Evaluable|0|||
23700390|NCT00469014|66280702|FG002|Adaptive Randomization|Not Evaluable|0|||
23700391|NCT00469014|66280703|FG003|Adaptive Randomization|Not Evaluable|1|||
23700392|NCT00469014|66280700|FG000|Adaptive Randomization|No Response|0|||
23700393|NCT00469014|66280701|FG001|Adaptive Randomization|No Response|1|||
23700394|NCT00469014|66280702|FG002|Adaptive Randomization|No Response|0|||
23700395|NCT00469014|66280703|FG003|Adaptive Randomization|No Response|0|||
23700396|NCT00469014|66280700|FG000|Adaptive Randomization|Death|0|||
23700397|NCT00469014|66280701|FG001|Adaptive Randomization|Death|0|||
23700398|NCT00469014|66280702|FG002|Adaptive Randomization|Death|1|||
23700399|NCT00469014|66280703|FG003|Adaptive Randomization|Death|0|||
23700400|NCT00931892|66280706|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
23700401|NCT00931892|66280707|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
23700402|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
23700403|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
23700404|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23700405|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23700406|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23700407|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
23700408|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
23700409|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23700410|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23700411|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23700412|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
23700413|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23700414|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23700415|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23700416|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23700417|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23700418|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
23700419|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23700420|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23700421|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23700422|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
23700423|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
23700424|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23700425|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23700426|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23700427|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
23700428|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
23700429|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23700430|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23700431|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23700432|NCT02660580|66280710|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
23700433|NCT02660580|66280711|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
23700434|NCT02660580|66280712|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23700435|NCT02660580|66280713|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23700436|NCT02660580|66280714|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23700437|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23700438|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23700439|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
23700440|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23700441|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
23700442|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23700443|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23700444|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
23700445|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23700446|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
23700447|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
23700448|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
23700449|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
23700450|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
23700451|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
23700452|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
23700453|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
23700454|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
23700455|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
23700456|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
23700457|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
23700458|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
23700459|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
23700460|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
23700461|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
23700462|NCT02660580|66280710|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23700463|NCT02660580|66280711|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23700464|NCT02660580|66280712|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23700465|NCT02660580|66280713|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
23700466|NCT02660580|66280714|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
23700467|NCT00515463|66280715|FG000|Overall Study|Physician Decision|4|||
23700468|NCT00515463|66280716|FG001|Overall Study|Physician Decision|2|||
23700469|NCT00515463|66280715|FG000|Overall Study|Adverse Event|1|||
23700470|NCT00515463|66280716|FG001|Overall Study|Adverse Event|2|||
23700471|NCT00515463|66280715|FG000|Overall Study|Withdrawal by Subject|3|||
23700472|NCT00515463|66280716|FG001|Overall Study|Withdrawal by Subject|4|||
23700473|NCT00515463|66280715|FG000|Overall Study|Lost to Follow-up|6|||
23700474|NCT00515463|66280716|FG001|Overall Study|Lost to Follow-up|5|||
23700475|NCT00515463|66280715|FG000|Overall Study|Other|0|||
23700476|NCT00515463|66280716|FG001|Overall Study|Other|1|||
23700477|NCT00791128|66280717|FG000|Overall Study|Adverse Event|4|||
23700478|NCT00791128|66280717|FG000|Overall Study|Device migration|2|||
23700479|NCT00791128|66280717|FG000|Overall Study|non-compliance by subject|2|||
23700480|NCT00791128|66280717|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
23700481|NCT02100657|66280718|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
23700482|NCT02100657|66280719|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
23700483|NCT02100657|66280720|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
23700484|NCT02100657|66280718|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
23700485|NCT02100657|66280719|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
23700486|NCT02100657|66280720|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
23700487|NCT02100657|66280718|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
23700488|NCT02100657|66280719|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
23700489|NCT02100657|66280720|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
23700490|NCT02100657|66280718|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
23700491|NCT02100657|66280719|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
23700492|NCT02100657|66280720|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
23700493|NCT02100657|66280718|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
23700494|NCT02100657|66280719|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
23700495|NCT02100657|66280720|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
23700496|NCT02100657|66280718|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
23700497|NCT02100657|66280719|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
23700498|NCT02100657|66280720|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
23700499|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
23700500|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
23700501|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
23700502|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Death|0|||
23700503|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Death|0|||
23700504|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Death|1|||
23700505|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
23700506|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
23606529|NCT00657709|65947270|FG004|Overall Study|Protocol Violation|2|||
23606530|NCT02400749|65947271|FG000|Week 0 -16|Withdrawal by Subject|5|||
23606531|NCT02400749|65947272|FG001|Week 0 -16|Withdrawal by Subject|5|||
23606532|NCT02400749|65947271|FG000|Week 0 -16|Adverse Event|3|||
23606533|NCT02400749|65947272|FG001|Week 0 -16|Adverse Event|1|||
23606534|NCT02400749|65947271|FG000|Week 0 -16|Lost to Follow-up|2|||
23606535|NCT02400749|65947272|FG001|Week 0 -16|Lost to Follow-up|0|||
23606536|NCT02400749|65947271|FG000|Week 0 -16|Protocol Violation|1|||
23606537|NCT02400749|65947272|FG001|Week 0 -16|Protocol Violation|0|||
23606538|NCT02400749|65947271|FG000|Week 17 - 32|Withdrawal by Subject|3|||
23606539|NCT02400749|65947272|FG001|Week 17 - 32|Withdrawal by Subject|2|||
23606540|NCT02400749|65947271|FG000|Week 17 - 32|Adverse Event|2|||
23606541|NCT02400749|65947272|FG001|Week 17 - 32|Adverse Event|1|||
23700507|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
23700508|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
23700509|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
23700510|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
23700511|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
23700512|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
23700513|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
23700514|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
23700515|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
23700516|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
23700517|NCT02100657|66280718|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
23700518|NCT02100657|66280719|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
23700519|NCT02100657|66280720|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
23700520|NCT00592358|66280721|FG000|Overall Study|Withdrawal by Subject|2|||
23700521|NCT00592358|66280721|FG000|Overall Study|Adverse Event|1|||
23700522|NCT00592358|66280721|FG000|Overall Study|Lack of Efficacy|2|||
23700523|NCT00592358|66280721|FG000|Overall Study|Inability to swallow pills|1|||
23700524|NCT03196297|66284066|FG000|Main Period|Withdrawal by Subject|4|||
23700525|NCT03196297|66284066|FG000|Extension Period|Withdrawal by Subject|1|||
23700526|NCT03196297|66284066|FG000|Extension Period|Lack of Efficacy|2|||
23700527|NCT01769404|66284070|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
23700528|NCT01769404|66284071|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
23700529|NCT01769404|66284070|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23700530|NCT01769404|66284071|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23700531|NCT01769404|66284070|FG000|Treatment Period 1|Sponsor decision|1|||
23700532|NCT01769404|66284071|FG001|Treatment Period 1|Sponsor decision|0|||
23700533|NCT01769404|66284070|FG000|Treatment Period 2|Sponsor decision|7|||
23700534|NCT01769404|66284071|FG001|Treatment Period 2|Sponsor decision|0|||
23700535|NCT01712438|66284074|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
23700536|NCT01712438|66284074|FG000|Overall Study|Ongoing ITI treatment|6|||
23700537|NCT01712438|66284074|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
23700538|NCT01712438|66284074|FG000|Overall Study|Prematurely Discontinued|25|||
23700539|NCT02834403|66284075|FG000|Overall Study|Physician Decision|2|||
23700540|NCT02834403|66284076|FG001|Overall Study|Physician Decision|1|||
23700541|NCT02834403|66284077|FG002|Overall Study|Physician Decision|2|||
23700542|NCT02834403|66284078|FG003|Overall Study|Physician Decision|1|||
23700543|NCT02834403|66284079|FG004|Overall Study|Physician Decision|1|||
23700544|NCT02834403|66284080|FG005|Overall Study|Physician Decision|2|||
23700545|NCT02834403|66284081|FG006|Overall Study|Physician Decision|12|||
23700546|NCT02834403|66284075|FG000|Overall Study|Adverse Event|0|||
23700547|NCT02834403|66284076|FG001|Overall Study|Adverse Event|0|||
23700548|NCT02834403|66284077|FG002|Overall Study|Adverse Event|0|||
23700549|NCT02834403|66284078|FG003|Overall Study|Adverse Event|0|||
23700550|NCT02834403|66284079|FG004|Overall Study|Adverse Event|1|||
23700551|NCT02834403|66284080|FG005|Overall Study|Adverse Event|1|||
23700552|NCT02834403|66284081|FG006|Overall Study|Adverse Event|3|||
23700553|NCT02834403|66284075|FG000|Overall Study|Withdrawal by Subject|0|||
23700554|NCT02834403|66284076|FG001|Overall Study|Withdrawal by Subject|1|||
23700555|NCT02834403|66284077|FG002|Overall Study|Withdrawal by Subject|0|||
23700556|NCT02834403|66284078|FG003|Overall Study|Withdrawal by Subject|0|||
23700557|NCT02834403|66284079|FG004|Overall Study|Withdrawal by Subject|1|||
23700558|NCT02834403|66284080|FG005|Overall Study|Withdrawal by Subject|0|||
23700559|NCT02834403|66284081|FG006|Overall Study|Withdrawal by Subject|0|||
23700560|NCT02834403|66284075|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
23700561|NCT02834403|66284076|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
23700562|NCT02834403|66284077|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
23700563|NCT02834403|66284078|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
23700564|NCT02834403|66284079|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
23700565|NCT02834403|66284080|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
23700566|NCT02834403|66284081|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
23700567|NCT01753115|66284082|FG000|Overall Study|Lost to Follow-up|3|||
23700568|NCT01753115|66284083|FG001|Overall Study|Lost to Follow-up|6|||
23700569|NCT01753115|66284084|FG002|Overall Study|Lost to Follow-up|8|||
23700570|NCT01753115|66284082|FG000|Overall Study|Withdrawal by Subject|6|||
23700571|NCT01753115|66284083|FG001|Overall Study|Withdrawal by Subject|5|||
23700572|NCT01753115|66284084|FG002|Overall Study|Withdrawal by Subject|6|||
23700573|NCT01753115|66284082|FG000|Overall Study|Subject non-compliant|3|||
23700574|NCT01753115|66284083|FG001|Overall Study|Subject non-compliant|3|||
23700575|NCT01753115|66284084|FG002|Overall Study|Subject non-compliant|0|||
23700576|NCT01753115|66284082|FG000|Overall Study|Used excluded drug|0|||
23700577|NCT01753115|66284083|FG001|Overall Study|Used excluded drug|1|||
23700578|NCT01753115|66284084|FG002|Overall Study|Used excluded drug|0|||
23700579|NCT01004146|66284085|FG000|Overall Study|Withdrawal by Subject|4|||
23700580|NCT01004146|66284086|FG001|Overall Study|Withdrawal by Subject|5|||
23700581|NCT01558089|66284090|FG000|Overall Study|Adverse Event|1|||
23700582|NCT01558089|66284090|FG000|Overall Study|Lack of Efficacy|1|||
23700583|NCT01558089|66284090|FG000|Overall Study|Lost to Follow-up|5|||
23700584|NCT01558089|66284090|FG000|Overall Study|Withdrawal by Subject|6|||
23700585|NCT02209597|66284093|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
23700586|NCT02209597|66284093|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
23700587|NCT02209597|66284093|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
23700588|NCT02209597|66284093|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
23700589|NCT01197378|66284097|FG000|Overall Study|Adverse Event|3|||
23700590|NCT01197378|66284097|FG000|Overall Study|Withdrawal by Subject|1|||
23700591|NCT01197378|66284097|FG000|Overall Study|Physician Decision|1|||
23700592|NCT01197378|66284097|FG000|Overall Study|Other|2|||
23700593|NCT03692910|66284101|FG000|Overall Study|Lost to Follow-up|4|||
23700594|NCT03692910|66284102|FG001|Overall Study|Lost to Follow-up|0|||
23700595|NCT03692910|66284103|FG002|Overall Study|Lost to Follow-up|0|||
23700596|NCT03692910|66284101|FG000|Overall Study|Withdrawal by Subject|2|||
23700597|NCT03692910|66284102|FG001|Overall Study|Withdrawal by Subject|0|||
23700598|NCT03692910|66284103|FG002|Overall Study|Withdrawal by Subject|0|||
23700599|NCT01312428|66284108|FG000|Overall Study|Study Termination|3|||
23700600|NCT01312428|66284109|FG001|Overall Study|Study Termination|4|||
23700601|NCT02028338|66284110|FG000|Overall Study|Withdrawal by Subject|3|||
23700602|NCT02028338|66284111|FG001|Overall Study|Withdrawal by Subject|1|||
23700603|NCT02028338|66284110|FG000|Overall Study|Unable to contact participant|1|||
23700604|NCT02028338|66284111|FG001|Overall Study|Unable to contact participant|0|||
23700605|NCT01733316|66284112|FG000|RP103 Phase|Non-compliance|1|||
23700606|NCT01733316|66284112|FG000|Long Term Extension Phase|Adverse Event|1|||
23700607|NCT01733316|66284112|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
23700608|NCT01733316|66284112|FG000|Long Term Extension Phase|Sponsor Decision|2|||
23700609|NCT01912872|66284113|FG000|Overall Study|Lost to Follow-up|2|||
23700610|NCT01912872|66284114|FG001|Overall Study|Lost to Follow-up|3|||
23700611|NCT01912872|66284115|FG002|Overall Study|Lost to Follow-up|5|||
23700612|NCT01912872|66284116|FG003|Overall Study|Lost to Follow-up|5|||
23700613|NCT01912872|66284113|FG000|Overall Study|Other unspecified|3|||
23700614|NCT01912872|66284114|FG001|Overall Study|Other unspecified|1|||
23700615|NCT01912872|66284115|FG002|Overall Study|Other unspecified|3|||
23700616|NCT01912872|66284116|FG003|Overall Study|Other unspecified|0|||
23700617|NCT01912872|66284113|FG000|Overall Study|Informed consent withdrawn|0|||
23700618|NCT01912872|66284114|FG001|Overall Study|Informed consent withdrawn|0|||
23700619|NCT01912872|66284115|FG002|Overall Study|Informed consent withdrawn|1|||
23700620|NCT01912872|66284116|FG003|Overall Study|Informed consent withdrawn|1|||
23700621|NCT01912872|66284113|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
23700622|NCT01912872|66284114|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
23700623|NCT01912872|66284115|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
23700624|NCT01912872|66284116|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
23700625|NCT01912872|66284113|FG000|Overall Study|Protocol Violation|0|||
23700626|NCT01912872|66284114|FG001|Overall Study|Protocol Violation|0|||
23700627|NCT01912872|66284115|FG002|Overall Study|Protocol Violation|1|||
23700628|NCT01912872|66284116|FG003|Overall Study|Protocol Violation|0|||
23700629|NCT01912872|66284113|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23700630|NCT01912872|66284114|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23700631|NCT01912872|66284115|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23700632|NCT01912872|66284116|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23700633|NCT01912872|66284113|FG000|Overall Study|Withdrawal of study medication|0|||
23700634|NCT01912872|66284114|FG001|Overall Study|Withdrawal of study medication|0|||
23700635|NCT01912872|66284115|FG002|Overall Study|Withdrawal of study medication|0|||
23700636|NCT01912872|66284116|FG003|Overall Study|Withdrawal of study medication|2|||
23700637|NCT01912872|66284113|FG000|Overall Study|Missing|0|||
23700638|NCT01912872|66284114|FG001|Overall Study|Missing|0|||
23700639|NCT01912872|66284115|FG002|Overall Study|Missing|0|||
23700640|NCT01912872|66284116|FG003|Overall Study|Missing|1|||
23700641|NCT00406315|66284117|FG000|Overall Study|Death|1|||
23700642|NCT00406315|66284117|FG000|Overall Study|Adverse Event|39|||
23700643|NCT00406315|66284117|FG000|Overall Study|Laboratory Abnormality|4|||
23700644|NCT00406315|66284117|FG000|Overall Study|Lack of Efficacy|13|||
23700645|NCT00406315|66284117|FG000|Overall Study|Other|33|||
23700646|NCT00406315|66284117|FG000|Overall Study|Lost to Follow-up|21|||
23700647|NCT00406315|66284117|FG000|Overall Study|Withdrawal by Subject|30|||
23700648|NCT00486226|66284123|FG000|Overall Study|Death|3|||
23700649|NCT00486226|66284123|FG000|Overall Study|Adverse Event|1|||
23700650|NCT00486226|66284123|FG000|Overall Study|Withdrawal by Subject|1|||
23700651|NCT00486226|66284123|FG000|Overall Study|Lost to Follow-up|8|||
23700652|NCT03153111|66284124|FG000|Overall Study|Death|2|||
23700653|NCT03153111|66284125|FG001|Overall Study|Death|5|||
23700654|NCT03153111|66284124|FG000|Overall Study|Lost to Follow-up|1|||
23700655|NCT03153111|66284125|FG001|Overall Study|Lost to Follow-up|0|||
23700656|NCT03153111|66284124|FG000|Overall Study|Physician Decision|5|||
23700657|NCT03153111|66284125|FG001|Overall Study|Physician Decision|1|||
23700658|NCT03153111|66284124|FG000|Overall Study|Withdrawal by Subject|3|||
23700659|NCT03153111|66284125|FG001|Overall Study|Withdrawal by Subject|3|||
23700660|NCT01100307|66284128|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
23700661|NCT01100307|66284129|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
23700662|NCT01100307|66284128|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
23700663|NCT01100307|66284129|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
23700664|NCT01100307|66284128|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
23700665|NCT01100307|66284129|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
23700666|NCT01100307|66284128|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
23700667|NCT01100307|66284129|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
23700668|NCT01100307|66284128|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
23700669|NCT01100307|66284129|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
23700670|NCT01100307|66284128|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
23700671|NCT01100307|66284129|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
23700672|NCT00863928|66284130|FG000|Overall Study|Protocol Violation|26|||
23700673|NCT00863928|66284131|FG001|Overall Study|Protocol Violation|0|||
23700674|NCT00863928|66284130|FG000|Overall Study|Withdrawal by Subject|3|||
23700675|NCT00863928|66284131|FG001|Overall Study|Withdrawal by Subject|0|||
23700676|NCT00863928|66284130|FG000|Overall Study|surgery cancellation|4|||
23700677|NCT00863928|66284131|FG001|Overall Study|surgery cancellation|0|||
23700678|NCT00863928|66284130|FG000|Overall Study|medication allergy|3|||
23700679|NCT00863928|66284131|FG001|Overall Study|medication allergy|0|||
23700680|NCT01400971|66284132|FG000|Overall Study|Death|82|||
23700681|NCT01400971|66284132|FG000|Overall Study|Lost to Follow-up|196|||
23700682|NCT01400971|66284132|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
23700683|NCT01400971|66284132|FG000|Overall Study|Physician Decision|57|||
23700684|NCT01400971|66284132|FG000|Overall Study|Withdrawal by Subject|158|||
23700685|NCT01400971|66284132|FG000|Overall Study|Other|422|||
23700686|NCT01809262|66284133|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700687|NCT01809262|66284134|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700688|NCT01809262|66284135|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700689|NCT01809262|66284136|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700690|NCT01809262|66284137|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
23700691|NCT01809262|66284138|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700692|NCT01809262|66284139|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700693|NCT01809262|66284140|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700694|NCT01809262|66284141|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700695|NCT01809262|66284142|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
23700696|NCT01809262|66284133|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700697|NCT01809262|66284134|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
23700698|NCT01809262|66284135|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700699|NCT01809262|66284136|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700700|NCT01809262|66284137|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700701|NCT01809262|66284138|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700702|NCT01809262|66284139|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700703|NCT01809262|66284140|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700704|NCT01809262|66284141|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700705|NCT01809262|66284142|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23700706|NCT03880227|66284143|FG000|First Visit|Withdrawal by Subject|1|||
23700707|NCT03880227|66284144|FG001|First Visit|Withdrawal by Subject|0|||
23700708|NCT03880227|66284145|FG002|First Visit|Withdrawal by Subject|0|||
23700709|NCT03880227|66284146|FG003|First Visit|Withdrawal by Subject|0|||
23700710|NCT03880227|66284143|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
23700711|NCT03880227|66284144|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
23700712|NCT03880227|66284145|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
23700713|NCT03880227|66284146|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
23700714|NCT03880227|66284143|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23700715|NCT03880227|66284144|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23700716|NCT03880227|66284145|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
23700717|NCT03880227|66284146|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23700718|NCT03880227|66284143|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23700719|NCT03880227|66284144|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23700720|NCT03880227|66284145|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
23700721|NCT03880227|66284146|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23700722|NCT04983940|66284147|FG000|Overall Study|Lost to Follow-up|14|||
23700723|NCT04983940|66284147|FG000|Overall Study|Lack of Efficacy|2|||
23700724|NCT02090114|66284148|FG000|Overall Study|Withdrawal by Subject|3|||
23700725|NCT02090114|66284149|FG001|Overall Study|Withdrawal by Subject|6|||
23700726|NCT02090114|66284150|FG002|Overall Study|Withdrawal by Subject|2|||
23700727|NCT02090114|66284151|FG003|Overall Study|Withdrawal by Subject|1|||
23700728|NCT02090114|66284148|FG000|Overall Study|Physician Decision|5|||
23700729|NCT02090114|66284149|FG001|Overall Study|Physician Decision|0|||
23700730|NCT02090114|66284150|FG002|Overall Study|Physician Decision|1|||
23700731|NCT02090114|66284151|FG003|Overall Study|Physician Decision|1|||
23700732|NCT02090114|66284148|FG000|Overall Study|Adverse Event|1|||
23700733|NCT02090114|66284149|FG001|Overall Study|Adverse Event|2|||
23700734|NCT02090114|66284150|FG002|Overall Study|Adverse Event|2|||
23700735|NCT02090114|66284151|FG003|Overall Study|Adverse Event|0|||
23700736|NCT02090114|66284148|FG000|Overall Study|Progressive Disease|20|||
23700737|NCT02090114|66284149|FG001|Overall Study|Progressive Disease|21|||
23700738|NCT02090114|66284150|FG002|Overall Study|Progressive Disease|23|||
23700739|NCT02090114|66284151|FG003|Overall Study|Progressive Disease|6|||
23700740|NCT02090114|66284148|FG000|Overall Study|Death|1|||
23700741|NCT02090114|66284149|FG001|Overall Study|Death|0|||
23700742|NCT02090114|66284150|FG002|Overall Study|Death|1|||
23700743|NCT02090114|66284151|FG003|Overall Study|Death|0|||
23700744|NCT02168946|66284152|FG000|Overall Study|Adverse Event|8|||
23700745|NCT02168946|66284153|FG001|Overall Study|Adverse Event|5|||
23700746|NCT02168946|66284152|FG000|Overall Study|Lost to Follow-up|3|||
23700747|NCT02168946|66284153|FG001|Overall Study|Lost to Follow-up|0|||
23700748|NCT02168946|66284152|FG000|Overall Study|Subject unable to come back for visits|1|||
23700749|NCT02168946|66284153|FG001|Overall Study|Subject unable to come back for visits|0|||
23700750|NCT00886821|66284156|FG000|Stage 2|Adverse Event|0|||
23700751|NCT00886821|66284157|FG001|Stage 2|Adverse Event|0|||
23700752|NCT00886821|66284158|FG002|Stage 2|Adverse Event|0|||
23700753|NCT00886821|66284159|FG003|Stage 2|Adverse Event|0|||
23700754|NCT00886821|66284160|FG004|Stage 2|Adverse Event|0|||
23700755|NCT00886821|66284161|FG005|Stage 2|Adverse Event|0|||
23700756|NCT00886821|66284162|FG006|Stage 2|Adverse Event|0|||
23700757|NCT00886821|66284163|FG007|Stage 2|Adverse Event|0|||
23700758|NCT00886821|66284164|FG008|Stage 2|Adverse Event|0|||
23700759|NCT00886821|66284165|FG009|Stage 2|Adverse Event|0|||
23700760|NCT00886821|66284166|FG010|Stage 2|Adverse Event|0|||
23700761|NCT00886821|66284167|FG011|Stage 2|Adverse Event|1|||
23700762|NCT00886821|66284168|FG012|Stage 2|Adverse Event|3|||
23700763|NCT00886821|66284169|FG013|Stage 2|Adverse Event|0|||
23700764|NCT00886821|66284156|FG000|Stage 2|Lost to Follow-up|0|||
23700765|NCT00886821|66284157|FG001|Stage 2|Lost to Follow-up|0|||
23700766|NCT00886821|66284158|FG002|Stage 2|Lost to Follow-up|0|||
23700767|NCT00886821|66284159|FG003|Stage 2|Lost to Follow-up|0|||
23700768|NCT00886821|66284160|FG004|Stage 2|Lost to Follow-up|0|||
23700769|NCT00886821|66284161|FG005|Stage 2|Lost to Follow-up|0|||
23700770|NCT00886821|66284162|FG006|Stage 2|Lost to Follow-up|0|||
23700771|NCT00886821|66284163|FG007|Stage 2|Lost to Follow-up|0|||
23700772|NCT00886821|66284164|FG008|Stage 2|Lost to Follow-up|0|||
23700773|NCT00886821|66284165|FG009|Stage 2|Lost to Follow-up|0|||
23700774|NCT00886821|66284166|FG010|Stage 2|Lost to Follow-up|0|||
23700775|NCT00886821|66284167|FG011|Stage 2|Lost to Follow-up|0|||
23700776|NCT00886821|66284168|FG012|Stage 2|Lost to Follow-up|2|||
23700777|NCT00886821|66284169|FG013|Stage 2|Lost to Follow-up|1|||
23700778|NCT00783705|66284170|FG000|Overall Study|Adverse Event|2|||
23700779|NCT00783705|66284171|FG001|Overall Study|Adverse Event|0|||
23700780|NCT00783705|66284170|FG000|Overall Study|Withdrawal by Subject|3|||
23700781|NCT00783705|66284171|FG001|Overall Study|Withdrawal by Subject|2|||
23700782|NCT00783705|66284170|FG000|Overall Study|Lost to Follow-up|1|||
23700783|NCT00783705|66284171|FG001|Overall Study|Lost to Follow-up|3|||
23700784|NCT00222729|66284172|FG000|Overall Study|Adverse Event|3|||
23700785|NCT00328198|66284173|FG000|Treatment|Adverse Event|21|||
23700786|NCT00328198|66284173|FG000|Treatment|Death|1|||
23700787|NCT00328198|66284173|FG000|Treatment|Physician Decision|5|||
23700788|NCT00328198|66284173|FG000|Treatment|Withdrawal by Subject|5|||
23700789|NCT00328198|66284173|FG000|Treatment|Evidence of disease progression|2|||
23700790|NCT00328198|66284173|FG000|Treatment|Non-compliance|1|||
23700791|NCT00328198|66284173|FG000|Treatment|Confirmed complete response, MRD -|3|||
23700792|NCT00328198|66284173|FG000|Follow-up|Lost to Follow-up|4|||
23700793|NCT00328198|66284173|FG000|Follow-up|Death|31|||
23700794|NCT01345786|66284174|FG000|Overall Study|Adverse Event|0|||
23700795|NCT01345786|66284175|FG001|Overall Study|Adverse Event|1|||
23700796|NCT01345786|66284176|FG002|Overall Study|Adverse Event|3|||
23700797|NCT01345786|66284177|FG003|Overall Study|Adverse Event|1|||
23700798|NCT01345786|66284174|FG000|Overall Study|Subject withdrew consent|2|||
23700799|NCT01345786|66284175|FG001|Overall Study|Subject withdrew consent|2|||
23700800|NCT01345786|66284176|FG002|Overall Study|Subject withdrew consent|1|||
23700801|NCT01345786|66284177|FG003|Overall Study|Subject withdrew consent|0|||
23700802|NCT01345786|66284174|FG000|Overall Study|Noncompliance with protocol|1|||
23700803|NCT01345786|66284175|FG001|Overall Study|Noncompliance with protocol|0|||
23700804|NCT01345786|66284176|FG002|Overall Study|Noncompliance with protocol|1|||
23700805|NCT01345786|66284177|FG003|Overall Study|Noncompliance with protocol|0|||
23700806|NCT01345786|66284174|FG000|Overall Study|Administrative|3|||
23700807|NCT01345786|66284175|FG001|Overall Study|Administrative|5|||
23700808|NCT01345786|66284176|FG002|Overall Study|Administrative|0|||
23700809|NCT01345786|66284177|FG003|Overall Study|Administrative|0|||
23700810|NCT01345786|66284174|FG000|Overall Study|Lost to Follow-up|0|||
23700811|NCT01345786|66284175|FG001|Overall Study|Lost to Follow-up|0|||
23700812|NCT01345786|66284176|FG002|Overall Study|Lost to Follow-up|0|||
23700813|NCT01345786|66284177|FG003|Overall Study|Lost to Follow-up|2|||
23700814|NCT01544114|66284181|FG000|Overall Study|Withdrawal by Subject|0|||
23700815|NCT01544114|66284182|FG001|Overall Study|Withdrawal by Subject|0|||
23700816|NCT01544114|66284183|FG002|Overall Study|Withdrawal by Subject|3|||
23700817|NCT01544114|66284181|FG000|Overall Study|Lost to Follow-up|0|||
23700818|NCT01544114|66284182|FG001|Overall Study|Lost to Follow-up|2|||
23700819|NCT01544114|66284183|FG002|Overall Study|Lost to Follow-up|0|||
23700820|NCT01544114|66284181|FG000|Overall Study|Adverse Event|1|||
23700821|NCT01544114|66284182|FG001|Overall Study|Adverse Event|1|||
23700822|NCT01544114|66284183|FG002|Overall Study|Adverse Event|2|||
23700823|NCT01544114|66284181|FG000|Overall Study|Protocol Violation|0|||
23700824|NCT01544114|66284182|FG001|Overall Study|Protocol Violation|1|||
23700825|NCT01544114|66284183|FG002|Overall Study|Protocol Violation|0|||
23700826|NCT01734993|66284185|FG000|Overall Study|Adverse Event|1|||
23700827|NCT01734993|66284185|FG000|Overall Study|Lack of Efficacy|1|||
23700828|NCT03135028|66284186|FG000|Overall Study|Death|6|||
23700829|NCT03135028|66284186|FG000|Overall Study|Study Terminated by Sponsor|2|||
23700830|NCT03135028|66284186|FG000|Overall Study|Withdrew Consent|1|||
23700831|NCT01214616|66284189|FG000|Overall Study|Progressive disease|2|||
23700832|NCT01214616|66284190|FG001|Overall Study|Progressive disease|2|||
23700833|NCT01214616|66284191|FG002|Overall Study|Progressive disease|2|||
23700834|NCT01214616|66284192|FG003|Overall Study|Progressive disease|4|||
23700835|NCT01214616|66284189|FG000|Overall Study|Dose limiting toxicity|0|||
23700836|NCT01214616|66284190|FG001|Overall Study|Dose limiting toxicity|2|||
23700837|NCT01214616|66284191|FG002|Overall Study|Dose limiting toxicity|0|||
23700838|NCT01214616|66284192|FG003|Overall Study|Dose limiting toxicity|0|||
23700839|NCT01214616|66284189|FG000|Overall Study|Other adverse events|0|||
23700840|NCT01214616|66284190|FG001|Overall Study|Other adverse events|1|||
23700841|NCT01214616|66284191|FG002|Overall Study|Other adverse events|1|||
23700842|NCT01214616|66284192|FG003|Overall Study|Other adverse events|1|||
23700843|NCT01214616|66284189|FG000|Overall Study|Withdrawal by Subject|1|||
23700844|NCT01214616|66284190|FG001|Overall Study|Withdrawal by Subject|0|||
23700845|NCT01214616|66284191|FG002|Overall Study|Withdrawal by Subject|0|||
23700846|NCT01214616|66284192|FG003|Overall Study|Withdrawal by Subject|1|||
23700847|NCT00450372|66284195|FG000|Overall Study|Physician Decision|1|||
23700848|NCT02691247|66284196|FG000|Overall Study|Withdrawal by Subject|1|||
23700849|NCT02691247|66284197|FG001|Overall Study|Withdrawal by Subject|2|||
23700850|NCT02691247|66284198|FG002|Overall Study|Withdrawal by Subject|2|||
23700851|NCT02691247|66284196|FG000|Overall Study|Lost to Follow-up|2|||
23700852|NCT02691247|66284197|FG001|Overall Study|Lost to Follow-up|0|||
23700853|NCT02691247|66284198|FG002|Overall Study|Lost to Follow-up|1|||
23700854|NCT02160977|66284199|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
23700855|NCT02160977|66284200|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
23700856|NCT02160977|66284199|FG000|Three Months After Surgery|Lost to Follow-up|0|||
23700857|NCT02160977|66284200|FG001|Three Months After Surgery|Lost to Follow-up|2|||
23700858|NCT02160977|66284199|FG000|Six Months After Surgery|Lost to Follow-up|2|||
23700859|NCT02160977|66284200|FG001|Six Months After Surgery|Lost to Follow-up|1|||
23700860|NCT01721369|66284205|FG000|Overall Study|Not initial etiological diagnosis|12|||
23700861|NCT00637273|66284206|FG000|Overall Study|Adverse Event|11|||
23700862|NCT00637273|66284207|FG001|Overall Study|Adverse Event|5|||
23700863|NCT00637273|66284208|FG002|Overall Study|Adverse Event|7|||
23700864|NCT00637273|66284206|FG000|Overall Study|Lost to Follow-up|8|||
23700865|NCT00637273|66284207|FG001|Overall Study|Lost to Follow-up|9|||
23700866|NCT00637273|66284208|FG002|Overall Study|Lost to Follow-up|13|||
23700867|NCT00637273|66284206|FG000|Overall Study|Protocol Violation|2|||
23700868|NCT00637273|66284207|FG001|Overall Study|Protocol Violation|4|||
23700869|NCT00637273|66284208|FG002|Overall Study|Protocol Violation|1|||
23700870|NCT00637273|66284206|FG000|Overall Study|Withdrawal of Consent|18|||
23700871|NCT00637273|66284207|FG001|Overall Study|Withdrawal of Consent|6|||
23700872|NCT00637273|66284208|FG002|Overall Study|Withdrawal of Consent|18|||
23700873|NCT00637273|66284206|FG000|Overall Study|Investigator Decision|1|||
23700874|NCT00637273|66284207|FG001|Overall Study|Investigator Decision|3|||
23700875|NCT00637273|66284208|FG002|Overall Study|Investigator Decision|1|||
23700876|NCT00637273|66284206|FG000|Overall Study|Administrative|2|||
23700877|NCT00637273|66284207|FG001|Overall Study|Administrative|0|||
23700878|NCT00637273|66284208|FG002|Overall Study|Administrative|0|||
23700879|NCT00637273|66284206|FG000|Overall Study|Loss of Glucose Control|1|||
23700880|NCT00637273|66284207|FG001|Overall Study|Loss of Glucose Control|1|||
23700881|NCT00637273|66284208|FG002|Overall Study|Loss of Glucose Control|1|||
23700882|NCT01757704|66284209|FG000|Overall Study|Protocol Violation|1|||
23700883|NCT01757704|66284210|FG001|Overall Study|Protocol Violation|3|||
23700884|NCT02518620|66284213|FG000|Overall Study|Adverse Event|23|||
23700885|NCT02518620|66284214|FG001|Overall Study|Adverse Event|11|||
23700886|NCT02518620|66284213|FG000|Overall Study|Lack of Efficacy|2|||
23700887|NCT02518620|66284214|FG001|Overall Study|Lack of Efficacy|0|||
23700888|NCT02518620|66284213|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23700889|NCT02518620|66284214|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23700890|NCT02518620|66284213|FG000|Overall Study|Physician Decision|1|||
23700891|NCT02518620|66284214|FG001|Overall Study|Physician Decision|1|||
23700892|NCT02518620|66284213|FG000|Overall Study|Sponsor's Decision|0|||
23700893|NCT02518620|66284214|FG001|Overall Study|Sponsor's Decision|3|||
23700894|NCT02518620|66284213|FG000|Overall Study|Lost to Follow-up|1|||
23700895|NCT02518620|66284214|FG001|Overall Study|Lost to Follow-up|1|||
23700896|NCT02518620|66284213|FG000|Overall Study|Withdrawal by Subject|17|||
23700897|NCT02518620|66284214|FG001|Overall Study|Withdrawal by Subject|9|||
23700898|NCT02518620|66284213|FG000|Overall Study|Death|1|||
23700899|NCT02518620|66284214|FG001|Overall Study|Death|0|||
23700900|NCT02518620|66284213|FG000|Overall Study|Pregnancy Wish|3|||
23700901|NCT02518620|66284214|FG001|Overall Study|Pregnancy Wish|0|||
23700902|NCT02518620|66284213|FG000|Overall Study|Pregnancy|1|||
23700903|NCT02518620|66284214|FG001|Overall Study|Pregnancy|0|||
23700904|NCT02518620|66284213|FG000|Overall Study|Relocation|2|||
23700905|NCT02518620|66284214|FG001|Overall Study|Relocation|1|||
23700906|NCT00069095|66284215|FG000|Primary Treatment Phase|Ongoing|0|||
23700907|NCT00069095|66284216|FG001|Primary Treatment Phase|Ongoing|0|||
23700908|NCT00069095|66284217|FG002|Primary Treatment Phase|Ongoing|5|||
23700909|NCT00069095|66284218|FG003|Primary Treatment Phase|Ongoing|7|||
23700910|NCT00069095|66284219|FG004|Primary Treatment Phase|Ongoing|7|||
23700911|NCT00069095|66284220|FG005|Primary Treatment Phase|Ongoing|4|||
23700912|NCT00069095|66284215|FG000|Primary Treatment Phase|Admin/Other|29|||
23700913|NCT00069095|66284216|FG001|Primary Treatment Phase|Admin/Other|38|||
23700914|NCT00069095|66284217|FG002|Primary Treatment Phase|Admin/Other|31|||
23700915|NCT00069095|66284218|FG003|Primary Treatment Phase|Admin/Other|45|||
23700916|NCT00069095|66284219|FG004|Primary Treatment Phase|Admin/Other|48|||
23700917|NCT00069095|66284220|FG005|Primary Treatment Phase|Admin/Other|42|||
23700918|NCT00069095|66284215|FG000|Primary Treatment Phase|Adverse Event|99|||
23700919|NCT00069095|66284216|FG001|Primary Treatment Phase|Adverse Event|92|||
23700920|NCT00069095|66284217|FG002|Primary Treatment Phase|Adverse Event|71|||
23700921|NCT00069095|66284218|FG003|Primary Treatment Phase|Adverse Event|72|||
23700922|NCT00069095|66284219|FG004|Primary Treatment Phase|Adverse Event|109|||
23700923|NCT00069095|66284220|FG005|Primary Treatment Phase|Adverse Event|101|||
23700924|NCT00069095|66284215|FG000|Primary Treatment Phase|Death|14|||
23700925|NCT00069095|66284216|FG001|Primary Treatment Phase|Death|8|||
23700926|NCT00069095|66284217|FG002|Primary Treatment Phase|Death|2|||
23700927|NCT00069095|66284218|FG003|Primary Treatment Phase|Death|5|||
23700928|NCT00069095|66284219|FG004|Primary Treatment Phase|Death|8|||
23700929|NCT00069095|66284220|FG005|Primary Treatment Phase|Death|8|||
23700930|NCT00069095|66284215|FG000|Primary Treatment Phase|Failure to return|5|||
23700931|NCT00069095|66284216|FG001|Primary Treatment Phase|Failure to return|5|||
23700932|NCT00069095|66284217|FG002|Primary Treatment Phase|Failure to return|0|||
23700933|NCT00069095|66284218|FG003|Primary Treatment Phase|Failure to return|0|||
23700934|NCT00069095|66284219|FG004|Primary Treatment Phase|Failure to return|0|||
23700935|NCT00069095|66284220|FG005|Primary Treatment Phase|Failure to return|2|||
23700936|NCT00069095|66284215|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
23700937|NCT00069095|66284216|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
23700938|NCT00069095|66284217|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
23700939|NCT00069095|66284218|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
23700940|NCT00069095|66284219|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
23700941|NCT00069095|66284220|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
23700942|NCT00069095|66284215|FG000|Primary Treatment Phase|Refused treatment|15|||
23700943|NCT00069095|66284216|FG001|Primary Treatment Phase|Refused treatment|26|||
23700944|NCT00069095|66284217|FG002|Primary Treatment Phase|Refused treatment|17|||
23700945|NCT00069095|66284218|FG003|Primary Treatment Phase|Refused treatment|31|||
23700946|NCT00069095|66284219|FG004|Primary Treatment Phase|Refused treatment|24|||
23700947|NCT00069095|66284220|FG005|Primary Treatment Phase|Refused treatment|27|||
23700948|NCT00069095|66284215|FG000|Primary Treatment Phase|Withdrew|2|||
23700949|NCT00069095|66284216|FG001|Primary Treatment Phase|Withdrew|3|||
23700950|NCT00069095|66284217|FG002|Primary Treatment Phase|Withdrew|8|||
23700951|NCT00069095|66284218|FG003|Primary Treatment Phase|Withdrew|2|||
23700952|NCT00069095|66284219|FG004|Primary Treatment Phase|Withdrew|4|||
23700953|NCT00069095|66284220|FG005|Primary Treatment Phase|Withdrew|9|||
23700954|NCT00069095|66284215|FG000|Primary Treatment Phase|Other Violation|0|||
23700955|NCT00069095|66284216|FG001|Primary Treatment Phase|Other Violation|1|||
23700956|NCT00069095|66284217|FG002|Primary Treatment Phase|Other Violation|1|||
23700957|NCT00069095|66284218|FG003|Primary Treatment Phase|Other Violation|1|||
23502110|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Change of location|0|||
23700958|NCT00069095|66284219|FG004|Primary Treatment Phase|Other Violation|0|||
23700959|NCT00069095|66284220|FG005|Primary Treatment Phase|Other Violation|1|||
23700960|NCT00069095|66284215|FG000|Primary Treatment Phase|Violation criteria|0|||
23700961|NCT00069095|66284216|FG001|Primary Treatment Phase|Violation criteria|2|||
23700962|NCT00069095|66284217|FG002|Primary Treatment Phase|Violation criteria|4|||
23700963|NCT00069095|66284218|FG003|Primary Treatment Phase|Violation criteria|3|||
23700964|NCT00069095|66284219|FG004|Primary Treatment Phase|Violation criteria|1|||
23700965|NCT00069095|66284220|FG005|Primary Treatment Phase|Violation criteria|5|||
23700966|NCT00069095|66284215|FG000|Post-study Treatment Phase|Missing reason|1|||
23700967|NCT00069095|66284216|FG001|Post-study Treatment Phase|Missing reason|3|||
23700968|NCT00069095|66284217|FG002|Post-study Treatment Phase|Missing reason|12|||
23700969|NCT00069095|66284218|FG003|Post-study Treatment Phase|Missing reason|8|||
23700970|NCT00069095|66284219|FG004|Post-study Treatment Phase|Missing reason|18|||
23700971|NCT00069095|66284220|FG005|Post-study Treatment Phase|Missing reason|17|||
23700972|NCT00069095|66284215|FG000|Post-study Treatment Phase|Adverse Event|2|||
23700973|NCT00069095|66284216|FG001|Post-study Treatment Phase|Adverse Event|3|||
23700974|NCT00069095|66284217|FG002|Post-study Treatment Phase|Adverse Event|1|||
23700975|NCT00069095|66284218|FG003|Post-study Treatment Phase|Adverse Event|0|||
23700976|NCT00069095|66284219|FG004|Post-study Treatment Phase|Adverse Event|5|||
23700977|NCT00069095|66284220|FG005|Post-study Treatment Phase|Adverse Event|1|||
23700978|NCT00069095|66284215|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
23700979|NCT00069095|66284216|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
23700980|NCT00069095|66284217|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
23700981|NCT00069095|66284218|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
23700982|NCT00069095|66284219|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
23700983|NCT00069095|66284220|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
23700984|NCT00069095|66284215|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
23700985|NCT00069095|66284216|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
23700986|NCT00069095|66284217|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
23700987|NCT00069095|66284218|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
23700988|NCT00069095|66284219|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
23700989|NCT00069095|66284220|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
23700990|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
23700991|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23700992|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23700993|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23700994|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23700995|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
23700996|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant had complete response|1|||
23700997|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant had complete response|1|||
23700998|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant had complete response|0|||
23700999|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant had complete response|0|||
23701000|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant had complete response|0|||
23701001|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant had complete response|0|||
23701002|NCT00069095|66284215|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23701003|NCT00069095|66284216|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
23701004|NCT00069095|66284217|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23701005|NCT00069095|66284218|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23701006|NCT00069095|66284219|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23701007|NCT00069095|66284220|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23701008|NCT00069095|66284215|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23701009|NCT00069095|66284216|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23701010|NCT00069095|66284217|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23701011|NCT00069095|66284218|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23701012|NCT00069095|66284219|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23701013|NCT00069095|66284220|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23701014|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
23701015|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
23701016|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
23701017|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
23701018|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
23701019|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
23701020|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
23701021|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
23701022|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
23701023|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
23701024|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
23701025|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
23701026|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23701027|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23701028|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23701029|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
23701030|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23701031|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23701032|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
23701033|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
23701034|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
23701035|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
23701036|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
23701037|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
23701038|NCT00069095|66284215|FG000|Post-study Treatment Phase|Surgery|0|||
23701039|NCT00069095|66284216|FG001|Post-study Treatment Phase|Surgery|0|||
23701040|NCT00069095|66284217|FG002|Post-study Treatment Phase|Surgery|0|||
23701041|NCT00069095|66284218|FG003|Post-study Treatment Phase|Surgery|1|||
23701042|NCT00069095|66284219|FG004|Post-study Treatment Phase|Surgery|1|||
23701043|NCT00069095|66284220|FG005|Post-study Treatment Phase|Surgery|0|||
23701044|NCT00069095|66284215|FG000|Post-study Treatment Phase|Death|0|||
23701045|NCT00069095|66284216|FG001|Post-study Treatment Phase|Death|0|||
23701046|NCT00069095|66284217|FG002|Post-study Treatment Phase|Death|0|||
23701047|NCT00069095|66284218|FG003|Post-study Treatment Phase|Death|0|||
23701048|NCT00069095|66284219|FG004|Post-study Treatment Phase|Death|1|||
23701049|NCT00069095|66284220|FG005|Post-study Treatment Phase|Death|0|||
23701050|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
23701051|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
23701052|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
23701053|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
23701054|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
23701055|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
23701056|NCT00069095|66284215|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23701057|NCT00069095|66284216|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23701058|NCT00069095|66284217|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23701059|NCT00069095|66284218|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23701060|NCT00069095|66284219|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
23701061|NCT00069095|66284220|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23701062|NCT00069095|66284215|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23701063|NCT00069095|66284216|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23701064|NCT00069095|66284217|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23701065|NCT00069095|66284218|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23701066|NCT00069095|66284219|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
23701067|NCT00069095|66284220|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23701068|NCT00069095|66284215|FG000|Post-study Treatment Phase|Investigator decision|0|||
23701069|NCT00069095|66284216|FG001|Post-study Treatment Phase|Investigator decision|0|||
23701070|NCT00069095|66284217|FG002|Post-study Treatment Phase|Investigator decision|0|||
23701071|NCT00069095|66284218|FG003|Post-study Treatment Phase|Investigator decision|0|||
23701072|NCT00069095|66284219|FG004|Post-study Treatment Phase|Investigator decision|0|||
23701073|NCT00069095|66284220|FG005|Post-study Treatment Phase|Investigator decision|1|||
23701074|NCT00069095|66284215|FG000|Follow-up Phase|Death|174|||
23701075|NCT00069095|66284216|FG001|Follow-up Phase|Death|206|||
23701076|NCT00069095|66284217|FG002|Follow-up Phase|Death|120|||
23701077|NCT00069095|66284218|FG003|Follow-up Phase|Death|112|||
23701078|NCT00069095|66284219|FG004|Follow-up Phase|Death|92|||
23701079|NCT00069095|66284220|FG005|Follow-up Phase|Death|101|||
23701080|NCT00151411|66284221|FG000|Overall Study|Lost to Follow-up|15|||
23701081|NCT00151411|66284222|FG001|Overall Study|Lost to Follow-up|19|||
23701082|NCT00151411|66284221|FG000|Overall Study|Withdrawal by Subject|12|||
23701083|NCT00151411|66284222|FG001|Overall Study|Withdrawal by Subject|20|||
23701084|NCT00151411|66284221|FG000|Overall Study|Adverse Event|6|||
23701085|NCT00151411|66284222|FG001|Overall Study|Adverse Event|0|||
23701086|NCT00151411|66284221|FG000|Overall Study|Pregnancy|0|||
23701087|NCT00151411|66284222|FG001|Overall Study|Pregnancy|4|||
23701088|NCT02815397|66284223|FG000|Overall Study|Physician Decision|2|||
23701089|NCT00778999|66284224|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
23701090|NCT00778999|66284225|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
23701091|NCT00778999|66284224|FG000|Overall Study|Did not receive recFSH|14|||
23701092|NCT00778999|66284225|FG001|Overall Study|Did not receive recFSH|20|||
23701093|NCT02807454|66284229|FG000|Overall Study|Adverse Event|1|||
23701094|NCT02807454|66284230|FG001|Overall Study|Adverse Event|0|||
23701095|NCT02807454|66284229|FG000|Overall Study|Withdrawal by Subject|0|||
23701096|NCT02807454|66284230|FG001|Overall Study|Withdrawal by Subject|1|||
23701097|NCT02807454|66284229|FG000|Overall Study|Progressive Disease|30|||
23701098|NCT02807454|66284230|FG001|Overall Study|Progressive Disease|3|||
23701099|NCT02807454|66284229|FG000|Overall Study|Other Reasons|1|||
23701100|NCT02807454|66284230|FG001|Overall Study|Other Reasons|1|||
23701101|NCT01372878|66284232|FG000|Overall Study|Withdrawal by Subject|63|||
23701102|NCT01372878|66284232|FG000|Overall Study|Protocol Violation|17|||
23701103|NCT01372878|66284232|FG000|Overall Study|incomplete study procedure|104|||
23701104|NCT01605071|66284233|FG000|Overall Study|Withdrawal by Subject|3|||
23701105|NCT01605071|66284234|FG001|Overall Study|Withdrawal by Subject|2|||
23701106|NCT02429427|66284240|FG000|Overall Study|Adverse Event|220|||
23701107|NCT02429427|66284241|FG001|Overall Study|Adverse Event|92|||
23701108|NCT02429427|66284240|FG000|Overall Study|Protocol Violation|10|||
23701109|NCT02429427|66284241|FG001|Overall Study|Protocol Violation|6|||
23701110|NCT02429427|66284240|FG000|Overall Study|Lost to Follow-up|15|||
23701111|NCT02429427|66284241|FG001|Overall Study|Lost to Follow-up|6|||
23701112|NCT02429427|66284240|FG000|Overall Study|Withdrawal by Subject|64|||
23701113|NCT02429427|66284241|FG001|Overall Study|Withdrawal by Subject|34|||
23701114|NCT02429427|66284240|FG000|Overall Study|Other|62|||
23701115|NCT02429427|66284241|FG001|Overall Study|Other|41|||
23701116|NCT01306058|66284245|FG000|Overall Study|Death|1|||
23701117|NCT01306058|66284245|FG000|Overall Study|Enrolled but did not get treatment|1|||
23701118|NCT01356602|66284246|FG000|Overall Study|Protocol Deviation|0|||
23701119|NCT01356602|66284247|FG001|Overall Study|Protocol Deviation|1|||
23701120|NCT01356602|66284248|FG002|Overall Study|Protocol Deviation|1|||
23701121|NCT01356602|66284246|FG000|Overall Study|Administrative Problems|1|||
23701122|NCT01356602|66284247|FG001|Overall Study|Administrative Problems|4|||
23701123|NCT01356602|66284248|FG002|Overall Study|Administrative Problems|5|||
23701124|NCT01356602|66284246|FG000|Overall Study|Lost to Follow-up|4|||
23701125|NCT01356602|66284247|FG001|Overall Study|Lost to Follow-up|5|||
23701126|NCT01356602|66284248|FG002|Overall Study|Lost to Follow-up|6|||
23701127|NCT01356602|66284246|FG000|Overall Study|Withdrawal by Subject|4|||
23701128|NCT01356602|66284247|FG001|Overall Study|Withdrawal by Subject|3|||
23701129|NCT01356602|66284248|FG002|Overall Study|Withdrawal by Subject|7|||
23701130|NCT01356602|66284246|FG000|Overall Study|Lack of Efficacy|0|||
23701131|NCT01356602|66284247|FG001|Overall Study|Lack of Efficacy|1|||
23701132|NCT01356602|66284248|FG002|Overall Study|Lack of Efficacy|4|||
23701133|NCT01356602|66284246|FG000|Overall Study|Adverse Event|0|||
23701134|NCT01356602|66284247|FG001|Overall Study|Adverse Event|1|||
23701135|NCT01356602|66284248|FG002|Overall Study|Adverse Event|1|||
23701136|NCT02546856|66284249|FG000|4 Months Evaluation|Death|2|||
23701137|NCT02546856|66284250|FG001|4 Months Evaluation|Death|3|||
23701138|NCT02546856|66284249|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
23701139|NCT02546856|66284250|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
23701140|NCT02546856|66284249|FG000|4 Months Evaluation|Lost to Follow-up|3|||
23701141|NCT02546856|66284250|FG001|4 Months Evaluation|Lost to Follow-up|3|||
23701142|NCT02546856|66284249|FG000|4 Months Evaluation|Physician Decision|3|||
23701143|NCT02546856|66284250|FG001|4 Months Evaluation|Physician Decision|0|||
23701144|NCT02546856|66284249|FG000|4 Months Evaluation|Working or living abroad|5|||
23701145|NCT02546856|66284250|FG001|4 Months Evaluation|Working or living abroad|1|||
23701146|NCT02546856|66284249|FG000|4 Months Evaluation|reasons not due to titration|4|||
23701147|NCT02546856|66284250|FG001|4 Months Evaluation|reasons not due to titration|1|||
23701148|NCT02546856|66284249|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
23701149|NCT02546856|66284250|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
23701150|NCT02546856|66284249|FG000|6 Months Evaluation|Death|1|||
23701151|NCT02546856|66284250|FG001|6 Months Evaluation|Death|1|||
23701152|NCT02546856|66284249|FG000|6 Months Evaluation|Lost to Follow-up|1|||
23701153|NCT02546856|66284250|FG001|6 Months Evaluation|Lost to Follow-up|1|||
23701154|NCT02546856|66284249|FG000|6 Months Evaluation|Working or living abroad|6|||
23701155|NCT02546856|66284250|FG001|6 Months Evaluation|Working or living abroad|4|||
23701156|NCT02546856|66284249|FG000|6 Months Evaluation|reasons not due to titration|0|||
23701157|NCT02546856|66284250|FG001|6 Months Evaluation|reasons not due to titration|1|||
23701158|NCT00769704|66284252|FG000|Overall Study|Lost to Follow-up|3|||
23701159|NCT00769704|66284253|FG001|Overall Study|Lost to Follow-up|2|||
23701160|NCT00769704|66284252|FG000|Overall Study|Death|95|||
23701161|NCT00769704|66284253|FG001|Overall Study|Death|190|||
23701162|NCT00769704|66284252|FG000|Overall Study|Withdrawal by Subject|12|||
23701163|NCT00769704|66284253|FG001|Overall Study|Withdrawal by Subject|5|||
23701164|NCT00769704|66284252|FG000|Overall Study|Other|1|||
23701165|NCT00769704|66284253|FG001|Overall Study|Other|2|||
23701166|NCT02260193|66284254|FG000|Overall Study|Lack of Efficacy|0|||
23701167|NCT02260193|66284255|FG001|Overall Study|Lack of Efficacy|1|||
23701168|NCT02260193|66284256|FG002|Overall Study|Lack of Efficacy|6|||
23701169|NCT02260193|66284254|FG000|Overall Study|Adverse Event|3|||
23701170|NCT02260193|66284255|FG001|Overall Study|Adverse Event|4|||
23701171|NCT02260193|66284256|FG002|Overall Study|Adverse Event|1|||
23701172|NCT02260193|66284254|FG000|Overall Study|Protocol Violation|0|||
23701173|NCT02260193|66284255|FG001|Overall Study|Protocol Violation|4|||
23701174|NCT02260193|66284256|FG002|Overall Study|Protocol Violation|0|||
23701175|NCT02260193|66284254|FG000|Overall Study|Withdrawal by Subject|3|||
23701176|NCT02260193|66284255|FG001|Overall Study|Withdrawal by Subject|0|||
23701177|NCT02260193|66284256|FG002|Overall Study|Withdrawal by Subject|2|||
23701178|NCT02260193|66284254|FG000|Overall Study|Kidney Transplantation|0|||
23701179|NCT02260193|66284255|FG001|Overall Study|Kidney Transplantation|0|||
23701180|NCT02260193|66284256|FG002|Overall Study|Kidney Transplantation|1|||
23701181|NCT00878072|66284260|FG000|Overall Study|Withdrew consent|2|||
23701182|NCT02874794|66284261|FG000|Overall Study|Physician Decision|3|||
23701183|NCT02874794|66284262|FG001|Overall Study|Physician Decision|2|||
23701184|NCT02874794|66284261|FG000|Overall Study|Withdrawal by Subject|2|||
23701185|NCT02874794|66284262|FG001|Overall Study|Withdrawal by Subject|8|||
23701186|NCT02874794|66284261|FG000|Overall Study|Death|2|||
23701187|NCT02874794|66284262|FG001|Overall Study|Death|1|||
23701188|NCT00149825|66284269|FG000|Overall Study|Intolerance to medication side effects|1|||
23701189|NCT00149825|66284270|FG001|Overall Study|Intolerance to medication side effects|2|||
23701190|NCT00149825|66284269|FG000|Overall Study|Time commitments|2|||
23701191|NCT00149825|66284270|FG001|Overall Study|Time commitments|1|||
23701192|NCT00149825|66284269|FG000|Overall Study|Not liking insomnia therapy|1|||
23701193|NCT00149825|66284270|FG001|Overall Study|Not liking insomnia therapy|0|||
23701194|NCT00149825|66284269|FG000|Overall Study|Other|1|||
23701195|NCT00149825|66284270|FG001|Overall Study|Other|0|||
23701196|NCT02433210|66284275|FG000|Overall Study|Physician Decision|1|||
23701197|NCT02433210|66284276|FG001|Overall Study|Physician Decision|0|||
23701198|NCT02433210|66284277|FG002|Overall Study|Physician Decision|0|||
23701199|NCT00907478|66284280|FG000|Overall Study|Ineligibility determined|0|||
23701200|NCT00907478|66284281|FG001|Overall Study|Ineligibility determined|0|||
23701201|NCT00907478|66284282|FG002|Overall Study|Ineligibility determined|1|||
23701202|NCT00907478|66284280|FG000|Overall Study|Noncompliance|0|||
23701203|NCT00907478|66284281|FG001|Overall Study|Noncompliance|0|||
23701204|NCT00907478|66284282|FG002|Overall Study|Noncompliance|1|||
23701205|NCT00907478|66284280|FG000|Overall Study|Adverse Event|3|||
23701206|NCT00907478|66284281|FG001|Overall Study|Adverse Event|1|||
23701207|NCT00907478|66284282|FG002|Overall Study|Adverse Event|2|||
23701208|NCT00907478|66284280|FG000|Overall Study|Withdrawal by Subject|8|||
23701209|NCT00907478|66284281|FG001|Overall Study|Withdrawal by Subject|9|||
23701210|NCT00907478|66284282|FG002|Overall Study|Withdrawal by Subject|6|||
23701211|NCT00907478|66284280|FG000|Overall Study|Requirement for alternative therapy|1|||
23701212|NCT00907478|66284281|FG001|Overall Study|Requirement for alternative therapy|2|||
23701213|NCT00907478|66284282|FG002|Overall Study|Requirement for alternative therapy|3|||
23701214|NCT00907478|66284280|FG000|Overall Study|Physician Decision|2|||
23701215|NCT00907478|66284281|FG001|Overall Study|Physician Decision|0|||
23701216|NCT00907478|66284282|FG002|Overall Study|Physician Decision|3|||
23701217|NCT00907478|66284280|FG000|Overall Study|Death|4|||
23701218|NCT00907478|66284281|FG001|Overall Study|Death|2|||
23701219|NCT00907478|66284282|FG002|Overall Study|Death|1|||
23701220|NCT00907478|66284280|FG000|Overall Study|Protocol-specified criteria|5|||
23701221|NCT00907478|66284281|FG001|Overall Study|Protocol-specified criteria|2|||
23701222|NCT00907478|66284282|FG002|Overall Study|Protocol-specified criteria|3|||
23701223|NCT00907478|66284280|FG000|Overall Study|Pregnancy|0|||
23701224|NCT00907478|66284281|FG001|Overall Study|Pregnancy|1|||
23701225|NCT00907478|66284282|FG002|Overall Study|Pregnancy|1|||
23701226|NCT00907478|66284280|FG000|Overall Study|Lost to Follow-up|1|||
23701227|NCT00907478|66284281|FG001|Overall Study|Lost to Follow-up|0|||
23701228|NCT00907478|66284282|FG002|Overall Study|Lost to Follow-up|0|||
23701229|NCT00907478|66284280|FG000|Overall Study|Other|3|||
23701230|NCT00907478|66284281|FG001|Overall Study|Other|0|||
23701231|NCT00907478|66284282|FG002|Overall Study|Other|1|||
23701232|NCT02612077|66284283|FG000|Overall Study|Adverse Event|3|||
23701233|NCT02612077|66284283|FG000|Overall Study|Withdrawal by Subject|9|||
23701234|NCT02612077|66284283|FG000|Overall Study|Protocol Violation|28|||
23701235|NCT02612077|66284283|FG000|Overall Study|Lost to Follow-up|20|||
23701236|NCT02612077|66284283|FG000|Overall Study|Death|377|||
23701237|NCT02612077|66284283|FG000|Overall Study|Moved or Changed Medical Team|23|||
23701238|NCT02612077|66284283|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
23701239|NCT02612077|66284283|FG000|Overall Study|Disease Progression|3|||
23701240|NCT02612077|66284283|FG000|Overall Study|Unknown reason|2|||
23701241|NCT01152450|66284284|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
23701242|NCT01152450|66284285|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
23701243|NCT01152450|66284286|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
23502111|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Change of location|1|||
23502112|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Change of location|0|||
23701244|NCT01152450|66284287|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
23701245|NCT01152450|66284288|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
23701246|NCT01152450|66284289|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
23701247|NCT01152450|66284284|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
23701248|NCT01152450|66284285|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
23701249|NCT01152450|66284286|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
23701250|NCT01152450|66284287|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
23701251|NCT01152450|66284288|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
23701252|NCT01152450|66284289|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
23701253|NCT01152450|66284284|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23701254|NCT01152450|66284285|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23701255|NCT01152450|66284286|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23701256|NCT01152450|66284287|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23701257|NCT01152450|66284288|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23701258|NCT01152450|66284289|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23701259|NCT01797783|66284295|FG000|Overall Study|Adverse Event|1|||
23701260|NCT01797783|66284296|FG001|Overall Study|Adverse Event|1|||
23701261|NCT01797783|66284295|FG000|Overall Study|Withdrawal by Subject|1|||
23701262|NCT01797783|66284296|FG001|Overall Study|Withdrawal by Subject|0|||
23701263|NCT01454401|66284297|FG000|Overall Study|Death|1|||
23701264|NCT01454401|66284297|FG000|Overall Study|hospitalised|1|||
23701265|NCT01454401|66284297|FG000|Overall Study|osteomyelitis|2|||
23701266|NCT01454401|66284297|FG000|Overall Study|non-adherence|1|||
23701267|NCT01215734|66284299|FG000|Overall Study|Death|0|||
23701268|NCT01215734|66284300|FG001|Overall Study|Death|1|||
23701269|NCT00950690|66284301|FG000|Overall Study|Death|4|||
23701270|NCT00950690|66284301|FG000|Overall Study|Adverse Event|15|||
23701271|NCT00950690|66284301|FG000|Overall Study|Lack of Efficacy|22|||
23701272|NCT00950690|66284301|FG000|Overall Study|Lost to Follow-up|40|||
23701273|NCT00950690|66284301|FG000|Overall Study|Other|163|||
23701274|NCT03345836|66284302|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
23701275|NCT03345836|66284303|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
23701276|NCT03345836|66284304|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
23701277|NCT03345836|66284305|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23701278|NCT03345836|66284306|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23701279|NCT03345836|66284307|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23701280|NCT03345836|66284302|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
23701281|NCT03345836|66284303|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
23701282|NCT03345836|66284304|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
23701283|NCT03345836|66284305|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23701284|NCT03345836|66284306|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23701285|NCT03345836|66284307|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23701286|NCT03345836|66284302|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23701287|NCT03345836|66284303|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
23701288|NCT03345836|66284304|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23701289|NCT03345836|66284305|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23701290|NCT03345836|66284306|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23701291|NCT03345836|66284307|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23701292|NCT03345836|66284302|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
23701293|NCT03345836|66284303|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
23701294|NCT03345836|66284304|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23701295|NCT03345836|66284305|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23701296|NCT03345836|66284306|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23701297|NCT03345836|66284307|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23701298|NCT03345836|66284302|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
23701299|NCT03345836|66284303|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
23701300|NCT03345836|66284304|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
23701301|NCT03345836|66284305|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23701302|NCT03345836|66284306|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23701303|NCT03345836|66284307|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23701304|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23701305|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23701306|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23701307|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
23701308|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
23701309|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23701310|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23701311|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23701312|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23701313|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23701314|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
23701315|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
23701316|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23701317|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23701318|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23701319|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23701320|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23701321|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
23701322|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23701323|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23701324|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23701325|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
23701326|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
23701327|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
23701328|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23701329|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23701330|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23701331|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23701332|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
23701333|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23701334|NCT03345836|66284302|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23701335|NCT03345836|66284303|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23701336|NCT03345836|66284304|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23701337|NCT03345836|66284305|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23701338|NCT03345836|66284306|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23701339|NCT03345836|66284307|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23701340|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
23701341|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
23701342|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
23701343|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23701344|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23701345|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23502113|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
23502114|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
23502115|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
23502116|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
23502117|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
23502118|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502119|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502120|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502121|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502122|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
23502123|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
23502124|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502125|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502126|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502127|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502128|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
23502129|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
23502130|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
23502131|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
23502132|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
23502133|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
23502134|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
23502135|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
23502136|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
23502137|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
23502138|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
23502139|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
23502140|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
23502141|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
23502142|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
23502143|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Death|0|||
23502144|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Death|1|||
23502145|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Death|0|||
23502146|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Death|1|||
23502147|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Death|0|||
23502148|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Change of location|1|||
23502149|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Change of location|1|||
23502150|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Change of location|0|||
23502151|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Change of location|1|||
23502152|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Change of location|0|||
23502153|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502154|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502155|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
23502156|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502157|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502158|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502159|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502160|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
23502161|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502162|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502163|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502164|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502165|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
23502166|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502167|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502168|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502169|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502170|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502171|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502172|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
23502173|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
23502174|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502175|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502176|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502177|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502178|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502179|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502180|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502181|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
23502182|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502183|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502184|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
23502185|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
23502186|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502187|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502188|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
23502189|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
23502190|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502191|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502192|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502193|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502194|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
23502195|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502196|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502197|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502198|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
23502199|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
23502200|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
23502201|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
23502202|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
23502203|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Missing|0|||
23502204|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Missing|0|||
23502205|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Missing|2|||
23502206|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Missing|0|||
23502207|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Missing|0|||
23502208|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502209|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502210|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502211|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502212|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
23502213|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502214|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502215|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
23502216|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502217|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502218|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
23502219|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
23502220|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
23502221|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
23502222|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
23502223|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502224|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502225|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
23502226|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502227|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502228|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502229|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502230|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502231|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
23502232|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502233|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
23502234|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502235|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502236|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502237|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502238|NCT02197520|65580132|FG000|Period 1|Withdrawal by Subject|1|||
23502239|NCT02197520|65580133|FG001|Period 1|Withdrawal by Subject|0|||
23502240|NCT02197520|65580132|FG000|Period 2|Adverse Event|0|||
23502241|NCT02197520|65580133|FG001|Period 2|Adverse Event|2|||
23502242|NCT02197520|65580132|FG000|Period 2|Withdrawal by Subject|1|||
23502243|NCT02197520|65580133|FG001|Period 2|Withdrawal by Subject|0|||
23502244|NCT01487200|65580134|FG000|Overall Study|Withdrawal by Subject|0|||
23502245|NCT01487200|65580135|FG001|Overall Study|Withdrawal by Subject|1|||
23502246|NCT01487200|65580136|FG002|Overall Study|Withdrawal by Subject|0|||
23502247|NCT01487200|65580137|FG003|Overall Study|Withdrawal by Subject|0|||
23502248|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Adverse Event|16|||
23502249|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Adverse Event|17|||
23502250|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Adverse Event|13|||
23502251|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Adverse Event|18|||
23502252|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Adverse Event|0|||
23502253|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Adverse Event|0|||
23502254|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Adverse Event|0|||
23502255|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Adverse Event|0|||
23502256|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
23502257|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
23502258|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
23502259|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
23502260|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502261|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502262|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502263|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502264|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
23502265|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
23502266|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
23502267|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
23502268|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
23502269|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
23502270|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
23502271|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
23502272|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
23502273|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
23502274|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
23502275|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
23502276|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502277|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502278|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502279|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502280|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
23502281|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502282|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
23502283|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
23502284|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502285|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502286|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502287|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502288|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
23502289|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
23502290|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
23502291|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
23701346|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23701347|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23701348|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
23701349|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
23701350|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
23701351|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23701352|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23701353|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23701354|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23701355|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23701356|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
23701357|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
23701358|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
23701359|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23701360|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23701361|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23701362|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23701363|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23701364|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23701365|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23701366|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701367|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701368|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701369|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701370|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701371|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23701372|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
23701373|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
23701374|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
23701375|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23701376|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23701377|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23701378|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23701379|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23701380|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
23701381|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
23701382|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701383|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701384|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701385|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701386|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701387|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23701388|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
23701389|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
23701390|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701391|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701392|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701393|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701394|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701395|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23701396|NCT01097616|66284312|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701397|NCT01097616|66284313|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701398|NCT01097616|66284314|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
23701399|NCT01097616|66284315|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701400|NCT01097616|66284316|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701401|NCT01097616|66284317|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701402|NCT01097616|66284318|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701403|NCT01097616|66284319|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23701404|NCT01097616|66284312|FG000|Optional DB EXT Phase|Adverse Event|0|||
23701405|NCT01097616|66284313|FG001|Optional DB EXT Phase|Adverse Event|7|||
23701406|NCT01097616|66284314|FG002|Optional DB EXT Phase|Adverse Event|2|||
23701407|NCT01097616|66284315|FG003|Optional DB EXT Phase|Adverse Event|0|||
23701408|NCT01097616|66284316|FG004|Optional DB EXT Phase|Adverse Event|0|||
23398903|NCT01900665|65207208|FG001|Placebo Controlled Period|Caregiver Decision|41|||
23398904|NCT01900665|65207207|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
23701409|NCT01097616|66284317|FG005|Optional DB EXT Phase|Adverse Event|0|||
23701410|NCT01097616|66284318|FG006|Optional DB EXT Phase|Adverse Event|0|||
23701411|NCT01097616|66284319|FG007|Optional DB EXT Phase|Adverse Event|0|||
23701412|NCT01097616|66284312|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
23701413|NCT01097616|66284313|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
23701414|NCT01097616|66284314|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
23701415|NCT01097616|66284315|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
23701416|NCT01097616|66284316|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
23701417|NCT01097616|66284317|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
23701418|NCT01097616|66284318|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
23701419|NCT01097616|66284319|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
23701420|NCT01097616|66284312|FG000|Optional DB EXT Phase|Protocol Violation|0|||
23701421|NCT01097616|66284313|FG001|Optional DB EXT Phase|Protocol Violation|2|||
23701422|NCT01097616|66284314|FG002|Optional DB EXT Phase|Protocol Violation|3|||
23701423|NCT01097616|66284315|FG003|Optional DB EXT Phase|Protocol Violation|0|||
23701424|NCT01097616|66284316|FG004|Optional DB EXT Phase|Protocol Violation|0|||
23701425|NCT01097616|66284317|FG005|Optional DB EXT Phase|Protocol Violation|0|||
23701426|NCT01097616|66284318|FG006|Optional DB EXT Phase|Protocol Violation|0|||
23701427|NCT01097616|66284319|FG007|Optional DB EXT Phase|Protocol Violation|0|||
23701428|NCT01097616|66284312|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
23701429|NCT01097616|66284313|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
23701430|NCT01097616|66284314|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
23701431|NCT01097616|66284315|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
23701432|NCT01097616|66284316|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
23701433|NCT01097616|66284317|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
23701434|NCT01097616|66284318|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
23701435|NCT01097616|66284319|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
23701436|NCT01097616|66284312|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
23701437|NCT01097616|66284313|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
23701438|NCT01097616|66284314|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
23701439|NCT01097616|66284315|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
23701440|NCT01097616|66284316|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
23701441|NCT01097616|66284317|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
23701442|NCT01097616|66284318|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
23701443|NCT01097616|66284319|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
23701444|NCT01097616|66284312|FG000|Optional DB EXT Phase|Physician Decision|1|||
23701445|NCT01097616|66284313|FG001|Optional DB EXT Phase|Physician Decision|0|||
23502292|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
23502293|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
23502294|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
23502295|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
23502296|NCT02975336|65580138|FG000|LTE (104 Weeks)|Adverse Event|0|||
23502297|NCT02975336|65580139|FG001|LTE (104 Weeks)|Adverse Event|0|||
23502298|NCT02975336|65580140|FG002|LTE (104 Weeks)|Adverse Event|0|||
23502299|NCT02975336|65580141|FG003|LTE (104 Weeks)|Adverse Event|0|||
23502300|NCT02975336|65580142|FG004|LTE (104 Weeks)|Adverse Event|7|||
23502301|NCT02975336|65580143|FG005|LTE (104 Weeks)|Adverse Event|4|||
23502302|NCT02975336|65580144|FG006|LTE (104 Weeks)|Adverse Event|2|||
23502303|NCT02975336|65580145|FG007|LTE (104 Weeks)|Adverse Event|0|||
23502304|NCT02975336|65580138|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
23502305|NCT02975336|65580139|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
23502306|NCT02975336|65580140|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
23502307|NCT02975336|65580141|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
23502308|NCT02975336|65580142|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
23502309|NCT02975336|65580143|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
23502310|NCT02975336|65580144|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
23502311|NCT02975336|65580145|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
23502312|NCT02975336|65580138|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
23502313|NCT02975336|65580139|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
23502314|NCT02975336|65580140|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
23502315|NCT02975336|65580141|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
23502316|NCT02975336|65580142|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
23502317|NCT02975336|65580143|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
23502318|NCT02975336|65580144|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
23502319|NCT02975336|65580145|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
23502320|NCT02975336|65580138|FG000|LTE (104 Weeks)|Other|0|||
23502321|NCT02975336|65580139|FG001|LTE (104 Weeks)|Other|0|||
23701446|NCT01097616|66284314|FG002|Optional DB EXT Phase|Physician Decision|0|||
23701447|NCT01097616|66284315|FG003|Optional DB EXT Phase|Physician Decision|0|||
23502322|NCT02975336|65580140|FG002|LTE (104 Weeks)|Other|0|||
23502323|NCT02975336|65580141|FG003|LTE (104 Weeks)|Other|0|||
23502324|NCT02975336|65580142|FG004|LTE (104 Weeks)|Other|55|||
23502325|NCT02975336|65580143|FG005|LTE (104 Weeks)|Other|63|||
23502326|NCT02975336|65580144|FG006|LTE (104 Weeks)|Other|76|||
23502327|NCT02975336|65580145|FG007|LTE (104 Weeks)|Other|72|||
23701448|NCT01097616|66284316|FG004|Optional DB EXT Phase|Physician Decision|0|||
23701449|NCT01097616|66284317|FG005|Optional DB EXT Phase|Physician Decision|0|||
23502328|NCT03926169|65580146|FG000|Period A|Adverse Event|2|||
23502329|NCT03926169|65580147|FG001|Period A|Adverse Event|2|||
23502330|NCT03926169|65580148|FG002|Period A|Adverse Event|1|||
23502331|NCT03926169|65580146|FG000|Period A|Withdrawal by Subject|2|||
23502332|NCT03926169|65580147|FG001|Period A|Withdrawal by Subject|2|||
23502333|NCT03926169|65580148|FG002|Period A|Withdrawal by Subject|2|||
23502334|NCT03926169|65580146|FG000|Period A|Lost to Follow-up|3|||
23502335|NCT03926169|65580147|FG001|Period A|Lost to Follow-up|1|||
23502336|NCT03926169|65580148|FG002|Period A|Lost to Follow-up|0|||
23502337|NCT03926169|65580146|FG000|Period A|Lack of Efficacy|0|||
23502338|NCT03926169|65580147|FG001|Period A|Lack of Efficacy|2|||
23502339|NCT03926169|65580148|FG002|Period A|Lack of Efficacy|2|||
23502340|NCT03926169|65580146|FG000|Period A|COVID-19 Infection|0|||
23502341|NCT03926169|65580147|FG001|Period A|COVID-19 Infection|1|||
23502342|NCT03926169|65580148|FG002|Period A|COVID-19 Infection|0|||
23502343|NCT03926169|65580146|FG000|Period A|COVID-19 Logistical Restrictions|0|||
23502344|NCT03926169|65580147|FG001|Period A|COVID-19 Logistical Restrictions|2|||
23502345|NCT03926169|65580148|FG002|Period A|COVID-19 Logistical Restrictions|1|||
23502346|NCT03926169|65580146|FG000|Period A|Other, Not Specified|1|||
23502347|NCT03926169|65580147|FG001|Period A|Other, Not Specified|0|||
23502348|NCT03926169|65580148|FG002|Period A|Other, Not Specified|0|||
23502349|NCT03926169|65580146|FG000|Period B|Adverse Event|3|||
23502350|NCT03926169|65580147|FG001|Period B|Adverse Event|1|||
23502351|NCT03926169|65580148|FG002|Period B|Adverse Event|1|||
23502352|NCT03926169|65580146|FG000|Period B|Withdrawal by Subject|1|||
23502353|NCT03926169|65580147|FG001|Period B|Withdrawal by Subject|3|||
23502354|NCT03926169|65580148|FG002|Period B|Withdrawal by Subject|0|||
23502355|NCT03926169|65580146|FG000|Period B|Lack of Efficacy|3|||
23502356|NCT03926169|65580147|FG001|Period B|Lack of Efficacy|1|||
23502357|NCT03926169|65580148|FG002|Period B|Lack of Efficacy|1|||
23502358|NCT03926169|65580146|FG000|Period B|Lost to Follow-up|1|||
23502359|NCT03926169|65580147|FG001|Period B|Lost to Follow-up|1|||
23502360|NCT03926169|65580148|FG002|Period B|Lost to Follow-up|4|||
23502361|NCT03926169|65580146|FG000|Period B|Other, Not Specified|62|||
23502362|NCT03926169|65580147|FG001|Period B|Other, Not Specified|57|||
23502363|NCT03926169|65580148|FG002|Period B|Other, Not Specified|65|||
23502364|NCT03715530|65580149|FG000|Overall Study|Lost to Follow-up|3|||
23502365|NCT03715530|65580150|FG001|Overall Study|Lost to Follow-up|1|||
23502366|NCT03715530|65580151|FG002|Overall Study|Lost to Follow-up|2|||
23502367|NCT02412618|65580152|FG000|Overall Study|Withdrawal by Subject|1|||
23502368|NCT02412618|65580153|FG001|Overall Study|Withdrawal by Subject|1|||
23502369|NCT02412618|65580152|FG000|Overall Study|Expulsion|1|||
23502370|NCT02412618|65580153|FG001|Overall Study|Expulsion|1|||
23502371|NCT02549937|65580154|FG000|Overall Study|Death|0|||
23502372|NCT02549937|65580155|FG001|Overall Study|Death|1|||
23502373|NCT02549937|65580156|FG002|Overall Study|Death|0|||
23502374|NCT02549937|65580157|FG003|Overall Study|Death|1|||
23502375|NCT02549937|65580158|FG004|Overall Study|Death|0|||
23502376|NCT02549937|65580159|FG005|Overall Study|Death|8|||
23502377|NCT02549937|65580160|FG006|Overall Study|Death|0|||
23502378|NCT02549937|65580161|FG007|Overall Study|Death|0|||
23502379|NCT02549937|65580162|FG008|Overall Study|Death|19|||
23502380|NCT02549937|65580154|FG000|Overall Study|No follow up required|3|||
23502381|NCT02549937|65580155|FG001|Overall Study|No follow up required|6|||
23502382|NCT02549937|65580156|FG002|Overall Study|No follow up required|3|||
23502383|NCT02549937|65580157|FG003|Overall Study|No follow up required|8|||
23502384|NCT02549937|65580158|FG004|Overall Study|No follow up required|12|||
23502385|NCT02549937|65580159|FG005|Overall Study|No follow up required|21|||
23502386|NCT02549937|65580160|FG006|Overall Study|No follow up required|9|||
23502387|NCT02549937|65580161|FG007|Overall Study|No follow up required|11|||
23502388|NCT02549937|65580162|FG008|Overall Study|No follow up required|0|||
23502389|NCT02549937|65580154|FG000|Overall Study|Other|0|||
23502390|NCT02549937|65580155|FG001|Overall Study|Other|0|||
23502391|NCT02549937|65580156|FG002|Overall Study|Other|0|||
23502392|NCT02549937|65580157|FG003|Overall Study|Other|0|||
23502393|NCT02549937|65580158|FG004|Overall Study|Other|1|||
23502394|NCT02549937|65580159|FG005|Overall Study|Other|0|||
23502395|NCT02549937|65580160|FG006|Overall Study|Other|3|||
23502396|NCT02549937|65580161|FG007|Overall Study|Other|2|||
23502397|NCT02549937|65580162|FG008|Overall Study|Other|3|||
23502398|NCT02549937|65580154|FG000|Overall Study|Lost to Follow-up|0|||
23502399|NCT02549937|65580155|FG001|Overall Study|Lost to Follow-up|0|||
23502400|NCT02549937|65580156|FG002|Overall Study|Lost to Follow-up|0|||
23502401|NCT02549937|65580157|FG003|Overall Study|Lost to Follow-up|0|||
23502402|NCT02549937|65580158|FG004|Overall Study|Lost to Follow-up|0|||
23502403|NCT02549937|65580159|FG005|Overall Study|Lost to Follow-up|0|||
23502404|NCT02549937|65580160|FG006|Overall Study|Lost to Follow-up|0|||
23502405|NCT02549937|65580161|FG007|Overall Study|Lost to Follow-up|0|||
23502406|NCT02549937|65580162|FG008|Overall Study|Lost to Follow-up|3|||
23502407|NCT02549937|65580154|FG000|Overall Study|Withdrawal by Subject|0|||
23502408|NCT02549937|65580155|FG001|Overall Study|Withdrawal by Subject|0|||
23502409|NCT02549937|65580156|FG002|Overall Study|Withdrawal by Subject|0|||
23502410|NCT02549937|65580157|FG003|Overall Study|Withdrawal by Subject|0|||
23502411|NCT02549937|65580158|FG004|Overall Study|Withdrawal by Subject|0|||
23502412|NCT02549937|65580159|FG005|Overall Study|Withdrawal by Subject|1|||
23502413|NCT02549937|65580160|FG006|Overall Study|Withdrawal by Subject|4|||
23502414|NCT02549937|65580161|FG007|Overall Study|Withdrawal by Subject|3|||
23502415|NCT02549937|65580162|FG008|Overall Study|Withdrawal by Subject|2|||
23502416|NCT02549937|65580154|FG000|Overall Study|Sponsor Decision|0|||
23502417|NCT02549937|65580155|FG001|Overall Study|Sponsor Decision|0|||
23502418|NCT02549937|65580156|FG002|Overall Study|Sponsor Decision|0|||
23502419|NCT02549937|65580157|FG003|Overall Study|Sponsor Decision|0|||
23502420|NCT02549937|65580158|FG004|Overall Study|Sponsor Decision|0|||
23502421|NCT02549937|65580159|FG005|Overall Study|Sponsor Decision|0|||
23502422|NCT02549937|65580160|FG006|Overall Study|Sponsor Decision|0|||
23502423|NCT02549937|65580161|FG007|Overall Study|Sponsor Decision|0|||
23502424|NCT02549937|65580162|FG008|Overall Study|Sponsor Decision|6|||
23502425|NCT01051323|65580163|FG000|Overall Study|Discontinuation of treatment|103|||
23502426|NCT01051323|65580163|FG000|Overall Study|Transplantation|28|||
23502427|NCT01051323|65580163|FG000|Overall Study|Dialysis dependency|22|||
23502428|NCT01051323|65580163|FG000|Overall Study|Withdrawal by Subject|13|||
23502429|NCT01051323|65580163|FG000|Overall Study|Lost to Follow-up|31|||
23502430|NCT01051323|65580163|FG000|Overall Study|Death|129|||
23502431|NCT01051323|65580163|FG000|Overall Study|Hospitalization|28|||
23502432|NCT01051323|65580163|FG000|Overall Study|Other|148|||
23502433|NCT01051323|65580163|FG000|Overall Study|Missing|37|||
23502434|NCT00555971|65580164|FG000|Overall Study|Adverse Event|1|||
23502435|NCT00555971|65580165|FG001|Overall Study|Adverse Event|1|||
23502436|NCT00667875|65580166|FG000|Overall Study|Adverse Event|0|||
23502437|NCT00667875|65580167|FG001|Overall Study|Adverse Event|2|||
23502438|NCT00667875|65580168|FG002|Overall Study|Adverse Event|6|||
23502439|NCT00667875|65580166|FG000|Overall Study|Withdrawal by Subject|10|||
23502440|NCT00667875|65580167|FG001|Overall Study|Withdrawal by Subject|9|||
23502441|NCT00667875|65580168|FG002|Overall Study|Withdrawal by Subject|7|||
23502442|NCT00006237|65580170|FG000|Overall Study|Adverse Event|39|||
23502443|NCT00006237|65580171|FG001|Overall Study|Adverse Event|29|||
23502444|NCT00006237|65580170|FG000|Overall Study|Death|1|||
23502445|NCT00006237|65580171|FG001|Overall Study|Death|0|||
23502446|NCT00006237|65580170|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
23502447|NCT00006237|65580171|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
23502448|NCT00006237|65580170|FG000|Overall Study|Progression/relapse|54|||
23502449|NCT00006237|65580171|FG001|Overall Study|Progression/relapse|2|||
23502450|NCT00006237|65580170|FG000|Overall Study|Not eligible|9|||
23502451|NCT00006237|65580171|FG001|Overall Study|Not eligible|20|||
23502452|NCT00006237|65580170|FG000|Overall Study|Withdrawal by Subject|0|||
23502453|NCT00006237|65580171|FG001|Overall Study|Withdrawal by Subject|1|||
23502454|NCT00006237|65580170|FG000|Overall Study|Not protocol specified|14|||
23502455|NCT00006237|65580171|FG001|Overall Study|Not protocol specified|5|||
23502456|NCT03693300|65580172|FG000|Overall Study|Withdrawal by Subject|6|||
23502457|NCT03693300|65580173|FG001|Overall Study|Withdrawal by Subject|0|||
23502458|NCT03693300|65580172|FG000|Overall Study|Death|50|||
23502459|NCT03693300|65580173|FG001|Overall Study|Death|2|||
23502460|NCT03693300|65580172|FG000|Overall Study|Lost to Follow-up|2|||
23502461|NCT03693300|65580173|FG001|Overall Study|Lost to Follow-up|0|||
23502462|NCT01217814|65580177|FG000|Overall Study|Adverse Event|1|||
23502463|NCT01217814|65580178|FG001|Overall Study|Adverse Event|1|||
23502464|NCT01217814|65580179|FG002|Overall Study|Adverse Event|0|||
23502465|NCT01217814|65580177|FG000|Overall Study|Lack of Efficacy|0|||
23502466|NCT01217814|65580178|FG001|Overall Study|Lack of Efficacy|0|||
23502467|NCT01217814|65580179|FG002|Overall Study|Lack of Efficacy|1|||
23502468|NCT02756013|65580180|FG000|Overall Study|Adverse Event|1|||
23502469|NCT02756013|65580180|FG000|Overall Study|Hypersensitivity|1|||
23502470|NCT00353262|65580185|FG000|Overall Study|Adverse Event|8|||
23502471|NCT00353262|65580185|FG000|Overall Study|Withdrawal by Subject|2|||
23502472|NCT00353262|65580185|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23502473|NCT00353262|65580185|FG000|Overall Study|Progression|1|||
23502474|NCT00353262|65580185|FG000|Overall Study|Surgery|4|||
23502475|NCT00353262|65580185|FG000|Overall Study|Break from Chemotherapy|1|||
23502476|NCT00283400|65580186|FG000|Overall Study|Withdrawal by Subject|1|||
23502477|NCT00283400|65580187|FG001|Overall Study|Withdrawal by Subject|1|||
23502478|NCT00283400|65580188|FG002|Overall Study|Withdrawal by Subject|0|||
23502479|NCT00283400|65580189|FG003|Overall Study|Withdrawal by Subject|0|||
23502480|NCT00283400|65580186|FG000|Overall Study|Death|1|||
23502481|NCT00283400|65580187|FG001|Overall Study|Death|0|||
23502482|NCT00283400|65580188|FG002|Overall Study|Death|1|||
23502483|NCT00283400|65580189|FG003|Overall Study|Death|0|||
23502484|NCT00519831|65580190|FG000|Overall Study|Adverse Event|3|||
23502485|NCT00777608|65580191|FG000|Overall Study|Lost to Follow-up|1|||
23502486|NCT00777608|65580192|FG001|Overall Study|Lost to Follow-up|1|||
23502487|NCT00777608|65580191|FG000|Overall Study|Withdrawal by Subject|1|||
23502488|NCT00777608|65580192|FG001|Overall Study|Withdrawal by Subject|3|||
23502489|NCT00777608|65580191|FG000|Overall Study|Protocol Violation|1|||
23502490|NCT00777608|65580192|FG001|Overall Study|Protocol Violation|0|||
23502491|NCT00777608|65580191|FG000|Overall Study|Investigator Decision|1|||
23502492|NCT00777608|65580192|FG001|Overall Study|Investigator Decision|2|||
23502493|NCT02197247|65580193|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
23502494|NCT02197247|65580193|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
23502495|NCT02197247|65580193|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
23502496|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
23502497|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
23502498|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
23502499|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
23502500|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
23502501|NCT03521934|65580197|FG000|Overall Study|Death|65|||
23502502|NCT03521934|65580198|FG001|Overall Study|Death|73|||
23502503|NCT03521934|65580197|FG000|Overall Study|Withdrawal by Subject|18|||
23502504|NCT03521934|65580198|FG001|Overall Study|Withdrawal by Subject|23|||
23502505|NCT03521934|65580197|FG000|Overall Study|Site Terminated by Sponsor|39|||
23502506|NCT03521934|65580198|FG001|Overall Study|Site Terminated by Sponsor|35|||
23502507|NCT03521934|65580197|FG000|Overall Study|Study Terminated by Sponsor|483|||
23502508|NCT03521934|65580198|FG001|Overall Study|Study Terminated by Sponsor|477|||
23502509|NCT03521934|65580197|FG000|Overall Study|Reason not Specified|3|||
23502510|NCT03521934|65580198|FG001|Overall Study|Reason not Specified|6|||
23502511|NCT03372096|65580199|FG000|Overall Study|Study Closed|8|||
23502512|NCT01063868|65580202|FG000|Overall Study|Adverse Event|9|||
23502513|NCT01063868|65580203|FG001|Overall Study|Adverse Event|7|||
23502514|NCT01063868|65580202|FG000|Overall Study|Withdrawal by Subject|3|||
23502515|NCT01063868|65580203|FG001|Overall Study|Withdrawal by Subject|1|||
23502516|NCT01063868|65580202|FG000|Overall Study|Study Terminated By Sponsor|23|||
23502517|NCT01063868|65580203|FG001|Overall Study|Study Terminated By Sponsor|4|||
23502518|NCT01619423|65580204|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
23502519|NCT01619423|65580205|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
23502520|NCT01619423|65580206|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
23502521|NCT01619423|65580207|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
23502522|NCT00743483|65580212|FG000|Baseline Period|Physician Decision|1|||
23502523|NCT00743483|65580212|FG000|Treatment Period|Adverse Event|1|||
23502524|NCT00119106|65580216|FG000|Overall Study|HIV infected at baseline|179|||
23502525|NCT00119106|65580217|FG001|Overall Study|HIV infected at baseline|178|||
23502526|NCT02430311|65580218|FG000|Part A|Adverse Event|0|||
23502527|NCT02430311|65580219|FG001|Part A|Adverse Event|1|||
23502528|NCT02430311|65580218|FG000|Part A|Withdrawal by Subject|1|||
23502529|NCT02430311|65580219|FG001|Part A|Withdrawal by Subject|0|||
23502530|NCT02430311|65580218|FG000|Part B|Meet study-specific withdrawal criteria|6|||
23502531|NCT02430311|65580219|FG001|Part B|Meet study-specific withdrawal criteria|6|||
23502532|NCT02430311|65580218|FG000|Part B|Withdrawal by Subject|2|||
23502533|NCT02430311|65580219|FG001|Part B|Withdrawal by Subject|2|||
23502534|NCT02430311|65580218|FG000|Part B|Adverse Event|1|||
23502535|NCT02430311|65580219|FG001|Part B|Adverse Event|0|||
23701450|NCT01097616|66284318|FG006|Optional DB EXT Phase|Physician Decision|0|||
23701451|NCT01097616|66284319|FG007|Optional DB EXT Phase|Physician Decision|0|||
23701452|NCT01097616|66284312|FG000|DB RO Phase|Adverse Event|0|||
23701453|NCT01097616|66284313|FG001|DB RO Phase|Adverse Event|0|||
23701454|NCT01097616|66284314|FG002|DB RO Phase|Adverse Event|0|||
23701455|NCT01097616|66284315|FG003|DB RO Phase|Adverse Event|0|||
23701456|NCT01097616|66284316|FG004|DB RO Phase|Adverse Event|0|||
23701457|NCT01097616|66284317|FG005|DB RO Phase|Adverse Event|0|||
23701458|NCT01097616|66284318|FG006|DB RO Phase|Adverse Event|1|||
23701459|NCT01097616|66284319|FG007|DB RO Phase|Adverse Event|0|||
23701460|NCT01097616|66284312|FG000|DB RO Phase|Withdrawal by Subject|0|||
23502536|NCT02430311|65580218|FG000|Part B|Death|1|||
23502537|NCT02430311|65580219|FG001|Part B|Death|0|||
23502538|NCT00963937|65580220|FG000|Overall Study|Protocol Violation|1|||
23502539|NCT00963937|65580221|FG001|Overall Study|Protocol Violation|1|||
23502540|NCT00963937|65580222|FG002|Overall Study|Protocol Violation|0|||
23502541|NCT00963937|65580220|FG000|Overall Study|Physician Decision|18|||
23502542|NCT00963937|65580221|FG001|Overall Study|Physician Decision|10|||
23502543|NCT00963937|65580222|FG002|Overall Study|Physician Decision|4|||
23502544|NCT02587234|65580225|FG000|Overall Study|Withdrawal by Subject|1|||
23701461|NCT01097616|66284313|FG001|DB RO Phase|Withdrawal by Subject|0|||
23502545|NCT02587234|65580226|FG001|Overall Study|Withdrawal by Subject|1|||
23502546|NCT02587234|65580225|FG000|Overall Study|Lost to Follow-up|0|||
23502547|NCT02587234|65580226|FG001|Overall Study|Lost to Follow-up|2|||
23502548|NCT03310775|65580230|FG000|Overall Study|Lost to Follow-up|2|||
23502549|NCT03310775|65580231|FG001|Overall Study|Lost to Follow-up|3|||
23502550|NCT03310775|65580230|FG000|Overall Study|aggravation of depression|0|||
23502551|NCT03310775|65580231|FG001|Overall Study|aggravation of depression|1|||
23701462|NCT01097616|66284314|FG002|DB RO Phase|Withdrawal by Subject|0|||
23701463|NCT01097616|66284315|FG003|DB RO Phase|Withdrawal by Subject|0|||
23701464|NCT01097616|66284316|FG004|DB RO Phase|Withdrawal by Subject|0|||
23701465|NCT01097616|66284317|FG005|DB RO Phase|Withdrawal by Subject|1|||
23701466|NCT01097616|66284318|FG006|DB RO Phase|Withdrawal by Subject|0|||
23701467|NCT01097616|66284319|FG007|DB RO Phase|Withdrawal by Subject|0|||
23701468|NCT01097616|66284312|FG000|DB RO Phase|Lost to Follow-up|0|||
23701469|NCT01097616|66284313|FG001|DB RO Phase|Lost to Follow-up|0|||
23701470|NCT01097616|66284314|FG002|DB RO Phase|Lost to Follow-up|0|||
23701471|NCT01097616|66284315|FG003|DB RO Phase|Lost to Follow-up|1|||
23701472|NCT01097616|66284316|FG004|DB RO Phase|Lost to Follow-up|1|||
23701473|NCT01097616|66284317|FG005|DB RO Phase|Lost to Follow-up|0|||
23701474|NCT01097616|66284318|FG006|DB RO Phase|Lost to Follow-up|0|||
23701475|NCT01097616|66284319|FG007|DB RO Phase|Lost to Follow-up|1|||
23701476|NCT01097616|66284312|FG000|DB RO Phase|Not Treated in RO|0|||
23701477|NCT01097616|66284313|FG001|DB RO Phase|Not Treated in RO|0|||
23701478|NCT01097616|66284314|FG002|DB RO Phase|Not Treated in RO|0|||
23701479|NCT01097616|66284315|FG003|DB RO Phase|Not Treated in RO|0|||
23701480|NCT01097616|66284316|FG004|DB RO Phase|Not Treated in RO|0|||
23701481|NCT01097616|66284317|FG005|DB RO Phase|Not Treated in RO|1|||
23701482|NCT01097616|66284318|FG006|DB RO Phase|Not Treated in RO|0|||
23701483|NCT01097616|66284319|FG007|DB RO Phase|Not Treated in RO|0|||
23701484|NCT01000064|66284320|FG000|Overall Study|Withdrawal by Subject|1|||
23701485|NCT01000064|66284321|FG001|Overall Study|Withdrawal by Subject|1|||
23701486|NCT02416908|66284322|FG000|Dose Escalation Phase|Adverse Event|0|||
23701487|NCT02416908|66284323|FG001|Dose Escalation Phase|Adverse Event|0|||
23701488|NCT02416908|66284324|FG002|Dose Escalation Phase|Adverse Event|3|||
23701489|NCT02416908|66284325|FG003|Dose Escalation Phase|Adverse Event|0|||
23701490|NCT02416908|66284322|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23701491|NCT02416908|66284323|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23701492|NCT02416908|66284324|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
23701493|NCT02416908|66284325|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23701494|NCT02037919|66284334|FG000|Overall Study|Lost to Follow-up|30|||
23701495|NCT02037919|66284335|FG001|Overall Study|Lost to Follow-up|45|||
23701496|NCT00938327|66284336|FG000|Overall Study|Adverse Event|2|||
23701497|NCT00938327|66284336|FG000|Overall Study|Protocol Violation|1|||
23701498|NCT00938327|66284336|FG000|Overall Study|Withdrawal by Subject|4|||
23701499|NCT00938327|66284336|FG000|Overall Study|Lost to Follow-up|37|||
23701500|NCT00938327|66284336|FG000|Overall Study|2nd dose received outside of the study|7|||
23701501|NCT00938327|66284336|FG000|Overall Study|Vaccine not received as out of stock|9|||
23701502|NCT02564120|66284337|FG000|Overall Study|Did not return release forms|160|||
23701503|NCT02564120|66284337|FG000|Overall Study|Death|58|||
23701504|NCT02564120|66284337|FG000|Overall Study|Withdrawal by Subject|204|||
23701505|NCT02564120|66284337|FG000|Overall Study|Other medical condition|24|||
23701506|NCT01703819|66284338|FG000|Overall Study|Adverse Event|0|||
23701507|NCT01703819|66284339|FG001|Overall Study|Adverse Event|1|||
23701508|NCT01703819|66284338|FG000|Overall Study|Withdrawal by Subject|0|||
23701509|NCT01703819|66284339|FG001|Overall Study|Withdrawal by Subject|1|||
23701510|NCT00849693|66284340|FG000|Acute Treatment Phase|Adverse Event|12|||
23701511|NCT00849693|66284341|FG001|Acute Treatment Phase|Adverse Event|7|||
23701512|NCT00849693|66284342|FG002|Acute Treatment Phase|Adverse Event|6|||
23701513|NCT00849693|66284343|FG003|Acute Treatment Phase|Adverse Event|4|||
23701514|NCT00849693|66284340|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
23701515|NCT00849693|66284341|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
23701516|NCT00849693|66284342|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
23701517|NCT00849693|66284343|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
23701518|NCT00849693|66284340|FG000|Acute Treatment Phase|Protocol Violation|1|||
23701519|NCT00849693|66284341|FG001|Acute Treatment Phase|Protocol Violation|5|||
23701520|NCT00849693|66284342|FG002|Acute Treatment Phase|Protocol Violation|2|||
23701521|NCT00849693|66284343|FG003|Acute Treatment Phase|Protocol Violation|6|||
23701522|NCT00849693|66284340|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
23701523|NCT00849693|66284341|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
23701524|NCT00849693|66284342|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
23701525|NCT00849693|66284343|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
23701526|NCT00849693|66284340|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
23701527|NCT00849693|66284341|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
23701528|NCT00849693|66284342|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
23701529|NCT00849693|66284343|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
23701530|NCT00849693|66284340|FG000|Acute Treatment Phase|Physician Decision|2|||
23701531|NCT00849693|66284341|FG001|Acute Treatment Phase|Physician Decision|1|||
23701532|NCT00849693|66284342|FG002|Acute Treatment Phase|Physician Decision|2|||
23701533|NCT00849693|66284343|FG003|Acute Treatment Phase|Physician Decision|1|||
23701534|NCT00849693|66284340|FG000|Acute Treatment Phase|Sponsor decision|0|||
23701535|NCT00849693|66284341|FG001|Acute Treatment Phase|Sponsor decision|0|||
23701536|NCT00849693|66284342|FG002|Acute Treatment Phase|Sponsor decision|1|||
23701537|NCT00849693|66284343|FG003|Acute Treatment Phase|Sponsor decision|0|||
23701538|NCT00849693|66284340|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
23701539|NCT00849693|66284341|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
23701540|NCT00849693|66284342|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
23701541|NCT00849693|66284343|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
23701542|NCT00849693|66284340|FG000|Extension Phase|Adverse Event|4|||
23701543|NCT00849693|66284341|FG001|Extension Phase|Adverse Event|6|||
23701544|NCT00849693|66284342|FG002|Extension Phase|Adverse Event|3|||
23701545|NCT00849693|66284343|FG003|Extension Phase|Adverse Event|7|||
23701546|NCT00849693|66284340|FG000|Extension Phase|Lost to Follow-up|7|||
23701547|NCT00849693|66284341|FG001|Extension Phase|Lost to Follow-up|5|||
23701548|NCT00849693|66284342|FG002|Extension Phase|Lost to Follow-up|6|||
23701549|NCT00849693|66284343|FG003|Extension Phase|Lost to Follow-up|6|||
23701550|NCT00849693|66284340|FG000|Extension Phase|Protocol Violation|0|||
23701551|NCT00849693|66284341|FG001|Extension Phase|Protocol Violation|3|||
23701552|NCT00849693|66284342|FG002|Extension Phase|Protocol Violation|2|||
23701553|NCT00849693|66284343|FG003|Extension Phase|Protocol Violation|3|||
23701554|NCT00849693|66284340|FG000|Extension Phase|Withdrawal by Subject|6|||
23701555|NCT00849693|66284341|FG001|Extension Phase|Withdrawal by Subject|9|||
23701556|NCT00849693|66284342|FG002|Extension Phase|Withdrawal by Subject|10|||
23701557|NCT00849693|66284343|FG003|Extension Phase|Withdrawal by Subject|15|||
23701558|NCT00849693|66284340|FG000|Extension Phase|Parent or caregiver decision|9|||
23701559|NCT00849693|66284341|FG001|Extension Phase|Parent or caregiver decision|4|||
23701560|NCT00849693|66284342|FG002|Extension Phase|Parent or caregiver decision|10|||
23701561|NCT00849693|66284343|FG003|Extension Phase|Parent or caregiver decision|5|||
23701562|NCT00849693|66284340|FG000|Extension Phase|Physician Decision|1|||
23701563|NCT00849693|66284341|FG001|Extension Phase|Physician Decision|1|||
23701564|NCT00849693|66284342|FG002|Extension Phase|Physician Decision|2|||
23701565|NCT00849693|66284343|FG003|Extension Phase|Physician Decision|0|||
23701566|NCT00849693|66284340|FG000|Extension Phase|Sponsor decision|1|||
23701567|NCT00849693|66284341|FG001|Extension Phase|Sponsor decision|0|||
23701568|NCT00849693|66284342|FG002|Extension Phase|Sponsor decision|0|||
23701569|NCT00849693|66284343|FG003|Extension Phase|Sponsor decision|1|||
23701570|NCT00849693|66284340|FG000|Extension Phase|Lack of Efficacy|2|||
23701571|NCT00849693|66284341|FG001|Extension Phase|Lack of Efficacy|2|||
23701572|NCT00849693|66284342|FG002|Extension Phase|Lack of Efficacy|2|||
23701573|NCT00849693|66284343|FG003|Extension Phase|Lack of Efficacy|1|||
23701574|NCT05258058|66284346|FG000|Overall Study|Withdrawal by Subject|2|||
23701575|NCT00651118|66284351|FG000|Overall Study|Adverse Event|4|||
23701576|NCT00651118|66284352|FG001|Overall Study|Adverse Event|0|||
23701577|NCT00651118|66284353|FG002|Overall Study|Adverse Event|1|||
23701578|NCT00651118|66284354|FG003|Overall Study|Adverse Event|1|||
23701579|NCT00651118|66284351|FG000|Overall Study|Protocol Violation|2|||
23701580|NCT00651118|66284352|FG001|Overall Study|Protocol Violation|2|||
23701581|NCT00651118|66284353|FG002|Overall Study|Protocol Violation|6|||
23701582|NCT00651118|66284354|FG003|Overall Study|Protocol Violation|2|||
23701583|NCT00651118|66284351|FG000|Overall Study|Lost to Follow-up|2|||
23701584|NCT00651118|66284352|FG001|Overall Study|Lost to Follow-up|0|||
23701585|NCT00651118|66284353|FG002|Overall Study|Lost to Follow-up|1|||
23701586|NCT00651118|66284354|FG003|Overall Study|Lost to Follow-up|2|||
23701587|NCT00651118|66284351|FG000|Overall Study|administrative|1|||
23701588|NCT00651118|66284352|FG001|Overall Study|administrative|4|||
23701589|NCT00651118|66284353|FG002|Overall Study|administrative|2|||
23701590|NCT00651118|66284354|FG003|Overall Study|administrative|1|||
23701591|NCT00651118|66284351|FG000|Overall Study|Withdrawal by Subject|0|||
23701592|NCT00651118|66284352|FG001|Overall Study|Withdrawal by Subject|1|||
23701593|NCT00651118|66284353|FG002|Overall Study|Withdrawal by Subject|1|||
23701594|NCT00651118|66284354|FG003|Overall Study|Withdrawal by Subject|1|||
23701595|NCT02399813|66284355|FG000|Overall Study|Progressive Disease-Radiographic|2|||
23701596|NCT02399813|66284355|FG000|Overall Study|Death|20|||
23701597|NCT02399813|66284355|FG000|Overall Study|Withdrawal by Subject|3|||
23701598|NCT02399813|66284355|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
23701599|NCT02399813|66284355|FG000|Overall Study|Lost to Follow-up|2|||
23701600|NCT02399813|66284355|FG000|Overall Study|Other than specified|5|||
23701601|NCT01214434|66284356|FG000|Overall Study|Withdrawal by Subject|1|||
23701602|NCT01214434|66284357|FG001|Overall Study|Withdrawal by Subject|0|||
23701603|NCT01214434|66284356|FG000|Overall Study|Lost to Follow-up|2|||
23701604|NCT01214434|66284357|FG001|Overall Study|Lost to Follow-up|2|||
23701605|NCT01214434|66284356|FG000|Overall Study|Site error|1|||
23398905|NCT01900665|65207208|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
23701606|NCT01214434|66284357|FG001|Overall Study|Site error|0|||
23701607|NCT01323673|66284358|FG000|Overall Study|Adverse Event|0|||
23701608|NCT01323673|66284359|FG001|Overall Study|Adverse Event|1|||
23701609|NCT01323673|66284358|FG000|Overall Study|Lost to Follow-up|0|||
23701610|NCT01323673|66284359|FG001|Overall Study|Lost to Follow-up|1|||
23701611|NCT01323673|66284358|FG000|Overall Study|Protocol Violation|1|||
23701612|NCT01323673|66284359|FG001|Overall Study|Protocol Violation|0|||
23398906|NCT01900665|65207207|FG000|Open Label Period|Adverse Event|16|||
23701613|NCT01323673|66284358|FG000|Overall Study|Withdrawal by Subject|2|||
23701614|NCT01323673|66284359|FG001|Overall Study|Withdrawal by Subject|3|||
23701615|NCT02190435|66284360|FG000|Overall Study|First 12 patients were lead-ins|12|||
23701616|NCT02190435|66284361|FG001|Overall Study|First 12 patients were lead-ins|0|||
23701617|NCT02190435|66284360|FG000|Overall Study|3 consented screen fails|3|||
23701618|NCT02190435|66284361|FG001|Overall Study|3 consented screen fails|0|||
23701619|NCT00718861|66284364|FG000|Overall Study|Withdrawal by Subject|15|||
23701620|NCT00718861|66284365|FG001|Overall Study|Withdrawal by Subject|10|||
23701621|NCT00718861|66284364|FG000|Overall Study|Adverse Event|2|||
23701622|NCT00718861|66284365|FG001|Overall Study|Adverse Event|1|||
23701623|NCT00718861|66284364|FG000|Overall Study|Lost to Follow-up|2|||
23701624|NCT00718861|66284365|FG001|Overall Study|Lost to Follow-up|1|||
23701625|NCT00718861|66284364|FG000|Overall Study|Administrative Problems|1|||
23701626|NCT00718861|66284365|FG001|Overall Study|Administrative Problems|1|||
23701627|NCT00718861|66284364|FG000|Overall Study|Death|1|||
23701628|NCT00718861|66284365|FG001|Overall Study|Death|5|||
23701629|NCT02582749|66284366|FG000|Overall Study|Study terminated by funder|5|||
23701630|NCT02582749|66284367|FG001|Overall Study|Study terminated by funder|10|||
23701631|NCT02582749|66284366|FG000|Overall Study|Withdrawal by Subject|0|||
23701632|NCT02582749|66284367|FG001|Overall Study|Withdrawal by Subject|1|||
23701633|NCT03303339|66284371|FG000|Overall Study|Death|2|||
23701634|NCT03303339|66284372|FG001|Overall Study|Death|2|||
23701635|NCT03303339|66284373|FG002|Overall Study|Death|2|||
23701636|NCT03303339|66284374|FG003|Overall Study|Death|1|||
23701637|NCT03303339|66284375|FG004|Overall Study|Death|4|||
23701638|NCT03303339|66284376|FG005|Overall Study|Death|2|||
23701639|NCT03303339|66284377|FG006|Overall Study|Death|2|||
23701640|NCT03303339|66284378|FG007|Overall Study|Death|2|||
23701641|NCT03303339|66284379|FG008|Overall Study|Death|3|||
23701642|NCT03303339|66284380|FG009|Overall Study|Death|3|||
23701643|NCT03303339|66284381|FG010|Overall Study|Death|4|||
23701644|NCT03303339|66284382|FG011|Overall Study|Death|24|||
23701645|NCT03303339|66284371|FG000|Overall Study|Study Terminated by Sponsor|0|||
23701646|NCT03303339|66284372|FG001|Overall Study|Study Terminated by Sponsor|0|||
23701647|NCT03303339|66284373|FG002|Overall Study|Study Terminated by Sponsor|0|||
23701648|NCT03303339|66284374|FG003|Overall Study|Study Terminated by Sponsor|0|||
23701649|NCT03303339|66284375|FG004|Overall Study|Study Terminated by Sponsor|0|||
23701650|NCT03303339|66284376|FG005|Overall Study|Study Terminated by Sponsor|0|||
23701651|NCT03303339|66284377|FG006|Overall Study|Study Terminated by Sponsor|0|||
23701652|NCT03303339|66284378|FG007|Overall Study|Study Terminated by Sponsor|0|||
23701653|NCT03303339|66284379|FG008|Overall Study|Study Terminated by Sponsor|1|||
23701654|NCT03303339|66284380|FG009|Overall Study|Study Terminated by Sponsor|0|||
23701655|NCT03303339|66284381|FG010|Overall Study|Study Terminated by Sponsor|1|||
23701656|NCT03303339|66284382|FG011|Overall Study|Study Terminated by Sponsor|1|||
23701657|NCT03303339|66284371|FG000|Overall Study|Withdrawal by Subject|1|||
23701658|NCT03303339|66284372|FG001|Overall Study|Withdrawal by Subject|0|||
23701659|NCT03303339|66284373|FG002|Overall Study|Withdrawal by Subject|0|||
23701660|NCT03303339|66284374|FG003|Overall Study|Withdrawal by Subject|0|||
23701661|NCT03303339|66284375|FG004|Overall Study|Withdrawal by Subject|0|||
23701662|NCT03303339|66284376|FG005|Overall Study|Withdrawal by Subject|1|||
23701663|NCT03303339|66284377|FG006|Overall Study|Withdrawal by Subject|1|||
23701664|NCT03303339|66284378|FG007|Overall Study|Withdrawal by Subject|0|||
23701665|NCT03303339|66284379|FG008|Overall Study|Withdrawal by Subject|0|||
23701666|NCT03303339|66284380|FG009|Overall Study|Withdrawal by Subject|0|||
23701667|NCT03303339|66284381|FG010|Overall Study|Withdrawal by Subject|0|||
23701668|NCT03303339|66284382|FG011|Overall Study|Withdrawal by Subject|2|||
23701669|NCT03303339|66284371|FG000|Overall Study|Physician Decision|0|||
23701670|NCT03303339|66284372|FG001|Overall Study|Physician Decision|0|||
23701671|NCT03303339|66284373|FG002|Overall Study|Physician Decision|0|||
23701672|NCT03303339|66284374|FG003|Overall Study|Physician Decision|0|||
23701673|NCT03303339|66284375|FG004|Overall Study|Physician Decision|1|||
23701674|NCT03303339|66284376|FG005|Overall Study|Physician Decision|0|||
23701675|NCT03303339|66284377|FG006|Overall Study|Physician Decision|0|||
23701676|NCT03303339|66284378|FG007|Overall Study|Physician Decision|0|||
23701677|NCT03303339|66284379|FG008|Overall Study|Physician Decision|0|||
23701678|NCT03303339|66284380|FG009|Overall Study|Physician Decision|0|||
23701679|NCT03303339|66284381|FG010|Overall Study|Physician Decision|0|||
23701680|NCT03303339|66284382|FG011|Overall Study|Physician Decision|0|||
23701681|NCT03303339|66284371|FG000|Overall Study|Safety/Non-compliance|0|||
23701682|NCT03303339|66284372|FG001|Overall Study|Safety/Non-compliance|0|||
23701683|NCT03303339|66284373|FG002|Overall Study|Safety/Non-compliance|0|||
23701684|NCT03303339|66284374|FG003|Overall Study|Safety/Non-compliance|0|||
23701685|NCT03303339|66284375|FG004|Overall Study|Safety/Non-compliance|0|||
23701686|NCT03303339|66284376|FG005|Overall Study|Safety/Non-compliance|0|||
23701687|NCT03303339|66284377|FG006|Overall Study|Safety/Non-compliance|0|||
23701688|NCT03303339|66284378|FG007|Overall Study|Safety/Non-compliance|0|||
23701689|NCT03303339|66284379|FG008|Overall Study|Safety/Non-compliance|0|||
23701690|NCT03303339|66284380|FG009|Overall Study|Safety/Non-compliance|0|||
23701691|NCT03303339|66284381|FG010|Overall Study|Safety/Non-compliance|0|||
23701692|NCT03303339|66284382|FG011|Overall Study|Safety/Non-compliance|1|||
23398907|NCT01900665|65207208|FG001|Open Label Period|Adverse Event|20|||
23701693|NCT00496873|66284383|FG000|Overall Study|Ineligible|2|||
23701694|NCT00496873|66284383|FG000|Overall Study|Death|2|||
23701695|NCT00496873|66284383|FG000|Overall Study|Withdrawal by Subject|3|||
23701696|NCT01971476|66284384|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
23701697|NCT01971476|66284385|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
23701698|NCT01971476|66284386|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
23701699|NCT01971476|66284384|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
23701700|NCT01971476|66284385|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
23701701|NCT01971476|66284386|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
23701702|NCT01971476|66284384|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
23701703|NCT01971476|66284385|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
23701704|NCT01971476|66284386|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
23701705|NCT00844428|66284387|FG000|Screening Period|Screen Failure|3|||
23701706|NCT00844428|66284387|FG000|Extension Treatment Period|Death|1|||
23701707|NCT00844428|66284387|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
23701708|NCT04956692|66284388|FG000|Overall Study|Death|115|||
23701709|NCT04956692|66284389|FG001|Overall Study|Death|47|||
23701710|NCT04956692|66284388|FG000|Overall Study|Lost to Follow-up|0|||
23701711|NCT04956692|66284389|FG001|Overall Study|Lost to Follow-up|1|||
23701712|NCT04956692|66284388|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23701713|NCT04956692|66284389|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23701714|NCT04956692|66284388|FG000|Overall Study|Withdrawal by Subject|5|||
23701715|NCT04956692|66284389|FG001|Overall Study|Withdrawal by Subject|2|||
23701716|NCT04956692|66284388|FG000|Overall Study|Ongoing in Study|236|||
23701717|NCT04956692|66284389|FG001|Overall Study|Ongoing in Study|123|||
23701718|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
23701719|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
23701720|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23701721|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
23701722|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23701723|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23701724|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
23701725|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23701726|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23701727|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23701728|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23701729|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23701730|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
23701731|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
23701732|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
23701733|NCT00611455|66284390|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
23701734|NCT00611455|66284391|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
23701735|NCT00611455|66284392|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
23701736|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23701737|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
23701738|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23701739|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23701740|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
23701741|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23701742|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23701743|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
23701744|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23701745|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23701746|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
23701747|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23701748|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23701749|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
23701750|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23701751|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
23701752|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
23701753|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
23701754|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23701755|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
23701756|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23701757|NCT00611455|66284390|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23701758|NCT00611455|66284391|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
23701759|NCT00611455|66284392|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23701760|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
23701761|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
23701762|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
23701763|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
23701764|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
23701765|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
23701766|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
23701767|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
23701768|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
23701769|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
23701770|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
23701771|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
23701772|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
23701773|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
23701774|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
23701775|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
23701776|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
23701777|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
23701778|NCT00611455|66284390|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
23701779|NCT00611455|66284391|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
23701780|NCT00611455|66284392|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
23701781|NCT01790438|66284393|FG000|Overall Study|Adverse Event|3|||
23701782|NCT01790438|66284394|FG001|Overall Study|Adverse Event|2|||
23701783|NCT01790438|66284393|FG000|Overall Study|Death|4|||
23701784|NCT01790438|66284394|FG001|Overall Study|Death|0|||
23701785|NCT01790438|66284393|FG000|Overall Study|Lost to Follow-up|5|||
23701786|NCT01790438|66284394|FG001|Overall Study|Lost to Follow-up|2|||
23701787|NCT01790438|66284393|FG000|Overall Study|Withdrawal by Subject|13|||
23701788|NCT01790438|66284394|FG001|Overall Study|Withdrawal by Subject|2|||
23701789|NCT01790438|66284393|FG000|Overall Study|Physician Decision|3|||
23701790|NCT01790438|66284394|FG001|Overall Study|Physician Decision|1|||
23701791|NCT01790438|66284393|FG000|Overall Study|Sponsor Decision|0|||
23701792|NCT01790438|66284394|FG001|Overall Study|Sponsor Decision|3|||
23701793|NCT01790438|66284393|FG000|Overall Study|Protocol Required Discontinuation|7|||
23701794|NCT01790438|66284394|FG001|Overall Study|Protocol Required Discontinuation|1|||
23701795|NCT04436822|66286803|FG000|Overall Study|Physician Decision|2|||
23701796|NCT04436822|66286804|FG001|Overall Study|Physician Decision|0|||
23701797|NCT04436822|66286803|FG000|Overall Study|Sponsor request|1|||
23701798|NCT04436822|66286804|FG001|Overall Study|Sponsor request|0|||
23701799|NCT04436822|66286803|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23701800|NCT04436822|66286804|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23701801|NCT04436822|66286803|FG000|Overall Study|Unsuccessful procedure|0|||
23701802|NCT04436822|66286804|FG001|Overall Study|Unsuccessful procedure|1|||
23701803|NCT04436822|66286803|FG000|Overall Study|Withdrawal due to Covid-19|8|||
23701804|NCT04436822|66286804|FG001|Overall Study|Withdrawal due to Covid-19|1|||
23701805|NCT04436822|66286803|FG000|Overall Study|Withdrawal by Subject|1|||
23701806|NCT04436822|66286804|FG001|Overall Study|Withdrawal by Subject|0|||
23701807|NCT04436822|66286803|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
23398908|NCT01900665|65207207|FG000|Open Label Period|Death|5|||
23398909|NCT01900665|65207208|FG001|Open Label Period|Death|6|||
23398910|NCT01900665|65207207|FG000|Open Label Period|Lost to Follow-up|1|||
23398911|NCT01900665|65207208|FG001|Open Label Period|Lost to Follow-up|1|||
23398912|NCT01900665|65207207|FG000|Open Label Period|Parent/Caregiver Decision|33|||
23398913|NCT01900665|65207208|FG001|Open Label Period|Parent/Caregiver Decision|34|||
23398914|NCT01900665|65207207|FG000|Open Label Period|Physician Decision|4|||
23398915|NCT01900665|65207208|FG001|Open Label Period|Physician Decision|4|||
23398916|NCT01900665|65207207|FG000|Open Label Period|Protocol Violation|0|||
23398917|NCT01900665|65207208|FG001|Open Label Period|Protocol Violation|1|||
23398918|NCT01900665|65207207|FG000|Open Label Period|Sponsor Decision|802|||
23398919|NCT01900665|65207208|FG001|Open Label Period|Sponsor Decision|765|||
23398920|NCT01900665|65207207|FG000|Open Label Period|Withdrawal by Subject|20|||
23398921|NCT01900665|65207208|FG001|Open Label Period|Withdrawal by Subject|28|||
23398922|NCT00457392|65207209|FG000|Overall Study|Objective Progression or Relapse|229|||
23398923|NCT00457392|65207210|FG001|Overall Study|Objective Progression or Relapse|296|||
23398924|NCT00457392|65207209|FG000|Overall Study|Death|106|||
23398925|NCT00457392|65207210|FG001|Overall Study|Death|106|||
23502552|NCT01405456|65580237|FG000|Overall Study|Lost to Follow-up|2|||
23502553|NCT01405456|65580238|FG001|Overall Study|Lost to Follow-up|1|||
23701808|NCT04436822|66286804|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
23398926|NCT00457392|65207209|FG000|Overall Study|Adverse Event|84|||
23398927|NCT00457392|65207210|FG001|Overall Study|Adverse Event|41|||
23502554|NCT01405456|65580237|FG000|Overall Study|Physician Decision|1|||
23502555|NCT01405456|65580238|FG001|Overall Study|Physician Decision|0|||
23502556|NCT01317160|65580239|FG000|Overall Study|Incorrect inclusion|1|||
23701809|NCT00515008|66286807|FG000|Overall Study|Lost to Follow-up|1|||
23701810|NCT00515008|66286808|FG001|Overall Study|Lost to Follow-up|0|||
23701811|NCT00515008|66286807|FG000|Overall Study|Declined|0|||
23701812|NCT00515008|66286808|FG001|Overall Study|Declined|3|||
23701813|NCT00515008|66286807|FG000|Overall Study|Left the Boston Area|1|||
23701814|NCT00515008|66286808|FG001|Overall Study|Left the Boston Area|1|||
23701815|NCT00515008|66286807|FG000|Overall Study|Scheduling conflict|1|||
23701816|NCT00515008|66286808|FG001|Overall Study|Scheduling conflict|0|||
23701817|NCT03242928|66286819|FG000|Overall Study|Adverse Event|2|||
23701818|NCT03242928|66286820|FG001|Overall Study|Adverse Event|1|||
23701819|NCT03242928|66286819|FG000|Overall Study|Lost to Follow-up|2|||
23701820|NCT03242928|66286820|FG001|Overall Study|Lost to Follow-up|0|||
23701821|NCT03242928|66286819|FG000|Overall Study|Physician Decision|0|||
23701822|NCT03242928|66286820|FG001|Overall Study|Physician Decision|1|||
23701823|NCT03242928|66286819|FG000|Overall Study|Withdrawal by Subject|5|||
23701824|NCT03242928|66286820|FG001|Overall Study|Withdrawal by Subject|3|||
23701825|NCT02778867|66286821|FG000|Phase 1|Withdrawal by Subject|2|||
23701826|NCT02778867|66286822|FG001|Phase 1|Withdrawal by Subject|3|||
23701827|NCT02778867|66286823|FG002|Phase 1|Withdrawal by Subject|0|||
23701828|NCT02778867|66286824|FG003|Phase 1|Withdrawal by Subject|0|||
23701829|NCT02778867|66286821|FG000|Phase 2|Withdrawal by Subject|0|||
23701830|NCT02778867|66286822|FG001|Phase 2|Withdrawal by Subject|0|||
23701831|NCT02778867|66286823|FG002|Phase 2|Withdrawal by Subject|1|||
23701832|NCT02778867|66286824|FG003|Phase 2|Withdrawal by Subject|0|||
23701833|NCT02778867|66286821|FG000|Phase 2|Physician Decision|0|||
23701834|NCT02778867|66286822|FG001|Phase 2|Physician Decision|0|||
23701835|NCT02778867|66286823|FG002|Phase 2|Physician Decision|0|||
23701836|NCT02778867|66286824|FG003|Phase 2|Physician Decision|1|||
23701837|NCT02778867|66286821|FG000|Phase 2|Adverse Event|0|||
23701838|NCT02778867|66286822|FG001|Phase 2|Adverse Event|0|||
23701839|NCT02778867|66286823|FG002|Phase 2|Adverse Event|0|||
23701840|NCT02778867|66286824|FG003|Phase 2|Adverse Event|1|||
23701841|NCT03191396|66286825|FG000|Overall Study|Lost to Follow-up|0|||
23701842|NCT03191396|66286826|FG001|Overall Study|Lost to Follow-up|3|||
23701843|NCT03191396|66286825|FG000|Overall Study|Withdrawal by Subject|3|||
23701844|NCT03191396|66286826|FG001|Overall Study|Withdrawal by Subject|2|||
23701845|NCT04598165|66286827|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
23701846|NCT04598165|66286828|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
23701847|NCT04598165|66286827|FG000|Completed 6-week Follow-up|Death|2|||
23701848|NCT04598165|66286828|FG001|Completed 6-week Follow-up|Death|1|||
23701849|NCT04598165|66286827|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
23701850|NCT04598165|66286828|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
23701851|NCT04598165|66286827|FG000|Completed 6-week Follow-up|Ineligible|4|||
23701852|NCT04598165|66286828|FG001|Completed 6-week Follow-up|Ineligible|3|||
23701853|NCT04598165|66286827|FG000|Completed 6-week Follow-up|Partner refusal|0|||
23701854|NCT04598165|66286828|FG001|Completed 6-week Follow-up|Partner refusal|1|||
23701855|NCT04598165|66286827|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
23701856|NCT04598165|66286828|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
23701857|NCT01486316|66286831|FG000|Overall Study|Device explanted with/without re-implant|3|||
23701858|NCT01486316|66286832|FG001|Overall Study|Device explanted with/without re-implant|2|||
23701859|NCT01486316|66286833|FG002|Overall Study|Device explanted with/without re-implant|0|||
23701860|NCT01486316|66286834|FG003|Overall Study|Device explanted with/without re-implant|2|||
23701861|NCT01486316|66286831|FG000|Overall Study|Not meeting eligibility criteria|0|||
23701862|NCT01486316|66286832|FG001|Overall Study|Not meeting eligibility criteria|0|||
23701863|NCT01486316|66286833|FG002|Overall Study|Not meeting eligibility criteria|1|||
23701864|NCT01486316|66286834|FG003|Overall Study|Not meeting eligibility criteria|0|||
23701865|NCT01486316|66286831|FG000|Overall Study|Withdrawal by Subject|1|||
23701866|NCT01486316|66286832|FG001|Overall Study|Withdrawal by Subject|0|||
23701867|NCT01486316|66286833|FG002|Overall Study|Withdrawal by Subject|3|||
23701868|NCT01486316|66286834|FG003|Overall Study|Withdrawal by Subject|0|||
23701869|NCT01486316|66286831|FG000|Overall Study|Physician Decision|0|||
23701870|NCT01486316|66286832|FG001|Overall Study|Physician Decision|0|||
23701871|NCT01486316|66286833|FG002|Overall Study|Physician Decision|1|||
23701872|NCT01486316|66286834|FG003|Overall Study|Physician Decision|0|||
23701873|NCT01486316|66286831|FG000|Overall Study|Death|0|||
23701874|NCT01486316|66286832|FG001|Overall Study|Death|1|||
23502557|NCT01317160|65580240|FG001|Overall Study|Incorrect inclusion|1|||
23701875|NCT01486316|66286833|FG002|Overall Study|Death|0|||
23701876|NCT01486316|66286834|FG003|Overall Study|Death|0|||
23701877|NCT01605396|66286835|FG000|Overall Study|Adverse Event|5|||
23701878|NCT01605396|66286836|FG001|Overall Study|Adverse Event|3|||
23502558|NCT01317160|65580239|FG000|Overall Study|Lost to Follow-up|3|||
23701879|NCT01605396|66286835|FG000|Overall Study|Lost to Follow-up|1|||
23701880|NCT01605396|66286836|FG001|Overall Study|Lost to Follow-up|0|||
23701881|NCT01605396|66286835|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23701882|NCT01605396|66286836|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23701883|NCT01605396|66286835|FG000|Overall Study|Physician Decision|2|||
23701884|NCT01605396|66286836|FG001|Overall Study|Physician Decision|2|||
23701885|NCT01605396|66286835|FG000|Overall Study|Progressive Disease|23|||
23701886|NCT01605396|66286836|FG001|Overall Study|Progressive Disease|27|||
23701887|NCT01605396|66286835|FG000|Overall Study|Withdrawal by Subject|4|||
23701888|NCT01605396|66286836|FG001|Overall Study|Withdrawal by Subject|2|||
23701889|NCT01605396|66286835|FG000|Overall Study|Transfer Off Study|4|||
23701890|NCT01605396|66286836|FG001|Overall Study|Transfer Off Study|5|||
23701891|NCT02839746|66286837|FG000|Overall Study|Not met selection criteria|12|||
23701892|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
23701893|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
23701894|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23701895|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23701896|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23701897|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23701898|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23701899|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23701900|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
23701901|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23701902|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23701903|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
23701904|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23701905|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23701906|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
23701907|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
23701908|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
23701909|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
23701910|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23701911|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23701912|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23701913|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Other|0|||
23701914|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Other|1|||
23701915|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Other|0|||
23701916|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Other|0|||
23701917|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Other|0|||
23701918|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Other|0|||
23701919|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Other|0|||
23701920|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
23701921|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
23701922|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
23701923|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
23701924|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
23701925|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
23701926|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
23701927|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
23701928|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
23701929|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23701930|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
23701931|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
23701932|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23701933|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23701934|NCT00365716|66286841|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
23701935|NCT00365716|66286842|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
23701936|NCT00365716|66286843|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
23701937|NCT00365716|66286844|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
23701938|NCT00365716|66286845|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
23701939|NCT00365716|66286846|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
23701940|NCT00365716|66286847|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
23701941|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
23701942|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23701943|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23701944|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
23701945|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
23701946|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23701947|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23701948|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
23701949|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
23701950|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
23701951|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
23701952|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
23701953|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
23701954|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
23701955|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
23701956|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
23701957|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
23701958|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
23701959|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23701960|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23701961|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23701962|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
23701963|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23701964|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23701965|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23701966|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
23701967|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23701968|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23701969|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23701970|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
23701971|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
23701972|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23701973|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23701974|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23701975|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23701976|NCT00365716|66286841|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
23701977|NCT00365716|66286842|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
23701978|NCT00365716|66286843|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
23701979|NCT00365716|66286844|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
23701980|NCT00365716|66286845|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
23701981|NCT00365716|66286846|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
23701982|NCT00365716|66286847|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
23701983|NCT00365716|66286841|FG000|Extension 1|Lost to Follow-up|0|||
23701984|NCT00365716|66286842|FG001|Extension 1|Lost to Follow-up|0|||
23701985|NCT00365716|66286843|FG002|Extension 1|Lost to Follow-up|0|||
23701986|NCT00365716|66286844|FG003|Extension 1|Lost to Follow-up|0|||
23701987|NCT00365716|66286845|FG004|Extension 1|Lost to Follow-up|0|||
23701988|NCT00365716|66286846|FG005|Extension 1|Lost to Follow-up|1|||
23701989|NCT00365716|66286847|FG006|Extension 1|Lost to Follow-up|0|||
23701990|NCT00365716|66286841|FG000|Extension 1|Other|0|||
23701991|NCT00365716|66286842|FG001|Extension 1|Other|0|||
23701992|NCT00365716|66286843|FG002|Extension 1|Other|0|||
23701993|NCT00365716|66286844|FG003|Extension 1|Other|0|||
23701994|NCT00365716|66286845|FG004|Extension 1|Other|0|||
23701995|NCT00365716|66286846|FG005|Extension 1|Other|9|||
23701996|NCT00365716|66286847|FG006|Extension 1|Other|0|||
23701997|NCT00365716|66286841|FG000|Extension 1|Moved|0|||
23701998|NCT00365716|66286842|FG001|Extension 1|Moved|0|||
23701999|NCT00365716|66286843|FG002|Extension 1|Moved|0|||
23702000|NCT00365716|66286844|FG003|Extension 1|Moved|0|||
23702001|NCT00365716|66286845|FG004|Extension 1|Moved|0|||
23702002|NCT00365716|66286846|FG005|Extension 1|Moved|4|||
23702003|NCT00365716|66286847|FG006|Extension 1|Moved|0|||
23702004|NCT00365716|66286841|FG000|Extension 1|Withdrawal by Subject|0|||
23702005|NCT00365716|66286842|FG001|Extension 1|Withdrawal by Subject|0|||
23702006|NCT00365716|66286843|FG002|Extension 1|Withdrawal by Subject|0|||
23702007|NCT00365716|66286844|FG003|Extension 1|Withdrawal by Subject|0|||
23702008|NCT00365716|66286845|FG004|Extension 1|Withdrawal by Subject|0|||
23702009|NCT00365716|66286846|FG005|Extension 1|Withdrawal by Subject|3|||
23702010|NCT00365716|66286847|FG006|Extension 1|Withdrawal by Subject|0|||
23702011|NCT00365716|66286841|FG000|Extension 1|Pregnancy|0|||
23702012|NCT00365716|66286842|FG001|Extension 1|Pregnancy|0|||
23702013|NCT00365716|66286843|FG002|Extension 1|Pregnancy|0|||
23702014|NCT00365716|66286844|FG003|Extension 1|Pregnancy|0|||
23702015|NCT00365716|66286845|FG004|Extension 1|Pregnancy|0|||
23702016|NCT00365716|66286846|FG005|Extension 1|Pregnancy|4|||
23702017|NCT00365716|66286847|FG006|Extension 1|Pregnancy|0|||
23702018|NCT00365716|66286841|FG000|Extension 1|Protocol Violation|0|||
23702019|NCT00365716|66286842|FG001|Extension 1|Protocol Violation|0|||
23702020|NCT00365716|66286843|FG002|Extension 1|Protocol Violation|0|||
23702021|NCT00365716|66286844|FG003|Extension 1|Protocol Violation|0|||
23702022|NCT00365716|66286845|FG004|Extension 1|Protocol Violation|0|||
23702023|NCT00365716|66286846|FG005|Extension 1|Protocol Violation|1|||
23702024|NCT00365716|66286847|FG006|Extension 1|Protocol Violation|0|||
23702025|NCT00365716|66286841|FG000|Extension 2|Lost to Follow-up|0|||
23702026|NCT00365716|66286842|FG001|Extension 2|Lost to Follow-up|0|||
23702027|NCT00365716|66286843|FG002|Extension 2|Lost to Follow-up|0|||
23702028|NCT00365716|66286844|FG003|Extension 2|Lost to Follow-up|0|||
23702029|NCT00365716|66286845|FG004|Extension 2|Lost to Follow-up|0|||
23702030|NCT00365716|66286846|FG005|Extension 2|Lost to Follow-up|0|||
23702031|NCT00365716|66286847|FG006|Extension 2|Lost to Follow-up|2|||
23702032|NCT00365716|66286841|FG000|Extension 2|Other|0|||
23702033|NCT00365716|66286842|FG001|Extension 2|Other|0|||
23702034|NCT00365716|66286843|FG002|Extension 2|Other|0|||
23702035|NCT00365716|66286844|FG003|Extension 2|Other|0|||
23702036|NCT00365716|66286845|FG004|Extension 2|Other|0|||
23702037|NCT00365716|66286846|FG005|Extension 2|Other|0|||
23702038|NCT00365716|66286847|FG006|Extension 2|Other|3|||
23702039|NCT00365716|66286841|FG000|Extension 2|Withdrawal by Subject|0|||
23702040|NCT00365716|66286842|FG001|Extension 2|Withdrawal by Subject|0|||
23702041|NCT00365716|66286843|FG002|Extension 2|Withdrawal by Subject|0|||
23702042|NCT00365716|66286844|FG003|Extension 2|Withdrawal by Subject|0|||
23702043|NCT00365716|66286845|FG004|Extension 2|Withdrawal by Subject|0|||
23702044|NCT00365716|66286846|FG005|Extension 2|Withdrawal by Subject|0|||
23702045|NCT00365716|66286847|FG006|Extension 2|Withdrawal by Subject|5|||
23702046|NCT00935220|66286848|FG000|Overall Study|Adverse Event|1|||
23702047|NCT00935220|66286848|FG000|Overall Study|Other reason (not specified)|1|||
23702048|NCT00798967|66286851|FG000|Overall Study|Adverse Event|2|||
23702049|NCT00798967|66286852|FG001|Overall Study|Adverse Event|3|||
23702050|NCT00798967|66286851|FG000|Overall Study|Withdrawal by Subject|0|||
23702051|NCT00798967|66286852|FG001|Overall Study|Withdrawal by Subject|1|||
23702052|NCT00798967|66286851|FG000|Overall Study|Physician Decision|1|||
23702053|NCT00798967|66286852|FG001|Overall Study|Physician Decision|0|||
23702054|NCT00798967|66286851|FG000|Overall Study|Randomized in error by site|1|||
23702055|NCT00798967|66286852|FG001|Overall Study|Randomized in error by site|0|||
23702056|NCT03648996|66286853|FG000|Overall Study|Withdrawal by Subject|0|||
23702057|NCT03648996|66286854|FG001|Overall Study|Withdrawal by Subject|2|||
23702058|NCT03648996|66286855|FG002|Overall Study|Withdrawal by Subject|2|||
23702059|NCT03648996|66286853|FG000|Overall Study|Physician Decision|2|||
23702060|NCT03648996|66286854|FG001|Overall Study|Physician Decision|0|||
23702061|NCT03648996|66286855|FG002|Overall Study|Physician Decision|0|||
23702062|NCT00589472|66286856|FG000|Overall Study|Adverse Event|1|||
23702063|NCT03844633|66286857|FG000|1 Week FU|Lost to Follow-up|0|||
23702064|NCT03844633|66286858|FG001|1 Week FU|Lost to Follow-up|1|||
23702065|NCT03844633|66286859|FG002|1 Week FU|Lost to Follow-up|4|||
23702066|NCT03844633|66286857|FG000|12-month Follow-up|Lost to Follow-up|7|||
23702067|NCT03844633|66286858|FG001|12-month Follow-up|Lost to Follow-up|5|||
23702068|NCT03844633|66286859|FG002|12-month Follow-up|Lost to Follow-up|8|||
23702069|NCT02379923|66286860|FG000|Overall Study|Death|5|||
23702070|NCT03643432|66286861|FG000|Overall Study|Lost to Follow-up|1|||
23702071|NCT03643432|66286862|FG001|Overall Study|Lost to Follow-up|0|||
23702072|NCT03288779|66286865|FG000|Overall Study|Withdrawal by Subject|3|||
23702073|NCT02951988|66286871|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
23702074|NCT02951988|66286872|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23702075|NCT02951988|66286873|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23702076|NCT02951988|66286874|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23702077|NCT02951988|66286871|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
23702078|NCT02951988|66286872|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
23702079|NCT02951988|66286873|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
23702080|NCT02951988|66286874|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
23702081|NCT02951988|66286871|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
23702082|NCT02951988|66286872|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23702083|NCT02951988|66286873|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23702084|NCT02951988|66286874|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23702085|NCT02951988|66286871|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
23702086|NCT02951988|66286872|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
23702087|NCT02951988|66286873|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
23702088|NCT02951988|66286874|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
23702089|NCT02951988|66286871|FG000|Open-Label Treatment Period|Protocol Violation|22|||
23702090|NCT02951988|66286872|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23702091|NCT02951988|66286873|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23702092|NCT02951988|66286874|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23702093|NCT02951988|66286871|FG000|Open-Label Treatment Period|Pregnancy|2|||
23702094|NCT02951988|66286872|FG001|Open-Label Treatment Period|Pregnancy|0|||
23502559|NCT01317160|65580240|FG001|Overall Study|Lost to Follow-up|3|||
23702095|NCT02951988|66286873|FG002|Open-Label Treatment Period|Pregnancy|0|||
23702096|NCT02951988|66286874|FG003|Open-Label Treatment Period|Pregnancy|0|||
23702097|NCT02951988|66286871|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
23702098|NCT02951988|66286872|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23702099|NCT02951988|66286873|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23702100|NCT02951988|66286874|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23702101|NCT02951988|66286871|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
23702102|NCT02951988|66286872|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23702103|NCT02951988|66286873|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23702104|NCT02951988|66286874|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23702105|NCT02951988|66286871|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
23702106|NCT02951988|66286872|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23702107|NCT02951988|66286873|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23702108|NCT02951988|66286874|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23702109|NCT02951988|66286871|FG000|Open-Label Treatment Period|Adverse Event|45|||
23702110|NCT02951988|66286872|FG001|Open-Label Treatment Period|Adverse Event|0|||
23702111|NCT02951988|66286873|FG002|Open-Label Treatment Period|Adverse Event|0|||
23702112|NCT02951988|66286874|FG003|Open-Label Treatment Period|Adverse Event|0|||
23702113|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
23702114|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
23702115|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
23702116|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
23702117|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
23702118|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
23702119|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
23702120|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
23702121|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
23702122|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
23702123|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
23702124|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
23702125|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23702126|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
23702127|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
23702128|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
23702129|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Pregnancy|0|||
23702130|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Pregnancy|1|||
23702131|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Pregnancy|1|||
23702132|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Pregnancy|0|||
23702133|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23702134|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
23702135|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
23702136|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
23702137|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23702138|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
23702139|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
23702140|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
23702141|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23702142|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Adverse Event|8|||
23702143|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Adverse Event|3|||
23702144|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Adverse Event|6|||
23702145|NCT02951988|66286871|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
23702146|NCT02951988|66286872|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
23702147|NCT02951988|66286873|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
23702148|NCT02951988|66286874|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
23702149|NCT00064662|66286876|FG000|Overall Study|Death|1|||
23702150|NCT00064662|66286877|FG001|Overall Study|Death|1|||
23702151|NCT00064662|66286876|FG000|Overall Study|Lost to Follow-up|57|||
23702152|NCT00064662|66286877|FG001|Overall Study|Lost to Follow-up|44|||
23702153|NCT00064662|66286876|FG000|Overall Study|Withdrawal by Subject|14|||
23702154|NCT00064662|66286877|FG001|Overall Study|Withdrawal by Subject|14|||
23702155|NCT00064662|66286876|FG000|Overall Study|Administratively withdrawn|2|||
23702156|NCT00064662|66286877|FG001|Overall Study|Administratively withdrawn|2|||
23702157|NCT03042611|66286878|FG000|Core Phase|Withdrawal by Subject|13|||
23702158|NCT03042611|66286879|FG001|Core Phase|Withdrawal by Subject|4|||
23702159|NCT03042611|66286880|FG002|Core Phase|Withdrawal by Subject|0|||
23702160|NCT03042611|66286881|FG003|Core Phase|Withdrawal by Subject|0|||
23702161|NCT03042611|66286878|FG000|Core Phase|Death|232|||
23702162|NCT03042611|66286879|FG001|Core Phase|Death|110|||
23702163|NCT03042611|66286880|FG002|Core Phase|Death|0|||
23702164|NCT03042611|66286881|FG003|Core Phase|Death|0|||
23702165|NCT03042611|66286878|FG000|Core Phase|Lost to Follow-up|4|||
23702166|NCT03042611|66286879|FG001|Core Phase|Lost to Follow-up|7|||
23702167|NCT03042611|66286880|FG002|Core Phase|Lost to Follow-up|0|||
23702168|NCT03042611|66286881|FG003|Core Phase|Lost to Follow-up|0|||
23702169|NCT03042611|66286878|FG000|Core Phase|Physician Decision|7|||
23702170|NCT03042611|66286879|FG001|Core Phase|Physician Decision|2|||
23398928|NCT00457392|65207209|FG000|Overall Study|Global Deterioration of Health Status|22|||
23398929|NCT00457392|65207210|FG001|Overall Study|Global Deterioration of Health Status|8|||
23398930|NCT00457392|65207209|FG000|Overall Study|Withdrawal by Subject|14|||
23702171|NCT03042611|66286880|FG002|Core Phase|Physician Decision|0|||
23702172|NCT03042611|66286881|FG003|Core Phase|Physician Decision|0|||
23702173|NCT03042611|66286878|FG000|Core Phase|Study Closed|0|||
23702174|NCT03042611|66286879|FG001|Core Phase|Study Closed|1|||
23702175|NCT03042611|66286880|FG002|Core Phase|Study Closed|0|||
23702176|NCT03042611|66286881|FG003|Core Phase|Study Closed|0|||
23702177|NCT03042611|66286878|FG000|Extension Phase|Death|0|||
23702178|NCT03042611|66286879|FG001|Extension Phase|Death|0|||
23702179|NCT03042611|66286880|FG002|Extension Phase|Death|34|||
23702180|NCT03042611|66286881|FG003|Extension Phase|Death|16|||
23702181|NCT03042611|66286878|FG000|Extension Phase|Lost to Follow-up|0|||
23702182|NCT03042611|66286879|FG001|Extension Phase|Lost to Follow-up|0|||
23702183|NCT03042611|66286880|FG002|Extension Phase|Lost to Follow-up|1|||
23702184|NCT03042611|66286881|FG003|Extension Phase|Lost to Follow-up|1|||
23702185|NCT03042611|66286878|FG000|Extension Phase|Study Closed|0|||
23702186|NCT03042611|66286879|FG001|Extension Phase|Study Closed|0|||
23702187|NCT03042611|66286880|FG002|Extension Phase|Study Closed|17|||
23702188|NCT03042611|66286881|FG003|Extension Phase|Study Closed|11|||
23702189|NCT00128206|66286885|FG000|Overall Study|Lost to Follow-up|137|||
23702190|NCT00128206|66286886|FG001|Overall Study|Lost to Follow-up|118|||
23702191|NCT00128206|66286885|FG000|Overall Study|Adverse Event|0|||
23702192|NCT00128206|66286886|FG001|Overall Study|Adverse Event|2|||
23702193|NCT01166659|66286887|FG000|Overall Study|Subject Decision|8|||
23702194|NCT01166659|66286887|FG000|Overall Study|Investigator Decision|2|||
23702195|NCT01166659|66286887|FG000|Overall Study|Death|1|||
23702196|NCT01166659|66286887|FG000|Overall Study|Lost to Follow-up|1|||
23702197|NCT01166659|66286887|FG000|Overall Study|Study Closed at Site|1|||
23702198|NCT04359823|66286888|FG000|Overall Study|Lost to Follow-up|0|||
23702199|NCT04359823|66286889|FG001|Overall Study|Lost to Follow-up|1|||
23702200|NCT04359823|66286888|FG000|Overall Study|Withdrawal by Subject|0|||
23702201|NCT04359823|66286889|FG001|Overall Study|Withdrawal by Subject|1|||
23702202|NCT03283163|66286892|FG000|Overall Study|Lost to Follow-up|1|||
23702203|NCT03283163|66286892|FG000|Overall Study|other life commitments|6|||
23702204|NCT03283163|66286892|FG000|Overall Study|COVID-19 institution wide halting|1|||
23702205|NCT03283163|66286892|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
23702206|NCT03283163|66286892|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
23702207|NCT01327339|66286895|FG000|Overall Study|Protocol Violation|8|||
23702208|NCT01954121|66286896|FG000|Overall Study|Lack of Efficacy|94|||
23702209|NCT01954121|66286897|FG001|Overall Study|Lack of Efficacy|41|||
23702210|NCT01954121|66286896|FG000|Overall Study|Protocol Violation|0|||
23702211|NCT01954121|66286897|FG001|Overall Study|Protocol Violation|2|||
23702212|NCT01954121|66286896|FG000|Overall Study|Lost to Follow-up|5|||
23702213|NCT01954121|66286897|FG001|Overall Study|Lost to Follow-up|6|||
23702214|NCT01954121|66286896|FG000|Overall Study|Withdrawal by Subject|18|||
23702215|NCT01954121|66286897|FG001|Overall Study|Withdrawal by Subject|12|||
23702216|NCT01954121|66286896|FG000|Overall Study|Pregnancy|1|||
23702217|NCT01954121|66286897|FG001|Overall Study|Pregnancy|1|||
23702218|NCT01954121|66286896|FG000|Overall Study|AE, serious fatal|1|||
23702219|NCT01954121|66286897|FG001|Overall Study|AE, serious fatal|0|||
23702220|NCT01954121|66286896|FG000|Overall Study|AE, non-serious non-fatal|5|||
23702221|NCT01954121|66286897|FG001|Overall Study|AE, non-serious non-fatal|22|||
23702222|NCT01954121|66286896|FG000|Overall Study|SAE, non-fatal|1|||
23702223|NCT01954121|66286897|FG001|Overall Study|SAE, non-fatal|4|||
23702224|NCT01954121|66286896|FG000|Overall Study|Non-compliant with study procedures|1|||
23702225|NCT01954121|66286897|FG001|Overall Study|Non-compliant with study procedures|0|||
23702226|NCT01954121|66286896|FG000|Overall Study|Non-compliant patient|1|||
23702227|NCT01954121|66286897|FG001|Overall Study|Non-compliant patient|1|||
23702228|NCT01954121|66286896|FG000|Overall Study|Subject did not follow instructions|0|||
23702229|NCT01954121|66286897|FG001|Overall Study|Subject did not follow instructions|2|||
23702230|NCT00858702|66286898|FG000|Overall Study|Lack of Efficacy|1|||
23702231|NCT00858702|66286899|FG001|Overall Study|Lack of Efficacy|0|||
23702232|NCT00858702|66286898|FG000|Overall Study|Protocol Violation|1|||
23702233|NCT00858702|66286899|FG001|Overall Study|Protocol Violation|1|||
23702234|NCT00858702|66286898|FG000|Overall Study|Other|2|||
23702235|NCT00858702|66286899|FG001|Overall Study|Other|1|||
23702236|NCT00858702|66286898|FG000|Overall Study|Withdrawal by Subject|1|||
23702237|NCT00858702|66286899|FG001|Overall Study|Withdrawal by Subject|0|||
23702238|NCT00001262|66286900|FG000|Overall Study|Death|10|||
23702239|NCT00001262|66286901|FG001|Overall Study|Death|11|||
23702240|NCT00001262|66286902|FG002|Overall Study|Death|0|||
23702241|NCT00001262|66286900|FG000|Overall Study|Withdrawal by Subject|0|||
23702242|NCT00001262|66286901|FG001|Overall Study|Withdrawal by Subject|3|||
23702243|NCT00001262|66286902|FG002|Overall Study|Withdrawal by Subject|0|||
23702244|NCT03229759|66286903|FG000|Overall Study|Screen Failure|30|||
23702245|NCT02538666|66286904|FG000|Pre-Treatment|Disease progression|1|||
23702246|NCT02538666|66286905|FG001|Pre-Treatment|Disease progression|0|||
23702247|NCT02538666|66286906|FG002|Pre-Treatment|Disease progression|0|||
23702248|NCT02538666|66286904|FG000|Pre-Treatment|no longer meets study criteria|1|||
23702249|NCT02538666|66286905|FG001|Pre-Treatment|no longer meets study criteria|0|||
23702250|NCT02538666|66286906|FG002|Pre-Treatment|no longer meets study criteria|0|||
23702251|NCT02538666|66286904|FG000|Pre-Treatment|Withdrew Consent|0|||
23702252|NCT02538666|66286905|FG001|Pre-Treatment|Withdrew Consent|1|||
23702253|NCT02538666|66286906|FG002|Pre-Treatment|Withdrew Consent|1|||
23702254|NCT02538666|66286904|FG000|Treatment|Disease progression|270|||
23398931|NCT00457392|65207210|FG001|Overall Study|Withdrawal by Subject|8|||
23398932|NCT00457392|65207209|FG000|Overall Study|Lost to Follow-up|6|||
23398933|NCT00457392|65207210|FG001|Overall Study|Lost to Follow-up|7|||
23398934|NCT00457392|65207209|FG000|Overall Study|Protocol Violation|4|||
23398935|NCT00457392|65207210|FG001|Overall Study|Protocol Violation|3|||
23398936|NCT00457392|65207209|FG000|Overall Study|Other|7|||
23398937|NCT00457392|65207210|FG001|Overall Study|Other|4|||
23398938|NCT00457392|65207209|FG000|Overall Study|Study Terminated by Sponsor|1|||
23398939|NCT00457392|65207210|FG001|Overall Study|Study Terminated by Sponsor|4|||
23398940|NCT00457392|65207209|FG000|Overall Study|Randomized, Not Treated|7|||
23398941|NCT00457392|65207210|FG001|Overall Study|Randomized, Not Treated|3|||
23398942|NCT02394561|65207212|FG000|CORE Phase|Adverse Event|7|||
23398943|NCT02394561|65207213|FG001|CORE Phase|Adverse Event|9|||
23398944|NCT02394561|65207212|FG000|CORE Phase|Death|0|||
23398945|NCT02394561|65207213|FG001|CORE Phase|Death|1|||
23398946|NCT02394561|65207212|FG000|CORE Phase|Pregnancy|1|||
23398947|NCT02394561|65207213|FG001|CORE Phase|Pregnancy|0|||
23398948|NCT02394561|65207212|FG000|CORE Phase|Lost to Follow-up|1|||
23398949|NCT02394561|65207213|FG001|CORE Phase|Lost to Follow-up|0|||
23398950|NCT02394561|65207212|FG000|CORE Phase|Physician Decision|1|||
23398951|NCT02394561|65207213|FG001|CORE Phase|Physician Decision|1|||
23398952|NCT02394561|65207212|FG000|CORE Phase|Withdrawal by Subject|2|||
23398953|NCT02394561|65207213|FG001|CORE Phase|Withdrawal by Subject|2|||
23398954|NCT02394561|65207212|FG000|CORE Phase|Lack of Efficacy|1|||
23398955|NCT02394561|65207213|FG001|CORE Phase|Lack of Efficacy|6|||
23398956|NCT02394561|65207212|FG000|Extension Phase|Adverse Event|6|||
23398957|NCT02394561|65207213|FG001|Extension Phase|Adverse Event|1|||
23398958|NCT02394561|65207212|FG000|Extension Phase|Death|0|||
23398959|NCT02394561|65207213|FG001|Extension Phase|Death|1|||
23398960|NCT02394561|65207212|FG000|Extension Phase|Protocol Violation|1|||
23398961|NCT02394561|65207213|FG001|Extension Phase|Protocol Violation|0|||
23398962|NCT02394561|65207212|FG000|Extension Phase|Lost to Follow-up|1|||
23398963|NCT02394561|65207213|FG001|Extension Phase|Lost to Follow-up|0|||
23398964|NCT02394561|65207212|FG000|Extension Phase|Physician Decision|0|||
23398965|NCT02394561|65207213|FG001|Extension Phase|Physician Decision|2|||
23398966|NCT02394561|65207212|FG000|Extension Phase|Withdrawal by Subject|0|||
23398967|NCT02394561|65207213|FG001|Extension Phase|Withdrawal by Subject|5|||
23398968|NCT02394561|65207212|FG000|Extension Phase|Lack of Efficacy|3|||
23398969|NCT02394561|65207213|FG001|Extension Phase|Lack of Efficacy|3|||
23398970|NCT01646827|65207215|FG000|Overall Study|Lost to Follow-up|0|||
23398971|NCT01646827|65207216|FG001|Overall Study|Lost to Follow-up|3|||
23398972|NCT01646827|65207215|FG000|Overall Study|Physician Decision|1|||
23398973|NCT01646827|65207216|FG001|Overall Study|Physician Decision|2|||
23398974|NCT01646827|65207215|FG000|Overall Study|Withdrawal by Subject|1|||
23398975|NCT01646827|65207216|FG001|Overall Study|Withdrawal by Subject|0|||
23398976|NCT01051661|65207217|FG000|Overall Study|Adverse Event|1|||
23398977|NCT01051661|65207218|FG001|Overall Study|Adverse Event|1|||
23398978|NCT01051661|65207219|FG002|Overall Study|Adverse Event|1|||
23398979|NCT01051661|65207220|FG003|Overall Study|Adverse Event|1|||
23398980|NCT01051661|65207221|FG004|Overall Study|Adverse Event|0|||
23398981|NCT01051661|65207222|FG005|Overall Study|Adverse Event|0|||
23398982|NCT01051661|65207217|FG000|Overall Study|Lost to Follow-up|13|||
23398983|NCT01051661|65207218|FG001|Overall Study|Lost to Follow-up|22|||
23398984|NCT01051661|65207219|FG002|Overall Study|Lost to Follow-up|15|||
23398985|NCT01051661|65207220|FG003|Overall Study|Lost to Follow-up|17|||
23398986|NCT01051661|65207221|FG004|Overall Study|Lost to Follow-up|10|||
23398987|NCT01051661|65207222|FG005|Overall Study|Lost to Follow-up|24|||
23398988|NCT01051661|65207217|FG000|Overall Study|Migrated/moved from study area|1|||
23398989|NCT01051661|65207218|FG001|Overall Study|Migrated/moved from study area|6|||
23398990|NCT01051661|65207219|FG002|Overall Study|Migrated/moved from study area|6|||
23398991|NCT01051661|65207220|FG003|Overall Study|Migrated/moved from study area|8|||
23398992|NCT01051661|65207221|FG004|Overall Study|Migrated/moved from study area|7|||
23398993|NCT01051661|65207222|FG005|Overall Study|Migrated/moved from study area|3|||
23702255|NCT02538666|66286905|FG001|Treatment|Disease progression|227|||
23398994|NCT01051661|65207217|FG000|Overall Study|Refused blood sampling|0|||
23398995|NCT01051661|65207218|FG001|Overall Study|Refused blood sampling|0|||
23398996|NCT01051661|65207219|FG002|Overall Study|Refused blood sampling|0|||
23398997|NCT01051661|65207220|FG003|Overall Study|Refused blood sampling|0|||
23398998|NCT01051661|65207221|FG004|Overall Study|Refused blood sampling|0|||
23398999|NCT01051661|65207222|FG005|Overall Study|Refused blood sampling|1|||
23399000|NCT01051661|65207217|FG000|Overall Study|Data not reliable|1|||
23702256|NCT02538666|66286906|FG002|Treatment|Disease progression|165|||
23399001|NCT01051661|65207218|FG001|Overall Study|Data not reliable|0|||
23399002|NCT01051661|65207219|FG002|Overall Study|Data not reliable|0|||
23399003|NCT01051661|65207220|FG003|Overall Study|Data not reliable|0|||
23399004|NCT01051661|65207221|FG004|Overall Study|Data not reliable|0|||
23702257|NCT02538666|66286904|FG000|Treatment|Study drug toxicity|1|||
23702258|NCT02538666|66286905|FG001|Treatment|Study drug toxicity|29|||
23702259|NCT02538666|66286906|FG002|Treatment|Study drug toxicity|92|||
23702260|NCT02538666|66286904|FG000|Treatment|Death|0|||
23702261|NCT02538666|66286905|FG001|Treatment|Death|2|||
23702262|NCT02538666|66286906|FG002|Treatment|Death|3|||
23702263|NCT02538666|66286904|FG000|Treatment|Adverse event unrelated to study drug|8|||
23702264|NCT02538666|66286905|FG001|Treatment|Adverse event unrelated to study drug|10|||
23702265|NCT02538666|66286906|FG002|Treatment|Adverse event unrelated to study drug|15|||
23702266|NCT02538666|66286904|FG000|Treatment|Participant request to discontinue study treatment|3|||
23702267|NCT02538666|66286905|FG001|Treatment|Participant request to discontinue study treatment|6|||
23702268|NCT02538666|66286906|FG002|Treatment|Participant request to discontinue study treatment|11|||
23702269|NCT02538666|66286904|FG000|Treatment|Participant withdrew consent|2|||
23702270|NCT02538666|66286905|FG001|Treatment|Participant withdrew consent|5|||
23702271|NCT02538666|66286906|FG002|Treatment|Participant withdrew consent|3|||
23702272|NCT02538666|66286904|FG000|Treatment|Lost to Follow-up|0|||
23702273|NCT02538666|66286905|FG001|Treatment|Lost to Follow-up|1|||
23702274|NCT02538666|66286906|FG002|Treatment|Lost to Follow-up|1|||
23702275|NCT02538666|66286904|FG000|Treatment|Maximum clinical benefit|4|||
23702276|NCT02538666|66286905|FG001|Treatment|Maximum clinical benefit|3|||
23702277|NCT02538666|66286906|FG002|Treatment|Maximum clinical benefit|4|||
23702278|NCT02538666|66286904|FG000|Treatment|Poor/non-compliance|0|||
23702279|NCT02538666|66286905|FG001|Treatment|Poor/non-compliance|1|||
23702280|NCT02538666|66286906|FG002|Treatment|Poor/non-compliance|0|||
23702281|NCT02538666|66286904|FG000|Treatment|Participant no longer meets study criteria|0|||
23702282|NCT02538666|66286905|FG001|Treatment|Participant no longer meets study criteria|2|||
23702283|NCT02538666|66286906|FG002|Treatment|Participant no longer meets study criteria|0|||
23702284|NCT02538666|66286904|FG000|Treatment|Administrative reason by sponsor|0|||
23702285|NCT02538666|66286905|FG001|Treatment|Administrative reason by sponsor|0|||
23702286|NCT02538666|66286906|FG002|Treatment|Administrative reason by sponsor|1|||
23702287|NCT02538666|66286904|FG000|Treatment|Other reasons|8|||
23702288|NCT02538666|66286905|FG001|Treatment|Other reasons|15|||
23702289|NCT02538666|66286906|FG002|Treatment|Other reasons|5|||
23702290|NCT02538666|66286904|FG000|Treatment|Not reported|2|||
23702291|NCT02538666|66286905|FG001|Treatment|Not reported|2|||
23702292|NCT02538666|66286906|FG002|Treatment|Not reported|2|||
23702293|NCT04743635|66286908|FG000|Overall Study|Lost to Follow-up|2|||
23702294|NCT04743635|66286909|FG001|Overall Study|Lost to Follow-up|0|||
23702295|NCT01678807|66286913|FG000|Overall Study|Adverse Event|4|||
23702296|NCT01678807|66286914|FG001|Overall Study|Adverse Event|4|||
23702297|NCT01678807|66286915|FG002|Overall Study|Adverse Event|0|||
23702298|NCT01678807|66286913|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
23702299|NCT01678807|66286914|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
23702300|NCT01678807|66286915|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23702301|NCT03123939|66286916|FG000|Overall Study|Lack of Efficacy|6|||
23702302|NCT03123939|66286916|FG000|Overall Study|Death|5|||
23702303|NCT03123939|66286916|FG000|Overall Study|Physician Decision|2|||
23702304|NCT03123939|66286916|FG000|Overall Study|Subject/guardian decision|2|||
23702305|NCT03123939|66286916|FG000|Overall Study|Lost to Follow-up|1|||
23702306|NCT03123939|66286916|FG000|Overall Study|New therapy for study indication|1|||
23702307|NCT03123939|66286916|FG000|Overall Study|Protocol deviation|1|||
23702308|NCT03123939|66286916|FG000|Overall Study|Progressive disease|18|||
23702309|NCT03123939|66286916|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
23702310|NCT03123939|66286916|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
23702311|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
23702312|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
23702313|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
23702314|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
23702315|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
23702316|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
23702317|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
23702318|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
23702319|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
23502560|NCT01317160|65580239|FG000|Overall Study|Withdrawal by Subject|0|||
23502561|NCT01317160|65580240|FG001|Overall Study|Withdrawal by Subject|2|||
23502562|NCT01866930|65580241|FG000|Treatment Period|Other|1|||
23502563|NCT01866930|65580242|FG001|Treatment Period|Other|0|||
23502564|NCT01866930|65580241|FG000|Treatment Period|Death|0|||
23502565|NCT01866930|65580242|FG001|Treatment Period|Death|2|||
23502566|NCT01866930|65580241|FG000|Treatment Period|Poor/non compliance|0|||
23502567|NCT01866930|65580242|FG001|Treatment Period|Poor/non compliance|2|||
23502568|NCT01866930|65580241|FG000|Treatment Period|No longer meets study criteria|0|||
23502569|NCT01866930|65580242|FG001|Treatment Period|No longer meets study criteria|1|||
23502570|NCT01866930|65580241|FG000|Treatment Period|Withdrawal by Subject|2|||
23502571|NCT01866930|65580242|FG001|Treatment Period|Withdrawal by Subject|8|||
23502572|NCT01866930|65580241|FG000|Treatment Period|Lack of Efficacy|1|||
23702320|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
23702321|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
23702322|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
23702323|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
23702324|NCT02232516|66286917|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
23702325|NCT02232516|66286917|FG000|Survival Follow-up|Death|15|||
23702326|NCT02232516|66286917|FG000|Survival Follow-up|Withdrawal by Subject|3|||
23702327|NCT02232516|66286917|FG000|Survival Follow-up|Lost to Follow-up|1|||
23702328|NCT02232516|66286917|FG000|Survival Follow-up|Still in follow-up|5|||
23702329|NCT01905397|66286918|FG000|Overall Study|Death|0|||
23702330|NCT01905397|66286919|FG001|Overall Study|Death|1|||
23702331|NCT01905397|66286918|FG000|Overall Study|Withdrawal by Subject|2|||
23702332|NCT01905397|66286919|FG001|Overall Study|Withdrawal by Subject|0|||
23702333|NCT01905397|66286918|FG000|Overall Study|Surgery canceled/aborted|9|||
23702334|NCT01905397|66286919|FG001|Overall Study|Surgery canceled/aborted|5|||
23702335|NCT01905397|66286918|FG000|Overall Study|Incision < 7 cm|2|||
23702336|NCT01905397|66286919|FG001|Overall Study|Incision < 7 cm|0|||
23702337|NCT01905397|66286918|FG000|Overall Study|Wrong treatment|1|||
23702338|NCT01905397|66286919|FG001|Overall Study|Wrong treatment|1|||
23702339|NCT01905397|66286918|FG000|Overall Study|Device not applied|3|||
23702340|NCT01905397|66286919|FG001|Overall Study|Device not applied|0|||
23702341|NCT01905397|66286918|FG000|Overall Study|Dressing not applied in operating room|1|||
23702342|NCT01905397|66286919|FG001|Overall Study|Dressing not applied in operating room|0|||
23702343|NCT01905397|66286918|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
23702344|NCT01905397|66286919|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
23702345|NCT00085540|66286922|FG000|Overall Study|Withdrawal by Subject|0|||
23702346|NCT00085540|66286923|FG001|Overall Study|Withdrawal by Subject|1|||
23702347|NCT00085540|66286922|FG000|Overall Study|Protocol Violation|0|||
23702348|NCT00085540|66286923|FG001|Overall Study|Protocol Violation|1|||
23702349|NCT03282123|66286924|FG000|Overall Study|Withdrawal by Subject|5|||
23702350|NCT03502707|66286925|FG000|Overall Study|Adverse Event|0|||
23702351|NCT03502707|66286926|FG001|Overall Study|Adverse Event|0|||
23702352|NCT03502707|66286927|FG002|Overall Study|Adverse Event|0|||
23702353|NCT03502707|66286928|FG003|Overall Study|Adverse Event|0|||
23702354|NCT03502707|66286929|FG004|Overall Study|Adverse Event|0|||
23702355|NCT03502707|66286930|FG005|Overall Study|Adverse Event|0|||
23702356|NCT03502707|66286931|FG006|Overall Study|Adverse Event|0|||
23702357|NCT03502707|66286932|FG007|Overall Study|Adverse Event|0|||
23702358|NCT03502707|66286933|FG008|Overall Study|Adverse Event|0|||
23702359|NCT03502707|66286934|FG009|Overall Study|Adverse Event|0|||
23702360|NCT03502707|66286935|FG010|Overall Study|Adverse Event|0|||
23702361|NCT03502707|66286936|FG011|Overall Study|Adverse Event|0|||
23702362|NCT03502707|66286937|FG012|Overall Study|Adverse Event|0|||
23702363|NCT03502707|66286938|FG013|Overall Study|Adverse Event|0|||
23702364|NCT03502707|66286939|FG014|Overall Study|Adverse Event|0|||
23702365|NCT03502707|66286940|FG015|Overall Study|Adverse Event|1|||
23702366|NCT03502707|66286941|FG016|Overall Study|Adverse Event|5|||
23702367|NCT03502707|66286942|FG017|Overall Study|Adverse Event|0|||
23702368|NCT03502707|66286925|FG000|Overall Study|Death|0|||
23702369|NCT03502707|66286926|FG001|Overall Study|Death|0|||
23702370|NCT03502707|66286927|FG002|Overall Study|Death|0|||
23702371|NCT03502707|66286928|FG003|Overall Study|Death|1|||
23702372|NCT03502707|66286929|FG004|Overall Study|Death|0|||
23702373|NCT03502707|66286930|FG005|Overall Study|Death|0|||
23702374|NCT03502707|66286931|FG006|Overall Study|Death|0|||
23702375|NCT03502707|66286932|FG007|Overall Study|Death|0|||
23702376|NCT03502707|66286933|FG008|Overall Study|Death|1|||
23702377|NCT03502707|66286934|FG009|Overall Study|Death|1|||
23702378|NCT03502707|66286935|FG010|Overall Study|Death|0|||
23702379|NCT03502707|66286936|FG011|Overall Study|Death|0|||
23702380|NCT03502707|66286937|FG012|Overall Study|Death|1|||
23702381|NCT03502707|66286938|FG013|Overall Study|Death|0|||
23702382|NCT03502707|66286939|FG014|Overall Study|Death|0|||
23702383|NCT03502707|66286940|FG015|Overall Study|Death|1|||
23702384|NCT03502707|66286941|FG016|Overall Study|Death|0|||
23702385|NCT03502707|66286942|FG017|Overall Study|Death|0|||
23702386|NCT03502707|66286925|FG000|Overall Study|Lost to Follow-up|0|||
23702387|NCT03502707|66286926|FG001|Overall Study|Lost to Follow-up|0|||
23702388|NCT03502707|66286927|FG002|Overall Study|Lost to Follow-up|0|||
23702389|NCT03502707|66286928|FG003|Overall Study|Lost to Follow-up|0|||
23702390|NCT03502707|66286929|FG004|Overall Study|Lost to Follow-up|0|||
23702391|NCT03502707|66286930|FG005|Overall Study|Lost to Follow-up|0|||
23702392|NCT03502707|66286931|FG006|Overall Study|Lost to Follow-up|0|||
23702393|NCT03502707|66286932|FG007|Overall Study|Lost to Follow-up|5|||
23702394|NCT03502707|66286933|FG008|Overall Study|Lost to Follow-up|0|||
23702395|NCT03502707|66286934|FG009|Overall Study|Lost to Follow-up|2|||
23702396|NCT03502707|66286935|FG010|Overall Study|Lost to Follow-up|1|||
23702397|NCT03502707|66286936|FG011|Overall Study|Lost to Follow-up|2|||
23702398|NCT03502707|66286937|FG012|Overall Study|Lost to Follow-up|1|||
23702399|NCT03502707|66286938|FG013|Overall Study|Lost to Follow-up|1|||
23702400|NCT03502707|66286939|FG014|Overall Study|Lost to Follow-up|0|||
23702401|NCT03502707|66286940|FG015|Overall Study|Lost to Follow-up|4|||
23702402|NCT03502707|66286941|FG016|Overall Study|Lost to Follow-up|9|||
23702403|NCT03502707|66286942|FG017|Overall Study|Lost to Follow-up|2|||
23702404|NCT03502707|66286925|FG000|Overall Study|Physician Decision|0|||
23702405|NCT03502707|66286926|FG001|Overall Study|Physician Decision|0|||
23702406|NCT03502707|66286927|FG002|Overall Study|Physician Decision|0|||
23702407|NCT03502707|66286928|FG003|Overall Study|Physician Decision|0|||
23702408|NCT03502707|66286929|FG004|Overall Study|Physician Decision|0|||
23702409|NCT03502707|66286930|FG005|Overall Study|Physician Decision|0|||
23702410|NCT03502707|66286931|FG006|Overall Study|Physician Decision|0|||
23702411|NCT03502707|66286932|FG007|Overall Study|Physician Decision|0|||
23702412|NCT03502707|66286933|FG008|Overall Study|Physician Decision|2|||
23702413|NCT03502707|66286934|FG009|Overall Study|Physician Decision|1|||
23702414|NCT03502707|66286935|FG010|Overall Study|Physician Decision|0|||
23702415|NCT03502707|66286936|FG011|Overall Study|Physician Decision|0|||
23702416|NCT03502707|66286937|FG012|Overall Study|Physician Decision|0|||
23702417|NCT03502707|66286938|FG013|Overall Study|Physician Decision|0|||
23702418|NCT03502707|66286939|FG014|Overall Study|Physician Decision|1|||
23702419|NCT03502707|66286940|FG015|Overall Study|Physician Decision|3|||
23702420|NCT03502707|66286941|FG016|Overall Study|Physician Decision|0|||
23702421|NCT03502707|66286942|FG017|Overall Study|Physician Decision|0|||
23702422|NCT03502707|66286925|FG000|Overall Study|Protocol Violation|0|||
23702423|NCT03502707|66286926|FG001|Overall Study|Protocol Violation|0|||
23702424|NCT03502707|66286927|FG002|Overall Study|Protocol Violation|0|||
23702425|NCT03502707|66286928|FG003|Overall Study|Protocol Violation|0|||
23702426|NCT03502707|66286929|FG004|Overall Study|Protocol Violation|0|||
23702427|NCT03502707|66286930|FG005|Overall Study|Protocol Violation|0|||
23702428|NCT03502707|66286931|FG006|Overall Study|Protocol Violation|0|||
23702429|NCT03502707|66286932|FG007|Overall Study|Protocol Violation|0|||
23702430|NCT03502707|66286933|FG008|Overall Study|Protocol Violation|0|||
23702431|NCT03502707|66286934|FG009|Overall Study|Protocol Violation|0|||
23702432|NCT03502707|66286935|FG010|Overall Study|Protocol Violation|0|||
23702433|NCT03502707|66286936|FG011|Overall Study|Protocol Violation|0|||
23702434|NCT03502707|66286937|FG012|Overall Study|Protocol Violation|0|||
23702435|NCT03502707|66286938|FG013|Overall Study|Protocol Violation|0|||
23702436|NCT03502707|66286939|FG014|Overall Study|Protocol Violation|0|||
23702437|NCT03502707|66286940|FG015|Overall Study|Protocol Violation|1|||
23702438|NCT03502707|66286941|FG016|Overall Study|Protocol Violation|0|||
23702439|NCT03502707|66286942|FG017|Overall Study|Protocol Violation|0|||
23702440|NCT03502707|66286925|FG000|Overall Study|Withdrawal by Subject|1|||
23702441|NCT03502707|66286926|FG001|Overall Study|Withdrawal by Subject|1|||
23702442|NCT03502707|66286927|FG002|Overall Study|Withdrawal by Subject|0|||
23702443|NCT03502707|66286928|FG003|Overall Study|Withdrawal by Subject|0|||
23702444|NCT03502707|66286929|FG004|Overall Study|Withdrawal by Subject|0|||
23702445|NCT03502707|66286930|FG005|Overall Study|Withdrawal by Subject|2|||
23702446|NCT03502707|66286931|FG006|Overall Study|Withdrawal by Subject|0|||
23702447|NCT03502707|66286932|FG007|Overall Study|Withdrawal by Subject|3|||
23702448|NCT03502707|66286933|FG008|Overall Study|Withdrawal by Subject|1|||
23702449|NCT03502707|66286934|FG009|Overall Study|Withdrawal by Subject|2|||
23702450|NCT03502707|66286935|FG010|Overall Study|Withdrawal by Subject|12|||
23702451|NCT03502707|66286936|FG011|Overall Study|Withdrawal by Subject|23|||
23702452|NCT03502707|66286937|FG012|Overall Study|Withdrawal by Subject|5|||
23702453|NCT03502707|66286938|FG013|Overall Study|Withdrawal by Subject|3|||
23702454|NCT03502707|66286939|FG014|Overall Study|Withdrawal by Subject|3|||
23702455|NCT03502707|66286940|FG015|Overall Study|Withdrawal by Subject|43|||
23702456|NCT03502707|66286941|FG016|Overall Study|Withdrawal by Subject|44|||
23702457|NCT03502707|66286942|FG017|Overall Study|Withdrawal by Subject|18|||
23702458|NCT03502707|66286925|FG000|Overall Study|Sponsor's Decision|1|||
23702459|NCT03502707|66286926|FG001|Overall Study|Sponsor's Decision|0|||
23702460|NCT03502707|66286927|FG002|Overall Study|Sponsor's Decision|0|||
23702461|NCT03502707|66286928|FG003|Overall Study|Sponsor's Decision|0|||
23702462|NCT03502707|66286929|FG004|Overall Study|Sponsor's Decision|0|||
23702463|NCT03502707|66286930|FG005|Overall Study|Sponsor's Decision|0|||
23702464|NCT03502707|66286931|FG006|Overall Study|Sponsor's Decision|0|||
23702465|NCT03502707|66286932|FG007|Overall Study|Sponsor's Decision|0|||
23702466|NCT03502707|66286933|FG008|Overall Study|Sponsor's Decision|0|||
23702467|NCT03502707|66286934|FG009|Overall Study|Sponsor's Decision|1|||
23702468|NCT03502707|66286935|FG010|Overall Study|Sponsor's Decision|0|||
23702469|NCT03502707|66286936|FG011|Overall Study|Sponsor's Decision|0|||
23702470|NCT03502707|66286937|FG012|Overall Study|Sponsor's Decision|0|||
23702471|NCT03502707|66286938|FG013|Overall Study|Sponsor's Decision|0|||
23702472|NCT03502707|66286939|FG014|Overall Study|Sponsor's Decision|0|||
23702473|NCT03502707|66286940|FG015|Overall Study|Sponsor's Decision|2|||
23702474|NCT03502707|66286941|FG016|Overall Study|Sponsor's Decision|1|||
23702475|NCT03502707|66286942|FG017|Overall Study|Sponsor's Decision|0|||
23702476|NCT03502707|66286925|FG000|Overall Study|Initiated Prohibited Medication|0|||
23702477|NCT03502707|66286926|FG001|Overall Study|Initiated Prohibited Medication|0|||
23702478|NCT03502707|66286927|FG002|Overall Study|Initiated Prohibited Medication|0|||
23702479|NCT03502707|66286928|FG003|Overall Study|Initiated Prohibited Medication|0|||
23702480|NCT03502707|66286929|FG004|Overall Study|Initiated Prohibited Medication|0|||
23702481|NCT03502707|66286930|FG005|Overall Study|Initiated Prohibited Medication|0|||
23702482|NCT03502707|66286931|FG006|Overall Study|Initiated Prohibited Medication|0|||
23702483|NCT03502707|66286932|FG007|Overall Study|Initiated Prohibited Medication|0|||
23702484|NCT03502707|66286933|FG008|Overall Study|Initiated Prohibited Medication|0|||
23702485|NCT03502707|66286934|FG009|Overall Study|Initiated Prohibited Medication|0|||
23702486|NCT03502707|66286935|FG010|Overall Study|Initiated Prohibited Medication|0|||
23702487|NCT03502707|66286936|FG011|Overall Study|Initiated Prohibited Medication|0|||
23702488|NCT03502707|66286937|FG012|Overall Study|Initiated Prohibited Medication|0|||
23702489|NCT03502707|66286938|FG013|Overall Study|Initiated Prohibited Medication|0|||
23702490|NCT03502707|66286939|FG014|Overall Study|Initiated Prohibited Medication|0|||
23702491|NCT03502707|66286940|FG015|Overall Study|Initiated Prohibited Medication|0|||
23702492|NCT03502707|66286941|FG016|Overall Study|Initiated Prohibited Medication|1|||
23702493|NCT03502707|66286942|FG017|Overall Study|Initiated Prohibited Medication|0|||
23702494|NCT03502707|66286925|FG000|Overall Study|Other|0|||
23702495|NCT03502707|66286926|FG001|Overall Study|Other|0|||
23702496|NCT03502707|66286927|FG002|Overall Study|Other|0|||
23702497|NCT03502707|66286928|FG003|Overall Study|Other|0|||
23702498|NCT03502707|66286929|FG004|Overall Study|Other|0|||
23702499|NCT03502707|66286930|FG005|Overall Study|Other|0|||
23702500|NCT03502707|66286931|FG006|Overall Study|Other|0|||
23702501|NCT03502707|66286932|FG007|Overall Study|Other|0|||
23702502|NCT03502707|66286933|FG008|Overall Study|Other|1|||
23702503|NCT03502707|66286934|FG009|Overall Study|Other|1|||
23702504|NCT03502707|66286935|FG010|Overall Study|Other|2|||
23399005|NCT01051661|65207222|FG005|Overall Study|Data not reliable|1|||
23399006|NCT01051661|65207217|FG000|Overall Study|Unable to attend visit(s)|2|||
23399007|NCT01051661|65207218|FG001|Overall Study|Unable to attend visit(s)|4|||
23399008|NCT01051661|65207219|FG002|Overall Study|Unable to attend visit(s)|2|||
23399009|NCT01051661|65207220|FG003|Overall Study|Unable to attend visit(s)|1|||
23399010|NCT01051661|65207221|FG004|Overall Study|Unable to attend visit(s)|3|||
23399011|NCT01051661|65207222|FG005|Overall Study|Unable to attend visit(s)|2|||
23399012|NCT01051661|65207217|FG000|Overall Study|Consent not received from both parents|0|||
23399013|NCT01051661|65207218|FG001|Overall Study|Consent not received from both parents|0|||
23399014|NCT01051661|65207219|FG002|Overall Study|Consent not received from both parents|0|||
23399015|NCT01051661|65207220|FG003|Overall Study|Consent not received from both parents|0|||
23702505|NCT03502707|66286936|FG011|Overall Study|Other|0|||
23702506|NCT03502707|66286937|FG012|Overall Study|Other|0|||
23702507|NCT03502707|66286938|FG013|Overall Study|Other|0|||
23702508|NCT03502707|66286939|FG014|Overall Study|Other|0|||
23702509|NCT03502707|66286940|FG015|Overall Study|Other|4|||
23702510|NCT03502707|66286941|FG016|Overall Study|Other|1|||
23702511|NCT03502707|66286942|FG017|Overall Study|Other|0|||
23702512|NCT03502707|66286925|FG000|Overall Study|Randomized but not vaccinated|0|||
23702513|NCT03502707|66286926|FG001|Overall Study|Randomized but not vaccinated|0|||
23702514|NCT03502707|66286927|FG002|Overall Study|Randomized but not vaccinated|0|||
23702515|NCT03502707|66286928|FG003|Overall Study|Randomized but not vaccinated|0|||
23702516|NCT03502707|66286929|FG004|Overall Study|Randomized but not vaccinated|0|||
23702517|NCT03502707|66286930|FG005|Overall Study|Randomized but not vaccinated|0|||
23702518|NCT03502707|66286931|FG006|Overall Study|Randomized but not vaccinated|0|||
23702519|NCT03502707|66286932|FG007|Overall Study|Randomized but not vaccinated|0|||
23702520|NCT03502707|66286933|FG008|Overall Study|Randomized but not vaccinated|0|||
23702521|NCT03502707|66286934|FG009|Overall Study|Randomized but not vaccinated|0|||
23702522|NCT03502707|66286935|FG010|Overall Study|Randomized but not vaccinated|0|||
23702523|NCT03502707|66286936|FG011|Overall Study|Randomized but not vaccinated|1|||
23702524|NCT03502707|66286937|FG012|Overall Study|Randomized but not vaccinated|0|||
23702525|NCT03502707|66286938|FG013|Overall Study|Randomized but not vaccinated|0|||
23702526|NCT03502707|66286939|FG014|Overall Study|Randomized but not vaccinated|0|||
23702527|NCT03502707|66286940|FG015|Overall Study|Randomized but not vaccinated|0|||
23702528|NCT03502707|66286941|FG016|Overall Study|Randomized but not vaccinated|0|||
23702529|NCT03502707|66286942|FG017|Overall Study|Randomized but not vaccinated|1|||
23702530|NCT04973228|66286943|FG000|Overall Study|Adverse Event|2|||
23702531|NCT04973228|66286944|FG001|Overall Study|Adverse Event|3|||
23702532|NCT04973228|66286943|FG000|Overall Study|Lack of Efficacy|1|||
23702533|NCT04973228|66286944|FG001|Overall Study|Lack of Efficacy|3|||
23399016|NCT01051661|65207221|FG004|Overall Study|Consent not received from both parents|0|||
23702534|NCT04973228|66286943|FG000|Overall Study|Lost to Follow-up|12|||
23702535|NCT04973228|66286944|FG001|Overall Study|Lost to Follow-up|4|||
23702536|NCT04973228|66286943|FG000|Overall Study|Withdrawal by Subject|11|||
23702537|NCT04973228|66286944|FG001|Overall Study|Withdrawal by Subject|4|||
23702538|NCT04973228|66286943|FG000|Overall Study|Did not tolerate application|1|||
23702539|NCT04973228|66286944|FG001|Overall Study|Did not tolerate application|0|||
23702540|NCT04973228|66286943|FG000|Overall Study|Wanted to early terminate and use own product|0|||
23702541|NCT04973228|66286944|FG001|Overall Study|Wanted to early terminate and use own product|1|||
23702542|NCT04973228|66286943|FG000|Overall Study|Missed visits due to new work schedule|1|||
23702543|NCT04973228|66286944|FG001|Overall Study|Missed visits due to new work schedule|0|||
23702544|NCT02574312|66286945|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
23702545|NCT02574312|66286946|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
23702546|NCT01520324|66286947|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
23702547|NCT00923091|66286948|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
23702548|NCT00923091|66286949|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
23702549|NCT00923091|66286950|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
23702550|NCT00923091|66286951|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
23702551|NCT00923091|66286952|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
23702552|NCT00923091|66286953|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
23702553|NCT00923091|66286954|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
23702554|NCT00923091|66286955|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
23702555|NCT00923091|66286956|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23702556|NCT00923091|66286957|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23702557|NCT00923091|66286958|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23702558|NCT00923091|66286959|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23702559|NCT00923091|66286960|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23702560|NCT00923091|66286948|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
23702561|NCT00923091|66286949|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
23702562|NCT00923091|66286950|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23702563|NCT00923091|66286951|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
23702564|NCT00923091|66286952|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
23702565|NCT00923091|66286953|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
23702566|NCT00923091|66286954|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23702567|NCT00923091|66286955|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23702568|NCT00923091|66286956|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23702569|NCT00923091|66286957|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23702570|NCT00923091|66286958|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23702571|NCT00923091|66286959|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23702572|NCT00923091|66286960|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23702573|NCT00923091|66286948|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23702574|NCT00923091|66286949|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23702575|NCT00923091|66286950|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23702576|NCT00923091|66286951|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
23702577|NCT00923091|66286952|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
23702578|NCT00923091|66286953|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
23702579|NCT00923091|66286954|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
23702580|NCT00923091|66286955|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
23702581|NCT00923091|66286956|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23702582|NCT00923091|66286957|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23702583|NCT00923091|66286958|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23702584|NCT00923091|66286959|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23702585|NCT00923091|66286960|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23702586|NCT00923091|66286948|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702587|NCT00923091|66286949|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702588|NCT00923091|66286950|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702589|NCT00923091|66286951|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702590|NCT00923091|66286952|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702591|NCT00923091|66286953|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
23702592|NCT00923091|66286954|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702593|NCT00923091|66286955|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702594|NCT00923091|66286956|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702595|NCT00923091|66286957|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702596|NCT00923091|66286958|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702597|NCT00923091|66286959|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702598|NCT00923091|66286960|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23702599|NCT00923091|66286948|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702600|NCT00923091|66286949|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23702601|NCT00923091|66286950|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702602|NCT00923091|66286951|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23702603|NCT00923091|66286952|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702604|NCT00923091|66286953|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23702605|NCT00923091|66286954|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702606|NCT00923091|66286955|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702607|NCT00923091|66286956|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702608|NCT00923091|66286957|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702609|NCT00923091|66286958|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702610|NCT00923091|66286959|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702611|NCT00923091|66286960|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23702612|NCT00923091|66286948|FG000|Period III (Single-Blind)|Adverse Event|5|||
23702613|NCT00923091|66286949|FG001|Period III (Single-Blind)|Adverse Event|0|||
23702614|NCT00923091|66286950|FG002|Period III (Single-Blind)|Adverse Event|0|||
23702615|NCT00923091|66286951|FG003|Period III (Single-Blind)|Adverse Event|0|||
23702616|NCT00923091|66286952|FG004|Period III (Single-Blind)|Adverse Event|0|||
23702617|NCT00923091|66286953|FG005|Period III (Single-Blind)|Adverse Event|0|||
23702618|NCT00923091|66286954|FG006|Period III (Single-Blind)|Adverse Event|0|||
23702619|NCT00923091|66286955|FG007|Period III (Single-Blind)|Adverse Event|0|||
23702620|NCT00923091|66286956|FG008|Period III (Single-Blind)|Adverse Event|0|||
23702621|NCT00923091|66286957|FG009|Period III (Single-Blind)|Adverse Event|0|||
23702622|NCT00923091|66286958|FG010|Period III (Single-Blind)|Adverse Event|0|||
23702623|NCT00923091|66286959|FG011|Period III (Single-Blind)|Adverse Event|0|||
23702624|NCT00923091|66286960|FG012|Period III (Single-Blind)|Adverse Event|0|||
23702625|NCT00923091|66286948|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
23702626|NCT00923091|66286949|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702627|NCT00923091|66286950|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702628|NCT00923091|66286951|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702629|NCT00923091|66286952|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702630|NCT00923091|66286953|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702631|NCT00923091|66286954|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702632|NCT00923091|66286955|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702633|NCT00923091|66286956|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702634|NCT00923091|66286957|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702635|NCT00923091|66286958|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702636|NCT00923091|66286959|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702637|NCT00923091|66286960|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
23702638|NCT00923091|66286948|FG000|Period III (Single-Blind)|Protocol Violation|3|||
23702639|NCT00923091|66286949|FG001|Period III (Single-Blind)|Protocol Violation|0|||
23702640|NCT00923091|66286950|FG002|Period III (Single-Blind)|Protocol Violation|0|||
23702641|NCT00923091|66286951|FG003|Period III (Single-Blind)|Protocol Violation|0|||
23702642|NCT00923091|66286952|FG004|Period III (Single-Blind)|Protocol Violation|0|||
23702643|NCT00923091|66286953|FG005|Period III (Single-Blind)|Protocol Violation|0|||
23702644|NCT00923091|66286954|FG006|Period III (Single-Blind)|Protocol Violation|0|||
23702645|NCT00923091|66286955|FG007|Period III (Single-Blind)|Protocol Violation|0|||
23702646|NCT00923091|66286956|FG008|Period III (Single-Blind)|Protocol Violation|0|||
23702647|NCT00923091|66286957|FG009|Period III (Single-Blind)|Protocol Violation|0|||
23702648|NCT00923091|66286958|FG010|Period III (Single-Blind)|Protocol Violation|0|||
23702649|NCT00923091|66286959|FG011|Period III (Single-Blind)|Protocol Violation|0|||
23702650|NCT00923091|66286960|FG012|Period III (Single-Blind)|Protocol Violation|0|||
23702651|NCT00923091|66286948|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
23702652|NCT00923091|66286949|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
23702653|NCT00923091|66286950|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
23702654|NCT00923091|66286951|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
23702655|NCT00923091|66286952|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
23702656|NCT00923091|66286953|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
23702657|NCT00923091|66286954|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
23702658|NCT00923091|66286955|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
23702659|NCT00923091|66286956|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
23702660|NCT00923091|66286957|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
23702661|NCT00923091|66286958|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
23702662|NCT00923091|66286959|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
23702663|NCT00923091|66286960|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
23702664|NCT00923091|66286948|FG000|Period IV (Double-Blind)|Adverse Event|2|||
23702665|NCT00923091|66286949|FG001|Period IV (Double-Blind)|Adverse Event|0|||
23702666|NCT00923091|66286950|FG002|Period IV (Double-Blind)|Adverse Event|0|||
23702667|NCT00923091|66286951|FG003|Period IV (Double-Blind)|Adverse Event|0|||
23702668|NCT00923091|66286952|FG004|Period IV (Double-Blind)|Adverse Event|0|||
23702669|NCT00923091|66286953|FG005|Period IV (Double-Blind)|Adverse Event|0|||
23702670|NCT00923091|66286954|FG006|Period IV (Double-Blind)|Adverse Event|0|||
23702671|NCT00923091|66286955|FG007|Period IV (Double-Blind)|Adverse Event|0|||
23702672|NCT00923091|66286956|FG008|Period IV (Double-Blind)|Adverse Event|0|||
23702673|NCT00923091|66286957|FG009|Period IV (Double-Blind)|Adverse Event|0|||
23702674|NCT00923091|66286958|FG010|Period IV (Double-Blind)|Adverse Event|0|||
23702675|NCT00923091|66286959|FG011|Period IV (Double-Blind)|Adverse Event|0|||
23702676|NCT00923091|66286960|FG012|Period IV (Double-Blind)|Adverse Event|0|||
23702677|NCT00923091|66286948|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702678|NCT00923091|66286949|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
23702679|NCT00923091|66286950|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702680|NCT00923091|66286951|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702681|NCT00923091|66286952|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702682|NCT00923091|66286953|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702683|NCT00923091|66286954|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702684|NCT00923091|66286955|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702685|NCT00923091|66286956|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702686|NCT00923091|66286957|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702687|NCT00923091|66286958|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702688|NCT00923091|66286959|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702689|NCT00923091|66286960|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23702690|NCT00923091|66286948|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
23702691|NCT00923091|66286949|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
23702692|NCT00923091|66286950|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
23702693|NCT00923091|66286951|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
23702694|NCT00923091|66286952|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
23702695|NCT00923091|66286953|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
23702696|NCT00923091|66286954|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
23702697|NCT00923091|66286955|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
23702698|NCT00923091|66286956|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
23702699|NCT00923091|66286957|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
23702700|NCT00923091|66286958|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
23702701|NCT00923091|66286959|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
23702702|NCT00923091|66286960|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
23702703|NCT00923091|66286948|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702704|NCT00923091|66286949|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702705|NCT00923091|66286950|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702706|NCT00923091|66286951|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702707|NCT00923091|66286952|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702708|NCT00923091|66286953|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702709|NCT00923091|66286954|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702710|NCT00923091|66286955|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702711|NCT00923091|66286956|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
23702712|NCT00923091|66286957|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702713|NCT00923091|66286958|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702714|NCT00923091|66286959|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
23702715|NCT00923091|66286960|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
23702716|NCT00923091|66286948|FG000|Period V (Double -Blind)|Protocol Violation|0|||
23702717|NCT00923091|66286949|FG001|Period V (Double -Blind)|Protocol Violation|0|||
23702718|NCT00923091|66286950|FG002|Period V (Double -Blind)|Protocol Violation|0|||
23702719|NCT00923091|66286951|FG003|Period V (Double -Blind)|Protocol Violation|0|||
23702720|NCT00923091|66286952|FG004|Period V (Double -Blind)|Protocol Violation|0|||
23702721|NCT00923091|66286953|FG005|Period V (Double -Blind)|Protocol Violation|0|||
23702722|NCT00923091|66286954|FG006|Period V (Double -Blind)|Protocol Violation|0|||
23702723|NCT00923091|66286955|FG007|Period V (Double -Blind)|Protocol Violation|0|||
23702724|NCT00923091|66286956|FG008|Period V (Double -Blind)|Protocol Violation|0|||
23702725|NCT00923091|66286957|FG009|Period V (Double -Blind)|Protocol Violation|0|||
23702726|NCT00923091|66286958|FG010|Period V (Double -Blind)|Protocol Violation|0|||
23702727|NCT00923091|66286959|FG011|Period V (Double -Blind)|Protocol Violation|0|||
23702728|NCT00923091|66286960|FG012|Period V (Double -Blind)|Protocol Violation|1|||
23702729|NCT00923091|66286948|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
23702730|NCT00923091|66286949|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
23702731|NCT00923091|66286950|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
23702732|NCT00923091|66286951|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
23702733|NCT00923091|66286952|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
23702734|NCT00923091|66286953|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
23702735|NCT00923091|66286954|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
23702736|NCT00923091|66286955|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
23702737|NCT00923091|66286956|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
23399017|NCT01051661|65207222|FG005|Overall Study|Consent not received from both parents|1|||
23702738|NCT00923091|66286957|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
23702739|NCT00923091|66286958|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
23702740|NCT00923091|66286959|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
23702741|NCT00923091|66286960|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
23702742|NCT00923091|66286948|FG000|Period VI (Open-Label)|Adverse Event|17|||
23702743|NCT00923091|66286949|FG001|Period VI (Open-Label)|Adverse Event|0|||
23702744|NCT00923091|66286950|FG002|Period VI (Open-Label)|Adverse Event|4|||
23702745|NCT00923091|66286951|FG003|Period VI (Open-Label)|Adverse Event|1|||
23702746|NCT00923091|66286952|FG004|Period VI (Open-Label)|Adverse Event|1|||
23702747|NCT00923091|66286953|FG005|Period VI (Open-Label)|Adverse Event|0|||
23702748|NCT00923091|66286954|FG006|Period VI (Open-Label)|Adverse Event|0|||
23702749|NCT00923091|66286955|FG007|Period VI (Open-Label)|Adverse Event|0|||
23702750|NCT00923091|66286956|FG008|Period VI (Open-Label)|Adverse Event|0|||
23702751|NCT00923091|66286957|FG009|Period VI (Open-Label)|Adverse Event|0|||
23702752|NCT00923091|66286958|FG010|Period VI (Open-Label)|Adverse Event|0|||
23702753|NCT00923091|66286959|FG011|Period VI (Open-Label)|Adverse Event|0|||
23702754|NCT00923091|66286960|FG012|Period VI (Open-Label)|Adverse Event|0|||
23702755|NCT00923091|66286948|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
23702756|NCT00923091|66286949|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
23702757|NCT00923091|66286950|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
23702758|NCT00923091|66286951|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702759|NCT00923091|66286952|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
23702760|NCT00923091|66286953|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702761|NCT00923091|66286954|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702762|NCT00923091|66286955|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702763|NCT00923091|66286956|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702764|NCT00923091|66286957|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702765|NCT00923091|66286958|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702766|NCT00923091|66286959|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702767|NCT00923091|66286960|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
23702768|NCT00923091|66286948|FG000|Period VI (Open-Label)|Protocol Violation|6|||
23702769|NCT00923091|66286949|FG001|Period VI (Open-Label)|Protocol Violation|1|||
23702770|NCT00923091|66286950|FG002|Period VI (Open-Label)|Protocol Violation|3|||
23702771|NCT00923091|66286951|FG003|Period VI (Open-Label)|Protocol Violation|1|||
23702772|NCT00923091|66286952|FG004|Period VI (Open-Label)|Protocol Violation|4|||
23702773|NCT00923091|66286953|FG005|Period VI (Open-Label)|Protocol Violation|0|||
23702774|NCT00923091|66286954|FG006|Period VI (Open-Label)|Protocol Violation|0|||
23702775|NCT00923091|66286955|FG007|Period VI (Open-Label)|Protocol Violation|0|||
23702776|NCT00923091|66286956|FG008|Period VI (Open-Label)|Protocol Violation|0|||
23702777|NCT00923091|66286957|FG009|Period VI (Open-Label)|Protocol Violation|0|||
23702778|NCT00923091|66286958|FG010|Period VI (Open-Label)|Protocol Violation|0|||
23702779|NCT00923091|66286959|FG011|Period VI (Open-Label)|Protocol Violation|0|||
23702780|NCT00923091|66286960|FG012|Period VI (Open-Label)|Protocol Violation|0|||
23702781|NCT00923091|66286948|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
23702782|NCT00923091|66286949|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
23702783|NCT00923091|66286950|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
23702784|NCT00923091|66286951|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
23702785|NCT00923091|66286952|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
23702786|NCT00923091|66286953|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
23702787|NCT00923091|66286954|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
23702788|NCT00923091|66286955|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
23702789|NCT00923091|66286956|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
23702790|NCT00923091|66286957|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
23702791|NCT00923091|66286958|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
23702792|NCT00923091|66286959|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
23702793|NCT00923091|66286960|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
23702794|NCT00923091|66286948|FG000|Period VI (Open-Label)|Other Reason|0|||
23702795|NCT00923091|66286949|FG001|Period VI (Open-Label)|Other Reason|0|||
23702796|NCT00923091|66286950|FG002|Period VI (Open-Label)|Other Reason|0|||
23702797|NCT00923091|66286951|FG003|Period VI (Open-Label)|Other Reason|1|||
23702798|NCT00923091|66286952|FG004|Period VI (Open-Label)|Other Reason|1|||
23702799|NCT00923091|66286953|FG005|Period VI (Open-Label)|Other Reason|0|||
23702800|NCT00923091|66286954|FG006|Period VI (Open-Label)|Other Reason|0|||
23702801|NCT00923091|66286955|FG007|Period VI (Open-Label)|Other Reason|0|||
23702802|NCT00923091|66286956|FG008|Period VI (Open-Label)|Other Reason|0|||
23702803|NCT00923091|66286957|FG009|Period VI (Open-Label)|Other Reason|0|||
23702804|NCT00923091|66286958|FG010|Period VI (Open-Label)|Other Reason|0|||
23702805|NCT00923091|66286959|FG011|Period VI (Open-Label)|Other Reason|0|||
23702806|NCT00923091|66286960|FG012|Period VI (Open-Label)|Other Reason|0|||
23702807|NCT00392171|66286961|FG000|Overall Study|Did not meet inclusion criteria|4|||
23702808|NCT00392171|66286961|FG000|Overall Study|Disease progression|101|||
23702809|NCT00504166|66286963|FG000|Overall Study|Adverse Event|1|||
23702810|NCT00504166|66286964|FG001|Overall Study|Adverse Event|4|||
23702811|NCT00504166|66286963|FG000|Overall Study|Withdrawal by Subject|3|||
23702812|NCT00504166|66286964|FG001|Overall Study|Withdrawal by Subject|6|||
23702813|NCT00504166|66286963|FG000|Overall Study|Physician Decision|1|||
23702814|NCT00504166|66286964|FG001|Overall Study|Physician Decision|1|||
23702815|NCT00504166|66286963|FG000|Overall Study|Lost to Follow-up|1|||
23702816|NCT00504166|66286964|FG001|Overall Study|Lost to Follow-up|3|||
23702817|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
23702818|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23702819|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23702820|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23702821|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
23702822|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23702823|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23702824|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23702825|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
23702826|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23702827|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23702828|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23702829|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
23502573|NCT01866930|65580242|FG001|Treatment Period|Lack of Efficacy|9|||
23502574|NCT01866930|65580241|FG000|Treatment Period|Adverse Event|4|||
23502575|NCT01866930|65580242|FG001|Treatment Period|Adverse Event|12|||
23502576|NCT01866930|65580241|FG000|Treatment Period|Lost to Follow-up|1|||
23502577|NCT01866930|65580242|FG001|Treatment Period|Lost to Follow-up|1|||
23502578|NCT01866930|65580241|FG000|Follow-up Period|Lost to Follow-up|1|||
23702830|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23702831|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23702832|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23702833|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
23702834|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23702835|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23702836|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23702837|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
23702838|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23702839|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23702840|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23702841|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
23702842|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23702843|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23702844|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23702845|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
23702846|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23702847|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23702848|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23702849|NCT00958568|66286965|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
23702850|NCT00958568|66286966|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23702851|NCT00958568|66286967|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23702852|NCT00958568|66286968|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23702853|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23702854|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
23702855|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23702856|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23702857|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23702858|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
23702859|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23702860|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23702861|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23702862|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
23702863|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23702864|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23702865|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23702866|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
23702867|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23702868|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23702869|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23702870|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
23702871|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23702872|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23702873|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23702874|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
23702875|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23702876|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23702877|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23502579|NCT01866930|65580242|FG001|Follow-up Period|Lost to Follow-up|1|||
23702878|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
23702879|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23702880|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23702881|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23702882|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
23399018|NCT01051661|65207217|FG000|Overall Study|Failure to comply with protocol|0|||
23399019|NCT01051661|65207218|FG001|Overall Study|Failure to comply with protocol|0|||
23399020|NCT01051661|65207219|FG002|Overall Study|Failure to comply with protocol|2|||
23399021|NCT01051661|65207220|FG003|Overall Study|Failure to comply with protocol|0|||
23399022|NCT01051661|65207221|FG004|Overall Study|Failure to comply with protocol|0|||
23399023|NCT01051661|65207222|FG005|Overall Study|Failure to comply with protocol|0|||
23399024|NCT01051661|65207217|FG000|Overall Study|Subject lost legal representation|0|||
23399025|NCT01051661|65207218|FG001|Overall Study|Subject lost legal representation|0|||
23399026|NCT01051661|65207219|FG002|Overall Study|Subject lost legal representation|0|||
23399027|NCT01051661|65207220|FG003|Overall Study|Subject lost legal representation|0|||
23399028|NCT01051661|65207221|FG004|Overall Study|Subject lost legal representation|1|||
23399029|NCT01051661|65207222|FG005|Overall Study|Subject lost legal representation|0|||
23399030|NCT01051661|65207217|FG000|Overall Study|Protocol Violation|0|||
23399031|NCT01051661|65207218|FG001|Overall Study|Protocol Violation|0|||
23399032|NCT01051661|65207219|FG002|Overall Study|Protocol Violation|0|||
23399033|NCT01051661|65207220|FG003|Overall Study|Protocol Violation|1|||
23399034|NCT01051661|65207221|FG004|Overall Study|Protocol Violation|2|||
23399035|NCT01051661|65207222|FG005|Overall Study|Protocol Violation|1|||
23399036|NCT01051661|65207217|FG000|Overall Study|Withdrawal by Subject|16|||
23399037|NCT01051661|65207218|FG001|Overall Study|Withdrawal by Subject|30|||
23399038|NCT01051661|65207219|FG002|Overall Study|Withdrawal by Subject|13|||
23399039|NCT01051661|65207220|FG003|Overall Study|Withdrawal by Subject|28|||
23399040|NCT01051661|65207221|FG004|Overall Study|Withdrawal by Subject|12|||
23399041|NCT01051661|65207222|FG005|Overall Study|Withdrawal by Subject|34|||
23399042|NCT05223673|65207227|FG000|Overall Study|Protocol Violation|1|||
23399043|NCT05223673|65207227|FG000|Overall Study|Study termination|6|||
23399044|NCT04484857|65207228|FG000|Overall Study|Adverse Event|2|||
23399045|NCT04484857|65207228|FG000|Overall Study|Death|10|||
23399046|NCT04484857|65207228|FG000|Overall Study|Withdrawal by Subject|3|||
23399047|NCT04484857|65207228|FG000|Overall Study|Transferred/Relocation|5|||
23399048|NCT04484857|65207228|FG000|Overall Study|Kidney Transplant|7|||
23399049|NCT04484857|65207228|FG000|Overall Study|Other than specified|4|||
23399050|NCT04484857|65207228|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
23399051|NCT01342094|65207233|FG000|Overall Study|Adverse Event|5|||
23399052|NCT01342094|65207234|FG001|Overall Study|Adverse Event|0|||
23399053|NCT01342094|65207233|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23399054|NCT01342094|65207234|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23399055|NCT01342094|65207233|FG000|Overall Study|Withdrawal by Subject|0|||
23399056|NCT01342094|65207234|FG001|Overall Study|Withdrawal by Subject|2|||
23399057|NCT00805389|65207242|FG000|Overall Study|Adverse Event|0|||
23399058|NCT00805389|65207243|FG001|Overall Study|Adverse Event|0|||
23399059|NCT00805389|65207244|FG002|Overall Study|Adverse Event|1|||
23399060|NCT00805389|65207245|FG003|Overall Study|Adverse Event|2|||
23399061|NCT00805389|65207246|FG004|Overall Study|Adverse Event|0|||
23399062|NCT00805389|65207242|FG000|Overall Study|Lost to Follow-up|4|||
23399063|NCT00805389|65207243|FG001|Overall Study|Lost to Follow-up|3|||
23399064|NCT00805389|65207244|FG002|Overall Study|Lost to Follow-up|6|||
23399065|NCT00805389|65207245|FG003|Overall Study|Lost to Follow-up|10|||
23399066|NCT00805389|65207246|FG004|Overall Study|Lost to Follow-up|9|||
23399067|NCT00805389|65207242|FG000|Overall Study|Protocol Violation|0|||
23399068|NCT00805389|65207243|FG001|Overall Study|Protocol Violation|0|||
23399069|NCT00805389|65207244|FG002|Overall Study|Protocol Violation|1|||
23399070|NCT00805389|65207245|FG003|Overall Study|Protocol Violation|0|||
23399071|NCT00805389|65207246|FG004|Overall Study|Protocol Violation|0|||
23399072|NCT00805389|65207242|FG000|Overall Study|Withdrawal by Subject|3|||
23399073|NCT00805389|65207243|FG001|Overall Study|Withdrawal by Subject|2|||
23399074|NCT00805389|65207244|FG002|Overall Study|Withdrawal by Subject|4|||
23399075|NCT00805389|65207245|FG003|Overall Study|Withdrawal by Subject|5|||
23399076|NCT00805389|65207246|FG004|Overall Study|Withdrawal by Subject|4|||
23399077|NCT01968980|65207247|FG000|Overall Study|Death|0|||
23502580|NCT01866930|65580241|FG000|Follow-up Period|Other|1|||
23502581|NCT01866930|65580242|FG001|Follow-up Period|Other|5|||
23399078|NCT01968980|65207248|FG001|Overall Study|Death|1|||
23399079|NCT01968980|65207247|FG000|Overall Study|Adverse Event|1|||
23399080|NCT01968980|65207248|FG001|Overall Study|Adverse Event|3|||
23399081|NCT01968980|65207247|FG000|Overall Study|Does not meet entry criteria|1|||
23399082|NCT01968980|65207248|FG001|Overall Study|Does not meet entry criteria|3|||
23399083|NCT01968980|65207247|FG000|Overall Study|Withdrawal by Subject|13|||
23399084|NCT01968980|65207248|FG001|Overall Study|Withdrawal by Subject|5|||
23399085|NCT01968980|65207247|FG000|Overall Study|Other unspecified|1|||
23399086|NCT01968980|65207248|FG001|Overall Study|Other unspecified|2|||
23399087|NCT02536664|65207253|FG000|Overall Study|Inadequate completion of documentation|2|||
23399088|NCT02536664|65207254|FG001|Overall Study|Inadequate completion of documentation|4|||
23399089|NCT02536664|65207253|FG000|Overall Study|Progression|13|||
23399090|NCT02536664|65207254|FG001|Overall Study|Progression|18|||
23399091|NCT02536664|65207253|FG000|Overall Study|Death due to lymphoma|2|||
23399092|NCT02536664|65207254|FG001|Overall Study|Death due to lymphoma|1|||
23399093|NCT02536664|65207253|FG000|Overall Study|Death due to other reason|3|||
23399094|NCT02536664|65207254|FG001|Overall Study|Death due to other reason|2|||
23399095|NCT02536664|65207253|FG000|Overall Study|Intolerability|8|||
23399096|NCT02536664|65207254|FG001|Overall Study|Intolerability|6|||
23399097|NCT02536664|65207253|FG000|Overall Study|Withdrawal by Subject|8|||
23399098|NCT02536664|65207254|FG001|Overall Study|Withdrawal by Subject|5|||
23399099|NCT02536664|65207253|FG000|Overall Study|Other|18|||
23399100|NCT02536664|65207254|FG001|Overall Study|Other|24|||
23399101|NCT02536664|65207253|FG000|Overall Study|Missing|53|||
23399102|NCT02536664|65207254|FG001|Overall Study|Missing|20|||
23399103|NCT02951780|65207255|FG000|Period 1|Adverse Event|0|||
23399104|NCT02951780|65207256|FG001|Period 1|Adverse Event|0|||
23399105|NCT02951780|65207257|FG002|Period 1|Adverse Event|0|||
23399106|NCT02951780|65207258|FG003|Period 1|Adverse Event|1|||
23399107|NCT02951780|65207259|FG004|Period 1|Adverse Event|0|||
23399108|NCT02951780|65207260|FG005|Period 1|Adverse Event|0|||
23399109|NCT02951780|65207261|FG006|Period 1|Adverse Event|0|||
23399110|NCT02951780|65207262|FG007|Period 1|Adverse Event|0|||
23399111|NCT02951780|65207263|FG008|Period 1|Adverse Event|0|||
23399112|NCT02951780|65207255|FG000|Period 1|Scheduling Conflicts|0|||
23399113|NCT02951780|65207256|FG001|Period 1|Scheduling Conflicts|0|||
23399114|NCT02951780|65207257|FG002|Period 1|Scheduling Conflicts|0|||
23399115|NCT02951780|65207258|FG003|Period 1|Scheduling Conflicts|0|||
23399116|NCT02951780|65207259|FG004|Period 1|Scheduling Conflicts|0|||
23399117|NCT02951780|65207260|FG005|Period 1|Scheduling Conflicts|0|||
23399118|NCT02951780|65207261|FG006|Period 1|Scheduling Conflicts|0|||
23399119|NCT02951780|65207262|FG007|Period 1|Scheduling Conflicts|1|||
23399120|NCT02951780|65207263|FG008|Period 1|Scheduling Conflicts|0|||
23399121|NCT02951780|65207255|FG000|Period 2|Scheduling Conflicts|0|||
23399122|NCT02951780|65207256|FG001|Period 2|Scheduling Conflicts|0|||
23399123|NCT02951780|65207257|FG002|Period 2|Scheduling Conflicts|0|||
23399124|NCT02951780|65207258|FG003|Period 2|Scheduling Conflicts|0|||
23399125|NCT02951780|65207259|FG004|Period 2|Scheduling Conflicts|0|||
23399126|NCT02951780|65207260|FG005|Period 2|Scheduling Conflicts|0|||
23399127|NCT02951780|65207261|FG006|Period 2|Scheduling Conflicts|0|||
23399128|NCT02951780|65207262|FG007|Period 2|Scheduling Conflicts|1|||
23399129|NCT02951780|65207263|FG008|Period 2|Scheduling Conflicts|0|||
23399130|NCT01323192|65207267|FG000|Overall Study|Adverse Event|6|||
23399131|NCT01323192|65207268|FG001|Overall Study|Adverse Event|1|||
23399132|NCT01323192|65207267|FG000|Overall Study|Withdrawal by Subject|3|||
23399133|NCT01323192|65207268|FG001|Overall Study|Withdrawal by Subject|1|||
23399134|NCT01323192|65207267|FG000|Overall Study|Noncompliance with study medication|0|||
23399135|NCT01323192|65207268|FG001|Overall Study|Noncompliance with study medication|3|||
23399136|NCT01323192|65207267|FG000|Overall Study|Nonmedical reasons|0|||
23399137|NCT01323192|65207268|FG001|Overall Study|Nonmedical reasons|1|||
23399138|NCT00746811|65207269|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
23399139|NCT00746811|65207270|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
23399140|NCT02805790|65207271|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
23399141|NCT02805790|65207272|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
23399142|NCT01880957|65207275|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
23399143|NCT01880957|65207276|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
23399144|NCT01880957|65207275|FG000|Overall Study|Lost to Follow-up|11|||
23399145|NCT01880957|65207276|FG001|Overall Study|Lost to Follow-up|0|||
23399146|NCT01880957|65207275|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
23399147|NCT01880957|65207276|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
23399148|NCT00545779|65207277|FG000|Overall Study|Violation of selection criteria at entry|8|||
23399149|NCT00545779|65207277|FG000|Overall Study|Other protocol violation|1|||
23399150|NCT00545779|65207277|FG000|Overall Study|Did not cooperate|7|||
23399151|NCT00545779|65207277|FG000|Overall Study|Withdrawal by Subject|20|||
23399152|NCT00545779|65207277|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
23399153|NCT00545779|65207277|FG000|Overall Study|Failure to return|3|||
23399154|NCT01049373|65207278|FG000|Overall Study|Protocol Violation|9|||
23399155|NCT01049373|65207279|FG001|Overall Study|Protocol Violation|9|||
23399156|NCT01049373|65207278|FG000|Overall Study|Withdrawal by Subject|8|||
23399157|NCT01049373|65207279|FG001|Overall Study|Withdrawal by Subject|5|||
23399158|NCT01049373|65207278|FG000|Overall Study|Adverse Event|3|||
23399159|NCT01049373|65207279|FG001|Overall Study|Adverse Event|3|||
23399160|NCT01049373|65207278|FG000|Overall Study|Lost to Follow-up|9|||
23399161|NCT01049373|65207279|FG001|Overall Study|Lost to Follow-up|4|||
23399162|NCT01049373|65207278|FG000|Overall Study|no evaluable study values|9|||
23399163|NCT01049373|65207279|FG001|Overall Study|no evaluable study values|21|||
23399164|NCT01049373|65207278|FG000|Overall Study|Other|1|||
23399165|NCT01049373|65207279|FG001|Overall Study|Other|1|||
23399166|NCT01049373|65207278|FG000|Overall Study|Non-cooperation|0|||
23399167|NCT01049373|65207279|FG001|Overall Study|Non-cooperation|1|||
23399168|NCT00590967|65207280|FG000|Overall Study|Withdrawal by Subject|1|||
23399169|NCT00590967|65207281|FG001|Overall Study|Withdrawal by Subject|1|||
23399170|NCT00590967|65207280|FG000|Overall Study|Ineligible|1|||
23399171|NCT00590967|65207281|FG001|Overall Study|Ineligible|0|||
23399172|NCT00590967|65207280|FG000|Overall Study|Poor performance status|0|||
23399173|NCT00590967|65207281|FG001|Overall Study|Poor performance status|1|||
23399174|NCT00590967|65207280|FG000|Overall Study|Non-compliant|0|||
23399175|NCT00590967|65207281|FG001|Overall Study|Non-compliant|2|||
23399176|NCT00590967|65207280|FG000|Overall Study|Did not sign consent form|0|||
23399177|NCT00590967|65207281|FG001|Overall Study|Did not sign consent form|1|||
23399178|NCT00590967|65207280|FG000|Overall Study|Did not receive chemo per protocol|1|||
23399179|NCT00590967|65207281|FG001|Overall Study|Did not receive chemo per protocol|0|||
23399180|NCT00730886|65207284|FG000|Overall Study|Lost to Follow-up|1|||
23399181|NCT00730886|65207285|FG001|Overall Study|Lost to Follow-up|0|||
23399182|NCT00730886|65207284|FG000|Overall Study|Physician Decision|1|||
23399183|NCT00730886|65207285|FG001|Overall Study|Physician Decision|0|||
23399184|NCT02538614|65207286|FG000|Overall Study|Progressive Disease|2|||
23399185|NCT00279214|65207287|FG000|Overall Study|Physician Decision|3|||
23399186|NCT00279214|65207288|FG001|Overall Study|Physician Decision|2|||
23399187|NCT00980044|65207292|FG000|Overall Study|Withdrawal by Subject|5|||
23399188|NCT00980044|65207293|FG001|Overall Study|Withdrawal by Subject|7|||
23399189|NCT00980044|65207294|FG002|Overall Study|Withdrawal by Subject|3|||
23399190|NCT00980044|65207292|FG000|Overall Study|Protocol Violation|0|||
23399191|NCT00980044|65207293|FG001|Overall Study|Protocol Violation|0|||
23399192|NCT00980044|65207294|FG002|Overall Study|Protocol Violation|2|||
23399193|NCT03443687|65207295|FG000|Overall Study|Lost to Follow-up|3|||
23399194|NCT03443687|65207296|FG001|Overall Study|Lost to Follow-up|5|||
23399195|NCT03443687|65207295|FG000|Overall Study|Withdrawal by Subject|1|||
23399196|NCT03443687|65207296|FG001|Overall Study|Withdrawal by Subject|0|||
23399197|NCT03443687|65207295|FG000|Overall Study|Discontinued intervention|1|||
23399198|NCT03443687|65207296|FG001|Overall Study|Discontinued intervention|1|||
23399199|NCT01378195|65207298|FG000|Overall Study|Lost to Follow-up|29|||
23399200|NCT01378195|65207299|FG001|Overall Study|Lost to Follow-up|18|||
23399201|NCT00461708|65207300|FG000|Overall Study|Adverse Event|17|||
23399202|NCT00461708|65207301|FG001|Overall Study|Adverse Event|7|||
23399203|NCT00461708|65207300|FG000|Overall Study|Lack of Efficacy|68|||
23399204|NCT00461708|65207301|FG001|Overall Study|Lack of Efficacy|20|||
23399205|NCT00461708|65207300|FG000|Overall Study|Physician Decision|10|||
23399206|NCT00461708|65207301|FG001|Overall Study|Physician Decision|4|||
23399207|NCT00461708|65207300|FG000|Overall Study|Withdrawal by Subject|8|||
23399208|NCT00461708|65207301|FG001|Overall Study|Withdrawal by Subject|2|||
23399209|NCT00461708|65207300|FG000|Overall Study|Other|4|||
23399210|NCT00461708|65207301|FG001|Overall Study|Other|4|||
23399211|NCT00461708|65207300|FG000|Overall Study|Death|8|||
23399212|NCT00461708|65207301|FG001|Overall Study|Death|1|||
23399213|NCT00506142|65207302|FG000|Overall Study|Adverse Event|8|||
23399214|NCT00506142|65207303|FG001|Overall Study|Adverse Event|7|||
23399215|NCT00506142|65207302|FG000|Overall Study|Lack of Efficacy|21|||
23399216|NCT00506142|65207303|FG001|Overall Study|Lack of Efficacy|7|||
23399217|NCT00506142|65207302|FG000|Overall Study|Withdrawal by Subject|4|||
23399218|NCT00506142|65207303|FG001|Overall Study|Withdrawal by Subject|5|||
23399219|NCT00506142|65207302|FG000|Overall Study|Physician Decision|1|||
23399220|NCT00506142|65207303|FG001|Overall Study|Physician Decision|0|||
23399221|NCT00506142|65207302|FG000|Overall Study|New health condition|1|||
23399222|NCT00506142|65207303|FG001|Overall Study|New health condition|0|||
23399223|NCT00261833|65207304|FG000|Overall Study|Death|1|||
23399224|NCT00261833|65207305|FG001|Overall Study|Death|3|||
23399225|NCT00261833|65207304|FG000|Overall Study|Adverse Event|1|||
23399226|NCT00261833|65207305|FG001|Overall Study|Adverse Event|4|||
23399227|NCT00261833|65207304|FG000|Overall Study|Withdrawal by Subject|5|||
23399228|NCT00261833|65207305|FG001|Overall Study|Withdrawal by Subject|7|||
23399229|NCT00261833|65207304|FG000|Overall Study|Protocol Violation|0|||
23399230|NCT00261833|65207305|FG001|Overall Study|Protocol Violation|1|||
23399231|NCT00261833|65207304|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
23399232|NCT00261833|65207305|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
23399233|NCT00261833|65207304|FG000|Overall Study|Lung transplantation|1|||
23399234|NCT00261833|65207305|FG001|Overall Study|Lung transplantation|1|||
23399235|NCT00261833|65207304|FG000|Overall Study|Missing reason|1|||
23399236|NCT00261833|65207305|FG001|Overall Study|Missing reason|0|||
23399237|NCT00261833|65207304|FG000|Overall Study|Not interested in being participant|0|||
23399238|NCT00261833|65207305|FG001|Overall Study|Not interested in being participant|1|||
23502582|NCT01866930|65580241|FG000|Follow-up Period|No longer required per protocol|1|||
23399239|NCT00698841|65207306|FG000|Overall Study|Withdrawal by Subject|2|||
23399240|NCT00698841|65207306|FG000|Overall Study|Adverse Event|3|||
23399241|NCT00698841|65207306|FG000|Overall Study|Disease progression|7|||
23502583|NCT01866930|65580242|FG001|Follow-up Period|No longer required per protocol|0|||
23399242|NCT00698841|65207306|FG000|Overall Study|Failure to meet eligibility criteria|2|||
23399243|NCT00698841|65207306|FG000|Overall Study|Study drug toxicity|2|||
23399244|NCT00698841|65207306|FG000|Overall Study|Other|2|||
23399245|NCT01802788|65207307|FG000|Overall Study|Withdrawal by Subject|102|||
23399246|NCT01802788|65207308|FG001|Overall Study|Withdrawal by Subject|5|||
23399247|NCT01802788|65207307|FG000|Overall Study|Death|382|||
23399248|NCT01802788|65207308|FG001|Overall Study|Death|18|||
23399249|NCT01802788|65207307|FG000|Overall Study|Lost to Follow-up|31|||
23399250|NCT01802788|65207308|FG001|Overall Study|Lost to Follow-up|2|||
23399251|NCT01802788|65207307|FG000|Overall Study|Physician Decision|3|||
23399252|NCT01802788|65207308|FG001|Overall Study|Physician Decision|0|||
23399253|NCT01802788|65207307|FG000|Overall Study|Patient Non-Compliance|1|||
23399254|NCT01802788|65207308|FG001|Overall Study|Patient Non-Compliance|0|||
23399255|NCT01802788|65207307|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
23399256|NCT01802788|65207308|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
23399257|NCT01802788|65207307|FG000|Overall Study|Other Reasons|19|||
23399258|NCT01802788|65207308|FG001|Overall Study|Other Reasons|0|||
23399259|NCT00077974|65207311|FG000|Overall Study|Adverse Event|22|||
23399260|NCT00077974|65207311|FG000|Overall Study|Protocol Violation|1|||
23399261|NCT00077974|65207311|FG000|Overall Study|Withdrawal by Subject|3|||
23399262|NCT00077974|65207311|FG000|Overall Study|Lack of Efficacy|76|||
23399263|NCT00077974|65207311|FG000|Overall Study|Decision of Sponsor|2|||
23399264|NCT00831389|65207312|FG000|Overall Study|Withdrawal by Subject|0|||
23399265|NCT00831389|65207313|FG001|Overall Study|Withdrawal by Subject|1|||
23399266|NCT00454116|65207314|FG000|Overall Study|Adverse Event|5|||
23399267|NCT00454116|65207315|FG001|Overall Study|Adverse Event|11|||
23399268|NCT00454116|65207316|FG002|Overall Study|Adverse Event|9|||
23399269|NCT00454116|65207314|FG000|Overall Study|Condition under investigation worsened|17|||
23399270|NCT00454116|65207315|FG001|Overall Study|Condition under investigation worsened|13|||
23399271|NCT00454116|65207316|FG002|Overall Study|Condition under investigation worsened|18|||
23399272|NCT00454116|65207314|FG000|Overall Study|Withdrawal by Subject|3|||
23399273|NCT00454116|65207315|FG001|Overall Study|Withdrawal by Subject|3|||
23399274|NCT00454116|65207316|FG002|Overall Study|Withdrawal by Subject|1|||
23399275|NCT00454116|65207314|FG000|Overall Study|Other|2|||
23399276|NCT00454116|65207315|FG001|Overall Study|Other|2|||
23399277|NCT00454116|65207316|FG002|Overall Study|Other|0|||
23399278|NCT03728933|65207317|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23399279|NCT03728933|65207318|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23399280|NCT03728933|65207319|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23399281|NCT03728933|65207317|FG000|Overall Study|Withdrawal by Subject|0|||
23399282|NCT03728933|65207318|FG001|Overall Study|Withdrawal by Subject|0|||
23399283|NCT03728933|65207319|FG002|Overall Study|Withdrawal by Subject|1|||
23399284|NCT03728933|65207317|FG000|Overall Study|Lost to Follow-up|0|||
23399285|NCT03728933|65207318|FG001|Overall Study|Lost to Follow-up|1|||
23399286|NCT03728933|65207319|FG002|Overall Study|Lost to Follow-up|0|||
23399287|NCT03728933|65207317|FG000|Overall Study|Adverse Event|1|||
23399288|NCT03728933|65207318|FG001|Overall Study|Adverse Event|0|||
23399289|NCT03728933|65207319|FG002|Overall Study|Adverse Event|0|||
23399290|NCT01983111|65207320|FG000|Overall Study|Withdrawal by Subject|8|||
23399291|NCT01983111|65207321|FG001|Overall Study|Withdrawal by Subject|6|||
23399292|NCT01983111|65207320|FG000|Overall Study|Adverse Event|4|||
23399293|NCT01983111|65207321|FG001|Overall Study|Adverse Event|0|||
23399294|NCT01983111|65207320|FG000|Overall Study|Protocol Violation|0|||
23399295|NCT01983111|65207321|FG001|Overall Study|Protocol Violation|1|||
23399296|NCT01990742|65207322|FG000|Overall Study|Withdrawal by facility|407|||
23399297|NCT01990742|65207323|FG001|Overall Study|Withdrawal by facility|1083|||
23399298|NCT01990742|65207322|FG000|Overall Study|Facility closed|0|||
23399299|NCT01990742|65207323|FG001|Overall Study|Facility closed|270|||
23399300|NCT00501644|65207326|FG000|Overall Study|Adverse Event|4|||
23399301|NCT00501644|65207326|FG000|Overall Study|Withdrawal by Subject|1|||
23399302|NCT03510273|65207331|FG000|Overall Study|Withdrawal by Subject|2|||
23399303|NCT03510273|65207331|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
23399304|NCT03510273|65207331|FG000|Overall Study|Moved away from study area|4|||
23399305|NCT00271544|65207336|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
23399306|NCT00271544|65207336|FG000|Overall Study|Model 4196 lead not attempted|9|||
23399307|NCT00271544|65207336|FG000|Overall Study|Implant not attempted|4|||
23399308|NCT02712788|65207337|FG000|Overall Study|Physician Decision|1|||
23702883|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23399309|NCT02712788|65207338|FG001|Overall Study|Physician Decision|0|||
23399310|NCT02712788|65207337|FG000|Overall Study|Protocol Violation|1|||
23399311|NCT02712788|65207338|FG001|Overall Study|Protocol Violation|0|||
23399312|NCT03323164|65207339|FG000|Overall Study|Poor quality imaging/scans|2|||
23399313|NCT03323164|65207340|FG001|Overall Study|Poor quality imaging/scans|2|||
23399314|NCT01493089|65207341|FG000|Overall Study|Protocol Violation|2|||
23399315|NCT01493089|65207342|FG001|Overall Study|Protocol Violation|2|||
23399316|NCT01493089|65207341|FG000|Overall Study|Withdrawal by Subject|1|||
23399317|NCT01493089|65207342|FG001|Overall Study|Withdrawal by Subject|0|||
23399318|NCT01493089|65207341|FG000|Overall Study|Physician Decision|0|||
23399319|NCT01493089|65207342|FG001|Overall Study|Physician Decision|1|||
23399320|NCT01905540|65207347|FG000|Period 3|Other|1|||
23399321|NCT01905540|65207348|FG001|Period 3|Other|0|||
23399322|NCT01905540|65207349|FG002|Period 3|Other|1|||
23399323|NCT01905540|65207350|FG003|Period 3|Other|1|||
23399324|NCT00657267|65207351|FG000|Overall Study|Progressive disease|45|||
23399325|NCT00657267|65207351|FG000|Overall Study|Adverse Event|9|||
23399326|NCT01876381|65207352|FG000|Overall Study|Lack of Efficacy|5|||
23399327|NCT01876381|65207352|FG000|Overall Study|Physician Decision|1|||
23399328|NCT01876381|65207352|FG000|Overall Study|Withdrawal by Subject|1|||
23399329|NCT01740687|65207355|FG000|Overall Study|Lost to Follow-up|11|||
23399330|NCT01740687|65207355|FG000|Overall Study|Withdrawal by Subject|2|||
23399331|NCT01740687|65207355|FG000|Overall Study|other reason|22|||
23399332|NCT01740687|65207355|FG000|Overall Study|treatment not received|2|||
23399333|NCT03781414|65207360|FG000|Overall Study|Study terminated by sponsor|39|||
23399334|NCT03781414|65207361|FG001|Overall Study|Study terminated by sponsor|34|||
23399335|NCT03781414|65207362|FG002|Overall Study|Study terminated by sponsor|25|||
23399336|NCT03781414|65207360|FG000|Overall Study|Adverse Event|3|||
23399337|NCT03781414|65207361|FG001|Overall Study|Adverse Event|6|||
23399338|NCT03781414|65207362|FG002|Overall Study|Adverse Event|3|||
23399339|NCT03781414|65207360|FG000|Overall Study|Physician Decision|2|||
23399340|NCT03781414|65207361|FG001|Overall Study|Physician Decision|0|||
23399341|NCT03781414|65207362|FG002|Overall Study|Physician Decision|1|||
23399342|NCT03781414|65207360|FG000|Overall Study|Withdrawal by Subject|2|||
23399343|NCT03781414|65207361|FG001|Overall Study|Withdrawal by Subject|3|||
23399344|NCT03781414|65207362|FG002|Overall Study|Withdrawal by Subject|3|||
23399345|NCT03781414|65207360|FG000|Overall Study|Death|1|||
23399346|NCT03781414|65207361|FG001|Overall Study|Death|4|||
23399347|NCT03781414|65207362|FG002|Overall Study|Death|0|||
23399348|NCT03781414|65207360|FG000|Overall Study|Lost to Follow-up|1|||
23399349|NCT03781414|65207361|FG001|Overall Study|Lost to Follow-up|1|||
23399350|NCT03781414|65207362|FG002|Overall Study|Lost to Follow-up|0|||
23399351|NCT01567722|65207365|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
23399352|NCT01567722|65207366|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
23399353|NCT01567722|65207367|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
23399354|NCT01567722|65207365|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
23399355|NCT01567722|65207366|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
23399356|NCT01567722|65207367|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
23399357|NCT01567722|65207365|FG000|Overall Study|Protocol closure by the OCG|2|||
23399358|NCT01567722|65207366|FG001|Overall Study|Protocol closure by the OCG|0|||
23399359|NCT01567722|65207367|FG002|Overall Study|Protocol closure by the OCG|0|||
23399360|NCT01567722|65207365|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
23399361|NCT01567722|65207366|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
23399362|NCT01567722|65207367|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
23399363|NCT00710593|65207368|FG000|Overall Study|Incarceration|1|||
23399364|NCT00710593|65207369|FG001|Overall Study|Incarceration|0|||
23399365|NCT00710593|65207368|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
23399366|NCT00710593|65207369|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
23399367|NCT00710593|65207368|FG000|Overall Study|Lost to Follow-up|3|||
23399368|NCT00710593|65207369|FG001|Overall Study|Lost to Follow-up|1|||
23399369|NCT00710593|65207368|FG000|Overall Study|Moved out of area|1|||
23399370|NCT00710593|65207369|FG001|Overall Study|Moved out of area|0|||
23399371|NCT00710593|65207368|FG000|Overall Study|Failure to adhere or complete study eval|1|||
23399372|NCT00710593|65207369|FG001|Overall Study|Failure to adhere or complete study eval|1|||
23399373|NCT00710593|65207368|FG000|Overall Study|Protocol Violation|1|||
23399374|NCT00710593|65207369|FG001|Overall Study|Protocol Violation|1|||
23399375|NCT00710593|65207368|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
23399376|NCT00710593|65207369|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
23399377|NCT00659425|65207372|FG000|Overall Study|Disease progression|1|||
23399378|NCT00659425|65207373|FG001|Overall Study|Disease progression|0|||
23399379|NCT00659425|65207374|FG002|Overall Study|Disease progression|0|||
23399380|NCT00659425|65207375|FG003|Overall Study|Disease progression|1|||
23399381|NCT00659425|65207376|FG004|Overall Study|Disease progression|0|||
23399382|NCT00659425|65207377|FG005|Overall Study|Disease progression|2|||
23399383|NCT00659425|65207378|FG006|Overall Study|Disease progression|4|||
23399384|NCT00659425|65207379|FG007|Overall Study|Disease progression|3|||
23399385|NCT00659425|65207380|FG008|Overall Study|Disease progression|5|||
23399386|NCT00659425|65207381|FG009|Overall Study|Disease progression|3|||
23399387|NCT00659425|65207372|FG000|Overall Study|Death|0|||
23399388|NCT00659425|65207373|FG001|Overall Study|Death|0|||
23399389|NCT00659425|65207374|FG002|Overall Study|Death|0|||
23399390|NCT00659425|65207375|FG003|Overall Study|Death|1|||
23399391|NCT00659425|65207376|FG004|Overall Study|Death|0|||
23399392|NCT00659425|65207377|FG005|Overall Study|Death|0|||
23399393|NCT00659425|65207378|FG006|Overall Study|Death|1|||
23399394|NCT00659425|65207379|FG007|Overall Study|Death|0|||
23399395|NCT00659425|65207380|FG008|Overall Study|Death|0|||
23399396|NCT00659425|65207381|FG009|Overall Study|Death|0|||
23399397|NCT00659425|65207372|FG000|Overall Study|Adverse Event|0|||
23399398|NCT00659425|65207373|FG001|Overall Study|Adverse Event|0|||
23399399|NCT00659425|65207374|FG002|Overall Study|Adverse Event|0|||
23399400|NCT00659425|65207375|FG003|Overall Study|Adverse Event|0|||
23399401|NCT00659425|65207376|FG004|Overall Study|Adverse Event|0|||
23399402|NCT00659425|65207377|FG005|Overall Study|Adverse Event|1|||
23399403|NCT00659425|65207378|FG006|Overall Study|Adverse Event|0|||
23399404|NCT00659425|65207379|FG007|Overall Study|Adverse Event|3|||
23399405|NCT00659425|65207380|FG008|Overall Study|Adverse Event|1|||
23399406|NCT00659425|65207381|FG009|Overall Study|Adverse Event|4|||
23399407|NCT00659425|65207372|FG000|Overall Study|Investigator Discretion|0|||
23399408|NCT00659425|65207373|FG001|Overall Study|Investigator Discretion|0|||
23399409|NCT00659425|65207374|FG002|Overall Study|Investigator Discretion|0|||
23399410|NCT00659425|65207375|FG003|Overall Study|Investigator Discretion|0|||
23399411|NCT00659425|65207376|FG004|Overall Study|Investigator Discretion|0|||
23399412|NCT00659425|65207377|FG005|Overall Study|Investigator Discretion|1|||
23399413|NCT00659425|65207378|FG006|Overall Study|Investigator Discretion|0|||
23399414|NCT00659425|65207379|FG007|Overall Study|Investigator Discretion|3|||
23399415|NCT00659425|65207380|FG008|Overall Study|Investigator Discretion|0|||
23399416|NCT00659425|65207381|FG009|Overall Study|Investigator Discretion|0|||
23399417|NCT00659425|65207372|FG000|Overall Study|Other|0|||
23399418|NCT00659425|65207373|FG001|Overall Study|Other|1|||
23399419|NCT00659425|65207374|FG002|Overall Study|Other|1|||
23399420|NCT00659425|65207375|FG003|Overall Study|Other|2|||
23399421|NCT00659425|65207376|FG004|Overall Study|Other|4|||
23399422|NCT00659425|65207377|FG005|Overall Study|Other|0|||
23399423|NCT00659425|65207378|FG006|Overall Study|Other|3|||
23399424|NCT00659425|65207379|FG007|Overall Study|Other|2|||
23399425|NCT00659425|65207380|FG008|Overall Study|Other|0|||
23399426|NCT00659425|65207381|FG009|Overall Study|Other|6|||
23399427|NCT00854360|65207382|FG000|Overall Study|Adverse Event|0|||
23399428|NCT00854360|65207383|FG001|Overall Study|Adverse Event|1|||
23399429|NCT00854360|65207384|FG002|Overall Study|Adverse Event|2|||
23399430|NCT00854360|65207385|FG003|Overall Study|Adverse Event|6|||
23399431|NCT00854360|65207382|FG000|Overall Study|Withdrawal by Subject|0|||
23399432|NCT00854360|65207383|FG001|Overall Study|Withdrawal by Subject|0|||
23399433|NCT00854360|65207384|FG002|Overall Study|Withdrawal by Subject|0|||
23399434|NCT00854360|65207385|FG003|Overall Study|Withdrawal by Subject|1|||
23399435|NCT00854360|65207382|FG000|Overall Study|Pregnancy|0|||
23399436|NCT00854360|65207383|FG001|Overall Study|Pregnancy|1|||
23399437|NCT00854360|65207384|FG002|Overall Study|Pregnancy|0|||
23399438|NCT00854360|65207385|FG003|Overall Study|Pregnancy|0|||
23399439|NCT00854360|65207382|FG000|Overall Study|Lack of Efficacy|2|||
23399440|NCT00854360|65207383|FG001|Overall Study|Lack of Efficacy|1|||
23399441|NCT00854360|65207384|FG002|Overall Study|Lack of Efficacy|0|||
23399442|NCT00854360|65207385|FG003|Overall Study|Lack of Efficacy|0|||
23399443|NCT00854360|65207382|FG000|Overall Study|Other|0|||
23399444|NCT00854360|65207383|FG001|Overall Study|Other|0|||
23399445|NCT00854360|65207384|FG002|Overall Study|Other|0|||
23399446|NCT00854360|65207385|FG003|Overall Study|Other|3|||
23399447|NCT04194450|65207387|FG000|Overall Study|not eligible|1|||
23399448|NCT04194450|65207388|FG001|Overall Study|not eligible|0|||
23399449|NCT01656161|65207392|FG000|Overall Study|Death|3|||
23399450|NCT01656161|65207392|FG000|Overall Study|Adverse Event|2|||
23399451|NCT01656161|65207392|FG000|Overall Study|Protocol Violation|1|||
23399452|NCT01656161|65207392|FG000|Overall Study|Withdrawal by Subject|1|||
23399453|NCT01823289|65210577|FG000|Overall Study|Lost to Follow-up|5|||
23399454|NCT01823289|65210577|FG000|Overall Study|Adverse Event|5|||
23399455|NCT01823289|65210577|FG000|Overall Study|Lack of Efficacy|1|||
23399456|NCT01823289|65210577|FG000|Overall Study|Physician Decision|9|||
23399457|NCT01823289|65210577|FG000|Overall Study|Administered contraindicated medicine|1|||
23399458|NCT01823289|65210577|FG000|Overall Study|Transaminase increased more than 3 times|1|||
23399459|NCT01823289|65210577|FG000|Overall Study|Drug affected efficacy and safety|1|||
23399460|NCT01823289|65210577|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
23399461|NCT02434081|65210578|FG000|Overall Study|Death (never started treatment)|2|||
23399462|NCT02434081|65210578|FG000|Overall Study|Death|2|||
23399463|NCT02434081|65210578|FG000|Overall Study|Progression|20|||
23399464|NCT02434081|65210578|FG000|Overall Study|Adverse Event|20|||
23399465|NCT02434081|65210578|FG000|Overall Study|Physician Decision|2|||
23399466|NCT02434081|65210578|FG000|Overall Study|Withdrawal by Subject|1|||
23399467|NCT02434081|65210578|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
23399468|NCT01854528|65210579|FG000|Overall Study|Adverse Event|0|||
23399469|NCT01854528|65210580|FG001|Overall Study|Adverse Event|4|||
23399470|NCT01854528|65210579|FG000|Overall Study|Withdrawal by Subject|0|||
23399471|NCT01854528|65210580|FG001|Overall Study|Withdrawal by Subject|2|||
23399472|NCT01854528|65210579|FG000|Overall Study|Virologic Failure|0|||
23399473|NCT01854528|65210580|FG001|Overall Study|Virologic Failure|9|||
23399474|NCT01492088|65210585|FG000|Overall Study|Withdrawal by Patient|0|||
23399475|NCT01492088|65210586|FG001|Overall Study|Withdrawal by Patient|2|||
23399476|NCT01492088|65210587|FG002|Overall Study|Withdrawal by Patient|0|||
23399477|NCT01492088|65210585|FG000|Overall Study|Death|1|||
23399478|NCT01492088|65210586|FG001|Overall Study|Death|6|||
23399479|NCT01492088|65210587|FG002|Overall Study|Death|2|||
23399480|NCT01492088|65210585|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
23399481|NCT01492088|65210586|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
23399482|NCT01492088|65210587|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
23399483|NCT01492088|65210585|FG000|Overall Study|Alive at Last Follow-up|0|||
23399484|NCT01492088|65210586|FG001|Overall Study|Alive at Last Follow-up|6|||
23399485|NCT01492088|65210587|FG002|Overall Study|Alive at Last Follow-up|11|||
23399486|NCT03186638|65210588|FG000|Overall Study|Withdrawal by Subject|4|||
23399487|NCT03186638|65210589|FG001|Overall Study|Withdrawal by Subject|4|||
23399488|NCT03186638|65210588|FG000|Overall Study|Withdrawn due to medical problem|3|||
23399489|NCT03186638|65210589|FG001|Overall Study|Withdrawn due to medical problem|2|||
23399490|NCT03186638|65210588|FG000|Overall Study|Lost to Follow-up|1|||
23399491|NCT03186638|65210589|FG001|Overall Study|Lost to Follow-up|0|||
23399492|NCT03904147|65210592|FG000|Overall Study|Death|15|||
23399493|NCT03904147|65210593|FG001|Overall Study|Death|13|||
23399494|NCT03904147|65210594|FG002|Overall Study|Death|15|||
23399495|NCT03904147|65210592|FG000|Overall Study|Withdrawal by Subject|7|||
23399496|NCT03904147|65210593|FG001|Overall Study|Withdrawal by Subject|12|||
23399497|NCT03904147|65210594|FG002|Overall Study|Withdrawal by Subject|1|||
23399498|NCT03904147|65210592|FG000|Overall Study|1Y visit completed after 365 days|1|||
23399499|NCT03904147|65210593|FG001|Overall Study|1Y visit completed after 365 days|1|||
23399500|NCT03904147|65210594|FG002|Overall Study|1Y visit completed after 365 days|0|||
23399501|NCT03984825|65210597|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
23399502|NCT03984825|65210597|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
23399503|NCT03984825|65210597|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
23399504|NCT00967616|65210598|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
23399505|NCT00967616|65210599|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
23399506|NCT00967616|65210598|FG000|Overall Study|Death|0|||
23399507|NCT00967616|65210599|FG001|Overall Study|Death|3|||
23399508|NCT00967616|65210598|FG000|Overall Study|Withdrawal by Subject|8|||
23399509|NCT00967616|65210599|FG001|Overall Study|Withdrawal by Subject|4|||
23399510|NCT00967616|65210598|FG000|Overall Study|Progressive Disease|31|||
23399511|NCT00967616|65210599|FG001|Overall Study|Progressive Disease|18|||
23399512|NCT00967616|65210598|FG000|Overall Study|Other|8|||
23399513|NCT00967616|65210599|FG001|Overall Study|Other|8|||
23399514|NCT00967616|65210598|FG000|Overall Study|Protocol Violation|1|||
23399515|NCT00967616|65210599|FG001|Overall Study|Protocol Violation|0|||
23399516|NCT01225952|65210600|FG000|Overall Study|Lost to Follow-up|1|||
23399517|NCT01225952|65210601|FG001|Overall Study|Lost to Follow-up|0|||
23399518|NCT01225952|65210602|FG002|Overall Study|Lost to Follow-up|0|||
23399519|NCT01225952|65210600|FG000|Overall Study|Study Eye Explanted|0|||
23399520|NCT01225952|65210601|FG001|Overall Study|Study Eye Explanted|0|||
23399521|NCT01225952|65210602|FG002|Overall Study|Study Eye Explanted|1|||
23399522|NCT01225952|65210600|FG000|Overall Study|Withdrawal by Subject|4|||
23399523|NCT01225952|65210601|FG001|Overall Study|Withdrawal by Subject|4|||
23399524|NCT01225952|65210602|FG002|Overall Study|Withdrawal by Subject|5|||
23399525|NCT01225952|65210600|FG000|Overall Study|Surgical complications|1|||
23399526|NCT01225952|65210601|FG001|Overall Study|Surgical complications|0|||
23399527|NCT01225952|65210602|FG002|Overall Study|Surgical complications|0|||
23399528|NCT01541371|65210603|FG000|Overall Study|Withdrawal by Subject|14|||
23399529|NCT01541371|65210603|FG000|Overall Study|Lost to Follow-up|21|||
23399530|NCT01541371|65210603|FG000|Overall Study|Adverse Event|15|||
23399531|NCT01541371|65210603|FG000|Overall Study|Lack of Efficacy|12|||
23399532|NCT01541371|65210603|FG000|Overall Study|Protocol Violation|6|||
23399533|NCT01541371|65210603|FG000|Overall Study|Study medication non-compliance|3|||
23399534|NCT01541371|65210603|FG000|Overall Study|Other|6|||
23399535|NCT01657305|65210604|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
23399536|NCT01657305|65210604|FG000|Overall Study|Withdrawal by Subject|4|||
23399537|NCT01657305|65210604|FG000|Overall Study|Adverse Event|1|||
23399538|NCT01657305|65210604|FG000|Overall Study|Lost to Follow-up|1|||
23399539|NCT01657305|65210604|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
23399540|NCT04046939|65210605|FG000|Primary Assessment Period|Adverse Event|1|||
23399541|NCT04046939|65210606|FG001|Primary Assessment Period|Adverse Event|0|||
23399542|NCT04046939|65210607|FG002|Primary Assessment Period|Adverse Event|0|||
23399543|NCT04046939|65210608|FG003|Primary Assessment Period|Adverse Event|0|||
23399544|NCT04046939|65210605|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
23399545|NCT04046939|65210606|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
23399546|NCT04046939|65210607|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
23399547|NCT04046939|65210608|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
23399548|NCT04046939|65210605|FG000|Primary Assessment Period|Physician Decision|0|||
23399549|NCT04046939|65210606|FG001|Primary Assessment Period|Physician Decision|0|||
23399550|NCT04046939|65210607|FG002|Primary Assessment Period|Physician Decision|1|||
23399551|NCT04046939|65210608|FG003|Primary Assessment Period|Physician Decision|0|||
23399552|NCT04046939|65210605|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
23399553|NCT04046939|65210606|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
23399554|NCT04046939|65210607|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
23399555|NCT04046939|65210608|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
23399556|NCT00565409|65210609|FG000|Period 1 Open Label|Adverse Event|17|||
23399557|NCT00565409|65210610|FG001|Period 1 Open Label|Adverse Event|0|||
23399558|NCT00565409|65210611|FG002|Period 1 Open Label|Adverse Event|0|||
23399559|NCT00565409|65210612|FG003|Period 1 Open Label|Adverse Event|0|||
23399560|NCT00565409|65210609|FG000|Period 1 Open Label|Death|2|||
23399561|NCT00565409|65210610|FG001|Period 1 Open Label|Death|0|||
23399562|NCT00565409|65210611|FG002|Period 1 Open Label|Death|0|||
23399563|NCT00565409|65210612|FG003|Period 1 Open Label|Death|0|||
23399564|NCT00565409|65210609|FG000|Period 1 Open Label|Lost to Follow-up|1|||
23399565|NCT00565409|65210610|FG001|Period 1 Open Label|Lost to Follow-up|0|||
23399566|NCT00565409|65210611|FG002|Period 1 Open Label|Lost to Follow-up|0|||
23399567|NCT00565409|65210612|FG003|Period 1 Open Label|Lost to Follow-up|0|||
23399568|NCT00565409|65210609|FG000|Period 1 Open Label|Other|21|||
23399569|NCT00565409|65210610|FG001|Period 1 Open Label|Other|0|||
23399570|NCT00565409|65210611|FG002|Period 1 Open Label|Other|0|||
23399571|NCT00565409|65210612|FG003|Period 1 Open Label|Other|0|||
23399572|NCT00565409|65210609|FG000|Period 1 Open Label|Protocol Violation|14|||
23399573|NCT00565409|65210610|FG001|Period 1 Open Label|Protocol Violation|0|||
23399574|NCT00565409|65210611|FG002|Period 1 Open Label|Protocol Violation|0|||
23399575|NCT00565409|65210612|FG003|Period 1 Open Label|Protocol Violation|0|||
23399576|NCT00565409|65210609|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
23399577|NCT00565409|65210610|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399578|NCT00565409|65210611|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399579|NCT00565409|65210612|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399580|NCT00565409|65210609|FG000|Period 1 Open Label|no conclusion of participation record|1|||
23399581|NCT00565409|65210610|FG001|Period 1 Open Label|no conclusion of participation record|0|||
23399582|NCT00565409|65210611|FG002|Period 1 Open Label|no conclusion of participation record|0|||
23399583|NCT00565409|65210612|FG003|Period 1 Open Label|no conclusion of participation record|0|||
23399584|NCT00565409|65210609|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
23399585|NCT00565409|65210610|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399586|NCT00565409|65210611|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399587|NCT00565409|65210612|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399588|NCT00565409|65210609|FG000|Period 2 Double-Blind|Adverse Event|0|||
23399589|NCT00565409|65210610|FG001|Period 2 Double-Blind|Adverse Event|7|||
23399590|NCT00565409|65210611|FG002|Period 2 Double-Blind|Adverse Event|4|||
23399591|NCT00565409|65210612|FG003|Period 2 Double-Blind|Adverse Event|5|||
23399592|NCT00565409|65210609|FG000|Period 2 Double-Blind|Death|0|||
23399593|NCT00565409|65210610|FG001|Period 2 Double-Blind|Death|2|||
23399594|NCT00565409|65210611|FG002|Period 2 Double-Blind|Death|0|||
23399595|NCT00565409|65210612|FG003|Period 2 Double-Blind|Death|0|||
23399596|NCT00565409|65210609|FG000|Period 2 Double-Blind|Protocol Violation|0|||
23399597|NCT00565409|65210610|FG001|Period 2 Double-Blind|Protocol Violation|4|||
23399598|NCT00565409|65210611|FG002|Period 2 Double-Blind|Protocol Violation|6|||
23399599|NCT00565409|65210612|FG003|Period 2 Double-Blind|Protocol Violation|2|||
23399600|NCT00565409|65210609|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
23399601|NCT00565409|65210610|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
23399602|NCT00565409|65210611|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
23399603|NCT00565409|65210612|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
23399604|NCT00565409|65210609|FG000|Period 2 Double-Blind|Other|0|||
23399605|NCT00565409|65210610|FG001|Period 2 Double-Blind|Other|4|||
23399606|NCT00565409|65210611|FG002|Period 2 Double-Blind|Other|5|||
23399607|NCT00565409|65210612|FG003|Period 2 Double-Blind|Other|9|||
23399608|NCT00565409|65210609|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
23399609|NCT00565409|65210610|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
23399610|NCT00565409|65210611|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
23399611|NCT00565409|65210612|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
23399612|NCT01627691|65210613|FG000|Overall Study|Death|11|||
23399613|NCT01627691|65210613|FG000|Overall Study|Lost to Follow-up|3|||
23399614|NCT01627691|65210613|FG000|Overall Study|Withdrawal by Subject|1|||
23399615|NCT01627691|65210613|FG000|Overall Study|Missed the visit|3|||
23399616|NCT02569853|65210614|FG000|Overall Study|Adverse Event|2|||
23399617|NCT02569853|65210615|FG001|Overall Study|Adverse Event|0|||
23399618|NCT02569853|65210614|FG000|Overall Study|Withdrawal by Subject|3|||
23399619|NCT02569853|65210615|FG001|Overall Study|Withdrawal by Subject|2|||
23399620|NCT02569853|65210614|FG000|Overall Study|Lost to Follow-up|3|||
23399621|NCT02569853|65210615|FG001|Overall Study|Lost to Follow-up|3|||
23399622|NCT02569853|65210614|FG000|Overall Study|Protocol Violation|1|||
23702884|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23399623|NCT02569853|65210615|FG001|Overall Study|Protocol Violation|1|||
23399624|NCT02569853|65210614|FG000|Overall Study|Did not experience migraine attack|10|||
23399625|NCT02569853|65210615|FG001|Overall Study|Did not experience migraine attack|7|||
23399626|NCT02569853|65210614|FG000|Overall Study|Physician Decision|1|||
23399627|NCT02569853|65210615|FG001|Overall Study|Physician Decision|1|||
23399628|NCT03322566|65210617|FG000|Overall Study|Death|34|||
23399629|NCT03322566|65210618|FG001|Overall Study|Death|35|||
23399630|NCT03322566|65210619|FG002|Overall Study|Death|23|||
23399631|NCT03322566|65210617|FG000|Overall Study|Physician Decision|6|||
23399632|NCT03322566|65210618|FG001|Overall Study|Physician Decision|7|||
23399633|NCT03322566|65210619|FG002|Overall Study|Physician Decision|2|||
23399634|NCT03322566|65210617|FG000|Overall Study|Withdrawal by Subject|4|||
23399635|NCT03322566|65210618|FG001|Overall Study|Withdrawal by Subject|3|||
23399636|NCT03322566|65210619|FG002|Overall Study|Withdrawal by Subject|6|||
23399637|NCT03322566|65210617|FG000|Overall Study|Lost to Follow-up|0|||
23399638|NCT03322566|65210618|FG001|Overall Study|Lost to Follow-up|0|||
23399639|NCT03322566|65210619|FG002|Overall Study|Lost to Follow-up|1|||
23399640|NCT03322566|65210617|FG000|Overall Study|Study terminated by sponsor|1|||
23399641|NCT03322566|65210618|FG001|Overall Study|Study terminated by sponsor|0|||
23399642|NCT03322566|65210619|FG002|Overall Study|Study terminated by sponsor|1|||
23399643|NCT01397253|65210621|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
23399644|NCT01397253|65210622|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
23399645|NCT01307449|65210623|FG000|Overall Study|Adverse Event|1|||
23399646|NCT01307449|65210624|FG001|Overall Study|Adverse Event|0|||
23399647|NCT01307449|65210625|FG002|Overall Study|Adverse Event|0|||
23399648|NCT01307449|65210626|FG003|Overall Study|Adverse Event|0|||
23399649|NCT01887717|65210627|FG000|Overall Study|Withdrawal by Subject|1|||
23399650|NCT01887717|65210628|FG001|Overall Study|Withdrawal by Subject|7|||
23399651|NCT01887717|65210627|FG000|Overall Study|Physician Decision|0|||
23399652|NCT01887717|65210628|FG001|Overall Study|Physician Decision|2|||
23399653|NCT01887717|65210627|FG000|Overall Study|Administrative reasons|5|||
23399654|NCT01887717|65210628|FG001|Overall Study|Administrative reasons|2|||
23399655|NCT03502681|65210629|FG000|Overall Study|Adverse Event|1|||
23399656|NCT03502681|65210630|FG001|Overall Study|Adverse Event|1|||
23399657|NCT03502681|65210629|FG000|Overall Study|Disease Progression|2|||
23399658|NCT03502681|65210630|FG001|Overall Study|Disease Progression|1|||
23399659|NCT03983421|65210631|FG000|Overall Study|Lost to Follow-up|1|||
23399660|NCT00276419|65210633|FG000|First Intervention|Adverse Event|1|||
23399661|NCT00276419|65210634|FG001|First Intervention|Adverse Event|0|||
23399662|NCT00276419|65210633|FG000|First Intervention|Withdrawal by Subject|0|||
23399663|NCT00276419|65210634|FG001|First Intervention|Withdrawal by Subject|2|||
23399664|NCT00590317|65210639|FG000|Overall Study|Lack of Efficacy|1|||
23399665|NCT00590317|65210640|FG001|Overall Study|Lack of Efficacy|5|||
23399666|NCT00943761|65210641|FG000|Overall Study|Lost to Follow-up|2|||
23399667|NCT00943761|65210642|FG001|Overall Study|Lost to Follow-up|0|||
23399668|NCT00943761|65210641|FG000|Overall Study|Withdrawal by Subject|2|||
23399669|NCT00943761|65210642|FG001|Overall Study|Withdrawal by Subject|1|||
23399670|NCT00503984|65210643|FG000|Overall Study|Protocol Violation|0|||
23399671|NCT00503984|65210644|FG001|Overall Study|Protocol Violation|1|||
23399672|NCT00503984|65210645|FG002|Overall Study|Protocol Violation|0|||
23399673|NCT00503984|65210646|FG003|Overall Study|Protocol Violation|0|||
23399674|NCT00503984|65210647|FG004|Overall Study|Protocol Violation|0|||
23399675|NCT00503984|65210648|FG005|Overall Study|Protocol Violation|0|||
23399676|NCT00503984|65210643|FG000|Overall Study|Adverse Event|0|||
23399677|NCT00503984|65210644|FG001|Overall Study|Adverse Event|1|||
23399678|NCT00503984|65210645|FG002|Overall Study|Adverse Event|0|||
23399679|NCT00503984|65210646|FG003|Overall Study|Adverse Event|0|||
23399680|NCT00503984|65210647|FG004|Overall Study|Adverse Event|0|||
23399681|NCT00503984|65210648|FG005|Overall Study|Adverse Event|0|||
23399682|NCT00503984|65210643|FG000|Overall Study|Death|0|||
23399683|NCT00503984|65210644|FG001|Overall Study|Death|0|||
23399684|NCT00503984|65210645|FG002|Overall Study|Death|0|||
23399685|NCT00503984|65210646|FG003|Overall Study|Death|0|||
23399686|NCT00503984|65210647|FG004|Overall Study|Death|1|||
23399687|NCT00503984|65210648|FG005|Overall Study|Death|0|||
23399688|NCT02639390|65210649|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
23399689|NCT02639390|65210650|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
23399690|NCT02332928|65210651|FG000|Overall Study|Withdrawal by Subject|0|||
23399691|NCT02332928|65210652|FG001|Overall Study|Withdrawal by Subject|2|||
23399692|NCT02332928|65210651|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
23399693|NCT02332928|65210652|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
23399694|NCT01164007|65210660|FG000|Overall Study|Adverse Event|5|||
23399695|NCT01164007|65210660|FG000|Overall Study|Progression of Disease|30|||
23399696|NCT01164007|65210660|FG000|Overall Study|Protocol Violation|1|||
23399697|NCT01164007|65210660|FG000|Overall Study|Withdrawal by Subject|1|||
23399698|NCT01164007|65210660|FG000|Overall Study|Medical Decision|3|||
23399699|NCT01392573|65210661|FG000|Overall Study|Adverse Event|1|||
23399700|NCT01392573|65210662|FG001|Overall Study|Adverse Event|3|||
23399701|NCT01392573|65210661|FG000|Overall Study|Lack of Efficacy|1|||
23399702|NCT01392573|65210662|FG001|Overall Study|Lack of Efficacy|2|||
23399703|NCT01392573|65210661|FG000|Overall Study|Protocol Violation|0|||
23399704|NCT01392573|65210662|FG001|Overall Study|Protocol Violation|2|||
23399705|NCT01392573|65210661|FG000|Overall Study|Withdrawal Criteria|13|||
23399706|NCT01392573|65210662|FG001|Overall Study|Withdrawal Criteria|15|||
23399707|NCT01392573|65210661|FG000|Overall Study|Site closure|8|||
23399708|NCT01392573|65210662|FG001|Overall Study|Site closure|7|||
23399709|NCT01392573|65210661|FG000|Overall Study|Unclassified|9|||
23399710|NCT01392573|65210662|FG001|Overall Study|Unclassified|6|||
23399711|NCT02803203|65210663|FG000|Overall Study|Adverse Event|4|||
23399712|NCT02803203|65210663|FG000|Overall Study|Death|4|||
23399713|NCT02803203|65210663|FG000|Overall Study|Progressive disease|29|||
23399714|NCT02803203|65210663|FG000|Overall Study|Withdrawal by Subject|8|||
23399715|NCT02803203|65210663|FG000|Overall Study|Complete resection of target disease|2|||
23399716|NCT02803203|65210663|FG000|Overall Study|Switched to commercial Osi|1|||
23399717|NCT02803203|65210663|FG000|Overall Study|Participant moved away|1|||
23399718|NCT01985022|65210668|FG000|Overall Study|Lost to Follow-up|0|||
23399719|NCT01985022|65210669|FG001|Overall Study|Lost to Follow-up|1|||
23399720|NCT01985022|65210668|FG000|Overall Study|Protocol Violation|0|||
23399721|NCT01985022|65210669|FG001|Overall Study|Protocol Violation|1|||
23399722|NCT01985022|65210668|FG000|Overall Study|Withdrawal by Subject|4|||
23399723|NCT01985022|65210669|FG001|Overall Study|Withdrawal by Subject|1|||
23399724|NCT04079738|65210670|FG000|Study Treatment|Death|1|||
23399725|NCT04079738|65210671|FG001|Study Treatment|Death|0|||
23399726|NCT04079738|65210672|FG002|Study Treatment|Death|0|||
23399727|NCT04079738|65210673|FG003|Study Treatment|Death|0|||
23399728|NCT04079738|65210670|FG000|Study Treatment|Adverse Event|2|||
23399729|NCT04079738|65210671|FG001|Study Treatment|Adverse Event|0|||
23399730|NCT04079738|65210672|FG002|Study Treatment|Adverse Event|0|||
23399731|NCT04079738|65210673|FG003|Study Treatment|Adverse Event|0|||
23399732|NCT04079738|65210670|FG000|Study Treatment|withdrawal before treatment|1|||
23399733|NCT04079738|65210671|FG001|Study Treatment|withdrawal before treatment|0|||
23399734|NCT04079738|65210672|FG002|Study Treatment|withdrawal before treatment|0|||
23399735|NCT04079738|65210673|FG003|Study Treatment|withdrawal before treatment|0|||
23399736|NCT04079738|65210670|FG000|Study Treatment|symptomatic deterioration|2|||
23399737|NCT04079738|65210671|FG001|Study Treatment|symptomatic deterioration|0|||
23399738|NCT04079738|65210672|FG002|Study Treatment|symptomatic deterioration|0|||
23399739|NCT04079738|65210673|FG003|Study Treatment|symptomatic deterioration|0|||
23399740|NCT04079738|65210670|FG000|Study Treatment|Disease Progression|1|||
23399741|NCT04079738|65210671|FG001|Study Treatment|Disease Progression|0|||
23399742|NCT04079738|65210672|FG002|Study Treatment|Disease Progression|0|||
23399743|NCT04079738|65210673|FG003|Study Treatment|Disease Progression|0|||
23399744|NCT04079738|65210670|FG000|Study Treatment|withdrawal after treatment|1|||
23399745|NCT04079738|65210671|FG001|Study Treatment|withdrawal after treatment|0|||
23399746|NCT04079738|65210672|FG002|Study Treatment|withdrawal after treatment|0|||
23399747|NCT04079738|65210673|FG003|Study Treatment|withdrawal after treatment|0|||
23399748|NCT04079738|65210670|FG000|Follow up|Withdrawal by Subject|3|||
23399749|NCT04079738|65210671|FG001|Follow up|Withdrawal by Subject|0|||
23399750|NCT04079738|65210672|FG002|Follow up|Withdrawal by Subject|0|||
23399751|NCT04079738|65210673|FG003|Follow up|Withdrawal by Subject|0|||
23399752|NCT04079738|65210670|FG000|Follow up|Death|5|||
23399753|NCT04079738|65210671|FG001|Follow up|Death|0|||
23399754|NCT04079738|65210672|FG002|Follow up|Death|0|||
23399755|NCT04079738|65210673|FG003|Follow up|Death|0|||
23399756|NCT01987557|65210675|FG000|Overall Study|Protocol Violation|1|||
23399757|NCT01987557|65210676|FG001|Overall Study|Protocol Violation|0|||
23399758|NCT01987557|65210677|FG002|Overall Study|Protocol Violation|1|||
23399759|NCT01987557|65210675|FG000|Overall Study|Withdrawal by Subject|2|||
23399760|NCT01987557|65210676|FG001|Overall Study|Withdrawal by Subject|1|||
23399761|NCT01987557|65210677|FG002|Overall Study|Withdrawal by Subject|2|||
23399762|NCT01987557|65210675|FG000|Overall Study|Adverse Event|0|||
23399763|NCT01987557|65210676|FG001|Overall Study|Adverse Event|2|||
23399764|NCT01987557|65210677|FG002|Overall Study|Adverse Event|0|||
23399765|NCT01404234|65210679|FG000|Overall Study|Withdrawal by Subject|2|||
23399766|NCT00560417|65210683|FG000|Overall Study|Adverse Event|3|||
23399767|NCT00560417|65210684|FG001|Overall Study|Adverse Event|2|||
23502584|NCT01866930|65580241|FG000|Follow-up Period|Withdrawal by Subject|3|||
23502585|NCT01866930|65580242|FG001|Follow-up Period|Withdrawal by Subject|3|||
23502586|NCT04974697|65580247|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
23502587|NCT04974697|65580247|FG000|Overall Study|Lens discomfort|1|||
23502588|NCT04444895|65580248|FG000|Overall Study|Adverse Event|2|||
23399768|NCT00560417|65210683|FG000|Overall Study|Entry Criteria Not Met|1|||
23399769|NCT00560417|65210684|FG001|Overall Study|Entry Criteria Not Met|0|||
23399770|NCT00560417|65210683|FG000|Overall Study|Lost to Follow-up|0|||
23399771|NCT00560417|65210684|FG001|Overall Study|Lost to Follow-up|1|||
23399772|NCT00560417|65210683|FG000|Overall Study|Physician Decision|2|||
23399773|NCT00560417|65210684|FG001|Overall Study|Physician Decision|6|||
23399774|NCT00560417|65210683|FG000|Overall Study|Protocol Violation|6|||
23399775|NCT00560417|65210684|FG001|Overall Study|Protocol Violation|5|||
23399776|NCT00560417|65210683|FG000|Overall Study|Sponsor Decision|2|||
23399777|NCT00560417|65210684|FG001|Overall Study|Sponsor Decision|0|||
23399778|NCT00560417|65210683|FG000|Overall Study|Withdrawal by Subject|3|||
23399779|NCT00560417|65210684|FG001|Overall Study|Withdrawal by Subject|3|||
23399780|NCT01359956|65210685|FG000|Overall Study|Death|58|||
23399781|NCT01359956|65210686|FG001|Overall Study|Death|60|||
23399782|NCT01359956|65210687|FG002|Overall Study|Death|66|||
23399783|NCT01359956|65210688|FG003|Overall Study|Death|57|||
23399784|NCT01359956|65210685|FG000|Overall Study|Lost to Follow-up|3|||
23399785|NCT01359956|65210686|FG001|Overall Study|Lost to Follow-up|4|||
23399786|NCT01359956|65210687|FG002|Overall Study|Lost to Follow-up|1|||
23399787|NCT01359956|65210688|FG003|Overall Study|Lost to Follow-up|1|||
23399788|NCT05489328|65210689|FG000|Overall Study|Lost to Follow-up|0|||
23399789|NCT05489328|65210690|FG001|Overall Study|Lost to Follow-up|0|||
23399790|NCT05489328|65210691|FG002|Overall Study|Lost to Follow-up|1|||
23399791|NCT05489328|65210692|FG003|Overall Study|Lost to Follow-up|0|||
23399792|NCT05489328|65210693|FG004|Overall Study|Lost to Follow-up|2|||
23399793|NCT05489328|65210694|FG005|Overall Study|Lost to Follow-up|0|||
23399794|NCT05489328|65210695|FG006|Overall Study|Lost to Follow-up|0|||
23399795|NCT05489328|65210696|FG007|Overall Study|Lost to Follow-up|1|||
23399796|NCT05489328|65210697|FG008|Overall Study|Lost to Follow-up|0|||
23399797|NCT05489328|65210689|FG000|Overall Study|Withdrawal by Subject|0|||
23399798|NCT05489328|65210690|FG001|Overall Study|Withdrawal by Subject|0|||
23399799|NCT05489328|65210691|FG002|Overall Study|Withdrawal by Subject|0|||
23399800|NCT05489328|65210692|FG003|Overall Study|Withdrawal by Subject|0|||
23399801|NCT05489328|65210693|FG004|Overall Study|Withdrawal by Subject|0|||
23399802|NCT05489328|65210694|FG005|Overall Study|Withdrawal by Subject|0|||
23399803|NCT05489328|65210695|FG006|Overall Study|Withdrawal by Subject|1|||
23399804|NCT05489328|65210696|FG007|Overall Study|Withdrawal by Subject|1|||
23399805|NCT05489328|65210697|FG008|Overall Study|Withdrawal by Subject|0|||
23399806|NCT05489328|65210689|FG000|Overall Study|Other|0|||
23399807|NCT05489328|65210690|FG001|Overall Study|Other|0|||
23399808|NCT05489328|65210691|FG002|Overall Study|Other|0|||
23399809|NCT05489328|65210692|FG003|Overall Study|Other|0|||
23399810|NCT05489328|65210693|FG004|Overall Study|Other|0|||
23399811|NCT05489328|65210694|FG005|Overall Study|Other|0|||
23399812|NCT05489328|65210695|FG006|Overall Study|Other|0|||
23399813|NCT05489328|65210696|FG007|Overall Study|Other|1|||
23399814|NCT05489328|65210697|FG008|Overall Study|Other|1|||
23399815|NCT01143402|65210710|FG000|Overall Study|Rapid clinical decline|1|||
23399816|NCT01143402|65210711|FG001|Overall Study|Rapid clinical decline|1|||
23399817|NCT01143402|65210712|FG002|Overall Study|Rapid clinical decline|0|||
23399818|NCT01143402|65210710|FG000|Overall Study|Not Treated|0|||
23399819|NCT01143402|65210711|FG001|Overall Study|Not Treated|0|||
23399820|NCT01143402|65210712|FG002|Overall Study|Not Treated|1|||
23399821|NCT01214837|65210714|FG000|Overall Study|Death|0|||
23399822|NCT01214837|65210715|FG001|Overall Study|Death|0|||
23399823|NCT01214837|65210716|FG002|Overall Study|Death|1|||
23399824|NCT01214837|65210714|FG000|Overall Study|Adverse Event|1|||
23399825|NCT01214837|65210715|FG001|Overall Study|Adverse Event|2|||
23399826|NCT01214837|65210716|FG002|Overall Study|Adverse Event|1|||
23399827|NCT01214837|65210714|FG000|Overall Study|Withdrawal by Subject|27|||
23399828|NCT01214837|65210715|FG001|Overall Study|Withdrawal by Subject|36|||
23399829|NCT01214837|65210716|FG002|Overall Study|Withdrawal by Subject|28|||
23399830|NCT01214837|65210714|FG000|Overall Study|Lost to Follow-up|20|||
23399831|NCT01214837|65210715|FG001|Overall Study|Lost to Follow-up|15|||
23399832|NCT01214837|65210716|FG002|Overall Study|Lost to Follow-up|21|||
23399833|NCT01214837|65210714|FG000|Overall Study|Inappropriate Enrolment|0|||
23399834|NCT01214837|65210715|FG001|Overall Study|Inappropriate Enrolment|1|||
23399835|NCT01214837|65210716|FG002|Overall Study|Inappropriate Enrolment|2|||
23399836|NCT01214837|65210714|FG000|Overall Study|Administrative Reason|2|||
23399837|NCT01214837|65210715|FG001|Overall Study|Administrative Reason|6|||
23502589|NCT04444895|65580248|FG000|Overall Study|Lost to Follow-up|2|||
23502590|NCT04444895|65580248|FG000|Overall Study|Withdrawal by Subject|5|||
23502591|NCT01749137|65580249|FG000|Overall Study|Adverse Event|4|||
23502592|NCT01749137|65580250|FG001|Overall Study|Adverse Event|4|||
23502593|NCT01749137|65580249|FG000|Overall Study|Lost to Follow-up|2|||
23502594|NCT01749137|65580250|FG001|Overall Study|Lost to Follow-up|3|||
23502595|NCT01749137|65580249|FG000|Overall Study|Physician Decision|1|||
23702885|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23702886|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
23399838|NCT01214837|65210716|FG002|Overall Study|Administrative Reason|4|||
23399839|NCT01214837|65210714|FG000|Overall Study|Protocol Violation|3|||
23399840|NCT01214837|65210715|FG001|Overall Study|Protocol Violation|1|||
23399841|NCT01214837|65210716|FG002|Overall Study|Protocol Violation|5|||
23399842|NCT01214837|65210714|FG000|Overall Study|Unable to Classify|1|||
23399843|NCT01214837|65210715|FG001|Overall Study|Unable to Classify|3|||
23399844|NCT01214837|65210716|FG002|Overall Study|Unable to Classify|0|||
23399845|NCT02493764|65210718|FG000|Overall Study|Adverse Event|2|||
23399846|NCT02493764|65210719|FG001|Overall Study|Adverse Event|2|||
23502596|NCT01749137|65580250|FG001|Overall Study|Physician Decision|0|||
23502597|NCT01749137|65580249|FG000|Overall Study|Withdrawal by Subject|8|||
23502598|NCT01749137|65580250|FG001|Overall Study|Withdrawal by Subject|4|||
23502599|NCT04659161|65580253|FG000|Overall Study|Adverse Event|10|||
23702887|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23702888|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23702889|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23702890|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
23702891|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23702892|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23702893|NCT00958568|66286965|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23702894|NCT00958568|66286966|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
23702895|NCT00958568|66286967|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23702896|NCT00958568|66286968|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23702897|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
23702898|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
23702899|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
23702900|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
23702901|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
23702902|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
23702903|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
23702904|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
23702905|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
23702906|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
23702907|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
23702908|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
23702909|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
23399847|NCT02493764|65210718|FG000|Overall Study|Death|44|||
23399848|NCT02493764|65210719|FG001|Overall Study|Death|58|||
23399849|NCT02493764|65210718|FG000|Overall Study|Lost to Follow-up|2|||
23399850|NCT02493764|65210719|FG001|Overall Study|Lost to Follow-up|1|||
23399851|NCT02493764|65210718|FG000|Overall Study|Protocol Violation|6|||
23399852|NCT02493764|65210719|FG001|Overall Study|Protocol Violation|7|||
23399853|NCT02493764|65210718|FG000|Overall Study|Physician Decision|1|||
23399854|NCT02493764|65210719|FG001|Overall Study|Physician Decision|1|||
23399855|NCT02493764|65210718|FG000|Overall Study|Participant moved|17|||
23399856|NCT02493764|65210719|FG001|Overall Study|Participant moved|5|||
23399857|NCT02493764|65210718|FG000|Overall Study|Withdrawal parent/guardian|0|||
23399858|NCT02493764|65210719|FG001|Overall Study|Withdrawal parent/guardian|1|||
23399859|NCT02493764|65210718|FG000|Overall Study|Withdrawal by Subject|11|||
23399860|NCT02493764|65210719|FG001|Overall Study|Withdrawal by Subject|7|||
23399861|NCT01368614|65210722|FG000|Screening Period|Screen Failure|58|||
23399862|NCT01368614|65210723|FG001|Screening Period|Screen Failure|0|||
23399863|NCT01368614|65210724|FG002|Screening Period|Screen Failure|0|||
23399864|NCT01368614|65210725|FG003|Screening Period|Screen Failure|0|||
23399865|NCT01368614|65210722|FG000|Study Period|Withdrawal by Subject|0|||
23399866|NCT01368614|65210723|FG001|Study Period|Withdrawal by Subject|1|||
23399867|NCT01368614|65210724|FG002|Study Period|Withdrawal by Subject|1|||
23399868|NCT01368614|65210725|FG003|Study Period|Withdrawal by Subject|3|||
23399869|NCT01368614|65210722|FG000|Study Period|Lost to Follow-up|0|||
23399870|NCT01368614|65210723|FG001|Study Period|Lost to Follow-up|0|||
23399871|NCT01368614|65210724|FG002|Study Period|Lost to Follow-up|1|||
23399872|NCT01368614|65210725|FG003|Study Period|Lost to Follow-up|0|||
23399873|NCT00639457|65210733|FG000|Overall Study|Withdrawal by Subject|2|||
23399874|NCT00639457|65210734|FG001|Overall Study|Withdrawal by Subject|3|||
23399875|NCT00387088|65210735|FG000|Overall Study|Adverse Event|143|||
23399876|NCT00387088|65210736|FG001|Overall Study|Adverse Event|156|||
23399877|NCT00387088|65210735|FG000|Overall Study|Protocol Violation|47|||
23399878|NCT00387088|65210736|FG001|Overall Study|Protocol Violation|35|||
23399879|NCT00387088|65210735|FG000|Overall Study|Withdrawal by Subject|20|||
23399880|NCT00387088|65210736|FG001|Overall Study|Withdrawal by Subject|35|||
23399881|NCT00387088|65210735|FG000|Overall Study|Lack of Efficacy|28|||
23399882|NCT00387088|65210736|FG001|Overall Study|Lack of Efficacy|67|||
23399883|NCT00387088|65210735|FG000|Overall Study|Lost to Follow-up|22|||
23399884|NCT00387088|65210736|FG001|Overall Study|Lost to Follow-up|28|||
23399885|NCT00387088|65210735|FG000|Overall Study|Other|58|||
23399886|NCT00387088|65210736|FG001|Overall Study|Other|52|||
23399887|NCT00237042|65210737|FG000|Treatment|Became ineligible post-randomization|0|||
23399888|NCT00237042|65210738|FG001|Treatment|Became ineligible post-randomization|1|||
23399889|NCT00237042|65210739|FG002|Treatment|Became ineligible post-randomization|16|||
23399890|NCT00237042|65210737|FG000|Treatment|Moved out of state|1|||
23399891|NCT00237042|65210738|FG001|Treatment|Moved out of state|1|||
23702910|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
23702911|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
23702912|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
23702913|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
23702914|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
23702915|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
23702916|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
23702917|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
23702918|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
23702919|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
23702920|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
23702921|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
23702922|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
23702923|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
23702924|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
23702925|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23702926|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23702927|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
23702928|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23702929|NCT00958568|66286965|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23702930|NCT00958568|66286966|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23702931|NCT00958568|66286967|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
23702932|NCT00958568|66286968|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23702933|NCT01465178|66286969|FG000|Overall Study|Withdrawal by Subject|1|||
23702934|NCT01465178|66286970|FG001|Overall Study|Withdrawal by Subject|0|||
23702935|NCT01844700|66286974|FG000|Overall Study|Lack of Efficacy|1|||
23702936|NCT01844700|66286975|FG001|Overall Study|Lack of Efficacy|0|||
23702937|NCT01844700|66286974|FG000|Overall Study|refused medication switch|1|||
23702938|NCT01844700|66286975|FG001|Overall Study|refused medication switch|0|||
23702939|NCT01844700|66286974|FG000|Overall Study|Withdrawal by Subject|1|||
23702940|NCT01844700|66286975|FG001|Overall Study|Withdrawal by Subject|0|||
23702941|NCT01844700|66286974|FG000|Overall Study|stopped taking meds|0|||
23702942|NCT01844700|66286975|FG001|Overall Study|stopped taking meds|1|||
23702943|NCT02092389|66286976|FG000|Overall Study|Adverse Event|1|||
23702944|NCT02092389|66286976|FG000|Overall Study|Other|5|||
23702945|NCT01721408|66286983|FG000|Overall Study|Adverse Event|6|||
23702946|NCT01721408|66286984|FG001|Overall Study|Adverse Event|1|||
23702947|NCT01721408|66286983|FG000|Overall Study|Death|1|||
23702948|NCT01721408|66286984|FG001|Overall Study|Death|0|||
23702949|NCT01721408|66286983|FG000|Overall Study|Insufficient clinical response|15|||
23702950|NCT01721408|66286984|FG001|Overall Study|Insufficient clinical response|6|||
23702951|NCT01721408|66286983|FG000|Overall Study|No longer willing to participate study|9|||
23702952|NCT01721408|66286984|FG001|Overall Study|No longer willing to participate study|10|||
23702953|NCT01721408|66286983|FG000|Overall Study|Protocol Violation|0|||
23702954|NCT01721408|66286984|FG001|Overall Study|Protocol Violation|2|||
23702955|NCT01721408|66286983|FG000|Overall Study|Other|3|||
23702956|NCT01721408|66286984|FG001|Overall Study|Other|3|||
23702957|NCT01721408|66286983|FG000|Overall Study|Lost to Follow-up|1|||
23702958|NCT01721408|66286984|FG001|Overall Study|Lost to Follow-up|2|||
23702959|NCT01721408|66286983|FG000|Overall Study|Does not meet entrance criteria|1|||
23702960|NCT01721408|66286984|FG001|Overall Study|Does not meet entrance criteria|0|||
23702961|NCT00524745|66286985|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
23702962|NCT00524745|66286986|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
23702963|NCT00524745|66286987|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
23702964|NCT00524745|66286988|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
23702965|NCT02650284|66286989|FG000|Overall Study|Lost to Follow-up|3|||
23702966|NCT02650284|66286990|FG001|Overall Study|Lost to Follow-up|3|||
23702967|NCT02650284|66286989|FG000|Overall Study|Consent incorrectly taken|0|||
23702968|NCT02650284|66286990|FG001|Overall Study|Consent incorrectly taken|1|||
23702969|NCT01936649|66286991|FG000|Overall Study|Withdrawal by Subject|4|||
23702970|NCT01936649|66286991|FG000|Overall Study|Physician Decision|2|||
23702971|NCT01936649|66286991|FG000|Overall Study|Protocol Violation|2|||
23702972|NCT01936649|66286991|FG000|Overall Study|Other than specified above|5|||
23702973|NCT04760314|66286995|FG000|Induction Period|Withdrawal by Subject|0|||
23702974|NCT04760314|66286996|FG001|Induction Period|Withdrawal by Subject|1|||
23702975|NCT04760314|66286997|FG002|Induction Period|Withdrawal by Subject|1|||
23702976|NCT04760314|66286998|FG003|Induction Period|Withdrawal by Subject|0|||
23702977|NCT04760314|66286999|FG004|Induction Period|Withdrawal by Subject|0|||
23702978|NCT04760314|66287000|FG005|Induction Period|Withdrawal by Subject|0|||
23702979|NCT04760314|66287001|FG006|Induction Period|Withdrawal by Subject|0|||
23702980|NCT04760314|66287002|FG007|Induction Period|Withdrawal by Subject|0|||
23702981|NCT04760314|66287003|FG008|Induction Period|Withdrawal by Subject|0|||
23702982|NCT04760314|66287004|FG009|Induction Period|Withdrawal by Subject|0|||
23702983|NCT04760314|66287005|FG010|Induction Period|Withdrawal by Subject|0|||
23702984|NCT04760314|66286995|FG000|Induction Period|Adverse Event|0|||
23702985|NCT04760314|66286996|FG001|Induction Period|Adverse Event|0|||
23702986|NCT04760314|66286997|FG002|Induction Period|Adverse Event|2|||
23702987|NCT04760314|66286998|FG003|Induction Period|Adverse Event|0|||
23702988|NCT04760314|66286999|FG004|Induction Period|Adverse Event|0|||
23702989|NCT04760314|66287000|FG005|Induction Period|Adverse Event|0|||
23702990|NCT04760314|66287001|FG006|Induction Period|Adverse Event|0|||
23702991|NCT04760314|66287002|FG007|Induction Period|Adverse Event|0|||
23702992|NCT04760314|66287003|FG008|Induction Period|Adverse Event|0|||
23702993|NCT04760314|66287004|FG009|Induction Period|Adverse Event|0|||
23702994|NCT04760314|66287005|FG010|Induction Period|Adverse Event|0|||
23702995|NCT04760314|66286995|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
23702996|NCT04760314|66286996|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
23702997|NCT04760314|66286997|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
23702998|NCT04760314|66286998|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
23702999|NCT04760314|66286999|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
23703000|NCT04760314|66287000|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
23703001|NCT04760314|66287001|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
23703002|NCT04760314|66287002|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
23703003|NCT04760314|66287003|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
23703004|NCT04760314|66287004|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
23703005|NCT04760314|66287005|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
23703006|NCT04760314|66286995|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703007|NCT04760314|66286996|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703008|NCT04760314|66286997|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703009|NCT04760314|66286998|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
23703010|NCT04760314|66286999|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703011|NCT04760314|66287000|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
23703012|NCT04760314|66287001|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
23703013|NCT04760314|66287002|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703014|NCT04760314|66287003|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703015|NCT04760314|66287004|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703016|NCT04760314|66287005|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23703017|NCT04760314|66286995|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703018|NCT04760314|66286996|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703019|NCT04760314|66286997|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703020|NCT04760314|66286998|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703021|NCT04760314|66286999|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
23703022|NCT04760314|66287000|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703023|NCT04760314|66287001|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703024|NCT04760314|66287002|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703025|NCT04760314|66287003|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703026|NCT04760314|66287004|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703027|NCT04760314|66287005|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23703028|NCT04760314|66286995|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
23703029|NCT04760314|66286996|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
23703030|NCT04760314|66286997|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
23703031|NCT04760314|66286998|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
23703032|NCT04760314|66286999|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
23703033|NCT04760314|66287000|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
23703034|NCT04760314|66287001|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
23703035|NCT04760314|66287002|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
23703036|NCT04760314|66287003|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
23703037|NCT04760314|66287004|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
23703038|NCT04760314|66287005|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
23703039|NCT04760314|66286995|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703040|NCT04760314|66286996|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703041|NCT04760314|66286997|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703042|NCT04760314|66286998|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703043|NCT04760314|66286999|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703044|NCT04760314|66287000|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703045|NCT04760314|66287001|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703046|NCT04760314|66287002|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23703047|NCT04760314|66287003|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23703048|NCT04760314|66287004|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23502600|NCT04659161|65580254|FG001|Overall Study|Adverse Event|6|||
23703049|NCT04760314|66287005|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23703050|NCT04760314|66286995|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703051|NCT04760314|66286996|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703052|NCT04760314|66286997|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703053|NCT04760314|66286998|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703054|NCT04760314|66286999|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703055|NCT04760314|66287000|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703056|NCT04760314|66287001|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703057|NCT04760314|66287002|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
23703058|NCT04760314|66287003|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
23703059|NCT04760314|66287004|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
23703060|NCT04760314|66287005|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23703061|NCT04760314|66286995|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703062|NCT04760314|66286996|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703063|NCT04760314|66286997|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703064|NCT04760314|66286998|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703065|NCT04760314|66286999|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703066|NCT04760314|66287000|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703067|NCT04760314|66287001|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703068|NCT04760314|66287002|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
23703069|NCT04760314|66287003|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703070|NCT04760314|66287004|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703071|NCT04760314|66287005|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23703072|NCT04760314|66286995|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703073|NCT04760314|66286996|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703074|NCT04760314|66286997|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703075|NCT04760314|66286998|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703076|NCT04760314|66286999|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703077|NCT04760314|66287000|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703078|NCT04760314|66287001|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703079|NCT04760314|66287002|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703080|NCT04760314|66287003|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
23703081|NCT04760314|66287004|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
23703082|NCT04760314|66287005|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23703083|NCT01254604|66287008|FG000|Overall Study|Lost to Follow-up|1|||
23703084|NCT01254604|66287009|FG001|Overall Study|Lost to Follow-up|1|||
23703085|NCT01254604|66287008|FG000|Overall Study|Protocol Violation|2|||
23703086|NCT01254604|66287009|FG001|Overall Study|Protocol Violation|2|||
23703087|NCT01254604|66287008|FG000|Overall Study|Withdrawal by Subject|2|||
23703088|NCT01254604|66287009|FG001|Overall Study|Withdrawal by Subject|4|||
23703089|NCT01254604|66287008|FG000|Overall Study|Adverse Event|3|||
23703090|NCT01254604|66287009|FG001|Overall Study|Adverse Event|2|||
23703091|NCT01555463|66287012|FG000|Treatment|Adverse Event|6|||
23703092|NCT01555463|66287013|FG001|Treatment|Adverse Event|12|||
23703093|NCT01555463|66287012|FG000|Treatment|Withdrawal by Subject|24|||
23703094|NCT01555463|66287013|FG001|Treatment|Withdrawal by Subject|36|||
23703095|NCT01555463|66287012|FG000|Treatment|Lost to Follow-up|28|||
23703096|NCT01555463|66287013|FG001|Treatment|Lost to Follow-up|23|||
23703097|NCT01555463|66287012|FG000|Treatment|Protocol Violation|4|||
23703098|NCT01555463|66287013|FG001|Treatment|Protocol Violation|5|||
23703099|NCT01555463|66287012|FG000|Treatment|Other reason|2|||
23703100|NCT01555463|66287013|FG001|Treatment|Other reason|3|||
23703101|NCT01555463|66287012|FG000|Follow up|Adverse Event|2|||
23703102|NCT01555463|66287013|FG001|Follow up|Adverse Event|5|||
23703103|NCT01555463|66287012|FG000|Follow up|Death|0|||
23703104|NCT01555463|66287013|FG001|Follow up|Death|1|||
23703105|NCT01555463|66287012|FG000|Follow up|Withdrawal by Subject|22|||
23703106|NCT01555463|66287013|FG001|Follow up|Withdrawal by Subject|22|||
23703107|NCT01555463|66287012|FG000|Follow up|Lost to Follow-up|9|||
23703108|NCT01555463|66287013|FG001|Follow up|Lost to Follow-up|10|||
23703109|NCT01555463|66287012|FG000|Follow up|Protocol Violation|2|||
23703110|NCT01555463|66287013|FG001|Follow up|Protocol Violation|4|||
23703111|NCT01555463|66287012|FG000|Follow up|Other reason|3|||
23703112|NCT01555463|66287013|FG001|Follow up|Other reason|3|||
23703113|NCT05094154|66287014|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
23703114|NCT05094154|66287015|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
23703115|NCT05094154|66287014|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
23703116|NCT05094154|66287015|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
23703117|NCT02761993|66287018|FG000|Overall Study|Adverse Event|0|||
23703118|NCT02761993|66287019|FG001|Overall Study|Adverse Event|2|||
23703119|NCT02761993|66287020|FG002|Overall Study|Adverse Event|0|||
23703120|NCT02761993|66287018|FG000|Overall Study|Lost to Follow-up|1|||
23703121|NCT02761993|66287019|FG001|Overall Study|Lost to Follow-up|3|||
23703122|NCT02761993|66287020|FG002|Overall Study|Lost to Follow-up|2|||
23703123|NCT02761993|66287018|FG000|Overall Study|Withdrawal by Subject|1|||
23703124|NCT02761993|66287019|FG001|Overall Study|Withdrawal by Subject|1|||
23703125|NCT02761993|66287020|FG002|Overall Study|Withdrawal by Subject|2|||
23703126|NCT00992446|66287021|FG000|Overall Study|Disease Progression|1|||
23703127|NCT00992446|66287021|FG000|Overall Study|Withdrawal by Subject|2|||
23703128|NCT00992446|66287021|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
23703129|NCT01915849|66287024|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
23703130|NCT01915849|66287025|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23703131|NCT01915849|66287026|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23703132|NCT01915849|66287027|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23703133|NCT01915849|66287024|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23703134|NCT01915849|66287025|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23703135|NCT01915849|66287026|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23703136|NCT01915849|66287027|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23703137|NCT00234104|66287028|FG000|Overall Study|Adverse Event|4|||
23703138|NCT00234104|66287029|FG001|Overall Study|Adverse Event|0|||
23703139|NCT00234104|66287030|FG002|Overall Study|Adverse Event|3|||
23703140|NCT00234104|66287031|FG003|Overall Study|Adverse Event|5|||
23703141|NCT00234104|66287028|FG000|Overall Study|Protocol Violation|0|||
23703142|NCT00234104|66287029|FG001|Overall Study|Protocol Violation|0|||
23703143|NCT00234104|66287030|FG002|Overall Study|Protocol Violation|0|||
23703144|NCT00234104|66287031|FG003|Overall Study|Protocol Violation|1|||
23703145|NCT00234104|66287028|FG000|Overall Study|Physician Decision|0|||
23703146|NCT00234104|66287029|FG001|Overall Study|Physician Decision|1|||
23703147|NCT00234104|66287030|FG002|Overall Study|Physician Decision|2|||
23703148|NCT00234104|66287031|FG003|Overall Study|Physician Decision|2|||
23703149|NCT00634543|66287032|FG000|Overall Study|Other|1|||
23703150|NCT00634543|66287033|FG001|Overall Study|Other|2|||
23703151|NCT00634543|66287032|FG000|Overall Study|Protocol Violation|3|||
23703152|NCT00634543|66287033|FG001|Overall Study|Protocol Violation|3|||
23703153|NCT00634543|66287032|FG000|Overall Study|Adverse Event|11|||
23703154|NCT00634543|66287033|FG001|Overall Study|Adverse Event|11|||
23703155|NCT00634543|66287032|FG000|Overall Study|Withdrawal by Subject|4|||
23703156|NCT00634543|66287033|FG001|Overall Study|Withdrawal by Subject|4|||
23703157|NCT00634543|66287032|FG000|Overall Study|Lost to Follow-up|0|||
23703158|NCT00634543|66287033|FG001|Overall Study|Lost to Follow-up|1|||
23703159|NCT01518699|66287038|FG000|Period 2|Protocol Violation|1|||
23703160|NCT01518699|66287039|FG001|Period 2|Protocol Violation|1|||
23703161|NCT01518699|66287040|FG002|Period 2|Protocol Violation|0|||
23703162|NCT01518699|66287041|FG003|Period 2|Protocol Violation|0|||
23703163|NCT01518699|66287042|FG004|Period 2|Protocol Violation|0|||
23703164|NCT01518699|66287043|FG005|Period 2|Protocol Violation|0|||
23703165|NCT01518699|66287038|FG000|Period 2|Lost to Follow-up|0|||
23703166|NCT01518699|66287039|FG001|Period 2|Lost to Follow-up|1|||
23703167|NCT01518699|66287040|FG002|Period 2|Lost to Follow-up|0|||
23703168|NCT01518699|66287041|FG003|Period 2|Lost to Follow-up|0|||
23703169|NCT01518699|66287042|FG004|Period 2|Lost to Follow-up|0|||
23703170|NCT01518699|66287043|FG005|Period 2|Lost to Follow-up|0|||
23703171|NCT01518699|66287038|FG000|Period 2|Adverse Event|1|||
23703172|NCT01518699|66287039|FG001|Period 2|Adverse Event|0|||
23703173|NCT01518699|66287040|FG002|Period 2|Adverse Event|0|||
23703174|NCT01518699|66287041|FG003|Period 2|Adverse Event|0|||
23703175|NCT01518699|66287042|FG004|Period 2|Adverse Event|0|||
23703176|NCT01518699|66287043|FG005|Period 2|Adverse Event|0|||
23703177|NCT00257192|66287051|FG000|Overall Study|Adverse Event|21|||
23703178|NCT00257192|66287052|FG001|Overall Study|Adverse Event|10|||
23703179|NCT00257192|66287051|FG000|Overall Study|Laboratory abnormality|1|||
23703180|NCT00257192|66287052|FG001|Overall Study|Laboratory abnormality|1|||
23703181|NCT00257192|66287051|FG000|Overall Study|Lost to Follow-up|3|||
23703182|NCT00257192|66287052|FG001|Overall Study|Lost to Follow-up|3|||
23703183|NCT00257192|66287051|FG000|Overall Study|Insufficient clinical response|18|||
23703184|NCT00257192|66287052|FG001|Overall Study|Insufficient clinical response|18|||
23703185|NCT00257192|66287051|FG000|Overall Study|Withdrawal by Subject|14|||
23703186|NCT00257192|66287052|FG001|Overall Study|Withdrawal by Subject|2|||
23703187|NCT00257192|66287051|FG000|Overall Study|Randomized but not treated|0|||
23703188|NCT00257192|66287052|FG001|Overall Study|Randomized but not treated|1|||
23703189|NCT00257192|66287051|FG000|Overall Study|Study terminated by sponsor|1|||
23703190|NCT00257192|66287052|FG001|Overall Study|Study terminated by sponsor|0|||
23703191|NCT00257192|66287051|FG000|Overall Study|Miscellaneous|0|||
23703192|NCT00257192|66287052|FG001|Overall Study|Miscellaneous|4|||
23703193|NCT03032068|66287053|FG000|Overall Study|Adverse Event|1|||
23703194|NCT03201198|66287054|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
23703195|NCT03201198|66287055|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
23502601|NCT04659161|65580253|FG000|Overall Study|Withdrawal by Subject|13|||
23703196|NCT03201198|66287054|FG000|Overall Study|Withdrawal by Subject|2|||
23399892|NCT00237042|65210739|FG002|Treatment|Moved out of state|1|||
23703197|NCT03201198|66287055|FG001|Overall Study|Withdrawal by Subject|3|||
23703198|NCT01302041|66287056|FG000|Overall Study|Death|5|||
23703199|NCT01302041|66287056|FG000|Overall Study|Withdrawal by Subject|4|||
23703200|NCT01302041|66287056|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
23703201|NCT01302041|66287056|FG000|Overall Study|Other-Miscellaneous Reason|2|||
23703202|NCT01879618|66287057|FG000|Overall Study|Does not meet entrance criteria|1|||
23703203|NCT01879618|66287057|FG000|Overall Study|Withdrawal by Subject|1|||
23703204|NCT01879618|66287057|FG000|Overall Study|Surgery;changed schedule; not available|8|||
23703205|NCT01879618|66287057|FG000|Overall Study|Protocol Violation|6|||
23703206|NCT01879618|66287057|FG000|Overall Study|Adverse Event|5|||
23703207|NCT00540436|66287058|FG000|First 12-Week Treatment Period|Adverse Event|1|||
23703208|NCT00540436|66287058|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
23703209|NCT00540436|66287058|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
23703210|NCT00540436|66287058|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
23703211|NCT01318083|66287061|FG000|Overall Study|Adverse Event|4|||
23703212|NCT01318083|66287062|FG001|Overall Study|Adverse Event|1|||
23703213|NCT01318083|66287063|FG002|Overall Study|Adverse Event|2|||
23703214|NCT01318083|66287061|FG000|Overall Study|Withdrawal by Subject|1|||
23703215|NCT01318083|66287062|FG001|Overall Study|Withdrawal by Subject|0|||
23703216|NCT01318083|66287063|FG002|Overall Study|Withdrawal by Subject|2|||
23703217|NCT01318083|66287061|FG000|Overall Study|Lack of Efficacy|0|||
23703218|NCT01318083|66287062|FG001|Overall Study|Lack of Efficacy|0|||
23703219|NCT01318083|66287063|FG002|Overall Study|Lack of Efficacy|1|||
23703220|NCT01318083|66287061|FG000|Overall Study|Treatment Complications|1|||
23703221|NCT01318083|66287062|FG001|Overall Study|Treatment Complications|0|||
23703222|NCT01318083|66287063|FG002|Overall Study|Treatment Complications|0|||
23703223|NCT01318083|66287061|FG000|Overall Study|Lack of Study Medication Compliance|0|||
23703224|NCT01318083|66287062|FG001|Overall Study|Lack of Study Medication Compliance|1|||
23703225|NCT01318083|66287063|FG002|Overall Study|Lack of Study Medication Compliance|0|||
23703226|NCT01666444|66287065|FG000|Overall Study|Did not initiate treatment|2|||
23703227|NCT01666444|66287066|FG001|Overall Study|Did not initiate treatment|1|||
23703228|NCT04229446|66287072|FG000|Overall Study|Death|12|||
23703229|NCT04229446|66287073|FG001|Overall Study|Death|10|||
23703230|NCT04229446|66287072|FG000|Overall Study|Lost to Follow-up|5|||
23703231|NCT04229446|66287073|FG001|Overall Study|Lost to Follow-up|8|||
23703232|NCT04160468|66287074|FG000|Overall Study|Lost to Follow-up|19|||
23703233|NCT04160468|66287075|FG001|Overall Study|Lost to Follow-up|4|||
23703234|NCT04160468|66287074|FG000|Overall Study|Randomized but not dosed|6|||
23703235|NCT04160468|66287075|FG001|Overall Study|Randomized but not dosed|0|||
23703236|NCT04160468|66287074|FG000|Overall Study|Withdrawal by Subject|4|||
23703237|NCT04160468|66287075|FG001|Overall Study|Withdrawal by Subject|1|||
23703238|NCT04160468|66287074|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
23703239|NCT04160468|66287075|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
23703240|NCT04160468|66287074|FG000|Overall Study|Participant incarcerated|1|||
23703241|NCT04160468|66287075|FG001|Overall Study|Participant incarcerated|0|||
23703242|NCT01221233|66287078|FG000|Overall Study|Withdrawal by Subject|3|||
23703243|NCT01221233|66287079|FG001|Overall Study|Withdrawal by Subject|1|||
23703244|NCT05836818|66287080|FG000|Overall Study|Physician Decision|1|||
23703245|NCT05836818|66287081|FG001|Overall Study|Physician Decision|1|||
23703246|NCT05836818|66287082|FG002|Overall Study|Physician Decision|0|||
23703247|NCT05836818|66287080|FG000|Overall Study|Withdrawal by Subject|0|||
23703248|NCT05836818|66287081|FG001|Overall Study|Withdrawal by Subject|0|||
23703249|NCT05836818|66287082|FG002|Overall Study|Withdrawal by Subject|1|||
23703250|NCT05836818|66287080|FG000|Overall Study|Later found to be previously vaccinated|0|||
23703251|NCT05836818|66287081|FG001|Overall Study|Later found to be previously vaccinated|1|||
23703252|NCT05836818|66287082|FG002|Overall Study|Later found to be previously vaccinated|3|||
23703253|NCT05836818|66287080|FG000|Overall Study|Pregnancy|0|||
23703254|NCT05836818|66287081|FG001|Overall Study|Pregnancy|1|||
23703255|NCT05836818|66287082|FG002|Overall Study|Pregnancy|0|||
23703256|NCT05836818|66287080|FG000|Overall Study|Allergic to vaccines|0|||
23703257|NCT05836818|66287081|FG001|Overall Study|Allergic to vaccines|1|||
23703258|NCT05836818|66287082|FG002|Overall Study|Allergic to vaccines|0|||
23703259|NCT02413398|66287084|FG000|Overall Study|Lost to Follow-up|2|||
23703260|NCT02413398|66287085|FG001|Overall Study|Lost to Follow-up|4|||
23703261|NCT02413398|66287084|FG000|Overall Study|Withdrawal by Subject|1|||
23703262|NCT02413398|66287085|FG001|Overall Study|Withdrawal by Subject|1|||
23703263|NCT02413398|66287084|FG000|Overall Study|Other Eligibility criteria|1|||
23703264|NCT02413398|66287085|FG001|Overall Study|Other Eligibility criteria|2|||
23703265|NCT03510663|66287089|FG000|Overall Study|Withdrawal by Subject|0|||
23703266|NCT03510663|66287090|FG001|Overall Study|Withdrawal by Subject|1|||
23703267|NCT03510663|66287091|FG002|Overall Study|Withdrawal by Subject|0|||
23703268|NCT03510663|66287092|FG003|Overall Study|Withdrawal by Subject|0|||
23703269|NCT03510663|66287093|FG004|Overall Study|Withdrawal by Subject|0|||
23399893|NCT00237042|65210737|FG000|Treatment|Completed no treatment|5|||
23703270|NCT03510663|66287094|FG005|Overall Study|Withdrawal by Subject|0|||
23703271|NCT03510663|66287095|FG006|Overall Study|Withdrawal by Subject|0|||
23703272|NCT03510663|66287096|FG007|Overall Study|Withdrawal by Subject|0|||
23703273|NCT04429503|66287105|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
23703274|NCT04429503|66287106|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
23703275|NCT04429503|66287107|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
23703276|NCT04429503|66287105|FG000|Overall Study|Adverse Event|1|||
23703277|NCT04429503|66287106|FG001|Overall Study|Adverse Event|9|||
23703278|NCT04429503|66287107|FG002|Overall Study|Adverse Event|2|||
23703279|NCT04429503|66287105|FG000|Overall Study|Decision by the investigator/sponsor|2|||
23703280|NCT04429503|66287106|FG001|Overall Study|Decision by the investigator/sponsor|9|||
23703281|NCT04429503|66287107|FG002|Overall Study|Decision by the investigator/sponsor|3|||
23703282|NCT04429503|66287105|FG000|Overall Study|Withdrawal by Subject|9|||
23703283|NCT04429503|66287106|FG001|Overall Study|Withdrawal by Subject|17|||
23703284|NCT04429503|66287107|FG002|Overall Study|Withdrawal by Subject|8|||
23703285|NCT04429503|66287105|FG000|Overall Study|Lost to Follow-up|5|||
23703286|NCT04429503|66287106|FG001|Overall Study|Lost to Follow-up|19|||
23703287|NCT04429503|66287107|FG002|Overall Study|Lost to Follow-up|7|||
23703288|NCT04429503|66287105|FG000|Overall Study|Death|9|||
23703289|NCT04429503|66287106|FG001|Overall Study|Death|18|||
23703290|NCT04429503|66287107|FG002|Overall Study|Death|5|||
23703291|NCT03072719|66287111|FG000|Overall Study|Adverse Event|1|||
23703292|NCT03072719|66287112|FG001|Overall Study|Adverse Event|1|||
23703293|NCT01097330|66289776|FG000|Overall Study|Study terminated early|7|||
23703294|NCT01097330|66289777|FG001|Overall Study|Study terminated early|5|||
23703295|NCT02552355|66289778|FG000|Overall Study|Adverse Event|0|||
23703296|NCT02552355|66289779|FG001|Overall Study|Adverse Event|2|||
23703297|NCT02552355|66289780|FG002|Overall Study|Adverse Event|2|||
23703298|NCT02552355|66289781|FG003|Overall Study|Adverse Event|0|||
23703299|NCT02552355|66289778|FG000|Overall Study|Withdrawal by Subject|0|||
23703300|NCT02552355|66289779|FG001|Overall Study|Withdrawal by Subject|0|||
23703301|NCT02552355|66289780|FG002|Overall Study|Withdrawal by Subject|0|||
23703302|NCT02552355|66289781|FG003|Overall Study|Withdrawal by Subject|1|||
23703303|NCT03596177|66289782|FG000|Single Blind Period|Withdrawal by Subject|1|||
23703304|NCT03596177|66289783|FG001|Single Blind Period|Withdrawal by Subject|1|||
23703305|NCT03596177|66289782|FG000|Single Blind Period|Other|1|||
23703306|NCT03596177|66289783|FG001|Single Blind Period|Other|0|||
23703307|NCT03596177|66289782|FG000|Double Blind Period|Withdrawal by Subject|0|||
23703308|NCT03596177|66289783|FG001|Double Blind Period|Withdrawal by Subject|1|||
23703309|NCT03596177|66289782|FG000|Double Blind Period|Other|0|||
23703310|NCT03596177|66289783|FG001|Double Blind Period|Other|4|||
23703311|NCT03596177|66289782|FG000|Double Blind Period|Death during safety follow-up|0|||
23703312|NCT03596177|66289783|FG001|Double Blind Period|Death during safety follow-up|1|||
23703313|NCT00850460|66289784|FG000|Overall Study|Lost to Follow-up|4|||
23703314|NCT00850460|66289785|FG001|Overall Study|Lost to Follow-up|4|||
23703315|NCT04346628|66289786|FG000|Overall Study|Lost to Follow-up|4|||
23703316|NCT04346628|66289787|FG001|Overall Study|Lost to Follow-up|4|||
23703317|NCT04346628|66289786|FG000|Overall Study|Withdrew (had personal reasons)|2|||
23703318|NCT04346628|66289787|FG001|Overall Study|Withdrew (had personal reasons)|5|||
23703319|NCT04346628|66289786|FG000|Overall Study|Withdrew (medication intolerant)|0|||
23703320|NCT04346628|66289787|FG001|Overall Study|Withdrew (medication intolerant)|3|||
23703321|NCT04346628|66289786|FG000|Overall Study|Withdrew (declined intervention)|0|||
23703322|NCT04346628|66289787|FG001|Overall Study|Withdrew (declined intervention)|1|||
23703323|NCT00875017|66289791|FG000|First Intervention|Withdrawal by Subject|1|||
23703324|NCT00875017|66289792|FG001|First Intervention|Withdrawal by Subject|0|||
23703325|NCT00875017|66289793|FG002|First Intervention|Withdrawal by Subject|1|||
23703326|NCT00875017|66289794|FG003|First Intervention|Withdrawal by Subject|0|||
23703327|NCT00875017|66289795|FG004|First Intervention|Withdrawal by Subject|0|||
23703328|NCT00875017|66289796|FG005|First Intervention|Withdrawal by Subject|0|||
23703329|NCT00875017|66289791|FG000|First Intervention|Adverse Event|0|||
23703330|NCT00875017|66289792|FG001|First Intervention|Adverse Event|0|||
23703331|NCT00875017|66289793|FG002|First Intervention|Adverse Event|0|||
23703332|NCT00875017|66289794|FG003|First Intervention|Adverse Event|1|||
23703333|NCT00875017|66289795|FG004|First Intervention|Adverse Event|0|||
23703334|NCT00875017|66289796|FG005|First Intervention|Adverse Event|0|||
23703335|NCT00875017|66289791|FG000|First Intervention|Problems collecting rectal effluent|1|||
23703336|NCT00875017|66289792|FG001|First Intervention|Problems collecting rectal effluent|0|||
23703337|NCT00875017|66289793|FG002|First Intervention|Problems collecting rectal effluent|0|||
23703338|NCT00875017|66289794|FG003|First Intervention|Problems collecting rectal effluent|0|||
23703339|NCT00875017|66289795|FG004|First Intervention|Problems collecting rectal effluent|0|||
23703340|NCT00875017|66289796|FG005|First Intervention|Problems collecting rectal effluent|0|||
23703341|NCT00875017|66289791|FG000|First Intervention|Intolerance to nasogastric tube|0|||
23703342|NCT00875017|66289792|FG001|First Intervention|Intolerance to nasogastric tube|0|||
23703343|NCT00875017|66289793|FG002|First Intervention|Intolerance to nasogastric tube|0|||
23703344|NCT00875017|66289794|FG003|First Intervention|Intolerance to nasogastric tube|0|||
23703345|NCT00875017|66289795|FG004|First Intervention|Intolerance to nasogastric tube|1|||
23703346|NCT00875017|66289796|FG005|First Intervention|Intolerance to nasogastric tube|0|||
23703347|NCT00875017|66289791|FG000|Washout|Problem collecting rectal effluent|0|||
23703348|NCT00875017|66289792|FG001|Washout|Problem collecting rectal effluent|0|||
23703349|NCT00875017|66289793|FG002|Washout|Problem collecting rectal effluent|1|||
23703350|NCT00875017|66289794|FG003|Washout|Problem collecting rectal effluent|0|||
23703351|NCT00875017|66289795|FG004|Washout|Problem collecting rectal effluent|0|||
23703352|NCT00875017|66289796|FG005|Washout|Problem collecting rectal effluent|0|||
23703353|NCT00875017|66289791|FG000|Second Intervention|Adverse Event|0|||
23703354|NCT00875017|66289792|FG001|Second Intervention|Adverse Event|0|||
23703355|NCT00875017|66289793|FG002|Second Intervention|Adverse Event|0|||
23703356|NCT00875017|66289794|FG003|Second Intervention|Adverse Event|1|||
23703357|NCT00875017|66289795|FG004|Second Intervention|Adverse Event|0|||
23703358|NCT00875017|66289796|FG005|Second Intervention|Adverse Event|0|||
23703359|NCT00875017|66289791|FG000|Washout|Problems collecting rectal effluent|0|||
23703360|NCT00875017|66289792|FG001|Washout|Problems collecting rectal effluent|1|||
23703361|NCT00875017|66289793|FG002|Washout|Problems collecting rectal effluent|0|||
23703362|NCT00875017|66289794|FG003|Washout|Problems collecting rectal effluent|0|||
23703363|NCT00875017|66289795|FG004|Washout|Problems collecting rectal effluent|0|||
23703364|NCT00875017|66289796|FG005|Washout|Problems collecting rectal effluent|0|||
23703365|NCT00875017|66289791|FG000|Third Intervention|Adverse Event|0|||
23703366|NCT00875017|66289792|FG001|Third Intervention|Adverse Event|1|||
23703367|NCT00875017|66289793|FG002|Third Intervention|Adverse Event|1|||
23703368|NCT00875017|66289794|FG003|Third Intervention|Adverse Event|0|||
23703369|NCT00875017|66289795|FG004|Third Intervention|Adverse Event|0|||
23703370|NCT00875017|66289796|FG005|Third Intervention|Adverse Event|0|||
23703371|NCT00875017|66289791|FG000|Washout|Withdrawal by Subject|0|||
23703372|NCT00875017|66289792|FG001|Washout|Withdrawal by Subject|0|||
23703373|NCT00875017|66289793|FG002|Washout|Withdrawal by Subject|0|||
23703374|NCT00875017|66289794|FG003|Washout|Withdrawal by Subject|0|||
23703375|NCT00875017|66289795|FG004|Washout|Withdrawal by Subject|1|||
23703376|NCT00875017|66289796|FG005|Washout|Withdrawal by Subject|0|||
23703377|NCT00875017|66289791|FG000|Fourth Intervention|Inability to comply with fasting|0|||
23703378|NCT00875017|66289792|FG001|Fourth Intervention|Inability to comply with fasting|0|||
23703379|NCT00875017|66289793|FG002|Fourth Intervention|Inability to comply with fasting|0|||
23703380|NCT00875017|66289794|FG003|Fourth Intervention|Inability to comply with fasting|0|||
23703381|NCT00875017|66289795|FG004|Fourth Intervention|Inability to comply with fasting|0|||
23703382|NCT00875017|66289796|FG005|Fourth Intervention|Inability to comply with fasting|1|||
23703383|NCT02426658|66289797|FG000|Overall Study|Withdrawal by Subject|1|||
23703384|NCT02426658|66289797|FG000|Overall Study|Patient expired before treatment|2|||
23703385|NCT03430245|66289798|FG000|Overall Study|Withdrawal by Subject|6|||
23703386|NCT03430245|66289798|FG000|Overall Study|Lost to Follow-up|1|||
23703387|NCT01554956|66289800|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
23703388|NCT01554956|66289801|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
23703389|NCT01554956|66289802|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
23703390|NCT01554956|66289800|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
23703391|NCT01554956|66289801|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
23703392|NCT01554956|66289802|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
23703393|NCT01554956|66289800|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
23703394|NCT01554956|66289801|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
23703395|NCT01554956|66289802|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
23703396|NCT05038163|66289803|FG000|Stage 1|Did not complete survey|374|||
23703397|NCT05038163|66289804|FG001|Stage 1|Did not complete survey|0|||
23703398|NCT05038163|66289805|FG002|Stage 1|Did not complete survey|0|||
23703399|NCT05038163|66289806|FG003|Stage 1|Did not complete survey|0|||
23703400|NCT05038163|66289807|FG004|Stage 1|Did not complete survey|0|||
23703401|NCT05038163|66289808|FG005|Stage 1|Did not complete survey|0|||
23703402|NCT05038163|66289803|FG000|Stage 2|Did not complete Stage 2 survey|0|||
23703403|NCT05038163|66289804|FG001|Stage 2|Did not complete Stage 2 survey|29|||
23703404|NCT05038163|66289805|FG002|Stage 2|Did not complete Stage 2 survey|30|||
23703405|NCT05038163|66289806|FG003|Stage 2|Did not complete Stage 2 survey|24|||
23703406|NCT05038163|66289807|FG004|Stage 2|Did not complete Stage 2 survey|21|||
23703407|NCT05038163|66289808|FG005|Stage 2|Did not complete Stage 2 survey|100|||
23703408|NCT03117049|66289815|FG000|Overall Study|Continued the follow-up period|109|||
23703409|NCT03117049|66289816|FG001|Overall Study|Continued the follow-up period|129|||
23703410|NCT03117049|66289815|FG000|Overall Study|Died|82|||
23703411|NCT03117049|66289816|FG001|Overall Study|Died|93|||
23703412|NCT03117049|66289815|FG000|Overall Study|Consent withdrawal|7|||
23703413|NCT03117049|66289816|FG001|Overall Study|Consent withdrawal|6|||
23703414|NCT03117049|66289815|FG000|Overall Study|Missing contact|3|||
23703415|NCT03117049|66289816|FG001|Overall Study|Missing contact|3|||
23703416|NCT00320385|66289817|FG000|Overall Study|Lost to Follow-up|7|||
23703417|NCT00320385|66289818|FG001|Overall Study|Lost to Follow-up|10|||
23703418|NCT00320385|66289817|FG000|Overall Study|Withdrawal by Subject|6|||
23703419|NCT00320385|66289818|FG001|Overall Study|Withdrawal by Subject|7|||
23703420|NCT00320385|66289817|FG000|Overall Study|Sponsor Terminated Study|2|||
23703421|NCT00320385|66289818|FG001|Overall Study|Sponsor Terminated Study|1|||
23703422|NCT00320385|66289817|FG000|Overall Study|Investigator Decision|0|||
23703423|NCT00320385|66289818|FG001|Overall Study|Investigator Decision|1|||
23703424|NCT00320385|66289817|FG000|Overall Study|Death|1|||
23703425|NCT00320385|66289818|FG001|Overall Study|Death|2|||
23703426|NCT00320385|66289817|FG000|Overall Study|Serious Adverse Event|1|||
23703427|NCT00320385|66289818|FG001|Overall Study|Serious Adverse Event|0|||
23703428|NCT00320385|66289817|FG000|Overall Study|Withdrew Consent|1|||
23703429|NCT00320385|66289818|FG001|Overall Study|Withdrew Consent|0|||
23703430|NCT00320385|66289817|FG000|Overall Study|Adverse Event|0|||
23703431|NCT00320385|66289818|FG001|Overall Study|Adverse Event|1|||
23703432|NCT01655823|66289820|FG000|Overall Study|Lost to Follow-up|0|||
23703433|NCT01655823|66289821|FG001|Overall Study|Lost to Follow-up|1|||
23703434|NCT01655823|66289822|FG002|Overall Study|Lost to Follow-up|0|||
23703435|NCT01655823|66289823|FG003|Overall Study|Lost to Follow-up|0|||
23703436|NCT01655823|66289824|FG004|Overall Study|Lost to Follow-up|1|||
23703437|NCT01655823|66289820|FG000|Overall Study|Withdrawal by Subject|0|||
23703438|NCT01655823|66289821|FG001|Overall Study|Withdrawal by Subject|1|||
23703439|NCT01655823|66289822|FG002|Overall Study|Withdrawal by Subject|0|||
23703440|NCT01655823|66289823|FG003|Overall Study|Withdrawal by Subject|1|||
23703441|NCT01655823|66289824|FG004|Overall Study|Withdrawal by Subject|0|||
23703442|NCT02775864|66289828|FG000|Overall Study|Data ended end of 2010|1764|||
23703443|NCT02775864|66289829|FG001|Overall Study|Data ended end of 2010|2880|||
23703444|NCT02775864|66289830|FG002|Overall Study|Data ended end of 2010|1140|||
23703445|NCT02775864|66289831|FG003|Overall Study|Data ended end of 2010|1194|||
23703446|NCT02775864|66289828|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
23703447|NCT02775864|66289829|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
23703448|NCT02775864|66289830|FG002|Overall Study|Medicaid eligibility discontinued|720|||
23703449|NCT02775864|66289831|FG003|Overall Study|Medicaid eligibility discontinued|890|||
23703450|NCT00536978|66289834|FG000|Overall Study|Not eligible for Adback Infusion|22|||
23703451|NCT03268746|66289837|FG000|Overall Study|Withdrawal by Subject|1|||
23703452|NCT01765764|66289840|FG000|Treatment Period|Adverse Event|1|||
23703453|NCT01765764|66289841|FG001|Treatment Period|Adverse Event|2|||
23703454|NCT01765764|66289842|FG002|Treatment Period|Adverse Event|1|||
23703455|NCT01765764|66289840|FG000|Treatment Period|Lost to Follow-up|0|||
23703456|NCT01765764|66289841|FG001|Treatment Period|Lost to Follow-up|3|||
23703457|NCT01765764|66289842|FG002|Treatment Period|Lost to Follow-up|2|||
23703458|NCT01765764|66289840|FG000|Treatment Period|Personal Reasons|1|||
23703459|NCT01765764|66289841|FG001|Treatment Period|Personal Reasons|2|||
23703460|NCT01765764|66289842|FG002|Treatment Period|Personal Reasons|1|||
23703461|NCT01765764|66289840|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
23703462|NCT01765764|66289841|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
23703463|NCT01765764|66289842|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
23703464|NCT00084682|66289843|FG000|Overall Study|Withdrawal by Subject|1|||
23703465|NCT01614769|66289844|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
23703466|NCT01614769|66289845|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
23703467|NCT01614769|66289846|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
23703468|NCT01614769|66289847|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
23703469|NCT01614769|66289848|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
23703470|NCT01614769|66289849|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
23703471|NCT01614769|66289844|FG000|Period 1|Protocol Violation|0|||
23703472|NCT01614769|66289845|FG001|Period 1|Protocol Violation|0|||
23703473|NCT01614769|66289846|FG002|Period 1|Protocol Violation|0|||
23703474|NCT01614769|66289847|FG003|Period 1|Protocol Violation|1|||
23703475|NCT01614769|66289848|FG004|Period 1|Protocol Violation|0|||
23703476|NCT01614769|66289849|FG005|Period 1|Protocol Violation|0|||
23703477|NCT01614769|66289844|FG000|Period 1|Withdrawal by Subject|1|||
23703478|NCT01614769|66289845|FG001|Period 1|Withdrawal by Subject|0|||
23703479|NCT01614769|66289846|FG002|Period 1|Withdrawal by Subject|0|||
23703480|NCT01614769|66289847|FG003|Period 1|Withdrawal by Subject|0|||
23703481|NCT01614769|66289848|FG004|Period 1|Withdrawal by Subject|0|||
23703482|NCT01614769|66289849|FG005|Period 1|Withdrawal by Subject|0|||
23703483|NCT01614769|66289844|FG000|Period 3|Withdrawal by Subject|0|||
23703484|NCT01614769|66289845|FG001|Period 3|Withdrawal by Subject|0|||
23703485|NCT01614769|66289846|FG002|Period 3|Withdrawal by Subject|1|||
23703486|NCT01614769|66289847|FG003|Period 3|Withdrawal by Subject|0|||
23703487|NCT01614769|66289848|FG004|Period 3|Withdrawal by Subject|0|||
23703488|NCT01614769|66289849|FG005|Period 3|Withdrawal by Subject|0|||
23703489|NCT02086565|66289850|FG000|Overall Study|Lost to Follow-up|9|||
23703490|NCT02086565|66289851|FG001|Overall Study|Lost to Follow-up|7|||
23703491|NCT02086565|66289850|FG000|Overall Study|Withdrawal by Subject|2|||
23703492|NCT02086565|66289851|FG001|Overall Study|Withdrawal by Subject|1|||
23703493|NCT02086565|66289850|FG000|Overall Study|Death|3|||
23703494|NCT02086565|66289851|FG001|Overall Study|Death|2|||
23703495|NCT02086565|66289850|FG000|Overall Study|withdrawn by research team|2|||
23703496|NCT02086565|66289851|FG001|Overall Study|withdrawn by research team|2|||
23703497|NCT03977727|66289852|FG000|Second Treatment|Lost to Follow-up|0|||
23703498|NCT03977727|66289853|FG001|Second Treatment|Lost to Follow-up|3|||
23703499|NCT00369668|66289854|FG000|Overall Study|Lack of Efficacy|4|||
23703500|NCT00369668|66289855|FG001|Overall Study|Lack of Efficacy|5|||
23703501|NCT00369668|66289856|FG002|Overall Study|Lack of Efficacy|7|||
23703502|NCT00705224|66289859|FG000|Overall Study|Adverse Event|1|||
23703503|NCT00705224|66289859|FG000|Overall Study|Lack of Efficacy|2|||
23703504|NCT00705224|66289859|FG000|Overall Study|Withdrawal by Subject|3|||
23703505|NCT00705224|66289859|FG000|Overall Study|Lost to Follow-up|5|||
23703506|NCT01873742|66289866|FG000|Overall Study|Lost to Follow-up|68|||
23703507|NCT01873742|66289867|FG001|Overall Study|Lost to Follow-up|76|||
23703508|NCT04070378|66289868|FG000|Overall Study|Withdrawal by Subject|2|||
23703509|NCT04070378|66289868|FG000|Overall Study|Screen Failure|6|||
23703510|NCT04070378|66289868|FG000|Overall Study|Physician Decision|1|||
23703511|NCT04070378|66289868|FG000|Overall Study|Adverse Event|1|||
23703512|NCT02065869|66289870|FG000|Overall Study|Death|7|||
23703513|NCT02065869|66289870|FG000|Overall Study|Disease relapse|16|||
23703514|NCT02065869|66289870|FG000|Overall Study|Lost to Follow-up|4|||
23703515|NCT02065869|66289870|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
23703516|NCT02065869|66289870|FG000|Overall Study|Withdrawal by Subject|1|||
23703517|NCT02084134|66289871|FG000|Overall Study|Protocol Violation|4|||
23703518|NCT02084134|66289872|FG001|Overall Study|Protocol Violation|2|||
23703519|NCT02084134|66289871|FG000|Overall Study|Death|0|||
23703520|NCT02084134|66289872|FG001|Overall Study|Death|1|||
23703521|NCT01539837|66289875|FG000|Overall Study|reduce neutrophil level|0|||
23703522|NCT01539837|66289876|FG001|Overall Study|reduce neutrophil level|1|||
23703523|NCT01539837|66289877|FG002|Overall Study|reduce neutrophil level|1|||
23703524|NCT01539837|66289875|FG000|Overall Study|bad compliance|0|||
23703525|NCT01539837|66289876|FG001|Overall Study|bad compliance|0|||
23703526|NCT01539837|66289877|FG002|Overall Study|bad compliance|1|||
23703527|NCT01993329|66289882|FG000|Period 2|Adverse Event|0|||
23703528|NCT01993329|66289883|FG001|Period 2|Adverse Event|0|||
23703529|NCT01993329|66289884|FG002|Period 2|Adverse Event|0|||
23703530|NCT01993329|66289885|FG003|Period 2|Adverse Event|0|||
23703531|NCT01993329|66289886|FG004|Period 2|Adverse Event|0|||
23703532|NCT01993329|66289887|FG005|Period 2|Adverse Event|1|||
23703533|NCT01993329|66289882|FG000|Wash-out|Personal reasons|0|||
23703534|NCT01993329|66289883|FG001|Wash-out|Personal reasons|1|||
23703535|NCT01993329|66289884|FG002|Wash-out|Personal reasons|0|||
23703536|NCT01993329|66289885|FG003|Wash-out|Personal reasons|0|||
23703537|NCT01993329|66289886|FG004|Wash-out|Personal reasons|0|||
23703538|NCT01993329|66289887|FG005|Wash-out|Personal reasons|0|||
23703539|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
23703540|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
23703541|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
23703542|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
23703543|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
23703544|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
23703545|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
23703546|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
23703547|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
23703548|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
23703549|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
23703550|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
23703551|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
23703552|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
23703553|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
23703554|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
23703555|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
23703556|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
23703557|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
23703558|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
23703559|NCT01259492|66289888|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
23703560|NCT01259492|66289889|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
23703561|NCT01259492|66289890|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
23703562|NCT01259492|66289891|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
23703563|NCT01259492|66289888|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
23703564|NCT01259492|66289889|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
23703565|NCT01259492|66289890|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
23703566|NCT01259492|66289891|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
23703567|NCT01259492|66289888|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
23703568|NCT01259492|66289889|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
23703569|NCT01259492|66289890|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
23703570|NCT01259492|66289891|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
23703571|NCT01259492|66289888|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
23703572|NCT01259492|66289889|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
23703573|NCT01259492|66289890|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
23703574|NCT01259492|66289891|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
23703575|NCT01259492|66289888|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23703576|NCT01259492|66289889|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23703577|NCT01259492|66289890|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
23703578|NCT01259492|66289891|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23703579|NCT01259492|66289888|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
23703580|NCT01259492|66289889|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
23703581|NCT01259492|66289890|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
23703582|NCT01259492|66289891|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
23703583|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
23703584|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
23703585|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
23703586|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
23703587|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23703588|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23703589|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23703590|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
23703591|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23703592|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23703593|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
23703594|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23703595|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
23703596|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
23703597|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
23703598|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
23703599|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
23703600|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23703601|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23703602|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23703603|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
23703604|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
23703605|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
23703606|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
23703607|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
23703608|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
23703609|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
23703610|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
23703611|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23703612|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23703613|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
23703614|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23703615|NCT01259492|66289888|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
23703616|NCT01259492|66289889|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
23703617|NCT01259492|66289890|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
23703618|NCT01259492|66289891|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
23703619|NCT01629667|66289894|FG000|Overall Study|Lost to Follow-up|0|||
23703620|NCT01629667|66289895|FG001|Overall Study|Lost to Follow-up|1|||
23703621|NCT01629667|66289896|FG002|Overall Study|Lost to Follow-up|1|||
23703622|NCT01629667|66289894|FG000|Overall Study|Withdrawal by Subject|31|||
23703623|NCT01629667|66289895|FG001|Overall Study|Withdrawal by Subject|20|||
23703624|NCT01629667|66289896|FG002|Overall Study|Withdrawal by Subject|28|||
23703625|NCT01629667|66289894|FG000|Overall Study|Death|1|||
23703626|NCT01629667|66289895|FG001|Overall Study|Death|5|||
23703627|NCT01629667|66289896|FG002|Overall Study|Death|3|||
23703628|NCT01629667|66289894|FG000|Overall Study|Randomized, not treated|2|||
23703629|NCT01629667|66289895|FG001|Overall Study|Randomized, not treated|1|||
23703630|NCT01629667|66289896|FG002|Overall Study|Randomized, not treated|0|||
23703631|NCT01629667|66289894|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
23703632|NCT01629667|66289895|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
23703633|NCT01629667|66289896|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
23703634|NCT01629667|66289894|FG000|Overall Study|Requiring lung transplant|2|||
23703635|NCT01629667|66289895|FG001|Overall Study|Requiring lung transplant|1|||
23703636|NCT01629667|66289896|FG002|Overall Study|Requiring lung transplant|3|||
23703637|NCT01629667|66289894|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
23703638|NCT01629667|66289895|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
23703639|NCT01629667|66289896|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
23399894|NCT00237042|65210738|FG001|Treatment|Completed no treatment|5|||
23703640|NCT01629667|66289894|FG000|Overall Study|Started other medicine|1|||
23703641|NCT01629667|66289895|FG001|Overall Study|Started other medicine|0|||
23703642|NCT01629667|66289896|FG002|Overall Study|Started other medicine|1|||
23703643|NCT01629667|66289894|FG000|Overall Study|Site error in safety follow-up|0|||
23703644|NCT01629667|66289895|FG001|Overall Study|Site error in safety follow-up|0|||
23703645|NCT01629667|66289896|FG002|Overall Study|Site error in safety follow-up|1|||
23703646|NCT01629667|66289894|FG000|Overall Study|Enrolled in another clinical study|0|||
23703647|NCT01629667|66289895|FG001|Overall Study|Enrolled in another clinical study|1|||
23703648|NCT01629667|66289896|FG002|Overall Study|Enrolled in another clinical study|0|||
23703649|NCT01629667|66289894|FG000|Overall Study|Code break|1|||
23703650|NCT01629667|66289895|FG001|Overall Study|Code break|0|||
23703651|NCT01629667|66289896|FG002|Overall Study|Code break|0|||
23703652|NCT01754922|66289898|FG000|Overall Study|Adverse Event|0|||
23703653|NCT01754922|66289899|FG001|Overall Study|Adverse Event|1|||
23703654|NCT00243230|66289903|FG000|Double-Blind Period|Adverse Event|0|||
23703655|NCT00243230|66289904|FG001|Double-Blind Period|Adverse Event|2|||
23703656|NCT00243230|66289905|FG002|Double-Blind Period|Adverse Event|2|||
23703657|NCT00243230|66289906|FG003|Double-Blind Period|Adverse Event|0|||
23703658|NCT00243230|66289903|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23703659|NCT00243230|66289904|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23703660|NCT00243230|66289905|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23703661|NCT00243230|66289906|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23703662|NCT00243230|66289903|FG000|Double-Blind Period|Protocol Violation|0|||
23703663|NCT00243230|66289904|FG001|Double-Blind Period|Protocol Violation|0|||
23703664|NCT00243230|66289905|FG002|Double-Blind Period|Protocol Violation|1|||
23703665|NCT00243230|66289906|FG003|Double-Blind Period|Protocol Violation|0|||
23703666|NCT00243230|66289903|FG000|Double-Blind Period|Randomized but Not Treated|0|||
23703667|NCT00243230|66289904|FG001|Double-Blind Period|Randomized but Not Treated|0|||
23703668|NCT00243230|66289905|FG002|Double-Blind Period|Randomized but Not Treated|2|||
23703669|NCT00243230|66289906|FG003|Double-Blind Period|Randomized but Not Treated|0|||
23703670|NCT00243230|66289903|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
23703671|NCT00243230|66289904|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
23703672|NCT00243230|66289905|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
23703673|NCT00243230|66289906|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
23703674|NCT00243230|66289903|FG000|Open Label Period|Adverse Event|0|||
23703675|NCT00243230|66289904|FG001|Open Label Period|Adverse Event|0|||
23703676|NCT00243230|66289905|FG002|Open Label Period|Adverse Event|0|||
23703677|NCT00243230|66289906|FG003|Open Label Period|Adverse Event|2|||
23703678|NCT00243230|66289903|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
23703679|NCT00243230|66289904|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
23703680|NCT00243230|66289905|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
23703681|NCT00243230|66289906|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
23703682|NCT00243230|66289903|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23703683|NCT00243230|66289904|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23703684|NCT00243230|66289905|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23703685|NCT00243230|66289906|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
23703686|NCT00243230|66289903|FG000|Open Label Period|Lost to Follow-up|0|||
23703687|NCT00243230|66289904|FG001|Open Label Period|Lost to Follow-up|0|||
23703688|NCT00243230|66289905|FG002|Open Label Period|Lost to Follow-up|0|||
23703689|NCT00243230|66289906|FG003|Open Label Period|Lost to Follow-up|2|||
23703690|NCT00243230|66289903|FG000|Open Label Period|Withdrawal by Subject|0|||
23703691|NCT00243230|66289904|FG001|Open Label Period|Withdrawal by Subject|0|||
23703692|NCT00243230|66289905|FG002|Open Label Period|Withdrawal by Subject|0|||
23703693|NCT00243230|66289906|FG003|Open Label Period|Withdrawal by Subject|2|||
23703694|NCT00243230|66289903|FG000|Open Label Period|Protocol Violation|0|||
23703695|NCT00243230|66289904|FG001|Open Label Period|Protocol Violation|0|||
23703696|NCT00243230|66289905|FG002|Open Label Period|Protocol Violation|0|||
23703697|NCT00243230|66289906|FG003|Open Label Period|Protocol Violation|2|||
23703698|NCT00243230|66289903|FG000|Open Label Period|Administrative Reason|0|||
23703699|NCT00243230|66289904|FG001|Open Label Period|Administrative Reason|0|||
23703700|NCT00243230|66289905|FG002|Open Label Period|Administrative Reason|0|||
23703701|NCT00243230|66289906|FG003|Open Label Period|Administrative Reason|63|||
23703702|NCT03011840|66289907|FG000|Overall Study|Not received PIL in post PIL phase|0|||
23703703|NCT03011840|66289908|FG001|Overall Study|Not received PIL in post PIL phase|21|||
23703704|NCT00641043|66289909|FG000|Overall Study|Adverse Event|6|||
23703705|NCT00641043|66289910|FG001|Overall Study|Adverse Event|4|||
23703706|NCT00641043|66289909|FG000|Overall Study|Protocol Violation|2|||
23703707|NCT00641043|66289910|FG001|Overall Study|Protocol Violation|3|||
23703708|NCT00641043|66289909|FG000|Overall Study|Lost to Follow-up|3|||
23703709|NCT00641043|66289910|FG001|Overall Study|Lost to Follow-up|2|||
23703710|NCT00641043|66289909|FG000|Overall Study|Withdrawal by Subject|4|||
23703711|NCT00641043|66289910|FG001|Overall Study|Withdrawal by Subject|4|||
23703712|NCT00641043|66289909|FG000|Overall Study|Other incl. lack of efficacy|4|||
23703713|NCT00641043|66289910|FG001|Overall Study|Other incl. lack of efficacy|2|||
23703714|NCT02075255|66289913|FG000|Overall Study|Study specific withdrawal criteria|0|||
23703715|NCT02075255|66289914|FG001|Overall Study|Study specific withdrawal criteria|1|||
23703716|NCT02075255|66289915|FG002|Overall Study|Study specific withdrawal criteria|1|||
23703717|NCT02075255|66289913|FG000|Overall Study|Withdrawal by Subject|4|||
23703718|NCT02075255|66289914|FG001|Overall Study|Withdrawal by Subject|1|||
23703719|NCT02075255|66289915|FG002|Overall Study|Withdrawal by Subject|0|||
23703720|NCT02075255|66289913|FG000|Overall Study|Lost to Follow-up|0|||
23703721|NCT02075255|66289914|FG001|Overall Study|Lost to Follow-up|0|||
23703722|NCT02075255|66289915|FG002|Overall Study|Lost to Follow-up|1|||
23703723|NCT02075255|66289913|FG000|Overall Study|Adverse Event|0|||
23703724|NCT02075255|66289914|FG001|Overall Study|Adverse Event|0|||
23703725|NCT02075255|66289915|FG002|Overall Study|Adverse Event|1|||
23703726|NCT02075255|66289913|FG000|Overall Study|Death|0|||
23703727|NCT02075255|66289914|FG001|Overall Study|Death|2|||
23703728|NCT02075255|66289915|FG002|Overall Study|Death|0|||
23703729|NCT02606045|66289920|FG000|Overall Study|Study closed before treament could begin|1|||
23703730|NCT02606045|66289921|FG001|Overall Study|Study closed before treament could begin|2|||
23703731|NCT01199263|66289922|FG000|Overall Study|Ineligible|0|||
23703732|NCT01199263|66289923|FG001|Overall Study|Ineligible|2|||
23703733|NCT01199263|66289922|FG000|Overall Study|Never Treated|6|||
23703734|NCT01199263|66289923|FG001|Overall Study|Never Treated|0|||
23703735|NCT01103349|66289924|FG000|Overall Study|Adverse Event|8|||
23703736|NCT01103349|66289925|FG001|Overall Study|Adverse Event|5|||
23703737|NCT01103349|66289926|FG002|Overall Study|Adverse Event|3|||
23703738|NCT01103349|66289924|FG000|Overall Study|Consent withdrawn|1|||
23703739|NCT01103349|66289925|FG001|Overall Study|Consent withdrawn|0|||
23703740|NCT01103349|66289926|FG002|Overall Study|Consent withdrawn|0|||
23703741|NCT01103349|66289924|FG000|Overall Study|Incorrectly included in the trial|1|||
23703742|NCT01103349|66289925|FG001|Overall Study|Incorrectly included in the trial|0|||
23703743|NCT01103349|66289926|FG002|Overall Study|Incorrectly included in the trial|0|||
23703744|NCT01103349|66289924|FG000|Overall Study|Withdrawal by Subject|1|||
23703745|NCT01103349|66289925|FG001|Overall Study|Withdrawal by Subject|1|||
23703746|NCT01103349|66289926|FG002|Overall Study|Withdrawal by Subject|0|||
23703747|NCT01103349|66289924|FG000|Overall Study|did not want to take trial medication|0|||
23703748|NCT01103349|66289925|FG001|Overall Study|did not want to take trial medication|1|||
23703749|NCT01103349|66289926|FG002|Overall Study|did not want to take trial medication|0|||
23703750|NCT01103349|66289924|FG000|Overall Study|forgot to take medication|0|||
23703751|NCT01103349|66289925|FG001|Overall Study|forgot to take medication|0|||
23703752|NCT01103349|66289926|FG002|Overall Study|forgot to take medication|1|||
23703753|NCT01371838|66289928|FG000|Overall Study|Withdrawal by Subject|27|||
23703754|NCT01371838|66289929|FG001|Overall Study|Withdrawal by Subject|33|||
23703755|NCT01371838|66289928|FG000|Overall Study|Lost to Follow-up|10|||
23703756|NCT01371838|66289929|FG001|Overall Study|Lost to Follow-up|20|||
23703757|NCT01371838|66289928|FG000|Overall Study|Death|3|||
23703758|NCT01371838|66289929|FG001|Overall Study|Death|4|||
23703759|NCT01371838|66289928|FG000|Overall Study|Protocol Violation|3|||
23703760|NCT01371838|66289929|FG001|Overall Study|Protocol Violation|0|||
23703761|NCT01371838|66289928|FG000|Overall Study|Investigator Decision|3|||
23703762|NCT01371838|66289929|FG001|Overall Study|Investigator Decision|8|||
23703763|NCT01371838|66289928|FG000|Overall Study|Last follow-up visit not conducted|2|||
23703764|NCT01371838|66289929|FG001|Overall Study|Last follow-up visit not conducted|0|||
23703765|NCT01371838|66289928|FG000|Overall Study|Lack of therapeutic response|0|||
23703766|NCT01371838|66289929|FG001|Overall Study|Lack of therapeutic response|1|||
23703767|NCT01371838|66289928|FG000|Overall Study|Surgery|1|||
23703768|NCT01371838|66289929|FG001|Overall Study|Surgery|0|||
23703769|NCT01814800|66289933|FG000|Overall Study|Adverse Event|2|||
23703770|NCT01814800|66289933|FG000|Overall Study|Pregnancy|1|||
23703771|NCT01814800|66289933|FG000|Overall Study|Sponsor decision|1|||
23703772|NCT01814800|66289933|FG000|Overall Study|Subject relocation|1|||
23703773|NCT02680847|66289941|FG000|Overall Study|Other|2|||
23703774|NCT02680847|66289942|FG001|Overall Study|Other|0|||
23703775|NCT02680847|66289943|FG002|Overall Study|Other|0|||
23703776|NCT02680847|66289941|FG000|Overall Study|No longer met eligibility criteria|2|||
23703777|NCT02680847|66289942|FG001|Overall Study|No longer met eligibility criteria|2|||
23703778|NCT02680847|66289943|FG002|Overall Study|No longer met eligibility criteria|0|||
23703779|NCT02680847|66289941|FG000|Overall Study|Unwilling to participate in study|1|||
23703780|NCT02680847|66289942|FG001|Overall Study|Unwilling to participate in study|1|||
23703781|NCT02680847|66289943|FG002|Overall Study|Unwilling to participate in study|0|||
23703782|NCT02680847|66289941|FG000|Overall Study|Lack of Efficacy|0|||
23703783|NCT02680847|66289942|FG001|Overall Study|Lack of Efficacy|0|||
23703784|NCT02680847|66289943|FG002|Overall Study|Lack of Efficacy|2|||
23703785|NCT02680847|66289941|FG000|Overall Study|Adverse Event|0|||
23703786|NCT02680847|66289942|FG001|Overall Study|Adverse Event|0|||
23703787|NCT02680847|66289943|FG002|Overall Study|Adverse Event|1|||
23703788|NCT00830037|66289951|FG000|Overall Study|Withdrawal by Subject|2|||
23703789|NCT00830037|66289952|FG001|Overall Study|Withdrawal by Subject|3|||
23703790|NCT00830037|66289951|FG000|Overall Study|Lost to Follow-up|1|||
23703791|NCT00830037|66289952|FG001|Overall Study|Lost to Follow-up|2|||
23703792|NCT00830037|66289951|FG000|Overall Study|Active when terminated by DSMB|15|||
23703793|NCT00830037|66289952|FG001|Overall Study|Active when terminated by DSMB|14|||
23399895|NCT00237042|65210739|FG002|Treatment|Completed no treatment|21|||
23399896|NCT00237042|65210737|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
23399897|NCT00237042|65210738|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
23399898|NCT00237042|65210739|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
23703794|NCT01158534|66289953|FG000|Overall Study|Withdrawal by Subject|1|||
23703795|NCT01158534|66289953|FG000|Overall Study|Death|1|||
23703796|NCT01158534|66289953|FG000|Overall Study|Other|1|||
23703797|NCT01108809|66289954|FG000|Overall Study|Adverse Event|3|||
23703798|NCT01108809|66289954|FG000|Overall Study|Lost to Follow-up|1|||
23703799|NCT00700752|66289955|FG000|First Intervention|Withdrawal by Subject|0|||
23703800|NCT00700752|66289956|FG001|First Intervention|Withdrawal by Subject|2|||
23703801|NCT02495077|66289957|FG000|Overall Study|Adverse Event|0|||
23703802|NCT02495077|66289958|FG001|Overall Study|Adverse Event|1|||
23703803|NCT02495077|66289959|FG002|Overall Study|Adverse Event|1|||
23703804|NCT02495077|66289960|FG003|Overall Study|Adverse Event|0|||
23703805|NCT02495077|66289957|FG000|Overall Study|Death|3|||
23703806|NCT02495077|66289958|FG001|Overall Study|Death|5|||
23703807|NCT02495077|66289959|FG002|Overall Study|Death|0|||
23703808|NCT02495077|66289960|FG003|Overall Study|Death|0|||
23703809|NCT02495077|66289957|FG000|Overall Study|Lost to Follow-up|6|||
23703810|NCT02495077|66289958|FG001|Overall Study|Lost to Follow-up|4|||
23703811|NCT02495077|66289959|FG002|Overall Study|Lost to Follow-up|0|||
23703812|NCT02495077|66289960|FG003|Overall Study|Lost to Follow-up|0|||
23703813|NCT02495077|66289957|FG000|Overall Study|Physician Decision|2|||
23703814|NCT02495077|66289958|FG001|Overall Study|Physician Decision|1|||
23703815|NCT02495077|66289959|FG002|Overall Study|Physician Decision|4|||
23703816|NCT02495077|66289960|FG003|Overall Study|Physician Decision|0|||
23703817|NCT02495077|66289957|FG000|Overall Study|Protocol Violation|0|||
23703818|NCT02495077|66289958|FG001|Overall Study|Protocol Violation|1|||
23703819|NCT02495077|66289959|FG002|Overall Study|Protocol Violation|0|||
23703820|NCT02495077|66289960|FG003|Overall Study|Protocol Violation|0|||
23703821|NCT02495077|66289957|FG000|Overall Study|Screen Failure|0|||
23703822|NCT02495077|66289958|FG001|Overall Study|Screen Failure|0|||
23703823|NCT02495077|66289959|FG002|Overall Study|Screen Failure|0|||
23703824|NCT02495077|66289960|FG003|Overall Study|Screen Failure|48|||
23703825|NCT02495077|66289957|FG000|Overall Study|Withdrawal by Subject|7|||
23703826|NCT02495077|66289958|FG001|Overall Study|Withdrawal by Subject|7|||
23703827|NCT02495077|66289959|FG002|Overall Study|Withdrawal by Subject|7|||
23703828|NCT02495077|66289960|FG003|Overall Study|Withdrawal by Subject|0|||
23703829|NCT02495077|66289957|FG000|Overall Study|Covid-19 research restrictions|1|||
23703830|NCT02495077|66289958|FG001|Overall Study|Covid-19 research restrictions|0|||
23703831|NCT02495077|66289959|FG002|Overall Study|Covid-19 research restrictions|0|||
23703832|NCT02495077|66289960|FG003|Overall Study|Covid-19 research restrictions|0|||
23703833|NCT02495077|66289957|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
23703834|NCT02495077|66289958|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
23703835|NCT02495077|66289959|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
23703836|NCT02495077|66289960|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
23703837|NCT02495077|66289957|FG000|Overall Study|Incarcerated|0|||
23703838|NCT02495077|66289958|FG001|Overall Study|Incarcerated|1|||
23703839|NCT02495077|66289959|FG002|Overall Study|Incarcerated|0|||
23703840|NCT02495077|66289960|FG003|Overall Study|Incarcerated|0|||
23703841|NCT02495077|66289957|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
23703842|NCT02495077|66289958|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
23703843|NCT02495077|66289959|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
23703844|NCT02495077|66289960|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
23703845|NCT02495077|66289957|FG000|Overall Study|Timing of transplant and randomization|0|||
23703846|NCT02495077|66289958|FG001|Overall Study|Timing of transplant and randomization|0|||
23703847|NCT02495077|66289959|FG002|Overall Study|Timing of transplant and randomization|5|||
23703848|NCT02495077|66289960|FG003|Overall Study|Timing of transplant and randomization|0|||
23703849|NCT01455428|66289961|FG000|Overall Study|Protocol Violation|2|||
23703850|NCT01455428|66289962|FG001|Overall Study|Protocol Violation|1|||
23703851|NCT01455428|66289961|FG000|Overall Study|Adverse Event|6|||
23703852|NCT01455428|66289962|FG001|Overall Study|Adverse Event|2|||
23703853|NCT01455428|66289961|FG000|Overall Study|Lost to Follow-up|1|||
23703854|NCT01455428|66289962|FG001|Overall Study|Lost to Follow-up|1|||
23703855|NCT01455428|66289961|FG000|Overall Study|Withdrawal by Subject|2|||
23703856|NCT01455428|66289962|FG001|Overall Study|Withdrawal by Subject|5|||
23703857|NCT01455428|66289961|FG000|Overall Study|Did not meet entrance criteria|0|||
23703858|NCT01455428|66289962|FG001|Overall Study|Did not meet entrance criteria|2|||
23703859|NCT01455428|66289961|FG000|Overall Study|Insufficient clinical response|0|||
23703860|NCT01455428|66289962|FG001|Overall Study|Insufficient clinical response|2|||
23703861|NCT01455428|66289961|FG000|Overall Study|Did not receive treatment|1|||
23399899|NCT00237042|65210737|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
23399900|NCT00237042|65210738|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
23399901|NCT00237042|65210739|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
23399902|NCT02300233|65210740|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
23399903|NCT02300233|65210741|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23399904|NCT02300233|65210742|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
23399905|NCT02300233|65210740|FG000|Overall Study|Withdrawal by Subject|1|||
23399906|NCT02300233|65210741|FG001|Overall Study|Withdrawal by Subject|0|||
23399907|NCT02300233|65210742|FG002|Overall Study|Withdrawal by Subject|3|||
23399908|NCT02300233|65210740|FG000|Overall Study|Investigator Judgement|0|||
23399909|NCT02300233|65210741|FG001|Overall Study|Investigator Judgement|0|||
23399910|NCT02300233|65210742|FG002|Overall Study|Investigator Judgement|1|||
23399911|NCT02300233|65210740|FG000|Overall Study|Reason Not Specified|0|||
23399912|NCT02300233|65210741|FG001|Overall Study|Reason Not Specified|0|||
23399913|NCT02300233|65210742|FG002|Overall Study|Reason Not Specified|5|||
23399914|NCT01193101|65210743|FG000|Overall Study|Adverse Event|0|||
23399915|NCT01193101|65210744|FG001|Overall Study|Adverse Event|1|||
23399916|NCT01193101|65210745|FG002|Overall Study|Adverse Event|1|||
23399917|NCT01193101|65210746|FG003|Overall Study|Adverse Event|3|||
23399918|NCT01193101|65210743|FG000|Overall Study|Lack of Efficacy|3|||
23399919|NCT01193101|65210744|FG001|Overall Study|Lack of Efficacy|1|||
23399920|NCT01193101|65210745|FG002|Overall Study|Lack of Efficacy|0|||
23399921|NCT01193101|65210746|FG003|Overall Study|Lack of Efficacy|8|||
23399922|NCT01193101|65210743|FG000|Overall Study|Withdrawal by Subject|2|||
23399923|NCT01193101|65210744|FG001|Overall Study|Withdrawal by Subject|4|||
23399924|NCT01193101|65210745|FG002|Overall Study|Withdrawal by Subject|1|||
23399925|NCT01193101|65210746|FG003|Overall Study|Withdrawal by Subject|1|||
23502602|NCT04659161|65580254|FG001|Overall Study|Withdrawal by Subject|12|||
23502603|NCT04659161|65580253|FG000|Overall Study|Other|9|||
23502604|NCT04659161|65580254|FG001|Overall Study|Other|8|||
23502605|NCT03288129|65580258|FG000|Overall Study|Adverse Event|10|||
23502606|NCT03288129|65580258|FG000|Overall Study|Lost to Follow-up|3|||
23502607|NCT03288129|65580258|FG000|Overall Study|Withdrawal by Subject|3|||
23502608|NCT03288129|65580258|FG000|Overall Study|Withdrawal of consent/assent|1|||
23502609|NCT03288129|65580258|FG000|Overall Study|Other|5|||
23502610|NCT04439110|65580259|FG000|Overall Study|Ineligible|2|||
23502611|NCT04439110|65580259|FG000|Overall Study|Adverse Event|4|||
23502612|NCT04439110|65580259|FG000|Overall Study|Death|2|||
23502613|NCT04439110|65580259|FG000|Overall Study|Disease proression|25|||
23502614|NCT04439110|65580259|FG000|Overall Study|Withdrawal by Subject|1|||
23502615|NCT04439110|65580259|FG000|Overall Study|Alternative therapy|1|||
23502616|NCT04439110|65580259|FG000|Overall Study|Other complicating disease|1|||
23502617|NCT04439110|65580259|FG000|Overall Study|Personal reasons|1|||
23502618|NCT04439110|65580259|FG000|Overall Study|Still on treatment|1|||
23502619|NCT01550289|65580263|FG000|Overall Study|Protocol Violation|1|||
23502620|NCT01550289|65580264|FG001|Overall Study|Protocol Violation|0|||
23502621|NCT01550289|65580263|FG000|Overall Study|Lost to Follow-up|1|||
23502622|NCT01550289|65580264|FG001|Overall Study|Lost to Follow-up|1|||
23502623|NCT01550289|65580263|FG000|Overall Study|Withdrawal by Subject|11|||
23502624|NCT01550289|65580264|FG001|Overall Study|Withdrawal by Subject|3|||
23502625|NCT00826943|65580265|FG000|Overall Study|Withdrawal by Subject|0|||
23399926|NCT01193101|65210743|FG000|Overall Study|Administrative problems|0|||
23399927|NCT01193101|65210744|FG001|Overall Study|Administrative problems|0|||
23399928|NCT01193101|65210745|FG002|Overall Study|Administrative problems|1|||
23399929|NCT01193101|65210746|FG003|Overall Study|Administrative problems|0|||
23399930|NCT01193101|65210743|FG000|Overall Study|Abnormal test procedure results|0|||
23399931|NCT01193101|65210744|FG001|Overall Study|Abnormal test procedure results|1|||
23399932|NCT01193101|65210745|FG002|Overall Study|Abnormal test procedure results|0|||
23399933|NCT01193101|65210746|FG003|Overall Study|Abnormal test procedure results|0|||
23399934|NCT03692403|65210747|FG000|Overall Study|Withdrawal by Subject|1|||
23399935|NCT03692403|65210748|FG001|Overall Study|Withdrawal by Subject|0|||
23399936|NCT03692403|65210749|FG002|Overall Study|Withdrawal by Subject|1|||
23399937|NCT03692403|65210750|FG003|Overall Study|Withdrawal by Subject|0|||
23399938|NCT03692403|65210747|FG000|Overall Study|Adverse Event|0|||
23399939|NCT03692403|65210748|FG001|Overall Study|Adverse Event|0|||
23399940|NCT03692403|65210749|FG002|Overall Study|Adverse Event|0|||
23399941|NCT03692403|65210750|FG003|Overall Study|Adverse Event|1|||
23399942|NCT03692403|65210747|FG000|Overall Study|Pregnancy|0|||
23399943|NCT03692403|65210748|FG001|Overall Study|Pregnancy|1|||
23399944|NCT03692403|65210749|FG002|Overall Study|Pregnancy|0|||
23502626|NCT00826943|65580266|FG001|Overall Study|Withdrawal by Subject|0|||
23502627|NCT00826943|65580267|FG002|Overall Study|Withdrawal by Subject|0|||
23502628|NCT00826943|65580268|FG003|Overall Study|Withdrawal by Subject|0|||
23502629|NCT00826943|65580269|FG004|Overall Study|Withdrawal by Subject|1|||
23502630|NCT00826943|65580270|FG005|Overall Study|Withdrawal by Subject|0|||
23502631|NCT00042289|65580271|FG000|Overall Study|Lost to Follow-up|3|||
23502632|NCT00042289|65580272|FG001|Overall Study|Lost to Follow-up|0|||
23502633|NCT00042289|65580273|FG002|Overall Study|Lost to Follow-up|0|||
23502634|NCT00042289|65580274|FG003|Overall Study|Lost to Follow-up|1|||
23502635|NCT00042289|65580275|FG004|Overall Study|Lost to Follow-up|3|||
23502636|NCT00042289|65580276|FG005|Overall Study|Lost to Follow-up|3|||
23502637|NCT00042289|65580277|FG006|Overall Study|Lost to Follow-up|6|||
23502638|NCT00042289|65580278|FG007|Overall Study|Lost to Follow-up|1|||
23502639|NCT00042289|65580279|FG008|Overall Study|Lost to Follow-up|1|||
23502640|NCT00042289|65580280|FG009|Overall Study|Lost to Follow-up|0|||
23502641|NCT00042289|65580281|FG010|Overall Study|Lost to Follow-up|0|||
23502642|NCT00042289|65580282|FG011|Overall Study|Lost to Follow-up|0|||
23502643|NCT00042289|65580283|FG012|Overall Study|Lost to Follow-up|0|||
23502644|NCT00042289|65580284|FG013|Overall Study|Lost to Follow-up|0|||
23502645|NCT00042289|65580285|FG014|Overall Study|Lost to Follow-up|0|||
23502646|NCT00042289|65580286|FG015|Overall Study|Lost to Follow-up|1|||
23502647|NCT00042289|65580287|FG016|Overall Study|Lost to Follow-up|1|||
23502648|NCT00042289|65580288|FG017|Overall Study|Lost to Follow-up|0|||
23502649|NCT00042289|65580289|FG018|Overall Study|Lost to Follow-up|3|||
23502650|NCT00042289|65580290|FG019|Overall Study|Lost to Follow-up|2|||
23502651|NCT00042289|65580291|FG020|Overall Study|Lost to Follow-up|0|||
23502652|NCT00042289|65580292|FG021|Overall Study|Lost to Follow-up|0|||
23502653|NCT00042289|65580293|FG022|Overall Study|Lost to Follow-up|0|||
23502654|NCT00042289|65580294|FG023|Overall Study|Lost to Follow-up|0|||
23502655|NCT00042289|65580295|FG024|Overall Study|Lost to Follow-up|0|||
23502656|NCT00042289|65580296|FG025|Overall Study|Lost to Follow-up|0|||
23502657|NCT00042289|65580297|FG026|Overall Study|Lost to Follow-up|2|||
23502658|NCT00042289|65580298|FG027|Overall Study|Lost to Follow-up|2|||
23502659|NCT00042289|65580299|FG028|Overall Study|Lost to Follow-up|2|||
23502660|NCT00042289|65580300|FG029|Overall Study|Lost to Follow-up|0|||
23502661|NCT00042289|65580301|FG030|Overall Study|Lost to Follow-up|0|||
23502662|NCT00042289|65580302|FG031|Overall Study|Lost to Follow-up|2|||
23502663|NCT00042289|65580303|FG032|Overall Study|Lost to Follow-up|1|||
23502664|NCT00042289|65580304|FG033|Overall Study|Lost to Follow-up|1|||
23502665|NCT00042289|65580305|FG034|Overall Study|Lost to Follow-up|1|||
23502666|NCT00042289|65580306|FG035|Overall Study|Lost to Follow-up|2|||
23502667|NCT00042289|65580307|FG036|Overall Study|Lost to Follow-up|1|||
23502668|NCT00042289|65580308|FG037|Overall Study|Lost to Follow-up|1|||
23502669|NCT00042289|65580309|FG038|Overall Study|Lost to Follow-up|0|||
23502670|NCT00042289|65580310|FG039|Overall Study|Lost to Follow-up|5|||
23502671|NCT00042289|65580311|FG040|Overall Study|Lost to Follow-up|0|||
23502672|NCT00042289|65580312|FG041|Overall Study|Lost to Follow-up|2|||
23502673|NCT00042289|65580313|FG042|Overall Study|Lost to Follow-up|2|||
23502674|NCT00042289|65580314|FG043|Overall Study|Lost to Follow-up|0|||
23502675|NCT00042289|65580315|FG044|Overall Study|Lost to Follow-up|0|||
23502676|NCT00042289|65580316|FG045|Overall Study|Lost to Follow-up|1|||
23502677|NCT00042289|65580317|FG046|Overall Study|Lost to Follow-up|0|||
23502678|NCT00042289|65580271|FG000|Overall Study|Other reason|0|||
23502679|NCT00042289|65580272|FG001|Overall Study|Other reason|0|||
23502680|NCT00042289|65580273|FG002|Overall Study|Other reason|0|||
23502681|NCT00042289|65580274|FG003|Overall Study|Other reason|2|||
23502682|NCT00042289|65580275|FG004|Overall Study|Other reason|0|||
23502683|NCT00042289|65580276|FG005|Overall Study|Other reason|0|||
23502684|NCT00042289|65580277|FG006|Overall Study|Other reason|0|||
23502685|NCT00042289|65580278|FG007|Overall Study|Other reason|0|||
23502686|NCT00042289|65580279|FG008|Overall Study|Other reason|0|||
23502687|NCT00042289|65580280|FG009|Overall Study|Other reason|0|||
23502688|NCT00042289|65580281|FG010|Overall Study|Other reason|0|||
23502689|NCT00042289|65580282|FG011|Overall Study|Other reason|0|||
23502690|NCT00042289|65580283|FG012|Overall Study|Other reason|0|||
23502691|NCT00042289|65580284|FG013|Overall Study|Other reason|0|||
23502692|NCT00042289|65580285|FG014|Overall Study|Other reason|0|||
23502693|NCT00042289|65580286|FG015|Overall Study|Other reason|0|||
23502694|NCT00042289|65580287|FG016|Overall Study|Other reason|0|||
23502695|NCT00042289|65580288|FG017|Overall Study|Other reason|0|||
23502696|NCT00042289|65580289|FG018|Overall Study|Other reason|1|||
23502697|NCT00042289|65580290|FG019|Overall Study|Other reason|0|||
23502698|NCT00042289|65580291|FG020|Overall Study|Other reason|0|||
23502699|NCT00042289|65580292|FG021|Overall Study|Other reason|0|||
23502700|NCT00042289|65580293|FG022|Overall Study|Other reason|0|||
23502701|NCT00042289|65580294|FG023|Overall Study|Other reason|1|||
23502702|NCT00042289|65580295|FG024|Overall Study|Other reason|0|||
23502703|NCT00042289|65580296|FG025|Overall Study|Other reason|0|||
23502704|NCT00042289|65580297|FG026|Overall Study|Other reason|1|||
23502705|NCT00042289|65580298|FG027|Overall Study|Other reason|0|||
23502706|NCT00042289|65580299|FG028|Overall Study|Other reason|3|||
23502707|NCT00042289|65580300|FG029|Overall Study|Other reason|0|||
23502708|NCT00042289|65580301|FG030|Overall Study|Other reason|0|||
23502709|NCT00042289|65580302|FG031|Overall Study|Other reason|1|||
23502710|NCT00042289|65580303|FG032|Overall Study|Other reason|0|||
23502711|NCT00042289|65580304|FG033|Overall Study|Other reason|1|||
23502712|NCT00042289|65580305|FG034|Overall Study|Other reason|0|||
23502713|NCT00042289|65580306|FG035|Overall Study|Other reason|2|||
23502714|NCT00042289|65580307|FG036|Overall Study|Other reason|0|||
23502715|NCT00042289|65580308|FG037|Overall Study|Other reason|0|||
23502716|NCT00042289|65580309|FG038|Overall Study|Other reason|0|||
23502717|NCT00042289|65580310|FG039|Overall Study|Other reason|0|||
23502718|NCT00042289|65580311|FG040|Overall Study|Other reason|0|||
23502719|NCT00042289|65580312|FG041|Overall Study|Other reason|0|||
23502720|NCT00042289|65580313|FG042|Overall Study|Other reason|0|||
23502721|NCT00042289|65580314|FG043|Overall Study|Other reason|1|||
23502722|NCT00042289|65580315|FG044|Overall Study|Other reason|0|||
23502723|NCT00042289|65580316|FG045|Overall Study|Other reason|0|||
23502724|NCT00042289|65580317|FG046|Overall Study|Other reason|0|||
23502725|NCT00042289|65580271|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23502726|NCT00042289|65580272|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23502727|NCT00042289|65580273|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23502728|NCT00042289|65580274|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23502729|NCT00042289|65580275|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23502730|NCT00042289|65580276|FG005|Overall Study|Severe debilitation, unable to continue|0|||
23502731|NCT00042289|65580277|FG006|Overall Study|Severe debilitation, unable to continue|0|||
23502732|NCT00042289|65580278|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23502733|NCT00042289|65580279|FG008|Overall Study|Severe debilitation, unable to continue|0|||
23502734|NCT00042289|65580280|FG009|Overall Study|Severe debilitation, unable to continue|0|||
23502735|NCT00042289|65580281|FG010|Overall Study|Severe debilitation, unable to continue|0|||
23502736|NCT00042289|65580282|FG011|Overall Study|Severe debilitation, unable to continue|0|||
23502737|NCT00042289|65580283|FG012|Overall Study|Severe debilitation, unable to continue|0|||
23502738|NCT00042289|65580284|FG013|Overall Study|Severe debilitation, unable to continue|0|||
23502739|NCT00042289|65580285|FG014|Overall Study|Severe debilitation, unable to continue|0|||
23502740|NCT00042289|65580286|FG015|Overall Study|Severe debilitation, unable to continue|0|||
23502741|NCT00042289|65580287|FG016|Overall Study|Severe debilitation, unable to continue|0|||
23502742|NCT00042289|65580288|FG017|Overall Study|Severe debilitation, unable to continue|0|||
23502743|NCT00042289|65580289|FG018|Overall Study|Severe debilitation, unable to continue|0|||
23502744|NCT00042289|65580290|FG019|Overall Study|Severe debilitation, unable to continue|0|||
23502745|NCT00042289|65580291|FG020|Overall Study|Severe debilitation, unable to continue|0|||
23502746|NCT00042289|65580292|FG021|Overall Study|Severe debilitation, unable to continue|1|||
23502747|NCT00042289|65580293|FG022|Overall Study|Severe debilitation, unable to continue|0|||
23502748|NCT00042289|65580294|FG023|Overall Study|Severe debilitation, unable to continue|1|||
23502749|NCT00042289|65580295|FG024|Overall Study|Severe debilitation, unable to continue|0|||
23502750|NCT00042289|65580296|FG025|Overall Study|Severe debilitation, unable to continue|0|||
23502751|NCT00042289|65580297|FG026|Overall Study|Severe debilitation, unable to continue|0|||
23502752|NCT00042289|65580298|FG027|Overall Study|Severe debilitation, unable to continue|1|||
23502753|NCT00042289|65580299|FG028|Overall Study|Severe debilitation, unable to continue|0|||
23502754|NCT00042289|65580300|FG029|Overall Study|Severe debilitation, unable to continue|0|||
23502755|NCT00042289|65580301|FG030|Overall Study|Severe debilitation, unable to continue|0|||
23502756|NCT00042289|65580302|FG031|Overall Study|Severe debilitation, unable to continue|1|||
23502757|NCT00042289|65580303|FG032|Overall Study|Severe debilitation, unable to continue|1|||
23502758|NCT00042289|65580304|FG033|Overall Study|Severe debilitation, unable to continue|0|||
23502759|NCT00042289|65580305|FG034|Overall Study|Severe debilitation, unable to continue|0|||
23502760|NCT00042289|65580306|FG035|Overall Study|Severe debilitation, unable to continue|0|||
23502761|NCT00042289|65580307|FG036|Overall Study|Severe debilitation, unable to continue|0|||
23502762|NCT00042289|65580308|FG037|Overall Study|Severe debilitation, unable to continue|0|||
23502763|NCT00042289|65580309|FG038|Overall Study|Severe debilitation, unable to continue|0|||
23502764|NCT00042289|65580310|FG039|Overall Study|Severe debilitation, unable to continue|0|||
23502765|NCT00042289|65580311|FG040|Overall Study|Severe debilitation, unable to continue|0|||
23502766|NCT00042289|65580312|FG041|Overall Study|Severe debilitation, unable to continue|0|||
23502767|NCT00042289|65580313|FG042|Overall Study|Severe debilitation, unable to continue|0|||
23502768|NCT00042289|65580314|FG043|Overall Study|Severe debilitation, unable to continue|0|||
23502769|NCT00042289|65580315|FG044|Overall Study|Severe debilitation, unable to continue|0|||
23502770|NCT00042289|65580316|FG045|Overall Study|Severe debilitation, unable to continue|0|||
23502771|NCT00042289|65580317|FG046|Overall Study|Severe debilitation, unable to continue|0|||
23502772|NCT00042289|65580271|FG000|Overall Study|Site closed|0|||
23502773|NCT00042289|65580272|FG001|Overall Study|Site closed|0|||
23502774|NCT00042289|65580273|FG002|Overall Study|Site closed|0|||
23502775|NCT00042289|65580274|FG003|Overall Study|Site closed|0|||
23502776|NCT00042289|65580275|FG004|Overall Study|Site closed|0|||
23502777|NCT00042289|65580276|FG005|Overall Study|Site closed|0|||
23502778|NCT00042289|65580277|FG006|Overall Study|Site closed|0|||
23502779|NCT00042289|65580278|FG007|Overall Study|Site closed|0|||
23502780|NCT00042289|65580279|FG008|Overall Study|Site closed|0|||
23502781|NCT00042289|65580280|FG009|Overall Study|Site closed|0|||
23502782|NCT00042289|65580281|FG010|Overall Study|Site closed|0|||
23502783|NCT00042289|65580282|FG011|Overall Study|Site closed|0|||
23502784|NCT00042289|65580283|FG012|Overall Study|Site closed|0|||
23502785|NCT00042289|65580284|FG013|Overall Study|Site closed|0|||
23502786|NCT00042289|65580285|FG014|Overall Study|Site closed|0|||
23502787|NCT00042289|65580286|FG015|Overall Study|Site closed|0|||
23502788|NCT00042289|65580287|FG016|Overall Study|Site closed|0|||
23502789|NCT00042289|65580288|FG017|Overall Study|Site closed|0|||
23502790|NCT00042289|65580289|FG018|Overall Study|Site closed|0|||
23502791|NCT00042289|65580290|FG019|Overall Study|Site closed|0|||
23502792|NCT00042289|65580291|FG020|Overall Study|Site closed|0|||
23502793|NCT00042289|65580292|FG021|Overall Study|Site closed|0|||
23502794|NCT00042289|65580293|FG022|Overall Study|Site closed|0|||
23502795|NCT00042289|65580294|FG023|Overall Study|Site closed|0|||
23502796|NCT00042289|65580295|FG024|Overall Study|Site closed|0|||
23502797|NCT00042289|65580296|FG025|Overall Study|Site closed|0|||
23502798|NCT00042289|65580297|FG026|Overall Study|Site closed|0|||
23502799|NCT00042289|65580298|FG027|Overall Study|Site closed|0|||
23502800|NCT00042289|65580299|FG028|Overall Study|Site closed|0|||
23502801|NCT00042289|65580300|FG029|Overall Study|Site closed|0|||
23502802|NCT00042289|65580301|FG030|Overall Study|Site closed|0|||
23502803|NCT00042289|65580302|FG031|Overall Study|Site closed|3|||
23502804|NCT00042289|65580303|FG032|Overall Study|Site closed|0|||
23502805|NCT00042289|65580304|FG033|Overall Study|Site closed|0|||
23502806|NCT00042289|65580305|FG034|Overall Study|Site closed|0|||
23502807|NCT00042289|65580306|FG035|Overall Study|Site closed|0|||
23502808|NCT00042289|65580307|FG036|Overall Study|Site closed|1|||
23502809|NCT00042289|65580308|FG037|Overall Study|Site closed|0|||
23502810|NCT00042289|65580309|FG038|Overall Study|Site closed|0|||
23502811|NCT00042289|65580310|FG039|Overall Study|Site closed|0|||
23502812|NCT00042289|65580311|FG040|Overall Study|Site closed|0|||
23502813|NCT00042289|65580312|FG041|Overall Study|Site closed|0|||
23502814|NCT00042289|65580313|FG042|Overall Study|Site closed|1|||
23502815|NCT00042289|65580314|FG043|Overall Study|Site closed|0|||
23502816|NCT00042289|65580315|FG044|Overall Study|Site closed|0|||
23502817|NCT00042289|65580316|FG045|Overall Study|Site closed|0|||
23502818|NCT00042289|65580317|FG046|Overall Study|Site closed|0|||
23502819|NCT00042289|65580271|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
23502820|NCT00042289|65580272|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
23502821|NCT00042289|65580273|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
23502822|NCT00042289|65580274|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
23502823|NCT00042289|65580275|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
23502824|NCT00042289|65580276|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
23502825|NCT00042289|65580277|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
23502826|NCT00042289|65580278|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
23502827|NCT00042289|65580279|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
23502828|NCT00042289|65580280|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
23502829|NCT00042289|65580281|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
23502830|NCT00042289|65580282|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
23502831|NCT00042289|65580283|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
23502832|NCT00042289|65580284|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
23502833|NCT00042289|65580285|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
23502834|NCT00042289|65580286|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
23502835|NCT00042289|65580287|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
23502836|NCT00042289|65580288|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
23502837|NCT00042289|65580289|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
23502838|NCT00042289|65580290|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
23502839|NCT00042289|65580291|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
23502840|NCT00042289|65580292|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
23502841|NCT00042289|65580293|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
23502842|NCT00042289|65580294|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
23502843|NCT00042289|65580295|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
23502844|NCT00042289|65580296|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
23502845|NCT00042289|65580297|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
23502846|NCT00042289|65580298|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
23502847|NCT00042289|65580299|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
23502848|NCT00042289|65580300|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
23502849|NCT00042289|65580301|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
23502850|NCT00042289|65580302|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
23502851|NCT00042289|65580303|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
23502852|NCT00042289|65580304|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
23502853|NCT00042289|65580305|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
23502854|NCT00042289|65580306|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
23502855|NCT00042289|65580307|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
23502856|NCT00042289|65580308|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
23502857|NCT00042289|65580309|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
23502858|NCT00042289|65580310|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
23502859|NCT00042289|65580311|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
23502860|NCT00042289|65580312|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
23502861|NCT00042289|65580313|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
23502862|NCT00042289|65580314|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
23502863|NCT00042289|65580315|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
23502864|NCT00042289|65580316|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
23502865|NCT00042289|65580317|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
23502866|NCT00042289|65580271|FG000|Overall Study|Protocol Violation|0|||
23502867|NCT00042289|65580272|FG001|Overall Study|Protocol Violation|0|||
23502868|NCT00042289|65580273|FG002|Overall Study|Protocol Violation|0|||
23502869|NCT00042289|65580274|FG003|Overall Study|Protocol Violation|0|||
23502870|NCT00042289|65580275|FG004|Overall Study|Protocol Violation|0|||
23502871|NCT00042289|65580276|FG005|Overall Study|Protocol Violation|1|||
23502872|NCT00042289|65580277|FG006|Overall Study|Protocol Violation|0|||
23502873|NCT00042289|65580278|FG007|Overall Study|Protocol Violation|1|||
23502874|NCT00042289|65580279|FG008|Overall Study|Protocol Violation|0|||
23502875|NCT00042289|65580280|FG009|Overall Study|Protocol Violation|0|||
23502876|NCT00042289|65580281|FG010|Overall Study|Protocol Violation|0|||
23502877|NCT00042289|65580282|FG011|Overall Study|Protocol Violation|0|||
23502878|NCT00042289|65580283|FG012|Overall Study|Protocol Violation|0|||
23502879|NCT00042289|65580284|FG013|Overall Study|Protocol Violation|0|||
23502880|NCT00042289|65580285|FG014|Overall Study|Protocol Violation|0|||
23502881|NCT00042289|65580286|FG015|Overall Study|Protocol Violation|0|||
23502882|NCT00042289|65580287|FG016|Overall Study|Protocol Violation|0|||
23502883|NCT00042289|65580288|FG017|Overall Study|Protocol Violation|0|||
23502884|NCT00042289|65580289|FG018|Overall Study|Protocol Violation|0|||
23502885|NCT00042289|65580290|FG019|Overall Study|Protocol Violation|0|||
23502886|NCT00042289|65580291|FG020|Overall Study|Protocol Violation|0|||
23502887|NCT00042289|65580292|FG021|Overall Study|Protocol Violation|0|||
23502888|NCT00042289|65580293|FG022|Overall Study|Protocol Violation|0|||
23502889|NCT00042289|65580294|FG023|Overall Study|Protocol Violation|1|||
23502890|NCT00042289|65580295|FG024|Overall Study|Protocol Violation|1|||
23502891|NCT00042289|65580296|FG025|Overall Study|Protocol Violation|0|||
23502892|NCT00042289|65580297|FG026|Overall Study|Protocol Violation|2|||
23502893|NCT00042289|65580298|FG027|Overall Study|Protocol Violation|0|||
23502894|NCT00042289|65580299|FG028|Overall Study|Protocol Violation|0|||
23502895|NCT00042289|65580300|FG029|Overall Study|Protocol Violation|0|||
23502896|NCT00042289|65580301|FG030|Overall Study|Protocol Violation|1|||
23502897|NCT00042289|65580302|FG031|Overall Study|Protocol Violation|0|||
23502898|NCT00042289|65580303|FG032|Overall Study|Protocol Violation|0|||
23502899|NCT00042289|65580304|FG033|Overall Study|Protocol Violation|0|||
23502900|NCT00042289|65580305|FG034|Overall Study|Protocol Violation|0|||
23502901|NCT00042289|65580306|FG035|Overall Study|Protocol Violation|0|||
23502902|NCT00042289|65580307|FG036|Overall Study|Protocol Violation|0|||
23502903|NCT00042289|65580308|FG037|Overall Study|Protocol Violation|0|||
23502904|NCT00042289|65580309|FG038|Overall Study|Protocol Violation|0|||
23502905|NCT00042289|65580310|FG039|Overall Study|Protocol Violation|0|||
23502906|NCT00042289|65580311|FG040|Overall Study|Protocol Violation|0|||
23502907|NCT00042289|65580312|FG041|Overall Study|Protocol Violation|1|||
23502908|NCT00042289|65580313|FG042|Overall Study|Protocol Violation|1|||
23502909|NCT00042289|65580314|FG043|Overall Study|Protocol Violation|1|||
23502910|NCT00042289|65580315|FG044|Overall Study|Protocol Violation|0|||
23502911|NCT00042289|65580316|FG045|Overall Study|Protocol Violation|0|||
23502912|NCT00042289|65580317|FG046|Overall Study|Protocol Violation|0|||
23502913|NCT00042289|65580271|FG000|Overall Study|Withdrawal by Subject|4|||
23502914|NCT00042289|65580272|FG001|Overall Study|Withdrawal by Subject|1|||
23502915|NCT00042289|65580273|FG002|Overall Study|Withdrawal by Subject|0|||
23502916|NCT00042289|65580274|FG003|Overall Study|Withdrawal by Subject|2|||
23502917|NCT00042289|65580275|FG004|Overall Study|Withdrawal by Subject|0|||
23502918|NCT00042289|65580276|FG005|Overall Study|Withdrawal by Subject|2|||
23502919|NCT00042289|65580277|FG006|Overall Study|Withdrawal by Subject|0|||
23502920|NCT00042289|65580278|FG007|Overall Study|Withdrawal by Subject|0|||
23502921|NCT00042289|65580279|FG008|Overall Study|Withdrawal by Subject|0|||
23502922|NCT00042289|65580280|FG009|Overall Study|Withdrawal by Subject|1|||
23502923|NCT00042289|65580281|FG010|Overall Study|Withdrawal by Subject|0|||
23502924|NCT00042289|65580282|FG011|Overall Study|Withdrawal by Subject|0|||
23502925|NCT00042289|65580283|FG012|Overall Study|Withdrawal by Subject|2|||
23502926|NCT00042289|65580284|FG013|Overall Study|Withdrawal by Subject|0|||
23502927|NCT00042289|65580285|FG014|Overall Study|Withdrawal by Subject|0|||
23502928|NCT00042289|65580286|FG015|Overall Study|Withdrawal by Subject|0|||
23502929|NCT00042289|65580287|FG016|Overall Study|Withdrawal by Subject|0|||
23502930|NCT00042289|65580288|FG017|Overall Study|Withdrawal by Subject|0|||
23502931|NCT00042289|65580289|FG018|Overall Study|Withdrawal by Subject|0|||
23502932|NCT00042289|65580290|FG019|Overall Study|Withdrawal by Subject|0|||
23502933|NCT00042289|65580291|FG020|Overall Study|Withdrawal by Subject|0|||
23502934|NCT00042289|65580292|FG021|Overall Study|Withdrawal by Subject|1|||
23502935|NCT00042289|65580293|FG022|Overall Study|Withdrawal by Subject|1|||
23502936|NCT00042289|65580294|FG023|Overall Study|Withdrawal by Subject|1|||
23502937|NCT00042289|65580295|FG024|Overall Study|Withdrawal by Subject|0|||
23502938|NCT00042289|65580296|FG025|Overall Study|Withdrawal by Subject|0|||
23502939|NCT00042289|65580297|FG026|Overall Study|Withdrawal by Subject|1|||
23502940|NCT00042289|65580298|FG027|Overall Study|Withdrawal by Subject|0|||
23399945|NCT03692403|65210750|FG003|Overall Study|Pregnancy|0|||
23399946|NCT03692403|65210747|FG000|Overall Study|Other|0|||
23399947|NCT03692403|65210748|FG001|Overall Study|Other|0|||
23399948|NCT03692403|65210749|FG002|Overall Study|Other|1|||
23399949|NCT03692403|65210750|FG003|Overall Study|Other|0|||
23399950|NCT00060944|65210751|FG000|Overall Study|Adverse Event|12|||
23399951|NCT00060944|65210752|FG001|Overall Study|Adverse Event|10|||
23399952|NCT00060944|65210751|FG000|Overall Study|Death|2|||
23399953|NCT00060944|65210752|FG001|Overall Study|Death|3|||
23399954|NCT00060944|65210751|FG000|Overall Study|Withdrawal by Subject|18|||
23399955|NCT00060944|65210752|FG001|Overall Study|Withdrawal by Subject|5|||
23399956|NCT00060944|65210751|FG000|Overall Study|Disease Progression|93|||
23399957|NCT00060944|65210752|FG001|Overall Study|Disease Progression|94|||
23399958|NCT00060944|65210751|FG000|Overall Study|Lost to Follow-up|1|||
23399959|NCT00060944|65210752|FG001|Overall Study|Lost to Follow-up|0|||
23399960|NCT00060944|65210751|FG000|Overall Study|Subject Ineligible To Continue|2|||
23399961|NCT00060944|65210752|FG001|Overall Study|Subject Ineligible To Continue|1|||
23399962|NCT00060944|65210751|FG000|Overall Study|Treatment Switch|0|||
23399963|NCT00060944|65210752|FG001|Overall Study|Treatment Switch|13|||
23399964|NCT00060944|65210751|FG000|Overall Study|Other|2|||
23502941|NCT00042289|65580299|FG028|Overall Study|Withdrawal by Subject|2|||
23502942|NCT00042289|65580300|FG029|Overall Study|Withdrawal by Subject|0|||
23502943|NCT00042289|65580301|FG030|Overall Study|Withdrawal by Subject|0|||
23502944|NCT00042289|65580302|FG031|Overall Study|Withdrawal by Subject|1|||
23502945|NCT00042289|65580303|FG032|Overall Study|Withdrawal by Subject|2|||
23502946|NCT00042289|65580304|FG033|Overall Study|Withdrawal by Subject|1|||
23502947|NCT00042289|65580305|FG034|Overall Study|Withdrawal by Subject|0|||
23502948|NCT00042289|65580306|FG035|Overall Study|Withdrawal by Subject|0|||
23502949|NCT00042289|65580307|FG036|Overall Study|Withdrawal by Subject|0|||
23502950|NCT00042289|65580308|FG037|Overall Study|Withdrawal by Subject|1|||
23502951|NCT00042289|65580309|FG038|Overall Study|Withdrawal by Subject|0|||
23502952|NCT00042289|65580310|FG039|Overall Study|Withdrawal by Subject|0|||
23502953|NCT00042289|65580311|FG040|Overall Study|Withdrawal by Subject|0|||
23502954|NCT00042289|65580312|FG041|Overall Study|Withdrawal by Subject|0|||
23502955|NCT00042289|65580313|FG042|Overall Study|Withdrawal by Subject|1|||
23502956|NCT00042289|65580314|FG043|Overall Study|Withdrawal by Subject|0|||
23502957|NCT00042289|65580315|FG044|Overall Study|Withdrawal by Subject|0|||
23502958|NCT00042289|65580316|FG045|Overall Study|Withdrawal by Subject|0|||
23502959|NCT00042289|65580317|FG046|Overall Study|Withdrawal by Subject|0|||
23502960|NCT00833794|65580330|FG000|Open-label Phase|Adverse Event|225|||
23502961|NCT00833794|65580331|FG001|Open-label Phase|Adverse Event|0|||
23502962|NCT00833794|65580330|FG000|Open-label Phase|Lack of Efficacy|28|||
23502963|NCT00833794|65580331|FG001|Open-label Phase|Lack of Efficacy|0|||
23502964|NCT00833794|65580330|FG000|Open-label Phase|Withdrawal by Subject|48|||
23502965|NCT00833794|65580331|FG001|Open-label Phase|Withdrawal by Subject|0|||
23502966|NCT00833794|65580330|FG000|Open-label Phase|Physician Decision|20|||
23502967|NCT00833794|65580331|FG001|Open-label Phase|Physician Decision|0|||
23502968|NCT00833794|65580330|FG000|Open-label Phase|Administrative reason|1|||
23502969|NCT00833794|65580331|FG001|Open-label Phase|Administrative reason|0|||
23502970|NCT00833794|65580330|FG000|Open-label Phase|Protocol Violation|47|||
23502971|NCT00833794|65580331|FG001|Open-label Phase|Protocol Violation|0|||
23502972|NCT00833794|65580330|FG000|Open-label Phase|Did not complete wash-out period|12|||
23502973|NCT00833794|65580331|FG001|Open-label Phase|Did not complete wash-out period|0|||
23502974|NCT00833794|65580330|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
23502975|NCT00833794|65580331|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
23502976|NCT00833794|65580330|FG000|Double-blind Phase|Adverse Event|44|||
23502977|NCT00833794|65580331|FG001|Double-blind Phase|Adverse Event|11|||
23502978|NCT00833794|65580330|FG000|Double-blind Phase|Lack of Efficacy|34|||
23502979|NCT00833794|65580331|FG001|Double-blind Phase|Lack of Efficacy|22|||
23502980|NCT00833794|65580330|FG000|Double-blind Phase|Withdrawal by Subject|23|||
23502981|NCT00833794|65580331|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23502982|NCT00833794|65580330|FG000|Double-blind Phase|Physician Decision|4|||
23703862|NCT01455428|66289962|FG001|Overall Study|Did not receive treatment|1|||
23399965|NCT00060944|65210752|FG001|Overall Study|Other|4|||
23399966|NCT00060944|65210751|FG000|Overall Study|randomized but not treated|6|||
23399967|NCT00060944|65210752|FG001|Overall Study|randomized but not treated|4|||
23399968|NCT01668004|65210757|FG000|Overall Study|Adverse Event|7|||
23502983|NCT00833794|65580331|FG001|Double-blind Phase|Physician Decision|7|||
23502984|NCT00833794|65580330|FG000|Double-blind Phase|Administrative reason|1|||
23502985|NCT00833794|65580331|FG001|Double-blind Phase|Administrative reason|3|||
23502986|NCT01434667|65580334|FG000|Overall Study|Lost to Follow-up|5|||
23502987|NCT01434667|65580335|FG001|Overall Study|Lost to Follow-up|10|||
23502988|NCT01540838|65580338|FG000|Overall Study|Open nasogastric tube|9|||
23502989|NCT01540838|65580339|FG001|Overall Study|Open nasogastric tube|7|||
23502990|NCT01540838|65580338|FG000|Overall Study|Treatment doses missing|8|||
23502991|NCT01540838|65580339|FG001|Overall Study|Treatment doses missing|12|||
23502992|NCT01540838|65580338|FG000|Overall Study|Additional antibiotic treatment|1|||
23502993|NCT01540838|65580339|FG001|Overall Study|Additional antibiotic treatment|2|||
23502994|NCT01540838|65580338|FG000|Overall Study|Died before treatment initiation|1|||
23502995|NCT01540838|65580339|FG001|Overall Study|Died before treatment initiation|1|||
23502996|NCT01540838|65580338|FG000|Overall Study|Not BM. Other treatment|3|||
23502997|NCT01540838|65580339|FG001|Overall Study|Not BM. Other treatment|1|||
23502998|NCT00521014|65580340|FG000|Overall Study|Inevaluable, not treated|1|||
23502999|NCT01845831|65580341|FG000|Inpatient Phase|Withdrawal by Subject|1|||
23503000|NCT01845831|65580342|FG001|Inpatient Phase|Withdrawal by Subject|1|||
23503001|NCT01845831|65580343|FG002|Inpatient Phase|Withdrawal by Subject|0|||
23503002|NCT01845831|65580344|FG003|Inpatient Phase|Withdrawal by Subject|0|||
23503003|NCT01845831|65580345|FG004|Inpatient Phase|Withdrawal by Subject|0|||
23503004|NCT01744197|65580346|FG000|Overall Study|Received 1 patch|2|||
23503005|NCT01744197|65580347|FG001|Overall Study|Received 1 patch|1|||
23503006|NCT01744197|65580346|FG000|Overall Study|No patch received|2|||
23503007|NCT01744197|65580347|FG001|Overall Study|No patch received|2|||
23503008|NCT05048784|65580348|FG000|Period 1|Adverse Event|3|||
23503009|NCT05048784|65580349|FG001|Period 1|Adverse Event|1|||
23503010|NCT05048784|65580350|FG002|Period 1|Adverse Event|0|||
23503011|NCT05048784|65580351|FG003|Period 1|Adverse Event|0|||
23503012|NCT05048784|65580348|FG000|Period 2|Lost to Follow-up|0|||
23503013|NCT05048784|65580349|FG001|Period 2|Lost to Follow-up|1|||
23503014|NCT05048784|65580350|FG002|Period 2|Lost to Follow-up|0|||
23503015|NCT05048784|65580351|FG003|Period 2|Lost to Follow-up|0|||
23503016|NCT00873912|65580359|FG000|Overall Study|Withdrawal by Subject|1|||
23503017|NCT00873912|65580360|FG001|Overall Study|Withdrawal by Subject|0|||
23503018|NCT00873912|65580359|FG000|Overall Study|Lost to Follow-up|2|||
23503019|NCT00873912|65580360|FG001|Overall Study|Lost to Follow-up|0|||
23503020|NCT02862171|65580362|FG000|Overall Study|Death|1|||
23503021|NCT02862171|65580362|FG000|Overall Study|Lost to Follow-up|13|||
23503022|NCT02862171|65580362|FG000|Overall Study|Withdrawal by Subject|57|||
23503023|NCT02862171|65580362|FG000|Overall Study|Non-compliance|4|||
23503024|NCT02862171|65580362|FG000|Overall Study|HIV-1 seroconversion|18|||
23503025|NCT00444912|65580365|FG000|Overall Study|Death|1|||
23503026|NCT00444912|65580366|FG001|Overall Study|Death|2|||
23503027|NCT00444912|65580365|FG000|Overall Study|Lost to Follow-up|1|||
23503028|NCT00444912|65580366|FG001|Overall Study|Lost to Follow-up|0|||
23503029|NCT00444912|65580365|FG000|Overall Study|Participant Failed Mobilization|1|||
23503030|NCT00444912|65580366|FG001|Overall Study|Participant Failed Mobilization|0|||
23503031|NCT03305575|65580369|FG000|Overall Study|Physician Decision|1|||
23503032|NCT03305575|65580370|FG001|Overall Study|Physician Decision|0|||
23503033|NCT02555683|65580373|FG000|Overall Study|Physician Decision|1|||
23503034|NCT02555683|65580374|FG001|Overall Study|Physician Decision|0|||
23503035|NCT02555683|65580375|FG002|Overall Study|Physician Decision|2|||
23503036|NCT02555683|65580373|FG000|Overall Study|Lost to Follow-up|2|||
23503037|NCT02555683|65580374|FG001|Overall Study|Lost to Follow-up|1|||
23503038|NCT02555683|65580375|FG002|Overall Study|Lost to Follow-up|2|||
23503039|NCT02555683|65580373|FG000|Overall Study|Technical Problems|1|||
23503040|NCT02555683|65580374|FG001|Overall Study|Technical Problems|1|||
23503041|NCT02555683|65580375|FG002|Overall Study|Technical Problems|0|||
23503042|NCT02555683|65580373|FG000|Overall Study|Protocol deviation|0|||
23503043|NCT02555683|65580374|FG001|Overall Study|Protocol deviation|1|||
23503044|NCT02555683|65580375|FG002|Overall Study|Protocol deviation|0|||
23503045|NCT02555683|65580373|FG000|Overall Study|Lack of Efficacy|2|||
23503046|NCT02555683|65580374|FG001|Overall Study|Lack of Efficacy|0|||
23503047|NCT02555683|65580375|FG002|Overall Study|Lack of Efficacy|0|||
23503048|NCT02555683|65580373|FG000|Overall Study|Death|0|||
23503049|NCT02555683|65580374|FG001|Overall Study|Death|1|||
23503050|NCT02555683|65580375|FG002|Overall Study|Death|2|||
23503051|NCT02555683|65580373|FG000|Overall Study|Adverse Event|1|||
23503052|NCT02555683|65580374|FG001|Overall Study|Adverse Event|0|||
23503053|NCT02555683|65580375|FG002|Overall Study|Adverse Event|1|||
23503054|NCT02555683|65580373|FG000|Overall Study|Subject/guardian decision|12|||
23503055|NCT02555683|65580374|FG001|Overall Study|Subject/guardian decision|12|||
23503056|NCT02555683|65580375|FG002|Overall Study|Subject/guardian decision|22|||
23503057|NCT02555683|65580373|FG000|Overall Study|Death post Treatment/safety period|0|||
23503058|NCT02555683|65580374|FG001|Overall Study|Death post Treatment/safety period|1|||
23503059|NCT02555683|65580375|FG002|Overall Study|Death post Treatment/safety period|0|||
23503060|NCT02955602|65580377|FG000|Overall Study|Adverse Event|0|||
23503061|NCT02955602|65580378|FG001|Overall Study|Adverse Event|3|||
23503062|NCT02955602|65580379|FG002|Overall Study|Adverse Event|0|||
23503063|NCT02955602|65580377|FG000|Overall Study|Withdrawal of informed consent|1|||
23503064|NCT02955602|65580378|FG001|Overall Study|Withdrawal of informed consent|3|||
23503065|NCT02955602|65580379|FG002|Overall Study|Withdrawal of informed consent|2|||
23503066|NCT02955602|65580377|FG000|Overall Study|Lost to Follow-up|0|||
23503067|NCT02955602|65580378|FG001|Overall Study|Lost to Follow-up|0|||
23503068|NCT02955602|65580379|FG002|Overall Study|Lost to Follow-up|1|||
23503069|NCT02955602|65580377|FG000|Overall Study|Other|0|||
23503070|NCT02955602|65580378|FG001|Overall Study|Other|1|||
23503071|NCT02955602|65580379|FG002|Overall Study|Other|3|||
23503072|NCT00518284|65580384|FG000|Overall Study|Adverse Event|0|||
23503073|NCT00518284|65580385|FG001|Overall Study|Adverse Event|1|||
23503074|NCT00518284|65580386|FG002|Overall Study|Adverse Event|0|||
23503075|NCT00518284|65580387|FG003|Overall Study|Adverse Event|0|||
23503076|NCT00518284|65580384|FG000|Overall Study|Study Termination|0|||
23503077|NCT00518284|65580385|FG001|Overall Study|Study Termination|2|||
23503078|NCT00518284|65580386|FG002|Overall Study|Study Termination|1|||
23503079|NCT00518284|65580387|FG003|Overall Study|Study Termination|2|||
23503080|NCT00726986|65580388|FG000|Induction Phase|Adverse Event|4|||
23503081|NCT00726986|65580388|FG000|Induction Phase|Withdrawal by Subject|2|||
23503082|NCT00726986|65580388|FG000|Induction Phase|Death|2|||
23503083|NCT00726986|65580388|FG000|Induction Phase|Lack of Efficacy|5|||
23503084|NCT00726986|65580388|FG000|Induction Phase|Secondary Disease|2|||
23503085|NCT00726986|65580388|FG000|Maintenance Phase|Adverse Event|1|||
23503086|NCT00726986|65580388|FG000|Maintenance Phase|Lack of Efficacy|2|||
23503087|NCT01061177|65580389|FG000|Overall Study|Adverse Event|117|||
23503088|NCT01061177|65580389|FG000|Overall Study|Withdrawal by Subject|27|||
23503089|NCT01061177|65580389|FG000|Overall Study|Disease progression|17|||
23503090|NCT01061177|65580389|FG000|Overall Study|Protocol Violation|11|||
23503091|NCT01061177|65580389|FG000|Overall Study|Lost to Follow-up|9|||
23503092|NCT01061177|65580389|FG000|Overall Study|New cancer therapy|9|||
23503093|NCT01061177|65580389|FG000|Overall Study|Abnormal laboratory values|6|||
23503094|NCT01061177|65580389|FG000|Overall Study|Abnormal test procedure results|4|||
23503095|NCT01061177|65580389|FG000|Overall Study|Administratie problems|4|||
23503096|NCT01061177|65580389|FG000|Overall Study|Death|4|||
23503097|NCT02094677|65580390|FG000|Overall Study|Screening|3|||
23503098|NCT02094677|65580391|FG001|Overall Study|Screening|1|||
23503099|NCT01427972|65580393|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503100|NCT01427972|65580394|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503101|NCT01427972|65580395|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503102|NCT01427972|65580396|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503103|NCT01427972|65580397|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503104|NCT01427972|65580398|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503105|NCT01427972|65580399|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503106|NCT01427972|65580400|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
23503107|NCT01427972|65580401|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503108|NCT01427972|65580402|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503109|NCT01427972|65580403|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503110|NCT01427972|65580404|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503111|NCT01427972|65580393|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503112|NCT01427972|65580394|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503113|NCT01427972|65580395|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503114|NCT01427972|65580396|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503115|NCT01427972|65580397|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503116|NCT01427972|65580398|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
23503117|NCT01427972|65580399|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503118|NCT01427972|65580400|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503119|NCT01427972|65580401|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503120|NCT01427972|65580402|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503121|NCT01427972|65580403|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503122|NCT01427972|65580404|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503123|NCT01427972|65580393|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503124|NCT01427972|65580394|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
23503125|NCT01427972|65580395|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503126|NCT01427972|65580396|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503127|NCT01427972|65580397|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503128|NCT01427972|65580398|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503129|NCT01427972|65580399|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503130|NCT01427972|65580400|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503131|NCT01427972|65580401|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503132|NCT01427972|65580402|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503133|NCT01427972|65580403|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503134|NCT01427972|65580404|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23703863|NCT01455428|66289961|FG000|Overall Study|Other|2|||
23503135|NCT02197130|65580405|FG000|Overall Study|Adverse Event|13|||
23503136|NCT02197130|65580406|FG001|Overall Study|Adverse Event|4|||
23503137|NCT02197130|65580407|FG002|Overall Study|Adverse Event|23|||
23503138|NCT02197130|65580405|FG000|Overall Study|Death|0|||
23503139|NCT02197130|65580406|FG001|Overall Study|Death|1|||
23503140|NCT02197130|65580407|FG002|Overall Study|Death|0|||
23503141|NCT02197130|65580405|FG000|Overall Study|Lost to Follow-up|2|||
23503142|NCT02197130|65580406|FG001|Overall Study|Lost to Follow-up|0|||
23503143|NCT02197130|65580407|FG002|Overall Study|Lost to Follow-up|1|||
23503144|NCT02197130|65580405|FG000|Overall Study|Does not meet entrance criteria|0|||
23503145|NCT02197130|65580406|FG001|Overall Study|Does not meet entrance criteria|0|||
23503146|NCT02197130|65580407|FG002|Overall Study|Does not meet entrance criteria|1|||
23503147|NCT02197130|65580405|FG000|Overall Study|Withdrawal by Subject|0|||
23503148|NCT02197130|65580406|FG001|Overall Study|Withdrawal by Subject|3|||
23503149|NCT02197130|65580407|FG002|Overall Study|Withdrawal by Subject|4|||
23503150|NCT02197130|65580405|FG000|Overall Study|Other|1|||
23503151|NCT02197130|65580406|FG001|Overall Study|Other|0|||
23503152|NCT02197130|65580407|FG002|Overall Study|Other|3|||
23503153|NCT01382212|65580409|FG000|Overall Study|Kidney transplant|1|||
23503154|NCT01382212|65580409|FG000|Overall Study|Withdrew consent|1|||
23503155|NCT02439138|65580411|FG000|Overall Study|Adverse Event|1|||
23503156|NCT02439138|65580411|FG000|Overall Study|PI decision to terminate the study|2|||
23503157|NCT02801396|65580412|FG000|Period 1|Withdrawal by Subject|0|||
23503158|NCT02801396|65580413|FG001|Period 1|Withdrawal by Subject|0|||
23503159|NCT02801396|65580414|FG002|Period 1|Withdrawal by Subject|0|||
23503160|NCT02801396|65580415|FG003|Period 1|Withdrawal by Subject|0|||
23503161|NCT02801396|65580416|FG004|Period 1|Withdrawal by Subject|1|||
23503162|NCT02801396|65580417|FG005|Period 1|Withdrawal by Subject|0|||
23503163|NCT02794883|65580418|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
23503164|NCT02794883|65580419|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
23503165|NCT02794883|65580420|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
23503166|NCT02794883|65580418|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
23503167|NCT02794883|65580419|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
23503168|NCT02794883|65580420|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
23503169|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
23503170|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
23503171|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
23503172|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
23503173|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
23503174|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
23503175|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
23503176|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
23503177|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
23503178|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
23503179|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
23503180|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
23503181|NCT02794883|65580418|FG000|Follow-up Period (up to 2 Years)|Death|12|||
23503182|NCT02794883|65580419|FG001|Follow-up Period (up to 2 Years)|Death|10|||
23503183|NCT02794883|65580420|FG002|Follow-up Period (up to 2 Years)|Death|10|||
23503184|NCT05074667|65580421|FG000|Overall Study|Death|1|||
23503185|NCT05074667|65580421|FG000|Overall Study|Withdrawal by Subject|4|||
23503186|NCT05074667|65580421|FG000|Overall Study|Lost to Follow-up|10|||
23503187|NCT00224042|65580432|FG000|Overall Study|Adverse Event|2|||
23503188|NCT00224042|65580433|FG001|Overall Study|Adverse Event|1|||
23503189|NCT00224042|65580432|FG000|Overall Study|Protocol Violation|0|||
23399969|NCT01668004|65210757|FG000|Overall Study|Withdrawal by Subject|2|||
23399970|NCT01668004|65210757|FG000|Overall Study|Lost to Follow-up|5|||
23399971|NCT01668004|65210757|FG000|Overall Study|Lack of Efficacy|9|||
23399972|NCT01668004|65210757|FG000|Overall Study|Non-compliance with treatment|2|||
23399973|NCT01378117|65210758|FG000|Overall Study|withdrawal|2|||
23399974|NCT01378117|65210759|FG001|Overall Study|withdrawal|1|||
23399975|NCT01378117|65210760|FG002|Overall Study|withdrawal|2|||
23399976|NCT01378117|65210758|FG000|Overall Study|discharged before med given|2|||
23399977|NCT01378117|65210759|FG001|Overall Study|discharged before med given|0|||
23503190|NCT00224042|65580433|FG001|Overall Study|Protocol Violation|1|||
23503191|NCT00224042|65580432|FG000|Overall Study|Physician Decision|0|||
23503192|NCT00224042|65580433|FG001|Overall Study|Physician Decision|1|||
23503193|NCT00224042|65580432|FG000|Overall Study|Did not meet lab incusion criteria|2|||
23503194|NCT00224042|65580433|FG001|Overall Study|Did not meet lab incusion criteria|3|||
23399978|NCT01378117|65210760|FG002|Overall Study|discharged before med given|1|||
23503195|NCT00224042|65580432|FG000|Overall Study|Other|2|||
23503196|NCT00224042|65580433|FG001|Overall Study|Other|0|||
23503197|NCT05201703|65583771|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
23503198|NCT05201703|65583772|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
23703864|NCT01455428|66289962|FG001|Overall Study|Other|4|||
23503199|NCT05201703|65583771|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
23503200|NCT05201703|65583772|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
23503201|NCT03003390|65583773|FG000|Overall Study|Physician Decision|2|||
23503202|NCT03003390|65583774|FG001|Overall Study|Physician Decision|0|||
23503203|NCT03003390|65583773|FG000|Overall Study|Parent refused intervention|2|||
23503204|NCT03003390|65583774|FG001|Overall Study|Parent refused intervention|0|||
23703865|NCT01519427|66289964|FG000|Overall Study|disease progression|2|||
23703866|NCT00850759|66289965|FG000|Overall Study|Lost to Follow-up|7|||
23703867|NCT00850759|66289966|FG001|Overall Study|Lost to Follow-up|5|||
23703868|NCT00850759|66289967|FG002|Overall Study|Lost to Follow-up|5|||
23703869|NCT00850759|66289968|FG003|Overall Study|Lost to Follow-up|3|||
23703870|NCT01283581|66289971|FG000|Overall Study|Lost to Follow-up|8|||
23703871|NCT01283581|66289972|FG001|Overall Study|Lost to Follow-up|6|||
23703872|NCT01283581|66289973|FG002|Overall Study|Lost to Follow-up|8|||
23703873|NCT01283581|66289971|FG000|Overall Study|Withdrawal by Subject|2|||
23703874|NCT01283581|66289972|FG001|Overall Study|Withdrawal by Subject|5|||
23703875|NCT01283581|66289973|FG002|Overall Study|Withdrawal by Subject|2|||
23703876|NCT01283581|66289971|FG000|Overall Study|Adverse Event|1|||
23703877|NCT01283581|66289972|FG001|Overall Study|Adverse Event|1|||
23703878|NCT01283581|66289973|FG002|Overall Study|Adverse Event|4|||
23703879|NCT01283581|66289971|FG000|Overall Study|Physician Decision|0|||
23703880|NCT01283581|66289972|FG001|Overall Study|Physician Decision|1|||
23703881|NCT01283581|66289973|FG002|Overall Study|Physician Decision|2|||
23703882|NCT01283581|66289971|FG000|Overall Study|Protocol Violation|0|||
23703883|NCT01283581|66289972|FG001|Overall Study|Protocol Violation|1|||
23703884|NCT01283581|66289973|FG002|Overall Study|Protocol Violation|2|||
23703885|NCT01283581|66289971|FG000|Overall Study|Noncompliance|1|||
23703886|NCT01283581|66289972|FG001|Overall Study|Noncompliance|0|||
23703887|NCT01283581|66289973|FG002|Overall Study|Noncompliance|0|||
23703888|NCT01283581|66289971|FG000|Overall Study|Investigator unblinded|0|||
23703889|NCT01283581|66289972|FG001|Overall Study|Investigator unblinded|0|||
23703890|NCT01283581|66289973|FG002|Overall Study|Investigator unblinded|1|||
23703891|NCT01283581|66289971|FG000|Overall Study|"Early termination"|0|||
23703892|NCT01283581|66289972|FG001|Overall Study|"Early termination"|0|||
23703893|NCT01283581|66289973|FG002|Overall Study|"Early termination"|1|||
23703894|NCT03865407|66289976|FG000|Overall Study|Adverse Event|1|||
23703895|NCT03865407|66289977|FG001|Overall Study|Adverse Event|0|||
23399979|NCT01152788|65210763|FG000|Overall Study|Withdrawal by Subject|0|||
23399980|NCT01152788|65210764|FG001|Overall Study|Withdrawal by Subject|3|||
23399981|NCT01152788|65210763|FG000|Overall Study|No treatment|0|||
23399982|NCT01152788|65210764|FG001|Overall Study|No treatment|1|||
23399983|NCT01959529|65210765|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
23503205|NCT00105469|65583777|FG000|Overall Study|Adverse Event|9|||
23503206|NCT00105469|65583778|FG001|Overall Study|Adverse Event|8|||
23503207|NCT00105469|65583777|FG000|Overall Study|Protocol Violation|4|||
23503208|NCT00105469|65583778|FG001|Overall Study|Protocol Violation|0|||
23503209|NCT00105469|65583777|FG000|Overall Study|Withdrawal by Subject|2|||
23503210|NCT00105469|65583778|FG001|Overall Study|Withdrawal by Subject|3|||
23503211|NCT00105469|65583777|FG000|Overall Study|Lost to Follow-up|1|||
23503212|NCT00105469|65583778|FG001|Overall Study|Lost to Follow-up|0|||
23503213|NCT00105469|65583777|FG000|Overall Study|Lack of Efficacy|2|||
23503214|NCT00105469|65583778|FG001|Overall Study|Lack of Efficacy|0|||
23399984|NCT01959529|65210766|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
23399985|NCT01959529|65210765|FG000|Overall Study|Lost to Follow-up|4|||
23399986|NCT01959529|65210766|FG001|Overall Study|Lost to Follow-up|1|||
23399987|NCT01959529|65210765|FG000|Overall Study|Other|70|||
23399988|NCT01959529|65210766|FG001|Overall Study|Other|68|||
23399989|NCT01959529|65210765|FG000|Overall Study|Hypoglycaemia|1|||
23399990|NCT01959529|65210766|FG001|Overall Study|Hypoglycaemia|1|||
23399991|NCT01959529|65210765|FG000|Overall Study|Lack of glycaemic control|1|||
23399992|NCT01959529|65210766|FG001|Overall Study|Lack of glycaemic control|1|||
23503215|NCT00105469|65583777|FG000|Overall Study|Other Reason|4|||
23503216|NCT00105469|65583778|FG001|Overall Study|Other Reason|0|||
23703896|NCT03865407|66289976|FG000|Overall Study|Withdrawal by Subject|1|||
23703897|NCT03865407|66289977|FG001|Overall Study|Withdrawal by Subject|0|||
23703898|NCT03865407|66289976|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
23703899|NCT03865407|66289977|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
23703900|NCT04095286|66289978|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23399993|NCT01882465|65210767|FG000|Period 1|Lens Discomfort|0|||
23399994|NCT01882465|65210768|FG001|Period 1|Lens Discomfort|0|||
23399995|NCT01882465|65210769|FG002|Period 1|Lens Discomfort|0|||
23503217|NCT01666782|65583780|FG000|Overall Study|Received 2 doses of vaccine|0|||
23703901|NCT04095286|66289979|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
23703902|NCT04095286|66289980|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703903|NCT04095286|66289981|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23503218|NCT01666782|65583781|FG001|Overall Study|Received 2 doses of vaccine|1|||
23503219|NCT01666782|65583780|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
23503220|NCT01666782|65583781|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
23503221|NCT00594659|65583782|FG000|Overall Study|Lost to Follow-up|13|||
23503222|NCT00594659|65583783|FG001|Overall Study|Lost to Follow-up|9|||
23503223|NCT00594659|65583784|FG002|Overall Study|Lost to Follow-up|7|||
23503224|NCT01756898|65583785|FG000|Overall Study|Adverse Event|7|||
23503225|NCT01756898|65583786|FG001|Overall Study|Adverse Event|1|||
23503226|NCT01756898|65583787|FG002|Overall Study|Adverse Event|0|||
23503227|NCT01756898|65583788|FG003|Overall Study|Adverse Event|0|||
23503228|NCT01756898|65583785|FG000|Overall Study|Lack of Efficacy|4|||
23503229|NCT01756898|65583786|FG001|Overall Study|Lack of Efficacy|7|||
23503230|NCT01756898|65583787|FG002|Overall Study|Lack of Efficacy|6|||
23503231|NCT01756898|65583788|FG003|Overall Study|Lack of Efficacy|6|||
23503232|NCT01756898|65583785|FG000|Overall Study|Lost to Follow-up|2|||
23503233|NCT01756898|65583786|FG001|Overall Study|Lost to Follow-up|4|||
23503234|NCT01756898|65583787|FG002|Overall Study|Lost to Follow-up|2|||
23503235|NCT01756898|65583788|FG003|Overall Study|Lost to Follow-up|3|||
23503236|NCT01756898|65583785|FG000|Overall Study|Protocol Violation|1|||
23503237|NCT01756898|65583786|FG001|Overall Study|Protocol Violation|2|||
23503238|NCT01756898|65583787|FG002|Overall Study|Protocol Violation|2|||
23503239|NCT01756898|65583788|FG003|Overall Study|Protocol Violation|1|||
23503240|NCT01756898|65583785|FG000|Overall Study|Withdrew Consent|5|||
23503241|NCT01756898|65583786|FG001|Overall Study|Withdrew Consent|3|||
23503242|NCT01756898|65583787|FG002|Overall Study|Withdrew Consent|5|||
23503243|NCT01756898|65583788|FG003|Overall Study|Withdrew Consent|6|||
23503244|NCT01756898|65583785|FG000|Overall Study|Other|0|||
23503245|NCT01756898|65583786|FG001|Overall Study|Other|2|||
23503246|NCT01756898|65583787|FG002|Overall Study|Other|2|||
23503247|NCT01756898|65583788|FG003|Overall Study|Other|0|||
23503248|NCT01644565|65583790|FG000|Overall Study|Undisclosed Medical History|1|||
23503249|NCT01644565|65583791|FG001|Overall Study|Undisclosed Medical History|0|||
23503250|NCT01644565|65583792|FG002|Overall Study|Undisclosed Medical History|0|||
23503251|NCT01644565|65583793|FG003|Overall Study|Undisclosed Medical History|0|||
23503252|NCT01644565|65583794|FG004|Overall Study|Undisclosed Medical History|0|||
23503253|NCT01644565|65583795|FG005|Overall Study|Undisclosed Medical History|0|||
23503254|NCT01644565|65583796|FG006|Overall Study|Undisclosed Medical History|0|||
23503255|NCT01644565|65583797|FG007|Overall Study|Undisclosed Medical History|0|||
23503256|NCT01644565|65583798|FG008|Overall Study|Undisclosed Medical History|0|||
23503257|NCT01644565|65583790|FG000|Overall Study|Lost to Follow-up|0|||
23503258|NCT01644565|65583791|FG001|Overall Study|Lost to Follow-up|0|||
23503259|NCT01644565|65583792|FG002|Overall Study|Lost to Follow-up|0|||
23503260|NCT01644565|65583793|FG003|Overall Study|Lost to Follow-up|1|||
23503261|NCT01644565|65583794|FG004|Overall Study|Lost to Follow-up|0|||
23503262|NCT01644565|65583795|FG005|Overall Study|Lost to Follow-up|0|||
23503263|NCT01644565|65583796|FG006|Overall Study|Lost to Follow-up|0|||
23503264|NCT01644565|65583797|FG007|Overall Study|Lost to Follow-up|2|||
23503265|NCT01644565|65583798|FG008|Overall Study|Lost to Follow-up|0|||
23503266|NCT01644565|65583790|FG000|Overall Study|Family emergency|0|||
23503267|NCT01644565|65583791|FG001|Overall Study|Family emergency|0|||
23503268|NCT01644565|65583792|FG002|Overall Study|Family emergency|0|||
23503269|NCT01644565|65583793|FG003|Overall Study|Family emergency|0|||
23503270|NCT01644565|65583794|FG004|Overall Study|Family emergency|1|||
23503271|NCT01644565|65583795|FG005|Overall Study|Family emergency|0|||
23503272|NCT01644565|65583796|FG006|Overall Study|Family emergency|0|||
23503273|NCT01644565|65583797|FG007|Overall Study|Family emergency|0|||
23503274|NCT01644565|65583798|FG008|Overall Study|Family emergency|0|||
23503275|NCT01644565|65583790|FG000|Overall Study|Relocation|0|||
23503276|NCT01644565|65583791|FG001|Overall Study|Relocation|0|||
23503277|NCT01644565|65583792|FG002|Overall Study|Relocation|0|||
23503278|NCT01644565|65583793|FG003|Overall Study|Relocation|0|||
23503279|NCT01644565|65583794|FG004|Overall Study|Relocation|0|||
23503280|NCT01644565|65583795|FG005|Overall Study|Relocation|0|||
23503281|NCT01644565|65583796|FG006|Overall Study|Relocation|0|||
23503282|NCT01644565|65583797|FG007|Overall Study|Relocation|0|||
23503283|NCT01644565|65583798|FG008|Overall Study|Relocation|1|||
23503284|NCT01785069|65583803|FG000|Overall Study|Implanted with nonstudy device|1|||
23503285|NCT01785069|65583804|FG001|Overall Study|Implanted with nonstudy device|2|||
23503286|NCT01785069|65583805|FG002|Overall Study|Implanted with nonstudy device|1|||
23503287|NCT01785069|65583806|FG003|Overall Study|Implanted with nonstudy device|0|||
23503288|NCT01785069|65583803|FG000|Overall Study|Death|0|||
23503289|NCT01785069|65583804|FG001|Overall Study|Death|0|||
23503290|NCT01785069|65583805|FG002|Overall Study|Death|2|||
23503291|NCT01785069|65583806|FG003|Overall Study|Death|0|||
23503292|NCT01785069|65583803|FG000|Overall Study|Subject choice|2|||
23503293|NCT01785069|65583804|FG001|Overall Study|Subject choice|2|||
23503294|NCT01785069|65583805|FG002|Overall Study|Subject choice|0|||
23503295|NCT01785069|65583806|FG003|Overall Study|Subject choice|1|||
23503296|NCT01785069|65583803|FG000|Overall Study|Lost to Follow-up|1|||
23503297|NCT01785069|65583804|FG001|Overall Study|Lost to Follow-up|2|||
23503298|NCT01785069|65583805|FG002|Overall Study|Lost to Follow-up|4|||
23503299|NCT01785069|65583806|FG003|Overall Study|Lost to Follow-up|1|||
23503300|NCT01785069|65583803|FG000|Overall Study|Reason not Specified|1|||
23503301|NCT01785069|65583804|FG001|Overall Study|Reason not Specified|2|||
23503302|NCT01785069|65583805|FG002|Overall Study|Reason not Specified|1|||
23503303|NCT01785069|65583806|FG003|Overall Study|Reason not Specified|4|||
23503304|NCT01785069|65583803|FG000|Overall Study|Not evaluable|7|||
23503305|NCT01785069|65583804|FG001|Overall Study|Not evaluable|4|||
23503306|NCT01785069|65583805|FG002|Overall Study|Not evaluable|5|||
23503307|NCT01785069|65583806|FG003|Overall Study|Not evaluable|8|||
23503308|NCT00717197|65583811|FG000|Overall Study|Unable to purchase study drug|5|||
23503309|NCT00717197|65583811|FG000|Overall Study|Tumor Progression|1|||
23503310|NCT00717197|65583811|FG000|Overall Study|Physician Decision|1|||
23503311|NCT00602797|65583814|FG000|Overall Study|Adverse Event|1|||
23503312|NCT01898806|65583817|FG000|Overall Study|Withdrawal by Subject|2|||
23503313|NCT01898806|65583817|FG000|Overall Study|Physician Decision|1|||
23399996|NCT01882465|65210770|FG003|Period 1|Lens Discomfort|1|||
23399997|NCT01882465|65210771|FG004|Period 1|Lens Discomfort|0|||
23399998|NCT01882465|65210772|FG005|Period 1|Lens Discomfort|0|||
23399999|NCT01882465|65210773|FG006|Period 1|Lens Discomfort|0|||
23400000|NCT01882465|65210767|FG000|Period 1|Withdrawal by Subject|0|||
23400001|NCT01882465|65210768|FG001|Period 1|Withdrawal by Subject|0|||
23400002|NCT01882465|65210769|FG002|Period 1|Withdrawal by Subject|0|||
23400003|NCT01882465|65210770|FG003|Period 1|Withdrawal by Subject|0|||
23400004|NCT01882465|65210771|FG004|Period 1|Withdrawal by Subject|0|||
23400005|NCT01882465|65210772|FG005|Period 1|Withdrawal by Subject|0|||
23400006|NCT01882465|65210773|FG006|Period 1|Withdrawal by Subject|1|||
23400007|NCT01882465|65210767|FG000|Period 2|Protocol Violation|0|||
23400008|NCT01882465|65210768|FG001|Period 2|Protocol Violation|0|||
23400009|NCT01882465|65210769|FG002|Period 2|Protocol Violation|0|||
23400010|NCT01882465|65210770|FG003|Period 2|Protocol Violation|0|||
23400011|NCT01882465|65210771|FG004|Period 2|Protocol Violation|1|||
23400012|NCT01882465|65210772|FG005|Period 2|Protocol Violation|0|||
23400013|NCT01882465|65210773|FG006|Period 2|Protocol Violation|0|||
23400014|NCT01114737|65210774|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
23400015|NCT01114737|65210775|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
23400016|NCT01114737|65210774|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
23400017|NCT01114737|65210775|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
23400018|NCT01114737|65210774|FG000|Randomized Treatment Period|Pregnancy|1|||
23400019|NCT01114737|65210775|FG001|Randomized Treatment Period|Pregnancy|0|||
23400020|NCT01114737|65210774|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
23400021|NCT01114737|65210775|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
23400022|NCT01114737|65210774|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
23400023|NCT01114737|65210775|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23400024|NCT01114737|65210774|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
23400025|NCT01114737|65210775|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
23400026|NCT02343302|65210780|FG000|Overall Study|Physician Decision|1|||
23400027|NCT02343302|65210781|FG001|Overall Study|Physician Decision|1|||
23400028|NCT01935947|65210782|FG000|Overall Study|Adverse Event|0|||
23400029|NCT01935947|65210783|FG001|Overall Study|Adverse Event|2|||
23400030|NCT01935947|65210784|FG002|Overall Study|Adverse Event|0|||
23400031|NCT01935947|65210782|FG000|Overall Study|Diease Progression|2|||
23400032|NCT01935947|65210783|FG001|Overall Study|Diease Progression|2|||
23400033|NCT01935947|65210784|FG002|Overall Study|Diease Progression|2|||
23400034|NCT01935947|65210782|FG000|Overall Study|Death|1|||
23400035|NCT01935947|65210783|FG001|Overall Study|Death|0|||
23400036|NCT01935947|65210784|FG002|Overall Study|Death|0|||
23400037|NCT01071954|65210797|FG000|Overall Study|Noncompliance|4|||
23400038|NCT01071954|65210797|FG000|Overall Study|Adverse Event|1|||
23400039|NCT01071954|65210797|FG000|Overall Study|Withdrawal by Subject|11|||
23400040|NCT01071954|65210797|FG000|Overall Study|Requirement for Alternative Therapy|5|||
23400041|NCT01071954|65210797|FG000|Overall Study|Administrative Decision|5|||
23400042|NCT01071954|65210797|FG000|Overall Study|Protocol Specified Criteria|1|||
23400043|NCT03508050|65210798|FG000|Overall Study|Pleural adhesions|1|||
23400044|NCT03508050|65210799|FG001|Overall Study|Pleural adhesions|0|||
23400045|NCT03508050|65210798|FG000|Overall Study|Mucus plug|1|||
23400046|NCT03508050|65210799|FG001|Overall Study|Mucus plug|0|||
23400047|NCT03508050|65210798|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
23400048|NCT03508050|65210799|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
23400049|NCT03508050|65210798|FG000|Overall Study|Sustained desaturation|0|||
23400050|NCT03508050|65210799|FG001|Overall Study|Sustained desaturation|1|||
23400051|NCT03047135|65210803|FG000|Overall Study|Still being treated|3|||
23400052|NCT00140140|65210804|FG000|Overall Study|Unacceptable toxicity|1|||
23400053|NCT00140140|65210805|FG001|Overall Study|Unacceptable toxicity|1|||
23400054|NCT00140140|65210806|FG002|Overall Study|Unacceptable toxicity|2|||
23400055|NCT00140140|65210804|FG000|Overall Study|Physician Decision|1|||
23400056|NCT00140140|65210805|FG001|Overall Study|Physician Decision|1|||
23400057|NCT00140140|65210806|FG002|Overall Study|Physician Decision|0|||
23400058|NCT01517984|65210807|FG000|Overall Study|Lost to Follow-up|0|||
23503314|NCT02578316|65583818|FG000|Extension Phase|Progression of disease|6|||
23503315|NCT01235351|65583820|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
23503316|NCT01235351|65583821|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
23503317|NCT01088997|65583822|FG000|Overall Study|Physician Decision|1|||
23503318|NCT01088997|65583823|FG001|Overall Study|Physician Decision|1|||
23503319|NCT01088997|65583822|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
23503320|NCT01088997|65583823|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
23503321|NCT01088997|65583822|FG000|Overall Study|Excluded prior to receiving drug|1|||
23503322|NCT01088997|65583823|FG001|Overall Study|Excluded prior to receiving drug|1|||
23503323|NCT01691781|65583824|FG000|Overall Study|Withdrawal by Subject|4|||
23503324|NCT01691781|65583825|FG001|Overall Study|Withdrawal by Subject|3|||
23503325|NCT01691781|65583824|FG000|Overall Study|Physician Decision|1|||
23503326|NCT01691781|65583825|FG001|Overall Study|Physician Decision|1|||
23503327|NCT01691781|65583824|FG000|Overall Study|Protocol Violation|2|||
23503328|NCT01691781|65583825|FG001|Overall Study|Protocol Violation|2|||
23503329|NCT01691781|65583824|FG000|Overall Study|Adverse Event|0|||
23503330|NCT01691781|65583825|FG001|Overall Study|Adverse Event|1|||
23503331|NCT02871297|65583826|FG000|Overall Study|Adverse Event|34|||
23503332|NCT02871297|65583826|FG000|Overall Study|Lack of Efficacy|10|||
23503333|NCT02871297|65583826|FG000|Overall Study|Non-compliance with study drug|15|||
23503334|NCT02871297|65583826|FG000|Overall Study|Protocol Violation|3|||
23503335|NCT02871297|65583826|FG000|Overall Study|Withdrawal by Subject|20|||
23503336|NCT02871297|65583826|FG000|Overall Study|Lost to Follow-up|13|||
23503337|NCT02871297|65583826|FG000|Overall Study|Rolled over to 13546A|2|||
23503338|NCT02871297|65583826|FG000|Overall Study|Other than specified|39|||
23503339|NCT01587001|65583827|FG000|Overall Study|Lost to Follow-up|2|||
23503340|NCT01587001|65583828|FG001|Overall Study|Lost to Follow-up|0|||
23503341|NCT01587001|65583827|FG000|Overall Study|Insufficient samples to complete testing|4|||
23503342|NCT01587001|65583828|FG001|Overall Study|Insufficient samples to complete testing|1|||
23503343|NCT02228460|65583829|FG000|Overall Study|Adverse Event|1|||
23503344|NCT02228460|65583829|FG000|Overall Study|Lost to Follow-up|1|||
23503345|NCT01367002|65583830|FG000|Overall Study|Withdrawal by Subject|1|||
23503346|NCT01367002|65583831|FG001|Overall Study|Withdrawal by Subject|0|||
23503347|NCT01367002|65583830|FG000|Overall Study|Physician Decision|0|||
23503348|NCT01367002|65583831|FG001|Overall Study|Physician Decision|2|||
23503349|NCT03310021|65583835|FG000|Overall Study|Withdrawal by Subject|0|||
23503350|NCT03310021|65583836|FG001|Overall Study|Withdrawal by Subject|0|||
23503351|NCT03310021|65583837|FG002|Overall Study|Withdrawal by Subject|0|||
23503352|NCT03310021|65583838|FG003|Overall Study|Withdrawal by Subject|0|||
23503353|NCT03310021|65583839|FG004|Overall Study|Withdrawal by Subject|0|||
23503354|NCT03310021|65583840|FG005|Overall Study|Withdrawal by Subject|0|||
23503355|NCT03310021|65583841|FG006|Overall Study|Withdrawal by Subject|1|||
23503356|NCT03310021|65583842|FG007|Overall Study|Withdrawal by Subject|0|||
23503357|NCT03310021|65583843|FG008|Overall Study|Withdrawal by Subject|0|||
23503358|NCT03310021|65583844|FG009|Overall Study|Withdrawal by Subject|0|||
23503359|NCT03310021|65583845|FG010|Overall Study|Withdrawal by Subject|0|||
23503360|NCT03310021|65583846|FG011|Overall Study|Withdrawal by Subject|0|||
23503361|NCT03310021|65583847|FG012|Overall Study|Withdrawal by Subject|0|||
23503362|NCT03310021|65583848|FG013|Overall Study|Withdrawal by Subject|0|||
23503363|NCT03310021|65583849|FG014|Overall Study|Withdrawal by Subject|0|||
23503364|NCT03310021|65583850|FG015|Overall Study|Withdrawal by Subject|0|||
23503365|NCT03310021|65583851|FG016|Overall Study|Withdrawal by Subject|0|||
23503366|NCT03310021|65583852|FG017|Overall Study|Withdrawal by Subject|0|||
23503367|NCT03310021|65583853|FG018|Overall Study|Withdrawal by Subject|0|||
23503368|NCT03310021|65583854|FG019|Overall Study|Withdrawal by Subject|0|||
23503369|NCT03310021|65583835|FG000|Overall Study|Lost to Follow-up|0|||
23503370|NCT03310021|65583836|FG001|Overall Study|Lost to Follow-up|0|||
23503371|NCT03310021|65583837|FG002|Overall Study|Lost to Follow-up|0|||
23503372|NCT03310021|65583838|FG003|Overall Study|Lost to Follow-up|0|||
23503373|NCT03310021|65583839|FG004|Overall Study|Lost to Follow-up|0|||
23503374|NCT03310021|65583840|FG005|Overall Study|Lost to Follow-up|0|||
23503375|NCT03310021|65583841|FG006|Overall Study|Lost to Follow-up|0|||
23503376|NCT03310021|65583842|FG007|Overall Study|Lost to Follow-up|0|||
23503377|NCT03310021|65583843|FG008|Overall Study|Lost to Follow-up|0|||
23503378|NCT03310021|65583844|FG009|Overall Study|Lost to Follow-up|0|||
23503379|NCT03310021|65583845|FG010|Overall Study|Lost to Follow-up|1|||
23503380|NCT03310021|65583846|FG011|Overall Study|Lost to Follow-up|0|||
23503381|NCT03310021|65583847|FG012|Overall Study|Lost to Follow-up|0|||
23503382|NCT03310021|65583848|FG013|Overall Study|Lost to Follow-up|0|||
23503383|NCT03310021|65583849|FG014|Overall Study|Lost to Follow-up|0|||
23503384|NCT03310021|65583850|FG015|Overall Study|Lost to Follow-up|0|||
23503385|NCT03310021|65583851|FG016|Overall Study|Lost to Follow-up|0|||
23503386|NCT03310021|65583852|FG017|Overall Study|Lost to Follow-up|0|||
23503387|NCT03310021|65583853|FG018|Overall Study|Lost to Follow-up|0|||
23503388|NCT03310021|65583854|FG019|Overall Study|Lost to Follow-up|0|||
23503389|NCT01243892|65583855|FG000|Overall Study|Did not meet eligibility criteria|2|||
23503390|NCT01243892|65583856|FG001|Overall Study|Did not meet eligibility criteria|0|||
23503391|NCT00228384|65583857|FG000|Overall Study|Death|9|||
23503392|NCT00228384|65583858|FG001|Overall Study|Death|3|||
23503393|NCT00228384|65583857|FG000|Overall Study|Lost to Follow-up|6|||
23503394|NCT00228384|65583858|FG001|Overall Study|Lost to Follow-up|10|||
23503395|NCT00228384|65583857|FG000|Overall Study|Surgical Intervention (bypass)|5|||
23503396|NCT00228384|65583858|FG001|Overall Study|Surgical Intervention (bypass)|5|||
23503397|NCT00228384|65583857|FG000|Overall Study|Withdrawal by Subject|9|||
23503398|NCT00228384|65583858|FG001|Overall Study|Withdrawal by Subject|10|||
23503399|NCT00228384|65583857|FG000|Overall Study|Physician Decision|0|||
23503400|NCT00228384|65583858|FG001|Overall Study|Physician Decision|1|||
23503401|NCT02036294|65583863|FG000|Overall Study|Death|7|||
23503402|NCT02036294|65583864|FG001|Overall Study|Death|8|||
23503403|NCT02036294|65583863|FG000|Overall Study|Withdrawal by Subject|2|||
23503404|NCT02036294|65583864|FG001|Overall Study|Withdrawal by Subject|3|||
23503405|NCT02849678|65583865|FG000|Overall Study|Protocol Violation|3|||
23503406|NCT02849678|65583866|FG001|Overall Study|Protocol Violation|6|||
23503407|NCT01950741|65583867|FG000|Overall Study|Lost to Follow-up|1|||
23503408|NCT01950741|65583867|FG000|Overall Study|Death|1|||
23503409|NCT01950741|65583867|FG000|Overall Study|Withdrawal by Subject|1|||
23503410|NCT02879305|65583869|FG000|Overall Study|Investigator Site Closed|55|||
23503411|NCT02879305|65583870|FG001|Overall Study|Investigator Site Closed|57|||
23503412|NCT02879305|65583869|FG000|Overall Study|Withdrawal by Subject|44|||
23503413|NCT02879305|65583870|FG001|Overall Study|Withdrawal by Subject|42|||
23503414|NCT02879305|65583869|FG000|Overall Study|Lost to Follow-up|17|||
23503415|NCT02879305|65583870|FG001|Overall Study|Lost to Follow-up|12|||
23503416|NCT02879305|65583869|FG000|Overall Study|Other|1|||
23503417|NCT02879305|65583870|FG001|Overall Study|Other|0|||
23503418|NCT03808545|65583872|FG000|Overall Study|Withdrawal by Subject|1|||
23503419|NCT03808545|65583873|FG001|Overall Study|Withdrawal by Subject|1|||
23503420|NCT01702805|65583879|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
23503421|NCT01702805|65583880|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
23503422|NCT01702805|65583879|FG000|Overall Study|Incomplete Follow-up|18|||
23503423|NCT01702805|65583880|FG001|Overall Study|Incomplete Follow-up|15|||
23503424|NCT01702805|65583879|FG000|Overall Study|Vital Status Assessment Only|40|||
23503425|NCT01702805|65583880|FG001|Overall Study|Vital Status Assessment Only|39|||
23503426|NCT01702805|65583879|FG000|Overall Study|Lost to Follow-up|5|||
23503427|NCT01702805|65583880|FG001|Overall Study|Lost to Follow-up|5|||
23503428|NCT00885846|65583883|FG000|Overall Study|Withdrawal by Subject|2|||
23503429|NCT00885846|65583884|FG001|Overall Study|Withdrawal by Subject|5|||
23503430|NCT00885846|65583885|FG002|Overall Study|Withdrawal by Subject|2|||
23503431|NCT00629707|65583886|FG000|Overall Study|Withdrawal by Subject|0|||
23503432|NCT00629707|65583887|FG001|Overall Study|Withdrawal by Subject|1|||
23503433|NCT00629707|65583886|FG000|Overall Study|Physician Decision|0|||
23503434|NCT00629707|65583887|FG001|Overall Study|Physician Decision|1|||
23503435|NCT00329238|65583891|FG000|Overall Study|Adverse Event|147|||
23503436|NCT00329238|65583892|FG001|Overall Study|Adverse Event|129|||
23503437|NCT00329238|65583891|FG000|Overall Study|Protocol Violation|23|||
23503438|NCT00329238|65583892|FG001|Overall Study|Protocol Violation|34|||
23503439|NCT00329238|65583891|FG000|Overall Study|Lost to Follow-up|2|||
23503440|NCT00329238|65583892|FG001|Overall Study|Lost to Follow-up|6|||
23503441|NCT00329238|65583891|FG000|Overall Study|Withdrawal by Subject|64|||
23503442|NCT00329238|65583892|FG001|Overall Study|Withdrawal by Subject|58|||
23503443|NCT00329238|65583891|FG000|Overall Study|Other reason (not specified)|40|||
23503444|NCT00329238|65583892|FG001|Overall Study|Other reason (not specified)|54|||
23503445|NCT02280304|65583893|FG000|Overall Study|Lost to Follow-up|7|||
23503446|NCT02280304|65583894|FG001|Overall Study|Lost to Follow-up|8|||
23503447|NCT01086033|65583895|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
23503448|NCT01086033|65583895|FG000|Overall Study|Lost to Follow-up|86|||
23503449|NCT01086033|65583895|FG000|Overall Study|Adverse Event|42|||
23503450|NCT01086033|65583895|FG000|Overall Study|Withdrawal by Subject|41|||
23503451|NCT01086033|65583895|FG000|Overall Study|Other|14|||
23503452|NCT01086033|65583895|FG000|Overall Study|Other|13|||
23503453|NCT01086033|65583895|FG000|Overall Study|AE and Withdrew Consent|5|||
23503454|NCT01086033|65583895|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
23503455|NCT01086033|65583895|FG000|Overall Study|Withdrew consent and Other Reason|4|||
23503456|NCT01086033|65583895|FG000|Overall Study|AE and Lack of Efficacy|4|||
23503457|NCT01086033|65583895|FG000|Overall Study|Death|1|||
23503458|NCT01086033|65583895|FG000|Overall Study|AE and Lost to Follow-up|1|||
23503459|NCT01086033|65583895|FG000|Overall Study|AE and Other Reason|1|||
23503460|NCT01086033|65583895|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
23503461|NCT03039283|65583900|FG000|Overall Study|Protocol Violation|2|||
23503462|NCT02634320|65583901|FG000|Overall Study|Adverse Event|2|||
23503463|NCT02634320|65583901|FG000|Overall Study|Lost to Follow-up|3|||
23503464|NCT02634320|65583901|FG000|Overall Study|Moved out of area|2|||
23503465|NCT02634320|65583901|FG000|Overall Study|Out of window for study visits|1|||
23503466|NCT02634320|65583901|FG000|Overall Study|Protocol Violation|1|||
23503467|NCT02634320|65583901|FG000|Overall Study|Withdrawal by Subject|5|||
23503468|NCT02634320|65583901|FG000|Overall Study|Lack of Efficacy|2|||
23503469|NCT01507298|65583907|FG000|Overall Study|Protocol Violation|0|||
23503470|NCT01507298|65583908|FG001|Overall Study|Protocol Violation|6|||
23503471|NCT00407797|65583909|FG000|Overall Study|Lost to Follow-up|2|||
23503472|NCT00407797|65583909|FG000|Overall Study|Adverse Event|6|||
23503473|NCT00407797|65583909|FG000|Overall Study|Other|7|||
23503474|NCT00407797|65583909|FG000|Overall Study|Withdrawal by Subject|3|||
23503475|NCT03736447|65583913|FG000|Overall Study|Adverse Event|5|||
23503476|NCT03736447|65583914|FG001|Overall Study|Adverse Event|1|||
23503477|NCT03736447|65583913|FG000|Overall Study|Withdrawal by Subject|5|||
23503478|NCT03736447|65583914|FG001|Overall Study|Withdrawal by Subject|1|||
23503479|NCT03736447|65583913|FG000|Overall Study|Lost to Follow-up|1|||
23503480|NCT03736447|65583914|FG001|Overall Study|Lost to Follow-up|0|||
23503481|NCT03736447|65583913|FG000|Overall Study|Physician Decision|1|||
23503482|NCT03736447|65583914|FG001|Overall Study|Physician Decision|0|||
23503483|NCT03736447|65583913|FG000|Overall Study|Continued commitment to study treatment|3|||
23503484|NCT03736447|65583914|FG001|Overall Study|Continued commitment to study treatment|0|||
23503485|NCT03736447|65583913|FG000|Overall Study|Taste aversion to study product|0|||
23503486|NCT03736447|65583914|FG001|Overall Study|Taste aversion to study product|1|||
23503487|NCT02944968|65583915|FG000|Overall Study|Subject excluded before study procedure|1|||
23503488|NCT02944968|65583915|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
23503489|NCT03200860|65583919|FG000|Overall Study|Withdrawal by Subject|1|||
23503490|NCT03200860|65583920|FG001|Overall Study|Withdrawal by Subject|0|||
23503491|NCT04189081|65583921|FG000|Overall Study|Lost to Follow-up|1|||
23503492|NCT04189081|65583922|FG001|Overall Study|Lost to Follow-up|0|||
23503493|NCT04189081|65583923|FG002|Overall Study|Lost to Follow-up|0|||
23503494|NCT04189081|65583921|FG000|Overall Study|Withdrawal by Subject|0|||
23503495|NCT04189081|65583922|FG001|Overall Study|Withdrawal by Subject|0|||
23503496|NCT04189081|65583923|FG002|Overall Study|Withdrawal by Subject|1|||
23503497|NCT03311724|65583924|FG000|Overall Study|Physician Decision|0|||
23503498|NCT03311724|65583925|FG001|Overall Study|Physician Decision|0|||
23503499|NCT03311724|65583926|FG002|Overall Study|Physician Decision|0|||
23503500|NCT03311724|65583927|FG003|Overall Study|Physician Decision|1|||
23503501|NCT03311724|65583924|FG000|Overall Study|Protocol Violation|1|||
23503502|NCT03311724|65583925|FG001|Overall Study|Protocol Violation|0|||
23503503|NCT03311724|65583926|FG002|Overall Study|Protocol Violation|1|||
23503504|NCT03311724|65583927|FG003|Overall Study|Protocol Violation|0|||
23503505|NCT03311724|65583924|FG000|Overall Study|Withdrawal by Subject|1|||
23503506|NCT03311724|65583925|FG001|Overall Study|Withdrawal by Subject|1|||
23503507|NCT03311724|65583926|FG002|Overall Study|Withdrawal by Subject|0|||
23503508|NCT03311724|65583927|FG003|Overall Study|Withdrawal by Subject|0|||
23503509|NCT03311724|65583924|FG000|Overall Study|Lost to Follow-up|1|||
23503510|NCT03311724|65583925|FG001|Overall Study|Lost to Follow-up|0|||
23503511|NCT03311724|65583926|FG002|Overall Study|Lost to Follow-up|0|||
23503512|NCT03311724|65583927|FG003|Overall Study|Lost to Follow-up|0|||
23503513|NCT03311724|65583924|FG000|Overall Study|Sponsor Decision|0|||
23503514|NCT03311724|65583925|FG001|Overall Study|Sponsor Decision|0|||
23503515|NCT03311724|65583926|FG002|Overall Study|Sponsor Decision|1|||
23503516|NCT03311724|65583927|FG003|Overall Study|Sponsor Decision|0|||
23503517|NCT02206048|65583941|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
23503518|NCT02468232|65583942|FG000|Core Part of Study|Adverse Event|0|||
23503519|NCT02468232|65583943|FG001|Core Part of Study|Adverse Event|1|||
23503520|NCT02468232|65583944|FG002|Core Part of Study|Adverse Event|0|||
23503521|NCT02468232|65583945|FG003|Core Part of Study|Adverse Event|0|||
23703904|NCT04095286|66289982|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703905|NCT04095286|66289983|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703906|NCT04095286|66289978|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
23703907|NCT04095286|66289979|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23703908|NCT04095286|66289980|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23703909|NCT04095286|66289981|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23703910|NCT04095286|66289982|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23703911|NCT04095286|66289983|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23703912|NCT04095286|66289978|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23703913|NCT04095286|66289979|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23503522|NCT02468232|65583942|FG000|Core Part of Study|Death|20|||
23503523|NCT02468232|65583943|FG001|Core Part of Study|Death|17|||
23503524|NCT02468232|65583944|FG002|Core Part of Study|Death|0|||
23503525|NCT02468232|65583945|FG003|Core Part of Study|Death|0|||
23503526|NCT02468232|65583942|FG000|Core Part of Study|Technical Problems|1|||
23503527|NCT02468232|65583943|FG001|Core Part of Study|Technical Problems|1|||
23703914|NCT04095286|66289980|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
23703915|NCT04095286|66289981|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23503528|NCT02468232|65583944|FG002|Core Part of Study|Technical Problems|0|||
23503529|NCT02468232|65583945|FG003|Core Part of Study|Technical Problems|0|||
23503530|NCT02468232|65583942|FG000|OLE Part of Study|Adverse Event|0|||
23503531|NCT02468232|65583943|FG001|OLE Part of Study|Adverse Event|0|||
23703916|NCT04095286|66289982|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23703917|NCT04095286|66289983|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23703918|NCT04095286|66289978|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703919|NCT04095286|66289979|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703920|NCT04095286|66289980|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
23703921|NCT04095286|66289981|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703922|NCT04095286|66289982|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703923|NCT04095286|66289983|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23703924|NCT04095286|66289978|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23703925|NCT04095286|66289979|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23703926|NCT04095286|66289980|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23703927|NCT04095286|66289981|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23703928|NCT04095286|66289982|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
23703929|NCT04095286|66289983|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23703930|NCT00520676|66289987|FG000|Overall Study|Death|84|||
23703931|NCT00520676|66289988|FG001|Overall Study|Death|81|||
23703932|NCT00520676|66289987|FG000|Overall Study|Lost to Follow-up|6|||
23703933|NCT00520676|66289988|FG001|Overall Study|Lost to Follow-up|10|||
23703934|NCT00520676|66289987|FG000|Overall Study|Physician Decision|4|||
23703935|NCT00520676|66289988|FG001|Overall Study|Physician Decision|1|||
23703936|NCT00520676|66289987|FG000|Overall Study|Withdrawal by Subject|7|||
23703937|NCT00520676|66289988|FG001|Overall Study|Withdrawal by Subject|11|||
23703938|NCT04328623|66289989|FG000|Overall Study|Protocol Violation|0|||
23703939|NCT04328623|66289990|FG001|Overall Study|Protocol Violation|1|||
23703940|NCT00321984|66289993|FG000|Overall Study|Adverse Event|9|||
23703941|NCT00321984|66289994|FG001|Overall Study|Adverse Event|6|||
23703942|NCT00321984|66289995|FG002|Overall Study|Adverse Event|8|||
23703943|NCT00321984|66289993|FG000|Overall Study|Protocol Violation|0|||
23703944|NCT00321984|66289994|FG001|Overall Study|Protocol Violation|1|||
23703945|NCT00321984|66289995|FG002|Overall Study|Protocol Violation|1|||
23703946|NCT00321984|66289993|FG000|Overall Study|Lost to Follow-up|2|||
23703947|NCT00321984|66289994|FG001|Overall Study|Lost to Follow-up|4|||
23703948|NCT00321984|66289995|FG002|Overall Study|Lost to Follow-up|2|||
23703949|NCT00321984|66289993|FG000|Overall Study|Withdrawal by Subject|8|||
23703950|NCT00321984|66289994|FG001|Overall Study|Withdrawal by Subject|6|||
23703951|NCT00321984|66289995|FG002|Overall Study|Withdrawal by Subject|5|||
23703952|NCT00321984|66289993|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
23703953|NCT00321984|66289994|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
23703954|NCT00321984|66289995|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23703955|NCT00321984|66289993|FG000|Overall Study|Lack of Efficacy|3|||
23703956|NCT00321984|66289994|FG001|Overall Study|Lack of Efficacy|1|||
23703957|NCT00321984|66289995|FG002|Overall Study|Lack of Efficacy|3|||
23703958|NCT00321984|66289993|FG000|Overall Study|Noncompliant|0|||
23703959|NCT00321984|66289994|FG001|Overall Study|Noncompliant|0|||
23703960|NCT00321984|66289995|FG002|Overall Study|Noncompliant|2|||
23703961|NCT00321984|66289993|FG000|Overall Study|Pregnancy|0|||
23703962|NCT00321984|66289994|FG001|Overall Study|Pregnancy|1|||
23703963|NCT00321984|66289995|FG002|Overall Study|Pregnancy|0|||
23703964|NCT00321984|66289993|FG000|Overall Study|Per Subject Request|1|||
23703965|NCT00321984|66289994|FG001|Overall Study|Per Subject Request|0|||
23703966|NCT00321984|66289995|FG002|Overall Study|Per Subject Request|0|||
23703967|NCT00321984|66289993|FG000|Overall Study|Per Investigator Request|1|||
23703968|NCT00321984|66289994|FG001|Overall Study|Per Investigator Request|0|||
23703969|NCT00321984|66289995|FG002|Overall Study|Per Investigator Request|0|||
23703970|NCT00321984|66289993|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
23703971|NCT00321984|66289994|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
23703972|NCT00321984|66289995|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
23703973|NCT00301067|66289996|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
23703974|NCT00301067|66289997|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
23703975|NCT00301067|66289998|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
23703976|NCT00301067|66289999|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
23703977|NCT00301067|66289996|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
23703978|NCT00301067|66289997|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23703979|NCT00301067|66289998|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23703980|NCT00301067|66289999|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
23703981|NCT00301067|66289996|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
23703982|NCT00301067|66289997|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
23703983|NCT00301067|66289998|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
23703984|NCT00301067|66289999|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
23703985|NCT00301067|66289996|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
23703986|NCT00301067|66289997|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
23703987|NCT00301067|66289998|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
23703988|NCT00301067|66289999|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
23703989|NCT00301067|66289996|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
23703990|NCT00301067|66289997|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
23703991|NCT00301067|66289998|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
23703992|NCT00301067|66289999|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
23703993|NCT00301067|66289996|FG000|Follow up Until Death|Alive at last data cut point|1|||
23703994|NCT00301067|66289997|FG001|Follow up Until Death|Alive at last data cut point|0|||
23703995|NCT00301067|66289998|FG002|Follow up Until Death|Alive at last data cut point|0|||
23703996|NCT00301067|66289999|FG003|Follow up Until Death|Alive at last data cut point|1|||
23703997|NCT01126619|66290002|FG000|Overall Study|Not eligible for the study|2|||
23703998|NCT01126619|66290002|FG000|Overall Study|Investigator decision|4|||
23703999|NCT01126619|66290002|FG000|Overall Study|Serious adverse event|1|||
23704000|NCT01126619|66290002|FG000|Overall Study|Withdrawal by Subject|9|||
23704001|NCT01126619|66290002|FG000|Overall Study|Non-compliance|1|||
23704002|NCT01752842|66290003|FG000|Overall Study|Adverse Event|3|||
23704003|NCT01752842|66290004|FG001|Overall Study|Adverse Event|0|||
23704004|NCT01752842|66290003|FG000|Overall Study|Withdrawal by Subject|0|||
23704005|NCT01752842|66290004|FG001|Overall Study|Withdrawal by Subject|2|||
23704006|NCT00633139|66290005|FG000|Overall Study|Non compliance|0|||
23704007|NCT00633139|66290006|FG001|Overall Study|Non compliance|0|||
23704008|NCT00633139|66290007|FG002|Overall Study|Non compliance|1|||
23704009|NCT00633139|66290005|FG000|Overall Study|Withdrawal by Subject|0|||
23704010|NCT00633139|66290006|FG001|Overall Study|Withdrawal by Subject|1|||
23704011|NCT00633139|66290007|FG002|Overall Study|Withdrawal by Subject|0|||
23704012|NCT00833248|66290012|FG000|Overall Study|Adverse Event|3|||
23704013|NCT00833248|66290013|FG001|Overall Study|Adverse Event|0|||
23704014|NCT00833248|66290012|FG000|Overall Study|Protocol Violation|1|||
23704015|NCT00833248|66290013|FG001|Overall Study|Protocol Violation|2|||
23704016|NCT00833248|66290012|FG000|Overall Study|Withdrawal by Subject|0|||
23704017|NCT00833248|66290013|FG001|Overall Study|Withdrawal by Subject|1|||
23704018|NCT02584634|66290014|FG000|Overall Study|Adverse Event|3|||
23704019|NCT02584634|66290015|FG001|Overall Study|Adverse Event|5|||
23704020|NCT02584634|66290014|FG000|Overall Study|Death|0|||
23704021|NCT02584634|66290015|FG001|Overall Study|Death|1|||
23704022|NCT02584634|66290014|FG000|Overall Study|Lost to Follow-up|0|||
23704023|NCT02584634|66290015|FG001|Overall Study|Lost to Follow-up|1|||
23704024|NCT02584634|66290014|FG000|Overall Study|Physician Decision|1|||
23704025|NCT02584634|66290015|FG001|Overall Study|Physician Decision|2|||
23704026|NCT02584634|66290014|FG000|Overall Study|Progressive disease|7|||
23704027|NCT02584634|66290015|FG001|Overall Study|Progressive disease|15|||
23704028|NCT02584634|66290014|FG000|Overall Study|Withdrawal by Subject|1|||
23704029|NCT02584634|66290015|FG001|Overall Study|Withdrawal by Subject|1|||
23704030|NCT02584634|66290014|FG000|Overall Study|Other|0|||
23704031|NCT02584634|66290015|FG001|Overall Study|Other|6|||
23704032|NCT00365976|66290016|FG000|Overall Study|Withdrawal by Subject|1|||
23704033|NCT00365976|66290017|FG001|Overall Study|Withdrawal by Subject|5|||
23704034|NCT01355068|66290018|FG000|First Intervention Period|Adverse Event|0|||
23704035|NCT01355068|66290019|FG001|First Intervention Period|Adverse Event|1|||
23704036|NCT01355068|66290018|FG000|First Intervention Period|Withdrawal by Subject|0|||
23704037|NCT01355068|66290019|FG001|First Intervention Period|Withdrawal by Subject|1|||
23704038|NCT02137772|66290020|FG000|Overall Study|Adverse Event|6|||
23704039|NCT02137772|66290021|FG001|Overall Study|Adverse Event|3|||
23704040|NCT02137772|66290020|FG000|Overall Study|Death|71|||
23704041|NCT02137772|66290021|FG001|Overall Study|Death|44|||
23704042|NCT02137772|66290020|FG000|Overall Study|Lost to Follow-up|8|||
23704043|NCT02137772|66290021|FG001|Overall Study|Lost to Follow-up|4|||
23704044|NCT02137772|66290020|FG000|Overall Study|Physician Decision|15|||
23704045|NCT02137772|66290021|FG001|Overall Study|Physician Decision|5|||
23704046|NCT02137772|66290020|FG000|Overall Study|Withdrawal by Subject|28|||
23704047|NCT02137772|66290021|FG001|Overall Study|Withdrawal by Subject|17|||
23704048|NCT02137772|66290020|FG000|Overall Study|Non-compliance with study drug|1|||
23704049|NCT02137772|66290021|FG001|Overall Study|Non-compliance with study drug|0|||
23704050|NCT02137772|66290020|FG000|Overall Study|Not treated|3|||
23704051|NCT02137772|66290021|FG001|Overall Study|Not treated|2|||
23704052|NCT01984346|66290022|FG000|Overall Study|Physician Decision|4|||
23704053|NCT01984346|66290023|FG001|Overall Study|Physician Decision|2|||
23704054|NCT01984346|66290022|FG000|Overall Study|Withdrawal by Subject|2|||
23704055|NCT01984346|66290023|FG001|Overall Study|Withdrawal by Subject|2|||
23704056|NCT01984346|66290022|FG000|Overall Study|Enrollment Closed|8|||
23704057|NCT01984346|66290023|FG001|Overall Study|Enrollment Closed|1|||
23704058|NCT01984346|66290022|FG000|Overall Study|Insurance Coverage|1|||
23704059|NCT01984346|66290023|FG001|Overall Study|Insurance Coverage|0|||
23704060|NCT01984346|66290022|FG000|Overall Study|Intra-operative Exclusion|2|||
23704061|NCT01984346|66290023|FG001|Overall Study|Intra-operative Exclusion|0|||
23704062|NCT01253421|66290026|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
23704063|NCT01253421|66290027|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
23704064|NCT01253421|66290028|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
23704065|NCT01253421|66290029|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
23704066|NCT01253421|66290030|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
23704067|NCT01253421|66290026|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
23704068|NCT01253421|66290027|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
23704069|NCT01253421|66290028|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
23704070|NCT01253421|66290029|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
23704071|NCT01253421|66290030|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
23704072|NCT01253421|66290026|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
23704073|NCT01253421|66290027|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
23704074|NCT01253421|66290028|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
23704075|NCT01253421|66290029|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
23704076|NCT01253421|66290030|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
23704077|NCT01253421|66290026|FG000|Assessment and Scheduling|Physician Decision|1|||
23704078|NCT01253421|66290027|FG001|Assessment and Scheduling|Physician Decision|0|||
23704079|NCT01253421|66290028|FG002|Assessment and Scheduling|Physician Decision|0|||
23704080|NCT01253421|66290029|FG003|Assessment and Scheduling|Physician Decision|0|||
23704081|NCT01253421|66290030|FG004|Assessment and Scheduling|Physician Decision|0|||
23704082|NCT01253421|66290026|FG000|Drug+Scanning Visit|Physician Decision|0|||
23704083|NCT01253421|66290027|FG001|Drug+Scanning Visit|Physician Decision|0|||
23704084|NCT01253421|66290028|FG002|Drug+Scanning Visit|Physician Decision|0|||
23704085|NCT01253421|66290029|FG003|Drug+Scanning Visit|Physician Decision|0|||
23704086|NCT01253421|66290030|FG004|Drug+Scanning Visit|Physician Decision|1|||
23704087|NCT03097328|66290031|FG000|Overall Study|Still on Therapy|2|||
23704088|NCT03097328|66290031|FG000|Overall Study|Progressive Disease|29|||
23704089|NCT03097328|66290031|FG000|Overall Study|Adverse Event|4|||
23704090|NCT03097328|66290031|FG000|Overall Study|Withdrawal by Subject|1|||
23704091|NCT03097328|66290031|FG000|Overall Study|Physician Decision|1|||
23704092|NCT03097328|66290031|FG000|Overall Study|Patient Decision|1|||
23704093|NCT03097328|66290031|FG000|Overall Study|Ineligible for Study Drug|1|||
23704094|NCT03885726|66290032|FG000|Overall Study|Staffing issues/lost interest|1|||
23704095|NCT03885726|66290032|FG000|Overall Study|Early discharge from hospital|3|||
23704096|NCT00540449|66290033|FG000|Overall Study|Adverse Event|12|||
23704097|NCT00540449|66290034|FG001|Overall Study|Adverse Event|32|||
23704098|NCT00540449|66290033|FG000|Overall Study|Sponsor's Decision|1|||
23704099|NCT00540449|66290034|FG001|Overall Study|Sponsor's Decision|1|||
23704100|NCT00540449|66290033|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23704101|NCT00540449|66290034|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
23704102|NCT00540449|66290033|FG000|Overall Study|Lost to Follow-up|19|||
23704103|NCT00540449|66290034|FG001|Overall Study|Lost to Follow-up|17|||
23704104|NCT00540449|66290033|FG000|Overall Study|Subject Non-Compliant|7|||
23704105|NCT00540449|66290034|FG001|Overall Study|Subject Non-Compliant|5|||
23704106|NCT00540449|66290033|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
23704107|NCT00540449|66290034|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
23704108|NCT00540449|66290033|FG000|Overall Study|Withdrawal by Subject|10|||
23704109|NCT00540449|66290034|FG001|Overall Study|Withdrawal by Subject|10|||
23704110|NCT00540449|66290033|FG000|Overall Study|Other|1|||
23704111|NCT00540449|66290034|FG001|Overall Study|Other|4|||
23704112|NCT01850563|66290035|FG000|Overall Study|Not eligible|3|||
23704113|NCT01850563|66290036|FG001|Overall Study|Not eligible|0|||
23704114|NCT01505491|66290044|FG000|Overall Study|Other reason not listed|1|||
23704115|NCT01505491|66290045|FG001|Overall Study|Other reason not listed|0|||
23704116|NCT01505491|66290046|FG002|Overall Study|Other reason not listed|0|||
23704117|NCT01505491|66290044|FG000|Overall Study|Withdrawal by Subject|1|||
23704118|NCT01505491|66290045|FG001|Overall Study|Withdrawal by Subject|1|||
23704119|NCT01505491|66290046|FG002|Overall Study|Withdrawal by Subject|4|||
23704120|NCT01505491|66290044|FG000|Overall Study|Lost to Follow-up|0|||
23704121|NCT01505491|66290045|FG001|Overall Study|Lost to Follow-up|0|||
23704122|NCT01505491|66290046|FG002|Overall Study|Lost to Follow-up|1|||
23704123|NCT00303108|66290047|FG000|Overall Study|Adverse Event|5|||
23704124|NCT00303108|66290048|FG001|Overall Study|Adverse Event|6|||
23704125|NCT00303108|66290049|FG002|Overall Study|Adverse Event|7|||
23704126|NCT00303108|66290047|FG000|Overall Study|Patient Request|4|||
23704127|NCT00303108|66290048|FG001|Overall Study|Patient Request|2|||
23704128|NCT00303108|66290049|FG002|Overall Study|Patient Request|8|||
23704129|NCT00303108|66290047|FG000|Overall Study|Failed Entry|1|||
23704130|NCT00303108|66290048|FG001|Overall Study|Failed Entry|0|||
23704131|NCT00303108|66290049|FG002|Overall Study|Failed Entry|1|||
23704132|NCT00303108|66290047|FG000|Overall Study|ineligible|2|||
23704133|NCT00303108|66290048|FG001|Overall Study|ineligible|1|||
23704134|NCT00303108|66290049|FG002|Overall Study|ineligible|0|||
23704135|NCT03691610|66290050|FG000|Overall Study|Adverse Event|0|||
23704136|NCT03691610|66290051|FG001|Overall Study|Adverse Event|1|||
23704137|NCT03691610|66290052|FG002|Overall Study|Adverse Event|0|||
23704138|NCT03691610|66290053|FG003|Overall Study|Adverse Event|0|||
23704139|NCT03691610|66290050|FG000|Overall Study|Protocol Deviation|15|||
23400059|NCT01517984|65210808|FG001|Overall Study|Lost to Follow-up|1|||
23704140|NCT03691610|66290051|FG001|Overall Study|Protocol Deviation|8|||
23704141|NCT03691610|66290052|FG002|Overall Study|Protocol Deviation|1|||
23704142|NCT03691610|66290053|FG003|Overall Study|Protocol Deviation|2|||
23704143|NCT03691610|66290050|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
23704144|NCT03691610|66290051|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
23704145|NCT03691610|66290052|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
23704146|NCT03691610|66290053|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
23704147|NCT03691610|66290050|FG000|Overall Study|Lost to Follow-up|20|||
23704148|NCT03691610|66290051|FG001|Overall Study|Lost to Follow-up|11|||
23704149|NCT03691610|66290052|FG002|Overall Study|Lost to Follow-up|5|||
23704150|NCT03691610|66290053|FG003|Overall Study|Lost to Follow-up|2|||
23704151|NCT03567291|66290054|FG000|Period I|Adverse Event|14|||
23704152|NCT03567291|66290055|FG001|Period I|Adverse Event|0|||
23704153|NCT03567291|66290056|FG002|Period I|Adverse Event|0|||
23704154|NCT03567291|66290057|FG003|Period I|Adverse Event|0|||
23704155|NCT03567291|66290054|FG000|Period I|Protocol Violation|1|||
23704156|NCT03567291|66290055|FG001|Period I|Protocol Violation|0|||
23704157|NCT03567291|66290056|FG002|Period I|Protocol Violation|0|||
23704158|NCT03567291|66290057|FG003|Period I|Protocol Violation|0|||
23704159|NCT03567291|66290054|FG000|Period I|Withdrawal by Subject|23|||
23704160|NCT03567291|66290055|FG001|Period I|Withdrawal by Subject|0|||
23704161|NCT03567291|66290056|FG002|Period I|Withdrawal by Subject|0|||
23704162|NCT03567291|66290057|FG003|Period I|Withdrawal by Subject|0|||
23704163|NCT03567291|66290054|FG000|Period I|Lost to Follow-up|2|||
23704164|NCT03567291|66290055|FG001|Period I|Lost to Follow-up|0|||
23704165|NCT03567291|66290056|FG002|Period I|Lost to Follow-up|0|||
23704166|NCT03567291|66290057|FG003|Period I|Lost to Follow-up|0|||
23704167|NCT03567291|66290054|FG000|Period I|Terminated by sponsor|44|||
23704168|NCT03567291|66290055|FG001|Period I|Terminated by sponsor|0|||
23704169|NCT03567291|66290056|FG002|Period I|Terminated by sponsor|0|||
23704170|NCT03567291|66290057|FG003|Period I|Terminated by sponsor|0|||
23704171|NCT03567291|66290054|FG000|Period I|Missing or unknown|7|||
23704172|NCT03567291|66290055|FG001|Period I|Missing or unknown|0|||
23704173|NCT03567291|66290056|FG002|Period I|Missing or unknown|0|||
23704174|NCT03567291|66290057|FG003|Period I|Missing or unknown|0|||
23704175|NCT03567291|66290054|FG000|Period II|Adverse Event|0|||
23704176|NCT03567291|66290055|FG001|Period II|Adverse Event|1|||
23704177|NCT03567291|66290056|FG002|Period II|Adverse Event|0|||
23704178|NCT03567291|66290057|FG003|Period II|Adverse Event|0|||
23704179|NCT03567291|66290054|FG000|Period II|Missing or unknown|0|||
23704180|NCT03567291|66290055|FG001|Period II|Missing or unknown|2|||
23704181|NCT03567291|66290056|FG002|Period II|Missing or unknown|1|||
23704182|NCT03567291|66290057|FG003|Period II|Missing or unknown|0|||
23704183|NCT03567291|66290054|FG000|Period III|Adverse Event|0|||
23704184|NCT03567291|66290055|FG001|Period III|Adverse Event|0|||
23704185|NCT03567291|66290056|FG002|Period III|Adverse Event|0|||
23704186|NCT03567291|66290057|FG003|Period III|Adverse Event|4|||
23704187|NCT03567291|66290054|FG000|Period III|Withdrawal by Subject|0|||
23704188|NCT03567291|66290055|FG001|Period III|Withdrawal by Subject|0|||
23704189|NCT03567291|66290056|FG002|Period III|Withdrawal by Subject|0|||
23704190|NCT03567291|66290057|FG003|Period III|Withdrawal by Subject|4|||
23704191|NCT03567291|66290054|FG000|Period III|Lost to Follow-up|0|||
23704192|NCT03567291|66290055|FG001|Period III|Lost to Follow-up|0|||
23704193|NCT03567291|66290056|FG002|Period III|Lost to Follow-up|0|||
23704194|NCT03567291|66290057|FG003|Period III|Lost to Follow-up|1|||
23704195|NCT03567291|66290054|FG000|Period III|Terminated by sponsor|0|||
23704196|NCT03567291|66290055|FG001|Period III|Terminated by sponsor|0|||
23704197|NCT03567291|66290056|FG002|Period III|Terminated by sponsor|0|||
23704198|NCT03567291|66290057|FG003|Period III|Terminated by sponsor|68|||
23704199|NCT03567291|66290054|FG000|Period III|Missing or unknown|0|||
23704200|NCT03567291|66290055|FG001|Period III|Missing or unknown|0|||
23704201|NCT03567291|66290056|FG002|Period III|Missing or unknown|0|||
23704202|NCT03567291|66290057|FG003|Period III|Missing or unknown|8|||
23705691|NCT00972244|66297592|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
23705692|NCT00972244|66297593|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23705693|NCT00972244|66297594|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23705694|NCT00972244|66297595|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
23705695|NCT00972244|66297596|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
23705696|NCT00972244|66297592|FG000|Overall Study|Withdrawal by Subject|1|||
23705697|NCT00972244|66297593|FG001|Overall Study|Withdrawal by Subject|2|||
23705698|NCT00972244|66297594|FG002|Overall Study|Withdrawal by Subject|1|||
23705699|NCT00972244|66297595|FG003|Overall Study|Withdrawal by Subject|0|||
23705700|NCT00972244|66297596|FG004|Overall Study|Withdrawal by Subject|1|||
23705701|NCT00972244|66297592|FG000|Overall Study|Safety|0|||
23705702|NCT00972244|66297593|FG001|Overall Study|Safety|0|||
23705703|NCT00972244|66297594|FG002|Overall Study|Safety|0|||
23705704|NCT00972244|66297595|FG003|Overall Study|Safety|0|||
23705705|NCT00972244|66297596|FG004|Overall Study|Safety|1|||
23705706|NCT00972244|66297592|FG000|Overall Study|Death|1|||
23705707|NCT00972244|66297593|FG001|Overall Study|Death|0|||
23705708|NCT00972244|66297594|FG002|Overall Study|Death|0|||
23704203|NCT03074162|66293394|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23704204|NCT03074162|66293395|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23704205|NCT03074162|66293396|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
23704206|NCT03074162|66293397|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23704207|NCT03074162|66293398|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23704208|NCT03074162|66293399|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23704209|NCT03074162|66293394|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23704210|NCT03074162|66293395|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23704211|NCT03074162|66293396|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
23704212|NCT03074162|66293397|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23704213|NCT03074162|66293398|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23704214|NCT03074162|66293399|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
23704215|NCT03074162|66293394|FG000|Period 3|Withdrawal by Subject|1|||
23704216|NCT03074162|66293395|FG001|Period 3|Withdrawal by Subject|0|||
23704217|NCT03074162|66293396|FG002|Period 3|Withdrawal by Subject|0|||
23704218|NCT03074162|66293397|FG003|Period 3|Withdrawal by Subject|0|||
23704219|NCT03074162|66293398|FG004|Period 3|Withdrawal by Subject|1|||
23704220|NCT03074162|66293399|FG005|Period 3|Withdrawal by Subject|0|||
23704221|NCT03161678|66293402|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23704222|NCT03161678|66293403|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23704223|NCT03161678|66293404|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23704224|NCT03161678|66293405|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
23704225|NCT03161678|66293406|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23704226|NCT03161678|66293407|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23704227|NCT03161678|66293402|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
23704228|NCT03161678|66293403|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
23704229|NCT03161678|66293404|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
23704230|NCT03161678|66293405|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
23704231|NCT03161678|66293406|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
23704232|NCT03161678|66293407|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
23704233|NCT03161678|66293402|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
23704234|NCT03161678|66293403|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
23704235|NCT03161678|66293404|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
23704236|NCT03161678|66293405|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
23704237|NCT03161678|66293406|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
23704238|NCT03161678|66293407|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
23704239|NCT03161678|66293402|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23704240|NCT03161678|66293403|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23704241|NCT03161678|66293404|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23704242|NCT03161678|66293405|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
23704243|NCT03161678|66293406|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23704244|NCT03161678|66293407|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23704245|NCT00101192|66293408|FG000|Overall Study|Ineligible|6|||
23704246|NCT00101192|66293408|FG000|Overall Study|Inevaluable|1|||
23704247|NCT02435277|66293409|FG000|Overall Study|Adverse Event|1|||
23704248|NCT02435277|66293410|FG001|Overall Study|Adverse Event|1|||
23704249|NCT02435277|66293411|FG002|Overall Study|Adverse Event|0|||
23704250|NCT02435277|66293412|FG003|Overall Study|Adverse Event|0|||
23704251|NCT02435277|66293409|FG000|Overall Study|Withdrawal by Subject|1|||
23704252|NCT02435277|66293410|FG001|Overall Study|Withdrawal by Subject|0|||
23704253|NCT02435277|66293411|FG002|Overall Study|Withdrawal by Subject|0|||
23704254|NCT02435277|66293412|FG003|Overall Study|Withdrawal by Subject|0|||
23704255|NCT00430521|66293413|FG000|Overall Study|Adverse Event|0|||
23704256|NCT00430521|66293414|FG001|Overall Study|Adverse Event|0|||
23704257|NCT00430521|66293415|FG002|Overall Study|Adverse Event|0|||
23704258|NCT00430521|66293416|FG003|Overall Study|Adverse Event|0|||
23704259|NCT00430521|66293417|FG004|Overall Study|Adverse Event|0|||
23704260|NCT00430521|66293418|FG005|Overall Study|Adverse Event|2|||
23704261|NCT00430521|66293419|FG006|Overall Study|Adverse Event|1|||
23704262|NCT00430521|66293420|FG007|Overall Study|Adverse Event|0|||
23704263|NCT00430521|66293413|FG000|Overall Study|Lost to Follow-up|7|||
23704264|NCT00430521|66293414|FG001|Overall Study|Lost to Follow-up|8|||
23704265|NCT00430521|66293415|FG002|Overall Study|Lost to Follow-up|3|||
23704266|NCT00430521|66293416|FG003|Overall Study|Lost to Follow-up|5|||
23704267|NCT00430521|66293417|FG004|Overall Study|Lost to Follow-up|5|||
23704268|NCT00430521|66293418|FG005|Overall Study|Lost to Follow-up|2|||
23704269|NCT00430521|66293419|FG006|Overall Study|Lost to Follow-up|8|||
23704270|NCT00430521|66293420|FG007|Overall Study|Lost to Follow-up|10|||
23704271|NCT00430521|66293413|FG000|Overall Study|Pregnancy|0|||
23704272|NCT00430521|66293414|FG001|Overall Study|Pregnancy|0|||
23704273|NCT00430521|66293415|FG002|Overall Study|Pregnancy|0|||
23704274|NCT00430521|66293416|FG003|Overall Study|Pregnancy|0|||
23704275|NCT00430521|66293417|FG004|Overall Study|Pregnancy|0|||
23704276|NCT00430521|66293418|FG005|Overall Study|Pregnancy|0|||
23704277|NCT00430521|66293419|FG006|Overall Study|Pregnancy|1|||
23704278|NCT00430521|66293420|FG007|Overall Study|Pregnancy|0|||
23704279|NCT00430521|66293413|FG000|Overall Study|Vaccine Expired|0|||
23704280|NCT00430521|66293414|FG001|Overall Study|Vaccine Expired|0|||
23704281|NCT00430521|66293415|FG002|Overall Study|Vaccine Expired|0|||
23704282|NCT00430521|66293416|FG003|Overall Study|Vaccine Expired|0|||
23704283|NCT00430521|66293417|FG004|Overall Study|Vaccine Expired|0|||
23704284|NCT00430521|66293418|FG005|Overall Study|Vaccine Expired|1|||
23704285|NCT00430521|66293419|FG006|Overall Study|Vaccine Expired|0|||
23704286|NCT00430521|66293420|FG007|Overall Study|Vaccine Expired|0|||
23704287|NCT00430521|66293413|FG000|Overall Study|Protocol Violation|1|||
23704288|NCT00430521|66293414|FG001|Overall Study|Protocol Violation|0|||
23704289|NCT00430521|66293415|FG002|Overall Study|Protocol Violation|0|||
23704290|NCT00430521|66293416|FG003|Overall Study|Protocol Violation|0|||
23704291|NCT00430521|66293417|FG004|Overall Study|Protocol Violation|0|||
23704292|NCT00430521|66293418|FG005|Overall Study|Protocol Violation|0|||
23704293|NCT00430521|66293419|FG006|Overall Study|Protocol Violation|0|||
23704294|NCT00430521|66293420|FG007|Overall Study|Protocol Violation|0|||
23704295|NCT00430521|66293413|FG000|Overall Study|Withdrawal by Subject|3|||
23704296|NCT00430521|66293414|FG001|Overall Study|Withdrawal by Subject|1|||
23704297|NCT00430521|66293415|FG002|Overall Study|Withdrawal by Subject|0|||
23704298|NCT00430521|66293416|FG003|Overall Study|Withdrawal by Subject|3|||
23704299|NCT00430521|66293417|FG004|Overall Study|Withdrawal by Subject|0|||
23704300|NCT00430521|66293418|FG005|Overall Study|Withdrawal by Subject|0|||
23704301|NCT00430521|66293419|FG006|Overall Study|Withdrawal by Subject|0|||
23704302|NCT00430521|66293420|FG007|Overall Study|Withdrawal by Subject|2|||
23704303|NCT03213626|66293421|FG000|Overall Study|Adverse Event|1|||
23704304|NCT03213626|66293421|FG000|Overall Study|Progressive Disease|6|||
23704305|NCT01930799|66293422|FG000|Overall Study|Withdrawal by Subject|3|||
23704306|NCT01930799|66293422|FG000|Overall Study|Lost to Follow-up|5|||
23704307|NCT01929044|66293423|FG000|Overall Study|Adverse Event|1|||
23704308|NCT01929044|66293424|FG001|Overall Study|Adverse Event|0|||
23704309|NCT01929044|66293423|FG000|Overall Study|Protocol Violation|9|||
23704310|NCT01929044|66293424|FG001|Overall Study|Protocol Violation|14|||
23704311|NCT01929044|66293423|FG000|Overall Study|Not Treated|1|||
23704312|NCT01929044|66293424|FG001|Overall Study|Not Treated|3|||
23704313|NCT01005732|66293431|FG000|Overall Study|Lost to Follow-up|10|||
23704314|NCT01005732|66293431|FG000|Overall Study|Death|1|||
23704315|NCT02508701|66293432|FG000|Overall Study|Lost to Follow-up|9|||
23704316|NCT02508701|66293433|FG001|Overall Study|Lost to Follow-up|5|||
23704317|NCT02508701|66293434|FG002|Overall Study|Lost to Follow-up|5|||
23704318|NCT02508701|66293435|FG003|Overall Study|Lost to Follow-up|3|||
23704319|NCT05896761|66293438|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
23704320|NCT05896761|66293439|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
23704321|NCT05896761|66293438|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
23704322|NCT05896761|66293439|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
23704323|NCT00913978|66293452|FG000|Overall Study|Surgeon choice|1|||
23704324|NCT00913978|66293453|FG001|Overall Study|Surgeon choice|3|||
23704325|NCT01259297|66293454|FG000|Double Blind Randomized Period|Death|1|||
23704326|NCT01259297|66293455|FG001|Double Blind Randomized Period|Death|1|||
23704327|NCT01259297|66293456|FG002|Double Blind Randomized Period|Death|1|||
23704328|NCT01259297|66293457|FG003|Double Blind Randomized Period|Death|2|||
23704329|NCT01259297|66293458|FG004|Double Blind Randomized Period|Death|1|||
23704330|NCT01259297|66293459|FG005|Double Blind Randomized Period|Death|5|||
23704331|NCT01259297|66293460|FG006|Double Blind Randomized Period|Death|2|||
23704332|NCT01259297|66293461|FG007|Double Blind Randomized Period|Death|1|||
23704333|NCT01259297|66293454|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23704334|NCT01259297|66293455|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23704335|NCT01259297|66293456|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
23704336|NCT01259297|66293457|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
23704337|NCT01259297|66293458|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
23704338|NCT01259297|66293459|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23704339|NCT01259297|66293460|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23704340|NCT01259297|66293461|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23704341|NCT01259297|66293454|FG000|Double Blind Randomized Period|Other reasons|0|||
23704342|NCT01259297|66293455|FG001|Double Blind Randomized Period|Other reasons|1|||
23704343|NCT01259297|66293456|FG002|Double Blind Randomized Period|Other reasons|0|||
23704344|NCT01259297|66293457|FG003|Double Blind Randomized Period|Other reasons|0|||
23704345|NCT01259297|66293458|FG004|Double Blind Randomized Period|Other reasons|1|||
23704346|NCT01259297|66293459|FG005|Double Blind Randomized Period|Other reasons|2|||
23704347|NCT01259297|66293460|FG006|Double Blind Randomized Period|Other reasons|3|||
23704348|NCT01259297|66293461|FG007|Double Blind Randomized Period|Other reasons|1|||
23704349|NCT01552928|66293468|FG000|Period 3|Adverse Event|0|||
23704350|NCT01552928|66293469|FG001|Period 3|Adverse Event|0|||
23704351|NCT01552928|66293470|FG002|Period 3|Adverse Event|1|||
23704352|NCT01552928|66293471|FG003|Period 3|Adverse Event|0|||
23704353|NCT00524316|66293472|FG000|Overall Study|Withdrawal by Subject|2|||
23704354|NCT00524316|66293472|FG000|Overall Study|Adverse Event|7|||
23704355|NCT00524316|66293472|FG000|Overall Study|Disease Progression|7|||
23704356|NCT03488472|66293473|FG000|Overall Study|disease progression additional mets|1|||
23704357|NCT04009096|66293479|FG000|Overall Study|Withdrawal by Subject|0|||
23704358|NCT04009096|66293480|FG001|Overall Study|Withdrawal by Subject|7|||
23704359|NCT04009096|66293481|FG002|Overall Study|Withdrawal by Subject|0|||
23704360|NCT04009096|66293479|FG000|Overall Study|Physician Decision|0|||
23704361|NCT04009096|66293480|FG001|Overall Study|Physician Decision|1|||
23704362|NCT04009096|66293481|FG002|Overall Study|Physician Decision|0|||
23704363|NCT03569293|66293482|FG000|Overall Study|Adverse Event|4|||
23704364|NCT03569293|66293483|FG001|Overall Study|Adverse Event|1|||
23704365|NCT03569293|66293484|FG002|Overall Study|Adverse Event|5|||
23704366|NCT03569293|66293485|FG003|Overall Study|Adverse Event|1|||
23704367|NCT03569293|66293486|FG004|Overall Study|Adverse Event|0|||
23704368|NCT03569293|66293487|FG005|Overall Study|Adverse Event|0|||
23704369|NCT03569293|66293482|FG000|Overall Study|Withdrawal by Subject|16|||
23704370|NCT03569293|66293483|FG001|Overall Study|Withdrawal by Subject|2|||
23704371|NCT03569293|66293484|FG002|Overall Study|Withdrawal by Subject|4|||
23704372|NCT03569293|66293485|FG003|Overall Study|Withdrawal by Subject|1|||
23704373|NCT03569293|66293486|FG004|Overall Study|Withdrawal by Subject|0|||
23704374|NCT03569293|66293487|FG005|Overall Study|Withdrawal by Subject|0|||
23704375|NCT03569293|66293482|FG000|Overall Study|Lost to Follow-up|1|||
23704376|NCT03569293|66293483|FG001|Overall Study|Lost to Follow-up|3|||
23704377|NCT03569293|66293484|FG002|Overall Study|Lost to Follow-up|1|||
23704378|NCT03569293|66293485|FG003|Overall Study|Lost to Follow-up|1|||
23704379|NCT03569293|66293486|FG004|Overall Study|Lost to Follow-up|0|||
23704380|NCT03569293|66293487|FG005|Overall Study|Lost to Follow-up|0|||
23704381|NCT03569293|66293482|FG000|Overall Study|Other|8|||
23704382|NCT03569293|66293483|FG001|Overall Study|Other|2|||
23704383|NCT03569293|66293484|FG002|Overall Study|Other|1|||
23704384|NCT03569293|66293485|FG003|Overall Study|Other|1|||
23704385|NCT03569293|66293486|FG004|Overall Study|Other|0|||
23704386|NCT03569293|66293487|FG005|Overall Study|Other|0|||
23704387|NCT03569293|66293482|FG000|Overall Study|Ongoing at Time of Analysis|8|||
23704388|NCT03569293|66293483|FG001|Overall Study|Ongoing at Time of Analysis|1|||
23704389|NCT03569293|66293484|FG002|Overall Study|Ongoing at Time of Analysis|3|||
23704390|NCT03569293|66293485|FG003|Overall Study|Ongoing at Time of Analysis|0|||
23704391|NCT03569293|66293486|FG004|Overall Study|Ongoing at Time of Analysis|0|||
23704392|NCT03569293|66293487|FG005|Overall Study|Ongoing at Time of Analysis|0|||
23704393|NCT03255291|66293488|FG000|Overall Study|Determined to be ineligible|10|||
23704394|NCT03255291|66293489|FG001|Overall Study|Determined to be ineligible|12|||
23704395|NCT03255291|66293490|FG002|Overall Study|Determined to be ineligible|6|||
23704396|NCT03255291|66293491|FG003|Overall Study|Determined to be ineligible|6|||
23704397|NCT03255291|66293492|FG004|Overall Study|Determined to be ineligible|5|||
23704398|NCT03255291|66293493|FG005|Overall Study|Determined to be ineligible|10|||
23704399|NCT03255291|66293488|FG000|Overall Study|Baseline data collection issues|3|||
23704400|NCT03255291|66293489|FG001|Overall Study|Baseline data collection issues|0|||
23704401|NCT03255291|66293490|FG002|Overall Study|Baseline data collection issues|0|||
23704402|NCT03255291|66293491|FG003|Overall Study|Baseline data collection issues|0|||
23704403|NCT03255291|66293492|FG004|Overall Study|Baseline data collection issues|2|||
23704404|NCT03255291|66293493|FG005|Overall Study|Baseline data collection issues|0|||
23704405|NCT01703286|66293498|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
23704406|NCT01703286|66293499|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
23704407|NCT01703286|66293500|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
23704408|NCT01703286|66293501|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
23704409|NCT01703286|66293502|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
23704410|NCT01703286|66293503|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
23704411|NCT01703286|66293498|FG000|Period 2 Including Washout|Adverse Event|0|||
23704412|NCT01703286|66293499|FG001|Period 2 Including Washout|Adverse Event|0|||
23704413|NCT01703286|66293500|FG002|Period 2 Including Washout|Adverse Event|0|||
23704414|NCT01703286|66293501|FG003|Period 2 Including Washout|Adverse Event|1|||
23704415|NCT01703286|66293502|FG004|Period 2 Including Washout|Adverse Event|0|||
23704416|NCT01703286|66293503|FG005|Period 2 Including Washout|Adverse Event|0|||
23704417|NCT00807846|66293504|FG000|Overall Study|Adverse Event|5|||
23704418|NCT00807846|66293505|FG001|Overall Study|Adverse Event|0|||
23704419|NCT00807846|66293504|FG000|Overall Study|Lack of Efficacy|2|||
23704420|NCT00807846|66293505|FG001|Overall Study|Lack of Efficacy|0|||
23704421|NCT00807846|66293504|FG000|Overall Study|Protocol Violation|2|||
23704422|NCT00807846|66293505|FG001|Overall Study|Protocol Violation|1|||
23704423|NCT00807846|66293504|FG000|Overall Study|Withdrawal by Subject|2|||
23704424|NCT00807846|66293505|FG001|Overall Study|Withdrawal by Subject|1|||
23704425|NCT00807846|66293504|FG000|Overall Study|Other|1|||
23704426|NCT00807846|66293505|FG001|Overall Study|Other|2|||
23704427|NCT01295905|66293506|FG000|Overall Study|Did not meet inclusion criteria|1|||
23704428|NCT01295905|66293507|FG001|Overall Study|Did not meet inclusion criteria|0|||
23704429|NCT01295905|66293506|FG000|Overall Study|Met exclusion criteria|1|||
23704430|NCT01295905|66293507|FG001|Overall Study|Met exclusion criteria|0|||
23704431|NCT01998581|66293513|FG000|Overall Study|Refused repeat treatment|20|||
23704432|NCT01998581|66293514|FG001|Overall Study|Refused repeat treatment|4|||
23704433|NCT01998581|66293513|FG000|Overall Study|Protocol Violation|1|||
23704434|NCT01998581|66293514|FG001|Overall Study|Protocol Violation|0|||
23704435|NCT01998581|66293513|FG000|Overall Study|Withdrawal by Subject|8|||
23704436|NCT01998581|66293514|FG001|Overall Study|Withdrawal by Subject|1|||
23704437|NCT01998581|66293513|FG000|Overall Study|Lost to Follow-up|12|||
23704438|NCT01998581|66293514|FG001|Overall Study|Lost to Follow-up|4|||
23704439|NCT01998581|66293513|FG000|Overall Study|Adverse Event|1|||
23704440|NCT01998581|66293514|FG001|Overall Study|Adverse Event|1|||
23704441|NCT01998581|66293513|FG000|Overall Study|Other reasons|3|||
23704442|NCT01998581|66293514|FG001|Overall Study|Other reasons|2|||
23704443|NCT01998581|66293513|FG000|Overall Study|Randomized but withdrew before treatment|1|||
23704444|NCT01998581|66293514|FG001|Overall Study|Randomized but withdrew before treatment|0|||
23704445|NCT03827473|66293515|FG000|Overall Study|Withdrawal by Subject|1|||
23704446|NCT03827473|66293516|FG001|Overall Study|Withdrawal by Subject|0|||
23704447|NCT00952289|66293519|FG000|All Participants|Death|9|||
23704448|NCT00952289|66293520|FG001|All Participants|Death|9|||
23704449|NCT00952289|66293519|FG000|All Participants|Adverse Event|8|||
23704450|NCT00952289|66293520|FG001|All Participants|Adverse Event|8|||
23704451|NCT00952289|66293519|FG000|All Participants|Disease progression|3|||
23704452|NCT00952289|66293520|FG001|All Participants|Disease progression|12|||
23704453|NCT00952289|66293519|FG000|All Participants|Withdrawal by Subject|1|||
23704454|NCT00952289|66293520|FG001|All Participants|Withdrawal by Subject|10|||
23704455|NCT00952289|66293519|FG000|All Participants|Data lost during site relocation|0|||
23704456|NCT00952289|66293520|FG001|All Participants|Data lost during site relocation|1|||
23704457|NCT00952289|66293519|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
23704458|NCT00952289|66293520|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
23704459|NCT00952289|66293519|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
23704460|NCT00952289|66293520|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
23704461|NCT00952289|66293519|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
23704462|NCT00952289|66293520|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
23704463|NCT00952289|66293519|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
23704464|NCT00952289|66293520|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
23704465|NCT00952289|66293519|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
23704466|NCT00952289|66293520|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
23704467|NCT03738566|66293521|FG000|Initial Study Phase|Withdrawal by Subject|1|||
23704468|NCT03738566|66293522|FG001|Initial Study Phase|Withdrawal by Subject|1|||
23704469|NCT03738566|66293523|FG002|Initial Study Phase|Withdrawal by Subject|2|||
23704470|NCT03738566|66293524|FG003|Initial Study Phase|Withdrawal by Subject|0|||
23704471|NCT03738566|66293521|FG000|Initial Study Phase|Death|0|||
23704472|NCT03738566|66293522|FG001|Initial Study Phase|Death|1|||
23704473|NCT03738566|66293523|FG002|Initial Study Phase|Death|0|||
23704474|NCT03738566|66293524|FG003|Initial Study Phase|Death|0|||
23704475|NCT03738566|66293521|FG000|Initial Study Phase|Treatment failure|5|||
23704476|NCT03738566|66293522|FG001|Initial Study Phase|Treatment failure|0|||
23704477|NCT03738566|66293523|FG002|Initial Study Phase|Treatment failure|0|||
23704478|NCT03738566|66293524|FG003|Initial Study Phase|Treatment failure|0|||
23704479|NCT03738566|66293521|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23704480|NCT03738566|66293522|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23704481|NCT03738566|66293523|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23704482|NCT03738566|66293524|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
23704483|NCT00859898|66293525|FG000|Overall Study|Lack of Efficacy|0|||
23704484|NCT00859898|66293526|FG001|Overall Study|Lack of Efficacy|1|||
23704485|NCT00859898|66293527|FG002|Overall Study|Lack of Efficacy|1|||
23704486|NCT00859898|66293525|FG000|Overall Study|Adverse Event|4|||
23704487|NCT00859898|66293526|FG001|Overall Study|Adverse Event|9|||
23704488|NCT00859898|66293527|FG002|Overall Study|Adverse Event|8|||
23704489|NCT00859898|66293525|FG000|Overall Study|Withdrawal by Subject|11|||
23704490|NCT00859898|66293526|FG001|Overall Study|Withdrawal by Subject|8|||
23704491|NCT00859898|66293527|FG002|Overall Study|Withdrawal by Subject|11|||
23704492|NCT00859898|66293525|FG000|Overall Study|Death|0|||
23704493|NCT00859898|66293526|FG001|Overall Study|Death|0|||
23704494|NCT00859898|66293527|FG002|Overall Study|Death|1|||
23704495|NCT00859898|66293525|FG000|Overall Study|Lost to Follow-up|10|||
23704496|NCT00859898|66293526|FG001|Overall Study|Lost to Follow-up|11|||
23704497|NCT00859898|66293527|FG002|Overall Study|Lost to Follow-up|5|||
23704498|NCT00859898|66293525|FG000|Overall Study|poor/non-compliance|2|||
23704499|NCT00859898|66293526|FG001|Overall Study|poor/non-compliance|0|||
23704500|NCT00859898|66293527|FG002|Overall Study|poor/non-compliance|0|||
23704501|NCT00859898|66293525|FG000|Overall Study|No longer meets criteria|0|||
23704502|NCT00859898|66293526|FG001|Overall Study|No longer meets criteria|1|||
23704503|NCT00859898|66293527|FG002|Overall Study|No longer meets criteria|0|||
23704504|NCT00859898|66293525|FG000|Overall Study|non-specified|1|||
23704505|NCT00859898|66293526|FG001|Overall Study|non-specified|1|||
23704506|NCT00859898|66293527|FG002|Overall Study|non-specified|1|||
23704507|NCT00051558|66293529|FG000|Overall Study|Adverse Event|30|||
23704508|NCT00051558|66293530|FG001|Overall Study|Adverse Event|18|||
23704509|NCT00051558|66293529|FG000|Overall Study|Withdrawal by Subject|29|||
23704510|NCT00051558|66293530|FG001|Overall Study|Withdrawal by Subject|42|||
23704511|NCT00051558|66293529|FG000|Overall Study|Death|9|||
23704512|NCT00051558|66293530|FG001|Overall Study|Death|15|||
23704513|NCT00051558|66293529|FG000|Overall Study|Lost to Follow-up|4|||
23704514|NCT00051558|66293530|FG001|Overall Study|Lost to Follow-up|13|||
23704515|NCT00051558|66293529|FG000|Overall Study|Protocol Violation|3|||
23704516|NCT00051558|66293530|FG001|Overall Study|Protocol Violation|4|||
23704517|NCT00051558|66293529|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
23704518|NCT00051558|66293530|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
23704519|NCT00051558|66293529|FG000|Overall Study|Sponsor Decision|6|||
23704520|NCT00051558|66293530|FG001|Overall Study|Sponsor Decision|1|||
23704521|NCT00051558|66293529|FG000|Overall Study|Other|2|||
23400060|NCT01517984|65210809|FG002|Overall Study|Lost to Follow-up|0|||
23400061|NCT01517984|65210810|FG003|Overall Study|Lost to Follow-up|0|||
23400062|NCT01517984|65210807|FG000|Overall Study|Withdrawal by Subject|1|||
23400063|NCT01517984|65210808|FG001|Overall Study|Withdrawal by Subject|8|||
23400064|NCT01517984|65210809|FG002|Overall Study|Withdrawal by Subject|4|||
23400065|NCT01517984|65210810|FG003|Overall Study|Withdrawal by Subject|1|||
23400066|NCT01517984|65210807|FG000|Overall Study|Screen Failure|4|||
23400067|NCT01517984|65210808|FG001|Overall Study|Screen Failure|0|||
23400068|NCT01517984|65210809|FG002|Overall Study|Screen Failure|0|||
23400069|NCT01517984|65210810|FG003|Overall Study|Screen Failure|0|||
23400070|NCT01517984|65210807|FG000|Overall Study|Ineligible for randomization|0|||
23400071|NCT01517984|65210808|FG001|Overall Study|Ineligible for randomization|14|||
23400072|NCT01517984|65210809|FG002|Overall Study|Ineligible for randomization|0|||
23400073|NCT01517984|65210810|FG003|Overall Study|Ineligible for randomization|0|||
23400074|NCT01673126|65210811|FG000|Overall Study|change of diagnosis|4|||
23400075|NCT01673126|65210812|FG001|Overall Study|change of diagnosis|3|||
23400076|NCT00688597|65210813|FG000|Overall Study|Adverse Event|2|||
23400077|NCT00688597|65210814|FG001|Overall Study|Adverse Event|0|||
23400078|NCT00688597|65210815|FG002|Overall Study|Adverse Event|0|||
23400079|NCT00688597|65210813|FG000|Overall Study|Physician Decision|1|||
23400080|NCT00688597|65210814|FG001|Overall Study|Physician Decision|0|||
23400081|NCT00688597|65210815|FG002|Overall Study|Physician Decision|0|||
23400082|NCT02553629|65210821|FG000|Overall Study|Logistic reasons|3|||
23400083|NCT02553629|65210822|FG001|Overall Study|Logistic reasons|6|||
23400084|NCT02935192|65210823|FG000|Overall Study|Withdrawal by Subject|8|||
23400085|NCT02935192|65210824|FG001|Overall Study|Withdrawal by Subject|4|||
23400086|NCT02268383|65210827|FG000|Overall Study|Death|12|||
23400087|NCT02268383|65210827|FG000|Overall Study|Lost to Follow-up|2|||
23400088|NCT02268383|65210827|FG000|Overall Study|Withdrawal by Subject|9|||
23400089|NCT02268383|65210827|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
23400090|NCT02268383|65210827|FG000|Overall Study|Protocol deviation|3|||
23400091|NCT02268383|65210827|FG000|Overall Study|Sponsor decision|22|||
23400092|NCT02268383|65210827|FG000|Overall Study|Not reported|12|||
23400093|NCT04108273|65210841|FG000|Overall Study|COVID Pandemic|1|||
23704522|NCT00051558|66293530|FG001|Overall Study|Other|1|||
23704523|NCT00051558|66293529|FG000|Overall Study|Significant Lab Value|2|||
23704524|NCT00051558|66293530|FG001|Overall Study|Significant Lab Value|0|||
23400094|NCT04108273|65210842|FG001|Overall Study|COVID Pandemic|0|||
23400095|NCT03366337|65210845|FG000|Overall Study|Lost to Follow-up|1|||
23400096|NCT03366337|65210846|FG001|Overall Study|Lost to Follow-up|0|||
23400097|NCT03366337|65210847|FG002|Overall Study|Lost to Follow-up|1|||
23400098|NCT03366337|65210848|FG003|Overall Study|Lost to Follow-up|0|||
23400099|NCT03366337|65210845|FG000|Overall Study|Withdrawal by Subject|2|||
23400100|NCT03366337|65210846|FG001|Overall Study|Withdrawal by Subject|0|||
23400101|NCT03366337|65210847|FG002|Overall Study|Withdrawal by Subject|1|||
23704525|NCT00051558|66293529|FG000|Overall Study|Physician Decision|5|||
23704526|NCT00051558|66293530|FG001|Overall Study|Physician Decision|0|||
23704527|NCT02064439|66293531|FG000|Overall Study|Adverse Event|51|||
23503532|NCT02468232|65583944|FG002|OLE Part of Study|Adverse Event|4|||
23503533|NCT02468232|65583945|FG003|OLE Part of Study|Adverse Event|5|||
23503534|NCT02468232|65583942|FG000|OLE Part of Study|Death|0|||
23503535|NCT02468232|65583943|FG001|OLE Part of Study|Death|0|||
23503536|NCT02468232|65583944|FG002|OLE Part of Study|Death|4|||
23503537|NCT02468232|65583945|FG003|OLE Part of Study|Death|2|||
23503538|NCT02468232|65583942|FG000|OLE Part of Study|Physician Decision|0|||
23503539|NCT02468232|65583943|FG001|OLE Part of Study|Physician Decision|0|||
23503540|NCT02468232|65583944|FG002|OLE Part of Study|Physician Decision|4|||
23503541|NCT02468232|65583945|FG003|OLE Part of Study|Physician Decision|0|||
23503542|NCT02468232|65583942|FG000|OLE Part of Study|Subject/Guardian decision|0|||
23503543|NCT02468232|65583943|FG001|OLE Part of Study|Subject/Guardian decision|0|||
23503544|NCT02468232|65583944|FG002|OLE Part of Study|Subject/Guardian decision|2|||
23503545|NCT02468232|65583945|FG003|OLE Part of Study|Subject/Guardian decision|5|||
23503546|NCT02612727|65583947|FG000|Overall Study|Parent request|4|||
23503547|NCT02612727|65583948|FG001|Overall Study|Parent request|1|||
23503548|NCT02612727|65583947|FG000|Overall Study|Needed treatment incompatible with PT|1|||
23503549|NCT02612727|65583948|FG001|Overall Study|Needed treatment incompatible with PT|1|||
23503550|NCT02612727|65583947|FG000|Overall Study|Direct hyperbilirubinemia|0|||
23503551|NCT02612727|65583948|FG001|Overall Study|Direct hyperbilirubinemia|2|||
23503552|NCT00729651|65583949|FG000|Overall Study|Withdrawal by Subject|5|||
23503553|NCT00729651|65583950|FG001|Overall Study|Withdrawal by Subject|6|||
23503554|NCT00729651|65583949|FG000|Overall Study|Lost to Follow-up|5|||
23503555|NCT00729651|65583950|FG001|Overall Study|Lost to Follow-up|4|||
23503556|NCT00729651|65583949|FG000|Overall Study|Protocol Violation|0|||
23503557|NCT00729651|65583950|FG001|Overall Study|Protocol Violation|1|||
23503558|NCT00729651|65583949|FG000|Overall Study|Adverse Event|7|||
23503559|NCT00729651|65583950|FG001|Overall Study|Adverse Event|3|||
23503560|NCT00729651|65583949|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
23503561|NCT00729651|65583950|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
23503562|NCT00729651|65583949|FG000|Overall Study|Subject's private reason|2|||
23503563|NCT00729651|65583950|FG001|Overall Study|Subject's private reason|0|||
23503564|NCT03060629|65583952|FG000|Overall Study|Death|4|||
23503565|NCT03060629|65583953|FG001|Overall Study|Death|5|||
23503566|NCT03060629|65583952|FG000|Overall Study|Withdrawal by Subject|50|||
23503567|NCT03060629|65583953|FG001|Overall Study|Withdrawal by Subject|35|||
23503568|NCT03060629|65583952|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
23503569|NCT03060629|65583953|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
23503570|NCT03060629|65583952|FG000|Overall Study|Participant Relocate|15|||
23503571|NCT03060629|65583953|FG001|Overall Study|Participant Relocate|15|||
23503572|NCT03060629|65583952|FG000|Overall Study|Unable to Contact Participant|34|||
23503573|NCT03060629|65583953|FG001|Overall Study|Unable to Contact Participant|23|||
23503574|NCT03060629|65583952|FG000|Overall Study|Investigator Decision|7|||
23503575|NCT03060629|65583953|FG001|Overall Study|Investigator Decision|7|||
23503576|NCT03060629|65583952|FG000|Overall Study|Study Terminated by Sponsor|1100|||
23503577|NCT03060629|65583953|FG001|Overall Study|Study Terminated by Sponsor|1123|||
23503578|NCT03060629|65583952|FG000|Overall Study|Other|4|||
23503579|NCT03060629|65583953|FG001|Overall Study|Other|4|||
23503580|NCT02244606|65583954|FG000|Overall Study|Adverse Event|0|||
23503581|NCT02244606|65583955|FG001|Overall Study|Adverse Event|1|||
23503582|NCT02244606|65583956|FG002|Overall Study|Adverse Event|1|||
23503583|NCT02244606|65583957|FG003|Overall Study|Adverse Event|0|||
23503584|NCT02244606|65583954|FG000|Overall Study|Lost to Follow-up|2|||
23503585|NCT02244606|65583955|FG001|Overall Study|Lost to Follow-up|2|||
23503586|NCT02244606|65583956|FG002|Overall Study|Lost to Follow-up|1|||
23503587|NCT02244606|65583957|FG003|Overall Study|Lost to Follow-up|0|||
23503588|NCT02244606|65583954|FG000|Overall Study|Protocol Violation|0|||
23503589|NCT02244606|65583955|FG001|Overall Study|Protocol Violation|0|||
23503590|NCT02244606|65583956|FG002|Overall Study|Protocol Violation|0|||
23503591|NCT02244606|65583957|FG003|Overall Study|Protocol Violation|1|||
23503592|NCT02244606|65583954|FG000|Overall Study|Withdrawal by Subject|1|||
23503593|NCT02244606|65583955|FG001|Overall Study|Withdrawal by Subject|1|||
23503594|NCT02244606|65583956|FG002|Overall Study|Withdrawal by Subject|0|||
23503595|NCT02244606|65583957|FG003|Overall Study|Withdrawal by Subject|0|||
23503596|NCT02244606|65583954|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
23503597|NCT02244606|65583955|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
23503598|NCT02244606|65583956|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
23503599|NCT02244606|65583957|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
23503600|NCT01626391|65583958|FG000|Overall Study|Physician Decision|1|||
23503601|NCT01626391|65583959|FG001|Overall Study|Physician Decision|0|||
23704528|NCT02064439|66293532|FG001|Overall Study|Adverse Event|47|||
23503602|NCT01626391|65583958|FG000|Overall Study|Withdrawal by Subject|1|||
23503603|NCT01626391|65583959|FG001|Overall Study|Withdrawal by Subject|0|||
23503604|NCT01862874|65583960|FG000|Overall Study|Randomized not treated|1|||
23503605|NCT01862874|65583961|FG001|Overall Study|Randomized not treated|0|||
23503606|NCT01862874|65583960|FG000|Overall Study|Adverse Event|0|||
23503607|NCT01862874|65583961|FG001|Overall Study|Adverse Event|3|||
23503608|NCT01862874|65583960|FG000|Overall Study|Lost to Follow-up|26|||
23503609|NCT01862874|65583961|FG001|Overall Study|Lost to Follow-up|29|||
23503610|NCT01862874|65583960|FG000|Overall Study|Physician Decision|5|||
23503611|NCT01862874|65583961|FG001|Overall Study|Physician Decision|3|||
23503612|NCT01862874|65583960|FG000|Overall Study|Withdrawn by parent/guardian|1|||
23503613|NCT01862874|65583961|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23503614|NCT01862874|65583960|FG000|Overall Study|Withdrawal by Subject|46|||
23503615|NCT01862874|65583961|FG001|Overall Study|Withdrawal by Subject|40|||
23503616|NCT01862874|65583960|FG000|Overall Study|Death|0|||
23503617|NCT01862874|65583961|FG001|Overall Study|Death|1|||
23503618|NCT00506662|65583962|FG000|Overall Study|Adverse Event|0|||
23503619|NCT00506662|65583963|FG001|Overall Study|Adverse Event|2|||
23503620|NCT00506662|65583962|FG000|Overall Study|Lack of Efficacy|1|||
23503621|NCT00506662|65583963|FG001|Overall Study|Lack of Efficacy|0|||
23503622|NCT00506662|65583962|FG000|Overall Study|Protocol Violation|2|||
23503623|NCT00506662|65583963|FG001|Overall Study|Protocol Violation|4|||
23503624|NCT00506662|65583962|FG000|Overall Study|Trial terminated|10|||
23503625|NCT00506662|65583963|FG001|Overall Study|Trial terminated|16|||
23503626|NCT00506662|65583962|FG000|Overall Study|Not recorded|4|||
23503627|NCT00506662|65583963|FG001|Overall Study|Not recorded|6|||
23503628|NCT04805541|65583966|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
23503629|NCT00913497|65583967|FG000|Overall Study|Adverse Event|1|||
23503630|NCT00913497|65583967|FG000|Overall Study|Withdrawal by Subject|2|||
23503631|NCT02340975|65583968|FG000|Overall Study|Death|6|||
23503632|NCT02340975|65583969|FG001|Overall Study|Death|23|||
23503633|NCT02340975|65583970|FG002|Overall Study|Death|21|||
23503634|NCT02340975|65583971|FG003|Overall Study|Death|7|||
23503635|NCT02340975|65583972|FG004|Overall Study|Death|21|||
23503636|NCT02340975|65583973|FG005|Overall Study|Death|13|||
23503637|NCT02340975|65583968|FG000|Overall Study|Lost to Follow-up|0|||
23503638|NCT02340975|65583969|FG001|Overall Study|Lost to Follow-up|0|||
23503639|NCT02340975|65583970|FG002|Overall Study|Lost to Follow-up|0|||
23503640|NCT02340975|65583971|FG003|Overall Study|Lost to Follow-up|0|||
23503641|NCT02340975|65583972|FG004|Overall Study|Lost to Follow-up|2|||
23503642|NCT02340975|65583973|FG005|Overall Study|Lost to Follow-up|0|||
23503643|NCT02340975|65583968|FG000|Overall Study|Withdrawal by Subject|0|||
23503644|NCT02340975|65583969|FG001|Overall Study|Withdrawal by Subject|0|||
23503645|NCT02340975|65583970|FG002|Overall Study|Withdrawal by Subject|3|||
23503646|NCT02340975|65583971|FG003|Overall Study|Withdrawal by Subject|3|||
23503647|NCT02340975|65583972|FG004|Overall Study|Withdrawal by Subject|2|||
23503648|NCT02340975|65583973|FG005|Overall Study|Withdrawal by Subject|0|||
23503649|NCT02340975|65583968|FG000|Overall Study|Other|0|||
23503650|NCT02340975|65583969|FG001|Overall Study|Other|4|||
23503651|NCT02340975|65583970|FG002|Overall Study|Other|0|||
23503652|NCT02340975|65583971|FG003|Overall Study|Other|2|||
23503653|NCT02340975|65583972|FG004|Overall Study|Other|0|||
23503654|NCT02340975|65583973|FG005|Overall Study|Other|6|||
23503655|NCT00571948|65583974|FG000|Overall Study|Lost to Follow-up|2|||
23503656|NCT00571948|65583975|FG001|Overall Study|Lost to Follow-up|0|||
23503657|NCT00571948|65583974|FG000|Overall Study|Withdrawal by Subject|1|||
23503658|NCT00571948|65583975|FG001|Overall Study|Withdrawal by Subject|2|||
23503659|NCT00571948|65583974|FG000|Overall Study|Protocol Violation|3|||
23503660|NCT00571948|65583975|FG001|Overall Study|Protocol Violation|3|||
23503661|NCT00571948|65583974|FG000|Overall Study|infant refused study meal|3|||
23503662|NCT00571948|65583975|FG001|Overall Study|infant refused study meal|4|||
23503663|NCT00571948|65583974|FG000|Overall Study|Parent were afraid of blood colection|2|||
23503664|NCT00571948|65583975|FG001|Overall Study|Parent were afraid of blood colection|5|||
23503665|NCT03338998|65583977|FG000|Treatment Period|Withdrawal by Subject|1|||
23503666|NCT03338998|65583978|FG001|Treatment Period|Withdrawal by Subject|1|||
23503667|NCT03338998|65583977|FG000|Treatment Period|Adverse Event|0|||
23503668|NCT03338998|65583978|FG001|Treatment Period|Adverse Event|2|||
23503669|NCT03338998|65583977|FG000|Treatment Period|Protocol deviation|1|||
23503670|NCT03338998|65583978|FG001|Treatment Period|Protocol deviation|0|||
23503671|NCT03338998|65583977|FG000|Treatment Period|Physician Decision|2|||
23503672|NCT03338998|65583978|FG001|Treatment Period|Physician Decision|0|||
23503673|NCT03338998|65583977|FG000|Treatment Period|Subject failed swallow test|4|||
23503674|NCT03338998|65583978|FG001|Treatment Period|Subject failed swallow test|0|||
23503675|NCT03338998|65583977|FG000|Safety Follow-Up Period|Adverse Event|0|||
23503676|NCT03338998|65583978|FG001|Safety Follow-Up Period|Adverse Event|1|||
23503677|NCT03338998|65583977|FG000|Safety Follow-Up Period|Protocol deviation|1|||
23503678|NCT03338998|65583978|FG001|Safety Follow-Up Period|Protocol deviation|0|||
23503679|NCT03338998|65583977|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
23503680|NCT03338998|65583978|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
23503681|NCT02478632|65583980|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
23503682|NCT02478632|65583981|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
23503683|NCT02478632|65583980|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
23503684|NCT02478632|65583981|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
23503685|NCT02478632|65583980|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
23503686|NCT02478632|65583981|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
23503687|NCT02006719|65583982|FG000|Overall Study|Withdrawal by Subject|10|||
23503688|NCT02006719|65583983|FG001|Overall Study|Withdrawal by Subject|2|||
23503689|NCT02006719|65583982|FG000|Overall Study|Lost to Follow-up|5|||
23503690|NCT02006719|65583983|FG001|Overall Study|Lost to Follow-up|1|||
23503691|NCT02006719|65583982|FG000|Overall Study|Protocol Violation|2|||
23503692|NCT02006719|65583983|FG001|Overall Study|Protocol Violation|0|||
23503693|NCT02006719|65583982|FG000|Overall Study|Adverse Event|1|||
23503694|NCT02006719|65583983|FG001|Overall Study|Adverse Event|1|||
23503695|NCT02006719|65583982|FG000|Overall Study|Other/Unknown|0|||
23503696|NCT02006719|65583983|FG001|Overall Study|Other/Unknown|1|||
23503697|NCT00621153|65583984|FG000|Overall Study|Safety Reason|8|||
23503698|NCT00621153|65583985|FG001|Overall Study|Safety Reason|7|||
23503699|NCT00621153|65583984|FG000|Overall Study|Adverse Event|3|||
23503700|NCT00621153|65583985|FG001|Overall Study|Adverse Event|2|||
23503701|NCT00621153|65583984|FG000|Overall Study|Lost to Follow-up|5|||
23503702|NCT00621153|65583985|FG001|Overall Study|Lost to Follow-up|1|||
23503703|NCT00621153|65583984|FG000|Overall Study|Withdrawal by Subject|4|||
23503704|NCT00621153|65583985|FG001|Overall Study|Withdrawal by Subject|5|||
23503705|NCT01678911|65583986|FG000|Second Intervention|Lost to Follow-up|2|||
23503706|NCT01678911|65583987|FG001|Second Intervention|Lost to Follow-up|0|||
23503707|NCT00536198|65583988|FG000|Overall Study|Lost to Follow-up|15|||
23503708|NCT00536198|65583989|FG001|Overall Study|Lost to Follow-up|14|||
23503709|NCT00536198|65583988|FG000|Overall Study|Withdrawal by Subject|16|||
23503710|NCT00536198|65583989|FG001|Overall Study|Withdrawal by Subject|12|||
23503711|NCT00536198|65583988|FG000|Overall Study|Adverse Event|2|||
23503712|NCT00536198|65583989|FG001|Overall Study|Adverse Event|2|||
23503713|NCT00536198|65583988|FG000|Overall Study|Rescue|3|||
23503714|NCT00536198|65583989|FG001|Overall Study|Rescue|9|||
23503715|NCT00536198|65583988|FG000|Overall Study|Pregnancy|1|||
23503716|NCT00536198|65583989|FG001|Overall Study|Pregnancy|1|||
23503717|NCT00536198|65583988|FG000|Overall Study|Protocol Violation|0|||
23503718|NCT00536198|65583989|FG001|Overall Study|Protocol Violation|1|||
23503719|NCT01626456|65583990|FG000|Overall Study|Withdrawal by Subject|21|||
23503720|NCT01626456|65583991|FG001|Overall Study|Withdrawal by Subject|46|||
23503721|NCT01626456|65583990|FG000|Overall Study|Adverse Event|2|||
23503722|NCT01626456|65583991|FG001|Overall Study|Adverse Event|27|||
23503723|NCT01626456|65583990|FG000|Overall Study|Lost to Follow-up|2|||
23503724|NCT01626456|65583991|FG001|Overall Study|Lost to Follow-up|27|||
23503725|NCT01626456|65583990|FG000|Overall Study|Lack of Efficacy|6|||
23503726|NCT01626456|65583991|FG001|Overall Study|Lack of Efficacy|7|||
23503727|NCT01626456|65583990|FG000|Overall Study|Physician Decision|1|||
23503728|NCT01626456|65583991|FG001|Overall Study|Physician Decision|4|||
23503729|NCT01626456|65583990|FG000|Overall Study|Protocol Violation|1|||
23503730|NCT01626456|65583991|FG001|Overall Study|Protocol Violation|1|||
23503731|NCT01626456|65583990|FG000|Overall Study|Site Closure|2|||
23503732|NCT01626456|65583991|FG001|Overall Study|Site Closure|3|||
23503733|NCT01626456|65583990|FG000|Overall Study|Incarceration|0|||
23503734|NCT01626456|65583991|FG001|Overall Study|Incarceration|2|||
23503735|NCT01446289|65583992|FG000|Overall Study|Withdrawal by Subject|1|||
23503736|NCT01446289|65583993|FG001|Overall Study|Withdrawal by Subject|0|||
23503737|NCT01446289|65583994|FG002|Overall Study|Withdrawal by Subject|1|||
23503738|NCT01446289|65583995|FG003|Overall Study|Withdrawal by Subject|0|||
23503739|NCT03572062|65584000|FG000|Overall Study|Adverse Event|0|||
23503740|NCT03572062|65584001|FG001|Overall Study|Adverse Event|0|||
23503741|NCT03572062|65584002|FG002|Overall Study|Adverse Event|0|||
23503742|NCT03572062|65584003|FG003|Overall Study|Adverse Event|0|||
23503743|NCT03572062|65584004|FG004|Overall Study|Adverse Event|0|||
23503744|NCT03572062|65584005|FG005|Overall Study|Adverse Event|0|||
23503745|NCT03572062|65584006|FG006|Overall Study|Adverse Event|0|||
23503746|NCT03572062|65584007|FG007|Overall Study|Adverse Event|0|||
23503747|NCT03572062|65584008|FG008|Overall Study|Adverse Event|1|||
23503748|NCT03572062|65584009|FG009|Overall Study|Adverse Event|3|||
23503749|NCT03572062|65584000|FG000|Overall Study|Death|0|||
23503750|NCT03572062|65584001|FG001|Overall Study|Death|0|||
23503751|NCT03572062|65584002|FG002|Overall Study|Death|0|||
23503752|NCT03572062|65584003|FG003|Overall Study|Death|0|||
23503753|NCT03572062|65584004|FG004|Overall Study|Death|0|||
23503754|NCT03572062|65584005|FG005|Overall Study|Death|1|||
23503755|NCT03572062|65584006|FG006|Overall Study|Death|0|||
23503756|NCT03572062|65584007|FG007|Overall Study|Death|0|||
23503757|NCT03572062|65584008|FG008|Overall Study|Death|0|||
23503758|NCT03572062|65584009|FG009|Overall Study|Death|0|||
23503759|NCT03572062|65584000|FG000|Overall Study|Lost to Follow-up|0|||
23503760|NCT03572062|65584001|FG001|Overall Study|Lost to Follow-up|0|||
23503761|NCT03572062|65584002|FG002|Overall Study|Lost to Follow-up|0|||
23503762|NCT03572062|65584003|FG003|Overall Study|Lost to Follow-up|0|||
23503763|NCT03572062|65584004|FG004|Overall Study|Lost to Follow-up|0|||
23503764|NCT03572062|65584005|FG005|Overall Study|Lost to Follow-up|1|||
23503765|NCT03572062|65584006|FG006|Overall Study|Lost to Follow-up|1|||
23503766|NCT03572062|65584007|FG007|Overall Study|Lost to Follow-up|0|||
23503767|NCT03572062|65584008|FG008|Overall Study|Lost to Follow-up|0|||
23503768|NCT03572062|65584009|FG009|Overall Study|Lost to Follow-up|0|||
23503769|NCT03572062|65584000|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503770|NCT03572062|65584001|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503771|NCT03572062|65584002|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503772|NCT03572062|65584003|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503773|NCT03572062|65584004|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503774|NCT03572062|65584005|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503775|NCT03572062|65584006|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503776|NCT03572062|65584007|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503777|NCT03572062|65584008|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
23503778|NCT03572062|65584009|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503779|NCT03572062|65584000|FG000|Overall Study|Study Terminated By Sponsor|0|||
23503780|NCT03572062|65584001|FG001|Overall Study|Study Terminated By Sponsor|0|||
23503781|NCT03572062|65584002|FG002|Overall Study|Study Terminated By Sponsor|0|||
23503782|NCT03572062|65584003|FG003|Overall Study|Study Terminated By Sponsor|0|||
23503783|NCT03572062|65584004|FG004|Overall Study|Study Terminated By Sponsor|0|||
23503784|NCT03572062|65584005|FG005|Overall Study|Study Terminated By Sponsor|0|||
23503785|NCT03572062|65584006|FG006|Overall Study|Study Terminated By Sponsor|0|||
23503786|NCT03572062|65584007|FG007|Overall Study|Study Terminated By Sponsor|0|||
23503787|NCT03572062|65584008|FG008|Overall Study|Study Terminated By Sponsor|29|||
23503788|NCT03572062|65584009|FG009|Overall Study|Study Terminated By Sponsor|27|||
23503789|NCT03572062|65584000|FG000|Overall Study|Physician Decision|0|||
23503790|NCT03572062|65584001|FG001|Overall Study|Physician Decision|0|||
23503791|NCT03572062|65584002|FG002|Overall Study|Physician Decision|0|||
23503792|NCT03572062|65584003|FG003|Overall Study|Physician Decision|0|||
23503793|NCT03572062|65584004|FG004|Overall Study|Physician Decision|0|||
23503794|NCT03572062|65584005|FG005|Overall Study|Physician Decision|0|||
23503795|NCT03572062|65584006|FG006|Overall Study|Physician Decision|0|||
23503796|NCT03572062|65584007|FG007|Overall Study|Physician Decision|0|||
23503797|NCT03572062|65584008|FG008|Overall Study|Physician Decision|1|||
23503798|NCT03572062|65584009|FG009|Overall Study|Physician Decision|0|||
23503799|NCT03572062|65584000|FG000|Overall Study|Withdrawal by Subject|0|||
23503800|NCT03572062|65584001|FG001|Overall Study|Withdrawal by Subject|0|||
23503801|NCT03572062|65584002|FG002|Overall Study|Withdrawal by Subject|0|||
23503802|NCT03572062|65584003|FG003|Overall Study|Withdrawal by Subject|0|||
23503803|NCT03572062|65584004|FG004|Overall Study|Withdrawal by Subject|0|||
23503804|NCT03572062|65584005|FG005|Overall Study|Withdrawal by Subject|0|||
23503805|NCT03572062|65584006|FG006|Overall Study|Withdrawal by Subject|0|||
23503806|NCT03572062|65584007|FG007|Overall Study|Withdrawal by Subject|0|||
23503807|NCT03572062|65584008|FG008|Overall Study|Withdrawal by Subject|0|||
23503808|NCT03572062|65584009|FG009|Overall Study|Withdrawal by Subject|1|||
23503809|NCT03572062|65584000|FG000|Overall Study|Randomized But Not Treated|0|||
23503810|NCT03572062|65584001|FG001|Overall Study|Randomized But Not Treated|0|||
23503811|NCT03572062|65584002|FG002|Overall Study|Randomized But Not Treated|0|||
23503812|NCT03572062|65584003|FG003|Overall Study|Randomized But Not Treated|0|||
23503813|NCT03572062|65584004|FG004|Overall Study|Randomized But Not Treated|1|||
23503814|NCT03572062|65584005|FG005|Overall Study|Randomized But Not Treated|2|||
23503815|NCT03572062|65584006|FG006|Overall Study|Randomized But Not Treated|0|||
23503816|NCT03572062|65584007|FG007|Overall Study|Randomized But Not Treated|1|||
23503817|NCT03572062|65584008|FG008|Overall Study|Randomized But Not Treated|0|||
23503818|NCT03572062|65584009|FG009|Overall Study|Randomized But Not Treated|0|||
23503819|NCT03648983|65584010|FG000|Overall Study|Study was terminated due to PI departure|95|||
23503820|NCT00745823|65584013|FG000|Overall Study|Adverse Event|5|||
23503821|NCT00745823|65584014|FG001|Overall Study|Adverse Event|3|||
23503822|NCT00745823|65584013|FG000|Overall Study|Lack of Efficacy|20|||
23503823|NCT00745823|65584014|FG001|Overall Study|Lack of Efficacy|6|||
23503824|NCT00745823|65584013|FG000|Overall Study|Lost to Follow-up|10|||
23503825|NCT00745823|65584014|FG001|Overall Study|Lost to Follow-up|11|||
23503826|NCT00745823|65584013|FG000|Overall Study|Physician Decision|10|||
23503827|NCT00745823|65584014|FG001|Overall Study|Physician Decision|5|||
23503828|NCT00745823|65584013|FG000|Overall Study|Pregnancy|0|||
23503829|NCT00745823|65584014|FG001|Overall Study|Pregnancy|4|||
23503830|NCT00745823|65584013|FG000|Overall Study|Withdrawal by Subject|14|||
23503831|NCT00745823|65584014|FG001|Overall Study|Withdrawal by Subject|8|||
23503832|NCT00745823|65584013|FG000|Overall Study|Study Terminated by Sponsor|326|||
23503833|NCT00745823|65584014|FG001|Overall Study|Study Terminated by Sponsor|349|||
23503834|NCT01405742|65584015|FG000|Overall Study|Lost to Follow-up|1|||
23503835|NCT01405742|65584016|FG001|Overall Study|Lost to Follow-up|0|||
23503836|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
23503837|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
23503838|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
23503839|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
23503840|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
23503841|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Adverse Event|1|||
23503842|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Adverse Event|1|||
23503843|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Adverse Event|1|||
23503844|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Adverse Event|0|||
23503845|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Adverse Event|0|||
23503846|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503847|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
23503848|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503849|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503850|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503851|NCT03919799|65584020|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503852|NCT03919799|65584021|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
23503853|NCT03919799|65584022|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503854|NCT03919799|65584023|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503855|NCT03919799|65584024|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503856|NCT03919799|65584020|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
23503857|NCT03919799|65584021|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
23503858|NCT03919799|65584022|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
23503859|NCT03919799|65584023|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
23503860|NCT03919799|65584024|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
23503861|NCT03978832|65584030|FG000|Overall Study|Adverse Event|1|||
23503862|NCT03978832|65584030|FG000|Overall Study|Lost to Follow-up|1|||
23503863|NCT03978832|65584030|FG000|Overall Study|Withdrawal by Subject|6|||
23503864|NCT03978832|65584030|FG000|Overall Study|Physician Decision|2|||
23503865|NCT03978832|65584030|FG000|Overall Study|did not pass screening criteria|44|||
23503866|NCT02859454|65584031|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
23503867|NCT01687998|65584032|FG000|Overall Study|Withdrawal by Subject|49|||
23503868|NCT01687998|65584033|FG001|Overall Study|Withdrawal by Subject|51|||
23503869|NCT01687998|65584032|FG000|Overall Study|Known to be Alive at Study End|54|||
23503870|NCT01687998|65584033|FG001|Overall Study|Known to be Alive at Study End|62|||
23503871|NCT01687998|65584032|FG000|Overall Study|Lost to Follow-up|9|||
23503872|NCT01687998|65584033|FG001|Overall Study|Lost to Follow-up|7|||
23503873|NCT00963547|65584038|FG000|Overall Study|Adverse Event|0|||
23503874|NCT00963547|65584039|FG001|Overall Study|Adverse Event|1|||
23503875|NCT00963547|65584040|FG002|Overall Study|Adverse Event|0|||
23503876|NCT00963547|65584041|FG003|Overall Study|Adverse Event|1|||
23503877|NCT00963547|65584042|FG004|Overall Study|Adverse Event|0|||
23503878|NCT00963547|65584043|FG005|Overall Study|Adverse Event|0|||
23503879|NCT00963547|65584044|FG006|Overall Study|Adverse Event|0|||
23503880|NCT00963547|65584038|FG000|Overall Study|Physician Decision|1|||
23503881|NCT00963547|65584039|FG001|Overall Study|Physician Decision|1|||
23503882|NCT00963547|65584040|FG002|Overall Study|Physician Decision|0|||
23503883|NCT00963547|65584041|FG003|Overall Study|Physician Decision|0|||
23503884|NCT00963547|65584042|FG004|Overall Study|Physician Decision|0|||
23503885|NCT00963547|65584043|FG005|Overall Study|Physician Decision|0|||
23503886|NCT00963547|65584044|FG006|Overall Study|Physician Decision|0|||
23503887|NCT00963547|65584038|FG000|Overall Study|Progressive Disease|3|||
23503888|NCT00963547|65584039|FG001|Overall Study|Progressive Disease|8|||
23503889|NCT00963547|65584040|FG002|Overall Study|Progressive Disease|9|||
23503890|NCT00963547|65584041|FG003|Overall Study|Progressive Disease|5|||
23503891|NCT00963547|65584042|FG004|Overall Study|Progressive Disease|0|||
23503892|NCT00963547|65584043|FG005|Overall Study|Progressive Disease|0|||
23503893|NCT00963547|65584044|FG006|Overall Study|Progressive Disease|0|||
23503894|NCT00963547|65584038|FG000|Overall Study|Withdrawal by Subject|0|||
23503895|NCT00963547|65584039|FG001|Overall Study|Withdrawal by Subject|0|||
23503896|NCT00963547|65584040|FG002|Overall Study|Withdrawal by Subject|3|||
23503897|NCT00963547|65584041|FG003|Overall Study|Withdrawal by Subject|0|||
23503898|NCT00963547|65584042|FG004|Overall Study|Withdrawal by Subject|0|||
23503899|NCT00963547|65584043|FG005|Overall Study|Withdrawal by Subject|0|||
23503900|NCT00963547|65584044|FG006|Overall Study|Withdrawal by Subject|0|||
23503901|NCT00963547|65584038|FG000|Overall Study|Reason Unknown|0|||
23503902|NCT00963547|65584039|FG001|Overall Study|Reason Unknown|1|||
23503903|NCT00963547|65584040|FG002|Overall Study|Reason Unknown|0|||
23503904|NCT00963547|65584041|FG003|Overall Study|Reason Unknown|0|||
23503905|NCT00963547|65584042|FG004|Overall Study|Reason Unknown|0|||
23503906|NCT00963547|65584043|FG005|Overall Study|Reason Unknown|0|||
23503907|NCT00963547|65584044|FG006|Overall Study|Reason Unknown|0|||
23704529|NCT02064439|66293533|FG002|Overall Study|Adverse Event|46|||
23704530|NCT02064439|66293531|FG000|Overall Study|Death|0|||
23503908|NCT02468674|65584045|FG000|Overall Study|Adverse Event|0|||
23503909|NCT02468674|65584046|FG001|Overall Study|Adverse Event|0|||
23503910|NCT02468674|65584047|FG002|Overall Study|Adverse Event|0|||
23503911|NCT02468674|65584048|FG003|Overall Study|Adverse Event|1|||
23503912|NCT02468674|65584049|FG004|Overall Study|Adverse Event|0|||
23503913|NCT02468674|65584050|FG005|Overall Study|Adverse Event|1|||
23503914|NCT02468674|65584051|FG006|Overall Study|Adverse Event|0|||
23704531|NCT02064439|66293532|FG001|Overall Study|Death|2|||
23704532|NCT02064439|66293533|FG002|Overall Study|Death|3|||
23503915|NCT02468674|65584052|FG007|Overall Study|Adverse Event|0|||
23503916|NCT02468674|65584053|FG008|Overall Study|Adverse Event|0|||
23503917|NCT02468674|65584045|FG000|Overall Study|Lost to Follow-up|1|||
23503918|NCT02468674|65584046|FG001|Overall Study|Lost to Follow-up|0|||
23503919|NCT02468674|65584047|FG002|Overall Study|Lost to Follow-up|0|||
23503920|NCT02468674|65584048|FG003|Overall Study|Lost to Follow-up|0|||
23503921|NCT02468674|65584049|FG004|Overall Study|Lost to Follow-up|0|||
23503922|NCT02468674|65584050|FG005|Overall Study|Lost to Follow-up|0|||
23503923|NCT02468674|65584051|FG006|Overall Study|Lost to Follow-up|0|||
23503924|NCT02468674|65584052|FG007|Overall Study|Lost to Follow-up|1|||
23503925|NCT02468674|65584053|FG008|Overall Study|Lost to Follow-up|1|||
23503926|NCT02468674|65584045|FG000|Overall Study|Physician Decision|0|||
23503927|NCT02468674|65584046|FG001|Overall Study|Physician Decision|0|||
23503928|NCT02468674|65584047|FG002|Overall Study|Physician Decision|0|||
23503929|NCT02468674|65584048|FG003|Overall Study|Physician Decision|0|||
23503930|NCT02468674|65584049|FG004|Overall Study|Physician Decision|0|||
23503931|NCT02468674|65584050|FG005|Overall Study|Physician Decision|0|||
23503932|NCT02468674|65584051|FG006|Overall Study|Physician Decision|1|||
23503933|NCT02468674|65584052|FG007|Overall Study|Physician Decision|0|||
23503934|NCT02468674|65584053|FG008|Overall Study|Physician Decision|0|||
23503935|NCT02468674|65584045|FG000|Overall Study|Patient/Guardian Decision|0|||
23503936|NCT02468674|65584046|FG001|Overall Study|Patient/Guardian Decision|0|||
23503937|NCT02468674|65584047|FG002|Overall Study|Patient/Guardian Decision|0|||
23503938|NCT02468674|65584048|FG003|Overall Study|Patient/Guardian Decision|0|||
23503939|NCT02468674|65584049|FG004|Overall Study|Patient/Guardian Decision|1|||
23503940|NCT02468674|65584050|FG005|Overall Study|Patient/Guardian Decision|0|||
23503941|NCT02468674|65584051|FG006|Overall Study|Patient/Guardian Decision|0|||
23503942|NCT02468674|65584052|FG007|Overall Study|Patient/Guardian Decision|2|||
23503943|NCT02468674|65584053|FG008|Overall Study|Patient/Guardian Decision|1|||
23503944|NCT02468674|65584045|FG000|Overall Study|Protocol Deviation|0|||
23503945|NCT02468674|65584046|FG001|Overall Study|Protocol Deviation|0|||
23503946|NCT02468674|65584047|FG002|Overall Study|Protocol Deviation|0|||
23503947|NCT02468674|65584048|FG003|Overall Study|Protocol Deviation|0|||
23503948|NCT02468674|65584049|FG004|Overall Study|Protocol Deviation|0|||
23503949|NCT02468674|65584050|FG005|Overall Study|Protocol Deviation|0|||
23503950|NCT02468674|65584051|FG006|Overall Study|Protocol Deviation|0|||
23503951|NCT02468674|65584052|FG007|Overall Study|Protocol Deviation|1|||
23503952|NCT02468674|65584053|FG008|Overall Study|Protocol Deviation|1|||
23503953|NCT00680017|65584054|FG000|Overall Study|Adverse Event|13|||
23503954|NCT00680017|65584055|FG001|Overall Study|Adverse Event|7|||
23503955|NCT00680017|65584054|FG000|Overall Study|Withdrawal by Subject|2|||
23503956|NCT00680017|65584055|FG001|Overall Study|Withdrawal by Subject|5|||
23503957|NCT00680017|65584054|FG000|Overall Study|Lost to Follow-up|2|||
23503958|NCT00680017|65584055|FG001|Overall Study|Lost to Follow-up|0|||
23503959|NCT00967668|65584063|FG000|Overall Study|Withdrawal by Subject|13|||
23503960|NCT00967668|65584064|FG001|Overall Study|Withdrawal by Subject|8|||
23503961|NCT00967668|65584065|FG002|Overall Study|Withdrawal by Subject|8|||
23503962|NCT00967668|65584063|FG000|Overall Study|Death|0|||
23503963|NCT00967668|65584064|FG001|Overall Study|Death|2|||
23503964|NCT00967668|65584065|FG002|Overall Study|Death|4|||
23503965|NCT00967668|65584063|FG000|Overall Study|Removed due to behavior|1|||
23503966|NCT00967668|65584064|FG001|Overall Study|Removed due to behavior|1|||
23503967|NCT00967668|65584065|FG002|Overall Study|Removed due to behavior|2|||
23503968|NCT00967668|65584063|FG000|Overall Study|Refused Year 2|11|||
23503969|NCT00967668|65584064|FG001|Overall Study|Refused Year 2|6|||
23503970|NCT00967668|65584065|FG002|Overall Study|Refused Year 2|4|||
23503971|NCT00967668|65584063|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
23503972|NCT00967668|65584064|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
23503973|NCT00967668|65584065|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
23503974|NCT00967668|65584063|FG000|Overall Study|Lost to Follow-up|15|||
23503975|NCT00967668|65584064|FG001|Overall Study|Lost to Follow-up|9|||
23503976|NCT00967668|65584065|FG002|Overall Study|Lost to Follow-up|16|||
23503977|NCT00967668|65584063|FG000|Overall Study|Refused 12-mo assessment|3|||
23503978|NCT00967668|65584064|FG001|Overall Study|Refused 12-mo assessment|1|||
23503979|NCT00967668|65584065|FG002|Overall Study|Refused 12-mo assessment|9|||
23503980|NCT00967668|65584063|FG000|Overall Study|Pregnancy|1|||
23503981|NCT00967668|65584064|FG001|Overall Study|Pregnancy|0|||
23503982|NCT00967668|65584065|FG002|Overall Study|Pregnancy|0|||
23503983|NCT03706079|65584066|FG000|Predecessor Study|Death|0|||
23503984|NCT03706079|65584067|FG001|Predecessor Study|Death|2|||
23503985|NCT03706079|65584068|FG002|Predecessor Study|Death|0|||
23503986|NCT03706079|65584069|FG003|Predecessor Study|Death|1|||
23503987|NCT03706079|65584070|FG004|Predecessor Study|Death|0|||
23503988|NCT03706079|65584071|FG005|Predecessor Study|Death|0|||
23503989|NCT03706079|65584066|FG000|Predecessor Study|Lost to Follow-up|5|||
23503990|NCT03706079|65584067|FG001|Predecessor Study|Lost to Follow-up|2|||
23503991|NCT03706079|65584068|FG002|Predecessor Study|Lost to Follow-up|0|||
23503992|NCT03706079|65584069|FG003|Predecessor Study|Lost to Follow-up|0|||
23503993|NCT03706079|65584070|FG004|Predecessor Study|Lost to Follow-up|1|||
23503994|NCT03706079|65584071|FG005|Predecessor Study|Lost to Follow-up|0|||
23503995|NCT03706079|65584066|FG000|Predecessor Study|Withdrawal by Subject|8|||
23503996|NCT03706079|65584067|FG001|Predecessor Study|Withdrawal by Subject|15|||
23503997|NCT03706079|65584068|FG002|Predecessor Study|Withdrawal by Subject|0|||
23503998|NCT03706079|65584069|FG003|Predecessor Study|Withdrawal by Subject|5|||
23503999|NCT03706079|65584070|FG004|Predecessor Study|Withdrawal by Subject|2|||
23504000|NCT03706079|65584071|FG005|Predecessor Study|Withdrawal by Subject|0|||
23504001|NCT03706079|65584066|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
23504002|NCT03706079|65584067|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
23504003|NCT03706079|65584068|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504004|NCT03706079|65584069|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504005|NCT03706079|65584070|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504006|NCT03706079|65584071|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504007|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504008|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504009|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504010|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504011|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504012|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
23504013|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
23504014|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504015|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
23504016|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504017|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504018|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504019|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
23504020|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504021|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504022|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504023|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504024|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504025|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504026|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504027|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504028|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
23504029|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504030|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
23504031|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
23504032|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504033|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504034|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
23504035|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504036|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
23400102|NCT03366337|65210848|FG003|Overall Study|Withdrawal by Subject|1|||
23400103|NCT02138825|65210849|FG000|Main Study Treatment|Adverse Event|11|||
23400104|NCT02138825|65210850|FG001|Main Study Treatment|Adverse Event|3|||
23400105|NCT02138825|65210849|FG000|Main Study Treatment|Death|1|||
23400106|NCT02138825|65210850|FG001|Main Study Treatment|Death|2|||
23400107|NCT02138825|65210849|FG000|Main Study Treatment|Protocol Violation|2|||
23400108|NCT02138825|65210850|FG001|Main Study Treatment|Protocol Violation|2|||
23400109|NCT02138825|65210849|FG000|Main Study Treatment|Sponsor decision|12|||
23400110|NCT02138825|65210850|FG001|Main Study Treatment|Sponsor decision|18|||
23400111|NCT02138825|65210849|FG000|Main Study Treatment|Study terminated by sponsor|10|||
23400112|NCT02138825|65210850|FG001|Main Study Treatment|Study terminated by sponsor|9|||
23400113|NCT02138825|65210849|FG000|Main Study Treatment|Withdrawal by Subject|3|||
23400114|NCT02138825|65210850|FG001|Main Study Treatment|Withdrawal by Subject|1|||
23400115|NCT02138825|65210849|FG000|Main Study Treatment|Medical decision|1|||
23400116|NCT02138825|65210850|FG001|Main Study Treatment|Medical decision|0|||
23400117|NCT02138825|65210849|FG000|Long-term Extension|Study termination by sponsor|32|||
23400118|NCT02138825|65210850|FG001|Long-term Extension|Study termination by sponsor|38|||
23400119|NCT02138825|65210849|FG000|Safety Follow-up|Adverse Event|4|||
23400120|NCT02138825|65210850|FG001|Safety Follow-up|Adverse Event|3|||
23400121|NCT02138825|65210849|FG000|Safety Follow-up|Death|11|||
23400122|NCT02138825|65210850|FG001|Safety Follow-up|Death|5|||
23400123|NCT02138825|65210849|FG000|Safety Follow-up|Withdrawal by Subject|5|||
23400124|NCT02138825|65210850|FG001|Safety Follow-up|Withdrawal by Subject|3|||
23400125|NCT02138825|65210849|FG000|Safety Follow-up|clinic worsening|1|||
23400126|NCT02138825|65210850|FG001|Safety Follow-up|clinic worsening|0|||
23400127|NCT02138825|65210849|FG000|Safety Follow-up|withdrawal by PI|1|||
23400128|NCT02138825|65210850|FG001|Safety Follow-up|withdrawal by PI|0|||
23400129|NCT02138825|65210849|FG000|Safety Follow-up|logistical difficulties|0|||
23400130|NCT02138825|65210850|FG001|Safety Follow-up|logistical difficulties|1|||
23400131|NCT02138825|65210849|FG000|Safety Follow-up|progressive disease|0|||
23400132|NCT02138825|65210850|FG001|Safety Follow-up|progressive disease|2|||
23400133|NCT02138825|65210849|FG000|Safety Follow-up|too unwell to attend the visit|0|||
23400134|NCT02138825|65210850|FG001|Safety Follow-up|too unwell to attend the visit|1|||
23400135|NCT02138825|65210849|FG000|Safety Follow-up|treatment unblinded|0|||
23400136|NCT02138825|65210850|FG001|Safety Follow-up|treatment unblinded|1|||
23400137|NCT02138825|65210849|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
23400138|NCT02138825|65210850|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
23400139|NCT00325143|65210851|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
23400140|NCT00325143|65210851|FG000|Overall Study|Migrated/moved from study area|1|||
23400141|NCT00325143|65210851|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
23400142|NCT00325143|65210851|FG000|Overall Study|Withdrawal by Subject|8|||
23400143|NCT03434834|65210852|FG000|Overall Study|unable to swallow OCT probe|16|||
23400144|NCT00633126|65210853|FG000|Overall Study|Did not receive full dose|1|||
23400145|NCT01932788|65210856|FG000|Overall Study|Protocol Violation|18|||
23400146|NCT01932788|65210857|FG001|Overall Study|Protocol Violation|0|||
23400147|NCT01932788|65210856|FG000|Overall Study|Lost to Follow-up|18|||
23400148|NCT01932788|65210857|FG001|Overall Study|Lost to Follow-up|46|||
23400149|NCT01932788|65210856|FG000|Overall Study|Lack of Efficacy|2|||
23400150|NCT01932788|65210857|FG001|Overall Study|Lack of Efficacy|0|||
23400151|NCT01932788|65210856|FG000|Overall Study|Withdrawal by Subject|0|||
23400152|NCT01932788|65210857|FG001|Overall Study|Withdrawal by Subject|5|||
23400153|NCT01816048|65210858|FG000|Overall Study|Adverse Event|1|||
23400154|NCT01816048|65210858|FG000|Overall Study|Death|1|||
23400155|NCT01816048|65210858|FG000|Overall Study|Withdrawal by Subject|1|||
23400156|NCT01816048|65210858|FG000|Overall Study|Disease Progression|3|||
23400157|NCT00002766|65210865|FG000|Overall Study|Withdrawal by Subject|0|||
23400158|NCT00002766|65210866|FG001|Overall Study|Withdrawal by Subject|1|||
23400159|NCT00002766|65210865|FG000|Overall Study|Patient Not Treated|1|||
23400160|NCT00002766|65210866|FG001|Overall Study|Patient Not Treated|2|||
23400161|NCT00002766|65210865|FG000|Overall Study|Adverse Event|1|||
23400162|NCT00002766|65210866|FG001|Overall Study|Adverse Event|1|||
23400163|NCT00002766|65210865|FG000|Overall Study|Protocol Violation|1|||
23400164|NCT00002766|65210866|FG001|Overall Study|Protocol Violation|0|||
23400165|NCT03358030|65210867|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
23400166|NCT03358030|65210868|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
23400167|NCT03358030|65210869|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
23400168|NCT03358030|65210870|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
23400169|NCT03358030|65210867|FG000|Overall Study|Ineligibility|0|||
23400170|NCT03358030|65210868|FG001|Overall Study|Ineligibility|0|||
23400171|NCT03358030|65210869|FG002|Overall Study|Ineligibility|0|||
23400172|NCT03358030|65210870|FG003|Overall Study|Ineligibility|2|||
23400173|NCT03358030|65210867|FG000|Overall Study|Voluntary Withdrawal|1|||
23400174|NCT03358030|65210868|FG001|Overall Study|Voluntary Withdrawal|1|||
23400175|NCT03358030|65210869|FG002|Overall Study|Voluntary Withdrawal|3|||
23400176|NCT03358030|65210870|FG003|Overall Study|Voluntary Withdrawal|1|||
23400177|NCT03358030|65210867|FG000|Overall Study|Other|0|||
23400178|NCT03358030|65210868|FG001|Overall Study|Other|0|||
23400179|NCT03358030|65210869|FG002|Overall Study|Other|1|||
23400180|NCT03358030|65210870|FG003|Overall Study|Other|0|||
23400181|NCT00145626|65210871|FG000|Overall Study|Did not have NK infusions|2|||
23400182|NCT00145626|65210871|FG000|Overall Study|Turned 2 years old before treatment|1|||
23400183|NCT00145626|65210871|FG000|Overall Study|Death|1|||
23400184|NCT00145626|65210871|FG000|Overall Study|Withdrawal by Subject|1|||
23400185|NCT02115321|65210872|FG000|Overall Study|Death|1|||
23400186|NCT02115321|65210873|FG001|Overall Study|Death|0|||
23402844|NCT01349673|65220031|FG000|Overall Study|Withdrawal by Subject|21|||
23402845|NCT01349673|65220031|FG000|Overall Study|Lost to Follow-up|6|||
23402846|NCT01349673|65220031|FG000|Overall Study|Adverse Event|17|||
23402847|NCT01349673|65220031|FG000|Overall Study|Study Terminated By Sponsor|50|||
23402848|NCT01349673|65220031|FG000|Overall Study|Lack of Efficacy|8|||
23402849|NCT01130337|65220034|FG000|Overall Study|Withdrawal by Subject|3|||
23402850|NCT01130337|65220034|FG000|Overall Study|Principal investigator decision|1|||
23402851|NCT01130337|65220034|FG000|Overall Study|Death|1|||
23402852|NCT01130337|65220034|FG000|Overall Study|Disease progression|1|||
23402853|NCT01130337|65220034|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
23402854|NCT01130337|65220034|FG000|Overall Study|Surgical resection (R2)|1|||
23402855|NCT03089047|65220035|FG000|Overall Study|Lost to Follow-up|1|||
23402856|NCT03089047|65220036|FG001|Overall Study|Lost to Follow-up|0|||
23402857|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
23402858|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
23400187|NCT01076010|65214042|FG000|Overall Study|Death|15|||
23400188|NCT01076010|65214043|FG001|Overall Study|Death|1|||
23400189|NCT01076010|65214044|FG002|Overall Study|Death|0|||
23400190|NCT01076010|65214042|FG000|Overall Study|Adverse Event|7|||
23400191|NCT01076010|65214043|FG001|Overall Study|Adverse Event|2|||
23400192|NCT01076010|65214044|FG002|Overall Study|Adverse Event|0|||
23400193|NCT01076010|65214042|FG000|Overall Study|Progressive disease|90|||
23400194|NCT01076010|65214043|FG001|Overall Study|Progressive disease|30|||
23400195|NCT01076010|65214044|FG002|Overall Study|Progressive disease|1|||
23400196|NCT01076010|65214042|FG000|Overall Study|Lack of Efficacy|4|||
23400197|NCT01076010|65214043|FG001|Overall Study|Lack of Efficacy|0|||
23400198|NCT01076010|65214044|FG002|Overall Study|Lack of Efficacy|0|||
23400199|NCT01076010|65214042|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
23400200|NCT01076010|65214043|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
23400201|NCT01076010|65214044|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
23400202|NCT01076010|65214042|FG000|Overall Study|Significant Surgical Procedure|0|||
23400203|NCT01076010|65214043|FG001|Overall Study|Significant Surgical Procedure|1|||
23400204|NCT01076010|65214044|FG002|Overall Study|Significant Surgical Procedure|0|||
23400205|NCT01076010|65214042|FG000|Overall Study|Protocol Violation|0|||
23400206|NCT01076010|65214043|FG001|Overall Study|Protocol Violation|1|||
23400207|NCT01076010|65214044|FG002|Overall Study|Protocol Violation|0|||
23400208|NCT01076010|65214042|FG000|Overall Study|Noncompliance|1|||
23400209|NCT01076010|65214043|FG001|Overall Study|Noncompliance|1|||
23400210|NCT01076010|65214044|FG002|Overall Study|Noncompliance|0|||
23400211|NCT01076010|65214042|FG000|Overall Study|Withdrawal by Subject|3|||
23400212|NCT01076010|65214043|FG001|Overall Study|Withdrawal by Subject|0|||
23400213|NCT01076010|65214044|FG002|Overall Study|Withdrawal by Subject|1|||
23400214|NCT01076010|65214042|FG000|Overall Study|Other|5|||
23400215|NCT01076010|65214043|FG001|Overall Study|Other|2|||
23400216|NCT01076010|65214044|FG002|Overall Study|Other|0|||
23400217|NCT00959907|65214050|FG000|Overall Study|Protocol Violation|0|||
23400218|NCT00959907|65214051|FG001|Overall Study|Protocol Violation|1|||
23400219|NCT00959907|65214050|FG000|Overall Study|Adverse Event|1|||
23400220|NCT00959907|65214051|FG001|Overall Study|Adverse Event|0|||
23400221|NCT00959907|65214050|FG000|Overall Study|Withdrawal by Subject|2|||
23400222|NCT00959907|65214051|FG001|Overall Study|Withdrawal by Subject|0|||
23400223|NCT01171677|65214052|FG000|Overall Study|Withdrawal by Subject|0|||
23400224|NCT01171677|65214053|FG001|Overall Study|Withdrawal by Subject|3|||
23400225|NCT01171677|65214052|FG000|Overall Study|Adverse Event|1|||
23400226|NCT01171677|65214053|FG001|Overall Study|Adverse Event|0|||
23400227|NCT01171677|65214052|FG000|Overall Study|completed <70% IntenSati classes|5|||
23400228|NCT01171677|65214053|FG001|Overall Study|completed <70% IntenSati classes|0|||
23400229|NCT01904721|65214054|FG000|Overall Study|Other Reasons|0|||
23400230|NCT01904721|65214055|FG001|Overall Study|Other Reasons|0|||
23400231|NCT01904721|65214056|FG002|Overall Study|Other Reasons|1|||
23400232|NCT01904721|65214057|FG003|Overall Study|Other Reasons|1|||
23400233|NCT01904721|65214058|FG004|Overall Study|Other Reasons|2|||
23400234|NCT01904721|65214059|FG005|Overall Study|Other Reasons|2|||
23400235|NCT01904721|65214060|FG006|Overall Study|Other Reasons|2|||
23400236|NCT01904721|65214054|FG000|Overall Study|Personal Reasons|0|||
23400237|NCT01904721|65214055|FG001|Overall Study|Personal Reasons|0|||
23400238|NCT01904721|65214056|FG002|Overall Study|Personal Reasons|0|||
23400239|NCT01904721|65214057|FG003|Overall Study|Personal Reasons|0|||
23400240|NCT01904721|65214058|FG004|Overall Study|Personal Reasons|2|||
23400241|NCT01904721|65214059|FG005|Overall Study|Personal Reasons|3|||
23400242|NCT01904721|65214060|FG006|Overall Study|Personal Reasons|3|||
23400243|NCT01904721|65214054|FG000|Overall Study|Lost to Follow-up|0|||
23400244|NCT01904721|65214055|FG001|Overall Study|Lost to Follow-up|0|||
23400245|NCT01904721|65214056|FG002|Overall Study|Lost to Follow-up|0|||
23400246|NCT01904721|65214057|FG003|Overall Study|Lost to Follow-up|0|||
23400247|NCT01904721|65214058|FG004|Overall Study|Lost to Follow-up|1|||
23400248|NCT01904721|65214059|FG005|Overall Study|Lost to Follow-up|3|||
23400249|NCT01904721|65214060|FG006|Overall Study|Lost to Follow-up|1|||
23400250|NCT01904721|65214054|FG000|Overall Study|Lack of Efficacy|0|||
23400251|NCT01904721|65214055|FG001|Overall Study|Lack of Efficacy|0|||
23400252|NCT01904721|65214056|FG002|Overall Study|Lack of Efficacy|0|||
23400253|NCT01904721|65214057|FG003|Overall Study|Lack of Efficacy|0|||
23400254|NCT01904721|65214058|FG004|Overall Study|Lack of Efficacy|0|||
23400255|NCT01904721|65214059|FG005|Overall Study|Lack of Efficacy|0|||
23400256|NCT01904721|65214060|FG006|Overall Study|Lack of Efficacy|1|||
23400257|NCT01904721|65214054|FG000|Overall Study|Adverse Event|0|||
23400258|NCT01904721|65214055|FG001|Overall Study|Adverse Event|0|||
23400259|NCT01904721|65214056|FG002|Overall Study|Adverse Event|0|||
23400260|NCT01904721|65214057|FG003|Overall Study|Adverse Event|0|||
23400261|NCT01904721|65214058|FG004|Overall Study|Adverse Event|3|||
23400262|NCT01904721|65214059|FG005|Overall Study|Adverse Event|1|||
23400263|NCT01904721|65214060|FG006|Overall Study|Adverse Event|0|||
23400264|NCT01881789|65214061|FG000|Overall Study|Withdrawal by Subject|0|||
23400265|NCT01881789|65214062|FG001|Overall Study|Withdrawal by Subject|2|||
23400266|NCT01881789|65214063|FG002|Overall Study|Withdrawal by Subject|1|||
23400267|NCT01881789|65214064|FG003|Overall Study|Withdrawal by Subject|0|||
23400268|NCT01881789|65214065|FG004|Overall Study|Withdrawal by Subject|1|||
23400269|NCT01881789|65214066|FG005|Overall Study|Withdrawal by Subject|1|||
23400270|NCT01881789|65214061|FG000|Overall Study|Study Terminated by Sponsor|0|||
23400271|NCT01881789|65214062|FG001|Overall Study|Study Terminated by Sponsor|0|||
23400272|NCT01881789|65214063|FG002|Overall Study|Study Terminated by Sponsor|0|||
23400273|NCT01881789|65214064|FG003|Overall Study|Study Terminated by Sponsor|0|||
23400274|NCT01881789|65214065|FG004|Overall Study|Study Terminated by Sponsor|0|||
23400275|NCT01881789|65214066|FG005|Overall Study|Study Terminated by Sponsor|1|||
23400276|NCT01881789|65214061|FG000|Overall Study|Other|3|||
23400277|NCT01881789|65214062|FG001|Overall Study|Other|5|||
23400278|NCT01881789|65214063|FG002|Overall Study|Other|2|||
23400279|NCT01881789|65214064|FG003|Overall Study|Other|3|||
23400280|NCT01881789|65214065|FG004|Overall Study|Other|1|||
23400281|NCT01881789|65214066|FG005|Overall Study|Other|1|||
23400282|NCT03376516|65214067|FG000|Overall Study|Not treated|1|||
23400283|NCT03376516|65214067|FG000|Overall Study|Consent withdrawn|1|||
23400284|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
23400285|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400286|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400287|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400288|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400289|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400290|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
23400291|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
23400292|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
23400293|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
23400294|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
23400295|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
23400296|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
23400297|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400298|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400299|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400300|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400301|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400302|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
23400303|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
23400304|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
23400305|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
23400306|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
23400307|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
23400308|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
23400309|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
23400310|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400311|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400312|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400313|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400314|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400315|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
23400316|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400317|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400318|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400319|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400320|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400321|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400322|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
23400323|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400324|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400325|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400326|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
23400327|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
23400328|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
23400329|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
23400330|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
23400331|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
23400332|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400333|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400334|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400335|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
23400336|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
23402992|NCT03314935|65220064|FG009|Phase 1|Withdrawal by Subject|0|||
23400337|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400338|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
23400339|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
23400340|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
23400341|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
23400342|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
23400343|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
23400344|NCT01074931|65214076|FG000|Overall Study|Economic reasons|1|||
23400345|NCT01074931|65214076|FG000|Overall Study|Death|5|||
23504037|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Death|8|||
23504038|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Death|2|||
23504039|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Death|2|||
23504040|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Death|1|||
23504041|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Death|0|||
23504042|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Death|0|||
23504043|NCT04678661|65584072|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
23504044|NCT04678661|65584073|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
23504045|NCT04678661|65584072|FG000|Overall Study|Protocol Violation|2|||
23504046|NCT04678661|65584073|FG001|Overall Study|Protocol Violation|0|||
23504047|NCT04678661|65584072|FG000|Overall Study|Withdrawal by Subject|1|||
23504048|NCT04678661|65584073|FG001|Overall Study|Withdrawal by Subject|0|||
23504049|NCT04678661|65584072|FG000|Overall Study|Lost to Follow-up|2|||
23504050|NCT04678661|65584073|FG001|Overall Study|Lost to Follow-up|0|||
23504051|NCT04678661|65584072|FG000|Overall Study|Death|2|||
23504052|NCT04678661|65584073|FG001|Overall Study|Death|0|||
23504053|NCT00619177|65584074|FG000|Overall Study|Adverse Event|18|||
23504054|NCT00619177|65584074|FG000|Overall Study|Lost to Follow-up|2|||
23504055|NCT00619177|65584074|FG000|Overall Study|Lack of Efficacy|1|||
23504056|NCT00619177|65584074|FG000|Overall Study|Missing termination information|481|||
23504057|NCT00619177|65584074|FG000|Overall Study|Not specified reasons|6|||
23504058|NCT03706456|65584075|FG000|Overall Study|Adverse Event|1|||
23504059|NCT03706456|65584075|FG000|Overall Study|Lack of Efficacy|2|||
23504060|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
23504061|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
23504062|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Progression|3|||
23504063|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
23504064|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Death|2|||
23504065|NCT00064337|65584078|FG000|Transplant|Adverse Event|9|||
23504066|NCT00064337|65584078|FG000|Transplant|Not protocol-specified|5|||
23504067|NCT00064337|65584078|FG000|Transplant|Death|3|||
23504068|NCT00064337|65584078|FG000|Transplant|Patient Refusal|2|||
23504069|NCT00064337|65584078|FG000|Transplant|Progression|2|||
23504070|NCT00064337|65584078|FG000|Maintenance|Adverse Event|3|||
23504071|NCT00064337|65584078|FG000|Maintenance|Progression|2|||
23504072|NCT00064337|65584078|FG000|Maintenance|On treatment at time of analysis|2|||
23504073|NCT00064337|65584078|FG000|Maintenance|Not protocol-specified|2|||
23504074|NCT00064337|65584078|FG000|Maintenance|Death|1|||
23504075|NCT03782792|65584079|FG000|Overall Study|Patient left the country|0|||
23504076|NCT03782792|65584080|FG001|Overall Study|Patient left the country|1|||
23504077|NCT03782792|65584079|FG000|Overall Study|Withdrawal by Subject|1|||
23504078|NCT03782792|65584080|FG001|Overall Study|Withdrawal by Subject|2|||
23504079|NCT01306942|65584081|FG000|Phase I|Adverse Event|2|||
23504080|NCT01306942|65584082|FG001|Phase I|Adverse Event|2|||
23504081|NCT01306942|65584083|FG002|Phase I|Adverse Event|0|||
23504082|NCT01306942|65584084|FG003|Phase I|Adverse Event|0|||
23504083|NCT01306942|65584081|FG000|Phase I|Physician Decision|3|||
23504084|NCT01306942|65584082|FG001|Phase I|Physician Decision|1|||
23504085|NCT01306942|65584083|FG002|Phase I|Physician Decision|0|||
23504086|NCT01306942|65584084|FG003|Phase I|Physician Decision|0|||
23504087|NCT01306942|65584081|FG000|Phase II|Adverse Event|0|||
23504088|NCT01306942|65584082|FG001|Phase II|Adverse Event|0|||
23504089|NCT01306942|65584083|FG002|Phase II|Adverse Event|0|||
23504090|NCT01306942|65584084|FG003|Phase II|Adverse Event|6|||
23504091|NCT01306942|65584081|FG000|Phase II|Physician Decision|2|||
23504092|NCT01306942|65584082|FG001|Phase II|Physician Decision|0|||
23504093|NCT01306942|65584083|FG002|Phase II|Physician Decision|0|||
23504094|NCT01306942|65584084|FG003|Phase II|Physician Decision|5|||
23504095|NCT01306942|65584081|FG000|Phase II|Withdrawal by Subject|0|||
23504096|NCT01306942|65584082|FG001|Phase II|Withdrawal by Subject|0|||
23504097|NCT01306942|65584083|FG002|Phase II|Withdrawal by Subject|0|||
23504098|NCT01306942|65584084|FG003|Phase II|Withdrawal by Subject|2|||
23504099|NCT01306942|65584081|FG000|Phase II|Death|0|||
23504100|NCT01306942|65584082|FG001|Phase II|Death|0|||
23504101|NCT01306942|65584083|FG002|Phase II|Death|0|||
23504102|NCT01306942|65584084|FG003|Phase II|Death|1|||
23400346|NCT02114177|65214077|FG000|Overall Study|Lost to Follow-up|1|||
23504103|NCT01306942|65584081|FG000|Phase II|Not finished treatment|0|||
23504104|NCT01306942|65584082|FG001|Phase II|Not finished treatment|0|||
23504105|NCT01306942|65584083|FG002|Phase II|Not finished treatment|0|||
23504106|NCT01306942|65584084|FG003|Phase II|Not finished treatment|1|||
23504107|NCT01306942|65584081|FG000|Phase II|Protocol Violation|0|||
23504108|NCT01306942|65584082|FG001|Phase II|Protocol Violation|0|||
23504109|NCT01306942|65584083|FG002|Phase II|Protocol Violation|0|||
23504110|NCT01306942|65584084|FG003|Phase II|Protocol Violation|1|||
23504111|NCT00753415|65584085|FG000|Part A|Disease progression|1|||
23504112|NCT00753415|65584086|FG001|Part A|Disease progression|0|||
23504113|NCT00753415|65584087|FG002|Part A|Disease progression|1|||
23504114|NCT00753415|65584088|FG003|Part A|Disease progression|2|||
23504115|NCT00753415|65584089|FG004|Part A|Disease progression|0|||
23504116|NCT00753415|65584090|FG005|Part A|Disease progression|0|||
23504117|NCT00753415|65584091|FG006|Part A|Disease progression|0|||
23504118|NCT00753415|65584092|FG007|Part A|Disease progression|0|||
23504119|NCT00753415|65584093|FG008|Part A|Disease progression|0|||
23504120|NCT00753415|65584094|FG009|Part A|Disease progression|0|||
23504121|NCT00753415|65584085|FG000|Part A|Withdrawal by Subject|0|||
23504122|NCT00753415|65584086|FG001|Part A|Withdrawal by Subject|0|||
23504123|NCT00753415|65584087|FG002|Part A|Withdrawal by Subject|1|||
23504124|NCT00753415|65584088|FG003|Part A|Withdrawal by Subject|0|||
23504125|NCT00753415|65584089|FG004|Part A|Withdrawal by Subject|0|||
23504126|NCT00753415|65584090|FG005|Part A|Withdrawal by Subject|0|||
23504127|NCT00753415|65584091|FG006|Part A|Withdrawal by Subject|0|||
23504128|NCT00753415|65584092|FG007|Part A|Withdrawal by Subject|0|||
23504129|NCT00753415|65584093|FG008|Part A|Withdrawal by Subject|0|||
23504130|NCT00753415|65584094|FG009|Part A|Withdrawal by Subject|0|||
23504131|NCT00753415|65584085|FG000|Part B|Lost to Follow-up|0|||
23504132|NCT00753415|65584086|FG001|Part B|Lost to Follow-up|0|||
23504133|NCT00753415|65584087|FG002|Part B|Lost to Follow-up|0|||
23504134|NCT00753415|65584088|FG003|Part B|Lost to Follow-up|0|||
23504135|NCT00753415|65584089|FG004|Part B|Lost to Follow-up|0|||
23504136|NCT00753415|65584090|FG005|Part B|Lost to Follow-up|0|||
23504137|NCT00753415|65584091|FG006|Part B|Lost to Follow-up|0|||
23504138|NCT00753415|65584092|FG007|Part B|Lost to Follow-up|1|||
23504139|NCT00753415|65584093|FG008|Part B|Lost to Follow-up|1|||
23504140|NCT00753415|65584094|FG009|Part B|Lost to Follow-up|0|||
23504141|NCT00753415|65584085|FG000|Part B|Disease progression|0|||
23504142|NCT00753415|65584086|FG001|Part B|Disease progression|0|||
23504143|NCT00753415|65584087|FG002|Part B|Disease progression|0|||
23504144|NCT00753415|65584088|FG003|Part B|Disease progression|0|||
23504145|NCT00753415|65584089|FG004|Part B|Disease progression|0|||
23504146|NCT00753415|65584090|FG005|Part B|Disease progression|0|||
23504147|NCT00753415|65584091|FG006|Part B|Disease progression|0|||
23504148|NCT00753415|65584092|FG007|Part B|Disease progression|0|||
23504149|NCT00753415|65584093|FG008|Part B|Disease progression|2|||
23504150|NCT00753415|65584094|FG009|Part B|Disease progression|1|||
23504151|NCT04213079|65584098|FG000|Overall Study|Lost to Follow-up|0|||
23504152|NCT04213079|65584099|FG001|Overall Study|Lost to Follow-up|2|||
23504153|NCT01918774|65584100|FG000|Overall Study|Lost prior to first CBTw session|4|||
23504154|NCT01918774|65584100|FG000|Overall Study|Lost to Follow-up|1|||
23504155|NCT03727347|65584101|FG000|Overall Study|Withdrawal by Subject|2|||
23504156|NCT03727347|65584101|FG000|Overall Study|Lost to Follow-up|1|||
23504157|NCT01751178|65584102|FG000|Overall Study|Adverse Event|2|||
23504158|NCT01751178|65584103|FG001|Overall Study|Adverse Event|0|||
23504159|NCT01751178|65584104|FG002|Overall Study|Adverse Event|0|||
23504160|NCT01751178|65584102|FG000|Overall Study|Other Reason (unknown)|1|||
23504161|NCT01751178|65584103|FG001|Overall Study|Other Reason (unknown)|0|||
23504162|NCT01751178|65584104|FG002|Overall Study|Other Reason (unknown)|2|||
23504163|NCT02042183|65584105|FG000|Overall Study|Physician Decision|7|||
23504164|NCT02042183|65584106|FG001|Overall Study|Physician Decision|2|||
23504165|NCT02042183|65584105|FG000|Overall Study|Lack of Efficacy|4|||
23504166|NCT02042183|65584106|FG001|Overall Study|Lack of Efficacy|3|||
23504167|NCT02042183|65584105|FG000|Overall Study|Non-compliance with Study Drug|2|||
23504168|NCT02042183|65584106|FG001|Overall Study|Non-compliance with Study Drug|3|||
23504169|NCT02042183|65584105|FG000|Overall Study|Adverse Event|17|||
23504170|NCT02042183|65584106|FG001|Overall Study|Adverse Event|6|||
23504171|NCT02042183|65584105|FG000|Overall Study|Other|3|||
23504172|NCT02042183|65584106|FG001|Overall Study|Other|3|||
23504173|NCT02042183|65584105|FG000|Overall Study|Withdrawal by Subject|21|||
23504174|NCT02042183|65584106|FG001|Overall Study|Withdrawal by Subject|16|||
23504175|NCT02042183|65584105|FG000|Overall Study|Site Terminated by Sponsor|2|||
23504176|NCT02042183|65584106|FG001|Overall Study|Site Terminated by Sponsor|1|||
23504177|NCT02042183|65584105|FG000|Overall Study|Lost to Follow-up|9|||
23504178|NCT02042183|65584106|FG001|Overall Study|Lost to Follow-up|2|||
23504179|NCT00133952|65584107|FG000|Overall Study|Adverse Event|1|||
23504180|NCT00133952|65584108|FG001|Overall Study|Adverse Event|2|||
23504181|NCT00133952|65584107|FG000|Overall Study|Death|3|||
23504182|NCT00133952|65584108|FG001|Overall Study|Death|2|||
23504183|NCT00133952|65584107|FG000|Overall Study|Lost to Follow-up|9|||
23504184|NCT00133952|65584108|FG001|Overall Study|Lost to Follow-up|14|||
23504185|NCT00133952|65584107|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
23504186|NCT00133952|65584108|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
23504187|NCT00133952|65584107|FG000|Overall Study|Protocol Violation|1|||
23504188|NCT00133952|65584108|FG001|Overall Study|Protocol Violation|1|||
23504189|NCT00133952|65584107|FG000|Overall Study|Withdrawal by Subject|20|||
23504190|NCT00133952|65584108|FG001|Overall Study|Withdrawal by Subject|4|||
23504191|NCT00133952|65584107|FG000|Overall Study|Physician Decision|4|||
23504192|NCT00133952|65584108|FG001|Overall Study|Physician Decision|3|||
23504193|NCT00133952|65584107|FG000|Overall Study|Sponsor Decision|0|||
23504194|NCT00133952|65584108|FG001|Overall Study|Sponsor Decision|1|||
23504195|NCT02397278|65584109|FG000|Overall Study|Withdrawal by Subject|0|||
23504196|NCT02397278|65584110|FG001|Overall Study|Withdrawal by Subject|2|||
23504197|NCT02397278|65584109|FG000|Overall Study|Deemed ineligible following surgery|1|||
23504198|NCT02397278|65584110|FG001|Overall Study|Deemed ineligible following surgery|1|||
23504199|NCT02864498|65584120|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
23504200|NCT02864498|65584121|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
23504201|NCT02864498|65584122|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
23504202|NCT02864498|65584120|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
23504203|NCT02864498|65584121|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
23504204|NCT02864498|65584122|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
23504205|NCT02864498|65584120|FG000|Overall Study|Investigator Discretion|0|||
23504206|NCT02864498|65584121|FG001|Overall Study|Investigator Discretion|2|||
23504207|NCT02864498|65584122|FG002|Overall Study|Investigator Discretion|1|||
23504208|NCT02864498|65584120|FG000|Overall Study|Lost to Follow-up|8|||
23504209|NCT02864498|65584121|FG001|Overall Study|Lost to Follow-up|6|||
23504210|NCT02864498|65584122|FG002|Overall Study|Lost to Follow-up|3|||
23504211|NCT02864498|65584120|FG000|Overall Study|Lack of Efficacy|5|||
23504212|NCT02864498|65584121|FG001|Overall Study|Lack of Efficacy|3|||
23504213|NCT02864498|65584122|FG002|Overall Study|Lack of Efficacy|3|||
23504214|NCT02864498|65584120|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
23504215|NCT02864498|65584121|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
23504216|NCT02864498|65584122|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
23504217|NCT02864498|65584120|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
23504218|NCT02864498|65584121|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
23504219|NCT02864498|65584122|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
23504220|NCT02864498|65584120|FG000|Overall Study|Subject moved out of the country.|0|||
23504221|NCT02864498|65584121|FG001|Overall Study|Subject moved out of the country.|0|||
23504222|NCT02864498|65584122|FG002|Overall Study|Subject moved out of the country.|1|||
23704533|NCT02064439|66293531|FG000|Overall Study|Withdrawal by Subject|29|||
23704534|NCT02064439|66293532|FG001|Overall Study|Withdrawal by Subject|18|||
23704535|NCT02064439|66293533|FG002|Overall Study|Withdrawal by Subject|26|||
23704536|NCT02064439|66293531|FG000|Overall Study|Protocol Violation|3|||
23704537|NCT02064439|66293532|FG001|Overall Study|Protocol Violation|5|||
23704538|NCT02064439|66293533|FG002|Overall Study|Protocol Violation|3|||
23704539|NCT02064439|66293531|FG000|Overall Study|Lost to Follow-up|1|||
23704540|NCT02064439|66293532|FG001|Overall Study|Lost to Follow-up|3|||
23704541|NCT02064439|66293533|FG002|Overall Study|Lost to Follow-up|4|||
23704542|NCT02064439|66293531|FG000|Overall Study|Non-compliance with study medication|21|||
23704543|NCT02064439|66293532|FG001|Overall Study|Non-compliance with study medication|19|||
23704544|NCT02064439|66293533|FG002|Overall Study|Non-compliance with study medication|23|||
23704545|NCT02064439|66293531|FG000|Overall Study|Physician Decision|0|||
23704546|NCT02064439|66293532|FG001|Overall Study|Physician Decision|1|||
23704547|NCT02064439|66293533|FG002|Overall Study|Physician Decision|1|||
23704548|NCT02064439|66293531|FG000|Overall Study|Logistical difficulties|6|||
23704549|NCT02064439|66293532|FG001|Overall Study|Logistical difficulties|5|||
23704550|NCT02064439|66293533|FG002|Overall Study|Logistical difficulties|2|||
23704551|NCT02064439|66293531|FG000|Overall Study|Efficacy outcome reached|18|||
23704552|NCT02064439|66293532|FG001|Overall Study|Efficacy outcome reached|16|||
23704553|NCT02064439|66293533|FG002|Overall Study|Efficacy outcome reached|57|||
23704554|NCT02064439|66293531|FG000|Overall Study|Safety outcome reached|12|||
23704555|NCT02064439|66293532|FG001|Overall Study|Safety outcome reached|20|||
23704556|NCT02064439|66293533|FG002|Overall Study|Safety outcome reached|10|||
23704557|NCT02064439|66293531|FG000|Overall Study|Other|2|||
23704558|NCT02064439|66293532|FG001|Overall Study|Other|2|||
23704559|NCT02064439|66293533|FG002|Overall Study|Other|7|||
23704560|NCT01441440|66293538|FG000|Overall Study|Death|1|||
23704561|NCT01441440|66293539|FG001|Overall Study|Death|0|||
23704562|NCT01441440|66293540|FG002|Overall Study|Death|1|||
23704563|NCT01441440|66293538|FG000|Overall Study|Adverse Event|2|||
23704564|NCT01441440|66293539|FG001|Overall Study|Adverse Event|9|||
23704565|NCT01441440|66293540|FG002|Overall Study|Adverse Event|9|||
23704566|NCT01441440|66293538|FG000|Overall Study|Lost to Follow-up|0|||
23704567|NCT01441440|66293539|FG001|Overall Study|Lost to Follow-up|2|||
23704568|NCT01441440|66293540|FG002|Overall Study|Lost to Follow-up|1|||
23704569|NCT01441440|66293538|FG000|Overall Study|Withdrawal by Subject|11|||
23704570|NCT01441440|66293539|FG001|Overall Study|Withdrawal by Subject|9|||
23704571|NCT01441440|66293540|FG002|Overall Study|Withdrawal by Subject|9|||
23704572|NCT01441440|66293538|FG000|Overall Study|Pregnancy|1|||
23704573|NCT01441440|66293539|FG001|Overall Study|Pregnancy|0|||
23704574|NCT01441440|66293540|FG002|Overall Study|Pregnancy|0|||
23704575|NCT01441440|66293538|FG000|Overall Study|Lack of Efficacy|1|||
23704576|NCT01441440|66293539|FG001|Overall Study|Lack of Efficacy|0|||
23704577|NCT01441440|66293540|FG002|Overall Study|Lack of Efficacy|1|||
23704578|NCT01441440|66293538|FG000|Overall Study|Moving|0|||
23704579|NCT01441440|66293539|FG001|Overall Study|Moving|1|||
23704580|NCT01441440|66293540|FG002|Overall Study|Moving|1|||
23704581|NCT01441440|66293538|FG000|Overall Study|Work-related matter|0|||
23704582|NCT01441440|66293539|FG001|Overall Study|Work-related matter|1|||
23704583|NCT01441440|66293540|FG002|Overall Study|Work-related matter|0|||
23704584|NCT01441440|66293538|FG000|Overall Study|Difficllty in keeping the schedule|1|||
23704585|NCT01441440|66293539|FG001|Overall Study|Difficllty in keeping the schedule|1|||
23704586|NCT01441440|66293540|FG002|Overall Study|Difficllty in keeping the schedule|0|||
23704587|NCT01457118|66293545|FG000|Overall Study|Adverse Event|1|||
23704588|NCT01457118|66293546|FG001|Overall Study|Adverse Event|0|||
23704589|NCT01457118|66293547|FG002|Overall Study|Adverse Event|0|||
23704590|NCT01457118|66293548|FG003|Overall Study|Adverse Event|1|||
23704591|NCT01457118|66293545|FG000|Overall Study|Clinical Progression|0|||
23704592|NCT01457118|66293546|FG001|Overall Study|Clinical Progression|1|||
23704593|NCT01457118|66293547|FG002|Overall Study|Clinical Progression|0|||
23704594|NCT01457118|66293548|FG003|Overall Study|Clinical Progression|1|||
23704595|NCT01457118|66293545|FG000|Overall Study|Physician Decision|2|||
23704596|NCT01457118|66293546|FG001|Overall Study|Physician Decision|0|||
23704597|NCT01457118|66293547|FG002|Overall Study|Physician Decision|0|||
23704598|NCT01457118|66293548|FG003|Overall Study|Physician Decision|0|||
23704599|NCT01457118|66293545|FG000|Overall Study|Progressive Disease by RECIST|12|||
23704600|NCT01457118|66293546|FG001|Overall Study|Progressive Disease by RECIST|3|||
23704601|NCT01457118|66293547|FG002|Overall Study|Progressive Disease by RECIST|1|||
23704602|NCT01457118|66293548|FG003|Overall Study|Progressive Disease by RECIST|0|||
23704603|NCT01457118|66293545|FG000|Overall Study|Withdrawal by Subject|5|||
23704604|NCT01457118|66293546|FG001|Overall Study|Withdrawal by Subject|0|||
23704605|NCT01457118|66293547|FG002|Overall Study|Withdrawal by Subject|0|||
23704606|NCT01457118|66293548|FG003|Overall Study|Withdrawal by Subject|0|||
23704607|NCT00337467|66293549|FG000|Overall Study|Adverse Event|3|||
23704608|NCT00337467|66293549|FG000|Overall Study|Subject Withdrew Consent|2|||
23704609|NCT00337467|66293549|FG000|Overall Study|Pregnancy|1|||
23704610|NCT00337467|66293549|FG000|Overall Study|Lost to Follow-up|2|||
23704611|NCT00337467|66293549|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
23704612|NCT03352414|66293550|FG000|Overall Study|Ineligible by operative criteria|12|||
23704613|NCT03352414|66293551|FG001|Overall Study|Ineligible by operative criteria|10|||
23704614|NCT01402284|66293552|FG000|Overall Study|Withdrawal consent|2|||
23704615|NCT01402284|66293552|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
23704616|NCT01402284|66293552|FG000|Overall Study|Physician Decision|1|||
23704617|NCT01402284|66293552|FG000|Overall Study|Disease progression on study|10|||
23704618|NCT02689219|66293553|FG000|Overall Study|Death|1|||
23704619|NCT02689219|66293554|FG001|Overall Study|Death|1|||
23704620|NCT02689219|66293553|FG000|Overall Study|Disease Progression|10|||
23704621|NCT02689219|66293554|FG001|Overall Study|Disease Progression|6|||
23704622|NCT02207530|66293556|FG000|Overall Study|Worsening condition under investigation|78|||
23704623|NCT02207530|66293556|FG000|Overall Study|Patient decision to stop study treatment|5|||
23704624|NCT02207530|66293556|FG000|Overall Study|Adverse Event|8|||
23704625|NCT01798706|66293568|FG000|Overall Study|Adverse Event|15|||
23704626|NCT01798706|66293569|FG001|Overall Study|Adverse Event|10|||
23704627|NCT01798706|66293568|FG000|Overall Study|Lack of Efficacy|0|||
23704628|NCT01798706|66293569|FG001|Overall Study|Lack of Efficacy|2|||
23704629|NCT01798706|66293568|FG000|Overall Study|Poor compliance to protocol|1|||
23704630|NCT01798706|66293569|FG001|Overall Study|Poor compliance to protocol|0|||
23704631|NCT01798706|66293568|FG000|Overall Study|Other than specified above|5|||
23704632|NCT01798706|66293569|FG001|Overall Study|Other than specified above|9|||
23704633|NCT03041116|66293574|FG000|Double-blind|Death|0|||
23704634|NCT03041116|66293575|FG001|Double-blind|Death|2|||
23704635|NCT03041116|66293574|FG000|Double-blind|Withdrawal by Subject|0|||
23704636|NCT03041116|66293575|FG001|Double-blind|Withdrawal by Subject|4|||
23704637|NCT03041116|66293574|FG000|Open-label|Death|1|||
23704638|NCT03041116|66293575|FG001|Open-label|Death|0|||
23704639|NCT03041116|66293574|FG000|Open-label|Termination of the study by Sponsor|39|||
23704640|NCT03041116|66293575|FG001|Open-label|Termination of the study by Sponsor|37|||
23704641|NCT03041116|66293574|FG000|Open-label|Withdrawal by Subject|1|||
23704642|NCT03041116|66293575|FG001|Open-label|Withdrawal by Subject|0|||
23704643|NCT02998554|66293576|FG000|Overall Study|Adverse Event|8|||
23704644|NCT02998554|66293577|FG001|Overall Study|Adverse Event|3|||
23704645|NCT02998554|66293576|FG000|Overall Study|Protocol deviation|1|||
23704646|NCT02998554|66293577|FG001|Overall Study|Protocol deviation|0|||
23704647|NCT02998554|66293576|FG000|Overall Study|Withdrawal by Subject|2|||
23704648|NCT02998554|66293577|FG001|Overall Study|Withdrawal by Subject|6|||
23704649|NCT02998554|66293576|FG000|Overall Study|Lost to Follow-up|0|||
23704650|NCT02998554|66293577|FG001|Overall Study|Lost to Follow-up|1|||
23704651|NCT02998554|66293576|FG000|Overall Study|Lack of Efficacy|0|||
23704652|NCT02998554|66293577|FG001|Overall Study|Lack of Efficacy|1|||
23704653|NCT01576016|66293578|FG000|Lead Safety|Death|132|||
23704654|NCT01576016|66293579|FG001|Lead Safety|Death|0|||
23704655|NCT01576016|66293578|FG000|Lead Safety|Withdrawal by Subject|81|||
23704656|NCT01576016|66293579|FG001|Lead Safety|Withdrawal by Subject|0|||
23704657|NCT01576016|66293578|FG000|Lead Safety|System Explanted without Replacement|24|||
23704658|NCT01576016|66293579|FG001|Lead Safety|System Explanted without Replacement|0|||
23704659|NCT01576016|66293578|FG000|Lead Safety|Physician Decision|14|||
23704660|NCT01576016|66293579|FG001|Lead Safety|Physician Decision|0|||
23704661|NCT01576016|66293578|FG000|Lead Safety|Lost to Follow-up|13|||
23704662|NCT01576016|66293579|FG001|Lead Safety|Lost to Follow-up|0|||
23704663|NCT01576016|66293578|FG000|Lead Safety|Unsuccessful implant|2|||
23704664|NCT01576016|66293579|FG001|Lead Safety|Unsuccessful implant|0|||
23704665|NCT01576016|66293578|FG000|Lead Safety|Sponsor request|1|||
23704666|NCT01576016|66293579|FG001|Lead Safety|Sponsor request|0|||
23704667|NCT01576016|66293578|FG000|Lead Safety|Device replaced with CRT-D|1|||
23704668|NCT01576016|66293579|FG001|Lead Safety|Device replaced with CRT-D|0|||
23704669|NCT01576016|66293578|FG000|Lead Safety|Patient on Palliative Care|1|||
23704670|NCT01576016|66293579|FG001|Lead Safety|Patient on Palliative Care|0|||
23704671|NCT01576016|66293578|FG000|Lead Safety|Patient noncompliance|1|||
23704672|NCT01576016|66293579|FG001|Lead Safety|Patient noncompliance|0|||
23704673|NCT01576016|66293578|FG000|Lead Safety|Too far from study site|1|||
23704674|NCT01576016|66293579|FG001|Lead Safety|Too far from study site|0|||
23704675|NCT01576016|66293578|FG000|Lead Safety|System deactivated|1|||
23704676|NCT01576016|66293579|FG001|Lead Safety|System deactivated|0|||
23704677|NCT01576016|66293578|FG000|Lead Safety|Patient no longer followed by study PI|1|||
23704678|NCT01576016|66293579|FG001|Lead Safety|Patient no longer followed by study PI|0|||
23704679|NCT01576016|66293578|FG000|MRI Safety|Withdrawal by Subject|0|||
23704680|NCT01576016|66293579|FG001|MRI Safety|Withdrawal by Subject|10|||
23704681|NCT01576016|66293578|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
23704682|NCT01576016|66293579|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
23704683|NCT01576016|66293578|FG000|MRI Safety|Has not yet completed MRI scan|0|||
23704684|NCT01576016|66293579|FG001|MRI Safety|Has not yet completed MRI scan|56|||
23704685|NCT01576016|66293578|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
23704686|NCT01576016|66293579|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
23704687|NCT03792750|66293580|FG000|Overall Study|Death|3|||
23704688|NCT01728584|66293581|FG000|Overall Study|Adverse Event|1|||
23704689|NCT01728584|66293582|FG001|Overall Study|Adverse Event|0|||
23704690|NCT01728584|66293583|FG002|Overall Study|Adverse Event|0|||
23704691|NCT01728584|66293584|FG003|Overall Study|Adverse Event|0|||
23704692|NCT01728584|66293581|FG000|Overall Study|Physician Decision|4|||
23704693|NCT01728584|66293582|FG001|Overall Study|Physician Decision|0|||
23704694|NCT01728584|66293583|FG002|Overall Study|Physician Decision|1|||
23704695|NCT01728584|66293584|FG003|Overall Study|Physician Decision|0|||
23704696|NCT01728584|66293581|FG000|Overall Study|Withdrawal by Subject|1|||
23704697|NCT01728584|66293582|FG001|Overall Study|Withdrawal by Subject|0|||
23704698|NCT01728584|66293583|FG002|Overall Study|Withdrawal by Subject|0|||
23704699|NCT01728584|66293584|FG003|Overall Study|Withdrawal by Subject|0|||
23704700|NCT01728584|66293581|FG000|Overall Study|Screen failure|1|||
23704701|NCT01728584|66293582|FG001|Overall Study|Screen failure|0|||
23704702|NCT01728584|66293583|FG002|Overall Study|Screen failure|0|||
23704703|NCT01728584|66293584|FG003|Overall Study|Screen failure|0|||
23704704|NCT01728584|66293581|FG000|Overall Study|Other reason (not specified)|1|||
23704705|NCT01728584|66293582|FG001|Overall Study|Other reason (not specified)|0|||
23704706|NCT01728584|66293583|FG002|Overall Study|Other reason (not specified)|0|||
23704707|NCT01728584|66293584|FG003|Overall Study|Other reason (not specified)|1|||
23704708|NCT01106534|66293585|FG000|Overall Study|Withdrawal by Subject|18|||
23704709|NCT01106534|66293585|FG000|Overall Study|Lost to Follow-up|2|||
23704710|NCT01106534|66293585|FG000|Overall Study|Death|16|||
23704711|NCT01106534|66293585|FG000|Overall Study|Physician Decision|1|||
23704712|NCT02531035|66293587|FG000|Overall Study|Death|0|||
23704713|NCT02531035|66293588|FG001|Overall Study|Death|1|||
23704714|NCT02531035|66293587|FG000|Overall Study|Protocol Violation|1|||
23704715|NCT02531035|66293588|FG001|Overall Study|Protocol Violation|1|||
23704716|NCT02531035|66293587|FG000|Overall Study|Noncompliance with study drug|8|||
23704717|NCT02531035|66293588|FG001|Overall Study|Noncompliance with study drug|3|||
23704718|NCT02531035|66293587|FG000|Overall Study|Physician Decision|1|||
23704719|NCT02531035|66293588|FG001|Overall Study|Physician Decision|0|||
23400347|NCT02114177|65214078|FG001|Overall Study|Lost to Follow-up|2|||
23704720|NCT02531035|66293587|FG000|Overall Study|Adverse Event|16|||
23704721|NCT02531035|66293588|FG001|Overall Study|Adverse Event|45|||
23704722|NCT02531035|66293587|FG000|Overall Study|Other|3|||
23704723|NCT02531035|66293588|FG001|Overall Study|Other|2|||
23704724|NCT02531035|66293587|FG000|Overall Study|Withdrawal by Subject|42|||
23704725|NCT02531035|66293588|FG001|Overall Study|Withdrawal by Subject|32|||
23704726|NCT02531035|66293587|FG000|Overall Study|Lost to Follow-up|8|||
23704727|NCT02531035|66293588|FG001|Overall Study|Lost to Follow-up|10|||
23704728|NCT02531035|66293587|FG000|Overall Study|Randomized, not treated|2|||
23704729|NCT02531035|66293588|FG001|Overall Study|Randomized, not treated|1|||
23704730|NCT01029002|66293590|FG000|Overall Study|Lost to Follow-up|2|||
23704731|NCT01029002|66293591|FG001|Overall Study|Lost to Follow-up|4|||
23704732|NCT02184143|66293594|FG000|Overall Study|Withdrawal by Subject|4|||
23704733|NCT02184143|66293595|FG001|Overall Study|Withdrawal by Subject|4|||
23704734|NCT02184143|66293594|FG000|Overall Study|Lost to Follow-up|5|||
23704735|NCT02184143|66293595|FG001|Overall Study|Lost to Follow-up|3|||
23704736|NCT02184143|66293594|FG000|Overall Study|Death|1|||
23704737|NCT02184143|66293595|FG001|Overall Study|Death|0|||
23704738|NCT01921270|66293596|FG000|Overall Study|Withdrawal by Subject|1|||
23704739|NCT01931462|66293600|FG000|Overall Study|Withdrawal by Subject|1|||
23704740|NCT00536731|66293601|FG000|Overall Study|Adverse Event|3|||
23704741|NCT00536731|66293602|FG001|Overall Study|Adverse Event|2|||
23704742|NCT00536731|66293603|FG002|Overall Study|Adverse Event|3|||
23704743|NCT00536731|66293601|FG000|Overall Study|Withdrawal by Subject|0|||
23704744|NCT00536731|66293602|FG001|Overall Study|Withdrawal by Subject|2|||
23704745|NCT00536731|66293603|FG002|Overall Study|Withdrawal by Subject|0|||
23704746|NCT00536731|66293601|FG000|Overall Study|Intake of prohibited conc. medication|0|||
23704747|NCT00536731|66293602|FG001|Overall Study|Intake of prohibited conc. medication|0|||
23704748|NCT00536731|66293603|FG002|Overall Study|Intake of prohibited conc. medication|1|||
23704749|NCT00536731|66293601|FG000|Overall Study|Safety reasons|0|||
23704750|NCT00536731|66293602|FG001|Overall Study|Safety reasons|0|||
23704751|NCT00536731|66293603|FG002|Overall Study|Safety reasons|1|||
23704752|NCT00536731|66293601|FG000|Overall Study|Other|1|||
23704753|NCT00536731|66293602|FG001|Overall Study|Other|1|||
23704754|NCT00536731|66293603|FG002|Overall Study|Other|0|||
23704755|NCT04964063|66293604|FG000|Overall Study|Adverse Event|4|||
23704756|NCT04964063|66293604|FG000|Overall Study|Lost to Follow-up|47|||
23704757|NCT04964063|66293604|FG000|Overall Study|Withdrawal by Subject|5|||
23704758|NCT04964063|66293604|FG000|Overall Study|Baseline Tasks Expired|41|||
23704759|NCT04964063|66293604|FG000|Overall Study|Participant withdrawn in error|1|||
23704760|NCT01987986|66293605|FG000|Overall Study|Lost to Follow-up|1|||
23704761|NCT01987986|66293606|FG001|Overall Study|Lost to Follow-up|0|||
23704762|NCT01987986|66293607|FG002|Overall Study|Lost to Follow-up|0|||
23704763|NCT01987986|66293608|FG003|Overall Study|Lost to Follow-up|0|||
23704764|NCT01987986|66293605|FG000|Overall Study|Adverse Event|1|||
23704765|NCT01987986|66293606|FG001|Overall Study|Adverse Event|0|||
23704766|NCT01987986|66293607|FG002|Overall Study|Adverse Event|2|||
23402993|NCT03314935|65220065|FG010|Phase 1|Withdrawal by Subject|0|||
23402994|NCT03314935|65220066|FG011|Phase 1|Withdrawal by Subject|0|||
23402995|NCT03314935|65220067|FG012|Phase 1|Withdrawal by Subject|0|||
23402996|NCT03314935|65220068|FG013|Phase 1|Withdrawal by Subject|0|||
23402997|NCT03314935|65220069|FG014|Phase 1|Withdrawal by Subject|0|||
23402998|NCT03314935|65220055|FG000|Phase 1|Progressive Disease|2|||
23402999|NCT03314935|65220056|FG001|Phase 1|Progressive Disease|0|||
23403000|NCT03314935|65220057|FG002|Phase 1|Progressive Disease|0|||
23403001|NCT03314935|65220058|FG003|Phase 1|Progressive Disease|1|||
23403002|NCT03314935|65220059|FG004|Phase 1|Progressive Disease|0|||
23403003|NCT03314935|65220060|FG005|Phase 1|Progressive Disease|0|||
23403004|NCT03314935|65220061|FG006|Phase 1|Progressive Disease|0|||
23403005|NCT03314935|65220062|FG007|Phase 1|Progressive Disease|0|||
23403006|NCT03314935|65220063|FG008|Phase 1|Progressive Disease|0|||
23403007|NCT03314935|65220064|FG009|Phase 1|Progressive Disease|0|||
23403008|NCT03314935|65220065|FG010|Phase 1|Progressive Disease|0|||
23403009|NCT03314935|65220066|FG011|Phase 1|Progressive Disease|0|||
23403010|NCT03314935|65220067|FG012|Phase 1|Progressive Disease|0|||
23403011|NCT03314935|65220068|FG013|Phase 1|Progressive Disease|0|||
23403012|NCT03314935|65220069|FG014|Phase 1|Progressive Disease|0|||
23403013|NCT03314935|65220055|FG000|Phase 1|Study Terminated by Sponsor|0|||
23403014|NCT03314935|65220056|FG001|Phase 1|Study Terminated by Sponsor|1|||
23403015|NCT03314935|65220057|FG002|Phase 1|Study Terminated by Sponsor|0|||
23403016|NCT03314935|65220058|FG003|Phase 1|Study Terminated by Sponsor|0|||
23403017|NCT03314935|65220059|FG004|Phase 1|Study Terminated by Sponsor|0|||
23403018|NCT03314935|65220060|FG005|Phase 1|Study Terminated by Sponsor|0|||
23403019|NCT03314935|65220061|FG006|Phase 1|Study Terminated by Sponsor|0|||
23403020|NCT03314935|65220062|FG007|Phase 1|Study Terminated by Sponsor|0|||
23403021|NCT03314935|65220063|FG008|Phase 1|Study Terminated by Sponsor|1|||
23403022|NCT03314935|65220064|FG009|Phase 1|Study Terminated by Sponsor|0|||
23403023|NCT03314935|65220065|FG010|Phase 1|Study Terminated by Sponsor|0|||
23403024|NCT03314935|65220066|FG011|Phase 1|Study Terminated by Sponsor|0|||
23403025|NCT03314935|65220067|FG012|Phase 1|Study Terminated by Sponsor|0|||
23403026|NCT03314935|65220068|FG013|Phase 1|Study Terminated by Sponsor|0|||
23403027|NCT03314935|65220069|FG014|Phase 1|Study Terminated by Sponsor|0|||
23403028|NCT03314935|65220055|FG000|Phase 1|"Captured as Other in Database"|0|||
23704767|NCT01987986|66293608|FG003|Overall Study|Adverse Event|0|||
23704768|NCT01035606|66293610|FG000|Overall Study|change in health, job demands,family|3|||
23704769|NCT01035606|66293611|FG001|Overall Study|change in health, job demands,family|3|||
23704770|NCT01035606|66293612|FG002|Overall Study|change in health, job demands,family|4|||
23704771|NCT04285346|66293613|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
23704772|NCT04285346|66293614|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
23704773|NCT04285346|66293613|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
23704774|NCT04285346|66293614|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23704775|NCT04285346|66293613|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
23704776|NCT04285346|66293614|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23704777|NCT00872170|66293617|FG000|Overall Study|Adverse Event|1|||
23704778|NCT00872170|66293618|FG001|Overall Study|Adverse Event|0|||
23704779|NCT02588248|66293619|FG000|Overall Study|Physician Decision|4|||
23704780|NCT02588248|66293620|FG001|Overall Study|Physician Decision|3|||
23704781|NCT02869867|66293621|FG000|Overall Study|Protocol Violation|1|||
23704782|NCT02869867|66293622|FG001|Overall Study|Protocol Violation|0|||
23704783|NCT02869867|66293621|FG000|Overall Study|Lost to Follow-up|5|||
23704784|NCT02869867|66293622|FG001|Overall Study|Lost to Follow-up|5|||
23704785|NCT00118482|66293623|FG000|Overall Study|Lost to Follow-up|7|||
23704786|NCT00118482|66293624|FG001|Overall Study|Lost to Follow-up|7|||
23704787|NCT00118482|66293623|FG000|Overall Study|Withdrawal by Subject|23|||
23704788|NCT00118482|66293624|FG001|Overall Study|Withdrawal by Subject|22|||
23704789|NCT01849250|66293625|FG000|Overall Study|Withdrawal by Subject|1|||
23704790|NCT01849250|66293626|FG001|Overall Study|Withdrawal by Subject|0|||
23704791|NCT01849250|66293625|FG000|Overall Study|Not Evaluable|5|||
23704792|NCT01849250|66293626|FG001|Overall Study|Not Evaluable|3|||
23704793|NCT01849250|66293625|FG000|Overall Study|Screen Failure|1|||
23704794|NCT01849250|66293626|FG001|Overall Study|Screen Failure|0|||
23704795|NCT01341652|66293633|FG000|Overall Study|Incorrect Random Assignment|0|||
23704796|NCT01341652|66293634|FG001|Overall Study|Incorrect Random Assignment|1|||
23704797|NCT01341652|66293633|FG000|Overall Study|ineligible; presence metastatic disease|0|||
23704798|NCT01341652|66293634|FG001|Overall Study|ineligible; presence metastatic disease|1|||
23704799|NCT02819310|66293642|FG000|Overall Study|Withdrawal by Subject|37|||
23704800|NCT02819310|66293642|FG000|Overall Study|Lost to Follow-up|16|||
23704801|NCT02819310|66293642|FG000|Overall Study|Adverse Event|13|||
23704802|NCT02819310|66293642|FG000|Overall Study|Lack of Efficacy|5|||
23704803|NCT02819310|66293642|FG000|Overall Study|Physician Decision|8|||
23704804|NCT02819310|66293642|FG000|Overall Study|Protocol Violation|30|||
23704805|NCT01331239|66293643|FG000|Part II: Core Study|Adverse Event|0|||
23704806|NCT01331239|66293644|FG001|Part II: Core Study|Adverse Event|3|||
23704807|NCT01331239|66293645|FG002|Part II: Core Study|Adverse Event|0|||
23704808|NCT01331239|66293643|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
23704809|NCT01331239|66293644|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
23704810|NCT01331239|66293645|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
23704811|NCT01331239|66293643|FG000|Part II: Core Study|Withdrawal by Subject|0|||
23704812|NCT01331239|66293644|FG001|Part II: Core Study|Withdrawal by Subject|2|||
23704813|NCT01331239|66293645|FG002|Part II: Core Study|Withdrawal by Subject|0|||
23704814|NCT01331239|66293643|FG000|Part II: Core Study|Administrative problems|0|||
23704815|NCT01331239|66293644|FG001|Part II: Core Study|Administrative problems|1|||
23704816|NCT01331239|66293645|FG002|Part II: Core Study|Administrative problems|0|||
23704817|NCT01856595|66293646|FG000|Overall Study|Withdrawal by Subject|0|||
23704818|NCT01856595|66293647|FG001|Overall Study|Withdrawal by Subject|1|||
23704819|NCT01856595|66293648|FG002|Overall Study|Withdrawal by Subject|0|||
23704820|NCT01856595|66293649|FG003|Overall Study|Withdrawal by Subject|0|||
23704821|NCT01856595|66293650|FG004|Overall Study|Withdrawal by Subject|0|||
23704822|NCT01856595|66293651|FG005|Overall Study|Withdrawal by Subject|0|||
23704823|NCT01856595|66293652|FG006|Overall Study|Withdrawal by Subject|1|||
23704824|NCT01856595|66293653|FG007|Overall Study|Withdrawal by Subject|0|||
23704825|NCT01856595|66293654|FG008|Overall Study|Withdrawal by Subject|0|||
23704826|NCT05373706|66293655|FG000|Overall Study|Lost to Follow-up|2|||
23704827|NCT05373706|66293656|FG001|Overall Study|Lost to Follow-up|2|||
23704828|NCT03807739|66293657|FG000|Overall Study|Adverse Event|1|||
23704829|NCT03807739|66293658|FG001|Overall Study|Adverse Event|0|||
23704830|NCT03807739|66293659|FG002|Overall Study|Adverse Event|0|||
23704831|NCT03807739|66293660|FG003|Overall Study|Adverse Event|0|||
23704832|NCT03807739|66293657|FG000|Overall Study|Withdrawal by Subject|1|||
23704833|NCT03807739|66293658|FG001|Overall Study|Withdrawal by Subject|0|||
23704834|NCT03807739|66293659|FG002|Overall Study|Withdrawal by Subject|0|||
23704835|NCT03807739|66293660|FG003|Overall Study|Withdrawal by Subject|0|||
23704836|NCT02427477|66293661|FG000|Period 1|Adverse Event|1|||
23704837|NCT02427477|66293662|FG001|Period 1|Adverse Event|0|||
23704838|NCT05118386|66293664|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23704839|NCT05118386|66293665|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23704840|NCT05118386|66293666|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23705709|NCT00972244|66297595|FG003|Overall Study|Death|0|||
23704841|NCT05118386|66293667|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
23704842|NCT05118386|66293668|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23704843|NCT05118386|66293669|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23704844|NCT05118386|66293664|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23704845|NCT05118386|66293665|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23704846|NCT05118386|66293666|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23704847|NCT05118386|66293667|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23704848|NCT05118386|66293668|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
23704849|NCT05118386|66293669|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23704850|NCT00988559|66293674|FG000|Overall Study|Withdrawal by Subject|1|||
23704851|NCT00988559|66293675|FG001|Overall Study|Withdrawal by Subject|1|||
23704852|NCT00988559|66293676|FG002|Overall Study|Withdrawal by Subject|0|||
23704853|NCT00988559|66293677|FG003|Overall Study|Withdrawal by Subject|1|||
23704854|NCT00988559|66293674|FG000|Overall Study|Pregnancy|0|||
23704855|NCT00988559|66293675|FG001|Overall Study|Pregnancy|1|||
23704856|NCT00988559|66293676|FG002|Overall Study|Pregnancy|1|||
23704857|NCT00988559|66293677|FG003|Overall Study|Pregnancy|0|||
23704858|NCT00988559|66293674|FG000|Overall Study|Lost to Follow-up|0|||
23704859|NCT00988559|66293675|FG001|Overall Study|Lost to Follow-up|0|||
23704860|NCT00988559|66293676|FG002|Overall Study|Lost to Follow-up|1|||
23704861|NCT00988559|66293677|FG003|Overall Study|Lost to Follow-up|0|||
23704862|NCT00417976|66293678|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
23704863|NCT00417976|66293678|FG000|Overall Study|Treatment -related toxicity|2|||
23704864|NCT04799405|66293679|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
23704865|NCT00748540|66293680|FG000|Overall Study|Physician Decision|1|||
23704866|NCT01958671|66293681|FG000|Overall Study|Adverse Event|1|||
23704867|NCT01958671|66293682|FG001|Overall Study|Adverse Event|1|||
23704868|NCT01958671|66293683|FG002|Overall Study|Adverse Event|5|||
23704869|NCT01958671|66293681|FG000|Overall Study|Death|1|||
23704870|NCT01958671|66293682|FG001|Overall Study|Death|0|||
23704871|NCT01958671|66293683|FG002|Overall Study|Death|0|||
23704872|NCT01958671|66293681|FG000|Overall Study|Excluded medication|0|||
23704873|NCT01958671|66293682|FG001|Overall Study|Excluded medication|0|||
23704874|NCT01958671|66293683|FG002|Overall Study|Excluded medication|1|||
23704875|NCT01958671|66293681|FG000|Overall Study|Hyperglycemia|0|||
23704876|NCT01958671|66293682|FG001|Overall Study|Hyperglycemia|0|||
23704877|NCT01958671|66293683|FG002|Overall Study|Hyperglycemia|2|||
23704878|NCT01958671|66293681|FG000|Overall Study|Lost to Follow-up|7|||
23704879|NCT01958671|66293682|FG001|Overall Study|Lost to Follow-up|11|||
23704880|NCT01958671|66293683|FG002|Overall Study|Lost to Follow-up|7|||
23704881|NCT01958671|66293681|FG000|Overall Study|Non-compliance with study drug|1|||
23704882|NCT01958671|66293682|FG001|Overall Study|Non-compliance with study drug|1|||
23704883|NCT01958671|66293683|FG002|Overall Study|Non-compliance with study drug|1|||
23704884|NCT01958671|66293681|FG000|Overall Study|Pregnancy|0|||
23704885|NCT01958671|66293682|FG001|Overall Study|Pregnancy|0|||
23704886|NCT01958671|66293683|FG002|Overall Study|Pregnancy|1|||
23704887|NCT01958671|66293681|FG000|Overall Study|Protocol Violation|0|||
23704888|NCT01958671|66293682|FG001|Overall Study|Protocol Violation|1|||
23704889|NCT01958671|66293683|FG002|Overall Study|Protocol Violation|0|||
23704890|NCT01958671|66293681|FG000|Overall Study|Study site terminated by sponsor|1|||
23704891|NCT01958671|66293682|FG001|Overall Study|Study site terminated by sponsor|0|||
23704892|NCT01958671|66293683|FG002|Overall Study|Study site terminated by sponsor|1|||
23704893|NCT01958671|66293681|FG000|Overall Study|Participant moved|0|||
23704894|NCT01958671|66293682|FG001|Overall Study|Participant moved|0|||
23704895|NCT01958671|66293683|FG002|Overall Study|Participant moved|1|||
23704896|NCT01958671|66293681|FG000|Overall Study|Withdrawal by Subject|8|||
23704897|NCT01958671|66293682|FG001|Overall Study|Withdrawal by Subject|10|||
23704898|NCT01958671|66293683|FG002|Overall Study|Withdrawal by Subject|13|||
23704899|NCT01617434|66293684|FG000|Overall Study|Adverse Event|12|||
23704900|NCT01617434|66293685|FG001|Overall Study|Adverse Event|3|||
23704901|NCT01617434|66293684|FG000|Overall Study|Protocol Violation|8|||
23704902|NCT01617434|66293685|FG001|Overall Study|Protocol Violation|7|||
23704903|NCT01617434|66293684|FG000|Overall Study|Withdrawal Criteria|12|||
23704904|NCT01617434|66293685|FG001|Overall Study|Withdrawal Criteria|37|||
23704905|NCT01617434|66293684|FG000|Overall Study|Unclassified|3|||
23704906|NCT01617434|66293685|FG001|Overall Study|Unclassified|4|||
23704907|NCT00553059|66293686|FG000|Overall Study|Deemed ineligible|1|||
23704908|NCT00553059|66293687|FG001|Overall Study|Deemed ineligible|1|||
23704909|NCT00553059|66293686|FG000|Overall Study|Drug supply not available|0|||
23704910|NCT00553059|66293687|FG001|Overall Study|Drug supply not available|1|||
23704911|NCT03260205|66293688|FG000|Overall Study|Adverse Event|2|||
23704912|NCT03260205|66293689|FG001|Overall Study|Adverse Event|0|||
23704913|NCT03260205|66293690|FG002|Overall Study|Adverse Event|2|||
23704914|NCT03260205|66293691|FG003|Overall Study|Adverse Event|2|||
23704915|NCT03260205|66293692|FG004|Overall Study|Adverse Event|4|||
23704916|NCT03260205|66293688|FG000|Overall Study|Lost to Follow-up|2|||
23704917|NCT03260205|66293689|FG001|Overall Study|Lost to Follow-up|2|||
23704918|NCT03260205|66293690|FG002|Overall Study|Lost to Follow-up|1|||
23704919|NCT03260205|66293691|FG003|Overall Study|Lost to Follow-up|1|||
23704920|NCT03260205|66293692|FG004|Overall Study|Lost to Follow-up|5|||
23704921|NCT03260205|66293688|FG000|Overall Study|Protocol Violation|0|||
23704922|NCT03260205|66293689|FG001|Overall Study|Protocol Violation|0|||
23704923|NCT03260205|66293690|FG002|Overall Study|Protocol Violation|2|||
23704924|NCT03260205|66293691|FG003|Overall Study|Protocol Violation|0|||
23704925|NCT03260205|66293692|FG004|Overall Study|Protocol Violation|1|||
23704926|NCT03260205|66293688|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
23704927|NCT03260205|66293689|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
23704928|NCT03260205|66293690|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
23704929|NCT03260205|66293691|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
23704930|NCT03260205|66293692|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
23704931|NCT03260205|66293688|FG000|Overall Study|Other: Unspecified|0|||
23704932|NCT03260205|66293689|FG001|Overall Study|Other: Unspecified|0|||
23704933|NCT03260205|66293690|FG002|Overall Study|Other: Unspecified|3|||
23704934|NCT03260205|66293691|FG003|Overall Study|Other: Unspecified|1|||
23704935|NCT03260205|66293692|FG004|Overall Study|Other: Unspecified|1|||
23704936|NCT03260205|66293688|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
23704937|NCT03260205|66293689|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
23704938|NCT03260205|66293690|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
23704939|NCT03260205|66293691|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
23704940|NCT03260205|66293692|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
23704941|NCT03375112|66293693|FG000|Overall Study|Withdrawal by Subject|3|||
23704942|NCT03375112|66293694|FG001|Overall Study|Withdrawal by Subject|0|||
23704943|NCT01193348|66293695|FG000|Screening Period|Screen Failure|5|||
23704944|NCT01193348|66293695|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
23704945|NCT01193348|66293695|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
23704946|NCT01193348|66293695|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
23704947|NCT01193348|66293695|FG000|Extension Treatment Period|Physician Decision|1|||
23704948|NCT01193348|66293695|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
23704949|NCT05523362|66293703|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
23704950|NCT05523362|66293703|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
23704951|NCT05523362|66293703|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
23704952|NCT05523362|66293703|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
23704953|NCT00114972|66293704|FG000|Overall Study|Withdrawal by Subject|40|||
23704954|NCT00114972|66293705|FG001|Overall Study|Withdrawal by Subject|7|||
23704955|NCT00114972|66293704|FG000|Overall Study|Lost to Follow-up|8|||
23704956|NCT00114972|66293705|FG001|Overall Study|Lost to Follow-up|5|||
23704957|NCT03010423|66293706|FG000|Overall Study|Study termination|8|||
23704958|NCT02739594|66293707|FG000|Overall Study|Undesired Event|3|||
23704959|NCT02739594|66293708|FG001|Overall Study|Undesired Event|4|||
23704960|NCT02739594|66293707|FG000|Overall Study|Violation of Eligibility Criteria|1|||
23704961|NCT02739594|66293708|FG001|Overall Study|Violation of Eligibility Criteria|2|||
23704962|NCT02739594|66293707|FG000|Overall Study|Protocol Violation|5|||
23704963|NCT02739594|66293708|FG001|Overall Study|Protocol Violation|6|||
23704964|NCT02739594|66293707|FG000|Overall Study|Death|4|||
23704965|NCT02739594|66293708|FG001|Overall Study|Death|2|||
23704966|NCT02739594|66293707|FG000|Overall Study|Renal Insufficiency|4|||
23704967|NCT02739594|66293708|FG001|Overall Study|Renal Insufficiency|6|||
23704968|NCT02739594|66293707|FG000|Overall Study|Administrative Reasons|1|||
23704969|NCT02739594|66293708|FG001|Overall Study|Administrative Reasons|3|||
23704970|NCT02739594|66293707|FG000|Overall Study|Withdrawal by Subject|1|||
23704971|NCT02739594|66293708|FG001|Overall Study|Withdrawal by Subject|1|||
23704972|NCT02739594|66293707|FG000|Overall Study|Lost to Follow-up|0|||
23704973|NCT02739594|66293708|FG001|Overall Study|Lost to Follow-up|1|||
23704974|NCT02739594|66293707|FG000|Overall Study|Elevated Serum Creatinine|0|||
23704975|NCT02739594|66293708|FG001|Overall Study|Elevated Serum Creatinine|1|||
23704976|NCT02739594|66293707|FG000|Overall Study|Other|6|||
23704977|NCT02739594|66293708|FG001|Overall Study|Other|2|||
23704978|NCT01428063|66293709|FG000|Overall Study|Lack of Efficacy|8|||
23704979|NCT01428063|66293710|FG001|Overall Study|Lack of Efficacy|4|||
23704980|NCT01428063|66293711|FG002|Overall Study|Lack of Efficacy|1|||
23704981|NCT01428063|66293709|FG000|Overall Study|Adverse Event|2|||
23704982|NCT01428063|66293710|FG001|Overall Study|Adverse Event|3|||
23704983|NCT01428063|66293711|FG002|Overall Study|Adverse Event|0|||
23704984|NCT01428063|66293709|FG000|Overall Study|Lost to Follow-up|0|||
23704985|NCT01428063|66293710|FG001|Overall Study|Lost to Follow-up|2|||
23704986|NCT01428063|66293711|FG002|Overall Study|Lost to Follow-up|0|||
23704987|NCT01428063|66293709|FG000|Overall Study|No longer meets study criteria|0|||
23704988|NCT01428063|66293710|FG001|Overall Study|No longer meets study criteria|1|||
23704989|NCT01428063|66293711|FG002|Overall Study|No longer meets study criteria|0|||
23704990|NCT03484923|66293712|FG000|Overall Study|Adverse Event|3|||
23704991|NCT03484923|66293713|FG001|Overall Study|Adverse Event|3|||
23704992|NCT03484923|66293714|FG002|Overall Study|Adverse Event|5|||
23704993|NCT03484923|66293715|FG003|Overall Study|Adverse Event|11|||
23704994|NCT03484923|66293716|FG004|Overall Study|Adverse Event|1|||
23704995|NCT03484923|66293712|FG000|Overall Study|Death|2|||
23704996|NCT03484923|66293713|FG001|Overall Study|Death|2|||
23704997|NCT03484923|66293714|FG002|Overall Study|Death|3|||
23704998|NCT03484923|66293715|FG003|Overall Study|Death|0|||
23704999|NCT03484923|66293716|FG004|Overall Study|Death|1|||
23705000|NCT03484923|66293712|FG000|Overall Study|Physician Decision|6|||
23705001|NCT03484923|66293713|FG001|Overall Study|Physician Decision|7|||
23705002|NCT03484923|66293714|FG002|Overall Study|Physician Decision|6|||
23705003|NCT03484923|66293715|FG003|Overall Study|Physician Decision|3|||
23705004|NCT03484923|66293716|FG004|Overall Study|Physician Decision|2|||
23705005|NCT03484923|66293712|FG000|Overall Study|Progressive disease|33|||
23705006|NCT03484923|66293713|FG001|Overall Study|Progressive disease|28|||
23705007|NCT03484923|66293714|FG002|Overall Study|Progressive disease|26|||
23705008|NCT03484923|66293715|FG003|Overall Study|Progressive disease|30|||
23705009|NCT03484923|66293716|FG004|Overall Study|Progressive disease|16|||
23705010|NCT03484923|66293712|FG000|Overall Study|Subject Decision|1|||
23705011|NCT03484923|66293713|FG001|Overall Study|Subject Decision|3|||
23705012|NCT03484923|66293714|FG002|Overall Study|Subject Decision|3|||
23705013|NCT03484923|66293715|FG003|Overall Study|Subject Decision|0|||
23705014|NCT03484923|66293716|FG004|Overall Study|Subject Decision|1|||
23705015|NCT02948777|66293721|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
23705016|NCT00532883|66293722|FG000|Overall Study|Adverse Event|1|||
23705017|NCT00532883|66293723|FG001|Overall Study|Adverse Event|0|||
23705018|NCT00532883|66293724|FG002|Overall Study|Adverse Event|0|||
23705019|NCT00532883|66293725|FG003|Overall Study|Adverse Event|1|||
23705020|NCT00532883|66293722|FG000|Overall Study|Lost to Follow-up|1|||
23705021|NCT00532883|66293723|FG001|Overall Study|Lost to Follow-up|1|||
23705022|NCT00532883|66293724|FG002|Overall Study|Lost to Follow-up|1|||
23705023|NCT00532883|66293725|FG003|Overall Study|Lost to Follow-up|0|||
23705024|NCT00532883|66293722|FG000|Overall Study|Withdrawal by Subject|0|||
23705025|NCT00532883|66293723|FG001|Overall Study|Withdrawal by Subject|1|||
23705026|NCT00532883|66293724|FG002|Overall Study|Withdrawal by Subject|1|||
23705027|NCT00532883|66293725|FG003|Overall Study|Withdrawal by Subject|0|||
23705028|NCT00532883|66293722|FG000|Overall Study|Subject was Nonadherent|0|||
23705029|NCT00532883|66293723|FG001|Overall Study|Subject was Nonadherent|1|||
23705030|NCT00532883|66293724|FG002|Overall Study|Subject was Nonadherent|1|||
23705031|NCT00532883|66293725|FG003|Overall Study|Subject was Nonadherent|0|||
23705032|NCT00532883|66293722|FG000|Overall Study|Early Study Termination|4|||
23705033|NCT00532883|66293723|FG001|Overall Study|Early Study Termination|4|||
23705034|NCT00532883|66293724|FG002|Overall Study|Early Study Termination|1|||
23705035|NCT00532883|66293725|FG003|Overall Study|Early Study Termination|4|||
23705036|NCT02052960|66293727|FG000|Overall Study|Adverse Event|19|||
23705037|NCT02052960|66293728|FG001|Overall Study|Adverse Event|17|||
23705038|NCT02052960|66293727|FG000|Overall Study|Protocol Violation|4|||
23705039|NCT02052960|66293728|FG001|Overall Study|Protocol Violation|3|||
23705040|NCT02052960|66293727|FG000|Overall Study|Withdrawal by Subject|6|||
23705041|NCT02052960|66293728|FG001|Overall Study|Withdrawal by Subject|11|||
23705042|NCT02052960|66293727|FG000|Overall Study|Other|25|||
23705043|NCT02052960|66293728|FG001|Overall Study|Other|15|||
23705044|NCT03744676|66293729|FG000|Pre-Treatment Phase|Death|7|||
23705045|NCT03744676|66293729|FG000|Pre-Treatment Phase|Disease related complications|2|||
23705046|NCT03744676|66293729|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
23705047|NCT03744676|66293729|FG000|Pre-Treatment Phase|Other reasons|8|||
23705048|NCT03744676|66293729|FG000|Treatment Phase|Ongoing in study|18|||
23705049|NCT03744676|66293729|FG000|Treatment Phase|Death|31|||
23705050|NCT03744676|66293729|FG000|Treatment Phase|Withdrawal of consent|8|||
23705051|NCT03744676|66293729|FG000|Treatment Phase|Other reasons|6|||
23705052|NCT01842620|66293730|FG000|Period 1|Withdrawal by Subject|1|||
23705053|NCT01842620|66293731|FG001|Period 1|Withdrawal by Subject|0|||
23705054|NCT00109733|66293732|FG000|Overall Study|Protocol Violation|0|||
23705055|NCT00109733|66293733|FG001|Overall Study|Protocol Violation|1|||
23705056|NCT00109733|66293732|FG000|Overall Study|Stopped taking study drug|1|||
23705057|NCT00109733|66293733|FG001|Overall Study|Stopped taking study drug|1|||
23705058|NCT00109733|66293732|FG000|Overall Study|Non-compliant|0|||
23705059|NCT00109733|66293733|FG001|Overall Study|Non-compliant|1|||
23705060|NCT00109733|66293732|FG000|Overall Study|Could not commit time for study|1|||
23705061|NCT00109733|66293733|FG001|Overall Study|Could not commit time for study|1|||
23705062|NCT00130208|66293734|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
23705063|NCT00130208|66293735|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
23705064|NCT00130208|66293734|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
23705065|NCT00130208|66293735|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
23705066|NCT00130208|66293734|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
23705067|NCT00130208|66293735|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
23705068|NCT00130208|66293734|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
23705069|NCT00130208|66293735|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
23705070|NCT00130208|66293734|FG000|Maintenance Period (26 Weeks)|Other|1|||
23705071|NCT00130208|66293735|FG001|Maintenance Period (26 Weeks)|Other|1|||
23705072|NCT00130208|66293734|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
23705073|NCT00130208|66293735|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
23705074|NCT00130208|66293734|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
23705075|NCT00130208|66293735|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
23705076|NCT00130208|66293734|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
23705077|NCT00130208|66293735|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
23705078|NCT00130208|66293734|FG000|Washout Period (8 Weeks)|Other|1|||
23705079|NCT00130208|66293735|FG001|Washout Period (8 Weeks)|Other|1|||
23705080|NCT02926573|66293736|FG000|Overall Study|Nausea|1|||
23705081|NCT02926573|66293737|FG001|Overall Study|Nausea|0|||
23705082|NCT02926573|66293736|FG000|Overall Study|Remain intubated|2|||
23705083|NCT02926573|66293737|FG001|Overall Study|Remain intubated|2|||
23705084|NCT02926573|66293736|FG000|Overall Study|Change in surgery plan|3|||
23705085|NCT02926573|66293737|FG001|Overall Study|Change in surgery plan|1|||
23705086|NCT02926573|66293736|FG000|Overall Study|Change to outpatient status|5|||
23705087|NCT02926573|66293737|FG001|Overall Study|Change to outpatient status|1|||
23705088|NCT02926573|66293736|FG000|Overall Study|Withdrawal by Subject|0|||
23705089|NCT02926573|66293737|FG001|Overall Study|Withdrawal by Subject|2|||
23705090|NCT02926573|66293736|FG000|Overall Study|Return to operating room|0|||
23705091|NCT02926573|66293737|FG001|Overall Study|Return to operating room|2|||
23705092|NCT02926573|66293736|FG000|Overall Study|Delirium|0|||
23705093|NCT02926573|66293737|FG001|Overall Study|Delirium|1|||
23705094|NCT02928406|66297406|FG000|Overall Study|Death|780|||
23705095|NCT02928406|66297406|FG000|Overall Study|Progressive disease|3|||
23705096|NCT02928406|66297406|FG000|Overall Study|Lost to Follow-up|49|||
23705097|NCT02928406|66297406|FG000|Overall Study|Non-compliance|2|||
23705098|NCT02928406|66297406|FG000|Overall Study|Withdrawal by Subject|40|||
23705099|NCT02928406|66297406|FG000|Overall Study|Study terminated by sponsor|57|||
23705100|NCT02928406|66297406|FG000|Overall Study|Physician Decision|1|||
23705101|NCT02928406|66297406|FG000|Overall Study|Various reasons|72|||
23705102|NCT02042404|66297413|FG000|Overall Study|Death|1|||
23705103|NCT02042404|66297414|FG001|Overall Study|Death|0|||
23705104|NCT02042404|66297413|FG000|Overall Study|Unrelated Adverse Event|3|||
23705105|NCT02042404|66297414|FG001|Overall Study|Unrelated Adverse Event|0|||
23705106|NCT02042404|66297413|FG000|Overall Study|Inability to meet time requirements|1|||
23705107|NCT02042404|66297414|FG001|Overall Study|Inability to meet time requirements|0|||
23705108|NCT03471767|66297415|FG000|Overall Study|Withdrawal by Subject|3|||
23705109|NCT03471767|66297416|FG001|Overall Study|Withdrawal by Subject|1|||
23705110|NCT03471767|66297415|FG000|Overall Study|Adverse Event|1|||
23705111|NCT03471767|66297416|FG001|Overall Study|Adverse Event|0|||
23705112|NCT03471767|66297415|FG000|Overall Study|Lost to Follow-up|1|||
23705113|NCT03471767|66297416|FG001|Overall Study|Lost to Follow-up|0|||
23705114|NCT03471767|66297415|FG000|Overall Study|PI Withdrawal|1|||
23705115|NCT03471767|66297416|FG001|Overall Study|PI Withdrawal|3|||
23705116|NCT01419665|66297417|FG000|Combination Treatment|Adverse Event|7|||
23705117|NCT01419665|66297418|FG001|Combination Treatment|Adverse Event|10|||
23705118|NCT01419665|66297417|FG000|Combination Treatment|Physician Decision|5|||
23705119|NCT01419665|66297418|FG001|Combination Treatment|Physician Decision|8|||
23705120|NCT01419665|66297417|FG000|Combination Treatment|Protocol Violation|6|||
23705121|NCT01419665|66297418|FG001|Combination Treatment|Protocol Violation|2|||
23705122|NCT01419665|66297417|FG000|Combination Treatment|disease progression|10|||
23705123|NCT01419665|66297418|FG001|Combination Treatment|disease progression|9|||
23705124|NCT01419665|66297417|FG000|Combination Treatment|Death|5|||
23705125|NCT01419665|66297418|FG001|Combination Treatment|Death|7|||
23705126|NCT01419665|66297417|FG000|Combination Treatment|administrative problems|0|||
23705127|NCT01419665|66297418|FG001|Combination Treatment|administrative problems|1|||
23705128|NCT01419665|66297417|FG000|Combination Treatment|Withdrawal by Subject|5|||
23705129|NCT01419665|66297418|FG001|Combination Treatment|Withdrawal by Subject|4|||
23705130|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
23705131|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
23705132|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
23705133|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
23705134|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
23705135|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
23705136|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
23705137|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
23705138|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
23705139|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
23705140|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
23705141|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
23705142|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Death|1|||
23705143|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Death|2|||
23705144|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
23705145|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
23705146|NCT01419665|66297417|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
23705147|NCT01419665|66297418|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
23705148|NCT01419665|66297417|FG000|Open Label Phase|Death|1|||
23705149|NCT01419665|66297418|FG001|Open Label Phase|Death|0|||
23705150|NCT01419665|66297417|FG000|Open Label Phase|disease progression|0|||
23705151|NCT01419665|66297418|FG001|Open Label Phase|disease progression|1|||
23705152|NCT00406640|66297426|FG000|Acute Phase|Adverse Event|18|||
23705153|NCT00406640|66297427|FG001|Acute Phase|Adverse Event|13|||
23705154|NCT00406640|66297426|FG000|Acute Phase|Failed to Return|5|||
23705155|NCT00406640|66297427|FG001|Acute Phase|Failed to Return|1|||
23705156|NCT00406640|66297426|FG000|Acute Phase|Physician Decision|0|||
23705157|NCT00406640|66297427|FG001|Acute Phase|Physician Decision|1|||
23705158|NCT00406640|66297426|FG000|Acute Phase|Lost to Follow-up|7|||
23705159|NCT00406640|66297427|FG001|Acute Phase|Lost to Follow-up|4|||
23705160|NCT00406640|66297426|FG000|Acute Phase|Protocol deviation|4|||
23705161|NCT00406640|66297427|FG001|Acute Phase|Protocol deviation|10|||
23705162|NCT00406640|66297426|FG000|Acute Phase|Protocol Violation|3|||
23705163|NCT00406640|66297427|FG001|Acute Phase|Protocol Violation|2|||
23705164|NCT00406640|66297426|FG000|Acute Phase|Withdrawal by Subject|11|||
23705165|NCT00406640|66297427|FG001|Acute Phase|Withdrawal by Subject|9|||
23705166|NCT00406640|66297426|FG000|Acute Phase|Lack of Efficacy|3|||
23705167|NCT00406640|66297427|FG001|Acute Phase|Lack of Efficacy|3|||
23705168|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
23705169|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
23705170|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Death|1|||
23705171|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Death|0|||
23705172|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
23705173|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
23705174|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
23705175|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
23400348|NCT02114177|65214077|FG000|Overall Study|Withdrawal by Subject|6|||
23400349|NCT02114177|65214078|FG001|Overall Study|Withdrawal by Subject|1|||
23400350|NCT02114177|65214077|FG000|Overall Study|Other|2|||
23400351|NCT02114177|65214078|FG001|Overall Study|Other|1|||
23400352|NCT03768427|65214079|FG000|Overall Study|Death|0|||
23400353|NCT03768427|65214080|FG001|Overall Study|Death|0|||
23400354|NCT03768427|65214081|FG002|Overall Study|Death|1|||
23400355|NCT03768427|65214082|FG003|Overall Study|Death|0|||
23400356|NCT03768427|65214079|FG000|Overall Study|Lost to Follow-up|2|||
23400357|NCT03768427|65214080|FG001|Overall Study|Lost to Follow-up|0|||
23400358|NCT03768427|65214081|FG002|Overall Study|Lost to Follow-up|0|||
23400359|NCT03768427|65214082|FG003|Overall Study|Lost to Follow-up|0|||
23400360|NCT03768427|65214079|FG000|Overall Study|Physician Decision|3|||
23400361|NCT03768427|65214080|FG001|Overall Study|Physician Decision|2|||
23400362|NCT03768427|65214081|FG002|Overall Study|Physician Decision|4|||
23400363|NCT03768427|65214082|FG003|Overall Study|Physician Decision|4|||
23400364|NCT03768427|65214079|FG000|Overall Study|Withdrawal by Subject|7|||
23400365|NCT03768427|65214080|FG001|Overall Study|Withdrawal by Subject|2|||
23400366|NCT03768427|65214081|FG002|Overall Study|Withdrawal by Subject|6|||
23400367|NCT03768427|65214082|FG003|Overall Study|Withdrawal by Subject|7|||
23400368|NCT01822925|65214083|FG000|Overall Study|Adverse Event|1|||
23400369|NCT01822925|65214084|FG001|Overall Study|Adverse Event|1|||
23400370|NCT01822925|65214085|FG002|Overall Study|Adverse Event|1|||
23400371|NCT01822925|65214086|FG003|Overall Study|Adverse Event|1|||
23400372|NCT01822925|65214083|FG000|Overall Study|Lost to Follow-up|0|||
23400373|NCT01822925|65214084|FG001|Overall Study|Lost to Follow-up|1|||
23400374|NCT01822925|65214085|FG002|Overall Study|Lost to Follow-up|0|||
23400375|NCT01822925|65214086|FG003|Overall Study|Lost to Follow-up|0|||
23400376|NCT01822925|65214083|FG000|Overall Study|Protocol Violation|1|||
23400377|NCT01822925|65214084|FG001|Overall Study|Protocol Violation|0|||
23400378|NCT01822925|65214085|FG002|Overall Study|Protocol Violation|0|||
23400379|NCT01822925|65214086|FG003|Overall Study|Protocol Violation|1|||
23400380|NCT01822925|65214083|FG000|Overall Study|Withdrawal by Subject|2|||
23400381|NCT01822925|65214084|FG001|Overall Study|Withdrawal by Subject|0|||
23400382|NCT01822925|65214085|FG002|Overall Study|Withdrawal by Subject|2|||
23400383|NCT01822925|65214086|FG003|Overall Study|Withdrawal by Subject|2|||
23400384|NCT01822925|65214083|FG000|Overall Study|Taking prohibited medication|2|||
23400385|NCT01822925|65214084|FG001|Overall Study|Taking prohibited medication|0|||
23400386|NCT01822925|65214085|FG002|Overall Study|Taking prohibited medication|0|||
23400387|NCT01822925|65214086|FG003|Overall Study|Taking prohibited medication|1|||
23400388|NCT01029535|65214091|FG000|Overall Study|Lost to Follow-up|24|||
23400389|NCT01029535|65214091|FG000|Overall Study|Protocol Violation|2|||
23400390|NCT01029535|65214091|FG000|Overall Study|Participant Withdrew Consent|2|||
23400391|NCT01029535|65214091|FG000|Overall Study|Adverse Event|1|||
23400392|NCT01029535|65214091|FG000|Overall Study|Use of Another Treatment|1|||
23400393|NCT01029535|65214091|FG000|Overall Study|Death|1|||
23400394|NCT02379052|65214092|FG000|Overall Study|Protocol Violation|0|||
23400395|NCT02379052|65214093|FG001|Overall Study|Protocol Violation|1|||
23400396|NCT02379052|65214092|FG000|Overall Study|Adverse Event|0|||
23400397|NCT02379052|65214093|FG001|Overall Study|Adverse Event|1|||
23400398|NCT02379052|65214092|FG000|Overall Study|Physician Decision|1|||
23400399|NCT02379052|65214093|FG001|Overall Study|Physician Decision|1|||
23400400|NCT02379052|65214092|FG000|Overall Study|Withdrawal by Subject|2|||
23400401|NCT02379052|65214093|FG001|Overall Study|Withdrawal by Subject|0|||
23400402|NCT02379052|65214092|FG000|Overall Study|Lost to Follow-up|2|||
23400403|NCT02379052|65214093|FG001|Overall Study|Lost to Follow-up|1|||
23400404|NCT02379052|65214092|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
23400405|NCT02379052|65214093|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
23400406|NCT02379052|65214092|FG000|Overall Study|Subject was Incarcerated|0|||
23400407|NCT02379052|65214093|FG001|Overall Study|Subject was Incarcerated|1|||
23400408|NCT02329743|65214094|FG000|Overall Study|Adverse Event|1|||
23400409|NCT02329743|65214095|FG001|Overall Study|Adverse Event|1|||
23400410|NCT02329743|65214096|FG002|Overall Study|Adverse Event|3|||
23400411|NCT02329743|65214094|FG000|Overall Study|Lost to Follow-up|1|||
23400412|NCT02329743|65214095|FG001|Overall Study|Lost to Follow-up|0|||
23400413|NCT02329743|65214096|FG002|Overall Study|Lost to Follow-up|1|||
23400414|NCT02329743|65214094|FG000|Overall Study|Withdrawal by Subject|4|||
23400415|NCT02329743|65214095|FG001|Overall Study|Withdrawal by Subject|4|||
23400416|NCT02329743|65214096|FG002|Overall Study|Withdrawal by Subject|1|||
23400417|NCT02329743|65214094|FG000|Overall Study|Other|0|||
23400418|NCT02329743|65214095|FG001|Overall Study|Other|2|||
23400419|NCT02329743|65214096|FG002|Overall Study|Other|3|||
23400420|NCT01812057|65214097|FG000|Overall Study|Protocol Violation|1|||
23400421|NCT01812057|65214098|FG001|Overall Study|Protocol Violation|0|||
23400422|NCT01812057|65214097|FG000|Overall Study|Physician Decision|1|||
23400423|NCT01812057|65214098|FG001|Overall Study|Physician Decision|0|||
23400424|NCT00329030|65214099|FG000|Overall Study|Withdrawal by Subject|1|||
23400425|NCT00329030|65214100|FG001|Overall Study|Withdrawal by Subject|3|||
23400426|NCT00329030|65214099|FG000|Overall Study|Progressive Disease|6|||
23400427|NCT00329030|65214100|FG001|Overall Study|Progressive Disease|2|||
23400428|NCT00329030|65214099|FG000|Overall Study|Ineligible Pathology|1|||
23400429|NCT00329030|65214100|FG001|Overall Study|Ineligible Pathology|1|||
23400430|NCT02296476|65214101|FG000|Overall Study|Disease Progression|6|||
23400431|NCT02296476|65214102|FG001|Overall Study|Disease Progression|4|||
23400432|NCT02296476|65214103|FG002|Overall Study|Disease Progression|2|||
23400433|NCT01644643|65214104|FG000|Overall Study|Death|1|||
23400434|NCT01644643|65214105|FG001|Overall Study|Death|0|||
23400435|NCT01644643|65214106|FG002|Overall Study|Death|3|||
23400436|NCT01644643|65214107|FG003|Overall Study|Death|3|||
23400437|NCT01644643|65214104|FG000|Overall Study|Lost to Follow-up|0|||
23400438|NCT01644643|65214105|FG001|Overall Study|Lost to Follow-up|0|||
23400439|NCT01644643|65214106|FG002|Overall Study|Lost to Follow-up|0|||
23400440|NCT01644643|65214107|FG003|Overall Study|Lost to Follow-up|4|||
23400441|NCT01644643|65214104|FG000|Overall Study|Withdrawal by Subject|1|||
23400442|NCT01644643|65214105|FG001|Overall Study|Withdrawal by Subject|0|||
23400443|NCT01644643|65214106|FG002|Overall Study|Withdrawal by Subject|2|||
23400444|NCT01644643|65214107|FG003|Overall Study|Withdrawal by Subject|1|||
23400445|NCT01644643|65214104|FG000|Overall Study|Other Eligibility criteria|0|||
23400446|NCT01644643|65214105|FG001|Overall Study|Other Eligibility criteria|0|||
23400447|NCT01644643|65214106|FG002|Overall Study|Other Eligibility criteria|0|||
23400448|NCT01644643|65214107|FG003|Overall Study|Other Eligibility criteria|2|||
23400449|NCT03545672|65214108|FG000|Overall Study|Uncertain diagnosis|2|||
23400450|NCT03545672|65214109|FG001|Overall Study|Uncertain diagnosis|1|||
23400451|NCT03545672|65214108|FG000|Overall Study|Protocol Violation|2|||
23400452|NCT03545672|65214109|FG001|Overall Study|Protocol Violation|2|||
23400453|NCT02750514|65214112|FG000|Track 1|Disease progression|20|||
23400454|NCT02750514|65214113|FG001|Track 1|Disease progression|1|||
23400455|NCT02750514|65214114|FG002|Track 1|Disease progression|0|||
23400456|NCT02750514|65214115|FG003|Track 1|Disease progression|1|||
23400457|NCT02750514|65214116|FG004|Track 1|Disease progression|0|||
23400458|NCT02750514|65214112|FG000|Track 1|Adverse event unrelated to study drug|1|||
23400459|NCT02750514|65214113|FG001|Track 1|Adverse event unrelated to study drug|0|||
23400460|NCT02750514|65214114|FG002|Track 1|Adverse event unrelated to study drug|0|||
23400461|NCT02750514|65214115|FG003|Track 1|Adverse event unrelated to study drug|0|||
23400462|NCT02750514|65214116|FG004|Track 1|Adverse event unrelated to study drug|0|||
23400463|NCT02750514|65214112|FG000|Track 1|Study drug toxicity|4|||
23400464|NCT02750514|65214113|FG001|Track 1|Study drug toxicity|1|||
23400465|NCT02750514|65214114|FG002|Track 1|Study drug toxicity|0|||
23400466|NCT02750514|65214115|FG003|Track 1|Study drug toxicity|1|||
23400467|NCT02750514|65214116|FG004|Track 1|Study drug toxicity|0|||
23400468|NCT02750514|65214112|FG000|Track 1|Participant request to discontinue|1|||
23400469|NCT02750514|65214113|FG001|Track 1|Participant request to discontinue|0|||
23400470|NCT02750514|65214114|FG002|Track 1|Participant request to discontinue|0|||
23400471|NCT02750514|65214115|FG003|Track 1|Participant request to discontinue|0|||
23400472|NCT02750514|65214116|FG004|Track 1|Participant request to discontinue|0|||
23400473|NCT02750514|65214112|FG000|Track 1|Other reasons|1|||
23400474|NCT02750514|65214113|FG001|Track 1|Other reasons|0|||
23400475|NCT02750514|65214114|FG002|Track 1|Other reasons|0|||
23400476|NCT02750514|65214115|FG003|Track 1|Other reasons|0|||
23400477|NCT02750514|65214116|FG004|Track 1|Other reasons|0|||
23400478|NCT02750514|65214112|FG000|Track 2|Disease progression|4|||
23400479|NCT02750514|65214113|FG001|Track 2|Disease progression|5|||
23400480|NCT02750514|65214114|FG002|Track 2|Disease progression|2|||
23400481|NCT02750514|65214115|FG003|Track 2|Disease progression|5|||
23400482|NCT02750514|65214116|FG004|Track 2|Disease progression|0|||
23400483|NCT02750514|65214112|FG000|Track 2|Adverse event unrelated to study drug|1|||
23400484|NCT02750514|65214113|FG001|Track 2|Adverse event unrelated to study drug|0|||
23400485|NCT02750514|65214114|FG002|Track 2|Adverse event unrelated to study drug|0|||
23400486|NCT02750514|65214115|FG003|Track 2|Adverse event unrelated to study drug|0|||
23400487|NCT02750514|65214116|FG004|Track 2|Adverse event unrelated to study drug|0|||
23400488|NCT02750514|65214112|FG000|Track 2|Study drug toxicity|1|||
23400489|NCT02750514|65214113|FG001|Track 2|Study drug toxicity|2|||
23400490|NCT02750514|65214114|FG002|Track 2|Study drug toxicity|0|||
23400491|NCT02750514|65214115|FG003|Track 2|Study drug toxicity|2|||
23400492|NCT02750514|65214116|FG004|Track 2|Study drug toxicity|0|||
23400493|NCT02750514|65214112|FG000|Track 2|Participant withdrew consent|0|||
23400494|NCT02750514|65214113|FG001|Track 2|Participant withdrew consent|1|||
23400495|NCT02750514|65214114|FG002|Track 2|Participant withdrew consent|0|||
23400496|NCT02750514|65214115|FG003|Track 2|Participant withdrew consent|0|||
23400497|NCT02750514|65214116|FG004|Track 2|Participant withdrew consent|0|||
23400498|NCT02750514|65214112|FG000|Track 3|Disease progression|0|||
23400499|NCT02750514|65214113|FG001|Track 3|Disease progression|24|||
23400500|NCT02750514|65214114|FG002|Track 3|Disease progression|13|||
23400501|NCT02750514|65214115|FG003|Track 3|Disease progression|14|||
23400502|NCT02750514|65214116|FG004|Track 3|Disease progression|0|||
23400503|NCT02750514|65214112|FG000|Track 3|Adverse event unrelated to study drug|0|||
23400504|NCT02750514|65214113|FG001|Track 3|Adverse event unrelated to study drug|1|||
23400505|NCT02750514|65214114|FG002|Track 3|Adverse event unrelated to study drug|1|||
23400506|NCT02750514|65214115|FG003|Track 3|Adverse event unrelated to study drug|1|||
23400507|NCT02750514|65214116|FG004|Track 3|Adverse event unrelated to study drug|0|||
23400508|NCT02750514|65214112|FG000|Track 3|Study drug toxicity|0|||
23400509|NCT02750514|65214113|FG001|Track 3|Study drug toxicity|3|||
23400510|NCT02750514|65214114|FG002|Track 3|Study drug toxicity|0|||
23400511|NCT02750514|65214115|FG003|Track 3|Study drug toxicity|1|||
23400512|NCT02750514|65214116|FG004|Track 3|Study drug toxicity|0|||
23400513|NCT02750514|65214112|FG000|Track 3|Participant request to discontinue|0|||
23400514|NCT02750514|65214113|FG001|Track 3|Participant request to discontinue|2|||
23400515|NCT02750514|65214114|FG002|Track 3|Participant request to discontinue|0|||
23400516|NCT02750514|65214115|FG003|Track 3|Participant request to discontinue|0|||
23400517|NCT02750514|65214116|FG004|Track 3|Participant request to discontinue|0|||
23400518|NCT02750514|65214112|FG000|Track 3|Participant withdrew consent|0|||
23400519|NCT02750514|65214113|FG001|Track 3|Participant withdrew consent|3|||
23400520|NCT02750514|65214114|FG002|Track 3|Participant withdrew consent|1|||
23400521|NCT02750514|65214115|FG003|Track 3|Participant withdrew consent|0|||
23400522|NCT02750514|65214116|FG004|Track 3|Participant withdrew consent|0|||
23400523|NCT02750514|65214112|FG000|Track 3|Other reasons|0|||
23400524|NCT02750514|65214113|FG001|Track 3|Other reasons|3|||
23400525|NCT02750514|65214114|FG002|Track 3|Other reasons|0|||
23400526|NCT02750514|65214115|FG003|Track 3|Other reasons|0|||
23400527|NCT02750514|65214116|FG004|Track 3|Other reasons|0|||
23400528|NCT02750514|65214112|FG000|Track 4|Study drug toxicity|0|||
23400529|NCT02750514|65214113|FG001|Track 4|Study drug toxicity|6|||
23400530|NCT02750514|65214114|FG002|Track 4|Study drug toxicity|0|||
23400531|NCT02750514|65214115|FG003|Track 4|Study drug toxicity|5|||
23400532|NCT02750514|65214116|FG004|Track 4|Study drug toxicity|0|||
23400533|NCT02750514|65214112|FG000|Track 4|Participant request to discontinue|0|||
23400534|NCT02750514|65214113|FG001|Track 4|Participant request to discontinue|1|||
23400535|NCT02750514|65214114|FG002|Track 4|Participant request to discontinue|0|||
23400536|NCT02750514|65214115|FG003|Track 4|Participant request to discontinue|1|||
23400537|NCT02750514|65214116|FG004|Track 4|Participant request to discontinue|0|||
23400538|NCT02750514|65214112|FG000|Track 4|Participant withdrew consent|0|||
23400539|NCT02750514|65214113|FG001|Track 4|Participant withdrew consent|1|||
23400540|NCT02750514|65214114|FG002|Track 4|Participant withdrew consent|0|||
23400541|NCT02750514|65214115|FG003|Track 4|Participant withdrew consent|0|||
23400542|NCT02750514|65214116|FG004|Track 4|Participant withdrew consent|0|||
23400543|NCT02750514|65214112|FG000|Track 4|Other reasons|0|||
23400544|NCT02750514|65214113|FG001|Track 4|Other reasons|5|||
23400545|NCT02750514|65214114|FG002|Track 4|Other reasons|0|||
23400546|NCT02750514|65214115|FG003|Track 4|Other reasons|3|||
23400547|NCT02750514|65214116|FG004|Track 4|Other reasons|0|||
23400548|NCT02750514|65214112|FG000|Track 4|Disease progression|0|||
23400549|NCT02750514|65214113|FG001|Track 4|Disease progression|33|||
23400550|NCT02750514|65214114|FG002|Track 4|Disease progression|0|||
23400551|NCT02750514|65214115|FG003|Track 4|Disease progression|32|||
23400552|NCT02750514|65214116|FG004|Track 4|Disease progression|0|||
23400553|NCT02750514|65214112|FG000|Track 4|Adverse event unrelated to study drug|0|||
23400554|NCT02750514|65214113|FG001|Track 4|Adverse event unrelated to study drug|5|||
23400555|NCT02750514|65214114|FG002|Track 4|Adverse event unrelated to study drug|0|||
23400556|NCT02750514|65214115|FG003|Track 4|Adverse event unrelated to study drug|0|||
23400557|NCT02750514|65214116|FG004|Track 4|Adverse event unrelated to study drug|0|||
23400558|NCT02750514|65214112|FG000|Track 4|Death|0|||
23400559|NCT02750514|65214113|FG001|Track 4|Death|0|||
23400560|NCT02750514|65214114|FG002|Track 4|Death|0|||
23400561|NCT02750514|65214115|FG003|Track 4|Death|1|||
23400562|NCT02750514|65214116|FG004|Track 4|Death|0|||
23400563|NCT02750514|65214112|FG000|Track 5|Disease progression|0|||
23400564|NCT02750514|65214113|FG001|Track 5|Disease progression|0|||
23400565|NCT02750514|65214114|FG002|Track 5|Disease progression|0|||
23400566|NCT02750514|65214115|FG003|Track 5|Disease progression|0|||
23400567|NCT02750514|65214116|FG004|Track 5|Disease progression|34|||
23400568|NCT02750514|65214112|FG000|Track 5|Adverse event unrelated to study drug|0|||
23400569|NCT02750514|65214113|FG001|Track 5|Adverse event unrelated to study drug|0|||
23400570|NCT02750514|65214114|FG002|Track 5|Adverse event unrelated to study drug|0|||
23400571|NCT02750514|65214115|FG003|Track 5|Adverse event unrelated to study drug|0|||
23400572|NCT02750514|65214116|FG004|Track 5|Adverse event unrelated to study drug|2|||
23400573|NCT02750514|65214112|FG000|Track 5|Study drug toxicity|0|||
23400574|NCT02750514|65214113|FG001|Track 5|Study drug toxicity|0|||
23400575|NCT02750514|65214114|FG002|Track 5|Study drug toxicity|0|||
23400576|NCT02750514|65214115|FG003|Track 5|Study drug toxicity|0|||
23400577|NCT02750514|65214116|FG004|Track 5|Study drug toxicity|2|||
23400578|NCT02750514|65214112|FG000|Track 5|Participant request to discontinue|0|||
23400579|NCT02750514|65214113|FG001|Track 5|Participant request to discontinue|0|||
23400580|NCT02750514|65214114|FG002|Track 5|Participant request to discontinue|0|||
23400581|NCT02750514|65214115|FG003|Track 5|Participant request to discontinue|0|||
23400582|NCT02750514|65214116|FG004|Track 5|Participant request to discontinue|3|||
23400583|NCT02750514|65214112|FG000|Track 5|Other reasons|0|||
23400584|NCT02750514|65214113|FG001|Track 5|Other reasons|0|||
23400585|NCT02750514|65214114|FG002|Track 5|Other reasons|0|||
23400586|NCT02750514|65214115|FG003|Track 5|Other reasons|0|||
23400587|NCT02750514|65214116|FG004|Track 5|Other reasons|2|||
23400588|NCT00110214|65214122|FG000|Overall Study|Never started treatment|21|||
23400589|NCT00110214|65214123|FG001|Overall Study|Never started treatment|20|||
23400590|NCT00110214|65214122|FG000|Overall Study|Disease progression or death|260|||
23400591|NCT00110214|65214123|FG001|Overall Study|Disease progression or death|151|||
23400592|NCT00110214|65214122|FG000|Overall Study|Adverse Event|115|||
23400593|NCT00110214|65214123|FG001|Overall Study|Adverse Event|192|||
23400594|NCT00110214|65214122|FG000|Overall Study|Refused further treatment|52|||
23400595|NCT00110214|65214123|FG001|Overall Study|Refused further treatment|65|||
23400596|NCT00110214|65214122|FG000|Overall Study|Other (not specified)|61|||
23400597|NCT00110214|65214123|FG001|Overall Study|Other (not specified)|75|||
23400598|NCT00442702|65214126|FG000|Titration Period|Adverse Event|2|||
23400599|NCT00442702|65214127|FG001|Titration Period|Adverse Event|0|||
23400600|NCT00442702|65214126|FG000|Titration Period|Death|3|||
23400601|NCT00442702|65214127|FG001|Titration Period|Death|2|||
23400602|NCT00442702|65214126|FG000|Titration Period|Insufficient Therapeutic Response|1|||
23400603|NCT00442702|65214127|FG001|Titration Period|Insufficient Therapeutic Response|0|||
23400604|NCT00442702|65214126|FG000|Titration Period|Refused Treatment|4|||
23400605|NCT00442702|65214127|FG001|Titration Period|Refused Treatment|1|||
23400606|NCT00442702|65214126|FG000|Titration Period|Failure to return|1|||
23400607|NCT00442702|65214127|FG001|Titration Period|Failure to return|0|||
23400608|NCT00442702|65214126|FG000|Titration Period|Hospitalized in another hospital|1|||
23400609|NCT00442702|65214127|FG001|Titration Period|Hospitalized in another hospital|0|||
23400610|NCT00442702|65214126|FG000|Evaluation Period|Adverse Event|1|||
23400611|NCT00442702|65214127|FG001|Evaluation Period|Adverse Event|0|||
23400612|NCT00442702|65214126|FG000|Evaluation Period|Death|1|||
23400613|NCT00442702|65214127|FG001|Evaluation Period|Death|1|||
23400614|NCT00442702|65214126|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
23400615|NCT00442702|65214127|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
23400616|NCT00442702|65214126|FG000|Evaluation Period|Refused treatment|1|||
23400617|NCT00442702|65214127|FG001|Evaluation Period|Refused treatment|1|||
23400618|NCT00442702|65214126|FG000|Evaluation Period|Renal transplant|0|||
23400619|NCT00442702|65214127|FG001|Evaluation Period|Renal transplant|1|||
23400620|NCT00442702|65214126|FG000|Evaluation Period|Failure to return|1|||
23400621|NCT00442702|65214127|FG001|Evaluation Period|Failure to return|0|||
23400622|NCT00442702|65214126|FG000|Evaluation Period|Site closure|0|||
23400623|NCT00442702|65214127|FG001|Evaluation Period|Site closure|1|||
23400624|NCT02505425|65214128|FG000|Overall Study|Lost to Follow-up|41|||
23400625|NCT02505425|65214129|FG001|Overall Study|Lost to Follow-up|61|||
23400626|NCT02505425|65214130|FG002|Overall Study|Lost to Follow-up|31|||
23400627|NCT02505425|65214131|FG003|Overall Study|Lost to Follow-up|19|||
23400628|NCT02505425|65214128|FG000|Overall Study|Withdrawal by Subject|39|||
23400629|NCT02505425|65214129|FG001|Overall Study|Withdrawal by Subject|9|||
23400630|NCT02505425|65214130|FG002|Overall Study|Withdrawal by Subject|19|||
23400631|NCT02505425|65214131|FG003|Overall Study|Withdrawal by Subject|7|||
23400632|NCT02505425|65214128|FG000|Overall Study|Death|8|||
23400633|NCT02505425|65214129|FG001|Overall Study|Death|12|||
23400634|NCT02505425|65214130|FG002|Overall Study|Death|0|||
23400635|NCT02505425|65214131|FG003|Overall Study|Death|0|||
23400636|NCT00920556|65214132|FG000|Overall Study|Adverse Event|16|||
23400637|NCT00920556|65214132|FG000|Overall Study|Physician Decision|7|||
23400638|NCT00920556|65214132|FG000|Overall Study|Withdrawal by Subject|1|||
23400639|NCT03423121|65214133|FG000|Overall Study|Lost to Follow-up|2|||
23400640|NCT03423121|65214134|FG001|Overall Study|Lost to Follow-up|6|||
23400641|NCT03423121|65214133|FG000|Overall Study|Adverse Event|1|||
23400642|NCT03423121|65214134|FG001|Overall Study|Adverse Event|0|||
23400643|NCT00100802|65214138|FG000|Overall Study|Adverse Event|9|||
23400644|NCT00100802|65214138|FG000|Overall Study|Death|1|||
23400645|NCT00100802|65214138|FG000|Overall Study|Lack of Efficacy|47|||
23400646|NCT00100802|65214138|FG000|Overall Study|Physician Decision|5|||
23400647|NCT00100802|65214138|FG000|Overall Study|Protocol Violation|1|||
23400648|NCT00100802|65214138|FG000|Overall Study|Withdrawal by Subject|5|||
23400649|NCT00100802|65214138|FG000|Overall Study|Ineligible|12|||
23400650|NCT01822665|65214142|FG000|Overall Study|Adverse Event|3|||
23400651|NCT01822665|65214142|FG000|Overall Study|Other Reason|5|||
23400652|NCT03213509|65214143|FG000|Overall Study|Did not consent for verbal autopsy|4|||
23400653|NCT03213509|65214144|FG001|Overall Study|Did not consent for verbal autopsy|5|||
23400654|NCT01374425|65214147|FG000|Overall Study|Radiographic Disease Progression|86|||
23400655|NCT01374425|65214148|FG001|Overall Study|Radiographic Disease Progression|81|||
23400656|NCT01374425|65214147|FG000|Overall Study|Clinical Disease Progression|9|||
23400657|NCT01374425|65214148|FG001|Overall Study|Clinical Disease Progression|6|||
23400658|NCT01374425|65214147|FG000|Overall Study|Adverse Event|29|||
23400659|NCT01374425|65214148|FG001|Overall Study|Adverse Event|18|||
23400660|NCT01374425|65214147|FG000|Overall Study|Death (Progression of Disease)|1|||
23400661|NCT01374425|65214148|FG001|Overall Study|Death (Progression of Disease)|0|||
23400662|NCT01374425|65214147|FG000|Overall Study|Death (Adverse Event)|2|||
23400663|NCT01374425|65214148|FG001|Overall Study|Death (Adverse Event)|4|||
23400664|NCT01374425|65214147|FG000|Overall Study|Withdrawal by Subject|6|||
23400665|NCT01374425|65214148|FG001|Overall Study|Withdrawal by Subject|7|||
23400666|NCT01374425|65214147|FG000|Overall Study|Refused Treatment|10|||
23400667|NCT01374425|65214148|FG001|Overall Study|Refused Treatment|24|||
23400668|NCT01374425|65214147|FG000|Overall Study|Protocol Violation|2|||
23400669|NCT01374425|65214148|FG001|Overall Study|Protocol Violation|3|||
23400670|NCT01374425|65214147|FG000|Overall Study|Sponsor Decision|0|||
23400671|NCT01374425|65214148|FG001|Overall Study|Sponsor Decision|1|||
23400672|NCT01374425|65214147|FG000|Overall Study|Lost to Follow-up|2|||
23400673|NCT01374425|65214148|FG001|Overall Study|Lost to Follow-up|1|||
23400674|NCT01374425|65214147|FG000|Overall Study|Other|41|||
23400675|NCT01374425|65214148|FG001|Overall Study|Other|43|||
23400676|NCT01242514|65214149|FG000|Overall Study|e.g., project closure|1042|||
23400677|NCT01242514|65214150|FG001|Overall Study|e.g., project closure|305|||
23400678|NCT01242514|65214151|FG002|Overall Study|e.g., project closure|171|||
23400679|NCT01242514|65214149|FG000|Overall Study|Subject decision|33|||
23400680|NCT01242514|65214150|FG001|Overall Study|Subject decision|8|||
23400681|NCT01242514|65214151|FG002|Overall Study|Subject decision|2|||
23400682|NCT01242514|65214149|FG000|Overall Study|Severe non-compliance to protocol|5|||
23400683|NCT01242514|65214150|FG001|Overall Study|Severe non-compliance to protocol|2|||
23400684|NCT01242514|65214151|FG002|Overall Study|Severe non-compliance to protocol|1|||
23400685|NCT01242514|65214149|FG000|Overall Study|Lack of therapeutic response|99|||
23400686|NCT01242514|65214150|FG001|Overall Study|Lack of therapeutic response|16|||
23400687|NCT01242514|65214151|FG002|Overall Study|Lack of therapeutic response|10|||
23400688|NCT01242514|65214149|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
23400689|NCT01242514|65214150|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
23400690|NCT01242514|65214151|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
23400691|NCT01242514|65214149|FG000|Overall Study|Lost to Follow-up|14|||
23400692|NCT01242514|65214150|FG001|Overall Study|Lost to Follow-up|5|||
23400693|NCT01242514|65214151|FG002|Overall Study|Lost to Follow-up|4|||
23400694|NCT01242514|65214149|FG000|Overall Study|Adverse Event|129|||
23400695|NCT01242514|65214150|FG001|Overall Study|Adverse Event|18|||
23400696|NCT01242514|65214151|FG002|Overall Study|Adverse Event|19|||
23400697|NCT00069641|65214152|FG000|Overall Study|Death|1|||
23400698|NCT00069641|65214153|FG001|Overall Study|Death|0|||
23400699|NCT00069641|65214154|FG002|Overall Study|Death|1|||
23400700|NCT02170064|65214165|FG000|Overall Study|Withdrawal by Subject|5|||
23400701|NCT02170064|65214166|FG001|Overall Study|Withdrawal by Subject|1|||
23400702|NCT02170064|65214167|FG002|Overall Study|Withdrawal by Subject|1|||
23400703|NCT02170064|65214165|FG000|Overall Study|Physician Decision|1|||
23400704|NCT02170064|65214166|FG001|Overall Study|Physician Decision|1|||
23400705|NCT02170064|65214167|FG002|Overall Study|Physician Decision|0|||
23400706|NCT02239926|65214169|FG000|Overall Study|Withdrawal by Subject|0|||
23400707|NCT02239926|65214170|FG001|Overall Study|Withdrawal by Subject|1|||
23400708|NCT01870869|65214171|FG000|Overall Study|Implanted with nonstudy device|1|||
23400709|NCT01870869|65214172|FG001|Overall Study|Implanted with nonstudy device|3|||
23400710|NCT01870869|65214173|FG002|Overall Study|Implanted with nonstudy device|14|||
23400711|NCT01870869|65214174|FG003|Overall Study|Implanted with nonstudy device|4|||
23400712|NCT01870869|65214171|FG000|Overall Study|Death|0|||
23400713|NCT01870869|65214172|FG001|Overall Study|Death|0|||
23400714|NCT01870869|65214173|FG002|Overall Study|Death|7|||
23400715|NCT01870869|65214174|FG003|Overall Study|Death|1|||
23400716|NCT01870869|65214171|FG000|Overall Study|Subject choice|6|||
23400717|NCT01870869|65214172|FG001|Overall Study|Subject choice|2|||
23400718|NCT01870869|65214173|FG002|Overall Study|Subject choice|22|||
23400719|NCT01870869|65214174|FG003|Overall Study|Subject choice|8|||
23400720|NCT01870869|65214171|FG000|Overall Study|Lost to Follow-up|10|||
23400721|NCT01870869|65214172|FG001|Overall Study|Lost to Follow-up|2|||
23400722|NCT01870869|65214173|FG002|Overall Study|Lost to Follow-up|25|||
23400723|NCT01870869|65214174|FG003|Overall Study|Lost to Follow-up|3|||
23400724|NCT01870869|65214171|FG000|Overall Study|Reason not Specified|1|||
23400725|NCT01870869|65214172|FG001|Overall Study|Reason not Specified|2|||
23400726|NCT01870869|65214173|FG002|Overall Study|Reason not Specified|20|||
23400727|NCT01870869|65214174|FG003|Overall Study|Reason not Specified|4|||
23400728|NCT01870869|65214171|FG000|Overall Study|Not evaluable|10|||
23400729|NCT01870869|65214172|FG001|Overall Study|Not evaluable|5|||
23400730|NCT01870869|65214173|FG002|Overall Study|Not evaluable|42|||
23400731|NCT01870869|65214174|FG003|Overall Study|Not evaluable|10|||
23400732|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
23400733|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
23400734|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
23400735|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
23400736|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
23400737|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
23400738|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
23400739|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
23400740|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
23400741|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
23400742|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
23400743|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
23400744|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
23400745|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
23400746|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
23400747|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
23400748|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
23400749|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
23400750|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
23400751|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
23400752|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
23400753|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
23400754|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
23400755|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
23400756|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
23400757|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
23400758|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
23400759|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
23400760|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
23400761|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
23400762|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
23400763|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
23400764|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
23400765|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
23400766|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
23400767|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
23400768|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
23400769|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
23400770|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
23400771|NCT01979614|65214178|FG000|Overall Study|Adverse Event|1|||
23400772|NCT01979614|65214179|FG001|Overall Study|Adverse Event|1|||
23400773|NCT01783444|65214185|FG000|Treatment Phase|Adverse Event|9|||
23400774|NCT01783444|65214186|FG001|Treatment Phase|Adverse Event|20|||
23400775|NCT01783444|65214187|FG002|Treatment Phase|Adverse Event|19|||
23400776|NCT01783444|65214185|FG000|Treatment Phase|Disease Progression|76|||
23400777|NCT01783444|65214186|FG001|Treatment Phase|Disease Progression|66|||
23400778|NCT01783444|65214187|FG002|Treatment Phase|Disease Progression|64|||
23400779|NCT01783444|65214185|FG000|Treatment Phase|Death|2|||
23400780|NCT01783444|65214186|FG001|Treatment Phase|Death|2|||
23400781|NCT01783444|65214187|FG002|Treatment Phase|Death|2|||
23400782|NCT01783444|65214185|FG000|Treatment Phase|Protocol Violation|1|||
23400783|NCT01783444|65214186|FG001|Treatment Phase|Protocol Violation|1|||
23400784|NCT01783444|65214187|FG002|Treatment Phase|Protocol Violation|2|||
23400785|NCT01783444|65214185|FG000|Treatment Phase|Withdrawal by Subject|6|||
23400786|NCT01783444|65214186|FG001|Treatment Phase|Withdrawal by Subject|8|||
23400787|NCT01783444|65214187|FG002|Treatment Phase|Withdrawal by Subject|9|||
23400788|NCT01783444|65214185|FG000|Treatment Phase|Administrative problems|2|||
23400789|NCT01783444|65214186|FG001|Treatment Phase|Administrative problems|0|||
23400790|NCT01783444|65214187|FG002|Treatment Phase|Administrative problems|1|||
23400791|NCT01783444|65214185|FG000|Treatment Phase|Physician Decision|8|||
23400792|NCT01783444|65214186|FG001|Treatment Phase|Physician Decision|6|||
23400793|NCT01783444|65214187|FG002|Treatment Phase|Physician Decision|5|||
23400794|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
23400795|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
23400796|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
23400797|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
23400798|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
23400799|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
23400800|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
23400801|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
23400802|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
23400803|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
23400804|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
23400805|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
23400806|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
23400807|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
23400808|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
23400809|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
23400810|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
23400811|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
23400812|NCT00976456|65214188|FG000|Overall Study|Adverse Event|17|||
23400813|NCT00976456|65214189|FG001|Overall Study|Adverse Event|22|||
23400814|NCT00976456|65214188|FG000|Overall Study|Death|7|||
23400815|NCT00976456|65214189|FG001|Overall Study|Death|9|||
23400816|NCT00976456|65214188|FG000|Overall Study|Lack of Efficacy|5|||
23400817|NCT00976456|65214189|FG001|Overall Study|Lack of Efficacy|2|||
23400818|NCT00976456|65214188|FG000|Overall Study|Withdrawal by Subject|3|||
23400819|NCT00976456|65214189|FG001|Overall Study|Withdrawal by Subject|1|||
23400820|NCT00976456|65214188|FG000|Overall Study|screening failure, unknown|11|||
23400821|NCT00976456|65214189|FG001|Overall Study|screening failure, unknown|4|||
23400822|NCT04102007|65214190|FG000|Overall Study|Adverse Event|4|||
23400823|NCT04102007|65214190|FG000|Overall Study|Lost to Follow-up|3|||
23400824|NCT04102007|65214190|FG000|Overall Study|Withdrawal by Subject|12|||
23400825|NCT04102007|65214190|FG000|Overall Study|Eligibility Violation|5|||
23400826|NCT04102007|65214190|FG000|Overall Study|Lack of Efficacy|6|||
23400827|NCT04102007|65214190|FG000|Overall Study|Protocol Deviation|5|||
23400828|NCT04102007|65214190|FG000|Overall Study|Protocol Compliance|1|||
23400829|NCT04102007|65214190|FG000|Overall Study|Withdrew Treatment|2|||
23400830|NCT04102007|65214190|FG000|Overall Study|Pregnancy|1|||
23400831|NCT02655887|65214196|FG000|Overall Study|Lost to Follow-up|3|||
23400832|NCT02655887|65214196|FG000|Overall Study|Death|4|||
23400833|NCT02655887|65214196|FG000|Overall Study|Withdrawal by Subject|3|||
23400834|NCT02655887|65214196|FG000|Overall Study|Missed 12-month follow-up visit|4|||
23400835|NCT01816295|65214200|FG000|Double Blind Phase|Adverse Event|11|||
23400836|NCT01816295|65214201|FG001|Double Blind Phase|Adverse Event|8|||
23400837|NCT01816295|65214200|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
23400838|NCT01816295|65214201|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
23400839|NCT01816295|65214200|FG000|Double Blind Phase|Lost to Follow-up|3|||
23400840|NCT01816295|65214201|FG001|Double Blind Phase|Lost to Follow-up|5|||
23400841|NCT01816295|65214200|FG000|Double Blind Phase|Physician Decision|2|||
23400842|NCT01816295|65214201|FG001|Double Blind Phase|Physician Decision|2|||
23400843|NCT01816295|65214200|FG000|Double Blind Phase|Protocol Violation|17|||
23400844|NCT01816295|65214201|FG001|Double Blind Phase|Protocol Violation|11|||
23400845|NCT01816295|65214200|FG000|Double Blind Phase|Sponsor Decision|8|||
23400846|NCT01816295|65214201|FG001|Double Blind Phase|Sponsor Decision|8|||
23400847|NCT01816295|65214200|FG000|Double Blind Phase|Withdrawal by Subject|22|||
23400848|NCT01816295|65214201|FG001|Double Blind Phase|Withdrawal by Subject|20|||
23400849|NCT01816295|65214200|FG000|OLE Phase|Adverse Event|17|||
23400850|NCT01816295|65214201|FG001|OLE Phase|Adverse Event|15|||
23400851|NCT01816295|65214200|FG000|OLE Phase|Death|1|||
23400852|NCT01816295|65214201|FG001|OLE Phase|Death|0|||
23400853|NCT01816295|65214200|FG000|OLE Phase|Entry Criteria Not Met|3|||
23400854|NCT01816295|65214201|FG001|OLE Phase|Entry Criteria Not Met|5|||
23400855|NCT01816295|65214200|FG000|OLE Phase|Lost to Follow-up|5|||
23400856|NCT01816295|65214201|FG001|OLE Phase|Lost to Follow-up|5|||
23400857|NCT01816295|65214200|FG000|OLE Phase|Physician Decision|3|||
23400858|NCT01816295|65214201|FG001|OLE Phase|Physician Decision|1|||
23400859|NCT01816295|65214200|FG000|OLE Phase|Protocol Violation|4|||
23400860|NCT01816295|65214201|FG001|OLE Phase|Protocol Violation|4|||
23400861|NCT01816295|65214200|FG000|OLE Phase|Sponsor Decision|7|||
23400862|NCT01816295|65214201|FG001|OLE Phase|Sponsor Decision|9|||
23400863|NCT01816295|65214200|FG000|OLE Phase|Withdrawal by Subject|10|||
23400864|NCT01816295|65214201|FG001|OLE Phase|Withdrawal by Subject|10|||
23400865|NCT01816295|65214200|FG000|OLE Phase|Lack of Efficacy|3|||
23400866|NCT01816295|65214201|FG001|OLE Phase|Lack of Efficacy|7|||
23400867|NCT01128569|65214204|FG000|Washout Period 1|Adverse Event|0|||
23400868|NCT01128569|65214205|FG001|Washout Period 1|Adverse Event|0|||
23400869|NCT01128569|65214206|FG002|Washout Period 1|Adverse Event|1|||
23400870|NCT01128569|65214207|FG003|Washout Period 1|Adverse Event|0|||
23400871|NCT01128569|65214208|FG004|Washout Period 1|Adverse Event|0|||
23400872|NCT01128569|65214209|FG005|Washout Period 1|Adverse Event|0|||
23400873|NCT01128569|65214204|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23400874|NCT01128569|65214205|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23400875|NCT01128569|65214206|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23400876|NCT01128569|65214207|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23400877|NCT01128569|65214208|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23400878|NCT01128569|65214209|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23400879|NCT01126190|65214212|FG000|Double-Blind Phase|Death|0|||
23400880|NCT01126190|65214213|FG001|Double-Blind Phase|Death|1|||
23400881|NCT01126190|65214214|FG002|Double-Blind Phase|Death|0|||
23400882|NCT01126190|65214212|FG000|Double-Blind Phase|Adverse Event|1|||
23400883|NCT01126190|65214213|FG001|Double-Blind Phase|Adverse Event|2|||
23400884|NCT01126190|65214214|FG002|Double-Blind Phase|Adverse Event|0|||
23400885|NCT01126190|65214212|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23400886|NCT01126190|65214213|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
23400887|NCT01126190|65214214|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23400888|NCT01126190|65214212|FG000|Double-Blind Phase|Request of Investigator|1|||
23400889|NCT01126190|65214213|FG001|Double-Blind Phase|Request of Investigator|0|||
23400890|NCT01126190|65214214|FG002|Double-Blind Phase|Request of Investigator|0|||
23400891|NCT01126190|65214212|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
23400892|NCT01126190|65214213|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
23400893|NCT01126190|65214214|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
23400894|NCT01126190|65214212|FG000|Double-Blind Phase|Non-compliance|1|||
23400895|NCT01126190|65214213|FG001|Double-Blind Phase|Non-compliance|0|||
23400896|NCT01126190|65214214|FG002|Double-Blind Phase|Non-compliance|0|||
23400897|NCT01126190|65214212|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23400898|NCT01126190|65214213|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23400899|NCT01126190|65214214|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23400900|NCT01126190|65214212|FG000|Open-Label Phase|Death|0|||
23400901|NCT01126190|65214213|FG001|Open-Label Phase|Death|0|||
23400902|NCT01126190|65214214|FG002|Open-Label Phase|Death|1|||
23400903|NCT01126190|65214212|FG000|Open-Label Phase|Adverse Event|0|||
23400904|NCT01126190|65214213|FG001|Open-Label Phase|Adverse Event|0|||
23400905|NCT01126190|65214214|FG002|Open-Label Phase|Adverse Event|4|||
23400906|NCT01126190|65214212|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23400907|NCT01126190|65214213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23400908|NCT01126190|65214214|FG002|Open-Label Phase|Withdrawal by Subject|6|||
23400909|NCT02301897|65214219|FG000|Treatment Course 1|Non-Compliance|0|||
23400910|NCT02301897|65214220|FG001|Treatment Course 1|Non-Compliance|0|||
23400911|NCT02301897|65214221|FG002|Treatment Course 1|Non-Compliance|1|||
23400912|NCT02301897|65214219|FG000|Treatment Course 1|Adverse Event|1|||
23400913|NCT02301897|65214220|FG001|Treatment Course 1|Adverse Event|1|||
23400914|NCT02301897|65214221|FG002|Treatment Course 1|Adverse Event|0|||
23400915|NCT02301897|65214219|FG000|Treatment Course 1|Lost to Follow-up|1|||
23400916|NCT02301897|65214220|FG001|Treatment Course 1|Lost to Follow-up|2|||
23400917|NCT02301897|65214221|FG002|Treatment Course 1|Lost to Follow-up|1|||
23400918|NCT02301897|65214219|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
23400919|NCT02301897|65214220|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
23400920|NCT02301897|65214221|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
23400921|NCT02301897|65214219|FG000|Treatment Course 1|Withdrawal by Subject|0|||
23400922|NCT02301897|65214220|FG001|Treatment Course 1|Withdrawal by Subject|0|||
23400923|NCT02301897|65214221|FG002|Treatment Course 1|Withdrawal by Subject|2|||
23400924|NCT02301897|65214219|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
23400925|NCT02301897|65214220|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
23400926|NCT02301897|65214221|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
23400927|NCT02301897|65214219|FG000|Treatment Course 2|Lost to Follow-up|0|||
23400928|NCT02301897|65214220|FG001|Treatment Course 2|Lost to Follow-up|2|||
23400929|NCT02301897|65214221|FG002|Treatment Course 2|Lost to Follow-up|0|||
23400930|NCT02301897|65214219|FG000|Treatment Course 2|Pregnancy|0|||
23400931|NCT02301897|65214220|FG001|Treatment Course 2|Pregnancy|1|||
23400932|NCT02301897|65214221|FG002|Treatment Course 2|Pregnancy|1|||
23400933|NCT02301897|65214219|FG000|Treatment Course 2|Withdrawal by Subject|0|||
23400934|NCT02301897|65214220|FG001|Treatment Course 2|Withdrawal by Subject|2|||
23400935|NCT02301897|65214221|FG002|Treatment Course 2|Withdrawal by Subject|0|||
23400936|NCT02301897|65214219|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
23400937|NCT02301897|65214220|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
23400938|NCT02301897|65214221|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
23400939|NCT03097289|65214222|FG000|Overall Study|Adverse Event|1|||
23400940|NCT03097289|65214222|FG000|Overall Study|Equipment failure|2|||
23400941|NCT03097289|65214222|FG000|Overall Study|Collected platelet product unusable|3|||
23400942|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
23400943|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
23400944|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
23400945|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
23400946|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
23400947|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
23400948|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
23400949|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
23400950|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
23400951|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
23400952|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
23400953|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
23400954|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
23400955|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
23400956|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
23400957|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
23400958|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
23400959|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
23400960|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
23400961|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
23400962|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
23400963|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
23400964|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
23400965|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
23400966|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Other Reason|0|||
23400967|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Other Reason|0|||
23400968|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Other Reason|1|||
23400969|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
23400970|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
23400971|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
23400972|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
23400973|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
23400974|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
23400975|NCT04409834|65214234|FG000|Overall Study|Death|55|||
23400976|NCT04409834|65214235|FG001|Overall Study|Death|62|||
23400977|NCT00904371|65214239|FG000|Overall Study|Adverse Event|2|||
23400978|NCT00904371|65214239|FG000|Overall Study|Lost to Follow-up|4|||
23400979|NCT00904371|65214239|FG000|Overall Study|Discontinued at target blood pressure|2|||
23400980|NCT00904371|65214239|FG000|Overall Study|Continued with Tritace|1|||
23400981|NCT00613106|65214240|FG000|Overall Study|Adverse Event|3|||
23400982|NCT00613106|65214241|FG001|Overall Study|Adverse Event|1|||
23400983|NCT00613106|65214240|FG000|Overall Study|Withdrawal by Subject|6|||
23400984|NCT00613106|65214241|FG001|Overall Study|Withdrawal by Subject|3|||
23400985|NCT00613106|65214240|FG000|Overall Study|Lost to Follow-up|7|||
23400986|NCT00613106|65214241|FG001|Overall Study|Lost to Follow-up|2|||
23400987|NCT00613106|65214240|FG000|Overall Study|misc|4|||
23400988|NCT00613106|65214241|FG001|Overall Study|misc|3|||
23400989|NCT02412670|65214243|FG000|Overall Study|Adverse Event|4|||
23400990|NCT02412670|65214244|FG001|Overall Study|Adverse Event|1|||
23400991|NCT02412670|65214243|FG000|Overall Study|Physician Decision|1|||
23400992|NCT02412670|65214244|FG001|Overall Study|Physician Decision|0|||
23400993|NCT02412670|65214243|FG000|Overall Study|Withdrawal by Subject|1|||
23400994|NCT02412670|65214244|FG001|Overall Study|Withdrawal by Subject|0|||
23400995|NCT02412670|65214243|FG000|Overall Study|Ineligible|1|||
23400996|NCT02412670|65214244|FG001|Overall Study|Ineligible|0|||
23400997|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Not Eligible|3|||
23400998|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
23400999|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
23401000|NCT00403130|65214245|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
23401001|NCT00382174|65214246|FG000|Overall Study|Lost to Follow-up|1|||
23401002|NCT00382174|65214247|FG001|Overall Study|Lost to Follow-up|4|||
23401003|NCT00382174|65214248|FG002|Overall Study|Lost to Follow-up|5|||
23401004|NCT00382174|65214246|FG000|Overall Study|Adverse Event|1|||
23401005|NCT00382174|65214247|FG001|Overall Study|Adverse Event|4|||
23401006|NCT00382174|65214248|FG002|Overall Study|Adverse Event|5|||
23401007|NCT00382174|65214246|FG000|Overall Study|Withdrawal by Subject|1|||
23401008|NCT00382174|65214247|FG001|Overall Study|Withdrawal by Subject|4|||
23401009|NCT00382174|65214248|FG002|Overall Study|Withdrawal by Subject|5|||
23401010|NCT00382174|65214246|FG000|Overall Study|Non compliance|1|||
23401011|NCT00382174|65214247|FG001|Overall Study|Non compliance|0|||
23705176|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
23401012|NCT00382174|65214248|FG002|Overall Study|Non compliance|1|||
23401013|NCT00382174|65214246|FG000|Overall Study|Physician Decision|0|||
23401014|NCT00382174|65214247|FG001|Overall Study|Physician Decision|2|||
23401015|NCT00382174|65214248|FG002|Overall Study|Physician Decision|2|||
23401016|NCT00382174|65214246|FG000|Overall Study|Failed to meet criteria|0|||
23401017|NCT00382174|65214247|FG001|Overall Study|Failed to meet criteria|1|||
23401018|NCT00382174|65214248|FG002|Overall Study|Failed to meet criteria|1|||
23401019|NCT00382174|65214246|FG000|Overall Study|Wounds merged|0|||
23401020|NCT00382174|65214247|FG001|Overall Study|Wounds merged|2|||
23401021|NCT00382174|65214248|FG002|Overall Study|Wounds merged|2|||
23401022|NCT01732536|65214249|FG000|Overall Study|Withdrawal by Subject|1|||
23401023|NCT01732536|65214250|FG001|Overall Study|Withdrawal by Subject|1|||
23401024|NCT02701764|65214251|FG000|Overall Study|Lost to Follow-up|0|||
23401025|NCT02701764|65214252|FG001|Overall Study|Lost to Follow-up|1|||
23401026|NCT01736917|65214253|FG000|Overall Study|Adverse Event|1|||
23401027|NCT01736917|65214253|FG000|Overall Study|Protocol Violation|10|||
23401028|NCT04211363|65214254|FG000|Overall Study|Adverse Event|5|||
23401029|NCT04211363|65214255|FG001|Overall Study|Adverse Event|2|||
23401030|NCT04211363|65214254|FG000|Overall Study|Physician Decision|0|||
23401031|NCT04211363|65214255|FG001|Overall Study|Physician Decision|1|||
23401032|NCT04211363|65214254|FG000|Overall Study|Protocol Violation|1|||
23401033|NCT04211363|65214255|FG001|Overall Study|Protocol Violation|0|||
23401034|NCT04211363|65214254|FG000|Overall Study|Pregnancy|1|||
23401035|NCT04211363|65214255|FG001|Overall Study|Pregnancy|0|||
23401036|NCT04211363|65214254|FG000|Overall Study|Lost to Follow-up|12|||
23401037|NCT04211363|65214255|FG001|Overall Study|Lost to Follow-up|4|||
23401038|NCT04211363|65214254|FG000|Overall Study|Withdrawal by Subject|11|||
23401039|NCT04211363|65214255|FG001|Overall Study|Withdrawal by Subject|11|||
23401040|NCT04211363|65214254|FG000|Overall Study|Other|1|||
23401041|NCT04211363|65214255|FG001|Overall Study|Other|2|||
23401042|NCT01425814|65214256|FG000|Period 1|Stability criteria not fulfilled|0|||
23401043|NCT01425814|65214257|FG001|Period 1|Stability criteria not fulfilled|1|||
23401044|NCT01425814|65214258|FG002|Period 1|Stability criteria not fulfilled|0|||
23401045|NCT01425814|65214259|FG003|Period 1|Stability criteria not fulfilled|0|||
23401046|NCT01425814|65214260|FG004|Period 1|Stability criteria not fulfilled|0|||
23401047|NCT01425814|65214261|FG005|Period 1|Stability criteria not fulfilled|0|||
23401048|NCT01425814|65214256|FG000|Period 2|Stability criteria not fulfilled|0|||
23401049|NCT01425814|65214257|FG001|Period 2|Stability criteria not fulfilled|1|||
23401050|NCT01425814|65214258|FG002|Period 2|Stability criteria not fulfilled|0|||
23401051|NCT01425814|65214259|FG003|Period 2|Stability criteria not fulfilled|0|||
23401052|NCT01425814|65214260|FG004|Period 2|Stability criteria not fulfilled|0|||
23401053|NCT01425814|65214261|FG005|Period 2|Stability criteria not fulfilled|0|||
23401054|NCT01425814|65214256|FG000|Period 3|Adverse Event|0|||
23401055|NCT01425814|65214257|FG001|Period 3|Adverse Event|0|||
23401056|NCT01425814|65214258|FG002|Period 3|Adverse Event|0|||
23401057|NCT01425814|65214259|FG003|Period 3|Adverse Event|0|||
23401058|NCT01425814|65214260|FG004|Period 3|Adverse Event|0|||
23401059|NCT01425814|65214261|FG005|Period 3|Adverse Event|1|||
23401060|NCT01425814|65214256|FG000|Period 4|Adverse Event|1|||
23401061|NCT01425814|65214257|FG001|Period 4|Adverse Event|0|||
23401062|NCT01425814|65214258|FG002|Period 4|Adverse Event|1|||
23401063|NCT01425814|65214259|FG003|Period 4|Adverse Event|0|||
23401064|NCT01425814|65214260|FG004|Period 4|Adverse Event|0|||
23401065|NCT01425814|65214261|FG005|Period 4|Adverse Event|0|||
23401066|NCT01425814|65214256|FG000|Period 5|Stability criteria not fulfilled|0|||
23401067|NCT01425814|65214257|FG001|Period 5|Stability criteria not fulfilled|0|||
23401068|NCT01425814|65214258|FG002|Period 5|Stability criteria not fulfilled|1|||
23401069|NCT01425814|65214259|FG003|Period 5|Stability criteria not fulfilled|0|||
23401070|NCT01425814|65214260|FG004|Period 5|Stability criteria not fulfilled|0|||
23401071|NCT01425814|65214261|FG005|Period 5|Stability criteria not fulfilled|1|||
23401072|NCT01847755|65214264|FG000|Overall Study|Adverse Event|2|||
23401073|NCT01847755|65214264|FG000|Overall Study|Withdrawal by Subject|2|||
23401074|NCT01847755|65214264|FG000|Overall Study|Physician Decision|1|||
23401075|NCT00049543|65214265|FG000|Overall Study|still on treatment|2|||
23401076|NCT00049543|65214266|FG001|Overall Study|still on treatment|9|||
23401077|NCT02612311|65214269|FG000|Overall Study|Adverse Event|16|||
23401078|NCT02612311|65214270|FG001|Overall Study|Adverse Event|12|||
23401079|NCT02612311|65214271|FG002|Overall Study|Adverse Event|7|||
23401080|NCT02612311|65214272|FG003|Overall Study|Adverse Event|13|||
23401081|NCT02612311|65214269|FG000|Overall Study|Death|29|||
23401082|NCT02612311|65214270|FG001|Overall Study|Death|10|||
23401083|NCT02612311|65214271|FG002|Overall Study|Death|11|||
23401084|NCT02612311|65214272|FG003|Overall Study|Death|11|||
23401085|NCT02612311|65214269|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
23401086|NCT02612311|65214270|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
23401087|NCT02612311|65214271|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
23401088|NCT02612311|65214272|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
23401089|NCT02612311|65214269|FG000|Overall Study|Investigator's Decision|11|||
23401090|NCT02612311|65214270|FG001|Overall Study|Investigator's Decision|15|||
23401091|NCT02612311|65214271|FG002|Overall Study|Investigator's Decision|6|||
23401092|NCT02612311|65214272|FG003|Overall Study|Investigator's Decision|6|||
23401093|NCT02612311|65214269|FG000|Overall Study|Lack of Efficacy|0|||
23401094|NCT02612311|65214270|FG001|Overall Study|Lack of Efficacy|0|||
23401095|NCT02612311|65214271|FG002|Overall Study|Lack of Efficacy|1|||
23401096|NCT02612311|65214272|FG003|Overall Study|Lack of Efficacy|1|||
23401097|NCT02612311|65214269|FG000|Overall Study|Lost to Follow-up|2|||
23401098|NCT02612311|65214270|FG001|Overall Study|Lost to Follow-up|2|||
23401099|NCT02612311|65214271|FG002|Overall Study|Lost to Follow-up|1|||
23401100|NCT02612311|65214272|FG003|Overall Study|Lost to Follow-up|2|||
23401101|NCT02612311|65214269|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
23401102|NCT02612311|65214270|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
23401103|NCT02612311|65214271|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
23401104|NCT02612311|65214272|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
23401105|NCT02612311|65214269|FG000|Overall Study|Site Terminated by Sponsor|29|||
23401106|NCT02612311|65214270|FG001|Overall Study|Site Terminated by Sponsor|12|||
23401107|NCT02612311|65214271|FG002|Overall Study|Site Terminated by Sponsor|13|||
23401108|NCT02612311|65214272|FG003|Overall Study|Site Terminated by Sponsor|5|||
23401109|NCT02612311|65214269|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
23401110|NCT02612311|65214270|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
23401111|NCT02612311|65214271|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
23401112|NCT02612311|65214272|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
23401113|NCT02612311|65214269|FG000|Overall Study|Reason Not Specified|3|||
23401114|NCT02612311|65214270|FG001|Overall Study|Reason Not Specified|7|||
23401115|NCT02612311|65214271|FG002|Overall Study|Reason Not Specified|4|||
23401116|NCT02612311|65214272|FG003|Overall Study|Reason Not Specified|5|||
23401117|NCT02612311|65214269|FG000|Overall Study|Unknown/Missing|10|||
23401118|NCT02612311|65214270|FG001|Overall Study|Unknown/Missing|13|||
23401119|NCT02612311|65214271|FG002|Overall Study|Unknown/Missing|4|||
23401120|NCT02612311|65214272|FG003|Overall Study|Unknown/Missing|0|||
23401121|NCT02612311|65214269|FG000|Overall Study|Non-Compliance with Study|1|||
23401122|NCT02612311|65214270|FG001|Overall Study|Non-Compliance with Study|0|||
23401123|NCT02612311|65214271|FG002|Overall Study|Non-Compliance with Study|0|||
23401124|NCT02612311|65214272|FG003|Overall Study|Non-Compliance with Study|0|||
23401125|NCT01865487|65214275|FG000|Overall Study|Lost to Follow-up|0|||
23401126|NCT01865487|65214276|FG001|Overall Study|Lost to Follow-up|0|||
23401127|NCT01865487|65214277|FG002|Overall Study|Lost to Follow-up|0|||
23401128|NCT01865487|65214278|FG003|Overall Study|Lost to Follow-up|1|||
23401129|NCT01865487|65214279|FG004|Overall Study|Lost to Follow-up|0|||
23401130|NCT01865487|65214280|FG005|Overall Study|Lost to Follow-up|0|||
23401131|NCT01865487|65214281|FG006|Overall Study|Lost to Follow-up|1|||
23401132|NCT01865487|65214282|FG007|Overall Study|Lost to Follow-up|0|||
23401133|NCT01865487|65214283|FG008|Overall Study|Lost to Follow-up|0|||
23401134|NCT01865487|65214284|FG009|Overall Study|Lost to Follow-up|0|||
23401135|NCT01865487|65214275|FG000|Overall Study|Withdrawal by Subject|0|||
23401136|NCT01865487|65214276|FG001|Overall Study|Withdrawal by Subject|0|||
23401137|NCT01865487|65214277|FG002|Overall Study|Withdrawal by Subject|0|||
23401138|NCT01865487|65214278|FG003|Overall Study|Withdrawal by Subject|0|||
23401139|NCT01865487|65214279|FG004|Overall Study|Withdrawal by Subject|1|||
23401140|NCT01865487|65214280|FG005|Overall Study|Withdrawal by Subject|0|||
23401141|NCT01865487|65214281|FG006|Overall Study|Withdrawal by Subject|0|||
23401142|NCT01865487|65214282|FG007|Overall Study|Withdrawal by Subject|0|||
23401143|NCT01865487|65214283|FG008|Overall Study|Withdrawal by Subject|0|||
23401144|NCT01865487|65214284|FG009|Overall Study|Withdrawal by Subject|0|||
23401145|NCT01463527|65214285|FG000|Overall Study|Protocol Violation|1|||
23401146|NCT01463527|65214286|FG001|Overall Study|Protocol Violation|1|||
23401147|NCT01463527|65214285|FG000|Overall Study|Crying >20% of sedation|5|||
23401148|NCT01463527|65214286|FG001|Overall Study|Crying >20% of sedation|6|||
23401149|NCT03961308|65214288|FG000|Overall Study|Withdrawal by Subject|1|||
23401150|NCT03961308|65214289|FG001|Overall Study|Withdrawal by Subject|0|||
23401151|NCT03961308|65214288|FG000|Overall Study|Other|1|||
23401152|NCT03961308|65214289|FG001|Overall Study|Other|0|||
23401153|NCT03961308|65214288|FG000|Overall Study|Lost to Follow-up|0|||
23401154|NCT03961308|65214289|FG001|Overall Study|Lost to Follow-up|1|||
23401155|NCT03961308|65214288|FG000|Overall Study|Adverse Event|0|||
23401156|NCT03961308|65214289|FG001|Overall Study|Adverse Event|1|||
23401157|NCT00105534|65214290|FG000|Overall Study|Adverse Event|2|||
23401158|NCT00105534|65214291|FG001|Overall Study|Adverse Event|5|||
23401159|NCT00105534|65214290|FG000|Overall Study|Protocol Violation|1|||
23401160|NCT00105534|65214291|FG001|Overall Study|Protocol Violation|4|||
23401161|NCT00105534|65214290|FG000|Overall Study|Withdrawal by Subject|6|||
23401162|NCT00105534|65214291|FG001|Overall Study|Withdrawal by Subject|6|||
23401163|NCT00105534|65214290|FG000|Overall Study|Lost to Follow-up|5|||
23401164|NCT00105534|65214291|FG001|Overall Study|Lost to Follow-up|1|||
23401165|NCT00105534|65214290|FG000|Overall Study|Lack of Efficacy|7|||
23401166|NCT00105534|65214291|FG001|Overall Study|Lack of Efficacy|15|||
23401167|NCT00105534|65214290|FG000|Overall Study|Treatment unmasked|1|||
23401168|NCT00105534|65214291|FG001|Overall Study|Treatment unmasked|0|||
23401169|NCT00105534|65214290|FG000|Overall Study|Other Reason|0|||
23401170|NCT00105534|65214291|FG001|Overall Study|Other Reason|2|||
23401171|NCT01445847|65214292|FG000|Overall Study|Protocol Violation|13|||
23401172|NCT01445847|65214293|FG001|Overall Study|Protocol Violation|14|||
23401173|NCT01445847|65214292|FG000|Overall Study|Missed Data|1|||
23401174|NCT01445847|65214293|FG001|Overall Study|Missed Data|0|||
23401175|NCT02573948|65214299|FG000|Longitudinal Cohort|Death|9|||
23401176|NCT02573948|65214299|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
23401177|NCT02573948|65214299|FG000|Longitudinal Cohort|Incarcerated|25|||
23401178|NCT00328172|65214304|FG000|Overall Study|Adverse Event|3|||
23401179|NCT00328172|65214305|FG001|Overall Study|Adverse Event|2|||
23401180|NCT00328172|65214306|FG002|Overall Study|Adverse Event|1|||
23401181|NCT00328172|65214307|FG003|Overall Study|Adverse Event|2|||
23401182|NCT00328172|65214308|FG004|Overall Study|Adverse Event|1|||
23401183|NCT00328172|65214304|FG000|Overall Study|Protocol Violation|0|||
23401184|NCT00328172|65214305|FG001|Overall Study|Protocol Violation|1|||
23401185|NCT00328172|65214306|FG002|Overall Study|Protocol Violation|1|||
23401186|NCT00328172|65214307|FG003|Overall Study|Protocol Violation|0|||
23401187|NCT00328172|65214308|FG004|Overall Study|Protocol Violation|0|||
23401188|NCT00328172|65214304|FG000|Overall Study|Lost to Follow-up|1|||
23401189|NCT00328172|65214305|FG001|Overall Study|Lost to Follow-up|1|||
23401190|NCT00328172|65214306|FG002|Overall Study|Lost to Follow-up|2|||
23401191|NCT00328172|65214307|FG003|Overall Study|Lost to Follow-up|1|||
23401192|NCT00328172|65214308|FG004|Overall Study|Lost to Follow-up|1|||
23401193|NCT00328172|65214304|FG000|Overall Study|Withdrawal by Subject|1|||
23401194|NCT00328172|65214305|FG001|Overall Study|Withdrawal by Subject|1|||
23401195|NCT00328172|65214306|FG002|Overall Study|Withdrawal by Subject|1|||
23401196|NCT00328172|65214307|FG003|Overall Study|Withdrawal by Subject|6|||
23401197|NCT00328172|65214308|FG004|Overall Study|Withdrawal by Subject|0|||
23401198|NCT00328172|65214304|FG000|Overall Study|Lack of Efficacy|14|||
23401199|NCT00328172|65214305|FG001|Overall Study|Lack of Efficacy|9|||
23401200|NCT00328172|65214306|FG002|Overall Study|Lack of Efficacy|4|||
23401201|NCT00328172|65214307|FG003|Overall Study|Lack of Efficacy|4|||
23401202|NCT00328172|65214308|FG004|Overall Study|Lack of Efficacy|3|||
23401203|NCT00328172|65214304|FG000|Overall Study|Other reason (not specified)|3|||
23401204|NCT00328172|65214305|FG001|Overall Study|Other reason (not specified)|0|||
23401205|NCT00328172|65214306|FG002|Overall Study|Other reason (not specified)|1|||
23401206|NCT00328172|65214307|FG003|Overall Study|Other reason (not specified)|0|||
23401207|NCT00328172|65214308|FG004|Overall Study|Other reason (not specified)|0|||
23401208|NCT00533429|65214309|FG000|Overall Study|Adverse Event|3|||
23401209|NCT00533429|65214310|FG001|Overall Study|Adverse Event|1|||
23401210|NCT00533429|65214309|FG000|Overall Study|Death|1|||
23401211|NCT00533429|65214310|FG001|Overall Study|Death|0|||
23401212|NCT00533429|65214309|FG000|Overall Study|Withdrawal by Subject|2|||
23401213|NCT00533429|65214310|FG001|Overall Study|Withdrawal by Subject|0|||
23401214|NCT00533429|65214309|FG000|Overall Study|Progressive Disease|12|||
23401215|NCT00533429|65214310|FG001|Overall Study|Progressive Disease|13|||
23401216|NCT00533429|65214309|FG000|Overall Study|Symptomatic deterioration|1|||
23401217|NCT00533429|65214310|FG001|Overall Study|Symptomatic deterioration|2|||
23401218|NCT01957865|65214315|FG000|Overall Study|Found HIV negative|0|||
23401219|NCT01957865|65214316|FG001|Overall Study|Found HIV negative|0|||
23401220|NCT01957865|65214317|FG002|Overall Study|Found HIV negative|1|||
23401221|NCT01957865|65214315|FG000|Overall Study|Lost to Follow-up|0|||
23401222|NCT01957865|65214316|FG001|Overall Study|Lost to Follow-up|2|||
23401223|NCT01957865|65214317|FG002|Overall Study|Lost to Follow-up|2|||
23401224|NCT02013609|65214322|FG000|Overall Study|Withdrawal by Subject|9|||
23401225|NCT02013609|65214322|FG000|Overall Study|Lost to Follow-up|3|||
23401226|NCT02013609|65214322|FG000|Overall Study|Adverse Event|3|||
23401227|NCT02013609|65214322|FG000|Overall Study|Met Withdrawal Criteria|3|||
23401228|NCT02359903|65214323|FG000|Overall Study|Adverse Event|0|||
23401229|NCT02359903|65214324|FG001|Overall Study|Adverse Event|2|||
23401230|NCT01077063|65214327|FG000|Overall Study|Adverse Event|3|||
23401231|NCT01077063|65214328|FG001|Overall Study|Adverse Event|0|||
23401232|NCT01077063|65214327|FG000|Overall Study|Death|1|||
23401233|NCT01077063|65214328|FG001|Overall Study|Death|1|||
23401234|NCT01077063|65214327|FG000|Overall Study|Withdrawal by Subject|0|||
23401235|NCT01077063|65214328|FG001|Overall Study|Withdrawal by Subject|2|||
23401236|NCT01182350|65214332|FG000|Overall Study|Adverse Event|5|||
23401237|NCT01182350|65214333|FG001|Overall Study|Adverse Event|0|||
23401238|NCT01182350|65214334|FG002|Overall Study|Adverse Event|0|||
23401239|NCT01182350|65214335|FG003|Overall Study|Adverse Event|0|||
23401240|NCT01182350|65214336|FG004|Overall Study|Adverse Event|0|||
23401241|NCT01182350|65214332|FG000|Overall Study|Disease Progression|15|||
23401242|NCT01182350|65214333|FG001|Overall Study|Disease Progression|12|||
23401243|NCT01182350|65214334|FG002|Overall Study|Disease Progression|0|||
23401244|NCT01182350|65214335|FG003|Overall Study|Disease Progression|1|||
23401245|NCT01182350|65214336|FG004|Overall Study|Disease Progression|0|||
23401246|NCT01182350|65214332|FG000|Overall Study|Death|0|||
23401247|NCT01182350|65214333|FG001|Overall Study|Death|1|||
23401248|NCT01182350|65214334|FG002|Overall Study|Death|1|||
23401249|NCT01182350|65214335|FG003|Overall Study|Death|0|||
23401250|NCT01182350|65214336|FG004|Overall Study|Death|0|||
23401251|NCT01182350|65214332|FG000|Overall Study|Withdrawal by Subject|3|||
23401252|NCT01182350|65214333|FG001|Overall Study|Withdrawal by Subject|1|||
23401253|NCT01182350|65214334|FG002|Overall Study|Withdrawal by Subject|0|||
23401254|NCT01182350|65214335|FG003|Overall Study|Withdrawal by Subject|1|||
23401255|NCT01182350|65214336|FG004|Overall Study|Withdrawal by Subject|0|||
23401256|NCT01182350|65214332|FG000|Overall Study|Alternative Therapy|2|||
23401257|NCT01182350|65214333|FG001|Overall Study|Alternative Therapy|0|||
23401258|NCT01182350|65214334|FG002|Overall Study|Alternative Therapy|1|||
23401259|NCT01182350|65214335|FG003|Overall Study|Alternative Therapy|0|||
23401260|NCT01182350|65214336|FG004|Overall Study|Alternative Therapy|0|||
23401261|NCT01182350|65214332|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
23401262|NCT01182350|65214333|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
23401263|NCT01182350|65214334|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
23401264|NCT01182350|65214335|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
23401265|NCT01182350|65214336|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
23401266|NCT01182350|65214332|FG000|Overall Study|Unevaluable for Biopsy|0|||
23401267|NCT01182350|65214333|FG001|Overall Study|Unevaluable for Biopsy|0|||
23401268|NCT01182350|65214334|FG002|Overall Study|Unevaluable for Biopsy|0|||
23401269|NCT01182350|65214335|FG003|Overall Study|Unevaluable for Biopsy|0|||
23401270|NCT01182350|65214336|FG004|Overall Study|Unevaluable for Biopsy|3|||
23401271|NCT01154452|65216746|FG000|Phase Ib|Not Treated|1|||
23401272|NCT01154452|65216747|FG001|Phase Ib|Not Treated|0|||
23401273|NCT01154452|65216748|FG002|Phase Ib|Not Treated|0|||
23401274|NCT01154452|65216749|FG003|Phase Ib|Not Treated|0|||
23401275|NCT01154452|65216746|FG000|Phase Ib|Adverse Event|2|||
23401276|NCT01154452|65216747|FG001|Phase Ib|Adverse Event|1|||
23401277|NCT01154452|65216748|FG002|Phase Ib|Adverse Event|0|||
23401278|NCT01154452|65216749|FG003|Phase Ib|Adverse Event|0|||
23401279|NCT01154452|65216746|FG000|Phase II|Withdrawal by Subject|0|||
23401280|NCT01154452|65216747|FG001|Phase II|Withdrawal by Subject|0|||
23401281|NCT01154452|65216748|FG002|Phase II|Withdrawal by Subject|1|||
23401282|NCT01154452|65216749|FG003|Phase II|Withdrawal by Subject|2|||
23401283|NCT01154452|65216746|FG000|Phase II|Adverse Event|0|||
23401284|NCT01154452|65216747|FG001|Phase II|Adverse Event|0|||
23401285|NCT01154452|65216748|FG002|Phase II|Adverse Event|4|||
23401286|NCT01154452|65216749|FG003|Phase II|Adverse Event|4|||
23401287|NCT02015039|65216750|FG000|Overall Study|Not eligible|0|||
23401288|NCT02015039|65216751|FG001|Overall Study|Not eligible|1|||
23401289|NCT01576783|65216752|FG000|Overall Study|Change in Medical Care|1|||
23401290|NCT01576783|65216753|FG001|Overall Study|Change in Medical Care|0|||
23401291|NCT01576783|65216752|FG000|Overall Study|Lost to Follow-up|14|||
23401292|NCT01576783|65216753|FG001|Overall Study|Lost to Follow-up|16|||
23401293|NCT01576783|65216752|FG000|Overall Study|Withdrawal by Subject|5|||
23401294|NCT01576783|65216753|FG001|Overall Study|Withdrawal by Subject|1|||
23401295|NCT01299389|65216754|FG000|Double-blind|Adverse Event|45|||
23401296|NCT01299389|65216755|FG001|Double-blind|Adverse Event|27|||
23401297|NCT01299389|65216756|FG002|Double-blind|Adverse Event|0|||
23401298|NCT01299389|65216757|FG003|Double-blind|Adverse Event|0|||
23401299|NCT01299389|65216754|FG000|Double-blind|Lack of Efficacy|45|||
23401300|NCT01299389|65216755|FG001|Double-blind|Lack of Efficacy|21|||
23401301|NCT01299389|65216756|FG002|Double-blind|Lack of Efficacy|0|||
23401302|NCT01299389|65216757|FG003|Double-blind|Lack of Efficacy|0|||
23401303|NCT01299389|65216754|FG000|Double-blind|Lost to Follow-up|2|||
23401304|NCT01299389|65216755|FG001|Double-blind|Lost to Follow-up|1|||
23401305|NCT01299389|65216756|FG002|Double-blind|Lost to Follow-up|0|||
23401306|NCT01299389|65216757|FG003|Double-blind|Lost to Follow-up|0|||
23401307|NCT01299389|65216754|FG000|Double-blind|Withdrawal by Subject|16|||
23401308|NCT01299389|65216755|FG001|Double-blind|Withdrawal by Subject|13|||
23401309|NCT01299389|65216756|FG002|Double-blind|Withdrawal by Subject|0|||
23401310|NCT01299389|65216757|FG003|Double-blind|Withdrawal by Subject|0|||
23401311|NCT01299389|65216754|FG000|Double-blind|Other|1|||
23401312|NCT01299389|65216755|FG001|Double-blind|Other|1|||
23401313|NCT01299389|65216756|FG002|Double-blind|Other|0|||
23401314|NCT01299389|65216757|FG003|Double-blind|Other|0|||
23401315|NCT01299389|65216754|FG000|Double-blind|"fail to meet study population criteria"|0|||
23401316|NCT01299389|65216755|FG001|Double-blind|"fail to meet study population criteria"|1|||
23401317|NCT01299389|65216756|FG002|Double-blind|"fail to meet study population criteria"|0|||
23705177|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
23401318|NCT01299389|65216757|FG003|Double-blind|"fail to meet study population criteria"|0|||
23401319|NCT01299389|65216754|FG000|Post-observational|Other|0|||
23401320|NCT01299389|65216755|FG001|Post-observational|Other|0|||
23401321|NCT01299389|65216756|FG002|Post-observational|Other|12|||
23401322|NCT01299389|65216757|FG003|Post-observational|Other|6|||
23401323|NCT02289469|65216760|FG000|Overall Study|Unable to match a control|6|||
23401324|NCT02289469|65216761|FG001|Overall Study|Unable to match a control|0|||
23401325|NCT01248793|65216767|FG000|Overall Study|Lost to Follow-up|0|||
23401326|NCT01248793|65216768|FG001|Overall Study|Lost to Follow-up|1|||
23401327|NCT01248793|65216767|FG000|Overall Study|Adverse Event|1|||
23401328|NCT01248793|65216768|FG001|Overall Study|Adverse Event|1|||
23401329|NCT01248793|65216767|FG000|Overall Study|Protocol Violation|0|||
23401330|NCT01248793|65216768|FG001|Overall Study|Protocol Violation|1|||
23401331|NCT01248793|65216767|FG000|Overall Study|Withdrawal by Subject|3|||
23401332|NCT01248793|65216768|FG001|Overall Study|Withdrawal by Subject|3|||
23401333|NCT01016132|65216770|FG000|Overall Study|Discomfort|1|||
23401334|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
23401335|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
23401336|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
23401337|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Death|0|||
23401338|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Death|0|||
23401339|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Death|1|||
23401340|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
23401341|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
23401342|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
23401343|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
23401344|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
23401345|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
23401346|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
23401347|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
23401348|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
23401349|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Graft loss|0|||
23401350|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Graft loss|0|||
23401351|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Graft loss|7|||
23401352|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
23401353|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
23401354|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
23401355|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
23401356|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
23401357|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
23401358|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
23401359|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
23401360|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
23401361|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
23401362|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
23401363|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
23401364|NCT00956293|65216771|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
23401365|NCT00956293|65216772|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
23401366|NCT00956293|65216773|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
23401367|NCT00956293|65216771|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
23401368|NCT00956293|65216772|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
23401369|NCT00956293|65216773|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
23401370|NCT00956293|65216771|FG000|Main Period (Randomization)|Adverse Event|0|||
23401371|NCT00956293|65216772|FG001|Main Period (Randomization)|Adverse Event|15|||
23401372|NCT00956293|65216773|FG002|Main Period (Randomization)|Adverse Event|0|||
23401373|NCT00956293|65216771|FG000|Follow-up Period|Follow-up period was terminated.|20|||
23401374|NCT00956293|65216772|FG001|Follow-up Period|Follow-up period was terminated.|32|||
23401375|NCT00956293|65216773|FG002|Follow-up Period|Follow-up period was terminated.|0|||
23401376|NCT01497197|65216774|FG000|Overall Study|Lost to Follow-up|1|||
23401377|NCT01497197|65216775|FG001|Overall Study|Lost to Follow-up|0|||
23401378|NCT01497197|65216774|FG000|Overall Study|Protocol Violation|0|||
23401379|NCT01497197|65216775|FG001|Overall Study|Protocol Violation|2|||
23401380|NCT01497197|65216774|FG000|Overall Study|Withdrawal by Subject|2|||
23401381|NCT01497197|65216775|FG001|Overall Study|Withdrawal by Subject|1|||
23401382|NCT01497197|65216774|FG000|Overall Study|Excessive/lack of response to treatment|1|||
23401383|NCT01497197|65216775|FG001|Overall Study|Excessive/lack of response to treatment|0|||
23401384|NCT01497197|65216774|FG000|Overall Study|Risk of OHSS|1|||
23401385|NCT01497197|65216775|FG001|Overall Study|Risk of OHSS|0|||
23401386|NCT01497197|65216774|FG000|Overall Study|No oocytes retrieved|3|||
23401387|NCT01497197|65216775|FG001|Overall Study|No oocytes retrieved|2|||
23401388|NCT01497197|65216774|FG000|Overall Study|No fertilisation|6|||
23401389|NCT01497197|65216775|FG001|Overall Study|No fertilisation|5|||
23401390|NCT01497197|65216774|FG000|Overall Study|Intention to freeze all embryos|0|||
23401391|NCT01497197|65216775|FG001|Overall Study|Intention to freeze all embryos|1|||
23401392|NCT01497197|65216774|FG000|Overall Study|All embryos discarded|0|||
23401393|NCT01497197|65216775|FG001|Overall Study|All embryos discarded|3|||
23401394|NCT01497197|65216774|FG000|Overall Study|Other|3|||
23401395|NCT01497197|65216775|FG001|Overall Study|Other|1|||
23401396|NCT03092479|65216777|FG000|Overall Study|Lost to Follow-up|3|||
23401397|NCT03092479|65216778|FG001|Overall Study|Lost to Follow-up|2|||
23401398|NCT03092479|65216777|FG000|Overall Study|Withdrawal by Subject|4|||
23401399|NCT03092479|65216778|FG001|Overall Study|Withdrawal by Subject|0|||
23401400|NCT01061385|65216779|FG000|Overall Study|Lost to Follow-up|1|||
23401401|NCT01061385|65216780|FG001|Overall Study|Lost to Follow-up|0|||
23401402|NCT01061385|65216779|FG000|Overall Study|subject decision not related to AE|0|||
23401403|NCT01061385|65216780|FG001|Overall Study|subject decision not related to AE|1|||
23705710|NCT00972244|66297596|FG004|Overall Study|Death|0|||
23705711|NCT00972244|66297592|FG000|Overall Study|Various|0|||
23705712|NCT00972244|66297593|FG001|Overall Study|Various|0|||
23401404|NCT03783780|65216781|FG000|Overall Study|Withdrawn prior to completion|1|||
23401405|NCT00714948|65216786|FG000|Overall Study|Adverse Event|2|||
23401406|NCT03108521|65216787|FG000|Overall Study|Lost to Follow-up|3|||
23401407|NCT03108521|65216788|FG001|Overall Study|Lost to Follow-up|0|||
23401408|NCT03108521|65216787|FG000|Overall Study|Lack of Efficacy|2|||
23401409|NCT03108521|65216788|FG001|Overall Study|Lack of Efficacy|0|||
23401410|NCT03108521|65216787|FG000|Overall Study|Physician Decision|4|||
23401411|NCT03108521|65216788|FG001|Overall Study|Physician Decision|0|||
23401412|NCT03108521|65216787|FG000|Overall Study|Adverse Event|3|||
23401413|NCT03108521|65216788|FG001|Overall Study|Adverse Event|0|||
23401414|NCT04592341|65216789|FG000|Overall Study|Physician Decision|5|||
23401415|NCT04592341|65216789|FG000|Overall Study|Study Terminated by Sponsor|5|||
23401416|NCT04592341|65216789|FG000|Overall Study|Withdrawal by Subject|53|||
23401417|NCT04592341|65216789|FG000|Overall Study|Lost to Follow-up|3|||
23401418|NCT04592341|65216789|FG000|Overall Study|Death|1|||
23401419|NCT04592341|65216789|FG000|Overall Study|Adverse Event|5|||
23401420|NCT04592341|65216789|FG000|Overall Study|other|4|||
23401421|NCT01444781|65216790|FG000|Overall Study|Lost to Follow-up|0|||
23401422|NCT01444781|65216791|FG001|Overall Study|Lost to Follow-up|3|||
23401423|NCT01444781|65216792|FG002|Overall Study|Lost to Follow-up|1|||
23401424|NCT01444781|65216790|FG000|Overall Study|Withdrawal by Subject|3|||
23401425|NCT01444781|65216791|FG001|Overall Study|Withdrawal by Subject|1|||
23401426|NCT01444781|65216792|FG002|Overall Study|Withdrawal by Subject|2|||
23401427|NCT02750930|65216796|FG000|Overall Study|Study closed/terminated|8|||
23401428|NCT02131766|65216799|FG000|Overall Study|Withdrawal by Subject|4|||
23401429|NCT00527618|65216802|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
23401430|NCT00527618|65216803|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
23401431|NCT00527618|65216802|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
23401432|NCT00527618|65216803|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
23401433|NCT00527618|65216802|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
23401434|NCT00527618|65216803|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
23401435|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
23401436|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
23401437|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
23401438|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
23401439|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
23401440|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
23401441|NCT01250054|65216805|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
23401442|NCT01250054|65216806|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
23401443|NCT01342926|65216807|FG000|Overall Study|Adverse Event|5|||
23401444|NCT01342926|65216808|FG001|Overall Study|Adverse Event|8|||
23401445|NCT01342926|65216809|FG002|Overall Study|Adverse Event|10|||
23401446|NCT01342926|65216810|FG003|Overall Study|Adverse Event|7|||
23401447|NCT01342926|65216807|FG000|Overall Study|Lost to Follow-up|0|||
23401448|NCT01342926|65216808|FG001|Overall Study|Lost to Follow-up|1|||
23401449|NCT01342926|65216809|FG002|Overall Study|Lost to Follow-up|1|||
23401450|NCT01342926|65216810|FG003|Overall Study|Lost to Follow-up|0|||
23401451|NCT01342926|65216807|FG000|Overall Study|Investigator Discretion|2|||
23401452|NCT01342926|65216808|FG001|Overall Study|Investigator Discretion|2|||
23401453|NCT01342926|65216809|FG002|Overall Study|Investigator Discretion|0|||
23401454|NCT01342926|65216810|FG003|Overall Study|Investigator Discretion|0|||
23401455|NCT01342926|65216807|FG000|Overall Study|Withdrawal by Subject|2|||
23401456|NCT01342926|65216808|FG001|Overall Study|Withdrawal by Subject|4|||
23401457|NCT01342926|65216809|FG002|Overall Study|Withdrawal by Subject|3|||
23401458|NCT01342926|65216810|FG003|Overall Study|Withdrawal by Subject|5|||
23401459|NCT02122380|65216815|FG000|First Intervention (30 Days)|Adverse Event|1|||
23401460|NCT02122380|65216816|FG001|First Intervention (30 Days)|Adverse Event|0|||
23401461|NCT02122380|65216815|FG000|First Intervention (30 Days)|Physician Decision|0|||
23401462|NCT02122380|65216816|FG001|First Intervention (30 Days)|Physician Decision|1|||
23401463|NCT02122380|65216815|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
23401464|NCT02122380|65216816|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
23401465|NCT02122380|65216815|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
23401466|NCT02122380|65216816|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
23401467|NCT02122380|65216815|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
23401468|NCT02122380|65216816|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
23401469|NCT00812955|65216819|FG000|Overall Study|Adverse Event|7|||
23401470|NCT00812955|65216820|FG001|Overall Study|Adverse Event|6|||
23401471|NCT00812955|65216821|FG002|Overall Study|Adverse Event|3|||
23401472|NCT00812955|65216822|FG003|Overall Study|Adverse Event|4|||
23401473|NCT00812955|65216819|FG000|Overall Study|Lost to Follow-up|2|||
23401474|NCT00812955|65216820|FG001|Overall Study|Lost to Follow-up|1|||
23401475|NCT00812955|65216821|FG002|Overall Study|Lost to Follow-up|1|||
23401476|NCT00812955|65216822|FG003|Overall Study|Lost to Follow-up|2|||
23401477|NCT00812955|65216819|FG000|Overall Study|Withdrawal by Subject|1|||
23401478|NCT00812955|65216820|FG001|Overall Study|Withdrawal by Subject|0|||
23401479|NCT00812955|65216821|FG002|Overall Study|Withdrawal by Subject|1|||
23401480|NCT00812955|65216822|FG003|Overall Study|Withdrawal by Subject|2|||
23401481|NCT00812955|65216819|FG000|Overall Study|randomized in error|0|||
23401482|NCT00812955|65216820|FG001|Overall Study|randomized in error|0|||
23401483|NCT00812955|65216821|FG002|Overall Study|randomized in error|1|||
23401484|NCT00812955|65216822|FG003|Overall Study|randomized in error|0|||
23401485|NCT01493414|65216823|FG000|Overall Study|Adverse Event|405|||
23401486|NCT01493414|65216823|FG000|Overall Study|Disease progression|204|||
23401487|NCT01493414|65216823|FG000|Overall Study|Death|101|||
23401488|NCT01493414|65216823|FG000|Overall Study|Physician Decision|93|||
23401489|NCT01493414|65216823|FG000|Overall Study|Withdrawal by Subject|79|||
23401490|NCT01493414|65216823|FG000|Overall Study|Protocol deviation|27|||
23401491|NCT01493414|65216823|FG000|Overall Study|Administrative problems|25|||
23401492|NCT01493414|65216823|FG000|Overall Study|Lost to Follow-up|16|||
23401493|NCT01343888|65216826|FG000|Overall Study|Adverse Event|12|||
23401494|NCT01343888|65216827|FG001|Overall Study|Adverse Event|22|||
23401495|NCT01343888|65216828|FG002|Overall Study|Adverse Event|5|||
23401496|NCT01343888|65216826|FG000|Overall Study|Lack of Efficacy|9|||
23401497|NCT01343888|65216827|FG001|Overall Study|Lack of Efficacy|9|||
23401498|NCT01343888|65216828|FG002|Overall Study|Lack of Efficacy|13|||
23401499|NCT01343888|65216826|FG000|Overall Study|Lost to Follow-up|0|||
23401500|NCT01343888|65216827|FG001|Overall Study|Lost to Follow-up|2|||
23401501|NCT01343888|65216828|FG002|Overall Study|Lost to Follow-up|1|||
23401502|NCT01343888|65216826|FG000|Overall Study|Protocol Violation|0|||
23401503|NCT01343888|65216827|FG001|Overall Study|Protocol Violation|2|||
23401504|NCT01343888|65216828|FG002|Overall Study|Protocol Violation|0|||
23401505|NCT01343888|65216826|FG000|Overall Study|Withdrawal by Subject|4|||
23401506|NCT01343888|65216827|FG001|Overall Study|Withdrawal by Subject|4|||
23705178|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|non-compliance|7|||
23705179|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|non-compliance|5|||
23705180|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
23705181|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
23705182|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
23705183|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
23705184|NCT00406640|66297426|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
23705185|NCT00406640|66297427|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
23705186|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
23705187|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
23705188|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
23705189|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
23705190|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
23705191|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
23705192|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
23705193|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
23705194|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
23705195|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
23705196|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
23705197|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
23705198|NCT00406640|66297426|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
23705199|NCT00406640|66297427|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
23705200|NCT00907881|66297430|FG000|Overall Study|Lost to Follow-up|59|||
23705201|NCT00907881|66297430|FG000|Overall Study|Noncompliance|5|||
23705202|NCT00907881|66297430|FG000|Overall Study|Withdrawal by Subject|5|||
23705203|NCT00907881|66297430|FG000|Overall Study|Protocol Violation|1|||
23705204|NCT00907881|66297430|FG000|Overall Study|Missing discontinuation information|15|||
23705205|NCT02361762|66297431|FG000|Overall Study|Withdrawal by Subject|0|||
23705206|NCT02361762|66297432|FG001|Overall Study|Withdrawal by Subject|1|||
23705207|NCT02361762|66297431|FG000|Overall Study|Lost to Follow-up|0|||
23705208|NCT02361762|66297432|FG001|Overall Study|Lost to Follow-up|1|||
23705209|NCT03126539|66297435|FG000|Overall Study|Lost to Follow-up|1|||
23705210|NCT03126539|66297436|FG001|Overall Study|Lost to Follow-up|1|||
23705211|NCT03126539|66297437|FG002|Overall Study|Lost to Follow-up|1|||
23705212|NCT03126539|66297438|FG003|Overall Study|Lost to Follow-up|0|||
23705213|NCT03126539|66297439|FG004|Overall Study|Lost to Follow-up|0|||
23705214|NCT00940342|66297440|FG000|Overall Study|Adverse Event|0|||
23705215|NCT00940342|66297441|FG001|Overall Study|Adverse Event|2|||
23705216|NCT00940342|66297442|FG002|Overall Study|Adverse Event|1|||
23705217|NCT01120093|66297443|FG000|Treatment Period 1|Adverse Event|0|||
23705218|NCT01120093|66297444|FG001|Treatment Period 1|Adverse Event|0|||
23705219|NCT01120093|66297445|FG002|Treatment Period 1|Adverse Event|1|||
23705220|NCT01120093|66297446|FG003|Treatment Period 1|Adverse Event|0|||
23401507|NCT01343888|65216828|FG002|Overall Study|Withdrawal by Subject|2|||
23705221|NCT01120093|66297447|FG004|Treatment Period 1|Adverse Event|1|||
23705222|NCT01120093|66297443|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23705223|NCT01120093|66297444|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23705224|NCT01120093|66297445|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23705225|NCT01120093|66297446|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23705226|NCT01120093|66297447|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23705227|NCT01120093|66297443|FG000|Treatment Period 2|Adverse Event|0|||
23705228|NCT01120093|66297444|FG001|Treatment Period 2|Adverse Event|0|||
23705229|NCT01120093|66297445|FG002|Treatment Period 2|Adverse Event|0|||
23705230|NCT01120093|66297446|FG003|Treatment Period 2|Adverse Event|1|||
23705231|NCT01120093|66297447|FG004|Treatment Period 2|Adverse Event|0|||
23705232|NCT01120093|66297443|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23705233|NCT01120093|66297444|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23705234|NCT01120093|66297445|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23705235|NCT01120093|66297446|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23705236|NCT01120093|66297447|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23705237|NCT01120093|66297443|FG000|Treatment Period 3|Lack of Efficacy|0|||
23705238|NCT01120093|66297444|FG001|Treatment Period 3|Lack of Efficacy|0|||
23705239|NCT01120093|66297445|FG002|Treatment Period 3|Lack of Efficacy|0|||
23705240|NCT01120093|66297446|FG003|Treatment Period 3|Lack of Efficacy|1|||
23705241|NCT01120093|66297447|FG004|Treatment Period 3|Lack of Efficacy|0|||
23705242|NCT01120093|66297443|FG000|Treatment Period 3|Adverse Event|0|||
23705243|NCT01120093|66297444|FG001|Treatment Period 3|Adverse Event|0|||
23705244|NCT01120093|66297445|FG002|Treatment Period 3|Adverse Event|0|||
23705245|NCT01120093|66297446|FG003|Treatment Period 3|Adverse Event|0|||
23705246|NCT01120093|66297447|FG004|Treatment Period 3|Adverse Event|1|||
23705247|NCT01120093|66297443|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23705248|NCT01120093|66297444|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23705249|NCT01120093|66297445|FG002|Treatment Period 3|Withdrawal by Subject|1|||
23705250|NCT01120093|66297446|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23705251|NCT01120093|66297447|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23705252|NCT01120093|66297443|FG000|Treatment Period 4|Adverse Event|1|||
23705253|NCT01120093|66297444|FG001|Treatment Period 4|Adverse Event|0|||
23705254|NCT01120093|66297445|FG002|Treatment Period 4|Adverse Event|0|||
23705255|NCT01120093|66297446|FG003|Treatment Period 4|Adverse Event|0|||
23705256|NCT01120093|66297447|FG004|Treatment Period 4|Adverse Event|0|||
23705257|NCT01120093|66297443|FG000|Treatment Period 5|Adverse Event|0|||
23705258|NCT01120093|66297444|FG001|Treatment Period 5|Adverse Event|1|||
23705259|NCT01120093|66297445|FG002|Treatment Period 5|Adverse Event|0|||
23705260|NCT01120093|66297446|FG003|Treatment Period 5|Adverse Event|1|||
23705261|NCT01120093|66297447|FG004|Treatment Period 5|Adverse Event|0|||
23705262|NCT01793051|66297448|FG000|Overall Study|Withdrawal by Subject|6|||
23705263|NCT01793051|66297449|FG001|Overall Study|Withdrawal by Subject|4|||
23705264|NCT01793051|66297448|FG000|Overall Study|Adverse Event|0|||
23705265|NCT01793051|66297449|FG001|Overall Study|Adverse Event|2|||
23705266|NCT01793051|66297448|FG000|Overall Study|Too ill to continue|1|||
23705267|NCT01793051|66297449|FG001|Overall Study|Too ill to continue|0|||
23705268|NCT01793051|66297448|FG000|Overall Study|Switched chemo|1|||
23705269|NCT01793051|66297449|FG001|Overall Study|Switched chemo|1|||
23705270|NCT01793051|66297448|FG000|Overall Study|Lack of compliance|1|||
23705271|NCT01793051|66297449|FG001|Overall Study|Lack of compliance|0|||
23705272|NCT01793051|66297448|FG000|Overall Study|Requested to be removed from the study|1|||
23705273|NCT01793051|66297449|FG001|Overall Study|Requested to be removed from the study|1|||
23705274|NCT00256867|66297453|FG000|Overall Study|Adverse Event|0|||
23705275|NCT00256867|66297454|FG001|Overall Study|Adverse Event|1|||
23401508|NCT01343888|65216826|FG000|Overall Study|other than stated above|0|||
23401509|NCT01343888|65216827|FG001|Overall Study|other than stated above|0|||
23401510|NCT01343888|65216828|FG002|Overall Study|other than stated above|1|||
23401511|NCT03218917|65216831|FG000|Overall Study|Adverse Event|3|||
23401512|NCT03218917|65216832|FG001|Overall Study|Adverse Event|3|||
23401513|NCT03218917|65216833|FG002|Overall Study|Adverse Event|2|||
23401514|NCT03218917|65216831|FG000|Overall Study|Subject withdrew consent|2|||
23401515|NCT03218917|65216832|FG001|Overall Study|Subject withdrew consent|4|||
23401516|NCT03218917|65216833|FG002|Overall Study|Subject withdrew consent|10|||
23401517|NCT03218917|65216831|FG000|Overall Study|Physician Decision|0|||
23401518|NCT03218917|65216832|FG001|Overall Study|Physician Decision|1|||
23401519|NCT03218917|65216833|FG002|Overall Study|Physician Decision|1|||
23401520|NCT03218917|65216831|FG000|Overall Study|Lost to Follow-up|1|||
23401521|NCT03218917|65216832|FG001|Overall Study|Lost to Follow-up|0|||
23401522|NCT03218917|65216833|FG002|Overall Study|Lost to Follow-up|0|||
23401523|NCT03218917|65216831|FG000|Overall Study|Reason Missing|0|||
23401524|NCT03218917|65216832|FG001|Overall Study|Reason Missing|2|||
23401525|NCT03218917|65216833|FG002|Overall Study|Reason Missing|0|||
23401526|NCT03218917|65216831|FG000|Overall Study|Death|0|||
23401527|NCT03218917|65216832|FG001|Overall Study|Death|1|||
23401528|NCT03218917|65216833|FG002|Overall Study|Death|0|||
23401529|NCT03218917|65216831|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23401530|NCT03218917|65216832|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23401531|NCT03218917|65216833|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23401532|NCT02030821|65216834|FG000|Overall Study|Physician Decision|2|||
23401533|NCT02030821|65216835|FG001|Overall Study|Physician Decision|2|||
23401534|NCT02030821|65216836|FG002|Overall Study|Physician Decision|5|||
23401535|NCT02030821|65216837|FG003|Overall Study|Physician Decision|2|||
23401536|NCT02986074|65216838|FG000|First Trial Period|Adverse Event|1|||
23401537|NCT02986074|65216839|FG001|First Trial Period|Adverse Event|0|||
23401538|NCT02986074|65216840|FG002|First Trial Period|Adverse Event|0|||
23401539|NCT02986074|65216841|FG003|First Trial Period|Adverse Event|0|||
23401540|NCT02986074|65216838|FG000|Follow up Period|system explant|0|||
23401541|NCT02986074|65216839|FG001|Follow up Period|system explant|0|||
23401542|NCT02986074|65216840|FG002|Follow up Period|system explant|1|||
23401543|NCT02986074|65216841|FG003|Follow up Period|system explant|2|||
23401544|NCT02986074|65216838|FG000|Follow up Period|Physician Decision|0|||
23401545|NCT02986074|65216839|FG001|Follow up Period|Physician Decision|0|||
23401546|NCT02986074|65216840|FG002|Follow up Period|Physician Decision|0|||
23401547|NCT02986074|65216841|FG003|Follow up Period|Physician Decision|1|||
23401548|NCT01788943|65216842|FG000|Overall Study|Withdrawal by Subject|1|||
23401549|NCT01788943|65216843|FG001|Overall Study|Withdrawal by Subject|0|||
23401550|NCT00894387|65216846|FG000|Overall Study|Adverse Event|44|||
23401551|NCT00894387|65216847|FG001|Overall Study|Adverse Event|45|||
23401552|NCT00894387|65216846|FG000|Overall Study|Abnormal Laboratory values|2|||
23401553|NCT00894387|65216847|FG001|Overall Study|Abnormal Laboratory values|2|||
23401554|NCT00894387|65216846|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23401555|NCT00894387|65216847|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23401556|NCT00894387|65216846|FG000|Overall Study|Lost to Follow-up|3|||
23401557|NCT00894387|65216847|FG001|Overall Study|Lost to Follow-up|5|||
23401558|NCT00894387|65216846|FG000|Overall Study|Administrative problems|2|||
23401559|NCT00894387|65216847|FG001|Overall Study|Administrative problems|2|||
23401560|NCT00894387|65216846|FG000|Overall Study|Death|77|||
23705276|NCT00256867|66297455|FG002|Overall Study|Adverse Event|1|||
23401561|NCT00894387|65216847|FG001|Overall Study|Death|76|||
23401562|NCT00894387|65216846|FG000|Overall Study|Protocol Deviation|4|||
23401563|NCT00894387|65216847|FG001|Overall Study|Protocol Deviation|0|||
23401564|NCT00894387|65216846|FG000|Overall Study|Patient's request|25|||
23401565|NCT00894387|65216847|FG001|Overall Study|Patient's request|30|||
23401566|NCT00894387|65216846|FG000|Overall Study|Other (Missing)|5|||
23401567|NCT00894387|65216847|FG001|Overall Study|Other (Missing)|3|||
23401568|NCT00894387|65216846|FG000|Overall Study|Mis-randomized|13|||
23401569|NCT00894387|65216847|FG001|Overall Study|Mis-randomized|9|||
23401570|NCT00894387|65216846|FG000|Overall Study|GCP non-compliance|0|||
23401571|NCT00894387|65216847|FG001|Overall Study|GCP non-compliance|2|||
23401572|NCT00776789|65216848|FG000|Overall Study|Consent refusal|2|||
23401573|NCT00776789|65216849|FG001|Overall Study|Consent refusal|2|||
23401574|NCT00776789|65216848|FG000|Overall Study|Poor quality video|1|||
23401575|NCT00776789|65216849|FG001|Overall Study|Poor quality video|1|||
23401576|NCT01657370|65216858|FG000|Overall Study|Withdrawal by Subject|0|||
23401577|NCT01657370|65216859|FG001|Overall Study|Withdrawal by Subject|0|||
23401578|NCT01657370|65216860|FG002|Overall Study|Withdrawal by Subject|1|||
23401579|NCT01657370|65216861|FG003|Overall Study|Withdrawal by Subject|0|||
23401580|NCT01657370|65216862|FG004|Overall Study|Withdrawal by Subject|0|||
23401581|NCT01657370|65216863|FG005|Overall Study|Withdrawal by Subject|1|||
23401582|NCT01657370|65216858|FG000|Overall Study|Physician Decision|2|||
23401583|NCT01657370|65216859|FG001|Overall Study|Physician Decision|3|||
23401584|NCT01657370|65216860|FG002|Overall Study|Physician Decision|1|||
23401585|NCT01657370|65216861|FG003|Overall Study|Physician Decision|2|||
23401586|NCT01657370|65216862|FG004|Overall Study|Physician Decision|5|||
23401587|NCT01657370|65216863|FG005|Overall Study|Physician Decision|0|||
23401588|NCT01657370|65216858|FG000|Overall Study|Lack of Qualifying Event|1|||
23401589|NCT01657370|65216859|FG001|Overall Study|Lack of Qualifying Event|0|||
23401590|NCT01657370|65216860|FG002|Overall Study|Lack of Qualifying Event|3|||
23401591|NCT01657370|65216861|FG003|Overall Study|Lack of Qualifying Event|2|||
23401592|NCT01657370|65216862|FG004|Overall Study|Lack of Qualifying Event|1|||
23401593|NCT01657370|65216863|FG005|Overall Study|Lack of Qualifying Event|2|||
23401594|NCT01657370|65216858|FG000|Overall Study|Adverse Event|0|||
23401595|NCT01657370|65216859|FG001|Overall Study|Adverse Event|0|||
23401596|NCT01657370|65216860|FG002|Overall Study|Adverse Event|0|||
23401597|NCT01657370|65216861|FG003|Overall Study|Adverse Event|0|||
23401598|NCT01657370|65216862|FG004|Overall Study|Adverse Event|1|||
23401599|NCT01657370|65216863|FG005|Overall Study|Adverse Event|0|||
23401600|NCT01657370|65216858|FG000|Overall Study|Protocol Violation|1|||
23401601|NCT01657370|65216859|FG001|Overall Study|Protocol Violation|1|||
23401602|NCT01657370|65216860|FG002|Overall Study|Protocol Violation|1|||
23401603|NCT01657370|65216861|FG003|Overall Study|Protocol Violation|1|||
23401604|NCT01657370|65216862|FG004|Overall Study|Protocol Violation|0|||
23401605|NCT01657370|65216863|FG005|Overall Study|Protocol Violation|0|||
23401606|NCT01657370|65216858|FG000|Overall Study|Lost to Follow-up|2|||
23401607|NCT01657370|65216859|FG001|Overall Study|Lost to Follow-up|0|||
23401608|NCT01657370|65216860|FG002|Overall Study|Lost to Follow-up|1|||
23401609|NCT01657370|65216861|FG003|Overall Study|Lost to Follow-up|0|||
23401610|NCT01657370|65216862|FG004|Overall Study|Lost to Follow-up|0|||
23401611|NCT01657370|65216863|FG005|Overall Study|Lost to Follow-up|1|||
23401612|NCT02756403|65216864|FG000|Overall Study|Unable to swallow medication|0|||
23401613|NCT02756403|65216865|FG001|Overall Study|Unable to swallow medication|1|||
23401614|NCT02756403|65216866|FG002|Overall Study|Unable to swallow medication|1|||
23401615|NCT02756403|65216867|FG003|Overall Study|Unable to swallow medication|1|||
23401616|NCT02756403|65216864|FG000|Overall Study|Did not complete Procedure|0|||
23401617|NCT02756403|65216865|FG001|Overall Study|Did not complete Procedure|1|||
23401618|NCT02756403|65216866|FG002|Overall Study|Did not complete Procedure|0|||
23401619|NCT02756403|65216867|FG003|Overall Study|Did not complete Procedure|0|||
23401620|NCT02756403|65216864|FG000|Overall Study|Changed Mind About Procedure|0|||
23401621|NCT02756403|65216865|FG001|Overall Study|Changed Mind About Procedure|0|||
23401622|NCT02756403|65216866|FG002|Overall Study|Changed Mind About Procedure|1|||
23401623|NCT02756403|65216867|FG003|Overall Study|Changed Mind About Procedure|0|||
23401624|NCT02756403|65216864|FG000|Overall Study|Protocol Violation|0|||
23401625|NCT02756403|65216865|FG001|Overall Study|Protocol Violation|1|||
23401626|NCT02756403|65216866|FG002|Overall Study|Protocol Violation|0|||
23401627|NCT02756403|65216867|FG003|Overall Study|Protocol Violation|1|||
23401628|NCT00698828|65216869|FG000|Overall Study|Adverse Event|3|||
23401629|NCT00698828|65216870|FG001|Overall Study|Adverse Event|4|||
23401630|NCT00698828|65216871|FG002|Overall Study|Adverse Event|4|||
23401631|NCT00698828|65216869|FG000|Overall Study|Death|0|||
23401632|NCT00698828|65216870|FG001|Overall Study|Death|0|||
23401633|NCT00698828|65216871|FG002|Overall Study|Death|1|||
23401634|NCT00698828|65216869|FG000|Overall Study|Exacerbation of COPD|1|||
23401635|NCT00698828|65216870|FG001|Overall Study|Exacerbation of COPD|3|||
23401636|NCT00698828|65216871|FG002|Overall Study|Exacerbation of COPD|0|||
23401637|NCT00698828|65216869|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
23401638|NCT00698828|65216870|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
23401639|NCT00698828|65216871|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
23401640|NCT00698828|65216869|FG000|Overall Study|Investigator/Sponsor decision|1|||
23401641|NCT00698828|65216870|FG001|Overall Study|Investigator/Sponsor decision|0|||
23401642|NCT00698828|65216871|FG002|Overall Study|Investigator/Sponsor decision|2|||
23401643|NCT00698828|65216869|FG000|Overall Study|Lost to Follow-up|1|||
23401644|NCT00698828|65216870|FG001|Overall Study|Lost to Follow-up|1|||
23401645|NCT00698828|65216871|FG002|Overall Study|Lost to Follow-up|0|||
23401646|NCT00698828|65216869|FG000|Overall Study|Withdrew consent|0|||
23401647|NCT00698828|65216870|FG001|Overall Study|Withdrew consent|7|||
23401648|NCT00698828|65216871|FG002|Overall Study|Withdrew consent|4|||
23401649|NCT00698828|65216869|FG000|Overall Study|Withdrew consent (not treated)|2|||
23401650|NCT00698828|65216870|FG001|Overall Study|Withdrew consent (not treated)|0|||
23401651|NCT00698828|65216871|FG002|Overall Study|Withdrew consent (not treated)|0|||
23401652|NCT01757665|65216872|FG000|Overall Study|Still on Study - Visit Completed|240|||
23401653|NCT01757665|65216873|FG001|Overall Study|Still on Study - Visit Completed|30|||
23401654|NCT01757665|65216872|FG000|Overall Study|Still on Study - Visit Pending|398|||
23401655|NCT01757665|65216873|FG001|Overall Study|Still on Study - Visit Pending|40|||
23401656|NCT01757665|65216872|FG000|Overall Study|Still on Study - Missed Visit|14|||
23401657|NCT01757665|65216873|FG001|Overall Study|Still on Study - Missed Visit|1|||
23401658|NCT01757665|65216872|FG000|Overall Study|Death|25|||
23401659|NCT01757665|65216873|FG001|Overall Study|Death|8|||
23401660|NCT01757665|65216872|FG000|Overall Study|Explant|1|||
23401661|NCT01757665|65216873|FG001|Overall Study|Explant|2|||
23401662|NCT01757665|65216872|FG000|Overall Study|Withdrawal by Subject|10|||
23401663|NCT01757665|65216873|FG001|Overall Study|Withdrawal by Subject|0|||
23401664|NCT01757665|65216872|FG000|Overall Study|Lost to Follow-up|1|||
23401665|NCT01757665|65216873|FG001|Overall Study|Lost to Follow-up|1|||
23705277|NCT00256867|66297456|FG003|Overall Study|Adverse Event|1|||
23705278|NCT00256867|66297457|FG004|Overall Study|Adverse Event|2|||
23705279|NCT00256867|66297458|FG005|Overall Study|Adverse Event|2|||
23705280|NCT00256867|66297459|FG006|Overall Study|Adverse Event|1|||
23705281|NCT00256867|66297460|FG007|Overall Study|Adverse Event|4|||
23705282|NCT00256867|66297453|FG000|Overall Study|Lost to Follow-up|2|||
23705283|NCT00256867|66297454|FG001|Overall Study|Lost to Follow-up|2|||
23705284|NCT00256867|66297455|FG002|Overall Study|Lost to Follow-up|2|||
23705285|NCT00256867|66297456|FG003|Overall Study|Lost to Follow-up|3|||
23705286|NCT00256867|66297457|FG004|Overall Study|Lost to Follow-up|2|||
23705287|NCT00256867|66297458|FG005|Overall Study|Lost to Follow-up|0|||
23705288|NCT00256867|66297459|FG006|Overall Study|Lost to Follow-up|1|||
23705289|NCT00256867|66297460|FG007|Overall Study|Lost to Follow-up|2|||
23705290|NCT00256867|66297453|FG000|Overall Study|Protocol Violation|0|||
23705291|NCT00256867|66297454|FG001|Overall Study|Protocol Violation|0|||
23705292|NCT00256867|66297455|FG002|Overall Study|Protocol Violation|0|||
23705293|NCT00256867|66297456|FG003|Overall Study|Protocol Violation|1|||
23705294|NCT00256867|66297457|FG004|Overall Study|Protocol Violation|0|||
23705295|NCT00256867|66297458|FG005|Overall Study|Protocol Violation|1|||
23705296|NCT00256867|66297459|FG006|Overall Study|Protocol Violation|0|||
23705297|NCT00256867|66297460|FG007|Overall Study|Protocol Violation|1|||
23705298|NCT00256867|66297453|FG000|Overall Study|Withdrawal by Subject|0|||
23705299|NCT00256867|66297454|FG001|Overall Study|Withdrawal by Subject|0|||
23705300|NCT00256867|66297455|FG002|Overall Study|Withdrawal by Subject|1|||
23705301|NCT00256867|66297456|FG003|Overall Study|Withdrawal by Subject|1|||
23705302|NCT00256867|66297457|FG004|Overall Study|Withdrawal by Subject|2|||
23705303|NCT00256867|66297458|FG005|Overall Study|Withdrawal by Subject|2|||
23705304|NCT00256867|66297459|FG006|Overall Study|Withdrawal by Subject|3|||
23705305|NCT00256867|66297460|FG007|Overall Study|Withdrawal by Subject|2|||
23705306|NCT00256867|66297453|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705307|NCT00256867|66297454|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
23705308|NCT00256867|66297455|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705309|NCT00256867|66297456|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705310|NCT00256867|66297457|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705311|NCT00256867|66297458|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705312|NCT00256867|66297459|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705313|NCT00256867|66297460|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23705314|NCT00256867|66297453|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705315|NCT00256867|66297454|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705316|NCT00256867|66297455|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705317|NCT00256867|66297456|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705318|NCT00256867|66297457|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705319|NCT00256867|66297458|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705320|NCT00256867|66297459|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23705713|NCT00972244|66297594|FG002|Overall Study|Various|0|||
23705321|NCT00256867|66297460|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
23705322|NCT00256867|66297453|FG000|Overall Study|Investigator's Decision|0|||
23705323|NCT00256867|66297454|FG001|Overall Study|Investigator's Decision|0|||
23705324|NCT00256867|66297455|FG002|Overall Study|Investigator's Decision|0|||
23705325|NCT00256867|66297456|FG003|Overall Study|Investigator's Decision|0|||
23705326|NCT00256867|66297457|FG004|Overall Study|Investigator's Decision|1|||
23705327|NCT00256867|66297458|FG005|Overall Study|Investigator's Decision|0|||
23705328|NCT00256867|66297459|FG006|Overall Study|Investigator's Decision|0|||
23705329|NCT00256867|66297460|FG007|Overall Study|Investigator's Decision|0|||
23705330|NCT00256867|66297453|FG000|Overall Study|Non-compliance with study medication|0|||
23705331|NCT00256867|66297454|FG001|Overall Study|Non-compliance with study medication|0|||
23705332|NCT00256867|66297455|FG002|Overall Study|Non-compliance with study medication|0|||
23705333|NCT00256867|66297456|FG003|Overall Study|Non-compliance with study medication|0|||
23705334|NCT00256867|66297457|FG004|Overall Study|Non-compliance with study medication|0|||
23705335|NCT00256867|66297458|FG005|Overall Study|Non-compliance with study medication|0|||
23705336|NCT00256867|66297459|FG006|Overall Study|Non-compliance with study medication|0|||
23705337|NCT00256867|66297460|FG007|Overall Study|Non-compliance with study medication|1|||
23705338|NCT00256867|66297453|FG000|Overall Study|Participant travelled Overseas|0|||
23705339|NCT00256867|66297454|FG001|Overall Study|Participant travelled Overseas|1|||
23705340|NCT00256867|66297455|FG002|Overall Study|Participant travelled Overseas|0|||
23705341|NCT00256867|66297456|FG003|Overall Study|Participant travelled Overseas|0|||
23705342|NCT00256867|66297457|FG004|Overall Study|Participant travelled Overseas|0|||
23705343|NCT00256867|66297458|FG005|Overall Study|Participant travelled Overseas|0|||
23705344|NCT00256867|66297459|FG006|Overall Study|Participant travelled Overseas|0|||
23705345|NCT00256867|66297460|FG007|Overall Study|Participant travelled Overseas|0|||
23705346|NCT00256867|66297453|FG000|Overall Study|Participant out of assessment window|0|||
23705347|NCT00256867|66297454|FG001|Overall Study|Participant out of assessment window|0|||
23705348|NCT00256867|66297455|FG002|Overall Study|Participant out of assessment window|1|||
23705349|NCT00256867|66297456|FG003|Overall Study|Participant out of assessment window|0|||
23705350|NCT00256867|66297457|FG004|Overall Study|Participant out of assessment window|0|||
23705351|NCT00256867|66297458|FG005|Overall Study|Participant out of assessment window|0|||
23705352|NCT00256867|66297459|FG006|Overall Study|Participant out of assessment window|0|||
23705353|NCT00256867|66297460|FG007|Overall Study|Participant out of assessment window|0|||
23705354|NCT00256867|66297453|FG000|Overall Study|Withdrawal by participant|0|||
23705355|NCT00256867|66297454|FG001|Overall Study|Withdrawal by participant|0|||
23705356|NCT00256867|66297455|FG002|Overall Study|Withdrawal by participant|0|||
23705357|NCT00256867|66297456|FG003|Overall Study|Withdrawal by participant|0|||
23705358|NCT00256867|66297457|FG004|Overall Study|Withdrawal by participant|0|||
23705359|NCT00256867|66297458|FG005|Overall Study|Withdrawal by participant|1|||
23705360|NCT00256867|66297459|FG006|Overall Study|Withdrawal by participant|0|||
23705361|NCT00256867|66297460|FG007|Overall Study|Withdrawal by participant|0|||
23705362|NCT02577406|66297462|FG000|Randomized Period|Death|1|||
23705363|NCT02577406|66297463|FG001|Randomized Period|Death|0|||
23705364|NCT02577406|66297462|FG000|Randomized Period|Other reasons|0|||
23705365|NCT02577406|66297463|FG001|Randomized Period|Other reasons|20|||
23705366|NCT02577406|66297462|FG000|Treatment Period|Transition to commercially available treatment|1|||
23705367|NCT02577406|66297463|FG001|Treatment Period|Transition to commercially available treatment|0|||
23705368|NCT02577406|66297462|FG000|Treatment Period|Progressive disease|47|||
23705369|NCT02577406|66297463|FG001|Treatment Period|Progressive disease|36|||
23705370|NCT02577406|66297462|FG000|Treatment Period|Death|36|||
23705371|NCT02577406|66297463|FG001|Treatment Period|Death|23|||
23705372|NCT02577406|66297462|FG000|Treatment Period|Other reasons|3|||
23705373|NCT02577406|66297463|FG001|Treatment Period|Other reasons|37|||
23705374|NCT02577406|66297462|FG000|Treatment Period|Withdrawal by Subject|10|||
23705375|NCT02577406|66297463|FG001|Treatment Period|Withdrawal by Subject|24|||
23705376|NCT02577406|66297462|FG000|Treatment Period|Adverse Event|17|||
23705377|NCT02577406|66297463|FG001|Treatment Period|Adverse Event|12|||
23705378|NCT02577406|66297462|FG000|Treatment Period|Disease relapse|27|||
23705379|NCT02577406|66297463|FG001|Treatment Period|Disease relapse|1|||
23705380|NCT02577406|66297462|FG000|Treatment Period|HSCT|6|||
23705381|NCT02577406|66297463|FG001|Treatment Period|HSCT|2|||
23705382|NCT02577406|66297462|FG000|Treatment Period|Lost to Follow-up|0|||
23705383|NCT02577406|66297463|FG001|Treatment Period|Lost to Follow-up|1|||
23705384|NCT02577406|66297462|FG000|Treatment Period|Protocol Violation|0|||
23705385|NCT02577406|66297463|FG001|Treatment Period|Protocol Violation|1|||
23705386|NCT00915005|66297467|FG000|Overall Study|Withdrawal by Subject|4|||
23401666|NCT01757665|65216872|FG000|Overall Study|Not Implanted with Device|5|||
23401667|NCT01757665|65216873|FG001|Overall Study|Not Implanted with Device|1|||
23401668|NCT02393859|65216874|FG000|Overall Study|Decision by Sponsor|2|||
23401669|NCT02393859|65216875|FG001|Overall Study|Decision by Sponsor|4|||
23401670|NCT02393859|65216874|FG000|Overall Study|Withdrawal by Subject|11|||
23401671|NCT02393859|65216875|FG001|Overall Study|Withdrawal by Subject|6|||
23401672|NCT02393859|65216874|FG000|Overall Study|Death|27|||
23401673|NCT02393859|65216875|FG001|Overall Study|Death|10|||
23401674|NCT02393859|65216874|FG000|Overall Study|Lost to Follow-up|1|||
23401675|NCT02393859|65216875|FG001|Overall Study|Lost to Follow-up|1|||
23401676|NCT00066690|65216876|FG000|Overall Study|Adverse Event|145|||
23401677|NCT00066690|65216877|FG001|Overall Study|Adverse Event|58|||
23401678|NCT00066690|65216878|FG002|Overall Study|Adverse Event|126|||
23401679|NCT00066690|65216876|FG000|Overall Study|Death|3|||
23401680|NCT00066690|65216877|FG001|Overall Study|Death|0|||
23401681|NCT00066690|65216878|FG002|Overall Study|Death|2|||
23401682|NCT00066690|65216876|FG000|Overall Study|Lack of Efficacy|114|||
23401683|NCT00066690|65216877|FG001|Overall Study|Lack of Efficacy|110|||
23401684|NCT00066690|65216878|FG002|Overall Study|Lack of Efficacy|76|||
23401685|NCT00066690|65216876|FG000|Overall Study|Lost to Follow-up|40|||
23401686|NCT00066690|65216877|FG001|Overall Study|Lost to Follow-up|21|||
23401687|NCT00066690|65216878|FG002|Overall Study|Lost to Follow-up|29|||
23401688|NCT00066690|65216876|FG000|Overall Study|Withdrawal by Subject|50|||
23401689|NCT00066690|65216877|FG001|Overall Study|Withdrawal by Subject|55|||
23401690|NCT00066690|65216878|FG002|Overall Study|Withdrawal by Subject|49|||
23401691|NCT00066690|65216876|FG000|Overall Study|Treatment Ongoing|246|||
23401692|NCT00066690|65216877|FG001|Overall Study|Treatment Ongoing|278|||
23401693|NCT00066690|65216878|FG002|Overall Study|Treatment Ongoing|282|||
23401694|NCT05142306|65216879|FG000|Overall Study|Withdrawal by Subject|0|||
23401695|NCT05142306|65216880|FG001|Overall Study|Withdrawal by Subject|0|||
23401696|NCT05142306|65216881|FG002|Overall Study|Withdrawal by Subject|1|||
23401697|NCT04716894|65216882|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
23401698|NCT04716894|65216882|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
23401699|NCT01173679|65216883|FG000|Overall Study|Death|1|||
23401700|NCT04778592|65216884|FG000|Overall Study|Adverse Event|1|||
23401701|NCT04778592|65216885|FG001|Overall Study|Adverse Event|2|||
23401702|NCT04778592|65216884|FG000|Overall Study|Withdrawal by Subject|1|||
23401703|NCT04778592|65216885|FG001|Overall Study|Withdrawal by Subject|2|||
23401704|NCT00692003|65216886|FG000|Overall Study|Sponsor Decision|5|||
23401705|NCT00692003|65216887|FG001|Overall Study|Sponsor Decision|1|||
23401706|NCT04781816|65216888|FG000|Overall Study|Adverse Event|0|||
23401707|NCT04781816|65216889|FG001|Overall Study|Adverse Event|1|||
23401708|NCT04781816|65216888|FG000|Overall Study|Withdrawal by Subject|1|||
23401709|NCT04781816|65216889|FG001|Overall Study|Withdrawal by Subject|1|||
23401710|NCT04781816|65216888|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
23401711|NCT04781816|65216889|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
23401712|NCT01819272|65216892|FG000|Overall Study|Adverse Event|1|||
23401713|NCT01819272|65216893|FG001|Overall Study|Adverse Event|0|||
23401714|NCT01819272|65216894|FG002|Overall Study|Adverse Event|0|||
23401715|NCT01819272|65216895|FG003|Overall Study|Adverse Event|2|||
23401716|NCT01819272|65216896|FG004|Overall Study|Adverse Event|0|||
23401717|NCT01819272|65216897|FG005|Overall Study|Adverse Event|0|||
23401718|NCT01819272|65216892|FG000|Overall Study|Lost to Follow-up|3|||
23401719|NCT01819272|65216893|FG001|Overall Study|Lost to Follow-up|0|||
23401720|NCT01819272|65216894|FG002|Overall Study|Lost to Follow-up|1|||
23401721|NCT01819272|65216895|FG003|Overall Study|Lost to Follow-up|0|||
23401722|NCT01819272|65216896|FG004|Overall Study|Lost to Follow-up|0|||
23401723|NCT01819272|65216897|FG005|Overall Study|Lost to Follow-up|3|||
23401724|NCT01819272|65216892|FG000|Overall Study|Protocol Violation|0|||
23401725|NCT01819272|65216893|FG001|Overall Study|Protocol Violation|0|||
23401726|NCT01819272|65216894|FG002|Overall Study|Protocol Violation|0|||
23401727|NCT01819272|65216895|FG003|Overall Study|Protocol Violation|1|||
23401728|NCT01819272|65216896|FG004|Overall Study|Protocol Violation|2|||
23401729|NCT01819272|65216897|FG005|Overall Study|Protocol Violation|3|||
23401730|NCT01819272|65216892|FG000|Overall Study|Physician Decision|0|||
23401731|NCT01819272|65216893|FG001|Overall Study|Physician Decision|1|||
23401732|NCT01819272|65216894|FG002|Overall Study|Physician Decision|0|||
23401733|NCT01819272|65216895|FG003|Overall Study|Physician Decision|0|||
23401734|NCT01819272|65216896|FG004|Overall Study|Physician Decision|0|||
23401735|NCT01819272|65216897|FG005|Overall Study|Physician Decision|0|||
23401736|NCT01819272|65216892|FG000|Overall Study|Withdrawal of Consent|0|||
23401737|NCT01819272|65216893|FG001|Overall Study|Withdrawal of Consent|1|||
23401738|NCT01819272|65216894|FG002|Overall Study|Withdrawal of Consent|2|||
23401739|NCT01819272|65216895|FG003|Overall Study|Withdrawal of Consent|1|||
23401740|NCT01819272|65216896|FG004|Overall Study|Withdrawal of Consent|0|||
23401741|NCT01819272|65216897|FG005|Overall Study|Withdrawal of Consent|1|||
23401742|NCT01819272|65216892|FG000|Overall Study|Loss of Glucose Control|2|||
23401743|NCT01819272|65216893|FG001|Overall Study|Loss of Glucose Control|1|||
23401744|NCT01819272|65216894|FG002|Overall Study|Loss of Glucose Control|0|||
23401745|NCT01819272|65216895|FG003|Overall Study|Loss of Glucose Control|1|||
23401746|NCT01819272|65216896|FG004|Overall Study|Loss of Glucose Control|2|||
23401747|NCT01819272|65216897|FG005|Overall Study|Loss of Glucose Control|0|||
23401748|NCT01088503|65216899|FG000|Overall Study|Withdrawal by Subject|118|||
23401749|NCT01088503|65216900|FG001|Overall Study|Withdrawal by Subject|327|||
23401750|NCT01088503|65216901|FG002|Overall Study|Withdrawal by Subject|10|||
23401751|NCT01088503|65216899|FG000|Overall Study|Death|64|||
23401752|NCT01088503|65216900|FG001|Overall Study|Death|358|||
23401753|NCT01088503|65216901|FG002|Overall Study|Death|7|||
23401754|NCT02761642|65216902|FG000|Overall Study|Did not Receive Study Treatment|3|||
23401755|NCT02761642|65216902|FG000|Overall Study|Adverse Event|13|||
23401756|NCT02761642|65216902|FG000|Overall Study|Withdrawal by Subject|2|||
23401757|NCT02761642|65216902|FG000|Overall Study|Non-compliant|7|||
23401758|NCT02761642|65216902|FG000|Overall Study|Death|3|||
23401759|NCT02761642|65216902|FG000|Overall Study|Lack of Efficacy|20|||
23401760|NCT02761642|65216902|FG000|Overall Study|Physician Decision|1|||
23401761|NCT02761642|65216902|FG000|Overall Study|Reason Unspecified|21|||
23401762|NCT02121509|65216908|FG000|Washout Period (35 Days)|Adverse Event|1|||
23401763|NCT02121509|65216909|FG001|Washout Period (35 Days)|Adverse Event|1|||
23401764|NCT02121509|65216910|FG002|Washout Period (35 Days)|Adverse Event|0|||
23401765|NCT02121509|65216911|FG003|Washout Period (35 Days)|Adverse Event|0|||
23401766|NCT02121509|65216908|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401767|NCT02121509|65216909|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
23401768|NCT02121509|65216910|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401769|NCT02121509|65216911|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401770|NCT02121509|65216908|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
23401771|NCT02121509|65216909|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401772|NCT02121509|65216910|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401773|NCT02121509|65216911|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401774|NCT03423602|65216916|FG000|Overall Study|Death|1|||
23401775|NCT03423602|65216916|FG000|Overall Study|Lost to Follow-up|6|||
23401776|NCT03423602|65216916|FG000|Overall Study|Protocol Violation|1|||
23401777|NCT03423602|65216916|FG000|Overall Study|Withdrawal by Subject|4|||
23401778|NCT03559270|65216917|FG000|Overall Study|Adverse Event|6|||
23401779|NCT03559270|65216918|FG001|Overall Study|Adverse Event|5|||
23401780|NCT03559270|65216919|FG002|Overall Study|Adverse Event|3|||
23401781|NCT03559270|65216920|FG003|Overall Study|Adverse Event|0|||
23401782|NCT03559270|65216917|FG000|Overall Study|Lack of Efficacy|34|||
23401783|NCT03559270|65216918|FG001|Overall Study|Lack of Efficacy|52|||
23401784|NCT03559270|65216919|FG002|Overall Study|Lack of Efficacy|37|||
23401785|NCT03559270|65216920|FG003|Overall Study|Lack of Efficacy|2|||
23401786|NCT03559270|65216917|FG000|Overall Study|Death|0|||
23401787|NCT03559270|65216918|FG001|Overall Study|Death|2|||
23401788|NCT03559270|65216919|FG002|Overall Study|Death|0|||
23401789|NCT03559270|65216920|FG003|Overall Study|Death|0|||
23401790|NCT03559270|65216917|FG000|Overall Study|Lost to Follow-up|16|||
23401791|NCT03559270|65216918|FG001|Overall Study|Lost to Follow-up|4|||
23401792|NCT03559270|65216919|FG002|Overall Study|Lost to Follow-up|12|||
23401793|NCT03559270|65216920|FG003|Overall Study|Lost to Follow-up|3|||
23401794|NCT03559270|65216917|FG000|Overall Study|Sponsor Decision|38|||
23401795|NCT03559270|65216918|FG001|Overall Study|Sponsor Decision|31|||
23401796|NCT03559270|65216919|FG002|Overall Study|Sponsor Decision|35|||
23401797|NCT03559270|65216920|FG003|Overall Study|Sponsor Decision|18|||
23401798|NCT03559270|65216917|FG000|Overall Study|Withdrawal by Subject|19|||
23401799|NCT03559270|65216918|FG001|Overall Study|Withdrawal by Subject|21|||
23401800|NCT03559270|65216919|FG002|Overall Study|Withdrawal by Subject|18|||
23401801|NCT03559270|65216920|FG003|Overall Study|Withdrawal by Subject|7|||
23401802|NCT03559270|65216917|FG000|Overall Study|Physician Decision|3|||
23401803|NCT03559270|65216918|FG001|Overall Study|Physician Decision|2|||
23401804|NCT03559270|65216919|FG002|Overall Study|Physician Decision|1|||
23401805|NCT03559270|65216920|FG003|Overall Study|Physician Decision|0|||
23401806|NCT03559270|65216917|FG000|Overall Study|Pregnancy|0|||
23401807|NCT03559270|65216918|FG001|Overall Study|Pregnancy|1|||
23401808|NCT03559270|65216919|FG002|Overall Study|Pregnancy|0|||
23401809|NCT03559270|65216920|FG003|Overall Study|Pregnancy|0|||
23401810|NCT03559270|65216917|FG000|Overall Study|Protocol Violation|1|||
23401811|NCT03559270|65216918|FG001|Overall Study|Protocol Violation|0|||
23401812|NCT03559270|65216919|FG002|Overall Study|Protocol Violation|2|||
23401813|NCT03559270|65216920|FG003|Overall Study|Protocol Violation|0|||
23401814|NCT02197572|65216921|FG000|Overall Study|Progressive Disease|28|||
23401815|NCT02197572|65216921|FG000|Overall Study|Withdrawal by Subject|9|||
23401816|NCT02197572|65216921|FG000|Overall Study|Adverse Event|3|||
23401817|NCT02197572|65216921|FG000|Overall Study|Reason Not Specified|4|||
23401818|NCT03507127|65216922|FG000|Overall Study|Withdrawal by Subject|1|||
23401819|NCT03507127|65216923|FG001|Overall Study|Withdrawal by Subject|0|||
23401820|NCT03507127|65216922|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
23401821|NCT03507127|65216923|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
23401822|NCT00707993|65216924|FG000|Overall Study|Adverse Event|16|||
23401823|NCT00707993|65216925|FG001|Overall Study|Adverse Event|20|||
23401824|NCT00707993|65216924|FG000|Overall Study|Protocol Violation|4|||
23401825|NCT00707993|65216925|FG001|Overall Study|Protocol Violation|7|||
23401826|NCT00707993|65216924|FG000|Overall Study|Lost to Follow-up|0|||
23401827|NCT00707993|65216925|FG001|Overall Study|Lost to Follow-up|4|||
23401828|NCT00707993|65216924|FG000|Overall Study|Withdrawal by Subject|12|||
23401829|NCT00707993|65216925|FG001|Overall Study|Withdrawal by Subject|16|||
23401830|NCT00707993|65216924|FG000|Overall Study|Hyperglycemic Rescue|55|||
23401831|NCT00707993|65216925|FG001|Overall Study|Hyperglycemic Rescue|47|||
23401832|NCT00707993|65216924|FG000|Overall Study|Other|2|||
23401833|NCT00707993|65216925|FG001|Overall Study|Other|0|||
23401834|NCT01500317|65216926|FG000|Overall Study|Withdrawal by Subject|3|||
23401835|NCT01500317|65216927|FG001|Overall Study|Withdrawal by Subject|2|||
23401836|NCT01500317|65216928|FG002|Overall Study|Withdrawal by Subject|0|||
23401837|NCT02431325|65216929|FG000|Overall Study|Adverse Event|3|||
23401838|NCT02431325|65216930|FG001|Overall Study|Adverse Event|0|||
23401839|NCT02431325|65216929|FG000|Overall Study|Lost to Follow-up|0|||
23401840|NCT02431325|65216930|FG001|Overall Study|Lost to Follow-up|1|||
23401841|NCT02431325|65216929|FG000|Overall Study|Withdrawal by Subject|1|||
23401842|NCT02431325|65216930|FG001|Overall Study|Withdrawal by Subject|2|||
23401843|NCT02431325|65216929|FG000|Overall Study|Declined to take study medication|1|||
23401844|NCT02431325|65216930|FG001|Overall Study|Declined to take study medication|0|||
23401845|NCT02431325|65216929|FG000|Overall Study|Withdrew before starting study medication|1|||
23401846|NCT02431325|65216930|FG001|Overall Study|Withdrew before starting study medication|0|||
23401847|NCT02431325|65216929|FG000|Overall Study|Placebo shortage|2|||
23401848|NCT02431325|65216930|FG001|Overall Study|Placebo shortage|0|||
23401849|NCT03698279|65216931|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23401850|NCT03698279|65216932|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23401851|NCT03698279|65216933|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23401852|NCT03698279|65216934|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23401853|NCT03698279|65216935|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23401854|NCT03698279|65216936|FG005|Overall Study|Withdrawal by parent/guardian|0|||
23401855|NCT03698279|65216931|FG000|Overall Study|Protocol deviation|1|||
23401856|NCT03698279|65216932|FG001|Overall Study|Protocol deviation|0|||
23401857|NCT03698279|65216933|FG002|Overall Study|Protocol deviation|1|||
23401858|NCT03698279|65216934|FG003|Overall Study|Protocol deviation|0|||
23401859|NCT03698279|65216935|FG004|Overall Study|Protocol deviation|0|||
23401860|NCT03698279|65216936|FG005|Overall Study|Protocol deviation|0|||
23401861|NCT03698279|65216931|FG000|Overall Study|Withdrawal by Subject|0|||
23401862|NCT03698279|65216932|FG001|Overall Study|Withdrawal by Subject|0|||
23401863|NCT03698279|65216933|FG002|Overall Study|Withdrawal by Subject|1|||
23401864|NCT03698279|65216934|FG003|Overall Study|Withdrawal by Subject|0|||
23401865|NCT03698279|65216935|FG004|Overall Study|Withdrawal by Subject|0|||
23401866|NCT03698279|65216936|FG005|Overall Study|Withdrawal by Subject|0|||
23401867|NCT03698279|65216931|FG000|Overall Study|Lost to Follow-up|3|||
23401868|NCT03698279|65216932|FG001|Overall Study|Lost to Follow-up|1|||
23401869|NCT03698279|65216933|FG002|Overall Study|Lost to Follow-up|4|||
23401870|NCT03698279|65216934|FG003|Overall Study|Lost to Follow-up|5|||
23401871|NCT03698279|65216935|FG004|Overall Study|Lost to Follow-up|0|||
23401872|NCT03698279|65216936|FG005|Overall Study|Lost to Follow-up|0|||
23401873|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
23401874|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
23401875|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
23401876|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
23401877|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401878|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
23401879|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401880|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401881|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401882|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
23401883|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401884|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401885|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401886|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
23401887|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401888|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401889|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401890|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
23401891|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401892|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401893|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401894|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401895|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401896|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
23401897|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401898|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401899|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401900|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
23401901|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401902|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401903|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401904|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
23401905|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
23401906|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
23401907|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
23401908|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
23401909|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
23401910|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
23401911|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
23401912|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
23401913|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
23401914|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
23401915|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
23401916|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
23401917|NCT00586157|65216946|FG000|First Intervention|Worsening behavior|1|||
23401918|NCT00586157|65216947|FG001|First Intervention|Worsening behavior|0|||
23401919|NCT00586157|65216946|FG000|Second Intervention|Withdrawal by Subject|1|||
23401920|NCT00586157|65216947|FG001|Second Intervention|Withdrawal by Subject|0|||
23401921|NCT00586157|65216946|FG000|Second Intervention|Worsening behavior|1|||
23401922|NCT00586157|65216947|FG001|Second Intervention|Worsening behavior|0|||
23401923|NCT00586157|65216946|FG000|Second Intervention|Adverse Event|0|||
23401924|NCT00586157|65216947|FG001|Second Intervention|Adverse Event|1|||
23401925|NCT00244621|65216948|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23401926|NCT00244621|65216949|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23401927|NCT00244621|65216950|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23401928|NCT00244621|65216948|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23401929|NCT00244621|65216949|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23401930|NCT00244621|65216950|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23401931|NCT00244621|65216948|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23401932|NCT00244621|65216949|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23401933|NCT00244621|65216950|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23401934|NCT00244621|65216948|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
23401935|NCT00244621|65216949|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
23401936|NCT00244621|65216950|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
23401937|NCT00244621|65216948|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23401938|NCT00244621|65216949|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
23401939|NCT00244621|65216950|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23401940|NCT00244621|65216948|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
23401941|NCT00244621|65216949|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23401942|NCT00244621|65216950|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23401943|NCT00244621|65216948|FG000|Open-label Treatment Period|Adverse Event|0|||
23401944|NCT00244621|65216949|FG001|Open-label Treatment Period|Adverse Event|0|||
23401945|NCT00244621|65216950|FG002|Open-label Treatment Period|Adverse Event|1|||
23401946|NCT00244621|65216948|FG000|Open-label Treatment Period|Moved abroad|0|||
23401947|NCT00244621|65216949|FG001|Open-label Treatment Period|Moved abroad|0|||
23401948|NCT00244621|65216950|FG002|Open-label Treatment Period|Moved abroad|1|||
23401949|NCT01083602|65216951|FG000|Overall Study|Adverse Event|11|||
23401950|NCT01083602|65216951|FG000|Overall Study|New Cancer Therapy|2|||
23401951|NCT01083602|65216951|FG000|Overall Study|Death|1|||
23401952|NCT01083602|65216951|FG000|Overall Study|Withdrawal by Subject|5|||
23401953|NCT01083602|65216951|FG000|Overall Study|Lack of Efficacy|36|||
23401954|NCT01897532|65216955|FG000|Discontinuation From Treatment|Not Treated|7|||
23401955|NCT01897532|65216956|FG001|Discontinuation From Treatment|Not Treated|5|||
23401956|NCT01897532|65216955|FG000|Discontinuation From Treatment|Other reason than specified|196|||
23401957|NCT01897532|65216956|FG001|Discontinuation From Treatment|Other reason than specified|176|||
23401958|NCT01897532|65216955|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
23401959|NCT01897532|65216956|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
23401960|NCT01897532|65216955|FG000|Discontinuation From Treatment|Non compliance|24|||
23401961|NCT01897532|65216956|FG001|Discontinuation From Treatment|Non compliance|15|||
23401962|NCT01897532|65216955|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
23401963|NCT01897532|65216956|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
23401964|NCT01897532|65216955|FG000|Discontinuation From Trial|Not Treated|7|||
23401965|NCT01897532|65216956|FG001|Discontinuation From Trial|Not Treated|5|||
23401966|NCT01897532|65216955|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
23401967|NCT01897532|65216956|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
23401968|NCT00278161|65216957|FG000|Overall Study|Death|11|||
23401969|NCT02297412|65216958|FG000|Overall Study|Canceled|1|||
23401970|NCT02297412|65216959|FG001|Overall Study|Canceled|1|||
23401971|NCT00487981|65216960|FG000|Overall Study|Hypothyroidism diagnosis|1|||
23401972|NCT00696878|65216961|FG000|Overall Study|Adverse Event|8|||
23401973|NCT00696878|65216961|FG000|Overall Study|Withdrawal by Subject|87|||
23401974|NCT00696878|65216961|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
23401975|NCT00696878|65216961|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
23401976|NCT00696878|65216961|FG000|Overall Study|Trial stopped|32|||
23401977|NCT00696878|65216961|FG000|Overall Study|Other reason (not specified)|55|||
23401978|NCT01897493|65216964|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
23401979|NCT02834819|65216966|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
23401980|NCT02834819|65216967|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
23401981|NCT02136914|65216971|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
23401982|NCT02136914|65216972|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
23401983|NCT02136914|65216971|FG000|Overall Study|Withdrawal by Subject|3|||
23401984|NCT02136914|65216972|FG001|Overall Study|Withdrawal by Subject|10|||
23401985|NCT02136914|65216971|FG000|Overall Study|Subject Unwilling to Proceed|7|||
23401986|NCT02136914|65216972|FG001|Overall Study|Subject Unwilling to Proceed|2|||
23401987|NCT02136914|65216971|FG000|Overall Study|Lost to Follow-up|1|||
23401988|NCT02136914|65216972|FG001|Overall Study|Lost to Follow-up|1|||
23401989|NCT02136914|65216971|FG000|Overall Study|Did Not Receive Study Drug|2|||
23401990|NCT02136914|65216972|FG001|Overall Study|Did Not Receive Study Drug|0|||
23401991|NCT02136914|65216971|FG000|Overall Study|Lack of Efficacy|1|||
23401992|NCT02136914|65216972|FG001|Overall Study|Lack of Efficacy|0|||
23401993|NCT02136914|65216971|FG000|Overall Study|Death|0|||
23401994|NCT02136914|65216972|FG001|Overall Study|Death|1|||
23401995|NCT02303262|65216973|FG000|Overall Study|Withdrawal by Subject|2|||
23401996|NCT03012334|65216977|FG000|Period 1|Withdrawal by Subject|0|||
23401997|NCT03012334|65216978|FG001|Period 1|Withdrawal by Subject|0|||
23401998|NCT03012334|65216979|FG002|Period 1|Withdrawal by Subject|0|||
23401999|NCT03012334|65216980|FG003|Period 1|Withdrawal by Subject|0|||
23402000|NCT03012334|65216981|FG004|Period 1|Withdrawal by Subject|0|||
23402001|NCT03012334|65216982|FG005|Period 1|Withdrawal by Subject|0|||
23402002|NCT03012334|65216983|FG006|Period 1|Withdrawal by Subject|0|||
23402003|NCT03012334|65216984|FG007|Period 1|Withdrawal by Subject|0|||
23402004|NCT03012334|65216985|FG008|Period 1|Withdrawal by Subject|0|||
23402005|NCT03012334|65216986|FG009|Period 1|Withdrawal by Subject|1|||
23402006|NCT03012334|65216977|FG000|Period 2|Withdrawal by Subject|0|||
23402007|NCT03012334|65216978|FG001|Period 2|Withdrawal by Subject|1|||
23402008|NCT03012334|65216979|FG002|Period 2|Withdrawal by Subject|0|||
23402009|NCT03012334|65216980|FG003|Period 2|Withdrawal by Subject|0|||
23402010|NCT03012334|65216981|FG004|Period 2|Withdrawal by Subject|0|||
23402011|NCT03012334|65216982|FG005|Period 2|Withdrawal by Subject|0|||
23402012|NCT03012334|65216983|FG006|Period 2|Withdrawal by Subject|0|||
23402013|NCT03012334|65216984|FG007|Period 2|Withdrawal by Subject|0|||
23402014|NCT03012334|65216985|FG008|Period 2|Withdrawal by Subject|0|||
23402015|NCT03012334|65216986|FG009|Period 2|Withdrawal by Subject|0|||
23402016|NCT03012334|65216977|FG000|Period 2|Protocol Violation|0|||
23402017|NCT03012334|65216978|FG001|Period 2|Protocol Violation|0|||
23402018|NCT03012334|65216979|FG002|Period 2|Protocol Violation|1|||
23402019|NCT03012334|65216980|FG003|Period 2|Protocol Violation|0|||
23402020|NCT03012334|65216981|FG004|Period 2|Protocol Violation|0|||
23402021|NCT03012334|65216982|FG005|Period 2|Protocol Violation|0|||
23402022|NCT03012334|65216983|FG006|Period 2|Protocol Violation|0|||
23402023|NCT03012334|65216984|FG007|Period 2|Protocol Violation|1|||
23402024|NCT03012334|65216985|FG008|Period 2|Protocol Violation|0|||
23402025|NCT03012334|65216986|FG009|Period 2|Protocol Violation|0|||
23402026|NCT03012334|65216977|FG000|Period 4|Non-Compliance|0|||
23402027|NCT03012334|65216978|FG001|Period 4|Non-Compliance|0|||
23402028|NCT03012334|65216979|FG002|Period 4|Non-Compliance|0|||
23402029|NCT03012334|65216980|FG003|Period 4|Non-Compliance|0|||
23402030|NCT03012334|65216981|FG004|Period 4|Non-Compliance|0|||
23402031|NCT03012334|65216982|FG005|Period 4|Non-Compliance|0|||
23402032|NCT03012334|65216983|FG006|Period 4|Non-Compliance|1|||
23402033|NCT03012334|65216984|FG007|Period 4|Non-Compliance|0|||
23402034|NCT03012334|65216985|FG008|Period 4|Non-Compliance|0|||
23402035|NCT03012334|65216986|FG009|Period 4|Non-Compliance|0|||
23402036|NCT03012334|65216977|FG000|Period 4|Adverse Event|0|||
23402037|NCT03012334|65216978|FG001|Period 4|Adverse Event|0|||
23402038|NCT03012334|65216979|FG002|Period 4|Adverse Event|0|||
23402039|NCT03012334|65216980|FG003|Period 4|Adverse Event|0|||
23402040|NCT03012334|65216981|FG004|Period 4|Adverse Event|0|||
23402041|NCT03012334|65216982|FG005|Period 4|Adverse Event|0|||
23402042|NCT03012334|65216983|FG006|Period 4|Adverse Event|0|||
23402043|NCT03012334|65216984|FG007|Period 4|Adverse Event|0|||
23402044|NCT03012334|65216985|FG008|Period 4|Adverse Event|1|||
23402045|NCT03012334|65216986|FG009|Period 4|Adverse Event|0|||
23402046|NCT00532844|65216988|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
23402047|NCT00532844|65216989|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
23402048|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
23402049|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
23402050|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
23402051|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
23402052|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
23402053|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
23402054|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
23402055|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
23402056|NCT03192137|65216995|FG000|Overall Study|Adverse Event|10|||
23402057|NCT03192137|65216996|FG001|Overall Study|Adverse Event|11|||
23402058|NCT03192137|65216995|FG000|Overall Study|Physician Decision|1|||
23402059|NCT03192137|65216996|FG001|Overall Study|Physician Decision|0|||
23402060|NCT03192137|65216995|FG000|Overall Study|Lack of Efficacy|20|||
23402061|NCT03192137|65216996|FG001|Overall Study|Lack of Efficacy|37|||
23402062|NCT03192137|65216995|FG000|Overall Study|Withdrawal by Subject|3|||
23402063|NCT03192137|65216996|FG001|Overall Study|Withdrawal by Subject|3|||
23402064|NCT03192137|65216995|FG000|Overall Study|Protocol Violation|4|||
23402065|NCT03192137|65216996|FG001|Overall Study|Protocol Violation|3|||
23402066|NCT03192137|65216995|FG000|Overall Study|Surgery Cancelled|4|||
23402067|NCT03192137|65216996|FG001|Overall Study|Surgery Cancelled|1|||
23402068|NCT03192137|65216995|FG000|Overall Study|Other - Various Administrative Reasons|8|||
23402069|NCT03192137|65216996|FG001|Overall Study|Other - Various Administrative Reasons|3|||
23402070|NCT02254291|65216997|FG000|Overall Study|Withdrawal by Subject|0|||
23402071|NCT02254291|65216998|FG001|Overall Study|Withdrawal by Subject|3|||
23402072|NCT02254291|65216999|FG002|Overall Study|Withdrawal by Subject|1|||
23402073|NCT02254291|65216997|FG000|Overall Study|Missing follow-up information|0|||
23402074|NCT02254291|65216998|FG001|Overall Study|Missing follow-up information|0|||
23402075|NCT02254291|65216999|FG002|Overall Study|Missing follow-up information|1|||
23402076|NCT01913327|65217000|FG000|Overall Study|Withdrawal by Subject|0|||
23402077|NCT01913327|65217001|FG001|Overall Study|Withdrawal by Subject|1|||
23402078|NCT03500211|65217002|FG000|Overall Study|Withdrawal by Subject|1|||
23402079|NCT03500211|65217003|FG001|Overall Study|Withdrawal by Subject|1|||
23402080|NCT01213082|65219749|FG000|Overall Study|Lost to Follow-up|6|||
23402081|NCT01213082|65219750|FG001|Overall Study|Lost to Follow-up|7|||
23402082|NCT01213082|65219751|FG002|Overall Study|Lost to Follow-up|4|||
23402083|NCT01213082|65219749|FG000|Overall Study|Physician Decision|0|||
23402084|NCT01213082|65219750|FG001|Overall Study|Physician Decision|0|||
23402085|NCT01213082|65219751|FG002|Overall Study|Physician Decision|1|||
23402086|NCT01334554|65219752|FG000|Overall Study|Adverse Event|4|||
23402087|NCT01334554|65219753|FG001|Overall Study|Adverse Event|2|||
23402088|NCT01847443|65219754|FG000|Study Period 1|Withdrawal by Subject|0|||
23402089|NCT01847443|65219755|FG001|Study Period 1|Withdrawal by Subject|1|||
23402090|NCT01847443|65219756|FG002|Study Period 1|Withdrawal by Subject|0|||
23402091|NCT01847443|65219757|FG003|Study Period 1|Withdrawal by Subject|0|||
23402092|NCT01847443|65219754|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
23402093|NCT01847443|65219755|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
23402094|NCT01847443|65219756|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
23402095|NCT01847443|65219757|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
23402096|NCT01847443|65219754|FG000|Washout Period Before Study Period 2|Other reason|1|||
23402097|NCT01847443|65219755|FG001|Washout Period Before Study Period 2|Other reason|0|||
23402098|NCT01847443|65219756|FG002|Washout Period Before Study Period 2|Other reason|0|||
23402099|NCT01847443|65219757|FG003|Washout Period Before Study Period 2|Other reason|0|||
23402100|NCT01847443|65219754|FG000|Washout Period Before Study Period 3|Other reason|1|||
23402101|NCT01847443|65219755|FG001|Washout Period Before Study Period 3|Other reason|0|||
23402102|NCT01847443|65219756|FG002|Washout Period Before Study Period 3|Other reason|0|||
23402103|NCT01847443|65219757|FG003|Washout Period Before Study Period 3|Other reason|0|||
23402104|NCT01847443|65219754|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
23402105|NCT01847443|65219755|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402106|NCT01847443|65219756|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402107|NCT01847443|65219757|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402108|NCT01847443|65219754|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
23402109|NCT01847443|65219755|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402110|NCT01847443|65219756|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402111|NCT01847443|65219757|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402112|NCT00948688|65219760|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
23402113|NCT00948688|65219761|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
23402114|NCT00948688|65219760|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
23402115|NCT00948688|65219761|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
23402116|NCT00948688|65219760|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
23402117|NCT00948688|65219761|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
23402118|NCT02332187|65219763|FG000|Overall Study|Withdrawal by Subject|2|||
23402119|NCT02332187|65219764|FG001|Overall Study|Withdrawal by Subject|2|||
23402120|NCT02332187|65219763|FG000|Overall Study|Adverse Event|0|||
23402121|NCT02332187|65219764|FG001|Overall Study|Adverse Event|1|||
23402122|NCT00305448|65219765|FG000|Overall Study|Protocol Violation|0|||
23402123|NCT00305448|65219766|FG001|Overall Study|Protocol Violation|1|||
23402124|NCT00305448|65219767|FG002|Overall Study|Protocol Violation|0|||
23402125|NCT00305448|65219765|FG000|Overall Study|Withdrawal by Subject|2|||
23402126|NCT00305448|65219766|FG001|Overall Study|Withdrawal by Subject|0|||
23402127|NCT00305448|65219767|FG002|Overall Study|Withdrawal by Subject|1|||
23402128|NCT00305448|65219765|FG000|Overall Study|Adverse Event|1|||
23402129|NCT00305448|65219766|FG001|Overall Study|Adverse Event|0|||
23402130|NCT00305448|65219767|FG002|Overall Study|Adverse Event|1|||
23402131|NCT00305448|65219765|FG000|Overall Study|Disease Progression|27|||
23402132|NCT00305448|65219766|FG001|Overall Study|Disease Progression|31|||
23402133|NCT00305448|65219767|FG002|Overall Study|Disease Progression|28|||
23402134|NCT00305448|65219765|FG000|Overall Study|Subjective Disease Progression|1|||
23402135|NCT00305448|65219766|FG001|Overall Study|Subjective Disease Progression|2|||
23402136|NCT00305448|65219767|FG002|Overall Study|Subjective Disease Progression|2|||
23402137|NCT00305448|65219765|FG000|Overall Study|Tumor Marker Elevation|0|||
23402138|NCT00305448|65219766|FG001|Overall Study|Tumor Marker Elevation|0|||
23402139|NCT00305448|65219767|FG002|Overall Study|Tumor Marker Elevation|1|||
23402140|NCT00436436|65219769|FG000|Overall Study|Progression|4|||
23402141|NCT00436436|65219769|FG000|Overall Study|Adverse Event|2|||
23402142|NCT00436436|65219769|FG000|Overall Study|Death|6|||
23402143|NCT04568603|65219770|FG000|Overall Study|Physician Decision|1|||
23402144|NCT01977222|65219784|FG000|Overall Study|Withdrawal by Subject|1|||
23402145|NCT00441272|65219787|FG000|Overall Study|Study terminated prior to enrollment|25|||
23402146|NCT00441272|65219788|FG001|Overall Study|Study terminated prior to enrollment|25|||
23402147|NCT02465931|65219789|FG000|Overall Study|Lost to Follow-up|9|||
23402148|NCT02465931|65219790|FG001|Overall Study|Lost to Follow-up|11|||
23402149|NCT02465931|65219789|FG000|Overall Study|Protocol Violation|1|||
23402150|NCT02465931|65219790|FG001|Overall Study|Protocol Violation|0|||
23402151|NCT02465931|65219789|FG000|Overall Study|Withdrawal by Subject|1|||
23402152|NCT02465931|65219790|FG001|Overall Study|Withdrawal by Subject|0|||
23402153|NCT04460183|65219791|FG000|Overall Study|Lost to Follow-up|3|||
23402154|NCT04460183|65219792|FG001|Overall Study|Lost to Follow-up|1|||
23402155|NCT04460183|65219791|FG000|Overall Study|Withdrawal by Subject|1|||
23402156|NCT04460183|65219792|FG001|Overall Study|Withdrawal by Subject|0|||
23402157|NCT01240863|65219793|FG000|Open-label Titration Period|Adverse Event|47|||
23402158|NCT01240863|65219794|FG001|Open-label Titration Period|Adverse Event|0|||
23402159|NCT01240863|65219795|FG002|Open-label Titration Period|Adverse Event|0|||
23402160|NCT01240863|65219793|FG000|Open-label Titration Period|Lack of Efficacy|19|||
23402161|NCT01240863|65219794|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23402162|NCT01240863|65219795|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23402163|NCT01240863|65219793|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
23402164|NCT01240863|65219794|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23402165|NCT01240863|65219795|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23402166|NCT01240863|65219793|FG000|Open-label Titration Period|Protocol Violation|7|||
23402167|NCT01240863|65219794|FG001|Open-label Titration Period|Protocol Violation|0|||
23402168|NCT01240863|65219795|FG002|Open-label Titration Period|Protocol Violation|0|||
23402169|NCT01240863|65219793|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
23402170|NCT01240863|65219794|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
23402171|NCT01240863|65219795|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
23402172|NCT01240863|65219793|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
23402173|NCT01240863|65219794|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
23402174|NCT01240863|65219795|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
23402175|NCT01240863|65219793|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
23402176|NCT01240863|65219794|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
23402177|NCT01240863|65219795|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
23402178|NCT01240863|65219793|FG000|Open-label Titration Period|Other|7|||
23402179|NCT01240863|65219794|FG001|Open-label Titration Period|Other|0|||
23402180|NCT01240863|65219795|FG002|Open-label Titration Period|Other|0|||
23402181|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
23402182|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
23402183|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
23402184|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23402185|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
23402186|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
23402187|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23402188|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
23402189|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
23402190|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
23402191|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
23402192|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
23402193|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
23402194|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
23402195|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
23402196|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
23402197|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
23402198|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
23402199|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
23402200|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
23402201|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
23402202|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
23402203|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
23402204|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
23402205|NCT01428219|65219796|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
23402206|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
23402207|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
23402208|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
23402209|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
23402210|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
23402211|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
23402212|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
23402213|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
23402214|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
23402215|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
23402216|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
23402217|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
23402218|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
23402219|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
23402220|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
23402221|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
23402222|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
23402223|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
23402224|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
23402225|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
23402226|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
23402227|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
23402228|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
23402229|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
23705714|NCT00972244|66297595|FG003|Overall Study|Various|0|||
23402230|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
23402231|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
23402232|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
23402233|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
23402234|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
23402235|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
23402236|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
23402237|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
23402238|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
23402239|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
23402240|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
23402241|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
23402242|NCT00806260|65219802|FG000|Period 1 (1 Day)|Adverse Event|0|||
23402243|NCT00806260|65219803|FG001|Period 1 (1 Day)|Adverse Event|0|||
23402244|NCT00806260|65219804|FG002|Period 1 (1 Day)|Adverse Event|0|||
23402245|NCT00806260|65219805|FG003|Period 1 (1 Day)|Adverse Event|0|||
23402246|NCT00806260|65219806|FG004|Period 1 (1 Day)|Adverse Event|3|||
23402247|NCT00806260|65219807|FG005|Period 1 (1 Day)|Adverse Event|0|||
23402248|NCT00806260|65219802|FG000|Period 2|Adverse Event|0|||
23402249|NCT00806260|65219803|FG001|Period 2|Adverse Event|0|||
23402250|NCT00806260|65219804|FG002|Period 2|Adverse Event|0|||
23402251|NCT00806260|65219805|FG003|Period 2|Adverse Event|1|||
23402252|NCT00806260|65219806|FG004|Period 2|Adverse Event|0|||
23402253|NCT00806260|65219807|FG005|Period 2|Adverse Event|0|||
23402254|NCT00806260|65219802|FG000|Period 2|Protocol Violation|1|||
23402255|NCT00806260|65219803|FG001|Period 2|Protocol Violation|0|||
23402256|NCT00806260|65219804|FG002|Period 2|Protocol Violation|1|||
23402257|NCT00806260|65219805|FG003|Period 2|Protocol Violation|0|||
23402258|NCT00806260|65219806|FG004|Period 2|Protocol Violation|0|||
23402259|NCT00806260|65219807|FG005|Period 2|Protocol Violation|0|||
23402260|NCT00806260|65219802|FG000|Period 2|Need to take concomitant medication|1|||
23402261|NCT00806260|65219803|FG001|Period 2|Need to take concomitant medication|0|||
23402262|NCT00806260|65219804|FG002|Period 2|Need to take concomitant medication|0|||
23402263|NCT00806260|65219805|FG003|Period 2|Need to take concomitant medication|0|||
23402264|NCT00806260|65219806|FG004|Period 2|Need to take concomitant medication|0|||
23402265|NCT00806260|65219807|FG005|Period 2|Need to take concomitant medication|0|||
23402266|NCT00806260|65219802|FG000|Period 2|sponsor request|0|||
23402267|NCT00806260|65219803|FG001|Period 2|sponsor request|0|||
23402268|NCT00806260|65219804|FG002|Period 2|sponsor request|1|||
23402269|NCT00806260|65219805|FG003|Period 2|sponsor request|1|||
23402270|NCT00806260|65219806|FG004|Period 2|sponsor request|0|||
23402271|NCT00806260|65219807|FG005|Period 2|sponsor request|0|||
23402272|NCT00806260|65219802|FG000|Period 3|Protocol Violation|0|||
23402273|NCT00806260|65219803|FG001|Period 3|Protocol Violation|1|||
23402274|NCT00806260|65219804|FG002|Period 3|Protocol Violation|1|||
23402275|NCT00806260|65219805|FG003|Period 3|Protocol Violation|0|||
23402276|NCT00806260|65219806|FG004|Period 3|Protocol Violation|0|||
23402277|NCT00806260|65219807|FG005|Period 3|Protocol Violation|0|||
23402278|NCT00806260|65219802|FG000|Period 3|Pregnancy|1|||
23402279|NCT00806260|65219803|FG001|Period 3|Pregnancy|0|||
23402280|NCT00806260|65219804|FG002|Period 3|Pregnancy|0|||
23402281|NCT00806260|65219805|FG003|Period 3|Pregnancy|0|||
23402282|NCT00806260|65219806|FG004|Period 3|Pregnancy|0|||
23402283|NCT00806260|65219807|FG005|Period 3|Pregnancy|0|||
23402284|NCT02031302|65219808|FG000|Overall Study|Death|115|||
23402285|NCT02031302|65219809|FG001|Overall Study|Death|0|||
23402286|NCT02031302|65219808|FG000|Overall Study|Not treated with study valve system|18|||
23402287|NCT02031302|65219809|FG001|Overall Study|Not treated with study valve system|0|||
23402288|NCT02031302|65219808|FG000|Overall Study|Missed Follow Up|27|||
23402289|NCT02031302|65219809|FG001|Overall Study|Missed Follow Up|0|||
23402290|NCT02031302|65219808|FG000|Overall Study|Lost to Follow-up|4|||
23402291|NCT02031302|65219809|FG001|Overall Study|Lost to Follow-up|0|||
23402292|NCT01976299|65219810|FG000|Overall Study|Withdrawal by Subject|3|||
23402293|NCT01976299|65219811|FG001|Overall Study|Withdrawal by Subject|1|||
23402294|NCT01976299|65219810|FG000|Overall Study|Death|4|||
23402295|NCT01976299|65219811|FG001|Overall Study|Death|2|||
23402296|NCT01976299|65219810|FG000|Overall Study|Lost to Follow-up|7|||
23402297|NCT01976299|65219811|FG001|Overall Study|Lost to Follow-up|1|||
23402298|NCT01976299|65219810|FG000|Overall Study|See clarification above in comments|9|||
23402299|NCT01976299|65219811|FG001|Overall Study|See clarification above in comments|2|||
23402300|NCT00583219|65219814|FG000|Phase 2|Withdrawal by Subject|1|||
23402301|NCT00742625|65219815|FG000|Remission Induction|Progression|6|||
23402302|NCT00742625|65219815|FG000|Remission Induction|Failed induction|8|||
23402303|NCT00742625|65219815|FG000|Remission Induction|Adverse Event|3|||
23402304|NCT00742625|65219815|FG000|Remission Induction|Death|10|||
23402305|NCT00742625|65219815|FG000|Remission Induction|Refusal|5|||
23402306|NCT00742625|65219815|FG000|Remission Induction|Non protocol treatment|17|||
23402307|NCT00742625|65219815|FG000|Remission Induction|Other, not specified|5|||
23402308|NCT00742625|65219815|FG000|Consolidation|Progression|5|||
23402309|NCT00742625|65219815|FG000|Consolidation|Adverse Event|1|||
23402310|NCT00742625|65219815|FG000|Consolidation|Death|1|||
23402311|NCT00742625|65219815|FG000|Consolidation|Refused|1|||
23402312|NCT00742625|65219815|FG000|Consolidation|Non protocol therapy|13|||
23402313|NCT02896257|65219830|FG000|Providers|Without eligible patients|21|||
23402314|NCT02896257|65219831|FG001|Providers|Without eligible patients|28|||
23402315|NCT02896257|65219830|FG000|Patients|PFT entry criteria not met|43|||
23402316|NCT02896257|65219831|FG001|Patients|PFT entry criteria not met|50|||
23402317|NCT02896257|65219830|FG000|Patients|No capacity to review|8|||
23402318|NCT02896257|65219831|FG001|Patients|No capacity to review|11|||
23402319|NCT02896257|65219830|FG000|Patients|Appointment rescheduled/cancelled|5|||
23402320|NCT02896257|65219831|FG001|Patients|Appointment rescheduled/cancelled|7|||
23402321|NCT02896257|65219830|FG000|Patients|PCP not assigned a clinic|4|||
23402322|NCT02896257|65219831|FG001|Patients|PCP not assigned a clinic|0|||
23402323|NCT02896257|65219830|FG000|Patients|No history of COPD|0|||
23402324|NCT02896257|65219831|FG001|Patients|No history of COPD|1|||
23402325|NCT02896257|65219830|FG000|Patients|Deceased between review and index date|0|||
23402326|NCT02896257|65219831|FG001|Patients|Deceased between review and index date|1|||
23402327|NCT02896257|65219830|FG000|Patients|No ICS Rx upon review|1|||
23402328|NCT02896257|65219831|FG001|Patients|No ICS Rx upon review|1|||
23402329|NCT02896257|65219830|FG000|Patients|Protocol Violation|2|||
23402330|NCT02896257|65219831|FG001|Patients|Protocol Violation|1|||
23402331|NCT02896257|65219830|FG000|Patients|Hospice care|0|||
23402332|NCT02896257|65219831|FG001|Patients|Hospice care|1|||
23402333|NCT04846231|65219832|FG000|Overall Study|Lost to Follow-up|1|||
23402334|NCT04846231|65219833|FG001|Overall Study|Lost to Follow-up|0|||
23402335|NCT04846231|65219834|FG002|Overall Study|Lost to Follow-up|0|||
23402336|NCT04846231|65219835|FG003|Overall Study|Lost to Follow-up|0|||
23402337|NCT04846231|65219836|FG004|Overall Study|Lost to Follow-up|0|||
23402338|NCT04846231|65219837|FG005|Overall Study|Lost to Follow-up|0|||
23402339|NCT04846231|65219838|FG006|Overall Study|Lost to Follow-up|0|||
23402340|NCT04846231|65219839|FG007|Overall Study|Lost to Follow-up|1|||
23402341|NCT04846231|65219832|FG000|Overall Study|Withdrawal by Subject|0|||
23402342|NCT04846231|65219833|FG001|Overall Study|Withdrawal by Subject|1|||
23402343|NCT04846231|65219834|FG002|Overall Study|Withdrawal by Subject|2|||
23402344|NCT04846231|65219835|FG003|Overall Study|Withdrawal by Subject|1|||
23402345|NCT04846231|65219836|FG004|Overall Study|Withdrawal by Subject|0|||
23402346|NCT04846231|65219837|FG005|Overall Study|Withdrawal by Subject|0|||
23402347|NCT04846231|65219838|FG006|Overall Study|Withdrawal by Subject|0|||
23402348|NCT04846231|65219839|FG007|Overall Study|Withdrawal by Subject|0|||
23402349|NCT04846231|65219832|FG000|Overall Study|Protocol Violation|0|||
23402350|NCT04846231|65219833|FG001|Overall Study|Protocol Violation|1|||
23402351|NCT04846231|65219834|FG002|Overall Study|Protocol Violation|0|||
23402352|NCT04846231|65219835|FG003|Overall Study|Protocol Violation|0|||
23402353|NCT04846231|65219836|FG004|Overall Study|Protocol Violation|0|||
23402354|NCT04846231|65219837|FG005|Overall Study|Protocol Violation|0|||
23402355|NCT04846231|65219838|FG006|Overall Study|Protocol Violation|0|||
23402356|NCT04846231|65219839|FG007|Overall Study|Protocol Violation|0|||
23402357|NCT04846231|65219832|FG000|Overall Study|Adverse Event|0|||
23402358|NCT04846231|65219833|FG001|Overall Study|Adverse Event|0|||
23402359|NCT04846231|65219834|FG002|Overall Study|Adverse Event|0|||
23402360|NCT04846231|65219835|FG003|Overall Study|Adverse Event|0|||
23402361|NCT04846231|65219836|FG004|Overall Study|Adverse Event|0|||
23402362|NCT04846231|65219837|FG005|Overall Study|Adverse Event|0|||
23402363|NCT04846231|65219838|FG006|Overall Study|Adverse Event|1|||
23402364|NCT04846231|65219839|FG007|Overall Study|Adverse Event|1|||
23402365|NCT04154605|65219840|FG000|Overall Study|Procedure Canceled|1|||
23402366|NCT04154605|65219841|FG001|Overall Study|Procedure Canceled|1|||
23402367|NCT04154605|65219840|FG000|Overall Study|Missed follow up|1|||
23402368|NCT04154605|65219841|FG001|Overall Study|Missed follow up|1|||
23402369|NCT04154605|65219840|FG000|Overall Study|Withdrawal by Subject|1|||
23402370|NCT04154605|65219841|FG001|Overall Study|Withdrawal by Subject|0|||
23402371|NCT02961244|65219842|FG000|Overall Study|Protocol Violation|0|||
23402372|NCT02961244|65219843|FG001|Overall Study|Protocol Violation|1|||
23402373|NCT02961244|65219842|FG000|Overall Study|Withdrawal by Subject|1|||
23402374|NCT02961244|65219843|FG001|Overall Study|Withdrawal by Subject|2|||
23402375|NCT02961244|65219842|FG000|Overall Study|Surgery plan change after study approval|0|||
23402376|NCT02961244|65219843|FG001|Overall Study|Surgery plan change after study approval|2|||
23402377|NCT02961244|65219842|FG000|Overall Study|Lost to Follow-up|0|||
23402378|NCT02961244|65219843|FG001|Overall Study|Lost to Follow-up|2|||
23402379|NCT02961244|65219842|FG000|Overall Study|İnadequate data|0|||
23402380|NCT02961244|65219843|FG001|Overall Study|İnadequate data|2|||
23402381|NCT02808429|65219844|FG000|Overall Study|Lost to Follow-up|1|||
23402382|NCT02808429|65219845|FG001|Overall Study|Lost to Follow-up|0|||
23402383|NCT02808429|65219846|FG002|Overall Study|Lost to Follow-up|0|||
23402384|NCT02808429|65219844|FG000|Overall Study|Protocol Violation|0|||
23402385|NCT02808429|65219845|FG001|Overall Study|Protocol Violation|1|||
23402386|NCT02808429|65219846|FG002|Overall Study|Protocol Violation|0|||
23402387|NCT02808429|65219844|FG000|Overall Study|Premature study termination by sponsor|2|||
23402388|NCT02808429|65219845|FG001|Overall Study|Premature study termination by sponsor|0|||
23402389|NCT02808429|65219846|FG002|Overall Study|Premature study termination by sponsor|1|||
23402390|NCT02808429|65219844|FG000|Overall Study|Relocation|0|||
23402391|NCT02808429|65219845|FG001|Overall Study|Relocation|0|||
23402392|NCT02808429|65219846|FG002|Overall Study|Relocation|1|||
23402393|NCT00552071|65219847|FG000|Overall Study|Adverse Event|1|||
23402394|NCT00552071|65219848|FG001|Overall Study|Adverse Event|0|||
23402395|NCT00552071|65219847|FG000|Overall Study|Lack of Efficacy|1|||
23402396|NCT00552071|65219848|FG001|Overall Study|Lack of Efficacy|0|||
23402397|NCT00552071|65219847|FG000|Overall Study|Physician Decision|1|||
23402398|NCT00552071|65219848|FG001|Overall Study|Physician Decision|0|||
23402399|NCT00552071|65219847|FG000|Overall Study|Pregnancy|1|||
23402400|NCT00552071|65219848|FG001|Overall Study|Pregnancy|0|||
23402401|NCT00552071|65219847|FG000|Overall Study|Death|0|||
23402402|NCT00552071|65219848|FG001|Overall Study|Death|1|||
23402403|NCT00552071|65219847|FG000|Overall Study|Withdrawal by Subject|0|||
23402404|NCT00552071|65219848|FG001|Overall Study|Withdrawal by Subject|1|||
23402405|NCT02829996|65219849|FG000|Overall Study|Withdrawal by Subject|1|||
23402406|NCT02829996|65219850|FG001|Overall Study|Withdrawal by Subject|0|||
23402407|NCT02829996|65219851|FG002|Overall Study|Withdrawal by Subject|0|||
23402408|NCT02829996|65219852|FG003|Overall Study|Withdrawal by Subject|0|||
23402409|NCT02829996|65219853|FG004|Overall Study|Withdrawal by Subject|0|||
23402410|NCT03965403|65219854|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
23402411|NCT02479880|65219861|FG000|Overall Study|Study Terminated by Sponsor|13|||
23402412|NCT02479880|65219862|FG001|Overall Study|Study Terminated by Sponsor|12|||
23402413|NCT02479880|65219861|FG000|Overall Study|Pregnancy|0|||
23402414|NCT02479880|65219862|FG001|Overall Study|Pregnancy|1|||
23402415|NCT02712996|65219863|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
23402416|NCT02712996|65219864|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
23402417|NCT03110029|65219867|FG000|Overall Study|Withdrawal by Subject|1|||
23402418|NCT03110029|65219868|FG001|Overall Study|Withdrawal by Subject|1|||
23402419|NCT02737501|65219869|FG000|Randomized Phase|Died|41|||
23402420|NCT02737501|65219870|FG001|Randomized Phase|Died|29|||
23402421|NCT02737501|65219871|FG002|Randomized Phase|Died|0|||
23402422|NCT02737501|65219869|FG000|Randomized Phase|Withdrawal by Subject|16|||
23402423|NCT02737501|65219870|FG001|Randomized Phase|Withdrawal by Subject|6|||
23402424|NCT02737501|65219871|FG002|Randomized Phase|Withdrawal by Subject|0|||
23402425|NCT02737501|65219869|FG000|Randomized Phase|Lost to Follow-up|0|||
23402426|NCT02737501|65219870|FG001|Randomized Phase|Lost to Follow-up|1|||
23402427|NCT02737501|65219871|FG002|Randomized Phase|Lost to Follow-up|0|||
23402428|NCT02737501|65219869|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
23402429|NCT02737501|65219870|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
23402430|NCT02737501|65219871|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
23402431|NCT02737501|65219869|FG000|Randomized Phase|Reason not Specified|1|||
23402432|NCT02737501|65219870|FG001|Randomized Phase|Reason not Specified|1|||
23402433|NCT02737501|65219871|FG002|Randomized Phase|Reason not Specified|0|||
23402434|NCT02737501|65219869|FG000|Randomized Phase|Never Treated|1|||
23402435|NCT02737501|65219870|FG001|Randomized Phase|Never Treated|1|||
23402436|NCT02737501|65219871|FG002|Randomized Phase|Never Treated|0|||
23402437|NCT02737501|65219869|FG000|Crossover Phase|Died|0|||
23402438|NCT02737501|65219870|FG001|Crossover Phase|Died|0|||
23402439|NCT02737501|65219871|FG002|Crossover Phase|Died|22|||
23402440|NCT02737501|65219869|FG000|Crossover Phase|Withdrew Consent|0|||
23402441|NCT02737501|65219870|FG001|Crossover Phase|Withdrew Consent|0|||
23402442|NCT02737501|65219871|FG002|Crossover Phase|Withdrew Consent|9|||
23402443|NCT02737501|65219869|FG000|Crossover Phase|Physician Decision|0|||
23402444|NCT02737501|65219870|FG001|Crossover Phase|Physician Decision|0|||
23402445|NCT02737501|65219871|FG002|Crossover Phase|Physician Decision|1|||
23402446|NCT02737501|65219869|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
23402447|NCT02737501|65219870|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
23402448|NCT02737501|65219871|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
23402449|NCT01944020|65219872|FG000|Overall Study|Withdrawal by Subject|5|||
23402450|NCT01944020|65219873|FG001|Overall Study|Withdrawal by Subject|0|||
23402451|NCT04099277|65219874|FG000|Overall Study|Physician Decision|1|||
23402452|NCT04099277|65219874|FG000|Overall Study|Withdrawal by Subject|1|||
23402453|NCT02709720|65219879|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
23402454|NCT02709720|65219879|FG000|Overall Study|Protocol Violation|1|||
23402455|NCT02709720|65219879|FG000|Overall Study|Not take study medication|1|||
23402456|NCT02071771|65219880|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
23402457|NCT02071771|65219881|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
23402458|NCT02071771|65219880|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
23402459|NCT02071771|65219881|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
23402460|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
23402461|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
23402462|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
23402463|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
23402464|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
23402465|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
23402466|NCT02026011|65219884|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
23402467|NCT02026011|65219885|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
23402468|NCT03637491|65219886|FG000|Overall Study|Death|9|||
23402469|NCT03637491|65219887|FG001|Overall Study|Death|9|||
23402470|NCT03637491|65219888|FG002|Overall Study|Death|5|||
23402471|NCT03637491|65219889|FG003|Overall Study|Death|3|||
23402472|NCT03637491|65219886|FG000|Overall Study|Lost to Follow-up|0|||
23402473|NCT03637491|65219887|FG001|Overall Study|Lost to Follow-up|1|||
23402474|NCT03637491|65219888|FG002|Overall Study|Lost to Follow-up|0|||
23402475|NCT03637491|65219889|FG003|Overall Study|Lost to Follow-up|1|||
23402476|NCT03637491|65219886|FG000|Overall Study|Study Terminated By Sponsor|0|||
23402477|NCT03637491|65219887|FG001|Overall Study|Study Terminated By Sponsor|2|||
23402478|NCT03637491|65219888|FG002|Overall Study|Study Terminated By Sponsor|1|||
23402479|NCT03637491|65219889|FG003|Overall Study|Study Terminated By Sponsor|0|||
23402480|NCT03637491|65219886|FG000|Overall Study|Withdrawal by Subject|1|||
23402481|NCT03637491|65219887|FG001|Overall Study|Withdrawal by Subject|0|||
23402482|NCT03637491|65219888|FG002|Overall Study|Withdrawal by Subject|1|||
23402483|NCT03637491|65219889|FG003|Overall Study|Withdrawal by Subject|2|||
23402484|NCT04819113|65219890|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23402485|NCT04819113|65219890|FG000|Overall Study|Lost to Follow-up|1|||
23402486|NCT04819113|65219890|FG000|Overall Study|Withdrawn before vaccination|2|||
23402487|NCT01282866|65219891|FG000|Overall Study|Adverse Event|1|||
23402488|NCT01612676|65219896|FG000|Overall Study|Adverse Event|2|||
23402489|NCT01612676|65219897|FG001|Overall Study|Adverse Event|3|||
23402490|NCT01612676|65219898|FG002|Overall Study|Adverse Event|1|||
23402491|NCT01612676|65219899|FG003|Overall Study|Adverse Event|3|||
23402492|NCT01612676|65219896|FG000|Overall Study|Protocol Violation|0|||
23402493|NCT01612676|65219897|FG001|Overall Study|Protocol Violation|1|||
23402494|NCT01612676|65219898|FG002|Overall Study|Protocol Violation|0|||
23402495|NCT01612676|65219899|FG003|Overall Study|Protocol Violation|0|||
23402496|NCT05111145|65219902|FG000|Overall Study|Commercial drug is available for participant|76|||
23402497|NCT05111145|65219902|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
23402498|NCT00598650|65219903|FG000|Overall Study|Withdrawal by Subject|3|||
23402499|NCT00598650|65219903|FG000|Overall Study|Adverse Event|18|||
23402500|NCT00598650|65219903|FG000|Overall Study|No treatment for 3 weeks|1|||
23402501|NCT00598650|65219903|FG000|Overall Study|Not eligible|1|||
23402502|NCT00598650|65219903|FG000|Overall Study|Prohibited Concomitant Medication|2|||
23402503|NCT00598650|65219903|FG000|Overall Study|Physician Decision|2|||
23402504|NCT00558636|65219904|FG000|Treatment|Adverse Event|9|||
23402505|NCT00558636|65219905|FG001|Treatment|Adverse Event|2|||
23402506|NCT00558636|65219904|FG000|Treatment|Withdrawal by Subject|2|||
23402507|NCT00558636|65219905|FG001|Treatment|Withdrawal by Subject|0|||
23402508|NCT00558636|65219904|FG000|Treatment|Premature termination of the study|35|||
23402509|NCT00558636|65219905|FG001|Treatment|Premature termination of the study|37|||
23402510|NCT00558636|65219904|FG000|Treatment|Disease progression|1|||
23402511|NCT00558636|65219905|FG001|Treatment|Disease progression|5|||
23402512|NCT00558636|65219904|FG000|Follow-up|Premature termination of the study|12|||
23402513|NCT00558636|65219905|FG001|Follow-up|Premature termination of the study|7|||
23402514|NCT01541865|65219909|FG000|Overall Study|Lost to Follow-up|11|||
23402515|NCT01541865|65219909|FG000|Overall Study|Withdrawal by Subject|9|||
23402516|NCT01541865|65219909|FG000|Overall Study|Adverse Event|1|||
23402517|NCT01541865|65219909|FG000|Overall Study|Protocol Violation|1|||
23402518|NCT00648037|65219910|FG000|Overall Study|Not Treated|1|||
23402519|NCT00648037|65219910|FG000|Overall Study|Withdrawal by Subject|1|||
23402520|NCT00648037|65219910|FG000|Overall Study|Adverse Event|11|||
23402521|NCT00648037|65219910|FG000|Overall Study|Relapse|2|||
23402522|NCT00648037|65219910|FG000|Overall Study|Other|1|||
23402523|NCT00939107|65219920|FG000|Overall Study|Lost to Follow-up|14|||
23402524|NCT00939107|65219921|FG001|Overall Study|Lost to Follow-up|12|||
23402525|NCT01434654|65219922|FG000|Overall Study|Withdrawal by Subject|1|||
23402526|NCT01434654|65219923|FG001|Overall Study|Withdrawal by Subject|0|||
23402527|NCT01434654|65219922|FG000|Overall Study|Lost to Follow-up|1|||
23402528|NCT01434654|65219923|FG001|Overall Study|Lost to Follow-up|0|||
23402529|NCT00775268|65219924|FG000|Baseline|Drug not synthesize dose|1|||
23402530|NCT00775268|65219925|FG001|Baseline|Drug not synthesize dose|0|||
23402531|NCT00775268|65219924|FG000|Baseline|Not treated-ineligible per CT|0|||
23402532|NCT00775268|65219925|FG001|Baseline|Not treated-ineligible per CT|1|||
23402533|NCT00775268|65219924|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
23402534|NCT00775268|65219925|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
23402535|NCT00775268|65219924|FG000|After Completion|Participant missed scan appointment|1|||
23402536|NCT00775268|65219925|FG001|After Completion|Participant missed scan appointment|0|||
23402537|NCT05173974|65219926|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402538|NCT05173974|65219927|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402539|NCT05173974|65219928|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402540|NCT05173974|65219929|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
23402541|NCT05173974|65219926|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402542|NCT05173974|65219927|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
23402543|NCT05173974|65219928|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402544|NCT05173974|65219929|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402545|NCT04067492|65219930|FG000|Overall Study|Lost to Follow-up|0|||
23402546|NCT04067492|65219931|FG001|Overall Study|Lost to Follow-up|0|||
23402547|NCT04067492|65219932|FG002|Overall Study|Lost to Follow-up|0|||
23402548|NCT04067492|65219933|FG003|Overall Study|Lost to Follow-up|0|||
23402549|NCT04067492|65219934|FG004|Overall Study|Lost to Follow-up|0|||
23402550|NCT04067492|65219935|FG005|Overall Study|Lost to Follow-up|1|||
23402551|NCT04067492|65219930|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402552|NCT04067492|65219931|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
23402553|NCT04067492|65219932|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402554|NCT04067492|65219933|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402555|NCT04067492|65219934|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402556|NCT04067492|65219935|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402557|NCT04067492|65219930|FG000|Overall Study|COVID-19 epidemiological situation|0|||
23402558|NCT04067492|65219931|FG001|Overall Study|COVID-19 epidemiological situation|0|||
23402559|NCT04067492|65219932|FG002|Overall Study|COVID-19 epidemiological situation|0|||
23402560|NCT04067492|65219933|FG003|Overall Study|COVID-19 epidemiological situation|1|||
23402561|NCT04067492|65219934|FG004|Overall Study|COVID-19 epidemiological situation|0|||
23402562|NCT04067492|65219935|FG005|Overall Study|COVID-19 epidemiological situation|0|||
23402563|NCT01273038|65219936|FG000|Second Intervention (14 Days)|Adverse Event|0|||
23402564|NCT01273038|65219937|FG001|Second Intervention (14 Days)|Adverse Event|1|||
23402565|NCT01273038|65219936|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23402566|NCT01273038|65219937|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23402567|NCT02651116|65219938|FG000|Overall Study|Adverse Event|0|||
23402568|NCT02651116|65219939|FG001|Overall Study|Adverse Event|1|||
23402569|NCT02651116|65219938|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
23402570|NCT02651116|65219939|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
23402571|NCT03281629|65219940|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
23402572|NCT03281629|65219941|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
23402573|NCT03281629|65219940|FG000|Overall Study|Death|0|||
23402574|NCT03281629|65219941|FG001|Overall Study|Death|1|||
23402575|NCT03281629|65219940|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
23402576|NCT03281629|65219941|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
23402577|NCT04940130|65219942|FG000|Overall Study|Travel|1|||
23402578|NCT04940130|65219943|FG001|Overall Study|Travel|0|||
23402579|NCT04940130|65219944|FG002|Overall Study|Travel|2|||
23402580|NCT04940130|65219942|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
23402581|NCT04940130|65219943|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
23402582|NCT04940130|65219944|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
23402583|NCT04940130|65219942|FG000|Overall Study|Adverse Event|0|||
23402584|NCT04940130|65219943|FG001|Overall Study|Adverse Event|0|||
23402585|NCT04940130|65219944|FG002|Overall Study|Adverse Event|2|||
23402586|NCT04940130|65219942|FG000|Overall Study|Disease progression/treatment failure|0|||
23402587|NCT04940130|65219943|FG001|Overall Study|Disease progression/treatment failure|0|||
23402588|NCT04940130|65219944|FG002|Overall Study|Disease progression/treatment failure|1|||
23402589|NCT04940130|65219942|FG000|Overall Study|Participant refusal|0|||
23402590|NCT04940130|65219943|FG001|Overall Study|Participant refusal|0|||
23402591|NCT04940130|65219944|FG002|Overall Study|Participant refusal|1|||
23402592|NCT01639469|65219945|FG000|Overall Study|Death|4|||
23402593|NCT01639469|65219946|FG001|Overall Study|Death|2|||
23402594|NCT01639469|65219945|FG000|Overall Study|Lost to Follow-up|1|||
23402595|NCT01639469|65219946|FG001|Overall Study|Lost to Follow-up|1|||
23402596|NCT01082614|65219947|FG000|Overall Study|Adverse Event|1|||
23402597|NCT01082614|65219948|FG001|Overall Study|Adverse Event|4|||
23402598|NCT01082614|65219947|FG000|Overall Study|Equipment Malfunction|0|||
23402599|NCT01082614|65219948|FG001|Overall Study|Equipment Malfunction|1|||
23402600|NCT01082614|65219947|FG000|Overall Study|Physician Decision|2|||
23402601|NCT01082614|65219948|FG001|Overall Study|Physician Decision|0|||
23402602|NCT01276106|65219952|FG000|Overall Study|Adverse Event|3|||
23402603|NCT01276106|65219953|FG001|Overall Study|Adverse Event|3|||
23402604|NCT01276106|65219954|FG002|Overall Study|Adverse Event|11|||
23402605|NCT01276106|65219955|FG003|Overall Study|Adverse Event|3|||
23402606|NCT01276106|65219952|FG000|Overall Study|Withdrawal by Subject|6|||
23402607|NCT01276106|65219953|FG001|Overall Study|Withdrawal by Subject|3|||
23402608|NCT01276106|65219954|FG002|Overall Study|Withdrawal by Subject|1|||
23402609|NCT01276106|65219955|FG003|Overall Study|Withdrawal by Subject|6|||
23402610|NCT01276106|65219952|FG000|Overall Study|Lack of Efficacy|0|||
23402611|NCT01276106|65219953|FG001|Overall Study|Lack of Efficacy|1|||
23402612|NCT01276106|65219954|FG002|Overall Study|Lack of Efficacy|0|||
23402613|NCT01276106|65219955|FG003|Overall Study|Lack of Efficacy|1|||
23402614|NCT01276106|65219952|FG000|Overall Study|Lost to Follow-up|2|||
23402615|NCT01276106|65219953|FG001|Overall Study|Lost to Follow-up|1|||
23402616|NCT01276106|65219954|FG002|Overall Study|Lost to Follow-up|1|||
23402617|NCT01276106|65219955|FG003|Overall Study|Lost to Follow-up|0|||
23402618|NCT01276106|65219952|FG000|Overall Study|Physician Decision|0|||
23402619|NCT01276106|65219953|FG001|Overall Study|Physician Decision|0|||
23402620|NCT01276106|65219954|FG002|Overall Study|Physician Decision|1|||
23402621|NCT01276106|65219955|FG003|Overall Study|Physician Decision|1|||
23402622|NCT01276106|65219952|FG000|Overall Study|Protocol Violation|1|||
23402623|NCT01276106|65219953|FG001|Overall Study|Protocol Violation|1|||
23402624|NCT01276106|65219954|FG002|Overall Study|Protocol Violation|0|||
23402625|NCT01276106|65219955|FG003|Overall Study|Protocol Violation|2|||
23402626|NCT01276106|65219952|FG000|Overall Study|Insufficient therapeutic effects|0|||
23402627|NCT01276106|65219953|FG001|Overall Study|Insufficient therapeutic effects|0|||
23402628|NCT01276106|65219954|FG002|Overall Study|Insufficient therapeutic effects|2|||
23402629|NCT01276106|65219955|FG003|Overall Study|Insufficient therapeutic effects|0|||
23402630|NCT03605693|65219956|FG000|Overall Study|Lost to Follow-up|4|||
23402631|NCT03605693|65219957|FG001|Overall Study|Lost to Follow-up|0|||
23402632|NCT03605693|65219956|FG000|Overall Study|Physician Decision|1|||
23402633|NCT03605693|65219957|FG001|Overall Study|Physician Decision|0|||
23402634|NCT04834726|65219958|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
23402635|NCT04834726|65219959|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
23402636|NCT04834726|65219960|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
23402637|NCT04834726|65219961|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
23402638|NCT04834726|65219962|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
23402639|NCT04834726|65219963|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
23402640|NCT04834726|65219964|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
23402641|NCT04834726|65219965|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
23402642|NCT04834726|65219966|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
23402643|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
23402644|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
23402645|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Adverse Event|2|||
23402646|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Adverse Event|1|||
23402647|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
23402648|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
23402649|NCT02848092|65219979|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
23402650|NCT02848092|65219980|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
23402651|NCT02848092|65219979|FG000|1-month Post-training Follow-up|fatigue|0|||
23402652|NCT02848092|65219980|FG001|1-month Post-training Follow-up|fatigue|1|||
23402653|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
23402654|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
23402655|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Adverse Event|1|||
23402656|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Adverse Event|1|||
23402657|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
23402658|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
23402659|NCT02848092|65219979|FG000|6-month Post-training Follow-up|frustrated with task|1|||
23402660|NCT02848092|65219980|FG001|6-month Post-training Follow-up|frustrated with task|0|||
23402661|NCT02848092|65219979|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
23402662|NCT02848092|65219980|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
23402663|NCT02848092|65219979|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
23402664|NCT02848092|65219980|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
23402665|NCT03289143|65219983|FG000|Overall Study|Caregiver Unavailability|1|||
23402666|NCT03289143|65219984|FG001|Overall Study|Caregiver Unavailability|1|||
23402667|NCT03289143|65219985|FG002|Overall Study|Caregiver Unavailability|0|||
23402668|NCT03289143|65219986|FG003|Overall Study|Caregiver Unavailability|0|||
23402669|NCT03289143|65219983|FG000|Overall Study|Research Department Closure|0|||
23402670|NCT03289143|65219984|FG001|Overall Study|Research Department Closure|0|||
23402671|NCT03289143|65219985|FG002|Overall Study|Research Department Closure|1|||
23402672|NCT03289143|65219986|FG003|Overall Study|Research Department Closure|0|||
23402673|NCT03289143|65219983|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402674|NCT03289143|65219984|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402675|NCT03289143|65219985|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
23402676|NCT03289143|65219986|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402677|NCT03289143|65219983|FG000|Overall Study|Medical Monitor Decision|1|||
23402678|NCT03289143|65219984|FG001|Overall Study|Medical Monitor Decision|0|||
23402679|NCT03289143|65219985|FG002|Overall Study|Medical Monitor Decision|0|||
23402680|NCT03289143|65219986|FG003|Overall Study|Medical Monitor Decision|0|||
23402681|NCT03289143|65219983|FG000|Overall Study|Participant Non-Compliance|0|||
23402682|NCT03289143|65219984|FG001|Overall Study|Participant Non-Compliance|0|||
23402683|NCT03289143|65219985|FG002|Overall Study|Participant Non-Compliance|1|||
23402684|NCT03289143|65219986|FG003|Overall Study|Participant Non-Compliance|0|||
23402685|NCT03289143|65219983|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402686|NCT03289143|65219984|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402687|NCT03289143|65219985|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
23402688|NCT03289143|65219986|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402689|NCT03289143|65219983|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402690|NCT03289143|65219984|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402691|NCT03289143|65219985|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
23402692|NCT03289143|65219986|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402693|NCT03289143|65219983|FG000|Overall Study|Caregiver Passed Away|1|||
23402694|NCT03289143|65219984|FG001|Overall Study|Caregiver Passed Away|0|||
23402695|NCT03289143|65219985|FG002|Overall Study|Caregiver Passed Away|0|||
23402696|NCT03289143|65219986|FG003|Overall Study|Caregiver Passed Away|0|||
23402697|NCT03289143|65219983|FG000|Overall Study|Physician Decision|0|||
23402698|NCT03289143|65219984|FG001|Overall Study|Physician Decision|2|||
23402699|NCT03289143|65219985|FG002|Overall Study|Physician Decision|2|||
23402700|NCT03289143|65219986|FG003|Overall Study|Physician Decision|2|||
23402701|NCT03289143|65219983|FG000|Overall Study|Protocol Deviation|2|||
23705387|NCT00915005|66297468|FG001|Overall Study|Withdrawal by Subject|4|||
23705388|NCT00915005|66297467|FG000|Overall Study|Patient preferred protons therapy|6|||
23705389|NCT00915005|66297468|FG001|Overall Study|Patient preferred protons therapy|0|||
23705390|NCT00915005|66297467|FG000|Overall Study|Insurance denial|3|||
23705391|NCT00915005|66297468|FG001|Overall Study|Insurance denial|15|||
23705392|NCT01617681|66297471|FG000|Period 1 Double Blind|Adverse Event|2|||
23705393|NCT01617681|66297472|FG001|Period 1 Double Blind|Adverse Event|0|||
23705394|NCT01617681|66297473|FG002|Period 1 Double Blind|Adverse Event|0|||
23705395|NCT01617681|66297474|FG003|Period 1 Double Blind|Adverse Event|2|||
23705396|NCT01617681|66297475|FG004|Period 1 Double Blind|Adverse Event|0|||
23705397|NCT01617681|66297471|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
23705398|NCT01617681|66297472|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
23705399|NCT01617681|66297473|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
23705400|NCT01617681|66297474|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
23705401|NCT01617681|66297475|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
23705402|NCT01617681|66297471|FG000|Period 2 Open Label|Adverse Event|0|||
23705403|NCT01617681|66297472|FG001|Period 2 Open Label|Adverse Event|0|||
23705404|NCT01617681|66297473|FG002|Period 2 Open Label|Adverse Event|0|||
23705405|NCT01617681|66297474|FG003|Period 2 Open Label|Adverse Event|0|||
23705406|NCT01617681|66297475|FG004|Period 2 Open Label|Adverse Event|3|||
23705407|NCT01617681|66297471|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
23705408|NCT01617681|66297472|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
23705409|NCT01617681|66297473|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
23705410|NCT01617681|66297474|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
23705411|NCT01617681|66297475|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
23705412|NCT01423617|66297480|FG000|Overall Study|Lost to Follow-up|0|||
23705413|NCT01423617|66297481|FG001|Overall Study|Lost to Follow-up|1|||
23705414|NCT02566525|66297482|FG000|Overall Study|Protocol Violation|3|||
23705415|NCT02566525|66297483|FG001|Overall Study|Protocol Violation|5|||
23705416|NCT04544709|66297486|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
23705417|NCT02720016|66297487|FG000|Overall Study|Separation of couple|6|||
23705418|NCT02720016|66297488|FG001|Overall Study|Separation of couple|8|||
23705419|NCT02720016|66297489|FG002|Overall Study|Separation of couple|2|||
23705420|NCT02720016|66297487|FG000|Overall Study|Withdrawal by Subject|6|||
23705421|NCT02720016|66297488|FG001|Overall Study|Withdrawal by Subject|6|||
23705422|NCT02720016|66297489|FG002|Overall Study|Withdrawal by Subject|4|||
23705423|NCT02720016|66297487|FG000|Overall Study|Scheduling issues|2|||
23705424|NCT02720016|66297488|FG001|Overall Study|Scheduling issues|4|||
23705425|NCT02720016|66297489|FG002|Overall Study|Scheduling issues|7|||
23705426|NCT02720016|66297487|FG000|Overall Study|Childcare|2|||
23705427|NCT02720016|66297488|FG001|Overall Study|Childcare|0|||
23705428|NCT02720016|66297489|FG002|Overall Study|Childcare|2|||
23705429|NCT02720016|66297487|FG000|Overall Study|Withdrawal by PI|2|||
23705430|NCT02720016|66297488|FG001|Overall Study|Withdrawal by PI|2|||
23705431|NCT02720016|66297489|FG002|Overall Study|Withdrawal by PI|0|||
23705432|NCT02720016|66297487|FG000|Overall Study|Moved away|2|||
23705433|NCT02720016|66297488|FG001|Overall Study|Moved away|0|||
23705434|NCT02720016|66297489|FG002|Overall Study|Moved away|0|||
23705435|NCT02720016|66297487|FG000|Overall Study|Not Primary Health Concern|0|||
23705436|NCT02720016|66297488|FG001|Overall Study|Not Primary Health Concern|0|||
23705437|NCT02720016|66297489|FG002|Overall Study|Not Primary Health Concern|2|||
23705438|NCT02720016|66297487|FG000|Overall Study|Transportation issues|0|||
23705439|NCT02720016|66297488|FG001|Overall Study|Transportation issues|0|||
23402859|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
23402860|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
23402861|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
23402862|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Other than specified|2|||
23402863|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
23402864|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
23402865|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23402866|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402867|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402868|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402869|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402870|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23402871|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402872|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402873|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402874|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402875|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402876|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402877|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23402878|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
23402879|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
23402880|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402881|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402882|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402883|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402884|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23402885|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23402886|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402887|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402888|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402889|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402890|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402891|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
23402892|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402893|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402894|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402895|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402896|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402897|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402898|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402899|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
23402900|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402901|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402902|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402903|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402904|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402905|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
23402906|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
23402907|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
23402908|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402909|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402910|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402911|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402912|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
23402913|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
23402914|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402915|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402916|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402917|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402918|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402919|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402920|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402921|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23705715|NCT00972244|66297596|FG004|Overall Study|Various|2|||
23402922|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402923|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402924|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
23402925|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
23402926|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402927|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402928|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402929|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23402930|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402931|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23402932|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23402933|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402934|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402935|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402936|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
23402937|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
23402938|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23402939|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
23402940|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402941|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402942|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402943|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402944|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
23402945|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
23402946|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402947|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402948|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402949|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402950|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402951|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402952|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
23402953|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402954|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402955|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402956|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402957|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
23402958|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
23402959|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
23402960|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
23402961|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402962|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402963|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402964|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402965|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402966|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
23402967|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
23402968|NCT03314935|65220055|FG000|Phase 1|Death|4|||
23402969|NCT03314935|65220056|FG001|Phase 1|Death|2|||
23402970|NCT03314935|65220057|FG002|Phase 1|Death|5|||
23402971|NCT03314935|65220058|FG003|Phase 1|Death|4|||
23402972|NCT03314935|65220059|FG004|Phase 1|Death|3|||
23402973|NCT03314935|65220060|FG005|Phase 1|Death|4|||
23402974|NCT03314935|65220061|FG006|Phase 1|Death|5|||
23402975|NCT03314935|65220062|FG007|Phase 1|Death|4|||
23402976|NCT03314935|65220063|FG008|Phase 1|Death|3|||
23402977|NCT03314935|65220064|FG009|Phase 1|Death|0|||
23402978|NCT03314935|65220065|FG010|Phase 1|Death|0|||
23402979|NCT03314935|65220066|FG011|Phase 1|Death|0|||
23402980|NCT03314935|65220067|FG012|Phase 1|Death|0|||
23402981|NCT03314935|65220068|FG013|Phase 1|Death|0|||
23402982|NCT03314935|65220069|FG014|Phase 1|Death|0|||
23402983|NCT03314935|65220055|FG000|Phase 1|Withdrawal by Subject|2|||
23402984|NCT03314935|65220056|FG001|Phase 1|Withdrawal by Subject|1|||
23402985|NCT03314935|65220057|FG002|Phase 1|Withdrawal by Subject|1|||
23402986|NCT03314935|65220058|FG003|Phase 1|Withdrawal by Subject|2|||
23402987|NCT03314935|65220059|FG004|Phase 1|Withdrawal by Subject|1|||
23402988|NCT03314935|65220060|FG005|Phase 1|Withdrawal by Subject|0|||
23402989|NCT03314935|65220061|FG006|Phase 1|Withdrawal by Subject|1|||
23402990|NCT03314935|65220062|FG007|Phase 1|Withdrawal by Subject|0|||
23402991|NCT03314935|65220063|FG008|Phase 1|Withdrawal by Subject|1|||
23403029|NCT03314935|65220056|FG001|Phase 1|"Captured as Other in Database"|2|||
23403030|NCT03314935|65220057|FG002|Phase 1|"Captured as Other in Database"|0|||
23403031|NCT03314935|65220058|FG003|Phase 1|"Captured as Other in Database"|0|||
23403032|NCT03314935|65220059|FG004|Phase 1|"Captured as Other in Database"|0|||
23403033|NCT03314935|65220060|FG005|Phase 1|"Captured as Other in Database"|0|||
23403034|NCT03314935|65220061|FG006|Phase 1|"Captured as Other in Database"|1|||
23403035|NCT03314935|65220062|FG007|Phase 1|"Captured as Other in Database"|1|||
23403036|NCT03314935|65220063|FG008|Phase 1|"Captured as Other in Database"|1|||
23403037|NCT03314935|65220064|FG009|Phase 1|"Captured as Other in Database"|0|||
23403038|NCT03314935|65220065|FG010|Phase 1|"Captured as Other in Database"|0|||
23403039|NCT03314935|65220066|FG011|Phase 1|"Captured as Other in Database"|0|||
23403040|NCT03314935|65220067|FG012|Phase 1|"Captured as Other in Database"|0|||
23403041|NCT03314935|65220068|FG013|Phase 1|"Captured as Other in Database"|0|||
23403042|NCT03314935|65220069|FG014|Phase 1|"Captured as Other in Database"|0|||
23403043|NCT03314935|65220055|FG000|Phase 1|Lost to Follow-up|0|||
23403044|NCT03314935|65220056|FG001|Phase 1|Lost to Follow-up|0|||
23403045|NCT03314935|65220057|FG002|Phase 1|Lost to Follow-up|0|||
23403046|NCT03314935|65220058|FG003|Phase 1|Lost to Follow-up|0|||
23403047|NCT03314935|65220059|FG004|Phase 1|Lost to Follow-up|0|||
23403048|NCT03314935|65220060|FG005|Phase 1|Lost to Follow-up|0|||
23403049|NCT03314935|65220061|FG006|Phase 1|Lost to Follow-up|0|||
23403050|NCT03314935|65220062|FG007|Phase 1|Lost to Follow-up|0|||
23403051|NCT03314935|65220063|FG008|Phase 1|Lost to Follow-up|1|||
23403052|NCT03314935|65220064|FG009|Phase 1|Lost to Follow-up|0|||
23403053|NCT03314935|65220065|FG010|Phase 1|Lost to Follow-up|0|||
23403054|NCT03314935|65220066|FG011|Phase 1|Lost to Follow-up|0|||
23403055|NCT03314935|65220067|FG012|Phase 1|Lost to Follow-up|0|||
23403056|NCT03314935|65220068|FG013|Phase 1|Lost to Follow-up|0|||
23403057|NCT03314935|65220069|FG014|Phase 1|Lost to Follow-up|0|||
23403058|NCT03314935|65220055|FG000|Phase 2|Death|0|||
23403059|NCT03314935|65220056|FG001|Phase 2|Death|0|||
23403060|NCT03314935|65220057|FG002|Phase 2|Death|0|||
23403061|NCT03314935|65220058|FG003|Phase 2|Death|0|||
23403062|NCT03314935|65220059|FG004|Phase 2|Death|0|||
23403063|NCT03314935|65220060|FG005|Phase 2|Death|0|||
23403064|NCT03314935|65220061|FG006|Phase 2|Death|0|||
23403065|NCT03314935|65220062|FG007|Phase 2|Death|0|||
23403066|NCT03314935|65220063|FG008|Phase 2|Death|0|||
23403067|NCT03314935|65220064|FG009|Phase 2|Death|5|||
23403068|NCT03314935|65220065|FG010|Phase 2|Death|20|||
23403069|NCT03314935|65220066|FG011|Phase 2|Death|6|||
23403070|NCT03314935|65220067|FG012|Phase 2|Death|7|||
23403071|NCT03314935|65220068|FG013|Phase 2|Death|6|||
23403072|NCT03314935|65220069|FG014|Phase 2|Death|17|||
23403073|NCT03314935|65220055|FG000|Phase 2|Withdrawal by Subject|0|||
23403074|NCT03314935|65220056|FG001|Phase 2|Withdrawal by Subject|0|||
23403075|NCT03314935|65220057|FG002|Phase 2|Withdrawal by Subject|0|||
23403076|NCT03314935|65220058|FG003|Phase 2|Withdrawal by Subject|0|||
23403077|NCT03314935|65220059|FG004|Phase 2|Withdrawal by Subject|0|||
23403078|NCT03314935|65220060|FG005|Phase 2|Withdrawal by Subject|0|||
23403079|NCT03314935|65220061|FG006|Phase 2|Withdrawal by Subject|0|||
23403080|NCT03314935|65220062|FG007|Phase 2|Withdrawal by Subject|0|||
23403081|NCT03314935|65220063|FG008|Phase 2|Withdrawal by Subject|0|||
23403082|NCT03314935|65220064|FG009|Phase 2|Withdrawal by Subject|1|||
23403083|NCT03314935|65220065|FG010|Phase 2|Withdrawal by Subject|4|||
23403084|NCT03314935|65220066|FG011|Phase 2|Withdrawal by Subject|0|||
23403085|NCT03314935|65220067|FG012|Phase 2|Withdrawal by Subject|1|||
23403086|NCT03314935|65220068|FG013|Phase 2|Withdrawal by Subject|0|||
23403087|NCT03314935|65220069|FG014|Phase 2|Withdrawal by Subject|1|||
23403088|NCT03314935|65220055|FG000|Phase 2|Progressive Disease|0|||
23403089|NCT03314935|65220056|FG001|Phase 2|Progressive Disease|0|||
23403090|NCT03314935|65220057|FG002|Phase 2|Progressive Disease|0|||
23403091|NCT03314935|65220058|FG003|Phase 2|Progressive Disease|0|||
23403092|NCT03314935|65220059|FG004|Phase 2|Progressive Disease|0|||
23403093|NCT03314935|65220060|FG005|Phase 2|Progressive Disease|0|||
23403094|NCT03314935|65220061|FG006|Phase 2|Progressive Disease|0|||
23403095|NCT03314935|65220062|FG007|Phase 2|Progressive Disease|0|||
23403096|NCT03314935|65220063|FG008|Phase 2|Progressive Disease|0|||
23403097|NCT03314935|65220064|FG009|Phase 2|Progressive Disease|1|||
23403098|NCT03314935|65220065|FG010|Phase 2|Progressive Disease|1|||
23403099|NCT03314935|65220066|FG011|Phase 2|Progressive Disease|1|||
23403100|NCT03314935|65220067|FG012|Phase 2|Progressive Disease|2|||
23403101|NCT03314935|65220068|FG013|Phase 2|Progressive Disease|0|||
23403102|NCT03314935|65220069|FG014|Phase 2|Progressive Disease|1|||
23403103|NCT03314935|65220055|FG000|Phase 2|Study Terminated by Sponsor|0|||
23403104|NCT03314935|65220056|FG001|Phase 2|Study Terminated by Sponsor|0|||
23403105|NCT03314935|65220057|FG002|Phase 2|Study Terminated by Sponsor|0|||
23403106|NCT03314935|65220058|FG003|Phase 2|Study Terminated by Sponsor|0|||
23403107|NCT03314935|65220059|FG004|Phase 2|Study Terminated by Sponsor|0|||
23403108|NCT03314935|65220060|FG005|Phase 2|Study Terminated by Sponsor|0|||
23403109|NCT03314935|65220061|FG006|Phase 2|Study Terminated by Sponsor|0|||
23403110|NCT03314935|65220062|FG007|Phase 2|Study Terminated by Sponsor|0|||
23403111|NCT03314935|65220063|FG008|Phase 2|Study Terminated by Sponsor|0|||
23403112|NCT03314935|65220064|FG009|Phase 2|Study Terminated by Sponsor|0|||
23403113|NCT03314935|65220065|FG010|Phase 2|Study Terminated by Sponsor|7|||
23403114|NCT03314935|65220066|FG011|Phase 2|Study Terminated by Sponsor|2|||
23403115|NCT03314935|65220067|FG012|Phase 2|Study Terminated by Sponsor|1|||
23403116|NCT03314935|65220068|FG013|Phase 2|Study Terminated by Sponsor|4|||
23403117|NCT03314935|65220069|FG014|Phase 2|Study Terminated by Sponsor|4|||
23403118|NCT03314935|65220055|FG000|Phase 2|Lost to Follow-up|0|||
23403119|NCT03314935|65220056|FG001|Phase 2|Lost to Follow-up|0|||
23403120|NCT03314935|65220057|FG002|Phase 2|Lost to Follow-up|0|||
23403121|NCT03314935|65220058|FG003|Phase 2|Lost to Follow-up|0|||
23403122|NCT03314935|65220059|FG004|Phase 2|Lost to Follow-up|0|||
23403123|NCT03314935|65220060|FG005|Phase 2|Lost to Follow-up|0|||
23403124|NCT03314935|65220061|FG006|Phase 2|Lost to Follow-up|0|||
23403125|NCT03314935|65220062|FG007|Phase 2|Lost to Follow-up|0|||
23403126|NCT03314935|65220063|FG008|Phase 2|Lost to Follow-up|0|||
23403127|NCT03314935|65220064|FG009|Phase 2|Lost to Follow-up|1|||
23403128|NCT03314935|65220065|FG010|Phase 2|Lost to Follow-up|0|||
23403129|NCT03314935|65220066|FG011|Phase 2|Lost to Follow-up|0|||
23403130|NCT03314935|65220067|FG012|Phase 2|Lost to Follow-up|0|||
23403131|NCT03314935|65220068|FG013|Phase 2|Lost to Follow-up|0|||
23403132|NCT03314935|65220069|FG014|Phase 2|Lost to Follow-up|1|||
23403133|NCT03314935|65220055|FG000|Phase 2|Physician Decision|0|||
23403134|NCT03314935|65220056|FG001|Phase 2|Physician Decision|0|||
23403135|NCT03314935|65220057|FG002|Phase 2|Physician Decision|0|||
23403136|NCT03314935|65220058|FG003|Phase 2|Physician Decision|0|||
23403137|NCT03314935|65220059|FG004|Phase 2|Physician Decision|0|||
23403138|NCT03314935|65220060|FG005|Phase 2|Physician Decision|0|||
23403139|NCT03314935|65220061|FG006|Phase 2|Physician Decision|0|||
23403140|NCT03314935|65220062|FG007|Phase 2|Physician Decision|0|||
23403141|NCT03314935|65220063|FG008|Phase 2|Physician Decision|0|||
23403142|NCT03314935|65220064|FG009|Phase 2|Physician Decision|0|||
23403143|NCT03314935|65220065|FG010|Phase 2|Physician Decision|1|||
23403144|NCT03314935|65220066|FG011|Phase 2|Physician Decision|0|||
23403145|NCT03314935|65220067|FG012|Phase 2|Physician Decision|0|||
23403146|NCT03314935|65220068|FG013|Phase 2|Physician Decision|0|||
23403147|NCT03314935|65220069|FG014|Phase 2|Physician Decision|0|||
23705440|NCT02720016|66297489|FG002|Overall Study|Transportation issues|1|||
23705441|NCT02720016|66297487|FG000|Overall Study|Other|0|||
23705442|NCT02720016|66297488|FG001|Overall Study|Other|0|||
23705443|NCT02720016|66297489|FG002|Overall Study|Other|2|||
23705444|NCT05131451|66297492|FG000|Overall Study|Protocol Violation|1|||
23705445|NCT05131451|66297493|FG001|Overall Study|Protocol Violation|0|||
23705446|NCT00894413|66297494|FG000|Overall Study|Physician Decision|0|||
23705447|NCT00894413|66297495|FG001|Overall Study|Physician Decision|2|||
23705448|NCT00894413|66297494|FG000|Overall Study|Adverse Event|0|||
23705449|NCT00894413|66297495|FG001|Overall Study|Adverse Event|2|||
23705450|NCT00894413|66297494|FG000|Overall Study|Withdrawal by Subject|0|||
23705451|NCT00894413|66297495|FG001|Overall Study|Withdrawal by Subject|4|||
23705452|NCT02632110|66297496|FG000|Overall Study|Withdrawal by Subject|1|||
23705453|NCT02632110|66297497|FG001|Overall Study|Withdrawal by Subject|1|||
23705454|NCT02632110|66297498|FG002|Overall Study|Withdrawal by Subject|0|||
23705455|NCT02632110|66297499|FG003|Overall Study|Withdrawal by Subject|0|||
23705456|NCT02632110|66297500|FG004|Overall Study|Withdrawal by Subject|1|||
23705457|NCT02632110|66297501|FG005|Overall Study|Withdrawal by Subject|1|||
23705458|NCT02632110|66297502|FG006|Overall Study|Withdrawal by Subject|3|||
23705459|NCT02632110|66297503|FG007|Overall Study|Withdrawal by Subject|3|||
23705460|NCT02632110|66297504|FG008|Overall Study|Withdrawal by Subject|1|||
23705461|NCT02632110|66297505|FG009|Overall Study|Withdrawal by Subject|1|||
23705462|NCT01519245|66297506|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
23705463|NCT01519245|66297507|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
23705464|NCT03294681|66297508|FG000|Overall Study|Withdrawal by Subject|1|||
23705465|NCT01474746|66297509|FG000|Overall Study|Lost to Follow-up|1|||
23705466|NCT01474746|66297510|FG001|Overall Study|Lost to Follow-up|1|||
23705467|NCT01474746|66297509|FG000|Overall Study|Withdrawal by Subject|2|||
23705468|NCT01474746|66297510|FG001|Overall Study|Withdrawal by Subject|1|||
23705469|NCT02196038|66297513|FG000|Overall Study|Death|16|||
23705470|NCT02196038|66297514|FG001|Overall Study|Death|21|||
23705471|NCT02196038|66297513|FG000|Overall Study|Withdrawal by Subject|0|||
23705472|NCT02196038|66297514|FG001|Overall Study|Withdrawal by Subject|1|||
23705473|NCT02196038|66297513|FG000|Overall Study|Lost to Follow-up|1|||
23705474|NCT02196038|66297514|FG001|Overall Study|Lost to Follow-up|0|||
23705475|NCT02750800|66297515|FG000|Overall Study|Adverse Event|18|||
23705476|NCT02750800|66297515|FG000|Overall Study|Lost to Follow-up|12|||
23705477|NCT02750800|66297515|FG000|Overall Study|Investigator decision|53|||
23705478|NCT02750800|66297515|FG000|Overall Study|Patient request|12|||
23705479|NCT02750800|66297515|FG000|Overall Study|Other, not specified|3|||
23705480|NCT03382899|66297516|FG000|Overall Study|Ineligibility Determined|0|||
23705481|NCT03382899|66297517|FG001|Overall Study|Ineligibility Determined|1|||
23705482|NCT03382899|66297516|FG000|Overall Study|Lost to Follow-up|0|||
23705483|NCT03382899|66297517|FG001|Overall Study|Lost to Follow-up|1|||
23705716|NCT02116660|66297599|FG000|Overall Study|Deteriorating renal function|0|||
23705717|NCT02116660|66297600|FG001|Overall Study|Deteriorating renal function|1|||
23705718|NCT02116660|66297599|FG000|Overall Study|Adverse Event|1|||
23705719|NCT02116660|66297600|FG001|Overall Study|Adverse Event|1|||
23705720|NCT02116660|66297599|FG000|Overall Study|Withdrawal by Subject|0|||
23705721|NCT02116660|66297600|FG001|Overall Study|Withdrawal by Subject|2|||
23705722|NCT02116660|66297599|FG000|Overall Study|Organization reason|1|||
23705723|NCT02116660|66297600|FG001|Overall Study|Organization reason|0|||
23705724|NCT02411201|66297601|FG000|Overall Study|Adverse Event|2|||
23705725|NCT02411201|66297601|FG000|Overall Study|Withdrawal by Subject|2|||
23705726|NCT02411201|66297601|FG000|Overall Study|Age group completed|2|||
23705727|NCT01187901|66297603|FG000|Overall Study|Protocol Violation|1|||
23705728|NCT01187901|66297604|FG001|Overall Study|Protocol Violation|0|||
23705729|NCT01187901|66297603|FG000|Overall Study|Lost to Follow-up|1|||
23705730|NCT01187901|66297604|FG001|Overall Study|Lost to Follow-up|2|||
23705731|NCT01187901|66297603|FG000|Overall Study|Unrelated Health Reasons|1|||
23705732|NCT01187901|66297604|FG001|Overall Study|Unrelated Health Reasons|2|||
23705733|NCT01187901|66297603|FG000|Overall Study|Suspected Allergic Reaction|1|||
23705734|NCT01187901|66297604|FG001|Overall Study|Suspected Allergic Reaction|1|||
23705735|NCT01187901|66297603|FG000|Overall Study|Adverse Event|3|||
23705736|NCT01187901|66297604|FG001|Overall Study|Adverse Event|0|||
23705737|NCT01187901|66297603|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
23705738|NCT01187901|66297604|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
23705739|NCT01187901|66297603|FG000|Overall Study|Pregnancy|0|||
23705740|NCT01187901|66297604|FG001|Overall Study|Pregnancy|2|||
23705741|NCT05058664|66297606|FG000|Overall Study|No follow-up data provided|4|||
23705742|NCT05058664|66297607|FG001|Overall Study|No follow-up data provided|0|||
23705743|NCT05058664|66297608|FG002|Overall Study|No follow-up data provided|2|||
23705744|NCT05058664|66297606|FG000|Overall Study|Withdrawal by Subject|0|||
23705745|NCT05058664|66297607|FG001|Overall Study|Withdrawal by Subject|0|||
23705746|NCT05058664|66297608|FG002|Overall Study|Withdrawal by Subject|1|||
23705747|NCT03007953|66297609|FG000|Overall Study|Withdrawal by Subject|5|||
23705748|NCT03007953|66297610|FG001|Overall Study|Withdrawal by Subject|2|||
23705749|NCT03007953|66297609|FG000|Overall Study|Death|5|||
23705750|NCT03007953|66297610|FG001|Overall Study|Death|7|||
23705751|NCT03007953|66297609|FG000|Overall Study|Lost to Follow-up|3|||
23705752|NCT03007953|66297610|FG001|Overall Study|Lost to Follow-up|2|||
23705753|NCT03007953|66297609|FG000|Overall Study|Enrolled in Hospice|3|||
23705754|NCT03007953|66297610|FG001|Overall Study|Enrolled in Hospice|2|||
23705755|NCT03342469|66297615|FG000|Overall Study|Withdrawal by Subject|0|||
23705756|NCT03342469|66297616|FG001|Overall Study|Withdrawal by Subject|1|||
23705757|NCT03342469|66297617|FG002|Overall Study|Withdrawal by Subject|0|||
23705758|NCT03342469|66297618|FG003|Overall Study|Withdrawal by Subject|0|||
23705759|NCT01876732|66297619|FG000|Overall Study|MMA was not over 800mg/dL|75|||
23705760|NCT05013905|66297620|FG000|Overall Study|Adverse Event|1|||
23705761|NCT05013905|66297620|FG000|Overall Study|Lack of Efficacy|1|||
23705762|NCT01379534|66297621|FG000|Treatment Phase|Withdrawal by Subject|2|||
23705763|NCT01379534|66297622|FG001|Treatment Phase|Withdrawal by Subject|2|||
23705764|NCT01379534|66297621|FG000|Treatment Phase|Progressive disease|13|||
23705765|NCT01379534|66297622|FG001|Treatment Phase|Progressive disease|22|||
23705766|NCT01379534|66297621|FG000|Treatment Phase|Adverse Event|7|||
23705767|NCT01379534|66297622|FG001|Treatment Phase|Adverse Event|7|||
23705768|NCT01379534|66297621|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
23705769|NCT01379534|66297622|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
23705770|NCT01379534|66297621|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
23705771|NCT01379534|66297622|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
23705772|NCT01379534|66297621|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
23705773|NCT01379534|66297622|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
23705774|NCT01379534|66297621|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
23705775|NCT01379534|66297622|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
23705776|NCT01808118|66297629|FG000|Period 1|Adverse Event|15|||
23705777|NCT01808118|66297630|FG001|Period 1|Adverse Event|0|||
23705778|NCT01808118|66297631|FG002|Period 1|Adverse Event|0|||
23705779|NCT01808118|66297629|FG000|Period 1|Withdrew consent|24|||
23705780|NCT01808118|66297630|FG001|Period 1|Withdrew consent|0|||
23705781|NCT01808118|66297631|FG002|Period 1|Withdrew consent|0|||
23705782|NCT01808118|66297629|FG000|Period 1|Lost to Follow-up|9|||
23705783|NCT01808118|66297630|FG001|Period 1|Lost to Follow-up|0|||
23705784|NCT01808118|66297631|FG002|Period 1|Lost to Follow-up|0|||
23705785|NCT01808118|66297629|FG000|Period 1|Did not meet criteria for remission|303|||
23705786|NCT01808118|66297630|FG001|Period 1|Did not meet criteria for remission|0|||
23705787|NCT01808118|66297631|FG002|Period 1|Did not meet criteria for remission|0|||
23705788|NCT01808118|66297629|FG000|Period 1|Enrolled in error|7|||
23705789|NCT01808118|66297630|FG001|Period 1|Enrolled in error|0|||
23705790|NCT01808118|66297631|FG002|Period 1|Enrolled in error|0|||
23705791|NCT01808118|66297629|FG000|Period 1|Did not meet inclusion criteria|3|||
23705792|NCT01808118|66297630|FG001|Period 1|Did not meet inclusion criteria|0|||
23705793|NCT01808118|66297631|FG002|Period 1|Did not meet inclusion criteria|0|||
23705794|NCT01808118|66297629|FG000|Period 1|Non-conformance with inclusion criteria|3|||
23705795|NCT01808118|66297630|FG001|Period 1|Non-conformance with inclusion criteria|0|||
23705796|NCT01808118|66297631|FG002|Period 1|Non-conformance with inclusion criteria|0|||
23705797|NCT01808118|66297629|FG000|Period 1|Investigator decision: site closure|2|||
23705798|NCT01808118|66297630|FG001|Period 1|Investigator decision: site closure|0|||
23705799|NCT01808118|66297631|FG002|Period 1|Investigator decision: site closure|0|||
23705800|NCT01808118|66297629|FG000|Period 1|Non-compliance per sponsor|1|||
23705801|NCT01808118|66297630|FG001|Period 1|Non-compliance per sponsor|0|||
23705802|NCT01808118|66297631|FG002|Period 1|Non-compliance per sponsor|0|||
23705803|NCT01808118|66297629|FG000|Period 1|Lack of Efficacy|1|||
23705804|NCT01808118|66297630|FG001|Period 1|Lack of Efficacy|0|||
23705805|NCT01808118|66297631|FG002|Period 1|Lack of Efficacy|0|||
23705806|NCT01808118|66297629|FG000|Period 2|Adverse Event|0|||
23705807|NCT01808118|66297630|FG001|Period 2|Adverse Event|4|||
23705808|NCT01808118|66297631|FG002|Period 2|Adverse Event|0|||
23705809|NCT01808118|66297629|FG000|Period 2|Withdrew consent|0|||
23705810|NCT01808118|66297630|FG001|Period 2|Withdrew consent|7|||
23705811|NCT01808118|66297631|FG002|Period 2|Withdrew consent|6|||
23705812|NCT01808118|66297629|FG000|Period 2|Lost to Follow-up|0|||
23705813|NCT01808118|66297630|FG001|Period 2|Lost to Follow-up|0|||
23705814|NCT01808118|66297631|FG002|Period 2|Lost to Follow-up|2|||
23705815|NCT01808118|66297629|FG000|Period 2|Investigator no longer conducting trials|0|||
23705816|NCT01808118|66297630|FG001|Period 2|Investigator no longer conducting trials|1|||
23705817|NCT01808118|66297631|FG002|Period 2|Investigator no longer conducting trials|0|||
23705818|NCT01808118|66297629|FG000|Period 2|Switched to other therapy|0|||
23705819|NCT01808118|66297630|FG001|Period 2|Switched to other therapy|1|||
23705820|NCT01808118|66297631|FG002|Period 2|Switched to other therapy|0|||
23705821|NCT02750813|66297632|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
23705822|NCT02750813|66297633|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
23705823|NCT02750813|66297632|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
23705824|NCT02750813|66297633|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
23705825|NCT02050048|66297636|FG000|Overall Study|Lost to Follow-up|0|||
23705826|NCT02050048|66297637|FG001|Overall Study|Lost to Follow-up|1|||
23705827|NCT02050048|66297636|FG000|Overall Study|Death|1|||
23705828|NCT02050048|66297637|FG001|Overall Study|Death|0|||
23705829|NCT02050048|66297636|FG000|Overall Study|Ineligible after ERCP|4|||
23705830|NCT02050048|66297637|FG001|Overall Study|Ineligible after ERCP|1|||
23705831|NCT04360187|66297638|FG000|Double-Blind Treatment|Adverse Event|9|||
23705832|NCT04360187|66297639|FG001|Double-Blind Treatment|Adverse Event|11|||
23705833|NCT04360187|66297638|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
23705834|NCT04360187|66297639|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
23705835|NCT04360187|66297638|FG000|Double-Blind Treatment|Physician Decision|1|||
23705836|NCT04360187|66297639|FG001|Double-Blind Treatment|Physician Decision|0|||
23705837|NCT04360187|66297638|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
23705838|NCT04360187|66297639|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
23705839|NCT04360187|66297638|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
23705840|NCT04360187|66297639|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
23705841|NCT04360187|66297638|FG000|Follow-Up|Lost to Follow-up|1|||
23705842|NCT04360187|66297639|FG001|Follow-Up|Lost to Follow-up|0|||
23705843|NCT01798134|66297640|FG000|Overall Study|Lost to Follow-up|1|||
23705844|NCT01798134|66297640|FG000|Overall Study|Withdrawal by Subject|3|||
23705845|NCT01798134|66297640|FG000|Overall Study|Death|2|||
23705846|NCT01798134|66297640|FG000|Overall Study|Adverse Event|3|||
23705847|NCT01798134|66297640|FG000|Overall Study|Physician Decision|3|||
23705848|NCT01798134|66297640|FG000|Overall Study|Liver transplant/surgery|4|||
23705849|NCT01087528|66297641|FG000|Overall Study|Withdrawal by Subject|1|||
23705850|NCT01087528|66297641|FG000|Overall Study|Incomplete CE procedure|6|||
23705851|NCT02626819|66297642|FG000|Overall Study|Lost to Follow-up|3|||
23705852|NCT02626819|66297643|FG001|Overall Study|Lost to Follow-up|2|||
23705853|NCT02626819|66297642|FG000|Overall Study|Withdrawal by Subject|1|||
23705854|NCT02626819|66297643|FG001|Overall Study|Withdrawal by Subject|0|||
23705855|NCT02626819|66297642|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
23705856|NCT02626819|66297643|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
23705857|NCT00740779|66297646|FG000|Overall Study|Adverse Event|4|||
23705858|NCT00740779|66297647|FG001|Overall Study|Adverse Event|6|||
23705859|NCT00740779|66297648|FG002|Overall Study|Adverse Event|3|||
23705860|NCT00740779|66297646|FG000|Overall Study|Protocol Violation|1|||
23705861|NCT00740779|66297647|FG001|Overall Study|Protocol Violation|1|||
23705862|NCT00740779|66297648|FG002|Overall Study|Protocol Violation|1|||
23705863|NCT00740779|66297646|FG000|Overall Study|Lack of Efficacy|0|||
23705864|NCT00740779|66297647|FG001|Overall Study|Lack of Efficacy|0|||
23705865|NCT00740779|66297648|FG002|Overall Study|Lack of Efficacy|2|||
23705866|NCT00740779|66297646|FG000|Overall Study|Withdrawal by Subject|2|||
23705867|NCT00740779|66297647|FG001|Overall Study|Withdrawal by Subject|4|||
23705868|NCT00740779|66297648|FG002|Overall Study|Withdrawal by Subject|2|||
23705869|NCT00740779|66297646|FG000|Overall Study|Lost to Follow-up|2|||
23705877|NCT01912768|66297650|FG000|Overall Study|Withdrawal by Subject|5|||
23705878|NCT01912768|66297651|FG001|Overall Study|Withdrawal by Subject|3|||
23705879|NCT01912768|66297650|FG000|Overall Study|Randomized in error|1|||
23705880|NCT01912768|66297651|FG001|Overall Study|Randomized in error|0|||
23705881|NCT01240811|66297654|FG000|Overall Study|Physician Decision|0|||
23705882|NCT01240811|66297655|FG001|Overall Study|Physician Decision|1|||
23705883|NCT01240811|66297656|FG002|Overall Study|Physician Decision|0|||
23705884|NCT01240811|66297654|FG000|Overall Study|Withdrawal by Subject|0|||
23705885|NCT01240811|66297655|FG001|Overall Study|Withdrawal by Subject|0|||
23705886|NCT01240811|66297656|FG002|Overall Study|Withdrawal by Subject|1|||
23705887|NCT03158688|66297659|FG000|Overall Study|Withdrawal by Subject|14|||
23705888|NCT03158688|66297660|FG001|Overall Study|Withdrawal by Subject|28|||
23705889|NCT03158688|66297659|FG000|Overall Study|Decision by sponsor|13|||
23705890|NCT03158688|66297660|FG001|Overall Study|Decision by sponsor|37|||
23705891|NCT03158688|66297659|FG000|Overall Study|Lost to Follow-up|4|||
23705892|NCT03158688|66297660|FG001|Overall Study|Lost to Follow-up|3|||
23705893|NCT03158688|66297659|FG000|Overall Study|Death|74|||
23705894|NCT03158688|66297660|FG001|Overall Study|Death|142|||
23705895|NCT03552549|66297661|FG000|Overall Study|Disease progression|25|||
23705896|NCT03552549|66297662|FG001|Overall Study|Disease progression|17|||
23705897|NCT03552549|66297661|FG000|Overall Study|Adverse event in first 12 months|12|||
23705898|NCT03552549|66297662|FG001|Overall Study|Adverse event in first 12 months|8|||
23705899|NCT03552549|66297661|FG000|Overall Study|Withdrawal by Subject|7|||
23705900|NCT03552549|66297662|FG001|Overall Study|Withdrawal by Subject|7|||
23705901|NCT03552549|66297661|FG000|Overall Study|Unknown (no reason provided)|4|||
23705902|NCT03552549|66297662|FG001|Overall Study|Unknown (no reason provided)|2|||
23705903|NCT03552549|66297661|FG000|Overall Study|Not in participant's best interest|2|||
23705904|NCT03552549|66297662|FG001|Overall Study|Not in participant's best interest|1|||
23705905|NCT03552549|66297661|FG000|Overall Study|Did not complete study treatment|2|||
23705906|NCT03552549|66297662|FG001|Overall Study|Did not complete study treatment|3|||
23705907|NCT03552549|66297661|FG000|Overall Study|Did not meet eligibility criteria|1|||
23705908|NCT03552549|66297662|FG001|Overall Study|Did not meet eligibility criteria|0|||
23705909|NCT03552549|66297661|FG000|Overall Study|Administrative|0|||
23705910|NCT03552549|66297662|FG001|Overall Study|Administrative|14|||
23705911|NCT01912729|66297664|FG000|Overall Study|Withdrawal by Subject|0|||
23705912|NCT01912729|66297665|FG001|Overall Study|Withdrawal by Subject|1|||
23705913|NCT01585961|66297666|FG000|Overall Study|Death|6|||
23705914|NCT01585961|66297666|FG000|Overall Study|Physician Decision|1|||
23705915|NCT01585961|66297666|FG000|Overall Study|Decision to use non-study catheter|1|||
23705916|NCT01585961|66297666|FG000|Overall Study|Withdrawal by Subject|1|||
23705917|NCT01585961|66297666|FG000|Overall Study|Lost to Follow-up|23|||
23705918|NCT01585961|66297666|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
23705919|NCT03491553|66297667|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
23705920|NCT03491553|66297668|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
23705921|NCT03491553|66297669|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
23705922|NCT03491553|66297670|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
23705923|NCT03491553|66297671|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
23705924|NCT03491553|66297672|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
23705925|NCT03491553|66297667|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
23705926|NCT03491553|66297668|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
23705927|NCT03491553|66297669|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
23705928|NCT03491553|66297670|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
23705929|NCT03491553|66297671|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
23705930|NCT03491553|66297672|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
23705931|NCT01701583|66297673|FG000|Overall Study|Withdrawal by Subject|2|||
23705932|NCT01701583|66297674|FG001|Overall Study|Withdrawal by Subject|0|||
23705933|NCT02575079|66297680|FG000|Overall Study|Death|3|||
23705934|NCT02575079|66297681|FG001|Overall Study|Death|0|||
23705935|NCT02575079|66297680|FG000|Overall Study|Withdrawal by Subject|3|||
23705936|NCT02575079|66297681|FG001|Overall Study|Withdrawal by Subject|0|||
23705937|NCT02179515|66297683|FG000|Overall Study|switched to alternative treatment|0|||
23705938|NCT02179515|66297684|FG001|Overall Study|switched to alternative treatment|1|||
23705939|NCT02179515|66297685|FG002|Overall Study|switched to alternative treatment|1|||
23705940|NCT02179515|66297683|FG000|Overall Study|Death|0|||
23705941|NCT02179515|66297684|FG001|Overall Study|Death|1|||
23705942|NCT02179515|66297685|FG002|Overall Study|Death|1|||
23705943|NCT02179515|66297683|FG000|Overall Study|refused further treatment|0|||
23705944|NCT02179515|66297684|FG001|Overall Study|refused further treatment|3|||
23705945|NCT02179515|66297685|FG002|Overall Study|refused further treatment|4|||
23705946|NCT02179515|66297683|FG000|Overall Study|Disease progression on study|2|||
23705947|NCT02179515|66297684|FG001|Overall Study|Disease progression on study|11|||
23705948|NCT02179515|66297685|FG002|Overall Study|Disease progression on study|8|||
23705949|NCT03599141|66297686|FG000|Overall Study|Lost to Follow-up|3|||
23705950|NCT03599141|66297687|FG001|Overall Study|Lost to Follow-up|1|||
23705951|NCT04072146|66297688|FG000|Overall Study|Adverse Event|0|||
23705952|NCT04072146|66297689|FG001|Overall Study|Adverse Event|1|||
23705953|NCT01839188|66297690|FG000|Overall Study|Withdrawal by Subject|1|||
23705954|NCT02817555|66297691|FG000|Overall Study|Death|1|||
23705955|NCT02817555|66297692|FG001|Overall Study|Death|3|||
23705956|NCT02817555|66297691|FG000|Overall Study|moved away|1|||
23705957|NCT02817555|66297692|FG001|Overall Study|moved away|0|||
23705958|NCT02817555|66297691|FG000|Overall Study|transplant|1|||
23705959|NCT02817555|66297692|FG001|Overall Study|transplant|1|||
23705960|NCT02817555|66297691|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
23705961|NCT02817555|66297692|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
23705962|NCT02460822|66297693|FG000|Overall Study|Withdrawal by Subject|1|||
23705963|NCT00804193|66297694|FG000|Overall Study|Lack of baseline fungus|32|||
23705964|NCT00804193|66297695|FG001|Overall Study|Lack of baseline fungus|31|||
23705965|NCT00804193|66297696|FG002|Overall Study|Lack of baseline fungus|19|||
23705966|NCT00804193|66297694|FG000|Overall Study|Adverse Event|0|||
23705967|NCT00804193|66297695|FG001|Overall Study|Adverse Event|0|||
23705968|NCT00804193|66297696|FG002|Overall Study|Adverse Event|2|||
23705969|NCT00804193|66297694|FG000|Overall Study|Lack of Efficacy|1|||
23705970|NCT00804193|66297695|FG001|Overall Study|Lack of Efficacy|1|||
23705971|NCT00804193|66297696|FG002|Overall Study|Lack of Efficacy|3|||
23705972|NCT00804193|66297694|FG000|Overall Study|Protocol Violation|0|||
23705973|NCT00804193|66297695|FG001|Overall Study|Protocol Violation|8|||
23705974|NCT00804193|66297696|FG002|Overall Study|Protocol Violation|2|||
23705975|NCT00804193|66297694|FG000|Overall Study|Lost to Follow-up|3|||
23705976|NCT00804193|66297695|FG001|Overall Study|Lost to Follow-up|3|||
23705977|NCT00804193|66297696|FG002|Overall Study|Lost to Follow-up|4|||
23705978|NCT00804193|66297694|FG000|Overall Study|Withdrawal by Subject|3|||
23705979|NCT00804193|66297695|FG001|Overall Study|Withdrawal by Subject|1|||
23705980|NCT00804193|66297696|FG002|Overall Study|Withdrawal by Subject|2|||
23705981|NCT02214186|66297698|FG000|Overall Study|Lost to Follow-up|1|||
23705982|NCT02214186|66297699|FG001|Overall Study|Lost to Follow-up|1|||
23705983|NCT02214186|66297698|FG000|Overall Study|Protocol Violation|1|||
23705984|NCT02214186|66297699|FG001|Overall Study|Protocol Violation|1|||
23705985|NCT05515601|66297700|FG000|Overall Study|Withdrawal by Subject|1|||
23705986|NCT05515601|66297701|FG001|Overall Study|Withdrawal by Subject|3|||
23705987|NCT05515601|66297702|FG002|Overall Study|Withdrawal by Subject|2|||
23705988|NCT05515601|66297703|FG003|Overall Study|Withdrawal by Subject|1|||
23705989|NCT05515601|66297704|FG004|Overall Study|Withdrawal by Subject|1|||
23705990|NCT05515601|66297705|FG005|Overall Study|Withdrawal by Subject|1|||
23705991|NCT05515601|66297700|FG000|Overall Study|Lost to Follow-up|0|||
23705992|NCT05515601|66297701|FG001|Overall Study|Lost to Follow-up|0|||
23705993|NCT05515601|66297702|FG002|Overall Study|Lost to Follow-up|0|||
23705994|NCT05515601|66297703|FG003|Overall Study|Lost to Follow-up|0|||
23705995|NCT05515601|66297704|FG004|Overall Study|Lost to Follow-up|1|||
23705996|NCT05515601|66297705|FG005|Overall Study|Lost to Follow-up|0|||
23705997|NCT01058369|66297706|FG000|Overall Study|Adverse Event|1|||
23705998|NCT01058369|66297706|FG000|Overall Study|Early termination study|1|||
23705999|NCT01543490|66297707|FG000|Overall Study|Adverse Event|4|||
23706000|NCT01543490|66297708|FG001|Overall Study|Adverse Event|0|||
23706001|NCT01543490|66297707|FG000|Overall Study|Physician Decision|1|||
23706002|NCT01543490|66297708|FG001|Overall Study|Physician Decision|0|||
23706003|NCT01543490|66297707|FG000|Overall Study|Lack of Efficacy|3|||
23706004|NCT01543490|66297708|FG001|Overall Study|Lack of Efficacy|3|||
23706005|NCT01543490|66297707|FG000|Overall Study|Lost to Follow-up|5|||
23706006|NCT01543490|66297708|FG001|Overall Study|Lost to Follow-up|0|||
23706007|NCT01543490|66297707|FG000|Overall Study|Withdrawal by Subject|2|||
23706008|NCT01543490|66297708|FG001|Overall Study|Withdrawal by Subject|0|||
23706009|NCT01543490|66297707|FG000|Overall Study|Other-Various Administrative Reasons|1|||
23706010|NCT01543490|66297708|FG001|Overall Study|Other-Various Administrative Reasons|2|||
23706011|NCT02596711|66301019|FG000|Overall Study|Lost to Follow-up|1|||
23706012|NCT02596711|66301020|FG001|Overall Study|Lost to Follow-up|2|||
23706013|NCT02596711|66301021|FG002|Overall Study|Lost to Follow-up|3|||
23706014|NCT01551758|66301022|FG000|Overall Study|Adverse Event|29|||
23706015|NCT01551758|66301023|FG001|Overall Study|Adverse Event|43|||
23706016|NCT01551758|66301022|FG000|Overall Study|Lack of Efficacy|0|||
23706017|NCT01551758|66301023|FG001|Overall Study|Lack of Efficacy|1|||
23706018|NCT01551758|66301022|FG000|Overall Study|Protocol Violation|5|||
23706019|NCT01551758|66301023|FG001|Overall Study|Protocol Violation|6|||
23706020|NCT01551758|66301022|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
23706021|NCT01551758|66301023|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
23706022|NCT01551758|66301022|FG000|Overall Study|Lost to Follow-up|29|||
23706023|NCT01551758|66301023|FG001|Overall Study|Lost to Follow-up|25|||
23706024|NCT01551758|66301022|FG000|Overall Study|Physician Decision|9|||
23706025|NCT01551758|66301023|FG001|Overall Study|Physician Decision|3|||
23706026|NCT01551758|66301022|FG000|Overall Study|Withdrawal by Subject|14|||
23706027|NCT01551758|66301023|FG001|Overall Study|Withdrawal by Subject|17|||
23706028|NCT00718419|66301029|FG000|Overall Study|Adverse Event|2|||
23706029|NCT00718419|66301030|FG001|Overall Study|Adverse Event|1|||
23706030|NCT00718419|66301029|FG000|Overall Study|Physician Decision|1|||
23706031|NCT00718419|66301030|FG001|Overall Study|Physician Decision|6|||
23706038|NCT00718419|66301029|FG000|Overall Study|Death Due to Progressive Disease|2|||
23706039|NCT00718419|66301030|FG001|Overall Study|Death Due to Progressive Disease|0|||
23706040|NCT00718419|66301029|FG000|Overall Study|Death Due to Study Drug Related|0|||
23706041|NCT00718419|66301030|FG001|Overall Study|Death Due to Study Drug Related|1|||
23706042|NCT00718419|66301029|FG000|Overall Study|Death Due to Adverse Events|1|||
23706043|NCT00718419|66301030|FG001|Overall Study|Death Due to Adverse Events|0|||
23706044|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
23706045|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
23706046|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Death|2|||
23706047|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Death|1|||
23706048|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
23706049|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
23706050|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
23706051|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
23706052|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
23706053|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
23706054|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
23706055|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
23706056|NCT03633227|66301031|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
23706057|NCT03633227|66301032|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
23706058|NCT03633227|66301031|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
23706059|NCT03633227|66301032|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
23706060|NCT03633227|66301031|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
23706061|NCT03633227|66301032|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
23706062|NCT03633227|66301031|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
23706063|NCT03633227|66301032|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
23706064|NCT03633227|66301031|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
23706065|NCT03633227|66301032|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
23706066|NCT03633227|66301031|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
23706067|NCT03633227|66301032|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
23706068|NCT03350750|66301033|FG000|Overall Study|Death|1|||
23706069|NCT03350750|66301034|FG001|Overall Study|Death|1|||
23706070|NCT01766336|66301035|FG000|Overall Study|Adverse Event|11|||
23706071|NCT01766336|66301036|FG001|Overall Study|Adverse Event|8|||
23706072|NCT01766336|66301035|FG000|Overall Study|Death|4|||
23706073|NCT01766336|66301036|FG001|Overall Study|Death|3|||
23706074|NCT01766336|66301035|FG000|Overall Study|Lost to Follow-up|1|||
23706075|NCT01766336|66301036|FG001|Overall Study|Lost to Follow-up|3|||
23706076|NCT01766336|66301035|FG000|Overall Study|Physician Decision|4|||
23706077|NCT01766336|66301036|FG001|Overall Study|Physician Decision|2|||
23706078|NCT01766336|66301035|FG000|Overall Study|Protocol Violation|0|||
23706079|NCT01766336|66301036|FG001|Overall Study|Protocol Violation|1|||
23706080|NCT01766336|66301035|FG000|Overall Study|Sponsor Decision|52|||
23706081|NCT01766336|66301036|FG001|Overall Study|Sponsor Decision|43|||
23706082|NCT01766336|66301035|FG000|Overall Study|Withdrawal by Subject|18|||
23706083|NCT01766336|66301036|FG001|Overall Study|Withdrawal by Subject|15|||
23706084|NCT04657016|66301037|FG000|Overall Study|Adverse Event|2|||
23706085|NCT04657016|66301038|FG001|Overall Study|Adverse Event|4|||
23706086|NCT04657016|66301037|FG000|Overall Study|Death|1|||
23706087|NCT04657016|66301038|FG001|Overall Study|Death|1|||
23706088|NCT04657016|66301037|FG000|Overall Study|Lost to Follow-up|24|||
23706089|NCT04657016|66301038|FG001|Overall Study|Lost to Follow-up|12|||
23706090|NCT04657016|66301037|FG000|Overall Study|Physician Decision|1|||
23706091|NCT04657016|66301038|FG001|Overall Study|Physician Decision|2|||
23706092|NCT04657016|66301037|FG000|Overall Study|Pregnancy|2|||
23706093|NCT04657016|66301038|FG001|Overall Study|Pregnancy|2|||
23706094|NCT04657016|66301037|FG000|Overall Study|Protocol Deviation|1|||
23706095|NCT04657016|66301038|FG001|Overall Study|Protocol Deviation|0|||
23706096|NCT04657016|66301037|FG000|Overall Study|Withdrawal by Subject|28|||
23706097|NCT04657016|66301038|FG001|Overall Study|Withdrawal by Subject|14|||
23706098|NCT04657016|66301037|FG000|Overall Study|Other - as reported by the investigator|6|||
23706099|NCT04657016|66301038|FG001|Overall Study|Other - as reported by the investigator|0|||
23706100|NCT01115569|66301041|FG000|Conversion/Titration Phase|Adverse Event|59|||
23706101|NCT01115569|66301042|FG001|Conversion/Titration Phase|Adverse Event|0|||
23706102|NCT01115569|66301041|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
23706103|NCT01115569|66301042|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
23706104|NCT01115569|66301041|FG000|Conversion/Titration Phase|Physician Decision|5|||
23706105|NCT01115569|66301042|FG001|Conversion/Titration Phase|Physician Decision|0|||
23706106|NCT01115569|66301041|FG000|Conversion/Titration Phase|Protocol Violation|68|||
23706107|NCT01115569|66301042|FG001|Conversion/Titration Phase|Protocol Violation|0|||
23706108|NCT01115569|66301041|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
23706109|NCT01115569|66301042|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
23706110|NCT01115569|66301041|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
23706111|NCT01115569|66301042|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
23706112|NCT01115569|66301041|FG000|Maintenance Phase|Adverse Event|0|||
23706113|NCT01115569|66301042|FG001|Maintenance Phase|Adverse Event|43|||
23706114|NCT01115569|66301041|FG000|Maintenance Phase|Lost to Follow-up|0|||
23706115|NCT01115569|66301042|FG001|Maintenance Phase|Lost to Follow-up|8|||
23706116|NCT01115569|66301041|FG000|Maintenance Phase|Physician Decision|0|||
23706117|NCT01115569|66301042|FG001|Maintenance Phase|Physician Decision|3|||
23706118|NCT01115569|66301041|FG000|Maintenance Phase|Protocol Violation|0|||
23706119|NCT01115569|66301042|FG001|Maintenance Phase|Protocol Violation|9|||
23706120|NCT01115569|66301041|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23706121|NCT01115569|66301042|FG001|Maintenance Phase|Withdrawal by Subject|27|||
23706122|NCT01115569|66301041|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
23706123|NCT01115569|66301042|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
23706124|NCT01115569|66301041|FG000|Maintenance Phase|Administrative|0|||
23706125|NCT01115569|66301042|FG001|Maintenance Phase|Administrative|1|||
23706126|NCT03141086|66301043|FG000|Overall Study|Study Terminated By Sponsor|1|||
23706127|NCT03141086|66301044|FG001|Overall Study|Study Terminated By Sponsor|1|||
23706128|NCT03141086|66301043|FG000|Overall Study|Withdrawal by Subject|0|||
23706129|NCT03141086|66301044|FG001|Overall Study|Withdrawal by Subject|1|||
23706130|NCT03141086|66301043|FG000|Overall Study|Protocol Violation|0|||
23706131|NCT03141086|66301044|FG001|Overall Study|Protocol Violation|1|||
23706132|NCT03141086|66301043|FG000|Overall Study|Adverse Event|0|||
23706133|NCT03141086|66301044|FG001|Overall Study|Adverse Event|2|||
23706134|NCT03235544|66301047|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
23706135|NCT03235544|66301048|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
23706136|NCT03235544|66301049|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
23706137|NCT03235544|66301050|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
23706138|NCT03235544|66301047|FG000|Overall Study|Death|11|||
23706139|NCT03235544|66301048|FG001|Overall Study|Death|23|||
23706140|NCT03235544|66301049|FG002|Overall Study|Death|11|||
23706141|NCT03235544|66301050|FG003|Overall Study|Death|20|||
23706142|NCT03235544|66301047|FG000|Overall Study|Lost to Follow-up|0|||
23706143|NCT03235544|66301048|FG001|Overall Study|Lost to Follow-up|1|||
23706144|NCT03235544|66301049|FG002|Overall Study|Lost to Follow-up|0|||
23706145|NCT03235544|66301050|FG003|Overall Study|Lost to Follow-up|1|||
23706146|NCT03235544|66301047|FG000|Overall Study|Withdrawal by Participant|0|||
23706147|NCT03235544|66301048|FG001|Overall Study|Withdrawal by Participant|0|||
23706148|NCT03235544|66301049|FG002|Overall Study|Withdrawal by Participant|1|||
23706149|NCT03235544|66301050|FG003|Overall Study|Withdrawal by Participant|0|||
23706150|NCT03235544|66301047|FG000|Overall Study|Reason not Specified|0|||
23706151|NCT03235544|66301048|FG001|Overall Study|Reason not Specified|4|||
23706152|NCT03235544|66301049|FG002|Overall Study|Reason not Specified|0|||
23706153|NCT03235544|66301050|FG003|Overall Study|Reason not Specified|1|||
23706154|NCT01675011|66301051|FG000|Overall Study|Trial terminated by Sponsor|3|||
23706155|NCT01675011|66301052|FG001|Overall Study|Trial terminated by Sponsor|1|||
23706156|NCT03196505|66301053|FG000|Overall Study|Physician Decision|26|||
23706157|NCT03196505|66301054|FG001|Overall Study|Physician Decision|26|||
23706158|NCT01361009|66301055|FG000|Overall Study|Protocol Violation|116|||
23706159|NCT02324842|66301058|FG000|Overall Study|Lost to Follow-up|1|||
23706160|NCT02324842|66301059|FG001|Overall Study|Lost to Follow-up|1|||
23706161|NCT02324842|66301060|FG002|Overall Study|Lost to Follow-up|2|||
23706162|NCT01597557|66301061|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
23706163|NCT01597557|66301062|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
23706164|NCT02993224|66301074|FG000|Core Phase - Period 1|Adverse Event|4|||
23706165|NCT02993224|66301074|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
23706166|NCT02993224|66301074|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
23706167|NCT02993224|66301074|FG000|Core Phase- Period 2|Adverse Event|1|||
23706168|NCT02993224|66301074|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
23706169|NCT02993224|66301074|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
23706170|NCT02993224|66301074|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
23706171|NCT02993224|66301074|FG000|Extension Phase|Adverse Event|3|||
23706172|NCT02993224|66301074|FG000|Extension Phase|Withdrawal by Subject|3|||
23706173|NCT02993224|66301074|FG000|Extension Phase|Lost to Follow-up|2|||
23706174|NCT02993224|66301074|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
23706175|NCT01242020|66301075|FG000|Overall Study|Withdrawal by Subject|2|||
23706176|NCT01242020|66301076|FG001|Overall Study|Withdrawal by Subject|0|||
23706177|NCT01242020|66301075|FG000|Overall Study|Failed screening|1|||
23706178|NCT01242020|66301076|FG001|Overall Study|Failed screening|0|||
23706179|NCT02234583|66301077|FG000|Overall Study|Adverse Event|172|||
23706180|NCT02234583|66301078|FG001|Overall Study|Adverse Event|156|||
23706181|NCT02234583|66301077|FG000|Overall Study|Withdrawal by Subject|109|||
23706182|NCT02234583|66301078|FG001|Overall Study|Withdrawal by Subject|157|||
23706183|NCT02234583|66301077|FG000|Overall Study|Lost to Follow-up|0|||
23706184|NCT02234583|66301078|FG001|Overall Study|Lost to Follow-up|1|||
23706206|NCT01258348|66301081|FG000|Overall Study|Withdrawal by Subject|0|||
23706207|NCT01258348|66301082|FG001|Overall Study|Withdrawal by Subject|1|||
23706208|NCT01258348|66301083|FG002|Overall Study|Withdrawal by Subject|0|||
23706209|NCT01258348|66301084|FG003|Overall Study|Withdrawal by Subject|0|||
23706210|NCT01258348|66301085|FG004|Overall Study|Withdrawal by Subject|0|||
23706211|NCT01689207|66301091|FG000|Overall Study|Adverse Event|0|||
23706212|NCT01689207|66301092|FG001|Overall Study|Adverse Event|1|||
23706213|NCT01689207|66301093|FG002|Overall Study|Adverse Event|0|||
23706214|NCT01689207|66301094|FG003|Overall Study|Adverse Event|0|||
23706215|NCT01689207|66301095|FG004|Overall Study|Adverse Event|2|||
23706216|NCT01689207|66301096|FG005|Overall Study|Adverse Event|1|||
23706217|NCT01689207|66301097|FG006|Overall Study|Adverse Event|0|||
23706218|NCT01689207|66301098|FG007|Overall Study|Adverse Event|0|||
23706219|NCT01689207|66301099|FG008|Overall Study|Adverse Event|1|||
23706220|NCT01689207|66301100|FG009|Overall Study|Adverse Event|0|||
23706221|NCT01689207|66301101|FG010|Overall Study|Adverse Event|0|||
23706222|NCT01863849|66301102|FG000|Overall Study|Lost to Follow-up|1|||
23706223|NCT01863849|66301103|FG001|Overall Study|Lost to Follow-up|0|||
23706224|NCT02164513|66301124|FG000|Overall Study|Adverse Event|162|||
23706225|NCT02164513|66301125|FG001|Overall Study|Adverse Event|180|||
23706226|NCT02164513|66301126|FG002|Overall Study|Adverse Event|111|||
23706227|NCT02164513|66301124|FG000|Overall Study|Other: Study Closed or terminated|5|||
23706228|NCT02164513|66301125|FG001|Overall Study|Other: Study Closed or terminated|2|||
23706229|NCT02164513|66301126|FG002|Overall Study|Other: Study Closed or terminated|4|||
23706230|NCT02164513|66301124|FG000|Overall Study|Lost to Follow-up|30|||
23706231|NCT02164513|66301125|FG001|Overall Study|Lost to Follow-up|36|||
23706232|NCT02164513|66301126|FG002|Overall Study|Lost to Follow-up|22|||
23706233|NCT02164513|66301124|FG000|Overall Study|Physician Decision|47|||
23706234|NCT02164513|66301125|FG001|Overall Study|Physician Decision|57|||
23706235|NCT02164513|66301126|FG002|Overall Study|Physician Decision|28|||
23706236|NCT02164513|66301124|FG000|Overall Study|Withdrawal by Subject|192|||
23706237|NCT02164513|66301125|FG001|Overall Study|Withdrawal by Subject|261|||
23706238|NCT02164513|66301126|FG002|Overall Study|Withdrawal by Subject|130|||
23706239|NCT02164513|66301124|FG000|Overall Study|Other: Reason not provided by site|1|||
23706240|NCT02164513|66301125|FG001|Overall Study|Other: Reason not provided by site|0|||
23706241|NCT02164513|66301126|FG002|Overall Study|Other: Reason not provided by site|0|||
23706242|NCT00975195|66301130|FG000|Overall Study|Adverse Event|108|||
23706243|NCT00975195|66301131|FG001|Overall Study|Adverse Event|101|||
23706244|NCT00975195|66301130|FG000|Overall Study|Lack of Efficacy|6|||
23706245|NCT00975195|66301131|FG001|Overall Study|Lack of Efficacy|6|||
23706246|NCT00975195|66301130|FG000|Overall Study|Protocol Violation|27|||
23706247|NCT00975195|66301131|FG001|Overall Study|Protocol Violation|23|||
23706248|NCT00975195|66301130|FG000|Overall Study|Lost to Follow-up|9|||
23706249|NCT00975195|66301131|FG001|Overall Study|Lost to Follow-up|7|||
23706250|NCT00975195|66301130|FG000|Overall Study|Withdrawal by Subject|48|||
23706251|NCT00975195|66301131|FG001|Overall Study|Withdrawal by Subject|61|||
23706252|NCT00975195|66301130|FG000|Overall Study|Other reason not defined above|29|||
23706253|NCT00975195|66301131|FG001|Overall Study|Other reason not defined above|33|||
23706254|NCT00975195|66301130|FG000|Overall Study|Not treated|1|||
23706255|NCT00975195|66301131|FG001|Overall Study|Not treated|2|||
23706256|NCT00634244|66301136|FG000|Overall Study|Never started treatment|0|||
23706257|NCT00634244|66301137|FG001|Overall Study|Never started treatment|1|||
23706258|NCT00634244|66301138|FG002|Overall Study|Never started treatment|0|||
23706259|NCT00634244|66301136|FG000|Overall Study|Death|1|||
23706260|NCT00634244|66301137|FG001|Overall Study|Death|6|||
23706261|NCT00634244|66301138|FG002|Overall Study|Death|0|||
23706262|NCT00634244|66301136|FG000|Overall Study|Adverse Event|0|||
23706263|NCT00634244|66301137|FG001|Overall Study|Adverse Event|2|||
23706264|NCT00634244|66301138|FG002|Overall Study|Adverse Event|0|||
23706265|NCT00634244|66301136|FG000|Overall Study|Withdrawal by Subject|0|||
23706266|NCT00634244|66301137|FG001|Overall Study|Withdrawal by Subject|1|||
23706267|NCT00634244|66301138|FG002|Overall Study|Withdrawal by Subject|0|||
23706268|NCT00634244|66301136|FG000|Overall Study|Physician Decision|0|||
23706269|NCT00634244|66301137|FG001|Overall Study|Physician Decision|1|||
23706270|NCT00634244|66301138|FG002|Overall Study|Physician Decision|0|||
23706271|NCT00634244|66301136|FG000|Overall Study|Disease progression/relapse|0|||
23706272|NCT00634244|66301137|FG001|Overall Study|Disease progression/relapse|1|||
23706273|NCT00634244|66301138|FG002|Overall Study|Disease progression/relapse|0|||
23706274|NCT00634244|66301136|FG000|Overall Study|Other complicating disease|0|||
23706275|NCT00634244|66301137|FG001|Overall Study|Other complicating disease|1|||
23706276|NCT00634244|66301138|FG002|Overall Study|Other complicating disease|0|||
23706277|NCT00431847|66301139|FG000|Overall Study|completion of less than two study visits|6|||
23706278|NCT00431847|66301140|FG001|Overall Study|completion of less than two study visits|3|||
23706279|NCT00431847|66301141|FG002|Overall Study|completion of less than two study visits|4|||
23706280|NCT00431847|66301142|FG003|Overall Study|completion of less than two study visits|14|||
23706281|NCT00431847|66301143|FG004|Overall Study|completion of less than two study visits|0|||
23706282|NCT00431847|66301139|FG000|Overall Study|Protocol Violation|0|||
23706287|NCT05142332|66301150|FG000|Overall Study|Withdrawal by Subject|0|||
23706288|NCT05142332|66301151|FG001|Overall Study|Withdrawal by Subject|1|||
23706289|NCT05142332|66301152|FG002|Overall Study|Withdrawal by Subject|2|||
23706290|NCT05142332|66301153|FG003|Overall Study|Withdrawal by Subject|0|||
23706291|NCT05142332|66301154|FG004|Overall Study|Withdrawal by Subject|0|||
23706292|NCT05142332|66301155|FG005|Overall Study|Withdrawal by Subject|2|||
23706293|NCT05142332|66301156|FG006|Overall Study|Withdrawal by Subject|6|||
23706294|NCT05142332|66301150|FG000|Overall Study|Left ED|3|||
23706295|NCT05142332|66301151|FG001|Overall Study|Left ED|0|||
23706296|NCT05142332|66301152|FG002|Overall Study|Left ED|4|||
23706297|NCT05142332|66301153|FG003|Overall Study|Left ED|6|||
23706298|NCT05142332|66301154|FG004|Overall Study|Left ED|1|||
23706299|NCT05142332|66301155|FG005|Overall Study|Left ED|2|||
23706300|NCT05142332|66301156|FG006|Overall Study|Left ED|6|||
23706301|NCT05142332|66301150|FG000|Overall Study|Physician Decision|0|||
23706302|NCT05142332|66301151|FG001|Overall Study|Physician Decision|0|||
23706303|NCT05142332|66301152|FG002|Overall Study|Physician Decision|2|||
23706304|NCT05142332|66301153|FG003|Overall Study|Physician Decision|1|||
23706305|NCT05142332|66301154|FG004|Overall Study|Physician Decision|0|||
23706306|NCT05142332|66301155|FG005|Overall Study|Physician Decision|0|||
23706307|NCT05142332|66301156|FG006|Overall Study|Physician Decision|3|||
23706308|NCT05142332|66301150|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
23706309|NCT05142332|66301151|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23706310|NCT05142332|66301152|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
23706311|NCT05142332|66301153|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
23706312|NCT05142332|66301154|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23706313|NCT05142332|66301155|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
23706314|NCT05142332|66301156|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23706315|NCT03521687|66301160|FG000|Overall Study|Adverse Event|4|||
23706316|NCT03521687|66301160|FG000|Overall Study|Physician Decision|1|||
23706317|NCT00702052|66301161|FG000|Overall Study|Adverse Event|23|||
23706318|NCT00702052|66301161|FG000|Overall Study|Disease Progression|30|||
23706319|NCT00702052|66301161|FG000|Overall Study|Withdrawal by Subject|5|||
23706320|NCT00789477|66301162|FG000|Overall Study|Withdrawal by Subject|2|||
23706321|NCT00789477|66301163|FG001|Overall Study|Withdrawal by Subject|1|||
23706322|NCT00789477|66301164|FG002|Overall Study|Withdrawal by Subject|3|||
23706323|NCT00789477|66301165|FG003|Overall Study|Withdrawal by Subject|2|||
23706324|NCT00789477|66301166|FG004|Overall Study|Withdrawal by Subject|3|||
23706325|NCT00789477|66301162|FG000|Overall Study|Protocol Violation|1|||
23706326|NCT00789477|66301163|FG001|Overall Study|Protocol Violation|0|||
23706327|NCT00789477|66301164|FG002|Overall Study|Protocol Violation|0|||
23706328|NCT00789477|66301165|FG003|Overall Study|Protocol Violation|1|||
23706329|NCT00789477|66301166|FG004|Overall Study|Protocol Violation|0|||
23706330|NCT00789477|66301162|FG000|Overall Study|Adverse Event|3|||
23706331|NCT00789477|66301163|FG001|Overall Study|Adverse Event|3|||
23706332|NCT00789477|66301164|FG002|Overall Study|Adverse Event|1|||
23706333|NCT00789477|66301165|FG003|Overall Study|Adverse Event|0|||
23706334|NCT00789477|66301166|FG004|Overall Study|Adverse Event|0|||
23706335|NCT00789477|66301162|FG000|Overall Study|Death|1|||
23706336|NCT00789477|66301163|FG001|Overall Study|Death|1|||
23706337|NCT00789477|66301164|FG002|Overall Study|Death|2|||
23706338|NCT00789477|66301165|FG003|Overall Study|Death|2|||
23706339|NCT00789477|66301166|FG004|Overall Study|Death|0|||
23706340|NCT00789477|66301162|FG000|Overall Study|Lost to Follow-up|0|||
23706341|NCT00789477|66301163|FG001|Overall Study|Lost to Follow-up|1|||
23706342|NCT00789477|66301164|FG002|Overall Study|Lost to Follow-up|4|||
23706343|NCT00789477|66301165|FG003|Overall Study|Lost to Follow-up|2|||
23706344|NCT00789477|66301166|FG004|Overall Study|Lost to Follow-up|4|||
23706345|NCT00789477|66301162|FG000|Overall Study|Lack of Efficacy|2|||
23706346|NCT00789477|66301163|FG001|Overall Study|Lack of Efficacy|0|||
23706347|NCT00789477|66301164|FG002|Overall Study|Lack of Efficacy|0|||
23706348|NCT00789477|66301165|FG003|Overall Study|Lack of Efficacy|0|||
23706349|NCT00789477|66301166|FG004|Overall Study|Lack of Efficacy|0|||
23706350|NCT00789477|66301162|FG000|Overall Study|Other|2|||
23706351|NCT00789477|66301163|FG001|Overall Study|Other|0|||
23706352|NCT00789477|66301164|FG002|Overall Study|Other|1|||
23706353|NCT00789477|66301165|FG003|Overall Study|Other|3|||
23706354|NCT00789477|66301166|FG004|Overall Study|Other|0|||
23706355|NCT02742649|66301167|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
23706356|NCT02742649|66301168|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23706357|NCT02742649|66301169|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23706358|NCT02742649|66301170|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23706359|NCT02742649|66301171|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23706360|NCT02742649|66301167|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23706361|NCT02742649|66301168|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23706362|NCT02742649|66301169|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23706363|NCT02742649|66301170|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23706364|NCT02742649|66301171|FG004|Double-Blind Treatment Period|Adverse Event|0|||
23706365|NCT02742649|66301167|FG000|Open-Label Period|Lost to Follow-up|0|||
23706366|NCT02742649|66301168|FG001|Open-Label Period|Lost to Follow-up|0|||
23706367|NCT02742649|66301169|FG002|Open-Label Period|Lost to Follow-up|0|||
23706368|NCT02742649|66301170|FG003|Open-Label Period|Lost to Follow-up|0|||
23706369|NCT02742649|66301171|FG004|Open-Label Period|Lost to Follow-up|1|||
23706370|NCT01228071|66301172|FG000|Overall Study|Protocol Violation|1|||
23706371|NCT01228071|66301172|FG000|Overall Study|Withdrawal by Subject|1|||
23706372|NCT01096446|66301182|FG000|Overall Study|Death|1|||
23706373|NCT01096446|66301183|FG001|Overall Study|Death|0|||
23706374|NCT01096446|66301182|FG000|Overall Study|Protocol Violation|2|||
23706375|NCT01096446|66301183|FG001|Overall Study|Protocol Violation|0|||
23706376|NCT03650452|66301184|FG000|Overall Study|Physician Decision|1|||
23706377|NCT03650452|66301185|FG001|Overall Study|Physician Decision|0|||
23706378|NCT03650452|66301184|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23706379|NCT03650452|66301185|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23706380|NCT03650452|66301184|FG000|Overall Study|Adverse Event|3|||
23706381|NCT03650452|66301185|FG001|Overall Study|Adverse Event|4|||
23706382|NCT03650452|66301184|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
23706383|NCT03650452|66301185|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
23706384|NCT03176277|66301189|FG000|Part A Dose Escalation Study|Adverse Event|1|||
23706385|NCT03176277|66301190|FG001|Part A Dose Escalation Study|Adverse Event|0|||
23706386|NCT03176277|66301191|FG002|Part A Dose Escalation Study|Adverse Event|1|||
23706387|NCT03176277|66301192|FG003|Part A Dose Escalation Study|Adverse Event|0|||
23706388|NCT03176277|66301189|FG000|Part A Dose Escalation Study|Physician Decision|1|||
23706389|NCT03176277|66301190|FG001|Part A Dose Escalation Study|Physician Decision|1|||
23706390|NCT03176277|66301191|FG002|Part A Dose Escalation Study|Physician Decision|2|||
23706391|NCT03176277|66301192|FG003|Part A Dose Escalation Study|Physician Decision|0|||
23706392|NCT03176277|66301189|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
23706393|NCT03176277|66301190|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
23706394|NCT03176277|66301191|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
23706395|NCT03176277|66301192|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
23706396|NCT03176277|66301189|FG000|Part A Dose Escalation Study|Progressive disease|3|||
23706397|NCT03176277|66301190|FG001|Part A Dose Escalation Study|Progressive disease|1|||
23706398|NCT03176277|66301191|FG002|Part A Dose Escalation Study|Progressive disease|3|||
23706399|NCT03176277|66301192|FG003|Part A Dose Escalation Study|Progressive disease|0|||
23706400|NCT03165721|66301193|FG000|Overall Study|Refused further treatment|3|||
23706401|NCT03165721|66301194|FG001|Overall Study|Refused further treatment|0|||
23706402|NCT03165721|66301195|FG002|Overall Study|Refused further treatment|0|||
23706403|NCT03165721|66301193|FG000|Overall Study|Physician Decision|1|||
23706404|NCT03165721|66301194|FG001|Overall Study|Physician Decision|0|||
23706405|NCT03165721|66301195|FG002|Overall Study|Physician Decision|0|||
23706406|NCT02145156|66301201|FG000|Overall Study|No match to vaccination records|60|||
23706407|NCT02145156|66301202|FG001|Overall Study|No match to vaccination records|52|||
23706408|NCT02145156|66301203|FG002|Overall Study|No match to vaccination records|41|||
23706409|NCT01260467|66301205|FG000|Overall Study|Withdrawal by Subject|2|||
23706410|NCT02488759|66301206|FG000|Overall Study|Disease progression|73|||
23706411|NCT02488759|66301207|FG001|Overall Study|Disease progression|111|||
23706412|NCT02488759|66301208|FG002|Overall Study|Disease progression|62|||
23706413|NCT02488759|66301209|FG003|Overall Study|Disease progression|7|||
23706414|NCT02488759|66301210|FG004|Overall Study|Disease progression|4|||
23706415|NCT02488759|66301211|FG005|Overall Study|Disease progression|2|||
23706416|NCT02488759|66301206|FG000|Overall Study|Study drug toxicity|11|||
23706417|NCT02488759|66301207|FG001|Overall Study|Study drug toxicity|33|||
23706418|NCT02488759|66301208|FG002|Overall Study|Study drug toxicity|31|||
23706419|NCT02488759|66301209|FG003|Overall Study|Study drug toxicity|0|||
23706420|NCT02488759|66301210|FG004|Overall Study|Study drug toxicity|0|||
23706421|NCT02488759|66301211|FG005|Overall Study|Study drug toxicity|2|||
23706422|NCT02488759|66301206|FG000|Overall Study|Adverse event unrelated to study drug|9|||
23706423|NCT02488759|66301207|FG001|Overall Study|Adverse event unrelated to study drug|11|||
23706424|NCT02488759|66301208|FG002|Overall Study|Adverse event unrelated to study drug|7|||
23706425|NCT02488759|66301209|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23706426|NCT02488759|66301210|FG004|Overall Study|Adverse event unrelated to study drug|1|||
23706427|NCT02488759|66301211|FG005|Overall Study|Adverse event unrelated to study drug|0|||
23706428|NCT02488759|66301206|FG000|Overall Study|Participant request to discontinue study treatment|6|||
23706429|NCT02488759|66301207|FG001|Overall Study|Participant request to discontinue study treatment|8|||
23706430|NCT02488759|66301208|FG002|Overall Study|Participant request to discontinue study treatment|4|||
23706431|NCT02488759|66301209|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23706432|NCT02488759|66301210|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23706433|NCT02488759|66301211|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23706434|NCT02488759|66301206|FG000|Overall Study|Withdrawal by Subject|4|||
23706435|NCT02488759|66301207|FG001|Overall Study|Withdrawal by Subject|0|||
23706436|NCT02488759|66301208|FG002|Overall Study|Withdrawal by Subject|3|||
23706437|NCT02488759|66301209|FG003|Overall Study|Withdrawal by Subject|0|||
23706438|NCT02488759|66301210|FG004|Overall Study|Withdrawal by Subject|0|||
23706439|NCT02488759|66301211|FG005|Overall Study|Withdrawal by Subject|2|||
23706440|NCT02488759|66301206|FG000|Overall Study|Lost to Follow-up|0|||
23706441|NCT02488759|66301207|FG001|Overall Study|Lost to Follow-up|0|||
23706442|NCT02488759|66301208|FG002|Overall Study|Lost to Follow-up|2|||
23706443|NCT02488759|66301209|FG003|Overall Study|Lost to Follow-up|0|||
23706444|NCT02488759|66301210|FG004|Overall Study|Lost to Follow-up|0|||
23706445|NCT02488759|66301211|FG005|Overall Study|Lost to Follow-up|0|||
23706446|NCT02488759|66301206|FG000|Overall Study|Maximum clinical benefit|3|||
23706447|NCT02488759|66301207|FG001|Overall Study|Maximum clinical benefit|0|||
23706448|NCT02488759|66301208|FG002|Overall Study|Maximum clinical benefit|1|||
23706449|NCT02488759|66301209|FG003|Overall Study|Maximum clinical benefit|0|||
23706450|NCT02488759|66301210|FG004|Overall Study|Maximum clinical benefit|0|||
23706451|NCT02488759|66301211|FG005|Overall Study|Maximum clinical benefit|0|||
23706452|NCT02488759|66301206|FG000|Overall Study|Other reasons|7|||
23706453|NCT02488759|66301207|FG001|Overall Study|Other reasons|32|||
23706454|NCT02488759|66301208|FG002|Overall Study|Other reasons|23|||
23706455|NCT02488759|66301209|FG003|Overall Study|Other reasons|1|||
23706456|NCT02488759|66301210|FG004|Overall Study|Other reasons|1|||
23706457|NCT02488759|66301211|FG005|Overall Study|Other reasons|1|||
23706458|NCT04439838|66301212|FG000|Overall Study|Withdrawal by Subject|0|||
23706459|NCT04439838|66301213|FG001|Overall Study|Withdrawal by Subject|0|||
23706460|NCT04439838|66301214|FG002|Overall Study|Withdrawal by Subject|0|||
23706461|NCT04439838|66301215|FG003|Overall Study|Withdrawal by Subject|0|||
23706462|NCT04439838|66301216|FG004|Overall Study|Withdrawal by Subject|0|||
23706463|NCT04439838|66301217|FG005|Overall Study|Withdrawal by Subject|0|||
23706464|NCT04439838|66301218|FG006|Overall Study|Withdrawal by Subject|0|||
23706465|NCT04439838|66301219|FG007|Overall Study|Withdrawal by Subject|0|||
23706466|NCT04439838|66301220|FG008|Overall Study|Withdrawal by Subject|1|||
23706467|NCT01204658|66301221|FG000|Primary Phase|Adverse Event|0|||
23706468|NCT01204658|66301222|FG001|Primary Phase|Adverse Event|0|||
23706469|NCT01204658|66301223|FG002|Primary Phase|Adverse Event|1|||
23706470|NCT01204658|66301224|FG003|Primary Phase|Adverse Event|0|||
23706471|NCT01577160|66301225|FG000|Overall Study|Adverse Event|9|||
23706472|NCT01577160|66301225|FG000|Overall Study|Lack of Efficacy|15|||
23706473|NCT01577160|66301225|FG000|Overall Study|Lost to Follow-up|40|||
23706474|NCT01577160|66301225|FG000|Overall Study|Withdrawal by Subject|18|||
23706475|NCT01577160|66301225|FG000|Overall Study|Subject Uncooperative|7|||
23706476|NCT01577160|66301225|FG000|Overall Study|Other|9|||
23706477|NCT02635737|66301226|FG000|Overall Study|Protocol Violation|1|||
23706478|NCT03276936|66301227|FG000|Overall Study|Adverse Event|4|||
23706479|NCT03276936|66301228|FG001|Overall Study|Adverse Event|2|||
23706480|NCT03276936|66301227|FG000|Overall Study|Lost to Follow-up|16|||
23706481|NCT03276936|66301228|FG001|Overall Study|Lost to Follow-up|13|||
23706482|NCT03276936|66301227|FG000|Overall Study|Withdrawal by Subject|30|||
23706483|NCT03276936|66301228|FG001|Overall Study|Withdrawal by Subject|20|||
23706484|NCT03276936|66301227|FG000|Overall Study|Not mentioned|6|||
23706485|NCT03276936|66301228|FG001|Overall Study|Not mentioned|3|||
23706486|NCT02493426|66301229|FG000|Overall Study|Withdrawal by Subject|0|||
23706487|NCT02493426|66301230|FG001|Overall Study|Withdrawal by Subject|1|||
23706488|NCT01104584|66301231|FG000|Overall Study|Study drug never administered|21|||
23706489|NCT01104584|66301231|FG000|Overall Study|Study prematurely discontinued|2|||
23706490|NCT01810042|66301232|FG000|Overall Study|Lost to Follow-up|10|||
23706491|NCT03554005|66301233|FG000|Overall Study|Not in participant's best interest|0|||
23706492|NCT03554005|66301234|FG001|Overall Study|Not in participant's best interest|0|||
23706493|NCT03554005|66301235|FG002|Overall Study|Not in participant's best interest|0|||
23706494|NCT03554005|66301236|FG003|Overall Study|Not in participant's best interest|0|||
23706495|NCT03554005|66301237|FG004|Overall Study|Not in participant's best interest|0|||
23706496|NCT03554005|66301238|FG005|Overall Study|Not in participant's best interest|1|||
23706497|NCT03554005|66301233|FG000|Overall Study|Disease Progression|1|||
23706498|NCT03554005|66301234|FG001|Overall Study|Disease Progression|1|||
23706499|NCT03554005|66301235|FG002|Overall Study|Disease Progression|1|||
23706500|NCT03554005|66301236|FG003|Overall Study|Disease Progression|1|||
23706501|NCT03554005|66301237|FG004|Overall Study|Disease Progression|5|||
23706502|NCT03554005|66301238|FG005|Overall Study|Disease Progression|6|||
23706503|NCT03554005|66301233|FG000|Overall Study|Adverse Event|0|||
23706504|NCT03554005|66301234|FG001|Overall Study|Adverse Event|0|||
23706505|NCT03554005|66301235|FG002|Overall Study|Adverse Event|0|||
23706506|NCT03554005|66301236|FG003|Overall Study|Adverse Event|0|||
23706507|NCT03554005|66301237|FG004|Overall Study|Adverse Event|0|||
23706508|NCT03554005|66301238|FG005|Overall Study|Adverse Event|3|||
23706509|NCT03554005|66301233|FG000|Overall Study|Physician Decision|0|||
23706510|NCT03554005|66301234|FG001|Overall Study|Physician Decision|0|||
23706511|NCT03554005|66301235|FG002|Overall Study|Physician Decision|0|||
23706512|NCT03554005|66301236|FG003|Overall Study|Physician Decision|0|||
23706513|NCT03554005|66301237|FG004|Overall Study|Physician Decision|1|||
23706521|NCT01469013|66301239|FG000|Part A (Treatment Period)|Adverse Event|1|||
23706522|NCT01469013|66301240|FG001|Part A (Treatment Period)|Adverse Event|0|||
23706523|NCT01469013|66301241|FG002|Part A (Treatment Period)|Adverse Event|0|||
23706524|NCT01469013|66301242|FG003|Part A (Treatment Period)|Adverse Event|0|||
23706525|NCT01469013|66301243|FG004|Part A (Treatment Period)|Adverse Event|1|||
23706526|NCT01469013|66301244|FG005|Part A (Treatment Period)|Adverse Event|0|||
23706527|NCT01469013|66301245|FG006|Part A (Treatment Period)|Adverse Event|0|||
23706528|NCT01469013|66301246|FG007|Part A (Treatment Period)|Adverse Event|0|||
23706529|NCT01469013|66301247|FG008|Part A (Treatment Period)|Adverse Event|0|||
23706530|NCT01469013|66301248|FG009|Part A (Treatment Period)|Adverse Event|0|||
23706531|NCT01469013|66301249|FG010|Part A (Treatment Period)|Adverse Event|0|||
23706532|NCT01469013|66301250|FG011|Part A (Treatment Period)|Adverse Event|0|||
23706533|NCT01469013|66301251|FG012|Part A (Treatment Period)|Adverse Event|0|||
23706534|NCT01469013|66301239|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706535|NCT01469013|66301240|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706536|NCT01469013|66301241|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
23706537|NCT01469013|66301242|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706538|NCT01469013|66301243|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706539|NCT01469013|66301244|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706540|NCT01469013|66301245|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706541|NCT01469013|66301246|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706542|NCT01469013|66301247|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706543|NCT01469013|66301248|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706544|NCT01469013|66301249|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706545|NCT01469013|66301250|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706546|NCT01469013|66301251|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
23706547|NCT01469013|66301239|FG000|Part B (Extension Period)|Adverse Event|0|||
23706548|NCT01469013|66301240|FG001|Part B (Extension Period)|Adverse Event|0|||
23706549|NCT01469013|66301241|FG002|Part B (Extension Period)|Adverse Event|0|||
23706550|NCT01469013|66301242|FG003|Part B (Extension Period)|Adverse Event|0|||
23706551|NCT01469013|66301243|FG004|Part B (Extension Period)|Adverse Event|0|||
23706552|NCT01469013|66301244|FG005|Part B (Extension Period)|Adverse Event|2|||
23706553|NCT01469013|66301245|FG006|Part B (Extension Period)|Adverse Event|5|||
23706554|NCT01469013|66301246|FG007|Part B (Extension Period)|Adverse Event|5|||
23706555|NCT01469013|66301247|FG008|Part B (Extension Period)|Adverse Event|3|||
23706556|NCT01469013|66301248|FG009|Part B (Extension Period)|Adverse Event|3|||
23706557|NCT01469013|66301249|FG010|Part B (Extension Period)|Adverse Event|1|||
23706558|NCT01469013|66301250|FG011|Part B (Extension Period)|Adverse Event|6|||
23706559|NCT01469013|66301251|FG012|Part B (Extension Period)|Adverse Event|3|||
23706560|NCT01469013|66301239|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
23706561|NCT01469013|66301240|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
23706562|NCT01469013|66301241|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
23706563|NCT01469013|66301242|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
23706564|NCT01469013|66301243|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
23706565|NCT01469013|66301244|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
23706566|NCT01469013|66301245|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
23706567|NCT01469013|66301246|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
23706568|NCT01469013|66301247|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
23706569|NCT01469013|66301248|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
23706570|NCT01469013|66301249|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
23706571|NCT01469013|66301250|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
23706572|NCT01469013|66301251|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
23706573|NCT00089843|66301255|FG000|Overall Study|Withdrawal by Subject|1|||
23706574|NCT00089843|66301256|FG001|Overall Study|Withdrawal by Subject|4|||
23706575|NCT00089843|66301257|FG002|Overall Study|Withdrawal by Subject|5|||
23706576|NCT00089843|66301258|FG003|Overall Study|Withdrawal by Subject|6|||
23706577|NCT00089843|66301255|FG000|Overall Study|Physician Decision|1|||
23706578|NCT00089843|66301256|FG001|Overall Study|Physician Decision|0|||
23706579|NCT00089843|66301257|FG002|Overall Study|Physician Decision|0|||
23706580|NCT00089843|66301258|FG003|Overall Study|Physician Decision|1|||
23706581|NCT04191577|66301259|FG000|Overall Study|Withdrawal by Subject|2|||
23706582|NCT04191577|66301260|FG001|Overall Study|Withdrawal by Subject|2|||
23706583|NCT04191577|66301261|FG002|Overall Study|Withdrawal by Subject|1|||
23706584|NCT04191577|66301259|FG000|Overall Study|Physician Decision|1|||
23706585|NCT04191577|66301260|FG001|Overall Study|Physician Decision|1|||
23706586|NCT04191577|66301261|FG002|Overall Study|Physician Decision|0|||
23706587|NCT04191577|66301259|FG000|Overall Study|Adverse Event|0|||
23706588|NCT04191577|66301260|FG001|Overall Study|Adverse Event|0|||
23706589|NCT04191577|66301261|FG002|Overall Study|Adverse Event|1|||
23706590|NCT04191577|66301259|FG000|Overall Study|Death|0|||
23706591|NCT04191577|66301260|FG001|Overall Study|Death|0|||
23706592|NCT04191577|66301261|FG002|Overall Study|Death|1|||
23706593|NCT00610935|66301262|FG000|Overall Study|Lost to Follow-up|0|||
23706594|NCT00610935|66301263|FG001|Overall Study|Lost to Follow-up|1|||
23706595|NCT00610935|66301262|FG000|Overall Study|Withdrawal by Subject|0|||
23706596|NCT00610935|66301263|FG001|Overall Study|Withdrawal by Subject|2|||
23706597|NCT00610935|66301262|FG000|Overall Study|Sponsor Discontinuation|1|||
23706598|NCT00610935|66301263|FG001|Overall Study|Sponsor Discontinuation|0|||
23706599|NCT01153763|66301264|FG000|Overall Study|Study Closed|16|||
23706600|NCT01153763|66301264|FG000|Overall Study|Lost to Follow-up|1|||
23706601|NCT01153763|66301264|FG000|Overall Study|Physician Decision|2|||
23706602|NCT01153763|66301264|FG000|Overall Study|Withdrawal by Subject|2|||
23706603|NCT01599754|66301268|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
23706604|NCT01599754|66301269|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
23706605|NCT01599754|66301268|FG000|Overall Study|Participant noncompliance|4|||
23706606|NCT01599754|66301269|FG001|Overall Study|Participant noncompliance|4|||
23706607|NCT01599754|66301268|FG000|Overall Study|Lost to Follow-up|13|||
23706608|NCT01599754|66301269|FG001|Overall Study|Lost to Follow-up|6|||
23706609|NCT01599754|66301268|FG000|Overall Study|Death|31|||
23706610|NCT01599754|66301269|FG001|Overall Study|Death|33|||
23706611|NCT01599754|66301268|FG000|Overall Study|Adverse Event|3|||
23706612|NCT01599754|66301269|FG001|Overall Study|Adverse Event|2|||
23706613|NCT01599754|66301268|FG000|Overall Study|Investigator decision|1|||
23706614|NCT01599754|66301269|FG001|Overall Study|Investigator decision|3|||
23706615|NCT01599754|66301268|FG000|Overall Study|Withdrawal by Subject|24|||
23706616|NCT01599754|66301269|FG001|Overall Study|Withdrawal by Subject|25|||
23706617|NCT01599754|66301268|FG000|Overall Study|Study terminated by sponsor|282|||
23706618|NCT01599754|66301269|FG001|Overall Study|Study terminated by sponsor|285|||
23706619|NCT03132805|66301271|FG000|Overall Study|Lost to Follow-up|142|||
23706620|NCT03132805|66301272|FG001|Overall Study|Lost to Follow-up|141|||
23706621|NCT03132805|66301273|FG002|Overall Study|Lost to Follow-up|113|||
23706622|NCT01477892|66301274|FG000|Overall Study|Withdrawal by Subject|0|||
23706623|NCT01477892|66301275|FG001|Overall Study|Withdrawal by Subject|2|||
23706624|NCT00926796|66301276|FG000|Overall Study|Did not receive randomized treatment|4|||
23706625|NCT00926796|66301277|FG001|Overall Study|Did not receive randomized treatment|7|||
23706626|NCT00926796|66301276|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
23706627|NCT00926796|66301277|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
23706628|NCT00926796|66301276|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
23706629|NCT00926796|66301277|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
23706630|NCT00926796|66301276|FG000|Overall Study|Adverse Event|7|||
23706631|NCT00926796|66301277|FG001|Overall Study|Adverse Event|14|||
23706632|NCT00926796|66301276|FG000|Overall Study|Lost to Follow-up|22|||
23706633|NCT00926796|66301277|FG001|Overall Study|Lost to Follow-up|13|||
23706634|NCT00926796|66301276|FG000|Overall Study|Protocol Violation|15|||
23706635|NCT00926796|66301277|FG001|Overall Study|Protocol Violation|11|||
23706636|NCT00926796|66301276|FG000|Overall Study|Withdrawal by Subject|1|||
23706637|NCT00926796|66301277|FG001|Overall Study|Withdrawal by Subject|0|||
23706638|NCT01028651|66301282|FG000|Overall Study|Death|2|||
23706639|NCT01028651|66301282|FG000|Overall Study|Adverse Event|1|||
23706640|NCT00138151|66301284|FG000|Overall Study|Withdrawal by Subject|3|||
23706641|NCT00138151|66301284|FG000|Overall Study|Physician Decision|1|||
23706642|NCT01252134|66301285|FG000|Period 1, 8 Hours|Personal Reasons|0|||
23706643|NCT01252134|66301286|FG001|Period 1, 8 Hours|Personal Reasons|1|||
23706644|NCT01252134|66301287|FG002|Period 1, 8 Hours|Personal Reasons|1|||
23706645|NCT01252134|66301288|FG003|Period 1, 8 Hours|Personal Reasons|0|||
23706646|NCT01252134|66301289|FG004|Period 1, 8 Hours|Personal Reasons|0|||
23706647|NCT01252134|66301290|FG005|Period 1, 8 Hours|Personal Reasons|0|||
23706648|NCT00411788|66301291|FG000|Overall Study|Protocol Violation|1|||
23706649|NCT00411788|66301291|FG000|Overall Study|Adverse Event|1|||
23706650|NCT02108951|66301292|FG000|Overall Study|Lost to Follow-up|1|||
23706651|NCT02108951|66301292|FG000|Overall Study|Patient's/guardian's decision|1|||
23706652|NCT02108951|66301292|FG000|Overall Study|Study Terminated by Sponsor|14|||
23706653|NCT00603980|66301294|FG000|Study Qualification|Protocol Violation|3|||
23706654|NCT00603980|66301294|FG000|Study Qualification|Inconsistent data reporting|13|||
23706655|NCT00603980|66301294|FG000|Main Study|14th subject completed trial|1|||
23706656|NCT03116399|66301295|FG000|Overall Study|Death|8|||
23706657|NCT03116399|66301296|FG001|Overall Study|Death|3|||
23706658|NCT03116399|66301295|FG000|Overall Study|Lost to Follow-up|7|||
23706659|NCT03116399|66301296|FG001|Overall Study|Lost to Follow-up|11|||
23706660|NCT03116399|66301295|FG000|Overall Study|Investigator Decision|1|||
23706661|NCT03116399|66301296|FG001|Overall Study|Investigator Decision|1|||
23706662|NCT03116399|66301295|FG000|Overall Study|Withdrawal by Subject|24|||
23706663|NCT03116399|66301296|FG001|Overall Study|Withdrawal by Subject|9|||
23706664|NCT00305006|66301307|FG000|Overall Study|Withdrawal by Subject|1|||
23706665|NCT00305006|66301308|FG001|Overall Study|Withdrawal by Subject|0|||
23706666|NCT00305006|66301307|FG000|Overall Study|Failure to complete pretest|0|||
23706667|NCT00305006|66301308|FG001|Overall Study|Failure to complete pretest|1|||
23706668|NCT03100942|66301309|FG000|Randomized Treatment Period|Withdrew Consent|4|||
23706669|NCT03100942|66301310|FG001|Randomized Treatment Period|Withdrew Consent|5|||
23706670|NCT03100942|66301311|FG002|Randomized Treatment Period|Withdrew Consent|3|||
23706671|NCT03100942|66301312|FG003|Randomized Treatment Period|Withdrew Consent|3|||
23706672|NCT03100942|66301313|FG004|Randomized Treatment Period|Withdrew Consent|0|||
23706673|NCT03100942|66301314|FG005|Randomized Treatment Period|Withdrew Consent|0|||
23706674|NCT03100942|66301315|FG006|Randomized Treatment Period|Withdrew Consent|0|||
23706675|NCT03100942|66301309|FG000|Randomized Treatment Period|Adverse Event|5|||
23706676|NCT03100942|66301310|FG001|Randomized Treatment Period|Adverse Event|2|||
23706677|NCT03100942|66301311|FG002|Randomized Treatment Period|Adverse Event|1|||
23706678|NCT03100942|66301312|FG003|Randomized Treatment Period|Adverse Event|0|||
23706679|NCT03100942|66301313|FG004|Randomized Treatment Period|Adverse Event|0|||
23706680|NCT03100942|66301314|FG005|Randomized Treatment Period|Adverse Event|0|||
23706681|NCT03100942|66301315|FG006|Randomized Treatment Period|Adverse Event|0|||
23706682|NCT03100942|66301309|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
23706683|NCT03100942|66301310|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
23706684|NCT03100942|66301311|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
23706685|NCT03100942|66301312|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
23706686|NCT03100942|66301313|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
23706687|NCT03100942|66301314|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
23706688|NCT03100942|66301315|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
23706689|NCT03100942|66301309|FG000|Randomized Treatment Period|Protocol Violation|0|||
23706690|NCT03100942|66301310|FG001|Randomized Treatment Period|Protocol Violation|1|||
23706691|NCT03100942|66301311|FG002|Randomized Treatment Period|Protocol Violation|1|||
23706692|NCT03100942|66301312|FG003|Randomized Treatment Period|Protocol Violation|1|||
23706693|NCT03100942|66301313|FG004|Randomized Treatment Period|Protocol Violation|0|||
23706694|NCT03100942|66301314|FG005|Randomized Treatment Period|Protocol Violation|0|||
23706695|NCT03100942|66301315|FG006|Randomized Treatment Period|Protocol Violation|0|||
23706696|NCT03100942|66301309|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
23706697|NCT03100942|66301310|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
23706698|NCT03100942|66301311|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
23706699|NCT03100942|66301312|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
23706700|NCT03100942|66301313|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
23706701|NCT03100942|66301314|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
23706702|NCT03100942|66301315|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
23706703|NCT03100942|66301309|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
23706704|NCT03100942|66301310|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23706705|NCT03100942|66301311|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23706706|NCT03100942|66301312|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
23706707|NCT03100942|66301313|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23706708|NCT03100942|66301314|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23706709|NCT03100942|66301315|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23706710|NCT03100942|66301309|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706711|NCT03100942|66301310|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706712|NCT03100942|66301311|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706713|NCT03100942|66301312|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706714|NCT03100942|66301313|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706715|NCT03100942|66301314|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23706716|NCT03100942|66301315|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
23706717|NCT00527111|66301316|FG000|Overall Study|Adverse Event|14|||
23706718|NCT00527111|66301317|FG001|Overall Study|Adverse Event|13|||
23706719|NCT00527111|66301316|FG000|Overall Study|Death|0|||
23706720|NCT00527111|66301317|FG001|Overall Study|Death|1|||
23706721|NCT00527111|66301316|FG000|Overall Study|Investigator Request|2|||
23706722|NCT00527111|66301317|FG001|Overall Study|Investigator Request|1|||
23706723|NCT00527111|66301316|FG000|Overall Study|Patient Request|2|||
23706724|NCT00527111|66301317|FG001|Overall Study|Patient Request|5|||
23706725|NCT00527111|66301316|FG000|Overall Study|Other|2|||
23706726|NCT00527111|66301317|FG001|Overall Study|Other|2|||
23706727|NCT00786838|66301318|FG000|Overall Study|Physician Decision|4|||
23706728|NCT00786838|66301318|FG000|Overall Study|Death|4|||
23706729|NCT00786838|66301318|FG000|Overall Study|Adverse Event|6|||
23706730|NCT00786838|66301318|FG000|Overall Study|Progressive disease|31|||
23706731|NCT00786838|66301318|FG000|Overall Study|Withdrawal by Subject|4|||
23706732|NCT02020031|66301319|FG000|Overall Study|Physician Decision|1|||
23706733|NCT02020031|66301320|FG001|Overall Study|Physician Decision|1|||
23706734|NCT00968253|66301321|FG000|Overall Study|Death|0|||
23706735|NCT00968253|66301322|FG001|Overall Study|Death|0|||
23706736|NCT00968253|66301323|FG002|Overall Study|Death|2|||
23706737|NCT00968253|66301321|FG000|Overall Study|Withdrawal by Subject|0|||
23706738|NCT00968253|66301322|FG001|Overall Study|Withdrawal by Subject|0|||
23706739|NCT00968253|66301323|FG002|Overall Study|Withdrawal by Subject|1|||
23706740|NCT00968253|66301321|FG000|Overall Study|Disease Progression|0|||
23706741|NCT00968253|66301322|FG001|Overall Study|Disease Progression|3|||
23706742|NCT00968253|66301323|FG002|Overall Study|Disease Progression|3|||
23706743|NCT00968253|66301321|FG000|Overall Study|Adverse Event|0|||
23706746|NCT01737840|66301328|FG000|Overall Study|Diagnosed with an other pathology|2|||
23706747|NCT01737840|66301329|FG001|Overall Study|Diagnosed with an other pathology|2|||
23706748|NCT02149836|66301331|FG000|Overall Study|Withdrawal by Subject|1|||
23706749|NCT01745393|66301332|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
23706750|NCT01745393|66301333|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
23706751|NCT01745393|66301332|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
23706752|NCT01745393|66301333|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
23706753|NCT01745393|66301332|FG000|12-month Follow-up|Lost to Follow-up|6|||
23706754|NCT01745393|66301333|FG001|12-month Follow-up|Lost to Follow-up|5|||
23706755|NCT01276457|66301334|FG000|Core Study|Adverse Event|6|||
23706756|NCT01276457|66301335|FG001|Core Study|Adverse Event|3|||
23706757|NCT01276457|66301334|FG000|Core Study|Lost to Follow-up|1|||
23706758|NCT01276457|66301335|FG001|Core Study|Lost to Follow-up|2|||
23706759|NCT01276457|66301334|FG000|Core Study|Administrative problems|1|||
23706760|NCT01276457|66301335|FG001|Core Study|Administrative problems|1|||
23706761|NCT01276457|66301334|FG000|Core Study|Death|2|||
23706762|NCT01276457|66301335|FG001|Core Study|Death|2|||
23706763|NCT01276457|66301334|FG000|Core Study|Lack of Efficacy|3|||
23706764|NCT01276457|66301335|FG001|Core Study|Lack of Efficacy|12|||
23706765|NCT01276457|66301334|FG000|Extension Study|Lost to Follow-up|3|||
23706766|NCT01276457|66301335|FG001|Extension Study|Lost to Follow-up|0|||
23706767|NCT01276457|66301334|FG000|Extension Study|Death|0|||
23706768|NCT01276457|66301335|FG001|Extension Study|Death|1|||
23706769|NCT01276457|66301334|FG000|Extension Study|Lack of Efficacy|3|||
23706770|NCT01276457|66301335|FG001|Extension Study|Lack of Efficacy|1|||
23706771|NCT00408421|66301336|FG000|Treatment Initial Randomization|Adverse Event|5|||
23706772|NCT00408421|66301337|FG001|Treatment Initial Randomization|Adverse Event|9|||
23706773|NCT00408421|66301338|FG002|Treatment Initial Randomization|Adverse Event|0|||
23706774|NCT00408421|66301336|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
23706775|NCT00408421|66301337|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
23706776|NCT00408421|66301338|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
23706777|NCT00408421|66301336|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
23706778|NCT00408421|66301337|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
23706779|NCT00408421|66301338|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
23706780|NCT00408421|66301336|FG000|Treatment Initial Randomization|Physician Decision|1|||
23706781|NCT00408421|66301337|FG001|Treatment Initial Randomization|Physician Decision|0|||
23706782|NCT00408421|66301338|FG002|Treatment Initial Randomization|Physician Decision|0|||
23706783|NCT00408421|66301336|FG000|Treatment Initial Randomization|Protocol Violation|0|||
23706784|NCT00408421|66301337|FG001|Treatment Initial Randomization|Protocol Violation|1|||
23706785|NCT00408421|66301338|FG002|Treatment Initial Randomization|Protocol Violation|0|||
23706786|NCT00408421|66301336|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
23706787|NCT00408421|66301337|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
23706788|NCT00408421|66301338|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
23706789|NCT00408421|66301336|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
23706790|NCT00408421|66301337|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
23706791|NCT00408421|66301338|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
23706792|NCT00408421|66301336|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
23706793|NCT00408421|66301337|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
23706794|NCT00408421|66301338|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
23706795|NCT00408421|66301336|FG000|Treatment Re-Randomization|Adverse Event|2|||
23706796|NCT00408421|66301337|FG001|Treatment Re-Randomization|Adverse Event|2|||
23706797|NCT00408421|66301338|FG002|Treatment Re-Randomization|Adverse Event|4|||
23706798|NCT00408421|66301336|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
23706799|NCT00408421|66301337|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
23706800|NCT00408421|66301338|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
23706801|NCT00408421|66301336|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
23706802|NCT00408421|66301337|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
23706803|NCT00408421|66301338|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
23706804|NCT00408421|66301336|FG000|Treatment Re-Randomization|Physician Decision|1|||
23706805|NCT00408421|66301337|FG001|Treatment Re-Randomization|Physician Decision|3|||
23706806|NCT00408421|66301338|FG002|Treatment Re-Randomization|Physician Decision|0|||
23706807|NCT00408421|66301336|FG000|Treatment Re-Randomization|Protocol Violation|1|||
23706808|NCT00408421|66301337|FG001|Treatment Re-Randomization|Protocol Violation|1|||
23706809|NCT00408421|66301338|FG002|Treatment Re-Randomization|Protocol Violation|0|||
23706810|NCT00408421|66301336|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
23706811|NCT00408421|66301337|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
23706812|NCT00408421|66301338|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
23706813|NCT00002663|66301339|FG000|Overall Study|Death|4|||
23706814|NCT00002663|66301340|FG001|Overall Study|Death|1|||
23706815|NCT00002663|66301341|FG002|Overall Study|Death|1|||
23706816|NCT00002663|66301342|FG003|Overall Study|Death|0|||
23706817|NCT00002663|66301343|FG004|Overall Study|Death|0|||
23706818|NCT00002663|66301344|FG005|Overall Study|Death|13|||
